PDB ID;Chain ID;Structure Title;Resolution;Ligand ID;Ligand Name;Macromolecule Name;Taxonomy ID;Ka (1/M)
158D;A;CRYSTALLOGRAPHIC ANALYSIS OF C-C-A-A-G-C-T-T-G-G AND ITS IMPLICATIONS FOR BENDING IN B-DNA;1.9;CA;CALCIUM ION;DNA (5'-D(*CP*CP*AP*AP*GP*CP*TP*TP*GP*G)-3');;
158D;B;CRYSTALLOGRAPHIC ANALYSIS OF C-C-A-A-G-C-T-T-G-G AND ITS IMPLICATIONS FOR BENDING IN B-DNA;1.9;CA;CALCIUM ION;DNA (5'-D(*CP*CP*AP*AP*GP*CP*TP*TP*GP*G)-3');;
196D;A;CRYSTAL STRUCTURE OF C-T-C-T-C-G-A-G-A-G: IMPLICATIONS FOR THE STRUCTURE OF THE HOLLIDAY JUNCTION;1.7;CA;CALCIUM ION;DNA (5'-D(*CP*TP*CP*TP*CP*GP*AP*GP*AP*G)-3');;
196D;B;CRYSTAL STRUCTURE OF C-T-C-T-C-G-A-G-A-G: IMPLICATIONS FOR THE STRUCTURE OF THE HOLLIDAY JUNCTION;1.7;CA;CALCIUM ION;DNA (5'-D(*CP*TP*CP*TP*CP*GP*AP*GP*AP*G)-3');;
1A0J;A;CRYSTAL STRUCTURE OF A NON-PSYCHROPHILIC TRYPSIN FROM A COLD-ADAPTED FISH SPECIES.;1.7;CA;CALCIUM ION;TRYPSIN;8030;
1A0S;P;SUCROSE-SPECIFIC PORIN;2.4;CA;CALCIUM ION;SUCROSE-SPECIFIC PORIN;90371;
1A0S;Q;SUCROSE-SPECIFIC PORIN;2.4;CA;CALCIUM ION;SUCROSE-SPECIFIC PORIN;90371;
1A0S;R;SUCROSE-SPECIFIC PORIN;2.4;CA;CALCIUM ION;SUCROSE-SPECIFIC PORIN;90371;
1A0T;P;SUCROSE-SPECIFIC PORIN, WITH BOUND SUCROSE MOLECULES;2.4;CA;CALCIUM ION;SUCROSE-SPECIFIC PORIN;90371;
1A0T;Q;SUCROSE-SPECIFIC PORIN, WITH BOUND SUCROSE MOLECULES;2.4;CA;CALCIUM ION;SUCROSE-SPECIFIC PORIN;90371;
1A0T;R;SUCROSE-SPECIFIC PORIN, WITH BOUND SUCROSE MOLECULES;2.4;CA;CALCIUM ION;SUCROSE-SPECIFIC PORIN;90371;
1A14;N;COMPLEX BETWEEN NC10 ANTI-INFLUENZA VIRUS NEURAMINIDASE SINGLE CHAIN ANTIBODY WITH A 5 RESIDUE LINKER AND INFLUENZA VIRUS NEURAMINIDASE;2.5;CA;CALCIUM ION;NEURAMINIDASE;11320;
1A25;A;C2 DOMAIN FROM PROTEIN KINASE C (BETA);2.7;CA;CALCIUM ION;PROTEIN KINASE C (BETA);10116;
1A25;B;C2 DOMAIN FROM PROTEIN KINASE C (BETA);2.7;CA;CALCIUM ION;PROTEIN KINASE C (BETA);10116;
1A29;A;CALMODULIN COMPLEXED WITH TRIFLUOPERAZINE (1:2 COMPLEX);2.74;CA;CALCIUM ION;CALMODULIN;9913;
1A2Q;A;SUBTILISIN BPN' MUTANT 7186;1.8;CA;CALCIUM ION;SUBTILISIN BPN';1390;
1A2T;A;STAPHYLOCOCCAL NUCLEASE, B-MERCAPTOETHANOL DISULFIDE TO V23C VARIANT;1.96;CA;CALCIUM ION;STAPHYLOCOCCAL NUCLEASE;1280;
1A2U;A;STAPHYLOCOCCAL NUCLEASE, V23C VARIANT, COMPLEX WITH 1-N-BUTANE THIOL AND 3',5'-THYMIDINE DIPHOSPHATE;2;CA;CALCIUM ION;STAPHYLOCOCCAL NUCLEASE;1280;
1A2X;A;COMPLEX OF TROPONIN C WITH A 47 RESIDUE (1-47) FRAGMENT OF TROPONIN I;2.3;CA;CALCIUM ION;TROPONIN C;9986;
1A3T;A;STAPHYLOCOCCAL NUCLEASE, V23C VARIANT, COMPLEX WITH 2-FLUOROETHANE THIOL AND 3',5'-THYMIDINE DIPHOSPHATE;2.1;CA;CALCIUM ION;STAPHYLOCOCCAL NUCLEASE;1280;
1A3U;A;STAPHYLOCOCCAL NUCLEASE, CYCLOHEXANE THIOL DISULFIDE TO V23C VARIANT;2.05;CA;CALCIUM ION;STAPHYLOCOCCAL NUCLEASE;1280;
1A3V;A;STAPHYLOCOCCAL NUCLEASE, CYCLOPENTANE THIOL DISULFIDE TO V23C VARIANT;2.2;CA;CALCIUM ION;STAPHYLOCOCCAL NUCLEASE;1280;
1A47;A;CGTASE FROM THERMOANAEROBACTERIUM THERMOSULFURIGENES EM1 IN COMPLEX WITH A MALTOHEXAOSE INHIBITOR;2.56;CA;CALCIUM ION;CYCLODEXTRIN GLYCOSYLTRANSFERASE;33950;
1A4G;A;INFLUENZA VIRUS B/BEIJING/1/87 NEURAMINIDASE COMPLEXED WITH ZANAMIVIR;2.2;CA;CALCIUM ION;NEURAMINIDASE;11520;
1A4G;B;INFLUENZA VIRUS B/BEIJING/1/87 NEURAMINIDASE COMPLEXED WITH ZANAMIVIR;2.2;CA;CALCIUM ION;NEURAMINIDASE;11520;
1A4Q;A;INFLUENZA VIRUS B/BEIJING/1/87 NEURAMINIDASE COMPLEXED WITH DIHYDROPYRAN-PHENETHYL-PROPYL-CARBOXAMIDE;1.9;CA;CALCIUM ION;NEURAMINIDASE;11520;
1A4Q;B;INFLUENZA VIRUS B/BEIJING/1/87 NEURAMINIDASE COMPLEXED WITH DIHYDROPYRAN-PHENETHYL-PROPYL-CARBOXAMIDE;1.9;CA;CALCIUM ION;NEURAMINIDASE;11520;
1A4V;A;ALPHA-LACTALBUMIN;1.8;CA;CALCIUM ION;ALPHA-LACTALBUMIN;9606;
1A75;A;WHITING PARVALBUMIN;1.9;CA;CALCIUM ION;PARVALBUMIN;8058;
1A75;B;WHITING PARVALBUMIN;1.9;CA;CALCIUM ION;PARVALBUMIN;8058;
1A85;A;MMP8 WITH MALONIC AND ASPARAGINE BASED INHIBITOR;2;CA;CALCIUM ION;MMP-8;9606;
1A86;A;MMP8 WITH MALONIC AND ASPARTIC ACID BASED INHIBITOR;2;CA;CALCIUM ION;MMP-8;9606;
1A8A;A;RAT ANNEXIN V COMPLEXED WITH GLYCEROPHOSPHOSERINE;1.9;CA;CALCIUM ION;ANNEXIN V;10116;
1A8B;A;RAT ANNEXIN V COMPLEXED WITH GLYCEROPHOSPHOETHANOLAMINE;1.9;CA;CALCIUM ION;ANNEXIN V;10116;
1ACC;A;ANTHRAX PROTECTIVE ANTIGEN;2.1;CA;CALCIUM ION;ANTHRAX PROTECTIVE ANTIGEN;1392;
1AD5;A;SRC FAMILY KINASE HCK-AMP-PNP COMPLEX;2.6;CA;CALCIUM ION;HAEMATOPOETIC CELL KINASE HCK;9606;
1AD5;B;SRC FAMILY KINASE HCK-AMP-PNP COMPLEX;2.6;CA;CALCIUM ION;HAEMATOPOETIC CELL KINASE HCK;9606;
1AEI;A;CRYSTAL STRUCTURE OF THE ANNEXIN XII HEXAMER;2.8;CA;CALCIUM ION;ANNEXIN XII;6087;
1AEI;B;CRYSTAL STRUCTURE OF THE ANNEXIN XII HEXAMER;2.8;CA;CALCIUM ION;ANNEXIN XII;6087;
1AEI;C;CRYSTAL STRUCTURE OF THE ANNEXIN XII HEXAMER;2.8;CA;CALCIUM ION;ANNEXIN XII;6087;
1AEI;D;CRYSTAL STRUCTURE OF THE ANNEXIN XII HEXAMER;2.8;CA;CALCIUM ION;ANNEXIN XII;6087;
1AEI;E;CRYSTAL STRUCTURE OF THE ANNEXIN XII HEXAMER;2.8;CA;CALCIUM ION;ANNEXIN XII;6087;
1AEI;F;CRYSTAL STRUCTURE OF THE ANNEXIN XII HEXAMER;2.8;CA;CALCIUM ION;ANNEXIN XII;6087;
1AEX;A;STAPHYLOCOCCAL NUCLEASE, METHANE THIOL DISULFIDE TO V23C VARIANT;2.1;CA;CALCIUM ION;STAPHYLOCOCCAL NUCLEASE;1280;
1AF0;A;SERRATIA PROTEASE IN COMPLEX WITH INHIBITOR;1.8;CA;CALCIUM ION;SERRATIA PROTEASE;615;
1AF4;A;CRYSTAL STRUCTURE OF SUBTILISIN CARLSBERG IN ANHYDROUS DIOXANE;2.6;CA;CALCIUM ION;SUBTILISIN CARLSBERG;1402;
1AFA;1;STRUCTURAL BASIS OF GALACTOSE RECOGNITION IN C-TYPE ANIMAL LECTINS;2;CA;CALCIUM ION;MANNOSE-BINDING PROTEIN-A;10116;
1AFA;2;STRUCTURAL BASIS OF GALACTOSE RECOGNITION IN C-TYPE ANIMAL LECTINS;2;CA;CALCIUM ION;MANNOSE-BINDING PROTEIN-A;10116;
1AFA;3;STRUCTURAL BASIS OF GALACTOSE RECOGNITION IN C-TYPE ANIMAL LECTINS;2;CA;CALCIUM ION;MANNOSE-BINDING PROTEIN-A;10116;
1AFB;1;STRUCTURAL BASIS OF GALACTOSE RECOGNITION IN C-TYPE ANIMAL LECTINS;1.9;CA;CALCIUM ION;MANNOSE-BINDING PROTEIN-A;10116;
1AFB;2;STRUCTURAL BASIS OF GALACTOSE RECOGNITION IN C-TYPE ANIMAL LECTINS;1.9;CA;CALCIUM ION;MANNOSE-BINDING PROTEIN-A;10116;
1AFB;3;STRUCTURAL BASIS OF GALACTOSE RECOGNITION IN C-TYPE ANIMAL LECTINS;1.9;CA;CALCIUM ION;MANNOSE-BINDING PROTEIN-A;10116;
1AFD;1;STRUCTURAL BASIS OF GALACTOSE RECOGNITION IN C-TYPE ANIMAL LECTINS;2;CA;CALCIUM ION;MANNOSE-BINDING PROTEIN-A;10116;
1AFD;2;STRUCTURAL BASIS OF GALACTOSE RECOGNITION IN C-TYPE ANIMAL LECTINS;2;CA;CALCIUM ION;MANNOSE-BINDING PROTEIN-A;10116;
1AFD;3;STRUCTURAL BASIS OF GALACTOSE RECOGNITION IN C-TYPE ANIMAL LECTINS;2;CA;CALCIUM ION;MANNOSE-BINDING PROTEIN-A;10116;
1AG9;A;FLAVODOXINS THAT ARE REQUIRED FOR ENZYME ACTIVATION: THE STRUCTURE OF OXIDIZED FLAVODOXIN FROM ESCHERICHIA COLI AT 1.8 ANGSTROMS RESOLUTION.;1.8;CA;CALCIUM ION;FLAVODOXIN;562;
1AG9;B;FLAVODOXINS THAT ARE REQUIRED FOR ENZYME ACTIVATION: THE STRUCTURE OF OXIDIZED FLAVODOXIN FROM ESCHERICHIA COLI AT 1.8 ANGSTROMS RESOLUTION.;1.8;CA;CALCIUM ION;FLAVODOXIN;562;
1AHN;A;E. COLI FLAVODOXIN AT 2.6 ANGSTROMS RESOLUTION;2.6;CA;CALCIUM ION;FLAVODOXIN;562;
1AHR;A;CALMODULIN MUTANT WITH A TWO RESIDUE DELETION IN THE CENTRAL HELIX;1.8;CA;CALCIUM ION;CALMODULIN;9031;
1AI4;B;PENICILLIN ACYLASE COMPLEXED WITH 3,4-DIHYDROXYPHENYLACETIC ACID;2.35;CA;CALCIUM ION;PENICILLIN AMIDOHYDROLASE;562;
1AI5;B;PENICILLIN ACYLASE COMPLEXED WITH M-NITROPHENYLACETIC ACID;2.36;CA;CALCIUM ION;PENICILLIN AMIDOHYDROLASE;562;
1AI6;B;PENICILLIN ACYLASE WITH P-HYDROXYPHENYLACETIC ACID;2.55;CA;CALCIUM ION;PENICILLIN AMIDOHYDROLASE;562;
1AI7;B;PENICILLIN ACYLASE COMPLEXED WITH PHENOL;2.5;CA;CALCIUM ION;PENICILLIN AMIDOHYDROLASE;562;
1AII;A;ANNEXIN III;1.95;CA;CALCIUM ION;ANNEXIN III;9606;
1AIN;A;CRYSTAL STRUCTURE OF HUMAN ANNEXIN I AT 2.5 ANGSTROMS RESOLUTION;2.5;CA;CALCIUM ION;ANNEXIN I;9606;
1AJ4;A;STRUCTURE OF CALCIUM-SATURATED CARDIAC TROPONIN C, NMR, 1 STRUCTURE;;CA;CALCIUM ION;TROPONIN C;9031;
1AJJ;A;LDL RECEPTOR LIGAND-BINDING MODULE 5, CALCIUM-COORDINATING;1.7;CA;CALCIUM ION;LOW-DENSITY LIPOPROTEIN RECEPTOR;9606;
1AJK;A;CIRCULARLY PERMUTED (1-3,1-4)-BETA-D-GLUCAN 4-GLUCANOHYDROLASE CPA16M-84;1.8;CA;CALCIUM ION;CIRCULARLY PERMUTED (1-3,1-4)-BETA-D-GLUCAN 4-GLUCANOHYDROLASE;44252;
1AJK;B;CIRCULARLY PERMUTED (1-3,1-4)-BETA-D-GLUCAN 4-GLUCANOHYDROLASE CPA16M-84;1.8;CA;CALCIUM ION;CIRCULARLY PERMUTED (1-3,1-4)-BETA-D-GLUCAN 4-GLUCANOHYDROLASE;44252;
1AJN;B;PENICILLIN ACYLASE COMPLEXED WITH P-NITROPHENYLACETIC ACID;2.36;CA;CALCIUM ION;PENICILLIN AMIDOHYDROLASE;562;
1AJO;A;CIRCULARLY PERMUTED (1-3,1-4)-BETA-D-GLUCAN 4-GLUCANOHYDROLASE CPA16M-127;2.07;CA;CALCIUM ION;CIRCULARLY PERMUTED (1-3,1-4)-BETA-D-GLUCAN 4-GLUCANOHYDROLASE CPA16M-127;44252;
1AJO;B;CIRCULARLY PERMUTED (1-3,1-4)-BETA-D-GLUCAN 4-GLUCANOHYDROLASE CPA16M-127;2.07;CA;CALCIUM ION;CIRCULARLY PERMUTED (1-3,1-4)-BETA-D-GLUCAN 4-GLUCANOHYDROLASE CPA16M-127;44252;
1AJP;B;PENICILLIN ACYLASE COMPLEXED WITH 2,5-DIHYDROXYPHENYLACETIC ACID;2.31;CA;CALCIUM ION;PENICILLIN AMIDOHYDROLASE;562;
1AJQ;B;PENICILLIN ACYLASE COMPLEXED WITH THIOPHENEACETIC ACID;2.05;CA;CALCIUM ION;PENICILLIN AMIDOHYDROLASE;562;
1AK9;A;SUBTILISIN MUTANT 8321;1.8;CA;CALCIUM ION;SUBTILISIN 8321;1390;
1AKL;A;ALKALINE PROTEASE FROM PSEUDOMONAS AERUGINOSA IFO3080;2;CA;CALCIUM ION;ALKALINE PROTEASE;287;
1AKS;A;CRYSTAL STRUCTURE OF THE FIRST ACTIVE AUTOLYSATE FORM OF THE PORCINE ALPHA TRYPSIN;1.8;CA;CALCIUM ION;ALPHA TRYPSIN;9823;
1ALA;A;STRUCTURE OF CHICKEN ANNEXIN V AT 2.25-ANGSTROMS RESOLUTION;2.25;CA;CALCIUM ION;ANNEXIN V;9031;
1ALC;A;REFINED STRUCTURE OF BABOON ALPHA-LACTALBUMIN AT 1.7 ANGSTROMS RESOLUTION. COMPARISON WITH C-TYPE LYSOZYME;1.7;CA;CALCIUM ION;ALPHA-LACTALBUMIN;9556;
1ALV;A;CALCIUM BOUND DOMAIN VI OF PORCINE CALPAIN;1.9;CA;CALCIUM ION;CALPAIN;9823;
1ALV;B;CALCIUM BOUND DOMAIN VI OF PORCINE CALPAIN;1.9;CA;CALCIUM ION;CALPAIN;9823;
1ALW;A;INHIBITOR AND CALCIUM BOUND DOMAIN VI OF PORCINE CALPAIN;2.03;CA;CALCIUM ION;CALPAIN;9823;
1ALW;B;INHIBITOR AND CALCIUM BOUND DOMAIN VI OF PORCINE CALPAIN;2.03;CA;CALCIUM ION;CALPAIN;9823;
1AMH;A;UNCOMPLEXED RAT TRYPSIN MUTANT WITH ASP 189 REPLACED WITH SER (D189S);2.5;CA;CALCIUM ION;ANIONIC TRYPSIN;10117;
1AMH;B;UNCOMPLEXED RAT TRYPSIN MUTANT WITH ASP 189 REPLACED WITH SER (D189S);2.5;CA;CALCIUM ION;ANIONIC TRYPSIN;10117;
1AMY;A;CRYSTAL AND MOLECULAR STRUCTURE OF BARLEY ALPHA-AMYLASE;2.8;CA;CALCIUM ION;1,4-ALPHA-D-GLUCAN GLUCANOHYDROLASE;4513;
1AN1;E;LEECH-DERIVED TRYPTASE INHIBITOR/TRYPSIN COMPLEX;2.03;CA;CALCIUM ION;TRYPSIN;9823;
1ANB;A;ANIONIC TRYPSIN MUTANT WITH SER 214 REPLACED BY GLU;2.8;CA;CALCIUM ION;ANIONIC TRYPSIN;10117;
1ANC;A;ANIONIC TRYPSIN MUTANT WITH SER 214 REPLACED BY LYS;2.2;CA;CALCIUM ION;ANIONIC TRYPSIN;10117;
1ANN;A;ANNEXIN IV;2.3;CA;CALCIUM ION;ANNEXIN IV;9913;
1ANW;A;THE EFFECT OF METAL BINDING ON THE STRUCTURE OF ANNEXIN V AND IMPLICATIONS FOR MEMBRANE BINDING;2.4;CA;CALCIUM ION;ANNEXIN V;9606;
1ANW;B;THE EFFECT OF METAL BINDING ON THE STRUCTURE OF ANNEXIN V AND IMPLICATIONS FOR MEMBRANE BINDING;2.4;CA;CALCIUM ION;ANNEXIN V;9606;
1ANX;A;THE CRYSTAL STRUCTURE OF A NEW HIGH-CALCIUM FORM OF ANNEXIN V;1.9;CA;CALCIUM ION;ANNEXIN V;9606;
1ANX;B;THE CRYSTAL STRUCTURE OF A NEW HIGH-CALCIUM FORM OF ANNEXIN V;1.9;CA;CALCIUM ION;ANNEXIN V;9606;
1ANX;C;THE CRYSTAL STRUCTURE OF A NEW HIGH-CALCIUM FORM OF ANNEXIN V;1.9;CA;CALCIUM ION;ANNEXIN V;9606;
1AP4;A;REGULATORY DOMAIN OF HUMAN CARDIAC TROPONIN C IN THE CALCIUM-SATURATED STATE, NMR, 40 STRUCTURES;;CA;CALCIUM ION;CARDIAC N-TROPONIN C;9606;
1AQH;A;ALPHA-AMYLASE FROM ALTEROMONAS HALOPLANCTIS;2;CA;CALCIUM ION;ALPHA-AMYLASE;228;
1AQM;A;ALPHA-AMYLASE FROM ALTEROMONAS HALOPLANCTIS COMPLEXED WITH TRIS;1.85;CA;CALCIUM ION;ALPHA-AMYLASE;228;
1AQN;A;SUBTILISIN MUTANT 8324;1.8;CA;CALCIUM ION;SUBTILISIN 8324;1390;
1AR1;A;Structure at 2.7 Angstrom Resolution of the Paracoccus Denitrificans two-subunit Cytochrome C Oxidase Complexed with an Antibody Fv Fragment;2.7;CA;CALCIUM ION;CYTOCHROME C OXIDASE;266;
1ARP;A;Crystal structure of the fungal peroxidase from Arthromyces ramosus at 1.9 angstroms resolution: structural comparisons with the lignin and cytochrome C peroxidases;1.9;CA;CALCIUM ION;PEROXIDASE;5079;
1ARU;A;CRYSTAL STRUCTURES OF CYANIDE-AND TRIIODIDE-BOUND FORMS OF ARTHROMYCES RAMOSUS PEROXIDASE AT DIFFERENT PH VALUES. PERTURBATIONS OF ACTIVE SITE RESIDUES AND THEIR IMPLICATION IN ENZYME CATALYSIS;1.6;CA;CALCIUM ION;PEROXIDASE;5451;
1ARV;A;CRYSTAL STRUCTURES OF CYANIDE-AND TRIIODIDE-BOUND FORMS OF ARTHROMYCES RAMOSUS PEROXIDASE AT DIFFERENT PH VALUES. PERTURBATIONS OF ACTIVE SITE RESIDUES AND THEIR IMPLICATION IN ENZYME CATALYSIS;1.6;CA;CALCIUM ION;PEROXIDASE;5451;
1ARW;A;CRYSTAL STRUCTURES OF CYANIDE-AND TRIIODIDE-BOUND FORMS OF ARTHROMYCES RAMOSUS PEROXIDASE AT DIFFERENT PH VALUES. PERTURBATIONS OF ACTIVE SITE RESIDUES AND THEIR IMPLICATION IN ENZYME CATALYSIS;1.6;CA;CALCIUM ION;PEROXIDASE;5451;
1ARX;A;CRYSTAL STRUCTURES OF CYANIDE-AND TRIIODIDE-BOUND FORMS OF ARTHROMYCES RAMOSUS PEROXIDASE AT DIFFERENT PH VALUES. PERTURBATIONS OF ACTIVE SITE RESIDUES AND THEIR IMPLICATION IN ENZYME CATALYSIS;1.9;CA;CALCIUM ION;PEROXIDASE;5451;
1ARY;A;CRYSTAL STRUCTURES OF CYANIDE-AND TRIIODIDE-BOUND FORMS OF ARTHROMYCES RAMOSUS PEROXIDASE AT DIFFERENT PH VALUES. PERTURBATIONS OF ACTIVE SITE RESIDUES AND THEIR IMPLICATION IN ENZYME CATALYSIS;1.9;CA;CALCIUM ION;PEROXIDASE;5451;
1ATJ;A;RECOMBINANT HORSERADISH PEROXIDASE C1A;2.15;CA;CALCIUM ION;PEROXIDASE C1A;3704;
1ATJ;B;RECOMBINANT HORSERADISH PEROXIDASE C1A;2.15;CA;CALCIUM ION;PEROXIDASE C1A;3704;
1ATJ;C;RECOMBINANT HORSERADISH PEROXIDASE C1A;2.15;CA;CALCIUM ION;PEROXIDASE C1A;3704;
1ATJ;D;RECOMBINANT HORSERADISH PEROXIDASE C1A;2.15;CA;CALCIUM ION;PEROXIDASE C1A;3704;
1ATJ;E;RECOMBINANT HORSERADISH PEROXIDASE C1A;2.15;CA;CALCIUM ION;PEROXIDASE C1A;3704;
1ATJ;F;RECOMBINANT HORSERADISH PEROXIDASE C1A;2.15;CA;CALCIUM ION;PEROXIDASE C1A;3704;
1ATL;A;Structural interaction of natural and synthetic inhibitors with the VENOM METALLOPROTEINASE, ATROLYSIN C (FORM-D);1.8;CA;CALCIUM ION;ATROLYSIN C;8730;
1ATL;B;Structural interaction of natural and synthetic inhibitors with the VENOM METALLOPROTEINASE, ATROLYSIN C (FORM-D);1.8;CA;CALCIUM ION;ATROLYSIN C;8730;
1ATN;A;Atomic structure of the actin:DNASE I complex;2.8;CA;CALCIUM ION;ACTIN;9986;
1ATN;D;Atomic structure of the actin:DNASE I complex;2.8;CA;CALCIUM ION;DEOXYRIBONUCLEASE I;9913;
1AU9;A;SUBTILISIN BPN' MUTANT 8324 IN CITRATE;1.8;CA;CALCIUM ION;SUBTILISIN BPN';1390;
1AUI;B;HUMAN CALCINEURIN HETERODIMER;2.1;CA;CALCIUM ION;SERINE/THREONINE PHOSPHATASE 2B;9606;
1AUJ;A;BOVINE TRYPSIN COMPLEXED TO META-CYANO-BENZYLIC INHIBITOR;2.1;CA;CALCIUM ION;TRYPSIN;9913;
1AUX;A;STRUCTURE OF THE C DOMAIN OF SYNAPSIN IA FROM BOVINE BRAIN WITH CALCIUM ATP-GAMMA-S BOUND;2.3;CA;CALCIUM ION;SYNAPSIN IA;9913;
1AUX;B;STRUCTURE OF THE C DOMAIN OF SYNAPSIN IA FROM BOVINE BRAIN WITH CALCIUM ATP-GAMMA-S BOUND;2.3;CA;CALCIUM ION;SYNAPSIN IA;9913;
1AVA;A;AMY2/BASI PROTEIN-PROTEIN COMPLEX FROM BARLEY SEED;1.9;CA;CALCIUM ION;BARLEY ALPHA-AMYLASE 2(CV MENUET);4513;
1AVA;B;AMY2/BASI PROTEIN-PROTEIN COMPLEX FROM BARLEY SEED;1.9;CA;CALCIUM ION;BARLEY ALPHA-AMYLASE 2(CV MENUET);4513;
1AVC;A;BOVINE ANNEXIN VI (CALCIUM-BOUND);2.9;CA;CALCIUM ION;ANNEXIN VI;9913;
1AVH;A;CRYSTAL AND MOLECULAR STRUCTURE OF HUMAN ANNEXIN V AFTER REFINEMENT. IMPLICATIONS FOR STRUCTURE, MEMBRANE BINDING AND ION CHANNEL FORMATION OF THE ANNEXIN FAMILY OF PROTEINS;2.3;CA;CALCIUM ION;ANNEXIN V;9606;
1AVH;B;CRYSTAL AND MOLECULAR STRUCTURE OF HUMAN ANNEXIN V AFTER REFINEMENT. IMPLICATIONS FOR STRUCTURE, MEMBRANE BINDING AND ION CHANNEL FORMATION OF THE ANNEXIN FAMILY OF PROTEINS;2.3;CA;CALCIUM ION;ANNEXIN V;9606;
1AVR;A;CRYSTAL AND MOLECULAR STRUCTURE OF HUMAN ANNEXIN V AFTER REFINEMENT. IMPLICATIONS FOR STRUCTURE, MEMBRANE BINDING AND ION CHANNEL FORMATION OF THE ANNEXIN FAMILY OF PROTEINS;2.3;CA;CALCIUM ION;ANNEXIN V;9606;
1AVS;A;X-RAY CRYSTALLOGRAPHIC STUDY OF CALCIUM-SATURATED N-TERMINAL DOMAIN OF TROPONIN C;1.75;CA;CALCIUM ION;TROPONIN C;9031;
1AVS;B;X-RAY CRYSTALLOGRAPHIC STUDY OF CALCIUM-SATURATED N-TERMINAL DOMAIN OF TROPONIN C;1.75;CA;CALCIUM ION;TROPONIN C;9031;
1AVW;A;COMPLEX PORCINE PANCREATIC TRYPSIN/SOYBEAN TRYPSIN INHIBITOR, ORTHORHOMBIC CRYSTAL FORM;1.75;CA;CALCIUM ION;TRYPSIN;9823;
1AVX;A;COMPLEX PORCINE PANCREATIC TRYPSIN/SOYBEAN TRYPSIN INHIBITOR, TETRAGONAL CRYSTAL FORM;1.9;CA;CALCIUM ION;TRYPSIN;9823;
1AWB;A;HUMAN MYO-INOSITOL MONOPHOSPHATASE IN COMPLEX WITH D-INOSITOL-1-PHOSPHATE AND CALCIUM;2.5;CA;CALCIUM ION;MYO-INOSITOL MONOPHOSPHATASE;9606;
1AWB;B;HUMAN MYO-INOSITOL MONOPHOSPHATASE IN COMPLEX WITH D-INOSITOL-1-PHOSPHATE AND CALCIUM;2.5;CA;CALCIUM ION;MYO-INOSITOL MONOPHOSPHATASE;9606;
1AX0;A;ERYTHRINA CORALLODENDRON LECTIN IN COMPLEX WITH N-ACTYLGALACTOSAMINE;1.9;CA;CALCIUM ION;LECTIN;3843;
1AX1;A;ERYTHRINA CORALLODENDRON LECTIN IN COMPLEX WITH LACTOSE;1.95;CA;CALCIUM ION;LECTIN;3843;
1AX2;A;ERYTHRINA CORALLODENDRON LECTIN IN COMPLEX WITH N-ACETYLLACTOSAMINE;1.95;CA;CALCIUM ION;LECTIN;3843;
1AXK;A;ENGINEERED BACILLUS BIFUNCTIONAL ENZYME GLUXYN-1;2.1;CA;CALCIUM ION;GLUXYN-1;1423;
1AXK;B;ENGINEERED BACILLUS BIFUNCTIONAL ENZYME GLUXYN-1;2.1;CA;CALCIUM ION;GLUXYN-1;1423;
1AXN;A;THE HIGH RESOLUTION STRUCTURE OF ANNEXIN III SHOWS DIFFERENCES WITH ANNEXIN V;1.78;CA;CALCIUM ION;ANNEXIN III;9606;
1AXY;A;ERYTHRINA CORALLODENDRON LECTIN;1.95;CA;CALCIUM ION;LECTIN;3843;
1AXZ;A;ERYTHRINA CORALLODENDRON LECTIN IN COMPLEX WITH D-GALACTOSE;1.95;CA;CALCIUM ION;LECTIN;3843;
1AY0;A;IDENTIFICATION OF CATALYTICALLY IMPORTANT RESIDUES IN YEAST TRANSKETOLASE;2.6;CA;CALCIUM ION;TRANSKETOLASE;4932;
1AY0;B;IDENTIFICATION OF CATALYTICALLY IMPORTANT RESIDUES IN YEAST TRANSKETOLASE;2.6;CA;CALCIUM ION;TRANSKETOLASE;4932;
1AYK;A;INHIBITOR-FREE CATALYTIC FRAGMENT OF HUMAN FIBROBLAST COLLAGENASE, NMR, 30 STRUCTURES;;CA;CALCIUM ION;COLLAGENASE;9606;
1AYO;B;RECEPTOR BINDING DOMAIN OF BOVINE ALPHA-2-MACROGLOBULIN;1.9;CA;CALCIUM ION;ALPHA-2-MACROGLOBULIN;9913;
1AYP;A;A PROBE MOLECULE COMPOSED OF SEVENTEEN PERCENT OF TOTAL DIFFRACTING MATTER GIVES CORRECT SOLUTIONS IN MOLECULAR REPLACEMENT;2.57;CA;CALCIUM ION;PHOSPHOLIPASE A2;9606;
1AYP;B;A PROBE MOLECULE COMPOSED OF SEVENTEEN PERCENT OF TOTAL DIFFRACTING MATTER GIVES CORRECT SOLUTIONS IN MOLECULAR REPLACEMENT;2.57;CA;CALCIUM ION;PHOSPHOLIPASE A2;9606;
1AYP;C;A PROBE MOLECULE COMPOSED OF SEVENTEEN PERCENT OF TOTAL DIFFRACTING MATTER GIVES CORRECT SOLUTIONS IN MOLECULAR REPLACEMENT;2.57;CA;CALCIUM ION;PHOSPHOLIPASE A2;9606;
1AYP;D;A PROBE MOLECULE COMPOSED OF SEVENTEEN PERCENT OF TOTAL DIFFRACTING MATTER GIVES CORRECT SOLUTIONS IN MOLECULAR REPLACEMENT;2.57;CA;CALCIUM ION;PHOSPHOLIPASE A2;9606;
1AYP;E;A PROBE MOLECULE COMPOSED OF SEVENTEEN PERCENT OF TOTAL DIFFRACTING MATTER GIVES CORRECT SOLUTIONS IN MOLECULAR REPLACEMENT;2.57;CA;CALCIUM ION;PHOSPHOLIPASE A2;9606;
1AYP;F;A PROBE MOLECULE COMPOSED OF SEVENTEEN PERCENT OF TOTAL DIFFRACTING MATTER GIVES CORRECT SOLUTIONS IN MOLECULAR REPLACEMENT;2.57;CA;CALCIUM ION;PHOSPHOLIPASE A2;9606;
1AZ0;A;ECORV ENDONUCLEASE/DNA COMPLEX;2;CA;CALCIUM ION;PROTEIN (TYPE II RESTRICTION ENZYME ECORV);562;
1AZ0;B;ECORV ENDONUCLEASE/DNA COMPLEX;2;CA;CALCIUM ION;PROTEIN (TYPE II RESTRICTION ENZYME ECORV);562;
1AZD;A;CONCANAVALIN FROM CANAVALIA BRASILIENSIS;3;CA;CALCIUM ION;CONBR;61861;
1AZD;B;CONCANAVALIN FROM CANAVALIA BRASILIENSIS;3;CA;CALCIUM ION;CONBR;61861;
1AZD;C;CONCANAVALIN FROM CANAVALIA BRASILIENSIS;3;CA;CALCIUM ION;CONBR;61861;
1AZD;D;CONCANAVALIN FROM CANAVALIA BRASILIENSIS;3;CA;CALCIUM ION;CONBR;61861;
1B08;A;LUNG SURFACTANT PROTEIN D (SP-D) (FRAGMENT);2.3;CA;CALCIUM ION;PROTEIN (LUNG SURFACTANT PROTEIN D);9606;
1B08;B;LUNG SURFACTANT PROTEIN D (SP-D) (FRAGMENT);2.3;CA;CALCIUM ION;PROTEIN (LUNG SURFACTANT PROTEIN D);9606;
1B08;C;LUNG SURFACTANT PROTEIN D (SP-D) (FRAGMENT);2.3;CA;CALCIUM ION;PROTEIN (LUNG SURFACTANT PROTEIN D);9606;
1B09;A;HUMAN C-REACTIVE PROTEIN COMPLEXED WITH PHOSPHOCHOLINE;2.5;CA;CALCIUM ION;PROTEIN (C-REACTIVE PROTEIN);9606;
1B09;B;HUMAN C-REACTIVE PROTEIN COMPLEXED WITH PHOSPHOCHOLINE;2.5;CA;CALCIUM ION;PROTEIN (C-REACTIVE PROTEIN);9606;
1B09;C;HUMAN C-REACTIVE PROTEIN COMPLEXED WITH PHOSPHOCHOLINE;2.5;CA;CALCIUM ION;PROTEIN (C-REACTIVE PROTEIN);9606;
1B09;D;HUMAN C-REACTIVE PROTEIN COMPLEXED WITH PHOSPHOCHOLINE;2.5;CA;CALCIUM ION;PROTEIN (C-REACTIVE PROTEIN);9606;
1B09;E;HUMAN C-REACTIVE PROTEIN COMPLEXED WITH PHOSPHOCHOLINE;2.5;CA;CALCIUM ION;PROTEIN (C-REACTIVE PROTEIN);9606;
1B0E;A;CRYSTAL STRUCTURE OF PORCINE PANCREATIC ELASTASE WITH MDL 101,146;1.8;CA;CALCIUM ION;PROTEIN (ELASTASE);9823;
1B0I;A;ALPHA-AMYLASE FROM ALTEROMONAS HALOPLANCTIS;2.4;CA;CALCIUM ION;PROTEIN (ALPHA-AMYLASE);228;
1B0P;A;CRYSTAL STRUCTURE OF PYRUVATE-FERREDOXIN OXIDOREDUCTASE FROM DESULFOVIBRIO AFRICANUS;2.31;CA;CALCIUM ION;PROTEIN (PYRUVATE-FERREDOXIN OXIDOREDUCTASE);873;
1B0P;B;CRYSTAL STRUCTURE OF PYRUVATE-FERREDOXIN OXIDOREDUCTASE FROM DESULFOVIBRIO AFRICANUS;2.31;CA;CALCIUM ION;PROTEIN (PYRUVATE-FERREDOXIN OXIDOREDUCTASE);873;
1B1C;A;CRYSTAL STRUCTURE OF THE FMN-BINDING DOMAIN OF HUMAN CYTOCHROME P450 REDUCTASE AT 1.93A RESOLUTION;1.93;CA;CALCIUM ION;PROTEIN (NADPH-CYTOCHROME P450 REDUCTASE);9606;
1B1G;A;SOLVATED REFINEMENT OF CA-LOADED CALBINDIN D9K;;CA;CALCIUM ION;PROTEIN (CALBINDIN D9K);9913;
1B2L;A;ALCOHOL DEHYDROGENASE FROM DROSOPHILA LEBANONENSIS: TERNARY COMPLEX WITH NAD-CYCLOHEXANONE;1.6;CA;CALCIUM ION;ALCOHOL DEHYDROGENASE;7225;
1B2V;A;HEME-BINDING PROTEIN A;1.9;CA;CALCIUM ION;PROTEIN (HEME-BINDING PROTEIN A);615;
1B2Y;A;STRUCTURE OF HUMAN PANCREATIC ALPHA-AMYLASE IN COMPLEX WITH THE CARBOHYDRATE INHIBITOR ACARBOSE;3.2;CA;CALCIUM ION;PROTEIN (ALPHA-AMYLASE);9606;
1B3D;A;STROMELYSIN-1;2.3;CA;CALCIUM ION;STROMELYSIN-1;9606;
1B3D;B;STROMELYSIN-1;2.3;CA;CALCIUM ION;STROMELYSIN-1;9606;
1B47;A;STRUCTURE OF THE N-TERMINAL DOMAIN OF CBL IN COMPLEX WITH ITS BINDING SITE IN ZAP-70;2.2;CA;CALCIUM ION;CBL;9606;
1B47;B;STRUCTURE OF THE N-TERMINAL DOMAIN OF CBL IN COMPLEX WITH ITS BINDING SITE IN ZAP-70;2.2;CA;CALCIUM ION;CBL;9606;
1B47;C;STRUCTURE OF THE N-TERMINAL DOMAIN OF CBL IN COMPLEX WITH ITS BINDING SITE IN ZAP-70;2.2;CA;CALCIUM ION;CBL;9606;
1B4N;A;FORMALDEHYDE FERREDOXIN OXIDOREDUCTASE FROM PYROCOCCUS FURIOSUS, COMPLEXED WITH GLUTARATE;2.4;CA;CALCIUM ION;FORMALDEHYDE FERREDOXIN OXIDOREDUCTASE;2261;
1B4N;B;FORMALDEHYDE FERREDOXIN OXIDOREDUCTASE FROM PYROCOCCUS FURIOSUS, COMPLEXED WITH GLUTARATE;2.4;CA;CALCIUM ION;FORMALDEHYDE FERREDOXIN OXIDOREDUCTASE;2261;
1B4N;C;FORMALDEHYDE FERREDOXIN OXIDOREDUCTASE FROM PYROCOCCUS FURIOSUS, COMPLEXED WITH GLUTARATE;2.4;CA;CALCIUM ION;FORMALDEHYDE FERREDOXIN OXIDOREDUCTASE;2261;
1B4N;D;FORMALDEHYDE FERREDOXIN OXIDOREDUCTASE FROM PYROCOCCUS FURIOSUS, COMPLEXED WITH GLUTARATE;2.4;CA;CALCIUM ION;FORMALDEHYDE FERREDOXIN OXIDOREDUCTASE;2261;
1B7T;Z;MYOSIN DIGESTED BY PAPAIN;2.5;CA;CALCIUM ION;MYOSIN ESSENTIAL LIGHT CHAIN;31199;
1B80;A;REC. LIGNIN PEROXIDASE H8 OXIDATIVELY PROCESSED;1.73;CA;CALCIUM ION;PROTEIN (RECOMBINANT LIGNIN PEROXIDASE H8);5306;
1B80;B;REC. LIGNIN PEROXIDASE H8 OXIDATIVELY PROCESSED;1.73;CA;CALCIUM ION;PROTEIN (RECOMBINANT LIGNIN PEROXIDASE H8);5306;
1B82;A;PRISTINE RECOMB. LIGNIN PEROXIDASE H8;1.8;CA;CALCIUM ION;PROTEIN (LIGNIN PEROXIDASE);5306;
1B82;B;PRISTINE RECOMB. LIGNIN PEROXIDASE H8;1.8;CA;CALCIUM ION;PROTEIN (LIGNIN PEROXIDASE);5306;
1B85;A;LIGNIN PEROXIDASE;1.85;CA;CALCIUM ION;Ligninase H8;5306;
1B85;B;LIGNIN PEROXIDASE;1.85;CA;CALCIUM ION;Ligninase H8;5306;
1B8L;A;Calcium-bound D51A/E101D/F102W Triple Mutant of Beta Carp Parvalbumin;1.7;CA;CALCIUM ION;PROTEIN (PARVALBUMIN);7962;
1B8R;A;PARVALBUMIN;1.9;CA;CALCIUM ION;PROTEIN (PARVALBUMIN);7962;
1B8Y;A;X-RAY STRUCTURE OF HUMAN STROMELYSIN CATALYTIC DOMAIN COMPLEXED WITH NON-PEPTIDE INHIBITORS: IMPLICATIONS FOR INHIBITOR SELECTIVITY;2;CA;CALCIUM ION;PROTEIN (STROMELYSIN-1);9606;
1B90;A;BACILLUS CEREUS BETA-AMYLASE APO FORM;2.5;CA;CALCIUM ION;PROTEIN (BETA-AMYLASE);1396;
1B94;A;RESTRICTION ENDONUCLEASE ECORV WITH CALCIUM;1.9;CA;CALCIUM ION;RESTRICTION ENDONUCLEASE ECORV;562;
1B94;B;RESTRICTION ENDONUCLEASE ECORV WITH CALCIUM;1.9;CA;CALCIUM ION;RESTRICTION ENDONUCLEASE ECORV;562;
1B9O;A;HUMAN ALPHA-LACTALBUMIN, LOW TEMPERATURE FORM;1.15;CA;CALCIUM ION;PROTEIN (ALPHA-LACTALBUMIN);9606;
1B9S;A;NOVEL AROMATIC INHIBITORS OF INFLUENZA VIRUS NEURAMINIDASE MAKE SELECTIVE INTERACTIONS WITH CONSERVED RESIDUES AND WATER MOLECULES IN THE ACTIVE SITE;2.5;CA;CALCIUM ION;PROTEIN (NEURAMINIDASE);518987;
1B9T;A;NOVEL AROMATIC INHIBITORS OF INFLUENZA VIRUS NEURAMINIDASE MAKE SELECTIVE INTERACTIONS WITH CONSERVED RESIDUES AND WATER MOLECULES IN THE ACTIVE SITE;2.4;CA;CALCIUM ION;PROTEIN (NEURAMINIDASE);518987;
1B9V;A;NOVEL AROMATIC INHIBITORS OF INFLUENZA VIRUS NEURAMINIDASE MAKE SELECTIVE INTERACTIONS WITH CONSERVED RESIDUES AND WATER MOLECULES IN TEH ACTIVE SITE;2.35;CA;CALCIUM ION;PROTEIN (NEURAMINIDASE);518987;
1B9Z;A;BACILLUS CEREUS BETA-AMYLASE COMPLEXED WITH MALTOSE;2.1;CA;CALCIUM ION;PROTEIN (BETA-AMYLASE);1396;
1BAG;A;ALPHA-AMYLASE FROM BACILLUS SUBTILIS COMPLEXED WITH MALTOPENTAOSE;2.5;CA;CALCIUM ION;ALPHA-1,4-GLUCAN-4-GLUCANOHYDROLASE;1423;
1BC0;A;RECOMBINANT RAT ANNEXIN V, W185A MUTANT;2;CA;CALCIUM ION;ANNEXIN V;10116;
1BC1;A;RECOMBINANT RAT ANNEXIN V, QUADRUPLE MUTANT (T72K, S144K, S228K, S303K);2.05;CA;CALCIUM ION;ANNEXIN V;10116;
1BC3;A;RECOMBINANT RAT ANNEXIN V, TRIPLE MUTANT (T72K, S144K, S228K);1.95;CA;CALCIUM ION;ANNEXIN V;10116;
1BCH;1;MANNOSE-BINDING PROTEIN-A MUTANT (QPDWGH) COMPLEXED WITH N-ACETYL-D-GALACTOSAMINE;2;CA;CALCIUM ION;MANNOSE-BINDING PROTEIN-A;10116;
1BCH;2;MANNOSE-BINDING PROTEIN-A MUTANT (QPDWGH) COMPLEXED WITH N-ACETYL-D-GALACTOSAMINE;2;CA;CALCIUM ION;MANNOSE-BINDING PROTEIN-A;10116;
1BCH;3;MANNOSE-BINDING PROTEIN-A MUTANT (QPDWGH) COMPLEXED WITH N-ACETYL-D-GALACTOSAMINE;2;CA;CALCIUM ION;MANNOSE-BINDING PROTEIN-A;10116;
1BCI;A;C2 DOMAIN OF CYTOSOLIC PHOSPHOLIPASE A2, NMR, MINIMIZED AVERAGE STRUCTURE;;CA;CALCIUM ION;CYTOSOLIC PHOSPHOLIPASE A2;9606;
1BCJ;1;MANNOSE-BINDING PROTEIN-A MUTANT (QPDWGHV) COMPLEXED WITH N-ACETYL-D-GALACTOSAMINE;2.1;CA;CALCIUM ION;MANNOSE-BINDING PROTEIN-A;10116;
1BCJ;2;MANNOSE-BINDING PROTEIN-A MUTANT (QPDWGHV) COMPLEXED WITH N-ACETYL-D-GALACTOSAMINE;2.1;CA;CALCIUM ION;MANNOSE-BINDING PROTEIN-A;10116;
1BCJ;3;MANNOSE-BINDING PROTEIN-A MUTANT (QPDWGHV) COMPLEXED WITH N-ACETYL-D-GALACTOSAMINE;2.1;CA;CALCIUM ION;MANNOSE-BINDING PROTEIN-A;10116;
1BCW;A;RECOMBINANT RAT ANNEXIN V, T72A MUTANT;2.1;CA;CALCIUM ION;ANNEXIN V;10116;
1BCY;A;RECOMBINANT RAT ANNEXIN V, T72K MUTANT;1.95;CA;CALCIUM ION;ANNEXIN V;10116;
1BCZ;A;RECOMBINANT RAT ANNEXIN V, T72S MUTANT;2.2;CA;CALCIUM ION;ANNEXIN V;10116;
1BE6;A;TRANS-CINNAMOYL-SUBTILISIN IN ANHYDROUS ACETONITRILE;2.15;CA;CALCIUM ION;SUBTILISIN CARLSBERG;1402;
1BE8;A;TRANS-CINNAMOYL-SUBTILISIN IN WATER;2.2;CA;CALCIUM ION;SUBTILISIN CARLSBERG;1402;
1BF2;A;STRUCTURE OF PSEUDOMONAS ISOAMYLASE;2;CA;CALCIUM ION;ISOAMYLASE;32043;
1BFD;A;BENZOYLFORMATE DECARBOXYLASE FROM PSEUDOMONAS PUTIDA;1.6;CA;CALCIUM ION;BENZOYLFORMATE DECARBOXYLASE;303;
1BFK;A;CRYSTAL STRUCTURE OF SUBTILISIN CARLSBERG IN 40% ACETONITRILE;2.3;CA;CALCIUM ION;SUBTILISIN CARLSBERG;1402;
1BFU;A;SUBTILISIN CARLSBERG IN 20% DIOXANE;2.2;CA;CALCIUM ION;SUBTILISIN CARLSBERG;1402;
1BG3;A;RAT BRAIN HEXOKINASE TYPE I COMPLEX WITH GLUCOSE AND INHIBITOR GLUCOSE-6-PHOSPHATE;2.8;CA;CALCIUM ION;HEXOKINASE;10116;
1BG7;A;LOCALIZED UNFOLDING AT THE JUNCTION OF THREE FERRITIN SUBUNITS. A MECHANISM FOR IRON RELEASE?;1.85;CA;CALCIUM ION;FERRITIN;8400;
1BG9;A;BARLEY ALPHA-AMYLASE WITH SUBSTRATE ANALOGUE ACARBOSE;2.8;CA;CALCIUM ION;1,4-ALPHA-D-GLUCAN GLUCANOHYDROLASE;4513;
1BGP;A;CRYSTAL STRUCTURE OF BARLEY GRAIN PEROXIDASE 1;1.9;CA;CALCIUM ION;BARLEY GRAIN PEROXIDASE;4513;
1BH6;A;SUBTILISIN DY IN COMPLEX WITH THE SYNTHETIC INHIBITOR N-BENZYLOXYCARBONYL-ALA-PRO-PHE-CHLOROMETHYL KETONE;1.75;CA;CALCIUM ION;SUBTILISIN DY;1402;
1BIR;A;RIBONUCLEASE T1, PHE 100 TO ALA MUTANT COMPLEXED WITH 2' GMP;1.8;CA;CALCIUM ION;RIBONUCLEASE T1;5062;
1BIR;B;RIBONUCLEASE T1, PHE 100 TO ALA MUTANT COMPLEXED WITH 2' GMP;1.8;CA;CALCIUM ION;RIBONUCLEASE T1;5062;
1BIT;A;THE CRYSTAL STRUCTURE OF ANIONIC SALMON TRYPSIN IN A SECOND CRYSTAL FORM;1.83;CA;CALCIUM ION;TRYPSIN;8030;
1BIW;A;DESIGN AND SYNTHESIS OF CONFORMATIONALLY-CONSTRAINED MMP INHIBITORS;2.5;CA;CALCIUM ION;PROTEIN (STROMELYSIN-1 COMPLEX);9606;
1BIW;B;DESIGN AND SYNTHESIS OF CONFORMATIONALLY-CONSTRAINED MMP INHIBITORS;2.5;CA;CALCIUM ION;PROTEIN (STROMELYSIN-1 COMPLEX);9606;
1BJ3;A;CRYSTAL STRUCTURE OF COAGULATION FACTOR IX-BINDING PROTEIN (IX-BP) FROM VENOM OF HABU SNAKE WITH A HETERODIMER OF C-TYPE LECTIN DOMAINS;2.6;CA;CALCIUM ION;PROTEIN (COAGULATION FACTOR IX-BINDING PROTEIN A);88087;
1BJ3;B;CRYSTAL STRUCTURE OF COAGULATION FACTOR IX-BINDING PROTEIN (IX-BP) FROM VENOM OF HABU SNAKE WITH A HETERODIMER OF C-TYPE LECTIN DOMAINS;2.6;CA;CALCIUM ION;PROTEIN (COAGULATION FACTOR IX-BINDING PROTEIN B);88087;
1BJF;A;CRYSTAL STRUCTURE OF RECOMBINANT BOVINE NEUROCALCIN DELTA AT 2.4 ANGSTROMS;2.4;CA;CALCIUM ION;NEUROCALCIN DELTA;9913;
1BJF;B;CRYSTAL STRUCTURE OF RECOMBINANT BOVINE NEUROCALCIN DELTA AT 2.4 ANGSTROMS;2.4;CA;CALCIUM ION;NEUROCALCIN DELTA;9913;
1BJI;A;THE X-RAY STRUCTURE OF A COMPLEX OF TERN N9 INFLUENZA VIRUS NEURAMINIDASE COMPLEXED WITH THE GLAXO 6-CARBOXAMIDE SIALIC ACID ANALOGUE GR217029;2;CA;CALCIUM ION;NEURAMINIDASE;11320;
1BJJ;A;AGKISTRODOTOXIN, A PHOSPHOLIPASE A2-TYPE PRESYNAPTIC NEUROTOXIN FROM AGKISTRODON HALYS PALLAS;2.8;CA;CALCIUM ION;AGKISTRODOTOXIN;8714;
1BJJ;B;AGKISTRODOTOXIN, A PHOSPHOLIPASE A2-TYPE PRESYNAPTIC NEUROTOXIN FROM AGKISTRODON HALYS PALLAS;2.8;CA;CALCIUM ION;AGKISTRODOTOXIN;8714;
1BJJ;C;AGKISTRODOTOXIN, A PHOSPHOLIPASE A2-TYPE PRESYNAPTIC NEUROTOXIN FROM AGKISTRODON HALYS PALLAS;2.8;CA;CALCIUM ION;AGKISTRODOTOXIN;8714;
1BJJ;D;AGKISTRODOTOXIN, A PHOSPHOLIPASE A2-TYPE PRESYNAPTIC NEUROTOXIN FROM AGKISTRODON HALYS PALLAS;2.8;CA;CALCIUM ION;AGKISTRODOTOXIN;8714;
1BJJ;E;AGKISTRODOTOXIN, A PHOSPHOLIPASE A2-TYPE PRESYNAPTIC NEUROTOXIN FROM AGKISTRODON HALYS PALLAS;2.8;CA;CALCIUM ION;AGKISTRODOTOXIN;8714;
1BJJ;F;AGKISTRODOTOXIN, A PHOSPHOLIPASE A2-TYPE PRESYNAPTIC NEUROTOXIN FROM AGKISTRODON HALYS PALLAS;2.8;CA;CALCIUM ION;AGKISTRODOTOXIN;8714;
1BJQ;A;THE DOLICHOS BIFLORUS SEED LECTIN IN COMPLEX WITH ADENINE;2.65;CA;CALCIUM ION;LECTIN;3917;
1BJQ;B;THE DOLICHOS BIFLORUS SEED LECTIN IN COMPLEX WITH ADENINE;2.65;CA;CALCIUM ION;LECTIN;3917;
1BJQ;C;THE DOLICHOS BIFLORUS SEED LECTIN IN COMPLEX WITH ADENINE;2.65;CA;CALCIUM ION;LECTIN;3917;
1BJQ;D;THE DOLICHOS BIFLORUS SEED LECTIN IN COMPLEX WITH ADENINE;2.65;CA;CALCIUM ION;LECTIN;3917;
1BJQ;E;THE DOLICHOS BIFLORUS SEED LECTIN IN COMPLEX WITH ADENINE;2.65;CA;CALCIUM ION;LECTIN;3917;
1BJQ;F;THE DOLICHOS BIFLORUS SEED LECTIN IN COMPLEX WITH ADENINE;2.65;CA;CALCIUM ION;LECTIN;3917;
1BJQ;G;THE DOLICHOS BIFLORUS SEED LECTIN IN COMPLEX WITH ADENINE;2.65;CA;CALCIUM ION;LECTIN;3917;
1BJQ;H;THE DOLICHOS BIFLORUS SEED LECTIN IN COMPLEX WITH ADENINE;2.65;CA;CALCIUM ION;LECTIN;3917;
1BJR;E;COMPLEX FORMED BETWEEN PROTEOLYTICALLY GENERATED LACTOFERRIN FRAGMENT AND PROTEINASE K;2.44;CA;CALCIUM ION;PROTEINASE K;37998;
1BJU;A;BETA-TRYPSIN COMPLEXED WITH ACPU;1.8;CA;CALCIUM ION;BETA-TRYPSIN;9913;
1BJV;A;BETA-TRYPSIN COMPLEXED WITH APPU;1.8;CA;CALCIUM ION;BETA-TRYPSIN;9913;
1BK9;A;PHOSPHOLIPASE A2 MODIFIED BY PBPB;2;CA;CALCIUM ION;PHOSPHOLIPASE A2;8714;
1BLI;A;BACILLUS LICHENIFORMIS ALPHA-AMYLASE;1.9;CA;CALCIUM ION;ALPHA-AMYLASE;1402;
1BLX;A;P19INK4D/CDK6 COMPLEX;1.9;CA;CALCIUM ION;CYCLIN-DEPENDENT KINASE 6;9606;
1BM6;A;SOLUTION STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN STROMELYSIN-1 COMPLEXED TO A POTENT NON-PEPTIDIC INHIBITOR, NMR, 20 STRUCTURES;;CA;CALCIUM ION;STROMELYSIN-1;9606;
1BMA;A;BENZYL METHYL AMINIMIDE INHIBITOR COMPLEXED TO PORCINE PANCREATIC ELASTASE;1.8;CA;CALCIUM ION;Chymotrypsin-like elastase family member 1;9823;
1BMO;A;BM-40, FS/EC DOMAIN PAIR;3.1;CA;CALCIUM ION;BM-40;9606;
1BMO;B;BM-40, FS/EC DOMAIN PAIR;3.1;CA;CALCIUM ION;BM-40;9606;
1BN8;A;BACILLUS SUBTILIS PECTATE LYASE;1.8;CA;CALCIUM ION;PROTEIN (PECTATE LYASE);1423;
1BOB;A;HISTONE ACETYLTRANSFERASE HAT1 FROM SACCHAROMYCES CEREVISIAE IN COMPLEX WITH ACETYL COENZYME A;2.3;CA;CALCIUM ION;HISTONE ACETYLTRANSFERASE;4932;
1BP2;A;STRUCTURE OF BOVINE PANCREATIC PHOSPHOLIPASE A2 AT 1.7 ANGSTROMS RESOLUTION;1.7;CA;CALCIUM ION;PHOSPHOLIPASE A2;9913;
1BP7;1;GROUP I MOBILE INTRON ENDONUCLEASE I-CREI COMPLEXED WITH HOMING SITE DNA;3;CA;CALCIUM ION;DNA (5'-D(*GP*CP*AP*AP*AP*AP*CP*GP*TP*CP*GP*TP*GP*AP*GP*AP*CP*AP*GP*TP*TP*TP* CP*G)-3');;
1BP7;3;GROUP I MOBILE INTRON ENDONUCLEASE I-CREI COMPLEXED WITH HOMING SITE DNA;3;CA;CALCIUM ION;DNA (5'-D(*GP*CP*AP*AP*AP*AP*CP*GP*TP*CP*GP*TP*GP*AP*GP*AP*CP*AP*GP*TP*TP*TP* CP*G)-3');;
1BP7;A;GROUP I MOBILE INTRON ENDONUCLEASE I-CREI COMPLEXED WITH HOMING SITE DNA;3;CA;CALCIUM ION;PROTEIN (I-CREI);3055;
1BP7;C;GROUP I MOBILE INTRON ENDONUCLEASE I-CREI COMPLEXED WITH HOMING SITE DNA;3;CA;CALCIUM ION;PROTEIN (I-CREI);3055;
1BPQ;A;PHOSPHOLIPASE A2 ENGINEERING. X-RAY STRUCTURAL AND FUNCTIONAL EVIDENCE FOR THE INTERACTION OF LYSINE-56 WITH SUBSTRATES;1.8;CA;CALCIUM ION;PHOSPHOLIPASE A2;9913;
1BQB;A;AUREOLYSIN, STAPHYLOCOCCUS AUREUS METALLOPROTEINASE;1.72;CA;CALCIUM ION;PROTEIN (AUREOLYSIN);1280;
1BQO;A;DISCOVERY OF POTENT, ACHIRAL MATRIX METALLOPROTEINASE INHIBITORS;2.3;CA;CALCIUM ION;STROMELYSIN-1;9606;
1BQO;B;DISCOVERY OF POTENT, ACHIRAL MATRIX METALLOPROTEINASE INHIBITORS;2.3;CA;CALCIUM ION;STROMELYSIN-1;9606;
1BQP;A;THE STRUCTURE OF THE PEA LECTIN-D-MANNOPYRANOSE COMPLEX;2.1;CA;CALCIUM ION;PROTEIN (LECTIN);3888;
1BQP;C;THE STRUCTURE OF THE PEA LECTIN-D-MANNOPYRANOSE COMPLEX;2.1;CA;CALCIUM ION;PROTEIN (LECTIN);3888;
1BQQ;M;CRYSTAL STRUCTURE OF THE MT1-MMP--TIMP-2 COMPLEX;2.75;CA;CALCIUM ION;MEMBRANE-TYPE MATRIX METALLOPROTEINASE;9606;
1BRA;A;RELOCATING A NEGATIVE CHARGE IN THE BINDING POCKET OF TRYPSIN;2.2;CA;CALCIUM ION;TRYPSIN;10117;
1BRW;A;THE CRYSTAL STRUCTURE OF PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE IN A CLOSED CONFORMATION;2.1;CA;CALCIUM ION;PROTEIN (PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE);1422;
1BRW;B;THE CRYSTAL STRUCTURE OF PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE IN A CLOSED CONFORMATION;2.1;CA;CALCIUM ION;PROTEIN (PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE);1422;
1BSI;A;HUMAN PANCREATIC ALPHA-AMYLASE FROM PICHIA PASTORIS, GLYCOSYLATED PROTEIN;2;CA;CALCIUM ION;ALPHA-AMYLASE;9606;
1BSS;A;ECORV-T93A/DNA/CA2+;2.15;CA;CALCIUM ION;ECORV ENDONUCLEASE;562;
1BSU;A;STRUCTURAL AND ENERGETIC ORIGINS OF INDIRECT READOUT IN SITE-SPECIFIC DNA CLEAVAGE BY A RESTRICTION ENDONUCLEASE;2;CA;CALCIUM ION;ENDONUCLEASE ECORV (3.1.21.4);562;
1BSU;B;STRUCTURAL AND ENERGETIC ORIGINS OF INDIRECT READOUT IN SITE-SPECIFIC DNA CLEAVAGE BY A RESTRICTION ENDONUCLEASE;2;CA;CALCIUM ION;ENDONUCLEASE ECORV (3.1.21.4);562;
1BSW;A;ACUTOLYSIN A FROM SNAKE VENOM OF AGKISTRODON ACUTUS AT PH 7.5;1.95;CA;CALCIUM ION;PROTEIN (ACUTOLYSIN A);36307;
1BTP;A;UNIQUE BINDING OF A NOVEL SYNTHETIC INHIBITOR, N-[3-[4-[4-(AMIDINOPHENOXY)-CARBONYL]PHENYL]-2-METHYL-2-PROPENOYL]-N-ALLYLGLYCINE METHANESULFONATE TO BOVINE TRYPSIN, REVEALED BY THE CRYSTAL STRUCTURE OF THE COMPLEX;2.2;CA;CALCIUM ION;BETA-TRYPSIN;9913;
1BTU;A;PORCINE PANCREATIC ELASTASE COMPLEXED WITH (3S, 4R)-1-TOLUENESULPHONYL-3-ETHYL-AZETIDIN-2-ONE-4-CARBOXYLIC ACID;1.6;CA;CALCIUM ION;ELASTASE;9823;
1BTW;A;Episelection: novel KI ~nanomolar inhibitors of serine proteases selected by binding or chemistry on an enzyme surface;1.7;CA;CALCIUM ION;BETA-TRYPSIN;9913;
1BTX;A;Episelection: Novel Ki ~Nanomolar Inhibitors of Serine Proteases Selected by Binding or Chemistry on an Enzyme Surface;1.7;CA;CALCIUM ION;BETA-TRYPSIN;9913;
1BTY;A;Crystal structure of beta-trypsin in complex with benzamidine;1.5;CA;CALCIUM ION;BETA-TRYPSIN;9913;
1BTZ;A;Episelection: novel KI ~nanomolar inhibitors of serine proteases selected by binding or chemistry on an enzyme surface;2;CA;CALCIUM ION;BETA-TRYPSIN;9913;
1BU3;A;REFINED CRYSTAL STRUCTURE OF CALCIUM-BOUND SILVER HAKE (PI 4.2) PARVALBUMIN AT 1.65 A.;1.65;CA;CALCIUM ION;CALCIUM-BINDING PROTEIN;79698;
1BU4;A;RIBONUCLEASE 1 COMPLEX WITH 2'GMP;1.9;CA;CALCIUM ION;RIBONUCLEASE T1;5062;
1BUD;A;ACUTOLYSIN A FROM SNAKE VENOM OF AGKISTRODON ACUTUS AT PH 5.0;1.9;CA;CALCIUM ION;PROTEIN (ACUTOLYSIN A);36307;
1BUV;M;CRYSTAL STRUCTURE OF THE MT1-MMP-TIMP-2 COMPLEX;2.75;CA;CALCIUM ION;PROTEIN (MEMBRANE-TYPE MATRIX METALLOPROTEINASE (CDMT1-MMP));9606;
1BVI;C;RIBONUCLEASE T1 (WILDTYPE) COMPLEXED WITH 2'GMP;1.9;CA;CALCIUM ION;PROTEIN (RIBONUCLEASE T1);5062;
1BVI;D;RIBONUCLEASE T1 (WILDTYPE) COMPLEXED WITH 2'GMP;1.9;CA;CALCIUM ION;PROTEIN (RIBONUCLEASE T1);5062;
1BVN;P;PIG PANCREATIC ALPHA-AMYLASE IN COMPLEX WITH THE PROTEINACEOUS INHIBITOR TENDAMISTAT;2.5;CA;CALCIUM ION;PROTEIN (ALPHA-AMYLASE);9823;
1BXH;A;CONCANAVALIN A COMPLEXED TO METHYL ALPHA1-2 MANNOBIOSIDE;2.75;CA;CALCIUM ION;Concanavalin-A;3823;
1BXH;B;CONCANAVALIN A COMPLEXED TO METHYL ALPHA1-2 MANNOBIOSIDE;2.75;CA;CALCIUM ION;Concanavalin-A;3823;
1BXH;C;CONCANAVALIN A COMPLEXED TO METHYL ALPHA1-2 MANNOBIOSIDE;2.75;CA;CALCIUM ION;Concanavalin-A;3823;
1BXH;D;CONCANAVALIN A COMPLEXED TO METHYL ALPHA1-2 MANNOBIOSIDE;2.75;CA;CALCIUM ION;Concanavalin-A;3823;
1BYH;A;MOLECULAR AND ACTIVE-SITE STRUCTURE OF A BACILLUS (1-3,1-4)-BETA-GLUCANASE;2.8;CA;CALCIUM ION;HYBRID;32630;
1BYN;A;SOLUTION STRUCTURE OF THE CALCIUM-BOUND FIRST C2-DOMAIN OF SYNAPTOTAGMIN I;;CA;CALCIUM ION;PROTEIN (SYNAPTOTAGMIN I);10116;
1BZS;A;CRYSTAL STRUCTURE OF MMP8 COMPLEXED WITH HMR2909;1.7;CA;CALCIUM ION;NEUTROPHIL COLLAGENASE;9606;
1BZW;A;PEANUT LECTIN COMPLEXED WITH C-LACTOSE;2.7;CA;CALCIUM ION;PROTEIN (PEANUT LECTIN);3818;
1BZW;B;PEANUT LECTIN COMPLEXED WITH C-LACTOSE;2.7;CA;CALCIUM ION;PROTEIN (PEANUT LECTIN);3818;
1BZW;C;PEANUT LECTIN COMPLEXED WITH C-LACTOSE;2.7;CA;CALCIUM ION;PROTEIN (PEANUT LECTIN);3818;
1BZW;D;PEANUT LECTIN COMPLEXED WITH C-LACTOSE;2.7;CA;CALCIUM ION;PROTEIN (PEANUT LECTIN);3818;
1BZX;E;THE CRYSTAL STRUCTURE OF ANIONIC SALMON TRYPSIN IN COMPLEX WITH BOVINE PANCREATIC TRYPSIN INHIBITOR;2.1;CA;CALCIUM ION;PROTEIN (TRYPSIN);8030;
1C07;A;STRUCTURE OF THE THIRD EPS15 HOMOLOGY DOMAIN OF HUMAN EPS15;;CA;CALCIUM ION;PROTEIN (EPIDERMAL GROWTH FACTOR RECEPTOR PATHWAY SUBSTRATE 15);9606;
1C0F;A;CRYSTAL STRUCTURE OF DICTYOSTELIUM CAATP-ACTIN IN COMPLEX WITH GELSOLIN SEGMENT 1;2.4;CA;CALCIUM ION;ACTIN;44689;
1C0F;S;CRYSTAL STRUCTURE OF DICTYOSTELIUM CAATP-ACTIN IN COMPLEX WITH GELSOLIN SEGMENT 1;2.4;CA;CALCIUM ION;GELSOLIN SEGMENT 1;9606;
1C0G;A;CRYSTAL STRUCTURE OF 1:1 COMPLEX BETWEEN GELSOLIN SEGMENT 1 AND A DICTYOSTELIUM/TETRAHYMENA CHIMERA ACTIN (MUTANT 228: Q228K/T229A/A230Y/E360H);2;CA;CALCIUM ION;PROTEIN (CHIMERIC ACTIN);591,144,689;
1C0G;S;CRYSTAL STRUCTURE OF 1:1 COMPLEX BETWEEN GELSOLIN SEGMENT 1 AND A DICTYOSTELIUM/TETRAHYMENA CHIMERA ACTIN (MUTANT 228: Q228K/T229A/A230Y/E360H);2;CA;CALCIUM ION;PROTEIN (GELSOLIN SEGMENT 1);9606;
1C1M;A;PORCINE ELASTASE UNDER XENON PRESSURE (8 BAR);2.2;CA;CALCIUM ION;PROTEIN (PORCINE ELASTASE);9823;
1C1N;A;RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES;1.4;CA;CALCIUM ION;TRYPSIN;9913;
1C1O;A;RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES;1.4;CA;CALCIUM ION;TRYPSIN;9913;
1C1P;A;RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES;1.37;CA;CALCIUM ION;TRYPSIN;9913;
1C1Q;A;RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES;1.37;CA;CALCIUM ION;TRYPSIN;9913;
1C1R;A;RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES;1.37;CA;CALCIUM ION;TRYPSIN;9913;
1C1S;A;RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES;1.63;CA;CALCIUM ION;TRYPSIN;9913;
1C1T;A;RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES;1.37;CA;CALCIUM ION;TRYPSIN;9913;
1C1Y;B;CRYSTAL STRUCTURE OF RAP.GMPPNP IN COMPLEX WITH THE RAS-BINDING-DOMAIN OF C-RAF1 KINASE (RAFRBD).;1.9;CA;CALCIUM ION;PROTO-ONCOGENE SERINE/THREONINE PROTEIN KINASE RAF-1;9606;
1C2D;A;RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES;1.65;CA;CALCIUM ION;TRYPSIN;9913;
1C2E;A;RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES;1.65;CA;CALCIUM ION;TRYPSIN;9913;
1C2F;A;RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES;1.7;CA;CALCIUM ION;TRYPSIN;9913;
1C2G;A;RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES;1.65;CA;CALCIUM ION;TRYPSIN;9913;
1C2H;A;RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES;1.4;CA;CALCIUM ION;TRYPSIN;9913;
1C2I;A;RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES;1.47;CA;CALCIUM ION;TRYPSIN;9913;
1C2J;A;RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES;1.4;CA;CALCIUM ION;TRYPSIN;9913;
1C2K;A;RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES;1.65;CA;CALCIUM ION;TRYPSIN;9913;
1C2L;A;RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES;1.5;CA;CALCIUM ION;TRYPSIN;9913;
1C2M;A;RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES;1.4;CA;CALCIUM ION;TRYPSIN;9913;
1C3H;D;ACRP30 CALCIUM COMPLEX;2.1;CA;CALCIUM ION;30 KD ADIPOCYTE COMPLEMENT-RELATED PROTEIN PRECURSOR;10090;
1C3H;E;ACRP30 CALCIUM COMPLEX;2.1;CA;CALCIUM ION;30 KD ADIPOCYTE COMPLEMENT-RELATED PROTEIN PRECURSOR;10090;
1C3H;F;ACRP30 CALCIUM COMPLEX;2.1;CA;CALCIUM ION;30 KD ADIPOCYTE COMPLEMENT-RELATED PROTEIN PRECURSOR;10090;
1C3I;A;HUMAN STROMELYSIN-1 CATALYTIC DOMAIN COMPLEXED WITH RO-26-2812;1.83;CA;CALCIUM ION;STROMELYSIN-1;9606;
1C3I;B;HUMAN STROMELYSIN-1 CATALYTIC DOMAIN COMPLEXED WITH RO-26-2812;1.83;CA;CALCIUM ION;STROMELYSIN-1;9606;
1C3L;A;SUBTILISIN-CARLSBERG COMPLEXED WITH XENON (8 BAR);2.16;CA;CALCIUM ION;SUBTILISIN-CARLSBERG;1402;
1C3X;B;PURINE NUCLEOSIDE PHOSPHORYLASE FROM CELLULOMONAS SP. IN COMPLEX WITH 8-IODO-GUANINE;2.4;CA;CALCIUM ION;PENTOSYLTRANSFERASE;40001;
1C57;A;DIRECT DETERMINATION OF THE POSITIONS OF DEUTERIUM ATOMS OF BOUND WATER IN CONCANAVALIN A BY NEUTRON LAUE CRYSTALLOGRAPHY;2.4;CA;CALCIUM ION;Concanavalin-Br;3823;
1C5L;H;STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR;1.47;CA;CALCIUM ION;thrombin;9606;
1C5N;H;STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR;1.5;CA;CALCIUM ION;Thrombin heavy chain;9606;
1C5P;A;STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR;1.43;CA;CALCIUM ION;PROTEIN (TRYPSIN);9913;
1C5Q;A;STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR;1.43;CA;CALCIUM ION;PROTEIN (TRYPSIN);9913;
1C5R;A;STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR;1.47;CA;CALCIUM ION;PROTEIN (TRYPSIN);9913;
1C5S;A;STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR;1.36;CA;CALCIUM ION;PROTEIN (TRYPSIN);9913;
1C5T;A;STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR;1.37;CA;CALCIUM ION;PROTEIN (TRYPSIN);9913;
1C5U;A;STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR;1.37;CA;CALCIUM ION;PROTEIN (TRYPSIN);9913;
1C5V;A;STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR;1.48;CA;CALCIUM ION;PROTEIN (TRYPSIN);9913;
1C74;A;Structure of the double mutant (K53,56M) of phospholipase A2;1.9;CA;CALCIUM ION;PHOSPHOLIPASE A2;9913;
1C7I;A;THERMOPHYLIC PNB ESTERASE;2;CA;CALCIUM ION;PROTEIN (PARA-NITROBENZYL ESTERASE);1423;
1C7K;A;CRYSTAL STRUCTURE OF THE ZINC PROTEASE;1;CA;CALCIUM ION;ZINC ENDOPROTEASE;53502;
1C8D;A;CANINE PANLEUKOPENIA VIRUS EMPTY CAPSID STRUCTURE;3;CA;CALCIUM ION;CANINE PARVOVIRUS CAPSID;1511906;
1C8F;A;FELINE PANLEUKOPENIA VIRUS EMPTY CAPSID STRUCTURE;3;CA;CALCIUM ION;FELINE PANLEUKOPENIA VIRUS CAPSID;1511906;
1C8G;A;FELINE PANLEUKOPENIA VIRUS EMPTY CAPSID STRUCTURE;3;CA;CALCIUM ION;FELINE PANLEUKOPENIA VIRUS CAPSID;1511906;
1C8H;A;CANINE PARVOVIRUS STRAIN D EMPTY CAPSID STRUCTURE AT PH 5.5;3.5;CA;CALCIUM ION;CANINE PARVOVIRUS CAPSID;1511906;
1C8I;A;BINDING MODE OF HYDROXYLAMINE TO ARTHROMYCES RAMOSUS PEROXIDASE;2;CA;CALCIUM ION;PROTEIN (PEROXIDASE);5451;
1C8N;A;TOBACCO NECROSIS VIRUS;2.25;CA;CALCIUM ION;COAT PROTEIN;12054;
1C8N;B;TOBACCO NECROSIS VIRUS;2.25;CA;CALCIUM ION;COAT PROTEIN;12054;
1C8N;C;TOBACCO NECROSIS VIRUS;2.25;CA;CALCIUM ION;COAT PROTEIN;12054;
1C8Q;A;STRUCTURE SOLUTION AND REFINEMENT OF THE RECOMBINANT HUMAN SALIVARY AMYLASE;2.3;CA;CALCIUM ION;ALPHA-AMYLASE;9606;
1C8T;A;HUMAN STROMELYSIN-1 (E202Q) CATALYTIC DOMAIN COMPLEXED WITH RO-26-2812;2.6;CA;CALCIUM ION;STROMELYSIN-1;9606;
1C8T;B;HUMAN STROMELYSIN-1 (E202Q) CATALYTIC DOMAIN COMPLEXED WITH RO-26-2812;2.6;CA;CALCIUM ION;STROMELYSIN-1;9606;
1C9J;A;BACILLUS LENTUS SUBTILISIN K27R/N87S/V104Y/N123S/T274A VARIANT;1.8;CA;CALCIUM ION;SERINE PROTEASE;1467;
1C9M;A;BACILLUS LENTUS SUBTILSIN (SER 87) N76D/S103A/V104I;1.67;CA;CALCIUM ION;SERINE PROTEASE;1467;
1C9N;A;BACILLUS LENTUS SUBSTILISIN VARIANT (SER 87) K27R/V104Y/N123S/T274A;1.5;CA;CALCIUM ION;SERINE PROTEASE;1467;
1C9P;A;COMPLEX OF BDELLASTASIN WITH PORCINE TRYPSIN;2.8;CA;CALCIUM ION;TRYPSIN;9823;
1C9U;A;CRYSTAL STRUCTURE OF THE SOLUBLE QUINOPROTEIN GLUCOSE DEHYDROGENASE IN COMPLEX WITH PQQ;2.2;CA;CALCIUM ION;SOLUBLE QUINOPROTEIN GLUCOSE DEHYDROGENASE;471;
1C9U;B;CRYSTAL STRUCTURE OF THE SOLUBLE QUINOPROTEIN GLUCOSE DEHYDROGENASE IN COMPLEX WITH PQQ;2.2;CA;CALCIUM ION;SOLUBLE QUINOPROTEIN GLUCOSE DEHYDROGENASE;471;
1CAQ;A;X-RAY STRUCTURE OF HUMAN STROMELYSIN CATALYTIC DOMAIN COMPLEXES WITH NON-PEPTIDE INHIBITORS: IMPLICATION FOR INHIBITOR SELECTIVITY;1.8;CA;CALCIUM ION;PROTEIN (STROMELYSIN-1);9606;
1CB8;A;CHONDROITINASE AC LYASE FROM FLAVOBACTERIUM HEPARINUM;1.9;CA;CALCIUM ION;PROTEIN (CHONDROITINASE AC);984;
1CDG;A;NUCLEOTIDE SEQUENCE AND X-RAY STRUCTURE OF CYCLODEXTRIN GLYCOSYLTRANSFERASE FROM BACILLUS CIRCULANS STRAIN 251 IN A MALTOSE-DEPENDENT CRYSTAL FORM;2;CA;CALCIUM ION;CYCLODEXTRIN GLYCOSYL-TRANSFERASE;1397;
1CDL;A;TARGET ENZYME RECOGNITION BY CALMODULIN: 2.4 ANGSTROMS STRUCTURE OF A CALMODULIN-PEPTIDE COMPLEX;2;CA;CALCIUM ION;CALMODULIN;9606;
1CDL;B;TARGET ENZYME RECOGNITION BY CALMODULIN: 2.4 ANGSTROMS STRUCTURE OF A CALMODULIN-PEPTIDE COMPLEX;2;CA;CALCIUM ION;CALMODULIN;9606;
1CDL;C;TARGET ENZYME RECOGNITION BY CALMODULIN: 2.4 ANGSTROMS STRUCTURE OF A CALMODULIN-PEPTIDE COMPLEX;2;CA;CALCIUM ION;CALMODULIN;9606;
1CDL;D;TARGET ENZYME RECOGNITION BY CALMODULIN: 2.4 ANGSTROMS STRUCTURE OF A CALMODULIN-PEPTIDE COMPLEX;2;CA;CALCIUM ION;CALMODULIN;9606;
1CDM;A;MODULATION OF CALMODULIN PLASTICITY IN MOLECULAR RECOGNITION ON THE BASIS OF X-RAY STRUCTURES;2;CA;CALCIUM ION;PEPTIDE CALMODULIN-DEPENDENT PROTEIN KINASE II;9913;
1CE5;A;BOVINE PANCREAS BETA-TRYPSIN IN COMPLEX WITH BENZAMIDINE;1.9;CA;CALCIUM ION;PROTEIN (TRYPSIN);9913;
1CEH;A;STRUCTURE AND FUNCTION OF THE CATALYTIC SITE MUTANT ASP99ASN OF PHOSPHOLIPASE A2: ABSENCE OF CONSERVED STRUCTURAL WATER;1.9;CA;CALCIUM ION;PHOSPHOLIPASE A2;9913;
1CEL;A;THE THREE-DIMENSIONAL CRYSTAL STRUCTURE OF THE CATALYTIC CORE OF CELLOBIOHYDROLASE I FROM TRICHODERMA REESEI;1.8;CA;CALCIUM ION;1,4-BETA-D-GLUCAN CELLOBIOHYDROLASE I;51453;
1CFF;A;NMR SOLUTION STRUCTURE OF A COMPLEX OF CALMODULIN WITH A BINDING PEPTIDE OF THE CA2+-PUMP;;CA;CALCIUM ION;CALMODULIN;8355;
1CGE;A;CRYSTAL STRUCTURES OF RECOMBINANT 19-KDA HUMAN FIBROBLAST COLLAGENASE COMPLEXED TO ITSELF;1.9;CA;CALCIUM ION;FIBROBLAST COLLAGENASE;9606;
1CGF;A;CRYSTAL STRUCTURES OF RECOMBINANT 19-KDA HUMAN FIBROBLAST COLLAGENASE COMPLEXED TO ITSELF;2.1;CA;CALCIUM ION;FIBROBLAST COLLAGENASE;9606;
1CGF;B;CRYSTAL STRUCTURES OF RECOMBINANT 19-KDA HUMAN FIBROBLAST COLLAGENASE COMPLEXED TO ITSELF;2.1;CA;CALCIUM ION;FIBROBLAST COLLAGENASE;9606;
1CGL;A;Structure of the catalytic domain of fibroblast collagenase complexed with an inhibitor;2.4;CA;CALCIUM ION;FIBROBLAST COLLAGENASE;9606;
1CGL;B;Structure of the catalytic domain of fibroblast collagenase complexed with an inhibitor;2.4;CA;CALCIUM ION;FIBROBLAST COLLAGENASE;9606;
1CGT;A;STRUCTURE OF CYCLODEXTRIN GLYCOSYLTRANSFERASE REFINED AT 2.0 ANGSTROMS RESOLUTION;2;CA;CALCIUM ION;CYCLODEXTRIN GLYCOSYL-TRANSFERASE;1397;
1CGU;A;CATALYTIC CENTER OF CYCLODEXTRIN GLYCOSYLTRANSFERASE DERIVED FROM X-RAY STRUCTURE ANALYSIS COMBINED WITH SITE-DIRECTED MUTAGENESIS;2.5;CA;CALCIUM ION;CYCLODEXTRIN GLYCOSYL-TRANSFERASE;1397;
1CGV;A;SITE DIRECTED MUTATIONS OF THE ACTIVE SITE RESIDUE TYROSINE 195 OF CYCLODEXTRIN GLYCOSYLTRANSFERASE FROM BACILLUS CIRCULANS STRAIN 251 AFFECTING ACTIVITY AND PRODUCT SPECIFICITY;2.5;CA;CALCIUM ION;CYCLOMALTODEXTRIN GLUCANOTRANSFERASE;1397;
1CGW;A;SITE DIRECTED MUTATIONS OF THE ACTIVE SITE RESIDUE TYROSINE 195 OF CYCLODEXTRIN GLYCOSYLTRANSFERASE FROM BACILLUS CIRCULANS STRAIN 251 AFFECTING ACTIVITY AND PRODUCT SPECIFICITY;2.5;CA;CALCIUM ION;CYCLOMALTODEXTRIN GLUCANOTRANSFERASE;1397;
1CGX;A;SITE DIRECTED MUTATIONS OF THE ACTIVE SITE RESIDUE TYROSINE 195 OF CYCLODEXTRIN GLYXOSYLTRANSFERASE FROM BACILLUS CIRCULANS STRAIN 251 AFFECTING ACTIVITY AND PRODUCT SPECIFICITY;2.5;CA;CALCIUM ION;CYCLOMALTODEXTRIN GLUCANOTRANSFERASE;1397;
1CGY;A;SITE DIRECTED MUTATIONS OF THE ACTIVE SITE RESIDUE TYROSINE 195 OF CYCLODEXTRIN GLYXOSYLTRANSFERASE FROM BACILLUS CIRCULANS STRAIN 251 AFFECTING ACTIVITY AND PRODUCT SPECIFICITY;2.5;CA;CALCIUM ION;CYCLOMALTODEXTRIN GLUCANOTRANSFERASE;1397;
1CH0;A;RNASE T1 VARIANT WITH ALTERED GUANINE BINDING SEGMENT;2.3;CA;CALCIUM ION;PROTEIN (RIBONUCLEASE T1);5062;
1CH0;B;RNASE T1 VARIANT WITH ALTERED GUANINE BINDING SEGMENT;2.3;CA;CALCIUM ION;PROTEIN (RIBONUCLEASE T1);5062;
1CH0;C;RNASE T1 VARIANT WITH ALTERED GUANINE BINDING SEGMENT;2.3;CA;CALCIUM ION;PROTEIN (RIBONUCLEASE T1);5062;
1CIU;A;THERMOSTABLE CGTASE FROM THERMOANAEROBACTERIUM THERMOSULFURIGENES EM1 AT PH 8.0.;2.3;CA;CALCIUM ION;CYCLODEXTRIN GLYCOSYLTRANSFERASE;33950;
1CIW;A;PEANUT LECTIN COMPLEXED WITH N-ACETYLLACTOSAMINE;2.7;CA;CALCIUM ION;PROTEIN (PEANUT LECTIN);3818;
1CIW;B;PEANUT LECTIN COMPLEXED WITH N-ACETYLLACTOSAMINE;2.7;CA;CALCIUM ION;PROTEIN (PEANUT LECTIN);3818;
1CIW;C;PEANUT LECTIN COMPLEXED WITH N-ACETYLLACTOSAMINE;2.7;CA;CALCIUM ION;PROTEIN (PEANUT LECTIN);3818;
1CIW;D;PEANUT LECTIN COMPLEXED WITH N-ACETYLLACTOSAMINE;2.7;CA;CALCIUM ION;PROTEIN (PEANUT LECTIN);3818;
1CIZ;A;X-RAY STRUCTURE OF HUMAN STROMELYSIN CATALYTIC DOMAIN COMPLEXES WITH NON-PEPTIDE INHIBITORS: IMPLICATION FOR INHIBITOR SELECTIVITY;1.64;CA;CALCIUM ION;PROTEIN (STROMELYSIN-1);9606;
1CJP;A;CONCANAVALIN A COMPLEX WITH 4'-METHYLUMBELLIFERYL-ALPHA-D-GLUCOPYRANOSIDE;2.78;CA;CALCIUM ION;CONCANAVALIN A;3823;
1CJP;B;CONCANAVALIN A COMPLEX WITH 4'-METHYLUMBELLIFERYL-ALPHA-D-GLUCOPYRANOSIDE;2.78;CA;CALCIUM ION;CONCANAVALIN A;3823;
1CJP;C;CONCANAVALIN A COMPLEX WITH 4'-METHYLUMBELLIFERYL-ALPHA-D-GLUCOPYRANOSIDE;2.78;CA;CALCIUM ION;CONCANAVALIN A;3823;
1CJP;D;CONCANAVALIN A COMPLEX WITH 4'-METHYLUMBELLIFERYL-ALPHA-D-GLUCOPYRANOSIDE;2.78;CA;CALCIUM ION;CONCANAVALIN A;3823;
1CJY;A;HUMAN CYTOSOLIC PHOSPHOLIPASE A2;2.5;CA;CALCIUM ION;PROTEIN (CYTOSOLIC PHOSPHOLIPASE A2);9606;
1CJY;B;HUMAN CYTOSOLIC PHOSPHOLIPASE A2;2.5;CA;CALCIUM ION;PROTEIN (CYTOSOLIC PHOSPHOLIPASE A2);9606;
1CK6;A;BINDING MODE OF SALICYLHYDROXAMIC ACID TO ARTHROMYCES RAMOSUS PEROXIDASE;1.9;CA;CALCIUM ION;PROTEIN (PEROXIDASE);5451;
1CK7;A;GELATINASE A (FULL-LENGTH);2.8;CA;CALCIUM ION;PROTEIN (GELATINASE A);9606;
1CKK;A;CALMODULIN/RAT CA2+/CALMODULIN DEPENDENT PROTEIN KINASE FRAGMENT;;CA;CALCIUM ION;Calmodulin-1;8355;
1CKL;A;N-TERMINAL TWO DOMAINS OF HUMAN CD46 (MEMBRANE COFACTOR PROTEIN, MCP);3.1;CA;CALCIUM ION;PROTEIN (CD46);9606;
1CKL;B;N-TERMINAL TWO DOMAINS OF HUMAN CD46 (MEMBRANE COFACTOR PROTEIN, MCP);3.1;CA;CALCIUM ION;PROTEIN (CD46);9606;
1CKL;C;N-TERMINAL TWO DOMAINS OF HUMAN CD46 (MEMBRANE COFACTOR PROTEIN, MCP);3.1;CA;CALCIUM ION;PROTEIN (CD46);9606;
1CKL;D;N-TERMINAL TWO DOMAINS OF HUMAN CD46 (MEMBRANE COFACTOR PROTEIN, MCP);3.1;CA;CALCIUM ION;PROTEIN (CD46);9606;
1CKL;E;N-TERMINAL TWO DOMAINS OF HUMAN CD46 (MEMBRANE COFACTOR PROTEIN, MCP);3.1;CA;CALCIUM ION;PROTEIN (CD46);9606;
1CKL;F;N-TERMINAL TWO DOMAINS OF HUMAN CD46 (MEMBRANE COFACTOR PROTEIN, MCP);3.1;CA;CALCIUM ION;PROTEIN (CD46);9606;
1CLC;A;THREE-DIMENSIONAL STRUCTURE OF ENDOGLUCANASE D AT 1.9 ANGSTROMS RESOLUTION;1.9;CA;CALCIUM ION;ENDOGLUCANASE CELD;;
1CLL;A;CALMODULIN STRUCTURE REFINED AT 1.7 ANGSTROMS RESOLUTION;1.7;CA;CALCIUM ION;CALMODULIN;9606;
1CLM;A;STRUCTURE OF PARAMECIUM TETRAURELIA CALMODULIN AT 1.8 ANGSTROMS RESOLUTION;1.8;CA;CALCIUM ION;CALMODULIN;5888;
1CLQ;A;CRYSTAL STRUCTURE OF A REPLICATION FORK DNA POLYMERASE EDITING COMPLEX AT 2.7 A RESOLUTION;2.7;CA;CALCIUM ION;PROTEIN (DNA POLYMERASE);1914161;
1CLQ;D;CRYSTAL STRUCTURE OF A REPLICATION FORK DNA POLYMERASE EDITING COMPLEX AT 2.7 A RESOLUTION;2.7;CA;CALCIUM ION;DNA (5'-D(*AP*GP*TP*AP*GP*TP*TP*CP*CP*GP*CP*G)-3');;
1CLQ;E;CRYSTAL STRUCTURE OF A REPLICATION FORK DNA POLYMERASE EDITING COMPLEX AT 2.7 A RESOLUTION;2.7;CA;CALCIUM ION;DNA (5'-D(*GP*CP*GP*GP*AP*AP*CP*TP*AP*CP*T)-3');;
1CLV;A;YELLOW MEAL WORM ALPHA-AMYLASE IN COMPLEX WITH THE AMARANTH ALPHA-AMYLASE INHIBITOR;2;CA;CALCIUM ION;PROTEIN (ALPHA-AMYLASE);7067;
1CLX;A;CATALYTIC CORE OF XYLANASE A;1.8;CA;CALCIUM ION;XYLANASE A;155077;
1CLX;B;CATALYTIC CORE OF XYLANASE A;1.8;CA;CALCIUM ION;XYLANASE A;155077;
1CLX;C;CATALYTIC CORE OF XYLANASE A;1.8;CA;CALCIUM ION;XYLANASE A;155077;
1CLX;D;CATALYTIC CORE OF XYLANASE A;1.8;CA;CALCIUM ION;XYLANASE A;155077;
1CM1;A;MOTIONS OF CALMODULIN-SINGLE-CONFORMER REFINEMENT;2;CA;CALCIUM ION;CALMODULIN;9913;
1CM4;A;Motions of calmodulin-four-conformer refinement;2;CA;CALCIUM ION;CALMODULIN;9913;
1CNM;A;ENHANCEMENT OF CATALYTIC EFFICIENCY OF PROTEINASE K THROUGH EXPOSURE TO ANHYDROUS ORGANIC SOLVENT AT 70 DEGREES CELSIUS;2.2;CA;CALCIUM ION;PROTEIN (PROTEINASE K);37998;
1CO7;E;R117H mutant rat anionic trypsin complexed with bovine pancreatic trypsin inhibitor (BPTI);1.9;CA;CALCIUM ION;TRYPSIN II;10116;
1CON;A;THE REFINED STRUCTURE OF CADMIUM SUBSTITUTED CONCANAVALIN A AT 2.0 ANGSTROMS RESOLUTION;2;CA;CALCIUM ION;CONCANAVALIN A;3823;
1CP7;A;AMINOPEPTIDASE FROM STREPTOMYCES GRISEUS;1.58;CA;CALCIUM ION;AMINOPEPTIDASE;1911;
1CP9;B;CRYSTAL STRUCTURE OF PENICILLIN G ACYLASE FROM THE BRO1 MUTANT STRAIN OF PROVIDENCIA RETTGERI;2.5;CA;CALCIUM ION;Penicillin G amidase;587;
1CPM;A;NATIVE-LIKE IN VIVO FOLDING OF A CIRCULARLY PERMUTED JELLYROLL PROTEIN SHOWN BY CRYSTAL STRUCTURE ANALYSIS;2;CA;CALCIUM ION;CIRCULARLY PERMUTED;44252;
1CPN;A;NATIVE-LIKE IN VIVO FOLDING OF A CIRCULARLY PERMUTED JELLYROLL PROTEIN SHOWN BY CRYSTAL STRUCTURE ANALYSIS;1.8;CA;CALCIUM ION;CIRCULARLY PERMUTED;44252;
1CPU;A;SUBSITE MAPPING OF THE ACTIVE SITE OF HUMAN PANCREATIC ALPHA-AMYLASE USING SUBSTRATES, THE PHARMACOLOGICAL INHIBITOR ACARBOSE, AND AN ACTIVE SITE VARIANT;2;CA;CALCIUM ION;PROTEIN (ALPHA-AMYLASE);9606;
1CQ1;A;Soluble Quinoprotein Glucose Dehydrogenase from Acinetobacter Calcoaceticus in Complex with PQQH2 and Glucose;1.9;CA;CALCIUM ION;SOLUBLE QUINOPROTEIN GLUCOSE DEHYDROGENASE;471;
1CQ1;B;Soluble Quinoprotein Glucose Dehydrogenase from Acinetobacter Calcoaceticus in Complex with PQQH2 and Glucose;1.9;CA;CALCIUM ION;SOLUBLE QUINOPROTEIN GLUCOSE DEHYDROGENASE;471;
1CQ9;A;PEANUT LECTIN-TRICLINIC FORM;3.5;CA;CALCIUM ION;PROTEIN (PEANUT LECTIN);3818;
1CQ9;B;PEANUT LECTIN-TRICLINIC FORM;3.5;CA;CALCIUM ION;PROTEIN (PEANUT LECTIN);3818;
1CQ9;C;PEANUT LECTIN-TRICLINIC FORM;3.5;CA;CALCIUM ION;PROTEIN (PEANUT LECTIN);3818;
1CQ9;D;PEANUT LECTIN-TRICLINIC FORM;3.5;CA;CALCIUM ION;PROTEIN (PEANUT LECTIN);3818;
1CQR;A;CRYSTAL STRUCTURE OF THE STROMELYSIN CATALYTIC DOMAIN AT 2.0 A RESOLUTION;2;CA;CALCIUM ION;STROMELYSIN-1;9606;
1CQR;B;CRYSTAL STRUCTURE OF THE STROMELYSIN CATALYTIC DOMAIN AT 2.0 A RESOLUTION;2;CA;CALCIUM ION;STROMELYSIN-1;9606;
1CR7;A;PEANUT LECTIN-LACTOSE COMPLEX MONOCLINIC FORM;2.6;CA;CALCIUM ION;LECTIN;3818;
1CR7;B;PEANUT LECTIN-LACTOSE COMPLEX MONOCLINIC FORM;2.6;CA;CALCIUM ION;LECTIN;3818;
1CR7;C;PEANUT LECTIN-LACTOSE COMPLEX MONOCLINIC FORM;2.6;CA;CALCIUM ION;LECTIN;3818;
1CR7;D;PEANUT LECTIN-LACTOSE COMPLEX MONOCLINIC FORM;2.6;CA;CALCIUM ION;LECTIN;3818;
1CR7;E;PEANUT LECTIN-LACTOSE COMPLEX MONOCLINIC FORM;2.6;CA;CALCIUM ION;LECTIN;3818;
1CR7;F;PEANUT LECTIN-LACTOSE COMPLEX MONOCLINIC FORM;2.6;CA;CALCIUM ION;LECTIN;3818;
1CR7;G;PEANUT LECTIN-LACTOSE COMPLEX MONOCLINIC FORM;2.6;CA;CALCIUM ION;LECTIN;3818;
1CR7;H;PEANUT LECTIN-LACTOSE COMPLEX MONOCLINIC FORM;2.6;CA;CALCIUM ION;LECTIN;3818;
1CR8;A;LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN COMPLEMENT REPEAT 8;;CA;CALCIUM ION;PROTEIN (LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN);9606;
1CRU;A;SOLUBLE QUINOPROTEIN GLUCOSE DEHYDROGENASE FROM ACINETOBACTER CALCOACETICUS IN COMPLEX WITH PQQ AND METHYLHYDRAZINE;1.5;CA;CALCIUM ION;PROTEIN (SOLUBLE QUINOPROTEIN GLUCOSE DEHYDROGENASE);471;
1CRU;B;SOLUBLE QUINOPROTEIN GLUCOSE DEHYDROGENASE FROM ACINETOBACTER CALCOACETICUS IN COMPLEX WITH PQQ AND METHYLHYDRAZINE;1.5;CA;CALCIUM ION;PROTEIN (SOLUBLE QUINOPROTEIN GLUCOSE DEHYDROGENASE);471;
1CSE;E;THE HIGH-RESOLUTION X-RAY CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN SUBTILISIN CARLSBERG AND EGLIN C, AN ELASTASE INHIBITOR FROM THE LEECH HIRUDO MEDICINALIS. STRUCTURAL ANALYSIS, SUBTILISIN STRUCTURE AND INTERFACE GEOMETRY;1.2;CA;CALCIUM ION;SUBTILISIN CARLSBERG;1423;
1CTA;A;DETERMINATION OF THE SOLUTION STRUCTURE OF A SYNTHETIC TWO-SITE CALCIUM-BINDING HOMODIMERIC PROTEIN DOMAIN BY NMR SPECTROSCOPY;;CA;CALCIUM ION;TROPONIN C SITE III - SITE III HOMODIMER;9031;
1CTA;B;DETERMINATION OF THE SOLUTION STRUCTURE OF A SYNTHETIC TWO-SITE CALCIUM-BINDING HOMODIMERIC PROTEIN DOMAIN BY NMR SPECTROSCOPY;;CA;CALCIUM ION;TROPONIN C SITE III - SITE III HOMODIMER;9031;
1CTD;A;DETERMINATION OF THE SOLUTION STRUCTURE OF A SYNTHETIC TWO-SITE CALCIUM-BINDING HOMODIMERIC PROTEIN DOMAIN BY NMR SPECTROSCOPY;;CA;CALCIUM ION;TROPONIN C SITE III - SITE III HOMODIMER;9031;
1CTD;B;DETERMINATION OF THE SOLUTION STRUCTURE OF A SYNTHETIC TWO-SITE CALCIUM-BINDING HOMODIMERIC PROTEIN DOMAIN BY NMR SPECTROSCOPY;;CA;CALCIUM ION;TROPONIN C SITE III - SITE III HOMODIMER;9031;
1CTR;A;DRUG BINDING BY CALMODULIN: CRYSTAL STRUCTURE OF A CALMODULIN-TRIFLUOPERAZINE COMPLEX;2.45;CA;CALCIUM ION;CALMODULIN;9606;
1CVL;A;CRYSTAL STRUCTURE OF BACTERIAL LIPASE FROM CHROMOBACTERIUM VISCOSUM ATCC 6918;1.6;CA;CALCIUM ION;TRIACYLGLYCEROL HYDROLASE;42739;
1CVM;A;CADMIUM INHIBITED CRYSTAL STRUCTURE OF PHYTASE FROM BACILLUS AMYLOLIQUEFACIENS;2.4;CA;CALCIUM ION;PHYTASE;1390;
1CVN;A;CONCANAVALIN A COMPLEXED TO TRIMANNOSIDE;2.3;CA;CALCIUM ION;CONCANAVALIN A;3823;
1CVN;B;CONCANAVALIN A COMPLEXED TO TRIMANNOSIDE;2.3;CA;CALCIUM ION;CONCANAVALIN A;3823;
1CVN;C;CONCANAVALIN A COMPLEXED TO TRIMANNOSIDE;2.3;CA;CALCIUM ION;CONCANAVALIN A;3823;
1CVN;D;CONCANAVALIN A COMPLEXED TO TRIMANNOSIDE;2.3;CA;CALCIUM ION;CONCANAVALIN A;3823;
1CVR;A;Crystal structure of the Arg specific cysteine proteinase gingipain R (RGPB);2;CA;CALCIUM ION;GINGIPAIN R;837;
1CVW;H;Crystal structure of active site-inhibited human coagulation factor VIIA (DES-GLA);2.28;CA;CALCIUM ION;COAGULATION FACTOR VIIA (HEAVY CHAIN) (DES-GLA);9606;
1CW9;A;DNA DECAMER WITH AN ENGINEERED CROSSLINK IN THE MINOR GROOVE;1.55;CA;CALCIUM ION;5'-D(*CP*CP*AP*GP*(G47)P*CP*CP*TP*GP*G)-3';;
1CXE;A;COMPLEX OF CGTASE WITH MALTOTETRAOSE AT ROOM TEMPERATURE AND PH 9.1 BASED ON DIFFRACTION DATA OF A CRYSTAL SOAKED WITH ALPHA-CYCLODEXTRIN;2.1;CA;CALCIUM ION;CYCLODEXTRIN GLYCOSYLTRANSFERASE;1397;
1CXF;A;COMPLEX OF A (D229N/E257Q) DOUBLE MUTANT CGTASE FROM BACILLUS CIRCULANS STRAIN 251 WITH MALTOTETRAOSE AT 120 K AND PH 9.1 OBTAINED AFTER SOAKING THE CRYSTAL WITH ALPHA-CYCLODEXTRIN;2.1;CA;CALCIUM ION;CYCLODEXTRIN GLYCOSYLTRANSFERASE;1397;
1CXH;A;COMPLEX OF CGTASE WITH MALTOTETRAOSE AT ROOM TEMPERATURE AND PH 9.6 BASED ON DIFFRACTION DATA OF A CRYSTAL SOAKED WITH MALTOHEPTAOSE;2.41;CA;CALCIUM ION;CYCLODEXTRIN GLYCOSYLTRANSFERASE;1397;
1CXI;A;WILD-TYPE CGTASE FROM BACILLUS CIRCULANS STRAIN 251 AT 120 K AND PH 7.55;2.2;CA;CALCIUM ION;CYCLODEXTRIN GLYCOSYLTRANSFERASE;1397;
1CXK;A;COMPLEX BETWEEN A MALTONONAOSE SUBSTRATE AND BACILLUS CIRCULANS STRAIN 251 CGTASE E257Q/D229N;2.09;CA;CALCIUM ION;PROTEIN (CYCLODEXTRIN-GLYCOSYLTRANSFERASE);1397;
1CXL;A;COMPLEX BETWEEN A COVALENT INTERMEDIATE AND BACILLUS CIRCULANS STRAIN 251 CGTASE E257Q;1.81;CA;CALCIUM ION;PROTEIN (CYCLODEXTRIN-GLYCOSYLTRANSFERASE);1397;
1CXP;C;CRYOGENIC CRYSTAL STRUCTURE OF HUMAN MYELOPEROXIDASE ISOFORM C;1.8;CA;CALCIUM ION;MYELOPEROXIDASE;9606;
1CXP;D;CRYOGENIC CRYSTAL STRUCTURE OF HUMAN MYELOPEROXIDASE ISOFORM C;1.8;CA;CALCIUM ION;MYELOPEROXIDASE;9606;
1CXV;A;STRUCTURE OF RECOMBINANT MOUSE COLLAGENASE-3 (MMP-13);2;CA;CALCIUM ION;PROTEIN (COLLAGENASE-3);10090;
1CXV;B;STRUCTURE OF RECOMBINANT MOUSE COLLAGENASE-3 (MMP-13);2;CA;CALCIUM ION;PROTEIN (COLLAGENASE-3);10090;
1CYG;A;CYCLODEXTRIN GLUCANOTRANSFERASE (E.C.2.4.1.19) (CGTASE);2.5;CA;CALCIUM ION;CYCLODEXTRIN GLUCANOTRANSFERASE;1422;
1D0B;A;INTERNALIN B LEUCINE RICH REPEAT DOMAIN;1.86;CA;CALCIUM ION;INTERNALIN B;1639;
1D0K;A;THE ESCHERICHIA COLI LYTIC TRANSGLYCOSYLASE SLT35 IN COMPLEX WITH TWO MURODIPEPTIDES (GLCNAC-MURNAC-L-ALA-D-GLU);2.02;CA;CALCIUM ION;35KD SOLUBLE LYTIC TRANSGLYCOSYLASE;562;
1D0L;A;THE ESCHERICHIA COLI LYTIC TRANSGLYCOSYLASE SLT35 IN COMPLEX WITH BULGECIN A;1.97;CA;CALCIUM ION;35KD SOLUBLE LYTIC TRANSGLYCOSYLASE;562;
1D0M;A;THE ESCHERICHIA COLI LYTIC TRANSGLYCOSYLASE SLT35 IN COMPLEX WITH BULGECIN A AND (GLCNAC)2;2.47;CA;CALCIUM ION;35KD SOLUBLE LYTIC TRANSGLYCOSYLASE;562;
1D2J;A;LDL RECEPTOR LIGAND-BINDING MODULE 6;;CA;CALCIUM ION;LOW-DENSITY LIPOPROTEIN RECEPTOR;9606;
1D2L;A;NMR SOLUTION STRUCTURE OF COMPLEMENT-LIKE REPEAT CR3 FROM THE LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN (LRP). EVIDENCE FOR SPECIFIC BINDING TO THE RECEPTOR BINDING DOMAIN OF HUMAN ALPHA-2 MACROGLOBULIN;;CA;CALCIUM ION;LIPOPROTEIN RECEPTOR RELATED PROTEIN;9606;
1D2S;A;CRYSTAL STRUCTURE OF THE N-TERMINAL LAMININ G-LIKE DOMAIN OF SHBG IN COMPLEX WITH DIHYDROTESTOSTERONE;1.55;CA;CALCIUM ION;SEX HORMONE-BINDING GLOBULIN;9606;
1D2V;A;CRYSTAL STRUCTURE OF BROMIDE-BOUND HUMAN MYELOPEROXIDASE ISOFORM C AT PH 5.5;1.75;CA;CALCIUM ION;MYELOPEROXIDASE;9606;
1D2V;B;CRYSTAL STRUCTURE OF BROMIDE-BOUND HUMAN MYELOPEROXIDASE ISOFORM C AT PH 5.5;1.75;CA;CALCIUM ION;MYELOPEROXIDASE;9606;
1D3C;A;MICHAELIS COMPLEX OF BACILLUS CIRCULANS STRAIN 251 CYCLODEXTRIN GLYCOSYLTRANSFERASE WITH GAMMA-CYCLODEXTRIN;1.78;CA;CALCIUM ION;CYCLODEXTRIN GLYCOSYLTRANSFERASE;1397;
1D4X;G;Crystal Structure of Caenorhabditis Elegans Mg-ATP Actin Complexed with Human Gelsolin Segment 1 at 1.75 A resolution.;1.75;CA;CALCIUM ION;GELSOLIN;9606;
1D56;A;ALTERNATIVE STRUCTURES FOR ALTERNATING POLY(DA-DT) TRACTS: THE STRUCTURE OF THE B-DNA DECAMER C-G-A-T-A-T-A-T-C-G;1.7;CA;CALCIUM ION;DNA (5'-D(*CP*GP*AP*TP*AP*TP*AP*TP*CP*G)-3');;
1D5J;A;CRYSTAL STRUCTURE OF MMP3 COMPLEXED WITH A THIAZEPINE BASED INHIBITOR.;2.6;CA;CALCIUM ION;STROMELYSIN-1;9606;
1D5J;B;CRYSTAL STRUCTURE OF MMP3 COMPLEXED WITH A THIAZEPINE BASED INHIBITOR.;2.6;CA;CALCIUM ION;STROMELYSIN-1;9606;
1D5L;C;CRYSTAL STRUCTURE OF CYANIDE-BOUND HUMAN MYELOPEROXIDASE ISOFORM C AT PH 5.5;1.9;CA;CALCIUM ION;MYELOPEROXIDASE;9606;
1D5L;D;CRYSTAL STRUCTURE OF CYANIDE-BOUND HUMAN MYELOPEROXIDASE ISOFORM C AT PH 5.5;1.9;CA;CALCIUM ION;MYELOPEROXIDASE;9606;
1D61;A;THE STRUCTURE OF THE B-DNA DECAMER C-C-A-A-C-I-T-T-G-G: MONOCLINIC FORM;1.3;CA;CALCIUM ION;DNA (5'-D(*CP*CP*AP*AP*CP*IP*TP*TP*GP*G)-3');;
1D6U;A;CRYSTAL STRUCTURE OF E. COLI AMINE OXIDASE ANAEROBICALLY REDUCED WITH BETA-PHENYLETHYLAMINE;2.4;CA;CALCIUM ION;COPPER AMINE OXIDASE;562;
1D6U;B;CRYSTAL STRUCTURE OF E. COLI AMINE OXIDASE ANAEROBICALLY REDUCED WITH BETA-PHENYLETHYLAMINE;2.4;CA;CALCIUM ION;COPPER AMINE OXIDASE;562;
1D6Y;A;CRYSTAL STRUCTURE OF E. COLI COPPER-CONTAINING AMINE OXIDASE ANAEROBICALLY REDUCED WITH BETA-PHENYLETHYLAMINE AND COMPLEXED WITH NITRIC OXIDE.;2.4;CA;CALCIUM ION;COPPER AMINE OXIDASE;562;
1D6Y;B;CRYSTAL STRUCTURE OF E. COLI COPPER-CONTAINING AMINE OXIDASE ANAEROBICALLY REDUCED WITH BETA-PHENYLETHYLAMINE AND COMPLEXED WITH NITRIC OXIDE.;2.4;CA;CALCIUM ION;COPPER AMINE OXIDASE;562;
1D6Z;A;CRYSTAL STRUCTURE OF THE AEROBICALLY FREEZE TRAPPED RATE-DETERMINING CATALYTIC INTERMEDIATE OF E. COLI COPPER-CONTAINING AMINE OXIDASE.;2.1;CA;CALCIUM ION;COPPER AMINE OXIDASE;562;
1D6Z;B;CRYSTAL STRUCTURE OF THE AEROBICALLY FREEZE TRAPPED RATE-DETERMINING CATALYTIC INTERMEDIATE OF E. COLI COPPER-CONTAINING AMINE OXIDASE.;2.1;CA;CALCIUM ION;COPPER AMINE OXIDASE;562;
1D7F;A;CRYSTAL STRUCTURE OF ASPARAGINE 233-REPLACED CYCLODEXTRIN GLUCANOTRANSFERASE FROM ALKALOPHILIC BACILLUS SP. 1011 DETERMINED AT 1.9 A RESOLUTION;1.9;CA;CALCIUM ION;CYCLODEXTRIN GLUCANOTRANSFERASE;1410;
1D7F;B;CRYSTAL STRUCTURE OF ASPARAGINE 233-REPLACED CYCLODEXTRIN GLUCANOTRANSFERASE FROM ALKALOPHILIC BACILLUS SP. 1011 DETERMINED AT 1.9 A RESOLUTION;1.9;CA;CALCIUM ION;CYCLODEXTRIN GLUCANOTRANSFERASE;1410;
1D7W;C;CRYSTAL STRUCTURE OF HUMAN MYELOPEROXIDASE ISOFORM C COMPLEXED WITH CYANIDE AND BROMIDE AT PH 4.0;1.9;CA;CALCIUM ION;MYELOPEROXIDASE;9606;
1D7W;D;CRYSTAL STRUCTURE OF HUMAN MYELOPEROXIDASE ISOFORM C COMPLEXED WITH CYANIDE AND BROMIDE AT PH 4.0;1.9;CA;CALCIUM ION;MYELOPEROXIDASE;9606;
1D7X;A;CRYSTAL STRUCTURE OF MMP3 COMPLEXED WITH A MODIFIED PROLINE SCAFFOLD BASED INHIBITOR.;2;CA;CALCIUM ION;STROMELYSIN-1 PRECURSOR;9606;
1D7X;B;CRYSTAL STRUCTURE OF MMP3 COMPLEXED WITH A MODIFIED PROLINE SCAFFOLD BASED INHIBITOR.;2;CA;CALCIUM ION;STROMELYSIN-1 PRECURSOR;9606;
1D8F;A;CRYSTAL STRUCTURE OF MMP3 COMPLEXED WITH A PIPERAZINE BASED INHIBITOR.;2.4;CA;CALCIUM ION;STROMELYSIN-1 PRECURSOR;9606;
1D8F;B;CRYSTAL STRUCTURE OF MMP3 COMPLEXED WITH A PIPERAZINE BASED INHIBITOR.;2.4;CA;CALCIUM ION;STROMELYSIN-1 PRECURSOR;9606;
1D8G;A;ULTRAHIGH RESOLUTION CRYSTAL STRUCTURE OF B-DNA DECAMER D(CCAGTACTGG);0.74;CA;CALCIUM ION;5'-D(*CP*CP*AP*GP*TP*AP*CP*TP*GP*GP*)-3';;
1D8M;A;CRYSTAL STRUCTURE OF MMP3 COMPLEXED WITH A HETEROCYCLE-BASED INHIBITOR;2.44;CA;CALCIUM ION;STROMELYSIN-1 PRECURSOR;9606;
1D8M;B;CRYSTAL STRUCTURE OF MMP3 COMPLEXED WITH A HETEROCYCLE-BASED INHIBITOR;2.44;CA;CALCIUM ION;STROMELYSIN-1 PRECURSOR;9606;
1DAF;A;DETHIOBIOTIN SYNTHETASE COMPLEXED WITH 7-(CARBOXYAMINO)-8-AMINO-NONANOIC ACID, ADP, AND CALCIUM;1.7;CA;CALCIUM ION;DETHIOBIOTIN SYNTHETASE;562;
1DAN;H;Complex of active site inhibited human blood coagulation factor VIIA with human recombinant soluble tissue factor;2;CA;CALCIUM ION;BLOOD COAGULATION FACTOR VIIA heavy chain;9606;
1DAN;L;Complex of active site inhibited human blood coagulation factor VIIA with human recombinant soluble tissue factor;2;CA;CALCIUM ION;BLOOD COAGULATION FACTOR VIIA light chain;9606;
1DAQ;A;SOLUTION STRUCTURE OF THE TYPE I DOCKERIN DOMAIN FROM THE CLOSTRIDIUM THERMOCELLUM CELLULOSOME (MINIMIZED AVERAGE STRUCTURE);;CA;CALCIUM ION;ENDOGLUCANASE SS;1515;
1DAV;A;SOLUTION STRUCTURE OF THE TYPE I DOCKERIN DOMAIN FROM THE CLOSTRIDIUM THERMOCELLUM CELLULOSOME (20 STRUCTURES);;CA;CALCIUM ION;ENDOGLUCANASE SS;1515;
1DB4;A;HUMAN S-PLA2 IN COMPLEX WITH INDOLE 8;2.2;CA;CALCIUM ION;PHOSPHOLIPASE A2;9606;
1DB5;A;HUMAN S-PLA2 IN COMPLEX WITH INDOLE 6;2.8;CA;CALCIUM ION;PROTEIN (PHOSPHOLIPASE A2);9606;
1DBI;A;CRYSTAL STRUCTURE OF A THERMOSTABLE SERINE PROTEASE;1.8;CA;CALCIUM ION;AK.1 SERINE PROTEASE;268807;
1DBN;A;MAACKIA AMURENSIS LEUKOAGGLUTININ (LECTIN) WITH SIALYLLACTOSE;2.75;CA;CALCIUM ION;PROTEIN (LEUKOAGGLUTININ);37501;
1DBN;B;MAACKIA AMURENSIS LEUKOAGGLUTININ (LECTIN) WITH SIALYLLACTOSE;2.75;CA;CALCIUM ION;PROTEIN (LEUKOAGGLUTININ);37501;
1DCT;A;DNA (CYTOSINE-5) METHYLASE FROM HAEIII COVALENTLY BOUND TO DNA;2.8;CA;CALCIUM ION;PROTEIN (MODIFICATION METHYLASE HAEIII);727;
1DCT;B;DNA (CYTOSINE-5) METHYLASE FROM HAEIII COVALENTLY BOUND TO DNA;2.8;CA;CALCIUM ION;PROTEIN (MODIFICATION METHYLASE HAEIII);727;
1DCY;A;CRYSTAL STRUCTURE OF HUMAN S-PLA2 IN COMPLEX WITH INDOLE 3 ACTIVE SITE INHIBITOR;2.7;CA;CALCIUM ION;PHOSPHOLIPASE A2;9606;
1DDR;B;MOLECULE: DIHYDROFOLATE REDUCTASE (E.C.1.5.1.3) COMPLEXED WITH METHOTREXATE AND UREA;2.45;CA;CALCIUM ION;DIHYDROFOLATE REDUCTASE;562;
1DDS;B;MOLECULE: DIHYDROFOLATE REDUCTASE (E.C.1.5.1.3) COMPLEXED WITH METHOTREXATE;2.2;CA;CALCIUM ION;DIHYDROFOLATE REDUCTASE;562;
1DE4;C;HEMOCHROMATOSIS PROTEIN HFE COMPLEXED WITH TRANSFERRIN RECEPTOR;2.8;CA;CALCIUM ION;TRANSFERRIN RECEPTOR;9606;
1DE4;F;HEMOCHROMATOSIS PROTEIN HFE COMPLEXED WITH TRANSFERRIN RECEPTOR;2.8;CA;CALCIUM ION;TRANSFERRIN RECEPTOR;9606;
1DE4;I;HEMOCHROMATOSIS PROTEIN HFE COMPLEXED WITH TRANSFERRIN RECEPTOR;2.8;CA;CALCIUM ION;TRANSFERRIN RECEPTOR;9606;
1DED;A;CRYSTAL STRUCTURE OF ALKALOPHILIC ASPARAGINE 233-REPLACED CYCLODEXTRIN GLUCANOTRANSFERASE COMPLEXED WITH AN INHIBITOR, ACARBOSE, AT 2.0 A RESOLUTION;2;CA;CALCIUM ION;CYCLODEXTRIN GLUCANOTRANSFERASE;1410;
1DED;B;CRYSTAL STRUCTURE OF ALKALOPHILIC ASPARAGINE 233-REPLACED CYCLODEXTRIN GLUCANOTRANSFERASE COMPLEXED WITH AN INHIBITOR, ACARBOSE, AT 2.0 A RESOLUTION;2;CA;CALCIUM ION;CYCLODEXTRIN GLUCANOTRANSFERASE;1410;
1DEG;A;THE LINKER OF DES-GLU84 CALMODULIN IS BENT AS SEEN IN THE CRYSTAL STRUCTURE;2.9;CA;CALCIUM ION;CALMODULIN;9913;
1DEJ;A;CRYSTAL STRUCTURE OF A DICTYOSTELIUM/TETRAHYMENA CHIMERA ACTIN (MUTANT 646: Q228K/T229A/A230Y/A231K/S232E/E360H) IN COMPLEX WITH HUMAN GELSOLIN SEGMENT 1;2.4;CA;CALCIUM ION;CHIMERIC ACTIN;591,144,689;
1DEJ;S;CRYSTAL STRUCTURE OF A DICTYOSTELIUM/TETRAHYMENA CHIMERA ACTIN (MUTANT 646: Q228K/T229A/A230Y/A231K/S232E/E360H) IN COMPLEX WITH HUMAN GELSOLIN SEGMENT 1;2.4;CA;CALCIUM ION;GELSOLIN;9606;
1DFK;Z;NUCLEOTIDE-FREE SCALLOP MYOSIN S1-NEAR RIGOR STATE;4.2;CA;CALCIUM ION;MYOSIN HEAD;31199;
1DFL;X;SCALLOP MYOSIN S1 COMPLEXED WITH MGADP:VANADATE-TRANSITION STATE;4.2;CA;CALCIUM ION;MYOSIN HEAD;31199;
1DFL;Z;SCALLOP MYOSIN S1 COMPLEXED WITH MGADP:VANADATE-TRANSITION STATE;4.2;CA;CALCIUM ION;MYOSIN HEAD;31199;
1DFM;A;Crystal structure of restriction endonuclease BGLII complexed with DNA 16-mer;1.5;CA;CALCIUM ION;ENDONUCLEASE BGLII;1423;
1DFM;B;Crystal structure of restriction endonuclease BGLII complexed with DNA 16-mer;1.5;CA;CALCIUM ION;ENDONUCLEASE BGLII;1423;
1DFX;A;DESULFOFERRODOXIN FROM DESULFOVIBRIO DESULFURICANS, ATCC 27774;1.9;CA;CALCIUM ION;DESULFOFERRODOXIN;876;
1DGL;A;LECTIN FROM DIOCLEA GRANDIFLORA COMPLEXED TO TRIMANNOSIDE;2.4;CA;CALCIUM ION;LECTIN;3837;
1DGL;B;LECTIN FROM DIOCLEA GRANDIFLORA COMPLEXED TO TRIMANNOSIDE;2.4;CA;CALCIUM ION;LECTIN;3837;
1DHI;B;LONG-RANGE STRUCTURAL EFFECTS IN A SECOND-SITE REVERTANT OF A MUTANT DIHYDROFOLATE REDUCTASE;1.9;CA;CALCIUM ION;DIHYDROFOLATE REDUCTASE;562;
1DHJ;B;LONG-RANGE STRUCTURAL EFFECTS IN A SECOND-SITE REVERTANT OF A MUTANT DIHYDROFOLATE REDUCTASE;1.8;CA;CALCIUM ION;DIHYDROFOLATE REDUCTASE;562;
1DHK;A;STRUCTURE OF PORCINE PANCREATIC ALPHA-AMYLASE;1.85;CA;CALCIUM ION;PORCINE PANCREATIC ALPHA-AMYLASE;9823;
1DHK;B;STRUCTURE OF PORCINE PANCREATIC ALPHA-AMYLASE;1.85;CA;CALCIUM ION;BEAN LECTIN-LIKE INHIBITOR;3885;
1DJI;A;PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C-DELTA1 FROM RAT COMPLEXED WITH CALCIUM;2.5;CA;CALCIUM ION;PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C, ISOZYME DELTA1;10116;
1DJI;B;PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C-DELTA1 FROM RAT COMPLEXED WITH CALCIUM;2.5;CA;CALCIUM ION;PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C, ISOZYME DELTA1;10116;
1DJW;A;PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C-DELTA1 FROM RAT COMPLEXED WITH INOSITOL-2-METHYLENE-1,2-CYCLIC-MONOPHOSPHONATE;2.45;CA;CALCIUM ION;PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C, ISOZYME DELTA1;10116;
1DJW;B;PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C-DELTA1 FROM RAT COMPLEXED WITH INOSITOL-2-METHYLENE-1,2-CYCLIC-MONOPHOSPHONATE;2.45;CA;CALCIUM ION;PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C, ISOZYME DELTA1;10116;
1DJX;A;PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C-DELTA1 FROM RAT COMPLEXED WITH INOSITOL-1,4,5-TRISPHOSPHATE;2.3;CA;CALCIUM ION;PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C, ISOZYME DELTA1;10116;
1DJX;B;PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C-DELTA1 FROM RAT COMPLEXED WITH INOSITOL-1,4,5-TRISPHOSPHATE;2.3;CA;CALCIUM ION;PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C, ISOZYME DELTA1;10116;
1DJY;A;PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C-DELTA1 FROM RAT COMPLEXED WITH INOSITOL-2,4,5-TRISPHOSPHATE;2.8;CA;CALCIUM ION;PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C, ISOZYME DELTA1;10116;
1DJY;B;PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C-DELTA1 FROM RAT COMPLEXED WITH INOSITOL-2,4,5-TRISPHOSPHATE;2.8;CA;CALCIUM ION;PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C, ISOZYME DELTA1;10116;
1DJZ;A;PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C-DELTA1 FROM RAT COMPLEXED WITH INOSITOL-4,5-BISPHOSPHATE;2.95;CA;CALCIUM ION;PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C, ISOZYME DELTA1;10116;
1DJZ;B;PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C-DELTA1 FROM RAT COMPLEXED WITH INOSITOL-4,5-BISPHOSPHATE;2.95;CA;CALCIUM ION;PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C, ISOZYME DELTA1;10116;
1DL2;A;CRYSTAL STRUCTURE OF CLASS I ALPHA-1,2-MANNOSIDASE FROM SACCHAROMYCES CEREVISIAE AT 1.54 ANGSTROM RESOLUTION;1.54;CA;CALCIUM ION;CLASS I ALPHA-1,2-MANNOSIDASE;4932;
1DM5;A;ANNEXIN XII E105K HOMOHEXAMER CRYSTAL STRUCTURE;1.93;CA;CALCIUM ION;ANNEXIN XII E105K MUTANT HOMOHEXAMER;6087;
1DM5;B;ANNEXIN XII E105K HOMOHEXAMER CRYSTAL STRUCTURE;1.93;CA;CALCIUM ION;ANNEXIN XII E105K MUTANT HOMOHEXAMER;6087;
1DM5;C;ANNEXIN XII E105K HOMOHEXAMER CRYSTAL STRUCTURE;1.93;CA;CALCIUM ION;ANNEXIN XII E105K MUTANT HOMOHEXAMER;6087;
1DM5;D;ANNEXIN XII E105K HOMOHEXAMER CRYSTAL STRUCTURE;1.93;CA;CALCIUM ION;ANNEXIN XII E105K MUTANT HOMOHEXAMER;6087;
1DM5;E;ANNEXIN XII E105K HOMOHEXAMER CRYSTAL STRUCTURE;1.93;CA;CALCIUM ION;ANNEXIN XII E105K MUTANT HOMOHEXAMER;6087;
1DM5;F;ANNEXIN XII E105K HOMOHEXAMER CRYSTAL STRUCTURE;1.93;CA;CALCIUM ION;ANNEXIN XII E105K MUTANT HOMOHEXAMER;6087;
1DMU;A;Crystal structure of the restriction endonuclease BglI (e.c.3.1.21.4) bound to its dna recognition sequence;2.2;CA;CALCIUM ION;BGLI RESTRICTION ENDONUCLEASE;1423;
1DMU;F;Crystal structure of the restriction endonuclease BglI (e.c.3.1.21.4) bound to its dna recognition sequence;2.2;CA;CALCIUM ION;DNA (5'-D(*AP*TP*CP*GP*CP*CP*TP*AP*AP*TP*AP*GP*GP*CP*GP*AP*T)-3');;
1DNU;C;STRUCTURAL ANALYSES OF HUMAN MYELOPEROXIDASE-THIOCYANATE COMPLEX;1.85;CA;CALCIUM ION;MYELOPEROXIDASE;9606;
1DNU;D;STRUCTURAL ANALYSES OF HUMAN MYELOPEROXIDASE-THIOCYANATE COMPLEX;1.85;CA;CALCIUM ION;MYELOPEROXIDASE;9606;
1DNW;C;HUMAN MYELOPEROXIDASE-CYANIDE-THIOCYANATE COMPLEX;1.9;CA;CALCIUM ION;MYELOPEROXIDASE;9606;
1DNW;D;HUMAN MYELOPEROXIDASE-CYANIDE-THIOCYANATE COMPLEX;1.9;CA;CALCIUM ION;MYELOPEROXIDASE;9606;
1DPO;A;STRUCTURE OF RAT TRYPSIN;1.59;CA;CALCIUM ION;TRYPSIN;10117;
1DQF;B;CRYSTAL STRUCTURE OF HELIX II OF THE X. LAEVIS SOMATIC 5S RRNA WITH A CYTOSINE BULGE IN TWO CONFORMATIONS;2.2;CA;CALCIUM ION;RNA (5'-R(*CP*AP*GP*GP*GP*UP*CP*GP*GP*C)-3');;
1DR1;A;2.2 ANGSTROMS CRYSTAL STRUCTURE OF CHICKEN LIVER DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADP+ AND BIOPTERIN;2.2;CA;CALCIUM ION;DIHYDROFOLATE REDUCTASE;9031;
1DR2;A;2.3 ANGSTROMS CRYSTAL STRUCTURE OF CHICKEN LIVER DIHYDROFOLATE REDUCTASE COMPLEXED WITH THIONADP+ AND BIOPTERIN;2.3;CA;CALCIUM ION;DIHYDROFOLATE REDUCTASE;9031;
1DR3;A;2.3 ANGSTROMS CRYSTAL STRUCTURE OF CHICKEN LIVER DIHYDROFOLATE REDUCTASE COMPLEXED WITH THIONADP+ AND BIOPTERIN;2.3;CA;CALCIUM ION;DIHYDROFOLATE REDUCTASE;9031;
1DR4;A;CRYSTAL STRUCTURES OF ORGANOMERCURIAL-ACTIVATED CHICKEN LIVER DIHYDROFOLATE REDUCTASE COMPLEXES;2.4;CA;CALCIUM ION;DIHYDROFOLATE REDUCTASE;9031;
1DR5;A;CRYSTAL STRUCTURES OF ORGANOMERCURIAL-ACTIVATED CHICKEN LIVER DIHYDROFOLATE REDUCTASE COMPLEXES;2.4;CA;CALCIUM ION;DIHYDROFOLATE REDUCTASE;9031;
1DR6;A;CRYSTAL STRUCTURES OF ORGANOMERCURIAL-ACTIVATED CHICKEN LIVER DIHYDROFOLATE REDUCTASE COMPLEXES;2.4;CA;CALCIUM ION;DIHYDROFOLATE REDUCTASE;9031;
1DR7;A;CRYSTAL STRUCTURES OF ORGANOMERCURIAL-ACTIVATED CHICKEN LIVER DIHYDROFOLATE REDUCTASE COMPLEXES;2.4;CA;CALCIUM ION;DIHYDROFOLATE REDUCTASE;9031;
1DRA;B;CRYSTAL STRUCTURE OF UNLIGANDED ESCHERICHIA COLI DIHYDROFOLATE REDUCTASE. LIGAND-INDUCED CONFORMATIONAL CHANGES AND COOPERATIVITY IN BINDING;1.9;CA;CALCIUM ION;DIHYDROFOLATE REDUCTASE;562;
1DRB;B;CRYSTAL STRUCTURE OF UNLIGANDED ESCHERICHIA COLI DIHYDROFOLATE REDUCTASE. LIGAND-INDUCED CONFORMATIONAL CHANGES AND COOPERATIVITY IN BINDING;1.96;CA;CALCIUM ION;DIHYDROFOLATE REDUCTASE;562;
1DSY;A;C2 DOMAIN FROM PROTEIN KINASE C (ALPHA) COMPLEXED WITH CA2+ AND PHOSPHATIDYLSERINE;2.6;CA;CALCIUM ION;PROTEIN KINASE C, ALPHA TYPE;10116;
1DT7;A;SOLUTION STRUCTURE OF THE C-TERMINAL NEGATIVE REGULATORY DOMAIN OF P53 IN A COMPLEX WITH CA2+-BOUND S100B(BB);;CA;CALCIUM ION;S100 CALCIUM-BINDING PROTEIN;10116;
1DT7;B;SOLUTION STRUCTURE OF THE C-TERMINAL NEGATIVE REGULATORY DOMAIN OF P53 IN A COMPLEX WITH CA2+-BOUND S100B(BB);;CA;CALCIUM ION;S100 CALCIUM-BINDING PROTEIN;10116;
1DTH;A;METALLOPROTEASE;2;CA;CALCIUM ION;ATROLYSIN C;8730;
1DTH;B;METALLOPROTEASE;2;CA;CALCIUM ION;ATROLYSIN C;8730;
1DTL;A;CRYSTAL STRUCTURE OF CALCIUM-SATURATED (3CA2+) CARDIAC TROPONIN C COMPLEXED WITH THE CALCIUM SENSITIZER BEPRIDIL AT 2.15 A RESOLUTION;2.15;CA;CALCIUM ION;CARDIAC TROPONIN C;9031;
1DTU;A;BACILLUS CIRCULANS STRAIN 251 CYCLODEXTRIN GLYCOSYLTRANSFERASE: A MUTANT Y89D/S146P COMPLEXED TO AN HEXASACCHARIDE INHIBITOR;2.4;CA;CALCIUM ION;PROTEIN (CYCLODEXTRIN GLYCOSYLTRANSFERASE);1397;
1DV8;A;CRYSTAL STRUCTURE OF THE CARBOHYDRATE RECOGNITION DOMAIN OF THE H1 SUBUNIT OF THE ASIALOGLYCOPROTEIN RECEPTOR;2.3;CA;CALCIUM ION;ASIALOGLYCOPROTEIN RECEPTOR 1;9606;
1DVA;H;Crystal Structure of the Complex Between the Peptide Exosite Inhibitor E-76 and Coagulation Factor VIIA;3;CA;CALCIUM ION;DES-GLA FACTOR VIIA (HEAVY CHAIN);9606;
1DVA;I;Crystal Structure of the Complex Between the Peptide Exosite Inhibitor E-76 and Coagulation Factor VIIA;3;CA;CALCIUM ION;DES-GLA FACTOR VIIA (HEAVY CHAIN);9606;
1DVA;L;Crystal Structure of the Complex Between the Peptide Exosite Inhibitor E-76 and Coagulation Factor VIIA;3;CA;CALCIUM ION;DES-GLA FACTOR VIIA (LIGHT CHAIN);9606;
1DVA;M;Crystal Structure of the Complex Between the Peptide Exosite Inhibitor E-76 and Coagulation Factor VIIA;3;CA;CALCIUM ION;DES-GLA FACTOR VIIA (LIGHT CHAIN);9606;
1DVI;A;CALPAIN DOMAIN VI WITH CALCIUM BOUND;2.3;CA;CALCIUM ION;CALPAIN;10116;
1DVI;B;CALPAIN DOMAIN VI WITH CALCIUM BOUND;2.3;CA;CALCIUM ION;CALPAIN;10116;
1DX5;I;Crystal structure of the thrombin-thrombomodulin complex;2.3;CA;CALCIUM ION;Thrombomodulin;9606;
1DX5;J;Crystal structure of the thrombin-thrombomodulin complex;2.3;CA;CALCIUM ION;Thrombomodulin;9606;
1DX5;K;Crystal structure of the thrombin-thrombomodulin complex;2.3;CA;CALCIUM ION;Thrombomodulin;9606;
1DX5;L;Crystal structure of the thrombin-thrombomodulin complex;2.3;CA;CALCIUM ION;Thrombomodulin;9606;
1DYH;B;ISOMORPHOUS CRYSTAL STRUCTURES OF ESCHERICHIA COLI DIHYDROFOLATE REDUCTASE COMPLEXED WITH FOLATE, 5-DEAZAFOLATE AND 5,10-DIDEAZATETRAHYDROFOLATE: MECHANISTIC IMPLICATIONS;1.9;CA;CALCIUM ION;DIHYDROFOLATE REDUCTASE;562;
1DYI;B;ISOMORPHOUS CRYSTAL STRUCTURES OF ESCHERICHIA COLI DIHYDROFOLATE REDUCTASE COMPLEXED WITH FOLATE, 5-DEAZAFOLATE AND 5,10-DIDEAZATETRAHYDROFOLATE: MECHANISTIC IMPLICATIONS;1.9;CA;CALCIUM ION;DIHYDROFOLATE REDUCTASE;562;
1DYJ;B;ISOMORPHOUS CRYSTAL STRUCTURES OF ESCHERICHIA COLI DIHYDROFOLATE REDUCTASE COMPLEXED WITH FOLATE, 5-DEAZAFOLATE AND 5,10-DIDEAZATETRAHYDROFOLATE: MECHANISTIC IMPLICATIONS;1.85;CA;CALCIUM ION;DIHYDROFOLATE REDUCTASE;562;
1DYK;A;Laminin alpha 2 chain LG4-5 domain pair;2;CA;CALCIUM ION;LAMININ ALPHA 2 CHAIN;10090;
1DYO;A;Xylan-Binding Domain from CBM 22, formally x6b domain;2.1;CA;CALCIUM ION;ENDO-1,4-BETA-XYLANASE Y;1515;
1DYO;B;Xylan-Binding Domain from CBM 22, formally x6b domain;2.1;CA;CALCIUM ION;ENDO-1,4-BETA-XYLANASE Y;1515;
1DYU;A;The active site base controls cofactor reactivity in Escherichia coli amine oxidase: X-ray crystallographic studies with mutational variants.;2.04;CA;CALCIUM ION;COPPER AMINE OXIDASE;562;
1DYU;B;The active site base controls cofactor reactivity in Escherichia coli amine oxidase: X-ray crystallographic studies with mutational variants.;2.04;CA;CALCIUM ION;COPPER AMINE OXIDASE;562;
1DZQ;A;LECTIN UEA-II COMPLEXED WITH GALACTOSE;2.85;CA;CALCIUM ION;LECTIN II;3902;
1DZQ;B;LECTIN UEA-II COMPLEXED WITH GALACTOSE;2.85;CA;CALCIUM ION;LECTIN II;3902;
1DZQ;C;LECTIN UEA-II COMPLEXED WITH GALACTOSE;2.85;CA;CALCIUM ION;LECTIN II;3902;
1DZQ;D;LECTIN UEA-II COMPLEXED WITH GALACTOSE;2.85;CA;CALCIUM ION;LECTIN II;3902;
1E1A;A;Crystal structure of DFPase from Loligo vulgaris;1.8;CA;CALCIUM ION;DIISOPROPYLFLUOROPHOSPHATASE;6622;
1.00E+29;A;PSII associated cytochrome C549 from Synechocystis sp.;1.21;CA;CALCIUM ION;CYTOCHROME C549;1143;
1.00E+34;B;PORCINE PANCREATIC ELASTASE COMPLEXED WITH (3S, 4S)N-PARA- TOLUENESULPHONYL-3-ETHYL-4-(CARBOXYLIC ACID) PYRROLIDIN-2-ONE SOAKED IN PH 9 BUFFER FOR ONE MINUTE;1.8;CA;CALCIUM ION;ELASTASE;9823;
1.00E+35;B;PORCINE PANCREATIC ELASTASE COMPLEXED WITH (3S, 4S)N-PARA-TOLUENESULPHONYL -3-ETHYL-4-(CARBOXYLIC ACID)PYRROLIDIN-2-ONE SOAKED IN PH 9 BUFFER FOR TWO MINUTES;1.9;CA;CALCIUM ION;ELASTASE;9823;
1.00E+36;B;PORCINE PANCREATIC ELASTASE COMPLEXED WITH (3S, 4S)N-PARA-NITROBENZENESULPHONYL -3-ETHYL-4-(CARBOXYLIC ACID)PYRROLIDIN-2-ONE;1.7;CA;CALCIUM ION;ELASTASE;9823;
1.00E+37;B;PORCINE PANCREATIC ELASTASE COMPLEXED WITH (3S, 4S)N-PARA-NITROBENZENESULPHONYL -3-ETHYL-4-(CARBOXYLIC ACID)PYRROLIDIN-2-ONE SOAKED IN PH 9 BUFFER FOR 1 MINUTE;1.75;CA;CALCIUM ION;ELASTASE;9823;
1.00E+38;B;PORCINE PANCREATIC ELASTASE COMPLEXED WITH (3S, 4S)N-PARA-NITROBENZENESULPHONYL -3-ETHYL-4-(CARBOXYLIC ACID)PYRROLIDIN-2-ONE SOAKED IN PH 9 BUFFER FOR 2 MINUTES;1.7;CA;CALCIUM ION;ELASTASE;9823;
1E3A;B;A slow processing precursor penicillin acylase from Escherichia coli;1.8;CA;CALCIUM ION;PENICILLIN AMIDASE BETA SUBUNIT;562;
1E3X;A;Native structure of chimaeric amylase from B. amyloliquefaciens and B. licheniformis at 1.92A;1.9;CA;CALCIUM ION;ALPHA-AMYLASE;1390;
1E3Z;A;Acarbose complex of chimaeric amylase from B. amyloliquefaciens and B. licheniformis at 1.93A;1.93;CA;CALCIUM ION;ALPHA-AMYLASE;1390;
1.00E+40;A;Tris/maltotriose complex of chimaeric amylase from B. amyloliquefaciens and B. licheniformis at 2.2A;2.2;CA;CALCIUM ION;ALPHA-AMYLASE;1390;
1.00E+43;A;Native structure of chimaeric amylase from B. amyloliquefaciens and B. licheniformis at 1.7A;1.7;CA;CALCIUM ION;ALPHA-AMYLASE;1390;
1.00E+54;A;Anion-selective porin from Comamonas acidovorans;2.1;CA;CALCIUM ION;OUTER MEMBRANE PORIN PROTEIN 32;80866;
1E5J;A;ENDOGLUCANASE CEL5A FROM BACILLUS AGARADHAERENS IN THE TETRAGONAL CRYSTAL FORM IN COMPLEX WITH METHYL-4II-S-ALPHA-CELLOBIOSYL-4II-THIO-BETA-CELLOBIOSIDE;1.85;CA;CALCIUM ION;ENDOGLUCANASE 5A;76935;
1E5N;A;E246C mutant of P fluorescens subsp. cellulosa xylanase A in complex with xylopentaose;3.2;CA;CALCIUM ION;ENDO-1,4-BETA-XYLANASE A;294;
1E5N;B;E246C mutant of P fluorescens subsp. cellulosa xylanase A in complex with xylopentaose;3.2;CA;CALCIUM ION;ENDO-1,4-BETA-XYLANASE A;294;
1.00E+77;A;COMPLEX OF ACTIVE MUTANT (Q365->C) OF GLUCOSE 6-PHOSPHATE DEHYDROGENASE FROM LEUCONOSTOC MESENTEROIDES WITH SUBSTRATE;2.69;CA;CALCIUM ION;GLUCOSE 6-PHOSPHATE 1-DEHYDROGENASE;1245;
1E7D;A;Endonuclease VII (ENDOVII) Ffrom Phage T4;2.8;CA;CALCIUM ION;RECOMBINATION ENDONUCLEASE VII;10665;
1E7D;B;Endonuclease VII (ENDOVII) Ffrom Phage T4;2.8;CA;CALCIUM ION;RECOMBINATION ENDONUCLEASE VII;10665;
1E7M;A;ACTIVE SITE MUTANT (D177->N) OF GLUCOSE 6-PHOSPHATE DEHYDROGENASE FROM LEUCONOSTOC MESENTEROIDES;2.54;CA;CALCIUM ION;GLUCOSE 6-PHOSPHATE 1-DEHYDROGENASE;1245;
1E7Y;A;ACTIVE SITE MUTANT (D177->N) OF GLUCOSE 6-PHOSPHATE DEHYDROGENASE FROM LEUCONOSTOC MESENTEROIDES COMPLEXED WITH SUBSTRATE AND NADPH;2.48;CA;CALCIUM ION;GLUCOSE 6-PHOSPHATE 1-DEHYDROGENASE;1245;
1E8A;A;The three-dimensional structure of human S100A12;1.95;CA;CALCIUM ION;S100A12;9606;
1E8A;B;The three-dimensional structure of human S100A12;1.95;CA;CALCIUM ION;S100A12;9606;
1E8T;A;Structure of the multifunctional paramyxovirus hemagglutinin-neuraminidase;2.5;CA;CALCIUM ION;HEMAGGLUTININ-NEURAMINIDASE;11176;
1E8U;A;Structure of the multifunctional paramyxovirus hemagglutinin-neuraminidase;2;CA;CALCIUM ION;HEMAGGLUTININ-NEURAMINIDASE;11176;
1E8U;B;Structure of the multifunctional paramyxovirus hemagglutinin-neuraminidase;2;CA;CALCIUM ION;HEMAGGLUTININ-NEURAMINIDASE;11176;
1E8V;A;Structure of the multifunctional paramyxovirus hemagglutinin-neuraminidase;2;CA;CALCIUM ION;HEMAGGLUTININ-NEURAMINIDASE;11176;
1E8V;B;Structure of the multifunctional paramyxovirus hemagglutinin-neuraminidase;2;CA;CALCIUM ION;HEMAGGLUTININ-NEURAMINIDASE;11176;
1EA7;A;Sphericase;0.93;CA;CALCIUM ION;SERINE PROTEASE;1421;
1EAK;A;Catalytic domain of proMMP-2 E404Q mutant;2.66;CA;CALCIUM ION;72 KDA TYPE IV COLLAGENASE;9606;
1EAK;B;Catalytic domain of proMMP-2 E404Q mutant;2.66;CA;CALCIUM ION;72 KDA TYPE IV COLLAGENASE;9606;
1EAK;C;Catalytic domain of proMMP-2 E404Q mutant;2.66;CA;CALCIUM ION;72 KDA TYPE IV COLLAGENASE;9606;
1EAK;D;Catalytic domain of proMMP-2 E404Q mutant;2.66;CA;CALCIUM ION;72 KDA TYPE IV COLLAGENASE;9606;
1EB2;A;Trypsin inhibitor complex (BPO);2;CA;CALCIUM ION;TRYPSIN;9913;
1EB7;A;Crystal structure of the di-haem cytochrome c peroxidase from Pseudomonas aeruginosa;2.4;CA;CALCIUM ION;CYTOCHROME C551 PEROXIDASE;287;
1EBM;C;CRYSTAL STRUCTURE OF THE HUMAN 8-OXOGUANINE GLYCOSYLASE (HOGG1) BOUND TO A SUBSTRATE OLIGONUCLEOTIDE;2.1;CA;CALCIUM ION;DNA (5'-D(*GP*CP*GP*TP*CP*CP*AP*(8OG)P*GP*TP*CP*TP*AP*CP*C)-3');;
1ECS;A;THE 1.7 A CRYSTAL STRUCTURE OF A BLEOMYCIN RESISTANCE DETERMINANT ENCODED ON THE TRANSPOSON TN5;1.7;CA;CALCIUM ION;BLEOMYCIN RESISTANCE PROTEIN;573;
1EDH;A;E-CADHERIN DOMAINS 1 AND 2 IN COMPLEX WITH CALCIUM;2;CA;CALCIUM ION;E-CADHERIN;10090;
1EDH;B;E-CADHERIN DOMAINS 1 AND 2 IN COMPLEX WITH CALCIUM;2;CA;CALCIUM ION;E-CADHERIN;10090;
1EDM;B;EPIDERMAL GROWTH FACTOR-LIKE DOMAIN FROM HUMAN FACTOR IX;1.5;CA;CALCIUM ION;FACTOR IX;9606;
1EDM;C;EPIDERMAL GROWTH FACTOR-LIKE DOMAIN FROM HUMAN FACTOR IX;1.5;CA;CALCIUM ION;FACTOR IX;9606;
1EE6;A;CRYSTAL STRUCTURE OF PECTATE LYASE FROM BACILLUS SP. STRAIN KSM-P15.;2.3;CA;CALCIUM ION;PECTATE LYASE;98226;
1EGG;A;STRUCTURE OF A C-TYPE CARBOHYDRATE-RECOGNITION DOMAIN (CRD-4) FROM THE MACROPHAGE MANNOSE RECEPTOR;2.3;CA;CALCIUM ION;MACROPHAGE MANNOSE RECEPTOR;9606;
1EGG;B;STRUCTURE OF A C-TYPE CARBOHYDRATE-RECOGNITION DOMAIN (CRD-4) FROM THE MACROPHAGE MANNOSE RECEPTOR;2.3;CA;CALCIUM ION;MACROPHAGE MANNOSE RECEPTOR;9606;
1EGI;A;STRUCTURE OF A C-TYPE CARBOHYDRATE-RECOGNITION DOMAIN (CRD-4) FROM THE MACROPHAGE MANNOSE RECEPTOR;2.3;CA;CALCIUM ION;MACROPHAGE MANNOSE RECEPTOR;9606;
1EGI;B;STRUCTURE OF A C-TYPE CARBOHYDRATE-RECOGNITION DOMAIN (CRD-4) FROM THE MACROPHAGE MANNOSE RECEPTOR;2.3;CA;CALCIUM ION;MACROPHAGE MANNOSE RECEPTOR;9606;
1EGQ;A;ENHANCEMENT OF ENZYME ACTIVITY THROUGH THREE-PHASE PARTITIONING: CRYSTAL STRUCTURE OF A MODIFIED SERINE PROTEINASE AT 1.5 A RESOLUTION;1.55;CA;CALCIUM ION;PROTEINASE K;37998;
1EGZ;A;CELLULASE CEL5 FROM ERWINIA CHRYSANTHEMI, A FAMILY GH 5-2 ENZYME;2.3;CA;CALCIUM ION;ENDOGLUCANASE Z;556;
1EGZ;B;CELLULASE CEL5 FROM ERWINIA CHRYSANTHEMI, A FAMILY GH 5-2 ENZYME;2.3;CA;CALCIUM ION;ENDOGLUCANASE Z;556;
1EGZ;C;CELLULASE CEL5 FROM ERWINIA CHRYSANTHEMI, A FAMILY GH 5-2 ENZYME;2.3;CA;CALCIUM ION;ENDOGLUCANASE Z;556;
1EH2;A;STRUCTURE OF THE SECOND EPS15 HOMOLOGY DOMAIN OF HUMAN EPS15, NMR, 20 STRUCTURES;;CA;CALCIUM ION;EPS15;9606;
1EJ8;A;CRYSTAL STRUCTURE OF DOMAIN 2 OF THE YEAST COPPER CHAPERONE FOR SUPEROXIDE DISMUTASE (LYS7) AT 1.55 A RESOLUTION;1.55;CA;CALCIUM ION;LYS7;4932;
1EK3;A;KAPPA-4 IMMUNOGLOBULIN VL, REC;1.9;CA;CALCIUM ION;KAPPA-4 IMMUNOGLOBULIN LIGHT CHAIN VL;9606;
1EKX;B;THE ISOLATED, UNREGULATED CATALYTIC TRIMER OF ASPARTATE TRANSCARBAMOYLASE COMPLEXED WITH BISUBSTRATE ANALOG PALA (N-(PHOSPHONACETYL)-L-ASPARTATE);1.95;CA;CALCIUM ION;ASPARTATE TRANSCARBAMOYLASE;562;
1EKX;C;THE ISOLATED, UNREGULATED CATALYTIC TRIMER OF ASPARTATE TRANSCARBAMOYLASE COMPLEXED WITH BISUBSTRATE ANALOG PALA (N-(PHOSPHONACETYL)-L-ASPARTATE);1.95;CA;CALCIUM ION;ASPARTATE TRANSCARBAMOYLASE;562;
1EL1;A;X-RAY CRYSTAL STRUCTURE ANALYSIS OF CANINE MILK LYSOZYME (HOLO-TYPE);1.9;CA;CALCIUM ION;LYSOZYME C;9612;
1EL1;B;X-RAY CRYSTAL STRUCTURE ANALYSIS OF CANINE MILK LYSOZYME (HOLO-TYPE);1.9;CA;CALCIUM ION;LYSOZYME C;9612;
1ELA;A;Analogous inhibitors of elastase do not always bind analogously;2;CA;CALCIUM ION;ELASTASE;9823;
1ELB;A;Analogous inhibitors of elastase do not always bind analogously;2.1;CA;CALCIUM ION;ELASTASE;9823;
1ELC;A;Analogous inhibitors of elastase do not always bind analogously;1.75;CA;CALCIUM ION;ELASTASE;9823;
1ELD;E;Structural analysis of the active site of porcine pancreatic elastase based on the x-ray crystal structures of complexes with trifluoroacetyl-dipeptide-anilide inhibitors;2;CA;CALCIUM ION;ELASTASE;9823;
1ELE;E;STRUCTURAL ANALYSIS OF THE ACTIVE SITE OF PORCINE PANCREATIC ELASTASE BASED ON THE X-RAY CRYSTAL STRUCTURES OF COMPLEXES WITH TRIFLUOROACETYL-DIPEPTIDE-ANILIDE INHIBITORS;2;CA;CALCIUM ION;ELASTASE;9823;
1ELF;A;NATURE OF THE INACTIVATION OF ELASTASE BY N-PEPTIDYL-O-AROYL HYDROXYLAMINE AS A FUNCTION OF PH;1.7;CA;CALCIUM ION;PORCINE PANCREATIC ELASTASE;9823;
1ELG;A;NATURE OF THE INACTIVATION OF ELASTASE BY N-PEPTIDYL-O-AROYL HYDROXYLAMINE AS A FUNCTION OF PH;1.65;CA;CALCIUM ION;PORCINE PANCREATIC ELASTASE;9823;
1ELT;A;STRUCTURE OF NATIVE PANCREATIC ELASTASE FROM NORTH ATLANTIC SALMON AT 1.61 ANGSTROMS RESOLUTION;1.61;CA;CALCIUM ION;ELASTASE;8030;
1EMN;A;NMR STUDY OF A PAIR OF FIBRILLIN CA2+ BINDING EPIDERMAL GROWTH FACTOR-LIKE DOMAINS, MINIMIZED AVERAGE STRUCTURE;;CA;CALCIUM ION;FIBRILLIN;9606;
1EMO;A;NMR STUDY OF A PAIR OF FIBRILLIN CA2+ BINDING EPIDERMAL GROWTH FACTOR-LIKE DOMAINS, 22 STRUCTURES;;CA;CALCIUM ION;FIBRILLIN;9606;
1EN7;A;ENDONUCLEASE VII (ENDOVII) FROM PHAGE T4;2.4;CA;CALCIUM ION;RECOMBINATION ENDONUCLEASE VII;10665;
1EN7;B;ENDONUCLEASE VII (ENDOVII) FROM PHAGE T4;2.4;CA;CALCIUM ION;RECOMBINATION ENDONUCLEASE VII;10665;
1EN8;A;1 A CRYSTAL STRUCTURES OF B-DNA REVEAL SEQUENCE-SPECIFIC BINDING AND GROOVE-SPECIFIC BENDING OF DNA BY MAGNESIUM AND CALCIUM;0.99;CA;CALCIUM ION;DNA (5'-D(*CP*CP*AP*AP*CP*GP*TP*TP*GP*G)-3');;
1ENA;A;CRYSTAL STRUCTURES OF THE BINARY CA2+ AND PDTP COMPLEXES AND THE TERNARY COMPLEX OF THE ASP 21->GLU MUTANT OF STAPHYLOCOCCAL NUCLEASE. IMPLICATIONS FOR CATALYSIS AND LIGAND BINDING;2.15;CA;CALCIUM ION;STAPHYLOCOCCAL NUCLEASE;1280;
1ENC;A;CRYSTAL STRUCTURES OF THE BINARY CA2+ AND PDTP COMPLEXES AND THE TERNARY COMPLEX OF THE ASP 21->GLU MUTANT OF STAPHYLOCOCCAL NUCLEASE. IMPLICATIONS FOR CATALYSIS AND LIGAND BINDING;1.95;CA;CALCIUM ION;STAPHYLOCOCCAL NUCLEASE;1280;
1-ene;A;1A CRYSTAL STRUCTURES OF B-DNA REVEAL SEQUENCE-SPECIFIC BINDING AND GROOVE-SPECIFIC BENDING OF DNA BY MAGNESIUM AND CALCIUM.;0.99;CA;CALCIUM ION;DNA (5'-D(*CP*CP*AP*GP*CP*GP*CP*TP*GP*G)-3');;
1ENR;A;CO-CRYSTALS OF DEMETALLIZED CONCANAVALIN A WITH ZINC AND CALCIUM HAVING A ZINC ION BOUND IN THE S1 SITE AND A CALCIUM ION BOUND IN THE S2 SITE;1.83;CA;CALCIUM ION;CONCANAVALIN A;3823;
1EO5;A;Bacillus circulans strain 251 cyclodextrin glycosyltransferase in complex with maltoheptaose;2;CA;CALCIUM ION;PROTEIN (CYCLODEXTRIN GLYCOSYLTRANSFERASE);1397;
1EO7;A;BACILLUS CIRCULANS STRAIN 251 CYCLODEXTRIN GLYCOSYLTRANSFERASE IN COMPLEX WITH MALTOHEXAOSE;2.48;CA;CALCIUM ION;PROTEIN (CYCLODEXTRIN GLYCOSYLTRANSFERASE);1397;
1EPF;C;CRYSTAL STRUCTURE OF THE TWO N-TERMINAL IMMUNOGLOBULIN DOMAINS OF THE NEURAL CELL ADHESION MOLECULE (NCAM);1.85;CA;CALCIUM ION;PROTEIN (NEURAL CELL ADHESION MOLECULE);10116;
1EPT;B;REFINED 1.8 ANGSTROMS RESOLUTION CRYSTAL STRUCTURE OF PORCINE EPSILON-TRYPSIN;1.8;CA;CALCIUM ION;PORCINE E-TRYPSIN;9823;
1EQY;A;COMPLEX BETWEEN RABBIT MUSCLE ALPHA-ACTIN: HUMAN GELSOLIN DOMAIN 1;2.3;CA;CALCIUM ION;ALPHA ACTIN;9986;
1EQY;S;COMPLEX BETWEEN RABBIT MUSCLE ALPHA-ACTIN: HUMAN GELSOLIN DOMAIN 1;2.3;CA;CALCIUM ION;GELSOLIN;9606;
1ESA;A;DIRECT STRUCTURE OBSERVATION OF AN ACYL-ENZYME INTERMEDIATE IN THE HYDROLYSIS OF AN ESTER SUBSTRATE BY ELASTASE;1.65;CA;CALCIUM ION;PORCINE PANCREATIC ELASTASE;9823;
1ESB;A;DIRECT STRUCTURE OBSERVATION OF AN ACYL-ENZYME INTERMEDIATE IN THE HYDROLYSIS OF AN ESTER SUBSTRATE BY ELASTASE;2.3;CA;CALCIUM ION;PORCINE PANCREATIC ELASTASE;9823;
1ESL;A;INSIGHT INTO E-SELECTIN(SLASH)LIGAND INTERACTION FROM THE CRYSTAL STRUCTURE AND MUTAGENESIS OF THE LEC(SLASH)EGF DOMAINS;2;CA;CALCIUM ION;HUMAN E-SELECTIN;9606;
1ESP;A;NEUTRAL PROTEASE MUTANT E144S;2.8;CA;CALCIUM ION;NEUTRAL PROTEASE MUTANT E144S;1396;
1ESV;A;COMPLEX BETWEEN LATRUNCULIN A:RABBIT MUSCLE ALPHA ACTIN:HUMAN GELSOLIN DOMAIN 1;2;CA;CALCIUM ION;ALPHA ACTIN;9986;
1ESV;S;COMPLEX BETWEEN LATRUNCULIN A:RABBIT MUSCLE ALPHA ACTIN:HUMAN GELSOLIN DOMAIN 1;2;CA;CALCIUM ION;GELSOLIN;9606;
1ETH;A;TRIACYLGLYCEROL LIPASE/COLIPASE COMPLEX;2.8;CA;CALCIUM ION;TRIACYLGLYCEROL ACYL-HYDROLASE;9823;
1ETH;C;TRIACYLGLYCEROL LIPASE/COLIPASE COMPLEX;2.8;CA;CALCIUM ION;TRIACYLGLYCEROL ACYL-HYDROLASE;9823;
1EUB;A;SOLUTION STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN COLLAGENASE-3 (MMP-13) COMPLEXED TO A POTENT NON-PEPTIDIC SULFONAMIDE INHIBITOR;;CA;CALCIUM ION;COLLAGENASE 3;9606;
1EVU;A;HUMAN FACTOR XIII WITH CALCIUM BOUND IN THE ION SITE;2.01;CA;CALCIUM ION;COAGULATION FACTOR XIII;9606;
1EVU;B;HUMAN FACTOR XIII WITH CALCIUM BOUND IN THE ION SITE;2.01;CA;CALCIUM ION;COAGULATION FACTOR XIII;9606;
1EX0;A;HUMAN FACTOR XIII, MUTANT W279F ZYMOGEN;2;CA;CALCIUM ION;COAGULATION FACTOR XIII A CHAIN;9606;
1EX0;B;HUMAN FACTOR XIII, MUTANT W279F ZYMOGEN;2;CA;CALCIUM ION;COAGULATION FACTOR XIII A CHAIN;9606;
1EX9;A;CRYSTAL STRUCTURE OF THE PSEUDOMONAS AERUGINOSA LIPASE COMPLEXED WITH RC-(RP,SP)-1,2-DIOCTYLCARBAMOYL-GLYCERO-3-O-OCTYLPHOSPHONATE;2.54;CA;CALCIUM ION;LACTONIZING LIPASE;287;
1EXR;A;THE 1.0 ANGSTROM CRYSTAL STRUCTURE OF CA+2 BOUND CALMODULIN;1;CA;CALCIUM ION;CALMODULIN;5888;
1EXZ;A;STRUCTURE OF STEM CELL FACTOR;2.3;CA;CALCIUM ION;STEM CELL FACTOR;9606;
1EXZ;C;STRUCTURE OF STEM CELL FACTOR;2.3;CA;CALCIUM ION;STEM CELL FACTOR;9606;
1EZJ;A;CRYSTAL STRUCTURE OF THE MULTIMERIZATION DOMAIN OF THE PHOSPHOPROTEIN FROM SENDAI VIRUS;1.9;CA;CALCIUM ION;NUCLEOCAPSID PHOSPHOPROTEIN;11191;
1EZM;A;THREE-DIMENSIONAL STRUCTURE OF THE ELASTASE OF PSEUDOMONAS AERUGINOSA AT 1.5 ANGSTROMS RESOLUTION;1.5;CA;CALCIUM ION;PSEUDOMONAS ELASTASE;287;
1EZQ;A;CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR128515;2.2;CA;CALCIUM ION;COAGULATION FACTOR XA;9606;
1EZR;A;CRYSTAL STRUCTURE OF NUCLEOSIDE HYDROLASE FROM LEISHMANIA MAJOR;2.5;CA;CALCIUM ION;NUCLEOSIDE HYDROLASE;5664;
1EZR;B;CRYSTAL STRUCTURE OF NUCLEOSIDE HYDROLASE FROM LEISHMANIA MAJOR;2.5;CA;CALCIUM ION;NUCLEOSIDE HYDROLASE;5664;
1EZR;C;CRYSTAL STRUCTURE OF NUCLEOSIDE HYDROLASE FROM LEISHMANIA MAJOR;2.5;CA;CALCIUM ION;NUCLEOSIDE HYDROLASE;5664;
1EZR;D;CRYSTAL STRUCTURE OF NUCLEOSIDE HYDROLASE FROM LEISHMANIA MAJOR;2.5;CA;CALCIUM ION;NUCLEOSIDE HYDROLASE;5664;
1EZS;C;CRYSTAL STRUCTURE OF ECOTIN MUTANT M84R, W67A, G68A, Y69A, D70A BOUND TO RAT ANIONIC TRYPSIN II;2.3;CA;CALCIUM ION;TRYPSIN II, ANIONIC;10116;
1EZS;D;CRYSTAL STRUCTURE OF ECOTIN MUTANT M84R, W67A, G68A, Y69A, D70A BOUND TO RAT ANIONIC TRYPSIN II;2.3;CA;CALCIUM ION;TRYPSIN II, ANIONIC;10116;
1EZU;C;ECOTIN Y69F, D70P BOUND TO D102N TRYPSIN;2.4;CA;CALCIUM ION;TRYPSIN II, ANIONIC;10116;
1EZU;D;ECOTIN Y69F, D70P BOUND TO D102N TRYPSIN;2.4;CA;CALCIUM ION;TRYPSIN II, ANIONIC;10116;
1F0O;A;PVUII ENDONUCLEASE/COGNATE DNA COMPLEX (GLUTARALDEHYDE-CROSSLINKED CRYSTAL) AT PH 7.5 WITH TWO CALCIUM IONS AT EACH ACTIVE SITE;2.5;CA;CALCIUM ION;TYPE II RESTRICTION ENZYME PVUII;585;
1F0O;B;PVUII ENDONUCLEASE/COGNATE DNA COMPLEX (GLUTARALDEHYDE-CROSSLINKED CRYSTAL) AT PH 7.5 WITH TWO CALCIUM IONS AT EACH ACTIVE SITE;2.5;CA;CALCIUM ION;TYPE II RESTRICTION ENZYME PVUII;585;
1F0R;A;CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208815;2.1;CA;CALCIUM ION;COAGULATION FACTOR XA;9606;
1F0S;A;Crystal Structure of Human Coagulation Factor XA Complexed with RPR208707;2.1;CA;CALCIUM ION;COAGULATION FACTOR XA;9606;
1F0T;A;BOVINE TRYPSIN COMPLEXED WITH RPR131247;1.8;CA;CALCIUM ION;TRYPSIN;9913;
1F0U;A;BOVINE TRYPSIN COMPLEXED WITH RPR128515;1.9;CA;CALCIUM ION;TRYPSIN;9913;
1F2N;A;RICE YELLOW MOTTLE VIRUS;2.8;CA;CALCIUM ION;CAPSID PROTEIN;31744;
1F2N;B;RICE YELLOW MOTTLE VIRUS;2.8;CA;CALCIUM ION;CAPSID PROTEIN;31744;
1F2N;C;RICE YELLOW MOTTLE VIRUS;2.8;CA;CALCIUM ION;CAPSID PROTEIN;31744;
1F2O;A;CRYSTAL STRUCTURE OF THE STREPTOMYCES GRISEUS AMINOPEPTIDASE COMPLEXED WITH L-LEUCINE;1.7;CA;CALCIUM ION;AMINOPEPTIDASE;1911;
1F2P;A;CRYSTAL STRUCTURE OF THE STREPTOMYCES GRISEUS AMINOPEPTIDASE COMPLEXED WITH L-PHENYLALANINE;1.8;CA;CALCIUM ION;AMINOPEPTIDASE;1911;
1F2S;E;CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN BOVINE BETA-TRYPSIN AND MCTI-A, A TRYPSIN INHIBITOR OF SQUASH FAMILY AT 1.8 A RESOLUTION;1.79;CA;CALCIUM ION;TRYPSIN;9913;
1F4M;A;P3(2) CRYSTAL STRUCTURE OF ALA2ILE2-6, A VERSION OF ROP WITH A REPACKED HYDROPHOBIC CORE AND A NEW FOLD.;2.25;CA;CALCIUM ION;ROP ALA2ILE2-6;562;
1F4M;C;P3(2) CRYSTAL STRUCTURE OF ALA2ILE2-6, A VERSION OF ROP WITH A REPACKED HYDROPHOBIC CORE AND A NEW FOLD.;2.25;CA;CALCIUM ION;ROP ALA2ILE2-6;562;
1F4M;E;P3(2) CRYSTAL STRUCTURE OF ALA2ILE2-6, A VERSION OF ROP WITH A REPACKED HYDROPHOBIC CORE AND A NEW FOLD.;2.25;CA;CALCIUM ION;ROP ALA2ILE2-6;562;
1F4N;A;C2 CRYSTAL STRUCTURE OF ALA2ILE2-6, A VERSION OF ROP WITH A REPACKED HYDROPHOBIC CORE AND A NEW FOLD.;1.9;CA;CALCIUM ION;ROP ALA2ILE2-6;562;
1F4N;B;C2 CRYSTAL STRUCTURE OF ALA2ILE2-6, A VERSION OF ROP WITH A REPACKED HYDROPHOBIC CORE AND A NEW FOLD.;1.9;CA;CALCIUM ION;ROP ALA2ILE2-6;562;
1F4O;B;CRYSTAL STRUCTURE OF GRANCALCIN WITH BOUND CALCIUM;2.5;CA;CALCIUM ION;GRANCALCIN;9606;
1F55;A;SOLUTION STRUCTURE OF THE CALCIUM BOUND N-TERMINAL DOMAIN OF YEAST CALMODULIN;;CA;CALCIUM ION;CALMODULIN;4932;
1F5F;A;CRYSTAL STRUCTURE OF THE N-TERMINAL G-DOMAIN OF SHBG IN COMPLEX WITH ZINC;1.7;CA;CALCIUM ION;SEX HORMONE-BINDING GLOBULIN;9606;
1F5R;A;RAT TRYPSINOGEN MUTANT COMPLEXED WITH BOVINE PANCREATIC TRYPSIN INHIBITOR;1.65;CA;CALCIUM ION;TRYPSIN II, ANIONIC;10116;
1F5Y;A;NMR STRUCTURE OF A CONCATEMER OF THE FIRST AND SECOND LIGAND-BINDING MODULES OF THE HUMAN LDL RECEPTOR;;CA;CALCIUM ION;LOW-DENSITY LIPOPROTEIN RECEPTOR;9606;
1F6S;A;CRYSTAL STRUCTURE OF BOVINE ALPHA-LACTALBUMIN;2.2;CA;CALCIUM ION;ALPHA-LACTALBUMIN;9913;
1F6S;B;CRYSTAL STRUCTURE OF BOVINE ALPHA-LACTALBUMIN;2.2;CA;CALCIUM ION;ALPHA-LACTALBUMIN;9913;
1F6S;C;CRYSTAL STRUCTURE OF BOVINE ALPHA-LACTALBUMIN;2.2;CA;CALCIUM ION;ALPHA-LACTALBUMIN;9913;
1F6S;D;CRYSTAL STRUCTURE OF BOVINE ALPHA-LACTALBUMIN;2.2;CA;CALCIUM ION;ALPHA-LACTALBUMIN;9913;
1F6S;E;CRYSTAL STRUCTURE OF BOVINE ALPHA-LACTALBUMIN;2.2;CA;CALCIUM ION;ALPHA-LACTALBUMIN;9913;
1F6S;F;CRYSTAL STRUCTURE OF BOVINE ALPHA-LACTALBUMIN;2.2;CA;CALCIUM ION;ALPHA-LACTALBUMIN;9913;
1F7L;A;HOLO-(ACYL CARRIER PROTEIN) SYNTHASE IN COMPLEX WITH COENZYME A AT 1.5A;1.5;CA;CALCIUM ION;HOLO-(ACYL CARRIER PROTEIN) SYNTHASE;1423;
1F7Z;A;RAT TRYPSINOGEN K15A COMPLEXED WITH BOVINE PANCREATIC TRYPSIN INHIBITOR;1.55;CA;CALCIUM ION;TRYPSIN II, ANIONIC;10116;
1F8B;A;Native Influenza Virus Neuraminidase in Complex with NEU5AC2EN;1.8;CA;CALCIUM ION;NEURAMINIDASE;11320;
1F8C;A;Native Influenza Neuraminidase in Complex with 4-amino-2-deoxy-2,3-dehydro-N-neuraminic Acid;1.7;CA;CALCIUM ION;NEURAMINIDASE;11320;
1F8D;A;Native Influenza Neuraminidase in Complex with 9-amino-2-deoxy-2,3-dehydro-N-neuraminic Acid;1.4;CA;CALCIUM ION;NEURAMINIDASE;11320;
1F8E;A;Native Influenza Neuraminidase in Complex with 4,9-diamino-2-deoxy-2,3-dehydro-N-acetyl-neuraminic Acid;1.4;CA;CALCIUM ION;NEURAMINIDASE;11320;
1F8H;A;STRUCTURE OF THE SECOND EPS15 HOMOLOGY DOMAIN OF HUMAN EPS15 IN COMPLEX WITH PTGSSSTNPFR;;CA;CALCIUM ION;EPIDERMAL GROWTH FACTOR RECEPTOR SUBSTRATE 15;9606;
1F8V;A;THE STRUCTURE OF PARIACOTO VIRUS REVEALS A DODECAHEDRAL CAGE OF DUPLEX RNA;3;CA;CALCIUM ION;MATURE CAPSID PROTEIN BETA;103782;
1F8Z;A;NMR STRUCTURE OF THE SIXTH LIGAND-BINDING MODULE OF THE LDL RECEPTOR;;CA;CALCIUM ION;LOW-DENSITY LIPOPROTEIN RECEPTOR;9606;
1F9D;A;Crystal structure of the cellulase CEL48F from C. cellulolyticum in complex with cellotetraose;2.3;CA;CALCIUM ION;ENDO-1,4-BETA-GLUCANASE F;1521;
1F9K;A;WINGED BEAN ACIDIC LECTIN COMPLEXED WITH METHYL-ALPHA-D-GALACTOSE;3;CA;CALCIUM ION;ACIDIC LECTIN;3891;
1F9K;B;WINGED BEAN ACIDIC LECTIN COMPLEXED WITH METHYL-ALPHA-D-GALACTOSE;3;CA;CALCIUM ION;ACIDIC LECTIN;3891;
1F9O;A;Crystal structure of the cellulase Cel48F from C. Cellulolyticum with the thiooligosaccharide inhibitor PIPS-IG3;2.5;CA;CALCIUM ION;ENDO-1,4-BETA-GLUCANASE F;1521;
1FAE;A;Crystal structure of the cellulase CEL48F from C. cellulolyticum in complex with cellobiose;2;CA;CALCIUM ION;ENDO-1,4-BETA-GLUCANASE F;1521;
1FAK;H;HUMAN TISSUE FACTOR COMPLEXED WITH COAGULATION FACTOR VIIA INHIBITED WITH A BPTI-MUTANT;2.1;CA;CALCIUM ION;PROTEIN (BLOOD COAGULATION FACTOR VIIA);9606;
1FAK;L;HUMAN TISSUE FACTOR COMPLEXED WITH COAGULATION FACTOR VIIA INHIBITED WITH A BPTI-MUTANT;2.1;CA;CALCIUM ION;PROTEIN (BLOOD COAGULATION FACTOR VIIA);9606;
1FAT;A;PHYTOHEMAGGLUTININ-L;2.8;CA;CALCIUM ION;PHYTOHEMAGGLUTININ-L;3885;
1FAT;B;PHYTOHEMAGGLUTININ-L;2.8;CA;CALCIUM ION;PHYTOHEMAGGLUTININ-L;3885;
1FAT;C;PHYTOHEMAGGLUTININ-L;2.8;CA;CALCIUM ION;PHYTOHEMAGGLUTININ-L;3885;
1FAT;D;PHYTOHEMAGGLUTININ-L;2.8;CA;CALCIUM ION;PHYTOHEMAGGLUTININ-L;3885;
1FAX;A;COAGULATION FACTOR XA INHIBITOR COMPLEX;3;CA;CALCIUM ION;FACTOR XA;9606;
1FAY;A;WINGED BEAN ACIDIC LECTIN COMPLEXED WITH METHYL-ALPHA-D-GALACTOSE (MONOCLINIC FORM);3.3;CA;CALCIUM ION;ACIDIC LECTIN;3891;
1FAY;B;WINGED BEAN ACIDIC LECTIN COMPLEXED WITH METHYL-ALPHA-D-GALACTOSE (MONOCLINIC FORM);3.3;CA;CALCIUM ION;ACIDIC LECTIN;3891;
1FAY;C;WINGED BEAN ACIDIC LECTIN COMPLEXED WITH METHYL-ALPHA-D-GALACTOSE (MONOCLINIC FORM);3.3;CA;CALCIUM ION;ACIDIC LECTIN;3891;
1FAY;D;WINGED BEAN ACIDIC LECTIN COMPLEXED WITH METHYL-ALPHA-D-GALACTOSE (MONOCLINIC FORM);3.3;CA;CALCIUM ION;ACIDIC LECTIN;3891;
1FAY;E;WINGED BEAN ACIDIC LECTIN COMPLEXED WITH METHYL-ALPHA-D-GALACTOSE (MONOCLINIC FORM);3.3;CA;CALCIUM ION;ACIDIC LECTIN;3891;
1FAY;F;WINGED BEAN ACIDIC LECTIN COMPLEXED WITH METHYL-ALPHA-D-GALACTOSE (MONOCLINIC FORM);3.3;CA;CALCIUM ION;ACIDIC LECTIN;3891;
1FAY;G;WINGED BEAN ACIDIC LECTIN COMPLEXED WITH METHYL-ALPHA-D-GALACTOSE (MONOCLINIC FORM);3.3;CA;CALCIUM ION;ACIDIC LECTIN;3891;
1FAY;H;WINGED BEAN ACIDIC LECTIN COMPLEXED WITH METHYL-ALPHA-D-GALACTOSE (MONOCLINIC FORM);3.3;CA;CALCIUM ION;ACIDIC LECTIN;3891;
1FBL;A;STRUCTURE OF FULL-LENGTH PORCINE SYNOVIAL COLLAGENASE (MMP1) REVEALS A C-TERMINAL DOMAIN CONTAINING A CALCIUM-LINKED, FOUR-BLADED BETA-PROPELLER;2.5;CA;CALCIUM ION;FIBROBLAST (INTERSTITIAL) COLLAGENASE (MMP-1);9823;
1FBO;A;Crystal structure of the cellulase CEL48F from C. cellulolyticum in complex with cellobiitol;2.3;CA;CALCIUM ION;ENDO-1,4-BETA-GLUCANASE F;1521;
1FBW;A;Crystal structure of the cellulase CEL48F from C. cellulolyticum in complex with cellohexaose;2;CA;CALCIUM ION;ENDO-1,4-BETA-GLUCANASE F;1521;
1FCE;A;PROCESSIVE ENDOCELLULASE CELF OF CLOSTRIDIUM CELLULOLYTICUM;2;CA;CALCIUM ION;CELLULASE CELF;1521;
1FDK;A;CARBOXYLIC ESTER HYDROLASE (PLA2-MJ33 INHIBITOR COMPLEX);1.91;CA;CALCIUM ION;PHOSPHOLIPASE A2;9913;
1FE5;A;SEQUENCE AND CRYSTAL STRUCTURE OF A BASIC PHOSPHOLIPASE A2 FROM COMMON KRAIT (BUNGARUS CAERULEUS) AT 2.4 RESOLUTION: IDENTIFICATION AND CHARACTERIZATION OF ITS PHARMACOLOGICAL SITES.;2.45;CA;CALCIUM ION;PHOSPHOLIPASE A2;132961;
1FF1;A;STRUCTURE OF THE SECOND EPS15 HOMOLOGY DOMAIN OF HUMAN EPS15 IN COMPLEX WITH PTGSSSTNPFL;;CA;CALCIUM ION;EPIDERMAL GROWTH FACTOR RECEPTOR SUBSTRATE 15;9606;
1FF5;A;STRUCTURE OF E-CADHERIN DOUBLE DOMAIN;2.93;CA;CALCIUM ION;EPITHELIAL CADHERIN;10090;
1FF5;B;STRUCTURE OF E-CADHERIN DOUBLE DOMAIN;2.93;CA;CALCIUM ION;EPITHELIAL CADHERIN;10090;
1FHA;A;SOLVING THE STRUCTURE OF HUMAN H FERRITIN BY GENETICALLY ENGINEERING INTERMOLECULAR CRYSTAL CONTACTS;2.4;CA;CALCIUM ION;FERRITIN;9606;
1FHF;A;THE STRUCTURE OF SOYBEAN PEROXIDASE;2.8;CA;CALCIUM ION;SEED COAT PEROXIDASE;3847;
1FHF;B;THE STRUCTURE OF SOYBEAN PEROXIDASE;2.8;CA;CALCIUM ION;SEED COAT PEROXIDASE;3847;
1FHF;C;THE STRUCTURE OF SOYBEAN PEROXIDASE;2.8;CA;CALCIUM ION;SEED COAT PEROXIDASE;3847;
1FHY;B;PSORALEN CROSS-LINKED D(CCGCTAGCGG) FORMS HOLLIDAY JUNCTION;2.2;CA;CALCIUM ION;DNA (5'-D(*CP*CP*GP*CP*TP*AP*GP*CP*GP*G)-3');;
1FI5;A;NMR STRUCTURE OF THE C TERMINAL DOMAIN OF CARDIAC TROPONIN C BOUND TO THE N TERMINAL DOMAIN OF CARDIAC TROPONIN I.;;CA;CALCIUM ION;PROTEIN (TROPONIN C);9031;
1FI6;A;SOLUTION STRUCTURE OF THE REPS1 EH DOMAIN;;CA;CALCIUM ION;EH DOMAIN PROTEIN REPS1;10090;
1FIB;A;RECOMBINANT HUMAN GAMMA-FIBRINOGEN CARBOXYL TERMINAL FRAGMENT (RESIDUES 143-411) BOUND TO CALCIUM AT PH 6.0;2.1;CA;CALCIUM ION;GAMMA-FIBRINOGEN CARBOXYL TERMINAL FRAGMENT;9606;
1FIC;A;STRUCTURE OF HUMAN GAMMA FIBRINOGEN 30 KD CARBOXYL TERMINAL FRAGMENT;2.5;CA;CALCIUM ION;GAMMA FIBRINOGEN;9606;
1FIC;B;STRUCTURE OF HUMAN GAMMA FIBRINOGEN 30 KD CARBOXYL TERMINAL FRAGMENT;2.5;CA;CALCIUM ION;GAMMA FIBRINOGEN;9606;
1FID;A;STRUCTURE OF HUMAN GAMMA FIBRINOGEN 30 KD CARBOXYL TERMINAL FRAGMENT;2.1;CA;CALCIUM ION;GAMMA FIBRINOGEN;9606;
1FIF;A;N-ACETYLGALACTOSAMINE-SELECTIVE MUTANT OF MANNOSE-BINDING PROTEIN-A (QPDWG-HDRPY);1.95;CA;CALCIUM ION;MANNOSE-BINDING PROTEIN-A;10116;
1FIF;B;N-ACETYLGALACTOSAMINE-SELECTIVE MUTANT OF MANNOSE-BINDING PROTEIN-A (QPDWG-HDRPY);1.95;CA;CALCIUM ION;MANNOSE-BINDING PROTEIN-A;10116;
1FIF;C;N-ACETYLGALACTOSAMINE-SELECTIVE MUTANT OF MANNOSE-BINDING PROTEIN-A (QPDWG-HDRPY);1.95;CA;CALCIUM ION;MANNOSE-BINDING PROTEIN-A;10116;
1FIH;A;N-ACETYLGALACTOSAMINE BINDING MUTANT OF MANNOSE-BINDING PROTEIN A (QPDWG-HDRPY), COMPLEX WITH N-ACETYLGALACTOSAMINE;1.95;CA;CALCIUM ION;MANNOSE-BINDING PROTEIN A;10116;
1FIH;B;N-ACETYLGALACTOSAMINE BINDING MUTANT OF MANNOSE-BINDING PROTEIN A (QPDWG-HDRPY), COMPLEX WITH N-ACETYLGALACTOSAMINE;1.95;CA;CALCIUM ION;MANNOSE-BINDING PROTEIN A;10116;
1FIH;C;N-ACETYLGALACTOSAMINE BINDING MUTANT OF MANNOSE-BINDING PROTEIN A (QPDWG-HDRPY), COMPLEX WITH N-ACETYLGALACTOSAMINE;1.95;CA;CALCIUM ION;MANNOSE-BINDING PROTEIN A;10116;
1FJ3;A;THERMOLYSIN (50% ACETONE SOAKED);2;CA;CALCIUM ION;THERMOLYSIN;1427;
1FJO;A;THERMOLYSIN (60% ACETONE SOAKED CRYSTALS);2;CA;CALCIUM ION;THERMOLYSIN;1427;
1FJQ;A;THERMOLYSIN (70% ACETONE SOAKED CRYSTALS);1.7;CA;CALCIUM ION;THERMOLYSIN;1427;
1FJS;A;CRYSTAL STRUCTURE OF THE INHIBITOR ZK-807834 (CI-1031) COMPLEXED WITH FACTOR XA;1.92;CA;CALCIUM ION;COAGULATION FACTOR XA;9606;
1FJT;A;THERMOLYSIN (50% ACETONITRILE SOAKED CRYSTALS);2.2;CA;CALCIUM ION;THERMOLYSIN;1427;
1FJU;A;THERMOLYSIN (80% ACETONITRILE SOAKED CRYSTALS);2;CA;CALCIUM ION;THERMOLYSIN;1427;
1FJV;A;THERMOLYSIN (60% ACETONITRILE SOAKED CRYSTALS);2;CA;CALCIUM ION;THERMOLYSIN;1427;
1FJW;A;THERMOLYSIN (50 MM PHENOL SOAKED);1.9;CA;CALCIUM ION;THERMOLYSIN;1427;
1FKQ;A;RECOMBINANT GOAT ALPHA-LACTALBUMIN T29V;1.8;CA;CALCIUM ION;ALPHA-LACTALBUMIN;9925;
1FKV;A;RECOMBINANT GOAT ALPHA-LACTALBUMIN T29I;2;CA;CALCIUM ION;ALPHA-LACTALBUMIN;9925;
1FLG;A;CRYSTAL STRUCTURE OF THE QUINOPROTEIN ETHANOL DEHYDROGENASE FROM PSEUDOMONAS AERUGINOSA;2.6;CA;CALCIUM ION;PROTEIN (QUINOPROTEIN ETHANOL DEHYDROGENASE);287;
1FLG;B;CRYSTAL STRUCTURE OF THE QUINOPROTEIN ETHANOL DEHYDROGENASE FROM PSEUDOMONAS AERUGINOSA;2.6;CA;CALCIUM ION;PROTEIN (QUINOPROTEIN ETHANOL DEHYDROGENASE);287;
1FLS;A;SOLUTION STRUCTURE OF THE CATALYTIC FRAGMENT OF HUMAN COLLAGENASE-3 (MMP-13) COMPLEXED WITH A HYDROXAMIC ACID INHIBITOR;;CA;CALCIUM ION;COLLAGENASE-3;9606;
1FM1;A;SOLUTION STRUCTURE OF THE CATALYTIC FRAGMENT OF HUMAN COLLAGENASE-3 (MMP-13) COMPLEXED WITH A HYDROXAMIC ACID INHIBITOR;;CA;CALCIUM ION;COLLAGENASE-3;9606;
1FMG;A;CRYSTAL STRUCTURE OF PORCINE BETA TRYPSIN WITH 0.04% POLYDOCANOL;1.9;CA;CALCIUM ION;TRYPSIN;9823;
1FMI;A;CRYSTAL STRUCTURE OF HUMAN CLASS I ALPHA1,2-MANNOSIDASE;1.9;CA;CALCIUM ION;ENDOPLASMIC RETICULUM ALPHA-MANNOSIDASE I;9606;
1FMJ;A;CRYSTAL STRUCTURE OF MERCURY DERIVATIVE OF RETINOL DEHYDRATASE IN A COMPLEX WITH RETINOL AND PAP;2;CA;CALCIUM ION;RETINOL DEHYDRATASE;7108;
1FMJ;B;CRYSTAL STRUCTURE OF MERCURY DERIVATIVE OF RETINOL DEHYDRATASE IN A COMPLEX WITH RETINOL AND PAP;2;CA;CALCIUM ION;RETINOL DEHYDRATASE;7108;
1FML;A;CRYSTAL STRUCTURE OF RETINOL DEHYDRATASE IN A COMPLEX WITH RETINOL AND PAP;2.75;CA;CALCIUM ION;RETINOL DEHYDRATASE;7108;
1FML;B;CRYSTAL STRUCTURE OF RETINOL DEHYDRATASE IN A COMPLEX WITH RETINOL AND PAP;2.75;CA;CALCIUM ION;RETINOL DEHYDRATASE;7108;
1FN6;A;CRYSTAL STRUCTURE OF PORCINE BETA TRYPSIN WITH 0.1% POLYDOCANOL;1.8;CA;CALCIUM ION;TRYPSIN;9823;
1FN7;D;COUPLING OF DAMAGE RECOGNITION AND CATALYSIS BY A HUMAN BASE-EXCISION DNA REPAIR PROTEIN;2.6;CA;CALCIUM ION;DNA (5'-D(*GP*CP*GP*TP*CP*CP*AP*(3DR)P*GP*TP*CP*TP*AP*CP*C)-3');;
1FNI;A;CRYSTAL STRUCTURE OF PORCINE BETA TRYPSIN WITH 0.01% POLYDOCANOL;1.6;CA;CALCIUM ION;TRYPSIN;9823;
1FNY;A;LEGUME LECTIN OF THE BARK OF ROBINIA PSEUDOACACIA.;1.81;CA;CALCIUM ION;BARK AGGLUTININ I,POLYPEPTIDE A;35938;
1FNZ;A;A bark lectin from robinia pseudoacacia in complex with N-acetylgalactosamine;2.05;CA;CALCIUM ION;BARK AGGLUTININ I, POLYPEPTIDE A;35938;
1FO2;A;CRYSTAL STRUCTURE OF HUMAN CLASS I ALPHA1,2-MANNOSIDASE IN COMPLEX WITH 1-DEOXYMANNOJIRIMYCIN;2.38;CA;CALCIUM ION;ALPHA1,2-MANNOSIDASE;9606;
1FO3;A;CRYSTAL STRUCTURE OF HUMAN CLASS I ALPHA1,2-MANNOSIDASE IN COMPLEX WITH KIFUNENSINE;1.75;CA;CALCIUM ION;ALPHA1,2-MANNOSIDASE;9606;
1FO4;A;CRYSTAL STRUCTURE OF XANTHINE DEHYDROGENASE ISOLATED FROM BOVINE MILK;2.1;CA;CALCIUM ION;XANTHINE DEHYDROGENASE;9913;
1FO4;B;CRYSTAL STRUCTURE OF XANTHINE DEHYDROGENASE ISOLATED FROM BOVINE MILK;2.1;CA;CALCIUM ION;XANTHINE DEHYDROGENASE;9913;
1FOB;A;CRYSTAL STRUCTURE OF BETA-1,4-GALACTANASE FROM ASPERGILLUS ACULEATUS AT 100K;1.8;CA;CALCIUM ION;BETA-1,4-GALACTANASE;5053;
1FP4;B;CRYSTAL STRUCTURE OF THE ALPHA-H195Q MUTANT OF NITROGENASE;2.5;CA;CALCIUM ION;NITROGENASE MOLYBDENUM-IRON PROTEIN BETA CHAIN;354;
1FP4;D;CRYSTAL STRUCTURE OF THE ALPHA-H195Q MUTANT OF NITROGENASE;2.5;CA;CALCIUM ION;NITROGENASE MOLYBDENUM-IRON PROTEIN BETA CHAIN;354;
1FPW;A;STRUCTURE OF YEAST FREQUENIN;;CA;CALCIUM ION;CALCIUM-BINDING PROTEIN NCS-1;4932;
1FS7;A;CYTOCHROME C NITRITE REDUCTASE FROM WOLINELLA SUCCINOGENES;1.6;CA;CALCIUM ION;CYTOCHROME C NITRITE REDUCTASE;844;
1FS8;A;CYTOCHROME C NITRITE REDUCTASE FROM WOLINELLA SUCCINOGENES-SULFATE COMPLEX;1.6;CA;CALCIUM ION;CYTOCHROME C NITRITE REDUCTASE;844;
1FS9;A;CYTOCHROME C NITRITE REDUCTASE FROM WOLINELLA SUCCINOGENES-AZIDE COMPLEX;2;CA;CALCIUM ION;CYTOCHROME C NITRITE REDUCTASE;844;
1FSU;A;Crystal Structure of 4-Sulfatase (human);2.5;CA;CALCIUM ION;N-ACETYLGALACTOSAMINE-4-SULFATASE;9606;
1FW2;A;OUTER MEMBRANE PHOSPHOLIPASE A FROM ESCHERICHIA COLI;2.6;CA;CALCIUM ION;OUTER MEMBRANE PHOSPHOLIPASE A;562;
1FW4;A;CRYSTAL STRUCTURE OF E. COLI FRAGMENT TR2C FROM CALMODULIN TO 1.7 A RESOLUTION;1.7;CA;CALCIUM ION;CALMODULIN;9913;
1FWX;A;CRYSTAL STRUCTURE OF NITROUS OXIDE REDUCTASE FROM P. DENITRIFICANS;1.6;CA;CALCIUM ION;NITROUS OXIDE REDUCTASE;266;
1FWX;B;CRYSTAL STRUCTURE OF NITROUS OXIDE REDUCTASE FROM P. DENITRIFICANS;1.6;CA;CALCIUM ION;NITROUS OXIDE REDUCTASE;266;
1FWX;C;CRYSTAL STRUCTURE OF NITROUS OXIDE REDUCTASE FROM P. DENITRIFICANS;1.6;CA;CALCIUM ION;NITROUS OXIDE REDUCTASE;266;
1FWX;D;CRYSTAL STRUCTURE OF NITROUS OXIDE REDUCTASE FROM P. DENITRIFICANS;1.6;CA;CALCIUM ION;NITROUS OXIDE REDUCTASE;266;
1FX5;A;CRYSTAL STRUCTURE ANALYSIS OF ULEX EUROPAEUS LECTIN I;2.2;CA;CALCIUM ION;ANTI-H(O) LECTIN I;3902;
1FX5;B;CRYSTAL STRUCTURE ANALYSIS OF ULEX EUROPAEUS LECTIN I;2.2;CA;CALCIUM ION;ANTI-H(O) LECTIN I;3902;
1FX9;A;CARBOXYLIC ESTER HYDROLASE COMPLEX (DIMERIC PLA2 + MJ33 INHIBITOR + SULPHATE IONS);2;CA;CALCIUM ION;PHOSPHOLIPASE A2, MAJOR ISOENZYME;9823;
1FX9;B;CARBOXYLIC ESTER HYDROLASE COMPLEX (DIMERIC PLA2 + MJ33 INHIBITOR + SULPHATE IONS);2;CA;CALCIUM ION;PHOSPHOLIPASE A2, MAJOR ISOENZYME;9823;
1FXF;A;CARBOXYLIC ESTER HYDROLASE COMPLEX (DIMERIC PLA2 + MJ33 INHIBITOR + PHOSPHATE IONS);1.85;CA;CALCIUM ION;PHOSPHOLIPASE A2, MAJOR ISOENZYME;9823;
1FXF;B;CARBOXYLIC ESTER HYDROLASE COMPLEX (DIMERIC PLA2 + MJ33 INHIBITOR + PHOSPHATE IONS);1.85;CA;CALCIUM ION;PHOSPHOLIPASE A2, MAJOR ISOENZYME;9823;
1FXH;B;MUTANT OF PENICILLIN ACYLASE IMPAIRED IN CATALYSIS WITH PHENYLACETIC ACID IN THE ACTIVE SITE;1.97;CA;CALCIUM ION;PENICILLIN ACYLASE;562;
1FXV;B;PENICILLIN ACYLASE MUTANT IMPAIRED IN CATALYSIS WITH PENICILLIN G IN THE ACTIVE SITE;2.25;CA;CALCIUM ION;PENICILLIN ACYLASE;562;
1FXW;A;CRYSTAL STRUCTURE OF THE RECOMBINANT ALPHA1/ALPHA2 CATALYTIC HETERODIMER OF BOVINE BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE IB.;2.1;CA;CALCIUM ION;PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE IB GAMMA SUBUNIT;9913;
1FY8;E;CRYSTAL STRUCTURE OF THE DELTAILE16VAL17 RAT ANIONIC TRYPSINOGEN-BPTI COMPLEX;1.7;CA;CALCIUM ION;TRYPSIN II, ANIONIC;10117;
1FYS;A;Ribonuclease T1 V16C mutant;2;CA;CALCIUM ION;GUANYL-SPECIFIC RIBONUCLEASE T1;5062;
1FYU;A;Crystal structure of erythrina corallodendron lectin in hexagonal crystal form;2.6;CA;CALCIUM ION;LECTIN;3843;
1FYU;B;Crystal structure of erythrina corallodendron lectin in hexagonal crystal form;2.6;CA;CALCIUM ION;LECTIN;3843;
1FYZ;A;METHANE MONOOXYGENASE HYDROXYLASE, FORM II REDUCED BY SOAKING;2.15;CA;CALCIUM ION;METHANE MONOOXYGENASE COMPONENT A, ALPHA CHAIN;414;
1FYZ;C;METHANE MONOOXYGENASE HYDROXYLASE, FORM II REDUCED BY SOAKING;2.15;CA;CALCIUM ION;METHANE MONOOXYGENASE COMPONENT A, BETA CHAIN;414;
1FZ0;A;METHANE MONOOXYGENASE HYDROXYLASE, FORM II MIXED-VALENT GROWN ANAEROBICALLY;2.07;CA;CALCIUM ION;METHANE MONOOXYGENASE COMPONENT A, ALPHA CHAIN;414;
1FZ0;C;METHANE MONOOXYGENASE HYDROXYLASE, FORM II MIXED-VALENT GROWN ANAEROBICALLY;2.07;CA;CALCIUM ION;METHANE MONOOXYGENASE COMPONENT A, BETA CHAIN;414;
1FZ1;A;METHANE MONOOXYGENASE HYDROXYLASE, FORM III OXIDIZED;1.96;CA;CALCIUM ION;METHANE MONOOXYGENASE COMPONENT A, ALPHA CHAIN;414;
1FZ1;C;METHANE MONOOXYGENASE HYDROXYLASE, FORM III OXIDIZED;1.96;CA;CALCIUM ION;METHANE MONOOXYGENASE COMPONENT A, BETA CHAIN;414;
1FZ2;A;METHANE MONOOXYGENASE HYDROXYLASE, FORM II MIXED-VALENT GENERATED BY CRYSTAL SOAKING;2.15;CA;CALCIUM ION;METHANE MONOOXYGENASE COMPONENT A, ALPHA CHAIN;414;
1FZ2;C;METHANE MONOOXYGENASE HYDROXYLASE, FORM II MIXED-VALENT GENERATED BY CRYSTAL SOAKING;2.15;CA;CALCIUM ION;METHANE MONOOXYGENASE COMPONENT A, BETA CHAIN;414;
1FZ3;A;METHANE MONOOXYGENASE HYDROXYLASE, FORM III SOAK AT PH 6.2 (0.1 M PIPES);2.03;CA;CALCIUM ION;METHANE MONOOXYGENASE COMPONENT A, ALPHA CHAIN;414;
1FZ3;C;METHANE MONOOXYGENASE HYDROXYLASE, FORM III SOAK AT PH 6.2 (0.1 M PIPES);2.03;CA;CALCIUM ION;METHANE MONOOXYGENASE COMPONENT A, BETA CHAIN;414;
1FZ4;A;METHANE MONOOXYGENASE HYDROXYLASE, FORM III SOAKED AT PH 8.5 (0.1 M TRIS);2.38;CA;CALCIUM ION;METHANE MONOOXYGENASE COMPONENT A, ALPHA CHAIN;414;
1FZ4;C;METHANE MONOOXYGENASE HYDROXYLASE, FORM III SOAKED AT PH 8.5 (0.1 M TRIS);2.38;CA;CALCIUM ION;METHANE MONOOXYGENASE COMPONENT A, BETA CHAIN;414;
1FZ5;A;METHANE MONOOXYGENASE HYDROXYLASE, FORM II CRYSTALLIZED ANAEROBICALLY FROM REDUCED ENZYME;2.4;CA;CALCIUM ION;METHANE MONOOXYGENASE COMPONENT A, ALPHA CHAIN;414;
1FZ5;C;METHANE MONOOXYGENASE HYDROXYLASE, FORM II CRYSTALLIZED ANAEROBICALLY FROM REDUCED ENZYME;2.4;CA;CALCIUM ION;METHANE MONOOXYGENASE COMPONENT A, BETA CHAIN;414;
1FZ6;A;METHANE MONOOXYGENASE HYDROXYLASE, FORM II SOAKED IN 1 M METHANOL;2.05;CA;CALCIUM ION;METHANE MONOOXYGENASE COMPONENT A, ALPHA CHAIN;414;
1FZ6;B;METHANE MONOOXYGENASE HYDROXYLASE, FORM II SOAKED IN 1 M METHANOL;2.05;CA;CALCIUM ION;METHANE MONOOXYGENASE COMPONENT A, ALPHA CHAIN;414;
1FZ6;C;METHANE MONOOXYGENASE HYDROXYLASE, FORM II SOAKED IN 1 M METHANOL;2.05;CA;CALCIUM ION;METHANE MONOOXYGENASE COMPONENT A, BETA CHAIN;414;
1FZ7;A;METHANE MONOOXYGENASE HYDROXYLASE, FORM III SOAKED IN 0.9 M ETHANOL;1.96;CA;CALCIUM ION;METHANE MONOOXYGENASE COMPONENT A, ALPHA CHAIN;414;
1FZ7;C;METHANE MONOOXYGENASE HYDROXYLASE, FORM III SOAKED IN 0.9 M ETHANOL;1.96;CA;CALCIUM ION;METHANE MONOOXYGENASE COMPONENT A, BETA CHAIN;414;
1FZ8;A;METHANE MONOOXYGENASE HYDROXYLASE, FORM II COCRYSTALLIZED WITH DIBROMOMETHANE;2.1;CA;CALCIUM ION;METHANE MONOOXYGENASE COMPONENT A, ALPHA CHAIN;414;
1FZ8;C;METHANE MONOOXYGENASE HYDROXYLASE, FORM II COCRYSTALLIZED WITH DIBROMOMETHANE;2.1;CA;CALCIUM ION;METHANE MONOOXYGENASE COMPONENT A, BETA CHAIN;414;
1FZ9;A;Methane monooxygenase hydroxylase, form II cocrystallized with iodoethane;2.3;CA;CALCIUM ION;METHANE MONOOXYGENASE COMPONENT A, ALPHA CHAIN;414;
1FZ9;C;Methane monooxygenase hydroxylase, form II cocrystallized with iodoethane;2.3;CA;CALCIUM ION;METHANE MONOOXYGENASE COMPONENT A, BETA CHAIN;414;
1FZA;C;CRYSTAL STRUCTURE OF FIBRINOGEN FRAGMENT D;2.9;CA;CALCIUM ION;FIBRINOGEN;9606;
1FZA;F;CRYSTAL STRUCTURE OF FIBRINOGEN FRAGMENT D;2.9;CA;CALCIUM ION;FIBRINOGEN;9606;
1FZB;C;CRYSTAL STRUCTURE OF CROSSLINKED FRAGMENT D;2.9;CA;CALCIUM ION;FIBRINOGEN;9606;
1FZB;F;CRYSTAL STRUCTURE OF CROSSLINKED FRAGMENT D;2.9;CA;CALCIUM ION;FIBRINOGEN;9606;
1FZC;B;CRYSTAL STRUCTURE OF FRAGMENT DOUBLE-D FROM HUMAN FIBRIN WITH TWO DIFFERENT BOUND LIGANDS;2.3;CA;CALCIUM ION;FIBRIN;9606;
1FZC;C;CRYSTAL STRUCTURE OF FRAGMENT DOUBLE-D FROM HUMAN FIBRIN WITH TWO DIFFERENT BOUND LIGANDS;2.3;CA;CALCIUM ION;FIBRIN;9606;
1FZC;E;CRYSTAL STRUCTURE OF FRAGMENT DOUBLE-D FROM HUMAN FIBRIN WITH TWO DIFFERENT BOUND LIGANDS;2.3;CA;CALCIUM ION;FIBRIN;9606;
1FZC;F;CRYSTAL STRUCTURE OF FRAGMENT DOUBLE-D FROM HUMAN FIBRIN WITH TWO DIFFERENT BOUND LIGANDS;2.3;CA;CALCIUM ION;FIBRIN;9606;
1FZD;A;STRUCTURE OF RECOMBINANT ALPHAEC DOMAIN FROM HUMAN FIBRINOGEN-420;2.1;CA;CALCIUM ION;FIBRINOGEN-420;9606;
1FZD;B;STRUCTURE OF RECOMBINANT ALPHAEC DOMAIN FROM HUMAN FIBRINOGEN-420;2.1;CA;CALCIUM ION;FIBRINOGEN-420;9606;
1FZD;C;STRUCTURE OF RECOMBINANT ALPHAEC DOMAIN FROM HUMAN FIBRINOGEN-420;2.1;CA;CALCIUM ION;FIBRINOGEN-420;9606;
1FZD;D;STRUCTURE OF RECOMBINANT ALPHAEC DOMAIN FROM HUMAN FIBRINOGEN-420;2.1;CA;CALCIUM ION;FIBRINOGEN-420;9606;
1FZD;E;STRUCTURE OF RECOMBINANT ALPHAEC DOMAIN FROM HUMAN FIBRINOGEN-420;2.1;CA;CALCIUM ION;FIBRINOGEN-420;9606;
1FZD;F;STRUCTURE OF RECOMBINANT ALPHAEC DOMAIN FROM HUMAN FIBRINOGEN-420;2.1;CA;CALCIUM ION;FIBRINOGEN-420;9606;
1FZD;G;STRUCTURE OF RECOMBINANT ALPHAEC DOMAIN FROM HUMAN FIBRINOGEN-420;2.1;CA;CALCIUM ION;FIBRINOGEN-420;9606;
1FZD;H;STRUCTURE OF RECOMBINANT ALPHAEC DOMAIN FROM HUMAN FIBRINOGEN-420;2.1;CA;CALCIUM ION;FIBRINOGEN-420;9606;
1FZE;B;CRYSTAL STRUCTURE OF FRAGMENT DOUBLE-D FROM HUMAN FIBRIN;3;CA;CALCIUM ION;FIBRINOGEN;9606;
1FZE;C;CRYSTAL STRUCTURE OF FRAGMENT DOUBLE-D FROM HUMAN FIBRIN;3;CA;CALCIUM ION;FIBRINOGEN;9606;
1FZE;E;CRYSTAL STRUCTURE OF FRAGMENT DOUBLE-D FROM HUMAN FIBRIN;3;CA;CALCIUM ION;FIBRINOGEN;9606;
1FZE;F;CRYSTAL STRUCTURE OF FRAGMENT DOUBLE-D FROM HUMAN FIBRIN;3;CA;CALCIUM ION;FIBRINOGEN;9606;
1FZF;B;CRYSTAL STRUCTURE OF FRAGMENT DOUBLE-D FROM HUMAN FIBRIN WITH THE PEPTIDE LIGAND GLY-HIS-ARG-PRO-AMIDE;2.7;CA;CALCIUM ION;FIBRINOGEN;9606;
1FZF;C;CRYSTAL STRUCTURE OF FRAGMENT DOUBLE-D FROM HUMAN FIBRIN WITH THE PEPTIDE LIGAND GLY-HIS-ARG-PRO-AMIDE;2.7;CA;CALCIUM ION;FIBRINOGEN;9606;
1FZF;E;CRYSTAL STRUCTURE OF FRAGMENT DOUBLE-D FROM HUMAN FIBRIN WITH THE PEPTIDE LIGAND GLY-HIS-ARG-PRO-AMIDE;2.7;CA;CALCIUM ION;FIBRINOGEN;9606;
1FZF;F;CRYSTAL STRUCTURE OF FRAGMENT DOUBLE-D FROM HUMAN FIBRIN WITH THE PEPTIDE LIGAND GLY-HIS-ARG-PRO-AMIDE;2.7;CA;CALCIUM ION;FIBRINOGEN;9606;
1FZG;B;CRYSTAL STRUCTURE OF FRAGMENT D FROM HUMAN FIBRINOGEN WITH THE PEPTIDE LIGAND GLY-HIS-ARG-PRO-AMIDE;2.5;CA;CALCIUM ION;FIBRINOGEN;9606;
1FZG;C;CRYSTAL STRUCTURE OF FRAGMENT D FROM HUMAN FIBRINOGEN WITH THE PEPTIDE LIGAND GLY-HIS-ARG-PRO-AMIDE;2.5;CA;CALCIUM ION;FIBRINOGEN;9606;
1FZG;E;CRYSTAL STRUCTURE OF FRAGMENT D FROM HUMAN FIBRINOGEN WITH THE PEPTIDE LIGAND GLY-HIS-ARG-PRO-AMIDE;2.5;CA;CALCIUM ION;FIBRINOGEN;9606;
1FZG;F;CRYSTAL STRUCTURE OF FRAGMENT D FROM HUMAN FIBRINOGEN WITH THE PEPTIDE LIGAND GLY-HIS-ARG-PRO-AMIDE;2.5;CA;CALCIUM ION;FIBRINOGEN;9606;
1FZH;A;METHANE MONOOXYGENASE HYDROXYLASE, FORM II PRESSURIZED WITH XENON GAS;2.6;CA;CALCIUM ION;METHANE MONOOXYGENASE COMPONENT A, ALPHA CHAIN;414;
1FZH;B;METHANE MONOOXYGENASE HYDROXYLASE, FORM II PRESSURIZED WITH XENON GAS;2.6;CA;CALCIUM ION;METHANE MONOOXYGENASE COMPONENT A, ALPHA CHAIN;414;
1FZH;C;METHANE MONOOXYGENASE HYDROXYLASE, FORM II PRESSURIZED WITH XENON GAS;2.6;CA;CALCIUM ION;METHANE MONOOXYGENASE COMPONENT A, BETA CHAIN;414;
1FZP;B;CRYSTAL STRUCTURES OF SARA: A PLEIOTROPIC REGULATOR OF VIRULENCE GENES IN S. AUREUS;2.95;CA;CALCIUM ION;STAPHYLOCOCCAL ACCESSORY REGULATOR A;1280;
1FZP;D;CRYSTAL STRUCTURES OF SARA: A PLEIOTROPIC REGULATOR OF VIRULENCE GENES IN S. AUREUS;2.95;CA;CALCIUM ION;STAPHYLOCOCCAL ACCESSORY REGULATOR A;1280;
1FZU;A;RNAse T1 V78A mutant;1.8;CA;CALCIUM ION;GUANYL-SPECIFIC RIBONUCLEASE T1;5062;
1G02;A;Ribonuclease T1 V16S mutant;1.86;CA;CALCIUM ION;GUANYL-SPECIFIC RIBONUCLEASE T1;5062;
1G05;A;HETEROCYCLE-BASED MMP INHIBITOR WITH P2'SUBSTITUENTS;2.45;CA;CALCIUM ION;STROMELYSIN-1 PRECURSOR;9606;
1G05;B;HETEROCYCLE-BASED MMP INHIBITOR WITH P2'SUBSTITUENTS;2.45;CA;CALCIUM ION;STROMELYSIN-1 PRECURSOR;9606;
1G0H;A;CRYSTAL STRUCTURE OF MJ0109 GENE PRODUCT INOSITOL MONOPHOSPHATASE-FRUCTOSE 1,6 BISPHOSPHATASE;2.3;CA;CALCIUM ION;INOSITOL MONOPHOSPHATASE;2190;
1G0H;B;CRYSTAL STRUCTURE OF MJ0109 GENE PRODUCT INOSITOL MONOPHOSPHATASE-FRUCTOSE 1,6 BISPHOSPHATASE;2.3;CA;CALCIUM ION;INOSITOL MONOPHOSPHATASE;2190;
1G1I;A;CRYSTAL STRUCTURE OF THE OLIGOMERIZATION DOMAIN FROM ROTAVIRUS NSP4;2;CA;CALCIUM ION;NON-STRUCTURAL GLYCOPROTEIN NSP4;10923;
1G1Q;A;Crystal structure of P-selectin lectin/EGF domains;2.4;CA;CALCIUM ION;P-SELECTIN;9606;
1G1Q;B;Crystal structure of P-selectin lectin/EGF domains;2.4;CA;CALCIUM ION;P-SELECTIN;9606;
1G1Q;C;Crystal structure of P-selectin lectin/EGF domains;2.4;CA;CALCIUM ION;P-SELECTIN;9606;
1G1Q;D;Crystal structure of P-selectin lectin/EGF domains;2.4;CA;CALCIUM ION;P-SELECTIN;9606;
1G1R;A;Crystal structure of P-selectin lectin/EGF domains complexed with SLeX;3.4;CA;CALCIUM ION;P-SELECTIN;9606;
1G1R;B;Crystal structure of P-selectin lectin/EGF domains complexed with SLeX;3.4;CA;CALCIUM ION;P-SELECTIN;9606;
1G1R;C;Crystal structure of P-selectin lectin/EGF domains complexed with SLeX;3.4;CA;CALCIUM ION;P-SELECTIN;9606;
1G1R;D;Crystal structure of P-selectin lectin/EGF domains complexed with SLeX;3.4;CA;CALCIUM ION;P-SELECTIN;9606;
1G1T;A;CRYSTAL STRUCTURE OF E-SELECTIN LECTIN/EGF DOMAINS COMPLEXED WITH SLEX;1.5;CA;CALCIUM ION;E-SELECTIN;9606;
1G20;B;MGATP-BOUND AND NUCLEOTIDE-FREE STRUCTURES OF A NITROGENASE PROTEIN COMPLEX BETWEEN LEU127DEL-FE PROTEIN AND THE MOFE PROTEIN;2.2;CA;CALCIUM ION;NITROGENASE MOLYBDENUM-IRON PROTEIN BETA CHAIN;354;
1G20;D;MGATP-BOUND AND NUCLEOTIDE-FREE STRUCTURES OF A NITROGENASE PROTEIN COMPLEX BETWEEN LEU127DEL-FE PROTEIN AND THE MOFE PROTEIN;2.2;CA;CALCIUM ION;NITROGENASE MOLYBDENUM-IRON PROTEIN BETA CHAIN;354;
1G21;B;MGATP-BOUND AND NUCLEOTIDE-FREE STRUCTURES OF A NITROGENASE PROTEIN COMPLEX BETWEEN LEU127DEL-FE PROTEIN AND THE MOFE PROTEIN;3;CA;CALCIUM ION;NITROGENASE MOLYBDENUM-IRON PROTEIN BETA CHAIN;354;
1G21;D;MGATP-BOUND AND NUCLEOTIDE-FREE STRUCTURES OF A NITROGENASE PROTEIN COMPLEX BETWEEN LEU127DEL-FE PROTEIN AND THE MOFE PROTEIN;3;CA;CALCIUM ION;NITROGENASE MOLYBDENUM-IRON PROTEIN BETA CHAIN;354;
1G2J;A;RNA OCTAMER R(CCCP*GGGG) CONTAINING PHENYL RIBONUCLEOTIDE;1.97;CA;CALCIUM ION;5'-R(*CP*CP*CP*(PYY)P*GP*GP*GP*G)-3';;
1G2L;A;FACTOR XA INHIBITOR COMPLEX;1.9;CA;CALCIUM ION;COAGULATION FACTOR X;9606;
1G2M;A;FACTOR XA INHIBITOR COMPLEX;3.02;CA;CALCIUM ION;COAGULATION FACTOR X;9606;
1G33;A;CRYSTAL STRUCTURE OF RAT PARVALBUMIN WITHOUT THE N-TERMINAL DOMAIN;1.44;CA;CALCIUM ION;PARVALBUMIN ALPHA;10116;
1G36;A;TRYPSIN INHIBITOR COMPLEX;1.9;CA;CALCIUM ION;TRYPSINOGEN, CATIONIC;9913;
1G3B;A;BOVINE BETA-TRYPSIN BOUND TO META-AMIDINO SCHIFF BASE MAGNESIUM(II) CHELATE;1.8;CA;CALCIUM ION;BETA-TRYPSIN;9913;
1G3C;A;BOVINE BETA-TRYPSIN BOUND TO PARA-AMIDINO SCHIFF BASE IRON(III) CHELATE;1.8;CA;CALCIUM ION;BETA-TRYPSIN;9913;
1G3D;A;BOVINE BETA-TRYPSIN BOUND TO META-AMIDINO SCHIFF BASE COPPER (II) CHELATE;1.8;CA;CALCIUM ION;BETA-TRYPSIN;9913;
1G3E;A;BOVINE BETA-TRYPSIN BOUND TO PARA-AMIDINO SCHIFF-BASE COPPER (II) CHELATE;1.8;CA;CALCIUM ION;BETA-TRYPSIN;9913;
1G42;A;STRUCTURE OF 1,3,4,6-TETRACHLORO-1,4-CYCLOHEXADIENE HYDROLASE (LINB) FROM SPHINGOMONAS PAUCIMOBILIS COMPLEXED WITH 1,2-DICHLOROPROPANE;1.8;CA;CALCIUM ION;1,3,4,6-TETRACHLORO-1,4-CYCLOHEXADIENE HYDROLASE;13689;
1G43;A;CRYSTAL STRUCTURE OF A FAMILY IIIA CBD FROM CLOSTRIDIUM CELLULOLYTICUM;2.2;CA;CALCIUM ION;SCAFFOLDING PROTEIN;1521;
1G49;A;A CARBOXYLIC ACID BASED INHIBITOR IN COMPLEX WITH MMP3;1.9;CA;CALCIUM ION;MATRIX METALLOPROTEINASE 3;9606;
1G49;B;A CARBOXYLIC ACID BASED INHIBITOR IN COMPLEX WITH MMP3;1.9;CA;CALCIUM ION;MATRIX METALLOPROTEINASE 3;9606;
1G4H;A;LINB COMPLEXED WITH BUTAN-1-OL;1.8;CA;CALCIUM ION;1,3,4,6-TETRACHLORO-1,4-CYCLOHEXADIENE HYDROLASE;13689;
1G4I;A;Crystal structure of the bovine pancreatic phospholipase A2 at 0.97A;0.97;CA;CALCIUM ION;PHOSPHOLIPASE A2;9913;
1G4K;A;X-ray Structure of a Novel Matrix Metalloproteinase Inhibitor Complexed to Stromelysin;2;CA;CALCIUM ION;STROMELYSIN-1;9606;
1G4K;B;X-ray Structure of a Novel Matrix Metalloproteinase Inhibitor Complexed to Stromelysin;2;CA;CALCIUM ION;STROMELYSIN-1;9606;
1G4K;C;X-ray Structure of a Novel Matrix Metalloproteinase Inhibitor Complexed to Stromelysin;2;CA;CALCIUM ION;STROMELYSIN-1;9606;
1G4Q;A;RNA/DNA HYBRID DECAMER OF CAAAGAAAAG/CTTTTCTTTG;1.15;CA;CALCIUM ION;5'-R(*CP*AP*AP*AP*GP*AP*AP*AP*AP*G)-3';;
1G4Y;R;1.60 A CRYSTAL STRUCTURE OF THE GATING DOMAIN FROM SMALL CONDUCTANCE POTASSIUM CHANNEL COMPLEXED WITH CALCIUM-CALMODULIN;1.6;CA;CALCIUM ION;CALMODULIN;10116;
1G5C;A;CRYSTAL STRUCTURE OF THE 'CAB' TYPE BETA CLASS CARBONIC ANHYDRASE FROM METHANOBACTERIUM THERMOAUTOTROPHICUM;2.1;CA;CALCIUM ION;BETA-CARBONIC ANHYDRASE;145262;
1G5C;B;CRYSTAL STRUCTURE OF THE 'CAB' TYPE BETA CLASS CARBONIC ANHYDRASE FROM METHANOBACTERIUM THERMOAUTOTROPHICUM;2.1;CA;CALCIUM ION;BETA-CARBONIC ANHYDRASE;145262;
1G5C;C;CRYSTAL STRUCTURE OF THE 'CAB' TYPE BETA CLASS CARBONIC ANHYDRASE FROM METHANOBACTERIUM THERMOAUTOTROPHICUM;2.1;CA;CALCIUM ION;BETA-CARBONIC ANHYDRASE;145262;
1G5C;E;CRYSTAL STRUCTURE OF THE 'CAB' TYPE BETA CLASS CARBONIC ANHYDRASE FROM METHANOBACTERIUM THERMOAUTOTROPHICUM;2.1;CA;CALCIUM ION;BETA-CARBONIC ANHYDRASE;145262;
1G5C;F;CRYSTAL STRUCTURE OF THE 'CAB' TYPE BETA CLASS CARBONIC ANHYDRASE FROM METHANOBACTERIUM THERMOAUTOTROPHICUM;2.1;CA;CALCIUM ION;BETA-CARBONIC ANHYDRASE;145262;
1G5F;A;STRUCTURE OF LINB COMPLEXED WITH 1,2-DICHLOROETHANE;1.8;CA;CALCIUM ION;1,3,4,6-TETRACHLORO-1,4-CYCLOHEXADIENE HYDROLASE;13689;
1G5N;A;ANNEXIN V COMPLEX WITH HEPARIN OLIGOSACCHARIDES;1.9;CA;CALCIUM ION;ANNEXIN V;10116;
1G6I;A;Crystal structure of the yeast alpha-1,2-mannosidase with bound 1-deoxymannojirimycin at 1.59 A resolution;1.59;CA;CALCIUM ION;CLASS I ALPHA-1,2-MANNOSIDASE;4932;
1G72;A;CATALYTIC MECHANISM OF QUINOPROTEIN METHANOL DEHYDROGENASE: A THEORETICAL AND X-RAY CRYSTALLOGRAPHIC INVESTIGATION;1.9;CA;CALCIUM ION;METHANOL DEHYDROGENASE HEAVY SUBUNIT;17;
1G72;C;CATALYTIC MECHANISM OF QUINOPROTEIN METHANOL DEHYDROGENASE: A THEORETICAL AND X-RAY CRYSTALLOGRAPHIC INVESTIGATION;1.9;CA;CALCIUM ION;METHANOL DEHYDROGENASE HEAVY SUBUNIT;17;
1G7Y;A;THE CRYSTAL STRUCTURE OF THE 58KD VEGETATIVE LECTIN FROM THE TROPICAL LEGUME DOLICHOS BIFLORUS;2.5;CA;CALCIUM ION;STEM/LEAF LECTIN DB58;3917;
1G7Y;B;THE CRYSTAL STRUCTURE OF THE 58KD VEGETATIVE LECTIN FROM THE TROPICAL LEGUME DOLICHOS BIFLORUS;2.5;CA;CALCIUM ION;STEM/LEAF LECTIN DB58;3917;
1G7Y;C;THE CRYSTAL STRUCTURE OF THE 58KD VEGETATIVE LECTIN FROM THE TROPICAL LEGUME DOLICHOS BIFLORUS;2.5;CA;CALCIUM ION;STEM/LEAF LECTIN DB58;3917;
1G7Y;D;THE CRYSTAL STRUCTURE OF THE 58KD VEGETATIVE LECTIN FROM THE TROPICAL LEGUME DOLICHOS BIFLORUS;2.5;CA;CALCIUM ION;STEM/LEAF LECTIN DB58;3917;
1G7Y;E;THE CRYSTAL STRUCTURE OF THE 58KD VEGETATIVE LECTIN FROM THE TROPICAL LEGUME DOLICHOS BIFLORUS;2.5;CA;CALCIUM ION;STEM/LEAF LECTIN DB58;3917;
1G7Y;F;THE CRYSTAL STRUCTURE OF THE 58KD VEGETATIVE LECTIN FROM THE TROPICAL LEGUME DOLICHOS BIFLORUS;2.5;CA;CALCIUM ION;STEM/LEAF LECTIN DB58;3917;
1G87;A;THE CRYSTAL STRUCTURE OF ENDOGLUCANASE 9G FROM CLOSTRIDIUM CELLULOLYTICUM;1.6;CA;CALCIUM ION;ENDOCELLULASE 9G;1521;
1G87;B;THE CRYSTAL STRUCTURE OF ENDOGLUCANASE 9G FROM CLOSTRIDIUM CELLULOLYTICUM;1.6;CA;CALCIUM ION;ENDOCELLULASE 9G;1521;
1G8F;A;ATP SULFURYLASE FROM S. CEREVISIAE;1.95;CA;CALCIUM ION;SULFATE ADENYLYLTRANSFERASE;4932;
1G8G;A;ATP SULFURYLASE FROM S. CEREVISIAE: THE BINARY PRODUCT COMPLEX WITH APS;2.6;CA;CALCIUM ION;SULFATE ADENYLYLTRANSFERASE;4932;
1G8G;B;ATP SULFURYLASE FROM S. CEREVISIAE: THE BINARY PRODUCT COMPLEX WITH APS;2.6;CA;CALCIUM ION;SULFATE ADENYLYLTRANSFERASE;4932;
1G8H;A;ATP SULFURYLASE FROM S. CEREVISIAE: THE TERNARY PRODUCT COMPLEX WITH APS AND PPI;2.8;CA;CALCIUM ION;SULFATE ADENYLYLTRANSFERASE;4932;
1G8H;B;ATP SULFURYLASE FROM S. CEREVISIAE: THE TERNARY PRODUCT COMPLEX WITH APS AND PPI;2.8;CA;CALCIUM ION;SULFATE ADENYLYLTRANSFERASE;4932;
1G8I;A;CRYSTAL STRUCTURE OF HUMAN FREQUENIN (NEURONAL CALCIUM SENSOR 1);1.9;CA;CALCIUM ION;NEURONAL CALCIUM SENSOR 1;9606;
1G8I;B;CRYSTAL STRUCTURE OF HUMAN FREQUENIN (NEURONAL CALCIUM SENSOR 1);1.9;CA;CALCIUM ION;NEURONAL CALCIUM SENSOR 1;9606;
1G8K;A;CRYSTAL STRUCTURE ANALYSIS OF ARSENITE OXIDASE FROM ALCALIGENES FAECALIS;1.64;CA;CALCIUM ION;ARSENITE OXIDASE;511;
1G8K;C;CRYSTAL STRUCTURE ANALYSIS OF ARSENITE OXIDASE FROM ALCALIGENES FAECALIS;1.64;CA;CALCIUM ION;ARSENITE OXIDASE;511;
1G8K;E;CRYSTAL STRUCTURE ANALYSIS OF ARSENITE OXIDASE FROM ALCALIGENES FAECALIS;1.64;CA;CALCIUM ION;ARSENITE OXIDASE;511;
1G8K;G;CRYSTAL STRUCTURE ANALYSIS OF ARSENITE OXIDASE FROM ALCALIGENES FAECALIS;1.64;CA;CALCIUM ION;ARSENITE OXIDASE;511;
1G8W;A;IMPROVED STRUCTURE OF PHYTOHEMAGGLUTININ-L FROM THE KIDNEY BEAN;2.8;CA;CALCIUM ION;LEUCOAGGLUTINATING PHYTOHEMAGGLUTININ;3885;
1G8W;B;IMPROVED STRUCTURE OF PHYTOHEMAGGLUTININ-L FROM THE KIDNEY BEAN;2.8;CA;CALCIUM ION;LEUCOAGGLUTINATING PHYTOHEMAGGLUTININ;3885;
1G8W;C;IMPROVED STRUCTURE OF PHYTOHEMAGGLUTININ-L FROM THE KIDNEY BEAN;2.8;CA;CALCIUM ION;LEUCOAGGLUTINATING PHYTOHEMAGGLUTININ;3885;
1G8W;D;IMPROVED STRUCTURE OF PHYTOHEMAGGLUTININ-L FROM THE KIDNEY BEAN;2.8;CA;CALCIUM ION;LEUCOAGGLUTINATING PHYTOHEMAGGLUTININ;3885;
1G94;A;CRYSTAL STRUCTURE ANALYSIS OF THE TERNARY COMPLEX BETWEEN PSYCHROPHILIC ALPHA AMYLASE FROM PSEUDOALTEROMONAS HALOPLANCTIS IN COMPLEX WITH A HEPTA-SACCHARIDE AND A TRIS MOLECULE;1.74;CA;CALCIUM ION;ALPHA-AMYLASE;228;
1G9F;A;CRYSTAL STRUCTURE OF THE SOYBEAN AGGLUTININ IN A COMPLEX WITH A BIANTENNARY BLOOD GROUP ANTIGEN ANALOG;2.5;CA;CALCIUM ION;LECTIN;3847;
1G9G;A;XTAL-STRUCTURE OF THE FREE NATIVE CELLULASE CEL48F;1.9;CA;CALCIUM ION;CELLULASE CEL48F;1521;
1G9H;A;TERNARY COMPLEX BETWEEN PSYCHROPHILIC ALPHA-AMYLASE, COMII (PSEUDO TRI-SACCHARIDE FROM BAYER) AND TRIS (2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL);1.8;CA;CALCIUM ION;ALPHA-AMYLASE;228;
1G9I;E;CRYSTAL STRUCTURE OF BETA-TRYSIN COMPLEX IN CYCLOHEXANE;2.2;CA;CALCIUM ION;TRYPSINOGEN, CATIONIC;9913;
1G9J;A;X-TAL STRUCTURE OF THE MUTANT E44Q OF THE CELLULASE CEL48F IN COMPLEX WITH A THIOOLIGOSACCHARIDE;1.9;CA;CALCIUM ION;CELLULASE CEL48F;1521;
1G9K;A;CRYSTAL STRUCTURE OF A PSYCHROPHILIC ALKALINE PROTEASE FROM PSEUDOMONAS TAC II 18;1.96;CA;CALCIUM ION;SERRALYSIN;286;
1G9U;A;CRYSTAL STRUCTURE OF YOPM-LEUCINE RICH EFFECTOR PROTEIN FROM YERSINIA PESTIS;2.35;CA;CALCIUM ION;OUTER PROTEIN YOPM;632;
1G9Y;A;HOMING ENDONUCLEASE I-CREI / DNA SUBSTRATE COMPLEX WITH CALCIUM;2.05;CA;CALCIUM ION;DNA ENDONUCLEASE I-CREI;3055;
1G9Y;B;HOMING ENDONUCLEASE I-CREI / DNA SUBSTRATE COMPLEX WITH CALCIUM;2.05;CA;CALCIUM ION;DNA ENDONUCLEASE I-CREI;3055;
1G9Y;C;HOMING ENDONUCLEASE I-CREI / DNA SUBSTRATE COMPLEX WITH CALCIUM;2.05;CA;CALCIUM ION;5'-D(*CP*GP*AP*AP*AP*CP*TP*GP*TP*CP*TP*CP*AP*CP*GP*AP*CP*GP*TP*TP*TP*TP*GP*C)-3';;
1GA1;A;CRYSTAL STRUCTURE ANALYSIS OF PSCP (PSEUDOMONAS SERINE-CARBOXYL PROTEINASE) COMPLEXED WITH A FRAGMENT OF IODOTYROSTATIN (THIS ENZYME RENAMED 'SEDOLISIN' IN 2003);1.4;CA;CALCIUM ION;SERINE-CARBOXYL PROTEINASE;306;
1GA2;A;THE CRYSTAL STRUCTURE OF ENDOGLUCANASE 9G FROM CLOSTRIDIUM CELLULOLYTICUM COMPLEXED WITH CELLOBIOSE;1.7;CA;CALCIUM ION;ENDOGLUCANASE 9G;1521;
1GA2;B;THE CRYSTAL STRUCTURE OF ENDOGLUCANASE 9G FROM CLOSTRIDIUM CELLULOLYTICUM COMPLEXED WITH CELLOBIOSE;1.7;CA;CALCIUM ION;ENDOGLUCANASE 9G;1521;
1GA4;A;CRYSTAL STRUCTURE ANALYSIS OF PSCP (PSEUDOMONAS SERINE-CARBOXYL PROTEINASE) COMPLEXED WITH INHIBITOR PSEUDOIODOTYROSTATIN (THIS ENZYME RENAMED 'SEDOLISIN' IN 2003);1.4;CA;CALCIUM ION;SERINE-CARBOXYL PROTEINASE;306;
1GA6;A;CRYSTAL STRUCTURE ANALYSIS OF PSCP (PSEUDOMONAS SERINE-CARBOXYL PROTEINASE) COMPLEXED WITH A FRAGMENT OF TYROSTATIN (THIS ENZYME RENAMED 'SEDOLISIN' IN 2003);1;CA;CALCIUM ION;SERINE-CARBOXYL PROTEINASE;306;
1GBG;A;BACILLUS LICHENIFORMIS BETA-GLUCANASE;1.8;CA;CALCIUM ION;(1,3-1,4)-BETA-D-GLUCAN 4 GLUCANOHYDROLASE;1402;
1GBT;A;STRUCTURE OF AN ACYL-ENZYME INTERMEDIATE DURING CATALYSIS: (GUANIDINOBENZOYL) TRYPSIN;2;CA;CALCIUM ION;BETA-TRYPSIN;9913;
1GCA;A;THE 1.7 ANGSTROMS REFINED X-RAY STRUCTURE OF THE PERIPLASMIC GLUCOSE(SLASH)GALACTOSE RECEPTOR FROM SALMONELLA TYPHIMURIUM;1.7;CA;CALCIUM ION;GLUCOSE/GALACTOSE-BINDING PROTEIN;90371;
1GCG;A;THE 1.9 ANGSTROMS X-RAY STRUCTURE OF A CLOSED UNLIGANDED FORM OF THE PERIPLASMIC GLUCOSE(SLASH)GALACTOSE RECEPTOR FROM SALMONELLA TYPHIMURIUM;1.9;CA;CALCIUM ION;GALACTOSE/GLUCOSE-BINDING PROTEIN;90371;
1GCI;A;THE 0.78 ANGSTROMS STRUCTURE OF A SERINE PROTEASE-BACILLUS LENTUS SUBTILISIN;0.78;CA;CALCIUM ION;SUBTILISIN;1467;
1GCY;A;HIGH RESOLUTION CRYSTAL STRUCTURE OF MALTOTETRAOSE-FORMING EXO-AMYLASE;1.6;CA;CALCIUM ION;GLUCAN 1,4-ALPHA-MALTOTETRAHYDROLASE;316;
1GEN;A;C-TERMINAL DOMAIN OF GELATINASE A;2.15;CA;CALCIUM ION;GELATINASE A;9606;
1GGU;A;HUMAN FACTOR XIII WITH CALCIUM BOUND IN THE ION SITE;2.1;CA;CALCIUM ION;PROTEIN (COAGULATION FACTOR XIII);9606;
1GGU;B;HUMAN FACTOR XIII WITH CALCIUM BOUND IN THE ION SITE;2.1;CA;CALCIUM ION;PROTEIN (COAGULATION FACTOR XIII);9606;
1GGZ;A;CRYSTAL STRUCTURE OF THE CALMODULIN-LIKE PROTEIN (HCLP) FROM HUMAN EPITHELIAL CELLS;1.5;CA;CALCIUM ION;CALMODULIN-RELATED PROTEIN NB-1;9606;
1GH4;A;Structure of the triple mutant (K56M, K120M, K121M) of phospholipase A2;1.9;CA;CALCIUM ION;PHOSPHOLIPASE A2;9913;
1GHX;H;A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE;1.65;CA;CALCIUM ION;THROMBIN;9606;
1GHY;H;A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE;1.85;CA;CALCIUM ION;THROMBIN;9606;
1GHZ;A;A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE;1.39;CA;CALCIUM ION;BETA-TRYPSIN;9913;
1GI0;A;A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE;1.42;CA;CALCIUM ION;BETA-TRYPSIN;9913;
1GI1;A;A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE;1.42;CA;CALCIUM ION;BETA-TRYPSIN;9913;
1GI2;A;A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE;1.38;CA;CALCIUM ION;BETA-TRYPSIN;9913;
1GI3;A;A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE;1.44;CA;CALCIUM ION;BETA-TRYPSIN;9913;
1GI4;A;A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE;1.37;CA;CALCIUM ION;BETA-TRYPSIN;9913;
1GI5;A;A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE;1.6;CA;CALCIUM ION;BETA-TRYPSIN;9913;
1GI6;A;A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE;1.49;CA;CALCIUM ION;BETA-TRYPSIN;9913;
1GIC;A;CONCANAVALIN A COMPLEXED WITH METHYL ALPHA-D-GLUCOPYRANOSIDE;2;CA;CALCIUM ION;CONCANAVALIN A;3823;
1GIC;B;CONCANAVALIN A COMPLEXED WITH METHYL ALPHA-D-GLUCOPYRANOSIDE;2;CA;CALCIUM ION;CONCANAVALIN A;3823;
1GJ6;A;ENGINEERING INHIBITORS HIGHLY SELECTIVE FOR THE S1 SITES OF SER190 TRYPSIN-LIKE SERINE PROTEASE DRUG TARGETS;1.5;CA;CALCIUM ION;BETA-TRYPSIN;9913;
1GK9;B;Crystal structures of penicillin acylase enzyme-substrate complexes: Structural insights into the catalytic mechanism;1.3;CA;CALCIUM ION;PENICILLIN G ACYLASE BETA SUBUNIT;562;
1GKB;A;CONCANAVALIN A, NEW CRYSTAL FORM;1.56;CA;CALCIUM ION;CONCANAVALIN A;3823;
1GKB;B;CONCANAVALIN A, NEW CRYSTAL FORM;1.56;CA;CALCIUM ION;CONCANAVALIN A;3823;
1GKC;A;MMP9-inhibitor complex;2.3;CA;CALCIUM ION;92 KDA TYPE IV COLLAGENASE;9606;
1GKC;B;MMP9-inhibitor complex;2.3;CA;CALCIUM ION;92 KDA TYPE IV COLLAGENASE;9606;
1GKD;A;MMP9 active site mutant-inhibitor complex;2.1;CA;CALCIUM ION;92 KDA TYPE IV COLLAGENASE;9606;
1GKD;B;MMP9 active site mutant-inhibitor complex;2.1;CA;CALCIUM ION;92 KDA TYPE IV COLLAGENASE;9606;
1GKF;B;Crystal structures of penicillin acylase enzyme-substrate complexes: Structural insights into the catalytic mechanism;1.41;CA;CALCIUM ION;PENICILLIN G ACYLASE BETA SUBUNIT;562;
1GLG;A;CRYSTALLOGRAPHIC ANALYSIS OF THE EPIMERIC AND ANOMERIC SPECIFICITY OF THE PERIPLASMIC TRANSPORT(SLASH)CHEMOTACTIC PROTEIN RECEPTOR FOR D-GLUCOSE AND D-GALACTOSE;2;CA;CALCIUM ION;GALACTOSE/GLUCOSE-BINDING PROTEIN;562;
1GM7;B;Crystal structures of penicillin acylase enzyme-substrate complexes: Structural insights into the catalytic mechanism;1.45;CA;CALCIUM ION;PENICILLIN G ACYLASE BETA SUBUNIT;562;
1GM8;B;Crystal structures of penicillin acylase enzyme-substrate complexes: Structural insights into the catalytic mechanism;2;CA;CALCIUM ION;PENICILLIN G ACYLASE BETA SUBUNIT;562;
1GM9;B;Crystal structures of penicillin acylase enzyme-substrate complexes: Structural insights into the catalytic mechanism;1.8;CA;CALCIUM ION;PENICILLIN G ACYLASE BETA SUBUNIT;562;
1GMM;A;Carbohydrate binding module CBM6 from xylanase U Clostridium thermocellum;2;CA;CALCIUM ION;CBM6;1515;
1GN1;F;crystal structure of the mouse CCT gamma apical domain (monoclinic);2.8;CA;CALCIUM ION;CCT-GAMMA;10090;
1GN1;H;crystal structure of the mouse CCT gamma apical domain (monoclinic);2.8;CA;CALCIUM ION;CCT-GAMMA;10090;
1GNH;A;HUMAN C-REACTIVE PROTEIN;3;CA;CALCIUM ION;C-REACTIVE PROTEIN;9606;
1GNH;B;HUMAN C-REACTIVE PROTEIN;3;CA;CALCIUM ION;C-REACTIVE PROTEIN;9606;
1GNH;C;HUMAN C-REACTIVE PROTEIN;3;CA;CALCIUM ION;C-REACTIVE PROTEIN;9606;
1GNH;E;HUMAN C-REACTIVE PROTEIN;3;CA;CALCIUM ION;C-REACTIVE PROTEIN;9606;
1GNH;F;HUMAN C-REACTIVE PROTEIN;3;CA;CALCIUM ION;C-REACTIVE PROTEIN;9606;
1GNH;G;HUMAN C-REACTIVE PROTEIN;3;CA;CALCIUM ION;C-REACTIVE PROTEIN;9606;
1GNH;H;HUMAN C-REACTIVE PROTEIN;3;CA;CALCIUM ION;C-REACTIVE PROTEIN;9606;
1GNH;I;HUMAN C-REACTIVE PROTEIN;3;CA;CALCIUM ION;C-REACTIVE PROTEIN;9606;
1GO7;P;The metzincin's methionine: PrtC M226C-E189K double mutant;2.1;CA;CALCIUM ION;PROTEASE C;556;
1GO8;P;The metzincin's methionine: PrtC M226L mutant;2;CA;CALCIUM ION;PROTEASE C;556;
1GP7;A;Acidic Phospholipase A2 from venom of Ophiophagus Hannah;2.6;CA;CALCIUM ION;PHOSPHOLIPASE A2;8665;
1GP7;B;Acidic Phospholipase A2 from venom of Ophiophagus Hannah;2.6;CA;CALCIUM ION;PHOSPHOLIPASE A2;8665;
1GP7;C;Acidic Phospholipase A2 from venom of Ophiophagus Hannah;2.6;CA;CALCIUM ION;PHOSPHOLIPASE A2;8665;
1GPL;A;RP2 LIPASE;2.01;CA;CALCIUM ION;RP2 LIPASE;10141;
1GPU;A;Transketolase complex with reaction intermediate;1.86;CA;CALCIUM ION;TRANSKETOLASE 1;4932;
1GPU;B;Transketolase complex with reaction intermediate;1.86;CA;CALCIUM ION;TRANSKETOLASE 1;4932;
1GQM;A;The structure of S100A12 in a hexameric form and its proposed role in receptor signalling;2.7;CA;CALCIUM ION;CALGRANULIN C;9606;
1GQM;B;The structure of S100A12 in a hexameric form and its proposed role in receptor signalling;2.7;CA;CALCIUM ION;CALGRANULIN C;9606;
1GQM;C;The structure of S100A12 in a hexameric form and its proposed role in receptor signalling;2.7;CA;CALCIUM ION;CALGRANULIN C;9606;
1GQM;D;The structure of S100A12 in a hexameric form and its proposed role in receptor signalling;2.7;CA;CALCIUM ION;CALGRANULIN C;9606;
1GQM;E;The structure of S100A12 in a hexameric form and its proposed role in receptor signalling;2.7;CA;CALCIUM ION;CALGRANULIN C;9606;
1GQM;F;The structure of S100A12 in a hexameric form and its proposed role in receptor signalling;2.7;CA;CALCIUM ION;CALGRANULIN C;9606;
1GQM;G;The structure of S100A12 in a hexameric form and its proposed role in receptor signalling;2.7;CA;CALCIUM ION;CALGRANULIN C;9606;
1GQM;H;The structure of S100A12 in a hexameric form and its proposed role in receptor signalling;2.7;CA;CALCIUM ION;CALGRANULIN C;9606;
1GQM;I;The structure of S100A12 in a hexameric form and its proposed role in receptor signalling;2.7;CA;CALCIUM ION;CALGRANULIN C;9606;
1GQM;J;The structure of S100A12 in a hexameric form and its proposed role in receptor signalling;2.7;CA;CALCIUM ION;CALGRANULIN C;9606;
1GQM;K;The structure of S100A12 in a hexameric form and its proposed role in receptor signalling;2.7;CA;CALCIUM ION;CALGRANULIN C;9606;
1GQM;L;The structure of S100A12 in a hexameric form and its proposed role in receptor signalling;2.7;CA;CALCIUM ION;CALGRANULIN C;9606;
1GR3;A;Structure of the human collagen X NC1 trimer;2;CA;CALCIUM ION;COLLAGEN X;9606;
1GSL;A;LECTIN (FOURTH ISOLATED FROM (GRIFFONIA SIMPLICIFOLIA)) COMPLEX WITH Y HUMAN BLOOD GROUP DETERMINANT;2;CA;CALCIUM ION;GRIFFONIA SIMPLICIFOLIA LECTIN 4;3850;
1GSP;A;RIBONUCLEASE T1 COMPLEXED WITH 2',3'-CGPS, 1 DAY;2.2;CA;CALCIUM ION;RIBONUCLEASE T1;5062;
1GT9;1;High resolution crystal structure of a thermostable serine-carboxyl type proteinase, kumamolisin (kscp);1.38;CA;CALCIUM ION;KUMAMOLYSIN;1423;
1GT9;2;High resolution crystal structure of a thermostable serine-carboxyl type proteinase, kumamolisin (kscp);1.38;CA;CALCIUM ION;KUMAMOLYSIN;1423;
1GTG;1;Crystal structure of the thermostable serine-carboxyl type proteinase, kumamolysin (kscp);2.3;CA;CALCIUM ION;KUMAMOLYSIN;198803;
1GTJ;1;Crystal structure of the thermostable serine-carboxyl type proteinase, kumamolisin (KSCP) - complex with Ac-Ile-Ala-Phe-cho;1.75;CA;CALCIUM ION;KUMAMOLYSIN;198803;
1GTJ;2;Crystal structure of the thermostable serine-carboxyl type proteinase, kumamolisin (KSCP) - complex with Ac-Ile-Ala-Phe-cho;1.75;CA;CALCIUM ION;KUMAMOLYSIN;198803;
1GTL;1;The thermostable serine-carboxyl type proteinase, kumamolisin (KSCP) - complex with Ac-Ile-Pro-Phe-cho;2.8;CA;CALCIUM ION;KUMAMOLYSIN;198803;
1GTL;2;The thermostable serine-carboxyl type proteinase, kumamolisin (KSCP) - complex with Ac-Ile-Pro-Phe-cho;2.8;CA;CALCIUM ION;KUMAMOLYSIN;198803;
1GTT;A;CRYSTAL STRUCTURE OF HPCE;1.7;CA;CALCIUM ION;4-HYDROXYPHENYLACETATE DEGRADATION BIFUNCTIONAL ISOMERASE/DECARBOXYLASE;562;
1GTT;B;CRYSTAL STRUCTURE OF HPCE;1.7;CA;CALCIUM ION;4-HYDROXYPHENYLACETATE DEGRADATION BIFUNCTIONAL ISOMERASE/DECARBOXYLASE;562;
1GTT;C;CRYSTAL STRUCTURE OF HPCE;1.7;CA;CALCIUM ION;4-HYDROXYPHENYLACETATE DEGRADATION BIFUNCTIONAL ISOMERASE/DECARBOXYLASE;562;
1GTT;D;CRYSTAL STRUCTURE OF HPCE;1.7;CA;CALCIUM ION;4-HYDROXYPHENYLACETATE DEGRADATION BIFUNCTIONAL ISOMERASE/DECARBOXYLASE;562;
1GU6;A;Structure of the Periplasmic Cytochrome c Nitrite Reductase from Escherichia coli;2.5;CA;CALCIUM ION;CYTOCHROME C552;562;
1GU6;C;Structure of the Periplasmic Cytochrome c Nitrite Reductase from Escherichia coli;2.5;CA;CALCIUM ION;CYTOCHROME C552;562;
1GU6;E;Structure of the Periplasmic Cytochrome c Nitrite Reductase from Escherichia coli;2.5;CA;CALCIUM ION;CYTOCHROME C552;562;
1GU6;G;Structure of the Periplasmic Cytochrome c Nitrite Reductase from Escherichia coli;2.5;CA;CALCIUM ION;CYTOCHROME C552;562;
1GUA;B;HUMAN RAP1A, RESIDUES 1-167, DOUBLE MUTANT (E30D,K31E) COMPLEXED WITH GPPNHP AND THE RAS-BINDING-DOMAIN OF HUMAN C-RAF1, RESIDUES 51-131;2;CA;CALCIUM ION;C-RAF1;9606;
1GUI;A;CBM4 structure and function;1.9;CA;CALCIUM ION;LAMINARINASE 16A;2336;
1GUN;A;MopII from Clostridium pasteurianum complexed with molybdate (partial);1.83;CA;CALCIUM ION;MOLYBDATE BINDING PROTEIN II;1501;
1GUN;D;MopII from Clostridium pasteurianum complexed with molybdate (partial);1.83;CA;CALCIUM ION;MOLYBDATE BINDING PROTEIN II;1501;
1GVK;B;Porcine pancreatic elastase acyl enzyme at 0.95 A resolution;0.94;CA;CALCIUM ION;ELASTASE 1;9823;
1GW2;A;RECOMBINANT HORSERADISH PEROXIDASE C1A THR171SER IN COMPLEX WITH FERULIC ACID;2.15;CA;CALCIUM ION;PEROXIDASE C1A;3704;
1GW9;A;Tri-iodide derivative of Xylose Isomerase from Streptomyces Rubiginosus;1.55;CA;CALCIUM ION;XYLOSE ISOMERASE;1929;
1GWA;A;Triiodide derivative of porcine pancreas elastase;1.85;CA;CALCIUM ION;ELASTASE 1;9823;
1GWO;A;Recombinant horseradish peroxidase C1A ALA170GLN;2.07;CA;CALCIUM ION;PEROXIDASE C1A;3704;
1GWT;A;RECOMBINANT HORSERADISH PEROXIDASE C1A PHE221MET;1.7;CA;CALCIUM ION;PEROXIDASE C1A;3704;
1GWU;A;RECOMBINANT HORSERADISH PEROXIDASE C1A ALA140GLY;1.31;CA;CALCIUM ION;PEROXIDASE C1A;3704;
1GX2;A;Recombinant horseradish peroxidase Phe209Ser complex with benzhydroxamic acid;2.2;CA;CALCIUM ION;PEROXIDASE C1A;3704;
1GX2;B;Recombinant horseradish peroxidase Phe209Ser complex with benzhydroxamic acid;2.2;CA;CALCIUM ION;PEROXIDASE C1A;3704;
1GXD;A;proMMP-2/TIMP-2 complex;3.1;CA;CALCIUM ION;72 KDA TYPE IV COLLAGENASE;9606;
1GXD;B;proMMP-2/TIMP-2 complex;3.1;CA;CALCIUM ION;72 KDA TYPE IV COLLAGENASE;9606;
1GXO;A;Mutant D189A of Family 10 polysaccharide lyase from Cellvibrio cellulosa in complex with trigalaturonic acid;2.05;CA;CALCIUM ION;PECTATE LYASE;155077;
1GXR;A;WD40 Region of Human Groucho/TLE1;1.65;CA;CALCIUM ION;TRANSDUCIN-LIKE ENHANCER PROTEIN 1;9606;
1GXW;A;the 2.2 A resolution structure of thermolysin crystallized in presence of potassium thiocyanate;2.18;CA;CALCIUM ION;THERMOLYSIN;1427;
1GYK;A;Serum Amyloid P Component co-crystallised with MOBDG at neutral pH;2.2;CA;CALCIUM ION;SERUM AMYLOID P-COMPONENT;9606;
1GYK;B;Serum Amyloid P Component co-crystallised with MOBDG at neutral pH;2.2;CA;CALCIUM ION;SERUM AMYLOID P-COMPONENT;9606;
1GYK;C;Serum Amyloid P Component co-crystallised with MOBDG at neutral pH;2.2;CA;CALCIUM ION;SERUM AMYLOID P-COMPONENT;9606;
1GYK;D;Serum Amyloid P Component co-crystallised with MOBDG at neutral pH;2.2;CA;CALCIUM ION;SERUM AMYLOID P-COMPONENT;9606;
1GYK;E;Serum Amyloid P Component co-crystallised with MOBDG at neutral pH;2.2;CA;CALCIUM ION;SERUM AMYLOID P-COMPONENT;9606;
1GZ9;A;High-Resolution Crystal Structure of Erythrina cristagalli Lectin in Complex with 2'-alpha-L-Fucosyllactose;1.7;CA;CALCIUM ION;ERYTHRINA CRISTA-GALLI LECTIN;49817;
1GZA;A;PEROXIDASE;2.06;CA;CALCIUM ION;PEROXIDASE;5451;
1GZB;A;PEROXIDASE;1.8;CA;CALCIUM ION;PEROXIDASE;5451;
1GZC;A;High-Resolution crystal structure of Erythrina cristagalli lectin in complex with lactose;1.58;CA;CALCIUM ION;ERYTHRINA CRISTA-GALLI LECTIN;49817;
1GZT;A;Pseudomonas aeruginosa lectin II (PA-IIL) together with fucose;1.3;CA;CALCIUM ION;FUCOSE-SPECIFIC LECTIN;287;
1GZT;B;Pseudomonas aeruginosa lectin II (PA-IIL) together with fucose;1.3;CA;CALCIUM ION;FUCOSE-SPECIFIC LECTIN;287;
1GZT;C;Pseudomonas aeruginosa lectin II (PA-IIL) together with fucose;1.3;CA;CALCIUM ION;FUCOSE-SPECIFIC LECTIN;287;
1GZT;D;Pseudomonas aeruginosa lectin II (PA-IIL) together with fucose;1.3;CA;CALCIUM ION;FUCOSE-SPECIFIC LECTIN;287;
1H0H;A;Tungsten containing Formate Dehydrogenase from Desulfovibrio Gigas;1.8;CA;CALCIUM ION;FORMATE DEHYDROGENASE SUBUNIT ALPHA;879;
1H0H;K;Tungsten containing Formate Dehydrogenase from Desulfovibrio Gigas;1.8;CA;CALCIUM ION;FORMATE DEHYDROGENASE SUBUNIT ALPHA;879;
1H1A;A;Thermophilic beta-1,4-xylanase from Chaetomium thermophilum;1.75;CA;CALCIUM ION;Endo-1,4-beta-xylanase;209285;
1H1V;A;gelsolin G4-G6/actin complex;2.99;CA;CALCIUM ION;ACTIN;9986;
1H1V;G;gelsolin G4-G6/actin complex;2.99;CA;CALCIUM ION;GELSOLIN;9606;
1H2G;B;Altered substrate specificity mutant of penicillin acylase;2;CA;CALCIUM ION;PENICILLIN G ACYLASE BETA SUBUNIT;562;
1H30;A;C-terminal LG domain pair of human Gas6;2.2;CA;CALCIUM ION;GROWTH-ARREST-SPECIFIC PROTEIN;9606;
1H3G;A;Cyclomaltodextrinase from Flavobacterium sp. No. 92: from DNA sequence to protein structure;2.1;CA;CALCIUM ION;Cyclomaltodextrinase;197856;
1H3G;B;Cyclomaltodextrinase from Flavobacterium sp. No. 92: from DNA sequence to protein structure;2.1;CA;CALCIUM ION;Cyclomaltodextrinase;197856;
1H3J;A;STRUCTURE OF RECOMBINANT COPRINUS CINEREUS PEROXIDASE DETERMINED TO 2.0 A;2;CA;CALCIUM ION;PEROXIDASE;5346;
1H3J;B;STRUCTURE OF RECOMBINANT COPRINUS CINEREUS PEROXIDASE DETERMINED TO 2.0 A;2;CA;CALCIUM ION;PEROXIDASE;5346;
1H4B;A;SOLUTION STRUCTURE OF THE BIRCH POLLEN ALLERGEN BET V 4;;CA;CALCIUM ION;POLCALCIN BET V 4;3505;
1H4I;A;Methylobacterium extorquens methanol dehydrogenase;1.94;CA;CALCIUM ION;METHANOL DEHYDROGENASE SUBUNIT 1;408;
1H4I;C;Methylobacterium extorquens methanol dehydrogenase;1.94;CA;CALCIUM ION;METHANOL DEHYDROGENASE SUBUNIT 1;408;
1H4J;A;Methylobacterium extorquens methanol dehydrogenase D303E mutant;3;CA;CALCIUM ION;Methanol dehydrogenase [cytochrome c] subunit 1;408;
1H4J;C;Methylobacterium extorquens methanol dehydrogenase D303E mutant;3;CA;CALCIUM ION;Methanol dehydrogenase [cytochrome c] subunit 1;408;
1H4J;E;Methylobacterium extorquens methanol dehydrogenase D303E mutant;3;CA;CALCIUM ION;Methanol dehydrogenase [cytochrome c] subunit 1;408;
1H4J;G;Methylobacterium extorquens methanol dehydrogenase D303E mutant;3;CA;CALCIUM ION;Methanol dehydrogenase [cytochrome c] subunit 1;408;
1H4W;A;Structure of human trypsin IV (brain trypsin);1.7;CA;CALCIUM ION;TRYPSIN IVA;9606;
1H55;A;STRUCTURE OF HORSERADISH PEROXIDASE C1A COMPOUND II;1.61;CA;CALCIUM ION;PEROXIDASE C1A;3704;
1H57;A;Structure of horseradish peroxidase C1A compound III;1.6;CA;CALCIUM ION;PEROXIDASE C1A;3704;
1H58;A;STRUCTURE OF FERROUS HORSERADISH PEROXIDASE C1A;1.7;CA;CALCIUM ION;PEROXIDASE C1A;3704;
1H5A;A;STRUCTURE OF FERRIC HORSERADISH PEROXIDASE C1A IN COMPLEX WITH ACETATE;1.6;CA;CALCIUM ION;PEROXIDASE C1A;3704;
1H5C;A;X-ray induced reduction of horseradish peroxidase C1A Compound III (100-200% dose);1.62;CA;CALCIUM ION;PEROXIDASE C1A;3704;
1H5D;A;X-ray induced reduction of horseradish peroxidase C1A Compound III (0-11% dose);1.6;CA;CALCIUM ION;PEROXIDASE C1A;3704;
1H5E;A;X-ray induced reduction of horseradish peroxidase C1A Compound III (11-22% dose);1.6;CA;CALCIUM ION;PEROXIDASE C1A;3704;
1H5F;A;X-ray induced reduction of horseradish peroxidase C1A Compound III (22-33% dose);1.6;CA;CALCIUM ION;PEROXIDASE C1A;3704;
1H5G;A;X-ray induced reduction of horseradish peroxidase C1A Compound III (33-44% dose);1.6;CA;CALCIUM ION;PEROXIDASE C1A;3704;
1H5H;A;X-ray induced reduction of horseradish peroxidase C1A Compound III (44-56% dose);1.6;CA;CALCIUM ION;PEROXIDASE C1A;3704;
1H5I;A;X-ray induced reduction of horseradish peroxidase C1A Compound III (56-67% dose);1.6;CA;CALCIUM ION;PEROXIDASE C1A;3704;
1H5J;A;X-ray induced reduction of horseradish peroxidase C1A Compound III (67-78% dose);1.6;CA;CALCIUM ION;PEROXIDASE C1A;3704;
1H5K;A;X-ray induced reduction of horseradish peroxidase C1A Compound III (78-89% dose);1.6;CA;CALCIUM ION;PEROXIDASE C1A;3704;
1H5L;A;X-ray induced reduction of horseradish peroxidase C1A Compound III (89-100% dose);1.6;CA;CALCIUM ION;PEROXIDASE C1A;3704;
1H5M;A;X-ray induced reduction of horseradish peroxidase C1A Compound III (0-100% dose);1.6;CA;CALCIUM ION;PEROXIDASE C1A;3704;
1H5V;A;Thiopentasaccharide complex of the endoglucanase Cel5A from Bacillus agaradharens at 1.1 A resolution in the tetragonal crystal form;1.1;CA;CALCIUM ION;ENDOGLUCANASE 5A;76935;
1H6G;A;alpha-catenin M-domain;2.2;CA;CALCIUM ION;ALPHA-1 CATENIN;9606;
1H6G;B;alpha-catenin M-domain;2.2;CA;CALCIUM ION;ALPHA-1 CATENIN;9606;
1H6L;A;beta-propeller phytase in complex with phosphate and calcium ions;1.8;CA;CALCIUM ION;3-PHYTASE;1390;
1H6X;A;The role of conserved amino acids in the cleft of the C-terminal family 22 carbohydrate binding module of Clostridium thermocellum Xyn10B in ligand binding;2.25;CA;CALCIUM ION;ENDO-1,4-BETA-XYLANASE Y;1515;
1H6Y;A;The role of conserved amino acids in the cleft of the C-terminal family 22 carbohydrate binding module of Clostridium thermocellum Xyn10B in ligand binding;2.2;CA;CALCIUM ION;ENDO-1,4-BETA-XYLANASE Y;1515;
1H6Y;B;The role of conserved amino acids in the cleft of the C-terminal family 22 carbohydrate binding module of Clostridium thermocellum Xyn10B in ligand binding;2.2;CA;CALCIUM ION;ENDO-1,4-BETA-XYLANASE Y;1515;
1H71;P;Psychrophilic Protease from Pseudoalteromonas 'TAC II 18';2.1;CA;CALCIUM ION;SERRALYSIN;76981;
1H80;A;1,3-ALPHA-1,4-BETA-D-GALACTOSE-4-SULFATE- 3,6-ANHYDRO-D-GALACTOSE-2-SULFATE 4 GALACTOHYDROLASE;1.6;CA;CALCIUM ION;IOTA-CARRAGEENASE;116059;
1H80;B;1,3-ALPHA-1,4-BETA-D-GALACTOSE-4-SULFATE- 3,6-ANHYDRO-D-GALACTOSE-2-SULFATE 4 GALACTOHYDROLASE;1.6;CA;CALCIUM ION;IOTA-CARRAGEENASE;116059;
1H93;A;ACTIVE MUTANT (S215->C) OF GLUCOSE 6-PHOSPHATE DEHYDROGENASE FROM LEUCONOSTOC MESENTEROIDES;2.2;CA;CALCIUM ION;GLUCOSE 6-PHOSPHATE 1-DEHYDROGENASE;1245;
1H9H;E;COMPLEX OF EETI-II WITH PORCINE TRYPSIN;1.5;CA;CALCIUM ION;TRYPSIN;9823;
1H9I;E;COMPLEX OF EETI-II MUTANT WITH PORCINE TRYPSIN;1.9;CA;CALCIUM ION;TRYPSIN;9823;
1H9L;B;PORCINE PANCREATIC ELASTASE COMPLEXED WITH ACETYL-VAL-GLU-PRO-ILE-COOH;1.67;CA;CALCIUM ION;ELASTASE;9823;
1H9W;A;Native Dioclea Guianensis seed lectin;2;CA;CALCIUM ION;SEED LECTIN;99571;
1H9W;B;Native Dioclea Guianensis seed lectin;2;CA;CALCIUM ION;SEED LECTIN;99571;
1HAX;B;Snapshots of serine protease catalysis: (A) acyl-enzyme intermediate between porcine pancreatic elastase and human beta-casomorphin-7 at pH 5;1.6;CA;CALCIUM ION;ELASTASE 1;9823;
1HAY;B;Snapshots of serine protease catalysis: (B) acyl-enzyme intermediate between porcine pancreatic elastase and human beta-casomorphin-7 jumped to pH 10 for 10 seconds;1.7;CA;CALCIUM ION;ELASTASE 1;9823;
1HAZ;B;Snapshots of serine protease catalysis: (C) acyl-enzyme intermediate between porcine pancreatic elastase and human beta-casomorphin-7 jumped to pH 9 for 1 minute;1.4;CA;CALCIUM ION;ELASTASE 1;9823;
1HB0;B;Snapshots of serine protease catalysis: (D) acyl-enzyme intermediate between porcine pancreatic elastase and human beta-casomorphin-7 jumped to pH 10 for 2 minutes;2.05;CA;CALCIUM ION;ELASTASE 1;9823;
1HCH;A;Structure of horseradish peroxidase C1A compound I;1.57;CA;CALCIUM ION;PEROXIDASE C1A;3704;
1HCU;A;alpha-1,2-mannosidase from Trichoderma reesei;2.37;CA;CALCIUM ION;ALPHA-1,2-MANNOSIDASE;51453;
1HCU;B;alpha-1,2-mannosidase from Trichoderma reesei;2.37;CA;CALCIUM ION;ALPHA-1,2-MANNOSIDASE;51453;
1HCU;C;alpha-1,2-mannosidase from Trichoderma reesei;2.37;CA;CALCIUM ION;ALPHA-1,2-MANNOSIDASE;51453;
1HCU;D;alpha-1,2-mannosidase from Trichoderma reesei;2.37;CA;CALCIUM ION;ALPHA-1,2-MANNOSIDASE;51453;
1HDF;A;Evolution of the eye lens beta-gamma-crystallin domain fold;2.35;CA;CALCIUM ION;SPHERULIN 3A;5791;
1HDF;B;Evolution of the eye lens beta-gamma-crystallin domain fold;2.35;CA;CALCIUM ION;SPHERULIN 3A;5791;
1HDH;A;Arylsulfatase from Pseudomonas aeruginosa;1.3;CA;CALCIUM ION;Arylsulfatase;287;
1HDH;B;Arylsulfatase from Pseudomonas aeruginosa;1.3;CA;CALCIUM ION;Arylsulfatase;287;
1HEI;A;STRUCTURE OF THE HEPATITIS C VIRUS RNA HELICASE DOMAIN;2.1;CA;CALCIUM ION;HCV HELICASE;11103;
1HEI;B;STRUCTURE OF THE HEPATITIS C VIRUS RNA HELICASE DOMAIN;2.1;CA;CALCIUM ION;HCV HELICASE;11103;
1HFC;A;1.56 ANGSTROM STRUCTURE OF MATURE TRUNCATED HUMAN FIBROBLAST COLLAGENASE;1.5;CA;CALCIUM ION;FIBROBLAST COLLAGENASE;9606;
1HFS;A;CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN FIBROBLAST STROMELYSIN-1 INHIBITED WITH THE N-CARBOXY-ALKYL INHIBITOR L-764,004;1.7;CA;CALCIUM ION;STROMELYSIN-1;9606;
1HFX;A;ALPHA-LACTALBUMIN;1.9;CA;CALCIUM ION;ALPHA-LACTALBUMIN;10141;
1HFY;A;ALPHA-LACTALBUMIN;2.3;CA;CALCIUM ION;ALPHA-LACTALBUMIN;9925;
1HFY;B;ALPHA-LACTALBUMIN;2.3;CA;CALCIUM ION;ALPHA-LACTALBUMIN;9925;
1HFZ;A;ALPHA-LACTALBUMIN;2.3;CA;CALCIUM ION;ALPHA-LACTALBUMIN;9913;
1HFZ;B;ALPHA-LACTALBUMIN;2.3;CA;CALCIUM ION;ALPHA-LACTALBUMIN;9913;
1HFZ;C;ALPHA-LACTALBUMIN;2.3;CA;CALCIUM ION;ALPHA-LACTALBUMIN;9913;
1HFZ;D;ALPHA-LACTALBUMIN;2.3;CA;CALCIUM ION;ALPHA-LACTALBUMIN;9913;
1HJ7;A;NMR study of a pair of LDL receptor Ca2+ binding epidermal growth factor-like domains, 20 structures;;CA;CALCIUM ION;LDL RECEPTOR;9606;
1HJ8;A;1.00 AA Trypsin from Atlantic Salmon;1;CA;CALCIUM ION;TRYPSIN I;8030;
1HJ9;A;Atomic resolution structures of trypsin provide insight into structural radiation damage;0.95;CA;CALCIUM ION;BETA-TRYPSIN;9913;
1HJO;A;ATPase domain of human heat shock 70kDa protein 1;2.3;CA;CALCIUM ION;PROTEIN (HEAT-SHOCK 70KD PROTEIN);9606;
1HKB;A;CRYSTAL STRUCTURE OF RECOMBINANT HUMAN BRAIN HEXOKINASE TYPE I COMPLEXED WITH GLUCOSE AND GLUCOSE-6-PHOSPHATE;2.8;CA;CALCIUM ION;D-GLUCOSE 6-PHOSPHOTRANSFERASE;9606;
1HKB;B;CRYSTAL STRUCTURE OF RECOMBINANT HUMAN BRAIN HEXOKINASE TYPE I COMPLEXED WITH GLUCOSE AND GLUCOSE-6-PHOSPHATE;2.8;CA;CALCIUM ION;D-GLUCOSE 6-PHOSPHOTRANSFERASE;9606;
1HKD;A;Structure of pea lectin in complex with alpha-methyl-D-glucopyranoside;2.09;CA;CALCIUM ION;PEA LECTIN ALPHA CHAIN;3888;
1HKD;C;Structure of pea lectin in complex with alpha-methyl-D-glucopyranoside;2.09;CA;CALCIUM ION;PEA LECTIN ALPHA CHAIN;3888;
1HL5;C;The Structure of Holo Type Human Cu, Zn Superoxide Dismutase;1.8;CA;CALCIUM ION;SUPEROXIDE DISMUTASE;9606;
1HL5;D;The Structure of Holo Type Human Cu, Zn Superoxide Dismutase;1.8;CA;CALCIUM ION;SUPEROXIDE DISMUTASE;9606;
1HL5;O;The Structure of Holo Type Human Cu, Zn Superoxide Dismutase;1.8;CA;CALCIUM ION;SUPEROXIDE DISMUTASE;9606;
1HLE;A;CRYSTAL STRUCTURE OF CLEAVED EQUINE LEUCOCYTE ELASTASE INHIBITOR DETERMINED AT 1.95 ANGSTROMS RESOLUTION;1.95;CA;CALCIUM ION;HORSE LEUKOCYTE ELASTASE INHIBITOR;9796;
1HLU;A;STRUCTURE OF BOVINE BETA-ACTIN-PROFILIN COMPLEX WITH ACTIN BOUND ATP PHOSPHATES SOLVENT ACCESSIBLE;2.65;CA;CALCIUM ION;BETA-ACTIN;9913;
1HM0;A;CRYSTAL STRUCTURE OF S.PNEUMONIAE N-ACETYLGLUCOSAMINE 1-PHOSPHATE URIDYLTRANSFERASE, GLMU;2.3;CA;CALCIUM ION;N-ACETYLGLUCOSAMINE 1-PHOSPHATE URIDYLTRANSFERASE;1313;
1HM0;B;CRYSTAL STRUCTURE OF S.PNEUMONIAE N-ACETYLGLUCOSAMINE 1-PHOSPHATE URIDYLTRANSFERASE, GLMU;2.3;CA;CALCIUM ION;N-ACETYLGLUCOSAMINE 1-PHOSPHATE URIDYLTRANSFERASE;1313;
1HM2;A;ACTIVE SITE OF CHONDROITINASE AC LYASE REVEALED BY THE STRUCTURE OF ENZYME-OLIGOSACCHARIDE COMPLEXES AND MUTAGENESIS;2;CA;CALCIUM ION;CHONDROITINASE AC;984;
1HM3;A;ACTIVE SITE OF CHONDROITINASE AC LYASE REVEALED BY THE STRUCTURE OF ENZYME-OLIGOSACCHARIDE COMPLEXES AND MUTAGENESIS;2.1;CA;CALCIUM ION;CHONDROITINASE AC;984;
1HM8;A;CRYSTAL STRUCTURE OF S.PNEUMONIAE N-ACETYLGLUCOSAMINE-1-PHOSPHATE URIDYLTRANSFERASE, GLMU, BOUND TO ACETYL COENZYME A;2.5;CA;CALCIUM ION;UDP-N-ACETYLGLUCOSAMINE-1-PHOSPHATE URIDYLTRANSFERASE;1313;
1HM8;B;CRYSTAL STRUCTURE OF S.PNEUMONIAE N-ACETYLGLUCOSAMINE-1-PHOSPHATE URIDYLTRANSFERASE, GLMU, BOUND TO ACETYL COENZYME A;2.5;CA;CALCIUM ION;UDP-N-ACETYLGLUCOSAMINE-1-PHOSPHATE URIDYLTRANSFERASE;1313;
1HM9;A;CRYSTAL STRUCTURE OF S.PNEUMONIAE N-ACETYLGLUCOSAMINE-1-PHOSPHATE URIDYLTRANSFERASE, GLMU, BOUND TO ACETYL COENZYME A AND UDP-N-ACETYLGLUCOSAMINE;1.75;CA;CALCIUM ION;UDP-N-ACETYLGLUCOSAMINE-1-PHOSPHATE URIDYLTRANSFERASE;1313;
1HM9;B;CRYSTAL STRUCTURE OF S.PNEUMONIAE N-ACETYLGLUCOSAMINE-1-PHOSPHATE URIDYLTRANSFERASE, GLMU, BOUND TO ACETYL COENZYME A AND UDP-N-ACETYLGLUCOSAMINE;1.75;CA;CALCIUM ION;UDP-N-ACETYLGLUCOSAMINE-1-PHOSPHATE URIDYLTRANSFERASE;1313;
1HMK;A;RECOMBINANT GOAT ALPHA-LACTALBUMIN;2;CA;CALCIUM ION;PROTEIN (ALPHA-LACTALBUMIN);9925;
1HML;A;ALPHA_LACTALBUMIN POSSESSES A DISTINCT ZINC BINDING SITE;1.7;CA;CALCIUM ION;ALPHA-LACTALBUMIN;9606;
1HMU;A;ACTIVE SITE OF CHONDROITINASE AC LYASE REVEALED BY THE STRUCTURE OF ENZYME-OLIGOSACCHARIDE COMPLEXES AND MUTAGENESIS;2;CA;CALCIUM ION;CHONDROITINASE AC;984;
1HMW;A;ACTIVE SITE OF CHONDROITINASE AC LYASE REVEALED BY THE STRUCTURE OF ENZYME-OLIGOSACCHARIDE COMPLEXES AND MUTAGENESIS;2.3;CA;CALCIUM ION;CHONDROITINASE AC;984;
1HN4;A;PROPHOSPHOLIPASE A2 DIMER COMPLEXED WITH MJ33, SULFATE, AND CALCIUM;1.5;CA;CALCIUM ION;PROPHOSPHOLIPASE A2;9823;
1HN4;B;PROPHOSPHOLIPASE A2 DIMER COMPLEXED WITH MJ33, SULFATE, AND CALCIUM;1.5;CA;CALCIUM ION;PROPHOSPHOLIPASE A2;9823;
1HNY;A;The structure of human pancreatic alpha-amylase at 1.8 angstroms resolution and comparisons with related enzymes;1.8;CA;CALCIUM ION;HUMAN PANCREATIC ALPHA-AMYLASE;9606;
1HOV;A;SOLUTION STRUCTURE OF A CATALYTIC DOMAIN OF MMP-2 COMPLEXED WITH SC-74020;;CA;CALCIUM ION;MATRIX METALLOPROTEINASE-2;9606;
1HOZ;A;CRYSTAL STRUCTURE OF AN INOSINE-ADENOSINE-GUANOSINE-PREFERRING NUCLEOSIDE HYDROLASE FROM TRYPANOSOMA VIVAX;1.6;CA;CALCIUM ION;INOSINE-ADENOSINE-GUANOSINE-PREFERRING NUCLEOSIDE HYDROLASE;5699;
1HOZ;B;CRYSTAL STRUCTURE OF AN INOSINE-ADENOSINE-GUANOSINE-PREFERRING NUCLEOSIDE HYDROLASE FROM TRYPANOSOMA VIVAX;1.6;CA;CALCIUM ION;INOSINE-ADENOSINE-GUANOSINE-PREFERRING NUCLEOSIDE HYDROLASE;5699;
1HP0;A;CRYSTAL STRUCTURE OF AN INOSINE-ADENOSINE-GUANOSINE-PREFERRING NUCLEOSIDE HYDROLASE FROM TRYPANOSOMA VIVAX IN COMPLEX WITH THE SUBSTRATE ANALOGUE 3-DEAZA-ADENOSINE;2.1;CA;CALCIUM ION;INOSINE-ADENOSINE-GUANOSINE-PREFERRING NUCLEOSIDE HYDROLASE;5699;
1HP0;B;CRYSTAL STRUCTURE OF AN INOSINE-ADENOSINE-GUANOSINE-PREFERRING NUCLEOSIDE HYDROLASE FROM TRYPANOSOMA VIVAX IN COMPLEX WITH THE SUBSTRATE ANALOGUE 3-DEAZA-ADENOSINE;2.1;CA;CALCIUM ION;INOSINE-ADENOSINE-GUANOSINE-PREFERRING NUCLEOSIDE HYDROLASE;5699;
1HPL;A;HORSE PANCREATIC LIPASE. THE CRYSTAL STRUCTURE AT 2.3 ANGSTROMS RESOLUTION;2.3;CA;CALCIUM ION;LIPASE;9796;
1HPL;B;HORSE PANCREATIC LIPASE. THE CRYSTAL STRUCTURE AT 2.3 ANGSTROMS RESOLUTION;2.3;CA;CALCIUM ION;LIPASE;9796;
1HQD;A;PSEUDOMONAS CEPACIA LIPASE COMPLEXED WITH TRANSITION STATE ANALOGUE OF 1-PHENOXY-2-ACETOXY BUTANE;2.3;CA;CALCIUM ION;LIPASE;292;
1HQL;A;The xenograft antigen in complex with the B4 isolectin of Griffonia simplicifolia lectin-1;2.2;CA;CALCIUM ION;LECTIN;3850;
1HQL;B;The xenograft antigen in complex with the B4 isolectin of Griffonia simplicifolia lectin-1;2.2;CA;CALCIUM ION;LECTIN;3850;
1HQV;A;STRUCTURE OF APOPTOSIS-LINKED PROTEIN ALG-2;2.3;CA;CALCIUM ION;PROGRAMMED CELL DEATH PROTEIN 6;10090;
1HQW;A;CRYSTAL STRUCTURE OF THE COMPLEX OF CONCANAVALIN A WITH A TRIPEPTIDE YPY;2.4;CA;CALCIUM ION;CONCANAVALIN A;3823;
1HSR;A;BINDING MODE OF BENZHYDROXAMIC ACID TO ARTHROMYCES RAMOSUS PEROXIDASE;1.6;CA;CALCIUM ION;PEROXIDASE;5451;
1HT3;A;MERCURY INDUCED MODIFICATIONS IN THE STEREOCHEMISTRY OF THE ACTIVE SITE THROUGH CYS-73 IN A SERINE PROTEASE: CRYSTAL STRUCTURE OF THE COMPLEX OF A PARTIALLY MODIFIED PROTEINASE K WITH MERCURY AT 1.8 A RESOLUTION;1.8;CA;CALCIUM ION;PROTEINASE K;37998;
1HT6;A;CRYSTAL STRUCTURE AT 1.5A RESOLUTION OF THE BARLEY ALPHA-AMYLASE ISOZYME 1;1.5;CA;CALCIUM ION;ALPHA-AMYLASE ISOZYME 1;4513;
1HT9;A;DOMAIN SWAPPING EF-HANDS;1.76;CA;CALCIUM ION;CALBINDIN D9K;9913;
1HT9;B;DOMAIN SWAPPING EF-HANDS;1.76;CA;CALCIUM ION;CALBINDIN D9K;9913;
1HTD;A;STRUCTURAL INTERACTION OF NATURAL AND SYNTHETIC INHIBITORS WITH THE VENOM METALLOPROTEINASE, ATROLYSIN C (HT-D);2.1;CA;CALCIUM ION;ATROLYSIN C;8730;
1HTD;B;STRUCTURAL INTERACTION OF NATURAL AND SYNTHETIC INHIBITORS WITH THE VENOM METALLOPROTEINASE, ATROLYSIN C (HT-D);2.1;CA;CALCIUM ION;ATROLYSIN C;8730;
1HTN;A;HUMAN TETRANECTIN, A TRIMERIC PLASMINOGEN BINDING PROTEIN WITH AN ALPHA-HELICAL COILED COIL;2.8;CA;CALCIUM ION;TETRANECTIN;9606;
1HU0;E;CRYSTAL STRUCTURE OF AN HOGG1-DNA BOROHYDRIDE TRAPPED INTERMEDIATE COMPLEX;2.35;CA;CALCIUM ION;5'-D(*GP*CP*GP*TP*CP*CP*AP*(PED)P*GP*TP*CP*TP*AP*CP*C)-3';;
1HUP;A;HUMAN MANNOSE BINDING PROTEIN CARBOHYDRATE RECOGNITION DOMAIN TRIMERIZES THROUGH A TRIPLE ALPHA-HELICAL COILED-COIL;2.5;CA;CALCIUM ION;MANNOSE-BINDING PROTEIN;9606;
1HV5;A;CRYSTAL STRUCTURE OF THE STROMELYSIN-3 (MMP-11) CATALYTIC DOMAIN COMPLEXED WITH A PHOSPHINIC INHIBITOR;2.6;CA;CALCIUM ION;STROMELYSIN 3;10090;
1HV5;B;CRYSTAL STRUCTURE OF THE STROMELYSIN-3 (MMP-11) CATALYTIC DOMAIN COMPLEXED WITH A PHOSPHINIC INHIBITOR;2.6;CA;CALCIUM ION;STROMELYSIN 3;10090;
1HV5;C;CRYSTAL STRUCTURE OF THE STROMELYSIN-3 (MMP-11) CATALYTIC DOMAIN COMPLEXED WITH A PHOSPHINIC INHIBITOR;2.6;CA;CALCIUM ION;STROMELYSIN 3;10090;
1HV5;D;CRYSTAL STRUCTURE OF THE STROMELYSIN-3 (MMP-11) CATALYTIC DOMAIN COMPLEXED WITH A PHOSPHINIC INHIBITOR;2.6;CA;CALCIUM ION;STROMELYSIN 3;10090;
1HV5;E;CRYSTAL STRUCTURE OF THE STROMELYSIN-3 (MMP-11) CATALYTIC DOMAIN COMPLEXED WITH A PHOSPHINIC INHIBITOR;2.6;CA;CALCIUM ION;STROMELYSIN 3;10090;
1HV5;F;CRYSTAL STRUCTURE OF THE STROMELYSIN-3 (MMP-11) CATALYTIC DOMAIN COMPLEXED WITH A PHOSPHINIC INHIBITOR;2.6;CA;CALCIUM ION;STROMELYSIN 3;10090;
1HVD;A;STRUCTURAL AND ELECTROPHYSIOLOGICAL ANALYSIS OF ANNEXIN V MUTANTS. MUTAGENESIS OF HUMAN ANNEXIN V, AN IN VITRO VOLTAGE-GATED CALCIUM CHANNEL, PROVIDES INFORMATION ABOUT THE STRUCTURAL FEATURES OF THE ION PATHWAY, THE VOLTAGE SENSOR AND THE ION SELECTIVITY FILTER;2;CA;CALCIUM ION;ANNEXIN V;9606;
1HVE;A;STRUCTURAL AND ELECTROPHYSIOLOGICAL ANALYSIS OF ANNEXIN V MUTANTS. MUTAGENESIS OF HUMAN ANNEXIN V, AN IN VITRO VOLTAGE-GATED CALCIUM CHANNEL, PROVIDES INFORMATION ABOUT THE STRUCTURAL FEATURES OF THE ION PATHWAY, THE VOLTAGE SENSOR AND THE ION SELECTIVITY FILTER;2.3;CA;CALCIUM ION;ANNEXIN V;9606;
1HVF;A;STRUCTURAL AND ELECTROPHYSIOLOGICAL ANALYSIS OF ANNEXIN V MUTANTS. MUTAGENESIS OF HUMAN ANNEXIN V, AN IN VITRO VOLTAGE-GATED CALCIUM CHANNEL, PROVIDES INFORMATION ABOUT THE STRUCTURAL FEATURES OF THE ION PATHWAY, THE VOLTAGE SENSOR AND THE ION SELECTIVITY FILTER;2;CA;CALCIUM ION;ANNEXIN V;9606;
1HVX;A;BACILLUS STEAROTHERMOPHILUS ALPHA-AMYLASE;2;CA;CALCIUM ION;ALPHA-AMYLASE;1422;
1HX0;A;Structure of pig pancreatic alpha-amylase complexed with the 'truncate' acarbose molecule (pseudotrisaccharide);1.38;CA;CALCIUM ION;ALPHA AMYLASE (PPA);9823;
1HY7;A;A CARBOXYLIC ACID BASED INHIBITOR IN COMPLEX WITH MMP3;1.5;CA;CALCIUM ION;STROMELYSIN-1;9606;
1HY7;B;A CARBOXYLIC ACID BASED INHIBITOR IN COMPLEX WITH MMP3;1.5;CA;CALCIUM ION;STROMELYSIN-1;9606;
1HYO;A;CRYSTAL STRUCTURE OF FUMARYLACETOACETATE HYDROLASE COMPLEXED WITH 4-(HYDROXYMETHYLPHOSPHINOYL)-3-OXO-BUTANOIC ACID;1.3;CA;CALCIUM ION;FUMARYLACETOACETATE HYDROLASE;10090;
1HYO;B;CRYSTAL STRUCTURE OF FUMARYLACETOACETATE HYDROLASE COMPLEXED WITH 4-(HYDROXYMETHYLPHOSPHINOYL)-3-OXO-BUTANOIC ACID;1.3;CA;CALCIUM ION;FUMARYLACETOACETATE HYDROLASE;10090;
1HYT;A;RE-DETERMINATION AND REFINEMENT OF THE COMPLEX OF BENZYLSUCCINIC ACID WITH THERMOLYSIN AND ITS RELATION TO THE COMPLEX WITH CARBOXYPEPTIDASE A;1.7;CA;CALCIUM ION;THERMOLYSIN;1427;
1HZ8;A;SOLUTION STRUCTURE AND BACKBONE DYNAMICS OF A CONCATEMER OF EGF-HOMOLOGY MODULES OF THE HUMAN LOW DENSITY LIPOPROTEIN RECEPTOR;;CA;CALCIUM ION;LOW DENSITY LIPOPROTEIN RECEPTOR;9606;
1I0U;A;SOLUTION STRUCTURE AND BACKBONE DYNAMICS OF A CONCATEMER OF EGF-HOMOLOGY MODULES OF THE HUMAN LOW DENSITY LIPOPROTEIN RECEPTOR;;CA;CALCIUM ION;LOW DENSITY LIPOPROTEIN RECEPTOR;9606;
1I0V;A;Ribonuclease T1 in complex with 2'GMP (form I crystal);1.23;CA;CALCIUM ION;GUANYL-SPECIFIC RIBONUCLEASE T1;5062;
1I0X;B;RIBONUCLEASE T1 IN COMPLEX WITH 2'GMP (FORM II CRYSTAL);1.65;CA;CALCIUM ION;GUANYL-SPECIFIC RIBONUCLEASE T1;5062;
1I0X;C;RIBONUCLEASE T1 IN COMPLEX WITH 2'GMP (FORM II CRYSTAL);1.65;CA;CALCIUM ION;GUANYL-SPECIFIC RIBONUCLEASE T1;5062;
1I0X;D;RIBONUCLEASE T1 IN COMPLEX WITH 2'GMP (FORM II CRYSTAL);1.65;CA;CALCIUM ION;GUANYL-SPECIFIC RIBONUCLEASE T1;5062;
1I22;A;MUTANT HUMAN LYSOZYME (A83K/Q86D/A92D);1.8;CA;CALCIUM ION;LYSOZYME C;9606;
1I22;B;MUTANT HUMAN LYSOZYME (A83K/Q86D/A92D);1.8;CA;CALCIUM ION;LYSOZYME C;9606;
1I22;C;MUTANT HUMAN LYSOZYME (A83K/Q86D/A92D);1.8;CA;CALCIUM ION;LYSOZYME C;9606;
1I22;D;MUTANT HUMAN LYSOZYME (A83K/Q86D/A92D);1.8;CA;CALCIUM ION;LYSOZYME C;9606;
1I2E;A;Ribonuclease T1 V16A mutant, form I;1.8;CA;CALCIUM ION;GUANYL-SPECIFIC RIBONUCLEASE T1;5062;
1I2F;A;Ribonuclease T1 V16A mutant, form II;1.95;CA;CALCIUM ION;GUANYL-SPECIFIC RIBONUCLEASE T1;5062;
1I2G;A;Ribonuclease T1 V16T mutant;1.85;CA;CALCIUM ION;GUANYL-SPECIFIC RIBONUCLEASE T1;5062;
1I3F;A;Ribonuclease T1 V89S mutant;2.35;CA;CALCIUM ION;GUANYL-SPECIFIC RIBONUCLEASE T1;5062;
1I3H;A;CONCANAVALIN A-DIMANNOSE STRUCTURE;1.2;CA;CALCIUM ION;Concanavalin-A;3823;
1I3I;A;Ribonuclease T1 V78T mutant;1.76;CA;CALCIUM ION;GUANYL-SPECIFIC RIBONUCLEASE T1;5062;
1I40;A;STRUCTURE OF INORGANIC PYROPHOSPHATASE;1.1;CA;CALCIUM ION;INORGANIC PYROPHOSPHATASE;562;
1I4A;A;CRYSTAL STRUCTURE OF PHOSPHORYLATION-MIMICKING MUTANT T6D OF ANNEXIN IV;2;CA;CALCIUM ION;ANNEXIN IV;9913;
1I52;A;CRYSTAL STRUCTURE OF 4-DIPHOSPHOCYTIDYL-2-C-METHYLERYTHRITOL (CDP-ME) SYNTHASE (YGBP) INVOLVED IN MEVALONATE INDEPENDENT ISOPRENOID BIOSYNTHESIS;1.5;CA;CALCIUM ION;4-DIPHOSPHOCYTIDYL-2-C-METHYLERYTHRITOL SYNTHASE;562;
1I6T;A;STRUCTURE OF INORGANIC PYROPHOSPHATASE;1.2;CA;CALCIUM ION;INORGANIC PYROPHOSPHATASE;562;
1I73;A;COMPLEX OF PRO-LEU-L-TRP PHOSPHONATE WITH THE CATALITIC DOMAIN OF MATRIX METALLO PROTEINASE-8 (MET80 FORM);1.4;CA;CALCIUM ION;NEUTROPHIL COLLAGENASE;9606;
1I75;A;CRYSTAL STRUCTURE OF CYCLODEXTRIN GLUCANOTRANSFERASE FROM ALKALOPHILIC BACILLUS SP.#1011 COMPLEXED WITH 1-DEOXYNOJIRIMYCIN;2;CA;CALCIUM ION;CYCLODEXTRIN GLUCANOTRANSFERASE;1409;
1I75;B;CRYSTAL STRUCTURE OF CYCLODEXTRIN GLUCANOTRANSFERASE FROM ALKALOPHILIC BACILLUS SP.#1011 COMPLEXED WITH 1-DEOXYNOJIRIMYCIN;2;CA;CALCIUM ION;CYCLODEXTRIN GLUCANOTRANSFERASE;1409;
1I76;A;COMPLEX OF 2-(BIPHENYL-4-SULFONYL)-1,2,3,4-TETRAHYDRO-ISOQUINOLINE-3-CARBOXYLIC ACID (D-TIC DERIVATIVE) WITH T CATALITIC DOMAIN OF MATRIX METALLO PROTEINASE-8 (MET80 FORM);1.2;CA;CALCIUM ION;NEUTROPHIL COLLAGENASE;9606;
1I7O;A;CRYSTAL STRUCTURE OF HPCE;1.7;CA;CALCIUM ION;4-HYDROXYPHENYLACETATE DEGRADATION BIFUNCTIONAL ISOMERASE/DECARBOXYLASE;562;
1I7O;B;CRYSTAL STRUCTURE OF HPCE;1.7;CA;CALCIUM ION;4-HYDROXYPHENYLACETATE DEGRADATION BIFUNCTIONAL ISOMERASE/DECARBOXYLASE;562;
1I7O;C;CRYSTAL STRUCTURE OF HPCE;1.7;CA;CALCIUM ION;4-HYDROXYPHENYLACETATE DEGRADATION BIFUNCTIONAL ISOMERASE/DECARBOXYLASE;562;
1I7O;D;CRYSTAL STRUCTURE OF HPCE;1.7;CA;CALCIUM ION;4-HYDROXYPHENYLACETATE DEGRADATION BIFUNCTIONAL ISOMERASE/DECARBOXYLASE;562;
1I82;A;FAMILY 9 CARBOHYDRATE-BINDING MODULE FROM THERMOTOGA MARITIMA XYLANASE 10A WITH CELLOBIOSE;1.9;CA;CALCIUM ION;ENDO-1,4-BETA-XYLANASE A;2336;
1I8A;A;FAMILY 9 CARBOHYDRATE-BINDING MODULE FROM THERMOTOGA MARITIMA XYLANASE 10A WITH GLUCOSE;1.9;CA;CALCIUM ION;ENDO-1,4-BETA-XYLANASE A;2336;
1I8U;A;FAMILY 9 CARBOHYDRATE-BINDING MODULE FROM THERMOTOGA MARITIMA XYLANASE 10A;1.9;CA;CALCIUM ION;ENDO-1,4-BETA-XYLANASE A;2336;
1I9B;A;X-RAY STRUCTURE OF ACETYLCHOLINE BINDING PROTEIN (ACHBP);2.7;CA;CALCIUM ION;ACETYLCHOLINE BINDING PROTEIN;6523;
1I9B;B;X-RAY STRUCTURE OF ACETYLCHOLINE BINDING PROTEIN (ACHBP);2.7;CA;CALCIUM ION;ACETYLCHOLINE BINDING PROTEIN;6523;
1I9B;C;X-RAY STRUCTURE OF ACETYLCHOLINE BINDING PROTEIN (ACHBP);2.7;CA;CALCIUM ION;ACETYLCHOLINE BINDING PROTEIN;6523;
1I9B;D;X-RAY STRUCTURE OF ACETYLCHOLINE BINDING PROTEIN (ACHBP);2.7;CA;CALCIUM ION;ACETYLCHOLINE BINDING PROTEIN;6523;
1I9B;E;X-RAY STRUCTURE OF ACETYLCHOLINE BINDING PROTEIN (ACHBP);2.7;CA;CALCIUM ION;ACETYLCHOLINE BINDING PROTEIN;6523;
1I9Z;A;CRYSTAL STRUCTURE OF INOSITOL POLYPHOSPHATE 5-PHOSPHATASE DOMAIN (IPP5C) OF SPSYNAPTOJANIN IN COMPLEX WITH INOSITOL (1,4)-BISPHOSPHATE AND CALCIUM ION;1.8;CA;CALCIUM ION;PHOSPHATIDYLINOSITOL PHOSPHATE PHOSPHATASE;4896;
1IA6;A;CRYSTAL STRUCTURE OF THE CELLULASE CEL9M OF C. CELLULOLYTICUM;1.8;CA;CALCIUM ION;CELLULASE CEL9M;1521;
1IA7;A;CRYSTAL STRUCTURE OF THE CELLULASE CEL9M OF C. CELLULOLYTICIUM IN COMPLEX WITH CELLOBIOSE;2;CA;CALCIUM ION;CELLULASE CEL9M;1521;
1IAG;A;FIRST STRUCTURE OF A SNAKE VENOM METALLOPROTEINASE: A PROTOTYPE FOR MATRIX METALLOPROTEINASES(SLASH)COLLAGENASES;2;CA;CALCIUM ION;ADAMALYSIN II;8729;
1IAV;A;STRUCTURE ON NATIVE (ASN 87) SUBTILISIN FROM BACILLUS LENTUS;1.8;CA;CALCIUM ION;SUBTILISIN SAVINASE;1467;
1IC6;A;STRUCTURE OF A SERINE PROTEASE PROTEINASE K FROM TRITIRACHIUM ALBUM LIMBER AT 0.98 A RESOLUTION;0.98;CA;CALCIUM ION;PROTEINASE K;37998;
1ID5;H;CRYSTAL STRUCTURE OF BOVINE THROMBIN COMPLEX WITH PROTEASE INHIBITOR ECOTIN;2.5;CA;CALCIUM ION;THROMBIN;9913;
1IG9;A;Structure of the Replicating Complex of a Pol Alpha Family DNA Polymerase;2.6;CA;CALCIUM ION;DNA POLYMERASE;1914161;
1IH0;A;Structure of the C-domain of Human Cardiac Troponin C in Complex with Ca2+ Sensitizer EMD 57033;;CA;CALCIUM ION;TROPONIN C, SLOW SKELETAL AND CARDIAC MUSCLES;9606;
1IJ6;A;CA2+-BOUND STRUCTURE OF MULTIDOMAIN EF-HAND PROTEIN, CBP40, FROM TRUE SLIME MOLD;3.1;CA;CALCIUM ION;PLASMODIAL SPECIFIC LAV1-2 PROTEIN;5791;
1IJL;A;Crystal structure of acidic phospholipase A2 from deinagkistrodon acutus;2.6;CA;CALCIUM ION;PHOSPHOLIPASE A2;36307;
1IJL;B;Crystal structure of acidic phospholipase A2 from deinagkistrodon acutus;2.6;CA;CALCIUM ION;PHOSPHOLIPASE A2;36307;
1IKA;A;STRUCTURE OF ISOCITRATE DEHYDROGENASE WITH ALPHA-KETOGLUTARATE AT 2.7 ANGSTROMS RESOLUTION: CONFORMATIONAL CHANGES INDUCED BY DECARBOXYLATION OF ISOCITRATE;2.7;CA;CALCIUM ION;ISOCITRATE DEHYDROGENASE;562;
1IME;A;STRUCTURAL STUDIES OF METAL BINDING BY INOSITOL MONOPHOSPHATASE: EVIDENCE FOR TWO-METAL ION CATALYSIS;2.25;CA;CALCIUM ION;INOSITOL MONOPHOSPHATASE;9606;
1IME;B;STRUCTURAL STUDIES OF METAL BINDING BY INOSITOL MONOPHOSPHATASE: EVIDENCE FOR TWO-METAL ION CATALYSIS;2.25;CA;CALCIUM ION;INOSITOL MONOPHOSPHATASE;9606;
1INC;A;CRYSTAL STRUCTURES OF THE COMPLEX OF PORCINE PANCREATIC ELASTASE WITH TWO VALINE-DERIVED BENZOXAZINONE INHIBITORS;1.94;CA;CALCIUM ION;PORCINE PANCREATIC ELASTASE;9823;
1INF;A;INFLUENZA VIRUS B/LEE/40 NEURAMINIDASE COMPLEXED WITH BANA113 INHIBITOR;2.4;CA;CALCIUM ION;INFLUENZA VIRUS B/LEE/40 NEURAMINIDASE;11520;
1ING;A;INFLUENZA A SUBTYPE N2 NEURAMINIDASE COMPLEXED WITH AROMATIC BANA109 INHIBITOR;2.4;CA;CALCIUM ION;INFLUENZA A SUBTYPE N2 NEURAMINIDASE;11320;
1ING;B;INFLUENZA A SUBTYPE N2 NEURAMINIDASE COMPLEXED WITH AROMATIC BANA109 INHIBITOR;2.4;CA;CALCIUM ION;INFLUENZA A SUBTYPE N2 NEURAMINIDASE;11320;
1INH;A;INFLUENZA A SUBTYPE N2 NEURAMINIDASE COMPLEXED WITH AROMATIC BANA111 INHIBITOR;2.4;CA;CALCIUM ION;INFLUENZA A SUBTYPE N2 NEURAMINIDASE;11320;
1INH;B;INFLUENZA A SUBTYPE N2 NEURAMINIDASE COMPLEXED WITH AROMATIC BANA111 INHIBITOR;2.4;CA;CALCIUM ION;INFLUENZA A SUBTYPE N2 NEURAMINIDASE;11320;
1INJ;A;CRYSTAL STRUCTURE OF THE APO FORM OF 4-DIPHOSPHOCYTIDYL-2-C-METHYLERYTHRITOL (CDP-ME) SYNTHETASE (YGBP) INVOLVED IN MEVALONATE INDEPENDENT ISOPRENOID BIOSYNTHESIS;1.55;CA;CALCIUM ION;4-DIPHOSPHOCYTIDYL-2-C-METHYLERYTHRITOL SYNTHETASE;562;
1INV;A;A SIALIC ACID DERIVED PHOSPHONATE ANALOG INHIBITS DIFFERENT STRAINS OF INFLUENZA VIRUS NEURAMINIDASE WITH DIFFERENT EFFICIENCIES;2.4;CA;CALCIUM ION;INFLUENZA VIRUS B/LEE/40 NEURAMINIDASE;11520;
1INW;A;A SIALIC ACID DERIVED PHOSPHONATE ANALOG INHIBITS DIFFERENT STRAINS OF INFLUENZA VIRUS NEURAMINIDASE WITH DIFFERENT EFFICIENCIES;2.4;CA;CALCIUM ION;INFLUENZA A SUBTYPE N2 NEURAMINIDASE;11320;
1INX;A;A SIALIC ACID DERIVED PHOSPHONATE ANALOG INHIBITS DIFFERENT STRAINS OF INFLUENZA VIRUS NEURAMINIDASE WITH DIFFERENT EFFICIENCIES;2.4;CA;CALCIUM ION;INFLUENZA A SUBTYPE N2 NEURAMINIDASE;11320;
1INY;A;A SIALIC ACID DERIVED PHOSPHONATE ANALOG INHIBITS DIFFERENT STRAINS OF INFLUENZA VIRUS NEURAMINIDASE WITH DIFFERENT EFFICIENCIES;2.4;CA;CALCIUM ION;INFLUENZA A SUBTYPE N9 NEURAMINIDASE;11320;
1IOD;A;CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THE COAGULATION FACTOR X BINDING PROTEIN FROM SNAKE VENOM AND THE GLA DOMAIN OF FACTOR X;2.3;CA;CALCIUM ION;COAGULATION FACTOR X BINDING PROTEIN;36307;
1IOD;B;CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THE COAGULATION FACTOR X BINDING PROTEIN FROM SNAKE VENOM AND THE GLA DOMAIN OF FACTOR X;2.3;CA;CALCIUM ION;COAGULATION FACTOR X BINDING PROTEIN;36307;
1IOD;G;CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THE COAGULATION FACTOR X BINDING PROTEIN FROM SNAKE VENOM AND THE GLA DOMAIN OF FACTOR X;2.3;CA;CALCIUM ION;COAGULATION FACTOR X GLA DOMAIN;9913;
1IOE;A;Human coagulation factor Xa in complex with M55532;2.9;CA;CALCIUM ION;COAGULATION FACTOR XA;9606;
1IQ3;A;SOLUTION STRUCTURE OF THE EPS15 HOMOLOGY DOMAIN OF A HUMAN POB1;;CA;CALCIUM ION;RALBP1-INTERACTING PROTEIN (PARTNER OF RALBP1);9606;
1IQ5;A;Calmodulin/nematode CA2+/Calmodulin dependent kinase kinase fragment;1.8;CA;CALCIUM ION;CALMODULIN;8355;
1IQC;A;Crystal structure of Di-Heme Peroxidase from Nitrosomonas europaea;1.8;CA;CALCIUM ION;di-heme peroxidase;915;
1IQC;B;Crystal structure of Di-Heme Peroxidase from Nitrosomonas europaea;1.8;CA;CALCIUM ION;di-heme peroxidase;915;
1IQC;C;Crystal structure of Di-Heme Peroxidase from Nitrosomonas europaea;1.8;CA;CALCIUM ION;di-heme peroxidase;915;
1IQC;D;Crystal structure of Di-Heme Peroxidase from Nitrosomonas europaea;1.8;CA;CALCIUM ION;di-heme peroxidase;915;
1IQE;A;Human coagulation factor Xa in complex with M55590;2.9;CA;CALCIUM ION;coagulation Factor Xa;9606;
1IQF;A;Human coagulation factor Xa in complex with M55165;3.2;CA;CALCIUM ION;coagulation Factor Xa;9606;
1IQG;A;Human coagulation factor Xa in complex with M55159;2.6;CA;CALCIUM ION;coagulation Factor Xa;9606;
1IQH;A;Human coagulation factor Xa in complex with M55143;3;CA;CALCIUM ION;coagulation Factor Xa;9606;
1IQI;A;Human coagulation factor Xa in complex with M55125;2.9;CA;CALCIUM ION;coagulation Factor Xa;9606;
1IQJ;A;Human coagulation factor Xa in complex with M55124;3;CA;CALCIUM ION;coagulation Factor Xa;9606;
1IQK;A;Human coagulation factor Xa in complex with M55113;3.2;CA;CALCIUM ION;coagulation Factor Xa;9606;
1IQL;A;Human coagulation factor Xa in complex with M54476;2.7;CA;CALCIUM ION;coagulation Factor Xa;9606;
1IQM;A;Human coagulation factor Xa in complex with M54471;2.6;CA;CALCIUM ION;coagulation Factor Xa;9606;
1IQN;A;Human coagulation factor Xa in complex with M55192;2.6;CA;CALCIUM ION;coagulation Factor Xa;9606;
1IRB;A;CARBOXYLIC ESTER HYDROLASE;1.9;CA;CALCIUM ION;PHOSPHOLIPASE A2;9913;
1IRJ;A;Crystal Structure of the MRP14 complexed with CHAPS;2.1;CA;CALCIUM ION;Migration Inhibitory Factor-Related Protein 14;9606;
1IRJ;B;Crystal Structure of the MRP14 complexed with CHAPS;2.1;CA;CALCIUM ION;Migration Inhibitory Factor-Related Protein 14;9606;
1IRJ;C;Crystal Structure of the MRP14 complexed with CHAPS;2.1;CA;CALCIUM ION;Migration Inhibitory Factor-Related Protein 14;9606;
1IRJ;D;Crystal Structure of the MRP14 complexed with CHAPS;2.1;CA;CALCIUM ION;Migration Inhibitory Factor-Related Protein 14;9606;
1IRJ;E;Crystal Structure of the MRP14 complexed with CHAPS;2.1;CA;CALCIUM ION;Migration Inhibitory Factor-Related Protein 14;9606;
1IRJ;F;Crystal Structure of the MRP14 complexed with CHAPS;2.1;CA;CALCIUM ION;Migration Inhibitory Factor-Related Protein 14;9606;
1IRJ;G;Crystal Structure of the MRP14 complexed with CHAPS;2.1;CA;CALCIUM ION;Migration Inhibitory Factor-Related Protein 14;9606;
1IRJ;H;Crystal Structure of the MRP14 complexed with CHAPS;2.1;CA;CALCIUM ION;Migration Inhibitory Factor-Related Protein 14;9606;
1IT4;A;Solution structure of the prokaryotic Phospholipase A2 from Streptomyces violaceoruber;;CA;CALCIUM ION;phospholipase A2;1935;
1ITC;A;Beta-Amylase from Bacillus cereus var. mycoides Complexed with Maltopentaose;2.1;CA;CALCIUM ION;Beta-Amylase;1396;
1IU9;A;Crystal structure of the C-terminal domain of aspartate racemase from Pyrococcus horikoshii OT3;2.04;CA;CALCIUM ION;aspartate racemase;53953;
1IVB;A;STRUCTURES OF AROMATIC INHIBITORS OF INFLUENZA VIRUS NEURAMINIDASE;2.4;CA;CALCIUM ION;INFLUENZA VIRUS B/LEE/40 NEURAMINIDASE;11520;
1IVC;A;STRUCTURES OF AROMATIC INHIBITORS OF INFLUENZA VIRUS NEURAMINIDASE;2.4;CA;CALCIUM ION;INFLUENZA A SUBTYPE N2 NEURAMINIDASE;11320;
1IVC;B;STRUCTURES OF AROMATIC INHIBITORS OF INFLUENZA VIRUS NEURAMINIDASE;2.4;CA;CALCIUM ION;INFLUENZA A SUBTYPE N2 NEURAMINIDASE;11320;
1IVD;A;STRUCTURES OF AROMATIC INHIBITORS OF INFLUENZA VIRUS NEURAMINIDASE;1.9;CA;CALCIUM ION;INFLUENZA A SUBTYPE N2 NEURAMINIDASE;11320;
1IVD;B;STRUCTURES OF AROMATIC INHIBITORS OF INFLUENZA VIRUS NEURAMINIDASE;1.9;CA;CALCIUM ION;INFLUENZA A SUBTYPE N2 NEURAMINIDASE;11320;
1IVE;A;STRUCTURES OF AROMATIC INHIBITORS OF INFLUENZA VIRUS NEURAMINIDASE;2.4;CA;CALCIUM ION;INFLUENZA A SUBTYPE N2 NEURAMINIDASE;11320;
1IVE;B;STRUCTURES OF AROMATIC INHIBITORS OF INFLUENZA VIRUS NEURAMINIDASE;2.4;CA;CALCIUM ION;INFLUENZA A SUBTYPE N2 NEURAMINIDASE;11320;
1IVF;A;STRUCTURES OF AROMATIC INHIBITORS OF INFLUENZA VIRUS NEURAMINIDASE;2.4;CA;CALCIUM ION;INFLUENZA A SUBTYPE N2 NEURAMINIDASE;11320;
1IVF;B;STRUCTURES OF AROMATIC INHIBITORS OF INFLUENZA VIRUS NEURAMINIDASE;2.4;CA;CALCIUM ION;INFLUENZA A SUBTYPE N2 NEURAMINIDASE;11320;
1IVG;A;STRUCTURES OF AROMATIC INHIBITORS OF INFLUENZA VIRUS NEURAMINIDASE;1.9;CA;CALCIUM ION;INFLUENZA A SUBTYPE N2 NEURAMINIDASE;11320;
1IVG;B;STRUCTURES OF AROMATIC INHIBITORS OF INFLUENZA VIRUS NEURAMINIDASE;1.9;CA;CALCIUM ION;INFLUENZA A SUBTYPE N2 NEURAMINIDASE;11320;
1IWQ;A;Crystal Structure of MARCKS calmodulin binding domain peptide complexed with Ca2+/Calmodulin;2;CA;CALCIUM ION;CALMODULIN;9606;
1IXX;A;CRYSTAL STRUCTURE OF COAGULATION FACTORS IX/X-BINDING PROTEIN (IX/X-BP) FROM VENOM OF HABU SNAKE WITH A HETERODIMER OF C-TYPE LECTIN DOMAINS;2.5;CA;CALCIUM ION;COAGULATION FACTORS IX/X-BINDING PROTEIN;88087;
1IXX;B;CRYSTAL STRUCTURE OF COAGULATION FACTORS IX/X-BINDING PROTEIN (IX/X-BP) FROM VENOM OF HABU SNAKE WITH A HETERODIMER OF C-TYPE LECTIN DOMAINS;2.5;CA;CALCIUM ION;COAGULATION FACTORS IX/X-BINDING PROTEIN;88087;
1IXX;C;CRYSTAL STRUCTURE OF COAGULATION FACTORS IX/X-BINDING PROTEIN (IX/X-BP) FROM VENOM OF HABU SNAKE WITH A HETERODIMER OF C-TYPE LECTIN DOMAINS;2.5;CA;CALCIUM ION;COAGULATION FACTORS IX/X-BINDING PROTEIN;88087;
1IXX;D;CRYSTAL STRUCTURE OF COAGULATION FACTORS IX/X-BINDING PROTEIN (IX/X-BP) FROM VENOM OF HABU SNAKE WITH A HETERODIMER OF C-TYPE LECTIN DOMAINS;2.5;CA;CALCIUM ION;COAGULATION FACTORS IX/X-BINDING PROTEIN;88087;
1IXX;E;CRYSTAL STRUCTURE OF COAGULATION FACTORS IX/X-BINDING PROTEIN (IX/X-BP) FROM VENOM OF HABU SNAKE WITH A HETERODIMER OF C-TYPE LECTIN DOMAINS;2.5;CA;CALCIUM ION;COAGULATION FACTORS IX/X-BINDING PROTEIN;88087;
1IXX;F;CRYSTAL STRUCTURE OF COAGULATION FACTORS IX/X-BINDING PROTEIN (IX/X-BP) FROM VENOM OF HABU SNAKE WITH A HETERODIMER OF C-TYPE LECTIN DOMAINS;2.5;CA;CALCIUM ION;COAGULATION FACTORS IX/X-BINDING PROTEIN;88087;
1IYI;C;Crystal structure of hematopoietic prostaglandin D synthase;1.8;CA;CALCIUM ION;HEMATOPOIETIC PROSTAGLANDIN D SYNTHASE;9606;
1IYI;D;Crystal structure of hematopoietic prostaglandin D synthase;1.8;CA;CALCIUM ION;HEMATOPOIETIC PROSTAGLANDIN D SYNTHASE;9606;
1IZ7;A;Re-refinement of the structure of hydrolytic haloalkane dehalogenase linb from sphingomonas paucimobilis UT26 AT 1.6 A resolution;1.58;CA;CALCIUM ION;HALOALKANE DEHALOGENASE, LINB;13689;
1IZ8;A;Re-refinement of the structure of hydrolytic haloalkane dehalogenase linb from sphingomonas paucimobilis UT26 with 1,3-propanediol, a product of debromidation of dibrompropane, at 2.0A resolution;2;CA;CALCIUM ION;HALOALKANE DEHALOGENASE, LINB;13689;
1IZJ;A;Thermoactinomyces vulgaris R-47 alpha-amylase 1 mutant enzyme f313a;2.2;CA;CALCIUM ION;amylase;2026;
1IZK;A;Thermoactinomyces vulgaris R-47 alpha-amylase 1 mutant enzyme w398v;2.2;CA;CALCIUM ION;amylase;2026;
1J0H;A;Crystal structure of Bacillus stearothermophilus neopullulanase;1.9;CA;CALCIUM ION;neopullulanase;1422;
1J0H;B;Crystal structure of Bacillus stearothermophilus neopullulanase;1.9;CA;CALCIUM ION;neopullulanase;1422;
1J0M;A;Crystal Structure of Bacillus sp. GL1 Xanthan Lyase that Acts on Side Chains of Xanthan;2.3;CA;CALCIUM ION;XANTHAN LYASE;84635;
1J0N;A;Crystal Structure of Bacillus sp. GL1 Xanthan Lyase that Acts on Side Chains of Xanthan;2.4;CA;CALCIUM ION;XANTHAN LYASE;84635;
1J0Y;A;Beta-amylase from Bacillus cereus var. mycoides in complex with glucose;2.1;CA;CALCIUM ION;Beta-amylase;1396;
1J0Y;B;Beta-amylase from Bacillus cereus var. mycoides in complex with glucose;2.1;CA;CALCIUM ION;Beta-amylase;1396;
1J0Y;C;Beta-amylase from Bacillus cereus var. mycoides in complex with glucose;2.1;CA;CALCIUM ION;Beta-amylase;1396;
1J0Y;D;Beta-amylase from Bacillus cereus var. mycoides in complex with glucose;2.1;CA;CALCIUM ION;Beta-amylase;1396;
1J0Z;A;Beta-amylase from Bacillus cereus var. mycoides in complex with maltose;2.2;CA;CALCIUM ION;Beta-amylase;1396;
1J0Z;B;Beta-amylase from Bacillus cereus var. mycoides in complex with maltose;2.2;CA;CALCIUM ION;Beta-amylase;1396;
1J0Z;C;Beta-amylase from Bacillus cereus var. mycoides in complex with maltose;2.2;CA;CALCIUM ION;Beta-amylase;1396;
1J0Z;D;Beta-amylase from Bacillus cereus var. mycoides in complex with maltose;2.2;CA;CALCIUM ION;Beta-amylase;1396;
1J10;A;beta-amylase from Bacillus cereus var. mycoides in complex with GGX;2.1;CA;CALCIUM ION;Beta-amylase;1396;
1J10;B;beta-amylase from Bacillus cereus var. mycoides in complex with GGX;2.1;CA;CALCIUM ION;Beta-amylase;1396;
1J10;C;beta-amylase from Bacillus cereus var. mycoides in complex with GGX;2.1;CA;CALCIUM ION;Beta-amylase;1396;
1J10;D;beta-amylase from Bacillus cereus var. mycoides in complex with GGX;2.1;CA;CALCIUM ION;Beta-amylase;1396;
1J11;A;beta-amylase from Bacillus cereus var. mycoides in complex with alpha-EPG;2;CA;CALCIUM ION;Beta-amylase;1396;
1J11;B;beta-amylase from Bacillus cereus var. mycoides in complex with alpha-EPG;2;CA;CALCIUM ION;Beta-amylase;1396;
1J11;C;beta-amylase from Bacillus cereus var. mycoides in complex with alpha-EPG;2;CA;CALCIUM ION;Beta-amylase;1396;
1J11;D;beta-amylase from Bacillus cereus var. mycoides in complex with alpha-EPG;2;CA;CALCIUM ION;Beta-amylase;1396;
1J12;A;Beta-Amylase from Bacillus cereus var. mycoides in Complex with alpha-EBG;2.1;CA;CALCIUM ION;Beta-amylase;1396;
1J12;B;Beta-Amylase from Bacillus cereus var. mycoides in Complex with alpha-EBG;2.1;CA;CALCIUM ION;Beta-amylase;1396;
1J12;C;Beta-Amylase from Bacillus cereus var. mycoides in Complex with alpha-EBG;2.1;CA;CALCIUM ION;Beta-amylase;1396;
1J12;D;Beta-Amylase from Bacillus cereus var. mycoides in Complex with alpha-EBG;2.1;CA;CALCIUM ION;Beta-amylase;1396;
1J14;A;BENZAMIDINE IN COMPLEX WITH RAT TRYPSIN MUTANT X99RT;2.4;CA;CALCIUM ION;trypsin II, anionic;10116;
1J15;A;BENZAMIDINE IN COMPLEX WITH RAT TRYPSIN MUTANT X99/175/190RT;2;CA;CALCIUM ION;Trypsin II, anionic;10116;
1J16;A;BENZAMIDINE IN COMPLEX WITH RAT TRYPSIN MUTANT X99/175/190RT;1.6;CA;CALCIUM ION;Trypsin II, anionic;10116;
1J17;T;FACTOR XA SPECIFIC INHIBITOR IN COMPLEX WITH RAT TRYPSIN MUTANT X99/175/190RT;2;CA;CALCIUM ION;Trypsin II, anionic;10116;
1J18;A;Crystal Structure of a Beta-Amylase from Bacillus cereus var. mycoides Cocrystallized with Maltose;2;CA;CALCIUM ION;Beta-amylase;1396;
1J1A;A;PANCREATIC SECRETORY PHOSPHOLIPASE A2 (IIa) WITH ANTI-INFLAMMATORY ACTIVITY;2.2;CA;CALCIUM ION;Phospholipase A2;9606;
1J1A;B;PANCREATIC SECRETORY PHOSPHOLIPASE A2 (IIa) WITH ANTI-INFLAMMATORY ACTIVITY;2.2;CA;CALCIUM ION;Phospholipase A2;9606;
1J1D;A;Crystal structure of the 46kDa domain of human cardiac troponin in the Ca2+ saturated form;2.61;CA;CALCIUM ION;Troponin C;9606;
1J1D;D;Crystal structure of the 46kDa domain of human cardiac troponin in the Ca2+ saturated form;2.61;CA;CALCIUM ION;Troponin C;9606;
1J1E;A;Crystal structure of the 52kDa domain of human cardiac troponin in the Ca2+ saturated form;3.3;CA;CALCIUM ION;Troponin C;9606;
1J1E;D;Crystal structure of the 52kDa domain of human cardiac troponin in the Ca2+ saturated form;3.3;CA;CALCIUM ION;Troponin C;9606;
1J1N;A;Structure Analysis of AlgQ2, A Macromolecule(Alginate)-Binding Periplasmic Protein Of Sphingomonas Sp. A1., Complexed with an Alginate Tetrasaccharide;1.6;CA;CALCIUM ION;AlgQ2;90322;
1J1N;B;Structure Analysis of AlgQ2, A Macromolecule(Alginate)-Binding Periplasmic Protein Of Sphingomonas Sp. A1., Complexed with an Alginate Tetrasaccharide;1.6;CA;CALCIUM ION;AlgQ2;90322;
1J1T;A;Alginate lyase from Alteromonas sp.272;2;CA;CALCIUM ION;Alginate Lyase;262966;
1J24;A;Crystal structure of archaeal XPF/Mus81 homolog, Hef from Pyrococcus furiosus, nuclease domain, Ca cocrystal;1.78;CA;CALCIUM ION;ATP-dependent RNA helicase, putative;2261;
1J34;A;Crystal Structure of Mg(II)-and Ca(II)-bound Gla Domain of Factor IX Complexed with Binding Protein;1.55;CA;CALCIUM ION;coagulation factor IX-binding protein A chain;88087;
1J34;B;Crystal Structure of Mg(II)-and Ca(II)-bound Gla Domain of Factor IX Complexed with Binding Protein;1.55;CA;CALCIUM ION;coagulation factor IX-binding protein B chain;88087;
1J34;C;Crystal Structure of Mg(II)-and Ca(II)-bound Gla Domain of Factor IX Complexed with Binding Protein;1.55;CA;CALCIUM ION;Coagulation factor IX;9913;
1J35;A;Crystal Structure of Ca(II)-bound Gla Domain of Factor IX Complexed with Binding Protein;1.8;CA;CALCIUM ION;coagulation factor IX-binding protein A chain;88087;
1J35;B;Crystal Structure of Ca(II)-bound Gla Domain of Factor IX Complexed with Binding Protein;1.8;CA;CALCIUM ION;Coagulation factor IX-binding protein B chain;88087;
1J35;C;Crystal Structure of Ca(II)-bound Gla Domain of Factor IX Complexed with Binding Protein;1.8;CA;CALCIUM ION;Coagulation factor IX;9913;
1J3B;A;Crystal structure of ATP-dependent phosphoenolpyruvate carboxykinase from Thermus thermophilus HB8;2;CA;CALCIUM ION;ATP-dependent phosphoenolpyruvate carboxykinase;274;
1J3B;B;Crystal structure of ATP-dependent phosphoenolpyruvate carboxykinase from Thermus thermophilus HB8;2;CA;CALCIUM ION;ATP-dependent phosphoenolpyruvate carboxykinase;274;
1J4G;A;crystal structure analysis of the trichosanthin delta C7;2;CA;CALCIUM ION;Trichosanthin delta C7;3677;
1J4G;B;crystal structure analysis of the trichosanthin delta C7;2;CA;CALCIUM ION;Trichosanthin delta C7;3677;
1J4G;C;crystal structure analysis of the trichosanthin delta C7;2;CA;CALCIUM ION;Trichosanthin delta C7;3677;
1J4G;D;crystal structure analysis of the trichosanthin delta C7;2;CA;CALCIUM ION;Trichosanthin delta C7;3677;
1J55;A;The Crystal Structure of Ca+-bound Human S100P Determined at 2.0A Resolution by X-ray;2;CA;CALCIUM ION;S-100P PROTEIN;9606;
1J5U;A;CRYSTAL STRUCTURE OF AN ARCHEASE, POSSIBLE CHAPERONE (TM1083) FROM THERMOTOGA MARITIMA AT 2.0 A RESOLUTION;2;CA;CALCIUM ION;archease, possible chaperone;2336;
1J6Z;A;UNCOMPLEXED ACTIN;1.54;CA;CALCIUM ION;ACTIN ALPHA 1;9986;
1J7O;A;Solution structure of Calcium-calmodulin N-terminal domain;;CA;CALCIUM ION;Calmodulin;9606;
1J7P;A;Solution structure of Calcium calmodulin C-terminal domain;;CA;CALCIUM ION;Calmodulin;9606;
1J83;A;STRUCTURE OF FAM17 CARBOHYDRATE BINDING MODULE FROM CLOSTRIDIUM CELLULOVORANS;1.7;CA;CALCIUM ION;ENDO-1,4-BETA GLUCANASE ENGF;1493;
1J83;B;STRUCTURE OF FAM17 CARBOHYDRATE BINDING MODULE FROM CLOSTRIDIUM CELLULOVORANS;1.7;CA;CALCIUM ION;ENDO-1,4-BETA GLUCANASE ENGF;1493;
1J84;A;STRUCTURE OF FAM17 CARBOHYDRATE BINDING MODULE FROM CLOSTRIDIUM CELLULOVORANS WITH BOUND CELLOTETRAOSE;2.02;CA;CALCIUM ION;endo-1,4-beta glucanase EngF;1493;
1J8A;A;CRYSTAL STRUCTURE OF BENZAMIDINE INHIBITED BOVINE PANCREATIC TRYPSIN AT 105K TO 1.21A RESOLUTION FROM LABORATORY SOURCE WITH HIGH NUMBER OF WATERS MODELLED;1.21;CA;CALCIUM ION;TRYPSINOGEN, CATIONIC;9913;
1J8E;A;Crystal structure of ligand-binding repeat CR7 from LRP;1.85;CA;CALCIUM ION;LOW-DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 1;9606;
1J8G;A;X-ray Analysis of a RNA Tetraplex r(uggggu)4 at Ultra-High Resolution;0.61;CA;CALCIUM ION;5'-R(*UP*GP*GP*GP*GP*U)-3';;
1J8G;B;X-ray Analysis of a RNA Tetraplex r(uggggu)4 at Ultra-High Resolution;0.61;CA;CALCIUM ION;5'-R(*UP*GP*GP*GP*GP*U)-3';;
1J8G;C;X-ray Analysis of a RNA Tetraplex r(uggggu)4 at Ultra-High Resolution;0.61;CA;CALCIUM ION;5'-R(*UP*GP*GP*GP*GP*U)-3';;
1J9C;H;Crystal Structure of tissue factor-factor VIIa complex;2.9;CA;CALCIUM ION;factor VIIa heavy chain;9606;
1J9H;A;Crystal Structure of an RNA Duplex with Uridine Bulges;1.4;CA;CALCIUM ION;5'-R(*GP*UP*GP*UP*CP*GP*(CBR)P*AP*C)-3';;
1J9H;B;Crystal Structure of an RNA Duplex with Uridine Bulges;1.4;CA;CALCIUM ION;5'-R(*GP*UP*GP*UP*CP*GP*(CBR)P*AP*C)-3';;
1J9H;C;Crystal Structure of an RNA Duplex with Uridine Bulges;1.4;CA;CALCIUM ION;5'-R(*GP*UP*GP*UP*CP*GP*(CBR)P*AP*C)-3';;
1J9H;D;Crystal Structure of an RNA Duplex with Uridine Bulges;1.4;CA;CALCIUM ION;5'-R(*GP*UP*GP*UP*CP*GP*(CBR)P*AP*C)-3';;
1J9K;A;CRYSTAL STRUCTURE OF SURE PROTEIN FROM T.MARITIMA IN COMPLEX WITH TUNGSTATE;2.1;CA;CALCIUM ION;STATIONARY PHASE SURVIVAL PROTEIN;2336;
1J9K;B;CRYSTAL STRUCTURE OF SURE PROTEIN FROM T.MARITIMA IN COMPLEX WITH TUNGSTATE;2.1;CA;CALCIUM ION;STATIONARY PHASE SURVIVAL PROTEIN;2336;
1J9L;A;CRYSTAL STRUCTURE OF SURE PROTEIN FROM T.MARITIMA IN COMPLEX WITH VANADATE;1.9;CA;CALCIUM ION;STATIONARY PHASE SURVIVAL PROTEIN;2336;
1J9L;B;CRYSTAL STRUCTURE OF SURE PROTEIN FROM T.MARITIMA IN COMPLEX WITH VANADATE;1.9;CA;CALCIUM ION;STATIONARY PHASE SURVIVAL PROTEIN;2336;
1JAE;A;STRUCTURE OF TENEBRIO MOLITOR LARVAL ALPHA-AMYLASE;1.65;CA;CALCIUM ION;ALPHA-AMYLASE;7067;
1JAN;A;COMPLEX OF PRO-LEU-GLY-HYDROXYLAMINE WITH THE CATALYTIC DOMAIN OF MATRIX METALLO PROTEINASE-8 (PHE79 FORM);2.5;CA;CALCIUM ION;MATRIX METALLO PROTEINASE-8 (PHE79 FORM);9606;
1JAO;A;COMPLEX OF 3-MERCAPTO-2-BENZYLPROPANOYL-ALA-GLY-NH2 WITH THE CATALYTIC DOMAIN OF MATRIX METALLO PROTEINASE-8 (MET80 FORM);2.4;CA;CALCIUM ION;MATRIX METALLO PROTEINASE-8 (MET80 FORM);9606;
1JAP;A;COMPLEX OF PRO-LEU-GLY-HYDROXYLAMINE WITH THE CATALYTIC DOMAIN OF MATRIX METALLO PROTEINASE-8 (MET80 FORM);1.82;CA;CALCIUM ION;MATRIX METALLO PROTEINASE-8 (MET80 FORM);9606;
1JAQ;A;COMPLEX OF 1-HYDROXYLAMINE-2-ISOBUTYLMALONYL-ALA-GLY-NH2 WITH THE CATALYTIC DOMAIN OF MATRIX METALLO PROTEINASE-8 (MET80 FORM);2.4;CA;CALCIUM ION;MATRIX METALLO PROTEINASE-8 (MET80 FORM);9606;
1JB0;L;Crystal Structure of Photosystem I: a Photosynthetic Reaction Center and Core Antenna System from Cyanobacteria;2.5;CA;CALCIUM ION;PHOTOSYSTEM 1 REACTION CENTRE SUBUNIT XI;32046;
1JBA;A;UNMYRISTOYLATED GCAP-2 WITH THREE CALCIUM IONS BOUND;;CA;CALCIUM ION;PROTEIN (GUANYLATE CYCLASE ACTIVATING PROTEIN 2);9913;
1JBC;A;CONCANAVALIN A;1.15;CA;CALCIUM ION;CONCANAVALIN A;3823;
1JC2;A;COMPLEX OF THE C-DOMAIN OF TROPONIN C WITH RESIDUES 1-40 OF TROPONIN I;;CA;CALCIUM ION;TROPONIN C, SKELETAL MUSCLE;9031;
1JC9;A;TACHYLECTIN 5A FROM TACHYPLEUS TRIDENTATUS (JAPANESE HORSESHOE CRAB);2.01;CA;CALCIUM ION;techylectin-5A;6853;
1JD7;A;CRYSTAL STRUCTURE ANALYSIS OF THE MUTANT K300R OF PSEUDOALTEROMONAS HALOPLANCTIS ALPHA-AMYLASE;2.25;CA;CALCIUM ION;ALPHA-AMYLASE;228;
1JD9;A;CRYSTAL STRUCTURE ANALYSIS OF THE MUTANT K300Q OF PSEUDOALTEROMONAS HALOPLANCTIS ALPHA-AMYLASE;2.5;CA;CALCIUM ION;ALPHA-AMYLASE;228;
1JDA;A;MALTOTETRAOSE-FORMING EXO-AMYLASE;2.2;CA;CALCIUM ION;1,4-ALPHA MALTOTETRAHYDROLASE;316;
1JDC;A;MUTANT (E219Q) MALTOTETRAOSE-FORMING EXO-AMYLASE COCRYSTALLIZED WITH MALTOTETRAOSE (CRYSTAL TYPE 1);1.9;CA;CALCIUM ION;1,4-ALPHA MALTOTETRAHYDROLASE;316;
1JDD;A;MUTANT (E219Q) MALTOTETRAOSE-FORMING EXO-AMYLASE COCRYSTALLIZED WITH MALTOTETRAOSE (CRYSTAL TYPE 2);1.9;CA;CALCIUM ION;1,4-ALPHA MALTOTETRAHYDROLASE;316;
1JE5;B;Crystal Structure of gp2.5, a Single-Stranded DNA Binding Protein Encoded by Bacteriophage T7;1.9;CA;CALCIUM ION;HELIX-DESTABILIZING PROTEIN;1985738;
1JEA;A;ALTERED TOPOLOGY AND FLEXIBILITY IN ENGINEERED SUBTILISIN;2;CA;CALCIUM ION;SUBTILISIN;1467;
1JEC;A;Crystal Structure of ATP Sulfurylase in complex with thiosulfate;2.5;CA;CALCIUM ION;SULFATE ADENYLYLTRANSFERASE;4932;
1JED;A;Crystal Structure of ATP Sulfurylase in complex with ADP;2.95;CA;CALCIUM ION;SULFATE ADENYLYLTRANSFERASE;4932;
1JED;B;Crystal Structure of ATP Sulfurylase in complex with ADP;2.95;CA;CALCIUM ION;SULFATE ADENYLYLTRANSFERASE;4932;
1JEE;A;Crystal Structure of ATP Sulfurylase in complex with chlorate;2.8;CA;CALCIUM ION;SULFATE ADENYLYLTRANSFERASE;4932;
1JEE;B;Crystal Structure of ATP Sulfurylase in complex with chlorate;2.8;CA;CALCIUM ION;SULFATE ADENYLYLTRANSFERASE;4932;
1JF5;A;CRYSTAL STRUCTURE OF THERMOACTINOMYCES VULGARIS R-47 ALPHA-AMYLASE 2 MUTANT F286A;3.2;CA;CALCIUM ION;ALPHA AMYLASE II;2026;
1JF5;B;CRYSTAL STRUCTURE OF THERMOACTINOMYCES VULGARIS R-47 ALPHA-AMYLASE 2 MUTANT F286A;3.2;CA;CALCIUM ION;ALPHA AMYLASE II;2026;
1JF6;A;Crystal structure of thermoactinomyces vulgaris r-47 alpha-amylase mutant F286Y;3.2;CA;CALCIUM ION;ALPHA AMYLASE II;2026;
1JF6;B;Crystal structure of thermoactinomyces vulgaris r-47 alpha-amylase mutant F286Y;3.2;CA;CALCIUM ION;ALPHA AMYLASE II;2026;
1JFH;A;STRUCTURE OF A PANCREATIC ALPHA-AMYLASE BOUND TO A SUBSTRATE ANALOGUE AT 2.03 ANGSTROM RESOLUTION;2.03;CA;CALCIUM ION;ALPHA-AMYLASE;9823;
1JFK;A;MINIMUM ENERGY REPRESENTATIVE STRUCTURE OF A CALCIUM BOUND EF-HAND PROTEIN FROM ENTAMOEBA HISTOLYTICA;;CA;CALCIUM ION;CALCIUM-BINDING PROTEIN;5759;
1JG8;A;Crystal Structure of Threonine Aldolase (Low-specificity);1.8;CA;CALCIUM ION;L-allo-threonine aldolase;2336;
1JG8;B;Crystal Structure of Threonine Aldolase (Low-specificity);1.8;CA;CALCIUM ION;L-allo-threonine aldolase;2336;
1JG8;C;Crystal Structure of Threonine Aldolase (Low-specificity);1.8;CA;CALCIUM ION;L-allo-threonine aldolase;2336;
1JG8;D;Crystal Structure of Threonine Aldolase (Low-specificity);1.8;CA;CALCIUM ION;L-allo-threonine aldolase;2336;
1JH1;A;Crystal Structure of MMP-8 complexed with a 6H-1,3,4-thiadiazine derived inhibitor;2.7;CA;CALCIUM ION;Matrix Metalloproteinase 8;9606;
1JHN;A;Crystal Structure of the Lumenal Domain of Calnexin;2.9;CA;CALCIUM ION;calnexin;9612;
1JI1;A;Crystal Structure Analysis of Thermoactinomyces vulgaris R-47 alpha-Amylase 1;1.6;CA;CALCIUM ION;ALPHA-AMYLASE I;2026;
1JI1;B;Crystal Structure Analysis of Thermoactinomyces vulgaris R-47 alpha-Amylase 1;1.6;CA;CALCIUM ION;ALPHA-AMYLASE I;2026;
1JI2;A;Improved X-ray Structure of Thermoactinomyces vulgaris R-47 alpha-Amylase 2;2.3;CA;CALCIUM ION;ALPHA-AMYLASE II;2026;
1JI2;B;Improved X-ray Structure of Thermoactinomyces vulgaris R-47 alpha-Amylase 2;2.3;CA;CALCIUM ION;ALPHA-AMYLASE II;2026;
1JI3;A;CRYSTAL STRUCTURE OF THE FIRST THERMOSTABLE BACTERIAL LIPASE FROM BACILLUS STEAROTHERMOPHILUS;2.2;CA;CALCIUM ION;lipase;1422;
1JI3;B;CRYSTAL STRUCTURE OF THE FIRST THERMOSTABLE BACTERIAL LIPASE FROM BACILLUS STEAROTHERMOPHILUS;2.2;CA;CALCIUM ION;lipase;1422;
1JIA;A;STRUCTURE OF A BASIC PHOSPHOLIPASE A2 FROM AGKISTRODON HALYS PALLAS AT 2.13A RESOLUTION;2.13;CA;CALCIUM ION;PHOSPHOLIPASE A2;8714;
1JIA;B;STRUCTURE OF A BASIC PHOSPHOLIPASE A2 FROM AGKISTRODON HALYS PALLAS AT 2.13A RESOLUTION;2.13;CA;CALCIUM ION;PHOSPHOLIPASE A2;8714;
1JIR;A;Crystal Structure of Trypsin Complex with Amylamine in Cyclohexane;2;CA;CALCIUM ION;beta-Trypsin;9913;
1JIW;P;Crystal structure of the APR-APRin complex;1.74;CA;CALCIUM ION;ALKALINE METALLOPROTEINASE;287;
1JIX;A;T4 Phage BGT in Complex with Ca2+;1.65;CA;CALCIUM ION;DNA BETA-GLUCOSYLTRANSFERASE;10665;
1JIZ;A;Crystal Structure Analysis of human Macrophage Elastase MMP-12;2.6;CA;CALCIUM ION;macrophage elastase MMP-12;9606;
1JIZ;B;Crystal Structure Analysis of human Macrophage Elastase MMP-12;2.6;CA;CALCIUM ION;macrophage elastase MMP-12;9606;
1JJ9;A;Crystal Structure of MMP8-Barbiturate Complex Reveals Mechanism for Collagen Substrate Recognition;2;CA;CALCIUM ION;Matrix Metalloproteinase 8;9606;
1JK3;A;Crystal structure of human MMP-12 (Macrophage Elastase) at true atomic resolution;1.09;CA;CALCIUM ION;MACROPHAGE METALLOELASTASE;9606;
1JKU;A;Crystal Structure of Manganese Catalase from Lactobacillus plantarum;1.84;CA;CALCIUM ION;pseudocatalase;1590;
1JKU;B;Crystal Structure of Manganese Catalase from Lactobacillus plantarum;1.84;CA;CALCIUM ION;pseudocatalase;1590;
1JKU;C;Crystal Structure of Manganese Catalase from Lactobacillus plantarum;1.84;CA;CALCIUM ION;pseudocatalase;1590;
1JKU;D;Crystal Structure of Manganese Catalase from Lactobacillus plantarum;1.84;CA;CALCIUM ION;pseudocatalase;1590;
1JKU;E;Crystal Structure of Manganese Catalase from Lactobacillus plantarum;1.84;CA;CALCIUM ION;pseudocatalase;1590;
1JKU;F;Crystal Structure of Manganese Catalase from Lactobacillus plantarum;1.84;CA;CALCIUM ION;pseudocatalase;1590;
1JKV;A;Crystal Structure of Manganese Catalase from Lactobacillus plantarum complexed with azide;1.39;CA;CALCIUM ION;pseudocatalase;1590;
1JKV;B;Crystal Structure of Manganese Catalase from Lactobacillus plantarum complexed with azide;1.39;CA;CALCIUM ION;pseudocatalase;1590;
1JKV;C;Crystal Structure of Manganese Catalase from Lactobacillus plantarum complexed with azide;1.39;CA;CALCIUM ION;pseudocatalase;1590;
1JKV;D;Crystal Structure of Manganese Catalase from Lactobacillus plantarum complexed with azide;1.39;CA;CALCIUM ION;pseudocatalase;1590;
1JKV;E;Crystal Structure of Manganese Catalase from Lactobacillus plantarum complexed with azide;1.39;CA;CALCIUM ION;pseudocatalase;1590;
1JKV;F;Crystal Structure of Manganese Catalase from Lactobacillus plantarum complexed with azide;1.39;CA;CALCIUM ION;pseudocatalase;1590;
1JL5;A;Novel Molecular Architecture of YopM-a Leucine-rich Effector Protein from Yersinia pestis;2.1;CA;CALCIUM ION;outer protein YopM;632;
1JMJ;A;Crystal Structure of Native Heparin Cofactor II;2.35;CA;CALCIUM ION;HEPARIN COFACTOR II;9606;
1JN2;P;Crystal Structure of meso-tetrasulphonatophenyl porphyrin complexed with Concanavalin A;1.9;CA;CALCIUM ION;Concanavalin-A;3823;
1JN9;A;Structure of Putative Asparaginase Encoded by Escherichia coli ybiK Gene;2.3;CA;CALCIUM ION;PUTATIVE L-ASPARAGINASE;562;
1JN9;B;Structure of Putative Asparaginase Encoded by Escherichia coli ybiK Gene;2.3;CA;CALCIUM ION;PUTATIVE L-ASPARAGINASE;562;
1JOJ;A;CONCANAVALIN A-HEXAPEPTIDE COMPLEX;3;CA;CALCIUM ION;Concanavalin-Br;3823;
1JOJ;B;CONCANAVALIN A-HEXAPEPTIDE COMPLEX;3;CA;CALCIUM ION;Concanavalin-Br;3823;
1JOJ;C;CONCANAVALIN A-HEXAPEPTIDE COMPLEX;3;CA;CALCIUM ION;Concanavalin-Br;3823;
1JOJ;D;CONCANAVALIN A-HEXAPEPTIDE COMPLEX;3;CA;CALCIUM ION;Concanavalin-Br;3823;
1JOL;B;THE CRYSTAL STRUCTURE OF THE BINARY COMPLEX BETWEEN FOLINIC ACID (LEUCOVORIN) AND E. COLI DIHYDROFOLATE REDUCTASE;1.96;CA;CALCIUM ION;DIHYDROFOLATE REDUCTASE;562;
1JOM;A;THE CRYSTAL STRUCTURE OF THE BINARY COMPLEX BETWEEN FOLINIC ACID (LEUCOVORIN) AND E. COLI DIHYDROFOLATE REDUCTASE;1.9;CA;CALCIUM ION;DIHYDROFOLATE REDUCTASE;562;
1JPN;A;GMPPNP Complex of SRP GTPase NG Domain;1.9;CA;CALCIUM ION;SIGNAL RECOGNITION PARTICLE PROTEIN;271;
1JPN;B;GMPPNP Complex of SRP GTPase NG Domain;1.9;CA;CALCIUM ION;SIGNAL RECOGNITION PARTICLE PROTEIN;271;
1JRF;A;NMR Solution Structure of the Viral Receptor Domain of Tva;;CA;CALCIUM ION;SUBGROUP A ROUS SARCOMA VIRUS RECEPTORS PG800 AND PG950;93934;
1JRO;B;Crystal Structure of Xanthine Dehydrogenase from Rhodobacter capsulatus;2.7;CA;CALCIUM ION;xanthine dehydrogenase, chain B;1061;
1JRO;D;Crystal Structure of Xanthine Dehydrogenase from Rhodobacter capsulatus;2.7;CA;CALCIUM ION;xanthine dehydrogenase, chain B;1061;
1JRO;F;Crystal Structure of Xanthine Dehydrogenase from Rhodobacter capsulatus;2.7;CA;CALCIUM ION;xanthine dehydrogenase, chain B;1061;
1JRO;H;Crystal Structure of Xanthine Dehydrogenase from Rhodobacter capsulatus;2.7;CA;CALCIUM ION;xanthine dehydrogenase, chain B;1061;
1JRP;B;Crystal Structure of Xanthine Dehydrogenase inhibited by alloxanthine from Rhodobacter capsulatus;3;CA;CALCIUM ION;xanthine dehydrogenase, chain B;1061;
1JRP;D;Crystal Structure of Xanthine Dehydrogenase inhibited by alloxanthine from Rhodobacter capsulatus;3;CA;CALCIUM ION;xanthine dehydrogenase, chain B;1061;
1JRP;F;Crystal Structure of Xanthine Dehydrogenase inhibited by alloxanthine from Rhodobacter capsulatus;3;CA;CALCIUM ION;xanthine dehydrogenase, chain B;1061;
1JRP;H;Crystal Structure of Xanthine Dehydrogenase inhibited by alloxanthine from Rhodobacter capsulatus;3;CA;CALCIUM ION;xanthine dehydrogenase, chain B;1061;
1JRQ;A;X-ray Structure Analysis of the Role of the Conserved Tyrosine-369 in Active Site of E. coli Amine Oxidase;2.15;CA;CALCIUM ION;Copper amine oxidase;562;
1JRQ;B;X-ray Structure Analysis of the Role of the Conserved Tyrosine-369 in Active Site of E. coli Amine Oxidase;2.15;CA;CALCIUM ION;Copper amine oxidase;562;
1JRS;A;HEMIACETAL COMPLEX BETWEEN LEUPEPTIN AND TRYPSIN;1.8;CA;CALCIUM ION;TRYPSIN;9913;
1JRT;A;HEMIACETAL COMPLEX BETWEEN LEUPEPTIN AND TRYPSIN;1.7;CA;CALCIUM ION;TRYPSIN;9913;
1JS4;A;ENDO/EXOCELLULASE:CELLOBIOSE FROM THERMOMONOSPORA;2;CA;CALCIUM ION;ENDO/EXOCELLULASE E4;2021;
1JS4;B;ENDO/EXOCELLULASE:CELLOBIOSE FROM THERMOMONOSPORA;2;CA;CALCIUM ION;ENDO/EXOCELLULASE E4;2021;
1JSA;A;MYRISTOYLATED RECOVERIN WITH TWO CALCIUMS BOUND, NMR, 24 STRUCTURES;;CA;CALCIUM ION;RECOVERIN;9913;
1JTD;A;Crystal structure of beta-lactamase inhibitor protein-II in complex with TEM-1 beta-lactamase;2.3;CA;CALCIUM ION;TEM-1 beta-lactamase;562;
1JTD;B;Crystal structure of beta-lactamase inhibitor protein-II in complex with TEM-1 beta-lactamase;2.3;CA;CALCIUM ION;beta-lactamase inhibitor protein II;1905;
1JTG;B;CRYSTAL STRUCTURE OF TEM-1 BETA-LACTAMASE / BETA-LACTAMASE INHIBITOR PROTEIN COMPLEX;1.73;CA;CALCIUM ION;BETA-LACTAMASE INHIBITORY PROTEIN;1901;
1JTG;D;CRYSTAL STRUCTURE OF TEM-1 BETA-LACTAMASE / BETA-LACTAMASE INHIBITOR PROTEIN COMPLEX;1.73;CA;CALCIUM ION;BETA-LACTAMASE INHIBITORY PROTEIN;1901;
1JUG;A;LYSOZYME FROM ECHIDNA MILK (TACHYGLOSSUS ACULEATUS);1.9;CA;CALCIUM ION;LYSOZYME;9261;
1JUI;A;CONCANAVALIN A-CARBOHYDRATE MIMICKING 10-MER PEPTIDE COMPLEX;2.75;CA;CALCIUM ION;Concanavalin-Br;3823;
1JUI;B;CONCANAVALIN A-CARBOHYDRATE MIMICKING 10-MER PEPTIDE COMPLEX;2.75;CA;CALCIUM ION;Concanavalin-Br;3823;
1JUI;C;CONCANAVALIN A-CARBOHYDRATE MIMICKING 10-MER PEPTIDE COMPLEX;2.75;CA;CALCIUM ION;Concanavalin-Br;3823;
1JUI;D;CONCANAVALIN A-CARBOHYDRATE MIMICKING 10-MER PEPTIDE COMPLEX;2.75;CA;CALCIUM ION;Concanavalin-Br;3823;
1JV2;A;CRYSTAL STRUCTURE OF THE EXTRACELLULAR SEGMENT OF INTEGRIN ALPHAVBETA3;3.1;CA;CALCIUM ION;INTEGRIN, ALPHA V;9606;
1JV2;B;CRYSTAL STRUCTURE OF THE EXTRACELLULAR SEGMENT OF INTEGRIN ALPHAVBETA3;3.1;CA;CALCIUM ION;PLATELET MEMBRANE GLYCOPROTEIN IIIA BETA SUBUNIT;9606;
1JW6;A;Crystal Structure of the Complex of Concanavalin A and Hexapeptide;1.93;CA;CALCIUM ION;Concanavalin A;3823;
1JX4;A;Crystal Structure of a Y-family DNA Polymerase in a Ternary Complex with DNA Substrates and an Incoming Nucleotide;1.7;CA;CALCIUM ION;DNA polymerase IV (family Y);2287;
1JX6;A;CRYSTAL STRUCTURE OF LUXP FROM VIBRIO HARVEYI COMPLEXED WITH AUTOINDUCER-2;1.5;CA;CALCIUM ION;LUXP PROTEIN;669;
1JX9;B;Penicillin Acylase, mutant;2.28;CA;CALCIUM ION;penicillin G acylase beta subunit;562;
1JXJ;A;Role of mobile loop in the mechanism of human salivary amylase;1.99;CA;CALCIUM ION;Alpha-amylase, salivary;9606;
1JXK;A;Role of ethe mobile loop in the mehanism of human salivary amylase;1.9;CA;CALCIUM ION;Alpha-amylase, salivary;9606;
1JXL;A;Crystal Structure of a Y-Family DNA Polymerase in a Ternary Complex with DNA Substrates and an Incoming Nucleotide;2.1;CA;CALCIUM ION;DNA polymerase IV (family Y);2287;
1JXN;A;Crystal Structure of the Lectin I from Ulex europaeus in complex with the methyl glycoside of alpha-L-fucose;2.3;CA;CALCIUM ION;anti-H(O) lectin I;3902;
1JXN;B;Crystal Structure of the Lectin I from Ulex europaeus in complex with the methyl glycoside of alpha-L-fucose;2.3;CA;CALCIUM ION;anti-H(O) lectin I;3902;
1JXN;C;Crystal Structure of the Lectin I from Ulex europaeus in complex with the methyl glycoside of alpha-L-fucose;2.3;CA;CALCIUM ION;anti-H(O) lectin I;3902;
1JXN;D;Crystal Structure of the Lectin I from Ulex europaeus in complex with the methyl glycoside of alpha-L-fucose;2.3;CA;CALCIUM ION;anti-H(O) lectin I;3902;
1JXZ;A;Structure of the H90Q mutant of 4-Chlorobenzoyl-Coenzyme A Dehalogenase complexed with 4-hydroxybenzoyl-Coenzyme A (product);1.9;CA;CALCIUM ION;4-chlorobenzoyl Coenzyme A dehalogenase;72586;
1JXZ;B;Structure of the H90Q mutant of 4-Chlorobenzoyl-Coenzyme A Dehalogenase complexed with 4-hydroxybenzoyl-Coenzyme A (product);1.9;CA;CALCIUM ION;4-chlorobenzoyl Coenzyme A dehalogenase;72586;
1JXZ;C;Structure of the H90Q mutant of 4-Chlorobenzoyl-Coenzyme A Dehalogenase complexed with 4-hydroxybenzoyl-Coenzyme A (product);1.9;CA;CALCIUM ION;4-chlorobenzoyl Coenzyme A dehalogenase;72586;
1JYC;A;CONCANAVALIN A/15-mer PEPTIDE COMPLEX;2.75;CA;CALCIUM ION;Concanavalin-Br;3823;
1JYC;B;CONCANAVALIN A/15-mer PEPTIDE COMPLEX;2.75;CA;CALCIUM ION;Concanavalin-Br;3823;
1JYC;C;CONCANAVALIN A/15-mer PEPTIDE COMPLEX;2.75;CA;CALCIUM ION;Concanavalin-Br;3823;
1JYC;D;CONCANAVALIN A/15-mer PEPTIDE COMPLEX;2.75;CA;CALCIUM ION;Concanavalin-Br;3823;
1JYI;A;CONCANAVALIN A/12-MER PEPTIDE COMPLEX;2.75;CA;CALCIUM ION;Concanavalin-Br;3823;
1JYI;B;CONCANAVALIN A/12-MER PEPTIDE COMPLEX;2.75;CA;CALCIUM ION;Concanavalin-Br;3823;
1JYI;C;CONCANAVALIN A/12-MER PEPTIDE COMPLEX;2.75;CA;CALCIUM ION;Concanavalin-Br;3823;
1JYI;D;CONCANAVALIN A/12-MER PEPTIDE COMPLEX;2.75;CA;CALCIUM ION;Concanavalin-Br;3823;
1JZN;A;crystal structure of a galactose-specific C-type lectin;2.2;CA;CALCIUM ION;Galactose-specific lectin;8730;
1JZN;B;crystal structure of a galactose-specific C-type lectin;2.2;CA;CALCIUM ION;Galactose-specific lectin;8730;
1JZN;C;crystal structure of a galactose-specific C-type lectin;2.2;CA;CALCIUM ION;Galactose-specific lectin;8730;
1JZN;D;crystal structure of a galactose-specific C-type lectin;2.2;CA;CALCIUM ION;Galactose-specific lectin;8730;
1JZN;E;crystal structure of a galactose-specific C-type lectin;2.2;CA;CALCIUM ION;Galactose-specific lectin;8730;
1K12;A;Fucose Binding lectin;1.9;CA;CALCIUM ION;LECTIN;7936;
1K1I;A;BOVINE TRYPSIN-INHIBITOR COMPLEX;2.2;CA;CALCIUM ION;TRYPSIN;9913;
1K1J;A;BOVINE TRYPSIN-INHIBITOR COMPLEX;2.2;CA;CALCIUM ION;TRYPSIN;9913;
1K1L;A;BOVINE TRYPSIN-INHIBITOR COMPLEX;2.5;CA;CALCIUM ION;TRYPSIN;9913;
1K1M;A;BOVINE TRYPSIN-INHIBITOR COMPLEX;2.2;CA;CALCIUM ION;TRYPSIN;9913;
1K1N;A;BOVINE TRYPSIN-INHIBITOR COMPLEX;2;CA;CALCIUM ION;TRYPSIN;9913;
1K1O;A;BOVINE TRYPSIN-INHIBITOR COMPLEX;2;CA;CALCIUM ION;TRYPSIN;9913;
1K1P;A;BOVINE TRYPSIN-INHIBITOR COMPLEX;1.9;CA;CALCIUM ION;TRYPSIN;9913;
1K1W;A;Crystal structure of 4-alpha-glucanotransferase from thermococcus litoralis;2.8;CA;CALCIUM ION;4-ALPHA-GLUCANOTRANSFERASE;2265;
1K1X;A;Crystal structure of 4-alpha-glucanotransferase from thermococcus litoralis;2.4;CA;CALCIUM ION;4-ALPHA-GLUCANOTRANSFERASE;2265;
1K1X;B;Crystal structure of 4-alpha-glucanotransferase from thermococcus litoralis;2.4;CA;CALCIUM ION;4-ALPHA-GLUCANOTRANSFERASE;2265;
1K1Y;A;Crystal structure of thermococcus litoralis 4-alpha-glucanotransferase complexed with acarbose;2.4;CA;CALCIUM ION;4-ALPHA-GLUCANOTRANSFERASE;2265;
1K1Y;B;Crystal structure of thermococcus litoralis 4-alpha-glucanotransferase complexed with acarbose;2.4;CA;CALCIUM ION;4-ALPHA-GLUCANOTRANSFERASE;2265;
1K3I;A;Crystal Structure of the Precursor of Galactose Oxidase;1.4;CA;CALCIUM ION;Galactose Oxidase Precursor;29916;
1K5Q;B;PENICILLIN ACYLASE, MUTANT COMPLEXED WITH PAA;2.34;CA;CALCIUM ION;PENICILLIN G ACYLASE BETA SUBUNIT;562;
1K5S;B;PENICILLIN ACYLASE, MUTANT COMPLEXED WITH PPA;2.43;CA;CALCIUM ION;PENICILLIN G ACYLASE BETA SUBUNIT;562;
1K5W;A;THREE-DIMENSIONAL STRUCTURE OF THE SYNAPTOTAGMIN 1 C2B-DOMAIN: SYNAPTOTAGMIN 1 AS A PHOSPHOLIPID BINDING MACHINE;;CA;CALCIUM ION;Synaptotagmin I;10116;
1K6S;A;STRUCTURE OF THE CLASS D BETA-LACTAMASE OXA-10 IN COMPLEX WITH A PHENYLBORONIC ACID;2.03;CA;CALCIUM ION;Beta-lactamase PSE-2;287;
1K6S;B;STRUCTURE OF THE CLASS D BETA-LACTAMASE OXA-10 IN COMPLEX WITH A PHENYLBORONIC ACID;2.03;CA;CALCIUM ION;Beta-lactamase PSE-2;287;
1K72;A;The X-ray Crystal Structure Of Cel9G Complexed With cellotriose;1.8;CA;CALCIUM ION;Endoglucanase 9G;1521;
1K72;B;The X-ray Crystal Structure Of Cel9G Complexed With cellotriose;1.8;CA;CALCIUM ION;Endoglucanase 9G;1521;
1K7D;B;Penicillin Acylase with Phenyl Proprionic Acid;2.15;CA;CALCIUM ION;penicillin Acylase beta subunit;562;
1K7G;A;PrtC from Erwinia chrysanthemi;2;CA;CALCIUM ION;secreted protease C;556;
1K7I;A;PrtC from Erwinia chrysanthemi: Y228F mutant;1.59;CA;CALCIUM ION;secreted protease C;556;
1K7Q;A;PrtC from Erwinia chrysanthemi: E189A mutant;1.8;CA;CALCIUM ION;SECRETED PROTEASE C;556;
1K90;D;Crystal structure of the adenylyl cyclase domain of anthrax edema factor (EF) in complex with calmodulin and 3' deoxy-ATP;2.75;CA;CALCIUM ION;CALMODULIN;9606;
1K90;E;Crystal structure of the adenylyl cyclase domain of anthrax edema factor (EF) in complex with calmodulin and 3' deoxy-ATP;2.75;CA;CALCIUM ION;CALMODULIN;9606;
1K90;F;Crystal structure of the adenylyl cyclase domain of anthrax edema factor (EF) in complex with calmodulin and 3' deoxy-ATP;2.75;CA;CALCIUM ION;CALMODULIN;9606;
1K93;D;Crystal structure of the adenylyl cyclase domain of anthrax edema factor (EF) in complex with calmodulin;2.95;CA;CALCIUM ION;CALMODULIN;9606;
1K93;E;Crystal structure of the adenylyl cyclase domain of anthrax edema factor (EF) in complex with calmodulin;2.95;CA;CALCIUM ION;CALMODULIN;9606;
1K93;F;Crystal structure of the adenylyl cyclase domain of anthrax edema factor (EF) in complex with calmodulin;2.95;CA;CALCIUM ION;CALMODULIN;9606;
1K94;A;Crystal structure of des(1-52)grancalcin with bound calcium;1.7;CA;CALCIUM ION;GRANCALCIN;9606;
1K94;B;Crystal structure of des(1-52)grancalcin with bound calcium;1.7;CA;CALCIUM ION;GRANCALCIN;9606;
1K96;A;CRYSTAL STRUCTURE OF CALCIUM BOUND HUMAN S100A6;1.44;CA;CALCIUM ION;S100A6;9606;
1K9I;A;Complex of DC-SIGN and GlcNAc2Man3;2.5;CA;CALCIUM ION;mDC-SIGN1B type I isoform;9606;
1K9I;B;Complex of DC-SIGN and GlcNAc2Man3;2.5;CA;CALCIUM ION;mDC-SIGN1B type I isoform;9606;
1K9I;C;Complex of DC-SIGN and GlcNAc2Man3;2.5;CA;CALCIUM ION;mDC-SIGN1B type I isoform;9606;
1K9I;D;Complex of DC-SIGN and GlcNAc2Man3;2.5;CA;CALCIUM ION;mDC-SIGN1B type I isoform;9606;
1K9I;E;Complex of DC-SIGN and GlcNAc2Man3;2.5;CA;CALCIUM ION;mDC-SIGN1B type I isoform;9606;
1K9I;F;Complex of DC-SIGN and GlcNAc2Man3;2.5;CA;CALCIUM ION;mDC-SIGN1B type I isoform;9606;
1K9I;G;Complex of DC-SIGN and GlcNAc2Man3;2.5;CA;CALCIUM ION;mDC-SIGN1B type I isoform;9606;
1K9I;H;Complex of DC-SIGN and GlcNAc2Man3;2.5;CA;CALCIUM ION;mDC-SIGN1B type I isoform;9606;
1K9I;I;Complex of DC-SIGN and GlcNAc2Man3;2.5;CA;CALCIUM ION;mDC-SIGN1B type I isoform;9606;
1K9I;J;Complex of DC-SIGN and GlcNAc2Man3;2.5;CA;CALCIUM ION;mDC-SIGN1B type I isoform;9606;
1K9J;A;Complex of DC-SIGNR and GlcNAc2Man3;1.9;CA;CALCIUM ION;mDC-SIGN2 TYPE I ISOFORM;9606;
1K9K;A;CRYSTAL STRUCTURE OF CALCIUM BOUND HUMAN S100A6;1.76;CA;CALCIUM ION;S100A6;9606;
1K9K;B;CRYSTAL STRUCTURE OF CALCIUM BOUND HUMAN S100A6;1.76;CA;CALCIUM ION;S100A6;9606;
1K9U;A;Crystal Structure of the Calcium-Binding Pollen Allergen Phl p 7 (Polcalcin) at 1.75 Angstroem;1.75;CA;CALCIUM ION;Polcalcin Phl p 7;15957;
1K9U;B;Crystal Structure of the Calcium-Binding Pollen Allergen Phl p 7 (Polcalcin) at 1.75 Angstroem;1.75;CA;CALCIUM ION;Polcalcin Phl p 7;15957;
1KA1;A;The PAPase Hal2p complexed with calcium and magnesium ions and reaction substrate: PAP;1.3;CA;CALCIUM ION;Halotolerance protein HAL2;4932;
1KAP;P;THREE-DIMENSIONAL STRUCTURE OF THE ALKALINE PROTEASE OF PSEUDOMONAS AERUGINOSA: A TWO-DOMAIN PROTEIN WITH A CALCIUM BINDING PARALLEL BETA ROLL MOTIF;1.64;CA;CALCIUM ION;ALKALINE PROTEASE;287;
1KB0;A;Crystal Structure of Quinohemoprotein Alcohol Dehydrogenase from Comamonas testosteroni;1.44;CA;CALCIUM ION;quinohemoprotein alcohol dehydrogenase;285;
1KB3;A;Three Dimensional Structure Analysis of the R195A Variant of Human Pancreatic Alpha Amylase;2.1;CA;CALCIUM ION;ALPHA-AMYLASE, PANCREATIC;9606;
1KBB;A;Mechanistic Analyses of Catalysis in Human Pancreatic alpha-Amylase: Detailed Kinetic and Structural Studies of Mutants of Three Conserved Carboxylic Acids;1.9;CA;CALCIUM ION;ALPHA-AMYLASE, PANCREATIC;9606;
1KBC;A;PROCARBOXYPEPTIDASE TERNARY COMPLEX;1.8;CA;CALCIUM ION;NEUTROPHIL COLLAGENASE;9606;
1KBC;B;PROCARBOXYPEPTIDASE TERNARY COMPLEX;1.8;CA;CALCIUM ION;NEUTROPHIL COLLAGENASE;9606;
1KBK;A;Mechanistic Analyses of Catalysis in Human Pancreatic Alpha-Amylase: Detailed Kinetic and Structural Studies of Mutants of Three Conserved Carboxylic Acids;1.9;CA;CALCIUM ION;ALPHA-AMYLASE, PANCREATIC;9606;
1KCK;A;Bacillus circulans strain 251 Cyclodextrin glycosyl transferase mutant N193G;2.43;CA;CALCIUM ION;CYCLODEXTRIN GLYCOSYLTRANSFERASE;1397;
1KCL;A;Bacillus ciruclans strain 251 Cyclodextrin glycosyl transferase mutant G179L;1.94;CA;CALCIUM ION;Cyclodextrin glycosyltransferase;1397;
1KDM;A;THE CRYSTAL STRUCTURE OF THE HUMAN SEX HORMONE-BINDING GLOBULIN (TETRAGONAL CRYSTAL FORM);2.35;CA;CALCIUM ION;sex hormone-binding globulin;9606;
1KDQ;A;Crystal Structure Analysis of the Mutant S189D Rat Chymotrypsin;2.55;CA;CALCIUM ION;CHYMOTRYPSIN B, B CHAIN;10116;
1KEC;B;PENICILLIN ACYLASE MUTANT WITH PHENYL PROPRIONIC ACID;2.3;CA;CALCIUM ION;PENICILLIN ACYLASE BETA SUBUNIT;562;
1KEI;A;Thermolysin (substrate-free);1.6;CA;CALCIUM ION;Thermolysin;1427;
1KEK;A;Crystal Structure of the Free Radical Intermediate of Pyruvate:Ferredoxin Oxidoreductase;1.9;CA;CALCIUM ION;Pyruvate-Ferredoxin Oxidoreductase;873;
1KEK;B;Crystal Structure of the Free Radical Intermediate of Pyruvate:Ferredoxin Oxidoreductase;1.9;CA;CALCIUM ION;Pyruvate-Ferredoxin Oxidoreductase;873;
1KFG;A;The X-ray Crystal Structure of Cel9G from Clostridium cellulolyticum complexed with a Thio-Oligosaccharide Inhibitor;1.9;CA;CALCIUM ION;ENDOGLUCANASE G;1521;
1KFG;B;The X-ray Crystal Structure of Cel9G from Clostridium cellulolyticum complexed with a Thio-Oligosaccharide Inhibitor;1.9;CA;CALCIUM ION;ENDOGLUCANASE G;1521;
1KFQ;A;Crystal Structure of Exocytosis-Sensitive Phosphoprotein, pp63/parafusin (Phosphoglucomutse) from Paramecium. OPEN FORM;2.4;CA;CALCIUM ION;phosphoglucomutase 1;5888;
1KFQ;B;Crystal Structure of Exocytosis-Sensitive Phosphoprotein, pp63/parafusin (Phosphoglucomutse) from Paramecium. OPEN FORM;2.4;CA;CALCIUM ION;phosphoglucomutase 1;5888;
1KGU;A;THREE DIMENSIONAL STRUCTURE ANALYSIS OF THE R337A VARIANT OF HUMAN PANCREATIC ALPHA-AMYLASE;2;CA;CALCIUM ION;ALPHA-AMYLASE, PANCREATIC;9606;
1KGW;A;THREE DIMENSIONAL STRUCTURE ANALYSIS OF THE R337Q VARIANT OF HUMAN PANCREATIC ALPHA-MYLASE;2.1;CA;CALCIUM ION;ALPHA-AMYLASE, PANCREATIC;9606;
1KGX;A;Three Dimensional Structure Analysis of the R195Q Variant of Human Pancreatic Alpha Amylase;2;CA;CALCIUM ION;ALPHA-AMYLASE, PANCREATIC;9606;
1KIC;A;Inosine-adenosine-guanosine preferring nucleoside hydrolase from Trypanosoma vivax: Asp10Ala mutant in complex with inosine;1.6;CA;CALCIUM ION;inosine-adenosine-guanosine preferring nucleoside hydrolase;5699;
1KIC;B;Inosine-adenosine-guanosine preferring nucleoside hydrolase from Trypanosoma vivax: Asp10Ala mutant in complex with inosine;1.6;CA;CALCIUM ION;inosine-adenosine-guanosine preferring nucleoside hydrolase;5699;
1KIE;A;Inosine-adenosine-guanosine preferring nucleoside hydrolase from Trypanosoma vivax: Asp10Ala mutant in complex with 3-deaza-adenosine;2;CA;CALCIUM ION;inosine-adenosine-guanosine preferring nucleoside hydrolase;5699;
1KIE;B;Inosine-adenosine-guanosine preferring nucleoside hydrolase from Trypanosoma vivax: Asp10Ala mutant in complex with 3-deaza-adenosine;2;CA;CALCIUM ION;inosine-adenosine-guanosine preferring nucleoside hydrolase;5699;
1KIT;A;VIBRIO CHOLERAE NEURAMINIDASE;2.3;CA;CALCIUM ION;SIALIDASE;666;
1KJO;A;Thermolysin complexed with Z-L-Threonine (benzyloxycarbonyl-L-Threonine);1.6;CA;CALCIUM ION;Thermolysin;1427;
1KJP;A;Thermolysin complexed with Z-L-Glutamic acid (benzyloxycarbonyl-L-Glutamic acid);1.6;CA;CALCIUM ION;Thermolysin;1427;
1KK7;Z;SCALLOP MYOSIN IN THE NEAR RIGOR CONFORMATION;3.2;CA;CALCIUM ION;MYOSIN ESSENTIAL LIGHT CHAIN, STRIATED ADDUCTOR MUSCLE;31199;
1KK8;C;SCALLOP MYOSIN (S1-ADP-BeFx) IN THE ACTIN-DETACHED CONFORMATION;2.3;CA;CALCIUM ION;Myosin Essential Light Chain,Striated adductor muscle;31199;
1KKK;A;Thermolysin complexed with Z-L-Aspartic Acid (benzyloxycarbonyl-L-Aspartic Acid);1.6;CA;CALCIUM ION;Thermolysin;1427;
1KKL;A;L.casei HprK/P in complex with B.subtilis HPr;2.8;CA;CALCIUM ION;HprK protein;1582;
1KKL;B;L.casei HprK/P in complex with B.subtilis HPr;2.8;CA;CALCIUM ION;HprK protein;1582;
1KKL;C;L.casei HprK/P in complex with B.subtilis HPr;2.8;CA;CALCIUM ION;HprK protein;1582;
1KKM;A;L.casei HprK/P in complex with B.subtilis P-Ser-HPr;2.8;CA;CALCIUM ION;HprK protein;1582;
1KKM;B;L.casei HprK/P in complex with B.subtilis P-Ser-HPr;2.8;CA;CALCIUM ION;HprK protein;1582;
1KKM;C;L.casei HprK/P in complex with B.subtilis P-Ser-HPr;2.8;CA;CALCIUM ION;HprK protein;1582;
1KKT;A;Structure of P. citrinum alpha 1,2-mannosidase reveals the basis for differences in specificity of the ER and Golgi Class I enzymes;2.2;CA;CALCIUM ION;Mannosyl-oligosaccharide alpha-1,2-mannosidase;5077;
1KKT;B;Structure of P. citrinum alpha 1,2-mannosidase reveals the basis for differences in specificity of the ER and Golgi Class I enzymes;2.2;CA;CALCIUM ION;Mannosyl-oligosaccharide alpha-1,2-mannosidase;5077;
1KL6;A;Thermolysin complexed with Z-L-Alanine (benzyloxycarbonyl-L-Alanine);1.8;CA;CALCIUM ION;Thermolysin;1427;
1KLI;H;Cofactor-and substrate-assisted activation of factor VIIa;1.69;CA;CALCIUM ION;factor VIIa;9606;
1KLJ;H;Crystal structure of uninhibited factor VIIa;2.44;CA;CALCIUM ION;factor VIIa;9606;
1KMB;1;SELECTIN-LIKE MUTANT OF MANNOSE-BINDING PROTEIN A;2.1;CA;CALCIUM ION;MANNOSE-BINDING PROTEIN-A;10116;
1KMB;2;SELECTIN-LIKE MUTANT OF MANNOSE-BINDING PROTEIN A;2.1;CA;CALCIUM ION;MANNOSE-BINDING PROTEIN-A;10116;
1KMB;3;SELECTIN-LIKE MUTANT OF MANNOSE-BINDING PROTEIN A;2.1;CA;CALCIUM ION;MANNOSE-BINDING PROTEIN-A;10116;
1KP4;A;CALCIUM-BOUND FORM OF PROKARYOTIC PHOSPHOLIPASE A2;1.6;CA;CALCIUM ION;phospholipase A2;1935;
1KQM;C;SCALLOP MYOSIN S1-AMPPNP IN THE ACTIN-DETACHED CONFORMATION;3;CA;CALCIUM ION;MYOSIN ESSENTIAL LIGHT CHAIN;31199;
1KQU;A;Human phospholipase A2 complexed with a substrate anologue;2.1;CA;CALCIUM ION;Phospholipase A2, membrane associated;9606;
1KR6;A;Thermolysin complexed with Z-D-Glutamic acid (benzyloxycarbonyl-D-Glutamic acid);1.8;CA;CALCIUM ION;Thermolysin;1427;
1KRE;A;STRUCTURE OF P. CITRINUM ALPHA 1,2-MANNOSIDASE REVEALS THE BASIS FOR DIFFERENCES IN SPECIFICITY OF THE ER AND GOLGI CLASS I ENZYMES;2.2;CA;CALCIUM ION;Mannosyl-oligosaccharide alpha-1,2-mannosidase;5077;
1KRE;B;STRUCTURE OF P. CITRINUM ALPHA 1,2-MANNOSIDASE REVEALS THE BASIS FOR DIFFERENCES IN SPECIFICITY OF THE ER AND GOLGI CLASS I ENZYMES;2.2;CA;CALCIUM ION;Mannosyl-oligosaccharide alpha-1,2-mannosidase;5077;
1KRF;A;STRUCTURE OF P. CITRINUM ALPHA 1,2-MANNOSIDASE REVEALS THE BASIS FOR DIFFERENCES IN SPECIFICITY OF THE ER AND GOLGI CLASS I ENZYMES;2.2;CA;CALCIUM ION;Mannosyl-oligosaccharide alpha-1,2-mannosidase;5077;
1KRF;B;STRUCTURE OF P. CITRINUM ALPHA 1,2-MANNOSIDASE REVEALS THE BASIS FOR DIFFERENCES IN SPECIFICITY OF THE ER AND GOLGI CLASS I ENZYMES;2.2;CA;CALCIUM ION;Mannosyl-oligosaccharide alpha-1,2-mannosidase;5077;
1KRO;A;Thermolysin complexed with Z-D-Threonine (benzyloxycarbonyl-D-Threonine);1.7;CA;CALCIUM ION;Thermolysin;1427;
1KS7;A;Thermolysin complexed with Z-D-Aspartic acid (benzyloxycarbonyl-D-Aspartic acid);1.7;CA;CALCIUM ION;Thermolysin;1427;
1KSC;A;The structure of Endoglucanase from termite, Nasutitermes takasagoensis, at pH 5.6.;1.55;CA;CALCIUM ION;Endo-b-1,4-glucanase;62960;
1KSD;A;The structure of Endoglucanase from termite, Nasutitermes takasagoensis, at pH 6.5.;1.6;CA;CALCIUM ION;Endo-b-1,4-glucanase;62960;
1KSN;A;Crystal Structure of Human Coagulation Factor XA Complexed with FXV673;2.1;CA;CALCIUM ION;COAGULATION FACTOR XA;9606;
1KTO;A;Thermolysin complexed with Z-D-Alanine (benzyloxycarbonyl-D-Alanine);1.9;CA;CALCIUM ION;Thermolysin;1427;
1KTW;A;IOTA-CARRAGEENASE COMPLEXED TO IOTA-CARRAGEENAN FRAGMENTS;2;CA;CALCIUM ION;IOTA-CARRAGEENASE;116059;
1KTW;B;IOTA-CARRAGEENASE COMPLEXED TO IOTA-CARRAGEENAN FRAGMENTS;2;CA;CALCIUM ION;IOTA-CARRAGEENASE;116059;
1KU0;A;Structure of the Bacillus stearothermophilus L1 lipase;2;CA;CALCIUM ION;L1 lipase;1422;
1KU0;B;Structure of the Bacillus stearothermophilus L1 lipase;2;CA;CALCIUM ION;L1 lipase;1422;
1KUH;A;ZINC PROTEASE FROM STREPTOMYCES CAESPITOSUS;1.6;CA;CALCIUM ION;ZINC PROTEASE;53502;
1KV9;A;Structure at 1.9 A Resolution of a Quinohemoprotein Alcohol Dehydrogenase from Pseudomonas putida HK5;1.9;CA;CALCIUM ION;TYPE II QUINOHEMOPROTEIN ALCOHOL DEHYDROGENASE;303;
1KVO;A;HUMAN PHOSPHOLIPASE A2 COMPLEXED WITH A HIGHLY POTENT SUBSTRATE ANOLOGUE;2;CA;CALCIUM ION;HUMAN PHOSPHOLIPASE A2;9606;
1KVO;B;HUMAN PHOSPHOLIPASE A2 COMPLEXED WITH A HIGHLY POTENT SUBSTRATE ANOLOGUE;2;CA;CALCIUM ION;HUMAN PHOSPHOLIPASE A2;9606;
1KVO;C;HUMAN PHOSPHOLIPASE A2 COMPLEXED WITH A HIGHLY POTENT SUBSTRATE ANOLOGUE;2;CA;CALCIUM ION;HUMAN PHOSPHOLIPASE A2;9606;
1KVO;D;HUMAN PHOSPHOLIPASE A2 COMPLEXED WITH A HIGHLY POTENT SUBSTRATE ANOLOGUE;2;CA;CALCIUM ION;HUMAN PHOSPHOLIPASE A2;9606;
1KVO;E;HUMAN PHOSPHOLIPASE A2 COMPLEXED WITH A HIGHLY POTENT SUBSTRATE ANOLOGUE;2;CA;CALCIUM ION;HUMAN PHOSPHOLIPASE A2;9606;
1KVO;F;HUMAN PHOSPHOLIPASE A2 COMPLEXED WITH A HIGHLY POTENT SUBSTRATE ANOLOGUE;2;CA;CALCIUM ION;HUMAN PHOSPHOLIPASE A2;9606;
1KVW;A;CARBOXYLIC ESTER HYDROLASE, SINGLE MUTANT H48Q OF BOVINE PANCREATIC PLA2 ENZYME;1.95;CA;CALCIUM ION;PHOSPHOLIPASE A2;9913;
1KVX;A;CARBOXYLIC ESTER HYDROLASE, SINGLE MUTANT D99A OF BOVINE PANCREATIC PLA2, 1.9 A ORTHORHOMBIC FORM;1.9;CA;CALCIUM ION;PHOSPHOLIPASE A2;9913;
1KVY;A;CARBOXYLIC ESTER HYDROLASE, SINGLE MUTANT D49E COORDINATED TO CALCIUM;1.9;CA;CALCIUM ION;PHOSPHOLIPASE A2;9913;
1KWH;A;Structure Analysis AlgQ2, a Macromolecule(alginate)-Binding Periplasmic Protein of Sphingomonas sp. A1.;2;CA;CALCIUM ION;Macromolecule-Binding Periplasmic Protein;90322;
1KWO;C;SCALLOP MYOSIN S1-ATPgammaS-p-PDM IN THE ACTIN-DETACHED CONFORMATION;3.8;CA;CALCIUM ION;MYOSIN ESSENTIAL LIGHT CHAIN;31199;
1KWT;A;Rat mannose binding protein A (native, MPD);1.95;CA;CALCIUM ION;MANNOSE-BINDING PROTEIN A;10116;
1KWT;B;Rat mannose binding protein A (native, MPD);1.95;CA;CALCIUM ION;MANNOSE-BINDING PROTEIN A;10116;
1KWT;C;Rat mannose binding protein A (native, MPD);1.95;CA;CALCIUM ION;MANNOSE-BINDING PROTEIN A;10116;
1KWU;A;Rat mannose binding protein A complexed with a-Me-Man;1.95;CA;CALCIUM ION;MANNOSE-BINDING PROTEIN A;10116;
1KWU;B;Rat mannose binding protein A complexed with a-Me-Man;1.95;CA;CALCIUM ION;MANNOSE-BINDING PROTEIN A;10116;
1KWU;C;Rat mannose binding protein A complexed with a-Me-Man;1.95;CA;CALCIUM ION;MANNOSE-BINDING PROTEIN A;10116;
1KWV;A;Rat mannose binding protein A complexed with a-Me-GlcNAc;2;CA;CALCIUM ION;MANNOSE-BINDING PROTEIN A;10116;
1KWV;B;Rat mannose binding protein A complexed with a-Me-GlcNAc;2;CA;CALCIUM ION;MANNOSE-BINDING PROTEIN A;10116;
1KWV;C;Rat mannose binding protein A complexed with a-Me-GlcNAc;2;CA;CALCIUM ION;MANNOSE-BINDING PROTEIN A;10116;
1KWW;A;Rat mannose protein A complexed with a-Me-Fuc.;1.9;CA;CALCIUM ION;MANNOSE-BINDING PROTEIN A;10116;
1KWW;B;Rat mannose protein A complexed with a-Me-Fuc.;1.9;CA;CALCIUM ION;MANNOSE-BINDING PROTEIN A;10116;
1KWW;C;Rat mannose protein A complexed with a-Me-Fuc.;1.9;CA;CALCIUM ION;MANNOSE-BINDING PROTEIN A;10116;
1KWX;A;Rat mannose protein A complexed with b-Me-Fuc.;2;CA;CALCIUM ION;MANNOSE-BINDING PROTEIN A;10116;
1KWX;B;Rat mannose protein A complexed with b-Me-Fuc.;2;CA;CALCIUM ION;MANNOSE-BINDING PROTEIN A;10116;
1KWX;C;Rat mannose protein A complexed with b-Me-Fuc.;2;CA;CALCIUM ION;MANNOSE-BINDING PROTEIN A;10116;
1KWY;A;Rat mannose protein A complexed with man-a13-man.;2;CA;CALCIUM ION;MANNOSE-BINDING PROTEIN A;10116;
1KWY;B;Rat mannose protein A complexed with man-a13-man.;2;CA;CALCIUM ION;MANNOSE-BINDING PROTEIN A;10116;
1KWY;C;Rat mannose protein A complexed with man-a13-man.;2;CA;CALCIUM ION;MANNOSE-BINDING PROTEIN A;10116;
1KWZ;A;Rat mannose protein A (H189V) complexed with Man-a13-Man;1.9;CA;CALCIUM ION;MANNOSE-BINDING PROTEIN A;10116;
1KWZ;B;Rat mannose protein A (H189V) complexed with Man-a13-Man;1.9;CA;CALCIUM ION;MANNOSE-BINDING PROTEIN A;10116;
1KWZ;C;Rat mannose protein A (H189V) complexed with Man-a13-Man;1.9;CA;CALCIUM ION;MANNOSE-BINDING PROTEIN A;10116;
1KX0;A;Rat mannose protein A (H189V I207V) complexed with man-a13-man;2;CA;CALCIUM ION;MANNOSE-BINDING PROTEIN A;10116;
1KX0;B;Rat mannose protein A (H189V I207V) complexed with man-a13-man;2;CA;CALCIUM ION;MANNOSE-BINDING PROTEIN A;10116;
1KX0;C;Rat mannose protein A (H189V I207V) complexed with man-a13-man;2;CA;CALCIUM ION;MANNOSE-BINDING PROTEIN A;10116;
1KX1;A;Rat mannose protein A complexed with Man6-GlcNAc2-Asn;2.8;CA;CALCIUM ION;MANNOSE-BINDING PROTEIN A;10116;
1KX1;B;Rat mannose protein A complexed with Man6-GlcNAc2-Asn;2.8;CA;CALCIUM ION;MANNOSE-BINDING PROTEIN A;10116;
1KX1;C;Rat mannose protein A complexed with Man6-GlcNAc2-Asn;2.8;CA;CALCIUM ION;MANNOSE-BINDING PROTEIN A;10116;
1KX1;D;Rat mannose protein A complexed with Man6-GlcNAc2-Asn;2.8;CA;CALCIUM ION;MANNOSE-BINDING PROTEIN A;10116;
1KX1;E;Rat mannose protein A complexed with Man6-GlcNAc2-Asn;2.8;CA;CALCIUM ION;MANNOSE-BINDING PROTEIN A;10116;
1KX1;F;Rat mannose protein A complexed with Man6-GlcNAc2-Asn;2.8;CA;CALCIUM ION;MANNOSE-BINDING PROTEIN A;10116;
1KXH;A;Crystal structure of the complex between an inactive mutant of psychrophilic alpha-amylase (D174N) and acarbose;2.3;CA;CALCIUM ION;alpha-amylase;228;
1KXQ;A;Camelid VHH Domain in Complex with Porcine Pancreatic alpha-Amylase;1.6;CA;CALCIUM ION;alpha-amylase, pancreatic;9823;
1KXQ;B;Camelid VHH Domain in Complex with Porcine Pancreatic alpha-Amylase;1.6;CA;CALCIUM ION;alpha-amylase, pancreatic;9823;
1KXQ;C;Camelid VHH Domain in Complex with Porcine Pancreatic alpha-Amylase;1.6;CA;CALCIUM ION;alpha-amylase, pancreatic;9823;
1KXQ;D;Camelid VHH Domain in Complex with Porcine Pancreatic alpha-Amylase;1.6;CA;CALCIUM ION;alpha-amylase, pancreatic;9823;
1KXR;A;Crystal Structure of Calcium-Bound Protease Core of Calpain I;2.07;CA;CALCIUM ION;thiol protease DOMAINS I AND II;10116;
1KXR;B;Crystal Structure of Calcium-Bound Protease Core of Calpain I;2.07;CA;CALCIUM ION;thiol protease DOMAINS I AND II;10116;
1KXT;A;Camelid VHH Domains in Complex with Porcine Pancreatic alpha-Amylase;2;CA;CALCIUM ION;ALPHA-AMYLASE, PANCREATIC;9823;
1KXT;C;Camelid VHH Domains in Complex with Porcine Pancreatic alpha-Amylase;2;CA;CALCIUM ION;ALPHA-AMYLASE, PANCREATIC;9823;
1KXT;E;Camelid VHH Domains in Complex with Porcine Pancreatic alpha-Amylase;2;CA;CALCIUM ION;ALPHA-AMYLASE, PANCREATIC;9823;
1KYT;A;Crystal Structure of Thermoplasma acidophilum 0175 (APC014);1.7;CA;CALCIUM ION;hypothetical protein TA0175;2303;
1KYT;B;Crystal Structure of Thermoplasma acidophilum 0175 (APC014);1.7;CA;CALCIUM ION;hypothetical protein TA0175;2303;
1KZA;1;Complex of MBP-C and Man-a13-Man;1.74;CA;CALCIUM ION;MANNOSE-BINDING PROTEIN C;10116;
1KZA;2;Complex of MBP-C and Man-a13-Man;1.74;CA;CALCIUM ION;MANNOSE-BINDING PROTEIN C;10116;
1KZB;1;Complex of MBP-C and trimannosyl core;1.8;CA;CALCIUM ION;MANNOSE-BINDING PROTEIN C;10116;
1KZB;2;Complex of MBP-C and trimannosyl core;1.8;CA;CALCIUM ION;MANNOSE-BINDING PROTEIN C;10116;
1KZC;1;Complex of MBP-C and high-affinity linear trimannose;1.85;CA;CALCIUM ION;MANNOSE-BINDING PROTEIN C;10116;
1KZC;2;Complex of MBP-C and high-affinity linear trimannose;1.85;CA;CALCIUM ION;MANNOSE-BINDING PROTEIN C;10116;
1KZD;1;Complex of MBP-C and GlcNAc-terminated core;1.9;CA;CALCIUM ION;MANNOSE-BINDING PROTEIN C;10116;
1KZD;2;Complex of MBP-C and GlcNAc-terminated core;1.9;CA;CALCIUM ION;MANNOSE-BINDING PROTEIN C;10116;
1KZE;1;Complex of MBP-C and bivalent Man-terminated glycopeptide;1.8;CA;CALCIUM ION;MANNOSE-BINDING PROTEIN C;10116;
1KZE;2;Complex of MBP-C and bivalent Man-terminated glycopeptide;1.8;CA;CALCIUM ION;MANNOSE-BINDING PROTEIN C;10116;
1KZM;A;Distal Heme Pocket Mutant (R38S/H42E) of Recombinant Horseradish Peroxidase C (HRP C).;2;CA;CALCIUM ION;Peroxidase C1A;3704;
1L0P;A;CRYSTAL STRUCTURE ANALYSIS OF THE COMPLEX BETWEEN PSYCHROPHILIC ALPHA AMYLASE FROM PSEUDOALTEROMONAS HALOPLANCTIS AND NITRATE;2.1;CA;CALCIUM ION;ALPHA-AMYLASE;228;
1L2O;C;SCALLOP MYOSIN S1-ADP-p-PDM IN THE ACTIN-DETACHED CONFORMATION;2.8;CA;CALCIUM ION;MYOSIN ESSENTIAL LIGHT CHAIN;31199;
1L3F;E;Thermolysin in the Absence of Substrate has an Open Conformation;2.3;CA;CALCIUM ION;Thermolysin;1427;
1L3W;A;C-cadherin Ectodomain;3.08;CA;CALCIUM ION;EP-cadherin;8355;
1L4J;A;Holliday Junction TCGGTACCGA with Na and Ca Binding Sites.;1.85;CA;CALCIUM ION;5'-D(*TP*CP*GP*GP*TP*AP*CP*CP*GP*A)-3';;
1L4J;B;Holliday Junction TCGGTACCGA with Na and Ca Binding Sites.;1.85;CA;CALCIUM ION;5'-D(*TP*CP*GP*GP*TP*AP*CP*CP*GP*A)-3';;
1L4J;C;Holliday Junction TCGGTACCGA with Na and Ca Binding Sites.;1.85;CA;CALCIUM ION;5'-D(*TP*CP*GP*GP*TP*AP*CP*CP*GP*A)-3';;
1L4J;D;Holliday Junction TCGGTACCGA with Na and Ca Binding Sites.;1.85;CA;CALCIUM ION;5'-D(*TP*CP*GP*GP*TP*AP*CP*CP*GP*A)-3';;
1L5H;B;FeMo-cofactor Deficient Nitrogenase MoFe Protein;2.3;CA;CALCIUM ION;nitrogenase molybdenum-iron protein beta chain;354;
1L6B;B;CRYSTAL STRUCTURE ANALYSIS OF THE ALL DNA HOLLIDAY JUNCTION STRUCTURE OF CCGGTACM5CGG;1.5;CA;CALCIUM ION;5'-D(*CP*CP*GP*GP*TP*AP*CP*(5CM)P*GP*G)-3';;
1L6J;A;Crystal structure of human matrix metalloproteinase MMP9 (gelatinase B).;2.5;CA;CALCIUM ION;Matrix metalloproteinase-9;9606;
1L6R;A;Crystal Structure of Thermoplasma acidophilum 0175 (APC0014);1.4;CA;CALCIUM ION;HYPOTHETICAL PROTEIN TA0175;2303;
1L6R;B;Crystal Structure of Thermoplasma acidophilum 0175 (APC0014);1.4;CA;CALCIUM ION;HYPOTHETICAL PROTEIN TA0175;2303;
1L7F;A;Crystal structure of influenza virus neuraminidase in complex with BCX-1812;1.8;CA;CALCIUM ION;neuraminidase;11320;
1L7G;A;Crystal structure of E119G mutant influenza virus neuraminidase in complex with BCX-1812;1.85;CA;CALCIUM ION;neuraminidase;11320;
1L7H;A;Crystal structure of R292K mutant influenza virus neuraminidase in complex with BCX-1812;1.85;CA;CALCIUM ION;neuraminidase;11320;
1L7L;A;Crystal structure of Pseudomonas aeruginosa lectin 1 determined by single wavelength anomalous scattering phasing method;1.5;CA;CALCIUM ION;PA-I galactophilic lectin;287;
1L7Z;A;Crystal structure of Ca2+/Calmodulin complexed with myristoylated CAP-23/NAP-22 peptide;2.3;CA;CALCIUM ION;CALMODULIN;9606;
1L8S;A;CARBOXYLIC ESTER HYDROLASE COMPLEX (DIMERIC PLA2 + LPC-ether + ACETATE + PHOSPHATE IONS);1.55;CA;CALCIUM ION;PHOSPHOLIPASE A2, MAJOR ISOENZYME;9823;
1L8S;B;CARBOXYLIC ESTER HYDROLASE COMPLEX (DIMERIC PLA2 + LPC-ether + ACETATE + PHOSPHATE IONS);1.55;CA;CALCIUM ION;PHOSPHOLIPASE A2, MAJOR ISOENZYME;9823;
1L9M;A;Three-dimensional structure of the human transglutaminase 3 enzyme: binding of calcium ions change structure for activation;2.1;CA;CALCIUM ION;Protein-glutamine glutamyltransferase E3;9606;
1L9M;B;Three-dimensional structure of the human transglutaminase 3 enzyme: binding of calcium ions change structure for activation;2.1;CA;CALCIUM ION;Protein-glutamine glutamyltransferase E3;9606;
1L9N;A;Three-dimensional structure of the human transglutaminase 3 enzyme: binding of calcium ions change structure for activation;2.1;CA;CALCIUM ION;Protein-glutamine glutamyltransferase E3;9606;
1L9N;B;Three-dimensional structure of the human transglutaminase 3 enzyme: binding of calcium ions change structure for activation;2.1;CA;CALCIUM ION;Protein-glutamine glutamyltransferase E3;9606;
1LA0;A;Solution Structure of Calcium Saturated Cardiac Troponin C in the Troponin C-Troponin I Complex;;CA;CALCIUM ION;Troponin C, slow skeletal and cardiac muscles;9031;
1LA3;A;Solution structure of recoverin mutant, E85Q;;CA;CALCIUM ION;Recoverin;9913;
1LBX;A;Crystal Structure of a ternary complex of dual activity FBPase/IMPase (AF2372) from Archaeoglobus fulgidus with Calcium ions and D-myo-Inositol-1-Phosphate;2.4;CA;CALCIUM ION;fructose 1,6-bisphosphatase/inositol monophosphatase;2234;
1LBX;B;Crystal Structure of a ternary complex of dual activity FBPase/IMPase (AF2372) from Archaeoglobus fulgidus with Calcium ions and D-myo-Inositol-1-Phosphate;2.4;CA;CALCIUM ION;fructose 1,6-bisphosphatase/inositol monophosphatase;2234;
1LBZ;A;Crystal Structure of a complex (P32 crystal form) of dual activity FBPase/IMPase (AF2372) from Archaeoglobus fulgidus with 3 Calcium ions and Fructose-1,6 bisphosphate;2.2;CA;CALCIUM ION;fructose 1,6-bisphosphatase/inositol monophosphatase;2234;
1LBZ;B;Crystal Structure of a complex (P32 crystal form) of dual activity FBPase/IMPase (AF2372) from Archaeoglobus fulgidus with 3 Calcium ions and Fructose-1,6 bisphosphate;2.2;CA;CALCIUM ION;fructose 1,6-bisphosphatase/inositol monophosphatase;2234;
1LCU;A;Polylysine Induces an Antiparallel Actin Dimer that Nucleates Filament Assembly: Crystal Structure at 3.5 A Resolution;3.5;CA;CALCIUM ION;Actin, alpha skeletal muscle;9986;
1LCU;B;Polylysine Induces an Antiparallel Actin Dimer that Nucleates Filament Assembly: Crystal Structure at 3.5 A Resolution;3.5;CA;CALCIUM ION;Actin, alpha skeletal muscle;9986;
1LDT;T;COMPLEX OF LEECH-DERIVED TRYPTASE INHIBITOR WITH PORCINE TRYPSIN;1.9;CA;CALCIUM ION;TRYPSIN;9823;
1LE6;A;CARBOXYLIC ESTER HYDROLASE, P 1 21 1 SPACE GROUP;1.97;CA;CALCIUM ION;Group X Secretory Phospholipase A2;9606;
1LE6;B;CARBOXYLIC ESTER HYDROLASE, P 1 21 1 SPACE GROUP;1.97;CA;CALCIUM ION;Group X Secretory Phospholipase A2;9606;
1LE6;C;CARBOXYLIC ESTER HYDROLASE, P 1 21 1 SPACE GROUP;1.97;CA;CALCIUM ION;Group X Secretory Phospholipase A2;9606;
1LE7;A;CARBOXYLIC ESTER HYDROLASE, C 2 2 21 space group;2.09;CA;CALCIUM ION;Group X Secretory Phospholipase A2;9606;
1LE7;B;CARBOXYLIC ESTER HYDROLASE, C 2 2 21 space group;2.09;CA;CALCIUM ION;Group X Secretory Phospholipase A2;9606;
1LEC;A;STRUCTURES OF THE LECTIN IV OF GRIFFONIA SIMPLICIFOLIA AND ITS COMPLEX WITH THE LEWIS B HUMAN BLOOD GROUP DETERMINANT AT 2.0 ANGSTROMS RESOLUTION;2;CA;CALCIUM ION;WEST-CENTRAL AFRICAN LEGUME LECTIN IV;3850;
1LED;A;STRUCTURES OF THE LECTIN IV OF GRIFFONIA SIMPLICIFOLIA AND ITS COMPLEX WITH THE LEWIS B HUMAN BLOOD GROUP DETERMINANT AT 2.0 ANGSTROMS RESOLUTION;2;CA;CALCIUM ION;WEST-CENTRAL AFRICAN LEGUME LECTIN IV;3850;
1LEM;A;THE MONOSACCHARIDE BINDING SITE OF LENTIL LECTIN: AN X-RAY AND MOLECULAR MODELLING STUDY;3;CA;CALCIUM ION;LECTIN;3864;
1LEN;A;REFINEMENT OF TWO CRYSTAL FORMS OF LENTIL LECTIN AT 1.8 ANGSTROMS RESOLUTION;1.8;CA;CALCIUM ION;LECTIN;3864;
1LEN;C;REFINEMENT OF TWO CRYSTAL FORMS OF LENTIL LECTIN AT 1.8 ANGSTROMS RESOLUTION;1.8;CA;CALCIUM ION;LECTIN;3864;
1LES;A;LENTIL LECTIN COMPLEXED WITH SUCROSE;1.9;CA;CALCIUM ION;LENTIL LECTIN;3864;
1LES;C;LENTIL LECTIN COMPLEXED WITH SUCROSE;1.9;CA;CALCIUM ION;LENTIL LECTIN;3864;
1LF0;A;Crystal Structure of RasA59G in the GTP-bound form;1.7;CA;CALCIUM ION;Transforming protein P21/H-RAS-1;9606;
1LGA;A;CRYSTALLOGRAPHIC REFINEMENT OF LIGNIN PEROXIDASE AT 2 ANGSTROMS;2.03;CA;CALCIUM ION;LIGNIN PEROXIDASE;5306;
1LGA;B;CRYSTALLOGRAPHIC REFINEMENT OF LIGNIN PEROXIDASE AT 2 ANGSTROMS;2.03;CA;CALCIUM ION;LIGNIN PEROXIDASE;5306;
1LGB;A;INTERACTION OF A LEGUME LECTIN WITH THE N2 FRAGMENT OF HUMAN LACTOTRANSFERRIN OR WITH THE ISOLATED BIANTENNARY GLYCOPEPTIDE: ROLE OF THE FUCOSE MOIETY;3.3;CA;CALCIUM ION;LEGUME ISOLECTIN II (ALPHA CHAIN);3858;
1LGC;A;INTERACTION OF A LEGUME LECTIN WITH THE N2 FRAGMENT OF HUMAN LACTOTRANSFERRIN OR WITH THE ISOLATED BIANTENNARY GLYCOPEPTIDE: ROLE OF THE FUCOSE MOIETY;2.8;CA;CALCIUM ION;LEGUME ISOLECTIN II (ALPHA CHAIN);3858;
1LGC;C;INTERACTION OF A LEGUME LECTIN WITH THE N2 FRAGMENT OF HUMAN LACTOTRANSFERRIN OR WITH THE ISOLATED BIANTENNARY GLYCOPEPTIDE: ROLE OF THE FUCOSE MOIETY;2.8;CA;CALCIUM ION;LEGUME ISOLECTIN II (ALPHA CHAIN);3858;
1LGC;E;INTERACTION OF A LEGUME LECTIN WITH THE N2 FRAGMENT OF HUMAN LACTOTRANSFERRIN OR WITH THE ISOLATED BIANTENNARY GLYCOPEPTIDE: ROLE OF THE FUCOSE MOIETY;2.8;CA;CALCIUM ION;LEGUME ISOLECTIN II (ALPHA CHAIN);3858;
1LGN;A;DECAMERIC DAMP COMPLEX OF HUMAN SERUM AMYLOID P COMPONENT;2.8;CA;CALCIUM ION;SERUM AMYLOID P COMPONENT;9606;
1LGN;B;DECAMERIC DAMP COMPLEX OF HUMAN SERUM AMYLOID P COMPONENT;2.8;CA;CALCIUM ION;SERUM AMYLOID P COMPONENT;9606;
1LGN;C;DECAMERIC DAMP COMPLEX OF HUMAN SERUM AMYLOID P COMPONENT;2.8;CA;CALCIUM ION;SERUM AMYLOID P COMPONENT;9606;
1LGN;D;DECAMERIC DAMP COMPLEX OF HUMAN SERUM AMYLOID P COMPONENT;2.8;CA;CALCIUM ION;SERUM AMYLOID P COMPONENT;9606;
1LGN;E;DECAMERIC DAMP COMPLEX OF HUMAN SERUM AMYLOID P COMPONENT;2.8;CA;CALCIUM ION;SERUM AMYLOID P COMPONENT;9606;
1LHN;A;CRYSTAL STRUCTURE OF THE N-TERMINAL LG-DOMAIN OF SHBG IN COMPLEX WITH 5ALPHA-ANDROSTANE-3BETA,17ALPHA-DIOL;2;CA;CALCIUM ION;SEX HORMONE-BINDING GLOBULIN;9606;
1LHO;A;CRYSTAL STRUCTURE OF THE N-TERMINAL LG-DOMAIN OF SHBG IN COMPLEX WITH 5ALPHA-ANDROSTANE-3BETA,17BETA-DIOL;2;CA;CALCIUM ION;SEX HORMONE-BINDING GLOBULIN;9606;
1LHU;A;CRYSTAL STRUCTURE OF THE N-TERMINAL LG-DOMAIN OF SHBG IN COMPLEX WITH ESTRADIOL;1.8;CA;CALCIUM ION;SEX HORMONE-BINDING GLOBULIN;9606;
1LHV;A;CRYSTAL STRUCTURE OF THE N-TERMINAL LG-DOMAIN OF SHBG IN COMPLEX WITH NORGESTREL;2;CA;CALCIUM ION;SEX HORMONE-BINDING GLOBULIN;9606;
1LHW;A;CRYSTAL STRUCTURE OF THE N-TERMINAL LG-DOMAIN OF SHBG IN COMPLEX WITH 2-METHOXYESTRADIOL;1.75;CA;CALCIUM ION;SEX HORMONE-BINDING GLOBULIN;9606;
1LIN;A;CALMODULIN COMPLEXED WITH TRIFLUOPERAZINE (1:4 COMPLEX);2;CA;CALCIUM ION;CALMODULIN;9913;
1LKA;A;Porcine Pancreatic Elastase/Ca-Complex;1.7;CA;CALCIUM ION;Elastase 1;9823;
1LKV;X;Crystal Structure of the Middle and C-terminal Domains of the Flagellar Rotor Protein FliG;2.8;CA;CALCIUM ION;FLAGELLAR MOTOR SWITCH PROTEIN FLIG;2336;
1LLP;A;LIGNIN PEROXIDASE (ISOZYME H2) PI 4.15;1.7;CA;CALCIUM ION;LIGNIN PEROXIDASE;5306;
1LMJ;A;NMR Study of the Fibrillin-1 cbEGF12-13 Pair of Ca2+ Binding Epidermal Growth Factor-like Domains;;CA;CALCIUM ION;fibrillin 1;9606;
1LN8;A;Crystal Structure of a New Isoform of Phospholipase A2 from Naja naja sagittifera at 1.6 A Resolution;1.65;CA;CALCIUM ION;Phospholipase A2;195058;
1LNA;E;A STRUCTURAL ANALYSIS OF METAL SUBSTITUTIONS IN THERMOLYSIN;1.9;CA;CALCIUM ION;THERMOLYSIN;1427;
1LNB;E;A STRUCTURAL ANALYSIS OF METAL SUBSTITUTIONS IN THERMOLYSIN;1.8;CA;CALCIUM ION;THERMOLYSIN;1427;
1LNC;E;A STRUCTURAL ANALYSIS OF METAL SUBSTITUTIONS IN THERMOLYSIN;1.8;CA;CALCIUM ION;THERMOLYSIN;1427;
1LND;E;A STRUCTURAL ANALYSIS OF METAL SUBSTITUTIONS IN THERMOLYSIN;1.7;CA;CALCIUM ION;THERMOLYSIN;1427;
1LNE;E;A STRUCTURAL ANALYSIS OF METAL SUBSTITUTIONS IN THERMOLYSIN;1.7;CA;CALCIUM ION;THERMOLYSIN;1427;
1LNF;E;A structural analysis of metal substitutions in thermolysin;1.7;CA;CALCIUM ION;THERMOLYSIN;1427;
1LNQ;A;CRYSTAL STRUCTURE OF MTHK AT 3.3 A;3.3;CA;CALCIUM ION;POTASSIUM CHANNEL RELATED PROTEIN;145262;
1LNQ;B;CRYSTAL STRUCTURE OF MTHK AT 3.3 A;3.3;CA;CALCIUM ION;POTASSIUM CHANNEL RELATED PROTEIN;145262;
1LNQ;C;CRYSTAL STRUCTURE OF MTHK AT 3.3 A;3.3;CA;CALCIUM ION;POTASSIUM CHANNEL RELATED PROTEIN;145262;
1LNQ;D;CRYSTAL STRUCTURE OF MTHK AT 3.3 A;3.3;CA;CALCIUM ION;POTASSIUM CHANNEL RELATED PROTEIN;145262;
1LNQ;E;CRYSTAL STRUCTURE OF MTHK AT 3.3 A;3.3;CA;CALCIUM ION;POTASSIUM CHANNEL RELATED PROTEIN;145262;
1LNQ;F;CRYSTAL STRUCTURE OF MTHK AT 3.3 A;3.3;CA;CALCIUM ION;POTASSIUM CHANNEL RELATED PROTEIN;145262;
1LNQ;G;CRYSTAL STRUCTURE OF MTHK AT 3.3 A;3.3;CA;CALCIUM ION;POTASSIUM CHANNEL RELATED PROTEIN;145262;
1LNQ;H;CRYSTAL STRUCTURE OF MTHK AT 3.3 A;3.3;CA;CALCIUM ION;POTASSIUM CHANNEL RELATED PROTEIN;145262;
1LNT;A;Crystal Structure of the Highly Conserved RNA Internal Loop of SRP;1.7;CA;CALCIUM ION;5'-R(*GP*CP*GP*UP*CP*AP*GP*GP*UP*CP*(CBV)P*G)-3';;
1LNT;B;Crystal Structure of the Highly Conserved RNA Internal Loop of SRP;1.7;CA;CALCIUM ION;5'-R(*CP*GP*GP*AP*AP*GP*CP*AP*GP*(CBV)P*GP*C)-3';;
1LOA;A;THREE-DIMENSIONAL STRUCTURES OF COMPLEXES OF LATHYRUS OCHRUS ISOLECTIN I WITH GLUCOSE AND MANNOSE: FINE SPECIFICITY OF THE MONOSACCHARIDE-BINDING SITE;2.2;CA;CALCIUM ION;LEGUME ISOLECTIN I (ALPHA CHAIN);3858;
1LOA;C;THREE-DIMENSIONAL STRUCTURES OF COMPLEXES OF LATHYRUS OCHRUS ISOLECTIN I WITH GLUCOSE AND MANNOSE: FINE SPECIFICITY OF THE MONOSACCHARIDE-BINDING SITE;2.2;CA;CALCIUM ION;LEGUME ISOLECTIN I (ALPHA CHAIN);3858;
1LOA;E;THREE-DIMENSIONAL STRUCTURES OF COMPLEXES OF LATHYRUS OCHRUS ISOLECTIN I WITH GLUCOSE AND MANNOSE: FINE SPECIFICITY OF THE MONOSACCHARIDE-BINDING SITE;2.2;CA;CALCIUM ION;LEGUME ISOLECTIN I (ALPHA CHAIN);3858;
1LOA;G;THREE-DIMENSIONAL STRUCTURES OF COMPLEXES OF LATHYRUS OCHRUS ISOLECTIN I WITH GLUCOSE AND MANNOSE: FINE SPECIFICITY OF THE MONOSACCHARIDE-BINDING SITE;2.2;CA;CALCIUM ION;LEGUME ISOLECTIN I (ALPHA CHAIN);3858;
1LOB;A;THREE-DIMENSIONAL STRUCTURES OF COMPLEXES OF LATHYRUS OCHRUS ISOLECTIN I WITH GLUCOSE AND MANNOSE: FINE SPECIFICITY OF THE MONOSACCHARIDE-BINDING SITE;2;CA;CALCIUM ION;LEGUME ISOLECTIN I (ALPHA CHAIN);3858;
1LOB;C;THREE-DIMENSIONAL STRUCTURES OF COMPLEXES OF LATHYRUS OCHRUS ISOLECTIN I WITH GLUCOSE AND MANNOSE: FINE SPECIFICITY OF THE MONOSACCHARIDE-BINDING SITE;2;CA;CALCIUM ION;LEGUME ISOLECTIN I (ALPHA CHAIN);3858;
1LOB;E;THREE-DIMENSIONAL STRUCTURES OF COMPLEXES OF LATHYRUS OCHRUS ISOLECTIN I WITH GLUCOSE AND MANNOSE: FINE SPECIFICITY OF THE MONOSACCHARIDE-BINDING SITE;2;CA;CALCIUM ION;LEGUME ISOLECTIN I (ALPHA CHAIN);3858;
1LOB;G;THREE-DIMENSIONAL STRUCTURES OF COMPLEXES OF LATHYRUS OCHRUS ISOLECTIN I WITH GLUCOSE AND MANNOSE: FINE SPECIFICITY OF THE MONOSACCHARIDE-BINDING SITE;2;CA;CALCIUM ION;LEGUME ISOLECTIN I (ALPHA CHAIN);3858;
1LOC;A;INTERACTION OF A LEGUME LECTIN WITH TWO COMPONENTS OF THE BACTERIAL CELL WALL;2.05;CA;CALCIUM ION;LEGUME ISOLECTIN I (ALPHA CHAIN);3858;
1LOC;C;INTERACTION OF A LEGUME LECTIN WITH TWO COMPONENTS OF THE BACTERIAL CELL WALL;2.05;CA;CALCIUM ION;LEGUME ISOLECTIN I (ALPHA CHAIN);3858;
1LOC;E;INTERACTION OF A LEGUME LECTIN WITH TWO COMPONENTS OF THE BACTERIAL CELL WALL;2.05;CA;CALCIUM ION;LEGUME ISOLECTIN I (ALPHA CHAIN);3858;
1LOC;G;INTERACTION OF A LEGUME LECTIN WITH TWO COMPONENTS OF THE BACTERIAL CELL WALL;2.05;CA;CALCIUM ION;LEGUME ISOLECTIN I (ALPHA CHAIN);3858;
1LOD;A;INTERACTION OF A LEGUME LECTIN WITH TWO COMPONENTS OF THE BACTERIAL CELL WALL;2.05;CA;CALCIUM ION;LEGUME ISOLECTIN I (ALPHA CHAIN);3858;
1LOD;C;INTERACTION OF A LEGUME LECTIN WITH TWO COMPONENTS OF THE BACTERIAL CELL WALL;2.05;CA;CALCIUM ION;LEGUME ISOLECTIN I (ALPHA CHAIN);3858;
1LOD;E;INTERACTION OF A LEGUME LECTIN WITH TWO COMPONENTS OF THE BACTERIAL CELL WALL;2.05;CA;CALCIUM ION;LEGUME ISOLECTIN I (ALPHA CHAIN);3858;
1LOD;G;INTERACTION OF A LEGUME LECTIN WITH TWO COMPONENTS OF THE BACTERIAL CELL WALL;2.05;CA;CALCIUM ION;LEGUME ISOLECTIN I (ALPHA CHAIN);3858;
1LOE;A;X-RAY CRYSTAL STRUCTURE DETERMINATION AND REFINEMENT AT 1.9 ANGSTROMS RESOLUTION OF ISOLECTIN I FROM THE SEEDS OF LATHYRUS OCHRUS;1.9;CA;CALCIUM ION;LEGUME ISOLECTIN I (ALPHA CHAIN);3858;
1LOE;C;X-RAY CRYSTAL STRUCTURE DETERMINATION AND REFINEMENT AT 1.9 ANGSTROMS RESOLUTION OF ISOLECTIN I FROM THE SEEDS OF LATHYRUS OCHRUS;1.9;CA;CALCIUM ION;LEGUME ISOLECTIN I (ALPHA CHAIN);3858;
1LOF;A;X-RAY STRUCTURE OF A BIANTENNARY OCTASACCHARIDE-LECTIN COMPLEX AT 2.3 ANGSTROMS RESOLUTION;2.3;CA;CALCIUM ION;LEGUME ISOLECTIN I (ALPHA CHAIN);3858;
1LOF;C;X-RAY STRUCTURE OF A BIANTENNARY OCTASACCHARIDE-LECTIN COMPLEX AT 2.3 ANGSTROMS RESOLUTION;2.3;CA;CALCIUM ION;LEGUME ISOLECTIN I (ALPHA CHAIN);3858;
1LOG;A;X-RAY STRUCTURE OF A (ALPHA-MAN(1-3)BETA-MAN(1-4)GLCNAC)-LECTIN COMPLEX AT 2.1 ANGSTROMS RESOLUTION;2.1;CA;CALCIUM ION;LEGUME ISOLECTIN I (ALPHA CHAIN);3858;
1LOG;C;X-RAY STRUCTURE OF A (ALPHA-MAN(1-3)BETA-MAN(1-4)GLCNAC)-LECTIN COMPLEX AT 2.1 ANGSTROMS RESOLUTION;2.1;CA;CALCIUM ION;LEGUME ISOLECTIN I (ALPHA CHAIN);3858;
1LOM;A;CYANOVIRIN-N DOUBLE MUTANT P51S S52P;1.72;CA;CALCIUM ION;Cyanovirin-N;45916;
1LOT;B;CRYSTAL STRUCTURE OF THE COMPLEX OF ACTIN WITH VITAMIN D-BINDING PROTEIN;2.5;CA;CALCIUM ION;Actin, alpha skeletal muscle;9986;
1LOV;A;X-ray structure of the E58A mutant of Ribonuclease T1 complexed with 3'-guanosine monophosphate;1.55;CA;CALCIUM ION;Guanyl-specific ribonuclease T1;5062;
1LOW;A;X-ray structure of the H40A mutant of Ribonuclease T1 complexed with 3'-guanosine monophosphate;1.9;CA;CALCIUM ION;Guanyl-specific ribonuclease T1;5062;
1LOY;A;X-ray structure of the H40A/E58A mutant of Ribonuclease T1 complexed with 3'-guanosine monophosphate;1.55;CA;CALCIUM ION;Guanyl-specific ribonuclease T1;5062;
1LPA;B;INTERFACIAL ACTIVATION OF THE LIPASE-PROCOLIPASE COMPLEX BY MIXED MICELLES REVEALED BY X-RAY CRYSTALLOGRAPHY;3.04;CA;CALCIUM ION;LIPASE;9606;
1LPB;B;THE 2.46 ANGSTROMS RESOLUTION STRUCTURE OF THE PANCREATIC LIPASE COLIPASE COMPLEX INHIBITED BY A C11 ALKYL PHOSPHONATE;2.46;CA;CALCIUM ION;LIPASE;9606;
1LPG;B;CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 79.;2;CA;CALCIUM ION;Blood coagulation factor Xa;9606;
1LPK;B;CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 125.;2.2;CA;CALCIUM ION;Blood coagulation factor Xa;9606;
1LPM;A;A STRUCTURAL BASIS FOR THE CHIRAL PREFERENCES OF LIPASES;2.18;CA;CALCIUM ION;LIPASE;5481;
1LPN;A;ANALOGS OF REACTION INTERMEDIATES IDENTIFY A UNIQUE SUBSTRATE BINDING SITE IN CANDIDA RUGOSA LIPASE;2.18;CA;CALCIUM ION;LIPASE;5481;
1LPO;A;ANALOGS OF REACTION INTERMEDIATES IDENTIFY A UNIQUE SUBSTRATE BINDING SITE IN CANDIDA RUGOSA LIPASE;2.18;CA;CALCIUM ION;LIPASE;5481;
1LPP;A;ANALOGS OF REACTION INTERMEDIATES IDENTIFY A UNIQUE SUBSTRATE BINDING SITE IN CANDIDA RUGOSA LIPASE;2.18;CA;CALCIUM ION;LIPASE;5481;
1LPS;A;A STRUCTURAL BASIS FOR THE CHIRAL PREFERENCES OF LIPASES;2.18;CA;CALCIUM ION;LIPASE;5481;
1LPZ;B;CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 41.;2.4;CA;CALCIUM ION;Blood coagulation factor Xa;9606;
1LQD;B;CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 45.;2.7;CA;CALCIUM ION;Blood coagulation factor Xa;9606;
1LQE;A;CRYSTAL STRUCTURE OF TRYPSIN IN COMPLEX WITH 79.;2.2;CA;CALCIUM ION;TRYPSIN;9913;
1LQV;C;Crystal structure of the Endothelial protein C receptor with phospholipid in the groove in complex with Gla domain of protein C.;1.6;CA;CALCIUM ION;Vitamin-K dependent protein C;9606;
1LQV;D;Crystal structure of the Endothelial protein C receptor with phospholipid in the groove in complex with Gla domain of protein C.;1.6;CA;CALCIUM ION;Vitamin-K dependent protein C;9606;
1LRW;A;Crystal structure of methanol dehydrogenase from P. denitrificans;2.5;CA;CALCIUM ION;methanol dehydrogenase subunit 1;266;
1LRW;C;Crystal structure of methanol dehydrogenase from P. denitrificans;2.5;CA;CALCIUM ION;methanol dehydrogenase subunit 1;266;
1LT9;B;Crystal Structure of Recombinant Human Fibrinogen Fragment D;2.8;CA;CALCIUM ION;Fibrinogen beta chain;9606;
1LT9;C;Crystal Structure of Recombinant Human Fibrinogen Fragment D;2.8;CA;CALCIUM ION;Fibrinogen gamma chain;9606;
1LT9;E;Crystal Structure of Recombinant Human Fibrinogen Fragment D;2.8;CA;CALCIUM ION;Fibrinogen beta chain;9606;
1LT9;F;Crystal Structure of Recombinant Human Fibrinogen Fragment D;2.8;CA;CALCIUM ION;Fibrinogen gamma chain;9606;
1LTE;A;STRUCTURE OF A LEGUME LECTIN WITH AN ORDERED N-LINKED CARBOHYDRATE IN COMPLEX WITH LACTOSE;2;CA;CALCIUM ION;CORAL TREE LECTIN;3843;
1LTJ;B;Crystal Structure of Recombinant Human Fibrinogen Fragment D with the Peptide Ligands Gly-Pro-Arg-Pro-Amide and Gly-His-Arg-Pro-Amide;2.8;CA;CALCIUM ION;Fibrinogen Beta chain;9606;
1LTJ;C;Crystal Structure of Recombinant Human Fibrinogen Fragment D with the Peptide Ligands Gly-Pro-Arg-Pro-Amide and Gly-His-Arg-Pro-Amide;2.8;CA;CALCIUM ION;Fibrinogen Gamma chain;9606;
1LTJ;E;Crystal Structure of Recombinant Human Fibrinogen Fragment D with the Peptide Ligands Gly-Pro-Arg-Pro-Amide and Gly-His-Arg-Pro-Amide;2.8;CA;CALCIUM ION;Fibrinogen Beta chain;9606;
1LTJ;F;Crystal Structure of Recombinant Human Fibrinogen Fragment D with the Peptide Ligands Gly-Pro-Arg-Pro-Amide and Gly-His-Arg-Pro-Amide;2.8;CA;CALCIUM ION;Fibrinogen Gamma chain;9606;
1LU1;A;THE STRUCTURE OF THE DOLICHOS BIFLORUS SEED LECTIN IN COMPLEX WITH THE FORSSMAN DISACCHARIDE;2.6;CA;CALCIUM ION;LECTIN;3917;
1LU2;A;DOLICHOS BIFLORUS SEED LECTIN IN COMPLEX WITH THE BLOOD GROUP A TRISACCHARIDE;2.8;CA;CALCIUM ION;LECTIN;3917;
1LU2;B;DOLICHOS BIFLORUS SEED LECTIN IN COMPLEX WITH THE BLOOD GROUP A TRISACCHARIDE;2.8;CA;CALCIUM ION;LECTIN;3917;
1LUL;A;DB58, A LEGUME LECTIN FROM DOLICHOS BIFLORUS;3.3;CA;CALCIUM ION;LECTIN DB58;3917;
1LUL;B;DB58, A LEGUME LECTIN FROM DOLICHOS BIFLORUS;3.3;CA;CALCIUM ION;LECTIN DB58;3917;
1LUL;C;DB58, A LEGUME LECTIN FROM DOLICHOS BIFLORUS;3.3;CA;CALCIUM ION;LECTIN DB58;3917;
1LUL;D;DB58, A LEGUME LECTIN FROM DOLICHOS BIFLORUS;3.3;CA;CALCIUM ION;LECTIN DB58;3917;
1LUL;E;DB58, A LEGUME LECTIN FROM DOLICHOS BIFLORUS;3.3;CA;CALCIUM ION;LECTIN DB58;3917;
1LUL;F;DB58, A LEGUME LECTIN FROM DOLICHOS BIFLORUS;3.3;CA;CALCIUM ION;LECTIN DB58;3917;
1LV8;A;Crystal structure of calf spleen purine nucleoside phosphorylase in a new space group with full trimer in the asymmetric unit;2.3;CA;CALCIUM ION;PURINE NUCLEOSIDE PHOSPHORYLASE;9913;
1LV8;B;Crystal structure of calf spleen purine nucleoside phosphorylase in a new space group with full trimer in the asymmetric unit;2.3;CA;CALCIUM ION;PURINE NUCLEOSIDE PHOSPHORYLASE;9913;
1LV8;C;Crystal structure of calf spleen purine nucleoside phosphorylase in a new space group with full trimer in the asymmetric unit;2.3;CA;CALCIUM ION;PURINE NUCLEOSIDE PHOSPHORYLASE;9913;
1LV8;D;Crystal structure of calf spleen purine nucleoside phosphorylase in a new space group with full trimer in the asymmetric unit;2.3;CA;CALCIUM ION;PURINE NUCLEOSIDE PHOSPHORYLASE;9913;
1LV8;E;Crystal structure of calf spleen purine nucleoside phosphorylase in a new space group with full trimer in the asymmetric unit;2.3;CA;CALCIUM ION;PURINE NUCLEOSIDE PHOSPHORYLASE;9913;
1LV8;F;Crystal structure of calf spleen purine nucleoside phosphorylase in a new space group with full trimer in the asymmetric unit;2.3;CA;CALCIUM ION;PURINE NUCLEOSIDE PHOSPHORYLASE;9913;
1LVC;D;Crystal structure of the adenylyl cyclase domain of anthrax edema factor (EF) in complex with calmodulin and 2' deoxy, 3' anthraniloyl ATP;3.6;CA;CALCIUM ION;calmodulin;9606;
1LVC;E;Crystal structure of the adenylyl cyclase domain of anthrax edema factor (EF) in complex with calmodulin and 2' deoxy, 3' anthraniloyl ATP;3.6;CA;CALCIUM ION;calmodulin;9606;
1LVC;F;Crystal structure of the adenylyl cyclase domain of anthrax edema factor (EF) in complex with calmodulin and 2' deoxy, 3' anthraniloyl ATP;3.6;CA;CALCIUM ION;calmodulin;9606;
1LVN;A;CRYSTAL STRUCTURE OF E. COLI AMINE OXIDASE COMPLEXED WITH TRANYLCYPROMINE;2.4;CA;CALCIUM ION;Copper amine oxidase;562;
1LVN;B;CRYSTAL STRUCTURE OF E. COLI AMINE OXIDASE COMPLEXED WITH TRANYLCYPROMINE;2.4;CA;CALCIUM ION;Copper amine oxidase;562;
1LVU;A;Crystal structure of calf spleen purine nucleoside phosphorylase in a new space group with full trimer in the asymmetric unit;2.05;CA;CALCIUM ION;Purine nucleoside phosphorylase;9913;
1LVU;B;Crystal structure of calf spleen purine nucleoside phosphorylase in a new space group with full trimer in the asymmetric unit;2.05;CA;CALCIUM ION;Purine nucleoside phosphorylase;9913;
1LVU;C;Crystal structure of calf spleen purine nucleoside phosphorylase in a new space group with full trimer in the asymmetric unit;2.05;CA;CALCIUM ION;Purine nucleoside phosphorylase;9913;
1LVU;D;Crystal structure of calf spleen purine nucleoside phosphorylase in a new space group with full trimer in the asymmetric unit;2.05;CA;CALCIUM ION;Purine nucleoside phosphorylase;9913;
1LVU;E;Crystal structure of calf spleen purine nucleoside phosphorylase in a new space group with full trimer in the asymmetric unit;2.05;CA;CALCIUM ION;Purine nucleoside phosphorylase;9913;
1LVU;F;Crystal structure of calf spleen purine nucleoside phosphorylase in a new space group with full trimer in the asymmetric unit;2.05;CA;CALCIUM ION;Purine nucleoside phosphorylase;9913;
1LVY;A;PORCINE ELASTASE;1.87;CA;CALCIUM ION;ELASTASE;9823;
1LW4;A;X-ray structure of L-Threonine Aldolase (low-specificity) in complex with L-allo-threonine;1.9;CA;CALCIUM ION;L-allo-threonine aldolase;2336;
1LW4;B;X-ray structure of L-Threonine Aldolase (low-specificity) in complex with L-allo-threonine;1.9;CA;CALCIUM ION;L-allo-threonine aldolase;2336;
1LW4;D;X-ray structure of L-Threonine Aldolase (low-specificity) in complex with L-allo-threonine;1.9;CA;CALCIUM ION;L-allo-threonine aldolase;2336;
1LW5;A;X-ray structure of L-Threonine Aldolase (low-specificity) in complex with glycine;2.05;CA;CALCIUM ION;L-allo-threonine aldolase;2336;
1LW5;B;X-ray structure of L-Threonine Aldolase (low-specificity) in complex with glycine;2.05;CA;CALCIUM ION;L-allo-threonine aldolase;2336;
1LW5;C;X-ray structure of L-Threonine Aldolase (low-specificity) in complex with glycine;2.05;CA;CALCIUM ION;L-allo-threonine aldolase;2336;
1LW5;D;X-ray structure of L-Threonine Aldolase (low-specificity) in complex with glycine;2.05;CA;CALCIUM ION;L-allo-threonine aldolase;2336;
1LW6;E;Crystal Structure of the Complex of Subtilisin BPN' with Chymotrypsin Inhibitor 2 at 1.5 Angstrom Resolution;1.5;CA;CALCIUM ION;SUBTILISIN BPN';1390;
1LWH;A;CRYSTAL STRUCTURE OF T. MARITIMA 4-ALPHA-GLUCANOTRANSFERASE;2.6;CA;CALCIUM ION;4-alpha-glucanotransferase;2336;
1LWH;B;CRYSTAL STRUCTURE OF T. MARITIMA 4-ALPHA-GLUCANOTRANSFERASE;2.6;CA;CALCIUM ION;4-alpha-glucanotransferase;2336;
1LWJ;A;CRYSTAL STRUCTURE OF T. MARITIMA 4-ALPHA-GLUCANOTRANSFERASE/ACARBOSE COMPLEX;2.5;CA;CALCIUM ION;4-ALPHA-GLUCANOTRANSFERASE;2336;
1LWJ;B;CRYSTAL STRUCTURE OF T. MARITIMA 4-ALPHA-GLUCANOTRANSFERASE/ACARBOSE COMPLEX;2.5;CA;CALCIUM ION;4-ALPHA-GLUCANOTRANSFERASE;2336;
1LWS;A;Crystal structure of the intein homing endonuclease PI-SceI bound to its recognition sequence;3.5;CA;CALCIUM ION;ENDONUCLEASE PI-SCEI;4932;
1LWU;B;Crystal structure of fragment D from lamprey fibrinogen complexed with the peptide Gly-His-Arg-Pro-amide;2.8;CA;CALCIUM ION;Fibrinogen beta chain;7757;
1LWU;C;Crystal structure of fragment D from lamprey fibrinogen complexed with the peptide Gly-His-Arg-Pro-amide;2.8;CA;CALCIUM ION;Fibrinogen gamma chain;7757;
1LWU;E;Crystal structure of fragment D from lamprey fibrinogen complexed with the peptide Gly-His-Arg-Pro-amide;2.8;CA;CALCIUM ION;Fibrinogen beta chain;7757;
1LWU;F;Crystal structure of fragment D from lamprey fibrinogen complexed with the peptide Gly-His-Arg-Pro-amide;2.8;CA;CALCIUM ION;Fibrinogen gamma chain;7757;
1LWU;H;Crystal structure of fragment D from lamprey fibrinogen complexed with the peptide Gly-His-Arg-Pro-amide;2.8;CA;CALCIUM ION;Fibrinogen beta chain;7757;
1LWU;I;Crystal structure of fragment D from lamprey fibrinogen complexed with the peptide Gly-His-Arg-Pro-amide;2.8;CA;CALCIUM ION;Fibrinogen gamma chain;7757;
1LWU;K;Crystal structure of fragment D from lamprey fibrinogen complexed with the peptide Gly-His-Arg-Pro-amide;2.8;CA;CALCIUM ION;Fibrinogen beta chain;7757;
1LWU;L;Crystal structure of fragment D from lamprey fibrinogen complexed with the peptide Gly-His-Arg-Pro-amide;2.8;CA;CALCIUM ION;Fibrinogen gamma chain;7757;
1LWV;E;Borohydride-trapped hOgg1 Intermediate Structure Co-Crystallized with 8-aminoguanine;2.3;CA;CALCIUM ION;5'-D(*GP*CP*GP*TP*CP*CP*AP*(PED)P*GP*TP*CP*TP*AP*CP*C)-3';;
1LWW;E;Borohydride-trapped hOgg1 Intermediate Structure Co-Crystallized with 8-bromoguanine;2.1;CA;CALCIUM ION;5'-D(*GP*CP*GP*TP*CP*CP*AP*(PED)P*GP*TP*CP*TP*AP*CP*C)-3';;
1LXF;C;Structure of the Regulatory N-domain of Human Cardiac Troponin C in Complex with Human Cardiac Troponin-I(147-163) and Bepridil;;CA;CALCIUM ION;TROPONIN C, SLOW SKELETAL AND CARDIAC MUSCLES;9606;
1LY8;A;The crystal structure of a mutant enzyme of Coprinus cinereus peroxidase provides an understanding of its increased thermostability and insight into modelling of protein structures;2.05;CA;CALCIUM ION;Peroxidase;5346;
1LY8;B;The crystal structure of a mutant enzyme of Coprinus cinereus peroxidase provides an understanding of its increased thermostability and insight into modelling of protein structures;2.05;CA;CALCIUM ION;Peroxidase;5346;
1LY9;A;The impact of the physical and chemical environment on the molecular structure of Coprinus cinereus peroxidase;2;CA;CALCIUM ION;Peroxidase;5346;
1LY9;B;The impact of the physical and chemical environment on the molecular structure of Coprinus cinereus peroxidase;2;CA;CALCIUM ION;Peroxidase;5346;
1LYC;A;The impact of the physical and chemical enviroment on the molecular structure of Coprinus cinereus peroxidase;1.57;CA;CALCIUM ION;Peroxidase;5346;
1LYC;B;The impact of the physical and chemical enviroment on the molecular structure of Coprinus cinereus peroxidase;1.57;CA;CALCIUM ION;Peroxidase;5346;
1LYK;A;THE IMPACT OF THE PHYSICAL AND CHEMICAL ENVIROMENT ON THE MOLECULAR STRUCTURE OF COPRINUS CINEREUS PEROXIDASE;2;CA;CALCIUM ION;Peroxidase;5346;
1LYK;B;THE IMPACT OF THE PHYSICAL AND CHEMICAL ENVIROMENT ON THE MOLECULAR STRUCTURE OF COPRINUS CINEREUS PEROXIDASE;2;CA;CALCIUM ION;Peroxidase;5346;
1M1J;B;Crystal structure of native chicken fibrinogen with two different bound ligands;2.7;CA;CALCIUM ION;Fibrinogen beta chain;9031;
1M1J;C;Crystal structure of native chicken fibrinogen with two different bound ligands;2.7;CA;CALCIUM ION;Fibrinogen gamma chain;9031;
1M1J;E;Crystal structure of native chicken fibrinogen with two different bound ligands;2.7;CA;CALCIUM ION;Fibrinogen beta chain;9031;
1M1J;F;Crystal structure of native chicken fibrinogen with two different bound ligands;2.7;CA;CALCIUM ION;Fibrinogen gamma chain;9031;
1M1N;B;Nitrogenase MoFe protein from Azotobacter vinelandii;1.16;CA;CALCIUM ION;Nitrogenase molybdenum-iron protein beta chain;354;
1M1N;D;Nitrogenase MoFe protein from Azotobacter vinelandii;1.16;CA;CALCIUM ION;Nitrogenase molybdenum-iron protein beta chain;354;
1M1N;F;Nitrogenase MoFe protein from Azotobacter vinelandii;1.16;CA;CALCIUM ION;Nitrogenase molybdenum-iron protein beta chain;354;
1M1N;H;Nitrogenase MoFe protein from Azotobacter vinelandii;1.16;CA;CALCIUM ION;Nitrogenase molybdenum-iron protein beta chain;354;
1M1U;A;AN ISOLEUCINE-BASED ALLOSTERIC SWITCH CONTROLS AFFINITY AND SHAPE SHIFTING IN INTEGRIN CD11B A-DOMAIN;2.3;CA;CALCIUM ION;Integrin alpha-M;9606;
1M1Y;B;Chemical Crosslink of Nitrogenase MoFe Protein and Fe Protein;3.2;CA;CALCIUM ION;Nitrogenase molybdenum-iron protein beta chain;354;
1M1Y;D;Chemical Crosslink of Nitrogenase MoFe Protein and Fe Protein;3.2;CA;CALCIUM ION;Nitrogenase molybdenum-iron protein beta chain;354;
1M1Y;J;Chemical Crosslink of Nitrogenase MoFe Protein and Fe Protein;3.2;CA;CALCIUM ION;Nitrogenase molybdenum-iron protein beta chain;354;
1M1Y;L;Chemical Crosslink of Nitrogenase MoFe Protein and Fe Protein;3.2;CA;CALCIUM ION;Nitrogenase molybdenum-iron protein beta chain;354;
1M34;B;Nitrogenase Complex From Azotobacter Vinelandii Stabilized By ADP-Tetrafluoroaluminate;2.3;CA;CALCIUM ION;Nitrogenase Molybdenum-Iron Protein beta chain;354;
1M34;D;Nitrogenase Complex From Azotobacter Vinelandii Stabilized By ADP-Tetrafluoroaluminate;2.3;CA;CALCIUM ION;Nitrogenase Molybdenum-Iron Protein beta chain;354;
1M34;J;Nitrogenase Complex From Azotobacter Vinelandii Stabilized By ADP-Tetrafluoroaluminate;2.3;CA;CALCIUM ION;Nitrogenase Molybdenum-Iron Protein beta chain;354;
1M34;L;Nitrogenase Complex From Azotobacter Vinelandii Stabilized By ADP-Tetrafluoroaluminate;2.3;CA;CALCIUM ION;Nitrogenase Molybdenum-Iron Protein beta chain;354;
1M3H;C;Crystal Structure of Hogg1 D268E Mutant with Product Oligonucleotide;2.05;CA;CALCIUM ION;5'-D(P*GP*CP*GP*TP*CP*CP*AP*(DDX))-3';;
1M3Q;C;Crystal Structure of hogg1 D268E Mutant with Base-Excised DNA and 8-aminoguanine;1.9;CA;CALCIUM ION;5'-D(*GP*CP*GP*TP*CP*CP*AP*(DRZ)P*GP*TP*CP*TP*AP*CP*C)-3';;
1M56;A;Structure of cytochrome c oxidase from Rhodobactor sphaeroides (Wild Type);2.3;CA;CALCIUM ION;CYTOCHROME C OXIDASE;1063;
1M56;G;Structure of cytochrome c oxidase from Rhodobactor sphaeroides (Wild Type);2.3;CA;CALCIUM ION;CYTOCHROME C OXIDASE;1063;
1M57;A;Structure of cytochrome c oxidase from Rhodobacter sphaeroides (EQ(I-286) mutant));3;CA;CALCIUM ION;CYTOCHROME C OXIDASE;1063;
1M57;G;Structure of cytochrome c oxidase from Rhodobacter sphaeroides (EQ(I-286) mutant));3;CA;CALCIUM ION;CYTOCHROME C OXIDASE;1063;
1M5K;A;Crystal structure of a hairpin ribozyme in the catalytically-active conformation;2.4;CA;CALCIUM ION;RNA INHIBITOR SUBSTRATE;;
1M5K;B;Crystal structure of a hairpin ribozyme in the catalytically-active conformation;2.4;CA;CALCIUM ION;RNA HAIRPIN RIBOZYME;;
1M5K;C;Crystal structure of a hairpin ribozyme in the catalytically-active conformation;2.4;CA;CALCIUM ION;PROTEIN (U1 SMALL NUCLEAR RIBONUCLEOPROTEIN A);9606;
1M5K;D;Crystal structure of a hairpin ribozyme in the catalytically-active conformation;2.4;CA;CALCIUM ION;RNA INHIBITOR SUBSTRATE;;
1M5K;E;Crystal structure of a hairpin ribozyme in the catalytically-active conformation;2.4;CA;CALCIUM ION;RNA HAIRPIN RIBOZYME;;
1M5K;F;Crystal structure of a hairpin ribozyme in the catalytically-active conformation;2.4;CA;CALCIUM ION;PROTEIN (U1 SMALL NUCLEAR RIBONUCLEOPROTEIN A);9606;
1M5O;A;Transition State Stabilization by a Catalytic RNA;2.2;CA;CALCIUM ION;RNA  SUBSTRATE;;
1M5O;B;Transition State Stabilization by a Catalytic RNA;2.2;CA;CALCIUM ION;RNA HAIRPIN RIBOZYME;;
1M5O;C;Transition State Stabilization by a Catalytic RNA;2.2;CA;CALCIUM ION;U1 SMALL NUCLEAR RIBONUCLEOPROTEIN A;9606;
1M5O;D;Transition State Stabilization by a Catalytic RNA;2.2;CA;CALCIUM ION;RNA  SUBSTRATE;;
1M5O;E;Transition State Stabilization by a Catalytic RNA;2.2;CA;CALCIUM ION;RNA HAIRPIN RIBOZYME;;
1M5O;F;Transition State Stabilization by a Catalytic RNA;2.2;CA;CALCIUM ION;U1 SMALL NUCLEAR RIBONUCLEOPROTEIN A;9606;
1M5P;B;Transition State Stabilization by a Catalytic RNA;2.6;CA;CALCIUM ION;RNA HAIRPIN RIBOZYME;;
1M5P;C;Transition State Stabilization by a Catalytic RNA;2.6;CA;CALCIUM ION;U1 SMALL NUCLEAR RIBONUCLEOPROTEIN A;9606;
1M5P;E;Transition State Stabilization by a Catalytic RNA;2.6;CA;CALCIUM ION;RNA HAIRPIN RIBOZYME;;
1M5P;F;Transition State Stabilization by a Catalytic RNA;2.6;CA;CALCIUM ION;U1 SMALL NUCLEAR RIBONUCLEOPROTEIN A;9606;
1M5P;P;Transition State Stabilization by a Catalytic RNA;2.6;CA;CALCIUM ION;RNA INHIBITOR SUBSTRATE;;
1M5V;B;Transition State Stabilization by a Catalytic RNA;2.4;CA;CALCIUM ION;RNA HAIRPIN RIBOZYME;;
1M5V;C;Transition State Stabilization by a Catalytic RNA;2.4;CA;CALCIUM ION;U1 SMALL NUCLEAR RIBONUCLEOPROTEIN A;9606;
1M5V;D;Transition State Stabilization by a Catalytic RNA;2.4;CA;CALCIUM ION;RNA INHIBITOR SUBSTRATE;;
1M5V;E;Transition State Stabilization by a Catalytic RNA;2.4;CA;CALCIUM ION;RNA HAIRPIN RIBOZYME;;
1M5V;P;Transition State Stabilization by a Catalytic RNA;2.4;CA;CALCIUM ION;RNA INHIBITOR SUBSTRATE;;
1M5X;A;Crystal structure of the homing endonuclease I-MsoI bound to its DNA substrate;2.25;CA;CALCIUM ION;DNA endonuclease I-MsoI;141716;
1M5X;B;Crystal structure of the homing endonuclease I-MsoI bound to its DNA substrate;2.25;CA;CALCIUM ION;DNA endonuclease I-MsoI;141716;
1M5X;C;Crystal structure of the homing endonuclease I-MsoI bound to its DNA substrate;2.25;CA;CALCIUM ION;5'-D(*GP*CP*AP*GP*AP*AP*CP*GP*TP*CP*GP*TP*GP*AP*GP*AP*CP*AP*GP*TP*TP*CP*CP*G)-3';;
1M63;B;Crystal structure of calcineurin-cyclophilin-cyclosporin shows common but distinct recognition of immunophilin-drug complexes;2.8;CA;CALCIUM ION;CALCINEURIN B SUBUNIT ISOFORM 1;9606;
1M63;F;Crystal structure of calcineurin-cyclophilin-cyclosporin shows common but distinct recognition of immunophilin-drug complexes;2.8;CA;CALCIUM ION;CALCINEURIN B SUBUNIT ISOFORM 1;9606;
1M6S;A;Crystal Structure Of Threonine Aldolase;1.8;CA;CALCIUM ION;L-allo-threonine aldolase;2336;
1M6S;B;Crystal Structure Of Threonine Aldolase;1.8;CA;CALCIUM ION;L-allo-threonine aldolase;2336;
1M6S;C;Crystal Structure Of Threonine Aldolase;1.8;CA;CALCIUM ION;L-allo-threonine aldolase;2336;
1M6S;D;Crystal Structure Of Threonine Aldolase;1.8;CA;CALCIUM ION;L-allo-threonine aldolase;2336;
1M8T;A;Structure of an acidic Phospholipase A2 from the venom of Ophiophagus hannah at 2.1 resolution from a hemihedrally twinned crystal form;2.1;CA;CALCIUM ION;Phospholipase a2;8665;
1M8T;B;Structure of an acidic Phospholipase A2 from the venom of Ophiophagus hannah at 2.1 resolution from a hemihedrally twinned crystal form;2.1;CA;CALCIUM ION;Phospholipase a2;8665;
1M8T;C;Structure of an acidic Phospholipase A2 from the venom of Ophiophagus hannah at 2.1 resolution from a hemihedrally twinned crystal form;2.1;CA;CALCIUM ION;Phospholipase a2;8665;
1M8T;D;Structure of an acidic Phospholipase A2 from the venom of Ophiophagus hannah at 2.1 resolution from a hemihedrally twinned crystal form;2.1;CA;CALCIUM ION;Phospholipase a2;8665;
1M8T;E;Structure of an acidic Phospholipase A2 from the venom of Ophiophagus hannah at 2.1 resolution from a hemihedrally twinned crystal form;2.1;CA;CALCIUM ION;Phospholipase a2;8665;
1M8T;F;Structure of an acidic Phospholipase A2 from the venom of Ophiophagus hannah at 2.1 resolution from a hemihedrally twinned crystal form;2.1;CA;CALCIUM ION;Phospholipase a2;8665;
1M8V;O;Structure of Pyrococcus abyssii Sm Protein in Complex with a Uridine Heptamer;2.6;CA;CALCIUM ION;5'-R(P*UP*UP*UP*UP*UP*UP*U)-3';;
1M8V;P;Structure of Pyrococcus abyssii Sm Protein in Complex with a Uridine Heptamer;2.6;CA;CALCIUM ION;5'-R(P*UP*UP*UP*UP*UP*UP*U)-3';;
1M8V;Q;Structure of Pyrococcus abyssii Sm Protein in Complex with a Uridine Heptamer;2.6;CA;CALCIUM ION;5'-R(P*UP*UP*UP*UP*UP*UP*U)-3';;
1M8V;R;Structure of Pyrococcus abyssii Sm Protein in Complex with a Uridine Heptamer;2.6;CA;CALCIUM ION;5'-R(P*UP*UP*UP*UP*UP*UP*U)-3';;
1M8V;S;Structure of Pyrococcus abyssii Sm Protein in Complex with a Uridine Heptamer;2.6;CA;CALCIUM ION;5'-R(P*UP*UP*UP*UP*UP*UP*U)-3';;
1M8V;T;Structure of Pyrococcus abyssii Sm Protein in Complex with a Uridine Heptamer;2.6;CA;CALCIUM ION;5'-R(P*UP*UP*UP*UP*UP*UP*U)-3';;
1M8V;U;Structure of Pyrococcus abyssii Sm Protein in Complex with a Uridine Heptamer;2.6;CA;CALCIUM ION;5'-R(P*UP*UP*UP*UP*UP*UP*U)-3';;
1M9I;A;Crystal Structure Of Phosphorylation-Mimicking Mutant T356D Of Annexin VI;2.65;CA;CALCIUM ION;Annexin VI;9606;
1MAC;A;CRYSTAL STRUCTURE AND SITE-DIRECTED MUTAGENESIS OF BACILLUS MACERANS ENDO-1,3-1,4-BETA-GLUCANASE;2.3;CA;CALCIUM ION;1,3-1,4-BETA-D-GLUCAN 4-GLUCANOHYDROLASE;44252;
1MAC;B;CRYSTAL STRUCTURE AND SITE-DIRECTED MUTAGENESIS OF BACILLUS MACERANS ENDO-1,3-1,4-BETA-GLUCANASE;2.3;CA;CALCIUM ION;1,3-1,4-BETA-D-GLUCAN 4-GLUCANOHYDROLASE;44252;
1MAX;A;BETA-TRYPSIN PHOSPHONATE INHIBITED;1.8;CA;CALCIUM ION;BETA-TRYPSIN;9913;
1-may;A;BETA-TRYPSIN PHOSPHONATE INHIBITED;1.8;CA;CALCIUM ION;BETA-TRYPSIN;9913;
1MBQ;A;Anionic Trypsin from Pacific Chum Salmon;1.8;CA;CALCIUM ION;Trypsin;8018;
1MCT;A;THE REFINED 1.6 ANGSTROMS RESOLUTION CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN PORCINE BETA-TRYPSIN AND MCTI-A, A TRYPSIN INHIBITOR OF SQUASH FAMILY;1.6;CA;CALCIUM ION;BETA-TRYPSIN;9823;
1MCV;A;Crystal Structure Analysis of a Hybrid Squash Inhibitor in Complex with Porcine Pancreatic Elastase;1.8;CA;CALCIUM ION;Elastase 1;9823;
1MCX;A;STRUCTURE OF FULL-LENGTH ANNEXIN A1 IN THE PRESENCE OF CALCIUM;2.03;CA;CALCIUM ION;ANNEXIN I;9823;
1MDU;A;Crystal structure of the chicken actin trimer complexed with human gelsolin segment 1 (GS-1);2.2;CA;CALCIUM ION;gelsolin precursor;9606;
1MDU;B;Crystal structure of the chicken actin trimer complexed with human gelsolin segment 1 (GS-1);2.2;CA;CALCIUM ION;a-actin;9031;
1MDU;D;Crystal structure of the chicken actin trimer complexed with human gelsolin segment 1 (GS-1);2.2;CA;CALCIUM ION;gelsolin precursor;9606;
1MDU;E;Crystal structure of the chicken actin trimer complexed with human gelsolin segment 1 (GS-1);2.2;CA;CALCIUM ION;a-actin;9031;
1MDW;A;Crystal Structure of Calcium-Bound Protease Core of Calpain II Reveals the Basis for Intrinsic Inactivation;1.95;CA;CALCIUM ION;Calpain II, catalytic subunit;10116;
1MDW;B;Crystal Structure of Calcium-Bound Protease Core of Calpain II Reveals the Basis for Intrinsic Inactivation;1.95;CA;CALCIUM ION;Calpain II, catalytic subunit;10116;
1MEE;A;THE COMPLEX BETWEEN THE SUBTILISIN FROM A MESOPHILIC BACTERIUM AND THE LEECH INHIBITOR EGLIN-C;2;CA;CALCIUM ION;MESENTERICOPEPTIDASE;1408;
1MF4;A;Structure-based design of potent and selective inhibitors of phospholipase A2: Crystal structure of the complex formed between phosholipase A2 from Naja Naja sagittifera and a designed peptide inhibitor at 1.9 A resolution;1.9;CA;CALCIUM ION;Phospholipase A2;195058;
1MF8;B;Crystal Structure of human calcineurin complexed with cyclosporin A and human cyclophilin;3.1;CA;CALCIUM ION;CALCINEURIN B SUBUNIT ISOFORM 1;9606;
1MFU;A;Probing the role of a mobile loop in human salivary amylase: Structural studies on the loop-deleted mutant;2;CA;CALCIUM ION;alpha-amylase, Salivary;9606;
1MFV;A;Probing the role of a mobile loop in human slaivary amylase: Structural studies on the loop-deleted enzyme;2;CA;CALCIUM ION;alpha-amylase, salivary;9606;
1MHL;A;CRYSTAL STRUCTURE OF HUMAN MYELOPEROXIDASE ISOFORM C CRYSTALLIZED IN SPACE GROUP P2(1) AT PH 5.5 AND 20 DEG C;2.25;CA;CALCIUM ION;MYELOPEROXIDASE;9606;
1MHL;B;CRYSTAL STRUCTURE OF HUMAN MYELOPEROXIDASE ISOFORM C CRYSTALLIZED IN SPACE GROUP P2(1) AT PH 5.5 AND 20 DEG C;2.25;CA;CALCIUM ION;MYELOPEROXIDASE;9606;
1MHO;A;THE 2.0 A STRUCTURE OF HOLO S100B FROM BOVINE BRAIN;2;CA;CALCIUM ION;S-100 PROTEIN;9913;
1MIO;B;X-RAY CRYSTAL STRUCTURE OF THE NITROGENASE MOLYBDENUM-IRON PROTEIN FROM CLOSTRIDIUM PASTEURIANUM AT 3.0 ANGSTROMS RESOLUTION;3;CA;CALCIUM ION;NITROGENASE MOLYBDENUM IRON PROTEIN (BETA CHAIN);1501;
1MIO;D;X-RAY CRYSTAL STRUCTURE OF THE NITROGENASE MOLYBDENUM-IRON PROTEIN FROM CLOSTRIDIUM PASTEURIANUM AT 3.0 ANGSTROMS RESOLUTION;3;CA;CALCIUM ION;NITROGENASE MOLYBDENUM IRON PROTEIN (BETA CHAIN);1501;
1MJ2;B;METHIONINE REPRESSOR MUTANT (Q44K) PLUS COREPRESSOR (S-ADENOSYL METHIONINE) COMPLEXED TO A CONSENSUS OPERATOR SEQUENCE;2.4;CA;CALCIUM ION;PROTEIN (METHIONINE REPRESSOR);562;
1MJO;B;METHIONINE HOLOREPRESSOR MUTANT (Q44K) PLUS COREPRESSOR (S-ADENOSYL METHIONINE) COMPLEXED TO THE MINIMAL MET CONSENSUS OPERATOR WITH THE CENTRAL TA STEP MUTATED TO AT;2.1;CA;CALCIUM ION;METHIONINE REPRESSOR;562;
1MKS;A;CARBOXYLIC ESTER HYDROLASE, TRIGONAL FORM OF THE TRIPLE MUTANT;1.9;CA;CALCIUM ION;PHOSPHOLIPASE A2;9913;
1MKT;A;CARBOXYLIC ESTER HYDROLASE, 1.72 ANGSTROM TRIGONAL FORM OF THE BOVINE RECOMBINANT PLA2 ENZYME;1.72;CA;CALCIUM ION;PHOSPHOLIPASE A2;9913;
1MKU;A;CARBOXYLIC ESTER HYDROLASE, ORTHORHOMBIC FORM OF THE TRIPLE MUTANT;1.8;CA;CALCIUM ION;PHOSPHOLIPASE A2;9913;
1MKV;A;CARBOXYLIC ESTER HYDROLASE COMPLEX (PLA2 + TRANSITION STATE ANALOG COMPLEX);1.89;CA;CALCIUM ION;PHOSPHOLIPASE A2;9913;
1MMB;A;COMPLEX OF BB94 WITH THE CATALYTIC DOMAIN OF MATRIX METALLOPROTEINASE-8;2.1;CA;CALCIUM ION;MATRIX METALLOPROTEINASE-8;9606;
1MMJ;N;Porcine pancreatic elastase complexed with a potent peptidyl inhibitor, FR136706;2.2;CA;CALCIUM ION;elastase 1;9823;
1MMP;A;MATRILYSIN COMPLEXED WITH CARBOXYLATE INHIBITOR;2.3;CA;CALCIUM ION;GELATINASE A;9606;
1MMP;B;MATRILYSIN COMPLEXED WITH CARBOXYLATE INHIBITOR;2.3;CA;CALCIUM ION;GELATINASE A;9606;
1MMQ;A;MATRILYSIN COMPLEXED WITH HYDROXAMATE INHIBITOR;1.9;CA;CALCIUM ION;MATRILYSIN;9606;
1MMR;A;MATRILYSIN COMPLEXED WITH SULFODIIMINE INHIBITOR;2.4;CA;CALCIUM ION;MATRILYSIN;9606;
1MN1;A;MANGANESE PEROXIDASE SUBSTRATE BINDING SITE MUTANT D179N;2;CA;CALCIUM ION;MANGANESE PEROXIDASE;5306;
1MN2;A;MANGANESE PEROXIDASE SUBSTRATE BINDING SITE MUTANT E35Q, D179N;2;CA;CALCIUM ION;MANGANESE PEROXIDASE;5306;
1MNC;A;STRUCTURE OF HUMAN NEUTROPHIL COLLAGENASE REVEALS LARGE S1' SPECIFICITY POCKET;2.1;CA;CALCIUM ION;NEUTROPHIL COLLAGENASE;9606;
1MNP;A;MANGANESE PEROXIDASE;2;CA;CALCIUM ION;MANGANESE PEROXIDASE;5306;
1MNZ;A;Atomic structure of Glucose isomerase;0.99;CA;CALCIUM ION;Xylose isomerase;1929;
1MPR;A;MALTOPORIN FROM SALMONELLA TYPHIMURIUM;2.8;CA;CALCIUM ION;MALTOPORIN;90371;
1MPT;A;CRYSTAL STRUCTURE OF A NEW ALKALINE SERINE PROTEASE (M-PROTEASE) FROM BACILLUS SP. KSM-K16;2.4;CA;CALCIUM ION;M-PROTEASE;79880;
1MPX;A;ALPHA-AMINO ACID ESTER HYDROLASE LABELED WITH SELENOMETHIONINE;1.9;CA;CALCIUM ION;alpha-amino acid ester hydrolase;346;
1MPX;B;ALPHA-AMINO ACID ESTER HYDROLASE LABELED WITH SELENOMETHIONINE;1.9;CA;CALCIUM ION;alpha-amino acid ester hydrolase;346;
1MPX;C;ALPHA-AMINO ACID ESTER HYDROLASE LABELED WITH SELENOMETHIONINE;1.9;CA;CALCIUM ION;alpha-amino acid ester hydrolase;346;
1MPX;D;ALPHA-AMINO ACID ESTER HYDROLASE LABELED WITH SELENOMETHIONINE;1.9;CA;CALCIUM ION;alpha-amino acid ester hydrolase;346;
1MQ5;A;Crystal Structure of 3-chloro-N-[4-chloro-2-[[(4-chlorophenyl)amino]carbonyl]phenyl]-4-[(4-methyl-1-piperazinyl)methyl]-2-thiophenecarboxamide Complexed with Human Factor Xa;2.1;CA;CALCIUM ION;COAGULATION FACTOR X HEAVY CHAIN;9606;
1MQ6;A;Crystal Structure of 3-chloro-N-[4-chloro-2-[[(5-chloro-2-pyridinyl)amino]carbonyl]-6-methoxyphenyl]-4-[[(4,5-dihydro-2-oxazolyl)methylamino]methyl]-2-thiophenecarboxamide Complexed with Human Factor Xa;2.1;CA;CALCIUM ION;COAGULATION FACTOR X HEAVY CHAIN;9606;
1MR8;A;MIGRATION INHIBITORY FACTOR-RELATED PROTEIN 8 FROM HUMAN;1.9;CA;CALCIUM ION;MIGRATION INHIBITORY FACTOR-RELATED PROTEIN 8;9606;
1MR8;B;MIGRATION INHIBITORY FACTOR-RELATED PROTEIN 8 FROM HUMAN;1.9;CA;CALCIUM ION;MIGRATION INHIBITORY FACTOR-RELATED PROTEIN 8;9606;
1MTS;A;FACTOR XA SPECIFIC INHIBITOR IN COMPLEX WITH BOVINE TRYPSIN;1.9;CA;CALCIUM ION;TRYPSIN;9913;
1MTU;A;FACTOR XA SPECIFIC INHIBITOR IN COMPLEX WITH BOVINE TRYPSIN;1.9;CA;CALCIUM ION;TRYPSIN;9913;
1MTV;A;FACTOR XA SPECIFIC INHIBITOR IN COMPLEX WITH BOVINE TRYPSIN;1.9;CA;CALCIUM ION;TRYPSIN;9913;
1MTW;A;FACTOR XA SPECIFIC INHIBITOR IN COMPLEX WITH BOVINE TRYPSIN;1.9;CA;CALCIUM ION;TRYPSIN;9913;
1MU5;A;Structure of topoisomerase subunit;2;CA;CALCIUM ION;Type II DNA topoisomerase VI Subunit B;2286;
1MUQ;A;X-ray Crystal Structure of Rattlesnake Venom Complexed With Thiodigalactoside;2.3;CA;CALCIUM ION;Galactose-specific lectin;8730;
1MUQ;B;X-ray Crystal Structure of Rattlesnake Venom Complexed With Thiodigalactoside;2.3;CA;CALCIUM ION;Galactose-specific lectin;8730;
1MUQ;C;X-ray Crystal Structure of Rattlesnake Venom Complexed With Thiodigalactoside;2.3;CA;CALCIUM ION;Galactose-specific lectin;8730;
1MUQ;D;X-ray Crystal Structure of Rattlesnake Venom Complexed With Thiodigalactoside;2.3;CA;CALCIUM ION;Galactose-specific lectin;8730;
1MUQ;E;X-ray Crystal Structure of Rattlesnake Venom Complexed With Thiodigalactoside;2.3;CA;CALCIUM ION;Galactose-specific lectin;8730;
1MUX;A;SOLUTION NMR STRUCTURE OF CALMODULIN/W-7 COMPLEX: THE BASIS OF DIVERSITY IN MOLECULAR RECOGNITION, 30 STRUCTURES;;CA;CALCIUM ION;CALMODULIN;8355;
1MVE;A;Crystal structure of a natural circularly-permutated jellyroll protein: 1,3-1,4-beta-D-glucanase from Fibrobacter succinogenes;1.7;CA;CALCIUM ION;Truncated 1,3-1,4-beta-D-glucanase;833;
1MVQ;A;Cratylia mollis lectin (isoform 1) in complex with methyl-alpha-D-mannose;1.77;CA;CALCIUM ION;lectin, isoform 1;252530;
1MWE;A;THE X-RAY STRUCTURE OF A COMPLEX OF TERN N9 INFLUENZA VIRUS NEURAMINIDASE COMPLEXED WITH SIALIC ACID AT 4 DEGREES C REVEALING A SECOND SIALIC ACID BINDING SITE;1.7;CA;CALCIUM ION;NEURAMINIDASE;11320;
1MWN;A;Solution NMR structure of S100B bound to the high-affinity target peptide TRTK-12;;CA;CALCIUM ION;S-100 protein, beta chain;10116;
1MWN;B;Solution NMR structure of S100B bound to the high-affinity target peptide TRTK-12;;CA;CALCIUM ION;S-100 protein, beta chain;10116;
1MWO;A;Crystal Structure Analysis of the Hyperthermostable Pyrocoocus woesei alpha-amylase;2.2;CA;CALCIUM ION;alpha amylase;2262;
1MXD;A;Structure of a (Ca,Zn)-dependent alpha-amylase from the hyperthermophilic archaeon Pyrococcus woesei;2;CA;CALCIUM ION;alpha amylase;2262;
1MXE;A;Structure of the Complex of Calmodulin with the Target Sequence of CaMKI;1.7;CA;CALCIUM ION;Calmodulin;7227;
1MXE;B;Structure of the Complex of Calmodulin with the Target Sequence of CaMKI;1.7;CA;CALCIUM ION;Calmodulin;7227;
1MXG;A;Crystal Strucutre of a (Ca,Zn)-dependent alpha-amylase from the hyperthermophilic archaeon Pyrococcus woesei in complex with acarbose;1.6;CA;CALCIUM ION;alpha amylase;2262;
1MXL;C;STRUCTURE OF CARDIAC TROPONIN C-TROPONIN I COMPLEX;;CA;CALCIUM ION;PROTEIN (TROPONIN C);9606;
1MYP;A;X-RAY CRYSTAL STRUCTURE OF CANINE MYELOPEROXIDASE AT 3 ANGSTROMS RESOLUTION;3;CA;CALCIUM ION;MYELOPEROXIDASE;9612;
1MYP;B;X-RAY CRYSTAL STRUCTURE OF CANINE MYELOPEROXIDASE AT 3 ANGSTROMS RESOLUTION;3;CA;CALCIUM ION;MYELOPEROXIDASE;9612;
1N28;A;Crystal structure of the H48Q mutant of human group IIA phospholipase A2;1.5;CA;CALCIUM ION;Phospholipase A2, membrane associated;9606;
1N28;B;Crystal structure of the H48Q mutant of human group IIA phospholipase A2;1.5;CA;CALCIUM ION;Phospholipase A2, membrane associated;9606;
1N29;A;Crystal structure of the N1A mutant of human group IIA phospholipase A2;2.6;CA;CALCIUM ION;Phospholipase A2, membrane associated;9606;
1N2C;B;NITROGENASE COMPLEX FROM AZOTOBACTER VINELANDII STABILIZED BY ADP-TETRAFLUOROALUMINATE;3;CA;CALCIUM ION;NITROGENASE MOLYBDENUM-IRON PROTEIN;354;
1N2C;D;NITROGENASE COMPLEX FROM AZOTOBACTER VINELANDII STABILIZED BY ADP-TETRAFLUOROALUMINATE;3;CA;CALCIUM ION;NITROGENASE MOLYBDENUM-IRON PROTEIN;354;
1N2K;A;Crystal structure of a covalent intermediate of endogenous human arylsulfatase A;2.75;CA;CALCIUM ION;ARYLSULFATASE A;9606;
1N2L;A;Crystal structure of a covalent intermediate of endogenous human arylsulfatase A;3.2;CA;CALCIUM ION;ARYLSULFATASE A;9606;
1N39;C;Structural and biochemical exploration of a critical amino acid in human 8-oxoguanine glycosylase;2.2;CA;CALCIUM ION;DNA inhibitor strand;;
1N3A;C;Structural and biochemical exploration of a critical amino acid in human 8-oxoguanine glycosylase;2.2;CA;CALCIUM ION;DNA inhibitor strand;;
1N3C;C;Structural and biochemical exploration of a critical amino acid in human 8-oxoguanine glycosylase;2.7;CA;CALCIUM ION;8-oxoG-containing DNA;;
1N3E;C;Crystal structure of I-CreI bound to a palindromic DNA sequence I (palindrome of left side of wildtype DNA target sequence);2.5;CA;CALCIUM ION;5'-D(*CP*GP*AP*AP*AP*AP*CP*GP*TP*CP*GP*TP*AP*C)-3';;
1N3E;D;Crystal structure of I-CreI bound to a palindromic DNA sequence I (palindrome of left side of wildtype DNA target sequence);2.5;CA;CALCIUM ION;5'-D(P*GP*AP*CP*GP*TP*TP*TP*TP*CP*G)-3';;
1N3E;F;Crystal structure of I-CreI bound to a palindromic DNA sequence I (palindrome of left side of wildtype DNA target sequence);2.5;CA;CALCIUM ION;5'-D(P*GP*AP*CP*GP*TP*TP*TP*TP*CP*G)-3';;
1N3E;I;Crystal structure of I-CreI bound to a palindromic DNA sequence I (palindrome of left side of wildtype DNA target sequence);2.5;CA;CALCIUM ION;5'-D(*CP*GP*AP*AP*AP*AP*CP*GP*TP*CP*GP*TP*AP*C)-3';;
1N3E;J;Crystal structure of I-CreI bound to a palindromic DNA sequence I (palindrome of left side of wildtype DNA target sequence);2.5;CA;CALCIUM ION;5'-D(P*GP*AP*CP*GP*TP*TP*TP*TP*CP*G)-3';;
1N3E;L;Crystal structure of I-CreI bound to a palindromic DNA sequence I (palindrome of left side of wildtype DNA target sequence);2.5;CA;CALCIUM ION;5'-D(P*GP*AP*CP*GP*TP*TP*TP*TP*CP*G)-3';;
1N3F;C;Crystal structure of I-CreI bound to a palindromic DNA sequence II (palindrome of right side of wildtype DNA target sequence);2;CA;CALCIUM ION;5'-D(*CP*GP*AP*AP*AP*CP*TP*GP*TP*CP*TP*CP*GP*A)-3';;
1N3F;D;Crystal structure of I-CreI bound to a palindromic DNA sequence II (palindrome of right side of wildtype DNA target sequence);2;CA;CALCIUM ION;5'-D(P*GP*AP*CP*AP*GP*TP*TP*TP*CP*G-3');;
1N3F;F;Crystal structure of I-CreI bound to a palindromic DNA sequence II (palindrome of right side of wildtype DNA target sequence);2;CA;CALCIUM ION;5'-D(P*GP*AP*CP*AP*GP*TP*TP*TP*CP*G-3');;
1N3F;I;Crystal structure of I-CreI bound to a palindromic DNA sequence II (palindrome of right side of wildtype DNA target sequence);2;CA;CALCIUM ION;5'-D(*CP*GP*AP*AP*AP*CP*TP*GP*TP*CP*TP*CP*GP*A)-3';;
1N3F;J;Crystal structure of I-CreI bound to a palindromic DNA sequence II (palindrome of right side of wildtype DNA target sequence);2;CA;CALCIUM ION;5'-D(P*GP*AP*CP*AP*GP*TP*TP*TP*CP*G-3');;
1N3F;L;Crystal structure of I-CreI bound to a palindromic DNA sequence II (palindrome of right side of wildtype DNA target sequence);2;CA;CALCIUM ION;5'-D(P*GP*AP*CP*AP*GP*TP*TP*TP*CP*G-3');;
1N3O;A;Pterocarcpus angolensis lectin in complex with alpha-methyl glucose;2;CA;CALCIUM ION;lectin PAL;182271;
1N3O;B;Pterocarcpus angolensis lectin in complex with alpha-methyl glucose;2;CA;CALCIUM ION;lectin PAL;182271;
1N3P;A;Pterocarpus angolensis lectin in complex with sucrose;2.1;CA;CALCIUM ION;lectin PAL;182271;
1N3P;B;Pterocarpus angolensis lectin in complex with sucrose;2.1;CA;CALCIUM ION;lectin PAL;182271;
1N3Q;A;Pterocarpus angolensis lectin complexed with turanose;2.2;CA;CALCIUM ION;lectin PAL;182271;
1N3Q;B;Pterocarpus angolensis lectin complexed with turanose;2.2;CA;CALCIUM ION;lectin PAL;182271;
1N41;A;Crystal Structure of Annexin V K27E Mutant;2.1;CA;CALCIUM ION;annexin V;10116;
1N42;A;Crystal Structure of Annexin V R149E Mutant;2.1;CA;CALCIUM ION;Annexin V;10116;
1N44;A;Crystal Structure of Annexin V R23E Mutant;3;CA;CALCIUM ION;Annexin V;10116;
1N47;A;Isolectin B4 from Vicia villosa in complex with the Tn antigen;2.7;CA;CALCIUM ION;Isolectin B4;3911;
1N47;B;Isolectin B4 from Vicia villosa in complex with the Tn antigen;2.7;CA;CALCIUM ION;Isolectin B4;3911;
1N47;C;Isolectin B4 from Vicia villosa in complex with the Tn antigen;2.7;CA;CALCIUM ION;Isolectin B4;3911;
1N47;D;Isolectin B4 from Vicia villosa in complex with the Tn antigen;2.7;CA;CALCIUM ION;Isolectin B4;3911;
1N48;A;Y-family DNA polymerase Dpo4 in complex with DNA containing abasic lesion;2.2;CA;CALCIUM ION;DNA polymerase IV;2287;
1N48;B;Y-family DNA polymerase Dpo4 in complex with DNA containing abasic lesion;2.2;CA;CALCIUM ION;5'-D(*GP*GP*GP*GP*GP*AP*AP*GP*GP*AP*CP*TP*A)-3';;
1N56;B;Y-family DNA polymerase Dpo4 in complex with DNA containing abasic lesion;2.4;CA;CALCIUM ION;DNA polymerase IV;2287;
1N6X;A;RIP-phasing on Bovine Trypsin;1.4;CA;CALCIUM ION;Trypsinogen, cationic;9913;
1N6Y;A;RIP-phasing on Bovine Trypsin;1.4;CA;CALCIUM ION;Trypsinogen, cationic;9913;
1N73;B;Fibrin D-Dimer, Lamprey complexed with the PEPTIDE LIGAND: GLY-HIS-ARG-PRO-AMIDE;2.9;CA;CALCIUM ION;Fibrin beta chain;7757;
1N73;C;Fibrin D-Dimer, Lamprey complexed with the PEPTIDE LIGAND: GLY-HIS-ARG-PRO-AMIDE;2.9;CA;CALCIUM ION;Fibrin gamma chain;7757;
1N73;E;Fibrin D-Dimer, Lamprey complexed with the PEPTIDE LIGAND: GLY-HIS-ARG-PRO-AMIDE;2.9;CA;CALCIUM ION;Fibrin beta chain;7757;
1N73;F;Fibrin D-Dimer, Lamprey complexed with the PEPTIDE LIGAND: GLY-HIS-ARG-PRO-AMIDE;2.9;CA;CALCIUM ION;Fibrin gamma chain;7757;
1N7D;A;Extracellular domain of the LDL receptor;3.7;CA;CALCIUM ION;Low-density lipoprotein receptor;9606;
1N7S;A;High Resolution Structure of a Truncated Neuronal SNARE Complex;1.45;CA;CALCIUM ION;vesicle-associated membrane protein 2;10116;
1N7S;C;High Resolution Structure of a Truncated Neuronal SNARE Complex;1.45;CA;CALCIUM ION;SNAP-25A;10116;
1N7U;A;THE RECEPTOR-BINDING PROTEIN P2 OF BACTERIOPHAGE PRD1: CRYSTAL FORM I;2.4;CA;CALCIUM ION;Adsorption protein P2;;
1N7V;A;THE RECEPTOR-BINDING PROTEIN P2 OF BACTERIOPHAGE PRD1: CRYSTAL FORM III;2.2;CA;CALCIUM ION;Adsorption protein P2;;
1N86;B;Crystal structure of human D-dimer from cross-linked fibrin complexed with GPR and GHRPLDK peptide ligands.;3.2;CA;CALCIUM ION;Fibrin beta chain;9606;
1N86;C;Crystal structure of human D-dimer from cross-linked fibrin complexed with GPR and GHRPLDK peptide ligands.;3.2;CA;CALCIUM ION;Fibrin gamma chain;9606;
1N86;E;Crystal structure of human D-dimer from cross-linked fibrin complexed with GPR and GHRPLDK peptide ligands.;3.2;CA;CALCIUM ION;Fibrin beta chain;9606;
1N86;F;Crystal structure of human D-dimer from cross-linked fibrin complexed with GPR and GHRPLDK peptide ligands.;3.2;CA;CALCIUM ION;Fibrin gamma chain;9606;
1N9E;A;Crystal structure of Pichia pastoris Lysyl Oxidase PPLO;1.65;CA;CALCIUM ION;LYSYL OXIDASE;4922;
1N9E;B;Crystal structure of Pichia pastoris Lysyl Oxidase PPLO;1.65;CA;CALCIUM ION;LYSYL OXIDASE;4922;
1N9E;C;Crystal structure of Pichia pastoris Lysyl Oxidase PPLO;1.65;CA;CALCIUM ION;LYSYL OXIDASE;4922;
1N9E;D;Crystal structure of Pichia pastoris Lysyl Oxidase PPLO;1.65;CA;CALCIUM ION;LYSYL OXIDASE;4922;
1NAE;A;Structure of CsCBM6-3 from Clostridium stercorarium in complex with xylotriose;2.05;CA;CALCIUM ION;putative xylanase;1510;
1NBC;A;BACTERIAL TYPE 3A CELLULOSE-BINDING DOMAIN;1.75;CA;CALCIUM ION;CELLULOSOMAL SCAFFOLDING PROTEIN A;1515;
1NBC;B;BACTERIAL TYPE 3A CELLULOSE-BINDING DOMAIN;1.75;CA;CALCIUM ION;CELLULOSOMAL SCAFFOLDING PROTEIN A;1515;
1NBW;A;Glycerol dehydratase reactivase;2.4;CA;CALCIUM ION;GLYCEROL DEHYDRATASE REACTIVASE ALPHA SUBUNIT;573;
1NBW;C;Glycerol dehydratase reactivase;2.4;CA;CALCIUM ION;GLYCEROL DEHYDRATASE REACTIVASE ALPHA SUBUNIT;573;
1NC6;A;Potent, small molecule inhibitors of human mast cell tryptase. Anti-asthmatic action of a dipeptide-based transition state analogue containing benzothiazole ketone;1.9;CA;CALCIUM ION;Trypsinogen;9913;
1NCA;N;REFINED CRYSTAL STRUCTURE OF THE INFLUENZA VIRUS N9 NEURAMINIDASE-NC41 FAB COMPLEX;2.5;CA;CALCIUM ION;INFLUENZA A SUBTYPE N9 NEURAMINIDASE;11320;
1NCB;N;CRYSTAL STRUCTURES OF TWO MUTANT NEURAMINIDASE-ANTIBODY COMPLEXES WITH AMINO ACID SUBSTITUTIONS IN THE INTERFACE;2.5;CA;CALCIUM ION;INFLUENZA A SUBTYPE N9 NEURAMINIDASE;11320;
1NCC;N;CRYSTAL STRUCTURES OF TWO MUTANT NEURAMINIDASE-ANTIBODY COMPLEXES WITH AMINO ACID SUBSTITUTIONS IN THE INTERFACE;2.5;CA;CALCIUM ION;INFLUENZA A SUBTYPE N9 NEURAMINIDASE;11320;
1NCD;N;REFINED CRYSTAL STRUCTURE OF THE INFLUENZA VIRUS N9 NEURAMINIDASE-NC41 FAB COMPLEX;2.9;CA;CALCIUM ION;INFLUENZA A SUBTYPE N9 NEURAMINIDASE;11320;
1NCJ;A;N-CADHERIN, TWO-DOMAIN FRAGMENT;3.4;CA;CALCIUM ION;PROTEIN (N-CADHERIN);10090;
1NDQ;A;Bacillus lentus subtilisin;1.8;CA;CALCIUM ION;Subtilisin Savinase;1467;
1NDU;A;Bacillus lentus subtilisin variant S101G/V104N;1.6;CA;CALCIUM ION;Subtilisin Savinase;1467;
1NEK;A;Complex II (Succinate Dehydrogenase) From E. Coli with ubiquinone bound;2.6;CA;CALCIUM ION;Succinate dehydrogenase flavoprotein subunit;562;
1NEK;B;Complex II (Succinate Dehydrogenase) From E. Coli with ubiquinone bound;2.6;CA;CALCIUM ION;Succinate dehydrogenase iron-sulfur protein;562;
1NEN;A;Complex II (Succinate Dehydrogenase) From E. Coli with Dinitrophenol-17 inhibitor co-crystallized at the ubiquinone binding site;2.9;CA;CALCIUM ION;Succinate dehydrogenase flavoprotein subunit;562;
1NEN;B;Complex II (Succinate Dehydrogenase) From E. Coli with Dinitrophenol-17 inhibitor co-crystallized at the ubiquinone binding site;2.9;CA;CALCIUM ION;Succinate dehydrogenase iron-sulfur protein;562;
1NES;E;STRUCTURE OF THE PRODUCT COMPLEX OF ACETYL-ALA-PRO-ALA WITH PORCINE PANCREATIC ELASTASE AT 1.65 ANGSTROMS RESOLUTION;1.65;CA;CALCIUM ION;ELASTASE;9823;
1NF5;A;Crystal Structure of Lactose Synthase, Complex with Glucose;2;CA;CALCIUM ION;Alpha-lactalbumin;10090;
1NF5;C;Crystal Structure of Lactose Synthase, Complex with Glucose;2;CA;CALCIUM ION;Alpha-lactalbumin;10090;
1NFU;A;CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR132747;2.05;CA;CALCIUM ION;COAGULATION FACTOR XA, HEAVY CHAIN;9606;
1NFW;A;CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR209685;2.1;CA;CALCIUM ION;COAGULATION FACTOR XA, heavy chain;9606;
1NFX;A;CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208944;2.15;CA;CALCIUM ION;COAGULATION FACTOR XA, heavy chain;9606;
1NFY;A;CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR200095;2.1;CA;CALCIUM ION;Coagulation factor XA, heavy chain;9606;
1NG0;A;The three-dimensional structure of Cocksfoot mottle virus at 2.7A resolution;2.7;CA;CALCIUM ION;coat protein;40979;
1NG0;B;The three-dimensional structure of Cocksfoot mottle virus at 2.7A resolution;2.7;CA;CALCIUM ION;coat protein;40979;
1NG0;C;The three-dimensional structure of Cocksfoot mottle virus at 2.7A resolution;2.7;CA;CALCIUM ION;coat protein;40979;
1NGI;A;STRUCTURAL BASIS OF THE 70-KILODALTON HEAT SHOCK COGNATE PROTEIN ATP HYDROLYTIC ACTIVITY, II. STRUCTURE OF THE ACTIVE SITE WITH ADP OR ATP BOUND TO WILD TYPE AND MUTANT ATPASE FRAGMENT;2.15;CA;CALCIUM ION;HEAT-SHOCK COGNATE 70 kD PROTEIN;9913;
1NGS;A;COMPLEX OF TRANSKETOLASE WITH THIAMIN DIPHOSPHATE, CA2+ AND ACCEPTOR SUBSTRATE ERYTHROSE-4-PHOSPHATE;2.4;CA;CALCIUM ION;TRANSKETOLASE;4932;
1NGS;B;COMPLEX OF TRANSKETOLASE WITH THIAMIN DIPHOSPHATE, CA2+ AND ACCEPTOR SUBSTRATE ERYTHROSE-4-PHOSPHATE;2.4;CA;CALCIUM ION;TRANSKETOLASE;4932;
1NHE;A;Crystal structure of Lactose synthase complex with UDP;2.5;CA;CALCIUM ION;ALPHA-LACTALBUMIN;10090;
1NHE;C;Crystal structure of Lactose synthase complex with UDP;2.5;CA;CALCIUM ION;ALPHA-LACTALBUMIN;10090;
1NIW;A;Crystal structure of endothelial nitric oxide synthase peptide bound to calmodulin;2.05;CA;CALCIUM ION;calmodulin;10116;
1NIW;C;Crystal structure of endothelial nitric oxide synthase peptide bound to calmodulin;2.05;CA;CALCIUM ION;calmodulin;10116;
1NIW;E;Crystal structure of endothelial nitric oxide synthase peptide bound to calmodulin;2.05;CA;CALCIUM ION;calmodulin;10116;
1NIW;G;Crystal structure of endothelial nitric oxide synthase peptide bound to calmodulin;2.05;CA;CALCIUM ION;calmodulin;10116;
1NKG;A;Rhamnogalacturonan lyase from Aspergillus aculeatus;1.5;CA;CALCIUM ION;Rhamnogalacturonase B;5053;
1NKH;A;Crystal structure of Lactose synthase complex with UDP and Manganese;2;CA;CALCIUM ION;ALPHA-LACTALBUMIN;10090;
1NKH;C;Crystal structure of Lactose synthase complex with UDP and Manganese;2;CA;CALCIUM ION;ALPHA-LACTALBUMIN;10090;
1NKQ;A;Crystal structure of yeast ynq8, a fumarylacetoacetate hydrolase family protein;2.2;CA;CALCIUM ION;Hypothetical 28.8 kDa protein in PSD1-SKO1 intergenic region;4932;
1NKQ;B;Crystal structure of yeast ynq8, a fumarylacetoacetate hydrolase family protein;2.2;CA;CALCIUM ION;Hypothetical 28.8 kDa protein in PSD1-SKO1 intergenic region;4932;
1NKQ;C;Crystal structure of yeast ynq8, a fumarylacetoacetate hydrolase family protein;2.2;CA;CALCIUM ION;Hypothetical 28.8 kDa protein in PSD1-SKO1 intergenic region;4932;
1NKQ;D;Crystal structure of yeast ynq8, a fumarylacetoacetate hydrolase family protein;2.2;CA;CALCIUM ION;Hypothetical 28.8 kDa protein in PSD1-SKO1 intergenic region;4932;
1NKQ;E;Crystal structure of yeast ynq8, a fumarylacetoacetate hydrolase family protein;2.2;CA;CALCIUM ION;Hypothetical 28.8 kDa protein in PSD1-SKO1 intergenic region;4932;
1NKQ;F;Crystal structure of yeast ynq8, a fumarylacetoacetate hydrolase family protein;2.2;CA;CALCIUM ION;Hypothetical 28.8 kDa protein in PSD1-SKO1 intergenic region;4932;
1NL0;G;Crystal structure of human factor IX Gla domain in complex of an inhibitory antibody, 10C12;2.2;CA;CALCIUM ION;factor IX;9606;
1NL1;A;BOVINE PROTHROMBIN FRAGMENT 1 IN COMPLEX WITH CALCIUM ION;1.9;CA;CALCIUM ION;Prothrombin;9913;
1NL2;A;BOVINE PROTHROMBIN FRAGMENT 1 IN COMPLEX WITH CALCIUM AND LYSOPHOSPHOTIDYLSERINE;2.3;CA;CALCIUM ION;Prothrombin;9913;
1NLS;A;CONCANAVALIN A AND ITS BOUND SOLVENT AT 0.94A RESOLUTION;0.94;CA;CALCIUM ION;CONCANAVALIN A;3823;
1NLU;A;Pseudomonas sedolisin (serine-carboxyl proteinase) complexed with two molecules of pseudo-iodotyrostatin;1.3;CA;CALCIUM ION;SEDOLISIN;306;
1NLV;A;Crystal Structure Of Dictyostelium Discoideum Actin Complexed With Ca ATP And Human Gelsolin Segment 1;1.8;CA;CALCIUM ION;Actin;44689;
1NLV;G;Crystal Structure Of Dictyostelium Discoideum Actin Complexed With Ca ATP And Human Gelsolin Segment 1;1.8;CA;CALCIUM ION;Gelsolin;9606;
1NM1;G;Crystal Structure of D. Dicsoideum Actin Complexed With Gelsolin Segment 1 and Mg ATP at 1.8 A Resolution;1.8;CA;CALCIUM ION;Gelsolin;9606;
1NM9;A;Crystal structure of recombinant human salivary amylase mutant W58A;2.1;CA;CALCIUM ION;Alpha-amylase, salivary;9606;
1NMB;N;THE STRUCTURE OF A COMPLEX BETWEEN THE NC10 ANTIBODY AND INFLUENZA VIRUS NEURAMINIDASE AND COMPARISON WITH THE OVERLAPPING BINDING SITE OF THE NC41 ANTIBODY;2.2;CA;CALCIUM ION;N9 NEURAMINIDASE;11320;
1NMC;A;COMPLEX BETWEEN NC10 ANTI-INFLUENZA VIRUS NEURAMINIDASE SINGLE CHAIN ANTIBODY WITH A 15 RESIDUE LINKER AND INFLUENZA VIRUS NEURAMINIDASE;2.5;CA;CALCIUM ION;NEURAMINIDASE;11320;
1NMC;N;COMPLEX BETWEEN NC10 ANTI-INFLUENZA VIRUS NEURAMINIDASE SINGLE CHAIN ANTIBODY WITH A 15 RESIDUE LINKER AND INFLUENZA VIRUS NEURAMINIDASE;2.5;CA;CALCIUM ION;NEURAMINIDASE;11320;
1NMD;G;Crystal Structure of D. Discoideum Actin-Gelsolin Segment 1 Complex Crystallized In Presence Of Lithium ATP;1.9;CA;CALCIUM ION;Gelsolin;9606;
1NMM;A;beta-1,4-galactosyltransferase mutant Cys342Thr complex with alpha-lactalbumin and GlcNAc;2;CA;CALCIUM ION;ALPHA-LACTALBUMIN;10090;
1NMM;C;beta-1,4-galactosyltransferase mutant Cys342Thr complex with alpha-lactalbumin and GlcNAc;2;CA;CALCIUM ION;ALPHA-LACTALBUMIN;10090;
1NN2;A;THREE-DIMENSIONAL STRUCTURE OF THE NEURAMINIDASE OF INFLUENZA VIRUS A(SLASH)TOKYO(SLASH)3(SLASH)67 AT 2.2 ANGSTROMS RESOLUTION;2.2;CA;CALCIUM ION;NEURAMINIDASE;11320;
1NNA;A;THREE-DIMENSIONAL STRUCTURE OF INFLUENZA A N9 NEURAMINIDASE AND ITS COMPLEX WITH THE INHIBITOR 2-DEOXY 2,3-DEHYDRO-N-ACETYL NEURAMINIC ACID;2.5;CA;CALCIUM ION;NEURAMINIDASE;11320;
1NNB;A;THREE-DIMENSIONAL STRUCTURE OF INFLUENZA A N9 NEURAMINIDASE AND ITS COMPLEX WITH THE INHIBITOR 2-DEOXY 2,3-DEHYDRO-N-ACETYL NEURAMINIC ACID;2.8;CA;CALCIUM ION;NEURAMINIDASE;11320;
1NNC;A;INFLUENZA VIRUS NEURAMINIDASE SUBTYPE N9 (TERN) COMPLEXED WITH 4-GUANIDINO-NEU5AC2EN INHIBITOR;1.8;CA;CALCIUM ION;NEURAMINIDASE N9;11320;
1NNL;A;Crystal structure of Human Phosphoserine Phosphatase;1.53;CA;CALCIUM ION;L-3-phosphoserine phosphatase;9606;
1NNL;B;Crystal structure of Human Phosphoserine Phosphatase;1.53;CA;CALCIUM ION;L-3-phosphoserine phosphatase;9606;
1NOL;A;OXYGENATED HEMOCYANIN (SUBUNIT TYPE II);2.4;CA;CALCIUM ION;HEMOCYANIN (SUBUNIT TYPE II);6850;
1NPC;A;THE STRUCTURE OF NEUTRAL PROTEASE FROM BACILLUS CEREUS AT 0.2-NM RESOLUTION;2;CA;CALCIUM ION;NEUTRAL PROTEASE;1396;
1NPH;A;Gelsolin Domains 4-6 in Active, Actin Free Conformation Identifies Sites of Regulatory Calcium Ions;3;CA;CALCIUM ION;Gelsolin;10090;
1NPQ;A;structure of a rhodamine-labeled N-domain Troponin C mutant (Ca2+ saturated) in complex with skeletal Troponin I 115-131;;CA;CALCIUM ION;Troponin C;9031;
1NPS;A;CRYSTAL STRUCTURE OF N-TERMINAL DOMAIN OF PROTEIN S;1.8;CA;CALCIUM ION;DEVELOPMENT-SPECIFIC PROTEIN S;34;
1NQD;A;CRYSTAL STRUCTURE OF CLOSTRIDIUM HISTOLYTICUM COLG COLLAGENASE COLLAGEN-BINDING DOMAIN 3B AT 1.65 ANGSTROM RESOLUTION IN PRESENCE OF CALCIUM;1.65;CA;CALCIUM ION;class 1 collagenase;1498;
1NQD;B;CRYSTAL STRUCTURE OF CLOSTRIDIUM HISTOLYTICUM COLG COLLAGENASE COLLAGEN-BINDING DOMAIN 3B AT 1.65 ANGSTROM RESOLUTION IN PRESENCE OF CALCIUM;1.65;CA;CALCIUM ION;class 1 collagenase;1498;
1NQG;A;OUTER MEMBRANE COBALAMIN TRANSPORTER (BTUB) FROM E. COLI, WITH BOUND CALCIUM;3.31;CA;CALCIUM ION;vitamin b12 receptor;562;
1NQH;A;OUTER MEMBRANE COBALAMIN TRANSPORTER (BTUB) FROM E. COLI, WITH BOUND CALCIUM AND CYANOCOBALAMIN (VITAMIN B12) SUBSTRATE;3.1;CA;CALCIUM ION;VITAMIN B12 RECEPTOR;562;
1NQI;A;crystal structure of lactose synthase, a 1:1 complex between beta1,4-galactosyltransferase and alpha-lactalbumin in the presence of GlcNAc;2;CA;CALCIUM ION;ALPHA-LACTALBUMIN;10090;
1NQI;C;crystal structure of lactose synthase, a 1:1 complex between beta1,4-galactosyltransferase and alpha-lactalbumin in the presence of GlcNAc;2;CA;CALCIUM ION;ALPHA-LACTALBUMIN;10090;
1NQS;B;Structural Characterisation of the Holliday Junction formed by the sequence d(TCGGTACCGA) at 1.97 A;1.97;CA;CALCIUM ION;5'-d(TpCpGpGpTpApCpCpGpA)-3';;
1NRW;A;The structure of a HALOACID DEHALOGENASE-LIKE HYDROLASE FROM B. SUBTILIS;1.7;CA;CALCIUM ION;hypothetical protein, haloacid dehalogenase-like hydrolase;1423;
1NSB;A;THE 2.2 ANGSTROMS RESOLUTION CRYSTAL STRUCTURE OF INFLUENZA B NEURAMINIDASE AND ITS COMPLEX WITH SIALIC ACID;2.2;CA;CALCIUM ION;NEURAMINIDASE;11520;
1NSB;B;THE 2.2 ANGSTROMS RESOLUTION CRYSTAL STRUCTURE OF INFLUENZA B NEURAMINIDASE AND ITS COMPLEX WITH SIALIC ACID;2.2;CA;CALCIUM ION;NEURAMINIDASE;11520;
1NSC;A;INFLUENZA B VIRUS NEURAMINIDASE CAN SYNTHESIZE ITS OWN INHIBITOR;1.7;CA;CALCIUM ION;NEURAMINIDASE;11520;
1NSC;B;INFLUENZA B VIRUS NEURAMINIDASE CAN SYNTHESIZE ITS OWN INHIBITOR;1.7;CA;CALCIUM ION;NEURAMINIDASE;11520;
1NSD;A;INFLUENZA B VIRUS NEURAMINIDASE CAN SYNTHESIZE ITS OWN INHIBITOR;1.8;CA;CALCIUM ION;NEURAMINIDASE;11520;
1NSD;B;INFLUENZA B VIRUS NEURAMINIDASE CAN SYNTHESIZE ITS OWN INHIBITOR;1.8;CA;CALCIUM ION;NEURAMINIDASE;11520;
1NT0;A;Crystal structure of the CUB1-EGF-CUB2 region of MASP2;2.7;CA;CALCIUM ION;mannose-binding protein associated serine protease-2;10116;
1NT0;G;Crystal structure of the CUB1-EGF-CUB2 region of MASP2;2.7;CA;CALCIUM ION;mannose-binding protein associated serine protease-2;10116;
1NT8;A;Structural Characterisation of the Holliday junction formed by the sequence CCGGTACCGG at 2.00 A;2;CA;CALCIUM ION;5'-d(CpCpGpGpTpApCpCpGpG)-3';;
1NT8;B;Structural Characterisation of the Holliday junction formed by the sequence CCGGTACCGG at 2.00 A;2;CA;CALCIUM ION;5'-d(CpCpGpGpTpApCpCpGpG)-3';;
1NUB;A;HELIX C DELETION MUTANT OF BM-40 FS-EC DOMAIN PAIR;2.8;CA;CALCIUM ION;BASEMENT MEMBRANE PROTEIN BM-40;9606;
1NUB;B;HELIX C DELETION MUTANT OF BM-40 FS-EC DOMAIN PAIR;2.8;CA;CALCIUM ION;BASEMENT MEMBRANE PROTEIN BM-40;9606;
1NUC;A;STAPHYLOCOCCAL NUCLEASE, V23C VARIANT;1.9;CA;CALCIUM ION;STAPHYLOCOCCAL NUCLEASE;1280;
1NUD;A;Role of Calcium Ions in the Activation and Activity of the Transglutaminase 3 Enzyme (3 calciums, active form);2.7;CA;CALCIUM ION;Protein-glutamine glutamyltransferase E;9606;
1NUD;B;Role of Calcium Ions in the Activation and Activity of the Transglutaminase 3 Enzyme (3 calciums, active form);2.7;CA;CALCIUM ION;Protein-glutamine glutamyltransferase E;9606;
1NUF;A;Role of Calcium Ions in the Activation and Activity of the Transglutaminase 3 Enzyme;2.7;CA;CALCIUM ION;Protein-glutamine glutamyltransferase E;9606;
1NUG;A;Role of Calcium Ions in the Activation and Activity of the Transglutaminase 3 Enzyme (2 calciums, 1 Mg, inactive form);2.4;CA;CALCIUM ION;Protein-glutamine glutamyltransferase E;9606;
1NUG;B;Role of Calcium Ions in the Activation and Activity of the Transglutaminase 3 Enzyme (2 calciums, 1 Mg, inactive form);2.4;CA;CALCIUM ION;Protein-glutamine glutamyltransferase E;9606;
1NVN;A;Structural Characterisation of the Holliday junction formed by the sequence CCGGTACCGG at 1.8 A;1.8;CA;CALCIUM ION;5'-D(CpCpGpGpTpApCpCpGpG)-3';;
1NVN;B;Structural Characterisation of the Holliday junction formed by the sequence CCGGTACCGG at 1.8 A;1.8;CA;CALCIUM ION;5'-D(CpCpGpGpTpApCpCpGpG)-3';;
1NW1;A;Crystal Structure of Choline Kinase;2.02;CA;CALCIUM ION;Choline kinase (49.2 kD);6239;
1NW1;B;Crystal Structure of Choline Kinase;2.02;CA;CALCIUM ION;Choline kinase (49.2 kD);6239;
1NWD;A;Solution Structure of Ca2+/Calmodulin bound to the C-terminal Domain of Petunia Glutamate Decarboxylase;;CA;CALCIUM ION;Calmodulin;8355;
1NWG;A;BETA-1,4-GALACTOSYLTRANSFERASE COMPLEX WITH ALPHA-LACTALBUMIN AND N-BUTANOYL-GLUCOAMINE;2.32;CA;CALCIUM ION;Alpha-lactalbumin;10090;
1NWG;C;BETA-1,4-GALACTOSYLTRANSFERASE COMPLEX WITH ALPHA-LACTALBUMIN AND N-BUTANOYL-GLUCOAMINE;2.32;CA;CALCIUM ION;Alpha-lactalbumin;10090;
1NWK;A;CRYSTAL STRUCTURE OF MONOMERIC ACTIN IN THE ATP STATE;1.85;CA;CALCIUM ION;Actin, alpha skeletal muscle;9986;
1NX0;A;Structure of Calpain Domain 6 in Complex with Calpastatin DIC;2.3;CA;CALCIUM ION;Calcium-dependent protease, small subunit;9823;
1NX0;B;Structure of Calpain Domain 6 in Complex with Calpastatin DIC;2.3;CA;CALCIUM ION;Calcium-dependent protease, small subunit;9823;
1NX1;A;Calpain Domain VI Complexed with Calpastatin Inhibitory Domain C (DIC);2;CA;CALCIUM ION;Calcium-dependent protease, small subunit;9823;
1NX1;B;Calpain Domain VI Complexed with Calpastatin Inhibitory Domain C (DIC);2;CA;CALCIUM ION;Calcium-dependent protease, small subunit;9823;
1NX2;A;Calpain Domain VI;2.2;CA;CALCIUM ION;Calcium-dependent protease, small subunit;9823;
1NX3;A;Calpain Domain VI in Complex with the Inhibitor PD150606;2.45;CA;CALCIUM ION;Calcium-dependent protease, small subunit;9823;
1NXC;A;Structure of mouse Golgi alpha-1,2-mannosidase IA reveals the molecular basis for substrate specificity among Class I enzymes (family 47 glycosidases);1.51;CA;CALCIUM ION;Mannosyl-oligosaccharide 1,2-alpha-mannosidase IA;10090;
1NYA;A;NMR SOLUTION STRUCTURE OF CALERYTHRIN, AN EF-HAND CALCIUM-BINDING PROTEIN;;CA;CALCIUM ION;Calerythrin;1836;
1NZI;A;Crystal Structure of the CUB1-EGF Interaction Domain of Complement Protease C1s;1.5;CA;CALCIUM ION;Complement C1s component;9606;
1NZI;B;Crystal Structure of the CUB1-EGF Interaction Domain of Complement Protease C1s;1.5;CA;CALCIUM ION;Complement C1s component;9606;
1NZY;A;4-CHLOROBENZOYL COENZYME A DEHALOGENASE FROM PSEUDOMONAS SP. STRAIN CBS-3;1.8;CA;CALCIUM ION;4-CHLOROBENZOYL COENZYME A DEHALOGENASE;72586;
1NZY;B;4-CHLOROBENZOYL COENZYME A DEHALOGENASE FROM PSEUDOMONAS SP. STRAIN CBS-3;1.8;CA;CALCIUM ION;4-CHLOROBENZOYL COENZYME A DEHALOGENASE;72586;
1NZY;C;4-CHLOROBENZOYL COENZYME A DEHALOGENASE FROM PSEUDOMONAS SP. STRAIN CBS-3;1.8;CA;CALCIUM ION;4-CHLOROBENZOYL COENZYME A DEHALOGENASE;72586;
1O0Q;A;Crystal structure of a cold adapted alkaline protease from Pseudomonas TAC II 18, co-crystallized with 1 mM EDTA;2.2;CA;CALCIUM ION;serralysin;76981;
1O0T;A;CRYSTAL STRUCTURE OF A COLD ADAPTED ALKALINE PROTEASE FROM PSEUDOMONAS TAC II 18, CO-CRYSTALLIZED WITH 5 mM EDTA (5 DAYS);2.5;CA;CALCIUM ION;serralysin;76981;
1O1H;A;STRUCTURE OF GLUCOSE ISOMERASE DERIVATIZED WITH KR.;1.4;CA;CALCIUM ION;Xylose isomerase;1929;
1O1H;B;STRUCTURE OF GLUCOSE ISOMERASE DERIVATIZED WITH KR.;1.4;CA;CALCIUM ION;Xylose isomerase;1929;
1O23;A;CRYSTAL STRUCTURE OF LACTOSE SYNTHASE IN THE PRESENCE OF UDP-GLUCOSE;2.32;CA;CALCIUM ION;ALPHA-LACTALBUMIN;10090;
1O23;C;CRYSTAL STRUCTURE OF LACTOSE SYNTHASE IN THE PRESENCE OF UDP-GLUCOSE;2.32;CA;CALCIUM ION;ALPHA-LACTALBUMIN;10090;
1O2E;A;Structure of the triple mutant (K53,56,120M) + Anisic acid complex of phospholipase A2;2.6;CA;CALCIUM ION;Phospholipase A2;9913;
1O2H;A;Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors;1.77;CA;CALCIUM ION;BETA-TRYPSIN;9913;
1O2I;A;Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors;1.5;CA;CALCIUM ION;BETA-TRYPSIN;9913;
1O2J;A;Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors;1.65;CA;CALCIUM ION;BETA-TRYPSIN;9913;
1O2K;A;Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors;1.63;CA;CALCIUM ION;BETA-TRYPSIN;9913;
1O2L;A;Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors;1.68;CA;CALCIUM ION;BETA-TRYPSIN;9913;
1O2M;A;Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors;1.69;CA;CALCIUM ION;BETA-TRYPSIN;9913;
1O2N;A;Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors;1.5;CA;CALCIUM ION;BETA-TRYPSIN;9913;
1O2O;A;Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors;1.63;CA;CALCIUM ION;BETA-TRYPSIN;9913;
1O2P;A;Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors;1.47;CA;CALCIUM ION;BETA-TRYPSIN;9913;
1O2Q;A;Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors;1.5;CA;CALCIUM ION;BETA-TRYPSIN;9913;
1O2R;A;Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors;1.45;CA;CALCIUM ION;BETA-TRYPSIN;9913;
1O2S;A;Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors;1.65;CA;CALCIUM ION;BETA-TRYPSIN;9913;
1O2T;A;Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors;1.62;CA;CALCIUM ION;BETA-TRYPSIN;9913;
1O2U;A;Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors;1.41;CA;CALCIUM ION;BETA-TRYPSIN;9913;
1O2V;A;Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors;1.5;CA;CALCIUM ION;BETA-TRYPSIN;9913;
1O2W;A;Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors;1.38;CA;CALCIUM ION;BETA-TRYPSIN;9913;
1O2X;A;Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors;1.46;CA;CALCIUM ION;BETA-TRYPSIN;9913;
1O2Y;A;Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors;1.45;CA;CALCIUM ION;BETA-TRYPSIN;9913;
1O2Z;A;Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors;1.65;CA;CALCIUM ION;BETA-TRYPSIN;9913;
1O30;A;Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors;1.55;CA;CALCIUM ION;BETA-TRYPSIN;9913;
1O31;A;Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors;1.66;CA;CALCIUM ION;BETA-TRYPSIN;9913;
1O32;A;Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors;1.78;CA;CALCIUM ION;BETA-TRYPSIN;9913;
1O33;A;Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors;1.46;CA;CALCIUM ION;BETA-TRYPSIN;9913;
1O34;A;Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors;1.5;CA;CALCIUM ION;BETA-TRYPSIN;9913;
1O35;A;Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors;1.41;CA;CALCIUM ION;BETA-TRYPSIN;9913;
1O36;A;Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors;1.7;CA;CALCIUM ION;BETA-TRYPSIN;9913;
1O37;A;Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors;1.45;CA;CALCIUM ION;BETA-TRYPSIN;9913;
1O38;A;Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors;1.38;CA;CALCIUM ION;BETA-TRYPSIN;9913;
1O39;A;Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors;1.59;CA;CALCIUM ION;BETA-TRYPSIN;9913;
1O3A;A;Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors;2;CA;CALCIUM ION;BETA-TRYPSIN;9913;
1O3B;A;Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors;1.75;CA;CALCIUM ION;BETA-TRYPSIN;9913;
1O3C;A;Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors;1.64;CA;CALCIUM ION;BETA-TRYPSIN;9913;
1O3D;A;Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors;1.33;CA;CALCIUM ION;BETA-TRYPSIN;9913;
1O3E;A;Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors;1.64;CA;CALCIUM ION;BETA-TRYPSIN;9913;
1O3F;A;Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors;1.55;CA;CALCIUM ION;BETA-TRYPSIN;9913;
1O3G;A;Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors;1.55;CA;CALCIUM ION;BETA-TRYPSIN;9913;
1O3H;A;Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors;1.53;CA;CALCIUM ION;BETA-TRYPSIN;9913;
1O3I;A;Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors;1.51;CA;CALCIUM ION;BETA-TRYPSIN;9913;
1O3J;A;Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors;1.4;CA;CALCIUM ION;BETA-TRYPSIN;9913;
1O3K;A;Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors;1.43;CA;CALCIUM ION;BETA-TRYPSIN;9913;
1O3L;A;Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors;1.4;CA;CALCIUM ION;BETA-TRYPSIN;9913;
1O3M;A;Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors;1.55;CA;CALCIUM ION;BETA-TRYPSIN;9913;
1O3N;A;Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors;1.55;CA;CALCIUM ION;BETA-TRYPSIN;9913;
1O3O;A;Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors;1.55;CA;CALCIUM ION;BETA-TRYPSIN;9913;
1O3W;A;Structure of the inhibitor free triple mutant (K53,56,120M) of phospholipase A2;1.85;CA;CALCIUM ION;Phospholipase A2;9913;
1O4Y;A;THE THREE-DIMENSIONAL STRUCTURE OF BETA-AGARASE A FROM ZOBELLIA GALACTANIVORANS;1.48;CA;CALCIUM ION;beta-agarase A;63186;
1O5G;H;Dissecting and Designing Inhibitor Selectivity Determinants at the S1 site Using an Artificial Ala190 Protease (Ala190 uPA);1.75;CA;CALCIUM ION;Prothrombin;9606;
1O5K;A;Crystal structure of Dihydrodipicolinate synthase (TM1521) from Thermotoga maritima at 1.80 A resolution;1.8;CA;CALCIUM ION;4-hydroxy-tetrahydrodipicolinate synthase;2336;
1O6S;A;Internalin (Listeria monocytogenes) / E-Cadherin (human) Recognition Complex;1.8;CA;CALCIUM ION;INTERNALIN A;1639;
1O6S;B;Internalin (Listeria monocytogenes) / E-Cadherin (human) Recognition Complex;1.8;CA;CALCIUM ION;E-CADHERIN;9606;
1O6T;A;Internalin (INLA, Listeria monocytogenes) - functional domain, uncomplexed;1.6;CA;CALCIUM ION;INTERNALIN A;1639;
1O6V;A;Internalin (INLA, Listeria monocytogenes) - functional domain, uncomplexed;1.5;CA;CALCIUM ION;INTERNALIN A;1639;
1O6V;B;Internalin (INLA, Listeria monocytogenes) - functional domain, uncomplexed;1.5;CA;CALCIUM ION;INTERNALIN A;1639;
1O7L;D;Molybdate-activated form of ModE from Escherichia coli;2.75;CA;CALCIUM ION;TRANSCRIPTIONAL REGULATOR MODE;562;
1O88;A;Pectate Lyase C From Erwinia Chrysanthemi at pH 11.2 with 30mM Ca2+;2.2;CA;CALCIUM ION;PECTATE LYASE C;556;
1O8D;A;Pectate Lyase C from Erwinia Chrysanthemi at pH 11.2 with 5mM CA2+;2.2;CA;CALCIUM ION;PECTATE LYASE C;556;
1O8E;A;Pectate Lyase C from Erwinia Chrysanthemi at pH 11.2 with 1mM Ca2+;2.2;CA;CALCIUM ION;PECTATE LYASE C;556;
1O8F;A;Pectate Lyase C from Erwinia Chrysanthemi at pH 9.5 with 30mM Ca2+;2.2;CA;CALCIUM ION;PECTATE LYASE C;556;
1O8G;A;Pectate Lyase C from Erwinia Chrysanthemi at pH 9.5 with 5mM Ca2+;2.2;CA;CALCIUM ION;PECTATE LYASE C;556;
1O8H;A;Pectate Lyase C from Erwinia Chrysanthemi at pH 9.5 with 0.3mM Ca2+ Added;2.2;CA;CALCIUM ION;PECTATE LYASE C;556;
1O8J;A;Pectate Lyase C from Erwinia Chrysanthemi at pH 4.5 with 30mM CA2+;2.2;CA;CALCIUM ION;PECTATE LYASE C;556;
1O8K;A;Pectate Lyase C from Erwinia Chrysanthemi at pH 4.5 with 20mM CA2+;2.2;CA;CALCIUM ION;PECTATE LYASE C;556;
1O8L;A;Pectate Lyase C from Erwinia Chrysanthemi at pH 4.5 with 5mM CA2+;2.2;CA;CALCIUM ION;PECTATE LYASE C;556;
1O8P;A;Unbound structure of CsCBM6-3 from Clostridium stercorarium;2;CA;CALCIUM ION;PUTATUVE ENDO-XYLANASE;1510;
1O8S;A;Structure of CsCBM6-3 from Clostridium stercorarium in complex with cellobiose;1.15;CA;CALCIUM ION;PUTATIVE ENDO-XYLANASE;1510;
1O9I;A;Crystal structure of the Y42F mutant of manganese catalase from Lactobacillus plantarum at 1.33A resolution;1.33;CA;CALCIUM ION;Manganese catalase;1590;
1O9I;B;Crystal structure of the Y42F mutant of manganese catalase from Lactobacillus plantarum at 1.33A resolution;1.33;CA;CALCIUM ION;Manganese catalase;1590;
1O9I;C;Crystal structure of the Y42F mutant of manganese catalase from Lactobacillus plantarum at 1.33A resolution;1.33;CA;CALCIUM ION;Manganese catalase;1590;
1O9I;D;Crystal structure of the Y42F mutant of manganese catalase from Lactobacillus plantarum at 1.33A resolution;1.33;CA;CALCIUM ION;Manganese catalase;1590;
1O9I;E;Crystal structure of the Y42F mutant of manganese catalase from Lactobacillus plantarum at 1.33A resolution;1.33;CA;CALCIUM ION;Manganese catalase;1590;
1O9I;F;Crystal structure of the Y42F mutant of manganese catalase from Lactobacillus plantarum at 1.33A resolution;1.33;CA;CALCIUM ION;Manganese catalase;1590;
1OAC;A;CRYSTAL STRUCTURE OF A QUINOENZYME: COPPER AMINE OXIDASE OF ESCHERICHIA COLI AT 2 ANGSTROEMS RESOLUTION;2;CA;CALCIUM ION;COPPER AMINE OXIDASE;562;
1OAC;B;CRYSTAL STRUCTURE OF A QUINOENZYME: COPPER AMINE OXIDASE OF ESCHERICHIA COLI AT 2 ANGSTROEMS RESOLUTION;2;CA;CALCIUM ION;COPPER AMINE OXIDASE;562;
1OAH;A;Cytochrome c Nitrite Reductase from Desulfovibrio desulfuricans ATCC 27774: The relevance of the two calcium sites in the structure of the catalytic subunit (NrfA).;2.3;CA;CALCIUM ION;CYTOCHROME C NITRITE REDUCTASE;876;
1OAH;B;Cytochrome c Nitrite Reductase from Desulfovibrio desulfuricans ATCC 27774: The relevance of the two calcium sites in the structure of the catalytic subunit (NrfA).;2.3;CA;CALCIUM ION;CYTOCHROME C NITRITE REDUCTASE;876;
1OB0;A;Kinetic stabilization of Bacillus licheniformis alpha-amylase through introduction of hydrophobic residues at the surface;1.83;CA;CALCIUM ION;ALPHA-AMYLASE;1402;
1OBR;A;CARBOXYPEPTIDASE T;2.3;CA;CALCIUM ION;CARBOXYPEPTIDASE T;2026;
1OC6;A;structure native of the D405N mutant of the CELLOBIOHYDROLASE CEL6A FROM HUMICOLA INSOLENS at 1.5 angstrom resolution;1.5;CA;CALCIUM ION;CELLOBIOHYDROLASE II;34413;
1OCN;A;Mutant D416A of the CELLOBIOHYDROLASE CEL6A FROM HUMICOLA INSOLENS in complex with a cellobio-derived isofagomine at 1.3 angstrom resolution;1.31;CA;CALCIUM ION;CELLOBIOHYDROLASE II;34413;
1OD3;A;Structure of CSCBM6-3 From Clostridium stercorarium in complex with laminaribiose;1;CA;CALCIUM ION;PUTATIVE XYLANASE;1510;
1ODB;A;THE CRYSTAL STRUCTURE OF HUMAN S100A12 - COPPER COMPLEX;2.19;CA;CALCIUM ION;CALGRANULIN C;9606;
1ODB;B;THE CRYSTAL STRUCTURE OF HUMAN S100A12 - COPPER COMPLEX;2.19;CA;CALCIUM ION;CALGRANULIN C;9606;
1ODB;C;THE CRYSTAL STRUCTURE OF HUMAN S100A12 - COPPER COMPLEX;2.19;CA;CALCIUM ION;CALGRANULIN C;9606;
1ODB;D;THE CRYSTAL STRUCTURE OF HUMAN S100A12 - COPPER COMPLEX;2.19;CA;CALCIUM ION;CALGRANULIN C;9606;
1ODB;E;THE CRYSTAL STRUCTURE OF HUMAN S100A12 - COPPER COMPLEX;2.19;CA;CALCIUM ION;CALGRANULIN C;9606;
1ODB;F;THE CRYSTAL STRUCTURE OF HUMAN S100A12 - COPPER COMPLEX;2.19;CA;CALCIUM ION;CALGRANULIN C;9606;
1OF3;A;Structural and thermodynamic dissection of specific mannan recognition by a carbohydrate-binding module, TmCBM27;2;CA;CALCIUM ION;BETA-MANNOSIDASE;2336;
1OF3;B;Structural and thermodynamic dissection of specific mannan recognition by a carbohydrate-binding module, TmCBM27;2;CA;CALCIUM ION;BETA-MANNOSIDASE;2336;
1OF4;A;Structural and thermodynamic dissection of specific mannan recognition by a carbohydrate-binding module, TmCBM27;1.6;CA;CALCIUM ION;BETA-MANNOSIDASE;2336;
1OFL;A;CRYSTAL STRUCTURE OF CHONDROITINASE B COMPLEXED TO DERMATAN SULFATE HEXASACCHARIDE;1.7;CA;CALCIUM ION;CHONDROITINASE B;984;
1OFS;A;Pea lectin-sucrose complex;1.8;CA;CALCIUM ION;PEA LECTIN ALPHA CHAIN;3888;
1OFS;C;Pea lectin-sucrose complex;1.8;CA;CALCIUM ION;PEA LECTIN ALPHA CHAIN;3888;
1OH2;P;Sucrose-Specific Porin, with Bound Sucrose Molecules;2.4;CA;CALCIUM ION;Sucrose porin;28901;
1OH2;Q;Sucrose-Specific Porin, with Bound Sucrose Molecules;2.4;CA;CALCIUM ION;Sucrose porin;28901;
1OH2;R;Sucrose-Specific Porin, with Bound Sucrose Molecules;2.4;CA;CALCIUM ION;Sucrose porin;28901;
1OH4;A;Structural and thermodynamic dissection of specific mannan recognition by a carbohydrate-binding module;1.35;CA;CALCIUM ION;BETA-MANNOSIDASE;2336;
1OHZ;B;Cohesin-Dockerin complex from the cellulosome of Clostridium thermocellum;2.2;CA;CALCIUM ION;ENDO-1,4-BETA-XYLANASE Y;1515;
1OIL;A;STRUCTURE OF LIPASE;2.1;CA;CALCIUM ION;LIPASE;292;
1OIL;B;STRUCTURE OF LIPASE;2.1;CA;CALCIUM ION;LIPASE;292;
1OKG;A;3-mercaptopyruvate sulfurtransferase from Leishmania major;2.1;CA;CALCIUM ION;POSSIBLE 3-MERCAPTOPYRUVATE SULFURTRANSFERASE;5664;
1OKO;A;Crystal structure of Pseudomonas Aeruginosa Lectin 1 complexed with galactose at 1.6 A resolution;1.6;CA;CALCIUM ION;PA-I GALACTOPHILIC LECTIN;287;
1OKO;B;Crystal structure of Pseudomonas Aeruginosa Lectin 1 complexed with galactose at 1.6 A resolution;1.6;CA;CALCIUM ION;PA-I GALACTOPHILIC LECTIN;287;
1OKO;C;Crystal structure of Pseudomonas Aeruginosa Lectin 1 complexed with galactose at 1.6 A resolution;1.6;CA;CALCIUM ION;PA-I GALACTOPHILIC LECTIN;287;
1OKO;D;Crystal structure of Pseudomonas Aeruginosa Lectin 1 complexed with galactose at 1.6 A resolution;1.6;CA;CALCIUM ION;PA-I GALACTOPHILIC LECTIN;287;
1OKQ;A;LAMININ ALPHA 2 CHAIN LG4-5 DOMAIN PAIR, CA1 SITE MUTANT;2.8;CA;CALCIUM ION;LAMININ ALPHA 2 CHAIN;10090;
1OLP;A;Alpha Toxin from Clostridium Absonum;2.5;CA;CALCIUM ION;ALPHA-TOXIN;29369;
1OLP;B;Alpha Toxin from Clostridium Absonum;2.5;CA;CALCIUM ION;ALPHA-TOXIN;29369;
1OLP;C;Alpha Toxin from Clostridium Absonum;2.5;CA;CALCIUM ION;ALPHA-TOXIN;29369;
1OLP;D;Alpha Toxin from Clostridium Absonum;2.5;CA;CALCIUM ION;ALPHA-TOXIN;29369;
1OM6;A;CRYSTAL STRUCTURE OF A COLD ADAPTED ALKALINE PROTEASE FROM PSEUDOMONAS TAC II 18, CO-CRYSTALLIZED WITH 5mM EDTA (2 MONTHS);2;CA;CALCIUM ION;serralysin;76981;
1OM7;A;CRYSTAL STRUCTURE OF A COLD ADAPTED ALKALINE PROTEASE FROM PSEUDOMONAS TAC II 18, SOAKED IN 85 mM EDTA;2.8;CA;CALCIUM ION;SERRALYSIN;76981;
1OM8;A;CRYSTAL STRUCTURE OF A COLD ADAPTED ALKALINE PROTEASE FROM PSEUDOMONAS TAC II 18, CO-CRYSTALLYZED WITH 10 mM EDTA;2;CA;CALCIUM ION;SERRALYSIN;76981;
1OMD;A;STRUCTURE OF ONCOMODULIN REFINED AT 1.85 ANGSTROMS RESOLUTION. AN EXAMPLE OF EXTENSIVE MOLECULAR AGGREGATION VIA CA2+;1.85;CA;CALCIUM ION;ONCOMODULIN;10116;
1OMJ;A;CRYSTAL STRUCTURE OF A PSYCHROPHILIC ALKALINE PROTEASE FROM PSEUDOMONAS TAC II 18;2.38;CA;CALCIUM ION;SERRALYSIN;76981;
1OMR;A;non-myristoylated wild-type bovine recoverin with calcium bound to EF-hand 3;1.5;CA;CALCIUM ION;recoverin;9913;
1OMV;A;non-myristoylated bovine recoverin (E85Q mutant) with calcium bound to EF-hand 3;1.9;CA;CALCIUM ION;recoverin;9913;
1ONA;A;CO-CRYSTALS OF CONCANAVALIN A WITH METHYL-3,6-DI-O-(ALPHA-D-MANNOPYRANOSYL)-ALPHA-D-MANNOPYRANOSIDE;2.35;CA;CALCIUM ION;CONCANAVALIN A;3823;
1ONA;B;CO-CRYSTALS OF CONCANAVALIN A WITH METHYL-3,6-DI-O-(ALPHA-D-MANNOPYRANOSYL)-ALPHA-D-MANNOPYRANOSIDE;2.35;CA;CALCIUM ION;CONCANAVALIN A;3823;
1ONA;C;CO-CRYSTALS OF CONCANAVALIN A WITH METHYL-3,6-DI-O-(ALPHA-D-MANNOPYRANOSYL)-ALPHA-D-MANNOPYRANOSIDE;2.35;CA;CALCIUM ION;CONCANAVALIN A;3823;
1ONA;D;CO-CRYSTALS OF CONCANAVALIN A WITH METHYL-3,6-DI-O-(ALPHA-D-MANNOPYRANOSYL)-ALPHA-D-MANNOPYRANOSIDE;2.35;CA;CALCIUM ION;CONCANAVALIN A;3823;
1OOJ;A;Structural genomics of Caenorhabditis elegans : Calmodulin;2.11;CA;CALCIUM ION;Calmodulin CMD-1;6239;
1OPO;B;THE STRUCTURE OF CARNATION MOTTLE VIRUS;3.2;CA;CALCIUM ION;Coat protein;11986;
1OQM;A;A 1:1 complex between alpha-lactalbumin and beta1,4-galactosyltransferase in the presence of UDP-N-acetyl-galactosamine;2.1;CA;CALCIUM ION;Alpha-lactalbumin;10090;
1OQM;C;A 1:1 complex between alpha-lactalbumin and beta1,4-galactosyltransferase in the presence of UDP-N-acetyl-galactosamine;2.1;CA;CALCIUM ION;Alpha-lactalbumin;10090;
1OS0;A;Thermolysin with an alpha-amino phosphinic inhibitor;2.1;CA;CALCIUM ION;Thermolysin;1427;
1OS1;A;Structure of Phosphoenolpyruvate Carboxykinase complexed with ATP,Mg, Ca and pyruvate.;1.8;CA;CALCIUM ION;Phosphoenolpyruvate carboxykinase [ATP];562;
1OS2;A;Ternary enzyme-product-inhibitor complexes of human MMP12;2.15;CA;CALCIUM ION;Macrophage metalloelastase;9606;
1OS2;B;Ternary enzyme-product-inhibitor complexes of human MMP12;2.15;CA;CALCIUM ION;Macrophage metalloelastase;9606;
1OS2;C;Ternary enzyme-product-inhibitor complexes of human MMP12;2.15;CA;CALCIUM ION;Macrophage metalloelastase;9606;
1OS2;D;Ternary enzyme-product-inhibitor complexes of human MMP12;2.15;CA;CALCIUM ION;Macrophage metalloelastase;9606;
1OS2;E;Ternary enzyme-product-inhibitor complexes of human MMP12;2.15;CA;CALCIUM ION;Macrophage metalloelastase;9606;
1OS2;F;Ternary enzyme-product-inhibitor complexes of human MMP12;2.15;CA;CALCIUM ION;Macrophage metalloelastase;9606;
1OS8;A;RECOMBINANT STREPTOMYCES GRISEUS TRYPSIN;1.55;CA;CALCIUM ION;trypsin;1911;
1OS9;A;Binary enzyme-product complexes of human MMP12;1.85;CA;CALCIUM ION;Macrophage metalloelastase;9606;
1OS9;B;Binary enzyme-product complexes of human MMP12;1.85;CA;CALCIUM ION;Macrophage metalloelastase;9606;
1OS9;C;Binary enzyme-product complexes of human MMP12;1.85;CA;CALCIUM ION;Macrophage metalloelastase;9606;
1OS9;D;Binary enzyme-product complexes of human MMP12;1.85;CA;CALCIUM ION;Macrophage metalloelastase;9606;
1OS9;E;Binary enzyme-product complexes of human MMP12;1.85;CA;CALCIUM ION;Macrophage metalloelastase;9606;
1OS9;F;Binary enzyme-product complexes of human MMP12;1.85;CA;CALCIUM ION;Macrophage metalloelastase;9606;
1OSA;A;CRYSTAL STRUCTURE OF RECOMBINANT PARAMECIUM TETRAURELIA CALMODULIN AT 1.68 ANGSTROMS RESOLUTION;1.68;CA;CALCIUM ION;CALMODULIN;5888;
1OSE;A;Porcine pancreatic alpha-amylase complexed with acarbose;2.3;CA;CALCIUM ION;PORCINE ALPHA-AMYLASE;9823;
1OSS;A;T190P STREPTOMYCES GRISEUS TRYPSIN IN COMPLEX WITH BENZAMIDINE;1.93;CA;CALCIUM ION;trypsin;1911;
1OT1;A;Bacillus circulans strain 251 Cyclodextrin glycosyl transferase mutant D135A;2;CA;CALCIUM ION;Cyclomaltodextrin glucanotransferase;1397;
1OT2;A;Bacillus circulans strain 251 Cyclodextrin glycosyl transferase mutant D135N;2.1;CA;CALCIUM ION;Cyclomaltodextrin glucanotransferase;1397;
1OT5;A;The 2.4 Angstrom Crystal Structure of Kex2 in complex with a peptidyl-boronic acid inhibitor;2.4;CA;CALCIUM ION;Kexin;4932;
1OT5;B;The 2.4 Angstrom Crystal Structure of Kex2 in complex with a peptidyl-boronic acid inhibitor;2.4;CA;CALCIUM ION;Kexin;4932;
1OTN;A;Calcium-binding mutant of the Internalin B LRR domain;1.97;CA;CALCIUM ION;Internalin B;1639;
1OTO;A;Calcium-binding mutant of the internalin B LRR domain;1.96;CA;CALCIUM ION;Internalin B;1639;
1OU9;A;Structure of SspB, a AAA+ protease delivery protein;1.8;CA;CALCIUM ION;Stringent starvation protein B homolog;727;
1OUP;A;Crystal structure of the periplasmic endonuclease Vvn complexed with octamer double stranded DNA;2.3;CA;CALCIUM ION;Nuclease;672;
1OUP;B;Crystal structure of the periplasmic endonuclease Vvn complexed with octamer double stranded DNA;2.3;CA;CALCIUM ION;Nuclease;672;
1OUR;A;LecB (PA-LII) in complex with mannose;1.42;CA;CALCIUM ION;hypothetical protein LecB;287;
1OUX;A;LecB (PA-LII) sugar-free;2;CA;CALCIUM ION;hypothetical protein LecB;287;
1OUX;B;LecB (PA-LII) sugar-free;2;CA;CALCIUM ION;hypothetical protein LecB;287;
1OUX;C;LecB (PA-LII) sugar-free;2;CA;CALCIUM ION;hypothetical protein LecB;287;
1OUX;D;LecB (PA-LII) sugar-free;2;CA;CALCIUM ION;hypothetical protein LecB;287;
1OVA;A;CRYSTAL STRUCTURE OF UNCLEAVED OVALBUMIN AT 1.95 ANGSTROMS RESOLUTION;1.95;CA;CALCIUM ION;OVALBUMIN;9031;
1OVP;A;LecB (PA-LII) in complex with fructose;1.4;CA;CALCIUM ION;hypothetical protein LecB;287;
1OVS;A;LecB (PA-LII) in complex with core trimannoside;1.75;CA;CALCIUM ION;hypothetical protein LecB;287;
1OVS;B;LecB (PA-LII) in complex with core trimannoside;1.75;CA;CALCIUM ION;hypothetical protein LecB;287;
1OVS;C;LecB (PA-LII) in complex with core trimannoside;1.75;CA;CALCIUM ION;hypothetical protein LecB;287;
1OVS;D;LecB (PA-LII) in complex with core trimannoside;1.75;CA;CALCIUM ION;hypothetical protein LecB;287;
1OX1;A;crystal structure of the bovine trypsin complex with a synthetic 11 peptide inhibitor;2;CA;CALCIUM ION;Trypsinogen, cationic;9913;
1OX7;B;Crystal structure of yeast cytosine deaminase apo-enzyme: inorganic zinc bound;1.43;CA;CALCIUM ION;Cytosine deaminase;4932;
1OXC;A;LecB (PA-LII) in complex with FUCOSE;1.2;CA;CALCIUM ION;hypothetical protein LecB;287;
1OXC;B;LecB (PA-LII) in complex with FUCOSE;1.2;CA;CALCIUM ION;hypothetical protein LecB;287;
1OXC;C;LecB (PA-LII) in complex with FUCOSE;1.2;CA;CALCIUM ION;hypothetical protein LecB;287;
1OXC;D;LecB (PA-LII) in complex with FUCOSE;1.2;CA;CALCIUM ION;hypothetical protein LecB;287;
1OXR;A;Aspirin induces its Anti-inflammatory effects through its specific binding to Phospholipase A2: Crystal structure of the complex formed between Phospholipase A2 and Aspirin at 1.9A resolution;1.93;CA;CALCIUM ION;Phospholipase A2 isoform 3;195058;
1OYG;A;Crystal structure of Bacillus subtilis levansucrase;1.5;CA;CALCIUM ION;levansucrase;1423;
1OYO;A;Regulation of protease activity by melanin: Crystal structure of the complex formed between proteinase K and melanin monomers at 2.0 resolution;2.02;CA;CALCIUM ION;Proteinase K;37998;
1OYQ;A;TRYPSIN INHIBITOR COMPLEX;1.9;CA;CALCIUM ION;Trypsin, cationic;9913;
1OYT;H;COMPLEX OF RECOMBINANT HUMAN THROMBIN WITH A DESIGNED FLUORINATED INHIBITOR;1.67;CA;CALCIUM ION;thrombin heavy chain;9606;
1OYV;A;Crystal structure of tomato inhibitor-II in a ternary complex with subtilisin Carlsberg;2.5;CA;CALCIUM ION;Subtilisin Carlsberg;1402;
1OYV;B;Crystal structure of tomato inhibitor-II in a ternary complex with subtilisin Carlsberg;2.5;CA;CALCIUM ION;Subtilisin Carlsberg;1402;
1OZ6;A;X-ray structure of acidic phospholipase A2 from Indian saw-scaled viper (Echis carinatus) with a potent platelet aggregation inhibitory activity;2.6;CA;CALCIUM ION;phospholipase A2;40353;
1OZS;A;C-domain of human cardiac troponin C in complex with the inhibitory region of human cardiac troponin I;;CA;CALCIUM ION;Troponin C, slow skeletal and cardiac muscles;9606;
1P2I;A;Structural consequences of accommodation of four non-cognate amino-acid residues in the S1 pocket of bovine trypsin and chymotrypsin;1.65;CA;CALCIUM ION;Trypsinogen, cationic;9913;
1P2J;A;Structural consequences of accommodation of four non-cognate amino-acid residues in the S1 pocket of bovine trypsin and chymotrypsin;1.35;CA;CALCIUM ION;Trypsinogen, cationic;9913;
1P2K;A;Structural consequences of accommodation of four non-cognate amino-acid residues in the S1 pocket of bovine trypsin and chymotrypsin;1.6;CA;CALCIUM ION;Trypsinogen, cationic;9913;
1P2P;A;STRUCTURE OF PORCINE PANCREATIC PHOSPHOLIPASE A2 AT 2.6 ANGSTROMS RESOLUTION AND COMPARISON WITH BOVINE PHOSPHOLIPASE A2;2.6;CA;CALCIUM ION;PHOSPHOLIPASE A2;9823;
1P3H;A;Crystal Structure of the Mycobacterium tuberculosis chaperonin 10 tetradecamer;2.8;CA;CALCIUM ION;10 kDa chaperonin;1773;
1P49;A;Structure of Human Placental Estrone/DHEA Sulfatase;2.6;CA;CALCIUM ION;STERYL-SULFATASE;9606;
1P54;A;Effect of Sequence on the Conformational Geometry of DNA Holliday Junctions;1.9;CA;CALCIUM ION;5'-D(*CP*CP*AP*GP*TP*AP*CP*(BRU)P*GP*G)-3';;
1P6O;B;The crystal structure of yeast cytosine deaminase bound to 4(R)-hydroxyl-3,4-dihydropyrimidine at 1.14 angstroms.;1.14;CA;CALCIUM ION;Cytosine deaminase;4932;
1P6W;A;Crystal structure of barley alpha-amylase isozyme 1 (AMY1) in complex with the substrate analogue, methyl 4I,4II,4III-tri-thiomaltotetraoside (thio-DP4);2;CA;CALCIUM ION;PROTEIN (Alpha-amylase type A isozyme);4513;
1P7V;A;Structure of a complex formed between Proteinase K and a designed heptapeptide inhibitor Pro-Ala-Pro-Phe-Ala-Ala-Ala at atomic resolution;1.08;CA;CALCIUM ION;proteinase K;37998;
1P7W;A;Crystal structure of the complex of Proteinase K with a designed heptapeptide inhibitor Pro-Ala-Pro-Phe-Ala-Ser-Ala at atomic resolution;1.02;CA;CALCIUM ION;proteinase K;37998;
1P8J;A;CRYSTAL STRUCTURE OF THE PROPROTEIN CONVERTASE FURIN;2.6;CA;CALCIUM ION;Furin precursor;10090;
1P8J;B;CRYSTAL STRUCTURE OF THE PROPROTEIN CONVERTASE FURIN;2.6;CA;CALCIUM ION;Furin precursor;10090;
1P8J;C;CRYSTAL STRUCTURE OF THE PROPROTEIN CONVERTASE FURIN;2.6;CA;CALCIUM ION;Furin precursor;10090;
1P8J;D;CRYSTAL STRUCTURE OF THE PROPROTEIN CONVERTASE FURIN;2.6;CA;CALCIUM ION;Furin precursor;10090;
1P8J;E;CRYSTAL STRUCTURE OF THE PROPROTEIN CONVERTASE FURIN;2.6;CA;CALCIUM ION;Furin precursor;10090;
1P8J;F;CRYSTAL STRUCTURE OF THE PROPROTEIN CONVERTASE FURIN;2.6;CA;CALCIUM ION;Furin precursor;10090;
1P8J;G;CRYSTAL STRUCTURE OF THE PROPROTEIN CONVERTASE FURIN;2.6;CA;CALCIUM ION;Furin precursor;10090;
1P8J;H;CRYSTAL STRUCTURE OF THE PROPROTEIN CONVERTASE FURIN;2.6;CA;CALCIUM ION;Furin precursor;10090;
1P8X;A;The Calcium-Activated C-terminal half of gelsolin;2;CA;CALCIUM ION;Gelsolin precursor, plasma;9606;
1P8X;B;The Calcium-Activated C-terminal half of gelsolin;2;CA;CALCIUM ION;Gelsolin precursor, plasma;9606;
1P8X;C;The Calcium-Activated C-terminal half of gelsolin;2;CA;CALCIUM ION;Gelsolin precursor, plasma;9606;
1P8Z;G;Complex Between Rabbit Muscle alpha-Actin: Human Gelsolin Residues Val26-Glu156;2.6;CA;CALCIUM ION;Gelsolin precursor, plasma;9606;
1PA2;A;ARABIDOPSIS THALIANA PEROXIDASE A2;1.45;CA;CALCIUM ION;PEROXIDASE;3702;
1PAL;A;IONIC INTERACTIONS WITH PARVALBUMINS. CRYSTAL STRUCTURE DETERMINATION OF PIKE 4.10 PARVALBUMIN IN FOUR DIFFERENT IONIC ENVIRONMENTS;1.65;CA;CALCIUM ION;PARVALBUMIN;8010;
1PAM;A;CYCLODEXTRIN GLUCANOTRANSFERASE;1.8;CA;CALCIUM ION;CYCLODEXTRIN GLUCANOTRANSFERASE;1410;
1PAM;B;CYCLODEXTRIN GLUCANOTRANSFERASE;1.8;CA;CALCIUM ION;CYCLODEXTRIN GLUCANOTRANSFERASE;1410;
1PB5;A;NMR Structure of a Prototype LNR Module from Human Notch1;;CA;CALCIUM ION;Neurogenic locus notch homolog protein 1;9606;
1PE5;A;Thermolysin with tricyclic inhibitor;1.7;CA;CALCIUM ION;Thermolysin;1427;
1PE7;A;Thermolysin with bicyclic inhibitor;1.82;CA;CALCIUM ION;Thermolysin;1427;
1PE8;A;Thermolysin with monocyclic inhibitor;1.8;CA;CALCIUM ION;Thermolysin;1427;
1PEX;A;COLLAGENASE-3 (MMP-13) C-TERMINAL HEMOPEXIN-LIKE DOMAIN;2.7;CA;CALCIUM ION;COLLAGENASE-3;9606;
1PEZ;A;Bacillus circulans strain 251 mutant A230V;2.32;CA;CALCIUM ION;Cyclomaltodextrin glucanotransferase;1397;
1PG6;A;X-Ray Crystal Structure of Protein SPYM3_0169 from Streptococcus pyogenes. Northeast Structural Genomics Consortium Target DR2.;1.7;CA;CALCIUM ION;Hypothetical protein SpyM3_0169;1314;
1PI3;A;E28Q mutant Benzoylformate Decarboxylase From Pseudomonas Putida;1.2;CA;CALCIUM ION;Benzoylformate decarboxylase;303;
1PIF;A;PIG ALPHA-AMYLASE;2.3;CA;CALCIUM ION;ALPHA-AMYLASE;9823;
1PIG;A;PIG PANCREATIC ALPHA-AMYLASE COMPLEXED WITH THE OLIGOSACCHARIDE V-1532;2.2;CA;CALCIUM ION;ALPHA-AMYLASE;9823;
1PIR;A;SOLUTION STRUCTURE OF PORCINE PANCREATIC PHOSPHOLIPASE A2;;CA;CALCIUM ION;PHOSPHOLIPASE A2;9823;
1PIS;A;SOLUTION STRUCTURE OF PORCINE PANCREATIC PHOSPHOLIPASE A2;;CA;CALCIUM ION;PHOSPHOLIPASE A2;9823;
1PJ9;A;Bacillus circulans strain 251 loop mutant 183-195;2;CA;CALCIUM ION;Cyclomaltodextrin glucanotransferase;1397;
1PJG;A;RNA/DNA Hybrid Decamer of CAAAGAAAAG/CTTTTCTTTG;1.15;CA;CALCIUM ION;5'-R(*CP*AP*AP*AP*GP*AP*AP*AP*AP*G)-3';;
1PJG;B;RNA/DNA Hybrid Decamer of CAAAGAAAAG/CTTTTCTTTG;1.15;CA;CALCIUM ION;5'-D(*CP*TP*TP*TP*TP*CP*TP*TP*TP*G)-3';;
1PJX;A;0.85 ANGSTROM STRUCTURE OF SQUID GANGLION DFPASE;0.85;CA;CALCIUM ION;DIISOPROPYLFLUOROPHOSPHATASE;6622;
1PK0;D;Crystal Structure of the EF3-CaM complexed with PMEApp;3.3;CA;CALCIUM ION;Calmodulin;9606;
1PK0;E;Crystal Structure of the EF3-CaM complexed with PMEApp;3.3;CA;CALCIUM ION;Calmodulin;9606;
1PK0;F;Crystal Structure of the EF3-CaM complexed with PMEApp;3.3;CA;CALCIUM ION;Calmodulin;9606;
1PK6;B;Globular Head of the Complement System Protein C1q;1.85;CA;CALCIUM ION;Complement C1q subcomponent, B chain precursor;9606;
1PK8;A;Crystal Structure of Rat Synapsin I C Domain Complexed to Ca.ATP;2.1;CA;CALCIUM ION;rat synapsin I;10116;
1PK8;B;Crystal Structure of Rat Synapsin I C Domain Complexed to Ca.ATP;2.1;CA;CALCIUM ION;rat synapsin I;10116;
1PK8;C;Crystal Structure of Rat Synapsin I C Domain Complexed to Ca.ATP;2.1;CA;CALCIUM ION;rat synapsin I;10116;
1PK8;D;Crystal Structure of Rat Synapsin I C Domain Complexed to Ca.ATP;2.1;CA;CALCIUM ION;rat synapsin I;10116;
1PK8;E;Crystal Structure of Rat Synapsin I C Domain Complexed to Ca.ATP;2.1;CA;CALCIUM ION;rat synapsin I;10116;
1PK8;F;Crystal Structure of Rat Synapsin I C Domain Complexed to Ca.ATP;2.1;CA;CALCIUM ION;rat synapsin I;10116;
1PK8;G;Crystal Structure of Rat Synapsin I C Domain Complexed to Ca.ATP;2.1;CA;CALCIUM ION;rat synapsin I;10116;
1PK8;H;Crystal Structure of Rat Synapsin I C Domain Complexed to Ca.ATP;2.1;CA;CALCIUM ION;rat synapsin I;10116;
1PMH;X;Crystal structure of Caldicellulosiruptor saccharolyticus CBM27-1 in complex with mannohexaose;1.06;CA;CALCIUM ION;beta-1,4-mannanase;44001;
1PMJ;X;Crystal structure of Caldicellulosiruptor saccharolyticus CBM27-1;1.55;CA;CALCIUM ION;beta-1,4-mannanase;44001;
1PNK;B;PENICILLIN ACYLASE HAS A SINGLE-AMINO-ACID CATALYTIC CENTRE;1.9;CA;CALCIUM ION;PENICILLIN AMIDOHYDROLASE;562;
1PNL;B;PENICILLIN ACYLASE HAS A SINGLE-AMINO-ACID CATALYTIC CENTRE;2.5;CA;CALCIUM ION;PENICILLIN AMIDOHYDROLASE;562;
1PNM;B;PENICILLIN ACYLASE HAS A SINGLE-AMINO-ACID CATALYTIC CENTRE;2.5;CA;CALCIUM ION;PENICILLIN AMIDOHYDROLASE;562;
1PO7;A;HIGH RESOLUTION STRUCTURE OF E28A MUTANT BENZOYLFORMATE DECARBOXYLASE FROM PSEUDOMONAS PUTIDA;1.2;CA;CALCIUM ION;Benzoylformate decarboxylase;303;
1POA;A;INTERFACIAL CATALYSIS: THE MECHANISM OF PHOSPHOLIPASE A2;1.5;CA;CALCIUM ION;PHOSPHOLIPASE A2;8656;
1POB;A;CRYSTAL STRUCTURE OF COBRA-VENOM PHOSPHOLIPASE A2 IN A COMPLEX WITH A TRANSITION-STATE ANALOGUE;2;CA;CALCIUM ION;PHOSPHOLIPASE A2;8656;
1POB;B;CRYSTAL STRUCTURE OF COBRA-VENOM PHOSPHOLIPASE A2 IN A COMPLEX WITH A TRANSITION-STATE ANALOGUE;2;CA;CALCIUM ION;PHOSPHOLIPASE A2;8656;
1POC;A;CRYSTAL STRUCTURE OF BEE-VENOM PHOSPHOLIPASE A2 IN A COMPLEX WITH A TRANSITION-STATE ANALOGUE;2;CA;CALCIUM ION;PHOSPHOLIPASE A2;7460;
1POD;A;STRUCTURES OF FREE AND INHIBITED HUMAN SECRETORY PHOSPHOLIPASE A2 FROM INFLAMMATORY EXUDATE;2.1;CA;CALCIUM ION;PHOSPHOLIPASE A2;9606;
1POE;A;STRUCTURES OF FREE AND INHIBITED HUMAN SECRETORY PHOSPHOLIPASE A2 FROM INFLAMMATORY EXUDATE;2.1;CA;CALCIUM ION;PHOSPHOLIPASE A2;9606;
1POE;B;STRUCTURES OF FREE AND INHIBITED HUMAN SECRETORY PHOSPHOLIPASE A2 FROM INFLAMMATORY EXUDATE;2.1;CA;CALCIUM ION;PHOSPHOLIPASE A2;9606;
1POO;A;THERMOSTABLE PHYTASE FROM BACILLUS SP;2.1;CA;CALCIUM ION;PROTEIN (PHYTASE);1390;
1PPC;E;GEOMETRY OF BINDING OF THE BENZAMIDINE-AND ARGININE-BASED INHIBITORS N-ALPHA-(2-NAPHTHYL-SULPHONYL-GLYCYL)-DL-P-AMIDINOPHENYLALANYL-PIPERIDINE (NAPAP) AND (2R,4R)-4-METHYL-1-[N-ALPHA-(3-METHYL-1,2,3,4-TETRAHYDRO-8-QUINOLINESULPHONYL)-L-ARGINYL]-2-PIPERIDINE CARBOXYLIC ACID (MQPA) TO HUMAN ALPHA-THROMBIN: X-RAY CRYSTALLOGRAPHIC DETERMINATION OF THE NAPAP-TRYPSIN COMPLEX AND MODELING OF NAPAP-THROMBIN AND MQPA-THROMBIN;1.8;CA;CALCIUM ION;TRYPSIN;9913;
1PPH;E;GEOMETRY OF BINDING OF THE NALPHA-TOSYLATED PIPERIDIDES OF M-AMIDINO-, P-AMIDINO-AND P-GUANIDINO PHENYLALANINE TO THROMBIN AND TRYPSIN: X-RAY CRYSTAL STRUCTURES OF THEIR TRYPSIN COMPLEXES AND MODELING OF THEIR THROMBIN COMPLEXES;1.9;CA;CALCIUM ION;TRYPSIN;9823;
1PPI;A;THE ACTIVE CENTER OF A MAMMALIAN ALPHA-AMYLASE. THE STRUCTURE OF THE COMPLEX OF A PANCREATIC ALPHA-AMYLASE WITH A CARBOHYDRATE INHIBITOR REFINED TO 2.2 ANGSTROMS RESOLUTION;2.2;CA;CALCIUM ION;ALPHA-AMYLASE;9823;
1PQW;A;Putative enoyl reductase domain of polyketide synthase;2.66;CA;CALCIUM ION;polyketide synthase;1773;
1PRR;A;NMR-DERIVED THREE-DIMENSIONAL SOLUTION STRUCTURE OF PROTEIN S COMPLEXED WITH CALCIUM;;CA;CALCIUM ION;DEVELOPMENT-SPECIFIC PROTEIN S;34;
1PRS;A;NMR-DERIVED THREE-DIMENSIONAL SOLUTION STRUCTURE OF PROTEIN S COMPLEXED WITH CALCIUM;;CA;CALCIUM ION;DEVELOPMENT-SPECIFIC PROTEIN S;34;
1PRW;A;Crystal structure of bovine brain Ca++ calmodulin in a compact form;1.7;CA;CALCIUM ION;Calmodulin;9913;
1PSH;A;CRYSTAL STRUCTURE OF PHOSPHOLIPASE A2 FROM INDIAN COBRA REVEALS A TRIMERIC ASSOCIATION;2.3;CA;CALCIUM ION;PHOSPHOLIPASE A2;35670;
1PSH;B;CRYSTAL STRUCTURE OF PHOSPHOLIPASE A2 FROM INDIAN COBRA REVEALS A TRIMERIC ASSOCIATION;2.3;CA;CALCIUM ION;PHOSPHOLIPASE A2;35670;
1PSH;C;CRYSTAL STRUCTURE OF PHOSPHOLIPASE A2 FROM INDIAN COBRA REVEALS A TRIMERIC ASSOCIATION;2.3;CA;CALCIUM ION;PHOSPHOLIPASE A2;35670;
1PSJ;A;ACIDIC PHOSPHOLIPASE A2 FROM AGKISTRODON HALYS PALLAS;2;CA;CALCIUM ION;PHOSPHOLIPASE A2;8714;
1PT2;A;Crystal structure of levansucrase (E342A) complexed with sucrose;2.1;CA;CALCIUM ION;Levansucrase;1423;
1PTK;A;STUDIES ON THE INHIBITORY ACTION OF MERCURY UPON PROTEINASE K;2.4;CA;CALCIUM ION;PROTEINASE K;37998;
1PU4;A;Crystal structure of human vascular adhesion protein-1;3.2;CA;CALCIUM ION;Membrane copper amine oxidase;9606;
1PU4;B;Crystal structure of human vascular adhesion protein-1;3.2;CA;CALCIUM ION;Membrane copper amine oxidase;9606;
1PVA;A;COMPARISON BETWEEN THE CRYSTAL AND THE SOLUTION STRUCTURES OF THE EF HAND PARVALBUMIN (ALPHA COMPONENT FROM PIKE MUSCLE);1.65;CA;CALCIUM ION;PARVALBUMIN;8010;
1PVA;B;COMPARISON BETWEEN THE CRYSTAL AND THE SOLUTION STRUCTURES OF THE EF HAND PARVALBUMIN (ALPHA COMPONENT FROM PIKE MUSCLE);1.65;CA;CALCIUM ION;PARVALBUMIN;8010;
1PVB;A;X-RAY STRUCTURE OF A NEW CRYSTAL FORM OF PIKE 4.10 PARVALBUMIN;1.75;CA;CALCIUM ION;PARVALBUMIN;8010;
1PVW;A;3,4-dihydroxy-2-butanone 4-phosphate synthase from M. jannaschii;2.45;CA;CALCIUM ION;3,4-dihydroxy-2-butanone 4-phosphate synthase;2190;
1PVY;A;3,4-dihydroxy-2-butanone 4-phosphate synthase from M. jannaschii in complex with ribulose 5-phosphate;1.7;CA;CALCIUM ION;3,4-dihydroxy-2-butanone 4-phosphate synthase;2190;
1PVY;B;3,4-dihydroxy-2-butanone 4-phosphate synthase from M. jannaschii in complex with ribulose 5-phosphate;1.7;CA;CALCIUM ION;3,4-dihydroxy-2-butanone 4-phosphate synthase;2190;
1PW9;A;High resolution crystal structure of an active recombinant fragment of human lung surfactant protein D;1.6;CA;CALCIUM ION;Pulmonary surfactant-associated protein D;9606;
1PW9;B;High resolution crystal structure of an active recombinant fragment of human lung surfactant protein D;1.6;CA;CALCIUM ION;Pulmonary surfactant-associated protein D;9606;
1PW9;C;High resolution crystal structure of an active recombinant fragment of human lung surfactant protein D;1.6;CA;CALCIUM ION;Pulmonary surfactant-associated protein D;9606;
1PWB;A;High resolution crystal structure of an active recombinant fragment of human lung surfactant protein D with maltose;1.4;CA;CALCIUM ION;Pulmonary surfactant-associated protein D;9606;
1PWB;B;High resolution crystal structure of an active recombinant fragment of human lung surfactant protein D with maltose;1.4;CA;CALCIUM ION;Pulmonary surfactant-associated protein D;9606;
1PWB;C;High resolution crystal structure of an active recombinant fragment of human lung surfactant protein D with maltose;1.4;CA;CALCIUM ION;Pulmonary surfactant-associated protein D;9606;
1PX2;A;Crystal Structure of Rat Synapsin I C Domain Complexed to Ca.ATP (Form 1);2.23;CA;CALCIUM ION;Synapsin I;10116;
1PX2;B;Crystal Structure of Rat Synapsin I C Domain Complexed to Ca.ATP (Form 1);2.23;CA;CALCIUM ION;Synapsin I;10116;
1PX7;B;A folding mutant of human class pi glutathione transferase, created by mutating aspartate 153 of the wild-type protein to glutamate;2.03;CA;CALCIUM ION;Glutathione S-transferase P;9606;
1PYT;C;TERNARY COMPLEX OF PROCARBOXYPEPTIDASE A, PROPROTEINASE E, AND CHYMOTRYPSINOGEN C;2.35;CA;CALCIUM ION;PROPROTEINASE E;9913;
1PZ7;A;Modulation of agrin function by alternative splicing and Ca2+ binding;1.42;CA;CALCIUM ION;Agrin;9031;
1PZ7;B;Modulation of agrin function by alternative splicing and Ca2+ binding;1.42;CA;CALCIUM ION;Agrin;9031;
1PZ8;A;Modulation of agrin function by alternative splicing and Ca2+ binding;2.35;CA;CALCIUM ION;Agrin;9031;
1PZ8;B;Modulation of agrin function by alternative splicing and Ca2+ binding;2.35;CA;CALCIUM ION;Agrin;9031;
1PZ8;C;Modulation of agrin function by alternative splicing and Ca2+ binding;2.35;CA;CALCIUM ION;Agrin;9031;
1PZ8;D;Modulation of agrin function by alternative splicing and Ca2+ binding;2.35;CA;CALCIUM ION;Agrin;9031;
1PZY;A;W314A-BETA1,4-GALACTOSYLTRANSFERASE-I COMPLEXED WITH ALPHA-LACTALBUMIN IN THE PRESENCE OF N-ACETYLGLUCOSAMINE, UDP AND MANGANESE;2.3;CA;CALCIUM ION;ALPHA-LACTALBUMIN;10090;
1PZY;C;W314A-BETA1,4-GALACTOSYLTRANSFERASE-I COMPLEXED WITH ALPHA-LACTALBUMIN IN THE PRESENCE OF N-ACETYLGLUCOSAMINE, UDP AND MANGANESE;2.3;CA;CALCIUM ION;ALPHA-LACTALBUMIN;10090;
1Q1P;A;E-Cadherin activation;3.2;CA;CALCIUM ION;Epithelial-cadherin;10090;
1Q23;A;Crystal structure of Chloramphenicol acetyltransferase I complexed with Fusidic acid at 2.18 A resolution;2.18;CA;CALCIUM ION;Chloramphenicol acetyltransferase;562;
1Q2E;B;CELLOBIOHYDROLASE CEL7A WITH LOOP DELETION 245-252 AND BOUND NON-HYDROLYSABLE CELLOTETRAOSE;1.75;CA;CALCIUM ION;EXOCELLOBIOHYDROLASE I;51453;
1Q39;A;Crystal structure of the DNA repair enzyme endonuclease-VIII (Nei) from E. coli: The WT enzyme at 2.8 resolution.;2.8;CA;CALCIUM ION;Endonuclease VIII;562;
1Q3A;A;Crystal structure of the catalytic domain of human matrix metalloproteinase 10;2.1;CA;CALCIUM ION;Stromelysin-2;9606;
1Q3A;B;Crystal structure of the catalytic domain of human matrix metalloproteinase 10;2.1;CA;CALCIUM ION;Stromelysin-2;9606;
1Q3A;C;Crystal structure of the catalytic domain of human matrix metalloproteinase 10;2.1;CA;CALCIUM ION;Stromelysin-2;9606;
1Q4N;X;Structural studies of Phe256Trp of human salivary alpha-amylase: implications for the role of a conserved water molecule and its associated chain in enzyme activity;2.07;CA;CALCIUM ION;Alpha-amylase, salivary;9606;
1Q55;A;W-shaped trans interactions of cadherins model based on fitting C-cadherin (1L3W) to 3D map of desmosomes obtained by electron tomography;30;CA;CALCIUM ION;EP-cadherin;10090;
1Q55;B;W-shaped trans interactions of cadherins model based on fitting C-cadherin (1L3W) to 3D map of desmosomes obtained by electron tomography;30;CA;CALCIUM ION;EP-cadherin;10090;
1Q55;C;W-shaped trans interactions of cadherins model based on fitting C-cadherin (1L3W) to 3D map of desmosomes obtained by electron tomography;30;CA;CALCIUM ION;EP-cadherin;10090;
1Q55;D;W-shaped trans interactions of cadherins model based on fitting C-cadherin (1L3W) to 3D map of desmosomes obtained by electron tomography;30;CA;CALCIUM ION;EP-cadherin;10090;
1Q5A;A;S-shaped trans interactions of cadherins model based on fitting C-cadherin (1L3W) to 3D map of desmosomes obtained by electron tomography;30;CA;CALCIUM ION;EP-cadherin;10090;
1Q5A;B;S-shaped trans interactions of cadherins model based on fitting C-cadherin (1L3W) to 3D map of desmosomes obtained by electron tomography;30;CA;CALCIUM ION;EP-cadherin;10090;
1Q5B;A;lambda-shaped TRANS and CIS interactions of cadherins model based on fitting C-cadherin (1L3W) to 3D map of desmosomes obtained by electron tomography;30;CA;CALCIUM ION;EP-cadherin;10090;
1Q5B;B;lambda-shaped TRANS and CIS interactions of cadherins model based on fitting C-cadherin (1L3W) to 3D map of desmosomes obtained by electron tomography;30;CA;CALCIUM ION;EP-cadherin;10090;
1Q5B;C;lambda-shaped TRANS and CIS interactions of cadherins model based on fitting C-cadherin (1L3W) to 3D map of desmosomes obtained by electron tomography;30;CA;CALCIUM ION;EP-cadherin;10090;
1Q5C;A;S-S-lambda-shaped TRANS and CIS interactions of cadherins model based on fitting C-cadherin (1L3W) to 3D map of desmosomes obtained by electron tomography;30;CA;CALCIUM ION;EP-cadherin;10090;
1Q5C;B;S-S-lambda-shaped TRANS and CIS interactions of cadherins model based on fitting C-cadherin (1L3W) to 3D map of desmosomes obtained by electron tomography;30;CA;CALCIUM ION;EP-cadherin;10090;
1Q5C;C;S-S-lambda-shaped TRANS and CIS interactions of cadherins model based on fitting C-cadherin (1L3W) to 3D map of desmosomes obtained by electron tomography;30;CA;CALCIUM ION;EP-cadherin;10090;
1Q5C;D;S-S-lambda-shaped TRANS and CIS interactions of cadherins model based on fitting C-cadherin (1L3W) to 3D map of desmosomes obtained by electron tomography;30;CA;CALCIUM ION;EP-cadherin;10090;
1Q5P;A;S156E/S166D variant of Bacillus lentus subtilisin;1.6;CA;CALCIUM ION;Serine protease;1467;
1Q6Z;A;HIGH RESOLUTION STRUCTURE OF E28A MUTANT BENZOYLFORMATE DECARBOXYLASE FROM PSEUDOMONAS PUTIDA COMPLEXED WITH THIAMIN THIAZOLONE DIPHOSPHATE;1;CA;CALCIUM ION;Benzoylformate decarboxylase;303;
1Q7B;A;The structure of betaketoacyl-[ACP] reductase from E. coli in complex with NADP+;2.05;CA;CALCIUM ION;3-oxoacyl-[acyl-carrier protein] reductase;562;
1Q7B;B;The structure of betaketoacyl-[ACP] reductase from E. coli in complex with NADP+;2.05;CA;CALCIUM ION;3-oxoacyl-[acyl-carrier protein] reductase;562;
1Q7B;C;The structure of betaketoacyl-[ACP] reductase from E. coli in complex with NADP+;2.05;CA;CALCIUM ION;3-oxoacyl-[acyl-carrier protein] reductase;562;
1Q7B;D;The structure of betaketoacyl-[ACP] reductase from E. coli in complex with NADP+;2.05;CA;CALCIUM ION;3-oxoacyl-[acyl-carrier protein] reductase;562;
1Q8F;A;Crystal Structure of the E.coli pyrimidine nucleoside hydrolase yeiK;1.7;CA;CALCIUM ION;Pyrimidine nucleoside hydrolase;562;
1Q8F;B;Crystal Structure of the E.coli pyrimidine nucleoside hydrolase yeiK;1.7;CA;CALCIUM ION;Pyrimidine nucleoside hydrolase;562;
1Q8F;C;Crystal Structure of the E.coli pyrimidine nucleoside hydrolase yeiK;1.7;CA;CALCIUM ION;Pyrimidine nucleoside hydrolase;562;
1Q8F;D;Crystal Structure of the E.coli pyrimidine nucleoside hydrolase yeiK;1.7;CA;CALCIUM ION;Pyrimidine nucleoside hydrolase;562;
1Q8H;A;Crystal structure of porcine osteocalcin;2;CA;CALCIUM ION;Osteocalcin;9823;
1Q8O;A;Pterocartpus angolensis lectin PAL in complex with the dimmanoside Man(alpha1-2)Man;2.2;CA;CALCIUM ION;lectin;182271;
1Q8O;B;Pterocartpus angolensis lectin PAL in complex with the dimmanoside Man(alpha1-2)Man;2.2;CA;CALCIUM ION;lectin;182271;
1Q8P;A;Pterocarpus angolensis lectin PAL in complex with the dimannoside Man(alpha1-3)Man;1.75;CA;CALCIUM ION;lectin;182271;
1Q8P;B;Pterocarpus angolensis lectin PAL in complex with the dimannoside Man(alpha1-3)Man;1.75;CA;CALCIUM ION;lectin;182271;
1Q8Q;A;Pterocarpus angolensis lectin (PAL) in complex with the dimannoside Man(alpha1-4)Man;2.05;CA;CALCIUM ION;lectin;182271;
1Q8Q;B;Pterocarpus angolensis lectin (PAL) in complex with the dimannoside Man(alpha1-4)Man;2.05;CA;CALCIUM ION;lectin;182271;
1Q8S;A;Pterocarpus angolensis lectin (PAL) in complex with the dimannoside Man(alpha1-6)Man;2.05;CA;CALCIUM ION;lectin;182271;
1Q8S;B;Pterocarpus angolensis lectin (PAL) in complex with the dimannoside Man(alpha1-6)Man;2.05;CA;CALCIUM ION;lectin;182271;
1Q8V;A;Pterocarpus angolensis lectin (PAL) in complex with the trimannoside [Man(Alpha1-3)]Man(alpha1-6)Man;1.85;CA;CALCIUM ION;lectin;182271;
1Q8V;B;Pterocarpus angolensis lectin (PAL) in complex with the trimannoside [Man(Alpha1-3)]Man(alpha1-6)Man;1.85;CA;CALCIUM ION;lectin;182271;
1Q9X;A;Crystal structure of Enterobacteria phage RB69 gp43 DNA polymerase complexed with tetrahydrofuran containing DNA;2.69;CA;CALCIUM ION;DNA polymerase;1914161;
1Q9X;B;Crystal structure of Enterobacteria phage RB69 gp43 DNA polymerase complexed with tetrahydrofuran containing DNA;2.69;CA;CALCIUM ION;DNA polymerase;1914161;
1Q9X;C;Crystal structure of Enterobacteria phage RB69 gp43 DNA polymerase complexed with tetrahydrofuran containing DNA;2.69;CA;CALCIUM ION;DNA polymerase;1914161;
1Q9X;D;Crystal structure of Enterobacteria phage RB69 gp43 DNA polymerase complexed with tetrahydrofuran containing DNA;2.69;CA;CALCIUM ION;DNA polymerase;1914161;
1Q9Y;A;CRYSTAL STRUCTURE OF ENTEROBACTERIA PHAGE RB69 GP43 DNA POLYMERASE COMPLEXED WITH 8-OXOGUANOSINE CONTAINING DNA;2.8;CA;CALCIUM ION;DNA POLYMERASE;1914161;
1QA0;A;BOVINE TRYPSIN 2-AMINOBENZIMIDAZOLE COMPLEX;1.8;CA;CALCIUM ION;TRYPSIN;9913;
1QAF;A;THE ACTIVE SITE BASE CONTROLS COFACTOR REACTIVITY IN ESCHERICHIA COLI AMINE OXIDASE : X-RAY CRYSTALLOGRAPHIC STUDIES WITH MUTATIONAL VARIANTS;2.2;CA;CALCIUM ION;PROTEIN (COPPER AMINE OXIDASE);562;
1QAF;B;THE ACTIVE SITE BASE CONTROLS COFACTOR REACTIVITY IN ESCHERICHIA COLI AMINE OXIDASE : X-RAY CRYSTALLOGRAPHIC STUDIES WITH MUTATIONAL VARIANTS;2.2;CA;CALCIUM ION;PROTEIN (COPPER AMINE OXIDASE);562;
1QAK;A;THE ACTIVE SITE BASE CONTROLS COFACTOR REACTIVITY IN ESCHERICHIA COLI AMINE OXIDASE : X-RAY CRYSTALLOGRAPHIC STUDIES WITH MUTATIONAL VARIANTS;2;CA;CALCIUM ION;COPPER AMINE OXIDASE;562;
1QAK;B;THE ACTIVE SITE BASE CONTROLS COFACTOR REACTIVITY IN ESCHERICHIA COLI AMINE OXIDASE : X-RAY CRYSTALLOGRAPHIC STUDIES WITH MUTATIONAL VARIANTS;2;CA;CALCIUM ION;COPPER AMINE OXIDASE;562;
1QAL;A;THE ACTIVE SITE BASE CONTROLS COFACTOR REACTIVITY IN ESCHERICHIA COLI AMINE OXIDASE : X-RAY CRYSTALLOGRAPHIC STUDIES WITH MUTATIONAL VARIANTS;2.2;CA;CALCIUM ION;COPPER AMINE OXIDASE;562;
1QAL;B;THE ACTIVE SITE BASE CONTROLS COFACTOR REACTIVITY IN ESCHERICHIA COLI AMINE OXIDASE : X-RAY CRYSTALLOGRAPHIC STUDIES WITH MUTATIONAL VARIANTS;2.2;CA;CALCIUM ION;COPPER AMINE OXIDASE;562;
1QB1;A;Bovine Trypsin with 1-[2-[5-[amino(imino)methyl]-2-hydroxyphenoxy]-6-[3-(4,5-dihydro-1-methyl-1H-imidazol-2-yl)phenoxy]pyridin-4-yl]piperidine-3-carboxylic Acid (ZK-806974);1.8;CA;CALCIUM ION;PROTEIN (TRYPSIN);9913;
1QB6;A;BOVINE TRYPSIN 3,3'-[3,5-DIFLUORO-4-METHYL-2, 6-PYRIDINEDIYLBIS(OXY)]BIS(BENZENECARBOXIMIDAMIDE) (ZK-805623) COMPLEX;1.8;CA;CALCIUM ION;PROTEIN (TRYPSIN);9913;
1QB9;A;BOVINE TRYPSIN 7-[[2-[[1-(1-IMINOETHYL)PIPERIDIN-4-YL]OXY]-9H-CARBOZOL-9-YL] METHYL]NAPHTHALENE-2-CARBOXIMIDAMIDE (ZK-806450) COMPLEX;1.8;CA;CALCIUM ION;PROTEIN (TRYPSIN);9913;
1QBI;A;SOLUBLE QUINOPROTEIN GLUCOSE DEHYDROGENASE FROM ACINETOBACTER CALCOACETICUS;1.72;CA;CALCIUM ION;SOLUBLE QUINOPROTEIN GLUCOSE DEHYDROGENASE;471;
1QBI;B;SOLUBLE QUINOPROTEIN GLUCOSE DEHYDROGENASE FROM ACINETOBACTER CALCOACETICUS;1.72;CA;CALCIUM ION;SOLUBLE QUINOPROTEIN GLUCOSE DEHYDROGENASE;471;
1QBN;A;Bovine Trypsin 2-[amino(imino)methyl]-2-hydroxyphenoxy]-6-[3-(4,5-dihydro-1H-imidazol-2-yl)phenoxy]pyridine-4-carboxylic Acid (ZK-806688) Complex;1.8;CA;CALCIUM ION;PROTEIN (TRYPSIN);9913;
1QBO;A;BOVINE TRYPSIN 7-[[6-[[1-(1-IMINOETHYL)PIPERIDIN-4-YL]OXY]-2-METHYL-BENZIMIDAZOL-1-YL]METHYL]NAPHTHALENE-2-CARBOXIMIDAMID ZK-806711 INHIBITOR COMPLEX;1.8;CA;CALCIUM ION;PROTEIN (TRYPSIN);9913;
1QCN;A;CRYSTAL STRUCTURE OF FUMARYLACETOACETATE HYDROLASE;1.9;CA;CALCIUM ION;FUMARYLACETOACETATE HYDROLASE;10090;
1QCN;B;CRYSTAL STRUCTURE OF FUMARYLACETOACETATE HYDROLASE;1.9;CA;CALCIUM ION;FUMARYLACETOACETATE HYDROLASE;10090;
1QCO;A;CRYSTAL STRUCTURE OF FUMARYLACETOACETATE HYDROLASE COMPLEXED WITH FUMARATE AND ACETOACETATE;1.9;CA;CALCIUM ION;FUMARYLACETOACETATE HYDROLASE;10090;
1QCO;B;CRYSTAL STRUCTURE OF FUMARYLACETOACETATE HYDROLASE COMPLEXED WITH FUMARATE AND ACETOACETATE;1.9;CA;CALCIUM ION;FUMARYLACETOACETATE HYDROLASE;10090;
1QCP;A;CRYSTAL STRUCTURE OF THE RWJ-51084 BOVINE PANCREATIC BETA-TRYPSIN AT 1.8 A;1.8;CA;CALCIUM ION;PROTEIN (BETA-TRYPSIN PROTEIN);9913;
1QD6;C;OUTER MEMBRANE PHOSPHOLIPASE A FROM ESCHERICHIA COLI;2.1;CA;CALCIUM ION;PROTEIN (OUTER MEMBRANE PHOSPHOLIPASE (OMPLA));562;
1QDB;A;CYTOCHROME C NITRITE REDUCTASE;1.9;CA;CALCIUM ION;CYTOCHROME C NITRITE REDUCTASE;65553;
1QDB;B;CYTOCHROME C NITRITE REDUCTASE;1.9;CA;CALCIUM ION;CYTOCHROME C NITRITE REDUCTASE;65553;
1QDB;C;CYTOCHROME C NITRITE REDUCTASE;1.9;CA;CALCIUM ION;CYTOCHROME C NITRITE REDUCTASE;65553;
1QDC;A;MAN(APLHA1-6)MAN(ALPHA1-O)METHYL CONCANAVALIN A COMPLEX;2;CA;CALCIUM ION;PROTEIN (CONCANAVALIN A);3823;
1QDC;B;MAN(APLHA1-6)MAN(ALPHA1-O)METHYL CONCANAVALIN A COMPLEX;2;CA;CALCIUM ION;PROTEIN (CONCANAVALIN A);3823;
1QDC;C;MAN(APLHA1-6)MAN(ALPHA1-O)METHYL CONCANAVALIN A COMPLEX;2;CA;CALCIUM ION;PROTEIN (CONCANAVALIN A);3823;
1QDC;D;MAN(APLHA1-6)MAN(ALPHA1-O)METHYL CONCANAVALIN A COMPLEX;2;CA;CALCIUM ION;PROTEIN (CONCANAVALIN A);3823;
1QDO;A;MAN(APLHA1-3)MAN(ALPHA1-O)METHYL CONCANAVALIN A COMPLEX;2.8;CA;CALCIUM ION;PROTEIN (CONCANAVALIN A);3823;
1QDO;B;MAN(APLHA1-3)MAN(ALPHA1-O)METHYL CONCANAVALIN A COMPLEX;2.8;CA;CALCIUM ION;PROTEIN (CONCANAVALIN A);3823;
1QDO;C;MAN(APLHA1-3)MAN(ALPHA1-O)METHYL CONCANAVALIN A COMPLEX;2.8;CA;CALCIUM ION;PROTEIN (CONCANAVALIN A);3823;
1QDO;D;MAN(APLHA1-3)MAN(ALPHA1-O)METHYL CONCANAVALIN A COMPLEX;2.8;CA;CALCIUM ION;PROTEIN (CONCANAVALIN A);3823;
1QDT;A;2.1 A RESOLUTION STRUCTURE OF ESCHERICHIA COLI LYTIC TRANSGLYCOYSLASE SLT35 IN COMPLEX WITH CALCIUM;2.1;CA;CALCIUM ION;LYTIC MUREIN TRANSGLYCOSYLASE B;562;
1QE5;B;PURINE NUCLEOSIDE PHOSPHORYLASE FROM CELLULOMONAS SP. IN COMPLEX WITH PHOSPHATE;2.2;CA;CALCIUM ION;PENTOSYLTRANSFERASE;40001;
1QF0;A;THERMOLYSIN (E.C.3.4.24.27) COMPLEXED WITH (2-SULPHANYL-3-PHENYLPROPANOYL)-PHE-TYR. PARAMETERS FOR ZN-BIDENTATION OF MERCAPTOACYLDIPEPTIDES IN METALLOENDOPEPTIDASE;2.2;CA;CALCIUM ION;PROTEIN (THERMOLYSIN);1427;
1QF1;A;THERMOLYSIN (E.C.3.4.24.27) COMPLEXED WITH (2-SULPHANYLHEPTANOYL)-PHE-ALA. PARAMETERS FOR ZN-BIDENTATION OF MERCAPTOACYLDIPEPTIDES IN METALLOENDOPEPTIDASE;2;CA;CALCIUM ION;PROTEIN (THERMOLYSIN);1427;
1QF2;A;THERMOLYSIN (E.C.3.4.24.27) COMPLEXED WITH (2-SULPHANYL-3-PHENYLPROPANOYL)-GLY-(5-PHENYLPROLINE). PARAMETERS FOR ZN-MONODENTATION OF MERCAPTOACYLDIPEPTIDES IN METALLOENDOPEPTIDASE;2.06;CA;CALCIUM ION;PROTEIN (THERMOLYSIN);1427;
1QF3;A;PEANUT LECTIN COMPLEXED WITH METHYL-BETA-GALACTOSE;2.8;CA;CALCIUM ION;PROTEIN (PEANUT LECTIN);3818;
1QF3;B;PEANUT LECTIN COMPLEXED WITH METHYL-BETA-GALACTOSE;2.8;CA;CALCIUM ION;PROTEIN (PEANUT LECTIN);3818;
1QF3;C;PEANUT LECTIN COMPLEXED WITH METHYL-BETA-GALACTOSE;2.8;CA;CALCIUM ION;PROTEIN (PEANUT LECTIN);3818;
1QF3;D;PEANUT LECTIN COMPLEXED WITH METHYL-BETA-GALACTOSE;2.8;CA;CALCIUM ION;PROTEIN (PEANUT LECTIN);3818;
1QFK;H;STRUCTURE OF HUMAN FACTOR VIIA AND ITS IMPLICATIONS FOR THE TRIGGERING OF BLOOD COAGULATION;2.8;CA;CALCIUM ION;COAGULATION FACTOR VIIA HEAVY CHAIN;9606;
1QGD;A;TRANSKETOLASE FROM ESCHERICHIA COLI;1.9;CA;CALCIUM ION;PROTEIN (TRANSKETOLASE);562;
1QGD;B;TRANSKETOLASE FROM ESCHERICHIA COLI;1.9;CA;CALCIUM ION;PROTEIN (TRANSKETOLASE);562;
1QGE;E;NEW CRYSTAL FORM OF PSEUDOMONAS GLUMAE (FORMERLY CHROMOBACTERIUM VISCOSUM ATCC 6918) LIPASE;1.7;CA;CALCIUM ION;PROTEIN (TRIACYLGLYCEROL HYDROLASE);337;
1QGF;A;PORCINE PANCREATIC ELASTASE COMPLEXED WITH (3R, 4S)N-PARA-TOLUENESULPHONYL-3-ETHYL-4-(CARBOXYLIC ACID)PYRROLIDIN-2-ONE;1.7;CA;CALCIUM ION;ELASTASE;9823;
1QGJ;A;ARABIDOPSIS THALIANA PEROXIDASE N;1.9;CA;CALCIUM ION;PEROXIDASE N;3702;
1QGJ;B;ARABIDOPSIS THALIANA PEROXIDASE N;1.9;CA;CALCIUM ION;PEROXIDASE N;3702;
1QGL;A;Room temperature structure of concanavalin A complexed to bivalent ligand;2.66;CA;CALCIUM ION;PROTEIN (SUCCINYLATED CONCANAVALIN A );3823;
1QGL;B;Room temperature structure of concanavalin A complexed to bivalent ligand;2.66;CA;CALCIUM ION;PROTEIN (SUCCINYLATED CONCANAVALIN A );3823;
1QH4;D;CRYSTAL STRUCTURE OF CHICKEN BRAIN-TYPE CREATINE KINASE AT 1.41 ANGSTROM RESOLUTION;1.41;CA;CALCIUM ION;CREATINE KINASE;9031;
1QHB;A;VANADIUM BROMOPEROXIDASE FROM RED ALGA CORALLINA OFFICINALIS;2.3;CA;CALCIUM ION;HALOPEROXIDASE;35170;
1QHB;B;VANADIUM BROMOPEROXIDASE FROM RED ALGA CORALLINA OFFICINALIS;2.3;CA;CALCIUM ION;HALOPEROXIDASE;35170;
1QHB;C;VANADIUM BROMOPEROXIDASE FROM RED ALGA CORALLINA OFFICINALIS;2.3;CA;CALCIUM ION;HALOPEROXIDASE;35170;
1QHB;D;VANADIUM BROMOPEROXIDASE FROM RED ALGA CORALLINA OFFICINALIS;2.3;CA;CALCIUM ION;HALOPEROXIDASE;35170;
1QHB;E;VANADIUM BROMOPEROXIDASE FROM RED ALGA CORALLINA OFFICINALIS;2.3;CA;CALCIUM ION;HALOPEROXIDASE;35170;
1QHB;F;VANADIUM BROMOPEROXIDASE FROM RED ALGA CORALLINA OFFICINALIS;2.3;CA;CALCIUM ION;HALOPEROXIDASE;35170;
1QHD;A;CRYSTAL STRUCTURE OF VP6, THE MAJOR CAPSID PROTEIN OF GROUP A ROTAVIRUS;1.95;CA;CALCIUM ION;VIRAL CAPSID VP6;10933;
1QHO;A;FIVE-DOMAIN ALPHA-AMYLASE FROM BACILLUS STEAROTHERMOPHILUS, MALTOSE/ACARBOSE COMPLEX;1.7;CA;CALCIUM ION;ALPHA-AMYLASE;1422;
1QHP;A;FIVE-DOMAIN ALPHA-AMYLASE FROM BACILLUS STEAROTHERMOPHILUS, MALTOSE COMPLEX;1.7;CA;CALCIUM ION;ALPHA-AMYLASE;1422;
1QHZ;A;NATIVE TETRAGONAL STRUCTURE OF THE ENDOGLUCANASE CEL5A FROM BACILLUS AGARADHAERENS;1.95;CA;CALCIUM ION;ENDOGLUCANASE B;76935;
1QI0;A;ENDOGLUCANASE CEL5A FROM BACILLUS AGARADHAERENS IN THE TETRAGONAL CRYSTAL FORM IN COMPLEX WITH CELLOBIOSE;2.1;CA;CALCIUM ION;ENDOGLUCANASE B;76935;
1QI2;A;ENDOGLUCANASE CEL5A FROM BACILLUS AGARADHAERENS IN THE TETRAGONAL CRYSTAL FORM IN COMPLEX WITH 2',4'-DINITROPHENYL 2-DEOXY-2-FLUORO-B-D-CELLOTRIOSIDE;1.75;CA;CALCIUM ION;ENDOGLUCANASE B;76935;
1QI3;A;MUTANT (D193N) MALTOTETRAOSE-FORMING EXO-AMYLASE IN COMPLEX WITH MALTOTETRAOSE;2;CA;CALCIUM ION;PROTEIN (EXO-MALTOTETRAOHYDROLASE);316;
1QI4;A;MUTANT (E219G) MALTOTETRAOSE-FORMING EXO-AMYLASE IN COMPLEX WITH MALTOTETRAOSE;2;CA;CALCIUM ION;PROTEIN (EXO-MALTOTETRAOHYDROLASE);316;
1QI5;A;MUTANT (D294N) MALTOTETRAOSE-FORMING EXO-AMYLASE IN COMPLEX WITH MALTOTETRAOSE;2;CA;CALCIUM ION;PROTEIN (EXO-MALTOTETRAOHYDROLASE);316;
1QIA;A;CRYSTAL STRUCTURE OF STROMELYSIN CATALYTIC DOMAIN;2;CA;CALCIUM ION;STROMELYSIN-1;9606;
1QIA;B;CRYSTAL STRUCTURE OF STROMELYSIN CATALYTIC DOMAIN;2;CA;CALCIUM ION;STROMELYSIN-1;9606;
1QIA;C;CRYSTAL STRUCTURE OF STROMELYSIN CATALYTIC DOMAIN;2;CA;CALCIUM ION;STROMELYSIN-1;9606;
1QIA;D;CRYSTAL STRUCTURE OF STROMELYSIN CATALYTIC DOMAIN;2;CA;CALCIUM ION;STROMELYSIN-1;9606;
1QIB;A;CRYSTAL STRUCTURE OF GELATINASE A CATALYTIC DOMAIN;2.8;CA;CALCIUM ION;72 kDa type IV collagenase;9606;
1QIC;A;CRYSTAL STRUCTURE OF STROMELYSIN CATALYTIC DOMAIN;2;CA;CALCIUM ION;PROTEIN (STROMELYSIN-1);9606;
1QIC;B;CRYSTAL STRUCTURE OF STROMELYSIN CATALYTIC DOMAIN;2;CA;CALCIUM ION;PROTEIN (STROMELYSIN-1);9606;
1QIC;C;CRYSTAL STRUCTURE OF STROMELYSIN CATALYTIC DOMAIN;2;CA;CALCIUM ION;PROTEIN (STROMELYSIN-1);9606;
1QIC;D;CRYSTAL STRUCTURE OF STROMELYSIN CATALYTIC DOMAIN;2;CA;CALCIUM ION;PROTEIN (STROMELYSIN-1);9606;
1QIV;A;CALMODULIN COMPLEXED WITH N-(3,3,-DIPHENYLPROPYL)-N'-[1-R-(3,4-BIS-BUTOXYPHENYL)-ETHYL]-PROPYLENEDIAMINE (DPD), 1:2 COMPLEX;2.64;CA;CALCIUM ION;CALMODULIN;9913;
1QIW;A;Calmodulin complexed with N-(3,3,-diphenylpropyl)-N'-[1-R-(3,4-bis-butoxyphenyl)-ethyl]-propylenediamine (DPD);2.3;CA;CALCIUM ION;CALMODULIN;9913;
1QIW;B;Calmodulin complexed with N-(3,3,-diphenylpropyl)-N'-[1-R-(3,4-bis-butoxyphenyl)-ethyl]-propylenediamine (DPD);2.3;CA;CALCIUM ION;CALMODULIN;9913;
1QIX;B;Porcine pancreatic elastase complexed with human beta-casomorphin-7;1.9;CA;CALCIUM ION;ELASTASE;9823;
1QL7;A;FACTOR XA SPECIFIC INHIBITOR IN COMPLEX WITH BOVINE TRYPSIN;2.1;CA;CALCIUM ION;TRYPSIN;9913;
1QL8;A;FACTOR XA SPECIFIC INHIBITOR IN COMPLEX WITH BOVINE TRYPSIN;3;CA;CALCIUM ION;TRYPSIN;9913;
1QL9;A;FACTOR XA SPECIFIC INHIBITOR IN COMPLEX WITH RAT TRYPSIN MUTANT X99RT;2.3;CA;CALCIUM ION;TRYPSIN;10116;
1QLB;A;respiratory complex II-like fumarate reductase from Wolinella succinogenes;2.33;CA;CALCIUM ION;FUMARATE REDUCTASE FLAVOPROTEIN SUBUNIT;844;
1QLB;D;respiratory complex II-like fumarate reductase from Wolinella succinogenes;2.33;CA;CALCIUM ION;FUMARATE REDUCTASE FLAVOPROTEIN SUBUNIT;844;
1QLE;A;CRYO-STRUCTURE OF THE PARACOCCUS DENITRIFICANS FOUR-SUBUNIT CYTOCHROME C OXIDASE IN THE COMPLETELY OXIDIZED STATE COMPLEXED WITH AN ANTIBODY FV FRAGMENT;3;CA;CALCIUM ION;CYTOCHROME C OXIDASE POLYPEPTIDE I-BETA;266;
1QLG;A;Crystal structure of phytase with magnesium from Bacillus amyloliquefaciens;2.2;CA;CALCIUM ION;3-PHYTASE;1390;
1QLK;A;SOLUTION STRUCTURE OF CA(2+)-LOADED RAT S100B (BETABETA) NMR, 20 STRUCTURES;;CA;CALCIUM ION;S-100 PROTEIN;10116;
1QLK;B;SOLUTION STRUCTURE OF CA(2+)-LOADED RAT S100B (BETABETA) NMR, 20 STRUCTURES;;CA;CALCIUM ION;S-100 PROTEIN;10116;
1QLS;A;S100C (S100A11),OR CALGIZZARIN, IN COMPLEX WITH ANNEXIN I N-TERMINUS;2.3;CA;CALCIUM ION;S100C PROTEIN;9823;
1QMD;A;calcium bound closed form alpha-toxin from Clostridium perfringens;2.2;CA;CALCIUM ION;PHOSPHOLIPASE C;1502;
1QMD;B;calcium bound closed form alpha-toxin from Clostridium perfringens;2.2;CA;CALCIUM ION;PHOSPHOLIPASE C;1502;
1QMO;A;Structure of FRIL, a legume lectin that delays hematopoietic progenitor maturation;3.5;CA;CALCIUM ION;MANNOSE BINDING LECTIN, FRIL;35936;
1QMO;B;Structure of FRIL, a legume lectin that delays hematopoietic progenitor maturation;3.5;CA;CALCIUM ION;MANNOSE BINDING LECTIN, FRIL;35936;
1QMO;C;Structure of FRIL, a legume lectin that delays hematopoietic progenitor maturation;3.5;CA;CALCIUM ION;MANNOSE BINDING LECTIN, FRIL;35936;
1QMO;D;Structure of FRIL, a legume lectin that delays hematopoietic progenitor maturation;3.5;CA;CALCIUM ION;MANNOSE BINDING LECTIN, FRIL;35936;
1QMP;A;Phosphorylated aspartate in the crystal structure of the sporulation response regulator, Spo0A;2;CA;CALCIUM ION;Stage 0 sporulation protein A;1422;
1QMP;B;Phosphorylated aspartate in the crystal structure of the sporulation response regulator, Spo0A;2;CA;CALCIUM ION;Stage 0 sporulation protein A;1422;
1QMP;C;Phosphorylated aspartate in the crystal structure of the sporulation response regulator, Spo0A;2;CA;CALCIUM ION;Stage 0 sporulation protein A;1422;
1QMP;D;Phosphorylated aspartate in the crystal structure of the sporulation response regulator, Spo0A;2;CA;CALCIUM ION;Stage 0 sporulation protein A;1422;
1QNI;A;Crystal Structure of Nitrous Oxide Reductase from Pseudomonas nautica, at 2.4A Resolution;2.4;CA;CALCIUM ION;NITROUS-OXIDE REDUCTASE;2743;
1QNI;B;Crystal Structure of Nitrous Oxide Reductase from Pseudomonas nautica, at 2.4A Resolution;2.4;CA;CALCIUM ION;NITROUS-OXIDE REDUCTASE;2743;
1QNI;C;Crystal Structure of Nitrous Oxide Reductase from Pseudomonas nautica, at 2.4A Resolution;2.4;CA;CALCIUM ION;NITROUS-OXIDE REDUCTASE;2743;
1QNI;D;Crystal Structure of Nitrous Oxide Reductase from Pseudomonas nautica, at 2.4A Resolution;2.4;CA;CALCIUM ION;NITROUS-OXIDE REDUCTASE;2743;
1QNI;E;Crystal Structure of Nitrous Oxide Reductase from Pseudomonas nautica, at 2.4A Resolution;2.4;CA;CALCIUM ION;NITROUS-OXIDE REDUCTASE;2743;
1QNI;F;Crystal Structure of Nitrous Oxide Reductase from Pseudomonas nautica, at 2.4A Resolution;2.4;CA;CALCIUM ION;NITROUS-OXIDE REDUCTASE;2743;
1QNW;A;lectin II from Ulex europaeus;2.35;CA;CALCIUM ION;CHITIN BINDING LECTIN, UEA-II;3902;
1QNW;B;lectin II from Ulex europaeus;2.35;CA;CALCIUM ION;CHITIN BINDING LECTIN, UEA-II;3902;
1QNW;C;lectin II from Ulex europaeus;2.35;CA;CALCIUM ION;CHITIN BINDING LECTIN, UEA-II;3902;
1QNW;D;lectin II from Ulex europaeus;2.35;CA;CALCIUM ION;CHITIN BINDING LECTIN, UEA-II;3902;
1QNY;A;X-ray refinement of D2O soaked crystal of concanavalin A;1.8;CA;CALCIUM ION;CONCANAVALIN A;3823;
1QO4;A;ARABIDOPSIS THALIANA PEROXIDASE A2 AT ROOM TEMPERATURE;3;CA;CALCIUM ION;PEROXIDASE;3702;
1QOO;A;lectin UEA-II complexed with NAG;2.75;CA;CALCIUM ION;CHITIN BINDING LECTIN, UEA-II;3902;
1QOO;B;lectin UEA-II complexed with NAG;2.75;CA;CALCIUM ION;CHITIN BINDING LECTIN, UEA-II;3902;
1QOO;C;lectin UEA-II complexed with NAG;2.75;CA;CALCIUM ION;CHITIN BINDING LECTIN, UEA-II;3902;
1QOO;D;lectin UEA-II complexed with NAG;2.75;CA;CALCIUM ION;CHITIN BINDING LECTIN, UEA-II;3902;
1QOS;A;lectin UEA-II complexed with chitobiose;2.95;CA;CALCIUM ION;CHITIN BINDING LECTIN, UEA-II;3902;
1QOS;B;lectin UEA-II complexed with chitobiose;2.95;CA;CALCIUM ION;CHITIN BINDING LECTIN, UEA-II;3902;
1QOT;A;lectin UEA-II complexed with fucosyllactose and fucosylgalactose;3;CA;CALCIUM ION;CHITIN BINDING LECTIN, UEA-II;3902;
1QOT;B;lectin UEA-II complexed with fucosyllactose and fucosylgalactose;3;CA;CALCIUM ION;CHITIN BINDING LECTIN, UEA-II;3902;
1QOT;C;lectin UEA-II complexed with fucosyllactose and fucosylgalactose;3;CA;CALCIUM ION;CHITIN BINDING LECTIN, UEA-II;3902;
1QOT;D;lectin UEA-II complexed with fucosyllactose and fucosylgalactose;3;CA;CALCIUM ION;CHITIN BINDING LECTIN, UEA-II;3902;
1QPA;A;LIGNIN PEROXIDASE ISOZYME LIP4.65 (PI 4.65);1.8;CA;CALCIUM ION;LIGNIN PEROXIDASE;5306;
1QPA;B;LIGNIN PEROXIDASE ISOZYME LIP4.65 (PI 4.65);1.8;CA;CALCIUM ION;LIGNIN PEROXIDASE;5306;
1QPK;A;MUTANT (D193G) MALTOTETRAOSE-FORMING EXO-AMYLASE IN COMPLEX WITH MALTOTETRAOSE;2;CA;CALCIUM ION;PROTEIN (MALTOTETRAOSE-FORMING AMYLASE);316;
1QQ9;A;STREPTOMYCES GRISEUS AMINOPEPTIDASE COMPLEXED WITH METHIONINE;1.53;CA;CALCIUM ION;AMINOPEPTIDASE;1911;
1QQJ;A;CRYSTAL STRUCTURE OF MOUSE FUMARYLACETOACETATE HYDROLASE REFINED AT 1.55 ANGSTROM RESOLUTION;1.55;CA;CALCIUM ION;FUMARYLACETOACETATE HYDROLASE;10090;
1QQJ;B;CRYSTAL STRUCTURE OF MOUSE FUMARYLACETOACETATE HYDROLASE REFINED AT 1.55 ANGSTROM RESOLUTION;1.55;CA;CALCIUM ION;FUMARYLACETOACETATE HYDROLASE;10090;
1QQU;A;CRYSTAL STRUCTURE OF PORCINE BETA TRYPSIN WITH BOUND ACETATE ION;1.63;CA;CALCIUM ION;BETA TRYPSIN;9823;
1QR3;E;Structure of porcine pancreatic elastase in complex with FR901277, a novel macrocyclic inhibitor of elastases at 1.6 angstrom resolution;1.6;CA;CALCIUM ION;ELASTASE 1;9823;
1QS7;A;The 1.8 angstrom structure of calmodulin rs20 peptide complex;1.8;CA;CALCIUM ION;CALMODULIN;562;
1QS7;C;The 1.8 angstrom structure of calmodulin rs20 peptide complex;1.8;CA;CALCIUM ION;CALMODULIN;562;
1QTX;A;THE 1.65 ANGSTROM STRUCTURE OF CALMODULIN RS20 PEPTIDE COMPLEX;1.65;CA;CALCIUM ION;PROTEIN (CALMODULIN);562;
1QU0;A;CRYSTAL STRUCTURE OF THE FIFTH LAMININ G-LIKE MODULE OF THE MOUSE LAMININ ALPHA2 CHAIN;2.35;CA;CALCIUM ION;LAMININ ALPHA2 CHAIN;10090;
1QU0;B;CRYSTAL STRUCTURE OF THE FIFTH LAMININ G-LIKE MODULE OF THE MOUSE LAMININ ALPHA2 CHAIN;2.35;CA;CALCIUM ION;LAMININ ALPHA2 CHAIN;10090;
1QU0;C;CRYSTAL STRUCTURE OF THE FIFTH LAMININ G-LIKE MODULE OF THE MOUSE LAMININ ALPHA2 CHAIN;2.35;CA;CALCIUM ION;LAMININ ALPHA2 CHAIN;10090;
1QU0;D;CRYSTAL STRUCTURE OF THE FIFTH LAMININ G-LIKE MODULE OF THE MOUSE LAMININ ALPHA2 CHAIN;2.35;CA;CALCIUM ION;LAMININ ALPHA2 CHAIN;10090;
1QV1;A;Atomic resolution structure of obelin from Obelia longissima;1.1;CA;CALCIUM ION;Obelin;32570;
1QVI;Z;Crystal structure of scallop myosin S1 in the pre-power stroke state to 2.6 Angstrom resolution: flexibility and function in the head;2.54;CA;CALCIUM ION;Myosin essential light chain, striated adductor muscle;31199;
1QX2;A;X-ray Structure of Calcium-loaded Calbindomodulin (A Calbindin D9k Re-engineered to Undergo a Conformational Opening) at 1.44 A Resolution;1.44;CA;CALCIUM ION;Vitamin D-dependent calcium-binding protein, intestinal;9913;
1QX2;B;X-ray Structure of Calcium-loaded Calbindomodulin (A Calbindin D9k Re-engineered to Undergo a Conformational Opening) at 1.44 A Resolution;1.44;CA;CALCIUM ION;Vitamin D-dependent calcium-binding protein, intestinal;9913;
1QZ5;A;Structure of rabbit actin in complex with kabiramide C;1.45;CA;CALCIUM ION;Actin, alpha skeletal muscle;9986;
1QZ6;A;Structure of rabbit actin in complex with jaspisamide A;1.6;CA;CALCIUM ION;Actin, alpha skeletal muscle;9986;
1R0R;E;1.1 Angstrom Resolution Structure of the Complex Between the Protein Inhibitor, OMTKY3, and the Serine Protease, Subtilisin Carlsberg;1.1;CA;CALCIUM ION;subtilisin carlsberg;1402;
1R13;A;Carbohydrate recognition and neck domains of surfactant protein A (SP-A);2.1;CA;CALCIUM ION;Pulmonary surfactant-associated protein A;10116;
1R17;A;Crystal Structure Analysis of S.epidermidis adhesin SdrG binding to Fibrinogen (adhesin-ligand complex);1.86;CA;CALCIUM ION;fibrinogen-binding protein SdrG;1282;
1R17;B;Crystal Structure Analysis of S.epidermidis adhesin SdrG binding to Fibrinogen (adhesin-ligand complex);1.86;CA;CALCIUM ION;fibrinogen-binding protein SdrG;1282;
1R1Z;A;The Crystal structure of the Carbohydrate recognition domain of the glycoprotein sorting receptor p58/ERGIC-53 reveals a novel metal binding site and conformational changes associated with calcium ion binding;2.4;CA;CALCIUM ION;ERGIC-53 protein;10116;
1R1Z;B;The Crystal structure of the Carbohydrate recognition domain of the glycoprotein sorting receptor p58/ERGIC-53 reveals a novel metal binding site and conformational changes associated with calcium ion binding;2.4;CA;CALCIUM ION;ERGIC-53 protein;10116;
1R1Z;C;The Crystal structure of the Carbohydrate recognition domain of the glycoprotein sorting receptor p58/ERGIC-53 reveals a novel metal binding site and conformational changes associated with calcium ion binding;2.4;CA;CALCIUM ION;ERGIC-53 protein;10116;
1R1Z;D;The Crystal structure of the Carbohydrate recognition domain of the glycoprotein sorting receptor p58/ERGIC-53 reveals a novel metal binding site and conformational changes associated with calcium ion binding;2.4;CA;CALCIUM ION;ERGIC-53 protein;10116;
1R2U;A;NMR structure of the N domain of trout cardiac troponin C at 30 C;;CA;CALCIUM ION;troponin C;8022;
1R4F;A;Inosine-Adenosine-Guanosine Preferring Nucleoside Hydrolase From Trypanosoma vivax: Trp260Ala Mutant In Complex With 3-Deaza-Adenosine;2.3;CA;CALCIUM ION;IAG-nucleoside hydrolase;5699;
1R4F;B;Inosine-Adenosine-Guanosine Preferring Nucleoside Hydrolase From Trypanosoma vivax: Trp260Ala Mutant In Complex With 3-Deaza-Adenosine;2.3;CA;CALCIUM ION;IAG-nucleoside hydrolase;5699;
1R54;A;Crystal structure of the catalytic domain of human ADAM33;1.85;CA;CALCIUM ION;ADAM 33;9606;
1R55;A;Crystal structure of the catalytic domain of human ADAM 33;1.58;CA;CALCIUM ION;ADAM 33;9606;
1R64;A;The 2.2 A crystal structure of Kex2 protease in complex with Ac-Arg-Glu-Lys-boroArg peptidyl boronic acid inhibitor;2.2;CA;CALCIUM ION;Kexin;4932;
1R64;B;The 2.2 A crystal structure of Kex2 protease in complex with Ac-Arg-Glu-Lys-boroArg peptidyl boronic acid inhibitor;2.2;CA;CALCIUM ION;Kexin;4932;
1R6P;A;NMR structure of the N-terminal domain of trout cardiac troponin C at 7 C;;CA;CALCIUM ION;troponin C;8022;
1R6V;A;Crystal structure of fervidolysin from Fervidobacterium pennivorans, a keratinolytic enzyme related to subtilisin;1.7;CA;CALCIUM ION;subtilisin-like serine protease;93466;
1R7M;A;The homing endonuclease I-SceI bound to its DNA recognition region;2.25;CA;CALCIUM ION;Intron-encoded endonuclease I-SceI;4932;
1R7M;B;The homing endonuclease I-SceI bound to its DNA recognition region;2.25;CA;CALCIUM ION;Intron-encoded endonuclease I-SceI;4932;
1R7M;C;The homing endonuclease I-SceI bound to its DNA recognition region;2.25;CA;CALCIUM ION;5'-D(*CP*AP*CP*GP*CP*TP*AP*GP*GP*GP*AP*TP*AP*AP*CP*AP*GP*GP*GP*TP*AP*AP*TP*AP*C)-3';;
1R7M;E;The homing endonuclease I-SceI bound to its DNA recognition region;2.25;CA;CALCIUM ION;5'-D(*CP*AP*CP*GP*CP*TP*AP*GP*GP*GP*AP*TP*AP*AP*CP*AP*GP*GP*GP*TP*AP*AP*TP*AP*C)-3';;
1R8L;A;The structure of endo-beta-1,4-galactanase from Bacillus licheniformis;2.6;CA;CALCIUM ION;endo-beta-1,4-galactanase;1402;
1R8L;B;The structure of endo-beta-1,4-galactanase from Bacillus licheniformis;2.6;CA;CALCIUM ION;endo-beta-1,4-galactanase;1402;
1R9J;A;Transketolase from Leishmania mexicana;2.22;CA;CALCIUM ION;transketolase;5665;
1R9J;B;Transketolase from Leishmania mexicana;2.22;CA;CALCIUM ION;transketolase;5665;
1RA1;A;DIHYDROFOLATE REDUCTASE COMPLEXED WITH NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE (REDUCED FORM);1.9;CA;CALCIUM ION;DIHYDROFOLATE REDUCTASE;562;
1RC8;A;T4 Polynucleotide Kinase bound to 5'-GTCAC-3' ssDNA;2.75;CA;CALCIUM ION;Polynucleotide kinase;10665;
1RDI;1;MANNOSE-BINDING PROTEIN, SUBTILISIN DIGEST FRAGMENT COMPLEX WITH ALPHA-METHYL-L-FUCOPYRANOSIDE;1.8;CA;CALCIUM ION;MANNOSE-BINDING PROTEIN-C;10117;
1RDI;2;MANNOSE-BINDING PROTEIN, SUBTILISIN DIGEST FRAGMENT COMPLEX WITH ALPHA-METHYL-L-FUCOPYRANOSIDE;1.8;CA;CALCIUM ION;MANNOSE-BINDING PROTEIN-C;10117;
1RDJ;1;MANNOSE-BINDING PROTEIN, SUBTILISIN DIGEST FRAGMENT COMPLEX WITH BETA-METHYL-L-FUCOPYRANOSIDE;1.8;CA;CALCIUM ION;MANNOSE-BINDING PROTEIN-C;10117;
1RDJ;2;MANNOSE-BINDING PROTEIN, SUBTILISIN DIGEST FRAGMENT COMPLEX WITH BETA-METHYL-L-FUCOPYRANOSIDE;1.8;CA;CALCIUM ION;MANNOSE-BINDING PROTEIN-C;10117;
1RDK;1;MANNOSE-BINDING PROTEIN, SUBTILISIN DIGEST FRAGMENT COMPLEX WITH D-GALACTOSE;1.8;CA;CALCIUM ION;MANNOSE-BINDING PROTEIN-C;10117;
1RDK;2;MANNOSE-BINDING PROTEIN, SUBTILISIN DIGEST FRAGMENT COMPLEX WITH D-GALACTOSE;1.8;CA;CALCIUM ION;MANNOSE-BINDING PROTEIN-C;10117;
1RDL;1;MANNOSE-BINDING PROTEIN, SUBTILISIN DIGEST FRAGMENT COMPLEX WITH ALPHA-METHYL-D-MANNOPYRANOSIDE (0.2 M);1.7;CA;CALCIUM ION;MANNOSE-BINDING PROTEIN-C;10117;
1RDL;2;MANNOSE-BINDING PROTEIN, SUBTILISIN DIGEST FRAGMENT COMPLEX WITH ALPHA-METHYL-D-MANNOPYRANOSIDE (0.2 M);1.7;CA;CALCIUM ION;MANNOSE-BINDING PROTEIN-C;10117;
1RDM;1;MANNOSE-BINDING PROTEIN, SUBTILISIN DIGEST FRAGMENT COMPLEX WITH ALPHA-METHYL-D-MANNOPYRANOSIDE (1.3 M);1.9;CA;CALCIUM ION;MANNOSE-BINDING PROTEIN-C;10117;
1RDM;2;MANNOSE-BINDING PROTEIN, SUBTILISIN DIGEST FRAGMENT COMPLEX WITH ALPHA-METHYL-D-MANNOPYRANOSIDE (1.3 M);1.9;CA;CALCIUM ION;MANNOSE-BINDING PROTEIN-C;10117;
1RDN;1;MANNOSE-BINDING PROTEIN, SUBTILISIN DIGEST FRAGMENT COMPLEX WITH ALPHA-METHYL-D-N-ACETYLGLUCOSAMINIDE;1.8;CA;CALCIUM ION;MANNOSE-BINDING PROTEIN-C;10117;
1RDN;2;MANNOSE-BINDING PROTEIN, SUBTILISIN DIGEST FRAGMENT COMPLEX WITH ALPHA-METHYL-D-N-ACETYLGLUCOSAMINIDE;1.8;CA;CALCIUM ION;MANNOSE-BINDING PROTEIN-C;10117;
1RDO;1;MANNOSE-BINDING PROTEIN, SUBTILISIN DIGEST FRAGMENT;1.7;CA;CALCIUM ION;MANNOSE-BINDING PROTEIN-C;10117;
1RDO;2;MANNOSE-BINDING PROTEIN, SUBTILISIN DIGEST FRAGMENT;1.7;CA;CALCIUM ION;MANNOSE-BINDING PROTEIN-C;10117;
1RDR;A;POLIOVIRUS 3D POLYMERASE;2.4;CA;CALCIUM ION;POLIOVIRUS 3D POLYMERASE;138950;
1RE3;B;Crystal Structure of Fragment D of BbetaD398A Fibrinogen with the Peptide Ligand Gly-His-Arg-Pro-Amide;2.45;CA;CALCIUM ION;Fibrinogen beta chain;9606;
1RE3;C;Crystal Structure of Fragment D of BbetaD398A Fibrinogen with the Peptide Ligand Gly-His-Arg-Pro-Amide;2.45;CA;CALCIUM ION;Fibrinogen gamma chain;9606;
1RE3;E;Crystal Structure of Fragment D of BbetaD398A Fibrinogen with the Peptide Ligand Gly-His-Arg-Pro-Amide;2.45;CA;CALCIUM ION;Fibrinogen beta chain;9606;
1RE3;F;Crystal Structure of Fragment D of BbetaD398A Fibrinogen with the Peptide Ligand Gly-His-Arg-Pro-Amide;2.45;CA;CALCIUM ION;Fibrinogen gamma chain;9606;
1RE4;B;Crystal Structure of Fragment D of BbetaD398A Fibrinogen;2.7;CA;CALCIUM ION;Fibrinogen beta chain;9606;
1RE4;C;Crystal Structure of Fragment D of BbetaD398A Fibrinogen;2.7;CA;CALCIUM ION;Fibrinogen gamma chain;9606;
1RE4;E;Crystal Structure of Fragment D of BbetaD398A Fibrinogen;2.7;CA;CALCIUM ION;Fibrinogen beta chain;9606;
1RE4;F;Crystal Structure of Fragment D of BbetaD398A Fibrinogen;2.7;CA;CALCIUM ION;Fibrinogen gamma chain;9606;
1REC;A;THREE-DIMENSIONAL STRUCTURE OF RECOVERIN, A CALCIUM SENSOR IN VISION;1.9;CA;CALCIUM ION;RECOVERIN;9913;
1RF0;B;Crystal Structure of Fragment D of gammaE132A Fibrinogen;2.81;CA;CALCIUM ION;Fibrinogen beta chain;9606;
1RF0;C;Crystal Structure of Fragment D of gammaE132A Fibrinogen;2.81;CA;CALCIUM ION;Fibrinogen gamma chain;9606;
1RF0;E;Crystal Structure of Fragment D of gammaE132A Fibrinogen;2.81;CA;CALCIUM ION;Fibrinogen beta chain;9606;
1RF0;F;Crystal Structure of Fragment D of gammaE132A Fibrinogen;2.81;CA;CALCIUM ION;Fibrinogen gamma chain;9606;
1RF1;B;Crystal Structure of Fragment D of gammaE132A Fibrinogen with the Peptide Ligand Gly-His-Arg-Pro-amide;2.53;CA;CALCIUM ION;Fibrinogen beta chain;9606;
1RF1;C;Crystal Structure of Fragment D of gammaE132A Fibrinogen with the Peptide Ligand Gly-His-Arg-Pro-amide;2.53;CA;CALCIUM ION;Fibrinogen gamma chain;9606;
1RF1;E;Crystal Structure of Fragment D of gammaE132A Fibrinogen with the Peptide Ligand Gly-His-Arg-Pro-amide;2.53;CA;CALCIUM ION;Fibrinogen beta chain;9606;
1RF1;F;Crystal Structure of Fragment D of gammaE132A Fibrinogen with the Peptide Ligand Gly-His-Arg-Pro-amide;2.53;CA;CALCIUM ION;Fibrinogen gamma chain;9606;
1RFJ;A;Crystal Structure of Potato Calmodulin PCM6;2;CA;CALCIUM ION;calmodulin;4113;
1RFN;A;HUMAN COAGULATION FACTOR IXA IN COMPLEX WITH P-AMINO BENZAMIDINE;2.8;CA;CALCIUM ION;PROTEIN (COAGULATION FACTOR IX);9606;
1RGA;A;CRYSTAL STRUCTURE OF RNASE T1 WITH 3'-GMP AND GUANOSINE: A PRODUCT COMPLEX;1.7;CA;CALCIUM ION;RIBONUCLEASE T1;5062;
1RGC;A;THE COMPLEX BETWEEN RIBONUCLEASE T1 AND 3'-GUANYLIC ACID SUGGESTS GEOMETRY OF ENZYMATIC REACTION PATH. AN X-RAY STUDY;2;CA;CALCIUM ION;RIBONUCLEASE T1;5062;
1RGC;B;THE COMPLEX BETWEEN RIBONUCLEASE T1 AND 3'-GUANYLIC ACID SUGGESTS GEOMETRY OF ENZYMATIC REACTION PATH. AN X-RAY STUDY;2;CA;CALCIUM ION;RIBONUCLEASE T1;5062;
1RGI;A;Crystal structure of gelsolin domains G1-G3 bound to actin;3;CA;CALCIUM ION;Actin, alpha skeletal muscle;9986;
1RGI;G;Crystal structure of gelsolin domains G1-G3 bound to actin;3;CA;CALCIUM ION;Gelsolin;9796;
1RGK;A;RNASE T1 MUTANT GLU46GLN BINDS THE INHIBITORS 2'GMP AND 2'AMP AT THE 3' SUBSITE;1.87;CA;CALCIUM ION;RIBONUCLEASE T1;5062;
1RGL;A;RNASE T1 MUTANT GLU46GLN BINDS THE INHIBITORS 2'GMP AND 2'AMP AT THE 3' SUBSITE;2;CA;CALCIUM ION;RIBONUCLEASE T1;5062;
1RHI;1;HUMAN RHINOVIRUS 3 COAT PROTEIN;3;CA;CALCIUM ION;HUMAN RHINOVIRUS 3 COAT PROTEIN;147712;
1RHL;A;RIBONUCLEASE T1 COMPLEXED WITH 2'GMP/G23A MUTANT;1.95;CA;CALCIUM ION;PROTEIN (RIBONUCLEASE T1);5062;
1RIN;A;X-RAY CRYSTAL STRUCTURE OF A PEA LECTIN-TRIMANNOSIDE COMPLEX AT 2.6 ANGSTROMS RESOLUTION;2.6;CA;CALCIUM ION;PEA LECTIN;3888;
1RIN;C;X-RAY CRYSTAL STRUCTURE OF A PEA LECTIN-TRIMANNOSIDE COMPLEX AT 2.6 ANGSTROMS RESOLUTION;2.6;CA;CALCIUM ION;PEA LECTIN;3888;
1RIO;A;Structure of bacteriophage lambda cI-NTD in complex with sigma-region4 of Thermus aquaticus bound to DNA;2.3;CA;CALCIUM ION;Repressor protein CI;10710;
1RIR;A;Crystal structure of meso-tetrasulphonatophenylporphyrin in complex with Peanut lectin.;2.9;CA;CALCIUM ION;Galactose-binding lectin;3818;
1RIR;B;Crystal structure of meso-tetrasulphonatophenylporphyrin in complex with Peanut lectin.;2.9;CA;CALCIUM ION;Galactose-binding lectin;3818;
1RIR;C;Crystal structure of meso-tetrasulphonatophenylporphyrin in complex with Peanut lectin.;2.9;CA;CALCIUM ION;Galactose-binding lectin;3818;
1RIR;D;Crystal structure of meso-tetrasulphonatophenylporphyrin in complex with Peanut lectin.;2.9;CA;CALCIUM ION;Galactose-binding lectin;3818;
1RIT;A;Crystal structure of Peanut lectin in complex with meso-tetrasulphonatophenylporphyrin and lactose;2.85;CA;CALCIUM ION;Galactose-binding lectin;3818;
1RIT;B;Crystal structure of Peanut lectin in complex with meso-tetrasulphonatophenylporphyrin and lactose;2.85;CA;CALCIUM ION;Galactose-binding lectin;3818;
1RIT;C;Crystal structure of Peanut lectin in complex with meso-tetrasulphonatophenylporphyrin and lactose;2.85;CA;CALCIUM ION;Galactose-binding lectin;3818;
1RIT;D;Crystal structure of Peanut lectin in complex with meso-tetrasulphonatophenylporphyrin and lactose;2.85;CA;CALCIUM ION;Galactose-binding lectin;3818;
1RJV;A;Solution Structure of Human alpha-Parvalbumin refined with a paramagnetism-based strategy;;CA;CALCIUM ION;Parvalbumin alpha;9606;
1RK8;A;Structure of the cytosolic protein PYM bound to the Mago-Y14 core of the exon junction complex;1.9;CA;CALCIUM ION;CG8781-PA protein;7227;
1RK9;A;Solution Structure of Human alpha-Parvalbumin (Minimized Average Structure);;CA;CALCIUM ION;Parvalbumin alpha;9606;
1RKY;A;PPLO + Xe;1.68;CA;CALCIUM ION;lysyl oxidase;4922;
1RLS;A;CRYSTAL STRUCTURE OF RNASE T1 COMPLEXED WITH THE PRODUCT NUCLEOTIDE 3'-GMP. STRUCTURAL EVIDENCE FOR DIRECT INTERACTION OF HISTIDINE 40 AND GLUTAMIC ACID 58 WITH THE 2'-HYDROXYL GROUP OF RIBOSE;1.9;CA;CALCIUM ION;RIBONUCLEASE T1;5062;
1RLW;A;CALCIUM-PHOSPHOLIPID BINDING DOMAIN FROM CYTOSOLIC PHOSPHOLIPASE A2;2.4;CA;CALCIUM ION;PHOSPHOLIPASE A2;9606;
1RM8;A;Crystal structure of the catalytic domain of MMP-16/MT3-MMP: Characterization of MT-MMP specific features;1.8;CA;CALCIUM ION;Matrix metalloproteinase-16;9606;
1RMZ;A;Crystal structure of the catalytic domain of human MMP12 complexed with the inhibitor NNGH at 1.3 A resolution;1.34;CA;CALCIUM ION;Macrophage metalloelastase;9606;
1ROS;A;Crystal structure of MMP-12 complexed to 2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethyl-4-(4-ethoxy[1,1-biphenyl]-4-yl)-4-oxobutanoic acid;2;CA;CALCIUM ION;Macrophage metalloelastase;9606;
1ROS;B;Crystal structure of MMP-12 complexed to 2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethyl-4-(4-ethoxy[1,1-biphenyl]-4-yl)-4-oxobutanoic acid;2;CA;CALCIUM ION;Macrophage metalloelastase;9606;
1RP1;A;DOG PANCREATIC LIPASE RELATED PROTEIN 1;2.1;CA;CALCIUM ION;PANCREATIC LIPASE RELATED PROTEIN 1;9612;
1RP8;A;Crystal structure of barley alpha-amylase isozyme 1 (amy1) inactive mutant d180a in complex with maltoheptaose;2;CA;CALCIUM ION;Alpha-amylase type 1 isozyme;4513;
1RP9;A;Crystal structure of barley alpha-amylase isozyme 1 (amy1) inactive mutant d180a in complex with acarbose;2;CA;CALCIUM ION;Alpha-amylase type 1 isozyme;4513;
1RPK;A;Crystal structure of barley alpha-amylase isozyme 1 (amy1) in complex with acarbose;2;CA;CALCIUM ION;Alpha-amylase type 1 isozyme;4513;
1RPZ;A;T4 POLYNUCLEOTIDE KINASE BOUND TO 5'-TGCAC-3' SSDNA;2.9;CA;CALCIUM ION;Polynucleotide kinase;10665;
1RQ5;A;Structural Basis for the Exocellulase Activity of the Cellobiohydrolase CbhA from C. thermocellum;2.4;CA;CALCIUM ION;Cellobiohydrolase;1515;
1RRC;A;T4 POLYNUCLEOTIDE KINASE BOUND TO 5'-GTC-3' SSDNA;2.46;CA;CALCIUM ION;Polynucleotide kinase;10665;
1RRO;A;REFINEMENT OF RECOMBINANT ONCOMODULIN AT 1.30 ANGSTROMS RESOLUTION;1.3;CA;CALCIUM ION;RAT ONCOMODULIN;10117;
1RRQ;A;MutY adenine glycosylase in complex with DNA containing an A:oxoG pair;2.22;CA;CALCIUM ION;MutY;1422;
1RRS;A;MutY adenine glycosylase in complex with DNA containing an abasic site;2.4;CA;CALCIUM ION;MutY;1422;
1RTG;A;C-TERMINAL DOMAIN (HAEMOPEXIN-LIKE DOMAIN) OF HUMAN MATRIX METALLOPROTEINASE-2;2.6;CA;CALCIUM ION;HUMAN GELATINASE A;9606;
1RTM;1;TRIMERIC STRUCTURE OF A C-TYPE MANNOSE-BINDING PROTEIN;1.8;CA;CALCIUM ION;MANNOSE-BINDING PROTEIN-A;10116;
1RTM;2;TRIMERIC STRUCTURE OF A C-TYPE MANNOSE-BINDING PROTEIN;1.8;CA;CALCIUM ION;MANNOSE-BINDING PROTEIN-A;10116;
1RTM;3;TRIMERIC STRUCTURE OF A C-TYPE MANNOSE-BINDING PROTEIN;1.8;CA;CALCIUM ION;MANNOSE-BINDING PROTEIN-A;10116;
1RTP;1;REFINED X-RAY STRUCTURE OF RAT PARVALBUMIN, A MAMMALIAN ALPHA-LINEAGE PARVALBUMIN, AT 2.0 A RESOLUTION;2;CA;CALCIUM ION;ALPHA-PARVALBUMIN;10117;
1RTP;2;REFINED X-RAY STRUCTURE OF RAT PARVALBUMIN, A MAMMALIAN ALPHA-LINEAGE PARVALBUMIN, AT 2.0 A RESOLUTION;2;CA;CALCIUM ION;ALPHA-PARVALBUMIN;10117;
1RTP;3;REFINED X-RAY STRUCTURE OF RAT PARVALBUMIN, A MAMMALIAN ALPHA-LINEAGE PARVALBUMIN, AT 2.0 A RESOLUTION;2;CA;CALCIUM ION;ALPHA-PARVALBUMIN;10117;
1RU4;A;Crystal structure of pectate lyase Pel9A;1.6;CA;CALCIUM ION;Pectate lyase;556;
1RWY;A;CRYSTAL STRUCTURE OF RAT ALPHA-PARVALBUMIN AT 1.05 RESOLUTION;1.05;CA;CALCIUM ION;PARVALBUMIN ALPHA;10116;
1RWY;B;CRYSTAL STRUCTURE OF RAT ALPHA-PARVALBUMIN AT 1.05 RESOLUTION;1.05;CA;CALCIUM ION;PARVALBUMIN ALPHA;10116;
1RWY;C;CRYSTAL STRUCTURE OF RAT ALPHA-PARVALBUMIN AT 1.05 RESOLUTION;1.05;CA;CALCIUM ION;PARVALBUMIN ALPHA;10116;
1RX1;A;DIHYDROFOLATE REDUCTASE (E.C.1.5.1.3) COMPLEXED WITH NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE (REDUCED FORM);2;CA;CALCIUM ION;DIHYDROFOLATE REDUCTASE;562;
1RX9;A;DIHYDROFOLATE REDUCTASE (E.C.1.5.1.3) COMPLEXED WITH NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE (OXIDIZED FORM);1.9;CA;CALCIUM ION;DIHYDROFOLATE REDUCTASE;562;
1RXO;B;ACTIVATED SPINACH RUBISCO IN COMPLEX WITH ITS SUBSTRATE RIBULOSE-1,5-BISPHOSPHATE AND CALCIUM;2.2;CA;CALCIUM ION;RIBULOSE BISPHOSPHATE CARBOXYLASE/OXYGENASE;3562;
1RXO;E;ACTIVATED SPINACH RUBISCO IN COMPLEX WITH ITS SUBSTRATE RIBULOSE-1,5-BISPHOSPHATE AND CALCIUM;2.2;CA;CALCIUM ION;RIBULOSE BISPHOSPHATE CARBOXYLASE/OXYGENASE;3562;
1RXO;H;ACTIVATED SPINACH RUBISCO IN COMPLEX WITH ITS SUBSTRATE RIBULOSE-1,5-BISPHOSPHATE AND CALCIUM;2.2;CA;CALCIUM ION;RIBULOSE BISPHOSPHATE CARBOXYLASE/OXYGENASE;3562;
1RXO;L;ACTIVATED SPINACH RUBISCO IN COMPLEX WITH ITS SUBSTRATE RIBULOSE-1,5-BISPHOSPHATE AND CALCIUM;2.2;CA;CALCIUM ION;RIBULOSE BISPHOSPHATE CARBOXYLASE/OXYGENASE;3562;
1RXP;A;STRUCTURE OF TRYPSIN (ORTHORHOMBIC) WITH 1-(4-TERT-BUTYLCARBAMOYL- PIPERAZINE-1-CARBONYL)-3-(3-GUANIDINO-PROPYL)-4-OXO-AZETIDINE-2-CARBOXYLIC ACID;1.7;CA;CALCIUM ION;TRYPSIN;9913;
1RYR;A;REPLICATION OF A CIS-SYN THYMINE DIMER AT ATOMIC RESOLUTION;2.28;CA;CALCIUM ION;DNA polymerase IV;2287;
1RYS;A;REPLICATION OF A CIS-SYN THYMINE DIMER AT ATOMIC RESOLUTION;2.03;CA;CALCIUM ION;DNA polymerase IV;2287;
1RYS;B;REPLICATION OF A CIS-SYN THYMINE DIMER AT ATOMIC RESOLUTION;2.03;CA;CALCIUM ION;DNA polymerase IV;2287;
1RYS;C;REPLICATION OF A CIS-SYN THYMINE DIMER AT ATOMIC RESOLUTION;2.03;CA;CALCIUM ION;5'-D(*GP*GP*GP*GP*AP*AP*GP*GP*AP*TP*TP*CP*A)-3';;
1RZ3;A;Structure of a Possible Uridine Kinase from Bacillus stearothermophilus;1.9;CA;CALCIUM ION;hypothetical protein RBSTP0775;1422;
1RZ5;A;Di-haem Cytochrome c Peroxidase, Form OUT;2.4;CA;CALCIUM ION;Cytochrome c peroxidase;2743;
1S01;A;LARGE INCREASES IN GENERAL STABILITY FOR SUBTILISIN BPN(PRIME) THROUGH INCREMENTAL CHANGES IN THE FREE ENERGY OF UNFOLDING;1.7;CA;CALCIUM ION;Subtilisin BPN';1390;
1S02;A;EFFECTS OF ENGINEERED SALT BRIDGES ON THE STABILITY OF SUBTILISIN BPN';1.9;CA;CALCIUM ION;SUBTILISIN BPN';1390;
1S0B;A;Crystal structure of botulinum neurotoxin type B at pH 4.0;2;CA;CALCIUM ION;Botulinum neurotoxin type B;1491;
1S0C;A;Crystal structure of botulinum neurotoxin type B at pH 5.0;2.2;CA;CALCIUM ION;Botulinum neurotoxin type B;1491;
1S0D;A;Crystal structure of botulinum neurotoxin type B at pH 5.5;2.2;CA;CALCIUM ION;Botulinum neurotoxin type B;1491;
1S0E;A;Crystal structure of botulinum neurotoxin type B at pH 6.0;1.9;CA;CALCIUM ION;Botulinum neurotoxin type B;1491;
1S0F;A;Crystal structure of botulinum neurotoxin type B at pH 7.0;2.3;CA;CALCIUM ION;Botulinum neurotoxin type B;1491;
1S0M;A;Crystal structure of a Benzo[a]pyrene Diol Epoxide adduct in a ternary complex with a DNA polymerase;2.7;CA;CALCIUM ION;DNA polymerase IV;2287;
1S0M;B;Crystal structure of a Benzo[a]pyrene Diol Epoxide adduct in a ternary complex with a DNA polymerase;2.7;CA;CALCIUM ION;DNA polymerase IV;2287;
1S0M;E;Crystal structure of a Benzo[a]pyrene Diol Epoxide adduct in a ternary complex with a DNA polymerase;2.7;CA;CALCIUM ION;5'-D(*GP*GP*GP*GP*GP*AP*AP*GP*GP*AP*TP*TP*T)-3';;
1S0N;A;Snapshots of replication through an abasic lesion: structural basis for base substitution and frameshift;2.8;CA;CALCIUM ION;DNA polymerase IV;2287;
1S0O;A;Snapshots of replication through an abasic lesion: structural basis for base substitution and frameshift;2.1;CA;CALCIUM ION;DNA polymerase IV;2287;
1S0O;B;Snapshots of replication through an abasic lesion: structural basis for base substitution and frameshift;2.1;CA;CALCIUM ION;DNA polymerase IV;2287;
1S0Q;A;Native Bovine Pancreatic Trypsin;1.02;CA;CALCIUM ION;Trypsinogen;9913;
1S0R;A;Bovine Pancreatic Trypsin inhibited with Benzamidine at Atomic resolution;1.02;CA;CALCIUM ION;Trypsinogen;9913;
1S0W;C;1b Lactamse/ b Lactamase Inhibitor;2.3;CA;CALCIUM ION;Beta-lactamase inhibitory protein;1901;
1S0W;D;1b Lactamse/ b Lactamase Inhibitor;2.3;CA;CALCIUM ION;Beta-lactamase inhibitory protein;1901;
1S10;A;Snapshots of replication through an abasic lesion: structural basis for base substitution and frameshift;2.1;CA;CALCIUM ION;DNA polymerase IV;2287;
1S18;A;Structure and protein design of human apyrase;1.7;CA;CALCIUM ION;apyrase;9606;
1S18;B;Structure and protein design of human apyrase;1.7;CA;CALCIUM ION;apyrase;9606;
1S1A;A;Pterocarpus angolensis seed lectin (PAL) with one binding site free and one binding site containing the disaccharide Man(a1-3)ManMe;1.8;CA;CALCIUM ION;lectin;182271;
1S1A;B;Pterocarpus angolensis seed lectin (PAL) with one binding site free and one binding site containing the disaccharide Man(a1-3)ManMe;1.8;CA;CALCIUM ION;lectin;182271;
1S1D;A;Structure and protein design of human apyrase;1.6;CA;CALCIUM ION;apyrase;9606;
1S1D;B;Structure and protein design of human apyrase;1.6;CA;CALCIUM ION;apyrase;9606;
1S1E;A;Crystal Structure of Kv Channel-interacting protein 1 (KChIP-1);2.3;CA;CALCIUM ION;Kv channel interacting protein 1;9606;
1S1K;A;INFLUENCE OF GROOVE INTERACTIONS ON DNA HOLLIDAY JUNCTION FORMATION;1.9;CA;CALCIUM ION;5'-D(*CP*CP*(1AP)P*GP*TP*AP*CP*TP*GP*G)-3';;
1S22;A;Absolute Stereochemistry of Ulapualide A;1.6;CA;CALCIUM ION;Actin;9986;
1S26;D;Structure of Anthrax Edema Factor-Calmodulin-alpha,beta-methyleneadenosine 5'-triphosphate Complex Reveals an Alternative Mode of ATP Binding to the Catalytic Site;3;CA;CALCIUM ION;Calmodulin;9606;
1S26;E;Structure of Anthrax Edema Factor-Calmodulin-alpha,beta-methyleneadenosine 5'-triphosphate Complex Reveals an Alternative Mode of ATP Binding to the Catalytic Site;3;CA;CALCIUM ION;Calmodulin;9606;
1S26;F;Structure of Anthrax Edema Factor-Calmodulin-alpha,beta-methyleneadenosine 5'-triphosphate Complex Reveals an Alternative Mode of ATP Binding to the Catalytic Site;3;CA;CALCIUM ION;Calmodulin;9606;
1S2N;A;Crystal structure of a cold adapted subtilisin-like serine proteinase;2.44;CA;CALCIUM ION;extracellular subtilisin-like serine proteinase;210249;
1S2N;B;Crystal structure of a cold adapted subtilisin-like serine proteinase;2.44;CA;CALCIUM ION;extracellular subtilisin-like serine proteinase;210249;
1S3P;A;Crystal structure of rat alpha-parvalbumin S55D/E59D mutant;2;CA;CALCIUM ION;Parvalbumin alpha;10116;
1S3X;A;The crystal structure of the human Hsp70 ATPase domain;1.84;CA;CALCIUM ION;Heat shock 70 kDa protein 1;9606;
1S5G;Z;Structure of Scallop myosin S1 reveals a novel nucleotide conformation;3.1;CA;CALCIUM ION;Myosin essential light chain, striated adductor muscle;31199;
1S5S;A;Porcine trypsin complexed with guanidine-3-propanol inhibitor;1.4;CA;CALCIUM ION;Trypsin;9823;
1S6B;A;X-ray Crystal Structure of a Complex Formed Between Two Homologous Isoforms of Phospholipase A2 from Naja naja sagittifera: Principle of Molecular Association and Inactivation;1.6;CA;CALCIUM ION;Phospholipase A2 isoform 1;195058;
1S6B;B;X-ray Crystal Structure of a Complex Formed Between Two Homologous Isoforms of Phospholipase A2 from Naja naja sagittifera: Principle of Molecular Association and Inactivation;1.6;CA;CALCIUM ION;Phospholipase A2 isoform 2;195058;
1S6C;A;Crystal structure of the complex between KChIP1 and Kv4.2 N1-30;2;CA;CALCIUM ION;Kv4 potassium channel-interacting protein KChIP1b;10116;
1S6F;A;PORCINE TRYPSIN COVALENT COMPLEX WITH BORATE AND GUANIDINE-3 INHIBITOR;1.8;CA;CALCIUM ION;Trypsin;9823;
1S6H;A;PORCINE TRYPSIN COMPLEXED WITH GUANIDINE-3-PROPANOL INHIBITOR;1.45;CA;CALCIUM ION;Trypsin;9823;
1S6I;A;Ca2+-regulatory region (CLD) from soybean calcium-dependent protein kinase-alpha (CDPK) in the presence of Ca2+ and the junction domain (JD);;CA;CALCIUM ION;Calcium-dependent protein kinase SK5;3847;
1S6J;A;N-terminal Region of the Ca2+-saturated calcium regulatory domain (CLD) from Soybean Calcium-dependent Protein Kinase-alpha (CDPK);;CA;CALCIUM ION;Calcium-dependent protein kinase SK5;3847;
1S81;A;PORCINE TRYPSIN WITH NO INHIBITOR BOUND;1.7;CA;CALCIUM ION;TRYPSIN;9823;
1S82;A;PORCINE TRYPSIN COMPLEXED WITH BORATE AND ETHYLENE GLYCOL;1.85;CA;CALCIUM ION;TRYPSIN;9823;
1S83;A;PORCINE TRYPSIN COMPLEXED WITH 4-AMINO PROPANOL;1.25;CA;CALCIUM ION;TRYPSIN;9823;
1S84;A;PORCINE TRYPSIN COVALENT COMPLEX WITH 4-AMINO BUTANOL, BORATE AND ETHYLENE GLYCOL;1.85;CA;CALCIUM ION;TRYPSIN;9823;
1S85;A;PORCINE TRYPSIN COMPLEXED WITH P-HYDROXYMETHYL BENZAMIDINE AND BORATE;2.2;CA;CALCIUM ION;TRYPSIN;9823;
1S97;A;DPO4 with GT mismatch;2.4;CA;CALCIUM ION;DNA polymerase IV;2287;
1S97;B;DPO4 with GT mismatch;2.4;CA;CALCIUM ION;DNA polymerase IV;2287;
1S97;C;DPO4 with GT mismatch;2.4;CA;CALCIUM ION;DNA polymerase IV;2287;
1S97;D;DPO4 with GT mismatch;2.4;CA;CALCIUM ION;DNA polymerase IV;2287;
1S99;A;The structure and function of B. subtilis YkoF gene product: ligand free protein;1.65;CA;CALCIUM ION;ykoF;1423;
1S9F;A;DPO with AT matched;2;CA;CALCIUM ION;DNA polymerase IV;2287;
1S9F;B;DPO with AT matched;2;CA;CALCIUM ION;DNA polymerase IV;2287;
1S9F;C;DPO with AT matched;2;CA;CALCIUM ION;DNA polymerase IV;2287;
1S9F;D;DPO with AT matched;2;CA;CALCIUM ION;DNA polymerase IV;2287;
1SAC;A;THE STRUCTURE OF PENTAMERIC HUMAN SERUM AMYLOID P COMPONENT;2;CA;CALCIUM ION;SERUM AMYLOID P COMPONENT;9606;
1SAC;B;THE STRUCTURE OF PENTAMERIC HUMAN SERUM AMYLOID P COMPONENT;2;CA;CALCIUM ION;SERUM AMYLOID P COMPONENT;9606;
1SAC;C;THE STRUCTURE OF PENTAMERIC HUMAN SERUM AMYLOID P COMPONENT;2;CA;CALCIUM ION;SERUM AMYLOID P COMPONENT;9606;
1SAC;D;THE STRUCTURE OF PENTAMERIC HUMAN SERUM AMYLOID P COMPONENT;2;CA;CALCIUM ION;SERUM AMYLOID P COMPONENT;9606;
1SAC;E;THE STRUCTURE OF PENTAMERIC HUMAN SERUM AMYLOID P COMPONENT;2;CA;CALCIUM ION;SERUM AMYLOID P COMPONENT;9606;
1SAT;A;CRYSTAL STRUCTURE OF THE 50 KDA METALLO PROTEASE FROM S. MARCESCENS;1.75;CA;CALCIUM ION;SERRATIA PROTEASE;615;
1SAV;A;HUMAN ANNEXIN V WITH PROLINE SUBSTITUTION BY THIOPROLINE;2.5;CA;CALCIUM ION;ANNEXIN V;9606;
1SBC;A;THE REFINED CRYSTAL STRUCTURE OF SUBTILISIN CARLSBERG AT 2.5 ANGSTROMS RESOLUTION;2.5;CA;CALCIUM ION;SUBTILISIN CARLSBERG;1423;
1SBD;A;SOYBEAN AGGLUTININ COMPLEXED WITH 2,4-PENTASACCHARIDE;2.52;CA;CALCIUM ION;SOYBEAN AGGLUTININ;3847;
1SBE;A;SOYBEAN AGGLUTININ FROM GLYCINE MAX;2.8;CA;CALCIUM ION;SOYBEAN AGGLUTININ;3847;
1SBF;A;SOYBEAN AGGLUTININ;2.43;CA;CALCIUM ION;SOYBEAN AGGLUTININ;3847;
1SBH;A;SUBTILISIN BPN' 8397+1 (E.C. 3.4.21.14) MUTANT (M50F, N76D, G169A, Q206C, N218S, K256Y);1.8;CA;CALCIUM ION;SUBTILISIN 8397+1;1390;
1SBI;A;SUBTILISIN BPN' 8397 (E.C. 3.4.21.14) MUTANT (M50F, N76D, G169A, Q206C, N218S);2.2;CA;CALCIUM ION;SUBTILISIN 8397;1390;
1SBN;E;REFINED CRYSTAL STRUCTURES OF SUBTILISIN NOVO IN COMPLEX WITH WILD-TYPE AND TWO MUTANT EGLINS. COMPARISON WITH OTHER SERINE PROTEINASE INHIBITOR COMPLEXES;2.1;CA;CALCIUM ION;SUBTILISIN NOVO BPN';1423;
1SBR;A;The structure and function of B. subtilis YkoF gene product: the complex with thiamin;2.3;CA;CALCIUM ION;ykoF;1423;
1SBW;A;CRYSTAL STRUCTURE OF MUNG BEAN INHIBITOR LYSINE ACTIVE FRAGMENT COMPLEX WITH BOVINE BETA-TRYPSIN AT 1.8A RESOLUTION;1.8;CA;CALCIUM ION;PROTEIN (BETA-TRYPSIN);9913;
1SCA;A;ENZYME CRYSTAL STRUCTURE IN A NEAT ORGANIC SOLVENT;2;CA;CALCIUM ION;SUBTILISIN CARLSBERG;1402;
1SCB;A;ENZYME CRYSTAL STRUCTURE IN A NEAT ORGANIC SOLVENT;2.3;CA;CALCIUM ION;SUBTILISIN CARLSBERG;1402;
1SCD;A;X-RAY CRYSTAL STRUCTURE OF CROSS-LINKED SUBTILISM CARLSBERG IN WATER VS. ACETONITRILE;2.3;CA;CALCIUM ION;SUBTILISIN CARLSBERG;1402;
1SCF;C;HUMAN RECOMBINANT STEM CELL FACTOR;2.2;CA;CALCIUM ION;STEM CELL FACTOR;9606;
1SCF;D;HUMAN RECOMBINANT STEM CELL FACTOR;2.2;CA;CALCIUM ION;STEM CELL FACTOR;9606;
1SCH;A;PEANUT PEROXIDASE;2.56;CA;CALCIUM ION;PEANUT PEROXIDASE, MAJOR CATIONIC ISOZYME;3818;
1SCH;B;PEANUT PEROXIDASE;2.56;CA;CALCIUM ION;PEANUT PEROXIDASE, MAJOR CATIONIC ISOZYME;3818;
1SCJ;A;CRYSTAL STRUCTURE OF SUBTILISIN-PROPEPTIDE COMPLEX;2;CA;CALCIUM ION;SUBTILISIN E;1423;
1SCM;B;STRUCTURE OF THE REGULATORY DOMAIN OF SCALLOP MYOSIN AT 2.8 ANGSTROMS RESOLUTION;2.8;CA;CALCIUM ION;MYOSIN REGULATORY LIGHT CHAIN;31199;
1SCM;C;STRUCTURE OF THE REGULATORY DOMAIN OF SCALLOP MYOSIN AT 2.8 ANGSTROMS RESOLUTION;2.8;CA;CALCIUM ION;MYOSIN ESSENTIAL LIGHT CHAIN;31199;
1SCN;E;INACTIVATION OF SUBTILISIN CARLSBERG BY N-(TERT-BUTOXYCARBONYL-ALANYL-PROLYL-PHENYLALANYL)-O-BENZOL HYDROXYLAMINE: FORMATION OF COVALENT ENZYME-INHIBITOR LINKAGE IN THE FORM OF A CARBAMATE DERIVATIVE;1.9;CA;CALCIUM ION;SUBTILISIN CARLSBERG;1402;
1SCR;A;HIGH-RESOLUTION STRUCTURES OF SINGLE-METAL-SUBSTITUTED CONCANAVALIN A: THE CO,CA-PROTEIN AT 1.6 ANGSTROMS AND THE NI,CA-PROTEIN AT 2.0 ANGSTROMS;2;CA;CALCIUM ION;CONCANAVALIN A;3823;
1SCS;A;HIGH-RESOLUTION STRUCTURES OF SINGLE-METAL-SUBSTITUTED CONCANAVALIN A: THE CO,CA-PROTEIN AT 1.6 ANGSTROMS AND THE NI,CA-PROTEIN AT 2.0 ANGSTROMS;1.6;CA;CALCIUM ION;CONCANAVALIN A;3823;
1SCV;A;NMR STRUCTURE OF THE C TERMINAL DOMAIN OF CARDIAC TROPONIN C BOUND TO THE N TERMINAL DOMAIN OF CARDIAC TROPONIN I;;CA;CALCIUM ION;Troponin C, slow skeletal and cardiac muscles;9031;
1SDD;A;Crystal Structure of Bovine Factor Vai;2.8;CA;CALCIUM ION;Coagulation factor V;9913;
1SDS;D;Structure of protein L7Ae bound to a K-turn derived from an archaeal box H/ACA sRNA;1.8;CA;CALCIUM ION;box H/ACA sRNA;;
1SDS;E;Structure of protein L7Ae bound to a K-turn derived from an archaeal box H/ACA sRNA;1.8;CA;CALCIUM ION;box H/ACA sRNA;;
1SDS;F;Structure of protein L7Ae bound to a K-turn derived from an archaeal box H/ACA sRNA;1.8;CA;CALCIUM ION;box H/ACA sRNA;;
1SEL;A;CRYSTAL STRUCTURE OF SELENOSUBTILISIN AT 2.0-ANGSTROMS RESOLUTION;2;CA;CALCIUM ION;SELENOSUBTILISIN;1423;
1SEL;B;CRYSTAL STRUCTURE OF SELENOSUBTILISIN AT 2.0-ANGSTROMS RESOLUTION;2;CA;CALCIUM ION;SELENOSUBTILISIN;1423;
1SFI;A;High resolution structure of a potent, cyclic protease inhibitor from sunflower seeds;1.65;CA;CALCIUM ION;TRYPSIN;9913;
1SFK;A;Core (C) protein from West Nile Virus, subtype Kunjin;3.2;CA;CALCIUM ION;Core protein;11082;
1SFK;D;Core (C) protein from West Nile Virus, subtype Kunjin;3.2;CA;CALCIUM ION;Core protein;11082;
1SFK;F;Core (C) protein from West Nile Virus, subtype Kunjin;3.2;CA;CALCIUM ION;Core protein;11082;
1SFK;G;Core (C) protein from West Nile Virus, subtype Kunjin;3.2;CA;CALCIUM ION;Core protein;11082;
1SFV;A;PORCINE PANCREAS PHOSPHOLIPASE A2, NMR, MINIMIZED AVERAGE STRUCTURE;;CA;CALCIUM ION;PHOSPHOLIPASE A2;9823;
1SFW;A;PORCINE PANCREAS PHOSPHOLIPASE A2, NMR, 18 STRUCTURES;;CA;CALCIUM ION;PHOSPHOLIPASE A2;9823;
1SFY;A;Crystal structure of recombinant Erythrina corallodandron Lectin;2.55;CA;CALCIUM ION;Lectin;3843;
1SFY;B;Crystal structure of recombinant Erythrina corallodandron Lectin;2.55;CA;CALCIUM ION;Lectin;3843;
1SFY;C;Crystal structure of recombinant Erythrina corallodandron Lectin;2.55;CA;CALCIUM ION;Lectin;3843;
1SFY;D;Crystal structure of recombinant Erythrina corallodandron Lectin;2.55;CA;CALCIUM ION;Lectin;3843;
1SFY;E;Crystal structure of recombinant Erythrina corallodandron Lectin;2.55;CA;CALCIUM ION;Lectin;3843;
1SFY;F;Crystal structure of recombinant Erythrina corallodandron Lectin;2.55;CA;CALCIUM ION;Lectin;3843;
1SGS;A;Crystal structure of a free kB DNA;1.6;CA;CALCIUM ION;kB DNA;;
1SGT;A;REFINED CRYSTAL STRUCTURE OF STREPTOMYCES GRISEUS TRYPSIN AT 1.7 ANGSTROMS RESOLUTION;1.7;CA;CALCIUM ION;TRYPSIN;1911;
1SH7;A;Crystal structure of a cold adapted subtilisin-like serine proteinase;1.84;CA;CALCIUM ION;extracellular subtilisin-like serine proteinase;210249;
1SH7;B;Crystal structure of a cold adapted subtilisin-like serine proteinase;1.84;CA;CALCIUM ION;extracellular subtilisin-like serine proteinase;210249;
1SIB;E;REFINED CRYSTAL STRUCTURES OF SUBTILISIN NOVO IN COMPLEX WITH WILD-TYPE AND TWO MUTANT EGLINS. COMPARISON WITH OTHER SERINE PROTEINASE INHIBITOR COMPLEXES;2.4;CA;CALCIUM ION;SUBTILISIN NOVO BPN';1423;
1SIO;A;Structure of Kumamolisin-As complexed with a covalently-bound inhibitor, AcIPF;1.8;CA;CALCIUM ION;kumamolisin-As;192387;
1SIO;B;Structure of Kumamolisin-As complexed with a covalently-bound inhibitor, AcIPF;1.8;CA;CALCIUM ION;kumamolisin-As;192387;
1SIO;C;Structure of Kumamolisin-As complexed with a covalently-bound inhibitor, AcIPF;1.8;CA;CALCIUM ION;kumamolisin-As;192387;
1SIU;A;KUMAMOLISIN-AS E78H MUTANT;2.31;CA;CALCIUM ION;kumamolisin-As;192387;
1SK5;A;The ultra-high resolution structure of d(CTTTTAAAAG)2: modulation of bending by T-A steps and its role in DNA recognition;0.89;CA;CALCIUM ION;5'-D(*CP*TP*TP*TP*TP*AP*AP*AP*AP*G)-3';;
1SK5;B;The ultra-high resolution structure of d(CTTTTAAAAG)2: modulation of bending by T-A steps and its role in DNA recognition;0.89;CA;CALCIUM ION;5'-D(*CP*TP*TP*TP*TP*AP*AP*AP*AP*G)-3';;
1SK6;D;Crystal structure of the adenylyl cyclase domain of anthrax edema factor (EF) in complex with calmodulin, 3',5' cyclic AMP (cAMP), and pyrophosphate;3.2;CA;CALCIUM ION;Calmodulin;9606;
1SK6;E;Crystal structure of the adenylyl cyclase domain of anthrax edema factor (EF) in complex with calmodulin, 3',5' cyclic AMP (cAMP), and pyrophosphate;3.2;CA;CALCIUM ION;Calmodulin;9606;
1SK6;F;Crystal structure of the adenylyl cyclase domain of anthrax edema factor (EF) in complex with calmodulin, 3',5' cyclic AMP (cAMP), and pyrophosphate;3.2;CA;CALCIUM ION;Calmodulin;9606;
1SL4;A;Crystal Structure of DC-SIGN carbohydrate recognition domain complexed with Man4;1.55;CA;CALCIUM ION;mDC-SIGN1B type I isoform;9606;
1SL5;A;Crystal Structure of DC-SIGN carbohydrate recognition domain complexed with LNFP III (Dextra L504).;1.8;CA;CALCIUM ION;mDC-SIGN1B type I isoform;9606;
1SL6;A;Crystal Structure of a fragment of DC-SIGNR (containg the carbohydrate recognition domain and two repeats of the neck) complexed with Lewis-x.;2.25;CA;CALCIUM ION;C-type lectin DC-SIGNR;9606;
1SL6;B;Crystal Structure of a fragment of DC-SIGNR (containg the carbohydrate recognition domain and two repeats of the neck) complexed with Lewis-x.;2.25;CA;CALCIUM ION;C-type lectin DC-SIGNR;9606;
1SL6;C;Crystal Structure of a fragment of DC-SIGNR (containg the carbohydrate recognition domain and two repeats of the neck) complexed with Lewis-x.;2.25;CA;CALCIUM ION;C-type lectin DC-SIGNR;9606;
1SL6;D;Crystal Structure of a fragment of DC-SIGNR (containg the carbohydrate recognition domain and two repeats of the neck) complexed with Lewis-x.;2.25;CA;CALCIUM ION;C-type lectin DC-SIGNR;9606;
1SL6;E;Crystal Structure of a fragment of DC-SIGNR (containg the carbohydrate recognition domain and two repeats of the neck) complexed with Lewis-x.;2.25;CA;CALCIUM ION;C-type lectin DC-SIGNR;9606;
1SL6;F;Crystal Structure of a fragment of DC-SIGNR (containg the carbohydrate recognition domain and two repeats of the neck) complexed with Lewis-x.;2.25;CA;CALCIUM ION;C-type lectin DC-SIGNR;9606;
1SL7;A;Crystal structure of calcium-loaded apo-obelin from Obelia longissima;2.2;CA;CALCIUM ION;Obelin;32570;
1SL8;A;Calcium-loaded apo-aequorin from Aequorea victoria;1.7;CA;CALCIUM ION;Aequorin 1;6100;
1SLM;A;CRYSTAL STRUCTURE OF FIBROBLAST STROMELYSIN-1: THE C-TRUNCATED HUMAN PROENZYME;1.9;CA;CALCIUM ION;STROMELYSIN-1;9606;
1SLN;A;CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN FIBROBLAST STROMELYSIN-1 INHIBITED WITH THE N-CARBOXY-ALKYL INHIBITOR L-702,842;2.27;CA;CALCIUM ION;STROMELYSIN-1;9606;
1SLU;B;RAT ANIONIC N143H, E151H TRYPSIN COMPLEXED TO A86H ECOTIN;1.8;CA;CALCIUM ION;ANIONIC TRYPSIN;10116;
1SMD;A;HUMAN SALIVARY AMYLASE;1.6;CA;CALCIUM ION;AMYLASE;9606;
1SMF;E;Studies on an artificial trypsin inhibitor peptide derived from the mung bean inhibitor;2.1;CA;CALCIUM ION;TRYPSIN;9913;
1SMG;A;CALCIUM-BOUND E41A MUTANT OF THE N-DOMAIN OF CHICKEN TROPONIN C, NMR, 40 STRUCTURES;;CA;CALCIUM ION;TROPONIN C;9031;
1SMP;A;CRYSTAL STRUCTURE OF A COMPLEX BETWEEN SERRATIA MARCESCENS METALLO-PROTEASE AND AN INHIBITOR FROM ERWINIA CHRYSANTHEMI;2.3;CA;CALCIUM ION;SERRATIA METALLO PROTEINASE;615;
1SMV;A;PRIMARY STRUCTURE OF SESBANIA MOSAIC VIRUS COAT PROTEIN: ITS IMPLICATIONS TO THE ASSEMBLY AND ARCHITECTURE OF THE VIRUS;3;CA;CALCIUM ION;SESBANIA MOSAIC VIRUS COAT PROTEIN;12558;
1SMV;C;PRIMARY STRUCTURE OF SESBANIA MOSAIC VIRUS COAT PROTEIN: ITS IMPLICATIONS TO THE ASSEMBLY AND ARCHITECTURE OF THE VIRUS;3;CA;CALCIUM ION;SESBANIA MOSAIC VIRUS COAT PROTEIN;12558;
1SN7;A;KUMAMOLISIN-AS, APOENZYME;2;CA;CALCIUM ION;kumamolisin-As;192387;
1SNC;A;THE CRYSTAL STRUCTURE OF THE TERNARY COMPLEX OF STAPHYLOCOCCAL NUCLEASE, CA2+, AND THE INHIBITOR PD*TP, REFINED AT 1.65 ANGSTROMS;1.65;CA;CALCIUM ION;THERMONUCLEASE PRECURSOR;1280;
1SNM;A;ACTIVE SITE MUTANT GLU-43 (RIGHT ARROW) ASP IN STAPHYLOCOCCAL NUCLEASE DISPLAYS NONLOCAL STRUCTURAL CHANGES;1.74;CA;CALCIUM ION;THERMONUCLEASE PRECURSOR;1280;
1SNN;A;3,4-dihydroxy-2-butanone 4-phosphate synthase from Methanococcus jannaschii;1.55;CA;CALCIUM ION;3,4-dihydroxy-2-butanone 4-phosphate synthase;2190;
1SNN;B;3,4-dihydroxy-2-butanone 4-phosphate synthase from Methanococcus jannaschii;1.55;CA;CALCIUM ION;3,4-dihydroxy-2-butanone 4-phosphate synthase;2190;
1SPJ;A;STRUCTURE OF MATURE HUMAN TISSUE KALLIKREIN (HUMAN KALLIKREIN 1 OR KLK1) AT 1.70 ANGSTROM RESOLUTION WITH VACANT ACTIVE SITE;1.7;CA;CALCIUM ION;Kallikrein 1;9606;
1SPU;A;STRUCTURE OF OXIDOREDUCTASE;2;CA;CALCIUM ION;COPPER AMINE OXIDASE;562;
1SPU;B;STRUCTURE OF OXIDOREDUCTASE;2;CA;CALCIUM ION;COPPER AMINE OXIDASE;562;
1SR6;C;Structure of nucleotide-free scallop myosin S1;2.75;CA;CALCIUM ION;Myosin essential light chain, striated adductor muscle;31199;
1SRA;A;STRUCTURE OF A NOVEL EXTRACELLULAR CA2+-BINDING MODULE IN BM-40(SLASH)SPARC(SLASH)OSTEONECTIN;2;CA;CALCIUM ION;SPARC;9606;
1SRP;A;STRUCTURAL ANALYSIS OF SERRATIA PROTEASE;2;CA;CALCIUM ION;SERRALYSIN;617;
1SRR;A;CRYSTAL STRUCTURE OF A PHOSPHATASE RESISTANT MUTANT OF SPORULATION RESPONSE REGULATOR SPO0F FROM BACILLUS SUBTILIS;1.9;CA;CALCIUM ION;SPORULATION RESPONSE REGULATORY PROTEIN;1423;
1SRR;C;CRYSTAL STRUCTURE OF A PHOSPHATASE RESISTANT MUTANT OF SPORULATION RESPONSE REGULATOR SPO0F FROM BACILLUS SUBTILIS;1.9;CA;CALCIUM ION;SPORULATION RESPONSE REGULATORY PROTEIN;1423;
1ST2;A;THE THREE-DIMENSIONAL STRUCTURE OF BACILLUS AMYLOLIQUEFACIENS SUBTILISIN AT 1.8 ANGSTROMS AND AN ANALYSIS OF THE STRUCTURAL CONSEQUENCES OF PEROXIDE INACTIVATION;2;CA;CALCIUM ION;SUBTILISIN BPN';1390;
1ST3;A;THE CRYSTAL STRUCTURE OF THE BACILLUS LENTUS ALKALINE PROTEASE, SUBTILISIN BL, AT 1.4 ANGSTROMS RESOLUTION;1.4;CA;CALCIUM ION;SUBTILISIN BL;1467;
1STA;A;ACCOMMODATION OF INSERTION MUTATIONS ON THE SURFACE AND IN THE INTERIOR OF STAPHYLOCOCCAL NUCLEASE;1.7;CA;CALCIUM ION;STAPHYLOCOCCAL NUCLEASE;1280;
1STB;A;ACCOMMODATION OF INSERTION MUTATIONS ON THE SURFACE AND IN THE INTERIOR OF STAPHYLOCOCCAL NUCLEASE;2;CA;CALCIUM ION;STAPHYLOCOCCAL NUCLEASE;1280;
1STY;A;THE ALPHA ANEURISM: A STRUCTURAL MOTIF REVEALED IN AN INSERTION MUTANT OF STAPHYLOCOCCAL NUCLEASE;1.67;CA;CALCIUM ION;STAPHYLOCOCCAL NUCLEASE;1280;
1SU3;A;X-ray structure of human proMMP-1: New insights into collagenase action;2.2;CA;CALCIUM ION;Interstitial collagenase;9606;
1SU3;B;X-ray structure of human proMMP-1: New insights into collagenase action;2.2;CA;CALCIUM ION;Interstitial collagenase;9606;
1SU4;A;Crystal structure of calcium ATPase with two bound calcium ions;2.4;CA;CALCIUM ION;Sarcoplasmic/endoplasmic reticulum calcium ATPase 1;9986;
1SUB;A;CALCIUM-INDEPENDENT SUBTILISIN BY DESIGN;1.75;CA;CALCIUM ION;SUBTILISIN BPN' CRB-S3;1390;
1SUD;A;CALCIUM-INDEPENDENT SUBTILISIN BY DESIGN;1.9;CA;CALCIUM ION;SUBTILISIN BPN' CRB-S3;1390;
1SUI;A;Alfalfa caffeoyl coenzyme A 3-O-methyltransferase;2.7;CA;CALCIUM ION;Caffeoyl-CoA O-methyltransferase;3879;
1SUI;B;Alfalfa caffeoyl coenzyme A 3-O-methyltransferase;2.7;CA;CALCIUM ION;Caffeoyl-CoA O-methyltransferase;3879;
1SUI;C;Alfalfa caffeoyl coenzyme A 3-O-methyltransferase;2.7;CA;CALCIUM ION;Caffeoyl-CoA O-methyltransferase;3879;
1SUI;D;Alfalfa caffeoyl coenzyme A 3-O-methyltransferase;2.7;CA;CALCIUM ION;Caffeoyl-CoA O-methyltransferase;3879;
1SUM;B;Crystal structure of a hypothetical protein at 2.0 A resolution;2;CA;CALCIUM ION;Phosphate transport system protein phoU homolog 2;2336;
1SUP;A;SUBTILISIN BPN' AT 1.6 ANGSTROMS RESOLUTION: ANALYSIS OF DISCRETE DISORDER AND COMPARISON OF CRYSTAL FORMS;1.6;CA;CALCIUM ION;SUBTILISIN BPN';1390;
1SUS;A;Crystal structure of alfalfa feruoyl coenzyme A 3-O-methyltransferase;2.7;CA;CALCIUM ION;Caffeoyl-CoA O-methyltransferase;3879;
1SUS;B;Crystal structure of alfalfa feruoyl coenzyme A 3-O-methyltransferase;2.7;CA;CALCIUM ION;Caffeoyl-CoA O-methyltransferase;3879;
1SUS;C;Crystal structure of alfalfa feruoyl coenzyme A 3-O-methyltransferase;2.7;CA;CALCIUM ION;Caffeoyl-CoA O-methyltransferase;3879;
1SUS;D;Crystal structure of alfalfa feruoyl coenzyme A 3-O-methyltransferase;2.7;CA;CALCIUM ION;Caffeoyl-CoA O-methyltransferase;3879;
1SVN;A;SAVINASE;1.4;CA;CALCIUM ION;SAVINASE (TM);1467;
1SVY;A;SEVERIN DOMAIN 2, 1.75 ANGSTROM CRYSTAL STRUCTURE;1.75;CA;CALCIUM ION;SEVERIN;44689;
1SW8;A;Solution structure of the N-terminal domain of Human N60D calmodulin refined with paramagnetism based strategy;;CA;CALCIUM ION;Calmodulin;9606;
1SXN;A;REDUCED BOVINE SUPEROXIDE DISMUTASE AT PH 5.0;1.9;CA;CALCIUM ION;CU, ZN SUPEROXIDE DISMUTASE;9913;
1SXN;B;REDUCED BOVINE SUPEROXIDE DISMUTASE AT PH 5.0;1.9;CA;CALCIUM ION;CU, ZN SUPEROXIDE DISMUTASE;9913;
1SXS;A;Reduced bovine superoxide dismutase at pH 5.0 complexed with thiocyanate;2;CA;CALCIUM ION;PROTEIN (CU-ZN SUPEROXIDE DISMUTASE);9913;
1SXS;B;Reduced bovine superoxide dismutase at pH 5.0 complexed with thiocyanate;2;CA;CALCIUM ION;PROTEIN (CU-ZN SUPEROXIDE DISMUTASE);9913;
1SXZ;A;Reduced bovine superoxide dismutase at pH 5.0 complexed with azide;2.05;CA;CALCIUM ION;PROTEIN (CU-ZN SUPEROXIDE DISMUTASE);9913;
1SXZ;B;Reduced bovine superoxide dismutase at pH 5.0 complexed with azide;2.05;CA;CALCIUM ION;PROTEIN (CU-ZN SUPEROXIDE DISMUTASE);9913;
1SY9;A;Structure of calmodulin complexed with a fragment of the olfactory CNG channel;;CA;CALCIUM ION;CALMODULIN;8355;
1SYB;A;TRANSFER OF A BETA-TURN STRUCTURE TO A NEW PROTEIN CONTEXT;1.8;CA;CALCIUM ION;STAPHYLOCOCCAL NUCLEASE;1280;
1SYD;A;ENGINEERING ALTERNATIVE BETA-TURN TYPES IN STAPHYLOCOCCAL NUCLEASE;1.7;CA;CALCIUM ION;STAPHYLOCOCCAL NUCLEASE;1280;
1SYF;A;ENGINEERING ALTERNATIVE BETA-TURN TYPES IN STAPHYLOCOCCAL NUCLEASE;1.8;CA;CALCIUM ION;STAPHYLOCOCCAL NUCLEASE;1280;
1SZ8;A;Crystal Structure of an Acidic Phospholipase A2 from Naja Naja Sagittifera at 1.5 A resolution;1.5;CA;CALCIUM ION;Phospholipase A2 isoform 3;195058;
1SZB;A;Crystal structure of the human MBL-associated protein 19 (MAp19);2.5;CA;CALCIUM ION;mannose binding lectin-associated serine protease-2 related protein, MAp19 (19kDa);9606;
1SZB;B;Crystal structure of the human MBL-associated protein 19 (MAp19);2.5;CA;CALCIUM ION;mannose binding lectin-associated serine protease-2 related protein, MAp19 (19kDa);9606;
1SZO;B;Crystal Structure Analysis of the 6-Oxo Camphor Hydrolase His122Ala Mutant Bound to Its Natural Product (2S,4S)-alpha-Campholinic Acid;1.9;CA;CALCIUM ION;6-oxocamphor hydrolase;157732;
1SZO;F;Crystal Structure Analysis of the 6-Oxo Camphor Hydrolase His122Ala Mutant Bound to Its Natural Product (2S,4S)-alpha-Campholinic Acid;1.9;CA;CALCIUM ION;6-oxocamphor hydrolase;157732;
1SZO;I;Crystal Structure Analysis of the 6-Oxo Camphor Hydrolase His122Ala Mutant Bound to Its Natural Product (2S,4S)-alpha-Campholinic Acid;1.9;CA;CALCIUM ION;6-oxocamphor hydrolase;157732;
1SZO;K;Crystal Structure Analysis of the 6-Oxo Camphor Hydrolase His122Ala Mutant Bound to Its Natural Product (2S,4S)-alpha-Campholinic Acid;1.9;CA;CALCIUM ION;6-oxocamphor hydrolase;157732;
1T0I;A;YLR011wp, a Saccharomyces cerevisiae NA(D)PH-dependent FMN reductase;2;CA;CALCIUM ION;YLR011wp;4932;
1T0L;A;Crystal structure of human cytosolic NADP(+)-dependent isocitrate dehydrogenase in complex with NADP, isocitrate, and calcium(2+);2.41;CA;CALCIUM ION;Isocitrate dehydrogenase [NADP] cytoplasmic;9606;
1T0L;B;Crystal structure of human cytosolic NADP(+)-dependent isocitrate dehydrogenase in complex with NADP, isocitrate, and calcium(2+);2.41;CA;CALCIUM ION;Isocitrate dehydrogenase [NADP] cytoplasmic;9606;
1T0L;C;Crystal structure of human cytosolic NADP(+)-dependent isocitrate dehydrogenase in complex with NADP, isocitrate, and calcium(2+);2.41;CA;CALCIUM ION;Isocitrate dehydrogenase [NADP] cytoplasmic;9606;
1T0L;D;Crystal structure of human cytosolic NADP(+)-dependent isocitrate dehydrogenase in complex with NADP, isocitrate, and calcium(2+);2.41;CA;CALCIUM ION;Isocitrate dehydrogenase [NADP] cytoplasmic;9606;
1T1E;A;High Resolution Crystal Structure of the Intact Pro-Kumamolisin, a Sedolisin Type Proteinase (previously called Kumamolysin or KSCP);1.18;CA;CALCIUM ION;kumamolisin;198803;
1T1G;A;High Resolution Crystal Structure of Mutant E23A of Kumamolisin, a sedolisin type proteinase (previously called Kumamolysin or KSCP);1.18;CA;CALCIUM ION;kumamolisin;198803;
1T1I;A;High Resolution Crystal Structure of Mutant W129A of Kumamolisin, a Sedolisin Type Proteinase (previously called Kumamolysin or KSCP);1.28;CA;CALCIUM ION;kumamolisin;198803;
1T44;A;Structural basis of actin sequestration by thymosin-B4: Implications for arp2/3 activation;2;CA;CALCIUM ION;Actin, alpha;9986;
1T44;G;Structural basis of actin sequestration by thymosin-B4: Implications for arp2/3 activation;2;CA;CALCIUM ION;Chimera of Gelsolin domain 1 and C-Terminal domain of thymosin Beta-4;960,610,090;
1T5D;X;4-Chlorobenzoyl-CoA Ligase/Synthetase bound to 4-chlorobenzoate;2.21;CA;CALCIUM ION;4-chlorobenzoyl CoA ligase;206162;
1T5H;X;4-Chlorobenzoyl-CoA Ligase/Synthetase unliganded, selenomethionine;2;CA;CALCIUM ION;4-chlorobenzoyl CoA ligase;206162;
1T5S;A;Structure of the (SR)Ca2+-ATPase Ca2-E1-AMPPCP form;2.6;CA;CALCIUM ION;Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 isoform SERCA1a;9986;
1T5T;A;Structure of the (SR)Ca2+-ATPase Ca2-E1-ADP:AlF4- form;2.9;CA;CALCIUM ION;Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 isoform SERCA1A;9986;
1T61;C;crystal structure of collagen IV NC1 domain from placenta basement membrane;1.5;CA;CALCIUM ION;Type IV Collagen;9913;
1T61;F;crystal structure of collagen IV NC1 domain from placenta basement membrane;1.5;CA;CALCIUM ION;Type IV Collagen;9913;
1T64;A;Crystal Structure of human HDAC8 complexed with Trichostatin A;1.9;CA;CALCIUM ION;Histone deacetylase 8;9606;
1T64;B;Crystal Structure of human HDAC8 complexed with Trichostatin A;1.9;CA;CALCIUM ION;Histone deacetylase 8;9606;
1T6B;X;Crystal structure of B. anthracis Protective Antigen complexed with human Anthrax toxin receptor;2.5;CA;CALCIUM ION;Protective Antigen;1392;
1T6C;A;Structural characterization of the Ppx/GppA protein family: crystal structure of the Aquifex aeolicus family member;1.53;CA;CALCIUM ION;exopolyphosphatase;63363;
1T6M;A;X-ray Structure of the R70D PI-PLC enzyme: Insight into the role of calcium and surrounding amino acids on active site geometry and catalysis.;2.11;CA;CALCIUM ION;1-phosphatidylinositol phosphodiesterase;1428;
1T6M;B;X-ray Structure of the R70D PI-PLC enzyme: Insight into the role of calcium and surrounding amino acids on active site geometry and catalysis.;2.11;CA;CALCIUM ION;1-phosphatidylinositol phosphodiesterase;1428;
1T6W;A;RATIONAL DESIGN OF A CALCIUM-BINDING ADHESION PROTEIN NMR, 20 STRUCTURES;;CA;CALCIUM ION;hypothetical protein XP_346638;10116;
1T9H;A;The crystal structure of YloQ, a circularly permuted GTPase.;1.6;CA;CALCIUM ION;Probable GTPase engC;1423;
1T9I;C;I-CreI(D20N)/DNA complex;1.6;CA;CALCIUM ION;5'-D(*GP*CP*AP*AP*AP*AP*CP*GP*TP*CP*GP*TP*GP*AP*GP*AP*CP*AP*GP*TP*TP*TP*CP*G)-3';;
1TAD;A;GTPASE MECHANISM OF GPROTEINS FROM THE 1.7-ANGSTROM CRYSTAL STRUCTURE OF TRANSDUCIN ALPHA-GDP-ALF4-;1.7;CA;CALCIUM ION;TRANSDUCIN-ALPHA;9913;
1TAD;B;GTPASE MECHANISM OF GPROTEINS FROM THE 1.7-ANGSTROM CRYSTAL STRUCTURE OF TRANSDUCIN ALPHA-GDP-ALF4-;1.7;CA;CALCIUM ION;TRANSDUCIN-ALPHA;9913;
1TAD;C;GTPASE MECHANISM OF GPROTEINS FROM THE 1.7-ANGSTROM CRYSTAL STRUCTURE OF TRANSDUCIN ALPHA-GDP-ALF4-;1.7;CA;CALCIUM ION;TRANSDUCIN-ALPHA;9913;
1TAH;A;THE CRYSTAL STRUCTURE OF TRIACYLGLYCEROL LIPASE FROM PSEUDOMONAS GLUMAE REVEALS A PARTIALLY REDUNDANT CATALYTIC ASPARTATE;3;CA;CALCIUM ION;LIPASE;337;
1TAH;B;THE CRYSTAL STRUCTURE OF TRIACYLGLYCEROL LIPASE FROM PSEUDOMONAS GLUMAE REVEALS A PARTIALLY REDUNDANT CATALYTIC ASPARTATE;3;CA;CALCIUM ION;LIPASE;337;
1TAH;C;THE CRYSTAL STRUCTURE OF TRIACYLGLYCEROL LIPASE FROM PSEUDOMONAS GLUMAE REVEALS A PARTIALLY REDUNDANT CATALYTIC ASPARTATE;3;CA;CALCIUM ION;LIPASE;337;
1TAH;D;THE CRYSTAL STRUCTURE OF TRIACYLGLYCEROL LIPASE FROM PSEUDOMONAS GLUMAE REVEALS A PARTIALLY REDUNDANT CATALYTIC ASPARTATE;3;CA;CALCIUM ION;LIPASE;337;
1TAW;A;BOVINE TRYPSIN COMPLEXED TO APPI;1.8;CA;CALCIUM ION;TRYPSIN;9913;
1TCF;A;CRYSTAL STRUCTURE OF CALCIUM-SATURATED RABBIT SKELETAL TROPONIN C;1.9;CA;CALCIUM ION;TROPONIN C;9986;
1TCM;A;CYCLODEXTRIN GLYCOSYLTRANSFERASE W616A MUTANT FROM BACILLUS CIRCULANS STRAIN 251;2.2;CA;CALCIUM ION;CYCLODEXTRIN GLYCOSYLTRANSFERASE;1397;
1TCM;B;CYCLODEXTRIN GLYCOSYLTRANSFERASE W616A MUTANT FROM BACILLUS CIRCULANS STRAIN 251;2.2;CA;CALCIUM ION;CYCLODEXTRIN GLYCOSYLTRANSFERASE;1397;
1TCO;B;TERNARY COMPLEX OF A CALCINEURIN A FRAGMENT, CALCINEURIN B, FKBP12 AND THE IMMUNOSUPPRESSANT DRUG FK506 (TACROLIMUS);2.5;CA;CALCIUM ION;SERINE/THREONINE PHOSPHATASE B2;9913;
1TD7;A;Interactions of a specific non-steroidal anti-inflammatory drug (NSAID) with group I phospholipase A2 (PLA2): Crystal structure of the complex formed between PLA2 and niflumic acid at 2.5 A resolution;2.5;CA;CALCIUM ION;Phospholipase A2 isoform 3;195058;
1TDQ;B;Structural basis for the interactions between tenascins and the C-type lectin domains from lecticans: evidence for a cross-linking role for tenascins;2.6;CA;CALCIUM ION;Aggrecan core protein;10116;
1TDR;B;EXPRESSION, CHARACTERIZATION, AND CRYSTALLOGRAPHIC ANALYSIS OF TELLUROMETHIONYL DIHYDROFOLATE REDUCTASE;2.5;CA;CALCIUM ION;TELLUROMETHIONYL DIHYDROFOLATE REDUCTASE;562;
1TE2;A;Putative Phosphatase Ynic from Escherichia coli K12;1.76;CA;CALCIUM ION;2-deoxyglucose-6-P phosphatase;562;
1TE2;B;Putative Phosphatase Ynic from Escherichia coli K12;1.76;CA;CALCIUM ION;2-deoxyglucose-6-P phosphatase;562;
1TEC;E;CRYSTALLOGRAPHIC REFINEMENT BY INCORPORATION OF MOLECULAR DYNAMICS. THE THERMOSTABLE SERINE PROTEASE THERMITASE COMPLEXED WITH EGLIN-C;2.2;CA;CALCIUM ION;THERMITASE;2026;
1TEI;A;STRUCTURE OF CONCANAVALIN A COMPLEXED TO BETA-D-GLCNAC (1,2)ALPHA-D-MAN-(1,6)[BETA-D-GLCNAC(1,2)ALPHA-D-MAN (1,6)]ALPHA-D-MAN;2.7;CA;CALCIUM ION;CONCANAVALIN A;3823;
1TEI;B;STRUCTURE OF CONCANAVALIN A COMPLEXED TO BETA-D-GLCNAC (1,2)ALPHA-D-MAN-(1,6)[BETA-D-GLCNAC(1,2)ALPHA-D-MAN (1,6)]ALPHA-D-MAN;2.7;CA;CALCIUM ION;CONCANAVALIN A;3823;
1TEI;C;STRUCTURE OF CONCANAVALIN A COMPLEXED TO BETA-D-GLCNAC (1,2)ALPHA-D-MAN-(1,6)[BETA-D-GLCNAC(1,2)ALPHA-D-MAN (1,6)]ALPHA-D-MAN;2.7;CA;CALCIUM ION;CONCANAVALIN A;3823;
1TEI;D;STRUCTURE OF CONCANAVALIN A COMPLEXED TO BETA-D-GLCNAC (1,2)ALPHA-D-MAN-(1,6)[BETA-D-GLCNAC(1,2)ALPHA-D-MAN (1,6)]ALPHA-D-MAN;2.7;CA;CALCIUM ION;CONCANAVALIN A;3823;
1TEI;E;STRUCTURE OF CONCANAVALIN A COMPLEXED TO BETA-D-GLCNAC (1,2)ALPHA-D-MAN-(1,6)[BETA-D-GLCNAC(1,2)ALPHA-D-MAN (1,6)]ALPHA-D-MAN;2.7;CA;CALCIUM ION;CONCANAVALIN A;3823;
1TEI;F;STRUCTURE OF CONCANAVALIN A COMPLEXED TO BETA-D-GLCNAC (1,2)ALPHA-D-MAN-(1,6)[BETA-D-GLCNAC(1,2)ALPHA-D-MAN (1,6)]ALPHA-D-MAN;2.7;CA;CALCIUM ION;CONCANAVALIN A;3823;
1TEI;G;STRUCTURE OF CONCANAVALIN A COMPLEXED TO BETA-D-GLCNAC (1,2)ALPHA-D-MAN-(1,6)[BETA-D-GLCNAC(1,2)ALPHA-D-MAN (1,6)]ALPHA-D-MAN;2.7;CA;CALCIUM ION;CONCANAVALIN A;3823;
1TEI;H;STRUCTURE OF CONCANAVALIN A COMPLEXED TO BETA-D-GLCNAC (1,2)ALPHA-D-MAN-(1,6)[BETA-D-GLCNAC(1,2)ALPHA-D-MAN (1,6)]ALPHA-D-MAN;2.7;CA;CALCIUM ION;CONCANAVALIN A;3823;
1TF4;A;ENDO/EXOCELLULASE FROM THERMOMONOSPORA;1.9;CA;CALCIUM ION;T. FUSCA ENDO/EXO-CELLULASE E4 CATALYTIC DOMAIN AND CELLULOSE-BINDING DOMAIN;2021;
1TF4;B;ENDO/EXOCELLULASE FROM THERMOMONOSPORA;1.9;CA;CALCIUM ION;T. FUSCA ENDO/EXO-CELLULASE E4 CATALYTIC DOMAIN AND CELLULOSE-BINDING DOMAIN;2021;
1TF8;A;Streptomyces griseus aminopeptidase complexed with L-tryptophan;1.3;CA;CALCIUM ION;Aminopeptidase;1911;
1TF9;A;Streptomyces griseus aminopeptidase complexed with P-Iodo-L-Phenylalanine;1.3;CA;CALCIUM ION;Aminopeptidase;1911;
1TFX;A;COMPLEX OF THE SECOND KUNITZ DOMAIN OF TISSUE FACTOR PATHWAY INHIBITOR WITH PORCINE TRYPSIN;2.6;CA;CALCIUM ION;TRYPSIN;9823;
1TFX;B;COMPLEX OF THE SECOND KUNITZ DOMAIN OF TISSUE FACTOR PATHWAY INHIBITOR WITH PORCINE TRYPSIN;2.6;CA;CALCIUM ION;TRYPSIN;9823;
1TGB;A;CRYSTAL STRUCTURE OF BOVINE TRYPSINOGEN AT 1.8 ANGSTROMS RESOLUTION. II. CRYSTALLOGRAPHIC REFINEMENT, REFINED CRYSTAL STRUCTURE AND COMPARISON WITH BOVINE TRYPSIN;1.8;CA;CALCIUM ION;TRYPSINOGEN;9913;
1TGC;A;ON THE DISORDERED ACTIVATION DOMAIN IN TRYPSINOGEN. CHEMICAL LABELLING AND LOW-TEMPERATURE CRYSTALLOGRAPHY;1.8;CA;CALCIUM ION;TRYPSINOGEN;9913;
1TGM;A;Crystal structure of a complex formed between group II phospholipase A2 and aspirin at 1.86 A resolution;1.86;CA;CALCIUM ION;Phospholipase A2;8707;
1TGS;Z;THREE-DIMENSIONAL STRUCTURE OF THE COMPLEX BETWEEN PANCREATIC SECRETORY INHIBITOR (KAZAL TYPE) AND TRYPSINOGEN AT 1.8 ANGSTROMS RESOLUTION. STRUCTURE SOLUTION, CRYSTALLOGRAPHIC REFINEMENT AND PRELIMINARY STRUCTURAL INTERPRETATION;1.8;CA;CALCIUM ION;TRYPSINOGEN;9913;
1TGT;A;ON THE DISORDERED ACTIVATION DOMAIN IN TRYPSINOGEN. CHEMICAL LABELLING AND LOW-TEMPERATURE CRYSTALLOGRAPHY;1.7;CA;CALCIUM ION;TRYPSINOGEN;9913;
1THL;A;Thermolysin complexed with a novel glutaramide derivative, n-(1-(2(r,s)-carboxy-4-phenylbutyl) cyclopentylcarbonyl)-(s)-tryptophan;1.7;CA;CALCIUM ION;THERMOLYSIN;1427;
1THM;A;CRYSTAL STRUCTURE OF THERMITASE AT 1.4 ANGSTROMS RESOLUTION;1.37;CA;CALCIUM ION;THERMITASE;2026;
1TIO;A;HIGH PACKING DENSITY FORM OF BOVINE BETA-TRYPSIN IN CYCLOHEXANE;1.93;CA;CALCIUM ION;PROTEIN (BETA-TRYPSIN);9913;
1TJX;A;Crystallographic Identification of Ca2+ Coordination Sites in Synaptotagmin I C2B Domain;1.04;CA;CALCIUM ION;similar to synaptotagminI/p65;10116;
1TK2;A;Crystal Structure of the Complex formed between Alkaline Proteinase Savinase and Gramicidin S at 1.5A Resolution;1.54;CA;CALCIUM ION;SUBTILISIN SAVINASE;1467;
1TKA;A;SPECIFICITY OF COENZYME BINDING IN THIAMIN DIPHOSPHATE DEPENDENT ENZYMES: CRYSTAL STRUCTURES OF YEAST TRANSKETOLASE IN COMPLEX WITH ANALOGS OF THIAMIN DIPHOSPHATE;2.7;CA;CALCIUM ION;TRANSKETOLASE;4932;
1TKA;B;SPECIFICITY OF COENZYME BINDING IN THIAMIN DIPHOSPHATE DEPENDENT ENZYMES: CRYSTAL STRUCTURES OF YEAST TRANSKETOLASE IN COMPLEX WITH ANALOGS OF THIAMIN DIPHOSPHATE;2.7;CA;CALCIUM ION;TRANSKETOLASE;4932;
1TKB;A;SPECIFICITY OF COENZYME BINDING IN THIAMIN DIPHOSPHATE DEPENDENT ENZYMES: CRYSTAL STRUCTURES OF YEAST TRANSKETOLASE IN COMPLEX WITH ANALOGS OF THIAMIN DIPHOSPHATE;2.3;CA;CALCIUM ION;TRANSKETOLASE;4932;
1TKB;B;SPECIFICITY OF COENZYME BINDING IN THIAMIN DIPHOSPHATE DEPENDENT ENZYMES: CRYSTAL STRUCTURES OF YEAST TRANSKETOLASE IN COMPLEX WITH ANALOGS OF THIAMIN DIPHOSPHATE;2.3;CA;CALCIUM ION;TRANSKETOLASE;4932;
1TKC;A;SPECIFICITY OF COENZYME BINDING IN THIAMIN DIPHOSPHATE DEPENDENT ENZYMES: CRYSTAL STRUCTURES OF YEAST TRANSKETOLASE IN COMPLEX WITH ANALOGS OF THIAMIN DIPHOSPHATE;2.7;CA;CALCIUM ION;TRANSKETOLASE;4932;
1TKC;B;SPECIFICITY OF COENZYME BINDING IN THIAMIN DIPHOSPHATE DEPENDENT ENZYMES: CRYSTAL STRUCTURES OF YEAST TRANSKETOLASE IN COMPLEX WITH ANALOGS OF THIAMIN DIPHOSPHATE;2.7;CA;CALCIUM ION;TRANSKETOLASE;4932;
1TKF;A;Streptomyces griseus aminopeptidase complexed with D-tryptophan;1.2;CA;CALCIUM ION;Aminopeptidase;1911;
1TKH;A;Streptomyces griseus aminopeptidase complexed with D-Phenylalanine;1.25;CA;CALCIUM ION;Aminopeptidase;1911;
1TKJ;A;Streptomyces griseus aminopeptidase complexed with D-Methionine;1.15;CA;CALCIUM ION;Aminopeptidase;1911;
1TL9;A;High resolution crystal structure of calpain I protease core in complex with leupeptin;1.8;CA;CALCIUM ION;Calpain 1, large [catalytic] subunit;10116;
1TLD;A;CRYSTAL STRUCTURE OF BOVINE BETA-TRYPSIN AT 1.5 ANGSTROMS RESOLUTION IN A CRYSTAL FORM WITH LOW MOLECULAR PACKING DENSITY. ACTIVE SITE GEOMETRY, ION PAIRS AND SOLVENT STRUCTURE;1.5;CA;CALCIUM ION;BETA-TRYPSIN;9913;
1TLG;A;STRUCTURE OF A TUNICATE C-TYPE LECTIN COMPLEXED WITH D-GALACTOSE;2.2;CA;CALCIUM ION;POLYANDROCARPA LECTIN;7723;
1TLG;B;STRUCTURE OF A TUNICATE C-TYPE LECTIN COMPLEXED WITH D-GALACTOSE;2.2;CA;CALCIUM ION;POLYANDROCARPA LECTIN;7723;
1TLI;A;THERMOLYSIN (2% ISOPROPANOL SOAKED CRYSTALS);2.05;CA;CALCIUM ION;THERMOLYSIN;1427;
1TLO;A;High resolution crystal structure of calpain I protease core in complex with E64;1.9;CA;CALCIUM ION;Calpain 1, large [catalytic] subunit;10116;
1TLP;E;CRYSTALLOGRAPHIC STRUCTURAL ANALYSIS OF PHOSPHORAMIDATES AS INHIBITORS AND TRANSITION-STATE ANALOGS OF THERMOLYSIN;2.3;CA;CALCIUM ION;THERMOLYSIN;1427;
1TLQ;A;Crystal structure of protein ypjQ from Bacillus subtilis, Pfam DUF64;2.4;CA;CALCIUM ION;Hypothetical protein ypjQ;1423;
1TLX;A;THERMOLYSIN (NATIVE);2.1;CA;CALCIUM ION;THERMOLYSIN;1427;
1TM1;E;CRYSTAL STRUCTURE OF THE COMPLEX OF SUBTILISIN BPN' WITH CHYMOTRYPSIN INHIBITOR 2;1.7;CA;CALCIUM ION;Subtilisin BPN' precursor;1390;
1TM3;E;crystal structure of the complex of subtilisin BPN' with chymotrypsin inhibitor 2 M59k mutant;1.57;CA;CALCIUM ION;Subtilisin BPN' precursor;1390;
1TM4;E;crystal structure of the complex of subtilsin BPN'with chymotrypsin inhibitor 2 M59G mutant;1.7;CA;CALCIUM ION;Subtilisin BPN' precursor;1390;
1TM5;E;crystal structure of the complex of subtilisin BPN' with chymotrypsin inhibitor 2 M59A mutant;1.45;CA;CALCIUM ION;Subtilisin BPN';1390;
1TM7;E;crystal structure of the complex of subtilisin BPN' with chymotrypsin inhibitor 2 M59Y mutant;1.59;CA;CALCIUM ION;Subtilisin BPN';1390;
1TMG;E;crystal structure of the complex of subtilisin BPN' with chymotrypsin inhibitor 2 M59F mutant;1.67;CA;CALCIUM ION;Subtilisin BPN';1390;
1TMN;E;Binding of n-carboxymethyl dipeptide inhibitors to thermolysin determined by x-ray crystallography. a novel class of transition-state analogues for zinc peptidases;1.9;CA;CALCIUM ION;THERMOLYSIN;1427;
1TMQ;A;STRUCTURE OF TENEBRIO MOLITOR LARVAL ALPHA-AMYLASE IN COMPLEX WITH RAGI BIFUNCTIONAL INHIBITOR;2.5;CA;CALCIUM ION;PROTEIN (ALPHA-AMYLASE);7067;
1TN3;A;THE C-TYPE LECTIN CARBOHYDRATE RECOGNITION DOMAIN OF HUMAN TETRANECTIN;2;CA;CALCIUM ION;TETRANECTIN;9606;
1TN4;A;FOUR CALCIUM TNC;1.95;CA;CALCIUM ION;TROPONIN C;9986;
1TNG;A;PREDICTION OF NOVEL SERINE PROTEASE INHIBITORS;1.8;CA;CALCIUM ION;TRYPSIN;9913;
1TNH;A;PREDICTION OF NOVEL SERINE PROTEASE INHIBITORS;1.8;CA;CALCIUM ION;TRYPSIN;9913;
1TNI;A;PREDICTION OF NOVEL SERINE PROTEASE INHIBITORS;1.9;CA;CALCIUM ION;TRYPSIN;9913;
1TNJ;A;PREDICTION OF NOVEL SERINE PROTEASE INHIBITORS;1.8;CA;CALCIUM ION;TRYPSIN;9913;
1TNK;A;PREDICTION OF NOVEL SERINE PROTEASE INHIBITORS;1.8;CA;CALCIUM ION;TRYPSIN;9913;
1TNL;A;PREDICTION OF NOVEL SERINE PROTEASE INHIBITORS;1.9;CA;CALCIUM ION;TRYPSIN;9913;
1TNQ;A;STRUCTURES OF THE APO AND CALCIUM TROPONIN-C REGULATORY DOMAINS: THE MUSCLE CONTRACTION SWITCH;;CA;CALCIUM ION;TROPONIN-C;9031;
1TO1;E;crystal structure of the complex of subtilisin BPN' with chymotrypsin inhibitor 2 Y61A mutant;1.68;CA;CALCIUM ION;Subtilisin BPN';1390;
1TO2;E;crystal structure of the complex of subtilisin BPN' with chymotrypsin inhibitor 2 M59K, in pH 9 cryosoak;1.3;CA;CALCIUM ION;Subtilisin BPN';1390;
1TOP;A;STRUCTURE OF CHICKEN SKELETAL MUSCLE TROPONIN-C AT 1.78 ANGSTROMS RESOLUTION;1.78;CA;CALCIUM ION;TROPONIN C;9031;
1TPA;E;THE GEOMETRY OF THE REACTIVE SITE AND OF THE PEPTIDE GROUPS IN TRYPSIN, TRYPSINOGEN AND ITS COMPLEXES WITH INHIBITORS;1.9;CA;CALCIUM ION;ANHYDRO-TRYPSIN;9913;
1TPO;A;THE GEOMETRY OF THE REACTIVE SITE AND OF THE PEPTIDE GROUPS IN TRYPSIN, TRYPSINOGEN AND ITS COMPLEXES WITH INHIBITORS;1.7;CA;CALCIUM ION;BETA-TRYPSIN;9913;
1TPP;A;THE GEOMETRY OF THE REACTIVE SITE AND OF THE PEPTIDE GROUPS IN TRYPSIN, TRYPSINOGEN AND ITS COMPLEXES WITH INHIBITORS;1.4;CA;CALCIUM ION;BETA-TRYPSIN;9913;
1TPS;A;ATOMIC STRUCTURE OF THE TRYPSIN-A90720A COMPLEX: A UNIFIED APPROACH TO STRUCTURE AND FUNCTION;1.9;CA;CALCIUM ION;TRYPSIN;9913;
1TR5;A;Room temperature structure of Staphylococcal nuclease variant truncated Delta+PHS I92E;2.1;CA;CALCIUM ION;Thermonuclease;1280;
1TRK;A;REFINED STRUCTURE OF TRANSKETOLASE FROM SACCHAROMYCES CEREVISIAE AT 2.0 ANGSTROMS RESOLUTION;2;CA;CALCIUM ION;TRANSKETOLASE;4932;
1TRK;B;REFINED STRUCTURE OF TRANSKETOLASE FROM SACCHAROMYCES CEREVISIAE AT 2.0 ANGSTROMS RESOLUTION;2;CA;CALCIUM ION;TRANSKETOLASE;4932;
1TRM;A;THE THREE-DIMENSIONAL STRUCTURE OF ASN102 MUTANT OF TRYPSIN. ROLE OF ASP102 IN SERINE PROTEASE CATALYSIS;2.3;CA;CALCIUM ION;TRYPSIN;10117;
1TRM;B;THE THREE-DIMENSIONAL STRUCTURE OF ASN102 MUTANT OF TRYPSIN. ROLE OF ASP102 IN SERINE PROTEASE CATALYSIS;2.3;CA;CALCIUM ION;TRYPSIN;10117;
1TRP;A;X-RAY CRYSTALLOGRAPHIC AND CALORIMERIC STUDIES OF THE EFFECTS OF THE MUTATION TRP 59 TYR IN RIBONUCLEASE T1;2.4;CA;CALCIUM ION;RIBONUCLEASE T1 ISOZYME;5062;
1TRP;B;X-RAY CRYSTALLOGRAPHIC AND CALORIMERIC STUDIES OF THE EFFECTS OF THE MUTATION TRP 59 TYR IN RIBONUCLEASE T1;2.4;CA;CALCIUM ION;RIBONUCLEASE T1 ISOZYME;5062;
1TRQ;A;X-RAY CRYSTALLOGRAPHIC AND CALORIMERIC STUDIES OF THE EFFECTS OF THE MUTATION TRP 59 TYR IN RIBONUCLEASE T1;2.3;CA;CALCIUM ION;RIBONUCLEASE T1 ISOZYME;5062;
1TRQ;B;X-RAY CRYSTALLOGRAPHIC AND CALORIMERIC STUDIES OF THE EFFECTS OF THE MUTATION TRP 59 TYR IN RIBONUCLEASE T1;2.3;CA;CALCIUM ION;RIBONUCLEASE T1 ISOZYME;5062;
1TT2;A;Cryogenic crystal structure of Staphylococcal nuclease variant truncated Delta+PHS I92K;1.85;CA;CALCIUM ION;Thermonuclease;1280;
1TTX;A;Solution Structure of human beta parvalbumin (oncomodulin) refined with a paramagnetism based strategy;;CA;CALCIUM ION;Oncomodulin;9606;
1TU5;A;Crystal structure of bovine plasma copper-containing amine oxidase;2.37;CA;CALCIUM ION;Copper amine oxidase, liver isozyme;9913;
1TU5;B;Crystal structure of bovine plasma copper-containing amine oxidase;2.37;CA;CALCIUM ION;Copper amine oxidase, liver isozyme;9913;
1TVG;A;X-ray structure of human PP25 gene product, HSPC034. Northeast Structural Genomics Target HR1958.;1.6;CA;CALCIUM ION;LOC51668 protein;9606;
1TW8;A;HincII bound to Ca2+ and cognate DNA GTCGAC;2.8;CA;CALCIUM ION;Hinc II endonuclease;727;
1TW8;B;HincII bound to Ca2+ and cognate DNA GTCGAC;2.8;CA;CALCIUM ION;Hinc II endonuclease;727;
1TW8;C;HincII bound to Ca2+ and cognate DNA GTCGAC;2.8;CA;CALCIUM ION;Hinc II endonuclease;727;
1TW8;D;HincII bound to Ca2+ and cognate DNA GTCGAC;2.8;CA;CALCIUM ION;Hinc II endonuclease;727;
1TW8;F;HincII bound to Ca2+ and cognate DNA GTCGAC;2.8;CA;CALCIUM ION;5'-D(*GP*CP*CP*GP*GP*TP*CP*GP*AP*CP*CP*GP*G)-3';;
1TW8;H;HincII bound to Ca2+ and cognate DNA GTCGAC;2.8;CA;CALCIUM ION;5'-D(*GP*CP*CP*GP*GP*TP*CP*GP*AP*CP*CP*GP*G)-3';;
1TX6;A;trypsin:BBI complex;2.2;CA;CALCIUM ION;Trypsin;9823;
1TX6;B;trypsin:BBI complex;2.2;CA;CALCIUM ION;Trypsin;9823;
1TX6;C;trypsin:BBI complex;2.2;CA;CALCIUM ION;Trypsin;9823;
1TX6;D;trypsin:BBI complex;2.2;CA;CALCIUM ION;Trypsin;9823;
1TX7;A;Bovine Trypsin complexed with p-amidinophenylmethylphosphinic acid (AMPA);1.75;CA;CALCIUM ION;Trypsinogen;9913;
1TX8;A;Bovine Trypsin complexed with AMSO;1.7;CA;CALCIUM ION;Trypsinogen;9913;
1TYE;A;Structural basis for allostery in integrins and binding of ligand-mimetic therapeutics to the platelet receptor for fibrinogen;2.9;CA;CALCIUM ION;Integrin alpha-IIb;9606;
1TYE;B;Structural basis for allostery in integrins and binding of ligand-mimetic therapeutics to the platelet receptor for fibrinogen;2.9;CA;CALCIUM ION;Integrin beta-3;9606;
1TYE;C;Structural basis for allostery in integrins and binding of ligand-mimetic therapeutics to the platelet receptor for fibrinogen;2.9;CA;CALCIUM ION;Integrin alpha-IIb;9606;
1TYE;D;Structural basis for allostery in integrins and binding of ligand-mimetic therapeutics to the platelet receptor for fibrinogen;2.9;CA;CALCIUM ION;Integrin beta-3;9606;
1TYE;E;Structural basis for allostery in integrins and binding of ligand-mimetic therapeutics to the platelet receptor for fibrinogen;2.9;CA;CALCIUM ION;Integrin alpha-IIb;9606;
1TYE;F;Structural basis for allostery in integrins and binding of ligand-mimetic therapeutics to the platelet receptor for fibrinogen;2.9;CA;CALCIUM ION;Integrin beta-3;9606;
1TYQ;A;Crystal structure of Arp2/3 complex with bound ATP and calcium;2.55;CA;CALCIUM ION;Actin-related protein 3;9913;
1TYQ;B;Crystal structure of Arp2/3 complex with bound ATP and calcium;2.55;CA;CALCIUM ION;Actin-related Protein 2;9913;
1TZN;A;Crystal Structure of the Anthrax Toxin Protective Antigen Heptameric Prepore bound to the VWA domain of CMG2, an anthrax toxin receptor;4.3;CA;CALCIUM ION;Protective antigen;1392;
1TZN;B;Crystal Structure of the Anthrax Toxin Protective Antigen Heptameric Prepore bound to the VWA domain of CMG2, an anthrax toxin receptor;4.3;CA;CALCIUM ION;Protective antigen;1392;
1TZN;C;Crystal Structure of the Anthrax Toxin Protective Antigen Heptameric Prepore bound to the VWA domain of CMG2, an anthrax toxin receptor;4.3;CA;CALCIUM ION;Protective antigen;1392;
1TZN;D;Crystal Structure of the Anthrax Toxin Protective Antigen Heptameric Prepore bound to the VWA domain of CMG2, an anthrax toxin receptor;4.3;CA;CALCIUM ION;Protective antigen;1392;
1TZN;E;Crystal Structure of the Anthrax Toxin Protective Antigen Heptameric Prepore bound to the VWA domain of CMG2, an anthrax toxin receptor;4.3;CA;CALCIUM ION;Protective antigen;1392;
1TZN;F;Crystal Structure of the Anthrax Toxin Protective Antigen Heptameric Prepore bound to the VWA domain of CMG2, an anthrax toxin receptor;4.3;CA;CALCIUM ION;Protective antigen;1392;
1TZN;G;Crystal Structure of the Anthrax Toxin Protective Antigen Heptameric Prepore bound to the VWA domain of CMG2, an anthrax toxin receptor;4.3;CA;CALCIUM ION;Protective antigen;1392;
1TZN;H;Crystal Structure of the Anthrax Toxin Protective Antigen Heptameric Prepore bound to the VWA domain of CMG2, an anthrax toxin receptor;4.3;CA;CALCIUM ION;Protective antigen;1392;
1TZN;I;Crystal Structure of the Anthrax Toxin Protective Antigen Heptameric Prepore bound to the VWA domain of CMG2, an anthrax toxin receptor;4.3;CA;CALCIUM ION;Protective antigen;1392;
1TZN;J;Crystal Structure of the Anthrax Toxin Protective Antigen Heptameric Prepore bound to the VWA domain of CMG2, an anthrax toxin receptor;4.3;CA;CALCIUM ION;Protective antigen;1392;
1TZN;K;Crystal Structure of the Anthrax Toxin Protective Antigen Heptameric Prepore bound to the VWA domain of CMG2, an anthrax toxin receptor;4.3;CA;CALCIUM ION;Protective antigen;1392;
1TZN;L;Crystal Structure of the Anthrax Toxin Protective Antigen Heptameric Prepore bound to the VWA domain of CMG2, an anthrax toxin receptor;4.3;CA;CALCIUM ION;Protective antigen;1392;
1TZN;M;Crystal Structure of the Anthrax Toxin Protective Antigen Heptameric Prepore bound to the VWA domain of CMG2, an anthrax toxin receptor;4.3;CA;CALCIUM ION;Protective antigen;1392;
1TZN;O;Crystal Structure of the Anthrax Toxin Protective Antigen Heptameric Prepore bound to the VWA domain of CMG2, an anthrax toxin receptor;4.3;CA;CALCIUM ION;Protective antigen;1392;
1TZO;A;Crystal Structure of the Anthrax Toxin Protective Antigen Heptameric Prepore;3.6;CA;CALCIUM ION;Protective antigen;1392;
1TZO;B;Crystal Structure of the Anthrax Toxin Protective Antigen Heptameric Prepore;3.6;CA;CALCIUM ION;Protective antigen;1392;
1TZO;C;Crystal Structure of the Anthrax Toxin Protective Antigen Heptameric Prepore;3.6;CA;CALCIUM ION;Protective antigen;1392;
1TZO;D;Crystal Structure of the Anthrax Toxin Protective Antigen Heptameric Prepore;3.6;CA;CALCIUM ION;Protective antigen;1392;
1TZO;E;Crystal Structure of the Anthrax Toxin Protective Antigen Heptameric Prepore;3.6;CA;CALCIUM ION;Protective antigen;1392;
1TZO;F;Crystal Structure of the Anthrax Toxin Protective Antigen Heptameric Prepore;3.6;CA;CALCIUM ION;Protective antigen;1392;
1TZO;G;Crystal Structure of the Anthrax Toxin Protective Antigen Heptameric Prepore;3.6;CA;CALCIUM ION;Protective antigen;1392;
1TZO;H;Crystal Structure of the Anthrax Toxin Protective Antigen Heptameric Prepore;3.6;CA;CALCIUM ION;Protective antigen;1392;
1TZO;I;Crystal Structure of the Anthrax Toxin Protective Antigen Heptameric Prepore;3.6;CA;CALCIUM ION;Protective antigen;1392;
1TZO;J;Crystal Structure of the Anthrax Toxin Protective Antigen Heptameric Prepore;3.6;CA;CALCIUM ION;Protective antigen;1392;
1TZO;K;Crystal Structure of the Anthrax Toxin Protective Antigen Heptameric Prepore;3.6;CA;CALCIUM ION;Protective antigen;1392;
1TZO;L;Crystal Structure of the Anthrax Toxin Protective Antigen Heptameric Prepore;3.6;CA;CALCIUM ION;Protective antigen;1392;
1TZO;M;Crystal Structure of the Anthrax Toxin Protective Antigen Heptameric Prepore;3.6;CA;CALCIUM ION;Protective antigen;1392;
1TZO;O;Crystal Structure of the Anthrax Toxin Protective Antigen Heptameric Prepore;3.6;CA;CALCIUM ION;Protective antigen;1392;
1TZW;A;T. maritima NusB, P3121, Form 2;1.6;CA;CALCIUM ION;N utilization substance protein B homolog;2336;
1U0A;A;Crystal structure of the engineered beta-1,3-1,4-endoglucanase H(A16-M) in complex with beta-glucan tetrasaccharide;1.64;CA;CALCIUM ION;Beta-glucanase;44252;
1U0A;B;Crystal structure of the engineered beta-1,3-1,4-endoglucanase H(A16-M) in complex with beta-glucan tetrasaccharide;1.64;CA;CALCIUM ION;Beta-glucanase;44252;
1U0A;C;Crystal structure of the engineered beta-1,3-1,4-endoglucanase H(A16-M) in complex with beta-glucan tetrasaccharide;1.64;CA;CALCIUM ION;Beta-glucanase;44252;
1U0A;D;Crystal structure of the engineered beta-1,3-1,4-endoglucanase H(A16-M) in complex with beta-glucan tetrasaccharide;1.64;CA;CALCIUM ION;Beta-glucanase;44252;
1U2V;A;Crystal structure of Arp2/3 complex with bound ADP and calcium;2.55;CA;CALCIUM ION;Actin-Related Protein 3;9913;
1U2Y;A;In situ extension as an approach for identifying novel alpha-amylase inhibitors, structure containing D-gluconhydroximo-1,5-lactam;1.95;CA;CALCIUM ION;Alpha-amylase, pancreatic;9606;
1U30;A;In situ extension as an approach for identifying novel alpha-amylase inhibitors, structure containing maltosyl-alpha (1,4)-D-gluconhydroximo-1,5-lactam;1.9;CA;CALCIUM ION;Alpha-amylase, pancreatic;9606;
1U33;A;In situ extension as an approach for identifying novel alpha-amylase inhibitors;1.95;CA;CALCIUM ION;Alpha-amylase, pancreatic;9606;
1U4G;A;Elastase of Pseudomonas aeruginosa with an inhibitor;1.4;CA;CALCIUM ION;Elastase;287;
1U5Q;A;Crystal Structure of the TAO2 Kinase Domain: Activation and Specifity of a Ste20p MAP3K;2.1;CA;CALCIUM ION;serine/threonine protein kinase TAO2;10116;
1U5Q;B;Crystal Structure of the TAO2 Kinase Domain: Activation and Specifity of a Ste20p MAP3K;2.1;CA;CALCIUM ION;serine/threonine protein kinase TAO2;10116;
1U5R;A;Crystal Structure of the TAO2 Kinase Domain: Activation and Specifity of a Ste20p MAP3K;2.1;CA;CALCIUM ION;serine/threonine protein kinase TAO2;10116;
1U5R;B;Crystal Structure of the TAO2 Kinase Domain: Activation and Specifity of a Ste20p MAP3K;2.1;CA;CALCIUM ION;serine/threonine protein kinase TAO2;10116;
1U7W;A;Phosphopantothenoylcysteine synthetase from E. coli, CTP-complex;2.5;CA;CALCIUM ION;Coenzyme A biosynthesis bifunctional protein coaBC;562;
1U7W;B;Phosphopantothenoylcysteine synthetase from E. coli, CTP-complex;2.5;CA;CALCIUM ION;Coenzyme A biosynthesis bifunctional protein coaBC;562;
1U7W;C;Phosphopantothenoylcysteine synthetase from E. coli, CTP-complex;2.5;CA;CALCIUM ION;Coenzyme A biosynthesis bifunctional protein coaBC;562;
1U8C;A;A novel adaptation of the integrin PSI domain revealed from its crystal structure;3.1;CA;CALCIUM ION;Integrin alpha-V;9606;
1U8C;B;A novel adaptation of the integrin PSI domain revealed from its crystal structure;3.1;CA;CALCIUM ION;Integrin beta-3;9606;
1U94;A;Crystal Structure of E. Coli RecA in a Compressed Helical Filament Form 2;1.9;CA;CALCIUM ION;RecA protein;562;
1UA3;A;Crystal structure of the pig pancreatic a-amylase complexed with malto-oligosaccharides;2.01;CA;CALCIUM ION;Alpha-amylase, pancreatic;9823;
1UA7;A;Crystal Structure Analysis of Alpha-Amylase from Bacillus Subtilis complexed with Acarbose;2.21;CA;CALCIUM ION;Alpha-amylase;1423;
1UBN;A;SELENOSUBTILISIN BPN;2.4;CA;CALCIUM ION;PROTEIN (SELENOSUBTILISIN BPN);1390;
1UCN;A;X-ray structure of human nucleoside diphosphate kinase A complexed with ADP at 2 A resolution;2;CA;CALCIUM ION;nucleoside diphosphate kinase A;9606;
1UCN;B;X-ray structure of human nucleoside diphosphate kinase A complexed with ADP at 2 A resolution;2;CA;CALCIUM ION;nucleoside diphosphate kinase A;9606;
1UCN;C;X-ray structure of human nucleoside diphosphate kinase A complexed with ADP at 2 A resolution;2;CA;CALCIUM ION;nucleoside diphosphate kinase A;9606;
1UEA;A;MMP-3/TIMP-1 COMPLEX;2.8;CA;CALCIUM ION;MATRIX METALLOPROTEINASE-3;9606;
1UEA;C;MMP-3/TIMP-1 COMPLEX;2.8;CA;CALCIUM ION;MATRIX METALLOPROTEINASE-3;9606;
1UET;A;Divergent evolutions of trinucleotide polymerization revealed by an archaeal CCA-adding enzyme structure;2;CA;CALCIUM ION;tRNA nucleotidyltransferase;2234;
1UEV;A;Divergent evolutions of trinucleotide polymerization revealed by an archaeal CCA-adding enzyme structure;2.7;CA;CALCIUM ION;tRNA nucleotidyltransferase;2234;
1UF3;A;Crystal structure of TT1561 of thermus thermophilus HB8;2.1;CA;CALCIUM ION;hypothetical protein TT1561;274;
1UF3;B;Crystal structure of TT1561 of thermus thermophilus HB8;2.1;CA;CALCIUM ION;hypothetical protein TT1561;274;
1UF3;C;Crystal structure of TT1561 of thermus thermophilus HB8;2.1;CA;CALCIUM ION;hypothetical protein TT1561;274;
1UF3;D;Crystal structure of TT1561 of thermus thermophilus HB8;2.1;CA;CALCIUM ION;hypothetical protein TT1561;274;
1UF3;E;Crystal structure of TT1561 of thermus thermophilus HB8;2.1;CA;CALCIUM ION;hypothetical protein TT1561;274;
1UF3;F;Crystal structure of TT1561 of thermus thermophilus HB8;2.1;CA;CALCIUM ION;hypothetical protein TT1561;274;
1UF3;G;Crystal structure of TT1561 of thermus thermophilus HB8;2.1;CA;CALCIUM ION;hypothetical protein TT1561;274;
1UF3;H;Crystal structure of TT1561 of thermus thermophilus HB8;2.1;CA;CALCIUM ION;hypothetical protein TT1561;274;
1UG9;A;Crystal Structure of Glucodextranase from Arthrobacter globiformis I42;2.5;CA;CALCIUM ION;glucodextranase;1665;
1UH2;A;Thermoactinomyces vulgaris R-47 alpha-amylase/malto-hexaose complex;2;CA;CALCIUM ION;alpha-amylase I;2026;
1UH3;A;Thermoactinomyces vulgaris R-47 alpha-amylase/acarbose complex;2.6;CA;CALCIUM ION;alpha-amylase I;2026;
1UH4;A;Thermoactinomyces vulgaris R-47 alpha-amylase 1/malto-tridecaose complex;1.8;CA;CALCIUM ION;alpha-amylase I;2026;
1UHA;A;Crystal Structure of Pokeweed Lectin-D2;1.5;CA;CALCIUM ION;lectin-D2;3527;
1UHB;A;Crystal structure of porcine alpha trypsin bound with auto catalyticaly produced native peptide at 2.15 A resolution;2.15;CA;CALCIUM ION;Trypsin;9823;
1UHN;A;The crystal structure of the calcium binding protein AtCBL2 from Arabidopsis thaliana;2.1;CA;CALCIUM ION;calcineurin B-like protein 2;3702;
1UIS;A;The 2.0 crystal structure of eqFP611, a far-red fluorescent protein from the sea anemone Entacmaea quadricolor;2;CA;CALCIUM ION;red fluorescent protein FP611;6118;
1UIS;B;The 2.0 crystal structure of eqFP611, a far-red fluorescent protein from the sea anemone Entacmaea quadricolor;2;CA;CALCIUM ION;red fluorescent protein FP611;6118;
1UJB;A;Structure of the protein histidine phosphatase SixA;2.06;CA;CALCIUM ION;Phosphohistidine phosphatase sixA;562;
1UJC;A;Structure of the protein histidine phosphatase SixA complexed with tungstate;1.9;CA;CALCIUM ION;Phosphohistidine phosphatase sixA;562;
1UKG;A;Pterocarps angolensis lectin PAL in complex with methyl-alpha-mannose;1.7;CA;CALCIUM ION;lectin;182271;
1UKG;B;Pterocarps angolensis lectin PAL in complex with methyl-alpha-mannose;1.7;CA;CALCIUM ION;lectin;182271;
1UKQ;A;Crystal structure of cyclodextrin glucanotransferase complexed with a pseudo-maltotetraose derived from acarbose;2;CA;CALCIUM ION;Cyclomaltodextrin glucanotransferase;1410;
1UKQ;B;Crystal structure of cyclodextrin glucanotransferase complexed with a pseudo-maltotetraose derived from acarbose;2;CA;CALCIUM ION;Cyclomaltodextrin glucanotransferase;1410;
1UKS;A;Crystal structure of F183L/F259L mutant cyclodextrin glucanotransferase complexed with a pseudo-maltotetraose derived from acarbose;1.9;CA;CALCIUM ION;Cyclomaltodextrin glucanotransferase;1410;
1UKS;B;Crystal structure of F183L/F259L mutant cyclodextrin glucanotransferase complexed with a pseudo-maltotetraose derived from acarbose;1.9;CA;CALCIUM ION;Cyclomaltodextrin glucanotransferase;1410;
1UKT;A;Crystal structure of Y100L mutant cyclodextrin glucanotransferase compexed with an acarbose;2.2;CA;CALCIUM ION;Cyclomaltodextrin glucanotransferase;1410;
1UKT;B;Crystal structure of Y100L mutant cyclodextrin glucanotransferase compexed with an acarbose;2.2;CA;CALCIUM ION;Cyclomaltodextrin glucanotransferase;1410;
1UL3;B;Crystal Structure of PII from Synechocystis sp. PCC 6803;2;CA;CALCIUM ION;Nitrogen regulatory protein P-II;1143;
1UL3;C;Crystal Structure of PII from Synechocystis sp. PCC 6803;2;CA;CALCIUM ION;Nitrogen regulatory protein P-II;1143;
1ULV;A;Crystal Structure of Glucodextranase Complexed with Acarbose;2.42;CA;CALCIUM ION;glucodextranase;1665;
1UMN;A;Crystal structure of Dps-like peroxide resistance protein (Dpr) from Streptococcus suis;1.95;CA;CALCIUM ION;DPS-LIKE PEROXIDE RESISTANCE PROTEIN;1307;
1UMN;B;Crystal structure of Dps-like peroxide resistance protein (Dpr) from Streptococcus suis;1.95;CA;CALCIUM ION;DPS-LIKE PEROXIDE RESISTANCE PROTEIN;1307;
1UMN;C;Crystal structure of Dps-like peroxide resistance protein (Dpr) from Streptococcus suis;1.95;CA;CALCIUM ION;DPS-LIKE PEROXIDE RESISTANCE PROTEIN;1307;
1UMN;D;Crystal structure of Dps-like peroxide resistance protein (Dpr) from Streptococcus suis;1.95;CA;CALCIUM ION;DPS-LIKE PEROXIDE RESISTANCE PROTEIN;1307;
1UMN;E;Crystal structure of Dps-like peroxide resistance protein (Dpr) from Streptococcus suis;1.95;CA;CALCIUM ION;DPS-LIKE PEROXIDE RESISTANCE PROTEIN;1307;
1UMN;F;Crystal structure of Dps-like peroxide resistance protein (Dpr) from Streptococcus suis;1.95;CA;CALCIUM ION;DPS-LIKE PEROXIDE RESISTANCE PROTEIN;1307;
1UMN;G;Crystal structure of Dps-like peroxide resistance protein (Dpr) from Streptococcus suis;1.95;CA;CALCIUM ION;DPS-LIKE PEROXIDE RESISTANCE PROTEIN;1307;
1UMN;H;Crystal structure of Dps-like peroxide resistance protein (Dpr) from Streptococcus suis;1.95;CA;CALCIUM ION;DPS-LIKE PEROXIDE RESISTANCE PROTEIN;1307;
1UMN;I;Crystal structure of Dps-like peroxide resistance protein (Dpr) from Streptococcus suis;1.95;CA;CALCIUM ION;DPS-LIKE PEROXIDE RESISTANCE PROTEIN;1307;
1UMN;J;Crystal structure of Dps-like peroxide resistance protein (Dpr) from Streptococcus suis;1.95;CA;CALCIUM ION;DPS-LIKE PEROXIDE RESISTANCE PROTEIN;1307;
1UMN;K;Crystal structure of Dps-like peroxide resistance protein (Dpr) from Streptococcus suis;1.95;CA;CALCIUM ION;DPS-LIKE PEROXIDE RESISTANCE PROTEIN;1307;
1UMN;L;Crystal structure of Dps-like peroxide resistance protein (Dpr) from Streptococcus suis;1.95;CA;CALCIUM ION;DPS-LIKE PEROXIDE RESISTANCE PROTEIN;1307;
1UMV;X;Crystal structure of an acidic, non-myotoxic phospholipase A2 from the venom of Bothrops jararacussu;1.79;CA;CALCIUM ION;HYPOTENSIVE PHOSPHOLIPASE A2;8726;
1UNE;A;CARBOXYLIC ESTER HYDROLASE, 1.5 ANGSTROM ORTHORHOMBIC FORM OF THE BOVINE RECOMBINANT PLA2;1.5;CA;CALCIUM ION;PHOSPHOLIPASE A2;9913;
1UOC;A;X-ray structure of the RNase domain of the yeast Pop2 protein;2.3;CA;CALCIUM ION;POP2;4932;
1UOC;B;X-ray structure of the RNase domain of the yeast Pop2 protein;2.3;CA;CALCIUM ION;POP2;4932;
1UOV;A;Calcium binding domain C2B;1.65;CA;CALCIUM ION;SYNAPTOTAGMIN I;10116;
1UOW;A;Calcium binding domain C2B;1.04;CA;CALCIUM ION;SYNAPTOTAGMIN I;10116;
1UP5;A;Chicken Calmodulin;1.9;CA;CALCIUM ION;Calmodulin;9031;
1UP5;B;Chicken Calmodulin;1.9;CA;CALCIUM ION;Calmodulin;9031;
1UP8;A;Recombinant vanadium-dependent bromoperoxidase from red algae Corallina pilulifera;2.2;CA;CALCIUM ION;VANADIUM-DEPENDENT BROMOPEROXIDASE 1;78447;
1UP8;B;Recombinant vanadium-dependent bromoperoxidase from red algae Corallina pilulifera;2.2;CA;CALCIUM ION;VANADIUM-DEPENDENT BROMOPEROXIDASE 1;78447;
1UP8;C;Recombinant vanadium-dependent bromoperoxidase from red algae Corallina pilulifera;2.2;CA;CALCIUM ION;VANADIUM-DEPENDENT BROMOPEROXIDASE 1;78447;
1UP8;D;Recombinant vanadium-dependent bromoperoxidase from red algae Corallina pilulifera;2.2;CA;CALCIUM ION;VANADIUM-DEPENDENT BROMOPEROXIDASE 1;78447;
1UPM;B;ACTIVATED SPINACH RUBISCO COMPLEXED WITH 2-CARBOXYARABINITOL 2 BISPHOSPHAT AND CA2+.;2.3;CA;CALCIUM ION;RIBULOSE BISPHOSPHATE CARBOXYLASE LARGE CHAIN;3562;
1UPM;E;ACTIVATED SPINACH RUBISCO COMPLEXED WITH 2-CARBOXYARABINITOL 2 BISPHOSPHAT AND CA2+.;2.3;CA;CALCIUM ION;RIBULOSE BISPHOSPHATE CARBOXYLASE LARGE CHAIN;3562;
1UPM;H;ACTIVATED SPINACH RUBISCO COMPLEXED WITH 2-CARBOXYARABINITOL 2 BISPHOSPHAT AND CA2+.;2.3;CA;CALCIUM ION;RIBULOSE BISPHOSPHATE CARBOXYLASE LARGE CHAIN;3562;
1UPM;K;ACTIVATED SPINACH RUBISCO COMPLEXED WITH 2-CARBOXYARABINITOL 2 BISPHOSPHAT AND CA2+.;2.3;CA;CALCIUM ION;RIBULOSE BISPHOSPHATE CARBOXYLASE LARGE CHAIN;3562;
1UPM;L;ACTIVATED SPINACH RUBISCO COMPLEXED WITH 2-CARBOXYARABINITOL 2 BISPHOSPHAT AND CA2+.;2.3;CA;CALCIUM ION;RIBULOSE BISPHOSPHATE CARBOXYLASE LARGE CHAIN;3562;
1UPM;O;ACTIVATED SPINACH RUBISCO COMPLEXED WITH 2-CARBOXYARABINITOL 2 BISPHOSPHAT AND CA2+.;2.3;CA;CALCIUM ION;RIBULOSE BISPHOSPHATE CARBOXYLASE LARGE CHAIN;3562;
1UPM;R;ACTIVATED SPINACH RUBISCO COMPLEXED WITH 2-CARBOXYARABINITOL 2 BISPHOSPHAT AND CA2+.;2.3;CA;CALCIUM ION;RIBULOSE BISPHOSPHATE CARBOXYLASE LARGE CHAIN;3562;
1UPM;V;ACTIVATED SPINACH RUBISCO COMPLEXED WITH 2-CARBOXYARABINITOL 2 BISPHOSPHAT AND CA2+.;2.3;CA;CALCIUM ION;RIBULOSE BISPHOSPHATE CARBOXYLASE LARGE CHAIN;3562;
1UPP;A;SPINACH RUBISCO IN COMPLEX WITH 2-CARBOXYARABINITOL 2 BISPHOSPHATE and Calcium.;2.3;CA;CALCIUM ION;RIBULOSE BISPHOSPHATE CARBOXYLASE LARGE CHAIN;3562;
1UPP;C;SPINACH RUBISCO IN COMPLEX WITH 2-CARBOXYARABINITOL 2 BISPHOSPHATE and Calcium.;2.3;CA;CALCIUM ION;RIBULOSE BISPHOSPHATE CARBOXYLASE LARGE CHAIN;3562;
1UPP;E;SPINACH RUBISCO IN COMPLEX WITH 2-CARBOXYARABINITOL 2 BISPHOSPHATE and Calcium.;2.3;CA;CALCIUM ION;RIBULOSE BISPHOSPHATE CARBOXYLASE LARGE CHAIN;3562;
1UPP;G;SPINACH RUBISCO IN COMPLEX WITH 2-CARBOXYARABINITOL 2 BISPHOSPHATE and Calcium.;2.3;CA;CALCIUM ION;RIBULOSE BISPHOSPHATE CARBOXYLASE LARGE CHAIN;3562;
1UPS;A;GlcNAc[alpha]1-4Gal releasing endo-[beta]-galactosidase from Clostridium perfringens;1.82;CA;CALCIUM ION;GLCNAC-ALPHA-1,4-GAL-RELEASING ENDO-BETA-GALACTOSIDASE;1502;
1UPS;B;GlcNAc[alpha]1-4Gal releasing endo-[beta]-galactosidase from Clostridium perfringens;1.82;CA;CALCIUM ION;GLCNAC-ALPHA-1,4-GAL-RELEASING ENDO-BETA-GALACTOSIDASE;1502;
1UQX;A;Ralstonia solanacearum lectin (RS-IIL) in complex with alpha-methylmannoside;1.7;CA;CALCIUM ION;LECTIN;305;
1UR0;A;The structure of endo-beta-1,4-galactanase from Bacillus licheniformis in complex with two oligosaccharide products.;2.5;CA;CALCIUM ION;GALACTANASE;1402;
1UR0;B;The structure of endo-beta-1,4-galactanase from Bacillus licheniformis in complex with two oligosaccharide products.;2.5;CA;CALCIUM ION;GALACTANASE;1402;
1UR4;A;The structure of endo-beta-1,4-galactanase from Bacillus licheniformis in complex with two oligosaccharide products.;2.2;CA;CALCIUM ION;GALACTANASE;1402;
1UR4;B;The structure of endo-beta-1,4-galactanase from Bacillus licheniformis in complex with two oligosaccharide products.;2.2;CA;CALCIUM ION;GALACTANASE;1402;
1URX;A;Crystallographic structure of beta-agarase A in complex with oligoagarose;1.7;CA;CALCIUM ION;BETA-AGARASE A;63186;
1US1;A;Crystal structure of human vascular adhesion protein-1;2.9;CA;CALCIUM ION;MEMBRANE COPPER AMINE OXIDASE;9606;
1US1;B;Crystal structure of human vascular adhesion protein-1;2.9;CA;CALCIUM ION;MEMBRANE COPPER AMINE OXIDASE;9606;
1USN;A;CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN FIBROBLAST STROMELYSIN-1 INHIBITED WITH THIADIAZOLE INHIBITOR PNU-142372;1.8;CA;CALCIUM ION;STROMELYSIN-1;9606;
1USR;A;Newcastle disease virus hemagglutinin-neuraminidase: Evidence for a second sialic acid binding site and implications for fusion;2;CA;CALCIUM ION;HEMAGGLUTININ-NEURAMINIDASE GLYCOPROTEIN;11176;
1USR;B;Newcastle disease virus hemagglutinin-neuraminidase: Evidence for a second sialic acid binding site and implications for fusion;2;CA;CALCIUM ION;HEMAGGLUTININ-NEURAMINIDASE GLYCOPROTEIN;11176;
1UTJ;A;Trypsin specificity as elucidated by LIE calculations, X-ray structures and association constant measurements;1.83;CA;CALCIUM ION;TRYPSIN I;8030;
1UTK;A;Trypsin specificity as elucidated by LIE calculations, X-ray structures and association constant measurements;1.53;CA;CALCIUM ION;TRYPSIN I;8030;
1UTL;M;Trypsin specificity as elucidated by LIE calculations, X-ray structures and association constant measurements;1.7;CA;CALCIUM ION;TRYPSIN I;8030;
1UTM;A;Trypsin specificity as elucidated by LIE calculations, X-ray structures and association constant measurements;1.5;CA;CALCIUM ION;TRYPSIN I;8030;
1UTN;A;Trypsin specificity as elucidated by LIE calculations, X-ray structures and association constant measurements;1.15;CA;CALCIUM ION;TRYPSINOGEN;9913;
1UTO;A;Trypsin specificity as elucidated by LIE calculations, X-ray structures and association constant measurements;1.15;CA;CALCIUM ION;TRYPSINOGEN;9913;
1UTP;A;Trypsin specificity as elucidated by LIE calculations, X-ray structures and association constant measurements;1.3;CA;CALCIUM ION;TRYPSINOGEN;9913;
1UTQ;A;Trypsin specificity as elucidated by LIE calculations, X-ray structures and association constant measurements;1.15;CA;CALCIUM ION;TRYPSINOGEN;9913;
1UTT;A;Crystal Structure of MMP-12 complexed to 2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethyl-4-(4-ethoxy[1,1-biphenyl]-4-yl)-4-oxobutanoic acid;2.2;CA;CALCIUM ION;MACROPHAGE METALLOELASTASE;9606;
1UTZ;A;Crystal Structure of MMP-12 complexed to (2R)-3-({[4-[(pyridin-4-yl)phenyl]-thien-2-yl}carboxamido)(phenyl)propanoic acid;2.5;CA;CALCIUM ION;MACROPHAGE METALLOELASTASE;9606;
1UTZ;B;Crystal Structure of MMP-12 complexed to (2R)-3-({[4-[(pyridin-4-yl)phenyl]-thien-2-yl}carboxamido)(phenyl)propanoic acid;2.5;CA;CALCIUM ION;MACROPHAGE METALLOELASTASE;9606;
1UV4;A;Native Bacillus subtilis Arabinanase Arb43A;1.5;CA;CALCIUM ION;ARABINAN-ENDO 1,5-ALPHA-L-ARABINASE;1423;
1UVN;A;The structural basis for RNA specificity and Ca2 inhibition of an RNA-dependent RNA polymerase phi6p2 ca2+ inhibition complex;3;CA;CALCIUM ION;RNA-directed RNA polymerase;10879;
1UVN;C;The structural basis for RNA specificity and Ca2 inhibition of an RNA-dependent RNA polymerase phi6p2 ca2+ inhibition complex;3;CA;CALCIUM ION;RNA-directed RNA polymerase;10879;
1UVN;E;The structural basis for RNA specificity and Ca2 inhibition of an RNA-dependent RNA polymerase phi6p2 ca2+ inhibition complex;3;CA;CALCIUM ION;RNA-directed RNA polymerase;10879;
1UWW;A;X-ray crystal structure of a non-crystalline cellulose specific carbohydrate-binding module: CBM28.;1.4;CA;CALCIUM ION;ENDOGLUCANASE;1411;
1UWW;B;X-ray crystal structure of a non-crystalline cellulose specific carbohydrate-binding module: CBM28.;1.4;CA;CALCIUM ION;ENDOGLUCANASE;1411;
1UX6;A;Structure of a thrombospondin C-terminal fragment reveals a novel calcium core in the type 3 repeats;1.9;CA;CALCIUM ION;THROMBOSPONDIN-1;9606;
1UX7;A;Carbohydrate-Binding Module CBM36 in complex with calcium and xylotriose;1.5;CA;CALCIUM ION;ENDO-1,4-BETA-XYLANASE D;1406;
1UXX;X;CBM6ct from Clostridium thermocellum in complex with xylopentaose;1.6;CA;CALCIUM ION;XYLANASE U;1515;
1UY0;A;Carbohydrate binding module (CBM6cm-2) from Cellvibrio mixtus lichenase 5A in complex with glc-1,3-glc-1,4-glc-1,3-glc;1.65;CA;CALCIUM ION;CELLULASE B;39650;
1UY0;B;Carbohydrate binding module (CBM6cm-2) from Cellvibrio mixtus lichenase 5A in complex with glc-1,3-glc-1,4-glc-1,3-glc;1.65;CA;CALCIUM ION;CELLULASE B;39650;
1UY1;A;Binding sub-site dissection of a family 6 carbohydrate-binding module by X-ray crystallography and isothermal titration calorimetry;1.8;CA;CALCIUM ION;ENDO-1,4-BETA-XYLANASE A;1510;
1UY2;A;Binding sub-site dissection of a family 6 carbohydrate-binding module by X-ray crystallography and isothermal titration calorimetry;1.7;CA;CALCIUM ION;ENDO-1,4-BETA-XYLANASE A;1510;
1UY3;A;Binding sub-site dissection of a family 6 carbohydrate-binding module by X-ray crystallography and isothermal titration calorimetry;1.89;CA;CALCIUM ION;ENDO-1,4-BETA-XYLANASE A;1510;
1UY4;A;Binding sub-site dissection of a family 6 carbohydrate-binding module by X-ray crystallography and isothermal titration calorimetry;1.69;CA;CALCIUM ION;ENDO-1,4-BETA-XYLANASE A;1510;
1UYX;A;Carbohydrate binding module (CBM6cm-2) from Cellvibrio mixtus lichenase 5A in complex with cellobiose;1.47;CA;CALCIUM ION;CELLULASE B;39650;
1UYX;B;Carbohydrate binding module (CBM6cm-2) from Cellvibrio mixtus lichenase 5A in complex with cellobiose;1.47;CA;CALCIUM ION;CELLULASE B;39650;
1UYY;A;Carbohydrate binding module (CBM6cm-2) from Cellvibrio mixtus lichenase 5A in complex with cellotriose;1.47;CA;CALCIUM ION;CELLULASE B;39650;
1UYY;B;Carbohydrate binding module (CBM6cm-2) from Cellvibrio mixtus lichenase 5A in complex with cellotriose;1.47;CA;CALCIUM ION;CELLULASE B;39650;
1UYZ;A;Carbohydrate binding module (CBM6cm-2) from Cellvibrio mixtus lichenase 5A in complex with xylotetraose;1.6;CA;CALCIUM ION;CELLULASE B;39650;
1UYZ;B;Carbohydrate binding module (CBM6cm-2) from Cellvibrio mixtus lichenase 5A in complex with xylotetraose;1.6;CA;CALCIUM ION;CELLULASE B;39650;
1UZ0;A;Carbohydrate binding module (CBM6cm-2) from Cellvibrio mixtus lichenase 5A in complex with Glc-4Glc-3Glc-4Glc;2;CA;CALCIUM ION;CELLULASE B;39650;
1UZJ;A;Integrin binding cbEGF22-TB4-cbEGF33 fragment of human fibrillin-1, holo form.;2.25;CA;CALCIUM ION;FIBRILLIN-1;9606;
1UZJ;B;Integrin binding cbEGF22-TB4-cbEGF33 fragment of human fibrillin-1, holo form.;2.25;CA;CALCIUM ION;FIBRILLIN-1;9606;
1UZJ;C;Integrin binding cbEGF22-TB4-cbEGF33 fragment of human fibrillin-1, holo form.;2.25;CA;CALCIUM ION;FIBRILLIN-1;9606;
1UZK;A;Integrin binding cbEGF22-TB4-cbEGF33 fragment of human fibrillin-1, Ca bound to cbEGF23 domain only;1.35;CA;CALCIUM ION;FIBRILLIN-1;9606;
1UZV;A;High affinity fucose binding of Pseudomonas aeruginosa lectin II: 1.0 A crystal structure of the complex;1;CA;CALCIUM ION;PSEUDOMONAS AERUGINOSA LECTIN II;287;
1UZV;B;High affinity fucose binding of Pseudomonas aeruginosa lectin II: 1.0 A crystal structure of the complex;1;CA;CALCIUM ION;PSEUDOMONAS AERUGINOSA LECTIN II;287;
1UZV;C;High affinity fucose binding of Pseudomonas aeruginosa lectin II: 1.0 A crystal structure of the complex;1;CA;CALCIUM ION;PSEUDOMONAS AERUGINOSA LECTIN II;287;
1UZV;D;High affinity fucose binding of Pseudomonas aeruginosa lectin II: 1.0 A crystal structure of the complex;1;CA;CALCIUM ION;PSEUDOMONAS AERUGINOSA LECTIN II;287;
1UZY;A;Erythrina crystagalli lectin;2;CA;CALCIUM ION;Lectin;49817;
1UZY;B;Erythrina crystagalli lectin;2;CA;CALCIUM ION;Lectin;49817;
1UZZ;A;Erythrina cristagalli bound to N-linked oligosaccharide and lactose;2.13;CA;CALCIUM ION;Lectin;49817;
1UZZ;B;Erythrina cristagalli bound to N-linked oligosaccharide and lactose;2.13;CA;CALCIUM ION;Lectin;49817;
1UZZ;C;Erythrina cristagalli bound to N-linked oligosaccharide and lactose;2.13;CA;CALCIUM ION;Lectin;49817;
1UZZ;D;Erythrina cristagalli bound to N-linked oligosaccharide and lactose;2.13;CA;CALCIUM ION;Lectin;49817;
1V00;A;Erythrina cristagalli lectin;1.7;CA;CALCIUM ION;LECTIN (ECL);49817;
1V00;B;Erythrina cristagalli lectin;1.7;CA;CALCIUM ION;LECTIN (ECL);49817;
1V00;C;Erythrina cristagalli lectin;1.7;CA;CALCIUM ION;LECTIN (ECL);49817;
1V00;D;Erythrina cristagalli lectin;1.7;CA;CALCIUM ION;LECTIN (ECL);49817;
1V04;A;serum paraoxonase by directed evolution;2.2;CA;CALCIUM ION;SERUM PARAOXONASE/ARYLESTERASE 1;960,699,861,009,010,000;
1V0A;A;Family 11 Carbohydrate-Binding Module of cellulosomal cellulase Lic26A-Cel5E of Clostridium thermocellum;1.98;CA;CALCIUM ION;ENDOGLUCANASE H;1515;
1V0C;A;Structure of AAC(6')-Ib in complex with Kanamycin C and AcetylCoA.;2.2;CA;CALCIUM ION;AAC(6')-IB;562;
1V0Z;A;Structure of Neuraminidase from English duck subtype N6;1.84;CA;CALCIUM ION;NEURAMINIDASE;11320;
1V0Z;B;Structure of Neuraminidase from English duck subtype N6;1.84;CA;CALCIUM ION;NEURAMINIDASE;11320;
1V0Z;C;Structure of Neuraminidase from English duck subtype N6;1.84;CA;CALCIUM ION;NEURAMINIDASE;11320;
1V0Z;D;Structure of Neuraminidase from English duck subtype N6;1.84;CA;CALCIUM ION;NEURAMINIDASE;11320;
1V1F;A;Structure of the Arabidopsis thaliana SOS3 complexed with Calcium(II) and Manganese(II) ions;3;CA;CALCIUM ION;CALCINEURIN B-LIKE PROTEIN 4;3702;
1V1G;A;Structure of the Arabidopsis thaliana SOS3 complexed with Calcium(II) ion;2.7;CA;CALCIUM ION;CALCINEURIN B-LIKE PROTEIN 4;3702;
1V2I;A;Structure of the hemagglutinin-neuraminidase from human parainfluenza virus type III;2.2;CA;CALCIUM ION;hemagglutinin-neuraminidase glycoprotein;11216;
1V2I;B;Structure of the hemagglutinin-neuraminidase from human parainfluenza virus type III;2.2;CA;CALCIUM ION;hemagglutinin-neuraminidase glycoprotein;11216;
1V2J;T;BENZAMIDINE IN COMPLEX WITH BOVINE TRYPSIN VARIANT X(SSRI)bT.C1;1.9;CA;CALCIUM ION;Trypsin;9913;
1V2K;T;Factor XA specific Inhibitor in complex with bovine trypsin variant X(triple.Glu)bT.D2;2;CA;CALCIUM ION;Trypsin;9913;
1V2L;T;Benzamidine in complex with bovine trypsin variant X(triple.Glu)bT.D1;1.6;CA;CALCIUM ION;Trypsin;9913;
1V2N;T;Potent factor XA inhibitor in complex with bovine trypsin variant X(99/175/190)bT;1.8;CA;CALCIUM ION;Trypsin;9913;
1V2O;T;Trypsin inhibitor in complex with bovine trypsin variant X(SSYI)bT.B4;1.62;CA;CALCIUM ION;Trypsin;9913;
1V2P;T;Trypsin inhibitor in complex with bovine trypsin variant X(SSYI)bT.A4;1.92;CA;CALCIUM ION;Trypsin;9913;
1V2Q;T;Trypsin inhibitor in complex with bovine trypsin variant X(SSWI)bT.B4;2.3;CA;CALCIUM ION;Trypsin;9913;
1V2R;T;Trypsin inhibitor in complex with bovine trypsin variant X(SSRI)bT.B4;1.7;CA;CALCIUM ION;Trypsin;9913;
1V2S;T;Benzamidine in complex with bovine trypsin variant X(SSFI.Glu)bT.D1;1.72;CA;CALCIUM ION;Trypsin;9913;
1V2T;T;Trypsin inhibitor in complex with bovine trypsin variant X(SSFI.Glu)bT.B4;1.9;CA;CALCIUM ION;Trypsin;9913;
1V2U;T;Benzamidine in complex with bovine trypsin varinat X(SSAI)bT.D1;1.8;CA;CALCIUM ION;Trypsin;9913;
1V2V;T;Benzamidine in complex with bovine trypsin variant X(SSAI)bT.C1;1.8;CA;CALCIUM ION;Trypsin;9913;
1V2W;T;Trypsin inhibitor in complex with bovine trypsin variant X(SSAI)bT.B4;1.75;CA;CALCIUM ION;Trypsin;9913;
1V3B;A;Structure of the hemagglutinin-neuraminidase from human parainfluenza virus type III;2;CA;CALCIUM ION;hemagglutinin-neuraminidase glycoprotein;11216;
1V3B;B;Structure of the hemagglutinin-neuraminidase from human parainfluenza virus type III;2;CA;CALCIUM ION;hemagglutinin-neuraminidase glycoprotein;11216;
1V3C;A;Structure of the hemagglutinin-neuraminidase from human parainfluenza virus type III: complex with NEU5AC;2.3;CA;CALCIUM ION;hemagglutinin-neuraminidase glycoprotein;11216;
1V3C;B;Structure of the hemagglutinin-neuraminidase from human parainfluenza virus type III: complex with NEU5AC;2.3;CA;CALCIUM ION;hemagglutinin-neuraminidase glycoprotein;11216;
1V3D;A;Structure of the hemagglutinin-neuraminidase from human parainfluenza virus type III: complex with NEU5AC2EN;2.28;CA;CALCIUM ION;hemagglutinin-neuraminidase glycoprotein;11216;
1V3D;B;Structure of the hemagglutinin-neuraminidase from human parainfluenza virus type III: complex with NEU5AC2EN;2.28;CA;CALCIUM ION;hemagglutinin-neuraminidase glycoprotein;11216;
1V3E;A;Structure of the hemagglutinin-neuraminidase from human parainfluenza virus type III: complex with ZANAMAVIR;1.89;CA;CALCIUM ION;hemagglutinin-neuraminidase glycoprotein;11216;
1V3E;B;Structure of the hemagglutinin-neuraminidase from human parainfluenza virus type III: complex with ZANAMAVIR;1.89;CA;CALCIUM ION;hemagglutinin-neuraminidase glycoprotein;11216;
1V3J;A;Crystal structure of F283L mutant cyclodextrin glycosyltransferase;2;CA;CALCIUM ION;Cyclomaltodextrin glucanotransferase;1410;
1V3J;B;Crystal structure of F283L mutant cyclodextrin glycosyltransferase;2;CA;CALCIUM ION;Cyclomaltodextrin glucanotransferase;1410;
1V3K;A;Crystal structure of F283Y mutant cyclodextrin glycosyltransferase;2;CA;CALCIUM ION;Cyclomaltodextrin glucanotransferase;1410;
1V3K;B;Crystal structure of F283Y mutant cyclodextrin glycosyltransferase;2;CA;CALCIUM ION;Cyclomaltodextrin glucanotransferase;1410;
1V3L;A;Crystal structure of F283L mutant cyclodextrin glycosyltransferase complexed with a pseudo-tetraose derived from acarbose;2.1;CA;CALCIUM ION;Cyclomaltodextrin glucanotransferase;1410;
1V3L;B;Crystal structure of F283L mutant cyclodextrin glycosyltransferase complexed with a pseudo-tetraose derived from acarbose;2.1;CA;CALCIUM ION;Cyclomaltodextrin glucanotransferase;1410;
1V3M;A;Crystal structure of F283Y mutant cyclodextrin glycosyltransferase complexed with a pseudo-tetraose derived from acarbose;2;CA;CALCIUM ION;Cyclomaltodextrin glucanotransferase;1410;
1V3M;B;Crystal structure of F283Y mutant cyclodextrin glycosyltransferase complexed with a pseudo-tetraose derived from acarbose;2;CA;CALCIUM ION;Cyclomaltodextrin glucanotransferase;1410;
1V3W;A;Structure of Ferripyochelin binding protein from Pyrococcus horikoshii OT3;1.5;CA;CALCIUM ION;ferripyochelin binding protein;53953;
1V3X;A;Factor Xa in complex with the inhibitor 1-[6-methyl-4,5,6,7-tetrahydrothiazolo(5,4-c)pyridin-2-yl] carbonyl-2-carbamoyl-4-(6-chloronaphth-2-ylsulphonyl)piperazine;2.2;CA;CALCIUM ION;Coagulation factor X, HEAVY CHAIN;9606;
1V5I;A;Crystal structure of serine protease inhibitor POIA1 in complex with subtilisin BPN';1.5;CA;CALCIUM ION;Subtilisin BPN';1390;
1V67;A;Structure of ferripyochelin binding protein from pyrococcus horikoshii OT3;2.3;CA;CALCIUM ION;ferripyochelin binding protein;53953;
1V6C;A;Crystal Structure of Psychrophilic Subtilisin-like Protease Apa1 from Antarctic Psychrotroph Pseudoalteromonas sp. AS-11;1.8;CA;CALCIUM ION;alkaline serine protease;247492;
1V6C;B;Crystal Structure of Psychrophilic Subtilisin-like Protease Apa1 from Antarctic Psychrotroph Pseudoalteromonas sp. AS-11;1.8;CA;CALCIUM ION;alkaline serine protease;247492;
1V6D;A;The crystal structure of the trypsin complex with synthetic heterochiral peptide;1.9;CA;CALCIUM ION;Trypsin;9823;
1V6I;A;Peanut lectin-lactose complex in acidic pH;2.15;CA;CALCIUM ION;Galactose-binding lectin;3818;
1V6I;B;Peanut lectin-lactose complex in acidic pH;2.15;CA;CALCIUM ION;Galactose-binding lectin;3818;
1V6I;C;Peanut lectin-lactose complex in acidic pH;2.15;CA;CALCIUM ION;Galactose-binding lectin;3818;
1V6I;D;Peanut lectin-lactose complex in acidic pH;2.15;CA;CALCIUM ION;Galactose-binding lectin;3818;
1V6J;A;peanut lectin-lactose complex crystallized in orthorhombic form at acidic pH;2.9;CA;CALCIUM ION;Galactose-binding lectin;3818;
1V6J;B;peanut lectin-lactose complex crystallized in orthorhombic form at acidic pH;2.9;CA;CALCIUM ION;Galactose-binding lectin;3818;
1V6J;C;peanut lectin-lactose complex crystallized in orthorhombic form at acidic pH;2.9;CA;CALCIUM ION;Galactose-binding lectin;3818;
1V6J;D;peanut lectin-lactose complex crystallized in orthorhombic form at acidic pH;2.9;CA;CALCIUM ION;Galactose-binding lectin;3818;
1V6K;A;Peanut lectin-lactose complex in the presence of peptide(IWSSAGNVA);2.4;CA;CALCIUM ION;Galactose-binding lectin;3818;
1V6K;B;Peanut lectin-lactose complex in the presence of peptide(IWSSAGNVA);2.4;CA;CALCIUM ION;Galactose-binding lectin;3818;
1V6K;C;Peanut lectin-lactose complex in the presence of peptide(IWSSAGNVA);2.4;CA;CALCIUM ION;Galactose-binding lectin;3818;
1V6K;D;Peanut lectin-lactose complex in the presence of peptide(IWSSAGNVA);2.4;CA;CALCIUM ION;Galactose-binding lectin;3818;
1V6L;A;Peanut lectin-lactose complex in the presence of 9mer peptide (PVIWSSATG);2.5;CA;CALCIUM ION;Galactose-binding lectin;3818;
1V6L;B;Peanut lectin-lactose complex in the presence of 9mer peptide (PVIWSSATG);2.5;CA;CALCIUM ION;Galactose-binding lectin;3818;
1V6L;C;Peanut lectin-lactose complex in the presence of 9mer peptide (PVIWSSATG);2.5;CA;CALCIUM ION;Galactose-binding lectin;3818;
1V6L;D;Peanut lectin-lactose complex in the presence of 9mer peptide (PVIWSSATG);2.5;CA;CALCIUM ION;Galactose-binding lectin;3818;
1V6M;A;Peanut Lectin with 9mer peptide (IWSSAGNVA);2.7;CA;CALCIUM ION;Galactose-binding lectin;3818;
1V6M;B;Peanut Lectin with 9mer peptide (IWSSAGNVA);2.7;CA;CALCIUM ION;Galactose-binding lectin;3818;
1V6M;C;Peanut Lectin with 9mer peptide (IWSSAGNVA);2.7;CA;CALCIUM ION;Galactose-binding lectin;3818;
1V6M;D;Peanut Lectin with 9mer peptide (IWSSAGNVA);2.7;CA;CALCIUM ION;Galactose-binding lectin;3818;
1V6M;E;Peanut Lectin with 9mer peptide (IWSSAGNVA);2.7;CA;CALCIUM ION;Galactose-binding lectin;3818;
1V6M;F;Peanut Lectin with 9mer peptide (IWSSAGNVA);2.7;CA;CALCIUM ION;Galactose-binding lectin;3818;
1V6M;G;Peanut Lectin with 9mer peptide (IWSSAGNVA);2.7;CA;CALCIUM ION;Galactose-binding lectin;3818;
1V6M;H;Peanut Lectin with 9mer peptide (IWSSAGNVA);2.7;CA;CALCIUM ION;Galactose-binding lectin;3818;
1V6N;A;Peanut lectin with 9mer peptide (PVIWSSATG);3.5;CA;CALCIUM ION;Galactose-binding lectin;3818;
1V6N;B;Peanut lectin with 9mer peptide (PVIWSSATG);3.5;CA;CALCIUM ION;Galactose-binding lectin;3818;
1V6N;C;Peanut lectin with 9mer peptide (PVIWSSATG);3.5;CA;CALCIUM ION;Galactose-binding lectin;3818;
1V6N;D;Peanut lectin with 9mer peptide (PVIWSSATG);3.5;CA;CALCIUM ION;Galactose-binding lectin;3818;
1V6N;E;Peanut lectin with 9mer peptide (PVIWSSATG);3.5;CA;CALCIUM ION;Galactose-binding lectin;3818;
1V6N;F;Peanut lectin with 9mer peptide (PVIWSSATG);3.5;CA;CALCIUM ION;Galactose-binding lectin;3818;
1V6N;G;Peanut lectin with 9mer peptide (PVIWSSATG);3.5;CA;CALCIUM ION;Galactose-binding lectin;3818;
1V6N;H;Peanut lectin with 9mer peptide (PVIWSSATG);3.5;CA;CALCIUM ION;Galactose-binding lectin;3818;
1V6O;A;Peanut lectin complexed with 10mer peptide (PVRIWSSATG);3;CA;CALCIUM ION;Galactose-binding lectin;3818;
1V6O;B;Peanut lectin complexed with 10mer peptide (PVRIWSSATG);3;CA;CALCIUM ION;Galactose-binding lectin;3818;
1V6O;C;Peanut lectin complexed with 10mer peptide (PVRIWSSATG);3;CA;CALCIUM ION;Galactose-binding lectin;3818;
1V6O;D;Peanut lectin complexed with 10mer peptide (PVRIWSSATG);3;CA;CALCIUM ION;Galactose-binding lectin;3818;
1V6O;E;Peanut lectin complexed with 10mer peptide (PVRIWSSATG);3;CA;CALCIUM ION;Galactose-binding lectin;3818;
1V6O;F;Peanut lectin complexed with 10mer peptide (PVRIWSSATG);3;CA;CALCIUM ION;Galactose-binding lectin;3818;
1V6O;G;Peanut lectin complexed with 10mer peptide (PVRIWSSATG);3;CA;CALCIUM ION;Galactose-binding lectin;3818;
1V6O;H;Peanut lectin complexed with 10mer peptide (PVRIWSSATG);3;CA;CALCIUM ION;Galactose-binding lectin;3818;
1V73;A;Crystal Structure of Cold-Active Protein-Tyrosine Phosphatase of a Psychrophile Shewanella SP.;1.82;CA;CALCIUM ION;psychrophilic phosphatase I;50422;
1V7V;A;Crystal structure of Vibrio proteolyticus chitobiose phosphorylase;1.8;CA;CALCIUM ION;chitobiose phosphorylase;671;
1V7W;A;Crystal structure of Vibrio proteolyticus chitobiose phosphorylase in complex with GlcNAc;1.6;CA;CALCIUM ION;chitobiose phosphorylase;671;
1V7X;A;Crystal structure of Vibrio proteolyticus chitobiose phosphorylase in complex with GlcNAc and sulfate;2;CA;CALCIUM ION;chitobiose phosphorylase;671;
1V97;A;Crystal Structure of Bovine Milk Xanthine Dehydrogenase FYX-051 bound form;1.94;CA;CALCIUM ION;Xanthine dehydrogenase;9913;
1V97;B;Crystal Structure of Bovine Milk Xanthine Dehydrogenase FYX-051 bound form;1.94;CA;CALCIUM ION;Xanthine dehydrogenase;9913;
1V9U;5;Human Rhinovirus 2 bound to a fragment of its cellular receptor protein;3.6;CA;CALCIUM ION;LDL-receptor class A 3;9606;
1VAH;A;Crystal structure of the pig pancreatic-amylase complexed with r-nitrophenyl-a-D-maltoside;2.4;CA;CALCIUM ION;Alpha-amylase, pancreatic;9823;
1VAK;A;T=1 capsid structure of Sesbania mosaic virus coat protein deletion mutant CP-N(delta)65;3.05;CA;CALCIUM ION;coat protein;12558;
1VAL;A;CONCANAVALIN A COMPLEX WITH 4'-NITROPHENYL-ALPHA-D-GLUCOPYRANOSIDE;3;CA;CALCIUM ION;CONCANAVALIN A;3823;
1VAL;B;CONCANAVALIN A COMPLEX WITH 4'-NITROPHENYL-ALPHA-D-GLUCOPYRANOSIDE;3;CA;CALCIUM ION;CONCANAVALIN A;3823;
1VAL;C;CONCANAVALIN A COMPLEX WITH 4'-NITROPHENYL-ALPHA-D-GLUCOPYRANOSIDE;3;CA;CALCIUM ION;CONCANAVALIN A;3823;
1VAL;D;CONCANAVALIN A COMPLEX WITH 4'-NITROPHENYL-ALPHA-D-GLUCOPYRANOSIDE;3;CA;CALCIUM ION;CONCANAVALIN A;3823;
1VAM;A;CONCANAVALIN A COMPLEX WITH 4'-NITROPHENYL-ALPHA-D-MANNOPYRANOSIDE;2.75;CA;CALCIUM ION;CONCANAVALIN A;3823;
1VAM;B;CONCANAVALIN A COMPLEX WITH 4'-NITROPHENYL-ALPHA-D-MANNOPYRANOSIDE;2.75;CA;CALCIUM ION;CONCANAVALIN A;3823;
1VAM;C;CONCANAVALIN A COMPLEX WITH 4'-NITROPHENYL-ALPHA-D-MANNOPYRANOSIDE;2.75;CA;CALCIUM ION;CONCANAVALIN A;3823;
1VAM;D;CONCANAVALIN A COMPLEX WITH 4'-NITROPHENYL-ALPHA-D-MANNOPYRANOSIDE;2.75;CA;CALCIUM ION;CONCANAVALIN A;3823;
1VB4;A;T=1 capsid structure of Sesbania mosaic virus coat protein deletion mutant CP-N(delta)36;3.3;CA;CALCIUM ION;coat protein;12558;
1VB9;A;Crystal structure of Thermoactinomyces vulgaris R-47 alpha-amylase II (TVA II) complexed with transglycosylated product;2.2;CA;CALCIUM ION;alpha-amylase II;2026;
1VB9;B;Crystal structure of Thermoactinomyces vulgaris R-47 alpha-amylase II (TVA II) complexed with transglycosylated product;2.2;CA;CALCIUM ION;alpha-amylase II;2026;
1VBL;A;Structure of the thermostable pectate lyase PL 47;1.91;CA;CALCIUM ION;pectate lyase 47;132676;
1VCH;C;Crystal Structure of a Phosphoribosyltransferase-related protein from Thermus thermophilus;1.94;CA;CALCIUM ION;Phosphoribosyltransferase-related protein;274;
1VCL;A;Crystal Structure of Hemolytic Lectin CEL-III;1.7;CA;CALCIUM ION;hemolytic lectin CEL-III;40245;
1VCL;B;Crystal Structure of Hemolytic Lectin CEL-III;1.7;CA;CALCIUM ION;hemolytic lectin CEL-III;40245;
1VDV;A;Bovine Milk Xanthine Dehydrogenase Y-700 Bound Form;1.98;CA;CALCIUM ION;Xanthine dehydrogenase/oxidase;9913;
1VDV;B;Bovine Milk Xanthine Dehydrogenase Y-700 Bound Form;1.98;CA;CALCIUM ION;Xanthine dehydrogenase/oxidase;9913;
1VE5;A;Crystal Structure of T.th. HB8 Threonine deaminase;2.15;CA;CALCIUM ION;Threonine deaminase;274;
1VE5;B;Crystal Structure of T.th. HB8 Threonine deaminase;2.15;CA;CALCIUM ION;Threonine deaminase;274;
1VE5;C;Crystal Structure of T.th. HB8 Threonine deaminase;2.15;CA;CALCIUM ION;Threonine deaminase;274;
1VE5;D;Crystal Structure of T.th. HB8 Threonine deaminase;2.15;CA;CALCIUM ION;Threonine deaminase;274;
1VEM;A;Crystal Structure Analysis of Bacillus Cereus Beta-Amylase at the optimum pH (6.5);1.85;CA;CALCIUM ION;Beta-amylase;1396;
1VEN;A;Crystal Structure Analysis of Y164E/maltose of Bacilus cereus Beta-amylase at pH 4.6;2.02;CA;CALCIUM ION;Beta-amylase;1396;
1VEO;A;Crystal Structure Analysis of Y164F/maltose of Bacillus cereus Beta-Amylase at pH 4.6;2.12;CA;CALCIUM ION;Beta-amylase;1396;
1VEP;A;Crystal Structure Analysis of Triple (T47M/Y164E/T328N)/maltose of Bacillus cereus Beta-Amylase at pH 6.5;2.06;CA;CALCIUM ION;Beta-amylase;1396;
1VFM;A;Crystal structure of Thermoactinomyces vulgaris R-47 alpha-amylase 2/alpha-cyclodextrin complex;2.9;CA;CALCIUM ION;Neopullulanase 2;2026;
1VFM;B;Crystal structure of Thermoactinomyces vulgaris R-47 alpha-amylase 2/alpha-cyclodextrin complex;2.9;CA;CALCIUM ION;Neopullulanase 2;2026;
1VFO;A;Crystal structure of Thermoactinomyces vulgaris R-47 alpha-amylase 2/beta-cyclodextrin complex;2.81;CA;CALCIUM ION;Neopullulanase 2;2026;
1VFO;B;Crystal structure of Thermoactinomyces vulgaris R-47 alpha-amylase 2/beta-cyclodextrin complex;2.81;CA;CALCIUM ION;Neopullulanase 2;2026;
1VFP;A;Crystal structure of the SR CA2+-ATPase with bound AMPPCP;2.9;CA;CALCIUM ION;Sarcoplasmic/endoplasmic reticulum calcium ATPase 1;9986;
1VFP;B;Crystal structure of the SR CA2+-ATPase with bound AMPPCP;2.9;CA;CALCIUM ION;Sarcoplasmic/endoplasmic reticulum calcium ATPase 1;9986;
1VFU;A;Crystal structure of Thermoactinomyces vulgaris R-47 amylase 2/gamma-cyclodextrin complex;3.1;CA;CALCIUM ION;Neopullulanase 2;2026;
1VFU;B;Crystal structure of Thermoactinomyces vulgaris R-47 amylase 2/gamma-cyclodextrin complex;3.1;CA;CALCIUM ION;Neopullulanase 2;2026;
1VIW;A;TENEBRIO MOLITOR ALPHA-AMYLASE-INHIBITOR COMPLEX;3;CA;CALCIUM ION;ALPHA-AMYLASE;7067;
1VKQ;A;A re-determination of the structure of the triple mutant (K53,56,120M) of phospholipase A2 at 1.6A resolution using sulphur-SAS at 1.54A wavelength;1.6;CA;CALCIUM ION;Phospholipase A2;9913;
1VL9;A;Atomic resolution (0.97A) structure of the triple mutant (K53,56,121M) of bovine pancreatic phospholipase A2;0.97;CA;CALCIUM ION;Phospholipase A2;9913;
1VLN;A;A TRICLINIC CRYSTAL FORM OF THE LECTIN CONCANAVALIN A;2.4;CA;CALCIUM ION;CONCANAVALIN A;3823;
1VLN;B;A TRICLINIC CRYSTAL FORM OF THE LECTIN CONCANAVALIN A;2.4;CA;CALCIUM ION;CONCANAVALIN A;3823;
1VLN;C;A TRICLINIC CRYSTAL FORM OF THE LECTIN CONCANAVALIN A;2.4;CA;CALCIUM ION;CONCANAVALIN A;3823;
1VLN;D;A TRICLINIC CRYSTAL FORM OF THE LECTIN CONCANAVALIN A;2.4;CA;CALCIUM ION;CONCANAVALIN A;3823;
1VLN;E;A TRICLINIC CRYSTAL FORM OF THE LECTIN CONCANAVALIN A;2.4;CA;CALCIUM ION;CONCANAVALIN A;3823;
1VLN;F;A TRICLINIC CRYSTAL FORM OF THE LECTIN CONCANAVALIN A;2.4;CA;CALCIUM ION;CONCANAVALIN A;3823;
1VLN;G;A TRICLINIC CRYSTAL FORM OF THE LECTIN CONCANAVALIN A;2.4;CA;CALCIUM ION;CONCANAVALIN A;3823;
1VLN;H;A TRICLINIC CRYSTAL FORM OF THE LECTIN CONCANAVALIN A;2.4;CA;CALCIUM ION;CONCANAVALIN A;3823;
1VLY;A;Crystal structure of a putative aminomethyltransferase (ygfz) from escherichia coli at 1.30 A resolution;1.3;CA;CALCIUM ION;Unknown protein from 2D-page;562;
1VRK;A;THE 1.9 ANGSTROM STRUCTURE OF E84K-CALMODULIN RS20 PEPTIDE COMPLEX;1.9;CA;CALCIUM ION;CALMODULIN;32630;
1VRL;A;MutY adenine glycosylase in complex with DNA and soaked adenine free base;2.5;CA;CALCIUM ION;MutY;1422;
1VSI;A;ASV INTEGRASE CORE DOMAIN WITH CA(II) COFACTOR;2.2;CA;CALCIUM ION;INTEGRASE;11886;
1VZG;A;Structure of superoxide reductase bound to ferrocyanide and active site expansion upon X-ray induced photoreduction;1.69;CA;CALCIUM ION;DESULFOFERRODOXIN;453230;
1VZH;A;Structure of superoxide reductase bound to ferrocyanide and active site expansion upon X-ray induced photoreduction;1.69;CA;CALCIUM ION;DESULFOFERRODOXIN;453230;
1VZI;A;Structure of superoxide reductase bound to ferrocyanide and active site expansion upon X-ray induced photoreduction;1.15;CA;CALCIUM ION;DESULFOFERRODOXIN;453230;
1VZQ;H;Complex of thrombin with designed inhibitor 7165;1.54;CA;CALCIUM ION;THROMBIN HEAVY;9606;
1W07;A;Arabidopsis thaliana acyl-CoA oxidase 1;2;CA;CALCIUM ION;ACYL-COA OXIDASE;3702;
1W0N;A;Structure of uncomplexed Carbohydrate Binding Domain CBM36;0.8;CA;CALCIUM ION;ENDO-1,4-BETA-XYLANASE D;1406;
1W0O;A;Vibrio cholerae sialidase;1.9;CA;CALCIUM ION;SIALIDASE;666;
1W0P;A;Vibrio cholerae sialidase with alpha-2,6-sialyllactose;1.6;CA;CALCIUM ION;SIALIDASE;666;
1W0Y;H;tf7a_3771 complex;2.5;CA;CALCIUM ION;BLOOD COAGULATION FACTOR VIIA;9606;
1W0Y;L;tf7a_3771 complex;2.5;CA;CALCIUM ION;BLOOD COAGULATION FACTOR VIIA;9606;
1W15;A;rat synaptotagmin 4 C2B domain in the presence of calcium;1.93;CA;CALCIUM ION;SYNAPTOTAGMIN IV;10116;
1W1X;A;Structure of Neuraminidase from English duck subtype N6 complexed with 30 mM sialic acid (NANA, Neu5Ac), crystal soaked for 3 hours at 277 K.;2;CA;CALCIUM ION;NEURAMINIDASE;11320;
1W1X;B;Structure of Neuraminidase from English duck subtype N6 complexed with 30 mM sialic acid (NANA, Neu5Ac), crystal soaked for 3 hours at 277 K.;2;CA;CALCIUM ION;NEURAMINIDASE;11320;
1W1X;C;Structure of Neuraminidase from English duck subtype N6 complexed with 30 mM sialic acid (NANA, Neu5Ac), crystal soaked for 3 hours at 277 K.;2;CA;CALCIUM ION;NEURAMINIDASE;11320;
1W1X;D;Structure of Neuraminidase from English duck subtype N6 complexed with 30 mM sialic acid (NANA, Neu5Ac), crystal soaked for 3 hours at 277 K.;2;CA;CALCIUM ION;NEURAMINIDASE;11320;
1W20;A;Structure of Neuraminidase from English duck subtype N6 complexed with 30 mM sialic acid (NANA, Neu5Ac), crystal soaked for 3 hours at 291 K;2.08;CA;CALCIUM ION;NEURAMINIDASE SUBTYPE N6;11320;
1W20;B;Structure of Neuraminidase from English duck subtype N6 complexed with 30 mM sialic acid (NANA, Neu5Ac), crystal soaked for 3 hours at 291 K;2.08;CA;CALCIUM ION;NEURAMINIDASE SUBTYPE N6;11320;
1W20;C;Structure of Neuraminidase from English duck subtype N6 complexed with 30 mM sialic acid (NANA, Neu5Ac), crystal soaked for 3 hours at 291 K;2.08;CA;CALCIUM ION;NEURAMINIDASE SUBTYPE N6;11320;
1W20;D;Structure of Neuraminidase from English duck subtype N6 complexed with 30 mM sialic acid (NANA, Neu5Ac), crystal soaked for 3 hours at 291 K;2.08;CA;CALCIUM ION;NEURAMINIDASE SUBTYPE N6;11320;
1W21;A;Structure of Neuraminidase from English duck subtype N6 complexed with 30 mM sialic acid (NANA, Neu5Ac), crystal soaked for 43 hours at 291 K.;2.08;CA;CALCIUM ION;NEURAMINIDASE;11320;
1W21;B;Structure of Neuraminidase from English duck subtype N6 complexed with 30 mM sialic acid (NANA, Neu5Ac), crystal soaked for 43 hours at 291 K.;2.08;CA;CALCIUM ION;NEURAMINIDASE;11320;
1W21;C;Structure of Neuraminidase from English duck subtype N6 complexed with 30 mM sialic acid (NANA, Neu5Ac), crystal soaked for 43 hours at 291 K.;2.08;CA;CALCIUM ION;NEURAMINIDASE;11320;
1W21;D;Structure of Neuraminidase from English duck subtype N6 complexed with 30 mM sialic acid (NANA, Neu5Ac), crystal soaked for 43 hours at 291 K.;2.08;CA;CALCIUM ION;NEURAMINIDASE;11320;
1W2K;H;tf7a_4380 complex;3;CA;CALCIUM ION;BLOOD COAGULATION FACTOR VIIA;9606;
1W2K;L;tf7a_4380 complex;3;CA;CALCIUM ION;BLOOD COAGULATION FACTOR VIIA;9606;
1W2M;A;Ca-substituted form of E. coli aminopeptidase P;2.4;CA;CALCIUM ION;XAA-PRO AMINOPEPTIDASE;562;
1W2M;B;Ca-substituted form of E. coli aminopeptidase P;2.4;CA;CALCIUM ION;XAA-PRO AMINOPEPTIDASE;562;
1W2M;C;Ca-substituted form of E. coli aminopeptidase P;2.4;CA;CALCIUM ION;XAA-PRO AMINOPEPTIDASE;562;
1W2M;D;Ca-substituted form of E. coli aminopeptidase P;2.4;CA;CALCIUM ION;XAA-PRO AMINOPEPTIDASE;562;
1W2M;E;Ca-substituted form of E. coli aminopeptidase P;2.4;CA;CALCIUM ION;XAA-PRO AMINOPEPTIDASE;562;
1W2M;F;Ca-substituted form of E. coli aminopeptidase P;2.4;CA;CALCIUM ION;XAA-PRO AMINOPEPTIDASE;562;
1W2P;A;The 3-dimensional structure of a xylanase (Xyn10A) from Cellvibrio japonicus;1.45;CA;CALCIUM ION;ENDO-1,4-BETA-XYLANASE A PRECURSOR;155077;
1W2P;B;The 3-dimensional structure of a xylanase (Xyn10A) from Cellvibrio japonicus;1.45;CA;CALCIUM ION;ENDO-1,4-BETA-XYLANASE A PRECURSOR;155077;
1W2V;A;The 3-dimensional structure of a thermostable mutant of a xylanase (Xyn10A) from Cellvibrio japonicus;1.55;CA;CALCIUM ION;ENDO-1,4-BETA-XYLANASE A PRECURSOR;155077;
1W2V;B;The 3-dimensional structure of a thermostable mutant of a xylanase (Xyn10A) from Cellvibrio japonicus;1.55;CA;CALCIUM ION;ENDO-1,4-BETA-XYLANASE A PRECURSOR;155077;
1W32;A;The 3-dimensional structure of a thermostable mutant of a xylanase (Xyn10A) from Cellvibrio japonicus;1.2;CA;CALCIUM ION;ENDO-1,4-BETA-XYLANASE A PRECURSOR;155077;
1W32;B;The 3-dimensional structure of a thermostable mutant of a xylanase (Xyn10A) from Cellvibrio japonicus;1.2;CA;CALCIUM ION;ENDO-1,4-BETA-XYLANASE A PRECURSOR;155077;
1W36;B;RecBCD:DNA complex;3.1;CA;CALCIUM ION;EXODEOXYRIBONUCLEASE V BETA CHAIN;562;
1W36;E;RecBCD:DNA complex;3.1;CA;CALCIUM ION;EXODEOXYRIBONUCLEASE V BETA CHAIN;562;
1W3B;A;The superhelical TPR domain of O-linked GlcNAc transferase reveals structural similarities to importin alpha.;2.85;CA;CALCIUM ION;UDP-N-ACETYLGLUCOSAMINE--PEPTIDE N-ACETYLGLUCOSAMINYLTRANSFERASE 110;9606;
1W3H;A;The 3-dimensional structure of a thermostable mutant of a xylanase (Xyn10A) from Cellvibrio japonicus;1.5;CA;CALCIUM ION;ENDO-1,4-BETA-XYLANASE A PRECURSOR;155077;
1W3H;B;The 3-dimensional structure of a thermostable mutant of a xylanase (Xyn10A) from Cellvibrio japonicus;1.5;CA;CALCIUM ION;ENDO-1,4-BETA-XYLANASE A PRECURSOR;155077;
1W3M;A;Crystal structure of tsushimycin;1;CA;CALCIUM ION;TSUSHIMYCIN;196914;
1W3M;B;Crystal structure of tsushimycin;1;CA;CALCIUM ION;TSUSHIMYCIN;196914;
1W3M;C;Crystal structure of tsushimycin;1;CA;CALCIUM ION;TSUSHIMYCIN;196914;
1W3M;D;Crystal structure of tsushimycin;1;CA;CALCIUM ION;TSUSHIMYCIN;196914;
1W3M;E;Crystal structure of tsushimycin;1;CA;CALCIUM ION;TSUSHIMYCIN;196914;
1W3M;F;Crystal structure of tsushimycin;1;CA;CALCIUM ION;TSUSHIMYCIN;196914;
1W3M;G;Crystal structure of tsushimycin;1;CA;CALCIUM ION;TSUSHIMYCIN;196914;
1W3M;H;Crystal structure of tsushimycin;1;CA;CALCIUM ION;TSUSHIMYCIN;196914;
1W3M;I;Crystal structure of tsushimycin;1;CA;CALCIUM ION;TSUSHIMYCIN;196914;
1W3M;J;Crystal structure of tsushimycin;1;CA;CALCIUM ION;TSUSHIMYCIN;196914;
1W3M;K;Crystal structure of tsushimycin;1;CA;CALCIUM ION;TSUSHIMYCIN;196914;
1W3M;L;Crystal structure of tsushimycin;1;CA;CALCIUM ION;TSUSHIMYCIN;196914;
1W3W;A;The 2.1 Angstroem resolution structure of annexin A8;1.99;CA;CALCIUM ION;ANNEXIN A8;9606;
1W4W;A;Ferric horseradish peroxidase C1A in complex with formate;1.55;CA;CALCIUM ION;HORSERADISH PEROXIDASE C1A;3704;
1W4Y;A;Ferrous horseradish peroxidase C1A in complex with carbon monoxide;1.6;CA;CALCIUM ION;HORSERADISH PEROXIDASE C1A;3704;
1W52;X;Crystal structure of a proteolyzed form of pancreatic lipase related protein 2 from horse;2.99;CA;CALCIUM ION;PANCREATIC LIPASE RELATED PROTEIN 2;9796;
1W5D;A;Crystal structure of PBP4a from Bacillus subtilis;2.1;CA;CALCIUM ION;PENICILLIN-BINDING PROTEIN;1423;
1W6S;A;The high resolution structure of methanol dehydrogenase from methylobacterium extorquens;1.2;CA;CALCIUM ION;METHANOL DEHYDROGENASE SUBUNIT 1;408;
1W6S;C;The high resolution structure of methanol dehydrogenase from methylobacterium extorquens;1.2;CA;CALCIUM ION;METHANOL DEHYDROGENASE SUBUNIT 1;408;
1W7C;A;PPLO at 1.23 Angstroms;1.23;CA;CALCIUM ION;LYSYL OXIDASE;4922;
1W7X;H;Factor7 - 413 complex;1.8;CA;CALCIUM ION;BLOOD COAGULATION FACTOR VIIA;9606;
1W8B;H;Factor7 - 413 complex;3;CA;CALCIUM ION;BLOOD COAGULATION FACTOR VIIA;9606;
1W8F;A;PSEUDOMONAS AERUGINOSA LECTIN II (PA-IIL)COMPLEXED WITH LACTO-N-NEO- FUCOPENTAOSE V(LNPFV);1.05;CA;CALCIUM ION;PSEUDOMONAS AERUGINOSA LECTIN II;287;
1W8F;B;PSEUDOMONAS AERUGINOSA LECTIN II (PA-IIL)COMPLEXED WITH LACTO-N-NEO- FUCOPENTAOSE V(LNPFV);1.05;CA;CALCIUM ION;PSEUDOMONAS AERUGINOSA LECTIN II;287;
1W8F;C;PSEUDOMONAS AERUGINOSA LECTIN II (PA-IIL)COMPLEXED WITH LACTO-N-NEO- FUCOPENTAOSE V(LNPFV);1.05;CA;CALCIUM ION;PSEUDOMONAS AERUGINOSA LECTIN II;287;
1W8F;D;PSEUDOMONAS AERUGINOSA LECTIN II (PA-IIL)COMPLEXED WITH LACTO-N-NEO- FUCOPENTAOSE V(LNPFV);1.05;CA;CALCIUM ION;PSEUDOMONAS AERUGINOSA LECTIN II;287;
1W8H;A;structure of pseudomonas aeruginosa lectin II (PA-IIL)complexed with lewisA trisaccharide;1.75;CA;CALCIUM ION;PSEUDOMONAS AERUGINOSA LECTIN II;287;
1W8H;B;structure of pseudomonas aeruginosa lectin II (PA-IIL)complexed with lewisA trisaccharide;1.75;CA;CALCIUM ION;PSEUDOMONAS AERUGINOSA LECTIN II;287;
1W8H;C;structure of pseudomonas aeruginosa lectin II (PA-IIL)complexed with lewisA trisaccharide;1.75;CA;CALCIUM ION;PSEUDOMONAS AERUGINOSA LECTIN II;287;
1W8H;D;structure of pseudomonas aeruginosa lectin II (PA-IIL)complexed with lewisA trisaccharide;1.75;CA;CALCIUM ION;PSEUDOMONAS AERUGINOSA LECTIN II;287;
1W9X;A;Bacillus halmapalus alpha amylase;2.1;CA;CALCIUM ION;ALPHA AMYLASE;79882;
1WAD;A;CYTOCHROME C3 WITH 4 HEME GROUPS AND ONE CALCIUM ION;1.8;CA;CALCIUM ION;CYTOCHROME C3;879;
1WBF;A;WINGED BEAN LECTIN, SACCHARIDE FREE FORM;2.3;CA;CALCIUM ION;PROTEIN (AGGLUTININ);3891;
1WBF;B;WINGED BEAN LECTIN, SACCHARIDE FREE FORM;2.3;CA;CALCIUM ION;PROTEIN (AGGLUTININ);3891;
1WBL;A;WINGED BEAN LECTIN COMPLEXED WITH METHYL-ALPHA-D-GALACTOSE;2.5;CA;CALCIUM ION;WINGED BEAN LECTIN;3891;
1WBL;B;WINGED BEAN LECTIN COMPLEXED WITH METHYL-ALPHA-D-GALACTOSE;2.5;CA;CALCIUM ION;WINGED BEAN LECTIN;3891;
1WBL;C;WINGED BEAN LECTIN COMPLEXED WITH METHYL-ALPHA-D-GALACTOSE;2.5;CA;CALCIUM ION;WINGED BEAN LECTIN;3891;
1WBL;D;WINGED BEAN LECTIN COMPLEXED WITH METHYL-ALPHA-D-GALACTOSE;2.5;CA;CALCIUM ION;WINGED BEAN LECTIN;3891;
1WC0;A;Soluble adenylyl cyclase CyaC from S. platensis in complex with alpha, beta-methylene-ATP;2.4;CA;CALCIUM ION;ADENYLATE CYCLASE;118562;
1WC0;B;Soluble adenylyl cyclase CyaC from S. platensis in complex with alpha, beta-methylene-ATP;2.4;CA;CALCIUM ION;ADENYLATE CYCLASE;118562;
1WC5;A;Soluble adenylyl cyclase CyaC from S. platensis in complex with alpha, beta-methylene-ATP in presence of bicarbonate;2.3;CA;CALCIUM ION;ADENYLATE CYCLASE;118562;
1WC5;B;Soluble adenylyl cyclase CyaC from S. platensis in complex with alpha, beta-methylene-ATP in presence of bicarbonate;2.3;CA;CALCIUM ION;ADENYLATE CYCLASE;118562;
1WC5;C;Soluble adenylyl cyclase CyaC from S. platensis in complex with alpha, beta-methylene-ATP in presence of bicarbonate;2.3;CA;CALCIUM ION;ADENYLATE CYCLASE;118562;
1WC5;D;Soluble adenylyl cyclase CyaC from S. platensis in complex with alpha, beta-methylene-ATP in presence of bicarbonate;2.3;CA;CALCIUM ION;ADENYLATE CYCLASE;118562;
1WD9;A;Calcium bound form of human peptidylarginine deiminase type4 (PAD4);2.6;CA;CALCIUM ION;Protein-arginine deiminase type IV;9606;
1WDA;A;Crystal structure of human peptidylarginine deiminase type4 (PAD4) in complex with benzoyl-L-arginine amide;2.3;CA;CALCIUM ION;Protein-arginine deiminase type IV;9606;
1WDC;C;SCALLOP MYOSIN REGULATORY DOMAIN;2;CA;CALCIUM ION;SCALLOP MYOSIN;31199;
1WKY;A;Crystal structure of alkaline mannanase from Bacillus sp. strain JAMB-602: catalytic domain and its Carbohydrate Binding Module;1.65;CA;CALCIUM ION;endo-beta-1,4-Mannanase;244966;
1WL7;A;Structure of the thermostable arabinanase;1.9;CA;CALCIUM ION;arabinanase-TS;33940;
1WMD;A;Crystal Structure of alkaline serine protease KP-43 from Bacillus sp. KSM-KP43 (1.30 angstrom, 100 K);1.3;CA;CALCIUM ION;protease;109322;
1WME;A;Crystal Structure of alkaline serine protease KP-43 from Bacillus sp. KSM-KP43 (1.50 angstrom, 293 K);1.5;CA;CALCIUM ION;protease;109322;
1WMF;A;Crystal Structure of alkaline serine protease KP-43 from Bacillus sp. KSM-KP43 (oxidized form, 1.73 angstrom);1.73;CA;CALCIUM ION;protease;109322;
1WMY;A;Crystal Structure of C-type Lectin CEL-I from Cucumaria echinata;2;CA;CALCIUM ION;lectin CEL-I, N-acetyl-D-galactosamine-specific C-type;40245;
1WMY;B;Crystal Structure of C-type Lectin CEL-I from Cucumaria echinata;2;CA;CALCIUM ION;lectin CEL-I, N-acetyl-D-galactosamine-specific C-type;40245;
1WMZ;A;Crystal Structure of C-type Lectin CEL-I complexed with N-acetyl-D-galactosamine;1.7;CA;CALCIUM ION;lectin CEL-I, N-acetyl-D-galactosamine-specific C-type;40245;
1WMZ;B;Crystal Structure of C-type Lectin CEL-I complexed with N-acetyl-D-galactosamine;1.7;CA;CALCIUM ION;lectin CEL-I, N-acetyl-D-galactosamine-specific C-type;40245;
1WMZ;C;Crystal Structure of C-type Lectin CEL-I complexed with N-acetyl-D-galactosamine;1.7;CA;CALCIUM ION;lectin CEL-I, N-acetyl-D-galactosamine-specific C-type;40245;
1WMZ;D;Crystal Structure of C-type Lectin CEL-I complexed with N-acetyl-D-galactosamine;1.7;CA;CALCIUM ION;lectin CEL-I, N-acetyl-D-galactosamine-specific C-type;40245;
1WND;A;Escherichia coli YdcW gene product is a medium-chain aldehyde dehydrogenase as determined by kinetics and crystal structure;2.1;CA;CALCIUM ION;Putative betaine aldehyde dehydrogenase;562;
1WND;B;Escherichia coli YdcW gene product is a medium-chain aldehyde dehydrogenase as determined by kinetics and crystal structure;2.1;CA;CALCIUM ION;Putative betaine aldehyde dehydrogenase;562;
1WND;C;Escherichia coli YdcW gene product is a medium-chain aldehyde dehydrogenase as determined by kinetics and crystal structure;2.1;CA;CALCIUM ION;Putative betaine aldehyde dehydrogenase;562;
1WND;D;Escherichia coli YdcW gene product is a medium-chain aldehyde dehydrogenase as determined by kinetics and crystal structure;2.1;CA;CALCIUM ION;Putative betaine aldehyde dehydrogenase;562;
1WO2;A;Crystal structure of the pig pancreatic alpha-amylase complexed with malto-oligosaacharides under the effect of the chloride ion;2.01;CA;CALCIUM ION;Alpha-amylase, pancreatic;9823;
1WP6;A;Crystal structure of maltohexaose-producing amylase from alkalophilic Bacillus sp.707.;2.1;CA;CALCIUM ION;Glucan 1,4-alpha-maltohexaosidase;1416;
1WPC;A;Crystal structure of maltohexaose-producing amylase complexed with pseudo-maltononaose;1.9;CA;CALCIUM ION;Glucan 1,4-alpha-maltohexaosidase;1416;
1WQV;H;Human Factor Viia-Tissue Factor Complexed with propylsulfonamide-D-Thr-Met-p-aminobenzamidine;2.5;CA;CALCIUM ION;Coagulation factor VII;9606;
1WQV;L;Human Factor Viia-Tissue Factor Complexed with propylsulfonamide-D-Thr-Met-p-aminobenzamidine;2.5;CA;CALCIUM ION;Coagulation factor VII;9606;
1WRA;A;Crystal Structure of Phosphorylcholine Esterase Domain of the Virulence Factor Choline Binding Protein E from Streptococcus Pneumoniae;2;CA;CALCIUM ION;Teichoic acid phosphorylcholine esterase/choline binding protein E (cbpE);1313;
1WRA;B;Crystal Structure of Phosphorylcholine Esterase Domain of the Virulence Factor Choline Binding Protein E from Streptococcus Pneumoniae;2;CA;CALCIUM ION;Teichoic acid phosphorylcholine esterase/choline binding protein E (cbpE);1313;
1WRK;A;Crystal structure of the N-terminal domain of human cardiac troponin C in complex with trifluoperazine (orthrombic crystal form);2.15;CA;CALCIUM ION;Troponin C, slow skeletal and cardiac muscles;9606;
1WRK;B;Crystal structure of the N-terminal domain of human cardiac troponin C in complex with trifluoperazine (orthrombic crystal form);2.15;CA;CALCIUM ION;Troponin C, slow skeletal and cardiac muscles;9606;
1WRL;A;Crystal structure of the N-terminal domain of human cardiac troponin C in complex with trifluoperazine (monoclinic crystal form);2.6;CA;CALCIUM ION;Troponin C, slow skeletal and cardiac muscles;9606;
1WRL;B;Crystal structure of the N-terminal domain of human cardiac troponin C in complex with trifluoperazine (monoclinic crystal form);2.6;CA;CALCIUM ION;Troponin C, slow skeletal and cardiac muscles;9606;
1WRL;C;Crystal structure of the N-terminal domain of human cardiac troponin C in complex with trifluoperazine (monoclinic crystal form);2.6;CA;CALCIUM ION;Troponin C, slow skeletal and cardiac muscles;9606;
1WRL;D;Crystal structure of the N-terminal domain of human cardiac troponin C in complex with trifluoperazine (monoclinic crystal form);2.6;CA;CALCIUM ION;Troponin C, slow skeletal and cardiac muscles;9606;
1WRL;E;Crystal structure of the N-terminal domain of human cardiac troponin C in complex with trifluoperazine (monoclinic crystal form);2.6;CA;CALCIUM ION;Troponin C, slow skeletal and cardiac muscles;9606;
1WRL;F;Crystal structure of the N-terminal domain of human cardiac troponin C in complex with trifluoperazine (monoclinic crystal form);2.6;CA;CALCIUM ION;Troponin C, slow skeletal and cardiac muscles;9606;
1WRZ;A;Calmodulin complexed with a peptide from a human death-associated protein kinase;2;CA;CALCIUM ION;calmodulin;9606;
1WSD;A;Alkaline M-protease form I crystal strcuture;1.5;CA;CALCIUM ION;M-protease;79880;
1WSS;H;Human Factor Viia-Tissue Factor in Complex with peptide-mimetic inhibitor that has two charged groups in P2 and P4;2.6;CA;CALCIUM ION;Coagulation factor VII;9606;
1WSS;L;Human Factor Viia-Tissue Factor in Complex with peptide-mimetic inhibitor that has two charged groups in P2 and P4;2.6;CA;CALCIUM ION;Coagulation factor VII;9606;
1WT9;A;crystal structure of Aa-X-bp-I, a snake venom protein with the activity of binding to coagulation factor X from Agkistrodon acutus;2.01;CA;CALCIUM ION;agkisacutacin A chain;36307;
1WT9;B;crystal structure of Aa-X-bp-I, a snake venom protein with the activity of binding to coagulation factor X from Agkistrodon acutus;2.01;CA;CALCIUM ION;anticoagulant protein-B;36307;
1WTG;H;Human Factor Viia-Tissue Factor Complexed with ethylsulfonamide-D-biphenylalanine-Gln-p-aminobenzamidine;2.2;CA;CALCIUM ION;Coagulation factor VII;9606;
1WTG;L;Human Factor Viia-Tissue Factor Complexed with ethylsulfonamide-D-biphenylalanine-Gln-p-aminobenzamidine;2.2;CA;CALCIUM ION;Coagulation factor VII;9606;
1WU1;A;Factor Xa in complex with the inhibitor 4-[(5-chloroindol-2-yl)sulfonyl]-2-(2-methylpropyl)-1-[[5-(pyridin-4-yl) pyrimidin-2-yl]carbonyl]piperazine;2.3;CA;CALCIUM ION;Coagulation factor X, heavy chain;9606;
1WUA;A;The structure of Aplyronine A-actin complex;1.45;CA;CALCIUM ION;Actin, alpha skeletal muscle;9986;
1WUN;H;Human Factor Viia-Tissue Factor Complexed with ethylsulfonamide-D-Trp-Gln-p-aminobenzamidine;2.4;CA;CALCIUM ION;Coagulation factor VII;9606;
1WUN;L;Human Factor Viia-Tissue Factor Complexed with ethylsulfonamide-D-Trp-Gln-p-aminobenzamidine;2.4;CA;CALCIUM ION;Coagulation factor VII;9606;
1WUV;A;Crystal structure of native Canavalia gladiata lectin (CGL): a tetrameric ConA-like lectin;2.3;CA;CALCIUM ION;Concanavalin A;3824;
1WUV;D;Crystal structure of native Canavalia gladiata lectin (CGL): a tetrameric ConA-like lectin;2.3;CA;CALCIUM ION;Concanavalin A;3824;
1WUV;G;Crystal structure of native Canavalia gladiata lectin (CGL): a tetrameric ConA-like lectin;2.3;CA;CALCIUM ION;Concanavalin A;3824;
1WUV;J;Crystal structure of native Canavalia gladiata lectin (CGL): a tetrameric ConA-like lectin;2.3;CA;CALCIUM ION;Concanavalin A;3824;
1WV7;H;Human Factor Viia-Tissue Factor Complexed with ethylsulfonamide-D-5-propoxy-Trp-Gln-p-aminobenzamidine;2.7;CA;CALCIUM ION;Coagulation factor VII;9606;
1WV7;L;Human Factor Viia-Tissue Factor Complexed with ethylsulfonamide-D-5-propoxy-Trp-Gln-p-aminobenzamidine;2.7;CA;CALCIUM ION;Coagulation factor VII;9606;
1WVM;A;Crystal Structure of Psychrophilic Subtilisin-like Serine Protease APA1 from Antarctic Psychrotroph Pseudoaleromonas sp. AS-11, Complexed with Inhibitor Chymostatin;1.6;CA;CALCIUM ION;alkaline serine protease;247492;
1WVM;B;Crystal Structure of Psychrophilic Subtilisin-like Serine Protease APA1 from Antarctic Psychrotroph Pseudoaleromonas sp. AS-11, Complexed with Inhibitor Chymostatin;1.6;CA;CALCIUM ION;alkaline serine protease;247492;
1WWS;A;Crystal structure of ttk003001566 from Thermus Thermophilus HB8;1.9;CA;CALCIUM ION;hypothetical protein TTHA1479;274;
1WWS;B;Crystal structure of ttk003001566 from Thermus Thermophilus HB8;1.9;CA;CALCIUM ION;hypothetical protein TTHA1479;274;
1WWS;D;Crystal structure of ttk003001566 from Thermus Thermophilus HB8;1.9;CA;CALCIUM ION;hypothetical protein TTHA1479;274;
1WWS;E;Crystal structure of ttk003001566 from Thermus Thermophilus HB8;1.9;CA;CALCIUM ION;hypothetical protein TTHA1479;274;
1WWS;F;Crystal structure of ttk003001566 from Thermus Thermophilus HB8;1.9;CA;CALCIUM ION;hypothetical protein TTHA1479;274;
1WWS;G;Crystal structure of ttk003001566 from Thermus Thermophilus HB8;1.9;CA;CALCIUM ION;hypothetical protein TTHA1479;274;
1WY9;A;Crystal structure of microglia-specific protein, Iba1;2.1;CA;CALCIUM ION;Allograft inflammatory factor 1;10090;
1WYG;A;Crystal Structure of a Rat Xanthine Dehydrogenase Triple Mutant (C535A, C992R and C1324S);2.6;CA;CALCIUM ION;Xanthine dehydrogenase/oxidase;10116;
1WZA;A;Crystal structure of alpha-amylase from H.orenii;1.6;CA;CALCIUM ION;alpha-amylase A;31909;
1WZK;A;Thermoactinomyces vulgaris R-47 alpha-amylase II (TVA II) mutatnt D465N;2.3;CA;CALCIUM ION;Alpha-amylase II;2026;
1WZK;B;Thermoactinomyces vulgaris R-47 alpha-amylase II (TVA II) mutatnt D465N;2.3;CA;CALCIUM ION;Alpha-amylase II;2026;
1WZL;A;Thermoactinomyces vulgaris R-47 alpha-amylase II (TVA II) mutatnt R469L;2;CA;CALCIUM ION;Alpha-amylase II;2026;
1WZL;B;Thermoactinomyces vulgaris R-47 alpha-amylase II (TVA II) mutatnt R469L;2;CA;CALCIUM ION;Alpha-amylase II;2026;
1WZM;A;Thermoactinomyces vulgaris R-47 alpha-amylase II (TVA II) mutatnt R469K;3.2;CA;CALCIUM ION;Alpha-amylase II;2026;
1WZM;B;Thermoactinomyces vulgaris R-47 alpha-amylase II (TVA II) mutatnt R469K;3.2;CA;CALCIUM ION;Alpha-amylase II;2026;
1X02;A;Solution structure of stereo array isotope labeled (SAIL) calmodulin;;CA;CALCIUM ION;calmodulin;8355;
1X1J;A;Crystal Structure of Xanthan Lyase (N194A) with a Substrate.;2.1;CA;CALCIUM ION;xanthan lyase;84635;
1X1N;A;Structure determination and refinement at 1.8 A resolution of Disproportionating Enzyme from Potato;1.8;CA;CALCIUM ION;4-alpha-glucanotransferase;4113;
1X2T;A;Crystal Structure of Habu IX-bp at pH 6.5;1.72;CA;CALCIUM ION;Coagulation factor IX/X-binding protein A chain;88087;
1X2T;B;Crystal Structure of Habu IX-bp at pH 6.5;1.72;CA;CALCIUM ION;Coagulation factor IX/factor X-binding protein B chain;88087;
1X2T;C;Crystal Structure of Habu IX-bp at pH 6.5;1.72;CA;CALCIUM ION;Coagulation factor IX/X-binding protein A chain;88087;
1X2T;D;Crystal Structure of Habu IX-bp at pH 6.5;1.72;CA;CALCIUM ION;Coagulation factor IX/factor X-binding protein B chain;88087;
1X33;A;T=3 recombinant capsid of SeMV CP;3.6;CA;CALCIUM ION;Coat protein;12558;
1X33;B;T=3 recombinant capsid of SeMV CP;3.6;CA;CALCIUM ION;Coat protein;12558;
1X33;C;T=3 recombinant capsid of SeMV CP;3.6;CA;CALCIUM ION;Coat protein;12558;
1X35;A;Recombinant T=3 capsid of a site specific mutant of SeMV CP;4.1;CA;CALCIUM ION;Coat protein;12558;
1X35;C;Recombinant T=3 capsid of a site specific mutant of SeMV CP;4.1;CA;CALCIUM ION;Coat protein;12558;
1X36;A;T=1 capsid of an amino-terminal deletion mutant of SeMV CP;2.7;CA;CALCIUM ION;Coat protein;12558;
1X7I;B;Crystal structure of the native copper homeostasis protein (cutCm) with calcium binding from Shigella flexneri 2a str. 301;1.7;CA;CALCIUM ION;Copper homeostasis protein cutC;623;
1X8C;B;Crystal structure of the SeMet-derivative copper homeostasis protein (cutCm) with calcium binding from Shigella flexneri 2a str. 301;2.1;CA;CALCIUM ION;Copper homeostasis protein cutC;623;
1X8J;A;Crystal structure of retinol dehydratase in complex with androsterone and inactive cofactor PAP;2.35;CA;CALCIUM ION;retinol dehydratase;7108;
1X8J;B;Crystal structure of retinol dehydratase in complex with androsterone and inactive cofactor PAP;2.35;CA;CALCIUM ION;retinol dehydratase;7108;
1X8K;A;Crystal structure of retinol dehydratase in complex with anhydroretinol and inactive cofactor PAP;2.75;CA;CALCIUM ION;retinol dehydratase;7108;
1X8K;B;Crystal structure of retinol dehydratase in complex with anhydroretinol and inactive cofactor PAP;2.75;CA;CALCIUM ION;retinol dehydratase;7108;
1X8L;A;Crystal structure of retinol dehydratase in complex with all-trans-4-oxoretinol and inactive cofactor PAP;2.1;CA;CALCIUM ION;retinol dehydratase;7108;
1X8L;B;Crystal structure of retinol dehydratase in complex with all-trans-4-oxoretinol and inactive cofactor PAP;2.1;CA;CALCIUM ION;retinol dehydratase;7108;
1X9D;A;Crystal Structure Of Human Class I alpha-1,2-Mannosidase In Complex With Thio-Disaccharide Substrate Analogue;1.41;CA;CALCIUM ION;Endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase;9606;
1XA5;A;Structure of Calmodulin in complex with KAR-2, a bis-indol alkaloid;2.12;CA;CALCIUM ION;Calmodulin;9913;
1XBU;A;Streptomyces griseus aminopeptidase complexed with p-iodo-D-phenylalanine;1.2;CA;CALCIUM ION;Aminopeptidase;1911;
1XCB;A;X-ray Structure of a Rex-Family Repressor/NADH Complex from Thermus Aquaticus;2.9;CA;CALCIUM ION;Redox-sensing transcriptional repressor rex;271;
1XCB;B;X-ray Structure of a Rex-Family Repressor/NADH Complex from Thermus Aquaticus;2.9;CA;CALCIUM ION;Redox-sensing transcriptional repressor rex;271;
1XCB;C;X-ray Structure of a Rex-Family Repressor/NADH Complex from Thermus Aquaticus;2.9;CA;CALCIUM ION;Redox-sensing transcriptional repressor rex;271;
1XCB;D;X-ray Structure of a Rex-Family Repressor/NADH Complex from Thermus Aquaticus;2.9;CA;CALCIUM ION;Redox-sensing transcriptional repressor rex;271;
1XCW;A;Acarbose Rearrangement Mechanism Implied by the Kinetic and Structural Analysis of Human Pancreatic alpha-Amylase in Complex with Analogues and Their Elongated Counterparts;2;CA;CALCIUM ION;Alpha-amylase;9606;
1XCX;A;Acarbose Rearrangement Mechanism Implied by the Kinetic and Structural Analysis of Human Pancreatic alpha-Amylase in Complex with Analogues and Their Elongated Counterparts;1.9;CA;CALCIUM ION;Alpha-amylase;9606;
1XD0;A;Acarbose Rearrangement Mechanism Implied by the Kinetic and Structural Analysis of Human Pancreatic alpha-Amylase in Complex with Analogues and Their Elongated Counterparts;2;CA;CALCIUM ION;Alpha-amylase;9606;
1XD1;A;Acarbose Rearrangement Mechanism Implied by the Kinetic and Structural Analysis of Human Pancreatic alpha-Amylase in Complex with Analogues and Their Elongated Counterparts;2.2;CA;CALCIUM ION;Alpha-amylase;9606;
1XF1;A;Structure of C5a peptidase- a key virulence factor from Streptococcus;1.9;CA;CALCIUM ION;C5a peptidase;1314;
1XF1;B;Structure of C5a peptidase- a key virulence factor from Streptococcus;1.9;CA;CALCIUM ION;C5a peptidase;1314;
1XFE;A;Solution structure of the LA7-EGFA pair from the LDL receptor;;CA;CALCIUM ION;Low-density lipoprotein receptor;9606;
1XFU;O;Crystal structure of anthrax edema factor (EF) truncation mutant, EF-delta 64 in complex with calmodulin;3.35;CA;CALCIUM ION;Calmodulin 2;9606;
1XFU;P;Crystal structure of anthrax edema factor (EF) truncation mutant, EF-delta 64 in complex with calmodulin;3.35;CA;CALCIUM ION;Calmodulin 2;9606;
1XFU;Q;Crystal structure of anthrax edema factor (EF) truncation mutant, EF-delta 64 in complex with calmodulin;3.35;CA;CALCIUM ION;Calmodulin 2;9606;
1XFU;R;Crystal structure of anthrax edema factor (EF) truncation mutant, EF-delta 64 in complex with calmodulin;3.35;CA;CALCIUM ION;Calmodulin 2;9606;
1XFU;S;Crystal structure of anthrax edema factor (EF) truncation mutant, EF-delta 64 in complex with calmodulin;3.35;CA;CALCIUM ION;Calmodulin 2;9606;
1XFU;T;Crystal structure of anthrax edema factor (EF) truncation mutant, EF-delta 64 in complex with calmodulin;3.35;CA;CALCIUM ION;Calmodulin 2;9606;
1XFV;O;Crystal structure of anthrax edema factor (EF) in complex with calmodulin and 3' deoxy-ATP;3.35;CA;CALCIUM ION;Calmodulin 2;9606;
1XFV;P;Crystal structure of anthrax edema factor (EF) in complex with calmodulin and 3' deoxy-ATP;3.35;CA;CALCIUM ION;Calmodulin 2;9606;
1XFV;Q;Crystal structure of anthrax edema factor (EF) in complex with calmodulin and 3' deoxy-ATP;3.35;CA;CALCIUM ION;Calmodulin 2;9606;
1XFV;R;Crystal structure of anthrax edema factor (EF) in complex with calmodulin and 3' deoxy-ATP;3.35;CA;CALCIUM ION;Calmodulin 2;9606;
1XFV;S;Crystal structure of anthrax edema factor (EF) in complex with calmodulin and 3' deoxy-ATP;3.35;CA;CALCIUM ION;Calmodulin 2;9606;
1XFV;T;Crystal structure of anthrax edema factor (EF) in complex with calmodulin and 3' deoxy-ATP;3.35;CA;CALCIUM ION;Calmodulin 2;9606;
1XFW;O;Crystal structure of anthrax edema factor (EF) in complex with calmodulin and 3'5' cyclic AMP (cAMP);3.4;CA;CALCIUM ION;Calmodulin 2;9606;
1XFW;P;Crystal structure of anthrax edema factor (EF) in complex with calmodulin and 3'5' cyclic AMP (cAMP);3.4;CA;CALCIUM ION;Calmodulin 2;9606;
1XFW;Q;Crystal structure of anthrax edema factor (EF) in complex with calmodulin and 3'5' cyclic AMP (cAMP);3.4;CA;CALCIUM ION;Calmodulin 2;9606;
1XFW;R;Crystal structure of anthrax edema factor (EF) in complex with calmodulin and 3'5' cyclic AMP (cAMP);3.4;CA;CALCIUM ION;Calmodulin 2;9606;
1XFW;S;Crystal structure of anthrax edema factor (EF) in complex with calmodulin and 3'5' cyclic AMP (cAMP);3.4;CA;CALCIUM ION;Calmodulin 2;9606;
1XFW;T;Crystal structure of anthrax edema factor (EF) in complex with calmodulin and 3'5' cyclic AMP (cAMP);3.4;CA;CALCIUM ION;Calmodulin 2;9606;
1XFX;O;Crystal structure of anthrax edema factor (EF) in complex with calmodulin in the presence of 10 millimolar exogenously added calcium chloride;3.2;CA;CALCIUM ION;Calmodulin 2;9606;
1XFX;P;Crystal structure of anthrax edema factor (EF) in complex with calmodulin in the presence of 10 millimolar exogenously added calcium chloride;3.2;CA;CALCIUM ION;Calmodulin 2;9606;
1XFX;Q;Crystal structure of anthrax edema factor (EF) in complex with calmodulin in the presence of 10 millimolar exogenously added calcium chloride;3.2;CA;CALCIUM ION;Calmodulin 2;9606;
1XFX;R;Crystal structure of anthrax edema factor (EF) in complex with calmodulin in the presence of 10 millimolar exogenously added calcium chloride;3.2;CA;CALCIUM ION;Calmodulin 2;9606;
1XFX;S;Crystal structure of anthrax edema factor (EF) in complex with calmodulin in the presence of 10 millimolar exogenously added calcium chloride;3.2;CA;CALCIUM ION;Calmodulin 2;9606;
1XFX;T;Crystal structure of anthrax edema factor (EF) in complex with calmodulin in the presence of 10 millimolar exogenously added calcium chloride;3.2;CA;CALCIUM ION;Calmodulin 2;9606;
1XFY;O;Crystal structure of anthrax edema factor (EF) in complex with calmodulin;3.3;CA;CALCIUM ION;Calmodulin 2;9606;
1XFY;P;Crystal structure of anthrax edema factor (EF) in complex with calmodulin;3.3;CA;CALCIUM ION;Calmodulin 2;9606;
1XFY;Q;Crystal structure of anthrax edema factor (EF) in complex with calmodulin;3.3;CA;CALCIUM ION;Calmodulin 2;9606;
1XFY;R;Crystal structure of anthrax edema factor (EF) in complex with calmodulin;3.3;CA;CALCIUM ION;Calmodulin 2;9606;
1XFY;S;Crystal structure of anthrax edema factor (EF) in complex with calmodulin;3.3;CA;CALCIUM ION;Calmodulin 2;9606;
1XFY;T;Crystal structure of anthrax edema factor (EF) in complex with calmodulin;3.3;CA;CALCIUM ION;Calmodulin 2;9606;
1XFZ;O;Crystal structure of anthrax edema factor (EF) in complex with calmodulin in the presence of 1 millimolar exogenously added calcium chloride;3.25;CA;CALCIUM ION;Calmodulin 2;9606;
1XFZ;P;Crystal structure of anthrax edema factor (EF) in complex with calmodulin in the presence of 1 millimolar exogenously added calcium chloride;3.25;CA;CALCIUM ION;Calmodulin 2;9606;
1XFZ;Q;Crystal structure of anthrax edema factor (EF) in complex with calmodulin in the presence of 1 millimolar exogenously added calcium chloride;3.25;CA;CALCIUM ION;Calmodulin 2;9606;
1XFZ;R;Crystal structure of anthrax edema factor (EF) in complex with calmodulin in the presence of 1 millimolar exogenously added calcium chloride;3.25;CA;CALCIUM ION;Calmodulin 2;9606;
1XFZ;S;Crystal structure of anthrax edema factor (EF) in complex with calmodulin in the presence of 1 millimolar exogenously added calcium chloride;3.25;CA;CALCIUM ION;Calmodulin 2;9606;
1XFZ;T;Crystal structure of anthrax edema factor (EF) in complex with calmodulin in the presence of 1 millimolar exogenously added calcium chloride;3.25;CA;CALCIUM ION;Calmodulin 2;9606;
1XGZ;A;Structure of the N298S variant of human pancreatic alpha-amylase;2;CA;CALCIUM ION;Alpha-amylase, pancreatic;9606;
1XH1;A;Structure of the N298S variant of human pancreatic alpha-amylase complexed with chloride;2.03;CA;CALCIUM ION;Alpha-amylase, pancreatic;9606;
1XH2;A;Structure of the N298S variant of human pancreatic alpha-amylase complexed with chloride and acarbose;2.2;CA;CALCIUM ION;Alpha-amylase, pancreatic;9606;
1XHB;A;The Crystal Structure of UDP-GalNAc: polypeptide alpha-N-acetylgalactosaminyltransferase-T1;2.5;CA;CALCIUM ION;Polypeptide N-acetylgalactosaminyltransferase 1;10090;
1XJL;A;Structure of human annexin A2 in the presence of calcium ions;2.59;CA;CALCIUM ION;Annexin A2;9606;
1XJL;B;Structure of human annexin A2 in the presence of calcium ions;2.59;CA;CALCIUM ION;Annexin A2;9606;
1XJO;A;STRUCTURE OF AMINOPEPTIDASE;1.75;CA;CALCIUM ION;AMINOPEPTIDASE;1911;
1XK4;A;Crystal structure of human calprotectin(S100A8/S100A9);1.8;CA;CALCIUM ION;Calgranulin A;9606;
1XK4;B;Crystal structure of human calprotectin(S100A8/S100A9);1.8;CA;CALCIUM ION;Calgranulin A;9606;
1XK4;C;Crystal structure of human calprotectin(S100A8/S100A9);1.8;CA;CALCIUM ION;Calgranulin B;9606;
1XK4;D;Crystal structure of human calprotectin(S100A8/S100A9);1.8;CA;CALCIUM ION;Calgranulin B;9606;
1XK4;E;Crystal structure of human calprotectin(S100A8/S100A9);1.8;CA;CALCIUM ION;Calgranulin A;9606;
1XK4;F;Crystal structure of human calprotectin(S100A8/S100A9);1.8;CA;CALCIUM ION;Calgranulin A;9606;
1XK4;G;Crystal structure of human calprotectin(S100A8/S100A9);1.8;CA;CALCIUM ION;Calgranulin B;9606;
1XK4;H;Crystal structure of human calprotectin(S100A8/S100A9);1.8;CA;CALCIUM ION;Calgranulin B;9606;
1XK4;I;Crystal structure of human calprotectin(S100A8/S100A9);1.8;CA;CALCIUM ION;Calgranulin A;9606;
1XK4;J;Crystal structure of human calprotectin(S100A8/S100A9);1.8;CA;CALCIUM ION;Calgranulin A;9606;
1XK4;K;Crystal structure of human calprotectin(S100A8/S100A9);1.8;CA;CALCIUM ION;Calgranulin B;9606;
1XK4;L;Crystal structure of human calprotectin(S100A8/S100A9);1.8;CA;CALCIUM ION;Calgranulin B;9606;
1XKA;C;FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S)-(3'-AMIDINO-3-BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID;2.3;CA;CALCIUM ION;BLOOD COAGULATION FACTOR XA;9606;
1XKB;A;FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S)-(3'-AMIDINO-3-BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID;2.4;CA;CALCIUM ION;BLOOD COAGULATION FACTOR XA;9606;
1XKB;C;FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S)-(3'-AMIDINO-3-BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID;2.4;CA;CALCIUM ION;BLOOD COAGULATION FACTOR XA;9606;
1XKB;D;FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S)-(3'-AMIDINO-3-BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID;2.4;CA;CALCIUM ION;BLOOD COAGULATION FACTOR XA;9606;
1XKD;A;Ternary complex of Isocitrate dehydrogenase from the hyperthermophile Aeropyrum pernix;2.3;CA;CALCIUM ION;isocitrate dehydrogenase;56636;
1XKV;A;Crystal Structure Of ATP-Dependent Phosphoenolpyruvate Carboxykinase From Thermus thermophilus HB8;2.2;CA;CALCIUM ION;ATP-dependent phosphoenolpyruvate carboxykinase;274;
1XKV;B;Crystal Structure Of ATP-Dependent Phosphoenolpyruvate Carboxykinase From Thermus thermophilus HB8;2.2;CA;CALCIUM ION;ATP-dependent phosphoenolpyruvate carboxykinase;274;
1XMF;A;Structure of Mn(II)-Soaked Apo Methane Monooxygenase Hydroxylase Crystals from M. capsulatus (Bath);2.32;CA;CALCIUM ION;Methane monooxygenase component A alpha chain;414;
1XMF;C;Structure of Mn(II)-Soaked Apo Methane Monooxygenase Hydroxylase Crystals from M. capsulatus (Bath);2.32;CA;CALCIUM ION;Methane monooxygenase component A beta chain;414;
1XMG;A;Crystal structure of apo methane monooxygenase hydroxylase from M. capsulatus (Bath);2.1;CA;CALCIUM ION;Methane monooxygenase component A alpha chain;414;
1XMG;C;Crystal structure of apo methane monooxygenase hydroxylase from M. capsulatus (Bath);2.1;CA;CALCIUM ION;Methane monooxygenase component A beta chain;414;
1XO5;A;Crystal structure of CIB1, an EF-hand, integrin and kinase-binding protein;1.99;CA;CALCIUM ION;Calcium and integrin-binding protein 1;9606;
1XO5;B;Crystal structure of CIB1, an EF-hand, integrin and kinase-binding protein;1.99;CA;CALCIUM ION;Calcium and integrin-binding protein 1;9606;
1XPH;A;Structure of DC-SIGNR and a portion of repeat domain 8;1.41;CA;CALCIUM ION;CD209 antigen-like protein 1;9606;
1XQN;A;The 15k neutron structure of saccharide-free concanavalin A;2.5;CA;CALCIUM ION;Concanavalin A;3823;
1XRX;A;Crystal structure of a DNA-binding protein;2.15;CA;CALCIUM ION;SeqA protein;562;
1XUC;A;Matrix metalloproteinase-13 complexed with non-zinc binding inhibitor;1.7;CA;CALCIUM ION;Collagenase 3;9606;
1XUC;B;Matrix metalloproteinase-13 complexed with non-zinc binding inhibitor;1.7;CA;CALCIUM ION;Collagenase 3;9606;
1XUD;A;Matrix metalloproteinase-13 complexed with non-zinc binding inhibitor;1.8;CA;CALCIUM ION;Collagenase 3;9606;
1XUD;B;Matrix metalloproteinase-13 complexed with non-zinc binding inhibitor;1.8;CA;CALCIUM ION;Collagenase 3;9606;
1XUF;A;TRYPSIN-BABIM-ZN+2, PH 8.2;1.9;CA;CALCIUM ION;TRYPSIN;9913;
1XUG;A;TRYPSIN-BABIM-ZN+2, PH 8.2;1.5;CA;CALCIUM ION;TRYPSIN;9913;
1XUH;A;TRYPSIN-KETO-BABIM-CO+2, PH 8.2;2.2;CA;CALCIUM ION;TRYPSIN;9913;
1XUI;A;TRYPSIN-KETO-BABIM, ZN+2-FREE, PH 8.2;1.5;CA;CALCIUM ION;TRYPSIN;9913;
1XUJ;A;TRYPSIN-KETO-BABIM-ZN+2, PH 8.2;1.92;CA;CALCIUM ION;TRYPSIN;9913;
1XUK;A;TRYPSIN-BABIM-SULFATE, PH 5.9;1.8;CA;CALCIUM ION;TRYPSIN;9913;
1XUR;A;Matrix metalloproteinase-13 complexed with non-zinc binding inhibitor;1.85;CA;CALCIUM ION;Collagenase 3;9606;
1XUR;B;Matrix metalloproteinase-13 complexed with non-zinc binding inhibitor;1.85;CA;CALCIUM ION;Collagenase 3;9606;
1XV8;A;Crystal Structure of Human Salivary Alpha-Amylase Dimer;3;CA;CALCIUM ION;Alpha-amylase;9606;
1XV8;B;Crystal Structure of Human Salivary Alpha-Amylase Dimer;3;CA;CALCIUM ION;Alpha-amylase;9606;
1XVB;C;soluble methane monooxygenase hydroxylase: 6-bromohexanol soaked structure;1.8;CA;CALCIUM ION;Methane monooxygenase component A beta chain;414;
1XVE;A;soluble methane monooxygenase hydroxylase: 3-bromo-3-butenol soaked structure;2.4;CA;CALCIUM ION;Methane monooxygenase component A alpha chain;414;
1XVE;C;soluble methane monooxygenase hydroxylase: 3-bromo-3-butenol soaked structure;2.4;CA;CALCIUM ION;Methane monooxygenase component A beta chain;414;
1XVG;A;soluble methane monooxygenase hydroxylase: bromoethanol soaked structure;1.96;CA;CALCIUM ION;Methane monooxygenase component A alpha chain;414;
1XVG;C;soluble methane monooxygenase hydroxylase: bromoethanol soaked structure;1.96;CA;CALCIUM ION;Methane monooxygenase component A beta chain;414;
1XVJ;A;Crystal Structure Of Rat alpha-Parvalbumin D94S/G98E Mutant;1.8;CA;CALCIUM ION;Parvalbumin alpha;10116;
1XVJ;B;Crystal Structure Of Rat alpha-Parvalbumin D94S/G98E Mutant;1.8;CA;CALCIUM ION;Parvalbumin alpha;10116;
1XXM;C;The modular architecture of protein-protein binding site;1.9;CA;CALCIUM ION;Beta-lactamase inhibitory protein;1901;
1XXM;D;The modular architecture of protein-protein binding site;1.9;CA;CALCIUM ION;Beta-lactamase inhibitory protein;1901;
1XYD;A;NMR Solution Structure of Rat Zinc-Calcium-S100B, 20 Structures;;CA;CALCIUM ION;S-100 protein, beta chain;10116;
1XYD;B;NMR Solution Structure of Rat Zinc-Calcium-S100B, 20 Structures;;CA;CALCIUM ION;S-100 protein, beta chain;10116;
1XYN;A;STRUCTURAL COMPARISON OF TWO MAJOR ENDO-1,4-BETA-XYLANASES FROM TRICHODREMA REESEI;2;CA;CALCIUM ION;ENDO-1,4-BETA-XYLANASE I;51453;
1XYS;A;CATALYTIC CORE OF XYLANASE A E246C MUTANT;2.5;CA;CALCIUM ION;XYLANASE A;155077;
1XYS;B;CATALYTIC CORE OF XYLANASE A E246C MUTANT;2.5;CA;CALCIUM ION;XYLANASE A;155077;
1XZO;A;Identification of a disulfide switch in BsSco, a member of the Sco family of cytochrome c oxidase assembly proteins;1.7;CA;CALCIUM ION;Hypothetical protein ypmQ;1423;
1XZO;B;Identification of a disulfide switch in BsSco, a member of the Sco family of cytochrome c oxidase assembly proteins;1.7;CA;CALCIUM ION;Hypothetical protein ypmQ;1423;
1Y0V;H;Crystal structure of anthrax edema factor (EF) in complex with calmodulin and pyrophosphate;3.6;CA;CALCIUM ION;Calmodulin;8355;
1Y0V;I;Crystal structure of anthrax edema factor (EF) in complex with calmodulin and pyrophosphate;3.6;CA;CALCIUM ION;Calmodulin;8355;
1Y0V;J;Crystal structure of anthrax edema factor (EF) in complex with calmodulin and pyrophosphate;3.6;CA;CALCIUM ION;Calmodulin;8355;
1Y0V;K;Crystal structure of anthrax edema factor (EF) in complex with calmodulin and pyrophosphate;3.6;CA;CALCIUM ION;Calmodulin;8355;
1Y0V;L;Crystal structure of anthrax edema factor (EF) in complex with calmodulin and pyrophosphate;3.6;CA;CALCIUM ION;Calmodulin;8355;
1Y0V;M;Crystal structure of anthrax edema factor (EF) in complex with calmodulin and pyrophosphate;3.6;CA;CALCIUM ION;Calmodulin;8355;
1Y10;A;Mycobacterial adenylyl cyclase Rv1264, holoenzyme, inhibited state;2.3;CA;CALCIUM ION;Hypothetical protein Rv1264/MT1302;1773;
1Y10;B;Mycobacterial adenylyl cyclase Rv1264, holoenzyme, inhibited state;2.3;CA;CALCIUM ION;Hypothetical protein Rv1264/MT1302;1773;
1Y10;C;Mycobacterial adenylyl cyclase Rv1264, holoenzyme, inhibited state;2.3;CA;CALCIUM ION;Hypothetical protein Rv1264/MT1302;1773;
1Y10;D;Mycobacterial adenylyl cyclase Rv1264, holoenzyme, inhibited state;2.3;CA;CALCIUM ION;Hypothetical protein Rv1264/MT1302;1773;
1Y17;A;crystal structure of Aa-X-bp-II, a snake venom protein with the activity of binding to coagulation factor X from Agkistrodon acutus;2.4;CA;CALCIUM ION;anticoagulant protein A;36307;
1Y17;B;crystal structure of Aa-X-bp-II, a snake venom protein with the activity of binding to coagulation factor X from Agkistrodon acutus;2.4;CA;CALCIUM ION;anticoagulant protein-B;36307;
1Y1A;A;CRYSTAL STRUCTURE OF CALCIUM AND INTEGRIN BINDING PROTEIN;2.3;CA;CALCIUM ION;Calcium and integrin binding 1 (calmyrin);9606;
1Y1A;B;CRYSTAL STRUCTURE OF CALCIUM AND INTEGRIN BINDING PROTEIN;2.3;CA;CALCIUM ION;Calcium and integrin binding 1 (calmyrin);9606;
1Y1E;X;human formylglycine generating enzyme;1.73;CA;CALCIUM ION;C-alpha-formyglycine-generating enzyme;9606;
1Y1F;X;human formylglycine generating enzyme with cysteine sulfenic acid;1.8;CA;CALCIUM ION;C-alpha-formyglycine-generating enzyme;9606;
1Y1G;X;Human formylglycine generating enzyme, double sulfonic acid form;1.67;CA;CALCIUM ION;C-alpha-formyglycine-generating enzyme;9606;
1Y1I;X;hyuman formylglycine generating enzyme, reduced form;2.61;CA;CALCIUM ION;C-alpha-formyglycine-generating enzyme;9606;
1Y1J;X;human formylglycine generating enzyme, sulfonic acid/desulfurated form;1.55;CA;CALCIUM ION;C-alpha-formyglycine-generating enzyme;9606;
1Y1K;E;Crystal structure of the complex of subtilisin BPN' with chymotrypsin inhibitor 2 T58A mutant;1.56;CA;CALCIUM ION;subtilisin BPN';1390;
1Y1X;A;Structural analysis of a homolog of programmed cell death 6 protein from Leishmania major Friedlin;1.95;CA;CALCIUM ION;Leishmania Major Homolog of Programmed Cell Death 6 Protein;5664;
1Y1X;B;Structural analysis of a homolog of programmed cell death 6 protein from Leishmania major Friedlin;1.95;CA;CALCIUM ION;Leishmania Major Homolog of Programmed Cell Death 6 Protein;5664;
1Y33;E;Crystal structure of the complex of subtilisin BPN' with chymotrypsin inhibitor 2 T58P mutant;1.8;CA;CALCIUM ION;subtilisin BPN';1390;
1Y34;E;Crystal structure of the complex of subtilisin BPN' with chymotrypsin inhibitor 2 E60A mutant;1.55;CA;CALCIUM ION;subtilisin BPN';1390;
1Y3B;E;Crystal structure of the complex of subtilisin BPN' with chymotrypsin inhibitor 2 E60S mutant;1.8;CA;CALCIUM ION;subtilisin BPN';1390;
1Y3C;E;Crystal structure of the complex of subtilisin BPN' with chymotrypsin inhibitor 2 R62A mutant;1.69;CA;CALCIUM ION;subtilisin BPN';1390;
1Y3D;E;Crystal structure of the complex of subtilisin BPN' with chymotrypsin inhibitor 2 R67A mutant;1.8;CA;CALCIUM ION;subtilisin BPN';1390;
1Y3F;E;Crystal structure of the complex of subtilisin BPN' with chymotrypsin inhibitor 2 F69A mutant;1.72;CA;CALCIUM ION;subtilisin BPN';1390;
1Y3G;E;Crystal Structure of a Silanediol Protease Inhibitor Bound to Thermolysin;2.1;CA;CALCIUM ION;Thermolysin;1427;
1Y3N;A;Structure of AlgQ1, alginate-binding protein, complexed with an alginate disaccharide;1.6;CA;CALCIUM ION;AlgQ1;90322;
1Y3P;A;Structure of AlgQ1, alginate-binding protein, complexed with an alginate tetrasaccharide;2;CA;CALCIUM ION;AlgQ1;90322;
1Y3Q;A;Structure of AlgQ1, alginate-binding protein;1.9;CA;CALCIUM ION;AlgQ1;90322;
1Y3U;A;TRYPSIN INHIBITOR COMPLEX;1.8;CA;CALCIUM ION;Trypsin, cationic;9913;
1Y3V;A;Trypsin Inhibitor Complex;1.6;CA;CALCIUM ION;Trypsin, cationic;9913;
1Y3W;A;TRYPSIN INHIBITOR COMPLEX;1.8;CA;CALCIUM ION;Trypsinogen, cationic;9913;
1Y3X;A;TRYPSIN INHIBITOR COMPLEX;1.7;CA;CALCIUM ION;Trypsinogen, cationic;9913;
1Y3Y;A;TRYPSIN INHIBITOR COMPLEX;1.75;CA;CALCIUM ION;Trypsin, cationic;9913;
1Y48;E;Crystal structure of the complex of subtilisin BPN' with chymotrypsin inhibitor 2 R65A mutant;1.84;CA;CALCIUM ION;subtilisin BPN';1390;
1Y4A;E;Crystal structure of the complex of subtilisin BPN' with chymotrypsin inhibitor 2 M59R/E60S mutant;1.6;CA;CALCIUM ION;subtilisin BPN';1390;
1Y4D;E;Crystal structure of the complex of subtilisin BPN' with chymotrypsin inhibitor 2 M59R/E60S mutant;2;CA;CALCIUM ION;subtilisin BPN';1390;
1Y4J;A;Crystal structure of the paralogue of the human formylglycine generating enzyme;1.86;CA;CALCIUM ION;Sulfatase modifying factor 2;9606;
1Y4J;B;Crystal structure of the paralogue of the human formylglycine generating enzyme;1.86;CA;CALCIUM ION;Sulfatase modifying factor 2;9606;
1Y59;T;Dianhydrosugar-based benzamidine, factor Xa specific inhibitor in complex with bovine trypsin mutant;1.2;CA;CALCIUM ION;Trypsin, cationic;9913;
1Y5A;T;Dianhydrosugar-based benzamidine, factor Xa specific inhibitor in complex with bovine trypsin mutant;1.4;CA;CALCIUM ION;Trypsin, cationic;9913;
1Y5B;T;Dianhydrosugar-based benzamidine, factor Xa specific inhibitor in complex with bovine trypsin mutant;1.65;CA;CALCIUM ION;Trypsin, cationic;9913;
1Y5U;T;Dianhydrosugar-based benzamidine, factor Xa specific inhibitor in complex with bovine trypsin mutant;1.6;CA;CALCIUM ION;Trypsin, cationic;9913;
1Y5Y;C;Structure of the tetrahydromethanopterin dependent formaldehyde-activating enzyme (Fae) from Methylobacterium extorquens AM1;2;CA;CALCIUM ION;Formaldehyde-activating enzyme fae;408;
1Y64;A;Bni1p Formin Homology 2 Domain complexed with ATP-actin;3.05;CA;CALCIUM ION;Actin, alpha skeletal muscle;9986;
1Y6O;A;Crystal structure of disulfide engineered porcine pancreatic phospholipase A2 to group-X isozyme in complex with inhibitor MJ33 and phosphate ions;2;CA;CALCIUM ION;Phospholipase A2, major isoenzyme;9823;
1Y6O;B;Crystal structure of disulfide engineered porcine pancreatic phospholipase A2 to group-X isozyme in complex with inhibitor MJ33 and phosphate ions;2;CA;CALCIUM ION;Phospholipase A2, major isoenzyme;9823;
1Y6P;A;Crystal structure of disulfide engineered porcine pancratic phospholipase a2 to group-x isozyme;2.25;CA;CALCIUM ION;Phospholipase A2, major isoenzyme;9823;
1Y6P;B;Crystal structure of disulfide engineered porcine pancratic phospholipase a2 to group-x isozyme;2.25;CA;CALCIUM ION;Phospholipase A2, major isoenzyme;9823;
1Y6W;A;Trapped intermediate of calmodulin;2.4;CA;CALCIUM ION;Calmodulin;9606;
1Y7B;A;BETA-D-XYLOSIDASE, A FAMILY 43 GLYCOSIDE HYDROLASE;1.6;CA;CALCIUM ION;Beta-xylosidase, family 43 glycosyl hydrolase;1488;
1Y7B;B;BETA-D-XYLOSIDASE, A FAMILY 43 GLYCOSIDE HYDROLASE;1.6;CA;CALCIUM ION;Beta-xylosidase, family 43 glycosyl hydrolase;1488;
1Y7B;C;BETA-D-XYLOSIDASE, A FAMILY 43 GLYCOSIDE HYDROLASE;1.6;CA;CALCIUM ION;Beta-xylosidase, family 43 glycosyl hydrolase;1488;
1Y7B;D;BETA-D-XYLOSIDASE, A FAMILY 43 GLYCOSIDE HYDROLASE;1.6;CA;CALCIUM ION;Beta-xylosidase, family 43 glycosyl hydrolase;1488;
1Y7O;A;The structure of Streptococcus pneumoniae A153P ClpP;2.51;CA;CALCIUM ION;ATP-dependent Clp protease proteolytic subunit;1313;
1Y7O;B;The structure of Streptococcus pneumoniae A153P ClpP;2.51;CA;CALCIUM ION;ATP-dependent Clp protease proteolytic subunit;1313;
1Y7O;C;The structure of Streptococcus pneumoniae A153P ClpP;2.51;CA;CALCIUM ION;ATP-dependent Clp protease proteolytic subunit;1313;
1Y7O;E;The structure of Streptococcus pneumoniae A153P ClpP;2.51;CA;CALCIUM ION;ATP-dependent Clp protease proteolytic subunit;1313;
1Y7O;F;The structure of Streptococcus pneumoniae A153P ClpP;2.51;CA;CALCIUM ION;ATP-dependent Clp protease proteolytic subunit;1313;
1Y7O;G;The structure of Streptococcus pneumoniae A153P ClpP;2.51;CA;CALCIUM ION;ATP-dependent Clp protease proteolytic subunit;1313;
1Y7U;A;Crystal Structure of Acyl-Coa hydrolase from Bacillus cereus;2.8;CA;CALCIUM ION;Acyl-CoA hydrolase;1396;
1Y93;A;Crystal structure of the catalytic domain of human MMP12 complexed with acetohydroxamic acid at atomic resolution;1.03;CA;CALCIUM ION;Macrophage metalloelastase;9606;
1Y9I;A;Crystal structure of low temperature requirement C protein from Listeria monocytogenes;1.8;CA;CALCIUM ION;low temperature requirement C protein;1639;
1Y9I;B;Crystal structure of low temperature requirement C protein from Listeria monocytogenes;1.8;CA;CALCIUM ION;low temperature requirement C protein;1639;
1Y9I;C;Crystal structure of low temperature requirement C protein from Listeria monocytogenes;1.8;CA;CALCIUM ION;low temperature requirement C protein;1639;
1Y9I;D;Crystal structure of low temperature requirement C protein from Listeria monocytogenes;1.8;CA;CALCIUM ION;low temperature requirement C protein;1639;
1Y9Z;A;Crystal Structure of Psychrophilic Subtilisin-like Serine Protease from Antarctic Psychrotroph Pseudoalteromonas sp. AS-11 at 0.14 nm resolution;1.4;CA;CALCIUM ION;alkaline serine protease;247492;
1Y9Z;B;Crystal Structure of Psychrophilic Subtilisin-like Serine Protease from Antarctic Psychrotroph Pseudoalteromonas sp. AS-11 at 0.14 nm resolution;1.4;CA;CALCIUM ION;alkaline serine protease;247492;
1YAG;G;STRUCTURE OF THE YEAST ACTIN-HUMAN GELSOLIN SEGMENT 1 COMPLEX;1.9;CA;CALCIUM ION;PROTEIN (GELSOLIN);9606;
1YAX;A;Cystal structure Analysis of S.typhimurium PhoQ sensor domain with Calcium;2.4;CA;CALCIUM ION;Virulence sensor protein phoQ, sensor domain;90371;
1YAX;B;Cystal structure Analysis of S.typhimurium PhoQ sensor domain with Calcium;2.4;CA;CALCIUM ION;Virulence sensor protein phoQ, sensor domain;90371;
1YAX;C;Cystal structure Analysis of S.typhimurium PhoQ sensor domain with Calcium;2.4;CA;CALCIUM ION;Virulence sensor protein phoQ, sensor domain;90371;
1YAX;D;Cystal structure Analysis of S.typhimurium PhoQ sensor domain with Calcium;2.4;CA;CALCIUM ION;Virulence sensor protein phoQ, sensor domain;90371;
1YCM;A;Solution Structure of matrix metalloproteinase 12 (MMP12) in the presence of N-Isobutyl-N-[4-methoxyphenylsulfonyl]glycyl hydroxamic acid (NNGH);;CA;CALCIUM ION;Macrophage metalloelastase;9606;
1YDN;A;Crystal Structure of the HMG-CoA Lyase from Brucella melitensis, Northeast Structural Genomics Target LR35.;2.3;CA;CALCIUM ION;HYDROXYMETHYLGLUTARYL-COA LYASE;29459;
1YDN;B;Crystal Structure of the HMG-CoA Lyase from Brucella melitensis, Northeast Structural Genomics Target LR35.;2.3;CA;CALCIUM ION;HYDROXYMETHYLGLUTARYL-COA LYASE;29459;
1YDN;C;Crystal Structure of the HMG-CoA Lyase from Brucella melitensis, Northeast Structural Genomics Target LR35.;2.3;CA;CALCIUM ION;HYDROXYMETHYLGLUTARYL-COA LYASE;29459;
1YDN;D;Crystal Structure of the HMG-CoA Lyase from Brucella melitensis, Northeast Structural Genomics Target LR35.;2.3;CA;CALCIUM ION;HYDROXYMETHYLGLUTARYL-COA LYASE;29459;
1YDY;A;Crystal structure of periplasmic glycerophosphodiester phosphodiesterase from Escherichia coli;1.7;CA;CALCIUM ION;Glycerophosphoryl diester phosphodiesterase;562;
1YDY;B;Crystal structure of periplasmic glycerophosphodiester phosphodiesterase from Escherichia coli;1.7;CA;CALCIUM ION;Glycerophosphoryl diester phosphodiesterase;562;
1YF4;A;Crystal Structure of trypsin-vasopressin complex;1.98;CA;CALCIUM ION;Trypsin;9823;
1YFJ;2;T4Dam in Complex with AdoHcy and 15-mer Oligonucleotide Showing Semi-specific and Specific Contact;2.69;CA;CALCIUM ION;5'-D(*TP*CP*AP*CP*AP*GP*GP*AP*TP*CP*CP*TP*GP*TP*G)-3';;
1YFJ;4;T4Dam in Complex with AdoHcy and 15-mer Oligonucleotide Showing Semi-specific and Specific Contact;2.69;CA;CALCIUM ION;5'-D(*TP*CP*AP*CP*AP*GP*GP*AP*TP*CP*CP*TP*GP*TP*G)-3';;
1YFQ;A;High resolution S. cerevisiae Bub3 mitotic checkpoint protein;1.1;CA;CALCIUM ION;Cell cycle arrest protein BUB3;4932;
1YGC;H;Short Factor VIIa with a small molecule inhibitor;2;CA;CALCIUM ION;Coagulation factor VII;9606;
1YI7;A;Beta-d-xylosidase (selenomethionine) XYND from Clostridium Acetobutylicum;1.9;CA;CALCIUM ION;Beta-xylosidase, family 43 glycosyl hydrolase;1488;
1YI7;B;Beta-d-xylosidase (selenomethionine) XYND from Clostridium Acetobutylicum;1.9;CA;CALCIUM ION;Beta-xylosidase, family 43 glycosyl hydrolase;1488;
1YI7;C;Beta-d-xylosidase (selenomethionine) XYND from Clostridium Acetobutylicum;1.9;CA;CALCIUM ION;Beta-xylosidase, family 43 glycosyl hydrolase;1488;
1YI7;D;Beta-d-xylosidase (selenomethionine) XYND from Clostridium Acetobutylicum;1.9;CA;CALCIUM ION;Beta-xylosidase, family 43 glycosyl hydrolase;1488;
1YII;A;Crystal Structures of Chicken Annexin V in Complex with Ca2+;1.42;CA;CALCIUM ION;Annexin A5;9031;
1YIQ;A;Molecular cloning and structural analysis of quinohemoprotein alcohol dehydrogenase ADHIIG from Pseudomonas putida HK5. Compariison to the other quinohemoprotein alcohol dehydrogenase ADHIIB found in the same microorganism.;2.2;CA;CALCIUM ION;Quinohemoprotein alcohol dehydrogenase;303;
1YJA;A;SUBTILISIN BPN' 8397+1 (E.C. 3.4.21.14) (MUTANT WITH MET 50 REPLACED BY PHE, ASN 76 REPLACED BY ASP, GLY 169 REPLACED BY ALA, GLN 206 REPLACED BY CYS, ASN 218 REPLACED BY SER AND LYS 256 REPLACED BY TYR) (M50F, N76D, G169A, Q206C, N218S, AND K256Y) IN 20% DIMETHYLFORMAMIDE;1.8;CA;CALCIUM ION;SUBTILISIN 8397+1;1390;
1YJB;A;SUBTILISIN BPN' 8397+1 (E.C. 3.4.21.14) (MUTANT WITH MET 50 REPLACED BY PHE, ASN 76 REPLACED BY ASP, GLY 169 REPLACED BY ALA, GLN 206 REPLACED BY CYS, ASN 218 REPLACED BY SER AND LYS 256 REPLACED BY TYR) (M50F, N76D, G169A, Q206C, N218S, AND K256Y) IN 35% DIMETHYLFORMAMIDE;1.8;CA;CALCIUM ION;SUBTILISIN 8397+1;1390;
1YJC;A;SUBTILISIN BPN' 8397+1 (E.C. 3.4.21.14) (MUTANT WITH MET 50 REPLACED BY PHE, ASN 76 REPLACED BY ASP, GLY 169 REPLACED BY ALA, GLN 206 REPLACED BY CYS, ASN 218 REPLACED BY SER AND LYS 256 REPLACED BY TYR) (M50F, N76D, G169A, Q206C, N218S, AND K256Y) IN 50% DIMETHYLFORMAMIDE;1.8;CA;CALCIUM ION;SUBTILISIN 8397+1;1390;
1YKT;A;Trypsin/Bpti complex mutant;1.7;CA;CALCIUM ION;Trypsin II;10116;
1YLC;A;Trypsin/BPTI complex mutant;1.7;CA;CALCIUM ION;Trypsin II;10116;
1YLD;A;Trypsin/BPTI complex mutant;1.7;CA;CALCIUM ION;Trypsin II;10116;
1YLE;A;The structure of arginine/ornithine succinyltransferase subunit AI from Pseudomonas aeruginosa.;1.7;CA;CALCIUM ION;Arginine N-succinyltransferase, alpha chain;287;
1YLI;A;Crystal structure of HI0827, a hexameric broad specificity acyl-coenzyme A thioesterase;1.95;CA;CALCIUM ION;Putative acyl-CoA thioester hydrolase HI0827;727;
1YLI;B;Crystal structure of HI0827, a hexameric broad specificity acyl-coenzyme A thioesterase;1.95;CA;CALCIUM ION;Putative acyl-CoA thioester hydrolase HI0827;727;
1YN8;B;SH3 domain of yeast NBP2;1.7;CA;CALCIUM ION;NAP1-binding protein 2;4932;
1YN8;C;SH3 domain of yeast NBP2;1.7;CA;CALCIUM ION;NAP1-binding protein 2;4932;
1YN8;D;SH3 domain of yeast NBP2;1.7;CA;CALCIUM ION;NAP1-binding protein 2;4932;
1YN8;E;SH3 domain of yeast NBP2;1.7;CA;CALCIUM ION;NAP1-binding protein 2;4932;
1YNO;A;High Resolution Structure of Benzoylformate Decarboxylase from Pseudomonas Putida Complexed with Thiamine Thiazolone Diphosphate;1.22;CA;CALCIUM ION;Benzoylformate decarboxylase;303;
1YO8;A;Structure of the C-terminal domain of human thrombospondin-2;2.6;CA;CALCIUM ION;thrombospondin-2;9606;
1YOE;A;Crystal structure of a the E. coli pyrimidine nucleoside hydrolase YbeK with bound ribose;1.78;CA;CALCIUM ION;Hypothetical protein ybeK;562;
1YOU;A;Crystal structure of the catalytic domain of MMP-13 complexed with a potent pyrimidinetrione inhibitor;2.3;CA;CALCIUM ION;Collagenase 3;9606;
1YOU;B;Crystal structure of the catalytic domain of MMP-13 complexed with a potent pyrimidinetrione inhibitor;2.3;CA;CALCIUM ION;Collagenase 3;9606;
1YP9;A;Trypsin Inhibitor Complex;2.1;CA;CALCIUM ION;Cationic trypsin;9913;
1YQK;A;Human 8-oxoguanine glycosylase crosslinked with guanine containing DNA;2.5;CA;CALCIUM ION;N-glycosylase/DNA lyase;9606;
1YQL;A;Catalytically inactive hOGG1 crosslinked with 7-deaza-8-azaguanine containing DNA;2.6;CA;CALCIUM ION;N-glycosylase/DNA lyase;9606;
1YQL;C;Catalytically inactive hOGG1 crosslinked with 7-deaza-8-azaguanine containing DNA;2.6;CA;CALCIUM ION;5'-D(P*GP*TP*CP*CP*AP*(PPW)P*GP*TP*CP*TP*AP*C)-3';;
1YQM;A;Catalytically inactive human 8-oxoguanine glycosylase crosslinked to 7-deazaguanine containing DNA;2.5;CA;CALCIUM ION;N-glycosylase/DNA lyase;9606;
1YQM;C;Catalytically inactive human 8-oxoguanine glycosylase crosslinked to 7-deazaguanine containing DNA;2.5;CA;CALCIUM ION;5'-D(P*GP*TP*CP*CP*AP*(7GU)P*GP*TP*CP*TP*AP*C)-3';;
1YQR;A;Catalytically inactive human 8-oxoguanine glycosylase crosslinked to oxoG containing DNA;2.43;CA;CALCIUM ION;N-glycosylase/DNA lyase;9606;
1YQR;C;Catalytically inactive human 8-oxoguanine glycosylase crosslinked to oxoG containing DNA;2.43;CA;CALCIUM ION;5'-D(P*CP*GP*TP*CP*CP*AP*(8OG)P*GP*TP*CP*TP*AP*CP*C)-3';;
1YR5;A;1.7-A structure of calmodulin bound to a peptide from DAP kinase;1.7;CA;CALCIUM ION;calmodulin;9606;
1YRO;A;Crystal structure of beta14,-galactosyltransferase mutant ARG228Lys in complex with alpha-lactalbumin in the presence of UDP-galactose and Mn;1.9;CA;CALCIUM ION;ALPHA-LACTALBUMIN;10090;
1YRO;C;Crystal structure of beta14,-galactosyltransferase mutant ARG228Lys in complex with alpha-lactalbumin in the presence of UDP-galactose and Mn;1.9;CA;CALCIUM ION;ALPHA-LACTALBUMIN;10090;
1YRT;B;Crystal Structure analysis of the adenylyl cyclaes catalytic domain of adenylyl cyclase toxin of Bordetella pertussis in presence of c-terminal calmodulin;2.1;CA;CALCIUM ION;Calmodulin;9606;
1YRU;B;Crystal Structure analysis of the adenylyl cyclaes catalytic domain of adenylyl cyclase toxin of Bordetella pertussis in presence of c-terminal calmodulin and 1mM calcium chloride;2.5;CA;CALCIUM ION;Calmodulin;9606;
1YS1;X;Burkholderia cepacia lipase complexed with hexylphosphonic acid (R)-2-methyl-3-phenylpropyl ester;1.1;CA;CALCIUM ION;Lipase;292;
1YS2;X;Burkholderia cepacia lipase complexed with hexylphosphonic acid (S) 2-methyl-3-phenylpropyl ester;1.5;CA;CALCIUM ION;Lipase;292;
1YS6;A;Crystal structure of the response regulatory protein PrrA from Mycobacterium Tuberculosis;1.77;CA;CALCIUM ION;Transcriptional regulatory protein prrA;1773;
1YS6;B;Crystal structure of the response regulatory protein PrrA from Mycobacterium Tuberculosis;1.77;CA;CALCIUM ION;Transcriptional regulatory protein prrA;1773;
1YSB;B;Yeast Cytosine Deaminase Triple Mutant;1.7;CA;CALCIUM ION;Cytosine deaminase;4932;
1YSD;B;Yeast Cytosine Deaminase Double Mutant;1.9;CA;CALCIUM ION;Cytosine deaminase;4932;
1YTZ;C;Crystal structure of skeletal muscle troponin in the Ca2+-activated state;3;CA;CALCIUM ION;Troponin C;9031;
1YU0;A;Major Tropism Determinant P1 Variant;1.56;CA;CALCIUM ION;Major Tropism Determinant (Mtd-P1);194699;
1YU6;A;Crystal Structure of the Subtilisin Carlsberg:OMTKY3 Complex;1.55;CA;CALCIUM ION;Subtilisin Carlsberg;1402;
1YU6;B;Crystal Structure of the Subtilisin Carlsberg:OMTKY3 Complex;1.55;CA;CALCIUM ION;Subtilisin Carlsberg;1402;
1YUT;A;Solution structure of Calcium-S100A13 (minimized mean structure);;CA;CALCIUM ION;S100 calcium-binding protein A13;9606;
1YUT;B;Solution structure of Calcium-S100A13 (minimized mean structure);;CA;CALCIUM ION;S100 calcium-binding protein A13;9606;
1YUU;A;Solution structure of Calcium-S100A13;;CA;CALCIUM ION;S100 calcium-binding protein A13;9606;
1YUU;B;Solution structure of Calcium-S100A13;;CA;CALCIUM ION;S100 calcium-binding protein A13;9606;
1YVN;G;THE YEAST ACTIN VAL 159 ASN MUTANT COMPLEX WITH HUMAN GELSOLIN SEGMENT 1.;2.1;CA;CALCIUM ION;PROTEIN (GELSOLIN);9606;
1YVU;A;Crystal structure of A. aeolicus Argonaute;2.9;CA;CALCIUM ION;hypothetical protein aq_1447;63363;
1YWT;B;Crystal structure of the human sigma isoform of 14-3-3 in complex with a mode-1 phosphopeptide;2.4;CA;CALCIUM ION;14-3-3 protein sigma;9606;
1YXH;A;Crystal structure of a novel phospholipase A2 from Naja naja sagittifera with a strong anticoagulant activity;1.86;CA;CALCIUM ION;phospholipase A2;195058;
1YXL;A;Crystal structure of a novel phospholipase A2 from Naja naja sagittifera at 1.5 A resolution;1.48;CA;CALCIUM ION;Phospholipase A2 isoform 3;195058;
1YY0;A;Crystal structure of an RNA duplex containing a 2'-amine substitution and a 2'-amide product produced by in-crystal acylation at a C-A mismatch;3.2;CA;CALCIUM ION;5'-R(*GP*CP*AP*GP*AP*(A5M)P*UP*UP*AP*AP*AP*UP*CP*UP*GP*C)-3';;
1YY0;C;Crystal structure of an RNA duplex containing a 2'-amine substitution and a 2'-amide product produced by in-crystal acylation at a C-A mismatch;3.2;CA;CALCIUM ION;5'-R(*GP*CP*AP*GP*AP*(A5M)P*UP*UP*AP*AP*AP*UP*CP*UP*GP*C)-3';;
1YYD;A;High Resolution Crystal Structure of Manganese Peroxidase;1.45;CA;CALCIUM ION;Peroxidase manganese-dependent I;5306;
1YYG;A;Manganese peroxidase complexed with Cd(II) inhibitor;1.6;CA;CALCIUM ION;Peroxidase manganese-dependent I;5306;
1YYY;1;Trypsin inhibitors with rigid tripeptidyl aldehydes;2.1;CA;CALCIUM ION;TRYPSIN;9913;
1YZD;A;Crystal structure of an RNA duplex containing a site specific 2'-amine substitution at a C-G Watson-Crick base pair;2.35;CA;CALCIUM ION;RNA 5'-R(*GP*CP*AP*GP*AP*(A5M)P*UP*UP*AP*AP*GP*UP*CP*UP*GP*C)-3';;
1YZP;A;Substrate-free manganese peroxidase;1.6;CA;CALCIUM ION;Peroxidase manganese-dependent I;5306;
1YZR;A;Manganese peroxidase-Sm(III) complex;1.6;CA;CALCIUM ION;Peroxidase manganese-dependent I;5306;
1Z0B;A;Crystal Structure of A. fulgidus Lon proteolytic domain E506A mutant;1.55;CA;CALCIUM ION;Putative protease La homolog type;2234;
1Z0W;A;Crystal Structure of A. fulgidus Lon proteolytic domain at 1.2A resolution;1.2;CA;CALCIUM ION;Putative protease La homolog type;2234;
1Z1C;B;Structural Determinants of Tissue Tropism and In Vivo Pathogenicity for the Parvovirus Minute virus of Mice;3.5;CA;CALCIUM ION;5'-D(*AP*TP*CP*CP*TP*CP*TP*AP*TP*CP*AP*C)-3';;
1Z29;A;Crystal Structures of SULT1A2 and SULT1A1*3: Implications in the bioactivation of N-hydroxy-2-acetylamino fluorine (OH-AAF);2.4;CA;CALCIUM ION;Phenol-sulfating phenol sulfotransferase 2;9606;
1Z32;X;Structure-function relationships in human salivary alpha-amylase: Role of aromatic residues;1.6;CA;CALCIUM ION;Salivary alpha-amylase;9606;
1Z3J;A;Solution Structure of MMP12 in the presence of N-isobutyl-N-4-methoxyphenylsulfonyl]glycyl hydroxamic acid (NNGH);;CA;CALCIUM ION;Macrophage metalloelastase;9606;
1Z3S;A;Angiopoietin-2 Receptor Binding Domain;2.35;CA;CALCIUM ION;Angiopoietin-2;9606;
1Z3S;B;Angiopoietin-2 Receptor Binding Domain;2.35;CA;CALCIUM ION;Angiopoietin-2;9606;
1Z3U;A;Structure of the Angiopoietin-2 Recptor Binding Domain and Identification of Surfaces Involved in Tie2 Recognition;2.25;CA;CALCIUM ION;Angiopoietin-2;9606;
1Z3U;B;Structure of the Angiopoietin-2 Recptor Binding Domain and Identification of Surfaces Involved in Tie2 Recognition;2.25;CA;CALCIUM ION;Angiopoietin-2;9606;
1Z3U;C;Structure of the Angiopoietin-2 Recptor Binding Domain and Identification of Surfaces Involved in Tie2 Recognition;2.25;CA;CALCIUM ION;Angiopoietin-2;9606;
1Z3U;D;Structure of the Angiopoietin-2 Recptor Binding Domain and Identification of Surfaces Involved in Tie2 Recognition;2.25;CA;CALCIUM ION;Angiopoietin-2;9606;
1Z4V;A;Parainfluenza Virus 5 (SV5) Hemagglutinin-Neuraminidase (HN) with ligand DANA (soaked with DANA, pH 7.0);2.3;CA;CALCIUM ION;Hemagglutinin-neuraminidase;1979162;
1Z4W;A;Parainfluenza Virus 5 (SV5) Hemagglutinin-Neuraminidase (HN) with ligand DANA (soaked with DANA, pH8.0);2.7;CA;CALCIUM ION;Hemagglutinin-neuraminidase;1979162;
1Z4X;A;Parainfluenza Virus 5 (SV5) Hemagglutinin-Neuraminidase (HN) with ligand Sialyllactose (soaked with Sialyllactose, pH8.0);2.5;CA;CALCIUM ION;Hemagglutinin-neuraminidase;1979162;
1Z4Y;A;Parainfluenza Virus 5 (SV5) Hemagglutinin-Neuraminidase (HN) (pH 8.0);2.6;CA;CALCIUM ION;Hemagglutinin-neuraminidase;1979162;
1Z4Z;A;Parainfluenza Virus 5 (SV5) Hemagglutinin-Neuraminidase (HN) with ligand DANA(soaked with sialic acid, pH7.0));2.5;CA;CALCIUM ION;Hemagglutinin-neuraminidase;1979162;
1Z50;A;Parainfluenza Virus 5 (SV5) Hemagglutinin-Neuraminidase (HN) with ligand DANA (soaked with sialic acid, pH 8.0);2.8;CA;CALCIUM ION;Hemagglutinin-neuraminidase;1979162;
1Z6C;A;Solution structure of an EGF pair (EGF34) from vitamin K-dependent protein S;;CA;CALCIUM ION;Vitamin K-dependent protein S;9606;
1Z6J;H;Crystal Structure of a ternary complex of Factor VIIa/Tissue Factor/Pyrazinone Inhibitor;2;CA;CALCIUM ION;Coagulation factor VII;9606;
1Z6J;L;Crystal Structure of a ternary complex of Factor VIIa/Tissue Factor/Pyrazinone Inhibitor;2;CA;CALCIUM ION;Coagulation factor VII;9606;
1Z6O;A;Crystal Structure of Trichoplusia ni secreted ferritin;1.91;CA;CALCIUM ION;Ferritin light chain;7111;
1Z6O;B;Crystal Structure of Trichoplusia ni secreted ferritin;1.91;CA;CALCIUM ION;Ferritin light chain;7111;
1Z6O;C;Crystal Structure of Trichoplusia ni secreted ferritin;1.91;CA;CALCIUM ION;Ferritin light chain;7111;
1Z6O;F;Crystal Structure of Trichoplusia ni secreted ferritin;1.91;CA;CALCIUM ION;Ferritin light chain;7111;
1Z70;X;1.15A resolution structure of the formylglycine generating enzyme FGE;1.15;CA;CALCIUM ION;C-alpha-formyglycine-generating enzyme;9606;
1Z79;C;Crystal structure of an RNA duplex containing site specific 2'-amine substitution at a C-A mismatch (at pH 5);2.55;CA;CALCIUM ION;RNA 5'-R(*GP*CP*AP*GP*AP*(A5M)P*UP*UP*AP*AP*AP*UP*CP*UP*GP*C)-3';;
1Z7S;1;The crystal structure of coxsackievirus A21;3.2;CA;CALCIUM ION;Human COXSACKIEVIRUS A21;138950;
1Z9G;E;Crystal Structure Analysis of Thermolysin Complexed with the Inhibitor (R)-retro-thiorphan;1.7;CA;CALCIUM ION;Thermolysin;1427;
1ZCH;A;Structure of the hypothetical oxidoreductase YcnD from Bacillus subtilis;1.85;CA;CALCIUM ION;Hypothetical oxidoreductase ycnD;1423;
1ZCM;A;Human calpain protease core inhibited by ZLLYCH2F;2;CA;CALCIUM ION;Calpain 1, large [catalytic] subunit;9606;
1ZDE;A;1.95 Angstrom Crystal Structure of a dnaE Intein Precursor from Synechocystis Sp. Pcc 6803;1.95;CA;CALCIUM ION;DNA polymerase III alpha subunit;1148;
1ZDP;E;Crystal Structure Analysis of Thermolysin Complexed with the Inhibitor (S)-thiorphan;1.7;CA;CALCIUM ION;Thermolysin;1427;
1ZEB;A;X-ray structure of alkaline phosphatase from human placenta in complex with 5'-AMP;1.9;CA;CALCIUM ION;Alkaline phosphatase;9606;
1ZED;A;Alkaline phosphatase from human placenta in complex with p-nitrophenyl-phosphonate;1.57;CA;CALCIUM ION;Alkaline phosphatase;9606;
1ZEF;A;structure of alkaline phosphatase from human placenta in complex with its uncompetitive inhibitor L-Phe;1.9;CA;CALCIUM ION;Alkaline phosphatase;9606;
1ZEZ;A;ACC Holliday Junction;2;CA;CALCIUM ION;5'-D(*CP*CP*GP*GP*TP*AP*CP*CP*GP*G)-3';;
1ZF0;A;B-DNA;1.5;CA;CALCIUM ION;5'-D(*CP*CP*GP*TP*TP*AP*AP*CP*GP*G)-3';;
1ZF0;B;B-DNA;1.5;CA;CALCIUM ION;5'-D(*CP*CP*GP*TP*TP*AP*AP*CP*GP*G)-3';;
1ZF3;B;ATC Four-stranded DNA Holliday Junction;1.84;CA;CALCIUM ION;5'-D(*CP*CP*GP*AP*TP*AP*TP*CP*GP*G)-3';;
1ZF6;A;TGG DUPLEX A-DNA;1.5;CA;CALCIUM ION;5'-D(*CP*CP*CP*CP*AP*TP*GP*GP*GP*G)-3';;
1ZF7;A;GAC Duplex B-DNA;1.05;CA;CALCIUM ION;5'-D(*CP*CP*GP*TP*CP*GP*AP*CP*GP*G)-3';;
1ZF7;B;GAC Duplex B-DNA;1.05;CA;CALCIUM ION;5'-D(*CP*CP*GP*TP*CP*GP*AP*CP*GP*G)-3';;
1ZF8;B;GGT Duplex A-DNA;1.48;CA;CALCIUM ION;5'-D(*CP*CP*AP*CP*CP*GP*GP*TP*GP*G)-3';;
1ZFA;B;GGA Duplex A-DNA;1.56;CA;CALCIUM ION;5'-D(*CP*CP*TP*CP*CP*GP*GP*AP*GP*G)-3';;
1ZFB;B;GGC Duplex B-DNA;1.65;CA;CALCIUM ION;5'-D(*CP*CP*GP*CP*CP*GP*GP*CP*GP*G)-3';;
1ZFS;A;Solution structure of S100A1 bound to calcium;;CA;CALCIUM ION;S-100 protein, alpha chain;10116;
1ZFS;B;Solution structure of S100A1 bound to calcium;;CA;CALCIUM ION;S-100 protein, alpha chain;10116;
1ZH2;A;Crystal Structure Of The Calcium-Bound Receiver Domain Of Kdp Potassium Transport System Response Regulator KdpE;2;CA;CALCIUM ION;KDP operon transcriptional regulatory protein kdpE;562;
1ZH2;B;Crystal Structure Of The Calcium-Bound Receiver Domain Of Kdp Potassium Transport System Response Regulator KdpE;2;CA;CALCIUM ION;KDP operon transcriptional regulatory protein kdpE;562;
1ZIV;A;Catalytic Domain of Human Calpain-9;2.31;CA;CALCIUM ION;Calpain 9;9606;
1ZJA;A;Crystal structure of the trehalulose synthase MutB from Pseudomonas mesoacidophila MX-45 (triclinic form);1.6;CA;CALCIUM ION;Trehalulose synthase;265293;
1ZJA;B;Crystal structure of the trehalulose synthase MutB from Pseudomonas mesoacidophila MX-45 (triclinic form);1.6;CA;CALCIUM ION;Trehalulose synthase;265293;
1ZJB;A;Crystal structure of the trehalulose synthase MutB from Pseudomonas mesoacidophila MX-45 (monoclinic form);1.8;CA;CALCIUM ION;Trehalulose synthase;265293;
1ZJB;B;Crystal structure of the trehalulose synthase MutB from Pseudomonas mesoacidophila MX-45 (monoclinic form);1.8;CA;CALCIUM ION;Trehalulose synthase;265293;
1ZL7;A;Crystal structure of catalytically-active phospholipase A2 with bound calcium;1.6;CA;CALCIUM ION;hypotensive phospholipase A2;8726;
1ZM1;A;Crystal structures of complex F. succinogenes 1,3-1,4-beta-D-glucanase and beta-1,3-1,4-cellotriose;2.3;CA;CALCIUM ION;Beta-glucanase;833;
1ZM1;B;Crystal structures of complex F. succinogenes 1,3-1,4-beta-D-glucanase and beta-1,3-1,4-cellotriose;2.3;CA;CALCIUM ION;Beta-glucanase;833;
1ZMR;A;Crystal Structure of the E. coli Phosphoglycerate Kinase;2.4;CA;CALCIUM ION;Phosphoglycerate kinase;562;
1ZOB;A;Crystal structure of dialkylglycine decarboxylases bound with calcium ion;2.75;CA;CALCIUM ION;2,2-dialkylglycine decarboxylase;292;
1ZOT;B;crystal structure analysis of the CyaA/C-Cam with PMEAPP;2.2;CA;CALCIUM ION;Calmodulin;9606;
1ZP5;A;Crystal structure of the complex between MMP-8 and a N-hydroxyurea inhibitor;1.8;CA;CALCIUM ION;Neutrophil collagenase;9606;
1ZR0;A;Crystal Structure of Kunitz Domain 1 of Tissue Factor Pathway Inhibitor-2 with Bovine Trypsin;1.8;CA;CALCIUM ION;Cationic trypsin;9913;
1ZR0;C;Crystal Structure of Kunitz Domain 1 of Tissue Factor Pathway Inhibitor-2 with Bovine Trypsin;1.8;CA;CALCIUM ION;Cationic trypsin;9913;
1ZS0;A;Crystal structure of the complex between MMP-8 and a phosphonate inhibitor (S-enantiomer);1.56;CA;CALCIUM ION;Neutrophil collagenase;9606;
1ZTQ;A;Crystal structure of the catalytic domain of MMP-13 complexed with WAY-033;2;CA;CALCIUM ION;Collagenase 3;9606;
1ZTQ;B;Crystal structure of the catalytic domain of MMP-13 complexed with WAY-033;2;CA;CALCIUM ION;Collagenase 3;9606;
1ZTQ;C;Crystal structure of the catalytic domain of MMP-13 complexed with WAY-033;2;CA;CALCIUM ION;Collagenase 3;9606;
1ZTQ;D;Crystal structure of the catalytic domain of MMP-13 complexed with WAY-033;2;CA;CALCIUM ION;Collagenase 3;9606;
1ZUD;1;Structure of ThiS-ThiF protein complex;1.98;CA;CALCIUM ION;Adenylyltransferase thiF;562;
1ZUD;3;Structure of ThiS-ThiF protein complex;1.98;CA;CALCIUM ION;Adenylyltransferase thiF;562;
1ZUZ;A;Calmodulin in complex with a mutant peptide from human DRP-1 kinase;1.91;CA;CALCIUM ION;calmodulin;9606;
1ZVJ;A;Structure of Kumamolisin-AS mutant, D164N;2.03;CA;CALCIUM ION;kumamolisin-As;192387;
1ZVK;A;Structure of Double mutant, D164N, E78H of Kumamolisin-As;2.04;CA;CALCIUM ION;kumamolisin-As;192387;
1ZVK;B;Structure of Double mutant, D164N, E78H of Kumamolisin-As;2.04;CA;CALCIUM ION;kumamolisin-As;192387;
1ZVX;A;Crystal structure of the complex between MMP-8 and a phosphonate inhibitor (R-enantiomer);1.87;CA;CALCIUM ION;Neutrophil collagenase;9606;
1ZW6;A;Crystal Structure of the GTP-bound form of RasQ61G;1.5;CA;CALCIUM ION;Transforming protein p21/H-Ras-1;9606;
1ZZH;A;Structure of the fully oxidized di-heme cytochrome c peroxidase from R. capsulatus;2.7;CA;CALCIUM ION;cytochrome c peroxidase;1061;
1ZZH;B;Structure of the fully oxidized di-heme cytochrome c peroxidase from R. capsulatus;2.7;CA;CALCIUM ION;cytochrome c peroxidase;1061;
1ZZH;C;Structure of the fully oxidized di-heme cytochrome c peroxidase from R. capsulatus;2.7;CA;CALCIUM ION;cytochrome c peroxidase;1061;
1ZZH;D;Structure of the fully oxidized di-heme cytochrome c peroxidase from R. capsulatus;2.7;CA;CALCIUM ION;cytochrome c peroxidase;1061;
1ZZZ;A;Trypsin inhibitors with rigid tripeptidyl aldehydes;1.9;CA;CALCIUM ION;TRYPSIN;9913;
244D;A;THE HIGH-RESOLUTION CRYSTAL STRUCTURE OF A PARALLEL-STRANDED GUANINE TETRAPLEX;1.2;CA;CALCIUM ION;DNA (5'-D(*TP*GP*GP*GP*GP*T)-3');;
244D;B;THE HIGH-RESOLUTION CRYSTAL STRUCTURE OF A PARALLEL-STRANDED GUANINE TETRAPLEX;1.2;CA;CALCIUM ION;DNA (5'-D(*TP*GP*GP*GP*GP*T)-3');;
244D;C;THE HIGH-RESOLUTION CRYSTAL STRUCTURE OF A PARALLEL-STRANDED GUANINE TETRAPLEX;1.2;CA;CALCIUM ION;DNA (5'-D(*TP*GP*GP*GP*GP*T)-3');;
244D;D;THE HIGH-RESOLUTION CRYSTAL STRUCTURE OF A PARALLEL-STRANDED GUANINE TETRAPLEX;1.2;CA;CALCIUM ION;DNA (5'-D(*TP*GP*GP*GP*GP*T)-3');;
244D;L;THE HIGH-RESOLUTION CRYSTAL STRUCTURE OF A PARALLEL-STRANDED GUANINE TETRAPLEX;1.2;CA;CALCIUM ION;DNA (5'-D(*TP*GP*GP*GP*GP*T)-3');;
244D;M;THE HIGH-RESOLUTION CRYSTAL STRUCTURE OF A PARALLEL-STRANDED GUANINE TETRAPLEX;1.2;CA;CALCIUM ION;DNA (5'-D(*TP*GP*GP*GP*GP*T)-3');;
244D;N;THE HIGH-RESOLUTION CRYSTAL STRUCTURE OF A PARALLEL-STRANDED GUANINE TETRAPLEX;1.2;CA;CALCIUM ION;DNA (5'-D(*TP*GP*GP*GP*GP*T)-3');;
244D;P;THE HIGH-RESOLUTION CRYSTAL STRUCTURE OF A PARALLEL-STRANDED GUANINE TETRAPLEX;1.2;CA;CALCIUM ION;DNA (5'-D(*TP*GP*GP*GP*GP*T)-3');;
249D;A;STRUCTURAL COMPARISON BETWEEN THE D(CTAG) SEQUENCE IN OLIGONUCLEOTIDES AND TRP AND MET REPRESSOR-OPERATOR COMPLEXES;2.25;CA;CALCIUM ION;DNA (5'-D(*CP*GP*CP*TP*CP*TP*AP*GP*AP*GP*CP*G)-3');;
2A11;A;Crystal Structure of Nuclease Domain of Ribonuclase III from Mycobacterium Tuberculosis;2.1;CA;CALCIUM ION;Ribonuclease III;1773;
2A2Q;H;Complex of Active-site Inhibited Human Coagulation Factor VIIa with Human Soluble Tissue Factor in the Presence of Ca2+, Mg2+, Na+, and Zn2+;1.8;CA;CALCIUM ION;Coagulation factor VII;9606;
2A2Q;L;Complex of Active-site Inhibited Human Coagulation Factor VIIa with Human Soluble Tissue Factor in the Presence of Ca2+, Mg2+, Na+, and Zn2+;1.8;CA;CALCIUM ION;Coagulation factor VII;9606;
2A2R;B;Crystal Structure of Glutathione Transferase Pi in complex with S-nitrosoglutathione;1.4;CA;CALCIUM ION;Glutathione S-transferase P;9606;
2A2S;B;Crystal Structure of Human Glutathione Transferase in complex with S-nitrosoglutathione in the absence of reducing agent;1.7;CA;CALCIUM ION;Glutathione S-transferase P;9606;
2A2Z;A;Crystal Structure of human deoxycytidine kinase in complex with deoxycytidine and uridine diphosphate;3.02;CA;CALCIUM ION;Deoxycytidine kinase;9606;
2A2Z;C;Crystal Structure of human deoxycytidine kinase in complex with deoxycytidine and uridine diphosphate;3.02;CA;CALCIUM ION;Deoxycytidine kinase;9606;
2A30;A;Crystal structure of human deoxycytidine kinase in complex with deoxycytidine;3.02;CA;CALCIUM ION;Deoxycytidine kinase;9606;
2A30;C;Crystal structure of human deoxycytidine kinase in complex with deoxycytidine;3.02;CA;CALCIUM ION;Deoxycytidine kinase;9606;
2A31;A;Trypsin in complex with borate;1.25;CA;CALCIUM ION;Trypsin;9823;
2A32;A;Trypsin in complex with benzene boronic acid;1.5;CA;CALCIUM ION;Trypsin;9823;
2A3W;A;Decameric structure of human serum amyloid P-component bound to Bis-1,2-{[(Z)-2-carboxy-2-methyl-1,3-dioxane]-5-yloxycarbamoyl}-ethane;2.2;CA;CALCIUM ION;Serum amyloid P-component;9606;
2A3W;B;Decameric structure of human serum amyloid P-component bound to Bis-1,2-{[(Z)-2-carboxy-2-methyl-1,3-dioxane]-5-yloxycarbamoyl}-ethane;2.2;CA;CALCIUM ION;Serum amyloid P-component;9606;
2A3W;C;Decameric structure of human serum amyloid P-component bound to Bis-1,2-{[(Z)-2-carboxy-2-methyl-1,3-dioxane]-5-yloxycarbamoyl}-ethane;2.2;CA;CALCIUM ION;Serum amyloid P-component;9606;
2A3W;D;Decameric structure of human serum amyloid P-component bound to Bis-1,2-{[(Z)-2-carboxy-2-methyl-1,3-dioxane]-5-yloxycarbamoyl}-ethane;2.2;CA;CALCIUM ION;Serum amyloid P-component;9606;
2A3W;E;Decameric structure of human serum amyloid P-component bound to Bis-1,2-{[(Z)-2-carboxy-2-methyl-1,3-dioxane]-5-yloxycarbamoyl}-ethane;2.2;CA;CALCIUM ION;Serum amyloid P-component;9606;
2A3W;F;Decameric structure of human serum amyloid P-component bound to Bis-1,2-{[(Z)-2-carboxy-2-methyl-1,3-dioxane]-5-yloxycarbamoyl}-ethane;2.2;CA;CALCIUM ION;Serum amyloid P-component;9606;
2A3W;G;Decameric structure of human serum amyloid P-component bound to Bis-1,2-{[(Z)-2-carboxy-2-methyl-1,3-dioxane]-5-yloxycarbamoyl}-ethane;2.2;CA;CALCIUM ION;Serum amyloid P-component;9606;
2A3W;H;Decameric structure of human serum amyloid P-component bound to Bis-1,2-{[(Z)-2-carboxy-2-methyl-1,3-dioxane]-5-yloxycarbamoyl}-ethane;2.2;CA;CALCIUM ION;Serum amyloid P-component;9606;
2A3W;I;Decameric structure of human serum amyloid P-component bound to Bis-1,2-{[(Z)-2-carboxy-2-methyl-1,3-dioxane]-5-yloxycarbamoyl}-ethane;2.2;CA;CALCIUM ION;Serum amyloid P-component;9606;
2A3W;J;Decameric structure of human serum amyloid P-component bound to Bis-1,2-{[(Z)-2-carboxy-2-methyl-1,3-dioxane]-5-yloxycarbamoyl}-ethane;2.2;CA;CALCIUM ION;Serum amyloid P-component;9606;
2A3W;K;Decameric structure of human serum amyloid P-component bound to Bis-1,2-{[(Z)-2-carboxy-2-methyl-1,3-dioxane]-5-yloxycarbamoyl}-ethane;2.2;CA;CALCIUM ION;Serum amyloid P-component;9606;
2A3W;L;Decameric structure of human serum amyloid P-component bound to Bis-1,2-{[(Z)-2-carboxy-2-methyl-1,3-dioxane]-5-yloxycarbamoyl}-ethane;2.2;CA;CALCIUM ION;Serum amyloid P-component;9606;
2A3W;M;Decameric structure of human serum amyloid P-component bound to Bis-1,2-{[(Z)-2-carboxy-2-methyl-1,3-dioxane]-5-yloxycarbamoyl}-ethane;2.2;CA;CALCIUM ION;Serum amyloid P-component;9606;
2A3W;N;Decameric structure of human serum amyloid P-component bound to Bis-1,2-{[(Z)-2-carboxy-2-methyl-1,3-dioxane]-5-yloxycarbamoyl}-ethane;2.2;CA;CALCIUM ION;Serum amyloid P-component;9606;
2A3W;O;Decameric structure of human serum amyloid P-component bound to Bis-1,2-{[(Z)-2-carboxy-2-methyl-1,3-dioxane]-5-yloxycarbamoyl}-ethane;2.2;CA;CALCIUM ION;Serum amyloid P-component;9606;
2A3W;P;Decameric structure of human serum amyloid P-component bound to Bis-1,2-{[(Z)-2-carboxy-2-methyl-1,3-dioxane]-5-yloxycarbamoyl}-ethane;2.2;CA;CALCIUM ION;Serum amyloid P-component;9606;
2A3W;Q;Decameric structure of human serum amyloid P-component bound to Bis-1,2-{[(Z)-2-carboxy-2-methyl-1,3-dioxane]-5-yloxycarbamoyl}-ethane;2.2;CA;CALCIUM ION;Serum amyloid P-component;9606;
2A3W;R;Decameric structure of human serum amyloid P-component bound to Bis-1,2-{[(Z)-2-carboxy-2-methyl-1,3-dioxane]-5-yloxycarbamoyl}-ethane;2.2;CA;CALCIUM ION;Serum amyloid P-component;9606;
2A3W;S;Decameric structure of human serum amyloid P-component bound to Bis-1,2-{[(Z)-2-carboxy-2-methyl-1,3-dioxane]-5-yloxycarbamoyl}-ethane;2.2;CA;CALCIUM ION;Serum amyloid P-component;9606;
2A3W;T;Decameric structure of human serum amyloid P-component bound to Bis-1,2-{[(Z)-2-carboxy-2-methyl-1,3-dioxane]-5-yloxycarbamoyl}-ethane;2.2;CA;CALCIUM ION;Serum amyloid P-component;9606;
2A3X;A;Decameric crystal structure of human serum amyloid P-component bound to Bis-1,2-{[(Z)-2carboxy- 2-methyl-1,3-dioxane]- 5-yloxycarbonyl}-piperazine;3;CA;CALCIUM ION;Serum amyloid P-component;9606;
2A3X;B;Decameric crystal structure of human serum amyloid P-component bound to Bis-1,2-{[(Z)-2carboxy- 2-methyl-1,3-dioxane]- 5-yloxycarbonyl}-piperazine;3;CA;CALCIUM ION;Serum amyloid P-component;9606;
2A3X;C;Decameric crystal structure of human serum amyloid P-component bound to Bis-1,2-{[(Z)-2carboxy- 2-methyl-1,3-dioxane]- 5-yloxycarbonyl}-piperazine;3;CA;CALCIUM ION;Serum amyloid P-component;9606;
2A3X;D;Decameric crystal structure of human serum amyloid P-component bound to Bis-1,2-{[(Z)-2carboxy- 2-methyl-1,3-dioxane]- 5-yloxycarbonyl}-piperazine;3;CA;CALCIUM ION;Serum amyloid P-component;9606;
2A3X;E;Decameric crystal structure of human serum amyloid P-component bound to Bis-1,2-{[(Z)-2carboxy- 2-methyl-1,3-dioxane]- 5-yloxycarbonyl}-piperazine;3;CA;CALCIUM ION;Serum amyloid P-component;9606;
2A3X;F;Decameric crystal structure of human serum amyloid P-component bound to Bis-1,2-{[(Z)-2carboxy- 2-methyl-1,3-dioxane]- 5-yloxycarbonyl}-piperazine;3;CA;CALCIUM ION;Serum amyloid P-component;9606;
2A3X;G;Decameric crystal structure of human serum amyloid P-component bound to Bis-1,2-{[(Z)-2carboxy- 2-methyl-1,3-dioxane]- 5-yloxycarbonyl}-piperazine;3;CA;CALCIUM ION;Serum amyloid P-component;9606;
2A3X;H;Decameric crystal structure of human serum amyloid P-component bound to Bis-1,2-{[(Z)-2carboxy- 2-methyl-1,3-dioxane]- 5-yloxycarbonyl}-piperazine;3;CA;CALCIUM ION;Serum amyloid P-component;9606;
2A3X;I;Decameric crystal structure of human serum amyloid P-component bound to Bis-1,2-{[(Z)-2carboxy- 2-methyl-1,3-dioxane]- 5-yloxycarbonyl}-piperazine;3;CA;CALCIUM ION;Serum amyloid P-component;9606;
2A3X;J;Decameric crystal structure of human serum amyloid P-component bound to Bis-1,2-{[(Z)-2carboxy- 2-methyl-1,3-dioxane]- 5-yloxycarbonyl}-piperazine;3;CA;CALCIUM ION;Serum amyloid P-component;9606;
2A3Y;A;Pentameric crystal structure of human serum amyloid P-component bound to Bis-1,2-{[(Z)-2carboxy-2-methyl-1,3-dioxane]-5-yloxycarbamoyl}-ethane.;2;CA;CALCIUM ION;Serum amyloid P-component;9606;
2A3Y;B;Pentameric crystal structure of human serum amyloid P-component bound to Bis-1,2-{[(Z)-2carboxy-2-methyl-1,3-dioxane]-5-yloxycarbamoyl}-ethane.;2;CA;CALCIUM ION;Serum amyloid P-component;9606;
2A3Y;C;Pentameric crystal structure of human serum amyloid P-component bound to Bis-1,2-{[(Z)-2carboxy-2-methyl-1,3-dioxane]-5-yloxycarbamoyl}-ethane.;2;CA;CALCIUM ION;Serum amyloid P-component;9606;
2A3Y;D;Pentameric crystal structure of human serum amyloid P-component bound to Bis-1,2-{[(Z)-2carboxy-2-methyl-1,3-dioxane]-5-yloxycarbamoyl}-ethane.;2;CA;CALCIUM ION;Serum amyloid P-component;9606;
2A3Y;E;Pentameric crystal structure of human serum amyloid P-component bound to Bis-1,2-{[(Z)-2carboxy-2-methyl-1,3-dioxane]-5-yloxycarbamoyl}-ethane.;2;CA;CALCIUM ION;Serum amyloid P-component;9606;
2A3Z;A;Ternary complex of the WH2 domain of WASP with Actin-DNAse I;2.08;CA;CALCIUM ION;Actin, alpha skeletal muscle;9986;
2A3Z;B;Ternary complex of the WH2 domain of WASP with Actin-DNAse I;2.08;CA;CALCIUM ION;Deoxyribonuclease-1;9913;
2A40;A;Ternary complex of the WH2 domain of WAVE with Actin-DNAse I;1.8;CA;CALCIUM ION;Actin, alpha skeletal muscle;9986;
2A40;B;Ternary complex of the WH2 domain of WAVE with Actin-DNAse I;1.8;CA;CALCIUM ION;Deoxyribonuclease-1;9913;
2A40;D;Ternary complex of the WH2 domain of WAVE with Actin-DNAse I;1.8;CA;CALCIUM ION;Actin, alpha skeletal muscle;9986;
2A40;E;Ternary complex of the WH2 domain of WAVE with Actin-DNAse I;1.8;CA;CALCIUM ION;Deoxyribonuclease-1;9913;
2A41;A;Ternary complex of the WH2 Domain of WIP with Actin-DNAse I;2.6;CA;CALCIUM ION;Actin, alpha skeletal muscle;9986;
2A41;B;Ternary complex of the WH2 Domain of WIP with Actin-DNAse I;2.6;CA;CALCIUM ION;Deoxyribonuclease-1;9913;
2A42;A;Actin-DNAse I Complex;1.85;CA;CALCIUM ION;Actin, alpha skeletal muscle;9986;
2A42;B;Actin-DNAse I Complex;1.85;CA;CALCIUM ION;Deoxyribonuclease-1;9913;
2A4E;A;Crystal structure of mouse cadherin-11 EC1-2;3.2;CA;CALCIUM ION;Cadherin-11;10090;
2A5X;A;Crystal Structure of a Cross-linked Actin Dimer;2.49;CA;CALCIUM ION;Actin, alpha skeletal muscle;9986;
2A62;A;Crystal structure of mouse cadherin-8 EC1-3;4.5;CA;CALCIUM ION;Cadherin-8;10090;
2A7A;A;On the Routine Use of Soft X-Rays in Macromolecular Crystallography, Part III- The Optimal Data Collection Wavelength;1.75;CA;CALCIUM ION;Concanavalin A;28958;
2A7G;E;On the Routine Use of Soft X-Rays in Macromolecular Crystallography, Part III- The Optimal Data Collection Wavelength;1.85;CA;CALCIUM ION;thermolysin;1427;
2A7H;A;On the Routine Use of Soft X-Rays in Macromolecular Crystallography, Part III- The Optimal Data Collection Wavelength;2.1;CA;CALCIUM ION;Cationic trypsin;9913;
2A7J;A;On the Routine Use of Soft X-Rays in Macromolecular Crystallography, Part III- The Optimal Data Collection Wavelength;1.65;CA;CALCIUM ION;Elastase 1;9823;
2A8K;A;Structural and Mutational Studies of the Catalytic Domain of Colicin E5a tRNA-Specific Ribonuclease;1.5;CA;CALCIUM ION;Colicin E5;562;
2A8K;B;Structural and Mutational Studies of the Catalytic Domain of Colicin E5a tRNA-Specific Ribonuclease;1.5;CA;CALCIUM ION;Colicin E5;562;
2A8K;C;Structural and Mutational Studies of the Catalytic Domain of Colicin E5a tRNA-Specific Ribonuclease;1.5;CA;CALCIUM ION;Colicin E5;562;
2A8K;D;Structural and Mutational Studies of the Catalytic Domain of Colicin E5a tRNA-Specific Ribonuclease;1.5;CA;CALCIUM ION;Colicin E5;562;
2AAA;A;CALCIUM BINDING IN ALPHA-AMYLASES: AN X-RAY DIFFRACTION STUDY AT 2.1 ANGSTROMS RESOLUTION OF TWO ENZYMES FROM ASPERGILLUS;2.12;CA;CALCIUM ION;ALPHA-AMYLASE;5061;
2AAD;A;THE ROLE OF HISTIDINE-40 IN RIBONUCLEASE T1 CATALYSIS: THREE-DIMENSIONAL STRUCTURES OF THE PARTIALLY ACTIVE HIS40LYS MUTANT;2;CA;CALCIUM ION;RIBONUCLEASE T1 ISOZYME;5062;
2AAD;B;THE ROLE OF HISTIDINE-40 IN RIBONUCLEASE T1 CATALYSIS: THREE-DIMENSIONAL STRUCTURES OF THE PARTIALLY ACTIVE HIS40LYS MUTANT;2;CA;CALCIUM ION;RIBONUCLEASE T1 ISOZYME;5062;
2AAE;A;THE ROLE OF HISTIDINE-40 IN RIBONUCLEASE T1 CATALYSIS: THREE-DIMENSIONAL STRUCTURES OF THE PARTIALLY ACTIVE HIS40LYS MUTANT;1.8;CA;CALCIUM ION;RIBONUCLEASE T1;5062;
2AAO;A;Regulatory apparatus of Calcium Dependent protein kinase from Arabidopsis thaliana;2;CA;CALCIUM ION;Calcium-dependent protein kinase, isoform AK1;3702;
2AAO;B;Regulatory apparatus of Calcium Dependent protein kinase from Arabidopsis thaliana;2;CA;CALCIUM ION;Calcium-dependent protein kinase, isoform AK1;3702;
2AD6;A;crystal structure of methanol dehydrogenase from M. W3A1 (form C);1.5;CA;CALCIUM ION;Methanol dehydrogenase subunit 1;17;
2AD6;C;crystal structure of methanol dehydrogenase from M. W3A1 (form C);1.5;CA;CALCIUM ION;Methanol dehydrogenase subunit 1;17;
2AD7;A;crystal structure of methanol dehydrogenase from M. W3A1 (form C) in the presence of methanol;1.5;CA;CALCIUM ION;Methanol dehydrogenase subunit 1;17;
2AD7;C;crystal structure of methanol dehydrogenase from M. W3A1 (form C) in the presence of methanol;1.5;CA;CALCIUM ION;Methanol dehydrogenase subunit 1;17;
2AD8;A;crystal structure of methanol dehydrogenase from M. W3A1 (form C) in the presence of ethanol;1.6;CA;CALCIUM ION;Methanol dehydrogenase subunit 1;17;
2AD8;C;crystal structure of methanol dehydrogenase from M. W3A1 (form C) in the presence of ethanol;1.6;CA;CALCIUM ION;Methanol dehydrogenase subunit 1;17;
2ADJ;A;Crystal structure of monoclonal anti-CD4 antibody Q425 in complex with Calcium;2.9;CA;CALCIUM ION;Q425 Fab Light chain;10090;
2AEF;A;Crystal Structures of the MthK RCK Domain in Ca2+ bound form;1.7;CA;CALCIUM ION;Calcium-gated potassium channel mthK;145262;
2AEF;B;Crystal Structures of the MthK RCK Domain in Ca2+ bound form;1.7;CA;CALCIUM ION;Calcium-gated potassium channel mthK;145262;
2AEI;H;Crystal structure of a ternary complex of factor VIIa/tissue factor and 2-[[6-[3-(aminoiminomethyl)phenoxy]-3,5-difluro-4-[(1-methyl-3-phenylpropyl)amino]-2-pyridinyl]oxy]-benzoic acid;2.52;CA;CALCIUM ION;Coagulation factor VII;9606;
2AEI;L;Crystal structure of a ternary complex of factor VIIa/tissue factor and 2-[[6-[3-(aminoiminomethyl)phenoxy]-3,5-difluro-4-[(1-methyl-3-phenylpropyl)amino]-2-pyridinyl]oxy]-benzoic acid;2.52;CA;CALCIUM ION;Coagulation factor VII;9606;
2AEP;A;An epidemiologically significant epitope of a 1998 influenza virus neuraminidase forms a highly hydrated interface in the NA-antibody complex.;2.1;CA;CALCIUM ION;neuraminidase;11320;
2AER;H;Crystal Structure of Benzamidine-Factor VIIa/Soluble Tissue Factor complex.;1.87;CA;CALCIUM ION;Coagulation factor VII;9606;
2AER;L;Crystal Structure of Benzamidine-Factor VIIa/Soluble Tissue Factor complex.;1.87;CA;CALCIUM ION;Coagulation factor VII;9606;
2AFB;A;Crystal structure of 2-dehydro-3- deoxygluconokinase (EC 2.7.1.45) (tm0067) from THERMOTOGA MARITIMA at 2.05 A resolution;2.05;CA;CALCIUM ION;2-keto-3-deoxygluconate kinase;2336;
2AFB;B;Crystal structure of 2-dehydro-3- deoxygluconokinase (EC 2.7.1.45) (tm0067) from THERMOTOGA MARITIMA at 2.05 A resolution;2.05;CA;CALCIUM ION;2-keto-3-deoxygluconate kinase;2336;
2AFH;B;Crystal Structure of Nucleotide-Free Av2-Av1 Complex;2.1;CA;CALCIUM ION;Nitrogenase molybdenum-iron protein;354;
2AFH;D;Crystal Structure of Nucleotide-Free Av2-Av1 Complex;2.1;CA;CALCIUM ION;Nitrogenase molybdenum-iron protein;354;
2AFI;B;Crystal Structure of MgADP bound Av2-Av1 Complex;3.1;CA;CALCIUM ION;Nitrogenase molybdenum-iron protein;354;
2AFI;J;Crystal Structure of MgADP bound Av2-Av1 Complex;3.1;CA;CALCIUM ION;Nitrogenase molybdenum-iron protein;354;
2AFI;L;Crystal Structure of MgADP bound Av2-Av1 Complex;3.1;CA;CALCIUM ION;Nitrogenase molybdenum-iron protein;354;
2AFT;X;Formylglycine generating enzyme C336S mutant;1.66;CA;CALCIUM ION;Sulfatase modifying factor 1;9606;
2AFY;X;Formylglycine generating enzyme C341S mutant;1.49;CA;CALCIUM ION;Sulfatase modifying factor 1;9606;
2AGE;X;Succinyl-AAPR-trypsin acyl-enzyme at 1.15 A resolution;1.15;CA;CALCIUM ION;beta-trypsin;9913;
2AGG;X;succinyl-AAPK-trypsin acyl-enzyme at 1.28 A resolution;1.28;CA;CALCIUM ION;beta-trypsin;9913;
2AGI;X;The leupeptin-trypsin covalent complex at 1.14 A resolution;1.14;CA;CALCIUM ION;beta-trypsin;9913;
2-ago;A;Fidelity of Dpo4: effect of metal ions, nucleotide selection and pyrophosphorolysis;2.85;CA;CALCIUM ION;DNA polymerase IV;2287;
2AGP;A;Fidelity of Dpo4: effect of metal ions, nucleotide selection and pyrophosphorolysis;2.9;CA;CALCIUM ION;DNA polymerase IV;2287;
2AGP;B;Fidelity of Dpo4: effect of metal ions, nucleotide selection and pyrophosphorolysis;2.9;CA;CALCIUM ION;DNA polymerase IV;2287;
2AGQ;A;Fidelity of Dpo4: effect of metal ions, nucleotide selection and pyrophosphorolysis;2.1;CA;CALCIUM ION;DNA polymerase IV;2287;
2AH4;X;guanidinobenzoyl-trypsin acyl-enzyme at 1.13 A resolution;1.13;CA;CALCIUM ION;beta-trypsin;9913;
2AHY;A;Na+ complex of the NaK Channel;2.4;CA;CALCIUM ION;Potassium channel protein;1396;
2AHZ;A;K+ complex of the NaK Channel;2.8;CA;CALCIUM ION;Potassium channel protein;1396;
2AIG;P;ADAMALYSIN II WITH PEPTIDOMIMETIC INHIBITOR POL647;2.6;CA;CALCIUM ION;ADAMALYSIN II;8729;
2AII;X;wild-type Formylglycine generating enzyme reacted with iodoacetamide;1.54;CA;CALCIUM ION;Sulfatase modifying factor 1;9606;
2AIJ;X;Formylglycine generating enzyme C336S mutant covalently bound to substrate peptide CTPSR;1.55;CA;CALCIUM ION;Sulfatase modifying factor 1;9606;
2AIK;X;Formylglycine generating enzyme C336S mutant covalently bound to substrate peptide LCTPSRA;1.73;CA;CALCIUM ION;Sulfatase modifying factor 1;9606;
2AMG;A;STRUCTURE OF HYDROLASE (GLYCOSIDASE);2;CA;CALCIUM ION;1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLASE;316;
2AOQ;A;Crystal structure of MutH-unmethylated DNA complex;2.2;CA;CALCIUM ION;DNA mismatch repair protein mutH;727;
2AOR;A;Crystal structure of MutH-hemimethylated DNA complex;2;CA;CALCIUM ION;DNA mismatch repair protein mutH;727;
2AOR;B;Crystal structure of MutH-hemimethylated DNA complex;2;CA;CALCIUM ION;DNA mismatch repair protein mutH;727;
2APR;A;STRUCTURE AND REFINEMENT AT 1.8 ANGSTROMS RESOLUTION OF THE ASPARTIC PROTEINASE FROM RHIZOPUS CHINENSIS;1.8;CA;CALCIUM ION;RHIZOPUSPEPSIN;58291;
2AR6;A;Pterocarpus angolensis Lectin (PAL) In Complex With The Pentasaccharide M592;1.8;CA;CALCIUM ION;lectin;182271;
2AR6;B;Pterocarpus angolensis Lectin (PAL) In Complex With The Pentasaccharide M592;1.8;CA;CALCIUM ION;lectin;182271;
2ARB;A;Pterocarpus angolensis Lectin (PAL) In Complex With The GlcNAc(beta1-2)Man Disaccharide;1.8;CA;CALCIUM ION;lectin;182271;
2ARB;B;Pterocarpus angolensis Lectin (PAL) In Complex With The GlcNAc(beta1-2)Man Disaccharide;1.8;CA;CALCIUM ION;lectin;182271;
2ARE;A;Pterocarpus angolensis Lectin (PAL) In Complex With D-Mannose (anomeric mixture);1.8;CA;CALCIUM ION;lectin;182271;
2ARE;B;Pterocarpus angolensis Lectin (PAL) In Complex With D-Mannose (anomeric mixture);1.8;CA;CALCIUM ION;lectin;182271;
2ARH;A;Crystal Structure of a Protein of Unknown Function AQ1966 from Aquifex aeolicus VF5;2.46;CA;CALCIUM ION;hypothetical protein aq_1966;63363;
2ARX;A;Pterocarpus angolensis seed lectin in complex with the decasaccharide NA2F;2;CA;CALCIUM ION;lectin;182271;
2ARX;B;Pterocarpus angolensis seed lectin in complex with the decasaccharide NA2F;2;CA;CALCIUM ION;lectin;182271;
2ARY;A;Catalytic domain of Human Calpain-1;2.4;CA;CALCIUM ION;Calpain-1 catalytic subunit;9606;
2ARY;B;Catalytic domain of Human Calpain-1;2.4;CA;CALCIUM ION;Calpain-1 catalytic subunit;9606;
2ASD;A;oxoG-modified Insertion Ternary Complex;1.95;CA;CALCIUM ION;DNA polymerase IV;2287;
2ASD;B;oxoG-modified Insertion Ternary Complex;1.95;CA;CALCIUM ION;DNA polymerase IV;2287;
2ASD;D;oxoG-modified Insertion Ternary Complex;1.95;CA;CALCIUM ION;5'-D(*GP*GP*TP*TP*GP*GP*AP*TP*GP*GP*TP*AP*(DDG))-3';;
2ASJ;A;oxoG-modified Preinsertion Binary Complex;2.35;CA;CALCIUM ION;DNA polymerase IV;2287;
2ASJ;B;oxoG-modified Preinsertion Binary Complex;2.35;CA;CALCIUM ION;DNA polymerase IV;2287;
2ASJ;E;oxoG-modified Preinsertion Binary Complex;2.35;CA;CALCIUM ION;5'-D(*CP*TP*AP*AP*CP*(8OG)*CP*TP*AP*CP*CP*AP*TP*CP*CP*AP*AP*CP*C)-3';;
2ASL;A;oxoG-modified Postinsertion Binary Complex;2.65;CA;CALCIUM ION;DNA polymerase IV;2287;
2ASL;B;oxoG-modified Postinsertion Binary Complex;2.65;CA;CALCIUM ION;DNA polymerase IV;2287;
2ASL;D;oxoG-modified Postinsertion Binary Complex;2.65;CA;CALCIUM ION;5'-D(*GP*GP*TP*TP*GP*GP*AP*TP*GP*GP*TP*AP*GP*(DOC))-3';;
2ASL;J;oxoG-modified Postinsertion Binary Complex;2.65;CA;CALCIUM ION;5'-D(*CP*T*AP*AP*CP*(8OG)P*CP*TP*AP*CP*CP*AP*TP*CP*CP*AP*AP*CP*C)-3';;
2ASM;A;Structure of Rabbit Actin In Complex With Reidispongiolide A;1.6;CA;CALCIUM ION;Actin, alpha skeletal muscle;9986;
2ASO;A;Structure of Rabbit Actin In Complex With Sphinxolide B;1.7;CA;CALCIUM ION;Actin, alpha skeletal muscle;9986;
2ASP;A;Structure of Rabbit Actin In Complex With Reidispongiolide C;1.64;CA;CALCIUM ION;Actin, alpha skeletal muscle;9986;
2ATJ;A;RECOMBINANT HORSERADISH PEROXIDASE COMPLEX WITH BENZHYDROXAMIC ACID;2;CA;CALCIUM ION;PEROXIDASE C1A;3704;
2ATJ;B;RECOMBINANT HORSERADISH PEROXIDASE COMPLEX WITH BENZHYDROXAMIC ACID;2;CA;CALCIUM ION;PEROXIDASE C1A;3704;
2ATL;A;Unmodified Insertion Ternary Complex;2.8;CA;CALCIUM ION;Dpo4 polymerase IV;2287;
2ATL;B;Unmodified Insertion Ternary Complex;2.8;CA;CALCIUM ION;Dpo4 polymerase IV;2287;
2ATL;D;Unmodified Insertion Ternary Complex;2.8;CA;CALCIUM ION;5'-D(*GP*GP*TP*TP*GP*GP*AP*TP*GP*GP*TP*AP*(DDG))-3';;
2ATL;H;Unmodified Insertion Ternary Complex;2.8;CA;CALCIUM ION;5'-D(*GP*GP*TP*TP*GP*GP*AP*TP*GP*GP*TP*AP*(DDG))-3';;
2AU0;A;Unmodified preinsertion binary complex;2.7;CA;CALCIUM ION;Dpo4 polymerase IV;2287;
2AU0;H;Unmodified preinsertion binary complex;2.7;CA;CALCIUM ION;5'-D(*GP*GP*TP*TP*GP*GP*AP*TP*GP*GP*TP*AP*(DDG))-3';;
2AU0;J;Unmodified preinsertion binary complex;2.7;CA;CALCIUM ION;5'-D(*CP*TP*AP*AP*CP*G*CP*TP*AP*CP*CP*AP*TP*CP*CP*AP*AP*CP*C)-3';;
2AUH;A;Crystal structure of the Grb14 BPS region in complex with the insulin receptor tyrosine kinase;3.2;CA;CALCIUM ION;Insulin receptor;9606;
2AUY;A;Pterocarpus angolensis lectin in complex with the trisaccharide GlcNAc(b1-2)Man(a1-3)Man;1.95;CA;CALCIUM ION;lectin;182271;
2AUY;B;Pterocarpus angolensis lectin in complex with the trisaccharide GlcNAc(b1-2)Man(a1-3)Man;1.95;CA;CALCIUM ION;lectin;182271;
2AWY;A;met-DcrH-Hr;2.1;CA;CALCIUM ION;hemerythrin-like domain protein DcrH;881;
2AXT;K;Crystal Structure of Photosystem II from Thermosynechococcus elongatus;3;CA;CALCIUM ION;Photosystem II reaction center protein K;146786;
2AXT;k;Crystal Structure of Photosystem II from Thermosynechococcus elongatus;3;CA;CALCIUM ION;Photosystem II reaction center protein K;146786;
2AYH;A;CRYSTAL AND MOLECULAR STRUCTURE AT 1.6 ANGSTROMS RESOLUTION OF THE HYBRID BACILLUS ENDO-1,3-1,4-BETA-D-GLUCAN 4-GLUCANOHYDROLASE H(A16-M);1.6;CA;CALCIUM ION;1,3-1,4-BETA-D-GLUCAN 4-GLUCANOHYDROLASE;37965;
2AYK;A;INHIBITOR-FREE CATALYTIC FRAGMENT OF HUMAN FIBROBLAST COLLAGENASE, NMR, MINIMIZED AVERAGE STRUCTURE;;CA;CALCIUM ION;COLLAGENASE;9606;
2AYW;A;Crystal Structure of the complex formed between trypsin and a designed synthetic highly potent inhibitor in the presence of benzamidine at 0.97 A resolution;0.97;CA;CALCIUM ION;Cationic trypsin;9913;
2AZ1;A;Structure of a halophilic nucleoside diphosphate kinase from Halobacterium salinarum;2.35;CA;CALCIUM ION;Nucleoside diphosphate kinase;2242;
2AZ1;C;Structure of a halophilic nucleoside diphosphate kinase from Halobacterium salinarum;2.35;CA;CALCIUM ION;Nucleoside diphosphate kinase;2242;
2AZ1;D;Structure of a halophilic nucleoside diphosphate kinase from Halobacterium salinarum;2.35;CA;CALCIUM ION;Nucleoside diphosphate kinase;2242;
2AZY;A;Crystal Structure of Porcine Pancreatic Phospholipase A2 in Complex with Cholate;1.9;CA;CALCIUM ION;Phospholipase A2, major isoenzyme;9823;
2AZZ;A;Crystal Structure of Porcine Pancreatic Phospholipase A2 in Complex with Taurocholate;2.2;CA;CALCIUM ION;Phospholipase A2, major isoenzyme;9823;
2B00;A;Crystal Structure of Porcine Pancreatic Phospholipase A2 in Complex with Glycocholate;1.85;CA;CALCIUM ION;Phospholipase A2, major isoenzyme;9823;
2B01;A;Crystal Structure of Porcine Pancreatic Phospholipase A2 in Complex with Taurochenodeoxycholate;2.2;CA;CALCIUM ION;Phospholipase A2, major isoenzyme;9823;
2B03;A;Crystal Structure of Porcine Pancreatic Phospholipase A2 in Complex with Taurochenodeoxycholate;2.3;CA;CALCIUM ION;Phospholipase A2, major isoenzyme;9823;
2B04;A;Crystal Structure of Porcine Pancreatic Phospholipase A2 in Complex with Glycochenodeoxycholate;2.5;CA;CALCIUM ION;Phospholipase A2, major isoenzyme;9823;
2B0D;A;EcoRV Restriction Endonuclease/GAATTC/Ca2+;2;CA;CALCIUM ION;Type II restriction enzyme EcoRV;562;
2B0E;A;EcoRV Restriction Endonuclease/GAAUTC/Ca2+;1.9;CA;CALCIUM ION;Type II restriction enzyme EcoRV;562;
2B1O;A;Solution Structure of Ca2+-bound DdCAD-1;;CA;CALCIUM ION;Calcium-dependent cell adhesion molecule-1;44689;
2B2B;A;Structural distortions in psoralen cross-linked DNA;1.5;CA;CALCIUM ION;5'-D(*CP*CP*GP*CP*TP*AP*GP*CP*GP*G)-3';;
2B2B;B;Structural distortions in psoralen cross-linked DNA;1.5;CA;CALCIUM ION;5'-D(*CP*CP*GP*CP*TP*AP*GP*CP*GP*G)-3';;
2B30;A;Initial Crystallographic Structural Analysis of a putative HAD/COF-like hydrolase from Plasmodium vivax;2.7;CA;CALCIUM ION;Pvivax hypothetical protein;5855;
2B30;B;Initial Crystallographic Structural Analysis of a putative HAD/COF-like hydrolase from Plasmodium vivax;2.7;CA;CALCIUM ION;Pvivax hypothetical protein;5855;
2B30;C;Initial Crystallographic Structural Analysis of a putative HAD/COF-like hydrolase from Plasmodium vivax;2.7;CA;CALCIUM ION;Pvivax hypothetical protein;5855;
2B30;D;Initial Crystallographic Structural Analysis of a putative HAD/COF-like hydrolase from Plasmodium vivax;2.7;CA;CALCIUM ION;Pvivax hypothetical protein;5855;
2B33;B;CRYSTAL STRUCTURE OF A PUTATIVE ENDORIBONUCLEASE (TM0215) FROM THERMOTOGA MARITIMA MSB8 AT 2.30 A RESOLUTION;2.3;CA;CALCIUM ION;protein synthesis inhibitor, putative;2336;
2B50;A;Human Nuclear Receptor-Ligand Complex 2;2;CA;CALCIUM ION;Peroxisome proliferator activated receptor delta;9606;
2B50;B;Human Nuclear Receptor-Ligand Complex 2;2;CA;CALCIUM ION;Peroxisome proliferator activated receptor delta;9606;
2B59;B;The type II cohesin dockerin complex;2.11;CA;CALCIUM ION;Cellulosomal scaffolding protein A;1515;
2B6N;A;The 1.8 A crystal structure of a Proteinase K like enzyme from a psychrotroph Serratia species;1.8;CA;CALCIUM ION;proteinase K;348903;
2B7Y;A;Fava Bean Lectin-Glucose Complex;3;CA;CALCIUM ION;Favin beta chain;3906;
2B7Y;C;Fava Bean Lectin-Glucose Complex;3;CA;CALCIUM ION;Favin beta chain;3906;
2B8O;H;Crystal Structure of Glu-Gly-Arg-Chloromethyl Ketone-Factor VIIa/Soluble Tissue Factor Complex;2.8;CA;CALCIUM ION;Coagulation factor VII heavy chain;9606;
2B8O;L;Crystal Structure of Glu-Gly-Arg-Chloromethyl Ketone-Factor VIIa/Soluble Tissue Factor Complex;2.8;CA;CALCIUM ION;Coagulation factor VII light chain;9606;
2B96;A;Third Calcium ion found in an inhibitor bound phospholipase A2;1.7;CA;CALCIUM ION;Phospholipase A2;9913;
2B9L;A;Crystal structure of prophenoloxidase activating factor-II from the beetle Holotrichia diomphalia;2;CA;CALCIUM ION;prophenoloxidase activating factor;33394;
2BAM;A;RESTRICTION ENDONUCLEASE BAMHI COMPLEX WITH DNA AND CALCIUM IONS (PRE-REACTIVE COMPLEX).;2;CA;CALCIUM ION;PROTEIN (ENDONUCLEASE BAMHI);1390;
2BAT;A;THE STRUCTURE OF THE COMPLEX BETWEEN INFLUENZA VIRUS NEURAMINIDASE AND SIALIC ACID, THE VIRAL RECEPTOR;2;CA;CALCIUM ION;NEURAMINIDASE N2;11320;
2BAX;A;Atomic Resolution Structure of the Double Mutant (K53,56M) of Bovine Pancreatic Phospholipase A2;1.1;CA;CALCIUM ION;Phospholipase A2;9913;
2BB4;A;Porcine pancreatic elastase complexed with beta-casomorphin-7 and Asp-Phe at pH 5.0;1.6;CA;CALCIUM ION;Elastase-1;9823;
2BBM;A;SOLUTION STRUCTURE OF A CALMODULIN-TARGET PEPTIDE COMPLEX BY MULTIDIMENSIONAL NMR;;CA;CALCIUM ION;CALMODULIN;7227;
2BBN;A;SOLUTION STRUCTURE OF A CALMODULIN-TARGET PEPTIDE COMPLEX BY MULTIDIMENSIONAL NMR;;CA;CALCIUM ION;CALMODULIN;7227;
2BBV;A;THE REFINED THREE-DIMENSIONAL STRUCTURE OF AN INSECT VIRUS AT 2.8 ANGSTROMS RESOLUTION;2.8;CA;CALCIUM ION;PROTEIN (BLACK BEETLE VIRUS CAPSID PROTEIN);12285;
2BBV;B;THE REFINED THREE-DIMENSIONAL STRUCTURE OF AN INSECT VIRUS AT 2.8 ANGSTROMS RESOLUTION;2.8;CA;CALCIUM ION;PROTEIN (BLACK BEETLE VIRUS CAPSID PROTEIN);12285;
2BBV;C;THE REFINED THREE-DIMENSIONAL STRUCTURE OF AN INSECT VIRUS AT 2.8 ANGSTROMS RESOLUTION;2.8;CA;CALCIUM ION;PROTEIN (BLACK BEETLE VIRUS CAPSID PROTEIN);12285;
2BCH;A;A possible of Second calcium ion in interfacial binding: Atomic and Medium resolution crystal structures of the quadruple mutant of phospholipase A2;1.1;CA;CALCIUM ION;Phospholipase A2;9913;
2BCX;A;Crystal structure of calmodulin in complex with a ryanodine receptor peptide;2;CA;CALCIUM ION;Calmodulin;9031;
2BD1;A;A possible role of the second calcium ion in interfacial binding: Atomic and medium resolution crystal structures of the quadruple mutant of phospholipase A2;1.9;CA;CALCIUM ION;Phospholipase A2;9913;
2BD1;B;A possible role of the second calcium ion in interfacial binding: Atomic and medium resolution crystal structures of the quadruple mutant of phospholipase A2;1.9;CA;CALCIUM ION;Phospholipase A2;9913;
2BD2;A;Porcine pancreatic elastase complexed with beta-casomorphin-7 and Arg-Phe at pH 5.0;1.7;CA;CALCIUM ION;Elastase-1;9823;
2BD3;A;Porcine pancreatic elastase complexed with beta-casomorphin-7 and Lys-Ala-NH2 at pH 5.0;1.6;CA;CALCIUM ION;Elastase-1;9823;
2BD4;A;Porcine pancreatic elastase complexed with beta-casomorphin-7 and Lys-Ser at pH 5.0;1.7;CA;CALCIUM ION;Elastase-1;9823;
2BD5;A;Porcine pancreatic elastase complexed with beta-casomorphin-7 and Lys-Ser at pH 5 and immersed in pH 9 buffer for 30 seconds;1.8;CA;CALCIUM ION;Elastase-1;9823;
2BD7;A;Porcine pancreatic elastase complexed with beta-casomorphin-7 and Arg-Phe at pH 5.0 (50 min soak);1.6;CA;CALCIUM ION;Elastase-1;9823;
2BD8;A;Porcine pancreatic elastase complexed with beta-casomorphin-7 and Arg-Phe at pH 5.0 (50 min soak) and immersed in pH 9 buffer for 30 seconds;1.7;CA;CALCIUM ION;Elastase-1;9823;
2BD9;A;Porcine pancreatic elastase complexed with beta-casomorphin-7 and Arg-Phe at pH 5.0 (50 min soak) and immersed in pH 9 buffer for 28 seconds (2nd pH jump);1.9;CA;CALCIUM ION;Elastase-1;9823;
2BDA;A;Porcine pancreatic elastase complexed with N-acetyl-NPI and Ala-Ala at pH 5.0;1.8;CA;CALCIUM ION;Elastase-1;9823;
2BDB;A;Porcine pancreatic elastase complexed with Asn-Pro-Ile and Ala-Ala at pH 5.0;1.7;CA;CALCIUM ION;Elastase-1;9823;
2BDC;A;Porcine pancreatic elastase complexed with Asn-Pro-Ile at pH 5.0;1.8;CA;CALCIUM ION;Elastase-1;9823;
2BE6;A;2.0 A crystal structure of the CaV1.2 IQ domain-Ca/CaM complex;2;CA;CALCIUM ION;Calmodulin 2;9606;
2BE6;B;2.0 A crystal structure of the CaV1.2 IQ domain-Ca/CaM complex;2;CA;CALCIUM ION;Calmodulin 2;9606;
2BE6;C;2.0 A crystal structure of the CaV1.2 IQ domain-Ca/CaM complex;2;CA;CALCIUM ION;Calmodulin 2;9606;
2BF0;X;crystal structure of the rpr of pcf11;2.3;CA;CALCIUM ION;PCF11;4932;
2BF6;A;Atomic Resolution Structure of the bacterial sialidase NanI from Clostridium perfringens in complex with alpha-Sialic Acid (Neu5Ac).;0.97;CA;CALCIUM ION;EXO-ALPHA-SIALIDASE;1502;
2BFN;A;The crystal structure of the complex of the haloalkane dehalogenase LinB with the product of dehalogenation reaction 1,2-dichloropropane.;1.6;CA;CALCIUM ION;HALOGENALKANE DEHALOGENASE;13689;
2BH1;A;X-ray structure of the general secretion pathway complex of the N- terminal domain of EpsE and the cytosolic domain of EpsL of Vibrio cholerae;2.4;CA;CALCIUM ION;GENERAL SECRETION PATHWAY PROTEIN L;666;
2BIB;A;Crystal structure of the complete modular teichioic acid phosphorylcholine esterase Pce (CbpE) from Streptococcus pneumoniae;1.92;CA;CALCIUM ION;TEICHOIC ACID PHOSPHORYLCHOLINE ESTERASE/ CHOLINE BINDING PROTEIN;1313;
2BIR;A;ADDITIVITY OF SUBSTRATE BINDING IN RIBONUCLEASE T1 (Y42A MUTANT);2.3;CA;CALCIUM ION;RIBONUCLEASE T1;5062;
2BKH;B;Myosin VI nucleotide-free (MDInsert2) crystal structure;2.4;CA;CALCIUM ION;CALMODULIN;7227;
2BKI;B;Myosin VI nucleotide-free (MDinsert2-IQ) crystal structure;2.9;CA;CALCIUM ION;CALMODULIN;9031;
2BKO;A;STRUCTURE ANALYSIS OF UNKNOWN FUNCTION PROTEIN;1.9;CA;CALCIUM ION;HYPOTHETICAL PROTEIN PH0236;53953;
2BL0;B;Physarum polycephalum myosin II regulatory domain;1.75;CA;CALCIUM ION;MYOSIN REGULATORY LIGHT CHAIN;5791;
2BL0;C;Physarum polycephalum myosin II regulatory domain;1.75;CA;CALCIUM ION;MYOSIN REGULATORY LIGHT CHAIN;5791;
2BLO;A;Elastase before a high dose x-ray 'burn';1.33;CA;CALCIUM ION;ELASTASE 1;9823;
2BLQ;A;Elastase After A High Dose X-Ray 'Burn';1.33;CA;CALCIUM ION;ELASTASE 1;9823;
2BLV;A;Trypsin before a high dose x-ray 'burn';1.2;CA;CALCIUM ION;TRYPSIN;9913;
2BLW;A;Trypsin after a high dose X-ray 'Burn';1.2;CA;CALCIUM ION;TRYPSIN;9913;
2BMG;B;Crystal structure of factor Xa in complex with 50;2.7;CA;CALCIUM ION;COAGULATION FACTOR X;9606;
2BNG;B;Structure of an M.tuberculosis LEH-like epoxide hydrolase;2.5;CA;CALCIUM ION;MB2760;1773;
2BO2;A;EGF Domains 1,2,5 of human EMR2, a 7-TM immune system molecule, in complex with calcium.;2.6;CA;CALCIUM ION;EGF-LIKE MODULE CONTAINING MUCIN-LIKE HORMONE RECEPTOR-LIKE 2 PRECURSOR;9606;
2BO2;B;EGF Domains 1,2,5 of human EMR2, a 7-TM immune system molecule, in complex with calcium.;2.6;CA;CALCIUM ION;EGF-LIKE MODULE CONTAINING MUCIN-LIKE HORMONE RECEPTOR-LIKE 2 PRECURSOR;9606;
2BOH;A;Crystal structure of factor Xa in complex with compound '1';2.2;CA;CALCIUM ION;COAGULATION FACTOR XA;9606;
2BOI;A;1.1A Structure of Chromobacterium Violaceum Lectin CV2L in Complex with alpha-methyl-fucoside;1.1;CA;CALCIUM ION;CV-IIL LECTIN;536;
2BOI;B;1.1A Structure of Chromobacterium Violaceum Lectin CV2L in Complex with alpha-methyl-fucoside;1.1;CA;CALCIUM ION;CV-IIL LECTIN;536;
2BOJ;A;crystal Structure of pseudomonas aeruginosa lectin (PA-IIL) complexed with methyl-B-D-Arabinopyranoside;1.8;CA;CALCIUM ION;PSEUDOMONAS AERUGINOSA LECTIN II;287;
2BOJ;B;crystal Structure of pseudomonas aeruginosa lectin (PA-IIL) complexed with methyl-B-D-Arabinopyranoside;1.8;CA;CALCIUM ION;PSEUDOMONAS AERUGINOSA LECTIN II;287;
2BOJ;C;crystal Structure of pseudomonas aeruginosa lectin (PA-IIL) complexed with methyl-B-D-Arabinopyranoside;1.8;CA;CALCIUM ION;PSEUDOMONAS AERUGINOSA LECTIN II;287;
2BOJ;D;crystal Structure of pseudomonas aeruginosa lectin (PA-IIL) complexed with methyl-B-D-Arabinopyranoside;1.8;CA;CALCIUM ION;PSEUDOMONAS AERUGINOSA LECTIN II;287;
2BOQ;A;Crystal structure of versatile peroxidase;1.33;CA;CALCIUM ION;VERSATILE PEROXIDASE VPL2;5323;
2BOU;A;EGF Domains 1,2,5 of human EMR2, a 7-TM immune system molecule, in complex with barium.;1.9;CA;CALCIUM ION;EGF-LIKE MODULE CONTAINING MUCIN-LIKE HORMONE RECEPTOR-LIKE 2 PRECURSOR;9606;
2BP6;A;crystal Structure of pseudomonas aeruginosa lectin (PA-IIL) complexed with a-L-Galactopyranoside;1.5;CA;CALCIUM ION;PSEUDOMONAS AERUGINOSA LECTIN II;287;
2BP6;B;crystal Structure of pseudomonas aeruginosa lectin (PA-IIL) complexed with a-L-Galactopyranoside;1.5;CA;CALCIUM ION;PSEUDOMONAS AERUGINOSA LECTIN II;287;
2BP6;C;crystal Structure of pseudomonas aeruginosa lectin (PA-IIL) complexed with a-L-Galactopyranoside;1.5;CA;CALCIUM ION;PSEUDOMONAS AERUGINOSA LECTIN II;287;
2BP6;D;crystal Structure of pseudomonas aeruginosa lectin (PA-IIL) complexed with a-L-Galactopyranoside;1.5;CA;CALCIUM ION;PSEUDOMONAS AERUGINOSA LECTIN II;287;
2BPE;A;STRUCTURE OF MURINE DECTIN-1;2.25;CA;CALCIUM ION;DECTIN-1;10090;
2BPE;B;STRUCTURE OF MURINE DECTIN-1;2.25;CA;CALCIUM ION;DECTIN-1;10090;
2BPP;A;PHOSPHOLIPASE A2 ENGINEERING. X-RAY STRUCTURAL AND FUNCTIONAL EVIDENCE FOR THE INTERACTION OF LYSINE-56 WITH SUBSTRATES;1.8;CA;CALCIUM ION;PHOSPHOLIPASE A2;9913;
2BQ3;A;DNA Adduct Bypass Polymerization by Sulfolobus solfataricus Dpo4. Analysis and Crystal Structures of Multiple Base-Pair Substitution and Frameshift Products with the Adduct 1,N2-Ethenoguanine;2;CA;CALCIUM ION;DNA POLYMERASE IV;2287;
2BQ4;A;Crystal structure of type I cytochrome c3 from Desulfovibrio africanus;1.68;CA;CALCIUM ION;BASIC CYTOCHROME C3;873;
2BQ4;B;Crystal structure of type I cytochrome c3 from Desulfovibrio africanus;1.68;CA;CALCIUM ION;BASIC CYTOCHROME C3;873;
2BQ6;B;Crystal structure of factor Xa in complex with 21;3;CA;CALCIUM ION;FACTOR XA;9606;
2BQ7;B;Crystal structure of factor Xa in complex with 43;2.2;CA;CALCIUM ION;FACTOR XA;9606;
2BQP;A;THE STRUCTURE OF THE PEA LECTIN-D-GLUCOPYRANOSE COMPLEX;1.9;CA;CALCIUM ION;PROTEIN (PEA LECTIN);3888;
2BQP;B;THE STRUCTURE OF THE PEA LECTIN-D-GLUCOPYRANOSE COMPLEX;1.9;CA;CALCIUM ION;PROTEIN (PEA LECTIN);3888;
2BQR;A;DNA Adduct Bypass Polymerization by Sulfolobus solfataricus Dpo4. Analysis and Crystal Structures of Multiple Base-Pair Substitution and Frameshift Products with the Adduct 1,N2-Ethenoguanine;2.37;CA;CALCIUM ION;DNA POLYMERASE IV;2287;
2BQU;A;DNA Adduct Bypass Polymerization by Sulfolobus solfataricus Dpo4. Analysis and Crystal Structures of Multiple Base-Pair Substitution and Frameshift Products with the Adduct 1,N2-Ethenoguanine;2.5;CA;CALCIUM ION;DNA POLYMERASE IV;2287;
2BQW;B;CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH COMPOUND 45;2.95;CA;CALCIUM ION;FACTOR XA;9606;
2BR0;A;DNA Adduct Bypass Polymerization by Sulfolobus solfataricus Dpo4. Analysis and Crystal Structures of Multiple Base-Pair Substitution and Frameshift Products with the Adduct 1,N2-Ethenoguanine;2.17;CA;CALCIUM ION;DNA POLYMERASE IV;2287;
2BS9;A;Native crystal structure of a GH39 beta-xylosidase XynB1 from Geobacillus stearothermophilus;2.2;CA;CALCIUM ION;BETA-XYLOSIDASE;1422;
2BS9;C;Native crystal structure of a GH39 beta-xylosidase XynB1 from Geobacillus stearothermophilus;2.2;CA;CALCIUM ION;BETA-XYLOSIDASE;1422;
2BS9;D;Native crystal structure of a GH39 beta-xylosidase XynB1 from Geobacillus stearothermophilus;2.2;CA;CALCIUM ION;BETA-XYLOSIDASE;1422;
2BS9;E;Native crystal structure of a GH39 beta-xylosidase XynB1 from Geobacillus stearothermophilus;2.2;CA;CALCIUM ION;BETA-XYLOSIDASE;1422;
2BS9;F;Native crystal structure of a GH39 beta-xylosidase XynB1 from Geobacillus stearothermophilus;2.2;CA;CALCIUM ION;BETA-XYLOSIDASE;1422;
2BS9;G;Native crystal structure of a GH39 beta-xylosidase XynB1 from Geobacillus stearothermophilus;2.2;CA;CALCIUM ION;BETA-XYLOSIDASE;1422;
2BS9;H;Native crystal structure of a GH39 beta-xylosidase XynB1 from Geobacillus stearothermophilus;2.2;CA;CALCIUM ION;BETA-XYLOSIDASE;1422;
2BSP;A;BACILLUS SUBTILIS PECTATE LYASE R279K MUTANT;1.8;CA;CALCIUM ION;PROTEIN (PECTATE LYASE);1423;
2BTC;E;BOVINE TRYPSIN IN COMPLEX WITH SQUASH SEED INHIBITOR (CUCURBITA PEPO TRYPSIN INHIBITOR II);1.5;CA;CALCIUM ION;PROTEIN (TRYPSIN);9913;
2BTW;A;Crystal structure of Alr0975;2;CA;CALCIUM ION;ALR0975 PROTEIN;103690;
2BTW;B;Crystal structure of Alr0975;2;CA;CALCIUM ION;ALR0975 PROTEIN;103690;
2BU3;A;Acyl-enzyme intermediate between Alr0975 and glutathione at pH 3.4;1.4;CA;CALCIUM ION;ALR0975 PROTEIN;1167;
2BU3;B;Acyl-enzyme intermediate between Alr0975 and glutathione at pH 3.4;1.4;CA;CALCIUM ION;ALR0975 PROTEIN;1167;
2BU4;A;RIBONUCLEASE T1 COMPLEX WITH 2'GMP;1.95;CA;CALCIUM ION;PROTEIN (RIBONUCLEASE T1);5062;
2BUE;A;Structure of AAC(6')-Ib in complex with Ribostamycin and Coenzyme A.;1.7;CA;CALCIUM ION;AAC(6')-IB;562;
2BUK;A;SATELLITE TOBACCO NECROSIS VIRUS;2.45;CA;CALCIUM ION;COAT PROTEIN;12054;
2BV2;A;beta gamma crystallin from Ciona Intestinalis;1.55;CA;CALCIUM ION;CIONA BETAGAMMA-CRYSTALLIN;7719;
2BV2;B;beta gamma crystallin from Ciona Intestinalis;1.55;CA;CALCIUM ION;CIONA BETAGAMMA-CRYSTALLIN;7719;
2BV4;A;1.0A Structure of Chromobacterium Violaceum Lectin in Complex with alpha-methyl-mannoside;1;CA;CALCIUM ION;LECTIN CV-IIL;536;
2BV4;B;1.0A Structure of Chromobacterium Violaceum Lectin in Complex with alpha-methyl-mannoside;1;CA;CALCIUM ION;LECTIN CV-IIL;536;
2BW1;K;Iron-bound crystal structure of Dps-like peroxide resistance protein (Dpr) from Streptococcus suis.;1.81;CA;CALCIUM ION;DPS-LIKE PEROXIDE RESISTANCE PROTEIN;1307;
2BW7;A;A novel mechanism for adenylyl cyclase inhibition from the crystal structure of its complex with catechol estrogen;2.3;CA;CALCIUM ION;ADENYLATE CYCLASE;118562;
2BW7;B;A novel mechanism for adenylyl cyclase inhibition from the crystal structure of its complex with catechol estrogen;2.3;CA;CALCIUM ION;ADENYLATE CYCLASE;118562;
2BW7;C;A novel mechanism for adenylyl cyclase inhibition from the crystal structure of its complex with catechol estrogen;2.3;CA;CALCIUM ION;ADENYLATE CYCLASE;118562;
2BW7;D;A novel mechanism for adenylyl cyclase inhibition from the crystal structure of its complex with catechol estrogen;2.3;CA;CALCIUM ION;ADENYLATE CYCLASE;118562;
2BWM;A;1.8A CRYSTAL STRUCTURE OF of Psathyrella velutina LECTIN IN COMPLEX WITH METHYL 2-ACETAMIDO-1,2-DIDEOXY-1-SELENO-BETA-D-GLUCOPYRANOSIDE;1.8;CA;CALCIUM ION;PSATHYRELLA VELUTINA LECTIN PVL;71681;
2BWR;A;Crystal Structure of Psathyrella Velutina Lectin at 1.5A Resolution;1.5;CA;CALCIUM ION;PSATHYRELLA VELUTINA LECTIN;71681;
2BWR;B;Crystal Structure of Psathyrella Velutina Lectin at 1.5A Resolution;1.5;CA;CALCIUM ION;PSATHYRELLA VELUTINA LECTIN;71681;
2BY5;X;Is radiation damage dependent on the dose-rate used during macromolecular crystallography data collection;1.3;CA;CALCIUM ION;CATIONIC TRYPSIN;9913;
2BY6;X;Is radiation damage dependent on the dose-rate used during macromolecular crystallography data collection;1.3;CA;CALCIUM ION;CATIONIC TRYPSIN;9913;
2BY7;X;Is radiation damage dependent on the dose-rate used during macromolecular crystallography data collection;1.3;CA;CALCIUM ION;CATIONIC TRYPSIN;9913;
2BY8;X;Is radiation damage dependent on the dose-rate used during macromolecular crystallography data collection;1.3;CA;CALCIUM ION;CATIONIC TRYPSIN;9913;
2BY9;X;Is radiation damage dependent on the dose-rate used during macromolecular crystallography data collection;1.3;CA;CALCIUM ION;CATIONIC TRYPSIN;9913;
2BYA;X;Is radiation damage dependent on the dose-rate used during macromolecular crystallography data collection;1.3;CA;CALCIUM ION;CATIONIC TRYPSIN;9913;
2BZ6;H;Orally available Factor7a inhibitor;1.6;CA;CALCIUM ION;BLOOD COAGULATION FACTOR VIIA;9606;
2BZA;A;BOVINE PANCREAS BETA-TRYPSIN IN COMPLEX WITH BENZYLAMINE;1.9;CA;CALCIUM ION;PROTEIN (TRYPSIN);9913;
2C04;A;GMPPCP complex of SRP GTPase Ffh NG Domain at ultra-high resolution;1.15;CA;CALCIUM ION;SIGNAL RECOGNITION PARTICLE PROTEIN;271;
2C0I;A;Src family kinase Hck with bound inhibitor A-420983;2.3;CA;CALCIUM ION;TYROSINE-PROTEIN KINASE HCK;9606;
2C0I;B;Src family kinase Hck with bound inhibitor A-420983;2.3;CA;CALCIUM ION;TYROSINE-PROTEIN KINASE HCK;9606;
2C0O;A;Src family kinase Hck with bound inhibitor A-770041;2.85;CA;CALCIUM ION;TYROSINE-PROTEIN KINASE HCK;9606;
2C0O;B;Src family kinase Hck with bound inhibitor A-770041;2.85;CA;CALCIUM ION;TYROSINE-PROTEIN KINASE HCK;9606;
2C0T;A;Src family kinase Hck with bound inhibitor A-641359;2.15;CA;CALCIUM ION;TYROSINE-PROTEIN KINASE HCK;9606;
2C0T;B;Src family kinase Hck with bound inhibitor A-641359;2.15;CA;CALCIUM ION;TYROSINE-PROTEIN KINASE HCK;9606;
2C10;A;The structure of a truncated, soluble version of semicarbazide- sensitive amine oxidase;2.5;CA;CALCIUM ION;MEMBRANE COPPER AMINE OXIDASE;9606;
2C10;B;The structure of a truncated, soluble version of semicarbazide- sensitive amine oxidase;2.5;CA;CALCIUM ION;MEMBRANE COPPER AMINE OXIDASE;9606;
2C10;C;The structure of a truncated, soluble version of semicarbazide- sensitive amine oxidase;2.5;CA;CALCIUM ION;MEMBRANE COPPER AMINE OXIDASE;9606;
2C10;D;The structure of a truncated, soluble version of semicarbazide- sensitive amine oxidase;2.5;CA;CALCIUM ION;MEMBRANE COPPER AMINE OXIDASE;9606;
2C11;A;Crystal structure of the 2-hydrazinopyridine of semicarbazide- sensitive amine oxidase;2.9;CA;CALCIUM ION;MEMBRANE COPPER AMINE OXIDASE;9606;
2C11;B;Crystal structure of the 2-hydrazinopyridine of semicarbazide- sensitive amine oxidase;2.9;CA;CALCIUM ION;MEMBRANE COPPER AMINE OXIDASE;9606;
2C11;C;Crystal structure of the 2-hydrazinopyridine of semicarbazide- sensitive amine oxidase;2.9;CA;CALCIUM ION;MEMBRANE COPPER AMINE OXIDASE;9606;
2C11;D;Crystal structure of the 2-hydrazinopyridine of semicarbazide- sensitive amine oxidase;2.9;CA;CALCIUM ION;MEMBRANE COPPER AMINE OXIDASE;9606;
2C1U;A;CRYSTAL STRUCTURE OF THE DI-HAEM CYTOCHROME C PEROXIDASE FROM PARACOCCUS PANTOTROPHUS - OXIDISED FORM;1.95;CA;CALCIUM ION;DI-HAEM CYTOCHROME C PEROXIDASE;82367;
2C1U;B;CRYSTAL STRUCTURE OF THE DI-HAEM CYTOCHROME C PEROXIDASE FROM PARACOCCUS PANTOTROPHUS - OXIDISED FORM;1.95;CA;CALCIUM ION;DI-HAEM CYTOCHROME C PEROXIDASE;82367;
2C1U;C;CRYSTAL STRUCTURE OF THE DI-HAEM CYTOCHROME C PEROXIDASE FROM PARACOCCUS PANTOTROPHUS - OXIDISED FORM;1.95;CA;CALCIUM ION;DI-HAEM CYTOCHROME C PEROXIDASE;82367;
2C1U;D;CRYSTAL STRUCTURE OF THE DI-HAEM CYTOCHROME C PEROXIDASE FROM PARACOCCUS PANTOTROPHUS - OXIDISED FORM;1.95;CA;CALCIUM ION;DI-HAEM CYTOCHROME C PEROXIDASE;82367;
2C1V;A;CRYSTAL STRUCTURE OF THE DI-HAEM CYTOCHROME C PEROXIDASE FROM PARACOCCUS PANTOTROPHUS - Mixed VALENCE FORM;1.2;CA;CALCIUM ION;DI-HAEM CYTOCHROME C PEROXIDASE;82367;
2C1V;B;CRYSTAL STRUCTURE OF THE DI-HAEM CYTOCHROME C PEROXIDASE FROM PARACOCCUS PANTOTROPHUS - Mixed VALENCE FORM;1.2;CA;CALCIUM ION;DI-HAEM CYTOCHROME C PEROXIDASE;82367;
2C22;A;Efficient and High Fidelity Incorporation of dCTP Opposite 7,8- Dihydro-8-oxodeoxyguanosine by Sulfolobus solfataricus DNA Polymerase Dpo4;2.56;CA;CALCIUM ION;DNA POLYMERASE IV;2287;
2C25;A;1.8A Crystal Structure of Psathyrella velutina lectin in complex with N-acetylneuraminic acid;1.8;CA;CALCIUM ION;PSATHYRELLA VELUTINA LECTIN PVL;71681;
2C25;B;1.8A Crystal Structure of Psathyrella velutina lectin in complex with N-acetylneuraminic acid;1.8;CA;CALCIUM ION;PSATHYRELLA VELUTINA LECTIN PVL;71681;
2C26;A;Structural basis for the promiscuous specificity of the carbohydrate- binding modules from the beta-sandwich super family;2.1;CA;CALCIUM ION;ENDOGLUCANASE;1515;
2C28;A;Efficient and High Fidelity Incorporation of dCTP Opposite 7,8- Dihydro-8-oxodeoxyguanosine by Sulfolobus solfataricus DNA Polymerase Dpo4;2.27;CA;CALCIUM ION;DNA POLYMERASE IV;2287;
2C2D;A;Efficient and High Fidelity Incorporation of dCTP Opposite 7,8- Dihydro-8-oxodeoxyguanosine by Sulfolobus solfataricus DNA Polymerase Dpo4;2.57;CA;CALCIUM ION;DNA POLYMERASE IV;2287;
2C2E;A;Efficient and High Fidelity Incorporation of dCTP Opposite 7,8- Dihydro-8-oxodeoxyguanosine by Sulfolobus solfataricus DNA Polymerase Dpo4;2.61;CA;CALCIUM ION;DNA POLYMERASE IV;2287;
2C2H;A;CRYSTAL STRUCTURE OF THE HUMAN RAC3 IN COMPLEX WITH GDP;1.85;CA;CALCIUM ION;RAS-RELATED C3 BOTULINUM TOXIN SUBSTRATE 3;9606;
2C2H;B;CRYSTAL STRUCTURE OF THE HUMAN RAC3 IN COMPLEX WITH GDP;1.85;CA;CALCIUM ION;RAS-RELATED C3 BOTULINUM TOXIN SUBSTRATE 3;9606;
2C2R;A;Efficient and High Fidelity Incorporation of dCTP Opposite 7,8- Dihydro-8-oxodeoxyguanosine by Sulfolobus solfataricus DNA Polymerase Dpo4;2.55;CA;CALCIUM ION;DNA POLYMERASE IV;2287;
2C3M;A;Crystal Structure Of Pyruvate-Ferredoxin Oxidoreductase From Desulfovibrio africanus;1.84;CA;CALCIUM ION;PYRUVATE-FERREDOXIN OXIDOREDUCTASE;873;
2C3M;B;Crystal Structure Of Pyruvate-Ferredoxin Oxidoreductase From Desulfovibrio africanus;1.84;CA;CALCIUM ION;PYRUVATE-FERREDOXIN OXIDOREDUCTASE;873;
2C3O;A;CRYSTAL STRUCTURE OF THE FREE RADICAL INTERMEDIATE OF PYRUVATE:FERREDOXIN OXIDOREDUCTASE FROM Desulfovibrio africanus;2.7;CA;CALCIUM ION;PYRUVATE-FERREDOXIN OXIDOREDUCTASE;873;
2C3O;B;CRYSTAL STRUCTURE OF THE FREE RADICAL INTERMEDIATE OF PYRUVATE:FERREDOXIN OXIDOREDUCTASE FROM Desulfovibrio africanus;2.7;CA;CALCIUM ION;PYRUVATE-FERREDOXIN OXIDOREDUCTASE;873;
2C3P;A;CRYSTAL STRUCTURE OF THE FREE RADICAL INTERMEDIATE OF PYRUVATE:FERREDOXIN OXIDOREDUCTASE FROM Desulfovibrio africanus;2.33;CA;CALCIUM ION;PYRUVATE-FERREDOXIN OXIDOREDUCTASE;873;
2C3P;B;CRYSTAL STRUCTURE OF THE FREE RADICAL INTERMEDIATE OF PYRUVATE:FERREDOXIN OXIDOREDUCTASE FROM Desulfovibrio africanus;2.33;CA;CALCIUM ION;PYRUVATE-FERREDOXIN OXIDOREDUCTASE;873;
2C3U;A;Crystal Structure Of Pyruvate-Ferredoxin Oxidoreductase From Desulfovibrio africanus, Oxygen inhibited form;2.32;CA;CALCIUM ION;PYRUVATE-FERREDOXIN OXIDOREDUCTASE;873;
2C3U;B;Crystal Structure Of Pyruvate-Ferredoxin Oxidoreductase From Desulfovibrio africanus, Oxygen inhibited form;2.32;CA;CALCIUM ION;PYRUVATE-FERREDOXIN OXIDOREDUCTASE;873;
2C3Y;A;CRYSTAL STRUCTURE OF THE RADICAL FORM OF PYRUVATE:FERREDOXIN OXIDOREDUCTASE FROM Desulfovibrio africanus;1.93;CA;CALCIUM ION;PYRUVATE-FERREDOXIN OXIDOREDUCTASE;873;
2C3Y;B;CRYSTAL STRUCTURE OF THE RADICAL FORM OF PYRUVATE:FERREDOXIN OXIDOREDUCTASE FROM Desulfovibrio africanus;1.93;CA;CALCIUM ION;PYRUVATE-FERREDOXIN OXIDOREDUCTASE;873;
2C40;A;CRYSTAL STRUCTURE OF INOSINE-URIDINE PREFERRING NUCLEOSIDE HYDROLASE FROM BACILLUS ANTHRACIS AT 2.2A RESOLUTION;2.2;CA;CALCIUM ION;INOSINE-URIDINE PREFERRING NUCLEOSIDE HYDROLASE FAMILY PROTEIN;1392;
2C40;B;CRYSTAL STRUCTURE OF INOSINE-URIDINE PREFERRING NUCLEOSIDE HYDROLASE FROM BACILLUS ANTHRACIS AT 2.2A RESOLUTION;2.2;CA;CALCIUM ION;INOSINE-URIDINE PREFERRING NUCLEOSIDE HYDROLASE FAMILY PROTEIN;1392;
2C42;A;Crystal Structure Of Pyruvate-Ferredoxin Oxidoreductase From Desulfovibrio africanus;1.78;CA;CALCIUM ION;PYRUVATE-FERREDOXIN OXIDOREDUCTASE;873;
2C42;B;Crystal Structure Of Pyruvate-Ferredoxin Oxidoreductase From Desulfovibrio africanus;1.78;CA;CALCIUM ION;PYRUVATE-FERREDOXIN OXIDOREDUCTASE;873;
2C4A;A;Structure of Neuraminidase Subtype N9 Complexed with 30 MM Sialic Acid (NANA, NEU5AC), Crystal Soaked for 3 Hours at 291 K.;2.15;CA;CALCIUM ION;NEURAMINIDASE SUBTYPE N9;11320;
2C4D;A;2.6A Crystal Structure of Psathyrella velutina Lectin in Complex with N-acetylglucosamine;2.6;CA;CALCIUM ION;PSATHYRELLA VELUTINA LECTIN PVL;71681;
2C4F;H;crystal structure of factor VII.stf complexed with pd0297121;1.72;CA;CALCIUM ION;COAGULATION FACTOR VII PRECURSOR;9606;
2C4F;L;crystal structure of factor VII.stf complexed with pd0297121;1.72;CA;CALCIUM ION;COAGULATION FACTOR VII PRECURSOR;9606;
2C4L;A;Structure of Neuraminidase Subtype N9 Complexed with 30 MM Sialic Acid (NANA, NEU5AC), Crystal Soaked for 24 Hours at 291 K and Finally Backsoaked for 30 Min in a Cryoprotectant Solution which did not contain NEU5AC;2.15;CA;CALCIUM ION;NEURAMINIDASE SUBTYPE N9;11320;
2C4X;A;Structural basis for the promiscuous specificity of the carbohydrate- binding modules from the beta-sandwich super family;2;CA;CALCIUM ION;ENDOGLUCANASE;1515;
2C5D;A;Structure of a minimal Gas6-Axl complex;3.3;CA;CALCIUM ION;GROWTH-ARREST-SPECIFIC PROTEIN 6 PRECURSOR;9606;
2C5D;B;Structure of a minimal Gas6-Axl complex;3.3;CA;CALCIUM ION;GROWTH-ARREST-SPECIFIC PROTEIN 6 PRECURSOR;9606;
2C5U;A;T4 RNA Ligase (Rnl1) Crystal Structure;2.21;CA;CALCIUM ION;RNA LIGASE;10665;
2C5U;B;T4 RNA Ligase (Rnl1) Crystal Structure;2.21;CA;CALCIUM ION;RNA LIGASE;10665;
2C60;A;crystal structure of human mitogen-activated protein kinase kinase kinase 3 isoform 2 phox domain at 1.25 A resolution;1.25;CA;CALCIUM ION;HUMAN MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 3 ISOFORM 2;9606;
2C6C;A;membrane-bound glutamate carboxypeptidase II (GCPII) in complex with GPI-18431 (S)-2-(4-iodobenzylphosphonomethyl)-pentanedioic acid;2;CA;CALCIUM ION;GLUTAMATE CARBOXYPEPTIDASE II;9606;
2C6G;A;Membrane-bound glutamate carboxypeptidase II (GCPII) with bound glutamate;2.2;CA;CALCIUM ION;GLUTAMATE CARBOXYPEPTIDASE II;9606;
2C6P;A;Membrane-bound glutamate carboxypeptidase II (GCPII) in complex with phosphate anion;2.39;CA;CALCIUM ION;GLUTAMATE CARBOXYPEPTIDASE II;9606;
2C8S;A;CYTOCHROME CL FROM METHYLOBACTERIUM EXTORQUENS;1.6;CA;CALCIUM ION;CYTOCHROME C-L;408;
2C9M;A;Structure of (SR) Calcium-ATPase in the Ca2E1 state solved in a P1 crystal form.;3;CA;CALCIUM ION;SARCOPLASMIC/ENDOPLASMIC RETICULUM CALCIUM ATPASE 1;9986;
2C9M;B;Structure of (SR) Calcium-ATPase in the Ca2E1 state solved in a P1 crystal form.;3;CA;CALCIUM ION;SARCOPLASMIC/ENDOPLASMIC RETICULUM CALCIUM ATPASE 1;9986;
2CBL;A;N-TERMINAL DOMAIN OF CBL IN COMPLEX WITH ITS BINDING SITE ON ZAP-70;2.1;CA;CALCIUM ION;PROTO-ONCOGENE CBL;9606;
2CBU;B;Beta-glucosidase from Thermotoga maritima in complex with castanospermine;1.85;CA;CALCIUM ION;BETA-GLUCOSIDASE A;2336;
2CCL;B;THE S45A, T46A MUTANT OF THE TYPE I COHESIN-DOCKERIN COMPLEX FROM THE CELLULOSOME OF CLOSTRIDIUM THERMOCELLUM;2.03;CA;CALCIUM ION;ENDO-1,4-BETA-XYLANASE Y;1515;
2CCL;D;THE S45A, T46A MUTANT OF THE TYPE I COHESIN-DOCKERIN COMPLEX FROM THE CELLULOSOME OF CLOSTRIDIUM THERMOCELLUM;2.03;CA;CALCIUM ION;ENDO-1,4-BETA-XYLANASE Y;1515;
2CCM;A;X-ray structure of Calexcitin from Loligo pealeii at 1.8A;1.8;CA;CALCIUM ION;CALEXCITIN;1051067;
2CCM;B;X-ray structure of Calexcitin from Loligo pealeii at 1.8A;1.8;CA;CALCIUM ION;CALEXCITIN;1051067;
2CCR;A;Structure of Beta-1,4-Galactanase;2.3;CA;CALCIUM ION;YVFO;1402;
2CCR;B;Structure of Beta-1,4-Galactanase;2.3;CA;CALCIUM ION;YVFO;1402;
2CDO;A;structure of agarase carbohydrate binding module in complex with neoagarohexaose;1.64;CA;CALCIUM ION;BETA-AGARASE 1;86304;
2CDO;B;structure of agarase carbohydrate binding module in complex with neoagarohexaose;1.64;CA;CALCIUM ION;BETA-AGARASE 1;86304;
2CDO;C;structure of agarase carbohydrate binding module in complex with neoagarohexaose;1.64;CA;CALCIUM ION;BETA-AGARASE 1;86304;
2CDO;D;structure of agarase carbohydrate binding module in complex with neoagarohexaose;1.64;CA;CALCIUM ION;BETA-AGARASE 1;86304;
2CDP;A;Structure of a CBM6 in complex with neoagarohexaose;1.59;CA;CALCIUM ION;BETA-AGARASE 1;86304;
2CDP;B;Structure of a CBM6 in complex with neoagarohexaose;1.59;CA;CALCIUM ION;BETA-AGARASE 1;86304;
2CDP;C;Structure of a CBM6 in complex with neoagarohexaose;1.59;CA;CALCIUM ION;BETA-AGARASE 1;86304;
2CDP;D;Structure of a CBM6 in complex with neoagarohexaose;1.59;CA;CALCIUM ION;BETA-AGARASE 1;86304;
2CEL;A;ACTIVE-SITE MUTANT E212Q DETERMINED AT PH 6.0 WITH NO LIGAND BOUND IN THE ACTIVE SITE;2;CA;CALCIUM ION;1,4-BETA-D-GLUCAN CELLOBIOHYDROLASE I;51453;
2CEL;B;ACTIVE-SITE MUTANT E212Q DETERMINED AT PH 6.0 WITH NO LIGAND BOUND IN THE ACTIVE SITE;2;CA;CALCIUM ION;1,4-BETA-D-GLUCAN CELLOBIOHYDROLASE I;51453;
2CES;B;Beta-glucosidase from Thermotoga maritima in complex with glucoimidazole;2.15;CA;CALCIUM ION;BETA-GLUCOSIDASE A;2336;
2CET;B;Beta-glucosidase from Thermotoga maritima in complex with phenethyl- substituted glucoimidazole;1.97;CA;CALCIUM ION;BETA-GLUCOSIDASE A;2336;
2CF7;D;Asp74Ala mutant crystal structure for Dps-like peroxide resistance protein Dpr from Streptococcus suis.;1.5;CA;CALCIUM ION;DPR;1307;
2CF7;J;Asp74Ala mutant crystal structure for Dps-like peroxide resistance protein Dpr from Streptococcus suis.;1.5;CA;CALCIUM ION;DPR;1307;
2CF7;K;Asp74Ala mutant crystal structure for Dps-like peroxide resistance protein Dpr from Streptococcus suis.;1.5;CA;CALCIUM ION;DPR;1307;
2CF8;H;Complex of recombinant human thrombin with an inhibitor;1.3;CA;CALCIUM ION;THROMBIN HEAVY CHAIN;9606;
2CF9;H;Complex of recombinant human thrombin with an inhibitor;1.79;CA;CALCIUM ION;THROMBIN HEAVY CHAIN;9606;
2CFT;A;Crystal structure of human pyridoxal 5'-phosphate phosphatase with its substrate;1.8;CA;CALCIUM ION;PYRIDOXAL PHOSPHATE PHOSPHATASE;9606;
2CHH;A;RALSTONIA SOLANACEARUM HIGH-AFFINITY MANNOSE-BINDING LECTIN;1;CA;CALCIUM ION;PROTEIN RSC3288;305;
2CHI;A;Recombinant human H ferritin, K86Q and E27D mutant;1.6;CA;CALCIUM ION;FERRITIN HEAVY CHAIN;9606;
2CHN;A;Bacteroides thetaiotaomicron hexosaminidase with O-GlcNAcase activity- NAG-thiazoline complex;1.95;CA;CALCIUM ION;GLUCOSAMINIDASE;818;
2CHN;B;Bacteroides thetaiotaomicron hexosaminidase with O-GlcNAcase activity- NAG-thiazoline complex;1.95;CA;CALCIUM ION;GLUCOSAMINIDASE;818;
2CHO;A;Bacteroides thetaiotaomicron hexosaminidase with O-GlcNAcase activity;1.85;CA;CALCIUM ION;GLUCOSAMINIDASE;818;
2CHO;B;Bacteroides thetaiotaomicron hexosaminidase with O-GlcNAcase activity;1.85;CA;CALCIUM ION;GLUCOSAMINIDASE;818;
2CIJ;A;membrane-bound glutamate carboxypeptidase II (GCPII) with bound methionine;2.4;CA;CALCIUM ION;GLUTAMATE CARBOXYPEPTIDASE II;9606;
2CJI;A;Crystal structure of a Human Factor Xa inhibitor complex;2.1;CA;CALCIUM ION;ACTIVATED FACTOR XA HEAVY CHAIN;9606;
2CKI;A;Structure of Ulilysin, a member of the pappalysin family of metzincin metalloendopeptidases.;1.7;CA;CALCIUM ION;ULILYSIN;2214;
2CKI;B;Structure of Ulilysin, a member of the pappalysin family of metzincin metalloendopeptidases.;1.7;CA;CALCIUM ION;ULILYSIN;2214;
2CL8;A;Dectin-1 in complex with beta-glucan;2.8;CA;CALCIUM ION;DECTIN-1;10090;
2CL8;B;Dectin-1 in complex with beta-glucan;2.8;CA;CALCIUM ION;DECTIN-1;10090;
2CLP;A;Crystal structure of human aflatoxin B1 aldehyde reductase member 3;3;CA;CALCIUM ION;AFLATOXIN B1 ALDEHYDE REDUCTASE MEMBER 3;9606;
2CLP;C;Crystal structure of human aflatoxin B1 aldehyde reductase member 3;3;CA;CALCIUM ION;AFLATOXIN B1 ALDEHYDE REDUCTASE MEMBER 3;9606;
2CLP;E;Crystal structure of human aflatoxin B1 aldehyde reductase member 3;3;CA;CALCIUM ION;AFLATOXIN B1 ALDEHYDE REDUCTASE MEMBER 3;9606;
2CLP;G;Crystal structure of human aflatoxin B1 aldehyde reductase member 3;3;CA;CALCIUM ION;AFLATOXIN B1 ALDEHYDE REDUCTASE MEMBER 3;9606;
2CLT;A;Crystal structure of the active form (full-length) of human fibroblast collagenase.;2.67;CA;CALCIUM ION;INTERSTITIAL COLLAGENASE;9606;
2CLT;B;Crystal structure of the active form (full-length) of human fibroblast collagenase.;2.67;CA;CALCIUM ION;INTERSTITIAL COLLAGENASE;9606;
2CLU;A;Recombinant human H ferritin, K86Q and E107D mutant;2.1;CA;CALCIUM ION;FERRITIN HEAVY CHAIN;9606;
2CM3;A;Structure of Protein Tyrosine Phosphatase 1B (C2);2.1;CA;CALCIUM ION;TYROSINE-PROTEIN PHOSPHATASE NON-RECEPTOR TYPE 1;9606;
2CM3;B;Structure of Protein Tyrosine Phosphatase 1B (C2);2.1;CA;CALCIUM ION;TYROSINE-PROTEIN PHOSPHATASE NON-RECEPTOR TYPE 1;9606;
2CM5;A;crystal structure of the C2B domain of rabphilin;1.28;CA;CALCIUM ION;RABPHILIN-3A;10116;
2CM6;A;crystal structure of the C2B domain of rabphilin3A;1.85;CA;CALCIUM ION;RABPHILIN-3A;10116;
2CM6;B;crystal structure of the C2B domain of rabphilin3A;1.85;CA;CALCIUM ION;RABPHILIN-3A;10116;
2CML;A;Structure of Neuraminidase from English Duck Subtype N6 Complexed with 30 MM ZANAMIVIR, Crystal Soaked for 3 Hours at 291 K.;2.15;CA;CALCIUM ION;NEURAMINIDASE;11320;
2CML;B;Structure of Neuraminidase from English Duck Subtype N6 Complexed with 30 MM ZANAMIVIR, Crystal Soaked for 3 Hours at 291 K.;2.15;CA;CALCIUM ION;NEURAMINIDASE;11320;
2CML;C;Structure of Neuraminidase from English Duck Subtype N6 Complexed with 30 MM ZANAMIVIR, Crystal Soaked for 3 Hours at 291 K.;2.15;CA;CALCIUM ION;NEURAMINIDASE;11320;
2CML;D;Structure of Neuraminidase from English Duck Subtype N6 Complexed with 30 MM ZANAMIVIR, Crystal Soaked for 3 Hours at 291 K.;2.15;CA;CALCIUM ION;NEURAMINIDASE;11320;
2CMY;A;Crystal complex between bovine trypsin and Veronica hederifolia trypsin inhibitor;2.25;CA;CALCIUM ION;CATIONIC TRYPSIN;9913;
2CN0;H;Complex of Recombinant Human Thrombin with a Designed Inhibitor;1.3;CA;CALCIUM ION;PROTHROMBIN PRECURSOR;9606;
2CN3;A;Crystal Structures of Clostridium thermocellum Xyloglucanase;1.95;CA;CALCIUM ION;BETA-1,4-XYLOGLUCAN HYDROLASE;1515;
2CN3;B;Crystal Structures of Clostridium thermocellum Xyloglucanase;1.95;CA;CALCIUM ION;BETA-1,4-XYLOGLUCAN HYDROLASE;1515;
2CN6;A;Recombinant human H ferritin, K86Q and E107D mutant, soaked with Zn ions;2.2;CA;CALCIUM ION;FERRITIN HEAVY CHAIN;9606;
2CN7;A;Recombinant human H ferritin, K86Q, E27D and E107D mutant;1.75;CA;CALCIUM ION;FERRITIN HEAVY CHAIN;9606;
2CNA;A;THE COVALENT AND THREE-DIMENSIONAL STRUCTURE OF CONCANAVALIN A, IV.ATOMIC COORDINATES,HYDROGEN BONDING,AND QUATERNARY STRUCTURE;2;CA;CALCIUM ION;CONCANAVALIN A;3823;
2CNH;A;Structural Insights into the Design of Nonpeptidic Isothiazolidinone- Containing Inhibitors of Protein Tyrosine Phosphatase 1B;1.8;CA;CALCIUM ION;TYROSINE-PROTEIN PHOSPHATASE NON-RECEPTOR TYPE 1;9606;
2COL;B;Crystal structure analysis of CyaA/C-Cam with Pyrophosphate;2.2;CA;CALCIUM ION;Calmodulin;8355;
2CPU;A;SUBSITE MAPPING OF THE ACTIVE SITE OF HUMAN PANCREATIC ALPHA-AMYLASE USING SUBSTRATES, THE PHARMACOLOGICAL INHIBITOR ACARBOSE, AND AN ACTIVE SITE VARIANT;2;CA;CALCIUM ION;ALPHA-AMYLASE;9606;
2CT9;A;The crystal structure of calcineurin B homologous proein 1 (CHP1);2.2;CA;CALCIUM ION;Calcium-binding protein p22;10116;
2CT9;B;The crystal structure of calcineurin B homologous proein 1 (CHP1);2.2;CA;CALCIUM ION;Calcium-binding protein p22;10116;
2CTN;A;STRUCTURE OF CALCIUM-SATURATED CARDIAC TROPONIN C, NMR, 30 STRUCTURES;;CA;CALCIUM ION;TROPONIN C;9031;
2CTV;A;HIGH RESOLUTION CRYSTALLOGRAPHIC STUDIES OF NATIVE CONCANAVALIN A USING RAPID LAUE DATA COLLECTION METHODS AND THE INTRODUCTION OF A MONOCHROMATIC LARGE-ANGLE OSCILLATION TECHNIQUE (LOT);1.95;CA;CALCIUM ION;CONCANAVALIN A;3823;
2CWM;A;Native Crystal Structure of NO releasing inductive lectin from seeds of the Canavalia maritima (ConM);1.95;CA;CALCIUM ION;lectin;3825;
2CWM;D;Native Crystal Structure of NO releasing inductive lectin from seeds of the Canavalia maritima (ConM);1.95;CA;CALCIUM ION;lectin;3825;
2CXG;A;CYCLODEXTRIN GLYCOSYLTRANSFERASE COMPLEXED TO THE INHIBITOR ACARBOSE;2.5;CA;CALCIUM ION;CYCLODEXTRIN GLYCOSYLTRANSFERASE;1397;
2CY4;A;Crystal structure of phosphotyrosine binding (PTB) domain of epidermal growth factor receptor pathway substrate-8 (EPS8) related protein 1 from Mus musculus (form-1 crystal);1.94;CA;CALCIUM ION;epidermal growth factor receptor pathway substrate 8-like protein 1;10090;
2CY5;A;Crystal structure of phosphotyrosine binding (PTB) domain of epidermal growth factor receptor pathway substrate-8 (EPS8) related protein 1 from Mus musculus (form-2 crystal);1.9;CA;CALCIUM ION;epidermal growth factor receptor pathway substrate 8-like protein 1;10090;
2CY6;A;Crystal structure of ConM in complex with trehalose and maltose;2;CA;CALCIUM ION;Lectin;3825;
2CY6;D;Crystal structure of ConM in complex with trehalose and maltose;2;CA;CALCIUM ION;Lectin;3825;
2CYF;A;The Crystal Structure of Canavalia Maritima Lectin (ConM) in Complex with Trehalose and Maltose;1.8;CA;CALCIUM ION;Lectin;3825;
2CYF;C;The Crystal Structure of Canavalia Maritima Lectin (ConM) in Complex with Trehalose and Maltose;1.8;CA;CALCIUM ION;Lectin;3825;
2CYY;A;Crystal structure of PH1519 from Pyrococcus horikosii OT3;1.8;CA;CALCIUM ION;Putative HTH-type transcriptional regulator PH1519;53953;
2CZI;A;Crystal structure of human myo-inositol monophosphatase 2 (IMPA2) with calcium and phosphate ions;3;CA;CALCIUM ION;Inositol monophosphatase 2;9606;
2D00;B;Subunit F of V-type ATPase/synthase;2.2;CA;CALCIUM ION;V-type ATP synthase subunit F;274;
2D00;C;Subunit F of V-type ATPase/synthase;2.2;CA;CALCIUM ION;V-type ATP synthase subunit F;274;
2D00;D;Subunit F of V-type ATPase/synthase;2.2;CA;CALCIUM ION;V-type ATP synthase subunit F;274;
2D0F;A;Crystal Structure of Thermoactinomyces vulgaris R-47 Alpha-Amylase 1 (TVAI) Mutant D356N complexed with P2, a pullulan model oligosaccharide;2.08;CA;CALCIUM ION;alpha-amylase I;2026;
2D0G;A;Crystal Structure of Thermoactinomyces vulgaris R-47 Alpha-Amylase 1 (TVAI) Mutant D356N/E396Q complexed with P5, a pullulan model oligosaccharide;2.6;CA;CALCIUM ION;alpha-amylase I;2026;
2D0H;A;Crystal Structure of Thermoactinomyces vulgaris R-47 Alpha-Amylase 1 (TVAI) Mutant D356N/E396Q complexed with P2, a pullulan model oligosaccharide;2.1;CA;CALCIUM ION;alpha-amylase I;2026;
2D0P;A;Strcuture of diol dehydratase-reactivating factor in nucleotide free form;3;CA;CALCIUM ION;diol dehydratase-reactivating factor large subunit;571;
2D0P;C;Strcuture of diol dehydratase-reactivating factor in nucleotide free form;3;CA;CALCIUM ION;diol dehydratase-reactivating factor large subunit;571;
2D0V;A;Crystal structure of methanol dehydrogenase from Hyphomicrobium denitrificans;2.49;CA;CALCIUM ION;methanol dehydrogenase large subunit;53399;
2D0V;D;Crystal structure of methanol dehydrogenase from Hyphomicrobium denitrificans;2.49;CA;CALCIUM ION;methanol dehydrogenase large subunit;53399;
2D0V;I;Crystal structure of methanol dehydrogenase from Hyphomicrobium denitrificans;2.49;CA;CALCIUM ION;methanol dehydrogenase large subunit;53399;
2D1J;A;Factor Xa in complex with the inhibitor 2-[[4-[(5-chloroindol-2-yl)sulfonyl]piperazin-1-yl] carbonyl]thieno[3,2-b]pyridine n-oxide;2.2;CA;CALCIUM ION;Coagulation factor X, heavy chain;9606;
2D1K;A;Ternary complex of the WH2 domain of mim with actin-dnase I;2.5;CA;CALCIUM ION;Actin, alpha skeletal muscle;9986;
2D1K;B;Ternary complex of the WH2 domain of mim with actin-dnase I;2.5;CA;CALCIUM ION;Deoxyribonuclease-1;9913;
2D1N;A;Collagenase-3 (MMP-13) complexed to a hydroxamic acid inhibitor;2.37;CA;CALCIUM ION;Collagenase 3;9606;
2D1N;B;Collagenase-3 (MMP-13) complexed to a hydroxamic acid inhibitor;2.37;CA;CALCIUM ION;Collagenase 3;9606;
2D1O;A;Stromelysin-1 (MMP-3) complexed to a hydroxamic acid inhibitor;2.02;CA;CALCIUM ION;Stromelysin-1;9606;
2D1O;B;Stromelysin-1 (MMP-3) complexed to a hydroxamic acid inhibitor;2.02;CA;CALCIUM ION;Stromelysin-1;9606;
2D2O;A;Structure of a complex of Thermoactinomyces vulgaris R-47 alpha-amylase 2 with maltohexaose demonstrates the important role of aromatic residues at the reducing end of the substrate binding cleft;2.1;CA;CALCIUM ION;Neopullulanase 2;2026;
2D2O;B;Structure of a complex of Thermoactinomyces vulgaris R-47 alpha-amylase 2 with maltohexaose demonstrates the important role of aromatic residues at the reducing end of the substrate binding cleft;2.1;CA;CALCIUM ION;Neopullulanase 2;2026;
2D3D;A;crystal structure of the RNA binding SAM domain of saccharomyces cerevisiae Vts1;1.6;CA;CALCIUM ION;Vts1 protein;4932;
2D3L;A;Crystal structure of maltohexaose-producing amylase from Bacillus sp.707 complexed with maltopentaose.;2.3;CA;CALCIUM ION;Glucan 1,4-alpha-maltohexaosidase;1416;
2D3N;A;Crystal structure of maltohexaose-producing amylase from Bacillus sp.707 complexed with maltohexaose;1.9;CA;CALCIUM ION;Glucan 1,4-alpha-maltohexaosidase;1416;
2D3P;A;Cratylia Floribunda seed lectin crystallized at basic pH;2.8;CA;CALCIUM ION;Lectin alpha chain;83131;
2D3P;B;Cratylia Floribunda seed lectin crystallized at basic pH;2.8;CA;CALCIUM ION;Lectin alpha chain;83131;
2D3P;C;Cratylia Floribunda seed lectin crystallized at basic pH;2.8;CA;CALCIUM ION;Lectin alpha chain;83131;
2D3P;D;Cratylia Floribunda seed lectin crystallized at basic pH;2.8;CA;CALCIUM ION;Lectin alpha chain;83131;
2D3R;A;Cratylia folibunda seed lectin at acidic pH;2.9;CA;CALCIUM ION;Lectin alpha chain;83131;
2D3R;B;Cratylia folibunda seed lectin at acidic pH;2.9;CA;CALCIUM ION;Lectin alpha chain;83131;
2D3R;C;Cratylia folibunda seed lectin at acidic pH;2.9;CA;CALCIUM ION;Lectin alpha chain;83131;
2D3R;D;Cratylia folibunda seed lectin at acidic pH;2.9;CA;CALCIUM ION;Lectin alpha chain;83131;
2D3S;A;Crystal Structure of basic winged bean lectin with Tn-antigen;2.35;CA;CALCIUM ION;Basic agglutinin;3891;
2D3S;B;Crystal Structure of basic winged bean lectin with Tn-antigen;2.35;CA;CALCIUM ION;Basic agglutinin;3891;
2D3S;C;Crystal Structure of basic winged bean lectin with Tn-antigen;2.35;CA;CALCIUM ION;Basic agglutinin;3891;
2D3S;D;Crystal Structure of basic winged bean lectin with Tn-antigen;2.35;CA;CALCIUM ION;Basic agglutinin;3891;
2D4C;A;Crystal structure of the endophilin BAR domain mutant;2.4;CA;CALCIUM ION;SH3-containing GRB2-like protein 2;9606;
2D73;A;Crystal Structure Analysis of SusB;1.6;CA;CALCIUM ION;alpha-glucosidase SusB;818;
2D73;B;Crystal Structure Analysis of SusB;1.6;CA;CALCIUM ION;alpha-glucosidase SusB;818;
2D7F;A;Crystal structure of A lectin from canavalia gladiata seeds complexed with alpha-methyl-mannoside and alpha-aminobutyric acid;2.31;CA;CALCIUM ION;Concanavalin A;3824;
2D7F;F;Crystal structure of A lectin from canavalia gladiata seeds complexed with alpha-methyl-mannoside and alpha-aminobutyric acid;2.31;CA;CALCIUM ION;Concanavalin A;3824;
2D7F;L;Crystal structure of A lectin from canavalia gladiata seeds complexed with alpha-methyl-mannoside and alpha-aminobutyric acid;2.31;CA;CALCIUM ION;Concanavalin A;3824;
2D7F;S;Crystal structure of A lectin from canavalia gladiata seeds complexed with alpha-methyl-mannoside and alpha-aminobutyric acid;2.31;CA;CALCIUM ION;Concanavalin A;3824;
2D8W;A;Structure of HYPER-VIL-trypsin;2;CA;CALCIUM ION;Cationic trypsin;9913;
2DBX;B;Crystal Structure of Gamma-glutamyltranspeptidase from Escherichia coli Complexed with L-Glutamate;1.7;CA;CALCIUM ION;Gamma-glutamyltranspeptidase;562;
2DBX;D;Crystal Structure of Gamma-glutamyltranspeptidase from Escherichia coli Complexed with L-Glutamate;1.7;CA;CALCIUM ION;Gamma-glutamyltranspeptidase;562;
2DCJ;A;A two-domain structure of alkaliphilic XynJ from Bacillus sp. 41M-1;2.24;CA;CALCIUM ION;xylanase J;98930;
2DCJ;B;A two-domain structure of alkaliphilic XynJ from Bacillus sp. 41M-1;2.24;CA;CALCIUM ION;xylanase J;98930;
2DCK;A;A tetragonal-lattice structure of alkaliphilic XynJ from Bacillus sp. 41M-1;2.1;CA;CALCIUM ION;xylanase J;98930;
2DDF;A;Crystal structure of TACE in complex with TAPI-2;1.7;CA;CALCIUM ION;ADAM 17;9606;
2DDR;A;Crystal structure of sphingomyelinase from Bacillus cereus with calcium ion;1.4;CA;CALCIUM ION;Sphingomyelin phosphodiesterase;1396;
2DDR;B;Crystal structure of sphingomyelinase from Bacillus cereus with calcium ion;1.4;CA;CALCIUM ION;Sphingomyelin phosphodiesterase;1396;
2DDR;C;Crystal structure of sphingomyelinase from Bacillus cereus with calcium ion;1.4;CA;CALCIUM ION;Sphingomyelin phosphodiesterase;1396;
2DDR;D;Crystal structure of sphingomyelinase from Bacillus cereus with calcium ion;1.4;CA;CALCIUM ION;Sphingomyelin phosphodiesterase;1396;
2DDU;A;Crystal structure of the third repeat domain of reelin;2.05;CA;CALCIUM ION;reelin;10090;
2DDY;A;Solution Structure of Matrilysin (MMP-7) Complexed to Constraint Conformational Sulfonamide Inhibitor;;CA;CALCIUM ION;Matrilysin;9606;
2DEW;X;Crystal structure of human peptidylarginine deiminase 4 in complex with histone H3 N-terminal tail including Arg8;2.1;CA;CALCIUM ION;Protein-arginine deiminase type IV;9606;
2DEX;X;Crystal structure of human peptidylarginine deiminase 4 in complex with histone H3 N-terminal peptide including Arg17;2.1;CA;CALCIUM ION;Protein-arginine deiminase type IV;9606;
2DEY;X;Crystal structure of human peptidylarginine deiminase 4 in complex with histone H4 N-terminal tail including Arg3;2.25;CA;CALCIUM ION;Protein-arginine deiminase type IV;9606;
2DF7;A;Crystal structure of infectious bursal disease virus VP2 subviral particle;2.6;CA;CALCIUM ION;structural polyprotein VP2;10995;
2DF7;B;Crystal structure of infectious bursal disease virus VP2 subviral particle;2.6;CA;CALCIUM ION;structural polyprotein VP2;10995;
2DF7;C;Crystal structure of infectious bursal disease virus VP2 subviral particle;2.6;CA;CALCIUM ION;structural polyprotein VP2;10995;
2DF7;G;Crystal structure of infectious bursal disease virus VP2 subviral particle;2.6;CA;CALCIUM ION;structural polyprotein VP2;10995;
2DF7;H;Crystal structure of infectious bursal disease virus VP2 subviral particle;2.6;CA;CALCIUM ION;structural polyprotein VP2;10995;
2DF7;I;Crystal structure of infectious bursal disease virus VP2 subviral particle;2.6;CA;CALCIUM ION;structural polyprotein VP2;10995;
2DF7;P;Crystal structure of infectious bursal disease virus VP2 subviral particle;2.6;CA;CALCIUM ION;structural polyprotein VP2;10995;
2DF7;R;Crystal structure of infectious bursal disease virus VP2 subviral particle;2.6;CA;CALCIUM ION;structural polyprotein VP2;10995;
2DG1;A;Crystal structure of Drp35, a 35kDa drug responsive protein from Staphylococcus aureus, complexed with Ca2+;1.72;CA;CALCIUM ION;DrP35;1280;
2DG1;B;Crystal structure of Drp35, a 35kDa drug responsive protein from Staphylococcus aureus, complexed with Ca2+;1.72;CA;CALCIUM ION;DrP35;1280;
2DG1;C;Crystal structure of Drp35, a 35kDa drug responsive protein from Staphylococcus aureus, complexed with Ca2+;1.72;CA;CALCIUM ION;DrP35;1280;
2DG1;D;Crystal structure of Drp35, a 35kDa drug responsive protein from Staphylococcus aureus, complexed with Ca2+;1.72;CA;CALCIUM ION;DrP35;1280;
2DG1;E;Crystal structure of Drp35, a 35kDa drug responsive protein from Staphylococcus aureus, complexed with Ca2+;1.72;CA;CALCIUM ION;DrP35;1280;
2DG1;F;Crystal structure of Drp35, a 35kDa drug responsive protein from Staphylococcus aureus, complexed with Ca2+;1.72;CA;CALCIUM ION;DrP35;1280;
2DG5;B;Crystal Structure of Gamma-glutamyl transpeptidase from Escherichia coli in complex with hydrolyzed Glutathione;1.6;CA;CALCIUM ION;Gamma-glutamyltranspeptidase;562;
2DG5;D;Crystal Structure of Gamma-glutamyl transpeptidase from Escherichia coli in complex with hydrolyzed Glutathione;1.6;CA;CALCIUM ION;Gamma-glutamyltranspeptidase;562;
2DIE;A;Alkaline alpha-amylase AmyK from Bacillus sp. KSM-1378;2.1;CA;CALCIUM ION;amylase;1409;
2DIJ;A;COMPLEX OF A Y195F MUTANT CGTASE FROM B. CIRCULANS STRAIN 251 COMPLEXED WITH A MALTONONAOSE INHIBITOR AT PH 9.8 OBTAINED AFTER SOAKING THE CRYSTAL WITH ACARBOSE AND MALTOHEXAOSE;2.6;CA;CALCIUM ION;CYCLODEXTRIN GLYCOSYLTRANSFERASE;1397;
2DOB;A;Crystal Structure of Human Saposin A;2;CA;CALCIUM ION;Proactivator polypeptide;9606;
2DOQ;A;crystal structure of Sfi1p/Cdc31p complex;3;CA;CALCIUM ION;Cell division control protein 31;4932;
2DOQ;B;crystal structure of Sfi1p/Cdc31p complex;3;CA;CALCIUM ION;Cell division control protein 31;4932;
2DOQ;C;crystal structure of Sfi1p/Cdc31p complex;3;CA;CALCIUM ION;Cell division control protein 31;4932;
2DPK;A;The Crystal Structure of the Primary Ca2+ Sensor of the Na+/Ca2+ Exchanger;2.5;CA;CALCIUM ION;Sodium/calcium exchanger 1;9612;
2DPQ;A;The crystal structures of the calcium-bound con-G and con-T(K7gamma) dimeric peptides demonstrate a novel metal-dependent helix-forming motif;1.25;CA;CALCIUM ION;Conantokin-G;6491;
2DPR;A;The crystal structures of the calcium-bound con-G and con-T(K7Glu) dimeric peptides demonstrate a novel metal-dependent helix-forming motif;1.7;CA;CALCIUM ION;Conantokin-T;6495;
2DPR;B;The crystal structures of the calcium-bound con-G and con-T(K7Glu) dimeric peptides demonstrate a novel metal-dependent helix-forming motif;1.7;CA;CALCIUM ION;Conantokin-T;6495;
2DQK;A;Crystal structure of the complex of proteinase K with a specific lactoferrin peptide Val-Leu-Leu-His at 1.93 A resolution;1.93;CA;CALCIUM ION;Proteinase K;37998;
2DRC;B;INVESTIGATION OF THE FUNCTIONAL ROLE OF TRYPTOPHAN-22 IN ESCHERICHIA COLI DIHYDROFOLATE REDUCTASE BY SITE-DIRECTED MUTAGENESIS;1.9;CA;CALCIUM ION;DIHYDROFOLATE REDUCTASE;562;
2DS5;B;Structure of the ZBD in the orthorhomibic crystal from;1.5;CA;CALCIUM ION;ATP-dependent Clp protease ATP-binding subunit clpX;562;
2DSN;A;Crystal structure of T1 lipase;1.5;CA;CALCIUM ION;Thermostable lipase;213419;
2DSN;B;Crystal structure of T1 lipase;1.5;CA;CALCIUM ION;Thermostable lipase;213419;
2DSO;A;Crystal structure of D138N mutant of Drp35, a 35kDa drug responsive protein from Staphylococcus aureus;2.1;CA;CALCIUM ION;Drp35;1280;
2DSO;B;Crystal structure of D138N mutant of Drp35, a 35kDa drug responsive protein from Staphylococcus aureus;2.1;CA;CALCIUM ION;Drp35;1280;
2DSO;C;Crystal structure of D138N mutant of Drp35, a 35kDa drug responsive protein from Staphylococcus aureus;2.1;CA;CALCIUM ION;Drp35;1280;
2DSO;D;Crystal structure of D138N mutant of Drp35, a 35kDa drug responsive protein from Staphylococcus aureus;2.1;CA;CALCIUM ION;Drp35;1280;
2DSO;E;Crystal structure of D138N mutant of Drp35, a 35kDa drug responsive protein from Staphylococcus aureus;2.1;CA;CALCIUM ION;Drp35;1280;
2DSO;F;Crystal structure of D138N mutant of Drp35, a 35kDa drug responsive protein from Staphylococcus aureus;2.1;CA;CALCIUM ION;Drp35;1280;
2DTW;A;Crystal Structure of basic winged bean lectin in complex with 2Me-O-D-Galactose;2.4;CA;CALCIUM ION;Basic agglutinin;3891;
2DTW;B;Crystal Structure of basic winged bean lectin in complex with 2Me-O-D-Galactose;2.4;CA;CALCIUM ION;Basic agglutinin;3891;
2DTW;C;Crystal Structure of basic winged bean lectin in complex with 2Me-O-D-Galactose;2.4;CA;CALCIUM ION;Basic agglutinin;3891;
2DTW;D;Crystal Structure of basic winged bean lectin in complex with 2Me-O-D-Galactose;2.4;CA;CALCIUM ION;Basic agglutinin;3891;
2DTY;A;Crystal structure of basic winged bean lectin complexed with N-acetyl-D-galactosamine;2.65;CA;CALCIUM ION;Basic agglutinin;3891;
2DTY;B;Crystal structure of basic winged bean lectin complexed with N-acetyl-D-galactosamine;2.65;CA;CALCIUM ION;Basic agglutinin;3891;
2DTY;C;Crystal structure of basic winged bean lectin complexed with N-acetyl-D-galactosamine;2.65;CA;CALCIUM ION;Basic agglutinin;3891;
2DTY;D;Crystal structure of basic winged bean lectin complexed with N-acetyl-D-galactosamine;2.65;CA;CALCIUM ION;Basic agglutinin;3891;
2DU0;A;Crystal structure of basic winged bean lectin in complex with Alpha-D-galactose;2.7;CA;CALCIUM ION;Basic agglutinin;3891;
2DU0;B;Crystal structure of basic winged bean lectin in complex with Alpha-D-galactose;2.7;CA;CALCIUM ION;Basic agglutinin;3891;
2DU0;C;Crystal structure of basic winged bean lectin in complex with Alpha-D-galactose;2.7;CA;CALCIUM ION;Basic agglutinin;3891;
2DU0;D;Crystal structure of basic winged bean lectin in complex with Alpha-D-galactose;2.7;CA;CALCIUM ION;Basic agglutinin;3891;
2DU1;A;Crystal Structure of basic winged bean lectin in complex with Methyl-alpha-N-acetyl-D galactosamine;2.6;CA;CALCIUM ION;Basic agglutinin;3891;
2DU1;B;Crystal Structure of basic winged bean lectin in complex with Methyl-alpha-N-acetyl-D galactosamine;2.6;CA;CALCIUM ION;Basic agglutinin;3891;
2DU1;C;Crystal Structure of basic winged bean lectin in complex with Methyl-alpha-N-acetyl-D galactosamine;2.6;CA;CALCIUM ION;Basic agglutinin;3891;
2DU1;D;Crystal Structure of basic winged bean lectin in complex with Methyl-alpha-N-acetyl-D galactosamine;2.6;CA;CALCIUM ION;Basic agglutinin;3891;
2DUJ;A;Crystal structure of the complex formed between proteinase K and a synthetic peptide Leu-Leu-Phe-Asn-Asp at 1.67 A resolution;1.67;CA;CALCIUM ION;Proteinase K;37998;
2DUO;A;Crystal structure of VIP36 exoplasmic/lumenal domain, Ca2+-bound form;1.8;CA;CALCIUM ION;Vesicular integral-membrane protein VIP36;9612;
2DUO;B;Crystal structure of VIP36 exoplasmic/lumenal domain, Ca2+-bound form;1.8;CA;CALCIUM ION;Vesicular integral-membrane protein VIP36;9612;
2DUP;A;Crystal structure of VIP36 exoplasmic/lumenal domain, metal-free form;2.1;CA;CALCIUM ION;Vesicular integral-membrane protein VIP36;9612;
2DUQ;A;Crystal structure of VIP36 exoplasmic/lumenal domain, Ca2+/Man-bound form;1.8;CA;CALCIUM ION;Vesicular integral-membrane protein VIP36;9612;
2DUQ;B;Crystal structure of VIP36 exoplasmic/lumenal domain, Ca2+/Man-bound form;1.8;CA;CALCIUM ION;Vesicular integral-membrane protein VIP36;9612;
2DUR;A;Crystal structure of VIP36 exoplasmic/lumenal domain, Ca2+/Man2-bound form;1.65;CA;CALCIUM ION;Vesicular integral-membrane protein VIP36;9612;
2DUR;B;Crystal structure of VIP36 exoplasmic/lumenal domain, Ca2+/Man2-bound form;1.65;CA;CALCIUM ION;Vesicular integral-membrane protein VIP36;9612;
2DV9;A;Crystal structure of peanut lectin GAL-BETA-1,3-GAL complex;2.48;CA;CALCIUM ION;Galactose-binding lectin;3818;
2DV9;B;Crystal structure of peanut lectin GAL-BETA-1,3-GAL complex;2.48;CA;CALCIUM ION;Galactose-binding lectin;3818;
2DV9;C;Crystal structure of peanut lectin GAL-BETA-1,3-GAL complex;2.48;CA;CALCIUM ION;Galactose-binding lectin;3818;
2DV9;D;Crystal structure of peanut lectin GAL-BETA-1,3-GAL complex;2.48;CA;CALCIUM ION;Galactose-binding lectin;3818;
2DVA;A;Crystal structure of peanut lectin GAL-BETA-1,3-GALNAC-ALPHA-O-ME (Methyl-T-antigen) complex;2.2;CA;CALCIUM ION;Galactose-binding lectin;3818;
2DVA;B;Crystal structure of peanut lectin GAL-BETA-1,3-GALNAC-ALPHA-O-ME (Methyl-T-antigen) complex;2.2;CA;CALCIUM ION;Galactose-binding lectin;3818;
2DVA;C;Crystal structure of peanut lectin GAL-BETA-1,3-GALNAC-ALPHA-O-ME (Methyl-T-antigen) complex;2.2;CA;CALCIUM ION;Galactose-binding lectin;3818;
2DVA;D;Crystal structure of peanut lectin GAL-BETA-1,3-GALNAC-ALPHA-O-ME (Methyl-T-antigen) complex;2.2;CA;CALCIUM ION;Galactose-binding lectin;3818;
2DVB;A;Crystal structure of peanut lectin GAl-beta-1,6-GalNAc complex;2.25;CA;CALCIUM ION;Galactose-binding lectin;3818;
2DVB;B;Crystal structure of peanut lectin GAl-beta-1,6-GalNAc complex;2.25;CA;CALCIUM ION;Galactose-binding lectin;3818;
2DVB;C;Crystal structure of peanut lectin GAl-beta-1,6-GalNAc complex;2.25;CA;CALCIUM ION;Galactose-binding lectin;3818;
2DVB;D;Crystal structure of peanut lectin GAl-beta-1,6-GalNAc complex;2.25;CA;CALCIUM ION;Galactose-binding lectin;3818;
2DVD;A;Crystal structure of peanut lectin GAL-ALPHA-1,3-GAL complex;2.25;CA;CALCIUM ION;Galactose-binding lectin;3818;
2DVD;B;Crystal structure of peanut lectin GAL-ALPHA-1,3-GAL complex;2.25;CA;CALCIUM ION;Galactose-binding lectin;3818;
2DVD;C;Crystal structure of peanut lectin GAL-ALPHA-1,3-GAL complex;2.25;CA;CALCIUM ION;Galactose-binding lectin;3818;
2DVD;D;Crystal structure of peanut lectin GAL-ALPHA-1,3-GAL complex;2.25;CA;CALCIUM ION;Galactose-binding lectin;3818;
2DVF;A;Crystals of peanut lectin grown in the presence of GAL-ALPHA-1,3-GAL-BETA-1,4-GAL;2.74;CA;CALCIUM ION;Galactose-binding lectin;3818;
2DVF;B;Crystals of peanut lectin grown in the presence of GAL-ALPHA-1,3-GAL-BETA-1,4-GAL;2.74;CA;CALCIUM ION;Galactose-binding lectin;3818;
2DVF;C;Crystals of peanut lectin grown in the presence of GAL-ALPHA-1,3-GAL-BETA-1,4-GAL;2.74;CA;CALCIUM ION;Galactose-binding lectin;3818;
2DVF;D;Crystals of peanut lectin grown in the presence of GAL-ALPHA-1,3-GAL-BETA-1,4-GAL;2.74;CA;CALCIUM ION;Galactose-binding lectin;3818;
2DVG;A;Crystal structure of peanut lectin GAL-ALPHA-1,6-GLC complex;2.78;CA;CALCIUM ION;Galactose-binding lectin;3818;
2DVG;B;Crystal structure of peanut lectin GAL-ALPHA-1,6-GLC complex;2.78;CA;CALCIUM ION;Galactose-binding lectin;3818;
2DVG;C;Crystal structure of peanut lectin GAL-ALPHA-1,6-GLC complex;2.78;CA;CALCIUM ION;Galactose-binding lectin;3818;
2DVG;D;Crystal structure of peanut lectin GAL-ALPHA-1,6-GLC complex;2.78;CA;CALCIUM ION;Galactose-binding lectin;3818;
2DW0;A;Crystal structure of VAP2 from Crotalus atrox venom (Form 2-1 crystal);2.15;CA;CALCIUM ION;Catrocollastatin;8730;
2DW0;B;Crystal structure of VAP2 from Crotalus atrox venom (Form 2-1 crystal);2.15;CA;CALCIUM ION;Catrocollastatin;8730;
2DW1;A;Crystal structure of VAP2 from Crotalus atrox venom (Form 2-2 crystal);2.5;CA;CALCIUM ION;Catrocollastatin;8730;
2DW1;B;Crystal structure of VAP2 from Crotalus atrox venom (Form 2-2 crystal);2.5;CA;CALCIUM ION;Catrocollastatin;8730;
2DW2;A;Crystal structure of VAP2 from Crotalus atrox venom (Form 2-5 crystal);2.7;CA;CALCIUM ION;Catrocollastatin;8730;
2DW2;B;Crystal structure of VAP2 from Crotalus atrox venom (Form 2-5 crystal);2.7;CA;CALCIUM ION;Catrocollastatin;8730;
2DW5;A;Crystal structure of human peptidylarginine deiminase 4 in complex with N-alpha-benzoyl-N5-(2-fluoro-1-iminoethyl)-L-ornithine amide;2.3;CA;CALCIUM ION;Protein-arginine deiminase type-4;9606;
2E0P;A;The crystal structure of Cel44A;1.6;CA;CALCIUM ION;Endoglucanase;1515;
2E0X;B;Crystal Structure of Gamma-glutamyltranspeptidase from Escherichia coli (monoclinic form);1.95;CA;CALCIUM ION;Gamma-glutamyltranspeptidase;562;
2E0X;D;Crystal Structure of Gamma-glutamyltranspeptidase from Escherichia coli (monoclinic form);1.95;CA;CALCIUM ION;Gamma-glutamyltranspeptidase;562;
2E1P;A;Crystal structure of pro-Tk-subtilisin;2.3;CA;CALCIUM ION;Tk-subtilisin;311400;
2E1Q;A;Crystal Structure of Human Xanthine Oxidoreductase mutant, Glu803Val;2.6;CA;CALCIUM ION;Xanthine dehydrogenase/oxidase;9606;
2E1Q;B;Crystal Structure of Human Xanthine Oxidoreductase mutant, Glu803Val;2.6;CA;CALCIUM ION;Xanthine dehydrogenase/oxidase;9606;
2E1Q;C;Crystal Structure of Human Xanthine Oxidoreductase mutant, Glu803Val;2.6;CA;CALCIUM ION;Xanthine dehydrogenase/oxidase;9606;
2E1Q;D;Crystal Structure of Human Xanthine Oxidoreductase mutant, Glu803Val;2.6;CA;CALCIUM ION;Xanthine dehydrogenase/oxidase;9606;
2.00E+26;A;Crystal structure of two repeat fragment of reelin;2;CA;CALCIUM ION;Reelin;10090;
2E2D;A;Flexibility and variability of TIMP binding: X-ray structure of the complex between collagenase-3/MMP-13 and TIMP-2;2;CA;CALCIUM ION;Matrix metallopeptidase 13;9606;
2.00E+30;A;Solution structure of the cytoplasmic region of Na+/H+ exchanger 1 complexed with essential cofactor calcineurin B homologous protein 1;;CA;CALCIUM ION;Calcium-binding protein p22;9606;
2.00E+39;A;Crystal structure of the CN-bound form of Arthromyces ramosus peroxidase at 1.3 Angstroms resolution;1.3;CA;CALCIUM ION;Peroxidase;5451;
2E3A;A;Crystal structure of the NO-bound form of Arthromyces ramosus peroxidase at 1.3 Angstroms resolution;1.3;CA;CALCIUM ION;Peroxidase;5451;
2E3B;A;Crystal structure of the HA-bound form of Arthromyces ramosus peroxidase at 1.3 Angstroms resolution;1.3;CA;CALCIUM ION;Peroxidase;5451;
2E3T;A;Crystal structure of rat xanthine oxidoreductase mutant (W335A and F336L);2.28;CA;CALCIUM ION;Xanthine dehydrogenase/oxidase;10116;
2E3T;B;Crystal structure of rat xanthine oxidoreductase mutant (W335A and F336L);2.28;CA;CALCIUM ION;Xanthine dehydrogenase/oxidase;10116;
2E3X;A;Crystal structure of Russell's viper venom metalloproteinase;2.91;CA;CALCIUM ION;Coagulation factor X-activating enzyme heavy chain;343250;
2E3X;B;Crystal structure of Russell's viper venom metalloproteinase;2.91;CA;CALCIUM ION;Coagulation factor X-activating enzyme light chain 2;343250;
2E4T;A;Crystal structure of Cel44A, GH family 44 endoglucanase from Clostridium thermocellum;0.96;CA;CALCIUM ION;Endoglucanase;1515;
2.00E+51;A;Crystal structure of basic winged bean lectin in complex with A blood group disaccharide;2.5;CA;CALCIUM ION;Basic agglutinin;3891;
2.00E+51;B;Crystal structure of basic winged bean lectin in complex with A blood group disaccharide;2.5;CA;CALCIUM ION;Basic agglutinin;3891;
2.00E+51;C;Crystal structure of basic winged bean lectin in complex with A blood group disaccharide;2.5;CA;CALCIUM ION;Basic agglutinin;3891;
2.00E+51;D;Crystal structure of basic winged bean lectin in complex with A blood group disaccharide;2.5;CA;CALCIUM ION;Basic agglutinin;3891;
2.00E+53;A;Crystal structure of basic winged bean lectin in complex with B blood group disaccharide;2.4;CA;CALCIUM ION;Basic agglutinin;3891;
2.00E+53;B;Crystal structure of basic winged bean lectin in complex with B blood group disaccharide;2.4;CA;CALCIUM ION;Basic agglutinin;3891;
2.00E+53;C;Crystal structure of basic winged bean lectin in complex with B blood group disaccharide;2.4;CA;CALCIUM ION;Basic agglutinin;3891;
2.00E+53;D;Crystal structure of basic winged bean lectin in complex with B blood group disaccharide;2.4;CA;CALCIUM ION;Basic agglutinin;3891;
2E6U;X;Crystal structure of hypothetical protein PH1109 from Pyrococcus horikoshii;1.8;CA;CALCIUM ION;hypothetical protein PH1109;53953;
2E6V;A;Crystal structure of VIP36 exoplasmic/lumenal domain, Ca2+/Man3GlcNAc-bound form;2.5;CA;CALCIUM ION;Vesicular integral-membrane protein VIP36;9612;
2E6V;B;Crystal structure of VIP36 exoplasmic/lumenal domain, Ca2+/Man3GlcNAc-bound form;2.5;CA;CALCIUM ION;Vesicular integral-membrane protein VIP36;9612;
2E6V;C;Crystal structure of VIP36 exoplasmic/lumenal domain, Ca2+/Man3GlcNAc-bound form;2.5;CA;CALCIUM ION;Vesicular integral-membrane protein VIP36;9612;
2E6V;D;Crystal structure of VIP36 exoplasmic/lumenal domain, Ca2+/Man3GlcNAc-bound form;2.5;CA;CALCIUM ION;Vesicular integral-membrane protein VIP36;9612;
2E6V;E;Crystal structure of VIP36 exoplasmic/lumenal domain, Ca2+/Man3GlcNAc-bound form;2.5;CA;CALCIUM ION;Vesicular integral-membrane protein VIP36;9612;
2E6W;A;Solution structure and calcium binding properties of EF-hands 3 and 4 of calsenilin;;CA;CALCIUM ION;Calsenilin;9606;
2E7F;A;5-methyltetrahydrofolate corrinoid/iron sulfur protein methyltransferase complexed with methyltetrahydrofolate to 2.2 Angsrom resolution;2.2;CA;CALCIUM ION;5-methyltetrahydrofolate corrinoid/iron sulfur protein methyltransferase;1525;
2E7F;B;5-methyltetrahydrofolate corrinoid/iron sulfur protein methyltransferase complexed with methyltetrahydrofolate to 2.2 Angsrom resolution;2.2;CA;CALCIUM ION;5-methyltetrahydrofolate corrinoid/iron sulfur protein methyltransferase;1525;
2E7Q;A;Crystal structure of basic winged bean lectin in complex with b blood group trisaccharide;2.75;CA;CALCIUM ION;Basic agglutinin;3891;
2E7Q;B;Crystal structure of basic winged bean lectin in complex with b blood group trisaccharide;2.75;CA;CALCIUM ION;Basic agglutinin;3891;
2E7Q;C;Crystal structure of basic winged bean lectin in complex with b blood group trisaccharide;2.75;CA;CALCIUM ION;Basic agglutinin;3891;
2E7Q;D;Crystal structure of basic winged bean lectin in complex with b blood group trisaccharide;2.75;CA;CALCIUM ION;Basic agglutinin;3891;
2E7T;A;Crystal structure of basic winged bean lectin in complex with a blood group trisaccharide;2.65;CA;CALCIUM ION;Basic agglutinin;3891;
2E7T;B;Crystal structure of basic winged bean lectin in complex with a blood group trisaccharide;2.65;CA;CALCIUM ION;Basic agglutinin;3891;
2E7T;C;Crystal structure of basic winged bean lectin in complex with a blood group trisaccharide;2.65;CA;CALCIUM ION;Basic agglutinin;3891;
2E7T;D;Crystal structure of basic winged bean lectin in complex with a blood group trisaccharide;2.65;CA;CALCIUM ION;Basic agglutinin;3891;
2.00E+80;A;Cytochrome c Nitrite Reductase from Wolinella succinogenes with bound substrate nitrite;1.6;CA;CALCIUM ION;Cytochrome c-552;844;
2.00E+81;A;Cytochrome c Nitrite Reductase from Wolinella succinogenes with bound intermediate hydroxylamine;2;CA;CALCIUM ION;Cytochrome c-552;844;
2.00E+85;A;Crystal Structure of the Hydrogenase 3 Maturation protease;1.7;CA;CALCIUM ION;Hydrogenase 3 maturation protease;562;
2.00E+85;B;Crystal Structure of the Hydrogenase 3 Maturation protease;1.7;CA;CALCIUM ION;Hydrogenase 3 maturation protease;562;
2E8Y;A;Crystal structure of pullulanase type I from Bacillus subtilis str. 168;2.11;CA;CALCIUM ION;AmyX protein;1423;
2E8Y;B;Crystal structure of pullulanase type I from Bacillus subtilis str. 168;2.11;CA;CALCIUM ION;AmyX protein;1423;
2E8Z;A;Crystal structure of pullulanase type I from Bacillus subtilis str. 168 complexed with alpha-cyclodextrin;2.2;CA;CALCIUM ION;AmyX protein;1423;
2E8Z;B;Crystal structure of pullulanase type I from Bacillus subtilis str. 168 complexed with alpha-cyclodextrin;2.2;CA;CALCIUM ION;AmyX protein;1423;
2E9B;A;Crystal structure of pullulanase type I from Bacillus subtilis str. 168 complexed with maltose;2.3;CA;CALCIUM ION;AmyX protein;1423;
2E9B;B;Crystal structure of pullulanase type I from Bacillus subtilis str. 168 complexed with maltose;2.3;CA;CALCIUM ION;AmyX protein;1423;
2E9E;A;Crystal structure of the complex of goat lactoperoxidase with Nitrate at 3.25 A resolution;3.25;CA;CALCIUM ION;Lactoperoxidase;9925;
2E9E;B;Crystal structure of the complex of goat lactoperoxidase with Nitrate at 3.25 A resolution;3.25;CA;CALCIUM ION;Lactoperoxidase;9925;
2EA7;A;Crystal Structure of Adzuki Bean 7S Globulin-1;1.8;CA;CALCIUM ION;7S globulin-1;3914;
2EA7;B;Crystal Structure of Adzuki Bean 7S Globulin-1;1.8;CA;CALCIUM ION;7S globulin-1;3914;
2EA7;C;Crystal Structure of Adzuki Bean 7S Globulin-1;1.8;CA;CALCIUM ION;7S globulin-1;3914;
2EAA;A;Crystal Structure of Adzuki Bean 7S Globulin-3;2.25;CA;CALCIUM ION;7S globulin-3;3914;
2EAA;B;Crystal Structure of Adzuki Bean 7S Globulin-3;2.25;CA;CALCIUM ION;7S globulin-3;3914;
2EAA;C;Crystal Structure of Adzuki Bean 7S Globulin-3;2.25;CA;CALCIUM ION;7S globulin-3;3914;
2EAB;A;Crystal structure of 1,2-a-L-fucosidase from Bifidobacterium bifidum (apo form);1.12;CA;CALCIUM ION;Alpha-fucosidase;1681;
2EAB;B;Crystal structure of 1,2-a-L-fucosidase from Bifidobacterium bifidum (apo form);1.12;CA;CALCIUM ION;Alpha-fucosidase;1681;
2EAC;A;Crystal structure of 1,2-a-L-fucosidase from Bifidobacterium bifidum in complex with deoxyfuconojirimycin;2.1;CA;CALCIUM ION;Alpha-fucosidase;1681;
2EAC;B;Crystal structure of 1,2-a-L-fucosidase from Bifidobacterium bifidum in complex with deoxyfuconojirimycin;2.1;CA;CALCIUM ION;Alpha-fucosidase;1681;
2EAD;A;Crystal structure of 1,2-a-L-fucosidase from Bifidobacterium bifidum in complex with substrate;1.89;CA;CALCIUM ION;Alpha-fucosidase;1681;
2EAD;B;Crystal structure of 1,2-a-L-fucosidase from Bifidobacterium bifidum in complex with substrate;1.89;CA;CALCIUM ION;Alpha-fucosidase;1681;
2EAE;A;Crystal structure of 1,2-a-L-fucosidase from Bifidobacterium bifidum in complexes with products;1.8;CA;CALCIUM ION;Alpha-fucosidase;1681;
2EC6;C;Placopecten Striated Muscle Myosin II;3.25;CA;CALCIUM ION;Myosin essential light chain;6577;
2EC9;H;Crystal structure analysis of human Factor VIIa , Souluble tissue factor complexed with BCX-3607;2;CA;CALCIUM ION;Coagulation factor VII;9606;
2EC9;L;Crystal structure analysis of human Factor VIIa , Souluble tissue factor complexed with BCX-3607;2;CA;CALCIUM ION;Coagulation factor VII;9606;
2EEK;A;Crystal structure of Atlantic cod trypsin complexed with benzamidine;1.85;CA;CALCIUM ION;Trypsin-1;8049;
2EEX;A;Crystal structure of Cel44A, GH family 44 endoglucanase from Clostridium thermocellum;2;CA;CALCIUM ION;Endoglucanase;1515;
2EF6;A;Canavalia gladiata lectin complexed with Man1-3Man-OMe;2.1;CA;CALCIUM ION;Concanavalin A;3824;
2EF6;B;Canavalia gladiata lectin complexed with Man1-3Man-OMe;2.1;CA;CALCIUM ION;Concanavalin A;3824;
2EF6;C;Canavalia gladiata lectin complexed with Man1-3Man-OMe;2.1;CA;CALCIUM ION;Concanavalin A;3824;
2EF6;D;Canavalia gladiata lectin complexed with Man1-3Man-OMe;2.1;CA;CALCIUM ION;Concanavalin A;3824;
2EFB;A;Crystal structure of the complex of goat lactoperoxidase with phosphate at 2.94 A resolution;2.94;CA;CALCIUM ION;Lactoperoxidase;9925;
2EFB;B;Crystal structure of the complex of goat lactoperoxidase with phosphate at 2.94 A resolution;2.94;CA;CALCIUM ION;Lactoperoxidase;9925;
2EGD;A;Crystal structure of human S100A13 in the Ca2+-bound state;1.8;CA;CALCIUM ION;Protein S100-A13;9606;
2EGD;B;Crystal structure of human S100A13 in the Ca2+-bound state;1.8;CA;CALCIUM ION;Protein S100-A13;9606;
2EHA;A;Crystal structure of goat lactoperoxidase complexed with formate anion at 3.3 A resolution;3.3;CA;CALCIUM ION;Lactoperoxidase;9925;
2EHA;B;Crystal structure of goat lactoperoxidase complexed with formate anion at 3.3 A resolution;3.3;CA;CALCIUM ION;Lactoperoxidase;9925;
2EHB;A;The structure of the C-terminal domain of the protein kinase AtSOS2 bound to the calcium sensor AtSOS3;2.1;CA;CALCIUM ION;Calcineurin B-like protein 4;3702;
2EI6;A;FACTOR XA IN COMPLEX WITH THE INHIBITOR (-)-cis-N1-[(5-Chloroindol-2-yl)carbonyl]-N2-[(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-yl)carbonyl]-1,2-cyclohexanediamine;2.3;CA;CALCIUM ION;Coagulation factor X, heavy chain;9606;
2EI7;A;FACTOR XA IN COMPLEX WITH THE INHIBITOR trans-N1-[(5-Chloroindol-2-yl)carbonyl]-N2-[(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-yl)carbonyl]-1,2-cyclohexanediamine;2.3;CA;CALCIUM ION;Coagulation factor X, heavy chain;9606;
2EI8;A;FACTOR XA IN COMPLEX WITH THE INHIBITOR (1S,2R,4S)-N1-[(5-chloroindol-2-yl)carbonyl]-4-(N,N-dimethylcarbamoyl)-N2-[(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-yl)carbonyl]-1,2-cyclohexanediamine;2.1;CA;CALCIUM ION;Coagulation factor X, heavy chain;9606;
2EIG;A;Lotus tetragonolobus seed lectin (Isoform);2;CA;CALCIUM ION;lectin;3868;
2EIG;B;Lotus tetragonolobus seed lectin (Isoform);2;CA;CALCIUM ION;lectin;3868;
2EIG;C;Lotus tetragonolobus seed lectin (Isoform);2;CA;CALCIUM ION;lectin;3868;
2EIG;D;Lotus tetragonolobus seed lectin (Isoform);2;CA;CALCIUM ION;lectin;3868;
2EJ1;A;Crystal structure of Cel44A, GH family 44 endoglucanase from Clostridium thermocellum;1.8;CA;CALCIUM ION;Endoglucanase;1515;
2EJN;A;Structural characterization of the tetrameric form of the major cat allergen fel D 1;1.64;CA;CALCIUM ION;Major allergen I polypeptide chain 1, chain 2;9685;
2EJN;B;Structural characterization of the tetrameric form of the major cat allergen fel D 1;1.64;CA;CALCIUM ION;Major allergen I polypeptide chain 1, chain 2;9685;
2EO7;A;Crystal structure of Cel44A, GH family 44 endoglucanase from Clostridium thermocellum;1.75;CA;CALCIUM ION;Endoglucanase;1515;
2EQD;A;Crystal structure of Cel44A, GH family 44 endoglucanase from Clostridium thermocellum;2.8;CA;CALCIUM ION;Endoglucanase;1515;
2ERO;A;Crystal structure of vascular apoptosis-inducing protein-1(orthorhombic crystal form);2.5;CA;CALCIUM ION;vascular apoptosis-inducing protein 1;8730;
2ERO;B;Crystal structure of vascular apoptosis-inducing protein-1(orthorhombic crystal form);2.5;CA;CALCIUM ION;vascular apoptosis-inducing protein 1;8730;
2ERP;A;Crystal structure of vascular apoptosis-inducing protein-1(inhibitor-bound form);2.95;CA;CALCIUM ION;vascular apoptosis-inducing protein 1;8730;
2ERP;B;Crystal structure of vascular apoptosis-inducing protein-1(inhibitor-bound form);2.95;CA;CALCIUM ION;vascular apoptosis-inducing protein 1;8730;
2ERQ;A;Crystal structure of vascular apoptosis-inducing protein-1(tetragonal crystal form);2.5;CA;CALCIUM ION;vascular apoptosis-inducing protein 1;8730;
2ERQ;B;Crystal structure of vascular apoptosis-inducing protein-1(tetragonal crystal form);2.5;CA;CALCIUM ION;vascular apoptosis-inducing protein 1;8730;
2ERV;A;Crystal structure of the outer membrane enzyme PagL;2;CA;CALCIUM ION;hypothetical protein Paer03002360;287;
2ES2;A;Crystal Structure Analysis of the Bacillus Subtilis Cold Shock Protein Bs-CspB in Complex with Hexathymidine;1.78;CA;CALCIUM ION;Cold shock protein cspB;1423;
2ES4;A;Crystal structure of the Burkholderia glumae lipase-specific foldase in complex with its cognate lipase;1.85;CA;CALCIUM ION;Lipase;337;
2ES4;B;Crystal structure of the Burkholderia glumae lipase-specific foldase in complex with its cognate lipase;1.85;CA;CALCIUM ION;Lipase;337;
2ESH;A;Crystal Structure of Conserved Protein of Unknown Function TM0937- a Potential Transcriptional Factor;2.3;CA;CALCIUM ION;conserved hypothetical protein TM0937;2336;
2ESL;A;Human Cyclophilin C in Complex with Cyclosporin A;1.9;CA;CALCIUM ION;Peptidyl-prolyl cis-trans isomerase C;9606;
2ESL;D;Human Cyclophilin C in Complex with Cyclosporin A;1.9;CA;CALCIUM ION;Peptidyl-prolyl cis-trans isomerase C;9606;
2ESL;F;Human Cyclophilin C in Complex with Cyclosporin A;1.9;CA;CALCIUM ION;Peptidyl-prolyl cis-trans isomerase C;9606;
2ESS;A;Crystal structure of an acyl-ACP thioesterase (NP_810988.1) from Bacteroides thetaiotaomicron VPI-5482 at 1.90 A resolution;1.9;CA;CALCIUM ION;acyl-ACP thioesterase;818;
2EU8;B;Crystal structure of a thermostable mutant of Bacillus subtilis Adenylate Kinase (Q199R);1.8;CA;CALCIUM ION;Adenylate kinase;1423;
2EUF;A;X-ray structure of human CDK6-Vcyclin in complex with the inhibitor PD0332991;3;CA;CALCIUM ION;viral Cyclin;10381;
2EV5;A;Bacillus subtilis manganese transport regulator (MNTR) bound to calcium;2;CA;CALCIUM ION;Transcriptional regulator mntR;1423;
2EV5;B;Bacillus subtilis manganese transport regulator (MNTR) bound to calcium;2;CA;CALCIUM ION;Transcriptional regulator mntR;1423;
2EWE;A;Crystal structure of Pectate Lyase C R218K mutant in complex with pentagalacturonic acid;2.2;CA;CALCIUM ION;Pectate lyase C;556;
2EX5;A;Group I Intron-encoded Homing Endonuclease I-CeuI Complexed With DNA;2.2;CA;CALCIUM ION;DNA endonuclease I-CeuI;3054;
2EX5;B;Group I Intron-encoded Homing Endonuclease I-CeuI Complexed With DNA;2.2;CA;CALCIUM ION;DNA endonuclease I-CeuI;3054;
2EX5;X;Group I Intron-encoded Homing Endonuclease I-CeuI Complexed With DNA;2.2;CA;CALCIUM ION;I-CeuI DNA target site;32630;
2EXH;A;Structure of the family43 beta-Xylosidase from geobacillus stearothermophilus;1.88;CA;CALCIUM ION;beta-D-xylosidase;1422;
2EXH;B;Structure of the family43 beta-Xylosidase from geobacillus stearothermophilus;1.88;CA;CALCIUM ION;beta-D-xylosidase;1422;
2EXH;C;Structure of the family43 beta-Xylosidase from geobacillus stearothermophilus;1.88;CA;CALCIUM ION;beta-D-xylosidase;1422;
2EXH;D;Structure of the family43 beta-Xylosidase from geobacillus stearothermophilus;1.88;CA;CALCIUM ION;beta-D-xylosidase;1422;
2EXI;A;Structure of the family43 beta-Xylosidase D15G mutant from geobacillus stearothermophilus;2.15;CA;CALCIUM ION;beta-D-xylosidase;1422;
2EXI;B;Structure of the family43 beta-Xylosidase D15G mutant from geobacillus stearothermophilus;2.15;CA;CALCIUM ION;beta-D-xylosidase;1422;
2EXI;C;Structure of the family43 beta-Xylosidase D15G mutant from geobacillus stearothermophilus;2.15;CA;CALCIUM ION;beta-D-xylosidase;1422;
2EXI;D;Structure of the family43 beta-Xylosidase D15G mutant from geobacillus stearothermophilus;2.15;CA;CALCIUM ION;beta-D-xylosidase;1422;
2EXJ;A;Structure of the family43 beta-Xylosidase D128G mutant from geobacillus stearothermophilus in complex with xylobiose;2.2;CA;CALCIUM ION;beta-D-xylosidase;1422;
2EXJ;B;Structure of the family43 beta-Xylosidase D128G mutant from geobacillus stearothermophilus in complex with xylobiose;2.2;CA;CALCIUM ION;beta-D-xylosidase;1422;
2EXJ;C;Structure of the family43 beta-Xylosidase D128G mutant from geobacillus stearothermophilus in complex with xylobiose;2.2;CA;CALCIUM ION;beta-D-xylosidase;1422;
2EXJ;D;Structure of the family43 beta-Xylosidase D128G mutant from geobacillus stearothermophilus in complex with xylobiose;2.2;CA;CALCIUM ION;beta-D-xylosidase;1422;
2EXK;A;Structure of the family43 beta-Xylosidase E187G from geobacillus stearothermophilus in complex with xylobiose;2.2;CA;CALCIUM ION;beta-D-xylosidase;1422;
2EXK;B;Structure of the family43 beta-Xylosidase E187G from geobacillus stearothermophilus in complex with xylobiose;2.2;CA;CALCIUM ION;beta-D-xylosidase;1422;
2EXK;C;Structure of the family43 beta-Xylosidase E187G from geobacillus stearothermophilus in complex with xylobiose;2.2;CA;CALCIUM ION;beta-D-xylosidase;1422;
2EXK;D;Structure of the family43 beta-Xylosidase E187G from geobacillus stearothermophilus in complex with xylobiose;2.2;CA;CALCIUM ION;beta-D-xylosidase;1422;
2EZV;A;Crystal structure of tetrameric restriction endonuclease SfiI bound to cognate DNA.;2.4;CA;CALCIUM ION;Type II restriction enzyme SfiI;68197;
2EZV;B;Crystal structure of tetrameric restriction endonuclease SfiI bound to cognate DNA.;2.4;CA;CALCIUM ION;Type II restriction enzyme SfiI;68197;
2F03;A;Crystal structure of tetrameric restriction endonuclease SfiI in complex with cognate DNA (partial bound form);3.05;CA;CALCIUM ION;Type II restriction enzyme SfiI;68197;
2F03;C;Crystal structure of tetrameric restriction endonuclease SfiI in complex with cognate DNA (partial bound form);3.05;CA;CALCIUM ION;Type II restriction enzyme SfiI;68197;
2F1W;A;Crystal structure of the TRAF-like domain of HAUSP/USP7;1.65;CA;CALCIUM ION;Ubiquitin carboxyl-terminal hydrolase 7;9606;
2F2O;A;Structure of calmodulin bound to a calcineurin peptide: a new way of making an old binding mode;2.17;CA;CALCIUM ION;Calmodulin fused with calmodulin-binding domain of calcineurin;9913;
2F2O;B;Structure of calmodulin bound to a calcineurin peptide: a new way of making an old binding mode;2.17;CA;CALCIUM ION;Calmodulin fused with calmodulin-binding domain of calcineurin;9913;
2F2P;A;Structure of calmodulin bound to a calcineurin peptide: a new way of making an old binding mode;2.6;CA;CALCIUM ION;Calmodulin fused with calmodulin-binding domain of calcineurin;9913;
2F2P;B;Structure of calmodulin bound to a calcineurin peptide: a new way of making an old binding mode;2.6;CA;CALCIUM ION;Calmodulin fused with calmodulin-binding domain of calcineurin;9913;
2F3C;E;Crystal structure of infestin 1, a Kazal-type serineprotease inhibitor, in complex with trypsin;2.5;CA;CALCIUM ION;Cationic trypsin;9913;
2F3Y;A;Calmodulin/IQ domain complex;1.45;CA;CALCIUM ION;Calmodulin;9606;
2F3Z;A;Calmodulin/IQ-AA domain complex;1.6;CA;CALCIUM ION;Calmodulin;9606;
2F59;A;Lumazine synthase RibH1 from Brucella abortus (Gene BruAb1_0785, Swiss-Prot entry Q57DY1) complexed with inhibitor 5-Nitro-6-(D-Ribitylamino)-2,4(1H,3H) Pyrimidinedione;2.3;CA;CALCIUM ION;6,7-dimethyl-8-ribityllumazine synthase 1;235;
2F59;B;Lumazine synthase RibH1 from Brucella abortus (Gene BruAb1_0785, Swiss-Prot entry Q57DY1) complexed with inhibitor 5-Nitro-6-(D-Ribitylamino)-2,4(1H,3H) Pyrimidinedione;2.3;CA;CALCIUM ION;6,7-dimethyl-8-ribityllumazine synthase 1;235;
2F59;C;Lumazine synthase RibH1 from Brucella abortus (Gene BruAb1_0785, Swiss-Prot entry Q57DY1) complexed with inhibitor 5-Nitro-6-(D-Ribitylamino)-2,4(1H,3H) Pyrimidinedione;2.3;CA;CALCIUM ION;6,7-dimethyl-8-ribityllumazine synthase 1;235;
2F59;D;Lumazine synthase RibH1 from Brucella abortus (Gene BruAb1_0785, Swiss-Prot entry Q57DY1) complexed with inhibitor 5-Nitro-6-(D-Ribitylamino)-2,4(1H,3H) Pyrimidinedione;2.3;CA;CALCIUM ION;6,7-dimethyl-8-ribityllumazine synthase 1;235;
2F8P;A;Crystal structure of obelin following Ca2+ triggered bioluminescence suggests neutral coelenteramide as the primary excited state;1.93;CA;CALCIUM ION;Obelin;32570;
2FCW;B;Structure of a Complex Between the Pair of the LDL Receptor Ligand-Binding Modules 3-4 and the Receptor Associated Protein (RAP).;1.26;CA;CALCIUM ION;Low-density lipoprotein receptor;9606;
2FE1;A;Crystal Structure of PAE0151 from Pyrobaculum aerophilum;2.2;CA;CALCIUM ION;conserved hypothetical protein PAE0151;13773;
2FF1;A;Crystal structure of Trypanosoma vivax nucleoside hydrolase soaked with ImmucillinH;2.07;CA;CALCIUM ION;IAG-nucleoside hydrolase;5699;
2FF1;B;Crystal structure of Trypanosoma vivax nucleoside hydrolase soaked with ImmucillinH;2.07;CA;CALCIUM ION;IAG-nucleoside hydrolase;5699;
2FF2;A;Crystal structure of Trypanosoma vivax nucleoside hydrolase co-crystallized with ImmucillinH;2.2;CA;CALCIUM ION;IAG-nucleoside hydrolase;5699;
2FF2;B;Crystal structure of Trypanosoma vivax nucleoside hydrolase co-crystallized with ImmucillinH;2.2;CA;CALCIUM ION;IAG-nucleoside hydrolase;5699;
2FF3;A;Crystal structure of Gelsolin domain 1:N-wasp V2 motif hybrid in complex with actin;2;CA;CALCIUM ION;Gelsolin;9606;
2FF3;B;Crystal structure of Gelsolin domain 1:N-wasp V2 motif hybrid in complex with actin;2;CA;CALCIUM ION;Actin, alpha skeletal muscle;9986;
2FF6;A;Crystal structure of Gelsolin domain 1:ciboulot domain 2 hybrid in complex with actin;2.05;CA;CALCIUM ION;Actin, alpha skeletal muscle;9986;
2FF6;G;Crystal structure of Gelsolin domain 1:ciboulot domain 2 hybrid in complex with actin;2.05;CA;CALCIUM ION;Gelsolin;9606;
2FFD;B;Fibrinogen Fragment D with 'A' knob peptide mimic GPRVVE;2.89;CA;CALCIUM ION;Fibrinogen beta chain;9606;
2FFD;C;Fibrinogen Fragment D with 'A' knob peptide mimic GPRVVE;2.89;CA;CALCIUM ION;Fibrinogen gamma chain;9606;
2FFD;E;Fibrinogen Fragment D with 'A' knob peptide mimic GPRVVE;2.89;CA;CALCIUM ION;Fibrinogen beta chain;9606;
2FFD;F;Fibrinogen Fragment D with 'A' knob peptide mimic GPRVVE;2.89;CA;CALCIUM ION;Fibrinogen gamma chain;9606;
2FGQ;X;High resolution X-ray structure of Omp32 in complex with malate;1.45;CA;CALCIUM ION;Outer membrane porin protein 32;80866;
2FGR;A;High resolution Xray structure of Omp32;1.5;CA;CALCIUM ION;Outer membrane porin protein 32;80866;
2FGZ;A;Crystal Structure Analysis of apo pullulanase from Klebsiella pneumoniae;1.75;CA;CALCIUM ION;pullulanase;548;
2FH1;A;C-terminal half of gelsolin soaked in low calcium at pH 4.5;1.55;CA;CALCIUM ION;Gelsolin;9606;
2FH1;B;C-terminal half of gelsolin soaked in low calcium at pH 4.5;1.55;CA;CALCIUM ION;Gelsolin;9606;
2FH1;C;C-terminal half of gelsolin soaked in low calcium at pH 4.5;1.55;CA;CALCIUM ION;Gelsolin;9606;
2FH2;A;C-terminal half of gelsolin soaked in EGTA at pH 4.5;2.5;CA;CALCIUM ION;Gelsolin;9606;
2FH2;B;C-terminal half of gelsolin soaked in EGTA at pH 4.5;2.5;CA;CALCIUM ION;Gelsolin;9606;
2FH2;C;C-terminal half of gelsolin soaked in EGTA at pH 4.5;2.5;CA;CALCIUM ION;Gelsolin;9606;
2FH3;A;C-terminal half of gelsolin soaked in low calcium at pH 8;2.87;CA;CALCIUM ION;Gelsolin;9606;
2FH3;B;C-terminal half of gelsolin soaked in low calcium at pH 8;2.87;CA;CALCIUM ION;Gelsolin;9606;
2FH3;C;C-terminal half of gelsolin soaked in low calcium at pH 8;2.87;CA;CALCIUM ION;Gelsolin;9606;
2FH6;A;Crystal Structure Analysis of Klebsiella pneumoniae pullulanase complexed with glucose;1.8;CA;CALCIUM ION;pullulanase;548;
2FH8;A;Crystal Structure Analysis of Klebsiella pneumoniae pullulanase complexed with isomaltose;1.9;CA;CALCIUM ION;pullulanase;548;
2FHA;A;HUMAN H CHAIN FERRITIN;1.9;CA;CALCIUM ION;FERRITIN;9606;
2FHB;A;Crystal Structure Analysis of Klebsiella pneumoniae pullulanase complexed with maltose;1.8;CA;CALCIUM ION;pullulanase;548;
2FHC;A;Crystal Structure Analysis of Klebsiella pneumoniae pullulanase complexed with maltotriose;1.85;CA;CALCIUM ION;pullulanase;548;
2FHF;A;Crystal Structure Analysis of Klebsiella pneumoniae pullulanase complexed with maltotetraose;1.65;CA;CALCIUM ION;pullulanase;548;
2FI1;A;The crystal structure of a hydrolase from Streptococcus pneumoniae TIGR4;1.4;CA;CALCIUM ION;hydrolase, haloacid dehalogenase-like family;1313;
2FI3;E;Crystal structure of a BPTI variant (Cys14->Ser, Cys38->Ser) in complex with trypsin;1.58;CA;CALCIUM ION;Cationic trypsin;9913;
2FI3;I;Crystal structure of a BPTI variant (Cys14->Ser, Cys38->Ser) in complex with trypsin;1.58;CA;CALCIUM ION;Pancreatic trypsin inhibitor;9913;
2FI4;E;Crystal structure of a BPTI variant (Cys14->Ser) in complex with trypsin;1.58;CA;CALCIUM ION;Cationic trypsin;9913;
2FI4;I;Crystal structure of a BPTI variant (Cys14->Ser) in complex with trypsin;1.58;CA;CALCIUM ION;Pancreatic trypsin inhibitor;9913;
2FI5;E;Crystal structure of a BPTI variant (Cys38->Ser) in complex with trypsin;1.58;CA;CALCIUM ION;Cationic trypsin;9913;
2FI5;I;Crystal structure of a BPTI variant (Cys38->Ser) in complex with trypsin;1.58;CA;CALCIUM ION;Pancreatic trypsin inhibitor;9913;
2FIB;A;RECOMBINANT HUMAN GAMMA-FIBRINOGEN CARBOXYL TERMINAL FRAGMENT (RESIDUES 143-411) COMPLEXED TO THE PEPTIDE GLY-PRO-ARG-PRO AT PH 6.0;2.01;CA;CALCIUM ION;FIBRINOGEN;9606;
2FIR;H;Crystal structure of DFPR-VIIa/sTF;2;CA;CALCIUM ION;Coagulation factor VII Heavy Chain (EC 3.4.21.21);9606;
2FIR;L;Crystal structure of DFPR-VIIa/sTF;2;CA;CALCIUM ION;Coagulation factor VII Light chain;9606;
2FJU;B;Activated Rac1 bound to its effector phospholipase C beta 2;2.2;CA;CALCIUM ION;1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase beta 2;9606;
2FKC;A;Crystal Form I of Pre-Reactive Complex of Restriction Endonuclease HinP1I with Cognate DNA and Calcium Ion;2.39;CA;CALCIUM ION;R.HinP1I restriction endonuclease;727;
2FKC;B;Crystal Form I of Pre-Reactive Complex of Restriction Endonuclease HinP1I with Cognate DNA and Calcium Ion;2.39;CA;CALCIUM ION;R.HinP1I restriction endonuclease;727;
2FKC;C;Crystal Form I of Pre-Reactive Complex of Restriction Endonuclease HinP1I with Cognate DNA and Calcium Ion;2.39;CA;CALCIUM ION;5'-D(*CP*CP*AP*GP*CP*GP*CP*TP*GP*G)-3';;
2FKH;B;Crystal Form II of Pre-Reactive Complex of Restriction Endonuclease HinP1I with Cognate DNA and Calcium Ions;3.09;CA;CALCIUM ION;R.HinP1I Restriction Endonuclease;727;
2FKH;E;Crystal Form II of Pre-Reactive Complex of Restriction Endonuclease HinP1I with Cognate DNA and Calcium Ions;3.09;CA;CALCIUM ION;5'-D(*CP*CP*AP*GP*CP*GP*CP*TP*GP*G)-3';;
2FLD;A;I-MsoI Re-Designed for Altered DNA Cleavage Specificity;2;CA;CALCIUM ION;DNA ENDONUCLEASE I-MSOI;141716;
2FLD;B;I-MsoI Re-Designed for Altered DNA Cleavage Specificity;2;CA;CALCIUM ION;DNA ENDONUCLEASE I-MSOI;141716;
2FM1;A;Crystal structure of L-ALLO-threonine aldolase (tm1744) from Thermotoga maritima at 2.25 A resolution;2.25;CA;CALCIUM ION;L-allo-threonine aldolase;2336;
2FMD;A;Structural basis of carbohydrate recognition by Bowringia milbraedii seed agglutinin;1.9;CA;CALCIUM ION;Lectin;28956;
2FMJ;A;220-loop mutant of streptomyces griseus trypsin;1.65;CA;CALCIUM ION;Trypsin;1911;
2FN3;A;High resolution structure of s26a mutant of benzoylformate decarboxylase from pseudomonas putida complexed with thiamine thiazolone diphosphate;1;CA;CALCIUM ION;Benzoylformate decarboxylase;303;
2FNQ;A;Insights from the X-ray crystal structure of coral 8R-lipoxygenase: calcium activation via A C2-like domain and a structural basis of product chirality;3.2;CA;CALCIUM ION;Allene oxide synthase-lipoxygenase protein;47982;
2FNQ;B;Insights from the X-ray crystal structure of coral 8R-lipoxygenase: calcium activation via A C2-like domain and a structural basis of product chirality;3.2;CA;CALCIUM ION;Allene oxide synthase-lipoxygenase protein;47982;
2FO9;A;Structure of porcine pancreatic elastase in 95% acetone;2;CA;CALCIUM ION;elastase-1;9823;
2FOA;A;Structure of porcine pancreatic elastase in 40/50/10 % benzene;1.9;CA;CALCIUM ION;elastase-1;9823;
2FOB;A;Structure of porcine pancreatic elastase in 40/50/10 cyclohexane;1.9;CA;CALCIUM ION;elastase-1;9823;
2FOC;A;Structure of porcine pancreatic elastase in 55% dimethylformamide;2;CA;CALCIUM ION;elastase-1;9823;
2FOD;A;Structure of porcine pancreatic elastase in 80% ethanol;2;CA;CALCIUM ION;elastase-1;9823;
2FOE;A;Structure of porcine pancreatic elastase in 80% hexane;2.2;CA;CALCIUM ION;elastase-1;9823;
2FOF;A;Structure of porcine pancreatic elastase in 80% isopropanol;2.2;CA;CALCIUM ION;elastase-1;9823;
2FOG;A;Structure of porcine pancreatic elastase in 40% trifluoroethanol;1.9;CA;CALCIUM ION;elastase-1;9823;
2FOH;A;Structure of porcine pancreatic elastase in 40% trifluoroethanol;1.8;CA;CALCIUM ION;elastase-1;9823;
2FOT;A;Crystal structure of the complex between calmodulin and alphaII-spectrin;2.45;CA;CALCIUM ION;Calmodulin;9913;
2FPS;A;Crystal structure of the N-terminal domain of E.coli HisB- Apo Ca model.;2.2;CA;CALCIUM ION;Histidine biosynthesis bifunctional protein hisB;562;
2FPS;B;Crystal structure of the N-terminal domain of E.coli HisB- Apo Ca model.;2.2;CA;CALCIUM ION;Histidine biosynthesis bifunctional protein hisB;562;
2FPW;A;Crystal Structure of the N-terminal Domain of E.coli HisB- Phosphoaspartate intermediate.;1.75;CA;CALCIUM ION;Histidine biosynthesis bifunctional protein hisB;562;
2FPW;B;Crystal Structure of the N-terminal Domain of E.coli HisB- Phosphoaspartate intermediate.;1.75;CA;CALCIUM ION;Histidine biosynthesis bifunctional protein hisB;562;
2FRH;A;Crystal Structure of Sara, A Transcription Regulator From Staphylococcus Aureus;2.5;CA;CALCIUM ION;Staphylococcal accessory regulator A;1280;
2FRH;B;Crystal Structure of Sara, A Transcription Regulator From Staphylococcus Aureus;2.5;CA;CALCIUM ION;Staphylococcal accessory regulator A;1280;
2FTL;E;Crystal structure of trypsin complexed with BPTI at 100K;1.62;CA;CALCIUM ION;Cationic trypsin;9913;
2FTL;I;Crystal structure of trypsin complexed with BPTI at 100K;1.62;CA;CALCIUM ION;Pancreatic trypsin inhibitor;9913;
2FTM;A;Crystal structure of trypsin complexed with the BPTI variant (Tyr35->Gly);1.65;CA;CALCIUM ION;Cationic trypsin;9913;
2FTM;B;Crystal structure of trypsin complexed with the BPTI variant (Tyr35->Gly);1.65;CA;CALCIUM ION;Pancreatic trypsin inhibitor;9913;
2FVY;A;High Resolution Glucose Bound Crystal Structure of GGBP;0.92;CA;CALCIUM ION;D-galactose-binding periplasmic protein;562;
2FW0;A;Apo Open Form of Glucose/Galactose Binding Protein;1.55;CA;CALCIUM ION;D-galactose-binding periplasmic protein;562;
2FWN;A;Phosphorylation of an active site serine in a ThDP-dependent enzyme by phosphonate inactivation;1.4;CA;CALCIUM ION;Benzoylformate decarboxylase;303;
2FWS;A;First Ca2+ binding domain of the Na,Ca-exchanger (NCX1);;CA;CALCIUM ION;Sodium/calcium exchanger 1;9612;
2FWU;A;Second Ca2+ binding domain of the Na,Ca-exchanger (NCX1);;CA;CALCIUM ION;Sodium/calcium exchanger 1;9612;
2FX4;A;Bovine trypsin bound by 4-piperidinebutyrate to make acylenzyme complex;1.65;CA;CALCIUM ION;trypsin;9913;
2FX6;A;bovine trypsin complexed with 2-aminobenzamidazole;1.57;CA;CALCIUM ION;Trypsin;9913;
2FXF;A;Human spermidine/spermine N1-acetyltransferase;2;CA;CALCIUM ION;Diamine acetyltransferase 1;9606;
2FXF;B;Human spermidine/spermine N1-acetyltransferase;2;CA;CALCIUM ION;Diamine acetyltransferase 1;9606;
2FXU;A;X-ray Structure of Bistramide A- Actin Complex at 1.35 A resolution.;1.35;CA;CALCIUM ION;Actin, alpha skeletal muscle;9986;
2FYC;A;Crystal structure of the catalytic domain of bovine beta1,4-galactosyltransferase-I in complex with alpha-lactalbumin, Ca and UDP-galactose;2;CA;CALCIUM ION;Alpha-lactalbumin;10090;
2FYC;B;Crystal structure of the catalytic domain of bovine beta1,4-galactosyltransferase-I in complex with alpha-lactalbumin, Ca and UDP-galactose;2;CA;CALCIUM ION;beta-1,4-galactosyltransferase;9913;
2FYC;C;Crystal structure of the catalytic domain of bovine beta1,4-galactosyltransferase-I in complex with alpha-lactalbumin, Ca and UDP-galactose;2;CA;CALCIUM ION;Alpha-lactalbumin;10090;
2FYC;D;Crystal structure of the catalytic domain of bovine beta1,4-galactosyltransferase-I in complex with alpha-lactalbumin, Ca and UDP-galactose;2;CA;CALCIUM ION;beta-1,4-galactosyltransferase;9913;
2FYD;A;catalytic domain of bovine beta 1, 4-galactosyltransferase in complex with alpha-lactalbumin, glucose, Mn, and UDP-N-acetylgalactosamine;2;CA;CALCIUM ION;Alpha-lactalbumin;10090;
2FYD;C;catalytic domain of bovine beta 1, 4-galactosyltransferase in complex with alpha-lactalbumin, glucose, Mn, and UDP-N-acetylgalactosamine;2;CA;CALCIUM ION;Alpha-lactalbumin;10090;
2FYL;B;Haddock model of the complex between double module of LRP, CR56, and first domain of receptor associated protein, RAP-d1.;;CA;CALCIUM ION;Low-density lipoprotein receptor-related protein 1;9606;
2FZA;A;Crystal structure of d(GCGGGAGC): the base-intercalated duplex;3.6;CA;CALCIUM ION;5'-D(*GP*(CBR)P*GP*GP*GP*AP*GP*C)-3';;
2FZA;B;Crystal structure of d(GCGGGAGC): the base-intercalated duplex;3.6;CA;CALCIUM ION;5'-D(*GP*(CBR)P*GP*GP*GP*AP*GP*C)-3';;
2FZV;A;Crystal Structure of an apo form of a Flavin-binding Protein from Shigella flexneri;1.7;CA;CALCIUM ION;putative arsenical resistance protein;623;
2G0I;A;Crystal structure of SMU.848 from Streptococcus mutans;1.85;CA;CALCIUM ION;hypothetical protein SMU.848;1309;
2G0I;B;Crystal structure of SMU.848 from Streptococcus mutans;1.85;CA;CALCIUM ION;hypothetical protein SMU.848;1309;
2G0Y;A;Crystal Structure of a Lumenal Pentapeptide Repeat Protein from Cyanothece sp 51142 at 2.3 Angstrom Resolution. Tetragonal Crystal Form;2.3;CA;CALCIUM ION;pentapeptide repeat protein;43989;
2G18;E;Crystal Structure of Nostoc sp. 7120 phycocyanobilin:ferredoxin oxidoreductase (PcyA) Apoprotein;2.5;CA;CALCIUM ION;Phycocyanobilin:ferredoxin oxidoreductase;1167;
2G32;L;Crystal structure of an RNA racemate;1.3;CA;CALCIUM ION;RNA (5'-R(*(0C)P*(0C)P*(0G)P*(0C)P*(0C)P*(0U)P*(0G)P*(0G))-3');274;
2G32;M;Crystal structure of an RNA racemate;1.3;CA;CALCIUM ION;RNA (5'-R(*(0C)P*(0U)P*(0G)P*(0G)P*(0G)P*(0C)P*(0G)P*(0G))-3');274;
2G32;N;Crystal structure of an RNA racemate;1.3;CA;CALCIUM ION;RNA (5'-R(*(0C)P*(0C)P*(0G)P*(0C)P*(0C)P*(0U)P*(0G)P*(0G))-3');274;
2G42;B;Crystal structure of a putative nucleic acid binding protein (tm0693) from thermotoga maritima at 2.28 A resolution;2.28;CA;CALCIUM ION;hypothetical protein TM_0693;2336;
2G4I;A;Anomalous substructure of Concanavalin A;2.4;CA;CALCIUM ION;Concanavalin A;28958;
2G4J;A;Anomalous substructure of Glucose isomerase;1.85;CA;CALCIUM ION;Xylose isomerase;1929;
2G4N;A;Anomalous substructure of alpha-lactalbumin;2.3;CA;CALCIUM ION;Alpha-lactalbumin;9913;
2G4N;B;Anomalous substructure of alpha-lactalbumin;2.3;CA;CALCIUM ION;Alpha-lactalbumin;9913;
2G4N;C;Anomalous substructure of alpha-lactalbumin;2.3;CA;CALCIUM ION;Alpha-lactalbumin;9913;
2G4N;D;Anomalous substructure of alpha-lactalbumin;2.3;CA;CALCIUM ION;Alpha-lactalbumin;9913;
2G4N;E;Anomalous substructure of alpha-lactalbumin;2.3;CA;CALCIUM ION;Alpha-lactalbumin;9913;
2G4N;F;Anomalous substructure of alpha-lactalbumin;2.3;CA;CALCIUM ION;Alpha-lactalbumin;9913;
2G4U;A;Anomalous substructure of porcine pancreatic elastaase (Ca);1.84;CA;CALCIUM ION;elastase-1;9823;
2G4V;A;anomalous substructure of proteinase K;2.14;CA;CALCIUM ION;Proteinase K;37998;
2G4Z;A;anomalous substructure of thermolysin;1.98;CA;CALCIUM ION;Thermolysin;1427;
2G55;A;Anomalous substructure of trypsin (P3121);1.82;CA;CALCIUM ION;Cationic trypsin;9913;
2G5N;A;Indole-amidine Complexes with Bovine Trypsin;1.51;CA;CALCIUM ION;Cationic trypsin;9913;
2G5V;A;Indole-amidine Complexes with Bovine Trypsin;1.45;CA;CALCIUM ION;Cationic trypsin;9913;
2G81;E;Crystal Structure of the Bowman-Birk Inhibitor from Vigna unguiculata Seeds in Complex with Beta-trypsin at 1.55 Angstrons Resolution;1.55;CA;CALCIUM ION;Cationic trypsin;9913;
2G8E;A;Calpain 1 proteolytic core in complex with SNJ-1715, a cyclic hemiacetal-type inhibitor;2.25;CA;CALCIUM ION;Calpain-1 catalytic subunit;10116;
2G8J;A;Calpain 1 proteolytic core in complex with SNJ-1945, a alpha-ketoamide-type inhibitor.;1.61;CA;CALCIUM ION;Calpain-1 catalytic subunit;10116;
2G8K;A;B. halodurans RNase H catalytic domain D192N mutant in complex with Ca2+ and RNA/DNA hybrid (non-P nick at the active site);1.65;CA;CALCIUM ION;Ribonuclease H;86665;
2G8S;A;Crystal structure of the soluble Aldose sugar dehydrogenase (Asd) from Escherichia coli in the apo-form;1.5;CA;CALCIUM ION;Glucose/sorbosone dehydrogenases;562;
2G8S;B;Crystal structure of the soluble Aldose sugar dehydrogenase (Asd) from Escherichia coli in the apo-form;1.5;CA;CALCIUM ION;Glucose/sorbosone dehydrogenases;562;
2G8T;A;Indole-amidine Complexes with Bovine Trypsin;1.41;CA;CALCIUM ION;Cationic trypsin;9913;
2G8W;A;B. halodurans RNase H catalytic domain E188A mutant in complex with Ca2+ and RNA/DNA hybrid;2.05;CA;CALCIUM ION;Ribonuclease H;86665;
2GA9;D;Crystal Structure of the Heterodimeric Vaccinia Virus Polyadenylate Polymerase with Bound ATP-gamma-S;2.3;CA;CALCIUM ION;Poly(A) polymerase catalytic subunit;10245;
2GBP;A;SUGAR AND SIGNAL-TRANSDUCER BINDING SITES OF THE ESCHERICHIA COLI GALACTOSE CHEMORECEPTOR PROTEIN;1.9;CA;CALCIUM ION;D-GALACTOSE/D-GLUCOSE BINDING PROTEIN;562;
2GD4;B;Crystal Structure of the Antithrombin-S195A Factor Xa-Pentasaccharide Complex;3.3;CA;CALCIUM ION;Coagulation factor, Stuart factor, Stuart-Prower factor, Contains: Factor X light chain;;
2GD4;H;Crystal Structure of the Antithrombin-S195A Factor Xa-Pentasaccharide Complex;3.3;CA;CALCIUM ION;Coagulation factor, Stuart factor, Stuart-Prower factor, Contains: Factor X light chain;;
2GDF;B;Crystal structure of Dioclea violacea seed lectin;2.4;CA;CALCIUM ION;lectin;192415;
2GDF;D;Crystal structure of Dioclea violacea seed lectin;2.4;CA;CALCIUM ION;lectin;192415;
2GE5;A;EcoRV Restriction Endonuclease C-terminal deletion mutant/GATATC/Ca2+;2.4;CA;CALCIUM ION;Type II restriction enzyme EcoRV;562;
2GEB;A;Crystal structure of the Thermoanaerobacter tengcongensis hypoxanthine-guanine phosphoribosyltransferase L160I mutant: insights into the inhibitor design;1.7;CA;CALCIUM ION;Hypoxanthine-guanine phosphoribosyltransferase;911092;
2GF4;A;Crystal structure of Vng1086c from Halobacterium salinarium (Halobacterium halobium). Northeast Structural Genomics Target HsR14;2.07;CA;CALCIUM ION;Protein Vng1086c;2242;
2GF4;B;Crystal structure of Vng1086c from Halobacterium salinarium (Halobacterium halobium). Northeast Structural Genomics Target HsR14;2.07;CA;CALCIUM ION;Protein Vng1086c;2242;
2GF6;C;CRYSTAL STRUCTURE OF A PUTATIVE THIOESTERASE (SSO2295) FROM SULFOLOBUS SOLFATARICUS AT 1.91 A RESOLUTION;1.91;CA;CALCIUM ION;Conserved hypothetical protein;2287;
2GFT;A;Crystal structure of the E263A nucleophile mutant of Bacillus licheniformis endo-beta-1,4-galactanase in complex with galactotriose;2.3;CA;CALCIUM ION;Glycosyl Hydrolase Family 53;1402;
2GFT;B;Crystal structure of the E263A nucleophile mutant of Bacillus licheniformis endo-beta-1,4-galactanase in complex with galactotriose;2.3;CA;CALCIUM ION;Glycosyl Hydrolase Family 53;1402;
2GGM;A;Human centrin 2 xeroderma pigmentosum group C protein complex;2.35;CA;CALCIUM ION;Centrin-2;9606;
2GGM;B;Human centrin 2 xeroderma pigmentosum group C protein complex;2.35;CA;CALCIUM ION;Centrin-2;9606;
2GGU;A;crystal structure of the trimeric neck and carbohydrate recognition domain of human surfactant protein D in complex with maltotriose;1.9;CA;CALCIUM ION;Pulmonary surfactant-associated protein D;9606;
2GGU;B;crystal structure of the trimeric neck and carbohydrate recognition domain of human surfactant protein D in complex with maltotriose;1.9;CA;CALCIUM ION;Pulmonary surfactant-associated protein D;9606;
2GGU;C;crystal structure of the trimeric neck and carbohydrate recognition domain of human surfactant protein D in complex with maltotriose;1.9;CA;CALCIUM ION;Pulmonary surfactant-associated protein D;9606;
2GGX;A;Crystal structure of the trimer neck and carbohydrate recognition domain of human surfactant protein D in complex with p-nitrophenyl maltoside;1.9;CA;CALCIUM ION;Pulmonary surfactant-associated protein D;9606;
2GGX;B;Crystal structure of the trimer neck and carbohydrate recognition domain of human surfactant protein D in complex with p-nitrophenyl maltoside;1.9;CA;CALCIUM ION;Pulmonary surfactant-associated protein D;9606;
2GGX;C;Crystal structure of the trimer neck and carbohydrate recognition domain of human surfactant protein D in complex with p-nitrophenyl maltoside;1.9;CA;CALCIUM ION;Pulmonary surfactant-associated protein D;9606;
2GGZ;A;Crystal Structure of Human Guanylate Cyclase Activating Protein-3;3;CA;CALCIUM ION;Guanylyl cyclase-activating protein 3;9606;
2GGZ;B;Crystal Structure of Human Guanylate Cyclase Activating Protein-3;3;CA;CALCIUM ION;Guanylyl cyclase-activating protein 3;9606;
2GIH;A;Q138F HincII bound to cognate DNA GTCGAC and Ca2+;2.5;CA;CALCIUM ION;Type II restriction enzyme HincII;727;
2GIH;B;Q138F HincII bound to cognate DNA GTCGAC and Ca2+;2.5;CA;CALCIUM ION;Type II restriction enzyme HincII;727;
2GIJ;A;Q138F HincII bound to cognate DNA GTTAAC and Ca2+;1.93;CA;CALCIUM ION;Type II restriction enzyme HincII;727;
2GIJ;B;Q138F HincII bound to cognate DNA GTTAAC and Ca2+;1.93;CA;CALCIUM ION;Type II restriction enzyme HincII;727;
2GJM;A;Crystal structure of Buffalo lactoperoxidase at 2.75A resolution;2.75;CA;CALCIUM ION;Lactoperoxidase;89462;
2GJP;A;Structure of Bacillus halmapalus alpha-amylase, crystallized with the substrate analogue acarbose and maltose;1.9;CA;CALCIUM ION;alpha-amylase;79882;
2GJR;A;Structure of bacillus halmapalus alpha-amylase without any substrate analogues;2.1;CA;CALCIUM ION;alpha-amylase;79882;
2GJV;A;Crystal Structure of a Protein of Unknown Function from Salmonella typhimurium;2.39;CA;CALCIUM ION;putative cytoplasmic protein;90371;
2GJV;B;Crystal Structure of a Protein of Unknown Function from Salmonella typhimurium;2.39;CA;CALCIUM ION;putative cytoplasmic protein;90371;
2GJV;C;Crystal Structure of a Protein of Unknown Function from Salmonella typhimurium;2.39;CA;CALCIUM ION;putative cytoplasmic protein;90371;
2GJV;D;Crystal Structure of a Protein of Unknown Function from Salmonella typhimurium;2.39;CA;CALCIUM ION;putative cytoplasmic protein;90371;
2GJV;E;Crystal Structure of a Protein of Unknown Function from Salmonella typhimurium;2.39;CA;CALCIUM ION;putative cytoplasmic protein;90371;
2GJV;F;Crystal Structure of a Protein of Unknown Function from Salmonella typhimurium;2.39;CA;CALCIUM ION;putative cytoplasmic protein;90371;
2GKO;A;S41 Psychrophilic Protease;1.4;CA;CALCIUM ION;microbial serine proteinases;;
2GND;A;One hour EDTA treatment, P. angolensis lectin;2.25;CA;CALCIUM ION;lectin;182271;
2GND;B;One hour EDTA treatment, P. angolensis lectin;2.25;CA;CALCIUM ION;lectin;182271;
2GNM;A;P. angolensis lectin (PAL) treated with EDTA for 39 hours;1.95;CA;CALCIUM ION;lectin;182271;
2GNM;B;P. angolensis lectin (PAL) treated with EDTA for 39 hours;1.95;CA;CALCIUM ION;lectin;182271;
2GNT;A;EDTA treated P. angolensis lectin (PAL) remetallized with calcium (1 hour treatment);2.02;CA;CALCIUM ION;lectin;182271;
2GNT;B;EDTA treated P. angolensis lectin (PAL) remetallized with calcium (1 hour treatment);2.02;CA;CALCIUM ION;lectin;182271;
2GP7;A;Estrogen Related Receptor-gamma ligand binding domain;2.45;CA;CALCIUM ION;Estrogen-related receptor gamma;9606;
2GPJ;A;CRYSTAL STRUCTURE OF A SIDEROPHORE-INTERACTING PROTEIN (SPUTCN32_0076) FROM SHEWANELLA PUTREFACIENS CN-32 AT 2.20 A RESOLUTION;2.2;CA;CALCIUM ION;Siderophore-interacting protein;24;
2GPM;L;Crystal structure of an RNA racemate;1.4;CA;CALCIUM ION;RNA (5'-R(*(0C)P*(0C)P*(0G)P*(0C)P*(0C)P*(0U)P*(0G)P*(0G))-3');;
2GPM;M;Crystal structure of an RNA racemate;1.4;CA;CALCIUM ION;RNA (5'-R(*(0C)P*(0U)P*(0G)P*(0G)P*(0G)P*(0C)P*(0G)P*(0G))-3');;
2GPM;N;Crystal structure of an RNA racemate;1.4;CA;CALCIUM ION;RNA (5'-R(*(0C)P*(0C)P*(0G)P*(0C)P*(0C)P*(0U)P*(0G)P*(0G))-3');;
2GQ4;L;Crystal structure of an RNA racemate;1.35;CA;CALCIUM ION;RNA (5'-R(*(0C)P*(0C)P*(0G)P*(0C)P*(0C)P*(0U)P*(0G)P*(0G))-3');;
2GQ4;M;Crystal structure of an RNA racemate;1.35;CA;CALCIUM ION;RNA (5'-R(*(0C)P*(0U)P*(0G)P*(0G)P*(0G)P*(0C)P*(0G)P*(0G))-3');;
2GQ4;N;Crystal structure of an RNA racemate;1.35;CA;CALCIUM ION;RNA (5'-R(*(0C)P*(0C)P*(0G)P*(0C)P*(0C)P*(0U)P*(0G)P*(0G))-3');;
2GQ5;L;Crystal structure of an RNA racemate;1.4;CA;CALCIUM ION;RNA (5'-R(*(0C)P*(0C)P*(0G)P*(0C)P*(0C)P*(0U)P*(0G)P*(0G))-3');;
2GQ5;M;Crystal structure of an RNA racemate;1.4;CA;CALCIUM ION;RNA (5'-R(*(0C)P*(0U)P*(0G)P*(0G)P*(0G)P*(0C)P*(0G)P*(0G))-3');;
2GQ5;N;Crystal structure of an RNA racemate;1.4;CA;CALCIUM ION;RNA (5'-R(*(0C)P*(0C)P*(0G)P*(0C)P*(0C)P*(0U)P*(0G)P*(0G))-3');;
2GQ6;L;Crystal structure of an RNA racemate;1.3;CA;CALCIUM ION;RNA (5'-R(*(0C)P*(0C)P*(0G)P*(0C)P*(0C)P*(0U)P*(0G)P*(0G))-3');;
2GQ6;M;Crystal structure of an RNA racemate;1.3;CA;CALCIUM ION;RNA (5'-R(*(0C)P*(0U)P*(0G)P*(0G)P*(0G)P*(0C)P*(0G)P*(0G))-3');;
2GQ6;N;Crystal structure of an RNA racemate;1.3;CA;CALCIUM ION;RNA (5'-R(*(0C)P*(0C)P*(0G)P*(0C)P*(0C)P*(0U)P*(0G)P*(0G))-3');;
2GQ7;L;Crystal structure of an RNA racemate;1.6;CA;CALCIUM ION;RNA (5'-R(*(0C)P*(0C)P*(0G)P*(0C)P*(0C)P*(0U)P*(0G)P*(0G))-3');;
2GQ7;M;Crystal structure of an RNA racemate;1.6;CA;CALCIUM ION;RNA (5'-R(*(0C)P*(0U)P*(0G)P*(0G)P*(0G)P*(0C)P*(0G)P*(0G))-3');;
2GQ7;N;Crystal structure of an RNA racemate;1.6;CA;CALCIUM ION;RNA (5'-R(*(0C)P*(0C)P*(0G)P*(0C)P*(0C)P*(0U)P*(0G)P*(0G))-3');;
2GQT;A;Crystal Structure of UDP-N-Acetylenolpyruvylglucosamine Reductase (MurB) from Thermus caldophilus;1.3;CA;CALCIUM ION;UDP-N-Acetylenolpyruvylglucosamine Reductase;272;
2GSE;A;Crystal Structure of Human Dihydropyrimidinease-like 2;2.4;CA;CALCIUM ION;Dihydropyrimidinase-related protein 2;9606;
2GSE;B;Crystal Structure of Human Dihydropyrimidinease-like 2;2.4;CA;CALCIUM ION;Dihydropyrimidinase-related protein 2;9606;
2GSE;C;Crystal Structure of Human Dihydropyrimidinease-like 2;2.4;CA;CALCIUM ION;Dihydropyrimidinase-related protein 2;9606;
2GSE;D;Crystal Structure of Human Dihydropyrimidinease-like 2;2.4;CA;CALCIUM ION;Dihydropyrimidinase-related protein 2;9606;
2GSK;A;Structure of the BtuB:TonB Complex;2.1;CA;CALCIUM ION;Vitamin B12 transporter btuB;562;
2GSM;A;Catalytic Core (Subunits I and II) of Cytochrome c oxidase from Rhodobacter sphaeroides;2;CA;CALCIUM ION;Cytochrome c oxidase subunit 1;1063;
2GSM;C;Catalytic Core (Subunits I and II) of Cytochrome c oxidase from Rhodobacter sphaeroides;2;CA;CALCIUM ION;Cytochrome c oxidase subunit 1;1063;
2GSP;A;RIBONUCLEASE T1/2',3'-CGPS AND 3'-GMP, 2 DAYS;1.8;CA;CALCIUM ION;RIBONUCLEASE T1;5062;
2GSY;A;The 2.6A structure of Infectious Bursal Virus Derived T=1 Particles;2.6;CA;CALCIUM ION;polyprotein;10995;
2GSY;B;The 2.6A structure of Infectious Bursal Virus Derived T=1 Particles;2.6;CA;CALCIUM ION;polyprotein;10995;
2GSY;C;The 2.6A structure of Infectious Bursal Virus Derived T=1 Particles;2.6;CA;CALCIUM ION;polyprotein;10995;
2GSY;D;The 2.6A structure of Infectious Bursal Virus Derived T=1 Particles;2.6;CA;CALCIUM ION;polyprotein;10995;
2GSY;F;The 2.6A structure of Infectious Bursal Virus Derived T=1 Particles;2.6;CA;CALCIUM ION;polyprotein;10995;
2GSY;G;The 2.6A structure of Infectious Bursal Virus Derived T=1 Particles;2.6;CA;CALCIUM ION;polyprotein;10995;
2GSY;L;The 2.6A structure of Infectious Bursal Virus Derived T=1 Particles;2.6;CA;CALCIUM ION;polyprotein;10995;
2GSY;M;The 2.6A structure of Infectious Bursal Virus Derived T=1 Particles;2.6;CA;CALCIUM ION;polyprotein;10995;
2GSY;O;The 2.6A structure of Infectious Bursal Virus Derived T=1 Particles;2.6;CA;CALCIUM ION;polyprotein;10995;
2GSY;S;The 2.6A structure of Infectious Bursal Virus Derived T=1 Particles;2.6;CA;CALCIUM ION;polyprotein;10995;
2GSY;T;The 2.6A structure of Infectious Bursal Virus Derived T=1 Particles;2.6;CA;CALCIUM ION;polyprotein;10995;
2GTL;M;Lumbricus Erythrocruorin at 3.5A resolution;3.5;CA;CALCIUM ION;Hemoglobin linker chain L1;6398;
2GTL;N;Lumbricus Erythrocruorin at 3.5A resolution;3.5;CA;CALCIUM ION;Extracellular hemoglobin linker L2 subunit;6398;
2GTL;O;Lumbricus Erythrocruorin at 3.5A resolution;3.5;CA;CALCIUM ION;Extracellular hemoglobin linker L3 subunit;6398;
2GUY;A;Orthorhombic crystal structure (space group P21212) of Aspergillus niger alpha-amylase at 1.6 A resolution;1.59;CA;CALCIUM ION;Alpha-amylase A;5062;
2GVU;A;Crystal structure of diisopropyl fluorophosphatase (DFPase), mutant D229N / N120D;2;CA;CALCIUM ION;Phosphotriesterase;6622;
2GVV;A;Structure of diisopropyl fluorophosphatase (DFPase) in complex with dicyclopentylphosphoroamidate (DcPPA);1.73;CA;CALCIUM ION;Phosphotriesterase;6622;
2GVW;A;Structure of diisopropyl fluorophosphatase (DFPase) holoenzyme (RT);1.86;CA;CALCIUM ION;Phosphotriesterase;6622;
2GVX;A;Structure of diisopropyl fluorophosphatase (DFPase), mutant D229N / N175D;2;CA;CALCIUM ION;diisopropyl fluorophosphatase;6622;
2GVY;A;Monoclinic crystal form of Aspergillus niger alpha-amylase in complex with maltose at 1.8 A resolution;1.8;CA;CALCIUM ION;Alpha-amylase A;5062;
2GVY;B;Monoclinic crystal form of Aspergillus niger alpha-amylase in complex with maltose at 1.8 A resolution;1.8;CA;CALCIUM ION;Alpha-amylase A;5062;
2GW0;A;A D(TGGGGT)- sodium and calcium complex.;1.55;CA;CALCIUM ION;5'-D(*TP*GP*GP*GP*GP*T)-3';;
2GW0;B;A D(TGGGGT)- sodium and calcium complex.;1.55;CA;CALCIUM ION;5'-D(*TP*GP*GP*GP*GP*T)-3';;
2GW0;D;A D(TGGGGT)- sodium and calcium complex.;1.55;CA;CALCIUM ION;5'-D(*TP*GP*GP*GP*GP*T)-3';;
2GWJ;A;SpvB ADP-ribosylated actin: hexagonal crystal form;1.9;CA;CALCIUM ION;Actin, alpha skeletal muscle;9986;
2GWK;A;SpvB ADP-ribosylated actin: orthorhombic crystal form;2;CA;CALCIUM ION;Actin, alpha skeletal muscle;9986;
2GWK;B;SpvB ADP-ribosylated actin: orthorhombic crystal form;2;CA;CALCIUM ION;Actin, alpha skeletal muscle;9986;
2GWR;A;Crystal structure of the response regulator protein mtrA from Mycobacterium Tuberculosis;2.1;CA;CALCIUM ION;DNA-binding response regulator mtrA;1773;
2GXS;A;HERA N-terminal domain in complex with AMP, crystal form 2;1.66;CA;CALCIUM ION;heat resistant RNA dependent ATPase;274;
2GXS;B;HERA N-terminal domain in complex with AMP, crystal form 2;1.66;CA;CALCIUM ION;heat resistant RNA dependent ATPase;274;
2GY7;A;Angiopoietin-2/Tie2 Complex Crystal Structure;3.7;CA;CALCIUM ION;Angiopoietin-2;9606;
2H0B;A;Crystal Structure of the second LNS/LG domain from Neurexin 1 alpha;2.1;CA;CALCIUM ION;Neurexin-1-alpha;9913;
2H0B;B;Crystal Structure of the second LNS/LG domain from Neurexin 1 alpha;2.1;CA;CALCIUM ION;Neurexin-1-alpha;9913;
2H0B;C;Crystal Structure of the second LNS/LG domain from Neurexin 1 alpha;2.1;CA;CALCIUM ION;Neurexin-1-alpha;9913;
2H0B;D;Crystal Structure of the second LNS/LG domain from Neurexin 1 alpha;2.1;CA;CALCIUM ION;Neurexin-1-alpha;9913;
2H0K;A;Crystal Structure of a Mutant of Rat Annexin A5;2.76;CA;CALCIUM ION;Annexin A5;10116;
2H0K;B;Crystal Structure of a Mutant of Rat Annexin A5;2.76;CA;CALCIUM ION;Annexin A5;10116;
2H0L;A;Crystal Structure of a Mutant of Rat Annexin A5;2.59;CA;CALCIUM ION;Annexin A5;10116;
2H1I;A;Crystal Structure of the Bacillus cereus Carboxylesterase;2.8;CA;CALCIUM ION;Carboxylesterase;1396;
2H1I;B;Crystal Structure of the Bacillus cereus Carboxylesterase;2.8;CA;CALCIUM ION;Carboxylesterase;1396;
2H1I;C;Crystal Structure of the Bacillus cereus Carboxylesterase;2.8;CA;CALCIUM ION;Carboxylesterase;1396;
2H1U;A;Porcine pancreatic elastase complexed with MetPheLeuGlu at pH 5.0;1.6;CA;CALCIUM ION;Elastase-1;9823;
2H2A;A;Crystal structure of Nicotinic acid mononucleotide adenylyltransferase from Staphylococcus aureus: product bound form 2;2.1;CA;CALCIUM ION;Probable nicotinate-nucleotide adenylyltransferase;1280;
2H2K;A;Crystal Structure Analysis of Human S100A13;2;CA;CALCIUM ION;Protein S100-A13;9606;
2H2K;B;Crystal Structure Analysis of Human S100A13;2;CA;CALCIUM ION;Protein S100-A13;9606;
2H2N;A;Crystal structure of human soluble calcium-activated nucleotidase (SCAN) with calcium ion;2.3;CA;CALCIUM ION;Soluble calcium-activated nucleotidase 1;9606;
2H2N;B;Crystal structure of human soluble calcium-activated nucleotidase (SCAN) with calcium ion;2.3;CA;CALCIUM ION;Soluble calcium-activated nucleotidase 1;9606;
2H2T;B;CD23 Lectin domain, Calcium 2+-bound;1.3;CA;CALCIUM ION;Low affinity immunoglobulin epsilon Fc receptor (Lymphocyte IgE receptor) (Fc-epsilon-RII) (Immunoglobulin E-binding factor) (CD23 antigen);9606;
2H2U;A;Crystal structure of the E130Y mutant of human soluble calcium-activated nucleotidase (SCAN) with calcium ion;2.4;CA;CALCIUM ION;Soluble calcium-activated nucleotidase 1;9606;
2H2U;B;Crystal structure of the E130Y mutant of human soluble calcium-activated nucleotidase (SCAN) with calcium ion;2.4;CA;CALCIUM ION;Soluble calcium-activated nucleotidase 1;9606;
2H43;B;Crystal Structure of Human Fragment D Complexed with Ala-His-Arg-Pro-amide;2.7;CA;CALCIUM ION;Fibrinogen beta chain;9606;
2H43;C;Crystal Structure of Human Fragment D Complexed with Ala-His-Arg-Pro-amide;2.7;CA;CALCIUM ION;Fibrinogen gamma chain;9606;
2H43;E;Crystal Structure of Human Fragment D Complexed with Ala-His-Arg-Pro-amide;2.7;CA;CALCIUM ION;Fibrinogen beta chain;9606;
2H43;F;Crystal Structure of Human Fragment D Complexed with Ala-His-Arg-Pro-amide;2.7;CA;CALCIUM ION;Fibrinogen gamma chain;9606;
2H61;A;X-ray structure of human Ca2+-loaded S100B;1.9;CA;CALCIUM ION;Protein S100-B;9606;
2H61;B;X-ray structure of human Ca2+-loaded S100B;1.9;CA;CALCIUM ION;Protein S100-B;9606;
2H61;C;X-ray structure of human Ca2+-loaded S100B;1.9;CA;CALCIUM ION;Protein S100-B;9606;
2H61;D;X-ray structure of human Ca2+-loaded S100B;1.9;CA;CALCIUM ION;Protein S100-B;9606;
2H61;E;X-ray structure of human Ca2+-loaded S100B;1.9;CA;CALCIUM ION;Protein S100-B;9606;
2H61;F;X-ray structure of human Ca2+-loaded S100B;1.9;CA;CALCIUM ION;Protein S100-B;9606;
2H61;G;X-ray structure of human Ca2+-loaded S100B;1.9;CA;CALCIUM ION;Protein S100-B;9606;
2H61;H;X-ray structure of human Ca2+-loaded S100B;1.9;CA;CALCIUM ION;Protein S100-B;9606;
2H9D;D;Pyruvate-Bound Structure of the Isochorismate-Pyruvate Lyase from Pseudomonas aerugionsa;1.95;CA;CALCIUM ION;Salicylate biosynthesis protein pchB;287;
2HAX;C;Crystal structure of Bacillus caldolyticus cold shock protein in complex with hexathymidine;1.29;CA;CALCIUM ION;5'-D(*TP*TP*TP*TP*TP*T)-3';;
2HCK;A;SRC FAMILY KINASE HCK-QUERCETIN COMPLEX;3;CA;CALCIUM ION;HEMATOPOETIC CELL KINASE HCK;9606;
2HCK;B;SRC FAMILY KINASE HCK-QUERCETIN COMPLEX;3;CA;CALCIUM ION;HEMATOPOETIC CELL KINASE HCK;9606;
2HCN;A;Crystal structure of RNA dependent RNA polymerase domain from west nile virus;2.35;CA;CALCIUM ION;RNA-directed RNA polymerase (NS5);11082;
2HD4;A;Crystal structure of proteinase K inhibited by a lactoferrin octapeptide Gly-Asp-Glu-Gln-Gly-Glu-Asn-Lys at 2.15 A resolution;2.15;CA;CALCIUM ION;Proteinase K;37998;
2HD9;A;Crystal structure of PH1033 from Pyrococcus horikoshii OT3;1.35;CA;CALCIUM ION;UPF0310 protein PH1033;53953;
2HES;X;Cytosolic Iron-sulphur Assembly Protein- 1;1.7;CA;CALCIUM ION;Ydr267cp;4932;
2HET;A;Non-myristoylated bovine recoverin (truncated at C-terminus) with calcium bound to EF-hand 3;3;CA;CALCIUM ION;Recoverin;9913;
2HET;B;Non-myristoylated bovine recoverin (truncated at C-terminus) with calcium bound to EF-hand 3;3;CA;CALCIUM ION;Recoverin;9913;
2HET;C;Non-myristoylated bovine recoverin (truncated at C-terminus) with calcium bound to EF-hand 3;3;CA;CALCIUM ION;Recoverin;9913;
2HET;D;Non-myristoylated bovine recoverin (truncated at C-terminus) with calcium bound to EF-hand 3;3;CA;CALCIUM ION;Recoverin;9913;
2HF3;A;Crystal structure of monomeric Actin in the ADP bound state;1.8;CA;CALCIUM ION;Actin-5C;7227;
2HF4;A;Crystal structure of Monomeric Actin in its ATP-bound state;1.8;CA;CALCIUM ION;Actin-5C;7227;
2HF5;A;The structure and function of a novel two-site calcium-binding fragment of calmodulin;;CA;CALCIUM ION;Calmodulin;9606;
2HI8;X;human formylglycine generating enzyme, C336S mutant, bromide co-crystallization;1.64;CA;CALCIUM ION;Sulfatase-modifying factor 1;9606;
2HIB;X;human formylglycine generating enzyme, C336S mutant, iodide co-crystallization;2;CA;CALCIUM ION;Sulfatase-modifying factor 1;9606;
2HIH;A;Crystal structure of Staphylococcus hyicus lipase;2.86;CA;CALCIUM ION;Lipase 46 kDa form;1284;
2HIH;B;Crystal structure of Staphylococcus hyicus lipase;2.86;CA;CALCIUM ION;Lipase 46 kDa form;1284;
2HLO;B;Crystal Structure of Fragment D-dimer from Human Fibrin Complexed with Gly-hydroxyPro-Arg-Pro-amide;2.6;CA;CALCIUM ION;Fibrin beta chain;9606;
2HLO;C;Crystal Structure of Fragment D-dimer from Human Fibrin Complexed with Gly-hydroxyPro-Arg-Pro-amide;2.6;CA;CALCIUM ION;Fibrin, gamma polypeptide;9606;
2HLO;E;Crystal Structure of Fragment D-dimer from Human Fibrin Complexed with Gly-hydroxyPro-Arg-Pro-amide;2.6;CA;CALCIUM ION;Fibrin beta chain;9606;
2HLO;F;Crystal Structure of Fragment D-dimer from Human Fibrin Complexed with Gly-hydroxyPro-Arg-Pro-amide;2.6;CA;CALCIUM ION;Fibrin, gamma polypeptide;9606;
2HN2;A;Crystal structure of the CorA Mg2+ transporter homologue from T. maritima in complex with divalent cations;3.7;CA;CALCIUM ION;Magnesium transport protein corA;2336;
2HN2;B;Crystal structure of the CorA Mg2+ transporter homologue from T. maritima in complex with divalent cations;3.7;CA;CALCIUM ION;Magnesium transport protein corA;2336;
2HN2;C;Crystal structure of the CorA Mg2+ transporter homologue from T. maritima in complex with divalent cations;3.7;CA;CALCIUM ION;Magnesium transport protein corA;2336;
2HN2;D;Crystal structure of the CorA Mg2+ transporter homologue from T. maritima in complex with divalent cations;3.7;CA;CALCIUM ION;Magnesium transport protein corA;2336;
2HN2;E;Crystal structure of the CorA Mg2+ transporter homologue from T. maritima in complex with divalent cations;3.7;CA;CALCIUM ION;Magnesium transport protein corA;2336;
2HNF;A;Structure of a Hyper-cleavable Monomeric Fragment of Phage lambda Repressor Containing the Cleavage Site Region;1.8;CA;CALCIUM ION;Repressor protein cI101-229DM-K192A;562;
2HO0;A;Structure of a Hyper-cleavable Monomeric Fragment of Phage Lambda Repressor Containing the Cleavage Site Region;2.5;CA;CALCIUM ION;Repressor protein cI101-229DM-K192A;562;
2HOD;B;Crystal Structure of Fragment D from Human Fibrinogen Complexed with Gly-hydroxyPro-Arg-Pro-amide;2.9;CA;CALCIUM ION;Fibrinogen beta chain;9606;
2HOD;C;Crystal Structure of Fragment D from Human Fibrinogen Complexed with Gly-hydroxyPro-Arg-Pro-amide;2.9;CA;CALCIUM ION;Fibrinogen, gamma polypeptide;9606;
2HOD;E;Crystal Structure of Fragment D from Human Fibrinogen Complexed with Gly-hydroxyPro-Arg-Pro-amide;2.9;CA;CALCIUM ION;Fibrinogen beta chain;9606;
2HOD;F;Crystal Structure of Fragment D from Human Fibrinogen Complexed with Gly-hydroxyPro-Arg-Pro-amide;2.9;CA;CALCIUM ION;Fibrinogen, gamma polypeptide;9606;
2HOD;H;Crystal Structure of Fragment D from Human Fibrinogen Complexed with Gly-hydroxyPro-Arg-Pro-amide;2.9;CA;CALCIUM ION;Fibrinogen beta chain;9606;
2HOD;I;Crystal Structure of Fragment D from Human Fibrinogen Complexed with Gly-hydroxyPro-Arg-Pro-amide;2.9;CA;CALCIUM ION;Fibrinogen, gamma polypeptide;9606;
2HOD;K;Crystal Structure of Fragment D from Human Fibrinogen Complexed with Gly-hydroxyPro-Arg-Pro-amide;2.9;CA;CALCIUM ION;Fibrinogen beta chain;9606;
2HOD;L;Crystal Structure of Fragment D from Human Fibrinogen Complexed with Gly-hydroxyPro-Arg-Pro-amide;2.9;CA;CALCIUM ION;Fibrinogen, gamma polypeptide;9606;
2HOH;C;RIBONUCLEASE T1 (N9A MUTANT) COMPLEXED WITH 2'GMP;1.9;CA;CALCIUM ION;PROTEIN (RIBONUCLEASE T1);5062;
2HOH;D;RIBONUCLEASE T1 (N9A MUTANT) COMPLEXED WITH 2'GMP;1.9;CA;CALCIUM ION;PROTEIN (RIBONUCLEASE T1);5062;
2HOK;A;Crystal structure of an E. coli thi-box riboswitch bound to thiamine pyrophosphate, calcium ions;3.2;CA;CALCIUM ION;thi-box riboswitch;;
2HOL;A;Crystal structure of an E. coli thi-box riboswitch bound to thiamine pyrophosphate, barium ions;2.9;CA;CALCIUM ION;thi-box riboswitch;;
2HOM;A;Crystal structure of an E. coli thi-box riboswitch bound to thiamine monophosphate;2.89;CA;CALCIUM ION;thi-box riboswitch;;
2HOO;A;Crystal structure of an E. coli thi-box riboswitch bound to benfotiamine;3;CA;CALCIUM ION;thi-box riboswitch;;
2HOP;A;Crystal structure of an E. coli thi-box riboswitch bound to pyrithiamine;3.3;CA;CALCIUM ION;thi-box riboswitch;;
2HPC;B;Crystal structure of fragment D from Human Fibrinogen Complexed with Gly-Pro-Arg-Pro-amide.;2.9;CA;CALCIUM ION;Fibrinogen beta chain;9606;
2HPC;C;Crystal structure of fragment D from Human Fibrinogen Complexed with Gly-Pro-Arg-Pro-amide.;2.9;CA;CALCIUM ION;Fibrinogen, gamma polypeptide;9606;
2HPC;E;Crystal structure of fragment D from Human Fibrinogen Complexed with Gly-Pro-Arg-Pro-amide.;2.9;CA;CALCIUM ION;Fibrinogen beta chain;9606;
2HPC;F;Crystal structure of fragment D from Human Fibrinogen Complexed with Gly-Pro-Arg-Pro-amide.;2.9;CA;CALCIUM ION;Fibrinogen, gamma polypeptide;9606;
2HPC;H;Crystal structure of fragment D from Human Fibrinogen Complexed with Gly-Pro-Arg-Pro-amide.;2.9;CA;CALCIUM ION;Fibrinogen beta chain;9606;
2HPC;I;Crystal structure of fragment D from Human Fibrinogen Complexed with Gly-Pro-Arg-Pro-amide.;2.9;CA;CALCIUM ION;Fibrinogen, gamma polypeptide;9606;
2HPC;K;Crystal structure of fragment D from Human Fibrinogen Complexed with Gly-Pro-Arg-Pro-amide.;2.9;CA;CALCIUM ION;Fibrinogen beta chain;9606;
2HPC;L;Crystal structure of fragment D from Human Fibrinogen Complexed with Gly-Pro-Arg-Pro-amide.;2.9;CA;CALCIUM ION;Fibrinogen, gamma polypeptide;9606;
2HPH;A;High resolution structure of E. coli glucose/galactose binding protein bound with glucose;1.33;CA;CALCIUM ION;D-galactose-binding periplasmic protein;562;
2HPZ;A;Crystal structure of proteinase K complex with a synthetic peptide KLKLLVVIRLK at 1.69 A resolution;1.69;CA;CALCIUM ION;Proteinase K;37998;
2HQ8;A;Crystal structure of coelenterazine-binding protein from renilla muelleri in the ca loaded apo form;1.8;CA;CALCIUM ION;Coelenterazine-binding protein ca-bound apo form;37510;
2HQ8;B;Crystal structure of coelenterazine-binding protein from renilla muelleri in the ca loaded apo form;1.8;CA;CALCIUM ION;Coelenterazine-binding protein ca-bound apo form;37510;
2HQW;A;Crystal Structure of Ca2+/Calmodulin bound to NMDA Receptor NR1C1 peptide;1.9;CA;CALCIUM ION;Calmodulin;10116;
2HRG;A;Crystal Structure of Blue Laccase from Trametes trogii complexed with p-methylbenzoate;1.58;CA;CALCIUM ION;Laccase;76130;
2HT5;A;N8 Neuraminidase;2.4;CA;CALCIUM ION;Neuraminidase;11320;
2HTV;A;N4 neuraminidase;2.8;CA;CALCIUM ION;Neuraminidase;11320;
2HTV;B;N4 neuraminidase;2.8;CA;CALCIUM ION;Neuraminidase;11320;
2HTY;A;N1 neuraminidase;2.5;CA;CALCIUM ION;Neuraminidase;11320;
2HTY;B;N1 neuraminidase;2.5;CA;CALCIUM ION;Neuraminidase;11320;
2HTY;C;N1 neuraminidase;2.5;CA;CALCIUM ION;Neuraminidase;11320;
2HTY;D;N1 neuraminidase;2.5;CA;CALCIUM ION;Neuraminidase;11320;
2HTY;E;N1 neuraminidase;2.5;CA;CALCIUM ION;Neuraminidase;11320;
2HTY;F;N1 neuraminidase;2.5;CA;CALCIUM ION;Neuraminidase;11320;
2HTY;G;N1 neuraminidase;2.5;CA;CALCIUM ION;Neuraminidase;11320;
2HTY;H;N1 neuraminidase;2.5;CA;CALCIUM ION;Neuraminidase;11320;
2HU6;A;Crystal structure of human MMP-12 in complex with acetohydroxamic acid and a bicyclic inhibitor;1.32;CA;CALCIUM ION;Macrophage metalloelastase;9606;
2HYJ;A;The crystal structure of a tetR-family transcriptional regulator from Streptomyces coelicolor;2.19;CA;CALCIUM ION;Putative tetR-family transcriptional regulator;1902;
2HYK;A;The crystal structure of an endo-beta-1,3-glucanase from alkaliphilic Nocardiopsis sp.strain F96;1.3;CA;CALCIUM ION;Beta-1,3-glucanase;221582;
2HYU;A;Human Annexin A2 with heparin tetrasaccharide bound;1.86;CA;CALCIUM ION;Annexin A2;9606;
2HYV;A;Human Annexin A2 with heparin hexasaccharide bound;1.42;CA;CALCIUM ION;Annexin A2;9606;
2HYW;A;Human Annexin A2 with Calcium bound;2.1;CA;CALCIUM ION;Annexin A2;9606;
2HYW;B;Human Annexin A2 with Calcium bound;2.1;CA;CALCIUM ION;Annexin A2;9606;
2HZY;A;Mouse fumarylacetoacetate hydrolase complexes with a transition-state mimic of the complete substrate;1.35;CA;CALCIUM ION;Fumarylacetoacetase;10090;
2I08;A;Solvation effect in conformational changes of EF-hand proteins: X-ray structure of Ca2+-saturated double mutant Q41L-K75I of N-domain of calmodulin;2;CA;CALCIUM ION;Calmodulin;9606;
2I0F;A;Lumazine synthase RibH1 from Brucella abortus (Gene BruAb1_0785, Swiss-Prot entry Q57DY1);2.22;CA;CALCIUM ION;6,7-dimethyl-8-ribityllumazine synthase 1;235;
2I0F;B;Lumazine synthase RibH1 from Brucella abortus (Gene BruAb1_0785, Swiss-Prot entry Q57DY1);2.22;CA;CALCIUM ION;6,7-dimethyl-8-ribityllumazine synthase 1;235;
2I0F;E;Lumazine synthase RibH1 from Brucella abortus (Gene BruAb1_0785, Swiss-Prot entry Q57DY1);2.22;CA;CALCIUM ION;6,7-dimethyl-8-ribityllumazine synthase 1;235;
2I0U;E;Crystal structures of phospholipases A2 from Vipera nikolskii venom revealing Triton X-100 bound in hydrophobic channel;2.2;CA;CALCIUM ION;Basic subunit of heterodimer phospholipase A2;1808362;
2I1P;A;Solution structure of the twelfth cysteine-rich ligand-binding repeat in rat megalin;;CA;CALCIUM ION;Low-density lipoprotein receptor-related protein 2;10116;
2I1Q;A;RadA Recombinase in complex with Calcium;1.9;CA;CALCIUM ION;DNA repair and recombination protein radA;2188;
2I2R;E;Crystal structure of the KChIP1/Kv4.3 T1 complex;3.35;CA;CALCIUM ION;Kv channel-interacting protein 1;9606;
2I2R;F;Crystal structure of the KChIP1/Kv4.3 T1 complex;3.35;CA;CALCIUM ION;Kv channel-interacting protein 1;9606;
2I2R;G;Crystal structure of the KChIP1/Kv4.3 T1 complex;3.35;CA;CALCIUM ION;Kv channel-interacting protein 1;9606;
2I2R;H;Crystal structure of the KChIP1/Kv4.3 T1 complex;3.35;CA;CALCIUM ION;Kv channel-interacting protein 1;9606;
2I2R;M;Crystal structure of the KChIP1/Kv4.3 T1 complex;3.35;CA;CALCIUM ION;Kv channel-interacting protein 1;9606;
2I2R;N;Crystal structure of the KChIP1/Kv4.3 T1 complex;3.35;CA;CALCIUM ION;Kv channel-interacting protein 1;9606;
2I2R;O;Crystal structure of the KChIP1/Kv4.3 T1 complex;3.35;CA;CALCIUM ION;Kv channel-interacting protein 1;9606;
2I2R;P;Crystal structure of the KChIP1/Kv4.3 T1 complex;3.35;CA;CALCIUM ION;Kv channel-interacting protein 1;9606;
2I3P;A;K28R mutant of Homing Endonuclease I-CreI;2.3;CA;CALCIUM ION;DNA endonuclease I-CreI;3055;
2I3P;B;K28R mutant of Homing Endonuclease I-CreI;2.3;CA;CALCIUM ION;DNA endonuclease I-CreI;3055;
2I3Q;A;Q44V mutant of Homing Endonuclease I-CreI;2.3;CA;CALCIUM ION;DNA endonuclease I-CreI;3055;
2I3Q;B;Q44V mutant of Homing Endonuclease I-CreI;2.3;CA;CALCIUM ION;DNA endonuclease I-CreI;3055;
2I44;A;Crystal structure of serine-threonine phosphatase 2C from Toxoplasma gondii;2.04;CA;CALCIUM ION;Serine-threonine phosphatase 2C;5811;
2I44;B;Crystal structure of serine-threonine phosphatase 2C from Toxoplasma gondii;2.04;CA;CALCIUM ION;Serine-threonine phosphatase 2C;5811;
2I44;C;Crystal structure of serine-threonine phosphatase 2C from Toxoplasma gondii;2.04;CA;CALCIUM ION;Serine-threonine phosphatase 2C;5811;
2I4B;A;Crystal structure of Bicarbonate Transport Protein CmpA from Synechocystis sp. PCC 6803 in complex with bicarbonate and calcium;1.35;CA;CALCIUM ION;Bicarbonate transporter;1148;
2I4C;A;Crystal structure of Bicarbonate Transport Protein CmpA from Synechocystis sp. PCC 6803 in complex with bicarbonate and calcium;1.7;CA;CALCIUM ION;Bicarbonate transporter;1148;
2I52;A;Crystal structure of protein PTO0218 from Picrophilus torridus, Pfam DUF372;2.08;CA;CALCIUM ION;Hypothetical protein;82076;
2I52;B;Crystal structure of protein PTO0218 from Picrophilus torridus, Pfam DUF372;2.08;CA;CALCIUM ION;Hypothetical protein;82076;
2I52;C;Crystal structure of protein PTO0218 from Picrophilus torridus, Pfam DUF372;2.08;CA;CALCIUM ION;Hypothetical protein;82076;
2I52;D;Crystal structure of protein PTO0218 from Picrophilus torridus, Pfam DUF372;2.08;CA;CALCIUM ION;Hypothetical protein;82076;
2I52;E;Crystal structure of protein PTO0218 from Picrophilus torridus, Pfam DUF372;2.08;CA;CALCIUM ION;Hypothetical protein;82076;
2I52;F;Crystal structure of protein PTO0218 from Picrophilus torridus, Pfam DUF372;2.08;CA;CALCIUM ION;Hypothetical protein;82076;
2I5W;A;Structure of hOGG1 crosslinked to DNA sampling a normal G adjacent to an oxoG;2.6;CA;CALCIUM ION;N-glycosylase/DNA lyase;9606;
2I5W;F;Structure of hOGG1 crosslinked to DNA sampling a normal G adjacent to an oxoG;2.6;CA;CALCIUM ION;5'-D(P*CP*CP*AP*GP*(G42)P*TP*CP*TP*AP*C)-3';;
2I6H;A;Structure of Protein of Unknown Function ATU0120 from Agrobacterium tumefaciens;1.75;CA;CALCIUM ION;Hypothetical protein Atu0120;1176649;
2I6H;B;Structure of Protein of Unknown Function ATU0120 from Agrobacterium tumefaciens;1.75;CA;CALCIUM ION;Hypothetical protein Atu0120;1176649;
2I6O;B;Crystal structure of the complex of the archaeal sulfolobus PTP-fold phosphatase with phosphopeptides N-G-(p)Y-K-N;1.9;CA;CALCIUM ION;NK(PTR)GN;;
2I7A;A;Domain IV of Human Calpain 13;1.8;CA;CALCIUM ION;Calpain 13;9606;
2I8T;A;GDP-mannose mannosyl hydrolase-calcium-GDP-mannose complex;1.3;CA;CALCIUM ION;GDP-mannose mannosyl hydrolase;562;
2I8T;B;GDP-mannose mannosyl hydrolase-calcium-GDP-mannose complex;1.3;CA;CALCIUM ION;GDP-mannose mannosyl hydrolase;562;
2I8U;A;GDP-mannose mannosyl hydrolase-calcium-GDP product complex;1.4;CA;CALCIUM ION;GDP-mannose mannosyl hydrolase;562;
2I8U;B;GDP-mannose mannosyl hydrolase-calcium-GDP product complex;1.4;CA;CALCIUM ION;GDP-mannose mannosyl hydrolase;562;
2I94;A;NMR Structure of recoverin bound to rhodopsin kinase;;CA;CALCIUM ION;Recoverin;9913;
2IA6;A;Bypass of Major Benzopyrene-dG Adduct by Y-Family DNA Polymerase with Unique Structural Gap;2.5;CA;CALCIUM ION;DNA polymerase IV;2287;
2IA6;B;Bypass of Major Benzopyrene-dG Adduct by Y-Family DNA Polymerase with Unique Structural Gap;2.5;CA;CALCIUM ION;DNA polymerase IV;2287;
2IAO;A;Crystal structure of squid ganglion DFPase E37Q mutant;2;CA;CALCIUM ION;DIISOPROPYLFLUOROPHOSPHATASE;6622;
2IAP;A;Crystal structure of squid ganglion DFPase E21Q mutant;1.9;CA;CALCIUM ION;Diisopropylfluorophosphatase;6622;
2IAQ;A;Crystal structure of squid ganglion DFPase S271A mutant;2.1;CA;CALCIUM ION;Diisopropylfluorophosphatase;6622;
2IAR;A;Crystal structure of squid ganglion DFPase W244H mutant;1.9;CA;CALCIUM ION;Diisopropylfluorophosphatase;6622;
2IAS;A;Crystal structure of squid ganglion DFPase W244F mutant;2;CA;CALCIUM ION;Diisopropylfluorophosphatase;6622;
2IAT;A;Crystal structure of squid ganglion DFPase W244L mutant;1.9;CA;CALCIUM ION;Diisopropylfluorophosphatase;6622;
2IAU;A;Crystal structure of squid ganglion DFPase W244Y mutant;2;CA;CALCIUM ION;Diisopropylfluorophosphatase;6622;
2IAV;A;Crystal structure of squid ganglion DFPase H287A mutant;1.07;CA;CALCIUM ION;Diisopropylfluorophosphatase;6622;
2IAW;A;Crystal structure of squid ganglion DFPase N175D mutant;1.74;CA;CALCIUM ION;Diisopropylfluorophosphatase;6622;
2IAX;A;Crystal structure of squid ganglion DFPase D232S mutant;1.1;CA;CALCIUM ION;Diisopropylfluorophosphatase;6622;
2IBK;A;Bypass of Major Benzopyrene-dG Adduct by Y-Family DNA Polymerase with Unique Structural Gap;2.25;CA;CALCIUM ION;DNA polymerase IV;2287;
2ICE;A;CRIg bound to C3c;3.1;CA;CALCIUM ION;Complement C3 beta chain;9606;
2ICE;D;CRIg bound to C3c;3.1;CA;CALCIUM ION;Complement C3 beta chain;9606;
2ICF;A;CRIg bound to C3b;4.1;CA;CALCIUM ION;Complement C3 beta chain;9606;
2ID3;A;Crystal structure of transcriptional regulator SCO5951 from Streptomyces coelicolor A3(2);1.7;CA;CALCIUM ION;Putative transcriptional regulator;1902;
2ID3;B;Crystal structure of transcriptional regulator SCO5951 from Streptomyces coelicolor A3(2);1.7;CA;CALCIUM ION;Putative transcriptional regulator;1902;
2ID4;A;The 1.9 A structure of Kex2 in complex with an Ac-R-E-R-K-chloromethyl ketone inhibitor.;1.9;CA;CALCIUM ION;Kexin;4932;
2ID4;B;The 1.9 A structure of Kex2 in complex with an Ac-R-E-R-K-chloromethyl ketone inhibitor.;1.9;CA;CALCIUM ION;Kexin;4932;
2ID8;A;Crystal structure of Proteinase K;1.27;CA;CALCIUM ION;Proteinase K;37998;
2IDJ;B;Crystal Structure of Rat Glycine N-Methyltransferase Apoprotein, Monoclinic Form;2.35;CA;CALCIUM ION;Glycine N-methyltransferase;10116;
2IDJ;C;Crystal Structure of Rat Glycine N-Methyltransferase Apoprotein, Monoclinic Form;2.35;CA;CALCIUM ION;Glycine N-methyltransferase;10116;
2IE6;A;Annexin V under 2.0 MPa pressure of xenon;1.83;CA;CALCIUM ION;Annexin A5;10116;
2IE7;A;Annexin V under 2.0 MPa pressure of nitrous oxide;1.75;CA;CALCIUM ION;Annexin A5;10116;
2IEW;A;Crystal structure of Inositol Phosphate Multikinase Ipk2 from S. cerevisiae;2;CA;CALCIUM ION;Inositol polyphosphate multikinase;4932;
2IEZ;A;Crystal Structure of mouse Rab27b bound to GDP in monoclinic space group;2.8;CA;CALCIUM ION;Ras-related protein Rab-27B;10090;
2IEZ;B;Crystal Structure of mouse Rab27b bound to GDP in monoclinic space group;2.8;CA;CALCIUM ION;Ras-related protein Rab-27B;10090;
2IEZ;H;Crystal Structure of mouse Rab27b bound to GDP in monoclinic space group;2.8;CA;CALCIUM ION;Ras-related protein Rab-27B;10090;
2IEZ;I;Crystal Structure of mouse Rab27b bound to GDP in monoclinic space group;2.8;CA;CALCIUM ION;Ras-related protein Rab-27B;10090;
2IF7;A;Crystal Structure of NTB-A;3;CA;CALCIUM ION;SLAM family member 6;9606;
2IF7;D;Crystal Structure of NTB-A;3;CA;CALCIUM ION;SLAM family member 6;9606;
2IF8;A;Crystal structure of Inositol Phosphate Multikinase Ipk2 in complex with ADP and Mn2+ from S. cerevisiae;2.4;CA;CALCIUM ION;Inositol polyphosphate multikinase;4932;
2IG9;B;Structure of a full-length Homoprotocatechuate 2,3-Dioxygenase from B. fuscum in a new spacegroup.;1.9;CA;CALCIUM ION;Homoprotocatechuate 2,3-dioxygenase;47914;
2IGA;B;Structure of Homoprotocatechuate 2,3-Dioxygenase from B. fuscum in complex with reactive intermediates formed via in crystallo reaction with 4-nitrocatechol at low oxygen concentrations.;1.95;CA;CALCIUM ION;Homoprotocatechuate 2,3-dioxygenase;47914;
2II1;A;Crystal structure of Acetamidase (10172637) from Bacillus Halodurans at 1.95 A resolution;1.95;CA;CALCIUM ION;Acetamidase;86665;
2II1;B;Crystal structure of Acetamidase (10172637) from Bacillus Halodurans at 1.95 A resolution;1.95;CA;CALCIUM ION;Acetamidase;86665;
2II1;C;Crystal structure of Acetamidase (10172637) from Bacillus Halodurans at 1.95 A resolution;1.95;CA;CALCIUM ION;Acetamidase;86665;
2II1;D;Crystal structure of Acetamidase (10172637) from Bacillus Halodurans at 1.95 A resolution;1.95;CA;CALCIUM ION;Acetamidase;86665;
2IIC;A;Calcium bound structure of alpha-11 giardin;2.93;CA;CALCIUM ION;Alpha-11 giardin;5741;
2IIC;B;Calcium bound structure of alpha-11 giardin;2.93;CA;CALCIUM ION;Alpha-11 giardin;5741;
2IIC;C;Calcium bound structure of alpha-11 giardin;2.93;CA;CALCIUM ION;Alpha-11 giardin;5741;
2IIC;D;Calcium bound structure of alpha-11 giardin;2.93;CA;CALCIUM ION;Alpha-11 giardin;5741;
2III;A;Crystal structure of the adenosylmethionine decarboxylase (aq_254) from aquifex aeolicus vf5;2.3;CA;CALCIUM ION;S-adenosylmethionine decarboxylase proenzyme;63363;
2IIM;A;SH3 Domain of Human Lck;1;CA;CALCIUM ION;Proto-oncogene tyrosine-protein kinase LCK;9606;
2IKC;A;Crystal structure of sheep lactoperoxidase at 3.25 A resolution reveals the binding sites for formate;3.25;CA;CALCIUM ION;milk lactoperoxidase;9940;
2IKC;B;Crystal structure of sheep lactoperoxidase at 3.25 A resolution reveals the binding sites for formate;3.25;CA;CALCIUM ION;milk lactoperoxidase;9940;
2IL1;A;Crystal structure of a predicted human GTPase in complex with GDP;2.1;CA;CALCIUM ION;Rab12;9606;
2IMW;P;Mechanism of Template-Independent Nucleotide Incorporation Catalyzed by a Template-Dependent DNA Polymerase;2.05;CA;CALCIUM ION;DNA polymerase IV;2287;
2IO4;B;Crystal structure of PCNA12 dimer from Sulfolobus solfataricus.;2.6;CA;CALCIUM ION;DNA polymerase sliding clamp C;2287;
2IPL;A;Crystal structure of a disulfide mutant glucose binding protein;1.2;CA;CALCIUM ION;D-galactose-binding periplasmic protein;562;
2IPM;A;Crystal structure of a disulfide mutant glucose binding protein;1.12;CA;CALCIUM ION;D-galactose-binding periplasmic protein;562;
2IPN;A;Crystal structure of a disulfide mutant glucose binding protein;1.15;CA;CALCIUM ION;D-galactose-binding periplasmic protein;562;
2IPS;A;Crystal structure of a ternary complex of bovine lactoperoxidase with thiocyanate and iodide at 3.1 A resolution;3.1;CA;CALCIUM ION;Lactoperoxidase;9913;
2IPX;A;Human Fibrillarin;1.82;CA;CALCIUM ION;rRNA 2'-O-methyltransferase fibrillarin;9606;
2IQY;A;Rat Phosphatidylethanolamine-Binding Protein;1.4;CA;CALCIUM ION;Phosphatidylethanolamine-binding protein 1;10116;
2ISM;A;Crystal structure of the putative oxidoreductase (glucose dehydrogenase) (TTHA0570) from thermus theromophilus HB8;1.9;CA;CALCIUM ION;Putative oxidoreductase;274;
2ISM;B;Crystal structure of the putative oxidoreductase (glucose dehydrogenase) (TTHA0570) from thermus theromophilus HB8;1.9;CA;CALCIUM ION;Putative oxidoreductase;274;
2IT5;A;Crystal Structure of DCSIGN-CRD with man6;2.4;CA;CALCIUM ION;CD209 antigen, DCSIGN-CRD;9606;
2IT6;A;Crystal Structure of DCSIGN-CRD with man2;1.95;CA;CALCIUM ION;CD209 antigen;9606;
2IUF;A;The structures of Penicillium vitale catalase: resting state, oxidised state (compound I) and complex with aminotriazole;1.71;CA;CALCIUM ION;CATALASE;5079;
2IUF;E;The structures of Penicillium vitale catalase: resting state, oxidised state (compound I) and complex with aminotriazole;1.71;CA;CALCIUM ION;CATALASE;5079;
2IUN;B;Structure of the C-terminal head domain of the avian adenovirus CELO long fibre (P21 crystal form);2.8;CA;CALCIUM ION;AVIAN ADENOVIRUS CELO LONG FIBRE;190061;
2IVZ;A;Structure of TolB in complex with a peptide of the colicin E9 T- domain;2;CA;CALCIUM ION;PROTEIN TOLB;562;
2IVZ;B;Structure of TolB in complex with a peptide of the colicin E9 T- domain;2;CA;CALCIUM ION;PROTEIN TOLB;562;
2IVZ;C;Structure of TolB in complex with a peptide of the colicin E9 T- domain;2;CA;CALCIUM ION;PROTEIN TOLB;562;
2IVZ;D;Structure of TolB in complex with a peptide of the colicin E9 T- domain;2;CA;CALCIUM ION;PROTEIN TOLB;562;
2IWA;A;Unbound glutaminyl cyclotransferase from Carica papaya.;1.6;CA;CALCIUM ION;GLUTAMINE CYCLOTRANSFERASE;3649;
2IWF;A;Resting form of pink nitrous oxide reductase from Achromobacter Cycloclastes;1.86;CA;CALCIUM ION;NITROUS-OXIDE REDUCTASE;223;
2IWF;B;Resting form of pink nitrous oxide reductase from Achromobacter Cycloclastes;1.86;CA;CALCIUM ION;NITROUS-OXIDE REDUCTASE;223;
2IWK;A;Inhibitor-bound form of nitrous oxide reductase from Achromobacter Cycloclastes at 1.7 Angstrom resolution;1.7;CA;CALCIUM ION;NITROUS OXIDE REDUCTASE;223;
2IWK;B;Inhibitor-bound form of nitrous oxide reductase from Achromobacter Cycloclastes at 1.7 Angstrom resolution;1.7;CA;CALCIUM ION;NITROUS OXIDE REDUCTASE;223;
2IWV;A;Structure of the monomeric outer membrane porin OmpG in the open and closed conformation;2.3;CA;CALCIUM ION;OUTER MEMBRANE PROTEIN G;562;
2IWV;B;Structure of the monomeric outer membrane porin OmpG in the open and closed conformation;2.3;CA;CALCIUM ION;OUTER MEMBRANE PROTEIN G;562;
2IWV;C;Structure of the monomeric outer membrane porin OmpG in the open and closed conformation;2.3;CA;CALCIUM ION;OUTER MEMBRANE PROTEIN G;562;
2IWV;D;Structure of the monomeric outer membrane porin OmpG in the open and closed conformation;2.3;CA;CALCIUM ION;OUTER MEMBRANE PROTEIN G;562;
2IX0;A;RNase II;2.44;CA;CALCIUM ION;EXORIBONUCLEASE 2;562;
2IXT;A;SPHERICASE;0.8;CA;CALCIUM ION;36KDA PROTEASE;1421;
2IXT;B;SPHERICASE;0.8;CA;CALCIUM ION;36KDA PROTEASE;1421;
2J0G;A;L-ficolin complexed to N-acetyl-mannosamine;2.85;CA;CALCIUM ION;FICOLIN-2;9606;
2J0G;B;L-ficolin complexed to N-acetyl-mannosamine;2.85;CA;CALCIUM ION;FICOLIN-2;9606;
2J0G;C;L-ficolin complexed to N-acetyl-mannosamine;2.85;CA;CALCIUM ION;FICOLIN-2;9606;
2J0G;D;L-ficolin complexed to N-acetyl-mannosamine;2.85;CA;CALCIUM ION;FICOLIN-2;9606;
2J0G;E;L-ficolin complexed to N-acetyl-mannosamine;2.85;CA;CALCIUM ION;FICOLIN-2;9606;
2J0G;F;L-ficolin complexed to N-acetyl-mannosamine;2.85;CA;CALCIUM ION;FICOLIN-2;9606;
2J0H;A;L-ficolin complexed to acetyl-choline;2.85;CA;CALCIUM ION;FICOLIN-2;9606;
2J0H;B;L-ficolin complexed to acetyl-choline;2.85;CA;CALCIUM ION;FICOLIN-2;9606;
2J0H;C;L-ficolin complexed to acetyl-choline;2.85;CA;CALCIUM ION;FICOLIN-2;9606;
2J0H;D;L-ficolin complexed to acetyl-choline;2.85;CA;CALCIUM ION;FICOLIN-2;9606;
2J0H;E;L-ficolin complexed to acetyl-choline;2.85;CA;CALCIUM ION;FICOLIN-2;9606;
2J0H;F;L-ficolin complexed to acetyl-choline;2.85;CA;CALCIUM ION;FICOLIN-2;9606;
2J0T;A;Crystal Structure of the Catalytic Domain of MMP-1 in Complex with the Inhibitory Domain of TIMP-1;2.54;CA;CALCIUM ION;INTERSTITIAL COLLAGENASE;9606;
2J0T;B;Crystal Structure of the Catalytic Domain of MMP-1 in Complex with the Inhibitory Domain of TIMP-1;2.54;CA;CALCIUM ION;INTERSTITIAL COLLAGENASE;9606;
2J0T;C;Crystal Structure of the Catalytic Domain of MMP-1 in Complex with the Inhibitory Domain of TIMP-1;2.54;CA;CALCIUM ION;INTERSTITIAL COLLAGENASE;9606;
2J0Y;B;L-ficolin complexed to b-1,3-D-glucan;2.35;CA;CALCIUM ION;FICOLIN-2;9606;
2J0Y;C;L-ficolin complexed to b-1,3-D-glucan;2.35;CA;CALCIUM ION;FICOLIN-2;9606;
2J0Y;E;L-ficolin complexed to b-1,3-D-glucan;2.35;CA;CALCIUM ION;FICOLIN-2;9606;
2J0Y;F;L-ficolin complexed to b-1,3-D-glucan;2.35;CA;CALCIUM ION;FICOLIN-2;9606;
2J12;B;Ad37 fibre head in complex with CAR D1;1.5;CA;CALCIUM ION;COXSACKIEVIRUS AND ADENOVIRUS RECEPTOR;9606;
2J1A;A;Structure of CBM32 from Clostridium perfringens beta-N- acetylhexosaminidase GH84C in complex with galactose;1.49;CA;CALCIUM ION;HYALURONIDASE;1502;
2J1E;A;High Resolution Crystal Structure of CBM32 from a N-acetyl-beta- hexosaminidase in complex with lacNAc;2.4;CA;CALCIUM ION;HYALURONIDASE;1502;
2J1G;B;L-ficolin complexed to N-acetyl-cystein;1.95;CA;CALCIUM ION;FICOLIN-2;9606;
2J1G;C;L-ficolin complexed to N-acetyl-cystein;1.95;CA;CALCIUM ION;FICOLIN-2;9606;
2J1G;D;L-ficolin complexed to N-acetyl-cystein;1.95;CA;CALCIUM ION;FICOLIN-2;9606;
2J1G;E;L-ficolin complexed to N-acetyl-cystein;1.95;CA;CALCIUM ION;FICOLIN-2;9606;
2J1G;F;L-ficolin complexed to N-acetyl-cystein;1.95;CA;CALCIUM ION;FICOLIN-2;9606;
2J1R;A;Structure of a Streptococcus pneumoniae fucose binding module;1.54;CA;CALCIUM ION;FUCOLECTIN-RELATED PROTEIN;1313;
2J1R;B;Structure of a Streptococcus pneumoniae fucose binding module;1.54;CA;CALCIUM ION;FUCOLECTIN-RELATED PROTEIN;1313;
2J1S;A;Structure of a Streptococcus pneumoniae fucose binding module in complex with fucose;1.5;CA;CALCIUM ION;FUCOLECTIN-RELATED PROTEIN;1313;
2J1S;B;Structure of a Streptococcus pneumoniae fucose binding module in complex with fucose;1.5;CA;CALCIUM ION;FUCOLECTIN-RELATED PROTEIN;1313;
2J1T;A;Structure of a Streptococcus pneumoniae fucose binding module in complex with the Lewis Y antigen;1.6;CA;CALCIUM ION;FUCOLECTIN-RELATED PROTEIN;1313;
2J1T;B;Structure of a Streptococcus pneumoniae fucose binding module in complex with the Lewis Y antigen;1.6;CA;CALCIUM ION;FUCOLECTIN-RELATED PROTEIN;1313;
2J1U;A;Structure of a Streptococcus pneumoniae fucose binding module in complex with the blood group A-tetrasaccharide;1.8;CA;CALCIUM ION;FUCOLECTIN-RELATED PROTEIN;1313;
2J1U;B;Structure of a Streptococcus pneumoniae fucose binding module in complex with the blood group A-tetrasaccharide;1.8;CA;CALCIUM ION;FUCOLECTIN-RELATED PROTEIN;1313;
2J1V;A;Structure of a Streptococcus pneumoniae fucose binding module in complex with the blood group H-trisaccharide;1.45;CA;CALCIUM ION;FUCOLECTIN-RELATED PROTEIN;1313;
2J1V;B;Structure of a Streptococcus pneumoniae fucose binding module in complex with the blood group H-trisaccharide;1.45;CA;CALCIUM ION;FUCOLECTIN-RELATED PROTEIN;1313;
2J1Y;A;Human p53 core domain mutant M133L-V203A-N239Y-G245S-N268D;1.69;CA;CALCIUM ION;CELLULAR TUMOR ANTIGEN P53;9606;
2J1Y;B;Human p53 core domain mutant M133L-V203A-N239Y-G245S-N268D;1.69;CA;CALCIUM ION;CELLULAR TUMOR ANTIGEN P53;9606;
2J1Y;C;Human p53 core domain mutant M133L-V203A-N239Y-G245S-N268D;1.69;CA;CALCIUM ION;CELLULAR TUMOR ANTIGEN P53;9606;
2J1Y;D;Human p53 core domain mutant M133L-V203A-N239Y-G245S-N268D;1.69;CA;CALCIUM ION;CELLULAR TUMOR ANTIGEN P53;9606;
2J22;A;Structure of a Streptococcus pneumoniae fucose binding module, SpX-3;1.8;CA;CALCIUM ION;FUCOLECTIN-RELATED PROTEIN;1313;
2J2P;A;L-ficolin complexed to N-acetyl-cystein (150mM);2.8;CA;CALCIUM ION;FICOLIN-2;9606;
2J2P;B;L-ficolin complexed to N-acetyl-cystein (150mM);2.8;CA;CALCIUM ION;FICOLIN-2;9606;
2J2P;C;L-ficolin complexed to N-acetyl-cystein (150mM);2.8;CA;CALCIUM ION;FICOLIN-2;9606;
2J2P;D;L-ficolin complexed to N-acetyl-cystein (150mM);2.8;CA;CALCIUM ION;FICOLIN-2;9606;
2J2P;E;L-ficolin complexed to N-acetyl-cystein (150mM);2.8;CA;CALCIUM ION;FICOLIN-2;9606;
2J2P;F;L-ficolin complexed to N-acetyl-cystein (150mM);2.8;CA;CALCIUM ION;FICOLIN-2;9606;
2J34;A;CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX;2.01;CA;CALCIUM ION;ACTIVATED FACTOR XA HEAVY CHAIN;9606;
2J38;A;CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX;2.1;CA;CALCIUM ION;ACTIVATED FACTOR XA HEAVY CHAIN;9606;
2J3F;A;L-ficolin complexed to N-acetyl-D-galactosamine;2.8;CA;CALCIUM ION;FICOLIN-2;9606;
2J3F;B;L-ficolin complexed to N-acetyl-D-galactosamine;2.8;CA;CALCIUM ION;FICOLIN-2;9606;
2J3F;C;L-ficolin complexed to N-acetyl-D-galactosamine;2.8;CA;CALCIUM ION;FICOLIN-2;9606;
2J3F;E;L-ficolin complexed to N-acetyl-D-galactosamine;2.8;CA;CALCIUM ION;FICOLIN-2;9606;
2J3F;F;L-ficolin complexed to N-acetyl-D-galactosamine;2.8;CA;CALCIUM ION;FICOLIN-2;9606;
2J3G;A;L-ficolin;2.5;CA;CALCIUM ION;FICOLIN-2;9606;
2J3G;B;L-ficolin;2.5;CA;CALCIUM ION;FICOLIN-2;9606;
2J3G;C;L-ficolin;2.5;CA;CALCIUM ION;FICOLIN-2;9606;
2J3G;D;L-ficolin;2.5;CA;CALCIUM ION;FICOLIN-2;9606;
2J3G;E;L-ficolin;2.5;CA;CALCIUM ION;FICOLIN-2;9606;
2J3G;F;L-ficolin;2.5;CA;CALCIUM ION;FICOLIN-2;9606;
2J3O;A;L-ficolin complexed to N-acetyl-D-glucosamine;2.65;CA;CALCIUM ION;FICOLIN-2;9606;
2J3O;B;L-ficolin complexed to N-acetyl-D-glucosamine;2.65;CA;CALCIUM ION;FICOLIN-2;9606;
2J3O;C;L-ficolin complexed to N-acetyl-D-glucosamine;2.65;CA;CALCIUM ION;FICOLIN-2;9606;
2J3O;D;L-ficolin complexed to N-acetyl-D-glucosamine;2.65;CA;CALCIUM ION;FICOLIN-2;9606;
2J3O;E;L-ficolin complexed to N-acetyl-D-glucosamine;2.65;CA;CALCIUM ION;FICOLIN-2;9606;
2J3O;F;L-ficolin complexed to N-acetyl-D-glucosamine;2.65;CA;CALCIUM ION;FICOLIN-2;9606;
2J3U;A;L-ficolin complexed to galactose;2.15;CA;CALCIUM ION;FICOLIN-2;9606;
2J3U;B;L-ficolin complexed to galactose;2.15;CA;CALCIUM ION;FICOLIN-2;9606;
2J3U;C;L-ficolin complexed to galactose;2.15;CA;CALCIUM ION;FICOLIN-2;9606;
2J3U;D;L-ficolin complexed to galactose;2.15;CA;CALCIUM ION;FICOLIN-2;9606;
2J3U;E;L-ficolin complexed to galactose;2.15;CA;CALCIUM ION;FICOLIN-2;9606;
2J3U;F;L-ficolin complexed to galactose;2.15;CA;CALCIUM ION;FICOLIN-2;9606;
2J45;A;Water structure of T. Aquaticus Ffh NG Domain At 1.1A Resolution;1.14;CA;CALCIUM ION;SIGNAL RECOGNITION PARTICLE PROTEIN;271;
2J45;B;Water structure of T. Aquaticus Ffh NG Domain At 1.1A Resolution;1.14;CA;CALCIUM ION;SIGNAL RECOGNITION PARTICLE PROTEIN;271;
2J4I;A;CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX;1.8;CA;CALCIUM ION;COAGULATION FACTOR X;9606;
2J5W;A;Ceruloplasmin revisited: structural and functional roles of various metal cation binding sites;2.8;CA;CALCIUM ION;CERULOPLASMIN;9606;
2J5Z;A;H-ficolin complexed to galactose;1.73;CA;CALCIUM ION;FICOLIN-3;9606;
2J5Z;B;H-ficolin complexed to galactose;1.73;CA;CALCIUM ION;FICOLIN-3;9606;
2J5Z;C;H-ficolin complexed to galactose;1.73;CA;CALCIUM ION;FICOLIN-3;9606;
2J60;A;H-ficolin complexed to D-fucose;1.8;CA;CALCIUM ION;FICOLIN-3;9606;
2J60;B;H-ficolin complexed to D-fucose;1.8;CA;CALCIUM ION;FICOLIN-3;9606;
2J60;C;H-ficolin complexed to D-fucose;1.8;CA;CALCIUM ION;FICOLIN-3;9606;
2J61;A;L-ficolin complexed to N-acetylglucosamine (forme C);2.7;CA;CALCIUM ION;FICOLIN-2;9606;
2J61;B;L-ficolin complexed to N-acetylglucosamine (forme C);2.7;CA;CALCIUM ION;FICOLIN-2;9606;
2J64;A;H-ficolin;2.2;CA;CALCIUM ION;FICOLIN-3;9606;
2J64;B;H-ficolin;2.2;CA;CALCIUM ION;FICOLIN-3;9606;
2J64;C;H-ficolin;2.2;CA;CALCIUM ION;FICOLIN-3;9606;
2J6S;A;Ternary complex of Sulfolobus solfataricus Dpo4 DNA polymerase, O6- methylguanine modified DNA, and dATP.;2.5;CA;CALCIUM ION;DNA POLYMERASE IV;2287;
2J6T;A;Ternary complex of Sulfolobus solfataricus Dpo4 DNA polymerase, O6- methylguanine modified DNA, and dATP.;2.6;CA;CALCIUM ION;DNA POLYMERASE IV;2287;
2J6U;A;Ternary complex of Sulfolobus solfataricus Dpo4 DNA polymerase, O6- methylguanine modified DNA, and dGTP.;2.5;CA;CALCIUM ION;DNA POLYMERASE IV;2287;
2J74;A;Structure of Beta-1,4-Galactanase;2.6;CA;CALCIUM ION;YVFO;1402;
2J74;B;Structure of Beta-1,4-Galactanase;2.6;CA;CALCIUM ION;YVFO;1402;
2J75;B;Beta-glucosidase from Thermotoga maritima in complex with noeuromycin;1.85;CA;CALCIUM ION;BETA-GLUCOSIDASE A;2336;
2J77;B;Beta-glucosidase from Thermotoga maritima in complex with deoxynojirimycin;2.1;CA;CALCIUM ION;BETA-GLUCOSIDASE A;2336;
2J78;A;Beta-glucosidase from Thermotoga maritima in complex with gluco- hydroximolactam;1.65;CA;CALCIUM ION;BETA-GLUCOSIDASE A;2336;
2J78;B;Beta-glucosidase from Thermotoga maritima in complex with gluco- hydroximolactam;1.65;CA;CALCIUM ION;BETA-GLUCOSIDASE A;2336;
2J79;B;Beta-glucosidase from Thermotoga maritima in complex with galacto- hydroximolactam;1.94;CA;CALCIUM ION;BETA-GLUCOSIDASE A;2336;
2J7A;A;Crystal structure of cytochrome c nitrite reductase NrfHA complex from Desulfovibrio vulgaris;2.3;CA;CALCIUM ION;CYTOCHROME C NITRITE REDUCTASE NRFA;881;
2J7A;B;Crystal structure of cytochrome c nitrite reductase NrfHA complex from Desulfovibrio vulgaris;2.3;CA;CALCIUM ION;CYTOCHROME C NITRITE REDUCTASE NRFA;881;
2J7A;D;Crystal structure of cytochrome c nitrite reductase NrfHA complex from Desulfovibrio vulgaris;2.3;CA;CALCIUM ION;CYTOCHROME C NITRITE REDUCTASE NRFA;881;
2J7A;E;Crystal structure of cytochrome c nitrite reductase NrfHA complex from Desulfovibrio vulgaris;2.3;CA;CALCIUM ION;CYTOCHROME C NITRITE REDUCTASE NRFA;881;
2J7A;G;Crystal structure of cytochrome c nitrite reductase NrfHA complex from Desulfovibrio vulgaris;2.3;CA;CALCIUM ION;CYTOCHROME C NITRITE REDUCTASE NRFA;881;
2J7A;H;Crystal structure of cytochrome c nitrite reductase NrfHA complex from Desulfovibrio vulgaris;2.3;CA;CALCIUM ION;CYTOCHROME C NITRITE REDUCTASE NRFA;881;
2J7A;J;Crystal structure of cytochrome c nitrite reductase NrfHA complex from Desulfovibrio vulgaris;2.3;CA;CALCIUM ION;CYTOCHROME C NITRITE REDUCTASE NRFA;881;
2J7A;K;Crystal structure of cytochrome c nitrite reductase NrfHA complex from Desulfovibrio vulgaris;2.3;CA;CALCIUM ION;CYTOCHROME C NITRITE REDUCTASE NRFA;881;
2J7A;M;Crystal structure of cytochrome c nitrite reductase NrfHA complex from Desulfovibrio vulgaris;2.3;CA;CALCIUM ION;CYTOCHROME C NITRITE REDUCTASE NRFA;881;
2J7A;N;Crystal structure of cytochrome c nitrite reductase NrfHA complex from Desulfovibrio vulgaris;2.3;CA;CALCIUM ION;CYTOCHROME C NITRITE REDUCTASE NRFA;881;
2J7A;P;Crystal structure of cytochrome c nitrite reductase NrfHA complex from Desulfovibrio vulgaris;2.3;CA;CALCIUM ION;CYTOCHROME C NITRITE REDUCTASE NRFA;881;
2J7A;Q;Crystal structure of cytochrome c nitrite reductase NrfHA complex from Desulfovibrio vulgaris;2.3;CA;CALCIUM ION;CYTOCHROME C NITRITE REDUCTASE NRFA;881;
2J7B;B;Beta-glucosidase from Thermotoga maritima in complex with gluco- tetrazole;1.87;CA;CALCIUM ION;BETA-GLUCOSIDASE A;2336;
2J7C;B;Beta-glucosidase from Thermotoga maritima in complex with phenylaminomethyl-derived glucoimidazole;2.09;CA;CALCIUM ION;BETA-GLUCOSIDASE A;2336;
2J7D;B;Beta-glucosidase from Thermotoga maritima in complex with methoxycarbonyl-substituted glucoimidazole;2.24;CA;CALCIUM ION;BETA-GLUCOSIDASE A;2336;
2J7E;B;Beta-glucosidase from Thermotoga maritima in complex with methyl acetate-substituted glucoimidazole;2.19;CA;CALCIUM ION;BETA-GLUCOSIDASE A;2336;
2J7F;B;Beta-glucosidase from Thermotoga maritima in complex with carboxylate- substituted glucoimidazole;2.28;CA;CALCIUM ION;BETA-GLUCOSIDASE A;2336;
2J7G;B;Beta-glucosidase from Thermotoga maritima in complex with methyl acetic acid-substituted glucoimidazole;1.91;CA;CALCIUM ION;BETA-GLUCOSIDASE A;2336;
2J7H;A;Beta-glucosidase from Thermotoga maritima in complex with azafagomine;1.95;CA;CALCIUM ION;BETA-GLUCOSIDASE A;2336;
2J7H;B;Beta-glucosidase from Thermotoga maritima in complex with azafagomine;1.95;CA;CALCIUM ION;BETA-GLUCOSIDASE A;2336;
2J7M;A;Characterization of a Family 32 CBM;2.3;CA;CALCIUM ION;HYALURONIDASE;1502;
2J7T;A;Crystal structure of human serine threonine kinase-10 bound to SU11274;2;CA;CALCIUM ION;SERINE/THREONINE-PROTEIN KINASE 10;9606;
2J82;A;Structural analysis of the PP2C Family Phosphatase tPphA from Thermosynechococcus elongatus;1.28;CA;CALCIUM ION;PROTEIN SERINE-THREONINE PHOSPHATASE;32046;
2J83;A;Ulilysin metalloprotease in complex with batimastat.;2;CA;CALCIUM ION;ULILYSIN;2214;
2J83;B;Ulilysin metalloprotease in complex with batimastat.;2;CA;CALCIUM ION;ULILYSIN;2214;
2J94;A;CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX;2.1;CA;CALCIUM ION;COAGULATION FACTOR X;9606;
2J95;A;CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX;2.01;CA;CALCIUM ION;ACTIVATED FACTOR XA HEAVY CHAIN;9606;
2J9N;A;Robotically harvested Trypsin complexed with Benzamidine containing polypeptide mediated crystal contacts;1.5;CA;CALCIUM ION;CATIONIC TRYPSIN;9913;
2JAL;B;Beta-glucosidase from Thermotoga maritima in complex with cyclophellitol;1.9;CA;CALCIUM ION;BETA-GLUCOSIDASE A;2336;
2JAM;A;Crystal structure of human calmodulin-dependent protein kinase I G;1.7;CA;CALCIUM ION;CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 1G;9606;
2JBH;A;Human phosphoribosyl transferase domain containing 1;1.7;CA;CALCIUM ION;PHOSPHORIBOSYLTRANSFERASE DOMAIN-CONTAINING PROTEIN 1;9606;
2JBH;B;Human phosphoribosyl transferase domain containing 1;1.7;CA;CALCIUM ION;PHOSPHORIBOSYLTRANSFERASE DOMAIN-CONTAINING PROTEIN 1;9606;
2JBJ;A;membrane-bound glutamate carboxypeptidase II (GCPII) in complex with 2-PMPA (2-phosphonoMethyl-pentanedioic acid);2.19;CA;CALCIUM ION;GLUTAMATE CARBOXYPEPTIDASE 2;9606;
2JBK;A;membrane-bound glutamate carboxypeptidase II (GCPII) in complex with quisqualic acid (quisqualate, alpha-amino-3,5-dioxo-1,2,4- oxadiazolidine-2-propanoic acid);2.99;CA;CALCIUM ION;GLUTAMATE CARBOXYPEPTIDASE 2;9606;
2JCG;A;Apo form of the catabolite control protein A (ccpA) from bacillus megaterium, with the DNA binding domain;2.6;CA;CALCIUM ION;GLUCOSE-RESISTANCE AMYLASE REGULATOR;1404;
2JD9;A;Structure of a pectin binding carbohydrate binding module determined in an orthorhombic crystal form.;1.8;CA;CALCIUM ION;YECBM32;630;
2JDA;A;Structure of a pectin binding carbohydrate binding module determined in an monoclinic crystal form.;1.35;CA;CALCIUM ION;YECBM32;630;
2JDA;B;Structure of a pectin binding carbohydrate binding module determined in an monoclinic crystal form.;1.35;CA;CALCIUM ION;YECBM32;630;
2JDH;A;Lectin PA-IIL of P.aeruginosa complexed with disaccharide derivative;1.1;CA;CALCIUM ION;FUCOSE-BINDING LECTIN PA-IIL;287;
2JDH;B;Lectin PA-IIL of P.aeruginosa complexed with disaccharide derivative;1.1;CA;CALCIUM ION;FUCOSE-BINDING LECTIN PA-IIL;287;
2JDH;C;Lectin PA-IIL of P.aeruginosa complexed with disaccharide derivative;1.1;CA;CALCIUM ION;FUCOSE-BINDING LECTIN PA-IIL;287;
2JDH;D;Lectin PA-IIL of P.aeruginosa complexed with disaccharide derivative;1.1;CA;CALCIUM ION;FUCOSE-BINDING LECTIN PA-IIL;287;
2JDK;A;Lectin PA-IIL of P.aeruginosa complexed with disaccharide derivative;1.1;CA;CALCIUM ION;FUCOSE-BINDING LECTIN PA-IIL;287;
2JDK;B;Lectin PA-IIL of P.aeruginosa complexed with disaccharide derivative;1.1;CA;CALCIUM ION;FUCOSE-BINDING LECTIN PA-IIL;287;
2JDK;C;Lectin PA-IIL of P.aeruginosa complexed with disaccharide derivative;1.1;CA;CALCIUM ION;FUCOSE-BINDING LECTIN PA-IIL;287;
2JDK;D;Lectin PA-IIL of P.aeruginosa complexed with disaccharide derivative;1.1;CA;CALCIUM ION;FUCOSE-BINDING LECTIN PA-IIL;287;
2JDM;A;Mutant (S22A) of Pseudomonas aeruginosa lectin II (PA-IIL) complexed with methyl-a-L-fucopyranoside;1.7;CA;CALCIUM ION;FUCOSE-BINDING LECTIN PA-IIL;287;
2JDM;B;Mutant (S22A) of Pseudomonas aeruginosa lectin II (PA-IIL) complexed with methyl-a-L-fucopyranoside;1.7;CA;CALCIUM ION;FUCOSE-BINDING LECTIN PA-IIL;287;
2JDM;C;Mutant (S22A) of Pseudomonas aeruginosa lectin II (PA-IIL) complexed with methyl-a-L-fucopyranoside;1.7;CA;CALCIUM ION;FUCOSE-BINDING LECTIN PA-IIL;287;
2JDM;D;Mutant (S22A) of Pseudomonas aeruginosa lectin II (PA-IIL) complexed with methyl-a-L-fucopyranoside;1.7;CA;CALCIUM ION;FUCOSE-BINDING LECTIN PA-IIL;287;
2JDN;A;Mutant (S22A) of Pseudomonas aeruginosa lectin II (PA-IIL) complexed with methyl-a-L-mannopyranoside;1.3;CA;CALCIUM ION;FUCOSE-BINDING LECTIN PA-IIL;287;
2JDN;B;Mutant (S22A) of Pseudomonas aeruginosa lectin II (PA-IIL) complexed with methyl-a-L-mannopyranoside;1.3;CA;CALCIUM ION;FUCOSE-BINDING LECTIN PA-IIL;287;
2JDN;C;Mutant (S22A) of Pseudomonas aeruginosa lectin II (PA-IIL) complexed with methyl-a-L-mannopyranoside;1.3;CA;CALCIUM ION;FUCOSE-BINDING LECTIN PA-IIL;287;
2JDN;D;Mutant (S22A) of Pseudomonas aeruginosa lectin II (PA-IIL) complexed with methyl-a-L-mannopyranoside;1.3;CA;CALCIUM ION;FUCOSE-BINDING LECTIN PA-IIL;287;
2JDP;A;Mutant (S23A) of Pseudomonas aeruginosa lectin II (PA-IIL) complexed with methyl-a-L-fucopyranoside;1.3;CA;CALCIUM ION;FUCOSE-BINDING LECTIN PA-IIL;287;
2JDP;B;Mutant (S23A) of Pseudomonas aeruginosa lectin II (PA-IIL) complexed with methyl-a-L-fucopyranoside;1.3;CA;CALCIUM ION;FUCOSE-BINDING LECTIN PA-IIL;287;
2JDP;C;Mutant (S23A) of Pseudomonas aeruginosa lectin II (PA-IIL) complexed with methyl-a-L-fucopyranoside;1.3;CA;CALCIUM ION;FUCOSE-BINDING LECTIN PA-IIL;287;
2JDP;D;Mutant (S23A) of Pseudomonas aeruginosa lectin II (PA-IIL) complexed with methyl-a-L-fucopyranoside;1.3;CA;CALCIUM ION;FUCOSE-BINDING LECTIN PA-IIL;287;
2JDU;C;Mutant (G24N) of Pseudomonas aeruginosa lectin II (PA-IIL) complexed with methyl-a-L-fucopyranoside;1.5;CA;CALCIUM ION;FUCOSE-BINDING LECTIN PA-IIL;287;
2JDU;D;Mutant (G24N) of Pseudomonas aeruginosa lectin II (PA-IIL) complexed with methyl-a-L-fucopyranoside;1.5;CA;CALCIUM ION;FUCOSE-BINDING LECTIN PA-IIL;287;
2JDY;A;Mutant (G24N) of Pseudomonas aeruginosa lectin II (PA-IIL) complexed with methyl-b-D-mannoyranoside;1.7;CA;CALCIUM ION;FUCOSE-BINDING LECTIN PA-IIL;287;
2JDY;B;Mutant (G24N) of Pseudomonas aeruginosa lectin II (PA-IIL) complexed with methyl-b-D-mannoyranoside;1.7;CA;CALCIUM ION;FUCOSE-BINDING LECTIN PA-IIL;287;
2JDY;C;Mutant (G24N) of Pseudomonas aeruginosa lectin II (PA-IIL) complexed with methyl-b-D-mannoyranoside;1.7;CA;CALCIUM ION;FUCOSE-BINDING LECTIN PA-IIL;287;
2JDY;D;Mutant (G24N) of Pseudomonas aeruginosa lectin II (PA-IIL) complexed with methyl-b-D-mannoyranoside;1.7;CA;CALCIUM ION;FUCOSE-BINDING LECTIN PA-IIL;287;
2JDZ;A;Crystal structure of recombinant Dioclea guianensis lectin complexed with 5-bromo-4-chloro-3-indolyl-a-D-mannose;2.1;CA;CALCIUM ION;LECTIN ALPHA CHAIN;99571;
2JE7;A;Crystal structure of recombinant Dioclea guianensis lectin S131H complexed with 5-bromo-4-chloro-3-indolyl-a-D-mannose;1.65;CA;CALCIUM ION;LECTIN ALPHA CHAIN;99571;
2JE9;A;CRYSTAL STRUCTURE OF RECOMBINANT DIOCLEA GRANDIFLORA LECTIN COMPLEXED WITH 5-BROMO-4-CHLORO-3-INDOLYL-A-D-MANNOSE;2.1;CA;CALCIUM ION;LECTIN ALPHA CHAIN;3837;
2JE9;B;CRYSTAL STRUCTURE OF RECOMBINANT DIOCLEA GRANDIFLORA LECTIN COMPLEXED WITH 5-BROMO-4-CHLORO-3-INDOLYL-A-D-MANNOSE;2.1;CA;CALCIUM ION;LECTIN ALPHA CHAIN;3837;
2JE9;C;CRYSTAL STRUCTURE OF RECOMBINANT DIOCLEA GRANDIFLORA LECTIN COMPLEXED WITH 5-BROMO-4-CHLORO-3-INDOLYL-A-D-MANNOSE;2.1;CA;CALCIUM ION;LECTIN ALPHA CHAIN;3837;
2JE9;D;CRYSTAL STRUCTURE OF RECOMBINANT DIOCLEA GRANDIFLORA LECTIN COMPLEXED WITH 5-BROMO-4-CHLORO-3-INDOLYL-A-D-MANNOSE;2.1;CA;CALCIUM ION;LECTIN ALPHA CHAIN;3837;
2JEC;A;crystal structure of recombinant DiocleA grandiflora lectin mutant E123A-H131N-K132Q complexed witH 5-bromo-4-chloro-3-indolyl-a-D- mannose;2;CA;CALCIUM ION;LECTIN ALPHA CHAIN;3837;
2JEC;B;crystal structure of recombinant DiocleA grandiflora lectin mutant E123A-H131N-K132Q complexed witH 5-bromo-4-chloro-3-indolyl-a-D- mannose;2;CA;CALCIUM ION;LECTIN ALPHA CHAIN;3837;
2JEC;C;crystal structure of recombinant DiocleA grandiflora lectin mutant E123A-H131N-K132Q complexed witH 5-bromo-4-chloro-3-indolyl-a-D- mannose;2;CA;CALCIUM ION;LECTIN ALPHA CHAIN;3837;
2JEC;D;crystal structure of recombinant DiocleA grandiflora lectin mutant E123A-H131N-K132Q complexed witH 5-bromo-4-chloro-3-indolyl-a-D- mannose;2;CA;CALCIUM ION;LECTIN ALPHA CHAIN;3837;
2JEF;A;The Molecular Basis of Selectivity of Nucleotide Triphosphate Incorporation Opposite O6-Benzylguanine by Sulfolobus solfataricus DNA Polymerase IV: Steady-state and Pre-steady-state and X-Ray Crystallography of Correct and Incorrect Pairing;2.17;CA;CALCIUM ION;DNA POLYMERASE IV;2287;
2JEG;A;The Molecular Basis of Selectivity of Nucleoside Triphosphate Incorporation Opposite O6-Benzylguanine by Sulfolobus solfataricus DNA Polymerase IV: Steady-state and Pre-steady-state Kinetics and X- Ray Crystallography of Correct and Incorrect Pairing;2.38;CA;CALCIUM ION;DNA POLYMERASE IV;2287;
2JEG;P;The Molecular Basis of Selectivity of Nucleoside Triphosphate Incorporation Opposite O6-Benzylguanine by Sulfolobus solfataricus DNA Polymerase IV: Steady-state and Pre-steady-state Kinetics and X- Ray Crystallography of Correct and Incorrect Pairing;2.38;CA;CALCIUM ION;5'-D(*GP*GP*GP*GP*GP*AP*AP*GP*GP*AP *TP*TP*CP*DOC)-3';;
2JEI;A;The Molecular Basis of Selectivity of Nucleoside Triphosphate Incorporation Opposite O6-Benzylguanine by Sulfolobus solfataricus DNA Polymerase IV: Steady-state and Pre-steady-state Kinetics and X- Ray Crystallography of Correct and Incorrect Pairing;2.39;CA;CALCIUM ION;DNA POLYMERASE IV;2287;
2JEJ;A;The Molecular Basis of Selectivity of Nucleoside Triphosphate Incorporation Opposite O6-Benzylguanine by Sulfolobus solfataricus DNA Polymerase IV: Steady-state and Pre-steady-state Kinetics and X- Ray Crystallography of Correct and Incorrect Pairing;1.86;CA;CALCIUM ION;DNA POLYMERASE IV;2287;
2JEJ;P;The Molecular Basis of Selectivity of Nucleoside Triphosphate Incorporation Opposite O6-Benzylguanine by Sulfolobus solfataricus DNA Polymerase IV: Steady-state and Pre-steady-state Kinetics and X- Ray Crystallography of Correct and Incorrect Pairing;1.86;CA;CALCIUM ION;5'-D(*GP*GP*GP*GP*GP*AP*AP*GP*GP*AP *TP*TP*CP*CP*G)-3';;
2JEP;A;Native family 5 xyloglucanase from Paenibacillus pabuli;1.4;CA;CALCIUM ION;XYLOGLUCANASE;1472;
2JEP;B;Native family 5 xyloglucanase from Paenibacillus pabuli;1.4;CA;CALCIUM ION;XYLOGLUCANASE;1472;
2JES;A;Portal protein (gp6) from bacteriophage SPP1;3.4;CA;CALCIUM ION;PORTAL PROTEIN;10724;
2JES;C;Portal protein (gp6) from bacteriophage SPP1;3.4;CA;CALCIUM ION;PORTAL PROTEIN;10724;
2JES;E;Portal protein (gp6) from bacteriophage SPP1;3.4;CA;CALCIUM ION;PORTAL PROTEIN;10724;
2JES;G;Portal protein (gp6) from bacteriophage SPP1;3.4;CA;CALCIUM ION;PORTAL PROTEIN;10724;
2JES;I;Portal protein (gp6) from bacteriophage SPP1;3.4;CA;CALCIUM ION;PORTAL PROTEIN;10724;
2JES;K;Portal protein (gp6) from bacteriophage SPP1;3.4;CA;CALCIUM ION;PORTAL PROTEIN;10724;
2JES;M;Portal protein (gp6) from bacteriophage SPP1;3.4;CA;CALCIUM ION;PORTAL PROTEIN;10724;
2JES;O;Portal protein (gp6) from bacteriophage SPP1;3.4;CA;CALCIUM ION;PORTAL PROTEIN;10724;
2JES;Q;Portal protein (gp6) from bacteriophage SPP1;3.4;CA;CALCIUM ION;PORTAL PROTEIN;10724;
2JES;S;Portal protein (gp6) from bacteriophage SPP1;3.4;CA;CALCIUM ION;PORTAL PROTEIN;10724;
2JES;U;Portal protein (gp6) from bacteriophage SPP1;3.4;CA;CALCIUM ION;PORTAL PROTEIN;10724;
2JES;W;Portal protein (gp6) from bacteriophage SPP1;3.4;CA;CALCIUM ION;PORTAL PROTEIN;10724;
2JES;Y;Portal protein (gp6) from bacteriophage SPP1;3.4;CA;CALCIUM ION;PORTAL PROTEIN;10724;
2JF9;P;ESTROGEN RECEPTOR ALPHA LBD IN COMPLEX WITH A TAMOXIFEN-SPECIFIC PEPTIDE ANTAGONIST;2.1;CA;CALCIUM ION;AB5 PEPTIDE;32630;
2JF9;R;ESTROGEN RECEPTOR ALPHA LBD IN COMPLEX WITH A TAMOXIFEN-SPECIFIC PEPTIDE ANTAGONIST;2.1;CA;CALCIUM ION;AB5 PEPTIDE;32630;
2JFP;A;Crystal structure of Enterococcus faecalis glutamate racemase in complex with D- Glutamate;1.98;CA;CALCIUM ION;GLUTAMATE RACEMASE;1351;
2JFP;B;Crystal structure of Enterococcus faecalis glutamate racemase in complex with D- Glutamate;1.98;CA;CALCIUM ION;GLUTAMATE RACEMASE;1351;
2JG8;B;Crystallographic structure of human C1q globular heads complexed to phosphatidyl-serine;2.05;CA;CALCIUM ION;Complement C1q subcomponent subunit B;9606;
2JG8;E;Crystallographic structure of human C1q globular heads complexed to phosphatidyl-serine;2.05;CA;CALCIUM ION;Complement C1q subcomponent subunit B;9606;
2JG9;B;Crystallographic structure of human C1q globular heads (P1);1.9;CA;CALCIUM ION;Complement C1q subcomponent subunit B;9606;
2JG9;E;Crystallographic structure of human C1q globular heads (P1);1.9;CA;CALCIUM ION;Complement C1q subcomponent subunit B;9606;
2JH0;D;Human Thrombin Hirugen Inhibitor complex;1.7;CA;CALCIUM ION;THROMBIN HEAVY CHAIN;9606;
2JH5;D;Human Thrombin Hirugen Inhibitor complex;2.5;CA;CALCIUM ION;THROMBIN HEAVY CHAIN;9606;
2JH6;D;Human Thrombin Hirugen Inhibitor complex;2.21;CA;CALCIUM ION;THROMBIN HEAVY CHAIN;9606;
2JHH;C;Structure of globular heads of M-ficolin at acidic pH;1.7;CA;CALCIUM ION;FICOLIN-1;9606;
2JHH;F;Structure of globular heads of M-ficolin at acidic pH;1.7;CA;CALCIUM ION;FICOLIN-1;9606;
2JHI;F;Structure of globular heads of M-ficolin complexed with N-acetyl-D- galactosamine;1.8;CA;CALCIUM ION;FICOLIN-1;9606;
2JHK;F;Structure of globular heads of M-ficolin complexed with N-acetyl-D- glucosamine;1.75;CA;CALCIUM ION;FICOLIN-1;9606;
2JHL;F;Structure of globular heads of M-ficolin complexed with sialic acid;1.75;CA;CALCIUM ION;FICOLIN-1;9606;
2JHM;F;Structure of globular heads of M-ficolin at neutral pH;1.52;CA;CALCIUM ION;FICOLIN-1;9606;
2JI1;A;X-ray structure of wild-type superoxide reductase from Desulfoarculus baarsii;1.7;CA;CALCIUM ION;Desulfoferrodoxin;453230;
2JI1;C;X-ray structure of wild-type superoxide reductase from Desulfoarculus baarsii;1.7;CA;CALCIUM ION;Desulfoferrodoxin;453230;
2JI2;B;X-ray structure of E114A mutant of superoxide reductase from Desulfoarculus baarsii in the native, reduced form;1.7;CA;CALCIUM ION;Desulfoferrodoxin;453230;
2JI2;C;X-ray structure of E114A mutant of superoxide reductase from Desulfoarculus baarsii in the native, reduced form;1.7;CA;CALCIUM ION;Desulfoferrodoxin;453230;
2JI3;A;X-ray structure of the iron-peroxide intermediate of superoxide reductase (E114A mutant) from Desulfoarculus baarsii;1.95;CA;CALCIUM ION;Desulfoferrodoxin;453230;
2JI3;B;X-ray structure of the iron-peroxide intermediate of superoxide reductase (E114A mutant) from Desulfoarculus baarsii;1.95;CA;CALCIUM ION;Desulfoferrodoxin;453230;
2JI3;C;X-ray structure of the iron-peroxide intermediate of superoxide reductase (E114A mutant) from Desulfoarculus baarsii;1.95;CA;CALCIUM ION;Desulfoferrodoxin;453230;
2JKA;A;Native structure of a family 97 alpha-glucosidase from Bacteroides thetaiotaomicron;1.9;CA;CALCIUM ION;ALPHA-GLUCOSIDASE (ALPHA-GLUCOSIDASE SUSB);818;
2JKA;B;Native structure of a family 97 alpha-glucosidase from Bacteroides thetaiotaomicron;1.9;CA;CALCIUM ION;ALPHA-GLUCOSIDASE (ALPHA-GLUCOSIDASE SUSB);818;
2JKE;A;Structure of a family 97 alpha-glucosidase from Bacteroides thetaiotaomicron in complex with deoxynojirimycin;1.7;CA;CALCIUM ION;ALPHA-GLUCOSIDASE (ALPHA-GLUCOSIDASE SUSB);818;
2JKE;B;Structure of a family 97 alpha-glucosidase from Bacteroides thetaiotaomicron in complex with deoxynojirimycin;1.7;CA;CALCIUM ION;ALPHA-GLUCOSIDASE (ALPHA-GLUCOSIDASE SUSB);818;
2JKH;A;Factor Xa - cation inhibitor complex;1.25;CA;CALCIUM ION;ACTIVATED FACTOR XA HEAVY CHAIN;9606;
2JKP;A;Structure of a family 97 alpha-glucosidase from Bacteroides thetaiotaomicron in complex with castanospermine;1.99;CA;CALCIUM ION;ALPHA-GLUCOSIDASE (ALPHA-GLUCOSIDASE SUSB);818;
2JKP;B;Structure of a family 97 alpha-glucosidase from Bacteroides thetaiotaomicron in complex with castanospermine;1.99;CA;CALCIUM ION;ALPHA-GLUCOSIDASE (ALPHA-GLUCOSIDASE SUSB);818;
2JKX;A;Galactose oxidase. MatGO. Copper free, expressed in Pichia Pastoris.;1.84;CA;CALCIUM ION;GALACTOSE OXIDASE;5518;
2JLL;A;Crystal structure of NCAM2 IgIV-FN3II;2.3;CA;CALCIUM ION;NEURAL CELL ADHESION MOLECULE 2;9606;
2JM4;A;The solution NMR structure of the relaxin (RXFP1) receptor LDLa module.;;CA;CALCIUM ION;Relaxin receptor 1;9606;
2JNP;A;Solution structure of matrix metalloproteinase 3 (MMP-3) in the presence of N-isobutyl-N-[4-methoxyphenylsulfonyl]glycyl hydroxamic acid (NNGH);;CA;CALCIUM ION;Matrix metalloproteinase-3;9606;
2JNX;A;NMR derived solution structure of an EF-hand Calcium Binding Protein from Entamoeba Histolytica;;CA;CALCIUM ION;Calcium binding protein 2;5759;
2JQ6;A;Structure of EH-domain of EHD1;;CA;CALCIUM ION;EH domain-containing protein 1;9606;
2JSD;A;Solution structure of MMP20 complexed with NNGH;;CA;CALCIUM ION;Matrix metalloproteinase-20;9606;
2JT5;A;solution structure of matrix metalloproteinase 3 (MMP-3) in the presence of n-hydroxy-2-[n-(2-hydroxyethyl)biphenyl-4-sulfonamide] hydroxamic acid (MLC88);;CA;CALCIUM ION;Stromelysin-1;9606;
2JT6;A;Solution structure of matrix metalloproteinase 3 (MMP-3) in the presence of 3-4'-cyanobyphenyl-4-yloxy)-n-hdydroxypropionamide (MMP-3 inhibitor VII);;CA;CALCIUM ION;Stromelysin-1;9606;
2JU0;A;Structure of Yeast Frequenin bound to PdtIns 4-kinase;;CA;CALCIUM ION;Calcium-binding protein NCS-1;4932;
2-jul;A;NMR Structure of DREAM;;CA;CALCIUM ION;Calsenilin;10090;
2JXC;A;Structure of the EPS15-EH2 Stonin2 Complex;;CA;CALCIUM ION;Epidermal growth factor receptor substrate 15;9606;
2JXL;A;Solution structure of cardiac N-domain troponin C mutant F77W-V82A;;CA;CALCIUM ION;Troponin C, slow skeletal and cardiac muscles;9606;
2JXY;A;Solution structure of the hemopexin-like domain of MMP12;;CA;CALCIUM ION;Macrophage metalloelastase;9606;
2JZI;A;Structure of Calmodulin complexed with the Calmodulin Binding Domain of Calcineurin;;CA;CALCIUM ION;Calmodulin;9606;
2K0E;A;A Coupled Equilibrium Shift Mechanism in Calmodulin-Mediated Signal Transduction;;CA;CALCIUM ION;Calmodulin;9606;
2K0F;A;Calmodulin complexed with calmodulin-binding peptide from smooth muscle myosin light chain kinase;;CA;CALCIUM ION;calmodulin;9606;
2K0J;A;Solution structure of CaM complexed to DRP1p;;CA;CALCIUM ION;calmodulin;9606;
2K1W;A;NMR solution structure of M-crystallin in calcium loaded form(holo).;;CA;CALCIUM ION;Beta/gama crystallin family protein;188937;
2K2F;A;Solution structure of Ca2+-S100A1-RyRP12;;CA;CALCIUM ION;Protein S100-A1;10116;
2K2F;B;Solution structure of Ca2+-S100A1-RyRP12;;CA;CALCIUM ION;Protein S100-A1;10116;
2K2V;A;Anabaena CcbP in the calcium-bound form;;CA;CALCIUM ION;Alr1010 protein;103690;
2K3H;A;Structural determinants for Ca2+ and PIP2 binding by the C2A domain of rabphilin-3A;;CA;CALCIUM ION;Rabphilin-3A;10090;
2K60;A;NMR structure of calcium-loaded STIM1 EF-SAM;;CA;CALCIUM ION;PROTEIN (Stromal interaction molecule 1);9606;
2K61;A;Solution structure of CaM complexed to DAPk peptide;;CA;CALCIUM ION;Calmodulin;9606;
2K7D;A;NMR Structure of Ca2+-bound CaBP1 C-domain;;CA;CALCIUM ION;Calcium-binding protein 1;9606;
2K7O;A;Ca2+-S100B, refined with RDCs;;CA;CALCIUM ION;Protein S100-B;10116;
2K7O;B;Ca2+-S100B, refined with RDCs;;CA;CALCIUM ION;Protein S100-B;10116;
2KAY;A;Solution structure and dynamics of S100A5 in the Ca2+ -bound states;;CA;CALCIUM ION;Protein S100-A5;9606;
2KAY;B;Solution structure and dynamics of S100A5 in the Ca2+ -bound states;;CA;CALCIUM ION;Protein S100-A5;9606;
2KBM;A;Ca-S100A1 interacting with TRTK12;;CA;CALCIUM ION;Protein S100-A1;10116;
2KBM;B;Ca-S100A1 interacting with TRTK12;;CA;CALCIUM ION;Protein S100-A1;10116;
2KDU;A;Structural basis of the Munc13-1/Ca2+-Calmodulin interaction: A novel 1-26 calmodulin binding motif with a bipartite binding mode;;CA;CALCIUM ION;Calmodulin;8355;
2KFF;A;Structure of the C-terminal domain of EHD1 with FNYESTNPFTAK;;CA;CALCIUM ION;EH domain-containing protein 1;9606;
2KFG;A;Structure of the C-terminal domain of EHD1 in complex with FNYESTDPFTAK;;CA;CALCIUM ION;EH domain-containing protein 1;9606;
2KFH;A;Structure of the C-terminal domain of EHD1 with FNYESTGPFTAK;;CA;CALCIUM ION;EH domain-containing protein 1;9606;
2KFX;T;Structure of the N-terminal domain of human cardiac troponin C bound to calcium ion and to the inhibitor W7;;CA;CALCIUM ION;Troponin C, slow skeletal and cardiac muscles;9606;
2KGB;C;NMR solution of the regulatory domain cardiac F77W-Troponin C in complex with the cardiac Troponin I 144-163 switch peptide;;CA;CALCIUM ION;Troponin C, slow skeletal and cardiac muscles;9606;
2KID;A;Solution Structure of the S. Aureus Sortase A-substrate Complex;;CA;CALCIUM ION;Sortase;1280;
2KMB;1;COMPLEX OF 3'-NEUAC-LEWIS-X WITH A SELECTIN-LIKE MUTANT OF MANNOSE-BINDING PROTEIN A;2;CA;CALCIUM ION;MANNOSE-BINDING PROTEIN-A;10116;
2KMB;2;COMPLEX OF 3'-NEUAC-LEWIS-X WITH A SELECTIN-LIKE MUTANT OF MANNOSE-BINDING PROTEIN A;2;CA;CALCIUM ION;MANNOSE-BINDING PROTEIN-A;10116;
2KMB;3;COMPLEX OF 3'-NEUAC-LEWIS-X WITH A SELECTIN-LIKE MUTANT OF MANNOSE-BINDING PROTEIN A;2;CA;CALCIUM ION;MANNOSE-BINDING PROTEIN-A;10116;
2KN2;A;Solution structure of the C-terminal domain of soybean calmodulin isoform 4 fused with the calmodulin-binding domain of NtMKP1;;CA;CALCIUM ION;Calmodulin;3847;
2KNE;A;Calmodulin wraps around its binding domain in the plasma membrane CA2+ pump anchored by a novel 18-1 motif;;CA;CALCIUM ION;Calmodulin;9606;
2KNX;A;Solution Structure of complement repeat CR17 from LRP-1;;CA;CALCIUM ION;Prolow-density lipoprotein receptor-related protein 1;9606;
2KNY;A;Fusion construct of CR17 from LRP-1 and ApoE residues 130-149;;CA;CALCIUM ION;LRP-1, linker, Apo-E;9606;
2KPN;A;Solution NMR structure of a Bacterial Ig-like (Big_3) domain from Bacillus cereus. Northeast Structural Genomics Consortium target BcR147A;;CA;CALCIUM ION;Bacillolysin;1396;
2KRD;C;Solution Structure of the Regulatory Domain of Human Cardiac Troponin C in Complex with the Switch Region of cardiac Troponin I and W7;;CA;CALCIUM ION;Troponin C, slow skeletal and cardiac muscles;9606;
2KRI;B;Structure of a complex between domain V of beta2-glycoprotein I and the fourth ligand-binding module from LDLR determined with Haddock;;CA;CALCIUM ION;Low-density lipoprotein receptor;9606;
2KSP;A;Mechanism for the selective interaction of C-terminal EH-domain proteins with specific NPF-containing partners;;CA;CALCIUM ION;EH domain-containing protein 1;9606;
2KUG;A;Halothane binds to druggable sites in calcium-calmodulin: Solution Structure of halothane-CaM N-terminal domain;;CA;CALCIUM ION;Calmodulin;9606;
2KUH;A;Halothane binds to druggable sites in calcium-calmodulin: Solution structure of halothane-CaM C-terminal domain;;CA;CALCIUM ION;Calmodulin;9606;
2KXV;A;NMR structure and calcium-binding properties of the tellurite resistance protein TerD from Klebsiella pneumoniae;;CA;CALCIUM ION;Tellurite resistance protein;573;
2KYF;A;solution structure of calcium-bound CPV3;;CA;CALCIUM ION;Parvalbumin, thymic CPV3;9031;
2KZ2;A;Calmodulin, C-terminal domain, F92E mutant;;CA;CALCIUM ION;Calmodulin;9031;
2L1R;A;The structure of the calcium-sensitizer, dfbp-o, in complex with the N-domain of troponin C and the switch region of troponin I;;CA;CALCIUM ION;Troponin C;9606;
2L1W;A;The solution structure of soybean calmodulin isoform 4 complexed with the vacuolar calcium ATPase BCA1 peptide;;CA;CALCIUM ION;Calmodulin;3847;
2L4H;A;The Solution Structure of Calcium Bound CIB1;;CA;CALCIUM ION;Calcium and integrin-binding protein 1;9606;
2L51;A;Solution structure of calcium bound S100A16;;CA;CALCIUM ION;Protein S100-A16;9606;
2L51;B;Solution structure of calcium bound S100A16;;CA;CALCIUM ION;Protein S100-A16;9606;
2L5Y;A;NMR structure of calcium-loaded STIM2 EF-SAM.;;CA;CALCIUM ION;Stromal interaction molecule 2;9606;
2L7L;A;Solution structure of Ca2+/calmodulin complexed with a peptide representing the calmodulin-binding domain of calmodulin kinase I;;CA;CALCIUM ION;Calmodulin;9606;
2L98;A;Structure of trans-Resveratrol in complex with the cardiac regulatory protein Troponin C;;CA;CALCIUM ION;Troponin C, slow skeletal and cardiac muscles;9606;
2LAL;A;CRYSTAL STRUCTURE DETERMINATION AND REFINEMENT AT 2.3 ANGSTROMS RESOLUTION OF THE LENTIL LECTIN;1.8;CA;CALCIUM ION;LENTIL LECTIN (ALPHA CHAIN);3864;
2LAL;C;CRYSTAL STRUCTURE DETERMINATION AND REFINEMENT AT 2.3 ANGSTROMS RESOLUTION OF THE LENTIL LECTIN;1.8;CA;CALCIUM ION;LENTIL LECTIN (ALPHA CHAIN);3864;
2LAN;A;NMR structure of Ca2+-bound CaBP1 N-domain with RDC;;CA;CALCIUM ION;Calcium-binding protein 1;9606;
2LAP;A;NMR structure of Ca2+-bound CaBP1 C-domain with RDC;;CA;CALCIUM ION;Calcium-binding protein 1;9606;
2LC5;A;Calmodulin-like Protein from Entamoeba histolytica: Solution Structure and Calcium-Binding Properties of a Partially Folded Protein;;CA;CALCIUM ION;Calmodulin, putative;5759;
2LCP;A;NMR structure of calcium loaded, un-myristoylated human NCS-1;;CA;CALCIUM ION;Neuronal calcium sensor 1;9606;
2LGF;A;Solution structure of Ca2+/calmodulin complexed with a peptide representing the calmodulin-binding domain of L-selectin;;CA;CALCIUM ION;Calmodulin;9606;
2LGP;A;Solution structure of LA45 from LDLR;;CA;CALCIUM ION;Low-density lipoprotein receptor;9606;
2LHH;A;Solution structure of Ca2+-bound yCaM;;CA;CALCIUM ION;Calmodulin;4932;
2LHI;A;Solution structure of Ca2+/CNA1 peptide-bound yCaM;;CA;CALCIUM ION;Calmodulin, Serine/threonine-protein phosphatase 2B catalytic subunit A1;493,232,630;
2LIP;A;PSEUDOMONAS LIPASE OPEN CONFORMATION;2.1;CA;CALCIUM ION;LIPASE;292;
2LLO;A;Solution NMR-derived structure of calmodulin N-lobe bound with ER alpha peptide;;CA;CALCIUM ION;Calmodulin;8355;
2LLQ;A;Solution nmr-derived structure of calmodulin c-lobe bound with er alpha peptide;;CA;CALCIUM ION;Calmodulin;8355;
2LM5;A;Solution structure of Ca2+-CIB1 in complex with the cytoplasmic domain of the integrin aIIb subunit;;CA;CALCIUM ION;Calcium and integrin-binding protein 1;9606;
2LMT;A;NMR structure of Androcam;;CA;CALCIUM ION;Calmodulin-related protein 97A;7227;
2LMU;A;Androcam at high calcium;;CA;CALCIUM ION;Calmodulin-related protein 97A;7227;
2LMV;A;Androcam at high calcium with three explicit Ca2+;;CA;CALCIUM ION;Calmodulin-related protein 97A;7227;
2LP2;A;Solution structure and dynamics of human S100A1 protein modified at cysteine 85 with homocysteine disulfide bond formation in calcium saturated form;;CA;CALCIUM ION;Protein S100-A1;9606;
2LP2;B;Solution structure and dynamics of human S100A1 protein modified at cysteine 85 with homocysteine disulfide bond formation in calcium saturated form;;CA;CALCIUM ION;Protein S100-A1;9606;
2LP3;A;Solution structure of S100A1 Ca2+;;CA;CALCIUM ION;Protein S100-A1;9606;
2LP3;B;Solution structure of S100A1 Ca2+;;CA;CALCIUM ION;Protein S100-A1;9606;
2LQC;A;NMR solution structure of a Ca2+-Calmodulin with a binding motif (NSCaTE) peptide from the N-terminal cytoplasmic domain of the L-type Voltage-Cated Calcium Channel alpha1C subunit;;CA;CALCIUM ION;Calmodulin;9606;
2LQP;A;NMR solution structure of the Ca2+-Calmodulin C-terminal domain in a complex with a peptide (NSCaTE) from the L-type Voltage-Gated Calcium Channel alpha1C subunit;;CA;CALCIUM ION;Calmodulin;9606;
2LRO;A;Solution structure, dynamics and binding studies of CtCBM11;;CA;CALCIUM ION;Endoglucanase H;1515;
2LRP;A;Solution structure, dynamics and binding studies of CtCBM11;;CA;CALCIUM ION;Endoglucanase H;1515;
2LTN;A;DESIGN, EXPRESSION, AND CRYSTALLIZATION OF RECOMBINANT LECTIN FROM THE GARDEN PEA (PISUM SATIVUM);1.7;CA;CALCIUM ION;PEA LECTIN, ALPHA CHAIN;3888;
2LTN;C;DESIGN, EXPRESSION, AND CRYSTALLIZATION OF RECOMBINANT LECTIN FROM THE GARDEN PEA (PISUM SATIVUM);1.7;CA;CALCIUM ION;PEA LECTIN, ALPHA CHAIN;3888;
2LUX;A;Calcium saturated form of human C85M S100A1 mutant;;CA;CALCIUM ION;Protein S100-A1;9606;
2LUX;B;Calcium saturated form of human C85M S100A1 mutant;;CA;CALCIUM ION;Protein S100-A1;9606;
2LV6;A;The complex between Ca-Calmodulin and skeletal muscle myosin light chain kinase from combination of NMR and aqueous and contrast-matched SAXS data;;CA;CALCIUM ION;Calmodulin;9606;
2LV7;A;Solution structure of Ca2+-bound CaBP7 N-terminal doman;;CA;CALCIUM ION;Calcium-binding protein 7;9606;
2LVK;A;Solution structure of Ca-bound Phl p 7;;CA;CALCIUM ION;Polcalcin Phl p 7;15957;
2M0J;A;3D Structure of Calmodulin and Calmodulin binding domain of Olfactory cyclic nucleotide-gated ion channel complex;;CA;CALCIUM ION;Calmodulin;9606;
2M0K;A;3D Structure of Calmodulin and Calmodulin Binding Domain of Rat Olfactory Cyclic Nucleotide-Gated Ion Channel;;CA;CALCIUM ION;Calmodulin;9606;
2M0P;A;Solution structure of the tenth complement type repeat of human megalin;;CA;CALCIUM ION;Low-density lipoprotein receptor-related protein 2;9606;
2M28;A;NMR structure of Ca2+ bound CaBP4 C-domain;;CA;CALCIUM ION;Calcium-binding protein 4;10090;
2M29;A;NMR structure of Ca2+ bound CaBP4 N-domain;;CA;CALCIUM ION;Calcium-binding protein 4;10090;
2M3S;A;Calmodulin, i85l, f92e, h107i, l112r, a128t, m144r mutant;;CA;CALCIUM ION;Calmodulin;9031;
2M55;A;NMR structure of the complex of an N-terminally acetylated alpha-synuclein peptide with calmodulin;;CA;CALCIUM ION;Calmodulin;9606;
2M5E;A;Structure of the C-domain of Calcium-saturated Calmodulin bound to the IQ motif of NaV1.2;;CA;CALCIUM ION;Calmodulin;5888;
2M7M;A;N-terminal domain of EhCaBP1 structure;;CA;CALCIUM ION;Calcium-binding protein;5759;
2M7N;A;C-terminal structure of (Y81F)-EhCaBP1;;CA;CALCIUM ION;Calcium-binding protein;5759;
2M7P;A;RXFP1 utilises hydrophobic moieties on a signalling surface of the LDLa module to mediate receptor activation;;CA;CALCIUM ION;Low-density lipoprotein receptor, Relaxin receptor 1;9606;
2M96;A;Solution NMR structure of the RXFP2 LDLa module;;CA;CALCIUM ION;Relaxin receptor 2;9606;
2M98;A;NMR Structure of BeF3 Activated Sma0114;;CA;CALCIUM ION;Two-component response regulator;382;
2MAS;A;PURINE NUCLEOSIDE HYDROLASE WITH A TRANSITION STATE INHIBITOR;2.3;CA;CALCIUM ION;INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDROLASE;5656;
2MAS;B;PURINE NUCLEOSIDE HYDROLASE WITH A TRANSITION STATE INHIBITOR;2.3;CA;CALCIUM ION;INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDROLASE;5656;
2MAS;C;PURINE NUCLEOSIDE HYDROLASE WITH A TRANSITION STATE INHIBITOR;2.3;CA;CALCIUM ION;INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDROLASE;5656;
2MAS;D;PURINE NUCLEOSIDE HYDROLASE WITH A TRANSITION STATE INHIBITOR;2.3;CA;CALCIUM ION;INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDROLASE;5656;
2MBX;A;Structure, dynamics and stability of allergen cod parvalbumin Gad m 1 by solution and high-pressure NMR.;;CA;CALCIUM ION;Parvalbumin beta;8049;
2MCM;A;MACROMOMYCIN;1.5;CA;CALCIUM ION;MACROMOMYCIN;1917;
2MES;A;Backbone 1H, 13C, 15N resonance assignments of calcium-bound calmodulin in complex with PSD95 N-terminal peptide;;CA;CALCIUM ION;Calmodulin;8355;
2MG9;A;Truncated EGF-A;;CA;CALCIUM ION;Low-density lipoprotein receptor;9606;
2MGU;A;Structure of the complex between calmodulin and the binding domain of HIV-1 matrix protein;;CA;CALCIUM ION;Calmodulin;10116;
2MIN;B;NITROGENASE MOFE PROTEIN FROM AZOTOBACTER VINELANDII, OXIDIZED STATE;2.03;CA;CALCIUM ION;NITROGENASE MOLYBDENUM IRON PROTEIN;354;
2MKP;C;N domain of cardiac troponin C bound to the switch fragment of fast skeletal troponin I at pH 6;;CA;CALCIUM ION;Troponin C, slow skeletal and cardiac muscles;9606;
2ML1;A;Solution Structure of AlgE6R1 subunit from the Azotobacter vinelandii Mannuronan C5-epimerase;;CA;CALCIUM ION;Poly(beta-D-mannuronate) C5 epimerase 6;354;
2ML2;A;Solution Structure of AlgE6R2 subunit from the Azotobacter vinelandii Mannuronan C5-epimerase;;CA;CALCIUM ION;Poly(beta-D-mannuronate) C5 epimerase 6;354;
2ML3;A;Solution Structure of AlgE6R3 subunit from the Azotobacter vinelandii Mannuronan C5-epimerase;;CA;CALCIUM ION;Poly(beta-D-mannuronate) C5 epimerase 6;354;
2MLE;C;NMR structure of the C-domain of troponin C bound to the anchoring region of troponin I;;CA;CALCIUM ION;Troponin C, slow skeletal and cardiac muscles;9606;
2MLF;C;NMR structure of the dilated cardiomyopathy mutation G159D in troponin C bound to the anchoring region of troponin I;;CA;CALCIUM ION;Troponin C, slow skeletal and cardiac muscles;9606;
2MLR;A;Membrane Bilayer complex with Matrix Metalloproteinase-12 at its Alpha-face;;CA;CALCIUM ION;Macrophage metalloelastase;9606;
2MLS;A;Membrane Bilayer complex with Matrix Metalloproteinase-12 at its Beta-face;;CA;CALCIUM ION;Macrophage metalloelastase;9606;
2MPR;A;MALTOPORIN FROM SALMONELLA TYPHIMURIUM;2.4;CA;CALCIUM ION;MALTOPORIN;90371;
2MSB;A;STRUCTURE OF A C-TYPE MANNOSE-BINDING PROTEIN COMPLEXED WITH AN OLIGOSACCHARIDE;1.7;CA;CALCIUM ION;MANNOSE-BINDING PROTEIN-A;10117;
2MSB;B;STRUCTURE OF A C-TYPE MANNOSE-BINDING PROTEIN COMPLEXED WITH AN OLIGOSACCHARIDE;1.7;CA;CALCIUM ION;MANNOSE-BINDING PROTEIN-A;10117;
2MTE;A;Solution structure of Doc48S;;CA;CALCIUM ION;Cellulose 1,4-beta-cellobiosidase (reducing end) CelS;1515;
2MZE;A;NMR Solution Structure of the PRO Form of Human Matrilysin (proMMP-7);;CA;CALCIUM ION;Matrilysin;9606;
2MZH;A;NMR Solution Structure of the PRO Form of Human Matrilysin (proMMP-7) in Complex with Zwitterionic Membrane;;CA;CALCIUM ION;Matrilysin;9606;
2MZI;A;NMR Solution Structure of the PRO Form of Human Matrilysin (proMMP-7) in Complex with Anionic Membrane;;CA;CALCIUM ION;Matrilysin;9606;
2MZP;C;Structure and dynamics of the acidosis-resistant a162H mutant of the switch region of troponin I bound to the regulatory domain of troponin C;;CA;CALCIUM ION;Troponin C, slow skeletal and cardiac muscles;9606;
2N27;A;Competitive inhibition of TRPV1 calmodulin interaction by vanilloids;;CA;CALCIUM ION;Calmodulin;9606;
2N6A;A;NMR structure of a human calmodulin/connexin-36 peptide hybrid;;CA;CALCIUM ION;human calmodulin/connexin-36 peptide hybrid;9606;
2N79;C;The structural and functional effects of the Familial Hypertrophic Cardiomyopathy-linked cardiac troponin C mutation, L29Q;;CA;CALCIUM ION;Troponin C, slow skeletal and cardiac muscles;9606;
2N7L;C;NMR structure of the N-domain of troponin C bound to the switch region of troponin I and the covalent levosimendan analog i9;;CA;CALCIUM ION;Troponin C/Troponin I chimera;9606;
2N8R;A;Productive complex between MMP-12 and synthetic triple-helical collagen, revealed through paramagnetic NMR;;CA;CALCIUM ION;Macrophage metalloelastase;9606;
2N8Y;A;Holo form of Calmodulin-Like Domain of Human Non-Muscle alpha-actinin 1;;CA;CALCIUM ION;Alpha-actinin-1;9606;
2NCE;A;Solution Structure of Ca2+-bound C2 domain from Protein Kinase C alpha in the form of complex with V5-pHM peptide;;CA;CALCIUM ION;Protein kinase C alpha type;10116;
2NOB;C;Structure of catalytically inactive H270A human 8-oxoguanine glycosylase crosslinked to 8-oxoguanine DNA;2.1;CA;CALCIUM ION;5'-D(*G*CP*GP*TP*CP*CP*AP*(G42)P*GP*TP*CP*TP*AP*CP*C)-3';;
2NOE;C;Structure of catalytically inactive G42A human 8-oxoguanine glycosylase complexed to 8-oxoguanine DNA;2.2;CA;CALCIUM ION;5'-D(*G*CP*GP*TP*CP*CP*AP*(G42)P*GP*TP*CP*TP*AP*CP*C)-3';;
2NOF;A;Structure of Q315F human 8-oxoguanine glycosylase proximal crosslink to 8-oxoguanine DNA;2.35;CA;CALCIUM ION;N-glycosylase/DNA lyase;9606;
2NOH;C;Structure of catalytically inactive Q315A human 8-oxoguanine glycosylase complexed to 8-oxoguanine DNA;2.01;CA;CALCIUM ION;5'-D(*GP*CP*GP*TP*CP*CP*AP*(G42)P*GP*TP*CP*TP*AP*CP*C)-3';;
2NOI;C;Structure of G42A human 8-oxoguanine glycosylase crosslinked to undamaged G-containing DNA;2.35;CA;CALCIUM ION;5'-D(*GP*CP*GP*TP*C*CP*AP*GP*GP*TP*CP*TP*AP*CP*C)-3';;
2NOL;A;Structure of catalytically inactive human 8-oxoguanine glycosylase distal crosslink to oxoG DNA;2.57;CA;CALCIUM ION;N-glycosylase/DNA lyase;9606;
2NOL;C;Structure of catalytically inactive human 8-oxoguanine glycosylase distal crosslink to oxoG DNA;2.57;CA;CALCIUM ION;5'-D(*GP*CP*GP*TP*CP*CP*AP*(G42)P*GP*TP*CP*TP*AP*CP*C)-3';;
2NOZ;C;Structure of Q315F human 8-oxoguanine glycosylase distal crosslink to 8-oxoguanine DNA;2.43;CA;CALCIUM ION;5'-D(*G*CP*GP*TP*CP*CP*AP*(G42)P*GP*TP*CP*TP*AP*CP*C)-3';;
2NP0;A;Crystal structure of the Botulinum neurotoxin type B complexed with synaptotagamin-II ectodomain;2.62;CA;CALCIUM ION;Botulinum neurotoxin type B;1491;
2NQ6;A;Crystal structure of human methionine aminopeptidase type 1 in complex with 3-tert-Butoxycarbonylaminopyridine-2-carboxylic acid thiazole-2-ylamide;1.5;CA;CALCIUM ION;Methionine aminopeptidase 1;9606;
2NQA;A;Catalytic Domain of Human Calpain 8;2.2;CA;CALCIUM ION;Calpain 8;9606;
2NQA;B;Catalytic Domain of Human Calpain 8;2.2;CA;CALCIUM ION;Calpain 8;9606;
2NQG;A;Calpain 1 proteolytic core inactivated by WR18(S,S), an epoxysuccinyl-type inhibitor.;2.04;CA;CALCIUM ION;Calpain-1 catalytic subunit;10116;
2NQI;A;Calpain 1 proteolytic core inactivated by WR13(R,R), an epoxysuccinyl-type inhibitor.;2.04;CA;CALCIUM ION;Calpain-1 catalytic subunit;10116;
2NQX;A;Crystal Structure of bovine lactoperoxidase with iodide ions at 2.9A resolution;2.95;CA;CALCIUM ION;Lactoperoxidase;9913;
2NUC;A;STAPHLOCOCCAL NUCLEASE, ETHANE THIOL DISULFIDE TO V23C VARIANT;2;CA;CALCIUM ION;STAPHYLOCOCCAL NUCLEASE;1280;
2NVO;A;Crystal structure of Deinococcus radiodurans RO (RSR) protein;1.89;CA;CALCIUM ION;Ro sixty-related protein, RSR;1299;
2NW6;A;Burkholderia cepacia lipase complexed with S-inhibitor;1.8;CA;CALCIUM ION;Lipase;292;
2NWH;A;Carbohydrate kinase from Agrobacterium tumefaciens;1.86;CA;CALCIUM ION;carbohydrate kinase;1176649;
2NXP;A;Structure of NTD2 domain of the human TAF5 subunit of TFIID;2.17;CA;CALCIUM ION;Transcription initiation factor TFIID subunit 5;9606;
2NXP;B;Structure of NTD2 domain of the human TAF5 subunit of TFIID;2.17;CA;CALCIUM ION;Transcription initiation factor TFIID subunit 5;9606;
2NXP;C;Structure of NTD2 domain of the human TAF5 subunit of TFIID;2.17;CA;CALCIUM ION;Transcription initiation factor TFIID subunit 5;9606;
2NXP;D;Structure of NTD2 domain of the human TAF5 subunit of TFIID;2.17;CA;CALCIUM ION;Transcription initiation factor TFIID subunit 5;9606;
2NXP;E;Structure of NTD2 domain of the human TAF5 subunit of TFIID;2.17;CA;CALCIUM ION;Transcription initiation factor TFIID subunit 5;9606;
2NXP;F;Structure of NTD2 domain of the human TAF5 subunit of TFIID;2.17;CA;CALCIUM ION;Transcription initiation factor TFIID subunit 5;9606;
2NXP;G;Structure of NTD2 domain of the human TAF5 subunit of TFIID;2.17;CA;CALCIUM ION;Transcription initiation factor TFIID subunit 5;9606;
2NXP;H;Structure of NTD2 domain of the human TAF5 subunit of TFIID;2.17;CA;CALCIUM ION;Transcription initiation factor TFIID subunit 5;9606;
2NXQ;A;Crystal structure of calcium binding protein 1 from Entamoeba histolytica: a novel arrangement of EF hand motifs;2.4;CA;CALCIUM ION;Calcium-binding protein;5759;
2NXQ;B;Crystal structure of calcium binding protein 1 from Entamoeba histolytica: a novel arrangement of EF hand motifs;2.4;CA;CALCIUM ION;Calcium-binding protein;5759;
2NYY;A;Crystal structure of botulinum neurotoxin type A complexed with monoclonal antibody CR1;2.61;CA;CALCIUM ION;Botulinum neurotoxin type A;1491;
2NZ0;A;Crystal structure of potassium channel Kv4.3 in complex with its regulatory subunit KChIP1 (CASP Target);3.2;CA;CALCIUM ION;Kv channel-interacting protein 1;9606;
2NZ0;C;Crystal structure of potassium channel Kv4.3 in complex with its regulatory subunit KChIP1 (CASP Target);3.2;CA;CALCIUM ION;Kv channel-interacting protein 1;9606;
2NZ9;A;Crystal structure of botulinum neurotoxin type A complexed with monoclonal antibody AR2;3.79;CA;CALCIUM ION;Botulinum neurotoxin type A;1491;
2NZ9;B;Crystal structure of botulinum neurotoxin type A complexed with monoclonal antibody AR2;3.79;CA;CALCIUM ION;Botulinum neurotoxin type A;1491;
2NZM;A;Hexasaccharide I bound to Bacillus subtilis pectate lyase;1.8;CA;CALCIUM ION;Pectate lyase;1423;
2O04;A;Pectate lyase bound to hexasaccharide compound II;1.7;CA;CALCIUM ION;Pectate lyase;1423;
2O0V;A;Pectate lyase bound to hexasaccharide compound III;1.9;CA;CALCIUM ION;Pectate lyase;1423;
2O0W;A;Pectate lyase bound to hexasaccharide compound IV;1.9;CA;CALCIUM ION;Pectate lyase;1423;
2O17;A;Pectate lyase bound to hexasaccharide;2.3;CA;CALCIUM ION;Pectate lyase;1423;
2O18;A;Crystal structure of a Thiamine biosynthesis lipoprotein apbE, NorthEast Strcutural Genomics target ER559;2.2;CA;CALCIUM ION;Thiamine biosynthesis lipoprotein apbE;562;
2O18;B;Crystal structure of a Thiamine biosynthesis lipoprotein apbE, NorthEast Strcutural Genomics target ER559;2.2;CA;CALCIUM ION;Thiamine biosynthesis lipoprotein apbE;562;
2O18;C;Crystal structure of a Thiamine biosynthesis lipoprotein apbE, NorthEast Strcutural Genomics target ER559;2.2;CA;CALCIUM ION;Thiamine biosynthesis lipoprotein apbE;562;
2O18;D;Crystal structure of a Thiamine biosynthesis lipoprotein apbE, NorthEast Strcutural Genomics target ER559;2.2;CA;CALCIUM ION;Thiamine biosynthesis lipoprotein apbE;562;
2O1D;A;Pectate lyase bound to trisaccharide;2;CA;CALCIUM ION;Pectate lyase;1423;
2O1J;B;Structure of the extended diarrhea-inducing domain of rotavirus enterotoxigenic protein NSP4;2.7;CA;CALCIUM ION;Nonstructural protein NSP4;28875;
2O1K;B;Structure of the extended diarrhea-inducing domain of rotavirus enterotoxigenic protein NSP4;1.67;CA;CALCIUM ION;Non-structural glycoprotein NSP4;28875;
2O39;C;Human Adenovirus type 11 knob in complex with domains SCR1 and SCR2 of CD46 (membrane cofactor protein, MCP);2.85;CA;CALCIUM ION;Membrane cofactor protein;9606;
2O39;D;Human Adenovirus type 11 knob in complex with domains SCR1 and SCR2 of CD46 (membrane cofactor protein, MCP);2.85;CA;CALCIUM ION;Membrane cofactor protein;9606;
2O3K;B;Yeast Cytosine Deaminase D92E Triple Mutant bound to transition state analogue HPY;2.3;CA;CALCIUM ION;Cytosine deaminase;4932;
2O4V;A;An arginine ladder in OprP mediates phosphate specific transfer across the outer membrane;1.94;CA;CALCIUM ION;Porin P;287;
2O4V;B;An arginine ladder in OprP mediates phosphate specific transfer across the outer membrane;1.94;CA;CALCIUM ION;Porin P;287;
2O4V;C;An arginine ladder in OprP mediates phosphate specific transfer across the outer membrane;1.94;CA;CALCIUM ION;Porin P;287;
2O5G;A;Calmodulin-smooth muscle light chain kinase peptide complex;1.08;CA;CALCIUM ION;Calmodulin;9031;
2O60;A;Calmodulin bound to peptide from neuronal nitric oxide synthase;1.55;CA;CALCIUM ION;Calmodulin;9031;
2O6H;A;Lumazine synthase RibH1 from Brucella melitensis (Gene BMEI1187, Swiss-Prot entry Q8YGH2) complexed with inhibitor 5-Nitro-6-(D-Ribitylamino)-2,4(1H,3H) Pyrimidinedione;2.7;CA;CALCIUM ION;6,7-dimethyl-8-ribityllumazine synthase 1;29459;
2O6H;B;Lumazine synthase RibH1 from Brucella melitensis (Gene BMEI1187, Swiss-Prot entry Q8YGH2) complexed with inhibitor 5-Nitro-6-(D-Ribitylamino)-2,4(1H,3H) Pyrimidinedione;2.7;CA;CALCIUM ION;6,7-dimethyl-8-ribityllumazine synthase 1;29459;
2O6H;C;Lumazine synthase RibH1 from Brucella melitensis (Gene BMEI1187, Swiss-Prot entry Q8YGH2) complexed with inhibitor 5-Nitro-6-(D-Ribitylamino)-2,4(1H,3H) Pyrimidinedione;2.7;CA;CALCIUM ION;6,7-dimethyl-8-ribityllumazine synthase 1;29459;
2O6H;D;Lumazine synthase RibH1 from Brucella melitensis (Gene BMEI1187, Swiss-Prot entry Q8YGH2) complexed with inhibitor 5-Nitro-6-(D-Ribitylamino)-2,4(1H,3H) Pyrimidinedione;2.7;CA;CALCIUM ION;6,7-dimethyl-8-ribityllumazine synthase 1;29459;
2O72;A;Crystal Structure Analysis of human E-cadherin (1-213);2;CA;CALCIUM ION;Epithelial-cadherin;9606;
2O86;A;Crystal structure of a ternary complex of buffalo lactoperoxidase with nitrate and iodide at 2.8 A resolution;2.8;CA;CALCIUM ION;Lactoperoxidase;89462;
2O8O;A;Crystal structure of Clostridium histolyticum colg collagenase collagen-binding domain 3B at 1.35 Angstrom resolution in presence of calcium;1.35;CA;CALCIUM ION;Collagenase;1498;
2O8O;B;Crystal structure of Clostridium histolyticum colg collagenase collagen-binding domain 3B at 1.35 Angstrom resolution in presence of calcium;1.35;CA;CALCIUM ION;Collagenase;1498;
2O9Q;A;The crystal structure of Bovine Trypsin complexed with a small inhibition peptide ORB2K;1.7;CA;CALCIUM ION;Cationic trypsin;9913;
2OA8;A;Crystal Structure of mTREX1 with ssDNA;2.1;CA;CALCIUM ION;Three prime repair exonuclease 1;10090;
2OA8;B;Crystal Structure of mTREX1 with ssDNA;2.1;CA;CALCIUM ION;Three prime repair exonuclease 1;10090;
2OA8;C;Crystal Structure of mTREX1 with ssDNA;2.1;CA;CALCIUM ION;5'-D(*GP*AP*CP*G)-3';;
2OA8;D;Crystal Structure of mTREX1 with ssDNA;2.1;CA;CALCIUM ION;5'-D(*GP*AP*CP*G)-3';;
2OAA;A;Restriction endonuclease MvaI-cognate DNA substrate complex;1.5;CA;CALCIUM ION;R.MvaI;1272;
2OAA;B;Restriction endonuclease MvaI-cognate DNA substrate complex;1.5;CA;CALCIUM ION;R.MvaI;1272;
2OAA;C;Restriction endonuclease MvaI-cognate DNA substrate complex;1.5;CA;CALCIUM ION;5'-D(*GP*GP*TP*AP*CP*CP*TP*GP*GP*AP*T)-3';;
2OAA;E;Restriction endonuclease MvaI-cognate DNA substrate complex;1.5;CA;CALCIUM ION;5'-D(*GP*GP*TP*AP*CP*CP*TP*GP*GP*AP*T)-3';;
2OAI;A;The structure of transporter associated domain CorC_HlyC from a Xylella fastidiosa Temecula1 hemolysin.;1.8;CA;CALCIUM ION;Hemolysin;2371;
2OAN;A;Structure of oxidized beta-actin;2.61;CA;CALCIUM ION;Actin, cytoplasmic 1;9913;
2OAN;B;Structure of oxidized beta-actin;2.61;CA;CALCIUM ION;Actin, cytoplasmic 1;9913;
2OAN;C;Structure of oxidized beta-actin;2.61;CA;CALCIUM ION;Actin, cytoplasmic 1;9913;
2OAN;D;Structure of oxidized beta-actin;2.61;CA;CALCIUM ION;Actin, cytoplasmic 1;9913;
2OBH;A;Centrin-XPC peptide;1.8;CA;CALCIUM ION;Centrin-2;9606;
2OBH;B;Centrin-XPC peptide;1.8;CA;CALCIUM ION;Centrin-2;9606;
2OBL;A;Structural and biochemical analysis of a prototypical ATPase from the type III secretion system of pathogenic bacteria;1.8;CA;CALCIUM ION;EscN;562;
2OBM;A;Structural and biochemical analysis of a prototypical ATPase from the type III secretion system of pathogenic bacteria;2.25;CA;CALCIUM ION;EscN;562;
2ODI;A;Restriction Endonuclease BCNI-Cognate DNA Substrate Complex;1.45;CA;CALCIUM ION;R.BcnI;54910;
2ODI;B;Restriction Endonuclease BCNI-Cognate DNA Substrate Complex;1.45;CA;CALCIUM ION;R.BcnI;54910;
2OEE;A;yheA from Bacillus subtilis;1.96;CA;CALCIUM ION;UPF0342 protein yheA;1423;
2OEE;B;yheA from Bacillus subtilis;1.96;CA;CALCIUM ION;UPF0342 protein yheA;1423;
2OEO;A;Cryogenic crystal structure of Staphylococcal Nuclease variant truncated Delta+PHS I92D;2;CA;CALCIUM ION;Staphylococcal thermonuclease;1280;
2OF1;A;Cryogenic crystal structure of the Staphylococcal Nuclease variant truncated Delta+PHS I92W;1.92;CA;CALCIUM ION;Staphylococcal thermonuclease;1280;
2OG9;A;Crystal Structure of mandelate racemase/muconate lactonizing enzyme from Polaromonas sp. JS666;1.9;CA;CALCIUM ION;Mandelate racemase/muconate lactonizing enzyme;296591;
2OG9;B;Crystal Structure of mandelate racemase/muconate lactonizing enzyme from Polaromonas sp. JS666;1.9;CA;CALCIUM ION;Mandelate racemase/muconate lactonizing enzyme;296591;
2OGY;A;Asn199Ala Mutant of the 5-methyltetrahydrofolate corrinoid/iron sulfur protein methyltransferase complexed with methyltetrahydrofolate to 2.3 Angstrom resolution;2.3;CA;CALCIUM ION;5-methyltetrahydrofolate corrinoid/iron sulfur protein methyltransferase;1525;
2OGY;B;Asn199Ala Mutant of the 5-methyltetrahydrofolate corrinoid/iron sulfur protein methyltransferase complexed with methyltetrahydrofolate to 2.3 Angstrom resolution;2.3;CA;CALCIUM ION;5-methyltetrahydrofolate corrinoid/iron sulfur protein methyltransferase;1525;
2OJV;A;Crystal structure of a ternary complex of goat lactoperoxidase with cyanide and iodide ions at 2.4 A resolution;2.4;CA;CALCIUM ION;Lactoperoxidase;9925;
2OKS;A;X-ray Structure of a DNA Repair Substrate Containing an Alkyl Interstrand Crosslink at 1.65 Resolution;1.65;CA;CALCIUM ION;5'-D(*CP*CP*AP*AP*(C34)P*GP*TP*TP*GP*G)-3';;
2OKX;A;Crystal structure of GH78 family rhamnosidase of Bacillus SP. GL1 AT 1.9 A;1.9;CA;CALCIUM ION;Rhamnosidase B;84635;
2OKX;B;Crystal structure of GH78 family rhamnosidase of Bacillus SP. GL1 AT 1.9 A;1.9;CA;CALCIUM ION;Rhamnosidase B;84635;
2OLG;A;Crystal structure of the serine protease domain of prophenoloxidase activating factor-I in a zymogen form;1.7;CA;CALCIUM ION;Pro-phenoloxidase activating enzyme-I;33394;
2OMT;A;Crystal structure of InlA G194S+S/hEC1 complex;2;CA;CALCIUM ION;Internalin-A;1639;
2OMU;B;Crystal structure of InlA G194S+S Y369S/hEC1 complex;1.8;CA;CALCIUM ION;Epithelial-cadherin;9606;
2OMV;A;Crystal structure of InlA S192N Y369S/hEC1 complex;1.9;CA;CALCIUM ION;Internalin-A;1639;
2OMV;B;Crystal structure of InlA S192N Y369S/hEC1 complex;1.9;CA;CALCIUM ION;Epithelial-cadherin;9606;
2OMX;B;Crystal structure of InlA S192N G194S+S/hEC1 complex;1.7;CA;CALCIUM ION;Epithelial-cadherin;9606;
2OMY;A;Crystal structure of InlA S192N/hEC1 complex;1.7;CA;CALCIUM ION;Internalin-A;1639;
2OMY;B;Crystal structure of InlA S192N/hEC1 complex;1.7;CA;CALCIUM ION;Epithelial-cadherin;9606;
2OO4;A;Structure of LNR-HD (Negative Regulatory Region) from human Notch 2;2;CA;CALCIUM ION;Neurogenic locus notch homolog protein 2;9606;
2OO4;B;Structure of LNR-HD (Negative Regulatory Region) from human Notch 2;2;CA;CALCIUM ION;Neurogenic locus notch homolog protein 2;9606;
2OOT;A;A High Resolution Structure of Ligand-free Human Glutamate Carboxypeptidase II;1.64;CA;CALCIUM ION;Glutamate carboxypeptidase 2;9606;
2OPO;A;Crystal structure of the calcium-binding pollen allergen Che a 3;1.75;CA;CALCIUM ION;Polcalcin Che a 3;3559;
2OPO;B;Crystal structure of the calcium-binding pollen allergen Che a 3;1.75;CA;CALCIUM ION;Polcalcin Che a 3;3559;
2OPO;C;Crystal structure of the calcium-binding pollen allergen Che a 3;1.75;CA;CALCIUM ION;Polcalcin Che a 3;3559;
2OPO;D;Crystal structure of the calcium-binding pollen allergen Che a 3;1.75;CA;CALCIUM ION;Polcalcin Che a 3;3559;
2OQU;A;High Pressure Cryocooling of Capillary Sample Cryoprotection and Diffraction Phasing at Long Wavelengths;1.8;CA;CALCIUM ION;Elastase-1;9823;
2OR4;A;A high resolution crystal structure of human glutamate carboxypeptidase II in complex with quisqualic acid;1.62;CA;CALCIUM ION;Glutamate carboxypeptidase 2;9606;
2ORJ;A;crystal structure of the trimeric neck and carbohydrate recognition domain of human surfactant protein D in complex with N-acetyl mannosamine;1.8;CA;CALCIUM ION;Pulmonary surfactant-associated protein D;9606;
2ORJ;B;crystal structure of the trimeric neck and carbohydrate recognition domain of human surfactant protein D in complex with N-acetyl mannosamine;1.8;CA;CALCIUM ION;Pulmonary surfactant-associated protein D;9606;
2ORJ;C;crystal structure of the trimeric neck and carbohydrate recognition domain of human surfactant protein D in complex with N-acetyl mannosamine;1.8;CA;CALCIUM ION;Pulmonary surfactant-associated protein D;9606;
2ORK;A;crystal structure of the trimeric neck and carbohydrate recognition domain of human surfactant protein D in complex with inositol-1-phosphate;1.89;CA;CALCIUM ION;Pulmonary surfactant-associated protein D;9606;
2ORK;B;crystal structure of the trimeric neck and carbohydrate recognition domain of human surfactant protein D in complex with inositol-1-phosphate;1.89;CA;CALCIUM ION;Pulmonary surfactant-associated protein D;9606;
2ORK;C;crystal structure of the trimeric neck and carbohydrate recognition domain of human surfactant protein D in complex with inositol-1-phosphate;1.89;CA;CALCIUM ION;Pulmonary surfactant-associated protein D;9606;
2OS8;C;Rigor-like structures of muscle myosins reveal key mechanical elements in the transduction pathways of this allosteric motor;3.27;CA;CALCIUM ION;Myosin essential light chain;6577;
2OS9;A;crystal structure of the trimeric neck and carbohydrate recognition domain of human surfactant protein D in complex with myoinositol;1.7;CA;CALCIUM ION;Pulmonary surfactant-associated protein D;9606;
2OS9;B;crystal structure of the trimeric neck and carbohydrate recognition domain of human surfactant protein D in complex with myoinositol;1.7;CA;CALCIUM ION;Pulmonary surfactant-associated protein D;9606;
2OS9;C;crystal structure of the trimeric neck and carbohydrate recognition domain of human surfactant protein D in complex with myoinositol;1.7;CA;CALCIUM ION;Pulmonary surfactant-associated protein D;9606;
2OSD;A;Crystal structure of a vinyl-4-reductase family protein (mj_1460) from methanocaldococcus jannaschii dsm at 2.40 A resolution;2.3;CA;CALCIUM ION;Hypothetical protein MJ1460;2190;
2OST;A;The structure of a bacterial homing endonuclease : I-Ssp6803I;3.1;CA;CALCIUM ION;Putative endonuclease;1148;
2OST;B;The structure of a bacterial homing endonuclease : I-Ssp6803I;3.1;CA;CALCIUM ION;Putative endonuclease;1148;
2OT4;A;Structure of a hexameric multiheme c nitrite reductase from the extremophile bacterium Thiolkalivibrio nitratireducens;1.5;CA;CALCIUM ION;Eight-heme nitrite reductase;186931;
2OT4;B;Structure of a hexameric multiheme c nitrite reductase from the extremophile bacterium Thiolkalivibrio nitratireducens;1.5;CA;CALCIUM ION;Eight-heme nitrite reductase;186931;
2OTG;C;Rigor-like structures of muscle myosins reveal key mechanical elements in the transduction pathways of this allosteric motor;3.12;CA;CALCIUM ION;Myosin essential light chain;6577;
2OTM;A;Crystal structure of a putative endoribonuclease (so_1960) from shewanella oneidensis mr-1 at 1.85 A resolution;1.85;CA;CALCIUM ION;Hypothetical protein;70863;
2OTV;A;Crystal structure of the complex formed between bovine trypsin and nicotinamide at 1.56 A resolution;1.56;CA;CALCIUM ION;Cationic trypsin;9913;
2OVU;A;Crystal structure of a lectin from Canavalia gladiata (CGL) in complex with man1-2man-OMe;1.5;CA;CALCIUM ION;Canavalia gladiata lectin;3824;
2OVX;A;MMP-9 active site mutant with barbiturate inhibitor;2;CA;CALCIUM ION;Matrix metalloproteinase-9 (EC 3.4.24.35) (MMP-9) (92 kDa type IV collagenase) (92 kDa gelatinase) (Gelatinase B) (GELB);9606;
2OVX;B;MMP-9 active site mutant with barbiturate inhibitor;2;CA;CALCIUM ION;Matrix metalloproteinase-9 (EC 3.4.24.35) (MMP-9) (92 kDa type IV collagenase) (92 kDa gelatinase) (Gelatinase B) (GELB);9606;
2OVZ;A;MMP-9 active site mutant with phosphinate inhibitor;2;CA;CALCIUM ION;Matrix metalloproteinase-9 (EC 3.4.24.35) (MMP-9) (92 kDa type IV collagenase) (92 kDa gelatinase) (Gelatinase B) (GELB);9606;
2OVZ;B;MMP-9 active site mutant with phosphinate inhibitor;2;CA;CALCIUM ION;Matrix metalloproteinase-9 (EC 3.4.24.35) (MMP-9) (92 kDa type IV collagenase) (92 kDa gelatinase) (Gelatinase B) (GELB);9606;
2OW0;A;MMP-9 active site mutant with iodine-labeled carboxylate inhibitor;2;CA;CALCIUM ION;Matrix metalloproteinase-9 (MMP-9) (92 kDa type IV collagenase) (92 kDa gelatinase) (Gelatinase B) (GELB);9606;
2OW0;B;MMP-9 active site mutant with iodine-labeled carboxylate inhibitor;2;CA;CALCIUM ION;Matrix metalloproteinase-9 (MMP-9) (92 kDa type IV collagenase) (92 kDa gelatinase) (Gelatinase B) (GELB);9606;
2OW1;A;MMP-9 active site mutant with trifluoromethyl hydroxamate inhibitor;2.2;CA;CALCIUM ION;Matrix metalloproteinase-9 (MMP-9) (92 kDa type IV collagenase) (92 kDa gelatinase) (Gelatinase B) (GELB);9606;
2OW1;B;MMP-9 active site mutant with trifluoromethyl hydroxamate inhibitor;2.2;CA;CALCIUM ION;Matrix metalloproteinase-9 (MMP-9) (92 kDa type IV collagenase) (92 kDa gelatinase) (Gelatinase B) (GELB);9606;
2OW2;A;MMP-9 active site mutant with difluoro butanoic acid inhibitor;2.9;CA;CALCIUM ION;Matrix metalloproteinase-9 (MMP-9) (92 kDa type IV collagenase) (92 kDa gelatinase) (Gelatinase B) (GELB);9606;
2OW2;B;MMP-9 active site mutant with difluoro butanoic acid inhibitor;2.9;CA;CALCIUM ION;Matrix metalloproteinase-9 (MMP-9) (92 kDa type IV collagenase) (92 kDa gelatinase) (Gelatinase B) (GELB);9606;
2OW4;A;Crystal structure of a lectin from Canavalia maritima seeds (ConM) in complex with man1-2man-OMe;1.6;CA;CALCIUM ION;Canavalia maritima lectin;3825;
2OW9;A;Crystal structure analysis of the MMP13 catalytic domain in complex with specific inhibitor;1.74;CA;CALCIUM ION;Collagenase 3;9606;
2OW9;B;Crystal structure analysis of the MMP13 catalytic domain in complex with specific inhibitor;1.74;CA;CALCIUM ION;Collagenase 3;9606;
2OWL;A;Crystal structure of E. coli RdgC;2.4;CA;CALCIUM ION;Recombination-associated protein rdgC;562;
2OWL;B;Crystal structure of E. coli RdgC;2.4;CA;CALCIUM ION;Recombination-associated protein rdgC;562;
2OX8;C;Human Scavenger Receptor C-type Lectin carbohydrate-recognition domain.;2.5;CA;CALCIUM ION;Scavenger receptor with C-type lectin type I;9606;
2OX8;D;Human Scavenger Receptor C-type Lectin carbohydrate-recognition domain.;2.5;CA;CALCIUM ION;Scavenger receptor with C-type lectin type I;9606;
2OX9;A;Mouse Scavenger Receptor C-type Lectin carbohydrate-recognition domain.;1.95;CA;CALCIUM ION;Collectin placenta 1;10090;
2OX9;B;Mouse Scavenger Receptor C-type Lectin carbohydrate-recognition domain.;1.95;CA;CALCIUM ION;Collectin placenta 1;10090;
2OX9;C;Mouse Scavenger Receptor C-type Lectin carbohydrate-recognition domain.;1.95;CA;CALCIUM ION;Collectin placenta 1;10090;
2OX9;D;Mouse Scavenger Receptor C-type Lectin carbohydrate-recognition domain.;1.95;CA;CALCIUM ION;Collectin placenta 1;10090;
2OXE;A;Structure of the Human Pancreatic Lipase-related Protein 2;2.8;CA;CALCIUM ION;Pancreatic lipase-related protein 2;9606;
2OXE;B;Structure of the Human Pancreatic Lipase-related Protein 2;2.8;CA;CALCIUM ION;Pancreatic lipase-related protein 2;9606;
2OXS;A;Crystal Structure of the trypsin complex with benzamidine at high temperature (35 C);1.32;CA;CALCIUM ION;Cationic trypsin;9913;
2OXU;A;Uninhibited form of human MMP-12;1.24;CA;CALCIUM ION;Macrophage metalloelastase;9606;
2OXW;A;Human MMP-12 complexed with the peptide IAG;1.15;CA;CALCIUM ION;Macrophage metalloelastase;9606;
2OXZ;A;Human MMP-12 in complex with two peptides PQG and IAG;1.9;CA;CALCIUM ION;Macrophage metalloelastase;9606;
2OY2;A;Human MMP-8 in complex with peptide IAG;1.5;CA;CALCIUM ION;Neutrophil collagenase;9606;
2OY2;F;Human MMP-8 in complex with peptide IAG;1.5;CA;CALCIUM ION;Neutrophil collagenase;9606;
2OY4;A;Uninhibited human MMP-8;1.7;CA;CALCIUM ION;Neutrophil collagenase;9606;
2OY4;F;Uninhibited human MMP-8;1.7;CA;CALCIUM ION;Neutrophil collagenase;9606;
2OYH;B;Crystal Structure of Fragment D of gammaD298,301A Fibrinogen with the Peptide Ligand Gly-His-Arg-Pro-Amide;2.4;CA;CALCIUM ION;Fibrinogen beta chain;9606;
2OYH;C;Crystal Structure of Fragment D of gammaD298,301A Fibrinogen with the Peptide Ligand Gly-His-Arg-Pro-Amide;2.4;CA;CALCIUM ION;Fibrinogen gamma chain;9606;
2OYH;E;Crystal Structure of Fragment D of gammaD298,301A Fibrinogen with the Peptide Ligand Gly-His-Arg-Pro-Amide;2.4;CA;CALCIUM ION;Fibrinogen beta chain;9606;
2OYH;F;Crystal Structure of Fragment D of gammaD298,301A Fibrinogen with the Peptide Ligand Gly-His-Arg-Pro-Amide;2.4;CA;CALCIUM ION;Fibrinogen gamma chain;9606;
2OYI;B;Crystal Structure of Fragment D of gammaD298,301A Fibrinogen with the Peptide Ligand Gly-Pro-Arg-Pro-Amide;2.7;CA;CALCIUM ION;Fibrinogen beta chain;9606;
2OYI;C;Crystal Structure of Fragment D of gammaD298,301A Fibrinogen with the Peptide Ligand Gly-Pro-Arg-Pro-Amide;2.7;CA;CALCIUM ION;Fibrinogen gamma chain;9606;
2OYI;E;Crystal Structure of Fragment D of gammaD298,301A Fibrinogen with the Peptide Ligand Gly-Pro-Arg-Pro-Amide;2.7;CA;CALCIUM ION;Fibrinogen beta chain;9606;
2OYI;F;Crystal Structure of Fragment D of gammaD298,301A Fibrinogen with the Peptide Ligand Gly-Pro-Arg-Pro-Amide;2.7;CA;CALCIUM ION;Fibrinogen gamma chain;9606;
2OZB;A;Structure of a human Prp31-15.5K-U4 snRNA complex;2.6;CA;CALCIUM ION;U4/U6.U5 tri-snRNP 15.5 kDa protein;9606;
2OZB;B;Structure of a human Prp31-15.5K-U4 snRNA complex;2.6;CA;CALCIUM ION;U4/U6 small nuclear ribonucleoprotein Prp31;9606;
2OZB;E;Structure of a human Prp31-15.5K-U4 snRNA complex;2.6;CA;CALCIUM ION;U4/U6 small nuclear ribonucleoprotein Prp31;9606;
2OZN;B;The Cohesin-Dockerin Complex of NagJ and NagH from Clostridium perfringens;1.6;CA;CALCIUM ION;Hyalurononglucosaminidase;1502;
2OZR;A;MMP13 Catalytic Domain Complexed with 4-{[1-methyl-2,4-dioxo-6-(3-phenylprop-1-yn-1-yl)-1,4-dihydroquinazolin-3(2H)-yl]methyl}benzoic acid;2.3;CA;CALCIUM ION;Collagenase 3;9606;
2OZR;B;MMP13 Catalytic Domain Complexed with 4-{[1-methyl-2,4-dioxo-6-(3-phenylprop-1-yn-1-yl)-1,4-dihydroquinazolin-3(2H)-yl]methyl}benzoic acid;2.3;CA;CALCIUM ION;Collagenase 3;9606;
2OZR;C;MMP13 Catalytic Domain Complexed with 4-{[1-methyl-2,4-dioxo-6-(3-phenylprop-1-yn-1-yl)-1,4-dihydroquinazolin-3(2H)-yl]methyl}benzoic acid;2.3;CA;CALCIUM ION;Collagenase 3;9606;
2OZR;D;MMP13 Catalytic Domain Complexed with 4-{[1-methyl-2,4-dioxo-6-(3-phenylprop-1-yn-1-yl)-1,4-dihydroquinazolin-3(2H)-yl]methyl}benzoic acid;2.3;CA;CALCIUM ION;Collagenase 3;9606;
2OZR;E;MMP13 Catalytic Domain Complexed with 4-{[1-methyl-2,4-dioxo-6-(3-phenylprop-1-yn-1-yl)-1,4-dihydroquinazolin-3(2H)-yl]methyl}benzoic acid;2.3;CA;CALCIUM ION;Collagenase 3;9606;
2OZR;F;MMP13 Catalytic Domain Complexed with 4-{[1-methyl-2,4-dioxo-6-(3-phenylprop-1-yn-1-yl)-1,4-dihydroquinazolin-3(2H)-yl]methyl}benzoic acid;2.3;CA;CALCIUM ION;Collagenase 3;9606;
2OZR;G;MMP13 Catalytic Domain Complexed with 4-{[1-methyl-2,4-dioxo-6-(3-phenylprop-1-yn-1-yl)-1,4-dihydroquinazolin-3(2H)-yl]methyl}benzoic acid;2.3;CA;CALCIUM ION;Collagenase 3;9606;
2OZR;H;MMP13 Catalytic Domain Complexed with 4-{[1-methyl-2,4-dioxo-6-(3-phenylprop-1-yn-1-yl)-1,4-dihydroquinazolin-3(2H)-yl]methyl}benzoic acid;2.3;CA;CALCIUM ION;Collagenase 3;9606;
2P0R;A;Structure of Human Calpain 9 in complex with Leupeptin;2.5;CA;CALCIUM ION;Calpain-9;9606;
2P0R;B;Structure of Human Calpain 9 in complex with Leupeptin;2.5;CA;CALCIUM ION;Calpain-9;9606;
2P16;A;Factor Xa in Complex with the Inhibitor APIXABAN (BMS-562247) AKA 1-(4-METHOXYPHENYL)-7-OXO-6-(4-(2-OXO-1-PIPERIDINYL)PHENYL)-4,5,6,7-TETRAHYDRO-1H-PYRAZOLO[3, 4-C]PYRIDINE-3-CARBOXAMIDE;2.3;CA;CALCIUM ION;Coagulation factor X (EC 3.4.21.6) (Stuart factor) (Stuart-Prower factor);9606;
2P1R;A;Crystal structure of Salmonella typhimurium YegS, a putative lipid kinase homologous to eukaryotic sphingosine and diacylglycerol kinases.;2.5;CA;CALCIUM ION;Lipid kinase yegS;28901;
2P1R;B;Crystal structure of Salmonella typhimurium YegS, a putative lipid kinase homologous to eukaryotic sphingosine and diacylglycerol kinases.;2.5;CA;CALCIUM ION;Lipid kinase yegS;28901;
2P1R;C;Crystal structure of Salmonella typhimurium YegS, a putative lipid kinase homologous to eukaryotic sphingosine and diacylglycerol kinases.;2.5;CA;CALCIUM ION;Lipid kinase yegS;28901;
2P1R;D;Crystal structure of Salmonella typhimurium YegS, a putative lipid kinase homologous to eukaryotic sphingosine and diacylglycerol kinases.;2.5;CA;CALCIUM ION;Lipid kinase yegS;28901;
2P2K;A;Crystal structure of a lectin from Canavalia gladiata seeds (CGL) in complex with man1-4man-OMe;1.98;CA;CALCIUM ION;Canavalia gladiata lectin;3824;
2P2K;B;Crystal structure of a lectin from Canavalia gladiata seeds (CGL) in complex with man1-4man-OMe;1.98;CA;CALCIUM ION;Canavalia gladiata lectin;3824;
2P2K;C;Crystal structure of a lectin from Canavalia gladiata seeds (CGL) in complex with man1-4man-OMe;1.98;CA;CALCIUM ION;Canavalia gladiata lectin;3824;
2P2K;D;Crystal structure of a lectin from Canavalia gladiata seeds (CGL) in complex with man1-4man-OMe;1.98;CA;CALCIUM ION;Canavalia gladiata lectin;3824;
2P34;A;Crystal structure of a lectin from Canavalia maritima seeds (CML) in complex with man1-4man-OMe;2.1;CA;CALCIUM ION;Lectin;3825;
2P34;B;Crystal structure of a lectin from Canavalia maritima seeds (CML) in complex with man1-4man-OMe;2.1;CA;CALCIUM ION;Lectin;3825;
2P34;C;Crystal structure of a lectin from Canavalia maritima seeds (CML) in complex with man1-4man-OMe;2.1;CA;CALCIUM ION;Lectin;3825;
2P34;D;Crystal structure of a lectin from Canavalia maritima seeds (CML) in complex with man1-4man-OMe;2.1;CA;CALCIUM ION;Lectin;3825;
2P37;A;Crystal structure of a lectin from Canavalia maritima seeds (CML) in complex with man1-3man-OMe;2.1;CA;CALCIUM ION;Concanavalin A;3825;
2P37;B;Crystal structure of a lectin from Canavalia maritima seeds (CML) in complex with man1-3man-OMe;2.1;CA;CALCIUM ION;Concanavalin A;3825;
2P37;C;Crystal structure of a lectin from Canavalia maritima seeds (CML) in complex with man1-3man-OMe;2.1;CA;CALCIUM ION;Concanavalin A;3825;
2P37;D;Crystal structure of a lectin from Canavalia maritima seeds (CML) in complex with man1-3man-OMe;2.1;CA;CALCIUM ION;Concanavalin A;3825;
2P3T;B;Crystal structure of human factor XA complexed with 3-Chloro-4-(2-methylamino-imidazol-1-ylmethyl)-thiophene-2-carboxylic acid [4-chloro-2-(5-chloro-pyridin-2-ylcarbamoyl)-6-methoxy-phenyl]-amide;1.92;CA;CALCIUM ION;Coagulation factor X;9606;
2P3U;B;Crystal structure of human factor XA complexed with 3-chloro-N-(4-chloro-2-{[(5-chloropyridin-2-yl)amino]carbonyl}-6-methoxyphenyl)-4-[(1-methyl-1H-imidazol-2-yl)methyl]thiophene-2-carboxamide {Pfizer 320663};1.62;CA;CALCIUM ION;Coagulation factor X;9606;
2P4P;A;Crystal structure of a CorC_HlyC domain from Haemophilus ducreyi;1.8;CA;CALCIUM ION;Hypothetical protein HD1797;730;
2P5R;A;Crystal structure of the poplar glutathione peroxidase 5 in the oxidized form;2.45;CA;CALCIUM ION;Glutathione peroxidase 5;3695;
2P5R;B;Crystal structure of the poplar glutathione peroxidase 5 in the oxidized form;2.45;CA;CALCIUM ION;Glutathione peroxidase 5;3695;
2P5V;A;Crystal Structure of Transcriptional Regulator NMB0573 from Neisseria Meningitidis;1.99;CA;CALCIUM ION;Transcriptional regulator, LRP/AsnC family;487;
2P5V;B;Crystal Structure of Transcriptional Regulator NMB0573 from Neisseria Meningitidis;1.99;CA;CALCIUM ION;Transcriptional regulator, LRP/AsnC family;487;
2P5V;C;Crystal Structure of Transcriptional Regulator NMB0573 from Neisseria Meningitidis;1.99;CA;CALCIUM ION;Transcriptional regulator, LRP/AsnC family;487;
2P5V;D;Crystal Structure of Transcriptional Regulator NMB0573 from Neisseria Meningitidis;1.99;CA;CALCIUM ION;Transcriptional regulator, LRP/AsnC family;487;
2P5V;F;Crystal Structure of Transcriptional Regulator NMB0573 from Neisseria Meningitidis;1.99;CA;CALCIUM ION;Transcriptional regulator, LRP/AsnC family;487;
2P5V;G;Crystal Structure of Transcriptional Regulator NMB0573 from Neisseria Meningitidis;1.99;CA;CALCIUM ION;Transcriptional regulator, LRP/AsnC family;487;
2P5V;H;Crystal Structure of Transcriptional Regulator NMB0573 from Neisseria Meningitidis;1.99;CA;CALCIUM ION;Transcriptional regulator, LRP/AsnC family;487;
2P5W;B;Crystal structures of high affinity human T-cell receptors bound to pMHC reveal native diagonal binding geometry;2.2;CA;CALCIUM ION;Beta-2-microglobulin;9606;
2P69;A;Crystal Structure of Human Pyridoxal Phosphate Phosphatase with PLP;2.25;CA;CALCIUM ION;Pyridoxal phosphate phosphatase;9606;
2P6B;B;Crystal Structure of Human Calcineurin in Complex with PVIVIT Peptide;2.3;CA;CALCIUM ION;Calcineurin subunit B isoform 1;9606;
2P6B;D;Crystal Structure of Human Calcineurin in Complex with PVIVIT Peptide;2.3;CA;CALCIUM ION;Calcineurin subunit B isoform 1;9606;
2P6S;B;Crystal Structure of Transcriptional Regulator NMB0573/L-Met Complex from Neisseria Meningitidis;2.8;CA;CALCIUM ION;Transcriptional regulator, LRP/AsnC family;487;
2P6S;C;Crystal Structure of Transcriptional Regulator NMB0573/L-Met Complex from Neisseria Meningitidis;2.8;CA;CALCIUM ION;Transcriptional regulator, LRP/AsnC family;487;
2P6S;D;Crystal Structure of Transcriptional Regulator NMB0573/L-Met Complex from Neisseria Meningitidis;2.8;CA;CALCIUM ION;Transcriptional regulator, LRP/AsnC family;487;
2P6S;E;Crystal Structure of Transcriptional Regulator NMB0573/L-Met Complex from Neisseria Meningitidis;2.8;CA;CALCIUM ION;Transcriptional regulator, LRP/AsnC family;487;
2P6S;F;Crystal Structure of Transcriptional Regulator NMB0573/L-Met Complex from Neisseria Meningitidis;2.8;CA;CALCIUM ION;Transcriptional regulator, LRP/AsnC family;487;
2P6T;B;CRYSTAL STRUCTURE OF TRANSCRIPTIONAL REGULATOR NMB0573 and L-LEUCINE COMPLEX FROM NEISSERIA MENINGITIDIS;2.9;CA;CALCIUM ION;Transcriptional regulator, LRP/AsnC family;487;
2P6T;C;CRYSTAL STRUCTURE OF TRANSCRIPTIONAL REGULATOR NMB0573 and L-LEUCINE COMPLEX FROM NEISSERIA MENINGITIDIS;2.9;CA;CALCIUM ION;Transcriptional regulator, LRP/AsnC family;487;
2P6T;D;CRYSTAL STRUCTURE OF TRANSCRIPTIONAL REGULATOR NMB0573 and L-LEUCINE COMPLEX FROM NEISSERIA MENINGITIDIS;2.9;CA;CALCIUM ION;Transcriptional regulator, LRP/AsnC family;487;
2P6T;E;CRYSTAL STRUCTURE OF TRANSCRIPTIONAL REGULATOR NMB0573 and L-LEUCINE COMPLEX FROM NEISSERIA MENINGITIDIS;2.9;CA;CALCIUM ION;Transcriptional regulator, LRP/AsnC family;487;
2P6T;G;CRYSTAL STRUCTURE OF TRANSCRIPTIONAL REGULATOR NMB0573 and L-LEUCINE COMPLEX FROM NEISSERIA MENINGITIDIS;2.9;CA;CALCIUM ION;Transcriptional regulator, LRP/AsnC family;487;
2P6T;H;CRYSTAL STRUCTURE OF TRANSCRIPTIONAL REGULATOR NMB0573 and L-LEUCINE COMPLEX FROM NEISSERIA MENINGITIDIS;2.9;CA;CALCIUM ION;Transcriptional regulator, LRP/AsnC family;487;
2P9I;A;Crystal Structure of bovine Arp2/3 Complex co-crystallized with ADP and crosslinked with gluteraldehyde;2.46;CA;CALCIUM ION;Actin-like protein 3;9913;
2P9I;B;Crystal Structure of bovine Arp2/3 Complex co-crystallized with ADP and crosslinked with gluteraldehyde;2.46;CA;CALCIUM ION;Actin-like protein 2;9913;
2P9K;A;Crystal structure of bovine Arp2/3 complex co-crystallized with ATP and crosslinked with glutaraldehyde;2.59;CA;CALCIUM ION;Actin-like protein 3;9913;
2P9K;B;Crystal structure of bovine Arp2/3 complex co-crystallized with ATP and crosslinked with glutaraldehyde;2.59;CA;CALCIUM ION;Actin-like protein 2;9913;
2P9N;A;Crystal Structure of bovine Arp2/3 complex co-crystallized with ADP;2.85;CA;CALCIUM ION;Actin-like protein 3;9913;
2P9P;A;Crystal Structure of bovine Arp2/3 complex co-crystallized with ADP;2.9;CA;CALCIUM ION;Actin-like protein 3;9913;
2P9U;A;Crystal structure of bovine Arp2/3 complex co-crystallized with AMP-PNP and calcium;2.75;CA;CALCIUM ION;Actin-like protein 3;9913;
2P9U;B;Crystal structure of bovine Arp2/3 complex co-crystallized with AMP-PNP and calcium;2.75;CA;CALCIUM ION;Actin-like protein 2;9913;
2PAG;A;Crystal structure of protein PSPTO_5518 from Pseudomonas syringae pv. tomato;1.6;CA;CALCIUM ION;Hypothetical protein;251701;
2PAS;A;COMPARISON BETWEEN THE CRYSTAL AND THE SOLUTION STRUCTURES OF THE EF HAND PARVALBUMIN;;CA;CALCIUM ION;PARVALBUMIN;8010;
2PAV;A;Ternary complex of Profilin-Actin with the Last Poly-Pro of Human VASP;1.8;CA;CALCIUM ION;Actin, alpha skeletal muscle;9986;
2PBD;A;Ternary complex of profilin-actin with the poly-PRO-GAB domain of VASP*;1.5;CA;CALCIUM ION;Actin, alpha skeletal muscle;9986;
2PC6;A;Crystal structure of putative acetolactate synthase- small subunit from Nitrosomonas europaea;2.5;CA;CALCIUM ION;Probable acetolactate synthase isozyme III (Small subunit);915;
2PC6;B;Crystal structure of putative acetolactate synthase- small subunit from Nitrosomonas europaea;2.5;CA;CALCIUM ION;Probable acetolactate synthase isozyme III (Small subunit);915;
2PC6;C;Crystal structure of putative acetolactate synthase- small subunit from Nitrosomonas europaea;2.5;CA;CALCIUM ION;Probable acetolactate synthase isozyme III (Small subunit);915;
2PC9;A;Crystal Structure Of ATP-Dependent Phosphoenolpyruvate Carboxykinase From Thermus thermophilus HB8;2.4;CA;CALCIUM ION;Phosphoenolpyruvate carboxykinase [ATP];274;
2PC9;B;Crystal Structure Of ATP-Dependent Phosphoenolpyruvate Carboxykinase From Thermus thermophilus HB8;2.4;CA;CALCIUM ION;Phosphoenolpyruvate carboxykinase [ATP];274;
2PC9;C;Crystal Structure Of ATP-Dependent Phosphoenolpyruvate Carboxykinase From Thermus thermophilus HB8;2.4;CA;CALCIUM ION;Phosphoenolpyruvate carboxykinase [ATP];274;
2PC9;D;Crystal Structure Of ATP-Dependent Phosphoenolpyruvate Carboxykinase From Thermus thermophilus HB8;2.4;CA;CALCIUM ION;Phosphoenolpyruvate carboxykinase [ATP];274;
2PDA;A;CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN PYRUVATE-FERREDOXIN OXIDOREDUCTASE FROM DESULFOVIBRIO AFRICANUS AND PYRUVATE.;3;CA;CALCIUM ION;PROTEIN (PYRUVATE-FERREDOXIN OXIDOREDUCTASE);873;
2PDA;B;CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN PYRUVATE-FERREDOXIN OXIDOREDUCTASE FROM DESULFOVIBRIO AFRICANUS AND PYRUVATE.;3;CA;CALCIUM ION;PROTEIN (PYRUVATE-FERREDOXIN OXIDOREDUCTASE);873;
2PEL;A;PEANUT LECTIN;2.25;CA;CALCIUM ION;PEANUT LECTIN;3818;
2PEL;B;PEANUT LECTIN;2.25;CA;CALCIUM ION;PEANUT LECTIN;3818;
2PEL;C;PEANUT LECTIN;2.25;CA;CALCIUM ION;PEANUT LECTIN;3818;
2PEL;D;PEANUT LECTIN;2.25;CA;CALCIUM ION;PEANUT LECTIN;3818;
2PF2;A;THE CA+2 ION AND MEMBRANE BINDING STRUCTURE OF THE GLA DOMAIN OF CA-PROTHROMBIN FRAGMENT 1;2.2;CA;CALCIUM ION;PROTHROMBIN FRAGMENT 1;9913;
2PFJ;A;Crystal Structure of T7 Endo I resolvase in complex with a Holliday Junction;3.1;CA;CALCIUM ION;Endodeoxyribonuclease 1;1985738;
2PFJ;B;Crystal Structure of T7 Endo I resolvase in complex with a Holliday Junction;3.1;CA;CALCIUM ION;Endodeoxyribonuclease 1;1985738;
2PFJ;Y;Crystal Structure of T7 Endo I resolvase in complex with a Holliday Junction;3.1;CA;CALCIUM ION;27-MER;;
2PFJ;Z;Crystal Structure of T7 Endo I resolvase in complex with a Holliday Junction;3.1;CA;CALCIUM ION;27-MER;;
2PHB;A;An Orally Efficacious Factor Xa Inhibitor;2.3;CA;CALCIUM ION;Coagulation factor X, heavy chain;9606;
2PHF;A;Pterocarpus angolensis lectin complexed with Man-6;2.1;CA;CALCIUM ION;Lectin;182271;
2PHF;B;Pterocarpus angolensis lectin complexed with Man-6;2.1;CA;CALCIUM ION;Lectin;182271;
2PHI;A;A LARGE CONFORMATIONAL CHANGE IS FOUND IN THE CRYSTAL STRUCTURE OF THE PORCINE PANCREATIC PHOSPHOLIPASE A2 POINT MUTANT F63V;2.2;CA;CALCIUM ION;PHOSPHOLIPASE A2;9823;
2PHI;B;A LARGE CONFORMATIONAL CHANGE IS FOUND IN THE CRYSTAL STRUCTURE OF THE PORCINE PANCREATIC PHOSPHOLIPASE A2 POINT MUTANT F63V;2.2;CA;CALCIUM ION;PHOSPHOLIPASE A2;9823;
2PHR;A;Pterocarpus angolensis lectin (PAL) in complex with Man-7D1;1.9;CA;CALCIUM ION;Lectin;182271;
2PHR;B;Pterocarpus angolensis lectin (PAL) in complex with Man-7D1;1.9;CA;CALCIUM ION;Lectin;182271;
2PHT;A;Pterocarpus angolensis lectin (P L) in complex with Man-7D3;2.1;CA;CALCIUM ION;Lectin;182271;
2PHT;B;Pterocarpus angolensis lectin (P L) in complex with Man-7D3;2.1;CA;CALCIUM ION;Lectin;182271;
2PHU;A;Pterocarpus angolensis lectin in complex with Man-8D1D3;2.2;CA;CALCIUM ION;Lectin;182271;
2PHU;B;Pterocarpus angolensis lectin in complex with Man-8D1D3;2.2;CA;CALCIUM ION;Lectin;182271;
2PHW;A;Pterocarpus angolensis lectin (PAL) in complex with Man-9;1.8;CA;CALCIUM ION;Lectin;182271;
2PHW;B;Pterocarpus angolensis lectin (PAL) in complex with Man-9;1.8;CA;CALCIUM ION;Lectin;182271;
2PHX;A;Pterocarpus angolensis lectin (PAL) in complex with Man-5;1.8;CA;CALCIUM ION;Lectin;182271;
2PHX;B;Pterocarpus angolensis lectin (PAL) in complex with Man-5;1.8;CA;CALCIUM ION;Lectin;182271;
2PJP;A;Structure of the mRNA-binding domain of elongation factor SelB from E.coli in complex with SECIS RNA;2.3;CA;CALCIUM ION;Selenocysteine-specific elongation factor;562;
2PJT;A;Crystal structure of the catalytic domain of MMP-13 complexed with WAY-344;2.8;CA;CALCIUM ION;Collagenase 3;9606;
2PJT;B;Crystal structure of the catalytic domain of MMP-13 complexed with WAY-344;2.8;CA;CALCIUM ION;Collagenase 3;9606;
2PJT;C;Crystal structure of the catalytic domain of MMP-13 complexed with WAY-344;2.8;CA;CALCIUM ION;Collagenase 3;9606;
2PJT;D;Crystal structure of the catalytic domain of MMP-13 complexed with WAY-344;2.8;CA;CALCIUM ION;Collagenase 3;9606;
2PKT;A;Crystal structure of the human CLP-36 (PDLIM1) bound to the C-terminal peptide of human alpha-actinin-1;1.5;CA;CALCIUM ION;PDZ and LIM domain protein 1;9606;
2PLT;A;STRUCTURE DETERMINATION OF PLASTOCYANIN FROM A CRYSTAL SPECIMEN WITH HEMIHEDRAL TWINNING FRACTION OF ONE-HALF;1.5;CA;CALCIUM ION;PLASTOCYANIN;3055;
2PLX;A;Trypsin complexed to a synthetic peptide from Veronica hederifolia;1.56;CA;CALCIUM ION;Cationic trypsin;9913;
2PLY;A;Structure of the mRNA binding fragment of elongation factor SelB in complex with SECIS RNA.;2.6;CA;CALCIUM ION;Selenocysteine-specific elongation factor;1525;
2PMY;A;EF-hand domain of human RASEF;2.3;CA;CALCIUM ION;RAS and EF-hand domain-containing protein;9606;
2PMY;B;EF-hand domain of human RASEF;2.3;CA;CALCIUM ION;RAS and EF-hand domain-containing protein;9606;
2PNC;A;Crystal Structure of Bovine Plasma Copper-Containing Amine Oxidase in Complex with Clonidine;2.4;CA;CALCIUM ION;Copper amine oxidase, liver isozyme;9913;
2PNC;B;Crystal Structure of Bovine Plasma Copper-Containing Amine Oxidase in Complex with Clonidine;2.4;CA;CALCIUM ION;Copper amine oxidase, liver isozyme;9913;
2PNY;A;Structure of Human Isopentenyl-diphosphate Delta-isomerase 2;1.81;CA;CALCIUM ION;Isopentenyl-diphosphate Delta-isomerase 2;9606;
2POJ;A;NMR Solution Structure of the Inhibitor-Free State of Macrophage Metalloelastase (MMP-12);;CA;CALCIUM ION;Macrophage metalloelastase;9606;
2POO;A;THERMOSTABLE PHYTASE IN FULLY CALCIUM LOADED STATE;2.05;CA;CALCIUM ION;PROTEIN (PHYTASE);1390;
2POR;A;STRUCTURE OF PORIN REFINED AT 1.8 ANGSTROMS RESOLUTION;1.8;CA;CALCIUM ION;PORIN;1061;
2PPL;A;Human Pancreatic lipase-related protein 1;2.2;CA;CALCIUM ION;Pancreatic lipase-related protein 1;9606;
2PQ2;A;Structure of serine proteinase K complex with a highly flexible hydrophobic peptide at 1.8A resolution;1.82;CA;CALCIUM ION;Proteinase K;37998;
2PQX;A;E. coli RNase 1 (in vivo folded);1.42;CA;CALCIUM ION;Ribonuclease I;562;
2PQY;A;E. coli RNase 1 (in vitro refolded with DsbA only);2.3;CA;CALCIUM ION;Ribonuclease I;562;
2PR3;A;Factor XA inhibitor;1.5;CA;CALCIUM ION;COAGULATION FACTOR X, HEAVY CHAIN;9606;
2PR7;A;Crystal structure of uncharacterized protein (NP_599989.1) from Corynebacterium glutamicum ATCC 13032 Kitasato at 1.44 A resolution;1.44;CA;CALCIUM ION;Haloacid dehalogenase/epoxide hydrolase family;1718;
2PR7;B;Crystal structure of uncharacterized protein (NP_599989.1) from Corynebacterium glutamicum ATCC 13032 Kitasato at 1.44 A resolution;1.44;CA;CALCIUM ION;Haloacid dehalogenase/epoxide hydrolase family;1718;
2PRK;A;SYNCHROTRON X-RAY DATA COLLECTION AND RESTRAINED LEAST-SQUARES REFINEMENT OF THE CRYSTAL STRUCTURE OF PROTEINASE K AT 1.5 ANGSTROMS RESOLUTION;1.5;CA;CALCIUM ION;PROTEINASE K;37998;
2PSR;A;HUMAN PSORIASIN (S100A7) CA2+ AND ZN2+ BOUND FORM (CRYSTAL FORM II);2.05;CA;CALCIUM ION;PSORIASIN;9606;
2PT3;A;Crystal structure of bovine lactoperoxidase at 2.34 A resolution reveals multiple anion binding sites;2.34;CA;CALCIUM ION;Lactoperoxidase;9913;
2PTC;E;THE GEOMETRY OF THE REACTIVE SITE AND OF THE PEPTIDE GROUPS IN TRYPSIN, TRYPSINOGEN AND ITS COMPLEXES WITH INHIBITORS;1.9;CA;CALCIUM ION;BETA-TRYPSIN;9913;
2PTN;A;ON THE DISORDERED ACTIVATION DOMAIN IN TRYPSINOGEN. CHEMICAL LABELLING AND LOW-TEMPERATURE CRYSTALLOGRAPHY;1.55;CA;CALCIUM ION;TRYPSIN;9913;
2PUM;A;Crystal structure of bovine lactoperoxidase complex with catechol and iodide at 2.7 A resolution;2.7;CA;CALCIUM ION;Lactoperoxidase;9913;
2PUQ;H;Crystal structure of active site inhibited coagulation factor VIIA in complex with soluble tissue factor;2.05;CA;CALCIUM ION;Coagulation factor VII;9606;
2PVB;A;PIKE PARVALBUMIN (PI 4.10) AT LOW TEMPERATURE (100K) AND ATOMIC RESOLUTION (0.91 A).;0.91;CA;CALCIUM ION;PROTEIN (PARVALBUMIN);8010;
2PVS;A;Structure of human pancreatic lipase related protein 2 mutant N336Q;3;CA;CALCIUM ION;Pancreatic lipase-related protein 2;9606;
2PVS;B;Structure of human pancreatic lipase related protein 2 mutant N336Q;3;CA;CALCIUM ION;Pancreatic lipase-related protein 2;9606;
2PVV;A;Structure of human glutamate carboxypeptidase II (GCPII) in complex with L-serine-O-sulfate;2.11;CA;CALCIUM ION;Glutamate carboxypeptidase 2;9606;
2PVW;A;A high resolution structure of human glutamate carboxypeptidase II (GCPII) in complex with 2-(phosphonomethyl)pentanedioic acid (2-PMPA);1.71;CA;CALCIUM ION;Glutamate carboxypeptidase 2;9606;
2PVZ;A;Crystal structure of methylaconitate isomerase PrpF from Shewanella oneidensis;1.97;CA;CALCIUM ION;PrpF methylaconitate isomerase;70863;
2PWA;A;Crystal Structure of the complex of Proteinase K with Alanine Boronic acid at 0.83A resolution;0.83;CA;CALCIUM ION;Proteinase K;37998;
2PWB;A;Crystal structure of the complex of proteinase K with coumarin at 1.9 A resolution;1.9;CA;CALCIUM ION;Proteinase K;37998;
2PWD;A;Crystal Structure of the Trehalulose Synthase MUTB from Pseudomonas Mesoacidophila MX-45 Complexed to the Inhibitor Deoxynojirmycin;1.8;CA;CALCIUM ION;Sucrose isomerase;265293;
2PWD;B;Crystal Structure of the Trehalulose Synthase MUTB from Pseudomonas Mesoacidophila MX-45 Complexed to the Inhibitor Deoxynojirmycin;1.8;CA;CALCIUM ION;Sucrose isomerase;265293;
2PWE;A;Crystal structure of the MutB E254Q mutant in complex with the substrate sucrose;2;CA;CALCIUM ION;Sucrose isomerase;265293;
2PWE;B;Crystal structure of the MutB E254Q mutant in complex with the substrate sucrose;2;CA;CALCIUM ION;Sucrose isomerase;265293;
2PWF;A;Crystal structure of the MutB D200A mutant in complex with glucose;1.8;CA;CALCIUM ION;Sucrose isomerase;265293;
2PWF;B;Crystal structure of the MutB D200A mutant in complex with glucose;1.8;CA;CALCIUM ION;Sucrose isomerase;265293;
2PWF;C;Crystal structure of the MutB D200A mutant in complex with glucose;1.8;CA;CALCIUM ION;Sucrose isomerase;265293;
2PWF;D;Crystal structure of the MutB D200A mutant in complex with glucose;1.8;CA;CALCIUM ION;Sucrose isomerase;265293;
2PWG;A;Crystal Structure of the Trehalulose Synthase MutB From Pseudomonas Mesoacidophila MX-45 Complexed to the Inhibitor Castanospermine;2.2;CA;CALCIUM ION;Sucrose isomerase;265293;
2PWG;B;Crystal Structure of the Trehalulose Synthase MutB From Pseudomonas Mesoacidophila MX-45 Complexed to the Inhibitor Castanospermine;2.2;CA;CALCIUM ION;Sucrose isomerase;265293;
2PWH;A;Crystal structure of the trehalulose synthase MutB from Pseudomonas mesoacidophila MX-45;2;CA;CALCIUM ION;Sucrose isomerase;265293;
2PWH;B;Crystal structure of the trehalulose synthase MutB from Pseudomonas mesoacidophila MX-45;2;CA;CALCIUM ION;Sucrose isomerase;265293;
2PY2;A;Structure of Herring Type II Antifreeze Protein;1.7;CA;CALCIUM ION;Antifreeze protein type II;7950;
2PY2;B;Structure of Herring Type II Antifreeze Protein;1.7;CA;CALCIUM ION;Antifreeze protein type II;7950;
2PY2;C;Structure of Herring Type II Antifreeze Protein;1.7;CA;CALCIUM ION;Antifreeze protein type II;7950;
2PY2;D;Structure of Herring Type II Antifreeze Protein;1.7;CA;CALCIUM ION;Antifreeze protein type II;7950;
2PY2;E;Structure of Herring Type II Antifreeze Protein;1.7;CA;CALCIUM ION;Antifreeze protein type II;7950;
2PY2;F;Structure of Herring Type II Antifreeze Protein;1.7;CA;CALCIUM ION;Antifreeze protein type II;7950;
2PYG;A;Azotobacter vinelandii Mannuronan C-5 epimerase AlgE4 A-module;2.1;CA;CALCIUM ION;Poly(beta-D-mannuronate) C5 epimerase 4;354;
2PYG;B;Azotobacter vinelandii Mannuronan C-5 epimerase AlgE4 A-module;2.1;CA;CALCIUM ION;Poly(beta-D-mannuronate) C5 epimerase 4;354;
2PYH;A;Azotobacter vinelandii Mannuronan C-5 epimerase AlgE4 A-module complexed with mannuronan trisaccharide;2.7;CA;CALCIUM ION;Poly(beta-D-mannuronate) C5 epimerase 4;354;
2PYH;B;Azotobacter vinelandii Mannuronan C-5 epimerase AlgE4 A-module complexed with mannuronan trisaccharide;2.7;CA;CALCIUM ION;Poly(beta-D-mannuronate) C5 epimerase 4;354;
2PYZ;A;Crystal structure of the complex of proteinase K with auramine at 1.8A resolution;1.79;CA;CALCIUM ION;Proteinase K;37998;
2PZ0;A;Crystal structure of Glycerophosphodiester Phosphodiesterase (GDPD) from T. tengcongensis;1.91;CA;CALCIUM ION;Glycerophosphoryl diester phosphodiesterase;911092;
2PZ0;B;Crystal structure of Glycerophosphodiester Phosphodiesterase (GDPD) from T. tengcongensis;1.91;CA;CALCIUM ION;Glycerophosphoryl diester phosphodiesterase;911092;
2Q04;A;Crystal structure of acetoin utilization protein (ZP_00540088.1) from Exiguobacterium sibiricum 255-15 at 2.33 A resolution;2.33;CA;CALCIUM ION;Acetoin utilization protein;332410;
2Q04;B;Crystal structure of acetoin utilization protein (ZP_00540088.1) from Exiguobacterium sibiricum 255-15 at 2.33 A resolution;2.33;CA;CALCIUM ION;Acetoin utilization protein;332410;
2Q04;C;Crystal structure of acetoin utilization protein (ZP_00540088.1) from Exiguobacterium sibiricum 255-15 at 2.33 A resolution;2.33;CA;CALCIUM ION;Acetoin utilization protein;332410;
2Q04;D;Crystal structure of acetoin utilization protein (ZP_00540088.1) from Exiguobacterium sibiricum 255-15 at 2.33 A resolution;2.33;CA;CALCIUM ION;Acetoin utilization protein;332410;
2Q04;E;Crystal structure of acetoin utilization protein (ZP_00540088.1) from Exiguobacterium sibiricum 255-15 at 2.33 A resolution;2.33;CA;CALCIUM ION;Acetoin utilization protein;332410;
2Q04;F;Crystal structure of acetoin utilization protein (ZP_00540088.1) from Exiguobacterium sibiricum 255-15 at 2.33 A resolution;2.33;CA;CALCIUM ION;Acetoin utilization protein;332410;
2Q0R;A;Structure of Pectenotoxin-2 Bound to Actin;1.7;CA;CALCIUM ION;Actin;9986;
2Q0U;A;Structure of Pectenotoxin-2 and Latrunculin B Bound to Actin;1.45;CA;CALCIUM ION;Actin;9986;
2Q10;A;RESTRICTION ENDONUCLEASE BcnI (WILD TYPE)-COGNATE DNA SUBSTRATE COMPLEX;1.75;CA;CALCIUM ION;R.BcnI;54910;
2Q10;B;RESTRICTION ENDONUCLEASE BcnI (WILD TYPE)-COGNATE DNA SUBSTRATE COMPLEX;1.75;CA;CALCIUM ION;R.BcnI;54910;
2Q10;C;RESTRICTION ENDONUCLEASE BcnI (WILD TYPE)-COGNATE DNA SUBSTRATE COMPLEX;1.75;CA;CALCIUM ION;DNA (5'-D(*AP*AP*CP*CP*CP*GP*GP*AP*GP*AP*C)-3');;
2Q16;A;Structure of the E. coli inosine triphosphate pyrophosphatase RgdB in complex with ITP;1.95;CA;CALCIUM ION;HAM1 protein homolog;562;
2Q16;B;Structure of the E. coli inosine triphosphate pyrophosphatase RgdB in complex with ITP;1.95;CA;CALCIUM ION;HAM1 protein homolog;562;
2Q17;A;Formylglycine Generating Enzyme from Streptomyces coelicolor;2.1;CA;CALCIUM ION;formylglycine generating enzyme;1902;
2Q17;B;Formylglycine Generating Enzyme from Streptomyces coelicolor;2.1;CA;CALCIUM ION;formylglycine generating enzyme;1902;
2Q17;C;Formylglycine Generating Enzyme from Streptomyces coelicolor;2.1;CA;CALCIUM ION;formylglycine generating enzyme;1902;
2Q17;D;Formylglycine Generating Enzyme from Streptomyces coelicolor;2.1;CA;CALCIUM ION;formylglycine generating enzyme;1902;
2Q17;E;Formylglycine Generating Enzyme from Streptomyces coelicolor;2.1;CA;CALCIUM ION;formylglycine generating enzyme;1902;
2Q1C;X;2-keto-3-deoxy-D-arabinonate dehydratase complexed with calcium and 2-oxobutyrate;2.8;CA;CALCIUM ION;2-keto-3-deoxy-D-arabinonate dehydratase;2287;
2Q1F;A;Crystal structure of chondroitin sulfate lyase abc from bacteroides thetaiotaomicron wal2926;2.85;CA;CALCIUM ION;Chondroitinase;818;
2Q1F;B;Crystal structure of chondroitin sulfate lyase abc from bacteroides thetaiotaomicron wal2926;2.85;CA;CALCIUM ION;Chondroitinase;818;
2Q1J;A;The discovery of glycine and related amino acid-based factor xa inhibitors;1.9;CA;CALCIUM ION;Activated factor Xa heavy chain (EC 3.4.21.6);9606;
2Q1N;A;Actin Dimer Cross-linked Between Residues 41 and 374;2.7;CA;CALCIUM ION;Actin, alpha skeletal muscle;9986;
2Q1N;B;Actin Dimer Cross-linked Between Residues 41 and 374;2.7;CA;CALCIUM ION;Actin, alpha skeletal muscle;9986;
2Q31;A;Actin Dimer Cross-linked Between Residues 41 and 374 and proteolytically cleaved by subtilisin between residues 47 and 48.;2.7;CA;CALCIUM ION;Actin, alpha skeletal muscle;9986;
2Q31;B;Actin Dimer Cross-linked Between Residues 41 and 374 and proteolytically cleaved by subtilisin between residues 47 and 48.;2.7;CA;CALCIUM ION;Actin, alpha skeletal muscle;9986;
2Q36;A;Actin Dimer Cross-linked between Residues 191 and 374 and complexed with Kabiramide C;2.5;CA;CALCIUM ION;Actin, alpha skeletal muscle;9986;
2Q67;A;Crystal Structure of Nak channel D66A mutant;2.3;CA;CALCIUM ION;Potassium channel protein;1396;
2Q68;A;Crystal Structure of Nak channel D66A, S70E double mutants;2.5;CA;CALCIUM ION;Potassium channel protein;1396;
2Q69;B;Crystal Structure of Nak channel D66N mutant;2.4;CA;CALCIUM ION;Potassium channel protein;1396;
2Q6A;A;Crystal Structure of Nak channel D66E mutant;2.6;CA;CALCIUM ION;Potassium channel protein;1396;
2Q91;A;Structure of the Ca2+-Bound Activated Form of the S100A4 Metastasis Factor;1.63;CA;CALCIUM ION;S100A4 Metastasis Factor;9606;
2Q91;B;Structure of the Ca2+-Bound Activated Form of the S100A4 Metastasis Factor;1.63;CA;CALCIUM ION;S100A4 Metastasis Factor;9606;
2Q97;A;Complex of mammalian actin with toxofilin from toxoplasma gondii;2.5;CA;CALCIUM ION;Actin, alpha skeletal muscle;9986;
2Q9I;B;Crystal Structure of D-Dimer from Human Fibrin Complexed with Met-His-Arg-Pro-Tyr-amide.;2.8;CA;CALCIUM ION;Fibrinogen beta chain;9606;
2Q9I;C;Crystal Structure of D-Dimer from Human Fibrin Complexed with Met-His-Arg-Pro-Tyr-amide.;2.8;CA;CALCIUM ION;Fibrinogen, gamma polypeptide;9606;
2Q9I;E;Crystal Structure of D-Dimer from Human Fibrin Complexed with Met-His-Arg-Pro-Tyr-amide.;2.8;CA;CALCIUM ION;Fibrinogen beta chain;9606;
2Q9I;F;Crystal Structure of D-Dimer from Human Fibrin Complexed with Met-His-Arg-Pro-Tyr-amide.;2.8;CA;CALCIUM ION;Fibrinogen, gamma polypeptide;9606;
2QEA;A;CRYSTAL STRUCTURE OF A PUTATIVE GENERAL STRESS PROTEIN 26 (JANN_0955) FROM JANNASCHIA SP. CCS1 AT 2.46 A RESOLUTION;2.46;CA;CALCIUM ION;Putative general stress protein 26;290400;
2QEA;B;CRYSTAL STRUCTURE OF A PUTATIVE GENERAL STRESS PROTEIN 26 (JANN_0955) FROM JANNASCHIA SP. CCS1 AT 2.46 A RESOLUTION;2.46;CA;CALCIUM ION;Putative general stress protein 26;290400;
2QEA;C;CRYSTAL STRUCTURE OF A PUTATIVE GENERAL STRESS PROTEIN 26 (JANN_0955) FROM JANNASCHIA SP. CCS1 AT 2.46 A RESOLUTION;2.46;CA;CALCIUM ION;Putative general stress protein 26;290400;
2QEJ;C;Crystal structure of a Staphylococcus aureus protein (SSL7) in complex with Fc of human IgA1;3.2;CA;CALCIUM ION;SUPERANTIGEN-LIKE MOLECULE 7;1280;
2QFX;A;Crystal structure of Saccharomyces cerevesiae mitochondrial NADP(+)-dependent isocitrate dehydrogenase in complex with NADPH, a-ketoglutarate and Ca(2+);2.7;CA;CALCIUM ION;Isocitrate dehydrogenase [NADP];4932;
2QFX;B;Crystal structure of Saccharomyces cerevesiae mitochondrial NADP(+)-dependent isocitrate dehydrogenase in complex with NADPH, a-ketoglutarate and Ca(2+);2.7;CA;CALCIUM ION;Isocitrate dehydrogenase [NADP];4932;
2QFX;C;Crystal structure of Saccharomyces cerevesiae mitochondrial NADP(+)-dependent isocitrate dehydrogenase in complex with NADPH, a-ketoglutarate and Ca(2+);2.7;CA;CALCIUM ION;Isocitrate dehydrogenase [NADP];4932;
2QFX;D;Crystal structure of Saccharomyces cerevesiae mitochondrial NADP(+)-dependent isocitrate dehydrogenase in complex with NADPH, a-ketoglutarate and Ca(2+);2.7;CA;CALCIUM ION;Isocitrate dehydrogenase [NADP];4932;
2QFX;E;Crystal structure of Saccharomyces cerevesiae mitochondrial NADP(+)-dependent isocitrate dehydrogenase in complex with NADPH, a-ketoglutarate and Ca(2+);2.7;CA;CALCIUM ION;Isocitrate dehydrogenase [NADP];4932;
2QFX;F;Crystal structure of Saccharomyces cerevesiae mitochondrial NADP(+)-dependent isocitrate dehydrogenase in complex with NADPH, a-ketoglutarate and Ca(2+);2.7;CA;CALCIUM ION;Isocitrate dehydrogenase [NADP];4932;
2QGA;B;Plasmodium vivax adenylosuccinate lyase Pv003765 with AMP bound;2.01;CA;CALCIUM ION;Adenylosuccinate lyase;5855;
2QGA;C;Plasmodium vivax adenylosuccinate lyase Pv003765 with AMP bound;2.01;CA;CALCIUM ION;Adenylosuccinate lyase;5855;
2QIF;B;Crystal structure of a metallochaperone with a tetranuclear Cu(I) cluster;1.5;CA;CALCIUM ION;Copper chaperone copZ;224308;
2QIM;A;Crystal Structure of Pathogenesis-related Protein LlPR-10.2B from yellow lupine in complex with Cytokinin;1.35;CA;CALCIUM ION;PR10.2B;3873;
2QKK;A;Human RNase H catalytic domain mutant D210N in complex with 14-mer RNA/DNA hybrid;3.2;CA;CALCIUM ION;Ribonuclease H1;9606;
2QKK;B;Human RNase H catalytic domain mutant D210N in complex with 14-mer RNA/DNA hybrid;3.2;CA;CALCIUM ION;Ribonuclease H1;9606;
2QKK;E;Human RNase H catalytic domain mutant D210N in complex with 14-mer RNA/DNA hybrid;3.2;CA;CALCIUM ION;Ribonuclease H1;9606;
2QKK;F;Human RNase H catalytic domain mutant D210N in complex with 14-mer RNA/DNA hybrid;3.2;CA;CALCIUM ION;Ribonuclease H1;9606;
2QKK;I;Human RNase H catalytic domain mutant D210N in complex with 14-mer RNA/DNA hybrid;3.2;CA;CALCIUM ION;Ribonuclease H1;9606;
2QKK;J;Human RNase H catalytic domain mutant D210N in complex with 14-mer RNA/DNA hybrid;3.2;CA;CALCIUM ION;Ribonuclease H1;9606;
2QKK;M;Human RNase H catalytic domain mutant D210N in complex with 14-mer RNA/DNA hybrid;3.2;CA;CALCIUM ION;Ribonuclease H1;9606;
2QKK;N;Human RNase H catalytic domain mutant D210N in complex with 14-mer RNA/DNA hybrid;3.2;CA;CALCIUM ION;Ribonuclease H1;9606;
2QKK;R;Human RNase H catalytic domain mutant D210N in complex with 14-mer RNA/DNA hybrid;3.2;CA;CALCIUM ION;Ribonuclease H1;9606;
2QKK;S;Human RNase H catalytic domain mutant D210N in complex with 14-mer RNA/DNA hybrid;3.2;CA;CALCIUM ION;Ribonuclease H1;9606;
2QKK;W;Human RNase H catalytic domain mutant D210N in complex with 14-mer RNA/DNA hybrid;3.2;CA;CALCIUM ION;Ribonuclease H1;9606;
2QLT;A;Crystal structure of an isoform of DL-glycerol-3-phosphatase, Rhr2p, from Saccharomyces cerevisiae;1.6;CA;CALCIUM ION;(DL)-glycerol-3-phosphatase 1;4932;
2QM3;A;Crystal structure of a predicted methyltransferase from Pyrococcus furiosus;2.05;CA;CALCIUM ION;Predicted methyltransferase;2261;
2QMK;A;Human pancreatic alpha-amylase complexed with nitrite;2.3;CA;CALCIUM ION;Pancreatic alpha-amylase;9606;
2QNG;A;Crystal structure of unknown function protein SAV2460;1.4;CA;CALCIUM ION;Uncharacterized protein SAV2460;33903;
2QNO;A;Crystal Structure of the Mutant E55Q of the Cellulase CEL48F in Complex with a Thio-Oligosaccharide;2;CA;CALCIUM ION;Endoglucanase F;1521;
2QOG;B;Crotoxin B, the basic PLA2 from Crotalus durissus terrificus.;2.28;CA;CALCIUM ION;Phospholipase A2 CB1;8731;
2QOG;C;Crotoxin B, the basic PLA2 from Crotalus durissus terrificus.;2.28;CA;CALCIUM ION;Phospholipase A2 CB1;8731;
2QP2;A;Structure of a MACPF/perforin-like protein;2;CA;CALCIUM ION;Unknown protein;2218628;
2QPK;A;Crystal structure of the complex of bovine lactoperoxidase with salicylhydroxamic acid at 2.34 A resolution;2.34;CA;CALCIUM ION;Lactoperoxidase;9913;
2QPS;A;'Sugar tongs' mutant Y380A in complex with acarbose;2.2;CA;CALCIUM ION;Alpha-amylase type A isozyme;4513;
2QPT;A;Crystal structure of an EHD ATPase involved in membrane remodelling;3.1;CA;CALCIUM ION;EH DOMAIN-CONTAINING PROTEIN-2;10090;
2QPU;A;Sugar tongs mutant S378P in complex with acarbose;1.7;CA;CALCIUM ION;Alpha-amylase type A isozyme;4513;
2QPU;B;Sugar tongs mutant S378P in complex with acarbose;1.7;CA;CALCIUM ION;Alpha-amylase type A isozyme;4513;
2QPU;C;Sugar tongs mutant S378P in complex with acarbose;1.7;CA;CALCIUM ION;Alpha-amylase type A isozyme;4513;
2QQM;A;Crystal Structure of the a2b1b2 Domains from Human Neuropilin-1;2;CA;CALCIUM ION;Neuropilin-1;9606;
2QQO;A;Crystal Structure of the a2b1b2 Domains from Human Neuropilin-2;2.3;CA;CALCIUM ION;Neuropilin-2;9606;
2QQO;B;Crystal Structure of the a2b1b2 Domains from Human Neuropilin-2;2.3;CA;CALCIUM ION;Neuropilin-2;9606;
2QQP;A;Crystal Structure of Authentic Providence Virus;3.8;CA;CALCIUM ION;Large Capsid protein;213633;
2QQP;G;Crystal Structure of Authentic Providence Virus;3.8;CA;CALCIUM ION;Large Capsid protein;213633;
2QQT;A;Crystal structure of the complex of bovine lactoperoxidase with acetyl salicylic acid at 2.5 A resolution;2.5;CA;CALCIUM ION;Lactoperoxidase;9913;
2QRB;A;Crystal structure of chloride saturated bovine lactoperoxidase at 2.5 A resolution shows multiple halide binding sites;2.5;CA;CALCIUM ION;Lactoperoxidase;9913;
2QT6;A;Crystal Structure Determination of a Blue Laccase from Lentinus Tigrinus;1.5;CA;CALCIUM ION;Laccase;5365;
2QT6;B;Crystal Structure Determination of a Blue Laccase from Lentinus Tigrinus;1.5;CA;CALCIUM ION;Laccase;5365;
2QT7;A;Crystallographic structure of the mature ectodomain of the human receptor-type protein-tyrosine phosphatase IA-2 at 1.30 Angstroms;1.3;CA;CALCIUM ION;Receptor-type tyrosine-protein phosphatase-like N;9606;
2QT7;B;Crystallographic structure of the mature ectodomain of the human receptor-type protein-tyrosine phosphatase IA-2 at 1.30 Angstroms;1.3;CA;CALCIUM ION;Receptor-type tyrosine-protein phosphatase-like N;9606;
2QTW;B;The Crystal Structure of PCSK9 at 1.9 Angstroms Resolution Reveals structural homology to Resistin within the C-terminal domain;1.9;CA;CALCIUM ION;Proprotein convertase subtilisin/kexin type 9;9606;
2QU1;A;Crystal Structure of a Cyclized GFP Variant;1.7;CA;CALCIUM ION;Green fluorescent protein;6100;
2QUA;A;Crystal structure of LipA from Serratia marcescens;1.95;CA;CALCIUM ION;Extracellular lipase;615;
2QUB;A;Crystal structure of extracellular lipase LipA from Serratia marcescens;1.8;CA;CALCIUM ION;Extracellular lipase;615;
2QUB;C;Crystal structure of extracellular lipase LipA from Serratia marcescens;1.8;CA;CALCIUM ION;Extracellular lipase;615;
2QUB;E;Crystal structure of extracellular lipase LipA from Serratia marcescens;1.8;CA;CALCIUM ION;Extracellular lipase;615;
2QUB;G;Crystal structure of extracellular lipase LipA from Serratia marcescens;1.8;CA;CALCIUM ION;Extracellular lipase;615;
2QUB;I;Crystal structure of extracellular lipase LipA from Serratia marcescens;1.8;CA;CALCIUM ION;Extracellular lipase;615;
2QUB;K;Crystal structure of extracellular lipase LipA from Serratia marcescens;1.8;CA;CALCIUM ION;Extracellular lipase;615;
2QV4;A;Human pancreatic alpha-amylase complexed with nitrite and acarbose;1.97;CA;CALCIUM ION;Pancreatic alpha-amylase;9606;
2QV6;A;GTP cyclohydrolase III from M. jannaschii (MJ0145) complexed with GTP and metal ions;2;CA;CALCIUM ION;GTP cyclohydrolase III;2190;
2QV6;B;GTP cyclohydrolase III from M. jannaschii (MJ0145) complexed with GTP and metal ions;2;CA;CALCIUM ION;GTP cyclohydrolase III;2190;
2QV6;C;GTP cyclohydrolase III from M. jannaschii (MJ0145) complexed with GTP and metal ions;2;CA;CALCIUM ION;GTP cyclohydrolase III;2190;
2QV6;D;GTP cyclohydrolase III from M. jannaschii (MJ0145) complexed with GTP and metal ions;2;CA;CALCIUM ION;GTP cyclohydrolase III;2190;
2QVF;B;mouse E-cadherin domains 1,2;2.4;CA;CALCIUM ION;Epithelial-cadherin (E-cadherin) (Uvomorulin) (Cadherin-1) (ARC-1) (CD324 antigen);10090;
2QVI;A;Crystal structure of N-cadherin domains EC12;3.01;CA;CALCIUM ION;Cadherin-2;10090;
2QVM;A;The second Ca2+-binding domain of the Na+-Ca2+ exchanger is essential for regulation: crystal structures and mutational analysis;1.7;CA;CALCIUM ION;Sodium/calcium exchanger 1;9612;
2QW1;A;Glucose/galactose binding protein bound to 3-O-methyl D-glucose;1.7;CA;CALCIUM ION;D-galactose-binding periplasmic protein;562;
2QWA;A;THE X-RAY STRUCTURE OF A DRUG RESISTANT VARIANT R292K OF TERN N9 INFLUENZA VIRUS NEURAMINIDASE;1.7;CA;CALCIUM ION;NEURAMINIDASE;11320;
2QWB;A;THE X-RAY STRUCTURE OF A COMPLEX OF SIALIC ACID AND A DRUG RESISTANT VARIANT R292K OF TERN N9 INFLUENZA VIRUS NEURAMINIDASE;2;CA;CALCIUM ION;NEURAMINIDASE;11320;
2QWC;A;THE X-RAY STRUCTURE OF A COMPLEX OF NEU5AC2EN AND A DRUG RESISTANT VARIANT R292K OF TERN N9 INFLUENZA VIRUS NEURAMINIDASE;1.6;CA;CALCIUM ION;NEURAMINIDASE;11320;
2QWD;A;THE X-RAY STRUCTURE OF A COMPLEX OF 4-AMINO-NEU5AC2EN AND A DRUG RESISTANT VARIANT R292K OF TERN N9 INFLUENZA VIRUS NEURAMINIDASE;2;CA;CALCIUM ION;NEURAMINIDASE;11320;
2QWE;A;THE X-RAY STRUCTURE OF A COMPLEX OF 4-GUANIDINO-NEU5AC2EN AND A DRUG RESISTANT VARIANT R292K OF TERN N9 INFLUENZA VIRUS NEURAMINIDASE;2;CA;CALCIUM ION;NEURAMINIDASE;11320;
2QWF;A;THE X-RAY STRUCTURE OF A COMPLEX OF N-ACETYL-4-GUANIDINO-6-METHYL(PROPYL)CARBOXAMIDE-4,5-DIHYDRO-2H-PYRAN-2-CARBOXYLIC ACID AND A DRUG RESISTANT VARIANT R292K OF TERN N9 INFLUENZA VIRUS NEURAMINIDASE;1.9;CA;CALCIUM ION;NEURAMINIDASE;11320;
2QWG;A;THE X-RAY STRUCTURE OF A COMPLEX OF 5-N-ACETYL-4-AMINO-6-DIETHYLCARBOXAMIDE-4,5-DIHYDRO-2H-PYRAN-2-CARBOXYLIC ACID AND A DRUG RESISTANT VARIANT R292K OF TERN N9 INFLUENZA VIRUS NEURAMINIDASE;1.8;CA;CALCIUM ION;NEURAMINIDASE;11320;
2QWH;A;THE X-RAY STRUCTURE OF A COMPLEX OF 5-N-ACETYL-5-AMINO-3-(1-ETHYLPROPOXY)-1-CYCLOHEXENE-1-CARBOXYLIC ACID (GS4071) AND A DRUG RESISTANT VARIANT R292K OF TERN N9 INFLUENZA VIRUS NEURAMINIDASE;1.8;CA;CALCIUM ION;NEURAMINIDASE;11320;
2QWI;A;THE X-RAY STRUCTURE OF A COMPLEX OF N-ACETYL-4-GUANIDINO-6-METHYL(PROPYL)CARBOXAMIDE-4,5-DIHYDRO-2H-PYRAN-2-CARBOXYLIC ACID AND WILDTYPE TERN N9 INFLUENZA VIRUS NEURAMINIDASE;2;CA;CALCIUM ION;NEURAMINIDASE;11320;
2QWJ;A;THE X-RAY STRUCTURE OF A COMPLEX OF 5-N-ACETYL-4-AMINO-6-DIETHYLCARBOXAMIDE-4,5-DIHYDRO-2H-PYRAN-2-CARBOXYLIC ACID AND A DRUG RESISTANT VARIANT R292K OF TERN N9 INFLUENZA VIRUS NEURAMINIDASE;2;CA;CALCIUM ION;NEURAMINIDASE;11320;
2QWK;A;THE X-RAY STRUCTURE OF A COMPLEX OF 5-N-ACETYL-5-AMINO-3-(1-ETHYLPROPOXY)-1-CYCLOHEXENE-1-CARBOXYLIC ACID (GS4071) AND WILDTYPE TERN N9 INFLUENZA VIRUS NEURAMINIDASE;1.8;CA;CALCIUM ION;NEURAMINIDASE;11320;
2QYI;A;Crystal structure of a binary complex between an engineered trypsin inhibitor and Bovine trypsin;2.6;CA;CALCIUM ION;Cationic trypsin;9913;
2QYI;C;Crystal structure of a binary complex between an engineered trypsin inhibitor and Bovine trypsin;2.6;CA;CALCIUM ION;Cationic trypsin;9913;
2R01;A;Crystal structure of a putative fmn-dependent nitroreductase (ct0345) from chlorobium tepidum tls at 1.15 A resolution;1.15;CA;CALCIUM ION;Nitroreductase family protein;1097;
2R16;A;Crystal Structure of bovine neurexin 1 alpha LNS/LG domain 4 (with no splice insert);1.04;CA;CALCIUM ION;Neurexin-1-alpha;9913;
2R1B;A;Crystal Structure of rat neurexin 1beta with a splice insert at SS#4;1.72;CA;CALCIUM ION;Neurexin-1-beta;10116;
2R1B;B;Crystal Structure of rat neurexin 1beta with a splice insert at SS#4;1.72;CA;CALCIUM ION;Neurexin-1-beta;10116;
2R1D;B;Crystal structure of rat neurexin 1beta in the Ca2+ containing form;2.6;CA;CALCIUM ION;Neurexin-1-beta;10116;
2R1D;D;Crystal structure of rat neurexin 1beta in the Ca2+ containing form;2.6;CA;CALCIUM ION;Neurexin-1-beta;10116;
2R1D;I;Crystal structure of rat neurexin 1beta in the Ca2+ containing form;2.6;CA;CALCIUM ION;Neurexin-1-beta;10116;
2R28;A;The complex Structure of Calmodulin Bound to a Calcineurin Peptide;1.86;CA;CALCIUM ION;Calmodulin;9606;
2R28;B;The complex Structure of Calmodulin Bound to a Calcineurin Peptide;1.86;CA;CALCIUM ION;Calmodulin;9606;
2R2I;A;Myristoylated Guanylate Cyclase Activating Protein-1 with Calcium Bound;2;CA;CALCIUM ION;Guanylyl cyclase-activating protein 1;9031;
2R49;A;Mutational and Structural Studies of E85I Reveal the Flexible Loops of Fibrobacter succinogenes 1,3-1,4-beta-D-GlucanaseGlucanase;2.2;CA;CALCIUM ION;Beta-glucanase;833;
2R5L;A;Crystal structure of lactoperoxidase at 2.4A resolution;2.4;CA;CALCIUM ION;Lactoperoxidase;9925;
2R5N;A;Crystal structure of transketolase from Escherichia coli in noncovalent complex with acceptor aldose ribose 5-phosphate;1.6;CA;CALCIUM ION;Transketolase 1;562;
2R5N;B;Crystal structure of transketolase from Escherichia coli in noncovalent complex with acceptor aldose ribose 5-phosphate;1.6;CA;CALCIUM ION;Transketolase 1;562;
2R7E;A;Crystal Structure Analysis of Coagulation Factor VIII;3.7;CA;CALCIUM ION;Coagulation factor VIII;9606;
2R8G;A;Selectivity of Nucleoside Triphosphate Incorporation Opposite 1,N2-Propanodeoxyguanosine (PdG) by the Sulfolobus solfataricus DNA Polymerase Dpo4 Polymerase;2.7;CA;CALCIUM ION;DNA polymerase IV;273057;
2R8H;A;Selectivity of Nucleoside Triphosphate Incorporation Opposite 1,N2-Propanodeoxyguanosine (PdG) by the Sulfolobus solfataricus DNA Polymerase Dpo4 Polymerase;2.48;CA;CALCIUM ION;DNA polymerase IV;2287;
2R8I;A;Selectivity of Nucleoside Triphosphate Incorporation Opposite 1,N2-Propanodeoxyguanosine (PdG) by the Sulfolobus solfataricus DNA Polymerase Dpo4 Polymerase;2.38;CA;CALCIUM ION;DNA polymerase IV;2287;
2R8J;A;Structure of the Eukaryotic DNA Polymerase eta in complex with 1,2-d(GpG)-cisplatin containing DNA;3.1;CA;CALCIUM ION;DNA polymerase eta;4932;
2R8J;B;Structure of the Eukaryotic DNA Polymerase eta in complex with 1,2-d(GpG)-cisplatin containing DNA;3.1;CA;CALCIUM ION;DNA polymerase eta;4932;
2R8K;A;Structure of the Eukaryotic DNA Polymerase eta in complex with 1,2-d(GpG)-cisplatin containing DNA;3.3;CA;CALCIUM ION;DNA polymerase eta;4932;
2R8K;B;Structure of the Eukaryotic DNA Polymerase eta in complex with 1,2-d(GpG)-cisplatin containing DNA;3.3;CA;CALCIUM ION;DNA polymerase eta;4932;
2R8O;A;Transketolase from E. coli in complex with substrate D-xylulose-5-phosphate;1.47;CA;CALCIUM ION;Transketolase 1;562;
2R8O;B;Transketolase from E. coli in complex with substrate D-xylulose-5-phosphate;1.47;CA;CALCIUM ION;Transketolase 1;562;
2R8P;A;Transketolase from E. coli in complex with substrate D-fructose-6-phosphate;1.65;CA;CALCIUM ION;Transketolase 1;562;
2R8P;B;Transketolase from E. coli in complex with substrate D-fructose-6-phosphate;1.65;CA;CALCIUM ION;Transketolase 1;562;
2R8Y;A;Crystal structure of YrbI phosphatase from Escherichia coli in a complex with Ca;1.85;CA;CALCIUM ION;YrbI from Escherichia coli;562;
2R8Y;B;Crystal structure of YrbI phosphatase from Escherichia coli in a complex with Ca;1.85;CA;CALCIUM ION;YrbI from Escherichia coli;562;
2R8Y;C;Crystal structure of YrbI phosphatase from Escherichia coli in a complex with Ca;1.85;CA;CALCIUM ION;YrbI from Escherichia coli;562;
2R8Y;D;Crystal structure of YrbI phosphatase from Escherichia coli in a complex with Ca;1.85;CA;CALCIUM ION;YrbI from Escherichia coli;562;
2R8Y;E;Crystal structure of YrbI phosphatase from Escherichia coli in a complex with Ca;1.85;CA;CALCIUM ION;YrbI from Escherichia coli;562;
2R8Y;F;Crystal structure of YrbI phosphatase from Escherichia coli in a complex with Ca;1.85;CA;CALCIUM ION;YrbI from Escherichia coli;562;
2R8Y;G;Crystal structure of YrbI phosphatase from Escherichia coli in a complex with Ca;1.85;CA;CALCIUM ION;YrbI from Escherichia coli;562;
2R8Y;H;Crystal structure of YrbI phosphatase from Escherichia coli in a complex with Ca;1.85;CA;CALCIUM ION;YrbI from Escherichia coli;562;
2R8Y;I;Crystal structure of YrbI phosphatase from Escherichia coli in a complex with Ca;1.85;CA;CALCIUM ION;YrbI from Escherichia coli;562;
2R8Y;J;Crystal structure of YrbI phosphatase from Escherichia coli in a complex with Ca;1.85;CA;CALCIUM ION;YrbI from Escherichia coli;562;
2R8Y;K;Crystal structure of YrbI phosphatase from Escherichia coli in a complex with Ca;1.85;CA;CALCIUM ION;YrbI from Escherichia coli;562;
2R8Y;L;Crystal structure of YrbI phosphatase from Escherichia coli in a complex with Ca;1.85;CA;CALCIUM ION;YrbI from Escherichia coli;562;
2R8Y;M;Crystal structure of YrbI phosphatase from Escherichia coli in a complex with Ca;1.85;CA;CALCIUM ION;YrbI from Escherichia coli;562;
2R8Y;N;Crystal structure of YrbI phosphatase from Escherichia coli in a complex with Ca;1.85;CA;CALCIUM ION;YrbI from Escherichia coli;562;
2R8Y;O;Crystal structure of YrbI phosphatase from Escherichia coli in a complex with Ca;1.85;CA;CALCIUM ION;YrbI from Escherichia coli;562;
2R8Y;P;Crystal structure of YrbI phosphatase from Escherichia coli in a complex with Ca;1.85;CA;CALCIUM ION;YrbI from Escherichia coli;562;
2R8Z;A;Crystal structure of YrbI phosphatase from Escherichia coli in complex with a phosphate and a calcium ion;2.1;CA;CALCIUM ION;3-deoxy-D-manno-octulosonate 8-phosphate phosphatase;562;
2R8Z;B;Crystal structure of YrbI phosphatase from Escherichia coli in complex with a phosphate and a calcium ion;2.1;CA;CALCIUM ION;3-deoxy-D-manno-octulosonate 8-phosphate phosphatase;562;
2R8Z;C;Crystal structure of YrbI phosphatase from Escherichia coli in complex with a phosphate and a calcium ion;2.1;CA;CALCIUM ION;3-deoxy-D-manno-octulosonate 8-phosphate phosphatase;562;
2R8Z;D;Crystal structure of YrbI phosphatase from Escherichia coli in complex with a phosphate and a calcium ion;2.1;CA;CALCIUM ION;3-deoxy-D-manno-octulosonate 8-phosphate phosphatase;562;
2R8Z;E;Crystal structure of YrbI phosphatase from Escherichia coli in complex with a phosphate and a calcium ion;2.1;CA;CALCIUM ION;3-deoxy-D-manno-octulosonate 8-phosphate phosphatase;562;
2R8Z;F;Crystal structure of YrbI phosphatase from Escherichia coli in complex with a phosphate and a calcium ion;2.1;CA;CALCIUM ION;3-deoxy-D-manno-octulosonate 8-phosphate phosphatase;562;
2R8Z;G;Crystal structure of YrbI phosphatase from Escherichia coli in complex with a phosphate and a calcium ion;2.1;CA;CALCIUM ION;3-deoxy-D-manno-octulosonate 8-phosphate phosphatase;562;
2R8Z;H;Crystal structure of YrbI phosphatase from Escherichia coli in complex with a phosphate and a calcium ion;2.1;CA;CALCIUM ION;3-deoxy-D-manno-octulosonate 8-phosphate phosphatase;562;
2R8Z;I;Crystal structure of YrbI phosphatase from Escherichia coli in complex with a phosphate and a calcium ion;2.1;CA;CALCIUM ION;3-deoxy-D-manno-octulosonate 8-phosphate phosphatase;562;
2R8Z;J;Crystal structure of YrbI phosphatase from Escherichia coli in complex with a phosphate and a calcium ion;2.1;CA;CALCIUM ION;3-deoxy-D-manno-octulosonate 8-phosphate phosphatase;562;
2R8Z;K;Crystal structure of YrbI phosphatase from Escherichia coli in complex with a phosphate and a calcium ion;2.1;CA;CALCIUM ION;3-deoxy-D-manno-octulosonate 8-phosphate phosphatase;562;
2R8Z;L;Crystal structure of YrbI phosphatase from Escherichia coli in complex with a phosphate and a calcium ion;2.1;CA;CALCIUM ION;3-deoxy-D-manno-octulosonate 8-phosphate phosphatase;562;
2R8Z;M;Crystal structure of YrbI phosphatase from Escherichia coli in complex with a phosphate and a calcium ion;2.1;CA;CALCIUM ION;3-deoxy-D-manno-octulosonate 8-phosphate phosphatase;562;
2R8Z;N;Crystal structure of YrbI phosphatase from Escherichia coli in complex with a phosphate and a calcium ion;2.1;CA;CALCIUM ION;3-deoxy-D-manno-octulosonate 8-phosphate phosphatase;562;
2R8Z;O;Crystal structure of YrbI phosphatase from Escherichia coli in complex with a phosphate and a calcium ion;2.1;CA;CALCIUM ION;3-deoxy-D-manno-octulosonate 8-phosphate phosphatase;562;
2R8Z;P;Crystal structure of YrbI phosphatase from Escherichia coli in complex with a phosphate and a calcium ion;2.1;CA;CALCIUM ION;3-deoxy-D-manno-octulosonate 8-phosphate phosphatase;562;
2R9C;A;Calpain 1 proteolytic core inactivated by ZLAK-3001, an alpha-ketoamide;1.8;CA;CALCIUM ION;Calpain-1 catalytic subunit;10116;
2R9F;A;Calpain 1 proteolytic core inactivated by ZLAK-3002, an alpha-ketoamide;1.6;CA;CALCIUM ION;Calpain-1 catalytic subunit;10116;
2RA3;A;Human cationic trypsin complexed with bovine pancreatic trypsin inhibitor (BPTI);1.46;CA;CALCIUM ION;Trypsin-1;9606;
2RA3;B;Human cationic trypsin complexed with bovine pancreatic trypsin inhibitor (BPTI);1.46;CA;CALCIUM ION;Trypsin-1;9606;
2RAN;A;RAT ANNEXIN V CRYSTAL STRUCTURE: CA2+-INDUCED CONFORMATIONAL CHANGES;1.89;CA;CALCIUM ION;ANNEXIN V;10116;
2RAQ;A;Crystal structure of the MTH889 protein from Methanothermobacter thermautotrophicus. Northeast Structural Genomics Consortium target TT205;3.11;CA;CALCIUM ION;Conserved protein MTH889;145262;
2RAQ;B;Crystal structure of the MTH889 protein from Methanothermobacter thermautotrophicus. Northeast Structural Genomics Consortium target TT205;3.11;CA;CALCIUM ION;Conserved protein MTH889;145262;
2RAQ;C;Crystal structure of the MTH889 protein from Methanothermobacter thermautotrophicus. Northeast Structural Genomics Consortium target TT205;3.11;CA;CALCIUM ION;Conserved protein MTH889;145262;
2RAQ;D;Crystal structure of the MTH889 protein from Methanothermobacter thermautotrophicus. Northeast Structural Genomics Consortium target TT205;3.11;CA;CALCIUM ION;Conserved protein MTH889;145262;
2RAQ;E;Crystal structure of the MTH889 protein from Methanothermobacter thermautotrophicus. Northeast Structural Genomics Consortium target TT205;3.11;CA;CALCIUM ION;Conserved protein MTH889;145262;
2RAQ;F;Crystal structure of the MTH889 protein from Methanothermobacter thermautotrophicus. Northeast Structural Genomics Consortium target TT205;3.11;CA;CALCIUM ION;Conserved protein MTH889;145262;
2RAQ;G;Crystal structure of the MTH889 protein from Methanothermobacter thermautotrophicus. Northeast Structural Genomics Consortium target TT205;3.11;CA;CALCIUM ION;Conserved protein MTH889;145262;
2RAU;A;Crystal structure of a putative lipase (NP_343859.1) from Sulfolobus solfataricus at 1.85 A resolution;1.85;CA;CALCIUM ION;Putative esterase;2287;
2RBM;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS I72K at cryogenic temperature;1.9;CA;CALCIUM ION;Thermonuclease;1280;
2RD4;A;Design of specific inhibitors of Phospholipase A2: Crystal structure of the complex of phospholipase A2 with pentapeptide Leu-Val-Phe-Phe-Ala at 2.9 A resolution;2.97;CA;CALCIUM ION;Phospholipase A2 isoform 1;195058;
2RD4;B;Design of specific inhibitors of Phospholipase A2: Crystal structure of the complex of phospholipase A2 with pentapeptide Leu-Val-Phe-Phe-Ala at 2.9 A resolution;2.97;CA;CALCIUM ION;Phospholipase A2 isoform 2;195058;
2RDJ;A;Snapshots of a Y-family DNA polymerase in replication: Dpo4 in apo and binary/ternary complex forms;2.2;CA;CALCIUM ION;DNA polymerase IV;273057;
2RDJ;B;Snapshots of a Y-family DNA polymerase in replication: Dpo4 in apo and binary/ternary complex forms;2.2;CA;CALCIUM ION;DNA polymerase IV;273057;
2RDZ;A;High Resolution Crystal Structure of the Escherichia coli Cytochrome c Nitrite Reductase.;1.74;CA;CALCIUM ION;Cytochrome c-552;562;
2RDZ;B;High Resolution Crystal Structure of the Escherichia coli Cytochrome c Nitrite Reductase.;1.74;CA;CALCIUM ION;Cytochrome c-552;562;
2RDZ;C;High Resolution Crystal Structure of the Escherichia coli Cytochrome c Nitrite Reductase.;1.74;CA;CALCIUM ION;Cytochrome c-552;562;
2RDZ;D;High Resolution Crystal Structure of the Escherichia coli Cytochrome c Nitrite Reductase.;1.74;CA;CALCIUM ION;Cytochrome c-552;562;
2RE1;A;Crystal structure of aspartokinase alpha and beta subunits;2.75;CA;CALCIUM ION;Aspartokinase, alpha and beta subunits;487;
2REX;B;Crystal structure of the effector domain of PLXNB1 bound with Rnd1 GTPase;2.3;CA;CALCIUM ION;Rho-related GTP-binding protein Rho6;9606;
2REX;D;Crystal structure of the effector domain of PLXNB1 bound with Rnd1 GTPase;2.3;CA;CALCIUM ION;Rho-related GTP-binding protein Rho6;9606;
2RF7;A;Crystal structure of the escherichia coli nrfa mutant Q263E;2.04;CA;CALCIUM ION;Cytochrome c-552;562;
2RF7;B;Crystal structure of the escherichia coli nrfa mutant Q263E;2.04;CA;CALCIUM ION;Cytochrome c-552;562;
2RF7;C;Crystal structure of the escherichia coli nrfa mutant Q263E;2.04;CA;CALCIUM ION;Cytochrome c-552;562;
2RF7;D;Crystal structure of the escherichia coli nrfa mutant Q263E;2.04;CA;CALCIUM ION;Cytochrome c-552;562;
2RGA;A;Crystal structure of H-RasQ61I-GppNHp;1.9;CA;CALCIUM ION;GTPase HRas;9606;
2RGB;A;Crystal structure of H-RasQ61K-GppNHp;1.35;CA;CALCIUM ION;GTPase HRas;9606;
2RGC;A;Crystal structure of H-RasQ61V-GppNHp;1.6;CA;CALCIUM ION;GTPase HRas;9606;
2RGD;A;Crystal structure of H-RasQ61L-GppNHp;2;CA;CALCIUM ION;GTPase HRas;9606;
2RGE;A;Crystal structure of H-Ras-GppNHp;1.4;CA;CALCIUM ION;GTPase HRas;9606;
2RHP;A;The Thrombospondin-1 Polymorphism Asn700Ser Associated with Cornoary Artery Disease Causes Local and Long-Ranging Changes in Protein Structure;2.9;CA;CALCIUM ION;Thrombospondin-2;9606;
2RI8;A;Penicillium citrinum alpha-1,2-mannosidase complex with glycerol;2.16;CA;CALCIUM ION;Mannosyl-oligosaccharide alpha-1,2-mannosidase;5077;
2RI8;B;Penicillium citrinum alpha-1,2-mannosidase complex with glycerol;2.16;CA;CALCIUM ION;Mannosyl-oligosaccharide alpha-1,2-mannosidase;5077;
2RI9;A;Penicillium citrinum alpha-1,2-mannosidase in complex with a substrate analog;1.95;CA;CALCIUM ION;Mannosyl-oligosaccharide alpha-1,2-mannosidase;5077;
2RI9;B;Penicillium citrinum alpha-1,2-mannosidase in complex with a substrate analog;1.95;CA;CALCIUM ION;Mannosyl-oligosaccharide alpha-1,2-mannosidase;5077;
2RIA;A;Crystal structure of the trimeric neck and carbohydrate recognition domain of human surfactant protein D in complex with D-glycero-D-manno-heptose;1.8;CA;CALCIUM ION;Pulmonary surfactant-associated protein D;9606;
2RIA;B;Crystal structure of the trimeric neck and carbohydrate recognition domain of human surfactant protein D in complex with D-glycero-D-manno-heptose;1.8;CA;CALCIUM ION;Pulmonary surfactant-associated protein D;9606;
2RIA;C;Crystal structure of the trimeric neck and carbohydrate recognition domain of human surfactant protein D in complex with D-glycero-D-manno-heptose;1.8;CA;CALCIUM ION;Pulmonary surfactant-associated protein D;9606;
2RIB;A;Crystal structure of the trimeric neck and carbohydrate recognition domain of human surfactant protein D in complex with L-glycero-D-manno-heptose;1.8;CA;CALCIUM ION;Pulmonary surfactant-associated protein D;9606;
2RIB;B;Crystal structure of the trimeric neck and carbohydrate recognition domain of human surfactant protein D in complex with L-glycero-D-manno-heptose;1.8;CA;CALCIUM ION;Pulmonary surfactant-associated protein D;9606;
2RIB;C;Crystal structure of the trimeric neck and carbohydrate recognition domain of human surfactant protein D in complex with L-glycero-D-manno-heptose;1.8;CA;CALCIUM ION;Pulmonary surfactant-associated protein D;9606;
2RIC;A;Crystal structure of the trimeric neck and carbohydrate recognition domain of human surfactant protein D in complex with L-glycero-D-manno-heptopyranosyl-(1-3)-L-glycero-D-manno-heptopyranose;1.8;CA;CALCIUM ION;Pulmonary surfactant-associated protein D;9606;
2RIC;B;Crystal structure of the trimeric neck and carbohydrate recognition domain of human surfactant protein D in complex with L-glycero-D-manno-heptopyranosyl-(1-3)-L-glycero-D-manno-heptopyranose;1.8;CA;CALCIUM ION;Pulmonary surfactant-associated protein D;9606;
2RIC;C;Crystal structure of the trimeric neck and carbohydrate recognition domain of human surfactant protein D in complex with L-glycero-D-manno-heptopyranosyl-(1-3)-L-glycero-D-manno-heptopyranose;1.8;CA;CALCIUM ION;Pulmonary surfactant-associated protein D;9606;
2RID;A;Crystal structure of the trimeric neck and carbohydrate recognition domain of human surfactant protein D in complex with Allyl 7-O-carbamoyl-L-glycero-D-manno-heptopyranoside;1.8;CA;CALCIUM ION;Pulmonary surfactant-associated protein D;9606;
2RID;B;Crystal structure of the trimeric neck and carbohydrate recognition domain of human surfactant protein D in complex with Allyl 7-O-carbamoyl-L-glycero-D-manno-heptopyranoside;1.8;CA;CALCIUM ION;Pulmonary surfactant-associated protein D;9606;
2RID;C;Crystal structure of the trimeric neck and carbohydrate recognition domain of human surfactant protein D in complex with Allyl 7-O-carbamoyl-L-glycero-D-manno-heptopyranoside;1.8;CA;CALCIUM ION;Pulmonary surfactant-associated protein D;9606;
2RIE;A;Crystal structure of the trimeric neck and carbohydrate recognition domain of human surfactant protein D in complex with 2-deoxy-L-glycero-D-manno-heptose;1.6;CA;CALCIUM ION;Pulmonary surfactant-associated protein D;9606;
2RIE;B;Crystal structure of the trimeric neck and carbohydrate recognition domain of human surfactant protein D in complex with 2-deoxy-L-glycero-D-manno-heptose;1.6;CA;CALCIUM ION;Pulmonary surfactant-associated protein D;9606;
2RIE;C;Crystal structure of the trimeric neck and carbohydrate recognition domain of human surfactant protein D in complex with 2-deoxy-L-glycero-D-manno-heptose;1.6;CA;CALCIUM ION;Pulmonary surfactant-associated protein D;9606;
2RJI;A;Malarial EBA-175 region VI crystallographic structure reveals a KIX-like binding interface;1.8;CA;CALCIUM ION;Erythrocyte binding antigen 175;5833;
2RJP;A;Crystal structure of ADAMTS4 with inhibitor bound;2.8;CA;CALCIUM ION;ADAMTS-4;9606;
2RJP;B;Crystal structure of ADAMTS4 with inhibitor bound;2.8;CA;CALCIUM ION;ADAMTS-4;9606;
2RJP;C;Crystal structure of ADAMTS4 with inhibitor bound;2.8;CA;CALCIUM ION;ADAMTS-4;9606;
2RJP;D;Crystal structure of ADAMTS4 with inhibitor bound;2.8;CA;CALCIUM ION;ADAMTS-4;9606;
2RJQ;A;Crystal structure of ADAMTS5 with inhibitor bound;2.6;CA;CALCIUM ION;ADAMTS-5;9606;
2RLD;A;CRYSTAL STRUCTURE OF A PROTEIN WITH UNKNOWN FUNCTION FROM S23 RIBOSOMAL PROTEIN FAMILY (BT_0352) FROM BACTEROIDES THETAIOTAOMICRON VPI-5482 AT 1.70 A RESOLUTION;1.7;CA;CALCIUM ION;Uncharacterized protein;818;
2RLD;C;CRYSTAL STRUCTURE OF A PROTEIN WITH UNKNOWN FUNCTION FROM S23 RIBOSOMAL PROTEIN FAMILY (BT_0352) FROM BACTEROIDES THETAIOTAOMICRON VPI-5482 AT 1.70 A RESOLUTION;1.7;CA;CALCIUM ION;Uncharacterized protein;818;
2RLD;D;CRYSTAL STRUCTURE OF A PROTEIN WITH UNKNOWN FUNCTION FROM S23 RIBOSOMAL PROTEIN FAMILY (BT_0352) FROM BACTEROIDES THETAIOTAOMICRON VPI-5482 AT 1.70 A RESOLUTION;1.7;CA;CALCIUM ION;Uncharacterized protein;818;
2RNT;A;THREE-DIMENSIONAL STRUCTURE OF RIBONUCLEASE T1 COMPLEXED WITH GUANYLYL-2(PRIME),5(PRIME)-GUANOSINE AT 1.8 ANGSTROMS RESOLUTION;1.8;CA;CALCIUM ION;RIBONUCLEASE T1;5062;
2RO8;A;Solution structure of calcium bound soybean calmodulin isoform 1 N-terminal domain;;CA;CALCIUM ION;Calmodulin;3847;
2RO9;A;Solution structure of calcium bound soybean calmodulin isoform 1 C-terminal domain;;CA;CALCIUM ION;Calmodulin-2;3847;
2ROA;A;Solution structure of calcium bound soybean calmodulin isoform 4 N-terminal domain;;CA;CALCIUM ION;Calmodulin;3847;
2ROB;A;Solution structure of calcium bound soybean calmodulin isoform 4 C-terminal domain;;CA;CALCIUM ION;Calmodulin;3847;
2SAS;A;STRUCTURE OF A SARCOPLASMIC CALCIUM-BINDING PROTEIN FROM AMPHIOXUS REFINED AT 2.4 ANGSTROMS RESOLUTION;2.4;CA;CALCIUM ION;SARCOPLASMIC CALCIUM-BINDING PROTEIN;7740;
2SBA;A;SOYBEAN AGGLUTININ COMPLEXED WITH 2,6-PENTASACCHARIDE;2.6;CA;CALCIUM ION;Lectin;3847;
2SCP;A;STRUCTURE OF A SARCOPLASMIC CALCIUM-BINDING PROTEIN FROM NEREIS DIVERSICOLOR REFINED AT 2.0 ANGSTROMS RESOLUTION;2;CA;CALCIUM ION;SARCOPLASMIC CALCIUM-BINDING PROTEIN;126592;
2SCP;B;STRUCTURE OF A SARCOPLASMIC CALCIUM-BINDING PROTEIN FROM NEREIS DIVERSICOLOR REFINED AT 2.0 ANGSTROMS RESOLUTION;2;CA;CALCIUM ION;SARCOPLASMIC CALCIUM-BINDING PROTEIN;126592;
2SEC;E;STRUCTURAL COMPARISON OF TWO SERINE PROTEINASE-PROTEIN INHIBITOR COMPLEXES. EGLIN-C-SUBTILISIN CARLSBERG AND CI-2-SUBTILISIN NOVO;1.8;CA;CALCIUM ION;SUBTILISIN CARLSBERG;1402;
2SIC;E;REFINED CRYSTAL STRUCTURE OF THE COMPLEX OF SUBTILISIN BPN' AND STREPTOMYCES SUBTILISIN INHIBITOR AT 1.8 ANGSTROMS RESOLUTION;1.8;CA;CALCIUM ION;SUBTILISIN BPN';1390;
2SNI;E;STRUCTURAL COMPARISON OF TWO SERINE PROTEINASE-PROTEIN INHIBITOR COMPLEXES. EGLIN-C-SUBTILISIN CARLSBERG AND CI-2-SUBTILISIN NOVO;2.1;CA;CALCIUM ION;SUBTILISIN NOVO;1390;
2SNM;A;IN A STAPHYLOCOCCAL NUCLEASE MUTANT THE SIDE-CHAIN of A LYSINE REPLACING VALINE 66 IS FULLY BURIED IN THE HYDROPHOBIC CORE;1.97;CA;CALCIUM ION;STAPHYLOCOCCAL NUCLEASE;1280;
2SNS;A;STAPHYLOCOCCAL NUCLEASE. PROPOSED MECHANISM OF ACTION BASED ON STRUCTURE OF ENZYME-THYMIDINE 3(PRIME),5(PRIME)-BIPHOSPHATE-CALCIUM ION COMPLEX AT 1.5-ANGSTROMS RESOLUTION;1.5;CA;CALCIUM ION;THERMONUCLEASE PRECURSOR;1280;
2ST1;A;THE THREE-DIMENSIONAL STRUCTURE OF BACILLUS AMYLOLIQUEFACIENS SUBTILISIN AT 1.8 ANGSTROMS AND AN ANALYSIS OF THE STRUCTURAL CONSEQUENCES OF PEROXIDE INACTIVATION;1.8;CA;CALCIUM ION;SUBTILISIN BPN';1390;
2STA;E;ANIONIC SALMON TRYPSIN IN COMPLEX WITH SQUASH SEED INHIBITOR (CUCURBITA MAXIMA TRYPSIN INHIBITOR I);1.8;CA;CALCIUM ION;PROTEIN (TRYPSIN);8030;
2STB;E;ANIONIC SALMON TRYPSIN IN COMPLEX WITH SQUASH SEED INHIBITOR (CUCURBITA PEPO TRYPSIN INHIBITOR II);1.8;CA;CALCIUM ION;PROTEIN (TRYPSIN);8030;
2TAA;A;STRUCTURE AND POSSIBLE CATALYTIC RESIDUES OF TAKA-AMYLASE A;3;CA;CALCIUM ION;TAKA-AMYLASE A;5062;
2TAA;B;STRUCTURE AND POSSIBLE CATALYTIC RESIDUES OF TAKA-AMYLASE A;3;CA;CALCIUM ION;TAKA-AMYLASE A;5062;
2TAA;C;STRUCTURE AND POSSIBLE CATALYTIC RESIDUES OF TAKA-AMYLASE A;3;CA;CALCIUM ION;TAKA-AMYLASE A;5062;
2TBS;A;COLD-ADAPTION OF ENZYMES: STRUCTURAL COMPARISON BETWEEN SALMON AND BOVINE TRYPSINS;1.8;CA;CALCIUM ION;TRYPSIN;8030;
2TBV;A;STRUCTURE OF TOMATO BUSHY STUNT VIRUS. V. COAT PROTEIN SEQUENCE DETERMINATION AND ITS STRUCTURAL IMPLICATIONS;2.9;CA;CALCIUM ION;TOMATO BUSHY STUNT VIRUS;12145;
2TBV;B;STRUCTURE OF TOMATO BUSHY STUNT VIRUS. V. COAT PROTEIN SEQUENCE DETERMINATION AND ITS STRUCTURAL IMPLICATIONS;2.9;CA;CALCIUM ION;TOMATO BUSHY STUNT VIRUS;12145;
2TBV;C;STRUCTURE OF TOMATO BUSHY STUNT VIRUS. V. COAT PROTEIN SEQUENCE DETERMINATION AND ITS STRUCTURAL IMPLICATIONS;2.9;CA;CALCIUM ION;TOMATO BUSHY STUNT VIRUS;12145;
2TCL;A;STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN FIBROBLAST COLLAGENASE COMPLEXED WITH AN INHIBITOR;2.2;CA;CALCIUM ION;FIBROBLAST COLLAGENASE;9606;
2TEC;E;MOLECULAR DYNAMICS REFINEMENT OF A THERMITASE-EGLIN-C COMPLEX AT 1.98 ANGSTROMS RESOLUTION AND COMPARISON OF TWO CRYSTAL FORMS THAT DIFFER IN CALCIUM CONTENT;1.98;CA;CALCIUM ION;THERMITASE;2026;
2TEP;A;PEANUT LECTIN COMPLEXED WITH T-ANTIGENIC DISACCHARIDE;2.5;CA;CALCIUM ION;PROTEIN (PEANUT LECTIN);3818;
2TEP;B;PEANUT LECTIN COMPLEXED WITH T-ANTIGENIC DISACCHARIDE;2.5;CA;CALCIUM ION;PROTEIN (PEANUT LECTIN);3818;
2TEP;C;PEANUT LECTIN COMPLEXED WITH T-ANTIGENIC DISACCHARIDE;2.5;CA;CALCIUM ION;PROTEIN (PEANUT LECTIN);3818;
2TEP;D;PEANUT LECTIN COMPLEXED WITH T-ANTIGENIC DISACCHARIDE;2.5;CA;CALCIUM ION;PROTEIN (PEANUT LECTIN);3818;
2TGA;A;ON THE DISORDERED ACTIVATION DOMAIN IN TRYPSINOGEN. CHEMICAL LABELLING AND LOW-TEMPERATURE CRYSTALLOGRAPHY;1.8;CA;CALCIUM ION;TRYPSINOGEN;9913;
2TGD;A;LACK OF THE TRANSITION STATE STABILIZATION SITE IS A FACTOR IN THE INACTIVITY OF TRYPSINOGEN, A SERINE PROTEASE ZYMOGEN. STRUCTURE OF DFP INHIBITED BOVINE TRYPSINOGEN AT 2.1 ANGSTROMS RESOLUTION;2.1;CA;CALCIUM ION;TRYPSINOGEN;9913;
2TGP;Z;THE GEOMETRY OF THE REACTIVE SITE AND OF THE PEPTIDE GROUPS IN TRYPSIN, TRYPSINOGEN AND ITS COMPLEXES WITH INHIBITORS;1.9;CA;CALCIUM ION;TRYPSINOGEN;9913;
2TGT;A;ON THE DISORDERED ACTIVATION DOMAIN IN TRYPSINOGEN. CHEMICAL LABELLING AND LOW-TEMPERATURE CRYSTALLOGRAPHY;1.7;CA;CALCIUM ION;TRYPSINOGEN;9913;
2TIO;A;LOW PACKING DENSITY FORM OF BOVINE BETA-TRYPSIN IN CYCLOHEXANE;1.93;CA;CALCIUM ION;PROTEIN (BETA-TRYPSIN);9913;
2TLI;A;THERMOLYSIN (5% ISOPROPANOL SOAKED CRYSTALS);1.95;CA;CALCIUM ION;THERMOLYSIN;1427;
2TLX;A;THERMOLYSIN (NATIVE);1.65;CA;CALCIUM ION;THERMOLYSIN;1427;
2TMN;E;CRYSTALLOGRAPHIC STRUCTURAL ANALYSIS OF PHOSPHORAMIDATES AS INHIBITORS AND TRANSITION-STATE ANALOGS OF THERMOLYSIN;1.6;CA;CALCIUM ION;Thermolysin;1427;
2TMV;R;VISUALIZATION OF PROTEIN-NUCLEIC ACID INTERACTIONS IN A VIRUS. REFINED STRUCTURE OF INTACT TOBACCO MOSAIC VIRUS AT 2.9 ANGSTROMS RESOLUTION BY X-RAY FIBER DIFFRACTION;2.9;CA;CALCIUM ION;RNA (5'-R(P*GP*AP*A)-3');;
2TN4;A;FOUR CALCIUM TNC;2;CA;CALCIUM ION;TROPONIN C;9986;
2TRM;A;THE THREE-DIMENSIONAL STRUCTURE OF ASN102 MUTANT OF TRYPSIN. ROLE OF ASP102 IN SERINE PROTEASE CATALYSIS;2.8;CA;CALCIUM ION;TRYPSIN;10116;
2USN;A;CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN FIBROBLAST STROMELYSIN-1 INHIBITED WITH THIADIAZOLE INHIBITOR PNU-141803;2.2;CA;CALCIUM ION;STROMELYSIN-1;9606;
2UU8;A;X-ray structure of Ni, Ca concanavalin A at Ultra-high resolution (0. 94A);0.94;CA;CALCIUM ION;CONCANAVALIN;3823;
2UUF;B;Thrombin-hirugen binary complex at 1.26A resolution;1.26;CA;CALCIUM ION;THROMBIN;9606;
2UUJ;B;Thrombin-hirugen-gw473178 ternary complex at 1.32A resolution;1.32;CA;CALCIUM ION;PROTHROMBIN;9606;
2UUK;B;Thrombin-hirugen-gw420128 ternary complex at 1.39A resolution;1.39;CA;CALCIUM ION;THROMBIN;9606;
2UUY;A;Structure of a tick tryptase inhibitor in complex with bovine trypsin;1.15;CA;CALCIUM ION;CATIONIC TRYPSIN;9913;
2UVP;B;Crystal structure of HobA (HP1230)from Helicobacter pylori;1.7;CA;CALCIUM ION;HOBA;210;
2UVP;C;Crystal structure of HobA (HP1230)from Helicobacter pylori;1.7;CA;CALCIUM ION;HOBA;210;
2UVR;A;Crystal structures of mutant Dpo4 DNA polymerases with 8-oxoG containing DNA template-primer constructs;2.9;CA;CALCIUM ION;DNA POLYMERASE IV;2287;
2UVU;A;Crystal structures of mutant Dpo4 DNA polymerases with 8-oxoG containing DNA template-primer constructs;2.7;CA;CALCIUM ION;DNA POLYMERASE IV;2287;
2UVV;A;Crystal structures of mutant Dpo4 DNA polymerases with 8-oxoG containing DNA template-primer constructs;2.2;CA;CALCIUM ION;DNA POLYMERASE IV;2287;
2UVW;A;Crystal structures of mutant Dpo4 DNA polymerases with 8-oxoG containing DNA template-primer constructs;2.09;CA;CALCIUM ION;DNA POLYMERASE IV;2287;
2UWF;A;Crystal structure of family 10 xylanase from Bacillus halodurans;2.1;CA;CALCIUM ION;ALKALINE ACTIVE ENDOXYLANASE;86665;
2UWP;A;Factor Xa inhibitor complex;1.75;CA;CALCIUM ION;COAGULATION FACTOR X;9606;
2UX1;D;Identification of two zinc-binding sites in the Streptococcus suis Dpr protein;1.8;CA;CALCIUM ION;DNA PROTECTION DURING STARVATION PROTEIN;1307;
2UX1;H;Identification of two zinc-binding sites in the Streptococcus suis Dpr protein;1.8;CA;CALCIUM ION;DNA PROTECTION DURING STARVATION PROTEIN;1307;
2UX1;I;Identification of two zinc-binding sites in the Streptococcus suis Dpr protein;1.8;CA;CALCIUM ION;DNA PROTECTION DURING STARVATION PROTEIN;1307;
2UX1;K;Identification of two zinc-binding sites in the Streptococcus suis Dpr protein;1.8;CA;CALCIUM ION;DNA PROTECTION DURING STARVATION PROTEIN;1307;
2UZ0;A;The Crystal crystal structure of the estA protein, a virulence factor estA protein from Streptococcus pneumonia;1.7;CA;CALCIUM ION;TRIBUTYRIN ESTERASE;1313;
2UZ0;B;The Crystal crystal structure of the estA protein, a virulence factor estA protein from Streptococcus pneumonia;1.7;CA;CALCIUM ION;TRIBUTYRIN ESTERASE;1313;
2UZA;A;CRYSTAL STRUCTURE OF THE FREE RADICAL INTERMEDIATE OF PYRUVATE:FERREDOXIN OXIDOREDUCTASE FROM DESULFOVIBRIO AFRICANUS;2.42;CA;CALCIUM ION;PYRUVATE FERREDOXIN OXIDOREDUCTASE;873;
2UZA;B;CRYSTAL STRUCTURE OF THE FREE RADICAL INTERMEDIATE OF PYRUVATE:FERREDOXIN OXIDOREDUCTASE FROM DESULFOVIBRIO AFRICANUS;2.42;CA;CALCIUM ION;PYRUVATE FERREDOXIN OXIDOREDUCTASE;873;
2UZP;A;Crystal structure of the C2 domain of human protein kinase C gamma.;2;CA;CALCIUM ION;PROTEIN KINASE C GAMMA TYPE;9606;
2UZP;B;Crystal structure of the C2 domain of human protein kinase C gamma.;2;CA;CALCIUM ION;PROTEIN KINASE C GAMMA TYPE;9606;
2UZP;C;Crystal structure of the C2 domain of human protein kinase C gamma.;2;CA;CALCIUM ION;PROTEIN KINASE C GAMMA TYPE;9606;
2V01;A;Recombinant vertebrate calmodulin complexed with Pb;2.15;CA;CALCIUM ION;CALMODULIN;9606;
2V02;A;Recombinant vertebrate calmodulin complexed with Ba;2.2;CA;CALCIUM ION;CALMODULIN;9606;
2V0B;A;SAD Structure solution porcine pancreatic elastase from a Selenate derivative;1.65;CA;CALCIUM ION;ELASTASE-1;9823;
2V15;B;Terbium binding in Streptococcus suis Dpr protein;2.1;CA;CALCIUM ION;DNA PROTECTION DURING STARVATION PROTEIN;1307;
2V15;G;Terbium binding in Streptococcus suis Dpr protein;2.1;CA;CALCIUM ION;DNA PROTECTION DURING STARVATION PROTEIN;1307;
2V15;H;Terbium binding in Streptococcus suis Dpr protein;2.1;CA;CALCIUM ION;DNA PROTECTION DURING STARVATION PROTEIN;1307;
2V15;K;Terbium binding in Streptococcus suis Dpr protein;2.1;CA;CALCIUM ION;DNA PROTECTION DURING STARVATION PROTEIN;1307;
2V3H;H;Thrombin with 3-cycle no F;1.79;CA;CALCIUM ION;THROMBIN HEAVY CHAIN;9606;
2V3O;H;Thrombin with 3-cycle with F;1.79;CA;CALCIUM ION;THROMBIN HEAVY CHAIN;9606;
2V3T;A;Structure of the ligand-binding core of the ionotropic glutamate receptor-like GluRdelta2 in the apo form;2.75;CA;CALCIUM ION;GLUTAMATE RECEPTOR DELTA-2 SUBUNIT SYNONYM GLURDELTA2, GLUR DELTA-2;10116;
2V3T;B;Structure of the ligand-binding core of the ionotropic glutamate receptor-like GluRdelta2 in the apo form;2.75;CA;CALCIUM ION;GLUTAMATE RECEPTOR DELTA-2 SUBUNIT SYNONYM GLURDELTA2, GLUR DELTA-2;10116;
2V4Q;A;Post-insertion complex of the Y-family DNA polymerase Dpo4 with M1dG containing template DNA;2.6;CA;CALCIUM ION;DNA POLYMERASE IV;2287;
2V4R;A;Non-productive complex of the Y-family DNA polymerase Dpo4 with dGTP skipping the M1dG adduct to pair with the next template cytosine;2.5;CA;CALCIUM ION;DNA POLYMERASE IV;2287;
2V51;B;Structure of MAL-RPEL1 complexed to actin;2.35;CA;CALCIUM ION;ACTIN, ALPHA SKELETAL MUSCLE;9986;
2V51;D;Structure of MAL-RPEL1 complexed to actin;2.35;CA;CALCIUM ION;ACTIN, ALPHA SKELETAL MUSCLE;9986;
2V53;A;Crystal structure of a SPARC-collagen complex;3.2;CA;CALCIUM ION;SPARC;9606;
2V5C;A;Family 84 glycoside hydrolase from Clostridium perfringens, 2.1 Angstrom structure;2.1;CA;CALCIUM ION;O-GLCNACASE NAGJ;1502;
2V5C;B;Family 84 glycoside hydrolase from Clostridium perfringens, 2.1 Angstrom structure;2.1;CA;CALCIUM ION;O-GLCNACASE NAGJ;1502;
2V5D;A;Structure of a Family 84 Glycoside Hydrolase and a Family 32 Carbohydrate-Binding Module in Tandem from Clostridium perfringens.;3.3;CA;CALCIUM ION;O-GLCNACASE NAGJ;1502;
2V72;A;The structure of the family 32 CBM from C. perfringens NanJ in complex with galactose;2.25;CA;CALCIUM ION;EXO-ALPHA-SIALIDASE;1502;
2V73;A;The structure of the family 40 CBM from C. perfringens NanJ in complex with a sialic acid containing molecule;2.2;CA;CALCIUM ION;PUTATIVE EXO-ALPHA-SIALIDASE;1502;
2V8B;A;SAD Structure solution of Proteinase K grown in selenate solution;0.94;CA;CALCIUM ION;PROTEINASE K;37998;
2V9M;A;L-RHAMNULOSE-1-PHOSPHATE ALDOLASE FROM ESCHERICHIA COLI (MUTANT A87M- T109F-E192A);1.3;CA;CALCIUM ION;RHAMNULOSE-1-PHOSPHATE ALDOLASE;562;
2V9W;A;Complex structure of Sulfolobus solfataricus DPO4 and DNA duplex containing a hydrophobic thymine isostere 2,4-difluorotoluene nucleotide in the template strand;3;CA;CALCIUM ION;DNA POLYMERASE IV;2287;
2V9W;B;Complex structure of Sulfolobus solfataricus DPO4 and DNA duplex containing a hydrophobic thymine isostere 2,4-difluorotoluene nucleotide in the template strand;3;CA;CALCIUM ION;DNA POLYMERASE IV;2287;
2VA2;A;Complex structure of Sulfolobus solfataricus DPO4 and DNA duplex containing a hydrophobic thymine isostere 2,4-difluorotoluene nucleotide in the template strand;2.8;CA;CALCIUM ION;DNA POLYMERASE IV;2287;
2VA2;B;Complex structure of Sulfolobus solfataricus DPO4 and DNA duplex containing a hydrophobic thymine isostere 2,4-difluorotoluene nucleotide in the template strand;2.8;CA;CALCIUM ION;DNA POLYMERASE IV;2287;
2VA3;A;Complex structure of Sulfolobus solfataricus DPO4 and DNA duplex containing a hydrophobic thymine isostere 2,4-difluorotoluene nucleotide in the template strand;2.98;CA;CALCIUM ION;DNA POLYMERASE IV;2287;
2VAS;B;Myosin VI (MD-insert2-CaM, Delta-Insert1) Post-rigor state;2.4;CA;CALCIUM ION;CALMODULIN;7227;
2VAY;A;Calmodulin complexed with CaV1.1 IQ peptide;1.94;CA;CALCIUM ION;CALMODULIN;9606;
2VB6;B;Myosin VI (MD-insert2-CaM, Delta Insert1) Post-rigor state (crystal form 2);2.3;CA;CALCIUM ION;CALMODULIN;9031;
2VBE;A;Tailspike protein of bacteriophage Sf6;1.98;CA;CALCIUM ION;TAILSPIKE-PROTEIN;10761;
2VBJ;A;Molecular basis of human XPC gene recognition and cleavage by engineered homing endonuclease heterodimers;1.95;CA;CALCIUM ION;DNA ENDONUCLEASE I-CREI;3055;
2VBN;A;Molecular basis of human XPC gene recognition and cleavage by engineered homing endonuclease heterodimers;1.9;CA;CALCIUM ION;DNA ENDONUCLEASE I-CREI;3055;
2VBN;B;Molecular basis of human XPC gene recognition and cleavage by engineered homing endonuclease heterodimers;1.9;CA;CALCIUM ION;DNA ENDONUCLEASE I-CREI;3055;
2VBO;A;Molecular basis of human XPC gene recognition and cleavage by engineered homing endonuclease heterodimers;1.8;CA;CALCIUM ION;DNA ENDONUCLEASE I-CREI;3055;
2VBO;B;Molecular basis of human XPC gene recognition and cleavage by engineered homing endonuclease heterodimers;1.8;CA;CALCIUM ION;DNA ENDONUCLEASE I-CREI;3055;
2VC2;A;Re-refinement of Integrin AlphaIIbBeta3 Headpiece Bound to Antagonist L-739758;3.1;CA;CALCIUM ION;INTEGRIN ALPHA-IIB;9606;
2VC2;B;Re-refinement of Integrin AlphaIIbBeta3 Headpiece Bound to Antagonist L-739758;3.1;CA;CALCIUM ION;INTEGRIN BETA-3;9606;
2VC9;A;Family 89 Glycoside Hydrolase from Clostridium perfringens in complex with 2-acetamido-1,2-dideoxynojirmycin;2.36;CA;CALCIUM ION;ALPHA-N-ACETYLGLUCOSAMINIDASE;1502;
2VCA;A;Family 89 glycoside hydrolase from Clostridium perfringens in complex with beta-N-acetyl-D-glucosamine;2.05;CA;CALCIUM ION;ALPHA-N-ACETYLGLUCOSAMINIDASE;1502;
2VCB;A;Family 89 Glycoside Hydrolase from Clostridium perfringens in complex with PUGNAc;2.2;CA;CALCIUM ION;ALPHA-N-ACETYLGLUCOSAMINIDASE;1502;
2VCC;A;Family 89 Glycoside Hydrolase from Clostridium perfringens;2;CA;CALCIUM ION;ALPHA-N-ACETYLGLUCOSAMINIDASE;1502;
2VCP;A;Crystal structure of N-Wasp VC domain in complex with skeletal actin;3.2;CA;CALCIUM ION;ACTIN, ALPHA SKELETAL MUSCLE;9986;
2VCP;B;Crystal structure of N-Wasp VC domain in complex with skeletal actin;3.2;CA;CALCIUM ION;ACTIN, ALPHA SKELETAL MUSCLE;9986;
2VDK;A;Re-refinement of Integrin AlphaIIbBeta3 Headpiece;2.8;CA;CALCIUM ION;INTEGRIN ALPHA-IIB;9606;
2VDK;B;Re-refinement of Integrin AlphaIIbBeta3 Headpiece;2.8;CA;CALCIUM ION;INTEGRIN BETA-3;9606;
2VDL;A;Re-refinement of Integrin AlphaIIbBeta3 Headpiece;2.75;CA;CALCIUM ION;INTEGRIN ALPHA-IIB;9606;
2VDL;B;Re-refinement of Integrin AlphaIIbBeta3 Headpiece;2.75;CA;CALCIUM ION;INTEGRIN BETA-3;9606;
2VDM;A;Re-refinement of Integrin AlphaIIbBeta3 Headpiece Bound to Antagonist Tirofiban;2.9;CA;CALCIUM ION;INTEGRIN ALPHA-IIB;9606;
2VDM;B;Re-refinement of Integrin AlphaIIbBeta3 Headpiece Bound to Antagonist Tirofiban;2.9;CA;CALCIUM ION;INTEGRIN BETA-3;9606;
2VDN;A;Re-refinement of Integrin AlphaIIbBeta3 Headpiece Bound to Antagonist Eptifibatide;2.9;CA;CALCIUM ION;INTEGRIN ALPHA-IIB;9606;
2VDN;B;Re-refinement of Integrin AlphaIIbBeta3 Headpiece Bound to Antagonist Eptifibatide;2.9;CA;CALCIUM ION;INTEGRIN BETA-3;9606;
2VDO;A;Integrin AlphaIIbBeta3 Headpiece Bound to Fibrinogen Gamma chain peptide, HHLGGAKQAGDV;2.51;CA;CALCIUM ION;INTEGRIN ALPHA-IIB;9606;
2VDO;B;Integrin AlphaIIbBeta3 Headpiece Bound to Fibrinogen Gamma chain peptide, HHLGGAKQAGDV;2.51;CA;CALCIUM ION;INTEGRIN BETA-3;9606;
2VDP;A;Integrin AlphaIIbBeta3 Headpiece Bound to Fibrinogen Gamma chain peptide,LGGAKQAGDV;2.8;CA;CALCIUM ION;INTEGRIN ALPHA-IIB;9606;
2VDP;B;Integrin AlphaIIbBeta3 Headpiece Bound to Fibrinogen Gamma chain peptide,LGGAKQAGDV;2.8;CA;CALCIUM ION;INTEGRIN BETA-3;9606;
2VDQ;A;Integrin AlphaIIbBeta3 Headpiece Bound to a Chimeric Fibrinogen Gamma chain peptide, HHLGGAKQRGDV;2.59;CA;CALCIUM ION;INTEGRIN ALPHA-IIB;9606;
2VDQ;B;Integrin AlphaIIbBeta3 Headpiece Bound to a Chimeric Fibrinogen Gamma chain peptide, HHLGGAKQRGDV;2.59;CA;CALCIUM ION;INTEGRIN BETA-3;9606;
2VDR;A;Integrin AlphaIIbBeta3 Headpiece Bound to a chimeric Fibrinogen Gamma chain peptide, LGGAKQRGDV;2.4;CA;CALCIUM ION;INTEGRIN ALPHA-IIB;9606;
2VDR;B;Integrin AlphaIIbBeta3 Headpiece Bound to a chimeric Fibrinogen Gamma chain peptide, LGGAKQRGDV;2.4;CA;CALCIUM ION;INTEGRIN BETA-3;9606;
2VDT;A;Crystallographic structure of Levansucrase from Bacillus subtilis mutant S164A;3.2;CA;CALCIUM ION;LEVANSUCRASE;1423;
2VF9;C;Crystal structure of bacteriophage PRR1;3.5;CA;CALCIUM ION;COAT PROTEIN;12024;
2VFM;A;Low Temperature Structure of P22 Tailspike Protein Fragment (109-666);1.5;CA;CALCIUM ION;BIFUNCTIONAL TAIL PROTEIN;10754;
2VFN;A;Low Temperature Structure of P22 Tailspike Protein Fragment (109-666), Mutant V125A;1.5;CA;CALCIUM ION;BIFUNCTIONAL TAIL PROTEIN;10754;
2VFO;A;Low Temperature Structure of P22 Tailspike Protein Fragment (109-666), Mutant V125L;1.5;CA;CALCIUM ION;P22 TAILSPIKE PROTEIN, MUTANT V125L;10754;
2VFP;A;Low Temperature Structure of P22 Tailspike Protein Fragment (109-666), Mutant V349L;1.55;CA;CALCIUM ION;P22 TAILSPIKE PROTEIN;10754;
2VFQ;A;Low Temperature Structure of P22 Tailspike Protein Fragment (109-666), Mutant V450A;1.55;CA;CALCIUM ION;P22 TAILSPIKE PROTEIN,;10754;
2VH0;A;Structure and property based design of factor Xa inhibitors:biaryl pyrrolidin-2-ones incorporating basic heterocyclic motifs;1.7;CA;CALCIUM ION;ACTIVATED FACTOR XA HEAVY CHAIN;9606;
2VHD;A;Crystal Structure Of The Di-Haem Cytochrome C Peroxidase From Pseudomonas aeruginosa - Mixed Valence Form;2.3;CA;CALCIUM ION;CYTOCHROME C551 PEROXIDASE;287;
2VHD;B;Crystal Structure Of The Di-Haem Cytochrome C Peroxidase From Pseudomonas aeruginosa - Mixed Valence Form;2.3;CA;CALCIUM ION;CYTOCHROME C551 PEROXIDASE;287;
2VJ3;A;Human Notch-1 EGFs 11-13;2.6;CA;CALCIUM ION;NEUROGENIC LOCUS NOTCH HOMOLOG PROTEIN 1;9606;
2VJJ;A;TAILSPIKE PROTEIN OF E.COLI BACTERIOPHAGE HK620 IN COMPLEX WITH HEXASACCHARIDE;1.59;CA;CALCIUM ION;TAILSPIKE PROTEIN;155148;
2VK5;A;THE STRUCTURE OF CLOSTRIDIUM PERFRINGENS NANI SIALIDASE AND ITS CATALYTIC INTERMEDIATES;0.97;CA;CALCIUM ION;EXO-ALPHA-SIALIDASE;1502;
2VK6;A;THE STRUCTURE OF CLOSTRIDIUM PERFRINGENS NANI SIALIDASE AND ITS CATALYTIC INTERMEDIATES;1.5;CA;CALCIUM ION;EXO-ALPHA-SIALIDASE;1502;
2VK7;A;THE STRUCTURE OF CLOSTRIDIUM PERFRINGENS NANI SIALIDASE AND ITS CATALYTIC INTERMEDIATES;1.2;CA;CALCIUM ION;EXO-ALPHA-SIALIDASE;1502;
2VK7;B;THE STRUCTURE OF CLOSTRIDIUM PERFRINGENS NANI SIALIDASE AND ITS CATALYTIC INTERMEDIATES;1.2;CA;CALCIUM ION;EXO-ALPHA-SIALIDASE;1502;
2VKA;A;Site-Directed Mutagenesis of the Catalytic Tryptophan Environment in Pleurotus eryngii Versatile Peroxidase;2;CA;CALCIUM ION;VERSATILE PEROXIDASE VPL2;5323;
2VKH;A;CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF LETHAL TOXIN FROM CLOSTRIDIUM SORDELLII IN COMPLEX WITH UDP-GLC AND CALCIUM ION;2.3;CA;CALCIUM ION;CYTOTOXIN L;1505;
2VKH;B;CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF LETHAL TOXIN FROM CLOSTRIDIUM SORDELLII IN COMPLEX WITH UDP-GLC AND CALCIUM ION;2.3;CA;CALCIUM ION;CYTOTOXIN L;1505;
2VKH;C;CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF LETHAL TOXIN FROM CLOSTRIDIUM SORDELLII IN COMPLEX WITH UDP-GLC AND CALCIUM ION;2.3;CA;CALCIUM ION;CYTOTOXIN L;1505;
2VL8;A;CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF LETHAL TOXIN FROM CLOSTRIDIUM SORDELLII IN COMPLEX WITH UDP, CASTANOSPERMINE AND CALCIUM ION;2.31;CA;CALCIUM ION;CYTOTOXIN L;1505;
2VL8;B;CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF LETHAL TOXIN FROM CLOSTRIDIUM SORDELLII IN COMPLEX WITH UDP, CASTANOSPERMINE AND CALCIUM ION;2.31;CA;CALCIUM ION;CYTOTOXIN L;1505;
2VL8;C;CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF LETHAL TOXIN FROM CLOSTRIDIUM SORDELLII IN COMPLEX WITH UDP, CASTANOSPERMINE AND CALCIUM ION;2.31;CA;CALCIUM ION;CYTOTOXIN L;1505;
2VM9;A;Native structure of the recombinant discoidin II of Dictyostelium discoideum at 1.75 angstrom;1.75;CA;CALCIUM ION;DISCOIDIN-2;44689;
2VMA;A;The three-dimensional structure of the cytoplasmic domains of EpsF from the Type 2 Secretion System of Vibrio cholerae;1.9;CA;CALCIUM ION;GENERAL SECRETION PATHWAY PROTEIN F;666;
2VMA;B;The three-dimensional structure of the cytoplasmic domains of EpsF from the Type 2 Secretion System of Vibrio cholerae;1.9;CA;CALCIUM ION;GENERAL SECRETION PATHWAY PROTEIN F;666;
2VMB;A;The three-dimensional structure of the cytoplasmic domains of EpsF from the Type 2 Secretion System of Vibrio cholerae;1.95;CA;CALCIUM ION;GENERAL SECRETION PATHWAY PROTEIN F;666;
2VMB;B;The three-dimensional structure of the cytoplasmic domains of EpsF from the Type 2 Secretion System of Vibrio cholerae;1.95;CA;CALCIUM ION;GENERAL SECRETION PATHWAY PROTEIN F;666;
2VMC;A;Structure of the complex of discoidin II from Dictyostelium discoideum with N-acetyl-galactosamine;1.9;CA;CALCIUM ION;DISCOIDIN-2;44689;
2VMD;A;Structure of the complex of discoidin II from Dictyostelium discoideum with beta-methyl-galactose;1.9;CA;CALCIUM ION;DISCOIDIN-2;44689;
2VME;A;Structure of the wild-type discoidin II from Dictyostelium discoideum;2.45;CA;CALCIUM ION;DISCOIDIN-2;44689;
2VME;B;Structure of the wild-type discoidin II from Dictyostelium discoideum;2.45;CA;CALCIUM ION;DISCOIDIN-2;44689;
2VME;C;Structure of the wild-type discoidin II from Dictyostelium discoideum;2.45;CA;CALCIUM ION;DISCOIDIN-2;44689;
2VME;D;Structure of the wild-type discoidin II from Dictyostelium discoideum;2.45;CA;CALCIUM ION;DISCOIDIN-2;44689;
2VME;E;Structure of the wild-type discoidin II from Dictyostelium discoideum;2.45;CA;CALCIUM ION;DISCOIDIN-2;44689;
2VME;F;Structure of the wild-type discoidin II from Dictyostelium discoideum;2.45;CA;CALCIUM ION;DISCOIDIN-2;44689;
2VMG;A;The structure of CBM51 from Clostridium perfringens GH95 in complex with methyl-galactose;1.9;CA;CALCIUM ION;FIBRONECTIN TYPE III DOMAIN PROTEIN;1502;
2VMH;A;The structure of CBM51 from Clostridium perfringens GH95;1.5;CA;CALCIUM ION;FIBRONECTIN TYPE III DOMAIN PROTEIN;1502;
2VMI;A;The structure of seleno-methionine labelled CBM51 from Clostridium perfringens GH95;1.7;CA;CALCIUM ION;FIBRONECTIN TYPE III DOMAIN PROTEIN;1502;
2VN5;B;The Clostridium cellulolyticum dockerin displays a dual binding mode for its cohesin partner;1.9;CA;CALCIUM ION;ENDOGLUCANASE A;1521;
2VN5;D;The Clostridium cellulolyticum dockerin displays a dual binding mode for its cohesin partner;1.9;CA;CALCIUM ION;ENDOGLUCANASE A;1521;
2VN6;B;The Clostridium cellulolyticum dockerin displays a dual binding mode for its cohesin partner;1.49;CA;CALCIUM ION;ENDOGLUCANASE A;1521;
2VN7;A;Glycoside Hydrolase Family 15 Glucoamylase from Hypocrea jecorina;1.9;CA;CALCIUM ION;GLUCOAMYLASE;51453;
2VNG;A;Family 51 carbohydrate binding module from a family 98 glycoside hydrolase produced by Clostridium perfringens in complex with blood group A-trisaccharide ligand.;1.4;CA;CALCIUM ION;CPE0329;1502;
2VNG;B;Family 51 carbohydrate binding module from a family 98 glycoside hydrolase produced by Clostridium perfringens in complex with blood group A-trisaccharide ligand.;1.4;CA;CALCIUM ION;CPE0329;1502;
2VNO;A;Family 51 carbohydrate binding module from a family 98 glycoside hydrolase produced by Clostridium perfringens in complex with blood group B-trisaccharide ligand.;1.45;CA;CALCIUM ION;CPE0329;1502;
2VNO;B;Family 51 carbohydrate binding module from a family 98 glycoside hydrolase produced by Clostridium perfringens in complex with blood group B-trisaccharide ligand.;1.45;CA;CALCIUM ION;CPE0329;1502;
2VNR;A;Family 51 carbohydrate binding module from a family 98 glycoside hydrolase produced by Clostridium perfringens.;1.55;CA;CALCIUM ION;CPE0329;1502;
2VNV;A;Crystal structure of BclA lectin from burkholderia cenocepacia in complex with alpha-methyl-mannoside at 1.7 Angstrom resolution;1.7;CA;CALCIUM ION;BCLA;95486;
2VNV;B;Crystal structure of BclA lectin from burkholderia cenocepacia in complex with alpha-methyl-mannoside at 1.7 Angstrom resolution;1.7;CA;CALCIUM ION;BCLA;95486;
2VNV;C;Crystal structure of BclA lectin from burkholderia cenocepacia in complex with alpha-methyl-mannoside at 1.7 Angstrom resolution;1.7;CA;CALCIUM ION;BCLA;95486;
2VNV;D;Crystal structure of BclA lectin from burkholderia cenocepacia in complex with alpha-methyl-mannoside at 1.7 Angstrom resolution;1.7;CA;CALCIUM ION;BCLA;95486;
2VNV;E;Crystal structure of BclA lectin from burkholderia cenocepacia in complex with alpha-methyl-mannoside at 1.7 Angstrom resolution;1.7;CA;CALCIUM ION;BCLA;95486;
2VOV;A;An oxidized tryptophan facilitates copper-binding in Methylococcus capsulatus secreted protein MopE. The structure of wild-type MopE to 1.35AA;1.35;CA;CALCIUM ION;SURFACE-ASSOCIATED PROTEIN;414;
2VOW;A;An oxidized tryptophan facilitates copper-binding in Methylococcus capsulatus secreted protein MopE. The structure of recombinant MopE to 1.65AA;1.65;CA;CALCIUM ION;SURFACE-ASSOCIATED PROTEIN;414;
2VOX;A;An oxidized tryptophan facilitates copper-binding in Methylococcus capsulatus secreted protein MopE. The structure of mercury soaked MopE to 1.9AA;1.9;CA;CALCIUM ION;SURFACE-ASSOCIATED PROTEIN;414;
2VPT;A;Clostridium thermocellum family 3 carbohydrate esterase;1.4;CA;CALCIUM ION;LIPOLYTIC ENZYME;1515;
2VQ0;A;Capsid structure of Sesbania mosaic virus coat protein deletion mutant rCP(delta 48 to 59);3.6;CA;CALCIUM ION;COAT PROTEIN;12558;
2VQ0;B;Capsid structure of Sesbania mosaic virus coat protein deletion mutant rCP(delta 48 to 59);3.6;CA;CALCIUM ION;COAT PROTEIN;12558;
2VQ0;C;Capsid structure of Sesbania mosaic virus coat protein deletion mutant rCP(delta 48 to 59);3.6;CA;CALCIUM ION;COAT PROTEIN;12558;
2VQR;A;Crystal structure of a phosphonate monoester hydrolase from rhizobium leguminosarum: a new member of the alkaline phosphatase superfamily;1.42;CA;CALCIUM ION;PUTATIVE SULFATASE;384;
2VQY;A;Structure of AAC(6')-Ib in complex with Parmomycin and AcetylCoA.;1.8;CA;CALCIUM ION;AAC(6')-IB;562;
2VR0;A;Crystal structure of cytochrome c nitrite reductase NrfHA complex bound to the HQNO inhibitor;2.8;CA;CALCIUM ION;CYTOCHROME C NITRITE REDUCTASE, CATALYTIC SUBUNIT NFRA;881;
2VR0;B;Crystal structure of cytochrome c nitrite reductase NrfHA complex bound to the HQNO inhibitor;2.8;CA;CALCIUM ION;CYTOCHROME C NITRITE REDUCTASE, CATALYTIC SUBUNIT NFRA;881;
2VR0;D;Crystal structure of cytochrome c nitrite reductase NrfHA complex bound to the HQNO inhibitor;2.8;CA;CALCIUM ION;CYTOCHROME C NITRITE REDUCTASE, CATALYTIC SUBUNIT NFRA;881;
2VR0;E;Crystal structure of cytochrome c nitrite reductase NrfHA complex bound to the HQNO inhibitor;2.8;CA;CALCIUM ION;CYTOCHROME C NITRITE REDUCTASE, CATALYTIC SUBUNIT NFRA;881;
2VRG;A;Structure of human MCFD2;;CA;CALCIUM ION;MULTIPLE COAGULATION FACTOR DEFICIENCY PROTEIN 2;9606;
2VRJ;A;Beta-glucosidase from Thermotoga maritima in complex with N-octyl-5- deoxy-6-oxa-N-(thio)carbamoylcalystegine;1.9;CA;CALCIUM ION;BETA-GLUCOSIDASE A;2336;
2VRJ;B;Beta-glucosidase from Thermotoga maritima in complex with N-octyl-5- deoxy-6-oxa-N-(thio)carbamoylcalystegine;1.9;CA;CALCIUM ION;BETA-GLUCOSIDASE A;2336;
2VS7;A;The crystal structure of I-DmoI in complex with DNA and Ca;2.05;CA;CALCIUM ION;HOMING ENDONUCLEASE I-DMOI;2275;
2VS7;D;The crystal structure of I-DmoI in complex with DNA and Ca;2.05;CA;CALCIUM ION;HOMING ENDONUCLEASE I-DMOI;2275;
2VS7;G;The crystal structure of I-DmoI in complex with DNA and Ca;2.05;CA;CALCIUM ION;HOMING ENDONUCLEASE I-DMOI;2275;
2VSF;A;Structure of XPD from Thermoplasma acidophilum;2.9;CA;CALCIUM ION;DNA REPAIR HELICASE RAD3 RELATED PROTEIN;2303;
2VSH;A;Synthesis of CDP-activated ribitol for teichoic acid precursors in Streptococcus pneumoniae;2;CA;CALCIUM ION;2-C-METHYL-D-ERYTHRITOL 4-PHOSPHATE CYTIDYLYLTRANSFERASE;1313;
2VSI;B;Synthesis of CDP-activated ribitol for teichoic acid precursors in Streptococcus pneumoniae;2.75;CA;CALCIUM ION;2-C-METHYL-D-ERYTHRITOL 4-PHOSPHATE CYTIDYLYLTRANSFERASE;1313;
2VUC;A;PA-IIL lectin from Pseudomonas aeruginosa complexed with Fucose- derived glycomimetics;1.3;CA;CALCIUM ION;FUCOSE-BINDING LECTIN PA-IIL;287;
2VUC;B;PA-IIL lectin from Pseudomonas aeruginosa complexed with Fucose- derived glycomimetics;1.3;CA;CALCIUM ION;FUCOSE-BINDING LECTIN PA-IIL;287;
2VUC;C;PA-IIL lectin from Pseudomonas aeruginosa complexed with Fucose- derived glycomimetics;1.3;CA;CALCIUM ION;FUCOSE-BINDING LECTIN PA-IIL;287;
2VUC;D;PA-IIL lectin from Pseudomonas aeruginosa complexed with Fucose- derived glycomimetics;1.3;CA;CALCIUM ION;FUCOSE-BINDING LECTIN PA-IIL;287;
2VUD;A;PA-IIL lectin from pseudomonas aeruginosa complexed with fucose- derived glycomimetics;1.7;CA;CALCIUM ION;FUCOSE-BINDING LECTIN PA-IIL;287;
2VUD;B;PA-IIL lectin from pseudomonas aeruginosa complexed with fucose- derived glycomimetics;1.7;CA;CALCIUM ION;FUCOSE-BINDING LECTIN PA-IIL;287;
2VUD;C;PA-IIL lectin from pseudomonas aeruginosa complexed with fucose- derived glycomimetics;1.7;CA;CALCIUM ION;FUCOSE-BINDING LECTIN PA-IIL;287;
2VUD;D;PA-IIL lectin from pseudomonas aeruginosa complexed with fucose- derived glycomimetics;1.7;CA;CALCIUM ION;FUCOSE-BINDING LECTIN PA-IIL;287;
2VUV;A;Crystal structure of Codakine at 1.3A resolution;1.3;CA;CALCIUM ION;CODAKINE;13016;
2VUZ;A;Crystal structure of Codakine in complex with biantennary nonasaccharide at 1.7A resolution;1.7;CA;CALCIUM ION;CODAKINE;13016;
2VVC;A;Aminopyrrolidine Factor Xa inhibitor;1.95;CA;CALCIUM ION;ACTIVATED FACTOR XA HEAVY CHAIN;9606;
2VVD;A;Crystal structure of the receptor binding domain of the spike protein P1 from bacteriophage PM2;2.26;CA;CALCIUM ION;SPIKE PROTEIN P1;10661;
2VVE;A;Crystal structure of the stem and receptor binding domain of the spike protein P1 from bacteriophage PM2;1.77;CA;CALCIUM ION;SPIKE PROTEIN P1;10661;
2VVE;B;Crystal structure of the stem and receptor binding domain of the spike protein P1 from bacteriophage PM2;1.77;CA;CALCIUM ION;SPIKE PROTEIN P1;10661;
2VVF;A;Crystal structure of the major capsid protein P2 from Bacteriophage PM2;2.5;CA;CALCIUM ION;MAJOR CAPSID PROTEIN P2;10661;
2VVF;B;Crystal structure of the major capsid protein P2 from Bacteriophage PM2;2.5;CA;CALCIUM ION;MAJOR CAPSID PROTEIN P2;10661;
2VVF;C;Crystal structure of the major capsid protein P2 from Bacteriophage PM2;2.5;CA;CALCIUM ION;MAJOR CAPSID PROTEIN P2;10661;
2VVF;D;Crystal structure of the major capsid protein P2 from Bacteriophage PM2;2.5;CA;CALCIUM ION;MAJOR CAPSID PROTEIN P2;10661;
2VVF;E;Crystal structure of the major capsid protein P2 from Bacteriophage PM2;2.5;CA;CALCIUM ION;MAJOR CAPSID PROTEIN P2;10661;
2VVF;F;Crystal structure of the major capsid protein P2 from Bacteriophage PM2;2.5;CA;CALCIUM ION;MAJOR CAPSID PROTEIN P2;10661;
2VVU;A;Aminopyrrolidine Factor Xa inhibitor;2.3;CA;CALCIUM ION;ACTIVATED FACTOR XA HEAVY CHAIN;9606;
2VVV;A;Aminopyrrolidine-related triazole Factor Xa inhibitor;1.73;CA;CALCIUM ION;ACTIVATED FACTOR XA HEAVY CHAIN;9606;
2VWL;A;Aminopyrrolidine Factor Xa inhibitor;1.8;CA;CALCIUM ION;ACTIVATED FACTOR XA HEAVY CHAIN;9606;
2VWN;A;Aminopyrrolidine Factor Xa inhibitor;1.61;CA;CALCIUM ION;ACTIVATED FACTOR XA HEAVY CHAIN;9606;
2VWO;A;Aminopyrrolidine Factor Xa inhibitor;1.6;CA;CALCIUM ION;ACTIVATED FACTOR XA HEAVY CHAIN;9606;
2VXJ;A;CRYSTAL STRUCTURE OF PA-IL LECTIN COMPLEXED WITH AGAL13BGAL14GLC AT 1.9 A RESOLUTION;1.9;CA;CALCIUM ION;PA-I GALACTOPHILIC LECTIN;287;
2VXJ;B;CRYSTAL STRUCTURE OF PA-IL LECTIN COMPLEXED WITH AGAL13BGAL14GLC AT 1.9 A RESOLUTION;1.9;CA;CALCIUM ION;PA-I GALACTOPHILIC LECTIN;287;
2VXJ;C;CRYSTAL STRUCTURE OF PA-IL LECTIN COMPLEXED WITH AGAL13BGAL14GLC AT 1.9 A RESOLUTION;1.9;CA;CALCIUM ION;PA-I GALACTOPHILIC LECTIN;287;
2VXJ;D;CRYSTAL STRUCTURE OF PA-IL LECTIN COMPLEXED WITH AGAL13BGAL14GLC AT 1.9 A RESOLUTION;1.9;CA;CALCIUM ION;PA-I GALACTOPHILIC LECTIN;287;
2VXJ;E;CRYSTAL STRUCTURE OF PA-IL LECTIN COMPLEXED WITH AGAL13BGAL14GLC AT 1.9 A RESOLUTION;1.9;CA;CALCIUM ION;PA-I GALACTOPHILIC LECTIN;287;
2VXJ;F;CRYSTAL STRUCTURE OF PA-IL LECTIN COMPLEXED WITH AGAL13BGAL14GLC AT 1.9 A RESOLUTION;1.9;CA;CALCIUM ION;PA-I GALACTOPHILIC LECTIN;287;
2VXJ;G;CRYSTAL STRUCTURE OF PA-IL LECTIN COMPLEXED WITH AGAL13BGAL14GLC AT 1.9 A RESOLUTION;1.9;CA;CALCIUM ION;PA-I GALACTOPHILIC LECTIN;287;
2VXJ;H;CRYSTAL STRUCTURE OF PA-IL LECTIN COMPLEXED WITH AGAL13BGAL14GLC AT 1.9 A RESOLUTION;1.9;CA;CALCIUM ION;PA-I GALACTOPHILIC LECTIN;287;
2VXJ;I;CRYSTAL STRUCTURE OF PA-IL LECTIN COMPLEXED WITH AGAL13BGAL14GLC AT 1.9 A RESOLUTION;1.9;CA;CALCIUM ION;PA-I GALACTOPHILIC LECTIN;287;
2VXJ;J;CRYSTAL STRUCTURE OF PA-IL LECTIN COMPLEXED WITH AGAL13BGAL14GLC AT 1.9 A RESOLUTION;1.9;CA;CALCIUM ION;PA-I GALACTOPHILIC LECTIN;287;
2VXJ;K;CRYSTAL STRUCTURE OF PA-IL LECTIN COMPLEXED WITH AGAL13BGAL14GLC AT 1.9 A RESOLUTION;1.9;CA;CALCIUM ION;PA-I GALACTOPHILIC LECTIN;287;
2VXJ;L;CRYSTAL STRUCTURE OF PA-IL LECTIN COMPLEXED WITH AGAL13BGAL14GLC AT 1.9 A RESOLUTION;1.9;CA;CALCIUM ION;PA-I GALACTOPHILIC LECTIN;287;
2VXJ;M;CRYSTAL STRUCTURE OF PA-IL LECTIN COMPLEXED WITH AGAL13BGAL14GLC AT 1.9 A RESOLUTION;1.9;CA;CALCIUM ION;PA-I GALACTOPHILIC LECTIN;287;
2VXJ;N;CRYSTAL STRUCTURE OF PA-IL LECTIN COMPLEXED WITH AGAL13BGAL14GLC AT 1.9 A RESOLUTION;1.9;CA;CALCIUM ION;PA-I GALACTOPHILIC LECTIN;287;
2VXJ;O;CRYSTAL STRUCTURE OF PA-IL LECTIN COMPLEXED WITH AGAL13BGAL14GLC AT 1.9 A RESOLUTION;1.9;CA;CALCIUM ION;PA-I GALACTOPHILIC LECTIN;287;
2VXJ;P;CRYSTAL STRUCTURE OF PA-IL LECTIN COMPLEXED WITH AGAL13BGAL14GLC AT 1.9 A RESOLUTION;1.9;CA;CALCIUM ION;PA-I GALACTOPHILIC LECTIN;287;
2VXJ;Q;CRYSTAL STRUCTURE OF PA-IL LECTIN COMPLEXED WITH AGAL13BGAL14GLC AT 1.9 A RESOLUTION;1.9;CA;CALCIUM ION;PA-I GALACTOPHILIC LECTIN;287;
2VXJ;R;CRYSTAL STRUCTURE OF PA-IL LECTIN COMPLEXED WITH AGAL13BGAL14GLC AT 1.9 A RESOLUTION;1.9;CA;CALCIUM ION;PA-I GALACTOPHILIC LECTIN;287;
2VXJ;S;CRYSTAL STRUCTURE OF PA-IL LECTIN COMPLEXED WITH AGAL13BGAL14GLC AT 1.9 A RESOLUTION;1.9;CA;CALCIUM ION;PA-I GALACTOPHILIC LECTIN;287;
2VXJ;T;CRYSTAL STRUCTURE OF PA-IL LECTIN COMPLEXED WITH AGAL13BGAL14GLC AT 1.9 A RESOLUTION;1.9;CA;CALCIUM ION;PA-I GALACTOPHILIC LECTIN;287;
2VXJ;U;CRYSTAL STRUCTURE OF PA-IL LECTIN COMPLEXED WITH AGAL13BGAL14GLC AT 1.9 A RESOLUTION;1.9;CA;CALCIUM ION;PA-I GALACTOPHILIC LECTIN;287;
2VXJ;V;CRYSTAL STRUCTURE OF PA-IL LECTIN COMPLEXED WITH AGAL13BGAL14GLC AT 1.9 A RESOLUTION;1.9;CA;CALCIUM ION;PA-I GALACTOPHILIC LECTIN;287;
2VXJ;W;CRYSTAL STRUCTURE OF PA-IL LECTIN COMPLEXED WITH AGAL13BGAL14GLC AT 1.9 A RESOLUTION;1.9;CA;CALCIUM ION;PA-I GALACTOPHILIC LECTIN;287;
2VXJ;X;CRYSTAL STRUCTURE OF PA-IL LECTIN COMPLEXED WITH AGAL13BGAL14GLC AT 1.9 A RESOLUTION;1.9;CA;CALCIUM ION;PA-I GALACTOPHILIC LECTIN;287;
2VY0;A;The X-ray structure of endo-beta-1,3-glucanase from Pyrococcus furiosus;2.16;CA;CALCIUM ION;ENDO-BETA-1,3-GLUCANASE;2261;
2VY0;B;The X-ray structure of endo-beta-1,3-glucanase from Pyrococcus furiosus;2.16;CA;CALCIUM ION;ENDO-BETA-1,3-GLUCANASE;2261;
2VYO;A;Chitin deacetylase family member from Encephalitozoon cuniculi;1.5;CA;CALCIUM ION;POLYSACCHARIDE DEACETYLASE DOMAIN-CONTAINING PROTEIN ECU11_0510;6035;
2VYP;A;Rabbit-muscle G-actin in complex with myxobacterial rhizopodin;2.35;CA;CALCIUM ION;ACTIN, ALPHA SKELETAL MUSCLE;9986;
2VYP;B;Rabbit-muscle G-actin in complex with myxobacterial rhizopodin;2.35;CA;CALCIUM ION;ACTIN, ALPHA SKELETAL MUSCLE;9986;
2VZ1;A;Premat-galactose oxidase;1.91;CA;CALCIUM ION;GALACTOSE OXIDASE;5518;
2VZP;A;Atomic Resolution Structure of the C-terminal CBM35 from Amycolatopsis orientalis exo-chitosanase CsxA;1.05;CA;CALCIUM ION;EXO-BETA-D-GLUCOSAMINIDASE;31958;
2VZP;B;Atomic Resolution Structure of the C-terminal CBM35 from Amycolatopsis orientalis exo-chitosanase CsxA;1.05;CA;CALCIUM ION;EXO-BETA-D-GLUCOSAMINIDASE;31958;
2VZQ;A;C-terminal CBM35 from Amycolatopsis orientalis exo-chitosanase CsxA in complex with digalacturonic acid;1.7;CA;CALCIUM ION;EXO-BETA-D-GLUCOSAMINIDASE;31958;
2VZQ;B;C-terminal CBM35 from Amycolatopsis orientalis exo-chitosanase CsxA in complex with digalacturonic acid;1.7;CA;CALCIUM ION;EXO-BETA-D-GLUCOSAMINIDASE;31958;
2VZR;A;C-terminal CBM35 from Amycolatopsis orientalis exo-chitosanase CsxA in complex with glucuronic acid;1.95;CA;CALCIUM ION;EXO-BETA-D-GLUCOSAMINIDASE;31958;
2VZR;B;C-terminal CBM35 from Amycolatopsis orientalis exo-chitosanase CsxA in complex with glucuronic acid;1.95;CA;CALCIUM ION;EXO-BETA-D-GLUCOSAMINIDASE;31958;
2W08;A;The structure of serum amyloid P component bound to 0-phospho- threonine;1.7;CA;CALCIUM ION;SERUM AMYLOID P-COMPONENT;9606;
2W08;B;The structure of serum amyloid P component bound to 0-phospho- threonine;1.7;CA;CALCIUM ION;SERUM AMYLOID P-COMPONENT;9606;
2W08;C;The structure of serum amyloid P component bound to 0-phospho- threonine;1.7;CA;CALCIUM ION;SERUM AMYLOID P-COMPONENT;9606;
2W08;D;The structure of serum amyloid P component bound to 0-phospho- threonine;1.7;CA;CALCIUM ION;SERUM AMYLOID P-COMPONENT;9606;
2W08;E;The structure of serum amyloid P component bound to 0-phospho- threonine;1.7;CA;CALCIUM ION;SERUM AMYLOID P-COMPONENT;9606;
2W0C;A;X-ray structure of the entire lipid-containing bacteriophage PM2;7;CA;CALCIUM ION;MAJOR CAPSID PROTEIN P2;10661;
2W0C;B;X-ray structure of the entire lipid-containing bacteriophage PM2;7;CA;CALCIUM ION;MAJOR CAPSID PROTEIN P2;10661;
2W0C;C;X-ray structure of the entire lipid-containing bacteriophage PM2;7;CA;CALCIUM ION;MAJOR CAPSID PROTEIN P2;10661;
2W0C;D;X-ray structure of the entire lipid-containing bacteriophage PM2;7;CA;CALCIUM ION;MAJOR CAPSID PROTEIN P2;10661;
2W0C;E;X-ray structure of the entire lipid-containing bacteriophage PM2;7;CA;CALCIUM ION;MAJOR CAPSID PROTEIN P2;10661;
2W0C;F;X-ray structure of the entire lipid-containing bacteriophage PM2;7;CA;CALCIUM ION;MAJOR CAPSID PROTEIN P2;10661;
2W0C;G;X-ray structure of the entire lipid-containing bacteriophage PM2;7;CA;CALCIUM ION;MAJOR CAPSID PROTEIN P2;10661;
2W0C;H;X-ray structure of the entire lipid-containing bacteriophage PM2;7;CA;CALCIUM ION;MAJOR CAPSID PROTEIN P2;10661;
2W0C;I;X-ray structure of the entire lipid-containing bacteriophage PM2;7;CA;CALCIUM ION;MAJOR CAPSID PROTEIN P2;10661;
2W0C;J;X-ray structure of the entire lipid-containing bacteriophage PM2;7;CA;CALCIUM ION;MAJOR CAPSID PROTEIN P2;10661;
2W0C;L;X-ray structure of the entire lipid-containing bacteriophage PM2;7;CA;CALCIUM ION;PROTEIN 2;10661;
2W0D;A;Does a Fast Nuclear Magnetic Resonance Spectroscopy- and X-Ray Crystallography Hybrid Approach Provide Reliable Structural Information of Ligand-Protein Complexes? A Case Study of Metalloproteinases.;2;CA;CALCIUM ION;MACROPHAGE METALLOELASTASE;9606;
2W0D;B;Does a Fast Nuclear Magnetic Resonance Spectroscopy- and X-Ray Crystallography Hybrid Approach Provide Reliable Structural Information of Ligand-Protein Complexes? A Case Study of Metalloproteinases.;2;CA;CALCIUM ION;MACROPHAGE METALLOELASTASE;9606;
2W0D;C;Does a Fast Nuclear Magnetic Resonance Spectroscopy- and X-Ray Crystallography Hybrid Approach Provide Reliable Structural Information of Ligand-Protein Complexes? A Case Study of Metalloproteinases.;2;CA;CALCIUM ION;MACROPHAGE METALLOELASTASE;9606;
2W0D;D;Does a Fast Nuclear Magnetic Resonance Spectroscopy- and X-Ray Crystallography Hybrid Approach Provide Reliable Structural Information of Ligand-Protein Complexes? A Case Study of Metalloproteinases.;2;CA;CALCIUM ION;MACROPHAGE METALLOELASTASE;9606;
2W0Q;A;E. coli copper amine oxidase in complex with Xenon;2.48;CA;CALCIUM ION;COPPER AMINE OXIDASE;562;
2W0Q;B;E. coli copper amine oxidase in complex with Xenon;2.48;CA;CALCIUM ION;COPPER AMINE OXIDASE;562;
2W1Q;A;Unique ligand binding specificity for a family 32 Carbohydrate- Binding Module from the Mu toxin produced by Clostridium perfringens;1.6;CA;CALCIUM ION;HYALURONOGLUCOSAMINIDASE;1502;
2W1Q;B;Unique ligand binding specificity for a family 32 Carbohydrate- Binding Module from the Mu toxin produced by Clostridium perfringens;1.6;CA;CALCIUM ION;HYALURONOGLUCOSAMINIDASE;1502;
2W1S;A;Unique ligand binding specificity of a family 32 Carbohydrate-Binding Module from the Mu toxin produced by Clostridium perfringens;1.45;CA;CALCIUM ION;HYALURONOGLUCOSAMINIDASE;1502;
2W1S;B;Unique ligand binding specificity of a family 32 Carbohydrate-Binding Module from the Mu toxin produced by Clostridium perfringens;1.45;CA;CALCIUM ION;HYALURONOGLUCOSAMINIDASE;1502;
2W1U;A;A family 32 carbohydrate-binding module, from the Mu toxin produced by Clostridium perfringens, in complex with beta-D-glcNAc-beta(1,3) galNAc;2;CA;CALCIUM ION;HYALURONOGLUCOSAMINIDASE;1502;
2W1U;B;A family 32 carbohydrate-binding module, from the Mu toxin produced by Clostridium perfringens, in complex with beta-D-glcNAc-beta(1,3) galNAc;2;CA;CALCIUM ION;HYALURONOGLUCOSAMINIDASE;1502;
2W1U;C;A family 32 carbohydrate-binding module, from the Mu toxin produced by Clostridium perfringens, in complex with beta-D-glcNAc-beta(1,3) galNAc;2;CA;CALCIUM ION;HYALURONOGLUCOSAMINIDASE;1502;
2W1U;D;A family 32 carbohydrate-binding module, from the Mu toxin produced by Clostridium perfringens, in complex with beta-D-glcNAc-beta(1,3) galNAc;2;CA;CALCIUM ION;HYALURONOGLUCOSAMINIDASE;1502;
2W1W;A;Native structure of a family 35 carbohydrate binding module from Clostridium thermocellum;1.55;CA;CALCIUM ION;LIPOLYTIC ENZYME, G-D-S-L;1515;
2W1W;B;Native structure of a family 35 carbohydrate binding module from Clostridium thermocellum;1.55;CA;CALCIUM ION;LIPOLYTIC ENZYME, G-D-S-L;1515;
2W22;A;Activation Mechanism of Bacterial Thermoalkalophilic Lipases;2.2;CA;CALCIUM ION;TRIACYLGLYCEROL LIPASE;33938;
2W23;A;Structure of mutant W169Y of Pleurotus eryngii versatile peroxidase (VP);1.94;CA;CALCIUM ION;VERSATILE PEROXIDASE VPL2;5323;
2W26;A;Factor Xa in complex with BAY59-7939;2.08;CA;CALCIUM ION;ACTIVATED FACTOR XA HEAVY CHAIN;9606;
2W27;A;CRYSTAL STRUCTURE OF THE BACILLUS SUBTILIS YKUI PROTEIN, WITH AN EAL DOMAIN, IN COMPLEX WITH SUBSTRATE C-DI-GMP AND CALCIUM;2.8;CA;CALCIUM ION;YKUI PROTEIN;1423;
2W27;B;CRYSTAL STRUCTURE OF THE BACILLUS SUBTILIS YKUI PROTEIN, WITH AN EAL DOMAIN, IN COMPLEX WITH SUBSTRATE C-DI-GMP AND CALCIUM;2.8;CA;CALCIUM ION;YKUI PROTEIN;1423;
2W2M;A;WT PCSK9-DELTAC BOUND TO WT EGF-A OF LDLR;2.4;CA;CALCIUM ION;PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9;9606;
2W2M;E;WT PCSK9-DELTAC BOUND TO WT EGF-A OF LDLR;2.4;CA;CALCIUM ION;LOW-DENSITY LIPOPROTEIN RECEPTOR;9606;
2W2N;A;WT PCSK9-deltaC bound to EGF-A H306Y mutant of LDLR;2.3;CA;CALCIUM ION;PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9;9606;
2W2N;E;WT PCSK9-deltaC bound to EGF-A H306Y mutant of LDLR;2.3;CA;CALCIUM ION;LOW-DENSITY LIPOPROTEIN RECEPTOR;9606;
2W2O;E;PCSK9-deltaC D374Y mutant bound to WT EGF-A of LDLR;2.62;CA;CALCIUM ION;LOW-DENSITY LIPOPROTEIN RECEPTOR;9606;
2W2P;E;PCSK9-deltaC D374A mutant bound to WT EGF-A of LDLR;2.62;CA;CALCIUM ION;LOW-DENSITY LIPOPROTEIN RECEPTOR;9606;
2W2Q;A;PCSK9-deltaC D374H mutant bound to WT EGF-A of LDLR;2.33;CA;CALCIUM ION;PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9;9606;
2W2Q;E;PCSK9-deltaC D374H mutant bound to WT EGF-A of LDLR;2.33;CA;CALCIUM ION;LOW-DENSITY LIPOPROTEIN RECEPTOR;9606;
2W3D;A;Structure of the first GAF domain of Mycobacterium tuberculosis DosS;2;CA;CALCIUM ION;TWO COMPONENT SENSOR HISTIDINE KINASE DEVS (GAF FAMILY PROTEIN);1773;
2W3E;A;Oxidized structure of the first GAF domain of Mycobacterium tuberculosis DosS;1.6;CA;CALCIUM ION;TWO COMPONENT SENSOR HISTIDINE KINASE DEVS (GAF FAMILY PROTEIN);1773;
2W3G;A;Air-oxidized structure of the first GAF domain of Mycobacterium tuberculosis DosS;1.4;CA;CALCIUM ION;TWO COMPONENT SENSOR HISTIDINE KINASE DEVS (GAF FAMILY PROTEIN);1773;
2W3H;A;Cyanide bound structure of the first GAF domain of Mycobacterium tuberculosis DosS;1.8;CA;CALCIUM ION;TWO COMPONENT SENSOR HISTIDINE KINASE DEVS (GAF FAMILY PROTEIN);1773;
2W3I;A;Crystal Structure of FXa in complex with 4,4-disubstituted pyrrolidine-1,2-dicarboxamide inhibitor 2;1.9;CA;CALCIUM ION;COAGULATION FACTOR X, HEAVY CHAIN;9606;
2W3J;A;Structure of a family 35 carbohydrate binding module from an environmental isolate;1.7;CA;CALCIUM ION;CARBOHYDRATE BINDING MODULE;77133;
2W3K;A;Crystal Structure of FXa in complex with 4,4-disubstituted pyrrolidine-1,2-dicarboxamide inhibitor 1;2.05;CA;CALCIUM ION;COAGULATION FACTOR X, HEAVY CHAIN;9606;
2W3O;A;Crystal structure of the human PNKP FHA domain in complex with an XRCC1-derived phosphopeptide;1.85;CA;CALCIUM ION;BIFUNCTIONAL POLYNUCLEOTIDE PHOSPHATASE/KINASE;9606;
2W3O;B;Crystal structure of the human PNKP FHA domain in complex with an XRCC1-derived phosphopeptide;1.85;CA;CALCIUM ION;BIFUNCTIONAL POLYNUCLEOTIDE PHOSPHATASE/KINASE;9606;
2W3O;C;Crystal structure of the human PNKP FHA domain in complex with an XRCC1-derived phosphopeptide;1.85;CA;CALCIUM ION;DNA REPAIR PROTEIN XRCC1;9606;
2W3O;D;Crystal structure of the human PNKP FHA domain in complex with an XRCC1-derived phosphopeptide;1.85;CA;CALCIUM ION;DNA REPAIR PROTEIN XRCC1;9606;
2W3R;B;Crystal Structure of Xanthine Dehydrogenase (desulfo form) from Rhodobacter capsulatus in complex with hypoxanthine;2.9;CA;CALCIUM ION;XANTHINE DEHYDROGENASE;1061;
2W3R;D;Crystal Structure of Xanthine Dehydrogenase (desulfo form) from Rhodobacter capsulatus in complex with hypoxanthine;2.9;CA;CALCIUM ION;XANTHINE DEHYDROGENASE;1061;
2W3R;F;Crystal Structure of Xanthine Dehydrogenase (desulfo form) from Rhodobacter capsulatus in complex with hypoxanthine;2.9;CA;CALCIUM ION;XANTHINE DEHYDROGENASE;1061;
2W3R;H;Crystal Structure of Xanthine Dehydrogenase (desulfo form) from Rhodobacter capsulatus in complex with hypoxanthine;2.9;CA;CALCIUM ION;XANTHINE DEHYDROGENASE;1061;
2W3S;B;Crystal Structure of Xanthine Dehydrogenase (desulfo form) from Rhodobacter capsulatus in Complex with Xanthine;2.6;CA;CALCIUM ION;XANTHINE DEHYDROGENASE;1061;
2W3S;D;Crystal Structure of Xanthine Dehydrogenase (desulfo form) from Rhodobacter capsulatus in Complex with Xanthine;2.6;CA;CALCIUM ION;XANTHINE DEHYDROGENASE;1061;
2W3S;F;Crystal Structure of Xanthine Dehydrogenase (desulfo form) from Rhodobacter capsulatus in Complex with Xanthine;2.6;CA;CALCIUM ION;XANTHINE DEHYDROGENASE;1061;
2W3S;H;Crystal Structure of Xanthine Dehydrogenase (desulfo form) from Rhodobacter capsulatus in Complex with Xanthine;2.6;CA;CALCIUM ION;XANTHINE DEHYDROGENASE;1061;
2W46;A;CBM35 from Cellvibrio japonicus Abf62;1.9;CA;CALCIUM ION;ESTERASE D;155077;
2W46;B;CBM35 from Cellvibrio japonicus Abf62;1.9;CA;CALCIUM ION;ESTERASE D;155077;
2W47;A;Clostridium thermocellum CBM35 in complex with delta-4,5- anhydrogalacturonic acid;1.4;CA;CALCIUM ION;LIPOLYTIC ENZYME, G-D-S-L;1515;
2W49;0;ISOMETRICALLY CONTRACTING INSECT ASYNCHRONOUS FLIGHT MUSCLE;;CA;CALCIUM ION;TROPONIN C, SKELETAL MUSCLE;9031;
2W49;3;ISOMETRICALLY CONTRACTING INSECT ASYNCHRONOUS FLIGHT MUSCLE;;CA;CALCIUM ION;TROPONIN C, SKELETAL MUSCLE;9031;
2W49;6;ISOMETRICALLY CONTRACTING INSECT ASYNCHRONOUS FLIGHT MUSCLE;;CA;CALCIUM ION;TROPONIN C, SKELETAL MUSCLE;9031;
2W49;9;ISOMETRICALLY CONTRACTING INSECT ASYNCHRONOUS FLIGHT MUSCLE;;CA;CALCIUM ION;TROPONIN C, SKELETAL MUSCLE;9031;
2W4X;A;BtGH84 in complex with STZ;2.42;CA;CALCIUM ION;O-GLCNACASE BT_4395;818;
2W4Y;A;Caulobacter bacteriophage 5 - virus-like particle;2.9;CA;CALCIUM ION;CAULOBACTER 5 VIRUS-LIKE PARTICLE;39802;
2W4Y;B;Caulobacter bacteriophage 5 - virus-like particle;2.9;CA;CALCIUM ION;CAULOBACTER 5 VIRUS-LIKE PARTICLE;39802;
2W4Y;C;Caulobacter bacteriophage 5 - virus-like particle;2.9;CA;CALCIUM ION;CAULOBACTER 5 VIRUS-LIKE PARTICLE;39802;
2W4Z;A;Caulobacter bacteriophage 5;3.6;CA;CALCIUM ION;CAULOBACTER BACTERIOPHAGE 5;39802;
2W4Z;B;Caulobacter bacteriophage 5;3.6;CA;CALCIUM ION;CAULOBACTER BACTERIOPHAGE 5;39802;
2W4Z;C;Caulobacter bacteriophage 5;3.6;CA;CALCIUM ION;CAULOBACTER BACTERIOPHAGE 5;39802;
2W66;A;BtGH84 in complex with HQ602;2.27;CA;CALCIUM ION;O-GLCNACASE BT_4395;818;
2W66;B;BtGH84 in complex with HQ602;2.27;CA;CALCIUM ION;O-GLCNACASE BT_4395;818;
2W67;A;BtGH84 in complex with FMA34;2.25;CA;CALCIUM ION;O-GLCNACASE BT_4395;818;
2W67;B;BtGH84 in complex with FMA34;2.25;CA;CALCIUM ION;O-GLCNACASE BT_4395;818;
2W68;A;ENHANCING THE RECEPTOR AFFINITY OF THE SIALIC ACID-BINDING DOMAIN OF VIBRIO CHOLERAE SIALIDASE THROUGH MULTIVALENCY;2.5;CA;CALCIUM ION;SIALIDASE;666;
2W73;A;High-resolution structure of the complex between calmodulin and a peptide from calcineurin A;1.45;CA;CALCIUM ION;CALMODULIN;9606;
2W73;B;High-resolution structure of the complex between calmodulin and a peptide from calcineurin A;1.45;CA;CALCIUM ION;CALMODULIN;9606;
2W73;E;High-resolution structure of the complex between calmodulin and a peptide from calcineurin A;1.45;CA;CALCIUM ION;CALMODULIN;9606;
2W73;F;High-resolution structure of the complex between calmodulin and a peptide from calcineurin A;1.45;CA;CALCIUM ION;CALMODULIN;9606;
2W7O;A;Structure and Activity of Bypass Synthesis by Human DNA Polymerase Kappa Opposite the 7,8-Dihydro-8-oxodeoxyguanosine Adduct;3.16;CA;CALCIUM ION;DNA POLYMERASE KAPPA;9606;
2W7O;B;Structure and Activity of Bypass Synthesis by Human DNA Polymerase Kappa Opposite the 7,8-Dihydro-8-oxodeoxyguanosine Adduct;3.16;CA;CALCIUM ION;DNA POLYMERASE KAPPA;9606;
2W7P;A;Structure and Activity of Bypass Synthesis by Human DNA Polymerase Kappa Opposite the 7,8-Dihydro-8-oxodeoxyguanosine Adduct;3.71;CA;CALCIUM ION;DNA POLYMERASE KAPPA;9606;
2W7P;B;Structure and Activity of Bypass Synthesis by Human DNA Polymerase Kappa Opposite the 7,8-Dihydro-8-oxodeoxyguanosine Adduct;3.71;CA;CALCIUM ION;DNA POLYMERASE KAPPA;9606;
2W86;A;Crystal structure of fibrillin-1 domains cbEGF9hyb2cbEGF10, calcium saturated form;1.8;CA;CALCIUM ION;FIBRILLIN-1;9606;
2W87;A;Xyl-CBM35 in complex with glucuronic acid containing disaccharide.;1.6;CA;CALCIUM ION;ESTERASE D;155077;
2W87;B;Xyl-CBM35 in complex with glucuronic acid containing disaccharide.;1.6;CA;CALCIUM ION;ESTERASE D;155077;
2W94;A;Native structure of the Discoidin I from Dictyostelium discoideum at 1.8 angstrom resolution;1.8;CA;CALCIUM ION;DISCOIDIN-1 SUBUNIT A;44689;
2W94;B;Native structure of the Discoidin I from Dictyostelium discoideum at 1.8 angstrom resolution;1.8;CA;CALCIUM ION;DISCOIDIN-1 SUBUNIT A;44689;
2W94;C;Native structure of the Discoidin I from Dictyostelium discoideum at 1.8 angstrom resolution;1.8;CA;CALCIUM ION;DISCOIDIN-1 SUBUNIT A;44689;
2W95;A;STructure of the Discoidin I from Dictyostelium discoideum in complex with GalNAc at 1.75 angstrom resolution;1.75;CA;CALCIUM ION;DISCOIDIN-1 SUBUNIT A;44689;
2W95;B;STructure of the Discoidin I from Dictyostelium discoideum in complex with GalNAc at 1.75 angstrom resolution;1.75;CA;CALCIUM ION;DISCOIDIN-1 SUBUNIT A;44689;
2W95;C;STructure of the Discoidin I from Dictyostelium discoideum in complex with GalNAc at 1.75 angstrom resolution;1.75;CA;CALCIUM ION;DISCOIDIN-1 SUBUNIT A;44689;
2W9D;H;Structure of Fab fragment of the ICSM 18 - anti-Prp therapeutic antibody at 1.57 A resolution.;1.57;CA;CALCIUM ION;ICSM 18-ANTI-PRP THERAPEUTIC FAB HEAVY CHAIN;10090;
2WBF;X;Crystal Structure Analysis of SERA5E from plasmodium falciparum with loop 690-700 ordered;1.6;CA;CALCIUM ION;SERINE-REPEAT ANTIGEN PROTEIN;5833;
2WBW;B;Ad37 fibre head in complex with CAR D1 and sialic acid;1.55;CA;CALCIUM ION;COXSACKIEVIRUS AND ADENOVIRUS RECEPTOR;9606;
2WBX;A;Crystal structure of mouse cadherin-23 EC1;1.5;CA;CALCIUM ION;CADHERIN-23;10090;
2WC4;C;Structure of family 1 beta-glucosidase from Thermotoga maritima in complex with 3-imino-2-thia-(+)-castanospermine;1.7;CA;CALCIUM ION;BETA-GLUCOSIDASE A;2336;
2WC4;D;Structure of family 1 beta-glucosidase from Thermotoga maritima in complex with 3-imino-2-thia-(+)-castanospermine;1.7;CA;CALCIUM ION;BETA-GLUCOSIDASE A;2336;
2WCA;A;BtGH84 in complex with n-butyl pugnac;2.3;CA;CALCIUM ION;O-GLCNACASE BT_4395;818;
2WCP;A;CRYSTAL STRUCTURE OF MOUSE CADHERIN-23 EC1-2;1.98;CA;CALCIUM ION;CADHERIN-23;10090;
2WD0;A;CRYSTAL STRUCTURE OF NONSYNDROMIC DEAFNESS (DFNB12) ASSOCIATED MUTANT D124G OF MOUSE CADHERIN-23 EC1-2;2.74;CA;CALCIUM ION;CADHERIN-23;10090;
2WD0;C;CRYSTAL STRUCTURE OF NONSYNDROMIC DEAFNESS (DFNB12) ASSOCIATED MUTANT D124G OF MOUSE CADHERIN-23 EC1-2;2.74;CA;CALCIUM ION;CADHERIN-23;10090;
2WD6;A;Crystal structure of the Variable Domain of the Streptococcus gordonii Surface Protein SspB;2.3;CA;CALCIUM ION;AGGLUTININ RECEPTOR;1302;
2WD6;B;Crystal structure of the Variable Domain of the Streptococcus gordonii Surface Protein SspB;2.3;CA;CALCIUM ION;AGGLUTININ RECEPTOR;1302;
2WDB;A;A family 32 carbohydrate-binding module, from the Mu toxin produced by Clostridium perfringens, in complex with beta-D-glcNAc-beta(1,2) mannose;2.03;CA;CALCIUM ION;HYALURONOGLUCOSAMINIDASE;1502;
2WDB;B;A family 32 carbohydrate-binding module, from the Mu toxin produced by Clostridium perfringens, in complex with beta-D-glcNAc-beta(1,2) mannose;2.03;CA;CALCIUM ION;HYALURONOGLUCOSAMINIDASE;1502;
2WDB;C;A family 32 carbohydrate-binding module, from the Mu toxin produced by Clostridium perfringens, in complex with beta-D-glcNAc-beta(1,2) mannose;2.03;CA;CALCIUM ION;HYALURONOGLUCOSAMINIDASE;1502;
2WDB;D;A family 32 carbohydrate-binding module, from the Mu toxin produced by Clostridium perfringens, in complex with beta-D-glcNAc-beta(1,2) mannose;2.03;CA;CALCIUM ION;HYALURONOGLUCOSAMINIDASE;1502;
2WEL;D;Crystal structure of SU6656-bound calcium/calmodulin-dependent protein kinase II delta in complex with calmodulin;1.9;CA;CALCIUM ION;CALMODULIN;9606;
2WFK;A;Calcium bound LipL32;2.3;CA;CALCIUM ION;LIPL32;28183;
2WFK;B;Calcium bound LipL32;2.3;CA;CALCIUM ION;LIPL32;28183;
2WFK;C;Calcium bound LipL32;2.3;CA;CALCIUM ION;LIPL32;28183;
2WFK;D;Calcium bound LipL32;2.3;CA;CALCIUM ION;LIPL32;28183;
2WFK;E;Calcium bound LipL32;2.3;CA;CALCIUM ION;LIPL32;28183;
2WFR;A;Crystal structure of the N-terminal signalling domain of human Dhh with calcium;1.95;CA;CALCIUM ION;DESERT HEDGEHOG PROTEIN N-PRODUCT;9606;
2WFX;A;Crystal structure of the complex between human hedgehog-interacting protein HIP and Sonic Hedgehog in the presence of calcium;3.2;CA;CALCIUM ION;SONIC HEDGEHOG PROTEIN N-PRODUCT;10090;
2WFX;B;Crystal structure of the complex between human hedgehog-interacting protein HIP and Sonic Hedgehog in the presence of calcium;3.2;CA;CALCIUM ION;HEDGEHOG-INTERACTING PROTEIN;9606;
2WG7;A;Structure of Oryza Sativa (Rice) PLA2;2;CA;CALCIUM ION;PUTATIVE PHOSPHOLIPASE A2;4530;
2WG7;B;Structure of Oryza Sativa (Rice) PLA2;2;CA;CALCIUM ION;PUTATIVE PHOSPHOLIPASE A2;4530;
2WG8;A;Structure of Oryza Sativa (Rice) PLA2, orthorhombic crystal form;2.3;CA;CALCIUM ION;PUTATIVE PHOSPHOLIPASE A2;4530;
2WG8;B;Structure of Oryza Sativa (Rice) PLA2, orthorhombic crystal form;2.3;CA;CALCIUM ION;PUTATIVE PHOSPHOLIPASE A2;4530;
2WG8;C;Structure of Oryza Sativa (Rice) PLA2, orthorhombic crystal form;2.3;CA;CALCIUM ION;PUTATIVE PHOSPHOLIPASE A2;4530;
2WG9;A;Structure of Oryza Sativa (Rice) PLA2, complex with octanoic acid;2;CA;CALCIUM ION;PUTATIVE PHOSPHOLIPASE A2;4530;
2WG9;B;Structure of Oryza Sativa (Rice) PLA2, complex with octanoic acid;2;CA;CALCIUM ION;PUTATIVE PHOSPHOLIPASE A2;4530;
2WGQ;A;Zinc substituted E Coli Copper Amine Oxidase, a model for the precursor for 2,4,5-trihydroxyphenylalaninequinone formation;2.5;CA;CALCIUM ION;AMINE OXIDASE;562;
2WGQ;B;Zinc substituted E Coli Copper Amine Oxidase, a model for the precursor for 2,4,5-trihydroxyphenylalaninequinone formation;2.5;CA;CALCIUM ION;AMINE OXIDASE;562;
2WH0;D;Recognition of an intrachain tandem 14-3-3 binding site within protein kinase C epsilon;2.25;CA;CALCIUM ION;14-3-3 PROTEIN ZETA/DELTA;9606;
2WHK;A;Structure of Bacillus subtilis mannanase man26;1.7;CA;CALCIUM ION;MANNAN ENDO-1,4-BETA-MANNOSIDASE;1423;
2WHV;A;CRYSTAL STRUCTURE OF MOUSE CADHERIN-23 EC1-2 (ALL CATION BINDING SITES OCCUPIED BY CALCIUM);2.36;CA;CALCIUM ION;CADHERIN-23;10090;
2WHZ;A;Dipeptide Inhibitors of Thermolysin;1.75;CA;CALCIUM ION;THERMOLYSIN;1427;
2WI0;A;Dipeptide Inhibitors of Thermolysin;1.95;CA;CALCIUM ION;THERMOLYSIN;1427;
2WII;A;Complement C3b in complex with factor H domains 1-4;2.7;CA;CALCIUM ION;COMPLEMENT C3 BETA CHAIN;9606;
2WIM;A;Crystal structure of NCAM2 IG1-3;3;CA;CALCIUM ION;NEURAL CELL ADHESION MOLECULE 2;9606;
2WJS;A;Crystal structure of the LG1-3 region of the laminin alpha2 chain;2.8;CA;CALCIUM ION;LAMININ SUBUNIT ALPHA-2;10090;
2WKP;A;Structure of a photoactivatable Rac1 containing Lov2 Wildtype;1.9;CA;CALCIUM ION;NPH1-1, RAS-RELATED C3 BOTULINUM TOXIN SUBSTRATE 1;44,989,606;
2WL3;A;crystal structure of catechol 2,3-dioxygenase;2.2;CA;CALCIUM ION;CATECHOL 2,3-DIOXYGENASE;186196;
2WLJ;A;Potassium channel from Magnetospirillum magnetotacticum;2.6;CA;CALCIUM ION;POTASSIUM CHANNEL;188;
2WM4;A;X-ray structure of Mycobacterium tuberculosis cytochrome P450 CYP124 in complex with phytanic acid;2.11;CA;CALCIUM ION;PUTATIVE CYTOCHROME P450 124;1773;
2WN2;A;Structure of the discoidin I from Dictyostelium discoideum in complex with galactose beta 1-3 galNAc at 1.8 A resolution.;1.82;CA;CALCIUM ION;DISCOIDIN-1 SUBUNIT A;44689;
2WN2;B;Structure of the discoidin I from Dictyostelium discoideum in complex with galactose beta 1-3 galNAc at 1.8 A resolution.;1.82;CA;CALCIUM ION;DISCOIDIN-1 SUBUNIT A;44689;
2WN2;C;Structure of the discoidin I from Dictyostelium discoideum in complex with galactose beta 1-3 galNAc at 1.8 A resolution.;1.82;CA;CALCIUM ION;DISCOIDIN-1 SUBUNIT A;44689;
2WN3;A;Crystal structure of Discoidin I from Dictyostelium discoideum in complex with the disaccharide GalNAc beta 1-3 galactose, at 1.6 A resolution.;1.59;CA;CALCIUM ION;DISCOIDIN-1 SUBUNIT A;44689;
2WN3;B;Crystal structure of Discoidin I from Dictyostelium discoideum in complex with the disaccharide GalNAc beta 1-3 galactose, at 1.6 A resolution.;1.59;CA;CALCIUM ION;DISCOIDIN-1 SUBUNIT A;44689;
2WN3;C;Crystal structure of Discoidin I from Dictyostelium discoideum in complex with the disaccharide GalNAc beta 1-3 galactose, at 1.6 A resolution.;1.59;CA;CALCIUM ION;DISCOIDIN-1 SUBUNIT A;44689;
2WND;A;Structure of an S100A7 triple mutant;1.6;CA;CALCIUM ION;PROTEIN S100-A7;9606;
2WNO;A;X-ray Structure of CUB_C domain from TSG-6;2.3;CA;CALCIUM ION;TUMOR NECROSIS FACTOR-INDUCIBLE GENE 6 PROTEIN;9606;
2WNP;F;M-ficolin mutant Y271F;1.21;CA;CALCIUM ION;FICOLIN-1;9606;
2WNV;B;Complex between C1q globular heads and deoxyribose;1.25;CA;CALCIUM ION;COMPLEMENT C1Q SUBCOMPONENT SUBUNIT B;9606;
2WNV;E;Complex between C1q globular heads and deoxyribose;1.25;CA;CALCIUM ION;COMPLEMENT C1Q SUBCOMPONENT SUBUNIT B;9606;
2WNX;A;3b' carbohydrate-binding module from the Cel9V glycoside hydrolase from Clostridium thermocellum;1.31;CA;CALCIUM ION;GLYCOSIDE HYDROLASE, FAMILY 9;1515;
2WO4;A;3b' carbohydrate-binding module from the Cel9V glycoside hydrolase from Clostridium thermocellum, in-house data;1.85;CA;CALCIUM ION;GLYCOSIDE HYDROLASE, FAMILY 9;1515;
2WO8;A;MMP12 complex with a beta hydroxy carboxylic acid;2;CA;CALCIUM ION;MACROPHAGE METALLOELASTASE;9606;
2WO8;B;MMP12 complex with a beta hydroxy carboxylic acid;2;CA;CALCIUM ION;MACROPHAGE METALLOELASTASE;9606;
2WO8;C;MMP12 complex with a beta hydroxy carboxylic acid;2;CA;CALCIUM ION;MACROPHAGE METALLOELASTASE;9606;
2WO8;D;MMP12 complex with a beta hydroxy carboxylic acid;2;CA;CALCIUM ION;MACROPHAGE METALLOELASTASE;9606;
2WO9;A;MMP12 complex with a beta hydroxy carboxylic acid;1.7;CA;CALCIUM ION;MACROPHAGE METALLOELASTASE;9606;
2WO9;B;MMP12 complex with a beta hydroxy carboxylic acid;1.7;CA;CALCIUM ION;MACROPHAGE METALLOELASTASE;9606;
2WO9;C;MMP12 complex with a beta hydroxy carboxylic acid;1.7;CA;CALCIUM ION;MACROPHAGE METALLOELASTASE;9606;
2WO9;D;MMP12 complex with a beta hydroxy carboxylic acid;1.7;CA;CALCIUM ION;MACROPHAGE METALLOELASTASE;9606;
2WOA;A;MMP12 complex with a beta hydroxy carboxylic acid;2.3;CA;CALCIUM ION;MACROPHAGE METALLOELASTASE;9606;
2WOA;B;MMP12 complex with a beta hydroxy carboxylic acid;2.3;CA;CALCIUM ION;MACROPHAGE METALLOELASTASE;9606;
2WOA;C;MMP12 complex with a beta hydroxy carboxylic acid;2.3;CA;CALCIUM ION;MACROPHAGE METALLOELASTASE;9606;
2WOA;D;MMP12 complex with a beta hydroxy carboxylic acid;2.3;CA;CALCIUM ION;MACROPHAGE METALLOELASTASE;9606;
2WOB;A;3b' carbohydrate-binding module from the Cel9V glycoside hydrolase from Clostridium thermocellum. Orthorhombic structure;2;CA;CALCIUM ION;GLYCOSIDE HYDROLASE, FAMILY 9;1515;
2WOB;C;3b' carbohydrate-binding module from the Cel9V glycoside hydrolase from Clostridium thermocellum. Orthorhombic structure;2;CA;CALCIUM ION;GLYCOSIDE HYDROLASE, FAMILY 9;1515;
2WOB;E;3b' carbohydrate-binding module from the Cel9V glycoside hydrolase from Clostridium thermocellum. Orthorhombic structure;2;CA;CALCIUM ION;GLYCOSIDE HYDROLASE, FAMILY 9;1515;
2WOH;A;Strontium soaked E. coli copper amine oxidase;2.7;CA;CALCIUM ION;PRIMARY AMINE OXIDASE;562;
2WOH;B;Strontium soaked E. coli copper amine oxidase;2.7;CA;CALCIUM ION;PRIMARY AMINE OXIDASE;562;
2WOR;A;co-structure of S100A7 with 1,8 ANS;1.7;CA;CALCIUM ION;PROTEIN S100-A7;9606;
2WOS;A;Structure of human S100A7 in complex with 2,6 ANS;1.7;CA;CALCIUM ION;PROTEIN S100-A7;9606;
2WOY;A;Crystal structure of the C-terminal domain of Streptococcus gordonii surface protein SspB;1.5;CA;CALCIUM ION;AGGLUTININ RECEPTOR;1302;
2WP4;B;crystal structure of Rv3119 from Mycobacterium tuberculosis;2.49;CA;CALCIUM ION;MOLYBDOPTERIN-CONVERTING FACTOR SUBUNIT 2 1;1773;
2WPH;S;factor IXa superactive triple mutant;1.5;CA;CALCIUM ION;COAGULATION FACTOR IXA HEAVY CHAIN;9606;
2WPI;S;factor IXa superactive double mutant;1.99;CA;CALCIUM ION;COAGULATION FACTOR IXA HEAVY CHAIN;9606;
2WPJ;S;factor IXa superactive triple mutant, NaCl-soaked;1.6;CA;CALCIUM ION;COAGULATION FACTOR IXA HEAVY CHAIN;9606;
2WPK;S;factor IXa superactive triple mutant, ethylene glycol-soaked;2.21;CA;CALCIUM ION;COAGULATION FACTOR IXA HEAVY CHAIN;9606;
2WPM;S;factor IXa superactive mutant, EGR-CMK inhibited;2;CA;CALCIUM ION;COAGULATION FACTOR IXA HEAVY CHAIN;9606;
2WQ5;A;Non-antibiotic properties of tetracyclines: structural basis for inhibition of secretory phospholipase A2.;1.65;CA;CALCIUM ION;PHOSPHOLIPASE A2, ACIDIC;35670;
2WQ8;A;Glycan labelling using engineered variants of galactose oxidase obtained by directed evolution;2.19;CA;CALCIUM ION;GALACTOSE OXIDASE;5518;
2WQD;A;Crystal structure of enzyme I of the phosphoenolpyruvate:sugar phosphotransferase system in the dephosphorylated state;2.4;CA;CALCIUM ION;PHOSPHOENOLPYRUVATE-PROTEIN PHOSPHOTRANSFERASE;1280;
2WQS;A;Crystal structure of the C-terminal domain of Streptococcus gordonii surface protein SspB;1.7;CA;CALCIUM ION;AGGLUTININ RECEPTOR;1302;
2WQZ;C;Crystal structure of synaptic protein neuroligin-4 in complex with neurexin-beta 1: alternative refinement;3.9;CA;CALCIUM ION;NEUREXIN-1-BETA;10116;
2WQZ;D;Crystal structure of synaptic protein neuroligin-4 in complex with neurexin-beta 1: alternative refinement;3.9;CA;CALCIUM ION;NEUREXIN-1-BETA;10116;
2WR9;A;CRYSTAL STRUCTURE OF BURKHOLDERIA CENOCEPACIA LECTIN (BCLA) COMPLEXED WITH AMAN1-3MAN DISACCHARIDE;1.75;CA;CALCIUM ION;LECTIN;95486;
2WR9;B;CRYSTAL STRUCTURE OF BURKHOLDERIA CENOCEPACIA LECTIN (BCLA) COMPLEXED WITH AMAN1-3MAN DISACCHARIDE;1.75;CA;CALCIUM ION;LECTIN;95486;
2WR9;C;CRYSTAL STRUCTURE OF BURKHOLDERIA CENOCEPACIA LECTIN (BCLA) COMPLEXED WITH AMAN1-3MAN DISACCHARIDE;1.75;CA;CALCIUM ION;LECTIN;95486;
2WR9;D;CRYSTAL STRUCTURE OF BURKHOLDERIA CENOCEPACIA LECTIN (BCLA) COMPLEXED WITH AMAN1-3MAN DISACCHARIDE;1.75;CA;CALCIUM ION;LECTIN;95486;
2WRA;A;BclA lectin from Burkholderia cenocepacia complexed with aMan1(aMan1- 6)-3Man trisaccharide;1.1;CA;CALCIUM ION;LECTIN;95486;
2WTF;A;DNA polymerase eta in complex with the cis-diammineplatinum (II) 1,3- GTG intrastrand cross-link;2.5;CA;CALCIUM ION;DNA POLYMERASE ETA;4932;
2WTF;B;DNA polymerase eta in complex with the cis-diammineplatinum (II) 1,3- GTG intrastrand cross-link;2.5;CA;CALCIUM ION;DNA POLYMERASE ETA;4932;
2WUV;A;Crystallographic analysis of counter-ion effects on subtilisin enzymatic action in acetonitrile;2.24;CA;CALCIUM ION;SUBTILISIN CARLSBERG;1402;
2WUW;E;Crystallographic analysis of counter-ion effects on subtilisin enzymatic action in acetonitrile (native data);2.23;CA;CALCIUM ION;SUBTILISIN CARLSBERG;1402;
2WVX;A;Structure of the Family GH92 Inverting Mannosidase BT3990 from Bacteroides thetaiotaomicron VPI-5482;1.9;CA;CALCIUM ION;PUTATIVE ALPHA-1,2-MANNOSIDASE;818;
2WVX;B;Structure of the Family GH92 Inverting Mannosidase BT3990 from Bacteroides thetaiotaomicron VPI-5482;1.9;CA;CALCIUM ION;PUTATIVE ALPHA-1,2-MANNOSIDASE;818;
2WVX;C;Structure of the Family GH92 Inverting Mannosidase BT3990 from Bacteroides thetaiotaomicron VPI-5482;1.9;CA;CALCIUM ION;PUTATIVE ALPHA-1,2-MANNOSIDASE;818;
2WVX;D;Structure of the Family GH92 Inverting Mannosidase BT3990 from Bacteroides thetaiotaomicron VPI-5482;1.9;CA;CALCIUM ION;PUTATIVE ALPHA-1,2-MANNOSIDASE;818;
2WVZ;A;Structure of the Family GH92 Inverting Mannosidase BT3990 from Bacteroides thetaiotaomicron VPI-5482;2.4;CA;CALCIUM ION;PUTATIVE ALPHA-1,2-MANNOSIDASE;818;
2WVZ;B;Structure of the Family GH92 Inverting Mannosidase BT3990 from Bacteroides thetaiotaomicron VPI-5482;2.4;CA;CALCIUM ION;PUTATIVE ALPHA-1,2-MANNOSIDASE;818;
2WVZ;C;Structure of the Family GH92 Inverting Mannosidase BT3990 from Bacteroides thetaiotaomicron VPI-5482;2.4;CA;CALCIUM ION;PUTATIVE ALPHA-1,2-MANNOSIDASE;818;
2WVZ;D;Structure of the Family GH92 Inverting Mannosidase BT3990 from Bacteroides thetaiotaomicron VPI-5482;2.4;CA;CALCIUM ION;PUTATIVE ALPHA-1,2-MANNOSIDASE;818;
2WW0;A;Structure of the Family GH92 Inverting Mannosidase BT3990 from Bacteroides thetaiotaomicron VPI-5482;2.8;CA;CALCIUM ION;PUTATIVE ALPHA-1,2-MANNOSIDASE;818;
2WW0;B;Structure of the Family GH92 Inverting Mannosidase BT3990 from Bacteroides thetaiotaomicron VPI-5482;2.8;CA;CALCIUM ION;PUTATIVE ALPHA-1,2-MANNOSIDASE;818;
2WW0;C;Structure of the Family GH92 Inverting Mannosidase BT3990 from Bacteroides thetaiotaomicron VPI-5482;2.8;CA;CALCIUM ION;PUTATIVE ALPHA-1,2-MANNOSIDASE;818;
2WW0;D;Structure of the Family GH92 Inverting Mannosidase BT3990 from Bacteroides thetaiotaomicron VPI-5482;2.8;CA;CALCIUM ION;PUTATIVE ALPHA-1,2-MANNOSIDASE;818;
2WW0;E;Structure of the Family GH92 Inverting Mannosidase BT3990 from Bacteroides thetaiotaomicron VPI-5482;2.8;CA;CALCIUM ION;PUTATIVE ALPHA-1,2-MANNOSIDASE;818;
2WW0;F;Structure of the Family GH92 Inverting Mannosidase BT3990 from Bacteroides thetaiotaomicron VPI-5482;2.8;CA;CALCIUM ION;PUTATIVE ALPHA-1,2-MANNOSIDASE;818;
2WW0;G;Structure of the Family GH92 Inverting Mannosidase BT3990 from Bacteroides thetaiotaomicron VPI-5482;2.8;CA;CALCIUM ION;PUTATIVE ALPHA-1,2-MANNOSIDASE;818;
2WW0;H;Structure of the Family GH92 Inverting Mannosidase BT3990 from Bacteroides thetaiotaomicron VPI-5482;2.8;CA;CALCIUM ION;PUTATIVE ALPHA-1,2-MANNOSIDASE;818;
2WW3;A;Structure of the Family GH92 Inverting Mannosidase BT3990 from Bacteroides thetaiotaomicron VPI-5482 in complex with thiomannobioside;2.1;CA;CALCIUM ION;PUTATIVE ALPHA-1,2-MANNOSIDASE;818;
2WW3;B;Structure of the Family GH92 Inverting Mannosidase BT3990 from Bacteroides thetaiotaomicron VPI-5482 in complex with thiomannobioside;2.1;CA;CALCIUM ION;PUTATIVE ALPHA-1,2-MANNOSIDASE;818;
2WW3;C;Structure of the Family GH92 Inverting Mannosidase BT3990 from Bacteroides thetaiotaomicron VPI-5482 in complex with thiomannobioside;2.1;CA;CALCIUM ION;PUTATIVE ALPHA-1,2-MANNOSIDASE;818;
2WW3;D;Structure of the Family GH92 Inverting Mannosidase BT3990 from Bacteroides thetaiotaomicron VPI-5482 in complex with thiomannobioside;2.1;CA;CALCIUM ION;PUTATIVE ALPHA-1,2-MANNOSIDASE;818;
2WW3;E;Structure of the Family GH92 Inverting Mannosidase BT3990 from Bacteroides thetaiotaomicron VPI-5482 in complex with thiomannobioside;2.1;CA;CALCIUM ION;PUTATIVE ALPHA-1,2-MANNOSIDASE;818;
2WW3;F;Structure of the Family GH92 Inverting Mannosidase BT3990 from Bacteroides thetaiotaomicron VPI-5482 in complex with thiomannobioside;2.1;CA;CALCIUM ION;PUTATIVE ALPHA-1,2-MANNOSIDASE;818;
2WW8;A;Structure of the pilus adhesin (RrgA) from Streptococcus pneumoniae;1.9;CA;CALCIUM ION;CELL WALL SURFACE ANCHOR FAMILY PROTEIN;1313;
2WXT;A;Clostridium perfringens alpha-toxin strain NCTC8237;2;CA;CALCIUM ION;PHOSPHOLIPASE C;1502;
2WXU;A;Clostridium perfringens alpha-toxin strain NCTC8237 mutant T74I;1.8;CA;CALCIUM ION;PHOSPHOLIPASE C;1502;
2WY6;A;Clostridium perfringens alpha-toxin strain NCTC8237 mutant T74I;3.2;CA;CALCIUM ION;PHOSPHOLIPASE C;1502;
2WY6;B;Clostridium perfringens alpha-toxin strain NCTC8237 mutant T74I;3.2;CA;CALCIUM ION;PHOSPHOLIPASE C;1502;
2WY6;C;Clostridium perfringens alpha-toxin strain NCTC8237 mutant T74I;3.2;CA;CALCIUM ION;PHOSPHOLIPASE C;1502;
2WYF;A;Crystal structure of PA-IL lectin complexed with aGal12bGal-O-Met at 2.4 A resolution;2.4;CA;CALCIUM ION;PA-I GALACTOPHILIC LECTIN;287;
2WYF;B;Crystal structure of PA-IL lectin complexed with aGal12bGal-O-Met at 2.4 A resolution;2.4;CA;CALCIUM ION;PA-I GALACTOPHILIC LECTIN;287;
2WYF;C;Crystal structure of PA-IL lectin complexed with aGal12bGal-O-Met at 2.4 A resolution;2.4;CA;CALCIUM ION;PA-I GALACTOPHILIC LECTIN;287;
2WYF;D;Crystal structure of PA-IL lectin complexed with aGal12bGal-O-Met at 2.4 A resolution;2.4;CA;CALCIUM ION;PA-I GALACTOPHILIC LECTIN;287;
2WYF;E;Crystal structure of PA-IL lectin complexed with aGal12bGal-O-Met at 2.4 A resolution;2.4;CA;CALCIUM ION;PA-I GALACTOPHILIC LECTIN;287;
2WYF;F;Crystal structure of PA-IL lectin complexed with aGal12bGal-O-Met at 2.4 A resolution;2.4;CA;CALCIUM ION;PA-I GALACTOPHILIC LECTIN;287;
2WYF;G;Crystal structure of PA-IL lectin complexed with aGal12bGal-O-Met at 2.4 A resolution;2.4;CA;CALCIUM ION;PA-I GALACTOPHILIC LECTIN;287;
2WYF;H;Crystal structure of PA-IL lectin complexed with aGal12bGal-O-Met at 2.4 A resolution;2.4;CA;CALCIUM ION;PA-I GALACTOPHILIC LECTIN;287;
2WYN;A;Structure of family 37 trehalase from Escherichia coli in complex with a casuarine-6-O-a-D-glucoside analogue;2.1;CA;CALCIUM ION;PERIPLASMIC TREHALASE;562;
2WYS;A;High resolution crystallographic structure of the Clostridium thermocellum N-terminal endo-1,4-beta-D-xylanase 10B (Xyn10B) CBM22-1- GH10 modules complexed with xylohexaose;2.75;CA;CALCIUM ION;ENDO-1,4-BETA-XYLANASE Y;1515;
2WYS;B;High resolution crystallographic structure of the Clostridium thermocellum N-terminal endo-1,4-beta-D-xylanase 10B (Xyn10B) CBM22-1- GH10 modules complexed with xylohexaose;2.75;CA;CALCIUM ION;ENDO-1,4-BETA-XYLANASE Y;1515;
2WZ8;A;Family 35 carbohydrate binding module from Clostridium thermocellum;1.5;CA;CALCIUM ION;CELLULOSOME PROTEIN DOCKERIN TYPE I;1515;
2WZA;A;Two intramolecular isopeptide bonds are identified in the crystal structure of the Streptococcus gordonii SspB C-terminal domain;2.08;CA;CALCIUM ION;AGGLUTININ RECEPTOR;1302;
2WZE;A;High resolution crystallographic structure of the Clostridium thermocellum N-terminal endo-1,4-beta-D-xylanase 10B (Xyn10B) CBM22-1- GH10 modules complexed with xylohexaose;2.5;CA;CALCIUM ION;ENDO-1,4-BETA-XYLANASE Y;1515;
2WZE;B;High resolution crystallographic structure of the Clostridium thermocellum N-terminal endo-1,4-beta-D-xylanase 10B (Xyn10B) CBM22-1- GH10 modules complexed with xylohexaose;2.5;CA;CALCIUM ION;ENDO-1,4-BETA-XYLANASE Y;1515;
2WZH;A;BtGH84 D242N in complex with MeUMB-derived oxazoline;2.2;CA;CALCIUM ION;O-GLCNACASE BT_4395;818;
2WZI;A;BtGH84 D243N in complex with 5F-oxazoline;1.9;CA;CALCIUM ION;O-GLCNACASE BT_4395;818;
2WZI;B;BtGH84 D243N in complex with 5F-oxazoline;1.9;CA;CALCIUM ION;O-GLCNACASE BT_4395;818;
2WZS;A;Structure of the Family GH92 Inverting Mannosidase BT3990 from Bacteroides thetaiotaomicron VPI-5482 in complex with Mannoimidazole;2.25;CA;CALCIUM ION;PUTATIVE ALPHA-1,2-MANNOSIDASE;818;
2WZS;B;Structure of the Family GH92 Inverting Mannosidase BT3990 from Bacteroides thetaiotaomicron VPI-5482 in complex with Mannoimidazole;2.25;CA;CALCIUM ION;PUTATIVE ALPHA-1,2-MANNOSIDASE;818;
2WZS;C;Structure of the Family GH92 Inverting Mannosidase BT3990 from Bacteroides thetaiotaomicron VPI-5482 in complex with Mannoimidazole;2.25;CA;CALCIUM ION;PUTATIVE ALPHA-1,2-MANNOSIDASE;818;
2WZS;D;Structure of the Family GH92 Inverting Mannosidase BT3990 from Bacteroides thetaiotaomicron VPI-5482 in complex with Mannoimidazole;2.25;CA;CALCIUM ION;PUTATIVE ALPHA-1,2-MANNOSIDASE;818;
2WZS;E;Structure of the Family GH92 Inverting Mannosidase BT3990 from Bacteroides thetaiotaomicron VPI-5482 in complex with Mannoimidazole;2.25;CA;CALCIUM ION;PUTATIVE ALPHA-1,2-MANNOSIDASE;818;
2WZS;F;Structure of the Family GH92 Inverting Mannosidase BT3990 from Bacteroides thetaiotaomicron VPI-5482 in complex with Mannoimidazole;2.25;CA;CALCIUM ION;PUTATIVE ALPHA-1,2-MANNOSIDASE;818;
2WZS;G;Structure of the Family GH92 Inverting Mannosidase BT3990 from Bacteroides thetaiotaomicron VPI-5482 in complex with Mannoimidazole;2.25;CA;CALCIUM ION;PUTATIVE ALPHA-1,2-MANNOSIDASE;818;
2WZS;H;Structure of the Family GH92 Inverting Mannosidase BT3990 from Bacteroides thetaiotaomicron VPI-5482 in complex with Mannoimidazole;2.25;CA;CALCIUM ION;PUTATIVE ALPHA-1,2-MANNOSIDASE;818;
2X0G;B;X-RAY STRUCTURE OF A DAP-KINASE CALMODULIN COMPLEX;2.2;CA;CALCIUM ION;CALMODULIN;9606;
2X0H;B;BtGH84 Michaelis complex;2.21;CA;CALCIUM ION;O-GLCNACASE BT_4395;818;
2X49;A;Crystal structure of the C-terminal domain of InvA;1.5;CA;CALCIUM ION;INVASION PROTEIN INVA;28901;
2X51;B;M6 delta Insert1;2.2;CA;CALCIUM ION;CALMODULIN;7227;
2X7P;A;The Conserved Candida albicans CA3427 Gene Product Defines a New Family of Proteins Exhibiting the Generic Periplasmic Binding Protein Structural Fold;2.34;CA;CALCIUM ION;POSSIBLE THIAMINE BIOSYNTHESIS ENZYME;5476;
2X7Q;A;The conserved Candida albicans CA3427 gene product defines a new family of proteins exhibiting the generic periplasmic binding protein structural fold;2;CA;CALCIUM ION;POSSIBLE THIAMINE BIOSYNTHESIS ENZYME;5476;
2X8F;A;Native structure of Endo-1,5-alpha-L-arabinanases from Bacillus subtilis;1.9;CA;CALCIUM ION;ENDO-ALPHA-1,5-L-ARABINANASE;1423;
2X8F;B;Native structure of Endo-1,5-alpha-L-arabinanases from Bacillus subtilis;1.9;CA;CALCIUM ION;ENDO-ALPHA-1,5-L-ARABINANASE;1423;
2X8H;A;Thioredoxin glutathione reductase from Schistosoma mansoni in complex with GSH;1.9;CA;CALCIUM ION;THIOREDOXIN GLUTATHIONE REDUCTASE;6183;
2X8S;B;Crystal Structure of the Abn2 D171A mutant in complex with arabinotriose;1.5;CA;CALCIUM ION;ENDO-ALPHA-1,5-L-ARABINANASE;1423;
2X8T;A;Crystal Structure of the Abn2 H318A mutant;1.79;CA;CALCIUM ION;ENDO-ALPHA-1,5-ARABINANASE;1423;
2X8T;B;Crystal Structure of the Abn2 H318A mutant;1.79;CA;CALCIUM ION;ENDO-ALPHA-1,5-ARABINANASE;1423;
2X99;A;Thioredoxin glutathione reductase from Schistosoma mansoni in complex with NADPH;2.3;CA;CALCIUM ION;THIOREDOXIN GLUTATHIONE REDUCTASE;6183;
2XB6;C;Revisited crystal structure of Neurexin1beta-Neuroligin4 complex;2.6;CA;CALCIUM ION;NEUREXIN-1-BETA;10116;
2XB6;D;Revisited crystal structure of Neurexin1beta-Neuroligin4 complex;2.6;CA;CALCIUM ION;NEUREXIN-1-BETA;10116;
2XBF;A;Nedd4 HECT structure;2.5;CA;CALCIUM ION;E3 UBIQUITIN-PROTEIN LIGASE NEDD4;9606;
2XBV;A;Factor Xa in complex with a pyrrolidine-3,4-dicarboxylic acid inhibitor;1.66;CA;CALCIUM ION;ACTIVATED FACTOR XA HEAVY CHAIN;9606;
2XBW;A;Factor Xa in complex with a pyrrolidine-3,4-dicarboxylic acid inhibitor;1.72;CA;CALCIUM ION;ACTIVATED FACTOR XA HEAVY CHAIN;9606;
2XBX;A;Factor Xa in complex with a pyrrolidine-3,4-dicarboxylic acid inhibitor;1.85;CA;CALCIUM ION;ACTIVATED FACTOR XA HEAVY CHAIN;9606;
2XBY;A;Factor Xa in complex with a pyrrolidine-3,4-dicarboxylic acid inhibitor;2.02;CA;CALCIUM ION;ACTIVATED FACTOR XA HEAVY CHAIN;9606;
2XC0;A;Factor Xa in complex with a pyrrolidine-3,4-dicarboxylic acid inhibitor;2.05;CA;CALCIUM ION;ACTIVATED FACTOR XA HEAVY CHAIN;9606;
2XC1;A;Full-length Tailspike Protein Mutant Y108W of Bacteriophage P22;1.65;CA;CALCIUM ION;BIFUNCTIONAL TAIL PROTEIN;10754;
2XC2;A;Crystal structure of oxidized Schistosoma mansoni Thioredoxin pre- protein at 1.6 Angstrom;1.56;CA;CALCIUM ION;THIOREDOXINN;6183;
2XC4;A;Factor Xa in complex with a pyrrolidine-3,4-dicarboxylic acid inhibitor;1.67;CA;CALCIUM ION;ACTIVATED FACTOR XA HEAVY CHAIN;9606;
2XC5;A;Factor Xa in complex with a pyrrolidine-3,4-dicarboxylic acid inhibitor;1.7;CA;CALCIUM ION;ACTIVATED FACTOR XA HEAVY CHAIN;9606;
2XCE;A;Structure of YncF in complex with dUpNHpp;1.85;CA;CALCIUM ION;PROBABLE DEOXYURIDINE 5'-TRIPHOSPHATE NUCLEOTIDOHYDROLASE YNCF;1423;
2XCE;B;Structure of YncF in complex with dUpNHpp;1.85;CA;CALCIUM ION;PROBABLE DEOXYURIDINE 5'-TRIPHOSPHATE NUCLEOTIDOHYDROLASE YNCF;1423;
2XCE;C;Structure of YncF in complex with dUpNHpp;1.85;CA;CALCIUM ION;PROBABLE DEOXYURIDINE 5'-TRIPHOSPHATE NUCLEOTIDOHYDROLASE YNCF;1423;
2XCE;D;Structure of YncF in complex with dUpNHpp;1.85;CA;CALCIUM ION;PROBABLE DEOXYURIDINE 5'-TRIPHOSPHATE NUCLEOTIDOHYDROLASE YNCF;1423;
2XCE;E;Structure of YncF in complex with dUpNHpp;1.85;CA;CALCIUM ION;PROBABLE DEOXYURIDINE 5'-TRIPHOSPHATE NUCLEOTIDOHYDROLASE YNCF;1423;
2XCO;A;The 3.1A crystal structure of the catalytic core (B'A' region) of Staphylococcus aureus DNA Gyrase;3.1;CA;CALCIUM ION;DNA GYRASE SUBUNIT B, DNA GYRASE SUBUNIT A;1280;
2XEC;B;Nocardia farcinica maleate cis-trans isomerase bound to TRIS;2.2;CA;CALCIUM ION;PUTATIVE MALEATE ISOMERASE;37329;
2XEC;D;Nocardia farcinica maleate cis-trans isomerase bound to TRIS;2.2;CA;CALCIUM ION;PUTATIVE MALEATE ISOMERASE;37329;
2XEF;A;Human glutamate carboxypeptidase II in complex with Antibody- Recruiting Molecule ARM-P8;1.59;CA;CALCIUM ION;GLUTAMATE CARBOXYPEPTIDASE 2;9606;
2XEG;A;Human glutamate carboxypeptidase II in complex with Antibody- Recruiting Molecule ARM-P4;1.59;CA;CALCIUM ION;GLUTAMATE CARBOXYPEPTIDASE 2;9606;
2XEI;A;Human glutamate carboxypeptidase II in complex with Antibody- Recruiting Molecule ARM-P2;1.69;CA;CALCIUM ION;GLUTAMATE CARBOXYPEPTIDASE 2;9606;
2XEJ;A;Human glutamate carboxypeptidase II in complex with ARM-M4, urea- based inhibitor;1.78;CA;CALCIUM ION;GLUTAMATE CARBOXYPEPTIDASE 2;9606;
2XF2;A;PVC-AT;1.8;CA;CALCIUM ION;CATALASE;5079;
2XF2;E;PVC-AT;1.8;CA;CALCIUM ION;CATALASE;5079;
2XFD;A;vCBM60 in complex with cellobiose;1.19;CA;CALCIUM ION;CARBOHYDRATE BINDING MODULE;562;
2XFE;A;vCBM60 in complex with galactobiose;1.82;CA;CALCIUM ION;CARBOHYDRATE BINDING MODULE;562;
2XFG;A;Reassembly and co-crystallization of a family 9 processive endoglucanase from separately expressed GH9 and CBM3c modules;1.68;CA;CALCIUM ION;ENDOGLUCANASE 1;1515;
2XFG;B;Reassembly and co-crystallization of a family 9 processive endoglucanase from separately expressed GH9 and CBM3c modules;1.68;CA;CALCIUM ION;ENDOGLUCANASE 1;1515;
2XFV;A;Structure of the amino-terminal domain from the cell-cycle regulator Swi6;1.9;CA;CALCIUM ION;REGULATORY PROTEIN SWI6;4932;
2XFV;B;Structure of the amino-terminal domain from the cell-cycle regulator Swi6;1.9;CA;CALCIUM ION;REGULATORY PROTEIN SWI6;4932;
2XGP;A;Yeast DNA polymerase eta in complex with C8-2-acetylaminofluorene containing DNA;2.7;CA;CALCIUM ION;DNA POLYMERASE ETA;4932;
2XGP;B;Yeast DNA polymerase eta in complex with C8-2-acetylaminofluorene containing DNA;2.7;CA;CALCIUM ION;DNA POLYMERASE ETA;4932;
2XGQ;A;Structure of yeast DNA polymerase eta in complex with C8-N-acetyl-2- aminoanthracene containing DNA;2.7;CA;CALCIUM ION;DNA POLYMERASE ETA;4932;
2XGQ;B;Structure of yeast DNA polymerase eta in complex with C8-N-acetyl-2- aminoanthracene containing DNA;2.7;CA;CALCIUM ION;DNA POLYMERASE ETA;4932;
2XHH;A;Circular permutation provides an evolutionary link between two families of calcium-dependent carbohydrate binding modules;1.6;CA;CALCIUM ION;CARBOHYDRATE BINDING MODULE;155077;
2XHI;A;Separation-of-function mutants unravel the dual reaction mode of human 8-oxoguanine DNA glycosylase;1.55;CA;CALCIUM ION;N-GLYCOSYLASE/DNA LYASE;9606;
2XHI;C;Separation-of-function mutants unravel the dual reaction mode of human 8-oxoguanine DNA glycosylase;1.55;CA;CALCIUM ION;5'-D(*GP*CP*GP*TP*CP*CP*AP*(8OG)P*GP*TP*CP*TP*AP*CP*C)-3';;
2XHJ;A;Circular permutation provides an evolutionary link between two families of calcium-dependent carbohydrate binding modules. SeMet form of vCBM60.;1.73;CA;CALCIUM ION;CALCIUM-DEPENDENT CARBOHYDRATE BINDING MODULE;155077;
2XHN;A;Rhamnogalacturonan lyase from Aspergillus aculeatus K150A active site mutant;1.52;CA;CALCIUM ION;RHAMNOGALACTURONASE B;5053;
2XHN;B;Rhamnogalacturonan lyase from Aspergillus aculeatus K150A active site mutant;1.52;CA;CALCIUM ION;RHAMNOGALACTURONASE B;5053;
2XJ7;A;BtGH84 in complex with 6-acetamido-6-deoxy-castanospermine;2;CA;CALCIUM ION;O-GLCNACASE BT_4395;818;
2XJ7;B;BtGH84 in complex with 6-acetamido-6-deoxy-castanospermine;2;CA;CALCIUM ION;O-GLCNACASE BT_4395;818;
2XJM;B;Crystal structure of Streptococcus suis Dpr with cobalt;2.3;CA;CALCIUM ION;DNA PROTECTION DURING STARVATION PROTEIN;1307;
2XJM;C;Crystal structure of Streptococcus suis Dpr with cobalt;2.3;CA;CALCIUM ION;DNA PROTECTION DURING STARVATION PROTEIN;1307;
2XJM;E;Crystal structure of Streptococcus suis Dpr with cobalt;2.3;CA;CALCIUM ION;DNA PROTECTION DURING STARVATION PROTEIN;1307;
2XJM;F;Crystal structure of Streptococcus suis Dpr with cobalt;2.3;CA;CALCIUM ION;DNA PROTECTION DURING STARVATION PROTEIN;1307;
2XJM;H;Crystal structure of Streptococcus suis Dpr with cobalt;2.3;CA;CALCIUM ION;DNA PROTECTION DURING STARVATION PROTEIN;1307;
2XJM;I;Crystal structure of Streptococcus suis Dpr with cobalt;2.3;CA;CALCIUM ION;DNA PROTECTION DURING STARVATION PROTEIN;1307;
2XJM;J;Crystal structure of Streptococcus suis Dpr with cobalt;2.3;CA;CALCIUM ION;DNA PROTECTION DURING STARVATION PROTEIN;1307;
2XJN;F;Crystal structure of Streptococcus suis Dpr with copper;2.1;CA;CALCIUM ION;DNA PROTECTION DURING STARVATION PROTEIN;1307;
2XJN;H;Crystal structure of Streptococcus suis Dpr with copper;2.1;CA;CALCIUM ION;DNA PROTECTION DURING STARVATION PROTEIN;1307;
2XJN;I;Crystal structure of Streptococcus suis Dpr with copper;2.1;CA;CALCIUM ION;DNA PROTECTION DURING STARVATION PROTEIN;1307;
2XJN;J;Crystal structure of Streptococcus suis Dpr with copper;2.1;CA;CALCIUM ION;DNA PROTECTION DURING STARVATION PROTEIN;1307;
2XJN;L;Crystal structure of Streptococcus suis Dpr with copper;2.1;CA;CALCIUM ION;DNA PROTECTION DURING STARVATION PROTEIN;1307;
2XJO;B;Crystal structure of Streptococcus suis Dpr with nickel;2.1;CA;CALCIUM ION;DNA PROTECTION DURING STARVATION PROTEIN;1307;
2XJO;D;Crystal structure of Streptococcus suis Dpr with nickel;2.1;CA;CALCIUM ION;DNA PROTECTION DURING STARVATION PROTEIN;1307;
2XJO;F;Crystal structure of Streptococcus suis Dpr with nickel;2.1;CA;CALCIUM ION;DNA PROTECTION DURING STARVATION PROTEIN;1307;
2XJO;I;Crystal structure of Streptococcus suis Dpr with nickel;2.1;CA;CALCIUM ION;DNA PROTECTION DURING STARVATION PROTEIN;1307;
2XJO;J;Crystal structure of Streptococcus suis Dpr with nickel;2.1;CA;CALCIUM ION;DNA PROTECTION DURING STARVATION PROTEIN;1307;
2XJO;K;Crystal structure of Streptococcus suis Dpr with nickel;2.1;CA;CALCIUM ION;DNA PROTECTION DURING STARVATION PROTEIN;1307;
2XJP;A;X-ray structure of the N-terminal domain of the flocculin Flo5 from Saccharomyces cerevisiae in complex with calcium and mannose;0.95;CA;CALCIUM ION;FLOCCULATION PROTEIN FLO5;4932;
2XJR;A;X-ray structure of the N-terminal domain of the flocculin Flo5 from Saccharomyces cerevisiae in complex with calcium and Man5(D2-D3);1.25;CA;CALCIUM ION;FLOCCULATION PROTEIN FLO5;4932;
2XJS;A;X-ray structure of the N-terminal domain of the flocculin Flo5 from Saccharomyces cerevisiae in complex with calcium and a1,2-mannobiose;1.3;CA;CALCIUM ION;FLOCCULATION PROTEIN FLO5;4932;
2XJT;A;X-ray structure of the N-terminal domain of the flocculin Flo5 from Saccharomyces cerevisiae in complex with calcium and Man5(D1);1.2;CA;CALCIUM ION;FLOCCULATION PROTEIN FLO5;4932;
2XJU;A;X-ray structure of the N-terminal domain of the flocculin Flo5 from Saccharomyces cerevisiae with mutation S227A in complex with calcium and a1,2-mannobiose;1.7;CA;CALCIUM ION;FLOCCULATION PROTEIN FLO5;4932;
2XJV;A;X-ray structure of the N-terminal domain of the flocculin Flo5 from Saccharomyces cerevisiae with mutation D201T in complex with calcium and glucose;1.74;CA;CALCIUM ION;FLOCCULATION PROTEIN FLO5;4932;
2XKQ;B;Crystal structure of Streptococcus suis Dpr with manganese;2.4;CA;CALCIUM ION;DNA PROTECTION DURING STARVATION PROTEIN;1307;
2XKQ;D;Crystal structure of Streptococcus suis Dpr with manganese;2.4;CA;CALCIUM ION;DNA PROTECTION DURING STARVATION PROTEIN;1307;
2XKQ;F;Crystal structure of Streptococcus suis Dpr with manganese;2.4;CA;CALCIUM ION;DNA PROTECTION DURING STARVATION PROTEIN;1307;
2XKQ;G;Crystal structure of Streptococcus suis Dpr with manganese;2.4;CA;CALCIUM ION;DNA PROTECTION DURING STARVATION PROTEIN;1307;
2XMD;A;G117H mutant of human butyrylcholinesterase in complex with echothiophate;2.3;CA;CALCIUM ION;CHOLINESTERASE;9606;
2XMO;A;The crystal structure of Lmo2642;1.7;CA;CALCIUM ION;LMO2642 PROTEIN;1639;
2XMO;B;The crystal structure of Lmo2642;1.7;CA;CALCIUM ION;LMO2642 PROTEIN;1639;
2XMR;A;Crystal structure of human NDRG2 protein provides insight into its role as a tumor suppressor;2;CA;CALCIUM ION;PROTEIN NDRG2;9606;
2XN5;A;Crystal structure of thyroxine-binding globulin complexed with Furosemide;1.7;CA;CALCIUM ION;THYROXINE-BINDING GLOBULIN;9606;
2XN6;A;Crystal structure of thyroxine-binding globulin complexed with thyroxine-fluoresein;1.29;CA;CALCIUM ION;THYROXINE-BINDING GLOBULIN;9606;
2XN7;A;Crystal structure of thyroxine-binding globulin complexed with thyroxine-fluoresein (T405-CF);1.43;CA;CALCIUM ION;THYROXINE-BINDING GLOBULIN;9606;
2XO2;A;Human Annexin V with incorporated Methionine analogue Azidohomoalanine;2.8;CA;CALCIUM ION;ANNEXIN A5;9606;
2XO3;A;Human Annexin V with incorporated Methionine analogue Homopropargylglycine;2.3;CA;CALCIUM ION;ANNEXIN A5;9606;
2XOM;A;Atomic resolution structure of TmCBM61 in complex with beta-1,4- galactotriose;0.95;CA;CALCIUM ION;ARABINOGALACTAN ENDO-1,4-BETA-GALACTOSIDASE;2336;
2XON;A;Structure of TmCBM61 in complex with beta-1,4-galactotriose at 1.4 A resolution;1.4;CA;CALCIUM ION;ARABINOGALACTAN ENDO-1,4-BETA-GALACTOSIDASE;2336;
2XON;L;Structure of TmCBM61 in complex with beta-1,4-galactotriose at 1.4 A resolution;1.4;CA;CALCIUM ION;ARABINOGALACTAN ENDO-1,4-BETA-GALACTOSIDASE;2336;
2XQG;A;X-ray Structure of human butyrylcholinesterase inhibited by racemic VR;2.3;CA;CALCIUM ION;CHOLINESTERASE;9606;
2XQJ;A;X-ray Structure of human butyrylcholinesterase inhibited by pure enantiomer VX-(R);2.4;CA;CALCIUM ION;CHOLINESTERASE;9606;
2XQK;A;X-ray Structure of human butyrylcholinesterase inhibited by pure enantiomer VX-(S);2.4;CA;CALCIUM ION;CHOLINESTERASE;9606;
2XQO;A;CtCel124: a cellulase from Clostridium thermocellum;1.4;CA;CALCIUM ION;CELLULOSOME ENZYME, DOCKERIN TYPE I;1515;
2XQX;A;Structure of the family 32 carbohydrate-binding module from Streptococcus pneumoniae EndoD;2.01;CA;CALCIUM ION;ENDO-BETA-N-ACETYLGLUCOSAMINIDASE D;1313;
2XQX;B;Structure of the family 32 carbohydrate-binding module from Streptococcus pneumoniae EndoD;2.01;CA;CALCIUM ION;ENDO-BETA-N-ACETYLGLUCOSAMINIDASE D;1313;
2XR5;A;Crystal structure of the complex of the carbohydrate recognition domain of human DC-SIGN with pseudo dimannoside mimic.;1.42;CA;CALCIUM ION;CD209 ANTIGEN;9606;
2XR6;A;Crystal structure of the complex of the carbohydrate recognition domain of human DC-SIGN with pseudo trimannoside mimic.;1.35;CA;CALCIUM ION;CD209 ANTIGEN;9606;
2XR9;A;Crystal structure of Autotaxin (ENPP2);2.05;CA;CALCIUM ION;ECTONUCLEOTIDE PYROPHOSPHATASE/PHOSPHODIESTERASE FAMILY MEMBER 2;10116;
2XRC;A;Human complement factor I;2.69;CA;CALCIUM ION;HUMAN COMPLEMENT FACTOR I;9606;
2XRC;B;Human complement factor I;2.69;CA;CALCIUM ION;HUMAN COMPLEMENT FACTOR I;9606;
2XRC;C;Human complement factor I;2.69;CA;CALCIUM ION;HUMAN COMPLEMENT FACTOR I;9606;
2XRC;D;Human complement factor I;2.69;CA;CALCIUM ION;HUMAN COMPLEMENT FACTOR I;9606;
2XRG;A;Crystal structure of Autotaxin (ENPP2) in complex with the HA155 boronic acid inhibitor;3.2;CA;CALCIUM ION;ECTONUCLEOTIDE PYROPHOSPHATASE/PHOSPHODIESTERASE FAMILY MEMBER 2;10116;
2XRM;A;Processed Intracellular subtilisin from B. clausii;2.6;CA;CALCIUM ION;INTRACELLULAR SUBTILISIN PROTEASE;79880;
2XSG;A;Structure of the gh92 family glycosyl hydrolase ccman5;2;CA;CALCIUM ION;CCMAN5;1710;
2XSG;B;Structure of the gh92 family glycosyl hydrolase ccman5;2;CA;CALCIUM ION;CCMAN5;1710;
2XT6;A;Crystal structure of Mycobacterium smegmatis alpha-ketoglutarate decarboxylase homodimer (orthorhombic form);2.74;CA;CALCIUM ION;2-OXOGLUTARATE DECARBOXYLASE;1772;
2XT6;B;Crystal structure of Mycobacterium smegmatis alpha-ketoglutarate decarboxylase homodimer (orthorhombic form);2.74;CA;CALCIUM ION;2-OXOGLUTARATE DECARBOXYLASE;1772;
2XTA;A;Crystal structure of the SucA domain of Mycobacterium smegmatis alpha- ketoglutarate decarboxylase in complex with acetyl-CoA (triclinic form);2.2;CA;CALCIUM ION;2-OXOGLUTARATE DECARBOXYLASE;1772;
2XTA;B;Crystal structure of the SucA domain of Mycobacterium smegmatis alpha- ketoglutarate decarboxylase in complex with acetyl-CoA (triclinic form);2.2;CA;CALCIUM ION;2-OXOGLUTARATE DECARBOXYLASE;1772;
2XTA;C;Crystal structure of the SucA domain of Mycobacterium smegmatis alpha- ketoglutarate decarboxylase in complex with acetyl-CoA (triclinic form);2.2;CA;CALCIUM ION;2-OXOGLUTARATE DECARBOXYLASE;1772;
2XTA;D;Crystal structure of the SucA domain of Mycobacterium smegmatis alpha- ketoglutarate decarboxylase in complex with acetyl-CoA (triclinic form);2.2;CA;CALCIUM ION;2-OXOGLUTARATE DECARBOXYLASE;1772;
2XTJ;A;The crystal structure of PCSK9 in complex with 1D05 Fab;2.7;CA;CALCIUM ION;PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9;9606;
2XTS;B;Crystal Structure of the Sulfane Dehydrogenase SoxCD from Paracoccus pantotrophus;1.33;CA;CALCIUM ION;CYTOCHROME;82367;
2XTS;D;Crystal Structure of the Sulfane Dehydrogenase SoxCD from Paracoccus pantotrophus;1.33;CA;CALCIUM ION;CYTOCHROME;82367;
2XTT;B;Bovine trypsin in complex with evolutionary enhanced Schistocerca gregaria protease inhibitor 1 (SGPI-1-P02);0.93;CA;CALCIUM ION;CATIONIC TRYPSIN;9913;
2XVT;C;Structure of the extracellular domain of human RAMP2;2.05;CA;CALCIUM ION;RECEPTOR ACTIVITY-MODIFYING PROTEIN 2;9606;
2XVT;F;Structure of the extracellular domain of human RAMP2;2.05;CA;CALCIUM ION;RECEPTOR ACTIVITY-MODIFYING PROTEIN 2;9606;
2XWG;A;Crystal structure of sortase C-1 from Actinomyces oris (formerly Actinomyces naeslundii);2.4;CA;CALCIUM ION;SORTASE;544580;
2XWG;B;Crystal structure of sortase C-1 from Actinomyces oris (formerly Actinomyces naeslundii);2.4;CA;CALCIUM ION;SORTASE;544580;
2XWG;C;Crystal structure of sortase C-1 from Actinomyces oris (formerly Actinomyces naeslundii);2.4;CA;CALCIUM ION;SORTASE;544580;
2XXL;A;Crystal structure of drosophila Grass clip serine protease of Toll pathway;1.8;CA;CALCIUM ION;GRAM-POSITIVE SPECIFIC SERINE PROTEASE, ISOFORM B;7227;
2XXL;B;Crystal structure of drosophila Grass clip serine protease of Toll pathway;1.8;CA;CALCIUM ION;GRAM-POSITIVE SPECIFIC SERINE PROTEASE, ISOFORM B;7227;
2XY8;A;Paramagnetic-based NMR structure of the complex between the N- terminal epsilon domain and the theta domain of the DNA polymerase III;;CA;CALCIUM ION;DNA POLYMERASE III SUBUNIT EPSILON;562;
2XZ1;A;The Structure of the 2:2 (Fully Occupied) Complex Between Stearoyl Acyl Carrier Protein Desaturase from Ricinus Communis (Castor Bean) and Acyl Carrier Protein.;3.35;CA;CALCIUM ION;ACYL-[ACYL-CARRIER-PROTEIN] DESATURASE, CHLOROPLASTIC;3988;
2XZ1;B;The Structure of the 2:2 (Fully Occupied) Complex Between Stearoyl Acyl Carrier Protein Desaturase from Ricinus Communis (Castor Bean) and Acyl Carrier Protein.;3.35;CA;CALCIUM ION;ACYL-[ACYL-CARRIER-PROTEIN] DESATURASE, CHLOROPLASTIC;3988;
2XZV;A;The cyanobacterial PP2C-like phosphatase tPphA requires three metals in the catalytic center for efficient catalysis;1.6;CA;CALCIUM ION;PROTEIN SERIN-THREONIN PHOSPHATASE;32046;
2Y09;A;The cyanobacterial PP2C-like phosphatase tPphA requires three metals in the catalytic center for efficient catalysis;1.7;CA;CALCIUM ION;PROTEIN SERIN-THREONIN PHOSPHATASE;32046;
2Y1M;A;Structure of native c-Cbl;2.67;CA;CALCIUM ION;E3 UBIQUITIN-PROTEIN LIGASE;9606;
2Y1M;B;Structure of native c-Cbl;2.67;CA;CALCIUM ION;E3 UBIQUITIN-PROTEIN LIGASE;9606;
2Y1M;C;Structure of native c-Cbl;2.67;CA;CALCIUM ION;E3 UBIQUITIN-PROTEIN LIGASE;9606;
2Y1M;D;Structure of native c-Cbl;2.67;CA;CALCIUM ION;E3 UBIQUITIN-PROTEIN LIGASE;9606;
2Y1M;E;Structure of native c-Cbl;2.67;CA;CALCIUM ION;E3 UBIQUITIN-PROTEIN LIGASE;9606;
2Y1M;F;Structure of native c-Cbl;2.67;CA;CALCIUM ION;E3 UBIQUITIN-PROTEIN LIGASE;9606;
2Y1N;A;Structure of c-Cbl-ZAP-70 peptide complex;2;CA;CALCIUM ION;E3 UBIQUITIN-PROTEIN LIGASE;9606;
2Y1N;C;Structure of c-Cbl-ZAP-70 peptide complex;2;CA;CALCIUM ION;E3 UBIQUITIN-PROTEIN LIGASE;9606;
2Y31;B;Simocyclinone C4 bound form of TetR-like repressor SimR;2.3;CA;CALCIUM ION;PUTATIVE REPRESSOR SIMREG2;1890;
2Y3C;A;Treponema denticola variable protein 1;1.4;CA;CALCIUM ION;TREPONEMA DENTICOLA VARIABLE PROTEIN 1;158;
2Y3N;B;Type II cohesin-dockerin domain from Bacteroides cellolosolvens;1.9;CA;CALCIUM ION;CELLULOSOMAL FAMILY-48 PROCESSIVE GLYCOSIDE HYDROLASE;35825;
2Y3N;D;Type II cohesin-dockerin domain from Bacteroides cellolosolvens;1.9;CA;CALCIUM ION;CELLULOSOMAL FAMILY-48 PROCESSIVE GLYCOSIDE HYDROLASE;35825;
2Y4Q;A;Solution structure of the EF-hand domain of Human Polycystin 2;;CA;CALCIUM ION;POLYCYSTIN-2;9606;
2Y4S;A;BARLEY LIMIT DEXTRINASE IN COMPLEX WITH BETA-CYCLODEXTRIN;2.1;CA;CALCIUM ION;LIMIT DEXTRINASE;4513;
2Y4V;A;CRYSTAL STRUCTURE OF HUMAN CALMODULIN IN COMPLEX WITH A DAP KINASE-1 MUTANT (W305Y) PEPTIDE;1.8;CA;CALCIUM ION;CALMODULIN;9606;
2Y5E;A;BARLEY LIMIT DEXTRINASE IN COMPLEX WITH ALPHA-CYCLODEXTRIN;2.49;CA;CALCIUM ION;LIMIT DEXTRINASE;4513;
2Y5I;A;S100Z from zebrafish in complex with calcium;2.03;CA;CALCIUM ION;S100 CALCIUM BINDING PROTEIN Z;7955;
2Y5I;B;S100Z from zebrafish in complex with calcium;2.03;CA;CALCIUM ION;S100 CALCIUM BINDING PROTEIN Z;7955;
2Y5I;C;S100Z from zebrafish in complex with calcium;2.03;CA;CALCIUM ION;S100 CALCIUM BINDING PROTEIN Z;7955;
2Y5I;D;S100Z from zebrafish in complex with calcium;2.03;CA;CALCIUM ION;S100 CALCIUM BINDING PROTEIN Z;7955;
2Y5I;E;S100Z from zebrafish in complex with calcium;2.03;CA;CALCIUM ION;S100 CALCIUM BINDING PROTEIN Z;7955;
2Y5I;F;S100Z from zebrafish in complex with calcium;2.03;CA;CALCIUM ION;S100 CALCIUM BINDING PROTEIN Z;7955;
2Y5P;A;B-repeat of Listeria monocytogenes InlB (internalin B);1.3;CA;CALCIUM ION;INTERNALIN B;1639;
2Y5P;B;B-repeat of Listeria monocytogenes InlB (internalin B);1.3;CA;CALCIUM ION;INTERNALIN B;1639;
2Y5P;C;B-repeat of Listeria monocytogenes InlB (internalin B);1.3;CA;CALCIUM ION;INTERNALIN B;1639;
2Y5P;D;B-repeat of Listeria monocytogenes InlB (internalin B);1.3;CA;CALCIUM ION;INTERNALIN B;1639;
2Y64;A;Xylopentaose binding mutated (X-2 L110F) CBM4-2 Carbohydrate Binding Module from a Thermostable Rhodothermus marinus Xylanase;1.4;CA;CALCIUM ION;XYLANASE;29549;
2Y6C;A;The Discovery of MMP7 inhibitors Exploiting a Novel Selectivity Trigger;1.7;CA;CALCIUM ION;MATRILYSIN;9606;
2Y6D;A;The Discovery of MMP7 Inhibitors Exploiting a Novel Selectivity Trigger;1.6;CA;CALCIUM ION;MATRILYSIN;9606;
2Y6G;A;Cellopentaose binding mutated (X-2 L110F) CBM4-2 Carbohydrate Binding Module from a Thermostable Rhodothermus marinus Xylanase;1.3;CA;CALCIUM ION;XYLANASE;29549;
2Y6H;A;X-2 L110F CBM4-2 Carbohydrate Binding Module from a Thermostable Rhodothermus marinus Xylanase;1.08;CA;CALCIUM ION;XYLANASE;29549;
2Y6J;A;X-2 engineered mutated CBM4-2 Carbohydrate Binding Module from a Thermostable Rhodothermus marinus Xylanase;1.7;CA;CALCIUM ION;XYLANASE;29549;
2Y6K;A;Xylotetraose bound to X-2 engineered mutated CBM4-2 Carbohydrate Binding Module from a Thermostable Rhodothermus marinus Xylanase;1.36;CA;CALCIUM ION;XYLANASE;29549;
2Y6L;A;Xylopentaose binding X-2 engineered mutated CBM4-2 Carbohydrate Binding Module from a Thermostable Rhodothermus marinus Xylanase;1.28;CA;CALCIUM ION;XYLANASE;29549;
2Y73;A;THE NATIVE STRUCTURES OF SOLUBLE HUMAN PRIMARY AMINE OXIDASE AOC3;2.6;CA;CALCIUM ION;MEMBRANE PRIMARY AMINE OXIDASE;9606;
2Y73;B;THE NATIVE STRUCTURES OF SOLUBLE HUMAN PRIMARY AMINE OXIDASE AOC3;2.6;CA;CALCIUM ION;MEMBRANE PRIMARY AMINE OXIDASE;9606;
2Y74;A;THE CRYSTAL STRUCTURE OF HUMAN SOLUBLE PRIMARY AMINE OXIDASE AOC3 IN THE OFF-COPPER CONFORMATION;2.95;CA;CALCIUM ION;MEMBRANE PRIMARY AMINE OXIDASE;9606;
2Y74;B;THE CRYSTAL STRUCTURE OF HUMAN SOLUBLE PRIMARY AMINE OXIDASE AOC3 IN THE OFF-COPPER CONFORMATION;2.95;CA;CALCIUM ION;MEMBRANE PRIMARY AMINE OXIDASE;9606;
2Y79;A;STRUCTURE OF THE FIRST GAF DOMAIN E87A MUTANT OF MYCOBACTERIUM TUBERCULOSIS DOSS;1.8;CA;CALCIUM ION;REDOX SENSOR HISTIDINE KINASE RESPONSE REGULATOR DEVS;1773;
2Y7X;A;The discovery of potent and long-acting oral factor Xa inhibitors with tetrahydroisoquinoline and benzazepine P4 motifs;1.9;CA;CALCIUM ION;ACTIVATED FACTOR XA HEAVY CHAIN;9606;
2Y7Z;A;Structure and property based design of factor Xa inhibitors: pyrrolidin-2-ones with aminoindane and phenylpyrrolidine P4 motifs;1.84;CA;CALCIUM ION;ACTIVATED FACTOR XA HEAVY CHAIN;9606;
2Y80;A;Structure and property based design of factor Xa inhibitors: pyrrolidin-2-ones with aminoindane and phenylpyrrolidine P4 motifs;1.9;CA;CALCIUM ION;ACTIVATED FACTOR XA HEAVY CHAIN;9606;
2Y81;A;Structure and property based design of factor Xa inhibitors: pyrrolidin-2-ones with aminoindane and phenylpyrrolidine P4 motifs;1.7;CA;CALCIUM ION;ACTIVATED FACTOR XA HEAVY CHAIN;9606;
2Y82;A;Structure and property based design of factor Xa inhibitors: pyrrolidin-2-ones with aminoindane and phenylpyrrolidine P4 motifs;2.2;CA;CALCIUM ION;ACTIVATED FACTOR XA HEAVY CHAIN;9606;
2Y83;O;Actin filament pointed end;22.9;CA;CALCIUM ION;ACTIN, ALPHA SKELETAL MUSCLE;9986;
2Y83;P;Actin filament pointed end;22.9;CA;CALCIUM ION;ACTIN, ALPHA SKELETAL MUSCLE;9986;
2Y83;Q;Actin filament pointed end;22.9;CA;CALCIUM ION;ACTIN, ALPHA SKELETAL MUSCLE;9986;
2Y83;R;Actin filament pointed end;22.9;CA;CALCIUM ION;ACTIN, ALPHA SKELETAL MUSCLE;9986;
2Y83;S;Actin filament pointed end;22.9;CA;CALCIUM ION;ACTIN, ALPHA SKELETAL MUSCLE;9986;
2Y83;T;Actin filament pointed end;22.9;CA;CALCIUM ION;ACTIN, ALPHA SKELETAL MUSCLE;9986;
2Y8H;A;STRUCTURE OF THE FIRST GAF DOMAIN E87G MUTANT OF MYCOBACTERIUM TUBERCULOSIS DOSS;1.9;CA;CALCIUM ION;TWO COMPONENT SENSOR HISTIDINE KINASE DEVS;1773;
2Y8K;A;Structure of CtGH5-CBM6, an arabinoxylan-specific xylanase.;1.47;CA;CALCIUM ION;CARBOHYDRATE BINDING FAMILY 6;1515;
2YA0;A;Catalytic Module of the Multi-modular glycogen-degrading pneumococcal virulence factor SpuA;1.85;CA;CALCIUM ION;PUTATIVE ALKALINE AMYLOPULLULANASE;1313;
2YA2;A;Catalytic Module of the Multi-modular glycogen-degrading pneumococcal virulence factor SpuA in complex with an inhibitor.;2.37;CA;CALCIUM ION;PUTATIVE ALKALINE AMYLOPULLULANASE;1313;
2YA9;A;Crystal structure of the autoinhibited form of mouse DAPK2;2.3;CA;CALCIUM ION;DEATH-ASSOCIATED PROTEIN KINASE 2;10090;
2YAA;A;Crystal structure of the autoinhibited form of mouse DAPK2 in complex with ATP;2.3;CA;CALCIUM ION;DEATH-ASSOCIATED PROTEIN KINASE 2;10090;
2YAB;A;Crystal structure of the autoinhibited form of mouse DAPK2 in complex with AMP;1.9;CA;CALCIUM ION;DEATH-ASSOCIATED PROTEIN KINASE 2;10090;
2YAY;A;The Crystal Structure of Leishmania major dUTPase in complex with substrate analogue dUpNpp;1.86;CA;CALCIUM ION;DUTPASE;5664;
2YB7;A;CBM62 in complex with 6-alpha-D-Galactosyl-mannotriose;1.7;CA;CALCIUM ION;CARBOHYDRATE BINDING FAMILY 6;1515;
2YB7;B;CBM62 in complex with 6-alpha-D-Galactosyl-mannotriose;1.7;CA;CALCIUM ION;CARBOHYDRATE BINDING FAMILY 6;1515;
2YBB;7;Fitted model for bovine mitochondrial supercomplex I1III2IV1 by single particle cryo-EM (EMD-1876);19;CA;CALCIUM ION;NADH-QUINONE OXIDOREDUCTASE SUBUNIT 15;274;
2YC2;A;Intraflagellar Transport Complex 25-27 from Chlamydomonas;2.59;CA;CALCIUM ION;INTRAFLAGELLAR TRANSPORT PROTEIN 25;3055;
2YC2;B;Intraflagellar Transport Complex 25-27 from Chlamydomonas;2.59;CA;CALCIUM ION;INTRAFLAGELLAR TRANSPORT PROTEIN 25;3055;
2YC4;A;Intraflagellar Transport Complex 25-27 from Chlamydomonas;2.8;CA;CALCIUM ION;INTRAFLAGELLAR TRANSPORT PROTEIN 25;3055;
2YC4;B;Intraflagellar Transport Complex 25-27 from Chlamydomonas;2.8;CA;CALCIUM ION;INTRAFLAGELLAR TRANSPORT PROTEIN 25;3055;
2YDP;A;Structure of the E242A mutant of the alpha-l-arabinofuranosidase arb93a from fusarium graminearum in complex with an iminosugar inhibitor;1.85;CA;CALCIUM ION;EXO-1,5-ALPHA-L-ARABINOFURANOBIOSIDASE;5518;
2YDP;B;Structure of the E242A mutant of the alpha-l-arabinofuranosidase arb93a from fusarium graminearum in complex with an iminosugar inhibitor;1.85;CA;CALCIUM ION;EXO-1,5-ALPHA-L-ARABINOFURANOBIOSIDASE;5518;
2YDP;C;Structure of the E242A mutant of the alpha-l-arabinofuranosidase arb93a from fusarium graminearum in complex with an iminosugar inhibitor;1.85;CA;CALCIUM ION;EXO-1,5-ALPHA-L-ARABINOFURANOBIOSIDASE;5518;
2YDX;A;Crystal structure of human S-adenosylmethionine synthetase 2, beta subunit;2.8;CA;CALCIUM ION;METHIONINE ADENOSYLTRANSFERASE 2 SUBUNIT BETA;9606;
2YEQ;A;Structure of PhoD;1.93;CA;CALCIUM ION;ALKALINE PHOSPHATASE D;1423;
2YEQ;B;Structure of PhoD;1.93;CA;CALCIUM ION;ALKALINE PHOSPHATASE D;1423;
2YFR;A;Crystal structure of inulosucrase from Lactobacillus johnsonii NCC533;1.75;CA;CALCIUM ION;LEVANSUCRASE;33959;
2YFS;A;Crystal structure of inulosucrase from Lactobacillus johnsonii NCC533 in complex with sucrose;2.6;CA;CALCIUM ION;LEVANSUCRASE;33959;
2YFT;A;Crystal structure of inulosucrase from Lactobacillus johnsonii NCC533 in complex with 1-kestose;1.85;CA;CALCIUM ION;LEVANSUCRASE;33959;
2YFU;A;CBM62 FROM CLOSTRIDIUM THERMOCELLUM XYL5A;1.65;CA;CALCIUM ION;CARBOHYDRATE BINDING FAMILY 6;1515;
2YFZ;A;CBM62 FROM CLOSTRIDIUM THERMOCELLUM XYL5A;1.8;CA;CALCIUM ION;CARBOHYDRATE BINDING FAMILY 6;1515;
2YG0;A;CBM62 FROM CLOSTRIDIUM THERMOCELLUM XYL5A;1.8;CA;CALCIUM ION;CARBOHYDRATE BINDING FAMILY 6;1515;
2YGG;B;Complex of CaMBR and CaM;2.23;CA;CALCIUM ION;CALMODULIN;10116;
2YGL;A;The X-ray crystal structure of tandem CBM51 modules of Sp3GH98, the family 98 glycoside hydrolase from Streptococcus pneumoniae SP3-BS71;2.1;CA;CALCIUM ION;BLOOD GROUP A-AND B-CLEAVING ENDO-BETA-GALACTOSIDASE;1313;
2YGL;B;The X-ray crystal structure of tandem CBM51 modules of Sp3GH98, the family 98 glycoside hydrolase from Streptococcus pneumoniae SP3-BS71;2.1;CA;CALCIUM ION;BLOOD GROUP A-AND B-CLEAVING ENDO-BETA-GALACTOSIDASE;1313;
2YGM;A;THE X-RAY CRYSTAL STRUCTURE OF TANDEM CBM51 MODULES OF SP3GH98, THE FAMILY 98 GLYCOSIDE HYDROLASE FROM STREPTOCOCCUS PNEUMONIAE SP3-BS71, IN COMPLEX WITH THE BLOOD GROUP B ANTIGEN;2.35;CA;CALCIUM ION;BLOOD GROUP A-AND B-CLEAVING ENDO-BETA-GALACTOSIDASE;1313;
2YGM;B;THE X-RAY CRYSTAL STRUCTURE OF TANDEM CBM51 MODULES OF SP3GH98, THE FAMILY 98 GLYCOSIDE HYDROLASE FROM STREPTOCOCCUS PNEUMONIAE SP3-BS71, IN COMPLEX WITH THE BLOOD GROUP B ANTIGEN;2.35;CA;CALCIUM ION;BLOOD GROUP A-AND B-CLEAVING ENDO-BETA-GALACTOSIDASE;1313;
2YGP;A;WIF domain-EGF-like domain 1 Met77Trp of human Wnt inhibitory factor 1 in complex with 1,2-dipalmitoylphosphatidylcholine;2.22;CA;CALCIUM ION;WNT INHIBITORY FACTOR 1;9606;
2YHG;A;Ab initio phasing of a nucleoside hydrolase-related hypothetical protein from Saccharophagus degradans that is associated with carbohydrate metabolism;1.08;CA;CALCIUM ION;CELLULOSE-BINDING PROTEIN;86304;
2YHW;A;High-resolution crystal structures of N-Acetylmannosamine kinase: Insights about substrate specificity, activity and inhibitor modelling.;1.64;CA;CALCIUM ION;BIFUNCTIONAL UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE/N-ACETYLMANNOSAMINE KINASE;9606;
2YHY;A;Structure of N-Acetylmannosamine kinase in complex with N- acetylmannosamine and ADP;1.82;CA;CALCIUM ION;BIFUNCTIONAL UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE/N-ACETYLMANNOSAMINE KINASE;9606;
2YI1;A;Crystal structure of N-Acetylmannosamine kinase in complex with N- acetyl mannosamine 6-phosphate and ADP.;2.15;CA;CALCIUM ION;BIFUNCTIONAL UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE/N-ACETYLMANNOSAMINE KINASE;9606;
2YIC;A;Crystal structure of the SucA domain of Mycobacterium smegmatis alpha- ketoglutarate decarboxylase (triclinic form);1.96;CA;CALCIUM ION;2-OXOGLUTARATE DECARBOXYLASE;1772;
2YIC;B;Crystal structure of the SucA domain of Mycobacterium smegmatis alpha- ketoglutarate decarboxylase (triclinic form);1.96;CA;CALCIUM ION;2-OXOGLUTARATE DECARBOXYLASE;1772;
2YIC;C;Crystal structure of the SucA domain of Mycobacterium smegmatis alpha- ketoglutarate decarboxylase (triclinic form);1.96;CA;CALCIUM ION;2-OXOGLUTARATE DECARBOXYLASE;1772;
2YIC;D;Crystal structure of the SucA domain of Mycobacterium smegmatis alpha- ketoglutarate decarboxylase (triclinic form);1.96;CA;CALCIUM ION;2-OXOGLUTARATE DECARBOXYLASE;1772;
2YID;A;Crystal structure of the SucA domain of Mycobacterium smegmatis alpha- ketoglutarate decarboxylase in complex with the enamine-ThDP intermediate;2.25;CA;CALCIUM ION;2-OXOGLUTARATE DECARBOXYLASE;1772;
2YID;B;Crystal structure of the SucA domain of Mycobacterium smegmatis alpha- ketoglutarate decarboxylase in complex with the enamine-ThDP intermediate;2.25;CA;CALCIUM ION;2-OXOGLUTARATE DECARBOXYLASE;1772;
2YID;C;Crystal structure of the SucA domain of Mycobacterium smegmatis alpha- ketoglutarate decarboxylase in complex with the enamine-ThDP intermediate;2.25;CA;CALCIUM ION;2-OXOGLUTARATE DECARBOXYLASE;1772;
2YID;D;Crystal structure of the SucA domain of Mycobacterium smegmatis alpha- ketoglutarate decarboxylase in complex with the enamine-ThDP intermediate;2.25;CA;CALCIUM ION;2-OXOGLUTARATE DECARBOXYLASE;1772;
2YIG;A;MMP13 in complex with a novel selective non zinc binding inhibitor;1.7;CA;CALCIUM ION;COLLAGENASE 3;9606;
2YIG;B;MMP13 in complex with a novel selective non zinc binding inhibitor;1.7;CA;CALCIUM ION;COLLAGENASE 3;9606;
2YIH;A;Structure of a Paenibacillus polymyxa Xyloglucanase from GH family 44 with Xyloglucan;1.7;CA;CALCIUM ION;CEL44C;1406;
2YIK;A;Catalytic domain of Clostridium thermocellum CelT;2.1;CA;CALCIUM ION;ENDOGLUCANASE;1515;
2YJQ;A;Structure of a Paenibacillus Polymyxa Xyloglucanase from Glycoside Hydrolase Family 44;2.25;CA;CALCIUM ION;CEL44C;1406;
2YJQ;B;Structure of a Paenibacillus Polymyxa Xyloglucanase from Glycoside Hydrolase Family 44;2.25;CA;CALCIUM ION;CEL44C;1406;
2YKK;A;Structure of a Paenibacillus Polymyxa Xyloglucanase from Glycoside Hydrolase Family 44;1.79;CA;CALCIUM ION;CEL44C;1406;
2YKM;A;Crystal structure of HIV-1 Reverse Transcriptase (RT) in complex with a Difluoromethylbenzoxazole (DFMB) Pyrimidine Thioether derivative, a non-nucleoside RT inhibitor (NNRTI);2.9;CA;CALCIUM ION;REVERSE TRANSCRIPTASE/RIBONUCLEASE H;11676;
2YKN;A;Crystal structure of HIV-1 Reverse Transcriptase (RT) in complex with a Difluoromethylbenzoxazole (DFMB) Pyrimidine Thioether derivative, a non-nucleoside RT inhibitor (NNRTI);2.12;CA;CALCIUM ION;REVERSE TRANSCRIPTASE/RIBONUCLEASE H;11676;
2YLJ;A;Horse Radish Peroxidase, mutant S167Y;1.69;CA;CALCIUM ION;PEROXIDASE C1A;3704;
2YLL;A;Inhibition of the pneumococcal virulence factor StrH and molecular insights into N-glycan recognition and hydrolysis;1.85;CA;CALCIUM ION;BETA-N-ACETYLHEXOSAMINIDASE;1313;
2YN3;A;Structural insight into the giant calcium-binding adhesin SiiE: implications for the adhesion of Salmonella enterica to polarized epithelial cells;2.12;CA;CALCIUM ION;PUTATIVE INNER MEMBRANE PROTEIN;28901;
2YN3;B;Structural insight into the giant calcium-binding adhesin SiiE: implications for the adhesion of Salmonella enterica to polarized epithelial cells;2.12;CA;CALCIUM ION;PUTATIVE INNER MEMBRANE PROTEIN;28901;
2YN3;C;Structural insight into the giant calcium-binding adhesin SiiE: implications for the adhesion of Salmonella enterica to polarized epithelial cells;2.12;CA;CALCIUM ION;PUTATIVE INNER MEMBRANE PROTEIN;28901;
2YN3;D;Structural insight into the giant calcium-binding adhesin SiiE: implications for the adhesion of Salmonella enterica to polarized epithelial cells;2.12;CA;CALCIUM ION;PUTATIVE INNER MEMBRANE PROTEIN;28901;
2YN5;A;Structural insight into the giant calcium-binding adhesin SiiE: implications for the adhesion of Salmonella enterica to polarized epithelial cells;1.85;CA;CALCIUM ION;PUTATIVE INNER MEMBRANE PROTEIN;28901;
2YN5;B;Structural insight into the giant calcium-binding adhesin SiiE: implications for the adhesion of Salmonella enterica to polarized epithelial cells;1.85;CA;CALCIUM ION;PUTATIVE INNER MEMBRANE PROTEIN;28901;
2YOA;A;Synaptotagmin-1 C2B domain with phosphoserine;1.5;CA;CALCIUM ION;SYNAPTOTAGMIN-1;10116;
2YOA;B;Synaptotagmin-1 C2B domain with phosphoserine;1.5;CA;CALCIUM ION;SYNAPTOTAGMIN-1;10116;
2YOC;A;Crystal structure of PulA from Klebsiella oxytoca;2.88;CA;CALCIUM ION;PULLULANASE;571;
2YOC;B;Crystal structure of PulA from Klebsiella oxytoca;2.88;CA;CALCIUM ION;PULLULANASE;571;
2YV7;A;Crystal structure of the CLIC homolog from drosophila melanogaster;1.7;CA;CALCIUM ION;CG10997-PA;7227;
2YV9;A;Crystal structure of the CLIC homologue EXC-4 from c. elegans;1.6;CA;CALCIUM ION;Chloride intracellular channel exc-4;6239;
2YV9;B;Crystal structure of the CLIC homologue EXC-4 from c. elegans;1.6;CA;CALCIUM ION;Chloride intracellular channel exc-4;6239;
2YZ4;A;The neutron structure of concanavalin A at 2.2 Angstroms;2.2;CA;CALCIUM ION;Concanavalin A;3823;
2YZ7;A;X-ray analyses of 3-hydroxybutyrate dehydrogenase from Alcaligenes faecalis;2.19;CA;CALCIUM ION;D-3-hydroxybutyrate dehydrogenase;511;
2YZ7;B;X-ray analyses of 3-hydroxybutyrate dehydrogenase from Alcaligenes faecalis;2.19;CA;CALCIUM ION;D-3-hydroxybutyrate dehydrogenase;511;
2YZ7;E;X-ray analyses of 3-hydroxybutyrate dehydrogenase from Alcaligenes faecalis;2.19;CA;CALCIUM ION;D-3-hydroxybutyrate dehydrogenase;511;
2YZ7;F;X-ray analyses of 3-hydroxybutyrate dehydrogenase from Alcaligenes faecalis;2.19;CA;CALCIUM ION;D-3-hydroxybutyrate dehydrogenase;511;
2Z0J;A;Crystal structure of uncharacterized conserved protein from Thermus thermophilus HB8;1.5;CA;CALCIUM ION;Putative uncharacterized protein TTHA1438;274;
2Z0J;B;Crystal structure of uncharacterized conserved protein from Thermus thermophilus HB8;1.5;CA;CALCIUM ION;Putative uncharacterized protein TTHA1438;274;
2Z0J;C;Crystal structure of uncharacterized conserved protein from Thermus thermophilus HB8;1.5;CA;CALCIUM ION;Putative uncharacterized protein TTHA1438;274;
2Z0J;D;Crystal structure of uncharacterized conserved protein from Thermus thermophilus HB8;1.5;CA;CALCIUM ION;Putative uncharacterized protein TTHA1438;274;
2Z0J;E;Crystal structure of uncharacterized conserved protein from Thermus thermophilus HB8;1.5;CA;CALCIUM ION;Putative uncharacterized protein TTHA1438;274;
2Z0J;F;Crystal structure of uncharacterized conserved protein from Thermus thermophilus HB8;1.5;CA;CALCIUM ION;Putative uncharacterized protein TTHA1438;274;
2Z0J;G;Crystal structure of uncharacterized conserved protein from Thermus thermophilus HB8;1.5;CA;CALCIUM ION;Putative uncharacterized protein TTHA1438;274;
2Z0J;H;Crystal structure of uncharacterized conserved protein from Thermus thermophilus HB8;1.5;CA;CALCIUM ION;Putative uncharacterized protein TTHA1438;274;
2Z2D;A;Solution structure of human macrophage elastase (MMP-12) catalytic domain complexed with a gamma-keto butanoic acid inhibitor;;CA;CALCIUM ION;Macrophage metalloelastase;9606;
2Z2X;A;Crystal structure of mature form of Tk-subtilisin;1.7;CA;CALCIUM ION;Tk-subtilisin;311400;
2Z2Y;A;Crystal structure of autoprocessed form of Tk-subtilisin;1.89;CA;CALCIUM ION;Tk-subtilisin;311400;
2Z2Y;C;Crystal structure of autoprocessed form of Tk-subtilisin;1.89;CA;CALCIUM ION;Tk-subtilisin;311400;
2Z2Z;A;Crystal structure of unautoprocessed form of Tk-subtilisin soaked by 10mM CaCl2;1.87;CA;CALCIUM ION;Tk-subtilisin precursor;311400;
2Z30;A;Crystal structure of complex form between mat-Tk-subtilisin and Tk-propeptide;1.65;CA;CALCIUM ION;Tk-subtilisin;311400;
2Z48;A;Crystal Structure of Hemolytic Lectin CEL-III Complexed with GalNac;1.7;CA;CALCIUM ION;Hemolytic lectin CEL-III;40245;
2Z48;B;Crystal Structure of Hemolytic Lectin CEL-III Complexed with GalNac;1.7;CA;CALCIUM ION;Hemolytic lectin CEL-III;40245;
2Z49;A;Crystal Structure of Hemolytic Lectin CEL-III Complexed with methyl-alpha-D-galactopylanoside;1.95;CA;CALCIUM ION;Hemolytic lectin CEL-III;40245;
2Z49;B;Crystal Structure of Hemolytic Lectin CEL-III Complexed with methyl-alpha-D-galactopylanoside;1.95;CA;CALCIUM ION;Hemolytic lectin CEL-III;40245;
2Z4E;B;Crystal Structure of D-Dimer from Human Fibrin Complexed with Gly-His-Arg-Pro-Tyr-amide;2.7;CA;CALCIUM ION;Fibrinogen beta chain;9606;
2Z4E;C;Crystal Structure of D-Dimer from Human Fibrin Complexed with Gly-His-Arg-Pro-Tyr-amide;2.7;CA;CALCIUM ION;Fibrinogen, gamma polypeptide;9606;
2Z4E;E;Crystal Structure of D-Dimer from Human Fibrin Complexed with Gly-His-Arg-Pro-Tyr-amide;2.7;CA;CALCIUM ION;Fibrinogen beta chain;9606;
2Z4E;F;Crystal Structure of D-Dimer from Human Fibrin Complexed with Gly-His-Arg-Pro-Tyr-amide;2.7;CA;CALCIUM ION;Fibrinogen, gamma polypeptide;9606;
2Z56;A;Crystal structure of G56S-propeptide:S324A-subtilisin complex;1.9;CA;CALCIUM ION;Tk-subtilisin;311400;
2Z57;A;Crystal structure of G56E-propeptide:S324A-subtilisin complex;1.8;CA;CALCIUM ION;Tk-subtilisin;311400;
2Z58;A;Crystal structure of G56W-propeptide:S324A-subtilisin complex;1.88;CA;CALCIUM ION;Tk-subtilisin;311400;
2Z5G;A;Crystal structure of T1 lipase F16L mutant;1.8;CA;CALCIUM ION;Thermostable lipase;213419;
2Z5G;B;Crystal structure of T1 lipase F16L mutant;1.8;CA;CALCIUM ION;Thermostable lipase;213419;
2Z5Z;A;Crystal structure of the complex of buffalo Lactoperoxidase with fluoride ion at 3.5A resolution;3.5;CA;CALCIUM ION;Lactoperoxidase;89462;
2Z6I;A;Crystal Structure of S. pneumoniae Enoyl-Acyl Carrier Protein Reductase (FabK);1.7;CA;CALCIUM ION;Trans-2-enoyl-ACP reductase II;1313;
2Z6I;B;Crystal Structure of S. pneumoniae Enoyl-Acyl Carrier Protein Reductase (FabK);1.7;CA;CALCIUM ION;Trans-2-enoyl-ACP reductase II;1313;
2Z6J;A;Crystal Structure of S. pneumoniae Enoyl-Acyl Carrier Protein Reductase (FabK) in Complex with an Inhibitor;2.3;CA;CALCIUM ION;Trans-2-enoyl-ACP reductase II;1313;
2Z6J;B;Crystal Structure of S. pneumoniae Enoyl-Acyl Carrier Protein Reductase (FabK) in Complex with an Inhibitor;2.3;CA;CALCIUM ION;Trans-2-enoyl-ACP reductase II;1313;
2Z6M;A;Crystal structure of Human Ferritin H8 as biotemplate for noble metal nanoparticle synthesis;2.72;CA;CALCIUM ION;Ferritin heavy chain;9606;
2Z6M;B;Crystal structure of Human Ferritin H8 as biotemplate for noble metal nanoparticle synthesis;2.72;CA;CALCIUM ION;Ferritin heavy chain;9606;
2Z6M;G;Crystal structure of Human Ferritin H8 as biotemplate for noble metal nanoparticle synthesis;2.72;CA;CALCIUM ION;Ferritin heavy chain;9606;
2Z6M;H;Crystal structure of Human Ferritin H8 as biotemplate for noble metal nanoparticle synthesis;2.72;CA;CALCIUM ION;Ferritin heavy chain;9606;
2Z70;A;E.coli RNase 1 in complex with d(CGCGATCGCG);1.7;CA;CALCIUM ION;Ribonuclease I;562;
2Z8R;A;Crystal structure of rhamnogalacturonan lyase YesW at 1.40 A resolution;1.4;CA;CALCIUM ION;YesW protein;1423;
2Z8R;B;Crystal structure of rhamnogalacturonan lyase YesW at 1.40 A resolution;1.4;CA;CALCIUM ION;YesW protein;1423;
2Z8S;A;Crystal structure of rhamnogalacturonan lyase YesW complexed with digalacturonic acid;2.5;CA;CALCIUM ION;YesW protein;1423;
2Z8S;B;Crystal structure of rhamnogalacturonan lyase YesW complexed with digalacturonic acid;2.5;CA;CALCIUM ION;YesW protein;1423;
2Z8X;A;Crystal structure of extracellular lipase from Pseudomonas sp. MIS38;1.48;CA;CALCIUM ION;Lipase;91465;
2Z8Z;A;Crystal structure of a platinum-bound S445C mutant of Pseudomonas sp. MIS38 lipase;1.8;CA;CALCIUM ION;Lipase;91465;
2ZAG;A;Crystal structure of the SeMet-substituted soluble domain of STT3 from P. furiosus;3;CA;CALCIUM ION;Oligosaccharyl transferase stt3 subunit related protein;2261;
2ZAG;B;Crystal structure of the SeMet-substituted soluble domain of STT3 from P. furiosus;3;CA;CALCIUM ION;Oligosaccharyl transferase stt3 subunit related protein;2261;
2ZAG;C;Crystal structure of the SeMet-substituted soluble domain of STT3 from P. furiosus;3;CA;CALCIUM ION;Oligosaccharyl transferase stt3 subunit related protein;2261;
2ZAG;D;Crystal structure of the SeMet-substituted soluble domain of STT3 from P. furiosus;3;CA;CALCIUM ION;Oligosaccharyl transferase stt3 subunit related protein;2261;
2ZAH;A;X-ray structure of Melon necrotic spot virus;2.81;CA;CALCIUM ION;Coat protein;11987;
2ZAH;B;X-ray structure of Melon necrotic spot virus;2.81;CA;CALCIUM ION;Coat protein;11987;
2ZAI;A;Crystal structure of the soluble domain of STT3 from P. furiosus;2.7;CA;CALCIUM ION;Oligosaccharyl transferase stt3 subunit related protein;2261;
2ZAI;B;Crystal structure of the soluble domain of STT3 from P. furiosus;2.7;CA;CALCIUM ION;Oligosaccharyl transferase stt3 subunit related protein;2261;
2ZAI;C;Crystal structure of the soluble domain of STT3 from P. furiosus;2.7;CA;CALCIUM ION;Oligosaccharyl transferase stt3 subunit related protein;2261;
2ZAI;D;Crystal structure of the soluble domain of STT3 from P. furiosus;2.7;CA;CALCIUM ION;Oligosaccharyl transferase stt3 subunit related protein;2261;
2ZAL;A;Crystal structure of E. coli isoaspartyl aminopeptidase/L-asparaginase in complex with L-aspartate;1.9;CA;CALCIUM ION;L-asparaginase;562;
2ZAL;B;Crystal structure of E. coli isoaspartyl aminopeptidase/L-asparaginase in complex with L-aspartate;1.9;CA;CALCIUM ION;L-asparaginase;562;
2ZBA;A;Crystal Structure of F. sporotrichioides TRI101 complexed with Coenzyme A and T-2;2;CA;CALCIUM ION;Trichothecene 3-O-acetyltransferase;5514;
2ZBD;A;Crystal Structure of the SR Calcium Pump with Bound Aluminium Fluoride, ADP and Calcium;2.4;CA;CALCIUM ION;Sarcoplasmic/endoplasmic reticulum calcium ATPase 1;9986;
2ZBJ;A;Crystal structure of Dioclea rostrata lectin;2.05;CA;CALCIUM ION;Lectin alpha chain;192416;
2ZDK;A;Exploring Trypsin S3 Pocket;1.67;CA;CALCIUM ION;Cationic trypsin;9913;
2ZDL;A;Exploring trypsin S3 pocket;1.8;CA;CALCIUM ION;Cationic trypsin;9913;
2ZDM;A;Exploring trypsin S3 pocket;1.93;CA;CALCIUM ION;Cationic trypsin;9913;
2ZDN;A;Exploring trypsin S3 pocket;1.98;CA;CALCIUM ION;Cationic trypsin;9913;
2ZE0;A;Alpha-glucosidase GSJ;2;CA;CALCIUM ION;Alpha-glucosidase;258999;
2ZEW;A;Family 16 Cabohydrate Binding Domain Module 1;1.4;CA;CALCIUM ION;S-layer associated multidomain endoglucanase;44256;
2ZEW;B;Family 16 Cabohydrate Binding Domain Module 1;1.4;CA;CALCIUM ION;S-layer associated multidomain endoglucanase;44256;
2ZEX;A;Family 16 carbohydrate binding module;1.2;CA;CALCIUM ION;S-layer associated multidomain endoglucanase;44256;
2ZEX;B;Family 16 carbohydrate binding module;1.2;CA;CALCIUM ION;S-layer associated multidomain endoglucanase;44256;
2ZEY;A;Family 16 carbohydrate binding module;2.2;CA;CALCIUM ION;S-layer associated multidomain endoglucanase;44256;
2ZEY;B;Family 16 carbohydrate binding module;2.2;CA;CALCIUM ION;S-layer associated multidomain endoglucanase;44256;
2ZEZ;A;Family 16 Carbohydrate Binding Module-2;1.9;CA;CALCIUM ION;S-layer associated multidomain endoglucanase;44256;
2ZEZ;B;Family 16 Carbohydrate Binding Module-2;1.9;CA;CALCIUM ION;S-layer associated multidomain endoglucanase;44256;
2ZEZ;C;Family 16 Carbohydrate Binding Module-2;1.9;CA;CALCIUM ION;S-layer associated multidomain endoglucanase;44256;
2ZEZ;D;Family 16 Carbohydrate Binding Module-2;1.9;CA;CALCIUM ION;S-layer associated multidomain endoglucanase;44256;
2ZFD;A;The crystal structure of plant specific calcium binding protein AtCBL2 in complex with the regulatory domain of AtCIPK14;1.2;CA;CALCIUM ION;Calcineurin B-like protein 2;3702;
2ZFS;A;Exploring trypsin S3 pocket;1.51;CA;CALCIUM ION;Cationic trypsin;9913;
2ZFT;A;Exploring trypsin S3 pocket;1.76;CA;CALCIUM ION;Cationic trypsin;9913;
2ZHD;A;Exploring trypsin S3 pocket;1.94;CA;CALCIUM ION;Cationic trypsin;9913;
2ZIC;A;Crystal structure of Streptococcus mutans dextran glucosidase;2.2;CA;CALCIUM ION;Dextran glucosidase;210007;
2ZID;A;Crystal structure of dextran glucosidase E236Q complex with isomaltotriose;2.2;CA;CALCIUM ION;Dextran glucosidase;210007;
2ZJ6;A;Crystal structure of D337A mutant of Pseudomonas sp. MIS38 lipase;2.25;CA;CALCIUM ION;Lipase;91465;
2ZJ7;A;Crystal structure of D157A mutant of Pseudomonas sp. MIS38 lipase;2.21;CA;CALCIUM ION;Lipase;91465;
2ZKM;X;Crystal Structure of Phospholipase C Beta 2;1.62;CA;CALCIUM ION;1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase beta-2;9606;
2ZKT;A;Structure of PH0037 protein from Pyrococcus horikoshii;2.4;CA;CALCIUM ION;2,3-bisphosphoglycerate-independent phosphoglycerate mutase;53953;
2ZKT;B;Structure of PH0037 protein from Pyrococcus horikoshii;2.4;CA;CALCIUM ION;2,3-bisphosphoglycerate-independent phosphoglycerate mutase;53953;
2ZL5;A;Atomic resolution structural characterization of recognition of histo-blood group antigen by Norwalk virus;1.47;CA;CALCIUM ION;58 kd capsid protein;524364;
2ZL5;B;Atomic resolution structural characterization of recognition of histo-blood group antigen by Norwalk virus;1.47;CA;CALCIUM ION;58 kd capsid protein;524364;
2ZL7;A;Atomic resolution structural characterization of recognition of histo-blood group antigens by Norwalk virus;1.35;CA;CALCIUM ION;58 kd capsid protein;524364;
2ZMK;A;Crystl structure of Basic Winged bean lectin in complex with Gal-alpha-1,4-Gal-Beta-Ethylene;2.5;CA;CALCIUM ION;Basic agglutinin;3891;
2ZMK;B;Crystl structure of Basic Winged bean lectin in complex with Gal-alpha-1,4-Gal-Beta-Ethylene;2.5;CA;CALCIUM ION;Basic agglutinin;3891;
2ZMK;C;Crystl structure of Basic Winged bean lectin in complex with Gal-alpha-1,4-Gal-Beta-Ethylene;2.5;CA;CALCIUM ION;Basic agglutinin;3891;
2ZMK;D;Crystl structure of Basic Winged bean lectin in complex with Gal-alpha-1,4-Gal-Beta-Ethylene;2.5;CA;CALCIUM ION;Basic agglutinin;3891;
2ZML;A;Crystal structure of basic winged bean lectin in complex with Gal-ALPHA 1,4 Gal;2.65;CA;CALCIUM ION;Basic agglutinin;3891;
2ZML;B;Crystal structure of basic winged bean lectin in complex with Gal-ALPHA 1,4 Gal;2.65;CA;CALCIUM ION;Basic agglutinin;3891;
2ZML;C;Crystal structure of basic winged bean lectin in complex with Gal-ALPHA 1,4 Gal;2.65;CA;CALCIUM ION;Basic agglutinin;3891;
2ZML;D;Crystal structure of basic winged bean lectin in complex with Gal-ALPHA 1,4 Gal;2.65;CA;CALCIUM ION;Basic agglutinin;3891;
2ZMN;A;Crystal Structure of basic winged bean lectin in complex with Gal-alpha- 1,6 Glc;2.9;CA;CALCIUM ION;Basic agglutinin;3891;
2ZMN;B;Crystal Structure of basic winged bean lectin in complex with Gal-alpha- 1,6 Glc;2.9;CA;CALCIUM ION;Basic agglutinin;3891;
2ZMN;C;Crystal Structure of basic winged bean lectin in complex with Gal-alpha- 1,6 Glc;2.9;CA;CALCIUM ION;Basic agglutinin;3891;
2ZMN;D;Crystal Structure of basic winged bean lectin in complex with Gal-alpha- 1,6 Glc;2.9;CA;CALCIUM ION;Basic agglutinin;3891;
2ZN9;A;Crystal structure of Ca2+-bound form of des3-20ALG-2;2.4;CA;CALCIUM ION;Programmed cell death protein 6;9606;
2ZN9;B;Crystal structure of Ca2+-bound form of des3-20ALG-2;2.4;CA;CALCIUM ION;Programmed cell death protein 6;9606;
2ZNI;C;Crystal structure of Pyrrolysyl-tRNA synthetase-tRNA(Pyl) complex from Desulfitobacterium hafniense;3.1;CA;CALCIUM ION;bacterial tRNA;;
2ZNI;D;Crystal structure of Pyrrolysyl-tRNA synthetase-tRNA(Pyl) complex from Desulfitobacterium hafniense;3.1;CA;CALCIUM ION;bacterial tRNA;;
2ZO5;A;Structure of the Thioalkalivibrio nitratireducens cytochrome c nitrite reductase in a complex with azide;1.7;CA;CALCIUM ION;Eight-heme nitrite reductase;186931;
2ZO5;B;Structure of the Thioalkalivibrio nitratireducens cytochrome c nitrite reductase in a complex with azide;1.7;CA;CALCIUM ION;Eight-heme nitrite reductase;186931;
2ZOC;A;Crystal structure of recombinant human annexin IV;2;CA;CALCIUM ION;Annexin A4;9606;
2ZOC;B;Crystal structure of recombinant human annexin IV;2;CA;CALCIUM ION;Annexin A4;9606;
2ZP0;H;Human factor viia-tissue factor complexed with benzylsulfonamide-D-ile-gln-P-aminobenzamidine;2.7;CA;CALCIUM ION;Factor VII heavy chain;9606;
2ZP0;L;Human factor viia-tissue factor complexed with benzylsulfonamide-D-ile-gln-P-aminobenzamidine;2.7;CA;CALCIUM ION;Factor VII light chain;9606;
2ZP3;A;Carboxylic ester hydrolase, single mutant d49n of bovine pancreatic pla2 enzyme;1.9;CA;CALCIUM ION;Phospholipase A2;9913;
2ZP4;A;Carboxylic ester hydrolase, single mutant h48n of bovine pancreatic pla2 enzyme;1.9;CA;CALCIUM ION;Phospholipase A2;9913;
2ZP5;A;Carboxylic ester hydrolase, single mutant d49k of bovine pancreatic pla2 enzyme;1.9;CA;CALCIUM ION;Phospholipase A2;9913;
2ZPQ;A;Crystal structure of anionic trypsin isoform 1 from chum salmon;1.9;CA;CALCIUM ION;Anionic trypsin;8018;
2ZPQ;B;Crystal structure of anionic trypsin isoform 1 from chum salmon;1.9;CA;CALCIUM ION;Anionic trypsin;8018;
2ZPR;A;Crystal structure of anionic trypsin isoform 2 from chum salmon;1.75;CA;CALCIUM ION;Anionic trypsin;8018;
2ZPR;B;Crystal structure of anionic trypsin isoform 2 from chum salmon;1.75;CA;CALCIUM ION;Anionic trypsin;8018;
2ZPS;A;Crystal structure of anionic trypsin isoform 3 from chum salmon;1.55;CA;CALCIUM ION;Anionic trypsin;8018;
2ZQ0;A;Crystal structure of SusB complexed with acarbose;1.6;CA;CALCIUM ION;Alpha-glucosidase (Alpha-glucosidase SusB);818;
2ZQ0;B;Crystal structure of SusB complexed with acarbose;1.6;CA;CALCIUM ION;Alpha-glucosidase (Alpha-glucosidase SusB);818;
2ZQ1;A;Exploring trypsin S3 pocket;1.68;CA;CALCIUM ION;Cationic trypsin;9913;
2ZQ2;A;Exploring trypsin S3 pocket;1.4;CA;CALCIUM ION;Cationic trypsin;9913;
2ZRQ;A;Crystal structure of S324A-subtilisin;2.16;CA;CALCIUM ION;Tk-subtilisin;311400;
2ZRS;A;Crystal structure of Ca2+-bound form of des3-23ALG-2;3.1;CA;CALCIUM ION;Programmed cell death protein 6;9606;
2ZRS;B;Crystal structure of Ca2+-bound form of des3-23ALG-2;3.1;CA;CALCIUM ION;Programmed cell death protein 6;9606;
2ZRS;C;Crystal structure of Ca2+-bound form of des3-23ALG-2;3.1;CA;CALCIUM ION;Programmed cell death protein 6;9606;
2ZRS;D;Crystal structure of Ca2+-bound form of des3-23ALG-2;3.1;CA;CALCIUM ION;Programmed cell death protein 6;9606;
2ZRS;E;Crystal structure of Ca2+-bound form of des3-23ALG-2;3.1;CA;CALCIUM ION;Programmed cell death protein 6;9606;
2ZRS;F;Crystal structure of Ca2+-bound form of des3-23ALG-2;3.1;CA;CALCIUM ION;Programmed cell death protein 6;9606;
2ZRS;G;Crystal structure of Ca2+-bound form of des3-23ALG-2;3.1;CA;CALCIUM ION;Programmed cell death protein 6;9606;
2ZRS;H;Crystal structure of Ca2+-bound form of des3-23ALG-2;3.1;CA;CALCIUM ION;Programmed cell death protein 6;9606;
2ZS0;A;Structural Basis for the Heterotropic and Homotropic Interactions of Invertebrate Giant Hemoglobin;1.6;CA;CALCIUM ION;Extracellular giant hemoglobin major globin subunit A1;55676;
2ZS0;B;Structural Basis for the Heterotropic and Homotropic Interactions of Invertebrate Giant Hemoglobin;1.6;CA;CALCIUM ION;Extracellular giant hemoglobin major globin subunit A2;55676;
2ZS0;C;Structural Basis for the Heterotropic and Homotropic Interactions of Invertebrate Giant Hemoglobin;1.6;CA;CALCIUM ION;Extracellular giant hemoglobin major globin subunit B2;55676;
2ZUX;A;Crystal structure of rhamnogalacturonan lyase YesW complexed with rhamnose;1.32;CA;CALCIUM ION;YesW protein;1423;
2ZUX;B;Crystal structure of rhamnogalacturonan lyase YesW complexed with rhamnose;1.32;CA;CALCIUM ION;YesW protein;1423;
2ZUY;A;Crystal structure of exotype rhamnogalacturonan lyase YesX;1.65;CA;CALCIUM ION;YesX protein;1423;
2ZVD;A;Crystal structure of Pseudomonas sp. MIS38 lipase in an open conformation;2.15;CA;CALCIUM ION;Lipase;91465;
2ZVD;C;Crystal structure of Pseudomonas sp. MIS38 lipase in an open conformation;2.15;CA;CALCIUM ION;Lipase;91465;
2ZWH;A;Model for the F-actin structure;3.3;CA;CALCIUM ION;Actin, alpha skeletal muscle;9986;
2ZWL;H;Human factor viia-tissue factor complexed with highly selective peptide inhibitor;2.2;CA;CALCIUM ION;Factor VII heavy chain;9606;
2ZWL;L;Human factor viia-tissue factor complexed with highly selective peptide inhibitor;2.2;CA;CALCIUM ION;Factor VII light chain;9606;
2ZWO;A;Crystal structure of Ca2 site mutant of Pro-S324A;2.07;CA;CALCIUM ION;Tk-subtilisin;311400;
2ZWO;B;Crystal structure of Ca2 site mutant of Pro-S324A;2.07;CA;CALCIUM ION;Tk-subtilisin;311400;
2ZWO;C;Crystal structure of Ca2 site mutant of Pro-S324A;2.07;CA;CALCIUM ION;Tk-subtilisin;311400;
2ZWP;A;Crystal structure of Ca3 site mutant of Pro-S324A;2.4;CA;CALCIUM ION;Tk-subtilisin;311400;
2ZWP;B;Crystal structure of Ca3 site mutant of Pro-S324A;2.4;CA;CALCIUM ION;Tk-subtilisin;311400;
2ZY6;A;Crystal structure of a truncated tRNA, TPHE39A;1.75;CA;CALCIUM ION;phenylalanyl transfer RNA;;
2ZYH;A;mutant A. Fulgidus lipase S136A complexed with fatty acid fragment;1.83;CA;CALCIUM ION;Lipase, putative;2234;
2ZYH;B;mutant A. Fulgidus lipase S136A complexed with fatty acid fragment;1.83;CA;CALCIUM ION;Lipase, putative;2234;
2ZYI;A;A. Fulgidus lipase with fatty acid fragment and calcium;2.3;CA;CALCIUM ION;Lipase, putative;2234;
2ZYI;B;A. Fulgidus lipase with fatty acid fragment and calcium;2.3;CA;CALCIUM ION;Lipase, putative;2234;
2ZZJ;A;Crystal structure of endo-beta-1,4-glucuronan lyase from fungus Trichoderma reesei;1.8;CA;CALCIUM ION;Glucuronan lyase A;51453;
2ZZU;H;Human Factor VIIA-Tissue Factor Complexed with ethylsulfonamide-D-5-(3-carboxybenzyloxy)-Trp-Gln-p-aminobenzamidine;2.5;CA;CALCIUM ION;Factor VII heavy chain;9606;
2ZZU;L;Human Factor VIIA-Tissue Factor Complexed with ethylsulfonamide-D-5-(3-carboxybenzyloxy)-Trp-Gln-p-aminobenzamidine;2.5;CA;CALCIUM ION;Factor VII light chain;9606;
2ZZV;A;Crystal Structure of a Periplasmic Substrate Binding Protein in Complex with Calcium and Lactate;1.4;CA;CALCIUM ION;ABC transporter, solute-binding protein;274;
2ZZV;B;Crystal Structure of a Periplasmic Substrate Binding Protein in Complex with Calcium and Lactate;1.4;CA;CALCIUM ION;ABC transporter, solute-binding protein;274;
2ZZX;C;Crystal Structure of a Periplasmic Substrate Binding Protein in Complex with Lactate;1.75;CA;CALCIUM ION;ABC transporter, solute-binding protein;274;
333D;A;THE CRYSTAL STRUCTURE OF AN RNA OLIGOMER INCORPORATING TANDEM ADENOSINE-INOSINE MISMATCHES;2.52;CA;CALCIUM ION;RNA (5'-R(*CP*GP*CP*AP*IP*GP*CP*G)-3');;
334D;A;DEFINING GC-SPECIFICITY IN THE MINOR GROOVE: SIDE-BY-SIDE BINDING OF THE DI-IMIDAZOLE LEXITROPSIN TO C-A-T-G-G-C-C-A-T-G;1.8;CA;CALCIUM ION;DNA (5'-D(*CP*AP*TP*GP*GP*CP*CP*AP*TP*G)-3');;
352D;A;THE CRYSTAL STRUCTURE OF A PARALLEL-STRANDED PARALLEL-STRANDED GUANINE TETRAPLEX AT 0.95 ANGSTROM RESOLUTION;0.95;CA;CALCIUM ION;DNA (5'-D(*TP*GP*GP*GP*GP*T)-3');;
352D;B;THE CRYSTAL STRUCTURE OF A PARALLEL-STRANDED PARALLEL-STRANDED GUANINE TETRAPLEX AT 0.95 ANGSTROM RESOLUTION;0.95;CA;CALCIUM ION;DNA (5'-D(*TP*GP*GP*GP*GP*T)-3');;
352D;C;THE CRYSTAL STRUCTURE OF A PARALLEL-STRANDED PARALLEL-STRANDED GUANINE TETRAPLEX AT 0.95 ANGSTROM RESOLUTION;0.95;CA;CALCIUM ION;DNA (5'-D(*TP*GP*GP*GP*GP*T)-3');;
352D;G;THE CRYSTAL STRUCTURE OF A PARALLEL-STRANDED PARALLEL-STRANDED GUANINE TETRAPLEX AT 0.95 ANGSTROM RESOLUTION;0.95;CA;CALCIUM ION;DNA (5'-D(*TP*GP*GP*GP*GP*T)-3');;
352D;K;THE CRYSTAL STRUCTURE OF A PARALLEL-STRANDED PARALLEL-STRANDED GUANINE TETRAPLEX AT 0.95 ANGSTROM RESOLUTION;0.95;CA;CALCIUM ION;DNA (5'-D(*TP*GP*GP*GP*GP*T)-3');;
352D;M;THE CRYSTAL STRUCTURE OF A PARALLEL-STRANDED PARALLEL-STRANDED GUANINE TETRAPLEX AT 0.95 ANGSTROM RESOLUTION;0.95;CA;CALCIUM ION;DNA (5'-D(*TP*GP*GP*GP*GP*T)-3');;
352D;N;THE CRYSTAL STRUCTURE OF A PARALLEL-STRANDED PARALLEL-STRANDED GUANINE TETRAPLEX AT 0.95 ANGSTROM RESOLUTION;0.95;CA;CALCIUM ION;DNA (5'-D(*TP*GP*GP*GP*GP*T)-3');;
352D;O;THE CRYSTAL STRUCTURE OF A PARALLEL-STRANDED PARALLEL-STRANDED GUANINE TETRAPLEX AT 0.95 ANGSTROM RESOLUTION;0.95;CA;CALCIUM ION;DNA (5'-D(*TP*GP*GP*GP*GP*T)-3');;
397D;A;A 1.3 A RESOLUTION CRYSTAL STRUCTURE OF THE HIV-1 TRANS-ACTIVATION RESPONSE REGION RNA STEM REVEALS A METAL ION-DEPENDENT BULGE CONFORMATION;1.3;CA;CALCIUM ION;RNA (5'-R(*GP*GP*CP*CP*AP*GP*AP*UP*CP*UP*GP*AP*GP*CP*G)-3');;
3A09;A;Crystal structure of Sphingomonas sp. A1 alginate-binding protein AlgQ1 in complex with unsaturated trimannuronate;1.4;CA;CALCIUM ION;AlgQ1;90322;
3A0K;A;Crystal structure of an antiflamatory legume lectin from Cymbosema roseum seeds;1.8;CA;CALCIUM ION;Cymbosema roseum mannose-specific lectin;202239;
3A0K;C;Crystal structure of an antiflamatory legume lectin from Cymbosema roseum seeds;1.8;CA;CALCIUM ION;Cymbosema roseum mannose-specific lectin;202239;
3A0K;E;Crystal structure of an antiflamatory legume lectin from Cymbosema roseum seeds;1.8;CA;CALCIUM ION;Cymbosema roseum mannose-specific lectin;202239;
3A0K;G;Crystal structure of an antiflamatory legume lectin from Cymbosema roseum seeds;1.8;CA;CALCIUM ION;Cymbosema roseum mannose-specific lectin;202239;
3A13;E;Crystal structure of Type III Rubisco SP4 mutant complexed with 2-CABP and activated with Ca;2.34;CA;CALCIUM ION;Ribulose bisphosphate carboxylase;311400;
3A13;J;Crystal structure of Type III Rubisco SP4 mutant complexed with 2-CABP and activated with Ca;2.34;CA;CALCIUM ION;Ribulose bisphosphate carboxylase;311400;
3A24;A;Crystal structure of BT1871 retaining glycosidase;2.3;CA;CALCIUM ION;alpha-galactosidase;818;
3A24;B;Crystal structure of BT1871 retaining glycosidase;2.3;CA;CALCIUM ION;alpha-galactosidase;818;
3A3N;A;Crystal structure of complex between SA-subtilisin and Tk-propeptide with deletion of the two C-terminal residues;2.2;CA;CALCIUM ION;Tk-subtilisin;311400;
3A3O;A;Crystal structure of complex between SA-subtilisin and Tk-propeptide with deletion of the five C-terminal residues;1.9;CA;CALCIUM ION;Tk-subtilisin;311400;
3A3P;A;Crystal structure of complex between E201A/SA-subtilisin and Tk-propeptide;1.9;CA;CALCIUM ION;Tk-subtilisin;311400;
3A47;A;Crystal structure of isomaltase from Saccharomyces cerevisiae;1.59;CA;CALCIUM ION;Oligo-1,6-glucosidase;4932;
3A4A;A;Crystal structure of isomaltase from Saccharomyces cerevisiae;1.6;CA;CALCIUM ION;Oligo-1,6-glucosidase;4932;
3A4H;A;Structure of cytochrome P450 vdh from Pseudonocardia autotrophica (orthorhombic crystal form);3.06;CA;CALCIUM ION;Vitamin D hydroxylase;2074;
3A4U;A;Crystal structure of MCFD2 in complex with carbohydrate recognition domain of ERGIC-53;1.84;CA;CALCIUM ION;Protein ERGIC-53;9606;
3A4U;B;Crystal structure of MCFD2 in complex with carbohydrate recognition domain of ERGIC-53;1.84;CA;CALCIUM ION;Multiple coagulation factor deficiency protein 2;9606;
3A4Z;A;Structure of cytochrome P450 Vdh mutant (Vdh-K1) obtained by directed evolution;2.2;CA;CALCIUM ION;Vitamin D hydroxylase;2074;
3A4Z;C;Structure of cytochrome P450 Vdh mutant (Vdh-K1) obtained by directed evolution;2.2;CA;CALCIUM ION;Vitamin D hydroxylase;2074;
3A4Z;D;Structure of cytochrome P450 Vdh mutant (Vdh-K1) obtained by directed evolution;2.2;CA;CALCIUM ION;Vitamin D hydroxylase;2074;
3A4Z;E;Structure of cytochrome P450 Vdh mutant (Vdh-K1) obtained by directed evolution;2.2;CA;CALCIUM ION;Vitamin D hydroxylase;2074;
3A50;A;Structure of cytochrome P450 Vdh mutant (Vdh-K1) obtained by directed evolution with bound vitamin D3;2.05;CA;CALCIUM ION;Vitamin D hydroxylase;2074;
3A50;C;Structure of cytochrome P450 Vdh mutant (Vdh-K1) obtained by directed evolution with bound vitamin D3;2.05;CA;CALCIUM ION;Vitamin D hydroxylase;2074;
3A50;D;Structure of cytochrome P450 Vdh mutant (Vdh-K1) obtained by directed evolution with bound vitamin D3;2.05;CA;CALCIUM ION;Vitamin D hydroxylase;2074;
3A50;E;Structure of cytochrome P450 Vdh mutant (Vdh-K1) obtained by directed evolution with bound vitamin D3;2.05;CA;CALCIUM ION;Vitamin D hydroxylase;2074;
3A51;A;Structure of cytochrome P450 Vdh mutant (Vdh-K1) obtained by directed evolution with bound 25-hydroxyvitamin D3;2;CA;CALCIUM ION;Vitamin D hydroxylase;2074;
3A51;C;Structure of cytochrome P450 Vdh mutant (Vdh-K1) obtained by directed evolution with bound 25-hydroxyvitamin D3;2;CA;CALCIUM ION;Vitamin D hydroxylase;2074;
3A51;D;Structure of cytochrome P450 Vdh mutant (Vdh-K1) obtained by directed evolution with bound 25-hydroxyvitamin D3;2;CA;CALCIUM ION;Vitamin D hydroxylase;2074;
3A51;E;Structure of cytochrome P450 Vdh mutant (Vdh-K1) obtained by directed evolution with bound 25-hydroxyvitamin D3;2;CA;CALCIUM ION;Vitamin D hydroxylase;2074;
3A5L;S;Crystal Structure of a Dictyostelium P109A Mg2+-Actin in Complex with Human Gelsolin Segment 1;2.4;CA;CALCIUM ION;Gelsolin;9606;
3A5M;S;Crystal Structure of a Dictyostelium P109I Mg2+-Actin in Complex with Human Gelsolin Segment 1;2.4;CA;CALCIUM ION;Gelsolin;9606;
3A5N;C;Crystal Structure of a Dictyostelium P109A Ca2+-Actin in Complex with Human Gelsolin Segment 1;2.36;CA;CALCIUM ION;Major actin;44689;
3A5N;S;Crystal Structure of a Dictyostelium P109A Ca2+-Actin in Complex with Human Gelsolin Segment 1;2.36;CA;CALCIUM ION;Gelsolin;9606;
3A5O;C;Crystal Structure of a Dictyostelium P109I Ca2+-Actin in Complex with Human Gelsolin Segment 1;2.4;CA;CALCIUM ION;Major actin;44689;
3A5O;S;Crystal Structure of a Dictyostelium P109I Ca2+-Actin in Complex with Human Gelsolin Segment 1;2.4;CA;CALCIUM ION;Gelsolin;9606;
3A68;A;Crystal structure of plant ferritin reveals a novel metal binding site that functions as a transit site for metal transfer in ferritin;1.8;CA;CALCIUM ION;Ferritin-4, chloroplastic;3847;
3A68;B;Crystal structure of plant ferritin reveals a novel metal binding site that functions as a transit site for metal transfer in ferritin;1.8;CA;CALCIUM ION;Ferritin-4, chloroplastic;3847;
3A68;C;Crystal structure of plant ferritin reveals a novel metal binding site that functions as a transit site for metal transfer in ferritin;1.8;CA;CALCIUM ION;Ferritin-4, chloroplastic;3847;
3A68;D;Crystal structure of plant ferritin reveals a novel metal binding site that functions as a transit site for metal transfer in ferritin;1.8;CA;CALCIUM ION;Ferritin-4, chloroplastic;3847;
3A68;E;Crystal structure of plant ferritin reveals a novel metal binding site that functions as a transit site for metal transfer in ferritin;1.8;CA;CALCIUM ION;Ferritin-4, chloroplastic;3847;
3A68;F;Crystal structure of plant ferritin reveals a novel metal binding site that functions as a transit site for metal transfer in ferritin;1.8;CA;CALCIUM ION;Ferritin-4, chloroplastic;3847;
3A68;G;Crystal structure of plant ferritin reveals a novel metal binding site that functions as a transit site for metal transfer in ferritin;1.8;CA;CALCIUM ION;Ferritin-4, chloroplastic;3847;
3A68;H;Crystal structure of plant ferritin reveals a novel metal binding site that functions as a transit site for metal transfer in ferritin;1.8;CA;CALCIUM ION;Ferritin-4, chloroplastic;3847;
3A68;I;Crystal structure of plant ferritin reveals a novel metal binding site that functions as a transit site for metal transfer in ferritin;1.8;CA;CALCIUM ION;Ferritin-4, chloroplastic;3847;
3A68;J;Crystal structure of plant ferritin reveals a novel metal binding site that functions as a transit site for metal transfer in ferritin;1.8;CA;CALCIUM ION;Ferritin-4, chloroplastic;3847;
3A68;K;Crystal structure of plant ferritin reveals a novel metal binding site that functions as a transit site for metal transfer in ferritin;1.8;CA;CALCIUM ION;Ferritin-4, chloroplastic;3847;
3A68;L;Crystal structure of plant ferritin reveals a novel metal binding site that functions as a transit site for metal transfer in ferritin;1.8;CA;CALCIUM ION;Ferritin-4, chloroplastic;3847;
3A68;M;Crystal structure of plant ferritin reveals a novel metal binding site that functions as a transit site for metal transfer in ferritin;1.8;CA;CALCIUM ION;Ferritin-4, chloroplastic;3847;
3A68;N;Crystal structure of plant ferritin reveals a novel metal binding site that functions as a transit site for metal transfer in ferritin;1.8;CA;CALCIUM ION;Ferritin-4, chloroplastic;3847;
3A68;O;Crystal structure of plant ferritin reveals a novel metal binding site that functions as a transit site for metal transfer in ferritin;1.8;CA;CALCIUM ION;Ferritin-4, chloroplastic;3847;
3A68;P;Crystal structure of plant ferritin reveals a novel metal binding site that functions as a transit site for metal transfer in ferritin;1.8;CA;CALCIUM ION;Ferritin-4, chloroplastic;3847;
3A68;Q;Crystal structure of plant ferritin reveals a novel metal binding site that functions as a transit site for metal transfer in ferritin;1.8;CA;CALCIUM ION;Ferritin-4, chloroplastic;3847;
3A68;R;Crystal structure of plant ferritin reveals a novel metal binding site that functions as a transit site for metal transfer in ferritin;1.8;CA;CALCIUM ION;Ferritin-4, chloroplastic;3847;
3A68;S;Crystal structure of plant ferritin reveals a novel metal binding site that functions as a transit site for metal transfer in ferritin;1.8;CA;CALCIUM ION;Ferritin-4, chloroplastic;3847;
3A68;T;Crystal structure of plant ferritin reveals a novel metal binding site that functions as a transit site for metal transfer in ferritin;1.8;CA;CALCIUM ION;Ferritin-4, chloroplastic;3847;
3A68;U;Crystal structure of plant ferritin reveals a novel metal binding site that functions as a transit site for metal transfer in ferritin;1.8;CA;CALCIUM ION;Ferritin-4, chloroplastic;3847;
3A68;V;Crystal structure of plant ferritin reveals a novel metal binding site that functions as a transit site for metal transfer in ferritin;1.8;CA;CALCIUM ION;Ferritin-4, chloroplastic;3847;
3A68;W;Crystal structure of plant ferritin reveals a novel metal binding site that functions as a transit site for metal transfer in ferritin;1.8;CA;CALCIUM ION;Ferritin-4, chloroplastic;3847;
3A68;X;Crystal structure of plant ferritin reveals a novel metal binding site that functions as a transit site for metal transfer in ferritin;1.8;CA;CALCIUM ION;Ferritin-4, chloroplastic;3847;
3A6O;A;Crystal structure of Thermoactinomyces vulgaris R-47 alpha-amylase 2/acarbose complex;2.8;CA;CALCIUM ION;Neopullulanase 2;2026;
3A6O;B;Crystal structure of Thermoactinomyces vulgaris R-47 alpha-amylase 2/acarbose complex;2.8;CA;CALCIUM ION;Neopullulanase 2;2026;
3A6Z;A;Crystal structure of Pseudomonas sp. MIS38 lipase (PML) in the open conformation following dialysis against Ca-free buffer;2.15;CA;CALCIUM ION;Lipase;91465;
3A6Z;C;Crystal structure of Pseudomonas sp. MIS38 lipase (PML) in the open conformation following dialysis against Ca-free buffer;2.15;CA;CALCIUM ION;Lipase;91465;
3A70;A;Crystal structure of Pseudomonas sp. MIS38 lipase in complex with diethyl phosphate;2.15;CA;CALCIUM ION;Lipase;91465;
3A70;C;Crystal structure of Pseudomonas sp. MIS38 lipase in complex with diethyl phosphate;2.15;CA;CALCIUM ION;Lipase;91465;
3A7Q;A;Structural basis for specific recognition of reelin by its receptors;2.6;CA;CALCIUM ION;Reelin;10090;
3A7Q;B;Structural basis for specific recognition of reelin by its receptors;2.6;CA;CALCIUM ION;Low-density lipoprotein receptor-related protein 8;9606;
3A7T;A;Crystal Structure of Trypsin complexed with 4-formylbenzimidamide;1.75;CA;CALCIUM ION;Cationic trypsin;9913;
3A7V;A;Crystal Structure of Trypsin complexed with 3-formylbenzimidamide;1.75;CA;CALCIUM ION;Cationic trypsin;9913;
3A7W;A;Crystal Structure of Trypsin complexed with (E)-4-((tetrahydro-2H-pyran-2-yloxyimino)methyl)benzimidamide (soaking 4hours);1.75;CA;CALCIUM ION;Cationic trypsin;9913;
3A7X;A;Crystal Structure of Trypsin complexed with (E)-2-(4-carbamimidoylbenzylideneaminooxy)acetic acid (soaking 45seconds);1.75;CA;CALCIUM ION;Cationic trypsin;9913;
3A7Y;A;Crystal Structure of Trypsin complexed with (E)-4-((1-methylpiperidin-3-yloxyimino)methyl)benzimidamide (soaking 2hours);1.81;CA;CALCIUM ION;Cationic trypsin;9913;
3A7Z;A;Crystal Structure of Trypsin complexed with (E)-4-((1-methylpiperidin-4-yloxyimino)methyl)benzimidamide (soaking 3hours);1.8;CA;CALCIUM ION;Cationic trypsin;9913;
3A80;A;Crystal Structure of Trypsin complexed with (E)-2-(4-carbamimidoylbenzylideneaminooxy)-2-methylpropanoic acid (soaking 40seconds);1.75;CA;CALCIUM ION;Cationic trypsin;9913;
3A81;A;Crystal Structure of Trypsin complexed with (E)-4-((2-nicotinoylhydrazono)methyl)benzimidamide (soaking 8 hours);1.78;CA;CALCIUM ION;Cationic trypsin;9913;
3A82;A;Crystal Structure of Trypsin complexed with pre-synthesized (E)-2-(4-carbamimidoylbenzylideneaminooxy)acetic acid;1.75;CA;CALCIUM ION;Cationic trypsin;9913;
3A83;A;Crystal Structure of Trypsin complexed with pre-synthesized (E)-4-((2-nicotinoylhydrazono)methyl)benzimidamide;1.78;CA;CALCIUM ION;Cationic trypsin;9913;
3A84;A;Crystal Structure of Trypsin complexed with(E)-2-(4-carbamimidoylbenzylideneaminooxy)acetic acid (soaking 5 seconds);1.75;CA;CALCIUM ION;Cationic trypsin;9913;
3A85;A;Crystal Structure of Trypsin complexed with (E)-2-(4-carbamimidoylbenzylideneaminooxy)acetic acid (soaking 15 seconds);1.75;CA;CALCIUM ION;Cationic trypsin;9913;
3A86;A;Crystal Structure of Trypsin complexed with (E)-2-(4-carbamimidoylbenzylideneaminooxy)acetic acid (soaking 30 seconds);1.75;CA;CALCIUM ION;Cationic trypsin;9913;
3A87;A;Crystal Structure of Trypsin complexed with (E)-4-((2-nicotinoylhydrazono)methyl)benzimidamide (soaking 5 minutes);1.75;CA;CALCIUM ION;Cationic trypsin;9913;
3A88;A;Crystal Structure of Trypsin complexed with (E)-4-((2-nicotinoylhydrazono)methyl)benzimidamide (soaking 30 minutes);1.75;CA;CALCIUM ION;Cationic trypsin;9913;
3A89;A;Crystal Structure of Trypsin complexed with (E)-4-((2-nicotinoylhydrazono)methyl)benzimidamide (soaking 4 hours);1.8;CA;CALCIUM ION;Cationic trypsin;9913;
3A8A;A;Crystal Structure of Trypsin complexed with 4-formylbenzimidamide and aniline;1.4;CA;CALCIUM ION;Cationic trypsin;9913;
3A8B;A;Crystal Structure of Trypsin complexed with (E)-4-((4-bromophenylimino)methyl)benzimidamide;1.75;CA;CALCIUM ION;Cationic trypsin;9913;
3A8C;A;Crystal Structure of Trypsin complexed with (E)-2-(4-carbamimidoylbenzylideneaminooxy)acetic acid (soaking with mixture of [(E)-2-(4-carbamimidoylbenzylideneaminooxy)acetic acid] and [(E)-2-(4-carbamimidoylbenzylideneaminooxy)-2-methylpropanoic acid]);1.85;CA;CALCIUM ION;Cationic trypsin;9913;
3A8D;A;Crystal Structure of Trypsin complexed with (E)-2-(4-carbamimidoylbenzylideneaminooxy)acetic acid (under aniline-free condition);1.75;CA;CALCIUM ION;Cationic trypsin;9913;
3A8R;A;The structure of the N-terminal regulatory domain of a plant NADPH oxidase;2.4;CA;CALCIUM ION;Putative uncharacterized protein;4530;
3A8R;B;The structure of the N-terminal regulatory domain of a plant NADPH oxidase;2.4;CA;CALCIUM ION;Putative uncharacterized protein;4530;
3A9G;A;Crystal Structure of PQQ-dependent sugar dehydrogenase apo-form;2.39;CA;CALCIUM ION;Putative uncharacterized protein;13773;
3A9H;A;Crystal Structure of PQQ-dependent sugar dehydrogenase holo-form;2.5;CA;CALCIUM ION;Putative uncharacterized protein;13773;
3A9Q;A;Crystal Structure Analysis of E173A variant of the soybean ferritin SFER4;1.9;CA;CALCIUM ION;Ferritin-4, chloroplastic;3847;
3A9Q;B;Crystal Structure Analysis of E173A variant of the soybean ferritin SFER4;1.9;CA;CALCIUM ION;Ferritin-4, chloroplastic;3847;
3A9Q;C;Crystal Structure Analysis of E173A variant of the soybean ferritin SFER4;1.9;CA;CALCIUM ION;Ferritin-4, chloroplastic;3847;
3A9Q;D;Crystal Structure Analysis of E173A variant of the soybean ferritin SFER4;1.9;CA;CALCIUM ION;Ferritin-4, chloroplastic;3847;
3A9Q;E;Crystal Structure Analysis of E173A variant of the soybean ferritin SFER4;1.9;CA;CALCIUM ION;Ferritin-4, chloroplastic;3847;
3A9Q;F;Crystal Structure Analysis of E173A variant of the soybean ferritin SFER4;1.9;CA;CALCIUM ION;Ferritin-4, chloroplastic;3847;
3A9Q;G;Crystal Structure Analysis of E173A variant of the soybean ferritin SFER4;1.9;CA;CALCIUM ION;Ferritin-4, chloroplastic;3847;
3A9Q;H;Crystal Structure Analysis of E173A variant of the soybean ferritin SFER4;1.9;CA;CALCIUM ION;Ferritin-4, chloroplastic;3847;
3A9Q;I;Crystal Structure Analysis of E173A variant of the soybean ferritin SFER4;1.9;CA;CALCIUM ION;Ferritin-4, chloroplastic;3847;
3A9Q;J;Crystal Structure Analysis of E173A variant of the soybean ferritin SFER4;1.9;CA;CALCIUM ION;Ferritin-4, chloroplastic;3847;
3A9Q;K;Crystal Structure Analysis of E173A variant of the soybean ferritin SFER4;1.9;CA;CALCIUM ION;Ferritin-4, chloroplastic;3847;
3A9Q;L;Crystal Structure Analysis of E173A variant of the soybean ferritin SFER4;1.9;CA;CALCIUM ION;Ferritin-4, chloroplastic;3847;
3A9Q;M;Crystal Structure Analysis of E173A variant of the soybean ferritin SFER4;1.9;CA;CALCIUM ION;Ferritin-4, chloroplastic;3847;
3A9Q;N;Crystal Structure Analysis of E173A variant of the soybean ferritin SFER4;1.9;CA;CALCIUM ION;Ferritin-4, chloroplastic;3847;
3A9Q;O;Crystal Structure Analysis of E173A variant of the soybean ferritin SFER4;1.9;CA;CALCIUM ION;Ferritin-4, chloroplastic;3847;
3A9Q;P;Crystal Structure Analysis of E173A variant of the soybean ferritin SFER4;1.9;CA;CALCIUM ION;Ferritin-4, chloroplastic;3847;
3A9Q;Q;Crystal Structure Analysis of E173A variant of the soybean ferritin SFER4;1.9;CA;CALCIUM ION;Ferritin-4, chloroplastic;3847;
3A9Q;R;Crystal Structure Analysis of E173A variant of the soybean ferritin SFER4;1.9;CA;CALCIUM ION;Ferritin-4, chloroplastic;3847;
3A9Q;S;Crystal Structure Analysis of E173A variant of the soybean ferritin SFER4;1.9;CA;CALCIUM ION;Ferritin-4, chloroplastic;3847;
3A9Q;T;Crystal Structure Analysis of E173A variant of the soybean ferritin SFER4;1.9;CA;CALCIUM ION;Ferritin-4, chloroplastic;3847;
3A9Q;U;Crystal Structure Analysis of E173A variant of the soybean ferritin SFER4;1.9;CA;CALCIUM ION;Ferritin-4, chloroplastic;3847;
3A9Q;V;Crystal Structure Analysis of E173A variant of the soybean ferritin SFER4;1.9;CA;CALCIUM ION;Ferritin-4, chloroplastic;3847;
3A9Q;W;Crystal Structure Analysis of E173A variant of the soybean ferritin SFER4;1.9;CA;CALCIUM ION;Ferritin-4, chloroplastic;3847;
3A9Q;X;Crystal Structure Analysis of E173A variant of the soybean ferritin SFER4;1.9;CA;CALCIUM ION;Ferritin-4, chloroplastic;3847;
3AAG;A;Crystal structure of C. jejuni pglb C-terminal domain;2.8;CA;CALCIUM ION;General glycosylation pathway protein;197;
3AAJ;A;Crystal structure of Ca2+-bound form of des3-23ALG-2deltaGF122;2.4;CA;CALCIUM ION;Programmed cell death protein 6;9606;
3AAJ;B;Crystal structure of Ca2+-bound form of des3-23ALG-2deltaGF122;2.4;CA;CALCIUM ION;Programmed cell death protein 6;9606;
3AAS;A;Bovine beta-trypsin bound to meta-guanidino schiff base copper (II) chelate;1.75;CA;CALCIUM ION;Cationic trypsin;9913;
3AAU;A;Bovine beta-trypsin bound to meta-diguanidino schiff base copper (II) chelate;1.8;CA;CALCIUM ION;Cationic trypsin;9913;
3AAV;A;Bovine beta-trypsin bound to meta-diamidino schiff base copper (II) chelate;1.7;CA;CALCIUM ION;Cationic trypsin;9913;
3AAV;B;Bovine beta-trypsin bound to meta-diamidino schiff base copper (II) chelate;1.7;CA;CALCIUM ION;Cationic trypsin;9913;
3AB9;A;Crystal Structure of lipoylated E. coli H-protein (reduced form);1.65;CA;CALCIUM ION;Glycine cleavage system H protein;562;
3ACF;A;Crystal Structure of Carbohydrate-Binding Module Family 28 from Clostridium josui Cel5A in a ligand-free form;1.6;CA;CALCIUM ION;Beta-1,4-endoglucanase;1499;
3ACG;A;Crystal Structure of Carbohydrate-Binding Module Family 28 from Clostridium josui Cel5A in complex with cellobiose;1.5;CA;CALCIUM ION;Beta-1,4-endoglucanase;1499;
3ACH;A;Crystal Structure of Carbohydrate-Binding Module Family 28 from Clostridium josui Cel5A in complex with cellotetraose;1.4;CA;CALCIUM ION;Beta-1,4-endoglucanase;1499;
3ACI;A;Crystal Structure of Carbohydrate-Binding Module Family 28 from Clostridium josui Cel5A in complex with cellopentaose;1.6;CA;CALCIUM ION;Beta-1,4-endoglucanase;1499;
3ACO;A;Crystal structure of the EFC/F-BAR domain of human PACSIN2/Syndapin II (2.7 A);2.7;CA;CALCIUM ION;Protein kinase C and casein kinase substrate in neurons protein 2;9606;
3AFG;A;Crystal structure of ProN-Tk-SP from Thermococcus kodakaraensis;2;CA;CALCIUM ION;Subtilisin-like serine protease;311400;
3AFG;B;Crystal structure of ProN-Tk-SP from Thermococcus kodakaraensis;2;CA;CALCIUM ION;Subtilisin-like serine protease;311400;
3AGN;A;Crystal Structure of Ustilago sphaerogena Ribonuclease U2 Complexed with adenosine 3'-monophosphate;0.96;CA;CALCIUM ION;Ribonuclease U2;5271;
3-ago;A;Crystal Structure of Ustilago sphaerogena Ribonuclease U2 complexed with adenosine 3'-monophosphate;0.99;CA;CALCIUM ION;Ribonuclease U2;5271;
3AGP;A;Structure of viral polymerase form I;2.8;CA;CALCIUM ION;Elongation factor Ts, Elongation factor Tu, LINKER, Q beta replicase;5,623,263,039,803;
3AGV;S;Crystal structure of a human IgG-aptamer complex;2.15;CA;CALCIUM ION;5'-R(*GP*GP*AP*GP*GP*(UFT)P*GP*(CFZ)P*(UFT)P*(CFZ)P*(CFZ)P*GP*AP*AP*A*GP*GP*AP*AP*(CFZ)P*(UFT)P*(CFZ)P*(CFZ)P*A)-3';;
3AGV;U;Crystal structure of a human IgG-aptamer complex;2.15;CA;CALCIUM ION;5'-R(*GP*GP*AP*GP*GP*(UFT)P*GP*(CFZ)P*(UFT)P*(CFZ)P*(CFZ)P*GP*AP*AP*A*GP*GP*AP*AP*(CFZ)P*(UFT)P*(CFZ)P*(CFZ)P*A)-3';;
3AHW;A;Crystal Structure of Ustilago sphaerogena Ribonuclease U2 complexed with adenosine 2'-monophosphate;1.03;CA;CALCIUM ION;Ribonuclease U2;5271;
3AI7;A;Crystal Structure of Bifidobacterium Longum Phosphoketolase;2.2;CA;CALCIUM ION;Xylulose-5-phosphate/fructose-6-phosphate phosphoketolase;216816;
3AI7;B;Crystal Structure of Bifidobacterium Longum Phosphoketolase;2.2;CA;CALCIUM ION;Xylulose-5-phosphate/fructose-6-phosphate phosphoketolase;216816;
3AI7;C;Crystal Structure of Bifidobacterium Longum Phosphoketolase;2.2;CA;CALCIUM ION;Xylulose-5-phosphate/fructose-6-phosphate phosphoketolase;216816;
3AI7;D;Crystal Structure of Bifidobacterium Longum Phosphoketolase;2.2;CA;CALCIUM ION;Xylulose-5-phosphate/fructose-6-phosphate phosphoketolase;216816;
3AI7;E;Crystal Structure of Bifidobacterium Longum Phosphoketolase;2.2;CA;CALCIUM ION;Xylulose-5-phosphate/fructose-6-phosphate phosphoketolase;216816;
3AI7;F;Crystal Structure of Bifidobacterium Longum Phosphoketolase;2.2;CA;CALCIUM ION;Xylulose-5-phosphate/fructose-6-phosphate phosphoketolase;216816;
3AI7;G;Crystal Structure of Bifidobacterium Longum Phosphoketolase;2.2;CA;CALCIUM ION;Xylulose-5-phosphate/fructose-6-phosphate phosphoketolase;216816;
3AI7;H;Crystal Structure of Bifidobacterium Longum Phosphoketolase;2.2;CA;CALCIUM ION;Xylulose-5-phosphate/fructose-6-phosphate phosphoketolase;216816;
3AIB;A;Crystal Structure of Glucansucrase;3.09;CA;CALCIUM ION;Glucosyltransferase-SI;1309;
3AIB;B;Crystal Structure of Glucansucrase;3.09;CA;CALCIUM ION;Glucosyltransferase-SI;1309;
3AIB;C;Crystal Structure of Glucansucrase;3.09;CA;CALCIUM ION;Glucosyltransferase-SI;1309;
3AIB;D;Crystal Structure of Glucansucrase;3.09;CA;CALCIUM ION;Glucosyltransferase-SI;1309;
3AIB;E;Crystal Structure of Glucansucrase;3.09;CA;CALCIUM ION;Glucosyltransferase-SI;1309;
3AIB;F;Crystal Structure of Glucansucrase;3.09;CA;CALCIUM ION;Glucosyltransferase-SI;1309;
3AIB;G;Crystal Structure of Glucansucrase;3.09;CA;CALCIUM ION;Glucosyltransferase-SI;1309;
3AIB;H;Crystal Structure of Glucansucrase;3.09;CA;CALCIUM ION;Glucosyltransferase-SI;1309;
3AIC;A;Crystal Structure of Glucansucrase from Streptococcus mutans;3.11;CA;CALCIUM ION;Glucosyltransferase-SI;1309;
3AIC;B;Crystal Structure of Glucansucrase from Streptococcus mutans;3.11;CA;CALCIUM ION;Glucosyltransferase-SI;1309;
3AIC;C;Crystal Structure of Glucansucrase from Streptococcus mutans;3.11;CA;CALCIUM ION;Glucosyltransferase-SI;1309;
3AIC;D;Crystal Structure of Glucansucrase from Streptococcus mutans;3.11;CA;CALCIUM ION;Glucosyltransferase-SI;1309;
3AIC;E;Crystal Structure of Glucansucrase from Streptococcus mutans;3.11;CA;CALCIUM ION;Glucosyltransferase-SI;1309;
3AIC;F;Crystal Structure of Glucansucrase from Streptococcus mutans;3.11;CA;CALCIUM ION;Glucosyltransferase-SI;1309;
3AIC;G;Crystal Structure of Glucansucrase from Streptococcus mutans;3.11;CA;CALCIUM ION;Glucosyltransferase-SI;1309;
3AIC;H;Crystal Structure of Glucansucrase from Streptococcus mutans;3.11;CA;CALCIUM ION;Glucosyltransferase-SI;1309;
3AIE;A;Crystal Structure of glucansucrase from Streptococcus mutans;2.1;CA;CALCIUM ION;Glucosyltransferase-SI;1309;
3AIE;B;Crystal Structure of glucansucrase from Streptococcus mutans;2.1;CA;CALCIUM ION;Glucosyltransferase-SI;1309;
3AIE;C;Crystal Structure of glucansucrase from Streptococcus mutans;2.1;CA;CALCIUM ION;Glucosyltransferase-SI;1309;
3AIE;D;Crystal Structure of glucansucrase from Streptococcus mutans;2.1;CA;CALCIUM ION;Glucosyltransferase-SI;1309;
3AIE;E;Crystal Structure of glucansucrase from Streptococcus mutans;2.1;CA;CALCIUM ION;Glucosyltransferase-SI;1309;
3AIE;F;Crystal Structure of glucansucrase from Streptococcus mutans;2.1;CA;CALCIUM ION;Glucosyltransferase-SI;1309;
3AIE;G;Crystal Structure of glucansucrase from Streptococcus mutans;2.1;CA;CALCIUM ION;Glucosyltransferase-SI;1309;
3AIE;H;Crystal Structure of glucansucrase from Streptococcus mutans;2.1;CA;CALCIUM ION;Glucosyltransferase-SI;1309;
3AIG;A;ADAMALYSIN II WITH PEPTIDOMIMETIC INHIBITOR POL656;2.8;CA;CALCIUM ION;ADAMALYSIN II;8729;
3AII;A;Archaeal non-discriminating glutamyl-tRNA synthetase from Methanothermobacter thermautotrophicus;1.65;CA;CALCIUM ION;Glutamyl-tRNA synthetase;145262;
3AJ7;A;Crystal Structure of isomaltase from Saccharomyces cerevisiae;1.3;CA;CALCIUM ION;Oligo-1,6-glucosidase;4932;
3AJ8;A;X-ray analysis of Crystal of Proteinase K Obtained from H2O Solution Using PEG 8000;1.1;CA;CALCIUM ION;Proteinase K;37998;
3AJ9;A;X-ray analysis of Crystal of Proteinase K Obtained from D2O Solution Using PEG 8000;1.1;CA;CALCIUM ION;Proteinase K;37998;
3AK5;A;Hemoglobin protease (Hbp) passenger missing domain-2;2.2;CA;CALCIUM ION;Hemoglobin-binding protease hbp;562;
3AK5;B;Hemoglobin protease (Hbp) passenger missing domain-2;2.2;CA;CALCIUM ION;Hemoglobin-binding protease hbp;562;
3AK5;C;Hemoglobin protease (Hbp) passenger missing domain-2;2.2;CA;CALCIUM ION;Hemoglobin-binding protease hbp;562;
3AK5;D;Hemoglobin protease (Hbp) passenger missing domain-2;2.2;CA;CALCIUM ION;Hemoglobin-binding protease hbp;562;
3AKA;A;Structural basis for prokaryotic calcium-mediated regulation by a Streptomyces coelicolor calcium-binding protein;1.8;CA;CALCIUM ION;Putative calcium binding protein;1902;
3AKB;A;Structural basis for prokaryotic calcium-mediated regulation by a Streptomyces coelicolor calcium-binding protein;1.5;CA;CALCIUM ION;Putative calcium binding protein;1902;
3ALA;A;Crystal structure of vascular adhesion protein-1 in space group C2;2.9;CA;CALCIUM ION;Membrane primary amine oxidase;9606;
3ALA;B;Crystal structure of vascular adhesion protein-1 in space group C2;2.9;CA;CALCIUM ION;Membrane primary amine oxidase;9606;
3ALA;C;Crystal structure of vascular adhesion protein-1 in space group C2;2.9;CA;CALCIUM ION;Membrane primary amine oxidase;9606;
3ALA;D;Crystal structure of vascular adhesion protein-1 in space group C2;2.9;CA;CALCIUM ION;Membrane primary amine oxidase;9606;
3ALA;E;Crystal structure of vascular adhesion protein-1 in space group C2;2.9;CA;CALCIUM ION;Membrane primary amine oxidase;9606;
3ALA;F;Crystal structure of vascular adhesion protein-1 in space group C2;2.9;CA;CALCIUM ION;Membrane primary amine oxidase;9606;
3ALA;G;Crystal structure of vascular adhesion protein-1 in space group C2;2.9;CA;CALCIUM ION;Membrane primary amine oxidase;9606;
3ALS;A;Crystal structure of CEL-IV;3;CA;CALCIUM ION;Lectin CEL-IV, C-type;40245;
3ALS;B;Crystal structure of CEL-IV;3;CA;CALCIUM ION;Lectin CEL-IV, C-type;40245;
3ALS;C;Crystal structure of CEL-IV;3;CA;CALCIUM ION;Lectin CEL-IV, C-type;40245;
3ALS;D;Crystal structure of CEL-IV;3;CA;CALCIUM ION;Lectin CEL-IV, C-type;40245;
3ALT;A;Crystal structure of CEL-IV complexed with Melibiose;2.5;CA;CALCIUM ION;Lectin CEL-IV, C-type;40245;
3ALT;B;Crystal structure of CEL-IV complexed with Melibiose;2.5;CA;CALCIUM ION;Lectin CEL-IV, C-type;40245;
3ALT;C;Crystal structure of CEL-IV complexed with Melibiose;2.5;CA;CALCIUM ION;Lectin CEL-IV, C-type;40245;
3ALT;D;Crystal structure of CEL-IV complexed with Melibiose;2.5;CA;CALCIUM ION;Lectin CEL-IV, C-type;40245;
3ALU;A;Crystal structure of CEL-IV complexed with Raffinose;1.65;CA;CALCIUM ION;Lectin CEL-IV, C-type;40245;
3ALU;B;Crystal structure of CEL-IV complexed with Raffinose;1.65;CA;CALCIUM ION;Lectin CEL-IV, C-type;40245;
3ALU;C;Crystal structure of CEL-IV complexed with Raffinose;1.65;CA;CALCIUM ION;Lectin CEL-IV, C-type;40245;
3ALU;D;Crystal structure of CEL-IV complexed with Raffinose;1.65;CA;CALCIUM ION;Lectin CEL-IV, C-type;40245;
3AM9;A;Complex of bovine xanthine dehydrogenase and trihydroxy FYX-051;2.17;CA;CALCIUM ION;Xanthine dehydrogenase/oxidase;9913;
3AM9;B;Complex of bovine xanthine dehydrogenase and trihydroxy FYX-051;2.17;CA;CALCIUM ION;Xanthine dehydrogenase/oxidase;9913;
3AMR;A;Crystal Structures of Bacillus subtilis Alkaline Phytase in Complex with Ca2+, Co2+, Ni2+, Mg2+ and myo-Inositol Hexasulfate;1.25;CA;CALCIUM ION;3-phytase;1423;
3AMS;A;Crystal Structures of Bacillus subtilis Alkaline Phytase in Complex with Ca2+, Cd2+, Co2+, Ni2+, Mg2+ and myo-Inositol Hexasulfate;2.08;CA;CALCIUM ION;3-phytase;1423;
3AMZ;A;Bovine Xanthine Oxidoreductase urate bound form;2.1;CA;CALCIUM ION;Xanthine dehydrogenase/oxidase;9913;
3AMZ;B;Bovine Xanthine Oxidoreductase urate bound form;2.1;CA;CALCIUM ION;Xanthine dehydrogenase/oxidase;9913;
3AN1;A;Crystal structure of rat D428A mutant, urate bound form;1.73;CA;CALCIUM ION;Xanthine dehydrogenase/oxidase;10116;
3AN1;B;Crystal structure of rat D428A mutant, urate bound form;1.73;CA;CALCIUM ION;Xanthine dehydrogenase/oxidase;10116;
3AQJ;C;Crystal Structure of a C-terminal domain of the bacteriophage P2 tail spike protein, gpV;1.27;CA;CALCIUM ION;Baseplate assembly protein V;10679;
3AQJ;P;Crystal Structure of a C-terminal domain of the bacteriophage P2 tail spike protein, gpV;1.27;CA;CALCIUM ION;Baseplate assembly protein V;10679;
3AR2;A;Calcium pump crystal structure with bound AMPPCP and Ca2+;2.5;CA;CALCIUM ION;Sarcoplasmic/endoplasmic reticulum calcium ATPase 1;9986;
3ATG;A;endo-1,3-beta-glucanase from Cellulosimicrobium cellulans;1.66;CA;CALCIUM ION;GLUCANASE;1710;
3ATI;A;Crystal structure of trypsin complexed with (3-methoxyphenyl)methanamine;1.71;CA;CALCIUM ION;Cationic trypsin;9913;
3ATJ;A;HEME LIGAND MUTANT OF RECOMBINANT HORSERADISH PEROXIDASE IN COMPLEX WITH BENZHYDROXAMIC ACID;2.2;CA;CALCIUM ION;PROTEIN (HORSERADISH PEROXIDASE C1A);3704;
3ATJ;B;HEME LIGAND MUTANT OF RECOMBINANT HORSERADISH PEROXIDASE IN COMPLEX WITH BENZHYDROXAMIC ACID;2.2;CA;CALCIUM ION;PROTEIN (HORSERADISH PEROXIDASE C1A);3704;
3ATK;A;Crystal structure of trypsin complexed with cycloheptanamine;1.74;CA;CALCIUM ION;Cationic trypsin;9913;
3ATL;A;Crystal structure of trypsin complexed with benzamidine;1.74;CA;CALCIUM ION;Cationic trypsin;9913;
3ATM;A;Crystal structure of trypsin complexed with 2-(1H-indol-3-yl)ethanamine;1.72;CA;CALCIUM ION;Cationic trypsin;9913;
3ATS;A;Crystal structure of Rv3168;1.67;CA;CALCIUM ION;Putative uncharacterized protein;1773;
3ATT;A;Crystal structure of Rv3168 with ATP;2;CA;CALCIUM ION;Putative uncharacterized protein;1773;
3AU2;A;DNA polymerase X from Thermus thermophilus HB8 complexed with Ca-dGTP;1.4;CA;CALCIUM ION;DNA polymerase beta family (X family);274;
3AU9;B;Crystal structure of the quaternary complex-1 of an isomerase;1.9;CA;CALCIUM ION;1-deoxy-D-xylulose 5-phosphate reductoisomerase;5833;
3AUA;B;Crystal structure of the quaternary complex-2 of an isomerase;2.15;CA;CALCIUM ION;1-deoxy-D-xylulose 5-phosphate reductoisomerase;5833;
3AUJ;A;Structure of diol dehydratase complexed with glycerol;2.1;CA;CALCIUM ION;Diol dehydrase alpha subunit;571;
3AUJ;L;Structure of diol dehydratase complexed with glycerol;2.1;CA;CALCIUM ION;Diol dehydrase alpha subunit;571;
3AUK;A;Crystal structure of a lipase from Geobacillus sp. SBS-4S;1.66;CA;CALCIUM ION;Lipase;446356;
3AVT;A;Structure of viral RNA polymerase complex 1;2.61;CA;CALCIUM ION;Elongation factor Ts, Elongation factor Tu, LINKER, Q beta replicase;5,623,263,039,803;
3AVU;A;Structure of viral RNA polymerase complex 2;2.91;CA;CALCIUM ION;Elongation factor Ts, Elongation factor Tu, LINKER, Q beta replicase;5,623,263,039,803;
3AVV;A;Structure of viral RNA polymerase complex 3;3.12;CA;CALCIUM ION;Elongation factor Ts, Elongation factor Tu, LINKER, Q beta replicase;5,623,263,039,803;
3AVW;A;Structure of viral RNA polymerase complex 4;2.6;CA;CALCIUM ION;Elongation factor Ts, Elongation factor Tu, LINKER, Q beta replicase;5,623,263,039,803;
3AVX;A;Structure of viral RNA polymerase complex 5;2.41;CA;CALCIUM ION;Elongation factor Ts, Elongation factor Tu, LINKER, Q beta replicase;56,239,803;
3AVY;A;Structure of viral RNA polymerase complex 6;2.62;CA;CALCIUM ION;Elongation factor Ts, Elongation factor Tu, LINKER, Q beta replicase;5,623,263,039,803;
3AX4;A;Three-dimensional structure of lectin from Dioclea violacea and comparative vasorelaxant effects with Dioclea rostrata;2.61;CA;CALCIUM ION;lectin;192415;
3AX7;A;Bovine Xanthine Oxidase, protease cleaved form;2.34;CA;CALCIUM ION;Xanthine dehydrogenase/oxidase;9913;
3AX7;B;Bovine Xanthine Oxidase, protease cleaved form;2.34;CA;CALCIUM ION;Xanthine dehydrogenase/oxidase;9913;
3AX9;A;Bovine xanthine oxidase, protease cleaved form;2.3;CA;CALCIUM ION;Xanthine dehydrogenase/oxidase;9913;
3AX9;B;Bovine xanthine oxidase, protease cleaved form;2.3;CA;CALCIUM ION;Xanthine dehydrogenase/oxidase;9913;
3AXD;A;The truncated Fibrobacter succinogenes 1,3-1,4-beta-D-glucanase V18Y/W203Y in apo-form;1.53;CA;CALCIUM ION;Beta-glucanase;833;
3AXD;B;The truncated Fibrobacter succinogenes 1,3-1,4-beta-D-glucanase V18Y/W203Y in apo-form;1.53;CA;CALCIUM ION;Beta-glucanase;833;
3AXE;A;The truncated Fibrobacter succinogenes 1,3-1,4-beta-D-glucanase V18Y/W203Y in complex with cellotetraose (cellobiose density was observed);1.53;CA;CALCIUM ION;Beta-glucanase;833;
3AXH;A;Crystal structure of isomaltase in complex with isomaltose;1.8;CA;CALCIUM ION;Oligo-1,6-glucosidase IMA1;4932;
3AXI;A;Crystal structure of isomaltase in complex with maltose;1.4;CA;CALCIUM ION;Oligo-1,6-glucosidase IMA1;4932;
3AY9;A;Crystal structure of human Hsp70 NBD in the ADP-, Mg ion-, and K ion-bound state;1.75;CA;CALCIUM ION;Heat shock 70 kDa protein 1A/1B;9606;
3AYF;A;Crystal structure of nitric oxide reductase;2.5;CA;CALCIUM ION;Nitric oxide reductase;1422;
3AYG;A;Crystal structure of nitric oxide reductase complex with HQNO;2.7;CA;CALCIUM ION;Nitric oxide reductase;1422;
3AYK;A;CATALYTIC FRAGMENT OF HUMAN FIBROBLAST COLLAGENASE COMPLEXED WITH CGS-27023A, NMR, MINIMIZED AVERAGE STRUCTURE;;CA;CALCIUM ION;PROTEIN (COLLAGENASE);9606;
3AYU;A;Crystal structure of MMP-2 active site mutant in complex with APP-drived decapeptide inhibitor;2;CA;CALCIUM ION;72 kDa type IV collagenase;9606;
3AZX;A;Crystal structure of the laminarinase catalytic domain from Thermotoga maritima MSB8;1.8;CA;CALCIUM ION;Laminarinase;2336;
3AZX;B;Crystal structure of the laminarinase catalytic domain from Thermotoga maritima MSB8;1.8;CA;CALCIUM ION;Laminarinase;2336;
3AZY;A;Crystal structure of the laminarinase catalytic domain from Thermotoga maritima MSB8;1.65;CA;CALCIUM ION;Laminarinase;2336;
3AZY;B;Crystal structure of the laminarinase catalytic domain from Thermotoga maritima MSB8;1.65;CA;CALCIUM ION;Laminarinase;2336;
3AZY;C;Crystal structure of the laminarinase catalytic domain from Thermotoga maritima MSB8;1.65;CA;CALCIUM ION;Laminarinase;2336;
3AZY;D;Crystal structure of the laminarinase catalytic domain from Thermotoga maritima MSB8;1.65;CA;CALCIUM ION;Laminarinase;2336;
3AZZ;A;Crystal structure of the laminarinase catalytic domain from Thermotoga maritima MSB8 in complex with gluconolactone;1.81;CA;CALCIUM ION;Laminarinase;2336;
3AZZ;B;Crystal structure of the laminarinase catalytic domain from Thermotoga maritima MSB8 in complex with gluconolactone;1.81;CA;CALCIUM ION;Laminarinase;2336;
3AZZ;C;Crystal structure of the laminarinase catalytic domain from Thermotoga maritima MSB8 in complex with gluconolactone;1.81;CA;CALCIUM ION;Laminarinase;2336;
3AZZ;D;Crystal structure of the laminarinase catalytic domain from Thermotoga maritima MSB8 in complex with gluconolactone;1.81;CA;CALCIUM ION;Laminarinase;2336;
3B00;A;Crystal structure of the laminarinase catalytic domain from Thermotoga maritima MSB8 in complex with cetyltrimethylammonium bromide;1.74;CA;CALCIUM ION;Laminarinase;2336;
3B00;B;Crystal structure of the laminarinase catalytic domain from Thermotoga maritima MSB8 in complex with cetyltrimethylammonium bromide;1.74;CA;CALCIUM ION;Laminarinase;2336;
3B00;C;Crystal structure of the laminarinase catalytic domain from Thermotoga maritima MSB8 in complex with cetyltrimethylammonium bromide;1.74;CA;CALCIUM ION;Laminarinase;2336;
3B00;D;Crystal structure of the laminarinase catalytic domain from Thermotoga maritima MSB8 in complex with cetyltrimethylammonium bromide;1.74;CA;CALCIUM ION;Laminarinase;2336;
3B01;A;Crystal structure of the laminarinase catalytic domain from Thermotoga maritima MSB8;1.87;CA;CALCIUM ION;Laminarinase;2336;
3B01;B;Crystal structure of the laminarinase catalytic domain from Thermotoga maritima MSB8;1.87;CA;CALCIUM ION;Laminarinase;2336;
3B01;C;Crystal structure of the laminarinase catalytic domain from Thermotoga maritima MSB8;1.87;CA;CALCIUM ION;Laminarinase;2336;
3B01;D;Crystal structure of the laminarinase catalytic domain from Thermotoga maritima MSB8;1.87;CA;CALCIUM ION;Laminarinase;2336;
3B0I;A;Crystal structure of recombinant human alpha lactalbumin;1.8;CA;CALCIUM ION;Alpha-lactalbumin;9606;
3B0K;A;Crystal structure of alpha-lactalbumin;1.6;CA;CALCIUM ION;Alpha-lactalbumin;9925;
3B0K;B;Crystal structure of alpha-lactalbumin;1.6;CA;CALCIUM ION;Alpha-lactalbumin;9925;
3B0O;A;Crystal structure of alpha-lactalbumin;1.61;CA;CALCIUM ION;Alpha-lactalbumin;9606;
3B0O;B;Crystal structure of alpha-lactalbumin;1.61;CA;CALCIUM ION;Alpha-lactalbumin;9606;
3B0X;A;K263A mutant of PolX from Thermus thermophilus HB8 complexed with Ca-dGTP;1.36;CA;CALCIUM ION;DNA polymerase beta family (X family);274;
3B0Y;A;K263D mutant of PolX from Thermus thermophilus HB8 complexed with Ca-dGTP;1.45;CA;CALCIUM ION;DNA polymerase beta family (X family);274;
3B1T;A;Crystal structure of human peptidylarginine deiminase 4 in complex with o-Cl-amidine;2.5;CA;CALCIUM ION;Protein-arginine deiminase type-4;9606;
3B1U;A;Crystal structure of human peptidylarginine deiminase 4 in complex with o-F-amidine;2.1;CA;CALCIUM ION;Protein-arginine deiminase type-4;9606;
3B2Z;A;Crystal Structure of ADAMTS4 (apo form);2.8;CA;CALCIUM ION;ADAMTS-4;9606;
3B2Z;B;Crystal Structure of ADAMTS4 (apo form);2.8;CA;CALCIUM ION;ADAMTS-4;9606;
3B2Z;C;Crystal Structure of ADAMTS4 (apo form);2.8;CA;CALCIUM ION;ADAMTS-4;9606;
3B2Z;D;Crystal Structure of ADAMTS4 (apo form);2.8;CA;CALCIUM ION;ADAMTS-4;9606;
3B2Z;E;Crystal Structure of ADAMTS4 (apo form);2.8;CA;CALCIUM ION;ADAMTS-4;9606;
3B2Z;F;Crystal Structure of ADAMTS4 (apo form);2.8;CA;CALCIUM ION;ADAMTS-4;9606;
3B2Z;G;Crystal Structure of ADAMTS4 (apo form);2.8;CA;CALCIUM ION;ADAMTS-4;9606;
3B2Z;H;Crystal Structure of ADAMTS4 (apo form);2.8;CA;CALCIUM ION;ADAMTS-4;9606;
3B32;A;Crystal Structure of Calcium-Saturated Calmodulin N-Terminal Domain Fragment, Residues 1-75;1.6;CA;CALCIUM ION;Calmodulin;10116;
3B3D;A;B.subtilis YtbE;2.3;CA;CALCIUM ION;Putative morphine dehydrogenase;1423;
3B3D;B;B.subtilis YtbE;2.3;CA;CALCIUM ION;Putative morphine dehydrogenase;1423;
3B3D;C;B.subtilis YtbE;2.3;CA;CALCIUM ION;Putative morphine dehydrogenase;1423;
3B3Q;E;Crystal structure of a synaptic adhesion complex;2.4;CA;CALCIUM ION;NRXN1 protein;9606;
3B3Q;F;Crystal structure of a synaptic adhesion complex;2.4;CA;CALCIUM ION;NRXN1 protein;9606;
3B40;A;Crystal structure of the probable dipeptidase PvdM from Pseudomonas aeruginosa;2;CA;CALCIUM ION;Probable dipeptidase;287;
3B4N;A;Crystal Structure Analysis of Pectate Lyase PelI from Erwinia chrysanthemi;1.45;CA;CALCIUM ION;Endo-pectate lyase;556;
3B4N;B;Crystal Structure Analysis of Pectate Lyase PelI from Erwinia chrysanthemi;1.45;CA;CALCIUM ION;Endo-pectate lyase;556;
3B55;A;Crystal structure of the Q81BN2_BACCR protein from Bacillus cereus. NESG target BcR135;2.3;CA;CALCIUM ION;Succinoglycan biosynthesis protein;1396;
3B7E;A;Neuraminidase of A/Brevig Mission/1/1918 H1N1 strain in complex with zanamivir;1.45;CA;CALCIUM ION;Neuraminidase;11320;
3B7E;B;Neuraminidase of A/Brevig Mission/1/1918 H1N1 strain in complex with zanamivir;1.45;CA;CALCIUM ION;Neuraminidase;11320;
3B7Y;A;Crystal structure of the C2 Domain of the E3 Ubiquitin-Protein Ligase NEDD4;1.8;CA;CALCIUM ION;E3 ubiquitin-protein ligase NEDD4;9606;
3B8Y;B;Crystal Structure of Pectate Lyase PelI from Erwinia chrysanthemi in complex with tetragalacturonic acid;2.3;CA;CALCIUM ION;Endo-pectate lyase;556;
3B8Z;A;High Resolution Crystal Structure of the Catalytic Domain of ADAMTS-5 (Aggrecanase-2);1.4;CA;CALCIUM ION;protein ADAMTS-5;9606;
3B8Z;B;High Resolution Crystal Structure of the Catalytic Domain of ADAMTS-5 (Aggrecanase-2);1.4;CA;CALCIUM ION;protein ADAMTS-5;9606;
3B90;A;Crystal Structure of the Catalytic Domain of Pectate Lyase PelI from Erwinia chrysanthemi;2.11;CA;CALCIUM ION;Endo-pectate lyase;556;
3B90;B;Crystal Structure of the Catalytic Domain of Pectate Lyase PelI from Erwinia chrysanthemi;2.11;CA;CALCIUM ION;Endo-pectate lyase;556;
3B9G;A;Crystal structure of loop deletion mutant of Trypanosoma vivax nucleoside hydrolase (3GTvNH) in complex with ImmH;1.4;CA;CALCIUM ION;IAG-nucleoside hydrolase;5699;
3B9G;B;Crystal structure of loop deletion mutant of Trypanosoma vivax nucleoside hydrolase (3GTvNH) in complex with ImmH;1.4;CA;CALCIUM ION;IAG-nucleoside hydrolase;5699;
3B9J;C;Structure of Xanthine Oxidase with 2-hydroxy-6-methylpurine;2.3;CA;CALCIUM ION;xanthine oxidase;9913;
3B9X;A;Crystal structure of the E. coli pyrimidine nucleoside hydrolase YeiK in complex with inosine;2.3;CA;CALCIUM ION;Pyrimidine-specific ribonucleoside hydrolase rihB;562;
3B9X;B;Crystal structure of the E. coli pyrimidine nucleoside hydrolase YeiK in complex with inosine;2.3;CA;CALCIUM ION;Pyrimidine-specific ribonucleoside hydrolase rihB;562;
3B9X;C;Crystal structure of the E. coli pyrimidine nucleoside hydrolase YeiK in complex with inosine;2.3;CA;CALCIUM ION;Pyrimidine-specific ribonucleoside hydrolase rihB;562;
3B9X;D;Crystal structure of the E. coli pyrimidine nucleoside hydrolase YeiK in complex with inosine;2.3;CA;CALCIUM ION;Pyrimidine-specific ribonucleoside hydrolase rihB;562;
3BA0;A;Crystal structure of full-length human MMP-12;3;CA;CALCIUM ION;Macrophage metalloelastase;9606;
3BA6;A;Structure of the Ca2E1P phosphoenzyme intermediate of the SERCA Ca2+-ATPase;2.8;CA;CALCIUM ION;Sarcoplasmic/endoplasmic reticulum calcium ATPase 1;9986;
3BAI;A;Human Pancreatic Alpha Amylase with Bound Nitrate;1.9;CA;CALCIUM ION;Pancreatic alpha-amylase;9606;
3BAJ;A;Human Pancreatic Alpha-Amylase in Complex with Nitrate and Acarbose;2.1;CA;CALCIUM ION;Pancreatic alpha-amylase;9606;
3BAK;A;N298S mutant of Human Pancreatic Alpha-Amylase in complex with nitrate;1.9;CA;CALCIUM ION;Pancreatic alpha-amylase;9606;
3BAW;A;Human pancreatic alpha-amylase complexed with azide;2;CA;CALCIUM ION;Pancreatic alpha-amylase;9606;
3BAX;A;N298S Variant of Human Pancreatic Alpha-Amylase in Complex with Azide;1.9;CA;CALCIUM ION;Pancreatic alpha-amylase;9606;
3BAY;A;N298S Variant of Human Pancreatic Alpha-Amylase in Complex with Nitrate and Acarbose;1.99;CA;CALCIUM ION;Pancreatic alpha-amylase;9606;
3BBY;A;Crystal structure of glutathione S-transferase (NP_416804.1) from Escherichia coli K12 at 1.85 A resolution;1.85;CA;CALCIUM ION;Uncharacterized GST-like protein yfcF;562;
3BC9;A;Alpha-amylase B in complex with acarbose;1.35;CA;CALCIUM ION;Alpha amylase, catalytic region;31909;
3BCD;A;Alpha-amylase B in complex with maltotetraose and alpha-cyclodextrin;2.2;CA;CALCIUM ION;Alpha amylase, catalytic region;31909;
3BCF;A;Alpha-amylase B from Halothermothrix orenii;2.3;CA;CALCIUM ION;Alpha amylase, catalytic region;31909;
3BDC;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS at cryogenic temperature;1.8;CA;CALCIUM ION;Thermonuclease;1280;
3BDJ;A;Crystal Structure of Bovine Milk Xanthine Dehydrogenase with a Covalently Bound Oxipurinol Inhibitor;2;CA;CALCIUM ION;Xanthine dehydrogenase/oxidase;9913;
3BDJ;B;Crystal Structure of Bovine Milk Xanthine Dehydrogenase with a Covalently Bound Oxipurinol Inhibitor;2;CA;CALCIUM ION;Xanthine dehydrogenase/oxidase;9913;
3BDV;A;Crystal structure of a putative yden-like hydrolase (eca3091) from pectobacterium atrosepticum scri1043 at 1.66 A resolution;1.66;CA;CALCIUM ION;Uncharacterized protein DUF1234;29471;
3BDV;B;Crystal structure of a putative yden-like hydrolase (eca3091) from pectobacterium atrosepticum scri1043 at 1.66 A resolution;1.66;CA;CALCIUM ION;Uncharacterized protein DUF1234;29471;
3BEQ;A;Neuraminidase of A/Brevig Mission/1/1918 H1N1 strain;1.64;CA;CALCIUM ION;Neuraminidase;11320;
3BEQ;B;Neuraminidase of A/Brevig Mission/1/1918 H1N1 strain;1.64;CA;CALCIUM ION;Neuraminidase;11320;
3BEU;A;Na+-Dependent Allostery Mediates Coagulation Factor Protease Active Site Selectivity;1.05;CA;CALCIUM ION;Trypsin;1911;
3BEU;B;Na+-Dependent Allostery Mediates Coagulation Factor Protease Active Site Selectivity;1.05;CA;CALCIUM ION;Trypsin;1911;
3BFM;A;Crystal structure of a biotin protein ligase-like protein of unknown function (tm1040_0394) from silicibacter sp. tm1040 at 1.70 A resolution;1.7;CA;CALCIUM ION;Biotin protein ligase-like protein of unknown function;292414;
3BH4;A;High resolution crystal structure of Bacillus amyloliquefaciens alpha-amylase;1.4;CA;CALCIUM ION;Alpha-amylase;1390;
3BH4;B;High resolution crystal structure of Bacillus amyloliquefaciens alpha-amylase;1.4;CA;CALCIUM ION;Alpha-amylase;1390;
3BHX;A;X-ray structure of human glutamate carboxypeptidase II (GCPII) in complex with a transition state analog of Asp-Glu;1.6;CA;CALCIUM ION;Glutamate carboxypeptidase 2;9606;
3BI0;A;X-ray structure of human glutamate carboxypeptidase II (GCPII) in complex with a transition state analog of Glu-Glu;1.67;CA;CALCIUM ION;Glutamate carboxypeptidase 2;9606;
3BI1;A;X-ray structure of human glutamate carboxypeptidase II (GCPII) in complex with a transition state analog of methotrexate-Glu;1.5;CA;CALCIUM ION;Glutamate carboxypeptidase 2;9606;
3BIR;A;DISECTING HISTIDINE INTERACTIONS IN RIBONUCLEASE T1 BY ASN AND GLN SUBSTITUTIONS;1.8;CA;CALCIUM ION;RIBONUCLEASE T1;5062;
3BIW;E;Crystal structure of the Neuroligin-1/Neurexin-1beta synaptic adhesion complex;3.5;CA;CALCIUM ION;Neurexin-1-beta;10116;
3BIW;F;Crystal structure of the Neuroligin-1/Neurexin-1beta synaptic adhesion complex;3.5;CA;CALCIUM ION;Neurexin-1-beta;10116;
3BIW;G;Crystal structure of the Neuroligin-1/Neurexin-1beta synaptic adhesion complex;3.5;CA;CALCIUM ION;Neurexin-1-beta;10116;
3BJE;B;Crystal structure of Trypanosoma brucei nucleoside phosphorylase shows uridine phosphorylase activity;1.44;CA;CALCIUM ION;Nucleoside phosphorylase, putative;5691;
3BJU;A;Crystal Structure of tetrameric form of human lysyl-tRNA synthetase;2.31;CA;CALCIUM ION;Lysyl-tRNA synthetase;9606;
3BJU;B;Crystal Structure of tetrameric form of human lysyl-tRNA synthetase;2.31;CA;CALCIUM ION;Lysyl-tRNA synthetase;9606;
3BJU;C;Crystal Structure of tetrameric form of human lysyl-tRNA synthetase;2.31;CA;CALCIUM ION;Lysyl-tRNA synthetase;9606;
3BJU;D;Crystal Structure of tetrameric form of human lysyl-tRNA synthetase;2.31;CA;CALCIUM ION;Lysyl-tRNA synthetase;9606;
3BLK;A;Role of aromatic residues in starch binding;2;CA;CALCIUM ION;Alpha-amylase 1;9606;
3BLP;X;Role of aromatic residues in human salivary alpha-amylase;1.6;CA;CALCIUM ION;Alpha-amylase 1;9606;
3BMV;A;Cyclodextrin glycosyl transferase from Thermoanerobacterium thermosulfurigenes EM1 mutant S77P;1.6;CA;CALCIUM ION;Cyclomaltodextrin glucanotransferase;33950;
3BMW;A;Cyclodextrin glycosyl transferase from Thermoanerobacterium thermosulfurigenes EM1 mutant S77P complexed with a maltoheptaose inhibitor;1.6;CA;CALCIUM ION;Cyclomaltodextrin glucanotransferase;33950;
3BNF;A;W. succinogenes NrfA Sulfite Complex;1.7;CA;CALCIUM ION;Cytochrome c-552;844;
3BNG;A;W. succinogenes NrfA Y218F;1.5;CA;CALCIUM ION;Cytochrome c-552;844;
3BNH;A;W. succinogenes NrfA Y218F Nitrite Complex;1.75;CA;CALCIUM ION;Cytochrome c-552;844;
3BNJ;A;W. succinogenes NrfA Y218F Sulfite Complex;1.3;CA;CALCIUM ION;Cytochrome c-552;844;
3BOD;A;Structure of mouse beta-neurexin 1;1.7;CA;CALCIUM ION;Neurexin-1-alpha;10090;
3BOW;A;Structure of M-calpain in complex with Calpastatin;2.4;CA;CALCIUM ION;Calpain-2 catalytic subunit;10116;
3BOW;B;Structure of M-calpain in complex with Calpastatin;2.4;CA;CALCIUM ION;Calpain small subunit 1;10116;
3BP2;A;ROLE OF THE N-TERMINUS IN THE INTERACTION OF PANCREATIC PHOSPHOLIPASE A2 WITH AGGREGATED SUBSTRATES. PROPERTIES AND CRYSTAL STRUCTURE OF TRANSAMINATED PHOSPHOLIPASE A2;2.1;CA;CALCIUM ION;PHOSPHOLIPASE A2;9913;
3BPS;E;PCSK9:EGF-A complex;2.41;CA;CALCIUM ION;Low-density lipoprotein receptor;9606;
3BQ0;A;Pre-insertion binary complex of Dbh DNA polymerase;2.6;CA;CALCIUM ION;DNA polymerase IV;2285;
3BQ1;A;Insertion ternary complex of Dbh DNA polymerase;2.7;CA;CALCIUM ION;DNA polymerase IV;2285;
3BQ2;A;Post-insertion binary complex of Dbh DNA polymerase;2.7;CA;CALCIUM ION;DNA polymerase IV;2285;
3BRX;A;Crystal Structure of calcium-bound cotton annexin Gh1;2.5;CA;CALCIUM ION;Annexin;3635;
3BS6;A;1.8 Angstrom crystal structure of the periplasmic domain of the membrane insertase YidC;1.8;CA;CALCIUM ION;Inner membrane protein oxaA;562;
3BSE;A;Crystal structure analysis of a 16-base-pair B-DNA;1.6;CA;CALCIUM ION;DNA (5'-D(*DA*DCP*DAP*DCP*DTP*DAP*DCP*DAP*DAP*DTP*DGP*DTP*DTP*DGP*DCP*DAP*DAP*DT)-3');;
3BSE;B;Crystal structure analysis of a 16-base-pair B-DNA;1.6;CA;CALCIUM ION;DNA (5'-D(*DG*DTP*DAP*DTP*DTP*DGP*DCP*DAP*DAP*DCP*DAP*DTP*DTP*DGP*DTP*DAP*DGP*DT)-3');;
3BSG;A;Barley alpha-amylase isozyme 1 (AMY1) H395A mutant;1.95;CA;CALCIUM ION;Alpha-amylase type A isozyme;4513;
3BSH;A;Barley alpha-amylase isozyme 1 (AMY1) double mutant Y105A/Y380A in complex with inhibitor acarbose;3;CA;CALCIUM ION;Alpha-amylase type A isozyme;4513;
3BTD;E;The Crystal Structures of the Complexes Between the Bovine Beta-Trypsin and Ten P1 Variants of BPTI.;1.9;CA;CALCIUM ION;PROTEIN (TRYPSIN);9913;
3BTE;E;The Crystal Structures of the Complexes Between Bovine Beta-Trypsin and Ten P1 Variants of BPTI.;1.85;CA;CALCIUM ION;TRYPSIN;9913;
3BTF;E;THE CRYSTAL STRUCTURES OF THE COMPLEXES BETWEEN BOVINE BETA-TRYPSIN AND TEN P1 VARIANTS OF BPTI.;1.8;CA;CALCIUM ION;PROTEIN (TRYPSIN);9913;
3BTG;E;THE CRYSTAL STRUCTURES OF THE COMPLEXES BETWEEN BOVINE BETA-TRYPSIN AND TEN P1 VARIANTS OF BPTI;1.9;CA;CALCIUM ION;PROTEIN (TRYPSIN);9913;
3BTH;E;THE CRYSTAL STRUCTURES OF THE COMPLEXES BETWEEN BOVINE BETA-TRYPSIN AND TEN P1 VARIANTS OF BPTI;1.75;CA;CALCIUM ION;PROTEIN (TRYPSIN);9913;
3BTK;E;THE CRYSTAL STRUCTURES OF THE COMPLEXES BETWEEN BOVINE BETA-TRYPSIN AND TEN P1 VARIANTS OF BPTI;1.85;CA;CALCIUM ION;PROTEIN (TRYPSIN);9913;
3BTM;E;THE CRYSTAL STRUCTURES OF THE COMPLEXES BETWEEN BOVINE BETA-TRYPSIN AND TEN P1 VARIANTS OF BPTI;1.8;CA;CALCIUM ION;PROTEIN (TRYPSIN);9913;
3BTQ;E;THE CRYSTAL STRUCTURES OF THE COMPLEXES BETWEEN BOVINE BETA-TRYPSIN AND TEN P1 VARIANTS OF BPTI;1.9;CA;CALCIUM ION;PROTEIN (TRYPSIN);9913;
3BTT;E;THE CRYSTAL STRUCTURES OF THE COMPLEXES BETWEEN BOVINE BETA-TRYPSIN AND TEN P1 VARIANTS OF BPTI;1.9;CA;CALCIUM ION;PROTEIN (TRYPSIN);9913;
3BTW;E;THE CRYSTAL STRUCTURES OF THE COMPLEXES BETWEEN BOVINE BETA-TRYPSIN AND TEN P1 VARIANTS OF BPTI;2.05;CA;CALCIUM ION;PROTEIN (TRYPSIN);9913;
3BU4;A;RIBONUCLEASE T1 COMPLEX WITH 2'GMP;1.77;CA;CALCIUM ION;PROTEIN (RIBONUCLEASE T1);5062;
3BUZ;B;Crystal structure of ia-bTAD-actin complex;2.81;CA;CALCIUM ION;Actin, alpha skeletal muscle;9986;
3BVC;A;Crystal structure of uncharacterized protein Ism_01780 from Roseovarius nubinhibens ISM;2.75;CA;CALCIUM ION;Uncharacterized protein Ism_01780;314263;
3BVC;B;Crystal structure of uncharacterized protein Ism_01780 from Roseovarius nubinhibens ISM;2.75;CA;CALCIUM ION;Uncharacterized protein Ism_01780;314263;
3BVH;B;Crystal Structure of Recombinant gammaD364A Fibrinogen Fragment D with the Peptide Ligand Gly-Pro-Arg-Pro-Amide;2.6;CA;CALCIUM ION;Fibrinogen beta chain;9606;
3BVH;C;Crystal Structure of Recombinant gammaD364A Fibrinogen Fragment D with the Peptide Ligand Gly-Pro-Arg-Pro-Amide;2.6;CA;CALCIUM ION;Fibrinogen gamma chain;9606;
3BVH;E;Crystal Structure of Recombinant gammaD364A Fibrinogen Fragment D with the Peptide Ligand Gly-Pro-Arg-Pro-Amide;2.6;CA;CALCIUM ION;Fibrinogen beta chain;9606;
3BVH;F;Crystal Structure of Recombinant gammaD364A Fibrinogen Fragment D with the Peptide Ligand Gly-Pro-Arg-Pro-Amide;2.6;CA;CALCIUM ION;Fibrinogen gamma chain;9606;
3BWX;A;Crystal structure of an alpha/beta hydrolase (YP_496220.1) from Novosphingobium aromaticivorans DSM 12444 at 1.50 A resolution;1.5;CA;CALCIUM ION;Alpha/beta hydrolase;48935;
3BX1;A;Complex between the Barley alpha-Amylase/Subtilisin Inhibitor and the subtilisin Savinase;1.85;CA;CALCIUM ION;Subtilisin Savinase;1467;
3BX1;B;Complex between the Barley alpha-Amylase/Subtilisin Inhibitor and the subtilisin Savinase;1.85;CA;CALCIUM ION;Subtilisin Savinase;1467;
3BX1;C;Complex between the Barley alpha-Amylase/Subtilisin Inhibitor and the subtilisin Savinase;1.85;CA;CALCIUM ION;Alpha-amylase/subtilisin inhibitor;4513;
3BX1;D;Complex between the Barley alpha-Amylase/Subtilisin Inhibitor and the subtilisin Savinase;1.85;CA;CALCIUM ION;Alpha-amylase/subtilisin inhibitor;4513;
3BXI;A;Structure of the complex of bovine lactoperoxidase with its catalyzed product hypothiocyanate ion at 2.3A resolution;2.3;CA;CALCIUM ION;Lactoperoxidase;9913;
3BXK;A;Crystal structure of the P/Q-type calcium channel (CaV2.1) IQ domain and CA2+calmodulin complex;2.55;CA;CALCIUM ION;Calmodulin;10116;
3BXK;C;Crystal structure of the P/Q-type calcium channel (CaV2.1) IQ domain and CA2+calmodulin complex;2.55;CA;CALCIUM ION;Calmodulin;10116;
3BXL;A;Crystal structure of the R-type calcium channeL (CaV2.3) IQ domain and CA2+calmodulin complex;2.3;CA;CALCIUM ION;Calmodulin;10116;
3BXM;A;Structure of an inactive mutant of human glutamate carboxypeptidase II [GCPII(E424A)] in complex with N-acetyl-Asp-Glu (NAAG);1.71;CA;CALCIUM ION;Glutamate carboxypeptidase 2;9606;
3BY6;A;Crystal structure of a transcriptional regulator from Oenococcus oeni;2.2;CA;CALCIUM ION;Predicted transcriptional regulator;1247;
3BY6;B;Crystal structure of a transcriptional regulator from Oenococcus oeni;2.2;CA;CALCIUM ION;Predicted transcriptional regulator;1247;
3BY6;C;Crystal structure of a transcriptional regulator from Oenococcus oeni;2.2;CA;CALCIUM ION;Predicted transcriptional regulator;1247;
3BY9;A;Crystal structure of the V. cholerae Histidine Kinase DctB Sensor Domain;1.7;CA;CALCIUM ION;Sensor protein;243277;
3BYA;A;Structure of a Calmodulin Complex;1.85;CA;CALCIUM ION;Calmodulin;9606;
3BYC;A;Joint neutron and X-ray structure of diisopropyl fluorophosphatase. Deuterium occupancies are 1-Q, where Q is occupancy of H;;CA;CALCIUM ION;Diisopropyl-fluorophosphatase;6622;
3BYJ;A;Crystal structure of B. subtilis levansucrase mutant D86A;2.1;CA;CALCIUM ION;Levansucrase;1423;
3BYK;A;Crystal structure of B. subtilis levansucrase mutant D247A;2.1;CA;CALCIUM ION;Levansucrase;1423;
3BYN;A;Crystal structure of B. subtilis levansucrase mutant E342A bound to raffinose;2.1;CA;CALCIUM ION;Levansucrase;1423;
3BZA;B;Structure of Mn-substituted Homoprotocatechuate 2,3-Dioxygenase from B.fuscum at 1.7 Ang resolution;1.7;CA;CALCIUM ION;Homoprotocatechuate 2,3-dioxygenase;47914;
3C0B;B;Crystal structure of the conserved archaeal protein Q6M145. Northeast Structural Genomics Consortium target MrR63;2.4;CA;CALCIUM ION;Conserved archaeal protein Q6M145;39152;
3C0B;D;Crystal structure of the conserved archaeal protein Q6M145. Northeast Structural Genomics Consortium target MrR63;2.4;CA;CALCIUM ION;Conserved archaeal protein Q6M145;39152;
3C0W;A;I-SceI in complex with a bottom nicked DNA substrate;2.2;CA;CALCIUM ION;Intron-encoded endonuclease I-SceI;4932;
3C0W;B;I-SceI in complex with a bottom nicked DNA substrate;2.2;CA;CALCIUM ION;DNA (5'-D(*DAP*DCP*DGP*DCP*DTP*DAP*DGP*DGP*DGP*DAP*DTP*DAP*DAP*DCP*DAP*DGP*DGP*DGP*DTP*DAP*DAP*DTP*DAP*DC)-3');;
3C0X;A;I-SceI in complex with a top nicked DNA substrate;2.3;CA;CALCIUM ION;Intron-encoded endonuclease I-SceI;4932;
3C0X;C;I-SceI in complex with a top nicked DNA substrate;2.3;CA;CALCIUM ION;DNA (5'-D(P*DCP*DAP*DGP*DGP*DGP*DTP*DAP*DAP*DTP*DAP*DC)-3');;
3C14;A;Complex of GS-Alpha with the Catalytic Domains of Mammalian Adenylyl Cyclase: Complex with Pyrophosphate and Ca;2.68;CA;CALCIUM ION;Adenylate cyclase type 5;9612;
3C16;A;Complex of GS-Alpha with the Catalytic Domains of Mammalian Adenylyl Cyclase: Complex with Adenosine-5'-Triphosphate and Ca;2.87;CA;CALCIUM ION;Adenylate cyclase type 5;9612;
3C1E;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS L125K at cryogenic temperature;1.9;CA;CALCIUM ION;Thermonuclease;1280;
3C1F;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS V104K at cryogenic temperature;2;CA;CALCIUM ION;Thermonuclease;1280;
3C1Q;A;The three-dimensional structure of the cytoplasmic domains of EpsF from the Type 2 Secretion System of Vibrio cholerae;1.7;CA;CALCIUM ION;General secretion pathway protein F;243277;
3C1Q;B;The three-dimensional structure of the cytoplasmic domains of EpsF from the Type 2 Secretion System of Vibrio cholerae;1.7;CA;CALCIUM ION;General secretion pathway protein F;243277;
3C1V;A;The 1.5 A Crystal structure of Ca2+-bound S100A4;1.5;CA;CALCIUM ION;Protein S100-A4;9606;
3C1V;B;The 1.5 A Crystal structure of Ca2+-bound S100A4;1.5;CA;CALCIUM ION;Protein S100-A4;9606;
3C1V;C;The 1.5 A Crystal structure of Ca2+-bound S100A4;1.5;CA;CALCIUM ION;Protein S100-A4;9606;
3C1V;D;The 1.5 A Crystal structure of Ca2+-bound S100A4;1.5;CA;CALCIUM ION;Protein S100-A4;9606;
3C22;A;Crystal structure of the carbohydrate recognition domain of human Langerin;1.5;CA;CALCIUM ION;C-type lectin domain family 4 member K;9606;
3C22;B;Crystal structure of the carbohydrate recognition domain of human Langerin;1.5;CA;CALCIUM ION;C-type lectin domain family 4 member K;9606;
3C22;C;Crystal structure of the carbohydrate recognition domain of human Langerin;1.5;CA;CALCIUM ION;C-type lectin domain family 4 member K;9606;
3C22;D;Crystal structure of the carbohydrate recognition domain of human Langerin;1.5;CA;CALCIUM ION;C-type lectin domain family 4 member K;9606;
3C25;A;Crystal Structure of NotI Restriction Endonuclease Bound to Cognate DNA;2.5;CA;CALCIUM ION;NotI restriction endonuclease;1823;
3C25;B;Crystal Structure of NotI Restriction Endonuclease Bound to Cognate DNA;2.5;CA;CALCIUM ION;NotI restriction endonuclease;1823;
3C3Y;A;Crystal Structure of PFOMT, Phenylpropanoid and Flavonoid O-methyltransferase from M. crystallinum;1.37;CA;CALCIUM ION;O-methyltransferase;3544;
3C3Y;B;Crystal Structure of PFOMT, Phenylpropanoid and Flavonoid O-methyltransferase from M. crystallinum;1.37;CA;CALCIUM ION;O-methyltransferase;3544;
3C52;A;Class II fructose-1,6-bisphosphate aldolase from helicobacter pylori in complex with phosphoglycolohydroxamic acid, a competitive inhibitor;2.3;CA;CALCIUM ION;Fructose-bisphosphate aldolase;210;
3C52;B;Class II fructose-1,6-bisphosphate aldolase from helicobacter pylori in complex with phosphoglycolohydroxamic acid, a competitive inhibitor;2.3;CA;CALCIUM ION;Fructose-bisphosphate aldolase;210;
3C5I;A;Crystal structure of Plasmodium knowlesi choline kinase, PKH_134520;2.2;CA;CALCIUM ION;Choline kinase;5850;
3C5I;B;Crystal structure of Plasmodium knowlesi choline kinase, PKH_134520;2.2;CA;CALCIUM ION;Choline kinase;5850;
3C5I;C;Crystal structure of Plasmodium knowlesi choline kinase, PKH_134520;2.2;CA;CALCIUM ION;Choline kinase;5850;
3C5I;D;Crystal structure of Plasmodium knowlesi choline kinase, PKH_134520;2.2;CA;CALCIUM ION;Choline kinase;5850;
3C62;A;Tetrameric Cytochrome cb562 (H59/D62/H63/H73/A74/H77) Assembly Stabilized by Interprotein Zinc Coordination;1.87;CA;CALCIUM ION;Soluble cytochrome b562;562;
3C62;B;Tetrameric Cytochrome cb562 (H59/D62/H63/H73/A74/H77) Assembly Stabilized by Interprotein Zinc Coordination;1.87;CA;CALCIUM ION;Soluble cytochrome b562;562;
3C62;D;Tetrameric Cytochrome cb562 (H59/D62/H63/H73/A74/H77) Assembly Stabilized by Interprotein Zinc Coordination;1.87;CA;CALCIUM ION;Soluble cytochrome b562;562;
3C63;A;Tetrameric Cytochrome cb562 (K34/H59/D62/H63/H73/A74/H77) Assembly Stabilized by Interprotein Zinc Coordination;1.75;CA;CALCIUM ION;Soluble cytochrome b562;562;
3C63;B;Tetrameric Cytochrome cb562 (K34/H59/D62/H63/H73/A74/H77) Assembly Stabilized by Interprotein Zinc Coordination;1.75;CA;CALCIUM ION;Soluble cytochrome b562;562;
3C63;D;Tetrameric Cytochrome cb562 (K34/H59/D62/H63/H73/A74/H77) Assembly Stabilized by Interprotein Zinc Coordination;1.75;CA;CALCIUM ION;Soluble cytochrome b562;562;
3C6L;A;Crystal structure of mouse MHC class II I-Ab/3K peptide complexed with mouse TCR 2W20;3.4;CA;CALCIUM ION;TCR 2W20 alpha chain;10090;
3C6L;E;Crystal structure of mouse MHC class II I-Ab/3K peptide complexed with mouse TCR 2W20;3.4;CA;CALCIUM ION;TCR 2W20 alpha chain;10090;
3C72;B;Engineered RabGGTase in complex with a peptidomimetic inhibitor;2.3;CA;CALCIUM ION;Geranylgeranyl transferase type-2 subunit beta;10116;
3C7E;A;Crystal structure of a glycoside hydrolase family 43 arabinoxylan arabinofuranohydrolase from Bacillus subtilis.;2;CA;CALCIUM ION;Endo-1,4-beta-xylanase;1423;
3C7F;A;Crystal structure of a glycoside hydrolase family 43 arabinoxylan arabinofuranohydrolase from bacillus subtilis in complex with xylotriose.;1.55;CA;CALCIUM ION;Endo-1,4-beta-xylanase;1423;
3C7G;A;Crystal structure of a glycoside hydrolase family 43 arabinoxylan arabinofuranohydrolase from Bacillus subtilis in complex with xylotetraose.;2.02;CA;CALCIUM ION;Endo-1,4-beta-xylanase;1423;
3C7H;A;Crystal structure of glycoside hydrolase family 43 arabinoxylan arabinofuranohydrolase from Bacillus subtilis in complex with AXOS-4-0.5.;2;CA;CALCIUM ION;Endo-1,4-beta-xylanase;1423;
3C7O;A;Crystal structure of a glycoside hydrolase family 43 arabinoxylan arabinofuranohydrolase from Bacillus subtilis in complex with cellotetraose.;1.8;CA;CALCIUM ION;Endo-1,4-beta-xylanase;1423;
3C9E;A;Crystal structure of the cathepsin K : chondroitin sulfate complex.;1.8;CA;CALCIUM ION;Cathepsin K;9606;
3C9I;A;Structure of P22 Tail-Needle GP26 Bound to Xenon Gas;1.95;CA;CALCIUM ION;Tail needle protein gp26;10754;
3C9I;D;Structure of P22 Tail-Needle GP26 Bound to Xenon Gas;1.95;CA;CALCIUM ION;Tail needle protein gp26;10754;
3CDX;A;Crystal structure of succinylglutamatedesuccinylase/aspartoacylase from Rhodobacter sphaeroides;2.1;CA;CALCIUM ION;Succinylglutamatedesuccinylase/aspartoacylase;1063;
3CDX;B;Crystal structure of succinylglutamatedesuccinylase/aspartoacylase from Rhodobacter sphaeroides;2.1;CA;CALCIUM ION;Succinylglutamatedesuccinylase/aspartoacylase;1063;
3CDX;C;Crystal structure of succinylglutamatedesuccinylase/aspartoacylase from Rhodobacter sphaeroides;2.1;CA;CALCIUM ION;Succinylglutamatedesuccinylase/aspartoacylase;1063;
3CDX;D;Crystal structure of succinylglutamatedesuccinylase/aspartoacylase from Rhodobacter sphaeroides;2.1;CA;CALCIUM ION;Succinylglutamatedesuccinylase/aspartoacylase;1063;
3CDX;E;Crystal structure of succinylglutamatedesuccinylase/aspartoacylase from Rhodobacter sphaeroides;2.1;CA;CALCIUM ION;Succinylglutamatedesuccinylase/aspartoacylase;1063;
3CDX;F;Crystal structure of succinylglutamatedesuccinylase/aspartoacylase from Rhodobacter sphaeroides;2.1;CA;CALCIUM ION;Succinylglutamatedesuccinylase/aspartoacylase;1063;
3CDZ;A;Crystal structure of human factor VIII;3.98;CA;CALCIUM ION;Coagulation factor VIII heavy chain;9606;
3CFP;A;Structure of the replicating complex of a POL Alpha family DNA Polymerase, ternary complex 1;2.5;CA;CALCIUM ION;DNA polymerase;12353;
3CFR;A;Structure of the replicating complex of a POL Alpha family DNA Polymerase, ternary complex 2;2.4;CA;CALCIUM ION;DNA polymerase;12353;
3CFW;A;L-selectin lectin and EGF domains;2.2;CA;CALCIUM ION;L-selectin;9606;
3CGA;A;Crystal structure of metastasis-associated protein S100A4 in the active, calcium-bound form;2.03;CA;CALCIUM ION;Protein S100-A4;9606;
3CGA;B;Crystal structure of metastasis-associated protein S100A4 in the active, calcium-bound form;2.03;CA;CALCIUM ION;Protein S100-A4;9606;
3CGT;A;STRUCTURE OF CYCLODEXTRIN GLYCOSYLTRANSFERASE COMPLEXED WITH ITS MAIN PRODUCT BETA-CYCLODEXTRIN;2.4;CA;CALCIUM ION;CYCLODEXTRIN GLYCOSYLTRANSFERASE;1397;
3CH2;X;Crystal Structure Analysis of SERA5E from plasmodium falciparum;1.8;CA;CALCIUM ION;Serine-repeat antigen protein;5833;
3CHJ;A;Crystal Structure of Alpha-14 Giardin;1.6;CA;CALCIUM ION;Alpha-14 giardin;5741;
3CHK;A;Calcium bound structure of alpha-14 giardin;1.65;CA;CALCIUM ION;Alpha-14 giardin;5741;
3CHW;A;Complex of Dictyostelium discoideum Actin with Profilin and the Last Poly-Pro of Human VASP;2.3;CA;CALCIUM ION;Major actin;44689;
3CI0;I;The Crystal Structure of the GspK-GspI-GspJ complex from enterotoxigenic Escherichia coli Type 2 Secretion System;2.2;CA;CALCIUM ION;Pseudopilin GspI;562;
3CI0;K;The Crystal Structure of the GspK-GspI-GspJ complex from enterotoxigenic Escherichia coli Type 2 Secretion System;2.2;CA;CALCIUM ION;Pseudopilin GspK;562;
3CI5;G;Complex of Phosphorylated Dictyostelium Discoideum Actin with Gelsolin;1.7;CA;CALCIUM ION;Gelsolin;9606;
3CIP;G;Complex of Dictyostelium Discoideum Actin with Gelsolin;1.6;CA;CALCIUM ION;Gelsolin;9606;
3CJ9;A;Structure of Rattus norvegicus NTPDase2 in complex with calcium, AMP and phosphate;1.8;CA;CALCIUM ION;Ectonucleoside triphosphate diphosphohydrolase 2;10116;
3CJA;A;Structure of Rattus norvegicus NTPDase2 in complex with calcium and AMPPNP;2.1;CA;CALCIUM ION;Ectonucleoside triphosphate diphosphohydrolase 2;10116;
3CJB;A;Actin dimer cross-linked by V. cholerae MARTX toxin and complexed with Gelsolin-segment 1;3.21;CA;CALCIUM ION;Actin, alpha skeletal muscle;9986;
3CJB;G;Actin dimer cross-linked by V. cholerae MARTX toxin and complexed with Gelsolin-segment 1;3.21;CA;CALCIUM ION;Gelsolin;9606;
3CJC;A;Actin dimer cross-linked by V. cholerae MARTX toxin and complexed with DNase I and Gelsolin-segment 1;3.9;CA;CALCIUM ION;Actin, alpha skeletal muscle;9986;
3CJC;G;Actin dimer cross-linked by V. cholerae MARTX toxin and complexed with DNase I and Gelsolin-segment 1;3.9;CA;CALCIUM ION;Gelsolin;9606;
3CJI;B;Structure of Seneca Valley Virus-001;2.3;CA;CALCIUM ION;Polyprotein;390157;
3CJY;A;Crystal structure of putative thioesterase (YP_496845.1) from Novosphingobium aromaticivorans DSM 12444 at 1.70 A resolution;1.7;CA;CALCIUM ION;Putative thioesterase;48935;
3CK7;A;B. thetaiotaomicron SusD with alpha-cyclodextrin;2.1;CA;CALCIUM ION;SusD;818;
3CK7;B;B. thetaiotaomicron SusD with alpha-cyclodextrin;2.1;CA;CALCIUM ION;SusD;818;
3CK7;C;B. thetaiotaomicron SusD with alpha-cyclodextrin;2.1;CA;CALCIUM ION;SusD;818;
3CK7;D;B. thetaiotaomicron SusD with alpha-cyclodextrin;2.1;CA;CALCIUM ION;SusD;818;
3CK8;A;B. thetaiotaomicron SusD with beta-cyclodextrin;2.1;CA;CALCIUM ION;SusD;818;
3CK8;B;B. thetaiotaomicron SusD with beta-cyclodextrin;2.1;CA;CALCIUM ION;SusD;818;
3CK9;A;B. thetaiotaomicron SusD with maltoheptaose;2.2;CA;CALCIUM ION;SusD;226186;
3CK9;B;B. thetaiotaomicron SusD with maltoheptaose;2.2;CA;CALCIUM ION;SusD;226186;
3CKB;A;B. thetaiotaomicron SusD with maltotriose;2.3;CA;CALCIUM ION;SusD;818;
3CKB;B;B. thetaiotaomicron SusD with maltotriose;2.3;CA;CALCIUM ION;SusD;818;
3CKC;A;B. thetaiotaomicron SusD;1.5;CA;CALCIUM ION;SusD;818;
3CKC;B;B. thetaiotaomicron SusD;1.5;CA;CALCIUM ION;SusD;818;
3CKZ;A;N1 Neuraminidase H274Y + Zanamivir;1.9;CA;CALCIUM ION;Neuraminidase;11320;
3CL0;A;N1 Neuraminidase H274Y + oseltamivir;2.2;CA;CALCIUM ION;Neuraminidase;11320;
3CLN;A;STRUCTURE OF CALMODULIN REFINED AT 2.2 ANGSTROMS RESOLUTION;2.2;CA;CALCIUM ION;CALMODULIN;10117;
3CNA;A;STRUCTURE OF CONCANAVALIN A AT 2.4 ANGSTROMS RESOLUTION;2.4;CA;CALCIUM ION;CONCANAVALIN A;3823;
3CNE;A;Crystal structure of the putative protease I from Bacteroides thetaiotaomicron;1.99;CA;CALCIUM ION;Putative protease I;818;
3CNE;B;Crystal structure of the putative protease I from Bacteroides thetaiotaomicron;1.99;CA;CALCIUM ION;Putative protease I;818;
3CNE;C;Crystal structure of the putative protease I from Bacteroides thetaiotaomicron;1.99;CA;CALCIUM ION;Putative protease I;818;
3CNE;D;Crystal structure of the putative protease I from Bacteroides thetaiotaomicron;1.99;CA;CALCIUM ION;Putative protease I;818;
3CNI;A;Crystal structure of a domain of a putative ABC type-2 transporter from Thermotoga maritima MSB8;2.3;CA;CALCIUM ION;Putative ABC type-2 transporter;2336;
3CO6;C;Crystal Structure of FoxO1 DBD Bound to DBE1 DNA;2.1;CA;CALCIUM ION;Forkhead box protein O1;9606;
3COA;C;Crystal Structure of FoxO1 DBD Bound to IRE DNA;2.2;CA;CALCIUM ION;Forkhead box protein O1;9606;
3COA;F;Crystal Structure of FoxO1 DBD Bound to IRE DNA;2.2;CA;CALCIUM ION;Forkhead box protein O1;9606;
3CPU;A;SUBSITE MAPPING OF THE ACTIVE SITE OF HUMAN PANCREATIC ALPHA-AMYLASE USING SUBSTRATES, THE PHARMACOLOGICAL INHIBITOR ACARBOSE, AND AN ACTIVE SITE VARIANT;2;CA;CALCIUM ION;ALPHA-AMYLASE;9606;
3CQ8;A;Ternary complex of the L415F mutant RB69 exo(-)polymerase;2.5;CA;CALCIUM ION;DNA polymerase;1914161;
3CQO;A;Crystal structure of a f-lectin (fucolectin) from morone saxatilis (striped bass) serum;2.32;CA;CALCIUM ION;FBP32;34816;
3CQO;B;Crystal structure of a f-lectin (fucolectin) from morone saxatilis (striped bass) serum;2.32;CA;CALCIUM ION;FBP32;34816;
3CQO;C;Crystal structure of a f-lectin (fucolectin) from morone saxatilis (striped bass) serum;2.32;CA;CALCIUM ION;FBP32;34816;
3CR2;A;X-ray structure of bovine Zn(2+),Ca(2+)-S100B;1.88;CA;CALCIUM ION;Protein S100-B;9913;
3CR4;X;X-ray structure of bovine Pnt,Ca(2+)-S100B;2.15;CA;CALCIUM ION;Protein S100-B;9913;
3CR5;X;X-ray structure of bovine Pnt-Zn(2+),Ca(2+)-S100B;1.85;CA;CALCIUM ION;Protein S100-B;9913;
3CS7;A;FACTOR XA IN COMPLEX WITH THE INHIBITOR 1-(4-methoxyphenyl)-6-(4-(1-(pyrrolidin-1-ylmethyl)cyclopropyl)phenyl)-3-(trifluoromethyl)-5,6-dihydro-1H-pyrazolo[3,4-c]pyridin-7(4H)-one;2.2;CA;CALCIUM ION;Coagulation factor X;9606;
3CSH;B;Crystal Structure of Glutathione Transferase Pi in complex with the Chlorambucil-Glutathione Conjugate;1.55;CA;CALCIUM ION;Glutathione S-transferase P;9606;
3CSI;B;Crystal Structure of the Glutathione Transferase Pi allelic variant*C, I104V/A113V, in complex with the Chlorambucil-Glutathione Conjugate;1.9;CA;CALCIUM ION;Glutathione S-transferase P;9606;
3CSI;D;Crystal Structure of the Glutathione Transferase Pi allelic variant*C, I104V/A113V, in complex with the Chlorambucil-Glutathione Conjugate;1.9;CA;CALCIUM ION;Glutathione S-transferase P;9606;
3CSU;B;CATALYTIC TRIMER OF ESCHERICHIA COLI ASPARTATE TRANSCARBAMOYLASE;1.88;CA;CALCIUM ION;PROTEIN (ASPARTATE CARBAMOYLTRANSFERASE);562;
3CSU;C;CATALYTIC TRIMER OF ESCHERICHIA COLI ASPARTATE TRANSCARBAMOYLASE;1.88;CA;CALCIUM ION;PROTEIN (ASPARTATE CARBAMOYLTRANSFERASE);562;
3CTN;A;STRUCTURE OF CALCIUM-SATURATED CARDIAC TROPONIN C, NMR, 30 STRUCTURES;;CA;CALCIUM ION;TROPONIN C;9031;
3CTZ;A;Structure of human cytosolic X-prolyl aminopeptidase;1.6;CA;CALCIUM ION;Xaa-Pro aminopeptidase 1;9606;
3CU2;A;Crystal structure of ribulose-5-phosphate 3-epimerase (YP_718263.1) from Haemophilus somnus 129PT at 1.91 A resolution;1.91;CA;CALCIUM ION;Ribulose-5-phosphate 3-epimerase;731;
3CU2;B;Crystal structure of ribulose-5-phosphate 3-epimerase (YP_718263.1) from Haemophilus somnus 129PT at 1.91 A resolution;1.91;CA;CALCIUM ION;Ribulose-5-phosphate 3-epimerase;731;
3CU9;A;High resolution crystal structure of 1,5-alpha-L-arabinanase from Geobacillus Stearothermophilus;1.06;CA;CALCIUM ION;Intracellular arabinanase;1422;
3CV1;A;Atomic Resolution Structures of Escherichia coli and Bacillis anthracis Malate Synthase A: Comparison with Isoform G and Implications for Structure Based Drug Design;1.68;CA;CALCIUM ION;Malate synthase A;562;
3CVG;A;Crystal structure of a periplasmic putative metal binding protein;1.97;CA;CALCIUM ION;Putative metal binding protein;5501;
3CVG;B;Crystal structure of a periplasmic putative metal binding protein;1.97;CA;CALCIUM ION;Putative metal binding protein;5501;
3CVG;C;Crystal structure of a periplasmic putative metal binding protein;1.97;CA;CALCIUM ION;Putative metal binding protein;5501;
3CVG;D;Crystal structure of a periplasmic putative metal binding protein;1.97;CA;CALCIUM ION;Putative metal binding protein;5501;
3CYE;A;Cyrstal structure of the native 1918 H1N1 neuraminidase from a crystal with lattice-translocation defects;1.65;CA;CALCIUM ION;Neuraminidase;88776;
3CYE;B;Cyrstal structure of the native 1918 H1N1 neuraminidase from a crystal with lattice-translocation defects;1.65;CA;CALCIUM ION;Neuraminidase;88776;
3CZT;X;Crystal Structure of S100B in the Calcium and Zinc Loaded State at pH 9;1.4;CA;CALCIUM ION;Protein S100-B;9606;
3D0Y;A;Crystal Structure of S100B in the Calcium and Zinc Loaded State at pH 6.5;1.5;CA;CALCIUM ION;Protein S100-B;9606;
3D0Y;B;Crystal Structure of S100B in the Calcium and Zinc Loaded State at pH 6.5;1.5;CA;CALCIUM ION;Protein S100-B;9606;
3D10;A;Crystal Structure of S100B in the Calcium and Zinc Loaded State at pH 10.0;1.65;CA;CALCIUM ION;Protein S100-B;9606;
3D10;B;Crystal Structure of S100B in the Calcium and Zinc Loaded State at pH 10.0;1.65;CA;CALCIUM ION;Protein S100-B;9606;
3D1I;A;Structure of the Thioalkalivibrio nitratireducens cytochrome c nitrite reductase in a complex with nitrite;1.8;CA;CALCIUM ION;Eight-heme nitrite reductase;186931;
3D1I;B;Structure of the Thioalkalivibrio nitratireducens cytochrome c nitrite reductase in a complex with nitrite;1.8;CA;CALCIUM ION;Eight-heme nitrite reductase;186931;
3D1M;A;Crystal Structure of Sonic Hedgehog Bound to the third FNIII domain of CDO;1.7;CA;CALCIUM ION;Sonic hedgehog protein;10090;
3D1M;B;Crystal Structure of Sonic Hedgehog Bound to the third FNIII domain of CDO;1.7;CA;CALCIUM ION;Sonic hedgehog protein;10090;
3D1R;A;Structure of E. coli GlpX with its substrate fructose 1,6-bisphosphate;1.85;CA;CALCIUM ION;Fructose-1,6-bisphosphatase class II glpX;562;
3D34;A;Structure of the F-spondin domain of mindin;1.8;CA;CALCIUM ION;Spondin-2;9606;
3D34;B;Structure of the F-spondin domain of mindin;1.8;CA;CALCIUM ION;Spondin-2;9606;
3D3I;A;Crystal structural of Escherichia coli K12 YgjK, a glucosidase belonging to glycoside hydrolase family 63;1.78;CA;CALCIUM ION;Uncharacterized protein ygjK;562;
3D3I;B;Crystal structural of Escherichia coli K12 YgjK, a glucosidase belonging to glycoside hydrolase family 63;1.78;CA;CALCIUM ION;Uncharacterized protein ygjK;562;
3D3N;B;Crystal structure of lipase/esterase (lp_2923) from Lactobacillus plantarum. Northeast Structural Genomics Consortium target LpR108;2.5;CA;CALCIUM ION;Putative lipase/esterase;1590;
3D43;A;The crystal structure of Sph at 0.8A;0.8;CA;CALCIUM ION;Sphericase;1421;
3D43;B;The crystal structure of Sph at 0.8A;0.8;CA;CALCIUM ION;Sphericase;1421;
3D4D;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS Y91E at cryogenic temperature;2.1;CA;CALCIUM ION;Thermonuclease;1280;
3D4D;B;Crystal structure of Staphylococcal nuclease variant Delta+PHS Y91E at cryogenic temperature;2.1;CA;CALCIUM ION;Thermonuclease;1280;
3D4G;A;ZP-N domain of mammalian sperm receptor ZP3 (crystal form II);2.3;CA;CALCIUM ION;Maltose-binding periplasmic protein, LINKER, Zona pellucida protein 3;56,210,090;
3D4G;B;ZP-N domain of mammalian sperm receptor ZP3 (crystal form II);2.3;CA;CALCIUM ION;Maltose-binding periplasmic protein, LINKER, Zona pellucida protein 3;56,210,090;
3D4G;C;ZP-N domain of mammalian sperm receptor ZP3 (crystal form II);2.3;CA;CALCIUM ION;Maltose-binding periplasmic protein, LINKER, Zona pellucida protein 3;56,210,090;
3D4G;D;ZP-N domain of mammalian sperm receptor ZP3 (crystal form II);2.3;CA;CALCIUM ION;Maltose-binding periplasmic protein, LINKER, Zona pellucida protein 3;56,210,090;
3D4G;E;ZP-N domain of mammalian sperm receptor ZP3 (crystal form II);2.3;CA;CALCIUM ION;Maltose-binding periplasmic protein, LINKER, Zona pellucida protein 3;56,210,090;
3D4G;F;ZP-N domain of mammalian sperm receptor ZP3 (crystal form II);2.3;CA;CALCIUM ION;Maltose-binding periplasmic protein, LINKER, Zona pellucida protein 3;56,210,090;
3D4G;G;ZP-N domain of mammalian sperm receptor ZP3 (crystal form II);2.3;CA;CALCIUM ION;Maltose-binding periplasmic protein, LINKER, Zona pellucida protein 3;56,210,090;
3D4G;H;ZP-N domain of mammalian sperm receptor ZP3 (crystal form II);2.3;CA;CALCIUM ION;Maltose-binding periplasmic protein, LINKER, Zona pellucida protein 3;56,210,090;
3D4K;A;Concanavalin A Complexed to a Synthetic Analog of the Trimannoside;1.8;CA;CALCIUM ION;Concanavalin-A;3823;
3D4K;B;Concanavalin A Complexed to a Synthetic Analog of the Trimannoside;1.8;CA;CALCIUM ION;Concanavalin-A;3823;
3D4K;C;Concanavalin A Complexed to a Synthetic Analog of the Trimannoside;1.8;CA;CALCIUM ION;Concanavalin-A;3823;
3D4K;D;Concanavalin A Complexed to a Synthetic Analog of the Trimannoside;1.8;CA;CALCIUM ION;Concanavalin-A;3823;
3D5Y;A;High resolution crystal structure of 1,5-alpha-arabinanase catalytic mutant (AbnBE201A);1.22;CA;CALCIUM ION;Intracellular arabinanase;1422;
3D5Z;A;Crystal Structure Analysis of 1,5-alpha-arabinanase catalytic mutant (AbnBE201A) complexed to arabinotriose;1.9;CA;CALCIUM ION;Intracellular arabinanase;1422;
3D60;A;Crystal Structure Analysis of 1,5-alpha-arabinanase catalytic mutant (D27A);1.9;CA;CALCIUM ION;Intracellular arabinanase;1422;
3D61;A;Crystal Structure Analysis of 1,5-alpha-arabinanase catalytic mutant (AbnBD147A) complexed to arabinobiose;1.95;CA;CALCIUM ION;Intracellular arabinanase;1422;
3D65;E;Crystal structure of Textilinin-1, a Kunitz-type serine protease inhibitor from the Australian Common Brown snake venom, in complex with trypsin;1.64;CA;CALCIUM ION;Cationic trypsin;9913;
3D6C;A;Crystal structure of Staphylococcal nuclease variant PHS L38E at cryogenic temperature;2;CA;CALCIUM ION;Thermonuclease;1280;
3D6E;A;Crystal structure of the engineered 1,3-1,4-beta-glucanase protein from Bacillus licheniformis;2.4;CA;CALCIUM ION;Beta-glucanase;1402;
3D6E;B;Crystal structure of the engineered 1,3-1,4-beta-glucanase protein from Bacillus licheniformis;2.4;CA;CALCIUM ION;Beta-glucanase;1402;
3D7D;A;A high resolution crystal structure of human glutamate carboxypeptidase II (GCPII) in a complex with DCFBD, a urea-based inhibitor;1.69;CA;CALCIUM ION;Glutamate carboxypeptidase 2;9606;
3D7F;A;A high resolution crystal structure of human glutamate carboxypeptidase II (GCPII) in a complex with DCIT, a urea-based inhibitor;1.54;CA;CALCIUM ION;Glutamate carboxypeptidase 2;9606;
3D7G;A;A high resolution crystal structure of human glutamate carboxypeptidase II (GCPII) in a complex with DCMC, a urea-based inhibitor;1.75;CA;CALCIUM ION;Glutamate carboxypeptidase 2;9606;
3D7H;A;A high resolution crystal structure of human glutamate carboxypeptidase II (GCPII) in a complex with DCIBzL, a urea-based inhibitor;1.55;CA;CALCIUM ION;Glutamate carboxypeptidase 2;9606;
3D7K;A;Crystal structure of benzaldehyde lyase in complex with the inhibitor MBP;2.49;CA;CALCIUM ION;Benzaldehyde lyase;294;
3D7K;B;Crystal structure of benzaldehyde lyase in complex with the inhibitor MBP;2.49;CA;CALCIUM ION;Benzaldehyde lyase;294;
3D8G;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS I72R at cryogenic temperature;1.99;CA;CALCIUM ION;Thermonuclease;1280;
3D8P;A;Crystal structure of acetyltransferase of GNAT family (NP_373092.1) from STAPHYLOCOCCUS AUREUS MU50 at 2.20 A resolution;2.2;CA;CALCIUM ION;acetyltransferase of GNAT family;1280;
3D94;A;Crystal structure of the insulin-like growth factor-1 receptor kinase in complex with PQIP;2.3;CA;CALCIUM ION;Insulin-like growth factor 1 receptor beta chain;9606;
3D9Q;X;Proteinase K by LB nanotemplate method before high X-Ray dose on ESRF ID23-1 beamline;1.43;CA;CALCIUM ION;Proteinase K;37998;
3DAS;A;Structure of the PQQ-bound form of Aldose Sugar Dehydrogenase (Adh) from Streptomyces coelicolor;1.6;CA;CALCIUM ION;Putative oxidoreductase;1902;
3DAW;A;Structure of the actin-depolymerizing factor homology domain in complex with actin;2.55;CA;CALCIUM ION;Actin, alpha skeletal muscle;9986;
3DB7;A;Crystal structure of a putative calcium-regulated periplasmic protein (bt0923) from bacteroides thetaiotaomicron at 1.40 A resolution;1.4;CA;CALCIUM ION;putative calcium-regulated periplasmic protein;818;
3DBK;A;Pseudomonas aeruginosa elastase with phosphoramidon;1.4;CA;CALCIUM ION;Elastase;287;
3DBZ;A;human surfactant protein D;1.8;CA;CALCIUM ION;Pulmonary surfactant-associated protein D;9606;
3DBZ;B;human surfactant protein D;1.8;CA;CALCIUM ION;Pulmonary surfactant-associated protein D;9606;
3DBZ;C;human surfactant protein D;1.8;CA;CALCIUM ION;Pulmonary surfactant-associated protein D;9606;
3DC0;A;Crystal structure of native alpha-amylase from Bacillus sp. KR-8104;2.78;CA;CALCIUM ION;alpha-amylase;306575;
3DCQ;A;LECB (PA-LII) in complex with the synthetic ligand 2G0;1.8;CA;CALCIUM ION;Fucose-binding lectin PA-IIL;287;
3DCQ;B;LECB (PA-LII) in complex with the synthetic ligand 2G0;1.8;CA;CALCIUM ION;Fucose-binding lectin PA-IIL;287;
3DCQ;C;LECB (PA-LII) in complex with the synthetic ligand 2G0;1.8;CA;CALCIUM ION;Fucose-binding lectin PA-IIL;287;
3DCQ;D;LECB (PA-LII) in complex with the synthetic ligand 2G0;1.8;CA;CALCIUM ION;Fucose-binding lectin PA-IIL;287;
3DD4;A;Structural Basis of KChIP4a Modulation of Kv4.3 Slow Inactivation;3;CA;CALCIUM ION;Kv channel-interacting protein 4;10090;
3DDZ;X;Proteinase K by LB nanotemplate method after the first step of high X-Ray dose on ESRF ID23-1 beamline;1.7;CA;CALCIUM ION;Proteinase K;37998;
3DE0;X;Proteinase K by LB nanotemplate method after the second step of high X-Ray dose on ESRF ID23-1 beamline;1.9;CA;CALCIUM ION;Proteinase K;37998;
3DE1;X;Proteinase K by LB nanotemplate method after the third step of high X-Ray dose on ESRF ID23-1 beamline;2;CA;CALCIUM ION;Proteinase K;37998;
3DE2;X;Proteinase K by LB nanotemplate method after the fourth step of high X-Ray dose on ESRF ID23-1 beamline;2.1;CA;CALCIUM ION;Proteinase K;37998;
3DE3;X;Proteinase K by Classical hanging drop method before high X-Ray dose on ESRF ID23-1 beamline;1.43;CA;CALCIUM ION;Proteinase K;37998;
3DE4;X;Proteinase K by Classical hanging drop method after the first step of high X-Ray dose on ESRF ID23-1 beamline;1.8;CA;CALCIUM ION;Proteinase K;37998;
3DE5;X;roteinase K by Classical hanging drop method after the second step of high X-Ray dose on ESRF ID23-1 beamline;2.1;CA;CALCIUM ION;Proteinase K;37998;
3DE6;X;Proteinase K by Classical hanging drop method after the third step of high X-Ray dose on ESRF ID23-1 beamline;2.2;CA;CALCIUM ION;Proteinase K;37998;
3DE7;X;Proteinase K by Classical hanging drop method after the fourth step of high X-Ray dose on ESRF ID23-1 beamline;2.3;CA;CALCIUM ION;Proteinase K;37998;
3DE8;A;Crystal Structure of a Dimeric Cytochrome cb562 Assembly Induced by Copper Coordination;1.72;CA;CALCIUM ION;Soluble cytochrome b562;562;
3DE8;B;Crystal Structure of a Dimeric Cytochrome cb562 Assembly Induced by Copper Coordination;1.72;CA;CALCIUM ION;Soluble cytochrome b562;562;
3DE8;C;Crystal Structure of a Dimeric Cytochrome cb562 Assembly Induced by Copper Coordination;1.72;CA;CALCIUM ION;Soluble cytochrome b562;562;
3DEB;A;Crystal Structure of apo form (Zinc removed) of the Botulinum Neurotoxin Type C Light Chain;1.95;CA;CALCIUM ION;Botulinum neurotoxin C1 light chain;1491;
3DED;A;C-terminal domain of Probable hemolysin from Chromobacterium violaceum;2.14;CA;CALCIUM ION;Probable hemolysin;536;
3DED;B;C-terminal domain of Probable hemolysin from Chromobacterium violaceum;2.14;CA;CALCIUM ION;Probable hemolysin;536;
3DED;C;C-terminal domain of Probable hemolysin from Chromobacterium violaceum;2.14;CA;CALCIUM ION;Probable hemolysin;536;
3DED;D;C-terminal domain of Probable hemolysin from Chromobacterium violaceum;2.14;CA;CALCIUM ION;Probable hemolysin;536;
3DED;E;C-terminal domain of Probable hemolysin from Chromobacterium violaceum;2.14;CA;CALCIUM ION;Probable hemolysin;536;
3DED;F;C-terminal domain of Probable hemolysin from Chromobacterium violaceum;2.14;CA;CALCIUM ION;Probable hemolysin;536;
3DEM;A;CUB1-EGF-CUB2 domain of HUMAN MASP-1/3;2.3;CA;CALCIUM ION;Complement factor MASP-3;9606;
3DEM;B;CUB1-EGF-CUB2 domain of HUMAN MASP-1/3;2.3;CA;CALCIUM ION;Complement factor MASP-3;9606;
3DF0;A;Calcium-dependent complex between m-calpain and calpastatin;2.95;CA;CALCIUM ION;Calpain-2 catalytic subunit;10116;
3DF0;B;Calcium-dependent complex between m-calpain and calpastatin;2.95;CA;CALCIUM ION;Calpain small subunit 1;10116;
3DF6;A;The thermo- and acido-stable ORF-99 from the archaeal virus AFV1;2.05;CA;CALCIUM ION;ORF99;235266;
3DF6;B;The thermo- and acido-stable ORF-99 from the archaeal virus AFV1;2.05;CA;CALCIUM ION;ORF99;235266;
3DF6;C;The thermo- and acido-stable ORF-99 from the archaeal virus AFV1;2.05;CA;CALCIUM ION;ORF99;235266;
3DGQ;B;Crystal structure of the glutathione transferase PI enzyme in complex with the bifunctional inhibitor, etharapta;1.6;CA;CALCIUM ION;Glutathione S-transferase P;9606;
3DHG;B;Crystal Structure of Toluene 4-Monoxygenase Hydroxylase;1.85;CA;CALCIUM ION;toluene 4-monooxygenase hydroxylase beta subunit;300;
3DHG;C;Crystal Structure of Toluene 4-Monoxygenase Hydroxylase;1.85;CA;CALCIUM ION;toluene 4-monooxygenase hydroxylase gamma subunit;300;
3DHG;E;Crystal Structure of Toluene 4-Monoxygenase Hydroxylase;1.85;CA;CALCIUM ION;toluene 4-monooxygenase hydroxylase beta subunit;300;
3DHG;F;Crystal Structure of Toluene 4-Monoxygenase Hydroxylase;1.85;CA;CALCIUM ION;toluene 4-monooxygenase hydroxylase gamma subunit;300;
3DHP;A;Probing the role of aromatic residues at the secondary saccharide binding sites of human salivary alpha-amylase in substrate hydrolysis and bacterial binding;1.5;CA;CALCIUM ION;Alpha-amylase 1;9606;
3DHQ;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS A90R at cryogenic temperature;2.15;CA;CALCIUM ION;Thermonuclease;1280;
3DJL;A;Crystal structure of alkylation response protein E. coli AidB;1.7;CA;CALCIUM ION;Protein aidB;562;
3DNG;A;Crystal structure of the complex between MMP-8 and a non-zinc chelating inhibitor;2;CA;CALCIUM ION;Neutrophil collagenase;9606;
3DNG;B;Crystal structure of the complex between MMP-8 and a non-zinc chelating inhibitor;2;CA;CALCIUM ION;Neutrophil collagenase;9606;
3DNI;A;CRYSTALLOGRAPHIC REFINEMENT AND STRUCTURE OF DNASE I AT 2 ANGSTROMS RESOLUTION;2;CA;CALCIUM ION;DEOXYRIBONUCLEASE I;9913;
3DNZ;A;Thermolysin by LB nanotemplate method before high X-Ray dose on ESRF ID14-2 beamline;1.2;CA;CALCIUM ION;Thermolysin;1427;
3DO0;A;Thermolysin by classical hanging drop method after high X-Ray dose on esrf ID14-2 beamline;1.36;CA;CALCIUM ION;Thermolysin;1427;
3DO1;A;Thermolysin by Classical hanging drop method before high X-Ray dose on ESRF ID14-2 beamline;1.33;CA;CALCIUM ION;Thermolysin;1427;
3DO2;A;Thermolysin by LB nanotemplate method after high X-Ray dose on ESRF ID14-2 beamline;1.22;CA;CALCIUM ION;Thermolysin;1427;
3DPE;A;Crystal structure of the complex between MMP-8 and a non-zinc chelating inhibitor;1.6;CA;CALCIUM ION;Neutrophil collagenase;9606;
3DPF;A;Crystal structure of the complex between MMP-8 and a non-zinc chelating inhibitor;2.1;CA;CALCIUM ION;Neutrophil collagenase;9606;
3DPF;B;Crystal structure of the complex between MMP-8 and a non-zinc chelating inhibitor;2.1;CA;CALCIUM ION;Neutrophil collagenase;9606;
3DPG;A;SgrAI with noncognate DNA bound;1.91;CA;CALCIUM ION;SgraIR restriction enzyme;1911;
3DPG;B;SgrAI with noncognate DNA bound;1.91;CA;CALCIUM ION;SgraIR restriction enzyme;1911;
3DPR;E;Human rhinovirus 2 bound to a concatamer of the VLDL receptor module V3;3.5;CA;CALCIUM ION;LDL-receptor class A 3;9606;
3DR2;A;Structural and Functional Analyses of XC5397 from Xanthomonas campestris: A Gluconolactonase Important in Glucose Secondary Metabolic Pathways;1.67;CA;CALCIUM ION;Exported gluconolactonase;339;
3DR2;B;Structural and Functional Analyses of XC5397 from Xanthomonas campestris: A Gluconolactonase Important in Glucose Secondary Metabolic Pathways;1.67;CA;CALCIUM ION;Exported gluconolactonase;339;
3DRC;B;INVESTIGATION OF THE FUNCTIONAL ROLE OF TRYPTOPHAN-22 IN ESCHERICHIA COLI DIHYDROFOLATE REDUCTASE BY SITE-DIRECTED MUTAGENESIS;1.9;CA;CALCIUM ION;DIHYDROFOLATE REDUCTASE;562;
3DSL;A;The Three-dimensional Structure of Bothropasin, the Main Hemorrhagic Factor from Bothrops jararaca venom.;2.7;CA;CALCIUM ION;Zinc metalloproteinase-disintegrin bothropasin;8724;
3DSL;B;The Three-dimensional Structure of Bothropasin, the Main Hemorrhagic Factor from Bothrops jararaca venom.;2.7;CA;CALCIUM ION;Zinc metalloproteinase-disintegrin bothropasin;8724;
3DT5;A;C_terminal domain of protein of unknown function AF_0924 from Archaeoglobus fulgidus.;1.94;CA;CALCIUM ION;Uncharacterized protein AF_0924;2234;
3DTN;A;Crystal structure of putative Methyltransferase-MM_2633 from Methanosarcina mazei .;2.09;CA;CALCIUM ION;Putative Methyltransferase MM_2633;2209;
3DTN;B;Crystal structure of putative Methyltransferase-MM_2633 from Methanosarcina mazei .;2.09;CA;CALCIUM ION;Putative Methyltransferase MM_2633;2209;
3DTU;A;Catalytic core subunits (I and II) of cytochrome c oxidase from Rhodobacter sphaeroides complexed with deoxycholic acid;2.15;CA;CALCIUM ION;Cytochrome c oxidase subunit 1;1063;
3DTU;C;Catalytic core subunits (I and II) of cytochrome c oxidase from Rhodobacter sphaeroides complexed with deoxycholic acid;2.15;CA;CALCIUM ION;Cytochrome c oxidase subunit 1;1063;
3DVE;A;Crystal Structure of Ca2+/CaM-CaV2.2 IQ domain complex;2.35;CA;CALCIUM ION;Calmodulin;9606;
3DVJ;A;Crystal Structure of Ca2+/CaM-CaV2.2 IQ domain (without cloning artifact, HM to TV) complex;2.8;CA;CALCIUM ION;Calmodulin;9606;
3DVK;A;Crystal Structure of Ca2+/CaM-CaV2.3 IQ domain complex;2.3;CA;CALCIUM ION;Calmodulin;9606;
3DVM;A;Crystal Structure of Ca2+/CaM-CaV2.1 IQ domain complex;2.6;CA;CALCIUM ION;Calmodulin;9606;
3DVO;A;SgrAI with cognate DNA and calcium bound;1.89;CA;CALCIUM ION;SgraIR restriction enzyme;1911;
3DVO;B;SgrAI with cognate DNA and calcium bound;1.89;CA;CALCIUM ION;SgraIR restriction enzyme;1911;
3DVO;C;SgrAI with cognate DNA and calcium bound;1.89;CA;CALCIUM ION;SgraIR restriction enzyme;1911;
3DVO;D;SgrAI with cognate DNA and calcium bound;1.89;CA;CALCIUM ION;SgraIR restriction enzyme;1911;
3DVQ;X;Proteinase K by LB nanotemplate method before high X-Ray dose on ESRF ID14-2 beamline;1.02;CA;CALCIUM ION;Proteinase K;37998;
3DVR;X;Proteinase K by LB nanotemplate method after the first step of high X-Ray dose on ESRF ID14-2 beamline;1.02;CA;CALCIUM ION;Proteinase K;37998;
3DVS;X;Proteinase K by LB nanotmplate method after the second step of high dose on ESRF ID14-2 beamline;1.02;CA;CALCIUM ION;Proteinase K;37998;
3DW1;X;Proteinase K by LB nanotemplate method after the third step high X-Ray dose on ESRF ID14-2 beamline;1.03;CA;CALCIUM ION;Proteinase K;37998;
3DW3;X;Proteinase K by Classical hanging drop method before high X Ray dose on ESRF ID 14-2 beamline;0.99;CA;CALCIUM ION;Proteinase K;37998;
3DWE;X;Proteinase K by Classical hanging drop method after high X-Ray dose on ESRF ID14-2 beamline;0.99;CA;CALCIUM ION;Proteinase K;37998;
3DXP;A;Crystal structure of a putative aminoglycoside phosphotransferase (reut_a1007) from ralstonia eutropha jmp134 at 2.32 A resolution;2.32;CA;CALCIUM ION;putative acyl-CoA dehydrogenase;248026;
3DYB;A;proteinase K- digalacturonic acid complex;1.32;CA;CALCIUM ION;Proteinase K;37998;
3DZC;A;2.35 Angstrom resolution structure of WecB (VC0917), a UDP-N-acetylglucosamine 2-epimerase from Vibrio cholerae.;2.35;CA;CALCIUM ION;UDP-N-acetylglucosamine 2-epimerase;666;
3DZC;B;2.35 Angstrom resolution structure of WecB (VC0917), a UDP-N-acetylglucosamine 2-epimerase from Vibrio cholerae.;2.35;CA;CALCIUM ION;UDP-N-acetylglucosamine 2-epimerase;666;
3DZM;A;Crystal structure of a major outer membrane protein from Thermus thermophilus HB27;2.8;CA;CALCIUM ION;Hypothetical conserved protein;274;
3DZM;B;Crystal structure of a major outer membrane protein from Thermus thermophilus HB27;2.8;CA;CALCIUM ION;Hypothetical conserved protein;274;
3DZM;C;Crystal structure of a major outer membrane protein from Thermus thermophilus HB27;2.8;CA;CALCIUM ION;Hypothetical conserved protein;274;
3DZZ;A;CRYSTAL STRUCTURE OF A PUTATIVE PLP-DEPENDENT AMINOTRANSFERASE (LBUL_1103) FROM LACTOBACILLUS DELBRUECKII SUBSP. AT 1.61 A RESOLUTION;1.61;CA;CALCIUM ION;putative pyridoxal 5'-phosphate-dependent C-S lyase;1584;
3.00E+03;A;Crystal structure of a putative dehydrogenase from Xanthomonas campestris;1.69;CA;CALCIUM ION;Short chain dehydrogenase;339;
3E0D;A;Insights into the Replisome from the Crystral Structure of the Ternary Complex of the Eubacterial DNA Polymerase III alpha-subunit;4.6;CA;CALCIUM ION;DNA polymerase III subunit alpha;271;
3E0D;B;Insights into the Replisome from the Crystral Structure of the Ternary Complex of the Eubacterial DNA Polymerase III alpha-subunit;4.6;CA;CALCIUM ION;DNA polymerase III subunit alpha;271;
3.00E+11;B;Crystal structure of a predicted zincin-like metalloprotease (acel_2062) from acidothermus cellulolyticus 11b at 1.80 A resolution;1.8;CA;CALCIUM ION;predicted zincin-like metalloprotease;28049;
3E1I;B;Crystal Structure of BbetaD432A Variant Fibrinogen Fragment D with the Peptide Ligand Gly-His-Arg-Pro-amide;2.3;CA;CALCIUM ION;Fibrinogen beta chain;9606;
3E1I;C;Crystal Structure of BbetaD432A Variant Fibrinogen Fragment D with the Peptide Ligand Gly-His-Arg-Pro-amide;2.3;CA;CALCIUM ION;Fibrinogen gamma chain;9606;
3E1I;E;Crystal Structure of BbetaD432A Variant Fibrinogen Fragment D with the Peptide Ligand Gly-His-Arg-Pro-amide;2.3;CA;CALCIUM ION;Fibrinogen beta chain;9606;
3E1I;F;Crystal Structure of BbetaD432A Variant Fibrinogen Fragment D with the Peptide Ligand Gly-His-Arg-Pro-amide;2.3;CA;CALCIUM ION;Fibrinogen gamma chain;9606;
3E3R;A;Crystal structure and biochemical characterization of recombinant human calcyphosine delineates a novel EF-hand-containing protein family;2.65;CA;CALCIUM ION;Calcyphosin;9606;
3E3R;B;Crystal structure and biochemical characterization of recombinant human calcyphosine delineates a novel EF-hand-containing protein family;2.65;CA;CALCIUM ION;Calcyphosin;9606;
3E3Y;A;Q138F HincII bound to GTTAAC and cocrystallized with 5 mM Ca2+;2.13;CA;CALCIUM ION;Type-2 restriction enzyme HindII;727;
3E3Y;B;Q138F HincII bound to GTTAAC and cocrystallized with 5 mM Ca2+;2.13;CA;CALCIUM ION;Type-2 restriction enzyme HindII;727;
3.00E+40;A;Q138F HincII bound to GTTAAC and cocrystallized with 5 mM Ca2+;2.1;CA;CALCIUM ION;Type-2 restriction enzyme HindII;727;
3.00E+40;B;Q138F HincII bound to GTTAAC and cocrystallized with 5 mM Ca2+;2.1;CA;CALCIUM ION;Type-2 restriction enzyme HindII;727;
3.00E+41;A;Q138F HincII bound to GTCGAC and 5 mM Ca2+;2.73;CA;CALCIUM ION;Type-2 restriction enzyme HindII;727;
3.00E+41;B;Q138F HincII bound to GTCGAC and 5 mM Ca2+;2.73;CA;CALCIUM ION;Type-2 restriction enzyme HindII;727;
3.00E+42;A;Q138F HincII bound to GTCGAC and Ca2+ (cocrystallized);2.68;CA;CALCIUM ION;Type-2 restriction enzyme HindII;727;
3.00E+42;E;Q138F HincII bound to GTCGAC and Ca2+ (cocrystallized);2.68;CA;CALCIUM ION;5'-D(*DGP*DCP*DCP*DGP*DGP*DTP*DCP*DGP*DAP*DCP*DCP*DGP*DGP*DC)-3';;
3.00E+45;A;Q138F HincII bound to Noncognate DNA (GTGCAC) and Ca2+;2.78;CA;CALCIUM ION;Type-2 restriction enzyme HindII;727;
3.00E+45;E;Q138F HincII bound to Noncognate DNA (GTGCAC) and Ca2+;2.78;CA;CALCIUM ION;5'-D(*DGP*DCP*DCP*DGP*DGP*DTP*DGP*DCP*DAP*DCP*DCP*DGP*DGP*DC)-3';;
3.00E+46;A;Crystal structure of ubiquitin-conjugating enzyme E2-25kDa (Huntington interacting protein 2) M172A mutant;1.86;CA;CALCIUM ION;Ubiquitin-conjugating enzyme E2-25 kDa;9606;
3E4Q;A;Crystal structure of apo DctB;2.75;CA;CALCIUM ION;C4-dicarboxylate transport sensor protein dctB;382;
3E4Q;B;Crystal structure of apo DctB;2.75;CA;CALCIUM ION;C4-dicarboxylate transport sensor protein dctB;382;
3E5S;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS L103K at cryogenic temperature;2;CA;CALCIUM ION;Thermonuclease;1280;
3E5S;B;Crystal structure of Staphylococcal nuclease variant Delta+PHS L103K at cryogenic temperature;2;CA;CALCIUM ION;Thermonuclease;1280;
3.00E+78;A;Structure determination of the cancer-associated Mycoplasma hyorhinis protein Mh-p37;1.9;CA;CALCIUM ION;High affinity transport system protein p37;2100;
3.00E+79;A;Structure determination of the cancer-associated Mycoplasma hyorhinis protein Mh-p37;1.9;CA;CALCIUM ION;High affinity transport system protein p37;2100;
3.00E+86;A;High resolution Crystal Structure of the open NaK channel pore;1.6;CA;CALCIUM ION;Potassium channel protein;1396;
3E8G;A;Crystal Structure of the the open NaK channel-Na+/Ca2+ complex;2;CA;CALCIUM ION;Potassium channel protein;1396;
3E8G;B;Crystal Structure of the the open NaK channel-Na+/Ca2+ complex;2;CA;CALCIUM ION;Potassium channel protein;1396;
3E8L;A;The Crystal Structure of the Double-headed Arrowhead Protease Inhibitor A in Complex with Two Trypsins;2.48;CA;CALCIUM ION;Cationic trypsin;9913;
3E8L;B;The Crystal Structure of the Double-headed Arrowhead Protease Inhibitor A in Complex with Two Trypsins;2.48;CA;CALCIUM ION;Cationic trypsin;9913;
3E9T;A;Crystal structure of Apo-form Calx CBD1 domain;1.6;CA;CALCIUM ION;Na/Ca exchange protein;7227;
3E9T;B;Crystal structure of Apo-form Calx CBD1 domain;1.6;CA;CALCIUM ION;Na/Ca exchange protein;7227;
3EAD;A;Crystal structure of CALX-CBD1;2.25;CA;CALCIUM ION;Na/Ca exchange protein;7227;
3EAD;B;Crystal structure of CALX-CBD1;2.25;CA;CALCIUM ION;Na/Ca exchange protein;7227;
3EAD;C;Crystal structure of CALX-CBD1;2.25;CA;CALCIUM ION;Na/Ca exchange protein;7227;
3EAD;D;Crystal structure of CALX-CBD1;2.25;CA;CALCIUM ION;Na/Ca exchange protein;7227;
3ECJ;B;Structure of E323L mutant of Homoprotocatechuate 2,3-Dioxygenase from Brevibacterium fuscum at 1.65A resolution;1.65;CA;CALCIUM ION;PROTEIN (Homoprotocatechuate 2,3-dioxygenase);47914;
3ECK;B;Structure of E323L Homoprotocatechuate 2,3-dioxygenase from Brevibacterium fuscum in complex with putative O-O bond cleavage intermediate formed via in crystallo reaction with 4-sulfonyl catechol at low oxygen concentrations;1.6;CA;CALCIUM ION;PROTEIN (Homoprotocatechuate 2,3-dioxygenase);47914;
3ECQ;A;Endo-alpha-N-acetylgalactosaminidase from Streptococcus pneumoniae: SeMet structure;2.9;CA;CALCIUM ION;Endo-alpha-N-acetylgalactosaminidase;1313;
3ECQ;B;Endo-alpha-N-acetylgalactosaminidase from Streptococcus pneumoniae: SeMet structure;2.9;CA;CALCIUM ION;Endo-alpha-N-acetylgalactosaminidase;1313;
3ECT;A;Crystal Structure of the Hexapeptide-Repeat Containing-Acetyltransferase VCA0836 from Vibrio cholerae;2.51;CA;CALCIUM ION;Hexapeptide-repeat containing-acetyltransferase;666;
3EDD;A;Structural base for cyclodextrin hydrolysis;2.65;CA;CALCIUM ION;Cyclomaltodextrinase;197856;
3EDD;B;Structural base for cyclodextrin hydrolysis;2.65;CA;CALCIUM ION;Cyclomaltodextrinase;197856;
3EDE;A;Structural base for cyclodextrin hydrolysis;1.71;CA;CALCIUM ION;Cyclomaltodextrinase;197856;
3EDE;B;Structural base for cyclodextrin hydrolysis;1.71;CA;CALCIUM ION;Cyclomaltodextrinase;197856;
3EDF;A;Structural base for cyclodextrin hydrolysis;1.65;CA;CALCIUM ION;Cyclomaltodextrinase;197856;
3EDF;B;Structural base for cyclodextrin hydrolysis;1.65;CA;CALCIUM ION;Cyclomaltodextrinase;197856;
3EDJ;A;Structural base for cyclodextrin hydrolysis;1.69;CA;CALCIUM ION;Cyclomaltodextrinase;197856;
3EDJ;B;Structural base for cyclodextrin hydrolysis;1.69;CA;CALCIUM ION;Cyclomaltodextrinase;197856;
3EDK;A;Structural base for cyclodextrin hydrolysis;1.77;CA;CALCIUM ION;Cyclomaltodextrinase;197856;
3EDK;B;Structural base for cyclodextrin hydrolysis;1.77;CA;CALCIUM ION;Cyclomaltodextrinase;197856;
3EDY;A;Crystal Structure of the Precursor Form of Human Tripeptidyl-Peptidase 1;1.85;CA;CALCIUM ION;Tripeptidyl-peptidase 1;9606;
3EE6;A;Crystal Structure Analysis of Tripeptidyl peptidase -I;2.35;CA;CALCIUM ION;Tripeptidyl-peptidase 1;9606;
3EE6;B;Crystal Structure Analysis of Tripeptidyl peptidase -I;2.35;CA;CALCIUM ION;Tripeptidyl-peptidase 1;9606;
3EF2;A;Structure of the Marasmius oreades mushroom lectin (MOA) in complex with Galalpha(1,3)[Fucalpha(1,2)]Gal and Calcium.;1.8;CA;CALCIUM ION;Agglutinin;181124;
3EF2;B;Structure of the Marasmius oreades mushroom lectin (MOA) in complex with Galalpha(1,3)[Fucalpha(1,2)]Gal and Calcium.;1.8;CA;CALCIUM ION;Agglutinin;181124;
3EF2;C;Structure of the Marasmius oreades mushroom lectin (MOA) in complex with Galalpha(1,3)[Fucalpha(1,2)]Gal and Calcium.;1.8;CA;CALCIUM ION;Agglutinin;181124;
3EF2;D;Structure of the Marasmius oreades mushroom lectin (MOA) in complex with Galalpha(1,3)[Fucalpha(1,2)]Gal and Calcium.;1.8;CA;CALCIUM ION;Agglutinin;181124;
3EF7;A;ZP-N domain of mammalian sperm receptor ZP3 (crystal form III);3.1;CA;CALCIUM ION;Maltose-binding periplasmic protein, LINKER, Zona pellucida protein 3;56,210,090;
3EF7;B;ZP-N domain of mammalian sperm receptor ZP3 (crystal form III);3.1;CA;CALCIUM ION;Maltose-binding periplasmic protein, LINKER, Zona pellucida protein 3;56,210,090;
3EH8;A;Crystal structure of Y2 I-AniI variant (F13Y/S111Y)/DNA complex with calcium;2.7;CA;CALCIUM ION;Intron-encoded DNA endonuclease I-AniI;162425;
3EH8;D;Crystal structure of Y2 I-AniI variant (F13Y/S111Y)/DNA complex with calcium;2.7;CA;CALCIUM ION;Intron-encoded DNA endonuclease I-AniI;162425;
3EH8;G;Crystal structure of Y2 I-AniI variant (F13Y/S111Y)/DNA complex with calcium;2.7;CA;CALCIUM ION;Intron-encoded DNA endonuclease I-AniI;162425;
3EHB;A;A D-Pathway Mutation Decouples the Paracoccus Denitrificans Cytochrome c Oxidase by Altering the side chain orientation of a distant, conserved Glutamate;2.32;CA;CALCIUM ION;Cytochrome c oxidase subunit 1-beta;266;
3EHH;A;Crystal structure of DesKC-H188V in complex with ADP;2.1;CA;CALCIUM ION;Sensor kinase (YocF protein);1423;
3EHH;B;Crystal structure of DesKC-H188V in complex with ADP;2.1;CA;CALCIUM ION;Sensor kinase (YocF protein);1423;
3EHJ;A;Crystal structure of DesKC-H188V in complex with AMP-PCP;2.5;CA;CALCIUM ION;Sensor kinase (YocF protein);1423;
3EHJ;B;Crystal structure of DesKC-H188V in complex with AMP-PCP;2.5;CA;CALCIUM ION;Sensor kinase (YocF protein);1423;
3EHU;A;Crystal structure of the extracellular domain of human corticotropin releasing factor receptor type 1 (CRFR1) in complex with CRF;1.96;CA;CALCIUM ION;FUSION PROTEIN OF CRFR1 EXTRACELLULAR DOMAIN AND MBP;5,629,606;
3EHU;B;Crystal structure of the extracellular domain of human corticotropin releasing factor receptor type 1 (CRFR1) in complex with CRF;1.96;CA;CALCIUM ION;FUSION PROTEIN OF CRFR1 EXTRACELLULAR DOMAIN AND MBP;5,629,606;
3EHX;A;Crystal structure of the catalytic domain of human MMP12 complexed with the inhibitor (R)-2-(biphenyl-4-ylsulfonamido)-4-methylpentanoic acid;1.9;CA;CALCIUM ION;Macrophage metalloelastase;9606;
3EHY;A;Crystal structure of the catalytic domain of human MMP12 complexed with the inhibitor (R)-2-(4-methoxyphenylsulfonamido)propanoic acid;1.9;CA;CALCIUM ION;Macrophage metalloelastase;9606;
3EIF;A;1.9 angstrom crystal structure of the active form of the C5a peptidase from Streptococcus pyogenes (ScpA);1.9;CA;CALCIUM ION;C5a peptidase;1314;
3EIM;A;Metal exchange in Thermolysin;1.88;CA;CALCIUM ION;Thermolysin;1427;
3EK4;A;Calcium-saturated GCaMP2 Monomer;2.65;CA;CALCIUM ION;Myosin light chain kinase, Green fluorescent protein, Calmodulin chimera;61,001,011,632,630;
3EK7;A;Calcium-saturated GCaMP2 dimer;1.85;CA;CALCIUM ION;Myosin light chain kinase, Green fluorescent protein, Calmodulin chimera;61,001,011,632,630;
3EK8;A;Calcium-saturated GCaMP2 T116V/G87R mutant monomer;2.8;CA;CALCIUM ION;Myosin light chain kinase, Green fluorescent protein, Calmodulin chimera;61,001,011,632,630;
3EKH;A;Calcium-saturated GCaMP2 T116V/K378W mutant monomer;2;CA;CALCIUM ION;Myosin light chain kinase, Green fluorescent protein, Calmodulin chimera;61,001,011,632,630;
3EKI;A;Structural insights of the Mycoplasma hyorhinis protein Mh-p37: A putative thiamine pyrophosphate transporter;1.6;CA;CALCIUM ION;High affinity transport system protein p37;2100;
3EKS;A;Crystal Structure of Monomeric Actin bound to Cytochalasin D;1.8;CA;CALCIUM ION;Actin-5C;7227;
3EKU;A;Crystal Structure of Monomeric Actin bound to Cytochalasin D;2.5;CA;CALCIUM ION;Actin-5C;7227;
3EL2;A;Crystal Structure of Monomeric Actin Bound to Ca-ATP;2.5;CA;CALCIUM ION;Actin-5C;7227;
3ELA;H;Crystal structure of active site inhibited coagulation factor VIIA mutant in complex with soluble tissue factor;2.2;CA;CALCIUM ION;Coagulation factor VIIA heavy chain;9606;
3ELM;A;Crystal Structure of MMP-13 Complexed with Inhibitor 24f;1.9;CA;CALCIUM ION;Collagenase 3;9606;
3ELM;B;Crystal Structure of MMP-13 Complexed with Inhibitor 24f;1.9;CA;CALCIUM ION;Collagenase 3;9606;
3EN8;A;Crystal structure of NTF-2 like protein of unknown function (YP_553245.1) from BURKHOLDERIA XENOVORANS LB400 at 1.85 A resolution;1.85;CA;CALCIUM ION;uncharacterized NTF-2 like protein;36873;
3ENR;A;ZINC-CALCIUM CONCANAVALIN A AT PH 6.15;2.4;CA;CALCIUM ION;Concanavalin-A;3823;
3ENR;B;ZINC-CALCIUM CONCANAVALIN A AT PH 6.15;2.4;CA;CALCIUM ION;Concanavalin-A;3823;
3ENS;B;Crystal structure of human FXA in complex with methyl (2Z)-3-[(3-chloro-1H-indol-7-yl)amino]-2-cyano-3-{[(3S)-2-oxo-1-(2-oxo-2-pyrrolidin-1-ylethyl)azepan-3-yl]amino}acrylate;2.3;CA;CALCIUM ION;Activated factor Xa heavy chain;9606;
3ENS;D;Crystal structure of human FXA in complex with methyl (2Z)-3-[(3-chloro-1H-indol-7-yl)amino]-2-cyano-3-{[(3S)-2-oxo-1-(2-oxo-2-pyrrolidin-1-ylethyl)azepan-3-yl]amino}acrylate;2.3;CA;CALCIUM ION;Activated factor Xa heavy chain;9606;
3EO7;A;Crystal structure of a putative nitroreductase (ava_2154) from anabaena variabilis atcc 29413 at 1.80 A resolution;1.8;CA;CALCIUM ION;Putative Nitroreductase;264691;
3EPW;A;Crystal structure of Trypanosoma vivax nucleoside hydrolase in complex with the inhibitor (2R,3R,4S)-1-[(4-hydroxy-5H-pyrrolo[3,2-d]pyrimidin-7-yl)methyl]-2-(hydroxymethyl)pyrrolidin-3,4-diol;1.3;CA;CALCIUM ION;IAG-nucleoside hydrolase;5699;
3EPW;B;Crystal structure of Trypanosoma vivax nucleoside hydrolase in complex with the inhibitor (2R,3R,4S)-1-[(4-hydroxy-5H-pyrrolo[3,2-d]pyrimidin-7-yl)methyl]-2-(hydroxymethyl)pyrrolidin-3,4-diol;1.3;CA;CALCIUM ION;IAG-nucleoside hydrolase;5699;
3EPX;A;Crystal structure of Trypanosoma vivax nucleoside hydrolase in complex with the inhibitor (2R,3R,4S)-2-(hydroxymethyl)-1-(quinolin-8-ylmethyl)pyrrolidin-3,4-diol;1.85;CA;CALCIUM ION;IAG-nucleoside hydrolase;5699;
3EPX;B;Crystal structure of Trypanosoma vivax nucleoside hydrolase in complex with the inhibitor (2R,3R,4S)-2-(hydroxymethyl)-1-(quinolin-8-ylmethyl)pyrrolidin-3,4-diol;1.85;CA;CALCIUM ION;IAG-nucleoside hydrolase;5699;
3EQC;A;X-ray structure of the human mitogen-activated protein kinase kinase 1 (MEK1) in a ternary complex with compound 1, ATP-GS AND MG2P;1.8;CA;CALCIUM ION;Dual specificity mitogen-activated protein kinase kinase 1;9606;
3EQD;A;X-ray structure of the human mitogen-activated protein kinase kinase 1 (MEK1) in a binary complex with ATP-GS and MG2P;2.1;CA;CALCIUM ION;Dual specificity mitogen-activated protein kinase kinase 1;9606;
3EQF;A;X-ray structure of the human mitogen-activated protein kinase kinase 1 (MEK1) in a binary complex with K252A and MG2P;2.7;CA;CALCIUM ION;Dual specificity mitogen-activated protein kinase kinase 1;9606;
3EQG;A;X-ray structure of the human mitogen-activated protein kinase kinase 1 (MEK1) in a ternary complex with PD, ADP AND MG2P;2.5;CA;CALCIUM ION;Dual specificity mitogen-activated protein kinase kinase 1;9606;
3EQH;A;X-ray structure of the human mitogen-activated protein kinase kinase 1 (MEK1) in a ternary complex with U0126, ADP and MG2P;2;CA;CALCIUM ION;Dual specificity mitogen-activated protein kinase kinase 1;9606;
3EQI;A;X-ray structure of the human mitogen-activated protein kinase kinase 1 (MEK1) in a binary complex with ADP and MG2P;1.9;CA;CALCIUM ION;Dual specificity mitogen-activated protein kinase kinase 1;9606;
3ER9;B;Crystal structure of the heterodimeric vaccinia virus mRNA polyadenylate polymerase complex with UU and 3'-deoxy ATP;2.06;CA;CALCIUM ION;Poly(A) polymerase catalytic subunit;10245;
3ERC;C;Crystal structure of the heterodimeric vaccinia virus mRNA polyadenylate polymerase with three fragments of RNA and 3'-deoxy ATP;3.21;CA;CALCIUM ION;Poly(A) polymerase catalytic subunit;10245;
3ERC;D;Crystal structure of the heterodimeric vaccinia virus mRNA polyadenylate polymerase with three fragments of RNA and 3'-deoxy ATP;3.21;CA;CALCIUM ION;Poly(A) polymerase catalytic subunit;10245;
3ERH;A;First structural evidence of substrate specificity in mammalian peroxidases: Crystal structures of substrate complexes with lactoperoxidases from two different species;2.4;CA;CALCIUM ION;Lactoperoxidase;89462;
3ERI;A;First structural evidence of substrate specificity in mammalian peroxidases: Crystal structures of substrate complexes with lactoperoxidases from two different species;2.5;CA;CALCIUM ION;Lactoperoxidase;9913;
3ERO;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS I72E at cryogenic temperature;1.85;CA;CALCIUM ION;Thermonuclease;1280;
3ERQ;A;Crystal structure of Staphylococcal nuclease variant L25K at cryogenic temperature;2.1;CA;CALCIUM ION;Thermonuclease;1280;
3ERZ;A;Directing Noble Metal Ion Chemistry within a Designed Ferritin Protein. Mercury Ions on the Three-Fold Channel;3.06;CA;CALCIUM ION;Ferritin heavy chain;9606;
3ERZ;G;Directing Noble Metal Ion Chemistry within a Designed Ferritin Protein. Mercury Ions on the Three-Fold Channel;3.06;CA;CALCIUM ION;Ferritin heavy chain;9606;
3ERZ;J;Directing Noble Metal Ion Chemistry within a Designed Ferritin Protein. Mercury Ions on the Three-Fold Channel;3.06;CA;CALCIUM ION;Ferritin heavy chain;9606;
3ES3;A;Directing Noble Metal Ion Chemistry within a Designed Ferritin Protein. The Complex with Gold ions. Ferritin H8-H9x Mutant;2.8;CA;CALCIUM ION;Ferritin heavy chain;9606;
3ESQ;A;Crystal Structure of Calcium-bound D,D-heptose 1.7-bisphosphate phosphatase from E. Coli;1.7;CA;CALCIUM ION;D,D-heptose 1,7-bisphosphate phosphatase;562;
3ESR;A;Crystal Structure of D,D-heptose1.7-bisphosphate phosphatase from E. coli in complex with calcium and phosphate;1.95;CA;CALCIUM ION;D,D-heptose 1,7-bisphosphate phosphatase;562;
3EST;A;STRUCTURE OF NATIVE PORCINE PANCREATIC ELASTASE AT 1.65 ANGSTROMS RESOLUTION;1.65;CA;CALCIUM ION;PORCINE PANCREATIC ELASTASE;9823;
3ESX;A;E16KE61KD126KD150K Flavodoxin from Anabaena;2.31;CA;CALCIUM ION;Flavodoxin;1168;
3ESX;B;E16KE61KD126KD150K Flavodoxin from Anabaena;2.31;CA;CALCIUM ION;Flavodoxin;1168;
3ETO;A;2 Angstrom Xray structure of the NOTCH1 Negative Regulatory Region (NRR);2;CA;CALCIUM ION;Neurogenic locus notch homolog protein 1;9606;
3ETO;B;2 Angstrom Xray structure of the NOTCH1 Negative Regulatory Region (NRR);2;CA;CALCIUM ION;Neurogenic locus notch homolog protein 1;9606;
3ETR;C;Crystal structure of xanthine oxidase in complex with lumazine;2.2;CA;CALCIUM ION;Xanthine dehydrogenase/oxidase;9913;
3EU3;A;Crystal Structure of BdbD from Bacillus subtilis (reduced);1.5;CA;CALCIUM ION;BdbD;1423;
3EU4;A;Crystal Structure of BdbD from Bacillus subtilis (oxidised);2.3;CA;CALCIUM ION;BdbD;1423;
3EVQ;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS L25E at cryogenic temperature;2;CA;CALCIUM ION;Thermonuclease;1280;
3EVR;A;Crystal structure of Calcium bound monomeric GCAMP2;2;CA;CALCIUM ION;Myosin light chain kinase, Green fluorescent protein, Calmodulin-1 chimera;610,010,116;
3EVU;A;Crystal structure of Calcium bound dimeric GCAMP2;1.75;CA;CALCIUM ION;Myosin light chain kinase, Green fluorescent protein, Calmodulin-1  chimera;6,100,903,110,116;
3EVV;A;Crystal Structure of Calcium bound dimeric GCAMP2 (#2);2.6;CA;CALCIUM ION;Myosin light chain kinase, Green fluorescent protein, Calmodulin chimera;61,009,606;
3EWT;A;Crystal Structure of calmodulin complexed with a peptide;2.4;CA;CALCIUM ION;Calmodulin;9606;
3EWV;A;Crystal Structure of calmodulin complexed with a peptide;2.6;CA;CALCIUM ION;Calmodulin;9606;
3EXM;A;Crystal structure of the phosphatase SC4828 with the non-hydrolyzable nucleotide GPCP;1.65;CA;CALCIUM ION;Phosphatase SC4828;1902;
3EY7;A;Structure from the mobile metagenome of V. Cholerae. Integron cassette protein VCH_CASS1;1.6;CA;CALCIUM ION;Biphenyl-2,3-diol 1,2-dioxygenase III-related protein;666;
3EY7;B;Structure from the mobile metagenome of V. Cholerae. Integron cassette protein VCH_CASS1;1.6;CA;CALCIUM ION;Biphenyl-2,3-diol 1,2-dioxygenase III-related protein;666;
3EZ8;A;Crystal Structure of endoglucanase Cel9A from the thermoacidophilic Alicyclobacillus acidocaldarius;2.3;CA;CALCIUM ION;Cellulase;405212;
3F15;A;Crystal structure of the catalytic domain of human mmp12 complexed with the inhibitor (S)-N-(2,3-dihydroxypropyl)-4-methoxy-N-(2-nitroso-2-oxoethyl)benzenesulfonamide;1.7;CA;CALCIUM ION;Macrophage metalloelastase;9606;
3F16;A;Crystal structure of the catalytic domain of human MMP12 complexed with the inhibitor (R)-N-(3-hydroxy-1-nitroso-1-oxopropan-2-yl)-4-methoxybenzenesulfonamide;1.16;CA;CALCIUM ION;Macrophage metalloelastase;9606;
3F17;A;Crystal structure of the catalytic domain of human MMP12 complexed with the inhibitor N-(2-nitroso-2-oxoethyl)biphenyl-4-sulfonamide;1.1;CA;CALCIUM ION;Macrophage metalloelastase;9606;
3F18;A;Crystal structure of the catalytic domain of human MMP12 complexed with the inhibitor 4-fluoro-N-(2-hydroxyethyl)-N-(2-nitroso-2-oxoethyl)benzenesulfonamide;1.13;CA;CALCIUM ION;Macrophage metalloelastase;9606;
3F19;A;Crystal structure of the catalytic domain of human MMP12 complexed with the inhibitor 4-fluoro-N-(2-nitroso-2-oxoethyl)benzenesulfonamide;1.13;CA;CALCIUM ION;Macrophage metalloelastase;9606;
3F1A;A;Crystal structure of the catalytic domain of human MMP12 complexed with the inhibitor N-(2-nitroso-2-oxoethyl)benzenesulfonamide;1.25;CA;CALCIUM ION;Macrophage metalloelastase;9606;
3F1V;A;E. coli Beta Sliding Clamp, 148-153 Ala Mutant;1.77;CA;CALCIUM ION;DNA polymerase III subunit beta;562;
3F1V;B;E. coli Beta Sliding Clamp, 148-153 Ala Mutant;1.77;CA;CALCIUM ION;DNA polymerase III subunit beta;562;
3F28;A;Thermolysin inhibition;1.68;CA;CALCIUM ION;Thermolysin;1427;
3F29;A;Structure of the Thioalkalivibrio nitratireducens cytochrome c nitrite reductase in complex with sulfite;2;CA;CALCIUM ION;Eight-heme nitrite reductase;186931;
3F29;B;Structure of the Thioalkalivibrio nitratireducens cytochrome c nitrite reductase in complex with sulfite;2;CA;CALCIUM ION;Eight-heme nitrite reductase;186931;
3F2P;A;Thermolysin inhibition;1.95;CA;CALCIUM ION;Thermolysin;1427;
3F45;A;Structure of the R75A mutant of rat alpha-Parvalbumin;2;CA;CALCIUM ION;Parvalbumin alpha;10116;
3F5V;A;C2 Crystal form of mite allergen DER P 1;1.36;CA;CALCIUM ION;Der p 1 allergen;6956;
3F5V;B;C2 Crystal form of mite allergen DER P 1;1.36;CA;CALCIUM ION;Der p 1 allergen;6956;
3F6U;H;Crystal structure of human Activated Protein C (APC) complexed with PPACK;2.8;CA;CALCIUM ION;Vitamin K-dependent protein C heavy chain;9606;
3F6Y;A;Conformational Closure of the Catalytic Site of Human CD38 Induced by Calcium;1.45;CA;CALCIUM ION;ADP-ribosyl cyclase 1;9606;
3F7O;A;Crystal structure of Cuticle-Degrading Protease from Paecilomyces lilacinus (PL646);2.2;CA;CALCIUM ION;Serine protease;33203;
3F7O;B;Crystal structure of Cuticle-Degrading Protease from Paecilomyces lilacinus (PL646);2.2;CA;CALCIUM ION;Serine protease;33203;
3F7P;D;Crystal structure of a complex between integrin beta4 and plectin;2.75;CA;CALCIUM ION;Integrin beta-4;9606;
3F8H;A;Crystal structure of a putative polyketide cyclase (tm1040_3560) from silicibacter sp. tm1040 at 2.00 A resolution;2;CA;CALCIUM ION;putative polyketide cyclase;292414;
3F92;A;Crystal structure of ubiquitin-conjugating enzyme E2-25kDa (Huntington Interacting Protein 2) M172A mutant crystallized at pH 8.5;2.23;CA;CALCIUM ION;Ubiquitin-conjugating enzyme E2 K;9606;
3F9P;C;Crystal structure of myeloperoxidase from human leukocytes;2.93;CA;CALCIUM ION;Myeloperoxidase;9606;
3F9P;D;Crystal structure of myeloperoxidase from human leukocytes;2.93;CA;CALCIUM ION;Myeloperoxidase;9606;
3FAQ;A;Crystal structure of lactoperoxidase complex with cyanide;2.7;CA;CALCIUM ION;Lactoperoxidase;89462;
3FAW;A;Crystal Structure of the Group B Streptococcus Pullulanase SAP;2.1;CA;CALCIUM ION;Reticulocyte binding protein;1311;
3FAX;A;The crystal structure of GBS pullulanase SAP in complex with maltotetraose;2.4;CA;CALCIUM ION;Reticulocyte binding protein;1311;
3FB0;A;Metal exchange in thermolysin;1.6;CA;CALCIUM ION;Thermolysin;1427;
3FBO;A;Metal exchange in Thermolysin;1.92;CA;CALCIUM ION;Thermolysin;1427;
3FBY;A;The crystal structure of the signature domain of cartilage oligomeric matrix protein.;3.15;CA;CALCIUM ION;Cartilage oligomeric matrix protein;9606;
3FBY;B;The crystal structure of the signature domain of cartilage oligomeric matrix protein.;3.15;CA;CALCIUM ION;Cartilage oligomeric matrix protein;9606;
3FBY;C;The crystal structure of the signature domain of cartilage oligomeric matrix protein.;3.15;CA;CALCIUM ION;Cartilage oligomeric matrix protein;9606;
3FCE;A;Crystal Structure of Bacillus cereus D-alanyl Carrier Protein Ligase DltA in Complex with ATP: Implications for Adenylation Mechanism;1.9;CA;CALCIUM ION;D-alanine--poly(phosphoribitol) ligase subunit 1;1396;
3FCQ;A;Thermolysin inhibition;1.75;CA;CALCIUM ION;Thermolysin;1427;
3FCS;A;Structure of complete ectodomain of integrin aIIBb3;2.55;CA;CALCIUM ION;Integrin, alpha 2b;9606;
3FCS;B;Structure of complete ectodomain of integrin aIIBb3;2.55;CA;CALCIUM ION;Integrin beta-3;9606;
3FCS;C;Structure of complete ectodomain of integrin aIIBb3;2.55;CA;CALCIUM ION;Integrin, alpha 2b;9606;
3FCS;D;Structure of complete ectodomain of integrin aIIBb3;2.55;CA;CALCIUM ION;Integrin beta-3;9606;
3FCT;A;MATURE METAL CHELATASE CATALYTIC ANTIBODY WITH HAPTEN;2.4;CA;CALCIUM ION;PROTEIN (METAL CHELATASE CATALYTIC ANTIBODY);9606;
3FCU;A;Structure of headpiece of integrin aIIBb3 in open conformation;2.9;CA;CALCIUM ION;Integrin, alpha 2b;9606;
3FCU;B;Structure of headpiece of integrin aIIBb3 in open conformation;2.9;CA;CALCIUM ION;Integrin beta-3;9606;
3FCU;C;Structure of headpiece of integrin aIIBb3 in open conformation;2.9;CA;CALCIUM ION;Integrin, alpha 2b;9606;
3FCU;D;Structure of headpiece of integrin aIIBb3 in open conformation;2.9;CA;CALCIUM ION;Integrin beta-3;9606;
3FCU;E;Structure of headpiece of integrin aIIBb3 in open conformation;2.9;CA;CALCIUM ION;Integrin, alpha 2b;9606;
3FCU;F;Structure of headpiece of integrin aIIBb3 in open conformation;2.9;CA;CALCIUM ION;Integrin beta-3;9606;
3FCX;A;Crystal structure of human esterase D;1.5;CA;CALCIUM ION;S-formylglutathione hydrolase;9606;
3FCX;B;Crystal structure of human esterase D;1.5;CA;CALCIUM ION;S-formylglutathione hydrolase;9606;
3FCY;A;Crystal Structure of Acetyl Xylan Esterase 1 from Thermoanaerobacterium sp. JW/SL YS485;2.1;CA;CALCIUM ION;Xylan esterase 1;1094508;
3FCY;C;Crystal Structure of Acetyl Xylan Esterase 1 from Thermoanaerobacterium sp. JW/SL YS485;2.1;CA;CALCIUM ION;Xylan esterase 1;1094508;
3FD0;A;Crystal structure of putative cystathionine beta-lyase involved in aluminum resistance (NP_470671.1) from LISTERIA INNOCUA at 2.12 A resolution;2.12;CA;CALCIUM ION;putative cystathionine beta-lyase involved in aluminum resistance;1642;
3FD2;A;Crystal structure of mMsoI/DNA complex with calcium;2.69;CA;CALCIUM ION;Site-specific DNA endonuclease I-MsoI;141716;
3FD3;A;Structure of the C-terminal domains of a LysR family protein from Agrobacterium tumefaciens str. C58.;1.7;CA;CALCIUM ION;chromosome replication initiation inhibitor protein;1176649;
3FEC;A;Crystal structure of human Glutamate Carboxypeptidase III (GCPIII/NAALADase II), pseudo-unliganded;1.49;CA;CALCIUM ION;Glutamate carboxypeptidase III;9606;
3FED;A;The high resolution structure of human glutamate carboxypeptidase III (GCPIII/NAALADase II) in complex with a transition state analog of Glu-Glu;1.29;CA;CALCIUM ION;Glutamate carboxypeptidase III;9606;
3FEE;A;The high resolution structure of human glutamate carboxypeptidase III (GCPIII/NAALADase II) in complex with quisqualic acid;1.56;CA;CALCIUM ION;Glutamate carboxypeptidase III;9606;
3FF3;A;The high resolution structure of human glutamate carboxypeptidase III (GCPIII/NAALADase II) in complex with L-glutamate;1.37;CA;CALCIUM ION;Glutamate carboxypeptidase III;9606;
3FF8;A;Structure of NK cell receptor KLRG1 bound to E-cadherin;2;CA;CALCIUM ION;Epithelial cadherin;9606;
3FF8;B;Structure of NK cell receptor KLRG1 bound to E-cadherin;2;CA;CALCIUM ION;Epithelial cadherin;9606;
3FFK;A;Crystal structure of human Gelsolin domains G1-G3 bound to Actin;3;CA;CALCIUM ION;plasma gelsolin;9606;
3FFK;B;Crystal structure of human Gelsolin domains G1-G3 bound to Actin;3;CA;CALCIUM ION;actin, alpha skeletal muscle;9986;
3FFK;D;Crystal structure of human Gelsolin domains G1-G3 bound to Actin;3;CA;CALCIUM ION;plasma gelsolin;9606;
3FFK;E;Crystal structure of human Gelsolin domains G1-G3 bound to Actin;3;CA;CALCIUM ION;actin, alpha skeletal muscle;9986;
3FG1;A;Crystal structure of Delta413-417:GS LOX;1.85;CA;CALCIUM ION;Allene oxide synthase-lipoxygenase protein;47982;
3FG1;B;Crystal structure of Delta413-417:GS LOX;1.85;CA;CALCIUM ION;Allene oxide synthase-lipoxygenase protein;47982;
3FG1;C;Crystal structure of Delta413-417:GS LOX;1.85;CA;CALCIUM ION;Allene oxide synthase-lipoxygenase protein;47982;
3FG1;D;Crystal structure of Delta413-417:GS LOX;1.85;CA;CALCIUM ION;Allene oxide synthase-lipoxygenase protein;47982;
3FG3;A;Crystal structure of Delta413-417:GS I805W LOX;1.9;CA;CALCIUM ION;Allene oxide synthase-lipoxygenase protein;47982;
3FG3;B;Crystal structure of Delta413-417:GS I805W LOX;1.9;CA;CALCIUM ION;Allene oxide synthase-lipoxygenase protein;47982;
3FG3;C;Crystal structure of Delta413-417:GS I805W LOX;1.9;CA;CALCIUM ION;Allene oxide synthase-lipoxygenase protein;47982;
3FG3;D;Crystal structure of Delta413-417:GS I805W LOX;1.9;CA;CALCIUM ION;Allene oxide synthase-lipoxygenase protein;47982;
3FG4;A;Crystal structure of Delta413-417:GS I805A LOX;2.31;CA;CALCIUM ION;Allene oxide synthase-lipoxygenase protein;47982;
3FG4;B;Crystal structure of Delta413-417:GS I805A LOX;2.31;CA;CALCIUM ION;Allene oxide synthase-lipoxygenase protein;47982;
3FG4;C;Crystal structure of Delta413-417:GS I805A LOX;2.31;CA;CALCIUM ION;Allene oxide synthase-lipoxygenase protein;47982;
3FG4;D;Crystal structure of Delta413-417:GS I805A LOX;2.31;CA;CALCIUM ION;Allene oxide synthase-lipoxygenase protein;47982;
3FG6;A;Structure of the C-terminus of Adseverin;3;CA;CALCIUM ION;Adseverin;9606;
3FG6;B;Structure of the C-terminus of Adseverin;3;CA;CALCIUM ION;Adseverin;9606;
3FG6;C;Structure of the C-terminus of Adseverin;3;CA;CALCIUM ION;Adseverin;9606;
3FG6;D;Structure of the C-terminus of Adseverin;3;CA;CALCIUM ION;Adseverin;9606;
3FG6;E;Structure of the C-terminus of Adseverin;3;CA;CALCIUM ION;Adseverin;9606;
3FG6;F;Structure of the C-terminus of Adseverin;3;CA;CALCIUM ION;Adseverin;9606;
3FG6;G;Structure of the C-terminus of Adseverin;3;CA;CALCIUM ION;Adseverin;9606;
3FG6;H;Structure of the C-terminus of Adseverin;3;CA;CALCIUM ION;Adseverin;9606;
3FGD;A;Drugscore FP: Thermoylsin in complex with fragment.;1.33;CA;CALCIUM ION;Thermolysin;1427;
3FGE;A;Crystal structure of putative flavin reductase with split barrel domain (YP_750721.1) from SHEWANELLA FRIGIDIMARINA NCIMB 400 at 1.74 A resolution;1.74;CA;CALCIUM ION;putative flavin reductase with split barrel domain;56812;
3FHA;A;Structure of endo-beta-N-acetylglucosaminidase A;2;CA;CALCIUM ION;Endo-beta-N-acetylglucosaminidase;37930;
3FHA;B;Structure of endo-beta-N-acetylglucosaminidase A;2;CA;CALCIUM ION;Endo-beta-N-acetylglucosaminidase;37930;
3FHA;C;Structure of endo-beta-N-acetylglucosaminidase A;2;CA;CALCIUM ION;Endo-beta-N-acetylglucosaminidase;37930;
3FHA;D;Structure of endo-beta-N-acetylglucosaminidase A;2;CA;CALCIUM ION;Endo-beta-N-acetylglucosaminidase;37930;
3FIA;A;Crystal structure of the EH 1 domain from human intersectin-1 protein. Northeast Structural Genomics Consortium target HR3646e.;1.45;CA;CALCIUM ION;Intersectin-1;9606;
3FIB;A;RECOMBINANT HUMAN GAMMA-FIBRINOGEN CARBOXYL TERMINAL FRAGMENT (RESIDUES 143-411) BOUND TO CALCIUM AT PH 6.0: A FURTHER REFINEMENT OF PDB ENTRY 1FIB, AND DIFFERS FROM 1FIB BY THE MODELLING OF A CIS PEPTIDE BOND BETWEEN RESIDUES K338 AND C339;2.1;CA;CALCIUM ION;FIBRINOGEN GAMMA CHAIN RESIDUES;9606;
3FIL;A;Structural and energetic determinants for hyperstable variants of GB1 obtained from in-vitro evolution;0.88;CA;CALCIUM ION;Immunoglobulin G-binding protein G;1320;
3FJW;A;Crystal Structure Analysis of Fungal Versatile Peroxidase from Pleurotus eryngii;2.8;CA;CALCIUM ION;Versatile peroxidase VPL2;5323;
3FJW;B;Crystal Structure Analysis of Fungal Versatile Peroxidase from Pleurotus eryngii;2.8;CA;CALCIUM ION;Versatile peroxidase VPL2;5323;
3FKG;A;Crystal Structure Analysis of Fungal Versatile Peroxidase from Pleurotus eryngii;1.81;CA;CALCIUM ION;Versatile peroxidase VPL2;5323;
3FKH;C;Crystal structure of Putative pyridoxamine 5'-phosphate oxidase (NP_601736.1) from CORYNEBACTERIUM GLUTAMICUM ATCC 13032 KITASATO at 2.51 A resolution;2.51;CA;CALCIUM ION;Putative pyridoxamine 5'-phosphate oxidase;1718;
3FL8;A;Crystal structure of B. anthracis dihydrofolate reductase (DHFR) with RAB1, a TMP-dihydrophthalazine derivative;2.29;CA;CALCIUM ION;Dihydrofolate reductase;1392;
3FL8;B;Crystal structure of B. anthracis dihydrofolate reductase (DHFR) with RAB1, a TMP-dihydrophthalazine derivative;2.29;CA;CALCIUM ION;Dihydrofolate reductase;1392;
3FL8;C;Crystal structure of B. anthracis dihydrofolate reductase (DHFR) with RAB1, a TMP-dihydrophthalazine derivative;2.29;CA;CALCIUM ION;Dihydrofolate reductase;1392;
3FL8;D;Crystal structure of B. anthracis dihydrofolate reductase (DHFR) with RAB1, a TMP-dihydrophthalazine derivative;2.29;CA;CALCIUM ION;Dihydrofolate reductase;1392;
3FL8;E;Crystal structure of B. anthracis dihydrofolate reductase (DHFR) with RAB1, a TMP-dihydrophthalazine derivative;2.29;CA;CALCIUM ION;Dihydrofolate reductase;1392;
3FL8;F;Crystal structure of B. anthracis dihydrofolate reductase (DHFR) with RAB1, a TMP-dihydrophthalazine derivative;2.29;CA;CALCIUM ION;Dihydrofolate reductase;1392;
3FL8;G;Crystal structure of B. anthracis dihydrofolate reductase (DHFR) with RAB1, a TMP-dihydrophthalazine derivative;2.29;CA;CALCIUM ION;Dihydrofolate reductase;1392;
3FL8;H;Crystal structure of B. anthracis dihydrofolate reductase (DHFR) with RAB1, a TMP-dihydrophthalazine derivative;2.29;CA;CALCIUM ION;Dihydrofolate reductase;1392;
3FL9;A;Crystal structure of B. anthracis dihydrofolate reductase (DHFR) with trimethoprim;2.4;CA;CALCIUM ION;dihydrofolate reductase (DHFR);1392;
3FL9;B;Crystal structure of B. anthracis dihydrofolate reductase (DHFR) with trimethoprim;2.4;CA;CALCIUM ION;dihydrofolate reductase (DHFR);1392;
3FL9;C;Crystal structure of B. anthracis dihydrofolate reductase (DHFR) with trimethoprim;2.4;CA;CALCIUM ION;dihydrofolate reductase (DHFR);1392;
3FL9;D;Crystal structure of B. anthracis dihydrofolate reductase (DHFR) with trimethoprim;2.4;CA;CALCIUM ION;dihydrofolate reductase (DHFR);1392;
3FL9;E;Crystal structure of B. anthracis dihydrofolate reductase (DHFR) with trimethoprim;2.4;CA;CALCIUM ION;dihydrofolate reductase (DHFR);1392;
3FL9;F;Crystal structure of B. anthracis dihydrofolate reductase (DHFR) with trimethoprim;2.4;CA;CALCIUM ION;dihydrofolate reductase (DHFR);1392;
3FL9;G;Crystal structure of B. anthracis dihydrofolate reductase (DHFR) with trimethoprim;2.4;CA;CALCIUM ION;dihydrofolate reductase (DHFR);1392;
3FL9;H;Crystal structure of B. anthracis dihydrofolate reductase (DHFR) with trimethoprim;2.4;CA;CALCIUM ION;dihydrofolate reductase (DHFR);1392;
3FLF;A;Thermolysin inhibition;1.97;CA;CALCIUM ION;Thermolysin;1427;
3FLP;A;Crystal structure of native heptameric SAP-like pentraxin from Limulus polyphemus;2.3;CA;CALCIUM ION;SAP-like pentraxin;6850;
3FLP;B;Crystal structure of native heptameric SAP-like pentraxin from Limulus polyphemus;2.3;CA;CALCIUM ION;SAP-like pentraxin;6850;
3FLP;C;Crystal structure of native heptameric SAP-like pentraxin from Limulus polyphemus;2.3;CA;CALCIUM ION;SAP-like pentraxin;6850;
3FLP;D;Crystal structure of native heptameric SAP-like pentraxin from Limulus polyphemus;2.3;CA;CALCIUM ION;SAP-like pentraxin;6850;
3FLP;E;Crystal structure of native heptameric SAP-like pentraxin from Limulus polyphemus;2.3;CA;CALCIUM ION;SAP-like pentraxin;6850;
3FLP;F;Crystal structure of native heptameric SAP-like pentraxin from Limulus polyphemus;2.3;CA;CALCIUM ION;SAP-like pentraxin;6850;
3FLP;G;Crystal structure of native heptameric SAP-like pentraxin from Limulus polyphemus;2.3;CA;CALCIUM ION;SAP-like pentraxin;6850;
3FLP;H;Crystal structure of native heptameric SAP-like pentraxin from Limulus polyphemus;2.3;CA;CALCIUM ION;SAP-like pentraxin;6850;
3FLP;I;Crystal structure of native heptameric SAP-like pentraxin from Limulus polyphemus;2.3;CA;CALCIUM ION;SAP-like pentraxin;6850;
3FLP;J;Crystal structure of native heptameric SAP-like pentraxin from Limulus polyphemus;2.3;CA;CALCIUM ION;SAP-like pentraxin;6850;
3FLP;K;Crystal structure of native heptameric SAP-like pentraxin from Limulus polyphemus;2.3;CA;CALCIUM ION;SAP-like pentraxin;6850;
3FLP;L;Crystal structure of native heptameric SAP-like pentraxin from Limulus polyphemus;2.3;CA;CALCIUM ION;SAP-like pentraxin;6850;
3FLP;M;Crystal structure of native heptameric SAP-like pentraxin from Limulus polyphemus;2.3;CA;CALCIUM ION;SAP-like pentraxin;6850;
3FLP;N;Crystal structure of native heptameric SAP-like pentraxin from Limulus polyphemus;2.3;CA;CALCIUM ION;SAP-like pentraxin;6850;
3FLR;A;Crystal structure of native octameric SAP-like pentraxin from Limulus polyphemus;3;CA;CALCIUM ION;SAP-like pentraxin;6850;
3FLR;B;Crystal structure of native octameric SAP-like pentraxin from Limulus polyphemus;3;CA;CALCIUM ION;SAP-like pentraxin;6850;
3FLT;A;Crystal structure of PE-bound octameric SAP-like pentraxin from Limulus polyphemus;2.7;CA;CALCIUM ION;SAP-like pentraxin;6850;
3FLT;B;Crystal structure of PE-bound octameric SAP-like pentraxin from Limulus polyphemus;2.7;CA;CALCIUM ION;SAP-like pentraxin;6850;
3FM1;A;Crystal Structure Analysis of Fungal Versatile Peroxidase from Pleurotus eryngii;1.78;CA;CALCIUM ION;Versatile peroxidase VPL2;5323;
3FM4;A;Crystal Structure Analysis of Fungal Versatile Peroxidase from Pleurotus eryngii;2.11;CA;CALCIUM ION;Versatile peroxidase VPL2;5323;
3FM6;A;Crystal Structure Analysis of Fungal Versatile Peroxidase from Pleurotus eryngii;1.13;CA;CALCIUM ION;Versatile peroxidase VPL2;5323;
3FMG;A;Structure of rotavirus outer capsid protein VP7 trimer in complex with a neutralizing Fab;3.4;CA;CALCIUM ION;Glycoprotein VP7;28875;
3FMU;A;Crystal Structure Analysis of Fungal Versatile Peroxidase from Pleurotus eryngii;1.04;CA;CALCIUM ION;Versatile peroxidase VPL2;5323;
3FNL;A;Crystal Structure of the Complex of Buffalo Lactoperoxidase with Salicylhydroxamic Acid at 2.48 A Resolution;2.48;CA;CALCIUM ION;Lactoperoxidase;89462;
3FO3;A;Structure of the Thioalkalivibrio nitratireducens cytochrome c nitrite reductase reduced by sodium dithionite (sulfite complex);1.4;CA;CALCIUM ION;Eight-heme nitrite reductase;186931;
3FO3;B;Structure of the Thioalkalivibrio nitratireducens cytochrome c nitrite reductase reduced by sodium dithionite (sulfite complex);1.4;CA;CALCIUM ION;Eight-heme nitrite reductase;186931;
3FOR;A;Thermolysin Complexed with BNPA (2-Benzyl-3-Nitro Propanoic Acid Amide);1.93;CA;CALCIUM ION;Thermolysin;1427;
3FOU;A;Low pH structure of the Rieske protein from Thermus thermophilus at 2.1 A;2.1;CA;CALCIUM ION;Quinol-cytochrome c reductase, Rieske iron-sulfur subunit;274;
3FOU;B;Low pH structure of the Rieske protein from Thermus thermophilus at 2.1 A;2.1;CA;CALCIUM ION;Quinol-cytochrome c reductase, Rieske iron-sulfur subunit;274;
3FOZ;B;Structure of E. coli Isopentenyl-tRNA transferase in complex with E. coli tRNA(Phe);2.5;CA;CALCIUM ION;tRNA delta(2)-isopentenylpyrophosphate transferase;562;
3FOZ;C;Structure of E. coli Isopentenyl-tRNA transferase in complex with E. coli tRNA(Phe);2.5;CA;CALCIUM ION;tRNA(Phe);;
3FOZ;D;Structure of E. coli Isopentenyl-tRNA transferase in complex with E. coli tRNA(Phe);2.5;CA;CALCIUM ION;tRNA(Phe);;
3FP6;E;Anionic trypsin in complex with bovine pancreatic trypsin inhibitor (BPTI) determined to the 1.49 A resolution limit;1.49;CA;CALCIUM ION;Anionic trypsin-2;10116;
3FP7;E;Anionic trypsin variant S195A in complex with bovine pancreatic trypsin inhibitor (BPTI) cleaved at the scissile bond (LYS15-ALA16) determined to the 1.46 A resolution limit;1.46;CA;CALCIUM ION;Anionic trypsin-2;10116;
3FP8;E;Anionic trypsin variant S195A in complex with bovine pancreatic trypsin inhibitor (BPTI) determined to the 1.46 A resolution limit;1.46;CA;CALCIUM ION;Anionic trypsin-2;10116;
3FPK;B;Crystal Structure of Ferredoxin-NADP Reductase from Salmonella typhimurium;1.7;CA;CALCIUM ION;Ferredoxin-NADP reductase;28901;
3FRP;A;Crystal Structure of Cobra Venom Factor, a Co-factor for C3- and C5 convertase CVFBb;2.61;CA;CALCIUM ION;Cobra venom factor alpha chain;8649;
3FS7;A;Crystal structure of Gallus gallus beta-parvalbumin (avian thymic hormone);1.95;CA;CALCIUM ION;Parvalbumin, thymic;9031;
3FS7;B;Crystal structure of Gallus gallus beta-parvalbumin (avian thymic hormone);1.95;CA;CALCIUM ION;Parvalbumin, thymic;9031;
3FS7;C;Crystal structure of Gallus gallus beta-parvalbumin (avian thymic hormone);1.95;CA;CALCIUM ION;Parvalbumin, thymic;9031;
3FS7;D;Crystal structure of Gallus gallus beta-parvalbumin (avian thymic hormone);1.95;CA;CALCIUM ION;Parvalbumin, thymic;9031;
3FS7;E;Crystal structure of Gallus gallus beta-parvalbumin (avian thymic hormone);1.95;CA;CALCIUM ION;Parvalbumin, thymic;9031;
3FS7;F;Crystal structure of Gallus gallus beta-parvalbumin (avian thymic hormone);1.95;CA;CALCIUM ION;Parvalbumin, thymic;9031;
3FS7;G;Crystal structure of Gallus gallus beta-parvalbumin (avian thymic hormone);1.95;CA;CALCIUM ION;Parvalbumin, thymic;9031;
3FS7;H;Crystal structure of Gallus gallus beta-parvalbumin (avian thymic hormone);1.95;CA;CALCIUM ION;Parvalbumin, thymic;9031;
3FSJ;X;Crystal structure of benzoylformate decarboxylase in complex with the inhibitor MBP;1.37;CA;CALCIUM ION;Benzoylformate decarboxylase;303;
3FSP;A;MutY adenine glycosylase bound to a transition state analog (1N) paired with dG in duplexed DNA;2.2;CA;CALCIUM ION;A/G-specific adenine glycosylase;1422;
3FU1;A;Crystal structure of the major pseudopilin from the type 2 secretion system of Vibrio cholerae;1.9;CA;CALCIUM ION;General secretion pathway protein G;666;
3FU1;B;Crystal structure of the major pseudopilin from the type 2 secretion system of Vibrio cholerae;1.9;CA;CALCIUM ION;General secretion pathway protein G;666;
3FU2;A;Cocrystal structure of a class-I preQ1 riboswitch;2.85;CA;CALCIUM ION;PreQ1 riboswitch;;
3FU2;B;Cocrystal structure of a class-I preQ1 riboswitch;2.85;CA;CALCIUM ION;PreQ1 riboswitch;;
3FU2;C;Cocrystal structure of a class-I preQ1 riboswitch;2.85;CA;CALCIUM ION;PreQ1 riboswitch;;
3FV4;A;Thermolysin inhibition;1.56;CA;CALCIUM ION;Thermolysin;1427;
3FVI;A;Crystal Structure of Complex of Phospholipase A2 with Octyl Sulfates;2.7;CA;CALCIUM ION;Phospholipase A2, major isoenzyme;9823;
3FVI;B;Crystal Structure of Complex of Phospholipase A2 with Octyl Sulfates;2.7;CA;CALCIUM ION;Phospholipase A2, major isoenzyme;9823;
3FVI;C;Crystal Structure of Complex of Phospholipase A2 with Octyl Sulfates;2.7;CA;CALCIUM ION;Phospholipase A2, major isoenzyme;9823;
3FVI;D;Crystal Structure of Complex of Phospholipase A2 with Octyl Sulfates;2.7;CA;CALCIUM ION;Phospholipase A2, major isoenzyme;9823;
3FVJ;A;Crystal structure of phospholipase A2 1B crystallized in the presence of octyl sulfate;2.3;CA;CALCIUM ION;Phospholipase A2, major isoenzyme;9823;
3FVP;A;Thermolysin inhibition;1.41;CA;CALCIUM ION;Thermolysin;1427;
3FVQ;A;Crystal structure of the nucleotide binding domain FbpC complexed with ATP;1.9;CA;CALCIUM ION;Fe(3+) ions import ATP-binding protein fbpC;485;
3FVQ;B;Crystal structure of the nucleotide binding domain FbpC complexed with ATP;1.9;CA;CALCIUM ION;Fe(3+) ions import ATP-binding protein fbpC;485;
3FVZ;A;Structure of Peptidyl-alpha-hydroxyglycine alpha-Amidating Lyase (PAL);2.35;CA;CALCIUM ION;Peptidyl-glycine alpha-amidating monooxygenase;10116;
3FW0;A;Structure of Peptidyl-alpha-hydroxyglycine alpha-Amidating Lyase (PAL) bound to alpha-hydroxyhippuric acid (non-peptidic substrate);2.52;CA;CALCIUM ION;Peptidyl-glycine alpha-amidating monooxygenase;10116;
3FXP;A;Thermolysin inhibition;2.05;CA;CALCIUM ION;Thermolysin;1427;
3FXS;A;Metal exchange in thermolysin;1.55;CA;CALCIUM ION;Thermolysin;1427;
3FYB;A;Crystal structure of a protein of unknown function (DUF1244) from Alcanivorax borkumensis;1.8;CA;CALCIUM ION;Protein of unknown function (DUF1244);59754;
3FYB;B;Crystal structure of a protein of unknown function (DUF1244) from Alcanivorax borkumensis;1.8;CA;CALCIUM ION;Protein of unknown function (DUF1244);59754;
3FYE;A;Catalytic core subunits (I and II) of cytochrome c oxidase from Rhodobacter sphaeroides in the reduced state;2.15;CA;CALCIUM ION;Cytochrome C oxidase subunit 1;1063;
3FYE;C;Catalytic core subunits (I and II) of cytochrome c oxidase from Rhodobacter sphaeroides in the reduced state;2.15;CA;CALCIUM ION;Cytochrome C oxidase subunit 1;1063;
3FYI;A;Catalytic core subunits (I and II) of cytochrome C oxidase from Rhodobacter sphaeroides in the reduced state bound with cyanide;2.2;CA;CALCIUM ION;Cytochrome c oxidase subunit 1;1063;
3FYI;C;Catalytic core subunits (I and II) of cytochrome C oxidase from Rhodobacter sphaeroides in the reduced state bound with cyanide;2.2;CA;CALCIUM ION;Cytochrome c oxidase subunit 1;1063;
3FZ0;A;Inosine-Guanosine Nucleoside Hydrolase (IG-NH);2.5;CA;CALCIUM ION;Nucleoside hydrolase, putative;5691;
3FZ0;B;Inosine-Guanosine Nucleoside Hydrolase (IG-NH);2.5;CA;CALCIUM ION;Nucleoside hydrolase, putative;5691;
3FZ0;C;Inosine-Guanosine Nucleoside Hydrolase (IG-NH);2.5;CA;CALCIUM ION;Nucleoside hydrolase, putative;5691;
3FZ0;D;Inosine-Guanosine Nucleoside Hydrolase (IG-NH);2.5;CA;CALCIUM ION;Nucleoside hydrolase, putative;5691;
3FZ3;A;Crystal Structure of almond Pru1 protein;2.4;CA;CALCIUM ION;Prunin;3755;
3FZ3;B;Crystal Structure of almond Pru1 protein;2.4;CA;CALCIUM ION;Prunin;3755;
3FZ3;C;Crystal Structure of almond Pru1 protein;2.4;CA;CALCIUM ION;Prunin;3755;
3FZ3;D;Crystal Structure of almond Pru1 protein;2.4;CA;CALCIUM ION;Prunin;3755;
3FZ3;E;Crystal Structure of almond Pru1 protein;2.4;CA;CALCIUM ION;Prunin;3755;
3FZ3;F;Crystal Structure of almond Pru1 protein;2.4;CA;CALCIUM ION;Prunin;3755;
3FZ5;A;Crystal structure of possible 2-hydroxychromene-2-carboxylate isomerase from Rhodobacter sphaeroides;2.4;CA;CALCIUM ION;Possible 2-hydroxychromene-2-carboxylate isomerase;1063;
3FZ5;C;Crystal structure of possible 2-hydroxychromene-2-carboxylate isomerase from Rhodobacter sphaeroides;2.4;CA;CALCIUM ION;Possible 2-hydroxychromene-2-carboxylate isomerase;1063;
3FZX;A;CRYSTAL STRUCTURE OF A PUTATIVE EXPORTED PROTEIN WITH YMCC-LIKE FOLD (BF2203) FROM BACTEROIDES FRAGILIS NCTC 9343 AT 2.22 A RESOLUTION;2.22;CA;CALCIUM ION;Putative exported protein;817;
3G0K;A;Crystal structure of a protein of unknown function with a cystatin-like fold (saro_2880) from novosphingobium aromaticivorans dsm at 1.30 A resolution;1.3;CA;CALCIUM ION;Putative membrane protein;48935;
3G0Q;A;Crystal Structure of MutY bound to its inhibitor DNA;2.2;CA;CALCIUM ION;A/G-specific adenine glycosylase;1422;
3G20;A;Crystal structure of the major pseudopilin from the type 2 secretion system of enterohaemorrhagic Escherichia coli;1.78;CA;CALCIUM ION;Type II secretion protein;562;
3G20;B;Crystal structure of the major pseudopilin from the type 2 secretion system of enterohaemorrhagic Escherichia coli;1.78;CA;CALCIUM ION;Type II secretion protein;562;
3G27;A;Structure of a putative bacteriophage protein from Escherichia coli str. K-12 substr. MG1655;2.1;CA;CALCIUM ION;82 prophage-derived uncharacterized protein ybcO;562;
3G43;A;Crystal structure of the calmodulin-bound Cav1.2 C-terminal regulatory domain dimer;2.1;CA;CALCIUM ION;Calmodulin;9606;
3G43;B;Crystal structure of the calmodulin-bound Cav1.2 C-terminal regulatory domain dimer;2.1;CA;CALCIUM ION;Calmodulin;9606;
3G43;C;Crystal structure of the calmodulin-bound Cav1.2 C-terminal regulatory domain dimer;2.1;CA;CALCIUM ION;Calmodulin;9606;
3G43;D;Crystal structure of the calmodulin-bound Cav1.2 C-terminal regulatory domain dimer;2.1;CA;CALCIUM ION;Calmodulin;9606;
3G4E;A;Crystal structure of human senescence marker protein-30(SMP30)(Calcium bound);1.42;CA;CALCIUM ION;Regucalcin;9606;
3G4E;B;Crystal structure of human senescence marker protein-30(SMP30)(Calcium bound);1.42;CA;CALCIUM ION;Regucalcin;9606;
3G4G;A;Crystal structure of human phosphodiesterase 4d with regulatory domain and d155871;2.3;CA;CALCIUM ION;cAMP-specific 3',5'-cyclic phosphodiesterase 4D;9606;
3G4G;B;Crystal structure of human phosphodiesterase 4d with regulatory domain and d155871;2.3;CA;CALCIUM ION;cAMP-specific 3',5'-cyclic phosphodiesterase 4D;9606;
3G4G;C;Crystal structure of human phosphodiesterase 4d with regulatory domain and d155871;2.3;CA;CALCIUM ION;cAMP-specific 3',5'-cyclic phosphodiesterase 4D;9606;
3G4G;D;Crystal structure of human phosphodiesterase 4d with regulatory domain and d155871;2.3;CA;CALCIUM ION;cAMP-specific 3',5'-cyclic phosphodiesterase 4D;9606;
3G5C;A;Structural and biochemical studies on the ectodomain of human ADAM22;2.36;CA;CALCIUM ION;ADAM 22;9606;
3G5C;B;Structural and biochemical studies on the ectodomain of human ADAM22;2.36;CA;CALCIUM ION;ADAM 22;9606;
3G5I;A;Crystal Structure of the E.coli RihA pyrimidine nucleosidase bound to a iminoribitol-based inhibitor;2.1;CA;CALCIUM ION;Pyrimidine-specific ribonucleoside hydrolase rihA;562;
3G5I;B;Crystal Structure of the E.coli RihA pyrimidine nucleosidase bound to a iminoribitol-based inhibitor;2.1;CA;CALCIUM ION;Pyrimidine-specific ribonucleoside hydrolase rihA;562;
3G5I;C;Crystal Structure of the E.coli RihA pyrimidine nucleosidase bound to a iminoribitol-based inhibitor;2.1;CA;CALCIUM ION;Pyrimidine-specific ribonucleoside hydrolase rihA;562;
3G5I;D;Crystal Structure of the E.coli RihA pyrimidine nucleosidase bound to a iminoribitol-based inhibitor;2.1;CA;CALCIUM ION;Pyrimidine-specific ribonucleoside hydrolase rihA;562;
3G5R;A;Crystal structure of Thermus thermophilus TrmFO in complex with tetrahydrofolate;1.6;CA;CALCIUM ION;Methylenetetrahydrofolate--tRNA-(uracil-5-)-methyltransferase trmFO;274;
3G6J;A;C3b in complex with a C3b specific Fab;3.1;CA;CALCIUM ION;Complement C3 beta chain;9606;
3G6J;C;C3b in complex with a C3b specific Fab;3.1;CA;CALCIUM ION;Complement C3 beta chain;9606;
3G81;A;Crystal structure of the trimeric neck and carbohydrate recognition domain of human surfactant protein D in complex with alpha methyl mannoside;1.8;CA;CALCIUM ION;Pulmonary surfactant-associated protein D;9606;
3G81;B;Crystal structure of the trimeric neck and carbohydrate recognition domain of human surfactant protein D in complex with alpha methyl mannoside;1.8;CA;CALCIUM ION;Pulmonary surfactant-associated protein D;9606;
3G81;C;Crystal structure of the trimeric neck and carbohydrate recognition domain of human surfactant protein D in complex with alpha methyl mannoside;1.8;CA;CALCIUM ION;Pulmonary surfactant-associated protein D;9606;
3G83;A;Crystal structure of the trimeric neck and carbohydrate recognition domain of human surfactant protein D in complex with alpha 1,2 dimannose.;1.9;CA;CALCIUM ION;Pulmonary surfactant-associated protein D;9606;
3G83;B;Crystal structure of the trimeric neck and carbohydrate recognition domain of human surfactant protein D in complex with alpha 1,2 dimannose.;1.9;CA;CALCIUM ION;Pulmonary surfactant-associated protein D;9606;
3G83;C;Crystal structure of the trimeric neck and carbohydrate recognition domain of human surfactant protein D in complex with alpha 1,2 dimannose.;1.9;CA;CALCIUM ION;Pulmonary surfactant-associated protein D;9606;
3G84;A;Crystal structure of the trimeric neck and carbohydrate recognition domain of R343V mutant of human surfactant protein D in complex with alpha 1,2 dimannose.;2.3;CA;CALCIUM ION;Pulmonary surfactant-associated protein D;9606;
3G84;B;Crystal structure of the trimeric neck and carbohydrate recognition domain of R343V mutant of human surfactant protein D in complex with alpha 1,2 dimannose.;2.3;CA;CALCIUM ION;Pulmonary surfactant-associated protein D;9606;
3G84;C;Crystal structure of the trimeric neck and carbohydrate recognition domain of R343V mutant of human surfactant protein D in complex with alpha 1,2 dimannose.;2.3;CA;CALCIUM ION;Pulmonary surfactant-associated protein D;9606;
3GA5;A;X-ray structure of glucose/galactose receptor from Salmonella typhimurium in complex with (2R)-glyceryl-beta-D-galactopyranoside;1.87;CA;CALCIUM ION;D-galactose-binding periplasmic protein;90371;
3GA5;B;X-ray structure of glucose/galactose receptor from Salmonella typhimurium in complex with (2R)-glyceryl-beta-D-galactopyranoside;1.87;CA;CALCIUM ION;D-galactose-binding periplasmic protein;90371;
3GAZ;A;Crystal structure of an alcohol dehydrogenase superfamily protein from Novosphingobium aromaticivorans;1.96;CA;CALCIUM ION;Alcohol dehydrogenase superfamily protein;48935;
3GAZ;B;Crystal structure of an alcohol dehydrogenase superfamily protein from Novosphingobium aromaticivorans;1.96;CA;CALCIUM ION;Alcohol dehydrogenase superfamily protein;48935;
3GBH;B;CRYSTAL STRUCTURE OF A PUTATIVE NAD(P)H:FMN OXIDOREDUCTASE (SE1966) FROM STAPHYLOCOCCUS EPIDERMIDIS ATCC 12228 AT 2.00 A RESOLUTION;2;CA;CALCIUM ION;NAD(P)H-flavin oxidoreductase;1282;
3GBH;D;CRYSTAL STRUCTURE OF A PUTATIVE NAD(P)H:FMN OXIDOREDUCTASE (SE1966) FROM STAPHYLOCOCCUS EPIDERMIDIS ATCC 12228 AT 2.00 A RESOLUTION;2;CA;CALCIUM ION;NAD(P)H-flavin oxidoreductase;1282;
3GBO;A;Crystal structure of BmooMPalpha-I, a non-hemorrhagic metalloproteinase isolated from Bothrops moojeni snake venom;1.77;CA;CALCIUM ION;Zinc metalloproteinase BmooMPalfa-I;98334;
3GBP;A;STRUCTURE OF THE PERIPLASMIC GLUCOSE/GALACTOSE RECEPTOR OF SALMONELLA TYPHIMURIUM;2.4;CA;CALCIUM ION;GALACTOSE-BINDING PROTEIN;90371;
3GC1;A;Crystal structure of bovine lactoperoxidase;2.5;CA;CALCIUM ION;Lactoperoxidase;9913;
3GCI;A;Crystal Structure of the Complex Formed Between a New Isoform of Phospholipase A2 with C-terminal Amyloid Beta Heptapeptide at 2 A Resolution;2.04;CA;CALCIUM ION;Phospholipase A2 isoform 3;195058;
3GCJ;A;Mode of ligand binding and assignment of subsites in mammalian peroxidases: crystal structure of lactoperoxidase complexes with acetyl salycylic acid, salicylhydroxamic acid and benzylhydroxamic acid;2.34;CA;CALCIUM ION;Lactoperoxidase;9913;
3GCK;A;Mode of ligand binding and assignment of subsites in mammalian peroxidases: crystal structure of lactoperoxidase complexes with acetyl salycylic acid, salicylhydroxamic acid and benzylhydroxamic acid;2.9;CA;CALCIUM ION;Lactoperoxidase;9913;
3GCL;A;Mode of ligand binding and assignment of subsites in mammalian peroxidases: crystal structure of lactoperoxidase complexes with acetyl salycylic acid, salicylhydroxamic acid and benzylhydroxamic acid;2.5;CA;CALCIUM ION;Lactoperoxidase;9913;
3GCW;E;PCSK9:EGFA(H306Y);2.7;CA;CALCIUM ION;Low-density lipoprotein receptor;9606;
3GCX;E;PCSK9:EGFA (pH 7.4);2.7;CA;CALCIUM ION;Low-density lipoprotein receptor;9606;
3GDC;A;Crystal structure of multicopper oxidase;1.8;CA;CALCIUM ION;Multicopper oxidase;290399;
3GDC;B;Crystal structure of multicopper oxidase;1.8;CA;CALCIUM ION;Multicopper oxidase;290399;
3GDC;C;Crystal structure of multicopper oxidase;1.8;CA;CALCIUM ION;Multicopper oxidase;290399;
3GE4;A;Crystal structure of ferritin:DNA-binding protein DPS from Brucella Melitensis;1.7;CA;CALCIUM ION;DNA PROTECTION DURING STARVATION PROTEIN;29459;
3GE4;B;Crystal structure of ferritin:DNA-binding protein DPS from Brucella Melitensis;1.7;CA;CALCIUM ION;DNA PROTECTION DURING STARVATION PROTEIN;29459;
3GE4;C;Crystal structure of ferritin:DNA-binding protein DPS from Brucella Melitensis;1.7;CA;CALCIUM ION;DNA PROTECTION DURING STARVATION PROTEIN;29459;
3GE4;D;Crystal structure of ferritin:DNA-binding protein DPS from Brucella Melitensis;1.7;CA;CALCIUM ION;DNA PROTECTION DURING STARVATION PROTEIN;29459;
3GE4;E;Crystal structure of ferritin:DNA-binding protein DPS from Brucella Melitensis;1.7;CA;CALCIUM ION;DNA PROTECTION DURING STARVATION PROTEIN;29459;
3GE4;F;Crystal structure of ferritin:DNA-binding protein DPS from Brucella Melitensis;1.7;CA;CALCIUM ION;DNA PROTECTION DURING STARVATION PROTEIN;29459;
3GE4;G;Crystal structure of ferritin:DNA-binding protein DPS from Brucella Melitensis;1.7;CA;CALCIUM ION;DNA PROTECTION DURING STARVATION PROTEIN;29459;
3GE4;H;Crystal structure of ferritin:DNA-binding protein DPS from Brucella Melitensis;1.7;CA;CALCIUM ION;DNA PROTECTION DURING STARVATION PROTEIN;29459;
3GE4;I;Crystal structure of ferritin:DNA-binding protein DPS from Brucella Melitensis;1.7;CA;CALCIUM ION;DNA PROTECTION DURING STARVATION PROTEIN;29459;
3GE4;J;Crystal structure of ferritin:DNA-binding protein DPS from Brucella Melitensis;1.7;CA;CALCIUM ION;DNA PROTECTION DURING STARVATION PROTEIN;29459;
3GE4;K;Crystal structure of ferritin:DNA-binding protein DPS from Brucella Melitensis;1.7;CA;CALCIUM ION;DNA PROTECTION DURING STARVATION PROTEIN;29459;
3GE4;L;Crystal structure of ferritin:DNA-binding protein DPS from Brucella Melitensis;1.7;CA;CALCIUM ION;DNA PROTECTION DURING STARVATION PROTEIN;29459;
3GEZ;A;Crystal Structure of the hypothetical egulator from Sulfolobus tokodaii 7;2;CA;CALCIUM ION;146aa long hypothetical transcriptional regulator;111955;
3GFJ;A;Crystal structure of the ST1710 mutant (R89A) protein;2.2;CA;CALCIUM ION;146aa long hypothetical transcriptional regulator;111955;
3GFL;A;Crystal structure of the ST1710 mutant (R90A) protein;1.9;CA;CALCIUM ION;146aa long hypothetical transcriptional regulator;111955;
3GFM;A;Crystal structure of the ST1710 mutant (K91A) protein;2.1;CA;CALCIUM ION;146aa long hypothetical transcriptional regulator;111955;
3GFX;A;Klebsiella pneumoniae BlrP1 pH 4.5 calcium/cy-diGMP complex;2.4;CA;CALCIUM ION;Klebsiella pneumoniae BlrP1;573;
3GFX;B;Klebsiella pneumoniae BlrP1 pH 4.5 calcium/cy-diGMP complex;2.4;CA;CALCIUM ION;Klebsiella pneumoniae BlrP1;573;
3GG1;A;Klebsiella pneumoniae BlrP1 pH 8.0 calcium/cy-diGMP complex;2.3;CA;CALCIUM ION;Klebsiella pneumoniae Blrp1;573;
3GG1;B;Klebsiella pneumoniae BlrP1 pH 8.0 calcium/cy-diGMP complex;2.3;CA;CALCIUM ION;Klebsiella pneumoniae Blrp1;573;
3GHG;B;Crystal Structure of Human Fibrinogen;2.9;CA;CALCIUM ION;Fibrinogen beta chain;9606;
3GHG;C;Crystal Structure of Human Fibrinogen;2.9;CA;CALCIUM ION;Fibrinogen gamma chain;9606;
3GHG;E;Crystal Structure of Human Fibrinogen;2.9;CA;CALCIUM ION;Fibrinogen beta chain;9606;
3GHG;F;Crystal Structure of Human Fibrinogen;2.9;CA;CALCIUM ION;Fibrinogen gamma chain;9606;
3GHG;H;Crystal Structure of Human Fibrinogen;2.9;CA;CALCIUM ION;Fibrinogen beta chain;9606;
3GHG;I;Crystal Structure of Human Fibrinogen;2.9;CA;CALCIUM ION;Fibrinogen gamma chain;9606;
3GHG;K;Crystal Structure of Human Fibrinogen;2.9;CA;CALCIUM ION;Fibrinogen beta chain;9606;
3GHG;L;Crystal Structure of Human Fibrinogen;2.9;CA;CALCIUM ION;Fibrinogen gamma chain;9606;
3GIF;A;Crystal structure of DesKC_H188E in complex with ADP;2.7;CA;CALCIUM ION;Sensor histidine kinase desK;1423;
3GII;A;Dpo4 extension ternary complex with disordered A opposite an oxoG in anti conformation;2.6;CA;CALCIUM ION;DNA polymerase IV;2287;
3GIJ;A;Dpo4 extension ternary complex with oxoG(syn)-A(anti) and oxoG(anti)-A(syn) pairs;2.4;CA;CALCIUM ION;DNA polymerase IV;2287;
3GIJ;B;Dpo4 extension ternary complex with oxoG(syn)-A(anti) and oxoG(anti)-A(syn) pairs;2.4;CA;CALCIUM ION;DNA polymerase IV;2287;
3GIK;A;Dpo4 extension ternary complex with the oxoG(anti)-C(anti) pair;2.9;CA;CALCIUM ION;DNA polymerase IV;2287;
3GIL;A;Dpo4 extension ternary complex with oxoG(anti)-T(anti) pair;2.71;CA;CALCIUM ION;DNA polymerase IV;2287;
3GIL;B;Dpo4 extension ternary complex with oxoG(anti)-T(anti) pair;2.71;CA;CALCIUM ION;DNA polymerase IV;2287;
3GIM;A;Dpo4 extension ternary complex with oxoG(anti)-G(syn) pair;2.7;CA;CALCIUM ION;DNA polymerase IV;2287;
3GIN;A;Crystal structure of E454K-CBD1;2.4;CA;CALCIUM ION;Sodium/calcium exchanger 1;9612;
3GIN;B;Crystal structure of E454K-CBD1;2.4;CA;CALCIUM ION;Sodium/calcium exchanger 1;9612;
3GIS;X;Crystal Structure of Na-free Thrombin in Complex with Thrombomodulin;2.4;CA;CALCIUM ION;Thrombomodulin;9606;
3GIS;Y;Crystal Structure of Na-free Thrombin in Complex with Thrombomodulin;2.4;CA;CALCIUM ION;Thrombomodulin;9606;
3GIS;Z;Crystal Structure of Na-free Thrombin in Complex with Thrombomodulin;2.4;CA;CALCIUM ION;Thrombomodulin;9606;
3GK1;A;X-ray structure of bovine SBi132,Ca(2+)-S100B;2.1;CA;CALCIUM ION;Protein S100-B;9913;
3GK2;A;X-ray structure of bovine SBi279,Ca(2+)-S100B;1.98;CA;CALCIUM ION;Protein S100-B;9913;
3GK4;X;X-ray structure of bovine SBi523,Ca(2+)-S100B;1.9;CA;CALCIUM ION;Protein S100-B;9913;
3GM6;A;Structure of the Thioalkalivibrio nitratireducens cytochrome c nitrite reductase in complex with phosphate;1.8;CA;CALCIUM ION;Eight-heme nitrite reductase;186931;
3GM6;B;Structure of the Thioalkalivibrio nitratireducens cytochrome c nitrite reductase in complex with phosphate;1.8;CA;CALCIUM ION;Eight-heme nitrite reductase;186931;
3GN4;B;Myosin lever arm;2.7;CA;CALCIUM ION;Calmodulin;7227;
3GN4;F;Myosin lever arm;2.7;CA;CALCIUM ION;Calmodulin;7227;
3GN9;A;Crystal structure of the major pseudopilin from the type 2 secretion system of Vibrio vulnificus;1.86;CA;CALCIUM ION;Type II secretory pathway, pseudopilin EpsG;672;
3GN9;B;Crystal structure of the major pseudopilin from the type 2 secretion system of Vibrio vulnificus;1.86;CA;CALCIUM ION;Type II secretory pathway, pseudopilin EpsG;672;
3GN9;C;Crystal structure of the major pseudopilin from the type 2 secretion system of Vibrio vulnificus;1.86;CA;CALCIUM ION;Type II secretory pathway, pseudopilin EpsG;672;
3GNK;A;Calcium bound to the Holliday junction sequence d(TCGGCGCCGA)4;2.1;CA;CALCIUM ION;5'-D(*TP*CP*GP*GP*CP*GP*CP*CP*GP*A)-3';;
3GNK;D;Calcium bound to the Holliday junction sequence d(TCGGCGCCGA)4;2.1;CA;CALCIUM ION;5'-D(*TP*CP*GP*GP*CP*GP*CP*CP*GP*A)-3';;
3GOA;B;Crystal structure of the Salmonella typhimurium FadA 3-ketoacyl-CoA thiolase;1.7;CA;CALCIUM ION;3-ketoacyl-CoA thiolase;90371;
3GOD;A;Structural basis for DNase activity of a conserved protein implicated in CRISPR-mediated antiviral defense;2.17;CA;CALCIUM ION;Cas1;287;
3GOD;B;Structural basis for DNase activity of a conserved protein implicated in CRISPR-mediated antiviral defense;2.17;CA;CALCIUM ION;Cas1;287;
3GOE;A;Molecular Mimicry of SUMO promotes DNA repair;0.97;CA;CALCIUM ION;DNA repair protein rad60;4896;
3GOF;A;Calmodulin bound to peptide from macrophage nitric oxide synthase;1.45;CA;CALCIUM ION;Calmodulin;9031;
3GOF;B;Calmodulin bound to peptide from macrophage nitric oxide synthase;1.45;CA;CALCIUM ION;Calmodulin;9031;
3GP2;A;Calmodulin bound to peptide from calmodulin kinase II (CaMKII);1.46;CA;CALCIUM ION;Calmodulin;9031;
3GPE;A;Crystal Structure Analysis of PKC (alpha)-C2 domain complexed with Ca2+ and PtdIns(4,5)P2;2;CA;CALCIUM ION;Protein kinase C alpha type;10116;
3GQ7;A;Crystal Structure of the Bacteriophage Phi29 Gene Product 12 N-terminal Fragment;2.05;CA;CALCIUM ION;Preneck appendage protein;10756;
3GQ8;A;Crystal Structure of the Bacteriophage phi29 gene product 12 N-terminal fragment in complex with 2-(N-cyclohexylamino)ethane sulfonic acid (CHES);2;CA;CALCIUM ION;Preneck appendage protein;10756;
3GQF;A;Structural and Biophysical Properties of the Pathogenic SOD1 Variant H46R/H48Q;2.2;CA;CALCIUM ION;Superoxide dismutase [Cu-Zn];9606;
3GQF;B;Structural and Biophysical Properties of the Pathogenic SOD1 Variant H46R/H48Q;2.2;CA;CALCIUM ION;Superoxide dismutase [Cu-Zn];9606;
3GQF;C;Structural and Biophysical Properties of the Pathogenic SOD1 Variant H46R/H48Q;2.2;CA;CALCIUM ION;Superoxide dismutase [Cu-Zn];9606;
3GQF;D;Structural and Biophysical Properties of the Pathogenic SOD1 Variant H46R/H48Q;2.2;CA;CALCIUM ION;Superoxide dismutase [Cu-Zn];9606;
3GQF;F;Structural and Biophysical Properties of the Pathogenic SOD1 Variant H46R/H48Q;2.2;CA;CALCIUM ION;Superoxide dismutase [Cu-Zn];9606;
3GRI;A;The Crystal Structure of a Dihydroorotase from Staphylococcus aureus;2;CA;CALCIUM ION;Dihydroorotase;1280;
3GRI;B;The Crystal Structure of a Dihydroorotase from Staphylococcus aureus;2;CA;CALCIUM ION;Dihydroorotase;1280;
3GSP;A;RIBONUCLEASE T1 COMPLEXED WITH 2',3'-CGPS + 3'-GMP, 4 DAYS;1.9;CA;CALCIUM ION;RIBONUCLEASE T1;5062;
3GUK;A;T4 lysozyme M102E/L99A mutant with buried charge in apolar cavity--Toluene binding;1.85;CA;CALCIUM ION;Lysozyme;10665;
3GUL;B;T4 lysozyme M102E/L99A mutant with buried charge in apolar cavity--ethylbenzene binding;2.07;CA;CALCIUM ION;Lysozyme;10665;
3GUM;B;T4 lysozyme M102E/L99A mutant with buried charge in apolar cavity--p-xylene binding;2.24;CA;CALCIUM ION;Lysozyme;10665;
3GUN;A;T4 lysozyme M102E/L99A mutant with buried charge in apolar cavity--aniline binding;1.5;CA;CALCIUM ION;Lysozyme;10665;
3GUO;A;T4 lysozyme M102E/L99A mutant with buried charge in apolar cavity--phenol binding;2.16;CA;CALCIUM ION;Lysozyme;10665;
3GV4;A;Crystal structure of human HDAC6 zinc finger domain and ubiquitin C-terminal peptide RLRGG;1.72;CA;CALCIUM ION;Histone deacetylase 6;9606;
3GV5;B;Human DNA polymerase iota in complex with T template DNA and incoming ddADP;2;CA;CALCIUM ION;DNA polymerase iota;9606;
3GV5;D;Human DNA polymerase iota in complex with T template DNA and incoming ddADP;2;CA;CALCIUM ION;DNA polymerase iota;9606;
3GV5;F;Human DNA polymerase iota in complex with T template DNA and incoming ddADP;2;CA;CALCIUM ION;5'-D(P*CP*AP*TP*TP*CP*TP*CP*AP*TP*CP*CP*AP*C)-3';;
3GV5;P;Human DNA polymerase iota in complex with T template DNA and incoming ddADP;2;CA;CALCIUM ION;5'-D(*GP*TP*GP*GP*AP*TP*GP*AP*G)-3';;
3GW6;F;Intramolecular Chaperone;2.6;CA;CALCIUM ION;Endo-N-acetylneuraminidase;344021;
3GWZ;A;Structure of the Mitomycin 7-O-methyltransferase MmcR;1.91;CA;CALCIUM ION;MmcR;1914;
3GWZ;D;Structure of the Mitomycin 7-O-methyltransferase MmcR;1.91;CA;CALCIUM ION;MmcR;1914;
3GXO;D;Structure of the Mitomycin 7-O-methyltransferase MmcR with bound Mitomycin A;2.3;CA;CALCIUM ION;MmcR;1914;
3GY2;A;A comparative study on the inhibition of bovine beta-trypsin by bis-benzamidines diminazene and pentamidine by X-ray crystallography and ITC;1.57;CA;CALCIUM ION;Cationic trypsin;9913;
3GY3;A;A comparative study on the inhibition of bovine beta-trypsin by bis-benzamidines diminazene and pentamidine by X-ray crystallography and ITC;1.7;CA;CALCIUM ION;Cationic trypsin;9913;
3GY4;A;A comparative study on the inhibition of bovine beta-trypsin by bis-benzamidines diminazene and pentamidine by X-ray crystallography and ITC;1.55;CA;CALCIUM ION;Cationic trypsin;9913;
3GY5;A;A comparative study on the inhibition of bovine beta-trypsin by bis-benzamidines diminazene and pentamidine by X-ray crystallography and ITC;1.57;CA;CALCIUM ION;Cationic trypsin;9913;
3GY6;A;A comparative study on the inhibition of bovine beta-trypsin by the bis-benzamidines diminazene and pentamidine;1.7;CA;CALCIUM ION;Cationic trypsin;9913;
3GY7;A;A comparative study on the inhibition of bovine beta-trypsin by bis-benzamidines diminazene and pentamidine by X-ray crystallography and ITC;1.55;CA;CALCIUM ION;Cationic trypsin;9913;
3GY8;A;A comparative study on the inhibition of bovine beta-trypsin by bis-benzamidines diminazene and pentamidine by X-ray crystallography and ITC;1.75;CA;CALCIUM ION;Cationic trypsin;9913;
3GYL;B;Structure of Prostasin at 1.3 Angstroms resolution in complex with a Calcium Ion.;1.3;CA;CALCIUM ION;Prostasin;9606;
3GZK;A;Structure of A. Acidocaldarius Cellulase CelA;1.8;CA;CALCIUM ION;Cellulase;405212;
3GZT;B;VP7 recoated rotavirus DLP;3.8;CA;CALCIUM ION;Outer capsid glycoprotein VP7;444185;
3GZT;F;VP7 recoated rotavirus DLP;3.8;CA;CALCIUM ION;Outer capsid glycoprotein VP7;444185;
3GZT;G;VP7 recoated rotavirus DLP;3.8;CA;CALCIUM ION;Outer capsid glycoprotein VP7;444185;
3GZT;H;VP7 recoated rotavirus DLP;3.8;CA;CALCIUM ION;Outer capsid glycoprotein VP7;444185;
3GZT;I;VP7 recoated rotavirus DLP;3.8;CA;CALCIUM ION;Outer capsid glycoprotein VP7;444185;
3GZT;J;VP7 recoated rotavirus DLP;3.8;CA;CALCIUM ION;Outer capsid glycoprotein VP7;444185;
3GZT;K;VP7 recoated rotavirus DLP;3.8;CA;CALCIUM ION;Outer capsid glycoprotein VP7;444185;
3GZT;L;VP7 recoated rotavirus DLP;3.8;CA;CALCIUM ION;Outer capsid glycoprotein VP7;444185;
3GZT;M;VP7 recoated rotavirus DLP;3.8;CA;CALCIUM ION;Outer capsid glycoprotein VP7;444185;
3GZT;N;VP7 recoated rotavirus DLP;3.8;CA;CALCIUM ION;Outer capsid glycoprotein VP7;444185;
3GZT;O;VP7 recoated rotavirus DLP;3.8;CA;CALCIUM ION;Outer capsid glycoprotein VP7;444185;
3GZT;P;VP7 recoated rotavirus DLP;3.8;CA;CALCIUM ION;Outer capsid glycoprotein VP7;444185;
3GZT;Q;VP7 recoated rotavirus DLP;3.8;CA;CALCIUM ION;Outer capsid glycoprotein VP7;444185;
3H0O;A;The importance of CH-Pi stacking interactions between carbohydrate and aromatic residues in truncated Fibrobacter succinogenes 1,3-1,4-beta-D-glucanase;1.4;CA;CALCIUM ION;Beta-glucanase;833;
3H2W;A;Structure of A. acidocaldarius cellulase CelA in complex with cellobiose;2.66;CA;CALCIUM ION;Cellulase;405212;
3H32;B;Crystal structure of D-dimer from human fibrin complexed with Gly-His-Arg-Pro-Tyr-amide;3.6;CA;CALCIUM ION;Fibrinogen beta chain;9606;
3H32;C;Crystal structure of D-dimer from human fibrin complexed with Gly-His-Arg-Pro-Tyr-amide;3.6;CA;CALCIUM ION;Fibrinogen gamma chain, isoform gamma-A;9606;
3H32;E;Crystal structure of D-dimer from human fibrin complexed with Gly-His-Arg-Pro-Tyr-amide;3.6;CA;CALCIUM ION;Fibrinogen beta chain;9606;
3H32;F;Crystal structure of D-dimer from human fibrin complexed with Gly-His-Arg-Pro-Tyr-amide;3.6;CA;CALCIUM ION;Fibrinogen gamma chain, isoform gamma-A;9606;
3H36;A;Structure of an uncharacterized domain in polyribonucleotide nucleotidyltransferase from Streptococcus mutans UA159;1.8;CA;CALCIUM ION;Polyribonucleotide nucleotidyltransferase;1309;
3H3K;A;Structure of A. acidocaldarius cellulase CelA in complex with cellotetraose;2.1;CA;CALCIUM ION;Cellulase;405212;
3H3P;H;Crystal structure of HIV epitope-scaffold 4E10 Fv complex;2.7;CA;CALCIUM ION;Fv 4E10 heavy chain;9606;
3H4S;E;Structure of the complex of a mitotic kinesin with its calcium binding regulator;2.4;CA;CALCIUM ION;KCBP interacting Ca2+-binding protein;3702;
3H6G;A;Crystal structure of the GluR6 amino terminal domain dimer assembly;2.7;CA;CALCIUM ION;Glutamate receptor, ionotropic kainate 2;10116;
3H6G;B;Crystal structure of the GluR6 amino terminal domain dimer assembly;2.7;CA;CALCIUM ION;Glutamate receptor, ionotropic kainate 2;10116;
3H6H;A;Crystal structure of the GluR6 amino terminal domain dimer assembly MPD form;2.9;CA;CALCIUM ION;Glutamate receptor, ionotropic kainate 2;10116;
3H6H;B;Crystal structure of the GluR6 amino terminal domain dimer assembly MPD form;2.9;CA;CALCIUM ION;Glutamate receptor, ionotropic kainate 2;10116;
3H6M;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS V104E at cryogenic temperature;1.7;CA;CALCIUM ION;Thermonuclease;1280;
3H7D;A;The crystal structure of the cathepsin K Variant M5 in complex with chondroitin-4-sulfate;2.24;CA;CALCIUM ION;Cathepsin K;9606;
3H7D;E;The crystal structure of the cathepsin K Variant M5 in complex with chondroitin-4-sulfate;2.24;CA;CALCIUM ION;Cathepsin K;9606;
3H81;A;Crystal structure of enoyl-CoA hydratase from Mycobacterium tuberculosis;1.8;CA;CALCIUM ION;enoyl-CoA hydratase echA8;1773;
3H81;C;Crystal structure of enoyl-CoA hydratase from Mycobacterium tuberculosis;1.8;CA;CALCIUM ION;enoyl-CoA hydratase echA8;1773;
3H9D;A;Crystal Structure of Trypanosoma brucei ATG8;2.3;CA;CALCIUM ION;Microtubule-associated protein 1A/1B, light chain 3, putative;5691;
3H9D;B;Crystal Structure of Trypanosoma brucei ATG8;2.3;CA;CALCIUM ION;Microtubule-associated protein 1A/1B, light chain 3, putative;5691;
3HAH;A;Crystal structure of human PACSIN1 F-BAR domain (C2 lattice);2.77;CA;CALCIUM ION;human PACSIN1 F-BAR;9606;
3HAH;B;Crystal structure of human PACSIN1 F-BAR domain (C2 lattice);2.77;CA;CALCIUM ION;human PACSIN1 F-BAR;9606;
3HAI;A;Crystal structure of human PACSIN1 F-BAR domain (P21 lattice);2.88;CA;CALCIUM ION;human PACSIN1 F-BAR;9606;
3HAJ;A;Crystal structure of human PACSIN2 F-BAR domain (p212121 lattice);2.78;CA;CALCIUM ION;human PACSIN2 F-BAR;9606;
3HAJ;B;Crystal structure of human PACSIN2 F-BAR domain (p212121 lattice);2.78;CA;CALCIUM ION;human PACSIN2 F-BAR;9606;
3HB2;P;PrtC methionine mutants: M226I;1.75;CA;CALCIUM ION;Secreted protease C;556;
3HB3;A;High resolution crystal structure of Paracoccus denitrificans cytochrome c oxidase;2.25;CA;CALCIUM ION;Cytochrome c oxidase subunit 1-beta;266;
3HBT;A;The structure of native G-actin;2.7;CA;CALCIUM ION;Actin;9986;
3HBU;P;PrtC methionine mutants: M226H DESY;1.77;CA;CALCIUM ION;Secreted protease C;556;
3HBV;P;PrtC methionine mutants: M226A in-house;1.95;CA;CALCIUM ION;Secreted protease C;556;
3HBZ;A;Crystal structure of a putative glycoside hydrolase (bt_2081) from bacteroides thetaiotaomicron vpi-5482 at 2.05 A resolution;2.05;CA;CALCIUM ION;putative glycoside hydrolase;818;
3HCI;B;Structure of MsrB from Xanthomonas campestris (complex-like form);2.59;CA;CALCIUM ION;Peptide methionine sulfoxide reductase;339;
3HCM;A;Crystal structure of human S100B in complex with S45;2;CA;CALCIUM ION;Protein S100-B;9606;
3HCM;B;Crystal structure of human S100B in complex with S45;2;CA;CALCIUM ION;Protein S100-B;9606;
3HDA;P;PrtC methionine mutants: M226A_DESY;2.13;CA;CALCIUM ION;Secreted protease C;556;
3HDB;A;Crystal structure of AaHIV, A metalloproteinase from venom of Agkistrodon Acutus;2.31;CA;CALCIUM ION;AAHIV;36307;
3HDL;A;Crystal Structure of Highly Glycosylated Peroxidase from Royal Palm Tree;1.85;CA;CALCIUM ION;Royal Palm Tree Peroxidase;145709;
3HFJ;A;Bacillus anthracis nicotinate mononucleotide adenylytransferase (nadD) in complex with inhibitor CID 3289443;2.02;CA;CALCIUM ION;Nicotinate (Nicotinamide) nucleotide adenylyltransferase;1392;
3HFJ;B;Bacillus anthracis nicotinate mononucleotide adenylytransferase (nadD) in complex with inhibitor CID 3289443;2.02;CA;CALCIUM ION;Nicotinate (Nicotinamide) nucleotide adenylyltransferase;1392;
3HGN;A;Structure of porcine pancreatic elastase complexed with a potent peptidyl inhibitor FR130180 determined by neutron crystallography;;CA;CALCIUM ION;Elastase-1;9823;
3HGP;A;Structure of porcine pancreatic elastase complexed with a potent peptidyl inhibitor FR130180 determined by high resolution crystallography;0.94;CA;CALCIUM ION;Elastase-1;9823;
3HGW;D;Apo Structure of Pseudomonas aeruginosa Isochorismate-Pyruvate Lyase I87T mutant;2.25;CA;CALCIUM ION;Salicylate biosynthesis protein pchB;287;
3HI7;A;Crystal structure of human diamine oxidase;1.8;CA;CALCIUM ION;Amiloride-sensitive amine oxidase;9606;
3HI7;B;Crystal structure of human diamine oxidase;1.8;CA;CALCIUM ION;Amiloride-sensitive amine oxidase;9606;
3HIG;A;Crystal structure of human diamine oxidase in complex with the inhibitor berenil;2.09;CA;CALCIUM ION;Amiloride-sensitive amine oxidase;9606;
3HIG;B;Crystal structure of human diamine oxidase in complex with the inhibitor berenil;2.09;CA;CALCIUM ION;Amiloride-sensitive amine oxidase;9606;
3HII;A;Crystal structure of human diamine oxidase in complex with the inhibitor pentamidine;2.15;CA;CALCIUM ION;Amiloride-sensitive amine oxidase;9606;
3HII;B;Crystal structure of human diamine oxidase in complex with the inhibitor pentamidine;2.15;CA;CALCIUM ION;Amiloride-sensitive amine oxidase;9606;
3HJB;A;1.5 Angstrom Crystal Structure of Glucose-6-phosphate Isomerase from Vibrio cholerae.;1.5;CA;CALCIUM ION;Glucose-6-phosphate isomerase;666;
3HJB;B;1.5 Angstrom Crystal Structure of Glucose-6-phosphate Isomerase from Vibrio cholerae.;1.5;CA;CALCIUM ION;Glucose-6-phosphate isomerase;666;
3HJB;C;1.5 Angstrom Crystal Structure of Glucose-6-phosphate Isomerase from Vibrio cholerae.;1.5;CA;CALCIUM ION;Glucose-6-phosphate isomerase;666;
3HJB;D;1.5 Angstrom Crystal Structure of Glucose-6-phosphate Isomerase from Vibrio cholerae.;1.5;CA;CALCIUM ION;Glucose-6-phosphate isomerase;666;
3HJM;A;Crystal structure of human Glutathione Transferase Pi Y108V mutant;2.1;CA;CALCIUM ION;Glutathione S-transferase P;9606;
3HJM;B;Crystal structure of human Glutathione Transferase Pi Y108V mutant;2.1;CA;CALCIUM ION;Glutathione S-transferase P;9606;
3HJM;C;Crystal structure of human Glutathione Transferase Pi Y108V mutant;2.1;CA;CALCIUM ION;Glutathione S-transferase P;9606;
3HJM;D;Crystal structure of human Glutathione Transferase Pi Y108V mutant;2.1;CA;CALCIUM ION;Glutathione S-transferase P;9606;
3HJO;A;Crystal Structure of Glutathione Transferase Pi Y108V Mutant in Complex with the Glutathione Conjugate of Ethacrynic Acid;1.95;CA;CALCIUM ION;Glutathione S-transferase P;9606;
3HJO;B;Crystal Structure of Glutathione Transferase Pi Y108V Mutant in Complex with the Glutathione Conjugate of Ethacrynic Acid;1.95;CA;CALCIUM ION;Glutathione S-transferase P;9606;
3HJR;A;Crystal structure of serine protease of Aeromonas sobria;1.65;CA;CALCIUM ION;Extracellular serine protease;646;
3HKR;A;Crystal Structure of Glutathione Transferase Pi Y108V Mutant;1.8;CA;CALCIUM ION;Glutathione S-transferase P;9606;
3HKR;B;Crystal Structure of Glutathione Transferase Pi Y108V Mutant;1.8;CA;CALCIUM ION;Glutathione S-transferase P;9606;
3HL0;A;Crystal structure of Maleylacetate reductase from Agrobacterium tumefaciens;1.6;CA;CALCIUM ION;Maleylacetate reductase;1176649;
3HL0;B;Crystal structure of Maleylacetate reductase from Agrobacterium tumefaciens;1.6;CA;CALCIUM ION;Maleylacetate reductase;1176649;
3HLH;A;Diisopropyl fluorophosphatase (DFPase), active site mutants;1.8;CA;CALCIUM ION;Diisopropyl-fluorophosphatase;6622;
3HLH;B;Diisopropyl fluorophosphatase (DFPase), active site mutants;1.8;CA;CALCIUM ION;Diisopropyl-fluorophosphatase;6622;
3HLH;C;Diisopropyl fluorophosphatase (DFPase), active site mutants;1.8;CA;CALCIUM ION;Diisopropyl-fluorophosphatase;6622;
3HLH;D;Diisopropyl fluorophosphatase (DFPase), active site mutants;1.8;CA;CALCIUM ION;Diisopropyl-fluorophosphatase;6622;
3HLI;A;diisopropyl fluorophosphatase (DFPase), active site mutants;1.4;CA;CALCIUM ION;Diisopropyl-fluorophosphatase;6622;
3HLI;B;diisopropyl fluorophosphatase (DFPase), active site mutants;1.4;CA;CALCIUM ION;Diisopropyl-fluorophosphatase;6622;
3HLI;C;diisopropyl fluorophosphatase (DFPase), active site mutants;1.4;CA;CALCIUM ION;Diisopropyl-fluorophosphatase;6622;
3HLI;D;diisopropyl fluorophosphatase (DFPase), active site mutants;1.4;CA;CALCIUM ION;Diisopropyl-fluorophosphatase;6622;
3HLN;1;Crystal structure of ClpP A153C mutant with inter-heptamer disulfide bonds;3.2;CA;CALCIUM ION;ATP-dependent Clp protease proteolytic subunit;562;
3HLN;2;Crystal structure of ClpP A153C mutant with inter-heptamer disulfide bonds;3.2;CA;CALCIUM ION;ATP-dependent Clp protease proteolytic subunit;562;
3HLN;E;Crystal structure of ClpP A153C mutant with inter-heptamer disulfide bonds;3.2;CA;CALCIUM ION;ATP-dependent Clp protease proteolytic subunit;562;
3HLN;I;Crystal structure of ClpP A153C mutant with inter-heptamer disulfide bonds;3.2;CA;CALCIUM ION;ATP-dependent Clp protease proteolytic subunit;562;
3HLN;J;Crystal structure of ClpP A153C mutant with inter-heptamer disulfide bonds;3.2;CA;CALCIUM ION;ATP-dependent Clp protease proteolytic subunit;562;
3HLN;M;Crystal structure of ClpP A153C mutant with inter-heptamer disulfide bonds;3.2;CA;CALCIUM ION;ATP-dependent Clp protease proteolytic subunit;562;
3HLN;T;Crystal structure of ClpP A153C mutant with inter-heptamer disulfide bonds;3.2;CA;CALCIUM ION;ATP-dependent Clp protease proteolytic subunit;562;
3HLN;V;Crystal structure of ClpP A153C mutant with inter-heptamer disulfide bonds;3.2;CA;CALCIUM ION;ATP-dependent Clp protease proteolytic subunit;562;
3HLN;Z;Crystal structure of ClpP A153C mutant with inter-heptamer disulfide bonds;3.2;CA;CALCIUM ION;ATP-dependent Clp protease proteolytic subunit;562;
3HLY;B;Crystal Structure of the Flavodoxin-like domain from Synechococcus sp Q5MZP6_SYNP6 protein. Northeast Structural Genomics Consortium Target SnR135d.;2.4;CA;CALCIUM ION;Flavodoxin-like domain;32046;
3HLZ;B;Crystal structure of BT_1490 (NP_810393.1) from BACTEROIDES THETAIOTAOMICRON VPI-5482 at 1.50 A resolution;1.5;CA;CALCIUM ION;uncharacterized protein BT_1490;818;
3HM2;D;Crystal Structure of Putative Precorrin-6Y C5,15-Methyltransferase Targeted Domain from Corynebacterium diphtheriae;2.2;CA;CALCIUM ION;precorrin-6Y C5,15-methyltransferase;1717;
3HM2;G;Crystal Structure of Putative Precorrin-6Y C5,15-Methyltransferase Targeted Domain from Corynebacterium diphtheriae;2.2;CA;CALCIUM ION;precorrin-6Y C5,15-methyltransferase;1717;
3HM5;A;SANT domain of human DNA methyltransferase 1 associated protein 1;1.8;CA;CALCIUM ION;DNA methyltransferase 1-associated protein 1;9606;
3HN8;A;Crystal structure of synaptotagmin;3.5;CA;CALCIUM ION;Synaptotagmin-3;10116;
3HN8;B;Crystal structure of synaptotagmin;3.5;CA;CALCIUM ION;Synaptotagmin-3;10116;
3HN8;C;Crystal structure of synaptotagmin;3.5;CA;CALCIUM ION;Synaptotagmin-3;10116;
3HO5;H;Crystal structure of Hedgehog-interacting protein (HHIP) and Sonic hedgehog (SHH) complex;3.01;CA;CALCIUM ION;Sonic hedgehog protein;9606;
3HOH;C;RIBONUCLEASE T1 (THR93GLN MUTANT) COMPLEXED WITH 2'GMP;1.95;CA;CALCIUM ION;PROTEIN (RIBONUCLEASE T1);5062;
3HOH;D;RIBONUCLEASE T1 (THR93GLN MUTANT) COMPLEXED WITH 2'GMP;1.95;CA;CALCIUM ION;PROTEIN (RIBONUCLEASE T1);5062;
3HPT;B;Crystal structure of human FxA in complex with (S)-2-cyano-1-(2-methylbenzofuran-5-yl)-3-(2-oxo-1-(2-oxo-2-(pyrrolidin-1-yl)ethyl)azepan-3-yl)guanidine;2.19;CA;CALCIUM ION;Coagulation factor X;9606;
3HPT;D;Crystal structure of human FxA in complex with (S)-2-cyano-1-(2-methylbenzofuran-5-yl)-3-(2-oxo-1-(2-oxo-2-(pyrrolidin-1-yl)ethyl)azepan-3-yl)guanidine;2.19;CA;CALCIUM ION;Coagulation factor X;9606;
3HQ6;A;Cytochrome c peroxidase from G. sulfurreducens, wild type;2;CA;CALCIUM ION;Cytochrome c551 peroxidase;35554;
3HQ6;B;Cytochrome c peroxidase from G. sulfurreducens, wild type;2;CA;CALCIUM ION;Cytochrome c551 peroxidase;35554;
3HQ7;A;CcpA from G. sulfurreducens, G94K/K97Q/R100I variant;2.31;CA;CALCIUM ION;Cytochrome c551 peroxidase;35554;
3HQ8;A;CcpA from G. sulfurreducens S134P/V135K variant;2.4;CA;CALCIUM ION;Cytochrome c551 peroxidase;35554;
3HQ8;B;CcpA from G. sulfurreducens S134P/V135K variant;2.4;CA;CALCIUM ION;Cytochrome c551 peroxidase;35554;
3HQ9;A;CcpA from G. sulfurreducens, S134P variant;1.52;CA;CALCIUM ION;Cytochrome c551 peroxidase;35554;
3HQ9;B;CcpA from G. sulfurreducens, S134P variant;1.52;CA;CALCIUM ION;Cytochrome c551 peroxidase;35554;
3HR4;B;Human iNOS Reductase and Calmodulin Complex;2.5;CA;CALCIUM ION;Calmodulin;9606;
3HR4;D;Human iNOS Reductase and Calmodulin Complex;2.5;CA;CALCIUM ION;Calmodulin;9606;
3HR4;F;Human iNOS Reductase and Calmodulin Complex;2.5;CA;CALCIUM ION;Calmodulin;9606;
3HR4;H;Human iNOS Reductase and Calmodulin Complex;2.5;CA;CALCIUM ION;Calmodulin;9606;
3HR6;A;Structure of the Corynebacterium diphtheriae major pilin SpaA points to a modular pilus assembly stabilizing isopeptide bonds;1.6;CA;CALCIUM ION;Putative surface-anchored fimbrial subunit;1717;
3HR9;A;The truncated Fibrobacter succinogenes 1,3-1,4-beta-D-glucanase F40I mutant;1.7;CA;CALCIUM ION;Beta-glucanase;833;
3HRD;E;Crystal structure of nicotinate dehydrogenase;2.2;CA;CALCIUM ION;Nicotinate dehydrogenase large molybdopterin subunit;1528;
3HSW;A;Crystal Structure of Porcine Pancreatic Phospholipase A2 in Complex with 2-methoxycyclohexa-2-5-diene-1,4-dione;2.5;CA;CALCIUM ION;Phospholipase A2, major isoenzyme;9823;
3HTL;X;Structure of the Corynebacterium diphtheriae major pilin SpaA points to a modular pilus assembly with stabilizing isopeptide bonds;1.8;CA;CALCIUM ION;Putative surface-anchored fimbrial subunit;1717;
3HUS;B;Crystal structure of recombinant gamma N308K fibrinogen fragment D with the peptide ligand Gly-Pro-Arg-Pro-amide;3.04;CA;CALCIUM ION;Fibrinogen beta chain;9606;
3HUS;C;Crystal structure of recombinant gamma N308K fibrinogen fragment D with the peptide ligand Gly-Pro-Arg-Pro-amide;3.04;CA;CALCIUM ION;Fibrinogen gamma chain;9606;
3HUS;E;Crystal structure of recombinant gamma N308K fibrinogen fragment D with the peptide ligand Gly-Pro-Arg-Pro-amide;3.04;CA;CALCIUM ION;Fibrinogen beta chain;9606;
3HUS;F;Crystal structure of recombinant gamma N308K fibrinogen fragment D with the peptide ligand Gly-Pro-Arg-Pro-amide;3.04;CA;CALCIUM ION;Fibrinogen gamma chain;9606;
3HVD;A;The Protective Antigen Component of Anthrax Toxin Forms Functional Octameric Complexes;3.21;CA;CALCIUM ION;Protective antigen;1392;
3HVD;B;The Protective Antigen Component of Anthrax Toxin Forms Functional Octameric Complexes;3.21;CA;CALCIUM ION;Protective antigen;1392;
3HVD;C;The Protective Antigen Component of Anthrax Toxin Forms Functional Octameric Complexes;3.21;CA;CALCIUM ION;Protective antigen;1392;
3HVD;D;The Protective Antigen Component of Anthrax Toxin Forms Functional Octameric Complexes;3.21;CA;CALCIUM ION;Protective antigen;1392;
3HVD;E;The Protective Antigen Component of Anthrax Toxin Forms Functional Octameric Complexes;3.21;CA;CALCIUM ION;Protective antigen;1392;
3HVD;F;The Protective Antigen Component of Anthrax Toxin Forms Functional Octameric Complexes;3.21;CA;CALCIUM ION;Protective antigen;1392;
3HVD;G;The Protective Antigen Component of Anthrax Toxin Forms Functional Octameric Complexes;3.21;CA;CALCIUM ION;Protective antigen;1392;
3HVD;H;The Protective Antigen Component of Anthrax Toxin Forms Functional Octameric Complexes;3.21;CA;CALCIUM ION;Protective antigen;1392;
3HX4;A;Crystal structure of CDPK1 of Toxoplasma gondii, TGME49_101440, in presence of calcium;1.95;CA;CALCIUM ION;Calmodulin-domain protein kinase 1;5811;
3HX6;A;Crystal structure of Pseudomonas aeruginosa PilY1 C-terminal domain;2.1;CA;CALCIUM ION;Type 4 fimbrial biogenesis protein PilY1;287;
3HX6;B;Crystal structure of Pseudomonas aeruginosa PilY1 C-terminal domain;2.1;CA;CALCIUM ION;Type 4 fimbrial biogenesis protein PilY1;287;
3HXC;B;Engineered RabGGTase in complex with a peptidomimetic inhibitor (compound 8);1.95;CA;CALCIUM ION;Geranylgeranyl transferase type-2 subunit beta;10116;
3HXD;B;Engineered RabGGTase in complex with a peptidomimetic inhibitor (compound 9);1.95;CA;CALCIUM ION;Geranylgeranyl transferase type-2 subunit beta;10116;
3HXE;B;Engineered RabGGTase in complex with a peptidomimetic inhibitor (compound 37);1.95;CA;CALCIUM ION;Geranylgeranyl transferase type-2 subunit beta;10116;
3HXF;B;Engineered RabGGTase in complex with a peptidomimetic inhibitor (compound 32);1.9;CA;CALCIUM ION;Geranylgeranyl transferase type-2 subunit beta;10116;
3HY7;A;Crystal Structure of the Catalytic Domain of ADAMTS-5 in Complex with Marimastat;1.69;CA;CALCIUM ION;A disintegrin and metalloproteinase with thrombospondin motifs 5;9606;
3HY7;B;Crystal Structure of the Catalytic Domain of ADAMTS-5 in Complex with Marimastat;1.69;CA;CALCIUM ION;A disintegrin and metalloproteinase with thrombospondin motifs 5;9606;
3HY9;A;Crystal Structure of the Catalytic Domain of ADAMTS-5 in Complex with an Amino-2-indanol compound;2.02;CA;CALCIUM ION;Catalytic Domain of ADAMTS-5;9606;
3HY9;B;Crystal Structure of the Catalytic Domain of ADAMTS-5 in Complex with an Amino-2-indanol compound;2.02;CA;CALCIUM ION;Catalytic Domain of ADAMTS-5;9606;
3HYG;A;Crystal Structure of the Catalytic Domain of ADAMTS-5 in Complex with an Amino-2-indanol compound;1.4;CA;CALCIUM ION;A disintegrin and metalloproteinase with thrombospondin motifs 5;9606;
3HYG;B;Crystal Structure of the Catalytic Domain of ADAMTS-5 in Complex with an Amino-2-indanol compound;1.4;CA;CALCIUM ION;A disintegrin and metalloproteinase with thrombospondin motifs 5;9606;
3HZ2;A;Crystal structure of a betagamma-crystallin from an Archaea;1.86;CA;CALCIUM ION;Beta/gama crystallin family protein;2214;
3HZ2;B;Crystal structure of a betagamma-crystallin from an Archaea;1.86;CA;CALCIUM ION;Beta/gama crystallin family protein;2214;
3HZ2;C;Crystal structure of a betagamma-crystallin from an Archaea;1.86;CA;CALCIUM ION;Beta/gama crystallin family protein;2214;
3HZ2;D;Crystal structure of a betagamma-crystallin from an Archaea;1.86;CA;CALCIUM ION;Beta/gama crystallin family protein;2214;
3HZ3;A;Lactobacillus reuteri N-terminally truncated glucansucrase GTF180(D1025N)-sucrose complex;2.22;CA;CALCIUM ION;Glucansucrase;1598;
3HZB;A;Crystal structure of a betagamma-crystallin domain from Flavobacterium johnsoniae;1.74;CA;CALCIUM ION;Carbohydrate binding protein;986;
3HZB;B;Crystal structure of a betagamma-crystallin domain from Flavobacterium johnsoniae;1.74;CA;CALCIUM ION;Carbohydrate binding protein;986;
3HZB;C;Crystal structure of a betagamma-crystallin domain from Flavobacterium johnsoniae;1.74;CA;CALCIUM ION;Carbohydrate binding protein;986;
3HZB;D;Crystal structure of a betagamma-crystallin domain from Flavobacterium johnsoniae;1.74;CA;CALCIUM ION;Carbohydrate binding protein;986;
3HZB;E;Crystal structure of a betagamma-crystallin domain from Flavobacterium johnsoniae;1.74;CA;CALCIUM ION;Carbohydrate binding protein;986;
3HZB;F;Crystal structure of a betagamma-crystallin domain from Flavobacterium johnsoniae;1.74;CA;CALCIUM ION;Carbohydrate binding protein;986;
3HZB;G;Crystal structure of a betagamma-crystallin domain from Flavobacterium johnsoniae;1.74;CA;CALCIUM ION;Carbohydrate binding protein;986;
3HZB;H;Crystal structure of a betagamma-crystallin domain from Flavobacterium johnsoniae;1.74;CA;CALCIUM ION;Carbohydrate binding protein;986;
3HZX;A;Crystal Structure of Staphylococcal nuclease variant D+PHS/V66K at pH 9 determined at 100 K;2;CA;CALCIUM ION;Thermonuclease;1280;
3I08;A;Crystal structure of the S1-cleaved Notch1 Negative Regulatory Region (NRR);3.2;CA;CALCIUM ION;Neurogenic locus notch homolog protein 1;9606;
3I08;C;Crystal structure of the S1-cleaved Notch1 Negative Regulatory Region (NRR);3.2;CA;CALCIUM ION;Neurogenic locus notch homolog protein 1;9606;
3I29;A;Crystal structure of a binary complex between an mutant trypsin inhibitor with bovine trypsin;2.4;CA;CALCIUM ION;Cationic trypsin;9913;
3I2Y;X;Proteinase K by Classical hanging drop Method before high X-Ray dose on ID14-2 Beamline at ESRF;1;CA;CALCIUM ION;Proteinase K;37998;
3I30;X;Proteinase K by Classical hanging drop Method after high X-Ray dose on ID14-2 Beamline at ESRF;0.99;CA;CALCIUM ION;Proteinase K;37998;
3I34;X;Proteinase K by LB Nanotemplate Method after high X-Ray dose on ID14-2 Beamline at ESRF;1;CA;CALCIUM ION;Proteinase K;37998;
3I37;X;Proteinase K by LB Nanotemplate Method before high X-Ray dose on ID14-2 Beamline at ESRF;1;CA;CALCIUM ION;Proteinase K;37998;
3I3S;R;Crystal Structure of H-Ras with Thr50 replaced by Isoleucine;1.36;CA;CALCIUM ION;GTPase HRas;9606;
3I46;A;Crystal structure of beta toxin from Staphylococcus aureus F277A, P278A mutant with bound calcium ions;2.6;CA;CALCIUM ION;Beta-hemolysin;1280;
3I46;B;Crystal structure of beta toxin from Staphylococcus aureus F277A, P278A mutant with bound calcium ions;2.6;CA;CALCIUM ION;Beta-hemolysin;1280;
3I4I;A;Crystal structure of a prokaryotic beta-1,3-1,4-glucanase (lichenase) derived from a mouse hindgut metagenome;1.89;CA;CALCIUM ION;1,3-1,4-beta-glucanase;314099;
3I4I;B;Crystal structure of a prokaryotic beta-1,3-1,4-glucanase (lichenase) derived from a mouse hindgut metagenome;1.89;CA;CALCIUM ION;1,3-1,4-beta-glucanase;314099;
3I4P;A;Crystal structure of AsnC family transcriptional regulator from Agrobacterium tumefaciens;2.3;CA;CALCIUM ION;Transcriptional regulator, AsnC family;1176649;
3I57;A;Type 2 repeat of the mucus binding protein MUB from Lactobacillus reuteri;1.8;CA;CALCIUM ION;Mucus binding protein;1598;
3I57;B;Type 2 repeat of the mucus binding protein MUB from Lactobacillus reuteri;1.8;CA;CALCIUM ION;Mucus binding protein;1598;
3I5E;A;Allosteric Modulation of DNA by Small Molecules;0.98;CA;CALCIUM ION;5'-D(*CP*CP*AP*GP*GP*CP*CP*TP*GP*G)-3';;
3I5G;C;Crystal structure of rigor-like squid myosin S1;2.6;CA;CALCIUM ION;Myosin catalytic light chain LC-1, mantle muscle;6637;
3I5H;C;The crystal structure of rigor like squid myosin S1 in the absence of nucleotide;3.4;CA;CALCIUM ION;Myosin catalytic light chain LC-1, mantle muscle;6637;
3I5I;C;The crystal structure of squid myosin S1 in the presence of SO4 2-;3.3;CA;CALCIUM ION;Myosin catalytic light chain LC-1, mantle muscle;6637;
3I5L;A;Allosteric Modulation of DNA by Small Molecules;1.18;CA;CALCIUM ION;5'-D(*CP*CP*AP*GP*GP*(C38)P*CP*TP*GP*G)-3';;
3I5L;B;Allosteric Modulation of DNA by Small Molecules;1.18;CA;CALCIUM ION;5'-D(*CP*CP*AP*GP*GP*(C38)P*CP*TP*GP*G)-3';;
3I6N;A;Mode of Binding of the Tuberculosis Prodrug Isoniazid to Peroxidases: Crystal Structure of Bovine Lactoperoxidase with Isoniazid at 2.7 Resolution;2.7;CA;CALCIUM ION;Lactoperoxidase;9913;
3I77;A;35/99/170-loops of FXa in SGT;2.1;CA;CALCIUM ION;Trypsin;1911;
3I7G;A;MMP-13 in complex with a non zinc-chelating inhibitor;1.95;CA;CALCIUM ION;Collagenase 3;9606;
3I7G;B;MMP-13 in complex with a non zinc-chelating inhibitor;1.95;CA;CALCIUM ION;Collagenase 3;9606;
3I7I;A;MMP-13 in complex with a non zinc-chelating inhibitor;2.21;CA;CALCIUM ION;Collagenase 3;9606;
3I7I;B;MMP-13 in complex with a non zinc-chelating inhibitor;2.21;CA;CALCIUM ION;Collagenase 3;9606;
3I98;A;X-ray crystallographic structure of Inorganic Pyrophosphatase at 298K from archaeon Thermococcus thioreducens;1.85;CA;CALCIUM ION;Th-IPP;277988;
3I98;B;X-ray crystallographic structure of Inorganic Pyrophosphatase at 298K from archaeon Thermococcus thioreducens;1.85;CA;CALCIUM ION;Th-IPP;277988;
3I98;C;X-ray crystallographic structure of Inorganic Pyrophosphatase at 298K from archaeon Thermococcus thioreducens;1.85;CA;CALCIUM ION;Th-IPP;277988;
3I98;D;X-ray crystallographic structure of Inorganic Pyrophosphatase at 298K from archaeon Thermococcus thioreducens;1.85;CA;CALCIUM ION;Th-IPP;277988;
3I98;E;X-ray crystallographic structure of Inorganic Pyrophosphatase at 298K from archaeon Thermococcus thioreducens;1.85;CA;CALCIUM ION;Th-IPP;277988;
3I98;F;X-ray crystallographic structure of Inorganic Pyrophosphatase at 298K from archaeon Thermococcus thioreducens;1.85;CA;CALCIUM ION;Th-IPP;277988;
3I9G;L;Crystal structure of the LT1009 (SONEPCIZUMAB) antibody Fab fragment in complex with sphingosine-1-phosphate;1.9;CA;CALCIUM ION;Sonepcizumab antibody Fab fragment, light chain;10090;
3I9H;A;Crystal structure of a betagamma-crystallin domain from Clostridium beijerinckii;2;CA;CALCIUM ION;Beta and gamma crystallin;1520;
3I9H;B;Crystal structure of a betagamma-crystallin domain from Clostridium beijerinckii;2;CA;CALCIUM ION;Beta and gamma crystallin;1520;
3I9H;C;Crystal structure of a betagamma-crystallin domain from Clostridium beijerinckii;2;CA;CALCIUM ION;Beta and gamma crystallin;1520;
3I9H;D;Crystal structure of a betagamma-crystallin domain from Clostridium beijerinckii;2;CA;CALCIUM ION;Beta and gamma crystallin;1520;
3I9H;E;Crystal structure of a betagamma-crystallin domain from Clostridium beijerinckii;2;CA;CALCIUM ION;Beta and gamma crystallin;1520;
3I9H;F;Crystal structure of a betagamma-crystallin domain from Clostridium beijerinckii;2;CA;CALCIUM ION;Beta and gamma crystallin;1520;
3I9H;G;Crystal structure of a betagamma-crystallin domain from Clostridium beijerinckii;2;CA;CALCIUM ION;Beta and gamma crystallin;1520;
3I9H;H;Crystal structure of a betagamma-crystallin domain from Clostridium beijerinckii;2;CA;CALCIUM ION;Beta and gamma crystallin;1520;
3I9V;3;Crystal structure of the hydrophilic domain of respiratory complex I from Thermus thermophilus, oxidized, 2 mol/ASU;3.1;CA;CALCIUM ION;NADH-quinone oxidoreductase subunit 3;274;
3I9V;C;Crystal structure of the hydrophilic domain of respiratory complex I from Thermus thermophilus, oxidized, 2 mol/ASU;3.1;CA;CALCIUM ION;NADH-quinone oxidoreductase subunit 3;274;
3IA7;A;Crystal Structure of CalG4, the Calicheamicin Glycosyltransferase;1.91;CA;CALCIUM ION;CalG4;1877;
3IA7;B;Crystal Structure of CalG4, the Calicheamicin Glycosyltransferase;1.91;CA;CALCIUM ION;CalG4;1877;
3IAE;A;Structure of benzaldehyde lyase A28S mutant with benzoylphosphonate;2.3;CA;CALCIUM ION;Benzaldehyde lyase;294;
3IAE;B;Structure of benzaldehyde lyase A28S mutant with benzoylphosphonate;2.3;CA;CALCIUM ION;Benzaldehyde lyase;294;
3IAJ;A;Crystal structure of a betagamma-crystallin domain from Clostridium beijerinckii-in alternate space group I422;2.1;CA;CALCIUM ION;Beta and gamma crystallin;1520;
3IAM;7;Crystal structure of the hydrophilic domain of respiratory complex I from Thermus thermophilus, reduced, 2 mol/ASU, with bound NADH;3.1;CA;CALCIUM ION;NADH-quinone oxidoreductase subunit 15;274;
3IAM;H;Crystal structure of the hydrophilic domain of respiratory complex I from Thermus thermophilus, reduced, 2 mol/ASU, with bound NADH;3.1;CA;CALCIUM ION;NADH-quinone oxidoreductase subunit 15;274;
3IAS;2;Crystal structure of the hydrophilic domain of respiratory complex I from Thermus thermophilus, oxidized, 4 mol/ASU, re-refined to 3.15 angstrom resolution;3.15;CA;CALCIUM ION;NADH-quinone oxidoreductase subunit 2;274;
3IAS;3;Crystal structure of the hydrophilic domain of respiratory complex I from Thermus thermophilus, oxidized, 4 mol/ASU, re-refined to 3.15 angstrom resolution;3.15;CA;CALCIUM ION;NADH-quinone oxidoreductase subunit 3;274;
3IAS;9;Crystal structure of the hydrophilic domain of respiratory complex I from Thermus thermophilus, oxidized, 4 mol/ASU, re-refined to 3.15 angstrom resolution;3.15;CA;CALCIUM ION;NADH-quinone oxidoreductase subunit 9;274;
3IAS;B;Crystal structure of the hydrophilic domain of respiratory complex I from Thermus thermophilus, oxidized, 4 mol/ASU, re-refined to 3.15 angstrom resolution;3.15;CA;CALCIUM ION;NADH-quinone oxidoreductase subunit 2;274;
3IAS;C;Crystal structure of the hydrophilic domain of respiratory complex I from Thermus thermophilus, oxidized, 4 mol/ASU, re-refined to 3.15 angstrom resolution;3.15;CA;CALCIUM ION;NADH-quinone oxidoreductase subunit 3;274;
3IAS;G;Crystal structure of the hydrophilic domain of respiratory complex I from Thermus thermophilus, oxidized, 4 mol/ASU, re-refined to 3.15 angstrom resolution;3.15;CA;CALCIUM ION;NADH-quinone oxidoreductase subunit 9;274;
3IAS;H;Crystal structure of the hydrophilic domain of respiratory complex I from Thermus thermophilus, oxidized, 4 mol/ASU, re-refined to 3.15 angstrom resolution;3.15;CA;CALCIUM ION;NADH-quinone oxidoreductase subunit 15;274;
3IAS;K;Crystal structure of the hydrophilic domain of respiratory complex I from Thermus thermophilus, oxidized, 4 mol/ASU, re-refined to 3.15 angstrom resolution;3.15;CA;CALCIUM ION;NADH-quinone oxidoreductase subunit 2;274;
3IAS;L;Crystal structure of the hydrophilic domain of respiratory complex I from Thermus thermophilus, oxidized, 4 mol/ASU, re-refined to 3.15 angstrom resolution;3.15;CA;CALCIUM ION;NADH-quinone oxidoreductase subunit 3;274;
3IAS;P;Crystal structure of the hydrophilic domain of respiratory complex I from Thermus thermophilus, oxidized, 4 mol/ASU, re-refined to 3.15 angstrom resolution;3.15;CA;CALCIUM ION;NADH-quinone oxidoreductase subunit 9;274;
3IAS;T;Crystal structure of the hydrophilic domain of respiratory complex I from Thermus thermophilus, oxidized, 4 mol/ASU, re-refined to 3.15 angstrom resolution;3.15;CA;CALCIUM ION;NADH-quinone oxidoreductase subunit 2;274;
3IAS;U;Crystal structure of the hydrophilic domain of respiratory complex I from Thermus thermophilus, oxidized, 4 mol/ASU, re-refined to 3.15 angstrom resolution;3.15;CA;CALCIUM ION;NADH-quinone oxidoreductase subunit 3;274;
3IAS;Y;Crystal structure of the hydrophilic domain of respiratory complex I from Thermus thermophilus, oxidized, 4 mol/ASU, re-refined to 3.15 angstrom resolution;3.15;CA;CALCIUM ION;NADH-quinone oxidoreductase subunit 9;274;
3IAS;Z;Crystal structure of the hydrophilic domain of respiratory complex I from Thermus thermophilus, oxidized, 4 mol/ASU, re-refined to 3.15 angstrom resolution;3.15;CA;CALCIUM ION;NADH-quinone oxidoreductase subunit 15;274;
3IAX;A;The crystal structure of the TolB box of Colicin A in complex with TolB reveals important differences in the recruitment of the common TolB translocation portal used by group A colicins;2.6;CA;CALCIUM ION;Protein tolB;562;
3IAY;A;Ternary complex of DNA polymerase delta;2;CA;CALCIUM ION;DNA polymerase delta catalytic subunit;4932;
3IAY;T;Ternary complex of DNA polymerase delta;2;CA;CALCIUM ION;5'-D(*TP*AP*AP*GP*GP*TP*AP*GP*GP*GP*GP*AP*GP*GP*AP*T)-3';;
3IBV;A;Karyopherin cytosolic state;3.1;CA;CALCIUM ION;Exportin-T;4896;
3IBV;B;Karyopherin cytosolic state;3.1;CA;CALCIUM ION;Exportin-T;4896;
3IBZ;A;Crystal structure of putative tellurium resistant like protein (TerD) from Streptomyces coelicolor A3(2);1.78;CA;CALCIUM ION;Putative tellurium resistant like protein TerD;1902;
3ICB;A;THE REFINED STRUCTURE OF VITAMIN D-DEPENDENT CALCIUM-BINDING PROTEIN FROM BOVINE INTESTINE. MOLECULAR DETAILS, ION BINDING, AND IMPLICATIONS FOR THE STRUCTURE OF OTHER CALCIUM-BINDING PROTEINS;2.3;CA;CALCIUM ION;CALCIUM-BINDING PROTEIN;9913;
3IF7;A;Structure of Calmodulin complexed with its first endogenous inhibitor, sphingosylphosphorylcholine;1.6;CA;CALCIUM ION;Calmodulin;9913;
3IFK;A;Crystal Structure Of Calcium-Saturated Calmodulin N-terminal Domain Fragment, Residues 1-90;2.03;CA;CALCIUM ION;CALMODULIN;10116;
3IFK;B;Crystal Structure Of Calcium-Saturated Calmodulin N-terminal Domain Fragment, Residues 1-90;2.03;CA;CALCIUM ION;CALMODULIN;10116;
3IGO;A;Crystal structure of Cryptosporidium parvum CDPK1, cgd3_920;2.25;CA;CALCIUM ION;Calmodulin-domain protein kinase 1;5807;
3IIT;A;Factor XA in complex with a cis-1,2-diaminocyclohexane derivative;1.8;CA;CALCIUM ION;Activated factor Xa heavy chain;9606;
3IJ7;A;Directed 'in situ' Elongation as a Strategy to Characterize the Covalent Glycosyl-Enzyme Catalytic Intermediate of Human Pancreatic a-Amylase;2;CA;CALCIUM ION;Pancreatic alpha-amylase;9606;
3IJ8;A;Directed 'in situ' Elongation as a Strategy to Characterize the Covalent Glycosyl-Enzyme Catalytic Intermediate of Human Pancreatic a-Amylase;1.43;CA;CALCIUM ION;Pancreatic alpha-amylase;9606;
3IJ9;A;Directed 'in situ' Elongation as a Strategy to Characterize the Covalent Glycosyl-Enzyme Catalytic Intermediate of Human Pancreatic a-Amylase;1.85;CA;CALCIUM ION;Pancreatic alpha-amylase;9606;
3IJE;A;Crystal structure of the complete integrin alhaVbeta3 ectodomain plus an Alpha/beta transmembrane fragment;2.9;CA;CALCIUM ION;Integrin alpha-V;9606;
3IJE;B;Crystal structure of the complete integrin alhaVbeta3 ectodomain plus an Alpha/beta transmembrane fragment;2.9;CA;CALCIUM ION;Integrin beta-3;9606;
3IK2;A;Crystal Structure of a Glycoside Hydrolase Family 44 Endoglucanase produced by Clostridium acetobutylium ATCC 824;2.2;CA;CALCIUM ION;Endoglucanase A;1488;
3IKN;A;Crystal structure of galactose bound trimeric human lung surfactant protein D;1.6;CA;CALCIUM ION;Pulmonary surfactant-associated protein D;9606;
3IKN;B;Crystal structure of galactose bound trimeric human lung surfactant protein D;1.6;CA;CALCIUM ION;Pulmonary surfactant-associated protein D;9606;
3IKN;C;Crystal structure of galactose bound trimeric human lung surfactant protein D;1.6;CA;CALCIUM ION;Pulmonary surfactant-associated protein D;9606;
3IKP;A;Crystal structure of inositol phosphate bound trimeric human lung surfactant protein D;1.75;CA;CALCIUM ION;Pulmonary surfactant-associated protein D;9606;
3IKP;B;Crystal structure of inositol phosphate bound trimeric human lung surfactant protein D;1.75;CA;CALCIUM ION;Pulmonary surfactant-associated protein D;9606;
3IKP;C;Crystal structure of inositol phosphate bound trimeric human lung surfactant protein D;1.75;CA;CALCIUM ION;Pulmonary surfactant-associated protein D;9606;
3IKQ;A;Crystal structure of alpha 1-2 mannobiose bound trimeric human lung surfactant protein D;2.25;CA;CALCIUM ION;Pulmonary surfactant-associated protein D;9606;
3IKQ;B;Crystal structure of alpha 1-2 mannobiose bound trimeric human lung surfactant protein D;2.25;CA;CALCIUM ION;Pulmonary surfactant-associated protein D;9606;
3IKQ;C;Crystal structure of alpha 1-2 mannobiose bound trimeric human lung surfactant protein D;2.25;CA;CALCIUM ION;Pulmonary surfactant-associated protein D;9606;
3IKR;A;Crystal structure of alpha 1-4 mannobiose bound trimeric human lung surfactant protein D;1.65;CA;CALCIUM ION;Pulmonary surfactant-associated protein D;9606;
3IKR;B;Crystal structure of alpha 1-4 mannobiose bound trimeric human lung surfactant protein D;1.65;CA;CALCIUM ION;Pulmonary surfactant-associated protein D;9606;
3IKR;C;Crystal structure of alpha 1-4 mannobiose bound trimeric human lung surfactant protein D;1.65;CA;CALCIUM ION;Pulmonary surfactant-associated protein D;9606;
3IKV;A;Crystal structure of a Rex-family repressor R90D mutant from Thermus aquaticus;2.4;CA;CALCIUM ION;Redox-sensing transcriptional repressor rex;274;
3IKW;A;Structure of Heparinase I from Bacteroides thetaiotaomicron;1.3;CA;CALCIUM ION;Heparin lyase I;818;
3ILF;A;Crystal structure of porphyranase A (PorA) in complex with neo-porphyrotetraose;1.8;CA;CALCIUM ION;porphyranase A;63186;
3ILN;A;X-ray structure of the laminarinase from Rhodothermus marinus;1.95;CA;CALCIUM ION;Laminarinase;29549;
3ILN;B;X-ray structure of the laminarinase from Rhodothermus marinus;1.95;CA;CALCIUM ION;Laminarinase;29549;
3ILR;A;Structure of Heparinase I from Bacteroides thetaiotaomicron in complex with tetrasaccharide product;1.5;CA;CALCIUM ION;Heparin lyase I;818;
3IM9;A;Crystal structure of MCAT from Staphylococcus aureus;1.46;CA;CALCIUM ION;Malonyl CoA-acyl carrier protein transacylase;1280;
3IMN;A;Crystal structure of heparin lyase I from Bacteroides thetaiotaomicron;1.81;CA;CALCIUM ION;Heparin lyase I;818;
3IN9;A;Crystal structure of heparin lyase I complexed with disaccharide heparin;2;CA;CALCIUM ION;Heparin lyase I;818;
3INA;A;Crystal structure of heparin lyase I H151A mutant complexed with a dodecasaccharide heparin;1.9;CA;CALCIUM ION;Heparin lyase I;818;
3INM;A;Crystal structure of human cytosolic NADP(+)-dependent isocitrate dehydrogenase R132H mutant in complex with NADPH, ALPHA-KETOGLUTARATE and CALCIUM(2+);2.1;CA;CALCIUM ION;Isocitrate dehydrogenase [NADP] cytoplasmic;9606;
3INM;B;Crystal structure of human cytosolic NADP(+)-dependent isocitrate dehydrogenase R132H mutant in complex with NADPH, ALPHA-KETOGLUTARATE and CALCIUM(2+);2.1;CA;CALCIUM ION;Isocitrate dehydrogenase [NADP] cytoplasmic;9606;
3INM;C;Crystal structure of human cytosolic NADP(+)-dependent isocitrate dehydrogenase R132H mutant in complex with NADPH, ALPHA-KETOGLUTARATE and CALCIUM(2+);2.1;CA;CALCIUM ION;Isocitrate dehydrogenase [NADP] cytoplasmic;9606;
3IO4;B;Huntingtin amino-terminal region with 17 Gln residues - Crystal C90;3.63;CA;CALCIUM ION;Maltose-binding periplasmic protein,Huntingtin fusion protein;5,629,606;
3IO4;C;Huntingtin amino-terminal region with 17 Gln residues - Crystal C90;3.63;CA;CALCIUM ION;Maltose-binding periplasmic protein,Huntingtin fusion protein;5,629,606;
3IO6;A;Huntingtin amino-terminal region with 17 Gln residues - crystal C92-a;3.7;CA;CALCIUM ION;Maltose-binding periplasmic protein, HUNTINGTIN FUSION PROTEIN;5,629,606;
3IO6;B;Huntingtin amino-terminal region with 17 Gln residues - crystal C92-a;3.7;CA;CALCIUM ION;Maltose-binding periplasmic protein, HUNTINGTIN FUSION PROTEIN;5,629,606;
3IO6;C;Huntingtin amino-terminal region with 17 Gln residues - crystal C92-a;3.7;CA;CALCIUM ION;Maltose-binding periplasmic protein, HUNTINGTIN FUSION PROTEIN;5,629,606;
3IOR;A;Huntingtin amino-terminal region with 17 Gln residues - crystal C95;3.6;CA;CALCIUM ION;Maltose-binding protein, huntingtin fusion protein;5,629,606;
3IOR;B;Huntingtin amino-terminal region with 17 Gln residues - crystal C95;3.6;CA;CALCIUM ION;Maltose-binding protein, huntingtin fusion protein;5,629,606;
3IOR;C;Huntingtin amino-terminal region with 17 Gln residues - crystal C95;3.6;CA;CALCIUM ION;Maltose-binding protein, huntingtin fusion protein;5,629,606;
3IOT;A;Huntingtin amino-terminal region with 17 Gln residues - crystal C92-b;3.5;CA;CALCIUM ION;Maltose-binding periplasmic protein,Huntingtin;5,629,606;
3IOT;B;Huntingtin amino-terminal region with 17 Gln residues - crystal C92-b;3.5;CA;CALCIUM ION;Maltose-binding periplasmic protein,Huntingtin;5,629,606;
3IOT;C;Huntingtin amino-terminal region with 17 Gln residues - crystal C92-b;3.5;CA;CALCIUM ION;Maltose-binding periplasmic protein,Huntingtin;5,629,606;
3IOU;A;Huntingtin amino-terminal region with 17 Gln residues - crystal C94;3.7;CA;CALCIUM ION;Maltose-binding periplasmic protein,Huntingtin;5,629,606;
3IOU;B;Huntingtin amino-terminal region with 17 Gln residues - crystal C94;3.7;CA;CALCIUM ION;Maltose-binding periplasmic protein,Huntingtin;5,629,606;
3IOU;C;Huntingtin amino-terminal region with 17 Gln residues - crystal C94;3.7;CA;CALCIUM ION;Maltose-binding periplasmic protein,Huntingtin;5,629,606;
3IOV;A;Huntingtin amino-terminal region with 17 Gln residues - crystal C99;3.7;CA;CALCIUM ION;Maltose-binding periplasmic protein,Huntingtin;5,629,606;
3IOV;B;Huntingtin amino-terminal region with 17 Gln residues - crystal C99;3.7;CA;CALCIUM ION;Maltose-binding periplasmic protein,Huntingtin;5,629,606;
3IOV;C;Huntingtin amino-terminal region with 17 Gln residues - crystal C99;3.7;CA;CALCIUM ION;Maltose-binding periplasmic protein,Huntingtin;5,629,606;
3IOW;A;Huntingtin amino-terminal region with 17 Gln residues - crystal C99-Hg;3.5;CA;CALCIUM ION;Maltose-binding periplasmic protein,Huntingtin;5,629,606;
3IOW;B;Huntingtin amino-terminal region with 17 Gln residues - crystal C99-Hg;3.5;CA;CALCIUM ION;Maltose-binding periplasmic protein,Huntingtin;5,629,606;
3IOW;C;Huntingtin amino-terminal region with 17 Gln residues - crystal C99-Hg;3.5;CA;CALCIUM ION;Maltose-binding periplasmic protein,Huntingtin;5,629,606;
3IOX;A;Crystal Structure of A3VP1 of AgI/II of Streptococcus mutans;1.8;CA;CALCIUM ION;AgI/II;1309;
3IP7;A;Structure of Atu2422-GABA receptor in complex with valine;1.7;CA;CALCIUM ION;ABC transporter, substrate binding protein (Amino acid);1176649;
3IPK;A;Crystal Structure of A3VP1 of AgI/II of Streptococcus mutans;2.04;CA;CALCIUM ION;AgI/II;1309;
3IPK;B;Crystal Structure of A3VP1 of AgI/II of Streptococcus mutans;2.04;CA;CALCIUM ION;AgI/II;1309;
3IPR;A;Crystal structure of the Enterococcus faecalis gluconate specific EIIA phosphotransferase system component;2.5;CA;CALCIUM ION;PTS system, IIA component;1351;
3IPR;B;Crystal structure of the Enterococcus faecalis gluconate specific EIIA phosphotransferase system component;2.5;CA;CALCIUM ION;PTS system, IIA component;1351;
3IPR;C;Crystal structure of the Enterococcus faecalis gluconate specific EIIA phosphotransferase system component;2.5;CA;CALCIUM ION;PTS system, IIA component;1351;
3IPR;D;Crystal structure of the Enterococcus faecalis gluconate specific EIIA phosphotransferase system component;2.5;CA;CALCIUM ION;PTS system, IIA component;1351;
3IPR;E;Crystal structure of the Enterococcus faecalis gluconate specific EIIA phosphotransferase system component;2.5;CA;CALCIUM ION;PTS system, IIA component;1351;
3IPR;F;Crystal structure of the Enterococcus faecalis gluconate specific EIIA phosphotransferase system component;2.5;CA;CALCIUM ION;PTS system, IIA component;1351;
3IPV;A;Crystal structure of Spatholobus parviflorus seed lectin;2.04;CA;CALCIUM ION;Lectin alpha chain;132465;
3IPV;B;Crystal structure of Spatholobus parviflorus seed lectin;2.04;CA;CALCIUM ION;Lectin beta chain;132465;
3IPV;C;Crystal structure of Spatholobus parviflorus seed lectin;2.04;CA;CALCIUM ION;Lectin alpha chain;132465;
3IPV;D;Crystal structure of Spatholobus parviflorus seed lectin;2.04;CA;CALCIUM ION;Lectin beta chain;132465;
3IQE;B;Structure of F420 dependent methylene-tetrahydromethanopterin dehydrogenase in complex with methylene-tetrahydromethanopterin and coenzyme F420;1.8;CA;CALCIUM ION;F420-dependent methylenetetrahydromethanopterin dehydrogenase;2320;
3IQE;C;Structure of F420 dependent methylene-tetrahydromethanopterin dehydrogenase in complex with methylene-tetrahydromethanopterin and coenzyme F420;1.8;CA;CALCIUM ION;F420-dependent methylenetetrahydromethanopterin dehydrogenase;2320;
3IQE;D;Structure of F420 dependent methylene-tetrahydromethanopterin dehydrogenase in complex with methylene-tetrahydromethanopterin and coenzyme F420;1.8;CA;CALCIUM ION;F420-dependent methylenetetrahydromethanopterin dehydrogenase;2320;
3IQF;B;Structure of F420 dependent methylene-tetrahydromethanopterin dehydrogenase in complex with methenyl-tetrahydromethanopterin;2.1;CA;CALCIUM ION;F420-dependent methylenetetrahydromethanopterin dehydrogenase;2320;
3IQF;E;Structure of F420 dependent methylene-tetrahydromethanopterin dehydrogenase in complex with methenyl-tetrahydromethanopterin;2.1;CA;CALCIUM ION;F420-dependent methylenetetrahydromethanopterin dehydrogenase;2320;
3IQF;I;Structure of F420 dependent methylene-tetrahydromethanopterin dehydrogenase in complex with methenyl-tetrahydromethanopterin;2.1;CA;CALCIUM ION;F420-dependent methylenetetrahydromethanopterin dehydrogenase;2320;
3IQF;J;Structure of F420 dependent methylene-tetrahydromethanopterin dehydrogenase in complex with methenyl-tetrahydromethanopterin;2.1;CA;CALCIUM ION;F420-dependent methylenetetrahydromethanopterin dehydrogenase;2320;
3IQF;K;Structure of F420 dependent methylene-tetrahydromethanopterin dehydrogenase in complex with methenyl-tetrahydromethanopterin;2.1;CA;CALCIUM ION;F420-dependent methylenetetrahydromethanopterin dehydrogenase;2320;
3IQF;L;Structure of F420 dependent methylene-tetrahydromethanopterin dehydrogenase in complex with methenyl-tetrahydromethanopterin;2.1;CA;CALCIUM ION;F420-dependent methylenetetrahydromethanopterin dehydrogenase;2320;
3IQO;A;1.5 angstrom X-ray structure of bovine Ca(2+)-S100B;1.5;CA;CALCIUM ION;Protein S100-B;9913;
3IQO;B;1.5 angstrom X-ray structure of bovine Ca(2+)-S100B;1.5;CA;CALCIUM ION;Protein S100-B;9913;
3IQQ;A;X-ray structure of bovine TRTK12-Ca(2+)-S100B;2.01;CA;CALCIUM ION;Protein S100-B;9913;
3IQT;A;Structure of the HPT domain of Sensor protein barA from Escherichia coli CFT073.;1.4;CA;CALCIUM ION;Signal transduction histidine-protein kinase barA;562;
3IQZ;B;Structure of F420 dependent methylene-tetrahydromethanopterin dehydrogenase in complex with methylene-tetrahydromethanopterin;2.1;CA;CALCIUM ION;F420-dependent methylenetetrahydromethanopterin dehydrogenase;2320;
3IRH;A;Structure of an Enterococcus Faecalis HD-domain protein complexed with dGTP and dATP;2.4;CA;CALCIUM ION;HD domain protein;1351;
3IRH;B;Structure of an Enterococcus Faecalis HD-domain protein complexed with dGTP and dATP;2.4;CA;CALCIUM ION;HD domain protein;1351;
3IRH;C;Structure of an Enterococcus Faecalis HD-domain protein complexed with dGTP and dATP;2.4;CA;CALCIUM ION;HD domain protein;1351;
3IRH;D;Structure of an Enterococcus Faecalis HD-domain protein complexed with dGTP and dATP;2.4;CA;CALCIUM ION;HD domain protein;1351;
3IS5;A;Crystal structure of CDPK kinase domain from toxoplasma Gondii, TGME49_018720;2.55;CA;CALCIUM ION;Calcium-dependent protein kinase;5811;
3IS5;C;Crystal structure of CDPK kinase domain from toxoplasma Gondii, TGME49_018720;2.55;CA;CALCIUM ION;Calcium-dependent protein kinase;5811;
3IS5;F;Crystal structure of CDPK kinase domain from toxoplasma Gondii, TGME49_018720;2.55;CA;CALCIUM ION;Calcium-dependent protein kinase;5811;
3ISV;A;Crystal structure of glutamate racemase from Listeria monocytogenes in complex with acetate ion;1.85;CA;CALCIUM ION;Glutamate racemase;1639;
3ITI;A;Structure of bovine trypsin with the MAD triangle B3C;1.55;CA;CALCIUM ION;Cationic trypsin;9913;
3ITP;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS F34K at cryogenic temperature;1.75;CA;CALCIUM ION;Nuclease A;1280;
3IUC;A;Crystal structure of the human 70kDa heat shock protein 5 (BiP/GRP78) ATPase domain in complex with ADP;2.4;CA;CALCIUM ION;Heat shock 70kDa protein 5 (Glucose-regulated protein, 78kDa);9606;
3IUC;C;Crystal structure of the human 70kDa heat shock protein 5 (BiP/GRP78) ATPase domain in complex with ADP;2.4;CA;CALCIUM ION;Heat shock 70kDa protein 5 (Glucose-regulated protein, 78kDa);9606;
3IWA;A;Crystal structure of a FAD-dependent pyridine nucleotide-disulphide oxidoreductase from Desulfovibrio vulgaris;2.3;CA;CALCIUM ION;FAD-dependent pyridine nucleotide-disulphide oxidoreductase;881;
3IWW;A;Crystal structure of human glutamate carboxypeptidase II (GCPII) in a complex with DBIBzL, a urea-based inhibitor;2.3;CA;CALCIUM ION;Glutamate carboxypeptidase 2;9606;
3J2Q;A;Model of membrane-bound factor VIII organized in 2D crystals;;CA;CALCIUM ION;Coagulation factor VIII heavy chain;9606;
3J41;E;Pseudo-atomic model of the Aquaporin-0/Calmodulin complex derived from electron microscopy;25;CA;CALCIUM ION;Calmodulin;9606;
3J41;F;Pseudo-atomic model of the Aquaporin-0/Calmodulin complex derived from electron microscopy;25;CA;CALCIUM ION;Calmodulin;9606;
3J7T;A;Calcium atpase structure with two bound calcium ions determined by electron crystallography of thin 3D crystals;3.4;CA;CALCIUM ION;Sarcoplasmic/endoplasmic reticulum calcium ATPase 1;9986;
3J82;A;Electron cryo-microscopy of DNGR-1 in complex with F-actin;7.7;CA;CALCIUM ION;C-type lectin domain family 9 member A;10090;
3J9C;A;CryoEM single particle reconstruction of anthrax toxin protective antigen pore at 2.9 Angstrom resolution;2.9;CA;CALCIUM ION;Protective antigen PA-63;1392;
3J9S;A;Single particle cryo-EM structure of rotavirus VP6 at 2.6 Angstrom resolution;2.6;CA;CALCIUM ION;Intermediate capsid protein VP6;28875;
3JBR;A;Cryo-EM structure of the rabbit voltage-gated calcium channel Cav1.1 complex at 4.2 angstrom;4.2;CA;CALCIUM ION;Voltage-dependent L-type calcium channel subunit alpha-1S;9986;
3JBY;A;Cryo-electron microscopy structure of RAG Paired Complex (C2 symmetry);3.7;CA;CALCIUM ION;V(D)J recombination-activating protein 1;7955;
3JBY;C;Cryo-electron microscopy structure of RAG Paired Complex (C2 symmetry);3.7;CA;CALCIUM ION;V(D)J recombination-activating protein 1;7955;
3JQ1;A;Crystal structure of SusD superfamily protein (YP_001297730.1) from Bacteroides vulgatus ATCC 8482 at 1.55 A resolution;1.55;CA;CALCIUM ION;SusD superfamily protein;821;
3JQ1;B;Crystal structure of SusD superfamily protein (YP_001297730.1) from Bacteroides vulgatus ATCC 8482 at 1.55 A resolution;1.55;CA;CALCIUM ION;SusD superfamily protein;821;
3JQ5;A;Phospholipase A2 Prevents the Aggregation of Amyloid Beta Peptides: Crystal Structure of the Complex of Phospholipase A2 with Octapeptide Fragment of Amyloid Beta Peptide, Asp-Ala-Glu-Phe-Arg-His-Asp-Ser at 2 A Resolution;2.03;CA;CALCIUM ION;Phospholipase A2 isoform 3;195058;
3JQL;A;Crystal Structure of the Complex Formed Between Phospholipase A2 and a Hexapeptide Fragment of Amyloid Beta Peptide, Lys-Leu-Val-Phe-Phe-Ala at 1.2 A Resolution;1.2;CA;CALCIUM ION;Phospholipase A2 isoform 3;195058;
3JQW;A;Crystal structure of Clostridium histolyticum colH collagenase collagen-binding domain 3 at 2 Angstrom resolution in presence of calcium;2;CA;CALCIUM ION;ColH protein;1498;
3JQW;B;Crystal structure of Clostridium histolyticum colH collagenase collagen-binding domain 3 at 2 Angstrom resolution in presence of calcium;2;CA;CALCIUM ION;ColH protein;1498;
3JQW;C;Crystal structure of Clostridium histolyticum colH collagenase collagen-binding domain 3 at 2 Angstrom resolution in presence of calcium;2;CA;CALCIUM ION;ColH protein;1498;
3JQX;A;Crystal structure of Clostridium histolyticum colH collagenase collagen binding domain 3 at 2.2 Angstrom resolution in the presence of calcium and cadmium;2.2;CA;CALCIUM ION;ColH protein;1498;
3JQX;B;Crystal structure of Clostridium histolyticum colH collagenase collagen binding domain 3 at 2.2 Angstrom resolution in the presence of calcium and cadmium;2.2;CA;CALCIUM ION;ColH protein;1498;
3JQX;C;Crystal structure of Clostridium histolyticum colH collagenase collagen binding domain 3 at 2.2 Angstrom resolution in the presence of calcium and cadmium;2.2;CA;CALCIUM ION;ColH protein;1498;
3JR8;A;Crystal Structure of BthTX-II (Asp49-PLA2 from Bothrops jararacussu snake venom) with calcium ions;2.1;CA;CALCIUM ION;Phospholipase A2 bothropstoxin-2;8726;
3JR8;B;Crystal Structure of BthTX-II (Asp49-PLA2 from Bothrops jararacussu snake venom) with calcium ions;2.1;CA;CALCIUM ION;Phospholipase A2 bothropstoxin-2;8726;
3JRU;A;Crystal structure of Leucyl Aminopeptidase (pepA) from Xoo0834,Xanthomonas oryzae pv. oryzae KACC10331;2.6;CA;CALCIUM ION;Probable cytosol aminopeptidase;347;
3JRU;B;Crystal structure of Leucyl Aminopeptidase (pepA) from Xoo0834,Xanthomonas oryzae pv. oryzae KACC10331;2.6;CA;CALCIUM ION;Probable cytosol aminopeptidase;347;
3JTC;C;Importance of Mg2+ in the Ca2+-Dependent Folding of the gamma-Carboxyglutamic Acid Domains of Vitamin K-Dependent clotting and anticlotting Proteins;1.6;CA;CALCIUM ION;Vitamin K-dependent protein C;9606;
3JTC;D;Importance of Mg2+ in the Ca2+-Dependent Folding of the gamma-Carboxyglutamic Acid Domains of Vitamin K-Dependent clotting and anticlotting Proteins;1.6;CA;CALCIUM ION;Vitamin K-dependent protein C;9606;
3JTI;A;Crystal structure of the complex formed between Phospholipase A2 with beta-amyloid fragment, Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met at 1.8 A resolution;1.8;CA;CALCIUM ION;Phospholipase A2 isoform 3;195058;
3JTX;B;Crystal structure of Aminotransferase (NP_283882.1) from NEISSERIA MENINGITIDIS Z2491 at 1.91 A resolution;1.91;CA;CALCIUM ION;aminotransferase;487;
3JU7;A;Crystal structure of Putative PLP-dependent aminotransferase (NP_978343.1) from Bacillus cereus ATCC 10987 at 2.19 A resolution;2.19;CA;CALCIUM ION;Putative PLP-dependent aminotransferase;1396;
3JU7;B;Crystal structure of Putative PLP-dependent aminotransferase (NP_978343.1) from Bacillus cereus ATCC 10987 at 2.19 A resolution;2.19;CA;CALCIUM ION;Putative PLP-dependent aminotransferase;1396;
3JU9;A;Crystal structure of a lectin from Canavalia brasiliensis seed (ConBr) complexed with alpha-aminobutyric acid;2.1;CA;CALCIUM ION;Concanavalin-Br;61861;
3JVF;B;Crystal structure of an Interleukin-17 receptor complex;3.3;CA;CALCIUM ION;Interleukin-17F;9606;
3JVT;C;Calcium-bound Scallop Myosin Regulatory Domain (Lever Arm) with Reconstituted Complete Light Chains;2.1;CA;CALCIUM ION;Myosin essential light chain, striated adductor muscle;31199;
3JXS;A;Crystal structure of XG34, an evolved xyloglucan binding CBM;1.6;CA;CALCIUM ION;Xylanase;29549;
3JXS;B;Crystal structure of XG34, an evolved xyloglucan binding CBM;1.6;CA;CALCIUM ION;Xylanase;29549;
3JXS;C;Crystal structure of XG34, an evolved xyloglucan binding CBM;1.6;CA;CALCIUM ION;Xylanase;29549;
3JZD;A;Crystal structure of Putative alcohol dehedrogenase (YP_298327.1) from RALSTONIA EUTROPHA JMP134 at 2.10 A resolution;2.1;CA;CALCIUM ION;Iron-containing alcohol dehydrogenase;248026;
3K1A;B;Insights into substrate binding at FeMo-cofactor in nitrogenase from the structure of an alpha-70Ile MoFe protein variant;2.23;CA;CALCIUM ION;Nitrogenase molybdenum-iron protein beta chain;354;
3K1A;D;Insights into substrate binding at FeMo-cofactor in nitrogenase from the structure of an alpha-70Ile MoFe protein variant;2.23;CA;CALCIUM ION;Nitrogenase molybdenum-iron protein beta chain;354;
3K1V;A;Cocrystal structure of a mutant class-I preQ1 riboswitch;2.2;CA;CALCIUM ION;PreQ1 riboswitch;;
3K21;A;Crystal Structure of carboxy-terminus of PFC0420w.;1.15;CA;CALCIUM ION;Calcium-dependent protein kinase 3;5833;
3K28;A;Crystal Structure of a glutamate-1-semialdehyde aminotransferase from Bacillus anthracis with bound Pyridoxal 5'Phosphate;1.95;CA;CALCIUM ION;Glutamate-1-semialdehyde 2,1-aminomutase 2;1392;
3K28;B;Crystal Structure of a glutamate-1-semialdehyde aminotransferase from Bacillus anthracis with bound Pyridoxal 5'Phosphate;1.95;CA;CALCIUM ION;Glutamate-1-semialdehyde 2,1-aminomutase 2;1392;
3K28;C;Crystal Structure of a glutamate-1-semialdehyde aminotransferase from Bacillus anthracis with bound Pyridoxal 5'Phosphate;1.95;CA;CALCIUM ION;Glutamate-1-semialdehyde 2,1-aminomutase 2;1392;
3K28;D;Crystal Structure of a glutamate-1-semialdehyde aminotransferase from Bacillus anthracis with bound Pyridoxal 5'Phosphate;1.95;CA;CALCIUM ION;Glutamate-1-semialdehyde 2,1-aminomutase 2;1392;
3K36;A;Crystal Structure of B/Perth Neuraminidase;2.2;CA;CALCIUM ION;Neuraminidase;11520;
3K36;B;Crystal Structure of B/Perth Neuraminidase;2.2;CA;CALCIUM ION;Neuraminidase;11520;
3K37;A;Crystal Structure of B/Perth Neuraminidase in complex with Peramivir;2;CA;CALCIUM ION;Neuraminidase;11520;
3K37;B;Crystal Structure of B/Perth Neuraminidase in complex with Peramivir;2;CA;CALCIUM ION;Neuraminidase;11520;
3K38;A;Crystal Structure of B/Perth Neuraminidase D197E mutant;2.19;CA;CALCIUM ION;Neuraminidase;11520;
3K38;B;Crystal Structure of B/Perth Neuraminidase D197E mutant;2.19;CA;CALCIUM ION;Neuraminidase;11520;
3K38;C;Crystal Structure of B/Perth Neuraminidase D197E mutant;2.19;CA;CALCIUM ION;Neuraminidase;11520;
3K38;D;Crystal Structure of B/Perth Neuraminidase D197E mutant;2.19;CA;CALCIUM ION;Neuraminidase;11520;
3K38;E;Crystal Structure of B/Perth Neuraminidase D197E mutant;2.19;CA;CALCIUM ION;Neuraminidase;11520;
3K38;F;Crystal Structure of B/Perth Neuraminidase D197E mutant;2.19;CA;CALCIUM ION;Neuraminidase;11520;
3K38;G;Crystal Structure of B/Perth Neuraminidase D197E mutant;2.19;CA;CALCIUM ION;Neuraminidase;11520;
3K38;H;Crystal Structure of B/Perth Neuraminidase D197E mutant;2.19;CA;CALCIUM ION;Neuraminidase;11520;
3K38;I;Crystal Structure of B/Perth Neuraminidase D197E mutant;2.19;CA;CALCIUM ION;Neuraminidase;11520;
3K38;J;Crystal Structure of B/Perth Neuraminidase D197E mutant;2.19;CA;CALCIUM ION;Neuraminidase;11520;
3K38;K;Crystal Structure of B/Perth Neuraminidase D197E mutant;2.19;CA;CALCIUM ION;Neuraminidase;11520;
3K38;L;Crystal Structure of B/Perth Neuraminidase D197E mutant;2.19;CA;CALCIUM ION;Neuraminidase;11520;
3K38;M;Crystal Structure of B/Perth Neuraminidase D197E mutant;2.19;CA;CALCIUM ION;Neuraminidase;11520;
3K38;N;Crystal Structure of B/Perth Neuraminidase D197E mutant;2.19;CA;CALCIUM ION;Neuraminidase;11520;
3K38;O;Crystal Structure of B/Perth Neuraminidase D197E mutant;2.19;CA;CALCIUM ION;Neuraminidase;11520;
3K38;P;Crystal Structure of B/Perth Neuraminidase D197E mutant;2.19;CA;CALCIUM ION;Neuraminidase;11520;
3K39;A;Crystal Structure of B/Perth Neuraminidase D197E mutant in complex with Peramivir;2.54;CA;CALCIUM ION;Neuraminidase;11520;
3K39;B;Crystal Structure of B/Perth Neuraminidase D197E mutant in complex with Peramivir;2.54;CA;CALCIUM ION;Neuraminidase;11520;
3K39;C;Crystal Structure of B/Perth Neuraminidase D197E mutant in complex with Peramivir;2.54;CA;CALCIUM ION;Neuraminidase;11520;
3K39;D;Crystal Structure of B/Perth Neuraminidase D197E mutant in complex with Peramivir;2.54;CA;CALCIUM ION;Neuraminidase;11520;
3K39;E;Crystal Structure of B/Perth Neuraminidase D197E mutant in complex with Peramivir;2.54;CA;CALCIUM ION;Neuraminidase;11520;
3K39;F;Crystal Structure of B/Perth Neuraminidase D197E mutant in complex with Peramivir;2.54;CA;CALCIUM ION;Neuraminidase;11520;
3K39;G;Crystal Structure of B/Perth Neuraminidase D197E mutant in complex with Peramivir;2.54;CA;CALCIUM ION;Neuraminidase;11520;
3K39;H;Crystal Structure of B/Perth Neuraminidase D197E mutant in complex with Peramivir;2.54;CA;CALCIUM ION;Neuraminidase;11520;
3K39;I;Crystal Structure of B/Perth Neuraminidase D197E mutant in complex with Peramivir;2.54;CA;CALCIUM ION;Neuraminidase;11520;
3K39;J;Crystal Structure of B/Perth Neuraminidase D197E mutant in complex with Peramivir;2.54;CA;CALCIUM ION;Neuraminidase;11520;
3K39;K;Crystal Structure of B/Perth Neuraminidase D197E mutant in complex with Peramivir;2.54;CA;CALCIUM ION;Neuraminidase;11520;
3K39;L;Crystal Structure of B/Perth Neuraminidase D197E mutant in complex with Peramivir;2.54;CA;CALCIUM ION;Neuraminidase;11520;
3K39;M;Crystal Structure of B/Perth Neuraminidase D197E mutant in complex with Peramivir;2.54;CA;CALCIUM ION;Neuraminidase;11520;
3K39;N;Crystal Structure of B/Perth Neuraminidase D197E mutant in complex with Peramivir;2.54;CA;CALCIUM ION;Neuraminidase;11520;
3K39;O;Crystal Structure of B/Perth Neuraminidase D197E mutant in complex with Peramivir;2.54;CA;CALCIUM ION;Neuraminidase;11520;
3K39;P;Crystal Structure of B/Perth Neuraminidase D197E mutant in complex with Peramivir;2.54;CA;CALCIUM ION;Neuraminidase;11520;
3K3A;A;Crystal Structure of B/Perth Neuraminidase D197E mutant in complex with Oseltamivir;2.59;CA;CALCIUM ION;Neuraminidase;11520;
3K3A;B;Crystal Structure of B/Perth Neuraminidase D197E mutant in complex with Oseltamivir;2.59;CA;CALCIUM ION;Neuraminidase;11520;
3K3A;C;Crystal Structure of B/Perth Neuraminidase D197E mutant in complex with Oseltamivir;2.59;CA;CALCIUM ION;Neuraminidase;11520;
3K3A;D;Crystal Structure of B/Perth Neuraminidase D197E mutant in complex with Oseltamivir;2.59;CA;CALCIUM ION;Neuraminidase;11520;
3K3A;E;Crystal Structure of B/Perth Neuraminidase D197E mutant in complex with Oseltamivir;2.59;CA;CALCIUM ION;Neuraminidase;11520;
3K3A;F;Crystal Structure of B/Perth Neuraminidase D197E mutant in complex with Oseltamivir;2.59;CA;CALCIUM ION;Neuraminidase;11520;
3K3A;G;Crystal Structure of B/Perth Neuraminidase D197E mutant in complex with Oseltamivir;2.59;CA;CALCIUM ION;Neuraminidase;11520;
3K3A;H;Crystal Structure of B/Perth Neuraminidase D197E mutant in complex with Oseltamivir;2.59;CA;CALCIUM ION;Neuraminidase;11520;
3K3A;I;Crystal Structure of B/Perth Neuraminidase D197E mutant in complex with Oseltamivir;2.59;CA;CALCIUM ION;Neuraminidase;11520;
3K3A;J;Crystal Structure of B/Perth Neuraminidase D197E mutant in complex with Oseltamivir;2.59;CA;CALCIUM ION;Neuraminidase;11520;
3K3A;K;Crystal Structure of B/Perth Neuraminidase D197E mutant in complex with Oseltamivir;2.59;CA;CALCIUM ION;Neuraminidase;11520;
3K3A;L;Crystal Structure of B/Perth Neuraminidase D197E mutant in complex with Oseltamivir;2.59;CA;CALCIUM ION;Neuraminidase;11520;
3K3A;M;Crystal Structure of B/Perth Neuraminidase D197E mutant in complex with Oseltamivir;2.59;CA;CALCIUM ION;Neuraminidase;11520;
3K3A;N;Crystal Structure of B/Perth Neuraminidase D197E mutant in complex with Oseltamivir;2.59;CA;CALCIUM ION;Neuraminidase;11520;
3K3A;O;Crystal Structure of B/Perth Neuraminidase D197E mutant in complex with Oseltamivir;2.59;CA;CALCIUM ION;Neuraminidase;11520;
3K3A;P;Crystal Structure of B/Perth Neuraminidase D197E mutant in complex with Oseltamivir;2.59;CA;CALCIUM ION;Neuraminidase;11520;
3K3W;B;Thermostable Penicillin G acylase from Alcaligenes faecalis in orthorhombic form;3.31;CA;CALCIUM ION;Penicillin G acylase;511;
3K5M;A;Crystal structure of E.coli Pol II-abasic DNA-ddGTP Lt(-2, 2) ternary complex;2.04;CA;CALCIUM ION;DNA polymerase II;562;
3K5S;A;Crystal structure of chicken T-cadherin EC1 EC2;2.9;CA;CALCIUM ION;Cadherin-13;9031;
3K5S;B;Crystal structure of chicken T-cadherin EC1 EC2;2.9;CA;CALCIUM ION;Cadherin-13;9031;
3K5T;A;Crystal structure of human diamine oxidase in space group C2221;2.11;CA;CALCIUM ION;Diamine oxidase;9606;
3K6S;A;Structure of integrin alphaXbeta2 ectodomain;3.5;CA;CALCIUM ION;Integrin alpha-X;9606;
3K6S;B;Structure of integrin alphaXbeta2 ectodomain;3.5;CA;CALCIUM ION;Integrin beta-2;9606;
3K6S;C;Structure of integrin alphaXbeta2 ectodomain;3.5;CA;CALCIUM ION;Integrin alpha-X;9606;
3K6S;D;Structure of integrin alphaXbeta2 ectodomain;3.5;CA;CALCIUM ION;Integrin beta-2;9606;
3K6S;E;Structure of integrin alphaXbeta2 ectodomain;3.5;CA;CALCIUM ION;Integrin alpha-X;9606;
3K6S;F;Structure of integrin alphaXbeta2 ectodomain;3.5;CA;CALCIUM ION;Integrin beta-2;9606;
3K6S;G;Structure of integrin alphaXbeta2 ectodomain;3.5;CA;CALCIUM ION;Integrin alpha-X;9606;
3K6S;H;Structure of integrin alphaXbeta2 ectodomain;3.5;CA;CALCIUM ION;Integrin beta-2;9606;
3K70;B;Crystal structure of the complete initiation complex of RecBCD;3.59;CA;CALCIUM ION;Exodeoxyribonuclease V beta chain;562;
3K70;E;Crystal structure of the complete initiation complex of RecBCD;3.59;CA;CALCIUM ION;Exodeoxyribonuclease V beta chain;562;
3K71;A;Structure of integrin alphaX beta2 ectodomain;3.95;CA;CALCIUM ION;Integrin alpha-X;9606;
3K71;B;Structure of integrin alphaX beta2 ectodomain;3.95;CA;CALCIUM ION;Integrin beta-2;9606;
3K71;C;Structure of integrin alphaX beta2 ectodomain;3.95;CA;CALCIUM ION;Integrin alpha-X;9606;
3K71;D;Structure of integrin alphaX beta2 ectodomain;3.95;CA;CALCIUM ION;Integrin beta-2;9606;
3K71;E;Structure of integrin alphaX beta2 ectodomain;3.95;CA;CALCIUM ION;Integrin alpha-X;9606;
3K71;F;Structure of integrin alphaX beta2 ectodomain;3.95;CA;CALCIUM ION;Integrin beta-2;9606;
3K71;G;Structure of integrin alphaX beta2 ectodomain;3.95;CA;CALCIUM ION;Integrin alpha-X;9606;
3K71;H;Structure of integrin alphaX beta2 ectodomain;3.95;CA;CALCIUM ION;Integrin beta-2;9606;
3K72;A;Structure of integrin alphaX beta2;3.7;CA;CALCIUM ION;Integrin alpha-X;9606;
3K72;B;Structure of integrin alphaX beta2;3.7;CA;CALCIUM ION;Integrin beta-2;9606;
3K72;C;Structure of integrin alphaX beta2;3.7;CA;CALCIUM ION;Integrin alpha-X;9606;
3K72;D;Structure of integrin alphaX beta2;3.7;CA;CALCIUM ION;Integrin beta-2;9606;
3K7L;A;Structures of two elapid snake venom metalloproteases with distinct activities highlight the disulfide patterns in the D domain of ADAMalysin family proteins;2.5;CA;CALCIUM ION;Atragin;8656;
3K7N;A;Structures of two elapid snake venom metalloproteases with distinct activities highlight the disulfide patterns in the D domain of ADAMalysin family proteins;2.3;CA;CALCIUM ION;K-like;8656;
3K8K;A;Crystal structure of SusG;2.2;CA;CALCIUM ION;Alpha-amylase, susG;818;
3K8K;B;Crystal structure of SusG;2.2;CA;CALCIUM ION;Alpha-amylase, susG;818;
3K8L;A;Crystal structure of SusG-D498N mutant with maltoheptaose;2.3;CA;CALCIUM ION;Alpha-amylase, susG;818;
3K8L;B;Crystal structure of SusG-D498N mutant with maltoheptaose;2.3;CA;CALCIUM ION;Alpha-amylase, susG;818;
3K8M;A;Crystal structure of SusG with acarbose;2.5;CA;CALCIUM ION;Alpha-amylase, susG;818;
3K8M;B;Crystal structure of SusG with acarbose;2.5;CA;CALCIUM ION;Alpha-amylase, susG;818;
3K8Y;A;Allosteric modulation of H-Ras GTPase;1.3;CA;CALCIUM ION;GTPase HRas;9606;
3K9J;A;Transposase domain of Metnase;1.9;CA;CALCIUM ION;Histone-lysine N-methyltransferase SETMAR;9606;
3K9L;A;Allosteric modulation of H-Ras GTPase;1.8;CA;CALCIUM ION;GTPase HRas;9606;
3K9L;B;Allosteric modulation of H-Ras GTPase;1.8;CA;CALCIUM ION;GTPase HRas;9606;
3K9N;A;Allosteric modulation of H-Ras GTPase;2;CA;CALCIUM ION;GTPase HRas;9606;
3K9X;B;X-ray crystal structure of human fxa in complex with (S)-N-((2-METHYLBENZOFURAN-5-YLAMINO)(2-OXO-1-(2-OXO-2- (PYRROLIDIN-1-YL)ETHYL)AZEPAN-3- YLAMINO)METHYLENE)NICOTINAMIDE;1.9;CA;CALCIUM ION;PROTEIN (Coagulation factor X);9606;
3K9X;D;X-ray crystal structure of human fxa in complex with (S)-N-((2-METHYLBENZOFURAN-5-YLAMINO)(2-OXO-1-(2-OXO-2- (PYRROLIDIN-1-YL)ETHYL)AZEPAN-3- YLAMINO)METHYLENE)NICOTINAMIDE;1.9;CA;CALCIUM ION;PROTEIN (Coagulation factor X);9606;
3KAA;B;Structure of Tim-3 in complex with phosphatidylserine;3;CA;CALCIUM ION;Hepatitis A virus cellular receptor 2;10090;
3KCG;H;Crystal structure of the antithrombin-factor IXa-pentasaccharide complex;1.7;CA;CALCIUM ION;Coagulation factor IXa heavy chain;9606;
3KCP;A;Crystal structure of interacting Clostridium thermocellum multimodular components;1.94;CA;CALCIUM ION;Cellulosomal-scaffolding protein A;1515;
3KEC;A;Crystal Structure of Human MMP-13 complexed with a phenyl-2H-tetrazole compound;2.05;CA;CALCIUM ION;Collagenase 3;9606;
3KEC;B;Crystal Structure of Human MMP-13 complexed with a phenyl-2H-tetrazole compound;2.05;CA;CALCIUM ION;Collagenase 3;9606;
3KEJ;A;Crystal Structure of Human MMP-13 complexed with a (pyridin-4-yl)-2H-tetrazole compound;2.3;CA;CALCIUM ION;Collagenase 3;9606;
3KEJ;B;Crystal Structure of Human MMP-13 complexed with a (pyridin-4-yl)-2H-tetrazole compound;2.3;CA;CALCIUM ION;Collagenase 3;9606;
3KEK;A;Crystal Structure of Human MMP-13 complexed with a (pyridin-4-yl)-2H-tetrazole compound;1.97;CA;CALCIUM ION;Collagenase 3;9606;
3KEK;B;Crystal Structure of Human MMP-13 complexed with a (pyridin-4-yl)-2H-tetrazole compound;1.97;CA;CALCIUM ION;Collagenase 3;9606;
3KEZ;A;Crystal structure of Putative sugar binding protein (YP_001299726.1) from Bacteroides vulgatus ATCC 8482 at 1.90 A resolution;1.9;CA;CALCIUM ION;Putative sugar binding protein;821;
3KEZ;B;Crystal structure of Putative sugar binding protein (YP_001299726.1) from Bacteroides vulgatus ATCC 8482 at 1.90 A resolution;1.9;CA;CALCIUM ION;Putative sugar binding protein;821;
3KF9;A;Crystal structure of the SdCen/skMLCK complex;2.6;CA;CALCIUM ION;Caltractin;3190;
3KF9;C;Crystal structure of the SdCen/skMLCK complex;2.6;CA;CALCIUM ION;Caltractin;3190;
3KFY;A;Dynamic switching and partial occupancies of a small molecule inhibitor complex of DHFR;2.08;CA;CALCIUM ION;Dihydrofolate reductase;562;
3KG6;A;Dehydratase domain from CurF module of Curacin polyketide synthase;2.7;CA;CALCIUM ION;CurF;158786;
3KG6;D;Dehydratase domain from CurF module of Curacin polyketide synthase;2.7;CA;CALCIUM ION;CurF;158786;
3KGG;A;X-ray structure of perdeuterated diisopropyl fluorophosphatase (DFPase): Perdeuteration of proteins for neutron diffraction;2.1;CA;CALCIUM ION;Diisopropyl-fluorophosphatase;6622;
3KH1;A;Crystal structure of Predicted metal-dependent phosphohydrolase (ZP_00055740.2) from Magnetospirillum magnetotacticum MS-1 at 1.37 A resolution;1.37;CA;CALCIUM ION;Predicted metal-dependent phosphohydrolase;188;
3KHE;A;Crystal structure of the calcium-loaded calmodulin-like domain of the CDPK, 541.m00134 from toxoplasma gondii;1.95;CA;CALCIUM ION;Calmodulin-like domain protein kinase isoform 3;5811;
3KHE;B;Crystal structure of the calcium-loaded calmodulin-like domain of the CDPK, 541.m00134 from toxoplasma gondii;1.95;CA;CALCIUM ION;Calmodulin-like domain protein kinase isoform 3;5811;
3KHG;A;Dpo4 extension ternary complex with misinserted A opposite the 2-aminofluorene-guanine [AF]G lesion;2.96;CA;CALCIUM ION;DNA polymerase IV;2287;
3KHG;B;Dpo4 extension ternary complex with misinserted A opposite the 2-aminofluorene-guanine [AF]G lesion;2.96;CA;CALCIUM ION;DNA polymerase IV;2287;
3KHH;A;Dpo4 extension ternary complex with a C base opposite the 2-aminofluorene-guanine [AF]G lesion;2.7;CA;CALCIUM ION;DNA polymerase IV;2287;
3KHH;B;Dpo4 extension ternary complex with a C base opposite the 2-aminofluorene-guanine [AF]G lesion;2.7;CA;CALCIUM ION;DNA polymerase IV;2287;
3KHL;A;Dpo4 post-extension ternary complex with misinserted A opposite the 2-aminofluorene-guanine [AF]G lesion;2.1;CA;CALCIUM ION;DNA polymerase IV;2287;
3KHL;B;Dpo4 post-extension ternary complex with misinserted A opposite the 2-aminofluorene-guanine [AF]G lesion;2.1;CA;CALCIUM ION;DNA polymerase IV;2287;
3KHR;A;Dpo4 post-extension ternary complex with the correct C opposite the 2-aminofluorene-guanine [AF]G lesion;2.01;CA;CALCIUM ION;DNA polymerase IV;2287;
3KHR;B;Dpo4 post-extension ternary complex with the correct C opposite the 2-aminofluorene-guanine [AF]G lesion;2.01;CA;CALCIUM ION;DNA polymerase IV;2287;
3KKF;A;Crystal structure of Putative antibiotic biosynthesis monooxygenase (NP_810307.1) from Bacteriodes thetaiotaomicron VPI-5482 at 1.30 A resolution;1.3;CA;CALCIUM ION;Putative antibiotic biosynthesis monooxygenase;818;
3KL6;A;Discovery of Tetrahydropyrimidin-2(1H)-one derivative TAK-442: A potent, selective and orally active factor Xa inhibitor;1.45;CA;CALCIUM ION;Coagulation Factor X heavy chain;9606;
3KLK;A;Crystal structure of Lactobacillus reuteri N-terminally truncated glucansucrase GTF180 in triclinic apo- form;1.65;CA;CALCIUM ION;Glucansucrase;1598;
3KLL;A;Crystal structure of Lactobacillus reuteri N-terminally truncated glucansucrase GTF180-maltose complex;2;CA;CALCIUM ION;Glucansucrase;1598;
3KLT;B;Crystal structure of a vimentin fragment;2.7;CA;CALCIUM ION;Vimentin;9606;
3KLT;C;Crystal structure of a vimentin fragment;2.7;CA;CALCIUM ION;Vimentin;9606;
3KLT;D;Crystal structure of a vimentin fragment;2.7;CA;CALCIUM ION;Vimentin;9606;
3KM5;A;Crystal Structure Analysis of the K2 Cleaved Adhesin Domain of Lys-gingipain (Kgp);1.4;CA;CALCIUM ION;Lysine specific cysteine protease;837;
3KM5;B;Crystal Structure Analysis of the K2 Cleaved Adhesin Domain of Lys-gingipain (Kgp);1.4;CA;CALCIUM ION;Lysine specific cysteine protease;837;
3KM6;A;Crystal Structure of the Human GST Pi C47S/Y108V Double Mutant in Complex with the Ethacrynic Acid-Glutathione Conjugate;2.1;CA;CALCIUM ION;Glutathione S-transferase P;9606;
3KM6;B;Crystal Structure of the Human GST Pi C47S/Y108V Double Mutant in Complex with the Ethacrynic Acid-Glutathione Conjugate;2.1;CA;CALCIUM ION;Glutathione S-transferase P;9606;
3KMB;1;COMPLEX OF 3'-SULFO-LEWIS-X WITH A SELECTIN-LIKE MUTANT OF MANNOSE-BINDING PROTEIN A;1.95;CA;CALCIUM ION;MANNOSE-BINDING PROTEIN-A;10116;
3KMB;2;COMPLEX OF 3'-SULFO-LEWIS-X WITH A SELECTIN-LIKE MUTANT OF MANNOSE-BINDING PROTEIN A;1.95;CA;CALCIUM ION;MANNOSE-BINDING PROTEIN-A;10116;
3KMB;3;COMPLEX OF 3'-SULFO-LEWIS-X WITH A SELECTIN-LIKE MUTANT OF MANNOSE-BINDING PROTEIN A;1.95;CA;CALCIUM ION;MANNOSE-BINDING PROTEIN-A;10116;
3KMN;A;Crystal Structure of the Human Apo GST Pi C47S/Y108V Double Mutant;1.8;CA;CALCIUM ION;Glutathione S-transferase P;9606;
3KMN;B;Crystal Structure of the Human Apo GST Pi C47S/Y108V Double Mutant;1.8;CA;CALCIUM ION;Glutathione S-transferase P;9606;
3KMO;A;Crystal Structure of the Human GST Pi C47S/Y108V Double Mutant in Complex with the Ethacrynic Acid-Glutathione Conjugate (Grown in the Absence of the Reducing Agent DTT);2.6;CA;CALCIUM ION;Glutathione S-transferase P;9606;
3KMO;B;Crystal Structure of the Human GST Pi C47S/Y108V Double Mutant in Complex with the Ethacrynic Acid-Glutathione Conjugate (Grown in the Absence of the Reducing Agent DTT);2.6;CA;CALCIUM ION;Glutathione S-transferase P;9606;
3KMV;A;Crystal structure of CBM42A from Clostridium thermocellum;1.8;CA;CALCIUM ION;Alpha-L-arabinofuranosidase B;1515;
3KMV;B;Crystal structure of CBM42A from Clostridium thermocellum;1.8;CA;CALCIUM ION;Alpha-L-arabinofuranosidase B;1515;
3KMV;C;Crystal structure of CBM42A from Clostridium thermocellum;1.8;CA;CALCIUM ION;Alpha-L-arabinofuranosidase B;1515;
3KMV;D;Crystal structure of CBM42A from Clostridium thermocellum;1.8;CA;CALCIUM ION;Alpha-L-arabinofuranosidase B;1515;
3KMV;E;Crystal structure of CBM42A from Clostridium thermocellum;1.8;CA;CALCIUM ION;Alpha-L-arabinofuranosidase B;1515;
3KMV;F;Crystal structure of CBM42A from Clostridium thermocellum;1.8;CA;CALCIUM ION;Alpha-L-arabinofuranosidase B;1515;
3KMV;G;Crystal structure of CBM42A from Clostridium thermocellum;1.8;CA;CALCIUM ION;Alpha-L-arabinofuranosidase B;1515;
3KMV;H;Crystal structure of CBM42A from Clostridium thermocellum;1.8;CA;CALCIUM ION;Alpha-L-arabinofuranosidase B;1515;
3KO0;A;Structure of the tfp-ca2+-bound activated form of the s100a4 Metastasis factor;2.3;CA;CALCIUM ION;Protein S100-A4;9606;
3KO0;B;Structure of the tfp-ca2+-bound activated form of the s100a4 Metastasis factor;2.3;CA;CALCIUM ION;Protein S100-A4;9606;
3KO0;C;Structure of the tfp-ca2+-bound activated form of the s100a4 Metastasis factor;2.3;CA;CALCIUM ION;Protein S100-A4;9606;
3KO0;D;Structure of the tfp-ca2+-bound activated form of the s100a4 Metastasis factor;2.3;CA;CALCIUM ION;Protein S100-A4;9606;
3KO0;E;Structure of the tfp-ca2+-bound activated form of the s100a4 Metastasis factor;2.3;CA;CALCIUM ION;Protein S100-A4;9606;
3KO0;F;Structure of the tfp-ca2+-bound activated form of the s100a4 Metastasis factor;2.3;CA;CALCIUM ION;Protein S100-A4;9606;
3KO0;G;Structure of the tfp-ca2+-bound activated form of the s100a4 Metastasis factor;2.3;CA;CALCIUM ION;Protein S100-A4;9606;
3KO0;H;Structure of the tfp-ca2+-bound activated form of the s100a4 Metastasis factor;2.3;CA;CALCIUM ION;Protein S100-A4;9606;
3KO0;I;Structure of the tfp-ca2+-bound activated form of the s100a4 Metastasis factor;2.3;CA;CALCIUM ION;Protein S100-A4;9606;
3KO0;J;Structure of the tfp-ca2+-bound activated form of the s100a4 Metastasis factor;2.3;CA;CALCIUM ION;Protein S100-A4;9606;
3KO0;K;Structure of the tfp-ca2+-bound activated form of the s100a4 Metastasis factor;2.3;CA;CALCIUM ION;Protein S100-A4;9606;
3KO0;L;Structure of the tfp-ca2+-bound activated form of the s100a4 Metastasis factor;2.3;CA;CALCIUM ION;Protein S100-A4;9606;
3KO0;M;Structure of the tfp-ca2+-bound activated form of the s100a4 Metastasis factor;2.3;CA;CALCIUM ION;Protein S100-A4;9606;
3KO0;N;Structure of the tfp-ca2+-bound activated form of the s100a4 Metastasis factor;2.3;CA;CALCIUM ION;Protein S100-A4;9606;
3KO0;O;Structure of the tfp-ca2+-bound activated form of the s100a4 Metastasis factor;2.3;CA;CALCIUM ION;Protein S100-A4;9606;
3KO0;P;Structure of the tfp-ca2+-bound activated form of the s100a4 Metastasis factor;2.3;CA;CALCIUM ION;Protein S100-A4;9606;
3KO0;Q;Structure of the tfp-ca2+-bound activated form of the s100a4 Metastasis factor;2.3;CA;CALCIUM ION;Protein S100-A4;9606;
3KO0;R;Structure of the tfp-ca2+-bound activated form of the s100a4 Metastasis factor;2.3;CA;CALCIUM ION;Protein S100-A4;9606;
3KO0;S;Structure of the tfp-ca2+-bound activated form of the s100a4 Metastasis factor;2.3;CA;CALCIUM ION;Protein S100-A4;9606;
3KO0;T;Structure of the tfp-ca2+-bound activated form of the s100a4 Metastasis factor;2.3;CA;CALCIUM ION;Protein S100-A4;9606;
3KO2;A;I-MsoI re-designed for altered DNA cleavage specificity (-7C);2.9;CA;CALCIUM ION;Site-specific DNA endonuclease I-MsoI;141716;
3KO2;C;I-MsoI re-designed for altered DNA cleavage specificity (-7C);2.9;CA;CALCIUM ION;5'-D(*GP*CP*AP*GP*AP*CP*CP*GP*TP*CP*GP*TP*GP*AP*GP*AP*CP*AP*GP*TP*TP*CP*CP*G)-3';;
3KO2;F;I-MsoI re-designed for altered DNA cleavage specificity (-7C);2.9;CA;CALCIUM ION;Site-specific DNA endonuclease I-MsoI;141716;
3KO2;H;I-MsoI re-designed for altered DNA cleavage specificity (-7C);2.9;CA;CALCIUM ION;5'-D(*GP*CP*AP*GP*AP*CP*CP*GP*TP*CP*GP*TP*GP*AP*GP*AP*CP*AP*GP*TP*TP*CP*CP*G)-3';;
3KPT;B;Crystal structure of BcpA, the major pilin subunit of Bacillus cereus;2.1;CA;CALCIUM ION;Collagen adhesion protein;1396;
3KPX;A;Crystal Structure Analysis of photoprotein clytin;1.9;CA;CALCIUM ION;Apophotoprotein clytin-3;27801;
3KQ4;B;Structure of Intrinsic Factor-Cobalamin bound to its receptor Cubilin;3.3;CA;CALCIUM ION;Cubilin;9606;
3KQ4;D;Structure of Intrinsic Factor-Cobalamin bound to its receptor Cubilin;3.3;CA;CALCIUM ION;Cubilin;9606;
3KQ4;F;Structure of Intrinsic Factor-Cobalamin bound to its receptor Cubilin;3.3;CA;CALCIUM ION;Cubilin;9606;
3KQA;A;MurA dead-end complex with terreic acid;2.25;CA;CALCIUM ION;UDP-N-acetylglucosamine 1-carboxyvinyltransferase;550;
3KQA;B;MurA dead-end complex with terreic acid;2.25;CA;CALCIUM ION;UDP-N-acetylglucosamine 1-carboxyvinyltransferase;550;
3KQA;C;MurA dead-end complex with terreic acid;2.25;CA;CALCIUM ION;UDP-N-acetylglucosamine 1-carboxyvinyltransferase;550;
3KQA;D;MurA dead-end complex with terreic acid;2.25;CA;CALCIUM ION;UDP-N-acetylglucosamine 1-carboxyvinyltransferase;550;
3KQF;A;1.8 Angstrom Resolution Crystal Structure of Enoyl-CoA Hydratase from Bacillus anthracis.;1.8;CA;CALCIUM ION;Enoyl-CoA hydratase/isomerase family protein;1392;
3KQF;D;1.8 Angstrom Resolution Crystal Structure of Enoyl-CoA Hydratase from Bacillus anthracis.;1.8;CA;CALCIUM ION;Enoyl-CoA hydratase/isomerase family protein;1392;
3KQF;E;1.8 Angstrom Resolution Crystal Structure of Enoyl-CoA Hydratase from Bacillus anthracis.;1.8;CA;CALCIUM ION;Enoyl-CoA hydratase/isomerase family protein;1392;
3KQF;F;1.8 Angstrom Resolution Crystal Structure of Enoyl-CoA Hydratase from Bacillus anthracis.;1.8;CA;CALCIUM ION;Enoyl-CoA hydratase/isomerase family protein;1392;
3KQG;A;Trimeric Structure of Langerin;2.3;CA;CALCIUM ION;C-type lectin domain family 4 member K;9606;
3KQG;B;Trimeric Structure of Langerin;2.3;CA;CALCIUM ION;C-type lectin domain family 4 member K;9606;
3KQG;C;Trimeric Structure of Langerin;2.3;CA;CALCIUM ION;C-type lectin domain family 4 member K;9606;
3KQG;D;Trimeric Structure of Langerin;2.3;CA;CALCIUM ION;C-type lectin domain family 4 member K;9606;
3KQG;E;Trimeric Structure of Langerin;2.3;CA;CALCIUM ION;C-type lectin domain family 4 member K;9606;
3KQG;F;Trimeric Structure of Langerin;2.3;CA;CALCIUM ION;C-type lectin domain family 4 member K;9606;
3KQR;A;The structure of serum amyloid p component bound to phosphoethanolamine;1.5;CA;CALCIUM ION;Serum amyloid P-component;9606;
3KQR;B;The structure of serum amyloid p component bound to phosphoethanolamine;1.5;CA;CALCIUM ION;Serum amyloid P-component;9606;
3KQR;C;The structure of serum amyloid p component bound to phosphoethanolamine;1.5;CA;CALCIUM ION;Serum amyloid P-component;9606;
3KQR;D;The structure of serum amyloid p component bound to phosphoethanolamine;1.5;CA;CALCIUM ION;Serum amyloid P-component;9606;
3KQR;E;The structure of serum amyloid p component bound to phosphoethanolamine;1.5;CA;CALCIUM ION;Serum amyloid P-component;9606;
3KRQ;A;Crystal structure of the complex of lactoperoxidase with a potent inhibitor amino-triazole at 2.2a resolution;2.25;CA;CALCIUM ION;Lactoperoxidase;9913;
3KRY;A;Crystal structure of MMP-13 in complex with SC-78080;1.9;CA;CALCIUM ION;Collagenase 3;9606;
3KRY;B;Crystal structure of MMP-13 in complex with SC-78080;1.9;CA;CALCIUM ION;Collagenase 3;9606;
3KRY;C;Crystal structure of MMP-13 in complex with SC-78080;1.9;CA;CALCIUM ION;Collagenase 3;9606;
3KRY;D;Crystal structure of MMP-13 in complex with SC-78080;1.9;CA;CALCIUM ION;Collagenase 3;9606;
3KST;A;Crystal structure of Endo-1,4-beta-xylanase (NP_811807.1) from BACTEROIDES THETAIOTAOMICRON VPI-5482 at 1.70 A resolution;1.7;CA;CALCIUM ION;Endo-1,4-beta-xylanase;818;
3KST;B;Crystal structure of Endo-1,4-beta-xylanase (NP_811807.1) from BACTEROIDES THETAIOTAOMICRON VPI-5482 at 1.70 A resolution;1.7;CA;CALCIUM ION;Endo-1,4-beta-xylanase;818;
3KTB;D;Crystal Structure of Arsenical Resistance Operon Trans-acting Repressor from Bacteroides vulgatus ATCC 8482;2.1;CA;CALCIUM ION;Arsenical resistance operon trans-acting repressor;821;
3KTU;A;Structure of human 8-oxoGuanine Glycosylase 1 bound to fluorninated oxoG-containing DNA;2.3;CA;CALCIUM ION;N-glycosylase/DNA lyase;9606;
3KTU;C;Structure of human 8-oxoGuanine Glycosylase 1 bound to fluorninated oxoG-containing DNA;2.3;CA;CALCIUM ION;DNA (5'-D(*GP*TP*CP*CP*AP*(FDG)P*GP*TP*CP*TP*AP*C)-3');32630;
3KUC;B;Complex of Rap1A(E30D/K31E)GDP with RafRBD(A85K/N71R);1.92;CA;CALCIUM ION;RAF proto-oncogene serine/threonine-protein kinase;9606;
3KWV;A;Structural basis for the unfolding of anthrax lethal factor by protective antigen oligomers;3.1;CA;CALCIUM ION;Protective antigen PA-63;1392;
3KWV;B;Structural basis for the unfolding of anthrax lethal factor by protective antigen oligomers;3.1;CA;CALCIUM ION;Protective antigen PA-63;1392;
3KWV;D;Structural basis for the unfolding of anthrax lethal factor by protective antigen oligomers;3.1;CA;CALCIUM ION;Protective antigen PA-63;1392;
3KWV;E;Structural basis for the unfolding of anthrax lethal factor by protective antigen oligomers;3.1;CA;CALCIUM ION;Protective antigen PA-63;1392;
3KWX;A;Chemically modified Taka alpha-amylase;2.4;CA;CALCIUM ION;Alpha-amylase A type-1/2;5062;
3KXZ;A;The complex crystal structure of LCK with a probe molecule w259;2.37;CA;CALCIUM ION;Proto-oncogene tyrosine-protein kinase LCK;9606;
3KZI;F;Crystal Structure of Monomeric Form of Cyanobacterial Photosystem II;3.6;CA;CALCIUM ION;Cytochrome b559 subunit beta;146786;
3KZI;K;Crystal Structure of Monomeric Form of Cyanobacterial Photosystem II;3.6;CA;CALCIUM ION;Photosystem II reaction center protein K;146786;
3KZI;O;Crystal Structure of Monomeric Form of Cyanobacterial Photosystem II;3.6;CA;CALCIUM ION;Photosystem II manganese-stabilizing polypeptide;146786;
3KZP;A;Crystal structure of putative diguanylate cyclase/phosphodiesterase from Listaria monocytigenes;2;CA;CALCIUM ION;Putative diguanylate cyclase/phosphodiesterase;1639;
3KZP;B;Crystal structure of putative diguanylate cyclase/phosphodiesterase from Listaria monocytigenes;2;CA;CALCIUM ION;Putative diguanylate cyclase/phosphodiesterase;1639;
3L19;A;Crystal structure of calcium binding domain of CpCDPK3, cgd5_820;2.14;CA;CALCIUM ION;Calcium/calmodulin dependent protein kinase with a kinase domain and 4 calmodulin like EF hands;5807;
3L19;B;Crystal structure of calcium binding domain of CpCDPK3, cgd5_820;2.14;CA;CALCIUM ION;Calcium/calmodulin dependent protein kinase with a kinase domain and 4 calmodulin like EF hands;5807;
3L1K;A;SAD structure solution of proteinase K grown in potassium tellurate solution;1.55;CA;CALCIUM ION;Proteinase K;37998;
3L1T;A;E. coli NrfA sulfite ocmplex;2.3;CA;CALCIUM ION;Cytochrome c-552;562;
3L1T;B;E. coli NrfA sulfite ocmplex;2.3;CA;CALCIUM ION;Cytochrome c-552;562;
3L1T;C;E. coli NrfA sulfite ocmplex;2.3;CA;CALCIUM ION;Cytochrome c-552;562;
3L1T;D;E. coli NrfA sulfite ocmplex;2.3;CA;CALCIUM ION;Cytochrome c-552;562;
3L1U;A;Crystal structure of Calcium-bound GmhB from E. coli.;1.95;CA;CALCIUM ION;D,D-heptose 1,7-bisphosphate phosphatase;562;
3L1U;B;Crystal structure of Calcium-bound GmhB from E. coli.;1.95;CA;CALCIUM ION;D,D-heptose 1,7-bisphosphate phosphatase;562;
3L1V;A;Crystal structure of GmhB from E. coli in complex with calcium and phosphate.;1.95;CA;CALCIUM ION;D,D-heptose 1,7-bisphosphate phosphatase;562;
3L1V;B;Crystal structure of GmhB from E. coli in complex with calcium and phosphate.;1.95;CA;CALCIUM ION;D,D-heptose 1,7-bisphosphate phosphatase;562;
3L2L;A;X-ray Crystallographic Analysis of Pig Pancreatic Alpha-Amylase with Limit Dextrin and Oligosaccharide;2.11;CA;CALCIUM ION;Pancreatic alpha-amylase;9823;
3L2M;A;X-ray Crystallographic Analysis of Pig Pancreatic Alpha-Amylase with Alpha-cyclodextrin;1.97;CA;CALCIUM ION;Pancreatic alpha-amylase;9823;
3L2N;A;Crystal structure of Putative carboxypeptidase A (YP_562911.1) from SHEWANELLA DENITRIFICANS OS-217 at 2.39 A resolution;2.39;CA;CALCIUM ION;Peptidase M14, carboxypeptidase A;192073;
3L2N;B;Crystal structure of Putative carboxypeptidase A (YP_562911.1) from SHEWANELLA DENITRIFICANS OS-217 at 2.39 A resolution;2.39;CA;CALCIUM ION;Peptidase M14, carboxypeptidase A;192073;
3L2Y;A;The structure of C-reactive protein bound to phosphoethanolamine;2.7;CA;CALCIUM ION;C-reactive protein;9606;
3L2Y;B;The structure of C-reactive protein bound to phosphoethanolamine;2.7;CA;CALCIUM ION;C-reactive protein;9606;
3L2Y;C;The structure of C-reactive protein bound to phosphoethanolamine;2.7;CA;CALCIUM ION;C-reactive protein;9606;
3L2Y;D;The structure of C-reactive protein bound to phosphoethanolamine;2.7;CA;CALCIUM ION;C-reactive protein;9606;
3L2Y;E;The structure of C-reactive protein bound to phosphoethanolamine;2.7;CA;CALCIUM ION;C-reactive protein;9606;
3L2Y;F;The structure of C-reactive protein bound to phosphoethanolamine;2.7;CA;CALCIUM ION;C-reactive protein;9606;
3L2Y;G;The structure of C-reactive protein bound to phosphoethanolamine;2.7;CA;CALCIUM ION;C-reactive protein;9606;
3L2Y;H;The structure of C-reactive protein bound to phosphoethanolamine;2.7;CA;CALCIUM ION;C-reactive protein;9606;
3L2Y;I;The structure of C-reactive protein bound to phosphoethanolamine;2.7;CA;CALCIUM ION;C-reactive protein;9606;
3L2Y;J;The structure of C-reactive protein bound to phosphoethanolamine;2.7;CA;CALCIUM ION;C-reactive protein;9606;
3L2Y;K;The structure of C-reactive protein bound to phosphoethanolamine;2.7;CA;CALCIUM ION;C-reactive protein;9606;
3L2Y;L;The structure of C-reactive protein bound to phosphoethanolamine;2.7;CA;CALCIUM ION;C-reactive protein;9606;
3L2Y;M;The structure of C-reactive protein bound to phosphoethanolamine;2.7;CA;CALCIUM ION;C-reactive protein;9606;
3L2Y;N;The structure of C-reactive protein bound to phosphoethanolamine;2.7;CA;CALCIUM ION;C-reactive protein;9606;
3L2Y;O;The structure of C-reactive protein bound to phosphoethanolamine;2.7;CA;CALCIUM ION;C-reactive protein;9606;
3L2Y;P;The structure of C-reactive protein bound to phosphoethanolamine;2.7;CA;CALCIUM ION;C-reactive protein;9606;
3L2Y;Q;The structure of C-reactive protein bound to phosphoethanolamine;2.7;CA;CALCIUM ION;C-reactive protein;9606;
3L2Y;R;The structure of C-reactive protein bound to phosphoethanolamine;2.7;CA;CALCIUM ION;C-reactive protein;9606;
3L2Y;S;The structure of C-reactive protein bound to phosphoethanolamine;2.7;CA;CALCIUM ION;C-reactive protein;9606;
3L2Y;T;The structure of C-reactive protein bound to phosphoethanolamine;2.7;CA;CALCIUM ION;C-reactive protein;9606;
3L30;A;Crystal structure of porcine pancreatic phospholipase A2 complexed with dihydroxyberberine;2.4;CA;CALCIUM ION;Phospholipase A2, major isoenzyme;9823;
3L33;A;Human mesotrypsin complexed with amyloid precursor protein inhibitor(APPI);2.48;CA;CALCIUM ION;Trypsin-3;9606;
3L33;B;Human mesotrypsin complexed with amyloid precursor protein inhibitor(APPI);2.48;CA;CALCIUM ION;Trypsin-3;9606;
3L33;C;Human mesotrypsin complexed with amyloid precursor protein inhibitor(APPI);2.48;CA;CALCIUM ION;Trypsin-3;9606;
3L33;D;Human mesotrypsin complexed with amyloid precursor protein inhibitor(APPI);2.48;CA;CALCIUM ION;Trypsin-3;9606;
3L3T;A;Human mesotrypsin complexed with amyloid precursor protein inhibitor variant (APPIR15K);2.38;CA;CALCIUM ION;PRSS3 protein;9606;
3L3T;B;Human mesotrypsin complexed with amyloid precursor protein inhibitor variant (APPIR15K);2.38;CA;CALCIUM ION;PRSS3 protein;9606;
3L3T;C;Human mesotrypsin complexed with amyloid precursor protein inhibitor variant (APPIR15K);2.38;CA;CALCIUM ION;PRSS3 protein;9606;
3L3T;D;Human mesotrypsin complexed with amyloid precursor protein inhibitor variant (APPIR15K);2.38;CA;CALCIUM ION;PRSS3 protein;9606;
3L4M;A;Crystal Structure of the MauG/pre-Methylamine Dehydrogenase Complex.;2.02;CA;CALCIUM ION;Methylamine utilization protein mauG;266;
3L4M;B;Crystal Structure of the MauG/pre-Methylamine Dehydrogenase Complex.;2.02;CA;CALCIUM ION;Methylamine utilization protein mauG;266;
3L4O;A;Crystal Structure of the MauG/pre-Methylamine Dehydrogenase Complex After Treatment with Hydrogen Peroxide;2.05;CA;CALCIUM ION;Methylamine utilization protein mauG;266;
3L4O;B;Crystal Structure of the MauG/pre-Methylamine Dehydrogenase Complex After Treatment with Hydrogen Peroxide;2.05;CA;CALCIUM ION;Methylamine utilization protein mauG;266;
3L4P;A;Crystal structure of the Aldehyde Dehydrogenase (a.k.a. AOR or MOP) of Desulfovibrio gigas covalently bound to [AsO3]-;1.45;CA;CALCIUM ION;Aldehyde oxidoreductase;879;
3L7F;D;Structure of IL-13 antibody H2L6, A humanized variant OF C836;2.6;CA;CALCIUM ION;H2L6 LIGHT CHAIN;9606;
3L8Y;A;Complex of Ras with cyclen;2.02;CA;CALCIUM ION;GTPase HRas;9606;
3L8Z;A;H-Ras wildtype new crystal form;1.44;CA;CALCIUM ION;GTPase HRas;9606;
3L95;X;Crystal structure of the human Notch1 Negative Regulatory Region (NRR) bound to the fab fragment of an antagonist antibody;2.19;CA;CALCIUM ION;Neurogenic locus notch homolog protein 1;9606;
3L95;Y;Crystal structure of the human Notch1 Negative Regulatory Region (NRR) bound to the fab fragment of an antagonist antibody;2.19;CA;CALCIUM ION;Neurogenic locus notch homolog protein 1;9606;
3L9I;C;Myosin VI nucleotide-free (mdinsert2) L310G mutant crystal structure;2.2;CA;CALCIUM ION;Calmodulin;7227;
3LA6;A;Octameric kinase domain of the E. coli tyrosine kinase Wzc with bound ADP;3.2;CA;CALCIUM ION;Tyrosine-protein kinase wzc;562;
3LA6;B;Octameric kinase domain of the E. coli tyrosine kinase Wzc with bound ADP;3.2;CA;CALCIUM ION;Tyrosine-protein kinase wzc;562;
3LA6;C;Octameric kinase domain of the E. coli tyrosine kinase Wzc with bound ADP;3.2;CA;CALCIUM ION;Tyrosine-protein kinase wzc;562;
3LA6;D;Octameric kinase domain of the E. coli tyrosine kinase Wzc with bound ADP;3.2;CA;CALCIUM ION;Tyrosine-protein kinase wzc;562;
3LA6;E;Octameric kinase domain of the E. coli tyrosine kinase Wzc with bound ADP;3.2;CA;CALCIUM ION;Tyrosine-protein kinase wzc;562;
3LA6;F;Octameric kinase domain of the E. coli tyrosine kinase Wzc with bound ADP;3.2;CA;CALCIUM ION;Tyrosine-protein kinase wzc;562;
3LA6;G;Octameric kinase domain of the E. coli tyrosine kinase Wzc with bound ADP;3.2;CA;CALCIUM ION;Tyrosine-protein kinase wzc;562;
3LA6;H;Octameric kinase domain of the E. coli tyrosine kinase Wzc with bound ADP;3.2;CA;CALCIUM ION;Tyrosine-protein kinase wzc;562;
3LA6;I;Octameric kinase domain of the E. coli tyrosine kinase Wzc with bound ADP;3.2;CA;CALCIUM ION;Tyrosine-protein kinase wzc;562;
3LA6;J;Octameric kinase domain of the E. coli tyrosine kinase Wzc with bound ADP;3.2;CA;CALCIUM ION;Tyrosine-protein kinase wzc;562;
3LA6;K;Octameric kinase domain of the E. coli tyrosine kinase Wzc with bound ADP;3.2;CA;CALCIUM ION;Tyrosine-protein kinase wzc;562;
3LA6;L;Octameric kinase domain of the E. coli tyrosine kinase Wzc with bound ADP;3.2;CA;CALCIUM ION;Tyrosine-protein kinase wzc;562;
3LA6;M;Octameric kinase domain of the E. coli tyrosine kinase Wzc with bound ADP;3.2;CA;CALCIUM ION;Tyrosine-protein kinase wzc;562;
3LA6;N;Octameric kinase domain of the E. coli tyrosine kinase Wzc with bound ADP;3.2;CA;CALCIUM ION;Tyrosine-protein kinase wzc;562;
3LA6;O;Octameric kinase domain of the E. coli tyrosine kinase Wzc with bound ADP;3.2;CA;CALCIUM ION;Tyrosine-protein kinase wzc;562;
3LA6;P;Octameric kinase domain of the E. coli tyrosine kinase Wzc with bound ADP;3.2;CA;CALCIUM ION;Tyrosine-protein kinase wzc;562;
3LAG;A;The crystal structure of a functionally unknown protein RPA4178 from Rhodopseudomonas palustris CGA009;1.15;CA;CALCIUM ION;uncharacterized protein RPA4178;1076;
3LB6;C;The structure of IL-13 in complex with IL-13Ralpha2;3.05;CA;CALCIUM ION;Interleukin-13 receptor subunit alpha-2;9606;
3LB6;D;The structure of IL-13 in complex with IL-13Ralpha2;3.05;CA;CALCIUM ION;Interleukin-13 receptor subunit alpha-2;9606;
3LBH;A;Ras soaked in Calcium Acetate;1.85;CA;CALCIUM ION;GTPase HRas;9606;
3LBI;A;Ras soaked in Magnesium Acetate and back soaked in Calcium Acetate;2.09;CA;CALCIUM ION;GTPase HRas;9606;
3LBN;A;Ras soaked in Magnesium Acetate;1.86;CA;CALCIUM ION;GTPase HRas;9606;
3LC3;A;Benzothiophene Inhibitors of Factor IXa;1.9;CA;CALCIUM ION;Coagulation factor IX;9606;
3LC3;C;Benzothiophene Inhibitors of Factor IXa;1.9;CA;CALCIUM ION;Coagulation factor IX;9606;
3LC5;A;Selective Benzothiophine Inhibitors of Factor IXa;2.62;CA;CALCIUM ION;Coagulation factor IX;9606;
3LCP;A;Crystal structure of the carbohydrate recognition domain of LMAN1 in complex with MCFD2;2.45;CA;CALCIUM ION;Protein ERGIC-53;9606;
3LCP;B;Crystal structure of the carbohydrate recognition domain of LMAN1 in complex with MCFD2;2.45;CA;CALCIUM ION;Protein ERGIC-53;9606;
3LCP;C;Crystal structure of the carbohydrate recognition domain of LMAN1 in complex with MCFD2;2.45;CA;CALCIUM ION;Multiple coagulation factor deficiency protein 2;9606;
3LCP;D;Crystal structure of the carbohydrate recognition domain of LMAN1 in complex with MCFD2;2.45;CA;CALCIUM ION;Multiple coagulation factor deficiency protein 2;9606;
3LDY;A;An extraordinary mechanism of DNA perturbation exhibited by the rare-cutting HNH restriction endonuclease PacI;1.97;CA;CALCIUM ION;restriction endonuclease PacI;43263;
3LE0;A;Lectin Domain of Lectinolysin complexed with Glycerol;1.91;CA;CALCIUM ION;Platelet aggregation factor Sm-hPAF;28037;
3LEG;A;Lectin Domain of Lectinolysin complexed with Lewis Y Antigen;2.01;CA;CALCIUM ION;Platelet aggregation factor Sm-hPAF;28037;
3LEI;A;Lectin Domain of Lectinolysin complexed with Fucose;1.9;CA;CALCIUM ION;Platelet aggregation factor Sm-hPAF;28037;
3LEK;A;Lectin Domain of Lectinolysin complexed with Lewis B Antigen;2;CA;CALCIUM ION;Platelet aggregation factor Sm-hPAF;28037;
3LEZ;A;Crystal structure of a halotolerant bacterial beta-lactamase;1.25;CA;CALCIUM ION;Beta-lactamase;182710;
3LG1;A;Structure of the Thioalkalivibrio nitratireducens cytochrome c nitrite reductase reduced by sodium borohydride (in complex with sulfite);1.95;CA;CALCIUM ION;Eight-heme nitrite reductase;186931;
3LG1;B;Structure of the Thioalkalivibrio nitratireducens cytochrome c nitrite reductase reduced by sodium borohydride (in complex with sulfite);1.95;CA;CALCIUM ION;Eight-heme nitrite reductase;186931;
3LGJ;A;Crystal structure of single-stranded binding protein (ssb) from Bartonella henselae;2.5;CA;CALCIUM ION;Single-stranded DNA-binding protein;38323;
3LGQ;A;Structure of the Thioalkalivibrio nitratireducens cytochrome c nitrite reductase in complex with sulfite (modified Tyr-303);1.8;CA;CALCIUM ION;Eight-heme nitrite reductase;186931;
3LGQ;B;Structure of the Thioalkalivibrio nitratireducens cytochrome c nitrite reductase in complex with sulfite (modified Tyr-303);1.8;CA;CALCIUM ION;Eight-heme nitrite reductase;186931;
3LHM;A;CRYSTAL STRUCTURES OF THE APO-AND HOLOMUTANT HUMAN LYSOZYMES WITH AN INTRODUCED CA2+ BINDING SITE;1.8;CA;CALCIUM ION;HUMAN LYSOZYME;9606;
3LI3;A;Diisopropyl fluorophosphatase (DFPase), D121E mutant;1.66;CA;CALCIUM ION;Diisopropyl-fluorophosphatase;6622;
3LI4;A;Diisopropyl fluorophosphatase (DFPase), N120D,N175D,D229N mutant;1.35;CA;CALCIUM ION;Diisopropyl-fluorophosphatase;6622;
3LI5;A;Diisopropyl fluorophosphatase (DFPase), E21Q,N120D,N175D,D229N mutant;1.36;CA;CALCIUM ION;Diisopropyl-fluorophosphatase;6622;
3LI6;A;Crystal structure and trimer-monomer transition of N-terminal domain of EhCaBP1 from Entamoeba histolytica;2.5;CA;CALCIUM ION;Calcium-binding protein;5759;
3LI6;D;Crystal structure and trimer-monomer transition of N-terminal domain of EhCaBP1 from Entamoeba histolytica;2.5;CA;CALCIUM ION;Calcium-binding protein;5759;
3LI6;G;Crystal structure and trimer-monomer transition of N-terminal domain of EhCaBP1 from Entamoeba histolytica;2.5;CA;CALCIUM ION;Calcium-binding protein;5759;
3LI6;J;Crystal structure and trimer-monomer transition of N-terminal domain of EhCaBP1 from Entamoeba histolytica;2.5;CA;CALCIUM ION;Calcium-binding protein;5759;
3LIJ;A;Crystal structure of full length CpCDPK3 (cgd5_820) in complex with Ca2+ and AMPPNP;1.9;CA;CALCIUM ION;Calcium/calmodulin dependent protein kinase with a kinase domain and 4 calmodulin like EF hands;5807;
3LIK;A;Human MMP12 in complex with non-zinc chelating inhibitor;1.8;CA;CALCIUM ION;Macrophage metalloelastase;9606;
3LIL;A;Human MMP12 in complex with non-zinc chelating inhibitor;1.8;CA;CALCIUM ION;Macrophage metalloelastase;9606;
3LIP;A;OPEN CONFORMATION OF PSEUDOMONAS CEPACIA LIPASE;2;CA;CALCIUM ION;TRIACYL-GLYCEROL-HYDROLASE;292;
3LIR;A;Human MMP12 in complex with non-zinc chelating inhibitor;1.9;CA;CALCIUM ION;Macrophage metalloelastase;9606;
3LIW;A;Factor XA in complex with (R)-2-(1-ADAMANTYLCARBAMOYLAMINO)-3-(3-CARBAMIDOYL-PHENYL)-N-PHENETHYL-PROPIONIC ACID AMIDE;2.22;CA;CALCIUM ION;Activated factor Xa heavy chain;9606;
3LJG;A;Human MMP12 in complex with non-zinc chelating inhibitor;1.31;CA;CALCIUM ION;Macrophage metalloelastase;9606;
3LJJ;A;Bovine trypsin in complex with UB-THR 10;1.55;CA;CALCIUM ION;Cationic trypsin;9913;
3LJK;A;Glucose-6-phosphate isomerase from Francisella tularensis.;1.48;CA;CALCIUM ION;Glucose-6-phosphate isomerase;263;
3LJM;B;Structure of de novo designed apo peptide coil SER L9C;1.36;CA;CALCIUM ION;COIL SER L9C;;
3LJO;A;Bovine trypsin in complex with UB-THR 11;1.5;CA;CALCIUM ION;Cationic trypsin;9913;
3LJT;A;Crystal Structure of the Catalytic Domain of ADAMTS-5 in Complex with an Amino-2-indanol compound;1.6;CA;CALCIUM ION;A disintegrin and metalloproteinase with thrombospondin motifs 5;9606;
3LJZ;A;Crystal Structure of Human MMP-13 complexed with an Amino-2-indanol compound;2;CA;CALCIUM ION;Collagenase 3;9606;
3LJZ;B;Crystal Structure of Human MMP-13 complexed with an Amino-2-indanol compound;2;CA;CALCIUM ION;Collagenase 3;9606;
3LJZ;C;Crystal Structure of Human MMP-13 complexed with an Amino-2-indanol compound;2;CA;CALCIUM ION;Collagenase 3;9606;
3LJZ;D;Crystal Structure of Human MMP-13 complexed with an Amino-2-indanol compound;2;CA;CALCIUM ION;Collagenase 3;9606;
3LK0;A;X-ray structure of bovine SC0067,Ca(2+)-S100B;2.04;CA;CALCIUM ION;Protein S100-B;9913;
3LK0;B;X-ray structure of bovine SC0067,Ca(2+)-S100B;2.04;CA;CALCIUM ION;Protein S100-B;9913;
3LK0;C;X-ray structure of bovine SC0067,Ca(2+)-S100B;2.04;CA;CALCIUM ION;Protein S100-B;9913;
3LK0;D;X-ray structure of bovine SC0067,Ca(2+)-S100B;2.04;CA;CALCIUM ION;Protein S100-B;9913;
3LK1;A;X-ray structure of bovine SC0322,Ca(2+)-S100B;1.79;CA;CALCIUM ION;Protein S100-B;9913;
3LK8;A;Crystal structure of the catalytic domain of human MMP12 complexed with the inhibitor paramethoxy-sulfonyl-glycine hydroxamate;1.8;CA;CALCIUM ION;Macrophage metalloelastase;9606;
3LKA;A;Catalytic domain of human MMP-12 complexed with hydroxamic acid and paramethoxy-sulfonyl amide;1.8;CA;CALCIUM ION;Macrophage metalloelastase;9606;
3LL8;B;Crystal Structure of Calcineurin in Complex with AKAP79 Peptide;2;CA;CALCIUM ION;Calcineurin subunit B type 1;9606;
3LL8;D;Crystal Structure of Calcineurin in Complex with AKAP79 Peptide;2;CA;CALCIUM ION;Calcineurin subunit B type 1;9606;
3LLE;A;X-ray structure of bovine SC0322,Ca(2+)-S100B;1.85;CA;CALCIUM ION;Protein S100-B;9913;
3LLE;B;X-ray structure of bovine SC0322,Ca(2+)-S100B;1.85;CA;CALCIUM ION;Protein S100-B;9913;
3LLL;A;Crystal structure of mouse pacsin2 F-BAR domain;3.3;CA;CALCIUM ION;Protein kinase C and casein kinase substrate in neurons protein 2;10090;
3LLL;B;Crystal structure of mouse pacsin2 F-BAR domain;3.3;CA;CALCIUM ION;Protein kinase C and casein kinase substrate in neurons protein 2;10090;
3LMS;A;Structure of human activated thrombin-activatable fibrinolysis inhibitor, TAFIa, in complex with tick-derived funnelin inhibitor, TCI.;2.5;CA;CALCIUM ION;Carboxypeptidase B2;9606;
3LMW;A;Crystal structure of iota-carrageenase family GH82 from A. fortis in absence of chloride ions;2.6;CA;CALCIUM ION;Iota-carrageenase, CgiA;116059;
3LND;A;Crystal structure of cadherin-6 EC12 W4A;2.82;CA;CALCIUM ION;Cdh6 protein;10090;
3LND;B;Crystal structure of cadherin-6 EC12 W4A;2.82;CA;CALCIUM ION;Cdh6 protein;10090;
3LND;C;Crystal structure of cadherin-6 EC12 W4A;2.82;CA;CALCIUM ION;Cdh6 protein;10090;
3LND;D;Crystal structure of cadherin-6 EC12 W4A;2.82;CA;CALCIUM ION;Cdh6 protein;10090;
3LNE;A;Crystal structure of E-cadherin EC12 K14E;2;CA;CALCIUM ION;Cadherin-1;10090;
3LNF;A;Crystal structure of E-cadherin EC12 K14EW2A;2.5;CA;CALCIUM ION;Cadherin-1;10090;
3LNF;B;Crystal structure of E-cadherin EC12 K14EW2A;2.5;CA;CALCIUM ION;Cadherin-1;10090;
3LNG;A;Crystal structure of E-cadherin EC12 AA extension;2.7;CA;CALCIUM ION;Cadherin-1;10090;
3LNG;B;Crystal structure of E-cadherin EC12 AA extension;2.7;CA;CALCIUM ION;Cadherin-1;10090;
3LNH;A;Crystal structure of E-cadherin EC12 W2A;2.6;CA;CALCIUM ION;Cadherin-1;10090;
3LNH;B;Crystal structure of E-cadherin EC12 W2A;2.6;CA;CALCIUM ION;Cadherin-1;10090;
3LNI;A;Crystal structure of E-cadherin EC12 E89A;2.3;CA;CALCIUM ION;Cadherin-1;10090;
3LNI;B;Crystal structure of E-cadherin EC12 E89A;2.3;CA;CALCIUM ION;Cadherin-1;10090;
3LNP;A;Crystal Structure of Amidohydrolase family Protein OLEI01672_1_465 from Oleispira antarctica;2.1;CA;CALCIUM ION;Amidohydrolase family Protein OLEI01672_1_465;188908;
3LO5;A;Crystal Structure of the dominant negative S17N mutant of Ras;2.57;CA;CALCIUM ION;GTPase HRas;9606;
3LO5;C;Crystal Structure of the dominant negative S17N mutant of Ras;2.57;CA;CALCIUM ION;GTPase HRas;9606;
3LO5;E;Crystal Structure of the dominant negative S17N mutant of Ras;2.57;CA;CALCIUM ION;GTPase HRas;9606;
3LOR;B;The Crystal Structure of a Thiol-disulfide Isomerase from Corynebacterium glutamicum to 2.2A;2.2;CA;CALCIUM ION;Thiol-disulfide isomerase and thioredoxins;1718;
3LP9;A;Crystal structure of LS24, A Seed Albumin from Lathyrus sativus;2.2;CA;CALCIUM ION;LS-24;3860;
3LP9;B;Crystal structure of LS24, A Seed Albumin from Lathyrus sativus;2.2;CA;CALCIUM ION;LS-24;3860;
3LP9;C;Crystal structure of LS24, A Seed Albumin from Lathyrus sativus;2.2;CA;CALCIUM ION;LS-24;3860;
3LP9;D;Crystal structure of LS24, A Seed Albumin from Lathyrus sativus;2.2;CA;CALCIUM ION;LS-24;3860;
3LPA;A;Crystal structure of a subtilisin-like protease;2;CA;CALCIUM ION;Acidic extracellular subtilisin-like protease AprV2;870;
3LPC;A;Crystal structure of a subtilisin-like protease;1.7;CA;CALCIUM ION;AprB2;870;
3LPD;A;Crystal structure of a subtilisin-like protease;2.1;CA;CALCIUM ION;Acidic extracellular subtilisin-like protease AprV2;870;
3LPT;A;HIV integrase;2;CA;CALCIUM ION;Integrase;11676;
3LPU;A;HIV integrase;1.95;CA;CALCIUM ION;Integrase;11676;
3LS7;A;Crystal structure of Thermolysin in complex with Xenon;1.98;CA;CALCIUM ION;Thermolysin;1427;
3LTL;A;Crystal structure of human BIG1 Sec7 domain;2.2;CA;CALCIUM ION;Brefeldin A-inhibited guanine nucleotide-exchange protein 1;9606;
3LUB;A;Crystal structure of Putative creatinine amidohydrolase (YP_211512.1) from Bacteroides fragilis NCTC 9343 at 2.11 A resolution;2.11;CA;CALCIUM ION;Putative creatinine amidohydrolase;817;
3LUB;C;Crystal structure of Putative creatinine amidohydrolase (YP_211512.1) from Bacteroides fragilis NCTC 9343 at 2.11 A resolution;2.11;CA;CALCIUM ION;Putative creatinine amidohydrolase;817;
3LUB;D;Crystal structure of Putative creatinine amidohydrolase (YP_211512.1) from Bacteroides fragilis NCTC 9343 at 2.11 A resolution;2.11;CA;CALCIUM ION;Putative creatinine amidohydrolase;817;
3LUB;E;Crystal structure of Putative creatinine amidohydrolase (YP_211512.1) from Bacteroides fragilis NCTC 9343 at 2.11 A resolution;2.11;CA;CALCIUM ION;Putative creatinine amidohydrolase;817;
3LUB;F;Crystal structure of Putative creatinine amidohydrolase (YP_211512.1) from Bacteroides fragilis NCTC 9343 at 2.11 A resolution;2.11;CA;CALCIUM ION;Putative creatinine amidohydrolase;817;
3LUB;G;Crystal structure of Putative creatinine amidohydrolase (YP_211512.1) from Bacteroides fragilis NCTC 9343 at 2.11 A resolution;2.11;CA;CALCIUM ION;Putative creatinine amidohydrolase;817;
3LUB;I;Crystal structure of Putative creatinine amidohydrolase (YP_211512.1) from Bacteroides fragilis NCTC 9343 at 2.11 A resolution;2.11;CA;CALCIUM ION;Putative creatinine amidohydrolase;817;
3LUB;J;Crystal structure of Putative creatinine amidohydrolase (YP_211512.1) from Bacteroides fragilis NCTC 9343 at 2.11 A resolution;2.11;CA;CALCIUM ION;Putative creatinine amidohydrolase;817;
3LUB;L;Crystal structure of Putative creatinine amidohydrolase (YP_211512.1) from Bacteroides fragilis NCTC 9343 at 2.11 A resolution;2.11;CA;CALCIUM ION;Putative creatinine amidohydrolase;817;
3LUM;A;Structure of ulilysin mutant M290L;1.7;CA;CALCIUM ION;Ulilysin;2214;
3LUM;B;Structure of ulilysin mutant M290L;1.7;CA;CALCIUM ION;Ulilysin;2214;
3LUM;C;Structure of ulilysin mutant M290L;1.7;CA;CALCIUM ION;Ulilysin;2214;
3LUM;D;Structure of ulilysin mutant M290L;1.7;CA;CALCIUM ION;Ulilysin;2214;
3LUN;A;Structure of ulilysin mutant M290C;1.8;CA;CALCIUM ION;Ulilysin;2214;
3LUN;B;Structure of ulilysin mutant M290C;1.8;CA;CALCIUM ION;Ulilysin;2214;
3LV4;A;Crystal structure of the glycoside hydrolase, family 43 YxiA protein from Bacillus licheniformis. Northeast Structural Genomics Consortium Target BiR14.;1.7;CA;CALCIUM ION;Glycoside hydrolase YxiA;1402;
3LV4;B;Crystal structure of the glycoside hydrolase, family 43 YxiA protein from Bacillus licheniformis. Northeast Structural Genomics Consortium Target BiR14.;1.7;CA;CALCIUM ION;Glycoside hydrolase YxiA;1402;
3LV8;A;1.8 Angstrom resolution crystal structure of a thymidylate kinase (tmk) from Vibrio cholerae O1 biovar eltor str. N16961 in complex with TMP, thymidine-5'-diphosphate and ADP;1.8;CA;CALCIUM ION;Thymidylate kinase;666;
3LVR;E;The crystal structure of ASAP3 in complex with Arf6 in transition state soaked with Calcium;3.38;CA;CALCIUM ION;Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 3, ADP-ribosylation factor 6;960,632,630;
3LVT;A;The Crystal Structure of a Protein in the Glycosyl Hydrolase Family 38 from Enterococcus faecalis to 2.55A;2.55;CA;CALCIUM ION;Glycosyl hydrolase, family 38;1351;
3LWA;A;The Crystal Structure of a Secreted Thiol-disulfide Isomerase from Corynebacterium glutamicum to 1.75A;1.75;CA;CALCIUM ION;Secreted thiol-disulfide isomerase;1718;
3LYB;A;Structure of putative endoribonuclease(KP1_3112) from Klebsiella pneumoniae;2.66;CA;CALCIUM ION;Putative endoribonuclease;573;
3LYB;B;Structure of putative endoribonuclease(KP1_3112) from Klebsiella pneumoniae;2.66;CA;CALCIUM ION;Putative endoribonuclease;573;
3LYB;D;Structure of putative endoribonuclease(KP1_3112) from Klebsiella pneumoniae;2.66;CA;CALCIUM ION;Putative endoribonuclease;573;
3LYE;A;Crystal structure of oxaloacetate acetylhydrolase;1.3;CA;CALCIUM ION;Oxaloacetate acetyl hydrolase;5116;
3LZI;A;RB69 DNA Polymerase (Y567A) ternary complex with dATP Opposite 7,8-dihydro-8-oxoguanine;2.3;CA;CALCIUM ION;DNA polymerase;1914161;
3LZJ;A;RB69 DNA Polymerase (Y567A) ternary complex with dCTP Opposite 7,8-Dihydro-8-oxoguanine;2.05;CA;CALCIUM ION;DNA polymerase;1914161;
3LZK;A;The crystal structure of a probably aromatic amino acid degradation proteiN from Sinorhizobium meliloti 1021;1.9;CA;CALCIUM ION;Fumarylacetoacetate hydrolase family protein;382;
3LZK;B;The crystal structure of a probably aromatic amino acid degradation proteiN from Sinorhizobium meliloti 1021;1.9;CA;CALCIUM ION;Fumarylacetoacetate hydrolase family protein;382;
3LZK;C;The crystal structure of a probably aromatic amino acid degradation proteiN from Sinorhizobium meliloti 1021;1.9;CA;CALCIUM ION;Fumarylacetoacetate hydrolase family protein;382;
3LZK;D;The crystal structure of a probably aromatic amino acid degradation proteiN from Sinorhizobium meliloti 1021;1.9;CA;CALCIUM ION;Fumarylacetoacetate hydrolase family protein;382;
3M0C;C;The X-ray Crystal Structure of PCSK9 in Complex with the LDL receptor;7.01;CA;CALCIUM ION;Low-density lipoprotein receptor;9606;
3M0J;A;Structure of oxaloacetate acetylhydrolase in complex with the inhibitor 3,3-difluorooxalacetate;1.55;CA;CALCIUM ION;Oxaloacetate acetyl hydrolase;5116;
3M0K;A;Structure of oxaloacetate acetylhydrolase in complex with the product oxalate;1.65;CA;CALCIUM ION;Oxaloacetate acetylhydrolase;5116;
3M0W;A;Structure of S100A4 with PCP;2.8;CA;CALCIUM ION;Protein S100-A4;9606;
3M0W;B;Structure of S100A4 with PCP;2.8;CA;CALCIUM ION;Protein S100-A4;9606;
3M0W;C;Structure of S100A4 with PCP;2.8;CA;CALCIUM ION;Protein S100-A4;9606;
3M0W;D;Structure of S100A4 with PCP;2.8;CA;CALCIUM ION;Protein S100-A4;9606;
3M0W;E;Structure of S100A4 with PCP;2.8;CA;CALCIUM ION;Protein S100-A4;9606;
3M0W;F;Structure of S100A4 with PCP;2.8;CA;CALCIUM ION;Protein S100-A4;9606;
3M0W;G;Structure of S100A4 with PCP;2.8;CA;CALCIUM ION;Protein S100-A4;9606;
3M0W;H;Structure of S100A4 with PCP;2.8;CA;CALCIUM ION;Protein S100-A4;9606;
3M0W;I;Structure of S100A4 with PCP;2.8;CA;CALCIUM ION;Protein S100-A4;9606;
3M0W;J;Structure of S100A4 with PCP;2.8;CA;CALCIUM ION;Protein S100-A4;9606;
3M1F;A;Crosslinked complex of actin with first W domain of Vibrio parahaemolyticus VopL;2.89;CA;CALCIUM ION;Actin, alpha skeletal muscle;9986;
3M1H;A;Crystal Structure Analysis of the K3 Cleaved Adhesin Domain of Lys-gingipain (Kgp) from Porphyromonas gingivalis w83;1.56;CA;CALCIUM ION;Lysine specific cysteine protease;837;
3M1H;B;Crystal Structure Analysis of the K3 Cleaved Adhesin Domain of Lys-gingipain (Kgp) from Porphyromonas gingivalis w83;1.56;CA;CALCIUM ION;Lysine specific cysteine protease;837;
3M1H;C;Crystal Structure Analysis of the K3 Cleaved Adhesin Domain of Lys-gingipain (Kgp) from Porphyromonas gingivalis w83;1.56;CA;CALCIUM ION;Lysine specific cysteine protease;837;
3M1H;D;Crystal Structure Analysis of the K3 Cleaved Adhesin Domain of Lys-gingipain (Kgp) from Porphyromonas gingivalis w83;1.56;CA;CALCIUM ION;Lysine specific cysteine protease;837;
3M1R;A;The crystal structure of formimidoylglutamase from Bacillus subtilis subsp. subtilis str. 168;2.2;CA;CALCIUM ION;Formimidoylglutamase;1423;
3M1R;B;The crystal structure of formimidoylglutamase from Bacillus subtilis subsp. subtilis str. 168;2.2;CA;CALCIUM ION;Formimidoylglutamase;1423;
3M1R;C;The crystal structure of formimidoylglutamase from Bacillus subtilis subsp. subtilis str. 168;2.2;CA;CALCIUM ION;Formimidoylglutamase;1423;
3M1R;D;The crystal structure of formimidoylglutamase from Bacillus subtilis subsp. subtilis str. 168;2.2;CA;CALCIUM ION;Formimidoylglutamase;1423;
3M1R;E;The crystal structure of formimidoylglutamase from Bacillus subtilis subsp. subtilis str. 168;2.2;CA;CALCIUM ION;Formimidoylglutamase;1423;
3M1R;F;The crystal structure of formimidoylglutamase from Bacillus subtilis subsp. subtilis str. 168;2.2;CA;CALCIUM ION;Formimidoylglutamase;1423;
3M34;A;Crystal structure of transketolase in complex with thiamin diphosphate and calcium ion;1.65;CA;CALCIUM ION;Transketolase;197;
3M35;A;Trypsin in complex with the inhibitor 1-[3-(aminomethyl)phenyl]-N-[3-fluoro-2'-(methylsulfonyl)biphenyl-4-yl]-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide (DPC423);2.2;CA;CALCIUM ION;Cationic trypsin;9913;
3M36;A;Factor XA in complex with the inhibitor 1-[3-(aminomethyl)phenyl]-N-[3-fluoro-2'-(methylsulfonyl)biphenyl-4-yl]-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide (DPC423);2.15;CA;CALCIUM ION;Coagulation factor X;9606;
3M37;A;Factor XA in complex with the inhibitor 1-[2-(aminomethyl)phenyl]-N-(3-fluoro-2'-sulfamoylbiphenyl-4-yl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide (DPC602);1.9;CA;CALCIUM ION;Coagulation factor X;9606;
3M3N;A;Structure of a Longitudinal Actin Dimer Assembled by Tandem W Domains;7;CA;CALCIUM ION;Actin, alpha skeletal muscle;9986;
3M3N;B;Structure of a Longitudinal Actin Dimer Assembled by Tandem W Domains;7;CA;CALCIUM ION;Actin, alpha skeletal muscle;9986;
3M5Q;A;0.93 A Structure of Manganese-Bound Manganese Peroxidase;0.93;CA;CALCIUM ION;Manganese peroxidase 1;5306;
3M6G;A;Crystal structure of actin in complex with lobophorolide;2;CA;CALCIUM ION;Actin, alpha skeletal muscle;9986;
3M6G;B;Crystal structure of actin in complex with lobophorolide;2;CA;CALCIUM ION;Actin, alpha skeletal muscle;9986;
3M6L;A;Crystal structure of transketolase in complex with thiamine diphosphate, ribose-5-phosphate and calcium ion;1.59;CA;CALCIUM ION;Transketolase;197;
3M6Y;A;Structure of 4-hydroxy-2-oxoglutarate aldolase from bacillus cereus at 1.45 a resolution.;1.45;CA;CALCIUM ION;4-Hydroxy-2-oxoglutarate aldolase;1396;
3M6Y;B;Structure of 4-hydroxy-2-oxoglutarate aldolase from bacillus cereus at 1.45 a resolution.;1.45;CA;CALCIUM ION;4-Hydroxy-2-oxoglutarate aldolase;1396;
3M81;A;Crystal structure of Acetyl xylan esterase (TM0077) from THERMOTOGA MARITIMA at 2.50 A resolution (native apo structure);2.5;CA;CALCIUM ION;Acetyl xylan esterase;2336;
3M81;B;Crystal structure of Acetyl xylan esterase (TM0077) from THERMOTOGA MARITIMA at 2.50 A resolution (native apo structure);2.5;CA;CALCIUM ION;Acetyl xylan esterase;2336;
3M81;C;Crystal structure of Acetyl xylan esterase (TM0077) from THERMOTOGA MARITIMA at 2.50 A resolution (native apo structure);2.5;CA;CALCIUM ION;Acetyl xylan esterase;2336;
3M81;D;Crystal structure of Acetyl xylan esterase (TM0077) from THERMOTOGA MARITIMA at 2.50 A resolution (native apo structure);2.5;CA;CALCIUM ION;Acetyl xylan esterase;2336;
3M81;E;Crystal structure of Acetyl xylan esterase (TM0077) from THERMOTOGA MARITIMA at 2.50 A resolution (native apo structure);2.5;CA;CALCIUM ION;Acetyl xylan esterase;2336;
3M81;F;Crystal structure of Acetyl xylan esterase (TM0077) from THERMOTOGA MARITIMA at 2.50 A resolution (native apo structure);2.5;CA;CALCIUM ION;Acetyl xylan esterase;2336;
3M82;A;Crystal structure of Acetyl xylan esterase (TM0077) from THERMOTOGA MARITIMA at 2.40 A resolution (PMSF inhibitor complex structure);2.4;CA;CALCIUM ION;Acetyl xylan esterase;2336;
3M82;B;Crystal structure of Acetyl xylan esterase (TM0077) from THERMOTOGA MARITIMA at 2.40 A resolution (PMSF inhibitor complex structure);2.4;CA;CALCIUM ION;Acetyl xylan esterase;2336;
3M82;C;Crystal structure of Acetyl xylan esterase (TM0077) from THERMOTOGA MARITIMA at 2.40 A resolution (PMSF inhibitor complex structure);2.4;CA;CALCIUM ION;Acetyl xylan esterase;2336;
3M82;D;Crystal structure of Acetyl xylan esterase (TM0077) from THERMOTOGA MARITIMA at 2.40 A resolution (PMSF inhibitor complex structure);2.4;CA;CALCIUM ION;Acetyl xylan esterase;2336;
3M82;E;Crystal structure of Acetyl xylan esterase (TM0077) from THERMOTOGA MARITIMA at 2.40 A resolution (PMSF inhibitor complex structure);2.4;CA;CALCIUM ION;Acetyl xylan esterase;2336;
3M82;F;Crystal structure of Acetyl xylan esterase (TM0077) from THERMOTOGA MARITIMA at 2.40 A resolution (PMSF inhibitor complex structure);2.4;CA;CALCIUM ION;Acetyl xylan esterase;2336;
3M83;A;Crystal structure of Acetyl xylan esterase (TM0077) from THERMOTOGA MARITIMA at 2.12 A resolution (paraoxon inhibitor complex structure);2.12;CA;CALCIUM ION;Acetyl xylan esterase;2336;
3M83;B;Crystal structure of Acetyl xylan esterase (TM0077) from THERMOTOGA MARITIMA at 2.12 A resolution (paraoxon inhibitor complex structure);2.12;CA;CALCIUM ION;Acetyl xylan esterase;2336;
3M83;C;Crystal structure of Acetyl xylan esterase (TM0077) from THERMOTOGA MARITIMA at 2.12 A resolution (paraoxon inhibitor complex structure);2.12;CA;CALCIUM ION;Acetyl xylan esterase;2336;
3M83;D;Crystal structure of Acetyl xylan esterase (TM0077) from THERMOTOGA MARITIMA at 2.12 A resolution (paraoxon inhibitor complex structure);2.12;CA;CALCIUM ION;Acetyl xylan esterase;2336;
3M83;E;Crystal structure of Acetyl xylan esterase (TM0077) from THERMOTOGA MARITIMA at 2.12 A resolution (paraoxon inhibitor complex structure);2.12;CA;CALCIUM ION;Acetyl xylan esterase;2336;
3M83;F;Crystal structure of Acetyl xylan esterase (TM0077) from THERMOTOGA MARITIMA at 2.12 A resolution (paraoxon inhibitor complex structure);2.12;CA;CALCIUM ION;Acetyl xylan esterase;2336;
3M8D;A;Crystal structure of spin-labeled BtuB V10R1 with bound calcium and cyanocobalamin;2.44;CA;CALCIUM ION;Vitamin B12 transporter btuB;562;
3M8M;A;1.05 A Structure of Manganese-free Manganese Peroxidase;1.05;CA;CALCIUM ION;Manganese peroxidase 1;5306;
3M9M;B;Crystal Structure of Dpo4 in complex with DNA containing the major cisplatin lesion;2.9;CA;CALCIUM ION;DNA polymerase IV;2287;
3M9N;B;Crystal Structure of Dpo4 in complex with DNA containing the major cisplatin lesion;1.93;CA;CALCIUM ION;DNA polymerase IV;2287;
3M9O;B;Crystal Structure of Dpo4 in complex with DNA containing the major cisplatin lesion;2;CA;CALCIUM ION;DNA polymerase IV;2287;
3M9O;T;Crystal Structure of Dpo4 in complex with DNA containing the major cisplatin lesion;2;CA;CALCIUM ION;DNA (5'-D(*TP*CP*TP*GP*GP*CP*TP*TP*TP*CP*CP*TP*TP*CP*CP*CP*CP*C)-3');;
3MA2;A;Complex membrane type-1 matrix metalloproteinase (MT1-MMP) with tissue inhibitor of metalloproteinase-1 (TIMP-1);2.05;CA;CALCIUM ION;Matrix metalloproteinase-14;9606;
3MA2;D;Complex membrane type-1 matrix metalloproteinase (MT1-MMP) with tissue inhibitor of metalloproteinase-1 (TIMP-1);2.05;CA;CALCIUM ION;Matrix metalloproteinase-14;9606;
3MAA;A;Complex of GS-Alpha with the Catalytic Domains of Mammalian Adenylyl Cyclase: Complex with Adenosine 5-O-(l-Thiophosphate) and Low Ca Concentration;3;CA;CALCIUM ION;Adenylate cyclase type 5;9612;
3MAX;A;Crystal Structure of Human HDAC2 complexed with an N-(2-aminophenyl)benzamide;2.05;CA;CALCIUM ION;Histone deacetylase 2;9606;
3MAX;B;Crystal Structure of Human HDAC2 complexed with an N-(2-aminophenyl)benzamide;2.05;CA;CALCIUM ION;Histone deacetylase 2;9606;
3MAX;C;Crystal Structure of Human HDAC2 complexed with an N-(2-aminophenyl)benzamide;2.05;CA;CALCIUM ION;Histone deacetylase 2;9606;
3MBR;X;Crystal Structure of the Glutaminyl Cyclase from Xanthomonas campestris;1.44;CA;CALCIUM ION;Glutamine cyclotransferase;339;
3MCY;A;Crystal structure of FimH lectin domain bound to biphenyl mannoside meta-methyl ester.;2.9;CA;CALCIUM ION;FimH;562;
3MCY;B;Crystal structure of FimH lectin domain bound to biphenyl mannoside meta-methyl ester.;2.9;CA;CALCIUM ION;FimH;562;
3MCY;C;Crystal structure of FimH lectin domain bound to biphenyl mannoside meta-methyl ester.;2.9;CA;CALCIUM ION;FimH;562;
3MCY;D;Crystal structure of FimH lectin domain bound to biphenyl mannoside meta-methyl ester.;2.9;CA;CALCIUM ION;FimH;562;
3MDO;A;Crystal structure of a Putative phosphoribosylformylglycinamidine cyclo-ligase (BDI_2101) from Parabacteroides distasonis ATCC 8503 at 1.91 A resolution;1.91;CA;CALCIUM ION;Putative phosphoribosylformylglycinamidine cyclo-ligase;823;
3MDO;B;Crystal structure of a Putative phosphoribosylformylglycinamidine cyclo-ligase (BDI_2101) from Parabacteroides distasonis ATCC 8503 at 1.91 A resolution;1.91;CA;CALCIUM ION;Putative phosphoribosylformylglycinamidine cyclo-ligase;823;
3MEH;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS I92A at cryogenic temperature;1.5;CA;CALCIUM ION;Thermonuclease;1280;
3MFJ;A;Bovine trypsin at 0.8 A resolution, restrained refinement;0.8;CA;CALCIUM ION;Cationic trypsin;9913;
3MHB;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS L38A at cryogenic temperature;1.55;CA;CALCIUM ION;Thermonuclease;1280;
3MHF;A;Tagatose-1,6-bisphosphate aldolase from Streptococcus pyogenes;1.87;CA;CALCIUM ION;Tagatose 1,6-diphosphate aldolase 2;1314;
3MHF;B;Tagatose-1,6-bisphosphate aldolase from Streptococcus pyogenes;1.87;CA;CALCIUM ION;Tagatose 1,6-diphosphate aldolase 2;1314;
3MHF;C;Tagatose-1,6-bisphosphate aldolase from Streptococcus pyogenes;1.87;CA;CALCIUM ION;Tagatose 1,6-diphosphate aldolase 2;1314;
3MHF;D;Tagatose-1,6-bisphosphate aldolase from Streptococcus pyogenes;1.87;CA;CALCIUM ION;Tagatose 1,6-diphosphate aldolase 2;1314;
3MHG;A;Dihydroxyacetone phosphate carbanion intermediate in tagatose-1,6-bisphosphate aldolase from Streptococcus pyogenes;1.92;CA;CALCIUM ION;Tagatose 1,6-diphosphate aldolase 2;1314;
3MHG;B;Dihydroxyacetone phosphate carbanion intermediate in tagatose-1,6-bisphosphate aldolase from Streptococcus pyogenes;1.92;CA;CALCIUM ION;Tagatose 1,6-diphosphate aldolase 2;1314;
3MHG;C;Dihydroxyacetone phosphate carbanion intermediate in tagatose-1,6-bisphosphate aldolase from Streptococcus pyogenes;1.92;CA;CALCIUM ION;Tagatose 1,6-diphosphate aldolase 2;1314;
3MHG;D;Dihydroxyacetone phosphate carbanion intermediate in tagatose-1,6-bisphosphate aldolase from Streptococcus pyogenes;1.92;CA;CALCIUM ION;Tagatose 1,6-diphosphate aldolase 2;1314;
3MHR;A;14-3-3 sigma in complex with YAP pS127-peptide;1.15;CA;CALCIUM ION;14-3-3 protein sigma;9606;
3MHZ;A;1.7A structure of 2-fluorohistidine labeled Protective Antigen;1.7;CA;CALCIUM ION;Protective antigen;1392;
3MI4;A;Bovine trypsin at 0.8 A resolution, non-restrained refinement;0.8;CA;CALCIUM ION;Cationic trypsin;9913;
3MIN;B;NITROGENASE MOFE PROTEIN FROM AZOTOBACTER VINELANDII, OXIDIZED STATE;2.03;CA;CALCIUM ION;NITROGENASE MOLYBDENUM IRON PROTEIN;354;
3MIN;D;NITROGENASE MOFE PROTEIN FROM AZOTOBACTER VINELANDII, OXIDIZED STATE;2.03;CA;CALCIUM ION;NITROGENASE MOLYBDENUM IRON PROTEIN;354;
3MIP;A;I-MsoI re-designed for altered DNA cleavage specificity (-8GCG);2.4;CA;CALCIUM ION;Mso-8G;32630;
3MIP;B;I-MsoI re-designed for altered DNA cleavage specificity (-8GCG);2.4;CA;CALCIUM ION;Mso-8G;32630;
3MIP;D;I-MsoI re-designed for altered DNA cleavage specificity (-8GCG);2.4;CA;CALCIUM ION;DNA (5'-D(*CP*GP*GP*AP*GP*CP*GP*GP*TP*CP*TP*CP*AP*CP*GP*AP*CP*CP*GP*CP*CP*TP*GP*C)-3');;
3MIS;A;I-MsoI re-designed for altered DNA cleavage specificity (-8G);2.3;CA;CALCIUM ION;Mso-8G;32630;
3MIS;B;I-MsoI re-designed for altered DNA cleavage specificity (-8G);2.3;CA;CALCIUM ION;Mso-8G;32630;
3MIS;C;I-MsoI re-designed for altered DNA cleavage specificity (-8G);2.3;CA;CALCIUM ION;DNA (5'-D(*GP*CP*AP*GP*GP*AP*CP*GP*TP*CP*GP*TP*GP*AP*GP*AP*CP*AP*GP*CP*TP*CP*CP*G)-3');;
3MK0;A;Refinement of placental alkaline phosphatase complexed with nitrophenyl;1.9;CA;CALCIUM ION;Alkaline phosphatase, placental type;9606;
3MK1;A;Refinement of placental alkaline phosphatase complexed with nitrophenyl;1.57;CA;CALCIUM ION;Alkaline phosphatase, placental type;9606;
3MK2;A;Placental alkaline phosphatase complexed with Phe;1.89;CA;CALCIUM ION;Alkaline phosphatase, placental type;9606;
3MK7;A;The structure of CBB3 cytochrome oxidase;3.2;CA;CALCIUM ION;Cytochrome c oxidase, cbb3-type, subunit N;316;
3MK7;B;The structure of CBB3 cytochrome oxidase;3.2;CA;CALCIUM ION;Cytochrome c oxidase, cbb3-type, subunit O;316;
3MK7;D;The structure of CBB3 cytochrome oxidase;3.2;CA;CALCIUM ION;Cytochrome c oxidase, cbb3-type, subunit N;316;
3MK7;E;The structure of CBB3 cytochrome oxidase;3.2;CA;CALCIUM ION;Cytochrome c oxidase, cbb3-type, subunit O;316;
3MK7;G;The structure of CBB3 cytochrome oxidase;3.2;CA;CALCIUM ION;Cytochrome c oxidase, cbb3-type, subunit N;316;
3MK7;K;The structure of CBB3 cytochrome oxidase;3.2;CA;CALCIUM ION;Cytochrome c oxidase, cbb3-type, subunit N;316;
3MKM;A;Crystal structure of the E. coli pyrimidine nucleoside hydrolase YeiK (Apo-form);2.2;CA;CALCIUM ION;Putative uncharacterized protein YeiK;562;
3MKM;B;Crystal structure of the E. coli pyrimidine nucleoside hydrolase YeiK (Apo-form);2.2;CA;CALCIUM ION;Putative uncharacterized protein YeiK;562;
3MKM;C;Crystal structure of the E. coli pyrimidine nucleoside hydrolase YeiK (Apo-form);2.2;CA;CALCIUM ION;Putative uncharacterized protein YeiK;562;
3MKM;D;Crystal structure of the E. coli pyrimidine nucleoside hydrolase YeiK (Apo-form);2.2;CA;CALCIUM ION;Putative uncharacterized protein YeiK;562;
3MKN;A;Crystal structure of the E. coli pyrimidine nucleosidase YeiK bound to a competitive inhibitor;2;CA;CALCIUM ION;Putative uncharacterized protein YeiK;562;
3MKN;B;Crystal structure of the E. coli pyrimidine nucleosidase YeiK bound to a competitive inhibitor;2;CA;CALCIUM ION;Putative uncharacterized protein YeiK;562;
3MKN;C;Crystal structure of the E. coli pyrimidine nucleosidase YeiK bound to a competitive inhibitor;2;CA;CALCIUM ION;Putative uncharacterized protein YeiK;562;
3MKN;D;Crystal structure of the E. coli pyrimidine nucleosidase YeiK bound to a competitive inhibitor;2;CA;CALCIUM ION;Putative uncharacterized protein YeiK;562;
3MKZ;A;Structure of SopB(155-272)-18mer complex, P21 form;2.98;CA;CALCIUM ION;Protein sopB;562;
3MKZ;U;Structure of SopB(155-272)-18mer complex, P21 form;2.98;CA;CALCIUM ION;Protein sopB;562;
3MKZ;Z;Structure of SopB(155-272)-18mer complex, P21 form;2.98;CA;CALCIUM ION;DNA (5'-D(*CP*TP*GP*GP*GP*AP*CP*CP*AP*TP*GP*GP*TP*CP*CP*CP*AP*G)-3');;
3ML0;B;Thermostable Penicillin G acylase from Alcaligenes faecalis in tetragonal form;3.5;CA;CALCIUM ION;Penicillin G acylase, beta subunit;511;
3MLI;D;2ouf-ds, a disulfide-linked dimer of Helicobacter pylori protein HP0242;2.9;CA;CALCIUM ION;Putative uncharacterized protein;210;
3MMO;A;Structure of the Thioalkalivibrio nitratireducens cytochrome c nitrite reductase in complex with cyanide;1.55;CA;CALCIUM ION;Eight-heme nitrite reductase;186931;
3MMO;B;Structure of the Thioalkalivibrio nitratireducens cytochrome c nitrite reductase in complex with cyanide;1.55;CA;CALCIUM ION;Eight-heme nitrite reductase;186931;
3MMV;A;Structures of actin-bound WH2 domains of Spire and the implication for filament nucleation;2.8;CA;CALCIUM ION;Actin-5C;7227;
3MMZ;A;CRYSTAL STRUCTURE OF putative HAD family hydrolase from Streptomyces avermitilis MA-4680;1.84;CA;CALCIUM ION;putative HAD family hydrolase;33903;
3MMZ;B;CRYSTAL STRUCTURE OF putative HAD family hydrolase from Streptomyces avermitilis MA-4680;1.84;CA;CALCIUM ION;putative HAD family hydrolase;33903;
3MMZ;C;CRYSTAL STRUCTURE OF putative HAD family hydrolase from Streptomyces avermitilis MA-4680;1.84;CA;CALCIUM ION;putative HAD family hydrolase;33903;
3MMZ;D;CRYSTAL STRUCTURE OF putative HAD family hydrolase from Streptomyces avermitilis MA-4680;1.84;CA;CALCIUM ION;putative HAD family hydrolase;33903;
3MN5;A;Structures of actin-bound WH2 domains of Spire and the implication for filament nucleation;1.5;CA;CALCIUM ION;Actin, alpha skeletal muscle;9986;
3MN6;A;Structures of actin-bound WH2 domains of Spire and the implication for filament nucleation;2;CA;CALCIUM ION;Actin-5C;7227;
3MN6;F;Structures of actin-bound WH2 domains of Spire and the implication for filament nucleation;2;CA;CALCIUM ION;Actin-5C;7227;
3MN6;K;Structures of actin-bound WH2 domains of Spire and the implication for filament nucleation;2;CA;CALCIUM ION;Actin-5C;7227;
3MN7;A;Structures of actin-bound WH2 domains of Spire and the implication for filament nucleation;2;CA;CALCIUM ION;Actin-5C;7227;
3MN9;A;Structures of actin-bound WH2 domains of Spire and the implication for filament nucleation;2;CA;CALCIUM ION;Actin-5C;7227;
3MOS;A;The structure of human Transketolase;1.75;CA;CALCIUM ION;Transketolase;9606;
3MPH;A;The structure of human diamine oxidase complexed with an inhibitor aminoguanidine;2.05;CA;CALCIUM ION;Amiloride-sensitive amine oxidase;9606;
3MPH;B;The structure of human diamine oxidase complexed with an inhibitor aminoguanidine;2.05;CA;CALCIUM ION;Amiloride-sensitive amine oxidase;9606;
3MQ6;A;Domain swapped SgrAI with DNA and calcium bound;2;CA;CALCIUM ION;SgraIR restriction enzyme;1911;
3MQ6;B;Domain swapped SgrAI with DNA and calcium bound;2;CA;CALCIUM ION;SgraIR restriction enzyme;1911;
3MQ6;C;Domain swapped SgrAI with DNA and calcium bound;2;CA;CALCIUM ION;SgraIR restriction enzyme;1911;
3MQ6;D;Domain swapped SgrAI with DNA and calcium bound;2;CA;CALCIUM ION;SgraIR restriction enzyme;1911;
3MQ6;E;Domain swapped SgrAI with DNA and calcium bound;2;CA;CALCIUM ION;SgraIR restriction enzyme;1911;
3MQ6;F;Domain swapped SgrAI with DNA and calcium bound;2;CA;CALCIUM ION;SgraIR restriction enzyme;1911;
3MQ6;G;Domain swapped SgrAI with DNA and calcium bound;2;CA;CALCIUM ION;SgraIR restriction enzyme;1911;
3MQ6;H;Domain swapped SgrAI with DNA and calcium bound;2;CA;CALCIUM ION;SgraIR restriction enzyme;1911;
3MQ7;E;Crystal Structure of Ectodomain Mutant of BST-2/Tetherin/CD317;2.28;CA;CALCIUM ION;Bone marrow stromal antigen 2;9606;
3MQ7;K;Crystal Structure of Ectodomain Mutant of BST-2/Tetherin/CD317;2.28;CA;CALCIUM ION;Bone marrow stromal antigen 2;9606;
3MS3;A;Crystal structure of Thermolysin in complex with Aniline;1.54;CA;CALCIUM ION;Thermolysin;1427;
3MSA;A;Crystal structure of Thermolysin in complex with 3-Bromophenol;1.66;CA;CALCIUM ION;Thermolysin;1427;
3MSE;B;Crystal structure of C-terminal domain of PF110239.;2.1;CA;CALCIUM ION;Calcium-dependent protein kinase, putative;5833;
3MSF;A;Crystal structure of Thermolysin in complex with Urea;2.09;CA;CALCIUM ION;Thermolysin;1427;
3MSN;A;Crystal structure of Thermolysin in complex with N-methylurea;1.97;CA;CALCIUM ION;Thermolysin;1427;
3MT5;A;Crystal Structure of the Human BK Gating Apparatus;3;CA;CALCIUM ION;Potassium large conductance calcium-activated channel, subfamily M, alpha member 1;9606;
3MVS;A;Structure of the N-terminus of Cadherin 23;1.1;CA;CALCIUM ION;Cadherin-23;10090;
3MVV;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS F34A at cryogenic temperature;1.72;CA;CALCIUM ION;Thermonuclease;1280;
3MW3;A;Crystal structure of beta-neurexin 2 with the splice insert 4;2.33;CA;CALCIUM ION;Neurexin-2-beta;10116;
3MW4;A;Crystal structure of beta-neurexin 3 without the splice insert 4;2;CA;CALCIUM ION;Neurexin-2-beta;10090;
3MWU;A;Activated Calcium-Dependent Protein Kinase 1 from Cryptosporidium parvum (CpCDPK1) in complex with bumped kinase inhibitor RM-1-95;1.98;CA;CALCIUM ION;Calmodulin-domain protein kinase 1;5807;
3MX9;A;Molecular basis of engineered meganuclease targeting of the endogenous human RAG1 locus;2.6;CA;CALCIUM ION;Protein scV3V2(G19S);3055;
3MXB;A;Molecular basis of engineered meganuclease targeting of the endogenous human RAG1 locus;2.3;CA;CALCIUM ION;V3(E8K);3055;
3MXB;B;Molecular basis of engineered meganuclease targeting of the endogenous human RAG1 locus;2.3;CA;CALCIUM ION;V2(K7E-G19S);3055;
3MXB;R;Molecular basis of engineered meganuclease targeting of the endogenous human RAG1 locus;2.3;CA;CALCIUM ION;V3(E8K);3055;
3MXB;S;Molecular basis of engineered meganuclease targeting of the endogenous human RAG1 locus;2.3;CA;CALCIUM ION;V2(K7E-G19S);3055;
3MXI;A;TREX1 3' Exonuclease D18N Familial Chilblain Lupus Mutant;2.55;CA;CALCIUM ION;Three prime repair exonuclease 1;10090;
3MXI;B;TREX1 3' Exonuclease D18N Familial Chilblain Lupus Mutant;2.55;CA;CALCIUM ION;Three prime repair exonuclease 1;10090;
3MXI;C;TREX1 3' Exonuclease D18N Familial Chilblain Lupus Mutant;2.55;CA;CALCIUM ION;DNA (5'-D(*GP*AP*CP*G)-3');;
3MXI;D;TREX1 3' Exonuclease D18N Familial Chilblain Lupus Mutant;2.55;CA;CALCIUM ION;DNA (5'-D(*GP*AP*CP*G)-3');;
3MXM;A;TREX1 3' Exonuclease V201D Aicardi-Goutieres Syndrome Mutant;1.75;CA;CALCIUM ION;Three prime repair exonuclease 1;10090;
3MXM;B;TREX1 3' Exonuclease V201D Aicardi-Goutieres Syndrome Mutant;1.75;CA;CALCIUM ION;Three prime repair exonuclease 1;10090;
3MXM;C;TREX1 3' Exonuclease V201D Aicardi-Goutieres Syndrome Mutant;1.75;CA;CALCIUM ION;DNA (5'-D(*GP*AP*CP*G)-3');;
3MXM;D;TREX1 3' Exonuclease V201D Aicardi-Goutieres Syndrome Mutant;1.75;CA;CALCIUM ION;DNA (5'-D(*GP*AP*CP*G)-3');;
3MXP;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS T62A at cryogenic temperature;1.61;CA;CALCIUM ION;Thermonuclease;1280;
3MXW;A;Crystal structure Sonic hedgehog bound to the 5E1 fab fragment;1.83;CA;CALCIUM ION;Sonic hedgehog protein;9606;
3MYW;A;The Bowman-Birk type inhibitor from mung bean in ternary complex with porcine trypsin;2.5;CA;CALCIUM ION;Trypsin;9823;
3MYW;B;The Bowman-Birk type inhibitor from mung bean in ternary complex with porcine trypsin;2.5;CA;CALCIUM ION;Trypsin;9823;
3MZ5;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS L103A at cryogenic temperature;1.58;CA;CALCIUM ION;Thermonuclease;1280;
3MZO;A;Crystal structure of a HD-domain phosphohydrolase (lin2634) from LISTERIA INNOCUA at 1.98 A resolution;1.98;CA;CALCIUM ION;Lin2634 protein;1642;
3MZO;B;Crystal structure of a HD-domain phosphohydrolase (lin2634) from LISTERIA INNOCUA at 1.98 A resolution;1.98;CA;CALCIUM ION;Lin2634 protein;1642;
3MZO;C;Crystal structure of a HD-domain phosphohydrolase (lin2634) from LISTERIA INNOCUA at 1.98 A resolution;1.98;CA;CALCIUM ION;Lin2634 protein;1642;
3N01;B;Crystal structure of an abridged form of the mature ectodomain of the Human Receptor-Type Protein Tyrosine Phosphatase ICA512/IA-2 at pH 8.5;1.3;CA;CALCIUM ION;Receptor-type tyrosine-protein phosphatase-like N;9606;
3N08;A;Crystal Structure of a Putative PhosphatidylEthanolamine-Binding Protein (PEBP) Homolog CT736 from Chlamydia trachomatis D/UW-3/CX;1.25;CA;CALCIUM ION;Putative PhosphatidylEthanolamine-Binding Protein (PEBP);813;
3N0A;A;Crystal structure of auxilin (40-400);2.2;CA;CALCIUM ION;Tyrosine-protein phosphatase auxilin;9913;
3N1F;A;Crystal Structure of IhhN bound to CDOFn3;1.6;CA;CALCIUM ION;Indian hedgehog protein;9606;
3N1F;B;Crystal Structure of IhhN bound to CDOFn3;1.6;CA;CALCIUM ION;Indian hedgehog protein;9606;
3N1F;C;Crystal Structure of IhhN bound to CDOFn3;1.6;CA;CALCIUM ION;Cell adhesion molecule-related/down-regulated by oncogenes;9606;
3N1G;A;Crystal structure of DhhN bound to BOCFn3;1.9;CA;CALCIUM ION;Desert hedgehog protein;9606;
3N1G;B;Crystal structure of DhhN bound to BOCFn3;1.9;CA;CALCIUM ION;Desert hedgehog protein;9606;
3N1M;B;Crystal Structure of IhhN bound to BOCFn3;1.69;CA;CALCIUM ION;Indian hedgehog protein;9606;
3N1O;C;Crystal structure of IhhN;2.55;CA;CALCIUM ION;Indian hedgehog protein;9606;
3N1P;B;Crystal Structure of IhhN bound to BOCFn3;2.7;CA;CALCIUM ION;Indian hedgehog protein;9606;
3N1Q;A;Crystal Structure of DhhN bound to CDOFn3;2.89;CA;CALCIUM ION;Desert hedgehog protein;9606;
3N1Q;B;Crystal Structure of DhhN bound to CDOFn3;2.89;CA;CALCIUM ION;Desert hedgehog protein;9606;
3N1Q;E;Crystal Structure of DhhN bound to CDOFn3;2.89;CA;CALCIUM ION;Desert hedgehog protein;9606;
3N1R;A;Crystal Structure of ShhN;2.13;CA;CALCIUM ION;Sonic hedgehog protein;10090;
3N1U;A;Structure of putative HAD superfamily (subfamily III A) hydrolase from Legionella pneumophila;1.8;CA;CALCIUM ION;Hydrolase, HAD superfamily, subfamily III A;446;
3N21;A;Crystal structure of Thermolysin in complex with S-1,2-Propandiol;1.87;CA;CALCIUM ION;Thermolysin;1427;
3N2U;A;Crystal structure of the catalytic domain of human MMP12 complexed with the inhibitor N-hydroxy-2-(4-methoxy-N(2-(3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)ethyl)phenylsulfonamido)acetamide;1.81;CA;CALCIUM ION;Macrophage metalloelastase;9606;
3N2V;A;Crystal structure of the catalytic domain of human MMP12 complexed with the inhibitor N-hydroxy-2-(N-hydroxyethyl)biphenyl-4-ylsulfonamido)acetamide;1.55;CA;CALCIUM ION;Macrophage metalloelastase;9606;
3N35;A;Erythrina corallodendron lectin mutant (Y106G) with N-Acetylgalactosamine;2;CA;CALCIUM ION;Lectin;3843;
3N36;A;Erythrina corallodendron lectin mutant (Y106G) in complex with Galactose;2.3;CA;CALCIUM ION;Lectin;3843;
3N3H;A;Erythrina corallodendron lectin mutant (Y106G) in complex with citrate;2;CA;CALCIUM ION;Lectin;3843;
3N4E;A;CRYSTAL STRUCTURE OF mandelate racemase/muconate lactonizing protein from Paracoccus denitrificans Pd1222;2.4;CA;CALCIUM ION;Mandelate racemase/muconate lactonizing enzyme, C-terminal domain protein;266;
3N4E;B;CRYSTAL STRUCTURE OF mandelate racemase/muconate lactonizing protein from Paracoccus denitrificans Pd1222;2.4;CA;CALCIUM ION;Mandelate racemase/muconate lactonizing enzyme, C-terminal domain protein;266;
3N4W;A;Crystal structure of an abridged SER to ALA mutant of the mature ectodomain of the human receptor-type protein-tyrosine phosphatase ICA512/IA-2 at pH 7.5;1.45;CA;CALCIUM ION;Receptor-type tyrosine-protein phosphatase-like N;9606;
3N5A;A;Synaptotagmin-7, C2B-domain, calcium bound;1.44;CA;CALCIUM ION;Synaptotagmin-7;10090;
3N7B;A;SgrAI bound to secondary site DNA and Ca(II);2.65;CA;CALCIUM ION;SgraIR restriction enzyme;1911;
3N7B;B;SgrAI bound to secondary site DNA and Ca(II);2.65;CA;CALCIUM ION;SgraIR restriction enzyme;1911;
3N7X;A;Crystal structure of Penaeus stylirostris densovirus capsid;2.5;CA;CALCIUM ION;Capsid protein;1513224;
3N8F;A;Crystal structure of the complex of goat lactoperoxidase with thiocyanate at 3.2 A resolution;3.25;CA;CALCIUM ION;Lactoperoxidase;9925;
3N8F;B;Crystal structure of the complex of goat lactoperoxidase with thiocyanate at 3.2 A resolution;3.25;CA;CALCIUM ION;Lactoperoxidase;9925;
3N8G;A;Structure of the (SR)Ca2+-ATPase Ca2-E1-CaAMPPCP form;2.59;CA;CALCIUM ION;Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 isoform SERCA 1a;9986;
3N91;A;Crystal structure of a STRUCTURAL GENOMICS, UNKNOWN FUNCTION (BACOVA_03430) from Bacteroides ovatus at 2.40 A resolution;2.4;CA;CALCIUM ION;uncharacterized protein;28116;
3N9I;B;Crystal structure of tryptophanyl-tRNA synthetase from Yersinia pestis CO92;1.95;CA;CALCIUM ION;Tryptophanyl-tRNA synthetase;632;
3N9J;A;Structure of human Glutathione Transferase Pi class in complex with Ethacraplatin;1.85;CA;CALCIUM ION;Glutathione S-transferase P;9606;
3N9J;B;Structure of human Glutathione Transferase Pi class in complex with Ethacraplatin;1.85;CA;CALCIUM ION;Glutathione S-transferase P;9606;
3N9K;A;F229A/E292S Double Mutant of Exo-beta-1,3-glucanase from Candida albicans in Complex with Laminaritriose at 1.7 A;1.7;CA;CALCIUM ION;Glucan 1,3-beta-glucosidase;5476;
3N9S;A;Class II fructose-1,6-bisphosphate aldolase from helicobacter pylori in complex with N-(4-hydroxybutyl)- glycolohydroxamic acid bis-phosphate, a competitive inhibitor;1.85;CA;CALCIUM ION;Fructose-bisphosphate aldolase;210;
3N9S;B;Class II fructose-1,6-bisphosphate aldolase from helicobacter pylori in complex with N-(4-hydroxybutyl)- glycolohydroxamic acid bis-phosphate, a competitive inhibitor;1.85;CA;CALCIUM ION;Fructose-bisphosphate aldolase;210;
3N9V;A;Crystal Structure of INPP5B;2.65;CA;CALCIUM ION;Type II inositol-1,4,5-trisphosphate 5-phosphatase;9606;
3N9V;B;Crystal Structure of INPP5B;2.65;CA;CALCIUM ION;Type II inositol-1,4,5-trisphosphate 5-phosphatase;9606;
3NA6;A;Crystal structure of a succinylglutamate desuccinylase (TM1040_2694) from SILICIBACTER SP. TM1040 at 2.00 A resolution;2;CA;CALCIUM ION;Succinylglutamate desuccinylase/aspartoacylase;292414;
3NAE;A;RB69 DNA Polymerase (Y567A) Ternary Complex with dATP Opposite Guanidinohydantoin;2;CA;CALCIUM ION;DNA polymerase;1914161;
3NAK;A;Crystal structure of the complex of goat lactoperoxidase with hypothiocyanite at 3.3 A resolution;3.3;CA;CALCIUM ION;Lactoperoxidase;9925;
3NAK;B;Crystal structure of the complex of goat lactoperoxidase with hypothiocyanite at 3.3 A resolution;3.3;CA;CALCIUM ION;Lactoperoxidase;9925;
3NCG;A;Activated Calcium-Dependent Protein Kinase 1 from Cryptosporidium parvum (CpCDPK1) in complex with bumped kinase inhibitor NM-PP1;2.49;CA;CALCIUM ION;Calmodulin-domain protein kinase 1;5807;
3NCI;A;RB69 DNA Polymerase Ternary Complex with dCTP Opposite dG at 1.8 angstrom resolution;1.79;CA;CALCIUM ION;DNA polymerase;1914161;
3NDK;A;RB69 DNA Polymerase (Y567A) Ternary Complex with dCTP Opposite dG;2;CA;CALCIUM ION;DNA polymerase;1914161;
3NE6;A;RB69 DNA Polymerase (S565G/Y567A) Ternary Complex with dCTP Opposite dG;2;CA;CALCIUM ION;DNA polymerase;1914161;
3NG8;B;Crystal structure of an abridged SER TO ALA MUTANT OF THE MATURE ECTODOMAIN of the human receptor-type protein-tyrosine phosphatase ICA512/IA-2 at PH 8.5;1.35;CA;CALCIUM ION;Receptor-type tyrosine-protein phosphatase-like N;9606;
3NGI;A;RB69 DNA Polymerase (Y567A) Ternary Complex with dTTP Opposite dG;1.89;CA;CALCIUM ION;DNA polymerase;1914161;
3NGW;A;Crystal Structure of Molybdopterin-guanine dinucleotide biosynthesis protein A from Archaeoglobus fulgidus, Northeast Structural Genomics Consortium Target GR189;2.31;CA;CALCIUM ION;Molybdopterin-guanine dinucleotide biosynthesis protein A (MobA);2234;
3NHG;A;RB69 DNA Polymerase (S565G/Y567A) Ternary Complex with dTTP Opposite dG;2.5;CA;CALCIUM ION;DNA polymerase;1914161;
3NHH;A;Crystal structure of Staphylococcal nuclease variant V23E-L36K at cryogenic temperature;2;CA;CALCIUM ION;Nuclease A;1280;
3NID;A;The Closed Headpiece of Integrin alphaIIB beta3 and its Complex with an alpahIIB beta3 -Specific Antagonist That Does Not Induce Opening;2.3;CA;CALCIUM ION;Integrin alpha-IIb;9606;
3NID;B;The Closed Headpiece of Integrin alphaIIB beta3 and its Complex with an alpahIIB beta3 -Specific Antagonist That Does Not Induce Opening;2.3;CA;CALCIUM ION;Integrin beta-3;9606;
3NID;C;The Closed Headpiece of Integrin alphaIIB beta3 and its Complex with an alpahIIB beta3 -Specific Antagonist That Does Not Induce Opening;2.3;CA;CALCIUM ION;Integrin alpha-IIb;9606;
3NID;D;The Closed Headpiece of Integrin alphaIIB beta3 and its Complex with an alpahIIB beta3 -Specific Antagonist That Does Not Induce Opening;2.3;CA;CALCIUM ION;Integrin beta-3;9606;
3NIF;A;The Closed Headpiece of Integrin IIb 3 and its Complex with an IIb 3 -Specific Antagonist That Does Not Induce Opening;2.4;CA;CALCIUM ION;Integrin alphaIIB beta3;9606;
3NIF;B;The Closed Headpiece of Integrin IIb 3 and its Complex with an IIb 3 -Specific Antagonist That Does Not Induce Opening;2.4;CA;CALCIUM ION;Integrin beta-3;9606;
3NIF;C;The Closed Headpiece of Integrin IIb 3 and its Complex with an IIb 3 -Specific Antagonist That Does Not Induce Opening;2.4;CA;CALCIUM ION;Integrin alphaIIB beta3;9606;
3NIF;D;The Closed Headpiece of Integrin IIb 3 and its Complex with an IIb 3 -Specific Antagonist That Does Not Induce Opening;2.4;CA;CALCIUM ION;Integrin beta-3;9606;
3NIG;A;The Closed Headpiece of Integrin IIb 3 and its Complex with an IIb 3 -Specific Antagonist That Does Not Induce Opening;2.25;CA;CALCIUM ION;Integrin alpha-IIb;9606;
3NIG;B;The Closed Headpiece of Integrin IIb 3 and its Complex with an IIb 3 -Specific Antagonist That Does Not Induce Opening;2.25;CA;CALCIUM ION;Integrin beta-3;9606;
3NIG;C;The Closed Headpiece of Integrin IIb 3 and its Complex with an IIb 3 -Specific Antagonist That Does Not Induce Opening;2.25;CA;CALCIUM ION;Integrin alpha-IIb;9606;
3NIG;D;The Closed Headpiece of Integrin IIb 3 and its Complex with an IIb 3 -Specific Antagonist That Does Not Induce Opening;2.25;CA;CALCIUM ION;Integrin beta-3;9606;
3NIU;A;Crystal structure of the complex of dimeric goat lactoperoxidase with diethylene glycol at 2.9 A resolution;2.94;CA;CALCIUM ION;Lactoperoxidase;9925;
3NIU;B;Crystal structure of the complex of dimeric goat lactoperoxidase with diethylene glycol at 2.9 A resolution;2.94;CA;CALCIUM ION;Lactoperoxidase;9925;
3NJH;A;D37A mutant of SO1698 protein, an aspartic peptidase from Shewanella oneidensis.;1.94;CA;CALCIUM ION;Peptidase;70863;
3NJH;B;D37A mutant of SO1698 protein, an aspartic peptidase from Shewanella oneidensis.;1.94;CA;CALCIUM ION;Peptidase;70863;
3NJH;C;D37A mutant of SO1698 protein, an aspartic peptidase from Shewanella oneidensis.;1.94;CA;CALCIUM ION;Peptidase;70863;
3NJH;D;D37A mutant of SO1698 protein, an aspartic peptidase from Shewanella oneidensis.;1.94;CA;CALCIUM ION;Peptidase;70863;
3NJN;A;Q118A mutant of SO1698 protein, an aspartic peptidase from Shewanella oneidensis;1.25;CA;CALCIUM ION;Peptidase;70863;
3NJN;C;Q118A mutant of SO1698 protein, an aspartic peptidase from Shewanella oneidensis;1.25;CA;CALCIUM ION;Peptidase;70863;
3NJU;A;Crystal structure of the complex of group I phospholipase A2 with 4-Methoxy-benzoicacid at 1.4A resolution;1.4;CA;CALCIUM ION;Phospholipase A2 isoform 3;195058;
3NJV;A;Rhamnogalacturonan lyase from Aspergillus aculeatus K150A substrate complex;2.4;CA;CALCIUM ION;Rhamnogalacturonase B;5053;
3NJX;A;Rhamnogalacturonan Lyase from Aspergillus aculeatus mutant H210A;1.94;CA;CALCIUM ION;Rhamnogalacturonase B;5053;
3NK8;A;Trypsin in complex with fluorine-containing fragment;1.15;CA;CALCIUM ION;Cationic trypsin;9913;
3NK9;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS V74A at cryogenic temperature;1.65;CA;CALCIUM ION;Nuclease A;1280;
3NKK;A;Trypsin in complex with fluorine containing fragment;1.12;CA;CALCIUM ION;Cationic trypsin;9913;
3NKM;A;Crystal structure of mouse autotaxin;2;CA;CALCIUM ION;Ectonucleotide pyrophosphatase/phosphodiesterase family member 2;10090;
3NKN;A;Crystal structure of mouse autotaxin in complex with 14:0-LPA;1.8;CA;CALCIUM ION;Ectonucleotide pyrophosphatase/phosphodiesterase family member 2;10090;
3NKO;A;Crystal structure of mouse autotaxin in complex with 16:0-LPA;1.75;CA;CALCIUM ION;Ectonucleotide pyrophosphatase/phosphodiesterase family member 2;10090;
3NKP;A;Crystal structure of mouse autotaxin in complex with 18:1-LPA;1.75;CA;CALCIUM ION;Ectonucleotide pyrophosphatase/phosphodiesterase family member 2;10090;
3NKQ;A;Crystal structure of mouse autotaxin in complex with 18:3-LPA;1.7;CA;CALCIUM ION;Ectonucleotide pyrophosphatase/phosphodiesterase family member 2;10090;
3NKR;A;Crystal structure of mouse autotaxin in complex with 22:6-LPA;1.7;CA;CALCIUM ION;Ectonucleotide pyrophosphatase/phosphodiesterase family member 2;10090;
3NN7;A;Crystal structure of Thermolysin in complex with 2-bromoacetate;2.05;CA;CALCIUM ION;Thermolysin;1427;
3NN9;A;REFINED ATOMIC STRUCTURES OF N9 SUBTYPE INFLUENZA VIRUS NEURAMINIDASE AND ESCAPE MUTANTS;2.3;CA;CALCIUM ION;NEURAMINIDASE N9;11309;
3NNG;A;Crystal structure of the F5/8 type C domain of Q5LFR2_BACFN protein from Bacteroides fragilis. Northeast Structural Genomics Consortium Target BfR258E;2.18;CA;CALCIUM ION;uncharacterized protein;817;
3NNG;B;Crystal structure of the F5/8 type C domain of Q5LFR2_BACFN protein from Bacteroides fragilis. Northeast Structural Genomics Consortium Target BfR258E;2.18;CA;CALCIUM ION;uncharacterized protein;817;
3NOI;A;Crystal Structure of Natural Killer Cell Cytotoxicity Receptor NKp30 (NCR3);1.84;CA;CALCIUM ION;Natural cytotoxicity triggering receptor 3;9606;
3NOI;B;Crystal Structure of Natural Killer Cell Cytotoxicity Receptor NKp30 (NCR3);1.84;CA;CALCIUM ION;Natural cytotoxicity triggering receptor 3;9606;
3NOK;A;Crystal structure of Myxococcus xanthus Glutaminyl Cyclase;1.65;CA;CALCIUM ION;Glutaminyl Cyclase;34;
3NOK;B;Crystal structure of Myxococcus xanthus Glutaminyl Cyclase;1.65;CA;CALCIUM ION;Glutaminyl Cyclase;34;
3NOL;A;Crystal structure of Zymomonas mobilis Glutaminyl Cyclase (trigonal form);1.7;CA;CALCIUM ION;Glutamine cyclotransferase;542;
3NOM;A;Crystal Structure of Zymomonas mobilis Glutaminyl Cyclase (monoclinic form);2.4;CA;CALCIUM ION;Glutamine cyclotransferase;542;
3NOM;B;Crystal Structure of Zymomonas mobilis Glutaminyl Cyclase (monoclinic form);2.4;CA;CALCIUM ION;Glutamine cyclotransferase;542;
3NP5;A;Crystal structure of an abridged form of the mature ectodomain of the human receptor-type protein tyrosine phosphatase ICA512/IA-2 AT pH 4.5;1.8;CA;CALCIUM ION;Receptor-type tyrosine-protein phosphatase-like N;9606;
3NP5;D;Crystal structure of an abridged form of the mature ectodomain of the human receptor-type protein tyrosine phosphatase ICA512/IA-2 AT pH 4.5;1.8;CA;CALCIUM ION;Receptor-type tyrosine-protein phosphatase-like N;9606;
3NP6;B;The crystal structure of Berberine bound to DNA d(CGTACG);2.3;CA;CALCIUM ION;5'-D(*CP*GP*TP*AP*CP*G)-3';;
3NP8;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS L36A at cryogenic temperature;1.7;CA;CALCIUM ION;Thermonuclease;1280;
3NQN;A;Crystal structure of a Protein with unknown function. (DR_2006) from DEINOCOCCUS RADIODURANS at 1.88 A resolution;1.88;CA;CALCIUM ION;uncharacterized protein;1299;
3NQN;B;Crystal structure of a Protein with unknown function. (DR_2006) from DEINOCOCCUS RADIODURANS at 1.88 A resolution;1.88;CA;CALCIUM ION;uncharacterized protein;1299;
3NQT;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS V66A at cryogenic temperature;1.9;CA;CALCIUM ION;Thermonuclease;1280;
3NQX;A;Crystal structure of vibriolysin MCP-02 mature enzyme, a zinc metalloprotease from M4 family;1.7;CA;CALCIUM ION;Secreted metalloprotease Mcp02;234831;
3NQY;B;Crystal structure of the autoprocessed complex of Vibriolysin MCP-02 with a single point mutation E346A;2.6;CA;CALCIUM ION;Secreted metalloprotease Mcp02;234831;
3NQZ;B;Crystal structure of the autoprocessed Vibriolysin MCP-02 with E369A mutation;2.05;CA;CALCIUM ION;Secreted metalloprotease Mcp02;234831;
3NSJ;A;The X-ray crystal structure of lymphocyte perforin;2.75;CA;CALCIUM ION;Perforin-1;10090;
3NSS;A;The 2009 pandemic H1N1 neuraminidase N1 lacks the 150-cavity in its active sites;1.9;CA;CALCIUM ION;Neuraminidase;11320;
3NSS;B;The 2009 pandemic H1N1 neuraminidase N1 lacks the 150-cavity in its active sites;1.9;CA;CALCIUM ION;Neuraminidase;11320;
3NTL;B;Crystal Structure of Glucose-1-phosphatase (AgpE) from Enterobacter cloacae;1.88;CA;CALCIUM ION;Acid glucose-1-phosphate phosphatase;550;
3NUC;A;STAPHLOCOCCAL NUCLEASE, 1-N-PROPANE THIOL DISULFIDE TO V23C VARIANT;1.9;CA;CALCIUM ION;STAPHYLOCOCCAL NUCLEASE;1280;
3NUR;A;Crystal structure of a putative amidohydrolase from Staphylococcus aureus;1.75;CA;CALCIUM ION;Amidohydrolase;1280;
3NVN;B;Molecular mechanism of guidance cue recognition;2.26;CA;CALCIUM ION;Plexin-C1;9606;
3NWK;A;A second C2221 form of concanavalin A (Canavalia ensiformis);2.09;CA;CALCIUM ION;Concanavalin-A;3823;
3NWK;B;A second C2221 form of concanavalin A (Canavalia ensiformis);2.09;CA;CALCIUM ION;Concanavalin-A;3823;
3NWK;C;A second C2221 form of concanavalin A (Canavalia ensiformis);2.09;CA;CALCIUM ION;Concanavalin-A;3823;
3NWK;D;A second C2221 form of concanavalin A (Canavalia ensiformis);2.09;CA;CALCIUM ION;Concanavalin-A;3823;
3NX5;D;The crystal structure of Sanguinarine bound to DNA d(CGTACG);2.31;CA;CALCIUM ION;5'-D(*CP*GP*TP*AP*CP*G)-3';;
3NX7;A;Crystal structure of the catalytic domain of human MMP12 complexed with the inhibitor N-Hydroxy-2-(N-(2-hydroxyethyl)4-methoxyphenylsulfonamido)acetamide;1.8;CA;CALCIUM ION;Macrophage metalloelastase;9606;
3NXW;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS L125A at cryogenic temperature;1.65;CA;CALCIUM ION;Thermonuclease;1280;
3NYH;A;Crystal structure of lactoperoxidase complexed simultaneously with thiocyanate ion, iodide ion, bromide ion, chloride ion through the substrate diffusion channel reveals a preferential queue of the inorganic substrates towards the distal heme cavity;1.77;CA;CALCIUM ION;Lactoperoxidase;9913;
3NZE;B;The crystal structure of a domain of a possible sugar-binding transcriptional regulator from Arthrobacter aurescens TC1.;1.7;CA;CALCIUM ION;Putative transcriptional regulator, sugar-binding family;43663;
3O03;A;Quaternary complex structure of gluconate 5-dehydrogenase from streptococcus suis type 2;1.9;CA;CALCIUM ION;Dehydrogenase with different specificities;1307;
3O0R;C;Crystal structure of nitric oxide reductase from Pseudomonas aeruginosa in complex with antibody fragment;2.7;CA;CALCIUM ION;Nitric oxide reductase subunit C;287;
3O0V;A;Crystal structure of the calreticulin lectin domain;2.3;CA;CALCIUM ION;Calreticulin;10090;
3O0W;A;Structural basis of carbohydrate recognition by calreticulin;1.95;CA;CALCIUM ION;Calreticulin;10090;
3O0X;A;Structural basis of carbohydrate recognition by calreticulin;2.01;CA;CALCIUM ION;Calreticulin;10090;
3O0X;B;Structural basis of carbohydrate recognition by calreticulin;2.01;CA;CALCIUM ION;Calreticulin;10090;
3O2X;A;MMP-13 in complex with selective tetrazole core inhibitor;1.9;CA;CALCIUM ION;Collagenase 3;9606;
3O2X;B;MMP-13 in complex with selective tetrazole core inhibitor;1.9;CA;CALCIUM ION;Collagenase 3;9606;
3O2X;C;MMP-13 in complex with selective tetrazole core inhibitor;1.9;CA;CALCIUM ION;Collagenase 3;9606;
3O2X;D;MMP-13 in complex with selective tetrazole core inhibitor;1.9;CA;CALCIUM ION;Collagenase 3;9606;
3O3G;A;T. maritima RNase H2 in complex with nucleic acid substrate and calcium ions;2.1;CA;CALCIUM ION;Ribonuclease HII;2336;
3O3G;C;T. maritima RNase H2 in complex with nucleic acid substrate and calcium ions;2.1;CA;CALCIUM ION;DNA (5'-D(*GP*AP*AP*TP*CP*AP*GP*GP*TP*GP*TP*C)-3');;
3O4M;A;Crystal structure of porcine pancreatic phospholipase A2 in complex with 1,2-dihydroxybenzene;2.5;CA;CALCIUM ION;Phospholipase A2, major isoenzyme;9823;
3O4P;A;DFPase at 0.85 Angstrom resolution (H atoms included);0.85;CA;CALCIUM ION;Diisopropyl-fluorophosphatase;6622;
3O4Y;A;Crystal structure of CAD domain of the Plasmodium Vivax CDPK, PVX_11610;2.2;CA;CALCIUM ION;Calcium-dependent protein kinase 3;5855;
3O5C;A;Cytochrome c Peroxidase BccP of Shewanella oneidensis;1.8;CA;CALCIUM ION;Cytochrome c551 peroxidase;70863;
3O5C;B;Cytochrome c Peroxidase BccP of Shewanella oneidensis;1.8;CA;CALCIUM ION;Cytochrome c551 peroxidase;70863;
3O5C;C;Cytochrome c Peroxidase BccP of Shewanella oneidensis;1.8;CA;CALCIUM ION;Cytochrome c551 peroxidase;70863;
3O5C;D;Cytochrome c Peroxidase BccP of Shewanella oneidensis;1.8;CA;CALCIUM ION;Cytochrome c551 peroxidase;70863;
3O5S;A;Crystal Structure of the endo-beta-1,3-1,4 glucanase from Bacillus subtilis (strain 168);2.2;CA;CALCIUM ION;Beta-glucanase;1423;
3O64;A;Crystal structure of catalytic domain of TACE with 2-(2-Aminothiazol-4-yl)pyrrolidine-Based Tartrate Diamides;1.88;CA;CALCIUM ION;TACE;9606;
3O77;A;The structure of Ca2+ Sensor (Case-16);2.35;CA;CALCIUM ION;Myosin light chain kinase, smooth muscle,Green fluorescent protein,Green fluorescent protein,Calmodulin-1;610,090,319,606;
3O78;A;The structure of Ca2+ Sensor (Case-12);2.6;CA;CALCIUM ION;Myosin light chain kinase, smooth muscle,Green fluorescent protein,Green fluorescent protein,Calmodulin-1;610,090,319,606;
3O78;B;The structure of Ca2+ Sensor (Case-12);2.6;CA;CALCIUM ION;Myosin light chain kinase, smooth muscle,Green fluorescent protein,Green fluorescent protein,Calmodulin-1;610,090,319,606;
3O82;A;Structure of BasE N-terminal domain from Acinetobacter baumannii bound to 5'-O-[N-(2,3-dihydroxybenzoyl)sulfamoyl] adenosine;2.7;CA;CALCIUM ION;Peptide arylation enzyme;470;
3O82;B;Structure of BasE N-terminal domain from Acinetobacter baumannii bound to 5'-O-[N-(2,3-dihydroxybenzoyl)sulfamoyl] adenosine;2.7;CA;CALCIUM ION;Peptide arylation enzyme;470;
3O83;A;Structure of BasE N-terminal domain from Acinetobacter baumannii bound to 2-(4-n-dodecyl-1,2,3-triazol-1-yl)-5'-O-[N-(2-hydroxybenzoyl)sulfamoyl]adenosine;1.9;CA;CALCIUM ION;Peptide arylation enzyme;470;
3O83;B;Structure of BasE N-terminal domain from Acinetobacter baumannii bound to 2-(4-n-dodecyl-1,2,3-triazol-1-yl)-5'-O-[N-(2-hydroxybenzoyl)sulfamoyl]adenosine;1.9;CA;CALCIUM ION;Peptide arylation enzyme;470;
3O84;A;Structure of BasE N-terminal domain from Acinetobacter baumannii bound to 6-phenyl-1-(pyridin-4-ylmethyl)-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid.;2.1;CA;CALCIUM ION;Peptide arylation enzyme;470;
3O84;B;Structure of BasE N-terminal domain from Acinetobacter baumannii bound to 6-phenyl-1-(pyridin-4-ylmethyl)-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid.;2.1;CA;CALCIUM ION;Peptide arylation enzyme;470;
3O9J;A;Influenza NA in complex with compound 5;2;CA;CALCIUM ION;Neuraminidase;11320;
3ODH;A;Structure of OkrAI/DNA complex;2.3;CA;CALCIUM ION;OkrAI endonuclease;64972;
3ODH;B;Structure of OkrAI/DNA complex;2.3;CA;CALCIUM ION;OkrAI endonuclease;64972;
3ODH;E;Structure of OkrAI/DNA complex;2.3;CA;CALCIUM ION;OkrAI endonuclease;64972;
3ODH;F;Structure of OkrAI/DNA complex;2.3;CA;CALCIUM ION;OkrAI endonuclease;64972;
3ODH;H;Structure of OkrAI/DNA complex;2.3;CA;CALCIUM ION;DNA (5'-D(*TP*AP*TP*GP*GP*AP*TP*CP*CP*AP*TP*A)-3');;
3ODT;A;Crystal structure of WD40 beta propeller domain of Doa1;1.35;CA;CALCIUM ION;Protein DOA1;4932;
3ODT;B;Crystal structure of WD40 beta propeller domain of Doa1;1.35;CA;CALCIUM ION;Protein DOA1;4932;
3OEA;A;Crystal structure of the Q121E mutants of C.polysaccharolyticus CBM16-1 bound to cellopentaose;1.35;CA;CALCIUM ION;S-layer associated multidomain endoglucanase;44256;
3OEA;B;Crystal structure of the Q121E mutants of C.polysaccharolyticus CBM16-1 bound to cellopentaose;1.35;CA;CALCIUM ION;S-layer associated multidomain endoglucanase;44256;
3OEB;A;Crystal structure of the Q121E mutant of C.polysaccharolyticus CBM16-1 bound to mannopentaose;1.55;CA;CALCIUM ION;S-layer associated multidomain endoglucanase;44256;
3OGW;A;Structure of the complex of bovine lactoperoxidase with indomethacin at 1.9A resolution;1.89;CA;CALCIUM ION;Lactoperoxidase;9913;
3OHE;A;Crystal structure of a Histidine triad protein (Maqu_1709) from Marinobacter aquaeolei VT8 at 1.20 A resolution;1.2;CA;CALCIUM ION;Histidine triad (HIT) protein;2743;
3OHE;B;Crystal structure of a Histidine triad protein (Maqu_1709) from Marinobacter aquaeolei VT8 at 1.20 A resolution;1.2;CA;CALCIUM ION;Histidine triad (HIT) protein;2743;
3OHL;A;catalytic domain of stromelysin-1 in complex with N-Hydroxy-2-(4-methoxy-N-(pyridine-3-ylmethyl)phenylsulfonamido)acetamide;2.36;CA;CALCIUM ION;Stromelysin-1;9606;
3OHM;B;Crystal structure of activated G alpha Q bound to its effector phospholipase C beta 3;2.7;CA;CALCIUM ION;1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase beta-3;9606;
3OHO;A;catalytic domain of stromelysin-1 in complex with N-Hydroxy-2-(4-methylphenylsulfonamido)acetamide;2.5;CA;CALCIUM ION;Stromelysin-1;9606;
3OIU;A;H-RasQ61L with allosteric switch in the 'on' state;1.32;CA;CALCIUM ION;GTPase HRas;9606;
3OIV;A;H-RasG12V with allosteric switch in the 'off' state;1.84;CA;CALCIUM ION;GTPase HRas;9606;
3OIW;A;H-RasG12V with allosteric switch in the 'on' state;1.3;CA;CALCIUM ION;GTPase HRas;9606;
3OJC;A;Crystal structure of a putative Asp/Glu Racemase from Yersinia pestis;1.75;CA;CALCIUM ION;Putative aspartate/glutamate racemase;632;
3OJC;B;Crystal structure of a putative Asp/Glu Racemase from Yersinia pestis;1.75;CA;CALCIUM ION;Putative aspartate/glutamate racemase;632;
3OJJ;B;Structure of Co-substituted Homoprotocatechuate 2,3-Dioxygenase from B.fuscum at 1.72 Ang resolution;1.72;CA;CALCIUM ION;Homoprotocatechuate 2,3-dioxygenase;47914;
3OJK;B;Structure of Co-substituted Homoprotocatechuate 2,3-Dioxygenase in complex with 4-nitrocatechol at 1.68 Ang resolution;1.68;CA;CALCIUM ION;Homoprotocatechuate 2,3-dioxygenase;47914;
3OJN;B;Structure of Mn-substituted Homoprotocatechuate 2,3-Dioxygenase at 1.65 Ang resolution;1.65;CA;CALCIUM ION;Homoprotocatechuate 2,3-dioxygenase;47914;
3OJT;B;Structure of native Fe-containing Homoprotocatechuate 2,3-Dioxygenase at 1.70 Ang resolution;1.7;CA;CALCIUM ION;Homoprotocatechuate 2,3-dioxygenase;47914;
3OJY;A;Crystal Structure of Human Complement Component C8;2.51;CA;CALCIUM ION;Complement component C8 alpha chain;9606;
3OJY;B;Crystal Structure of Human Complement Component C8;2.51;CA;CALCIUM ION;Complement component C8 beta chain;9606;
3OLD;A;Crystal structure of alpha-amylase in complex with acarviostatin I03;2;CA;CALCIUM ION;Pancreatic alpha-amylase;9606;
3OLE;A;Structures of human pancreatic alpha-amylase in complex with acarviostatin II03;1.55;CA;CALCIUM ION;Pancreatic alpha-amylase;9606;
3OLG;A;Structures of human pancreatic alpha-amylase in complex with acarviostatin III03;2.3;CA;CALCIUM ION;Pancreatic alpha-amylase;9606;
3OLI;A;Structures of human pancreatic alpha-amylase in complex with acarviostatin IV03;1.5;CA;CALCIUM ION;Pancreatic alpha-amylase;9606;
3OM2;A;Crystal structure of B. megaterium levansucrase mutant D257A;1.9;CA;CALCIUM ION;Levansucrase;1404;
3OM3;A;Catalytic core subunits (I and II) of cytochrome C oxidase from Rhodobacter sphaeroides with K362M mutation in the reduced state;2.6;CA;CALCIUM ION;Cytochrome c oxidase, aa3 type, subunit I;1063;
3OM3;C;Catalytic core subunits (I and II) of cytochrome C oxidase from Rhodobacter sphaeroides with K362M mutation in the reduced state;2.6;CA;CALCIUM ION;Cytochrome c oxidase, aa3 type, subunit I;1063;
3OM4;A;Crystal structure of B. megaterium levansucrase mutant K373A;1.75;CA;CALCIUM ION;Levansucrase;1404;
3OM4;B;Crystal structure of B. megaterium levansucrase mutant K373A;1.75;CA;CALCIUM ION;Levansucrase;1404;
3OM4;C;Crystal structure of B. megaterium levansucrase mutant K373A;1.75;CA;CALCIUM ION;Levansucrase;1404;
3OM4;D;Crystal structure of B. megaterium levansucrase mutant K373A;1.75;CA;CALCIUM ION;Levansucrase;1404;
3OM5;A;Crystal structure of B. megaterium levansucrase mutant N252A;1.95;CA;CALCIUM ION;Levansucrase;1404;
3OM5;B;Crystal structure of B. megaterium levansucrase mutant N252A;1.95;CA;CALCIUM ION;Levansucrase;1404;
3OM5;C;Crystal structure of B. megaterium levansucrase mutant N252A;1.95;CA;CALCIUM ION;Levansucrase;1404;
3OM5;D;Crystal structure of B. megaterium levansucrase mutant N252A;1.95;CA;CALCIUM ION;Levansucrase;1404;
3OM6;A;Crystal structure of B. megaterium levansucrase mutant Y247A;1.96;CA;CALCIUM ION;Levansucrase;1404;
3OM6;B;Crystal structure of B. megaterium levansucrase mutant Y247A;1.96;CA;CALCIUM ION;Levansucrase;1404;
3OM6;C;Crystal structure of B. megaterium levansucrase mutant Y247A;1.96;CA;CALCIUM ION;Levansucrase;1404;
3OM6;D;Crystal structure of B. megaterium levansucrase mutant Y247A;1.96;CA;CALCIUM ION;Levansucrase;1404;
3OM7;A;Crystal structure of B. megaterium levansucrase mutant Y247W;1.86;CA;CALCIUM ION;Levansucrase;1404;
3OM7;B;Crystal structure of B. megaterium levansucrase mutant Y247W;1.86;CA;CALCIUM ION;Levansucrase;1404;
3OM7;C;Crystal structure of B. megaterium levansucrase mutant Y247W;1.86;CA;CALCIUM ION;Levansucrase;1404;
3OM7;D;Crystal structure of B. megaterium levansucrase mutant Y247W;1.86;CA;CALCIUM ION;Levansucrase;1404;
3OMA;A;Catalytic core subunits (I and II) of cytochrome C oxidase from Rhodobacter sphaeroides with K362M mutation;2.3;CA;CALCIUM ION;Cytochrome c oxidase, aa3 type, subunit I;1063;
3OMA;C;Catalytic core subunits (I and II) of cytochrome C oxidase from Rhodobacter sphaeroides with K362M mutation;2.3;CA;CALCIUM ION;Cytochrome c oxidase, aa3 type, subunit I;1063;
3OMI;A;Catalytic core subunits (I and II) of cytochrome C oxidase from Rhodobacter sphaeroides with D132A mutation;2.15;CA;CALCIUM ION;Cytochrome c oxidase, aa3 type, subunit I;1063;
3OMI;C;Catalytic core subunits (I and II) of cytochrome C oxidase from Rhodobacter sphaeroides with D132A mutation;2.15;CA;CALCIUM ION;Cytochrome c oxidase, aa3 type, subunit I;1063;
3OMJ;A;Structural Basis for Cyclic Py-Im Polyamide Allosteric Inhibition of Nuclear Receptor Binding;0.95;CA;CALCIUM ION;5'-D(*CP*(C38)P*AP*GP*TP*AP*CP*TP*GP*G)-3';;
3OMJ;B;Structural Basis for Cyclic Py-Im Polyamide Allosteric Inhibition of Nuclear Receptor Binding;0.95;CA;CALCIUM ION;5'-D(*CP*(C38)P*AP*GP*TP*AP*CP*TP*GP*G)-3';;
3OMN;A;Catalytic core subunits (I and II) of cytochrome C oxidase from Rhodobacter sphaeroides with D132A mutation in the reduced state;2.15;CA;CALCIUM ION;Cytochrome c oxidase, aa3 type, subunit I;1063;
3OMN;C;Catalytic core subunits (I and II) of cytochrome C oxidase from Rhodobacter sphaeroides with D132A mutation in the reduced state;2.15;CA;CALCIUM ION;Cytochrome c oxidase, aa3 type, subunit I;1063;
3ONR;A;Crystal structure of the calcium chelating immunodominant antigen, calcium dodecin (Rv0379),from Mycobacterium tuberculosis with a novel calcium-binding site;1.8;CA;CALCIUM ION;PROTEIN TRANSPORT PROTEIN SECE2;1773;
3ONR;D;Crystal structure of the calcium chelating immunodominant antigen, calcium dodecin (Rv0379),from Mycobacterium tuberculosis with a novel calcium-binding site;1.8;CA;CALCIUM ION;PROTEIN TRANSPORT PROTEIN SECE2;1773;
3ONR;G;Crystal structure of the calcium chelating immunodominant antigen, calcium dodecin (Rv0379),from Mycobacterium tuberculosis with a novel calcium-binding site;1.8;CA;CALCIUM ION;PROTEIN TRANSPORT PROTEIN SECE2;1773;
3ONR;J;Crystal structure of the calcium chelating immunodominant antigen, calcium dodecin (Rv0379),from Mycobacterium tuberculosis with a novel calcium-binding site;1.8;CA;CALCIUM ION;PROTEIN TRANSPORT PROTEIN SECE2;1773;
3OOL;A;I-SceI complexed with C/G+4 DNA substrate;2.3;CA;CALCIUM ION;Intron encoded endonuclease I-SceI;4932;
3OOL;C;I-SceI complexed with C/G+4 DNA substrate;2.3;CA;CALCIUM ION;5'-D(*CP*AP*CP*GP*CP*TP*AP*GP*GP*GP*AP*TP*AP*AP*CP*CP*GP*GP*GP*TP*AP*AP*TP*AP*C)-3';;
3OOR;A;I-SceI mutant (K86R/G100T)complexed with C/G+4 DNA substrate;2.5;CA;CALCIUM ION;Intron encoded endonuclease I-SceI;4932;
3OOR;D;I-SceI mutant (K86R/G100T)complexed with C/G+4 DNA substrate;2.5;CA;CALCIUM ION;5'-D(*GP*GP*TP*AP*TP*TP*AP*CP*CP*CP*GP*GP*TP*TP*AP*TP*CP*CP*CP*TP*AP*GP*CP*GP*T)-3';;
3OOY;A;Crystal structure of human Transketolase (TKT);2.05;CA;CALCIUM ION;Transketolase;9606;
3OOY;B;Crystal structure of human Transketolase (TKT);2.05;CA;CALCIUM ION;Transketolase;9606;
3OPU;A;Crystal structure of the C-terminal domain of Streptococcus mutans surface protein SpaP;2.18;CA;CALCIUM ION;SpaP;1309;
3OPU;B;Crystal structure of the C-terminal domain of Streptococcus mutans surface protein SpaP;2.18;CA;CALCIUM ION;SpaP;1309;
3OPU;C;Crystal structure of the C-terminal domain of Streptococcus mutans surface protein SpaP;2.18;CA;CALCIUM ION;SpaP;1309;
3OPU;D;Crystal structure of the C-terminal domain of Streptococcus mutans surface protein SpaP;2.18;CA;CALCIUM ION;SpaP;1309;
3OPU;E;Crystal structure of the C-terminal domain of Streptococcus mutans surface protein SpaP;2.18;CA;CALCIUM ION;SpaP;1309;
3OPU;F;Crystal structure of the C-terminal domain of Streptococcus mutans surface protein SpaP;2.18;CA;CALCIUM ION;SpaP;1309;
3OQQ;A;Crystal structure of a Putative lipoprotein (BACOVA_00967) from Bacteroides ovatus at 2.08 A resolution;2.08;CA;CALCIUM ION;Putative lipoprotein;28116;
3OR3;A;Restriction endonuclease HPY188I in complex with product DNA;1.95;CA;CALCIUM ION;RESTRICTION ENDONUCLEASE HPY188I;210;
3ORV;A;Crystal Structure of the Y294H-MauG/pre-Methylamine Dehydrogenase Complex;1.91;CA;CALCIUM ION;Methylamine utilization protein mauG;266;
3ORV;B;Crystal Structure of the Y294H-MauG/pre-Methylamine Dehydrogenase Complex;1.91;CA;CALCIUM ION;Methylamine utilization protein mauG;266;
3OSH;A;Crystal Structure of The Complex of Group 1 Phospholipase A2 With Atropin At 1.5 A Resolution;1.5;CA;CALCIUM ION;Phospholipase A2 isoform 3;195058;
3OSO;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS L25A at cryogenic temperature;1.6;CA;CALCIUM ION;Thermonuclease;1280;
3OSS;D;The crystal structure of enterotoxigenic Escherichia coli GspC-GspD complex from the type II secretion system;2.63;CA;CALCIUM ION;TYPE 2 SECRETION SYSTEM, SECRETIN GSPD;562;
3OSZ;A;Crystal Structure of the complex of proteinase K with an antimicrobial nonapeptide, at 2.26 A resolution;2.26;CA;CALCIUM ION;Proteinase K;37998;
3OTJ;E;A Crystal Structure of Trypsin Complexed with BPTI (Bovine Pancreatic Trypsin Inhibitor) by X-ray/Neutron Joint Refinement;;CA;CALCIUM ION;Cationic trypsin;9913;
3OUU;A;Crystal Structure of Biotin Carboxylase-beta-gamma-ATP Complex from Campylobacter jejuni;2.25;CA;CALCIUM ION;Biotin carboxylase;197;
3OUU;B;Crystal Structure of Biotin Carboxylase-beta-gamma-ATP Complex from Campylobacter jejuni;2.25;CA;CALCIUM ION;Biotin carboxylase;197;
3OVS;A;How the CCA-adding Enzyme Selects Adenine over Cytosine in Position 76 of tRNA;2.8;CA;CALCIUM ION;CCA-Adding Enzyme;2234;
3OWF;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS V66R at cryogenic temperature;1.85;CA;CALCIUM ION;Thermonuclease;1280;
3OWM;A;Structure of the Thioalkalivibrio nitratireducens cytochrome c nitrite reductase in a complex with hydroxylamine;1.65;CA;CALCIUM ION;Eight-heme nitrite reductase;186931;
3OWM;B;Structure of the Thioalkalivibrio nitratireducens cytochrome c nitrite reductase in a complex with hydroxylamine;1.65;CA;CALCIUM ION;Eight-heme nitrite reductase;186931;
3OX5;A;Crystal Structure of the calcium sensor calcium-binding protein 1 (CaBP1);2.9;CA;CALCIUM ION;Calcium-binding protein 1;9606;
3OX5;B;Crystal Structure of the calcium sensor calcium-binding protein 1 (CaBP1);2.9;CA;CALCIUM ION;Calcium-binding protein 1;9606;
3OX5;C;Crystal Structure of the calcium sensor calcium-binding protein 1 (CaBP1);2.9;CA;CALCIUM ION;Calcium-binding protein 1;9606;
3OX5;D;Crystal Structure of the calcium sensor calcium-binding protein 1 (CaBP1);2.9;CA;CALCIUM ION;Calcium-binding protein 1;9606;
3OX5;E;Crystal Structure of the calcium sensor calcium-binding protein 1 (CaBP1);2.9;CA;CALCIUM ION;Calcium-binding protein 1;9606;
3OX5;F;Crystal Structure of the calcium sensor calcium-binding protein 1 (CaBP1);2.9;CA;CALCIUM ION;Calcium-binding protein 1;9606;
3OX6;A;Crystal Structure of the calcium sensor calcium-binding protein 1 (CaBP1);2.4;CA;CALCIUM ION;Calcium-binding protein 1;9606;
3OX6;B;Crystal Structure of the calcium sensor calcium-binding protein 1 (CaBP1);2.4;CA;CALCIUM ION;Calcium-binding protein 1;9606;
3OX6;C;Crystal Structure of the calcium sensor calcium-binding protein 1 (CaBP1);2.4;CA;CALCIUM ION;Calcium-binding protein 1;9606;
3OX6;D;Crystal Structure of the calcium sensor calcium-binding protein 1 (CaBP1);2.4;CA;CALCIUM ION;Calcium-binding protein 1;9606;
3OX6;E;Crystal Structure of the calcium sensor calcium-binding protein 1 (CaBP1);2.4;CA;CALCIUM ION;Calcium-binding protein 1;9606;
3OX6;F;Crystal Structure of the calcium sensor calcium-binding protein 1 (CaBP1);2.4;CA;CALCIUM ION;Calcium-binding protein 1;9606;
3OXQ;A;Crystal Structure of Ca2+/CaM-CaV1.2 pre-IQ/IQ domain complex;2.55;CA;CALCIUM ION;Calmodulin;9606;
3OXQ;B;Crystal Structure of Ca2+/CaM-CaV1.2 pre-IQ/IQ domain complex;2.55;CA;CALCIUM ION;Calmodulin;9606;
3OXQ;C;Crystal Structure of Ca2+/CaM-CaV1.2 pre-IQ/IQ domain complex;2.55;CA;CALCIUM ION;Calmodulin;9606;
3OXQ;D;Crystal Structure of Ca2+/CaM-CaV1.2 pre-IQ/IQ domain complex;2.55;CA;CALCIUM ION;Calmodulin;9606;
3OYO;A;Crystal structure of hemopexin fold protein CP4 from cow pea;2.1;CA;CALCIUM ION;hemopexin fold protein CP4;3917;
3OYO;B;Crystal structure of hemopexin fold protein CP4 from cow pea;2.1;CA;CALCIUM ION;hemopexin fold protein CP4;3917;
3OYR;B;Crystal structure of polyprenyl synthase from Caulobacter crescentus CB15 complexed with calcium and isoprenyl diphosphate;2;CA;CALCIUM ION;Trans-isoprenyl diphosphate synthase;155892;
3P0V;H;anti-EGFR/HER3 Fab DL11 alone;2.85;CA;CALCIUM ION;Fab DL11 heavy chain;9606;
3P0V;I;anti-EGFR/HER3 Fab DL11 alone;2.85;CA;CALCIUM ION;Fab DL11 heavy chain;9606;
3P1H;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS V23K/I92A at cryogenic temperature;1.79;CA;CALCIUM ION;thermonuclease;1280;
3P1O;A;Crystal structure of human 14-3-3 sigma in complex with TASK-3 peptide and stabilisator Fusicoccin A;1.9;CA;CALCIUM ION;14-3-3 protein sigma;9606;
3P1Q;A;Crystal structure of human 14-3-3 sigma C38N/N166H in complex with TASK-3 Peptide and stabilizer fusicoccin A;1.7;CA;CALCIUM ION;14-3-3 protein sigma;9606;
3P1R;A;Crystal structure of human 14-3-3 sigma C38V/N166H in complex with TASK-3 peptide;1.7;CA;CALCIUM ION;14-3-3 protein sigma;9606;
3P2P;A;ENHANCED ACTIVITY AND ALTERED SPECIFICITY OF PHOSPHOLIPASE A2 BY DELETION OF A SURFACE LOOP;2.1;CA;CALCIUM ION;PHOSPHOLIPASE A2;9823;
3P2P;B;ENHANCED ACTIVITY AND ALTERED SPECIFICITY OF PHOSPHOLIPASE A2 BY DELETION OF A SURFACE LOOP;2.1;CA;CALCIUM ION;PHOSPHOLIPASE A2;9823;
3P2Y;A;Crystal structure of alanine dehydrogenase/pyridine nucleotide transhydrogenase from Mycobacterium smegmatis;1.82;CA;CALCIUM ION;Alanine dehydrogenase/pyridine nucleotide transhydrogenase;1772;
3P4G;A;X-ray crystal structure of a hyperactive, Ca2+-dependent, beta-helical antifreeze protein from an Antarctic bacterium;1.7;CA;CALCIUM ION;Antifreeze protein;178399;
3P4G;B;X-ray crystal structure of a hyperactive, Ca2+-dependent, beta-helical antifreeze protein from an Antarctic bacterium;1.7;CA;CALCIUM ION;Antifreeze protein;178399;
3P4G;C;X-ray crystal structure of a hyperactive, Ca2+-dependent, beta-helical antifreeze protein from an Antarctic bacterium;1.7;CA;CALCIUM ION;Antifreeze protein;178399;
3P4G;D;X-ray crystal structure of a hyperactive, Ca2+-dependent, beta-helical antifreeze protein from an Antarctic bacterium;1.7;CA;CALCIUM ION;Antifreeze protein;178399;
3P5B;A;The structure of the LDLR/PCSK9 complex reveals the receptor in an extended conformation;3.3;CA;CALCIUM ION;Proprotein convertase subtilisin/kexin type 9;9606;
3P5B;L;The structure of the LDLR/PCSK9 complex reveals the receptor in an extended conformation;3.3;CA;CALCIUM ION;Low density lipoprotein receptor variant;9606;
3P5C;A;The structure of the LDLR/PCSK9 complex reveals the receptor in an extended conformation;4.2;CA;CALCIUM ION;Proprotein convertase subtilisin/kexin type 9;9606;
3P5C;L;The structure of the LDLR/PCSK9 complex reveals the receptor in an extended conformation;4.2;CA;CALCIUM ION;Low density lipoprotein receptor variant;9606;
3P5D;A;Structure of the carbohydrate-recognition domain of human Langerin with man5 (Man alpha1-3(Man alpha1-6)Man alpha1-6)(Man- alpha1-3)Man;1.8;CA;CALCIUM ION;C-type lectin domain family 4 member K;9606;
3P5D;B;Structure of the carbohydrate-recognition domain of human Langerin with man5 (Man alpha1-3(Man alpha1-6)Man alpha1-6)(Man- alpha1-3)Man;1.8;CA;CALCIUM ION;C-type lectin domain family 4 member K;9606;
3P5D;C;Structure of the carbohydrate-recognition domain of human Langerin with man5 (Man alpha1-3(Man alpha1-6)Man alpha1-6)(Man- alpha1-3)Man;1.8;CA;CALCIUM ION;C-type lectin domain family 4 member K;9606;
3P5D;D;Structure of the carbohydrate-recognition domain of human Langerin with man5 (Man alpha1-3(Man alpha1-6)Man alpha1-6)(Man- alpha1-3)Man;1.8;CA;CALCIUM ION;C-type lectin domain family 4 member K;9606;
3P5E;A;Structure of the carbohydrate-recognition domain of human Langerin with man4 (Man alpha1-3(Man alpha1-6)Man alpha1-6Man);1.7;CA;CALCIUM ION;C-type lectin domain family 4 member K;9606;
3P5E;B;Structure of the carbohydrate-recognition domain of human Langerin with man4 (Man alpha1-3(Man alpha1-6)Man alpha1-6Man);1.7;CA;CALCIUM ION;C-type lectin domain family 4 member K;9606;
3P5E;C;Structure of the carbohydrate-recognition domain of human Langerin with man4 (Man alpha1-3(Man alpha1-6)Man alpha1-6Man);1.7;CA;CALCIUM ION;C-type lectin domain family 4 member K;9606;
3P5E;D;Structure of the carbohydrate-recognition domain of human Langerin with man4 (Man alpha1-3(Man alpha1-6)Man alpha1-6Man);1.7;CA;CALCIUM ION;C-type lectin domain family 4 member K;9606;
3P5F;A;Structure of the carbohydrate-recognition domain of human Langerin with man2 (Man alpha1-2 Man);1.75;CA;CALCIUM ION;C-type lectin domain family 4 member K;9606;
3P5F;B;Structure of the carbohydrate-recognition domain of human Langerin with man2 (Man alpha1-2 Man);1.75;CA;CALCIUM ION;C-type lectin domain family 4 member K;9606;
3P5F;C;Structure of the carbohydrate-recognition domain of human Langerin with man2 (Man alpha1-2 Man);1.75;CA;CALCIUM ION;C-type lectin domain family 4 member K;9606;
3P5F;D;Structure of the carbohydrate-recognition domain of human Langerin with man2 (Man alpha1-2 Man);1.75;CA;CALCIUM ION;C-type lectin domain family 4 member K;9606;
3P5G;A;Structure of the carbohydrate-recognition domain of human Langerin with Blood group B trisaccharide (Gal alpha1-3(Fuc alpha1-2)Gal);1.6;CA;CALCIUM ION;C-type lectin domain family 4 member K;9606;
3P5G;B;Structure of the carbohydrate-recognition domain of human Langerin with Blood group B trisaccharide (Gal alpha1-3(Fuc alpha1-2)Gal);1.6;CA;CALCIUM ION;C-type lectin domain family 4 member K;9606;
3P5G;C;Structure of the carbohydrate-recognition domain of human Langerin with Blood group B trisaccharide (Gal alpha1-3(Fuc alpha1-2)Gal);1.6;CA;CALCIUM ION;C-type lectin domain family 4 member K;9606;
3P5G;D;Structure of the carbohydrate-recognition domain of human Langerin with Blood group B trisaccharide (Gal alpha1-3(Fuc alpha1-2)Gal);1.6;CA;CALCIUM ION;C-type lectin domain family 4 member K;9606;
3P5H;A;Structure of the carbohydrate-recognition domain of human Langerin with Laminaritriose;1.61;CA;CALCIUM ION;C-type lectin domain family 4 member K;9606;
3P5H;B;Structure of the carbohydrate-recognition domain of human Langerin with Laminaritriose;1.61;CA;CALCIUM ION;C-type lectin domain family 4 member K;9606;
3P5H;C;Structure of the carbohydrate-recognition domain of human Langerin with Laminaritriose;1.61;CA;CALCIUM ION;C-type lectin domain family 4 member K;9606;
3P5H;D;Structure of the carbohydrate-recognition domain of human Langerin with Laminaritriose;1.61;CA;CALCIUM ION;C-type lectin domain family 4 member K;9606;
3P5I;A;Structure of the carbohydrate-recognition domain of human Langerin with 6-SO4-Gal-GlcNAc;1.8;CA;CALCIUM ION;C-type lectin domain family 4 member K;9606;
3P5I;B;Structure of the carbohydrate-recognition domain of human Langerin with 6-SO4-Gal-GlcNAc;1.8;CA;CALCIUM ION;C-type lectin domain family 4 member K;9606;
3P5I;C;Structure of the carbohydrate-recognition domain of human Langerin with 6-SO4-Gal-GlcNAc;1.8;CA;CALCIUM ION;C-type lectin domain family 4 member K;9606;
3P5I;D;Structure of the carbohydrate-recognition domain of human Langerin with 6-SO4-Gal-GlcNAc;1.8;CA;CALCIUM ION;C-type lectin domain family 4 member K;9606;
3P6B;A;The crystal structure of CelK CBM4 from Clostridium thermocellum;2;CA;CALCIUM ION;Cellulose 1,4-beta-cellobiosidase;1515;
3P6B;B;The crystal structure of CelK CBM4 from Clostridium thermocellum;2;CA;CALCIUM ION;Cellulose 1,4-beta-cellobiosidase;1515;
3P75;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS V104D at cryogenic temperature;1.9;CA;CALCIUM ION;Thermonuclease;1280;
3P7F;A;Structure of the human Langerin carbohydrate recognition domain;2.5;CA;CALCIUM ION;C-type lectin domain family 4 member K;9606;
3P7F;B;Structure of the human Langerin carbohydrate recognition domain;2.5;CA;CALCIUM ION;C-type lectin domain family 4 member K;9606;
3P7F;C;Structure of the human Langerin carbohydrate recognition domain;2.5;CA;CALCIUM ION;C-type lectin domain family 4 member K;9606;
3P7F;D;Structure of the human Langerin carbohydrate recognition domain;2.5;CA;CALCIUM ION;C-type lectin domain family 4 member K;9606;
3P7G;A;Structure of the human Langerin carbohydrate recognition domain in complex with mannose;1.5;CA;CALCIUM ION;C-type lectin domain family 4 member K;9606;
3P7G;B;Structure of the human Langerin carbohydrate recognition domain in complex with mannose;1.5;CA;CALCIUM ION;C-type lectin domain family 4 member K;9606;
3P7G;C;Structure of the human Langerin carbohydrate recognition domain in complex with mannose;1.5;CA;CALCIUM ION;C-type lectin domain family 4 member K;9606;
3P7G;D;Structure of the human Langerin carbohydrate recognition domain in complex with mannose;1.5;CA;CALCIUM ION;C-type lectin domain family 4 member K;9606;
3P7H;A;Structure of the human Langerin carbohydrate recognition domain in complex with maltose;2.3;CA;CALCIUM ION;C-type lectin domain family 4 member K;9606;
3P7H;B;Structure of the human Langerin carbohydrate recognition domain in complex with maltose;2.3;CA;CALCIUM ION;C-type lectin domain family 4 member K;9606;
3P7H;C;Structure of the human Langerin carbohydrate recognition domain in complex with maltose;2.3;CA;CALCIUM ION;C-type lectin domain family 4 member K;9606;
3P7H;D;Structure of the human Langerin carbohydrate recognition domain in complex with maltose;2.3;CA;CALCIUM ION;C-type lectin domain family 4 member K;9606;
3P7P;E;Radiation damage study of thermolysin - 100K structure A (0.1 MGy);2.2;CA;CALCIUM ION;Thermolysin;1427;
3P7Q;E;Radiation damage study of thermolysin - 100K structure B (2.5 MGy);2.2;CA;CALCIUM ION;Thermolysin;1427;
3P7R;E;Radiation damage study of thermolysin - 100K structure C (4.9 MGy);2.2;CA;CALCIUM ION;Thermolysin;1427;
3P7S;E;Radiation damage study of thermolysin - 100K structure D (7.2 MGy);2.2;CA;CALCIUM ION;Thermolysin;1427;
3P7T;E;Radiation damage study of thermolysin - 160K structure A (0.1 MGy);2.2;CA;CALCIUM ION;Thermolysin;1427;
3P7U;E;Radiation damage study of thermolysin - 160K structure B (2.4 MGy);2.2;CA;CALCIUM ION;Thermolysin;1427;
3P7V;E;Radiation damage study of thermolysin - 160K structure C (4.8 MGy);2.2;CA;CALCIUM ION;Thermolysin;1427;
3P7W;E;Radiation damage study of thermolysin - 160K structure D (7.1 MGy);2.2;CA;CALCIUM ION;Thermolysin;1427;
3P85;A;Crystal structure enoyl-coa hydratase from mycobacterium avium;1.9;CA;CALCIUM ION;Enoyl-CoA hydratase;1764;
3P92;A;Human mesotrypsin complexed with bovine pancreatic trypsin inhibitor variant (BPTI-K15R/R17G);1.6;CA;CALCIUM ION;PRSS3 protein;9606;
3P95;A;Human mesotrypsin complexed with bovine pancreatic trypsin inhibitor variant (BPTI-K15R/R17D);1.3;CA;CALCIUM ION;PRSS3 protein;9606;
3P9L;B;Crystal Structure of H2-Kb in complex with the chicken ovalbumin epitope OVA;2;CA;CALCIUM ION;Beta-2-microglobulin;10090;
3P9L;D;Crystal Structure of H2-Kb in complex with the chicken ovalbumin epitope OVA;2;CA;CALCIUM ION;H-2 class I histocompatibility antigen, K-B alpha chain;10090;
3P9L;E;Crystal Structure of H2-Kb in complex with the chicken ovalbumin epitope OVA;2;CA;CALCIUM ION;Beta-2-microglobulin;10090;
3PA8;A;Structure of the C. difficile TcdB cysteine protease domain in complex with a peptide inhibitor;2;CA;CALCIUM ION;Toxin B;1496;
3PAK;A;Crystal Structure of Rat Surfactant Protein A neck and carbohydrate recognition domain (NCRD) complexed with Mannose;1.9;CA;CALCIUM ION;Pulmonary surfactant-associated protein A;10116;
3PAL;A;IONIC INTERACTIONS WITH PARVALBUMINS. CRYSTAL STRUCTURE DETERMINATION OF PIKE 4.10 PARVALBUMIN IN FOUR DIFFERENT IONIC ENVIRONMENTS;2.4;CA;CALCIUM ION;PARVALBUMIN;8010;
3PAQ;A;Surfactant Protein A neck and carbohydrate recognition domain (NCRD) complexed with alpha-methylmannose;2.1;CA;CALCIUM ION;Pulmonary surfactant-associated protein A;10116;
3PAR;A;Surfactant Protein-A neck and carbohydrate recognition domain (NCRD) in the absence of ligand;2.3;CA;CALCIUM ION;Pulmonary surfactant-associated protein A;10116;
3PAT;A;COMPARISON BETWEEN THE CRYSTAL AND THE SOLUTION STRUCTURES OF THE EF HAND PARVALBUMIN;;CA;CALCIUM ION;PARVALBUMIN;8010;
3PBF;A;Surfactant Protein-A neck and carbohydrate recognition domain (NCRD) complexed with glycerol;1.8;CA;CALCIUM ION;Pulmonary surfactant-associated protein A;10116;
3PCQ;L;Femtosecond X-ray protein Nanocrystallography;8.98;CA;CALCIUM ION;Photosystem I reaction center subunit XI;146786;
3PDD;A;Structures of Clostridium thermocellum CbhA fibronectin(III)-like modules;1.72;CA;CALCIUM ION;Glycoside hydrolase, family 9;1515;
3PE0;A;Structure of the central region of the plakin domain of plectin;2.95;CA;CALCIUM ION;Plectin;9606;
3PE0;B;Structure of the central region of the plakin domain of plectin;2.95;CA;CALCIUM ION;Plectin;9606;
3PE7;A;Oligogalacturonate lyase in complex with manganese;1.65;CA;CALCIUM ION;Oligogalacturonate lyase;630;
3PEE;B;Structure of the C. difficile TcdB cysteine protease domain;2.1;CA;CALCIUM ION;Toxin B;1496;
3PF2;A;The Crystal Structure of the Major Pilin GBS80 of Streptococcus agalactiae 35kDa C-terminal fragment;1.7;CA;CALCIUM ION;Cell wall surface anchor family protein;1311;
3PF3;A;Crystal structure of a mutant (C202A) of Triosephosphate isomerase from Giardia lamblia derivatized with MMTS;2.1;CA;CALCIUM ION;Triosephosphate isomerase;5741;
3PFQ;A;Crystal Structure and Allosteric Activation of Protein Kinase C beta II;4;CA;CALCIUM ION;Protein kinase C beta type;10116;
3PG2;A;The Crystal structure of the major pilin GBS80 of Streptococcus agalactiae 35 kDa C-terminal fragment;1.8;CA;CALCIUM ION;Cell wall surface anchor family protein;1311;
3PG2;B;The Crystal structure of the major pilin GBS80 of Streptococcus agalactiae 35 kDa C-terminal fragment;1.8;CA;CALCIUM ION;Cell wall surface anchor family protein;1311;
3PGB;A;Crystal structure of Aspergillus nidulans amine oxidase;2.45;CA;CALCIUM ION;Putative uncharacterized protein;162425;
3PGS;A;Phe3Gly mutant of EcFadL;1.9;CA;CALCIUM ION;Long-chain fatty acid transport protein;562;
3PGV;A;Crystal structure of a haloacid dehalogenase-like hydrolase (KPN_04322) from Klebsiella pneumoniae subsp. pneumoniae MGH 78578 at 2.39 A resolution;2.39;CA;CALCIUM ION;haloacid dehalogenase-like hydrolase;573;
3PGV;B;Crystal structure of a haloacid dehalogenase-like hydrolase (KPN_04322) from Klebsiella pneumoniae subsp. pneumoniae MGH 78578 at 2.39 A resolution;2.39;CA;CALCIUM ION;haloacid dehalogenase-like hydrolase;573;
3PGV;C;Crystal structure of a haloacid dehalogenase-like hydrolase (KPN_04322) from Klebsiella pneumoniae subsp. pneumoniae MGH 78578 at 2.39 A resolution;2.39;CA;CALCIUM ION;haloacid dehalogenase-like hydrolase;573;
3PGV;D;Crystal structure of a haloacid dehalogenase-like hydrolase (KPN_04322) from Klebsiella pneumoniae subsp. pneumoniae MGH 78578 at 2.39 A resolution;2.39;CA;CALCIUM ION;haloacid dehalogenase-like hydrolase;573;
3PK0;A;Crystal structure of Short-chain dehydrogenase/reductase SDR from Mycobacterium smegmatis;1.75;CA;CALCIUM ION;Short-chain dehydrogenase/reductase SDR;1772;
3PK0;B;Crystal structure of Short-chain dehydrogenase/reductase SDR from Mycobacterium smegmatis;1.75;CA;CALCIUM ION;Short-chain dehydrogenase/reductase SDR;1772;
3PK0;C;Crystal structure of Short-chain dehydrogenase/reductase SDR from Mycobacterium smegmatis;1.75;CA;CALCIUM ION;Short-chain dehydrogenase/reductase SDR;1772;
3PK0;D;Crystal structure of Short-chain dehydrogenase/reductase SDR from Mycobacterium smegmatis;1.75;CA;CALCIUM ION;Short-chain dehydrogenase/reductase SDR;1772;
3PLB;A;Bovine trypsin variant X(tripleIle227) in complex with small molecule inhibitor;1.18;CA;CALCIUM ION;Cationic trypsin;9913;
3PLF;B;Reverse Binding Mode of MetRD peptide complexed with c-Cbl TKB domain;1.92;CA;CALCIUM ION;E3 ubiquitin-protein ligase CBL;9606;
3PLF;D;Reverse Binding Mode of MetRD peptide complexed with c-Cbl TKB domain;1.92;CA;CALCIUM ION;E3 ubiquitin-protein ligase CBL;9606;
3PLK;A;Bovine trypsin variant X(tripleIle227) in complex with small molecule inhibitor;1.53;CA;CALCIUM ION;Cationic trypsin;9913;
3PLP;A;Bovine trypsin variant X(tripleIle227) in complex with small molecule inhibitor;1.63;CA;CALCIUM ION;Cationic trypsin;9913;
3PM3;A;Bovine trypsin variant X(tripleIle227) in complex with small molecule inhibitor;1.53;CA;CALCIUM ION;Cationic trypsin;9913;
3PM8;A;CAD domain of PFF0520w, Calcium dependent protein kinase;2;CA;CALCIUM ION;Calcium-dependent protein kinase 2;5833;
3PM8;B;CAD domain of PFF0520w, Calcium dependent protein kinase;2;CA;CALCIUM ION;Calcium-dependent protein kinase 2;5833;
3PMF;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS V23A at cryogenic temperature;1.6;CA;CALCIUM ION;Thermonuclease;1280;
3PMJ;A;Bovine trypsin variant X(tripleIle227) in complex with small molecule inhibitor;1.45;CA;CALCIUM ION;Cationic trypsin;9913;
3PMQ;A;Crystal structure of the outer membrane decaheme cytochrome MtrF;3.2;CA;CALCIUM ION;Decaheme cytochrome c MtrF;70863;
3PN7;C;Visualizing new hinges and a potential major source of compliance in the lever arm of myosin;2.25;CA;CALCIUM ION;Myosin essential light chain;6577;
3PN7;F;Visualizing new hinges and a potential major source of compliance in the lever arm of myosin;2.25;CA;CALCIUM ION;Myosin essential light chain;6577;
3POB;A;Crystal structure of MASP-1 CUB2 domain in complex with the collagen-like domain of MBL;1.8;CA;CALCIUM ION;Mannan-binding lectin serine protease 1;10116;
3POE;A;Crystal structure of the MASP-1 CUB2 domain bound to Ca2+;1.5;CA;CALCIUM ION;Mannan-binding lectin serine protease 1;10116;
3POF;A;Crystal structure of MASP-1 CUB2 domain bound to Ca2+;1.5;CA;CALCIUM ION;Mannan-binding lectin serine protease 1;10116;
3POF;B;Crystal structure of MASP-1 CUB2 domain bound to Ca2+;1.5;CA;CALCIUM ION;Mannan-binding lectin serine protease 1;10116;
3POG;A;Crystal structure of the MASP-1 CUB2 domain bound to Ca2+;2.75;CA;CALCIUM ION;Mannan-binding lectin serine protease 1;10116;
3POG;B;Crystal structure of the MASP-1 CUB2 domain bound to Ca2+;2.75;CA;CALCIUM ION;Mannan-binding lectin serine protease 1;10116;
3POG;C;Crystal structure of the MASP-1 CUB2 domain bound to Ca2+;2.75;CA;CALCIUM ION;Mannan-binding lectin serine protease 1;10116;
3POI;A;Crystal structure of MASP-1 CUB2 domain bound to Methylamine;1.7;CA;CALCIUM ION;Mannan-binding lectin serine protease 1;10116;
3POI;B;Crystal structure of MASP-1 CUB2 domain bound to Methylamine;1.7;CA;CALCIUM ION;Mannan-binding lectin serine protease 1;10116;
3POJ;A;Crystal structure of MASP-1 CUB2 domain bound to Ethylamine;1.45;CA;CALCIUM ION;Mannan-binding lectin serine protease 1;10116;
3POJ;B;Crystal structure of MASP-1 CUB2 domain bound to Ethylamine;1.45;CA;CALCIUM ION;Mannan-binding lectin serine protease 1;10116;
3POS;A;Crystal structure of the globular domain of human calreticulin;1.65;CA;CALCIUM ION;Calreticulin;9606;
3POS;B;Crystal structure of the globular domain of human calreticulin;1.65;CA;CALCIUM ION;Calreticulin;9606;
3POS;C;Crystal structure of the globular domain of human calreticulin;1.65;CA;CALCIUM ION;Calreticulin;9606;
3POW;A;Crystal structure of the globular domain of human calreticulin;1.55;CA;CALCIUM ION;calreticulin;9606;
3PP5;A;High-resolution structure of the trimeric Scar/WAVE complex precursor Brk1;1.5;CA;CALCIUM ION;Brk1;44689;
3PPE;A;Crystal structure of chicken VE-cadherin EC1-2;2.1;CA;CALCIUM ION;Vascular endothelial cadherin;9031;
3PPE;B;Crystal structure of chicken VE-cadherin EC1-2;2.1;CA;CALCIUM ION;Vascular endothelial cadherin;9031;
3PPV;A;Crystal structure of an engineered VWF A2 domain (N1493C and C1670S);1.9;CA;CALCIUM ION;von Willebrand factor;9606;
3PR4;A;Dpo4 Y12A mutant incorporating dADP opposite template dT;2.65;CA;CALCIUM ION;DNA polymerase IV;2287;
3PR5;B;Dpo4 Y12A mutant incorporating ADP opposite template dT;2.4;CA;CALCIUM ION;DNA polymerase IV;2287;
3PRK;E;INHIBITION OF PROTEINASE K BY METHOXYSUCCINYL-ALA-ALA-PRO-ALA-CHLOROMETHYL KETONE. AN X-RAY STUDY AT 2.2-ANGSTROMS RESOLUTION;2.2;CA;CALCIUM ION;PROTEINASE K;37998;
3PRT;A;Mutant of the Carboxypeptidase T;1.66;CA;CALCIUM ION;Carboxypeptidase T;2026;
3PSR;A;HUMAN PSORIASIN (S100A7) CA2+ BOUND FORM (CRYSTAL FORM I);2.5;CA;CALCIUM ION;PSORIASIN;9606;
3PSR;B;HUMAN PSORIASIN (S100A7) CA2+ BOUND FORM (CRYSTAL FORM I);2.5;CA;CALCIUM ION;PSORIASIN;9606;
3PTB;A;THE GEOMETRY OF THE REACTIVE SITE AND OF THE PEPTIDE GROUPS IN TRYPSIN, TRYPSINOGEN AND ITS COMPLEXES WITH INHIBITORS;1.7;CA;CALCIUM ION;BETA-TRYPSIN;9913;
3PTN;A;ON THE DISORDERED ACTIVATION DOMAIN IN TRYPSINOGEN. CHEMICAL LABELLING AND LOW-TEMPERATURE CRYSTALLOGRAPHY;1.7;CA;CALCIUM ION;TRYPSIN;9913;
3PTY;A;Crystal structure of the C-terminal extracellular domain of Mycobacterium tuberculosis EmbC;2;CA;CALCIUM ION;Arabinosyltransferase C;1773;
3PVH;A;Structural and Functional Analysis of Arabidopsis thaliana thylakoid lumen protein AtTLP18.3;1.6;CA;CALCIUM ION;UPF0603 protein At1g54780, chloroplastic;3702;
3PVN;A;Triclinic form of Human C-Reactive Protein in complex with Zinc;1.98;CA;CALCIUM ION;C-reactive protein;9606;
3PVN;B;Triclinic form of Human C-Reactive Protein in complex with Zinc;1.98;CA;CALCIUM ION;C-reactive protein;9606;
3PVN;C;Triclinic form of Human C-Reactive Protein in complex with Zinc;1.98;CA;CALCIUM ION;C-reactive protein;9606;
3PVN;D;Triclinic form of Human C-Reactive Protein in complex with Zinc;1.98;CA;CALCIUM ION;C-reactive protein;9606;
3PVN;E;Triclinic form of Human C-Reactive Protein in complex with Zinc;1.98;CA;CALCIUM ION;C-reactive protein;9606;
3PVN;F;Triclinic form of Human C-Reactive Protein in complex with Zinc;1.98;CA;CALCIUM ION;C-reactive protein;9606;
3PVN;G;Triclinic form of Human C-Reactive Protein in complex with Zinc;1.98;CA;CALCIUM ION;C-reactive protein;9606;
3PVN;H;Triclinic form of Human C-Reactive Protein in complex with Zinc;1.98;CA;CALCIUM ION;C-reactive protein;9606;
3PVN;I;Triclinic form of Human C-Reactive Protein in complex with Zinc;1.98;CA;CALCIUM ION;C-reactive protein;9606;
3PVN;J;Triclinic form of Human C-Reactive Protein in complex with Zinc;1.98;CA;CALCIUM ION;C-reactive protein;9606;
3PVN;K;Triclinic form of Human C-Reactive Protein in complex with Zinc;1.98;CA;CALCIUM ION;C-reactive protein;9606;
3PVN;L;Triclinic form of Human C-Reactive Protein in complex with Zinc;1.98;CA;CALCIUM ION;C-reactive protein;9606;
3PVN;M;Triclinic form of Human C-Reactive Protein in complex with Zinc;1.98;CA;CALCIUM ION;C-reactive protein;9606;
3PVN;N;Triclinic form of Human C-Reactive Protein in complex with Zinc;1.98;CA;CALCIUM ION;C-reactive protein;9606;
3PVN;O;Triclinic form of Human C-Reactive Protein in complex with Zinc;1.98;CA;CALCIUM ION;C-reactive protein;9606;
3PVN;P;Triclinic form of Human C-Reactive Protein in complex with Zinc;1.98;CA;CALCIUM ION;C-reactive protein;9606;
3PVN;Q;Triclinic form of Human C-Reactive Protein in complex with Zinc;1.98;CA;CALCIUM ION;C-reactive protein;9606;
3PVN;R;Triclinic form of Human C-Reactive Protein in complex with Zinc;1.98;CA;CALCIUM ION;C-reactive protein;9606;
3PVN;S;Triclinic form of Human C-Reactive Protein in complex with Zinc;1.98;CA;CALCIUM ION;C-reactive protein;9606;
3PVN;T;Triclinic form of Human C-Reactive Protein in complex with Zinc;1.98;CA;CALCIUM ION;C-reactive protein;9606;
3PVO;A;Monoclinic form of Human C-Reactive Protein;3;CA;CALCIUM ION;C-Reactive Protein;9606;
3PVO;B;Monoclinic form of Human C-Reactive Protein;3;CA;CALCIUM ION;C-Reactive Protein;9606;
3PVO;C;Monoclinic form of Human C-Reactive Protein;3;CA;CALCIUM ION;C-Reactive Protein;9606;
3PVO;D;Monoclinic form of Human C-Reactive Protein;3;CA;CALCIUM ION;C-Reactive Protein;9606;
3PVO;E;Monoclinic form of Human C-Reactive Protein;3;CA;CALCIUM ION;C-Reactive Protein;9606;
3PVO;F;Monoclinic form of Human C-Reactive Protein;3;CA;CALCIUM ION;C-Reactive Protein;9606;
3PVO;G;Monoclinic form of Human C-Reactive Protein;3;CA;CALCIUM ION;C-Reactive Protein;9606;
3PVO;H;Monoclinic form of Human C-Reactive Protein;3;CA;CALCIUM ION;C-Reactive Protein;9606;
3PVO;I;Monoclinic form of Human C-Reactive Protein;3;CA;CALCIUM ION;C-Reactive Protein;9606;
3PVO;J;Monoclinic form of Human C-Reactive Protein;3;CA;CALCIUM ION;C-Reactive Protein;9606;
3PVO;K;Monoclinic form of Human C-Reactive Protein;3;CA;CALCIUM ION;C-Reactive Protein;9606;
3PVO;L;Monoclinic form of Human C-Reactive Protein;3;CA;CALCIUM ION;C-Reactive Protein;9606;
3PVO;M;Monoclinic form of Human C-Reactive Protein;3;CA;CALCIUM ION;C-Reactive Protein;9606;
3PVO;N;Monoclinic form of Human C-Reactive Protein;3;CA;CALCIUM ION;C-Reactive Protein;9606;
3PVO;O;Monoclinic form of Human C-Reactive Protein;3;CA;CALCIUM ION;C-Reactive Protein;9606;
3PVO;P;Monoclinic form of Human C-Reactive Protein;3;CA;CALCIUM ION;C-Reactive Protein;9606;
3PVO;Q;Monoclinic form of Human C-Reactive Protein;3;CA;CALCIUM ION;C-Reactive Protein;9606;
3PVO;R;Monoclinic form of Human C-Reactive Protein;3;CA;CALCIUM ION;C-Reactive Protein;9606;
3PVO;S;Monoclinic form of Human C-Reactive Protein;3;CA;CALCIUM ION;C-Reactive Protein;9606;
3PVO;T;Monoclinic form of Human C-Reactive Protein;3;CA;CALCIUM ION;C-Reactive Protein;9606;
3PVX;A;Binary complex of Aflatoxin B1 Adduct modified DNA (AFB1-FAPY) with DNA Polymerase IV;3.03;CA;CALCIUM ION;DNA polymerase IV;2287;
3PW0;A;Ternary complex of Aflatoxin B1 Adduct modified DNA (AFB1-FAPY) with DNA Polymerase IV and incoming dATP;2.91;CA;CALCIUM ION;DNA polymerase IV;2287;
3PW2;A;Ternary complex of Aflatoxin B1 Adduct modified DNA (AFB1-FAPY) with DNA Polymerase IV and incoming dTTP;2.74;CA;CALCIUM ION;DNA polymerase IV;2287;
3PW4;A;Ternary complex of Aflatoxin B1 Adduct modified DNA (AFB1-N7-Gua) with DNA Polymerase IV and incoming dATP;2.9;CA;CALCIUM ION;DNA polymerase IV;2287;
3PW5;A;Ternary complex of Aflatoxin B1 Adduct modified DNA (AFB1-N7-Gua) with DNA Polymerase IV and incoming dTTP;3;CA;CALCIUM ION;DNA polymerase IV;2287;
3PW7;A;Ternary complex of Aflatoxin B1 Adduct modified DNA (AFB1-N7-Gua) with DNA Polymerase IV and incoming dCTP;2.9;CA;CALCIUM ION;DNA polymerase IV;2287;
3PW7;E;Ternary complex of Aflatoxin B1 Adduct modified DNA (AFB1-N7-Gua) with DNA Polymerase IV and incoming dCTP;2.9;CA;CALCIUM ION;DNA polymerase IV;2287;
3PW9;A;Structural and functional Analysis of Arabidopsis thaliana thylakoid lumen protein AtTLP18.3;2.1;CA;CALCIUM ION;UPF0603 protein At1g54780, chloroplastic;3702;
3PWB;A;Bovine trypsin variant X(tripleGlu217Ile227) in complex with small molecule inhibitor;1.63;CA;CALCIUM ION;Cationic trypsin;9913;
3PWC;A;Bovine trypsin variant X(tripleGlu217Ile227) in complex with small molecule inhibitor;1.6;CA;CALCIUM ION;Cationic trypsin;9913;
3PXS;A;Crystal Structure of Diferrous MauG in Complex with Pre-Methylamine Dehydrogenase:;2.22;CA;CALCIUM ION;Methylamine utilization protein MauG;266;
3PXS;B;Crystal Structure of Diferrous MauG in Complex with Pre-Methylamine Dehydrogenase:;2.22;CA;CALCIUM ION;Methylamine utilization protein MauG;266;
3PXT;A;Crystal Structure of Ferrous CO Adduct of MauG in Complex with Pre-Methylamine Dehydrogenase;2.16;CA;CALCIUM ION;Methylamine utilization protein MauG;266;
3PXT;B;Crystal Structure of Ferrous CO Adduct of MauG in Complex with Pre-Methylamine Dehydrogenase;2.16;CA;CALCIUM ION;Methylamine utilization protein MauG;266;
3PXW;A;Crystal Structure of Ferrous NO Adduct of MauG in Complex with Pre-Methylamine Dehydrogenase;2.11;CA;CALCIUM ION;Methylamine utilization protein MauG;266;
3PXW;B;Crystal Structure of Ferrous NO Adduct of MauG in Complex with Pre-Methylamine Dehydrogenase;2.11;CA;CALCIUM ION;Methylamine utilization protein MauG;266;
3PY4;A;Crystal structure of bovine lactoperoxidase in complex with paracetamol at 2.4A resolution;2.42;CA;CALCIUM ION;Lactoperoxidase;9913;
3PYH;A;Bovine trypsin variant X(tripleGlu217Ile227) in complex with small molecule inhibitor;2;CA;CALCIUM ION;Cationic trypsin;9913;
3PZ0;B;The crystal structure of AaLeuRS-CP1;2.4;CA;CALCIUM ION;Leucyl-tRNA synthetase subunit alpha;63363;
3Q00;A;Bovine trypsin variant X(tripleGlu217Ile227) in complex with small molecule inhibitor;1.7;CA;CALCIUM ION;Cationic trypsin;9913;
3Q08;A;Crystal Structure of Chlorite Dismutase from D. Aromatica at pH 6.5;3.05;CA;CALCIUM ION;Chlorite dismutase;259537;
3Q08;B;Crystal Structure of Chlorite Dismutase from D. Aromatica at pH 6.5;3.05;CA;CALCIUM ION;Chlorite dismutase;259537;
3Q08;C;Crystal Structure of Chlorite Dismutase from D. Aromatica at pH 6.5;3.05;CA;CALCIUM ION;Chlorite dismutase;259537;
3Q08;D;Crystal Structure of Chlorite Dismutase from D. Aromatica at pH 6.5;3.05;CA;CALCIUM ION;Chlorite dismutase;259537;
3Q08;E;Crystal Structure of Chlorite Dismutase from D. Aromatica at pH 6.5;3.05;CA;CALCIUM ION;Chlorite dismutase;259537;
3Q08;F;Crystal Structure of Chlorite Dismutase from D. Aromatica at pH 6.5;3.05;CA;CALCIUM ION;Chlorite dismutase;259537;
3Q08;G;Crystal Structure of Chlorite Dismutase from D. Aromatica at pH 6.5;3.05;CA;CALCIUM ION;Chlorite dismutase;259537;
3Q08;H;Crystal Structure of Chlorite Dismutase from D. Aromatica at pH 6.5;3.05;CA;CALCIUM ION;Chlorite dismutase;259537;
3Q08;I;Crystal Structure of Chlorite Dismutase from D. Aromatica at pH 6.5;3.05;CA;CALCIUM ION;Chlorite dismutase;259537;
3Q08;J;Crystal Structure of Chlorite Dismutase from D. Aromatica at pH 6.5;3.05;CA;CALCIUM ION;Chlorite dismutase;259537;
3Q08;K;Crystal Structure of Chlorite Dismutase from D. Aromatica at pH 6.5;3.05;CA;CALCIUM ION;Chlorite dismutase;259537;
3Q08;L;Crystal Structure of Chlorite Dismutase from D. Aromatica at pH 6.5;3.05;CA;CALCIUM ION;Chlorite dismutase;259537;
3Q08;M;Crystal Structure of Chlorite Dismutase from D. Aromatica at pH 6.5;3.05;CA;CALCIUM ION;Chlorite dismutase;259537;
3Q08;N;Crystal Structure of Chlorite Dismutase from D. Aromatica at pH 6.5;3.05;CA;CALCIUM ION;Chlorite dismutase;259537;
3Q08;O;Crystal Structure of Chlorite Dismutase from D. Aromatica at pH 6.5;3.05;CA;CALCIUM ION;Chlorite dismutase;259537;
3Q08;P;Crystal Structure of Chlorite Dismutase from D. Aromatica at pH 6.5;3.05;CA;CALCIUM ION;Chlorite dismutase;259537;
3Q08;Q;Crystal Structure of Chlorite Dismutase from D. Aromatica at pH 6.5;3.05;CA;CALCIUM ION;Chlorite dismutase;259537;
3Q08;R;Crystal Structure of Chlorite Dismutase from D. Aromatica at pH 6.5;3.05;CA;CALCIUM ION;Chlorite dismutase;259537;
3Q08;S;Crystal Structure of Chlorite Dismutase from D. Aromatica at pH 6.5;3.05;CA;CALCIUM ION;Chlorite dismutase;259537;
3Q08;T;Crystal Structure of Chlorite Dismutase from D. Aromatica at pH 6.5;3.05;CA;CALCIUM ION;Chlorite dismutase;259537;
3Q09;A;Crystal Structure of Chlorite Dismutase from D. Aromatica at pH 9.0;3;CA;CALCIUM ION;Chlorite dismutase;259537;
3Q09;B;Crystal Structure of Chlorite Dismutase from D. Aromatica at pH 9.0;3;CA;CALCIUM ION;Chlorite dismutase;259537;
3Q09;C;Crystal Structure of Chlorite Dismutase from D. Aromatica at pH 9.0;3;CA;CALCIUM ION;Chlorite dismutase;259537;
3Q09;D;Crystal Structure of Chlorite Dismutase from D. Aromatica at pH 9.0;3;CA;CALCIUM ION;Chlorite dismutase;259537;
3Q09;E;Crystal Structure of Chlorite Dismutase from D. Aromatica at pH 9.0;3;CA;CALCIUM ION;Chlorite dismutase;259537;
3Q09;F;Crystal Structure of Chlorite Dismutase from D. Aromatica at pH 9.0;3;CA;CALCIUM ION;Chlorite dismutase;259537;
3Q09;G;Crystal Structure of Chlorite Dismutase from D. Aromatica at pH 9.0;3;CA;CALCIUM ION;Chlorite dismutase;259537;
3Q09;H;Crystal Structure of Chlorite Dismutase from D. Aromatica at pH 9.0;3;CA;CALCIUM ION;Chlorite dismutase;259537;
3Q09;I;Crystal Structure of Chlorite Dismutase from D. Aromatica at pH 9.0;3;CA;CALCIUM ION;Chlorite dismutase;259537;
3Q09;J;Crystal Structure of Chlorite Dismutase from D. Aromatica at pH 9.0;3;CA;CALCIUM ION;Chlorite dismutase;259537;
3Q09;K;Crystal Structure of Chlorite Dismutase from D. Aromatica at pH 9.0;3;CA;CALCIUM ION;Chlorite dismutase;259537;
3Q09;L;Crystal Structure of Chlorite Dismutase from D. Aromatica at pH 9.0;3;CA;CALCIUM ION;Chlorite dismutase;259537;
3Q09;M;Crystal Structure of Chlorite Dismutase from D. Aromatica at pH 9.0;3;CA;CALCIUM ION;Chlorite dismutase;259537;
3Q09;N;Crystal Structure of Chlorite Dismutase from D. Aromatica at pH 9.0;3;CA;CALCIUM ION;Chlorite dismutase;259537;
3Q09;O;Crystal Structure of Chlorite Dismutase from D. Aromatica at pH 9.0;3;CA;CALCIUM ION;Chlorite dismutase;259537;
3Q09;P;Crystal Structure of Chlorite Dismutase from D. Aromatica at pH 9.0;3;CA;CALCIUM ION;Chlorite dismutase;259537;
3Q09;Q;Crystal Structure of Chlorite Dismutase from D. Aromatica at pH 9.0;3;CA;CALCIUM ION;Chlorite dismutase;259537;
3Q09;R;Crystal Structure of Chlorite Dismutase from D. Aromatica at pH 9.0;3;CA;CALCIUM ION;Chlorite dismutase;259537;
3Q09;S;Crystal Structure of Chlorite Dismutase from D. Aromatica at pH 9.0;3;CA;CALCIUM ION;Chlorite dismutase;259537;
3Q09;T;Crystal Structure of Chlorite Dismutase from D. Aromatica at pH 9.0;3;CA;CALCIUM ION;Chlorite dismutase;259537;
3Q0K;A;Crystal structure of Human PACSIN 2 F-BAR;2.6;CA;CALCIUM ION;Protein kinase C and casein kinase substrate in neurons protein 2;9606;
3Q0K;B;Crystal structure of Human PACSIN 2 F-BAR;2.6;CA;CALCIUM ION;Protein kinase C and casein kinase substrate in neurons protein 2;9606;
3Q0K;C;Crystal structure of Human PACSIN 2 F-BAR;2.6;CA;CALCIUM ION;Protein kinase C and casein kinase substrate in neurons protein 2;9606;
3Q0K;D;Crystal structure of Human PACSIN 2 F-BAR;2.6;CA;CALCIUM ION;Protein kinase C and casein kinase substrate in neurons protein 2;9606;
3Q13;A;The Structure of the Ca2+-binding, Glycosylated F-spondin Domain of F-spondin, A C2-domain Variant from Extracellular Matrix;1.95;CA;CALCIUM ION;Spondin-1;9606;
3Q2J;A;Crystal Structure of 3',5'-Aminoglycoside Phosphotransferase Type IIIa Protein Kinase Inhibitor CKI-7 Complex;2.15;CA;CALCIUM ION;Aminoglycoside 3'-phosphotransferase;1351;
3Q2J;B;Crystal Structure of 3',5'-Aminoglycoside Phosphotransferase Type IIIa Protein Kinase Inhibitor CKI-7 Complex;2.15;CA;CALCIUM ION;Aminoglycoside 3'-phosphotransferase;1351;
3Q2L;A;Mouse E-cadherin EC1-2 V81D mutant;2.7;CA;CALCIUM ION;Cadherin-1;10090;
3Q2L;B;Mouse E-cadherin EC1-2 V81D mutant;2.7;CA;CALCIUM ION;Cadherin-1;10090;
3Q2N;A;Mouse E-cadherin EC1-2 L175D mutant;2.73;CA;CALCIUM ION;Cadherin-1;10090;
3Q2N;B;Mouse E-cadherin EC1-2 L175D mutant;2.73;CA;CALCIUM ION;Cadherin-1;10090;
3Q2Q;A;Crystal structure of geranylgeranyl pyrophosphate synthase from Corynebacterium glutamicum complexed with calcium and isoprenyl diphosphate;1.9;CA;CALCIUM ION;Geranylgeranyl pyrophosphate synthase;1718;
3Q2V;A;Crystal structure of mouse E-cadherin ectodomain;3.4;CA;CALCIUM ION;Cadherin-1;10090;
3Q2V;B;Crystal structure of mouse E-cadherin ectodomain;3.4;CA;CALCIUM ION;Cadherin-1;10090;
3Q2W;A;Crystal structure of mouse N-cadherin ectodomain;3.2;CA;CALCIUM ION;Cadherin-2;10090;
3Q3G;E;Crystal Structure of A-domain in complex with antibody;2.7;CA;CALCIUM ION;Integrin alpha-M;9606;
3Q3G;G;Crystal Structure of A-domain in complex with antibody;2.7;CA;CALCIUM ION;Integrin alpha-M;9606;
3Q3G;I;Crystal Structure of A-domain in complex with antibody;2.7;CA;CALCIUM ION;Integrin alpha-M;9606;
3Q3G;L;Crystal Structure of A-domain in complex with antibody;2.7;CA;CALCIUM ION;Integrin alpha-M;9606;
3Q3K;A;Factor Xa in complex with a phenylenediamine derivative;2;CA;CALCIUM ION;Activated factor Xa heavy chain;9606;
3Q3L;A;The neutron crystallographic structure of inorganic pyrophosphatase from Thermococcus thioreducens;2.5;CA;CALCIUM ION;Tt-IPPase;277988;
3Q3L;B;The neutron crystallographic structure of inorganic pyrophosphatase from Thermococcus thioreducens;2.5;CA;CALCIUM ION;Tt-IPPase;277988;
3Q3L;C;The neutron crystallographic structure of inorganic pyrophosphatase from Thermococcus thioreducens;2.5;CA;CALCIUM ION;Tt-IPPase;277988;
3Q3L;D;The neutron crystallographic structure of inorganic pyrophosphatase from Thermococcus thioreducens;2.5;CA;CALCIUM ION;Tt-IPPase;277988;
3Q3L;E;The neutron crystallographic structure of inorganic pyrophosphatase from Thermococcus thioreducens;2.5;CA;CALCIUM ION;Tt-IPPase;277988;
3Q3L;F;The neutron crystallographic structure of inorganic pyrophosphatase from Thermococcus thioreducens;2.5;CA;CALCIUM ION;Tt-IPPase;277988;
3Q3Q;A;Crystal Structure of SPAP: an novel alkaline phosphatase from bacterium Sphingomonas sp. strain BSAR-1;1.95;CA;CALCIUM ION;Alkaline phosphatase;298335;
3Q3U;A;Trametes cervina lignin peroxidase;1.85;CA;CALCIUM ION;Lignin peroxidase;1111950;
3Q40;A;Sulphur SAD structure solution of proteinase K grown in SO4-less solution.;1.8;CA;CALCIUM ION;Proteinase K;37998;
3Q4G;A;Structure of NAD synthetase from Vibrio cholerae;2.4;CA;CALCIUM ION;NH(3)-dependent NAD(+) synthetase;666;
3Q4G;B;Structure of NAD synthetase from Vibrio cholerae;2.4;CA;CALCIUM ION;NH(3)-dependent NAD(+) synthetase;666;
3Q4W;A;The structure of archaeal inorganic pyrophosphatase in complex with substrate;1.44;CA;CALCIUM ION;Tt-IPPase;277988;
3Q4Y;A;Crystal structure of group I phospholipase A2 at 2.3 A resolution in 40% ethanol revealed the critical elements of hydrophobicity of the substrate-binding site;2.3;CA;CALCIUM ION;Phospholipase A2 isoform 3;195058;
3Q5G;A;Sulphur SAD structure solution of proteinase K grown in SO4 solution;1.77;CA;CALCIUM ION;Proteinase K;37998;
3Q5I;A;Crystal Structure of PBANKA_031420;2.1;CA;CALCIUM ION;Protein kinase;5821;
3Q6D;A;Xaa-Pro dipeptidase from Bacillus anthracis.;1.97;CA;CALCIUM ION;Proline dipeptidase;1392;
3Q6D;B;Xaa-Pro dipeptidase from Bacillus anthracis.;1.97;CA;CALCIUM ION;Proline dipeptidase;1392;
3Q6D;C;Xaa-Pro dipeptidase from Bacillus anthracis.;1.97;CA;CALCIUM ION;Proline dipeptidase;1392;
3Q6D;D;Xaa-Pro dipeptidase from Bacillus anthracis.;1.97;CA;CALCIUM ION;Proline dipeptidase;1392;
3Q72;A;Crystal Structure of Rad G-domain-GTP Analog Complex;1.65;CA;CALCIUM ION;GTP-binding protein RAD;9606;
3Q72;B;Crystal Structure of Rad G-domain-GTP Analog Complex;1.65;CA;CALCIUM ION;GTP-binding protein RAD;9606;
3Q7H;A;Structure of the ClpP subunit of the ATP-dependent Clp Protease from Coxiella burnetii;2.5;CA;CALCIUM ION;ATP-dependent Clp protease proteolytic subunit;777;
3Q7H;B;Structure of the ClpP subunit of the ATP-dependent Clp Protease from Coxiella burnetii;2.5;CA;CALCIUM ION;ATP-dependent Clp protease proteolytic subunit;777;
3Q7H;C;Structure of the ClpP subunit of the ATP-dependent Clp Protease from Coxiella burnetii;2.5;CA;CALCIUM ION;ATP-dependent Clp protease proteolytic subunit;777;
3Q7H;D;Structure of the ClpP subunit of the ATP-dependent Clp Protease from Coxiella burnetii;2.5;CA;CALCIUM ION;ATP-dependent Clp protease proteolytic subunit;777;
3Q7H;E;Structure of the ClpP subunit of the ATP-dependent Clp Protease from Coxiella burnetii;2.5;CA;CALCIUM ION;ATP-dependent Clp protease proteolytic subunit;777;
3Q7H;F;Structure of the ClpP subunit of the ATP-dependent Clp Protease from Coxiella burnetii;2.5;CA;CALCIUM ION;ATP-dependent Clp protease proteolytic subunit;777;
3Q7H;G;Structure of the ClpP subunit of the ATP-dependent Clp Protease from Coxiella burnetii;2.5;CA;CALCIUM ION;ATP-dependent Clp protease proteolytic subunit;777;
3Q7H;H;Structure of the ClpP subunit of the ATP-dependent Clp Protease from Coxiella burnetii;2.5;CA;CALCIUM ION;ATP-dependent Clp protease proteolytic subunit;777;
3Q7H;I;Structure of the ClpP subunit of the ATP-dependent Clp Protease from Coxiella burnetii;2.5;CA;CALCIUM ION;ATP-dependent Clp protease proteolytic subunit;777;
3Q7H;J;Structure of the ClpP subunit of the ATP-dependent Clp Protease from Coxiella burnetii;2.5;CA;CALCIUM ION;ATP-dependent Clp protease proteolytic subunit;777;
3Q7H;K;Structure of the ClpP subunit of the ATP-dependent Clp Protease from Coxiella burnetii;2.5;CA;CALCIUM ION;ATP-dependent Clp protease proteolytic subunit;777;
3Q7H;L;Structure of the ClpP subunit of the ATP-dependent Clp Protease from Coxiella burnetii;2.5;CA;CALCIUM ION;ATP-dependent Clp protease proteolytic subunit;777;
3Q7H;M;Structure of the ClpP subunit of the ATP-dependent Clp Protease from Coxiella burnetii;2.5;CA;CALCIUM ION;ATP-dependent Clp protease proteolytic subunit;777;
3Q7H;N;Structure of the ClpP subunit of the ATP-dependent Clp Protease from Coxiella burnetii;2.5;CA;CALCIUM ION;ATP-dependent Clp protease proteolytic subunit;777;
3Q7I;A;Glucose-6-phosphate isomerase from Francisella tularensis complexed with 6-phosphogluconic acid.;1.54;CA;CALCIUM ION;Glucose-6-phosphate isomerase;263;
3Q7Q;A;Crystal Structure of Rad G-domain Q148A-GTP Analog Complex;2.3;CA;CALCIUM ION;GTP-binding protein RAD;9606;
3Q84;B;Crystal structure of human PACSIN 1 F-BAR domain;2.8;CA;CALCIUM ION;Protein kinase C and casein kinase substrate in neurons protein 1;9606;
3Q84;G;Crystal structure of human PACSIN 1 F-BAR domain;2.8;CA;CALCIUM ION;Protein kinase C and casein kinase substrate in neurons protein 1;9606;
3Q84;M;Crystal structure of human PACSIN 1 F-BAR domain;2.8;CA;CALCIUM ION;Protein kinase C and casein kinase substrate in neurons protein 1;9606;
3Q84;N;Crystal structure of human PACSIN 1 F-BAR domain;2.8;CA;CALCIUM ION;Protein kinase C and casein kinase substrate in neurons protein 1;9606;
3Q88;A;Glucose-6-phosphate isomerase from Francisella tularensis complexed with ribose 1,5-bisphosphate.;1.7;CA;CALCIUM ION;Glucose-6-phosphate isomerase;263;
3Q8A;A;Crystal structure of WT Protective Antigen (pH 5.5);3.13;CA;CALCIUM ION;Protective antigen;1392;
3Q8B;A;Crystal structure of WT Protective Antigen (pH 9.0);2;CA;CALCIUM ION;Protective antigen;1392;
3Q8C;A;Crystal structure of Protective Antigen W346F (pH 5.5);2.85;CA;CALCIUM ION;Protective antigen;1392;
3Q8E;A;Crystal structure of Protective Antigen W346F (pH 8.5);2.1;CA;CALCIUM ION;Protective antigen;1392;
3Q8F;A;Crystal structure of 2-Fluorohistine labeled Protective Antigen (pH 5.8);2.1;CA;CALCIUM ION;Protective antigen;1392;
3Q9K;A;Crystal structure of bovine lactoperoxidase complexed with Phenyl isothiocyanate at 1.7 A resolution;1.7;CA;CALCIUM ION;lactoperoxidase;9913;
3QA3;E;Crystal Structure of A-domain in complex with antibody;3;CA;CALCIUM ION;Integrin alpha-M;9606;
3QA3;G;Crystal Structure of A-domain in complex with antibody;3;CA;CALCIUM ION;Integrin alpha-M;9606;
3QA3;I;Crystal Structure of A-domain in complex with antibody;3;CA;CALCIUM ION;Integrin alpha-M;9606;
3QA3;L;Crystal Structure of A-domain in complex with antibody;3;CA;CALCIUM ION;Integrin alpha-M;9606;
3QB0;A;Crystal structure of Actin-related protein Arp4 from S. cerevisiae complexed with ATP;3.4;CA;CALCIUM ION;Actin-related protein 4;4932;
3QB0;B;Crystal structure of Actin-related protein Arp4 from S. cerevisiae complexed with ATP;3.4;CA;CALCIUM ION;Actin-related protein 4;4932;
3QB0;C;Crystal structure of Actin-related protein Arp4 from S. cerevisiae complexed with ATP;3.4;CA;CALCIUM ION;Actin-related protein 4;4932;
3QB0;D;Crystal structure of Actin-related protein Arp4 from S. cerevisiae complexed with ATP;3.4;CA;CALCIUM ION;Actin-related protein 4;4932;
3QB3;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS I92KL25A at cryogenic temperature;1.63;CA;CALCIUM ION;Thermonuclease;1280;
3QC6;X;GspB;1.9;CA;CALCIUM ION;Platelet binding protein GspB;1302;
3QDN;A;Putative thioredoxin protein from Salmonella typhimurium;2.09;CA;CALCIUM ION;Putative thioredoxin protein;28901;
3QE2;A;Crystal Structure of Human NADPH-Cytochrome P450 Reductase;1.75;CA;CALCIUM ION;NADPH--cytochrome P450 reductase;9606;
3QE5;A;Complete structure of Streptococcus mutans Antigen I/II carboxy-terminus;2.5;CA;CALCIUM ION;Major cell-surface adhesin PAc;1309;
3QE5;B;Complete structure of Streptococcus mutans Antigen I/II carboxy-terminus;2.5;CA;CALCIUM ION;Major cell-surface adhesin PAc;1309;
3QE9;Y;Crystal structure of human exonuclease 1 Exo1 (D173A) in complex with DNA (complex I);2.51;CA;CALCIUM ION;Exonuclease 1;9606;
3QE9;Z;Crystal structure of human exonuclease 1 Exo1 (D173A) in complex with DNA (complex I);2.51;CA;CALCIUM ION;Exonuclease 1;9606;
3QED;A;The structure and function of an arabinan-specific alpha-1,2-arabinofuranosidase identified from screening the activities of bacterial GH43 glycoside hydrolases;2.99;CA;CALCIUM ION;Beta-xylosidase/alpha-L-arabinfuranosidase, gly43N;155077;
3QED;B;The structure and function of an arabinan-specific alpha-1,2-arabinofuranosidase identified from screening the activities of bacterial GH43 glycoside hydrolases;2.99;CA;CALCIUM ION;Beta-xylosidase/alpha-L-arabinfuranosidase, gly43N;155077;
3QED;C;The structure and function of an arabinan-specific alpha-1,2-arabinofuranosidase identified from screening the activities of bacterial GH43 glycoside hydrolases;2.99;CA;CALCIUM ION;Beta-xylosidase/alpha-L-arabinfuranosidase, gly43N;155077;
3QED;D;The structure and function of an arabinan-specific alpha-1,2-arabinofuranosidase identified from screening the activities of bacterial GH43 glycoside hydrolases;2.99;CA;CALCIUM ION;Beta-xylosidase/alpha-L-arabinfuranosidase, gly43N;155077;
3QEE;A;The structure and function of an arabinan-specific alpha-1,2-arabinofuranosidase identified from screening the activities of bacterial GH43 glycoside hydrolases;1.64;CA;CALCIUM ION;Beta-xylosidase/alpha-L-arabinfuranosidase, gly43N;155077;
3QEE;B;The structure and function of an arabinan-specific alpha-1,2-arabinofuranosidase identified from screening the activities of bacterial GH43 glycoside hydrolases;1.64;CA;CALCIUM ION;Beta-xylosidase/alpha-L-arabinfuranosidase, gly43N;155077;
3QEF;A;The structure and function of an arabinan-specific alpha-1,2-arabinofuranosidase identified from screening the activities of bacterial GH43 glycoside hydrolases;1.79;CA;CALCIUM ION;Beta-xylosidase/alpha-L-arabinfuranosidase, gly43N;155077;
3QEF;B;The structure and function of an arabinan-specific alpha-1,2-arabinofuranosidase identified from screening the activities of bacterial GH43 glycoside hydrolases;1.79;CA;CALCIUM ION;Beta-xylosidase/alpha-L-arabinfuranosidase, gly43N;155077;
3QEI;A;RB69 DNA Polymerase (L561A/S565G/Y567A) Ternary Complex with dCTP Opposite Difluorotoluene Nucleoside;2.18;CA;CALCIUM ION;DNA polymerase;1914161;
3QEP;A;RB69 DNA Polymerase (L561A/S565G/Y567A) Ternary Complex with dTTP Opposite Difluorotoluene Nucleoside;1.8;CA;CALCIUM ION;DNA polymerase;1914161;
3QEP;P;RB69 DNA Polymerase (L561A/S565G/Y567A) Ternary Complex with dTTP Opposite Difluorotoluene Nucleoside;1.8;CA;CALCIUM ION;DNA (5'-D(*GP*CP*GP*GP*AP*CP*TP*GP*CP*TP*TP*AP*(DOC))-3');32630;
3QER;A;RB69 DNA Polymerase (L561A/S565G/Y567A) Ternary Complex with dATP Opposite Difluorotoluene Nucleoside;1.96;CA;CALCIUM ION;DNA polymerase;1914161;
3QES;A;RB69 DNA Polymerase (L561A/S565G/Y567A) Ternary Complex with dGTP Opposite Difluorotoluene Nucleoside;1.98;CA;CALCIUM ION;DNA polymerase;1914161;
3QET;A;RB69 DNA Polymerase (L561A/S565G/Y567A) Ternary Complex with dTTP Opposite dT;2.08;CA;CALCIUM ION;DNA polymerase;1914161;
3QEV;A;RB69 DNA Polymerase (L561A/S565G/Y567A) Ternary Complex with dCTP Opposite dT;1.77;CA;CALCIUM ION;DNA polymerase;1914161;
3QEV;P;RB69 DNA Polymerase (L561A/S565G/Y567A) Ternary Complex with dCTP Opposite dT;1.77;CA;CALCIUM ION;DNA (5'-D(*GP*CP*GP*GP*AP*CP*TP*GP*CP*TP*TP*AP*(DOC))-3');32630;
3QEW;A;RB69 DNA Polymerase (L561A/S565G/Y567A) Ternary Complex with dDTP Opposite dT;1.84;CA;CALCIUM ION;DNA polymerase;1914161;
3QEX;A;RB69 DNA Polymerase (L561A/S565G/Y567A) Ternary Complex with dGTP Opposite dT;1.73;CA;CALCIUM ION;DNA polymerase;1914161;
3QF1;A;Crystal structure of the complex of caprine lactoperoxidase with diethylenediamine at 2.6A resolution;2.6;CA;CALCIUM ION;Lactoperoxidase;9925;
3QFC;A;Crystal Structure of Human NADPH-Cytochrome P450 (V492E mutant);1.8;CA;CALCIUM ION;NADPH--cytochrome P450 reductase;9606;
3QFE;A;Crystal structures of a putative dihydrodipicolinate synthase family protein from Coccidioides immitis;2.35;CA;CALCIUM ION;Putative dihydrodipicolinate synthase family protein;5501;
3QFE;B;Crystal structures of a putative dihydrodipicolinate synthase family protein from Coccidioides immitis;2.35;CA;CALCIUM ION;Putative dihydrodipicolinate synthase family protein;5501;
3QFR;A;Crystal Structure of Human NADPH-Cytochrome P450 Reductase (R457H Mutant);2.4;CA;CALCIUM ION;NADPH--cytochrome P450 reductase;9606;
3QGM;A;p-nitrophenyl phosphatase from Archaeoglobus fulgidus;2;CA;CALCIUM ION;p-nitrophenyl phosphatase (Pho2);2234;
3QGM;B;p-nitrophenyl phosphatase from Archaeoglobus fulgidus;2;CA;CALCIUM ION;p-nitrophenyl phosphatase (Pho2);2234;
3QGM;C;p-nitrophenyl phosphatase from Archaeoglobus fulgidus;2;CA;CALCIUM ION;p-nitrophenyl phosphatase (Pho2);2234;
3QGM;D;p-nitrophenyl phosphatase from Archaeoglobus fulgidus;2;CA;CALCIUM ION;p-nitrophenyl phosphatase (Pho2);2234;
3QGO;A;Structure of Thermolysin in complex with L-Phenylalanine methylester;1.45;CA;CALCIUM ION;Thermolysin;1427;
3QGV;A;Crystal structure of a thermostable amylase variant;2.1;CA;CALCIUM ION;Alpha amylase;2262;
3QH1;A;Structure of Thermolysin in complex with N-benzyloxycarbonyl-L-aspartic acid;1.55;CA;CALCIUM ION;Thermolysin;1427;
3QH5;A;Structure of Thermolysin in complex with N-Carbobenzyloxy-L-aspartic acid and L-Phenylalanine Methyl Ester;1.5;CA;CALCIUM ION;Thermolysin;1427;
3QHQ;A;Structure of CRISPR-associated protein Csn2;2;CA;CALCIUM ION;Sag0897 family CRISPR-associated protein;1311;
3QHQ;B;Structure of CRISPR-associated protein Csn2;2;CA;CALCIUM ION;Sag0897 family CRISPR-associated protein;1311;
3QK1;A;Crystal Structure of Enterokinase-like Trypsin Variant;2.08;CA;CALCIUM ION;Cationic trypsin;9913;
3QL6;A;Crystal structure of the complex of bovine lactoperoxidase with nimesulide at 1.7 A resolution;1.7;CA;CALCIUM ION;Lactoperoxidase;9913;
3QLE;A;Structural Basis for the Function of Tim50 in the Mitochondrial Presequence Translocase;1.83;CA;CALCIUM ION;Tim50p;4932;
3QLM;A;Crystal structure of porcine pancreatic phospholipase A2 in complex with n-hexadecanoic acid;2.5;CA;CALCIUM ION;Phospholipase A2, major isoenzyme;9823;
3QLQ;A;Crystal structure of Concanavalin A bound to an octa-alpha-mannosyl-octasilsesquioxane cluster;1.7;CA;CALCIUM ION;Concanavalin-A;28958;
3QLQ;B;Crystal structure of Concanavalin A bound to an octa-alpha-mannosyl-octasilsesquioxane cluster;1.7;CA;CALCIUM ION;Concanavalin-A;28958;
3QLQ;C;Crystal structure of Concanavalin A bound to an octa-alpha-mannosyl-octasilsesquioxane cluster;1.7;CA;CALCIUM ION;Concanavalin-A;28958;
3QLQ;D;Crystal structure of Concanavalin A bound to an octa-alpha-mannosyl-octasilsesquioxane cluster;1.7;CA;CALCIUM ION;Concanavalin-A;28958;
3QM2;A;2.25 Angstrom Crystal Structure of Phosphoserine Aminotransferase (SerC) from Salmonella enterica subsp. enterica serovar Typhimurium;2.25;CA;CALCIUM ION;Phosphoserine aminotransferase;28901;
3QM2;B;2.25 Angstrom Crystal Structure of Phosphoserine Aminotransferase (SerC) from Salmonella enterica subsp. enterica serovar Typhimurium;2.25;CA;CALCIUM ION;Phosphoserine aminotransferase;28901;
3QMB;B;Structural Basis of Selective Binding of Nonmethylated CpG Islands by the CXXC Domain of CFP1;2.06;CA;CALCIUM ION;5'-D(*GP*CP*CP*AP*CP*CP*GP*GP*TP*GP*GP*C)-3';;
3QMN;A;Crystal Structure of 4'-Phosphopantetheinyl Transferase AcpS from Vibrio cholerae O1 biovar eltor;1.85;CA;CALCIUM ION;Holo-[acyl-carrier-protein] synthase;666;
3QMN;B;Crystal Structure of 4'-Phosphopantetheinyl Transferase AcpS from Vibrio cholerae O1 biovar eltor;1.85;CA;CALCIUM ION;Holo-[acyl-carrier-protein] synthase;666;
3QMN;C;Crystal Structure of 4'-Phosphopantetheinyl Transferase AcpS from Vibrio cholerae O1 biovar eltor;1.85;CA;CALCIUM ION;Holo-[acyl-carrier-protein] synthase;666;
3QMN;D;Crystal Structure of 4'-Phosphopantetheinyl Transferase AcpS from Vibrio cholerae O1 biovar eltor;1.85;CA;CALCIUM ION;Holo-[acyl-carrier-protein] synthase;666;
3QMN;E;Crystal Structure of 4'-Phosphopantetheinyl Transferase AcpS from Vibrio cholerae O1 biovar eltor;1.85;CA;CALCIUM ION;Holo-[acyl-carrier-protein] synthase;666;
3QMN;F;Crystal Structure of 4'-Phosphopantetheinyl Transferase AcpS from Vibrio cholerae O1 biovar eltor;1.85;CA;CALCIUM ION;Holo-[acyl-carrier-protein] synthase;666;
3QMN;G;Crystal Structure of 4'-Phosphopantetheinyl Transferase AcpS from Vibrio cholerae O1 biovar eltor;1.85;CA;CALCIUM ION;Holo-[acyl-carrier-protein] synthase;666;
3QMN;H;Crystal Structure of 4'-Phosphopantetheinyl Transferase AcpS from Vibrio cholerae O1 biovar eltor;1.85;CA;CALCIUM ION;Holo-[acyl-carrier-protein] synthase;666;
3QMN;I;Crystal Structure of 4'-Phosphopantetheinyl Transferase AcpS from Vibrio cholerae O1 biovar eltor;1.85;CA;CALCIUM ION;Holo-[acyl-carrier-protein] synthase;666;
3QMN;J;Crystal Structure of 4'-Phosphopantetheinyl Transferase AcpS from Vibrio cholerae O1 biovar eltor;1.85;CA;CALCIUM ION;Holo-[acyl-carrier-protein] synthase;666;
3QMN;K;Crystal Structure of 4'-Phosphopantetheinyl Transferase AcpS from Vibrio cholerae O1 biovar eltor;1.85;CA;CALCIUM ION;Holo-[acyl-carrier-protein] synthase;666;
3QMN;L;Crystal Structure of 4'-Phosphopantetheinyl Transferase AcpS from Vibrio cholerae O1 biovar eltor;1.85;CA;CALCIUM ION;Holo-[acyl-carrier-protein] synthase;666;
3QMN;M;Crystal Structure of 4'-Phosphopantetheinyl Transferase AcpS from Vibrio cholerae O1 biovar eltor;1.85;CA;CALCIUM ION;Holo-[acyl-carrier-protein] synthase;666;
3QMN;N;Crystal Structure of 4'-Phosphopantetheinyl Transferase AcpS from Vibrio cholerae O1 biovar eltor;1.85;CA;CALCIUM ION;Holo-[acyl-carrier-protein] synthase;666;
3QMN;O;Crystal Structure of 4'-Phosphopantetheinyl Transferase AcpS from Vibrio cholerae O1 biovar eltor;1.85;CA;CALCIUM ION;Holo-[acyl-carrier-protein] synthase;666;
3QMN;P;Crystal Structure of 4'-Phosphopantetheinyl Transferase AcpS from Vibrio cholerae O1 biovar eltor;1.85;CA;CALCIUM ION;Holo-[acyl-carrier-protein] synthase;666;
3QMN;Q;Crystal Structure of 4'-Phosphopantetheinyl Transferase AcpS from Vibrio cholerae O1 biovar eltor;1.85;CA;CALCIUM ION;Holo-[acyl-carrier-protein] synthase;666;
3QMN;R;Crystal Structure of 4'-Phosphopantetheinyl Transferase AcpS from Vibrio cholerae O1 biovar eltor;1.85;CA;CALCIUM ION;Holo-[acyl-carrier-protein] synthase;666;
3QMN;S;Crystal Structure of 4'-Phosphopantetheinyl Transferase AcpS from Vibrio cholerae O1 biovar eltor;1.85;CA;CALCIUM ION;Holo-[acyl-carrier-protein] synthase;666;
3QMN;T;Crystal Structure of 4'-Phosphopantetheinyl Transferase AcpS from Vibrio cholerae O1 biovar eltor;1.85;CA;CALCIUM ION;Holo-[acyl-carrier-protein] synthase;666;
3QMN;U;Crystal Structure of 4'-Phosphopantetheinyl Transferase AcpS from Vibrio cholerae O1 biovar eltor;1.85;CA;CALCIUM ION;Holo-[acyl-carrier-protein] synthase;666;
3QMN;V;Crystal Structure of 4'-Phosphopantetheinyl Transferase AcpS from Vibrio cholerae O1 biovar eltor;1.85;CA;CALCIUM ION;Holo-[acyl-carrier-protein] synthase;666;
3QMN;W;Crystal Structure of 4'-Phosphopantetheinyl Transferase AcpS from Vibrio cholerae O1 biovar eltor;1.85;CA;CALCIUM ION;Holo-[acyl-carrier-protein] synthase;666;
3QMN;X;Crystal Structure of 4'-Phosphopantetheinyl Transferase AcpS from Vibrio cholerae O1 biovar eltor;1.85;CA;CALCIUM ION;Holo-[acyl-carrier-protein] synthase;666;
3QMP;A;Selenium SAD structure solution of proteinase K grown in SO4-less solution and soaked in selenate.;1.1;CA;CALCIUM ION;Proteinase K;37998;
3QNI;A;Crystal structure of human PACSIN 1 F-BAR domain;2.8;CA;CALCIUM ION;Protein kinase C and casein kinase substrate in neurons protein 1;9606;
3QNI;B;Crystal structure of human PACSIN 1 F-BAR domain;2.8;CA;CALCIUM ION;Protein kinase C and casein kinase substrate in neurons protein 1;9606;
3QNN;A;RB69 DNA Polymerase (Y567A) Ternary Complex with dGT Opposite 3tCo;1.92;CA;CALCIUM ION;DNA polymerase;1914161;
3QNO;A;RB69 DNA Polymerase (Y567A) Ternary Complex with dATP Opposite 3tCo;1.88;CA;CALCIUM ION;DNA Polymerase;1914161;
3QOJ;A;Cryogenic structure of Staphylococcal nuclease variant D+PHS/V23K;1.6;CA;CALCIUM ION;Thermonuclease;1280;
3QOL;A;Crystal structure of Staphylococcal nuclease variant D+PHS/V23E at pH 6 determined at 100 K;1.9;CA;CALCIUM ION;Thermonuclease;1280;
3QOU;A;Crystal Structure of E. coli YbbN;1.8;CA;CALCIUM ION;protein ybbN;562;
3QQZ;A;Crystal structure of the C-terminal domain of the yjiK protein from Escherichia coli CFT073;2.55;CA;CALCIUM ION;Putative uncharacterized protein yjiK;562;
3QR0;A;Crystal Structure of S. officinalis PLC21;2;CA;CALCIUM ION;phospholipase C-beta (PLC-beta);6610;
3QR1;A;Crystal Structure of L. pealei PLC21;3.2;CA;CALCIUM ION;PHOSPHOLIPASE C-BETA (PLC-BETA);1051067;
3QR1;D;Crystal Structure of L. pealei PLC21;3.2;CA;CALCIUM ION;PHOSPHOLIPASE C-BETA (PLC-BETA);1051067;
3QR7;A;Crystal structure of the C-terminal fragment of the bacteriophage P2 membrane-piercing protein gpV;0.94;CA;CALCIUM ION;Baseplate assembly protein V;10679;
3QR7;B;Crystal structure of the C-terminal fragment of the bacteriophage P2 membrane-piercing protein gpV;0.94;CA;CALCIUM ION;Baseplate assembly protein V;10679;
3QRB;A;crystal structure of E-cadherin EC1-2 P5A P6A;1.8;CA;CALCIUM ION;Cadherin-1;10090;
3QRB;B;crystal structure of E-cadherin EC1-2 P5A P6A;1.8;CA;CALCIUM ION;Cadherin-1;10090;
3QRX;A;Chlamydomonas reinhardtii centrin bound to melittin;2.2;CA;CALCIUM ION;Centrin;3055;
3QSJ;A;Crystal structure of NUDIX hydrolase from Alicyclobacillus acidocaldarius;1.7;CA;CALCIUM ION;NUDIX hydrolase;405212;
3QTA;A;Crystal structure of a CheC-like protein (rrnAC0528) from Haloarcula marismortui ATCC 43049 at 2.00 A resolution;2;CA;CALCIUM ION;Chemotaxis protein CheC;2238;
3QTA;B;Crystal structure of a CheC-like protein (rrnAC0528) from Haloarcula marismortui ATCC 43049 at 2.00 A resolution;2;CA;CALCIUM ION;Chemotaxis protein CheC;2238;
3QU7;A;Crystal structure of pyrophosphatase from bacteroides thetaiotaomicron, asp13asn mutant complexed with calcium and phosphate;1.9;CA;CALCIUM ION;INORGANIC PYROPHOSPHATASE;818;
3QU7;B;Crystal structure of pyrophosphatase from bacteroides thetaiotaomicron, asp13asn mutant complexed with calcium and phosphate;1.9;CA;CALCIUM ION;INORGANIC PYROPHOSPHATASE;818;
3QVM;B;The structure of olei00960, a hydrolase from Oleispira antarctica;2;CA;CALCIUM ION;Olei00960;188908;
3QWU;A;Putative ATP-dependent DNA ligase from Aquifex aeolicus.;2.35;CA;CALCIUM ION;DNA ligase;63363;
3QWU;B;Putative ATP-dependent DNA ligase from Aquifex aeolicus.;2.35;CA;CALCIUM ION;DNA ligase;63363;
3QXG;A;Crystal structure of pyrophosphatase from bacteroides thetaiotaomicron complexed with calcium, a closed cap conformation;1.24;CA;CALCIUM ION;INORGANIC PYROPHOSPHATASE;818;
3QXG;B;Crystal structure of pyrophosphatase from bacteroides thetaiotaomicron complexed with calcium, a closed cap conformation;1.24;CA;CALCIUM ION;INORGANIC PYROPHOSPHATASE;818;
3QYL;A;Sensitivity of receptor internal motions to ligand binding affinity and kinetic off-rate;1.79;CA;CALCIUM ION;Dihydrofolate reductase;562;
3QYO;A;Sensitivity of receptor internal motions to ligand binding affinity and kinetic off-rate;2.09;CA;CALCIUM ION;Dihydrofolate reductase;562;
3QYP;A;Crystal structure of pyrophosphatase from bacteroides thetaiotaomicron, glu47asn mutant complexed with calcium and phosphate;1.6;CA;CALCIUM ION;INORGANIC PYROPHOSPHATASE;818;
3QYP;B;Crystal structure of pyrophosphatase from bacteroides thetaiotaomicron, glu47asn mutant complexed with calcium and phosphate;1.6;CA;CALCIUM ION;INORGANIC PYROPHOSPHATASE;818;
3QZ7;A;T-3 ternary complex of Dpo4;2;CA;CALCIUM ION;DNA polymerase IV;2287;
3QZ8;A;TT-4 ternary complex of Dpo4;2;CA;CALCIUM ION;DNA polymerase IV;2287;
3R1E;A;Crystal structure of GC(8BrG)GCGGC duplex;0.97;CA;CALCIUM ION;RNA (5'-R(*GP*CP*(GRB)P*GP*CP*GP*GP*C)-3');;
3R1E;B;Crystal structure of GC(8BrG)GCGGC duplex;0.97;CA;CALCIUM ION;RNA (5'-R(*GP*CP*(GRB)P*GP*CP*GP*GP*C)-3');;
3R1H;C;Crystal structure of the Class I ligase ribozyme-substrate preligation complex, C47U mutant, Ca2+ bound;3.15;CA;CALCIUM ION;Class I ligase ribozyme;;
3R1H;E;Crystal structure of the Class I ligase ribozyme-substrate preligation complex, C47U mutant, Ca2+ bound;3.15;CA;CALCIUM ION;5'-R(*UP*CP*CP*AP*GP*UP*A)-3';;
3R1H;F;Crystal structure of the Class I ligase ribozyme-substrate preligation complex, C47U mutant, Ca2+ bound;3.15;CA;CALCIUM ION;Class I ligase ribozyme;;
3R33;A;Evidence for dynamic motion in proteins as a mechanism for ligand dissociation;2.09;CA;CALCIUM ION;Dihydrofolate reductase;562;
3R3O;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS T62A at cryogenic temperature and with high redundancy;1.9;CA;CALCIUM ION;Thermonuclease;1280;
3R3T;A;Crystal Structure of 30S Ribosomal Protein S from Bacillus anthracis;2.3;CA;CALCIUM ION;30S ribosomal protein S6;1392;
3R3T;B;Crystal Structure of 30S Ribosomal Protein S from Bacillus anthracis;2.3;CA;CALCIUM ION;30S ribosomal protein S6;1392;
3R3V;A;Crystal Structure of the Fluoroacetate Dehalogenase RPA1163 - Asp110Asn/Fluoroacetate;1.5;CA;CALCIUM ION;Fluoroacetate dehalogenase;1076;
3R3W;A;Crystal Structure of the Fluoroacetate Dehalogenase RPA1163 - Asp110Asn/Chloroacetate;1.6;CA;CALCIUM ION;Fluoroacetate dehalogenase;1076;
3R3X;A;Crystal Structure of the Fluoroacetate Dehalogenase RPA1163 - Asp110Asn/Bromoacetate;1.8;CA;CALCIUM ION;Fluoroacetate dehalogenase;1076;
3R3Y;A;Crystal Structure of the Fluoroacetate Dehalogenase RPA1163 - His280Asn/Fluoroacetate;1.15;CA;CALCIUM ION;Fluoroacetate dehalogenase;1076;
3R40;A;Crystal Structure of the Fluoroacetate Dehalogenase RPA1163 - Asp110Asn/apo;1.05;CA;CALCIUM ION;Fluoroacetate dehalogenase;1076;
3R41;A;Crystal Structure of the Fluoroacetate Dehalogenase RPA1163 - His280Asn/apo;1.05;CA;CALCIUM ION;Fluoroacetate dehalogenase;1076;
3R41;B;Crystal Structure of the Fluoroacetate Dehalogenase RPA1163 - His280Asn/apo;1.05;CA;CALCIUM ION;Fluoroacetate dehalogenase;1076;
3R4I;A;Crystal structure of a Citrate lyase (Bxe_B2899) from BURKHOLDERIA XENOVORANS LB400 at 2.24 A resolution;2.24;CA;CALCIUM ION;Citrate Lyase;36873;
3R4I;B;Crystal structure of a Citrate lyase (Bxe_B2899) from BURKHOLDERIA XENOVORANS LB400 at 2.24 A resolution;2.24;CA;CALCIUM ION;Citrate Lyase;36873;
3R4I;C;Crystal structure of a Citrate lyase (Bxe_B2899) from BURKHOLDERIA XENOVORANS LB400 at 2.24 A resolution;2.24;CA;CALCIUM ION;Citrate Lyase;36873;
3R4I;D;Crystal structure of a Citrate lyase (Bxe_B2899) from BURKHOLDERIA XENOVORANS LB400 at 2.24 A resolution;2.24;CA;CALCIUM ION;Citrate Lyase;36873;
3R4I;E;Crystal structure of a Citrate lyase (Bxe_B2899) from BURKHOLDERIA XENOVORANS LB400 at 2.24 A resolution;2.24;CA;CALCIUM ION;Citrate Lyase;36873;
3R4I;F;Crystal structure of a Citrate lyase (Bxe_B2899) from BURKHOLDERIA XENOVORANS LB400 at 2.24 A resolution;2.24;CA;CALCIUM ION;Citrate Lyase;36873;
3R4X;A;Crystal structure of bovine lactoperoxidase complexed with pyrazine-2-carboxamide at 2 A resolution;2.01;CA;CALCIUM ION;Lactoperoxidase;9913;
3R55;A;Crystal structure of the complex of goat lactoperoxidase with Pyrazinamide at 2.1 A resolution;2.1;CA;CALCIUM ION;Lactoperoxidase;9925;
3R5O;A;Crystal structure of the complex of bovine lactoperoxidase with 4-allyl-2-methoxyphenol at 2.6 A resolution;2.6;CA;CALCIUM ION;Lactoperoxidase;9913;
3R5Q;A;Crystal structure of sheep lactoperoxidase in complex with tetrahydrofuran at 2.7 A resolution;2.7;CA;CALCIUM ION;Airway lactoperoxidase;9940;
3R5V;A;The structure of calcium bound Thermococcus thioreducens inorganic pyrophosphatase at 298K;1.65;CA;CALCIUM ION;Tt-IPPase;277988;
3R5V;B;The structure of calcium bound Thermococcus thioreducens inorganic pyrophosphatase at 298K;1.65;CA;CALCIUM ION;Tt-IPPase;277988;
3R5V;C;The structure of calcium bound Thermococcus thioreducens inorganic pyrophosphatase at 298K;1.65;CA;CALCIUM ION;Tt-IPPase;277988;
3R5V;D;The structure of calcium bound Thermococcus thioreducens inorganic pyrophosphatase at 298K;1.65;CA;CALCIUM ION;Tt-IPPase;277988;
3R5V;E;The structure of calcium bound Thermococcus thioreducens inorganic pyrophosphatase at 298K;1.65;CA;CALCIUM ION;Tt-IPPase;277988;
3R5V;F;The structure of calcium bound Thermococcus thioreducens inorganic pyrophosphatase at 298K;1.65;CA;CALCIUM ION;Tt-IPPase;277988;
3R5X;A;Crystal Structure of D-alanine--D-Alanine Ligase from Bacillus anthracis complexed with ATP;2;CA;CALCIUM ION;D-alanine--D-alanine ligase;1392;
3R5X;B;Crystal Structure of D-alanine--D-Alanine Ligase from Bacillus anthracis complexed with ATP;2;CA;CALCIUM ION;D-alanine--D-alanine ligase;1392;
3R5X;C;Crystal Structure of D-alanine--D-Alanine Ligase from Bacillus anthracis complexed with ATP;2;CA;CALCIUM ION;D-alanine--D-alanine ligase;1392;
3R5X;D;Crystal Structure of D-alanine--D-Alanine Ligase from Bacillus anthracis complexed with ATP;2;CA;CALCIUM ION;D-alanine--D-alanine ligase;1392;
3R68;A;Molecular Analysis of the PDZ3 domain of PDZK1;1.3;CA;CALCIUM ION;Na(+)/H(+) exchange regulatory cofactor NHE-RF3;10090;
3R6Q;A;A triclinic-lattice structure of aspartase from Bacillus sp. YM55-1;2.4;CA;CALCIUM ION;Aspartase;96471;
3R6Q;D;A triclinic-lattice structure of aspartase from Bacillus sp. YM55-1;2.4;CA;CALCIUM ION;Aspartase;96471;
3R6Q;E;A triclinic-lattice structure of aspartase from Bacillus sp. YM55-1;2.4;CA;CALCIUM ION;Aspartase;96471;
3R6Q;H;A triclinic-lattice structure of aspartase from Bacillus sp. YM55-1;2.4;CA;CALCIUM ION;Aspartase;96471;
3R6V;A;Crystal structure of aspartase from Bacillus sp. YM55-1 with bound L-aspartate;2.6;CA;CALCIUM ION;Aspartase;96471;
3R6V;D;Crystal structure of aspartase from Bacillus sp. YM55-1 with bound L-aspartate;2.6;CA;CALCIUM ION;Aspartase;96471;
3R6V;E;Crystal structure of aspartase from Bacillus sp. YM55-1 with bound L-aspartate;2.6;CA;CALCIUM ION;Aspartase;96471;
3R6V;H;Crystal structure of aspartase from Bacillus sp. YM55-1 with bound L-aspartate;2.6;CA;CALCIUM ION;Aspartase;96471;
3R6Y;B;Crystal structure of chymotrypsin-treated aspartase from Bacillus sp. YM55-1;3;CA;CALCIUM ION;Aspartase;96471;
3R6Y;F;Crystal structure of chymotrypsin-treated aspartase from Bacillus sp. YM55-1;3;CA;CALCIUM ION;Aspartase;96471;
3R8Y;A;Structure of the Bacillus anthracis tetrahydropicolinate succinyltransferase;1.7;CA;CALCIUM ION;2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-acetyltransferase;1392;
3R8Y;B;Structure of the Bacillus anthracis tetrahydropicolinate succinyltransferase;1.7;CA;CALCIUM ION;2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-acetyltransferase;1392;
3R8Y;C;Structure of the Bacillus anthracis tetrahydropicolinate succinyltransferase;1.7;CA;CALCIUM ION;2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-acetyltransferase;1392;
3R8Y;D;Structure of the Bacillus anthracis tetrahydropicolinate succinyltransferase;1.7;CA;CALCIUM ION;2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-acetyltransferase;1392;
3R8Y;F;Structure of the Bacillus anthracis tetrahydropicolinate succinyltransferase;1.7;CA;CALCIUM ION;2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-acetyltransferase;1392;
3R9W;B;Crystal structure of Era in complex with MgGDPNP and nucleotides 1506-1542 of 16S ribosomal RNA;2.05;CA;CALCIUM ION;RNA301;;
3RAQ;A;Dpo4 extension ternary complex with 3'-terminal primer C base opposite the 1-methylguanine (MG1) lesion;2.25;CA;CALCIUM ION;DNA polymerase IV;2287;
3RAQ;B;Dpo4 extension ternary complex with 3'-terminal primer C base opposite the 1-methylguanine (MG1) lesion;2.25;CA;CALCIUM ION;DNA polymerase IV;2287;
3RAR;A;X-ray structure of a bound phosphonate transition state analog and enantioselectivity of Candida rugosa lipase toward chiral carboxylic acids;2.19;CA;CALCIUM ION;Lipase 1;5481;
3RAX;A;Dpo4 extension ternary complex with 3'-terminal primer T base opposite the 1-methylguanine (M1G) lesion;1.89;CA;CALCIUM ION;DNA polymerase IV;2287;
3RAX;B;Dpo4 extension ternary complex with 3'-terminal primer T base opposite the 1-methylguanine (M1G) lesion;1.89;CA;CALCIUM ION;DNA polymerase IV;2287;
3RB0;A;Dpo4 extension ternary complex with 3'-terminal primer G base opposite the 1-methylguanine (M1G) lesion;3.22;CA;CALCIUM ION;DNA polymerase IV;2287;
3RB0;B;Dpo4 extension ternary complex with 3'-terminal primer G base opposite the 1-methylguanine (M1G) lesion;3.22;CA;CALCIUM ION;DNA polymerase IV;2287;
3RB3;A;Dpo4 extension ternary complex with 3'-terminal primer A base opposite the 1-methylguanine (m1g) lesion;2.8;CA;CALCIUM ION;DNA polymerase IV;2287;
3RB4;A;Dpo4 extension ternary complex with 3'-terminal primer G base opposite the 3-methylcytosine (m3c) lesion;2.81;CA;CALCIUM ION;DNA polymerase IV;2287;
3RB4;B;Dpo4 extension ternary complex with 3'-terminal primer G base opposite the 3-methylcytosine (m3c) lesion;2.81;CA;CALCIUM ION;DNA polymerase IV;2287;
3RB5;A;Crystal structure of calcium binding domain CBD12 of CALX1.1;2.35;CA;CALCIUM ION;Na/Ca exchange protein;7227;
3RB5;B;Crystal structure of calcium binding domain CBD12 of CALX1.1;2.35;CA;CALCIUM ION;Na/Ca exchange protein;7227;
3RB6;A;Dpo4 extension ternary complex with 3'-terminal primer A base opposite the 3-methylcytosine (m3c) lesion;2.7;CA;CALCIUM ION;DNA polymerase IV;2287;
3RB6;B;Dpo4 extension ternary complex with 3'-terminal primer A base opposite the 3-methylcytosine (m3c) lesion;2.7;CA;CALCIUM ION;DNA polymerase IV;2287;
3RB7;A;Crystal structure of CBD12 from CALX1.2;2.9;CA;CALCIUM ION;Na/Ca exchange protein;7227;
3RB7;B;Crystal structure of CBD12 from CALX1.2;2.9;CA;CALCIUM ION;Na/Ca exchange protein;7227;
3RB7;E;Crystal structure of CBD12 from CALX1.2;2.9;CA;CALCIUM ION;Na/Ca exchange protein;7227;
3RB7;G;Crystal structure of CBD12 from CALX1.2;2.9;CA;CALCIUM ION;Na/Ca exchange protein;7227;
3RBD;A;Dpo4 extension ternary complex with 3'-terminal primer C base opposite the 3-methylcytosine (m3c) lesion;2.5;CA;CALCIUM ION;DNA polymerase IV;2287;
3RBD;B;Dpo4 extension ternary complex with 3'-terminal primer C base opposite the 3-methylcytosine (m3c) lesion;2.5;CA;CALCIUM ION;DNA polymerase IV;2287;
3RBE;A;Dpo4 extension ternary complex with 3'-terminal primer t base opposite the 3-methylcytosine (m3c) lesion;2.8;CA;CALCIUM ION;DNA polymerase IV;2287;
3RBE;B;Dpo4 extension ternary complex with 3'-terminal primer t base opposite the 3-methylcytosine (m3c) lesion;2.8;CA;CALCIUM ION;DNA polymerase IV;2287;
3RBH;A;Structure of alginate export protein AlgE from Pseudomonas aeruginosa;2.3;CA;CALCIUM ION;Alginate production protein AlgE;287;
3RBH;B;Structure of alginate export protein AlgE from Pseudomonas aeruginosa;2.3;CA;CALCIUM ION;Alginate production protein AlgE;287;
3RBH;C;Structure of alginate export protein AlgE from Pseudomonas aeruginosa;2.3;CA;CALCIUM ION;Alginate production protein AlgE;287;
3RBH;D;Structure of alginate export protein AlgE from Pseudomonas aeruginosa;2.3;CA;CALCIUM ION;Alginate production protein AlgE;287;
3RBU;A;N-terminally AviTEV-tagged Human Glutamate Carboxypeptidase II in complex with 2-PMPA;1.6;CA;CALCIUM ION;Glutamate carboxypeptidase 2;9606;
3RBX;A;MthK RCK domain D184N mutant, Ca2+-bound;2.8;CA;CALCIUM ION;Calcium-gated potassium channel mthK;145262;
3RBX;B;MthK RCK domain D184N mutant, Ca2+-bound;2.8;CA;CALCIUM ION;Calcium-gated potassium channel mthK;145262;
3RBX;C;MthK RCK domain D184N mutant, Ca2+-bound;2.8;CA;CALCIUM ION;Calcium-gated potassium channel mthK;145262;
3RBX;E;MthK RCK domain D184N mutant, Ca2+-bound;2.8;CA;CALCIUM ION;Calcium-gated potassium channel mthK;145262;
3RBX;F;MthK RCK domain D184N mutant, Ca2+-bound;2.8;CA;CALCIUM ION;Calcium-gated potassium channel mthK;145262;
3RBZ;A;MthK channel, Ca2+-bound;3.4;CA;CALCIUM ION;Calcium-gated potassium channel mthK;145262;
3RBZ;B;MthK channel, Ca2+-bound;3.4;CA;CALCIUM ION;Calcium-gated potassium channel mthK;145262;
3RBZ;C;MthK channel, Ca2+-bound;3.4;CA;CALCIUM ION;Calcium-gated potassium channel mthK;145262;
3RBZ;D;MthK channel, Ca2+-bound;3.4;CA;CALCIUM ION;Calcium-gated potassium channel mthK;145262;
3RDZ;A;Crystal Structure of rBTI-trypsin complex at 2.26 angstrom resolution;2.26;CA;CALCIUM ION;Cationic trypsin;9913;
3RDZ;B;Crystal Structure of rBTI-trypsin complex at 2.26 angstrom resolution;2.26;CA;CALCIUM ION;Cationic trypsin;9913;
3RF7;A;Crystal structure of an Iron-containing alcohol dehydrogenase (Sden_2133) from Shewanella denitrificans OS-217 at 2.12 A resolution;2.12;CA;CALCIUM ION;Iron-containing alcohol dehydrogenase;192073;
3RG0;A;Structural and functional relationships between the lectin and arm domains of calreticulin;2.57;CA;CALCIUM ION;Calreticulin;10090;
3RHT;A;Crystal structure of type 1 glutamine amidotransferase (GATase1)-like protein from Planctomyces limnophilus;1.83;CA;CALCIUM ION;(GATase1)-like protein;120;
3RHT;B;Crystal structure of type 1 glutamine amidotransferase (GATase1)-like protein from Planctomyces limnophilus;1.83;CA;CALCIUM ION;(GATase1)-like protein;120;
3RHT;C;Crystal structure of type 1 glutamine amidotransferase (GATase1)-like protein from Planctomyces limnophilus;1.83;CA;CALCIUM ION;(GATase1)-like protein;120;
3RHT;D;Crystal structure of type 1 glutamine amidotransferase (GATase1)-like protein from Planctomyces limnophilus;1.83;CA;CALCIUM ION;(GATase1)-like protein;120;
3RIV;A;The Crystal Structure of Leishmania major Peroxidase;1.76;CA;CALCIUM ION;Ascorbate peroxidase;5664;
3RIV;B;The Crystal Structure of Leishmania major Peroxidase;1.76;CA;CALCIUM ION;Ascorbate peroxidase;5664;
3RIW;A;The Crystal Structure of Leishmania major Peroxidase mutant C197T;2.37;CA;CALCIUM ION;Ascorbate peroxidase;5664;
3RIW;B;The Crystal Structure of Leishmania major Peroxidase mutant C197T;2.37;CA;CALCIUM ION;Ascorbate peroxidase;5664;
3RK2;B;Truncated SNARE complex;2.2;CA;CALCIUM ION;Syntaxin-1A;10116;
3RK2;C;Truncated SNARE complex;2.2;CA;CALCIUM ION;Synaptosomal-associated protein 25;9606;
3RKE;A;Crystal Structure of goat Lactoperoxidase complexed with a tightly bound inhibitor, 4-aminophenyl-4H-imidazole-1-yl methanone at 2.3 A resolution;2.3;CA;CALCIUM ION;Lactoperoxidase;9925;
3RKH;A;Structure of the Thioalkalivibrio nitratireducens cytochrome c nitrite reductase in a complex with nitrite (full occupancy);1.83;CA;CALCIUM ION;Eight-heme nitrite reductase;186931;
3RKH;B;Structure of the Thioalkalivibrio nitratireducens cytochrome c nitrite reductase in a complex with nitrite (full occupancy);1.83;CA;CALCIUM ION;Eight-heme nitrite reductase;186931;
3RL5;A;Rat metallophosphodiesterase MPPED2 H67R Mutant;1.26;CA;CALCIUM ION;Metallophosphoesterase MPPED2;10116;
3RLM;A;Structure of the W199F MauG/pre-Methylamine Dehydrogenase complex after treatment with hydrogen peroxide;2.13;CA;CALCIUM ION;Methylamine utilization protein MauG;266;
3RLM;B;Structure of the W199F MauG/pre-Methylamine Dehydrogenase complex after treatment with hydrogen peroxide;2.13;CA;CALCIUM ION;Methylamine utilization protein MauG;266;
3RLZ;A;2.0 Angstrom X-ray structure of bovine Ca(2+)-S100B D63N;2.01;CA;CALCIUM ION;Protein S100-B;9913;
3RLZ;B;2.0 Angstrom X-ray structure of bovine Ca(2+)-S100B D63N;2.01;CA;CALCIUM ION;Protein S100-B;9913;
3RM1;A;1.24 Angstrom X-ray structure of bovine TRTK12-Ca(2+)-S100B D63N;1.24;CA;CALCIUM ION;Protein S100-B;9913;
3RMK;A;Toluene 4 monooxygenase H with 4-bromophenol;1.95;CA;CALCIUM ION;Toluene-4-monooxygenase system protein A;300;
3RMK;B;Toluene 4 monooxygenase H with 4-bromophenol;1.95;CA;CALCIUM ION;Toluene-4-monooxygenase system protein E;300;
3RMK;D;Toluene 4 monooxygenase H with 4-bromophenol;1.95;CA;CALCIUM ION;Toluene-4-monooxygenase system protein A;300;
3RMK;E;Toluene 4 monooxygenase H with 4-bromophenol;1.95;CA;CALCIUM ION;Toluene-4-monooxygenase system protein E;300;
3RMK;F;Toluene 4 monooxygenase H with 4-bromophenol;1.95;CA;CALCIUM ION;Toluene-4-monooxygenase system protein B;300;
3RMZ;A;Crystal Structure of the W199F-MauG/pre-Methylamine Dehydrogenase Complex;1.72;CA;CALCIUM ION;Methylamine utilization protein MauG;266;
3RMZ;B;Crystal Structure of the W199F-MauG/pre-Methylamine Dehydrogenase Complex;1.72;CA;CALCIUM ION;Methylamine utilization protein MauG;266;
3RN0;A;Crystal Structure of the W199K-MauG/pre-Methylamine Dehydrogenase Complex;1.91;CA;CALCIUM ION;Methylamine utilization protein MauG;266;
3RN0;B;Crystal Structure of the W199K-MauG/pre-Methylamine Dehydrogenase Complex;1.91;CA;CALCIUM ION;Methylamine utilization protein MauG;266;
3RN1;A;Crystal Structure of the W199E-MauG/pre-Methylamine Dehydrogenase Complex;1.93;CA;CALCIUM ION;Methylamine utilization protein MauG;266;
3RN1;B;Crystal Structure of the W199E-MauG/pre-Methylamine Dehydrogenase Complex;1.93;CA;CALCIUM ION;Methylamine utilization protein MauG;266;
3RNT;A;CRYSTAL STRUCTURE OF GUANOSINE-FREE RIBONUCLEASE T1, COMPLEXED WITH VANADATE(V), SUGGESTS CONFORMATIONAL CHANGE UPON SUBSTRATE BINDING;1.8;CA;CALCIUM ION;RIBONUCLEASE T1;5062;
3RQ0;A;The crystal structure of a glycosyl hydrolases (GH) family protein 16 from Mycobacterium smegmatis str. MC2 155;2.02;CA;CALCIUM ION;Glycosyl hydrolases family protein 16;1772;
3RQI;A;Crystal structure of a response regulator protein from Burkholderia pseudomallei with a phosphorylated aspartic acid, calcium ion and citrate;1.7;CA;CALCIUM ION;Response regulator protein;28450;
3RRD;A;Native structure of Dioclea virgata lectin;2.46;CA;CALCIUM ION;Lectin alpha chain;167618;
3RRV;A;Crystal structure of an enoyl-CoA hydratase/isomerase from Mycobacterium paratuberculosis;2.45;CA;CALCIUM ION;enoyl-CoA hydratase/isomerase;1764;
3RRV;B;Crystal structure of an enoyl-CoA hydratase/isomerase from Mycobacterium paratuberculosis;2.45;CA;CALCIUM ION;enoyl-CoA hydratase/isomerase;1764;
3RRV;C;Crystal structure of an enoyl-CoA hydratase/isomerase from Mycobacterium paratuberculosis;2.45;CA;CALCIUM ION;enoyl-CoA hydratase/isomerase;1764;
3RRV;D;Crystal structure of an enoyl-CoA hydratase/isomerase from Mycobacterium paratuberculosis;2.45;CA;CALCIUM ION;enoyl-CoA hydratase/isomerase;1764;
3RRV;E;Crystal structure of an enoyl-CoA hydratase/isomerase from Mycobacterium paratuberculosis;2.45;CA;CALCIUM ION;enoyl-CoA hydratase/isomerase;1764;
3RRV;F;Crystal structure of an enoyl-CoA hydratase/isomerase from Mycobacterium paratuberculosis;2.45;CA;CALCIUM ION;enoyl-CoA hydratase/isomerase;1764;
3RRW;A;Crystal structure of the TL29 protein from Arabidopsis thaliana;2.5;CA;CALCIUM ION;Thylakoid lumenal 29 kDa protein, chloroplastic;3702;
3RRW;B;Crystal structure of the TL29 protein from Arabidopsis thaliana;2.5;CA;CALCIUM ION;Thylakoid lumenal 29 kDa protein, chloroplastic;3702;
3RRX;A;Crystal Structure of Q683A mutant of Exo-1,3/1,4-beta-glucanase (ExoP) from Pseudoalteromonas sp. BB1;1.9;CA;CALCIUM ION;Exo-1,3/1,4-beta-glucanase;368972;
3RRY;A;H-Ras crosslinked control, soaked in aqueous solution: one of 10 in MSCS set;1.6;CA;CALCIUM ION;GTPase HRas;9606;
3RRZ;A;H-Ras in 70% glycerol: one of 10 in MSCS set;1.6;CA;CALCIUM ION;GTPase HRas;9606;
3RS0;A;H-Ras soaked in neat cyclopentanol: one of 10 in MSCS set;1.4;CA;CALCIUM ION;GTPase HRas;9606;
3RS2;A;H-Ras soaked in 50% 2,2,2-trifluoroethanol: one of 10 in MSCS set;1.84;CA;CALCIUM ION;GTPase HRas;9606;
3RS3;A;H-Ras soaked in neat hexane: 1 of 10 in MSCS set;1.52;CA;CALCIUM ION;GTPase HRas;9606;
3RS4;A;H-Ras soaked in 60% 1,6-hexanediol: 1 of 10 in MSCS set;1.7;CA;CALCIUM ION;GTPase HRas;9606;
3RS5;A;H-Ras soaked in 55% dimethylformamide: 1 of 10 in MSCS set;1.68;CA;CALCIUM ION;GTPase HRas;9606;
3RS6;A;Crystal structure Dioclea virgata lectin in complexed with X-mannose;1.8;CA;CALCIUM ION;Lectin alpha chain;167618;
3RS7;A;H-Ras soaked in 50% isopropanol: 1 of 10 in MSCS set;1.7;CA;CALCIUM ION;GTPase HRas;9606;
3RSL;A;H-Ras soaked in 90% R,S,R-bisfuranol: one of 10 in MSCS set;1.7;CA;CALCIUM ION;GTPase HRas;9606;
3RSO;A;H-Ras soaked in 20% S,R,S-bisfuranol: 1 of 10 in MSCS set;1.6;CA;CALCIUM ION;GTPase HRas;9606;
3RTS;A;Human MMP-12 catalytic domain in complex with*N*-Hydroxy-2-(2-phenylethylsulfonamido)acetamide;1.81;CA;CALCIUM ION;Macrophage metalloelastase;9606;
3RTT;A;Human MMP-12 catalytic domain in complex with*(R)-N*-Hydroxy-1-(phenethylsulfonyl)pyrrolidine-2-carboxamide;1.82;CA;CALCIUM ION;Macrophage metalloelastase;9606;
3RU4;T;Crystal structure of the Bowman-Birk serine protease inhibitor BTCI in complex with trypsin and chymotrypsin;1.68;CA;CALCIUM ION;Cationic trypsin;9913;
3RUP;A;Crystal structure of E.coli biotin carboxylase in complex with two ADP and two Ca ions;1.99;CA;CALCIUM ION;Biotin carboxylase;562;
3RUP;B;Crystal structure of E.coli biotin carboxylase in complex with two ADP and two Ca ions;1.99;CA;CALCIUM ION;Biotin carboxylase;562;
3RUZ;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS V74K at cryogenic temperature;1.58;CA;CALCIUM ION;Thermonuclease;1280;
3RV2;A;Crystal structure of S-adenosylmethionine synthetase from Mycobacterium marinum;2;CA;CALCIUM ION;S-adenosylmethionine synthase;1781;
3RV2;B;Crystal structure of S-adenosylmethionine synthetase from Mycobacterium marinum;2;CA;CALCIUM ION;S-adenosylmethionine synthase;1781;
3RV5;B;Crystal structure of human cardiac troponin C regulatory domain in complex with cadmium and deoxycholic acid;2.2;CA;CALCIUM ION;Troponin C, slow skeletal and cardiac muscles;9606;
3RV5;C;Crystal structure of human cardiac troponin C regulatory domain in complex with cadmium and deoxycholic acid;2.2;CA;CALCIUM ION;Troponin C, slow skeletal and cardiac muscles;9606;
3RVV;A;Crystal structure of Der f 1 complexed with Fab 4C1;1.9;CA;CALCIUM ION;Peptidase 1;6954;
3RVW;A;Crystal structure of Der p 1 complexed with Fab 4C1;1.95;CA;CALCIUM ION;Peptidase 1;6956;
3RVX;A;Crystal structure of Der p 1 complexed with Fab 4C1;2.5;CA;CALCIUM ION;Peptidase 1;6956;
3RWU;A;RB69 DNA Polymerase (Y567A) Ternary Complex with dATP Opposite Difluorotoluene Nucleoside;2.33;CA;CALCIUM ION;DNA polymerase;1914161;
3RX5;A;structure of AaCel9A in complex with cellotriose-like isofagomine;1.99;CA;CALCIUM ION;Cellulase;405212;
3RX7;A;Structure of AaCel9A in complex with cellotetraose-like isofagomine;2.02;CA;CALCIUM ION;Cellulase;405212;
3RX8;A;structure of AaCel9A in complex with cellobiose-like isofagomine;2.56;CA;CALCIUM ION;Cellulase;405212;
3RXA;A;Crystal structure of Trypsin complexed with cycloheptanamine;1.7;CA;CALCIUM ION;Cationic trypsin;9913;
3RXB;A;Crystal structure of Trypsin complexed with 4-guanidinobutanoic acid;1.7;CA;CALCIUM ION;Cationic trypsin;9913;
3RXC;A;Crystal structure of Trypsin complexed with 2-aminopyridine;1.7;CA;CALCIUM ION;Cationic trypsin;9913;
3RXD;A;Crystal structure of Trypsin complexed with (3-methoxyphenyl)methanamine;1.7;CA;CALCIUM ION;Cationic trypsin;9913;
3RXE;A;Crystal structure of Trypsin complexed with benzamide;1.7;CA;CALCIUM ION;Cationic trypsin;9913;
3RXF;A;Crystal structure of Trypsin complexed with 4-aminopyridine;1.7;CA;CALCIUM ION;Cationic trypsin;9913;
3RXG;A;Crystal structure of Trypsin complexed with 4-aminocyclohexanol;1.7;CA;CALCIUM ION;Cationic trypsin;9913;
3RXH;A;Crystal structure of Trypsin complexed with 2-(1H-imidazol-4-yl)ethanamine;1.7;CA;CALCIUM ION;Cationic trypsin;9913;
3RXI;A;Crystal structure of Trypsin complexed with 2-(1H-indol-3-yl)ethanamine;1.6;CA;CALCIUM ION;Cationic trypsin;9913;
3RXJ;A;Crystal structure of Trypsin complexed with 4-guanidinobenzoic acid;1.7;CA;CALCIUM ION;Cationic trypsin;9913;
3RXK;A;Crystal structure of Trypsin complexed with methyl 4-amino-1-methyl-pyrrolidine-2-carboxylate;1.6;CA;CALCIUM ION;Cationic trypsin;9913;
3RXL;A;Crystal structure of Trypsin complexed with (2,5-dimethyl-3-furyl)methanamine;1.7;CA;CALCIUM ION;Cationic trypsin;9913;
3RXM;A;Crystal structure of Trypsin complexed with [2-(2-thienyl)thiazol-4-yl]methanamine;1.7;CA;CALCIUM ION;Cationic trypsin;9913;
3RXO;A;Crystal structure of Trypsin complexed with (3-pyrrol-1-ylphenyl)methanamine;1.6;CA;CALCIUM ION;Cationic trypsin;9913;
3RXP;A;Crystal structure of Trypsin complexed with (1,5-dimethylpyrazol-3-yl)methanamine;1.6;CA;CALCIUM ION;Cationic trypsin;9913;
3RXQ;A;Crystal structure of Trypsin complexed with benzamide (F01 and F05, cocktail experiment);1.68;CA;CALCIUM ION;Cationic trypsin;9913;
3RXR;A;Crystal structure of Trypsin complexed with cycloheptanamine (F01 and F03, cocktail experiment);1.72;CA;CALCIUM ION;Cationic trypsin;9913;
3RXS;A;Crystal structure of Trypsin complexed with (3-methoxyphenyl)methanamine (F04 and A06, cocktail experiment);1.74;CA;CALCIUM ION;Cationic trypsin;9913;
3RXT;A;Crystal structure of Trypsin complexed with (3-methoxyphenyl)methanamin (F04 and F03, cocktail experiment);1.7;CA;CALCIUM ION;Cationic trypsin;9913;
3RXU;A;Crystal structure of Trypsin complexed with benzamide (F05 and A06, cocktail experiment);1.68;CA;CALCIUM ION;Cationic trypsin;9913;
3RXV;A;Crystal structure of Trypsin complexed with benzamide (F05 and F03, cocktail experiment);1.7;CA;CALCIUM ION;Cationic trypsin;9913;
3RYD;A;Crystal strucutre of Ca bound IMPase family protein from Staphylococcus aureus;2.37;CA;CALCIUM ION;Inositol monophosphatase family protein;1280;
3RYD;C;Crystal strucutre of Ca bound IMPase family protein from Staphylococcus aureus;2.37;CA;CALCIUM ION;Inositol monophosphatase family protein;1280;
3RZA;A;Crystal structure of a tripeptidase (SAV1512) from staphylococcus aureus subsp. aureus mu50 at 2.10 A resolution;2.1;CA;CALCIUM ION;tripeptidase;1280;
3RZA;B;Crystal structure of a tripeptidase (SAV1512) from staphylococcus aureus subsp. aureus mu50 at 2.10 A resolution;2.1;CA;CALCIUM ION;tripeptidase;1280;
3S18;A;Crystal structure of a plant albumin from cicer arietinum showing hemagglutination;2.2;CA;CALCIUM ION;lectin;3827;
3S18;B;Crystal structure of a plant albumin from cicer arietinum showing hemagglutination;2.2;CA;CALCIUM ION;lectin;3827;
3S35;H;Structural basis for the function of two anti-VEGF receptor antibodies;2.2;CA;CALCIUM ION;6.64 Fab heavy chain;960,610,090;
3S35;L;Structural basis for the function of two anti-VEGF receptor antibodies;2.2;CA;CALCIUM ION;6.64 Fab light chain;960,610,090;
3S35;X;Structural basis for the function of two anti-VEGF receptor antibodies;2.2;CA;CALCIUM ION;Vascular endothelial growth factor receptor 2;9606;
3S3T;A;Universal stress protein UspA from Lactobacillus plantarum;1.9;CA;CALCIUM ION;Nucleotide-binding protein, universal stress protein UspA family;1590;
3S3T;B;Universal stress protein UspA from Lactobacillus plantarum;1.9;CA;CALCIUM ION;Nucleotide-binding protein, universal stress protein UspA family;1590;
3S3T;C;Universal stress protein UspA from Lactobacillus plantarum;1.9;CA;CALCIUM ION;Nucleotide-binding protein, universal stress protein UspA family;1590;
3S3T;D;Universal stress protein UspA from Lactobacillus plantarum;1.9;CA;CALCIUM ION;Nucleotide-binding protein, universal stress protein UspA family;1590;
3S3T;E;Universal stress protein UspA from Lactobacillus plantarum;1.9;CA;CALCIUM ION;Nucleotide-binding protein, universal stress protein UspA family;1590;
3S3T;F;Universal stress protein UspA from Lactobacillus plantarum;1.9;CA;CALCIUM ION;Nucleotide-binding protein, universal stress protein UspA family;1590;
3S3T;G;Universal stress protein UspA from Lactobacillus plantarum;1.9;CA;CALCIUM ION;Nucleotide-binding protein, universal stress protein UspA family;1590;
3S3T;H;Universal stress protein UspA from Lactobacillus plantarum;1.9;CA;CALCIUM ION;Nucleotide-binding protein, universal stress protein UspA family;1590;
3S4F;A;Crystal structure of the complex of bovine lactoperoxidase with 1H-pyrazolo[4,3-c] pyridine at 1.99 A resolution;2;CA;CALCIUM ION;Lactoperoxidase;9913;
3S4L;A;The CRISPR-associated Cas3 HD domain protein MJ0384 from Methanocaldococcus jannaschii;2.3;CA;CALCIUM ION;CAS3 Metal dependent phosphohydrolase;2190;
3S4Y;A;Crystal structure of human thiamin pyrophosphokinase 1;1.8;CA;CALCIUM ION;Thiamin pyrophosphokinase 1;9606;
3S4Y;B;Crystal structure of human thiamin pyrophosphokinase 1;1.8;CA;CALCIUM ION;Thiamin pyrophosphokinase 1;9606;
3S55;A;Crystal structure of a putative short-chain dehydrogenase/reductase from Mycobacterium abscessus bound to NAD;2.1;CA;CALCIUM ION;Putative short-chain dehydrogenase/reductase;36809;
3S55;B;Crystal structure of a putative short-chain dehydrogenase/reductase from Mycobacterium abscessus bound to NAD;2.1;CA;CALCIUM ION;Putative short-chain dehydrogenase/reductase;36809;
3S55;D;Crystal structure of a putative short-chain dehydrogenase/reductase from Mycobacterium abscessus bound to NAD;2.1;CA;CALCIUM ION;Putative short-chain dehydrogenase/reductase;36809;
3S55;E;Crystal structure of a putative short-chain dehydrogenase/reductase from Mycobacterium abscessus bound to NAD;2.1;CA;CALCIUM ION;Putative short-chain dehydrogenase/reductase;36809;
3S55;F;Crystal structure of a putative short-chain dehydrogenase/reductase from Mycobacterium abscessus bound to NAD;2.1;CA;CALCIUM ION;Putative short-chain dehydrogenase/reductase;36809;
3S55;H;Crystal structure of a putative short-chain dehydrogenase/reductase from Mycobacterium abscessus bound to NAD;2.1;CA;CALCIUM ION;Putative short-chain dehydrogenase/reductase;36809;
3S5U;A;Crystal structure of CRISPR associated protein;2.7;CA;CALCIUM ION;Putative uncharacterized protein;1351;
3S5U;B;Crystal structure of CRISPR associated protein;2.7;CA;CALCIUM ION;Putative uncharacterized protein;1351;
3S5U;C;Crystal structure of CRISPR associated protein;2.7;CA;CALCIUM ION;Putative uncharacterized protein;1351;
3S5U;D;Crystal structure of CRISPR associated protein;2.7;CA;CALCIUM ION;Putative uncharacterized protein;1351;
3S5U;E;Crystal structure of CRISPR associated protein;2.7;CA;CALCIUM ION;Putative uncharacterized protein;1351;
3S5U;F;Crystal structure of CRISPR associated protein;2.7;CA;CALCIUM ION;Putative uncharacterized protein;1351;
3S5U;G;Crystal structure of CRISPR associated protein;2.7;CA;CALCIUM ION;Putative uncharacterized protein;1351;
3S5U;H;Crystal structure of CRISPR associated protein;2.7;CA;CALCIUM ION;Putative uncharacterized protein;1351;
3S69;A;Crystal structure of saxthrombin;1.43;CA;CALCIUM ION;Thrombin-like enzyme defibrase;92067;
3S6F;A;Crystal structure of a putative acetyltransferase (DR_1678) from Deinococcus radiodurans R1 at 1.19 A resolution;1.19;CA;CALCIUM ION;Hypothetical acetyltransferase;1299;
3S6J;A;The crystal structure of a hydrolase from Pseudomonas syringae;2.2;CA;CALCIUM ION;Hydrolase, haloacid dehalogenase-like family;251701;
3S6J;B;The crystal structure of a hydrolase from Pseudomonas syringae;2.2;CA;CALCIUM ION;Hydrolase, haloacid dehalogenase-like family;251701;
3S6J;C;The crystal structure of a hydrolase from Pseudomonas syringae;2.2;CA;CALCIUM ION;Hydrolase, haloacid dehalogenase-like family;251701;
3S6J;D;The crystal structure of a hydrolase from Pseudomonas syringae;2.2;CA;CALCIUM ION;Hydrolase, haloacid dehalogenase-like family;251701;
3S6J;E;The crystal structure of a hydrolase from Pseudomonas syringae;2.2;CA;CALCIUM ION;Hydrolase, haloacid dehalogenase-like family;251701;
3S6J;F;The crystal structure of a hydrolase from Pseudomonas syringae;2.2;CA;CALCIUM ION;Hydrolase, haloacid dehalogenase-like family;251701;
3S6P;B;Crystal Structure of Helicoverpa Armigera Stunt Virus;2.5;CA;CALCIUM ION;Capsid protein;37206;
3S6P;C;Crystal Structure of Helicoverpa Armigera Stunt Virus;2.5;CA;CALCIUM ION;Capsid protein;37206;
3S6U;A;Caclcium-bound Ac-ASP-7;2.7;CA;CALCIUM ION;Ac-ASP-7;29170;
3S7W;A;Structure of the TvNiRb form of Thioalkalivibrio nitratireducens cytochrome c nitrite reductase with an oxidized Gln360 in a complex with hydroxylamine;1.79;CA;CALCIUM ION;Eight-heme nitrite reductase;186931;
3S7W;B;Structure of the TvNiRb form of Thioalkalivibrio nitratireducens cytochrome c nitrite reductase with an oxidized Gln360 in a complex with hydroxylamine;1.79;CA;CALCIUM ION;Eight-heme nitrite reductase;186931;
3S82;A;Structure of a S-adenosylmethionine synthetase from Mycobacterium avium;1.73;CA;CALCIUM ION;S-adenosylmethionine synthase;1764;
3S82;B;Structure of a S-adenosylmethionine synthetase from Mycobacterium avium;1.73;CA;CALCIUM ION;S-adenosylmethionine synthase;1764;
3S9H;A;RB69 DNA Polymerase Triple Mutant(L561A/S565G/Y567A) ternary complex with dUpNpp and a dideoxy-terminated primer in the presence of Ca2+;1.95;CA;CALCIUM ION;DNA polymerase;1914161;
3S9H;T;RB69 DNA Polymerase Triple Mutant(L561A/S565G/Y567A) ternary complex with dUpNpp and a dideoxy-terminated primer in the presence of Ca2+;1.95;CA;CALCIUM ION;5'-D(*TP*CP*AP*AP*GP*TP*AP*AP*GP*CP*AP*GP*TP*CP*CP*GP*CP*G)-3';;
3S9L;A;Complex between transferrin receptor 1 and transferrin with iron in the N-Lobe, cryocooled 2;3.22;CA;CALCIUM ION;Transferrin receptor protein 1;9606;
3S9L;B;Complex between transferrin receptor 1 and transferrin with iron in the N-Lobe, cryocooled 2;3.22;CA;CALCIUM ION;Transferrin receptor protein 1;9606;
3S9M;A;Complex between transferrin receptor 1 and transferrin with iron in the N-Lobe, cryocooled 1;3.32;CA;CALCIUM ION;Transferrin receptor protein 1;9606;
3S9M;B;Complex between transferrin receptor 1 and transferrin with iron in the N-Lobe, cryocooled 1;3.32;CA;CALCIUM ION;Transferrin receptor protein 1;9606;
3S9N;A;Complex between transferrin receptor 1 and transferrin with iron in the N-Lobe, room temperature;3.25;CA;CALCIUM ION;Transferrin receptor protein 1;9606;
3S9N;B;Complex between transferrin receptor 1 and transferrin with iron in the N-Lobe, room temperature;3.25;CA;CALCIUM ION;Transferrin receptor protein 1;9606;
3S9W;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS M98G bound to Ca2+ and thymidine-5',3'-diphosphate at cryogenic temperature;1.9;CA;CALCIUM ION;Thermonuclease;1280;
3SAL;A;Crystal Structure of Influenza A Virus Neuraminidase N5;1.5;CA;CALCIUM ION;Neuraminidase;11320;
3SAL;B;Crystal Structure of Influenza A Virus Neuraminidase N5;1.5;CA;CALCIUM ION;Neuraminidase;11320;
3SAN;A;Crystal structure of influenza A virus neuraminidase N5 complexed with Zanamivir;1.6;CA;CALCIUM ION;Neuraminidase;11320;
3SAN;B;Crystal structure of influenza A virus neuraminidase N5 complexed with Zanamivir;1.6;CA;CALCIUM ION;Neuraminidase;11320;
3SBP;A;Pseudomonas stutzeri nitrous oxide reductase, P1 crystal form;2.1;CA;CALCIUM ION;Nitrous-oxide reductase;316;
3SBP;B;Pseudomonas stutzeri nitrous oxide reductase, P1 crystal form;2.1;CA;CALCIUM ION;Nitrous-oxide reductase;316;
3SBP;C;Pseudomonas stutzeri nitrous oxide reductase, P1 crystal form;2.1;CA;CALCIUM ION;Nitrous-oxide reductase;316;
3SBP;D;Pseudomonas stutzeri nitrous oxide reductase, P1 crystal form;2.1;CA;CALCIUM ION;Nitrous-oxide reductase;316;
3SBP;E;Pseudomonas stutzeri nitrous oxide reductase, P1 crystal form;2.1;CA;CALCIUM ION;Nitrous-oxide reductase;316;
3SBP;F;Pseudomonas stutzeri nitrous oxide reductase, P1 crystal form;2.1;CA;CALCIUM ION;Nitrous-oxide reductase;316;
3SBP;G;Pseudomonas stutzeri nitrous oxide reductase, P1 crystal form;2.1;CA;CALCIUM ION;Nitrous-oxide reductase;316;
3SBP;H;Pseudomonas stutzeri nitrous oxide reductase, P1 crystal form;2.1;CA;CALCIUM ION;Nitrous-oxide reductase;316;
3SBQ;A;Pseudomonas stutzeri nitrous oxide reductase, P65 crystal form;1.7;CA;CALCIUM ION;Nitrous-oxide reductase;316;
3SBQ;B;Pseudomonas stutzeri nitrous oxide reductase, P65 crystal form;1.7;CA;CALCIUM ION;Nitrous-oxide reductase;316;
3SBR;A;Pseudomonas stutzeri nitrous oxide reductase, P1 crystal form with substrate;2.24;CA;CALCIUM ION;Nitrous-oxide reductase;316;
3SBR;B;Pseudomonas stutzeri nitrous oxide reductase, P1 crystal form with substrate;2.24;CA;CALCIUM ION;Nitrous-oxide reductase;316;
3SBR;C;Pseudomonas stutzeri nitrous oxide reductase, P1 crystal form with substrate;2.24;CA;CALCIUM ION;Nitrous-oxide reductase;316;
3SBR;D;Pseudomonas stutzeri nitrous oxide reductase, P1 crystal form with substrate;2.24;CA;CALCIUM ION;Nitrous-oxide reductase;316;
3SBR;E;Pseudomonas stutzeri nitrous oxide reductase, P1 crystal form with substrate;2.24;CA;CALCIUM ION;Nitrous-oxide reductase;316;
3SBR;F;Pseudomonas stutzeri nitrous oxide reductase, P1 crystal form with substrate;2.24;CA;CALCIUM ION;Nitrous-oxide reductase;316;
3SBR;G;Pseudomonas stutzeri nitrous oxide reductase, P1 crystal form with substrate;2.24;CA;CALCIUM ION;Nitrous-oxide reductase;316;
3SBR;H;Pseudomonas stutzeri nitrous oxide reductase, P1 crystal form with substrate;2.24;CA;CALCIUM ION;Nitrous-oxide reductase;316;
3SCE;A;Structure of the Thioalkalivibrio nitratireducens cytochrome c nitrite reductase with a covalent bond between the CE1 atom of Tyr303 and the CG atom of Gln360 (TvNiRb);1.45;CA;CALCIUM ION;Eight-heme nitrite reductase;186931;
3SCE;B;Structure of the Thioalkalivibrio nitratireducens cytochrome c nitrite reductase with a covalent bond between the CE1 atom of Tyr303 and the CG atom of Gln360 (TvNiRb);1.45;CA;CALCIUM ION;Eight-heme nitrite reductase;186931;
3SCX;A;RB69 DNA Polymerase Triple Mutant(L561A/S565G/Y567A) Ternary Complex with dUpNpp and a Deoxy-terminated Primer in the Presence of Ca2+;2.35;CA;CALCIUM ION;DNA polymerase;1914161;
3SD6;A;Crystal structure of the amino-terminal domain of human cardiac troponin C in complex with cadmium at 1.4 resolution.;1.37;CA;CALCIUM ION;Troponin C, slow skeletal and cardiac muscles;9606;
3SER;A;Zn-mediated Polymer of Maltose-binding Protein K26H/K30H by Synthetic Symmetrization;2.35;CA;CALCIUM ION;Maltose-binding periplasmic protein;562;
3SG2;A;Crystal Structure of GCaMP2-T116V,D381Y;2;CA;CALCIUM ION;Myosin light chain kinase, Green fluorescent protein, Calmodulin-1 chimera;6,100,903,110,116;
3SG3;A;Crystal Structure of GCaMP3-D380Y;2.1;CA;CALCIUM ION;Myosin light chain kinase, Green fluorescent protein, Calmodulin-1 chimera;6,100,903,110,116;
3SG4;A;Crystal Structure of GCaMP3-D380Y, LP(linker 2);2.4;CA;CALCIUM ION;Myosin light chain kinase, Green fluorescent protein, Calmodulin-1 chimera;6,100,903,110,116;
3SG5;A;Crystal Structure of Dimeric GCaMP3-D380Y, QP(linker 1), LP(linker 2);1.9;CA;CALCIUM ION;Myosin light chain kinase, Green fluorescent protein, Calmodulin-1 chimera;6,100,903,110,116;
3SG6;A;Crystal Structure of Dimeric GCaMP2-LIA(linker 1);1.7;CA;CALCIUM ION;Myosin light chain kinase, Green fluorescent protein, Calmodulin-1 chimera;6,100,903,110,116;
3SG7;A;Crystal Structure of GCaMP3-KF(linker 1);1.9;CA;CALCIUM ION;Myosin light chain kinase, Green fluorescent protein, Calmodulin-1 chimera;6,100,903,110,116;
3SGD;I;Crystal structure of the mouse mAb 17.2;2.31;CA;CALCIUM ION;Light Chain;10090;
3SGD;L;Crystal structure of the mouse mAb 17.2;2.31;CA;CALCIUM ION;Light Chain;10090;
3SGE;I;Crystal structure of mAb 17.2 in complex with R13 peptide;1.89;CA;CALCIUM ION;Light Chain;10090;
3SGE;L;Crystal structure of mAb 17.2 in complex with R13 peptide;1.89;CA;CALCIUM ION;Light Chain;10090;
3SH3;A;Crystal structure of a pro-inflammatory lectin from the seeds of Dioclea wilsonii STANDL;2.3;CA;CALCIUM ION;Lectin alpha chain;763456;
3SH5;A;Calcium-bound Laminin G like domain 3 from human perlecan;2.8;CA;CALCIUM ION;LG3 peptide;9606;
3SHI;A;Crystal structure of human MMP1 catalytic domain at 2.2 A resolution;2.2;CA;CALCIUM ION;Interstitial collagenase;9606;
3SHI;G;Crystal structure of human MMP1 catalytic domain at 2.2 A resolution;2.2;CA;CALCIUM ION;Interstitial collagenase;9606;
3SHI;M;Crystal structure of human MMP1 catalytic domain at 2.2 A resolution;2.2;CA;CALCIUM ION;Interstitial collagenase;9606;
3SHL;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS V74KL25A at cryogenic temperature;1.48;CA;CALCIUM ION;Thermonuclease;1280;
3SIA;A;Crystal structure of URE3-binding protein, (D127A,N129A) mutant, iodide phased;2.05;CA;CALCIUM ION;URE3-BP sequence specific DNA binding protein;5759;
3SIB;A;Crystal structure of URE3-binding protein, wild-type;1.9;CA;CALCIUM ION;URE3-BP sequence specific DNA binding protein;5759;
3SIC;E;MOLECULAR RECOGNITION AT THE ACTIVE SITE OF SUBTILISIN BPN': CRYSTALLOGRAPHIC STUDIES USING GENETICALLY ENGINEERED PROTEINACEOUS INHIBITOR SSI (STREPTOMYCES SUBTILISIN INHIBITOR);1.8;CA;CALCIUM ION;SUBTILISIN BPN';1390;
3SJE;A;X-ray structure of human glutamate carboxypeptidase II (the E424A inactive mutant) in complex with N-acetyl-aspartyl-aminononanoic acid;1.7;CA;CALCIUM ION;Glutamate carboxypeptidase 2;9606;
3SJF;A;X-ray structure of human glutamate carboxypeptidase II in complex with a urea-based inhibitor (A25);1.65;CA;CALCIUM ION;Glutamate carboxypeptidase 2;9606;
3SJG;A;Human glutamate carboxypeptidase II (E424A inactive mutant ) in complex with N-acetyl-aspartyl-aminooctanoic acid;1.65;CA;CALCIUM ION;Glutamate carboxypeptidase 2;9606;
3SJL;A;Crystal Structure of the P107S-MauG/pre-Methylamine Dehydrogenase Complex;1.63;CA;CALCIUM ION;Methylamine utilization protein mauG;266;
3SJL;B;Crystal Structure of the P107S-MauG/pre-Methylamine Dehydrogenase Complex;1.63;CA;CALCIUM ION;Methylamine utilization protein mauG;266;
3SJQ;A;Crystal structure of a small conductance potassium channel splice variant complexed with calcium-calmodulin;1.9;CA;CALCIUM ION;Calmodulin;10116;
3SJQ;B;Crystal structure of a small conductance potassium channel splice variant complexed with calcium-calmodulin;1.9;CA;CALCIUM ION;Calmodulin;10116;
3SJS;A;Crystal structure of URE3-binding protein from Entamoeba histolytica, (D127A,N129A) mutant, native form;1.9;CA;CALCIUM ION;URE3-BP sequence specific DNA binding protein;5759;
3SJX;A;X-ray structure of human glutamate carboxypeptidase II (the E424A inactive mutant) in complex with N-acetyl-aspartyl-methionine;1.66;CA;CALCIUM ION;Glutamate carboxypeptidase 2;9606;
3SK5;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS V39D at cryogenic temperature;1.7;CA;CALCIUM ION;Thermonuclease;1280;
3SLE;A;Crystal Structure of the P107C-MauG/pre-Methylamine Dehydrogenase Complex;2.52;CA;CALCIUM ION;Methylamine utilization protein MauG;266;
3SLE;B;Crystal Structure of the P107C-MauG/pre-Methylamine Dehydrogenase Complex;2.52;CA;CALCIUM ION;Methylamine utilization protein MauG;266;
3SLP;A;Crystal Structure of Lambda Exonuclease in Complex with a 12 BP Symmetric DNA Duplex;2.3;CA;CALCIUM ION;Exonuclease;10710;
3SLP;B;Crystal Structure of Lambda Exonuclease in Complex with a 12 BP Symmetric DNA Duplex;2.3;CA;CALCIUM ION;Exonuclease;10710;
3SLP;C;Crystal Structure of Lambda Exonuclease in Complex with a 12 BP Symmetric DNA Duplex;2.3;CA;CALCIUM ION;Exonuclease;10710;
3SM3;A;Crystal Structure of SAM-dependent methyltransferases Q8PUK2_METMA from Methanosarcina mazei. Northeast Structural Genomics Consortium Target MaR262.;2.2;CA;CALCIUM ION;SAM-dependent methyltransferases;2209;
3SMN;A;Crystal structure of human 14-3-3 sigma C38N/N166H in complex with task-3 peptide and stabilizer Fusicoccin A-THF;2;CA;CALCIUM ION;14-3-3 protein sigma;9606;
3SNM;A;Crystal structure of a lectin from Canavalia maritima seeds complexed with Indole-3-Acetic Acid;2.15;CA;CALCIUM ION;Concanavalin-A;28957;
3SNY;A;Crystal structure of a mutant T82R of a betagamma-crystallin domain from Clostridium beijerinckii;1.85;CA;CALCIUM ION;Clostrillin;1520;
3SNZ;A;Crystal structure of a mutant W39D of a betagamma-crystallin domain from Clostridium beijerinckii;2;CA;CALCIUM ION;Clostrillin;1520;
3SO0;A;Crystal structure of a mutant T41S of a betagamma-crystallin domain from Clostridium beijerinckii;1.93;CA;CALCIUM ION;Clostrillin;1520;
3SO0;B;Crystal structure of a mutant T41S of a betagamma-crystallin domain from Clostridium beijerinckii;1.93;CA;CALCIUM ION;Clostrillin;1520;
3SO0;C;Crystal structure of a mutant T41S of a betagamma-crystallin domain from Clostridium beijerinckii;1.93;CA;CALCIUM ION;Clostrillin;1520;
3SO0;D;Crystal structure of a mutant T41S of a betagamma-crystallin domain from Clostridium beijerinckii;1.93;CA;CALCIUM ION;Clostrillin;1520;
3SO0;E;Crystal structure of a mutant T41S of a betagamma-crystallin domain from Clostridium beijerinckii;1.93;CA;CALCIUM ION;Clostrillin;1520;
3SO0;F;Crystal structure of a mutant T41S of a betagamma-crystallin domain from Clostridium beijerinckii;1.93;CA;CALCIUM ION;Clostrillin;1520;
3SO0;G;Crystal structure of a mutant T41S of a betagamma-crystallin domain from Clostridium beijerinckii;1.93;CA;CALCIUM ION;Clostrillin;1520;
3SO1;A;Crystal structure of a double mutant T41S T82S of a betagamma-crystallin domain from Clostridium beijerinckii;1.85;CA;CALCIUM ION;Clostrillin;1520;
3SO1;B;Crystal structure of a double mutant T41S T82S of a betagamma-crystallin domain from Clostridium beijerinckii;1.85;CA;CALCIUM ION;Clostrillin;1520;
3SO1;C;Crystal structure of a double mutant T41S T82S of a betagamma-crystallin domain from Clostridium beijerinckii;1.85;CA;CALCIUM ION;Clostrillin;1520;
3SO1;D;Crystal structure of a double mutant T41S T82S of a betagamma-crystallin domain from Clostridium beijerinckii;1.85;CA;CALCIUM ION;Clostrillin;1520;
3SO1;E;Crystal structure of a double mutant T41S T82S of a betagamma-crystallin domain from Clostridium beijerinckii;1.85;CA;CALCIUM ION;Clostrillin;1520;
3SO1;F;Crystal structure of a double mutant T41S T82S of a betagamma-crystallin domain from Clostridium beijerinckii;1.85;CA;CALCIUM ION;Clostrillin;1520;
3SO1;G;Crystal structure of a double mutant T41S T82S of a betagamma-crystallin domain from Clostridium beijerinckii;1.85;CA;CALCIUM ION;Clostrillin;1520;
3SO1;H;Crystal structure of a double mutant T41S T82S of a betagamma-crystallin domain from Clostridium beijerinckii;1.85;CA;CALCIUM ION;Clostrillin;1520;
3SOB;B;The structure of the first YWTD beta propeller domain of LRP6 in complex with a FAB;1.9;CA;CALCIUM ION;Low-density lipoprotein receptor-related protein 6;9606;
3SON;A;Crystal structure of a putativel NUDIX hydrolase (LMOf2365_2679) from Listeria monocytogenes str. 4b F2365 at 1.70 A resolution;1.71;CA;CALCIUM ION;Hypothetical NUDIX hydrolase;1639;
3SON;B;Crystal structure of a putativel NUDIX hydrolase (LMOf2365_2679) from Listeria monocytogenes str. 4b F2365 at 1.70 A resolution;1.71;CA;CALCIUM ION;Hypothetical NUDIX hydrolase;1639;
3SOQ;A;The structure of the first YWTD beta propeller domain of LRP6 in complex with a DKK1 peptide;1.9;CA;CALCIUM ION;Low-density lipoprotein receptor-related protein 6;9606;
3SPZ;A;DNA Polymerase(L415A/L561A/S565G/Y567A) Ternary Complex with dUpCpp Opposite dA (Ca2+);2.43;CA;CALCIUM ION;DNA polymerase;1914161;
3SQ1;A;RB69 DNA Polymerase Ternary Complex with dUpCpp Opposite dA;1.82;CA;CALCIUM ION;DNA polymerase;1914161;
3SQ2;A;RB69 DNA Polymerase Ternary Complex with dTTP Opposite 2AP (AT rich sequence);2.1;CA;CALCIUM ION;DNA polymerase;1914161;
3SQ4;A;RB69 DNA Polymerase Ternary Complex with dTTP Opposite 2AP (GC rich sequence);2.23;CA;CALCIUM ION;DNA polymerase;1914161;
3SQG;A;Crystal structure of a methyl-coenzyme M reductase purified from Black Sea mats;2.1;CA;CALCIUM ION;Methyl coenzyme M reductase, alpha subunit;115547;
3SQG;G;Crystal structure of a methyl-coenzyme M reductase purified from Black Sea mats;2.1;CA;CALCIUM ION;Methyl coenzyme M reductase, alpha subunit;115547;
3SR1;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS A69G bound to Ca2+ and thymidine-5',3'-diphosphate at cryogenic temperature;1.45;CA;CALCIUM ION;thermonuclease;1280;
3SRE;A;Serum paraoxonase-1 by directed evolution at pH 6.5;1.99;CA;CALCIUM ION;serum paraoxonase;32630;
3SRG;A;Serum paraoxonase-1 by directed evolution at pH 6.5 in complex with 2-hydroxyquinoline;2.19;CA;CALCIUM ION;serum paraoxonase;32630;
3SSB;A;Structure of Insect Metalloproteinase Inhibitor in Complex with Thermolysin;1.8;CA;CALCIUM ION;Thermolysin;1427;
3SSB;B;Structure of Insect Metalloproteinase Inhibitor in Complex with Thermolysin;1.8;CA;CALCIUM ION;Thermolysin;1427;
3ST9;B;Crystal structure of ClpP in heptameric form from Staphylococcus aureus;2.43;CA;CALCIUM ION;ATP-dependent Clp protease proteolytic subunit;1280;
3STD;B;SCYTALONE DEHYDRATASE AND CYANOCINNOLINE INHIBITOR;1.65;CA;CALCIUM ION;PROTEIN (SCYTALONE DEHYDRATASE);148305;
3STD;C;SCYTALONE DEHYDRATASE AND CYANOCINNOLINE INHIBITOR;1.65;CA;CALCIUM ION;PROTEIN (SCYTALONE DEHYDRATASE);148305;
3SUC;A;Crystal structure of the pre-mature bacteriophage phi29 gene product 12;2.15;CA;CALCIUM ION;Preneck appendage protein;10756;
3SUI;A;Crystal structure of ca2+-calmodulin in complex with a trpv1 c-terminal peptide;1.95;CA;CALCIUM ION;Calmodulin;9606;
3SUN;A;RB69 DNA Polymerase (Y567A) Ternary Complex with dTTP Opposite 2AP (AT rich sequence);2.42;CA;CALCIUM ION;DNA polymerase;1914161;
3SUO;A;RB69 DNA Polymerase (Y567A) Ternary Complex with dTTP Opposite 2AP (GC rich sequence);2.23;CA;CALCIUM ION;DNA polymerase;1914161;
3SUP;A;RB69 DNA Polymerase (Y567A) Ternary Complex with dCTP Opposite 2AP (GC rich sequence);2.32;CA;CALCIUM ION;DNA polymerase;1914161;
3SUQ;A;RB69 DNA Polymerase (Y567A) Ternary Complex with dCTP Opposite 2AP (AT rich sequence);3.15;CA;CALCIUM ION;DNA polymerase;1914161;
3SVL;A;Structural basis of the improvement of ChrR - a multi-purpose enzyme;2.2;CA;CALCIUM ION;protein yieF;562;
3SVW;A;Crystal Structure of the P107V-MauG/pre-Methylamine Dehydrogenase Complex;1.86;CA;CALCIUM ION;Methylamine utilization protein MauG;266;
3SVW;B;Crystal Structure of the P107V-MauG/pre-Methylamine Dehydrogenase Complex;1.86;CA;CALCIUM ION;Methylamine utilization protein MauG;266;
3SW2;B;X-ray crystal structure of human FXA in complex with 6-chloro-N-((3S)-2-oxo-1-(2-oxo-2-((5S)-8-oxo-5,6-dihydro-1H-1,5-methanopyrido[1,2-a][1,5]diazocin-3(2H,4H,8H)-yl)ethyl)piperidin-3-yl)naphthalene-2-sulfonamide;2.42;CA;CALCIUM ION;Coagulation factor X;9606;
3SWB;A;Crystal structure of the amino-terminal domain of human cardiac troponin C in complex with cadmium at 1.7 A resolution;1.67;CA;CALCIUM ION;Troponin C, slow skeletal and cardiac muscles;9606;
3SWS;A;Crystal Structure of the Quinone Form of Methylamine Dehydrogenase in Complex with the Diferric Form of MauG;1.86;CA;CALCIUM ION;Methylamine utilization protein MauG;266;
3SWS;B;Crystal Structure of the Quinone Form of Methylamine Dehydrogenase in Complex with the Diferric Form of MauG;1.86;CA;CALCIUM ION;Methylamine utilization protein MauG;266;
3SXH;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS I92AL103A at cryogenic temperature;1.4;CA;CALCIUM ION;Thermonuclease;1280;
3SXQ;A;Structure of a hexameric multiheme c nitrite reductase from the extremophile bacterium Thiolkalivibrio paradoxus;1.9;CA;CALCIUM ION;Eight-heme nitrite reductase;108010;
3SXQ;B;Structure of a hexameric multiheme c nitrite reductase from the extremophile bacterium Thiolkalivibrio paradoxus;1.9;CA;CALCIUM ION;Eight-heme nitrite reductase;108010;
3SXT;A;Crystal Structure of the Quinol Form of Methylamine Dehydrogenase in Complex with the Diferrous Form of MauG;1.81;CA;CALCIUM ION;Methylamine utilization protein MauG;266;
3SXT;B;Crystal Structure of the Quinol Form of Methylamine Dehydrogenase in Complex with the Diferrous Form of MauG;1.81;CA;CALCIUM ION;Methylamine utilization protein MauG;266;
3SXV;A;Crystal structure of the complex of goat lactoperoxidase with amitrole at 2.1 A resolution;2.1;CA;CALCIUM ION;Lactoperoxidase;9925;
3T13;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS A69G at cryogenic temperature;1.8;CA;CALCIUM ION;Thermonuclease;1280;
3T13;B;Crystal structure of Staphylococcal nuclease variant Delta+PHS A69G at cryogenic temperature;1.8;CA;CALCIUM ION;Thermonuclease;1280;
3T1G;A;Engineering of organophosphate hydrolase by computational design and directed evolution;2.35;CA;CALCIUM ION;organophosphate hydrolase;10090;
3T25;A;TMAO-grown orthorhombic trypsin (bovine);1.7;CA;CALCIUM ION;Cationic trypsin;9913;
3T26;A;Orthorhombic trypsin (bovine) in the presence of sarcosine;1.7;CA;CALCIUM ION;Cationic trypsin;9913;
3T27;A;Orthorhombic trypsin (bovine) in the presence of betaine;1.95;CA;CALCIUM ION;Cationic trypsin;9913;
3T28;A;TMAO-grown trypsin (bovine)-previously unreported tetragonal crystal form;2.8;CA;CALCIUM ION;Cationic trypsin;9913;
3T29;A;TMAO-grown trigonal trypsin (bovine);1.75;CA;CALCIUM ION;Cationic trypsin;9913;
3T2H;E;Tetragonal thermolysin in the presence of TMAO;1.95;CA;CALCIUM ION;Thermolysin;1427;
3T2I;E;Tetragonal thermolysin in the presence of sarcosine;2.1;CA;CALCIUM ION;Thermolysin;1427;
3T2J;E;Tetragonal thermolysin in the presence of betaine;2;CA;CALCIUM ION;Thermolysin;1427;
3T3M;A;A Novel High Affinity Integrin alphaIIbbeta3 Receptor Antagonist That Unexpectedly Displaces Mg2+ from the beta3 MIDAS;2.6;CA;CALCIUM ION;Integrin alpha-IIb;9606;
3T3M;B;A Novel High Affinity Integrin alphaIIbbeta3 Receptor Antagonist That Unexpectedly Displaces Mg2+ from the beta3 MIDAS;2.6;CA;CALCIUM ION;Integrin beta-3;9606;
3T3M;C;A Novel High Affinity Integrin alphaIIbbeta3 Receptor Antagonist That Unexpectedly Displaces Mg2+ from the beta3 MIDAS;2.6;CA;CALCIUM ION;Integrin alpha-IIb;9606;
3T3M;D;A Novel High Affinity Integrin alphaIIbbeta3 Receptor Antagonist That Unexpectedly Displaces Mg2+ from the beta3 MIDAS;2.6;CA;CALCIUM ION;Integrin beta-3;9606;
3T3P;A;A Novel High Affinity Integrin alphaIIbbeta3 Receptor Antagonist That Unexpectedly Displaces Mg2+ from the beta3 MIDAS;2.2;CA;CALCIUM ION;Integrin alpha-IIb;9606;
3T3P;B;A Novel High Affinity Integrin alphaIIbbeta3 Receptor Antagonist That Unexpectedly Displaces Mg2+ from the beta3 MIDAS;2.2;CA;CALCIUM ION;Integrin beta-3;9606;
3T3P;C;A Novel High Affinity Integrin alphaIIbbeta3 Receptor Antagonist That Unexpectedly Displaces Mg2+ from the beta3 MIDAS;2.2;CA;CALCIUM ION;Integrin alpha-IIb;9606;
3T3P;D;A Novel High Affinity Integrin alphaIIbbeta3 Receptor Antagonist That Unexpectedly Displaces Mg2+ from the beta3 MIDAS;2.2;CA;CALCIUM ION;Integrin beta-3;9606;
3T41;A;1.95 Angstrom Resolution Crystal Structure of Epidermin Leader Peptide Processing Serine Protease (EpiP) S393A Mutant from Staphylococcus aureus;1.95;CA;CALCIUM ION;Epidermin leader peptide processing serine protease EpiP;1280;
3T41;B;1.95 Angstrom Resolution Crystal Structure of Epidermin Leader Peptide Processing Serine Protease (EpiP) S393A Mutant from Staphylococcus aureus;1.95;CA;CALCIUM ION;Epidermin leader peptide processing serine protease EpiP;1280;
3T4M;A;Ac-AChBP ligand binding domain mutated to human alpha-7 nAChR (intermediate);3;CA;CALCIUM ION;Soluble acetylcholine receptor;6500;
3T4M;B;Ac-AChBP ligand binding domain mutated to human alpha-7 nAChR (intermediate);3;CA;CALCIUM ION;Soluble acetylcholine receptor;6500;
3T4M;C;Ac-AChBP ligand binding domain mutated to human alpha-7 nAChR (intermediate);3;CA;CALCIUM ION;Soluble acetylcholine receptor;6500;
3T4M;D;Ac-AChBP ligand binding domain mutated to human alpha-7 nAChR (intermediate);3;CA;CALCIUM ION;Soluble acetylcholine receptor;6500;
3T4M;E;Ac-AChBP ligand binding domain mutated to human alpha-7 nAChR (intermediate);3;CA;CALCIUM ION;Soluble acetylcholine receptor;6500;
3T4M;F;Ac-AChBP ligand binding domain mutated to human alpha-7 nAChR (intermediate);3;CA;CALCIUM ION;Soluble acetylcholine receptor;6500;
3T4M;G;Ac-AChBP ligand binding domain mutated to human alpha-7 nAChR (intermediate);3;CA;CALCIUM ION;Soluble acetylcholine receptor;6500;
3T4M;H;Ac-AChBP ligand binding domain mutated to human alpha-7 nAChR (intermediate);3;CA;CALCIUM ION;Soluble acetylcholine receptor;6500;
3T4M;J;Ac-AChBP ligand binding domain mutated to human alpha-7 nAChR (intermediate);3;CA;CALCIUM ION;Soluble acetylcholine receptor;6500;
3T5H;A;Ternary complex of HNE Adduct modified DNA (5'-CXG-3' vs 13-mer) with Dpo4 and incoming dDGT;2.35;CA;CALCIUM ION;DNA polymerase IV;2287;
3T5J;A;Ternary complex of HNE Adduct modified DNA (5'-TXG-3' vs 13-mer) with Dpo4 and incoming dDTP;2.4;CA;CALCIUM ION;DNA polymerase IV;2287;
3T5K;A;Ternary complex of HNE Adduct modified DNA (5'-TXG-3' vs 14-mer) with Dpo4 and incoming dDTP;2.9;CA;CALCIUM ION;DNA polymerase IV;2287;
3T5L;A;Ternary complex of HNE Adduct modified DNA (5'-CXG-3' vs 14-mer) with Dpo4 and incoming dDGT;2.9;CA;CALCIUM ION;DNA polymerase IV;2287;
3T66;A;Crystal structure of Nickel ABC transporter from Bacillus halodurans;2.8;CA;CALCIUM ION;Nickel ABC transporter (Nickel-binding protein);86665;
3T73;A;Thermolysin In Complex With UBTLN22;1.6;CA;CALCIUM ION;Thermolysin;1427;
3T74;A;Thermolysin In Complex With UBTLN27;1.28;CA;CALCIUM ION;Thermolysin;1427;
3T86;A;d(GCATGCT) + calcium;1.9;CA;CALCIUM ION;DNA (5'-D(*GP*CP*AP*TP*GP*CP*T)-3');;
3T87;A;Thermolysin In Complex With UBTLN28;1.28;CA;CALCIUM ION;Thermolysin;1427;
3T8C;A;Thermolysin In Complex With UBTLN30;1.66;CA;CALCIUM ION;Thermolysin;1427;
3T8D;A;Thermolysin In Complex With UBTLN31;1.41;CA;CALCIUM ION;Thermolysin;1427;
3T8F;A;Thermolysin In Complex With UBTLN34;1.44;CA;CALCIUM ION;Thermolysin;1427;
3T8G;A;Thermolysin In Complex With UBTLN26;1.5;CA;CALCIUM ION;Thermolysin;1427;
3T8H;A;Thermolysin In Complex With UBTLN29;1.45;CA;CALCIUM ION;Thermolysin;1427;
3T8I;A;Structural analysis of thermostable S. solfataricus purine-specific nucleoside hydrolase;1.8;CA;CALCIUM ION;Purine nucleosidase, (IunH-2);2287;
3T8I;B;Structural analysis of thermostable S. solfataricus purine-specific nucleoside hydrolase;1.8;CA;CALCIUM ION;Purine nucleosidase, (IunH-2);2287;
3T8I;C;Structural analysis of thermostable S. solfataricus purine-specific nucleoside hydrolase;1.8;CA;CALCIUM ION;Purine nucleosidase, (IunH-2);2287;
3T8I;D;Structural analysis of thermostable S. solfataricus purine-specific nucleoside hydrolase;1.8;CA;CALCIUM ION;Purine nucleosidase, (IunH-2);2287;
3T8P;B;Crystal structure of d(CGGGTACCCG)4 as a four-way Holliday junction;2.35;CA;CALCIUM ION;DNA (5'-D(*CP*GP*GP*GP*TP*AP*CP*CP*CP*G)-3');;
3T9G;A;The crystal structure of family 3 pectate lyase from Caldicellulosiruptor bescii;1.5;CA;CALCIUM ION;Pectate lyase;31899;
3T9G;B;The crystal structure of family 3 pectate lyase from Caldicellulosiruptor bescii;1.5;CA;CALCIUM ION;Pectate lyase;31899;
3TB3;B;Crystal structure of the UCH domain of UCH-L5 with 6 residues deleted;2.3;CA;CALCIUM ION;Ubiquitin carboxyl-terminal hydrolase isozyme L5;9606;
3TB4;A;Crystal structure of the ISC domain of VibB;1.35;CA;CALCIUM ION;Vibriobactin-specific isochorismatase;666;
3TBD;A;Crystal Structure of domain VI and LE1 of human Netrin-G2;1.8;CA;CALCIUM ION;Netrin-G2;9606;
3TCP;A;Crystal structure of the catalytic domain of the proto-oncogene tyrosine-protein kinase MER in complex with inhibitor UNC569;2.69;CA;CALCIUM ION;Tyrosine-protein kinase Mer;9606;
3TCP;B;Crystal structure of the catalytic domain of the proto-oncogene tyrosine-protein kinase MER in complex with inhibitor UNC569;2.69;CA;CALCIUM ION;Tyrosine-protein kinase Mer;9606;
3TEC;E;CALCIUM BINDING TO THERMITASE. CRYSTALLOGRAPHIC STUDIES OF THERMITASE AT 0, 5 AND 100 MM CALCIUM;2;CA;CALCIUM ION;THERMITASE;2026;
3TEW;A;Crystal Structure of Anthrax Protective Antigen (Membrane Insertion Loop Deleted) to 1.45-A resolution;1.45;CA;CALCIUM ION;Protective antigen;1392;
3TEX;A;Crystal Structure of Anthrax Protective Antigen (Membrane Insertion Loop Deleted) to 1.7-A resolution;1.7;CA;CALCIUM ION;Protective antigen;1392;
3TEY;A;Crystal Structure of Anthrax Protective Antigen (Membrane Insertion Loop Deleted) Mutant S337C N664C to 2.06-A resolution;2.12;CA;CALCIUM ION;Protective antigen;1392;
3TEZ;A;Crystal Structure of Anthrax Protective Antigen Mutant S337C N664C and dithiolacetone modified to 1.8-A resolution;1.83;CA;CALCIUM ION;Protective antigen;1392;
3TF4;A;ENDO/EXOCELLULASE:CELLOTRIOSE FROM THERMOMONOSPORA;2.2;CA;CALCIUM ION;T. FUSCA ENDO/EXO-CELLULASE E4 CATALYTIC DOMAIN AND CELLULOSE-BINDING DOMAIN;2021;
3TF4;B;ENDO/EXOCELLULASE:CELLOTRIOSE FROM THERMOMONOSPORA;2.2;CA;CALCIUM ION;T. FUSCA ENDO/EXO-CELLULASE E4 CATALYTIC DOMAIN AND CELLULOSE-BINDING DOMAIN;2021;
3TGI;E;WILD-TYPE RAT ANIONIC TRYPSIN COMPLEXED WITH BOVINE PANCREATIC TRYPSIN INHIBITOR (BPTI);1.8;CA;CALCIUM ION;TRYPSIN;10116;
3TGJ;E;S195A TRYPSINOGEN COMPLEXED WITH BOVINE PANCREATIC TRYPSIN INHIBITOR (BPTI);2.2;CA;CALCIUM ION;TRYPSIN;10116;
3TGK;E;TRYPSINOGEN MUTANT D194N AND DELETION OF ILE 16-VAL 17 COMPLEXED WITH BOVINE PANCREATIC TRYPSIN INHIBITOR (BPTI);1.7;CA;CALCIUM ION;TRYPSIN II, ANIONIC;10116;
3TGY;A;Crystal structure of the complex of Bovine Lactoperoxidase with Ascorbic acid at 2.35 A resolution;2.35;CA;CALCIUM ION;Lactoperoxidase;9913;
3TH2;H;Mg2+ Is Required for Optimal Folding of the Gamma-Carboxyglutamic Acid (Gla) Domains of Vitamin K-Dependent Clotting Factors At Physiological Ca2+;1.72;CA;CALCIUM ION;Coagulation factor VII heavy chain;9606;
3TH2;L;Mg2+ Is Required for Optimal Folding of the Gamma-Carboxyglutamic Acid (Gla) Domains of Vitamin K-Dependent Clotting Factors At Physiological Ca2+;1.72;CA;CALCIUM ION;Coagulation factor VII light chain;9606;
3TH3;H;Mg2+ Is Required for Optimal Folding of the Gamma-Carboxyglutamic Acid (Gla) Domains of Vitamin K-Dependent Clotting Factors At Physiological Ca2+;2.7;CA;CALCIUM ION;Coagulation factor VII heavy chain;9606;
3TH3;L;Mg2+ Is Required for Optimal Folding of the Gamma-Carboxyglutamic Acid (Gla) Domains of Vitamin K-Dependent Clotting Factors At Physiological Ca2+;2.7;CA;CALCIUM ION;Coagulation factor VII light chain;9606;
3TH4;H;Mg2+ Is Required for Optimal Folding of the Gamma-Carboxyglutamic Acid (Gla) Domains of Vitamin K-Dependent Clotting Factors At Physiological Ca2+;1.8;CA;CALCIUM ION;Coagulation factor VII heavy chain;9606;
3TH4;L;Mg2+ Is Required for Optimal Folding of the Gamma-Carboxyglutamic Acid (Gla) Domains of Vitamin K-Dependent Clotting Factors At Physiological Ca2+;1.8;CA;CALCIUM ION;Coagulation factor VII light chain;9606;
3TI3;A;Crystal structure of 2009 pandemic H1N1 neuraminidase complexed with laninamivir;1.8;CA;CALCIUM ION;Neuraminidase;11320;
3TI3;B;Crystal structure of 2009 pandemic H1N1 neuraminidase complexed with laninamivir;1.8;CA;CALCIUM ION;Neuraminidase;11320;
3TI4;A;Crystal structure of 2009 pandemic H1N1 neuraminidase complexed with laninamivir octanoate;1.6;CA;CALCIUM ION;Neuraminidase;11320;
3TI4;B;Crystal structure of 2009 pandemic H1N1 neuraminidase complexed with laninamivir octanoate;1.6;CA;CALCIUM ION;Neuraminidase;11320;
3TI5;A;Crystal structure of 2009 pandemic H1N1 neuraminidase complexed with Zanamivir;1.9;CA;CALCIUM ION;Neuraminidase;11320;
3TI5;B;Crystal structure of 2009 pandemic H1N1 neuraminidase complexed with Zanamivir;1.9;CA;CALCIUM ION;Neuraminidase;11320;
3TI6;A;Crystal structure of 2009 pandemic H1N1 neuraminidase complexed with oseltamivir;1.69;CA;CALCIUM ION;Neuraminidase;11320;
3TI6;B;Crystal structure of 2009 pandemic H1N1 neuraminidase complexed with oseltamivir;1.69;CA;CALCIUM ION;Neuraminidase;11320;
3TI7;A;Crystal structure of the basic protease BprV from the ovine footrot pathogen, Dichelobacter nodosus;2;CA;CALCIUM ION;Basic extracellular subtilisin-like protease BprV;870;
3TI8;A;Crystal structure of influenza A virus neuraminidase N5 complexed with laninamivir;1.6;CA;CALCIUM ION;Neuraminidase;11320;
3TI8;B;Crystal structure of influenza A virus neuraminidase N5 complexed with laninamivir;1.6;CA;CALCIUM ION;Neuraminidase;11320;
3TI9;A;Crystal structure of the basic protease BprB from the ovine footrot pathogen, Dichelobacter nodosus;1.8;CA;CALCIUM ION;Serine protease;870;
3TIA;A;Crystal structure of 1957 pandemic H2N2 neuraminidase complexed with laninamivir;1.8;CA;CALCIUM ION;Neuraminidase;11320;
3TIA;B;Crystal structure of 1957 pandemic H2N2 neuraminidase complexed with laninamivir;1.8;CA;CALCIUM ION;Neuraminidase;11320;
3TIA;C;Crystal structure of 1957 pandemic H2N2 neuraminidase complexed with laninamivir;1.8;CA;CALCIUM ION;Neuraminidase;11320;
3TIA;D;Crystal structure of 1957 pandemic H2N2 neuraminidase complexed with laninamivir;1.8;CA;CALCIUM ION;Neuraminidase;11320;
3TIB;A;Crystal structure of 1957 pandemic H2N2 neuraminidase complexed with laninamivir octanoate;2.2;CA;CALCIUM ION;Neuraminidase;11320;
3TIB;B;Crystal structure of 1957 pandemic H2N2 neuraminidase complexed with laninamivir octanoate;2.2;CA;CALCIUM ION;Neuraminidase;11320;
3TIB;C;Crystal structure of 1957 pandemic H2N2 neuraminidase complexed with laninamivir octanoate;2.2;CA;CALCIUM ION;Neuraminidase;11320;
3TIB;D;Crystal structure of 1957 pandemic H2N2 neuraminidase complexed with laninamivir octanoate;2.2;CA;CALCIUM ION;Neuraminidase;11320;
3TIC;A;Crystal structure of 1957 pandemic H2N2 neuraminidase complexed with zanamivir;1.89;CA;CALCIUM ION;Neuraminidase;11320;
3TIC;B;Crystal structure of 1957 pandemic H2N2 neuraminidase complexed with zanamivir;1.89;CA;CALCIUM ION;Neuraminidase;11320;
3TIC;C;Crystal structure of 1957 pandemic H2N2 neuraminidase complexed with zanamivir;1.89;CA;CALCIUM ION;Neuraminidase;11320;
3TIC;D;Crystal structure of 1957 pandemic H2N2 neuraminidase complexed with zanamivir;1.89;CA;CALCIUM ION;Neuraminidase;11320;
3TK5;A;Factor Xa in complex with D102-4380;2.2;CA;CALCIUM ION;Factor X heavy chain;9606;
3TK6;A;factor Xa in complex with D46-5241;1.8;CA;CALCIUM ION;Factor X heavy chain;9606;
3TKK;A;Crystal Structure Analysis of a recombinant predicted acetamidase/ formamidase from the thermophile thermoanaerobacter tengcongensis;1.99;CA;CALCIUM ION;Predicted acetamidase/formamidase;911092;
3TKK;B;Crystal Structure Analysis of a recombinant predicted acetamidase/ formamidase from the thermophile thermoanaerobacter tengcongensis;1.99;CA;CALCIUM ION;Predicted acetamidase/formamidase;911092;
3TKK;C;Crystal Structure Analysis of a recombinant predicted acetamidase/ formamidase from the thermophile thermoanaerobacter tengcongensis;1.99;CA;CALCIUM ION;Predicted acetamidase/formamidase;911092;
3TKK;D;Crystal Structure Analysis of a recombinant predicted acetamidase/ formamidase from the thermophile thermoanaerobacter tengcongensis;1.99;CA;CALCIUM ION;Predicted acetamidase/formamidase;911092;
3TLI;A;THERMOLYSIN (10% ISOPROPANOL SOAKED CRYSTALS);1.95;CA;CALCIUM ION;THERMOLYSIN;1427;
3TLM;A;Crystal Structure of Endoplasmic Reticulum Ca2+-ATPase (SERCA) From Bovine Muscle;2.95;CA;CALCIUM ION;Sarcoplasmic/endoplasmic reticulum calcium ATPase 1;9913;
3TMN;E;THE BINDING OF L-VALYL-L-TRYPTOPHAN TO CRYSTALLINE THERMOLYSIN ILLUSTRATES THE MODE OF INTERACTION OF A PRODUCT OF PEPTIDE HYDROLYSIS;1.7;CA;CALCIUM ION;THERMOLYSIN;1427;
3TO5;A;High resolution structure of CheY3 from Vibrio cholerae;1.65;CA;CALCIUM ION;CheY homolog;666;
3TOC;A;Crystal structure of Streptococcus pyogenes Csn2;2.2;CA;CALCIUM ION;Putative uncharacterized protein;1314;
3TOC;B;Crystal structure of Streptococcus pyogenes Csn2;2.2;CA;CALCIUM ION;Putative uncharacterized protein;1314;
3TOL;A;Crystal structure of an engineered cytochrome cb562 that forms 1D, Zn-mediated coordination polymers;2;CA;CALCIUM ION;Soluble cytochrome b562;562;
3TOL;C;Crystal structure of an engineered cytochrome cb562 that forms 1D, Zn-mediated coordination polymers;2;CA;CALCIUM ION;Soluble cytochrome b562;562;
3TOR;A;Crystal structure of Escherichia coli NrfA with Europium bound;2;CA;CALCIUM ION;Cytochrome c nitrite reductase;562;
3TOR;B;Crystal structure of Escherichia coli NrfA with Europium bound;2;CA;CALCIUM ION;Cytochrome c nitrite reductase;562;
3TOR;C;Crystal structure of Escherichia coli NrfA with Europium bound;2;CA;CALCIUM ION;Cytochrome c nitrite reductase;562;
3TOR;D;Crystal structure of Escherichia coli NrfA with Europium bound;2;CA;CALCIUM ION;Cytochrome c nitrite reductase;562;
3TOY;A;CRYSTAL STRUCTURE OF ENOLASE BRADO_4202 (TARGET EFI-501651) FROM Bradyrhizobium sp. ORS278 WITH CALCIUM AND ACETATE BOUND;1.8;CA;CALCIUM ION;Mandelate racemase/muconate lactonizing enzyme family protein;114615;
3TOY;B;CRYSTAL STRUCTURE OF ENOLASE BRADO_4202 (TARGET EFI-501651) FROM Bradyrhizobium sp. ORS278 WITH CALCIUM AND ACETATE BOUND;1.8;CA;CALCIUM ION;Mandelate racemase/muconate lactonizing enzyme family protein;114615;
3TOY;C;CRYSTAL STRUCTURE OF ENOLASE BRADO_4202 (TARGET EFI-501651) FROM Bradyrhizobium sp. ORS278 WITH CALCIUM AND ACETATE BOUND;1.8;CA;CALCIUM ION;Mandelate racemase/muconate lactonizing enzyme family protein;114615;
3TOY;D;CRYSTAL STRUCTURE OF ENOLASE BRADO_4202 (TARGET EFI-501651) FROM Bradyrhizobium sp. ORS278 WITH CALCIUM AND ACETATE BOUND;1.8;CA;CALCIUM ION;Mandelate racemase/muconate lactonizing enzyme family protein;114615;
3TP6;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS L36E/L103K at cryogenic temperature;1.8;CA;CALCIUM ION;Thermonuclease;1280;
3TP7;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS V99E at cryogenic temperature;1.9;CA;CALCIUM ION;Thermonuclease;1280;
3TP8;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS L36E at cryogenic temperature;1.6;CA;CALCIUM ION;Thermonuclease;1280;
3TPI;Z;THE GEOMETRY OF THE REACTIVE SITE AND OF THE PEPTIDE GROUPS IN TRYPSIN, TRYPSINOGEN AND ITS COMPLEXES WITH INHIBITORS;1.9;CA;CALCIUM ION;TRYPSINOGEN;9913;
3TPQ;A;Crystal structure of wild-type MAL RPEL domain in complex with five G-actins;3.45;CA;CALCIUM ION;Actin, alpha skeletal muscle;9986;
3TPQ;B;Crystal structure of wild-type MAL RPEL domain in complex with five G-actins;3.45;CA;CALCIUM ION;Actin, alpha skeletal muscle;9986;
3TPQ;C;Crystal structure of wild-type MAL RPEL domain in complex with five G-actins;3.45;CA;CALCIUM ION;Actin, alpha skeletal muscle;9986;
3TPQ;D;Crystal structure of wild-type MAL RPEL domain in complex with five G-actins;3.45;CA;CALCIUM ION;Actin, alpha skeletal muscle;9986;
3TPQ;E;Crystal structure of wild-type MAL RPEL domain in complex with five G-actins;3.45;CA;CALCIUM ION;Actin, alpha skeletal muscle;9986;
3TQK;A;Structure of Phospho-2-dehydro-3-deoxyheptonate aldolase from Francisella tularensis SCHU S4;2.3;CA;CALCIUM ION;Phospho-2-dehydro-3-deoxyheptonate aldolase;263;
3TQU;A;Structure of a HAM1 protein from Coxiella burnetii;1.9;CA;CALCIUM ION;Non-canonical purine NTP pyrophosphatase;777;
3TQU;B;Structure of a HAM1 protein from Coxiella burnetii;1.9;CA;CALCIUM ION;Non-canonical purine NTP pyrophosphatase;777;
3TQU;C;Structure of a HAM1 protein from Coxiella burnetii;1.9;CA;CALCIUM ION;Non-canonical purine NTP pyrophosphatase;777;
3TQU;D;Structure of a HAM1 protein from Coxiella burnetii;1.9;CA;CALCIUM ION;Non-canonical purine NTP pyrophosphatase;777;
3TR5;A;Structure of a peptide chain release factor 3 (prfC) from Coxiella burnetii;2.11;CA;CALCIUM ION;Peptide chain release factor 3;777;
3TR5;B;Structure of a peptide chain release factor 3 (prfC) from Coxiella burnetii;2.11;CA;CALCIUM ION;Peptide chain release factor 3;777;
3TR5;C;Structure of a peptide chain release factor 3 (prfC) from Coxiella burnetii;2.11;CA;CALCIUM ION;Peptide chain release factor 3;777;
3TR5;D;Structure of a peptide chain release factor 3 (prfC) from Coxiella burnetii;2.11;CA;CALCIUM ION;Peptide chain release factor 3;777;
3TRP;A;Crystal structure of recombinant rabbit skeletal calsequestrin;1.88;CA;CALCIUM ION;Calsequestrin-1;9986;
3TRQ;A;Crystal structure of native rabbit skeletal calsequestrin;1.76;CA;CALCIUM ION;Calsequestrin-1;9986;
3TS4;A;Human MMP12 in complex with L-glutamate motif inhibitor;1.59;CA;CALCIUM ION;Macrophage metalloelastase;9606;
3TS5;C;Crystal Structure of a Light Chain Domain of Scallop Smooth Muscle Myosin;2.39;CA;CALCIUM ION;Myosin essential light chain;6577;
3TS5;F;Crystal Structure of a Light Chain Domain of Scallop Smooth Muscle Myosin;2.39;CA;CALCIUM ION;Myosin essential light chain;6577;
3TSK;A;Human MMP12 in complex with L-glutamate motif inhibitor;2;CA;CALCIUM ION;Macrophage metalloelastase;9606;
3TT4;A;Human MMP8 in complex with L-glutamate motif inhibitor;1.88;CA;CALCIUM ION;Neutrophil collagenase;9606;
3TTB;A;Structure of the Thioalkalivibrio paradoxus cytochrome c nitrite reductase in complex with sulfite;2;CA;CALCIUM ION;Eight-heme nitrite reductase;108010;
3TTB;B;Structure of the Thioalkalivibrio paradoxus cytochrome c nitrite reductase in complex with sulfite;2;CA;CALCIUM ION;Eight-heme nitrite reductase;108010;
3TTO;A;Crystal structure of Leuconostoc mesenteroides NRRL B-1299 N-terminally truncated dextransucrase DSR-E in triclinic form;3.3;CA;CALCIUM ION;Dextransucrase;1245;
3TTO;B;Crystal structure of Leuconostoc mesenteroides NRRL B-1299 N-terminally truncated dextransucrase DSR-E in triclinic form;3.3;CA;CALCIUM ION;Dextransucrase;1245;
3TTO;C;Crystal structure of Leuconostoc mesenteroides NRRL B-1299 N-terminally truncated dextransucrase DSR-E in triclinic form;3.3;CA;CALCIUM ION;Dextransucrase;1245;
3TTO;D;Crystal structure of Leuconostoc mesenteroides NRRL B-1299 N-terminally truncated dextransucrase DSR-E in triclinic form;3.3;CA;CALCIUM ION;Dextransucrase;1245;
3TTQ;A;Crystal structure of Leuconostoc mesenteroides NRRL B-1299 N-terminally truncated dextransucrase DSR-E in orthorhombic apo-form at 1.9 angstrom resolution;1.9;CA;CALCIUM ION;Dextransucrase;1245;
3TU5;A;Actin complex with Gelsolin Segment 1 fused to Cobl segment;3;CA;CALCIUM ION;Actin, alpha skeletal muscle;9986;
3TU5;B;Actin complex with Gelsolin Segment 1 fused to Cobl segment;3;CA;CALCIUM ION;Gelsolin,Protein cordon-bleu,Thymosin beta-4;960,610,090;
3TUY;C;Phosphorylated Light Chain Domain of Scallop smooth Muscle Myosin;2.5;CA;CALCIUM ION;Myosin essential light chain;6577;
3TUY;F;Phosphorylated Light Chain Domain of Scallop smooth Muscle Myosin;2.5;CA;CALCIUM ION;Myosin essential light chain;6577;
3TVC;A;Human MMP13 in complex with L-glutamate motif inhibitor;2.43;CA;CALCIUM ION;Collagenase 3;9606;
3TZ1;A;Crystal structure of the Ca2+-saturated C-terminal domain of Akazara scallop troponin C in complex with a troponin I fragment;1.8;CA;CALCIUM ION;Troponin C;6570;
3U0K;A;Crystal Structure of the genetically encoded calcium indicator RCaMP;2.1;CA;CALCIUM ION;RCaMP;6118;
3U16;A;Structure of BasE N-terminal domain from Acinetobacter baumannii bound to 6-(p-benzyloxy)phenyl-1-(pyridin-4-ylmethyl)-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid.;2.1;CA;CALCIUM ION;Peptide arylation enzyme;470;
3U16;B;Structure of BasE N-terminal domain from Acinetobacter baumannii bound to 6-(p-benzyloxy)phenyl-1-(pyridin-4-ylmethyl)-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid.;2.1;CA;CALCIUM ION;Peptide arylation enzyme;470;
3U17;A;Structure of BasE N-terminal domain from Acinetobacter baumannii bound to 6-(p-benzoyl)phenyl-1-(pyridin-4-ylmethyl)-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid;2.1;CA;CALCIUM ION;Peptide arylation enzyme;470;
3U17;B;Structure of BasE N-terminal domain from Acinetobacter baumannii bound to 6-(p-benzoyl)phenyl-1-(pyridin-4-ylmethyl)-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid;2.1;CA;CALCIUM ION;Peptide arylation enzyme;470;
3U1R;A;Structure Analysis of A New Psychrophilic Marine Protease;2;CA;CALCIUM ION;Alkaline metalloprotease;686394;
3U1W;A;Crystal structure of a Calcium binding protein (BDI_1975) from Parabacteroides distasonis ATCC 8503 at 2.00 A resolution;2;CA;CALCIUM ION;Hypothetical PERIPLASMIC PROTEIN;823;
3U1W;B;Crystal structure of a Calcium binding protein (BDI_1975) from Parabacteroides distasonis ATCC 8503 at 2.00 A resolution;2;CA;CALCIUM ION;Hypothetical PERIPLASMIC PROTEIN;823;
3U1W;C;Crystal structure of a Calcium binding protein (BDI_1975) from Parabacteroides distasonis ATCC 8503 at 2.00 A resolution;2;CA;CALCIUM ION;Hypothetical PERIPLASMIC PROTEIN;823;
3U24;A;The structure of a putative lipoprotein of unknown function from Shewanella oneidensis.;2.25;CA;CALCIUM ION;putative Lipoprotein;70863;
3U27;A;Crystal structure of ethanolamine utilization protein EutL from Leptotrichia buccalis C-1013-b;1.85;CA;CALCIUM ION;Microcompartments protein;40542;
3U27;C;Crystal structure of ethanolamine utilization protein EutL from Leptotrichia buccalis C-1013-b;1.85;CA;CALCIUM ION;Microcompartments protein;40542;
3U39;A;Crystal Structure of the apo Bacillus Stearothermophilus phosphofructokinase;2.79;CA;CALCIUM ION;6-phosphofructokinase;1422;
3U39;B;Crystal Structure of the apo Bacillus Stearothermophilus phosphofructokinase;2.79;CA;CALCIUM ION;6-phosphofructokinase;1422;
3U39;C;Crystal Structure of the apo Bacillus Stearothermophilus phosphofructokinase;2.79;CA;CALCIUM ION;6-phosphofructokinase;1422;
3U3W;A;Crystal Structure of Bacillus thuringiensis PlcR in complex with the peptide PapR7 and DNA;2.4;CA;CALCIUM ION;Transcriptional activator PlcR protein;1428;
3U3W;B;Crystal Structure of Bacillus thuringiensis PlcR in complex with the peptide PapR7 and DNA;2.4;CA;CALCIUM ION;Transcriptional activator PlcR protein;1428;
3U3Y;C;Mouse TREX1 D200H mutant;2.28;CA;CALCIUM ION;5'-D(*GP*AP*CP*G)-3';;
3U3Y;D;Mouse TREX1 D200H mutant;2.28;CA;CALCIUM ION;5'-D(*GP*AP*CP*G)-3';;
3U43;B;Crystal structure of the colicin E2 DNase-Im2 complex;1.72;CA;CALCIUM ION;Colicin-E2;562;
3U48;A;From soil to structure: a novel dimeric family 3-beta-glucosidase isolated from compost using metagenomic analysis;2.2;CA;CALCIUM ION;JMB19063;702656;
3U48;B;From soil to structure: a novel dimeric family 3-beta-glucosidase isolated from compost using metagenomic analysis;2.2;CA;CALCIUM ION;JMB19063;702656;
3U4A;A;From soil to structure: a novel dimeric family 3-beta-glucosidase isolated from compost using metagenomic analysis;2.2;CA;CALCIUM ION;JMB19063;702656;
3U4J;A;Crystal structure of NAD-dependent aldehyde dehydrogenase from Sinorhizobium meliloti;2;CA;CALCIUM ION;NAD-dependent aldehyde dehydrogenase;382;
3U4L;A;Cryocooled bovine profilin:actin crystal structure to 2.4 A;2.4;CA;CALCIUM ION;Actin, cytoplasmic 1;9913;
3U4X;A;Crystal structure of a lectin from Camptosema pedicellatum seeds in complex with 5-bromo-4-chloro-3-indolyl-alpha-D-mannose;2.16;CA;CALCIUM ION;Camptosema pedicellatum lectin (CPL);232302;
3U5M;A;Crystal structure of TRIM33 PHD-Bromo in the free state;3.08;CA;CALCIUM ION;E3 ubiquitin-protein ligase TRIM33;9606;
3U5M;B;Crystal structure of TRIM33 PHD-Bromo in the free state;3.08;CA;CALCIUM ION;E3 ubiquitin-protein ligase TRIM33;9606;
3U5M;C;Crystal structure of TRIM33 PHD-Bromo in the free state;3.08;CA;CALCIUM ION;E3 ubiquitin-protein ligase TRIM33;9606;
3U5M;E;Crystal structure of TRIM33 PHD-Bromo in the free state;3.08;CA;CALCIUM ION;E3 ubiquitin-protein ligase TRIM33;9606;
3U5M;F;Crystal structure of TRIM33 PHD-Bromo in the free state;3.08;CA;CALCIUM ION;E3 ubiquitin-protein ligase TRIM33;9606;
3U5M;I;Crystal structure of TRIM33 PHD-Bromo in the free state;3.08;CA;CALCIUM ION;E3 ubiquitin-protein ligase TRIM33;9606;
3U6N;A;Open Structure of the BK channel Gating Ring;3.61;CA;CALCIUM ION;High-Conductance Ca2+-Activated K+ Channel protein;7955;
3U6N;B;Open Structure of the BK channel Gating Ring;3.61;CA;CALCIUM ION;High-Conductance Ca2+-Activated K+ Channel protein;7955;
3U6N;C;Open Structure of the BK channel Gating Ring;3.61;CA;CALCIUM ION;High-Conductance Ca2+-Activated K+ Channel protein;7955;
3U6N;D;Open Structure of the BK channel Gating Ring;3.61;CA;CALCIUM ION;High-Conductance Ca2+-Activated K+ Channel protein;7955;
3U6N;E;Open Structure of the BK channel Gating Ring;3.61;CA;CALCIUM ION;High-Conductance Ca2+-Activated K+ Channel protein;7955;
3U6N;F;Open Structure of the BK channel Gating Ring;3.61;CA;CALCIUM ION;High-Conductance Ca2+-Activated K+ Channel protein;7955;
3U6N;G;Open Structure of the BK channel Gating Ring;3.61;CA;CALCIUM ION;High-Conductance Ca2+-Activated K+ Channel protein;7955;
3U6N;H;Open Structure of the BK channel Gating Ring;3.61;CA;CALCIUM ION;High-Conductance Ca2+-Activated K+ Channel protein;7955;
3U7Q;B;A. vinelandii nitrogenase MoFe protein at atomic resolution;1;CA;CALCIUM ION;Nitrogenase molybdenum-iron protein beta chain;354;
3U7Z;A;Crystal structure of a putative metal binding protein RUMGNA_00854 (ZP_02040092.1) from Ruminococcus gnavus ATCC 29149 at 1.30 A resolution;1.3;CA;CALCIUM ION;putative metal binding protein RUMGNA_00854;33038;
3U7Z;B;Crystal structure of a putative metal binding protein RUMGNA_00854 (ZP_02040092.1) from Ruminococcus gnavus ATCC 29149 at 1.30 A resolution;1.3;CA;CALCIUM ION;putative metal binding protein RUMGNA_00854;33038;
3U8B;A;Functionally selective inhibition of Group IIA phospholipase A2 reveals a role for vimentin in regulating arachidonic acid metabolism;2.3;CA;CALCIUM ION;Phospholipase A2, membrane associated;9606;
3U8D;A;Functionally selective inhibition of Group IIA phospholipase A2 reveals a role for vimentin in regulating arachidonic acid metabolism;1.8;CA;CALCIUM ION;Phospholipase A2, membrane associated;9606;
3U8D;B;Functionally selective inhibition of Group IIA phospholipase A2 reveals a role for vimentin in regulating arachidonic acid metabolism;1.8;CA;CALCIUM ION;Phospholipase A2, membrane associated;9606;
3U8H;A;Functionally selective inhibition of Group IIA phospholipase A2 reveals a role for vimentin in regulating arachidonic acid metabolism;2.3;CA;CALCIUM ION;Phospholipase A2, membrane associated;9606;
3U8H;B;Functionally selective inhibition of Group IIA phospholipase A2 reveals a role for vimentin in regulating arachidonic acid metabolism;2.3;CA;CALCIUM ION;Phospholipase A2, membrane associated;9606;
3U8I;A;Functionally selective inhibition of Group IIA phospholipase A2 reveals a role for vimentin in regulating arachidonic acid metabolism;1.1;CA;CALCIUM ION;Phospholipase A2, membrane associated;9606;
3U8I;B;Functionally selective inhibition of Group IIA phospholipase A2 reveals a role for vimentin in regulating arachidonic acid metabolism;1.1;CA;CALCIUM ION;Phospholipase A2, membrane associated;9606;
3UB5;A;Profilin:actin with a wide open nucleotide cleft;2.2;CA;CALCIUM ION;Actin, cytoplasmic 1;9913;
3UBA;A;Crystal structure of the complex of bovine lactoperoxidase with p-hydroxycinnamic acid at 2.6 A resolution;2.65;CA;CALCIUM ION;Lactoperoxidase;9913;
3UBF;A;Crystal structure of Drosophila N-cadherin EC1-3, I;2.5;CA;CALCIUM ION;Neural-cadherin;7227;
3UBG;A;Crystal structure of Drosophila N-cadherin EC1-3, II;2.5;CA;CALCIUM ION;Neural-cadherin;7227;
3UBG;B;Crystal structure of Drosophila N-cadherin EC1-3, II;2.5;CA;CALCIUM ION;Neural-cadherin;7227;
3UBH;A;Crystal structure of Drosophila N-cadherin EC1-4;2.7;CA;CALCIUM ION;Neural-cadherin;7227;
3UBR;A;Laue structure of Shewanella oneidensis cytochrome-c Nitrite Reductase;2.59;CA;CALCIUM ION;Cytochrome c-552;70863;
3UBR;B;Laue structure of Shewanella oneidensis cytochrome-c Nitrite Reductase;2.59;CA;CALCIUM ION;Cytochrome c-552;70863;
3UC1;A;Mycobacterium tuberculosis gyrase type IIA topoisomerase C-terminal domain;1.65;CA;CALCIUM ION;DNA gyrase subunit A;1773;
3UCP;A;Outer membrane Endecaheme cytochrome UndA from Shewanella sp. HRCR-6;1.76;CA;CALCIUM ION;UndA;1043181;
3UE5;A;ECP-cleaved Actin in complex with Spir domain D;2.76;CA;CALCIUM ION;Actin, alpha skeletal muscle;9986;
3UE9;C;Crystal structure of Adenylosuccinate synthetase (AMPSase) (purA) from Burkholderia thailandensis;1.95;CA;CALCIUM ION;Adenylosuccinate synthetase;57975;
3UE9;D;Crystal structure of Adenylosuccinate synthetase (AMPSase) (purA) from Burkholderia thailandensis;1.95;CA;CALCIUM ION;Adenylosuccinate synthetase;57975;
3UF5;A;Crystal structure of the mouse Colony-Stimulating Factor 1 (mCSF-1) cytokine;2.8;CA;CALCIUM ION;Macrophage colony-stimulating factor 1;10090;
3UF5;B;Crystal structure of the mouse Colony-Stimulating Factor 1 (mCSF-1) cytokine;2.8;CA;CALCIUM ION;Macrophage colony-stimulating factor 1;10090;
3UFH;A;Crystal structure of UndA with Iron Citrate bound;2.23;CA;CALCIUM ION;UndA;1043181;
3UFK;A;Crystal structure of UndA complexed with Iron Nitrilotriacetate;2.1;CA;CALCIUM ION;UndA;1043181;
3UHO;A;Crystal Structure of Glutamate Racemase from Campylobacter jejuni subsp. jejuni;2.2;CA;CALCIUM ION;Glutamate racemase;197;
3UHO;B;Crystal Structure of Glutamate Racemase from Campylobacter jejuni subsp. jejuni;2.2;CA;CALCIUM ION;Glutamate racemase;197;
3UIQ;A;RB69 DNA Polymerase Ternary Complex containing dUpNpp;1.88;CA;CALCIUM ION;DNA polymerase;1914161;
3UIX;A;Crystal structure of Pim1 kinase in complex with small molecule inhibitor;2.2;CA;CALCIUM ION;Proto-oncogene serine/threonine-protein kinase pim-1;9606;
3UJI;L;Crystal structure of anti-HIV-1 V3 Fab 2558 in complex with MN peptide;1.6;CA;CALCIUM ION;Light chain of anti-HIV-1 V3 monoclonal antibody 2558;9606;
3UJO;A;Galactose-specific seed lectin from Dolichos lablab in complex with adenine and galactose;2;CA;CALCIUM ION;Legume lectin;35936;
3UJO;B;Galactose-specific seed lectin from Dolichos lablab in complex with adenine and galactose;2;CA;CALCIUM ION;Legume lectin;35936;
3UJO;C;Galactose-specific seed lectin from Dolichos lablab in complex with adenine and galactose;2;CA;CALCIUM ION;Legume lectin;35936;
3UJO;D;Galactose-specific seed lectin from Dolichos lablab in complex with adenine and galactose;2;CA;CALCIUM ION;Legume lectin;35936;
3UJQ;A;Galactose-specific lectin from Dolichos lablab in complex with galactose;2.06;CA;CALCIUM ION;Legume lectin;35936;
3UJQ;B;Galactose-specific lectin from Dolichos lablab in complex with galactose;2.06;CA;CALCIUM ION;Legume lectin;35936;
3UJQ;C;Galactose-specific lectin from Dolichos lablab in complex with galactose;2.06;CA;CALCIUM ION;Legume lectin;35936;
3UJQ;D;Galactose-specific lectin from Dolichos lablab in complex with galactose;2.06;CA;CALCIUM ION;Legume lectin;35936;
3UK9;A;Galactose-specific lectin from Dolichos lablab;3.11;CA;CALCIUM ION;Legume lectin;35936;
3UK9;B;Galactose-specific lectin from Dolichos lablab;3.11;CA;CALCIUM ION;Legume lectin;35936;
3UK9;C;Galactose-specific lectin from Dolichos lablab;3.11;CA;CALCIUM ION;Legume lectin;35936;
3UK9;D;Galactose-specific lectin from Dolichos lablab;3.11;CA;CALCIUM ION;Legume lectin;35936;
3UK9;E;Galactose-specific lectin from Dolichos lablab;3.11;CA;CALCIUM ION;Legume lectin;35936;
3UK9;F;Galactose-specific lectin from Dolichos lablab;3.11;CA;CALCIUM ION;Legume lectin;35936;
3UK9;G;Galactose-specific lectin from Dolichos lablab;3.11;CA;CALCIUM ION;Legume lectin;35936;
3UK9;H;Galactose-specific lectin from Dolichos lablab;3.11;CA;CALCIUM ION;Legume lectin;35936;
3UKG;A;Crystal structure of Rap1/DNA complex;2.95;CA;CALCIUM ION;DNA-binding protein RAP1;4932;
3UL2;A;Galactose-specific lectin from Dolichos lablab in P6522 space group;2.5;CA;CALCIUM ION;Legume lectin;35936;
3UL2;B;Galactose-specific lectin from Dolichos lablab in P6522 space group;2.5;CA;CALCIUM ION;Legume lectin;35936;
3UL2;C;Galactose-specific lectin from Dolichos lablab in P6522 space group;2.5;CA;CALCIUM ION;Legume lectin;35936;
3UL2;D;Galactose-specific lectin from Dolichos lablab in P6522 space group;2.5;CA;CALCIUM ION;Legume lectin;35936;
3UL4;B;Crystal structure of Coh-OlpA(Cthe_3080)-Doc918(Cthe_0918) complex: A novel type I Cohesin-Dockerin complex from Clostridium thermocellum ATTC 27405;1.95;CA;CALCIUM ION;Cellulosome enzyme, dockerin type I;1515;
3ULE;A;Structure of Bos taurus Arp2/3 complex with bound inhibitor CK-869 and ATP;2.5;CA;CALCIUM ION;Actin-related protein 3;9913;
3ULE;B;Structure of Bos taurus Arp2/3 complex with bound inhibitor CK-869 and ATP;2.5;CA;CALCIUM ION;Actin-related protein 2;9913;
3UMJ;A;Crystal Structure of D311E Lipase;2.1;CA;CALCIUM ION;Thermostable lipase;213419;
3UMJ;B;Crystal Structure of D311E Lipase;2.1;CA;CALCIUM ION;Thermostable lipase;213419;
3UNA;A;Crystal Structure of Bovine Milk Xanthine Dehydrogenase with NAD Bound;1.9;CA;CALCIUM ION;Xanthine dehydrogenase/oxidase;9913;
3UNA;B;Crystal Structure of Bovine Milk Xanthine Dehydrogenase with NAD Bound;1.9;CA;CALCIUM ION;Xanthine dehydrogenase/oxidase;9913;
3UNC;A;Crystal Structure of Bovine Milk Xanthine Dehydrogenase to 1.65A Resolution;1.65;CA;CALCIUM ION;Xanthine dehydrogenase/oxidase;9913;
3UNC;B;Crystal Structure of Bovine Milk Xanthine Dehydrogenase to 1.65A Resolution;1.65;CA;CALCIUM ION;Xanthine dehydrogenase/oxidase;9913;
3UNG;C;Structure of the Cmr2 subunit of the CRISPR RNA silencing complex;2.31;CA;CALCIUM ION;Cmr2dHD;2261;
3UNI;A;Crystal Structure of Bovine Milk Xanthine Dehydrogenase with NADH Bound;2.2;CA;CALCIUM ION;Xanthine dehydrogenase/oxidase;9913;
3UNI;B;Crystal Structure of Bovine Milk Xanthine Dehydrogenase with NADH Bound;2.2;CA;CALCIUM ION;Xanthine dehydrogenase/oxidase;9913;
3UNQ;A;Bovine trypsin variant X(triplePhe227) in complex with small molecule inhibitor;1.62;CA;CALCIUM ION;Cationic trypsin;9913;
3UNR;A;Bond length analysis of asp, glu and his residues in trypsin at 1.2A resolution;1.2;CA;CALCIUM ION;Cationic trypsin;9913;
3UNS;A;Bovine trypsin variant X(triplePhe227) in complex with small molecule inhibitor;1.8;CA;CALCIUM ION;Cationic trypsin;9913;
3UNX;A;Bond length analysis of asp, glu and his residues in subtilisin Carlsberg at 1.26A resolution;1.26;CA;CALCIUM ION;Subtilisin Carlsberg;1402;
3UOM;A;Ca2+ complex of Human skeletal calsequestrin;2.02;CA;CALCIUM ION;Calsequestrin-1;9606;
3UOM;B;Ca2+ complex of Human skeletal calsequestrin;2.02;CA;CALCIUM ION;Calsequestrin-1;9606;
3UOM;C;Ca2+ complex of Human skeletal calsequestrin;2.02;CA;CALCIUM ION;Calsequestrin-1;9606;
3UOM;D;Ca2+ complex of Human skeletal calsequestrin;2.02;CA;CALCIUM ION;Calsequestrin-1;9606;
3UOM;E;Ca2+ complex of Human skeletal calsequestrin;2.02;CA;CALCIUM ION;Calsequestrin-1;9606;
3UOM;F;Ca2+ complex of Human skeletal calsequestrin;2.02;CA;CALCIUM ION;Calsequestrin-1;9606;
3UOP;A;Bovine trypsin variant X(triplePhe227) in complex with small molecule inhibitor;1.69;CA;CALCIUM ION;Cationic trypsin;9913;
3UOW;A;Crystal Structure of PF10_0123, a GMP Synthetase from Plasmodium Falciparum;2.72;CA;CALCIUM ION;GMP synthetase;5833;
3UPE;A;Bovine trypsin variant X(triplePhe227) in complex with small molecule inhibitor;1.54;CA;CALCIUM ION;Cationic trypsin;9913;
3UPG;A;Loop deletion mutant of Salmonella typhi osmoporin (OmpC):an Outer Membrane Protein.;3.2;CA;CALCIUM ION;Outer membrane protein C;28901;
3UPT;A;Crystal structure of a transketolase from Burkholderia pseudomallei bound to TPP, calcium and ribose-5-phosphate;2.4;CA;CALCIUM ION;Transketolase;57975;
3UPT;B;Crystal structure of a transketolase from Burkholderia pseudomallei bound to TPP, calcium and ribose-5-phosphate;2.4;CA;CALCIUM ION;Transketolase;57975;
3UQO;A;Bovine trypsin variant X(triplePhe227) in complex with small molecule inhibitor;1.8;CA;CALCIUM ION;Cationic trypsin;9913;
3UQV;A;Bovine trypsin variant X(triplePhe227) in complex with small molecule inhibitor;2.4;CA;CALCIUM ION;Cationic trypsin;9913;
3UR3;C;Structure of the Cmr2 subunit of the CRISPR RNA silencing complex;2.4;CA;CALCIUM ION;Cmr2dHD;2261;
3US3;A;Recombinant rabbit skeletal calsequestrin-MPD complex;1.74;CA;CALCIUM ION;Calsequestrin-1;9986;
3US9;A;Crystal Structure of the NCX1 Intracellular Tandem Calcium Binding Domains(CBD12);2.68;CA;CALCIUM ION;Sodium/calcium exchanger 1;9612;
3USN;A;STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN FIBROBLAST STROMELYSIN-1 INHIBITED WITH THE THIADIAZOLE INHIBITOR IPNU-107859, NMR, 1 STRUCTURE;;CA;CALCIUM ION;STROMELYSIN-1;9606;
3USU;A;Crystal structure of Butea monosperma seed lectin;2.46;CA;CALCIUM ION;Lectin Alpha chain;56060;
3USU;B;Crystal structure of Butea monosperma seed lectin;2.46;CA;CALCIUM ION;Lectin Beta Chain;56060;
3USU;C;Crystal structure of Butea monosperma seed lectin;2.46;CA;CALCIUM ION;Lectin Alpha chain;56060;
3USU;D;Crystal structure of Butea monosperma seed lectin;2.46;CA;CALCIUM ION;Lectin Beta Chain;56060;
3USU;E;Crystal structure of Butea monosperma seed lectin;2.46;CA;CALCIUM ION;Lectin Alpha chain;56060;
3USU;F;Crystal structure of Butea monosperma seed lectin;2.46;CA;CALCIUM ION;Lectin Beta Chain;56060;
3USU;G;Crystal structure of Butea monosperma seed lectin;2.46;CA;CALCIUM ION;Lectin Alpha chain;56060;
3USU;H;Crystal structure of Butea monosperma seed lectin;2.46;CA;CALCIUM ION;Lectin Beta Chain;56060;
3USZ;A;Crystal structure of truncated exo-1,3/1,4-beta-glucanase (EXOP) from Pseudoalteromonas sp. BB1;2.1;CA;CALCIUM ION;Exo-1,3/1,4-beta-glucanase;368972;
3UT0;A;Crystal structure of exo-1,3/1,4-beta-glucanase (EXOP) from Pseudoalteromonas sp. BB1;2.3;CA;CALCIUM ION;Exo-1,3/1,4-beta-glucanase;368972;
3UT0;B;Crystal structure of exo-1,3/1,4-beta-glucanase (EXOP) from Pseudoalteromonas sp. BB1;2.3;CA;CALCIUM ION;Exo-1,3/1,4-beta-glucanase;368972;
3UT0;C;Crystal structure of exo-1,3/1,4-beta-glucanase (EXOP) from Pseudoalteromonas sp. BB1;2.3;CA;CALCIUM ION;Exo-1,3/1,4-beta-glucanase;368972;
3UT0;D;Crystal structure of exo-1,3/1,4-beta-glucanase (EXOP) from Pseudoalteromonas sp. BB1;2.3;CA;CALCIUM ION;Exo-1,3/1,4-beta-glucanase;368972;
3UU9;A;Structure of the free TvNiRb form of Thioalkalivibrio nitratireducens cytochrome c nitrite reductase;2.2;CA;CALCIUM ION;Eight-heme nitrite reductase;186931;
3UU9;B;Structure of the free TvNiRb form of Thioalkalivibrio nitratireducens cytochrome c nitrite reductase;2.2;CA;CALCIUM ION;Eight-heme nitrite reductase;186931;
3UUZ;A;Bovine trypsin variant X(triplePhe227) in complex with small molecule inhibitor;2.1;CA;CALCIUM ION;Cationic trypsin;9913;
3UUZ;B;Bovine trypsin variant X(triplePhe227) in complex with small molecule inhibitor;2.1;CA;CALCIUM ION;Cationic trypsin;9913;
3UVC;A;MMP12 in a complex with the dimeric adduct: 5-(5-phenylhydantoin)-5-phenylhydantoin;1.3;CA;CALCIUM ION;Macrophage metalloelastase;9606;
3UVC;B;MMP12 in a complex with the dimeric adduct: 5-(5-phenylhydantoin)-5-phenylhydantoin;1.3;CA;CALCIUM ION;Macrophage metalloelastase;9606;
3UVF;A;Expanding LAGALIDADG endonuclease scaffold diversity by rapidly surveying evolutionary sequence space;3;CA;CALCIUM ION;Intron-encoded DNA endonuclease I-HjeMI;51453;
3UVF;B;Expanding LAGALIDADG endonuclease scaffold diversity by rapidly surveying evolutionary sequence space;3;CA;CALCIUM ION;Intron-encoded DNA endonuclease I-HjeMI;51453;
3UVF;E;Expanding LAGALIDADG endonuclease scaffold diversity by rapidly surveying evolutionary sequence space;3;CA;CALCIUM ION;synthetic oligo;;
3UWI;A;Bovine trypsin variant X(tripleGlu217Phe227) in complex with small molecule inhibitor;1.43;CA;CALCIUM ION;Cationic trypsin;9913;
3UXF;A;Structure of the fimbrial protein FimP from Actonomyces oris;1.6;CA;CALCIUM ION;Fimbrial subunit type 1;544580;
3UY9;A;Bovine trypsin variant X(tripleGlu217Phe227) in complex with small molecule inhibitor;3.22;CA;CALCIUM ION;Cationic trypsin;9913;
3UY9;B;Bovine trypsin variant X(tripleGlu217Phe227) in complex with small molecule inhibitor;3.22;CA;CALCIUM ION;Cationic trypsin;9913;
3UY9;C;Bovine trypsin variant X(tripleGlu217Phe227) in complex with small molecule inhibitor;3.22;CA;CALCIUM ION;Cationic trypsin;9913;
3UY9;D;Bovine trypsin variant X(tripleGlu217Phe227) in complex with small molecule inhibitor;3.22;CA;CALCIUM ION;Cationic trypsin;9913;
3UY9;E;Bovine trypsin variant X(tripleGlu217Phe227) in complex with small molecule inhibitor;3.22;CA;CALCIUM ION;Cationic trypsin;9913;
3UY9;F;Bovine trypsin variant X(tripleGlu217Phe227) in complex with small molecule inhibitor;3.22;CA;CALCIUM ION;Cationic trypsin;9913;
3UY9;G;Bovine trypsin variant X(tripleGlu217Phe227) in complex with small molecule inhibitor;3.22;CA;CALCIUM ION;Cationic trypsin;9913;
3UY9;H;Bovine trypsin variant X(tripleGlu217Phe227) in complex with small molecule inhibitor;3.22;CA;CALCIUM ION;Cationic trypsin;9913;
3UY9;I;Bovine trypsin variant X(tripleGlu217Phe227) in complex with small molecule inhibitor;3.22;CA;CALCIUM ION;Cationic trypsin;9913;
3UY9;J;Bovine trypsin variant X(tripleGlu217Phe227) in complex with small molecule inhibitor;3.22;CA;CALCIUM ION;Cationic trypsin;9913;
3UY9;K;Bovine trypsin variant X(tripleGlu217Phe227) in complex with small molecule inhibitor;3.22;CA;CALCIUM ION;Cationic trypsin;9913;
3UY9;L;Bovine trypsin variant X(tripleGlu217Phe227) in complex with small molecule inhibitor;3.22;CA;CALCIUM ION;Cationic trypsin;9913;
3UY9;M;Bovine trypsin variant X(tripleGlu217Phe227) in complex with small molecule inhibitor;3.22;CA;CALCIUM ION;Cationic trypsin;9913;
3UY9;N;Bovine trypsin variant X(tripleGlu217Phe227) in complex with small molecule inhibitor;3.22;CA;CALCIUM ION;Cationic trypsin;9913;
3UY9;O;Bovine trypsin variant X(tripleGlu217Phe227) in complex with small molecule inhibitor;3.22;CA;CALCIUM ION;Cationic trypsin;9913;
3UY9;P;Bovine trypsin variant X(tripleGlu217Phe227) in complex with small molecule inhibitor;3.22;CA;CALCIUM ION;Cationic trypsin;9913;
3V03;A;Crystal structure of Bovine Serum Albumin;2.7;CA;CALCIUM ION;Serum albumin;9913;
3V03;B;Crystal structure of Bovine Serum Albumin;2.7;CA;CALCIUM ION;Serum albumin;9913;
3V0A;A;2.7 angstrom crystal structure of BoNT/Ai in complex with NTNHA;2.7;CA;CALCIUM ION;BoNT/A;1491;
3V0B;A;3.9 angstrom crystal structure of BoNT/Ai in complex with NTNHA;3.9;CA;CALCIUM ION;BoNT/A;1491;
3V0X;A;Bovine trypsin variant X(tripleGlu217Phe227) in complex with small molecule inhibitor;1.9;CA;CALCIUM ION;Cationic trypsin;9913;
3V12;A;Bovine trypsin variant X(tripleGlu217Phe227) in complex with small molecule inhibitor;1.8;CA;CALCIUM ION;Cationic trypsin;9913;
3V13;A;Bovine trypsin variant X(tripleGlu217Phe227) in complex with small molecule inhibitor;1.63;CA;CALCIUM ION;Cationic trypsin;9913;
3V1W;A;Molecular Basis for Multiple Ligand Binding of Calsequestrin and Potential Inhibition by Caffeine and Gallocatecin;1.91;CA;CALCIUM ION;Calsequestrin-1;9986;
3V20;A;Crystal structure of Type IIF restriction endonuclease Bse634I with cognate DNA;2.35;CA;CALCIUM ION;Endonuclease Bse634IR;1422;
3V20;B;Crystal structure of Type IIF restriction endonuclease Bse634I with cognate DNA;2.35;CA;CALCIUM ION;Endonuclease Bse634IR;1422;
3V2T;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS I92A/V66A at cryogenic temperature;1.8;CA;CALCIUM ION;Thermonuclease;1280;
3V4F;A;H-Ras PEG 400/CaCl2, ordered off;1.39;CA;CALCIUM ION;GTPase HRas;10116;
3V4P;A;crystal structure of a4b7 headpiece complexed with Fab ACT-1;3.15;CA;CALCIUM ION;Integrin alpha-4;9606;
3V4P;B;crystal structure of a4b7 headpiece complexed with Fab ACT-1;3.15;CA;CALCIUM ION;Integrin beta-7;9606;
3V4P;C;crystal structure of a4b7 headpiece complexed with Fab ACT-1;3.15;CA;CALCIUM ION;Integrin alpha-4;9606;
3V4P;D;crystal structure of a4b7 headpiece complexed with Fab ACT-1;3.15;CA;CALCIUM ION;Integrin beta-7;9606;
3V4V;A;crystal structure of a4b7 headpiece complexed with Fab ACT-1 and RO0505376;3.1;CA;CALCIUM ION;Integrin alpha-4;9606;
3V4V;B;crystal structure of a4b7 headpiece complexed with Fab ACT-1 and RO0505376;3.1;CA;CALCIUM ION;Integrin beta-7;9606;
3V4V;C;crystal structure of a4b7 headpiece complexed with Fab ACT-1 and RO0505376;3.1;CA;CALCIUM ION;Integrin alpha-4;9606;
3V4V;D;crystal structure of a4b7 headpiece complexed with Fab ACT-1 and RO0505376;3.1;CA;CALCIUM ION;Integrin beta-7;9606;
3V5U;A;Structure of Sodium/Calcium Exchanger from Methanocaldococcus jannaschii DSM 2661;1.9;CA;CALCIUM ION;Uncharacterized membrane protein MJ0091;2190;
3V64;A;Crystal Structure of agrin and LRP4;2.85;CA;CALCIUM ION;agrin;10116;
3V64;B;Crystal Structure of agrin and LRP4;2.85;CA;CALCIUM ION;agrin;10116;
3V64;C;Crystal Structure of agrin and LRP4;2.85;CA;CALCIUM ION;Low-density lipoprotein receptor-related protein 4;10116;
3V64;D;Crystal Structure of agrin and LRP4;2.85;CA;CALCIUM ION;Low-density lipoprotein receptor-related protein 4;10116;
3V65;A;Crystal structure of agrin and LRP4 complex;3.3;CA;CALCIUM ION;Agrin;10116;
3V65;C;Crystal structure of agrin and LRP4 complex;3.3;CA;CALCIUM ION;Agrin;10116;
3V6H;A;Replication of N2,3-Ethenoguanine by DNA Polymerases;2.3;CA;CALCIUM ION;DNA polymerase IV;2287;
3V6H;B;Replication of N2,3-Ethenoguanine by DNA Polymerases;2.3;CA;CALCIUM ION;DNA polymerase IV;2287;
3V6H;D;Replication of N2,3-Ethenoguanine by DNA Polymerases;2.3;CA;CALCIUM ION;DNA (5'-D(*GP*G*GP*GP*GP*AP*AP*GP*GP*AP*TP*TP*(DOC))-3');;
3V6I;A;Crystal structure of the peripheral stalk of Thermus thermophilus H+-ATPase/synthase at 2.25 A resolution;2.25;CA;CALCIUM ION;V-type ATP synthase subunit E;274;
3V6I;B;Crystal structure of the peripheral stalk of Thermus thermophilus H+-ATPase/synthase at 2.25 A resolution;2.25;CA;CALCIUM ION;V-type ATP synthase, subunit (VAPC-THERM);274;
3V6K;A;Replication of N2,3-Ethenoguanine by DNA Polymerases;3.6;CA;CALCIUM ION;DNA polymerase IV;2287;
3V6K;J;Replication of N2,3-Ethenoguanine by DNA Polymerases;3.6;CA;CALCIUM ION;DNA polymerase IV;2287;
3V6N;A;Crystal structure of a plant albumin from Cicer Arietinum showing hemagglutination;2.2;CA;CALCIUM ION;Lectin;3827;
3V6N;B;Crystal structure of a plant albumin from Cicer Arietinum showing hemagglutination;2.2;CA;CALCIUM ION;Lectin;3827;
3V6Q;A;Crystal structure of the complex of bovine lactoperoxidase with Carbon monoxide at 2.0 A resolution;2;CA;CALCIUM ION;Lactoperoxidase;9913;
3V7F;A;Crystal Structure of Streptococcus pyogenes Csn2;2.9;CA;CALCIUM ION;Putative uncharacterized protein;1314;
3V7F;B;Crystal Structure of Streptococcus pyogenes Csn2;2.9;CA;CALCIUM ION;Putative uncharacterized protein;1314;
3V7Z;A;Carboxypeptidase T with GEMSA;1.61;CA;CALCIUM ION;Carboxypeptidase T;2026;
3V96;B;Complex of matrix metalloproteinase-10 catalytic domain (MMP-10cd) with tissue inhibitor of metalloproteinases-1 (TIMP-1);1.9;CA;CALCIUM ION;Stromelysin-2;9606;
3V9M;A;Phospholipase ACII4 from Australian King Brown Snake;1.56;CA;CALCIUM ION;Phospholipase A2 isozyme PA-11;8670;
3V9M;B;Phospholipase ACII4 from Australian King Brown Snake;1.56;CA;CALCIUM ION;Phospholipase A2 isozyme PA-11;8670;
3VA5;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS I92A/V23A at cryogenic temperature;1.55;CA;CALCIUM ION;Thermonuclease;1280;
3VCZ;B;1.80 Angstrom resolution crystal structure of a putative translation initiation inhibitor from Vibrio vulnificus CMCP6;1.8;CA;CALCIUM ION;Endoribonuclease L-PSP;672;
3VCZ;C;1.80 Angstrom resolution crystal structure of a putative translation initiation inhibitor from Vibrio vulnificus CMCP6;1.8;CA;CALCIUM ION;Endoribonuclease L-PSP;672;
3VDQ;B;Crystal structure of alcaligenes faecalis D-3-hydroxybutyrate dehydrogenase in complex with NAD(+) and acetate;2.2;CA;CALCIUM ION;D-3-hydroxybutyrate dehydrogenase;511;
3VDQ;C;Crystal structure of alcaligenes faecalis D-3-hydroxybutyrate dehydrogenase in complex with NAD(+) and acetate;2.2;CA;CALCIUM ION;D-3-hydroxybutyrate dehydrogenase;511;
3VDR;A;Crystal structure of D-3-hydroxybutyrate dehydrogenase, prepared in the presence of the substrate D-3-hydroxybutyrate and NAD(+);3;CA;CALCIUM ION;D-3-hydroxybutyrate dehydrogenase;511;
3VDR;B;Crystal structure of D-3-hydroxybutyrate dehydrogenase, prepared in the presence of the substrate D-3-hydroxybutyrate and NAD(+);3;CA;CALCIUM ION;D-3-hydroxybutyrate dehydrogenase;511;
3VEB;M;Crystal Structure of Matp-matS;2.8;CA;CALCIUM ION;5'-D(*AP*CP*GP*TP*GP*AP*CP*AP*AP*TP*GP*TP*CP*AP*CP*G)-3';;
3VEB;N;Crystal Structure of Matp-matS;2.8;CA;CALCIUM ION;5'-D(*TP*CP*GP*TP*GP*AP*CP*AP*TP*TP*GP*TP*CP*AP*CP*G)-3';;
3VEQ;B;A binary complex betwwen bovine pancreatic trypsin and a engineered mutant trypsin inhibitor;2.25;CA;CALCIUM ION;Cationic trypsin;9913;
3VGI;A;The crystal structure of hyperthermophilic family 12 endocellulase from Pyrococcus furiosus;1.07;CA;CALCIUM ION;Endoglucanase A;2261;
3VHQ;A;Crystal structure of the Ca6 site mutant of Pro-SA-subtilisin;2.15;CA;CALCIUM ION;Tk-subtilisin;311400;
3VI1;A;Crystal structure of Pseudomonas aerginosa alkaline protease complexed with Substance P(1-6);2;CA;CALCIUM ION;Alkaline metalloproteinase;287;
3VI1;B;Crystal structure of Pseudomonas aerginosa alkaline protease complexed with Substance P(1-6);2;CA;CALCIUM ION;Alkaline metalloproteinase;287;
3VI3;A;Crystal structure of alpha5beta1 integrin headpiece (ligand-free form);2.9;CA;CALCIUM ION;Integrin alpha-5;9606;
3VI3;B;Crystal structure of alpha5beta1 integrin headpiece (ligand-free form);2.9;CA;CALCIUM ION;Integrin beta-1;9606;
3VI3;C;Crystal structure of alpha5beta1 integrin headpiece (ligand-free form);2.9;CA;CALCIUM ION;Integrin alpha-5;9606;
3VI3;D;Crystal structure of alpha5beta1 integrin headpiece (ligand-free form);2.9;CA;CALCIUM ION;Integrin beta-1;9606;
3VI4;A;Crystal structure of alpha5beta1 integrin headpiece in complex with RGD peptide;2.9;CA;CALCIUM ION;Integrin alpha-5;9606;
3VI4;B;Crystal structure of alpha5beta1 integrin headpiece in complex with RGD peptide;2.9;CA;CALCIUM ION;Integrin beta-1;9606;
3VI4;C;Crystal structure of alpha5beta1 integrin headpiece in complex with RGD peptide;2.9;CA;CALCIUM ION;Integrin alpha-5;9606;
3VI4;D;Crystal structure of alpha5beta1 integrin headpiece in complex with RGD peptide;2.9;CA;CALCIUM ION;Integrin beta-1;9606;
3VI5;C;Human hematopoietic prostaglandin D synthase inhibitor complex structures;2;CA;CALCIUM ION;Hematopoietic prostaglandin D synthase;9606;
3VI5;D;Human hematopoietic prostaglandin D synthase inhibitor complex structures;2;CA;CALCIUM ION;Hematopoietic prostaglandin D synthase;9606;
3VI7;C;Human hematopoietic prostaglandin D synthase inhibitor complex structures;2;CA;CALCIUM ION;Hematopoietic prostaglandin D synthase;9606;
3VI7;D;Human hematopoietic prostaglandin D synthase inhibitor complex structures;2;CA;CALCIUM ION;Hematopoietic prostaglandin D synthase;9606;
3VJ9;A;Crystal structure of the human squalene synthase;1.52;CA;CALCIUM ION;Squalene synthase;9606;
3VKF;C;Crystal Structure of Neurexin 1beta/Neuroligin 1 complex;3.3;CA;CALCIUM ION;Neurexin-1-beta;9913;
3VKF;D;Crystal Structure of Neurexin 1beta/Neuroligin 1 complex;3.3;CA;CALCIUM ION;Neurexin-1-beta;9913;
3VKZ;A;3-isopropylmalate dehydrogenase from Shewanella oneidensis MR-1 at atmospheric pressure;1.84;CA;CALCIUM ION;3-isopropylmalate dehydrogenase;70863;
3VL2;A;3-isopropylmalate dehydrogenase from Shewanella oneidensis MR-1 at 160 MPa;2.06;CA;CALCIUM ION;3-isopropylmalate dehydrogenase;70863;
3VL3;A;3-isopropylmalate dehydrogenase from Shewanella oneidensis MR-1 at 340 MPa;1.8;CA;CALCIUM ION;3-isopropylmalate dehydrogenase;70863;
3VL4;A;3-isopropylmalate dehydrogenase from Shewanella oneidensis MR-1 at 410 MPa;1.88;CA;CALCIUM ION;3-isopropylmalate dehydrogenase;70863;
3VL6;A;3-isopropylmalate dehydrogenase from Shewanella oneidensis MR-1 at 580 MPa;2.07;CA;CALCIUM ION;3-isopropylmalate dehydrogenase;70863;
3VL7;A;3-isopropylmalate dehydrogenase from Shewanella oneidensis MR-1 at 650 MPa;2.2;CA;CALCIUM ION;3-isopropylmalate dehydrogenase;70863;
3VLU;A;Crystal structure of Sphingomonas sp. A1 alginate-binding protein AlgQ1 in complex with saturated trimannuronate;1.55;CA;CALCIUM ION;AlgQ1;90322;
3VLV;A;Crystal structure of Sphingomonas sp. A1 alginate-binding ptotein AlgQ1 in complex with unsaturated triguluronate;1.5;CA;CALCIUM ION;AlgQ1;90322;
3VLW;A;Crystal structure of Sphingomonas sp. A1 alginate-binding protein AlgQ1 in complex with mannuronate-guluronate disaccharide;2;CA;CALCIUM ION;AlgQ1;90322;
3VLW;B;Crystal structure of Sphingomonas sp. A1 alginate-binding protein AlgQ1 in complex with mannuronate-guluronate disaccharide;2;CA;CALCIUM ION;AlgQ1;90322;
3VM5;A;Recombinant medaka fish alpha-amylase expressed in yeast Pichia pastoris;2.85;CA;CALCIUM ION;alpha-amylase;8090;
3VM7;A;Structure of an Alpha-Amylase from Malbranchea cinnamomea;2.25;CA;CALCIUM ION;Alpha-amylase;5041;
3VNU;A;Complex structure of viral RNA polymerase I;3.2;CA;CALCIUM ION;Elongation factor Ts, Elongation factor Tu, LINKER, Q beta replicase;56,239,803;
3VNV;A;Complex structure of viral RNA polymerase II;2.6;CA;CALCIUM ION;Elongation factor Ts, Elongation factor Tu, LINKER, Q beta replicase;56,239,803;
3VNX;A;Crystal structure of ferritin from multicellular green algae, Ulva pertusa.;2.4;CA;CALCIUM ION;ferritin;3120;
3VO8;A;Staphylococcus aureus FtsZ GDP-form;2.26;CA;CALCIUM ION;Cell division protein FtsZ;1280;
3VO8;B;Staphylococcus aureus FtsZ GDP-form;2.26;CA;CALCIUM ION;Cell division protein FtsZ;1280;
3VOA;A;Staphylococcus aureus FtsZ 12-316 GDP-form;1.73;CA;CALCIUM ION;Cell division protein FtsZ;1280;
3VOB;A;Staphylococcus aureus FtsZ with PC190723;2.7;CA;CALCIUM ION;Cell division protein FtsZ;1280;
3VOC;A;Crystal structure of the catalytic domain of beta-amylase from paenibacillus polymyxa;1.95;CA;CALCIUM ION;Beta/alpha-amylase;1406;
3VOT;A;Crystal structure of L-amino acid ligase from Bacillus licheniformis;1.8;CA;CALCIUM ION;L-amino acid ligase, BL00235;1402;
3VOT;B;Crystal structure of L-amino acid ligase from Bacillus licheniformis;1.8;CA;CALCIUM ION;L-amino acid ligase, BL00235;1402;
3VPK;A;Crystal Structure of 6-Guanidinohexanoyl Trypsin;1.94;CA;CALCIUM ION;Cationic trypsin;9913;
3VPP;A;Crystal Structure of the Human CLEC9A C-type Lectin-Like Domain;1.64;CA;CALCIUM ION;C-type lectin domain family 9 member A;9606;
3VPP;B;Crystal Structure of the Human CLEC9A C-type Lectin-Like Domain;1.64;CA;CALCIUM ION;C-type lectin domain family 9 member A;9606;
3VRN;A;Crystal structure of the tyrosine kinase binding domain of Cbl-c;1.64;CA;CALCIUM ION;Signal transduction protein CBL-C;9606;
3VRO;A;Crystal structure of the tyrosine kinase binding domain of Cbl-c in complex with phospho-Src peptide;1.8;CA;CALCIUM ION;Signal transduction protein CBL-C;9606;
3VRP;A;Crystal structure of the tyrosine kinase binding domain of Cbl-c in complex with phospho-EGFR peptide;1.52;CA;CALCIUM ION;Signal transduction protein CBL-C;9606;
3VRQ;A;Crystal structure of the tyrosine kinase binding domain of Cbl-c (PL mutant);2.39;CA;CALCIUM ION;Signal transduction protein CBL-C;9606;
3VRQ;B;Crystal structure of the tyrosine kinase binding domain of Cbl-c (PL mutant);2.39;CA;CALCIUM ION;Signal transduction protein CBL-C;9606;
3VRR;A;Crystal structure of the tyrosine kinase binding domain of Cbl-c (PL mutant) in complex with phospho-EGFR peptide;2;CA;CALCIUM ION;Signal transduction protein CBL-C;9606;
3VRY;A;Crystal structure of HCK complexed with a pyrrolo-pyrimidine inhibitor 4-Amino-5-(4-phenoxyphenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl-cyclopentane;2.48;CA;CALCIUM ION;Tyrosine-protein kinase HCK;9606;
3VRY;B;Crystal structure of HCK complexed with a pyrrolo-pyrimidine inhibitor 4-Amino-5-(4-phenoxyphenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl-cyclopentane;2.48;CA;CALCIUM ION;Tyrosine-protein kinase HCK;9606;
3VRZ;A;Crystal structure of HCK complexed with a pyrrolo-pyrimidine inhibitor 1-[4-(4-amino-7-cyclopentyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)phenyl]-3-benzylurea;2.22;CA;CALCIUM ION;Tyrosine-protein kinase HCK;9606;
3VRZ;B;Crystal structure of HCK complexed with a pyrrolo-pyrimidine inhibitor 1-[4-(4-amino-7-cyclopentyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)phenyl]-3-benzylurea;2.22;CA;CALCIUM ION;Tyrosine-protein kinase HCK;9606;
3VS0;A;Crystal structure of HCK complexed with a pyrrolo-pyrimidine inhibitor N-[4-(4-amino-7-cyclopentyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)phenyl]benzamide;2.93;CA;CALCIUM ION;Tyrosine-protein kinase HCK;9606;
3VS0;B;Crystal structure of HCK complexed with a pyrrolo-pyrimidine inhibitor N-[4-(4-amino-7-cyclopentyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)phenyl]benzamide;2.93;CA;CALCIUM ION;Tyrosine-protein kinase HCK;9606;
3VS1;A;Crystal structure of HCK complexed with a pyrrolo-pyrimidine inhibitor 1-[4-(4-amino-7-cyclopentyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)phenyl]-3-phenylurea;2.46;CA;CALCIUM ION;Tyrosine-protein kinase HCK;9606;
3VS1;B;Crystal structure of HCK complexed with a pyrrolo-pyrimidine inhibitor 1-[4-(4-amino-7-cyclopentyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)phenyl]-3-phenylurea;2.46;CA;CALCIUM ION;Tyrosine-protein kinase HCK;9606;
3VS2;A;Crystal structure of HCK complexed with a pyrrolo-pyrimidine inhibitor 7-[cis-4-(4-methylpiperazin-1-yl)cyclohexyl]-5-(4-phenoxyphenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine;2.61;CA;CALCIUM ION;Tyrosine-protein kinase HCK;9606;
3VS2;B;Crystal structure of HCK complexed with a pyrrolo-pyrimidine inhibitor 7-[cis-4-(4-methylpiperazin-1-yl)cyclohexyl]-5-(4-phenoxyphenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine;2.61;CA;CALCIUM ION;Tyrosine-protein kinase HCK;9606;
3VS3;A;Crystal structure of HCK complexed with a pyrrolo-pyrimidine inhibitor 7-[trans-4-(4-methylpiperazin-1-yl)cyclohexyl]-5-(4-phenoxyphenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine;2.17;CA;CALCIUM ION;Tyrosine-protein kinase HCK;9606;
3VS3;B;Crystal structure of HCK complexed with a pyrrolo-pyrimidine inhibitor 7-[trans-4-(4-methylpiperazin-1-yl)cyclohexyl]-5-(4-phenoxyphenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine;2.17;CA;CALCIUM ION;Tyrosine-protein kinase HCK;9606;
3VS4;A;Crystal structure of HCK complexed with a pyrrolo-pyrimidine inhibitor 5-(4-phenoxyphenyl)-7-(tetrahydro-2H-pyran-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine;2.75;CA;CALCIUM ION;Tyrosine-protein kinase HCK;9606;
3VS4;B;Crystal structure of HCK complexed with a pyrrolo-pyrimidine inhibitor 5-(4-phenoxyphenyl)-7-(tetrahydro-2H-pyran-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine;2.75;CA;CALCIUM ION;Tyrosine-protein kinase HCK;9606;
3VS5;A;Crystal structure of HCK complexed with a pyrrolo-pyrimidine inhibitor 7-(1-methylpiperidin-4-yl)-5-(4-phenoxyphenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine;2.85;CA;CALCIUM ION;Tyrosine-protein kinase HCK;9606;
3VS5;B;Crystal structure of HCK complexed with a pyrrolo-pyrimidine inhibitor 7-(1-methylpiperidin-4-yl)-5-(4-phenoxyphenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine;2.85;CA;CALCIUM ION;Tyrosine-protein kinase HCK;9606;
3VS6;A;Crystal structure of HCK complexed with a pyrazolo-pyrimidine inhibitor tert-butyl {4-[4-amino-1-(propan-2-yl)-1H-pyrazolo[3,4-d]pyrimidin-3-yl]-2-methoxyphenyl}carbamate;2.37;CA;CALCIUM ION;Tyrosine-protein kinase HCK;9606;
3VS6;B;Crystal structure of HCK complexed with a pyrazolo-pyrimidine inhibitor tert-butyl {4-[4-amino-1-(propan-2-yl)-1H-pyrazolo[3,4-d]pyrimidin-3-yl]-2-methoxyphenyl}carbamate;2.37;CA;CALCIUM ION;Tyrosine-protein kinase HCK;9606;
3VS7;A;Crystal structure of HCK complexed with a pyrazolo-pyrimidine inhibitor 1-cyclopentyl-3-(1H-pyrrolo[2,3-b]pyridin-5-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine;3;CA;CALCIUM ION;Tyrosine-protein kinase HCK;9606;
3VS7;B;Crystal structure of HCK complexed with a pyrazolo-pyrimidine inhibitor 1-cyclopentyl-3-(1H-pyrrolo[2,3-b]pyridin-5-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine;3;CA;CALCIUM ION;Tyrosine-protein kinase HCK;9606;
3VTO;A;The crystal structure of the C-terminal domain of Mu phage central spike;1.44;CA;CALCIUM ION;Protein gp45;10677;
3VTO;Q;The crystal structure of the C-terminal domain of Mu phage central spike;1.44;CA;CALCIUM ION;Protein gp45;10677;
3VU1;A;Crystal structure of the C-terminal globular domain of oligosaccharyltransferase (PhAglB-L, O74088_PYRHO) from Pyrococcus horikoshii;2.7;CA;CALCIUM ION;Putative uncharacterized protein PH0242;53953;
3VU1;B;Crystal structure of the C-terminal globular domain of oligosaccharyltransferase (PhAglB-L, O74088_PYRHO) from Pyrococcus horikoshii;2.7;CA;CALCIUM ION;Putative uncharacterized protein PH0242;53953;
3VV2;A;Crystal structure of complex form between S324A-subtilisin and mutant Tkpro;1.83;CA;CALCIUM ION;Tk-subtilisin;311400;
3VV3;A;Crystal structure of deseasin MCP-01 from Pseudoalteromonas sp. SM9913;1.76;CA;CALCIUM ION;Deseasin MCP-01;234831;
3VV3;B;Crystal structure of deseasin MCP-01 from Pseudoalteromonas sp. SM9913;1.76;CA;CALCIUM ION;Deseasin MCP-01;234831;
3VX0;A;Crystal Structure of alpha-amylase from Aspergillus oryzae;1.5;CA;CALCIUM ION;Alpha-amylase A type-1/2;5062;
3VX1;A;Crystal Structure of alpha-Amylase from Aspergillus oryzae;2.2;CA;CALCIUM ION;Alpha-amylase A type-1/2;5062;
3VYK;A;Crystal structure of C-type lectin domain of murine dendritic cell inhibitory receptor 2 in complex with N-glycan;1.5;CA;CALCIUM ION;C-type lectin domain family 4, member a4;10090;
3VYV;A;Crystal structure of subtilisin NAT at 1.36;1.36;CA;CALCIUM ION;Subtilisin NAT;1423;
3VYV;B;Crystal structure of subtilisin NAT at 1.36;1.36;CA;CALCIUM ION;Subtilisin NAT;1423;
3W09;A;Influenza virus neuraminidase subtype N9 (TERN) complexed with 2,3-dif guanidino-neu5ac2en inhibitor;2;CA;CALCIUM ION;Neuraminidase;11320;
3W3D;A;Crystal structure of smooth muscle G actin DNase I complex;1.8;CA;CALCIUM ION;Actin, gamma-enteric smooth muscle;9031;
3W3D;B;Crystal structure of smooth muscle G actin DNase I complex;1.8;CA;CALCIUM ION;Deoxyribonuclease-1;9913;
3W57;A;Structure of a C2 domain;1.66;CA;CALCIUM ION;C2 domain protein;52904;
3W57;B;Structure of a C2 domain;1.66;CA;CALCIUM ION;C2 domain protein;52904;
3W5E;A;Crystal structure of phosphodiesterase 4B in complex with compound 31e;2.3;CA;CALCIUM ION;cAMP-specific 3',5'-cyclic phosphodiesterase 4B;9606;
3W5E;B;Crystal structure of phosphodiesterase 4B in complex with compound 31e;2.3;CA;CALCIUM ION;cAMP-specific 3',5'-cyclic phosphodiesterase 4B;9606;
3W5M;A;Crystal Structure of Streptomyces avermitilis alpha-L-rhamnosidase;1.8;CA;CALCIUM ION;Putative rhamnosidase;33903;
3W5N;A;Crystal Structure of Streptomyces avermitilis alpha-L-rhamnosidase complexed with L-rhamnose;1.8;CA;CALCIUM ION;Putative rhamnosidase;33903;
3W6N;B;Crystal structure of human Dlp1 in complex with GMP-PN.Pi;2;CA;CALCIUM ION;Dynamin-1-like protein;9606;
3W6O;B;Crystal structure of human Dlp1 in complex with GMP-PCP;1.9;CA;CALCIUM ION;Dynamin-1-like protein;9606;
3W6P;B;Crystal structure of human Dlp1 in complex with GDP.AlF4;1.7;CA;CALCIUM ION;Dynamin-1-like protein;9606;
3W7A;A;Crystal Structure of azoreductase AzrC fin complex with sulfone-modified azo dye Acid Red 88;2.1;CA;CALCIUM ION;FMN-dependent NADH-azoreductase;391699;
3W7A;C;Crystal Structure of azoreductase AzrC fin complex with sulfone-modified azo dye Acid Red 88;2.1;CA;CALCIUM ION;FMN-dependent NADH-azoreductase;391699;
3W7S;A;Escherichia coli K12 YgjK complexed with glucose;1.9;CA;CALCIUM ION;Uncharacterized protein YgjK;562;
3W7S;B;Escherichia coli K12 YgjK complexed with glucose;1.9;CA;CALCIUM ION;Uncharacterized protein YgjK;562;
3W7T;A;Escherichia coli K12 YgjK complexed with mannose;1.5;CA;CALCIUM ION;Uncharacterized protein YgjK;562;
3W7T;B;Escherichia coli K12 YgjK complexed with mannose;1.5;CA;CALCIUM ION;Uncharacterized protein YgjK;562;
3W7U;A;Escherichia coli K12 YgjK complexed with galactose;1.99;CA;CALCIUM ION;Uncharacterized protein YgjK;562;
3W7U;B;Escherichia coli K12 YgjK complexed with galactose;1.99;CA;CALCIUM ION;Uncharacterized protein YgjK;562;
3W7W;A;Crystal structure of E. coli YgjK E727A complexed with 2-O-alpha-D-glucopyranosyl-alpha-D-galactopyranose;2;CA;CALCIUM ION;Uncharacterized protein YgjK;562;
3W7W;B;Crystal structure of E. coli YgjK E727A complexed with 2-O-alpha-D-glucopyranosyl-alpha-D-galactopyranose;2;CA;CALCIUM ION;Uncharacterized protein YgjK;562;
3W7X;A;Crystal structure of E. coli YgjK D324N complexed with melibiose;2.7;CA;CALCIUM ION;Uncharacterized protein YgjK;562;
3W7X;B;Crystal structure of E. coli YgjK D324N complexed with melibiose;2.7;CA;CALCIUM ION;Uncharacterized protein YgjK;562;
3W9T;A;pore-forming CEL-III;2.9;CA;CALCIUM ION;Hemolytic lectin CEL-III;40245;
3W9T;B;pore-forming CEL-III;2.9;CA;CALCIUM ION;Hemolytic lectin CEL-III;40245;
3W9T;C;pore-forming CEL-III;2.9;CA;CALCIUM ION;Hemolytic lectin CEL-III;40245;
3W9T;D;pore-forming CEL-III;2.9;CA;CALCIUM ION;Hemolytic lectin CEL-III;40245;
3W9T;E;pore-forming CEL-III;2.9;CA;CALCIUM ION;Hemolytic lectin CEL-III;40245;
3W9T;F;pore-forming CEL-III;2.9;CA;CALCIUM ION;Hemolytic lectin CEL-III;40245;
3W9T;G;pore-forming CEL-III;2.9;CA;CALCIUM ION;Hemolytic lectin CEL-III;40245;
3WA5;A;Crystal Structure of type VI peptidoglycan muramidase effector Tse3 in complex with its cognate immunity protein Tsi3;1.9;CA;CALCIUM ION;Type VI secretion exported 3;287;
3WAV;A;Crystal Structure of Autotaxin in Complex with Compound 10;1.8;CA;CALCIUM ION;Ectonucleotide pyrophosphatase/phosphodiesterase family member 2;10090;
3WAW;A;Crystal Structure of Autotaxin in Complex with 2BoA;1.95;CA;CALCIUM ION;Ectonucleotide pyrophosphatase/phosphodiesterase family member 2;10090;
3WAX;A;Crystal Structure of Autotaxin in Complex with 3BoA;1.9;CA;CALCIUM ION;Ectonucleotide pyrophosphatase/phosphodiesterase family member 2;10090;
3WAY;A;Crystal Structure of Autotaxin in Complex with 4BoA;1.75;CA;CALCIUM ION;Ectonucleotide pyrophosphatase/phosphodiesterase family member 2;10090;
3WC3;A;Crystal structure of endo-1,4-beta-glucanase from Eisenia fetida;1.5;CA;CALCIUM ION;Endo-1, 4-beta-glucanase;6396;
3WCS;A;Crystal structure of plant lectin (ligand-bound form);1.75;CA;CALCIUM ION;Erythroagglutinin;3885;
3WCS;B;Crystal structure of plant lectin (ligand-bound form);1.75;CA;CALCIUM ION;Erythroagglutinin;3885;
3WCT;B;The structure of a deoxygenated 400 kda hemoglobin provides a more accurate description of the cooperative mechanism of giant hemoglobins: Oxygenated form;2.4;CA;CALCIUM ION;A2 globin chain of giant V2 hemoglobin;104711;
3WCT;F;The structure of a deoxygenated 400 kda hemoglobin provides a more accurate description of the cooperative mechanism of giant hemoglobins: Oxygenated form;2.4;CA;CALCIUM ION;A2 globin chain of giant V2 hemoglobin;104711;
3WCU;B;The structure of a deoxygenated 400 kda hemoglobin provides a more accurate description of the cooperative mechanism of giant hemoglobins: Deoxygenated form;2.9;CA;CALCIUM ION;A2 globin chain of giant V2 hemoglobin;104711;
3WCU;F;The structure of a deoxygenated 400 kda hemoglobin provides a more accurate description of the cooperative mechanism of giant hemoglobins: Deoxygenated form;2.9;CA;CALCIUM ION;A2 globin chain of giant V2 hemoglobin;104711;
3WCV;A;The structure of a deoxygenated 400 kda hemoglobin provides a more accurate description of the cooperative mechanism of giant hemoglobins: CA bound form;2.6;CA;CALCIUM ION;A1 globin chain of giant V2 hemoglobin;104711;
3WCV;B;The structure of a deoxygenated 400 kda hemoglobin provides a more accurate description of the cooperative mechanism of giant hemoglobins: CA bound form;2.6;CA;CALCIUM ION;A2 globin chain of giant V2 hemoglobin;104711;
3WCV;F;The structure of a deoxygenated 400 kda hemoglobin provides a more accurate description of the cooperative mechanism of giant hemoglobins: CA bound form;2.6;CA;CALCIUM ION;A2 globin chain of giant V2 hemoglobin;104711;
3WD9;A;Crystal structure of phosphodiesterase 4B in complex with compound 10f;2.5;CA;CALCIUM ION;cAMP-specific 3',5'-cyclic phosphodiesterase 4B;9606;
3WD9;B;Crystal structure of phosphodiesterase 4B in complex with compound 10f;2.5;CA;CALCIUM ION;cAMP-specific 3',5'-cyclic phosphodiesterase 4B;9606;
3WDH;A;Crystal structure of Pullulanase from Anoxybacillus sp. LM18-11;1.75;CA;CALCIUM ION;Type I pullulanase;1070988;
3WDI;A;Crystal structure of Pullulanase complexed with maltotriose from Anoxybacillus sp. LM18-11;2.2;CA;CALCIUM ION;Type I pullulanase;1070988;
3WDJ;A;Crystal structure of Pullulanase complexed with maltotetraose from Anoxybacillus sp. LM18-11;2.22;CA;CALCIUM ION;Type I pullulanase;1070988;
3WFB;B;Reduced cytochrome c-dependent nitric oxide reductase (cNOR) from Pseudomonas aeruginosa in complex with antibody fragment;2.7;CA;CALCIUM ION;Nitric oxide reductase subunit B;287;
3WFC;B;Reduced and carbonmonoxide-bound cytochrome c-dependent nitric oxide reductase (cNOR) from Pseudomonas aeruginosa in complex with antibody fragment;2.5;CA;CALCIUM ION;Nitric oxide reductase subunit B;287;
3WFD;B;Reduced and acetaldoxime-bound cytochrome c-dependent nitric oxide reductase (cNOR) from Pseudomonas aeruginosa in complex with antibody fragment;2.3;CA;CALCIUM ION;Nitric oxide reductase subunit B;287;
3WFE;B;Reduced and cyanide-bound cytochrome c-dependent nitric oxide reductase (cNOR) from Pseudomonas aeruginosa in complex with antibody fragment;2.49;CA;CALCIUM ION;Nitric oxide reductase subunit B;287;
3WGJ;A;STAPHYLOCOCCUS AUREUS FTSZ T7 chimera mutant, T7Bs;2.18;CA;CALCIUM ION;Cell division protein FtsZ;1280;
3WGJ;B;STAPHYLOCOCCUS AUREUS FTSZ T7 chimera mutant, T7Bs;2.18;CA;CALCIUM ION;Cell division protein FtsZ;1280;
3WH2;A;Human Mincle in complex with citrate;1.3;CA;CALCIUM ION;C-type lectin domain family 4 member E;9606;
3WH3;A;human Mincle, ligand free form;1.32;CA;CALCIUM ION;C-type lectin domain family 4 member E;9606;
3WHD;A;C-type lectin, human MCL;2.29;CA;CALCIUM ION;C-type lectin domain family 4 member D;9606;
3WHD;C;C-type lectin, human MCL;2.29;CA;CALCIUM ION;C-type lectin domain family 4 member D;9606;
3WHI;A;Crystal structure of unautoprocessed form of IS1-inserted Pro-subtilisin E;2.4;CA;CALCIUM ION;Subtilisin E;1423;
3WHI;B;Crystal structure of unautoprocessed form of IS1-inserted Pro-subtilisin E;2.4;CA;CALCIUM ION;Subtilisin E;1423;
3WHN;A;Hemerythrin-like domain of DcrH I119H mutant (met);1.9;CA;CALCIUM ION;Hemerythrin-like domain protein DcrH;881;
3WHN;B;Hemerythrin-like domain of DcrH I119H mutant (met);1.9;CA;CALCIUM ION;Hemerythrin-like domain protein DcrH;881;
3WHT;B;Crystal structure of ERGIC-53/MCFD2, Calcium-free form;1.8;CA;CALCIUM ION;Multiple coagulation factor deficiency protein 2;9606;
3WHU;A;Crystal structure of ERGIC-53/MCFD2, Calcium/Man2-bound form;2.6;CA;CALCIUM ION;Protein ERGIC-53;9606;
3WHU;B;Crystal structure of ERGIC-53/MCFD2, Calcium/Man2-bound form;2.6;CA;CALCIUM ION;Multiple coagulation factor deficiency protein 2;9606;
3WIU;A;Crystal structure of Pro-S324A/L349A;1.8;CA;CALCIUM ION;Tk-subtilisin;311400;
3WIU;B;Crystal structure of Pro-S324A/L349A;1.8;CA;CALCIUM ION;Tk-subtilisin;311400;
3WIU;C;Crystal structure of Pro-S324A/L349A;1.8;CA;CALCIUM ION;Tk-subtilisin;311400;
3WIV;A;Crystal structure of Pro-S324A/D356A;1.9;CA;CALCIUM ION;Tk-subtilisin;311400;
3WIV;B;Crystal structure of Pro-S324A/D356A;1.9;CA;CALCIUM ION;Tk-subtilisin;311400;
3WIV;C;Crystal structure of Pro-S324A/D356A;1.9;CA;CALCIUM ION;Tk-subtilisin;311400;
3WL4;A;N,N'-diacetylchitobiose deacetylase (Se-derivative) from Pyrococcus furiosus;1.54;CA;CALCIUM ION;Uncharacterized protein;2261;
3WL4;B;N,N'-diacetylchitobiose deacetylase (Se-derivative) from Pyrococcus furiosus;1.54;CA;CALCIUM ION;Uncharacterized protein;2261;
3WLC;A;Crystal structure of dimeric GCaMP6m;2.49;CA;CALCIUM ION;Myosin light chain kinase, Green fluorescent protein, Calmodulin;6,100,903,110,116;
3WLD;A;Crystal structure of monomeric GCaMP6m;2.7;CA;CALCIUM ION;Myosin light chain kinase, Green fluorescent protein, Calmodulin;6,100,903,110,116;
3WMM;1;Crystal structure of the LH1-RC complex from Thermochromatium tepidum in C2 form;3.01;CA;CALCIUM ION;LH1 alpha polypeptide;1050;
3WMM;3;Crystal structure of the LH1-RC complex from Thermochromatium tepidum in C2 form;3.01;CA;CALCIUM ION;LH1 alpha polypeptide;1050;
3WMM;5;Crystal structure of the LH1-RC complex from Thermochromatium tepidum in C2 form;3.01;CA;CALCIUM ION;LH1 alpha polypeptide;1050;
3WMM;7;Crystal structure of the LH1-RC complex from Thermochromatium tepidum in C2 form;3.01;CA;CALCIUM ION;LH1 alpha polypeptide;1050;
3WMM;9;Crystal structure of the LH1-RC complex from Thermochromatium tepidum in C2 form;3.01;CA;CALCIUM ION;LH1 alpha polypeptide;1050;
3WMM;A;Crystal structure of the LH1-RC complex from Thermochromatium tepidum in C2 form;3.01;CA;CALCIUM ION;LH1 alpha polypeptide;1050;
3WMM;C;Crystal structure of the LH1-RC complex from Thermochromatium tepidum in C2 form;3.01;CA;CALCIUM ION;Photosynthetic reaction center C subunit;1050;
3WMM;D;Crystal structure of the LH1-RC complex from Thermochromatium tepidum in C2 form;3.01;CA;CALCIUM ION;LH1 alpha polypeptide;1050;
3WMM;F;Crystal structure of the LH1-RC complex from Thermochromatium tepidum in C2 form;3.01;CA;CALCIUM ION;LH1 alpha polypeptide;1050;
3WMM;I;Crystal structure of the LH1-RC complex from Thermochromatium tepidum in C2 form;3.01;CA;CALCIUM ION;LH1 alpha polypeptide;1050;
3WMM;K;Crystal structure of the LH1-RC complex from Thermochromatium tepidum in C2 form;3.01;CA;CALCIUM ION;LH1 alpha polypeptide;1050;
3WMM;O;Crystal structure of the LH1-RC complex from Thermochromatium tepidum in C2 form;3.01;CA;CALCIUM ION;LH1 alpha polypeptide;1050;
3WMM;Q;Crystal structure of the LH1-RC complex from Thermochromatium tepidum in C2 form;3.01;CA;CALCIUM ION;LH1 alpha polypeptide;1050;
3WMM;S;Crystal structure of the LH1-RC complex from Thermochromatium tepidum in C2 form;3.01;CA;CALCIUM ION;LH1 alpha polypeptide;1050;
3WMM;U;Crystal structure of the LH1-RC complex from Thermochromatium tepidum in C2 form;3.01;CA;CALCIUM ION;LH1 alpha polypeptide;1050;
3WMM;W;Crystal structure of the LH1-RC complex from Thermochromatium tepidum in C2 form;3.01;CA;CALCIUM ION;LH1 alpha polypeptide;1050;
3WMM;Y;Crystal structure of the LH1-RC complex from Thermochromatium tepidum in C2 form;3.01;CA;CALCIUM ION;LH1 alpha polypeptide;1050;
3WMS;A;The crystal structure of Y195I mutant alpha-cyclodextrin glycosyltransferase from Paenibacillus macerans;2.3;CA;CALCIUM ION;Alpha-cyclodextrin glucanotransferase;44252;
3WMT;A;Crystal structure of feruloyl esterase B from Aspergillus oryzae;1.5;CA;CALCIUM ION;Probable feruloyl esterase B-1;5062;
3WMT;B;Crystal structure of feruloyl esterase B from Aspergillus oryzae;1.5;CA;CALCIUM ION;Probable feruloyl esterase B-1;5062;
3WMW;A;GalE-like L-Threonine dehydrogenase from Cupriavidus necator (apo form);2.25;CA;CALCIUM ION;NAD dependent epimerase/dehydratase;106590;
3WMW;B;GalE-like L-Threonine dehydrogenase from Cupriavidus necator (apo form);2.25;CA;CALCIUM ION;NAD dependent epimerase/dehydratase;106590;
3WMY;A;Crystal Structure of Streptomyces coelicolor alpha-L-arabinofuranosidase;1.4;CA;CALCIUM ION;Extracellular exo-alpha-L-arabinofuranosidase;1902;
3WMZ;A;Crystal Structure of Streptomyces coelicolor alpha-L-arabinofuranosidase ethylmercury derivative;1.9;CA;CALCIUM ION;Extracellular exo-alpha-L-arabinofuranosidase;1902;
3WN0;A;Crystal Structure of Streptomyces coelicolor alpha-L-arabinofuranosidase in complex with L-arabinose;1.9;CA;CALCIUM ION;Extracellular exo-alpha-L-arabinofuranosidase;1902;
3WN1;A;Crystal Structure of Streptomyces coelicolor alpha-L-arabinofuranosidase in complex with xylotriose;2;CA;CALCIUM ION;Extracellular exo-alpha-L-arabinofuranosidase;1902;
3WN2;A;Crystal Structure of Streptomyces coelicolor alpha-L-arabinofuranosidase in complex with xylohexaose;2.1;CA;CALCIUM ION;Extracellular exo-alpha-L-arabinofuranosidase;1902;
3WN6;A;Crystal structure of alpha-amylase AmyI-1 from Oryza sativa;2.16;CA;CALCIUM ION;Alpha-amylase;4530;
3WN6;B;Crystal structure of alpha-amylase AmyI-1 from Oryza sativa;2.16;CA;CALCIUM ION;Alpha-amylase;4530;
3WN6;C;Crystal structure of alpha-amylase AmyI-1 from Oryza sativa;2.16;CA;CALCIUM ION;Alpha-amylase;4530;
3WN6;D;Crystal structure of alpha-amylase AmyI-1 from Oryza sativa;2.16;CA;CALCIUM ION;Alpha-amylase;4530;
3WNK;A;Crystal Structure of Bacillus circulans T-3040 cycloisomaltooligosaccharide glucanotransferase;2.3;CA;CALCIUM ION;Cycloisomaltooligosaccharide glucanotransferase;1397;
3WNL;A;D308A mutant of Bacillus circulans T-3040 cycloisomaltooligosaccharide glucanotransferase complexed with isomaltohexaose;2.6;CA;CALCIUM ION;Cycloisomaltooligosaccharide glucanotransferase;1397;
3WNM;A;D308A mutant of Bacillus circulans T-3040 cycloisomaltooligosaccharide glucanotransferase complexed with isomaltoheptaose;2.25;CA;CALCIUM ION;Cycloisomaltooligosaccharide glucanotransferase;1397;
3WNN;A;D308A mutant of Bacillus circulans T-3040 cycloisomaltooligosaccharide glucanotransferase complexed with isomaltooctaose;2.25;CA;CALCIUM ION;Cycloisomaltooligosaccharide glucanotransferase;1397;
3WNN;B;D308A mutant of Bacillus circulans T-3040 cycloisomaltooligosaccharide glucanotransferase complexed with isomaltooctaose;2.25;CA;CALCIUM ION;Cycloisomaltooligosaccharide glucanotransferase;1397;
3WNO;A;D308A mutant of Bacillus circulans T-3040 cycloisomaltooligosaccharide glucanotransferase complexed with cycloisomaltooctaose;1.9;CA;CALCIUM ION;Cycloisomaltooligosaccharide glucanotransferase;1397;
3WNO;B;D308A mutant of Bacillus circulans T-3040 cycloisomaltooligosaccharide glucanotransferase complexed with cycloisomaltooctaose;1.9;CA;CALCIUM ION;Cycloisomaltooligosaccharide glucanotransferase;1397;
3WNP;A;D308A, F268V, D469Y, A513V, and Y515S quintuple mutant of Bacillus circulans T-3040 cycloisomaltooligosaccharide glucanotransferase complexed with isomaltoundecaose;2.8;CA;CALCIUM ION;Cycloisomaltooligosaccharide glucanotransferase;1397;
3WNP;B;D308A, F268V, D469Y, A513V, and Y515S quintuple mutant of Bacillus circulans T-3040 cycloisomaltooligosaccharide glucanotransferase complexed with isomaltoundecaose;2.8;CA;CALCIUM ION;Cycloisomaltooligosaccharide glucanotransferase;1397;
3WNX;A;Crystal structure of ERGIC-53/MCFD2, Calcium/Man3-bound form;2.75;CA;CALCIUM ION;Protein ERGIC-53;9606;
3WNX;B;Crystal structure of ERGIC-53/MCFD2, Calcium/Man3-bound form;2.75;CA;CALCIUM ION;Multiple coagulation factor deficiency protein 2;9606;
3WOG;A;Crystal structure plant lectin in complex with ligand;2;CA;CALCIUM ION;Erythroagglutinin;3885;
3WOG;B;Crystal structure plant lectin in complex with ligand;2;CA;CALCIUM ION;Erythroagglutinin;3885;
3WOV;A;Crystal structure of the C-terminal globular domain of oligosaccharyltransferase (PaAglB-L, Q9V250_PYRAB, PAB2202) from Pyrococcus abyssi;3.11;CA;CALCIUM ION;Oligosaccharyl transferase;29292;
3WQ0;A;Structure of hyperthermophilic family 12 endocellulase from Pyrococcus furiosus in complex with gluco-oligosaccharide;1.22;CA;CALCIUM ION;Endoglucanase A;2261;
3WQ1;A;Structure of hyperthermophilic family 12 endocellulase from Pyrococcus furiosus in complex with cello-oligosaccharide;1.3;CA;CALCIUM ION;Endoglucanase A;2261;
3WQ7;A;New crystal form of the hyperthermophilic family 12 endo-cellulase from Pyrococcus furiosus;1.68;CA;CALCIUM ION;Endoglucanase A;2261;
3WQ7;B;New crystal form of the hyperthermophilic family 12 endo-cellulase from Pyrococcus furiosus;1.68;CA;CALCIUM ION;Endoglucanase A;2261;
3WQB;A;Crystal structure of aeromonas sobria serine protease (ASP) and the chaperone (ORF2) complex;1.41;CA;CALCIUM ION;Extracellular serine protease;646;
3WQQ;B;Crystal structure of PfDXR complexed with inhibitor-3;2.25;CA;CALCIUM ION;1-deoxy-D-xylulose 5-phosphate reductoisomerase, apicoplast;5833;
3WQR;B;Crystal structure of pfdxr complexed with inhibitor-12;1.97;CA;CALCIUM ION;1-deoxy-D-xylulose 5-phosphate reductoisomerase, apicoplast;5833;
3WR0;A;Structure of hyperthermophilic family 12 endocellulase mutant from Pyrococcus furiosus;1.16;CA;CALCIUM ION;Endoglucanase A;2261;
3WRZ;A;N288Q-N321Q mutant BETA-LACTAMASE DERIVED FROM CHROMOHALOBACTER SP.560 (without soaking);1.8;CA;CALCIUM ION;Beta-lactamase;169132;
3WRZ;B;N288Q-N321Q mutant BETA-LACTAMASE DERIVED FROM CHROMOHALOBACTER SP.560 (without soaking);1.8;CA;CALCIUM ION;Beta-lactamase;169132;
3WRZ;C;N288Q-N321Q mutant BETA-LACTAMASE DERIVED FROM CHROMOHALOBACTER SP.560 (without soaking);1.8;CA;CALCIUM ION;Beta-lactamase;169132;
3WS0;A;N288Q-N321Q mutant BETA-LACTAMASE DERIVED FROM CHROMOHALOBACTER SP.560 (Condition-1A);2;CA;CALCIUM ION;Beta-lactamase;169132;
3WS0;B;N288Q-N321Q mutant BETA-LACTAMASE DERIVED FROM CHROMOHALOBACTER SP.560 (Condition-1A);2;CA;CALCIUM ION;Beta-lactamase;169132;
3WS0;C;N288Q-N321Q mutant BETA-LACTAMASE DERIVED FROM CHROMOHALOBACTER SP.560 (Condition-1A);2;CA;CALCIUM ION;Beta-lactamase;169132;
3WS1;A;N288Q-N321Q mutant BETA-LACTAMASE DERIVED FROM CHROMOHALOBACTER SP.560 (Condition-1B);1.8;CA;CALCIUM ION;Beta-lactamase;169132;
3WS1;B;N288Q-N321Q mutant BETA-LACTAMASE DERIVED FROM CHROMOHALOBACTER SP.560 (Condition-1B);1.8;CA;CALCIUM ION;Beta-lactamase;169132;
3WS1;C;N288Q-N321Q mutant BETA-LACTAMASE DERIVED FROM CHROMOHALOBACTER SP.560 (Condition-1B);1.8;CA;CALCIUM ION;Beta-lactamase;169132;
3WS2;A;N288Q-N321Q mutant BETA-LACTAMASE DERIVED FROM CHROMOHALOBACTER SP.560 (Condition-1C);2.1;CA;CALCIUM ION;Beta-lactamase;169132;
3WS2;B;N288Q-N321Q mutant BETA-LACTAMASE DERIVED FROM CHROMOHALOBACTER SP.560 (Condition-1C);2.1;CA;CALCIUM ION;Beta-lactamase;169132;
3WS2;C;N288Q-N321Q mutant BETA-LACTAMASE DERIVED FROM CHROMOHALOBACTER SP.560 (Condition-1C);2.1;CA;CALCIUM ION;Beta-lactamase;169132;
3WS5;B;N288Q-N321Q mutant BETA-LACTAMASE DERIVED FROM CHROMOHALOBACTER SP.560 (Condition-2B);2.8;CA;CALCIUM ION;Beta-lactamase;169132;
3WT3;A;New crystal form of a hyperthermophilic endocellulase;1.68;CA;CALCIUM ION;Endoglucanase A;2261;
3WT3;B;New crystal form of a hyperthermophilic endocellulase;1.68;CA;CALCIUM ION;Endoglucanase A;2261;
3WU2;B;Crystal structure analysis of Photosystem II complex;1.9;CA;CALCIUM ION;Photosystem II CP47 chlorophyll apoprotein;32053;
3WU2;F;Crystal structure analysis of Photosystem II complex;1.9;CA;CALCIUM ION;Cytochrome b559 subunit beta;32053;
3WU2;O;Crystal structure analysis of Photosystem II complex;1.9;CA;CALCIUM ION;Photosystem II manganese-stabilizing polypeptide;32053;
3WU2;b;Crystal structure analysis of Photosystem II complex;1.9;CA;CALCIUM ION;Photosystem II CP47 chlorophyll apoprotein;32053;
3WU2;c;Crystal structure analysis of Photosystem II complex;1.9;CA;CALCIUM ION;Photosystem II 44 kDa reaction center protein;32053;
3WU2;f;Crystal structure analysis of Photosystem II complex;1.9;CA;CALCIUM ION;Cytochrome b559 subunit beta;32053;
3WU2;o;Crystal structure analysis of Photosystem II complex;1.9;CA;CALCIUM ION;Photosystem II manganese-stabilizing polypeptide;32053;
3WV1;A;Crystal structure of the catalytic domain of MMP-13 complexed with 4-(2-((6-fluoro-2-((3-methoxybenzyl)carbamoyl)-4-oxo-3,4-dihydroquinazolin-5-yl)oxy)ethyl)benzoic acid;1.98;CA;CALCIUM ION;Collagenase 3;9606;
3WV1;B;Crystal structure of the catalytic domain of MMP-13 complexed with 4-(2-((6-fluoro-2-((3-methoxybenzyl)carbamoyl)-4-oxo-3,4-dihydroquinazolin-5-yl)oxy)ethyl)benzoic acid;1.98;CA;CALCIUM ION;Collagenase 3;9606;
3WV2;A;Crystal structure of the catalytic domain of MMP-13 complexed with N-(3-methoxybenzyl)-4-oxo-3,4-dihydroquinazoline-2-carboxamide;2.3;CA;CALCIUM ION;Collagenase 3;9606;
3WV2;B;Crystal structure of the catalytic domain of MMP-13 complexed with N-(3-methoxybenzyl)-4-oxo-3,4-dihydroquinazoline-2-carboxamide;2.3;CA;CALCIUM ION;Collagenase 3;9606;
3WV3;A;Crystal structure of the catalytic domain of MMP-13 complexed with N-(3-methoxybenzyl)-4-oxo-3,4-dihydrothieno[2,3-d]pyrimidine-2-carboxamide;1.6;CA;CALCIUM ION;Collagenase 3;9606;
3WV3;B;Crystal structure of the catalytic domain of MMP-13 complexed with N-(3-methoxybenzyl)-4-oxo-3,4-dihydrothieno[2,3-d]pyrimidine-2-carboxamide;1.6;CA;CALCIUM ION;Collagenase 3;9606;
3WWO;A;S-selective hydroxynitrile lyase from Baliospermum montanum (apo1);2.55;CA;CALCIUM ION;(S)-hydroxynitrile lyase;316758;
3WWO;B;S-selective hydroxynitrile lyase from Baliospermum montanum (apo1);2.55;CA;CALCIUM ION;(S)-hydroxynitrile lyase;316758;
3WWT;A;Crystal Structure of the Y3:STAT1ND complex;2;CA;CALCIUM ION;Signal transducer and activator of transcription 1-alpha/beta;9606;
3WWT;B;Crystal Structure of the Y3:STAT1ND complex;2;CA;CALCIUM ION;Protein C';11191;
3WX7;A;Crystal structure of COD;1.35;CA;CALCIUM ION;Chitin oligosaccharide deacetylase;670;
3WX7;B;Crystal structure of COD;1.35;CA;CALCIUM ION;Chitin oligosaccharide deacetylase;670;
3WXP;A;Structure of hyperthermophilic family 12 endocellulase (E197A) from Pyrococcus furiosus in complex with cellobiose;1.42;CA;CALCIUM ION;Endoglucanase A;2261;
3WY6;A;Structure of hyperthermophilic family 12 endocellulase (E197A) from Pyrococcus furiosus in complex with laminaribiose;1.45;CA;CALCIUM ION;Endoglucanase A;2261;
3WYN;A;Structure of calcium bound cutinase Est119 from Thermobifida alba.;1.68;CA;CALCIUM ION;Esterase;53522;
3WYN;B;Structure of calcium bound cutinase Est119 from Thermobifida alba.;1.68;CA;CALCIUM ION;Esterase;53522;
3X17;A;Crystal structure of metagenome-derived glycoside hydrolase family 9 endoglucanase;2.15;CA;CALCIUM ION;Endoglucanase;77133;
3X17;B;Crystal structure of metagenome-derived glycoside hydrolase family 9 endoglucanase;2.15;CA;CALCIUM ION;Endoglucanase;77133;
3X32;A;Crystal structure of the oxidized form of the solubilized domain of porcine cytochrome b5 in form 1 crystal;0.83;CA;CALCIUM ION;Cytochrome b5;9823;
3X34;A;Crystal structure of the reduced form of the solubilized domain of porcine cytochrome b5 in form 1 crystal;0.76;CA;CALCIUM ION;Cytochrome b5;9823;
3X3M;A;Crystal structure of EccB1 of Mycobacterium tuberculosis in spacegroup P212121;1.9;CA;CALCIUM ION;ESX-1 secretion system protein EccB1;1773;
3X3N;A;Crystal structure of EccB1 of Mycobacterium tuberculosis in spacegroup P21;2;CA;CALCIUM ION;ESX-1 secretion system protein EccB1;1773;
3ZDC;A;Structure of E. coli ExoIX in complex with the palindromic 5ov4 DNA oligonucleotide, potassium and calcium;1.53;CA;CALCIUM ION;PROTEIN XNI;562;
3ZDV;A;Crystal structure of the LecB lectin from Pseudomonas aeruginosa in complex with Methyl 6-(2,4,6-trimethylphenylsulfonylamido)-6-deoxy-alpha-D-mannopyranoside;1.41;CA;CALCIUM ION;FUCOSE-BINDING LECTIN PA-IIL;287;
3ZDV;B;Crystal structure of the LecB lectin from Pseudomonas aeruginosa in complex with Methyl 6-(2,4,6-trimethylphenylsulfonylamido)-6-deoxy-alpha-D-mannopyranoside;1.41;CA;CALCIUM ION;FUCOSE-BINDING LECTIN PA-IIL;287;
3ZDV;C;Crystal structure of the LecB lectin from Pseudomonas aeruginosa in complex with Methyl 6-(2,4,6-trimethylphenylsulfonylamido)-6-deoxy-alpha-D-mannopyranoside;1.41;CA;CALCIUM ION;FUCOSE-BINDING LECTIN PA-IIL;287;
3ZDV;D;Crystal structure of the LecB lectin from Pseudomonas aeruginosa in complex with Methyl 6-(2,4,6-trimethylphenylsulfonylamido)-6-deoxy-alpha-D-mannopyranoside;1.41;CA;CALCIUM ION;FUCOSE-BINDING LECTIN PA-IIL;287;
3ZDX;A;Integrin alphaIIB beta3 headpiece and RGD peptide complex;2.45;CA;CALCIUM ION;INTEGRIN ALPHA-IIB;9606;
3ZDX;C;Integrin alphaIIB beta3 headpiece and RGD peptide complex;2.45;CA;CALCIUM ION;INTEGRIN ALPHA-IIB;9606;
3ZDY;A;Integrin alphaIIB beta3 headpiece and RGD peptide complex;2.45;CA;CALCIUM ION;INTEGRIN ALPHA-IIB;9606;
3ZDY;B;Integrin alphaIIB beta3 headpiece and RGD peptide complex;2.45;CA;CALCIUM ION;INTEGRIN BETA-3;9606;
3ZDY;C;Integrin alphaIIB beta3 headpiece and RGD peptide complex;2.45;CA;CALCIUM ION;INTEGRIN ALPHA-IIB;9606;
3ZDY;D;Integrin alphaIIB beta3 headpiece and RGD peptide complex;2.45;CA;CALCIUM ION;INTEGRIN BETA-3;9606;
3ZDZ;A;Integrin alphaIIB beta3 headpiece and RGD peptide complex;2.75;CA;CALCIUM ION;INTEGRIN ALPHA-IIB;9606;
3ZDZ;C;Integrin alphaIIB beta3 headpiece and RGD peptide complex;2.75;CA;CALCIUM ION;INTEGRIN ALPHA-IIB;9606;
3ZE0;A;Integrin alphaIIB beta3 headpiece and RGD peptide complex;2.95;CA;CALCIUM ION;INTEGRIN ALPHA-IIB;9606;
3ZE0;C;Integrin alphaIIB beta3 headpiece and RGD peptide complex;2.95;CA;CALCIUM ION;INTEGRIN ALPHA-IIB;9606;
3ZE1;A;Integrin alphaIIB beta3 headpiece and RGD peptide complex;3;CA;CALCIUM ION;INTEGRIN ALPHA-IIB;9606;
3ZE1;C;Integrin alphaIIB beta3 headpiece and RGD peptide complex;3;CA;CALCIUM ION;INTEGRIN ALPHA-IIB;9606;
3ZE2;A;Integrin alphaIIB beta3 headpiece and RGD peptide complex;2.35;CA;CALCIUM ION;INTEGRIN ALPHA-IIB;9606;
3ZE2;C;Integrin alphaIIB beta3 headpiece and RGD peptide complex;2.35;CA;CALCIUM ION;INTEGRIN ALPHA-IIB;9606;
3ZHG;A;Crystallographic structure of the native mouse SIGN-R1 CRD domain;1.87;CA;CALCIUM ION;CD209 ANTIGEN-LIKE PROTEIN B;10090;
3ZHG;B;Crystallographic structure of the native mouse SIGN-R1 CRD domain;1.87;CA;CALCIUM ION;CD209 ANTIGEN-LIKE PROTEIN B;10090;
3ZHG;C;Crystallographic structure of the native mouse SIGN-R1 CRD domain;1.87;CA;CALCIUM ION;CD209 ANTIGEN-LIKE PROTEIN B;10090;
3ZHG;D;Crystallographic structure of the native mouse SIGN-R1 CRD domain;1.87;CA;CALCIUM ION;CD209 ANTIGEN-LIKE PROTEIN B;10090;
3ZHQ;A;Crystal structure of the H747A mutant of the SucA domain of Mycobacterium smegmatis KGD;2.5;CA;CALCIUM ION;MULTIFUNCTIONAL 2-OXOGLUTARATE METABOLISM ENZYME;1772;
3ZHQ;B;Crystal structure of the H747A mutant of the SucA domain of Mycobacterium smegmatis KGD;2.5;CA;CALCIUM ION;MULTIFUNCTIONAL 2-OXOGLUTARATE METABOLISM ENZYME;1772;
3ZHQ;C;Crystal structure of the H747A mutant of the SucA domain of Mycobacterium smegmatis KGD;2.5;CA;CALCIUM ION;MULTIFUNCTIONAL 2-OXOGLUTARATE METABOLISM ENZYME;1772;
3ZHQ;D;Crystal structure of the H747A mutant of the SucA domain of Mycobacterium smegmatis KGD;2.5;CA;CALCIUM ION;MULTIFUNCTIONAL 2-OXOGLUTARATE METABOLISM ENZYME;1772;
3ZHR;A;Crystal structure of the H747A mutant of the SucA domain of Mycobacterium smegmatis KGD showing the active site lid closed;2.1;CA;CALCIUM ION;MULTIFUNCTIONAL 2-OXOGLUTARATE METABOLISM ENZYME;1772;
3ZHR;B;Crystal structure of the H747A mutant of the SucA domain of Mycobacterium smegmatis KGD showing the active site lid closed;2.1;CA;CALCIUM ION;MULTIFUNCTIONAL 2-OXOGLUTARATE METABOLISM ENZYME;1772;
3ZHR;C;Crystal structure of the H747A mutant of the SucA domain of Mycobacterium smegmatis KGD showing the active site lid closed;2.1;CA;CALCIUM ION;MULTIFUNCTIONAL 2-OXOGLUTARATE METABOLISM ENZYME;1772;
3ZHR;D;Crystal structure of the H747A mutant of the SucA domain of Mycobacterium smegmatis KGD showing the active site lid closed;2.1;CA;CALCIUM ION;MULTIFUNCTIONAL 2-OXOGLUTARATE METABOLISM ENZYME;1772;
3ZHS;A;Crystal structure of the SucA domain of Mycobacterium smegmatis KGD, first post-decarboxylation intermediate from alpha-ketoglutarate;2.1;CA;CALCIUM ION;MULTIFUNCTIONAL 2-OXOGLUTARATE METABOLISM ENZYME;1772;
3ZHS;B;Crystal structure of the SucA domain of Mycobacterium smegmatis KGD, first post-decarboxylation intermediate from alpha-ketoglutarate;2.1;CA;CALCIUM ION;MULTIFUNCTIONAL 2-OXOGLUTARATE METABOLISM ENZYME;1772;
3ZHS;C;Crystal structure of the SucA domain of Mycobacterium smegmatis KGD, first post-decarboxylation intermediate from alpha-ketoglutarate;2.1;CA;CALCIUM ION;MULTIFUNCTIONAL 2-OXOGLUTARATE METABOLISM ENZYME;1772;
3ZHS;D;Crystal structure of the SucA domain of Mycobacterium smegmatis KGD, first post-decarboxylation intermediate from alpha-ketoglutarate;2.1;CA;CALCIUM ION;MULTIFUNCTIONAL 2-OXOGLUTARATE METABOLISM ENZYME;1772;
3ZHT;A;Crystal structure of the SucA domain of Mycobacterium smegmatis KGD, first post-decarboxylation intermediate from 2-oxoadipate;2.15;CA;CALCIUM ION;MULTIFUNCTIONAL 2-OXOGLUTARATE METABOLISM ENZYME;1772;
3ZHT;B;Crystal structure of the SucA domain of Mycobacterium smegmatis KGD, first post-decarboxylation intermediate from 2-oxoadipate;2.15;CA;CALCIUM ION;MULTIFUNCTIONAL 2-OXOGLUTARATE METABOLISM ENZYME;1772;
3ZHT;C;Crystal structure of the SucA domain of Mycobacterium smegmatis KGD, first post-decarboxylation intermediate from 2-oxoadipate;2.15;CA;CALCIUM ION;MULTIFUNCTIONAL 2-OXOGLUTARATE METABOLISM ENZYME;1772;
3ZHT;D;Crystal structure of the SucA domain of Mycobacterium smegmatis KGD, first post-decarboxylation intermediate from 2-oxoadipate;2.15;CA;CALCIUM ION;MULTIFUNCTIONAL 2-OXOGLUTARATE METABOLISM ENZYME;1772;
3ZHU;A;Crystal structure of the SucA domain of Mycobacterium smegmatis KGD, second post-decarboxylation intermediate from 2-oxoadipate;2.3;CA;CALCIUM ION;MULTIFUNCTIONAL 2-OXOGLUTARATE METABOLISM ENZYME;1772;
3ZHU;B;Crystal structure of the SucA domain of Mycobacterium smegmatis KGD, second post-decarboxylation intermediate from 2-oxoadipate;2.3;CA;CALCIUM ION;MULTIFUNCTIONAL 2-OXOGLUTARATE METABOLISM ENZYME;1772;
3ZHU;C;Crystal structure of the SucA domain of Mycobacterium smegmatis KGD, second post-decarboxylation intermediate from 2-oxoadipate;2.3;CA;CALCIUM ION;MULTIFUNCTIONAL 2-OXOGLUTARATE METABOLISM ENZYME;1772;
3ZHU;D;Crystal structure of the SucA domain of Mycobacterium smegmatis KGD, second post-decarboxylation intermediate from 2-oxoadipate;2.3;CA;CALCIUM ION;MULTIFUNCTIONAL 2-OXOGLUTARATE METABOLISM ENZYME;1772;
3ZHV;A;Crystal structure of the SucA domain of Mycobacterium smegmatis KGD, post-decarboxylation intermediate from pyruvate (2-hydroxyethyl-ThDP);2.3;CA;CALCIUM ION;MULTIFUNCTIONAL 2-OXOGLUTARATE METABOLISM ENZYME;1772;
3ZHV;B;Crystal structure of the SucA domain of Mycobacterium smegmatis KGD, post-decarboxylation intermediate from pyruvate (2-hydroxyethyl-ThDP);2.3;CA;CALCIUM ION;MULTIFUNCTIONAL 2-OXOGLUTARATE METABOLISM ENZYME;1772;
3ZHV;C;Crystal structure of the SucA domain of Mycobacterium smegmatis KGD, post-decarboxylation intermediate from pyruvate (2-hydroxyethyl-ThDP);2.3;CA;CALCIUM ION;MULTIFUNCTIONAL 2-OXOGLUTARATE METABOLISM ENZYME;1772;
3ZHV;D;Crystal structure of the SucA domain of Mycobacterium smegmatis KGD, post-decarboxylation intermediate from pyruvate (2-hydroxyethyl-ThDP);2.3;CA;CALCIUM ION;MULTIFUNCTIONAL 2-OXOGLUTARATE METABOLISM ENZYME;1772;
3ZI6;A;Structure of thermolysin solved by SAD from data collected by Direct Data Collection (DDC) using the GRob robot goniometer;2;CA;CALCIUM ION;THERMOLYSIN;1427;
3ZM8;A;Crystal structure of Podospora anserina GH26-CBM35 beta-(1,4)- mannanase;2.85;CA;CALCIUM ION;GH26 ENDO-BETA-1,4-MANNANASE;5145;
3ZNI;A;Structure of phosphoTyr363-Cbl-b - UbcH5B-Ub - ZAP-70 peptide complex;2.21;CA;CALCIUM ION;E3 UBIQUITIN-PROTEIN LIGASE CBL-B;9606;
3ZNI;E;Structure of phosphoTyr363-Cbl-b - UbcH5B-Ub - ZAP-70 peptide complex;2.21;CA;CALCIUM ION;E3 UBIQUITIN-PROTEIN LIGASE CBL-B;9606;
3ZNI;I;Structure of phosphoTyr363-Cbl-b - UbcH5B-Ub - ZAP-70 peptide complex;2.21;CA;CALCIUM ION;E3 UBIQUITIN-PROTEIN LIGASE CBL-B;9606;
3ZNI;M;Structure of phosphoTyr363-Cbl-b - UbcH5B-Ub - ZAP-70 peptide complex;2.21;CA;CALCIUM ION;E3 UBIQUITIN-PROTEIN LIGASE CBL-B;9606;
3ZNV;A;Crystal structure of the OTU domain of OTULIN at 1.3 Angstroms.;1.3;CA;CALCIUM ION;PROTEIN FAM105B;9606;
3ZNX;A;Crystal structure of the OTU domain of OTULIN D336A mutant;1.35;CA;CALCIUM ION;PROTEIN FAM105B;9606;
3ZO9;A;The structure of Trehalose Synthase (TreS) of Mycobacterium smegmatis;1.84;CA;CALCIUM ION;TREHALOSE SYNTHASE/AMYLASE TRES;1772;
3ZO9;B;The structure of Trehalose Synthase (TreS) of Mycobacterium smegmatis;1.84;CA;CALCIUM ION;TREHALOSE SYNTHASE/AMYLASE TRES;1772;
3ZOA;A;The structure of Trehalose Synthase (TreS) of Mycobacterium smegmatis in complex with acarbose;1.85;CA;CALCIUM ION;TREHALOSE SYNTHASE/AMYLASE TRES;1772;
3ZOA;B;The structure of Trehalose Synthase (TreS) of Mycobacterium smegmatis in complex with acarbose;1.85;CA;CALCIUM ION;TREHALOSE SYNTHASE/AMYLASE TRES;1772;
3ZPP;A;Structure of the Streptococcus pneumoniae surface protein and adhesin PfbA;2.28;CA;CALCIUM ION;CELL WALL SURFACE ANCHOR FAMILY PROTEIN;1313;
3ZQ4;A;Unusual, dual endo- and exo-nuclease activity in the degradosome explained by crystal structure analysis of RNase J1;3;CA;CALCIUM ION;RIBONUCLEASE J 1;1423;
3ZQ4;C;Unusual, dual endo- and exo-nuclease activity in the degradosome explained by crystal structure analysis of RNase J1;3;CA;CALCIUM ION;RIBONUCLEASE J 1;1423;
3ZQ4;D;Unusual, dual endo- and exo-nuclease activity in the degradosome explained by crystal structure analysis of RNase J1;3;CA;CALCIUM ION;RIBONUCLEASE J 1;1423;
3ZQ4;E;Unusual, dual endo- and exo-nuclease activity in the degradosome explained by crystal structure analysis of RNase J1;3;CA;CALCIUM ION;RIBONUCLEASE J 1;1423;
3ZQ9;A;Structure of a Paenibacillus Polymyxa Xyloglucanase from Glycoside Hydrolase Family 44;1.86;CA;CALCIUM ION;XYLOGLUCANASE;1406;
3ZQK;A;Von Willebrand Factor A2 domain with calcium;1.7;CA;CALCIUM ION;VON WILLEBRAND FACTOR;9606;
3ZQK;B;Von Willebrand Factor A2 domain with calcium;1.7;CA;CALCIUM ION;VON WILLEBRAND FACTOR;9606;
3ZQK;C;Von Willebrand Factor A2 domain with calcium;1.7;CA;CALCIUM ION;VON WILLEBRAND FACTOR;9606;
3ZQW;A;Structure of CBM3b of major scaffoldin subunit ScaA from Acetivibrio cellulolyticus;1.07;CA;CALCIUM ION;CELLULOSOMAL SCAFFOLDIN;35830;
3ZQX;A;Carbohydrate-binding module CBM3b from the cellulosomal cellobiohydrolase 9A from Clostridium thermocellum;1.04;CA;CALCIUM ION;CELLULOSE 1,4-BETA-CELLOBIOSIDASE;1515;
3ZR5;A;STRUCTURE OF GALACTOCEREBROSIDASE FROM MOUSE;2.1;CA;CALCIUM ION;GALACTOCEREBROSIDASE;10090;
3ZR6;A;STRUCTURE OF GALACTOCEREBROSIDASE FROM MOUSE IN COMPLEX WITH GALACTOSE;2.44;CA;CALCIUM ION;GALACTOCEREBROSIDASE;10090;
3ZRR;A;Crystal structure and substrate specificity of a thermophilic archaeal serine : pyruvate aminotransferase from Sulfolobus solfataricus;1.99;CA;CALCIUM ION;SERINE-PYRUVATE AMINOTRANSFERASE (AGXT);2287;
3ZRR;B;Crystal structure and substrate specificity of a thermophilic archaeal serine : pyruvate aminotransferase from Sulfolobus solfataricus;1.99;CA;CALCIUM ION;SERINE-PYRUVATE AMINOTRANSFERASE (AGXT);2287;
3ZS0;C;Human Myeloperoxidase inactivated by TX2;2.3;CA;CALCIUM ION;MYELOPEROXIDASE HEAVY CHAIN;9606;
3ZS0;D;Human Myeloperoxidase inactivated by TX2;2.3;CA;CALCIUM ION;MYELOPEROXIDASE HEAVY CHAIN;9606;
3ZS1;C;Human Myeloperoxidase inactivated by TX5;2.6;CA;CALCIUM ION;MYELOPEROXIDASE HEAVY CHAIN;9606;
3ZS1;D;Human Myeloperoxidase inactivated by TX5;2.6;CA;CALCIUM ION;MYELOPEROXIDASE HEAVY CHAIN;9606;
3ZU8;A;STRUCTURE OF CBM3B OF MAJOR SCAFFOLDIN SUBUNIT SCAA FROM ACETIVIBRIO CELLULOLYTICUS DETERMINED ON THE NIKEL ABSORPTION EDGE;1.8;CA;CALCIUM ION;CELLULOSOMAL SCAFFOLDIN;35830;
3ZUC;A;Structure of CBM3b of major scaffoldin subunit ScaA from Acetivibrio cellulolyticus determined from the crystals grown in the presence of Nickel;1;CA;CALCIUM ION;CELLULOSOMAL SCAFFOLDIN;35830;
3ZUK;B;CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS ZINC METALLOPROTEASE ZMP1 IN COMPLEX WITH INHIBITOR;2.6;CA;CALCIUM ION;ENDOPEPTIDASE, PEPTIDASE FAMILY M13;1773;
3ZVX;A;STRUCTURE OF THE LECTIN FROM PLATYPODIUM ELEGANS IN COMPLEX WITH A TRIMANNOSIDE;2.1;CA;CALCIUM ION;LECTIN;115002;
3ZVX;B;STRUCTURE OF THE LECTIN FROM PLATYPODIUM ELEGANS IN COMPLEX WITH A TRIMANNOSIDE;2.1;CA;CALCIUM ION;LECTIN;115002;
3ZWH;A;Ca2+-bound S100A4 C3S, C81S, C86S and F45W mutant complexed with myosin IIA;1.94;CA;CALCIUM ION;PROTEIN S100-A4;9606;
3ZWH;B;Ca2+-bound S100A4 C3S, C81S, C86S and F45W mutant complexed with myosin IIA;1.94;CA;CALCIUM ION;PROTEIN S100-A4;9606;
3ZWU;A;Pseudomonas fluorescens PhoX in complex with vanadate, a transition state analogue;1.39;CA;CALCIUM ION;ALKALINE PHOSPHATASE PHOX;294;
3ZWU;B;Pseudomonas fluorescens PhoX in complex with vanadate, a transition state analogue;1.39;CA;CALCIUM ION;ALKALINE PHOSPHATASE PHOX;294;
3ZXH;A;MMP-13 complexed with 2-Napthylsulfonamide hydroxamic acid inhibitor;1.3;CA;CALCIUM ION;COLLAGENASE 3;9606;
3ZXH;B;MMP-13 complexed with 2-Napthylsulfonamide hydroxamic acid inhibitor;1.3;CA;CALCIUM ION;COLLAGENASE 3;9606;
3ZXU;A;Crystal structure of the Ctf19-Mcm21 kinetochore heterodimer from yeast;3.7;CA;CALCIUM ION;MCM21;28985;
3ZXU;C;Crystal structure of the Ctf19-Mcm21 kinetochore heterodimer from yeast;3.7;CA;CALCIUM ION;MCM21;28985;
3ZXU;D;Crystal structure of the Ctf19-Mcm21 kinetochore heterodimer from yeast;3.7;CA;CALCIUM ION;CTF19;28985;
3ZYB;A;CRYSTAL STRUCTURE OF PA-IL LECTIN COMPLEXED WITH GALAG0 AT 2.3 A RESOLUTION;2.29;CA;CALCIUM ION;PA-I galactophilic lectin;287;
3ZYB;B;CRYSTAL STRUCTURE OF PA-IL LECTIN COMPLEXED WITH GALAG0 AT 2.3 A RESOLUTION;2.29;CA;CALCIUM ION;PA-I galactophilic lectin;287;
3ZYB;C;CRYSTAL STRUCTURE OF PA-IL LECTIN COMPLEXED WITH GALAG0 AT 2.3 A RESOLUTION;2.29;CA;CALCIUM ION;PA-I galactophilic lectin;287;
3ZYB;D;CRYSTAL STRUCTURE OF PA-IL LECTIN COMPLEXED WITH GALAG0 AT 2.3 A RESOLUTION;2.29;CA;CALCIUM ION;PA-I galactophilic lectin;287;
3ZYB;E;CRYSTAL STRUCTURE OF PA-IL LECTIN COMPLEXED WITH GALAG0 AT 2.3 A RESOLUTION;2.29;CA;CALCIUM ION;PA-I galactophilic lectin;287;
3ZYB;F;CRYSTAL STRUCTURE OF PA-IL LECTIN COMPLEXED WITH GALAG0 AT 2.3 A RESOLUTION;2.29;CA;CALCIUM ION;PA-I galactophilic lectin;287;
3ZYB;G;CRYSTAL STRUCTURE OF PA-IL LECTIN COMPLEXED WITH GALAG0 AT 2.3 A RESOLUTION;2.29;CA;CALCIUM ION;PA-I galactophilic lectin;287;
3ZYB;H;CRYSTAL STRUCTURE OF PA-IL LECTIN COMPLEXED WITH GALAG0 AT 2.3 A RESOLUTION;2.29;CA;CALCIUM ION;PA-I galactophilic lectin;287;
3ZYF;A;CRYSTAL STRUCTURE OF PA-IL LECTIN COMPLEXED WITH NPG AT 1.9 A RESOLUTION;1.94;CA;CALCIUM ION;PA-I GALACTOPHILIC LECTIN;287;
3ZYF;B;CRYSTAL STRUCTURE OF PA-IL LECTIN COMPLEXED WITH NPG AT 1.9 A RESOLUTION;1.94;CA;CALCIUM ION;PA-I GALACTOPHILIC LECTIN;287;
3ZYF;C;CRYSTAL STRUCTURE OF PA-IL LECTIN COMPLEXED WITH NPG AT 1.9 A RESOLUTION;1.94;CA;CALCIUM ION;PA-I GALACTOPHILIC LECTIN;287;
3ZYF;D;CRYSTAL STRUCTURE OF PA-IL LECTIN COMPLEXED WITH NPG AT 1.9 A RESOLUTION;1.94;CA;CALCIUM ION;PA-I GALACTOPHILIC LECTIN;287;
3ZYG;A;NETRING2 LAM AND EGF1 DOMAINS;2.2;CA;CALCIUM ION;NETRIN-G2;9606;
3ZYG;B;NETRING2 LAM AND EGF1 DOMAINS;2.2;CA;CALCIUM ION;NETRIN-G2;9606;
3ZYH;A;CRYSTAL STRUCTURE OF PA-IL LECTIN COMPLEXED WITH GALBG0 AT 1.5 A RESOLUTION;1.5;CA;CALCIUM ION;PA-I galactophilic lectin;287;
3ZYH;B;CRYSTAL STRUCTURE OF PA-IL LECTIN COMPLEXED WITH GALBG0 AT 1.5 A RESOLUTION;1.5;CA;CALCIUM ION;PA-I galactophilic lectin;287;
3ZYI;B;NetrinG2 in complex with NGL2;2.6;CA;CALCIUM ION;NETRIN-G2;9606;
3ZYJ;B;NetrinG1 in complex with NGL1;3.25;CA;CALCIUM ION;NETRIN-G1;9606;
3ZYJ;D;NetrinG1 in complex with NGL1;3.25;CA;CALCIUM ION;NETRIN-G1;9606;
3ZYP;A;Cellulose induced protein, Cip1;1.5;CA;CALCIUM ION;CIP1;51453;
3ZYR;A;Structure of the lectin from Platypodium elegans in complex with heptasaccharide;1.65;CA;CALCIUM ION;LECTIN;115002;
3ZYR;B;Structure of the lectin from Platypodium elegans in complex with heptasaccharide;1.65;CA;CALCIUM ION;LECTIN;115002;
3ZZR;A;Crystal structure of the CG11501 protein in P21212 spacegroup;1.45;CA;CALCIUM ION;CG11501;7227;
426D;A;THE STRUCTURE OF MOST STUDIED DNA FRAGMENT CHANGES UNDER THE INFLUENCE OF IONS: A NEW PACKING OF D(CGCGAATTCGCG);3;CA;CALCIUM ION;5'-D(CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)-3';;
456C;A;CRYSTAL STRUCTURE OF COLLAGENASE-3 (MMP-13) COMPLEXED TO A DIPHENYL-ETHER SULPHONE BASED HYDROXAMIC ACID;2.4;CA;CALCIUM ION;MMP-13;9606;
456C;B;CRYSTAL STRUCTURE OF COLLAGENASE-3 (MMP-13) COMPLEXED TO A DIPHENYL-ETHER SULPHONE BASED HYDROXAMIC ACID;2.4;CA;CALCIUM ION;MMP-13;9606;
463D;A;CALCIUM FORM OF D(CGCGAATTCGCG)2;1.45;CA;CALCIUM ION;DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)-3');;
463D;B;CALCIUM FORM OF D(CGCGAATTCGCG)2;1.45;CA;CALCIUM ION;DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)-3');;
476D;A;CALCIUM FORM OF B-DNA UNDECAMER GCGAATTCGCG;1.3;CA;CALCIUM ION;5'-D(*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)-3';;
476D;B;CALCIUM FORM OF B-DNA UNDECAMER GCGAATTCGCG;1.3;CA;CALCIUM ION;5'-D(*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)-3';;
477D;A;CALCIUM FORM OF THE B-DNA DODECAMER GGCGAATTCGCG;1.7;CA;CALCIUM ION;5'-D(*GP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)-3';;
477D;B;CALCIUM FORM OF THE B-DNA DODECAMER GGCGAATTCGCG;1.7;CA;CALCIUM ION;5'-D(*GP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)-3';;
478D;A;CRYSTAL STRUCTURE OF THE B-DNA DODECAMER 5'-D(CGCGAA(TAF)TCGCG), WHERE TAF IS 2'-DEOXY-2'-FLUORO-ARABINO-FURANOSYL THYMINE;2.2;CA;CALCIUM ION;5'-D(*CP*GP*CP*GP*AP*AP*(TAF)P*TP*CP*GP*CP*G)-3';;
478D;B;CRYSTAL STRUCTURE OF THE B-DNA DODECAMER 5'-D(CGCGAA(TAF)TCGCG), WHERE TAF IS 2'-DEOXY-2'-FLUORO-ARABINO-FURANOSYL THYMINE;2.2;CA;CALCIUM ION;5'-D(*CP*GP*CP*GP*AP*AP*(TAF)P*TP*CP*GP*CP*G)-3';;
4A08;B;Structure of hsDDB1-drDDB2 bound to a 13 bp CPD-duplex (purine at D-1 position) at 3.0 A resolution (CPD 1);3;CA;CALCIUM ION;DNA DAMAGE-BINDING PROTEIN 2;7955;
4A08;H;Structure of hsDDB1-drDDB2 bound to a 13 bp CPD-duplex (purine at D-1 position) at 3.0 A resolution (CPD 1);3;CA;CALCIUM ION;5'-D(*TP*GP*GP*GP*CP*GP*CP*CP*CP*TP*CP*GP*CP*G)-3';32630;
4A09;B;Structure of hsDDB1-drDDB2 bound to a 15 bp CPD-duplex (purine at D-1 position) at 3.1 A resolution (CPD 2);3.1;CA;CALCIUM ION;DNA DAMAGE-BINDING PROTEIN 2;7955;
4A0A;C;Structure of hsDDB1-drDDB2 bound to a 16 bp CPD-duplex (pyrimidine at D-1 position) at 3.6 A resolution (CPD 3);3.6;CA;CALCIUM ION;5'-D(*GP*GP*TP*GP*AP*AP*AP*(TTD)P*AP*GP*CP*AP*GP*DGP)-3';32630;
4A0P;A;Crystal structure of LRP6P3E3P4E4;1.9;CA;CALCIUM ION;LOW-DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 6;9606;
4A15;A;Crystal structure of an XPD DNA complex;2.2;CA;CALCIUM ION;ATP-DEPENDENT DNA HELICASE TA0057;2303;
4A3X;A;Structure of the N-terminal domain of the Epa1 adhesin (Epa1-Np) from the pathogenic yeast Candida glabrata, in complex with calcium and lactose;1.65;CA;CALCIUM ION;EPA1P;5478;
4A3Z;A;CpGH89CBM32-4 (seleno-methionine labeled) produced by Clostridium perfringens;1.55;CA;CALCIUM ION;ALPHA-N-ACETYLGLUCOSAMINIDASE FAMILY PROTEIN;1502;
4A41;A;CpGH89CBM32-5, from Clostridium perfringens, in complex with galactose;1.55;CA;CALCIUM ION;ALPHA-N-ACETYLGLUCOSAMINIDASE FAMILY PROTEIN;1502;
4A42;A;CpGH89CBM32-6 produced by Clostridium perfringens;1.55;CA;CALCIUM ION;ALPHA-N-ACETYLGLUCOSAMINIDASE FAMILY PROTEIN;1502;
4A42;B;CpGH89CBM32-6 produced by Clostridium perfringens;1.55;CA;CALCIUM ION;ALPHA-N-ACETYLGLUCOSAMINIDASE FAMILY PROTEIN;1502;
4A44;A;CpGH89CBM32-5, from Clostridium perfringens, in complex with the Tn Antigen;1.7;CA;CALCIUM ION;ALPHA-N-ACETYLGLUCOSAMINIDASE FAMILY PROTEIN;1502;
4A45;A;CpGH89CBM32-5, from Clostridium perfringens, in complex with GalNAc- beta-1,3-galactose;1.75;CA;CALCIUM ION;ALPHA-N-ACETYLGLUCOSAMINIDASE FAMILY PROTEIN;1502;
4A4A;A;CpGH89 (E483Q, E601Q), from Clostridium perfringens, in complex with its substrate GlcNAc-alpha-1,4-galactose;1.9;CA;CALCIUM ION;ALPHA-N-ACETYLGLUCOSAMINIDASE FAMILY PROTEIN;1502;
4A4B;A;Structure of modified phosphoTyr371-c-Cbl-UbcH5B-ZAP-70 complex;2.79;CA;CALCIUM ION;E3 UBIQUITIN-PROTEIN LIGASE CBL;9606;
4A4C;A;Structure of phosphoTyr371-c-Cbl-UbcH5B-ZAP-70 complex;2.7;CA;CALCIUM ION;E3 UBIQUITIN-PROTEIN LIGASE CBL;9606;
4A5G;A;Raphanus sativus anionic peroxidase.;2.05;CA;CALCIUM ION;ANIONIC PEROXIDASE;3726;
4A5G;B;Raphanus sativus anionic peroxidase.;2.05;CA;CALCIUM ION;ANIONIC PEROXIDASE;3726;
4A5W;B;Crystal structure of C5b6;3.5;CA;CALCIUM ION;COMPLEMENT COMPONENT C6;9606;
4A6O;A;CpGH89CBM32-4, produced by Clostridium perfringens, in complex with glcNAc-alpha-1,4-galactose;2.8;CA;CALCIUM ION;ALPHA-N-ACETYLGLUCOSAMINIDASE FAMILY PROTEIN;1502;
4A6O;B;CpGH89CBM32-4, produced by Clostridium perfringens, in complex with glcNAc-alpha-1,4-galactose;2.8;CA;CALCIUM ION;ALPHA-N-ACETYLGLUCOSAMINIDASE FAMILY PROTEIN;1502;
4A6S;A;Structure of the PAIL lectin from Pseudomonas aeruginosa in complex with 2-Naphtyl-1-thio-beta-D-galactopyranoside;2.15;CA;CALCIUM ION;PA-I GALACTOPHILIC LECTIN;287;
4A6S;B;Structure of the PAIL lectin from Pseudomonas aeruginosa in complex with 2-Naphtyl-1-thio-beta-D-galactopyranoside;2.15;CA;CALCIUM ION;PA-I GALACTOPHILIC LECTIN;287;
4A6S;C;Structure of the PAIL lectin from Pseudomonas aeruginosa in complex with 2-Naphtyl-1-thio-beta-D-galactopyranoside;2.15;CA;CALCIUM ION;PA-I GALACTOPHILIC LECTIN;287;
4A6S;D;Structure of the PAIL lectin from Pseudomonas aeruginosa in complex with 2-Naphtyl-1-thio-beta-D-galactopyranoside;2.15;CA;CALCIUM ION;PA-I GALACTOPHILIC LECTIN;287;
4A7B;A;MMP13 IN COMPLEX WITH A NOVEL SELECTIVE NON ZINC BINDING INHIBITOR CMPD22;2.2;CA;CALCIUM ION;COLLAGENASE 3;9606;
4A7B;B;MMP13 IN COMPLEX WITH A NOVEL SELECTIVE NON ZINC BINDING INHIBITOR CMPD22;2.2;CA;CALCIUM ION;COLLAGENASE 3;9606;
4A7F;A;Structure of the Actin-Tropomyosin-Myosin Complex (rigor ATM 3);7.7;CA;CALCIUM ION;ACTIN, ALPHA SKELETAL MUSCLE;9986;
4A7F;D;Structure of the Actin-Tropomyosin-Myosin Complex (rigor ATM 3);7.7;CA;CALCIUM ION;ACTIN, ALPHA SKELETAL MUSCLE;9986;
4A7F;E;Structure of the Actin-Tropomyosin-Myosin Complex (rigor ATM 3);7.7;CA;CALCIUM ION;ACTIN, ALPHA SKELETAL MUSCLE;9986;
4A7F;F;Structure of the Actin-Tropomyosin-Myosin Complex (rigor ATM 3);7.7;CA;CALCIUM ION;ACTIN, ALPHA SKELETAL MUSCLE;9986;
4A7F;I;Structure of the Actin-Tropomyosin-Myosin Complex (rigor ATM 3);7.7;CA;CALCIUM ION;ACTIN, ALPHA SKELETAL MUSCLE;9986;
4A7H;A;Structure of the Actin-Tropomyosin-Myosin Complex (rigor ATM 2);7.8;CA;CALCIUM ION;ACTIN, ALPHA SKELETAL MUSCLE;9986;
4A7H;D;Structure of the Actin-Tropomyosin-Myosin Complex (rigor ATM 2);7.8;CA;CALCIUM ION;ACTIN, ALPHA SKELETAL MUSCLE;9986;
4A7H;E;Structure of the Actin-Tropomyosin-Myosin Complex (rigor ATM 2);7.8;CA;CALCIUM ION;ACTIN, ALPHA SKELETAL MUSCLE;9986;
4A7H;F;Structure of the Actin-Tropomyosin-Myosin Complex (rigor ATM 2);7.8;CA;CALCIUM ION;ACTIN, ALPHA SKELETAL MUSCLE;9986;
4A7H;G;Structure of the Actin-Tropomyosin-Myosin Complex (rigor ATM 2);7.8;CA;CALCIUM ION;ACTIN, ALPHA SKELETAL MUSCLE;9986;
4A7I;B;Factor Xa in complex with a potent 2-amino-ethane sulfonamide inhibitor;2.4;CA;CALCIUM ION;ACTIVATED FACTOR XA HEAVY CHAIN XA;9606;
4A7L;A;Structure of the Actin-Tropomyosin-Myosin Complex (rigor ATM 1);8.1;CA;CALCIUM ION;ACTIN, ALPHA SKELETON MUSCLE;9986;
4A7L;D;Structure of the Actin-Tropomyosin-Myosin Complex (rigor ATM 1);8.1;CA;CALCIUM ION;ACTIN, ALPHA SKELETON MUSCLE;9986;
4A7L;E;Structure of the Actin-Tropomyosin-Myosin Complex (rigor ATM 1);8.1;CA;CALCIUM ION;ACTIN, ALPHA SKELETON MUSCLE;9986;
4A7L;F;Structure of the Actin-Tropomyosin-Myosin Complex (rigor ATM 1);8.1;CA;CALCIUM ION;ACTIN, ALPHA SKELETON MUSCLE;9986;
4A7L;I;Structure of the Actin-Tropomyosin-Myosin Complex (rigor ATM 1);8.1;CA;CALCIUM ION;ACTIN, ALPHA SKELETON MUSCLE;9986;
4A7N;A;Structure of bare F-actin filaments obtained from the same sample as the Actin-Tropomyosin-Myosin Complex;8.9;CA;CALCIUM ION;F-ACTIN;9986;
4A7N;B;Structure of bare F-actin filaments obtained from the same sample as the Actin-Tropomyosin-Myosin Complex;8.9;CA;CALCIUM ION;F-ACTIN;9986;
4A7N;C;Structure of bare F-actin filaments obtained from the same sample as the Actin-Tropomyosin-Myosin Complex;8.9;CA;CALCIUM ION;F-ACTIN;9986;
4A7N;D;Structure of bare F-actin filaments obtained from the same sample as the Actin-Tropomyosin-Myosin Complex;8.9;CA;CALCIUM ION;F-ACTIN;9986;
4A7N;E;Structure of bare F-actin filaments obtained from the same sample as the Actin-Tropomyosin-Myosin Complex;8.9;CA;CALCIUM ION;F-ACTIN;9986;
4A9V;A;Pseudomonas fluorescens PhoX;1.1;CA;CALCIUM ION;PHOX;294;
4A9X;A;Pseudomonas fluorescens PhoX in complex with the substrate analogue AppCp;1.79;CA;CALCIUM ION;PHOX;294;
4AAG;A;Crystal structure of the mutant D75N I-CreI in complex with its wild- type target in presence of Ca at the active site (The four central bases, 2NN region, are composed by GTAC from 5' to 3');2.8;CA;CALCIUM ION;DNA ENDONUCLEASE I-CREI;3055;
4AAG;B;Crystal structure of the mutant D75N I-CreI in complex with its wild- type target in presence of Ca at the active site (The four central bases, 2NN region, are composed by GTAC from 5' to 3');2.8;CA;CALCIUM ION;DNA ENDONUCLEASE I-CREI;3055;
4AAH;A;METHANOL DEHYDROGENASE FROM METHYLOPHILUS W3A1;2.4;CA;CALCIUM ION;METHANOL DEHYDROGENASE;17;
4AAH;C;METHANOL DEHYDROGENASE FROM METHYLOPHILUS W3A1;2.4;CA;CALCIUM ION;METHANOL DEHYDROGENASE;17;
4AAL;A;MacA wild-type oxidized;1.84;CA;CALCIUM ION;CYTOCHROME C551 PEROXIDASE;35554;
4AAL;B;MacA wild-type oxidized;1.84;CA;CALCIUM ION;CYTOCHROME C551 PEROXIDASE;35554;
4AAM;A;MacA wild-type mixed-valence;2.17;CA;CALCIUM ION;CYTOCHROME C551 PEROXIDASE;35554;
4AAN;A;MacA wild-type fully reduced;1.22;CA;CALCIUM ION;CYTOCHROME C551 PEROXIDASE;35554;
4AAO;A;MacA-H93G;2.3;CA;CALCIUM ION;CYTOCHROME C551 PEROXIDASE;35554;
4AAO;B;MacA-H93G;2.3;CA;CALCIUM ION;CYTOCHROME C551 PEROXIDASE;35554;
4AAX;A;CpGH89CBM32-5, from Clostridium perfringens, in complex with N- acetylgalactosamine;1.9;CA;CALCIUM ION;ALPHA-N-ACETYLGLUCOSAMINIDASE;1502;
4AB8;A;Fragments bound to bovine trypsin for the SAMPL challenge;1.6;CA;CALCIUM ION;CATIONIC TRYPSIN;9913;
4AB9;A;Fragments bound to bovine trypsin for the SAMPL challenge;1.2;CA;CALCIUM ION;CATIONIC TRYPSIN;9913;
4ABA;A;Fragments bound to bovine trypsin for the SAMPL challenge;1.25;CA;CALCIUM ION;CATIONIC TRYPSIN;9913;
4ABB;A;Fragments bound to bovine trypsin for the SAMPL challenge;1.25;CA;CALCIUM ION;CATIONIC TRYPSIN;9913;
4ABD;A;Fragments bound to bovine trypsin for the SAMPL challenge;1.25;CA;CALCIUM ION;CATIONIC TRYPSIN;9913;
4ABE;A;Fragments bound to bovine trypsin for the SAMPL challenge;1.3;CA;CALCIUM ION;CATIONIC TRYPSIN;9913;
4ABF;A;Fragments bound to bovine trypsin for the SAMPL challenge;1.3;CA;CALCIUM ION;CATIONIC TRYPSIN;9913;
4ABG;A;Fragments bound to bovine trypsin for the SAMPL challenge;1.52;CA;CALCIUM ION;CATIONIC TRYPSIN;9913;
4ABH;A;Fragments bound to bovine trypsin for the SAMPL challenge;1.25;CA;CALCIUM ION;CATIONIC TRYPSIN;9913;
4ABI;A;Co-complex structure of bovine trypsin with a modified Bowman-Birk inhibitor (PtA)SFTI-1(1,14), that was 1,4-disubstituted with a 1,2,3- trizol to mimic a trans amide bond;1.55;CA;CALCIUM ION;CATIONIC TRYPSIN;9913;
4ABJ;A;Co-complex structure of bovine trypsin with a modified Bowman-Birk inhibitor (IcA)SFTI-1(1,14), that was 1,5-disubstituted with 1,2,3- trizol to mimic a cis amide bond;1.45;CA;CALCIUM ION;CATIONIC TRYPSIN;9913;
4ABT;A;Crystal structure of Type IIF restriction endonuclease NgoMIV with cognate uncleaved DNA;2.22;CA;CALCIUM ION;TYPE-2 RESTRICTION ENZYME NGOMIV;485;
4ABT;B;Crystal structure of Type IIF restriction endonuclease NgoMIV with cognate uncleaved DNA;2.22;CA;CALCIUM ION;TYPE-2 RESTRICTION ENZYME NGOMIV;485;
4ABT;E;Crystal structure of Type IIF restriction endonuclease NgoMIV with cognate uncleaved DNA;2.22;CA;CALCIUM ION;5'-D(*TP*GP*CP*GP*CP*CP*GP*GP*CP*GP*CP)-3';485;
4AC8;A;R2-like ligand binding Mn-Fe oxidase from M. tuberculosis with an organized C-terminal helix;2.75;CA;CALCIUM ION;R2-LIKE LIGAND BINDING OXIDASE;1773;
4AC8;B;R2-like ligand binding Mn-Fe oxidase from M. tuberculosis with an organized C-terminal helix;2.75;CA;CALCIUM ION;R2-LIKE LIGAND BINDING OXIDASE;1773;
4ADG;A;Crystal structure of the Rubella virus envelope Glycoprotein E1 in post-fusion form (crystal form II);2.18;CA;CALCIUM ION;E1 ENVELOPE GLYCOPROTEIN;11041;
4ADG;B;Crystal structure of the Rubella virus envelope Glycoprotein E1 in post-fusion form (crystal form II);2.18;CA;CALCIUM ION;E1 ENVELOPE GLYCOPROTEIN;11041;
4ADG;C;Crystal structure of the Rubella virus envelope Glycoprotein E1 in post-fusion form (crystal form II);2.18;CA;CALCIUM ION;E1 ENVELOPE GLYCOPROTEIN;11041;
4ADJ;A;Crystal structure of the Rubella virus glycoprotein E1 in its post-fusion form crystallized in presence of 1mM of calcium acetate;1.94;CA;CALCIUM ION;E1 ENVELOPE GLYCOPROTEIN;11041;
4ADJ;B;Crystal structure of the Rubella virus glycoprotein E1 in its post-fusion form crystallized in presence of 1mM of calcium acetate;1.94;CA;CALCIUM ION;E1 ENVELOPE GLYCOPROTEIN;11041;
4ADJ;C;Crystal structure of the Rubella virus glycoprotein E1 in its post-fusion form crystallized in presence of 1mM of calcium acetate;1.94;CA;CALCIUM ION;E1 ENVELOPE GLYCOPROTEIN;11041;
4AE2;A;Crystal structure of Human fibrillar procollagen type III C- propeptide trimer;1.68;CA;CALCIUM ION;COLLAGEN ALPHA-1(III) CHAIN;9606;
4AE2;B;Crystal structure of Human fibrillar procollagen type III C- propeptide trimer;1.68;CA;CALCIUM ION;COLLAGEN ALPHA-1(III) CHAIN;9606;
4AE2;C;Crystal structure of Human fibrillar procollagen type III C- propeptide trimer;1.68;CA;CALCIUM ION;COLLAGEN ALPHA-1(III) CHAIN;9606;
4AED;B;Crystal structure of Human enterovirus 71;3.8;CA;CALCIUM ION;VP2;138948;
4AED;C;Crystal structure of Human enterovirus 71;3.8;CA;CALCIUM ION;VP3;138948;
4AEJ;A;Crystal structure of Human fibrillar procollagen type III C- propeptide trimer;2.21;CA;CALCIUM ION;COLLAGEN ALPHA-1(III) CHAIN;9606;
4AEJ;B;Crystal structure of Human fibrillar procollagen type III C- propeptide trimer;2.21;CA;CALCIUM ION;COLLAGEN ALPHA-1(III) CHAIN;9606;
4AEJ;C;Crystal structure of Human fibrillar procollagen type III C- propeptide trimer;2.21;CA;CALCIUM ION;COLLAGEN ALPHA-1(III) CHAIN;9606;
4AF9;A;Crystal Structure of Epithelial Adhesin 1 A domain (Epa1A) from Candida glabrata in complex with Galb1-3Glc;1.5;CA;CALCIUM ION;EPA1P;5478;
4AFA;A;Crystal Structure of subtype-switched Epithelial Adhesin 1 to 2 A domain (Epa1to2A) from Candida glabrata in complex with glycerol;2.05;CA;CALCIUM ION;EPA1P;5478;
4AFB;A;Crystal Structure of subtype-switched Epithelial Adhesin 1 to 3 A domain (Epa1to3A) from Candida glabrata in complex with glycerol;1.9;CA;CALCIUM ION;EPA1P;5478;
4AFC;A;Crystal Structure of subtype-switched Epithelial Adhesin 1 to 6 A domain (Epa1to6A) from Candida glabrata in complex with Galb1-3Glc;1.55;CA;CALCIUM ION;EPA1P;5478;
4AFK;A;In meso structure of alginate transporter, AlgE, from Pseudomonas aeruginosa, PAO1;1.9;CA;CALCIUM ION;ALGINATE PRODUCTION PROTEIN ALGE;287;
4AFX;A;Crystal structure of the reactive loop cleaved ZPI in I2 space group;2.09;CA;CALCIUM ION;PROTEIN Z DEPENDENT PROTEASE INHIBITOR;9606;
4AG4;A;Crystal structure of a DDR1-Fab complex;2.8;CA;CALCIUM ION;EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1;9606;
4AIE;A;Structure of glucan-1,6-alpha-glucosidase from Lactobacillus acidophilus NCFM;2.05;CA;CALCIUM ION;GLUCAN 1,6-ALPHA-GLUCOSIDASE;1579;
4AIG;A;ADAMALYSIN II WITH PHOSPHONATE INHIBITOR;2;CA;CALCIUM ION;ADAMALYSIN II;8729;
4AIO;A;Crystal structure of the starch debranching enzyme barley limit dextrinase;1.9;CA;CALCIUM ION;LIMIT DEXTRINASE;4513;
4AIU;A;A complex structure of BtGH84;2.25;CA;CALCIUM ION;O-GLCNACASE BT_4395;818;
4AJ3;A;3D structure of E. coli Isocitrate Dehydrogenase in complex with Isocitrate, calcium(II) and NADP - The pseudo-Michaelis complex;1.9;CA;CALCIUM ION;NADP ISOCITRATE DEHYDROGENASE;562;
4AJA;A;3D structure of E. coli Isocitrate Dehydrogenase in complex with Isocitrate, calcium(II) and thioNADP;1.8;CA;CALCIUM ION;NADP ISOCITRATE DEHYDROGENASE;562;
4AJC;A;3D structure of E. coli Isocitrate Dehydrogenase K100M mutant in complex with alpha-ketoglutarate, calcium(II) and adenine nucleotide phosphate;2.3;CA;CALCIUM ION;NADP ISOCITRATE DEHYDROGENASE;562;
4AK3;A;Crystal structure of Human fibrillar procollagen type III C- propeptide trimer;3.5;CA;CALCIUM ION;COLLAGEN ALPHA-1(III) CHAIN;9606;
4AK7;A;Crystal structure of BpGH117_E303Q in complex with neoagarobiose;1.8;CA;CALCIUM ION;ANHYDRO-ALPHA-L-GALACTOSIDASE;310297;
4AK8;A;Structure of F241L mutant of langerin carbohydrate recognition domain.;1.4;CA;CALCIUM ION;C-TYPE LECTIN DOMAIN FAMILY 4 MEMBER K;9606;
4AK8;B;Structure of F241L mutant of langerin carbohydrate recognition domain.;1.4;CA;CALCIUM ION;C-TYPE LECTIN DOMAIN FAMILY 4 MEMBER K;9606;
4AK8;C;Structure of F241L mutant of langerin carbohydrate recognition domain.;1.4;CA;CALCIUM ION;C-TYPE LECTIN DOMAIN FAMILY 4 MEMBER K;9606;
4AK8;D;Structure of F241L mutant of langerin carbohydrate recognition domain.;1.4;CA;CALCIUM ION;C-TYPE LECTIN DOMAIN FAMILY 4 MEMBER K;9606;
4AL9;A;Crystal structure of the lectin PA-IL from Pseudomonas aeruginoas in complex with melibiose;1.75;CA;CALCIUM ION;PA-I GALACTOPHILIC LECTIN;287;
4AL9;B;Crystal structure of the lectin PA-IL from Pseudomonas aeruginoas in complex with melibiose;1.75;CA;CALCIUM ION;PA-I GALACTOPHILIC LECTIN;287;
4AL9;C;Crystal structure of the lectin PA-IL from Pseudomonas aeruginoas in complex with melibiose;1.75;CA;CALCIUM ION;PA-I GALACTOPHILIC LECTIN;287;
4AL9;D;Crystal structure of the lectin PA-IL from Pseudomonas aeruginoas in complex with melibiose;1.75;CA;CALCIUM ION;PA-I GALACTOPHILIC LECTIN;287;
4AL9;E;Crystal structure of the lectin PA-IL from Pseudomonas aeruginoas in complex with melibiose;1.75;CA;CALCIUM ION;PA-I GALACTOPHILIC LECTIN;287;
4AL9;F;Crystal structure of the lectin PA-IL from Pseudomonas aeruginoas in complex with melibiose;1.75;CA;CALCIUM ION;PA-I GALACTOPHILIC LECTIN;287;
4AL9;G;Crystal structure of the lectin PA-IL from Pseudomonas aeruginoas in complex with melibiose;1.75;CA;CALCIUM ION;PA-I GALACTOPHILIC LECTIN;287;
4AL9;H;Crystal structure of the lectin PA-IL from Pseudomonas aeruginoas in complex with melibiose;1.75;CA;CALCIUM ION;PA-I GALACTOPHILIC LECTIN;287;
4ALF;A;Pseudomonas fluorescens PhoX in complex with phosphate;1.25;CA;CALCIUM ION;ALKALINE PHOSPHATASE PHOX;294;
4ALF;B;Pseudomonas fluorescens PhoX in complex with phosphate;1.25;CA;CALCIUM ION;ALKALINE PHOSPHATASE PHOX;294;
4AMC;A;Crystal structure of Lactobacillus reuteri 121 N-terminally truncated glucansucrase GTFA;3.6;CA;CALCIUM ION;GLUCANSUCRASE;1598;
4AMF;A;Pseudomonas fluorescens PhoX in complex with the substrate analogue AppCp;1.52;CA;CALCIUM ION;PHOX;294;
4AMF;B;Pseudomonas fluorescens PhoX in complex with the substrate analogue AppCp;1.52;CA;CALCIUM ION;PHOX;294;
4AN7;A;Kunitz type trypsin inhibitor complex with porcine trypsin;2.23;CA;CALCIUM ION;TRYPSIN;9823;
4ANG;B;Small RNA phage PRR1 in complex with an RNA operator fragment;3.5;CA;CALCIUM ION;COAT PROTEIN;12024;
4ANJ;B;MYOSIN VI (MDinsert2-GFP fusion) PRE-POWERSTROKE STATE (MG.ADP.AlF4);2.6;CA;CALCIUM ION;CALMODULIN;7227;
4ANR;A;Crystal structure of soluble lytic Transglycosylase SltB1 from Pseudomonas aeruginosa;1.84;CA;CALCIUM ION;SOLUBLE LYTIC TRANSGLYCOSYLASE B;287;
4AOC;A;crystal structure of BC2L-A Lectin from Burkolderia cenocepacia in complex with methyl-heptoside;2.7;CA;CALCIUM ION;BC2L-A LECTIN;95486;
4AOC;B;crystal structure of BC2L-A Lectin from Burkolderia cenocepacia in complex with methyl-heptoside;2.7;CA;CALCIUM ION;BC2L-A LECTIN;95486;
4AOC;C;crystal structure of BC2L-A Lectin from Burkolderia cenocepacia in complex with methyl-heptoside;2.7;CA;CALCIUM ION;BC2L-A LECTIN;95486;
4AOC;D;crystal structure of BC2L-A Lectin from Burkolderia cenocepacia in complex with methyl-heptoside;2.7;CA;CALCIUM ION;BC2L-A LECTIN;95486;
4AOC;E;crystal structure of BC2L-A Lectin from Burkolderia cenocepacia in complex with methyl-heptoside;2.7;CA;CALCIUM ION;BC2L-A LECTIN;95486;
4AOQ;A;Cationic trypsin in complex with mutated Spinacia oleracea trypsin inhibitor III (SOTI-III) (F14A);2;CA;CALCIUM ION;CATIONIC TRYPSIN;9913;
4AOQ;B;Cationic trypsin in complex with mutated Spinacia oleracea trypsin inhibitor III (SOTI-III) (F14A);2;CA;CALCIUM ION;CATIONIC TRYPSIN;9913;
4AOQ;C;Cationic trypsin in complex with mutated Spinacia oleracea trypsin inhibitor III (SOTI-III) (F14A);2;CA;CALCIUM ION;CATIONIC TRYPSIN;9913;
4AOR;A;Cationic trypsin in complex with the Spinacia oleracea trypsin inhibitor III (SOTI-III);1.7;CA;CALCIUM ION;CATIONIC TRYPSIN;9913;
4AOR;B;Cationic trypsin in complex with the Spinacia oleracea trypsin inhibitor III (SOTI-III);1.7;CA;CALCIUM ION;CATIONIC TRYPSIN;9913;
4AOR;C;Cationic trypsin in complex with the Spinacia oleracea trypsin inhibitor III (SOTI-III);1.7;CA;CALCIUM ION;CATIONIC TRYPSIN;9913;
4APB;A;Crystal structure of Mycobacterium tuberculosis fumarase (Rv1098c) S318C in complex with fumarate;1.94;CA;CALCIUM ION;FUMARATE HYDRATASE CLASS II;1773;
4APB;B;Crystal structure of Mycobacterium tuberculosis fumarase (Rv1098c) S318C in complex with fumarate;1.94;CA;CALCIUM ION;FUMARATE HYDRATASE CLASS II;1773;
4APB;D;Crystal structure of Mycobacterium tuberculosis fumarase (Rv1098c) S318C in complex with fumarate;1.94;CA;CALCIUM ION;FUMARATE HYDRATASE CLASS II;1773;
4APM;A;Crystal Structure of AMA1 from Babesia divergens;2.3;CA;CALCIUM ION;APICAL MEMBRANE ANTIGEN 1;32595;
4APX;A;CRYSTAL STRUCTURE OF MOUSE CADHERIN-23 EC1-2 AND PROTOCADHERIN-15 EC1- 2 FORM I;1.65;CA;CALCIUM ION;CADHERIN-23;10090;
4APX;B;CRYSTAL STRUCTURE OF MOUSE CADHERIN-23 EC1-2 AND PROTOCADHERIN-15 EC1- 2 FORM I;1.65;CA;CALCIUM ION;PROTOCADHERIN-15;10090;
4AQ0;A;Structure of the Gh92 Family Glycosyl Hydrolase Ccman5 in complex with deoxymannojirimycin;2.09;CA;CALCIUM ION;CCMAN5;1710;
4AQ0;B;Structure of the Gh92 Family Glycosyl Hydrolase Ccman5 in complex with deoxymannojirimycin;2.09;CA;CALCIUM ION;CCMAN5;1710;
4AQ1;A;Structure of the SbsB S-layer protein of Geobacillus stearothermophilus PV72p2 in complex with nanobody KB6;2.42;CA;CALCIUM ION;SBSB PROTEIN;1422;
4AQ1;C;Structure of the SbsB S-layer protein of Geobacillus stearothermophilus PV72p2 in complex with nanobody KB6;2.42;CA;CALCIUM ION;SBSB PROTEIN;1422;
4AQ8;A;CRYSTAL STRUCTURE OF MOUSE CADHERIN-23 EC1-2 AND PROTOCADHERIN-15 EC1- 2 FORM II;2.63;CA;CALCIUM ION;CADHERIN-23;10090;
4AQ8;B;CRYSTAL STRUCTURE OF MOUSE CADHERIN-23 EC1-2 AND PROTOCADHERIN-15 EC1- 2 FORM II;2.63;CA;CALCIUM ION;CADHERIN-23;10090;
4AQ8;C;CRYSTAL STRUCTURE OF MOUSE CADHERIN-23 EC1-2 AND PROTOCADHERIN-15 EC1- 2 FORM II;2.63;CA;CALCIUM ION;PROTOCADHERIN-15;10090;
4AQ8;D;CRYSTAL STRUCTURE OF MOUSE CADHERIN-23 EC1-2 AND PROTOCADHERIN-15 EC1- 2 FORM II;2.63;CA;CALCIUM ION;PROTOCADHERIN-15;10090;
4AQA;A;CRYSTAL STRUCTURE OF DEAFNESS ASSOCIATED MUTANT MOUSE CADHERIN-23 EC1- 2D124G AND PROTOCADHERIN-15 EC1-2 FORM I;1.96;CA;CALCIUM ION;CADHERIN-23;10090;
4AQA;B;CRYSTAL STRUCTURE OF DEAFNESS ASSOCIATED MUTANT MOUSE CADHERIN-23 EC1- 2D124G AND PROTOCADHERIN-15 EC1-2 FORM I;1.96;CA;CALCIUM ION;PROTOCADHERIN-15;10090;
4AQB;A;MBL-Ficolin Associated Protein-1, MAP-1 aka MAP44;4.2;CA;CALCIUM ION;MANNAN-BINDING LECTIN SERINE PROTEASE 1;9606;
4AQE;A;CRYSTAL STRUCTURE OF DEAFNESS ASSOCIATED MUTANT MOUSE CADHERIN-23 EC1- 2S70P AND PROTOCADHERIN-15 EC1-2 FORM I;2.27;CA;CALCIUM ION;CADHERIN-23;10090;
4AQE;B;CRYSTAL STRUCTURE OF DEAFNESS ASSOCIATED MUTANT MOUSE CADHERIN-23 EC1- 2S70P AND PROTOCADHERIN-15 EC1-2 FORM I;2.27;CA;CALCIUM ION;PROTOCADHERIN-15;10090;
4AQI;A;Structure of human S100A15 bound to zinc and calcium;1.7;CA;CALCIUM ION;PROTEIN S100-A7A;9606;
4AQJ;A;Structure of human S100A7 D24G bound to zinc and calcium;1.6;CA;CALCIUM ION;PROTEIN S100-A7;9606;
4AQO;A;CRYSTAL STRUCTURE OF THE CALCIUM BOUND PKD-like DOMAIN OF COLLAGENASE G FROM CLOSTRIDIUM HISTOLYTICUM AT 0.99 ANGSTROM RESOLUTION.;0.99;CA;CALCIUM ION;COLLAGENASE;1498;
4AQQ;A;Dodecahedron formed of penton base protein from adenovirus Ad3;4.75;CA;CALCIUM ION;L2 PROTEIN III (PENTON BASE);108098;
4AQR;A;Crystal structure of calmodulin in complex with the regulatory domain of a plasma-membrane Ca2+-ATPase;1.95;CA;CALCIUM ION;CALMODULIN-7;3702;
4AQR;B;Crystal structure of calmodulin in complex with the regulatory domain of a plasma-membrane Ca2+-ATPase;1.95;CA;CALCIUM ION;CALMODULIN-7;3702;
4AQT;A;Laminin gamma1 LN-LE1-2 structure;3.2;CA;CALCIUM ION;LAMININ SUBUNIT GAMMA-1;10090;
4AQU;A;Crystal structure of I-CreI complexed with its target methylated at position plus 2 (in the b strand) in the presence of calcium;2.3;CA;CALCIUM ION;DNA ENDONUCLEASE I-CREI;3055;
4AR1;A;Crystal Structure of the Peptidase Domain of Collagenase H from Clostridium histolyticum at 2.01 Angstrom resolution.;2.01;CA;CALCIUM ION;COLH PROTEIN;1498;
4AR2;A;Dodecahedron formed of penton base protein from adenovirus Ad3;3.8;CA;CALCIUM ION;L2 PROTEIN III (PENTON BASE);108098;
4AR8;A;Crystal structure of the peptidase domain of collagenase T from Clostridium tetani complexed with the peptidic inhibitor isoamyl- phosphonyl-Gly-Pro-Ala at 2.05 angstrom resolution.;2.05;CA;CALCIUM ION;COLLAGENASE COLT;1513;
4AR8;B;Crystal structure of the peptidase domain of collagenase T from Clostridium tetani complexed with the peptidic inhibitor isoamyl- phosphonyl-Gly-Pro-Ala at 2.05 angstrom resolution.;2.05;CA;CALCIUM ION;COLLAGENASE COLT;1513;
4AR9;A;Crystal structure of the peptidase domain of collagenase T from Clostridium tetani at 1.69 angstrom resolution.;1.69;CA;CALCIUM ION;COLLAGENASE COLT;1513;
4AR9;B;Crystal structure of the peptidase domain of collagenase T from Clostridium tetani at 1.69 angstrom resolution.;1.69;CA;CALCIUM ION;COLLAGENASE COLT;1513;
4ARF;A;CRYSTAL STRUCTURE OF THE PEPTIDASE DOMAIN OF COLLAGENASE H FROM CLOSTRIDIUM HISTOLYTICUM IN COMPLEX WITH THE PEPTIDIC INHIBITOR ISOAMYLPHOSPHONYL-GLY-PRO-ALA AT 1.77 ANGSTROM RESOLUTION.;1.77;CA;CALCIUM ION;COLH PROTEIN;1498;
4ASL;A;Structure of Epa1A in complex with the T-antigen (Gal-b1-3- GalNAc);1.24;CA;CALCIUM ION;EPA1P;5478;
4ASM;B;Crystal structure of the catalytic domain of beta-agarase D from Zobellia galactanivorans;1.5;CA;CALCIUM ION;BETA-AGARASE D;63186;
4ATE;A;High resolution crystal structure of beta-porphyranase A from Zobellia galactanivorans;1.1;CA;CALCIUM ION;BETA-PORPHYRANASE A;63186;
4ATJ;A;DISTAL HEME POCKET MUTANT (H42E) OF RECOMBINANT HORSERADISH PEROXIDASE IN COMPLEX WITH BENZHYDROXAMIC ACID;2.5;CA;CALCIUM ION;PROTEIN (PEROXIDASE C1A);3704;
4ATJ;B;DISTAL HEME POCKET MUTANT (H42E) OF RECOMBINANT HORSERADISH PEROXIDASE IN COMPLEX WITH BENZHYDROXAMIC ACID;2.5;CA;CALCIUM ION;PROTEIN (PEROXIDASE C1A);3704;
4AUE;B;Crystal structure, recombinant expression and mutagenesis studies of the bifunctional catalase-phenol oxidase from Scytalidium thermophilum;2.7;CA;CALCIUM ION;CATALASE-PHENOL OXIDASE;85995;
4AUL;A;Crystal structure, recombinant expression and mutagenesis studies of the bifunctional catalase-phenol oxidase from Scytalidium thermophilum;1.5;CA;CALCIUM ION;CATALASE-PHENOL OXIDASE;85995;
4AUL;B;Crystal structure, recombinant expression and mutagenesis studies of the bifunctional catalase-phenol oxidase from Scytalidium thermophilum;1.5;CA;CALCIUM ION;CATALASE-PHENOL OXIDASE;85995;
4AUL;C;Crystal structure, recombinant expression and mutagenesis studies of the bifunctional catalase-phenol oxidase from Scytalidium thermophilum;1.5;CA;CALCIUM ION;CATALASE-PHENOL OXIDASE;85995;
4AUL;D;Crystal structure, recombinant expression and mutagenesis studies of the bifunctional catalase-phenol oxidase from Scytalidium thermophilum;1.5;CA;CALCIUM ION;CATALASE-PHENOL OXIDASE;85995;
4AUM;A;Crystal structure, recombinant expression and mutagenesis studies of the bifunctional catalase-phenol oxidase from Scytalidium thermophilum;1.4;CA;CALCIUM ION;CATALASE-PHENOL OXIDASE;85995;
4AUM;B;Crystal structure, recombinant expression and mutagenesis studies of the bifunctional catalase-phenol oxidase from Scytalidium thermophilum;1.4;CA;CALCIUM ION;CATALASE-PHENOL OXIDASE;85995;
4AUM;C;Crystal structure, recombinant expression and mutagenesis studies of the bifunctional catalase-phenol oxidase from Scytalidium thermophilum;1.4;CA;CALCIUM ION;CATALASE-PHENOL OXIDASE;85995;
4AUM;D;Crystal structure, recombinant expression and mutagenesis studies of the bifunctional catalase-phenol oxidase from Scytalidium thermophilum;1.4;CA;CALCIUM ION;CATALASE-PHENOL OXIDASE;85995;
4AUN;A;Crystal structure, recombinant expression and mutagenesis studies of the bifunctional catalase-phenol oxidase from Scytalidium thermophilum;1.92;CA;CALCIUM ION;CATALASE-PHENOL OXIDASE;85995;
4AUN;B;Crystal structure, recombinant expression and mutagenesis studies of the bifunctional catalase-phenol oxidase from Scytalidium thermophilum;1.92;CA;CALCIUM ION;CATALASE-PHENOL OXIDASE;85995;
4AUN;C;Crystal structure, recombinant expression and mutagenesis studies of the bifunctional catalase-phenol oxidase from Scytalidium thermophilum;1.92;CA;CALCIUM ION;CATALASE-PHENOL OXIDASE;85995;
4AUN;D;Crystal structure, recombinant expression and mutagenesis studies of the bifunctional catalase-phenol oxidase from Scytalidium thermophilum;1.92;CA;CALCIUM ION;CATALASE-PHENOL OXIDASE;85995;
4AUN;E;Crystal structure, recombinant expression and mutagenesis studies of the bifunctional catalase-phenol oxidase from Scytalidium thermophilum;1.92;CA;CALCIUM ION;CATALASE-PHENOL OXIDASE;85995;
4AUN;F;Crystal structure, recombinant expression and mutagenesis studies of the bifunctional catalase-phenol oxidase from Scytalidium thermophilum;1.92;CA;CALCIUM ION;CATALASE-PHENOL OXIDASE;85995;
4AUN;G;Crystal structure, recombinant expression and mutagenesis studies of the bifunctional catalase-phenol oxidase from Scytalidium thermophilum;1.92;CA;CALCIUM ION;CATALASE-PHENOL OXIDASE;85995;
4AUN;H;Crystal structure, recombinant expression and mutagenesis studies of the bifunctional catalase-phenol oxidase from Scytalidium thermophilum;1.92;CA;CALCIUM ION;CATALASE-PHENOL OXIDASE;85995;
4AUO;A;Crystal structure of MMP-1(E200A) in complex with a triple-helical collagen peptide;3;CA;CALCIUM ION;INTERSTITIAL COLLAGENASE;9606;
4AUO;B;Crystal structure of MMP-1(E200A) in complex with a triple-helical collagen peptide;3;CA;CALCIUM ION;INTERSTITIAL COLLAGENASE;9606;
4AV3;A;Crystal structure of Thermotoga Maritima sodium pumping membrane integral pyrophosphatase with metal ions in active site;2.6;CA;CALCIUM ION;K(+)-STIMULATED PYROPHOSPHATE-ENERGIZED SODIUM PUMP;2336;
4AV3;B;Crystal structure of Thermotoga Maritima sodium pumping membrane integral pyrophosphatase with metal ions in active site;2.6;CA;CALCIUM ION;K(+)-STIMULATED PYROPHOSPHATE-ENERGIZED SODIUM PUMP;2336;
4AVN;A;Thermobifida fusca cellobiohydrolase Cel6B catalytic mutant D226A- S232A cocrystallized with cellobiose;2;CA;CALCIUM ION;CELLOBIOHYDROLASE. GLYCOSYL HYDROLASE FAMILY 6;2021;
4AVO;A;Thermobifida fusca cellobiohydrolase Cel6B catalytic mutant D274A cocrystallized with cellobiose;1.8;CA;CALCIUM ION;BETA-1,4-EXOCELLULASE;2021;
4AVS;A;Structure of N-Acetyl-L-Proline bound to Serum Amyloid P Component;1.4;CA;CALCIUM ION;SERUM AMYLOID P-COMPONENT;9606;
4AVS;B;Structure of N-Acetyl-L-Proline bound to Serum Amyloid P Component;1.4;CA;CALCIUM ION;SERUM AMYLOID P-COMPONENT;9606;
4AVS;C;Structure of N-Acetyl-L-Proline bound to Serum Amyloid P Component;1.4;CA;CALCIUM ION;SERUM AMYLOID P-COMPONENT;9606;
4AVS;D;Structure of N-Acetyl-L-Proline bound to Serum Amyloid P Component;1.4;CA;CALCIUM ION;SERUM AMYLOID P-COMPONENT;9606;
4AVS;E;Structure of N-Acetyl-L-Proline bound to Serum Amyloid P Component;1.4;CA;CALCIUM ION;SERUM AMYLOID P-COMPONENT;9606;
4AVT;A;Structure of CPHPC bound to Serum Amyloid P Component;3.2;CA;CALCIUM ION;SERUM AMYLOID P-COMPONENT;9606;
4AVT;B;Structure of CPHPC bound to Serum Amyloid P Component;3.2;CA;CALCIUM ION;SERUM AMYLOID P-COMPONENT;9606;
4AVT;C;Structure of CPHPC bound to Serum Amyloid P Component;3.2;CA;CALCIUM ION;SERUM AMYLOID P-COMPONENT;9606;
4AVT;D;Structure of CPHPC bound to Serum Amyloid P Component;3.2;CA;CALCIUM ION;SERUM AMYLOID P-COMPONENT;9606;
4AVT;E;Structure of CPHPC bound to Serum Amyloid P Component;3.2;CA;CALCIUM ION;SERUM AMYLOID P-COMPONENT;9606;
4AVT;F;Structure of CPHPC bound to Serum Amyloid P Component;3.2;CA;CALCIUM ION;SERUM AMYLOID P-COMPONENT;9606;
4AVT;G;Structure of CPHPC bound to Serum Amyloid P Component;3.2;CA;CALCIUM ION;SERUM AMYLOID P-COMPONENT;9606;
4AVT;H;Structure of CPHPC bound to Serum Amyloid P Component;3.2;CA;CALCIUM ION;SERUM AMYLOID P-COMPONENT;9606;
4AVT;I;Structure of CPHPC bound to Serum Amyloid P Component;3.2;CA;CALCIUM ION;SERUM AMYLOID P-COMPONENT;9606;
4AVT;J;Structure of CPHPC bound to Serum Amyloid P Component;3.2;CA;CALCIUM ION;SERUM AMYLOID P-COMPONENT;9606;
4AW7;A;BpGH86A: A beta-porphyranase of glycoside hydrolase family 86 from the human gut bacterium Bacteroides plebeius;1.33;CA;CALCIUM ION;GH86A BETA-PORPHYRANASE;310297;
4AWD;A;Crystal structure of the beta-porphyranase BpGH16B (BACPLE_01689) from the human gut bacterium Bacteroides plebeius;2.4;CA;CALCIUM ION;BETA-PORPHYRANASE;310297;
4AWD;B;Crystal structure of the beta-porphyranase BpGH16B (BACPLE_01689) from the human gut bacterium Bacteroides plebeius;2.4;CA;CALCIUM ION;BETA-PORPHYRANASE;310297;
4AWN;A;Structure of recombinant human DNase I (rhDNaseI) in complex with Magnesium and Phosphate.;1.95;CA;CALCIUM ION;DEOXYRIBONUCLEASE-1;9606;
4AWY;B;Crystal Structure of the Mobile Metallo-beta-Lactamase AIM-1 from Pseudomonas aeruginosa: Insights into Antibiotic Binding and the role of Gln157;1.6;CA;CALCIUM ION;METALLO-BETA-LACTAMASE AIM-1;287;
4AWZ;A;Crystal Structure of the Mobile Metallo-beta-Lactamase AIM-1 from Pseudomonas aeruginosa: Insights into Antibiotic Binding and the role of Gln157;1.8;CA;CALCIUM ION;METALLO-BETA-LACTAMASE AIM-1;287;
4AWZ;B;Crystal Structure of the Mobile Metallo-beta-Lactamase AIM-1 from Pseudomonas aeruginosa: Insights into Antibiotic Binding and the role of Gln157;1.8;CA;CALCIUM ION;METALLO-BETA-LACTAMASE AIM-1;287;
4AWZ;C;Crystal Structure of the Mobile Metallo-beta-Lactamase AIM-1 from Pseudomonas aeruginosa: Insights into Antibiotic Binding and the role of Gln157;1.8;CA;CALCIUM ION;METALLO-BETA-LACTAMASE AIM-1;287;
4AX0;B;Q157A mutant. Crystal Structure of the Mobile Metallo-beta-Lactamase AIM-1 from Pseudomonas aeruginosa: Insights into Antibiotic Binding and the role of Gln157;1.74;CA;CALCIUM ION;METALLO-BETA-LACTAMASE AIM-1;287;
4AX1;B;Q157N mutant. Crystal Structure of the Mobile Metallo-beta-Lactamase AIM-1 from Pseudomonas aeruginosa: Insights into Antibiotic Binding and the role of Gln157;1.4;CA;CALCIUM ION;METALLO-BETA-LACTAMASE AIM-1;287;
4AXN;A;Hallmarks of processive and non-processive glycoside hydrolases revealed from computational and crystallographic studies of the Serratia marcescens chitinases;1.68;CA;CALCIUM ION;CHITINASE C1;615;
4AXN;B;Hallmarks of processive and non-processive glycoside hydrolases revealed from computational and crystallographic studies of the Serratia marcescens chitinases;1.68;CA;CALCIUM ION;CHITINASE C1;615;
4AXW;A;CRYSTAL STRUCTURE OF MOUSE CADHERIN-23 EC1-2 AND PROTOCADHERIN-15 EC1- 2, FORM I 2.2A.;2.23;CA;CALCIUM ION;CADHERIN-23;10090;
4AXW;B;CRYSTAL STRUCTURE OF MOUSE CADHERIN-23 EC1-2 AND PROTOCADHERIN-15 EC1- 2, FORM I 2.2A.;2.23;CA;CALCIUM ION;PROTOCADHERIN-15;10090;
4AYG;A;Lactobacillus reuteri N-terminally truncated glucansucrase GTF180 in orthorhombic apo-form;2;CA;CALCIUM ION;GLUCANSUCRASE;1598;
4AYG;B;Lactobacillus reuteri N-terminally truncated glucansucrase GTF180 in orthorhombic apo-form;2;CA;CALCIUM ION;GLUCANSUCRASE;1598;
4AYK;A;CATALYTIC FRAGMENT OF HUMAN FIBROBLAST COLLAGENASE COMPLEXED WITH CGS-27023A, NMR, 30 STRUCTURES;;CA;CALCIUM ION;PROTEIN (COLLAGENASE);9606;
4AYL;A;Molecular structure of a metal-independent bacterial glycosyltransferase that catalyzes the synthesis of histo-blood group A antigen;1.92;CA;CALCIUM ION;BOGT-METAL-INDEPENDENT GLYCOSYLTRANSFERASE;28116;
4AYO;A;Structure of The GH47 processing alpha-1,2-mannosidase from Caulobacter strain K31;0.85;CA;CALCIUM ION;MANNOSYL-OLIGOSACCHARIDE 1,2-ALPHA-MANNOSIDASE;366602;
4AYP;A;Structure of The GH47 processing alpha-1,2-mannosidase from Caulobacter strain K31 in complex with thiomannobioside;0.85;CA;CALCIUM ION;MANNOSYL-OLIGOSACCHARIDE 1,2-ALPHA-MANNOSIDASE;366602;
4AYQ;A;Structure of The GH47 processing alpha-1,2-mannosidase from Caulobacter strain K31 in complex with mannoimidazole;1.1;CA;CALCIUM ION;MANNOSYL-OLIGOSACCHARIDE 1,2-ALPHA-MANNOSIDASE;366602;
4AYR;A;Structure of The GH47 processing alpha-1,2-mannosidase from Caulobacter strain K31 in complex with noeuromycin;1.1;CA;CALCIUM ION;MANNOSYL-OLIGOSACCHARIDE 1,2-ALPHA-MANNOSIDASE;366602;
4AYU;A;Structure of N-Acetyl-D-Proline bound to serum amyloid P component;1.5;CA;CALCIUM ION;SERUM AMYLOID P-COMPONENT;9606;
4AYU;B;Structure of N-Acetyl-D-Proline bound to serum amyloid P component;1.5;CA;CALCIUM ION;SERUM AMYLOID P-COMPONENT;9606;
4AYU;C;Structure of N-Acetyl-D-Proline bound to serum amyloid P component;1.5;CA;CALCIUM ION;SERUM AMYLOID P-COMPONENT;9606;
4AYU;D;Structure of N-Acetyl-D-Proline bound to serum amyloid P component;1.5;CA;CALCIUM ION;SERUM AMYLOID P-COMPONENT;9606;
4AYU;E;Structure of N-Acetyl-D-Proline bound to serum amyloid P component;1.5;CA;CALCIUM ION;SERUM AMYLOID P-COMPONENT;9606;
4AZL;A;In meso structure of alginate transporter, AlgE, from Pseudomoas aeruginosa, PAO1, crystal form 2.;2.8;CA;CALCIUM ION;ALGINATE PRODUCTION PROTEIN ALGE;287;
4AZL;B;In meso structure of alginate transporter, AlgE, from Pseudomoas aeruginosa, PAO1, crystal form 2.;2.8;CA;CALCIUM ION;ALGINATE PRODUCTION PROTEIN ALGE;287;
4B0A;A;The high-resolution structure of yTBP-yTAF1 identifies conserved and competing interaction surfaces in transcriptional activation;1.97;CA;CALCIUM ION;TRANSCRIPTION INITIATION FACTOR TFIID SUBUNIT 1, LINKER, TATA-BOX-BINDING PROTEIN;4932;
4B0O;A;Crystal structure of soman-aged human butyrylcholinesterase in complex with benzyl pyridinium-4-methyltrichloroacetimidate;2.35;CA;CALCIUM ION;CHOLINESTERASE;9606;
4B0P;A;Crystal structure of soman-aged human butyrylcholinesterase in complex with methyl 2-(pentafluorobenzyloxyimino)pyridinium;2.5;CA;CALCIUM ION;CHOLINESTERASE;9606;
4B1T;A;Structure of the factor Xa-like trypsin variant triple-Ala (TA) in complex with eglin C;1.78;CA;CALCIUM ION;CATIONIC TRYPSIN;9913;
4B1T;C;Structure of the factor Xa-like trypsin variant triple-Ala (TA) in complex with eglin C;1.78;CA;CALCIUM ION;CATIONIC TRYPSIN;9913;
4B1U;M;Structure of the Phactr1 RPEL domain and RPEL motif directed assemblies with G-actin reveal the molecular basis for actin binding cooperativity.;2;CA;CALCIUM ION;PHOSPHATASE AND ACTIN REGULATOR 1;9986;
4B2A;A;Structure of the factor Xa-like trypsin variant triple-Ala (TGA) in complex with eglin C;1.89;CA;CALCIUM ION;CATIONIC TRYPSIN;9913;
4B2A;C;Structure of the factor Xa-like trypsin variant triple-Ala (TGA) in complex with eglin C;1.89;CA;CALCIUM ION;CATIONIC TRYPSIN;9913;
4B2B;A;Structure of the factor Xa-like trypsin variant triple-Ala (TGPA) in complex with eglin C;1.36;CA;CALCIUM ION;CATIONIC TRYPSIN;9913;
4B2B;C;Structure of the factor Xa-like trypsin variant triple-Ala (TGPA) in complex with eglin C;1.36;CA;CALCIUM ION;CATIONIC TRYPSIN;9913;
4B2C;A;Structure of the factor Xa-like trypsin variant triple-Ala (TPA) in complex with eglin C;1.43;CA;CALCIUM ION;CATIONIC TRYPSIN;9913;
4B2C;C;Structure of the factor Xa-like trypsin variant triple-Ala (TPA) in complex with eglin C;1.43;CA;CALCIUM ION;CATIONIC TRYPSIN;9913;
4B2Y;A;Probing the active center of catalase-phenol oxidase from Scytalidium thermophilum;1.9;CA;CALCIUM ION;CATALASE-PHENOL OXIDASE;85995;
4B2Y;B;Probing the active center of catalase-phenol oxidase from Scytalidium thermophilum;1.9;CA;CALCIUM ION;CATALASE-PHENOL OXIDASE;85995;
4B2Y;C;Probing the active center of catalase-phenol oxidase from Scytalidium thermophilum;1.9;CA;CALCIUM ION;CATALASE-PHENOL OXIDASE;85995;
4B2Y;D;Probing the active center of catalase-phenol oxidase from Scytalidium thermophilum;1.9;CA;CALCIUM ION;CATALASE-PHENOL OXIDASE;85995;
4B31;A;Probing the active center of catalase-phenol oxidase from Scytalidium thermophilum;2.25;CA;CALCIUM ION;CATALASE-PHENOL OXIDASE;85995;
4B31;B;Probing the active center of catalase-phenol oxidase from Scytalidium thermophilum;2.25;CA;CALCIUM ION;CATALASE-PHENOL OXIDASE;85995;
4B31;C;Probing the active center of catalase-phenol oxidase from Scytalidium thermophilum;2.25;CA;CALCIUM ION;CATALASE-PHENOL OXIDASE;85995;
4B31;D;Probing the active center of catalase-phenol oxidase from Scytalidium thermophilum;2.25;CA;CALCIUM ION;CATALASE-PHENOL OXIDASE;85995;
4B3O;D;Structures of HIV-1 RT and RNA-DNA Complex Reveal a Unique RT Conformation and Substrate Interface;3.3;CA;CALCIUM ION;5'-D(*CP*GP*TP*AP*TP*GP*CP*CP*TP*AP*TP*AP*GP*TP *TP*AP*TP*TP*GP*TP*GP*GP*CP*C)-3';32630;
4B3O;R;Structures of HIV-1 RT and RNA-DNA Complex Reveal a Unique RT Conformation and Substrate Interface;3.3;CA;CALCIUM ION;5'-R(*AP*UP*GP*AP*3DRP*GP*GP*CP*CP*AP*CP*AP*AP*UP*AP *AP*CP*UP*AP*UP*AP*GP*GP*CP*AP*UP*A)-3';32630;
4B3V;A;Crystal structure of the Rubella virus glycoprotein E1 in its post-fusion form crystallized in presence of 20mM of Calcium Acetate;1.98;CA;CALCIUM ION;E1 ENVELOPE GLYCOPROTEIN;11041;
4B3V;B;Crystal structure of the Rubella virus glycoprotein E1 in its post-fusion form crystallized in presence of 20mM of Calcium Acetate;1.98;CA;CALCIUM ION;E1 ENVELOPE GLYCOPROTEIN;11041;
4B3V;C;Crystal structure of the Rubella virus glycoprotein E1 in its post-fusion form crystallized in presence of 20mM of Calcium Acetate;1.98;CA;CALCIUM ION;E1 ENVELOPE GLYCOPROTEIN;11041;
4B40;A;Probing the active center of catalase-phenol oxidase from Scytalidium thermophilum;1.93;CA;CALCIUM ION;CATALASE-PHENOL OXIDASE;85995;
4B40;B;Probing the active center of catalase-phenol oxidase from Scytalidium thermophilum;1.93;CA;CALCIUM ION;CATALASE-PHENOL OXIDASE;85995;
4B40;C;Probing the active center of catalase-phenol oxidase from Scytalidium thermophilum;1.93;CA;CALCIUM ION;CATALASE-PHENOL OXIDASE;85995;
4B40;D;Probing the active center of catalase-phenol oxidase from Scytalidium thermophilum;1.93;CA;CALCIUM ION;CATALASE-PHENOL OXIDASE;85995;
4B4F;A;Thermobifida fusca Cel6B(E3) co-crystallized with cellobiose;2.2;CA;CALCIUM ION;BETA-1,4-EXOCELLULASE;2021;
4B4F;B;Thermobifida fusca Cel6B(E3) co-crystallized with cellobiose;2.2;CA;CALCIUM ION;BETA-1,4-EXOCELLULASE;2021;
4B52;A;Crystal structure of Gentlyase, the neutral metalloprotease of Paenibacillus polymyxa;1.76;CA;CALCIUM ION;BACILLOLYSIN;1406;
4B52;B;Crystal structure of Gentlyase, the neutral metalloprotease of Paenibacillus polymyxa;1.76;CA;CALCIUM ION;BACILLOLYSIN;1406;
4B56;A;Structure of ectonucleotide pyrophosphatase-phosphodiesterase-1 (NPP1);3;CA;CALCIUM ION;ECTONUCLEOTIDE PYROPHOSPHATASE/PHOSPHODIESTERASE FAMILY MEMBER 1;10090;
4B56;B;Structure of ectonucleotide pyrophosphatase-phosphodiesterase-1 (NPP1);3;CA;CALCIUM ION;ECTONUCLEOTIDE PYROPHOSPHATASE/PHOSPHODIESTERASE FAMILY MEMBER 1;10090;
4B5K;A;Probing the active center of catalase-phenol oxidase from Scytalidium thermophilum;1.7;CA;CALCIUM ION;CATALASE-PHENOL OXIDASE;85995;
4B5K;B;Probing the active center of catalase-phenol oxidase from Scytalidium thermophilum;1.7;CA;CALCIUM ION;CATALASE-PHENOL OXIDASE;85995;
4B5K;C;Probing the active center of catalase-phenol oxidase from Scytalidium thermophilum;1.7;CA;CALCIUM ION;CATALASE-PHENOL OXIDASE;85995;
4B5K;D;Probing the active center of catalase-phenol oxidase from Scytalidium thermophilum;1.7;CA;CALCIUM ION;CATALASE-PHENOL OXIDASE;85995;
4B5L;A;The 1.6 A High Energy Room Temperature Structure of Proteinase K at 38.4 keV and 0.04 MGy;1.6;CA;CALCIUM ION;PROTEINASE K;37998;
4B5W;A;Crystal structures of divalent metal dependent pyruvate aldolase R70A mutant, HpaI, in complex with pyruvate;1.79;CA;CALCIUM ION;4-HYDROXY-2-OXO-HEPTANE-1,7-DIOATE ALDOLASE;562;
4B5W;C;Crystal structures of divalent metal dependent pyruvate aldolase R70A mutant, HpaI, in complex with pyruvate;1.79;CA;CALCIUM ION;4-HYDROXY-2-OXO-HEPTANE-1,7-DIOATE ALDOLASE;562;
4B5W;D;Crystal structures of divalent metal dependent pyruvate aldolase R70A mutant, HpaI, in complex with pyruvate;1.79;CA;CALCIUM ION;4-HYDROXY-2-OXO-HEPTANE-1,7-DIOATE ALDOLASE;562;
4B5W;E;Crystal structures of divalent metal dependent pyruvate aldolase R70A mutant, HpaI, in complex with pyruvate;1.79;CA;CALCIUM ION;4-HYDROXY-2-OXO-HEPTANE-1,7-DIOATE ALDOLASE;562;
4B5W;F;Crystal structures of divalent metal dependent pyruvate aldolase R70A mutant, HpaI, in complex with pyruvate;1.79;CA;CALCIUM ION;4-HYDROXY-2-OXO-HEPTANE-1,7-DIOATE ALDOLASE;562;
4B60;B;Structure of rFnBPA(189-505) in complex with fibrinogen gamma chain C- terminal peptide;1.83;CA;CALCIUM ION;FIBRONECTIN-BINDING PROTEIN A;1280;
4B7A;A;Probing the active center of catalase-phenol oxidase from Scytalidium thermophilum;1.95;CA;CALCIUM ION;CATALASE-PHENOL OXIDASE;85995;
4B7A;B;Probing the active center of catalase-phenol oxidase from Scytalidium thermophilum;1.95;CA;CALCIUM ION;CATALASE-PHENOL OXIDASE;85995;
4B7A;C;Probing the active center of catalase-phenol oxidase from Scytalidium thermophilum;1.95;CA;CALCIUM ION;CATALASE-PHENOL OXIDASE;85995;
4B7A;D;Probing the active center of catalase-phenol oxidase from Scytalidium thermophilum;1.95;CA;CALCIUM ION;CATALASE-PHENOL OXIDASE;85995;
4B7B;A;Eg5-3;2.5;CA;CALCIUM ION;KINESIN-LIKE PROTEIN KIF11;9606;
4B7J;A;H1N1 2009 Pandemic Influenza Virus: Resistance of the I223R Neuraminidase Mutant Explained by Kinetic and Structural Analysis;2.42;CA;CALCIUM ION;NEURAMINIDASE;11320;
4B7M;A;H1N1 2009 Pandemic Influenza Virus: Resistance of the I223R Neuraminidase Mutant Explained by Kinetic and Structural Analysis;2.5;CA;CALCIUM ION;NEURAMINIDASE;11320;
4B7M;B;H1N1 2009 Pandemic Influenza Virus: Resistance of the I223R Neuraminidase Mutant Explained by Kinetic and Structural Analysis;2.5;CA;CALCIUM ION;NEURAMINIDASE;11320;
4B7N;A;H1N1 2009 Pandemic Influenza Virus: Resistance of the I223R Neuraminidase Mutant Explained by Kinetic and Structural Analysis;2.84;CA;CALCIUM ION;NEURAMINIDASE;11320;
4B7Q;A;H1N1 2009 Pandemic Influenza Virus: Resistance of the I223R Neuraminidase Mutant Explained by Kinetic and Structural Analysis;2.73;CA;CALCIUM ION;NEURAMINIDASE;11320;
4B7Q;B;H1N1 2009 Pandemic Influenza Virus: Resistance of the I223R Neuraminidase Mutant Explained by Kinetic and Structural Analysis;2.73;CA;CALCIUM ION;NEURAMINIDASE;11320;
4B7Q;C;H1N1 2009 Pandemic Influenza Virus: Resistance of the I223R Neuraminidase Mutant Explained by Kinetic and Structural Analysis;2.73;CA;CALCIUM ION;NEURAMINIDASE;11320;
4B7Q;D;H1N1 2009 Pandemic Influenza Virus: Resistance of the I223R Neuraminidase Mutant Explained by Kinetic and Structural Analysis;2.73;CA;CALCIUM ION;NEURAMINIDASE;11320;
4B7R;A;H1N1 2009 Pandemic Influenza Virus: Resistance of the I223R Neuraminidase Mutant Explained by Kinetic and Structural Analysis;1.9;CA;CALCIUM ION;NEURAMINIDASE;11320;
4B7R;B;H1N1 2009 Pandemic Influenza Virus: Resistance of the I223R Neuraminidase Mutant Explained by Kinetic and Structural Analysis;1.9;CA;CALCIUM ION;NEURAMINIDASE;11320;
4B7R;C;H1N1 2009 Pandemic Influenza Virus: Resistance of the I223R Neuraminidase Mutant Explained by Kinetic and Structural Analysis;1.9;CA;CALCIUM ION;NEURAMINIDASE;11320;
4B7R;D;H1N1 2009 Pandemic Influenza Virus: Resistance of the I223R Neuraminidase Mutant Explained by Kinetic and Structural Analysis;1.9;CA;CALCIUM ION;NEURAMINIDASE;11320;
4B7U;A;PLASMODIUM FALCIPARUM L-LACTATE DEHYDROGENASE COMPLEXED WITH BICINE;1.88;CA;CALCIUM ION;L-LACTATE DEHYDROGENASE;5833;
4B7U;B;PLASMODIUM FALCIPARUM L-LACTATE DEHYDROGENASE COMPLEXED WITH BICINE;1.88;CA;CALCIUM ION;L-LACTATE DEHYDROGENASE;5833;
4B7U;C;PLASMODIUM FALCIPARUM L-LACTATE DEHYDROGENASE COMPLEXED WITH BICINE;1.88;CA;CALCIUM ION;L-LACTATE DEHYDROGENASE;5833;
4B7U;D;PLASMODIUM FALCIPARUM L-LACTATE DEHYDROGENASE COMPLEXED WITH BICINE;1.88;CA;CALCIUM ION;L-LACTATE DEHYDROGENASE;5833;
4B96;A;Family 3b carbohydrate-binding module from the biomass sensoring system of Clostridium clariflavum;1.91;CA;CALCIUM ION;CELLULOSE BINDING DOMAIN-CONTAINING PROTEIN;288965;
4B97;A;Biomass sensing modules from putative Rsgi-like proteins of Clostridium thermocellum resemble family 3 carbohydrate-binding module of cellulosome;1.28;CA;CALCIUM ION;CELLULOSE BINDING DOMAIN-CONTAINING PROTEIN;1515;
4B98;A;The structure of the omega aminotransferase from Pseudomonas aeruginosa;1.65;CA;CALCIUM ION;BETA-ALANINE--PYRUVATE TRANSAMINASE;287;
4B98;B;The structure of the omega aminotransferase from Pseudomonas aeruginosa;1.65;CA;CALCIUM ION;BETA-ALANINE--PYRUVATE TRANSAMINASE;287;
4B9B;E;The structure of the omega aminotransferase from Pseudomonas aeruginosa;1.64;CA;CALCIUM ION;BETA-ALANINE-PYRUVATE TRANSAMINASE;287;
4B9B;F;The structure of the omega aminotransferase from Pseudomonas aeruginosa;1.64;CA;CALCIUM ION;BETA-ALANINE-PYRUVATE TRANSAMINASE;287;
4B9B;G;The structure of the omega aminotransferase from Pseudomonas aeruginosa;1.64;CA;CALCIUM ION;BETA-ALANINE-PYRUVATE TRANSAMINASE;287;
4B9B;H;The structure of the omega aminotransferase from Pseudomonas aeruginosa;1.64;CA;CALCIUM ION;BETA-ALANINE-PYRUVATE TRANSAMINASE;287;
4B9C;A;Biomass sensoring modules from putative Rsgi-like proteins of Clostridium thermocellum resemble family 3 carbohydrate-binding module of cellulosome;1.17;CA;CALCIUM ION;TYPE 3A CELLULOSE-BINDING DOMAIN PROTEIN;1515;
4B9F;A;High resolution structure for family 3a carbohydrate binding module from the cipA scaffolding of clostridium thermocellum;1.19;CA;CALCIUM ION;CELLULOSOMAL-SCAFFOLDING PROTEIN A;1515;
4B9F;B;High resolution structure for family 3a carbohydrate binding module from the cipA scaffolding of clostridium thermocellum;1.19;CA;CALCIUM ION;CELLULOSOMAL-SCAFFOLDING PROTEIN A;1515;
4B9P;A;Biomass sensoring module from putative Rsgi2 protein of Clostridium thermocellum resemble family 3 carbohydrate-binding module of cellulosome;1.18;CA;CALCIUM ION;TYPE 3A CELLULOSE-BINDING DOMAIN PROTEIN;1515;
4BAE;A;Optimisation of pyrroleamides as mycobacterial GyrB ATPase inhibitors: Structure Activity Relationship and in vivo efficacy in the mouse model of tuberculosis;2.35;CA;CALCIUM ION;DNA GYRASE SUBUNIT B;1772;
4BAE;C;Optimisation of pyrroleamides as mycobacterial GyrB ATPase inhibitors: Structure Activity Relationship and in vivo efficacy in the mouse model of tuberculosis;2.35;CA;CALCIUM ION;DNA GYRASE SUBUNIT B;1772;
4BAE;D;Optimisation of pyrroleamides as mycobacterial GyrB ATPase inhibitors: Structure Activity Relationship and in vivo efficacy in the mouse model of tuberculosis;2.35;CA;CALCIUM ION;DNA GYRASE SUBUNIT B;1772;
4BB9;A;Crystal structure of glucokinase regulatory protein complexed to fructose-1-phosphate;1.47;CA;CALCIUM ION;GLUCOKINASE REGULATORY PROTEIN;9606;
4BCU;A;Satellite Tobacco Necrosis Virus (STNV) virus like particle in complex with the B3 aptamer;2.29;CA;CALCIUM ION;COAT PROTEIN;1925803;
4BDV;A;CRYSTAL STRUCTURE OF A TRUNCATED B-DOMAIN HUMAN FACTOR VIII;3.98;CA;CALCIUM ION;FACTOR VIIIA HEAVY CHAIN, 92 KDA ISOFORM, B DOMAIN;9606;
4BE6;B;V. cholera biofilm scaffolding protein RbmA;2.05;CA;CALCIUM ION;RBMA;666;
4BGB;A;Nucleotide-bound closed form of a putative sugar kinase MK0840 from Methanopyrus kandleri;1.34;CA;CALCIUM ION;PUTATIVE SUGAR KINASE MK0840;2320;
4BHV;B;Measles virus phosphoprotein tetramerization domain;2.1;CA;CALCIUM ION;PHOSPHOPROTEIN;11234;
4BIH;A;Crystal structure of the conserved staphylococcal antigen 1A, Csa1A;2.46;CA;CALCIUM ION;UNCHARACTERIZED LIPOPROTEIN SAOUHSC_00053;1280;
4BIR;A;RIBONUCLEASE T1: FREE HIS92GLN MUTANT;1.7;CA;CALCIUM ION;GUANYL-SPECIFIC RIBONUCLEASE T1;5062;
4BJ0;A;Xyloglucan binding module (CBM4-2 X2-L110F) in complex with branched xyloses;1;CA;CALCIUM ION;XYLANASE;29549;
4BLK;A;CRYSTAL STRUCTURE OF FUNGAL VERSATILE PEROXIDASE I FROM PLEUROTUS OSTREATUS - CRYSTAL FORM I;1.05;CA;CALCIUM ION;VERSATILE PEROXIDASE I;5322;
4BLL;A;CRYSTAL STRUCTURE OF FUNGAL VERSATILE PEROXIDASE I FROM PLEUROTUS OSTREATUS - CRYSTAL FORM II;1.1;CA;CALCIUM ION;VERSATILE PEROXIDASE I;5322;
4BLN;A;CRYSTAL STRUCTURE OF FUNGAL VERSATILE PEROXIDASE I FROM PLEUROTUS OSTREATUS - CRYSTAL FORM III;1.15;CA;CALCIUM ION;VERSATILE PEROXIDASE I;5322;
4BLO;A;P4 PROTEIN FROM BACTERIOPHAGE PHI6 IN COMPLEX WITH ADP;2.8;CA;CALCIUM ION;PACKAGING ENZYME P4;10879;
4BLO;B;P4 PROTEIN FROM BACTERIOPHAGE PHI6 IN COMPLEX WITH ADP;2.8;CA;CALCIUM ION;PACKAGING ENZYME P4;10879;
4BLO;C;P4 PROTEIN FROM BACTERIOPHAGE PHI6 IN COMPLEX WITH ADP;2.8;CA;CALCIUM ION;PACKAGING ENZYME P4;10879;
4BLO;D;P4 PROTEIN FROM BACTERIOPHAGE PHI6 IN COMPLEX WITH ADP;2.8;CA;CALCIUM ION;PACKAGING ENZYME P4;10879;
4BLO;E;P4 PROTEIN FROM BACTERIOPHAGE PHI6 IN COMPLEX WITH ADP;2.8;CA;CALCIUM ION;PACKAGING ENZYME P4;10879;
4BLO;F;P4 PROTEIN FROM BACTERIOPHAGE PHI6 IN COMPLEX WITH ADP;2.8;CA;CALCIUM ION;PACKAGING ENZYME P4;10879;
4BLO;G;P4 PROTEIN FROM BACTERIOPHAGE PHI6 IN COMPLEX WITH ADP;2.8;CA;CALCIUM ION;PACKAGING ENZYME P4;10879;
4BLO;H;P4 PROTEIN FROM BACTERIOPHAGE PHI6 IN COMPLEX WITH ADP;2.8;CA;CALCIUM ION;PACKAGING ENZYME P4;10879;
4BLO;I;P4 PROTEIN FROM BACTERIOPHAGE PHI6 IN COMPLEX WITH ADP;2.8;CA;CALCIUM ION;PACKAGING ENZYME P4;10879;
4BLO;J;P4 PROTEIN FROM BACTERIOPHAGE PHI6 IN COMPLEX WITH ADP;2.8;CA;CALCIUM ION;PACKAGING ENZYME P4;10879;
4BLO;K;P4 PROTEIN FROM BACTERIOPHAGE PHI6 IN COMPLEX WITH ADP;2.8;CA;CALCIUM ION;PACKAGING ENZYME P4;10879;
4BLO;L;P4 PROTEIN FROM BACTERIOPHAGE PHI6 IN COMPLEX WITH ADP;2.8;CA;CALCIUM ION;PACKAGING ENZYME P4;10879;
4BLX;A;CRYSTAL STRUCTURE OF FUNGAL VERSATILE PEROXIDASE I FROM PLEUROTUS OSTREATUS - CRYSTAL FORM IV;1.25;CA;CALCIUM ION;VERSATILE PEROXIDASE I;5322;
4BLY;A;CRYSTAL STRUCTURE OF FUNGAL VERSATILE PEROXIDASE I FROM PLEUROTUS OSTREATUS - CRYSTAL FORM V;1.79;CA;CALCIUM ION;VERSATILE PEROXIDASE I;5322;
4BLZ;A;CRYSTAL STRUCTURE OF FUNGAL VERSATILE PEROXIDASE I FROM PLEUROTUS OSTREATUS - CRYSTAL FORM VI;2;CA;CALCIUM ION;VERSATILE PEROXIDASE I;5322;
4BLZ;B;CRYSTAL STRUCTURE OF FUNGAL VERSATILE PEROXIDASE I FROM PLEUROTUS OSTREATUS - CRYSTAL FORM VI;2;CA;CALCIUM ION;VERSATILE PEROXIDASE I;5322;
4BM0;A;CRYSTAL STRUCTURE OF FUNGAL VERSATILE PEROXIDASE I FROM PLEUROTUS OSTREATUS - CRYSTAL FORM VII;2.2;CA;CALCIUM ION;VERSATILE PEROXIDASE I;5322;
4BM1;A;CRYSTAL STRUCTURE OF MANGANESE PEROXIDASE 4 FROM PLEUROTUS OSTREATUS - CRYSTAL FORM I;1.1;CA;CALCIUM ION;MANGANESE PEROXIDASE 4;5322;
4BM1;B;CRYSTAL STRUCTURE OF MANGANESE PEROXIDASE 4 FROM PLEUROTUS OSTREATUS - CRYSTAL FORM I;1.1;CA;CALCIUM ION;MANGANESE PEROXIDASE 4;5322;
4BM2;A;CRYSTAL STRUCTURE OF MANGANESE PEROXIDASE 4 FROM PLEUROTUS OSTREATUS - CRYSTAL FORM II;1.39;CA;CALCIUM ION;MANGANESE PEROXIDASE 4;5322;
4BM3;A;CRYSTAL STRUCTURE OF MANGANESE PEROXIDASE 4 FROM PLEUROTUS OSTREATUS - CRYSTAL FORM III;1.65;CA;CALCIUM ION;MANGANESE PEROXIDASE 4;5322;
4BM4;A;CRYSTAL STRUCTURE OF MANGANESE PEROXIDASE 4 FROM PLEUROTUS OSTREATUS - CRYSTAL FORM IV;2.3;CA;CALCIUM ION;MANGANESE PEROXIDASE 4;5322;
4BN1;A;Crystal structure of V174M mutant of Aurora-A kinase;2.5;CA;CALCIUM ION;AURORA KINASE A;9606;
4BNR;A;Extremely stable complex of crayfish trypsin with bovine trypsin inhibitor;2;CA;CALCIUM ION;HEPATOPANCREAS TRYPSIN;6717;
4BNR;B;Extremely stable complex of crayfish trypsin with bovine trypsin inhibitor;2;CA;CALCIUM ION;HEPATOPANCREAS TRYPSIN;6717;
4BOW;A;Crystal structure of LamA_E269S from Z. galactanivorans in complex with laminaritriose and laminaritetraose;1.35;CA;CALCIUM ION;ENDO-1,3-BETA-GLUCANASE, FAMILY GH16;63186;
4BOW;B;Crystal structure of LamA_E269S from Z. galactanivorans in complex with laminaritriose and laminaritetraose;1.35;CA;CALCIUM ION;ENDO-1,3-BETA-GLUCANASE, FAMILY GH16;63186;
4BP2;A;CRYSTALLOGRAPHIC REFINEMENT OF BOVINE PRO-PHOSPHOLIPASE A2 AT 1.6 ANGSTROMS RESOLUTION;1.6;CA;CALCIUM ION;PHOSPHOLIPASE A2;9913;
4BPZ;A;Crystal structure of lamA_E269S from Zobellia galactanivorans in complex with a trisaccharide of 1,3-1,4-beta-D-glucan.;1.13;CA;CALCIUM ION;ENDO-1,3-BETA-GLUCANASE, FAMILY GH16;63186;
4BPZ;B;Crystal structure of lamA_E269S from Zobellia galactanivorans in complex with a trisaccharide of 1,3-1,4-beta-D-glucan.;1.13;CA;CALCIUM ION;ENDO-1,3-BETA-GLUCANASE, FAMILY GH16;63186;
4BQ1;A;Crystal structure of of LamAcat from Zobellia galactanivorans;1.5;CA;CALCIUM ION;ENDO-1,3-BETA-GLUCANASE, FAMILY GH16;63186;
4BQ1;B;Crystal structure of of LamAcat from Zobellia galactanivorans;1.5;CA;CALCIUM ION;ENDO-1,3-BETA-GLUCANASE, FAMILY GH16;63186;
4BQ2;A;Structural analysis of an exo-beta-agarase;1.9;CA;CALCIUM ION;B-AGARASE;86304;
4BQ2;B;Structural analysis of an exo-beta-agarase;1.9;CA;CALCIUM ION;B-AGARASE;86304;
4BQ2;C;Structural analysis of an exo-beta-agarase;1.9;CA;CALCIUM ION;B-AGARASE;86304;
4BQ2;D;Structural analysis of an exo-beta-agarase;1.9;CA;CALCIUM ION;B-AGARASE;86304;
4BQ3;A;Structural analysis of an exo-beta-agarase;2.1;CA;CALCIUM ION;B-AGARASE;86304;
4BQ3;B;Structural analysis of an exo-beta-agarase;2.1;CA;CALCIUM ION;B-AGARASE;86304;
4BQ3;C;Structural analysis of an exo-beta-agarase;2.1;CA;CALCIUM ION;B-AGARASE;86304;
4BQ3;D;Structural analysis of an exo-beta-agarase;2.1;CA;CALCIUM ION;B-AGARASE;86304;
4BQ4;A;Structural analysis of an exo-beta-agarase;2.05;CA;CALCIUM ION;B-AGARASE;86304;
4BQ4;B;Structural analysis of an exo-beta-agarase;2.05;CA;CALCIUM ION;B-AGARASE;86304;
4BQ5;A;Structural analysis of an exo-beta-agarase;2.3;CA;CALCIUM ION;B-AGARASE;86304;
4BQ5;B;Structural analysis of an exo-beta-agarase;2.3;CA;CALCIUM ION;B-AGARASE;86304;
4BR0;A;rat NTPDase2 in complex with Ca AMPNP;2.05;CA;CALCIUM ION;ECTONUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE 2;10116;
4BR2;A;rat NTPDase2 in complex with Ca UMPPNP;2;CA;CALCIUM ION;ECTONUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE 2;10116;
4BTI;B;factor Xa in complex with the dual thrombin-FXa inhibitor 58.;2.3;CA;CALCIUM ION;COAGULATION FACTOR X LIGHT CHAIN;9606;
4BTI;F;factor Xa in complex with the dual thrombin-FXa inhibitor 58.;2.3;CA;CALCIUM ION;COAGULATION FACTOR X LIGHT CHAIN;9606;
4BTT;B;factor Xa in complex with the dual thrombin-FXa inhibitor 31.;2.59;CA;CALCIUM ION;COAGULATION FACTOR X;9606;
4BTT;F;factor Xa in complex with the dual thrombin-FXa inhibitor 31.;2.59;CA;CALCIUM ION;COAGULATION FACTOR X;9606;
4BTU;B;Factor Xa in complex with the dual thrombin-FXa inhibitor 57.;2.37;CA;CALCIUM ION;COAGULATION FACTOR X HEAVY CHAIN;9606;
4BTU;F;Factor Xa in complex with the dual thrombin-FXa inhibitor 57.;2.37;CA;CALCIUM ION;COAGULATION FACTOR X HEAVY CHAIN;9606;
4BTW;A;Crystal structure of human vascular adhesion protein-1 in complex with pyridazinone inhibitors;2.8;CA;CALCIUM ION;MEMBRANE PRIMARY AMINE OXIDASE;9606;
4BTW;B;Crystal structure of human vascular adhesion protein-1 in complex with pyridazinone inhibitors;2.8;CA;CALCIUM ION;MEMBRANE PRIMARY AMINE OXIDASE;9606;
4BTX;A;Crystal structure of human vascular adhesion protein-1 in complex with pyridazinone inhibitors;2.78;CA;CALCIUM ION;MEMBRANE PRIMARY AMINE OXIDASE;9606;
4BTX;B;Crystal structure of human vascular adhesion protein-1 in complex with pyridazinone inhibitors;2.78;CA;CALCIUM ION;MEMBRANE PRIMARY AMINE OXIDASE;9606;
4BTY;A;Crystal structure of human vascular adhesion protein-1 in complex with pyridazinone inhibitors;3.1;CA;CALCIUM ION;MEMBRANE PRIMARY AMINE OXIDASE;9606;
4BTY;B;Crystal structure of human vascular adhesion protein-1 in complex with pyridazinone inhibitors;3.1;CA;CALCIUM ION;MEMBRANE PRIMARY AMINE OXIDASE;9606;
4BU4;A;RIBONUCLEASE T1 COMPLEX WITH 2'GMP;1.8;CA;CALCIUM ION;PROTEIN (RIBONUCLEASE T1);5062;
4BW8;A;Calmodulin with small bend in central helix;1.8;CA;CALCIUM ION;CALMODULIN;9606;
4BW8;B;Calmodulin with small bend in central helix;1.8;CA;CALCIUM ION;CALMODULIN;9606;
4BWE;A;Crystal structure of C-terminally truncated glypican-1 after controlled dehydration to 86 percent relative humidity;2.46;CA;CALCIUM ION;Glypican-1;9606;
4BWE;B;Crystal structure of C-terminally truncated glypican-1 after controlled dehydration to 86 percent relative humidity;2.46;CA;CALCIUM ION;Glypican-1;9606;
4BWE;C;Crystal structure of C-terminally truncated glypican-1 after controlled dehydration to 86 percent relative humidity;2.46;CA;CALCIUM ION;Glypican-1;9606;
4BWE;D;Crystal structure of C-terminally truncated glypican-1 after controlled dehydration to 86 percent relative humidity;2.46;CA;CALCIUM ION;Glypican-1;9606;
4BXO;A;Architecture and DNA recognition elements of the Fanconi anemia FANCM- FAAP24 complex;2.15;CA;CALCIUM ION;FANCONI ANEMIA GROUP M PROTEIN;9606;
4BXO;B;Architecture and DNA recognition elements of the Fanconi anemia FANCM- FAAP24 complex;2.15;CA;CALCIUM ION;FANCONI ANEMIA-ASSOCIATED PROTEIN OF 24 KDA;9606;
4BXS;V;Crystal Structure of the Prothrombinase Complex from the Venom of Pseudonaja Textilis;3.32;CA;CALCIUM ION;VENOM PROTHROMBIN ACTIVATOR PSEUTARIN-C NON-CATALYTIC SUBUNIT;8673;
4BY4;A;Crystal structure of Drosophila Frq2;2.3;CA;CALCIUM ION;FI18190P1;7227;
4BY4;B;Crystal structure of Drosophila Frq2;2.3;CA;CALCIUM ION;FI18190P1;7227;
4BY5;A;Crystal structure of Drosophila Frq2;2.22;CA;CALCIUM ION;FI18190P1;7227;
4BY5;B;Crystal structure of Drosophila Frq2;2.22;CA;CALCIUM ION;FI18190P1;7227;
4BY5;C;Crystal structure of Drosophila Frq2;2.22;CA;CALCIUM ION;FI18190P1;7227;
4BY5;D;Crystal structure of Drosophila Frq2;2.22;CA;CALCIUM ION;FI18190P1;7227;
4BY6;A;Yeast Not1-Not2-Not5 complex;2.8;CA;CALCIUM ION;GENERAL NEGATIVE REGULATOR OF TRANSCRIPTION SUBUNIT 1;4932;
4BY6;D;Yeast Not1-Not2-Not5 complex;2.8;CA;CALCIUM ION;GENERAL NEGATIVE REGULATOR OF TRANSCRIPTION SUBUNIT 1;4932;
4BYA;A;Calmodulin, C-terminal domain, M144H mutant;;CA;CALCIUM ION;CALMODULIN, C-TERMINAL DOMAIN, M144H MUTANT;9031;
4BZ4;A;CorA is a surface-associated copper-binding protein important in Methylomicrobium album BG8 copper acquisition;1.6;CA;CALCIUM ION;COPPER-REPRESSIBLE POLYPEPTIDE;39775;
4BZ4;B;CorA is a surface-associated copper-binding protein important in Methylomicrobium album BG8 copper acquisition;1.6;CA;CALCIUM ION;COPPER-REPRESSIBLE POLYPEPTIDE;39775;
4BZ4;C;CorA is a surface-associated copper-binding protein important in Methylomicrobium album BG8 copper acquisition;1.6;CA;CALCIUM ION;COPPER-REPRESSIBLE POLYPEPTIDE;39775;
4BZ4;D;CorA is a surface-associated copper-binding protein important in Methylomicrobium album BG8 copper acquisition;1.6;CA;CALCIUM ION;COPPER-REPRESSIBLE POLYPEPTIDE;39775;
4BZ4;E;CorA is a surface-associated copper-binding protein important in Methylomicrobium album BG8 copper acquisition;1.6;CA;CALCIUM ION;COPPER-REPRESSIBLE POLYPEPTIDE;39775;
4BZ4;F;CorA is a surface-associated copper-binding protein important in Methylomicrobium album BG8 copper acquisition;1.6;CA;CALCIUM ION;COPPER-REPRESSIBLE POLYPEPTIDE;39775;
4C07;A;Crystal structure of M. musculus protein arginine methyltransferase PRMT6 with CaCl2 at 1.5 Angstroms;1.5;CA;CALCIUM ION;PROTEIN ARGININE N-METHYLTRANSFERASE 6;10090;
4C08;A;Crystal structure of M. musculus protein arginine methyltransferase PRMT6 with CaCl2 at 1.34 Angstroms;1.34;CA;CALCIUM ION;PROTEIN ARGININE N-METHYLTRANSFERASE 6;10090;
4C0K;A;Crystal structure of Drosophila Miro EF hand and cGTPase domains bound to one calcium ion (Ca-MiroS);2.8;CA;CALCIUM ION;MITOCHONDRIAL RHO GTPASE;7227;
4C16;A;E-selectin lectin, EGF-like and two SCR domains complexed with glycomimetic antagonist;1.93;CA;CALCIUM ION;E-SELECTIN;9606;
4C16;B;E-selectin lectin, EGF-like and two SCR domains complexed with glycomimetic antagonist;1.93;CA;CALCIUM ION;E-SELECTIN;9606;
4C1M;C;Myeloperoxidase in complex with the revesible inhibitor HX1;2;CA;CALCIUM ION;MYELOPEROXIDASE HEAVY CHAIN;9606;
4C1M;D;Myeloperoxidase in complex with the revesible inhibitor HX1;2;CA;CALCIUM ION;MYELOPEROXIDASE HEAVY CHAIN;9606;
4C1Y;A;Crystal Structure of Fucose binding lectin from Aspergillus Fumigatus (AFL) in complex with b-methylfucoside;2.23;CA;CALCIUM ION;FUCOSE-SPECIFIC LECTIN FLEA;746128;
4C29;A;Crystal Structure of High-Affinity von Willebrand Factor A1 domain with Disulfide Mutation;2.2;CA;CALCIUM ION;VON WILLEBRAND FACTOR;9606;
4C29;B;Crystal Structure of High-Affinity von Willebrand Factor A1 domain with Disulfide Mutation;2.2;CA;CALCIUM ION;VON WILLEBRAND FACTOR;9606;
4C2A;A;Crystal Structure of High-Affinity von Willebrand Factor A1 domain with R1306Q and I1309V Mutations in Complex with High Affinity GPIb alpha;2.08;CA;CALCIUM ION;VON WILLEBRAND FACTOR;9606;
4C3U;A;Extensive counter-ion interactions with subtilisin in aqueous medium, Cs derivative;2.29;CA;CALCIUM ION;SUBTILISIN CARLSBERG;1402;
4C3V;A;Extensive counter-ion interactions with subtilisin in aqueous medium, no Cs soak;2.26;CA;CALCIUM ION;SUBTILISIN CARLSBERG;1402;
4C4M;A;Crystal structure of the Sonic Hedgehog-chondroitin-4-sulphate complex;1.74;CA;CALCIUM ION;SONIC HEDGEHOG PROTEIN;10090;
4C4N;A;Crystal structure of the Sonic Hedgehog-heparin complex;2.36;CA;CALCIUM ION;SONIC HEDGEHOG PROTEIN;10090;
4C4N;B;Crystal structure of the Sonic Hedgehog-heparin complex;2.36;CA;CALCIUM ION;SONIC HEDGEHOG PROTEIN;10090;
4C9F;A;Structure of SIGN-R1 in complex with Sulfodextran;2.6;CA;CALCIUM ION;CD209 ANTIGEN-LIKE PROTEIN B;10090;
4C9F;B;Structure of SIGN-R1 in complex with Sulfodextran;2.6;CA;CALCIUM ION;CD209 ANTIGEN-LIKE PROTEIN B;10090;
4C9F;C;Structure of SIGN-R1 in complex with Sulfodextran;2.6;CA;CALCIUM ION;CD209 ANTIGEN-LIKE PROTEIN B;10090;
4C9F;D;Structure of SIGN-R1 in complex with Sulfodextran;2.6;CA;CALCIUM ION;CD209 ANTIGEN-LIKE PROTEIN B;10090;
4CAG;A;Bacillus licheniformis Rhamnogalacturonan Lyase PL11;2.5;CA;CALCIUM ION;POLYSACCHARIDE LYASE FAMILY 11 PROTEIN;1402;
4CAJ;A;Crystallographic structure of the mouse SIGN-R1 CRD domain in complex with sialic acid;2.19;CA;CALCIUM ION;CD209 ANTIGEN-LIKE PROTEIN B;10090;
4CAJ;B;Crystallographic structure of the mouse SIGN-R1 CRD domain in complex with sialic acid;2.19;CA;CALCIUM ION;CD209 ANTIGEN-LIKE PROTEIN B;10090;
4CAJ;C;Crystallographic structure of the mouse SIGN-R1 CRD domain in complex with sialic acid;2.19;CA;CALCIUM ION;CD209 ANTIGEN-LIKE PROTEIN B;10090;
4CAJ;D;Crystallographic structure of the mouse SIGN-R1 CRD domain in complex with sialic acid;2.19;CA;CALCIUM ION;CD209 ANTIGEN-LIKE PROTEIN B;10090;
4CBU;A;Crystal structure of Plasmodium falciparum actin I;1.3;CA;CALCIUM ION;ACTIN-1;5833;
4CBU;G;Crystal structure of Plasmodium falciparum actin I;1.3;CA;CALCIUM ION;GELSOLIN;10090;
4CBW;A;Crystal structure of Plasmodium berghei actin I with D-loop from muscle actin;2.5;CA;CALCIUM ION;ACTIN, ALPHA SKELETAL MUSCLE, ACTIN;582,132,630;
4CBW;G;Crystal structure of Plasmodium berghei actin I with D-loop from muscle actin;2.5;CA;CALCIUM ION;GELSOLIN;10090;
4CBX;A;Crystal structure of Plasmodium berghei actin II;2.2;CA;CALCIUM ION;ACTIN-2;5821;
4CBX;G;Crystal structure of Plasmodium berghei actin II;2.2;CA;CALCIUM ION;GELSOLIN;10090;
4CC0;A;Notch ligand, Jagged-1, contains an N-terminal C2 domain;2.32;CA;CALCIUM ION;PROTEIN JAGGED-1;9606;
4CC0;B;Notch ligand, Jagged-1, contains an N-terminal C2 domain;2.32;CA;CALCIUM ION;PROTEIN JAGGED-1;9606;
4CC1;A;Notch ligand, Jagged-1, contains an N-terminal C2 domain;2.84;CA;CALCIUM ION;PROTEIN JAGGED-1;9606;
4CC1;B;Notch ligand, Jagged-1, contains an N-terminal C2 domain;2.84;CA;CALCIUM ION;PROTEIN JAGGED-1;9606;
4CCC;A;STRUCTURE OF MOUSE GALACTOCEREBROSIDASE WITH 4NBDG: ENZYME-SUBSTRATE COMPLEX;2.09;CA;CALCIUM ION;GALACTOCEREBROSIDASE;10090;
4CCD;A;STRUCTURE OF MOUSE GALACTOCEREBROSIDASE WITH D-GALACTAL: ENZYME- INTERMEDIATE COMPLEX;1.97;CA;CALCIUM ION;GALACTOCEREBROSIDASE;10090;
4CCE;A;STRUCTURE OF MOUSE GALACTOCEREBROSIDASE WITH GALACTOSE: ENZYME- PRODUCT COMPLEX;2.06;CA;CALCIUM ION;GALACTOCEREBROSIDASE;10090;
4CE5;B;First crystal structure of an (R)-selective omega-transaminase from Aspergillus terreus;1.63;CA;CALCIUM ION;AT-OMEGATA;33178;
4CE8;A;Perdeuterated Pseudomonas aeruginosa Lectin II complex with hydrogenated L-Fucose and Calcium;0.9;CA;CALCIUM ION;FUCOSE-BINDING LECTIN PA-IIL;287;
4CE8;B;Perdeuterated Pseudomonas aeruginosa Lectin II complex with hydrogenated L-Fucose and Calcium;0.9;CA;CALCIUM ION;FUCOSE-BINDING LECTIN PA-IIL;287;
4CE8;C;Perdeuterated Pseudomonas aeruginosa Lectin II complex with hydrogenated L-Fucose and Calcium;0.9;CA;CALCIUM ION;FUCOSE-BINDING LECTIN PA-IIL;287;
4CE8;D;Perdeuterated Pseudomonas aeruginosa Lectin II complex with hydrogenated L-Fucose and Calcium;0.9;CA;CALCIUM ION;FUCOSE-BINDING LECTIN PA-IIL;287;
4CEL;A;ACTIVE-SITE MUTANT D214N DETERMINED AT PH 6.0 WITH NO LIGAND BOUND IN THE ACTIVE SITE;2.2;CA;CALCIUM ION;1,4-BETA-D-GLUCAN CELLOBIOHYDROLASE I;51453;
4CEL;B;ACTIVE-SITE MUTANT D214N DETERMINED AT PH 6.0 WITH NO LIGAND BOUND IN THE ACTIVE SITE;2.2;CA;CALCIUM ION;1,4-BETA-D-GLUCAN CELLOBIOHYDROLASE I;51453;
4CFQ;A;Ca-bound truncated (delta13C) and C3S, C81S and C86S mutated S100A4 complexed with non-muscle myosin IIA;1.37;CA;CALCIUM ION;PROTEIN S100-A4;9606;
4CFQ;B;Ca-bound truncated (delta13C) and C3S, C81S and C86S mutated S100A4 complexed with non-muscle myosin IIA;1.37;CA;CALCIUM ION;PROTEIN S100-A4;9606;
4CFQ;C;Ca-bound truncated (delta13C) and C3S, C81S and C86S mutated S100A4 complexed with non-muscle myosin IIA;1.37;CA;CALCIUM ION;PROTEIN S100-A4;9606;
4CFQ;D;Ca-bound truncated (delta13C) and C3S, C81S and C86S mutated S100A4 complexed with non-muscle myosin IIA;1.37;CA;CALCIUM ION;PROTEIN S100-A4;9606;
4CFR;A;Ca-bound S100A4 C3S, C81S, C86S and F45W mutant complexed with non- muscle myosin IIA;1.4;CA;CALCIUM ION;PROTEIN S100-A4;9606;
4CFR;B;Ca-bound S100A4 C3S, C81S, C86S and F45W mutant complexed with non- muscle myosin IIA;1.4;CA;CALCIUM ION;PROTEIN S100-A4;9606;
4CFY;A;SAVINASE CRYSTAL STRUCTURES FOR COMBINED SINGLE CRYSTAL DIFFRACTION AND POWDER DIFFRACTION ANALYSIS;1.17;CA;CALCIUM ION;SUBTILISIN SAVINASE;1467;
4CFZ;A;SAVINASE CRYSTAL STRUCTURES FOR COMBINED SINGLE CRYSTAL DIFFRACTION AND POWDER DIFFRACTION ANALYSIS;1.57;CA;CALCIUM ION;SUBTILISIN SAVINASE;1467;
4CG0;A;Savinase crystal structures for combined single crystal diffraction and powder diffraction analysis;1.36;CA;CALCIUM ION;SUBTILISIN SAVINASE;1467;
4CGT;A;DELETION MUTANT DELTA(145-150), F151D OF CYCLODEXTRIN GLYCOSYLTRANSFERASE;2.6;CA;CALCIUM ION;CYCLODEXTRIN GLYCOSYLTRANSFERASE;1397;
4CHT;A;Crystal structure of the human topoisomerase III alpha-RMI1 complex with bound calcium ion;3.25;CA;CALCIUM ION;DNA TOPOISOMERASE 3-ALPHA;9606;
4CI6;A;Mechanisms of crippling actin-dependent phagocytosis by YopO;2.65;CA;CALCIUM ION;ACTIN;7108;
4CI7;A;The crystal structure of the cysteine protease and lectin-like domains of Cwp84, a surface layer associated protein of Clostridium difficile;1.4;CA;CALCIUM ION;CELL SURFACE PROTEIN (PUTATIVE CELL SURFACE-ASSOCIATED CYSTEINE PROTEASE);1496;
4CI7;B;The crystal structure of the cysteine protease and lectin-like domains of Cwp84, a surface layer associated protein of Clostridium difficile;1.4;CA;CALCIUM ION;CELL SURFACE PROTEIN (PUTATIVE CELL SURFACE-ASSOCIATED CYSTEINE PROTEASE);1496;
4CID;A;Structural insights into the N-terminus of the EHD2 ATPase;3;CA;CALCIUM ION;EH DOMAIN-CONTAINING PROTEIN 2;10090;
4CIN;A;Complex of Bcl-xL with its BH3 domain;2.69;CA;CALCIUM ION;BCL-2-LIKE PROTEIN 1;9606;
4CIN;B;Complex of Bcl-xL with its BH3 domain;2.69;CA;CALCIUM ION;BCL-2-LIKE PROTEIN 1;9606;
4CJ0;A;Crystal structure of CelD in complex with affitin E12;1.1;CA;CALCIUM ION;ENDOGLUCANASE D;1515;
4CJ1;A;Crystal structure of CelD in complex with affitin H3;1.63;CA;CALCIUM ION;ENDOGLUCANASE D;1515;
4CLK;A;Crystal structure of human soluble Adenylyl Cyclase in complex with alpha,beta-methyleneadenosine-5'-triphosphate;2.2;CA;CALCIUM ION;ADENYLATE CYCLASE TYPE 10;9606;
4CLN;A;STRUCTURE OF A RECOMBINANT CALMODULIN FROM DROSOPHILA MELANOGASTER REFINED AT 2.2-ANGSTROMS RESOLUTION;2.2;CA;CALCIUM ION;CALMODULIN;7227;
4CLW;A;Crystal structure of human soluble Adenylyl Cyclase in complex with alpha,beta-methyleneadenosine-5'-triphosphate soaked with bisulfite;2.15;CA;CALCIUM ION;ADENYLATE CYCLASE TYPE 10;9606;
4CM0;A;Crystal structure of human soluble Adenylyl Cyclase with alpha,beta- methyleneadenosine-5'-triphosphate soaked with bicarbonate;3.2;CA;CALCIUM ION;SOLUBLE ADENYLYL CYCLASE;9606;
4CNW;B;Surface residue engineering of bovine carbonic anhydrase to an extreme halophilic enzyme for potential application in postcombustion CO2 capture;2.03;CA;CALCIUM ION;CARBONIC ANHYDRASE 2;9913;
4COU;A;Crystal Structure of Epithelial Adhesin 6 A domain (Epa6A) from Candida glabrata in complex with Lactose;1.48;CA;CALCIUM ION;EPITHELIAL ADHESIN 6;5478;
4COV;A;Crystal Structure of Epithelial Adhesin 6 A domain (Epa6A) from Candida glabrata in complex with Gala1-3Gal;1.5;CA;CALCIUM ION;EPITHELIAL ADHESIN 6;5478;
4COW;A;Crystal Structure of Epithelial Adhesin 6 A domain (Epa6A) from Candida glabrata in complex with the T-antigen (Galb1-3GalNAc);2.15;CA;CALCIUM ION;EPITHELIAL ADHESIN 6;5478;
4COY;A;Crystal Structure of Epithelial Adhesin 6 A domain (Epa6A) from Candida glabrata in complex with Galb1-4GlcNAc;1.8;CA;CALCIUM ION;EPITHELIAL ADHESIN 6;5478;
4COZ;A;Crystal Structure of Epithelial Adhesin 6 A domain (Epa6A) from Candida glabrata in complex with Galb1-3GlcNAc;2.3;CA;CALCIUM ION;EPITHELIAL ADHESIN 6;5478;
4CP0;A;Crystal Structure of Epithelial Adhesin 9 A domain (Epa9A) from Candida glabrata in complex with Lactose;2.15;CA;CALCIUM ION;EPITHELIAL ADHESIN 9;5478;
4CP1;A;Crystal Structure of Epithelial Adhesin 9 A domain (Epa9A) from Candida glabrata in complex with Galb1-3GlcNAc;2.5;CA;CALCIUM ION;EPITHELIAL ADHESIN 9;5478;
4CP2;A;Crystal Structure of Epithelial Adhesin 9 A domain (Epa9A) from Candida glabrata in complex with Galb1-4GlcNAc;2.6;CA;CALCIUM ION;EPITHELIAL ADHESIN 9;5478;
4CP9;A;Crystal structure OF lecA lectin complexed with a divalent galactoside at 1.65 angstrom;1.65;CA;CALCIUM ION;PA-I GALACTOPHILIC LECTIN;287;
4CP9;B;Crystal structure OF lecA lectin complexed with a divalent galactoside at 1.65 angstrom;1.65;CA;CALCIUM ION;PA-I GALACTOPHILIC LECTIN;287;
4CP9;C;Crystal structure OF lecA lectin complexed with a divalent galactoside at 1.65 angstrom;1.65;CA;CALCIUM ION;PA-I GALACTOPHILIC LECTIN;287;
4CP9;D;Crystal structure OF lecA lectin complexed with a divalent galactoside at 1.65 angstrom;1.65;CA;CALCIUM ION;PA-I GALACTOPHILIC LECTIN;287;
4CPB;A;CRYSTAL STRUCTURE OF LECA IN COMPLEX WITH A DIVALENT GALACTOSIDE AT 1. 57 ANGSTROM IN MAGNESIUM;1.57;CA;CALCIUM ION;PA-I GALACTOPHILIC LECTIN;287;
4CPB;B;CRYSTAL STRUCTURE OF LECA IN COMPLEX WITH A DIVALENT GALACTOSIDE AT 1. 57 ANGSTROM IN MAGNESIUM;1.57;CA;CALCIUM ION;PA-I GALACTOPHILIC LECTIN;287;
4CPB;C;CRYSTAL STRUCTURE OF LECA IN COMPLEX WITH A DIVALENT GALACTOSIDE AT 1. 57 ANGSTROM IN MAGNESIUM;1.57;CA;CALCIUM ION;PA-I GALACTOPHILIC LECTIN;287;
4CPB;D;CRYSTAL STRUCTURE OF LECA IN COMPLEX WITH A DIVALENT GALACTOSIDE AT 1. 57 ANGSTROM IN MAGNESIUM;1.57;CA;CALCIUM ION;PA-I GALACTOPHILIC LECTIN;287;
4CPI;A;streptavidin A86D mutant with love-hate ligand 4;1.54;CA;CALCIUM ION;STREPTAVIDIN;1895;
4CPI;D;streptavidin A86D mutant with love-hate ligand 4;1.54;CA;CALCIUM ION;STREPTAVIDIN;1895;
4CPL;A;Structure of the Neuraminidase from the B/Brisbane/60/2008 virus.;2;CA;CALCIUM ION;NEURAMINIDASE;11520;
4CPL;B;Structure of the Neuraminidase from the B/Brisbane/60/2008 virus.;2;CA;CALCIUM ION;NEURAMINIDASE;11520;
4CPM;A;Structure of the Neuraminidase from the B/Brisbane/60/2008 virus in complex with Oseltamivir;2.75;CA;CALCIUM ION;NEURAMINIDASE;11520;
4CPM;B;Structure of the Neuraminidase from the B/Brisbane/60/2008 virus in complex with Oseltamivir;2.75;CA;CALCIUM ION;NEURAMINIDASE;11520;
4CPN;A;Structure of the Neuraminidase from the B/Brisbane/60/2008 virus in complex with Zanamivir;2.4;CA;CALCIUM ION;NEURAMINIDASE;11520;
4CPN;B;Structure of the Neuraminidase from the B/Brisbane/60/2008 virus in complex with Zanamivir;2.4;CA;CALCIUM ION;NEURAMINIDASE;11520;
4CPO;A;Structure of the Neuraminidase from the B/Lyon/CHU/15.216/2011 virus;2.2;CA;CALCIUM ION;NEURAMINIDASE;11520;
4CPO;B;Structure of the Neuraminidase from the B/Lyon/CHU/15.216/2011 virus;2.2;CA;CALCIUM ION;NEURAMINIDASE;11520;
4CPV;A;REFINED CRYSTAL STRUCTURE OF CALCIUM-LIGANDED CARP PARVALBUMIN 4.25 AT 1.5-ANGSTROMS RESOLUTION;1.5;CA;CALCIUM ION;CALCIUM-BINDING PARVALBUMIN;7962;
4CPY;A;Structure of the Neuraminidase from the B/Lyon/CHU/15.216/2011 virus in complex with Oseltamivir;1.8;CA;CALCIUM ION;NEURAMINIDASE;11520;
4CPY;B;Structure of the Neuraminidase from the B/Lyon/CHU/15.216/2011 virus in complex with Oseltamivir;1.8;CA;CALCIUM ION;NEURAMINIDASE;11520;
4CPZ;A;Structure of the Neuraminidase from the B/Lyon/CHU/15.216/2011 virus in complex with Zanamivir;2.2;CA;CALCIUM ION;NEURAMINIDASE;11520;
4CPZ;B;Structure of the Neuraminidase from the B/Lyon/CHU/15.216/2011 virus in complex with Zanamivir;2.2;CA;CALCIUM ION;NEURAMINIDASE;11520;
4CPZ;C;Structure of the Neuraminidase from the B/Lyon/CHU/15.216/2011 virus in complex with Zanamivir;2.2;CA;CALCIUM ION;NEURAMINIDASE;11520;
4CPZ;D;Structure of the Neuraminidase from the B/Lyon/CHU/15.216/2011 virus in complex with Zanamivir;2.2;CA;CALCIUM ION;NEURAMINIDASE;11520;
4CPZ;E;Structure of the Neuraminidase from the B/Lyon/CHU/15.216/2011 virus in complex with Zanamivir;2.2;CA;CALCIUM ION;NEURAMINIDASE;11520;
4CPZ;F;Structure of the Neuraminidase from the B/Lyon/CHU/15.216/2011 virus in complex with Zanamivir;2.2;CA;CALCIUM ION;NEURAMINIDASE;11520;
4CPZ;G;Structure of the Neuraminidase from the B/Lyon/CHU/15.216/2011 virus in complex with Zanamivir;2.2;CA;CALCIUM ION;NEURAMINIDASE;11520;
4CPZ;H;Structure of the Neuraminidase from the B/Lyon/CHU/15.216/2011 virus in complex with Zanamivir;2.2;CA;CALCIUM ION;NEURAMINIDASE;11520;
4CRQ;A;Crystal structure of the catalytic domain of the modular laminarinase ZgLamC mutant E142S;1.5;CA;CALCIUM ION;ENDO-1,3-BETA-GLUCANASE, FAMILY GH16;63186;
4CRQ;B;Crystal structure of the catalytic domain of the modular laminarinase ZgLamC mutant E142S;1.5;CA;CALCIUM ION;ENDO-1,3-BETA-GLUCANASE, FAMILY GH16;63186;
4CSH;A;Native structure of the lytic CHAPK domain of the endolysin LysK from Staphylococcus aureus bacteriophage K;1.79;CA;CALCIUM ION;LYSK;221915;
4CSH;B;Native structure of the lytic CHAPK domain of the endolysin LysK from Staphylococcus aureus bacteriophage K;1.79;CA;CALCIUM ION;LYSK;221915;
4CSH;C;Native structure of the lytic CHAPK domain of the endolysin LysK from Staphylococcus aureus bacteriophage K;1.79;CA;CALCIUM ION;LYSK;221915;
4CSH;D;Native structure of the lytic CHAPK domain of the endolysin LysK from Staphylococcus aureus bacteriophage K;1.79;CA;CALCIUM ION;LYSK;221915;
4CSY;A;E-selectin lectin, EGF-like and two SCR domains complexed with Sialyl Lewis X;2.41;CA;CALCIUM ION;E-SELECTIN;9606;
4CSY;B;E-selectin lectin, EGF-like and two SCR domains complexed with Sialyl Lewis X;2.41;CA;CALCIUM ION;E-SELECTIN;9606;
4CT3;A;Methylmercury chloride derivative structure of the lytic CHAPK domain of the endolysin LysK from Staphylococcus aureus bacteriophage K;1.69;CA;CALCIUM ION;ORF30/ORF32;221915;
4CT3;B;Methylmercury chloride derivative structure of the lytic CHAPK domain of the endolysin LysK from Staphylococcus aureus bacteriophage K;1.69;CA;CALCIUM ION;ORF30/ORF32;221915;
4CT3;C;Methylmercury chloride derivative structure of the lytic CHAPK domain of the endolysin LysK from Staphylococcus aureus bacteriophage K;1.69;CA;CALCIUM ION;ORF30/ORF32;221915;
4CT3;D;Methylmercury chloride derivative structure of the lytic CHAPK domain of the endolysin LysK from Staphylococcus aureus bacteriophage K;1.69;CA;CALCIUM ION;ORF30/ORF32;221915;
4CTE;A;Crystal structure of the catalytic domain of the modular laminarinase ZgLamC mutant E142S in complex with a thio-oligosaccharide;1.8;CA;CALCIUM ION;ENDO-1,3-BETA-GLUCANASE, FAMILY GH16;63186;
4CTE;B;Crystal structure of the catalytic domain of the modular laminarinase ZgLamC mutant E142S in complex with a thio-oligosaccharide;1.8;CA;CALCIUM ION;ENDO-1,3-BETA-GLUCANASE, FAMILY GH16;63186;
4CU9;A;Unravelling the multiple functions of the architecturally intricate Streptococcus pneumoniae beta-galactosidase, BgaA;1.83;CA;CALCIUM ION;BETA-GALACTOSIDASE;1313;
4CU9;B;Unravelling the multiple functions of the architecturally intricate Streptococcus pneumoniae beta-galactosidase, BgaA;1.83;CA;CALCIUM ION;BETA-GALACTOSIDASE;1313;
4CUA;A;Unravelling the multiple functions of the architecturally intricate Streptococcus pneumoniae beta-galactosidase, BgaA;1.54;CA;CALCIUM ION;BETA-GALACTOSIDASE;1313;
4CUA;B;Unravelling the multiple functions of the architecturally intricate Streptococcus pneumoniae beta-galactosidase, BgaA;1.54;CA;CALCIUM ION;BETA-GALACTOSIDASE;1313;
4CUB;A;Unravelling the multiple functions of the architecturally intricate Streptococcus pneumoniae beta-galactosidase, BgaA;2.1;CA;CALCIUM ION;BETA-GALACTOSIDASE;1313;
4CUB;B;Unravelling the multiple functions of the architecturally intricate Streptococcus pneumoniae beta-galactosidase, BgaA;2.1;CA;CALCIUM ION;BETA-GALACTOSIDASE;1313;
4CUD;A;Human Notch1 EGF domains 11-13 mutant fucosylated at T466;1.85;CA;CALCIUM ION;NEUROGENIC LOCUS NOTCH HOMOLOG PROTEIN 1;9606;
4CUE;A;Human Notch1 EGF domains 11-13 mutant T466V;3;CA;CALCIUM ION;NEUROGENIC LOCUS NOTCH HOMOLOG PROTEIN 1;9606;
4CUF;A;Human Notch1 EGF domains 11-13 mutant T466S;2.29;CA;CALCIUM ION;NEUROGENIC LOCUS NOTCH HOMOLOG PROTEIN 1;9606;
4CUO;A;Banyan peroxidase with glycosylation;1.67;CA;CALCIUM ION;BANYAN PEROXIDASE;309271;
4CVB;A;Crystal structure of quinone-dependent alcohol dehydrogenase from Pseudogluconobacter saccharoketogenenes;1.72;CA;CALCIUM ION;ALCOHOL DEHYDROGENASE;133921;
4CVU;A;Structure of Fungal beta-mannosidase from Glycoside Hydrolase Family 2 of Trichoderma harzianum;1.9;CA;CALCIUM ION;BETA-MANNOSIDASE;5544;
4CVW;A;Structure of the barley limit dextrinase-limit dextrinase inhibitor complex;2.67;CA;CALCIUM ION;LIMIT DEXTRINASE;4513;
4CVW;B;Structure of the barley limit dextrinase-limit dextrinase inhibitor complex;2.67;CA;CALCIUM ION;LIMIT DEXTRINASE;4513;
4CXK;A;G9 mutant of PAS, arylsulfatase from Pseudomonas Aeruginosa;1.86;CA;CALCIUM ION;ARYLSULFATASE;287;
4CXK;B;G9 mutant of PAS, arylsulfatase from Pseudomonas Aeruginosa;1.86;CA;CALCIUM ION;ARYLSULFATASE;287;
4CXS;A;G4 mutant of PAS, arylsulfatase from Pseudomonas aeruginosa, in complex with Phenylphosphonic acid;2.3;CA;CALCIUM ION;ARYLSULFATASE;287;
4CXS;B;G4 mutant of PAS, arylsulfatase from Pseudomonas aeruginosa, in complex with Phenylphosphonic acid;2.3;CA;CALCIUM ION;ARYLSULFATASE;287;
4CXU;A;G4 mutant of PAS, arylsulfatase from Pseudomonas Aeruginosa, in complex with 3-Br-Phenolphenylphosphonate;2.03;CA;CALCIUM ION;ARYLSULFATASE;287;
4CXU;B;G4 mutant of PAS, arylsulfatase from Pseudomonas Aeruginosa, in complex with 3-Br-Phenolphenylphosphonate;2.03;CA;CALCIUM ION;ARYLSULFATASE;287;
4CYR;A;G4 mutant of PAS, arylsulfatase from Pseudomonas Aeruginosa;1.72;CA;CALCIUM ION;ARYLSULFATASE;287;
4CYR;B;G4 mutant of PAS, arylsulfatase from Pseudomonas Aeruginosa;1.72;CA;CALCIUM ION;ARYLSULFATASE;287;
4CYS;A;G6 mutant of PAS, arylsulfatase from Pseudomonas Aeruginosa, in complex with Phenylphosphonic acid;1.88;CA;CALCIUM ION;ARYLSULFATASE;287;
4CYS;B;G6 mutant of PAS, arylsulfatase from Pseudomonas Aeruginosa, in complex with Phenylphosphonic acid;1.88;CA;CALCIUM ION;ARYLSULFATASE;287;
4CZN;A;Crystal structure of the extralong fungal manganese peroxidase from Ceriporiopsis subvermispora;1.2;CA;CALCIUM ION;EXTRALONG MANGANESE PEROXIDASE;42742;
4CZO;A;Crystal structure of the extralong fungal manganese peroxidase from Ceriporiopsis subvermispora in complex with manganese;1.2;CA;CALCIUM ION;EXTRALONG MANGANESE PEROXIDASE;42742;
4CZP;A;Crystal structure of the extralong fungal manganese peroxidase from ceriporiopsis subvermispora in complex with manganese (anomalous data);1.9;CA;CALCIUM ION;EXTRALONG MANGANESE PEROXIDASE;42742;
4CZQ;A;Crystal structure of the extralong fungal manganese peroxidase from Ceriporiopsis subvermispora in complex with cadmium;1.2;CA;CALCIUM ION;EXTRALONG MANGANESE PEROXIDASE;42742;
4CZR;A;Crystal structure of the extralong fungal manganese peroxidase from Ceriporiopsis subvermispora in complex with cadmium (anomalous data);1.98;CA;CALCIUM ION;EXTRALONG MANGANESE PEROXIDASE;42742;
4CZS;A;Discovery of Glycomimetic Ligands via Genetically-encoded Library of Phage displaying Mannose-peptides;1.73;CA;CALCIUM ION;CONCANAVALIN-A;28958;
4CZS;B;Discovery of Glycomimetic Ligands via Genetically-encoded Library of Phage displaying Mannose-peptides;1.73;CA;CALCIUM ION;CONCANAVALIN-A;28958;
4CZS;C;Discovery of Glycomimetic Ligands via Genetically-encoded Library of Phage displaying Mannose-peptides;1.73;CA;CALCIUM ION;CONCANAVALIN-A;28958;
4CZS;D;Discovery of Glycomimetic Ligands via Genetically-encoded Library of Phage displaying Mannose-peptides;1.73;CA;CALCIUM ION;CONCANAVALIN-A;28958;
4D0E;A;Human Notch1 EGF domains 11-13 mutant GlcNAc-fucose disaccharide modified at T466;1.61;CA;CALCIUM ION;NEUROGENIC LOCUS NOTCH HOMOLOG PROTEIN 1;9606;
4D0F;A;Human Notch1 EGF domains 11-13 mutant T466A;2.8;CA;CALCIUM ION;NEUROGENIC LOCUS NOTCH HOMOLOG PROTEIN 1;9606;
4D3L;B;SeMet structure of a novel carbohydrate binding module from glycoside hydrolase family 9 (Cel9A) from Ruminococcus flavefaciens FD-1 in the orthorhombic form;2;CA;CALCIUM ION;CARBOHYDRATE BINDING MODULE;1265;
4D3W;A;Crystal Structure of Epithelial Adhesin 1 A domain (Epa1A) from Candida glabrata in complex with the T-antigen (Galb1-3GalNAc);1.5;CA;CALCIUM ION;EPITHELIAL ADHESIN 1;5478;
4D59;A;Clostridial Cysteine protease Cwp84 C116A after propeptide cleavage;1.84;CA;CALCIUM ION;CELL SURFACE PROTEIN (PUTATIVE CELL SURFACE-ASSOCIATED CYSTEINE PROTEASE);1496;
4D59;B;Clostridial Cysteine protease Cwp84 C116A after propeptide cleavage;1.84;CA;CALCIUM ION;CELL SURFACE PROTEIN (PUTATIVE CELL SURFACE-ASSOCIATED CYSTEINE PROTEASE);1496;
4D5A;A;Clostridial Cysteine protease Cwp84 C116A after propeptide cleavage;1.6;CA;CALCIUM ION;CELL SURFACE PROTEIN (PUTATIVE CELL SURFACE-ASSOCIATED CYSTEINE PROTEASE);1496;
4D5A;B;Clostridial Cysteine protease Cwp84 C116A after propeptide cleavage;1.6;CA;CALCIUM ION;CELL SURFACE PROTEIN (PUTATIVE CELL SURFACE-ASSOCIATED CYSTEINE PROTEASE);1496;
4D8S;A;Influenza NA in complex with antiviral compound;2.4;CA;CALCIUM ION;Neuraminidase;11320;
4D90;A;Crystal Structure of Del-1 EGF domains;2.6;CA;CALCIUM ION;EGF-like repeat and discoidin I-like domain-containing protein 3;9606;
4D90;B;Crystal Structure of Del-1 EGF domains;2.6;CA;CALCIUM ION;EGF-like repeat and discoidin I-like domain-containing protein 3;9606;
4D91;A;Thermolysin In Complex With DMSO And Acetate;1.9;CA;CALCIUM ION;Thermolysin;1427;
4D9W;A;Thermolysin In Complex With UBTLN32;1.38;CA;CALCIUM ION;Thermolysin;1427;
4D9X;B;The crystal structure of Coptisine bound to DNA d(CGTACG);2.44;CA;CALCIUM ION;DNA (5'-D(*CP*GP*TP*AP*CP*G)-3');;
4D9Y;B;The crystal structure of Chelerythrine bound to DNA d(CGTACG);2.1;CA;CALCIUM ION;DNA (5'-D(*CP*GP*TP*AP*CP*G)-3');;
4DA2;A;The structure of Pyrococcus Furiosus SfsA in complex with Ca2+;1.8;CA;CALCIUM ION;Sugar fermentation stimulation protein homolog;2261;
4DA2;B;The structure of Pyrococcus Furiosus SfsA in complex with Ca2+;1.8;CA;CALCIUM ION;Sugar fermentation stimulation protein homolog;2261;
4DBK;A;Crystal structure of porcine pancreatic phospholipase A2 complexed with berberine;2.3;CA;CALCIUM ION;Phospholipase A2, major isoenzyme;9823;
4DBP;C;Myosin VI nucleotide-free (MDINSERT2) D179Y crystal structure;2.2;CA;CALCIUM ION;Calmodulin;7227;
4DBQ;B;MYOSIN VI D179Y (MD-INSERT2-CAM, DELTA-INSERT1) post-rigor state;2.6;CA;CALCIUM ION;Calmodulin;7227;
4DD8;A;ADAM-8 metalloproteinase domain with bound batimastat;2.1;CA;CALCIUM ION;Disintegrin and metalloproteinase domain-containing protein 8;9606;
4DD8;B;ADAM-8 metalloproteinase domain with bound batimastat;2.1;CA;CALCIUM ION;Disintegrin and metalloproteinase domain-containing protein 8;9606;
4DD8;C;ADAM-8 metalloproteinase domain with bound batimastat;2.1;CA;CALCIUM ION;Disintegrin and metalloproteinase domain-containing protein 8;9606;
4DD8;D;ADAM-8 metalloproteinase domain with bound batimastat;2.1;CA;CALCIUM ION;Disintegrin and metalloproteinase domain-containing protein 8;9606;
4DEU;B;Crystal Structure of the Wild Type TTR Binding Naringenin (TTRwt:NAR);1.6;CA;CALCIUM ION;Transthyretin;9606;
4DF7;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS V23L/V99I at cryogenic temperature;1.5;CA;CALCIUM ION;Thermonuclease;1280;
4DFA;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS I92A/L36A at cryogenic temperature;1.4;CA;CALCIUM ION;Thermonuclease;1280;
4DFR;B;CRYSTAL STRUCTURES OF ESCHERICHIA COLI AND LACTOBACILLUS CASEI DIHYDROFOLATE REDUCTASE REFINED AT 1.7 ANGSTROMS RESOLUTION. I. GENERAL FEATURES AND BINDING OF METHOTREXATE;1.7;CA;CALCIUM ION;DIHYDROFOLATE REDUCTASE;562;
4DFS;A;Structure of the catalytic domain of an endo-1,3-beta-glucanase (laminarinase) from Thermotoga petrophila RKU-1;3.75;CA;CALCIUM ION;Glycoside hydrolase, family 16;93929;
4DFS;B;Structure of the catalytic domain of an endo-1,3-beta-glucanase (laminarinase) from Thermotoga petrophila RKU-1;3.75;CA;CALCIUM ION;Glycoside hydrolase, family 16;93929;
4DG4;A;Human mesotrypsin-S39Y complexed with bovine pancreatic trypsin inhibitor (BPTI);1.4;CA;CALCIUM ION;PRSS3 protein;9606;
4DGR;A;Influenza Subtype 9 Neuraminidase Benzoic Acid Inhibitor Complex;1.55;CA;CALCIUM ION;Neuraminidase;11320;
4DGZ;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS I92A/L125A at cryogenic temperature;1.47;CA;CALCIUM ION;Thermonuclease;1280;
4DH2;B;Crystal structure of Coh-OlpC(Cthe_0452)-Doc435(Cthe_0435) complex: A novel type I Cohesin-Dockerin complex from Clostridium thermocellum ATTC 27405;1.75;CA;CALCIUM ION;Dockerin type 1;1515;
4DH2;D;Crystal structure of Coh-OlpC(Cthe_0452)-Doc435(Cthe_0435) complex: A novel type I Cohesin-Dockerin complex from Clostridium thermocellum ATTC 27405;1.75;CA;CALCIUM ION;Dockerin type 1;1515;
4DIR;A;2.6 Angstrom X-ray structure of human CA(2+)-S100A5;2.6;CA;CALCIUM ION;Protein S100-A5;9606;
4DIR;B;2.6 Angstrom X-ray structure of human CA(2+)-S100A5;2.6;CA;CALCIUM ION;Protein S100-A5;9606;
4DJC;A;1.35 A crystal structure of the NaV1.5 DIII-IV-Ca/CaM complex;1.35;CA;CALCIUM ION;Calmodulin;9606;
4DJD;A;Crystal structure of folate-free corrinoid iron-sulfur protein (CFeSP) in complex with its methyltransferase (MeTr);2.38;CA;CALCIUM ION;5-methyltetrahydrofolate corrinoid/iron sulfur protein methyltransferase;1525;
4DJD;B;Crystal structure of folate-free corrinoid iron-sulfur protein (CFeSP) in complex with its methyltransferase (MeTr);2.38;CA;CALCIUM ION;5-methyltetrahydrofolate corrinoid/iron sulfur protein methyltransferase;1525;
4DJE;A;Crystal structure of folate-bound corrinoid iron-sulfur protein (CFeSP) in complex with its methyltransferase (MeTr), co-crystallized with folate;3.5;CA;CALCIUM ION;5-methyltetrahydrofolate corrinoid/iron sulfur protein methyltransferase;1525;
4DJE;B;Crystal structure of folate-bound corrinoid iron-sulfur protein (CFeSP) in complex with its methyltransferase (MeTr), co-crystallized with folate;3.5;CA;CALCIUM ION;5-methyltetrahydrofolate corrinoid/iron sulfur protein methyltransferase;1525;
4DJF;A;Crystal structure of folate-bound corrinoid iron-sulfur protein (CFeSP) in complex with its methyltransferase (MeTr), co-crystallized with folate and Ti(III) citrate reductant;3.03;CA;CALCIUM ION;5-methyltetrahydrofolate corrinoid/iron sulfur protein methyltransferase;1525;
4DJF;B;Crystal structure of folate-bound corrinoid iron-sulfur protein (CFeSP) in complex with its methyltransferase (MeTr), co-crystallized with folate and Ti(III) citrate reductant;3.03;CA;CALCIUM ION;5-methyltetrahydrofolate corrinoid/iron sulfur protein methyltransferase;1525;
4DJL;A;Carboxypeptidase T with N-sulfamoyl-L-phenylalanine;1.55;CA;CALCIUM ION;Carboxypeptidase T;2026;
4DK4;A;Crystal Structure of Trypanosoma brucei dUTPase with dUpNp, Ca2+ and Na+;1.9;CA;CALCIUM ION;Deoxyuridine triphosphatase;5691;
4DK4;B;Crystal Structure of Trypanosoma brucei dUTPase with dUpNp, Ca2+ and Na+;1.9;CA;CALCIUM ION;Deoxyuridine triphosphatase;5691;
4DK7;A;Crystal structure of LXR ligand binding domain in complex with full agonist 1;2.45;CA;CALCIUM ION;Oxysterols receptor LXR-beta;9606;
4DK7;C;Crystal structure of LXR ligand binding domain in complex with full agonist 1;2.45;CA;CALCIUM ION;Oxysterols receptor LXR-beta;9606;
4DK8;A;Crystal structure of LXR ligand binding domain in complex with partial agonist 5;2.75;CA;CALCIUM ION;Oxysterols receptor LXR-beta;9606;
4DK8;C;Crystal structure of LXR ligand binding domain in complex with partial agonist 5;2.75;CA;CALCIUM ION;Oxysterols receptor LXR-beta;9606;
4DKB;A;Crystal Structure of Trypanosoma brucei dUTPase with dUpNp and Ca2+;1.83;CA;CALCIUM ION;Deoxyuridine triphosphatase;5691;
4DKT;A;Crystal structure of human peptidylarginine deiminase 4 in complex with N-acetyl-L-threonyl-L-alpha-aspartyl-N5-[(1E)-2-fluoroethanimidoyl]-L-ornithinamide;2.98;CA;CALCIUM ION;Protein-arginine deiminase type-4;9606;
4DL1;C;Crystal Structure of human Myeloperoxidase with covalent thioxanthine analog;2;CA;CALCIUM ION;Myeloperoxidase heavy chain;9606;
4DL1;D;Crystal Structure of human Myeloperoxidase with covalent thioxanthine analog;2;CA;CALCIUM ION;Myeloperoxidase heavy chain;9606;
4DL1;G;Crystal Structure of human Myeloperoxidase with covalent thioxanthine analog;2;CA;CALCIUM ION;Myeloperoxidase heavy chain;9606;
4DL1;H;Crystal Structure of human Myeloperoxidase with covalent thioxanthine analog;2;CA;CALCIUM ION;Myeloperoxidase heavy chain;9606;
4DL1;K;Crystal Structure of human Myeloperoxidase with covalent thioxanthine analog;2;CA;CALCIUM ION;Myeloperoxidase heavy chain;9606;
4DL1;L;Crystal Structure of human Myeloperoxidase with covalent thioxanthine analog;2;CA;CALCIUM ION;Myeloperoxidase heavy chain;9606;
4DL1;O;Crystal Structure of human Myeloperoxidase with covalent thioxanthine analog;2;CA;CALCIUM ION;Myeloperoxidase heavy chain;9606;
4DL1;P;Crystal Structure of human Myeloperoxidase with covalent thioxanthine analog;2;CA;CALCIUM ION;Myeloperoxidase heavy chain;9606;
4DLK;A;Crystal Structure of ATP-Ca++ complex of purK: N5-carboxyaminoimidazole ribonucleotide synthetase;2.02;CA;CALCIUM ION;Phosphoribosylaminoimidazole carboxylase, ATPase subunit;1392;
4DLK;B;Crystal Structure of ATP-Ca++ complex of purK: N5-carboxyaminoimidazole ribonucleotide synthetase;2.02;CA;CALCIUM ION;Phosphoribosylaminoimidazole carboxylase, ATPase subunit;1392;
4DLR;A;H-Ras PEG 400/Ca(OAc)2, ordered off;1.32;CA;CALCIUM ION;GTPase HRas;9606;
4DLS;A;H-Ras Set 1 CaCl2 'Mixed';1.82;CA;CALCIUM ION;GTPase HRas;9606;
4DLT;A;H-Ras Set 2 Ca(OAc)2, on;1.7;CA;CALCIUM ION;GTPase HRas;9606;
4DLU;A;H-Ras Set 1 Ca(OAc)2, on;1.6;CA;CALCIUM ION;GTPase HRas;9606;
4DLV;A;H-Ras Set 2 CaCl2/DTT, ordered off;1.57;CA;CALCIUM ION;GTPase HRas;9606;
4DLW;A;H-Ras Set 2 Ca(OAc)2/DTT, on;1.72;CA;CALCIUM ION;GTPase HRas;9606;
4DLX;A;H-Ras Set 1 CaCl2/DTE, ordered off;1.73;CA;CALCIUM ION;GTPase HRas;9606;
4DLY;A;Set 1 CaCl2/DTT, ordered off;1.57;CA;CALCIUM ION;GTPase HRas;9606;
4DLZ;A;H-Ras Set 2 Ca(OAc)2/DTE, ordered off;1.66;CA;CALCIUM ION;GTPase HRas;9606;
4DN8;A;Structure of porcine surfactant protein D neck and carbohydrate recognition domain complexed with mannose;2.2;CA;CALCIUM ION;Pulmonary surfactant-associated protein D;9823;
4DNN;B;Crystal structure of the Quaking Qua1 homodimerization domain;2.1;CA;CALCIUM ION;Protein quaking;10090;
4DOD;A;The structure of Cbescii CelA GH9 module;1.7;CA;CALCIUM ION;1,4-beta-glucanase;31899;
4DOE;A;The liganded structure of Cbescii CelA GH9 module;1.56;CA;CALCIUM ION;1,4-beta-glucanase;31899;
4DOK;A;Crystal structure of Arabidopsis thaliana chalcone-isomerase like protein At5g05270 (AtCHIL);1.7;CA;CALCIUM ION;Similarity to chalcone-flavonone isomerase;3702;
4DOK;B;Crystal structure of Arabidopsis thaliana chalcone-isomerase like protein At5g05270 (AtCHIL);1.7;CA;CALCIUM ION;Similarity to chalcone-flavonone isomerase;3702;
4DOQ;A;Crystal structure of the complex of Porcine Pancreatic Trypsin with 1/2SLPI;2;CA;CALCIUM ION;Trypsin;9823;
4DOQ;C;Crystal structure of the complex of Porcine Pancreatic Trypsin with 1/2SLPI;2;CA;CALCIUM ION;Trypsin;9823;
4DOQ;E;Crystal structure of the complex of Porcine Pancreatic Trypsin with 1/2SLPI;2;CA;CALCIUM ION;Trypsin;9823;
4DOU;A;Crystal Structure of a Single-chain Trimer of Human Adiponectin Globular Domain;2;CA;CALCIUM ION;Adiponectin;9606;
4DPE;A;Structure of MMP3 complexed with a platinum-based inhibitor.;1.96;CA;CALCIUM ION;Stromelysin-1;9606;
4DPE;B;Structure of MMP3 complexed with a platinum-based inhibitor.;1.96;CA;CALCIUM ION;Stromelysin-1;9606;
4DPN;A;Crystal Structure of ConM Complexed with Resveratrol;2.55;CA;CALCIUM ION;Concanavalin-A;28957;
4DPN;D;Crystal Structure of ConM Complexed with Resveratrol;2.55;CA;CALCIUM ION;Concanavalin-A;28957;
4DRZ;A;Crystal structure of human RAB14;2.3;CA;CALCIUM ION;Ras-related protein Rab-14;9606;
4DSI;C;Crystal structure of fragment DNA polymerase I from Bacillus stearothermophilus with duplex DNA, Se-dGTP and Calcium;2.05;CA;CALCIUM ION;Se-dGTP;;
4DSJ;A;Crystal structure of fragment DNA polymerase I from Bacillus stearothermophilus with duplex DNA, dGTP and Calcium;2.86;CA;CALCIUM ION;DNA polymerase;1422;
4DSK;A;Crystal structure of fragment DNA polymerase I from Bacillus stearothermophilus with duplex DNA, PPi and Calcium;2.18;CA;CALCIUM ION;DNA polymerase;1422;
4DSK;B;Crystal structure of fragment DNA polymerase I from Bacillus stearothermophilus with duplex DNA, PPi and Calcium;2.18;CA;CALCIUM ION;DNA (5'-D(*GP*GP*CP*TP*AP*CP*AP*GP*GP*AP*CP*TP*CP*G)-3');;
4DTJ;A;RB69 DNA Polymerase Ternary Complex with dTTP Opposite an Abasic Site and ddT/dA as the Penultimate Base-pair;1.9;CA;CALCIUM ION;DNA polymerase;1914161;
4DTM;A;RB69 DNA Polymerase Ternary Complex with dCTP Opposite an Abasic Site and ddG/dC as the Penultimate Base-pair;1.95;CA;CALCIUM ION;DNA polymerase;1914161;
4DTN;A;RB69 DNA Polymerase Ternary Complex with dATP Opposite an Abasic Site and ddA/dT as the Penultimate Base-pair;1.96;CA;CALCIUM ION;DNA polymerase;1914161;
4DTO;A;RB69 DNA Polymerase Ternary Complex with dCTP Opposite an Abasic Site and ddA/dT as the Penultimate Base-pair;2.05;CA;CALCIUM ION;DNA polymerase;1914161;
4DTP;A;RB69 DNA Polymerase Ternary Complex with dGTP Opposite an Abasic Site and ddA/dT as the Penultimate Base-pair;2.05;CA;CALCIUM ION;DNA polymerase;1914161;
4DTR;A;RB69 DNA Polymerase Ternary Complex with dATP Opposite an Abasic Site and ddC/dG as the Penultimate Base-pair;2.04;CA;CALCIUM ION;DNA polymerase;1914161;
4DTS;A;RB69 DNA Polymerase Ternary Complex with dCTP Opposite an Abasic Site and ddC/dG as the Penultimate Base-pair;1.96;CA;CALCIUM ION;DNA polymerase;1914161;
4DTU;A;RB69 DNA Polymerase Ternary Complex with dGTP Opposite an Abasic Site and ddC/dG as the Penultimate Base-pair;1.86;CA;CALCIUM ION;DNA polymerase;1914161;
4DTU;P;RB69 DNA Polymerase Ternary Complex with dGTP Opposite an Abasic Site and ddC/dG as the Penultimate Base-pair;1.86;CA;CALCIUM ION;DNA primer;;
4DTX;A;RB69 DNA Polymerase Ternary Complex with dTTP Opposite an Abasic Site and ddC/dG as the Penultimate Base-pair;1.84;CA;CALCIUM ION;DNA polymerase;1914161;
4DU1;A;RB69 DNA Polymerase Ternary Complex with dATP Opposite dT;2.15;CA;CALCIUM ION;DNA polymerase;1914161;
4DU3;A;RB69 DNA Polymerase Ternary Complex with dDTP Opposite dT with 3-Deaza-adenine at the N-1 Position of Template Strand;2.02;CA;CALCIUM ION;DNA polymerase;1914161;
4DU4;A;RB69 DNA Polymerase Ternary Complex with dATP Opposite dT with 3-Deaza-adenine at the N-3 Position of Primer Strand;2.28;CA;CALCIUM ION;DNA polymerase;1914161;
4DU6;B;Crystal structure of GTP cyclohydrolase I from Yersinia pestis complexed with GTP;2.11;CA;CALCIUM ION;GTP cyclohydrolase 1;632;
4DU6;C;Crystal structure of GTP cyclohydrolase I from Yersinia pestis complexed with GTP;2.11;CA;CALCIUM ION;GTP cyclohydrolase 1;632;
4DU6;D;Crystal structure of GTP cyclohydrolase I from Yersinia pestis complexed with GTP;2.11;CA;CALCIUM ION;GTP cyclohydrolase 1;632;
4DU9;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS I92A/V74A at cryogenic temperature;1.63;CA;CALCIUM ION;Thermonuclease;1280;
4DUK;A;Carboxypeptidase T with L-BENZYLSUCCINIC ACID;1.57;CA;CALCIUM ION;Carboxypeptidase T;2026;
4DUQ;A;The Structure of Ca2+-loaded S100A2 at 1.3A resolution;1.3;CA;CALCIUM ION;Protein S100-A2;9606;
4DUQ;B;The Structure of Ca2+-loaded S100A2 at 1.3A resolution;1.3;CA;CALCIUM ION;Protein S100-A2;9606;
4DWI;C;Crystal structure of fragment DNA polymerase I from Bacillus stearothermophilus with self complementary DNA, Se-dGTP and Calcium;1.85;CA;CALCIUM ION;DNA (5'-D(*AP*CP*TP*GP*GP*AP*TP*CP*CP*A)-3');;
4DWW;A;Crystal Structure of Nattokinase from Bacillus subtilis natto;1.74;CA;CALCIUM ION;Subtilisin NAT;1423;
4DXW;A;Crystal structure of NavRh, a voltage-gated sodium channel;3.05;CA;CALCIUM ION;Ion transport protein;684719;
4DXW;B;Crystal structure of NavRh, a voltage-gated sodium channel;3.05;CA;CALCIUM ION;Ion transport protein;684719;
4DY7;A;Crystal structures of protease nexin-1 in complex with S195A thrombin;2.8;CA;CALCIUM ION;Thrombin light chain;9606;
4DY7;F;Crystal structures of protease nexin-1 in complex with S195A thrombin;2.8;CA;CALCIUM ION;Glia-derived nexin;9606;
4DYX;A;Crystal Structure of the Cu-adduct of Human H-Ferritin variant 4His-delta C-star;1.85;CA;CALCIUM ION;Ferritin heavy chain;9606;
4DYY;A;Crystal Structure of the Cu-adduct of Human H-Ferritin variant MIC1;1.9;CA;CALCIUM ION;Ferritin heavy chain;9606;
4DYZ;A;Crystal Structure of the apo form of Human H-Ferritin variant MIC1;2.3;CA;CALCIUM ION;Ferritin heavy chain;9606;
4DZ0;A;Crystal structure of the Cu-adduct of human H-Ferritin variant MIC1 labeled with a dansyl fluorophore;2.5;CA;CALCIUM ION;Ferritin heavy chain;9606;
4DZ2;A;Crystal structure of a Peptidyl-prolyl cis-trans isomerase with surface mutation R92G from Burkholderia pseudomallei complexed with FK506;2;CA;CALCIUM ION;Peptidyl-prolyl cis-trans isomerase;28450;
4DZ2;B;Crystal structure of a Peptidyl-prolyl cis-trans isomerase with surface mutation R92G from Burkholderia pseudomallei complexed with FK506;2;CA;CALCIUM ION;Peptidyl-prolyl cis-trans isomerase;28450;
4DZ3;A;Crystal structure of a Peptidyl-prolyl cis-trans isomerase with surface mutation M61H from Burkholderia pseudomallei complexed with FK506;2;CA;CALCIUM ION;Peptidyl-prolyl cis-trans isomerase;28450;
4DZ3;B;Crystal structure of a Peptidyl-prolyl cis-trans isomerase with surface mutation M61H from Burkholderia pseudomallei complexed with FK506;2;CA;CALCIUM ION;Peptidyl-prolyl cis-trans isomerase;28450;
4DZR;A;The crystal structure of protein-(glutamine-N5) methyltransferase (release factor-specific) from Alicyclobacillus acidocaldarius subsp. acidocaldarius DSM 446;2.55;CA;CALCIUM ION;Protein-(Glutamine-N5) methyltransferase, release factor-specific;405212;
4DZT;A;Aqualysin I: the crystal structure of a serine protease from an extreme thermophile, Thermus aquaticus YT-1;1.95;CA;CALCIUM ION;Aqualysin-1;271;
4E0S;B;Crystal Structure of C5b-6;4.21;CA;CALCIUM ION;Complement component C6;9606;
4E2O;A;Crystal structure of alpha-amylase from Geobacillus thermoleovorans, GTA, complexed with acarbose;2.1;CA;CALCIUM ION;Alpha-amylase;33941;
4E3S;A;RB69 DNA Polymerase Ternary Complex with dQTP Opposite dT;2.04;CA;CALCIUM ION;DNA polymerase;1914161;
4.00E+52;A;Crystal structure of Haemophilus Eagan 4A polysaccharide bound human lung surfactant protein D;1.7;CA;CALCIUM ION;Pulmonary surfactant-associated protein D;9606;
4.00E+52;B;Crystal structure of Haemophilus Eagan 4A polysaccharide bound human lung surfactant protein D;1.7;CA;CALCIUM ION;Pulmonary surfactant-associated protein D;9606;
4.00E+52;C;Crystal structure of Haemophilus Eagan 4A polysaccharide bound human lung surfactant protein D;1.7;CA;CALCIUM ION;Pulmonary surfactant-associated protein D;9606;
4.00E+55;A;Crystal Structure of spacer removed cephalosporin acylase mutant;2.3;CA;CALCIUM ION;Cephalosporin acylase;81841;
4.00E+55;B;Crystal Structure of spacer removed cephalosporin acylase mutant;2.3;CA;CALCIUM ION;Cephalosporin acylase;81841;
4.00E+56;A;Crystal Structure of spacer 8aa-shortened cephalosporin acylase mutant;2.2;CA;CALCIUM ION;Cephalosporin acylase;81841;
4.00E+56;B;Crystal Structure of spacer 8aa-shortened cephalosporin acylase mutant;2.2;CA;CALCIUM ION;Cephalosporin acylase;81841;
4E5U;A;The crystal structure of thymidylate kinase from Pseudomonas aeruginosa PAO1 in complex with thymidine monophosphate.;1.81;CA;CALCIUM ION;Thymidylate kinase;287;
4E5U;B;The crystal structure of thymidylate kinase from Pseudomonas aeruginosa PAO1 in complex with thymidine monophosphate.;1.81;CA;CALCIUM ION;Thymidylate kinase;287;
4E8K;A;Structure of Oceanobacillus iheyensis group II intron in the presence of K+, Ca2+ and a non-hydrolyzed oligonucleotide substrate;3.03;CA;CALCIUM ION;Group IIC intron;182710;
4E8K;B;Structure of Oceanobacillus iheyensis group II intron in the presence of K+, Ca2+ and a non-hydrolyzed oligonucleotide substrate;3.03;CA;CALCIUM ION;5'-R(*CP*G*AP*UP*UP*UP*AP*UP*UP*A)-3';;
4E8T;A;Structure of Oceanobacillus iheyensis group II intron in the presence of K+, Ca2+ and an oligonucleotide fragment substrate (low energy dataset);3.34;CA;CALCIUM ION;Group IIC intron;182710;
4EBC;A;Conformationally Restrained North-methanocarba-2'-deoxyadenosine Corrects the Error-Prone Nature of Human DNA Polymerase Iota;2.9;CA;CALCIUM ION;DNA polymerase iota;9606;
4EBD;A;Conformationally Restrained North-methanocarba-2'-deoxyadenosine Corrects the Error-Prone Nature of Human DNA Polymerase Iota;2.57;CA;CALCIUM ION;DNA polymerase iota;9606;
4EBE;A;Conformationally Restrained North-methanocarba-2'-deoxyadenosine Corrects the Error-Prone Nature of Human DNA Polymerase Iota;2.1;CA;CALCIUM ION;DNA polymerase iota;9606;
4EC5;B;Crystal structure of the S210C (dimer) mutant from the N-terminal domain of the secretin XcpQ from Pseudomonas aeruginosa;2.2;CA;CALCIUM ION;General secretion pathway protein D;287;
4ECG;A;Crystal structure of a putative iron-regulated protein A precursor (BDI_2603) from Parabacteroides distasonis ATCC 8503 at 2.30 A resolution;2.3;CA;CALCIUM ION;Putative iron-regulated protein A;823;
4ECQ;A;Human DNA polymerase eta- DNA ternary complex: AT crystal at pH6.8(K+ MES) with 1 Ca2+ ion;1.5;CA;CALCIUM ION;DNA polymerase eta;9606;
4ECR;A;Human DNA polymerase eta - DNA ternary complex: Reaction in the AT crystal at pH 7.0 for 40 sec;1.89;CA;CALCIUM ION;DNA polymerase eta;9606;
4ECS;A;Human DNA polymerase eta - DNA ternary complex: Reaction in the AT crystal at pH 7.0 for 80 sec;1.95;CA;CALCIUM ION;DNA polymerase eta;9606;
4ECT;A;Human DNA polymerase eta - DNA ternary complex: Reaction in the AT crystal at pH 7.0 for 140 sec;1.79;CA;CALCIUM ION;DNA polymerase eta;9606;
4ECU;A;Human DNA polymerase eta - DNA ternary complex: Reaction in the AT crystal at pH 7.0 for 200 sec;1.95;CA;CALCIUM ION;DNA polymerase eta;9606;
4ECV;A;Human DNA polymerase eta - DNA ternary complex: Reaction in the AT crystal at pH 7.0 for 230 sec;1.52;CA;CALCIUM ION;DNA polymerase eta;9606;
4ECW;A;Human DNA polymerase eta - DNA ternary complex: Reaction in the AT crystal at pH 7.0 for 250 sec;1.9;CA;CALCIUM ION;DNA polymerase eta;9606;
4ECX;A;Human DNA polymerase eta - DNA ternary complex: Reaction in the AT crystal at pH 7.0 for 300 sec;1.74;CA;CALCIUM ION;DNA polymerase eta;9606;
4ECY;A;Human DNA polymerase eta - DNA ternary complex: AT crystal at pH 6.0 (Na+ MES) with 1 Ca2+ ion;1.94;CA;CALCIUM ION;DNA polymerase eta;9606;
4ECZ;P;Human DNA polymerase eta - DNA ternary complex: AT crystal at pH 6.5 (Na+ MES) with 1 Ca2+ ion;1.83;CA;CALCIUM ION;DNA (5'-D(*AP*GP*CP*GP*TP*CP*AP*T)-3');;
4ED0;A;Human DNA polymerase eta - DNA ternary complex: AT crystal at pH 6.8 (Na+ MES) with 1 Ca2+ ion;1.65;CA;CALCIUM ION;DNA polymerase eta;9606;
4ED1;A;Human DNA polymerase eta - DNA ternary complex: AT crystal at pH 7.0 (Na+ MES) with 1 Ca2+ ion;1.81;CA;CALCIUM ION;DNA polymerase eta;9606;
4ED2;A;Human DNA polymerase eta - DNA ternary complex: AT crystal at pH 7.2 (Na+ HEPES) with 1 Ca2+ ion;1.71;CA;CALCIUM ION;DNA polymerase eta;9606;
4ED3;A;Human DNA polymerase eta - DNA ternary complex: AT crystal at pH 7.5 (Na+ HEPES) with 1 Ca2+ ion;1.79;CA;CALCIUM ION;DNA polymerase eta;9606;
4ED7;A;Human DNA polymerase eta - DNA ternary complex: TG crystal at pH 7.0 (K+ MES) with 1 Ca2+ ion;1.72;CA;CALCIUM ION;DNA polymerase eta;9606;
4ED8;A;Human DNA polymerase eta - DNA ternary complex: Reaction in the TG crystal at pH 7.0, Normal translocation;1.52;CA;CALCIUM ION;DNA polymerase eta;9606;
4EE2;A;Crystal Structure of Anthrax Protective Antigen K446M Mutant to 1.91-A Resolution;1.91;CA;CALCIUM ION;Protective antigen;1392;
4EF4;A;Crystal structure of STING CTD complex with c-di-GMP;2.15;CA;CALCIUM ION;Transmembrane protein 173;9606;
4EF4;B;Crystal structure of STING CTD complex with c-di-GMP;2.15;CA;CALCIUM ION;Transmembrane protein 173;9606;
4EFH;A;Acanthamoeba Actin complex with Spir domain D;2.48;CA;CALCIUM ION;Actin-1;5755;
4EFJ;A;Crystal structure of I-GzeII LAGLIDADG homing endonuclease in complex with DNA target site;2.8;CA;CALCIUM ION;LAGLIDADG endonuclease;5518;
4EFJ;B;Crystal structure of I-GzeII LAGLIDADG homing endonuclease in complex with DNA target site;2.8;CA;CALCIUM ION;LAGLIDADG endonuclease;5518;
4EFJ;C;Crystal structure of I-GzeII LAGLIDADG homing endonuclease in complex with DNA target site;2.8;CA;CALCIUM ION;DNA target site top strand;;
4EFS;A;Human MMP12 in complex with L-glutamate motif inhibitor;1.63;CA;CALCIUM ION;Macrophage metalloelastase;9606;
4EFZ;A;Crystal Structure of a hypothetical metallo-beta-lactamase from Burkholderia pseudomallei;1.6;CA;CALCIUM ION;Metallo-beta-lactamase family protein;28450;
4EFZ;B;Crystal Structure of a hypothetical metallo-beta-lactamase from Burkholderia pseudomallei;1.6;CA;CALCIUM ION;Metallo-beta-lactamase family protein;28450;
4EG9;A;1.9 Angstrom resolution crystal structure of Se-methionine hypothetical protein SAOUHSC_02783 from Staphylococcus aureus;1.9;CA;CALCIUM ION;Uncharacterized protein SAOUHSC_02783;1280;
4EGD;A;1.85 Angstrom crystal structure of native hypothetical protein SAOUHSC_02783 from Staphylococcus aureus;1.85;CA;CALCIUM ION;Uncharacterized protein SAOUHSC_02783;1280;
4EGY;U;Crystal Structure of AraR(DBD) in complex with operator ORA1;2.3;CA;CALCIUM ION;5'-D(*AP*AP*AP*AP*TP*TP*GP*TP*TP*CP*GP*TP*AP*CP*AP*AP*AP*TP*AP*TP*T)-3';;
4EHM;B;RabGGTase in complex with covalently bound Psoromic acid;2.2;CA;CALCIUM ION;Geranylgeranyl transferase type-2 subunit beta;10116;
4EHQ;A;Crystal Structure of Calmodulin Binding Domain of Orai1 in Complex with Ca2+/Calmodulin Displays a Unique Binding Mode;1.9;CA;CALCIUM ION;Calmodulin;10116;
4EJ7;A;Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, ATP-bound;2.29;CA;CALCIUM ION;Aminoglycoside 3'-phosphotransferase AphA1-IAB;470;
4EJ7;B;Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, ATP-bound;2.29;CA;CALCIUM ION;Aminoglycoside 3'-phosphotransferase AphA1-IAB;470;
4EJ7;C;Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, ATP-bound;2.29;CA;CALCIUM ION;Aminoglycoside 3'-phosphotransferase AphA1-IAB;470;
4EL8;A;The unliganded structure of C.bescii CelA GH48 module;2.45;CA;CALCIUM ION;Glycoside hydrolase family 48;31899;
4ELB;A;Structure-activity relationship guides enantiomeric preference among potent inhibitors of B. anthracis dihydrofolate reductase;2.6;CA;CALCIUM ION;Dihydrofolate reductase;1392;
4ELB;B;Structure-activity relationship guides enantiomeric preference among potent inhibitors of B. anthracis dihydrofolate reductase;2.6;CA;CALCIUM ION;Dihydrofolate reductase;1392;
4ELB;C;Structure-activity relationship guides enantiomeric preference among potent inhibitors of B. anthracis dihydrofolate reductase;2.6;CA;CALCIUM ION;Dihydrofolate reductase;1392;
4ELB;D;Structure-activity relationship guides enantiomeric preference among potent inhibitors of B. anthracis dihydrofolate reductase;2.6;CA;CALCIUM ION;Dihydrofolate reductase;1392;
4ELB;E;Structure-activity relationship guides enantiomeric preference among potent inhibitors of B. anthracis dihydrofolate reductase;2.6;CA;CALCIUM ION;Dihydrofolate reductase;1392;
4ELB;F;Structure-activity relationship guides enantiomeric preference among potent inhibitors of B. anthracis dihydrofolate reductase;2.6;CA;CALCIUM ION;Dihydrofolate reductase;1392;
4ELB;G;Structure-activity relationship guides enantiomeric preference among potent inhibitors of B. anthracis dihydrofolate reductase;2.6;CA;CALCIUM ION;Dihydrofolate reductase;1392;
4ELB;H;Structure-activity relationship guides enantiomeric preference among potent inhibitors of B. anthracis dihydrofolate reductase;2.6;CA;CALCIUM ION;Dihydrofolate reductase;1392;
4ELE;A;Structure-activity relationship guides enantiomeric preference among potent inhibitors of B. anthracis dihydrofolate reductase;2.35;CA;CALCIUM ION;Dihydrofolate reductase;1392;
4ELE;B;Structure-activity relationship guides enantiomeric preference among potent inhibitors of B. anthracis dihydrofolate reductase;2.35;CA;CALCIUM ION;Dihydrofolate reductase;1392;
4ELE;C;Structure-activity relationship guides enantiomeric preference among potent inhibitors of B. anthracis dihydrofolate reductase;2.35;CA;CALCIUM ION;Dihydrofolate reductase;1392;
4ELE;D;Structure-activity relationship guides enantiomeric preference among potent inhibitors of B. anthracis dihydrofolate reductase;2.35;CA;CALCIUM ION;Dihydrofolate reductase;1392;
4ELE;E;Structure-activity relationship guides enantiomeric preference among potent inhibitors of B. anthracis dihydrofolate reductase;2.35;CA;CALCIUM ION;Dihydrofolate reductase;1392;
4ELE;F;Structure-activity relationship guides enantiomeric preference among potent inhibitors of B. anthracis dihydrofolate reductase;2.35;CA;CALCIUM ION;Dihydrofolate reductase;1392;
4ELE;G;Structure-activity relationship guides enantiomeric preference among potent inhibitors of B. anthracis dihydrofolate reductase;2.35;CA;CALCIUM ION;Dihydrofolate reductase;1392;
4ELE;H;Structure-activity relationship guides enantiomeric preference among potent inhibitors of B. anthracis dihydrofolate reductase;2.35;CA;CALCIUM ION;Dihydrofolate reductase;1392;
4ELF;A;Structure-activity relationship guides enantiomeric preference among potent inhibitors of B. anthracis dihydrofolate reductase;2.3;CA;CALCIUM ION;Dihydrofolate reductase;1392;
4ELF;B;Structure-activity relationship guides enantiomeric preference among potent inhibitors of B. anthracis dihydrofolate reductase;2.3;CA;CALCIUM ION;Dihydrofolate reductase;1392;
4ELF;C;Structure-activity relationship guides enantiomeric preference among potent inhibitors of B. anthracis dihydrofolate reductase;2.3;CA;CALCIUM ION;Dihydrofolate reductase;1392;
4ELF;D;Structure-activity relationship guides enantiomeric preference among potent inhibitors of B. anthracis dihydrofolate reductase;2.3;CA;CALCIUM ION;Dihydrofolate reductase;1392;
4ELF;E;Structure-activity relationship guides enantiomeric preference among potent inhibitors of B. anthracis dihydrofolate reductase;2.3;CA;CALCIUM ION;Dihydrofolate reductase;1392;
4ELF;F;Structure-activity relationship guides enantiomeric preference among potent inhibitors of B. anthracis dihydrofolate reductase;2.3;CA;CALCIUM ION;Dihydrofolate reductase;1392;
4ELF;G;Structure-activity relationship guides enantiomeric preference among potent inhibitors of B. anthracis dihydrofolate reductase;2.3;CA;CALCIUM ION;Dihydrofolate reductase;1392;
4ELF;H;Structure-activity relationship guides enantiomeric preference among potent inhibitors of B. anthracis dihydrofolate reductase;2.3;CA;CALCIUM ION;Dihydrofolate reductase;1392;
4ELG;A;Structure-activity relationship guides enantiomeric preference among potent inhibitors of B. anthracis dihydrofolate reductase;2.1;CA;CALCIUM ION;Dihydrofolate reductase;1392;
4ELG;B;Structure-activity relationship guides enantiomeric preference among potent inhibitors of B. anthracis dihydrofolate reductase;2.1;CA;CALCIUM ION;Dihydrofolate reductase;1392;
4ELG;C;Structure-activity relationship guides enantiomeric preference among potent inhibitors of B. anthracis dihydrofolate reductase;2.1;CA;CALCIUM ION;Dihydrofolate reductase;1392;
4ELG;D;Structure-activity relationship guides enantiomeric preference among potent inhibitors of B. anthracis dihydrofolate reductase;2.1;CA;CALCIUM ION;Dihydrofolate reductase;1392;
4ELG;E;Structure-activity relationship guides enantiomeric preference among potent inhibitors of B. anthracis dihydrofolate reductase;2.1;CA;CALCIUM ION;Dihydrofolate reductase;1392;
4ELG;F;Structure-activity relationship guides enantiomeric preference among potent inhibitors of B. anthracis dihydrofolate reductase;2.1;CA;CALCIUM ION;Dihydrofolate reductase;1392;
4ELG;G;Structure-activity relationship guides enantiomeric preference among potent inhibitors of B. anthracis dihydrofolate reductase;2.1;CA;CALCIUM ION;Dihydrofolate reductase;1392;
4ELG;H;Structure-activity relationship guides enantiomeric preference among potent inhibitors of B. anthracis dihydrofolate reductase;2.1;CA;CALCIUM ION;Dihydrofolate reductase;1392;
4ELH;A;Structure-activity relationship guides enantiomeric preference among potent inhibitors of B. anthracis dihydrofolate reductase;2.1;CA;CALCIUM ION;Dihydrofolate reductase;1392;
4ELH;B;Structure-activity relationship guides enantiomeric preference among potent inhibitors of B. anthracis dihydrofolate reductase;2.1;CA;CALCIUM ION;Dihydrofolate reductase;1392;
4ELH;C;Structure-activity relationship guides enantiomeric preference among potent inhibitors of B. anthracis dihydrofolate reductase;2.1;CA;CALCIUM ION;Dihydrofolate reductase;1392;
4ELH;D;Structure-activity relationship guides enantiomeric preference among potent inhibitors of B. anthracis dihydrofolate reductase;2.1;CA;CALCIUM ION;Dihydrofolate reductase;1392;
4ELH;E;Structure-activity relationship guides enantiomeric preference among potent inhibitors of B. anthracis dihydrofolate reductase;2.1;CA;CALCIUM ION;Dihydrofolate reductase;1392;
4ELH;F;Structure-activity relationship guides enantiomeric preference among potent inhibitors of B. anthracis dihydrofolate reductase;2.1;CA;CALCIUM ION;Dihydrofolate reductase;1392;
4ELH;G;Structure-activity relationship guides enantiomeric preference among potent inhibitors of B. anthracis dihydrofolate reductase;2.1;CA;CALCIUM ION;Dihydrofolate reductase;1392;
4ELH;H;Structure-activity relationship guides enantiomeric preference among potent inhibitors of B. anthracis dihydrofolate reductase;2.1;CA;CALCIUM ION;Dihydrofolate reductase;1392;
4ELV;A;Snapshot of the large fragment of DNA polymerase I from Thermus Aquaticus processing modified pyrimidines;1.9;CA;CALCIUM ION;DNA polymerase I, thermostable;271;
4EM6;A;The structure of Glucose-6-phosphate isomerase (GPI) from Brucella melitensis;1.9;CA;CALCIUM ION;Glucose-6-phosphate isomerase;29459;
4EM6;B;The structure of Glucose-6-phosphate isomerase (GPI) from Brucella melitensis;1.9;CA;CALCIUM ION;Glucose-6-phosphate isomerase;29459;
4EM6;C;The structure of Glucose-6-phosphate isomerase (GPI) from Brucella melitensis;1.9;CA;CALCIUM ION;Glucose-6-phosphate isomerase;29459;
4EM6;D;The structure of Glucose-6-phosphate isomerase (GPI) from Brucella melitensis;1.9;CA;CALCIUM ION;Glucose-6-phosphate isomerase;29459;
4EMT;B;Crystal Structure of human STING bound to c-di-GMP;1.5;CA;CALCIUM ION;Transmembrane protein 173;9606;
4EMU;B;Crystal structure of ligand free human STING;1.9;CA;CALCIUM ION;Transmembrane protein 173;9606;
4ENZ;A;Structure of human ceruloplasmin at 2.6 A resolution;2.6;CA;CALCIUM ION;Ceruloplasmin;9606;
4EOY;A;Plasmodium falciparum Atg8 in complex with Plasmodium falciparum Atg3 peptide;2.22;CA;CALCIUM ION;Microtubule-associated protein 1 light chain 3;5833;
4EOY;C;Plasmodium falciparum Atg8 in complex with Plasmodium falciparum Atg3 peptide;2.22;CA;CALCIUM ION;Microtubule-associated protein 1 light chain 3;5833;
4EPU;A;Ang1 fibrinogen-related domain (FReD);2.1;CA;CALCIUM ION;Angiopoietin-1;9606;
4EPU;B;Ang1 fibrinogen-related domain (FReD);2.1;CA;CALCIUM ION;Angiopoietin-1;9606;
4EPZ;A;Crystal structure of a transcription anti-terminator antagonist UpxZ (BACUNI_04315) from Bacteroides uniformis ATCC 8492 at 1.68 A resolution;1.68;CA;CALCIUM ION;transcription anti-terminator antagonist UpxZ;820;
4EQB;A;1.5 Angstrom Crystal Structure of Spermidine/Putrescine ABC Transporter Substrate-Binding Protein PotD from Streptococcus pneumoniae strain Canada MDR_19A in Complex with Calcium and HEPES;1.5;CA;CALCIUM ION;Spermidine/putrescine ABC superfamily ATP binding cassette transporter, binding protein;1313;
4EQB;B;1.5 Angstrom Crystal Structure of Spermidine/Putrescine ABC Transporter Substrate-Binding Protein PotD from Streptococcus pneumoniae strain Canada MDR_19A in Complex with Calcium and HEPES;1.5;CA;CALCIUM ION;Spermidine/putrescine ABC superfamily ATP binding cassette transporter, binding protein;1313;
4EQN;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS V23E/I72K at cryogenic temperature;1.8;CA;CALCIUM ION;Thermonuclease;1280;
4EQO;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS V99D at cryogenic temperature;1.7;CA;CALCIUM ION;Thermonuclease;1280;
4EQP;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS I72D at cryogenic temperature;1.35;CA;CALCIUM ION;Thermonuclease;1280;
4EQU;A;Human STK-10 (LOK) kinase domain in DFG-out conformation with inhibitor DSA-7;2;CA;CALCIUM ION;Serine/threonine-protein kinase 10;9606;
4EQU;B;Human STK-10 (LOK) kinase domain in DFG-out conformation with inhibitor DSA-7;2;CA;CALCIUM ION;Serine/threonine-protein kinase 10;9606;
4EST;E;CRYSTAL STRUCTURE OF THE COVALENT COMPLEX FORMED BY A PEPTIDYL ALPHA,ALPHA-DIFLUORO-BETA-KETO AMIDE WITH PORCINE PANCREATIC ELASTASE AT 1.78-ANGSTROMS RESOLUTION;1.78;CA;CALCIUM ION;ELASTASE;9823;
4ESV;A;A New Twist on the Translocation Mechanism of Helicases from the Structure of DnaB with its Substrates;3.2;CA;CALCIUM ION;Replicative helicase;1422;
4ESV;B;A New Twist on the Translocation Mechanism of Helicases from the Structure of DnaB with its Substrates;3.2;CA;CALCIUM ION;Replicative helicase;1422;
4ESV;C;A New Twist on the Translocation Mechanism of Helicases from the Structure of DnaB with its Substrates;3.2;CA;CALCIUM ION;Replicative helicase;1422;
4ESV;D;A New Twist on the Translocation Mechanism of Helicases from the Structure of DnaB with its Substrates;3.2;CA;CALCIUM ION;Replicative helicase;1422;
4ESV;E;A New Twist on the Translocation Mechanism of Helicases from the Structure of DnaB with its Substrates;3.2;CA;CALCIUM ION;Replicative helicase;1422;
4ESV;F;A New Twist on the Translocation Mechanism of Helicases from the Structure of DnaB with its Substrates;3.2;CA;CALCIUM ION;Replicative helicase;1422;
4ESV;G;A New Twist on the Translocation Mechanism of Helicases from the Structure of DnaB with its Substrates;3.2;CA;CALCIUM ION;Replicative helicase;1422;
4ESV;I;A New Twist on the Translocation Mechanism of Helicases from the Structure of DnaB with its Substrates;3.2;CA;CALCIUM ION;Replicative helicase;1422;
4ESV;L;A New Twist on the Translocation Mechanism of Helicases from the Structure of DnaB with its Substrates;3.2;CA;CALCIUM ION;Replicative helicase;1422;
4ETO;A;Structure of S100A4 in complex with non-muscle myosin-IIA peptide;1.54;CA;CALCIUM ION;Protein S100-A4;9606;
4ETO;B;Structure of S100A4 in complex with non-muscle myosin-IIA peptide;1.54;CA;CALCIUM ION;Protein S100-A4;9606;
4EUL;A;Crystal structure of enhanced Green Fluorescent Protein to 1.35A resolution reveals alternative conformations for Glu222;1.35;CA;CALCIUM ION;Green fluorescent protein;6100;
4EVH;A;Crystal structure of calcium-bound alpha-1 giardin;2.6;CA;CALCIUM ION;Giardin subunit alpha-1;5741;
4EW9;A;The liganded structure of C. bescii family 3 pectate lyase;1.6;CA;CALCIUM ION;Pectate lyase;31899;
4EW9;B;The liganded structure of C. bescii family 3 pectate lyase;1.6;CA;CALCIUM ION;Pectate lyase;31899;
4EWG;B;Crystal structure of a Beta-ketoacyl synthase from Burkholderia phymatum STM815;2.25;CA;CALCIUM ION;Beta-ketoacyl synthase;148447;
4EX8;A;Crystal structure of the prealnumycin C-glycosynthase AlnA;2.1;CA;CALCIUM ION;AlnA;569580;
4EX9;A;Crystal structure of the prealnumycin C-glycosynthase AlnA in complex with ribulose 5-phosphate;3.15;CA;CALCIUM ION;AlnA;569580;
4F0Z;B;Crystal Structure of Calcineurin in Complex with the Calcineurin-Inhibiting Domain of the African Swine Fever Virus Protein A238L;1.7;CA;CALCIUM ION;Calcineurin subunit B type 1;9606;
4F3R;B;Structure of phosphopantetheine adenylyltransferase (CBU_0288) from Coxiella burnetii;2.25;CA;CALCIUM ION;Phosphopantetheine adenylyltransferase;777;
4F4W;A;Y-family DNA polymerase chimera Dbh-Dpo4-Dpo4 #1;1.9;CA;CALCIUM ION;DNA polymerase IV;22,852,287;
4F4W;B;Y-family DNA polymerase chimera Dbh-Dpo4-Dpo4 #1;1.9;CA;CALCIUM ION;DNA polymerase IV;22,852,287;
4F4X;A;Y-family DNA polymerase chimera Dbh-Dpo4-Dpo4 #2;2.05;CA;CALCIUM ION;DNA polymerase IV;22,852,287;
4F4X;P;Y-family DNA polymerase chimera Dbh-Dpo4-Dpo4 #2;2.05;CA;CALCIUM ION;DNA (5'-D(*GP*GP*CP*AP*CP*TP*GP*AP*TP*CP*GP*GP*GP*C)-3');;
4F4Y;A;Y-family DNA polymerase chimera Dbh-Dpo4-Dbh;2.34;CA;CALCIUM ION;DNA polymerase IV;22,852,287;
4F4Y;B;Y-family DNA polymerase chimera Dbh-Dpo4-Dbh;2.34;CA;CALCIUM ION;DNA polymerase IV;22,852,287;
4F4Z;A;Y-family DNA polymerase chimera Dpo4-Dpo4-Dbh;2.31;CA;CALCIUM ION;DNA polymerase IV;22,852,287;
4F4Z;B;Y-family DNA polymerase chimera Dpo4-Dpo4-Dbh;2.31;CA;CALCIUM ION;DNA polymerase IV;22,852,287;
4F50;A;Y-family DNA polymerase chimera Dbh-Dbh-Dpo4;2.21;CA;CALCIUM ION;DNA polymerase IV;22,852,287;
4F53;A;Crystal structure of a susd homolog (BACOVA_04803) from Bacteroides ovatus ATCC 8483 at 2.25 A resolution;2.25;CA;CALCIUM ION;SusD homolog;28116;
4F53;B;Crystal structure of a susd homolog (BACOVA_04803) from Bacteroides ovatus ATCC 8483 at 2.25 A resolution;2.25;CA;CALCIUM ION;SusD homolog;28116;
4F5W;A;Crystal structure of ligand free human STING CTD;2.2;CA;CALCIUM ION;Transmembrane protein 173;9606;
4F5Y;A;Crystal structure of human STING CTD complex with C-di-GMP;2.4;CA;CALCIUM ION;Transmembrane protein 173;9606;
4F5Y;B;Crystal structure of human STING CTD complex with C-di-GMP;2.4;CA;CALCIUM ION;Transmembrane protein 173;9606;
4F7X;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS I92A/L25A at cryogenic temperature;1.7;CA;CALCIUM ION;Thermonuclease;1280;
4F8M;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS V23I/I92V at cryogenic temperature;1.6;CA;CALCIUM ION;Thermonuclease;1280;
4F8Z;A;Carboxypeptidase T with Boc-Leu;1.38;CA;CALCIUM ION;Carboxypeptidase T;2026;
4F9D;A;Structure of Escherichia coli PgaB 42-655 in complex with nickel;1.9;CA;CALCIUM ION;Poly-beta-1,6-N-acetyl-D-glucosamine N-deacetylase;562;
4F9D;B;Structure of Escherichia coli PgaB 42-655 in complex with nickel;1.9;CA;CALCIUM ION;Poly-beta-1,6-N-acetyl-D-glucosamine N-deacetylase;562;
4F9J;A;Structure of Escherichia coli PgaB 42-655 in complex with iron;2.1;CA;CALCIUM ION;Poly-beta-1,6-N-acetyl-D-glucosamine N-deacetylase;562;
4F9J;B;Structure of Escherichia coli PgaB 42-655 in complex with iron;2.1;CA;CALCIUM ION;Poly-beta-1,6-N-acetyl-D-glucosamine N-deacetylase;562;
4FA1;A;Crystal Structure of WT MauG in Complex with Pre-Methylamine Dehydrogenase Aged 130 Days.;2.18;CA;CALCIUM ION;Methylamine utilization protein MauG;266;
4FA1;B;Crystal Structure of WT MauG in Complex with Pre-Methylamine Dehydrogenase Aged 130 Days.;2.18;CA;CALCIUM ION;Methylamine utilization protein MauG;266;
4FA4;A;Crystal Structure of WT MauG in Complex with Pre-Methylamine Dehydrogenase Aged 10 Days;2.14;CA;CALCIUM ION;Methylamine utilization protein MauG;266;
4FA4;B;Crystal Structure of WT MauG in Complex with Pre-Methylamine Dehydrogenase Aged 10 Days;2.14;CA;CALCIUM ION;Methylamine utilization protein MauG;266;
4FA5;A;Crystal Structure of WT MauG in Complex with Pre-Methylamine Dehydrogenase Aged 20 Days;1.94;CA;CALCIUM ION;Methylamine utilization protein MauG;266;
4FA5;B;Crystal Structure of WT MauG in Complex with Pre-Methylamine Dehydrogenase Aged 20 Days;1.94;CA;CALCIUM ION;Methylamine utilization protein MauG;266;
4FA9;A;Crystal Structure of WT MauG in Complex with Pre-Methylamine Dehydrogenase Aged 30 Days;2.09;CA;CALCIUM ION;Methylamine utilization protein MauG;266;
4FA9;B;Crystal Structure of WT MauG in Complex with Pre-Methylamine Dehydrogenase Aged 30 Days;2.09;CA;CALCIUM ION;Methylamine utilization protein MauG;266;
4FAN;A;Crystal Structure of WT MauG in Complex with Pre-Methylamine Dehydrogenase Aged 40 Days;2.08;CA;CALCIUM ION;Methylamine utilization protein MauG;266;
4FAN;B;Crystal Structure of WT MauG in Complex with Pre-Methylamine Dehydrogenase Aged 40 Days;2.08;CA;CALCIUM ION;Methylamine utilization protein MauG;266;
4FAQ;A;Structure of Oceanobacillus iheyensis group II intron in the presence of K+, Ca2+ and 5'-exon;3.11;CA;CALCIUM ION;Group IIC intron;182710;
4FAV;A;Crystal Structure of WT MauG in Complex with Pre-Methylamine Dehydrogenase Aged 50 Days;2.08;CA;CALCIUM ION;Methylamine utilization protein MauG;266;
4FAV;B;Crystal Structure of WT MauG in Complex with Pre-Methylamine Dehydrogenase Aged 50 Days;2.08;CA;CALCIUM ION;Methylamine utilization protein MauG;266;
4FB1;A;Crystal Structure of WT MauG in Complex with Pre-Methylamine Dehydrogenase Aged 60 Days;2.15;CA;CALCIUM ION;Methylamine utilization protein MauG;266;
4FB1;B;Crystal Structure of WT MauG in Complex with Pre-Methylamine Dehydrogenase Aged 60 Days;2.15;CA;CALCIUM ION;Methylamine utilization protein MauG;266;
4FBT;A;Dpo4 post-insertion complex with the N-(deoxyguanosin-8-yl)-1-aminopyrene lesion;2;CA;CALCIUM ION;DNA polymerase IV;2287;
4FBU;A;Dpo4 polymerase pre-insertion binary complex with the N-(deoxyguanosin-8-yl)-1-aminopyrene lesion;2.6;CA;CALCIUM ION;DNA polymerase IV;2287;
4FBU;B;Dpo4 polymerase pre-insertion binary complex with the N-(deoxyguanosin-8-yl)-1-aminopyrene lesion;2.6;CA;CALCIUM ION;DNA polymerase IV;2287;
4FBY;O;fs X-ray diffraction of Photosystem II;6.56;CA;CALCIUM ION;Photosystem II manganese-stabilizing polypeptide;146786;
4FBY;f;fs X-ray diffraction of Photosystem II;6.56;CA;CALCIUM ION;Photosystem II manganese-stabilizing polypeptide;146786;
4FCN;A;The crystal structures of several mutants of pleurotus eryngii versatile peroxidase;1.7;CA;CALCIUM ION;Versatile peroxidase VPL2;5323;
4FCS;A;The crystal structures of several mutants of pleurotus eryngii versatile peroxidase;1.5;CA;CALCIUM ION;Versatile peroxidase VPL2;5323;
4FDI;A;The molecular basis of mucopolysaccharidosis IV A;2.2;CA;CALCIUM ION;N-acetylgalactosamine-6-sulfatase;9606;
4FDI;B;The molecular basis of mucopolysaccharidosis IV A;2.2;CA;CALCIUM ION;N-acetylgalactosamine-6-sulfatase;9606;
4FDJ;A;The molecular basis of mucopolysaccharidosis IV A, complex with GalNAc;2.81;CA;CALCIUM ION;N-acetylgalactosamine-6-sulfatase;9606;
4FDJ;B;The molecular basis of mucopolysaccharidosis IV A, complex with GalNAc;2.81;CA;CALCIUM ION;N-acetylgalactosamine-6-sulfatase;9606;
4FDM;A;Crystallization and 3D structure elucidation of thermostable L2 lipase from thermophilic locally isolated Bacillus sp. L2.;1.6;CA;CALCIUM ION;Thermostable lipase;307644;
4FDQ;A;The crystal structures of several mutants of pleurotus eryngii versatile peroxidase;1.6;CA;CALCIUM ION;Versatile peroxidase VPL2;5323;
4FE1;L;Improving the Accuracy of Macromolecular Structure Refinement at 7 A Resolution;4.92;CA;CALCIUM ION;Photosystem I reaction center subunit XI;146786;
4FED;A;Crystal Structure of Htt36Q3H;2.81;CA;CALCIUM ION;Maltose-binding periplasmic protein,Huntingtin;5,629,606;
4FEF;A;The crystal structures of several mutants of pleurotus eryngii versatile peroxidase;2;CA;CALCIUM ION;Versatile peroxidase VPL2;5323;
4FGC;B;Crystal Structure of Active Site Mutant C55A of Nitrile Reductase QueF, Bound to Substrate PreQ0;2.5;CA;CALCIUM ION;NADPH-dependent 7-cyano-7-deazaguanine reductase;1423;
4FGC;C;Crystal Structure of Active Site Mutant C55A of Nitrile Reductase QueF, Bound to Substrate PreQ0;2.5;CA;CALCIUM ION;NADPH-dependent 7-cyano-7-deazaguanine reductase;1423;
4FGC;D;Crystal Structure of Active Site Mutant C55A of Nitrile Reductase QueF, Bound to Substrate PreQ0;2.5;CA;CALCIUM ION;NADPH-dependent 7-cyano-7-deazaguanine reductase;1423;
4FGC;E;Crystal Structure of Active Site Mutant C55A of Nitrile Reductase QueF, Bound to Substrate PreQ0;2.5;CA;CALCIUM ION;NADPH-dependent 7-cyano-7-deazaguanine reductase;1423;
4FGO;A;Legionella pneumophila LapG (calcium-bound);1.9;CA;CALCIUM ION;Periplasmic protein;446;
4FHP;A;Crystal structures of the Cid1 poly (U) polymerase reveal the mechanism for UTP selectivity - CaUTP bound;2.5;CA;CALCIUM ION;Poly(A) RNA polymerase protein cid1;4896;
4FJ5;A;RB69 DNA polymerase ternary complex with dATP/dT;2.05;CA;CALCIUM ION;DNA polymerase;1914161;
4FJ7;A;RB69 DNA polymerase ternary complex with dGTP/dT;1.9;CA;CALCIUM ION;DNA polymerase;1914161;
4FJ8;A;RB69 DNA polymerase ternary complex with dCTP/dT;2.19;CA;CALCIUM ION;DNA polymerase;1914161;
4FJ9;A;RB69 DNA polymerase ternary complex with dTTP/dT;1.97;CA;CALCIUM ION;DNA polymerase;1914161;
4FJG;A;RB69 DNA polymerase ternary complex with dATP/dC;2.02;CA;CALCIUM ION;DNA polymerase;1914161;
4FJH;A;RB69 DNA polymerase ternary complex with dGTP/dC;2.11;CA;CALCIUM ION;DNA polymerase;1914161;
4FJI;A;RB69 DNA polymerase ternary complex with dcTP/dC;2.2;CA;CALCIUM ION;DNA polymerase;1914161;
4FJJ;A;RB69 DNA polymerase ternary complex with dTTP/dC;1.99;CA;CALCIUM ION;DNA polymerase;1914161;
4FJK;A;RB69 DNA polymerase ternary complex with dATP/dA;2;CA;CALCIUM ION;DNA polymerase;1914161;
4FJL;A;RB69 DNA polymerase ternary complex with dGTP/dA;1.87;CA;CALCIUM ION;DNA polymerase;1914161;
4FJM;A;RB69 DNA polymerase ternary complex with dCTP/dA;2.02;CA;CALCIUM ION;DNA polymerase;1914161;
4FJN;A;RB69 DNA polymerase ternary complex with dTTP/dA;1.98;CA;CALCIUM ION;DNA polymerase;1914161;
4FJX;A;RB69 DNA polymerase ternary complex with dATP/dG;2.11;CA;CALCIUM ION;DNA polymerase;1914161;
4FK0;A;RB69 DNA polymerase ternary complex with dCTP/dG;2.18;CA;CALCIUM ION;DNA polymerase;1914161;
4FK0;T;RB69 DNA polymerase ternary complex with dCTP/dG;2.18;CA;CALCIUM ION;DNA template;;
4FK2;A;RB69 DNA polymerase ternary complex with dTTP/dG;1.98;CA;CALCIUM ION;DNA polymerase;1914161;
4FK4;A;RB69 DNA polymerase ternary complex with dGTP/dG;1.9;CA;CALCIUM ION;DNA polymerase;1914161;
4FKB;A;An Organic solvent tolerant lipase 42;1.22;CA;CALCIUM ION;Thermostable organic solvent tolerant lipase;294830;
4FKB;B;An Organic solvent tolerant lipase 42;1.22;CA;CALCIUM ION;Thermostable organic solvent tolerant lipase;294830;
4FL4;A;Scaffoldin conformation and dynamics revealed by a ternary complex from the Clostridium thermocellum cellulosome;2.8;CA;CALCIUM ION;Glycoside hydrolase family 9;1515;
4FL4;C;Scaffoldin conformation and dynamics revealed by a ternary complex from the Clostridium thermocellum cellulosome;2.8;CA;CALCIUM ION;Cellulosome anchoring protein cohesin region;1515;
4FL4;D;Scaffoldin conformation and dynamics revealed by a ternary complex from the Clostridium thermocellum cellulosome;2.8;CA;CALCIUM ION;Glycoside hydrolase family 9;1515;
4FL4;F;Scaffoldin conformation and dynamics revealed by a ternary complex from the Clostridium thermocellum cellulosome;2.8;CA;CALCIUM ION;Cellulosome anchoring protein cohesin region;1515;
4FL4;G;Scaffoldin conformation and dynamics revealed by a ternary complex from the Clostridium thermocellum cellulosome;2.8;CA;CALCIUM ION;Glycoside hydrolase family 9;1515;
4FL4;I;Scaffoldin conformation and dynamics revealed by a ternary complex from the Clostridium thermocellum cellulosome;2.8;CA;CALCIUM ION;Cellulosome anchoring protein cohesin region;1515;
4FL4;J;Scaffoldin conformation and dynamics revealed by a ternary complex from the Clostridium thermocellum cellulosome;2.8;CA;CALCIUM ION;Glycoside hydrolase family 9;1515;
4FL4;L;Scaffoldin conformation and dynamics revealed by a ternary complex from the Clostridium thermocellum cellulosome;2.8;CA;CALCIUM ION;Cellulosome anchoring protein cohesin region;1515;
4FL5;A;Crystal structure of human 14-3-3 sigma in complex with a Tau-protein peptide surrounding pS214;1.9;CA;CALCIUM ION;14-3-3 protein sigma;9606;
4FL5;B;Crystal structure of human 14-3-3 sigma in complex with a Tau-protein peptide surrounding pS214;1.9;CA;CALCIUM ION;14-3-3 protein sigma;9606;
4FMP;A;Crystal structure of thermostable, organic-solvent tolerant lipase from Geobacillus sp. strain ARM;2.3;CA;CALCIUM ION;Lipase;1422;
4FMP;B;Crystal structure of thermostable, organic-solvent tolerant lipase from Geobacillus sp. strain ARM;2.3;CA;CALCIUM ION;Lipase;1422;
4FON;A;High Energy Remote SAD structure solution of Proteinase K from the 37.8 keV Tellurium K edge;1.05;CA;CALCIUM ION;Proteinase K;37998;
4FOU;A;Structure of the PilZ-FimX(EAL domain)-c-di-GMP complex responsible for the regulation of bacterial Type IV pilus biogenesis;2.1;CA;CALCIUM ION;FimX;346;
4FOU;B;Structure of the PilZ-FimX(EAL domain)-c-di-GMP complex responsible for the regulation of bacterial Type IV pilus biogenesis;2.1;CA;CALCIUM ION;FimX;346;
4FQO;A;Crystal Structure of Calcium-Loaded S100B Bound to SBi4211;1.65;CA;CALCIUM ION;Protein S100-B;9913;
4FS6;A;Crystal structure of the Z-DNA hexamer CGCGCG at 500 mM CaCl2;1.3;CA;CALCIUM ION;DNA (5'-D(*CP*GP*CP*GP*CP*G)-3');;
4FS8;A;The structure of an As(III) S-adenosylmethionine methyltransferase: insights into the mechanism of arsenic biotransformation;1.78;CA;CALCIUM ION;Arsenic methyltransferase;610260;
4FSD;A;ArsM arsenic(III) S-adenosylmethionine methyltransferase with As(III);1.75;CA;CALCIUM ION;Arsenic methyltransferase;610260;
4FSJ;A;Crystal structure of the virus like particle of Flock House virus;3.5;CA;CALCIUM ION;Capsid protein beta;12287;
4FSJ;B;Crystal structure of the virus like particle of Flock House virus;3.5;CA;CALCIUM ION;Capsid protein beta;12287;
4FSO;A;Crystal Structure of Pseudomonas aeruginosa OccK10 (OpdN);2.75;CA;CALCIUM ION;Probable porin;287;
4FTB;A;Crystal structure of the authentic Flock House virus particle;2.7;CA;CALCIUM ION;Capsid protein beta;12287;
4FTB;B;Crystal structure of the authentic Flock House virus particle;2.7;CA;CALCIUM ION;Capsid protein beta;12287;
4FTE;A;Crystal structure of the D75N mutant capsid of Flock House virus;3.5;CA;CALCIUM ION;Capsid protein alpha;12287;
4FTE;B;Crystal structure of the D75N mutant capsid of Flock House virus;3.5;CA;CALCIUM ION;Capsid protein alpha;12287;
4FTE;C;Crystal structure of the D75N mutant capsid of Flock House virus;3.5;CA;CALCIUM ION;Capsid protein alpha;12287;
4FTS;A;Crystal structure of the N363T mutant of the Flock House virus capsid;3.2;CA;CALCIUM ION;Capsid protein alpha;12287;
4FTS;B;Crystal structure of the N363T mutant of the Flock House virus capsid;3.2;CA;CALCIUM ION;Capsid protein alpha;12287;
4FTS;C;Crystal structure of the N363T mutant of the Flock House virus capsid;3.2;CA;CALCIUM ION;Capsid protein alpha;12287;
4FU4;A;Human collagenase 3 (MMP-13) with peptide from pro-domain;2.85;CA;CALCIUM ION;Collagenase 3;9606;
4FU4;B;Human collagenase 3 (MMP-13) with peptide from pro-domain;2.85;CA;CALCIUM ION;Collagenase 3;9606;
4FUS;A;The X-ray structure of Hahella chejuensis family 48 glycosyl hydrolase;1.75;CA;CALCIUM ION;RTX toxins and related Ca2+-binding protein;158327;
4FVK;A;Structural and functional characterization of neuraminidase-like molecule N10 derived from bat influenza A virus;2.2;CA;CALCIUM ION;Neuraminidase;11320;
4FVK;B;Structural and functional characterization of neuraminidase-like molecule N10 derived from bat influenza A virus;2.2;CA;CALCIUM ION;Neuraminidase;11320;
4FVL;A;Human collagenase 3 (MMP-13) full form with peptides from pro-domain;2.44;CA;CALCIUM ION;Collagenase 3;9606;
4FVL;B;Human collagenase 3 (MMP-13) full form with peptides from pro-domain;2.44;CA;CALCIUM ION;Collagenase 3;9606;
4FWT;A;Complex structure of viral RNA polymerase form III;3.2;CA;CALCIUM ION;Elongation factor Ts, Elongation factor Tu, LINKER, Q beta replicase;56,239,803;
4FZL;A;High resolution structure of truncated bacteriocin syringacin M from Pseudomonas syringae pv. tomato DC3000;1.46;CA;CALCIUM ION;Bacteriocin;251701;
4FZL;B;High resolution structure of truncated bacteriocin syringacin M from Pseudomonas syringae pv. tomato DC3000;1.46;CA;CALCIUM ION;Bacteriocin;251701;
4FZM;A;Crystal structure of the bacteriocin syringacin M from Pseudomonas syringae pv. tomato DC3000;2.83;CA;CALCIUM ION;Bacteriocin;251701;
4G01;A;ARA7-GDP-Ca2+/VPS9a;2.2;CA;CALCIUM ION;Vacuolar protein sorting-associated protein 9A;3702;
4G05;A;The crystal structures of several mutants of Pleurotus eryngii versatile peroxidase;2.35;CA;CALCIUM ION;Versatile peroxidase VPL2;5323;
4G0D;A;Human collagenase 3 (MMP-13) full form with peptides from pro-domain;2.54;CA;CALCIUM ION;Collagenase 3;9606;
4G0D;B;Human collagenase 3 (MMP-13) full form with peptides from pro-domain;2.54;CA;CALCIUM ION;Collagenase 3;9606;
4G0D;C;Human collagenase 3 (MMP-13) full form with peptides from pro-domain;2.54;CA;CALCIUM ION;Collagenase 3;9606;
4G0D;D;Human collagenase 3 (MMP-13) full form with peptides from pro-domain;2.54;CA;CALCIUM ION;Collagenase 3;9606;
4G0N;A;Crystal Structure of wt H-Ras-GppNHp bound to the RBD of Raf Kinase;2.45;CA;CALCIUM ION;GTPase HRas;9606;
4G1E;A;Crystal structure of integrin alpha V beta 3 with coil-coiled tag.;3;CA;CALCIUM ION;Integrin alpha-V;9606;
4G1E;B;Crystal structure of integrin alpha V beta 3 with coil-coiled tag.;3;CA;CALCIUM ION;Integrin beta-3;9606;
4G1H;A;Group B Streptococcus Pilus Island 1 Sortase C2;1.8;CA;CALCIUM ION;Sortase family protein;1311;
4G1M;A;Re-refinement of alpha V beta 3 structure;2.9;CA;CALCIUM ION;Integrin alpha-V;9606;
4G1M;B;Re-refinement of alpha V beta 3 structure;2.9;CA;CALCIUM ION;Integrin beta-3;9606;
4G26;A;Crystal Structure of proteinaceous RNase P 1 (PRORP1) from A. thaliana with Ca;1.75;CA;CALCIUM ION;Pentatricopeptide repeat-containing protein At2g32230, mitochondrial;3702;
4G27;R;Calcium-calmodulin complexed with the calmodulin binding domain from a small conductance potassium channel splice variant and phenylurea;1.65;CA;CALCIUM ION;Calmodulin;10116;
4G28;R;Calcium-calmodulin complexed with the calmodulin binding domain from a small conductance potassium channel splice variant and EBIO-1;1.63;CA;CALCIUM ION;Calmodulin;10116;
4G2S;B;Crystal structure of a Salmonella type III secretion system protein;1.86;CA;CALCIUM ION;Protein prgH;28901;
4G3I;A;Crystal structure of Dpo4 in complex with DNA duplex;2.5;CA;CALCIUM ION;DNA polymerase IV;2287;
4G3I;B;Crystal structure of Dpo4 in complex with DNA duplex;2.5;CA;CALCIUM ION;DNA polymerase IV;2287;
4G5I;A;Crystal Structure of Porcine pancreatic PlA2 in complex with DBP;2.4;CA;CALCIUM ION;Phospholipase A2, major isoenzyme;9823;
4G97;A;Crystal structure of the response regulator PhyR from Brucella abortus;2.05;CA;CALCIUM ION;Response regulator receiver;235;
4G9A;A;Crystal structure of calcium2+-bound wild-type CD23 lectin domain;2;CA;CALCIUM ION;Low affinity immunoglobulin epsilon Fc receptor;9606;
4G9A;B;Crystal structure of calcium2+-bound wild-type CD23 lectin domain;2;CA;CALCIUM ION;Low affinity immunoglobulin epsilon Fc receptor;9606;
4G9A;C;Crystal structure of calcium2+-bound wild-type CD23 lectin domain;2;CA;CALCIUM ION;Low affinity immunoglobulin epsilon Fc receptor;9606;
4G9A;D;Crystal structure of calcium2+-bound wild-type CD23 lectin domain;2;CA;CALCIUM ION;Low affinity immunoglobulin epsilon Fc receptor;9606;
4G9L;A;Structure of MMP3 complexed with NNGH inhibitor.;1.88;CA;CALCIUM ION;Stromelysin-1;9606;
4G9L;B;Structure of MMP3 complexed with NNGH inhibitor.;1.88;CA;CALCIUM ION;Stromelysin-1;9606;
4GB1;A;Synthesis and Evaluation of Novel 3-C-alkylated-Neu5Ac2en Derivatives as Probes of Influenza Virus Sialidase 150-loop flexibility;2.62;CA;CALCIUM ION;Neuraminidase;11320;
4GC6;A;Crystal structure of Dpo4 in complex with N-MC-dAMP opposite dT;2.89;CA;CALCIUM ION;DNA polymerase IV;2287;
4GC7;A;Crystal structure of Dpo4 in complex with S-MC-dADP opposite dT;2.89;CA;CALCIUM ION;DNA polymerase IV;2287;
4GC7;B;Crystal structure of Dpo4 in complex with S-MC-dADP opposite dT;2.89;CA;CALCIUM ION;DNA polymerase IV;2287;
4GDI;A;A subtype N10 neuraminidase-like protein of A/little yellow-shouldered bat/Guatemala/164/2009;1.95;CA;CALCIUM ION;Neuraminidase;11320;
4GDI;B;A subtype N10 neuraminidase-like protein of A/little yellow-shouldered bat/Guatemala/164/2009;1.95;CA;CALCIUM ION;Neuraminidase;11320;
4GDI;C;A subtype N10 neuraminidase-like protein of A/little yellow-shouldered bat/Guatemala/164/2009;1.95;CA;CALCIUM ION;Neuraminidase;11320;
4GDI;D;A subtype N10 neuraminidase-like protein of A/little yellow-shouldered bat/Guatemala/164/2009;1.95;CA;CALCIUM ION;Neuraminidase;11320;
4GDI;E;A subtype N10 neuraminidase-like protein of A/little yellow-shouldered bat/Guatemala/164/2009;1.95;CA;CALCIUM ION;Neuraminidase;11320;
4GDI;F;A subtype N10 neuraminidase-like protein of A/little yellow-shouldered bat/Guatemala/164/2009;1.95;CA;CALCIUM ION;Neuraminidase;11320;
4GDJ;A;A subtype N10 neuraminidase-like protein of A/little yellow-shouldered bat/Guatemala/060/2010;2;CA;CALCIUM ION;Neuraminidase;11320;
4GDJ;B;A subtype N10 neuraminidase-like protein of A/little yellow-shouldered bat/Guatemala/060/2010;2;CA;CALCIUM ION;Neuraminidase;11320;
4GDJ;C;A subtype N10 neuraminidase-like protein of A/little yellow-shouldered bat/Guatemala/060/2010;2;CA;CALCIUM ION;Neuraminidase;11320;
4GDJ;D;A subtype N10 neuraminidase-like protein of A/little yellow-shouldered bat/Guatemala/060/2010;2;CA;CALCIUM ION;Neuraminidase;11320;
4GEJ;A;N-terminal domain of VDUP-1;2.9;CA;CALCIUM ION;Thioredoxin-interacting protein;9606;
4GEJ;C;N-terminal domain of VDUP-1;2.9;CA;CALCIUM ION;Thioredoxin-interacting protein;9606;
4GEJ;D;N-terminal domain of VDUP-1;2.9;CA;CALCIUM ION;Thioredoxin-interacting protein;9606;
4GEJ;H;N-terminal domain of VDUP-1;2.9;CA;CALCIUM ION;Thioredoxin-interacting protein;9606;
4GEJ;I;N-terminal domain of VDUP-1;2.9;CA;CALCIUM ION;Thioredoxin-interacting protein;9606;
4GER;A;Crystal structure of Gentlyase, the neutral metalloprotease of Paenibacillus polymyxa;1.59;CA;CALCIUM ION;Gentlyase metalloprotease;1406;
4GER;B;Crystal structure of Gentlyase, the neutral metalloprotease of Paenibacillus polymyxa;1.59;CA;CALCIUM ION;Gentlyase metalloprotease;1406;
4GEZ;A;Structure of a neuraminidase-like protein from A/bat/Guatemala/164/2009;2.5;CA;CALCIUM ION;Neuraminidase;11320;
4GEZ;B;Structure of a neuraminidase-like protein from A/bat/Guatemala/164/2009;2.5;CA;CALCIUM ION;Neuraminidase;11320;
4GEZ;C;Structure of a neuraminidase-like protein from A/bat/Guatemala/164/2009;2.5;CA;CALCIUM ION;Neuraminidase;11320;
4GEZ;D;Structure of a neuraminidase-like protein from A/bat/Guatemala/164/2009;2.5;CA;CALCIUM ION;Neuraminidase;11320;
4GEZ;E;Structure of a neuraminidase-like protein from A/bat/Guatemala/164/2009;2.5;CA;CALCIUM ION;Neuraminidase;11320;
4GEZ;F;Structure of a neuraminidase-like protein from A/bat/Guatemala/164/2009;2.5;CA;CALCIUM ION;Neuraminidase;11320;
4GEZ;G;Structure of a neuraminidase-like protein from A/bat/Guatemala/164/2009;2.5;CA;CALCIUM ION;Neuraminidase;11320;
4GEZ;H;Structure of a neuraminidase-like protein from A/bat/Guatemala/164/2009;2.5;CA;CALCIUM ION;Neuraminidase;11320;
4GEZ;I;Structure of a neuraminidase-like protein from A/bat/Guatemala/164/2009;2.5;CA;CALCIUM ION;Neuraminidase;11320;
4GEZ;J;Structure of a neuraminidase-like protein from A/bat/Guatemala/164/2009;2.5;CA;CALCIUM ION;Neuraminidase;11320;
4GEZ;K;Structure of a neuraminidase-like protein from A/bat/Guatemala/164/2009;2.5;CA;CALCIUM ION;Neuraminidase;11320;
4GEZ;L;Structure of a neuraminidase-like protein from A/bat/Guatemala/164/2009;2.5;CA;CALCIUM ION;Neuraminidase;11320;
4GF6;B;crystal structure of GFP with cuprum bound at the Incorporated metal Chelating Amino Acid PYZ151;1.1;CA;CALCIUM ION;green fluorescent protein;6100;
4GFB;A;Rap1/DNA complex;2.99;CA;CALCIUM ION;DNA-binding protein RAP1;4932;
4GG1;A;Crystal Structure of Benzoylformate Decarboxylase Mutant L403T;1.07;CA;CALCIUM ION;Benzoylformate decarboxylase;303;
4GGB;A;Crystal structure of a proposed galactarolactone cycloisomerase from agrobacterium tumefaciens, TARGET EFI-500704, WITH BOUND CA, DISORDERED LOOPS;2;CA;CALCIUM ION;Putative uncharacterized protein;1176649;
4GGF;A;Crystal structure of Mn2+ bound calprotectin;1.6;CA;CALCIUM ION;Protein S100-A8;9606;
4GGF;C;Crystal structure of Mn2+ bound calprotectin;1.6;CA;CALCIUM ION;Protein S100-A9;9606;
4GGF;K;Crystal structure of Mn2+ bound calprotectin;1.6;CA;CALCIUM ION;Protein S100-A8;9606;
4GGF;L;Crystal structure of Mn2+ bound calprotectin;1.6;CA;CALCIUM ION;Protein S100-A9;9606;
4GGF;S;Crystal structure of Mn2+ bound calprotectin;1.6;CA;CALCIUM ION;Protein S100-A8;9606;
4GGF;T;Crystal structure of Mn2+ bound calprotectin;1.6;CA;CALCIUM ION;Protein S100-A9;9606;
4GGF;U;Crystal structure of Mn2+ bound calprotectin;1.6;CA;CALCIUM ION;Protein S100-A8;9606;
4GGF;V;Crystal structure of Mn2+ bound calprotectin;1.6;CA;CALCIUM ION;Protein S100-A9;9606;
4GGQ;A;Crystal structure of a SMT fusion Peptidyl-prolyl cis-trans isomerase from Burkholderia pseudomallei complexed with CJ40;1.95;CA;CALCIUM ION;Ubiquitin-like protein SMT3, Peptidyl-prolyl cis-trans isomerase;493,228,450;
4GGQ;C;Crystal structure of a SMT fusion Peptidyl-prolyl cis-trans isomerase from Burkholderia pseudomallei complexed with CJ40;1.95;CA;CALCIUM ION;Ubiquitin-like protein SMT3, Peptidyl-prolyl cis-trans isomerase;493,228,450;
4GH8;A;Crystal structure of a 'humanized' E. coli dihydrofolate reductase;1.85;CA;CALCIUM ION;Dihydrofolate reductase;562;
4GH8;B;Crystal structure of a 'humanized' E. coli dihydrofolate reductase;1.85;CA;CALCIUM ION;Dihydrofolate reductase;562;
4GHC;B;Structure of Y257F variant of Homoprotocatechuate 2,3-Dioxygenase from B.fuscum at 1.55 Ang resolution;1.55;CA;CALCIUM ION;Homoprotocatechuate 2,3-dioxygenase;47914;
4GHD;B;Structure of Y257F variant of Homoprotocatechuate 2,3-Dioxygenase from B.fuscum in complex with HPCA at 1.85 Ang resolution;1.85;CA;CALCIUM ION;Homoprotocatechuate 2,3-dioxygenase;47914;
4GHE;B;Structure of Y257F variant of Homoprotocatechuate 2,3-Dioxygenase from B.fuscum in complex with 4-nitrocatechol at 1.60 Ang resolution;1.6;CA;CALCIUM ION;Homoprotocatechuate 2,3-dioxygenase;47914;
4GHF;B;Structure of Y257F variant of Homoprotocatechuate 2,3-Dioxygenase from B.fuscum in complex with 4-Nitrocatechol and dioxygen at 1.67 Ang resolution;1.67;CA;CALCIUM ION;Homoprotocatechuate 2,3-dioxygenase;47914;
4GHG;B;Structure of Homoprotocatechuate 2,3-Dioxygenase from B.fuscum in complex with HPCA at 1.50 Ang resolution;1.5;CA;CALCIUM ION;Homoprotocatechuate 2,3-dioxygenase;47914;
4GHH;B;Structure of Homoprotocatechuate 2,3-Dioxygenase from B.fuscum in complex with 4-Nitrocatechol at 1.55 Ang resolution;1.55;CA;CALCIUM ION;Homoprotocatechuate 2,3-dioxygenase;47914;
4GI6;A;Crystal structure of the MUTB F164L mutant in complex with glucose;2.15;CA;CALCIUM ION;Sucrose isomerase;1071045;
4GI6;B;Crystal structure of the MUTB F164L mutant in complex with glucose;2.15;CA;CALCIUM ION;Sucrose isomerase;1071045;
4GI8;A;Crystal structure of the MUTB F164L mutant from crystals soaked with the substrate sucrose;1.95;CA;CALCIUM ION;Sucrose isomerase;1071045;
4GI8;B;Crystal structure of the MUTB F164L mutant from crystals soaked with the substrate sucrose;1.95;CA;CALCIUM ION;Sucrose isomerase;1071045;
4GI9;A;Crystal structure of the MUTB F164L mutant from crystals soaked with Trehalulose;2.15;CA;CALCIUM ION;Sucrose isomerase;1071045;
4GI9;B;Crystal structure of the MUTB F164L mutant from crystals soaked with Trehalulose;2.15;CA;CALCIUM ION;Sucrose isomerase;1071045;
4GIA;A;Crystal structure of the MUTB F164L mutant from crystals soaked with isomaltulose;2.01;CA;CALCIUM ION;Sucrose isomerase;1071045;
4GIA;B;Crystal structure of the MUTB F164L mutant from crystals soaked with isomaltulose;2.01;CA;CALCIUM ION;Sucrose isomerase;1071045;
4GIN;A;Crystal structure of the MUTB R284C mutant from crystals soaked with the inhibitor deoxynojirimycin;1.9;CA;CALCIUM ION;Sucrose isomerase;1071045;
4GJE;A;Crystal structure of the refolded amino-terminal domain of human cardiac troponin C in complex with cadmium;1.6;CA;CALCIUM ION;Troponin C, slow skeletal and cardiac muscles;9606;
4GJF;A;Crystal structure of the amino-terminal domain of human cardiac troponin C mutant L29Q in complex with cadmium;1.9;CA;CALCIUM ION;Troponin C, slow skeletal and cardiac muscles;9606;
4GJG;A;Crystal structure of the amino-terminal domain of human cardiac troponin C mutant D2N/V28I/L29Q/G30D (NIQD) in complex with cadmium.;2;CA;CALCIUM ION;Troponin C, slow skeletal and cardiac muscles;9606;
4GKB;A;Crystal structure of a short chain dehydrogenase homolog (target efi-505321) from burkholderia multivorans, unliganded structure;1.5;CA;CALCIUM ION;3-oxoacyl-[acyl-carrier protein] reductase;87883;
4GKB;B;Crystal structure of a short chain dehydrogenase homolog (target efi-505321) from burkholderia multivorans, unliganded structure;1.5;CA;CALCIUM ION;3-oxoacyl-[acyl-carrier protein] reductase;87883;
4GKB;C;Crystal structure of a short chain dehydrogenase homolog (target efi-505321) from burkholderia multivorans, unliganded structure;1.5;CA;CALCIUM ION;3-oxoacyl-[acyl-carrier protein] reductase;87883;
4GKO;G;Crystal structure of the calcium2+-bound human IgE-Fc(epsilon)3-4 bound to its B cell receptor derCD23;3.3;CA;CALCIUM ION;Low affinity immunoglobulin epsilon Fc receptor;9606;
4GKO;H;Crystal structure of the calcium2+-bound human IgE-Fc(epsilon)3-4 bound to its B cell receptor derCD23;3.3;CA;CALCIUM ION;Low affinity immunoglobulin epsilon Fc receptor;9606;
4GKO;I;Crystal structure of the calcium2+-bound human IgE-Fc(epsilon)3-4 bound to its B cell receptor derCD23;3.3;CA;CALCIUM ION;Low affinity immunoglobulin epsilon Fc receptor;9606;
4GKO;J;Crystal structure of the calcium2+-bound human IgE-Fc(epsilon)3-4 bound to its B cell receptor derCD23;3.3;CA;CALCIUM ION;Low affinity immunoglobulin epsilon Fc receptor;9606;
4GKO;K;Crystal structure of the calcium2+-bound human IgE-Fc(epsilon)3-4 bound to its B cell receptor derCD23;3.3;CA;CALCIUM ION;Low affinity immunoglobulin epsilon Fc receptor;9606;
4GKO;L;Crystal structure of the calcium2+-bound human IgE-Fc(epsilon)3-4 bound to its B cell receptor derCD23;3.3;CA;CALCIUM ION;Low affinity immunoglobulin epsilon Fc receptor;9606;
4GKX;A;Crystal structure of a carbohydrate-binding domain;2.7;CA;CALCIUM ION;Protein ERGIC-53;9606;
4GKX;B;Crystal structure of a carbohydrate-binding domain;2.7;CA;CALCIUM ION;Protein ERGIC-53;9606;
4GKX;C;Crystal structure of a carbohydrate-binding domain;2.7;CA;CALCIUM ION;Protein ERGIC-53;9606;
4GKX;D;Crystal structure of a carbohydrate-binding domain;2.7;CA;CALCIUM ION;Protein ERGIC-53;9606;
4GKX;E;Crystal structure of a carbohydrate-binding domain;2.7;CA;CALCIUM ION;Protein ERGIC-53;9606;
4GKX;F;Crystal structure of a carbohydrate-binding domain;2.7;CA;CALCIUM ION;Protein ERGIC-53;9606;
4GKY;A;Crystal structure of a carbohydrate-binding domain;2.42;CA;CALCIUM ION;Protein ERGIC-53;9606;
4GM0;A;Crystal Structure of Benzoylformate Decarboxylase Mutant L403N;1.07;CA;CALCIUM ION;Benzoylformate decarboxylase;303;
4GM1;A;Crystal Structure of Benzoylformate Decarboxylase Mutant L403S;1.26;CA;CALCIUM ION;Benzoylformate decarboxylase;303;
4GM4;A;Crystal Structure of Benzoylformate Decarboxylase Mutant L403I;1.28;CA;CALCIUM ION;Benzoylformate decarboxylase;303;
4GM5;A;Carboxypeptidase T with Sulphamoil Arginine;1.39;CA;CALCIUM ION;Carboxypeptidase T;2026;
4GM7;A;Structure of cinnamic acid bound bovine lactoperoxidase at 2.6A resolution.;2.6;CA;CALCIUM ION;Lactoperoxidase;9913;
4GMD;D;The crystal structure of thymidylate kinase from Pseudomonas aeruginosa PAO1 in complex with AZT Monophosphate;1.98;CA;CALCIUM ION;Thymidylate kinase;287;
4GN6;A;Structure of paracetamol bound bovine lactoperoxidase at 2.45A resolution.;2.42;CA;CALCIUM ION;Lactoperoxidase;9913;
4GN7;A;mouse SMP30/GNL;1.95;CA;CALCIUM ION;Regucalcin;10090;
4GN7;B;mouse SMP30/GNL;1.95;CA;CALCIUM ION;Regucalcin;10090;
4GN8;A;mouse SMP30/GNL-1,5-AG complex;1.7;CA;CALCIUM ION;Regucalcin;10090;
4GN8;B;mouse SMP30/GNL-1,5-AG complex;1.7;CA;CALCIUM ION;Regucalcin;10090;
4GN9;A;mouse SMP30/GNL-glucose complex;2;CA;CALCIUM ION;Regucalcin;10090;
4GN9;B;mouse SMP30/GNL-glucose complex;2;CA;CALCIUM ION;Regucalcin;10090;
4GNA;A;mouse SMP30/GNL-xylitol complex;1.85;CA;CALCIUM ION;Regucalcin;10090;
4GNB;A;human SMP30/GNL;1.5;CA;CALCIUM ION;Regucalcin;9606;
4GNB;B;human SMP30/GNL;1.5;CA;CALCIUM ION;Regucalcin;9606;
4GNC;A;human SMP30/GNL-1,5-AG complex;1.75;CA;CALCIUM ION;Regucalcin;9606;
4GNC;B;human SMP30/GNL-1,5-AG complex;1.75;CA;CALCIUM ION;Regucalcin;9606;
4GNK;B;Crystal structure of Galphaq in complex with full-length human PLCbeta3;4;CA;CALCIUM ION;1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-3;9606;
4GNK;D;Crystal structure of Galphaq in complex with full-length human PLCbeta3;4;CA;CALCIUM ION;1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-3;9606;
4GO8;A;Crystal Structure of the TREHALULOSE SYNTHASE MUTB, MUTANT A258V, in complex with TRIS;2.15;CA;CALCIUM ION;Sucrose isomerase;265293;
4GO8;B;Crystal Structure of the TREHALULOSE SYNTHASE MUTB, MUTANT A258V, in complex with TRIS;2.15;CA;CALCIUM ION;Sucrose isomerase;265293;
4GO9;A;CRYSTAL STRUCTURE of the TREHALULOSE SYNTHASE MUTANT, MUTB D415N, in COMPLEX with TRIS;2.2;CA;CALCIUM ION;Sucrose isomerase;265293;
4GO9;B;CRYSTAL STRUCTURE of the TREHALULOSE SYNTHASE MUTANT, MUTB D415N, in COMPLEX with TRIS;2.2;CA;CALCIUM ION;Sucrose isomerase;265293;
4GOW;D;Crystal Structure of Ca2+/CaM:Kv7.4 (KCNQ4) B helix complex;2.6;CA;CALCIUM ION;Calmodulin;9606;
4GP9;A;Crystal Structure of Benzoylformate Decarboxylase Mutant L403F;1.07;CA;CALCIUM ION;Benzoylformate decarboxylase;303;
4GPE;A;Crystal Structure of Benzoylformate Decarboxylase Mutant L403M;1.39;CA;CALCIUM ION;Benzoylformate decarboxylase;303;
4GQ7;A;Crystal structure of Lg-Flo1p;2.53;CA;CALCIUM ION;Flocculin;27292;
4GQL;A;Crystal structure of the catalytic domain of Human MMP12 in complex with selective phosphinic inhibitor RXP470.1;1.15;CA;CALCIUM ION;Macrophage metalloelastase;9606;
4GQQ;A;Human pancreatic alpha-amylase with bound ethyl caffeate;1.35;CA;CALCIUM ION;Pancreatic alpha-amylase;9606;
4GQR;A;Human Pancreatic alpha-amylase in complex with myricetin;1.2;CA;CALCIUM ION;Pancreatic alpha-amylase;9606;
4GR0;A;Crystal structure of the catalytic domain of Human MMP12 in complex with selective phosphinic inhibitor RXP470B;1.5;CA;CALCIUM ION;Macrophage metalloelastase;9606;
4GR3;A;Crystal structure of the catalytic domain of Human MMP12 in complex with selective phosphinic inhibitor RXP470A;1.49;CA;CALCIUM ION;Macrophage metalloelastase;9606;
4GR8;A;Crystal structure of the catalytic domain of Human MMP12 in complex with selective phosphinic inhibitor RXP470C;1.3;CA;CALCIUM ION;Macrophage metalloelastase;9606;
4GRC;A;Crystal structure of DyP-type peroxidase (SCO2276) from Streptomyces coelicolor;2;CA;CALCIUM ION;Putative membrane protein;1902;
4GSP;A;RIBONUCLEASE T1 COMPLEXED WITH 2',3'-CGPS + 3'-GMP, 7 DAYS;1.65;CA;CALCIUM ION;RIBONUCLEASE T1;5062;
4GSQ;A;Structural basis for the inhibition of Mycobacterium tuberculosis L,D-transpeptidase by meropenem, a drug effective against extensively drug-resistant strains;1.8;CA;CALCIUM ION;Probable conserved lipoprotein LPPS;1773;
4GTS;B;Engineered RabGGTase in complex with BMS analogue 16;2.45;CA;CALCIUM ION;Geranylgeranyl transferase type-2 subunit beta;10116;
4GTT;B;Engineered RabGGTase in complex with BMS analogue 12;2.05;CA;CALCIUM ION;Geranylgeranyl transferase type-2 subunit beta;10116;
4GTV;B;Engineered RabGGTase in complex with BMS analogue 13;1.95;CA;CALCIUM ION;Geranylgeranyl transferase type-2 subunit beta;10116;
4GTW;A;Crystal structure of mouse Enpp1 in complex with AMP;2.7;CA;CALCIUM ION;Ectonucleotide pyrophosphatase/phosphodiesterase family member 2, Alkaline phosphodiesterase I;10090;
4GTW;B;Crystal structure of mouse Enpp1 in complex with AMP;2.7;CA;CALCIUM ION;Ectonucleotide pyrophosphatase/phosphodiesterase family member 2, Alkaline phosphodiesterase I;10090;
4GTX;A;Crystal structure of mouse Enpp1 in complex with TMP;3.2;CA;CALCIUM ION;Ectonucleotide pyrophosphatase/phosphodiesterase family member 2, Alkaline phosphodiesterase I;10090;
4GTX;B;Crystal structure of mouse Enpp1 in complex with TMP;3.2;CA;CALCIUM ION;Ectonucleotide pyrophosphatase/phosphodiesterase family member 2, Alkaline phosphodiesterase I;10090;
4GTY;A;Crystal structure of mouse Enpp1 in complex with GMP;3.19;CA;CALCIUM ION;Ectonucleotide pyrophosphatase/phosphodiesterase family member 2, Alkaline phosphodiesterase I;10090;
4GTY;B;Crystal structure of mouse Enpp1 in complex with GMP;3.19;CA;CALCIUM ION;Ectonucleotide pyrophosphatase/phosphodiesterase family member 2, Alkaline phosphodiesterase I;10090;
4GTZ;A;Crystal structure of mouse Enpp1 in complex with CMP;3.19;CA;CALCIUM ION;Ectonucleotide pyrophosphatase/phosphodiesterase family member 2, Alkaline phosphodiesterase I;10090;
4GTZ;B;Crystal structure of mouse Enpp1 in complex with CMP;3.19;CA;CALCIUM ION;Ectonucleotide pyrophosphatase/phosphodiesterase family member 2, Alkaline phosphodiesterase I;10090;
4GUK;A;New crystal form structure of human NCS1;1.75;CA;CALCIUM ION;Neuronal calcium sensor 1;9606;
4GUK;B;New crystal form structure of human NCS1;1.75;CA;CALCIUM ION;Neuronal calcium sensor 1;9606;
4GUK;C;New crystal form structure of human NCS1;1.75;CA;CALCIUM ION;Neuronal calcium sensor 1;9606;
4GUK;D;New crystal form structure of human NCS1;1.75;CA;CALCIUM ION;Neuronal calcium sensor 1;9606;
4GUX;A;Crystal structure of trypsin:MCoTi-II complex;1.8;CA;CALCIUM ION;Cationic trypsin;9913;
4GUX;B;Crystal structure of trypsin:MCoTi-II complex;1.8;CA;CALCIUM ION;Cationic trypsin;9913;
4GUX;C;Crystal structure of trypsin:MCoTi-II complex;1.8;CA;CALCIUM ION;Cationic trypsin;9913;
4GUY;A;Human MMP12 catalytic domain in complex with*N*-Hydroxy-2-(2-(4-methoxyphenyl)ethylsulfonamido)acetamide;2;CA;CALCIUM ION;Macrophage metalloelastase;9606;
4GVL;A;Crystal Structure of the GsuK RCK domain;3;CA;CALCIUM ION;TrkA domain protein;35554;
4GVL;B;Crystal Structure of the GsuK RCK domain;3;CA;CALCIUM ION;TrkA domain protein;35554;
4GVL;C;Crystal Structure of the GsuK RCK domain;3;CA;CALCIUM ION;TrkA domain protein;35554;
4GVU;A;Lyngbyastatin 7-Porcine Pancreatic Elastase Co-crystal Structure;1.55;CA;CALCIUM ION;Chymotrypsin-like elastase family member 1;9823;
4GW3;A;Crystal Structure of the Lipase from Proteus mirabilis;2;CA;CALCIUM ION;Putative lipase;584;
4GWB;A;Crystal structure of putative Peptide methionine sulfoxide reductase from Sinorhizobium meliloti 1021;1.2;CA;CALCIUM ION;Peptide methionine sulfoxide reductase MsrA 3;382;
4GWI;A;His 62 mutant of the lectin binding domain of lectinolysin complexed with Lewis y;1.6;CA;CALCIUM ION;Platelet aggregation factor Sm-hPAF;28037;
4GWJ;A;His 62 mutant of the lectin binding domain of Lectinolysin complexed with Lewis b;1.6;CA;CALCIUM ION;Platelet aggregation factor Sm-hPAF;28037;
4GX0;A;Crystal structure of the GsuK L97D mutant;2.6;CA;CALCIUM ION;TrkA domain protein;35554;
4GX0;B;Crystal structure of the GsuK L97D mutant;2.6;CA;CALCIUM ION;TrkA domain protein;35554;
4GX0;C;Crystal structure of the GsuK L97D mutant;2.6;CA;CALCIUM ION;TrkA domain protein;35554;
4GX1;A;Crystal structure of the GsuK bound to ADP;2.8;CA;CALCIUM ION;TrkA domain protein;35554;
4GX1;B;Crystal structure of the GsuK bound to ADP;2.8;CA;CALCIUM ION;TrkA domain protein;35554;
4GX1;C;Crystal structure of the GsuK bound to ADP;2.8;CA;CALCIUM ION;TrkA domain protein;35554;
4GX2;A;GsuK channel bound to NAD;3.2;CA;CALCIUM ION;TrkA domain protein;35554;
4GX2;B;GsuK channel bound to NAD;3.2;CA;CALCIUM ION;TrkA domain protein;35554;
4GX2;C;GsuK channel bound to NAD;3.2;CA;CALCIUM ION;TrkA domain protein;35554;
4GX5;A;GsuK Channel;3.7;CA;CALCIUM ION;TrkA domain protein;35554;
4GX5;B;GsuK Channel;3.7;CA;CALCIUM ION;TrkA domain protein;35554;
4GX5;C;GsuK Channel;3.7;CA;CALCIUM ION;TrkA domain protein;35554;
4GXN;A;Diethylphosphonate Inhibited Structure of the Proteus mirabilis Lipase;2.2;CA;CALCIUM ION;Putative lipase;584;
4GY2;B;Crystal structure of apo-Ia-actin complex;2.71;CA;CALCIUM ION;Actin, alpha skeletal muscle;9986;
4GZ8;A;Mouse Semaphorin 3A, domains Sema-PSI-IG;3.3;CA;CALCIUM ION;Semaphorin-3A;10090;
4GZ8;B;Mouse Semaphorin 3A, domains Sema-PSI-IG;3.3;CA;CALCIUM ION;Semaphorin-3A;10090;
4GZ9;A;Mouse Neuropilin-1, extracellular domains 1-4 (a1a2b1b2);2.7;CA;CALCIUM ION;Neuropilin-1;10090;
4GZA;H;Complex of mouse Plexin A2 - Semaphorin 3A - Neuropilin-1;7;CA;CALCIUM ION;Neuropilin-1;10090;
4GZN;B;Mouse ZFP57 zinc fingers in complex with methylated DNA;0.99;CA;CALCIUM ION;DNA (5'-D(*AP*CP*TP*GP*(5CM)P*GP*GP*CP*AP*AP*T)-3');;
4GZO;A;N2 neuraminidase of A/Tanzania/205/2010 H3N2 in complex with hepes;2.6;CA;CALCIUM ION;neuraminidase;11320;
4GZP;A;N2 Neuraminidase of A/Tanzania/205/2010 H3N2 in complex with oseltamivir carboxylate;2.3;CA;CALCIUM ION;Neuraminidase;11320;
4GZQ;A;N2 neuraminidase of A/Tanzania/205/2010 H3N2 in complex with sialic acid;2.2;CA;CALCIUM ION;Nueraminidase;11320;
4GZS;A;N2 neuraminidase D151G mutant of a/Tanzania/205/2010 H3N2 in complex with hepes;2.35;CA;CALCIUM ION;Neuraminidase;11320;
4GZS;B;N2 neuraminidase D151G mutant of a/Tanzania/205/2010 H3N2 in complex with hepes;2.35;CA;CALCIUM ION;Neuraminidase;11320;
4GZS;C;N2 neuraminidase D151G mutant of a/Tanzania/205/2010 H3N2 in complex with hepes;2.35;CA;CALCIUM ION;Neuraminidase;11320;
4GZS;D;N2 neuraminidase D151G mutant of a/Tanzania/205/2010 H3N2 in complex with hepes;2.35;CA;CALCIUM ION;Neuraminidase;11320;
4GZT;A;N2 neuraminidase D151G mutant of A/Tanzania/205/2010 H3N2 in complex with oseltamivir carboxylate;2.19;CA;CALCIUM ION;neuraminidase;11320;
4GZT;B;N2 neuraminidase D151G mutant of A/Tanzania/205/2010 H3N2 in complex with oseltamivir carboxylate;2.19;CA;CALCIUM ION;neuraminidase;11320;
4GZT;C;N2 neuraminidase D151G mutant of A/Tanzania/205/2010 H3N2 in complex with oseltamivir carboxylate;2.19;CA;CALCIUM ION;neuraminidase;11320;
4GZT;D;N2 neuraminidase D151G mutant of A/Tanzania/205/2010 H3N2 in complex with oseltamivir carboxylate;2.19;CA;CALCIUM ION;neuraminidase;11320;
4GZW;A;N2 neuraminidase D151G mutant of A/Tanzania/205/2010 H3N2 in complex with avian sialic acid receptor;2.45;CA;CALCIUM ION;neuraminidase;11320;
4GZW;B;N2 neuraminidase D151G mutant of A/Tanzania/205/2010 H3N2 in complex with avian sialic acid receptor;2.45;CA;CALCIUM ION;neuraminidase;11320;
4GZW;C;N2 neuraminidase D151G mutant of A/Tanzania/205/2010 H3N2 in complex with avian sialic acid receptor;2.45;CA;CALCIUM ION;neuraminidase;11320;
4GZW;D;N2 neuraminidase D151G mutant of A/Tanzania/205/2010 H3N2 in complex with avian sialic acid receptor;2.45;CA;CALCIUM ION;neuraminidase;11320;
4GZX;A;N2 neuraminidase D151G mutant of A/Tanzania/205/2010 H3N2 in complex with human sialic acid receptor;2.45;CA;CALCIUM ION;neuraminidase;11320;
4GZX;B;N2 neuraminidase D151G mutant of A/Tanzania/205/2010 H3N2 in complex with human sialic acid receptor;2.45;CA;CALCIUM ION;neuraminidase;11320;
4GZX;C;N2 neuraminidase D151G mutant of A/Tanzania/205/2010 H3N2 in complex with human sialic acid receptor;2.45;CA;CALCIUM ION;neuraminidase;11320;
4GZX;D;N2 neuraminidase D151G mutant of A/Tanzania/205/2010 H3N2 in complex with human sialic acid receptor;2.45;CA;CALCIUM ION;neuraminidase;11320;
4H03;B;Crystal structure of NAD+-Ia-actin complex;1.75;CA;CALCIUM ION;Actin, alpha skeletal muscle;9986;
4H0E;T;Crystal Structure of mutant ORR3 in complex with NTD of AraR;1.97;CA;CALCIUM ION;5'-D(*TP*AP*TP*AP*AP*AP*AP*TP*GP*TP*AP*CP*GP*GP*AP*CP*AP*AP*AP*TP*T)-3';;
4H0N;A;Crystal structure of Spodoptera frugiperda DNMT2 E260A/E261A/K263A mutant;2.71;CA;CALCIUM ION;DNMT2;7108;
4H0N;B;Crystal structure of Spodoptera frugiperda DNMT2 E260A/E261A/K263A mutant;2.71;CA;CALCIUM ION;DNMT2;7108;
4H0N;C;Crystal structure of Spodoptera frugiperda DNMT2 E260A/E261A/K263A mutant;2.71;CA;CALCIUM ION;DNMT2;7108;
4H0N;D;Crystal structure of Spodoptera frugiperda DNMT2 E260A/E261A/K263A mutant;2.71;CA;CALCIUM ION;DNMT2;7108;
4H0T;B;Crystal structure of Ia-ADPR-actin complex;2.2;CA;CALCIUM ION;Actin, alpha skeletal muscle;9986;
4H0V;B;Crystal structure of NAD+-Ia(E378S)-actin complex;2.03;CA;CALCIUM ION;Actin, alpha skeletal muscle;9986;
4H0X;B;Crystal structure of NAD+-Ia(E380A)-actin complex;2.33;CA;CALCIUM ION;Actin, alpha skeletal muscle;9986;
4H0Y;B;Crystal structure of NAD+-Ia(E380S)-actin complex;1.94;CA;CALCIUM ION;Actin, alpha skeletal muscle;9986;
4H15;A;Crystal Structure of a short chain alcohol dehydrogenase-related dehydrogenase (target ID NYSGRC-011812) from Sinorhizobium meliloti 1021 in space group P21;1.45;CA;CALCIUM ION;Short chain alcohol dehydrogenase-related dehydrogenase;382;
4H15;B;Crystal Structure of a short chain alcohol dehydrogenase-related dehydrogenase (target ID NYSGRC-011812) from Sinorhizobium meliloti 1021 in space group P21;1.45;CA;CALCIUM ION;Short chain alcohol dehydrogenase-related dehydrogenase;382;
4H15;C;Crystal Structure of a short chain alcohol dehydrogenase-related dehydrogenase (target ID NYSGRC-011812) from Sinorhizobium meliloti 1021 in space group P21;1.45;CA;CALCIUM ION;Short chain alcohol dehydrogenase-related dehydrogenase;382;
4H15;D;Crystal Structure of a short chain alcohol dehydrogenase-related dehydrogenase (target ID NYSGRC-011812) from Sinorhizobium meliloti 1021 in space group P21;1.45;CA;CALCIUM ION;Short chain alcohol dehydrogenase-related dehydrogenase;382;
4H19;A;Crystal structure of an enolase (mandelate racemase subgroup, target EFI-502087) from agrobacterium tumefaciens, with bound Mg and d-ribonohydroxamate, ordered loop;1.8;CA;CALCIUM ION;Mandelate racemase;1176649;
4H19;B;Crystal structure of an enolase (mandelate racemase subgroup, target EFI-502087) from agrobacterium tumefaciens, with bound Mg and d-ribonohydroxamate, ordered loop;1.8;CA;CALCIUM ION;Mandelate racemase;1176649;
4H19;D;Crystal structure of an enolase (mandelate racemase subgroup, target EFI-502087) from agrobacterium tumefaciens, with bound Mg and d-ribonohydroxamate, ordered loop;1.8;CA;CALCIUM ION;Mandelate racemase;1176649;
4H19;G;Crystal structure of an enolase (mandelate racemase subgroup, target EFI-502087) from agrobacterium tumefaciens, with bound Mg and d-ribonohydroxamate, ordered loop;1.8;CA;CALCIUM ION;Mandelate racemase;1176649;
4H19;H;Crystal structure of an enolase (mandelate racemase subgroup, target EFI-502087) from agrobacterium tumefaciens, with bound Mg and d-ribonohydroxamate, ordered loop;1.8;CA;CALCIUM ION;Mandelate racemase;1176649;
4H19;J;Crystal structure of an enolase (mandelate racemase subgroup, target EFI-502087) from agrobacterium tumefaciens, with bound Mg and d-ribonohydroxamate, ordered loop;1.8;CA;CALCIUM ION;Mandelate racemase;1176649;
4H19;K;Crystal structure of an enolase (mandelate racemase subgroup, target EFI-502087) from agrobacterium tumefaciens, with bound Mg and d-ribonohydroxamate, ordered loop;1.8;CA;CALCIUM ION;Mandelate racemase;1176649;
4H19;M;Crystal structure of an enolase (mandelate racemase subgroup, target EFI-502087) from agrobacterium tumefaciens, with bound Mg and d-ribonohydroxamate, ordered loop;1.8;CA;CALCIUM ION;Mandelate racemase;1176649;
4H19;N;Crystal structure of an enolase (mandelate racemase subgroup, target EFI-502087) from agrobacterium tumefaciens, with bound Mg and d-ribonohydroxamate, ordered loop;1.8;CA;CALCIUM ION;Mandelate racemase;1176649;
4H19;O;Crystal structure of an enolase (mandelate racemase subgroup, target EFI-502087) from agrobacterium tumefaciens, with bound Mg and d-ribonohydroxamate, ordered loop;1.8;CA;CALCIUM ION;Mandelate racemase;1176649;
4H1Q;A;Crystal structure of mutant MMP-9 catalytic domain in complex with a twin inhibitor.;1.59;CA;CALCIUM ION;Matrix metalloproteinase-9;9606;
4H1Q;B;Crystal structure of mutant MMP-9 catalytic domain in complex with a twin inhibitor.;1.59;CA;CALCIUM ION;Matrix metalloproteinase-9;9606;
4H1Y;P;Human ecto-5'-nucleotidase (CD73): crystal form II (open) in complex with PSB11552;1.58;CA;CALCIUM ION;5'-nucleotidase;9606;
4H2A;A;Crystal structure of wild type protective antigen to 1.62 A (pH 7.5);1.62;CA;CALCIUM ION;Protective antigen;1392;
4H2B;A;Human ecto-5'-nucleotidase (CD73): crystal form II (open) in complex with Baicalin;1.7;CA;CALCIUM ION;5'-nucleotidase;9606;
4H2C;A;Trehalulose synthase MutB R284C mutant;1.7;CA;CALCIUM ION;Sucrose isomerase;1071045;
4H2E;A;Crystal structure of an MMP twin inhibitor complexing two MMP-9 catalytic domains;2.9;CA;CALCIUM ION;Matrix metalloproteinase-9;9606;
4H2E;B;Crystal structure of an MMP twin inhibitor complexing two MMP-9 catalytic domains;2.9;CA;CALCIUM ION;Matrix metalloproteinase-9;9606;
4H2F;A;Human ecto-5'-nucleotidase (CD73): crystal form I (open) in complex with adenosine;1.85;CA;CALCIUM ION;5'-nucleotidase;9606;
4H2G;A;Human ecto-5'-nucleotidase (CD73): crystal form II (open) in complex with adenosine;1.55;CA;CALCIUM ION;5'-nucleotidase;9606;
4H2I;A;Human ecto-5'-nucleotidase (CD73): crystal form III (closed) in complex with AMPCP;2;CA;CALCIUM ION;5'-nucleotidase;9606;
4H30;A;Crystal structure of the catalytic domain of MMP-12 in complex with a twin inhibitor.;1.43;CA;CALCIUM ION;Macrophage metalloelastase;9606;
4H30;B;Crystal structure of the catalytic domain of MMP-12 in complex with a twin inhibitor.;1.43;CA;CALCIUM ION;Macrophage metalloelastase;9606;
4H3X;A;Crystal structure of an MMP broad spectrum hydroxamate based inhibitor CC27 in complex with the MMP-9 catalytic domain;1.76;CA;CALCIUM ION;Matrix metalloproteinase-9;9606;
4H3X;B;Crystal structure of an MMP broad spectrum hydroxamate based inhibitor CC27 in complex with the MMP-9 catalytic domain;1.76;CA;CALCIUM ION;Matrix metalloproteinase-9;9606;
4H49;A;Crystal structure of the catalytic domain of MMP-12 in complex with a twin inhibitor.;2.16;CA;CALCIUM ION;Macrophage metalloelastase;9606;
4H49;B;Crystal structure of the catalytic domain of MMP-12 in complex with a twin inhibitor.;2.16;CA;CALCIUM ION;Macrophage metalloelastase;9606;
4H49;C;Crystal structure of the catalytic domain of MMP-12 in complex with a twin inhibitor.;2.16;CA;CALCIUM ION;Macrophage metalloelastase;9606;
4H49;D;Crystal structure of the catalytic domain of MMP-12 in complex with a twin inhibitor.;2.16;CA;CALCIUM ION;Macrophage metalloelastase;9606;
4H52;A;Wild-type influenza N2 neuraminidase covalent complex with 3-fluoro-Neu5Ac;1.8;CA;CALCIUM ION;Neuraminidase;11320;
4H52;B;Wild-type influenza N2 neuraminidase covalent complex with 3-fluoro-Neu5Ac;1.8;CA;CALCIUM ION;Neuraminidase;11320;
4H53;A;Influenza N2-Tyr406Asp neuraminidase in complex with beta-Neu5Ac;1.5;CA;CALCIUM ION;Neuraminidase;11320;
4H53;B;Influenza N2-Tyr406Asp neuraminidase in complex with beta-Neu5Ac;1.5;CA;CALCIUM ION;Neuraminidase;11320;
4H53;C;Influenza N2-Tyr406Asp neuraminidase in complex with beta-Neu5Ac;1.5;CA;CALCIUM ION;Neuraminidase;11320;
4H55;A;Crystal structure of Canavalia brasiliensis seed lectin (ConBr) in complex with beta-d-ribofuranose;2.15;CA;CALCIUM ION;Concanavalin-Br;61861;
4H57;A;Thermolysin inhibition;1.56;CA;CALCIUM ION;Thermolysin;1427;
4H60;A;High resolution structure of Vibrio cholerae chemotaxis protein CheY4 crystallized in low pH (4.0) condition;1.66;CA;CALCIUM ION;Chemotaxis protein CheY;666;
4H76;A;Crystal structure of the catalytic domain of Human MMP12 in complex with a broad spectrum hydroxamate inhibitor;1.5;CA;CALCIUM ION;Macrophage metalloelastase;9606;
4H77;A;Crystal structure of haloalkane dehalogenase LinB from Sphingobium sp. MI1205;1.6;CA;CALCIUM ION;Haloalkane dehalogenase;407020;
4H7D;A;Crystal structure of haloalkane dehalogenase LinB T81A mutant from Sphingobium sp. MI1205;1.95;CA;CALCIUM ION;Haloalkane dehalogenase;407020;
4H7E;A;Crystal structure of haloalkane dehalogenase LinB V112A mutant from Sphingobium sp. MI1205;1.8;CA;CALCIUM ION;Haloalkane dehalogenase;407020;
4H7F;A;Crystal structure of haloalkane dehalogenase LinB V134I mutant from Sphingobium sp. MI1205;1.8;CA;CALCIUM ION;Haloalkane dehalogenase;407020;
4H7H;A;Crystal structure of haloalkane dehalogenase LinB T135A mutant from Sphingobium sp. MI1205;2.1;CA;CALCIUM ION;Haloalkane dehalogenase;407020;
4H7I;A;Crystal structure of haloalkane dehalogenase LinB L138I mutant from Sphingobium sp. MI1205;1.8;CA;CALCIUM ION;Haloalkane dehalogenase;407020;
4H7J;A;Crystal structure of haloalkane dehalogenase LinB H247A mutant from Sphingobium sp. MI1205;1.8;CA;CALCIUM ION;Haloalkane dehalogenase;407020;
4H7K;A;Crystal structure of haloalkane dehalogenase LinB I253M mutant from Sphingobium sp. MI1205;1.75;CA;CALCIUM ION;Haloalkane dehalogenase;407020;
4H7V;A;MUTB inactive double mutant D200A-D415N in complex with GLUCOSE;1.8;CA;CALCIUM ION;Sucrose isomerase;1071045;
4H7V;B;MUTB inactive double mutant D200A-D415N in complex with GLUCOSE;1.8;CA;CALCIUM ION;Sucrose isomerase;1071045;
4H82;A;Crystal structure of mutant MMP-9 catalytic domain in complex with a twin inhibitor.;1.9;CA;CALCIUM ION;Matrix metalloproteinase-9;9606;
4H82;B;Crystal structure of mutant MMP-9 catalytic domain in complex with a twin inhibitor.;1.9;CA;CALCIUM ION;Matrix metalloproteinase-9;9606;
4H82;C;Crystal structure of mutant MMP-9 catalytic domain in complex with a twin inhibitor.;1.9;CA;CALCIUM ION;Matrix metalloproteinase-9;9606;
4H82;D;Crystal structure of mutant MMP-9 catalytic domain in complex with a twin inhibitor.;1.9;CA;CALCIUM ION;Matrix metalloproteinase-9;9606;
4H84;A;Crystal structure of the catalytic domain of Human MMP12 in complex with a selective carboxylate based inhibitor.;1.59;CA;CALCIUM ION;Macrophage metalloelastase;9606;
4H84;B;Crystal structure of the catalytic domain of Human MMP12 in complex with a selective carboxylate based inhibitor.;1.59;CA;CALCIUM ION;Macrophage metalloelastase;9606;
4H8H;A;MUTB inactive double mutant E254Q-D415N;2;CA;CALCIUM ION;Sucrose isomerase;1071045;
4H8H;B;MUTB inactive double mutant E254Q-D415N;2;CA;CALCIUM ION;Sucrose isomerase;1071045;
4H8U;A;MUTB inactive double mutant D200A-D415N soaked with sucrose and having as bound ligands sucrose in molecule A and the reaction product trehalulose in molecule B;2;CA;CALCIUM ION;Sucrose isomerase;1071045;
4H8U;B;MUTB inactive double mutant D200A-D415N soaked with sucrose and having as bound ligands sucrose in molecule A and the reaction product trehalulose in molecule B;2;CA;CALCIUM ION;Sucrose isomerase;1071045;
4H8V;A;Crystal structure of the trehalulose synthase MUTB in complex with trehalulose;1.95;CA;CALCIUM ION;Sucrose isomerase;1071045;
4H8V;B;Crystal structure of the trehalulose synthase MUTB in complex with trehalulose;1.95;CA;CALCIUM ION;Sucrose isomerase;1071045;
4HA1;A;MutB inactive double mutant D200A-D415N in complex with isomaltulose;2.2;CA;CALCIUM ION;Sucrose isomerase;1071045;
4HA1;B;MutB inactive double mutant D200A-D415N in complex with isomaltulose;2.2;CA;CALCIUM ION;Sucrose isomerase;1071045;
4HAP;A;Crystal Structure of a GH7 family cellobiohydrolase from Limnoria quadripunctata in complex with cellobiose;1.6;CA;CALCIUM ION;GH7 family protein;161573;
4HAP;B;Crystal Structure of a GH7 family cellobiohydrolase from Limnoria quadripunctata in complex with cellobiose;1.6;CA;CALCIUM ION;GH7 family protein;161573;
4HAQ;B;Crystal Structure of a GH7 family cellobiohydrolase from Limnoria quadripunctata in complex with cellobiose and cellotriose;1.9;CA;CALCIUM ION;GH7 family protein;161573;
4HEX;A;A novel conformation of calmodulin;2;CA;CALCIUM ION;Calmodulin;10090;
4HEX;B;A novel conformation of calmodulin;2;CA;CALCIUM ION;Calmodulin;10090;
4HG9;A;Crystal structure of AhV_bPA, a basic PLA2 from Agkistrodon halys pallas venom;1.6;CA;CALCIUM ION;Basic phospholipase A2 B;8714;
4HG9;B;Crystal structure of AhV_bPA, a basic PLA2 from Agkistrodon halys pallas venom;1.6;CA;CALCIUM ION;Basic phospholipase A2 B;8714;
4HG9;C;Crystal structure of AhV_bPA, a basic PLA2 from Agkistrodon halys pallas venom;1.6;CA;CALCIUM ION;Basic phospholipase A2 B;8714;
4HG9;D;Crystal structure of AhV_bPA, a basic PLA2 from Agkistrodon halys pallas venom;1.6;CA;CALCIUM ION;Basic phospholipase A2 B;8714;
4HGC;A;Crystal structure of bovine trypsin complexed with sfti-1 analog containing a peptoid residue at position p1;1.29;CA;CALCIUM ION;Cationic trypsin;9913;
4HHO;A;Serum paraoxonase-1 by directed evolution with the H115W mutation;2.1;CA;CALCIUM ION;SERUM PARAOXONASE BY DIRECTED EVOLUTION;32630;
4HHQ;A;Serum paraoxonase-1 by directed evolution with the H115Q and H134Q mutations;2.3;CA;CALCIUM ION;SERUM PARAOXONASE BY DIRECTED EVOLUTION;32630;
4HHR;A;Crystal Structure of fatty acid alpha-dioxygenase (Arabidopsis thaliana);1.51;CA;CALCIUM ION;Alpha-dioxygenase;3702;
4HHS;A;Crystal Structure of fatty acid alpha-dioxygenase (Arabidopsis thaliana);1.7;CA;CALCIUM ION;Alpha-dioxygenase;3702;
4HHT;A;T. maritima RNase H2 G21S in complex with nucleic acid substrate and calcium ions;3.1;CA;CALCIUM ION;Ribonuclease HII;2336;
4HIZ;A;Phage phi92 endosialidase;1.6;CA;CALCIUM ION;Endosialidase;948870;
4HIZ;B;Phage phi92 endosialidase;1.6;CA;CALCIUM ION;Endosialidase;948870;
4HIZ;C;Phage phi92 endosialidase;1.6;CA;CALCIUM ION;Endosialidase;948870;
4HJF;A;EAL domain of phosphodiesterase PdeA in complex with c-di-GMP and Ca++;1.75;CA;CALCIUM ION;GGDEF family protein;155892;
4HKS;A;Calcium release-activated calcium (CRAC) channel ORAI, K163W mutant;3.35;CA;CALCIUM ION;Calcium release-activated calcium channel protein 1;7227;
4HKW;A;Crystal Structures of Mutant Endo-beta-1,4-xylanase II Complexed with Substrate and Products;1.65;CA;CALCIUM ION;Endo-1,4-beta-xylanase 2;51453;
4HMA;A;Crystal structure of an MMP twin carboxylate based inhibitor LC20 in complex with the MMP-9 catalytic domain;1.94;CA;CALCIUM ION;Matrix metalloproteinase-9;9606;
4HMA;B;Crystal structure of an MMP twin carboxylate based inhibitor LC20 in complex with the MMP-9 catalytic domain;1.94;CA;CALCIUM ION;Matrix metalloproteinase-9;9606;
4HMI;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS V99K at cryogenic temperature;1.75;CA;CALCIUM ION;Thermonuclease;1280;
4HMJ;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS L36D at cryogenic temperature;1.35;CA;CALCIUM ION;Thermonuclease;1280;
4HOH;C;RIBONUCLEASE T1 (THR93ALA MUTANT) COMPLEXED WITH 2'GMP;2.05;CA;CALCIUM ION;PROTEIN (RIBONUCLEASE T1);5062;
4HOH;D;RIBONUCLEASE T1 (THR93ALA MUTANT) COMPLEXED WITH 2'GMP;2.05;CA;CALCIUM ION;PROTEIN (RIBONUCLEASE T1);5062;
4HOJ;A;Crystal structure of glutathione transferase homolog from Neisseria Gonorrhoeae, target EFI-501841, with bound glutathione;1.4;CA;CALCIUM ION;RegF protein;485;
4HOW;A;The crystal structure of isomaltulose synthase from Erwinia rhapontici NX5;1.7;CA;CALCIUM ION;Sucrose isomerase;55212;
4HOX;A;The crystal structure of isomaltulose synthase from Erwinia rhapontici NX5 in complex with Tris;2;CA;CALCIUM ION;Sucrose isomerase;55212;
4HOZ;A;The crystal structure of isomaltulose synthase mutant D241A from Erwinia rhapontici NX5 in complex with D-glucose;2;CA;CALCIUM ION;Sucrose isomerase;55212;
4HP5;A;The crystal structure of isomaltulose synthase mutant E295A from Erwinia rhapontici NX5 in complex with D-glucose;2;CA;CALCIUM ION;Sucrose isomerase;55212;
4HPH;A;The crystal structure of isomaltulose synthase mutant E295Q from Erwinia rhapontici NX5 in complex with its natural substrate sucrose;1.7;CA;CALCIUM ION;Sucrose isomerase;55212;
4HPK;A;Crystal structure of Clostridium histolyticum colg collagenase collagen-binding domain 3B at 1.35 Angstrom resolution in presence of calcium nitrate;1.35;CA;CALCIUM ION;Collagenase;1498;
4HPK;B;Crystal structure of Clostridium histolyticum colg collagenase collagen-binding domain 3B at 1.35 Angstrom resolution in presence of calcium nitrate;1.35;CA;CALCIUM ION;Collagenase;1498;
4HPN;A;Crystal structure of a proposed galactarolactone cycloisomerase from Agrobacterium Tumefaciens, target EFI-500704, with bound Ca, ordered loops;1.6;CA;CALCIUM ION;Putative uncharacterized protein;1176649;
4HPP;A;Crystal structure of novel glutamine synthase homolog;2.5;CA;CALCIUM ION;Probable glutamine synthetase;287;
4HRI;C;Crystal structure of HetR in complex with a 21-bp palindromic DNA at the upstream of the hetP promoter from Anabaena;2.95;CA;CALCIUM ION;DNA (5'-D(P*GP*CP*GP*AP*GP*GP*GP*GP*TP*CP*TP*AP*AP*CP*CP*CP*CP*TP*CP*AP*T)-3');103690;
4HRI;D;Crystal structure of HetR in complex with a 21-bp palindromic DNA at the upstream of the hetP promoter from Anabaena;2.95;CA;CALCIUM ION;DNA (5'-D(P*AP*TP*GP*AP*GP*GP*GP*GP*TP*TP*AP*GP*AP*CP*CP*CP*CP*TP*CP*GP*C)-3');103690;
4HRO;A;Crystal structure of H. volcanii small archaeal modifier protein 1;1.15;CA;CALCIUM ION;Small archaeal modifier protein 1;2246;
4HRO;B;Crystal structure of H. volcanii small archaeal modifier protein 1;1.15;CA;CALCIUM ION;Small archaeal modifier protein 1;2246;
4HS9;A;Methanol tolerant mutant of the Proteus mirabilis lipase;1.8;CA;CALCIUM ION;Lipase;584;
4HSQ;A;Crystal Structure of Domains D2 and D3 of the Major Pilin SpaD from Corynebacterium diphtheriae;1.87;CA;CALCIUM ION;Putative fimbrial subunit;1717;
4HSS;A;Structure of the Full-Length Major Pilin SpaD from Corynebacterium diphtheriae;2.5;CA;CALCIUM ION;Putative fimbrial subunit;1717;
4HSS;B;Structure of the Full-Length Major Pilin SpaD from Corynebacterium diphtheriae;2.5;CA;CALCIUM ION;Putative fimbrial subunit;1717;
4HSZ;A;Structure of truncated (delta8C) S100A4;2.25;CA;CALCIUM ION;Protein S100-A4;9606;
4HSZ;B;Structure of truncated (delta8C) S100A4;2.25;CA;CALCIUM ION;Protein S100-A4;9606;
4HSZ;C;Structure of truncated (delta8C) S100A4;2.25;CA;CALCIUM ION;Protein S100-A4;9606;
4HSZ;D;Structure of truncated (delta8C) S100A4;2.25;CA;CALCIUM ION;Protein S100-A4;9606;
4HT4;A;Molecular Basis of Vancomycin Resistance Transfer in Staphylococcus aureus;2.91;CA;CALCIUM ION;Nicking enzyme;1280;
4HT4;B;Molecular Basis of Vancomycin Resistance Transfer in Staphylococcus aureus;2.91;CA;CALCIUM ION;DNA (28-MER);;
4HTE;A;Crystal Structure of the C-terminal domain of Nicking Enzyme from Staphylococcus aureus;3;CA;CALCIUM ION;Nicking enzyme;1280;
4HVK;A;Crystal structure and functional studies of an unusual L-cysteine desulfurase from Archaeoglobus fulgidus.;1.43;CA;CALCIUM ION;Probable cysteine desulfurase 2;2234;
4HWV;A;Structure of Pectate Lyase from Acidovorax avenae subsp citrulli;1.37;CA;CALCIUM ION;Pectate lyase/Amb allergen;80869;
4HWV;B;Structure of Pectate Lyase from Acidovorax avenae subsp citrulli;1.37;CA;CALCIUM ION;Pectate lyase/Amb allergen;80869;
4HX2;A;Crystal structure of Streptomyces caespitosus sermetstatin in complex with Bacillus licheniformis subtilisin;2.25;CA;CALCIUM ION;KerA;1402;
4HX2;C;Crystal structure of Streptomyces caespitosus sermetstatin in complex with Bacillus licheniformis subtilisin;2.25;CA;CALCIUM ION;KerA;1402;
4HXB;H;Crystal structure of 6B9 FAB;2.45;CA;CALCIUM ION;6B9 FAB HEAVY CHAIN;10090;
4HXB;L;Crystal structure of 6B9 FAB;2.45;CA;CALCIUM ION;6B9 FAB LIGHT CHAIN;10090;
4HZV;A;The crystal structure of influenza A neuraminidase N3;1.8;CA;CALCIUM ION;Neuraminidase;11320;
4HZW;A;Crystal structure of influenza A neuraminidase N3 complexed with laninamivir;1.7;CA;CALCIUM ION;Neuraminidase;11320;
4HZX;A;Crystal structure of influenza A neuraminidase N3 complexed with oseltamivir;2.2;CA;CALCIUM ION;Neuraminidase;11320;
4HZY;A;Crystal structure of influenza A neuraminidase N3-H274Y;1.6;CA;CALCIUM ION;Neuraminidase;11320;
4HZZ;A;Crystal structure of influenza neuraminidase N3-H274Y complexed with oseltamivir;1.6;CA;CALCIUM ION;Neuraminidase;11320;
4I00;A;Crystal structure of influenza A neuraminidase N3-H274Y complexed with zanamivir;1.6;CA;CALCIUM ION;Neuraminidase;11320;
4I03;A;Human MMP12 in complex with a PEG-linked bifunctional L-glutamate motif inhibitor;1.7;CA;CALCIUM ION;Macrophage metalloelastase;9606;
4I18;B;Crystal structure of human prolactin receptor complexed with Fab fragment;3.24;CA;CALCIUM ION;antibody light chain;10090;
4I18;H;Crystal structure of human prolactin receptor complexed with Fab fragment;3.24;CA;CALCIUM ION;antibody heavy chain;10090;
4I2N;A;Crystal structure of 31kD Heat Shock Protein, VcHsp31 from Vibrio cholerae;1.9;CA;CALCIUM ION;Intracellular protease/amidase;666;
4I2N;B;Crystal structure of 31kD Heat Shock Protein, VcHsp31 from Vibrio cholerae;1.9;CA;CALCIUM ION;Intracellular protease/amidase;666;
4I2N;C;Crystal structure of 31kD Heat Shock Protein, VcHsp31 from Vibrio cholerae;1.9;CA;CALCIUM ION;Intracellular protease/amidase;666;
4I2N;D;Crystal structure of 31kD Heat Shock Protein, VcHsp31 from Vibrio cholerae;1.9;CA;CALCIUM ION;Intracellular protease/amidase;666;
4I2N;E;Crystal structure of 31kD Heat Shock Protein, VcHsp31 from Vibrio cholerae;1.9;CA;CALCIUM ION;Intracellular protease/amidase;666;
4I2N;F;Crystal structure of 31kD Heat Shock Protein, VcHsp31 from Vibrio cholerae;1.9;CA;CALCIUM ION;Intracellular protease/amidase;666;
4I2Y;A;Crystal Structure of the genetically encoded calcium indicator RGECO1;2.2;CA;CALCIUM ION;RGECO1;90,311,011,686,600;
4I2Y;B;Crystal Structure of the genetically encoded calcium indicator RGECO1;2.2;CA;CALCIUM ION;RGECO1;90,311,011,686,600;
4I30;A;Crystal structure of Canavalia maritima seeds lectin (ConM) co-crystalized with gamma-aminobutyric acid (GABA) and soaked with adenine;1.89;CA;CALCIUM ION;Concanavalin-A;28957;
4I35;A;The crystal structure of serralysin;1.5;CA;CALCIUM ION;Serralysin;613;
4I3S;L;Crystal structure of the outer domain of HIV-1 gp120 in complex with VRC-PG04 space group P21;2.85;CA;CALCIUM ION;Light chain of VRC-PG04 Fab;9606;
4I4T;A;Crystal structure of tubulin-RB3-TTL-Zampanolide complex;1.8;CA;CALCIUM ION;Tubulin alpha-1B chain;9913;
4I4T;B;Crystal structure of tubulin-RB3-TTL-Zampanolide complex;1.8;CA;CALCIUM ION;Tubulin beta-2B chain;9913;
4I4T;C;Crystal structure of tubulin-RB3-TTL-Zampanolide complex;1.8;CA;CALCIUM ION;Tubulin alpha-1B chain;9913;
4I50;A;Crystal structure of tubulin-stathmin-TTL-Epothilone A complex;2.3;CA;CALCIUM ION;Tubulin alpha-1B chain;9913;
4I50;B;Crystal structure of tubulin-stathmin-TTL-Epothilone A complex;2.3;CA;CALCIUM ION;Tubulin beta-2B chain;9913;
4I50;C;Crystal structure of tubulin-stathmin-TTL-Epothilone A complex;2.3;CA;CALCIUM ION;Tubulin alpha-1B chain;9913;
4I55;A;Crystal structure of tubulin-stathmin-TTL complex;2.2;CA;CALCIUM ION;Tubulin alpha-1B chain;9913;
4I55;B;Crystal structure of tubulin-stathmin-TTL complex;2.2;CA;CALCIUM ION;Tubulin beta-2B chain;9913;
4I55;C;Crystal structure of tubulin-stathmin-TTL complex;2.2;CA;CALCIUM ION;Tubulin alpha-1B chain;9913;
4I5J;A;PP2A PR70 Holoenzyme;2.09;CA;CALCIUM ION;Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit alpha;9606;
4I5K;A;PP2A PR70 Holoenzyme model3_diCa_rcsb.pdb bppnat5_extend.mtz;2.9;CA;CALCIUM ION;Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit alpha;9606;
4I5K;B;PP2A PR70 Holoenzyme model3_diCa_rcsb.pdb bppnat5_extend.mtz;2.9;CA;CALCIUM ION;Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit alpha;9606;
4I5L;B;Structural mechanism of trimeric PP2A holoenzyme involving PR70: insight for Cdc6 dephosphorylation;2.43;CA;CALCIUM ION;Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit beta - Cell division control protein 6 homolog chimeric construct;9606;
4I5L;E;Structural mechanism of trimeric PP2A holoenzyme involving PR70: insight for Cdc6 dephosphorylation;2.43;CA;CALCIUM ION;Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit beta - Cell division control protein 6 homolog chimeric construct;9606;
4I5N;B;Structural mechanism of trimeric PP2A holoenzyme involving PR70: insight for Cdc6 dephosphorylation;2.8;CA;CALCIUM ION;Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit beta - Cell division control protein 6 homolog chimeric construct;9606;
4I5N;E;Structural mechanism of trimeric PP2A holoenzyme involving PR70: insight for Cdc6 dephosphorylation;2.8;CA;CALCIUM ION;Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit beta - Cell division control protein 6 homolog chimeric construct;9606;
4I70;A;Crystal structure of the Trypanosoma brucei Inosine-Adenosine-Guanosine nucleoside hydrolase;1.6;CA;CALCIUM ION;Inosine-adenosine-guanosine-nucleoside hydrolase;185431;
4I71;A;Crystal structure of the Trypanosoma brucei Inosine-Adenosine-Guanosine nucleoside hydrolase in complex with a trypanocidal compound;1.28;CA;CALCIUM ION;Inosine-adenosine-guanosine-nucleoside hydrolase;185431;
4I72;A;Crystal structure of the Trypanosoma brucei Inosine-Adenosine-Guanosine nucleoside hydrolase in complex with Immucillin A;2.05;CA;CALCIUM ION;Inosine-adenosine-guanosine-nucleoside hydrolase;185431;
4I72;B;Crystal structure of the Trypanosoma brucei Inosine-Adenosine-Guanosine nucleoside hydrolase in complex with Immucillin A;2.05;CA;CALCIUM ION;Inosine-adenosine-guanosine-nucleoside hydrolase;185431;
4I73;A;Crystal structure of the Trypanosoma brucei Inosine-Adenosine-Guanosine nucleoside hydrolase in complex with compound UAMC-00312;2.18;CA;CALCIUM ION;Inosine-adenosine-guanosine-nucleoside hydrolase;185431;
4I73;B;Crystal structure of the Trypanosoma brucei Inosine-Adenosine-Guanosine nucleoside hydrolase in complex with compound UAMC-00312;2.18;CA;CALCIUM ION;Inosine-adenosine-guanosine-nucleoside hydrolase;185431;
4I73;C;Crystal structure of the Trypanosoma brucei Inosine-Adenosine-Guanosine nucleoside hydrolase in complex with compound UAMC-00312;2.18;CA;CALCIUM ION;Inosine-adenosine-guanosine-nucleoside hydrolase;185431;
4I73;D;Crystal structure of the Trypanosoma brucei Inosine-Adenosine-Guanosine nucleoside hydrolase in complex with compound UAMC-00312;2.18;CA;CALCIUM ION;Inosine-adenosine-guanosine-nucleoside hydrolase;185431;
4I74;A;Crystal structure of the Trypanosoma brucei Inosine-Adenosine-Guanosine nucleoside hydrolase in complex with compound UAMC-00312 and allosterically inhibited by a Ni2+ ion;1.68;CA;CALCIUM ION;Inosine-adenosine-guanosine-nucleoside hydrolase;185431;
4I75;A;Crystal structure of the Trypanosoma brucei Inosine-Adenosine-Guanosine nucleoside hydrolase in complex with the NiTris metalorganic complex;1.8;CA;CALCIUM ION;Inosine-adenosine-guanosine-nucleoside hydrolase;185431;
4I75;B;Crystal structure of the Trypanosoma brucei Inosine-Adenosine-Guanosine nucleoside hydrolase in complex with the NiTris metalorganic complex;1.8;CA;CALCIUM ION;Inosine-adenosine-guanosine-nucleoside hydrolase;185431;
4I8G;A;Bovine trypsin at 0.8 resolution;0.8;CA;CALCIUM ION;Cationic trypsin;9913;
4I8H;A;Bovine trypsin at 0.75 resolution;0.75;CA;CALCIUM ION;Cationic trypsin;9913;
4I8J;A;Bovine trypsin at 0.87 A resolution;0.87;CA;CALCIUM ION;Cationic trypsin;9913;
4I8K;A;Bovine trypsin at 0.85 resolution;0.85;CA;CALCIUM ION;Cationic trypsin;9913;
4I8L;A;Bovine trypsin at 0.87 resolution;0.87;CA;CALCIUM ION;Cationic trypsin;9913;
4I9F;A;Crystal structure of glycerol phosphate phosphatase Rv1692 from Mycobacterium tuberculosis in complex with calcium;2.21;CA;CALCIUM ION;Glycerol 3-phosphate phosphatase;1773;
4I9F;B;Crystal structure of glycerol phosphate phosphatase Rv1692 from Mycobacterium tuberculosis in complex with calcium;2.21;CA;CALCIUM ION;Glycerol 3-phosphate phosphatase;1773;
4I9Q;A;Crystal structure of the ternary complex of the D714A mutant of RB69 DNA polymerase;2.3;CA;CALCIUM ION;DNA polymerase;1914161;
4I9Q;B;Crystal structure of the ternary complex of the D714A mutant of RB69 DNA polymerase;2.3;CA;CALCIUM ION;DNA polymerase;1914161;
4I9W;A;Human two pore domain K+ channel TRAAK (K2P4.1) - Fab complex structure;2.75;CA;CALCIUM ION;Potassium channel subfamily K member 4;9606;
4I9W;G;Human two pore domain K+ channel TRAAK (K2P4.1) - Fab complex structure;2.75;CA;CALCIUM ION;ANTIBODY FAB FRAGMENT HEAVY CHAIN;10090;
4I9X;A;Crystal structure of human cytomegalovirus glycoprotein UL141 targeting the death receptor TRAIL-R2;2.1;CA;CALCIUM ION;Protein UL141;10359;
4I9X;B;Crystal structure of human cytomegalovirus glycoprotein UL141 targeting the death receptor TRAIL-R2;2.1;CA;CALCIUM ION;Protein UL141;10359;
4I9X;D;Crystal structure of human cytomegalovirus glycoprotein UL141 targeting the death receptor TRAIL-R2;2.1;CA;CALCIUM ION;Tumor necrosis factor receptor superfamily member 10B;9606;
4IAI;A;X-ray Structure of cAMP dependent protein kinase A in complex with high Ca2+ concentration, ADP and phosphorylated peptide pSP20;1.55;CA;CALCIUM ION;cAMP-dependent protein kinase catalytic subunit alpha;10090;
4IAL;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS H121E at cryogenic temperature;1.6;CA;CALCIUM ION;Thermonuclease;1280;
4IAU;A;Atomic resolution structure of Geodin, a beta-gamma crystallin from Geodia cydonium;0.99;CA;CALCIUM ION;Beta-gamma-crystallin;6047;
4IAV;A;G215S, A251G, T257A, D260G, T262D mutant of carboxypeptidase T from Thermoactinomyces vulgaris with N-Sulfamoyl-L-phenylalanine;1.35;CA;CALCIUM ION;Carboxypeptidase T;2026;
4IBL;H;Rubidium Sites in Blood Coagulation Factor VIIa;1.8;CA;CALCIUM ION;Coagulation factor VII;9606;
4IBL;L;Rubidium Sites in Blood Coagulation Factor VIIa;1.8;CA;CALCIUM ION;Coagulation factor VII;9606;
4IBR;A;Crystal structure of stabilized TEM-1 beta-lactamase variant v.13 carrying G238S/E104K mutations;2.2;CA;CALCIUM ION;TEM-94 ES-beta-lactamase;562;
4IBX;A;Crystal structure of stabilized TEM-1 beta-lactamase variant v.13;2.68;CA;CALCIUM ION;Beta-lactamase TEM;562;
4IBX;C;Crystal structure of stabilized TEM-1 beta-lactamase variant v.13;2.68;CA;CALCIUM ION;Beta-lactamase TEM;562;
4IC5;A;Crystal structure of Deg5;2.61;CA;CALCIUM ION;Protease Do-like 5, chloroplastic;3702;
4IC5;B;Crystal structure of Deg5;2.61;CA;CALCIUM ION;Protease Do-like 5, chloroplastic;3702;
4IC5;C;Crystal structure of Deg5;2.61;CA;CALCIUM ION;Protease Do-like 5, chloroplastic;3702;
4ICB;A;PROLINE CIS-TRANS ISOMERS IN CALBINDIN D9K OBSERVED BY X-RAY CRYSTALLOGRAPHY;1.6;CA;CALCIUM ION;CALBINDIN D9K;9913;
4IEB;A;Crystal Structure of a Gly128Met mutant of the toxoplasma CDPK, TGME49_101440;2.05;CA;CALCIUM ION;Calmodulin-domain protein kinase 1;5811;
4IEF;B;Complex of Porphyromonas gingivalis RgpB pro- and mature domains;2.3;CA;CALCIUM ION;Gingipain R2 Mature Domain;837;
4IEF;D;Complex of Porphyromonas gingivalis RgpB pro- and mature domains;2.3;CA;CALCIUM ION;Gingipain R2 Mature Domain;837;
4IEF;F;Complex of Porphyromonas gingivalis RgpB pro- and mature domains;2.3;CA;CALCIUM ION;Gingipain R2 Mature Domain;837;
4IEF;H;Complex of Porphyromonas gingivalis RgpB pro- and mature domains;2.3;CA;CALCIUM ION;Gingipain R2 Mature Domain;837;
4IEJ;A;Crystal structure of a DNA methyltransferase 1 associated protein 1 (DMAP1) from Homo sapiens at 1.45 A resolution;1.45;CA;CALCIUM ION;DNA methyltransferase 1-associated protein 1;9606;
4IG5;A;Crystal Structure of Methimazole Inhibited Dimeric Goat Lactoperoxidase at 1.97A Resolution;1.97;CA;CALCIUM ION;Lactoperoxidase;9925;
4IG5;B;Crystal Structure of Methimazole Inhibited Dimeric Goat Lactoperoxidase at 1.97A Resolution;1.97;CA;CALCIUM ION;Lactoperoxidase;9925;
4IHB;E;X-RAY STRUCTURE OF THE canonical C2A DOMAIN FROM HUMAN DYSFERLIN;2.04;CA;CALCIUM ION;Dysferlin;9606;
4IHJ;A;Crystal structure of tubulin-stathmin-TTL-ADP complex;2;CA;CALCIUM ION;Tubulin alpha-1B chain;9913;
4IHJ;B;Crystal structure of tubulin-stathmin-TTL-ADP complex;2;CA;CALCIUM ION;Tubulin beta-2B chain;9913;
4IHJ;C;Crystal structure of tubulin-stathmin-TTL-ADP complex;2;CA;CALCIUM ION;Tubulin alpha-1B chain;9913;
4IHM;A;G215S, A251G, T257A, D260G, T262D mutant of carboxypeptidase T from Thermoactinomyces vulgaris;1.29;CA;CALCIUM ION;Carboxypeptidase T;2026;
4II3;A;Crystal structure of S. pombe Ubiquitin activating enzyme 1 (Uba1) in complex with ubiquitin and ATP/Mg;2.9;CA;CALCIUM ION;Ubiquitin-activating enzyme E1 1;4896;
4II3;C;Crystal structure of S. pombe Ubiquitin activating enzyme 1 (Uba1) in complex with ubiquitin and ATP/Mg;2.9;CA;CALCIUM ION;Ubiquitin-activating enzyme E1 1;4896;
4IIJ;A;Crystal structure of tubulin-stathmin-TTL-apo complex;2.6;CA;CALCIUM ION;Tubulin alpha-1B chain;9913;
4IIJ;B;Crystal structure of tubulin-stathmin-TTL-apo complex;2.6;CA;CALCIUM ION;Tubulin beta-2B chain;9913;
4IIJ;C;Crystal structure of tubulin-stathmin-TTL-apo complex;2.6;CA;CALCIUM ION;Tubulin alpha-1B chain;9913;
4IJO;A;Unraveling hidden allosteric regulatory sites in structurally homologues metalloproteases;1.9;CA;CALCIUM ION;Macrophage metalloelastase;9606;
4IK1;A;High resolution structure of GCaMPJ at pH 8.5;2;CA;CALCIUM ION;RCaMP, Green fluorescent protein;61,006,118;
4IK2;A;G215S, A251G, T257A, D260G, T262D mutant of carboxypeptidase T from Thermoactinomyces vulgaris with N-BOC-L-Leu;1.4;CA;CALCIUM ION;Carboxypeptidase T;2026;
4IK3;A;High resolution structure of GCaMP3 at pH 8.5;2.01;CA;CALCIUM ION;RCaMP, Green fluorescent protein;61,006,118;
4IK4;A;High resolution structure of GCaMP3 at pH 5.0;2.01;CA;CALCIUM ION;RCaMP, Green fluorescent protein;61,006,118;
4IK5;A;High resolution structure of Delta-REST-GCaMP3;2.5;CA;CALCIUM ION;RCaMP, Green fluorescent protein;61,006,118;
4IK8;A;High resolution structure of GCaMP3 dimer form 1 at pH 7.5;1.55;CA;CALCIUM ION;RCaMP, Green fluorescent protein;61,006,118;
4IK9;A;High resolution structure of GCaMP3 dimer form 2 at pH 7.5;1.8;CA;CALCIUM ION;RCaMP, Green fluorescent protein;61,006,118;
4IL1;A;Crystal Structure of the Rat Calcineurin;3;CA;CALCIUM ION;Calmodulin, Calcineurin subunit B type 1, Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform;10116;
4IL1;B;Crystal Structure of the Rat Calcineurin;3;CA;CALCIUM ION;Calmodulin, Calcineurin subunit B type 1, Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform;10116;
4IL1;C;Crystal Structure of the Rat Calcineurin;3;CA;CALCIUM ION;Calmodulin, Calcineurin subunit B type 1, Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform;10116;
4IL1;D;Crystal Structure of the Rat Calcineurin;3;CA;CALCIUM ION;Calmodulin, Calcineurin subunit B type 1, Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform;10116;
4ILD;A;Crystal structure of truncated Bovine viral diarrhea virus 1 E2 envelope protein;3.27;CA;CALCIUM ION;Envelope glycoprotein E2;2170080;
4ILD;B;Crystal structure of truncated Bovine viral diarrhea virus 1 E2 envelope protein;3.27;CA;CALCIUM ION;Envelope glycoprotein E2;2170080;
4ILW;D;Complex of matrix metalloproteinase-10 catalytic domain (MMP-10cd) with tissue inhibitor of metalloproteinases-2 (TIMP-2);2.1;CA;CALCIUM ION;Stromelysin-2;9606;
4ILW;F;Complex of matrix metalloproteinase-10 catalytic domain (MMP-10cd) with tissue inhibitor of metalloproteinases-2 (TIMP-2);2.1;CA;CALCIUM ION;Stromelysin-2;9606;
4IMM;A;The crystal structure of BamB from Moraxella catarrhalis;2.33;CA;CALCIUM ION;Outer membrane assembly lipoprotein YfgL;480;
4IMM;B;The crystal structure of BamB from Moraxella catarrhalis;2.33;CA;CALCIUM ION;Outer membrane assembly lipoprotein YfgL;480;
4INF;A;Crystal structure of amidohydrolase saro_0799 (target efi-505250) from novosphingobium aromaticivorans dsm 12444 with bound calcium;1.48;CA;CALCIUM ION;METAL-DEPENDENT HYDROLASE;48935;
4INF;B;Crystal structure of amidohydrolase saro_0799 (target efi-505250) from novosphingobium aromaticivorans dsm 12444 with bound calcium;1.48;CA;CALCIUM ION;METAL-DEPENDENT HYDROLASE;48935;
4INF;C;Crystal structure of amidohydrolase saro_0799 (target efi-505250) from novosphingobium aromaticivorans dsm 12444 with bound calcium;1.48;CA;CALCIUM ION;METAL-DEPENDENT HYDROLASE;48935;
4INF;D;Crystal structure of amidohydrolase saro_0799 (target efi-505250) from novosphingobium aromaticivorans dsm 12444 with bound calcium;1.48;CA;CALCIUM ION;METAL-DEPENDENT HYDROLASE;48935;
4IPM;A;Crystal structure of a GH7 family cellobiohydrolase from Limnoria quadripunctata in complex with thiocellobiose;1.14;CA;CALCIUM ION;GH7 family protein;161573;
4IRZ;A;Crystal structure of A4b7 headpiece complexed with Fab Natalizumab;2.84;CA;CALCIUM ION;Integrin alpha4 subunit;9986;
4ISH;H;Structure of FACTOR VIIA in complex with the inhibitor BMS-593214 also known as 2'-[(6R,6AR,11BR)-2-CARBAMIMIDOYL-6,6A,7,11B-TETRAHYDRO-5H-INDENO[2,1-C]QUINOLIN-6-YL]-5'-HYDROXY-4'-METHOXYBIPHENYL-4-CARBOXYLIC ACID;1.82;CA;CALCIUM ION;Factor VII heavy chain;9606;
4ISI;H;Structure of FACTOR VIIA in complex with the inhibitor (6S)-N-(4-CARBAMIMIDOYLBENZYL)-1-CHLORO-3-(CYCLOBUTYLAMINO)-8,8-DIETHYL-4-OXO-4,6,7,8-TETRAHYDROPYRROLO[1,2-A]PYRAZINE-6-CARBOXAMIDE;1.94;CA;CALCIUM ION;Factor VII heavy chain;9606;
4IT5;A;Chaperone HscB from Vibrio cholerae;2.15;CA;CALCIUM ION;Co-chaperone protein HscB homolog;666;
4IT5;B;Chaperone HscB from Vibrio cholerae;2.15;CA;CALCIUM ION;Co-chaperone protein HscB homolog;666;
4IT5;C;Chaperone HscB from Vibrio cholerae;2.15;CA;CALCIUM ION;Co-chaperone protein HscB homolog;666;
4IT5;D;Chaperone HscB from Vibrio cholerae;2.15;CA;CALCIUM ION;Co-chaperone protein HscB homolog;666;
4ITC;A;Crystal Structure Analysis of the K1 Cleaved Adhesin domain of Lys-gingipain (Kgp) from Porphyromonas gingivalis W83;1.55;CA;CALCIUM ION;Lys-gingipain W83;837;
4ITX;A;P113S mutant of E. coli Cystathionine beta-lyase MetC inhibited by reaction with L-Ala-P;1.61;CA;CALCIUM ION;Cystathionine beta-lyase MetC;562;
4ITX;B;P113S mutant of E. coli Cystathionine beta-lyase MetC inhibited by reaction with L-Ala-P;1.61;CA;CALCIUM ION;Cystathionine beta-lyase MetC;562;
4IU2;A;Cohesin-dockerin -X domain complex from Ruminococcus flavefacience;2;CA;CALCIUM ION;Cell-wall anchoring protein;1265;
4IU2;B;Cohesin-dockerin -X domain complex from Ruminococcus flavefacience;2;CA;CALCIUM ION;Cellulose-binding protein;1265;
4IU3;A;Cohesin-dockerin -X domain complex from Ruminococcus flavefacience;1.97;CA;CALCIUM ION;Cell-wall anchoring protein;1265;
4IU3;B;Cohesin-dockerin -X domain complex from Ruminococcus flavefacience;1.97;CA;CALCIUM ION;Cellulose-binding protein;1265;
4IUN;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS R126E at cryogenic temperature;1.6;CA;CALCIUM ION;Thermonuclease;1280;
4IXO;B;X-ray structure of NifS-like protein from Rickettsia africae ESF-5;2.2;CA;CALCIUM ION;NifS-like protein;35788;
4IXQ;K;RT fs X-ray diffraction of Photosystem II, dark state;5.7;CA;CALCIUM ION;Photosystem II reaction center protein K;146786;
4IXQ;O;RT fs X-ray diffraction of Photosystem II, dark state;5.7;CA;CALCIUM ION;Photosystem II manganese-stabilizing polypeptide;146786;
4IXQ;k;RT fs X-ray diffraction of Photosystem II, dark state;5.7;CA;CALCIUM ION;Photosystem II reaction center protein K;146786;
4IXQ;o;RT fs X-ray diffraction of Photosystem II, dark state;5.7;CA;CALCIUM ION;Photosystem II manganese-stabilizing polypeptide;146786;
4IXR;K;RT fs X-ray diffraction of Photosystem II, first illuminated state;5.9;CA;CALCIUM ION;Photosystem II reaction center protein K;146786;
4IXR;O;RT fs X-ray diffraction of Photosystem II, first illuminated state;5.9;CA;CALCIUM ION;Photosystem II manganese-stabilizing polypeptide;146786;
4IXR;k;RT fs X-ray diffraction of Photosystem II, first illuminated state;5.9;CA;CALCIUM ION;Photosystem II reaction center protein K;146786;
4IXR;o;RT fs X-ray diffraction of Photosystem II, first illuminated state;5.9;CA;CALCIUM ION;Photosystem II manganese-stabilizing polypeptide;146786;
4IYQ;A;Crystal structure of divalent ion tolerance protein CutA1 from Ehrlichia chaffeensis;2.55;CA;CALCIUM ION;Divalent ion tolerance protein CutA1;945;
4IYQ;B;Crystal structure of divalent ion tolerance protein CutA1 from Ehrlichia chaffeensis;2.55;CA;CALCIUM ION;Divalent ion tolerance protein CutA1;945;
4IYQ;C;Crystal structure of divalent ion tolerance protein CutA1 from Ehrlichia chaffeensis;2.55;CA;CALCIUM ION;Divalent ion tolerance protein CutA1;945;
4IZ8;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS H8E at cryogenic temperature;1.7;CA;CALCIUM ION;Thermonuclease;1280;
4J0N;B;Crystal structure of a manganese dependent isatin hydrolase;2.25;CA;CALCIUM ION;Isatin hydrolase B;187304;
4J1M;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS R105E at cryogenic temperature;1.65;CA;CALCIUM ION;Thermonuclease;1280;
4J2A;A;RB69 DNA Polymerase L415A Ternary Complex;1.8;CA;CALCIUM ION;DNA polymerase;1914161;
4J2A;P;RB69 DNA Polymerase L415A Ternary Complex;1.8;CA;CALCIUM ION;DNA (5'-D(*GP*CP*GP*GP*AP*CP*TP*GP*CP*TP*TP*AP*C)-3');;
4J2B;A;RB69 DNA Polymerase L415G Ternary Complex;2.04;CA;CALCIUM ION;DNA polymerase;1914161;
4J2D;A;RB69 DNA Polymerase L415K Ternary Complex;1.76;CA;CALCIUM ION;DNA polymerase;1914161;
4J2E;A;RB69 DNA Polymerase L415M Ternary Complex;2.02;CA;CALCIUM ION;DNA polymerase;1914161;
4J2E;P;RB69 DNA Polymerase L415M Ternary Complex;2.02;CA;CALCIUM ION;DNA (5'-D(*GP*CP*GP*GP*AP*CP*TP*GP*CP*TP*TP*AP*G)-3');;
4J3H;A;Ring cycle for dilating and constricting the nuclear pore: structure of a Nup54 homo-tetramer.;1.5;CA;CALCIUM ION;Nuclear pore complex protein Nup54;10116;
4J3H;B;Ring cycle for dilating and constricting the nuclear pore: structure of a Nup54 homo-tetramer.;1.5;CA;CALCIUM ION;Nuclear pore complex protein Nup54;10116;
4J3S;A;Crystal structure of barley limit dextrinase soaked with 300mM maltotetraose;1.75;CA;CALCIUM ION;Limit dextrinase;4513;
4J3T;A;Crystal structure of barley Limit dextrinase co-crystallized with 25mM maltotetraose;1.6;CA;CALCIUM ION;Limit dextrinase;4513;
4J3U;A;Crystal structure of barley limit dextrinase in complex with maltosyl-S-betacyclodextrin;1.7;CA;CALCIUM ION;Limit dextrinase;4513;
4J3U;B;Crystal structure of barley limit dextrinase in complex with maltosyl-S-betacyclodextrin;1.7;CA;CALCIUM ION;Limit dextrinase;4513;
4J3V;A;Crystal structure of barley limit dextrinase in complex with a branched thio-linked hexasaccharide;1.45;CA;CALCIUM ION;Limit dextrinase;4513;
4J3W;A;Crystal structure of barley limit dextrinase (E510A mutant) in complex with a branched maltohexasaccharide;1.67;CA;CALCIUM ION;Limit dextrinase;4513;
4J3X;A;Crystal structure of barley limit dextrinase (E510A mutant) in complex with a branched maltoheptasaccharide;1.75;CA;CALCIUM ION;Limit dextrinase;4513;
4J6H;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS H121Q at cryogenic temperature;1.6;CA;CALCIUM ION;Thermonuclease;1280;
4J6R;G;Crystal structure of broadly and potently neutralizing antibody VRC23 in complex with HIV-1 gp120;1.64;CA;CALCIUM ION;Envelope glycoprotein gp160;11676;
4J6R;L;Crystal structure of broadly and potently neutralizing antibody VRC23 in complex with HIV-1 gp120;1.64;CA;CALCIUM ION;LIGHT CHAIN OF ANTIBODY VRC23;9606;
4J7M;A;Crystal structure of mouse DXO in complex with substrate mimic RNA and calcium ion;1.7;CA;CALCIUM ION;Protein Dom3Z;10090;
4J9Y;R;Calcium-calmodulin complexed with the calmodulin binding domain from a small conductance potassium channel splice variant;1.51;CA;CALCIUM ION;Calmodulin;10116;
4J9Z;R;Calcium-calmodulin complexed with the calmodulin binding domain from a small conductance potassium channel splice variant and NS309;1.66;CA;CALCIUM ION;Calmodulin;10116;
4JA1;A;Structure of MMP3 complexed with a platinum-based inhibitor;1.96;CA;CALCIUM ION;Stromelysin-1;9606;
4JA1;B;Structure of MMP3 complexed with a platinum-based inhibitor;1.96;CA;CALCIUM ION;Stromelysin-1;9606;
4JA8;A;Complex of Mitochondrial Isocitrate Dehydrogenase R140Q Mutant with AGI-6780 Inhibitor;1.55;CA;CALCIUM ION;Isocitrate dehydrogenase [NADP], mitochondrial;9606;
4JA8;B;Complex of Mitochondrial Isocitrate Dehydrogenase R140Q Mutant with AGI-6780 Inhibitor;1.55;CA;CALCIUM ION;Isocitrate dehydrogenase [NADP], mitochondrial;9606;
4JBE;A;1.95 Angstrom Crystal Structure of Gamma-glutamyl phosphate Reductase from Saccharomonospora viridis.;1.95;CA;CALCIUM ION;Gamma-glutamyl phosphate reductase;1852;
4JBE;B;1.95 Angstrom Crystal Structure of Gamma-glutamyl phosphate Reductase from Saccharomonospora viridis.;1.95;CA;CALCIUM ION;Gamma-glutamyl phosphate reductase;1852;
4JCL;A;Crystal structure of Alpha-CGT from Paenibacillus macerans at 1.7 Angstrom resolution;1.7;CA;CALCIUM ION;Cyclomaltodextrin glucanotransferase;44252;
4JCM;A;Crystal structure of Gamma-CGTASE from Alkalophilic bacillus clarkii at 1.65 Angstrom resolution;1.65;CA;CALCIUM ION;Cyclodextrin glucanotransferase;79879;
4JD2;A;Crystal structure of Bos taurus Arp2/3 complex binding with Mus musculus GMF;3.08;CA;CALCIUM ION;Actin-related protein 3;9913;
4JD2;B;Crystal structure of Bos taurus Arp2/3 complex binding with Mus musculus GMF;3.08;CA;CALCIUM ION;Actin-related protein 2;9913;
4JD5;A;Crystal Structure of Benzoylformate Decarboxylase Mutant L403E;1.33;CA;CALCIUM ION;Benzoylformate decarboxylase;303;
4JDU;A;The crystal structure of an aerotolerance-related membrane protein from Bacteroides fragilis NCTC 9343 with multiple mutations to serines.;1.47;CA;CALCIUM ION;Aerotolerance-related membrane protein;817;
4JDZ;A;Structures of SdrD from Staphylococcus aureus reveal the molecular mechanism of how the cell surface receptors recognize their ligands;2.1;CA;CALCIUM ION;Ser-Asp rich fibrinogen/bone sialoprotein-binding protein SdrD;1280;
4JDZ;B;Structures of SdrD from Staphylococcus aureus reveal the molecular mechanism of how the cell surface receptors recognize their ligands;2.1;CA;CALCIUM ION;Ser-Asp rich fibrinogen/bone sialoprotein-binding protein SdrD;1280;
4JE0;A;Structures of SdrD from Staphylococcus aureus reveal the molecular mechanism of how the cell surface receptors recognize their ligands;1.7;CA;CALCIUM ION;Ser-Asp rich fibrinogen/bone sialoprotein-binding protein SdrD;1280;
4JF7;A;Structure of the parainfluenza virus 5 (PIV5) hemagglutinin-neuraminidase (HN) ectodomain;2.5;CA;CALCIUM ION;Hemagglutinin-neuraminidase;1979162;
4JF7;B;Structure of the parainfluenza virus 5 (PIV5) hemagglutinin-neuraminidase (HN) ectodomain;2.5;CA;CALCIUM ION;Hemagglutinin-neuraminidase;1979162;
4JF7;C;Structure of the parainfluenza virus 5 (PIV5) hemagglutinin-neuraminidase (HN) ectodomain;2.5;CA;CALCIUM ION;Hemagglutinin-neuraminidase;1979162;
4JF7;D;Structure of the parainfluenza virus 5 (PIV5) hemagglutinin-neuraminidase (HN) ectodomain;2.5;CA;CALCIUM ION;Hemagglutinin-neuraminidase;1979162;
4JGL;A;Crystal structure of a streptavidin-like protein (BACEGG_01519) from Bacteroides eggerthii DSM 20697 at 1.25 A resolution;1.25;CA;CALCIUM ION;hypothetical protein;28111;
4JGU;A;Crystal structure of Clostridium histolyticum ColH collagenase polycystic kidney-disease-like domain 2b at 1.4 Angstrom resolution in the presence of calcium;1.42;CA;CALCIUM ION;ColH protein;1498;
4JGU;B;Crystal structure of Clostridium histolyticum ColH collagenase polycystic kidney-disease-like domain 2b at 1.4 Angstrom resolution in the presence of calcium;1.42;CA;CALCIUM ION;ColH protein;1498;
4JIJ;A;Crystal structure of an inactive mutant of MMP-9 catalytic domain in complex with a fluorogenic synthetic peptidic substrate;1.7;CA;CALCIUM ION;Matrix metalloproteinase-9;9606;
4JIJ;B;Crystal structure of an inactive mutant of MMP-9 catalytic domain in complex with a fluorogenic synthetic peptidic substrate;1.7;CA;CALCIUM ION;Matrix metalloproteinase-9;9606;
4JJJ;A;The structure of T. fusca GH48 D224N mutant;1.6;CA;CALCIUM ION;Cellulose 1,4-beta-cellobiosidase;2021;
4JK4;A;Crystal Structure of Bovine Serum Albumin in complex with 3,5-diiodosalicylic acid;2.65;CA;CALCIUM ION;Serum albumin;9913;
4JK4;B;Crystal Structure of Bovine Serum Albumin in complex with 3,5-diiodosalicylic acid;2.65;CA;CALCIUM ION;Serum albumin;9913;
4JML;A;Crystal structure of the TolB(P201C)-ColicinE9 TBE peptide(A33C) complex.;2;CA;CALCIUM ION;Protein TolB;562;
4JO1;H;Crystal structure of rabbit mAb R56 Fab in complex with V3 crown of HIV-1 JR-FL gp120;2.03;CA;CALCIUM ION;monoclonal anti-HIV-1 gp120 V3 antibody R56 heavy chain;9986;
4JO1;I;Crystal structure of rabbit mAb R56 Fab in complex with V3 crown of HIV-1 JR-FL gp120;2.03;CA;CALCIUM ION;monoclonal anti-HIV-1 gp120 V3 antibody R56 heavy chain;9986;
4JO1;L;Crystal structure of rabbit mAb R56 Fab in complex with V3 crown of HIV-1 JR-FL gp120;2.03;CA;CALCIUM ION;monoclonal anti-HIV-1 gp120 V3 antibody R56 light chain;9986;
4JO1;M;Crystal structure of rabbit mAb R56 Fab in complex with V3 crown of HIV-1 JR-FL gp120;2.03;CA;CALCIUM ION;monoclonal anti-HIV-1 gp120 V3 antibody R56 light chain;9986;
4JO2;H;Crystal structure of rabbit mAb R56 Fab in complex with V3 crown of HIV-1 Consensus A gp120;2.5;CA;CALCIUM ION;monoclonal anti-HIV-1 gp120 V3 antibody R56 heavy chain;9986;
4JO2;I;Crystal structure of rabbit mAb R56 Fab in complex with V3 crown of HIV-1 Consensus A gp120;2.5;CA;CALCIUM ION;monoclonal anti-HIV-1 gp120 V3 antibody R56 heavy chain;9986;
4JO2;L;Crystal structure of rabbit mAb R56 Fab in complex with V3 crown of HIV-1 Consensus A gp120;2.5;CA;CALCIUM ION;monoclonal anti-HIV-1 gp120 V3 antibody R56 light chain;9986;
4JO2;M;Crystal structure of rabbit mAb R56 Fab in complex with V3 crown of HIV-1 Consensus A gp120;2.5;CA;CALCIUM ION;monoclonal anti-HIV-1 gp120 V3 antibody R56 light chain;9986;
4JO5;A;CBM3a-L domain with flanking linkers from scaffoldin cipA of cellulosome of Clostridium thermocellum;1.98;CA;CALCIUM ION;Cellulosome anchoring protein cohesin region;1515;
4JP4;A;Mmp13 in complex with a reverse hydroxamate Zn-binder;1.43;CA;CALCIUM ION;Collagenase 3;9606;
4JP4;B;Mmp13 in complex with a reverse hydroxamate Zn-binder;1.43;CA;CALCIUM ION;Collagenase 3;9606;
4JP8;A;Crystal structure of Pro-F17H/S324A;2.21;CA;CALCIUM ION;Tk-subtilisin;311400;
4JPA;A;Mmp13 in complex with a piperazine hydantoin ligand;2;CA;CALCIUM ION;Collagenase 3;9606;
4JPA;B;Mmp13 in complex with a piperazine hydantoin ligand;2;CA;CALCIUM ION;Collagenase 3;9606;
4JPZ;C;Voltage-gated sodium channel 1.2 C-terminal domain in complex with FGF13U and Ca2+/calmodulin;3.02;CA;CALCIUM ION;Calmodulin;9606;
4JPZ;I;Voltage-gated sodium channel 1.2 C-terminal domain in complex with FGF13U and Ca2+/calmodulin;3.02;CA;CALCIUM ION;Calmodulin;9606;
4JQ0;C;Voltage-gated sodium channel 1.5 C-terminal domain in complex with FGF12B and Ca2+/calmodulin;3.84;CA;CALCIUM ION;Calmodulin;9606;
4JQG;A;Crystal structure of an inactive mutant of MMP-9 catalytic domain in complex with a fluorogenic synthetic peptidic substrate with a fluorine atom.;1.85;CA;CALCIUM ION;Matrix metalloproteinase-9;9606;
4JQG;B;Crystal structure of an inactive mutant of MMP-9 catalytic domain in complex with a fluorogenic synthetic peptidic substrate with a fluorine atom.;1.85;CA;CALCIUM ION;Matrix metalloproteinase-9;9606;
4JQP;A;X-ray crystal structure of a 4-hydroxythreonine-4-phosphate dehydrogenase from Burkholderia phymatum;1.65;CA;CALCIUM ION;4-hydroxythreonine-4-phosphate dehydrogenase;148447;
4JQP;B;X-ray crystal structure of a 4-hydroxythreonine-4-phosphate dehydrogenase from Burkholderia phymatum;1.65;CA;CALCIUM ION;4-hydroxythreonine-4-phosphate dehydrogenase;148447;
4JRF;A;Crystal structure of a putative cell adhesion protein (BACOVA_01548) from Bacteroides ovatus ATCC 8483 at 1.98 A resolution (PSI Community Target, Nakayama);1.98;CA;CALCIUM ION;putative cell adhesion protein;28116;
4JSD;A;The X-ray crystal structure of a thermophilic cellobiose binding protein bound with laminaribiose;2.05;CA;CALCIUM ION;Oligopeptide ABC transporter, periplasmic oligopeptide-binding protein;2336;
4JSO;A;The X-ray crystal structure of a thermophilic cellobiose binding protein bound with laminaripentaose;2.07;CA;CALCIUM ION;Oligopeptide ABC transporter, periplasmic oligopeptide-binding protein;2336;
4JU8;A;Crystal Structure of the His70Phe mutant of Benzoylformate Decarboxylase from Pseudomonas putida;1.25;CA;CALCIUM ION;Benzoylformate decarboxylase;303;
4JU9;A;Crystal Structure of the His70Leu mutant of Benzoylformate Decarboxylase from Pseudomonas putida;1.12;CA;CALCIUM ION;Benzoylformate decarboxylase;303;
4JUA;A;Crystal Structure of the His70Ser mutant of Benzoylformate Decarboxylase from Pseudomonas putida;1.15;CA;CALCIUM ION;Benzoylformate decarboxylase;303;
4JUB;A;Crystal Structure of the His70Thr mutant of Benzoylformate Decarboxylase from Pseudomonas putida;1.9;CA;CALCIUM ION;Benzoylformate decarboxylase;303;
4JUB;B;Crystal Structure of the His70Thr mutant of Benzoylformate Decarboxylase from Pseudomonas putida;1.9;CA;CALCIUM ION;Benzoylformate decarboxylase;303;
4JUB;C;Crystal Structure of the His70Thr mutant of Benzoylformate Decarboxylase from Pseudomonas putida;1.9;CA;CALCIUM ION;Benzoylformate decarboxylase;303;
4JUB;D;Crystal Structure of the His70Thr mutant of Benzoylformate Decarboxylase from Pseudomonas putida;1.9;CA;CALCIUM ION;Benzoylformate decarboxylase;303;
4JUC;A;Crystal Structure of the Ser26Met mutant of Benzoylformate Decarboxylase from Pseudomonas putida;2.3;CA;CALCIUM ION;Benzoylformate decarboxylase;303;
4JUC;B;Crystal Structure of the Ser26Met mutant of Benzoylformate Decarboxylase from Pseudomonas putida;2.3;CA;CALCIUM ION;Benzoylformate decarboxylase;303;
4JUC;C;Crystal Structure of the Ser26Met mutant of Benzoylformate Decarboxylase from Pseudomonas putida;2.3;CA;CALCIUM ION;Benzoylformate decarboxylase;303;
4JUC;D;Crystal Structure of the Ser26Met mutant of Benzoylformate Decarboxylase from Pseudomonas putida;2.3;CA;CALCIUM ION;Benzoylformate decarboxylase;303;
4JUD;X;Crystal Structure of the Ser26Thr mutant of Benzoylformate Decarboxylase from Pseudomonas putida;1.65;CA;CALCIUM ION;Benzoylformate decarboxylase;303;
4JUF;A;Crystal Structure of His281Ala mutant of Benzoylformate Decarboxylase from Pseudomonas putida;2.15;CA;CALCIUM ION;Benzoylformate decarboxylase;303;
4JUF;B;Crystal Structure of His281Ala mutant of Benzoylformate Decarboxylase from Pseudomonas putida;2.15;CA;CALCIUM ION;Benzoylformate decarboxylase;303;
4JUF;C;Crystal Structure of His281Ala mutant of Benzoylformate Decarboxylase from Pseudomonas putida;2.15;CA;CALCIUM ION;Benzoylformate decarboxylase;303;
4JUF;D;Crystal Structure of His281Ala mutant of Benzoylformate Decarboxylase from Pseudomonas putida;2.15;CA;CALCIUM ION;Benzoylformate decarboxylase;303;
4JUZ;A;Ternary complex of gamma-OHPDG adduct modified dna (zero primer) with dna polymerase iv and incoming dgtp;2.65;CA;CALCIUM ION;DNA polymerase IV;2287;
4JV0;A;Ring-Opening of the -OH-PdG Adduct in Ternary Complexes with the Sulfolobus solfataricus DNA polymerase Dpo4;2.95;CA;CALCIUM ION;DNA polymerase IV;2287;
4JV1;A;Ternary complex of gamma-OHPDG adduct modified dna with dna (-1 primer) polymerase iv and incoming dgtp;2.3;CA;CALCIUM ION;DNA polymerase IV;2287;
4JV1;C;Ternary complex of gamma-OHPDG adduct modified dna with dna (-1 primer) polymerase iv and incoming dgtp;2.3;CA;CALCIUM ION;DNA (5'-D(*GP*GP*GP*GP*GP*AP*AP*GP*GP*AP*TP*TP*C)-3');;
4JV2;A;Ternary complex of gamma-OHPDG adduct modified dna with dna (-1 primer) polymerase iv and incoming datp;2.74;CA;CALCIUM ION;DNA polymerase IV;2287;
4JWP;A;Crystal structure of Ribosomal-protein-alanine N-acetyltransferase from Brucella melitensis in complex with Acetyl CoA;2;CA;CALCIUM ION;GCN5-related N-acetyltransferase;235;
4JWP;B;Crystal structure of Ribosomal-protein-alanine N-acetyltransferase from Brucella melitensis in complex with Acetyl CoA;2;CA;CALCIUM ION;GCN5-related N-acetyltransferase;235;
4JWQ;A;Crystal Structure of the Calcium Binding Domain of CDPK3 from Plasmodium Berghei, PB000947.00;2.15;CA;CALCIUM ION;Calcium-dependent protein kinase;5821;
4JWQ;C;Crystal Structure of the Calcium Binding Domain of CDPK3 from Plasmodium Berghei, PB000947.00;2.15;CA;CALCIUM ION;Calcium-dependent protein kinase;5821;
4JWS;A;Crystal structure of Cytochrome P450cam-putidaredoxin complex;2.15;CA;CALCIUM ION;Camphor 5-monooxygenase;303;
4JWS;B;Crystal structure of Cytochrome P450cam-putidaredoxin complex;2.15;CA;CALCIUM ION;Camphor 5-monooxygenase;303;
4JWU;A;Crystal structure of Cytochrome P450cam-putidaredoxin complex;2.2;CA;CALCIUM ION;Camphor 5-monooxygenase;303;
4JWU;B;Crystal structure of Cytochrome P450cam-putidaredoxin complex;2.2;CA;CALCIUM ION;Camphor 5-monooxygenase;303;
4JX1;A;Crystal structure of reduced Cytochrome P450cam-putidaredoxin complex bound to camphor and 5-exo-hydroxycamphor;2.09;CA;CALCIUM ION;Camphor 5-monooxygenase;303;
4JX1;B;Crystal structure of reduced Cytochrome P450cam-putidaredoxin complex bound to camphor and 5-exo-hydroxycamphor;2.09;CA;CALCIUM ION;Camphor 5-monooxygenase;303;
4JX1;E;Crystal structure of reduced Cytochrome P450cam-putidaredoxin complex bound to camphor and 5-exo-hydroxycamphor;2.09;CA;CALCIUM ION;Camphor 5-monooxygenase;303;
4JX1;F;Crystal structure of reduced Cytochrome P450cam-putidaredoxin complex bound to camphor and 5-exo-hydroxycamphor;2.09;CA;CALCIUM ION;Camphor 5-monooxygenase;303;
4JYO;X;Structural basis for angiopoietin-1 mediated signaling initiation;2.5;CA;CALCIUM ION;Angiopoietin-1;9606;
4JYU;H;Structure of factor VIIA in complex with the inhibitor (2R)-2-[(1-AMINOISOQUINOLIN-6-YL)AMINO]-2-[3-ETHOXY-4-(PROPAN-2-YLOXY)PHENYL]-N-(PHENYLSULFONYL)ETHANAMIDE;1.8;CA;CALCIUM ION;Factor VII light chain;9606;
4JYV;H;Structure of factor VIIA in complex with the inhibitor (2R)-2-[3-ETHOXY-4-(PROPAN-2-YLOXY)PHENYL]-2-(ISOQUINOLIN-6-YLAMINO)-N-[(3-SULFAMOYLPHENYL)SULFONYL]ETHANAMIDE;2.19;CA;CALCIUM ION;Factor VII light chain;9606;
4JYW;A;X-ray structure of human glutamate carboxypeptidase II (GCPII) in complex with CTT1057;1.73;CA;CALCIUM ION;Glutamate carboxypeptidase 2;9606;
4JZ0;A;X-ray structure of human glutamate carboxypeptidase II (GCPII) in complex with CTT1055;1.83;CA;CALCIUM ION;Glutamate carboxypeptidase 2;9606;
4JZB;A;Crystal Structure of Leshmaniasis major Farnesyl diphosphate synthase in complex with 1-(2-HYDROXY-2,2-DIPHOSPHONOETHYL)-3-PHENYLPYRIDINIUM, IPP and Ca2+;1.9;CA;CALCIUM ION;Farnesyl pyrophosphate synthase;5664;
4JZB;B;Crystal Structure of Leshmaniasis major Farnesyl diphosphate synthase in complex with 1-(2-HYDROXY-2,2-DIPHOSPHONOETHYL)-3-PHENYLPYRIDINIUM, IPP and Ca2+;1.9;CA;CALCIUM ION;Farnesyl pyrophosphate synthase;5664;
4JZD;H;Structure of factor VIIA in complex with the inhibitor 2-{2-[(4-carbamimidoylphenyl)carbamoyl]-6-methoxypyridin-3-yl}-5-{[(2S)-1-hydroxy-3,3-dimethylbutan-2-yl]carbamoyl}benzoic acid;2.2;CA;CALCIUM ION;Factor VIIa (Heavy Chain);9606;
4JZE;H;Structure of factor VIIA in complex with the inhibitor 2-{2-[(1-aminoisoquinolin-6-yl)carbamoyl]-6-methoxypyridin-3-yl}-5-{[(2S)-1-hydroxy-3,3-dimethylbutan-2-yl]carbamoyl}benzoic acid;1.52;CA;CALCIUM ION;Factor VIIa (Heavy Chain);9606;
4JZF;H;Structure of factor VIIA in complex with the inhibitor 2-{2-[(3-carbamoylphenyl)carbamoyl]-6-methoxypyridin-3-yl}-5-{[(2S)-1-hydroxy-3,3-dimethylbutan-2-yl]carbamoyl}benzoic acid;1.84;CA;CALCIUM ION;Factor VIIa (Heavy Chain);9606;
4JZX;A;Crystal Structure of Leshmaniasis major Farnesyl diphosphate synthase in complex with 3-BUTYL-1-(2,2-DIPHOSPHONOETHYL)PYRIDINIUM, IPP and Ca2+;1.8;CA;CALCIUM ION;Farnesyl pyrophosphate synthase;5664;
4JZX;B;Crystal Structure of Leshmaniasis major Farnesyl diphosphate synthase in complex with 3-BUTYL-1-(2,2-DIPHOSPHONOETHYL)PYRIDINIUM, IPP and Ca2+;1.8;CA;CALCIUM ION;Farnesyl pyrophosphate synthase;5664;
4K0G;A;Crystal structure of human CLIC1 C24S mutant;1.4;CA;CALCIUM ION;Chloride intracellular channel protein 1;9606;
4K1C;A;VCX1 Calcium/Proton Exchanger;2.3;CA;CALCIUM ION;Vacuolar calcium ion transporter;4932;
4K1C;B;VCX1 Calcium/Proton Exchanger;2.3;CA;CALCIUM ION;Vacuolar calcium ion transporter;4932;
4K1H;A;Induced opening of influenza virus neuraminidase N2 150-loop suggests an important role in inhibitor binding;1.8;CA;CALCIUM ION;Neuraminidase;11320;
4K1H;B;Induced opening of influenza virus neuraminidase N2 150-loop suggests an important role in inhibitor binding;1.8;CA;CALCIUM ION;Neuraminidase;11320;
4K1I;A;Induced opening of influenza virus neuraminidase N2 150-loop suggests an important role in inhibitor binding;1.8;CA;CALCIUM ION;Neuraminidase;11320;
4K1I;B;Induced opening of influenza virus neuraminidase N2 150-loop suggests an important role in inhibitor binding;1.8;CA;CALCIUM ION;Neuraminidase;11320;
4K1J;A;Induced opening of influenza virus neuraminidase N2 150-loop suggests an important role in inhibitor binding;2.2;CA;CALCIUM ION;Neuraminidase;11320;
4K1J;B;Induced opening of influenza virus neuraminidase N2 150-loop suggests an important role in inhibitor binding;2.2;CA;CALCIUM ION;Neuraminidase;11320;
4K1K;A;Induced opening of influenza virus neuraminidase N2 150-loop suggests an important role in inhibitor binding;1.6;CA;CALCIUM ION;Neuraminidase;11320;
4K1K;B;Induced opening of influenza virus neuraminidase N2 150-loop suggests an important role in inhibitor binding;1.6;CA;CALCIUM ION;Neuraminidase;11320;
4K1Y;A;Crystal structure of Canavalia boliviana lectin in complex with Man1-3Man-OMe;2.5;CA;CALCIUM ION;Canavalia boliviana lectin;232300;
4K1Y;B;Crystal structure of Canavalia boliviana lectin in complex with Man1-3Man-OMe;2.5;CA;CALCIUM ION;Canavalia boliviana lectin;232300;
4K1Y;C;Crystal structure of Canavalia boliviana lectin in complex with Man1-3Man-OMe;2.5;CA;CALCIUM ION;Canavalia boliviana lectin;232300;
4K1Y;D;Crystal structure of Canavalia boliviana lectin in complex with Man1-3Man-OMe;2.5;CA;CALCIUM ION;Canavalia boliviana lectin;232300;
4K1Z;A;Crystal structure of Canavalia boliviana lectin in complex with Man1-4Man-OMe;2.3;CA;CALCIUM ION;Canavalia boliviana lectin;232300;
4K1Z;B;Crystal structure of Canavalia boliviana lectin in complex with Man1-4Man-OMe;2.3;CA;CALCIUM ION;Canavalia boliviana lectin;232300;
4K1Z;C;Crystal structure of Canavalia boliviana lectin in complex with Man1-4Man-OMe;2.3;CA;CALCIUM ION;Canavalia boliviana lectin;232300;
4K1Z;D;Crystal structure of Canavalia boliviana lectin in complex with Man1-4Man-OMe;2.3;CA;CALCIUM ION;Canavalia boliviana lectin;232300;
4K20;A;Crystal structure of Canavalia boliviana lectin;3.4;CA;CALCIUM ION;Canavalia boliviana lectin;232300;
4K20;B;Crystal structure of Canavalia boliviana lectin;3.4;CA;CALCIUM ION;Canavalia boliviana lectin;232300;
4K21;A;Crystal structure of Canavalia boliviana lectin in complex with Xman;1.6;CA;CALCIUM ION;Canavalia boliviana lectin;232300;
4K25;A;Crystal Structure of yeast Qri7 homodimer;2.88;CA;CALCIUM ION;Probable tRNA threonylcarbamoyladenosine biosynthesis protein QRI7, mitochondrial;4932;
4K2K;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS L25A/L36A/I92A at cryogenic temperature;1.65;CA;CALCIUM ION;Thermonuclease;1280;
4K2L;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS I92Q at cryogenic temperature;1.55;CA;CALCIUM ION;Thermonuclease;1280;
4K2P;A;The Structure of a Quintuple Mutant of the Tiam1 PH-CC-Ex Domain;1.98;CA;CALCIUM ION;T-lymphoma invasion and metastasis-inducing protein 1;9606;
4K2P;B;The Structure of a Quintuple Mutant of the Tiam1 PH-CC-Ex Domain;1.98;CA;CALCIUM ION;T-lymphoma invasion and metastasis-inducing protein 1;9606;
4K2P;C;The Structure of a Quintuple Mutant of the Tiam1 PH-CC-Ex Domain;1.98;CA;CALCIUM ION;T-lymphoma invasion and metastasis-inducing protein 1;9606;
4K2P;D;The Structure of a Quintuple Mutant of the Tiam1 PH-CC-Ex Domain;1.98;CA;CALCIUM ION;T-lymphoma invasion and metastasis-inducing protein 1;9606;
4K3I;A;Crystal Structure of the Quinol Form of Methylamine Dehydrogenase in Complex with the Diferrous Form of MauG, C2 Space Group;2;CA;CALCIUM ION;Methylamine utilization protein MauG;266;
4K3I;B;Crystal Structure of the Quinol Form of Methylamine Dehydrogenase in Complex with the Diferrous Form of MauG, C2 Space Group;2;CA;CALCIUM ION;Methylamine utilization protein MauG;266;
4K3K;A;E. Coli sliding clamp in complex with (S)-2-(4-methylpentanamido)-3-phenylpropanoic acid;1.85;CA;CALCIUM ION;DNA polymerase III subunit beta;562;
4K3K;B;E. Coli sliding clamp in complex with (S)-2-(4-methylpentanamido)-3-phenylpropanoic acid;1.85;CA;CALCIUM ION;DNA polymerase III subunit beta;562;
4K3L;A;E. coli sliding clamp in complex with AcLF dipeptide;1.5;CA;CALCIUM ION;DNA polymerase III subunit beta;562;
4K3L;B;E. coli sliding clamp in complex with AcLF dipeptide;1.5;CA;CALCIUM ION;DNA polymerase III subunit beta;562;
4K3M;A;E.coli sliding clamp in complex with AcALDLF peptide;1.85;CA;CALCIUM ION;DNA polymerase III subunit beta;562;
4K3M;B;E.coli sliding clamp in complex with AcALDLF peptide;1.85;CA;CALCIUM ION;DNA polymerase III subunit beta;562;
4K3O;A;E. coli sliding clamp in complex with AcQADLF;2;CA;CALCIUM ION;DNA polymerase III subunit beta;562;
4K3O;B;E. coli sliding clamp in complex with AcQADLF;2;CA;CALCIUM ION;DNA polymerase III subunit beta;562;
4K3P;A;E. coli sliding clamp in complex with AcQLALF;2.15;CA;CALCIUM ION;DNA polymerase III subunit beta;562;
4K3P;B;E. coli sliding clamp in complex with AcQLALF;2.15;CA;CALCIUM ION;DNA polymerase III subunit beta;562;
4K3Q;A;E. coli sliding clamp in complex with AcQLDAF;1.85;CA;CALCIUM ION;DNA polymerase III subunit beta;562;
4K3Q;B;E. coli sliding clamp in complex with AcQLDAF;1.85;CA;CALCIUM ION;DNA polymerase III subunit beta;562;
4K3R;A;E. coli sliding clamp in complex with AcQLDLA;1.86;CA;CALCIUM ION;DNA polymerase III subunit beta;562;
4K3R;B;E. coli sliding clamp in complex with AcQLDLA;1.86;CA;CALCIUM ION;DNA polymerase III subunit beta;562;
4K3S;A;E. coli sliding clamp in P1 crystal space group;1.75;CA;CALCIUM ION;DNA polymerase III subunit beta;562;
4K3Y;A;Crystal structure of a subtype N11 neuraminidase-like protein of A/flat-faced bat/Peru/033/2010 (H18N11);2.68;CA;CALCIUM ION;neuraminidase;11320;
4K3Y;B;Crystal structure of a subtype N11 neuraminidase-like protein of A/flat-faced bat/Peru/033/2010 (H18N11);2.68;CA;CALCIUM ION;neuraminidase;11320;
4K3Y;C;Crystal structure of a subtype N11 neuraminidase-like protein of A/flat-faced bat/Peru/033/2010 (H18N11);2.68;CA;CALCIUM ION;neuraminidase;11320;
4K3Y;D;Crystal structure of a subtype N11 neuraminidase-like protein of A/flat-faced bat/Peru/033/2010 (H18N11);2.68;CA;CALCIUM ION;neuraminidase;11320;
4K41;A;Crystal structure of actin in complex with marine macrolide kabiramide C;1.4;CA;CALCIUM ION;Actin, alpha skeletal muscle;9986;
4K42;A;Crystal structure of actin in complex with synthetic AplC tail analogue SF01 [(3R,4S,5R,6S,10R,11R,12R)-11-(acetyloxy)-1-(benzyloxy)-14-[formyl(methyl)amino]-5-hydroxy-4,6,10,12-tetramethyl-9-oxotetradecan-3-yl propanoate];2.9;CA;CALCIUM ION;Actin, alpha skeletal muscle;9986;
4K42;B;Crystal structure of actin in complex with synthetic AplC tail analogue SF01 [(3R,4S,5R,6S,10R,11R,12R)-11-(acetyloxy)-1-(benzyloxy)-14-[formyl(methyl)amino]-5-hydroxy-4,6,10,12-tetramethyl-9-oxotetradecan-3-yl propanoate];2.9;CA;CALCIUM ION;Actin, alpha skeletal muscle;9986;
4K42;C;Crystal structure of actin in complex with synthetic AplC tail analogue SF01 [(3R,4S,5R,6S,10R,11R,12R)-11-(acetyloxy)-1-(benzyloxy)-14-[formyl(methyl)amino]-5-hydroxy-4,6,10,12-tetramethyl-9-oxotetradecan-3-yl propanoate];2.9;CA;CALCIUM ION;Actin, alpha skeletal muscle;9986;
4K42;D;Crystal structure of actin in complex with synthetic AplC tail analogue SF01 [(3R,4S,5R,6S,10R,11R,12R)-11-(acetyloxy)-1-(benzyloxy)-14-[formyl(methyl)amino]-5-hydroxy-4,6,10,12-tetramethyl-9-oxotetradecan-3-yl propanoate];2.9;CA;CALCIUM ION;Actin, alpha skeletal muscle;9986;
4K43;A;Crystal structure of actin in complex with synthetic AplC tail analogue GC04 [N-{(1E,4R,5R,7E,9S,10S,11S)-4,10-dimethoxy-11-[(2S,4S,5S)-2-(4-methoxyphenyl)-5-methyl-1,3-dioxan-4-yl]-5,9-dimethyl-6-oxododeca-1,7-dien-1-yl}-N-methylformamide];2.9;CA;CALCIUM ION;Actin, alpha skeletal muscle;9986;
4K43;B;Crystal structure of actin in complex with synthetic AplC tail analogue GC04 [N-{(1E,4R,5R,7E,9S,10S,11S)-4,10-dimethoxy-11-[(2S,4S,5S)-2-(4-methoxyphenyl)-5-methyl-1,3-dioxan-4-yl]-5,9-dimethyl-6-oxododeca-1,7-dien-1-yl}-N-methylformamide];2.9;CA;CALCIUM ION;Actin, alpha skeletal muscle;9986;
4K4G;A;Ternary crystal structures of human DNA POLYMERASE LAMBDA IN COMPLEX WITH DNA AND L-DCTP.;2.15;CA;CALCIUM ION;DNA polymerase lambda;9606;
4K4G;B;Ternary crystal structures of human DNA POLYMERASE LAMBDA IN COMPLEX WITH DNA AND L-DCTP.;2.15;CA;CALCIUM ION;DNA (5'-D(*CP*GP*GP*CP*GP*GP*TP*AP*CP*TP*G)-3');;
4K4G;E;Ternary crystal structures of human DNA POLYMERASE LAMBDA IN COMPLEX WITH DNA AND L-DCTP.;2.15;CA;CALCIUM ION;DNA polymerase lambda;9606;
4K4G;F;Ternary crystal structures of human DNA POLYMERASE LAMBDA IN COMPLEX WITH DNA AND L-DCTP.;2.15;CA;CALCIUM ION;DNA (5'-D(*CP*GP*GP*CP*GP*GP*TP*AP*CP*TP*G)-3');;
4K4G;I;Ternary crystal structures of human DNA POLYMERASE LAMBDA IN COMPLEX WITH DNA AND L-DCTP.;2.15;CA;CALCIUM ION;DNA polymerase lambda;9606;
4K4G;J;Ternary crystal structures of human DNA POLYMERASE LAMBDA IN COMPLEX WITH DNA AND L-DCTP.;2.15;CA;CALCIUM ION;DNA (5'-D(*CP*GP*GP*CP*GP*GP*TP*AP*CP*TP*G)-3');;
4K4G;L;Ternary crystal structures of human DNA POLYMERASE LAMBDA IN COMPLEX WITH DNA AND L-DCTP.;2.15;CA;CALCIUM ION;DNA (5'-D(P*GP*CP*CP*G)-3');;
4K4G;M;Ternary crystal structures of human DNA POLYMERASE LAMBDA IN COMPLEX WITH DNA AND L-DCTP.;2.15;CA;CALCIUM ION;DNA polymerase lambda;9606;
4K4H;A;Ternary crystal structures of a human DNA POLYMERASE LAMBDA IN COMPLEX WITH DNA AND (-)3TC-TP.;2.1;CA;CALCIUM ION;DNA polymerase lambda;9606;
4K4H;B;Ternary crystal structures of a human DNA POLYMERASE LAMBDA IN COMPLEX WITH DNA AND (-)3TC-TP.;2.1;CA;CALCIUM ION;DNA (5'-D(*CP*GP*GP*CP*GP*GP*TP*AP*CP*TP*G)-3');9606;
4K4H;E;Ternary crystal structures of a human DNA POLYMERASE LAMBDA IN COMPLEX WITH DNA AND (-)3TC-TP.;2.1;CA;CALCIUM ION;DNA polymerase lambda;9606;
4K4H;F;Ternary crystal structures of a human DNA POLYMERASE LAMBDA IN COMPLEX WITH DNA AND (-)3TC-TP.;2.1;CA;CALCIUM ION;DNA (5'-D(*CP*GP*GP*CP*GP*GP*TP*AP*CP*TP*G)-3');9606;
4K4H;I;Ternary crystal structures of a human DNA POLYMERASE LAMBDA IN COMPLEX WITH DNA AND (-)3TC-TP.;2.1;CA;CALCIUM ION;DNA polymerase lambda;9606;
4K4H;J;Ternary crystal structures of a human DNA POLYMERASE LAMBDA IN COMPLEX WITH DNA AND (-)3TC-TP.;2.1;CA;CALCIUM ION;DNA (5'-D(*CP*GP*GP*CP*GP*GP*TP*AP*CP*TP*G)-3');9606;
4K4H;M;Ternary crystal structures of a human DNA POLYMERASE LAMBDA IN COMPLEX WITH DNA AND (-)3TC-TP.;2.1;CA;CALCIUM ION;DNA polymerase lambda;9606;
4K4H;N;Ternary crystal structures of a human DNA POLYMERASE LAMBDA IN COMPLEX WITH DNA AND (-)3TC-TP.;2.1;CA;CALCIUM ION;DNA (5'-D(*CP*GP*GP*CP*GP*GP*TP*AP*CP*TP*G)-3');9606;
4K4I;A;Ternary crystal structures of a human DNA POLYMERASE LAMBDA IN COMPLEX WITH DNA AND (-)FTC-TP.;2.25;CA;CALCIUM ION;DNA polymerase lambda;9606;
4K4I;B;Ternary crystal structures of a human DNA POLYMERASE LAMBDA IN COMPLEX WITH DNA AND (-)FTC-TP.;2.25;CA;CALCIUM ION;DNA (5'-D(*CP*GP*GP*CP*GP*GP*TP*AP*CP*TP*G)-3');;
4K4I;E;Ternary crystal structures of a human DNA POLYMERASE LAMBDA IN COMPLEX WITH DNA AND (-)FTC-TP.;2.25;CA;CALCIUM ION;DNA polymerase lambda;9606;
4K4I;F;Ternary crystal structures of a human DNA POLYMERASE LAMBDA IN COMPLEX WITH DNA AND (-)FTC-TP.;2.25;CA;CALCIUM ION;DNA (5'-D(*CP*GP*GP*CP*GP*GP*TP*AP*CP*TP*G)-3');;
4K4I;I;Ternary crystal structures of a human DNA POLYMERASE LAMBDA IN COMPLEX WITH DNA AND (-)FTC-TP.;2.25;CA;CALCIUM ION;DNA polymerase lambda;9606;
4K4I;J;Ternary crystal structures of a human DNA POLYMERASE LAMBDA IN COMPLEX WITH DNA AND (-)FTC-TP.;2.25;CA;CALCIUM ION;DNA (5'-D(*CP*GP*GP*CP*GP*GP*TP*AP*CP*TP*G)-3');;
4K4I;K;Ternary crystal structures of a human DNA POLYMERASE LAMBDA IN COMPLEX WITH DNA AND (-)FTC-TP.;2.25;CA;CALCIUM ION;DNA (5'-D(*CP*AP*GP*TP*AP*C)-3');;
4K4I;M;Ternary crystal structures of a human DNA POLYMERASE LAMBDA IN COMPLEX WITH DNA AND (-)FTC-TP.;2.25;CA;CALCIUM ION;DNA polymerase lambda;9606;
4K4I;N;Ternary crystal structures of a human DNA POLYMERASE LAMBDA IN COMPLEX WITH DNA AND (-)FTC-TP.;2.25;CA;CALCIUM ION;DNA (5'-D(*CP*GP*GP*CP*GP*GP*TP*AP*CP*TP*G)-3');;
4K5V;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS V23T/L36A/V99T at cryogenic temperature;1.75;CA;CALCIUM ION;Thermonuclease;1280;
4K5W;A;Crystal structure of Staphylococcal nuclease variant V23M/L25F/T62F at cryogenic temperature;1.65;CA;CALCIUM ION;Thermonuclease;1280;
4K5X;A;Crystal structure of Staphylococcal nuclease variant V23M/L36F at cryogenic temperature;1.65;CA;CALCIUM ION;Thermonuclease;1280;
4K6D;A;Crystal structure of Staphylococcal nuclease variant V23M/T62F at cryogenic temperature;1.65;CA;CALCIUM ION;Thermonuclease;1280;
4K6T;G;Crystal structure of Ad37 fiber knob in complex with trivalent sialic acid inhibitor ME0385;2;CA;CALCIUM ION;Fiber protein;130310;
4K70;A;Crystal Structure of N-terminal half of Pseudorabiesvirus UL37 protein;2;CA;CALCIUM ION;UL37;10345;
4K70;B;Crystal Structure of N-terminal half of Pseudorabiesvirus UL37 protein;2;CA;CALCIUM ION;UL37;10345;
4K73;A;X-ray crystal structure of an L,D-transpeptidase from Mycobacterium tuberculosis H37Rv;1.65;CA;CALCIUM ION;L,D-transpeptidase;1773;
4K89;A;Crystal structure of Pseudomonas aeruginosa strain K solvent tolerant elastase;1.39;CA;CALCIUM ION;Organic solvent tolerant elastase;287;
4K90;A;Extracellular metalloproteinase from Aspergillus;1.8;CA;CALCIUM ION;Extracellular metalloproteinase mep;746128;
4K9K;A;Crystal Structure of the His281Tyr mutant of Benzoylformate Decarboxylase from Pseudomonas putida;1.3;CA;CALCIUM ION;Benzoylformate decarboxylase;303;
4K9L;A;Crystal Structure of the His281Thr mutant of Benzoylformate Decarboxylase from Pseudomonas putida;1.65;CA;CALCIUM ION;Benzoylformate decarboxylase;303;
4K9M;A;Crystal Structure of the His281Asn mutant of Benzoylformate Decarboxylase from Pseudomonas putida;1.15;CA;CALCIUM ION;Benzoylformate decarboxylase;303;
4K9O;A;Crystal Structure of the Phe397Ala mutant of Benzoylformate Decarboxylase from Pseudomonas putida;1.89;CA;CALCIUM ION;Benzoylformate decarboxylase;303;
4K9O;B;Crystal Structure of the Phe397Ala mutant of Benzoylformate Decarboxylase from Pseudomonas putida;1.89;CA;CALCIUM ION;Benzoylformate decarboxylase;303;
4K9O;C;Crystal Structure of the Phe397Ala mutant of Benzoylformate Decarboxylase from Pseudomonas putida;1.89;CA;CALCIUM ION;Benzoylformate decarboxylase;303;
4K9O;D;Crystal Structure of the Phe397Ala mutant of Benzoylformate Decarboxylase from Pseudomonas putida;1.89;CA;CALCIUM ION;Benzoylformate decarboxylase;303;
4K9P;A;Crystal Structure of the His281Tyr/Ala460Ile Double Mutant of Benzoylformate Decarboxylase from Pseudomonas putida;2.24;CA;CALCIUM ION;Benzoylformate decarboxylase;303;
4K9P;B;Crystal Structure of the His281Tyr/Ala460Ile Double Mutant of Benzoylformate Decarboxylase from Pseudomonas putida;2.24;CA;CALCIUM ION;Benzoylformate decarboxylase;303;
4K9P;C;Crystal Structure of the His281Tyr/Ala460Ile Double Mutant of Benzoylformate Decarboxylase from Pseudomonas putida;2.24;CA;CALCIUM ION;Benzoylformate decarboxylase;303;
4K9P;D;Crystal Structure of the His281Tyr/Ala460Ile Double Mutant of Benzoylformate Decarboxylase from Pseudomonas putida;2.24;CA;CALCIUM ION;Benzoylformate decarboxylase;303;
4KAK;A;Crystal structure of human dihydrofolate reductase complexed with NADPH and 6-ethyl-5-[(3S)-3-[3-methoxy-5-(pyridine-4-yl)phenyl]but-1-yn-1-yl]pyrimidine-2,4-diamine (UCP1006);1.8;CA;CALCIUM ION;Dihydrofolate reductase;9606;
4KAK;B;Crystal structure of human dihydrofolate reductase complexed with NADPH and 6-ethyl-5-[(3S)-3-[3-methoxy-5-(pyridine-4-yl)phenyl]but-1-yn-1-yl]pyrimidine-2,4-diamine (UCP1006);1.8;CA;CALCIUM ION;Dihydrofolate reductase;9606;
4KC7;A;Crystal Structure of Endo-1,5-alpha-L-arabinanase from Thermotoga petrophila RKU-1;1.75;CA;CALCIUM ION;Glycoside hydrolase, family 43;93929;
4KC7;B;Crystal Structure of Endo-1,5-alpha-L-arabinanase from Thermotoga petrophila RKU-1;1.75;CA;CALCIUM ION;Glycoside hydrolase, family 43;93929;
4KC7;C;Crystal Structure of Endo-1,5-alpha-L-arabinanase from Thermotoga petrophila RKU-1;1.75;CA;CALCIUM ION;Glycoside hydrolase, family 43;93929;
4KC8;A;Crystal Structure of Endo-1,5-alpha-L-arabinanase from Thermotoga petrophila RKU-1 in complex with TRIS;1.76;CA;CALCIUM ION;Glycoside hydrolase, family 43;93929;
4KC8;B;Crystal Structure of Endo-1,5-alpha-L-arabinanase from Thermotoga petrophila RKU-1 in complex with TRIS;1.76;CA;CALCIUM ION;Glycoside hydrolase, family 43;93929;
4KC8;C;Crystal Structure of Endo-1,5-alpha-L-arabinanase from Thermotoga petrophila RKU-1 in complex with TRIS;1.76;CA;CALCIUM ION;Glycoside hydrolase, family 43;93929;
4KD3;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS L25A/V66A/I92A at cryogenic temperature;1.75;CA;CALCIUM ION;Thermonuclease;1280;
4KD4;A;Crystal structure of Staphylococcal nuclease variant V23L/L25V/V66I/I72V at cryogenic temperature;1.55;CA;CALCIUM ION;Thermonuclease;1280;
4KDV;A;Crystal structure of a bacterial immunoglobulin-like domain from the M. primoryensis ice-binding adhesin;2.42;CA;CALCIUM ION;Antifreeze protein;178399;
4KDW;A;Crystal structure of a bacterial immunoglobulin-like domain from the M. primoryensis ice-binding adhesin;1.35;CA;CALCIUM ION;Antifreeze protein;178399;
4KH9;A;Crystal structure of a DUF4785 family protein (lpg0956) from Legionella pneumophila subsp. pneumophila str. Philadelphia 1 at 2.00 A resolution;2;CA;CALCIUM ION;hypothetical protein;446;
4KH9;B;Crystal structure of a DUF4785 family protein (lpg0956) from Legionella pneumophila subsp. pneumophila str. Philadelphia 1 at 2.00 A resolution;2;CA;CALCIUM ION;hypothetical protein;446;
4KHN;A;Crystal structure of the ternary complex of the D714A mutant of RB69 DNA polymerase;2.55;CA;CALCIUM ION;DNA polymerase;1914161;
4KHN;B;Crystal structure of the ternary complex of the D714A mutant of RB69 DNA polymerase;2.55;CA;CALCIUM ION;DNA polymerase;1914161;
4KHO;A;Structure of the FACT complex Subunit Spt16M;2;CA;CALCIUM ION;Uncharacterized protein Spt16M;209285;
4KHQ;A;Ternary complex of RB69 mutant L415F wit DUMPNPP;2.19;CA;CALCIUM ION;DNA polymerase;1914161;
4KHS;A;Ternary complex of RB69 mutant L415F with a ribonucleotide at 0 position;2.12;CA;CALCIUM ION;DNA polymerase;1914161;
4KHU;A;Ternary complex of rb69 mutant L415F with a ribonucleotide at -1 position;2.05;CA;CALCIUM ION;DNA polymerase;1914161;
4KHV;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS V23S at cryogenic temperature;1.6;CA;CALCIUM ION;Thermonuclease;1280;
4KHW;A;Ternary complex of RB69 mutant L415F with ribonucleotide at -2 position;2.37;CA;CALCIUM ION;DNA polymerase;1914161;
4KHY;A;Ternary complex of rb69 mutant L415F with ribonucleotide at -3 position;2.25;CA;CALCIUM ION;DNA polymerase;1914161;
4KI4;A;Ternary complex of rb69 mutant L415F with ribonucleotides at 0 and -1 position;2.45;CA;CALCIUM ION;DNA polymerase;1914161;
4KI6;A;Ternary complex of rb69 mutant l415f with ribonucleotides at -1 and -2 position;2.55;CA;CALCIUM ION;DNA polymerase;1914161;
4KI8;A;Crystal structure of a GroEL-ADP complex in the relaxed allosteric state;2.72;CA;CALCIUM ION;GroEL protein;562;
4KI8;B;Crystal structure of a GroEL-ADP complex in the relaxed allosteric state;2.72;CA;CALCIUM ION;GroEL protein;562;
4KI8;D;Crystal structure of a GroEL-ADP complex in the relaxed allosteric state;2.72;CA;CALCIUM ION;GroEL protein;562;
4KI8;E;Crystal structure of a GroEL-ADP complex in the relaxed allosteric state;2.72;CA;CALCIUM ION;GroEL protein;562;
4KI8;F;Crystal structure of a GroEL-ADP complex in the relaxed allosteric state;2.72;CA;CALCIUM ION;GroEL protein;562;
4KI8;G;Crystal structure of a GroEL-ADP complex in the relaxed allosteric state;2.72;CA;CALCIUM ION;GroEL protein;562;
4KIB;A;Crystal structure of methyltransferase from Streptomyces hygroscopicus complexed with S-adenosyl-L-homocysteine and methylphenylpyruvic acid;2;CA;CALCIUM ION;Methyltransferase MppJ;1912;
4KIB;B;Crystal structure of methyltransferase from Streptomyces hygroscopicus complexed with S-adenosyl-L-homocysteine and methylphenylpyruvic acid;2;CA;CALCIUM ION;Methyltransferase MppJ;1912;
4KIC;A;Crystal structure of methyltransferase from Streptomyces hygroscopicus complexed with S-adenosyl-L-methionine and phenylpyruvic acid;2.43;CA;CALCIUM ION;Methyltransferase MppJ;1912;
4KIC;B;Crystal structure of methyltransferase from Streptomyces hygroscopicus complexed with S-adenosyl-L-methionine and phenylpyruvic acid;2.43;CA;CALCIUM ION;Methyltransferase MppJ;1912;
4KIF;A;Crystal structure of methyltransferase from Streptomyces hygroscopicus complexed with phenylpyruvic acid;2.5;CA;CALCIUM ION;Methyltransferase MppJ;1912;
4KIF;B;Crystal structure of methyltransferase from Streptomyces hygroscopicus complexed with phenylpyruvic acid;2.5;CA;CALCIUM ION;Methyltransferase MppJ;1912;
4KIG;A;Crystal structure of methyltransferase from Streptomyces hygroscopicus complexed with 4-hydroxyphenylpyruvic acid;2.4;CA;CALCIUM ION;Methyltransferase MppJ;1912;
4KIG;B;Crystal structure of methyltransferase from Streptomyces hygroscopicus complexed with 4-hydroxyphenylpyruvic acid;2.4;CA;CALCIUM ION;Methyltransferase MppJ;1912;
4KIS;A;Crystal Structure of a LSR-DNA Complex;3.2;CA;CALCIUM ION;Putative integrase [Bacteriophage A118];1642;
4KIS;B;Crystal Structure of a LSR-DNA Complex;3.2;CA;CALCIUM ION;Putative integrase [Bacteriophage A118];1642;
4KIS;C;Crystal Structure of a LSR-DNA Complex;3.2;CA;CALCIUM ION;Putative integrase [Bacteriophage A118];1642;
4KIS;D;Crystal Structure of a LSR-DNA Complex;3.2;CA;CALCIUM ION;Putative integrase [Bacteriophage A118];1642;
4KIS;E;Crystal Structure of a LSR-DNA Complex;3.2;CA;CALCIUM ION;DNA (26-MER);;
4KJK;A;Room Temperature WT DHFR;1.35;CA;CALCIUM ION;Dihydrofolate reductase;562;
4KJN;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS V23T/V66A/V99T at cryogenic temperature;1.55;CA;CALCIUM ION;Thermonuclease;1280;
4KJO;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS L36A/V66T/V99T at cryogenic temperature;1.9;CA;CALCIUM ION;Thermonuclease;1280;
4KKI;A;Crystal Structure of Haptocorrin in Complex with CNCbl;2.35;CA;CALCIUM ION;Transcobalamin-1;9606;
4KKM;B;Crystal structure of a FPP/GFPP synthase (Target EFI-501952) from Zymomonas mobilis, apo structure;1.9;CA;CALCIUM ION;Polyprenyl synthetase;542;
4KL0;A;Crystal structure of the effector protein XOO4466;1.6;CA;CALCIUM ION;Putative uncharacterized protein;347;
4KL8;L;High-resolution structure of anaerobically purified Dm. baculatum [NiFeSe]-hydrogenase after crystallization under air;1.52;CA;CALCIUM ION;Nickel-dependent hydrogenase large subunit;899;
4KL8;M;High-resolution structure of anaerobically purified Dm. baculatum [NiFeSe]-hydrogenase after crystallization under air;1.52;CA;CALCIUM ION;Nickel-dependent hydrogenase large subunit;899;
4KL8;S;High-resolution structure of anaerobically purified Dm. baculatum [NiFeSe]-hydrogenase after crystallization under air;1.52;CA;CALCIUM ION;Periplasmic [NiFeSe] hydrogenase small subunit;899;
4KL8;T;High-resolution structure of anaerobically purified Dm. baculatum [NiFeSe]-hydrogenase after crystallization under air;1.52;CA;CALCIUM ION;Periplasmic [NiFeSe] hydrogenase small subunit;899;
4KLD;A;DNA polymerase beta matched substrate complex with Ca2+, 0 s;1.92;CA;CALCIUM ION;DNA polymerase beta;9606;
4KM6;A;Human folate receptor alpha (FOLR1) at acidic pH, orthorhombic form;1.55;CA;CALCIUM ION;Folate receptor alpha;9606;
4KMB;1;COMPLEX OF 4'-SULFO-LEWIS-X WITH A SELECTIN-LIKE MUTANT OF MANNOSE-BINDING PROTEIN A;2;CA;CALCIUM ION;MANNOSE-BINDING PROTEIN-A;10116;
4KMB;2;COMPLEX OF 4'-SULFO-LEWIS-X WITH A SELECTIN-LIKE MUTANT OF MANNOSE-BINDING PROTEIN A;2;CA;CALCIUM ION;MANNOSE-BINDING PROTEIN-A;10116;
4KMB;3;COMPLEX OF 4'-SULFO-LEWIS-X WITH A SELECTIN-LIKE MUTANT OF MANNOSE-BINDING PROTEIN A;2;CA;CALCIUM ION;MANNOSE-BINDING PROTEIN-A;10116;
4KN9;L;High-resolution structure of H2-activated anaerobically purified Dm. baculatum [NiFeSe]-hydrogenase after crystallization under air;1.4;CA;CALCIUM ION;Nickel-dependent hydrogenase large subunit;899;
4KN9;M;High-resolution structure of H2-activated anaerobically purified Dm. baculatum [NiFeSe]-hydrogenase after crystallization under air;1.4;CA;CALCIUM ION;Nickel-dependent hydrogenase large subunit;899;
4KN9;S;High-resolution structure of H2-activated anaerobically purified Dm. baculatum [NiFeSe]-hydrogenase after crystallization under air;1.4;CA;CALCIUM ION;Periplasmic [NiFeSe] hydrogenase small subunit;899;
4KN9;T;High-resolution structure of H2-activated anaerobically purified Dm. baculatum [NiFeSe]-hydrogenase after crystallization under air;1.4;CA;CALCIUM ION;Periplasmic [NiFeSe] hydrogenase small subunit;899;
4KNA;A;Crystal structure of an N-succinylglutamate 5-semialdehyde dehydrogenase from Burkholderia thailandensis;1.95;CA;CALCIUM ION;N-succinylglutamate 5-semialdehyde dehydrogenase;57975;
4KNA;B;Crystal structure of an N-succinylglutamate 5-semialdehyde dehydrogenase from Burkholderia thailandensis;1.95;CA;CALCIUM ION;N-succinylglutamate 5-semialdehyde dehydrogenase;57975;
4KO1;L;High X-ray dose structure of H2-activated anaerobically purified Dm. baculatum [NiFeSe]-hydrogenase after crystallization under air;1.55;CA;CALCIUM ION;Nickel-dependent hydrogenase large subunit;899;
4KO1;M;High X-ray dose structure of H2-activated anaerobically purified Dm. baculatum [NiFeSe]-hydrogenase after crystallization under air;1.55;CA;CALCIUM ION;Nickel-dependent hydrogenase large subunit;899;
4KO1;S;High X-ray dose structure of H2-activated anaerobically purified Dm. baculatum [NiFeSe]-hydrogenase after crystallization under air;1.55;CA;CALCIUM ION;Periplasmic [NiFeSe] hydrogenase small subunit;899;
4KO1;T;High X-ray dose structure of H2-activated anaerobically purified Dm. baculatum [NiFeSe]-hydrogenase after crystallization under air;1.55;CA;CALCIUM ION;Periplasmic [NiFeSe] hydrogenase small subunit;899;
4KO2;L;Low X-ray dose structure of H2-activated anaerobically purified Dm. baculatum [NiFeSe]-hydrogenase after crystallization under air;1.6;CA;CALCIUM ION;Nickel-dependent hydrogenase large subunit;899;
4KO2;M;Low X-ray dose structure of H2-activated anaerobically purified Dm. baculatum [NiFeSe]-hydrogenase after crystallization under air;1.6;CA;CALCIUM ION;Nickel-dependent hydrogenase large subunit;899;
4KO2;S;Low X-ray dose structure of H2-activated anaerobically purified Dm. baculatum [NiFeSe]-hydrogenase after crystallization under air;1.6;CA;CALCIUM ION;Periplasmic [NiFeSe] hydrogenase small subunit;899;
4KO2;T;Low X-ray dose structure of H2-activated anaerobically purified Dm. baculatum [NiFeSe]-hydrogenase after crystallization under air;1.6;CA;CALCIUM ION;Periplasmic [NiFeSe] hydrogenase small subunit;899;
4KO3;L;Low X-ray dose structure of anaerobically purified Dm. baculatum [NiFeSe]-hydrogenase after crystallization under air;1.7;CA;CALCIUM ION;Nickel-dependent hydrogenase large subunit;899;
4KO3;M;Low X-ray dose structure of anaerobically purified Dm. baculatum [NiFeSe]-hydrogenase after crystallization under air;1.7;CA;CALCIUM ION;Nickel-dependent hydrogenase large subunit;899;
4KO3;S;Low X-ray dose structure of anaerobically purified Dm. baculatum [NiFeSe]-hydrogenase after crystallization under air;1.7;CA;CALCIUM ION;Periplasmic [NiFeSe] hydrogenase small subunit;899;
4KO3;T;Low X-ray dose structure of anaerobically purified Dm. baculatum [NiFeSe]-hydrogenase after crystallization under air;1.7;CA;CALCIUM ION;Periplasmic [NiFeSe] hydrogenase small subunit;899;
4KO4;L;High X-ray dose structure of anaerobically purified Dm. baculatum [NiFeSe]-hydrogenase after crystallization under air;2;CA;CALCIUM ION;Nickel-dependent hydrogenase large subunit;899;
4KO4;M;High X-ray dose structure of anaerobically purified Dm. baculatum [NiFeSe]-hydrogenase after crystallization under air;2;CA;CALCIUM ION;Nickel-dependent hydrogenase large subunit;899;
4KO4;S;High X-ray dose structure of anaerobically purified Dm. baculatum [NiFeSe]-hydrogenase after crystallization under air;2;CA;CALCIUM ION;Periplasmic [NiFeSe] hydrogenase small subunit;899;
4KO4;T;High X-ray dose structure of anaerobically purified Dm. baculatum [NiFeSe]-hydrogenase after crystallization under air;2;CA;CALCIUM ION;Periplasmic [NiFeSe] hydrogenase small subunit;899;
4KPN;A;Plant nucleoside hydrolase - PpNRh1 enzyme;3.35;CA;CALCIUM ION;Nucleoside N-ribohydrolase 1;3218;
4KPN;B;Plant nucleoside hydrolase - PpNRh1 enzyme;3.35;CA;CALCIUM ION;Nucleoside N-ribohydrolase 1;3218;
4KPN;C;Plant nucleoside hydrolase - PpNRh1 enzyme;3.35;CA;CALCIUM ION;Nucleoside N-ribohydrolase 1;3218;
4KPN;D;Plant nucleoside hydrolase - PpNRh1 enzyme;3.35;CA;CALCIUM ION;Nucleoside N-ribohydrolase 1;3218;
4KPN;E;Plant nucleoside hydrolase - PpNRh1 enzyme;3.35;CA;CALCIUM ION;Nucleoside N-ribohydrolase 1;3218;
4KPN;F;Plant nucleoside hydrolase - PpNRh1 enzyme;3.35;CA;CALCIUM ION;Nucleoside N-ribohydrolase 1;3218;
4KPN;G;Plant nucleoside hydrolase - PpNRh1 enzyme;3.35;CA;CALCIUM ION;Nucleoside N-ribohydrolase 1;3218;
4KPN;H;Plant nucleoside hydrolase - PpNRh1 enzyme;3.35;CA;CALCIUM ION;Nucleoside N-ribohydrolase 1;3218;
4KPO;A;Plant nucleoside hydrolase - ZmNRh3 enzyme;2.49;CA;CALCIUM ION;Nucleoside N-ribohydrolase 3;4577;
4KPO;B;Plant nucleoside hydrolase - ZmNRh3 enzyme;2.49;CA;CALCIUM ION;Nucleoside N-ribohydrolase 3;4577;
4KPP;A;Crystal Structure of H+/Ca2+ Exchanger CAX;2.3;CA;CALCIUM ION;Putative uncharacterized protein;2234;
4KPP;B;Crystal Structure of H+/Ca2+ Exchanger CAX;2.3;CA;CALCIUM ION;Putative uncharacterized protein;2234;
4KS1;A;Influenza neuraminidase in complex with antiviral compound (3S,4R,5R)-4-(acetylamino)-3-amino-5-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylic acid;2.2;CA;CALCIUM ION;Neuraminidase;11320;
4KS2;A;Influenza Neuraminidase in complex with antiviral compound (3S,4R,5R)-4-(acetylamino)-3-carbamimidamido-5-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylic acid;2.6;CA;CALCIUM ION;Neuraminidase;11320;
4KS3;A;Influenza Neuraminidase in complex with antiviral compound (3S,4R,5R)-4-(acetylamino)-3-[4-(3-hydroxypropyl)-1H-1,2,3-triazol-1-yl]-5-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylic acid;2.6;CA;CALCIUM ION;Neuraminidase;11320;
4KS4;A;Influenza Neuraminidase in complex with antiviral compound (3S,4R,5R)-4-(acetylamino)-3-{4-[(1R)-1-hydroxypropyl]-1H-1,2,3-triazol-1-yl}-5-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylic acid;2.49;CA;CALCIUM ION;Neuraminidase;11320;
4KS5;A;Influenza neuraminidase in complex with antiviral compound (3S,4R,5R)-4-(acetylamino)-3-[4-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl]-5-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylic acid;2.7;CA;CALCIUM ION;Neuraminidase;11320;
4KSZ;A;Crystal structure of bovine lactoperoxidase complexed with cystiene at 1.98A resolution;1.98;CA;CALCIUM ION;Lactoperoxidase;9913;
4KTA;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS R105Q at cryogenic temperatures;1.95;CA;CALCIUM ION;Thermonuclease;1280;
4KTP;B;Crystal structure of 2-O-alpha-glucosylglycerol phosphorylase in complex with glucose;1.9;CA;CALCIUM ION;Glycoside hydrolase family 65 central catalytic;85683;
4KTR;A;Crystal structure of 2-O-alpha-glucosylglycerol phosphorylase in complex with isofagomine and glycerol;2.3;CA;CALCIUM ION;Glycoside hydrolase family 65 central catalytic;85683;
4KTR;B;Crystal structure of 2-O-alpha-glucosylglycerol phosphorylase in complex with isofagomine and glycerol;2.3;CA;CALCIUM ION;Glycoside hydrolase family 65 central catalytic;85683;
4KTR;C;Crystal structure of 2-O-alpha-glucosylglycerol phosphorylase in complex with isofagomine and glycerol;2.3;CA;CALCIUM ION;Glycoside hydrolase family 65 central catalytic;85683;
4KTR;D;Crystal structure of 2-O-alpha-glucosylglycerol phosphorylase in complex with isofagomine and glycerol;2.3;CA;CALCIUM ION;Glycoside hydrolase family 65 central catalytic;85683;
4KTR;E;Crystal structure of 2-O-alpha-glucosylglycerol phosphorylase in complex with isofagomine and glycerol;2.3;CA;CALCIUM ION;Glycoside hydrolase family 65 central catalytic;85683;
4KTR;G;Crystal structure of 2-O-alpha-glucosylglycerol phosphorylase in complex with isofagomine and glycerol;2.3;CA;CALCIUM ION;Glycoside hydrolase family 65 central catalytic;85683;
4KTS;A;Bovine trypsin in complex with microviridin J at pH 8.5;1.3;CA;CALCIUM ION;Cationic trypsin;9913;
4KTU;A;Bovine trypsin in complex with microviridin J at pH 6.5;1.35;CA;CALCIUM ION;Cationic trypsin;9913;
4KTY;A;Fibrin-stabilizing factor with a bound ligand;1.98;CA;CALCIUM ION;Coagulation factor XIII A chain;9606;
4KTY;B;Fibrin-stabilizing factor with a bound ligand;1.98;CA;CALCIUM ION;Coagulation factor XIII A chain;9606;
4KV6;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS R126Q at cryogenic temperature;1.55;CA;CALCIUM ION;Thermonuclease;1280;
4KVJ;A;Crystal structure of Oryza sativa fatty acid alpha-dioxygenase with hydrogen peroxide;2.12;CA;CALCIUM ION;Fatty acid alpha-oxidase;4530;
4KVK;A;Crystal structure of Oryza sativa fatty acid alpha-dioxygenase;1.98;CA;CALCIUM ION;Fatty acid alpha-oxidase;4530;
4KVL;A;Crystal structure of Oryza sativa fatty acid alpha-dioxygenase Y379F with palmitic acid;1.96;CA;CALCIUM ION;Fatty acid alpha-oxidase;4530;
4KW7;A;The structure of an As(III) S-adenosylmethionine methyltransferase with Phenylarsine oxide(PAO);1.8;CA;CALCIUM ION;Arsenic methyltransferase;610260;
4KWU;A;1.9 Angstrom resolution crystal structure of uncharacterized protein lmo2446 from Listeria monocytogenes EGD-e in complex with alpha-D-glucose, beta-D-glucose, magnesium and calcium;1.9;CA;CALCIUM ION;Lmo2446 protein;1639;
4KXA;A;Crystal structure of human aminopeptidase A complexed with aspartate and calcium;2.4;CA;CALCIUM ION;Glutamyl aminopeptidase;9606;
4KXD;A;Crystal structure of human aminopeptidase A complexed with glutamate and calcium;2.15;CA;CALCIUM ION;Glutamyl aminopeptidase;9606;
4KXV;A;Human transketolase in covalent complex with donor ketose D-xylulose-5-phosphate, crystal 1;0.97;CA;CALCIUM ION;Transketolase;9606;
4KXY;A;Human transketolase in complex with ThDP analogue (R)-2-(1,2-dihydroxyethyl)-3-deaza-ThDP;1.26;CA;CALCIUM ION;Transketolase;9606;
4KXY;B;Human transketolase in complex with ThDP analogue (R)-2-(1,2-dihydroxyethyl)-3-deaza-ThDP;1.26;CA;CALCIUM ION;Transketolase;9606;
4KY5;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS V23D at pH 7 and cryogenic temperature;1.4;CA;CALCIUM ION;Thermonuclease;1280;
4KY6;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS L25D at pH 6 and cryogenic temperature;1.7;CA;CALCIUM ION;Thermonuclease;1280;
4KY7;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS V74D at cryogenic temperature;1.55;CA;CALCIUM ION;Thermonuclease;1280;
4KYW;A;Restriction endonuclease DPNI in complex with two DNA molecules;2.35;CA;CALCIUM ION;Type-2 restriction enzyme DpnI;1313;
4KZO;A;Crystal Structure Analysis of human IDH1 mutants in complex with NADP+ and Ca2+/alpha-Ketoglutarate;2.2;CA;CALCIUM ION;Isocitrate dehydrogenase [NADP] cytoplasmic;9606;
4KZO;B;Crystal Structure Analysis of human IDH1 mutants in complex with NADP+ and Ca2+/alpha-Ketoglutarate;2.2;CA;CALCIUM ION;Isocitrate dehydrogenase [NADP] cytoplasmic;9606;
4KZO;C;Crystal Structure Analysis of human IDH1 mutants in complex with NADP+ and Ca2+/alpha-Ketoglutarate;2.2;CA;CALCIUM ION;Isocitrate dehydrogenase [NADP] cytoplasmic;9606;
4KZV;A;Structure of the carbohydrate-recognition domain of the C-type lectin mincle bound to trehalose;1.4;CA;CALCIUM ION;C-type lectin mincle;9913;
4KZV;B;Structure of the carbohydrate-recognition domain of the C-type lectin mincle bound to trehalose;1.4;CA;CALCIUM ION;C-type lectin mincle;9913;
4KZW;A;Structure of the carbohydrate-recognition domain of the C-type lectin mincle;1.85;CA;CALCIUM ION;C-TYPE LECTIN MINCLE;9913;
4KZW;B;Structure of the carbohydrate-recognition domain of the C-type lectin mincle;1.85;CA;CALCIUM ION;C-TYPE LECTIN MINCLE;9913;
4L03;A;Crystal Structure Analysis of human IDH1 mutants in complex with NADP+ and Ca2+/alpha-Ketoglutarate;2.1;CA;CALCIUM ION;Isocitrate dehydrogenase [NADP] cytoplasmic;9606;
4L03;B;Crystal Structure Analysis of human IDH1 mutants in complex with NADP+ and Ca2+/alpha-Ketoglutarate;2.1;CA;CALCIUM ION;Isocitrate dehydrogenase [NADP] cytoplasmic;9606;
4L03;C;Crystal Structure Analysis of human IDH1 mutants in complex with NADP+ and Ca2+/alpha-Ketoglutarate;2.1;CA;CALCIUM ION;Isocitrate dehydrogenase [NADP] cytoplasmic;9606;
4L04;A;Crystal Structure Analysis of human IDH1 mutants in complex with NADP+ and Ca2+/alpha-Ketoglutarate;2.87;CA;CALCIUM ION;Isocitrate dehydrogenase [NADP] cytoplasmic;9606;
4L04;C;Crystal Structure Analysis of human IDH1 mutants in complex with NADP+ and Ca2+/alpha-Ketoglutarate;2.87;CA;CALCIUM ION;Isocitrate dehydrogenase [NADP] cytoplasmic;9606;
4L04;D;Crystal Structure Analysis of human IDH1 mutants in complex with NADP+ and Ca2+/alpha-Ketoglutarate;2.87;CA;CALCIUM ION;Isocitrate dehydrogenase [NADP] cytoplasmic;9606;
4L04;E;Crystal Structure Analysis of human IDH1 mutants in complex with NADP+ and Ca2+/alpha-Ketoglutarate;2.87;CA;CALCIUM ION;Isocitrate dehydrogenase [NADP] cytoplasmic;9606;
4L04;F;Crystal Structure Analysis of human IDH1 mutants in complex with NADP+ and Ca2+/alpha-Ketoglutarate;2.87;CA;CALCIUM ION;Isocitrate dehydrogenase [NADP] cytoplasmic;9606;
4L06;A;Crystal Structure Analysis of human IDH1 mutants in complex with NADP+ and Ca2+/alpha-Ketoglutarate;2.28;CA;CALCIUM ION;Isocitrate dehydrogenase [NADP] cytoplasmic;9606;
4L06;B;Crystal Structure Analysis of human IDH1 mutants in complex with NADP+ and Ca2+/alpha-Ketoglutarate;2.28;CA;CALCIUM ION;Isocitrate dehydrogenase [NADP] cytoplasmic;9606;
4L06;C;Crystal Structure Analysis of human IDH1 mutants in complex with NADP+ and Ca2+/alpha-Ketoglutarate;2.28;CA;CALCIUM ION;Isocitrate dehydrogenase [NADP] cytoplasmic;9606;
4L06;D;Crystal Structure Analysis of human IDH1 mutants in complex with NADP+ and Ca2+/alpha-Ketoglutarate;2.28;CA;CALCIUM ION;Isocitrate dehydrogenase [NADP] cytoplasmic;9606;
4L06;E;Crystal Structure Analysis of human IDH1 mutants in complex with NADP+ and Ca2+/alpha-Ketoglutarate;2.28;CA;CALCIUM ION;Isocitrate dehydrogenase [NADP] cytoplasmic;9606;
4L06;F;Crystal Structure Analysis of human IDH1 mutants in complex with NADP+ and Ca2+/alpha-Ketoglutarate;2.28;CA;CALCIUM ION;Isocitrate dehydrogenase [NADP] cytoplasmic;9606;
4L0P;B;Structure of the human EphA3 receptor ligand binding domain complexed with ephrin-A5;2.26;CA;CALCIUM ION;Ephrin-A5;9606;
4L19;A;Matrix metalloproteinase-13 complexed with selective inhibitor compound Q1;1.66;CA;CALCIUM ION;Collagenase 3;9606;
4L19;B;Matrix metalloproteinase-13 complexed with selective inhibitor compound Q1;1.66;CA;CALCIUM ION;Collagenase 3;9606;
4L1I;A;Crystal structure of EGFP-based Calcium Sensor CatchER complexed with Ca;1.2;CA;CALCIUM ION;EGFP-based Calcium Sensor CatchER;6100;
4L1Q;A;Crystal Structure of the E113Q-MauG/pre-Methylamine Dehydrogenase Complex;1.92;CA;CALCIUM ION;Methylamine utilization protein MauG;266;
4L1Q;B;Crystal Structure of the E113Q-MauG/pre-Methylamine Dehydrogenase Complex;1.92;CA;CALCIUM ION;Methylamine utilization protein MauG;266;
4L38;A;Nitrite complex of TvNiR, low dose data set;1.8;CA;CALCIUM ION;Eight-heme nitrite reductase;186931;
4L38;B;Nitrite complex of TvNiR, low dose data set;1.8;CA;CALCIUM ION;Eight-heme nitrite reductase;186931;
4L3G;A;Crystal Structure of the E113Q-MauG/pre-Methylamine Dehydrogenase Complex Aged 120 Days;2.05;CA;CALCIUM ION;Methylamine utilization protein MauG;266;
4L3G;B;Crystal Structure of the E113Q-MauG/pre-Methylamine Dehydrogenase Complex Aged 120 Days;2.05;CA;CALCIUM ION;Methylamine utilization protein MauG;266;
4L3H;A;Crystal Structure of the E113Q-MauG/pre-Methylamine Dehydrogenase Complex After Treatment with Hydrogen Peroxide;1.79;CA;CALCIUM ION;Methylamine utilization protein MauG;266;
4L3H;B;Crystal Structure of the E113Q-MauG/pre-Methylamine Dehydrogenase Complex After Treatment with Hydrogen Peroxide;1.79;CA;CALCIUM ION;Methylamine utilization protein MauG;266;
4L3X;A;Nitrite complex of TvNiR, first middle dose data set;1.85;CA;CALCIUM ION;Eight-heme nitrite reductase;186931;
4L3X;B;Nitrite complex of TvNiR, first middle dose data set;1.85;CA;CALCIUM ION;Eight-heme nitrite reductase;186931;
4L3Y;A;Nitrite complex of TvNiR, high dose data set (NO complex);1.95;CA;CALCIUM ION;Eight-heme nitrite reductase;186931;
4L3Y;B;Nitrite complex of TvNiR, high dose data set (NO complex);1.95;CA;CALCIUM ION;Eight-heme nitrite reductase;186931;
4L3Z;A;Nitrite complex of TvNiR, second middle dose data set;1.85;CA;CALCIUM ION;Eight-heme nitrite reductase;186931;
4L3Z;B;Nitrite complex of TvNiR, second middle dose data set;1.85;CA;CALCIUM ION;Eight-heme nitrite reductase;186931;
4L41;A;Human Lactose synthase: A 2:1 complex between human alpha-lactalbumin and human beta1,4-galactosyltransferase;2.7;CA;CALCIUM ION;Alpha-lactalbumin;9606;
4L41;B;Human Lactose synthase: A 2:1 complex between human alpha-lactalbumin and human beta1,4-galactosyltransferase;2.7;CA;CALCIUM ION;Alpha-lactalbumin;9606;
4L73;A;Ca2+-bound MthK RCK domain at 2.5 Angstrom;2.5;CA;CALCIUM ION;Calcium-gated potassium channel MthK;145262;
4L73;B;Ca2+-bound MthK RCK domain at 2.5 Angstrom;2.5;CA;CALCIUM ION;Calcium-gated potassium channel MthK;145262;
4L74;A;Ca2+-bound MthK RCK domain at 1.9 Angstrom with single ligand;1.84;CA;CALCIUM ION;Calcium-gated potassium channel MthK;145262;
4L74;B;Ca2+-bound MthK RCK domain at 1.9 Angstrom with single ligand;1.84;CA;CALCIUM ION;Calcium-gated potassium channel MthK;145262;
4L75;A;Ca2+-bound D184N mutant MthK RCK domain at 2.4 Angstrom;2.39;CA;CALCIUM ION;Calcium-gated potassium channel MthK;145262;
4L75;B;Ca2+-bound D184N mutant MthK RCK domain at 2.4 Angstrom;2.39;CA;CALCIUM ION;Calcium-gated potassium channel MthK;145262;
4L75;C;Ca2+-bound D184N mutant MthK RCK domain at 2.4 Angstrom;2.39;CA;CALCIUM ION;Calcium-gated potassium channel MthK;145262;
4L75;D;Ca2+-bound D184N mutant MthK RCK domain at 2.4 Angstrom;2.39;CA;CALCIUM ION;Calcium-gated potassium channel MthK;145262;
4L75;E;Ca2+-bound D184N mutant MthK RCK domain at 2.4 Angstrom;2.39;CA;CALCIUM ION;Calcium-gated potassium channel MthK;145262;
4L75;F;Ca2+-bound D184N mutant MthK RCK domain at 2.4 Angstrom;2.39;CA;CALCIUM ION;Calcium-gated potassium channel MthK;145262;
4L76;A;Ca2+-bound E212Q mutant MthK RCK domain;2.99;CA;CALCIUM ION;Calcium-gated potassium channel MthK;145262;
4L76;B;Ca2+-bound E212Q mutant MthK RCK domain;2.99;CA;CALCIUM ION;Calcium-gated potassium channel MthK;145262;
4L76;C;Ca2+-bound E212Q mutant MthK RCK domain;2.99;CA;CALCIUM ION;Calcium-gated potassium channel MthK;145262;
4L76;D;Ca2+-bound E212Q mutant MthK RCK domain;2.99;CA;CALCIUM ION;Calcium-gated potassium channel MthK;145262;
4L76;E;Ca2+-bound E212Q mutant MthK RCK domain;2.99;CA;CALCIUM ION;Calcium-gated potassium channel MthK;145262;
4L76;F;Ca2+-bound E212Q mutant MthK RCK domain;2.99;CA;CALCIUM ION;Calcium-gated potassium channel MthK;145262;
4L7V;A;Crystal structure of Protein L-isoaspartyl-O-methyltransferase of Vibrio cholerae;2.05;CA;CALCIUM ION;Protein-L-isoaspartate O-methyltransferase;666;
4L8Q;A;Crystal structure of Canavalia grandiflora seed lectin complexed with X-Man.;2.3;CA;CALCIUM ION;Canavalia grandiflora seed lectin;232301;
4L9D;B;Crystal structure of the PKD1 domain from Vibrio cholerae metalloprotease PrtV;1.1;CA;CALCIUM ION;Protease;666;
4L9O;A;Crystal Structure of the Sec13-Sec16 blade-inserted complex from Pichia pastoris;1.6;CA;CALCIUM ION;Sec16,Protein transport protein SEC13;4,922,460,519;
4L9O;B;Crystal Structure of the Sec13-Sec16 blade-inserted complex from Pichia pastoris;1.6;CA;CALCIUM ION;Sec16,Protein transport protein SEC13;4,922,460,519;
4L9S;A;Crystal Structure of H-Ras G12C, GDP-bound;1.61;CA;CALCIUM ION;GTPase HRas;9606;
4L9W;A;Crystal Structure of H-Ras G12C, GMPPNP-bound;1.95;CA;CALCIUM ION;GTPase HRas;9606;
4LAA;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS L36H at cryogenic temperature;1.58;CA;CALCIUM ION;Thermonuclease;1280;
4LCV;C;Crystal Structure of DOC2B C2A domain;2;CA;CALCIUM ION;Double C2-like domain-containing protein beta;10116;
4LDC;A;Crystal Structure of DOC2B C2B domain;1.26;CA;CALCIUM ION;Double C2-like domain-containing protein beta;10116;
4LFY;A;Crystal structure of a dihydroorotase from Burkholderia cenocepacia J2315;1.8;CA;CALCIUM ION;Dihydroorotase;95486;
4LFY;B;Crystal structure of a dihydroorotase from Burkholderia cenocepacia J2315;1.8;CA;CALCIUM ION;Dihydroorotase;95486;
4LG0;A;Structure of a ternary FOXO1-ETS1 DNA complex;2.19;CA;CALCIUM ION;Forkhead box protein O1;9606;
4LHK;A;Structure of the N-terminal domain of the Lg-Flo1 adhesin (N-Lg-Flo1p) from the yeast Saccharomyces pastorianus, in complex with calcium and alpha-1,2-mannobiose;1.73;CA;CALCIUM ION;Flocculin;27292;
4LHK;B;Structure of the N-terminal domain of the Lg-Flo1 adhesin (N-Lg-Flo1p) from the yeast Saccharomyces pastorianus, in complex with calcium and alpha-1,2-mannobiose;1.73;CA;CALCIUM ION;Flocculin;27292;
4LHN;A;Structure of the N-terminal domain of the Flo1 adhesin (N-Flo1p) from the yeast Saccharomyces cerevisiae, in complex with calcium and mannose;2.12;CA;CALCIUM ION;Flocculation protein FLO1;4932;
4LIN;A;Exploring the atomic structure and conformational flexibility of a 320 angstrom long engineered viral fiber using X-ray crystallography;2.7;CA;CALCIUM ION;Tail needle protein gp26;10754;
4LIN;E;Exploring the atomic structure and conformational flexibility of a 320 angstrom long engineered viral fiber using X-ray crystallography;2.7;CA;CALCIUM ION;Tail needle protein gp26;10754;
4LIN;G;Exploring the atomic structure and conformational flexibility of a 320 angstrom long engineered viral fiber using X-ray crystallography;2.7;CA;CALCIUM ION;Tail needle protein gp26;10754;
4LIN;J;Exploring the atomic structure and conformational flexibility of a 320 angstrom long engineered viral fiber using X-ray crystallography;2.7;CA;CALCIUM ION;Tail needle protein gp26;10754;
4LIP;D;PSEUDOMONAS LIPASE COMPLEXED WITH RC-(RP, SP)-DIBUTYLCARBAMOYLGLYCERO-3-O-BUTYLPHOSPHONATE;1.75;CA;CALCIUM ION;TRIACYL-GLYCEROL-HYDROLASE;292;
4LIP;E;PSEUDOMONAS LIPASE COMPLEXED WITH RC-(RP, SP)-DIBUTYLCARBAMOYLGLYCERO-3-O-BUTYLPHOSPHONATE;1.75;CA;CALCIUM ION;TRIACYL-GLYCEROL-HYDROLASE;292;
4LJ3;A;Crystal structure of the EAL domain of c-di-GMP specific phosphodiesterase YahA in complex with substrate c-di-GMP and Ca++;1.7;CA;CALCIUM ION;Cyclic di-GMP phosphodiesterase YahA;562;
4LJ3;B;Crystal structure of the EAL domain of c-di-GMP specific phosphodiesterase YahA in complex with substrate c-di-GMP and Ca++;1.7;CA;CALCIUM ION;Cyclic di-GMP phosphodiesterase YahA;562;
4LJH;A;Crystal Structure of Pseudomonas aeruginosa Lectin LecA Complexed with 1-Methyl-3-indolyl-b-D-galactopyranoside at 1.45 A Resolution;1.45;CA;CALCIUM ION;PA-I galactophilic lectin;287;
4LJH;B;Crystal Structure of Pseudomonas aeruginosa Lectin LecA Complexed with 1-Methyl-3-indolyl-b-D-galactopyranoside at 1.45 A Resolution;1.45;CA;CALCIUM ION;PA-I galactophilic lectin;287;
4LJH;C;Crystal Structure of Pseudomonas aeruginosa Lectin LecA Complexed with 1-Methyl-3-indolyl-b-D-galactopyranoside at 1.45 A Resolution;1.45;CA;CALCIUM ION;PA-I galactophilic lectin;287;
4LJH;D;Crystal Structure of Pseudomonas aeruginosa Lectin LecA Complexed with 1-Methyl-3-indolyl-b-D-galactopyranoside at 1.45 A Resolution;1.45;CA;CALCIUM ION;PA-I galactophilic lectin;287;
4LJJ;A;Crystal Structure of the Complex of goat Lactoperoxidase with Acrylonitrile at 1.98 A Resolution;1.98;CA;CALCIUM ION;Lactoperoxidase;9925;
4LK6;A;Crystal Structure of Pseudomonas aeruginosa Lectin LecA Complexed with Chlorophenol Red-b-D-galactopyranoside at 2.86 A Resolution;2.86;CA;CALCIUM ION;PA-I galactophilic lectin;287;
4LK6;B;Crystal Structure of Pseudomonas aeruginosa Lectin LecA Complexed with Chlorophenol Red-b-D-galactopyranoside at 2.86 A Resolution;2.86;CA;CALCIUM ION;PA-I galactophilic lectin;287;
4LK6;C;Crystal Structure of Pseudomonas aeruginosa Lectin LecA Complexed with Chlorophenol Red-b-D-galactopyranoside at 2.86 A Resolution;2.86;CA;CALCIUM ION;PA-I galactophilic lectin;287;
4LK6;D;Crystal Structure of Pseudomonas aeruginosa Lectin LecA Complexed with Chlorophenol Red-b-D-galactopyranoside at 2.86 A Resolution;2.86;CA;CALCIUM ION;PA-I galactophilic lectin;287;
4LK6;E;Crystal Structure of Pseudomonas aeruginosa Lectin LecA Complexed with Chlorophenol Red-b-D-galactopyranoside at 2.86 A Resolution;2.86;CA;CALCIUM ION;PA-I galactophilic lectin;287;
4LK6;F;Crystal Structure of Pseudomonas aeruginosa Lectin LecA Complexed with Chlorophenol Red-b-D-galactopyranoside at 2.86 A Resolution;2.86;CA;CALCIUM ION;PA-I galactophilic lectin;287;
4LK6;G;Crystal Structure of Pseudomonas aeruginosa Lectin LecA Complexed with Chlorophenol Red-b-D-galactopyranoside at 2.86 A Resolution;2.86;CA;CALCIUM ION;PA-I galactophilic lectin;287;
4LK6;H;Crystal Structure of Pseudomonas aeruginosa Lectin LecA Complexed with Chlorophenol Red-b-D-galactopyranoside at 2.86 A Resolution;2.86;CA;CALCIUM ION;PA-I galactophilic lectin;287;
4LK6;I;Crystal Structure of Pseudomonas aeruginosa Lectin LecA Complexed with Chlorophenol Red-b-D-galactopyranoside at 2.86 A Resolution;2.86;CA;CALCIUM ION;PA-I galactophilic lectin;287;
4LK6;J;Crystal Structure of Pseudomonas aeruginosa Lectin LecA Complexed with Chlorophenol Red-b-D-galactopyranoside at 2.86 A Resolution;2.86;CA;CALCIUM ION;PA-I galactophilic lectin;287;
4LK6;K;Crystal Structure of Pseudomonas aeruginosa Lectin LecA Complexed with Chlorophenol Red-b-D-galactopyranoside at 2.86 A Resolution;2.86;CA;CALCIUM ION;PA-I galactophilic lectin;287;
4LK6;L;Crystal Structure of Pseudomonas aeruginosa Lectin LecA Complexed with Chlorophenol Red-b-D-galactopyranoside at 2.86 A Resolution;2.86;CA;CALCIUM ION;PA-I galactophilic lectin;287;
4LK7;A;Crystal Structure of Pseudomonas aeruginosa Lectin LecA Complexed with Resorufin-b-D-galactopyranoside at 1.76 A Resolution;1.76;CA;CALCIUM ION;PA-I galactophilic lectin;287;
4LK7;B;Crystal Structure of Pseudomonas aeruginosa Lectin LecA Complexed with Resorufin-b-D-galactopyranoside at 1.76 A Resolution;1.76;CA;CALCIUM ION;PA-I galactophilic lectin;287;
4LK7;C;Crystal Structure of Pseudomonas aeruginosa Lectin LecA Complexed with Resorufin-b-D-galactopyranoside at 1.76 A Resolution;1.76;CA;CALCIUM ION;PA-I galactophilic lectin;287;
4LK7;D;Crystal Structure of Pseudomonas aeruginosa Lectin LecA Complexed with Resorufin-b-D-galactopyranoside at 1.76 A Resolution;1.76;CA;CALCIUM ION;PA-I galactophilic lectin;287;
4LKD;A;Crystal Structure of Pseudomonas aeruginosa Lectin LecA Complexed with GalA-QRS at 2.31 A Resolution;2.31;CA;CALCIUM ION;PA-I galactophilic lectin;287;
4LKD;B;Crystal Structure of Pseudomonas aeruginosa Lectin LecA Complexed with GalA-QRS at 2.31 A Resolution;2.31;CA;CALCIUM ION;PA-I galactophilic lectin;287;
4LKD;C;Crystal Structure of Pseudomonas aeruginosa Lectin LecA Complexed with GalA-QRS at 2.31 A Resolution;2.31;CA;CALCIUM ION;PA-I galactophilic lectin;287;
4LKD;D;Crystal Structure of Pseudomonas aeruginosa Lectin LecA Complexed with GalA-QRS at 2.31 A Resolution;2.31;CA;CALCIUM ION;PA-I galactophilic lectin;287;
4LKD;E;Crystal Structure of Pseudomonas aeruginosa Lectin LecA Complexed with GalA-QRS at 2.31 A Resolution;2.31;CA;CALCIUM ION;PA-I galactophilic lectin;287;
4LKD;F;Crystal Structure of Pseudomonas aeruginosa Lectin LecA Complexed with GalA-QRS at 2.31 A Resolution;2.31;CA;CALCIUM ION;PA-I galactophilic lectin;287;
4LKD;G;Crystal Structure of Pseudomonas aeruginosa Lectin LecA Complexed with GalA-QRS at 2.31 A Resolution;2.31;CA;CALCIUM ION;PA-I galactophilic lectin;287;
4LKD;H;Crystal Structure of Pseudomonas aeruginosa Lectin LecA Complexed with GalA-QRS at 2.31 A Resolution;2.31;CA;CALCIUM ION;PA-I galactophilic lectin;287;
4LKE;A;Crystal Structure of Pseudomonas aeruginosa Lectin LecA Complexed with GalA-WRI at 1.65 A Resolution;1.65;CA;CALCIUM ION;PA-I galactophilic lectin;287;
4LKE;B;Crystal Structure of Pseudomonas aeruginosa Lectin LecA Complexed with GalA-WRI at 1.65 A Resolution;1.65;CA;CALCIUM ION;PA-I galactophilic lectin;287;
4LKE;C;Crystal Structure of Pseudomonas aeruginosa Lectin LecA Complexed with GalA-WRI at 1.65 A Resolution;1.65;CA;CALCIUM ION;PA-I galactophilic lectin;287;
4LKE;D;Crystal Structure of Pseudomonas aeruginosa Lectin LecA Complexed with GalA-WRI at 1.65 A Resolution;1.65;CA;CALCIUM ION;PA-I galactophilic lectin;287;
4LKF;A;Crystal Structure of Pseudomonas aeruginosa Lectin LecA Complexed with GalA-WKY at 1.64 A Resolution;1.64;CA;CALCIUM ION;PA-I galactophilic lectin;287;
4LKF;B;Crystal Structure of Pseudomonas aeruginosa Lectin LecA Complexed with GalA-WKY at 1.64 A Resolution;1.64;CA;CALCIUM ION;PA-I galactophilic lectin;287;
4LKS;A;Structure of CBM32-3 from a family 31 glycoside hydrolase from Clostridium perfringens in complex with galactose;1.5;CA;CALCIUM ION;Glycosyl hydrolase, family 31/fibronectin type III domain protein;1502;
4LKS;C;Structure of CBM32-3 from a family 31 glycoside hydrolase from Clostridium perfringens in complex with galactose;1.5;CA;CALCIUM ION;Glycosyl hydrolase, family 31/fibronectin type III domain protein;1502;
4LL2;B;Crystal structure of plant lectin with two metal binding sites from cicer arietinum at 2.6 angstrom resolution;2.6;CA;CALCIUM ION;Lectin;3827;
4LL5;A;Crystal Structure of Pim-1 in complex with the fluorescent compound SKF86002;2;CA;CALCIUM ION;Serine/threonine-protein kinase pim-1;9606;
4LLF;B;Crystal structure of Cucumber Necrosis Virus;2.89;CA;CALCIUM ION;Capsid protein;12143;
4LLF;D;Crystal structure of Cucumber Necrosis Virus;2.89;CA;CALCIUM ION;Capsid protein;12143;
4LLF;E;Crystal structure of Cucumber Necrosis Virus;2.89;CA;CALCIUM ION;Capsid protein;12143;
4LLF;F;Crystal structure of Cucumber Necrosis Virus;2.89;CA;CALCIUM ION;Capsid protein;12143;
4LLF;H;Crystal structure of Cucumber Necrosis Virus;2.89;CA;CALCIUM ION;Capsid protein;12143;
4LLF;I;Crystal structure of Cucumber Necrosis Virus;2.89;CA;CALCIUM ION;Capsid protein;12143;
4LLF;K;Crystal structure of Cucumber Necrosis Virus;2.89;CA;CALCIUM ION;Capsid protein;12143;
4LLF;M;Crystal structure of Cucumber Necrosis Virus;2.89;CA;CALCIUM ION;Capsid protein;12143;
4LLF;N;Crystal structure of Cucumber Necrosis Virus;2.89;CA;CALCIUM ION;Capsid protein;12143;
4LLF;O;Crystal structure of Cucumber Necrosis Virus;2.89;CA;CALCIUM ION;Capsid protein;12143;
4LLS;A;Crystal structure of a farnesyl diphosphate synthase from Roseobacter denitrificans OCh 114, target EFI-509393, with IPP, GSPP, and calcium bound in active site;1.5;CA;CALCIUM ION;Geranyltranstransferase;2434;
4LLS;B;Crystal structure of a farnesyl diphosphate synthase from Roseobacter denitrificans OCh 114, target EFI-509393, with IPP, GSPP, and calcium bound in active site;1.5;CA;CALCIUM ION;Geranyltranstransferase;2434;
4LLT;A;Crystal structure of a farnesyl diphosphate synthase from Roseobacter denitrificans OCh 114, target EFI-509393, with two IPP and calcium bound in active site;1.55;CA;CALCIUM ION;Geranyltranstransferase;2434;
4LLT;B;Crystal structure of a farnesyl diphosphate synthase from Roseobacter denitrificans OCh 114, target EFI-509393, with two IPP and calcium bound in active site;1.55;CA;CALCIUM ION;Geranyltranstransferase;2434;
4LM8;A;Crystal structure of the outer membrane decaheme cytochrome MtrC;1.8;CA;CALCIUM ION;Extracellular iron oxide respiratory system surface decaheme cytochrome c component MtrC;70863;
4LMF;A;C1s CUB1-EGF-CUB2;2.92;CA;CALCIUM ION;Complement C1s subcomponent heavy chain;9606;
4LMF;B;C1s CUB1-EGF-CUB2;2.92;CA;CALCIUM ION;Complement C1s subcomponent heavy chain;9606;
4LMF;C;C1s CUB1-EGF-CUB2;2.92;CA;CALCIUM ION;Complement C1s subcomponent heavy chain;9606;
4LMF;D;C1s CUB1-EGF-CUB2;2.92;CA;CALCIUM ION;Complement C1s subcomponent heavy chain;9606;
4LMH;A;Crystal structure of the outer membrane decaheme cytochrome OmcA;2.7;CA;CALCIUM ION;Extracellular iron oxide respiratory system surface decaheme cytochrome c component OmcA;70863;
4LMH;B;Crystal structure of the outer membrane decaheme cytochrome OmcA;2.7;CA;CALCIUM ION;Extracellular iron oxide respiratory system surface decaheme cytochrome c component OmcA;70863;
4LMH;C;Crystal structure of the outer membrane decaheme cytochrome OmcA;2.7;CA;CALCIUM ION;Extracellular iron oxide respiratory system surface decaheme cytochrome c component OmcA;70863;
4LMH;D;Crystal structure of the outer membrane decaheme cytochrome OmcA;2.7;CA;CALCIUM ION;Extracellular iron oxide respiratory system surface decaheme cytochrome c component OmcA;70863;
4LN1;A;CRYSTAL STRUCTURE OF L-lactate dehydrogenase from Bacillus cereus ATCC 14579 complexed with calcium, NYSGRC Target 029452;1.9;CA;CALCIUM ION;L-lactate dehydrogenase 1;1396;
4LN1;B;CRYSTAL STRUCTURE OF L-lactate dehydrogenase from Bacillus cereus ATCC 14579 complexed with calcium, NYSGRC Target 029452;1.9;CA;CALCIUM ION;L-lactate dehydrogenase 1;1396;
4LN1;C;CRYSTAL STRUCTURE OF L-lactate dehydrogenase from Bacillus cereus ATCC 14579 complexed with calcium, NYSGRC Target 029452;1.9;CA;CALCIUM ION;L-lactate dehydrogenase 1;1396;
4LN1;D;CRYSTAL STRUCTURE OF L-lactate dehydrogenase from Bacillus cereus ATCC 14579 complexed with calcium, NYSGRC Target 029452;1.9;CA;CALCIUM ION;L-lactate dehydrogenase 1;1396;
4LN6;A;The crystal structure of hemagglutinin from a h7n9 influenza virus (a/shanghai/2/2013);2.12;CA;CALCIUM ION;Hemagglutinin;11320;
4LN6;C;The crystal structure of hemagglutinin from a h7n9 influenza virus (a/shanghai/2/2013);2.12;CA;CALCIUM ION;Hemagglutinin;11320;
4LN6;E;The crystal structure of hemagglutinin from a h7n9 influenza virus (a/shanghai/2/2013);2.12;CA;CALCIUM ION;Hemagglutinin;11320;
4LN6;G;The crystal structure of hemagglutinin from a h7n9 influenza virus (a/shanghai/2/2013);2.12;CA;CALCIUM ION;Hemagglutinin;11320;
4LN6;I;The crystal structure of hemagglutinin from a h7n9 influenza virus (a/shanghai/2/2013);2.12;CA;CALCIUM ION;Hemagglutinin;11320;
4LN6;K;The crystal structure of hemagglutinin from a h7n9 influenza virus (a/shanghai/2/2013);2.12;CA;CALCIUM ION;Hemagglutinin;11320;
4LN8;A;The crystal structure of hemagglutinin from a h7n9 influenza virus (a/shanghai/2/2013) in complex with lstb;2.5;CA;CALCIUM ION;Hemagglutinin;11320;
4LN8;C;The crystal structure of hemagglutinin from a h7n9 influenza virus (a/shanghai/2/2013) in complex with lstb;2.5;CA;CALCIUM ION;Hemagglutinin;11320;
4LN8;E;The crystal structure of hemagglutinin from a h7n9 influenza virus (a/shanghai/2/2013) in complex with lstb;2.5;CA;CALCIUM ION;Hemagglutinin;11320;
4LN8;G;The crystal structure of hemagglutinin from a h7n9 influenza virus (a/shanghai/2/2013) in complex with lstb;2.5;CA;CALCIUM ION;Hemagglutinin;11320;
4LN8;I;The crystal structure of hemagglutinin from a h7n9 influenza virus (a/shanghai/2/2013) in complex with lstb;2.5;CA;CALCIUM ION;Hemagglutinin;11320;
4LN8;K;The crystal structure of hemagglutinin from a h7n9 influenza virus (a/shanghai/2/2013) in complex with lstb;2.5;CA;CALCIUM ION;Hemagglutinin;11320;
4LNM;A;Structure of Escherichia coli Threonine Aldolase in Complex with Serine;2.1;CA;CALCIUM ION;Low-specificity L-threonine aldolase;562;
4LNM;B;Structure of Escherichia coli Threonine Aldolase in Complex with Serine;2.1;CA;CALCIUM ION;Low-specificity L-threonine aldolase;562;
4LOR;A;C1s CUB1-EGF-CUB2 in complex with a collagen-like peptide from C1q;2.5;CA;CALCIUM ION;Complement C1s subcomponent heavy chain;9606;
4LOS;A;C1s CUB2-CCP1;2;CA;CALCIUM ION;Complement C1s subcomponent heavy chain;9606;
4LP7;A;Crystal structure of the human metapneumovirus matrix protein;2.83;CA;CALCIUM ION;Matrix protein M;162145;
4LP7;B;Crystal structure of the human metapneumovirus matrix protein;2.83;CA;CALCIUM ION;Matrix protein M;162145;
4LP7;C;Crystal structure of the human metapneumovirus matrix protein;2.83;CA;CALCIUM ION;Matrix protein M;162145;
4LP7;D;Crystal structure of the human metapneumovirus matrix protein;2.83;CA;CALCIUM ION;Matrix protein M;162145;
4LPK;A;Crystal Structure of K-Ras WT, GDP-bound;1.5;CA;CALCIUM ION;GTPase KRas;9606;
4LPK;B;Crystal Structure of K-Ras WT, GDP-bound;1.5;CA;CALCIUM ION;GTPase KRas;9606;
4LPL;A;Structure of CBM32-1 from a family 31 glycoside hydrolase from Clostridium perfringens;1.35;CA;CALCIUM ION;Glycosyl hydrolase, family 31/fibronectin type III domain protein;1502;
4LQ0;A;Crystal structure of the I-LtrWI LAGLIDADG homing endonuclease bound to target DNA.;2.68;CA;CALCIUM ION;LAGLIDADG homing endonuclease;330483;
4LQG;A;X-ray structure of human glutamate carboxypeptidase II (GCPII) in complex with a phosphoramidate inhibitor CTT1056;1.77;CA;CALCIUM ION;Glutamate carboxypeptidase 2;9606;
4LQR;A;Structure of CBM32-3 from a family 31 glycoside hydrolase from Clostridium perfringens;1.58;CA;CALCIUM ION;Glycosyl hydrolase, family 31/fibronectin type III domain protein;1502;
4LT6;A;Crystal Structure of human poly(A) polymerase gamma;2.79;CA;CALCIUM ION;Poly(A) polymerase gamma;9606;
4LT6;B;Crystal Structure of human poly(A) polymerase gamma;2.79;CA;CALCIUM ION;Poly(A) polymerase gamma;9606;
4LT7;A;Crystal structure of the c2a domain of rabphilin-3a in complex with a calcium;2.5;CA;CALCIUM ION;Rabphilin-3A;10116;
4LTO;A;Bacterial sodium channel in high calcium, I222 space group;3.46;CA;CALCIUM ION;Ion transport protein;351052;
4LTO;B;Bacterial sodium channel in high calcium, I222 space group;3.46;CA;CALCIUM ION;Ion transport protein;351052;
4LTO;D;Bacterial sodium channel in high calcium, I222 space group;3.46;CA;CALCIUM ION;Ion transport protein;351052;
4LTP;A;Bacterial sodium channel in high calcium, I222 space group, crystal 2;3.8;CA;CALCIUM ION;Ion transport protein;351052;
4LTP;B;Bacterial sodium channel in high calcium, I222 space group, crystal 2;3.8;CA;CALCIUM ION;Ion transport protein;351052;
4LTP;C;Bacterial sodium channel in high calcium, I222 space group, crystal 2;3.8;CA;CALCIUM ION;Ion transport protein;351052;
4LTP;D;Bacterial sodium channel in high calcium, I222 space group, crystal 2;3.8;CA;CALCIUM ION;Ion transport protein;351052;
4LUC;A;Crystal Structure of small molecule disulfide 6 bound to K-Ras G12C;1.29;CA;CALCIUM ION;GTPase KRas;9606;
4LUC;B;Crystal Structure of small molecule disulfide 6 bound to K-Ras G12C;1.29;CA;CALCIUM ION;GTPase KRas;9606;
4LUD;A;Crystal Structure of HCK in complex with the fluorescent compound SKF86002;2.85;CA;CALCIUM ION;Tyrosine-protein kinase HCK;9606;
4LUD;B;Crystal Structure of HCK in complex with the fluorescent compound SKF86002;2.85;CA;CALCIUM ION;Tyrosine-protein kinase HCK;9606;
4LUE;A;Crystal Structure of HCK in complex with 7-[trans-4-(4-methylpiperazin-1-yl)cyclohexyl]-5-(4-phenoxyphenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine (resulting from displacement of SKF86002);3.04;CA;CALCIUM ION;Tyrosine-protein kinase HCK;9606;
4LUE;B;Crystal Structure of HCK in complex with 7-[trans-4-(4-methylpiperazin-1-yl)cyclohexyl]-5-(4-phenoxyphenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine (resulting from displacement of SKF86002);3.04;CA;CALCIUM ION;Tyrosine-protein kinase HCK;9606;
4LUQ;A;Crystal structure of virulence effector Tse3 in complex with neutralizer Tsi3;1.77;CA;CALCIUM ION;Uncharacterized protein;287;
4LUQ;B;Crystal structure of virulence effector Tse3 in complex with neutralizer Tsi3;1.77;CA;CALCIUM ION;Uncharacterized protein;287;
4LV6;A;Crystal Structure of small molecule disulfide 4 covalently bound to K-Ras G12C;1.5;CA;CALCIUM ION;GTPase KRas;9606;
4LV6;B;Crystal Structure of small molecule disulfide 4 covalently bound to K-Ras G12C;1.5;CA;CALCIUM ION;GTPase KRas;9606;
4LVH;A;Insight into highly conserved H1 subtype-specific epitopes in influenza virus hemagglutinin;2.8;CA;CALCIUM ION;Hemagglutinin;11320;
4LVH;D;Insight into highly conserved H1 subtype-specific epitopes in influenza virus hemagglutinin;2.8;CA;CALCIUM ION;Hemagglutinin;11320;
4LVH;G;Insight into highly conserved H1 subtype-specific epitopes in influenza virus hemagglutinin;2.8;CA;CALCIUM ION;Hemagglutinin;11320;
4LVH;J;Insight into highly conserved H1 subtype-specific epitopes in influenza virus hemagglutinin;2.8;CA;CALCIUM ION;Hemagglutinin;11320;
4LVN;A;Crystal structure of PfSUB1-prodomain-NIMP.M7 Fab complex;2.25;CA;CALCIUM ION;Subtilisin-like serine protease;5833;
4LVO;A;Crystal structure of PfSUB1-prodomain-NIMP.M7 Fab complex with added CaCl2;2.26;CA;CALCIUM ION;Subtilisin-like serine protease;5833;
4LW9;A;Crystal structure of Vibrio cholera major pseudopilin EpsG;1.9;CA;CALCIUM ION;Type II secretion system protein G;666;
4LW9;B;Crystal structure of Vibrio cholera major pseudopilin EpsG;1.9;CA;CALCIUM ION;Type II secretion system protein G;666;
4LW9;C;Crystal structure of Vibrio cholera major pseudopilin EpsG;1.9;CA;CALCIUM ION;Type II secretion system protein G;666;
4LW9;D;Crystal structure of Vibrio cholera major pseudopilin EpsG;1.9;CA;CALCIUM ION;Type II secretion system protein G;666;
4LW9;E;Crystal structure of Vibrio cholera major pseudopilin EpsG;1.9;CA;CALCIUM ION;Type II secretion system protein G;666;
4LW9;F;Crystal structure of Vibrio cholera major pseudopilin EpsG;1.9;CA;CALCIUM ION;Type II secretion system protein G;666;
4LW9;I;Crystal structure of Vibrio cholera major pseudopilin EpsG;1.9;CA;CALCIUM ION;Type II secretion system protein G;666;
4LW9;J;Crystal structure of Vibrio cholera major pseudopilin EpsG;1.9;CA;CALCIUM ION;Type II secretion system protein G;666;
4LW9;K;Crystal structure of Vibrio cholera major pseudopilin EpsG;1.9;CA;CALCIUM ION;Type II secretion system protein G;666;
4LW9;L;Crystal structure of Vibrio cholera major pseudopilin EpsG;1.9;CA;CALCIUM ION;Type II secretion system protein G;666;
4LW9;Q;Crystal structure of Vibrio cholera major pseudopilin EpsG;1.9;CA;CALCIUM ION;Type II secretion system protein G;666;
4LW9;R;Crystal structure of Vibrio cholera major pseudopilin EpsG;1.9;CA;CALCIUM ION;Type II secretion system protein G;666;
4LXF;A;Crystal structure of M. tuberculosis TreS;2.6;CA;CALCIUM ION;Trehalose synthase;1773;
4LXF;B;Crystal structure of M. tuberculosis TreS;2.6;CA;CALCIUM ION;Trehalose synthase;1773;
4LXO;A;Crystal structure of 9,10Fn3-elegantin chimera;1.42;CA;CALCIUM ION;Fibronectin;9606;
4LXO;B;Crystal structure of 9,10Fn3-elegantin chimera;1.42;CA;CALCIUM ION;Fibronectin;9606;
4LXZ;A;Structure of Human HDAC2 in complex with SAHA (vorinostat);1.85;CA;CALCIUM ION;Histone deacetylase 2;9606;
4LXZ;B;Structure of Human HDAC2 in complex with SAHA (vorinostat);1.85;CA;CALCIUM ION;Histone deacetylase 2;9606;
4LXZ;C;Structure of Human HDAC2 in complex with SAHA (vorinostat);1.85;CA;CALCIUM ION;Histone deacetylase 2;9606;
4LY1;A;Structure of Human HDAC2 in complex with inhibitor 4-(acetylamino)-N-[2-amino-5-(thiophen-2-yl)phenyl]benzamide;1.57;CA;CALCIUM ION;Histone deacetylase 2;9606;
4LY1;B;Structure of Human HDAC2 in complex with inhibitor 4-(acetylamino)-N-[2-amino-5-(thiophen-2-yl)phenyl]benzamide;1.57;CA;CALCIUM ION;Histone deacetylase 2;9606;
4LY1;C;Structure of Human HDAC2 in complex with inhibitor 4-(acetylamino)-N-[2-amino-5-(thiophen-2-yl)phenyl]benzamide;1.57;CA;CALCIUM ION;Histone deacetylase 2;9606;
4M00;A;Crystal structure of the ligand binding region of staphylococcal adhesion SraP;2.05;CA;CALCIUM ION;Serine-rich adhesin for platelets;1280;
4M01;A;N terminal fragment(residues 245-575) of binding region of SraP;2.1;CA;CALCIUM ION;Serine-rich adhesin for platelets;1280;
4M01;B;N terminal fragment(residues 245-575) of binding region of SraP;2.1;CA;CALCIUM ION;Serine-rich adhesin for platelets;1280;
4M01;C;N terminal fragment(residues 245-575) of binding region of SraP;2.1;CA;CALCIUM ION;Serine-rich adhesin for platelets;1280;
4M01;D;N terminal fragment(residues 245-575) of binding region of SraP;2.1;CA;CALCIUM ION;Serine-rich adhesin for platelets;1280;
4M02;A;Middle fragment(residues 494-663) of the binding region of SraP;1.59;CA;CALCIUM ION;Serine-rich adhesin for platelets;1280;
4M03;A;C-terminal fragment(residues 576-751) of binding region of SraP;2.24;CA;CALCIUM ION;Serine-rich adhesin for platelets;1280;
4M0J;B;Crystal structure of a D-amino acid aminotransferase from Burkholderia thailandensis E264;2.05;CA;CALCIUM ION;D-amino acid aminotransferase;57975;
4M0K;A;Crystal structure of adenine phosphoribosyltransferase from Rhodothermus marinus DSM 4252, NYSGRC Target 029775.;1.4;CA;CALCIUM ION;Adenine phosphoribosyltransferase;29549;
4M0K;B;Crystal structure of adenine phosphoribosyltransferase from Rhodothermus marinus DSM 4252, NYSGRC Target 029775.;1.4;CA;CALCIUM ION;Adenine phosphoribosyltransferase;29549;
4M0K;C;Crystal structure of adenine phosphoribosyltransferase from Rhodothermus marinus DSM 4252, NYSGRC Target 029775.;1.4;CA;CALCIUM ION;Adenine phosphoribosyltransferase;29549;
4M0K;D;Crystal structure of adenine phosphoribosyltransferase from Rhodothermus marinus DSM 4252, NYSGRC Target 029775.;1.4;CA;CALCIUM ION;Adenine phosphoribosyltransferase;29549;
4M17;A;Crystal Structure of Surfactant Protein-D D325A/R343V mutant;2.1;CA;CALCIUM ION;Pulmonary surfactant-associated protein D;9606;
4M17;B;Crystal Structure of Surfactant Protein-D D325A/R343V mutant;2.1;CA;CALCIUM ION;Pulmonary surfactant-associated protein D;9606;
4M17;C;Crystal Structure of Surfactant Protein-D D325A/R343V mutant;2.1;CA;CALCIUM ION;Pulmonary surfactant-associated protein D;9606;
4M17;D;Crystal Structure of Surfactant Protein-D D325A/R343V mutant;2.1;CA;CALCIUM ION;Pulmonary surfactant-associated protein D;9606;
4M17;E;Crystal Structure of Surfactant Protein-D D325A/R343V mutant;2.1;CA;CALCIUM ION;Pulmonary surfactant-associated protein D;9606;
4M17;F;Crystal Structure of Surfactant Protein-D D325A/R343V mutant;2.1;CA;CALCIUM ION;Pulmonary surfactant-associated protein D;9606;
4M17;G;Crystal Structure of Surfactant Protein-D D325A/R343V mutant;2.1;CA;CALCIUM ION;Pulmonary surfactant-associated protein D;9606;
4M17;H;Crystal Structure of Surfactant Protein-D D325A/R343V mutant;2.1;CA;CALCIUM ION;Pulmonary surfactant-associated protein D;9606;
4M17;I;Crystal Structure of Surfactant Protein-D D325A/R343V mutant;2.1;CA;CALCIUM ION;Pulmonary surfactant-associated protein D;9606;
4M17;J;Crystal Structure of Surfactant Protein-D D325A/R343V mutant;2.1;CA;CALCIUM ION;Pulmonary surfactant-associated protein D;9606;
4M17;K;Crystal Structure of Surfactant Protein-D D325A/R343V mutant;2.1;CA;CALCIUM ION;Pulmonary surfactant-associated protein D;9606;
4M17;L;Crystal Structure of Surfactant Protein-D D325A/R343V mutant;2.1;CA;CALCIUM ION;Pulmonary surfactant-associated protein D;9606;
4M18;A;Crystal Structure of Surfactant Protein-D D325A/R343V mutant in complex with trimannose (Man-a1,2Man-a1,2Man);3.2;CA;CALCIUM ION;Pulmonary surfactant-associated protein D;9606;
4M18;B;Crystal Structure of Surfactant Protein-D D325A/R343V mutant in complex with trimannose (Man-a1,2Man-a1,2Man);3.2;CA;CALCIUM ION;Pulmonary surfactant-associated protein D;9606;
4M18;C;Crystal Structure of Surfactant Protein-D D325A/R343V mutant in complex with trimannose (Man-a1,2Man-a1,2Man);3.2;CA;CALCIUM ION;Pulmonary surfactant-associated protein D;9606;
4M18;D;Crystal Structure of Surfactant Protein-D D325A/R343V mutant in complex with trimannose (Man-a1,2Man-a1,2Man);3.2;CA;CALCIUM ION;Pulmonary surfactant-associated protein D;9606;
4M18;E;Crystal Structure of Surfactant Protein-D D325A/R343V mutant in complex with trimannose (Man-a1,2Man-a1,2Man);3.2;CA;CALCIUM ION;Pulmonary surfactant-associated protein D;9606;
4M18;F;Crystal Structure of Surfactant Protein-D D325A/R343V mutant in complex with trimannose (Man-a1,2Man-a1,2Man);3.2;CA;CALCIUM ION;Pulmonary surfactant-associated protein D;9606;
4M18;G;Crystal Structure of Surfactant Protein-D D325A/R343V mutant in complex with trimannose (Man-a1,2Man-a1,2Man);3.2;CA;CALCIUM ION;Pulmonary surfactant-associated protein D;9606;
4M18;H;Crystal Structure of Surfactant Protein-D D325A/R343V mutant in complex with trimannose (Man-a1,2Man-a1,2Man);3.2;CA;CALCIUM ION;Pulmonary surfactant-associated protein D;9606;
4M18;I;Crystal Structure of Surfactant Protein-D D325A/R343V mutant in complex with trimannose (Man-a1,2Man-a1,2Man);3.2;CA;CALCIUM ION;Pulmonary surfactant-associated protein D;9606;
4M18;J;Crystal Structure of Surfactant Protein-D D325A/R343V mutant in complex with trimannose (Man-a1,2Man-a1,2Man);3.2;CA;CALCIUM ION;Pulmonary surfactant-associated protein D;9606;
4M18;K;Crystal Structure of Surfactant Protein-D D325A/R343V mutant in complex with trimannose (Man-a1,2Man-a1,2Man);3.2;CA;CALCIUM ION;Pulmonary surfactant-associated protein D;9606;
4M18;L;Crystal Structure of Surfactant Protein-D D325A/R343V mutant in complex with trimannose (Man-a1,2Man-a1,2Man);3.2;CA;CALCIUM ION;Pulmonary surfactant-associated protein D;9606;
4M1L;A;Complex of IQCG and Ca2+-bound CaM;2.1;CA;CALCIUM ION;Calmodulin;9606;
4M2O;A;Crystal structure of a non-myristoylated C39A recoverin mutant with one calcium ion bound to EF-hand 3;1.5;CA;CALCIUM ION;Recoverin;9913;
4M2P;A;Crystal structure of a non-myristoylated C39D recoverin mutant with one calcium ion bound to EF-hand 3;1.45;CA;CALCIUM ION;Recoverin;9913;
4M2Q;A;Crystal structure of non-myristoylated recoverin with Cysteine-39 oxidized to sulfenic acid;1.9;CA;CALCIUM ION;Recoverin;9913;
4M3C;A;Structure of a binary complex between homologous tetrameric legume lectins from Butea monosperma and Spatholobus parviflorus seeds;2.5;CA;CALCIUM ION;Lectin Alpha chain;56060;
4M3C;B;Structure of a binary complex between homologous tetrameric legume lectins from Butea monosperma and Spatholobus parviflorus seeds;2.5;CA;CALCIUM ION;Lectin Beta Chain;56060;
4M3C;C;Structure of a binary complex between homologous tetrameric legume lectins from Butea monosperma and Spatholobus parviflorus seeds;2.5;CA;CALCIUM ION;Lectin Alpha chain;56060;
4M3C;D;Structure of a binary complex between homologous tetrameric legume lectins from Butea monosperma and Spatholobus parviflorus seeds;2.5;CA;CALCIUM ION;Lectin Beta Chain;56060;
4M3C;E;Structure of a binary complex between homologous tetrameric legume lectins from Butea monosperma and Spatholobus parviflorus seeds;2.5;CA;CALCIUM ION;Seed lectin alpha chain;132465;
4M3C;F;Structure of a binary complex between homologous tetrameric legume lectins from Butea monosperma and Spatholobus parviflorus seeds;2.5;CA;CALCIUM ION;Seed lectin beta chain;132465;
4M3C;G;Structure of a binary complex between homologous tetrameric legume lectins from Butea monosperma and Spatholobus parviflorus seeds;2.5;CA;CALCIUM ION;Seed lectin alpha chain;132465;
4M3C;H;Structure of a binary complex between homologous tetrameric legume lectins from Butea monosperma and Spatholobus parviflorus seeds;2.5;CA;CALCIUM ION;Seed lectin beta chain;132465;
4M3M;A;Influenza Neuraminidase in complex with a stereomutated analogue of Oseltamivir carboxylate;2.1;CA;CALCIUM ION;Neuraminidase;11320;
4M3R;A;RB69 DNA polymerase ternary complex with dT/dG at position n-1 of primer/template duplex;2.07;CA;CALCIUM ION;DNA polymerase;1914161;
4M3T;A;RB69 DNA polymerase ternary complex with dT/dG at position n-2 of primer/template duplex;1.9;CA;CALCIUM ION;DNA polymerase;1914161;
4M3U;A;RB69 DNA polymerase ternary complex with dT/dG at position n-3 of primer/template duplex;2.07;CA;CALCIUM ION;DNA polymerase;1914161;
4M3W;A;RB69 DNA polymerase ternary complex with dT/dG at position n-4 of primer/template duplex;2.1;CA;CALCIUM ION;DNA polymerase;1914161;
4M3X;A;RB69 DNA polymerase ternary complex with dT/dG at position n-5 of primer/template duplex;2.2;CA;CALCIUM ION;DNA polymerase;1914161;
4M3Y;A;RB69 DNA polymerase ternary complex with dG/dT at position n-1 of primer/template duplex;1.86;CA;CALCIUM ION;DNA polymerase;1914161;
4M3Z;A;RB69 DNA polymerase ternary complex with dG/dT at position n-2 of primer/tempLate duplex;1.84;CA;CALCIUM ION;DNA polymerase;1914161;
4M41;A;RB69 DNA polymerase ternary complex with dG/dT at position n-3 of primer/tempLate duplex;2.15;CA;CALCIUM ION;DNA polymerase;1914161;
4M42;A;RB69 DNA polymerase ternary complex with dG/dT at position n-4 of primer/tempLate duplex;2.04;CA;CALCIUM ION;DNA polymerase;1914161;
4M45;A;RB69 DNA polymerase ternary complex with dG/dT at position n-5 of primer/template duplex;1.89;CA;CALCIUM ION;DNA polymerase;1914161;
4M5E;A;Tse3 structure;1.49;CA;CALCIUM ION;Uncharacterized protein;287;
4M5F;A;complex structure of Tse3-Tsi3;2.5;CA;CALCIUM ION;Uncharacterized protein;287;
4M5G;A;The Identification, Analysis and Structure-Based Development of Novel Inhibitors of 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase;1.31;CA;CALCIUM ION;2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase;562;
4M5H;A;The Identification, Analysis and Structure-Based Development of Novel Inhibitors of 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase;1.11;CA;CALCIUM ION;2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase;562;
4M5I;A;The Identification, Analysis and Structure-Based Development of Novel Inhibitors of 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase;1.08;CA;CALCIUM ION;2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase;562;
4M5K;A;The Identification, Analysis and Structure-Based Development of Novel Inhibitors of 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase;1.3;CA;CALCIUM ION;2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase;562;
4M5L;A;The Identification, Analysis and Structure-Based Development of Novel Inhibitors of 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase;1.09;CA;CALCIUM ION;2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase;562;
4M5M;A;The Identification, Analysis and Structure-Based Development of Novel Inhibitors of 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase;1.12;CA;CALCIUM ION;2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase;562;
4M5V;A;Influenza 2009 H1N1 endonuclease with 100 millimolar calcium;1.8;CA;CALCIUM ION;Polymerase PA;11320;
4M63;C;Crystal Structure of a Filament-Like Actin Trimer Bound to the Bacterial Effector VopL;2.75;CA;CALCIUM ION;Actin-5C;7227;
4M63;D;Crystal Structure of a Filament-Like Actin Trimer Bound to the Bacterial Effector VopL;2.75;CA;CALCIUM ION;Actin-5C;7227;
4M63;E;Crystal Structure of a Filament-Like Actin Trimer Bound to the Bacterial Effector VopL;2.75;CA;CALCIUM ION;Actin-5C;7227;
4M65;A;In situ thermolysin crystallized on a MiTeGen micromesh with asparagine ligand;1.6;CA;CALCIUM ION;Thermolysin;274;
4M6X;A;Mutant structure of methyltransferase from Streptomyces hygroscopicus complexed with S-adenosyl-L-homocysteine and methylphenylpyruvic acid;2.3;CA;CALCIUM ION;Methyltransferase MppJ;1912;
4M6X;B;Mutant structure of methyltransferase from Streptomyces hygroscopicus complexed with S-adenosyl-L-homocysteine and methylphenylpyruvic acid;2.3;CA;CALCIUM ION;Methyltransferase MppJ;1912;
4M6Y;A;Mutant structure of methyltransferase from Streptomyces hygroscopicus complexed with S-adenosyl-L-homocysteine and methylphenylpyruvic acid;2.5;CA;CALCIUM ION;Methyltransferase MppJ;1912;
4M6Y;B;Mutant structure of methyltransferase from Streptomyces hygroscopicus complexed with S-adenosyl-L-homocysteine and methylphenylpyruvic acid;2.5;CA;CALCIUM ION;Methyltransferase MppJ;1912;
4M71;A;Mutant structure of methyltransferase from Streptomyces hygroscopicus complexed with S-adenosyl-L-homocysteine and methylphenylpyruvic acid;2.21;CA;CALCIUM ION;Methyltransferase MppJ;1912;
4M71;B;Mutant structure of methyltransferase from Streptomyces hygroscopicus complexed with S-adenosyl-L-homocysteine and methylphenylpyruvic acid;2.21;CA;CALCIUM ION;Methyltransferase MppJ;1912;
4M72;A;Mutant structure of methyltransferase from Streptomyces hygroscopicus;2.1;CA;CALCIUM ION;Methyltransferase MppJ;1912;
4M72;B;Mutant structure of methyltransferase from Streptomyces hygroscopicus;2.1;CA;CALCIUM ION;Methyltransferase MppJ;1912;
4M73;A;Mutant structure of methyltransferase from Streptomyces hygroscopicus;2;CA;CALCIUM ION;Methyltransferase MppJ;1912;
4M73;B;Mutant structure of methyltransferase from Streptomyces hygroscopicus;2;CA;CALCIUM ION;Methyltransferase MppJ;1912;
4M74;A;Mutant structure of methyltransferase from Streptomyces hygroscopicus;2.2;CA;CALCIUM ION;Methyltransferase MppJ;1912;
4M74;B;Mutant structure of methyltransferase from Streptomyces hygroscopicus;2.2;CA;CALCIUM ION;Methyltransferase MppJ;1912;
4M7F;A;Crystal structure of tetrameric fibrinogen-like recognition domain of FIBCD1 with bound ManNAc;2.1;CA;CALCIUM ION;Fibrinogen C domain-containing protein 1;9606;
4M7F;B;Crystal structure of tetrameric fibrinogen-like recognition domain of FIBCD1 with bound ManNAc;2.1;CA;CALCIUM ION;Fibrinogen C domain-containing protein 1;9606;
4M7H;A;Crystal structure of tetrameric fibrinogen-like recognition domain of FIBCD1;2;CA;CALCIUM ION;Fibrinogen C domain-containing protein 1;9606;
4M7H;B;Crystal structure of tetrameric fibrinogen-like recognition domain of FIBCD1;2;CA;CALCIUM ION;Fibrinogen C domain-containing protein 1;9606;
4M7K;H;Crystal structure of anti-tissue factor antibody 10H10;1.9;CA;CALCIUM ION;10H10 heavy chain;960,610,090;
4M7Z;B;Unliganded 1 crystal structure of S25-26 Fab;2.75;CA;CALCIUM ION;S25-26 Fab (Igg1k) Heavy Chain;10090;
4M7Z;H;Unliganded 1 crystal structure of S25-26 Fab;2.75;CA;CALCIUM ION;S25-26 Fab (Igg1k) Heavy Chain;10090;
4M7Z;L;Unliganded 1 crystal structure of S25-26 Fab;2.75;CA;CALCIUM ION;S25-26 Fab (Igg1k) Light Chain;10090;
4M8D;A;Crystal structure of an isatin hydrolase bound to product analogue thioisatinate;1.9;CA;CALCIUM ION;Putative uncharacterized protein;187304;
4M8D;B;Crystal structure of an isatin hydrolase bound to product analogue thioisatinate;1.9;CA;CALCIUM ION;Putative uncharacterized protein;187304;
4M8D;C;Crystal structure of an isatin hydrolase bound to product analogue thioisatinate;1.9;CA;CALCIUM ION;Putative uncharacterized protein;187304;
4M8D;D;Crystal structure of an isatin hydrolase bound to product analogue thioisatinate;1.9;CA;CALCIUM ION;Putative uncharacterized protein;187304;
4M8D;F;Crystal structure of an isatin hydrolase bound to product analogue thioisatinate;1.9;CA;CALCIUM ION;Putative uncharacterized protein;187304;
4M8D;I;Crystal structure of an isatin hydrolase bound to product analogue thioisatinate;1.9;CA;CALCIUM ION;Putative uncharacterized protein;187304;
4M8D;J;Crystal structure of an isatin hydrolase bound to product analogue thioisatinate;1.9;CA;CALCIUM ION;Putative uncharacterized protein;187304;
4M8D;L;Crystal structure of an isatin hydrolase bound to product analogue thioisatinate;1.9;CA;CALCIUM ION;Putative uncharacterized protein;187304;
4M8U;A;The Structure of MalL mutant enzyme V200A from Bacillus subtilus;1.45;CA;CALCIUM ION;Oligo-1,6-glucosidase 1;1423;
4M93;B;Unliganded 2 crystal structure of S25-26 Fab;2.09;CA;CALCIUM ION;S25-26 Fab (IgG1k) heavy chain;10090;
4M9V;B;Zfp57 mutant (E182Q) in complex with 5-carboxylcytosine DNA;0.97;CA;CALCIUM ION;DNA (5'-D(*AP*CP*TP*GP*(1CC)P*GP*GP*CP*AP*AP*T)-3');;
4M9V;E;Zfp57 mutant (E182Q) in complex with 5-carboxylcytosine DNA;0.97;CA;CALCIUM ION;DNA (5'-D(*AP*CP*TP*GP*(1CC)P*GP*GP*CP*AP*AP*T)-3');;
4MB1;A;The Structure of MalL mutant enzyme G202P from Bacillus subtilus;1.4;CA;CALCIUM ION;Oligo-1,6-glucosidase 1;1423;
4MBE;A;Sac3:Sus1:Cdc31:Nup1 complex;2.61;CA;CALCIUM ION;Cell division control protein 31;4932;
4MBE;D;Sac3:Sus1:Cdc31:Nup1 complex;2.61;CA;CALCIUM ION;Cell division control protein 31;4932;
4MBO;A;1.65 Angstrom Crystal Structure of Serine-rich Repeat Adhesion Glycoprotein (Srr1) from Streptococcus agalactiae;1.65;CA;CALCIUM ION;Serine-rich Repeat Adhesion Glycoprotein (Srr1);1311;
4MBX;A;Structure of unliganded B-Lymphotropic Polyomavirus VP1;1.92;CA;CALCIUM ION;Major Capsid Protein VP1;12480;
4MBX;B;Structure of unliganded B-Lymphotropic Polyomavirus VP1;1.92;CA;CALCIUM ION;Major Capsid Protein VP1;12480;
4MBX;C;Structure of unliganded B-Lymphotropic Polyomavirus VP1;1.92;CA;CALCIUM ION;Major Capsid Protein VP1;12480;
4MBX;D;Structure of unliganded B-Lymphotropic Polyomavirus VP1;1.92;CA;CALCIUM ION;Major Capsid Protein VP1;12480;
4MBX;E;Structure of unliganded B-Lymphotropic Polyomavirus VP1;1.92;CA;CALCIUM ION;Major Capsid Protein VP1;12480;
4MBX;F;Structure of unliganded B-Lymphotropic Polyomavirus VP1;1.92;CA;CALCIUM ION;Major Capsid Protein VP1;12480;
4MBX;G;Structure of unliganded B-Lymphotropic Polyomavirus VP1;1.92;CA;CALCIUM ION;Major Capsid Protein VP1;12480;
4MBX;H;Structure of unliganded B-Lymphotropic Polyomavirus VP1;1.92;CA;CALCIUM ION;Major Capsid Protein VP1;12480;
4MBX;I;Structure of unliganded B-Lymphotropic Polyomavirus VP1;1.92;CA;CALCIUM ION;Major Capsid Protein VP1;12480;
4MBX;J;Structure of unliganded B-Lymphotropic Polyomavirus VP1;1.92;CA;CALCIUM ION;Major Capsid Protein VP1;12480;
4MBY;A;Structure of B-Lymphotropic Polyomavirus VP1 in complex with 3'-sialyllactose;1.48;CA;CALCIUM ION;Major Capsid Protein VP1;12480;
4MBY;B;Structure of B-Lymphotropic Polyomavirus VP1 in complex with 3'-sialyllactose;1.48;CA;CALCIUM ION;Major Capsid Protein VP1;12480;
4MBY;C;Structure of B-Lymphotropic Polyomavirus VP1 in complex with 3'-sialyllactose;1.48;CA;CALCIUM ION;Major Capsid Protein VP1;12480;
4MBY;D;Structure of B-Lymphotropic Polyomavirus VP1 in complex with 3'-sialyllactose;1.48;CA;CALCIUM ION;Major Capsid Protein VP1;12480;
4MBY;E;Structure of B-Lymphotropic Polyomavirus VP1 in complex with 3'-sialyllactose;1.48;CA;CALCIUM ION;Major Capsid Protein VP1;12480;
4MBY;F;Structure of B-Lymphotropic Polyomavirus VP1 in complex with 3'-sialyllactose;1.48;CA;CALCIUM ION;Major Capsid Protein VP1;12480;
4MBY;G;Structure of B-Lymphotropic Polyomavirus VP1 in complex with 3'-sialyllactose;1.48;CA;CALCIUM ION;Major Capsid Protein VP1;12480;
4MBY;H;Structure of B-Lymphotropic Polyomavirus VP1 in complex with 3'-sialyllactose;1.48;CA;CALCIUM ION;Major Capsid Protein VP1;12480;
4MBY;I;Structure of B-Lymphotropic Polyomavirus VP1 in complex with 3'-sialyllactose;1.48;CA;CALCIUM ION;Major Capsid Protein VP1;12480;
4MBY;J;Structure of B-Lymphotropic Polyomavirus VP1 in complex with 3'-sialyllactose;1.48;CA;CALCIUM ION;Major Capsid Protein VP1;12480;
4MBZ;A;Structure of B-Lymphotropic Polyomavirus VP1 in complex with 3'-sialyllactosamine;1.75;CA;CALCIUM ION;Major Capsid Protein VP1;12480;
4MBZ;B;Structure of B-Lymphotropic Polyomavirus VP1 in complex with 3'-sialyllactosamine;1.75;CA;CALCIUM ION;Major Capsid Protein VP1;12480;
4MBZ;C;Structure of B-Lymphotropic Polyomavirus VP1 in complex with 3'-sialyllactosamine;1.75;CA;CALCIUM ION;Major Capsid Protein VP1;12480;
4MBZ;D;Structure of B-Lymphotropic Polyomavirus VP1 in complex with 3'-sialyllactosamine;1.75;CA;CALCIUM ION;Major Capsid Protein VP1;12480;
4MBZ;E;Structure of B-Lymphotropic Polyomavirus VP1 in complex with 3'-sialyllactosamine;1.75;CA;CALCIUM ION;Major Capsid Protein VP1;12480;
4MBZ;F;Structure of B-Lymphotropic Polyomavirus VP1 in complex with 3'-sialyllactosamine;1.75;CA;CALCIUM ION;Major Capsid Protein VP1;12480;
4MBZ;G;Structure of B-Lymphotropic Polyomavirus VP1 in complex with 3'-sialyllactosamine;1.75;CA;CALCIUM ION;Major Capsid Protein VP1;12480;
4MBZ;H;Structure of B-Lymphotropic Polyomavirus VP1 in complex with 3'-sialyllactosamine;1.75;CA;CALCIUM ION;Major Capsid Protein VP1;12480;
4MBZ;I;Structure of B-Lymphotropic Polyomavirus VP1 in complex with 3'-sialyllactosamine;1.75;CA;CALCIUM ION;Major Capsid Protein VP1;12480;
4MBZ;J;Structure of B-Lymphotropic Polyomavirus VP1 in complex with 3'-sialyllactosamine;1.75;CA;CALCIUM ION;Major Capsid Protein VP1;12480;
4MC7;A;Crystal structure of a subtype N11 neuraminidase-like protein of A/flat-faced bat/Peru/033/2010 (H18N11);2.99;CA;CALCIUM ION;NEURAMINIDASE;11320;
4MC7;B;Crystal structure of a subtype N11 neuraminidase-like protein of A/flat-faced bat/Peru/033/2010 (H18N11);2.99;CA;CALCIUM ION;NEURAMINIDASE;11320;
4MC7;C;Crystal structure of a subtype N11 neuraminidase-like protein of A/flat-faced bat/Peru/033/2010 (H18N11);2.99;CA;CALCIUM ION;NEURAMINIDASE;11320;
4MC7;D;Crystal structure of a subtype N11 neuraminidase-like protein of A/flat-faced bat/Peru/033/2010 (H18N11);2.99;CA;CALCIUM ION;NEURAMINIDASE;11320;
4MCP;A;A high resolution structure of human glutamate carboxypeptidase II (GCPII) in complex with folyl-gamma-L-glutamic acid (pteroyldi-gamma-L-glutamic acid);1.65;CA;CALCIUM ION;Glutamate carboxypeptidase 2;9606;
4MCQ;A;A high resolution structure of human glutamate carboxypeptidase II (GCPII) in complex with folyldi-gamma-L-glutamic acid (pteroyltri-gamma-L-glutamic acid);2;CA;CALCIUM ION;Glutamate carboxypeptidase 2;9606;
4MCR;A;A high resolution structure of human glutamate carboxypeptidase II (GCPII) in complex with folyltri-gamma-L-glutamic acid (pteroyltetra-gamma-L-glutamic acid);1.65;CA;CALCIUM ION;Glutamate carboxypeptidase 2;9606;
4MCS;A;A high resolution structure of human glutamate carboxypeptidase II (GCPII) His475Tyr variant in complex with glutamic acid;1.83;CA;CALCIUM ION;Glutamate carboxypeptidase 2;9606;
4MDV;A;Crystal structure of calcium-bound annexin (Sm)1;2.5;CA;CALCIUM ION;Annexin;6183;
4MDV;B;Crystal structure of calcium-bound annexin (Sm)1;2.5;CA;CALCIUM ION;Annexin;6183;
4ME5;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS V23S/V66A at cryogenic temperature;1.8;CA;CALCIUM ION;Thermonuclease;1280;
4MEH;A;In vitro evolved glmS ribozyme triple mutant, calcium ion complex;3.12;CA;CALCIUM ION;glmS triple mutant ribozyme;;
4MEH;B;In vitro evolved glmS ribozyme triple mutant, calcium ion complex;3.12;CA;CALCIUM ION;(122-MER) ribozyme;;
4MEW;A;Structure of the core fragment of human PR70;1.99;CA;CALCIUM ION;Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit beta;9606;
4MGQ;A;PbXyn10C CBM APO;1.68;CA;CALCIUM ION;Glycosyl hydrolase family 10;77095;
4MH1;B;Crystal structure and functional studies of quinoprotein L-sorbose dehydrogenase from Ketogulonicigenium vulgare Y25;2.7;CA;CALCIUM ION;Sorbose dehydrogenase;92945;
4MHV;A;Crystal structure of the PNT domain of human ETS2;2.45;CA;CALCIUM ION;Protein C-ets-2;9606;
4MHX;A;Crystal Structure of Sulfamidase;2;CA;CALCIUM ION;N-sulphoglucosamine sulphohydrolase;9606;
4MHX;B;Crystal Structure of Sulfamidase;2;CA;CALCIUM ION;N-sulphoglucosamine sulphohydrolase;9606;
4MIU;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS V23T/V99T at cryogenic temperature;1.67;CA;CALCIUM ION;Thermonuclease;1280;
4MIV;A;Crystal Structure of Sulfamidase, Crystal Form L;2.4;CA;CALCIUM ION;N-sulphoglucosamine sulphohydrolase;9606;
4MIV;B;Crystal Structure of Sulfamidase, Crystal Form L;2.4;CA;CALCIUM ION;N-sulphoglucosamine sulphohydrolase;9606;
4MIV;C;Crystal Structure of Sulfamidase, Crystal Form L;2.4;CA;CALCIUM ION;N-sulphoglucosamine sulphohydrolase;9606;
4MIV;D;Crystal Structure of Sulfamidase, Crystal Form L;2.4;CA;CALCIUM ION;N-sulphoglucosamine sulphohydrolase;9606;
4MIV;E;Crystal Structure of Sulfamidase, Crystal Form L;2.4;CA;CALCIUM ION;N-sulphoglucosamine sulphohydrolase;9606;
4MIV;F;Crystal Structure of Sulfamidase, Crystal Form L;2.4;CA;CALCIUM ION;N-sulphoglucosamine sulphohydrolase;9606;
4MIV;G;Crystal Structure of Sulfamidase, Crystal Form L;2.4;CA;CALCIUM ION;N-sulphoglucosamine sulphohydrolase;9606;
4MIV;H;Crystal Structure of Sulfamidase, Crystal Form L;2.4;CA;CALCIUM ION;N-sulphoglucosamine sulphohydrolase;9606;
4MIX;A;PaToxG Glycosyltransferase;1.8;CA;CALCIUM ION;Putative insecticidal toxin;291112;
4MIX;B;PaToxG Glycosyltransferase;1.8;CA;CALCIUM ION;Putative insecticidal toxin;291112;
4MJP;A;E. coli sliding clamp in complex with (R)-Vedaprofen;1.86;CA;CALCIUM ION;DNA polymerase III subunit beta;562;
4MJQ;A;E. coli sliding clamp in complex with Bromfenac;1.73;CA;CALCIUM ION;DNA polymerase III subunit beta;562;
4MJQ;B;E. coli sliding clamp in complex with Bromfenac;1.73;CA;CALCIUM ION;DNA polymerase III subunit beta;562;
4MJR;B;E. coli sliding clamp in complex with (S)-Carprofen;1.62;CA;CALCIUM ION;DNA polymerase III subunit beta;562;
4MJU;A;Influenza Neuraminidase in complex with a novel antiviral compound;2.35;CA;CALCIUM ION;Neuraminidase;11320;
4MJV;A;Influenza Neuraminidase in complex with a novel antiviral compound;2.65;CA;CALCIUM ION;Neuraminidase;11320;
4MKF;A;Crystal structure of a stable adenylate kinase variant AKv3;1.7;CA;CALCIUM ION;Adenylate kinase;1423;
4MKF;B;Crystal structure of a stable adenylate kinase variant AKv3;1.7;CA;CALCIUM ION;Adenylate kinase;1423;
4MKM;A;Repeat domains 1 & 2 of Clostridium perfringens Cpe0147;1.75;CA;CALCIUM ION;Putative surface anchored protein;1502;
4MLC;A;ABC Transporter Substrate-Binding Protein fromDesulfitobacterium hafniense;2.7;CA;CALCIUM ION;Extracellular ligand-binding receptor;49338;
4MLG;A;Structure of RS223-Beta-xylosidase;2.7;CA;CALCIUM ION;Beta-xylosidase;155900;
4MLG;B;Structure of RS223-Beta-xylosidase;2.7;CA;CALCIUM ION;Beta-xylosidase;155900;
4MLG;C;Structure of RS223-Beta-xylosidase;2.7;CA;CALCIUM ION;Beta-xylosidase;155900;
4MLG;D;Structure of RS223-Beta-xylosidase;2.7;CA;CALCIUM ION;Beta-xylosidase;155900;
4MLG;E;Structure of RS223-Beta-xylosidase;2.7;CA;CALCIUM ION;Beta-xylosidase;155900;
4MLG;F;Structure of RS223-Beta-xylosidase;2.7;CA;CALCIUM ION;Beta-xylosidase;155900;
4MLG;G;Structure of RS223-Beta-xylosidase;2.7;CA;CALCIUM ION;Beta-xylosidase;155900;
4MLG;H;Structure of RS223-Beta-xylosidase;2.7;CA;CALCIUM ION;Beta-xylosidase;155900;
4MLG;I;Structure of RS223-Beta-xylosidase;2.7;CA;CALCIUM ION;Beta-xylosidase;155900;
4MLG;J;Structure of RS223-Beta-xylosidase;2.7;CA;CALCIUM ION;Beta-xylosidase;155900;
4MLG;K;Structure of RS223-Beta-xylosidase;2.7;CA;CALCIUM ION;Beta-xylosidase;155900;
4MLG;L;Structure of RS223-Beta-xylosidase;2.7;CA;CALCIUM ION;Beta-xylosidase;155900;
4MLW;A;Crystal structure of non-myristoylated recoverin at 1.45 A resolution with calcium bound to EF-hand 3;1.45;CA;CALCIUM ION;Recoverin;9913;
4MLZ;A;Crystal structure of periplasmic binding protein from Jonesia denitrificans;1.72;CA;CALCIUM ION;Periplasmic binding protein;43674;
4MLZ;B;Crystal structure of periplasmic binding protein from Jonesia denitrificans;1.72;CA;CALCIUM ION;Periplasmic binding protein;43674;
4MMH;A;Crystal structure of heparan sulfate lyase HepC from Pedobacter heparinus;2.2;CA;CALCIUM ION;Heparinase III protein;984;
4MMI;A;Crystal structure of heparan sulfate lyase HepC mutant from Pedobacter heparinus;2.4;CA;CALCIUM ION;Heparinase III protein;984;
4MN0;A;Spatial structure of the novel light-sensitive photoprotein berovin from the ctenophore Beroe abyssicola in the Ca2+-loaded apoprotein conformation state;1.9;CA;CALCIUM ION;Berovin;320166;
4MPJ;A;Phosphorylation of an active site threonine in the benzyolformate decarboxylase mutant S26T by phosphonate inactivation;1.5;CA;CALCIUM ION;Benzoylformate decarboxylase;303;
4MPP;A;Crystal Structure of Benzoylformate Decarboxylase Mutant H281Y/T377P/F397T/A460I;1.5;CA;CALCIUM ION;Benzoylformate decarboxylase;303;
4MPR;A;Benzoylformate Decarboxylase: Is the tetramer vital for activity?;1.4;CA;CALCIUM ION;Benzoylformate decarboxylase;303;
4MQ5;A;Crystal Structure of Benzoylformate Decarboxylase Mutant A306F;1.5;CA;CALCIUM ION;Benzoylformate decarboxylase;303;
4MR0;A;Crystal structure of PfbA, a surface adhesin of Streptococcus pneumoniae;1.95;CA;CALCIUM ION;Plasmin and fibronectin-binding protein A;1313;
4MR0;B;Crystal structure of PfbA, a surface adhesin of Streptococcus pneumoniae;1.95;CA;CALCIUM ION;Plasmin and fibronectin-binding protein A;1313;
4MRB;A;Wild Type Human Transthyretin pH 7.5;1.27;CA;CALCIUM ION;Transthyretin;9606;
4MRB;B;Wild Type Human Transthyretin pH 7.5;1.27;CA;CALCIUM ION;Transthyretin;9606;
4MRC;A;Human Transthyretin Ser52Pro Mutant;1.54;CA;CALCIUM ION;Transthyretin;9606;
4MRC;B;Human Transthyretin Ser52Pro Mutant;1.54;CA;CALCIUM ION;Transthyretin;9606;
4MRY;A;Crystal Structure of Ca(2+)- discharged Y138F obelin mutant from Obelia longissima at 1.30 Angstrom resolution;1.3;CA;CALCIUM ION;Obelin;32570;
4MS2;A;Structural basis of Ca2+ selectivity of a voltage-gated calcium channel;2.75;CA;CALCIUM ION;Ion transport protein;28197;
4MS2;D;Structural basis of Ca2+ selectivity of a voltage-gated calcium channel;2.75;CA;CALCIUM ION;Ion transport protein;28197;
4MSF;A;Crystal structure of the complex of goat lactoperoxidase with 3-hydroxymethyl phenol at 1.98 Angstrom resolution;1.98;CA;CALCIUM ION;Lactoperoxidase;9925;
4MSP;A;Crystal structure of human peptidyl-prolyl cis-trans isomerase FKBP22 (aka FKBP14) containing two EF-hand motifs;1.9;CA;CALCIUM ION;Peptidyl-prolyl cis-trans isomerase FKBP14;9606;
4MSP;B;Crystal structure of human peptidyl-prolyl cis-trans isomerase FKBP22 (aka FKBP14) containing two EF-hand motifs;1.9;CA;CALCIUM ION;Peptidyl-prolyl cis-trans isomerase FKBP14;9606;
4MTB;A;Bovine trypsin in complex with small molecule inhibitor;1.22;CA;CALCIUM ION;Cationic trypsin;9913;
4MTF;A;Structural Basis of Ca2+ Selectivity of a Voltage-gated Calcium Channel;3.2;CA;CALCIUM ION;Ion transport protein;28197;
4MTF;C;Structural Basis of Ca2+ Selectivity of a Voltage-gated Calcium Channel;3.2;CA;CALCIUM ION;Ion transport protein;28197;
4MTG;A;Structural Basis for Ca2+ Selectivity of a Voltage-gated Calcium Channel;3.3;CA;CALCIUM ION;Ion transport protein;28197;
4MTO;A;Structural Basis for Ca2+ Selectivity of a Voltage-gated Calcium Channel;3.4;CA;CALCIUM ION;Ion transport protein;28197;
4MTO;B;Structural Basis for Ca2+ Selectivity of a Voltage-gated Calcium Channel;3.4;CA;CALCIUM ION;Ion transport protein;28197;
4MTW;E;Thermolysin in complex with UBTLN36;1.32;CA;CALCIUM ION;Thermolysin;1427;
4MVF;A;Crystal Structure of Plasmodium falciparum CDPK2 complexed with inhibitor staurosporine;2;CA;CALCIUM ION;Calcium-dependent protein kinase 2;5833;
4MVM;A;Structural Basis for Ca2+ Selectivity of a Voltage-gated Calcium Channel;3.2;CA;CALCIUM ION;Ion transport protein;28197;
4MVM;C;Structural Basis for Ca2+ Selectivity of a Voltage-gated Calcium Channel;3.2;CA;CALCIUM ION;Ion transport protein;28197;
4MVO;A;Structural Basis for Ca2+ Selectivity of a Voltage-gated Calcium Channel;3.3;CA;CALCIUM ION;Ion transport protein;28197;
4MVO;B;Structural Basis for Ca2+ Selectivity of a Voltage-gated Calcium Channel;3.3;CA;CALCIUM ION;Ion transport protein;28197;
4MVQ;A;Structural Basis for Ca2+ Selectivity of a Voltage-gated Calcium Channel;3.4;CA;CALCIUM ION;Ion transport protein;28197;
4MVU;C;Structural Basis for Ca2+ Selectivity of a Voltage-gated Calcium Channel;3.2;CA;CALCIUM ION;Ion transport protein;28197;
4MVU;D;Structural Basis for Ca2+ Selectivity of a Voltage-gated Calcium Channel;3.2;CA;CALCIUM ION;Ion transport protein;28197;
4MVZ;A;Structural Basis for Ca2+ Selectivity of a Voltage-gated Calcium Channel;3.3;CA;CALCIUM ION;Ion transport protein;28197;
4MVZ;C;Structural Basis for Ca2+ Selectivity of a Voltage-gated Calcium Channel;3.3;CA;CALCIUM ION;Ion transport protein;28197;
4MW3;A;Structural Basis for Ca2+ Selectivity of a Voltage-gated Calcium Channel;3.3;CA;CALCIUM ION;Ion transport protein;28197;
4MW3;B;Structural Basis for Ca2+ Selectivity of a Voltage-gated Calcium Channel;3.3;CA;CALCIUM ION;Ion transport protein;28197;
4MW8;A;Structural Basis for Ca2+ Selectivity of a Voltage-gated Calcium Channel;3.26;CA;CALCIUM ION;Ion transport protein;28197;
4MWJ;A;Anhui N9;1.8;CA;CALCIUM ION;Neuraminidase;11320;
4MWL;A;Shanghai N9;1.8;CA;CALCIUM ION;Neuraminidase;11320;
4MWP;E;Thermolysin in complex with UBTLN46;1.23;CA;CALCIUM ION;Thermolysin;1427;
4MWQ;A;Anhui N9-oseltamivir carboxylate;2;CA;CALCIUM ION;Neuraminidase;11320;
4MWR;A;Anhui N9-zanamivir;1.8;CA;CALCIUM ION;Neuraminidase;11320;
4MWU;A;Anhui N9-laninamivir;1.8;CA;CALCIUM ION;Neuraminidase;11320;
4MWV;A;Anhui N9-peramivir;2;CA;CALCIUM ION;Neuraminidase;11320;
4MWW;A;Shanghai N9-oseltamivir carboxylate;1.9;CA;CALCIUM ION;Neuraminidase;11320;
4MWX;A;Shanghai N9-zanamivir;1.8;CA;CALCIUM ION;Neuraminidase;11320;
4MWY;A;Shanghai N9-laninamivir;1.8;CA;CALCIUM ION;Neuraminidase;11320;
4MX0;A;Shanghai N9-peramivir;2.1;CA;CALCIUM ION;Neuraminidase;11320;
4MXJ;E;Thermolysin in complex with UBTLN35;1.35;CA;CALCIUM ION;Thermolysin;1427;
4MYE;A;Cymosema roseum seed lectin structure complexed with X-man;1.65;CA;CALCIUM ION;Cymbosema roseum mannose-specific lectin;202239;
4MZ0;A;Structure of a ketosynthase-acyltransferase di-domain from module CurL of the curacin A polyketide synthase;2.8;CA;CALCIUM ION;CurL;1155739;
4MZ0;B;Structure of a ketosynthase-acyltransferase di-domain from module CurL of the curacin A polyketide synthase;2.8;CA;CALCIUM ION;CurL;1155739;
4MZA;A;Crystal structure of hPIV3 hemagglutinin-neuraminidase;1.65;CA;CALCIUM ION;Hemagglutinin-neuraminidase;11216;
4MZA;B;Crystal structure of hPIV3 hemagglutinin-neuraminidase;1.65;CA;CALCIUM ION;Hemagglutinin-neuraminidase;11216;
4MZE;A;Crystal structure of hPIV3 hemagglutinin-neuraminidase, H552Q/Q559R mutant;1.8;CA;CALCIUM ION;Hemagglutinin-neuraminidase;11216;
4MZE;B;Crystal structure of hPIV3 hemagglutinin-neuraminidase, H552Q/Q559R mutant;1.8;CA;CALCIUM ION;Hemagglutinin-neuraminidase;11216;
4MZN;E;Thermolysin in complex with UBTLN59;1.17;CA;CALCIUM ION;Thermolysin;1427;
4MZX;A;Crystal Structure of Benzoylformate Decarboxylase Mutant T377L/A460Y;1.56;CA;CALCIUM ION;Benzoylformate decarboxlyase;303;
4N0B;D;Crystal structure of Bacillus subtilis GabR, an autorepressor and transcriptional activator of GabT;2.7;CA;CALCIUM ION;HTH-type transcriptional regulatory protein GabR;1423;
4N0O;A;Complex structure of Arterivirus nonstructural protein 10 (helicase) with DNA;2.65;CA;CALCIUM ION;Replicase polyprotein 1ab;2499620;
4N0O;C;Complex structure of Arterivirus nonstructural protein 10 (helicase) with DNA;2.65;CA;CALCIUM ION;Replicase polyprotein 1ab;2499620;
4N0O;E;Complex structure of Arterivirus nonstructural protein 10 (helicase) with DNA;2.65;CA;CALCIUM ION;Replicase polyprotein 1ab;2499620;
4N0O;G;Complex structure of Arterivirus nonstructural protein 10 (helicase) with DNA;2.65;CA;CALCIUM ION;Replicase polyprotein 1ab;2499620;
4N17;A;Crystal structure of a TRAP periplasmic solute binding protein from Burkholderia ambifaria (BAM_6123), Target EFI-510059, With bound beta-D-galacturonate;1.5;CA;CALCIUM ION;TRAP dicarboxylate transporter, DctP subunit;152480;
4N1G;A;Crystal Structure of Ca(2+)- discharged F88Y obelin mutant from Obelia longissima at 1.50 Angstrom resolution;1.5;CA;CALCIUM ION;Obelin;32570;
4N1G;B;Crystal Structure of Ca(2+)- discharged F88Y obelin mutant from Obelia longissima at 1.50 Angstrom resolution;1.5;CA;CALCIUM ION;Obelin;32570;
4N1I;A;Crystal Structure of the alpha-L-arabinofuranosidase UmAbf62A from Ustilago maidys;1;CA;CALCIUM ION;alpha-L-arabinofuranosidase UmAbf62A;5270;
4N20;A;Crystal structure of Protein Arginine Deiminase 2 (0 mM Ca2+);1.66;CA;CALCIUM ION;Protein-arginine deiminase type-2;9606;
4N22;A;Crystal structure of Protein Arginine Deiminase 2 (50 uM Ca2+);1.89;CA;CALCIUM ION;Protein-arginine deiminase type-2;9606;
4N24;A;Crystal structure of Protein Arginine Deiminase 2 (100 uM Ca2+);1.97;CA;CALCIUM ION;Protein-arginine deiminase type-2;9606;
4N25;A;Crystal structure of Protein Arginine Deiminase 2 (250 uM Ca2+);1.93;CA;CALCIUM ION;Protein-arginine deiminase type-2;9606;
4N26;A;Crystal structure of Protein Arginine Deiminase 2 (500 uM Ca2+);1.94;CA;CALCIUM ION;Protein-arginine deiminase type-2;9606;
4N28;A;Crystal structure of Protein Arginine Deiminase 2 (1 mM Ca2+);1.88;CA;CALCIUM ION;Protein-arginine deiminase type-2;9606;
4N2A;A;Crystal structure of Protein Arginine Deiminase 2 (5 mM Ca2+);1.7;CA;CALCIUM ION;Protein-arginine deiminase type-2;9606;
4N2B;A;Crystal structure of Protein Arginine Deiminase 2 (10 mM Ca2+);1.69;CA;CALCIUM ION;Protein-arginine deiminase type-2;9606;
4N2C;A;Crystal structure of Protein Arginine Deiminase 2 (F221/222A, 10 mM Ca2+);3.02;CA;CALCIUM ION;Protein-arginine deiminase type-2;9606;
4N2D;A;Crystal structure of Protein Arginine Deiminase 2 (D123N, 0 mM Ca2+);2;CA;CALCIUM ION;Protein-arginine deiminase type-2;9606;
4N2E;A;Crystal structure of Protein Arginine Deiminase 2 (D123N, 10 mM Ca2+);1.86;CA;CALCIUM ION;Protein-arginine deiminase type-2;9606;
4N2F;A;Crystal structure of Protein Arginine Deiminase 2 (D169A, 0 mM Ca2+);1.8;CA;CALCIUM ION;Protein-arginine deiminase type-2;9606;
4N2G;A;Crystal structure of Protein Arginine Deiminase 2 (D169A, 10 mM Ca2+);1.85;CA;CALCIUM ION;Protein-arginine deiminase type-2;9606;
4N2H;A;Crystal structure of Protein Arginine Deiminase 2 (D177A, 0 mM Ca2+);1.81;CA;CALCIUM ION;Protein-arginine deiminase type-2;9606;
4N2I;A;Crystal structure of Protein Arginine Deiminase 2 (D177A, 10 mM Ca2+);1.9;CA;CALCIUM ION;Protein-arginine deiminase type-2;9606;
4N2K;A;Crystal structure of Protein Arginine Deiminase 2 (Q350A, 0 mM Ca2+);1.57;CA;CALCIUM ION;Protein-arginine deiminase type-2;9606;
4N2L;A;Crystal structure of Protein Arginine Deiminase 2 (Q350A, 10 mM Ca2+);2.1;CA;CALCIUM ION;Protein-arginine deiminase type-2;9606;
4N2M;A;Crystal structure of Protein Arginine Deiminase 2 (E354A, 0 mM Ca2+);1.6;CA;CALCIUM ION;Protein-arginine deiminase type-2;9606;
4N2N;A;Crystal structure of Protein Arginine Deiminase 2 (E354A, 10 mM Ca2+);1.8;CA;CALCIUM ION;Protein-arginine deiminase type-2;9606;
4N2P;A;Structure of Archease from Pyrococcus horikoshii;1.43;CA;CALCIUM ION;Protein archease;53953;
4N2P;C;Structure of Archease from Pyrococcus horikoshii;1.43;CA;CALCIUM ION;Protein archease;53953;
4N2R;A;Crystal Structure of the alpha-L-arabinofuranosidase UmAbf62A from Ustilago maydis in complex with L-arabinofuranose;1.2;CA;CALCIUM ION;alpha-L-arabinofuranosidase UmAbf62A;5270;
4N2Z;A;Crystal Structure of the alpha-L-arabinofuranosidase PaAbf62A from Podospora anserina in complex with cellotriose;1.8;CA;CALCIUM ION;GH62 arabinofuranosidase;5145;
4N32;A;Structure of langerin CRD with alpha-Me-GlcNAc.;1.75;CA;CALCIUM ION;C-type lectin domain family 4 member K;9606;
4N32;B;Structure of langerin CRD with alpha-Me-GlcNAc.;1.75;CA;CALCIUM ION;C-type lectin domain family 4 member K;9606;
4N32;C;Structure of langerin CRD with alpha-Me-GlcNAc.;1.75;CA;CALCIUM ION;C-type lectin domain family 4 member K;9606;
4N32;D;Structure of langerin CRD with alpha-Me-GlcNAc.;1.75;CA;CALCIUM ION;C-type lectin domain family 4 member K;9606;
4N33;A;Structure of langerin CRD complexed with GlcNAc-beta1-3Gal-beta1-4Glc-beta-CH2CH2N3;1.85;CA;CALCIUM ION;C-type lectin domain family 4 member K;9606;
4N33;B;Structure of langerin CRD complexed with GlcNAc-beta1-3Gal-beta1-4Glc-beta-CH2CH2N3;1.85;CA;CALCIUM ION;C-type lectin domain family 4 member K;9606;
4N33;C;Structure of langerin CRD complexed with GlcNAc-beta1-3Gal-beta1-4Glc-beta-CH2CH2N3;1.85;CA;CALCIUM ION;C-type lectin domain family 4 member K;9606;
4N33;D;Structure of langerin CRD complexed with GlcNAc-beta1-3Gal-beta1-4Glc-beta-CH2CH2N3;1.85;CA;CALCIUM ION;C-type lectin domain family 4 member K;9606;
4N34;A;Structure of langerin CRD I313 with alpha-MeGlcNAc;1.75;CA;CALCIUM ION;C-type lectin domain family 4 member K;9606;
4N34;B;Structure of langerin CRD I313 with alpha-MeGlcNAc;1.75;CA;CALCIUM ION;C-type lectin domain family 4 member K;9606;
4N34;C;Structure of langerin CRD I313 with alpha-MeGlcNAc;1.75;CA;CALCIUM ION;C-type lectin domain family 4 member K;9606;
4N34;D;Structure of langerin CRD I313 with alpha-MeGlcNAc;1.75;CA;CALCIUM ION;C-type lectin domain family 4 member K;9606;
4N35;A;Structure of langerin CRD I313 complexed with GlcNAc-beta1-3Gal-beta1-4Glc-beta-CH2CH2N3;1.85;CA;CALCIUM ION;C-type lectin domain family 4 member K;9606;
4N35;B;Structure of langerin CRD I313 complexed with GlcNAc-beta1-3Gal-beta1-4Glc-beta-CH2CH2N3;1.85;CA;CALCIUM ION;C-type lectin domain family 4 member K;9606;
4N35;C;Structure of langerin CRD I313 complexed with GlcNAc-beta1-3Gal-beta1-4Glc-beta-CH2CH2N3;1.85;CA;CALCIUM ION;C-type lectin domain family 4 member K;9606;
4N35;D;Structure of langerin CRD I313 complexed with GlcNAc-beta1-3Gal-beta1-4Glc-beta-CH2CH2N3;1.85;CA;CALCIUM ION;C-type lectin domain family 4 member K;9606;
4N36;A;Structure of langerin CRD I313 D288 complexed with Me-GlcNAc;1.85;CA;CALCIUM ION;C-type lectin domain family 4 member K;9606;
4N36;B;Structure of langerin CRD I313 D288 complexed with Me-GlcNAc;1.85;CA;CALCIUM ION;C-type lectin domain family 4 member K;9606;
4N36;C;Structure of langerin CRD I313 D288 complexed with Me-GlcNAc;1.85;CA;CALCIUM ION;C-type lectin domain family 4 member K;9606;
4N36;D;Structure of langerin CRD I313 D288 complexed with Me-GlcNAc;1.85;CA;CALCIUM ION;C-type lectin domain family 4 member K;9606;
4N37;A;Structure of langerin CRD I313 D288 complexed with Me-Man;2;CA;CALCIUM ION;C-type lectin domain family 4 member K;9606;
4N37;B;Structure of langerin CRD I313 D288 complexed with Me-Man;2;CA;CALCIUM ION;C-type lectin domain family 4 member K;9606;
4N37;C;Structure of langerin CRD I313 D288 complexed with Me-Man;2;CA;CALCIUM ION;C-type lectin domain family 4 member K;9606;
4N37;D;Structure of langerin CRD I313 D288 complexed with Me-Man;2;CA;CALCIUM ION;C-type lectin domain family 4 member K;9606;
4N38;A;Structure of langerin CRD I313 D288 complexed with GlcNAc-beta1-3Gal-beta1-4GlcNAc-beta-CH2CH2N3;2;CA;CALCIUM ION;C-type lectin domain family 4 member K;9606;
4N38;B;Structure of langerin CRD I313 D288 complexed with GlcNAc-beta1-3Gal-beta1-4GlcNAc-beta-CH2CH2N3;2;CA;CALCIUM ION;C-type lectin domain family 4 member K;9606;
4N38;C;Structure of langerin CRD I313 D288 complexed with GlcNAc-beta1-3Gal-beta1-4GlcNAc-beta-CH2CH2N3;2;CA;CALCIUM ION;C-type lectin domain family 4 member K;9606;
4N38;D;Structure of langerin CRD I313 D288 complexed with GlcNAc-beta1-3Gal-beta1-4GlcNAc-beta-CH2CH2N3;2;CA;CALCIUM ION;C-type lectin domain family 4 member K;9606;
4N3O;B;2.4 Angstrom Resolution Crystal Structure of Putative Sugar Kinase from Campylobacter jejuni.;2.4;CA;CALCIUM ION;Putative D-glycero-D-manno-heptose 7-phosphate kinase;197;
4N4B;A;Crystal Structure of the alpha-L-arabinofuranosidase PaAbf62A from Podospora anserina;1.44;CA;CALCIUM ION;GH62 arabinofuranosidase;5145;
4N4E;E;Thermolysin in complex with UBTLN58;1.13;CA;CALCIUM ION;Thermolysin;1427;
4N5H;X;Crystal structure of ESTERASE B from Lactobacillus Rhamnosis (HN001);1.71;CA;CALCIUM ION;Esterase/lipase;47715;
4N5P;E;Thermolysin in complex with UBTLN20;1.25;CA;CALCIUM ION;Thermolysin;1427;
4N5X;A;Crystal structure of N-terminal calmodulin-like Calcium sensor of human mitochondrial ATP-Mg/Pi carrier SCaMC1;2.1;CA;CALCIUM ION;Calcium-binding mitochondrial carrier protein SCaMC-1;9606;
4N66;E;Thermolysin in complex with UBTLN37;1.44;CA;CALCIUM ION;Thermolysin;1427;
4N6F;A;Crystal structure of Amycolatopsis orientalis BexX complexed with G6P;2.25;CA;CALCIUM ION;Putative thiosugar synthase;31958;
4N6F;B;Crystal structure of Amycolatopsis orientalis BexX complexed with G6P;2.25;CA;CALCIUM ION;Putative thiosugar synthase;31958;
4N7A;A;Crystal structure of goat lactoperoxidase with 3-Amino pyrazole at 1.79 Angstrom resolution;1.79;CA;CALCIUM ION;Lactoperoxidase;9925;
4N7S;A;Crystal structure of Tse3-Tsi3 complex with Zinc ion;2.1;CA;CALCIUM ION;Uncharacterized protein;287;
4N7S;C;Crystal structure of Tse3-Tsi3 complex with Zinc ion;2.1;CA;CALCIUM ION;Uncharacterized protein;287;
4N80;A;Crystal structure of Tse3-Tsi3 complex;2.4;CA;CALCIUM ION;Uncharacterized protein;287;
4N85;A;Crystal structure of human transthyretin;1.6;CA;CALCIUM ION;Transthyretin;9606;
4N85;B;Crystal structure of human transthyretin;1.6;CA;CALCIUM ION;Transthyretin;9606;
4N86;A;Crystal structure of human transthyretin complexed with glabridin;2;CA;CALCIUM ION;Transthyretin;9606;
4N88;A;Crystal structure of Tse3-Tsi3 complex with calcium ion;2.8;CA;CALCIUM ION;Uncharacterized protein;287;
4N88;C;Crystal structure of Tse3-Tsi3 complex with calcium ion;2.8;CA;CALCIUM ION;Uncharacterized protein;287;
4N94;B;E. coli sliding clamp in complex with 3,4-difluorobenzamide;1.73;CA;CALCIUM ION;DNA polymerase III subunit beta;562;
4N95;A;E. coli sliding clamp in complex with 5-chloroindoline-2,3-dione;1.8;CA;CALCIUM ION;DNA polymerase III subunit beta;562;
4N96;A;E. coli sliding clamp in complex with 6-nitroindazole;1.7;CA;CALCIUM ION;DNA polymerase III subunit beta;562;
4N96;B;E. coli sliding clamp in complex with 6-nitroindazole;1.7;CA;CALCIUM ION;DNA polymerase III subunit beta;562;
4N97;A;E. coli sliding clamp in complex with 5-nitroindole;1.97;CA;CALCIUM ION;DNA polymerase III subunit beta;562;
4N98;A;E. coli sliding clamp in complex with 4'-fluorobiphenyl-4-carboxylic acid;1.7;CA;CALCIUM ION;DNA polymerase III subunit beta;562;
4N98;B;E. coli sliding clamp in complex with 4'-fluorobiphenyl-4-carboxylic acid;1.7;CA;CALCIUM ION;DNA polymerase III subunit beta;562;
4N99;A;E. coli sliding clamp in complex with 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-7-carboxylic acid;2.3;CA;CALCIUM ION;DNA polymerase III subunit beta;562;
4N99;B;E. coli sliding clamp in complex with 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-7-carboxylic acid;2.3;CA;CALCIUM ION;DNA polymerase III subunit beta;562;
4N9A;A;E. coli sliding clamp in complex with (R)-6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxylic acid;1.9;CA;CALCIUM ION;DNA polymerase III subunit beta;562;
4N9A;B;E. coli sliding clamp in complex with (R)-6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxylic acid;1.9;CA;CALCIUM ION;DNA polymerase III subunit beta;562;
4N9P;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS V23T/L25A/V99T at cryogenic temperature;1.4;CA;CALCIUM ION;Thermonuclease;1280;
4N9T;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS V66A/I92S at cryogenic temperature;1.6;CA;CALCIUM ION;Thermonuclease;1280;
4NA9;H;Factor VIIa in complex with the inhibitor 3'-amino-5'-[(2s,4r)-6-carbamimidoyl-4-phenyl-1,2,3,4-tetrahydroquinolin-2-yl]biphenyl-2-carboxylic acid;2.24;CA;CALCIUM ION;Coagulation factor VII heavy chain;9606;
4NAB;A;Structure of the (SR)Ca2+-ATPase mutant E309Q in the Ca2-E1-MgAMPPCP form;3.5;CA;CALCIUM ION;Sarcoplasmic/endoplasmic reticulum calcium ATPase 1;9986;
4NAM;A;1.7A structure of 5-Fluoro Tryptophan Labeled Protective Antigen (W206Y);1.7;CA;CALCIUM ION;Protective antigen;1392;
4NAS;A;The crystal structure of a rubisco-like protein (MtnW) from Alicyclobacillus acidocaldarius subsp. acidocaldarius DSM 446;1.92;CA;CALCIUM ION;Ribulose-bisphosphate carboxylase;405212;
4NAS;B;The crystal structure of a rubisco-like protein (MtnW) from Alicyclobacillus acidocaldarius subsp. acidocaldarius DSM 446;1.92;CA;CALCIUM ION;Ribulose-bisphosphate carboxylase;405212;
4NAS;C;The crystal structure of a rubisco-like protein (MtnW) from Alicyclobacillus acidocaldarius subsp. acidocaldarius DSM 446;1.92;CA;CALCIUM ION;Ribulose-bisphosphate carboxylase;405212;
4NAS;D;The crystal structure of a rubisco-like protein (MtnW) from Alicyclobacillus acidocaldarius subsp. acidocaldarius DSM 446;1.92;CA;CALCIUM ION;Ribulose-bisphosphate carboxylase;405212;
4NCY;A;In situ trypsin crystallized on a MiTeGen micromesh with imidazole ligand;1.42;CA;CALCIUM ION;Cationic trypsin;9913;
4NCZ;A;Spermidine N-acetyltransferase from Vibrio cholerae in complex with 2-[n-cyclohexylamino]ethane sulfonate.;1.89;CA;CALCIUM ION;Spermidine n1-acetyltransferase;666;
4NCZ;B;Spermidine N-acetyltransferase from Vibrio cholerae in complex with 2-[n-cyclohexylamino]ethane sulfonate.;1.89;CA;CALCIUM ION;Spermidine n1-acetyltransferase;666;
4NDB;A;X-ray structure of a mutant (T61D) of calexcitin - a neuronal calcium-signalling protein;2;CA;CALCIUM ION;Calexcitin;1051067;
4NDB;B;X-ray structure of a mutant (T61D) of calexcitin - a neuronal calcium-signalling protein;2;CA;CALCIUM ION;Calexcitin;1051067;
4NDC;A;X-ray structure of a mutant (T188D) of calexcitin - a neuronal calcium-signalling protein;2;CA;CALCIUM ION;Calexcitin;1051067;
4NDC;B;X-ray structure of a mutant (T188D) of calexcitin - a neuronal calcium-signalling protein;2;CA;CALCIUM ION;Calexcitin;1051067;
4NDD;A;X-ray structure of a double mutant of calexcitin - a neuronal calcium-signalling protein;2.9;CA;CALCIUM ION;Calexcitin;1051067;
4NDD;B;X-ray structure of a double mutant of calexcitin - a neuronal calcium-signalling protein;2.9;CA;CALCIUM ION;Calexcitin;1051067;
4NDX;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS I92N at cryogenic temperature;1.5;CA;CALCIUM ION;Thermonuclease;1280;
4NE9;D;PCSK9 in complex with LDLR peptide;2.6;CA;CALCIUM ION;Low-density lipoprotein receptor;9606;
4NEH;A;An internal ligand-bound, metastable state of a leukocyte integrin, aXb2;2.75;CA;CALCIUM ION;Integrin alpha-X;9606;
4NEH;B;An internal ligand-bound, metastable state of a leukocyte integrin, aXb2;2.75;CA;CALCIUM ION;Integrin beta-2;9606;
4NEN;A;An internal ligand-bound, metastable state of a leukocyte integrin, aXb2;2.9;CA;CALCIUM ION;Integrin alpha-X;9606;
4NEN;B;An internal ligand-bound, metastable state of a leukocyte integrin, aXb2;2.9;CA;CALCIUM ION;Integrin beta-2;9606;
4NG9;H;Factor viia in complex with the inhibitor (2R)-2-[(1-aminoisoquinolin-6-yl)amino]-2-[3-ethoxy-4-(propan-2-yloxy)phenyl]-n-(3-sulfamoylbenzyl)ethanamide;2.2;CA;CALCIUM ION;Factor VIIa (Heavy Chain);9606;
4NGA;H;Factor viia in complex with the inhibitor (2R)-2-[(1-aminoisoquinolin-6-yl)amino]-2-[3-ethoxy-4-(propan-2-yloxy)phenyl]-N-[2-(propan-2-ylsulfonyl)benzyl]ethanamide;2.15;CA;CALCIUM ION;Factor VIIa (Heavy Chain);9606;
4NGM;A;Crystal Structure of Glutamate Carboxypeptidase II in a complex with urea-based inhibitor;1.84;CA;CALCIUM ION;Glutamate carboxypeptidase 2;9606;
4NGN;A;Crystal Structure of Glutamate Carboxypeptidase II in a complex with urea-based inhibitor;1.64;CA;CALCIUM ION;Glutamate carboxypeptidase 2;9606;
4NGP;A;Crystal Structure of Glutamate Carboxypeptidase II in a complex with urea-based inhibitor;1.63;CA;CALCIUM ION;Glutamate carboxypeptidase 2;9606;
4NGQ;A;Crystal Structure of Glutamate Carboxypeptidase II in a complex with urea-based inhibitor;2.08;CA;CALCIUM ION;Glutamate carboxypeptidase 2;9606;
4NGR;A;Crystal Structure of Glutamate Carboxypeptidase II in a complex with urea-based inhibitor;1.9;CA;CALCIUM ION;Glutamate carboxypeptidase 2;9606;
4NGS;A;Crystal Structure of Glutamate Carboxypeptidase II in a complex with urea-based inhibitor;1.68;CA;CALCIUM ION;Glutamate carboxypeptidase 2;9606;
4NGT;A;Crystal Structure of Glutamate Carboxypeptidase II in a complex with urea-based inhibitor;2.31;CA;CALCIUM ION;Glutamate carboxypeptidase 2;9606;
4NHD;A;Crystal structure of beta-ketoacyl-ACP synthase III (FabH) from Vibrio Cholerae in complex with Coenzyme A;1.78;CA;CALCIUM ION;3-oxoacyl-[acyl-carrier-protein] synthase 3 protein 1;666;
4NHD;B;Crystal structure of beta-ketoacyl-ACP synthase III (FabH) from Vibrio Cholerae in complex with Coenzyme A;1.78;CA;CALCIUM ION;3-oxoacyl-[acyl-carrier-protein] synthase 3 protein 1;666;
4NHD;C;Crystal structure of beta-ketoacyl-ACP synthase III (FabH) from Vibrio Cholerae in complex with Coenzyme A;1.78;CA;CALCIUM ION;3-oxoacyl-[acyl-carrier-protein] synthase 3 protein 1;666;
4NHD;D;Crystal structure of beta-ketoacyl-ACP synthase III (FabH) from Vibrio Cholerae in complex with Coenzyme A;1.78;CA;CALCIUM ION;3-oxoacyl-[acyl-carrier-protein] synthase 3 protein 1;666;
4NHF;B;Crystal structure of the soluble domain of TrwG Type IV secretion machinery from Bartonella grahamii;2;CA;CALCIUM ION;TrwG protein;33045;
4NHF;C;Crystal structure of the soluble domain of TrwG Type IV secretion machinery from Bartonella grahamii;2;CA;CALCIUM ION;TrwG protein;33045;
4NHF;E;Crystal structure of the soluble domain of TrwG Type IV secretion machinery from Bartonella grahamii;2;CA;CALCIUM ION;TrwG protein;33045;
4NHF;F;Crystal structure of the soluble domain of TrwG Type IV secretion machinery from Bartonella grahamii;2;CA;CALCIUM ION;TrwG protein;33045;
4NIV;A;Crystal structure of trypsiligase (K60E/N143H/Y151H/D189K trypsin) trigonal form;1;CA;CALCIUM ION;Cationic trypsin;9913;
4NIW;A;Crystal structure of trypsiligase (K60E/N143H/Y151H/D189K trypsin) orthorhombic form;1.31;CA;CALCIUM ION;Cationic trypsin;9913;
4NIX;A;Crystal structure of trypsiligase (K60E/N143H/Y151H/D189K trypsin) orthorhombic form, zinc-bound;1.3;CA;CALCIUM ION;Cationic trypsin;9913;
4NIY;A;Crystal structure of trypsiligase (K60E/N143H/Y151H/D189K trypsin) complexed to YRH-ecotin (M84Y/M85R/A86H ecotin);2.84;CA;CALCIUM ION;Cationic trypsin;9913;
4NIY;B;Crystal structure of trypsiligase (K60E/N143H/Y151H/D189K trypsin) complexed to YRH-ecotin (M84Y/M85R/A86H ecotin);2.84;CA;CALCIUM ION;Cationic trypsin;9913;
4NIY;C;Crystal structure of trypsiligase (K60E/N143H/Y151H/D189K trypsin) complexed to YRH-ecotin (M84Y/M85R/A86H ecotin);2.84;CA;CALCIUM ION;Cationic trypsin;9913;
4NIY;D;Crystal structure of trypsiligase (K60E/N143H/Y151H/D189K trypsin) complexed to YRH-ecotin (M84Y/M85R/A86H ecotin);2.84;CA;CALCIUM ION;Cationic trypsin;9913;
4NJB;A;Crystal structure of the complex of lactoperoxidase from bovine with 3,3-oxydipyridine at 2.31 A resolution;2.31;CA;CALCIUM ION;Lactoperoxidase;9913;
4NKL;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS V66A/I92Q at cryogenic temperature;1.6;CA;CALCIUM ION;Thermonuclease;1280;
4NLG;A;Y-family DNA polymerase chimera Dbh-Dpo4(243-245)-Dbh;2.4;CA;CALCIUM ION;DNA polymerase IV;2285;
4NMZ;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS V23Q/V66A at cryogenic temperature;1.7;CA;CALCIUM ION;Thermonuclease;1280;
4NN9;A;REFINED ATOMIC STRUCTURES OF N9 SUBTYPE INFLUENZA VIRUS NEURAMINIDASE AND ESCAPE MUTANTS;2.3;CA;CALCIUM ION;NEURAMINIDASE N9;11320;
4NOE;B;Crystal structure of DdrB bound to 30b ssDNA;2.2;CA;CALCIUM ION;Single-stranded DNA-binding protein DdrB;1299;
4NOE;D;Crystal structure of DdrB bound to 30b ssDNA;2.2;CA;CALCIUM ION;Single-stranded DNA-binding protein DdrB;1299;
4NOT;A;Crystal structure of Dioclea sclerocarpa lectin complexed with X-man;2.35;CA;CALCIUM ION;Lectin alpha chain;1176036;
4-nov;A;Xsa43E, a GH43 family enzyme from Butyrivibrio proteoclasticus;1.33;CA;CALCIUM ION;Xylosidase/arabinofuranosidase Xsa43E;43305;
4NP5;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS V66A/I92N at cryogenic temperature;1.5;CA;CALCIUM ION;Thermonuclease;1280;
4NPK;A;Extended-Synaptotagmin 2, C2A- and C2B-domains, calcium bound;2.55;CA;CALCIUM ION;Extended synaptotagmin-2;9606;
4NQQ;A;Crystal structure of mouse P-cadherin extracellular domains EC1-EC2;3.2;CA;CALCIUM ION;Cadherin-3;10090;
4NQQ;B;Crystal structure of mouse P-cadherin extracellular domains EC1-EC2;3.2;CA;CALCIUM ION;Cadherin-3;10090;
4NQQ;C;Crystal structure of mouse P-cadherin extracellular domains EC1-EC2;3.2;CA;CALCIUM ION;Cadherin-3;10090;
4NQQ;D;Crystal structure of mouse P-cadherin extracellular domains EC1-EC2;3.2;CA;CALCIUM ION;Cadherin-3;10090;
4NRE;A;The structure of human 15-lipoxygenase-2 with a substrate mimic;2.63;CA;CALCIUM ION;Arachidonate 15-lipoxygenase B;9606;
4NSD;A;Crystal Structure of CBARA1 in the Ca2+ Binding Form;2.7;CA;CALCIUM ION;Calcium uptake protein 1, mitochondrial;9606;
4NSD;B;Crystal Structure of CBARA1 in the Ca2+ Binding Form;2.7;CA;CALCIUM ION;Calcium uptake protein 1, mitochondrial;9606;
4NSY;B;Wild-type lysobacter enzymogenes lysc endoproteinase covalently inhibited by TLCK;1.1;CA;CALCIUM ION;Lysyl endopeptidase;69;
4NT0;A;Crystal structure of orotidine 5'-monophosphate decarboxylase from Methanobacterium thermoautotrophicum complexed with 3-deazauridine 5'-monophosphate;1.77;CA;CALCIUM ION;Orotidine 5'-phosphate decarboxylase;145262;
4NT0;B;Crystal structure of orotidine 5'-monophosphate decarboxylase from Methanobacterium thermoautotrophicum complexed with 3-deazauridine 5'-monophosphate;1.77;CA;CALCIUM ION;Orotidine 5'-phosphate decarboxylase;145262;
4NT3;A;Structure of the complex of bovine lactoperoxidase with 3,3'-dipyridyl ketone at 1.99 A resolution;1.99;CA;CALCIUM ION;Lactoperoxidase;9913;
4NUM;A;Crystal structure of mouse N-cadherin EC1-2 A78SI92M;3.3;CA;CALCIUM ION;Cadherin-2;10090;
4NUM;B;Crystal structure of mouse N-cadherin EC1-2 A78SI92M;3.3;CA;CALCIUM ION;Cadherin-2;10090;
4NUM;C;Crystal structure of mouse N-cadherin EC1-2 A78SI92M;3.3;CA;CALCIUM ION;Cadherin-2;10090;
4NUM;D;Crystal structure of mouse N-cadherin EC1-2 A78SI92M;3.3;CA;CALCIUM ION;Cadherin-2;10090;
4NUP;A;Crystal structure of mouse N-cadherin EC1-2 with AA insertion between residues 2 and 3;2.7;CA;CALCIUM ION;N-CADHERIN EC1-2;10090;
4NUP;B;Crystal structure of mouse N-cadherin EC1-2 with AA insertion between residues 2 and 3;2.7;CA;CALCIUM ION;N-CADHERIN EC1-2;10090;
4NUP;C;Crystal structure of mouse N-cadherin EC1-2 with AA insertion between residues 2 and 3;2.7;CA;CALCIUM ION;N-CADHERIN EC1-2;10090;
4NUQ;A;Crystal structure of mouse N-cadherin EC1-2 W2F;2.12;CA;CALCIUM ION;Cadherin-2;10090;
4NUY;A;Crystal structure of EndoS, an endo-beta-N-acetyl-glucosaminidase from Streptococcus pyogenes;2.61;CA;CALCIUM ION;Endo-beta-N-acetylglucosaminidase F2;1314;
4NUZ;A;Crystal structure of a glycosynthase mutant (D233Q) of EndoS, an endo-beta-N-acetyl-glucosaminidase from Streptococcus pyogenes;1.9;CA;CALCIUM ION;Endo-beta-N-acetylglucosaminidase F2;1314;
4NVR;A;2.22 Angstrom Resolution Crystal Structure of a Putative Acyltransferase from Salmonella enterica;2.22;CA;CALCIUM ION;Putative acyltransferase;28901;
4NVR;B;2.22 Angstrom Resolution Crystal Structure of a Putative Acyltransferase from Salmonella enterica;2.22;CA;CALCIUM ION;Putative acyltransferase;28901;
4NVR;C;2.22 Angstrom Resolution Crystal Structure of a Putative Acyltransferase from Salmonella enterica;2.22;CA;CALCIUM ION;Putative acyltransferase;28901;
4NVR;D;2.22 Angstrom Resolution Crystal Structure of a Putative Acyltransferase from Salmonella enterica;2.22;CA;CALCIUM ION;Putative acyltransferase;28901;
4NWO;A;Computationally Designed Two-Component Self-Assembling Tetrahedral Cage T33-15;2.8;CA;CALCIUM ION;Molybdenum cofactor biosynthesis protein MogA;70863;
4NWV;A;Crystal structure of Orsay virus-like particle;3.25;CA;CALCIUM ION;Capsid protein;977912;
4NWV;C;Crystal structure of Orsay virus-like particle;3.25;CA;CALCIUM ION;Capsid protein;977912;
4NWW;A;Crystal structure of an N-terminally truncated capsid protein mutant of Orsay virus;3.75;CA;CALCIUM ION;Capsid protein;977912;
4NWW;B;Crystal structure of an N-terminally truncated capsid protein mutant of Orsay virus;3.75;CA;CALCIUM ION;Capsid protein;977912;
4NWW;C;Crystal structure of an N-terminally truncated capsid protein mutant of Orsay virus;3.75;CA;CALCIUM ION;Capsid protein;977912;
4NY2;A;Structure of Vibrio cholerae chitin de-N-acetylase in complex with acetate ion (ACT) in P 21;1.88;CA;CALCIUM ION;Deacetylase DA1;666;
4NY2;B;Structure of Vibrio cholerae chitin de-N-acetylase in complex with acetate ion (ACT) in P 21;1.88;CA;CALCIUM ION;Deacetylase DA1;666;
4NYT;A;L-Ficolin Complexed to Phosphocholine;2.25;CA;CALCIUM ION;Ficolin-2;9606;
4NYT;B;L-Ficolin Complexed to Phosphocholine;2.25;CA;CALCIUM ION;Ficolin-2;9606;
4NYT;C;L-Ficolin Complexed to Phosphocholine;2.25;CA;CALCIUM ION;Ficolin-2;9606;
4NYU;A;Structure of Vibrio cholerae chitin de-N-acetylase in complex with acetate ion (ACT) in C 2 2 21;2.03;CA;CALCIUM ION;Deacetylase DA1;666;
4NZ1;A;Structure of Vibrio cholerae chitin de-N-acetylase in complex with DI(N-ACETYL-D-GLUCOSAMINE) (CBS) in P 21;2.05;CA;CALCIUM ION;Deacetylase DA1;666;
4NZ1;B;Structure of Vibrio cholerae chitin de-N-acetylase in complex with DI(N-ACETYL-D-GLUCOSAMINE) (CBS) in P 21;2.05;CA;CALCIUM ION;Deacetylase DA1;666;
4NZ4;A;Structure of Vibrio cholerae chitin de-N-acetylase in complex with 2-(ACETYLAMINO)-2-DEOXY-A-D-GLUCOPYRANOSE (NDG) and zinc ion;1.94;CA;CALCIUM ION;Deacetylase DA1;666;
4NZ4;B;Structure of Vibrio cholerae chitin de-N-acetylase in complex with 2-(ACETYLAMINO)-2-DEOXY-A-D-GLUCOPYRANOSE (NDG) and zinc ion;1.94;CA;CALCIUM ION;Deacetylase DA1;666;
4O03;A;Crystal structure of Ca2+ bound prothrombin deletion mutant residues 146-167;3.38;CA;CALCIUM ION;Prothrombin;9606;
4O1Q;A;Crystal Structure of the Q103N-MauG/pre-Methylamine Dehydrogenase Complex;2.59;CA;CALCIUM ION;Methylamine utilization protein MauG;266;
4O1Q;B;Crystal Structure of the Q103N-MauG/pre-Methylamine Dehydrogenase Complex;2.59;CA;CALCIUM ION;Methylamine utilization protein MauG;266;
4O1Y;A;Crystal structure of Porcine Pancreatic Phospholipase A2 in complex with 1-Naphthaleneacetic acid;2.5;CA;CALCIUM ION;Phospholipase A2, major isoenzyme;9823;
4O2A;A;Tubulin-BAL27862 complex;2.5;CA;CALCIUM ION;Tubulin alpha-1B chain;9913;
4O2A;B;Tubulin-BAL27862 complex;2.5;CA;CALCIUM ION;Tubulin beta-2B chain;9913;
4O2A;C;Tubulin-BAL27862 complex;2.5;CA;CALCIUM ION;Tubulin alpha-1B chain;9913;
4O2A;E;Tubulin-BAL27862 complex;2.5;CA;CALCIUM ION;Stathmin-4;10116;
4O2B;A;Tubulin-Colchicine complex;2.3;CA;CALCIUM ION;Tubulin alpha-1B chain;9913;
4O2B;B;Tubulin-Colchicine complex;2.3;CA;CALCIUM ION;Tubulin beta-2B chain;9913;
4O2B;C;Tubulin-Colchicine complex;2.3;CA;CALCIUM ION;Tubulin alpha-1B chain;9913;
4O3M;A;Ternary complex of Bloom's syndrome helicase;2.3;CA;CALCIUM ION;Bloom syndrome protein;9606;
4O4H;A;Tubulin-Laulimalide complex;2.1;CA;CALCIUM ION;Tubulin alpha-1B chain;9913;
4O4H;B;Tubulin-Laulimalide complex;2.1;CA;CALCIUM ION;Tubulin beta-2B chain;9913;
4O4I;A;Tubulin-Laulimalide-Epothilone A complex;2.4;CA;CALCIUM ION;Tubulin alpha-1B chain;9913;
4O4I;B;Tubulin-Laulimalide-Epothilone A complex;2.4;CA;CALCIUM ION;Tubulin beta-2B chain;9913;
4O4I;C;Tubulin-Laulimalide-Epothilone A complex;2.4;CA;CALCIUM ION;Tubulin alpha-1B chain;9913;
4O4J;A;Tubulin-Peloruside A complex;2.2;CA;CALCIUM ION;Tubulin alpha-1B chain;9913;
4O4L;A;Tubulin-Peloruside A-Epothilone A complex;2.2;CA;CALCIUM ION;Tubulin alpha-1B chain;9913;
4O4L;B;Tubulin-Peloruside A-Epothilone A complex;2.2;CA;CALCIUM ION;Tubulin beta-2B chain;9913;
4O5M;A;X-ray Crystal Structure of Isovaleryl-CoA Dehydrogenase from Brucella suis;2.2;CA;CALCIUM ION;Isovaleryl-CoA dehydrogenase;29461;
4O6M;A;Structure of AF2299, a CDP-alcohol phosphotransferase (CMP-bound);1.9;CA;CALCIUM ION;AF2299, a CDP-alcohol phosphotransferase;2234;
4O6M;B;Structure of AF2299, a CDP-alcohol phosphotransferase (CMP-bound);1.9;CA;CALCIUM ION;AF2299, a CDP-alcohol phosphotransferase;2234;
4O6N;A;Structure of AF2299, a CDP-alcohol phosphotransferase (CDP-bound);2.1;CA;CALCIUM ION;AF2299, a CDP-alcohol phosphotransferase;2234;
4O6N;B;Structure of AF2299, a CDP-alcohol phosphotransferase (CDP-bound);2.1;CA;CALCIUM ION;AF2299, a CDP-alcohol phosphotransferase;2234;
4O8N;A;Crystal structure of SthAraf62A, a GH62 family alpha-L-arabinofuranosidase from Streptomyces thermoviolaceus, in the apoprotein form;1.65;CA;CALCIUM ION;Alpha-L-arabinofuranosidase;1952;
4O8O;A;Crystal structure of SthAraf62A, a GH62 family alpha-L-arabinofuranosidase from Streptomyces thermoviolaceus, bound to alpha-L-arabinose;1.21;CA;CALCIUM ION;Alpha-L-arabinofuranosidase;1952;
4O8P;A;Crystal structure of SthAraf62A, a GH62 family alpha-L-arabinofuranosidase from Streptomyces thermoviolaceus, bound to xylotetraose;1.56;CA;CALCIUM ION;Alpha-L-arabinofuranosidase;1952;
4OA3;A;Crystal structure of the BA42 protein from BIZIONIA ARGENTINENSIS;1.39;CA;CALCIUM ION;PROTEIN BA42;456455;
4OC0;A;X-ray structure of of human glutamate carboxypeptidase II (GCPII) in a complex with CCIBzL, a urea-based inhibitor N~2~-[(1-carboxycyclopropyl)carbamoyl]-N~6~-(4-iodobenzoyl)-L-lysine;1.85;CA;CALCIUM ION;Glutamate carboxypeptidase 2;9606;
4OC1;A;X-ray structure of of human glutamate carboxypeptidase II (GCPII) in a complex with COIBzL, a urea-based inhibitor (2S)-2-[({(1S)-1-carboxy-2-[(2S)-oxiran-2-yl]ethyl}carbamoyl)amino]-6-[(4-iodobenzoyl)amino]hexanoic acid;1.75;CA;CALCIUM ION;Glutamate carboxypeptidase 2;9606;
4OC2;A;X-ray structure of of human glutamate carboxypeptidase II (GCPII) in a complex with CEIBzL, a urea-based inhibitor N~2~-{[(1S)-1-carboxybut-3-yn-1-yl]carbamoyl}-N~6~-(4-iodobenzoyl)-L-lysine;1.65;CA;CALCIUM ION;Glutamate carboxypeptidase 2;9606;
4OC3;A;X-ray structure of of human glutamate carboxypeptidase II (GCPII) in a complex with CFIBzL, a urea-based inhibitor N~2~-{[(1S)-1-carboxy-2-(furan-2-yl)ethyl]carbamoyl}-N~6~-(4-iodobenzoyl)-L-lysine;1.79;CA;CALCIUM ION;Glutamate carboxypeptidase 2;9606;
4OC4;A;X-ray structure of of human glutamate carboxypeptidase II (GCPII) in a complex with CPIBzL, a urea-based inhibitor N~2~-{[(1S)-1-carboxy-2-(pyridin-4-yl)ethyl]carbamoyl}-N~6~-(4-iodobenzoyl)-L-lysine;1.66;CA;CALCIUM ION;Glutamate carboxypeptidase 2;9606;
4OC5;A;X-ray structure of of human glutamate carboxypeptidase II (GCPII) in a complex with CHIBzL, a urea-based inhibitor N~2~-{[(S)-carboxy(4-hydroxyphenyl)methyl]carbamoyl}-N~6~-(4-iodobenzoyl)-L-lysine;1.7;CA;CALCIUM ION;Glutamate carboxypeptidase 2;9606;
4OCI;A;Crystal Structure of Calcium Binding Protein-5 from Entamoeba histolytica and its involvement in initiation of phagocytosis of human erythrocytes;2.01;CA;CALCIUM ION;Calmodulin, putative;5759;
4ODG;A;Crystal structure of Staphylococcal nuclease variant V23I/V66I/V74I/V99I at cryogenic temperature;1.73;CA;CALCIUM ION;Thermonuclease;1280;
4ODP;A;Structure of SlyD delta-IF from Thermus thermophilus in complex with S2-W23A peptide;1.75;CA;CALCIUM ION;Peptidyl-prolyl cis-trans isomerase SlyD, Peptidyl-prolyl cis-trans isomerase FKBP1A chimera;2,749,606;
4ODQ;A;Structure of SlyD delta-IF from Thermus thermophilus in complex with S3 peptide;2;CA;CALCIUM ION;Peptidyl-prolyl cis-trans isomerase SlyD, Peptidyl-prolyl cis-trans isomerase FKBP1A chimera;2,749,606;
4OEK;A;Crystal Structure of the Complex of goat Lactoperoxidase with Phenylethylamine at 2.47 A Resolution;2.47;CA;CALCIUM ION;Lactoperoxidase;9925;
4OFQ;A;Structure of the C-terminal domain of the Streptococcus pyogenes antigen I/II-family protein AspA;1.8;CA;CALCIUM ION;Putative cell surface protein;1314;
4OFQ;B;Structure of the C-terminal domain of the Streptococcus pyogenes antigen I/II-family protein AspA;1.8;CA;CALCIUM ION;Putative cell surface protein;1314;
4OI5;E;Glycerol-free structure of thermolysin in complex with ubtln58;1.3;CA;CALCIUM ION;Thermolysin;1427;
4OJ4;A;Crystal structure of V290M PPARgamma mutant in complex with diclofenac;2.3;CA;CALCIUM ION;Peroxisome proliferator-activated receptor gamma;9606;
4OJQ;B;Crystal Structure of Hepatitis C Virus NS3 Helicase Inhibitor Co-complex with Fragment 1 [(5-bromo-1H-indol-3-yl)acetic acid];2.25;CA;CALCIUM ION;Serine protease NS3;11103;
4OK3;A;Crystal Structure of Hepatitis C Virus NS3 Helicase Inhibitor Co-complex with Compound 7 [[1-(3-chlorobenzyl)-1H-indol-3-yl]acetic acid];2.3;CA;CALCIUM ION;Serine protease NS3;11103;
4OK5;A;Crystal Structure of Hepatitis C Virus NS3 Helicase Inhibitor Co-complex with Compound 9 [1-(3-ethynylbenzyl)-1H-indol-3-yl]acetic acid];2.15;CA;CALCIUM ION;Serine protease NS3;11103;
4OK6;A;Crystal Structure of Hepatitis C Virus NS3 Helicase Inhibitor Co-complex with Compound 13 [[1-(2-methoxy-5-nitrobenzyl)-1H-indol-3-yl]acetic acid];2.4;CA;CALCIUM ION;Serine protease NS3;11103;
4OKH;A;Crystal structure of calpain-3 penta-EF-hand domain;2.45;CA;CALCIUM ION;Calpain-3;9606;
4OKH;B;Crystal structure of calpain-3 penta-EF-hand domain;2.45;CA;CALCIUM ION;Calpain-3;9606;
4OKH;C;Crystal structure of calpain-3 penta-EF-hand domain;2.45;CA;CALCIUM ION;Calpain-3;9606;
4OKS;A;Crystal Structure of Hepatitis C Virus NS3 Helicase Inhibitor Co-complex with Compound 19 [[6-(3,5-diaminophenyl)-1-(2-methoxy-5-nitrobenzyl)-1H-indol-3-yl]acetic acid];2.25;CA;CALCIUM ION;Serine protease NS3;11103;
4OL7;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS V66E A109E at cryogenic temperature;1.67;CA;CALCIUM ION;Thermonuclease;1280;
4OL7;B;Crystal structure of Staphylococcal nuclease variant Delta+PHS V66E A109E at cryogenic temperature;1.67;CA;CALCIUM ION;Thermonuclease;1280;
4OLK;A;The CHAP domain of LysGH15;2.69;CA;CALCIUM ION;Endolysin;1924732;
4OLK;B;The CHAP domain of LysGH15;2.69;CA;CALCIUM ION;Endolysin;1924732;
4OLL;A;cAMP-binding acyltransferase from Mycobacterium smegmatis;1.9;CA;CALCIUM ION;Acetyltransferase Pat;1772;
4OMC;A;X-ray structure of human furin in complex with the competitive inhibitor meta-guanidinomethyl-Phac-RVR-Amba;2.3;CA;CALCIUM ION;Furin;9606;
4OMC;B;X-ray structure of human furin in complex with the competitive inhibitor meta-guanidinomethyl-Phac-RVR-Amba;2.3;CA;CALCIUM ION;Furin;9606;
4OMC;C;X-ray structure of human furin in complex with the competitive inhibitor meta-guanidinomethyl-Phac-RVR-Amba;2.3;CA;CALCIUM ION;Furin;9606;
4OMC;D;X-ray structure of human furin in complex with the competitive inhibitor meta-guanidinomethyl-Phac-RVR-Amba;2.3;CA;CALCIUM ION;Furin;9606;
4OMC;E;X-ray structure of human furin in complex with the competitive inhibitor meta-guanidinomethyl-Phac-RVR-Amba;2.3;CA;CALCIUM ION;Furin;9606;
4OMC;F;X-ray structure of human furin in complex with the competitive inhibitor meta-guanidinomethyl-Phac-RVR-Amba;2.3;CA;CALCIUM ION;Furin;9606;
4OMD;A;X-ray structure of human furin in complex with the competitive inhibitor Phac-RVR-Amba;2.7;CA;CALCIUM ION;Furin;9606;
4OMD;B;X-ray structure of human furin in complex with the competitive inhibitor Phac-RVR-Amba;2.7;CA;CALCIUM ION;Furin;9606;
4OMD;C;X-ray structure of human furin in complex with the competitive inhibitor Phac-RVR-Amba;2.7;CA;CALCIUM ION;Furin;9606;
4OMD;D;X-ray structure of human furin in complex with the competitive inhibitor Phac-RVR-Amba;2.7;CA;CALCIUM ION;Furin;9606;
4OMD;E;X-ray structure of human furin in complex with the competitive inhibitor Phac-RVR-Amba;2.7;CA;CALCIUM ION;Furin;9606;
4OMD;F;X-ray structure of human furin in complex with the competitive inhibitor Phac-RVR-Amba;2.7;CA;CALCIUM ION;Furin;9606;
4OME;A;X-ray structure of human glutamate carboxypeptidase II in complex with DCCBL, a urea based inhibitor with distal carborane moiety;1.79;CA;CALCIUM ION;Glutamate carboxypeptidase 2;9606;
4ONU;A;cAMP-binding acyltransferase from Mycobacterium smegmatis, E234A mutant;2.25;CA;CALCIUM ION;Acetyltransferase Pat;1772;
4OP5;A;Crystal structure of stabilized TEM-1 beta-lactamase variant v.13 carrying R164S mutation;1.05;CA;CALCIUM ION;Extended spectrum beta-lactamase TEM-63;562;
4OP8;A;Room temperature crystal structure of stabilized TEM-1 beta-lactamase variant v.13 carrying G238S mutation;1.95;CA;CALCIUM ION;TEM-94 ES-beta-lactamase;562;
4OPQ;A;Room temperature crystal structure of stabilized TEM-1 beta-lactamase variant v.13 carrying R164S/G238S mutations;1.7;CA;CALCIUM ION;TEM-94 ES-beta-lactamase;562;
4OPR;A;Crystal structure of stabilized TEM-1 beta-lactamase variant v.13 carrying G238S mutation;1.45;CA;CALCIUM ION;TEM-94 ES-beta-lactamase;562;
4OPY;A;Room temperature crystal structure of stabilized TEM-1 beta-lactamase variant v.13 carrying R164S mutation;1.75;CA;CALCIUM ION;Extended spectrum beta-lactamase TEM-63;562;
4OPZ;A;Crystal structure of stabilized TEM-1 beta-lactamase variant v.13 carrying G238S mutation in complex with boron-based inhibitor EC25;1.45;CA;CALCIUM ION;TEM-94 ES-beta-lactamase;562;
4OQ0;A;Crystal structure of stabilized TEM-1 beta-lactamase variant v.13 carrying R164S/G238S mutation in complex with boron-based inhibitor EC25;1.42;CA;CALCIUM ION;TEM-94 ES-beta-lactamase;562;
4OQH;A;Crystal structure of stabilized TEM-1 beta-lactamase variant v.13 carrying R164S mutation in complex with boron-based inhibitor EC25;1.7;CA;CALCIUM ION;Extended spectrum beta-lactamase TEM-63;562;
4OQI;A;Crystal structure of stabilized TEM-1 beta-lactamase variant v.13 carrying R164S/G238S mutations;1.13;CA;CALCIUM ION;TEM-94 ES-beta-lactamase;562;
4OR9;B;Crystal structure of human calcineurin;2.23;CA;CALCIUM ION;Calcineurin subunit B type 1;9606;
4ORA;B;Crystal structure of a human calcineurin mutant;2.75;CA;CALCIUM ION;Calcineurin subunit B type 1;9606;
4ORB;B;Crystal structure of mouse calcineurin;3.11;CA;CALCIUM ION;Calcineurin subunit B type 1;10090;
4ORC;B;Crystal structure of mammalian calcineurin;2.7;CA;CALCIUM ION;Calcineurin subunit B type 1;9606;
4OSG;C;Klebsiella pneumoniae complexed with NADPH and 6-ethyl-5-[(3R)-3-[3-methoxyl-5-(pyridine-4-yl)phenyl]but-1-yn-1-yl]pyrimidine-2,4-diamine (UCP1006);2.7;CA;CALCIUM ION;Dihydrofolate reductase;573;
4OSG;D;Klebsiella pneumoniae complexed with NADPH and 6-ethyl-5-[(3R)-3-[3-methoxyl-5-(pyridine-4-yl)phenyl]but-1-yn-1-yl]pyrimidine-2,4-diamine (UCP1006);2.7;CA;CALCIUM ION;Dihydrofolate reductase;573;
4OUL;A;Crystal structure of human Caprin-2 C1q domain;1.95;CA;CALCIUM ION;Caprin-2;9606;
4OUL;B;Crystal structure of human Caprin-2 C1q domain;1.95;CA;CALCIUM ION;Caprin-2;9606;
4OUL;D;Crystal structure of human Caprin-2 C1q domain;1.95;CA;CALCIUM ION;Caprin-2;9606;
4OUL;E;Crystal structure of human Caprin-2 C1q domain;1.95;CA;CALCIUM ION;Caprin-2;9606;
4OUS;A;Crystal structure of zebrafish Caprin-2 C1q domain;1.05;CA;CALCIUM ION;Caprin-2;7955;
4OV2;A;Crystal structure of C-terminally truncated Neuronal Calcium Sensor (NCS-1) from Rattus norvegicus;2.6;CA;CALCIUM ION;Neuronal calcium sensor 1;10116;
4OV2;B;Crystal structure of C-terminally truncated Neuronal Calcium Sensor (NCS-1) from Rattus norvegicus;2.6;CA;CALCIUM ION;Neuronal calcium sensor 1;10116;
4OV2;C;Crystal structure of C-terminally truncated Neuronal Calcium Sensor (NCS-1) from Rattus norvegicus;2.6;CA;CALCIUM ION;Neuronal calcium sensor 1;10116;
4OV2;D;Crystal structure of C-terminally truncated Neuronal Calcium Sensor (NCS-1) from Rattus norvegicus;2.6;CA;CALCIUM ION;Neuronal calcium sensor 1;10116;
4OVD;A;Crystal structure of a putative peptidoglycan glycosyltransferase from Atopobium parvulum DSM 20469;2;CA;CALCIUM ION;Peptidoglycan glycosyltransferase;1382;
4OVE;A;X-ray Crystal Structure of Mouse Netrin-1;2.64;CA;CALCIUM ION;Netrin-1;10090;
4OVF;A;E. coli sliding clamp in complex with (R)-6-chloro-2,3,4,9-tetrahydro-1H-carbazole-2-carboxylic acid;2.05;CA;CALCIUM ION;DNA polymerase III subunit beta;562;
4OVF;B;E. coli sliding clamp in complex with (R)-6-chloro-2,3,4,9-tetrahydro-1H-carbazole-2-carboxylic acid;2.05;CA;CALCIUM ION;DNA polymerase III subunit beta;562;
4OVG;A;E. coli sliding clamp in complex with (R)-9-(2-amino-2-oxoethyl)-6-chloro-2,3,4,9-tetrahydro-1H-carbazole-2-carboxylic acid;1.9;CA;CALCIUM ION;DNA polymerase III subunit beta;562;
4OVH;A;E. coli sliding clamp in complex with (R)-6-bromo-9-(2-(carboxymethylamino)-2-oxoethyl)-2,3,4,9-tetrahydro-1H-carbazole-2-carboxylic acid;2.25;CA;CALCIUM ION;DNA polymerase III subunit beta;562;
4OVY;A;Crystal structure of Haloacid dehalogenase domain protein hydrolase from Planctomyces limnophilus DSM 3776;1.8;CA;CALCIUM ION;Haloacid dehalogenase domain protein hydrolase;120;
4OW3;A;Thermolysin structure determined by free-electron laser;2.1;CA;CALCIUM ION;Thermolysin;1427;
4OY7;B;Structure of cellulose active LPMO CelS2 (ScLPMO10C) in complex with Copper.;1.5;CA;CALCIUM ION;Putative secreted cellulose binding protein;1902;
4OY7;E;Structure of cellulose active LPMO CelS2 (ScLPMO10C) in complex with Copper.;1.5;CA;CALCIUM ION;Putative secreted cellulose binding protein;1902;
4OY7;G;Structure of cellulose active LPMO CelS2 (ScLPMO10C) in complex with Copper.;1.5;CA;CALCIUM ION;Putative secreted cellulose binding protein;1902;
4OY7;H;Structure of cellulose active LPMO CelS2 (ScLPMO10C) in complex with Copper.;1.5;CA;CALCIUM ION;Putative secreted cellulose binding protein;1902;
4OY9;A;Crystal structure of human P-Cadherin EC1-EC2 in closed conformation;1.62;CA;CALCIUM ION;Cadherin-3;9606;
4OYX;A;Human solAC Complexed with AMPCPP;1.89;CA;CALCIUM ION;Adenylate cyclase type 10;9606;
4OZG;C;D2 protein complex;3;CA;CALCIUM ION;HLA class II histocompatibility antigen, DQ alpha 1 chain;9606;
4OZH;G;S16 protein complex;2.8;CA;CALCIUM ION;T-cell receptor, s16, alpha chain;9606;
4OZI;B;S2 protein complex;3.2;CA;CALCIUM ION;HLA class II histocompatibility antigen, DQ beta 1 chain;9606;
4OZI;D;S2 protein complex;3.2;CA;CALCIUM ION;HLA class II histocompatibility antigen, DQ beta 1 chain;9606;
4P0D;A;The T6 backbone pilin of serotype M6 Streptococcus pyogenes has a modular three-domain structure decorated with variable loops and extensions;1.9;CA;CALCIUM ION;Trypsin-resistant surface T6 protein;1314;
4P14;A;Crystal structure of Canavalia brasiliensis (ConBr) complexed with adenine;2;CA;CALCIUM ION;Concanavalin-Br;61861;
4P2P;A;AN INDEPENDENT CRYSTALLOGRAPHIC REFINEMENT OF PORCINE PHOSPHOLIPASE A2 AT 2.4 ANGSTROMS RESOLUTION;2.4;CA;CALCIUM ION;PHOSPHOLIPASE A2;9823;
4P2Y;B;Crystal structure of the human RAGE ectodomain (fragment VC1C2) in complex with mouse S100A6;2.3;CA;CALCIUM ION;Protein S100-A6;10090;
4P3Q;A;Room-temperature WT DHFR, time-averaged ensemble;1.35;CA;CALCIUM ION;Dihydrofolate reductase;562;
4P43;A;Crystal structure of the bacterial A1408U-mutant ribosomal decoding site (C2 form 2);2;CA;CALCIUM ION;5'-R(*UP*UP*GP*CP*GP*UP*CP*UP*CP*GP*UP*CP*GP*AP*CP*GP*AP*AP*GP*UP*CP*GP*C)-3';32630;
4P43;B;Crystal structure of the bacterial A1408U-mutant ribosomal decoding site (C2 form 2);2;CA;CALCIUM ION;5'-R(*UP*UP*GP*CP*GP*UP*CP*UP*CP*GP*UP*CP*GP*AP*CP*GP*AP*AP*GP*UP*CP*GP*C)-3';32630;
4P44;A;X-ray structure of human glutamate carboxypeptidase II (GCPII) in complex with a phosphoramidate inhibitor JRB-4-81;1.75;CA;CALCIUM ION;Glutamate carboxypeptidase 2;9606;
4P45;A;X-ray structure of human glutamate carboxypeptidase II (GCPII) in complex with a phosphoramidate inhibitor JRB-4-73;1.87;CA;CALCIUM ION;Glutamate carboxypeptidase 2;9606;
4P4B;A;X-ray structure of human glutamate carboxypeptidase II (GCPII) in complex with a phosphoramidate inhibitor CTT54;1.93;CA;CALCIUM ION;Glutamate carboxypeptidase 2;9606;
4P4D;A;X-ray structure of human glutamate carboxypeptidase II (GCPII) in complex with a phosphoramidate inhibitor MP1C;1.65;CA;CALCIUM ION;Glutamate carboxypeptidase 2;9606;
4P4E;A;X-ray structure of human glutamate carboxypeptidase II (GCPII) in complex with a phosphoramidate inhibitor MP1D;1.67;CA;CALCIUM ION;Glutamate carboxypeptidase 2;9606;
4P4F;A;X-ray structure of human glutamate carboxypeptidase II (GCPII) in complex with a phosphoramidate inhibitor NC-2-40;1.86;CA;CALCIUM ION;Glutamate carboxypeptidase 2;9606;
4P4I;A;X-ray structure of human glutamate carboxypeptidase II (GCPII) in complex with a phosphoramidate inhibitor T33;1.87;CA;CALCIUM ION;Glutamate carboxypeptidase 2;9606;
4P4J;A;X-ray structure of human glutamate carboxypeptidase II (GCPII) in complex with a phosphoramidate inhibitor T33D;1.66;CA;CALCIUM ION;Glutamate carboxypeptidase 2;9606;
4P57;B;MHC TCR peptide complex;2.6;CA;CALCIUM ION;mim2 peptide,HLA class II histocompatibility antigen, DP beta 1 chain;9606;
4P57;D;MHC TCR peptide complex;2.6;CA;CALCIUM ION;mim2 peptide,HLA class II histocompatibility antigen, DP beta 1 chain;9606;
4P5E;B;CRYSTAL STRUCTURE OF HUMAN DNPH1 (RCL) WITH 6-NAPHTHYL-PURINE-RIBOSIDE-MONOPHOSPHATE;1.35;CA;CALCIUM ION;2'-deoxynucleoside 5'-phosphate N-hydrolase 1;9606;
4P5F;A;The crystal structure of type III effector protein XopQ complexed with adenosine diphosphate ribose;2.1;CA;CALCIUM ION;Inosine-uridine nucleoside N-ribohydrolase;347;
4P5F;B;The crystal structure of type III effector protein XopQ complexed with adenosine diphosphate ribose;2.1;CA;CALCIUM ION;Inosine-uridine nucleoside N-ribohydrolase;347;
4P5W;A;Structure of the N- and C-terminal domain fusion of the human mitochondrial aspartate/glutamate carrier Citrin in the calcium-bound state;2.4;CA;CALCIUM ION;Calcium-binding mitochondrial carrier protein Aralar2,Calcium-binding mitochondrial carrier protein Aralar2;9606;
4P5W;B;Structure of the N- and C-terminal domain fusion of the human mitochondrial aspartate/glutamate carrier Citrin in the calcium-bound state;2.4;CA;CALCIUM ION;Calcium-binding mitochondrial carrier protein Aralar2,Calcium-binding mitochondrial carrier protein Aralar2;9606;
4P5X;A;Structure of the N-terminal domain of the human mitochondrial aspartate/glutamate carrier Aralar in the calcium-bound state;2.26;CA;CALCIUM ION;Calcium-binding mitochondrial carrier protein Aralar1;9606;
4P5Y;A;Structure of CBM32-3 from a family 31 glycoside hydrolase from Clostridium perfringens in complex with N-acetylgalactosamine;2.5;CA;CALCIUM ION;Glycosyl hydrolase, family 31/fibronectin type III domain protein;1502;
4P66;A;Electrostatics of Active Site Microenvironments of E. coli DHFR;1.84;CA;CALCIUM ION;Dihydrofolate reductase;562;
4P68;A;Electrostatics of Active Site Microenvironments for E. coli DHFR;2.26;CA;CALCIUM ION;Dihydrofolate reductase;562;
4P6V;C;Crystal structure of the Na+-translocating NADH: ubiquinone oxidoreductase from Vibrio cholerae;3.5;CA;CALCIUM ION;Na(+)-translocating NADH-quinone reductase subunit C;666;
4P97;A;Functional conservation despite structural divergence in ligand-responsive RNA switches;1.86;CA;CALCIUM ION;RNA (5'-R(*CP*GP*UP*CP*UP*AP*CP*CP*CP*AP*CP*CP*UP*CP*GP*C)-3');390157;
4P97;C;Functional conservation despite structural divergence in ligand-responsive RNA switches;1.86;CA;CALCIUM ION;RNA (5'-R(*CP*GP*UP*CP*UP*AP*CP*CP*CP*AP*CP*CP*UP*CP*GP*C)-3');390157;
4P99;A;Ca2+-stabilized adhesin helps an Antarctic bacterium reach out and bind ice;1.8;CA;CALCIUM ION;MpAFP_RII tetra-tandemer;178399;
4P99;B;Ca2+-stabilized adhesin helps an Antarctic bacterium reach out and bind ice;1.8;CA;CALCIUM ION;MpAFP_RII tetra-tandemer;178399;
4P99;C;Ca2+-stabilized adhesin helps an Antarctic bacterium reach out and bind ice;1.8;CA;CALCIUM ION;MpAFP_RII tetra-tandemer;178399;
4P99;D;Ca2+-stabilized adhesin helps an Antarctic bacterium reach out and bind ice;1.8;CA;CALCIUM ION;MpAFP_RII tetra-tandemer;178399;
4P9W;A;Structure of ConA/Rh3Man;2.11;CA;CALCIUM ION;Concanavalin-A;3823;
4P9W;B;Structure of ConA/Rh3Man;2.11;CA;CALCIUM ION;Concanavalin-A;3823;
4P9W;C;Structure of ConA/Rh3Man;2.11;CA;CALCIUM ION;Concanavalin-A;3823;
4P9W;D;Structure of ConA/Rh3Man;2.11;CA;CALCIUM ION;Concanavalin-A;3823;
4P9X;A;Structure of ConA/Rh3Glu complex;2.06;CA;CALCIUM ION;Concanavalin-A;3823;
4P9X;B;Structure of ConA/Rh3Glu complex;2.06;CA;CALCIUM ION;Concanavalin-A;3823;
4P9X;C;Structure of ConA/Rh3Glu complex;2.06;CA;CALCIUM ION;Concanavalin-A;3823;
4P9X;D;Structure of ConA/Rh3Glu complex;2.06;CA;CALCIUM ION;Concanavalin-A;3823;
4P9Y;A;Structure of ConA/Rh4man;1.89;CA;CALCIUM ION;Concanavalin-A;3823;
4P9Y;B;Structure of ConA/Rh4man;1.89;CA;CALCIUM ION;Concanavalin-A;3823;
4PAL;A;IONIC INTERACTIONS WITH PARVALBUMINS. CRYSTAL STRUCTURE DETERMINATION OF PIKE 4.10 PARVALBUMIN IN FOUR DIFFERENT IONIC ENVIRONMENTS;1.8;CA;CALCIUM ION;PARVALBUMIN;8010;
4PBP;A;crystal structure of zebrafish short-chain pentraxin protein;1.65;CA;CALCIUM ION;C-reactive protein;7955;
4PBP;B;crystal structure of zebrafish short-chain pentraxin protein;1.65;CA;CALCIUM ION;C-reactive protein;7955;
4PBP;C;crystal structure of zebrafish short-chain pentraxin protein;1.65;CA;CALCIUM ION;C-reactive protein;7955;
4PBU;B;Serial Time-resolved crystallography of Photosystem II using a femtosecond X-ray laser The S1 state;5;CA;CALCIUM ION;Photosystem II core light harvesting protein;146786;
4PBU;F;Serial Time-resolved crystallography of Photosystem II using a femtosecond X-ray laser The S1 state;5;CA;CALCIUM ION;Cytochrome b559 subunit beta;146786;
4PBU;O;Serial Time-resolved crystallography of Photosystem II using a femtosecond X-ray laser The S1 state;5;CA;CALCIUM ION;Photosystem II manganese-stabilizing polypeptide;146786;
4PBU;b;Serial Time-resolved crystallography of Photosystem II using a femtosecond X-ray laser The S1 state;5;CA;CALCIUM ION;Photosystem II core light harvesting protein;146786;
4PBU;c;Serial Time-resolved crystallography of Photosystem II using a femtosecond X-ray laser The S1 state;5;CA;CALCIUM ION;Photosystem II CP43 protein;146786;
4PBU;f;Serial Time-resolved crystallography of Photosystem II using a femtosecond X-ray laser The S1 state;5;CA;CALCIUM ION;Cytochrome b559 subunit beta;146786;
4PBU;o;Serial Time-resolved crystallography of Photosystem II using a femtosecond X-ray laser The S1 state;5;CA;CALCIUM ION;Photosystem II manganese-stabilizing polypeptide;146786;
4PC0;A;Structure of the human RbAp48-MTA1(670-711) complex;2.5;CA;CALCIUM ION;Histone-binding protein RBBP4;9606;
4PC0;B;Structure of the human RbAp48-MTA1(670-711) complex;2.5;CA;CALCIUM ION;Histone-binding protein RBBP4;9606;
4PCR;A;Crystal structure of Canavalia brasiliensis seed lectin (ConBr) complexed with Gamma-Aminobutyric Acid (GABA);2.15;CA;CALCIUM ION;Concanavalin-Br;61861;
4PCR;D;Crystal structure of Canavalia brasiliensis seed lectin (ConBr) complexed with Gamma-Aminobutyric Acid (GABA);2.15;CA;CALCIUM ION;Concanavalin-Br;61861;
4PCW;A;Crystal Structure of the N-terminal Domain of Human Profilaggrin at 2.2 A Resolution;2.2;CA;CALCIUM ION;Filaggrin;9606;
4PCW;B;Crystal Structure of the N-terminal Domain of Human Profilaggrin at 2.2 A Resolution;2.2;CA;CALCIUM ION;Filaggrin;9606;
4PCW;C;Crystal Structure of the N-terminal Domain of Human Profilaggrin at 2.2 A Resolution;2.2;CA;CALCIUM ION;Filaggrin;9606;
4PCW;D;Crystal Structure of the N-terminal Domain of Human Profilaggrin at 2.2 A Resolution;2.2;CA;CALCIUM ION;Filaggrin;9606;
4PDZ;A;Crystal Structure of Calcium-loaded S100B bound to SBi4172;1.73;CA;CALCIUM ION;Protein S100-B;9913;
4PDZ;B;Crystal Structure of Calcium-loaded S100B bound to SBi4172;1.73;CA;CALCIUM ION;Protein S100-B;9913;
4PE0;A;Crystal Structure of Calcium-loaded S100B bound to SBi4434;1.08;CA;CALCIUM ION;Protein S100-B;9913;
4PE0;X;Crystal Structure of Calcium-loaded S100B bound to SBi4434;1.08;CA;CALCIUM ION;Protein S100-B;9913;
4PE1;A;Crystal Structure of Calcium-loaded S100B bound to SC124;1.58;CA;CALCIUM ION;Protein S100-B;9913;
4PE1;B;Crystal Structure of Calcium-loaded S100B bound to SC124;1.58;CA;CALCIUM ION;Protein S100-B;9913;
4PE4;A;Crystal Structure of Calcium-loaded S100B bound to SC1475;2.18;CA;CALCIUM ION;Protein S100-B;9913;
4PE4;X;Crystal Structure of Calcium-loaded S100B bound to SC1475;2.18;CA;CALCIUM ION;Protein S100-B;9913;
4PE7;A;Crystal Structure of Calcium-loaded S100B bound to SC1982;1.65;CA;CALCIUM ION;Protein S100-B;9913;
4PEL;A;S1C mutant of Penicillin G acylase from Kluyvera citrophila;2.8;CA;CALCIUM ION;Penicillin G acylase subunit alpha;580;
4PEL;C;S1C mutant of Penicillin G acylase from Kluyvera citrophila;2.8;CA;CALCIUM ION;Penicillin G acylase subunit alpha;580;
4PEL;E;S1C mutant of Penicillin G acylase from Kluyvera citrophila;2.8;CA;CALCIUM ION;Penicillin G acylase subunit alpha;580;
4PEL;G;S1C mutant of Penicillin G acylase from Kluyvera citrophila;2.8;CA;CALCIUM ION;Penicillin G acylase subunit alpha;580;
4PEM;A;Crystal Structure of S1G mutant of Penicillin G Acylase from Kluyvera citrophila;2.5;CA;CALCIUM ION;Penicillin G acylase Alpha;580;
4PET;A;CRYSTAL STRUCTURE OF A TRAP PERIPLASMIC SOLUTE BINDING PROTEIN FROM COLWELLIA PSYCHRERYTHRAEA (CPS_0129, TARGET EFI-510097) WITH BOUND CALCIUM AND PYRUVATE;1.9;CA;CALCIUM ION;Extracellular solute-binding protein, family 7;28229;
4PET;B;CRYSTAL STRUCTURE OF A TRAP PERIPLASMIC SOLUTE BINDING PROTEIN FROM COLWELLIA PSYCHRERYTHRAEA (CPS_0129, TARGET EFI-510097) WITH BOUND CALCIUM AND PYRUVATE;1.9;CA;CALCIUM ION;Extracellular solute-binding protein, family 7;28229;
4PEU;A;Structure of the polysaccharide lyase-like protein Cthe_2159 from C. thermocellum, native form with Calcium bound;1.8;CA;CALCIUM ION;Uncharacterized protein;1515;
4PHJ;A;The Structural Basis of Differential Inhibition of Human Calpain by Indole and Phenyl alpha-Mercaptoacrylic Acids: Human unliganded protein;1.6;CA;CALCIUM ION;Calpain small subunit 1;9606;
4PHJ;B;The Structural Basis of Differential Inhibition of Human Calpain by Indole and Phenyl alpha-Mercaptoacrylic Acids: Human unliganded protein;1.6;CA;CALCIUM ION;Calpain small subunit 1;9606;
4PHK;A;The Structural Basis of Differential Inhibition of Human Calpain by Indole and Phenyl alpha-Mercaptoacrylic Acids. The complex with (Z)-3-(4-chlorophenyl)-2-mercaptoacrylic acid;2.05;CA;CALCIUM ION;Calpain small subunit 1;9606;
4PHK;B;The Structural Basis of Differential Inhibition of Human Calpain by Indole and Phenyl alpha-Mercaptoacrylic Acids. The complex with (Z)-3-(4-chlorophenyl)-2-mercaptoacrylic acid;2.05;CA;CALCIUM ION;Calpain small subunit 1;9606;
4PHM;A;The Structural Basis of Differential Inhibition of Human Calpain by Indole and Phenyl alpha-Mercaptoacrylic Acids;2.03;CA;CALCIUM ION;Calpain small subunit 1;9606;
4PHM;B;The Structural Basis of Differential Inhibition of Human Calpain by Indole and Phenyl alpha-Mercaptoacrylic Acids;2.03;CA;CALCIUM ION;Calpain small subunit 1;9606;
4PHN;A;The Structural Basis of Differential Inhibition of Human Calpain by Indole and Phenyl alpha-Mercaptoacrylic Acids;1.79;CA;CALCIUM ION;Calpain small subunit 1;9823;
4PHN;B;The Structural Basis of Differential Inhibition of Human Calpain by Indole and Phenyl alpha-Mercaptoacrylic Acids;1.79;CA;CALCIUM ION;Calpain small subunit 1;9823;
4PIB;A;Crystal Structure of Uncharacterized Conserved Protein PixA from Burkholderia thailandensis;2;CA;CALCIUM ION;inclusion body protein;57975;
4PIB;B;Crystal Structure of Uncharacterized Conserved Protein PixA from Burkholderia thailandensis;2;CA;CALCIUM ION;inclusion body protein;57975;
4PIB;C;Crystal Structure of Uncharacterized Conserved Protein PixA from Burkholderia thailandensis;2;CA;CALCIUM ION;inclusion body protein;57975;
4PIB;D;Crystal Structure of Uncharacterized Conserved Protein PixA from Burkholderia thailandensis;2;CA;CALCIUM ION;inclusion body protein;57975;
4PIB;E;Crystal Structure of Uncharacterized Conserved Protein PixA from Burkholderia thailandensis;2;CA;CALCIUM ION;inclusion body protein;57975;
4PIB;F;Crystal Structure of Uncharacterized Conserved Protein PixA from Burkholderia thailandensis;2;CA;CALCIUM ION;inclusion body protein;57975;
4PIB;G;Crystal Structure of Uncharacterized Conserved Protein PixA from Burkholderia thailandensis;2;CA;CALCIUM ION;inclusion body protein;57975;
4PIB;H;Crystal Structure of Uncharacterized Conserved Protein PixA from Burkholderia thailandensis;2;CA;CALCIUM ION;inclusion body protein;57975;
4PIB;I;Crystal Structure of Uncharacterized Conserved Protein PixA from Burkholderia thailandensis;2;CA;CALCIUM ION;inclusion body protein;57975;
4PIB;J;Crystal Structure of Uncharacterized Conserved Protein PixA from Burkholderia thailandensis;2;CA;CALCIUM ION;inclusion body protein;57975;
4PIG;A;Crystal structure of the ubiquitin K11S mutant;1.95;CA;CALCIUM ION;Ubiquitin;9606;
4PIG;B;Crystal structure of the ubiquitin K11S mutant;1.95;CA;CALCIUM ION;Ubiquitin;9606;
4PIG;D;Crystal structure of the ubiquitin K11S mutant;1.95;CA;CALCIUM ION;Ubiquitin;9606;
4PIH;A;X-ray crystal structure of the K33S mutant of ubiquitin;1.5;CA;CALCIUM ION;Ubiquitin;9606;
4PIH;B;X-ray crystal structure of the K33S mutant of ubiquitin;1.5;CA;CALCIUM ION;Ubiquitin;9606;
4PJJ;B;MYOSIN VI (MD-INSERT2-CAM, DELTA-INSERT1) post-rigor state - long soaking with PO4;2.4;CA;CALCIUM ION;Calmodulin;7227;
4PJS;A;Crystal structure of designed (SeMet)-cPPR-NRE protein;2.6;CA;CALCIUM ION;Pentatricopeptide repeat protein;32644;
4PKG;A;Complex of ATP-actin With the N-terminal Actin-Binding Domain of Tropomodulin;1.8;CA;CALCIUM ION;Actin, alpha skeletal muscle;9986;
4PKG;G;Complex of ATP-actin With the N-terminal Actin-Binding Domain of Tropomodulin;1.8;CA;CALCIUM ION;Gelsolin,Tropomodulin-1 chimera;9606;
4PKH;A;Complex of ADP-actin With the N-terminal Actin-Binding Domain of Tropomodulin;2.15;CA;CALCIUM ION;Actin, alpha skeletal muscle;9986;
4PKH;B;Complex of ADP-actin With the N-terminal Actin-Binding Domain of Tropomodulin;2.15;CA;CALCIUM ION;Gelsolin,Tropomodulin-1 chimera;9606;
4PKH;D;Complex of ADP-actin With the N-terminal Actin-Binding Domain of Tropomodulin;2.15;CA;CALCIUM ION;Actin, alpha skeletal muscle;9986;
4PKH;E;Complex of ADP-actin With the N-terminal Actin-Binding Domain of Tropomodulin;2.15;CA;CALCIUM ION;Gelsolin,Tropomodulin-1 chimera;9606;
4PKH;F;Complex of ADP-actin With the N-terminal Actin-Binding Domain of Tropomodulin;2.15;CA;CALCIUM ION;Actin, alpha skeletal muscle;9986;
4PKH;G;Complex of ADP-actin With the N-terminal Actin-Binding Domain of Tropomodulin;2.15;CA;CALCIUM ION;Gelsolin,Tropomodulin-1 chimera;9606;
4PKH;I;Complex of ADP-actin With the N-terminal Actin-Binding Domain of Tropomodulin;2.15;CA;CALCIUM ION;Actin, alpha skeletal muscle;9986;
4PKH;J;Complex of ADP-actin With the N-terminal Actin-Binding Domain of Tropomodulin;2.15;CA;CALCIUM ION;Gelsolin,Tropomodulin-1 chimera;9606;
4PKI;A;Complex of ATP-actin With the C-terminal Actin-Binding Domain of Tropomodulin;2.3;CA;CALCIUM ION;Actin, alpha skeletal muscle;9986;
4PKI;G;Complex of ATP-actin With the C-terminal Actin-Binding Domain of Tropomodulin;2.3;CA;CALCIUM ION;Gelsolin,Tropomodulin-1 chimera;9606;
4PL7;A;Structure of Komagataella pastoris actin-thymosin beta4 hybrid;2.3;CA;CALCIUM ION;Actin,Thymosin beta-4;9,606,460,519;
4PL7;B;Structure of Komagataella pastoris actin-thymosin beta4 hybrid;2.3;CA;CALCIUM ION;Actin,Thymosin beta-4;9,606,460,519;
4PL8;A;Structure of rabbit skeletal muscle actin in complex with a hybrid peptide comprising thymosin beta4 and the lysine-rich region of Cordon-Bleu;2;CA;CALCIUM ION;Actin, alpha skeletal muscle;9986;
4PL8;B;Structure of rabbit skeletal muscle actin in complex with a hybrid peptide comprising thymosin beta4 and the lysine-rich region of Cordon-Bleu;2;CA;CALCIUM ION;Actin, alpha skeletal muscle;9986;
4PLM;A;Crystal Structure of Chicken Netrin-1 (LN-LE3);2.8;CA;CALCIUM ION;Netrin-1;9031;
4PLN;A;Crystal Structure of Chicken Netrin-1 (LN-LE3) complexed with mouse Neogenin (FN4-5);3.2;CA;CALCIUM ION;Netrin-1;9031;
4PLN;B;Crystal Structure of Chicken Netrin-1 (LN-LE3) complexed with mouse Neogenin (FN4-5);3.2;CA;CALCIUM ION;Netrin-1;9031;
4PLO;A;Crystal Structure of chicken Netrin-1 (LN-LE3) in complex with mouse DCC (FN4-5);2.9;CA;CALCIUM ION;Netrin-1;9031;
4PLR;A;Crystal Structures of Designed Armadillo Repeat Proteins: Implications of Construct Design and Crystallization Conditions on Overall Structure.;2.1;CA;CALCIUM ION;Arm00008;32630;
4PLR;B;Crystal Structures of Designed Armadillo Repeat Proteins: Implications of Construct Design and Crystallization Conditions on Overall Structure.;2.1;CA;CALCIUM ION;Arm00008;32630;
4PLS;A;Crystal Structures of Designed Armadillo Repeat Proteins: Implications of Construct Design and Crystallization Conditions on Overall Structure.;2.35;CA;CALCIUM ION;Arm00010;32630;
4PLS;B;Crystal Structures of Designed Armadillo Repeat Proteins: Implications of Construct Design and Crystallization Conditions on Overall Structure.;2.35;CA;CALCIUM ION;Arm00010;32630;
4PMB;A;Crystal structure of Staphylcoccal nuclease variant Delta+PHS I92S at cryogenic temperature;1.8;CA;CALCIUM ION;Thermonuclease;1280;
4PMC;A;Crystal structure of Staphylcoccal nuclease variant Delta+PHS I72K V74K at cryogenic temperature;1.65;CA;CALCIUM ION;Thermonuclease;1280;
4PMX;A;Crystal structure of GH10 endo-b-1,4-xylanase (XynB) from Xanthomonas axonopodis pv citri in the native form;1.3;CA;CALCIUM ION;Xylanase;346;
4PMY;A;Crystal structure of GH10 endo-b-1,4-xylanase (XynB) from Xanthomonas axonopodis pv citri complexed with xylose;1.6;CA;CALCIUM ION;Xylanase;346;
4PMY;B;Crystal structure of GH10 endo-b-1,4-xylanase (XynB) from Xanthomonas axonopodis pv citri complexed with xylose;1.6;CA;CALCIUM ION;Xylanase;346;
4PMZ;A;Crystal structure of GH10 endo-b-1,4-xylanase (XynB) from Xanthomonas axonopodis pv citri complexed with xylobiose;1.4;CA;CALCIUM ION;Xylanase;346;
4PMZ;B;Crystal structure of GH10 endo-b-1,4-xylanase (XynB) from Xanthomonas axonopodis pv citri complexed with xylobiose;1.4;CA;CALCIUM ION;Xylanase;346;
4PN2;A;Crystal structure of GH10 endo-b-1,4-xylanase (XynB) from Xanthomonas axonopodis pv citri complexed with xylotriose;1.42;CA;CALCIUM ION;Xylanase;346;
4PN2;B;Crystal structure of GH10 endo-b-1,4-xylanase (XynB) from Xanthomonas axonopodis pv citri complexed with xylotriose;1.42;CA;CALCIUM ION;Xylanase;346;
4PNU;A;E. coli sliding clamp in complex with (R)-6-bromo-9-(2-((R)-1-carboxy-2-phenylethylamino)-2-oxoethyl)-2,3,4,9-tetrahydro-1H-carbazole-2-carboxylic acid;1.9;CA;CALCIUM ION;DNA polymerase III subunit beta;562;
4PNV;A;E. coli sliding clamp apo-crystal in P21 space group with larger cell dimensions;1.86;CA;CALCIUM ION;DNA polymerase III subunit beta;562;
4PNV;B;E. coli sliding clamp apo-crystal in P21 space group with larger cell dimensions;1.86;CA;CALCIUM ION;DNA polymerase III subunit beta;562;
4PNW;A;E. coli sliding clamp in complex with (R)-6-bromo-9-(2-((S)-1-carboxy-2-phenylethylamino)-2-oxoethyl)-2,3,4,9-tetrahydro-1H-carbazole-2-carboxylic acid;2;CA;CALCIUM ION;DNA polymerase III subunit beta;562;
4PNW;B;E. coli sliding clamp in complex with (R)-6-bromo-9-(2-((S)-1-carboxy-2-phenylethylamino)-2-oxoethyl)-2,3,4,9-tetrahydro-1H-carbazole-2-carboxylic acid;2;CA;CALCIUM ION;DNA polymerase III subunit beta;562;
4PNX;A;Crystal structure of the complex of lactoperoxidase with bromo methane at 2.41 angstrom resolution;2.41;CA;CALCIUM ION;Lactoperoxidase;9913;
4PNY;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS I72H at cryogenic temperature;1.68;CA;CALCIUM ION;Thermonuclease;1280;
4POQ;A;Structure of unliganded VP1 pentamer of Human Polyomavirus 9;2;CA;CALCIUM ION;VP1;943908;
4POQ;B;Structure of unliganded VP1 pentamer of Human Polyomavirus 9;2;CA;CALCIUM ION;VP1;943908;
4POQ;C;Structure of unliganded VP1 pentamer of Human Polyomavirus 9;2;CA;CALCIUM ION;VP1;943908;
4POQ;D;Structure of unliganded VP1 pentamer of Human Polyomavirus 9;2;CA;CALCIUM ION;VP1;943908;
4POQ;E;Structure of unliganded VP1 pentamer of Human Polyomavirus 9;2;CA;CALCIUM ION;VP1;943908;
4POQ;F;Structure of unliganded VP1 pentamer of Human Polyomavirus 9;2;CA;CALCIUM ION;VP1;943908;
4POQ;G;Structure of unliganded VP1 pentamer of Human Polyomavirus 9;2;CA;CALCIUM ION;VP1;943908;
4POQ;H;Structure of unliganded VP1 pentamer of Human Polyomavirus 9;2;CA;CALCIUM ION;VP1;943908;
4POQ;I;Structure of unliganded VP1 pentamer of Human Polyomavirus 9;2;CA;CALCIUM ION;VP1;943908;
4POQ;J;Structure of unliganded VP1 pentamer of Human Polyomavirus 9;2;CA;CALCIUM ION;VP1;943908;
4POR;A;Structure of Human Polyomavirus 9 VP1 pentamer in complex with 3'-sialyllactose;2.09;CA;CALCIUM ION;VP1;943908;
4POR;B;Structure of Human Polyomavirus 9 VP1 pentamer in complex with 3'-sialyllactose;2.09;CA;CALCIUM ION;VP1;943908;
4POR;C;Structure of Human Polyomavirus 9 VP1 pentamer in complex with 3'-sialyllactose;2.09;CA;CALCIUM ION;VP1;943908;
4POR;D;Structure of Human Polyomavirus 9 VP1 pentamer in complex with 3'-sialyllactose;2.09;CA;CALCIUM ION;VP1;943908;
4POR;E;Structure of Human Polyomavirus 9 VP1 pentamer in complex with 3'-sialyllactose;2.09;CA;CALCIUM ION;VP1;943908;
4POR;F;Structure of Human Polyomavirus 9 VP1 pentamer in complex with 3'-sialyllactose;2.09;CA;CALCIUM ION;VP1;943908;
4POR;G;Structure of Human Polyomavirus 9 VP1 pentamer in complex with 3'-sialyllactose;2.09;CA;CALCIUM ION;VP1;943908;
4POR;H;Structure of Human Polyomavirus 9 VP1 pentamer in complex with 3'-sialyllactose;2.09;CA;CALCIUM ION;VP1;943908;
4POR;I;Structure of Human Polyomavirus 9 VP1 pentamer in complex with 3'-sialyllactose;2.09;CA;CALCIUM ION;VP1;943908;
4POR;J;Structure of Human Polyomavirus 9 VP1 pentamer in complex with 3'-sialyllactose;2.09;CA;CALCIUM ION;VP1;943908;
4POS;A;Structure of Human Polyomavirus 9 VP1 pentamer in complex with 3'-sialyllactosamine;2;CA;CALCIUM ION;VP1;943908;
4POS;B;Structure of Human Polyomavirus 9 VP1 pentamer in complex with 3'-sialyllactosamine;2;CA;CALCIUM ION;VP1;943908;
4POS;C;Structure of Human Polyomavirus 9 VP1 pentamer in complex with 3'-sialyllactosamine;2;CA;CALCIUM ION;VP1;943908;
4POS;D;Structure of Human Polyomavirus 9 VP1 pentamer in complex with 3'-sialyllactosamine;2;CA;CALCIUM ION;VP1;943908;
4POS;E;Structure of Human Polyomavirus 9 VP1 pentamer in complex with 3'-sialyllactosamine;2;CA;CALCIUM ION;VP1;943908;
4POS;F;Structure of Human Polyomavirus 9 VP1 pentamer in complex with 3'-sialyllactosamine;2;CA;CALCIUM ION;VP1;943908;
4POS;G;Structure of Human Polyomavirus 9 VP1 pentamer in complex with 3'-sialyllactosamine;2;CA;CALCIUM ION;VP1;943908;
4POS;H;Structure of Human Polyomavirus 9 VP1 pentamer in complex with 3'-sialyllactosamine;2;CA;CALCIUM ION;VP1;943908;
4POS;I;Structure of Human Polyomavirus 9 VP1 pentamer in complex with 3'-sialyllactosamine;2;CA;CALCIUM ION;VP1;943908;
4POS;J;Structure of Human Polyomavirus 9 VP1 pentamer in complex with 3'-sialyllactosamine;2;CA;CALCIUM ION;VP1;943908;
4POT;A;Structure of Human Polyomavirus 9 VP1 pentamer in complex with N-glycolylneuraminic acid containing 3'-sialyllactosamine;2.1;CA;CALCIUM ION;VP1;943908;
4POT;B;Structure of Human Polyomavirus 9 VP1 pentamer in complex with N-glycolylneuraminic acid containing 3'-sialyllactosamine;2.1;CA;CALCIUM ION;VP1;943908;
4POT;C;Structure of Human Polyomavirus 9 VP1 pentamer in complex with N-glycolylneuraminic acid containing 3'-sialyllactosamine;2.1;CA;CALCIUM ION;VP1;943908;
4POT;D;Structure of Human Polyomavirus 9 VP1 pentamer in complex with N-glycolylneuraminic acid containing 3'-sialyllactosamine;2.1;CA;CALCIUM ION;VP1;943908;
4POT;E;Structure of Human Polyomavirus 9 VP1 pentamer in complex with N-glycolylneuraminic acid containing 3'-sialyllactosamine;2.1;CA;CALCIUM ION;VP1;943908;
4POT;F;Structure of Human Polyomavirus 9 VP1 pentamer in complex with N-glycolylneuraminic acid containing 3'-sialyllactosamine;2.1;CA;CALCIUM ION;VP1;943908;
4POT;G;Structure of Human Polyomavirus 9 VP1 pentamer in complex with N-glycolylneuraminic acid containing 3'-sialyllactosamine;2.1;CA;CALCIUM ION;VP1;943908;
4POT;H;Structure of Human Polyomavirus 9 VP1 pentamer in complex with N-glycolylneuraminic acid containing 3'-sialyllactosamine;2.1;CA;CALCIUM ION;VP1;943908;
4POT;I;Structure of Human Polyomavirus 9 VP1 pentamer in complex with N-glycolylneuraminic acid containing 3'-sialyllactosamine;2.1;CA;CALCIUM ION;VP1;943908;
4POT;J;Structure of Human Polyomavirus 9 VP1 pentamer in complex with N-glycolylneuraminic acid containing 3'-sialyllactosamine;2.1;CA;CALCIUM ION;VP1;943908;
4PP1;A;The crystal structure of Der p 1 allergen complexed with Fab fragment of mAb 5H8;3;CA;CALCIUM ION;Peptidase 1;6956;
4PP1;B;The crystal structure of Der p 1 allergen complexed with Fab fragment of mAb 5H8;3;CA;CALCIUM ION;Peptidase 1;6956;
4PP2;E;The crystal structure of Der p 1 allergen complexed with Fab fragment of mAb 10B9;2.74;CA;CALCIUM ION;Peptidase 1;6956;
4PP2;F;The crystal structure of Der p 1 allergen complexed with Fab fragment of mAb 10B9;2.74;CA;CALCIUM ION;Peptidase 1;6956;
4PQI;A;Crystal structure of glutathione transferase lambda3 from Populus trichocarpa;1.95;CA;CALCIUM ION;In2-1 family protein, glutathione transferase lambda3;3694;
4PTF;A;Ternary crystal structure of yeast DNA polymerase epsilon with template G;2.81;CA;CALCIUM ION;DNA polymerase epsilon catalytic subunit A;4932;
4PTF;T;Ternary crystal structure of yeast DNA polymerase epsilon with template G;2.81;CA;CALCIUM ION;5'-D(*TP*AP*AP*GP*GP*TP*AP*GP*GP*GP*GP*AP*GP*GP*AP*T)-3';;
4PWD;A;Crystal structure of HIV-1 reverse transcriptase in complex with bulge-RNA/DNA and Nevirapine;3;CA;CALCIUM ION;HIV-1 Reverse Transcriptase, P66 subunit;11676;
4PWD;C;Crystal structure of HIV-1 reverse transcriptase in complex with bulge-RNA/DNA and Nevirapine;3;CA;CALCIUM ION;HIV-1 Reverse Transcriptase, P66 subunit;11676;
4PWG;A;Crystal structure of V30M mutant human transthyretin complexed with caffeic acid ethyl ester;1.8;CA;CALCIUM ION;Transthyretin;9606;
4PWH;A;Crystal structure of V30M mutant human transthyretin complexed with caffeic acid 1,1-dimethylallyl ester;1.8;CA;CALCIUM ION;Transthyretin;9606;
4PXG;A;Crystal Structure of TypeII restriction Enzyme Sau3AI;2.45;CA;CALCIUM ION;Type-2 restriction enzyme Sau3AI;1280;
4PXL;A;Structure of Zm ALDH2-3 (RF2C) in complex with NAD;2.25;CA;CALCIUM ION;Cytosolic aldehyde dehydrogenase RF2C;4577;
4PZ1;A;Crystal structure of a sHIP (UniProt Id: Q99XU0) mutant from Streptococcus pyogenes;1.73;CA;CALCIUM ION;sHIP;1314;
4PZL;A;The crystal structure of adenylate kinase from Francisella tularensis subsp. tularensis SCHU S4;2.1;CA;CALCIUM ION;Adenylate kinase;263;
4PZL;C;The crystal structure of adenylate kinase from Francisella tularensis subsp. tularensis SCHU S4;2.1;CA;CALCIUM ION;Adenylate kinase;263;
4Q0T;A;Free form of TvNiR, low dose data set;1.7;CA;CALCIUM ION;Eight-heme nitrite reductase;186931;
4Q0T;B;Free form of TvNiR, low dose data set;1.7;CA;CALCIUM ION;Eight-heme nitrite reductase;186931;
4Q0W;A;he catalytic core of Rad2 in complex with DNA substrate (complex II);2.1;CA;CALCIUM ION;DNA repair protein RAD2;4932;
4Q0W;B;he catalytic core of Rad2 in complex with DNA substrate (complex II);2.1;CA;CALCIUM ION;DNA repair protein RAD2;4932;
4Q0Z;A;The catalytic core of Rad2 in complex with DNA substrate (complex III);2.4;CA;CALCIUM ION;Rad2p;4932;
4Q0Z;B;The catalytic core of Rad2 in complex with DNA substrate (complex III);2.4;CA;CALCIUM ION;Rad2p;4932;
4Q0Z;E;The catalytic core of Rad2 in complex with DNA substrate (complex III);2.4;CA;CALCIUM ION;Rad2p;4932;
4Q0Z;F;The catalytic core of Rad2 in complex with DNA substrate (complex III);2.4;CA;CALCIUM ION;Rad2p;4932;
4Q10;A;The catalytic core of Rad2 in complex with DNA substrate (complex IV);2.7;CA;CALCIUM ION;DNA repair protein RAD2;4932;
4Q10;B;The catalytic core of Rad2 in complex with DNA substrate (complex IV);2.7;CA;CALCIUM ION;DNA repair protein RAD2;4932;
4Q17;A;Free form of TvNiR, middle dose data set;1.75;CA;CALCIUM ION;Eight-heme nitrite reductase;186931;
4Q17;B;Free form of TvNiR, middle dose data set;1.75;CA;CALCIUM ION;Eight-heme nitrite reductase;186931;
4Q1L;A;Crystal structure of Leucurolysin-a complexed with an endogenous tripeptide (QSW).;1.9;CA;CALCIUM ION;Snake venom metalloproteinase leucurolysin-A;157295;
4Q1O;A;Free form of TvNiR, high dose data set;1.75;CA;CALCIUM ION;Eight-heme nitrite reductase;186931;
4Q1O;B;Free form of TvNiR, high dose data set;1.75;CA;CALCIUM ION;Eight-heme nitrite reductase;186931;
4Q1U;A;Serum paraoxonase-1 by directed evolution with the K192Q mutation;2.3;CA;CALCIUM ION;Serum paraoxonase/arylesterase 1;37965;
4Q4U;A;TvNiR in complex with sulfite, low dose data set;1.62;CA;CALCIUM ION;Eight-heme nitrite reductase;186931;
4Q4U;B;TvNiR in complex with sulfite, low dose data set;1.62;CA;CALCIUM ION;Eight-heme nitrite reductase;186931;
4Q4W;1;High-resolution crystal structure of Coxsackievirus A24v;1.4;CA;CALCIUM ION;Coxsackievirus capsid protein VP1;138950;
4Q4W;2;High-resolution crystal structure of Coxsackievirus A24v;1.4;CA;CALCIUM ION;Coxsackievirus capsid protein VP2;138950;
4Q4X;1;Crystal structure of Coxsackievirus A24v soaked with 6'-Sialyllactose (6SL);1.65;CA;CALCIUM ION;Coxsackievirus capsid protein VP1;138950;
4Q4X;2;Crystal structure of Coxsackievirus A24v soaked with 6'-Sialyllactose (6SL);1.65;CA;CALCIUM ION;Coxsackievirus capsid protein VP2;138950;
4Q4X;3;Crystal structure of Coxsackievirus A24v soaked with 6'-Sialyllactose (6SL);1.65;CA;CALCIUM ION;Coxsackievirus capsid protein VP3;138950;
4Q4Y;1;Crystal structure of Coxsackievirus A24v soaked with Disialyllacto-N-tetraose (DSLNT);1.88;CA;CALCIUM ION;Coxsackievirus capsid protein VP1;138950;
4Q4Y;2;Crystal structure of Coxsackievirus A24v soaked with Disialyllacto-N-tetraose (DSLNT);1.88;CA;CALCIUM ION;Coxsackievirus capsid protein VP2;138950;
4Q4Y;3;Crystal structure of Coxsackievirus A24v soaked with Disialyllacto-N-tetraose (DSLNT);1.88;CA;CALCIUM ION;Coxsackievirus capsid protein VP3;138950;
4Q51;A;Crystal structure of a putative molybdenum cofactor biosynthesis protein F from Burkholderia cenocepacia J2315;1.9;CA;CALCIUM ION;Uncharacterized protein;95486;
4Q51;B;Crystal structure of a putative molybdenum cofactor biosynthesis protein F from Burkholderia cenocepacia J2315;1.9;CA;CALCIUM ION;Uncharacterized protein;95486;
4Q57;A;Crystal structure of the plectin 1a actin-binding domain/N-terminal domain of calmodulin complex;1.8;CA;CALCIUM ION;Calmodulin;9606;
4Q5B;A;TvNiR in complex with sulfite, high dose data set;1.8;CA;CALCIUM ION;Eight-heme nitrite reductase;186931;
4Q5B;B;TvNiR in complex with sulfite, high dose data set;1.8;CA;CALCIUM ION;Eight-heme nitrite reductase;186931;
4Q5C;A;TvNiR in complex with sulfite, middle dose data set;1.62;CA;CALCIUM ION;Eight-heme nitrite reductase;186931;
4Q5C;B;TvNiR in complex with sulfite, middle dose data set;1.62;CA;CALCIUM ION;Eight-heme nitrite reductase;186931;
4Q5U;A;Structure of calmodulin bound to its recognition site from calcineurin;1.95;CA;CALCIUM ION;Calmodulin;9606;
4Q6B;A;Crystal Structure of ABC Transporter Substrate-Binding Protein fromDesulfitobacterium hafniense complex with Leu;1.67;CA;CALCIUM ION;Extracellular ligand-binding receptor;49338;
4Q6M;A;Structural analysis of the apo-form of Helicobacter pylori Csd4, a D,L-carboxypeptidase;1.6;CA;CALCIUM ION;Conserved hypothetical secreted protein;210;
4Q6N;A;Structural analysis of the tripeptide-bound form of Helicobacter pylori Csd4, a D,L-carboxypeptidase;1.55;CA;CALCIUM ION;Conserved hypothetical secreted protein;210;
4Q6O;A;Structural analysis of the mDAP-bound form of Helicobacter pylori Csd4, a D,L-carboxypeptidase;1.41;CA;CALCIUM ION;Conserved hypothetical secreted protein;210;
4Q6P;A;Structural analysis of the Zn-form I of Helicobacter pylori Csd4, a D,L-carboxypeptidase;2.62;CA;CALCIUM ION;Conserved hypothetical secreted protein;210;
4Q6Q;A;Structural analysis of the Zn-form II of Helicobacter pylori Csd4, a D,L-carboxypeptidase;2.4;CA;CALCIUM ION;Conserved hypothetical secreted protein;210;
4Q7C;A;Structure of AF2299, a CDP-alcohol phosphotransferase;3.1;CA;CALCIUM ION;AF2299, a CDP-alcohol phosphotransferase;2234;
4Q7C;B;Structure of AF2299, a CDP-alcohol phosphotransferase;3.1;CA;CALCIUM ION;AF2299, a CDP-alcohol phosphotransferase;2234;
4Q8K;A;Crystal structure of polysaccharide lyase family 18 aly-SJ02 P-CATD;1.65;CA;CALCIUM ION;Alginase;515257;
4Q8L;A;Crystal structure of polysacchride lyase family 18 aly-SJ02 r-CATD;2.1;CA;CALCIUM ION;Alginase;515257;
4Q8L;B;Crystal structure of polysacchride lyase family 18 aly-SJ02 r-CATD;2.1;CA;CALCIUM ION;Alginase;515257;
4QAW;A;Structure of modular Xyn30D from Paenibacillus barcinonensis;2.4;CA;CALCIUM ION;Xyn30D;198119;
4QAW;B;Structure of modular Xyn30D from Paenibacillus barcinonensis;2.4;CA;CALCIUM ION;Xyn30D;198119;
4QAW;C;Structure of modular Xyn30D from Paenibacillus barcinonensis;2.4;CA;CALCIUM ION;Xyn30D;198119;
4QAW;D;Structure of modular Xyn30D from Paenibacillus barcinonensis;2.4;CA;CALCIUM ION;Xyn30D;198119;
4QAW;E;Structure of modular Xyn30D from Paenibacillus barcinonensis;2.4;CA;CALCIUM ION;Xyn30D;198119;
4QAW;F;Structure of modular Xyn30D from Paenibacillus barcinonensis;2.4;CA;CALCIUM ION;Xyn30D;198119;
4QAW;G;Structure of modular Xyn30D from Paenibacillus barcinonensis;2.4;CA;CALCIUM ION;Xyn30D;198119;
4QAW;H;Structure of modular Xyn30D from Paenibacillus barcinonensis;2.4;CA;CALCIUM ION;Xyn30D;198119;
4QB1;A;Structure of CBM35 from Paenibacillus barcinonensis;2.19;CA;CALCIUM ION;Xyn30D;198119;
4QB2;A;Structure of CBM35 in complex with glucuronic acid;1.5;CA;CALCIUM ION;Xyn30D;198119;
4QB6;A;Structure of CBM35 in complex with aldouronic acid;1.35;CA;CALCIUM ION;Xyn30D;198119;
4QD2;E;Molecular basis for disruption of E-cadherin adhesion by botulinum neurotoxin A complex;2.4;CA;CALCIUM ION;Cadherin-1;10090;
4QD2;J;Molecular basis for disruption of E-cadherin adhesion by botulinum neurotoxin A complex;2.4;CA;CALCIUM ION;Cadherin-1;10090;
4QEG;A;Crystal structure of domain I10 from titin (space group P41);2;CA;CALCIUM ION;Titin;9606;
4QEL;A;Crystal Structure of Benzoylformate Decarboxylase Mutant H70A;1.43;CA;CALCIUM ION;Benzoylformate decarboxylase;303;
4QF4;A;Crystal structure of Staphylococcal nuclease variant V23M at cryogenic temperature;1.8;CA;CALCIUM ION;Thermonuclease;1280;
4QF4;B;Crystal structure of Staphylococcal nuclease variant V23M at cryogenic temperature;1.8;CA;CALCIUM ION;Thermonuclease;1280;
4QIL;A;Crystal structure of the ROQ domain of human Roquin in complex with the Hmg19 stem-loop RNA;2.9;CA;CALCIUM ION;Roquin-1;9606;
4QIL;B;Crystal structure of the ROQ domain of human Roquin in complex with the Hmg19 stem-loop RNA;2.9;CA;CALCIUM ION;Roquin-1;9606;
4QJ3;B;Structure of a fragment of human phospholipase C-beta3 delta472-559, in complex with Galphaq;3;CA;CALCIUM ION;1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-3;9606;
4QJ4;B;Structure of a fragment of human phospholipase C-beta3 delta472-569, bound to IP3 and in complex with Galphaq;3.3;CA;CALCIUM ION;1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-3;9606;
4QJ5;B;Structure of a fragment of human phospholipase C-beta3 delta472-581, bound to IP3 and in complex with Galphaq;3.41;CA;CALCIUM ION;1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-3;9606;
4QJQ;A;Crystal structure of goat lactoperoxidase in complex with octopamine at 2.1 Angstrom resolution;2.1;CA;CALCIUM ION;Lactoperoxidase;9925;
4QK7;A;Influenza A M2 wild type TM domain at high pH in the lipidic cubic phase under cryo diffraction conditions;1.1;CA;CALCIUM ION;influenza M2 monomer;11320;
4QKC;A;Influenza A M2 wild type TM domain at low pH in the lipidic cubic phase under cryo diffraction conditions;1.1;CA;CALCIUM ION;influenza M2 monomer;11320;
4QKL;A;Influenza A M2 wild type TM domain at high pH in the lipidic cubic phase under room temperature diffraction conditions;1.71;CA;CALCIUM ION;influenza M2 monomer, TM domain (22-46);11320;
4QKM;A;Influenza A M2 wild type TM domain at low pH in the lipidic cubic phase under room temperature diffraction conditions;1.44;CA;CALCIUM ION;influenza M2 monomer;11320;
4QKZ;A;X-ray structure of the catalytic domain of MMP-8 with the inhibitor ML115;1.2;CA;CALCIUM ION;Neutrophil collagenase;9606;
4QN3;A;Crystal structure of Neuraminidase N7;2.09;CA;CALCIUM ION;Neuraminidase;11320;
4QN3;B;Crystal structure of Neuraminidase N7;2.09;CA;CALCIUM ION;Neuraminidase;11320;
4QN4;A;Crystal structure of Neuraminidase N6;1.8;CA;CALCIUM ION;Neuraminidase;11320;
4QN4;B;Crystal structure of Neuraminidase N6;1.8;CA;CALCIUM ION;Neuraminidase;11320;
4QN5;A;Neuraminidase N5 binds LSTa at the second SIA binding site;1.7;CA;CALCIUM ION;Neuraminidase;11320;
4QN5;B;Neuraminidase N5 binds LSTa at the second SIA binding site;1.7;CA;CALCIUM ION;Neuraminidase;11320;
4QN6;A;Crystal structure of Neuraminidase N6 complexed with Laninamivir;1.95;CA;CALCIUM ION;Neuraminidase;11320;
4QN6;B;Crystal structure of Neuraminidase N6 complexed with Laninamivir;1.95;CA;CALCIUM ION;Neuraminidase;11320;
4QN7;A;Crystal structure of neuramnidase N7 complexed with Oseltamivir;2.3;CA;CALCIUM ION;Neuraminidase;11320;
4QN7;B;Crystal structure of neuramnidase N7 complexed with Oseltamivir;2.3;CA;CALCIUM ION;Neuraminidase;11320;
4QNH;R;Calcium-calmodulin (T79D) complexed with the calmodulin binding domain from a small conductance potassium channel SK2-a;2.02;CA;CALCIUM ION;Calmodulin;10116;
4QNP;A;Crystal structure of the 2009 pandemic H1N1 influenza virus neuraminidase with a neutralizing antibody;2.8;CA;CALCIUM ION;Neuraminidase;11320;
4QNP;B;Crystal structure of the 2009 pandemic H1N1 influenza virus neuraminidase with a neutralizing antibody;2.8;CA;CALCIUM ION;Neuraminidase;11320;
4QO5;A;Hypothetical multiheme protein;1.7;CA;CALCIUM ION;Hypothetical multiheme protein;160233;
4QPJ;A;2.7 Angstrom Structure of a Phosphotransferase in Complex with a Receiver Domain;2.74;CA;CALCIUM ION;Phosphotransferase;235;
4QPJ;B;2.7 Angstrom Structure of a Phosphotransferase in Complex with a Receiver Domain;2.74;CA;CALCIUM ION;Phosphotransferase;235;
4QPJ;C;2.7 Angstrom Structure of a Phosphotransferase in Complex with a Receiver Domain;2.74;CA;CALCIUM ION;Cell cycle response regulator CtrA;235;
4QRA;A;Structure and specificity of L-D-Transpeptidase from Mycobacterium tuberculosis and antibiotic resistance: Calcium binding promotes dimer formation;2.29;CA;CALCIUM ION;L,d-transpeptidase LdtB;1773;
4QRK;A;Crystal structure of a putative cell adhesion protein (CLOSPO_03726) from Clostridium sporogenes ATCC 15579 at 1.95 A resolution;1.95;CA;CALCIUM ION;Hypothetical protein;1509;
4QTQ;A;Structure of a Xanthomonas Type IV Secretion System related protein;2;CA;CALCIUM ION;XAC2610 protein;346;
4QU3;A;GES-2 ertapenem acyl-enzyme complex;1.4;CA;CALCIUM ION;Beta-lactamase GES-2;287;
4QU6;A;Crystal structure of a G-rich RNA sequence binding factor 1 (GRSF1) from Homo sapiens at 1.75 A resolution;1.75;CA;CALCIUM ION;G-rich sequence factor 1;9606;
4QW8;A;TERNARY CRYSTAL STRUCTURES of A Y-FAMILY DNA POLYMERASE DPO4 FROM SULFOLOBUS SOLFATARICUS IN COMPLEX WITH DNA AND D-DCTP;2.29;CA;CALCIUM ION;DNA polymerase IV;2287;
4QW9;A;TERNARY CRYSTAL STRUCTURES of A Y-FAMILY DNA POLYMERASE DPO4 FROM SULFOLOBUS SOLFATARICUS IN COMPLEX WITH DNA AND (-)FTC-PPNP;2.4;CA;CALCIUM ION;DNA polymerase IV;2287;
4QWA;A;TERNARY CRYSTAL STRUCTURES OF A Y-FAMILY DNA POLYMERASE DPO4 FROM SULFOLOBUS SOLFATARICUS in COMPLEX WITH DNA AND (-)3TC-DP;2.2;CA;CALCIUM ION;DNA polymerase IV;2287;
4QWB;A;CRYSTAL STRUCTURE of DPO4 LINKER REGION P236A MUTANT WITH AN INCOMING D-dCDP;1.8;CA;CALCIUM ION;DNA polymerase IV;2287;
4QWB;B;CRYSTAL STRUCTURE of DPO4 LINKER REGION P236A MUTANT WITH AN INCOMING D-dCDP;1.8;CA;CALCIUM ION;DNA (5'-D(*GP*GP*CP*TP*AP*CP*AP*GP*GP*AP*CP*TP*(DOC))-3');;
4QWC;A;TERNARY CRYSTAL STRUCTURES of A Y-FAMILY DNA POLYMERASE DPO4 FROM SULFOLOBUS SOLFATARICUS IN COMPLEX WITH DNA AND L-DCDP;2.4;CA;CALCIUM ION;DNA polymerase IV;2287;
4QWC;D;TERNARY CRYSTAL STRUCTURES of A Y-FAMILY DNA POLYMERASE DPO4 FROM SULFOLOBUS SOLFATARICUS IN COMPLEX WITH DNA AND L-DCDP;2.4;CA;CALCIUM ION;DNA polymerase IV;2287;
4QWD;A;TERNARY CRYSTAL STRUCTURES of A Y-FAMILY DNA POLYMERASE DPO4 FROM SULFOLOBUS SOLFATARICUS IN COMPLEX WITH DNA AND (-)3TC-PPNP;2.05;CA;CALCIUM ION;DNA polymerase IV;2287;
4QWE;A;TERNARY CRYSTAL STRUCTURES of A Y-FAMILY DNA POLYMERASE DPO4 FROM SULFOLOBUS SOLFATARICUS IN COMPLEX WITH DNA AND (-)FTC-DP;2.2;CA;CALCIUM ION;DNA polymerase IV;2287;
4QWT;A;Anaerobic crystal structure of delta413-417:GS LOX in complex with arachidonate;2;CA;CALCIUM ION;Allene oxide synthase-lipoxygenase protein;47982;
4QWT;B;Anaerobic crystal structure of delta413-417:GS LOX in complex with arachidonate;2;CA;CALCIUM ION;Allene oxide synthase-lipoxygenase protein;47982;
4QWT;C;Anaerobic crystal structure of delta413-417:GS LOX in complex with arachidonate;2;CA;CALCIUM ION;Allene oxide synthase-lipoxygenase protein;47982;
4QWT;D;Anaerobic crystal structure of delta413-417:GS LOX in complex with arachidonate;2;CA;CALCIUM ION;Allene oxide synthase-lipoxygenase protein;47982;
4QYQ;A;Crystal structure of the complex of goat lactoperoxidase with an antithyroid agent propylthiouracil at 2.5 A resolution;2.5;CA;CALCIUM ION;Lactoperoxidase;9925;
4QYQ;B;Crystal structure of the complex of goat lactoperoxidase with an antithyroid agent propylthiouracil at 2.5 A resolution;2.5;CA;CALCIUM ION;Lactoperoxidase;9925;
4QYQ;C;Crystal structure of the complex of goat lactoperoxidase with an antithyroid agent propylthiouracil at 2.5 A resolution;2.5;CA;CALCIUM ION;Lactoperoxidase;9925;
4QYQ;D;Crystal structure of the complex of goat lactoperoxidase with an antithyroid agent propylthiouracil at 2.5 A resolution;2.5;CA;CALCIUM ION;Lactoperoxidase;9925;
4R12;A;Crystal structure of the gamma-secretase component Nicastrin;1.95;CA;CALCIUM ION;Putative uncharacterized protein;5786;
4R1D;A;The crystal structure of Tle4-Tli4 complex;1.75;CA;CALCIUM ION;Uncharacterized protein;287;
4R36;A;Crystal structure analysis of LpxA, a UDP-N-acetylglucosamine acyltransferase from Bacteroides fragilis 9343;1.9;CA;CALCIUM ION;Putative acyl-[acyl-carrier-protein]--UDP-N-acetylglucosamine O-acyltransferase;817;
4R36;B;Crystal structure analysis of LpxA, a UDP-N-acetylglucosamine acyltransferase from Bacteroides fragilis 9343;1.9;CA;CALCIUM ION;Putative acyl-[acyl-carrier-protein]--UDP-N-acetylglucosamine O-acyltransferase;817;
4R37;A;Crystal structure analysis of LpxA, a UDP-N-acetylglucosamine acyltransferase from Bacteroides fragilis 9343 with UDP-GlcNAc;1.9;CA;CALCIUM ION;Putative acyl-[acyl-carrier-protein]--UDP-N-acetylglucosamine O-acyltransferase;817;
4R37;B;Crystal structure analysis of LpxA, a UDP-N-acetylglucosamine acyltransferase from Bacteroides fragilis 9343 with UDP-GlcNAc;1.9;CA;CALCIUM ION;Putative acyl-[acyl-carrier-protein]--UDP-N-acetylglucosamine O-acyltransferase;817;
4R3K;A;Crystal structure of Ard1 N-terminal acetyltransferase from Sulfolobus solfataricus bound to CoA;2.13;CA;CALCIUM ION;Uncharacterized N-acetyltransferase SSO0209;2287;
4R3V;A;Structure of karilysin propeptide and catalytic MMP domain;2.01;CA;CALCIUM ION;Karilysin;28112;
4R3V;B;Structure of karilysin propeptide and catalytic MMP domain;2.01;CA;CALCIUM ION;Karilysin;28112;
4R42;A;Crystal structure of KatB, a manganese catalase from Anabaena PCC7120;1.9;CA;CALCIUM ION;Alr3090 protein;103690;
4R42;B;Crystal structure of KatB, a manganese catalase from Anabaena PCC7120;1.9;CA;CALCIUM ION;Alr3090 protein;103690;
4R42;C;Crystal structure of KatB, a manganese catalase from Anabaena PCC7120;1.9;CA;CALCIUM ION;Alr3090 protein;103690;
4R48;B;Racemic crystal structure of a calcium-bound DNA four-way junction;2.33;CA;CALCIUM ION;5'-D(*CP*CP*GP*GP*TP*AP*CP*CP*GP*G)-3';32630;
4R49;A;Racemic crystal structure of a calcium-bound B-DNA duplex;1.28;CA;CALCIUM ION;5'-D(*CP*CP*GP*GP*TP*AP*CP*CP*GP*G)-3';32630;
4R49;B;Racemic crystal structure of a calcium-bound B-DNA duplex;1.28;CA;CALCIUM ION;5'-D(*CP*CP*GP*GP*TP*AP*CP*CP*GP*G)-3';32630;
4R5F;A;X-ray structure of the D199K mutant of the cysteine desulfurase IscS from A. fulgidus;1.9;CA;CALCIUM ION;Cysteine desulfurase IscS 2;2234;
4R5J;A;Crystal structure of the DnaK C-terminus (Dnak-SBD-A);2.36;CA;CALCIUM ION;Chaperone protein DnaK;562;
4R5J;B;Crystal structure of the DnaK C-terminus (Dnak-SBD-A);2.36;CA;CALCIUM ION;Chaperone protein DnaK;562;
4R5J;C;Crystal structure of the DnaK C-terminus (Dnak-SBD-A);2.36;CA;CALCIUM ION;Chaperone protein DnaK;562;
4R5J;D;Crystal structure of the DnaK C-terminus (Dnak-SBD-A);2.36;CA;CALCIUM ION;Chaperone protein DnaK;562;
4R5K;A;Crystal structure of the DnaK C-terminus (Dnak-SBD-B);1.75;CA;CALCIUM ION;Chaperone protein DnaK;562;
4R5L;C;Crystal structure of the DnaK C-terminus (Dnak-SBD-C);2.97;CA;CALCIUM ION;Chaperone protein DnaK;562;
4R5O;A;Crystal structure of a Quinonprotein alcohol dehydrogenase-like protein (BT1487) from Bacteroides thetaiotaomicron VPI-5482 at 2.64 A resolution;2.64;CA;CALCIUM ION;Quinonprotein alcohol dehydrogenase-like protein;818;
4R5O;B;Crystal structure of a Quinonprotein alcohol dehydrogenase-like protein (BT1487) from Bacteroides thetaiotaomicron VPI-5482 at 2.64 A resolution;2.64;CA;CALCIUM ION;Quinonprotein alcohol dehydrogenase-like protein;818;
4R6G;A;Crystal structure of computational designed leucine rich repeats DLRR_K in space group P22121;2.8;CA;CALCIUM ION;leucine rich repeats DLRR_K;32630;
4R82;A;Streptomyces globisporus C-1027 NADH:FAD oxidoreductase SgcE6 in complex with NAD and FAD fragments;1.66;CA;CALCIUM ION;Oxidoreductase;1908;
4R82;B;Streptomyces globisporus C-1027 NADH:FAD oxidoreductase SgcE6 in complex with NAD and FAD fragments;1.66;CA;CALCIUM ION;Oxidoreductase;1908;
4R83;A;Crystal structure of Sialyltransferase from Photobacterium damsela;1.93;CA;CALCIUM ION;Sialyltransferase 0160;38293;
4R83;B;Crystal structure of Sialyltransferase from Photobacterium damsela;1.93;CA;CALCIUM ION;Sialyltransferase 0160;38293;
4R83;C;Crystal structure of Sialyltransferase from Photobacterium damsela;1.93;CA;CALCIUM ION;Sialyltransferase 0160;38293;
4R83;D;Crystal structure of Sialyltransferase from Photobacterium damsela;1.93;CA;CALCIUM ION;Sialyltransferase 0160;38293;
4R84;A;Crystal structure of Sialyltransferase from Photobacterium damsela with CMP-3F(a)Neu5Ac bound;1.7;CA;CALCIUM ION;Sialyltransferase 0160;38293;
4R84;B;Crystal structure of Sialyltransferase from Photobacterium damsela with CMP-3F(a)Neu5Ac bound;1.7;CA;CALCIUM ION;Sialyltransferase 0160;38293;
4R84;C;Crystal structure of Sialyltransferase from Photobacterium damsela with CMP-3F(a)Neu5Ac bound;1.7;CA;CALCIUM ION;Sialyltransferase 0160;38293;
4R84;D;Crystal structure of Sialyltransferase from Photobacterium damsela with CMP-3F(a)Neu5Ac bound;1.7;CA;CALCIUM ION;Sialyltransferase 0160;38293;
4R8N;A;Crystal structure of Staphylococcal nuclease variant V23I/V66I/I72V/I92V at cryogenic temperature;1.65;CA;CALCIUM ION;Thermonuclease;1280;
4R90;H;Anti CD70 Llama glama Fab 27B3;1.75;CA;CALCIUM ION;Anti CD70 Llama glama Fab 27B3 Heavy chain;9844;
4R9J;A;L-ficolin complexed to glucosamine-6-sulfate;2.1;CA;CALCIUM ION;Ficolin-2;9606;
4R9J;B;L-ficolin complexed to glucosamine-6-sulfate;2.1;CA;CALCIUM ION;Ficolin-2;9606;
4R9J;G;L-ficolin complexed to glucosamine-6-sulfate;2.1;CA;CALCIUM ION;Ficolin-2;9606;
4R9T;A;L-ficolin complexed to sulphates;2.25;CA;CALCIUM ION;Ficolin-2;9606;
4R9T;B;L-ficolin complexed to sulphates;2.25;CA;CALCIUM ION;Ficolin-2;9606;
4R9T;C;L-ficolin complexed to sulphates;2.25;CA;CALCIUM ION;Ficolin-2;9606;
4R9V;A;Crystal structure of sialyltransferase from photobacterium damselae, residues 113-497 corresponding to the gt-b domain;2.3;CA;CALCIUM ION;Sialyltransferase 0160;38293;
4R9X;A;Crystal Structure of Putative Copper Homeostasis Protein CutC from Bacillus anthracis;1.85;CA;CALCIUM ION;Copper homeostasis protein CutC;1392;
4R9X;B;Crystal Structure of Putative Copper Homeostasis Protein CutC from Bacillus anthracis;1.85;CA;CALCIUM ION;Copper homeostasis protein CutC;1392;
4RA0;A;An engineered Axl 'decoy receptor' effectively silences the Gas6-Axl signaling axis;3.07;CA;CALCIUM ION;Growth arrest-specific protein 6;9606;
4RA0;B;An engineered Axl 'decoy receptor' effectively silences the Gas6-Axl signaling axis;3.07;CA;CALCIUM ION;Growth arrest-specific protein 6;9606;
4RBM;A;Porphyromonas gingivalis gingipain K (Kgp) catalytic and immunoglobulin superfamily-like domains;1.75;CA;CALCIUM ION;Lys-gingipain W83;837;
4RDQ;A;Calcium-activated chloride channel bestrophin-1, from chicken, in complex with Fab antibody fragments, chloride and calcium;2.85;CA;CALCIUM ION;Bestrophin-1;9031;
4RDQ;B;Calcium-activated chloride channel bestrophin-1, from chicken, in complex with Fab antibody fragments, chloride and calcium;2.85;CA;CALCIUM ION;Bestrophin-1;9031;
4RDQ;C;Calcium-activated chloride channel bestrophin-1, from chicken, in complex with Fab antibody fragments, chloride and calcium;2.85;CA;CALCIUM ION;Bestrophin-1;9031;
4RDQ;D;Calcium-activated chloride channel bestrophin-1, from chicken, in complex with Fab antibody fragments, chloride and calcium;2.85;CA;CALCIUM ION;Bestrophin-1;9031;
4RDQ;E;Calcium-activated chloride channel bestrophin-1, from chicken, in complex with Fab antibody fragments, chloride and calcium;2.85;CA;CALCIUM ION;Bestrophin-1;9031;
4RFU;A;Crystal structure of truncated P-domain from Grouper nervous necrosis virus capsid protein at 1.2A;1.2;CA;CALCIUM ION;Coat protein;43763;
4RFU;B;Crystal structure of truncated P-domain from Grouper nervous necrosis virus capsid protein at 1.2A;1.2;CA;CALCIUM ION;Coat protein;43763;
4RGP;A;Crystal Structure of Uncharacterized CRISPR/Cas System-associated Protein Csm6 from Streptococcus mutans;2.3;CA;CALCIUM ION;Csm6_III-A;1309;
4RGP;B;Crystal Structure of Uncharacterized CRISPR/Cas System-associated Protein Csm6 from Streptococcus mutans;2.3;CA;CALCIUM ION;Csm6_III-A;1309;
4RHH;A;Crystal structure of the catalytic mutant Xyn52B2-E335G, a GH52 Beta-D-xylosidase from Geobacillus stearothermophilus T6;2.15;CA;CALCIUM ION;Beta-xylosidase;1422;
4RHH;B;Crystal structure of the catalytic mutant Xyn52B2-E335G, a GH52 Beta-D-xylosidase from Geobacillus stearothermophilus T6;2.15;CA;CALCIUM ION;Beta-xylosidase;1422;
4RHH;C;Crystal structure of the catalytic mutant Xyn52B2-E335G, a GH52 Beta-D-xylosidase from Geobacillus stearothermophilus T6;2.15;CA;CALCIUM ION;Beta-xylosidase;1422;
4RHH;D;Crystal structure of the catalytic mutant Xyn52B2-E335G, a GH52 Beta-D-xylosidase from Geobacillus stearothermophilus T6;2.15;CA;CALCIUM ION;Beta-xylosidase;1422;
4RHZ;B;Crystal structure of Cry23Aa1 and Cry37Aa1 binary protein complex;2.35;CA;CALCIUM ION;Cry37AA1;1428;
4RI8;A;FAN1 Nuclease bound to 5' phosphorylated p(dG)/3'(dT-dT-dT-dT) double flap DNA;2.9;CA;CALCIUM ION;Fanconi-associated nuclease 1;9606;
4RI8;B;FAN1 Nuclease bound to 5' phosphorylated p(dG)/3'(dT-dT-dT-dT) double flap DNA;2.9;CA;CALCIUM ION;Fanconi-associated nuclease 1;9606;
4RIB;A;FAN1 Nuclease bound to 5' phosphorylated p(dT) single flap DNA;3.25;CA;CALCIUM ION;Fanconi-associated nuclease 1;9606;
4RIB;B;FAN1 Nuclease bound to 5' phosphorylated p(dT) single flap DNA;3.25;CA;CALCIUM ION;Fanconi-associated nuclease 1;9606;
4RIC;A;FAN1 Nuclease bound to 5' hydroxyl (dT-dT) single flap DNA;2.8;CA;CALCIUM ION;Fanconi-associated nuclease 1;9606;
4RIC;B;FAN1 Nuclease bound to 5' hydroxyl (dT-dT) single flap DNA;2.8;CA;CALCIUM ION;Fanconi-associated nuclease 1;9606;
4RJ1;B;Structural variations and solvent structure of UGGGGU quadruplexes stabilized by Sr2+ ions;0.92;CA;CALCIUM ION;RNA (5'-R(*UP*GP*GP*GP*GP*U)-3');32630;
4RJD;A;TFP bound in alternate orientations to calcium-saturated Calmodulin C-Domains;2;CA;CALCIUM ION;Calmodulin;10116;
4RJD;B;TFP bound in alternate orientations to calcium-saturated Calmodulin C-Domains;2;CA;CALCIUM ION;Calmodulin;10116;
4RKB;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS V66T/V99T at cryogenic temperature;1.88;CA;CALCIUM ION;Thermonuclease;1280;
4RKL;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS V23T/V66T at cryogenic temperature;1.66;CA;CALCIUM ION;Thermonuclease;1280;
4RKV;B;Structural variations and solvent structure of UGGGGU quadruplexes stabilized by Sr2+ ions;0.88;CA;CALCIUM ION;RNA (5'-R(*UP*GP*GP*GP*GP*U)-3');32630;
4RMK;A;Crystal structure of the Olfactomedin domain of latrophilin 3 in P65 crystal form;1.61;CA;CALCIUM ION;Latrophilin-3;10090;
4RMO;A;Crystal Structure of the CptIN Type III Toxin-Antitoxin System from Eubacterium rectale;2.2;CA;CALCIUM ION;CptN Toxin;39491;
4RMO;B;Crystal Structure of the CptIN Type III Toxin-Antitoxin System from Eubacterium rectale;2.2;CA;CALCIUM ION;RNA (45-MER);32630;
4RMO;C;Crystal Structure of the CptIN Type III Toxin-Antitoxin System from Eubacterium rectale;2.2;CA;CALCIUM ION;CptN Toxin;39491;
4RMO;D;Crystal Structure of the CptIN Type III Toxin-Antitoxin System from Eubacterium rectale;2.2;CA;CALCIUM ION;RNA (45-MER);32630;
4RMO;E;Crystal Structure of the CptIN Type III Toxin-Antitoxin System from Eubacterium rectale;2.2;CA;CALCIUM ION;CptN Toxin;39491;
4RMO;F;Crystal Structure of the CptIN Type III Toxin-Antitoxin System from Eubacterium rectale;2.2;CA;CALCIUM ION;RNA (45-MER);32630;
4RMO;G;Crystal Structure of the CptIN Type III Toxin-Antitoxin System from Eubacterium rectale;2.2;CA;CALCIUM ION;CptN Toxin;39491;
4RMO;H;Crystal Structure of the CptIN Type III Toxin-Antitoxin System from Eubacterium rectale;2.2;CA;CALCIUM ION;RNA (45-MER);32630;
4RMO;I;Crystal Structure of the CptIN Type III Toxin-Antitoxin System from Eubacterium rectale;2.2;CA;CALCIUM ION;CptN Toxin;39491;
4RMO;J;Crystal Structure of the CptIN Type III Toxin-Antitoxin System from Eubacterium rectale;2.2;CA;CALCIUM ION;RNA (45-MER);32630;
4RMO;K;Crystal Structure of the CptIN Type III Toxin-Antitoxin System from Eubacterium rectale;2.2;CA;CALCIUM ION;CptN Toxin;39491;
4RMO;L;Crystal Structure of the CptIN Type III Toxin-Antitoxin System from Eubacterium rectale;2.2;CA;CALCIUM ION;RNA (45-MER);32630;
4RMO;M;Crystal Structure of the CptIN Type III Toxin-Antitoxin System from Eubacterium rectale;2.2;CA;CALCIUM ION;CptN Toxin;39491;
4RMO;N;Crystal Structure of the CptIN Type III Toxin-Antitoxin System from Eubacterium rectale;2.2;CA;CALCIUM ION;RNA (45-MER);32630;
4RMO;O;Crystal Structure of the CptIN Type III Toxin-Antitoxin System from Eubacterium rectale;2.2;CA;CALCIUM ION;CptN Toxin;39491;
4RMO;P;Crystal Structure of the CptIN Type III Toxin-Antitoxin System from Eubacterium rectale;2.2;CA;CALCIUM ION;RNA (45-MER);32630;
4RNE;B;Structural variations and solvent structure of UGGGGU quadruplexes stabilized by Sr2+ ions;1.01;CA;CALCIUM ION;RNA (5'-R(*UP*GP*GP*GP*GP*U)-3');32630;
4RNE;C;Structural variations and solvent structure of UGGGGU quadruplexes stabilized by Sr2+ ions;1.01;CA;CALCIUM ION;RNA (5'-R(*UP*GP*GP*GP*GP*U)-3');32630;
4RNE;D;Structural variations and solvent structure of UGGGGU quadruplexes stabilized by Sr2+ ions;1.01;CA;CALCIUM ION;RNA (5'-R(*UP*GP*GP*GP*GP*U)-3');32630;
4RNE;E;Structural variations and solvent structure of UGGGGU quadruplexes stabilized by Sr2+ ions;1.01;CA;CALCIUM ION;RNA (5'-R(*UP*GP*GP*GP*GP*U)-3');32630;
4RNE;F;Structural variations and solvent structure of UGGGGU quadruplexes stabilized by Sr2+ ions;1.01;CA;CALCIUM ION;RNA (5'-R(*UP*GP*GP*GP*GP*U)-3');32630;
4RNE;G;Structural variations and solvent structure of UGGGGU quadruplexes stabilized by Sr2+ ions;1.01;CA;CALCIUM ION;RNA (5'-R(*UP*GP*GP*GP*GP*U)-3');32630;
4RNO;A;Crystal structure of human polymerase eta extending an abasic site-dA pair by inserting dCTP opposite template G;2.82;CA;CALCIUM ION;DNA polymerase eta;9606;
4ROP;A;Crystal structure of Enolase from Synechococcus elongatus;2.05;CA;CALCIUM ION;Enolase;32046;
4ROR;A;Crystal structure of Malate Dehydrogenase from Methylobacterium extorquens;1.66;CA;CALCIUM ION;Malate dehydrogenase;408;
4ROS;A;Crystal structure of Methylobacterium extorquens malate dehydrogenase complexed with oxaloacetate and adenosine-5-diphosphoribose;1.95;CA;CALCIUM ION;Malate dehydrogenase;408;
4RPU;B;Crystal Structure of Human Presequence Protease in Complex with Inhibitor MitoBloCK-60;2.27;CA;CALCIUM ION;Presequence protease, mitochondrial;9606;
4RPX;A;Precatalytic ternary complex of Human DNA Polymerase Beta With Gapped DNA Containing an 8-oxo-7,8-dihydro-Guanine (8-oxoG) and dCTP in the presence of CaCl2;1.9;CA;CALCIUM ION;DNA polymerase beta;9606;
4RQ3;A;Precatalytic ternary complex of Human DNA Polymerase Beta With Gapped DNA Containing an 8-oxo-7,8-dihydro-Guanine (8-oxoG) and dATP in the presence of CaCl2;2;CA;CALCIUM ION;DNA polymerase beta;9606;
4RQW;A;Crystal structure of Myc3 N-terminal JAZ-binding domain [44-238] from Arabidopsis;2.2;CA;CALCIUM ION;Transcription factor MYC3;3702;
4RRU;A;Myc3 N-terminal JAZ-binding domain[5-242] from arabidopsis;2.1;CA;CALCIUM ION;Transcription factor MYC3;3702;
4RSR;A;ArsM arsenic(III) S-adenosylmethionine methyltransferase with trivalent phenyl arsencial derivative-Roxarsone;2.25;CA;CALCIUM ION;Arsenic methyltransferase;610260;
4RU3;A;Crystal structure of the cell puncturing protein gp41 from Pseudomonas phage SN;1.17;CA;CALCIUM ION;puncturing protein gp41;2006180;
4RU4;A;Crystal structure of the tailspike protein gp49 from Pseudomonas phage LKA1;1.9;CA;CALCIUM ION;tail spike protein gp49;1985731;
4RU4;B;Crystal structure of the tailspike protein gp49 from Pseudomonas phage LKA1;1.9;CA;CALCIUM ION;tail spike protein gp49;1985731;
4RU4;C;Crystal structure of the tailspike protein gp49 from Pseudomonas phage LKA1;1.9;CA;CALCIUM ION;tail spike protein gp49;1985731;
4RU4;D;Crystal structure of the tailspike protein gp49 from Pseudomonas phage LKA1;1.9;CA;CALCIUM ION;tail spike protein gp49;1985731;
4RU4;E;Crystal structure of the tailspike protein gp49 from Pseudomonas phage LKA1;1.9;CA;CALCIUM ION;tail spike protein gp49;1985731;
4RU4;F;Crystal structure of the tailspike protein gp49 from Pseudomonas phage LKA1;1.9;CA;CALCIUM ION;tail spike protein gp49;1985731;
4RU5;A;Crystal Structure of the Pseudomonas phage phi297 tailspike gp61;1.52;CA;CALCIUM ION;tailspike gp27;1129145;
4RU5;B;Crystal Structure of the Pseudomonas phage phi297 tailspike gp61;1.52;CA;CALCIUM ION;tailspike gp27;1129145;
4RU5;C;Crystal Structure of the Pseudomonas phage phi297 tailspike gp61;1.52;CA;CALCIUM ION;tailspike gp27;1129145;
4RUA;A;Crystal structure of Y-family DNA polymerase Dpo4 bypassing a MeFapy-dG adduct;3.07;CA;CALCIUM ION;DNA polymerase IV;2287;
4RUC;A;Crystal structure of Y-family DNA polymerase Dpo4 extending from a MeFapy-dG:dC pair;2.9;CA;CALCIUM ION;DNA polymerase IV;2287;
4RUK;E;crystal structure of Phosphoapantetheine adenylyltransferase PPAT/CoaD with CoA and pyrophosphate from Pseudomonas aeruginosa;2.2;CA;CALCIUM ION;Phosphopantetheine adenylyltransferase;287;
4RUK;F;crystal structure of Phosphoapantetheine adenylyltransferase PPAT/CoaD with CoA and pyrophosphate from Pseudomonas aeruginosa;2.2;CA;CALCIUM ION;Phosphopantetheine adenylyltransferase;287;
4RUQ;A;Carp Fishelectin, apo form;1.35;CA;CALCIUM ION;Fish-egg lectin;7962;
4RUQ;B;Carp Fishelectin, apo form;1.35;CA;CALCIUM ION;Fish-egg lectin;7962;
4RUS;A;Carp Fishelectin, holo form;1.7;CA;CALCIUM ION;Fish-egg lectin;7962;
4RUS;B;Carp Fishelectin, holo form;1.7;CA;CALCIUM ION;Fish-egg lectin;7962;
4RUS;C;Carp Fishelectin, holo form;1.7;CA;CALCIUM ION;Fish-egg lectin;7962;
4RUS;D;Carp Fishelectin, holo form;1.7;CA;CALCIUM ION;Fish-egg lectin;7962;
4RUS;E;Carp Fishelectin, holo form;1.7;CA;CALCIUM ION;Fish-egg lectin;7962;
4RUS;F;Carp Fishelectin, holo form;1.7;CA;CALCIUM ION;Fish-egg lectin;7962;
4RVY;B;Serial Time resolved crystallography of Photosystem II using a femtosecond X-ray laser. The S state after two flashes (S3);5.5;CA;CALCIUM ION;Photosystem II CP47 reaction center protein;146786;
4RVY;F;Serial Time resolved crystallography of Photosystem II using a femtosecond X-ray laser. The S state after two flashes (S3);5.5;CA;CALCIUM ION;Cytochrome b559 subunit beta;146786;
4RVY;O;Serial Time resolved crystallography of Photosystem II using a femtosecond X-ray laser. The S state after two flashes (S3);5.5;CA;CALCIUM ION;Photosystem II manganese-stabilizing polypeptide;146786;
4RVY;b;Serial Time resolved crystallography of Photosystem II using a femtosecond X-ray laser. The S state after two flashes (S3);5.5;CA;CALCIUM ION;Photosystem II CP47 reaction center protein;146786;
4RVY;f;Serial Time resolved crystallography of Photosystem II using a femtosecond X-ray laser. The S state after two flashes (S3);5.5;CA;CALCIUM ION;Cytochrome b559 subunit beta;146786;
4RVY;o;Serial Time resolved crystallography of Photosystem II using a femtosecond X-ray laser. The S state after two flashes (S3);5.5;CA;CALCIUM ION;Photosystem II manganese-stabilizing polypeptide;146786;
4RY0;A;Crystal structure of ribose transporter solute binding protein RHE_PF00037 from Rhizobium etli CFN 42, TARGET EFI-511357, in complex with D-ribose;1.4;CA;CALCIUM ION;Probable ribose ABC transporter, substrate-binding protein;29449;
4RYD;A;X-ray structure of human furin in complex with the competitive inhibitor para-guanidinomethyl-Phac-R-Tle-R-Amba;2.15;CA;CALCIUM ION;Furin;9606;
4RYD;B;X-ray structure of human furin in complex with the competitive inhibitor para-guanidinomethyl-Phac-R-Tle-R-Amba;2.15;CA;CALCIUM ION;Furin;9606;
4RYD;C;X-ray structure of human furin in complex with the competitive inhibitor para-guanidinomethyl-Phac-R-Tle-R-Amba;2.15;CA;CALCIUM ION;Furin;9606;
4RYD;D;X-ray structure of human furin in complex with the competitive inhibitor para-guanidinomethyl-Phac-R-Tle-R-Amba;2.15;CA;CALCIUM ION;Furin;9606;
4RYD;E;X-ray structure of human furin in complex with the competitive inhibitor para-guanidinomethyl-Phac-R-Tle-R-Amba;2.15;CA;CALCIUM ION;Furin;9606;
4RYD;F;X-ray structure of human furin in complex with the competitive inhibitor para-guanidinomethyl-Phac-R-Tle-R-Amba;2.15;CA;CALCIUM ION;Furin;9606;
4RZR;A;Bypass of a bulky adduct dG1,8 by DPO4;2.2;CA;CALCIUM ION;DNA polymerase IV;2287;
4RZR;D;Bypass of a bulky adduct dG1,8 by DPO4;2.2;CA;CALCIUM ION;DNA polymerase IV;2287;
4S10;C;Gelsolin nanobody shielding mutant plasma gelsolin from furin proteolysis;2.61;CA;CALCIUM ION;Gelsolin;9606;
4S10;D;Gelsolin nanobody shielding mutant plasma gelsolin from furin proteolysis;2.61;CA;CALCIUM ION;Gelsolin;9606;
4S2V;A;E. coli RppH structure, KI soak;1.7;CA;CALCIUM ION;RNA pyrophosphohydrolase;562;
4S37;B;Crystal structure of R2 pyocin membrane-piercing spike;2.2;CA;CALCIUM ION;Phage baseplate protein;287;
4S37;D;Crystal structure of R2 pyocin membrane-piercing spike;2.2;CA;CALCIUM ION;Phage baseplate protein;287;
4S37;F;Crystal structure of R2 pyocin membrane-piercing spike;2.2;CA;CALCIUM ION;Phage baseplate protein;287;
4S37;H;Crystal structure of R2 pyocin membrane-piercing spike;2.2;CA;CALCIUM ION;Phage baseplate protein;287;
4S37;J;Crystal structure of R2 pyocin membrane-piercing spike;2.2;CA;CALCIUM ION;Phage baseplate protein;287;
4S37;O;Crystal structure of R2 pyocin membrane-piercing spike;2.2;CA;CALCIUM ION;Phage baseplate protein;287;
4S3S;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS I92K/V23A at cryogenic temperature;1.64;CA;CALCIUM ION;Thermonuclease;1280;
4SBV;A;The REFINEMENT OF SOUTHERN BEAN MOSAIC VIRUS IN RECIPROCAL SPACE;2.8;CA;CALCIUM ION;SOUTHERN BEAN MOSAIC VIRUS COAT PROTEIN;12139;
4SBV;B;The REFINEMENT OF SOUTHERN BEAN MOSAIC VIRUS IN RECIPROCAL SPACE;2.8;CA;CALCIUM ION;SOUTHERN BEAN MOSAIC VIRUS COAT PROTEIN;12139;
4SBV;C;The REFINEMENT OF SOUTHERN BEAN MOSAIC VIRUS IN RECIPROCAL SPACE;2.8;CA;CALCIUM ION;SOUTHERN BEAN MOSAIC VIRUS COAT PROTEIN;12139;
4SGB;E;STRUCTURE OF THE COMPLEX OF STREPTOMYCES GRISEUS PROTEINASE B AND POLYPEPTIDE CHYMOTRYPSIN INHIBITOR-1 FROM RUSSET BURBANK POTATO TUBERS AT 2.1 ANGSTROMS RESOLUTION;2.1;CA;CALCIUM ION;SERINE PROTEINASE B;1911;
4TF4;A;ENDO/EXOCELLULASE:CELLOPENTAOSE FROM THERMOMONOSPORA;2;CA;CALCIUM ION;T. FUSCA ENDO/EXO-CELLULASE E4 CATALYTIC DOMAIN AND CELLULOSE-BINDING DOMAIN;2021;
4TF4;B;ENDO/EXOCELLULASE:CELLOPENTAOSE FROM THERMOMONOSPORA;2;CA;CALCIUM ION;T. FUSCA ENDO/EXO-CELLULASE E4 CATALYTIC DOMAIN AND CELLULOSE-BINDING DOMAIN;2021;
4TKQ;A;Native-SAD phasing for YetJ from Bacillus Subtilis;2.8;CA;CALCIUM ION;Uncharacterized protein YetJ;1423;
4TLI;A;THERMOLYSIN (25% ISOPROPANOL SOAKED CRYSTALS);1.95;CA;CALCIUM ION;PROTEIN (THERMOLYSIN);1427;
4TLN;A;BINDING OF HYDROXAMIC ACID INHIBITORS TO CRYSTALLINE THERMOLYSIN SUGGESTS A PENTACOORDINATE ZINC INTERMEDIATE IN CATALYSIS;2.3;CA;CALCIUM ION;THERMOLYSIN;1427;
4TMN;E;SLOW-AND FAST-BINDING INHIBITORS OF THERMOLYSIN DISPLAY DIFFERENT MODES OF BINDING. CRYSTALLOGRAPHIC ANALYSIS OF EXTENDED PHOSPHONAMIDATE TRANSITION-STATE ANALOGUES;1.7;CA;CALCIUM ION;THERMOLYSIN;1427;
4TNC;A;REFINED STRUCTURE OF CHICKEN SKELETAL MUSCLE TROPONIN C IN THE TWO-CALCIUM STATE AT 2-ANGSTROMS RESOLUTION;2;CA;CALCIUM ION;TROPONIN C;9031;
4TNH;K;RT XFEL structure of Photosystem II in the dark state at 4.9 A resolution;4.9;CA;CALCIUM ION;Photosystem II reaction center protein K;146786;
4TNH;O;RT XFEL structure of Photosystem II in the dark state at 4.9 A resolution;4.9;CA;CALCIUM ION;Photosystem II manganese-stabilizing polypeptide;146786;
4TNH;k;RT XFEL structure of Photosystem II in the dark state at 4.9 A resolution;4.9;CA;CALCIUM ION;Photosystem II reaction center protein K;146786;
4TNH;o;RT XFEL structure of Photosystem II in the dark state at 4.9 A resolution;4.9;CA;CALCIUM ION;Photosystem II manganese-stabilizing polypeptide;146786;
4TNI;K;RT XFEL structure of Photosystem II 500 ms after the third illumination at 4.6 A resolution;4.6;CA;CALCIUM ION;Photosystem II reaction center protein K;146786;
4TNI;O;RT XFEL structure of Photosystem II 500 ms after the third illumination at 4.6 A resolution;4.6;CA;CALCIUM ION;Photosystem II manganese-stabilizing polypeptide;146786;
4TNI;k;RT XFEL structure of Photosystem II 500 ms after the third illumination at 4.6 A resolution;4.6;CA;CALCIUM ION;Photosystem II reaction center protein K;146786;
4TNI;o;RT XFEL structure of Photosystem II 500 ms after the third illumination at 4.6 A resolution;4.6;CA;CALCIUM ION;Photosystem II manganese-stabilizing polypeptide;146786;
4TNJ;K;RT XFEL structure of Photosystem II 500 ms after the 2nd illumination (2F) at 4.5 A resolution;4.5;CA;CALCIUM ION;Photosystem II reaction center protein K;146786;
4TNJ;O;RT XFEL structure of Photosystem II 500 ms after the 2nd illumination (2F) at 4.5 A resolution;4.5;CA;CALCIUM ION;Photosystem II manganese-stabilizing polypeptide;146786;
4TNJ;k;RT XFEL structure of Photosystem II 500 ms after the 2nd illumination (2F) at 4.5 A resolution;4.5;CA;CALCIUM ION;Photosystem II reaction center protein K;146786;
4TNJ;o;RT XFEL structure of Photosystem II 500 ms after the 2nd illumination (2F) at 4.5 A resolution;4.5;CA;CALCIUM ION;Photosystem II manganese-stabilizing polypeptide;146786;
4TNK;K;RT XFEL structure of Photosystem II 250 microsec after the third illumination at 5.2 A resolution;5.2;CA;CALCIUM ION;Photosystem II reaction center protein K;146786;
4TNK;O;RT XFEL structure of Photosystem II 250 microsec after the third illumination at 5.2 A resolution;5.2;CA;CALCIUM ION;Photosystem II manganese-stabilizing polypeptide;146786;
4TNK;k;RT XFEL structure of Photosystem II 250 microsec after the third illumination at 5.2 A resolution;5.2;CA;CALCIUM ION;Photosystem II reaction center protein K;146786;
4TNK;o;RT XFEL structure of Photosystem II 250 microsec after the third illumination at 5.2 A resolution;5.2;CA;CALCIUM ION;Photosystem II manganese-stabilizing polypeptide;146786;
4TNL;A;1.8 A resolution room temperature structure of Thermolysin recorded using an XFEL;1.8;CA;CALCIUM ION;Thermolysin;1427;
4TPI;Z;THE REFINED 2.2-ANGSTROMS (0.22-NM) X-RAY CRYSTAL STRUCTURE OF THE TERNARY COMPLEX FORMED BY BOVINE TRYPSINOGEN, VALINE-VALINE AND THE ARG15 ANALOGUE OF BOVINE PANCREATIC TRYPSIN INHIBITOR;2.2;CA;CALCIUM ION;TRYPSINOGEN;9913;
4TPY;A;High throughput screening using acoustic droplet ejection to combine protein crystals and chemical libraries on crystallization plates at high density;1.3;CA;CALCIUM ION;Cationic trypsin;9913;
4TQO;A;The crystal structure of methanol dehydrogenase from Methylococcus capsulatus (Bath);2.57;CA;CALCIUM ION;Methanol dehydrogenase protein, large subunit;414;
4TQO;B;The crystal structure of methanol dehydrogenase from Methylococcus capsulatus (Bath);2.57;CA;CALCIUM ION;Methanol dehydrogenase protein, large subunit;414;
4TQO;C;The crystal structure of methanol dehydrogenase from Methylococcus capsulatus (Bath);2.57;CA;CALCIUM ION;Methanol dehydrogenase protein, large subunit;414;
4TQO;D;The crystal structure of methanol dehydrogenase from Methylococcus capsulatus (Bath);2.57;CA;CALCIUM ION;Methanol dehydrogenase protein, large subunit;414;
4TQO;E;The crystal structure of methanol dehydrogenase from Methylococcus capsulatus (Bath);2.57;CA;CALCIUM ION;Methanol dehydrogenase protein, large subunit;414;
4TQO;F;The crystal structure of methanol dehydrogenase from Methylococcus capsulatus (Bath);2.57;CA;CALCIUM ION;Methanol dehydrogenase protein, large subunit;414;
4TQO;G;The crystal structure of methanol dehydrogenase from Methylococcus capsulatus (Bath);2.57;CA;CALCIUM ION;Methanol dehydrogenase protein, large subunit;414;
4TQO;H;The crystal structure of methanol dehydrogenase from Methylococcus capsulatus (Bath);2.57;CA;CALCIUM ION;Methanol dehydrogenase protein, large subunit;414;
4TQR;P;Ternary complex of Y-family DNA polymerase Dpo4 with (5'S)-8,5'-Cyclo-2'-deoxyguanosine and dTTP;1.58;CA;CALCIUM ION;DNA (5'-D(*GP*GP*GP*GP*GP*AP*AP*GP*GP*AP*TP*T)-3');32630;
4TQR;T;Ternary complex of Y-family DNA polymerase Dpo4 with (5'S)-8,5'-Cyclo-2'-deoxyguanosine and dTTP;1.58;CA;CALCIUM ION;DNA (5'-D(*TP*CP*AP*CP*(2LF)P*GP*AP*AP*TP*CP*CP*TP*TP*CP*CP*CP*CP*C)-3');32630;
4TQU;Q;Crystal structure of a bacterial ABC transporter involved in the import of the acidic polysaccharide alginate;3.2;CA;CALCIUM ION;AlgQ2;28214;
4TR2;A;Crystal structure of PvSUB1;2.7;CA;CALCIUM ION;Subtilisin-like 1 serine protease;5855;
4TR2;B;Crystal structure of PvSUB1;2.7;CA;CALCIUM ION;Subtilisin-like 1 serine protease;5855;
4TRD;A;Crystal structure of Staphylcoccal nuclease variant Delta+PHS I72K/V74K at pH 9.0 at cryogenic temperature;1.6;CA;CALCIUM ION;Thermonuclease;1280;
4TSH;B;A Novel Protein Fold Forms an Intramolecular Lock to Stabilize the Tertiary Structure of Streptococcus mutans Adhesin P1;2;CA;CALCIUM ION;Surface protein adhesin;1309;
4TTU;A;N-terminally truncated dextransucrase DSR-E from Leuconostoc mesenteroides NRRL B-1299 in complex with isomaltotriose;2.18;CA;CALCIUM ION;Dextransucrase;1245;
4TUW;C;drosophila stem-loop binding protein complexed with histone mRNA stem-loop, phospho mimic of TPNK and C-terminal region;2.9;CA;CALCIUM ION;HISTONE MRNA 3' STEM LOOP;32630;
4TUW;D;drosophila stem-loop binding protein complexed with histone mRNA stem-loop, phospho mimic of TPNK and C-terminal region;2.9;CA;CALCIUM ION;HISTONE MRNA 3' STEM LOOP;32630;
4TUX;C;drosophila stem-loop binding protein complexed with histone mRNA stem-loop;3.08;CA;CALCIUM ION;RNA (26-MER);32630;
4TUX;D;drosophila stem-loop binding protein complexed with histone mRNA stem-loop;3.08;CA;CALCIUM ION;RNA (26-MER);32630;
4TUY;A;Tubulin-Rhizoxin complex;2.1;CA;CALCIUM ION;Tubulin alpha-1B chain;9913;
4TUY;C;Tubulin-Rhizoxin complex;2.1;CA;CALCIUM ION;Tubulin alpha-1B chain;9913;
4TV0;B;Drosophila stem-loop binding protein complexed with histone mRNA stem-loop, Selenomethionine derivative;2.6;CA;CALCIUM ION;RNA (26-MER);32630;
4TV5;A;Crystal Structure of Citrate Synthase SbnG;1.85;CA;CALCIUM ION;2-dehydro-3-deoxyglucarate aldolase;1280;
4TV8;A;Tubulin-Maytansine complex;2.1;CA;CALCIUM ION;Tubulin alpha-1B chain;9913;
4TV8;B;Tubulin-Maytansine complex;2.1;CA;CALCIUM ION;Tubulin beta-2B chain;9913;
4TV8;C;Tubulin-Maytansine complex;2.1;CA;CALCIUM ION;Tubulin alpha-1B chain;9913;
4TV9;A;Tubulin-PM060184 complex;2;CA;CALCIUM ION;Tubulin alpha-1B chain;9913;
4TV9;C;Tubulin-PM060184 complex;2;CA;CALCIUM ION;Tubulin alpha-1B chain;9913;
4TVC;A;N-terminally truncated dextransucrase DSR-E from Leuconostoc mesenteroides NRRL B-1299 in complex with gluco-oligosaccharides;1.85;CA;CALCIUM ION;Dextransucrase;1245;
4TVD;A;N-terminally truncated dextransucrase DSR-E from Leuconostoc mesenteroides NRRL B-1299 in complex with D-glucose;2.3;CA;CALCIUM ION;Dextransucrase;1245;
4TVU;A;Crystal structure of trehalose synthase from Deinococcus radiodurans reveals a closed conformation for catalysis of the intramolecular isomerization;2.7;CA;CALCIUM ION;Trehalose synthase;1299;
4TVU;B;Crystal structure of trehalose synthase from Deinococcus radiodurans reveals a closed conformation for catalysis of the intramolecular isomerization;2.7;CA;CALCIUM ION;Trehalose synthase;1299;
4TVU;C;Crystal structure of trehalose synthase from Deinococcus radiodurans reveals a closed conformation for catalysis of the intramolecular isomerization;2.7;CA;CALCIUM ION;Trehalose synthase;1299;
4TVU;D;Crystal structure of trehalose synthase from Deinococcus radiodurans reveals a closed conformation for catalysis of the intramolecular isomerization;2.7;CA;CALCIUM ION;Trehalose synthase;1299;
4TVU;E;Crystal structure of trehalose synthase from Deinococcus radiodurans reveals a closed conformation for catalysis of the intramolecular isomerization;2.7;CA;CALCIUM ION;Trehalose synthase;1299;
4TVU;F;Crystal structure of trehalose synthase from Deinococcus radiodurans reveals a closed conformation for catalysis of the intramolecular isomerization;2.7;CA;CALCIUM ION;Trehalose synthase;1299;
4TVU;G;Crystal structure of trehalose synthase from Deinococcus radiodurans reveals a closed conformation for catalysis of the intramolecular isomerization;2.7;CA;CALCIUM ION;Trehalose synthase;1299;
4TVU;H;Crystal structure of trehalose synthase from Deinococcus radiodurans reveals a closed conformation for catalysis of the intramolecular isomerization;2.7;CA;CALCIUM ION;Trehalose synthase;1299;
4TWE;A;Structure of ligand-free N-acetylated-alpha-linked-acidic-dipeptidase like protein (NAALADaseL);1.75;CA;CALCIUM ION;N-acetylated-alpha-linked acidic dipeptidase-like protein;9606;
4TWE;B;Structure of ligand-free N-acetylated-alpha-linked-acidic-dipeptidase like protein (NAALADaseL);1.75;CA;CALCIUM ION;N-acetylated-alpha-linked acidic dipeptidase-like protein;9606;
4TX8;A;Crystal Structure of a Family GH18 Chitinase from Chromobacterium violaceum;2.17;CA;CALCIUM ION;Probable chitinase A;536;
4TXW;A;Crystal structure of CBM32-4 from the Clostridium perfringens NagH;1.4;CA;CALCIUM ION;Hyaluronoglucosaminidase;1502;
4TYQ;A;Crystal structure of an adenylate kinase mutant--AKm2;1.65;CA;CALCIUM ION;Adenylate kinase;1423;
4U08;A;Structure of Leptospira interrogans LRR protein LIC11098;1.95;CA;CALCIUM ION;LIC11098;173;
4U2A;A;Structure of a lectin from the seeds of Vatairea macrocarpa complexed with GalNAc;1.74;CA;CALCIUM ION;Seed lectin;77050;
4U2W;A;Atomic resolution crystal structure of HV-BBI protease inhibitor from amphibian skin in complex with bovine trypsin;1;CA;CALCIUM ION;Cationic trypsin;9913;
4U30;A;Human mesotrypsin complexed with bikunin Kunitz domain 2;2.5;CA;CALCIUM ION;Trypsin-3;9606;
4U30;B;Human mesotrypsin complexed with bikunin Kunitz domain 2;2.5;CA;CALCIUM ION;Trypsin-3;9606;
4U30;C;Human mesotrypsin complexed with bikunin Kunitz domain 2;2.5;CA;CALCIUM ION;Trypsin-3;9606;
4U30;D;Human mesotrypsin complexed with bikunin Kunitz domain 2;2.5;CA;CALCIUM ION;Trypsin-3;9606;
4U32;A;Human mesotrypsin complexed with HAI-2 Kunitz domain 1;1.65;CA;CALCIUM ION;Trypsin-3;9606;
4U36;A;Crystal structure of a seed lectin from Vatairea macrocarpa complexed with Tn-antigen;1.4;CA;CALCIUM ION;Seed lectin;77050;
4U3L;A;octameric RNA duplex co-crystallized in calcium(II)chloride;1.48;CA;CALCIUM ION;RNA (5'-R(*UP*CP*GP*UP*AP*CP*GP*A)-3');32630;
4U3L;B;octameric RNA duplex co-crystallized in calcium(II)chloride;1.48;CA;CALCIUM ION;RNA (5'-R(*UP*CP*GP*UP*AP*CP*GP*A)-3');32630;
4U3S;B;Crystal structure of Coh3ScaB-XDoc_M1ScaA complex: A N-terminal interface mutant of type II Cohesin-X-Dockerin complex from Acetivibrio cellulolyticus;1.64;CA;CALCIUM ION;Cellulosomal scaffoldin;35830;
4U49;B;Crystal structure of Pectate Lyase Pel3 from Pectobacterium carotovorum with two monomers in the A.U;1.8;CA;CALCIUM ION;Pectate lyase;554;
4U65;E;Structure of the periplasmic output domain of the Legionella pneumophila LapD ortholog CdgS9 in complex with Pseudomonas fluorescens LapG;2.1;CA;CALCIUM ION;Putative cystine protease;294;
4U65;F;Structure of the periplasmic output domain of the Legionella pneumophila LapD ortholog CdgS9 in complex with Pseudomonas fluorescens LapG;2.1;CA;CALCIUM ION;Putative cystine protease;294;
4U6B;A;Zg3597, a family 117 glycoside hydrolase, produced by the marine bacterium Zobellia galactanivorans;2.3;CA;CALCIUM ION;Conserved hypothetical lipoprotein;63186;
4U6B;B;Zg3597, a family 117 glycoside hydrolase, produced by the marine bacterium Zobellia galactanivorans;2.3;CA;CALCIUM ION;Conserved hypothetical lipoprotein;63186;
4U6B;C;Zg3597, a family 117 glycoside hydrolase, produced by the marine bacterium Zobellia galactanivorans;2.3;CA;CALCIUM ION;Conserved hypothetical lipoprotein;63186;
4U6B;D;Zg3597, a family 117 glycoside hydrolase, produced by the marine bacterium Zobellia galactanivorans;2.3;CA;CALCIUM ION;Conserved hypothetical lipoprotein;63186;
4U6D;A;Zg3615, a family 117 glycoside hydrolase in complex with beta-3,6-anhydro-L-galactose;1.7;CA;CALCIUM ION;Conserved hypothetical periplasmic protein;63186;
4U6D;B;Zg3615, a family 117 glycoside hydrolase in complex with beta-3,6-anhydro-L-galactose;1.7;CA;CALCIUM ION;Conserved hypothetical periplasmic protein;63186;
4U6Q;A;CtBP1 bound to inhibitor 2-(hydroxyimino)-3-phenylpropanoic acid;2.3;CA;CALCIUM ION;C-terminal-binding protein 1;9606;
4U6S;A;CtBP1 in complex with substrate phenylpyruvate;2.1;CA;CALCIUM ION;C-terminal-binding protein 1;9606;
4U78;A;Octameric RNA duplex soaked in copper(II)chloride;1.5;CA;CALCIUM ION;RNA (5'-R(*UP*CP*GP*UP*AP*CP*GP*A)-3');32630;
4U7K;A;Crystal structure of the Clostridium histolyticum colH collagenase polycystic kidney disease-like domain 2a in the presence of calcium at 1.9 Angstrom resolution;1.91;CA;CALCIUM ION;ColH protein;1498;
4U7K;B;Crystal structure of the Clostridium histolyticum colH collagenase polycystic kidney disease-like domain 2a in the presence of calcium at 1.9 Angstrom resolution;1.91;CA;CALCIUM ION;ColH protein;1498;
4U7K;C;Crystal structure of the Clostridium histolyticum colH collagenase polycystic kidney disease-like domain 2a in the presence of calcium at 1.9 Angstrom resolution;1.91;CA;CALCIUM ION;ColH protein;1498;
4U7K;D;Crystal structure of the Clostridium histolyticum colH collagenase polycystic kidney disease-like domain 2a in the presence of calcium at 1.9 Angstrom resolution;1.91;CA;CALCIUM ION;ColH protein;1498;
4U7K;E;Crystal structure of the Clostridium histolyticum colH collagenase polycystic kidney disease-like domain 2a in the presence of calcium at 1.9 Angstrom resolution;1.91;CA;CALCIUM ION;ColH protein;1498;
4U7K;F;Crystal structure of the Clostridium histolyticum colH collagenase polycystic kidney disease-like domain 2a in the presence of calcium at 1.9 Angstrom resolution;1.91;CA;CALCIUM ION;ColH protein;1498;
4U7K;G;Crystal structure of the Clostridium histolyticum colH collagenase polycystic kidney disease-like domain 2a in the presence of calcium at 1.9 Angstrom resolution;1.91;CA;CALCIUM ION;ColH protein;1498;
4U7K;H;Crystal structure of the Clostridium histolyticum colH collagenase polycystic kidney disease-like domain 2a in the presence of calcium at 1.9 Angstrom resolution;1.91;CA;CALCIUM ION;ColH protein;1498;
4U8U;M;The Crystallographic structure of the giant hemoglobin from Glossoscolex paulistus at 3.2 A resolution.;3.2;CA;CALCIUM ION;Linker L1;1046353;
4U8U;N;The Crystallographic structure of the giant hemoglobin from Glossoscolex paulistus at 3.2 A resolution.;3.2;CA;CALCIUM ION;Linker L2;1046353;
4U8U;O;The Crystallographic structure of the giant hemoglobin from Glossoscolex paulistus at 3.2 A resolution.;3.2;CA;CALCIUM ION;Linker L3;1046353;
4U8U;b;The Crystallographic structure of the giant hemoglobin from Glossoscolex paulistus at 3.2 A resolution.;3.2;CA;CALCIUM ION;Linker L1;1046353;
4U8U;c;The Crystallographic structure of the giant hemoglobin from Glossoscolex paulistus at 3.2 A resolution.;3.2;CA;CALCIUM ION;Linker L2;1046353;
4U8U;d;The Crystallographic structure of the giant hemoglobin from Glossoscolex paulistus at 3.2 A resolution.;3.2;CA;CALCIUM ION;Linker L3;1046353;
4U8U;q;The Crystallographic structure of the giant hemoglobin from Glossoscolex paulistus at 3.2 A resolution.;3.2;CA;CALCIUM ION;Linker L1;1046353;
4U8U;r;The Crystallographic structure of the giant hemoglobin from Glossoscolex paulistus at 3.2 A resolution.;3.2;CA;CALCIUM ION;Linker L2;1046353;
4U8U;s;The Crystallographic structure of the giant hemoglobin from Glossoscolex paulistus at 3.2 A resolution.;3.2;CA;CALCIUM ION;Linker L3;1046353;
4U91;A;GephE in complex with Para-Phenyl crosslinked Glycine receptor beta subunit derived dimeric peptide;2;CA;CALCIUM ION;Gephyrin;10116;
4U9E;A;Crystal structure of the Zn-directed tetramer of the engineered cyt cb562 variant, A104/57G AB3;2.8;CA;CALCIUM ION;Soluble cytochrome b562;562;
4UAP;A;X-ray structure of GH31 CBM32-2 bound to GalNAc;2;CA;CALCIUM ION;Glycosyl hydrolase, family 31/fibronectin type III domain protein;1502;
4UAP;B;X-ray structure of GH31 CBM32-2 bound to GalNAc;2;CA;CALCIUM ION;Glycosyl hydrolase, family 31/fibronectin type III domain protein;1502;
4UAW;A;DNA polymerase beta substrate complex with a templating adenine and incoming 8-oxodGTP, 0 s;1.9;CA;CALCIUM ION;DNA polymerase beta;9606;
4UB4;A;DNA polymerase beta substrate complex with a templating cytosine and incoming dGTP, 0 s;1.95;CA;CALCIUM ION;DNA polymerase beta;9606;
4UB6;B;Native structure of photosystem II (dataset-1) by a femtosecond X-ray laser;1.95;CA;CALCIUM ION;Photosystem II CP47 chlorophyll apoprotein;32053;
4UB6;F;Native structure of photosystem II (dataset-1) by a femtosecond X-ray laser;1.95;CA;CALCIUM ION;Cytochrome b559 subunit beta;32053;
4UB6;O;Native structure of photosystem II (dataset-1) by a femtosecond X-ray laser;1.95;CA;CALCIUM ION;Photosystem II manganese-stabilizing polypeptide;32053;
4UB6;b;Native structure of photosystem II (dataset-1) by a femtosecond X-ray laser;1.95;CA;CALCIUM ION;Photosystem II CP47 chlorophyll apoprotein;32053;
4UB6;c;Native structure of photosystem II (dataset-1) by a femtosecond X-ray laser;1.95;CA;CALCIUM ION;Photosystem II 44 kDa reaction center protein;32053;
4UB6;f;Native structure of photosystem II (dataset-1) by a femtosecond X-ray laser;1.95;CA;CALCIUM ION;Cytochrome b559 subunit beta;32053;
4UB6;o;Native structure of photosystem II (dataset-1) by a femtosecond X-ray laser;1.95;CA;CALCIUM ION;Photosystem II manganese-stabilizing polypeptide;32053;
4UB8;B;Native structure of photosystem II (dataset-2) by a femtosecond X-ray laser;1.95;CA;CALCIUM ION;Photosystem II CP47 chlorophyll apoprotein;32053;
4UB8;F;Native structure of photosystem II (dataset-2) by a femtosecond X-ray laser;1.95;CA;CALCIUM ION;Cytochrome b559 subunit beta;32053;
4UB8;O;Native structure of photosystem II (dataset-2) by a femtosecond X-ray laser;1.95;CA;CALCIUM ION;Photosystem II manganese-stabilizing polypeptide;32053;
4UB8;b;Native structure of photosystem II (dataset-2) by a femtosecond X-ray laser;1.95;CA;CALCIUM ION;Photosystem II CP47 chlorophyll apoprotein;32053;
4UB8;c;Native structure of photosystem II (dataset-2) by a femtosecond X-ray laser;1.95;CA;CALCIUM ION;Photosystem II 44 kDa reaction center protein;32053;
4UB8;f;Native structure of photosystem II (dataset-2) by a femtosecond X-ray laser;1.95;CA;CALCIUM ION;Cytochrome b559 subunit beta;32053;
4UB8;o;Native structure of photosystem II (dataset-2) by a femtosecond X-ray laser;1.95;CA;CALCIUM ION;Photosystem II manganese-stabilizing polypeptide;32053;
4UBB;P;DNA polymerase beta reactant complex with a templating cytosine and incoming 8-oxodGTP, 40 s;1.9;CA;CALCIUM ION;5'-D(*GP*CP*TP*GP*AP*TP*GP*CP*GP*CP*(8OG))-3';32630;
4UBC;A;DNA polymerase beta substrate complex with a templating cytosine and incoming 8-oxodGTP, 0 s;2;CA;CALCIUM ION;DNA polymerase beta;9606;
4UBC;P;DNA polymerase beta substrate complex with a templating cytosine and incoming 8-oxodGTP, 0 s;2;CA;CALCIUM ION;5'-D(*GP*CP*TP*GP*AP*TP*GP*CP*GP*C)-3';32630;
4UDM;A;Crystal structure of Im3 in complex with Y52A mutant of E3RNase;2.96;CA;CALCIUM ION;COLICIN-E3 IMMUNITY PROTEIN;562;
4UDM;B;Crystal structure of Im3 in complex with Y52A mutant of E3RNase;2.96;CA;CALCIUM ION;COLICIN-E3;562;
4UEQ;Q;Structure of the V74C large subunit mutant of D. fructosovorans NiFe- hydrogenase;1.7;CA;CALCIUM ION;NICKEL-DEPENDENT HYDROGENASE LARGE SUBUNIT;878;
4UEQ;R;Structure of the V74C large subunit mutant of D. fructosovorans NiFe- hydrogenase;1.7;CA;CALCIUM ION;NICKEL-DEPENDENT HYDROGENASE LARGE SUBUNIT;878;
4UEQ;S;Structure of the V74C large subunit mutant of D. fructosovorans NiFe- hydrogenase;1.7;CA;CALCIUM ION;NICKEL-DEPENDENT HYDROGENASE LARGE SUBUNIT;878;
4UEQ;T;Structure of the V74C large subunit mutant of D. fructosovorans NiFe- hydrogenase;1.7;CA;CALCIUM ION;NICKEL-DEPENDENT HYDROGENASE LARGE SUBUNIT;878;
4UEQ;U;Structure of the V74C large subunit mutant of D. fructosovorans NiFe- hydrogenase;1.7;CA;CALCIUM ION;NICKEL-DEPENDENT HYDROGENASE LARGE SUBUNIT;878;
4UEQ;V;Structure of the V74C large subunit mutant of D. fructosovorans NiFe- hydrogenase;1.7;CA;CALCIUM ION;NICKEL-DEPENDENT HYDROGENASE LARGE SUBUNIT;878;
4UFC;A;Crystal structure of the GH95 enzyme BACOVA_03438;2.81;CA;CALCIUM ION;GH95;28116;
4UFC;B;Crystal structure of the GH95 enzyme BACOVA_03438;2.81;CA;CALCIUM ION;GH95;28116;
4UFH;A;Mouse Galactocerebrosidase complexed with iso-galacto-fagomine IGF;2.16;CA;CALCIUM ION;GALACTOCEREBROSIDASE;10090;
4UFI;A;Mouse Galactocerebrosidase complexed with aza-galacto-fagomine AGF;2.4;CA;CALCIUM ION;GALACTOCEREBROSIDASE;10090;
4UFJ;A;Mouse Galactocerebrosidase complexed with iso-galacto-fagomine lactam IGL;2.2;CA;CALCIUM ION;GALACTOCEREBROSIDASE;10090;
4UFK;A;Mouse Galactocerebrosidase complexed with dideoxy-imino-lyxitol DIL;2.4;CA;CALCIUM ION;GALACTOCEREBROSIDASE;10090;
4UFL;A;Mouse Galactocerebrosidase complexed with deoxy-galacto-noeurostegine DGN;2.4;CA;CALCIUM ION;GALACTOCEREBROSIDASE;10090;
4UFM;A;Mouse Galactocerebrosidase complexed with 1-deoxy-galacto-nojirimycin DGJ;2.4;CA;CALCIUM ION;GALACTOCEREBROSIDASE;10090;
4UIE;A;Crystal structure of the S-layer protein SbsC, domains 7, 8 and 9;3.1;CA;CALCIUM ION;SURFACE LAYER PROTEIN;1422;
4UIX;A;N-TERMINAL BROMODOMAIN OF HUMAN BRD4 WITH 7-(3,4-dimethoxyphenyl)-N-(1,1-dioxo-1-thian-4-yl)-5-methyl-4-oxo-4H,5H-thieno-3,2-c-pyridine-2- carboxamide;1.58;CA;CALCIUM ION;BROMODOMAIN-CONTAINING PROTEIN 4;9606;
4UIX;B;N-TERMINAL BROMODOMAIN OF HUMAN BRD4 WITH 7-(3,4-dimethoxyphenyl)-N-(1,1-dioxo-1-thian-4-yl)-5-methyl-4-oxo-4H,5H-thieno-3,2-c-pyridine-2- carboxamide;1.58;CA;CALCIUM ION;BROMODOMAIN-CONTAINING PROTEIN 4;9606;
4UJ7;A;Structure of the S-layer protein SbsC, domains 5-6;1.54;CA;CALCIUM ION;SURFACE LAYER PROTEIN;1422;
4UJ8;A;Structure of surface layer protein SbsC, domains 6-7;1.7;CA;CALCIUM ION;SURFACE LAYER PROTEIN;1422;
4UJ8;B;Structure of surface layer protein SbsC, domains 6-7;1.7;CA;CALCIUM ION;SURFACE LAYER PROTEIN;1422;
4UJ8;C;Structure of surface layer protein SbsC, domains 6-7;1.7;CA;CALCIUM ION;SURFACE LAYER PROTEIN;1422;
4UJ8;D;Structure of surface layer protein SbsC, domains 6-7;1.7;CA;CALCIUM ION;SURFACE LAYER PROTEIN;1422;
4UM8;A;Crystal structure of alpha V beta 6;2.85;CA;CALCIUM ION;INTEGRIN ALPHA-V;9606;
4UM8;B;Crystal structure of alpha V beta 6;2.85;CA;CALCIUM ION;INTEGRIN BETA-6;9606;
4UM8;C;Crystal structure of alpha V beta 6;2.85;CA;CALCIUM ION;INTEGRIN ALPHA-V;9606;
4UM8;D;Crystal structure of alpha V beta 6;2.85;CA;CALCIUM ION;INTEGRIN BETA-6;9606;
4UM9;A;Crystal structure of alpha V beta 6 with peptide;2.5;CA;CALCIUM ION;INTEGRIN ALPHA-V;9606;
4UM9;B;Crystal structure of alpha V beta 6 with peptide;2.5;CA;CALCIUM ION;INTEGRIN BETA-6;9606;
4UM9;C;Crystal structure of alpha V beta 6 with peptide;2.5;CA;CALCIUM ION;INTEGRIN ALPHA-V;9606;
4UM9;D;Crystal structure of alpha V beta 6 with peptide;2.5;CA;CALCIUM ION;INTEGRIN BETA-6;9606;
4UMO;C;Crystal Structure of the Kv7.1 proximal C-terminal Domain in Complex with Calmodulin;3;CA;CALCIUM ION;CALMODULIN;9606;
4UMO;D;Crystal Structure of the Kv7.1 proximal C-terminal Domain in Complex with Calmodulin;3;CA;CALCIUM ION;CALMODULIN;9606;
4UNO;A;Crystal structure of the ETS domain of human ETV5 in complex with DNA;1.95;CA;CALCIUM ION;ETS TRANSLOCATION VARIANT 5;9606;
4UOJ;B;Structure of Fungal beta-mannosidase (GH2) from Trichoderma harzianum;2.5;CA;CALCIUM ION;BETA-MANNOSIDASE GH2;5544;
4UP4;A;Structure of the recombinant lectin PVL from Psathyrella velutina in complex with GlcNAcb-D-1,3Galactoside;1.95;CA;CALCIUM ION;LECTIN PVL;71681;
4UP4;B;Structure of the recombinant lectin PVL from Psathyrella velutina in complex with GlcNAcb-D-1,3Galactoside;1.95;CA;CALCIUM ION;LECTIN PVL;71681;
4UPE;Q;Structure of the unready Ni-A state of the S499C mutant of D. fructosovorans NiFe-hydrogenase;1.8;CA;CALCIUM ION;NICKEL-DEPENDENT HYDROGENASE LARGE SUBUNIT;878;
4UPE;R;Structure of the unready Ni-A state of the S499C mutant of D. fructosovorans NiFe-hydrogenase;1.8;CA;CALCIUM ION;NICKEL-DEPENDENT HYDROGENASE LARGE SUBUNIT;878;
4UPE;S;Structure of the unready Ni-A state of the S499C mutant of D. fructosovorans NiFe-hydrogenase;1.8;CA;CALCIUM ION;NICKEL-DEPENDENT HYDROGENASE LARGE SUBUNIT;878;
4UPU;A;Crystal structure of IP3 3-K calmodulin binding region in complex with Calmodulin;2.34;CA;CALCIUM ION;CALMODULIN;9606;
4UR9;B;Structure of ligand bound glycosylhydrolase;2.2;CA;CALCIUM ION;O-GLCNACASE BT_4395;818;
4URT;A;The crystal structure of a fragment of netrin-1 in complex with FN5- FN6 of DCC;3.1;CA;CALCIUM ION;NETRIN-1;9606;
4US6;A;New Crystal Form of Glucose Isomerase Grown in Short Peptide Supramolecular Hydrogels;1.2;CA;CALCIUM ION;XYLOSE ISOMERASE;1929;
4US6;B;New Crystal Form of Glucose Isomerase Grown in Short Peptide Supramolecular Hydrogels;1.2;CA;CALCIUM ION;XYLOSE ISOMERASE;1929;
4USC;A;Crystal structure of peroxidase from palm tree Chamaerops excelsa;2.6;CA;CALCIUM ION;PEROXIDASE;14027;
4USC;B;Crystal structure of peroxidase from palm tree Chamaerops excelsa;2.6;CA;CALCIUM ION;PEROXIDASE;14027;
4USL;A;The X-ray structure of calcium bound human sorcin;1.65;CA;CALCIUM ION;SORCIN;9606;
4USU;A;Crystal structure of human soluble Adenylyl Cyclase in complex with alpha,beta-methyleneadenosine-5'-triphosphate;1.95;CA;CALCIUM ION;ADENYLATE CYCLASE TYPE 10;9606;
4USV;A;Crystal structure of human soluble Adenylyl Cyclase with pyrophosphate resulting from soaking with ATP and Calcium;2;CA;CALCIUM ION;ADENYLATE CYCLASE TYPE 10;9606;
4UT5;A;Crystal structure of the LecB lectin from Pseudomonas aeruginosa strain PA7 in complex with lewis a tetrasaccharide;1.75;CA;CALCIUM ION;LECB LECTIN;287;
4UT5;B;Crystal structure of the LecB lectin from Pseudomonas aeruginosa strain PA7 in complex with lewis a tetrasaccharide;1.75;CA;CALCIUM ION;LECB LECTIN;287;
4UT5;C;Crystal structure of the LecB lectin from Pseudomonas aeruginosa strain PA7 in complex with lewis a tetrasaccharide;1.75;CA;CALCIUM ION;LECB LECTIN;287;
4UT5;D;Crystal structure of the LecB lectin from Pseudomonas aeruginosa strain PA7 in complex with lewis a tetrasaccharide;1.75;CA;CALCIUM ION;LECB LECTIN;287;
4UX8;A;RET recognition of GDNF-GFRalpha1 ligand by a composite binding site promotes membrane-proximal self-association;24;CA;CALCIUM ION;PROTO-ONCOGENE TYROSINE-PROTEIN KINASE RECEPTOR RET;9606;
4UX8;B;RET recognition of GDNF-GFRalpha1 ligand by a composite binding site promotes membrane-proximal self-association;24;CA;CALCIUM ION;PROTO-ONCOGENE TYROSINE-PROTEIN KINASE RECEPTOR RET;9606;
4UY1;A;Novel pyrazole series of group X Secretory Phospholipase A2 (sPLA2-X) inhibitors;2.2;CA;CALCIUM ION;GROUP 10 SECRETORY PHOSPHOLIPASE A2;9606;
4UY1;B;Novel pyrazole series of group X Secretory Phospholipase A2 (sPLA2-X) inhibitors;2.2;CA;CALCIUM ION;GROUP 10 SECRETORY PHOSPHOLIPASE A2;9606;
4UYP;B;High resolution structure of the third cohesin ScaC in complex with the ScaB dockerin with a mutation in the N-terminal helix (IN to SI) from Acetivibrio cellulolyticus displaying a type I interaction.;1.49;CA;CALCIUM ION;Cellulosomal scaffoldin adaptor protein B;35830;
4UYP;D;High resolution structure of the third cohesin ScaC in complex with the ScaB dockerin with a mutation in the N-terminal helix (IN to SI) from Acetivibrio cellulolyticus displaying a type I interaction.;1.49;CA;CALCIUM ION;Cellulosomal scaffoldin adaptor protein B;35830;
4UYQ;A;High resolution structure of the third cohesin ScaC in complex with the ScaB dockerin with a mutation in the C-terminal helix (IN to SI) from Acetivibrio cellulolyticus displaying a type I interaction.;1.81;CA;CALCIUM ION;Cellulosomal scaffoldin anchoring protein C;35830;
4UYQ;B;High resolution structure of the third cohesin ScaC in complex with the ScaB dockerin with a mutation in the C-terminal helix (IN to SI) from Acetivibrio cellulolyticus displaying a type I interaction.;1.81;CA;CALCIUM ION;Cellulosomal scaffoldin adaptor protein B;35830;
4UZG;A;Crystal structure of group B streptococcus pilus 2b backbone protein SAK_1440;1.06;CA;CALCIUM ION;SURFACE PROTEIN SPB1;1311;
4UZU;A;Three-dimensional structure of a variant `Termamyl-like' Geobacillus stearothermophilus alpha-amylase at 1.9 A resolution;1.9;CA;CALCIUM ION;ALPHA-AMYLASE;1422;
4V0C;C;Crystal Structure of the Kv7.1 proximal C-terminal Domain in Complex with Calmodulin;2.86;CA;CALCIUM ION;CALMODULIN;9606;
4V0C;D;Crystal Structure of the Kv7.1 proximal C-terminal Domain in Complex with Calmodulin;2.86;CA;CALCIUM ION;CALMODULIN;9606;
4V11;A;Structure of Synaptotagmin-1 with SV2A peptide phosphorylated at Thr84;1.95;CA;CALCIUM ION;SYNAPTOTAGMIN-1;9606;
4V1K;A;SeMet structure of a novel carbohydrate binding module from glycoside hydrolase family 9 (Cel9A) from Ruminococcus flavefaciens FD-1;1.6;CA;CALCIUM ION;CARBOHYDRATE BINDING MODULE;1265;
4V1U;A;Heterocyclase in complex with substrate and Cofactor;2.86;CA;CALCIUM ION;LYND;118322;
4V1U;B;Heterocyclase in complex with substrate and Cofactor;2.86;CA;CALCIUM ION;LYND;118322;
4V29;A;The crystal structure of Arabidopsis thaliana CAR4 in complex with two calcium ions;1.6;CA;CALCIUM ION;AT3G17980;3702;
4V29;B;The crystal structure of Arabidopsis thaliana CAR4 in complex with two calcium ions;1.6;CA;CALCIUM ION;AT3G17980;3702;
4V2X;A;High resolution structure of the full length tri-modular endo-beta-1, 4-glucanase B (Cel5B) from Bacillus halodurans;1.64;CA;CALCIUM ION;ENDO-BETA-1,4-GLUCANASE (CELLULASE B);86665;
4V35;A;The Structure of A-PGS from Pseudomonas aeruginosa;2.3;CA;CALCIUM ION;ALANYL-TRNA-DEPENDENT L-ALANYL- PHOPHATIDYLGLYCEROL SYNTHASE;287;
4V3O;A;Designed armadillo repeat protein with 5 internal repeats, 2nd generation C-cap and 3rd generation N-cap.;2;CA;CALCIUM ION;YIII_M5_AII;32630;
4V3O;B;Designed armadillo repeat protein with 5 internal repeats, 2nd generation C-cap and 3rd generation N-cap.;2;CA;CALCIUM ION;YIII_M5_AII;32630;
4V3O;C;Designed armadillo repeat protein with 5 internal repeats, 2nd generation C-cap and 3rd generation N-cap.;2;CA;CALCIUM ION;YIII_M5_AII;32630;
4V3O;D;Designed armadillo repeat protein with 5 internal repeats, 2nd generation C-cap and 3rd generation N-cap.;2;CA;CALCIUM ION;YIII_M5_AII;32630;
4V3Q;A;Designed armadillo repeat protein with 4 internal repeats, 2nd generation C-cap and 3rd generation N-cap.;1.8;CA;CALCIUM ION;YIII_M4_AII;32630;
4V3Q;B;Designed armadillo repeat protein with 4 internal repeats, 2nd generation C-cap and 3rd generation N-cap.;1.8;CA;CALCIUM ION;YIII_M4_AII;32630;
4V3Q;C;Designed armadillo repeat protein with 4 internal repeats, 2nd generation C-cap and 3rd generation N-cap.;1.8;CA;CALCIUM ION;YIII_M4_AII;32630;
4V3Q;D;Designed armadillo repeat protein with 4 internal repeats, 2nd generation C-cap and 3rd generation N-cap.;1.8;CA;CALCIUM ION;YIII_M4_AII;32630;
4V4C;A;Crystal Structure of Pyrogallol-Phloroglucinol Transhydroxylase from Pelobacter acidigallici;2.35;CA;CALCIUM ION;Pyrogallol hydroxytransferase large subunit;35816;
4V4C;B;Crystal Structure of Pyrogallol-Phloroglucinol Transhydroxylase from Pelobacter acidigallici;2.35;CA;CALCIUM ION;Pyrogallol hydroxytransferase small subunit;35816;
4V4C;C;Crystal Structure of Pyrogallol-Phloroglucinol Transhydroxylase from Pelobacter acidigallici;2.35;CA;CALCIUM ION;Pyrogallol hydroxytransferase large subunit;35816;
4V4C;D;Crystal Structure of Pyrogallol-Phloroglucinol Transhydroxylase from Pelobacter acidigallici;2.35;CA;CALCIUM ION;Pyrogallol hydroxytransferase small subunit;35816;
4V4C;E;Crystal Structure of Pyrogallol-Phloroglucinol Transhydroxylase from Pelobacter acidigallici;2.35;CA;CALCIUM ION;Pyrogallol hydroxytransferase large subunit;35816;
4V4C;F;Crystal Structure of Pyrogallol-Phloroglucinol Transhydroxylase from Pelobacter acidigallici;2.35;CA;CALCIUM ION;Pyrogallol hydroxytransferase small subunit;35816;
4V4C;G;Crystal Structure of Pyrogallol-Phloroglucinol Transhydroxylase from Pelobacter acidigallici;2.35;CA;CALCIUM ION;Pyrogallol hydroxytransferase large subunit;35816;
4V4C;H;Crystal Structure of Pyrogallol-Phloroglucinol Transhydroxylase from Pelobacter acidigallici;2.35;CA;CALCIUM ION;Pyrogallol hydroxytransferase small subunit;35816;
4V4C;I;Crystal Structure of Pyrogallol-Phloroglucinol Transhydroxylase from Pelobacter acidigallici;2.35;CA;CALCIUM ION;Pyrogallol hydroxytransferase large subunit;35816;
4V4C;J;Crystal Structure of Pyrogallol-Phloroglucinol Transhydroxylase from Pelobacter acidigallici;2.35;CA;CALCIUM ION;Pyrogallol hydroxytransferase small subunit;35816;
4V4C;K;Crystal Structure of Pyrogallol-Phloroglucinol Transhydroxylase from Pelobacter acidigallici;2.35;CA;CALCIUM ION;Pyrogallol hydroxytransferase large subunit;35816;
4V4C;L;Crystal Structure of Pyrogallol-Phloroglucinol Transhydroxylase from Pelobacter acidigallici;2.35;CA;CALCIUM ION;Pyrogallol hydroxytransferase small subunit;35816;
4V4C;M;Crystal Structure of Pyrogallol-Phloroglucinol Transhydroxylase from Pelobacter acidigallici;2.35;CA;CALCIUM ION;Pyrogallol hydroxytransferase large subunit;35816;
4V4C;N;Crystal Structure of Pyrogallol-Phloroglucinol Transhydroxylase from Pelobacter acidigallici;2.35;CA;CALCIUM ION;Pyrogallol hydroxytransferase small subunit;35816;
4V4C;O;Crystal Structure of Pyrogallol-Phloroglucinol Transhydroxylase from Pelobacter acidigallici;2.35;CA;CALCIUM ION;Pyrogallol hydroxytransferase large subunit;35816;
4V4C;P;Crystal Structure of Pyrogallol-Phloroglucinol Transhydroxylase from Pelobacter acidigallici;2.35;CA;CALCIUM ION;Pyrogallol hydroxytransferase small subunit;35816;
4V4C;Q;Crystal Structure of Pyrogallol-Phloroglucinol Transhydroxylase from Pelobacter acidigallici;2.35;CA;CALCIUM ION;Pyrogallol hydroxytransferase large subunit;35816;
4V4C;R;Crystal Structure of Pyrogallol-Phloroglucinol Transhydroxylase from Pelobacter acidigallici;2.35;CA;CALCIUM ION;Pyrogallol hydroxytransferase small subunit;35816;
4V4C;S;Crystal Structure of Pyrogallol-Phloroglucinol Transhydroxylase from Pelobacter acidigallici;2.35;CA;CALCIUM ION;Pyrogallol hydroxytransferase large subunit;35816;
4V4C;T;Crystal Structure of Pyrogallol-Phloroglucinol Transhydroxylase from Pelobacter acidigallici;2.35;CA;CALCIUM ION;Pyrogallol hydroxytransferase small subunit;35816;
4V4C;U;Crystal Structure of Pyrogallol-Phloroglucinol Transhydroxylase from Pelobacter acidigallici;2.35;CA;CALCIUM ION;Pyrogallol hydroxytransferase large subunit;35816;
4V4C;V;Crystal Structure of Pyrogallol-Phloroglucinol Transhydroxylase from Pelobacter acidigallici;2.35;CA;CALCIUM ION;Pyrogallol hydroxytransferase small subunit;35816;
4V4C;W;Crystal Structure of Pyrogallol-Phloroglucinol Transhydroxylase from Pelobacter acidigallici;2.35;CA;CALCIUM ION;Pyrogallol hydroxytransferase large subunit;35816;
4V4C;X;Crystal Structure of Pyrogallol-Phloroglucinol Transhydroxylase from Pelobacter acidigallici;2.35;CA;CALCIUM ION;Pyrogallol hydroxytransferase small subunit;35816;
4V4D;A;Crystal Structure of Pyrogallol-Phloroglucinol Transhydroxylase from Pelobacter acidigallici complexed with pyrogallol;2.2;CA;CALCIUM ION;Pyrogallol hydroxytransferase large subunit;35816;
4V4D;B;Crystal Structure of Pyrogallol-Phloroglucinol Transhydroxylase from Pelobacter acidigallici complexed with pyrogallol;2.2;CA;CALCIUM ION;Pyrogallol hydroxytransferase small subunit;35816;
4V4D;C;Crystal Structure of Pyrogallol-Phloroglucinol Transhydroxylase from Pelobacter acidigallici complexed with pyrogallol;2.2;CA;CALCIUM ION;Pyrogallol hydroxytransferase large subunit;35816;
4V4D;D;Crystal Structure of Pyrogallol-Phloroglucinol Transhydroxylase from Pelobacter acidigallici complexed with pyrogallol;2.2;CA;CALCIUM ION;Pyrogallol hydroxytransferase small subunit;35816;
4V4D;E;Crystal Structure of Pyrogallol-Phloroglucinol Transhydroxylase from Pelobacter acidigallici complexed with pyrogallol;2.2;CA;CALCIUM ION;Pyrogallol hydroxytransferase large subunit;35816;
4V4D;F;Crystal Structure of Pyrogallol-Phloroglucinol Transhydroxylase from Pelobacter acidigallici complexed with pyrogallol;2.2;CA;CALCIUM ION;Pyrogallol hydroxytransferase small subunit;35816;
4V4D;G;Crystal Structure of Pyrogallol-Phloroglucinol Transhydroxylase from Pelobacter acidigallici complexed with pyrogallol;2.2;CA;CALCIUM ION;Pyrogallol hydroxytransferase large subunit;35816;
4V4D;H;Crystal Structure of Pyrogallol-Phloroglucinol Transhydroxylase from Pelobacter acidigallici complexed with pyrogallol;2.2;CA;CALCIUM ION;Pyrogallol hydroxytransferase small subunit;35816;
4V4D;I;Crystal Structure of Pyrogallol-Phloroglucinol Transhydroxylase from Pelobacter acidigallici complexed with pyrogallol;2.2;CA;CALCIUM ION;Pyrogallol hydroxytransferase large subunit;35816;
4V4D;K;Crystal Structure of Pyrogallol-Phloroglucinol Transhydroxylase from Pelobacter acidigallici complexed with pyrogallol;2.2;CA;CALCIUM ION;Pyrogallol hydroxytransferase large subunit;35816;
4V4D;L;Crystal Structure of Pyrogallol-Phloroglucinol Transhydroxylase from Pelobacter acidigallici complexed with pyrogallol;2.2;CA;CALCIUM ION;Pyrogallol hydroxytransferase small subunit;35816;
4V4D;M;Crystal Structure of Pyrogallol-Phloroglucinol Transhydroxylase from Pelobacter acidigallici complexed with pyrogallol;2.2;CA;CALCIUM ION;Pyrogallol hydroxytransferase large subunit;35816;
4V4D;N;Crystal Structure of Pyrogallol-Phloroglucinol Transhydroxylase from Pelobacter acidigallici complexed with pyrogallol;2.2;CA;CALCIUM ION;Pyrogallol hydroxytransferase small subunit;35816;
4V4D;O;Crystal Structure of Pyrogallol-Phloroglucinol Transhydroxylase from Pelobacter acidigallici complexed with pyrogallol;2.2;CA;CALCIUM ION;Pyrogallol hydroxytransferase large subunit;35816;
4V4D;P;Crystal Structure of Pyrogallol-Phloroglucinol Transhydroxylase from Pelobacter acidigallici complexed with pyrogallol;2.2;CA;CALCIUM ION;Pyrogallol hydroxytransferase small subunit;35816;
4V4D;Q;Crystal Structure of Pyrogallol-Phloroglucinol Transhydroxylase from Pelobacter acidigallici complexed with pyrogallol;2.2;CA;CALCIUM ION;Pyrogallol hydroxytransferase large subunit;35816;
4V4D;R;Crystal Structure of Pyrogallol-Phloroglucinol Transhydroxylase from Pelobacter acidigallici complexed with pyrogallol;2.2;CA;CALCIUM ION;Pyrogallol hydroxytransferase small subunit;35816;
4V4D;S;Crystal Structure of Pyrogallol-Phloroglucinol Transhydroxylase from Pelobacter acidigallici complexed with pyrogallol;2.2;CA;CALCIUM ION;Pyrogallol hydroxytransferase large subunit;35816;
4V4D;T;Crystal Structure of Pyrogallol-Phloroglucinol Transhydroxylase from Pelobacter acidigallici complexed with pyrogallol;2.2;CA;CALCIUM ION;Pyrogallol hydroxytransferase small subunit;35816;
4V4D;U;Crystal Structure of Pyrogallol-Phloroglucinol Transhydroxylase from Pelobacter acidigallici complexed with pyrogallol;2.2;CA;CALCIUM ION;Pyrogallol hydroxytransferase large subunit;35816;
4V4D;V;Crystal Structure of Pyrogallol-Phloroglucinol Transhydroxylase from Pelobacter acidigallici complexed with pyrogallol;2.2;CA;CALCIUM ION;Pyrogallol hydroxytransferase small subunit;35816;
4V4D;W;Crystal Structure of Pyrogallol-Phloroglucinol Transhydroxylase from Pelobacter acidigallici complexed with pyrogallol;2.2;CA;CALCIUM ION;Pyrogallol hydroxytransferase large subunit;35816;
4V4D;X;Crystal Structure of Pyrogallol-Phloroglucinol Transhydroxylase from Pelobacter acidigallici complexed with pyrogallol;2.2;CA;CALCIUM ION;Pyrogallol hydroxytransferase small subunit;35816;
4V4E;A;Crystal Structure of Pyrogallol-Phloroglucinol Transhydroxylase from Pelobacter acidigallici complexed with inhibitor 1,2,4,5-tetrahydroxy-benzene;2;CA;CALCIUM ION;Pyrogallol hydroxytransferase large subunit;35816;
4V4E;B;Crystal Structure of Pyrogallol-Phloroglucinol Transhydroxylase from Pelobacter acidigallici complexed with inhibitor 1,2,4,5-tetrahydroxy-benzene;2;CA;CALCIUM ION;Pyrogallol hydroxytransferase small subunit;35816;
4V4E;C;Crystal Structure of Pyrogallol-Phloroglucinol Transhydroxylase from Pelobacter acidigallici complexed with inhibitor 1,2,4,5-tetrahydroxy-benzene;2;CA;CALCIUM ION;Pyrogallol hydroxytransferase large subunit;35816;
4V4E;D;Crystal Structure of Pyrogallol-Phloroglucinol Transhydroxylase from Pelobacter acidigallici complexed with inhibitor 1,2,4,5-tetrahydroxy-benzene;2;CA;CALCIUM ION;Pyrogallol hydroxytransferase small subunit;35816;
4V4E;E;Crystal Structure of Pyrogallol-Phloroglucinol Transhydroxylase from Pelobacter acidigallici complexed with inhibitor 1,2,4,5-tetrahydroxy-benzene;2;CA;CALCIUM ION;Pyrogallol hydroxytransferase large subunit;35816;
4V4E;F;Crystal Structure of Pyrogallol-Phloroglucinol Transhydroxylase from Pelobacter acidigallici complexed with inhibitor 1,2,4,5-tetrahydroxy-benzene;2;CA;CALCIUM ION;Pyrogallol hydroxytransferase small subunit;35816;
4V4E;G;Crystal Structure of Pyrogallol-Phloroglucinol Transhydroxylase from Pelobacter acidigallici complexed with inhibitor 1,2,4,5-tetrahydroxy-benzene;2;CA;CALCIUM ION;Pyrogallol hydroxytransferase large subunit;35816;
4V4E;H;Crystal Structure of Pyrogallol-Phloroglucinol Transhydroxylase from Pelobacter acidigallici complexed with inhibitor 1,2,4,5-tetrahydroxy-benzene;2;CA;CALCIUM ION;Pyrogallol hydroxytransferase small subunit;35816;
4V4E;I;Crystal Structure of Pyrogallol-Phloroglucinol Transhydroxylase from Pelobacter acidigallici complexed with inhibitor 1,2,4,5-tetrahydroxy-benzene;2;CA;CALCIUM ION;Pyrogallol hydroxytransferase large subunit;35816;
4V4E;J;Crystal Structure of Pyrogallol-Phloroglucinol Transhydroxylase from Pelobacter acidigallici complexed with inhibitor 1,2,4,5-tetrahydroxy-benzene;2;CA;CALCIUM ION;Pyrogallol hydroxytransferase small subunit;35816;
4V4E;K;Crystal Structure of Pyrogallol-Phloroglucinol Transhydroxylase from Pelobacter acidigallici complexed with inhibitor 1,2,4,5-tetrahydroxy-benzene;2;CA;CALCIUM ION;Pyrogallol hydroxytransferase large subunit;35816;
4V4E;L;Crystal Structure of Pyrogallol-Phloroglucinol Transhydroxylase from Pelobacter acidigallici complexed with inhibitor 1,2,4,5-tetrahydroxy-benzene;2;CA;CALCIUM ION;Pyrogallol hydroxytransferase small subunit;35816;
4V4E;M;Crystal Structure of Pyrogallol-Phloroglucinol Transhydroxylase from Pelobacter acidigallici complexed with inhibitor 1,2,4,5-tetrahydroxy-benzene;2;CA;CALCIUM ION;Pyrogallol hydroxytransferase large subunit;35816;
4V4E;N;Crystal Structure of Pyrogallol-Phloroglucinol Transhydroxylase from Pelobacter acidigallici complexed with inhibitor 1,2,4,5-tetrahydroxy-benzene;2;CA;CALCIUM ION;Pyrogallol hydroxytransferase small subunit;35816;
4V4E;O;Crystal Structure of Pyrogallol-Phloroglucinol Transhydroxylase from Pelobacter acidigallici complexed with inhibitor 1,2,4,5-tetrahydroxy-benzene;2;CA;CALCIUM ION;Pyrogallol hydroxytransferase large subunit;35816;
4V4E;P;Crystal Structure of Pyrogallol-Phloroglucinol Transhydroxylase from Pelobacter acidigallici complexed with inhibitor 1,2,4,5-tetrahydroxy-benzene;2;CA;CALCIUM ION;Pyrogallol hydroxytransferase small subunit;35816;
4V4E;Q;Crystal Structure of Pyrogallol-Phloroglucinol Transhydroxylase from Pelobacter acidigallici complexed with inhibitor 1,2,4,5-tetrahydroxy-benzene;2;CA;CALCIUM ION;Pyrogallol hydroxytransferase large subunit;35816;
4V4E;R;Crystal Structure of Pyrogallol-Phloroglucinol Transhydroxylase from Pelobacter acidigallici complexed with inhibitor 1,2,4,5-tetrahydroxy-benzene;2;CA;CALCIUM ION;Pyrogallol hydroxytransferase small subunit;35816;
4V4E;S;Crystal Structure of Pyrogallol-Phloroglucinol Transhydroxylase from Pelobacter acidigallici complexed with inhibitor 1,2,4,5-tetrahydroxy-benzene;2;CA;CALCIUM ION;Pyrogallol hydroxytransferase large subunit;35816;
4V4E;T;Crystal Structure of Pyrogallol-Phloroglucinol Transhydroxylase from Pelobacter acidigallici complexed with inhibitor 1,2,4,5-tetrahydroxy-benzene;2;CA;CALCIUM ION;Pyrogallol hydroxytransferase small subunit;35816;
4V4E;U;Crystal Structure of Pyrogallol-Phloroglucinol Transhydroxylase from Pelobacter acidigallici complexed with inhibitor 1,2,4,5-tetrahydroxy-benzene;2;CA;CALCIUM ION;Pyrogallol hydroxytransferase large subunit;35816;
4V4E;V;Crystal Structure of Pyrogallol-Phloroglucinol Transhydroxylase from Pelobacter acidigallici complexed with inhibitor 1,2,4,5-tetrahydroxy-benzene;2;CA;CALCIUM ION;Pyrogallol hydroxytransferase small subunit;35816;
4V4E;W;Crystal Structure of Pyrogallol-Phloroglucinol Transhydroxylase from Pelobacter acidigallici complexed with inhibitor 1,2,4,5-tetrahydroxy-benzene;2;CA;CALCIUM ION;Pyrogallol hydroxytransferase large subunit;35816;
4V4E;X;Crystal Structure of Pyrogallol-Phloroglucinol Transhydroxylase from Pelobacter acidigallici complexed with inhibitor 1,2,4,5-tetrahydroxy-benzene;2;CA;CALCIUM ION;Pyrogallol hydroxytransferase small subunit;35816;
4V4M;0;1.45 Angstrom Structure of STNV coat protein;1.45;CA;CALCIUM ION;Coat protein;1971235;
4V4M;1;1.45 Angstrom Structure of STNV coat protein;1.45;CA;CALCIUM ION;Coat protein;1971235;
4V4M;2;1.45 Angstrom Structure of STNV coat protein;1.45;CA;CALCIUM ION;Coat protein;1971235;
4V4M;3;1.45 Angstrom Structure of STNV coat protein;1.45;CA;CALCIUM ION;Coat protein;1971235;
4V4M;4;1.45 Angstrom Structure of STNV coat protein;1.45;CA;CALCIUM ION;Coat protein;1971235;
4V4M;5;1.45 Angstrom Structure of STNV coat protein;1.45;CA;CALCIUM ION;Coat protein;1971235;
4V4M;6;1.45 Angstrom Structure of STNV coat protein;1.45;CA;CALCIUM ION;Coat protein;1971235;
4V4M;7;1.45 Angstrom Structure of STNV coat protein;1.45;CA;CALCIUM ION;Coat protein;1971235;
4V4M;A;1.45 Angstrom Structure of STNV coat protein;1.45;CA;CALCIUM ION;Coat protein;1971235;
4V4M;B;1.45 Angstrom Structure of STNV coat protein;1.45;CA;CALCIUM ION;Coat protein;1971235;
4V4M;C;1.45 Angstrom Structure of STNV coat protein;1.45;CA;CALCIUM ION;Coat protein;1971235;
4V4M;D;1.45 Angstrom Structure of STNV coat protein;1.45;CA;CALCIUM ION;Coat protein;1971235;
4V4M;E;1.45 Angstrom Structure of STNV coat protein;1.45;CA;CALCIUM ION;Coat protein;1971235;
4V4M;F;1.45 Angstrom Structure of STNV coat protein;1.45;CA;CALCIUM ION;Coat protein;1971235;
4V4M;G;1.45 Angstrom Structure of STNV coat protein;1.45;CA;CALCIUM ION;Coat protein;1971235;
4V4M;H;1.45 Angstrom Structure of STNV coat protein;1.45;CA;CALCIUM ION;Coat protein;1971235;
4V4M;I;1.45 Angstrom Structure of STNV coat protein;1.45;CA;CALCIUM ION;Coat protein;1971235;
4V4M;J;1.45 Angstrom Structure of STNV coat protein;1.45;CA;CALCIUM ION;Coat protein;1971235;
4V4M;K;1.45 Angstrom Structure of STNV coat protein;1.45;CA;CALCIUM ION;Coat protein;1971235;
4V4M;L;1.45 Angstrom Structure of STNV coat protein;1.45;CA;CALCIUM ION;Coat protein;1971235;
4V4M;M;1.45 Angstrom Structure of STNV coat protein;1.45;CA;CALCIUM ION;Coat protein;1971235;
4V4M;N;1.45 Angstrom Structure of STNV coat protein;1.45;CA;CALCIUM ION;Coat protein;1971235;
4V4M;O;1.45 Angstrom Structure of STNV coat protein;1.45;CA;CALCIUM ION;Coat protein;1971235;
4V4M;P;1.45 Angstrom Structure of STNV coat protein;1.45;CA;CALCIUM ION;Coat protein;1971235;
4V4M;Q;1.45 Angstrom Structure of STNV coat protein;1.45;CA;CALCIUM ION;Coat protein;1971235;
4V4M;R;1.45 Angstrom Structure of STNV coat protein;1.45;CA;CALCIUM ION;Coat protein;1971235;
4V4M;S;1.45 Angstrom Structure of STNV coat protein;1.45;CA;CALCIUM ION;Coat protein;1971235;
4V4M;T;1.45 Angstrom Structure of STNV coat protein;1.45;CA;CALCIUM ION;Coat protein;1971235;
4V4M;U;1.45 Angstrom Structure of STNV coat protein;1.45;CA;CALCIUM ION;Coat protein;1971235;
4V4M;V;1.45 Angstrom Structure of STNV coat protein;1.45;CA;CALCIUM ION;Coat protein;1971235;
4V4M;W;1.45 Angstrom Structure of STNV coat protein;1.45;CA;CALCIUM ION;Coat protein;1971235;
4V4M;X;1.45 Angstrom Structure of STNV coat protein;1.45;CA;CALCIUM ION;Coat protein;1971235;
4V4M;Y;1.45 Angstrom Structure of STNV coat protein;1.45;CA;CALCIUM ION;Coat protein;1971235;
4V4M;Z;1.45 Angstrom Structure of STNV coat protein;1.45;CA;CALCIUM ION;Coat protein;1971235;
4V4M;a;1.45 Angstrom Structure of STNV coat protein;1.45;CA;CALCIUM ION;Coat protein;1971235;
4V4M;b;1.45 Angstrom Structure of STNV coat protein;1.45;CA;CALCIUM ION;Coat protein;1971235;
4V4M;c;1.45 Angstrom Structure of STNV coat protein;1.45;CA;CALCIUM ION;Coat protein;1971235;
4V4M;d;1.45 Angstrom Structure of STNV coat protein;1.45;CA;CALCIUM ION;Coat protein;1971235;
4V4M;e;1.45 Angstrom Structure of STNV coat protein;1.45;CA;CALCIUM ION;Coat protein;1971235;
4V4M;f;1.45 Angstrom Structure of STNV coat protein;1.45;CA;CALCIUM ION;Coat protein;1971235;
4V4M;g;1.45 Angstrom Structure of STNV coat protein;1.45;CA;CALCIUM ION;Coat protein;1971235;
4V4M;h;1.45 Angstrom Structure of STNV coat protein;1.45;CA;CALCIUM ION;Coat protein;1971235;
4V4M;i;1.45 Angstrom Structure of STNV coat protein;1.45;CA;CALCIUM ION;Coat protein;1971235;
4V4M;j;1.45 Angstrom Structure of STNV coat protein;1.45;CA;CALCIUM ION;Coat protein;1971235;
4V4M;k;1.45 Angstrom Structure of STNV coat protein;1.45;CA;CALCIUM ION;Coat protein;1971235;
4V4M;l;1.45 Angstrom Structure of STNV coat protein;1.45;CA;CALCIUM ION;Coat protein;1971235;
4V4M;m;1.45 Angstrom Structure of STNV coat protein;1.45;CA;CALCIUM ION;Coat protein;1971235;
4V4M;n;1.45 Angstrom Structure of STNV coat protein;1.45;CA;CALCIUM ION;Coat protein;1971235;
4V4M;o;1.45 Angstrom Structure of STNV coat protein;1.45;CA;CALCIUM ION;Coat protein;1971235;
4V4M;p;1.45 Angstrom Structure of STNV coat protein;1.45;CA;CALCIUM ION;Coat protein;1971235;
4V4M;q;1.45 Angstrom Structure of STNV coat protein;1.45;CA;CALCIUM ION;Coat protein;1971235;
4V4M;r;1.45 Angstrom Structure of STNV coat protein;1.45;CA;CALCIUM ION;Coat protein;1971235;
4V4M;s;1.45 Angstrom Structure of STNV coat protein;1.45;CA;CALCIUM ION;Coat protein;1971235;
4V4M;t;1.45 Angstrom Structure of STNV coat protein;1.45;CA;CALCIUM ION;Coat protein;1971235;
4V4M;u;1.45 Angstrom Structure of STNV coat protein;1.45;CA;CALCIUM ION;Coat protein;1971235;
4V4M;v;1.45 Angstrom Structure of STNV coat protein;1.45;CA;CALCIUM ION;Coat protein;1971235;
4V4M;w;1.45 Angstrom Structure of STNV coat protein;1.45;CA;CALCIUM ION;Coat protein;1971235;
4V4M;x;1.45 Angstrom Structure of STNV coat protein;1.45;CA;CALCIUM ION;Coat protein;1971235;
4V4M;y;1.45 Angstrom Structure of STNV coat protein;1.45;CA;CALCIUM ION;Coat protein;1971235;
4V4M;z;1.45 Angstrom Structure of STNV coat protein;1.45;CA;CALCIUM ION;Coat protein;1971235;
4V5I;AS;Structure of the Phage P2 Baseplate in its Activated Conformation with Ca;5.46;CA;CALCIUM ION;ORF15;254252;
4V5I;AT;Structure of the Phage P2 Baseplate in its Activated Conformation with Ca;5.46;CA;CALCIUM ION;ORF15;254252;
4V5I;AU;Structure of the Phage P2 Baseplate in its Activated Conformation with Ca;5.46;CA;CALCIUM ION;ORF15;254252;
4V5I;AV;Structure of the Phage P2 Baseplate in its Activated Conformation with Ca;5.46;CA;CALCIUM ION;ORF15;254252;
4V5I;AW;Structure of the Phage P2 Baseplate in its Activated Conformation with Ca;5.46;CA;CALCIUM ION;ORF15;254252;
4V5I;AX;Structure of the Phage P2 Baseplate in its Activated Conformation with Ca;5.46;CA;CALCIUM ION;ORF15;254252;
4V5I;BS;Structure of the Phage P2 Baseplate in its Activated Conformation with Ca;5.46;CA;CALCIUM ION;ORF15;254252;
4V5I;BT;Structure of the Phage P2 Baseplate in its Activated Conformation with Ca;5.46;CA;CALCIUM ION;ORF15;254252;
4V5I;BU;Structure of the Phage P2 Baseplate in its Activated Conformation with Ca;5.46;CA;CALCIUM ION;ORF15;254252;
4V5I;BV;Structure of the Phage P2 Baseplate in its Activated Conformation with Ca;5.46;CA;CALCIUM ION;ORF15;254252;
4V5I;BW;Structure of the Phage P2 Baseplate in its Activated Conformation with Ca;5.46;CA;CALCIUM ION;ORF15;254252;
4V5I;BX;Structure of the Phage P2 Baseplate in its Activated Conformation with Ca;5.46;CA;CALCIUM ION;ORF15;254252;
4V62;AK;Crystal Structure of cyanobacterial Photosystem II;2.9;CA;CALCIUM ION;Photosystem II reaction center protein K;146786;
4V62;AO;Crystal Structure of cyanobacterial Photosystem II;2.9;CA;CALCIUM ION;Photosystem II manganese-stabilizing polypeptide;146786;
4V62;BK;Crystal Structure of cyanobacterial Photosystem II;2.9;CA;CALCIUM ION;Photosystem II reaction center protein K;146786;
4V62;BO;Crystal Structure of cyanobacterial Photosystem II;2.9;CA;CALCIUM ION;Photosystem II manganese-stabilizing polypeptide;146786;
4V6B;AA;Crystal structure of human ferritin Phe167SerfsX26 mutant.;2.85;CA;CALCIUM ION;Ferritin;9606;
4V6B;AB;Crystal structure of human ferritin Phe167SerfsX26 mutant.;2.85;CA;CALCIUM ION;Ferritin;9606;
4V6B;AC;Crystal structure of human ferritin Phe167SerfsX26 mutant.;2.85;CA;CALCIUM ION;Ferritin;9606;
4V6B;AF;Crystal structure of human ferritin Phe167SerfsX26 mutant.;2.85;CA;CALCIUM ION;Ferritin;9606;
4V6B;AH;Crystal structure of human ferritin Phe167SerfsX26 mutant.;2.85;CA;CALCIUM ION;Ferritin;9606;
4V6B;AL;Crystal structure of human ferritin Phe167SerfsX26 mutant.;2.85;CA;CALCIUM ION;Ferritin;9606;
4V6B;AM;Crystal structure of human ferritin Phe167SerfsX26 mutant.;2.85;CA;CALCIUM ION;Ferritin;9606;
4V6B;AO;Crystal structure of human ferritin Phe167SerfsX26 mutant.;2.85;CA;CALCIUM ION;Ferritin;9606;
4V6B;Aa;Crystal structure of human ferritin Phe167SerfsX26 mutant.;2.85;CA;CALCIUM ION;Ferritin;9606;
4V6B;Ac;Crystal structure of human ferritin Phe167SerfsX26 mutant.;2.85;CA;CALCIUM ION;Ferritin;9606;
4V6B;Ad;Crystal structure of human ferritin Phe167SerfsX26 mutant.;2.85;CA;CALCIUM ION;Ferritin;9606;
4V6B;Ae;Crystal structure of human ferritin Phe167SerfsX26 mutant.;2.85;CA;CALCIUM ION;Ferritin;9606;
4V6B;Ag;Crystal structure of human ferritin Phe167SerfsX26 mutant.;2.85;CA;CALCIUM ION;Ferritin;9606;
4V6B;Ah;Crystal structure of human ferritin Phe167SerfsX26 mutant.;2.85;CA;CALCIUM ION;Ferritin;9606;
4V6B;Aj;Crystal structure of human ferritin Phe167SerfsX26 mutant.;2.85;CA;CALCIUM ION;Ferritin;9606;
4V6B;An;Crystal structure of human ferritin Phe167SerfsX26 mutant.;2.85;CA;CALCIUM ION;Ferritin;9606;
4V6B;BA;Crystal structure of human ferritin Phe167SerfsX26 mutant.;2.85;CA;CALCIUM ION;Ferritin;9606;
4V6B;BB;Crystal structure of human ferritin Phe167SerfsX26 mutant.;2.85;CA;CALCIUM ION;Ferritin;9606;
4V6B;BC;Crystal structure of human ferritin Phe167SerfsX26 mutant.;2.85;CA;CALCIUM ION;Ferritin;9606;
4V6B;BD;Crystal structure of human ferritin Phe167SerfsX26 mutant.;2.85;CA;CALCIUM ION;Ferritin;9606;
4V6B;BG;Crystal structure of human ferritin Phe167SerfsX26 mutant.;2.85;CA;CALCIUM ION;Ferritin;9606;
4V6B;BH;Crystal structure of human ferritin Phe167SerfsX26 mutant.;2.85;CA;CALCIUM ION;Ferritin;9606;
4V6B;BN;Crystal structure of human ferritin Phe167SerfsX26 mutant.;2.85;CA;CALCIUM ION;Ferritin;9606;
4V6B;BR;Crystal structure of human ferritin Phe167SerfsX26 mutant.;2.85;CA;CALCIUM ION;Ferritin;9606;
4V6B;Ba;Crystal structure of human ferritin Phe167SerfsX26 mutant.;2.85;CA;CALCIUM ION;Ferritin;9606;
4V6B;Bb;Crystal structure of human ferritin Phe167SerfsX26 mutant.;2.85;CA;CALCIUM ION;Ferritin;9606;
4V6B;Bc;Crystal structure of human ferritin Phe167SerfsX26 mutant.;2.85;CA;CALCIUM ION;Ferritin;9606;
4V6B;Bd;Crystal structure of human ferritin Phe167SerfsX26 mutant.;2.85;CA;CALCIUM ION;Ferritin;9606;
4V6B;Be;Crystal structure of human ferritin Phe167SerfsX26 mutant.;2.85;CA;CALCIUM ION;Ferritin;9606;
4V6B;Bf;Crystal structure of human ferritin Phe167SerfsX26 mutant.;2.85;CA;CALCIUM ION;Ferritin;9606;
4V6B;Bg;Crystal structure of human ferritin Phe167SerfsX26 mutant.;2.85;CA;CALCIUM ION;Ferritin;9606;
4V6B;Bu;Crystal structure of human ferritin Phe167SerfsX26 mutant.;2.85;CA;CALCIUM ION;Ferritin;9606;
4V6B;CA;Crystal structure of human ferritin Phe167SerfsX26 mutant.;2.85;CA;CALCIUM ION;Ferritin;9606;
4V6B;CB;Crystal structure of human ferritin Phe167SerfsX26 mutant.;2.85;CA;CALCIUM ION;Ferritin;9606;
4V6B;CC;Crystal structure of human ferritin Phe167SerfsX26 mutant.;2.85;CA;CALCIUM ION;Ferritin;9606;
4V6B;CD;Crystal structure of human ferritin Phe167SerfsX26 mutant.;2.85;CA;CALCIUM ION;Ferritin;9606;
4V6B;CE;Crystal structure of human ferritin Phe167SerfsX26 mutant.;2.85;CA;CALCIUM ION;Ferritin;9606;
4V6B;CF;Crystal structure of human ferritin Phe167SerfsX26 mutant.;2.85;CA;CALCIUM ION;Ferritin;9606;
4V6B;CH;Crystal structure of human ferritin Phe167SerfsX26 mutant.;2.85;CA;CALCIUM ION;Ferritin;9606;
4V6B;CO;Crystal structure of human ferritin Phe167SerfsX26 mutant.;2.85;CA;CALCIUM ION;Ferritin;9606;
4V6B;Ca;Crystal structure of human ferritin Phe167SerfsX26 mutant.;2.85;CA;CALCIUM ION;Ferritin;9606;
4V6B;Cb;Crystal structure of human ferritin Phe167SerfsX26 mutant.;2.85;CA;CALCIUM ION;Ferritin;9606;
4V6B;Ce;Crystal structure of human ferritin Phe167SerfsX26 mutant.;2.85;CA;CALCIUM ION;Ferritin;9606;
4V6B;Cg;Crystal structure of human ferritin Phe167SerfsX26 mutant.;2.85;CA;CALCIUM ION;Ferritin;9606;
4V6B;Ck;Crystal structure of human ferritin Phe167SerfsX26 mutant.;2.85;CA;CALCIUM ION;Ferritin;9606;
4V6B;Cl;Crystal structure of human ferritin Phe167SerfsX26 mutant.;2.85;CA;CALCIUM ION;Ferritin;9606;
4V6B;Cn;Crystal structure of human ferritin Phe167SerfsX26 mutant.;2.85;CA;CALCIUM ION;Ferritin;9606;
4V6B;Cp;Crystal structure of human ferritin Phe167SerfsX26 mutant.;2.85;CA;CALCIUM ION;Ferritin;9606;
4V82;AF;Crystal structure of cyanobacterial Photosystem II in complex with terbutryn;3.2;CA;CALCIUM ION;Cytochrome b559 subunit beta;146786;
4V82;AK;Crystal structure of cyanobacterial Photosystem II in complex with terbutryn;3.2;CA;CALCIUM ION;Photosystem II reaction center protein K;146786;
4V82;AO;Crystal structure of cyanobacterial Photosystem II in complex with terbutryn;3.2;CA;CALCIUM ION;Photosystem II manganese-stabilizing polypeptide;146786;
4V82;BF;Crystal structure of cyanobacterial Photosystem II in complex with terbutryn;3.2;CA;CALCIUM ION;Cytochrome b559 subunit beta;146786;
4V82;BK;Crystal structure of cyanobacterial Photosystem II in complex with terbutryn;3.2;CA;CALCIUM ION;Photosystem II reaction center protein K;146786;
4V82;BO;Crystal structure of cyanobacterial Photosystem II in complex with terbutryn;3.2;CA;CALCIUM ION;Photosystem II manganese-stabilizing polypeptide;146786;
4V8K;A1;Crystal structure of the LH1-RC complex from Thermochromatium tepidum in P21 form;3.01;CA;CALCIUM ION;LH1 alpha polypeptide;1050;
4V8K;A3;Crystal structure of the LH1-RC complex from Thermochromatium tepidum in P21 form;3.01;CA;CALCIUM ION;LH1 alpha polypeptide;1050;
4V8K;A5;Crystal structure of the LH1-RC complex from Thermochromatium tepidum in P21 form;3.01;CA;CALCIUM ION;LH1 alpha polypeptide;1050;
4V8K;A7;Crystal structure of the LH1-RC complex from Thermochromatium tepidum in P21 form;3.01;CA;CALCIUM ION;LH1 alpha polypeptide;1050;
4V8K;A9;Crystal structure of the LH1-RC complex from Thermochromatium tepidum in P21 form;3.01;CA;CALCIUM ION;LH1 alpha polypeptide;1050;
4V8K;AA;Crystal structure of the LH1-RC complex from Thermochromatium tepidum in P21 form;3.01;CA;CALCIUM ION;LH1 alpha polypeptide;1050;
4V8K;AC;Crystal structure of the LH1-RC complex from Thermochromatium tepidum in P21 form;3.01;CA;CALCIUM ION;Photosynthetic reaction center cytochrome c subunit;1050;
4V8K;AD;Crystal structure of the LH1-RC complex from Thermochromatium tepidum in P21 form;3.01;CA;CALCIUM ION;LH1 alpha polypeptide;1050;
4V8K;AF;Crystal structure of the LH1-RC complex from Thermochromatium tepidum in P21 form;3.01;CA;CALCIUM ION;LH1 alpha polypeptide;1050;
4V8K;AI;Crystal structure of the LH1-RC complex from Thermochromatium tepidum in P21 form;3.01;CA;CALCIUM ION;LH1 alpha polypeptide;1050;
4V8K;AK;Crystal structure of the LH1-RC complex from Thermochromatium tepidum in P21 form;3.01;CA;CALCIUM ION;LH1 alpha polypeptide;1050;
4V8K;AO;Crystal structure of the LH1-RC complex from Thermochromatium tepidum in P21 form;3.01;CA;CALCIUM ION;LH1 alpha polypeptide;1050;
4V8K;AQ;Crystal structure of the LH1-RC complex from Thermochromatium tepidum in P21 form;3.01;CA;CALCIUM ION;LH1 alpha polypeptide;1050;
4V8K;AS;Crystal structure of the LH1-RC complex from Thermochromatium tepidum in P21 form;3.01;CA;CALCIUM ION;LH1 alpha polypeptide;1050;
4V8K;AU;Crystal structure of the LH1-RC complex from Thermochromatium tepidum in P21 form;3.01;CA;CALCIUM ION;LH1 alpha polypeptide;1050;
4V8K;AV;Crystal structure of the LH1-RC complex from Thermochromatium tepidum in P21 form;3.01;CA;CALCIUM ION;LH1 beta polypeptide;1050;
4V8K;AY;Crystal structure of the LH1-RC complex from Thermochromatium tepidum in P21 form;3.01;CA;CALCIUM ION;LH1 alpha polypeptide;1050;
4V8K;B1;Crystal structure of the LH1-RC complex from Thermochromatium tepidum in P21 form;3.01;CA;CALCIUM ION;LH1 alpha polypeptide;1050;
4V8K;B3;Crystal structure of the LH1-RC complex from Thermochromatium tepidum in P21 form;3.01;CA;CALCIUM ION;LH1 alpha polypeptide;1050;
4V8K;B5;Crystal structure of the LH1-RC complex from Thermochromatium tepidum in P21 form;3.01;CA;CALCIUM ION;LH1 alpha polypeptide;1050;
4V8K;B7;Crystal structure of the LH1-RC complex from Thermochromatium tepidum in P21 form;3.01;CA;CALCIUM ION;LH1 alpha polypeptide;1050;
4V8K;B9;Crystal structure of the LH1-RC complex from Thermochromatium tepidum in P21 form;3.01;CA;CALCIUM ION;LH1 alpha polypeptide;1050;
4V8K;BA;Crystal structure of the LH1-RC complex from Thermochromatium tepidum in P21 form;3.01;CA;CALCIUM ION;LH1 alpha polypeptide;1050;
4V8K;BC;Crystal structure of the LH1-RC complex from Thermochromatium tepidum in P21 form;3.01;CA;CALCIUM ION;Photosynthetic reaction center cytochrome c subunit;1050;
4V8K;BD;Crystal structure of the LH1-RC complex from Thermochromatium tepidum in P21 form;3.01;CA;CALCIUM ION;LH1 alpha polypeptide;1050;
4V8K;BF;Crystal structure of the LH1-RC complex from Thermochromatium tepidum in P21 form;3.01;CA;CALCIUM ION;LH1 alpha polypeptide;1050;
4V8K;BI;Crystal structure of the LH1-RC complex from Thermochromatium tepidum in P21 form;3.01;CA;CALCIUM ION;LH1 alpha polypeptide;1050;
4V8K;BK;Crystal structure of the LH1-RC complex from Thermochromatium tepidum in P21 form;3.01;CA;CALCIUM ION;LH1 alpha polypeptide;1050;
4V8K;BO;Crystal structure of the LH1-RC complex from Thermochromatium tepidum in P21 form;3.01;CA;CALCIUM ION;LH1 alpha polypeptide;1050;
4V8K;BQ;Crystal structure of the LH1-RC complex from Thermochromatium tepidum in P21 form;3.01;CA;CALCIUM ION;LH1 alpha polypeptide;1050;
4V8K;BS;Crystal structure of the LH1-RC complex from Thermochromatium tepidum in P21 form;3.01;CA;CALCIUM ION;LH1 alpha polypeptide;1050;
4V8K;BU;Crystal structure of the LH1-RC complex from Thermochromatium tepidum in P21 form;3.01;CA;CALCIUM ION;LH1 alpha polypeptide;1050;
4V8K;BW;Crystal structure of the LH1-RC complex from Thermochromatium tepidum in P21 form;3.01;CA;CALCIUM ION;LH1 alpha polypeptide;1050;
4V8K;BY;Crystal structure of the LH1-RC complex from Thermochromatium tepidum in P21 form;3.01;CA;CALCIUM ION;LH1 alpha polypeptide;1050;
4V99;A1;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;A4;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;AA;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;AF;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;AL;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;AP;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;AU;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;AZ;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;Af;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;Aj;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;Ao;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;At;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;B5;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;BB;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;BF;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;BK;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;BQ;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;BU;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;BZ;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;Be;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;Bk;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;Bo;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;Bt;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;By;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;C4;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;CA;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;CG;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;CK;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;CP;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;CU;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;CZ;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;Ce;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;Cj;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;Co;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;Ct;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;Cy;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;D4;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;DA;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;DF;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;DK;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;DP;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;DU;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;DZ;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;Df;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;Dj;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;Do;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;Dt;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;Dy;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;E4;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;EC;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;EF;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;EK;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;EP;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;EU;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;EZ;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;Ee;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;Ek;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;Eo;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;Et;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;Ey;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;F1;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;F4;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;FA;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;FF;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;FK;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;FP;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;FU;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;FZ;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;Fe;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;Fk;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;Fo;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;Ft;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;G1;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;G4;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;GA;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;GF;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;GK;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;GP;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;GU;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;GZ;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;Ge;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;Gj;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;Go;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;Gt;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;H4;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;HA;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;HF;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;HK;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;HP;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;HU;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;HZ;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;Hg;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;Hj;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;Ho;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;Ht;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;Hy;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;I1;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;I4;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;IA;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;IF;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;IK;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;IR;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;IU;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;IZ;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;If;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;Ij;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;Io;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;It;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;J4;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;JA;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;JF;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;JL;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;JP;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;JU;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;JZ;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;Je;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;Jj;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;Jo;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;Jt;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4V99;Jy;The Crystallographic Structure of Panicum Mosaic Virus;2.9;CA;CALCIUM ION;Capsid protein;40279;
4W4Q;A;Glucose isomerase structure determined by serial femtosecond crystallography at SACLA;2;CA;CALCIUM ION;Xylose isomerase;1929;
4W65;A;Crystal Structure of Glycosyl hydrolase family protein from Mycobacterium fortuitum;1.38;CA;CALCIUM ION;Glycosyl hydrolase family protein;1766;
4W78;E;Crystal structure of the ChsH1-ChsH2 complex from Mycobacterium tuberculosis;1.54;CA;CALCIUM ION;Hydratase ChsH1;1773;
4W78;G;Crystal structure of the ChsH1-ChsH2 complex from Mycobacterium tuberculosis;1.54;CA;CALCIUM ION;Hydratase ChsH1;1773;
4W8J;A;Structure of the full-length insecticidal protein Cry1Ac reveals intriguing details of toxin packaging into in vivo formed crystals;2.78;CA;CALCIUM ION;Pesticidal crystal protein cry1Ac;1428;
4W8L;A;Structure of GH10 from Paenibacillus barcinonensis;1.76;CA;CALCIUM ION;Endo-1,4-beta-xylanase C;198119;
4W8L;B;Structure of GH10 from Paenibacillus barcinonensis;1.76;CA;CALCIUM ION;Endo-1,4-beta-xylanase C;198119;
4W8L;C;Structure of GH10 from Paenibacillus barcinonensis;1.76;CA;CALCIUM ION;Endo-1,4-beta-xylanase C;198119;
4W93;A;Human pancreatic alpha-amylase in complex with montbretin A;1.35;CA;CALCIUM ION;Pancreatic alpha-amylase;9606;
4W9Y;A;X-ray structure of human glutamate carboxypeptidase II (GCPII) in complex with a glutamyl sulfamide inhibitor CJC47;1.64;CA;CALCIUM ION;Glutamate carboxypeptidase 2;9606;
4WA3;A;The crystal structure of neuraminidase from a H3N8 influenza virus isolated from New England harbor seals;1.8;CA;CALCIUM ION;Neuraminidase;11320;
4WA4;A;The crystal structure of neuraminidase from a H3N8 influenza virus isolated from New England harbor seals in complex with oseltamivir carboxylate;1.95;CA;CALCIUM ION;Neuraminidase;11320;
4WA5;A;The crystal structure of neuraminidase from a H3N8 influenza virus isolated from New England harbor seals in complex with zanamivir;1.95;CA;CALCIUM ION;Neuraminidase;11320;
4WB2;A;Crystal structure of the mirror-image L-RNA/L-DNA aptamer NOX-D20 in complex with mouse C5a complement anaphylatoxin;1.8;CA;CALCIUM ION;Complement C5;10090;
4WB2;C;Crystal structure of the mirror-image L-RNA/L-DNA aptamer NOX-D20 in complex with mouse C5a complement anaphylatoxin;1.8;CA;CALCIUM ION;Complement C5;10090;
4WB2;D;Crystal structure of the mirror-image L-RNA/L-DNA aptamer NOX-D20 in complex with mouse C5a complement anaphylatoxin;1.8;CA;CALCIUM ION;mixed L-RNA/L-DNA mirror-image aptamer NOX-D20 (40-MER);32630;
4WB2;E;Crystal structure of the mirror-image L-RNA/L-DNA aptamer NOX-D20 in complex with mouse C5a complement anaphylatoxin;1.8;CA;CALCIUM ION;mixed L-RNA/L-DNA mirror-image aptamer NOX-D20 (40-MER);32630;
4WB3;A;Crystal structure of the mirror-image L-RNA/L-DNA aptamer NOX-D20 in complex with mouse C5a-desArg complement anaphylatoxin;2;CA;CALCIUM ION;Complement C5;10090;
4WB3;C;Crystal structure of the mirror-image L-RNA/L-DNA aptamer NOX-D20 in complex with mouse C5a-desArg complement anaphylatoxin;2;CA;CALCIUM ION;Complement C5;10090;
4WB3;D;Crystal structure of the mirror-image L-RNA/L-DNA aptamer NOX-D20 in complex with mouse C5a-desArg complement anaphylatoxin;2;CA;CALCIUM ION;mixed L-RNA/L-DNA aptamer NOX-D20 (40-MER);32630;
4WB3;E;Crystal structure of the mirror-image L-RNA/L-DNA aptamer NOX-D20 in complex with mouse C5a-desArg complement anaphylatoxin;2;CA;CALCIUM ION;mixed L-RNA/L-DNA aptamer NOX-D20 (40-MER);32630;
4WB4;A;wt SA11 NSP4_CCD;2.03;CA;CALCIUM ION;Non-structural glycoprotein NSP4;28875;
4WBB;A;Single Turnover Autophosphorylation Cycle of the PKA RIIb Holoenzyme;2.8;CA;CALCIUM ION;cAMP-dependent protein kinase type II-beta regulatory subunit;10090;
4WBB;B;Single Turnover Autophosphorylation Cycle of the PKA RIIb Holoenzyme;2.8;CA;CALCIUM ION;cAMP-dependent protein kinase catalytic subunit alpha;10090;
4WBQ;A;Crystal structure of the exonuclease domain of QIP (QDE-2 interacting protein) solved by native-SAD phasing.;2.69;CA;CALCIUM ION;QDE-2-interacting protein;5141;
4WBQ;B;Crystal structure of the exonuclease domain of QIP (QDE-2 interacting protein) solved by native-SAD phasing.;2.69;CA;CALCIUM ION;QDE-2-interacting protein;5141;
4WD1;A;Acetoacetyl-CoA Synthetase from Streptomyces lividans;1.9;CA;CALCIUM ION;Acetoacetate-CoA ligase;1916;
4WDR;A;Crystal structure of haloalkane dehalogenase LinB 140A+143L+177W+211L mutant (LinB86) from Sphingobium japonicum UT26;2.5;CA;CALCIUM ION;Haloalkane dehalogenase;332056;
4WEF;A;Structure of the Hemagglutinin-neuraminidase from Human parainfluenza virus type III: complex with difluorosialic acid;2.5;CA;CALCIUM ION;Hemagglutinin-neuraminidase glycoprotein;11216;
4WEF;B;Structure of the Hemagglutinin-neuraminidase from Human parainfluenza virus type III: complex with difluorosialic acid;2.5;CA;CALCIUM ION;Hemagglutinin-neuraminidase glycoprotein;11216;
4WEG;A;influenza virus neuraminidase N9 in complex 2,3-difluorosialic acid;2.1;CA;CALCIUM ION;Neuraminidase;11320;
4WF7;A;Crystal structures of trehalose synthase from Deinococcus radiodurans reveal that a closed conformation is involved in the intramolecular isomerization catalysis;2.21;CA;CALCIUM ION;Trehalose synthase;1299;
4WF7;B;Crystal structures of trehalose synthase from Deinococcus radiodurans reveal that a closed conformation is involved in the intramolecular isomerization catalysis;2.21;CA;CALCIUM ION;Trehalose synthase;1299;
4WF7;C;Crystal structures of trehalose synthase from Deinococcus radiodurans reveal that a closed conformation is involved in the intramolecular isomerization catalysis;2.21;CA;CALCIUM ION;Trehalose synthase;1299;
4WF7;D;Crystal structures of trehalose synthase from Deinococcus radiodurans reveal that a closed conformation is involved in the intramolecular isomerization catalysis;2.21;CA;CALCIUM ION;Trehalose synthase;1299;
4WFE;A;Human TRAAK K+ channel in a K+ bound conductive conformation;2.5;CA;CALCIUM ION;Potassium channel subfamily K member 4;9606;
4WFE;G;Human TRAAK K+ channel in a K+ bound conductive conformation;2.5;CA;CALCIUM ION;ANTI-TRAAK ANTIBODY 13E9 FAB FRAGMENT HEAVY CHAIN;10090;
4WFF;A;Human TRAAK K+ channel in a K+ bound nonconductive conformation;2.5;CA;CALCIUM ION;Potassium channel subfamily K member 4;9606;
4WFF;G;Human TRAAK K+ channel in a K+ bound nonconductive conformation;2.5;CA;CALCIUM ION;ANTI-TRAAK ANTIBODY 13E9 FAB FRAGMENT HEAVY CHAIN;10090;
4WFG;A;Human TRAAK K+ channel in a Tl+ bound conductive conformation;3;CA;CALCIUM ION;Potassium channel subfamily K member 4;9606;
4WFG;G;Human TRAAK K+ channel in a Tl+ bound conductive conformation;3;CA;CALCIUM ION;ANTI-TRAAK ANTIBODY 13E9 FAB FRAGMENT HEAVY CHAIN;10090;
4WFH;A;Human TRAAK K+ channel in a Tl+ bound nonconductive conformation;3.01;CA;CALCIUM ION;Potassium channel subfamily K member 4;9606;
4WFH;G;Human TRAAK K+ channel in a Tl+ bound nonconductive conformation;3.01;CA;CALCIUM ION;ANTI-TRAAK ANTIBODY 13E9 FAB FRAGMENT HEAVY CHAIN;10090;
4WFJ;A;Crystal structure of PET-degrading cutinase Cut190 S226P mutant in Ca(2+)-bound state at 1.75 angstrom resolution;1.75;CA;CALCIUM ION;Cutinase;1852;
4WFK;A;Crystal structure of PET-degrading cutinase Cut190 S226P mutant in Ca(2+)-bound state at 2.35 angstrom resolution;2.35;CA;CALCIUM ION;Cutinase;1852;
4WGK;A;Crystal structure of human neutral ceramidase with Zn-bound phosphate;2.58;CA;CALCIUM ION;Neutral ceramidase;9606;
4WGK;B;Crystal structure of human neutral ceramidase with Zn-bound phosphate;2.58;CA;CALCIUM ION;Neutral ceramidase;9606;
4WI0;B;Crystal structure of Coh3ScaB-XDoc_M2ScaA complex: A C-terminal interface mutant of type II Cohesin-X-Dockerin complex from Acetivibrio cellulolyticus;1.93;CA;CALCIUM ION;Cellulosomal scaffoldin;35830;
4WIB;B;Crystal structure of Magnesium transporter MgtE;3.2;CA;CALCIUM ION;Magnesium transporter MgtE;274;
4WIS;A;Crystal structure of the lipid scramblase nhTMEM16 in crystal form 1;3.3;CA;CALCIUM ION;lipid scramblase;140110;
4WIS;B;Crystal structure of the lipid scramblase nhTMEM16 in crystal form 1;3.3;CA;CALCIUM ION;lipid scramblase;140110;
4WIT;A;TMEM16 lipid scramblase in crystal form 2;3.4;CA;CALCIUM ION;Predicted protein;140110;
4WIT;B;TMEM16 lipid scramblase in crystal form 2;3.4;CA;CALCIUM ION;Predicted protein;140110;
4WIW;A;Crystal structure of C-terminal domain of putative chitinase from Desulfitobacterium hafniense DCB-2;2.64;CA;CALCIUM ION;Glycoside hydrolase family 18;49338;
4WIW;B;Crystal structure of C-terminal domain of putative chitinase from Desulfitobacterium hafniense DCB-2;2.64;CA;CALCIUM ION;Glycoside hydrolase family 18;49338;
4WIW;C;Crystal structure of C-terminal domain of putative chitinase from Desulfitobacterium hafniense DCB-2;2.64;CA;CALCIUM ION;Glycoside hydrolase family 18;49338;
4WIW;D;Crystal structure of C-terminal domain of putative chitinase from Desulfitobacterium hafniense DCB-2;2.64;CA;CALCIUM ION;Glycoside hydrolase family 18;49338;
4WIW;E;Crystal structure of C-terminal domain of putative chitinase from Desulfitobacterium hafniense DCB-2;2.64;CA;CALCIUM ION;Glycoside hydrolase family 18;49338;
4WIW;F;Crystal structure of C-terminal domain of putative chitinase from Desulfitobacterium hafniense DCB-2;2.64;CA;CALCIUM ION;Glycoside hydrolase family 18;49338;
4WIZ;AA;Crystal structure of Grouper nervous necrosis virus-like particle at 3.6A;3.6;CA;CALCIUM ION;Coat protein;43763;
4WIZ;AB;Crystal structure of Grouper nervous necrosis virus-like particle at 3.6A;3.6;CA;CALCIUM ION;Coat protein;43763;
4WIZ;AC;Crystal structure of Grouper nervous necrosis virus-like particle at 3.6A;3.6;CA;CALCIUM ION;Coat protein;43763;
4WIZ;AD;Crystal structure of Grouper nervous necrosis virus-like particle at 3.6A;3.6;CA;CALCIUM ION;Coat protein;43763;
4WIZ;AE;Crystal structure of Grouper nervous necrosis virus-like particle at 3.6A;3.6;CA;CALCIUM ION;Coat protein;43763;
4WIZ;AF;Crystal structure of Grouper nervous necrosis virus-like particle at 3.6A;3.6;CA;CALCIUM ION;Coat protein;43763;
4WIZ;AG;Crystal structure of Grouper nervous necrosis virus-like particle at 3.6A;3.6;CA;CALCIUM ION;Coat protein;43763;
4WIZ;AH;Crystal structure of Grouper nervous necrosis virus-like particle at 3.6A;3.6;CA;CALCIUM ION;Coat protein;43763;
4WIZ;AI;Crystal structure of Grouper nervous necrosis virus-like particle at 3.6A;3.6;CA;CALCIUM ION;Coat protein;43763;
4WIZ;AJ;Crystal structure of Grouper nervous necrosis virus-like particle at 3.6A;3.6;CA;CALCIUM ION;Coat protein;43763;
4WIZ;AK;Crystal structure of Grouper nervous necrosis virus-like particle at 3.6A;3.6;CA;CALCIUM ION;Coat protein;43763;
4WIZ;AL;Crystal structure of Grouper nervous necrosis virus-like particle at 3.6A;3.6;CA;CALCIUM ION;Coat protein;43763;
4WIZ;AM;Crystal structure of Grouper nervous necrosis virus-like particle at 3.6A;3.6;CA;CALCIUM ION;Coat protein;43763;
4WIZ;AN;Crystal structure of Grouper nervous necrosis virus-like particle at 3.6A;3.6;CA;CALCIUM ION;Coat protein;43763;
4WIZ;AO;Crystal structure of Grouper nervous necrosis virus-like particle at 3.6A;3.6;CA;CALCIUM ION;Coat protein;43763;
4WIZ;AP;Crystal structure of Grouper nervous necrosis virus-like particle at 3.6A;3.6;CA;CALCIUM ION;Coat protein;43763;
4WIZ;AQ;Crystal structure of Grouper nervous necrosis virus-like particle at 3.6A;3.6;CA;CALCIUM ION;Coat protein;43763;
4WIZ;AR;Crystal structure of Grouper nervous necrosis virus-like particle at 3.6A;3.6;CA;CALCIUM ION;Coat protein;43763;
4WIZ;AS;Crystal structure of Grouper nervous necrosis virus-like particle at 3.6A;3.6;CA;CALCIUM ION;Coat protein;43763;
4WIZ;AT;Crystal structure of Grouper nervous necrosis virus-like particle at 3.6A;3.6;CA;CALCIUM ION;Coat protein;43763;
4WIZ;AU;Crystal structure of Grouper nervous necrosis virus-like particle at 3.6A;3.6;CA;CALCIUM ION;Coat protein;43763;
4WIZ;AV;Crystal structure of Grouper nervous necrosis virus-like particle at 3.6A;3.6;CA;CALCIUM ION;Coat protein;43763;
4WIZ;AW;Crystal structure of Grouper nervous necrosis virus-like particle at 3.6A;3.6;CA;CALCIUM ION;Coat protein;43763;
4WIZ;AX;Crystal structure of Grouper nervous necrosis virus-like particle at 3.6A;3.6;CA;CALCIUM ION;Coat protein;43763;
4WIZ;AY;Crystal structure of Grouper nervous necrosis virus-like particle at 3.6A;3.6;CA;CALCIUM ION;Coat protein;43763;
4WIZ;AZ;Crystal structure of Grouper nervous necrosis virus-like particle at 3.6A;3.6;CA;CALCIUM ION;Coat protein;43763;
4WIZ;Aa;Crystal structure of Grouper nervous necrosis virus-like particle at 3.6A;3.6;CA;CALCIUM ION;Coat protein;43763;
4WIZ;Ab;Crystal structure of Grouper nervous necrosis virus-like particle at 3.6A;3.6;CA;CALCIUM ION;Coat protein;43763;
4WIZ;Ac;Crystal structure of Grouper nervous necrosis virus-like particle at 3.6A;3.6;CA;CALCIUM ION;Coat protein;43763;
4WIZ;Ad;Crystal structure of Grouper nervous necrosis virus-like particle at 3.6A;3.6;CA;CALCIUM ION;Coat protein;43763;
4WIZ;BA;Crystal structure of Grouper nervous necrosis virus-like particle at 3.6A;3.6;CA;CALCIUM ION;Coat protein;43763;
4WIZ;BB;Crystal structure of Grouper nervous necrosis virus-like particle at 3.6A;3.6;CA;CALCIUM ION;Coat protein;43763;
4WIZ;BC;Crystal structure of Grouper nervous necrosis virus-like particle at 3.6A;3.6;CA;CALCIUM ION;Coat protein;43763;
4WIZ;BD;Crystal structure of Grouper nervous necrosis virus-like particle at 3.6A;3.6;CA;CALCIUM ION;Coat protein;43763;
4WIZ;BE;Crystal structure of Grouper nervous necrosis virus-like particle at 3.6A;3.6;CA;CALCIUM ION;Coat protein;43763;
4WIZ;BF;Crystal structure of Grouper nervous necrosis virus-like particle at 3.6A;3.6;CA;CALCIUM ION;Coat protein;43763;
4WIZ;BG;Crystal structure of Grouper nervous necrosis virus-like particle at 3.6A;3.6;CA;CALCIUM ION;Coat protein;43763;
4WIZ;BH;Crystal structure of Grouper nervous necrosis virus-like particle at 3.6A;3.6;CA;CALCIUM ION;Coat protein;43763;
4WIZ;BI;Crystal structure of Grouper nervous necrosis virus-like particle at 3.6A;3.6;CA;CALCIUM ION;Coat protein;43763;
4WIZ;BJ;Crystal structure of Grouper nervous necrosis virus-like particle at 3.6A;3.6;CA;CALCIUM ION;Coat protein;43763;
4WIZ;BK;Crystal structure of Grouper nervous necrosis virus-like particle at 3.6A;3.6;CA;CALCIUM ION;Coat protein;43763;
4WIZ;BL;Crystal structure of Grouper nervous necrosis virus-like particle at 3.6A;3.6;CA;CALCIUM ION;Coat protein;43763;
4WIZ;BM;Crystal structure of Grouper nervous necrosis virus-like particle at 3.6A;3.6;CA;CALCIUM ION;Coat protein;43763;
4WIZ;BN;Crystal structure of Grouper nervous necrosis virus-like particle at 3.6A;3.6;CA;CALCIUM ION;Coat protein;43763;
4WIZ;BO;Crystal structure of Grouper nervous necrosis virus-like particle at 3.6A;3.6;CA;CALCIUM ION;Coat protein;43763;
4WIZ;BP;Crystal structure of Grouper nervous necrosis virus-like particle at 3.6A;3.6;CA;CALCIUM ION;Coat protein;43763;
4WIZ;BQ;Crystal structure of Grouper nervous necrosis virus-like particle at 3.6A;3.6;CA;CALCIUM ION;Coat protein;43763;
4WIZ;BR;Crystal structure of Grouper nervous necrosis virus-like particle at 3.6A;3.6;CA;CALCIUM ION;Coat protein;43763;
4WIZ;BS;Crystal structure of Grouper nervous necrosis virus-like particle at 3.6A;3.6;CA;CALCIUM ION;Coat protein;43763;
4WIZ;BT;Crystal structure of Grouper nervous necrosis virus-like particle at 3.6A;3.6;CA;CALCIUM ION;Coat protein;43763;
4WIZ;BU;Crystal structure of Grouper nervous necrosis virus-like particle at 3.6A;3.6;CA;CALCIUM ION;Coat protein;43763;
4WIZ;BV;Crystal structure of Grouper nervous necrosis virus-like particle at 3.6A;3.6;CA;CALCIUM ION;Coat protein;43763;
4WIZ;BW;Crystal structure of Grouper nervous necrosis virus-like particle at 3.6A;3.6;CA;CALCIUM ION;Coat protein;43763;
4WIZ;BX;Crystal structure of Grouper nervous necrosis virus-like particle at 3.6A;3.6;CA;CALCIUM ION;Coat protein;43763;
4WIZ;BY;Crystal structure of Grouper nervous necrosis virus-like particle at 3.6A;3.6;CA;CALCIUM ION;Coat protein;43763;
4WIZ;BZ;Crystal structure of Grouper nervous necrosis virus-like particle at 3.6A;3.6;CA;CALCIUM ION;Coat protein;43763;
4WIZ;Ba;Crystal structure of Grouper nervous necrosis virus-like particle at 3.6A;3.6;CA;CALCIUM ION;Coat protein;43763;
4WIZ;Bb;Crystal structure of Grouper nervous necrosis virus-like particle at 3.6A;3.6;CA;CALCIUM ION;Coat protein;43763;
4WIZ;Bc;Crystal structure of Grouper nervous necrosis virus-like particle at 3.6A;3.6;CA;CALCIUM ION;Coat protein;43763;
4WIZ;Bd;Crystal structure of Grouper nervous necrosis virus-like particle at 3.6A;3.6;CA;CALCIUM ION;Coat protein;43763;
4WJK;A;Metal Ion and Ligand Binding of Integrin;1.85;CA;CALCIUM ION;Integrin alpha-5;9606;
4WJK;B;Metal Ion and Ligand Binding of Integrin;1.85;CA;CALCIUM ION;Integrin beta-1;9606;
4WJY;A;Esherichia coli nitrite reductase NrfA H264N;2.15;CA;CALCIUM ION;Cytochrome c-552;562;
4WJY;B;Esherichia coli nitrite reductase NrfA H264N;2.15;CA;CALCIUM ION;Cytochrome c-552;562;
4WK0;A;Metal Ion and Ligand Binding of Integrin;1.78;CA;CALCIUM ION;Integrin alpha-5;9606;
4WK0;B;Metal Ion and Ligand Binding of Integrin;1.78;CA;CALCIUM ION;Integrin beta-1;9606;
4WK1;A;Crystal structure of Staphylococcus aureus PstA in complex with c-di-AMP;1.98;CA;CALCIUM ION;PstA;1280;
4WK2;A;Metal Ion and Ligand Binding of Integrin;2.5;CA;CALCIUM ION;Integrin alpha-5;9606;
4WK2;B;Metal Ion and Ligand Binding of Integrin;2.5;CA;CALCIUM ION;Integrin beta-1;9606;
4WK4;A;Metal Ion and Ligand Binding of Integrin;2.5;CA;CALCIUM ION;Integrin alpha-5;9606;
4WK4;B;Metal Ion and Ligand Binding of Integrin;2.5;CA;CALCIUM ION;Integrin beta-1;9606;
4WK7;A;Crystal structure of human ADAMTS-4 in complex with inhibitor (compound 1, 2-(4-chlorophenoxy)-N-{[(4R)-4-methyl-2,5-dioxoimidazolidin-4-yl]methyl} acetamide);1.24;CA;CALCIUM ION;A disintegrin and metalloproteinase with thrombospondin motifs 4;9606;
4WKE;A;Crystal structure of human ADAMTS-4 in complex with inhibitor 5-chloro-N-{[(4R)-2,5-dioxo-4-(1,3-thiazol-2-yl)imidazolidin-4-yl]methyl}-1-benzofuran-2-carboxamide (compound 10);1.62;CA;CALCIUM ION;A disintegrin and metalloproteinase with thrombospondin motifs 4;9606;
4WKI;A;Crystal structure of human ADAMTS-4 in complex with inhibitor 5-CHLORO-N-{[(4S)-4-(1-METHYL-1H-IMIDAZOL-2-YL)-2,5-DIOXOIMIDAZOLIDIN-4-YL]METHYL}-1-BENZOFURAN-2-CARBOXAMIDE (compound 11);1.6;CA;CALCIUM ION;A disintegrin and metalloproteinase with thrombospondin motifs 4;9606;
4WKZ;A;Complex of autonomous ScaG cohesin CohG and X-doc domains;1.79;CA;CALCIUM ION;Putative cellulose-binding protein;1265;
4WLC;A;Structure of dextran glucosidase with glucose;2.4;CA;CALCIUM ION;Glucan 1,6-alpha-glucosidase;1309;
4WMO;A;Selenomethionine derivative of Xenopus laevis embryonic epidermal lectin carbohydrate-binding domain;2.3;CA;CALCIUM ION;XEEL protein;8355;
4WMO;B;Selenomethionine derivative of Xenopus laevis embryonic epidermal lectin carbohydrate-binding domain;2.3;CA;CALCIUM ION;XEEL protein;8355;
4WMO;C;Selenomethionine derivative of Xenopus laevis embryonic epidermal lectin carbohydrate-binding domain;2.3;CA;CALCIUM ION;XEEL protein;8355;
4WMO;D;Selenomethionine derivative of Xenopus laevis embryonic epidermal lectin carbohydrate-binding domain;2.3;CA;CALCIUM ION;XEEL protein;8355;
4WMO;E;Selenomethionine derivative of Xenopus laevis embryonic epidermal lectin carbohydrate-binding domain;2.3;CA;CALCIUM ION;XEEL protein;8355;
4WMO;F;Selenomethionine derivative of Xenopus laevis embryonic epidermal lectin carbohydrate-binding domain;2.3;CA;CALCIUM ION;XEEL protein;8355;
4WMQ;A;Structure of Human Intelectin-1;1.8;CA;CALCIUM ION;Intelectin-1;9606;
4WMQ;B;Structure of Human Intelectin-1;1.8;CA;CALCIUM ION;Intelectin-1;9606;
4WMY;A;Structure of Human intelectin-1 in complex with allyl-beta-galactofuranose;1.6;CA;CALCIUM ION;Intelectin-1;9606;
4WMY;B;Structure of Human intelectin-1 in complex with allyl-beta-galactofuranose;1.6;CA;CALCIUM ION;Intelectin-1;9606;
4WN0;A;Xenopus laevis embryonic epidermal lectin in complex with glycerol phosphate;2.2;CA;CALCIUM ION;XEEL protein;8355;
4WNB;A;Crystal structure of the ChsH1-ChsH2 complex from Mycobacterium tuberculosis bound to 3-OPC-CoA;1.76;CA;CALCIUM ION;Hydratase ChsH2;1773;
4WNX;A;Netrin 4 lacking the C-terminal Domain;2.72;CA;CALCIUM ION;Netrin-4;10090;
4WO1;A;Crystal structure of the DAP12 transmembrane domain in lipid cubic phase;2.14;CA;CALCIUM ION;TYRO protein tyrosine kinase-binding protein;9606;
4WOR;A;Staphylococcal nuclease in complex with Ca2+ and thymidine-3'-5'-diphosphate (pdTp) at room temperature;1.6;CA;CALCIUM ION;Thermonuclease;1280;
4WP9;A;Crystal structure of Adenylyl cyclase MA1120 from Mycobacterium Avium bound to 2'5'-DD-3'-ATP, Calcium and Magnesium ion;1.38;CA;CALCIUM ION;Ma1120;1764;
4WP9;B;Crystal structure of Adenylyl cyclase MA1120 from Mycobacterium Avium bound to 2'5'-DD-3'-ATP, Calcium and Magnesium ion;1.38;CA;CALCIUM ION;Ma1120;1764;
4WPA;A;Crystal structure of Adenylyl cyclase Ma1120 from Mycobacterium Avium bound to Pyrophosphate and Calcium;1.7;CA;CALCIUM ION;Ma1120;1764;
4WPA;B;Crystal structure of Adenylyl cyclase Ma1120 from Mycobacterium Avium bound to Pyrophosphate and Calcium;1.7;CA;CALCIUM ION;Ma1120;1764;
4WQ2;A;Human calpain PEF(S) with (Z)-3-(6-bromondol-3-yl)-2-mercaptoacrylic acid bound;1.64;CA;CALCIUM ION;Calpain small subunit 1;9606;
4WQ2;B;Human calpain PEF(S) with (Z)-3-(6-bromondol-3-yl)-2-mercaptoacrylic acid bound;1.64;CA;CALCIUM ION;Calpain small subunit 1;9606;
4WQ3;A;Human calpain PEF(S) with (2Z,2Z')-2,2'-disulfanediylbis(3-(6-bromoindol-3-yl)acrylic acid) bound;1.79;CA;CALCIUM ION;Calpain small subunit 1;9606;
4WQ3;B;Human calpain PEF(S) with (2Z,2Z')-2,2'-disulfanediylbis(3-(6-bromoindol-3-yl)acrylic acid) bound;1.79;CA;CALCIUM ION;Calpain small subunit 1;9606;
4WQQ;A;Structure of EPNH mutant of CEL-I;1.7;CA;CALCIUM ION;Lectin CEL-I, N-acetyl-D-galactosamine-specific C-type;40245;
4WQQ;B;Structure of EPNH mutant of CEL-I;1.7;CA;CALCIUM ION;Lectin CEL-I, N-acetyl-D-galactosamine-specific C-type;40245;
4WQQ;C;Structure of EPNH mutant of CEL-I;1.7;CA;CALCIUM ION;Lectin CEL-I, N-acetyl-D-galactosamine-specific C-type;40245;
4WQQ;D;Structure of EPNH mutant of CEL-I;1.7;CA;CALCIUM ION;Lectin CEL-I, N-acetyl-D-galactosamine-specific C-type;40245;
4WR2;A;Crystal structure of a putative pyrimidine-specific ribonucleoside hydrolase (RihA) Protein from Shewanella loihica PV-4 (SHEW_0697, Target PSI-029635) with divalent cation and PEG 400 bound at the active site;1.7;CA;CALCIUM ION;Pyrimidine-specific ribonucleoside hydrolase RihA;359303;
4WR9;A;Crystal Structure of Surfactant Protein-A DED Mutant (E171D/P175E/K203D);2.3;CA;CALCIUM ION;Pulmonary surfactant-associated protein A;10116;
4WRC;A;Crystal Structure of Surfactant Protein-A DEDN Mutant (E171D/P175E/R197N/K203D);1.8;CA;CALCIUM ION;Pulmonary surfactant-associated protein A;10116;
4WRD;A;Crystal structure of Staphylcoccal nulease variant Delta+PHS V66E L125E at cryogenic temperature;1.65;CA;CALCIUM ION;Thermonuclease;1280;
4WRE;A;Crystal Structure of Surfactant Protein-A DEDN Mutant (E171D/P175E/R197N/K203D) Complexed with Inositol;1.75;CA;CALCIUM ION;Pulmonary surfactant-associated protein A;10116;
4WRF;A;Crystal Structure of Surfactant Protein-A DEDN Mutant (E171D/P175E/R197N/K203D) Complexed with Mannose;1.9;CA;CALCIUM ION;Pulmonary surfactant-associated protein A;10116;
4WUT;A;CRYSTAL STRUCTURE OF AN ABC TRANSPORTER SOLUTE BINDING PROTEIN (IPR025997) FROM AGROBACTERIUM VITIS (Avi_5133, TARGET EFI-511220) WITH BOUND D-FUCOSE;1.5;CA;CALCIUM ION;ABC transporter substrate binding protein (Ribose);373;
4WUW;A;Crystal Structure of Surfactant Protein-A DED Mutant (E171D/P175E/K203D) Complexed with Inositol;2.4;CA;CALCIUM ION;Pulmonary surfactant-associated protein A;10116;
4WUX;A;Crystal Structure of Surfactant Protein-A DED Mutant (E171D/P175E/K203D) Complexed with Mannose;1.9;CA;CALCIUM ION;Pulmonary surfactant-associated protein A;10116;
4WUZ;A;Crystal structure of lambda exonuclease in complex with DNA and Ca2+;2.38;CA;CALCIUM ION;Exonuclease;10710;
4WUZ;B;Crystal structure of lambda exonuclease in complex with DNA and Ca2+;2.38;CA;CALCIUM ION;Exonuclease;10710;
4WUZ;C;Crystal structure of lambda exonuclease in complex with DNA and Ca2+;2.38;CA;CALCIUM ION;Exonuclease;10710;
4WV8;A;Crystal structure of a recombinant Vatairea macrocarpa seed lectin complexed with lactose;1.83;CA;CALCIUM ION;Seed lectin;77050;
4WV8;B;Crystal structure of a recombinant Vatairea macrocarpa seed lectin complexed with lactose;1.83;CA;CALCIUM ION;Seed lectin;77050;
4WV8;C;Crystal structure of a recombinant Vatairea macrocarpa seed lectin complexed with lactose;1.83;CA;CALCIUM ION;Seed lectin;77050;
4WV8;D;Crystal structure of a recombinant Vatairea macrocarpa seed lectin complexed with lactose;1.83;CA;CALCIUM ION;Seed lectin;77050;
4WWY;B;human cationic trypsin G193R mutant in complex with bovine pancreatic trypsin inhibitor;1.7;CA;CALCIUM ION;Trypsin-1;9606;
4WXQ;A;Crystal Structure of the Myocilin Olfactomedin Domain;2.15;CA;CALCIUM ION;Myocilin;9606;
4WXS;A;Crystal Structure of the E396D SNP Variant of the Myocilin Olfactomedin Domain;1.9;CA;CALCIUM ION;Myocilin;9606;
4WXU;A;Crystal Structure of the Selenomthionine Incorporated Myocilin Olfactomedin Domain E396D Variant.;2.09;CA;CALCIUM ION;Myocilin;9606;
4WXV;A;Human cationic trypsin K97D mutant in complex with bovine pancreatic trypsin inhibitor (BPTI);2.1;CA;CALCIUM ION;Trypsin-1;9606;
4WXV;B;Human cationic trypsin K97D mutant in complex with bovine pancreatic trypsin inhibitor (BPTI);2.1;CA;CALCIUM ION;Trypsin-1;9606;
4WYB;A;Structure of the Bud6 flank domain in complex with actin;3.49;CA;CALCIUM ION;Actin, alpha skeletal muscle;9986;
4WYB;C;Structure of the Bud6 flank domain in complex with actin;3.49;CA;CALCIUM ION;Actin, alpha skeletal muscle;9986;
4WYB;E;Structure of the Bud6 flank domain in complex with actin;3.49;CA;CALCIUM ION;Actin, alpha skeletal muscle;9986;
4WYB;G;Structure of the Bud6 flank domain in complex with actin;3.49;CA;CALCIUM ION;Actin, alpha skeletal muscle;9986;
4WYB;I;Structure of the Bud6 flank domain in complex with actin;3.49;CA;CALCIUM ION;Actin, alpha skeletal muscle;9986;
4WYB;K;Structure of the Bud6 flank domain in complex with actin;3.49;CA;CALCIUM ION;Actin, alpha skeletal muscle;9986;
4WYB;M;Structure of the Bud6 flank domain in complex with actin;3.49;CA;CALCIUM ION;Actin, alpha skeletal muscle;9986;
4WYB;O;Structure of the Bud6 flank domain in complex with actin;3.49;CA;CALCIUM ION;Actin, alpha skeletal muscle;9986;
4WYB;Q;Structure of the Bud6 flank domain in complex with actin;3.49;CA;CALCIUM ION;Actin, alpha skeletal muscle;9986;
4WYB;S;Structure of the Bud6 flank domain in complex with actin;3.49;CA;CALCIUM ION;Actin, alpha skeletal muscle;9986;
4WYB;U;Structure of the Bud6 flank domain in complex with actin;3.49;CA;CALCIUM ION;Actin, alpha skeletal muscle;9986;
4WYB;X;Structure of the Bud6 flank domain in complex with actin;3.49;CA;CALCIUM ION;Actin, alpha skeletal muscle;9986;
4WZF;A;Crystal structural basis for Rv0315, an immunostimulatory antigen and pseudo beta-1, 3-glucanase of Mycobacterium tuberculosis;1.7;CA;CALCIUM ION;1,3-beta-glucanase;1773;
4WZF;B;Crystal structural basis for Rv0315, an immunostimulatory antigen and pseudo beta-1, 3-glucanase of Mycobacterium tuberculosis;1.7;CA;CALCIUM ION;1,3-beta-glucanase;1773;
4WZV;A;Crystal structure of a hydroxamate based inhibitor EN140 in complex with the MMP-9 catalytic domain;1.65;CA;CALCIUM ION;Matrix metalloproteinase-9,Matrix metalloproteinase-9;9606;
4WZV;B;Crystal structure of a hydroxamate based inhibitor EN140 in complex with the MMP-9 catalytic domain;1.65;CA;CALCIUM ION;Matrix metalloproteinase-9,Matrix metalloproteinase-9;9606;
4X0N;A;Porcine pancreatic alpha-amylase in complex with helianthamide, a novel proteinaceous inhibitor;2.6;CA;CALCIUM ION;Pancreatic alpha-amylase;9823;
4X0P;A;Ternary complex of human DNA polymerase theta C-terminal domain binding ddATP opposite a tetrahydrofuran AP site analog;3.91;CA;CALCIUM ION;DNA polymerase theta;9606;
4X0P;B;Ternary complex of human DNA polymerase theta C-terminal domain binding ddATP opposite a tetrahydrofuran AP site analog;3.91;CA;CALCIUM ION;DNA polymerase theta;9606;
4X0P;C;Ternary complex of human DNA polymerase theta C-terminal domain binding ddATP opposite a tetrahydrofuran AP site analog;3.91;CA;CALCIUM ION;DNA polymerase theta;9606;
4X0P;D;Ternary complex of human DNA polymerase theta C-terminal domain binding ddATP opposite a tetrahydrofuran AP site analog;3.91;CA;CALCIUM ION;DNA polymerase theta;9606;
4X3N;A;Crystal structure of 34 kDa F-actin bundling protein from Dictyostelium discoideum;1.89;CA;CALCIUM ION;Calcium-regulated actin-bundling protein;44689;
4X3N;B;Crystal structure of 34 kDa F-actin bundling protein from Dictyostelium discoideum;1.89;CA;CALCIUM ION;Calcium-regulated actin-bundling protein;44689;
4X3N;C;Crystal structure of 34 kDa F-actin bundling protein from Dictyostelium discoideum;1.89;CA;CALCIUM ION;Calcium-regulated actin-bundling protein;44689;
4X3R;A;Avi-GCPII structure in complex with FITC-conjugated GCPII-specific inhibitor;1.86;CA;CALCIUM ION;Glutamate carboxypeptidase 2;9606;
4X49;A;Crystal structure of the intramolecular trans-sialidase from Ruminococcus gnavus in complex with oseltamivir carboxylate;2.01;CA;CALCIUM ION;Anhydrosialidase;33038;
4X6U;A;Crystal Structure of lipase from Geobacillus stearothermophilus T6;2.2;CA;CALCIUM ION;Lipase;1422;
4X71;A;Crystal Structure of lipase from Geobacillus stearothermophilus T6 methanol stable variant A269T;2;CA;CALCIUM ION;Lipase;1422;
4X7B;A;Crystal Structure of lipase from Geobacillus stearothermophilus T6 methanol stable variant H86Y/A269T;2.4;CA;CALCIUM ION;Lipase;1422;
4X85;A;Crystal Structure of lipase from Geobacillus stearothermophilus T6 methanol stable variant H86Y/A269T/R374W;2.19;CA;CALCIUM ION;Lipase;1422;
4X8B;A;Ergothioneine-biosynthetic sulfoxide synthase EgtB, apo form;1.7;CA;CALCIUM ION;Sulfoxide synthase EgtB;1797;
4X8B;B;Ergothioneine-biosynthetic sulfoxide synthase EgtB, apo form;1.7;CA;CALCIUM ION;Sulfoxide synthase EgtB;1797;
4X8C;A;Crystal structure of human peptidylarginine deiminase type4 (PAD4) in complex with GSK147;3.1;CA;CALCIUM ION;Protein-arginine deiminase type-4;9606;
4X8D;A;Ergothioneine-biosynthetic sulfoxide synthase EgtB in complex with N,N-dimethyl-histidine and gamma-glutamyl-cysteine;1.98;CA;CALCIUM ION;Sulfoxide synthase EgtB;1797;
4X8D;B;Ergothioneine-biosynthetic sulfoxide synthase EgtB in complex with N,N-dimethyl-histidine and gamma-glutamyl-cysteine;1.98;CA;CALCIUM ION;Sulfoxide synthase EgtB;1797;
4X8E;A;Ergothioneine-biosynthetic sulfoxide synthase EgtB in complex with N,N,N-trimethyl-histidine;1.6;CA;CALCIUM ION;Sulfoxide synthase EgtB;1797;
4X8E;B;Ergothioneine-biosynthetic sulfoxide synthase EgtB in complex with N,N,N-trimethyl-histidine;1.6;CA;CALCIUM ION;Sulfoxide synthase EgtB;1797;
4X8G;A;Crystal structure of human peptidylarginine deiminase type4 (PAD4) in complex with GSK199;3.29;CA;CALCIUM ION;Protein-arginine deiminase type-4;9606;
4X8S;H;FACTOR VIIA IN COMPLEX WITH THE INHIBITOR 4-BROMO-2-METHOXYPHENOL;2.1;CA;CALCIUM ION;Factor VIIa (Heavy Chain);9606;
4X8T;H;FACTOR VIIA IN COMPLEX WITH THE INHIBITOR 7-chloro-3,4-dihydroisoquinolin-1(2H)-one;2.2;CA;CALCIUM ION;Factor VIIa (Heavy Chain);9606;
4X8U;H;FACTOR VIIA IN COMPLEX WITH THE INHIBITOR 5-CHLORO-1H-INDOLE-2-CARBOXYLIC ACID;2.1;CA;CALCIUM ION;Factor VIIa (Heavy Chain);9606;
4X8V;H;FACTOR VIIA IN COMPLEX WITH THE INHIBITOR (methyl {3-[(2R)-1-{(2R)-2-(3,4-dimethoxyphenyl)-2-[(1-oxo-1,2,3,4-tetrahydroisoquinolin-7-yl)amino]acetyl}pyrrolidin-2-yl]-4-(propan-2-ylsulfonyl)phenyl}carbamate);2.5;CA;CALCIUM ION;Factor VIIa (Heavy Chain);9606;
4X9P;A;Crystal structure of bovine Annexin A2;2.01;CA;CALCIUM ION;Annexin A2;9913;
4X9Y;A;Wild-Type Human Pancreatic Alpha-Amylase at True Atomic Resolution (1.07 A);1.07;CA;CALCIUM ION;Pancreatic alpha-amylase;9606;
4XAT;A;Crystal structure of the olfactomedin domain from noelin/pancortin/olfactomedin-1;2.11;CA;CALCIUM ION;Noelin;9606;
4XB3;A;Structure of dextran glucosidase;2.09;CA;CALCIUM ION;Glucan 1,6-alpha-glucosidase;1309;
4XCT;A;Crystal structure of a hydroxamate based inhibitor ARP101 (EN73) in complex with the MMP-9 catalytic domain.;1.3;CA;CALCIUM ION;Matrix metalloproteinase-9,Matrix metalloproteinase-9;9606;
4XDQ;A;Crystal structure of a Glycoside hydrolase family protein (Rv0315 ortholog) from Mycobacterium thermorestibile;1.35;CA;CALCIUM ION;Glycoside hydrolase family protein;1797;
4XED;A;PKD domain of M14-like peptidase from Thermoplasmatales archaeon SCGC AB-540-F20;1.23;CA;CALCIUM ION;Peptidase M14, carboxypeptidase A;1242866;
4XER;A;Crystal Structure of C2 form of E112A/H234A Mutant of Stationary Phase Survival Protein (SurE) from Salmonella typhimurium;1.97;CA;CALCIUM ION;5'/3'-nucleotidase SurE;28901;
4XEU;A;Crystal structure of a transketolase from Pseudomonas aeruginosa;1.95;CA;CALCIUM ION;Transketolase;287;
4XGA;A;Crystal structure of BamB and BamA P3-5 complex from E.coli;2.15;CA;CALCIUM ION;Outer membrane protein assembly factor BamB;562;
4XGV;A;Crystal structure of Escherichia coli Flavin trafficking protein, an FMN transferase;1.88;CA;CALCIUM ION;FAD:protein FMN transferase;562;
4XGV;B;Crystal structure of Escherichia coli Flavin trafficking protein, an FMN transferase;1.88;CA;CALCIUM ION;FAD:protein FMN transferase;562;
4XGV;C;Crystal structure of Escherichia coli Flavin trafficking protein, an FMN transferase;1.88;CA;CALCIUM ION;FAD:protein FMN transferase;562;
4XGV;D;Crystal structure of Escherichia coli Flavin trafficking protein, an FMN transferase;1.88;CA;CALCIUM ION;FAD:protein FMN transferase;562;
4XGW;A;Crystal structure of Escherichia coli Flavin trafficking protein, an FMN transferase, E169K mutant;1.75;CA;CALCIUM ION;FAD:protein FMN transferase;562;
4XGW;B;Crystal structure of Escherichia coli Flavin trafficking protein, an FMN transferase, E169K mutant;1.75;CA;CALCIUM ION;FAD:protein FMN transferase;562;
4XGW;C;Crystal structure of Escherichia coli Flavin trafficking protein, an FMN transferase, E169K mutant;1.75;CA;CALCIUM ION;FAD:protein FMN transferase;562;
4XGW;D;Crystal structure of Escherichia coli Flavin trafficking protein, an FMN transferase, E169K mutant;1.75;CA;CALCIUM ION;FAD:protein FMN transferase;562;
4XHE;B;Crystal Structure of A-AChBP in complex with pinnatoxin A;1.9;CA;CALCIUM ION;Soluble acetylcholine receptor;6500;
4XHE;D;Crystal Structure of A-AChBP in complex with pinnatoxin A;1.9;CA;CALCIUM ION;Soluble acetylcholine receptor;6500;
4XHE;I;Crystal Structure of A-AChBP in complex with pinnatoxin A;1.9;CA;CALCIUM ION;Soluble acetylcholine receptor;6500;
4XHU;A;The complex structure of Timeless_PAB and PARP-1_catalytic domain;2.09;CA;CALCIUM ION;Poly [ADP-ribose] polymerase 1;9606;
4XHZ;A;Crystal Structure of Human Protocadherin-15 EC8-10;2.8;CA;CALCIUM ION;Protocadherin-15;9606;
4XJK;A;Crystal structure of Mn(II) Ca(II) Na(I) bound calprotectin;1.76;CA;CALCIUM ION;Protein S100-A8;9606;
4XJK;B;Crystal structure of Mn(II) Ca(II) Na(I) bound calprotectin;1.76;CA;CALCIUM ION;Protein S100-A9;9606;
4XJK;C;Crystal structure of Mn(II) Ca(II) Na(I) bound calprotectin;1.76;CA;CALCIUM ION;Protein S100-A8;9606;
4XJK;D;Crystal structure of Mn(II) Ca(II) Na(I) bound calprotectin;1.76;CA;CALCIUM ION;Protein S100-A9;9606;
4XJK;E;Crystal structure of Mn(II) Ca(II) Na(I) bound calprotectin;1.76;CA;CALCIUM ION;Protein S100-A8;9606;
4XJK;F;Crystal structure of Mn(II) Ca(II) Na(I) bound calprotectin;1.76;CA;CALCIUM ION;Protein S100-A9;9606;
4XJK;G;Crystal structure of Mn(II) Ca(II) Na(I) bound calprotectin;1.76;CA;CALCIUM ION;Protein S100-A8;9606;
4XJK;H;Crystal structure of Mn(II) Ca(II) Na(I) bound calprotectin;1.76;CA;CALCIUM ION;Protein S100-A9;9606;
4XJK;I;Crystal structure of Mn(II) Ca(II) Na(I) bound calprotectin;1.76;CA;CALCIUM ION;Protein S100-A8;9606;
4XJK;J;Crystal structure of Mn(II) Ca(II) Na(I) bound calprotectin;1.76;CA;CALCIUM ION;Protein S100-A9;9606;
4XJQ;A;The catalytic mechanism of human parainfluenza virus type 3 haemagglutinin-neuraminidase revealed;1.9;CA;CALCIUM ION;Hemagglutinin-neuraminidase;11216;
4XJQ;B;The catalytic mechanism of human parainfluenza virus type 3 haemagglutinin-neuraminidase revealed;1.9;CA;CALCIUM ION;Hemagglutinin-neuraminidase;11216;
4XJR;A;The catalytic mechanism of human parainfluenza virus type 3 haemagglutinin-neuraminidase revealed;3;CA;CALCIUM ION;Hemagglutinin-neuraminidase;11216;
4XJR;B;The catalytic mechanism of human parainfluenza virus type 3 haemagglutinin-neuraminidase revealed;3;CA;CALCIUM ION;Hemagglutinin-neuraminidase;11216;
4XL1;A;Complex of Notch1 (EGF11-13) bound to Delta-like 4 (N-EGF1);2.3;CA;CALCIUM ION;Neurogenic locus notch homolog protein 1;10116;
4XL1;D;Complex of Notch1 (EGF11-13) bound to Delta-like 4 (N-EGF1);2.3;CA;CALCIUM ION;Neurogenic locus notch homolog protein 1;10116;
4XLW;A;Complex of Notch1 (EGF11-13) bound to Delta-like 4 (N-EGF2);3.39;CA;CALCIUM ION;Neurogenic locus notch homolog protein 1;10116;
4XLW;C;Complex of Notch1 (EGF11-13) bound to Delta-like 4 (N-EGF2);3.39;CA;CALCIUM ION;Neurogenic locus notch homolog protein 1;10116;
4XLW;E;Complex of Notch1 (EGF11-13) bound to Delta-like 4 (N-EGF2);3.39;CA;CALCIUM ION;Neurogenic locus notch homolog protein 1;10116;
4XLW;G;Complex of Notch1 (EGF11-13) bound to Delta-like 4 (N-EGF2);3.39;CA;CALCIUM ION;Neurogenic locus notch homolog protein 1;10116;
4XNK;A;X-ray structure of AlgE1;2.8;CA;CALCIUM ION;Alginate production protein AlgE;287;
4XNL;A;X-ray structure of AlgE2;2.9;CA;CALCIUM ION;Alginate production protein AlgE;287;
4XOJ;A;Structure of bovine trypsin in complex with analogues of sunflower inhibitor 1 (SFTI-1);0.91;CA;CALCIUM ION;Cationic trypsin;9913;
4XOU;A;Crystal structure of the SR Ca2+-ATPase in the Ca2-E1-MgAMPPCP form determined by serial femtosecond crystallography using an X-ray free-electron laser.;2.8;CA;CALCIUM ION;Sarcoplasmic/endoplasmic reticulum calcium ATPase 1;9986;
4XPI;B;Fe protein independent substrate reduction by nitrogenase variants altered in intramolecular electron transfer;1.97;CA;CALCIUM ION;Nitrogenase molybdenum-iron protein beta chain;354;
4XQJ;E;Crystal structure of AgrA LytTR domain in complex with promoters;1.9;CA;CALCIUM ION;DNA (5'-D(P*AP*CP*AP*GP*TP*TP*AP*AP*GP*AP*AP*T)-3');32630;
4XQJ;F;Crystal structure of AgrA LytTR domain in complex with promoters;1.9;CA;CALCIUM ION;DNA (5'-D(*AP*AP*TP*TP*CP*TP*TP*AP*AP*CP*TP*GP*T)-3');32630;
4XQZ;A;Calcium(II) and copper(II) bound to the Z-DNA form of d(CGCGCG), complexed by chloride and MES;2.15;CA;CALCIUM ION;DNA (5'-D(*CP*GP*CP*GP*CP*G)-3');32630;
4XQZ;E;Calcium(II) and copper(II) bound to the Z-DNA form of d(CGCGCG), complexed by chloride and MES;2.15;CA;CALCIUM ION;DNA (5'-D(*CP*GP*CP*GP*CP*G)-3');32630;
4XTM;A;Crystal structure of a recombinant Vatairea macrocarpa seed lectin complexed with GalNAc;2.7;CA;CALCIUM ION;Seed lectin;77050;
4XTP;A;Crystal structure of a recombinant Vatairea macrocarpa seed lectin complexed with Tn antigen;1.97;CA;CALCIUM ION;Seed lectin;77050;
4XUN;A;Structure of the CBM22-2 xylan-binding domain from Paenibacillus barcinonensis Xyn10C;1.75;CA;CALCIUM ION;Endo-1,4-beta-xylanase C;198119;
4XUN;B;Structure of the CBM22-2 xylan-binding domain from Paenibacillus barcinonensis Xyn10C;1.75;CA;CALCIUM ION;Endo-1,4-beta-xylanase C;198119;
4XUN;C;Structure of the CBM22-2 xylan-binding domain from Paenibacillus barcinonensis Xyn10C;1.75;CA;CALCIUM ION;Endo-1,4-beta-xylanase C;198119;
4XUO;A;Structure of the CBM22-1 xylan-binding domain from Paenibacillus barcinonensis Xyn10C;1.7;CA;CALCIUM ION;Endo-1,4-beta-xylanase C;198119;
4XUO;B;Structure of the CBM22-1 xylan-binding domain from Paenibacillus barcinonensis Xyn10C;1.7;CA;CALCIUM ION;Endo-1,4-beta-xylanase C;198119;
4XUP;A;Structure of the N-terminal CBM22-1-CBM22-2 tandem domain from Paenibacillus barcinonensis Xyn10C;2.43;CA;CALCIUM ION;Endo-1,4-beta-xylanase C;198119;
4XUP;B;Structure of the N-terminal CBM22-1-CBM22-2 tandem domain from Paenibacillus barcinonensis Xyn10C;2.43;CA;CALCIUM ION;Endo-1,4-beta-xylanase C;198119;
4XUP;C;Structure of the N-terminal CBM22-1-CBM22-2 tandem domain from Paenibacillus barcinonensis Xyn10C;2.43;CA;CALCIUM ION;Endo-1,4-beta-xylanase C;198119;
4XUP;D;Structure of the N-terminal CBM22-1-CBM22-2 tandem domain from Paenibacillus barcinonensis Xyn10C;2.43;CA;CALCIUM ION;Endo-1,4-beta-xylanase C;198119;
4XUP;E;Structure of the N-terminal CBM22-1-CBM22-2 tandem domain from Paenibacillus barcinonensis Xyn10C;2.43;CA;CALCIUM ION;Endo-1,4-beta-xylanase C;198119;
4XUP;F;Structure of the N-terminal CBM22-1-CBM22-2 tandem domain from Paenibacillus barcinonensis Xyn10C;2.43;CA;CALCIUM ION;Endo-1,4-beta-xylanase C;198119;
4XUQ;A;Structure of the CBM22-2 xylan-binding domain from Paenibacillus barcinonensis Xyn10C in complex with xylotriose;1.95;CA;CALCIUM ION;Endo-1,4-beta-xylanase C;198119;
4XUQ;B;Structure of the CBM22-2 xylan-binding domain from Paenibacillus barcinonensis Xyn10C in complex with xylotriose;1.95;CA;CALCIUM ION;Endo-1,4-beta-xylanase C;198119;
4XUQ;C;Structure of the CBM22-2 xylan-binding domain from Paenibacillus barcinonensis Xyn10C in complex with xylotriose;1.95;CA;CALCIUM ION;Endo-1,4-beta-xylanase C;198119;
4XUR;A;Structure of the CBM22-2 xylan-binding domain from Paenibacillus barcinonensis Xyn10C in complex with xylotetraose;1.67;CA;CALCIUM ION;Endo-1,4-beta-xylanase C;198119;
4XUR;B;Structure of the CBM22-2 xylan-binding domain from Paenibacillus barcinonensis Xyn10C in complex with xylotetraose;1.67;CA;CALCIUM ION;Endo-1,4-beta-xylanase C;198119;
4XUR;C;Structure of the CBM22-2 xylan-binding domain from Paenibacillus barcinonensis Xyn10C in complex with xylotetraose;1.67;CA;CALCIUM ION;Endo-1,4-beta-xylanase C;198119;
4XUT;A;Structure of the CBM22-2 xylan-binding domain in complex with 1,3:1,4 Beta-glucotetraose B from Paenibacillus barcinonensis Xyn10C;1.8;CA;CALCIUM ION;Endo-1,4-beta-xylanase C;198119;
4XUT;B;Structure of the CBM22-2 xylan-binding domain in complex with 1,3:1,4 Beta-glucotetraose B from Paenibacillus barcinonensis Xyn10C;1.8;CA;CALCIUM ION;Endo-1,4-beta-xylanase C;198119;
4XUT;C;Structure of the CBM22-2 xylan-binding domain in complex with 1,3:1,4 Beta-glucotetraose B from Paenibacillus barcinonensis Xyn10C;1.8;CA;CALCIUM ION;Endo-1,4-beta-xylanase C;198119;
4XVR;A;H-Ras Y137F;2.03;CA;CALCIUM ION;GTPase HRas;9606;
4XW4;A;X-ray structure of PKAc with AMPPNP, SP20, calcium ions;1.82;CA;CALCIUM ION;cAMP-dependent protein kinase catalytic subunit alpha;10090;
4XW5;A;X-ray structure of PKAc with ATP, CP20, calcium ions;1.95;CA;CALCIUM ION;cAMP-dependent protein kinase catalytic subunit alpha;10090;
4XWL;A;Catalytic domain of Clostridium Cellulovorans Exgs;2.05;CA;CALCIUM ION;Exoglucanase S;1493;
4XWM;A;Complex structure of catalytic domain of Clostridium Cellulovorans Exgs and Cellobiose;1.7;CA;CALCIUM ION;Exoglucanase S;1493;
4XWN;A;Complex structure of catalytic domain of Clostridium Cellulovorans Exgs and Cellotetraose;2.88;CA;CALCIUM ION;Exoglucanase S;1493;
4XWP;A;Structure of PE-PPE domains of ESX-1 secreted protein EspB, C2221 in presence of Ca;1.82;CA;CALCIUM ION;ESX-1 secretion-associated protein EspB;1773;
4XXA;A;Crystal structure of a recombinant Vatairea macrocarpa seed lectin;1.9;CA;CALCIUM ION;Seed lectin;77050;
4XXA;B;Crystal structure of a recombinant Vatairea macrocarpa seed lectin;1.9;CA;CALCIUM ION;Seed lectin;77050;
4XXW;A;Crystal structure of mouse Cadherin-23 EC1-2 and Protocadherin-15 EC1-2 splice variant;2.26;CA;CALCIUM ION;Protocadherin-15;10090;
4XXW;B;Crystal structure of mouse Cadherin-23 EC1-2 and Protocadherin-15 EC1-2 splice variant;2.26;CA;CALCIUM ION;Protocadherin-15;10090;
4XXW;C;Crystal structure of mouse Cadherin-23 EC1-2 and Protocadherin-15 EC1-2 splice variant;2.26;CA;CALCIUM ION;Cadherin-23;10090;
4XXW;D;Crystal structure of mouse Cadherin-23 EC1-2 and Protocadherin-15 EC1-2 splice variant;2.26;CA;CALCIUM ION;Cadherin-23;10090;
4XYD;A;Nitric oxide reductase from Roseobacter denitrificans (RdNOR);2.85;CA;CALCIUM ION;Nitric-oxide reductase subunit B;2434;
4XYM;B;Ca. Korarchaeum cryptofilum dinucleotide forming Acetyl-coenzyme A synthetase 1 in complex with coenzyme A, Ca-AMPCP and HgCl+;1.9;CA;CALCIUM ION;beta subunit of Acyl-CoA synthetase (NDP forming);498846;
4XYM;D;Ca. Korarchaeum cryptofilum dinucleotide forming Acetyl-coenzyme A synthetase 1 in complex with coenzyme A, Ca-AMPCP and HgCl+;1.9;CA;CALCIUM ION;beta subunit of Acyl-CoA synthetase (NDP forming);498846;
4XYN;A;X-ray structure of Ca(2+)-S100B with human RAGE-derived W61 peptide;2.55;CA;CALCIUM ION;Protein S100-B;9606;
4XYN;B;X-ray structure of Ca(2+)-S100B with human RAGE-derived W61 peptide;2.55;CA;CALCIUM ION;Protein S100-B;9606;
4XYN;C;X-ray structure of Ca(2+)-S100B with human RAGE-derived W61 peptide;2.55;CA;CALCIUM ION;Protein S100-B;9606;
4XYN;D;X-ray structure of Ca(2+)-S100B with human RAGE-derived W61 peptide;2.55;CA;CALCIUM ION;Protein S100-B;9606;
4XZ6;A;TmoX in complex with TMAO;2.2;CA;CALCIUM ION;Glycine betaine/proline ABC transporter, periplasmic substrate-binding protein;89184;
4XZ6;B;TmoX in complex with TMAO;2.2;CA;CALCIUM ION;Glycine betaine/proline ABC transporter, periplasmic substrate-binding protein;89184;
4XZP;A;Crystal structure of the N-terminal domain of human galectin-4;1.48;CA;CALCIUM ION;Galectin-4;9606;
4XZW;A;Endo-glucanase chimera C10;1.5;CA;CALCIUM ION;endo-glucanase chimera C10;77,133,575,526;
4Y0Y;E;Trypsin in complex with with BPTI;1.25;CA;CALCIUM ION;Cationic trypsin;9913;
4Y0Z;E;Trypsin in complex with with BPTI mutant AMINOBUTYRIC ACID;1.37;CA;CALCIUM ION;Cationic trypsin;9913;
4Y10;E;Trypsin in complex with with BPTI mutant (2S)-2-amino-4,4-difluorobutanoic acid;1.37;CA;CALCIUM ION;Cationic trypsin;9913;
4Y11;E;Trypsin in complex with with BPTI mutant (2S)-2-amino-4,4,4-trifluorobutanoic acid;1.3;CA;CALCIUM ION;Cationic trypsin;9913;
4Y1S;A;Structural basis for Ca2+-mediated interaction of the perforin C2 domain with lipid membranes;1.61;CA;CALCIUM ION;Perforin-1;10090;
4Y1T;A;Structural basis for Ca2+-mediated interaction of the perforin C2 domain with lipid membranes;2.67;CA;CALCIUM ION;Perforin-1;10090;
4Y28;B;The structure of plant photosystem I super-complex at 2.8 angstrom resolution.;2.8;CA;CALCIUM ION;Photosystem I P700 chlorophyll a apoprotein A2;3888;
4Y2L;F;Structure of CFA/I pili major subunit CfaB trimer;1.75;CA;CALCIUM ION;CFA/I fimbrial subunit B;562;
4Y55;A;Crystal structure of Buffalo lactoperoxidase with Rhodanide at 2.09 Angstrom resolution;2.1;CA;CALCIUM ION;Lactoperoxidase;89462;
4Y5Q;A;Activated Calcium-Dependent Protein Kinase 1 from Cryptosporidium parvum (CpCDPK1) in complex with AMP;2;CA;CALCIUM ION;Calmodulin-domain protein kinase 1, putative;5807;
4Y5R;A;Crystal Structure of a T67A MauG/pre-Methylamine Dehydrogenase Complex;2.8;CA;CALCIUM ION;Methylamine utilization protein MauG;266;
4Y5R;B;Crystal Structure of a T67A MauG/pre-Methylamine Dehydrogenase Complex;2.8;CA;CALCIUM ION;Methylamine utilization protein MauG;266;
4Y6P;B;Structure of Plasmodium falciparum DXR in complex with a beta-substituted fosmidomycin analogue, RC177, and manganese;1.9;CA;CALCIUM ION;1-deoxy-D-xylulose 5-phosphate reductoisomerase, apicoplast;5833;
4Y71;A;Factor Xa complex with GTC000398;1.8;CA;CALCIUM ION;Coagulation factor X;9606;
4Y76;A;Factor Xa complex with GTC000401;2;CA;CALCIUM ION;Coagulation factor X;9606;
4Y79;A;Factor Xa complex with GTC000406;2.1;CA;CALCIUM ION;Coagulation factor X;9606;
4Y7A;A;Factor Xa complex with GTC000422;1.99;CA;CALCIUM ION;Coagulation factor X;9606;
4Y7B;A;Factor Xa complex with GTC000441;1.79;CA;CALCIUM ION;Coagulation factor X;9606;
4Y7E;A;Crystal structure of beta-mannanase from Streptomyces thermolilacinus with mannohexaose;1.5;CA;CALCIUM ION;Endoglucanase;285540;
4Y7E;B;Crystal structure of beta-mannanase from Streptomyces thermolilacinus with mannohexaose;1.5;CA;CALCIUM ION;Endoglucanase;285540;
4Y8E;A;PA3825-EAL Ca-Apo Structure;1.61;CA;CALCIUM ION;PA3825 EAL;287;
4Y8E;B;PA3825-EAL Ca-Apo Structure;1.61;CA;CALCIUM ION;PA3825 EAL;287;
4Y90;A;Crystal structure of Triosephosphate Isomerase from Deinococcus radiodurans;2.1;CA;CALCIUM ION;Triosephosphate isomerase;1299;
4Y90;B;Crystal structure of Triosephosphate Isomerase from Deinococcus radiodurans;2.1;CA;CALCIUM ION;Triosephosphate isomerase;1299;
4Y90;C;Crystal structure of Triosephosphate Isomerase from Deinococcus radiodurans;2.1;CA;CALCIUM ION;Triosephosphate isomerase;1299;
4Y90;D;Crystal structure of Triosephosphate Isomerase from Deinococcus radiodurans;2.1;CA;CALCIUM ION;Triosephosphate isomerase;1299;
4Y93;A;Crystal structure of the PH-TH-kinase construct of Bruton's tyrosine kinase (Btk);1.7;CA;CALCIUM ION;Non-specific protein-tyrosine kinase,Non-specific protein-tyrosine kinase;9913;
4Y96;A;Crystal structure of Triosephosphate Isomerase from Gemmata obscuriglobus;1.58;CA;CALCIUM ION;Triosephosphate Isomerase;114;
4Y99;A;Core domain of human cardiac troponin;2;CA;CALCIUM ION;Troponin C, slow skeletal and cardiac muscles;9606;
4Y9B;A;Crystal structure of V30M mutated transthyretin in complex with alpha-mangostin;1.4;CA;CALCIUM ION;Transthyretin;9606;
4Y9P;A;PA3825-EAL Ca-CdG Structure;2.44;CA;CALCIUM ION;PA3825-EAL;287;
4Y9P;B;PA3825-EAL Ca-CdG Structure;2.44;CA;CALCIUM ION;PA3825-EAL;287;
4YBH;B;Crystal structure of the human RAGE ectodomain (VC1C2 fragment) in complex with human S100A6;2.4;CA;CALCIUM ION;Protein S100-A6;9606;
4YDO;A;CRYSTAL STRUCTURE OF CANDIDA ALBICANS PROTEIN FARNESYLTRANSFERASE IN APO FORM;3;CA;CALCIUM ION;Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha;5476;
4YDO;B;CRYSTAL STRUCTURE OF CANDIDA ALBICANS PROTEIN FARNESYLTRANSFERASE IN APO FORM;3;CA;CALCIUM ION;Uncharacterized protein;5476;
4YEB;A;Structural characterization of a synaptic adhesion complex;3.19;CA;CALCIUM ION;Latrophilin-3;10090;
4YGA;A;CDPK1, from Toxoplasma gondii, bound to inhibitory VHH-1B7;2.94;CA;CALCIUM ION;Calmodulin-domain protein kinase 1;5811;
4YGA;C;CDPK1, from Toxoplasma gondii, bound to inhibitory VHH-1B7;2.94;CA;CALCIUM ION;Calmodulin-domain protein kinase 1;5811;
4YGA;E;CDPK1, from Toxoplasma gondii, bound to inhibitory VHH-1B7;2.94;CA;CALCIUM ION;Calmodulin-domain protein kinase 1;5811;
4YGA;G;CDPK1, from Toxoplasma gondii, bound to inhibitory VHH-1B7;2.94;CA;CALCIUM ION;Calmodulin-domain protein kinase 1;5811;
4YGB;B;Crystal structure of ERGIC-53/MCFD2, monoclinic calcium-free form;1.6;CA;CALCIUM ION;Multiple coagulation factor deficiency protein 2;9606;
4YGB;D;Crystal structure of ERGIC-53/MCFD2, monoclinic calcium-free form;1.6;CA;CALCIUM ION;Multiple coagulation factor deficiency protein 2;9606;
4YGC;A;Crystal structure of ERGIC-53/MCFD2, monoclinic calcium-bound form 1;2.4;CA;CALCIUM ION;Protein ERGIC-53;9606;
4YGC;B;Crystal structure of ERGIC-53/MCFD2, monoclinic calcium-bound form 1;2.4;CA;CALCIUM ION;Multiple coagulation factor deficiency protein 2;9606;
4YGC;C;Crystal structure of ERGIC-53/MCFD2, monoclinic calcium-bound form 1;2.4;CA;CALCIUM ION;Protein ERGIC-53;9606;
4YGC;D;Crystal structure of ERGIC-53/MCFD2, monoclinic calcium-bound form 1;2.4;CA;CALCIUM ION;Multiple coagulation factor deficiency protein 2;9606;
4YGC;E;Crystal structure of ERGIC-53/MCFD2, monoclinic calcium-bound form 1;2.4;CA;CALCIUM ION;Protein ERGIC-53;9606;
4YGC;F;Crystal structure of ERGIC-53/MCFD2, monoclinic calcium-bound form 1;2.4;CA;CALCIUM ION;Multiple coagulation factor deficiency protein 2;9606;
4YGC;G;Crystal structure of ERGIC-53/MCFD2, monoclinic calcium-bound form 1;2.4;CA;CALCIUM ION;Protein ERGIC-53;9606;
4YGC;H;Crystal structure of ERGIC-53/MCFD2, monoclinic calcium-bound form 1;2.4;CA;CALCIUM ION;Multiple coagulation factor deficiency protein 2;9606;
4YGD;A;Crystal structure of ERGIC-53/MCFD2, monoclinic calcium-bound form 2;2.51;CA;CALCIUM ION;Protein ERGIC-53;9606;
4YGD;B;Crystal structure of ERGIC-53/MCFD2, monoclinic calcium-bound form 2;2.51;CA;CALCIUM ION;Multiple coagulation factor deficiency protein 2;9606;
4YGD;C;Crystal structure of ERGIC-53/MCFD2, monoclinic calcium-bound form 2;2.51;CA;CALCIUM ION;Protein ERGIC-53;9606;
4YGD;D;Crystal structure of ERGIC-53/MCFD2, monoclinic calcium-bound form 2;2.51;CA;CALCIUM ION;Multiple coagulation factor deficiency protein 2;9606;
4YGD;E;Crystal structure of ERGIC-53/MCFD2, monoclinic calcium-bound form 2;2.51;CA;CALCIUM ION;Protein ERGIC-53;9606;
4YGD;F;Crystal structure of ERGIC-53/MCFD2, monoclinic calcium-bound form 2;2.51;CA;CALCIUM ION;Multiple coagulation factor deficiency protein 2;9606;
4YGD;G;Crystal structure of ERGIC-53/MCFD2, monoclinic calcium-bound form 2;2.51;CA;CALCIUM ION;Protein ERGIC-53;9606;
4YGD;H;Crystal structure of ERGIC-53/MCFD2, monoclinic calcium-bound form 2;2.51;CA;CALCIUM ION;Multiple coagulation factor deficiency protein 2;9606;
4YGE;A;Crystal structure of ERGIC-53/MCFD2, trigonal calcium-bound form 2;3.05;CA;CALCIUM ION;Protein ERGIC-53;9606;
4YGE;B;Crystal structure of ERGIC-53/MCFD2, trigonal calcium-bound form 2;3.05;CA;CALCIUM ION;Multiple coagulation factor deficiency protein 2;9606;
4YGE;C;Crystal structure of ERGIC-53/MCFD2, trigonal calcium-bound form 2;3.05;CA;CALCIUM ION;Protein ERGIC-53;9606;
4YGE;D;Crystal structure of ERGIC-53/MCFD2, trigonal calcium-bound form 2;3.05;CA;CALCIUM ION;Multiple coagulation factor deficiency protein 2;9606;
4YGE;F;Crystal structure of ERGIC-53/MCFD2, trigonal calcium-bound form 2;3.05;CA;CALCIUM ION;Multiple coagulation factor deficiency protein 2;9606;
4YGO;A;Dodecameric structure of spermidine N-acetyltransferase from Vibrio cholerae in intermediate state;2.5;CA;CALCIUM ION;Spermidine n1-acetyltransferase;666;
4YGO;B;Dodecameric structure of spermidine N-acetyltransferase from Vibrio cholerae in intermediate state;2.5;CA;CALCIUM ION;Spermidine n1-acetyltransferase;666;
4YGO;D;Dodecameric structure of spermidine N-acetyltransferase from Vibrio cholerae in intermediate state;2.5;CA;CALCIUM ION;Spermidine n1-acetyltransferase;666;
4YGO;E;Dodecameric structure of spermidine N-acetyltransferase from Vibrio cholerae in intermediate state;2.5;CA;CALCIUM ION;Spermidine n1-acetyltransferase;666;
4YHX;A;Crystal Structure of LAGLIDADG Meganuclease I-GpeMI Bound to Uncleaved DNA;2.15;CA;CALCIUM ION;Ribosomal protein 3/homing endonuclease-like fusion protein;360150;
4YI8;A;Crystal structure of non-myristoylated E153A recoverin at 1.2 A resolution with calcium ions bound to EF-hands 2 and 3;1.2;CA;CALCIUM ION;Recoverin;9913;
4YI9;A;Crystal structure of non-myristoylated E153A recoverin at 1.35 A resolution with a sodium ion bound to EF-hand 2 and calcium ion bound to EF-hand 3;1.35;CA;CALCIUM ION;Recoverin;9913;
4YIA;A;Structural mechanism of hormone release in thyroxine binding globulin;1.58;CA;CALCIUM ION;Thyroxine-binding globulin;9606;
4YIA;B;Structural mechanism of hormone release in thyroxine binding globulin;1.58;CA;CALCIUM ION;Thyroxine-binding globulin;9606;
4YIC;A;CRYSTAL STRUCTURE OF A TRAP TRANSPORTER SOLUTE BINDING PROTEIN (IPR025997) FROM BORDETELLA BRONCHISEPTICA RB50 (BB0280, TARGET EFI-500035) WITH BOUND PICOLINIC ACID;1.6;CA;CALCIUM ION;TRAP TRANSPORTER SOLUTE BINDING PROTEIN;518;
4YIC;B;CRYSTAL STRUCTURE OF A TRAP TRANSPORTER SOLUTE BINDING PROTEIN (IPR025997) FROM BORDETELLA BRONCHISEPTICA RB50 (BB0280, TARGET EFI-500035) WITH BOUND PICOLINIC ACID;1.6;CA;CALCIUM ION;TRAP TRANSPORTER SOLUTE BINDING PROTEIN;518;
4YIJ;A;Crystal structure of Staphylcoccal nuclease variant Delta+PHS A109E at cryogenic temperature;1.64;CA;CALCIUM ION;Nuclease A;1280;
4YIJ;B;Crystal structure of Staphylcoccal nuclease variant Delta+PHS A109E at cryogenic temperature;1.64;CA;CALCIUM ION;Nuclease A;1280;
4YIS;A;Crystal Structure of LAGLIDADG Meganuclease I-CpaMI Bound to Uncleaved DNA;2.89;CA;CALCIUM ION;Meganuclease I-CpaMI;5116;
4YIS;B;Crystal Structure of LAGLIDADG Meganuclease I-CpaMI Bound to Uncleaved DNA;2.89;CA;CALCIUM ION;Meganuclease I-CpaMI;5116;
4YIT;A;Crystal Structure of LAGLIDADG Meganuclease I-AabMI Bound to Uncleaved DNA;3.24;CA;CALCIUM ION;Meganuclease I-AabMI;127520;
4YIT;D;Crystal Structure of LAGLIDADG Meganuclease I-AabMI Bound to Uncleaved DNA;3.24;CA;CALCIUM ION;Meganuclease I-AabMI;127520;
4YJ2;A;Crystal structure of tubulin bound to MI-181;2.6;CA;CALCIUM ION;Tubulin alpha-1B chain;9913;
4YJ2;B;Crystal structure of tubulin bound to MI-181;2.6;CA;CALCIUM ION;Tubulin beta-2B chain;9913;
4YJ2;C;Crystal structure of tubulin bound to MI-181;2.6;CA;CALCIUM ION;Tubulin alpha-1B chain;9913;
4YJ3;A;Crystal structure of tubulin bound to compound 2;3.75;CA;CALCIUM ION;Tubulin alpha-1B chain;9913;
4YJ3;B;Crystal structure of tubulin bound to compound 2;3.75;CA;CALCIUM ION;Tubulin beta-2B chain;9913;
4YJ3;C;Crystal structure of tubulin bound to compound 2;3.75;CA;CALCIUM ION;Tubulin alpha-1B chain;9913;
4YL9;B;Crystal Structure of wild-type of hsp14.1 from Sulfolobus solfatataricus P2;2.35;CA;CALCIUM ION;Heat shock protein Hsp20;2287;
4YL9;C;Crystal Structure of wild-type of hsp14.1 from Sulfolobus solfatataricus P2;2.35;CA;CALCIUM ION;Heat shock protein Hsp20;2287;
4YL9;D;Crystal Structure of wild-type of hsp14.1 from Sulfolobus solfatataricus P2;2.35;CA;CALCIUM ION;Heat shock protein Hsp20;2287;
4YLI;A;CL-K1 trimer;2.45;CA;CALCIUM ION;Collectin-11;9606;
4YLI;B;CL-K1 trimer;2.45;CA;CALCIUM ION;Collectin-11;9606;
4YLI;C;CL-K1 trimer;2.45;CA;CALCIUM ION;Collectin-11;9606;
4YLI;D;CL-K1 trimer;2.45;CA;CALCIUM ION;Collectin-11;9606;
4YLI;E;CL-K1 trimer;2.45;CA;CALCIUM ION;Collectin-11;9606;
4YLI;F;CL-K1 trimer;2.45;CA;CALCIUM ION;Collectin-11;9606;
4YLQ;H;Crystal Structure of a FVIIa-Trypsin Chimera (FT) in Complex with Soluble Tissue Factor;1.4;CA;CALCIUM ION;Coagulation factor VII;9606;
4YLQ;L;Crystal Structure of a FVIIa-Trypsin Chimera (FT) in Complex with Soluble Tissue Factor;1.4;CA;CALCIUM ION;Coagulation factor VII;9606;
4YMD;A;CL-K1 trimer bound to man(alpha1-2)man;2.87;CA;CALCIUM ION;Collectin-11;9606;
4YMD;B;CL-K1 trimer bound to man(alpha1-2)man;2.87;CA;CALCIUM ION;Collectin-11;9606;
4YMD;C;CL-K1 trimer bound to man(alpha1-2)man;2.87;CA;CALCIUM ION;Collectin-11;9606;
4YMD;D;CL-K1 trimer bound to man(alpha1-2)man;2.87;CA;CALCIUM ION;Collectin-11;9606;
4YMD;E;CL-K1 trimer bound to man(alpha1-2)man;2.87;CA;CALCIUM ION;Collectin-11;9606;
4YMD;F;CL-K1 trimer bound to man(alpha1-2)man;2.87;CA;CALCIUM ION;Collectin-11;9606;
4YP3;A;Mutant Human DNA Polymerase Eta Q38A/R61A Inserting dCTP Opposite an 8-Oxoguanine Lesion;1.89;CA;CALCIUM ION;DNA polymerase eta;9606;
4YP9;B;Crystal Structure of LuxP In Complex With a Formose Derived AI-2 Analogue;2.7;CA;CALCIUM ION;Autoinducer 2-binding periplasmic protein LuxP;669;
4YQW;A;Mutant Human DNA Polymerase Eta Q38A/R61A Inserting dCTP Opposite Template G;2.06;CA;CALCIUM ION;DNA polymerase eta;9606;
4YR0;A;Mutant Human DNA Polymerase Eta R61M Inserting dCTP Opposite an 8-Oxoguanine Lesion;1.78;CA;CALCIUM ION;DNA polymerase eta;9606;
4YR2;A;Mutant Human DNA Polymerase Eta R61M Inserting dATP Opposite an 8-Oxoguanine Lesion;1.95;CA;CALCIUM ION;DNA polymerase eta;9606;
4YR3;A;Mutant Human DNA Polymerase Eta R61M Inserting dCTP Opposite Template G;2;CA;CALCIUM ION;DNA polymerase eta;9606;
4YRU;A;Crystal structure of C-terminally truncated Neuronal Calcium Sensor (NCS-1) from Rattus norvegicus;2.8;CA;CALCIUM ION;Neuronal calcium sensor 1;10116;
4YRU;B;Crystal structure of C-terminally truncated Neuronal Calcium Sensor (NCS-1) from Rattus norvegicus;2.8;CA;CALCIUM ION;Neuronal calcium sensor 1;10116;
4YRU;C;Crystal structure of C-terminally truncated Neuronal Calcium Sensor (NCS-1) from Rattus norvegicus;2.8;CA;CALCIUM ION;Neuronal calcium sensor 1;10116;
4YRU;D;Crystal structure of C-terminally truncated Neuronal Calcium Sensor (NCS-1) from Rattus norvegicus;2.8;CA;CALCIUM ION;Neuronal calcium sensor 1;10116;
4YRV;B;Crystal structure of Anabaena transcription factor HetR complexed with 21-bp DNA from hetP promoter;2.8;CA;CALCIUM ION;Heterocyst differentiation control protein;103690;
4YRV;C;Crystal structure of Anabaena transcription factor HetR complexed with 21-bp DNA from hetP promoter;2.8;CA;CALCIUM ION;DNA (5'-D(P*GP*CP*GP*AP*GP*GP*GP*GP*TP*CP*TP*AP*AP*CP*CP*CP*CP*TP*CP*AP*T)-3');103690;
4YRV;D;Crystal structure of Anabaena transcription factor HetR complexed with 21-bp DNA from hetP promoter;2.8;CA;CALCIUM ION;DNA (5'-D(P*AP*TP*GP*AP*GP*GP*GP*GP*TP*TP*AP*GP*AP*CP*CP*CP*CP*TP*CP*GP*C)-3');103690;
4YRW;A;rat xanthine oxidoreductase, C-terminal deletion protein variant;1.99;CA;CALCIUM ION;Xanthine dehydrogenase/oxidase;10116;
4YRW;B;rat xanthine oxidoreductase, C-terminal deletion protein variant;1.99;CA;CALCIUM ION;Xanthine dehydrogenase/oxidase;10116;
4YSJ;A;Calcium-Dependent Protein Kinase from Eimeria tenella in complex with ADP;2.7;CA;CALCIUM ION;Calmodulin-like domain protein kinase;5802;
4YSJ;B;Calcium-Dependent Protein Kinase from Eimeria tenella in complex with ADP;2.7;CA;CALCIUM ION;Calmodulin-like domain protein kinase;5802;
4YSM;A;Calcium-Dependent Protein Kinase from Eimeria tenella;3.19;CA;CALCIUM ION;Calmodulin-like domain protein kinase;5802;
4YSM;B;Calcium-Dependent Protein Kinase from Eimeria tenella;3.19;CA;CALCIUM ION;Calmodulin-like domain protein kinase;5802;
4YSW;A;Structure of rat xanthine oxidoreductase, C-terminal deletion protein variant, NADH bound form;1.99;CA;CALCIUM ION;Xanthine dehydrogenase/oxidase;10116;
4YSW;B;Structure of rat xanthine oxidoreductase, C-terminal deletion protein variant, NADH bound form;1.99;CA;CALCIUM ION;Xanthine dehydrogenase/oxidase;10116;
4YT6;H;Factor VIIa in complex with the inhibitor 4-{[(R)-[5-ethoxy-2-fluoro-3-(propan-2-yloxy)phenyl](4-phenyl-1H-imidazol-2-yl)methyl]amino}benzenecarboximidamide;2.07;CA;CALCIUM ION;Coagulation factor VII (heavy chain);9606;
4YT7;H;Factor VIIa in complex with the inhibitor 2-(2-{(R)-[(4-carbamimidoylphenyl)amino][5-ethoxy-2-fluoro-3-(propan-2-yloxy)phenyl]methyl}-1H-imidazol-4-yl)benzamide;2.3;CA;CALCIUM ION;Coagulation factor VII (heavy chain);9606;
4YTA;A;BOND LENGTH ANALYSIS OF ASP, GLU AND HIS RESIDUES IN TRYPSIN AT 1.2A RESOLUTION;1.2;CA;CALCIUM ION;Cationic trypsin;9913;
4YTY;A;Structure of rat xanthine oxidoreductase, C535A/C992R/C1324S, NADH bound form;2.2;CA;CALCIUM ION;Xanthine dehydrogenase/oxidase;10116;
4YTY;B;Structure of rat xanthine oxidoreductase, C535A/C992R/C1324S, NADH bound form;2.2;CA;CALCIUM ION;Xanthine dehydrogenase/oxidase;10116;
4YTZ;A;Rat xanthine oxidoreductase, C-terminal deletion protein variant, crystal grown without dithiothreitol;2.3;CA;CALCIUM ION;Xanthine dehydrogenase/oxidase;10116;
4YTZ;B;Rat xanthine oxidoreductase, C-terminal deletion protein variant, crystal grown without dithiothreitol;2.3;CA;CALCIUM ION;Xanthine dehydrogenase/oxidase;10116;
4YU5;A;Crystal structure of selenomethionine variant of Bacillus anthracis immune inhibitor A2 peptidase zymogen;2.9;CA;CALCIUM ION;Immune inhibitor A, metalloprotease;1396;
4YU5;B;Crystal structure of selenomethionine variant of Bacillus anthracis immune inhibitor A2 peptidase zymogen;2.9;CA;CALCIUM ION;Immune inhibitor A, metalloprotease;1396;
4YU6;A;Crystal structure of Bacillus anthracis immune inhibitor A2 peptidase zymogen;2.6;CA;CALCIUM ION;Immune inhibitor A, metalloprotease;1396;
4YU6;B;Crystal structure of Bacillus anthracis immune inhibitor A2 peptidase zymogen;2.6;CA;CALCIUM ION;Immune inhibitor A, metalloprotease;1396;
4YUQ;A;CDPK1 from Eimeria tenella in complex with inhibitor UW1354;2.8;CA;CALCIUM ION;Calmodulin-like domain protein kinase;5802;
4YUQ;B;CDPK1 from Eimeria tenella in complex with inhibitor UW1354;2.8;CA;CALCIUM ION;Calmodulin-like domain protein kinase;5802;
4YUU;O1;Crystal structure of oxygen-evolving photosystem II from a red alga;2.77;CA;CALCIUM ION;PHOTOSYSTEM II MANGANESE-STABILIZING POLYPEPTIDE, PSBO;2771;
4YUU;o2;Crystal structure of oxygen-evolving photosystem II from a red alga;2.77;CA;CALCIUM ION;PHOTOSYSTEM II MANGANESE-STABILIZING POLYPEPTIDE, PSBO;2771;
4YW6;A;Structural Insight into Divalent Galactoside Binding to Pseudomonas aeruginosa lectin LecA;1.4;CA;CALCIUM ION;PA-I galactophilic lectin;287;
4YW6;B;Structural Insight into Divalent Galactoside Binding to Pseudomonas aeruginosa lectin LecA;1.4;CA;CALCIUM ION;PA-I galactophilic lectin;287;
4YW6;C;Structural Insight into Divalent Galactoside Binding to Pseudomonas aeruginosa lectin LecA;1.4;CA;CALCIUM ION;PA-I galactophilic lectin;287;
4YW6;D;Structural Insight into Divalent Galactoside Binding to Pseudomonas aeruginosa lectin LecA;1.4;CA;CALCIUM ION;PA-I galactophilic lectin;287;
4YW7;A;Structural Insight into Divalent Galactoside Binding to Pseudomonas aeruginosa lectin LecA;1.82;CA;CALCIUM ION;PA-I galactophilic lectin;287;
4YW7;B;Structural Insight into Divalent Galactoside Binding to Pseudomonas aeruginosa lectin LecA;1.82;CA;CALCIUM ION;PA-I galactophilic lectin;287;
4YW7;C;Structural Insight into Divalent Galactoside Binding to Pseudomonas aeruginosa lectin LecA;1.82;CA;CALCIUM ION;PA-I galactophilic lectin;287;
4YW7;D;Structural Insight into Divalent Galactoside Binding to Pseudomonas aeruginosa lectin LecA;1.82;CA;CALCIUM ION;PA-I galactophilic lectin;287;
4YW7;E;Structural Insight into Divalent Galactoside Binding to Pseudomonas aeruginosa lectin LecA;1.82;CA;CALCIUM ION;PA-I galactophilic lectin;287;
4YW7;F;Structural Insight into Divalent Galactoside Binding to Pseudomonas aeruginosa lectin LecA;1.82;CA;CALCIUM ION;PA-I galactophilic lectin;287;
4YW7;G;Structural Insight into Divalent Galactoside Binding to Pseudomonas aeruginosa lectin LecA;1.82;CA;CALCIUM ION;PA-I galactophilic lectin;287;
4YW7;H;Structural Insight into Divalent Galactoside Binding to Pseudomonas aeruginosa lectin LecA;1.82;CA;CALCIUM ION;PA-I galactophilic lectin;287;
4YW7;I;Structural Insight into Divalent Galactoside Binding to Pseudomonas aeruginosa lectin LecA;1.82;CA;CALCIUM ION;PA-I galactophilic lectin;287;
4YW7;J;Structural Insight into Divalent Galactoside Binding to Pseudomonas aeruginosa lectin LecA;1.82;CA;CALCIUM ION;PA-I galactophilic lectin;287;
4YW7;K;Structural Insight into Divalent Galactoside Binding to Pseudomonas aeruginosa lectin LecA;1.82;CA;CALCIUM ION;PA-I galactophilic lectin;287;
4YW7;L;Structural Insight into Divalent Galactoside Binding to Pseudomonas aeruginosa lectin LecA;1.82;CA;CALCIUM ION;PA-I galactophilic lectin;287;
4YW7;M;Structural Insight into Divalent Galactoside Binding to Pseudomonas aeruginosa lectin LecA;1.82;CA;CALCIUM ION;PA-I galactophilic lectin;287;
4YW7;N;Structural Insight into Divalent Galactoside Binding to Pseudomonas aeruginosa lectin LecA;1.82;CA;CALCIUM ION;PA-I galactophilic lectin;287;
4YW7;O;Structural Insight into Divalent Galactoside Binding to Pseudomonas aeruginosa lectin LecA;1.82;CA;CALCIUM ION;PA-I galactophilic lectin;287;
4YW7;P;Structural Insight into Divalent Galactoside Binding to Pseudomonas aeruginosa lectin LecA;1.82;CA;CALCIUM ION;PA-I galactophilic lectin;287;
4YWA;A;Structural Insight into Divalent Galactoside Binding to Pseudomonas aeruginosa lectin LecA;1.19;CA;CALCIUM ION;PA-I galactophilic lectin;287;
4YWA;B;Structural Insight into Divalent Galactoside Binding to Pseudomonas aeruginosa lectin LecA;1.19;CA;CALCIUM ION;PA-I galactophilic lectin;287;
4YWA;C;Structural Insight into Divalent Galactoside Binding to Pseudomonas aeruginosa lectin LecA;1.19;CA;CALCIUM ION;PA-I galactophilic lectin;287;
4YWA;D;Structural Insight into Divalent Galactoside Binding to Pseudomonas aeruginosa lectin LecA;1.19;CA;CALCIUM ION;PA-I galactophilic lectin;287;
4YWE;A;Crystal Structure of a Putative Aldehyde Dehydrogenase from Burkholderia cenocepacia;2.15;CA;CALCIUM ION;Putative aldehyde dehydrogenase;95486;
4YWE;B;Crystal Structure of a Putative Aldehyde Dehydrogenase from Burkholderia cenocepacia;2.15;CA;CALCIUM ION;Putative aldehyde dehydrogenase;95486;
4YWE;C;Crystal Structure of a Putative Aldehyde Dehydrogenase from Burkholderia cenocepacia;2.15;CA;CALCIUM ION;Putative aldehyde dehydrogenase;95486;
4YWE;D;Crystal Structure of a Putative Aldehyde Dehydrogenase from Burkholderia cenocepacia;2.15;CA;CALCIUM ION;Putative aldehyde dehydrogenase;95486;
4YWE;E;Crystal Structure of a Putative Aldehyde Dehydrogenase from Burkholderia cenocepacia;2.15;CA;CALCIUM ION;Putative aldehyde dehydrogenase;95486;
4YWE;F;Crystal Structure of a Putative Aldehyde Dehydrogenase from Burkholderia cenocepacia;2.15;CA;CALCIUM ION;Putative aldehyde dehydrogenase;95486;
4YWE;G;Crystal Structure of a Putative Aldehyde Dehydrogenase from Burkholderia cenocepacia;2.15;CA;CALCIUM ION;Putative aldehyde dehydrogenase;95486;
4YWE;H;Crystal Structure of a Putative Aldehyde Dehydrogenase from Burkholderia cenocepacia;2.15;CA;CALCIUM ION;Putative aldehyde dehydrogenase;95486;
4YWT;A;Crystal structure of full-length glypican-1 core protein after controlled crystal dehydration to 87% relative humidity;2.38;CA;CALCIUM ION;Glypican-1;9606;
4YWT;B;Crystal structure of full-length glypican-1 core protein after controlled crystal dehydration to 87% relative humidity;2.38;CA;CALCIUM ION;Glypican-1;9606;
4YWT;C;Crystal structure of full-length glypican-1 core protein after controlled crystal dehydration to 87% relative humidity;2.38;CA;CALCIUM ION;Glypican-1;9606;
4YWT;D;Crystal structure of full-length glypican-1 core protein after controlled crystal dehydration to 87% relative humidity;2.38;CA;CALCIUM ION;Glypican-1;9606;
4YX1;B;SpaO(SPOA2);1.35;CA;CALCIUM ION;Surface presentation of antigens protein SpaO;28901;
4YX6;A;Architectural hierarchy of trans-acting enoyl reductases from polyunsaturated fatty acid and trans-AT polyketide synthases;1.86;CA;CALCIUM ION;Omega-3 polyunsaturated fatty acid synthase subunit PfaD;70863;
4YX6;B;Architectural hierarchy of trans-acting enoyl reductases from polyunsaturated fatty acid and trans-AT polyketide synthases;1.86;CA;CALCIUM ION;Omega-3 polyunsaturated fatty acid synthase subunit PfaD;70863;
4YYM;A;Crystal structure of TAF1 BD2 Bromodomain bound to a butyryllysine peptide;1.5;CA;CALCIUM ION;Transcription initiation factor TFIID subunit 1;9606;
4YZ0;A;C. bescii Family 3 pectate lyase double mutant K108A/E39Q in complex with trigalacturonic acid;1.15;CA;CALCIUM ION;Pectate lyase;31899;
4YZ0;B;C. bescii Family 3 pectate lyase double mutant K108A/E39Q in complex with trigalacturonic acid;1.15;CA;CALCIUM ION;Pectate lyase;31899;
4YZA;A;C. bescii Family 3 pectate lyase double mutant K108A/Q111A in complex with trigalacturonic acid;1.25;CA;CALCIUM ION;Pectate lyase;31899;
4YZA;B;C. bescii Family 3 pectate lyase double mutant K108A/Q111A in complex with trigalacturonic acid;1.25;CA;CALCIUM ION;Pectate lyase;31899;
4YZB;A;CDPK1 from Eimeria tenella in complex with inhibitor UW1521;2.9;CA;CALCIUM ION;Calmodulin-like domain protein kinase;5802;
4YZB;B;CDPK1 from Eimeria tenella in complex with inhibitor UW1521;2.9;CA;CALCIUM ION;Calmodulin-like domain protein kinase;5802;
4YZO;C;Crystal Structure Analysis of Thiolase-like protein, ST0096 from Sulfolobus Tokodaii;1.7;CA;CALCIUM ION;Putative acyl-CoA acyltransferase;111955;
4YZO;D;Crystal Structure Analysis of Thiolase-like protein, ST0096 from Sulfolobus Tokodaii;1.7;CA;CALCIUM ION;Putative acyl-CoA acyltransferase;111955;
4YZQ;A;C. bescii Family 3 pectate lyase double mutant K108A/Q111N in complex with trigalacturonic acid;1.48;CA;CALCIUM ION;Pectate lyase;31899;
4YZQ;B;C. bescii Family 3 pectate lyase double mutant K108A/Q111N in complex with trigalacturonic acid;1.48;CA;CALCIUM ION;Pectate lyase;31899;
4YZX;A;C. bescii Family 3 pectate lyase double mutant K108A/D107N in complex with trigalacturonic acid;1.25;CA;CALCIUM ION;Pectate lyase;31899;
4YZX;B;C. bescii Family 3 pectate lyase double mutant K108A/D107N in complex with trigalacturonic acid;1.25;CA;CALCIUM ION;Pectate lyase;31899;
4YZZ;A;Crystal structure of a TRAP transporter solute binding protein (IPR025997) from Bordetella bronchiseptica RB50 (BB0280, TARGET EFI-500035) mixed occupancy dimer, copurified calcium and picolinate bound active site versus apo site;1.3;CA;CALCIUM ION;TRAP TRANSPORTER SOLUTE BINDING PROTEIN;518;
4Z03;A;C. bescii Family 3 pectate lyase double mutant K108A in complex with trigalacturonic acid;1.4;CA;CALCIUM ION;Pectate lyase;31899;
4Z03;B;C. bescii Family 3 pectate lyase double mutant K108A in complex with trigalacturonic acid;1.4;CA;CALCIUM ION;Pectate lyase;31899;
4Z05;A;C. bescii Family 3 pectate lyase mutant E84A;1.5;CA;CALCIUM ION;Pectate lyase;31899;
4Z05;B;C. bescii Family 3 pectate lyase mutant E84A;1.5;CA;CALCIUM ION;Pectate lyase;31899;
4Z06;A;C. bescii Family 3 pectate lyase double mutant K108A/R133A in complex with ALPHA-D-GALACTOPYRANURONIC ACID;1.55;CA;CALCIUM ION;Pectate lyase;31899;
4Z06;B;C. bescii Family 3 pectate lyase double mutant K108A/R133A in complex with ALPHA-D-GALACTOPYRANURONIC ACID;1.55;CA;CALCIUM ION;Pectate lyase;31899;
4Z0N;A;Crystal Structure of a Periplasmic Solute binding protein (IPR025997) from Streptobacillus moniliformis DSM-12112 (Smon_0317, TARGET EFI-511281) with bound D-Galactose;1.26;CA;CALCIUM ION;Periplasmic binding protein/LacI transcriptional regulator;34105;
4Z1X;A;Crystal structure of LAGLIDADG homing endonuclease I-GzeII in complex with DNA target;2.8;CA;CALCIUM ION;LAGLIDADG endonuclease;5518;
4Z1X;B;Crystal structure of LAGLIDADG homing endonuclease I-GzeII in complex with DNA target;2.8;CA;CALCIUM ION;LAGLIDADG endonuclease;5518;
4Z1Z;A;Crystal Structure of Meganuclease I-SmaMI Bound to Uncleaveable DNA with a TTCT Central Four;3.2;CA;CALCIUM ION;Meganuclease I-SmaMI;5147;
4Z1Z;B;Crystal Structure of Meganuclease I-SmaMI Bound to Uncleaveable DNA with a TTCT Central Four;3.2;CA;CALCIUM ION;Meganuclease I-SmaMI;5147;
4Z20;A;Crystal Structure of Meganuclease I-SmaMI Bound to Uncleaveable DNA with a TTGT Central Four;3.2;CA;CALCIUM ION;MEGANUCLEASE I-SMAMI;5147;
4Z20;D;Crystal Structure of Meganuclease I-SmaMI Bound to Uncleaveable DNA with a TTGT Central Four;3.2;CA;CALCIUM ION;MEGANUCLEASE I-SMAMI;5147;
4Z2A;A;Crystal structure of unglycosylated apo human furin @1.89A;1.89;CA;CALCIUM ION;Furin;9606;
4Z6A;H;Crystal Structure of a FVIIa-Trypsin Chimera (YT) in Complex with Soluble Tissue Factor;2.25;CA;CALCIUM ION;Coagulation factor VII;9606;
4Z6L;B;Structure of H200E variant of Homoprotocatechuate 2,3-Dioxygenase from B.fuscum at 1.65 Ang resolution;1.65;CA;CALCIUM ION;Homoprotocatechuate 2,3-dioxygenase;47914;
4Z6M;B;Structure of H200Q variant of Homoprotocatechuate 2,3-Dioxygenase from B.fuscum at 1.35 Ang resolution;1.35;CA;CALCIUM ION;Homoprotocatechuate 2,3-dioxygenase;47914;
4Z6N;B;Structure of H200N variant of Homoprotocatechuate 2,3-Dioxygenase from B.fuscum at 1.52 Ang resolution;1.52;CA;CALCIUM ION;Homoprotocatechuate 2,3-dioxygenase;47914;
4Z6O;B;Structure of H200E variant of Homoprotocatechuate 2,3-Dioxygenase from B.fuscum in complex with HPCA at 1.63 Ang resolution;1.63;CA;CALCIUM ION;Homoprotocatechuate 2,3-dioxygenase;47914;
4Z6Q;B;Structure of H200N variant of Homoprotocatechuate 2,3-Dioxygenase from B.fuscum in complex with HPCA at 1.57 Ang resolution;1.57;CA;CALCIUM ION;Homoprotocatechuate 2,3-dioxygenase;47914;
4Z6R;B;Structure of H200E variant of Homoprotocatechuate 2,3-Dioxygenase from B.fuscum in complex with 4-sulfonyl catechol at 1.70 Ang resolution;1.7;CA;CALCIUM ION;Homoprotocatechuate 2,3-dioxygenase;47914;
4Z6S;B;Structure of H200Q variant of Homoprotocatechuate 2,3-Dioxygenase from B.fuscum in complex with 4-sulfonyl catechol at 1.42 Ang resolution;1.42;CA;CALCIUM ION;Homoprotocatechuate 2,3-dioxygenase;47914;
4Z6T;B;Structure of H200N variant of Homoprotocatechuate 2,3-Dioxygenase from B.fuscum in complex with 4-sulfonyl catechol at 1.50 Ang resolution;1.5;CA;CALCIUM ION;Homoprotocatechuate 2,3-dioxygenase;47914;
4Z6U;B;Structure of H200E variant of Homoprotocatechuate 2,3-Dioxygenase from B.fuscum in complex with 4-nitrocatechol at 1.48 Ang resolution;1.48;CA;CALCIUM ION;Homoprotocatechuate 2,3-dioxygenase;47914;
4Z6V;B;Structure of H200Q variant of Homoprotocatechuate 2,3-Dioxygenase from B.fuscum in complex with 4-nitrocatechol at 1.37 Ang resolution;1.37;CA;CALCIUM ION;Homoprotocatechuate 2,3-dioxygenase;47914;
4Z6W;B;Structure of H200N variant of Homoprotocatechuate 2,3-Dioxygenase from B.fuscum in complex with 4-nitrocatechol at 1.57 Ang resolution;1.57;CA;CALCIUM ION;Homoprotocatechuate 2,3-dioxygenase;47914;
4Z6Z;B;Structure of Homoprotocatechuate 2,3-Dioxygenase from B.fuscum in complex with 4-sulfonyl catechol at 1.52 Ang resolution;1.52;CA;CALCIUM ION;Homoprotocatechuate 2,3-dioxygenase;47914;
4Z70;A;Crystal structure of inorganic pyrophosphatase from Mycobacterium tuberculosis in complex with Ca ions;1.95;CA;CALCIUM ION;Inorganic pyrophosphatase;1773;
4Z70;B;Crystal structure of inorganic pyrophosphatase from Mycobacterium tuberculosis in complex with Ca ions;1.95;CA;CALCIUM ION;Inorganic pyrophosphatase;1773;
4Z70;C;Crystal structure of inorganic pyrophosphatase from Mycobacterium tuberculosis in complex with Ca ions;1.95;CA;CALCIUM ION;Inorganic pyrophosphatase;1773;
4Z72;A;Crystal structure of inorganic pyrophosphatase from Mycobacterium tuberculosis in complex with two phosphate ions;2.35;CA;CALCIUM ION;Inorganic pyrophosphatase;1773;
4Z74;A;Crystal structure of inorganic pyrophosphatase from Mycobacterium tuberculosis in complex with inorganic pyrophosphate;2.55;CA;CALCIUM ION;Inorganic pyrophosphatase;1773;
4Z74;B;Crystal structure of inorganic pyrophosphatase from Mycobacterium tuberculosis in complex with inorganic pyrophosphate;2.55;CA;CALCIUM ION;Inorganic pyrophosphatase;1773;
4Z74;C;Crystal structure of inorganic pyrophosphatase from Mycobacterium tuberculosis in complex with inorganic pyrophosphate;2.55;CA;CALCIUM ION;Inorganic pyrophosphatase;1773;
4Z74;D;Crystal structure of inorganic pyrophosphatase from Mycobacterium tuberculosis in complex with inorganic pyrophosphate;2.55;CA;CALCIUM ION;Inorganic pyrophosphatase;1773;
4Z74;E;Crystal structure of inorganic pyrophosphatase from Mycobacterium tuberculosis in complex with inorganic pyrophosphate;2.55;CA;CALCIUM ION;Inorganic pyrophosphatase;1773;
4Z74;F;Crystal structure of inorganic pyrophosphatase from Mycobacterium tuberculosis in complex with inorganic pyrophosphate;2.55;CA;CALCIUM ION;Inorganic pyrophosphatase;1773;
4Z74;G;Crystal structure of inorganic pyrophosphatase from Mycobacterium tuberculosis in complex with inorganic pyrophosphate;2.55;CA;CALCIUM ION;Inorganic pyrophosphatase;1773;
4Z74;H;Crystal structure of inorganic pyrophosphatase from Mycobacterium tuberculosis in complex with inorganic pyrophosphate;2.55;CA;CALCIUM ION;Inorganic pyrophosphatase;1773;
4Z74;I;Crystal structure of inorganic pyrophosphatase from Mycobacterium tuberculosis in complex with inorganic pyrophosphate;2.55;CA;CALCIUM ION;Inorganic pyrophosphatase;1773;
4Z74;J;Crystal structure of inorganic pyrophosphatase from Mycobacterium tuberculosis in complex with inorganic pyrophosphate;2.55;CA;CALCIUM ION;Inorganic pyrophosphatase;1773;
4Z74;K;Crystal structure of inorganic pyrophosphatase from Mycobacterium tuberculosis in complex with inorganic pyrophosphate;2.55;CA;CALCIUM ION;Inorganic pyrophosphatase;1773;
4Z74;L;Crystal structure of inorganic pyrophosphatase from Mycobacterium tuberculosis in complex with inorganic pyrophosphate;2.55;CA;CALCIUM ION;Inorganic pyrophosphatase;1773;
4Z7N;A;Integrin alphaIIbbeta3 in complex with AGDV peptide;2.6;CA;CALCIUM ION;Integrin alpha-IIb;9606;
4Z7N;C;Integrin alphaIIbbeta3 in complex with AGDV peptide;2.6;CA;CALCIUM ION;Integrin alpha-IIb;9606;
4Z7O;A;Integrin alphaIIbbeta3 in complex with AGDV peptide;2.85;CA;CALCIUM ION;Integrin alpha-IIb;9606;
4Z7O;C;Integrin alphaIIbbeta3 in complex with AGDV peptide;2.85;CA;CALCIUM ION;Integrin alpha-IIb;9606;
4Z7Q;A;Integrin alphaIIbbeta3 in complex with AGDV-NH2 peptide;2.7;CA;CALCIUM ION;Integrin alpha-IIb;9606;
4Z7Q;C;Integrin alphaIIbbeta3 in complex with AGDV-NH2 peptide;2.7;CA;CALCIUM ION;Integrin alpha-IIb;9606;
4Z89;B;SH3-II of Drosophila Rim-binding protein bound to a Cacophony derived peptide;2.64;CA;CALCIUM ION;RIM-binding protein, isoform F;7227;
4Z8B;A;crystal structure of a DGL mutant - H51G H131N;1.95;CA;CALCIUM ION;Lectin alpha chain;3837;
4Z8N;B;Crystal structure of the erythrocyte-binding domain from Plasmodium vivax reticulocyte-binding protein 2a (PvRBP2a);2.12;CA;CALCIUM ION;Reticulocyte-binding protein 2a;5855;
4Z94;A;Actin Complex With a Chimera of Tropomodulin-1 and Leiomodin-1 Actin-Binding Site 2;2.4;CA;CALCIUM ION;Actin, alpha skeletal muscle;9986;
4Z94;G;Actin Complex With a Chimera of Tropomodulin-1 and Leiomodin-1 Actin-Binding Site 2;2.4;CA;CALCIUM ION;Gelsolin, Tropomodulin-1, Leiomodin-1 chimera;9606;
4ZA6;A;Structure of the R. erythropolis transcriptional repressor QsdR from TetR family;1.97;CA;CALCIUM ION;TetR family transcriptional regulator;1833;
4ZA6;B;Structure of the R. erythropolis transcriptional repressor QsdR from TetR family;1.97;CA;CALCIUM ION;TetR family transcriptional regulator;1833;
4ZAR;A;Crystal Structure of Proteinase K from Engyodontium albuminhibited by METHOXYSUCCINYL-ALA-ALA-PRO-PHE-CHLOROMETHYL KETONE at 1.15 A resolution;1.15;CA;CALCIUM ION;Proteinase K;37998;
4ZCF;D;Structural basis of asymmetric DNA methylation and ATP-triggered long-range diffusion by EcoP15I;2.6;CA;CALCIUM ION;DNA 20-mer ATACAGCAGTAGACTATGAT;562;
4ZCU;A;Structure of calcium-bound regulatory domain of the human ATP-Mg/Pi carrier in the P2 form;2.1;CA;CALCIUM ION;Calcium-binding mitochondrial carrier protein SCaMC-1;9606;
4ZCU;B;Structure of calcium-bound regulatory domain of the human ATP-Mg/Pi carrier in the P2 form;2.1;CA;CALCIUM ION;Calcium-binding mitochondrial carrier protein SCaMC-1;9606;
4ZCU;C;Structure of calcium-bound regulatory domain of the human ATP-Mg/Pi carrier in the P2 form;2.1;CA;CALCIUM ION;Calcium-binding mitochondrial carrier protein SCaMC-1;9606;
4ZCV;A;Structure of calcium-bound regulatory domain of the human ATP-Mg/Pi carrier in the P212121 form;2.8;CA;CALCIUM ION;Calcium-binding mitochondrial carrier protein SCaMC-1;9606;
4ZCV;B;Structure of calcium-bound regulatory domain of the human ATP-Mg/Pi carrier in the P212121 form;2.8;CA;CALCIUM ION;Calcium-binding mitochondrial carrier protein SCaMC-1;9606;
4ZCV;C;Structure of calcium-bound regulatory domain of the human ATP-Mg/Pi carrier in the P212121 form;2.8;CA;CALCIUM ION;Calcium-binding mitochondrial carrier protein SCaMC-1;9606;
4ZCV;D;Structure of calcium-bound regulatory domain of the human ATP-Mg/Pi carrier in the P212121 form;2.8;CA;CALCIUM ION;Calcium-binding mitochondrial carrier protein SCaMC-1;9606;
4ZDI;A;Crystal structure of the M. tuberculosis CTP synthase PyrG (apo form);3.52;CA;CALCIUM ION;CTP synthase;1773;
4ZDI;B;Crystal structure of the M. tuberculosis CTP synthase PyrG (apo form);3.52;CA;CALCIUM ION;CTP synthase;1773;
4ZDI;C;Crystal structure of the M. tuberculosis CTP synthase PyrG (apo form);3.52;CA;CALCIUM ION;CTP synthase;1773;
4ZDI;D;Crystal structure of the M. tuberculosis CTP synthase PyrG (apo form);3.52;CA;CALCIUM ION;CTP synthase;1773;
4ZDI;E;Crystal structure of the M. tuberculosis CTP synthase PyrG (apo form);3.52;CA;CALCIUM ION;CTP synthase;1773;
4ZDI;F;Crystal structure of the M. tuberculosis CTP synthase PyrG (apo form);3.52;CA;CALCIUM ION;CTP synthase;1773;
4ZDI;G;Crystal structure of the M. tuberculosis CTP synthase PyrG (apo form);3.52;CA;CALCIUM ION;CTP synthase;1773;
4ZDI;H;Crystal structure of the M. tuberculosis CTP synthase PyrG (apo form);3.52;CA;CALCIUM ION;CTP synthase;1773;
4ZES;A;Blood dendritic cell antigen 2 (BDCA-2) complexed with methyl-mannoside;1.65;CA;CALCIUM ION;C-type lectin domain family 4 member C;9606;
4ZES;B;Blood dendritic cell antigen 2 (BDCA-2) complexed with methyl-mannoside;1.65;CA;CALCIUM ION;C-type lectin domain family 4 member C;9606;
4ZET;A;Blood dendritic cell antigen 2 (BDCA-2) complexed with GalGlcNAcMan;2.9;CA;CALCIUM ION;C-type lectin domain family 4 member C;9606;
4ZET;B;Blood dendritic cell antigen 2 (BDCA-2) complexed with GalGlcNAcMan;2.9;CA;CALCIUM ION;C-type lectin domain family 4 member C;9606;
4ZFG;A;Dual-specificity Fab 5A12 in complex with Angiopoietin 2;2.27;CA;CALCIUM ION;Angiopoietin-2;9606;
4ZG6;A;Structural basis for inhibition of human autotaxin by four novel compounds;1.8;CA;CALCIUM ION;Ectonucleotide pyrophosphatase/phosphodiesterase family member 2;9606;
4ZG6;B;Structural basis for inhibition of human autotaxin by four novel compounds;1.8;CA;CALCIUM ION;Ectonucleotide pyrophosphatase/phosphodiesterase family member 2;9606;
4ZG7;A;Structural basis for inhibition of human autotaxin by four novel compounds;1.75;CA;CALCIUM ION;Ectonucleotide pyrophosphatase/phosphodiesterase family member 2;9606;
4ZG8;A;Crystal structure of Endoglucanase from Perinereis brevicirris;1.39;CA;CALCIUM ION;Endoglucanase;6356;
4ZG8;B;Crystal structure of Endoglucanase from Perinereis brevicirris;1.39;CA;CALCIUM ION;Endoglucanase;6356;
4ZG9;A;Structural basis for inhibition of human autotaxin by four novel compounds;2.95;CA;CALCIUM ION;Ectonucleotide pyrophosphatase/phosphodiesterase family member 2;9606;
4ZG9;B;Structural basis for inhibition of human autotaxin by four novel compounds;2.95;CA;CALCIUM ION;Ectonucleotide pyrophosphatase/phosphodiesterase family member 2;9606;
4ZGA;A;Structural basis for inhibition of human autotaxin by four novel compounds;2.6;CA;CALCIUM ION;Ectonucleotide pyrophosphatase/phosphodiesterase family member 2;9606;
4ZGF;A;Crystal structure of a duf4847 family protein (BVU_2626) from Bacteroides vulgatus ATCC 8482 at 1.00 A resolution;1;CA;CALCIUM ION;Uncharacterized protein;821;
4ZH5;A;Crystal structure of Endoglucanase from Perinereis brevicirris with Cellobiose;1.35;CA;CALCIUM ION;Endoglucanase;6356;
4ZH5;B;Crystal structure of Endoglucanase from Perinereis brevicirris with Cellobiose;1.35;CA;CALCIUM ION;Endoglucanase;6356;
4ZH8;A;Factor Xa complex with GTC000006;1.8;CA;CALCIUM ION;Coagulation factor X;9606;
4ZHA;A;Factor Xa complex with GTC000102;1.86;CA;CALCIUM ION;Coagulation factor X;9606;
4ZHQ;A;Crystal structure of Tubulin-Stathmin-TTL-MMAE Complex;2.55;CA;CALCIUM ION;Tubulin alpha-1B chain;9823;
4ZHQ;B;Crystal structure of Tubulin-Stathmin-TTL-MMAE Complex;2.55;CA;CALCIUM ION;Tubulin beta chain;9823;
4ZHQ;C;Crystal structure of Tubulin-Stathmin-TTL-MMAE Complex;2.55;CA;CALCIUM ION;Tubulin alpha-1B chain;9823;
4ZI7;A;CRYSTAL STRUCTURE OF TUBULIN-STATHMIN-TTL-HTI286 COMPLEX;2.51;CA;CALCIUM ION;Tubulin alpha-1B chain;9823;
4ZI7;B;CRYSTAL STRUCTURE OF TUBULIN-STATHMIN-TTL-HTI286 COMPLEX;2.51;CA;CALCIUM ION;Tubulin beta chain;9823;
4ZI7;C;CRYSTAL STRUCTURE OF TUBULIN-STATHMIN-TTL-HTI286 COMPLEX;2.51;CA;CALCIUM ION;Tubulin alpha-1B chain;9823;
4ZI8;A;Structure of mouse clustered PcdhgC3 EC1-3;1.7;CA;CALCIUM ION;Protein Pcdhgc3;10090;
4ZI8;B;Structure of mouse clustered PcdhgC3 EC1-3;1.7;CA;CALCIUM ION;Protein Pcdhgc3;10090;
4ZI9;A;Structure of mouse clustered PcdhgA1 EC1-3;1.7;CA;CALCIUM ION;MCG133388, isoform CRA_t;10090;
4ZI9;B;Structure of mouse clustered PcdhgA1 EC1-3;1.7;CA;CALCIUM ION;MCG133388, isoform CRA_t;10090;
4ZKP;A;P22 Tail Needle Gp26 crystallized at pH 7.0;2.1;CA;CALCIUM ION;Tail needle protein gp26;10754;
4ZKP;B;P22 Tail Needle Gp26 crystallized at pH 7.0;2.1;CA;CALCIUM ION;Tail needle protein gp26;10754;
4ZKU;A;P22 Tail Needle Gp26 crystallized at pH 10.0;2.5;CA;CALCIUM ION;Tail needle protein gp26;10754;
4ZKU;B;P22 Tail Needle Gp26 crystallized at pH 10.0;2.5;CA;CALCIUM ION;Tail needle protein gp26;10754;
4ZLK;B;Crystal structure of mouse myosin-5a in complex with calcium-bound calmodulin;2.5;CA;CALCIUM ION;Calmodulin;10090;
4ZLP;A;Crystal Structure of Notch3 Negative Regulatory Region;2.48;CA;CALCIUM ION;Neurogenic locus notch homolog protein 3;9606;
4ZLP;B;Crystal Structure of Notch3 Negative Regulatory Region;2.48;CA;CALCIUM ION;Neurogenic locus notch homolog protein 3;9606;
4ZMA;H;Crystal Structure of a FVIIa-Trypsin Chimera (ST) in Complex with Soluble Tissue Factor;2.3;CA;CALCIUM ION;Coagulation factor VII;9606;
4ZMA;L;Crystal Structure of a FVIIa-Trypsin Chimera (ST) in Complex with Soluble Tissue Factor;2.3;CA;CALCIUM ION;Coagulation factor VII;9606;
4ZML;A;Crystal structure of human P-cadherin (ss-dimer);1.85;CA;CALCIUM ION;Cadherin-3;9606;
4ZMN;A;Crystal structure of human P-cadherin (ss-dimer long);2.6;CA;CALCIUM ION;Cadherin-3;9606;
4ZMO;A;Crystal structure of human P-cadherin (ss-dimer K14E);2.48;CA;CALCIUM ION;Cadherin-3;9606;
4ZMP;A;Crystal structure of human P-cadherin (ss-dimer Q101L);2.15;CA;CALCIUM ION;Cadherin-3;9606;
4ZMQ;A;Crystal structure of human P-cadherin (ss-X-dimer);2.2;CA;CALCIUM ION;Cadherin-3;9606;
4ZMQ;B;Crystal structure of human P-cadherin (ss-X-dimer);2.2;CA;CALCIUM ION;Cadherin-3;9606;
4ZMT;A;Crystal structure of human P-cadherin (ss-X-dimer-long);2.7;CA;CALCIUM ION;Cadherin-3;9606;
4ZMT;B;Crystal structure of human P-cadherin (ss-X-dimer-long);2.7;CA;CALCIUM ION;Cadherin-3;9606;
4ZMT;C;Crystal structure of human P-cadherin (ss-X-dimer-long);2.7;CA;CALCIUM ION;Cadherin-3;9606;
4ZMT;D;Crystal structure of human P-cadherin (ss-X-dimer-long);2.7;CA;CALCIUM ION;Cadherin-3;9606;
4ZMT;E;Crystal structure of human P-cadherin (ss-X-dimer-long);2.7;CA;CALCIUM ION;Cadherin-3;9606;
4ZMT;F;Crystal structure of human P-cadherin (ss-X-dimer-long);2.7;CA;CALCIUM ION;Cadherin-3;9606;
4ZMV;A;Crystal structure of human P-cadherin (ss-X-dimer pocket I);2.4;CA;CALCIUM ION;Cadherin-3;9606;
4ZMV;B;Crystal structure of human P-cadherin (ss-X-dimer pocket I);2.4;CA;CALCIUM ION;Cadherin-3;9606;
4ZMW;A;Crystal structure of human P-cadherin (enc-X-dimer);2.3;CA;CALCIUM ION;Cadherin-3;9606;
4ZMW;B;Crystal structure of human P-cadherin (enc-X-dimer);2.3;CA;CALCIUM ION;Cadherin-3;9606;
4ZMX;A;Crystal structure of human P-cadherin (int-X-dimer);3.1;CA;CALCIUM ION;Cadherin-3;9606;
4ZMX;B;Crystal structure of human P-cadherin (int-X-dimer);3.1;CA;CALCIUM ION;Cadherin-3;9606;
4ZMY;A;Crystal structure of human P-cadherin (monomer 1);1.5;CA;CALCIUM ION;Cadherin-3;9606;
4ZMZ;A;Crystal structure of human P-cadherin (monomer 2);2.05;CA;CALCIUM ION;Cadherin-3;9606;
4ZOL;A;Crystal Structure of Tubulin-Stathmin-TTL-Tubulysin M Complex;2.5;CA;CALCIUM ION;Tubulin alpha-1B chain;9823;
4ZOL;C;Crystal Structure of Tubulin-Stathmin-TTL-Tubulysin M Complex;2.5;CA;CALCIUM ION;Tubulin alpha-1B chain;9823;
4ZPL;A;Crystal Structure of Protocadherin Beta 1 EC1-3;3.3;CA;CALCIUM ION;Protein Pcdhb1;10090;
4ZPM;A;Crystal Structure of Protocadherin Alpha C2 EC1-3;2.4;CA;CALCIUM ION;Protein Pcdhac2;10090;
4ZPM;B;Crystal Structure of Protocadherin Alpha C2 EC1-3;2.4;CA;CALCIUM ION;Protein Pcdhac2;10090;
4ZPN;A;Crystal Structure of Protocadherin Gamma C5 EC1-3 with extended N-terminus;3.3;CA;CALCIUM ION;MCG133388, isoform CRA_f;10090;
4ZPN;B;Crystal Structure of Protocadherin Gamma C5 EC1-3 with extended N-terminus;3.3;CA;CALCIUM ION;MCG133388, isoform CRA_f;10090;
4ZPO;A;Crystal Structure of Protocadherin Gamma C5 EC1-3;2.9;CA;CALCIUM ION;MCG133388, isoform CRA_f;10090;
4ZPP;A;Crystal Structure of Protocadherin Gamma C5 EC1-3;3;CA;CALCIUM ION;MCG133388, isoform CRA_f;10090;
4ZPP;B;Crystal Structure of Protocadherin Gamma C5 EC1-3;3;CA;CALCIUM ION;MCG133388, isoform CRA_f;10090;
4ZPQ;A;Crystal Structure of Protocadherin Gamma C5 EC1-3;3.1;CA;CALCIUM ION;MCG133388, isoform CRA_f;10090;
4ZPQ;B;Crystal Structure of Protocadherin Gamma C5 EC1-3;3.1;CA;CALCIUM ION;MCG133388, isoform CRA_f;10090;
4ZPQ;C;Crystal Structure of Protocadherin Gamma C5 EC1-3;3.1;CA;CALCIUM ION;MCG133388, isoform CRA_f;10090;
4ZPS;A;Crystal Structure of Protocadherin Gamma A8 EC1-3;2.9;CA;CALCIUM ION;MCG133388, isoform CRA_m;10090;
4ZQ3;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS I92T at cryogenic temperature;1.9;CA;CALCIUM ION;Thermonuclease;1280;
4ZRP;A;TC:CD320;2.1;CA;CALCIUM ION;Transcobalamin-2;9606;
4ZRP;C;TC:CD320;2.1;CA;CALCIUM ION;CD320 antigen;9606;
4ZRP;D;TC:CD320;2.1;CA;CALCIUM ION;CD320 antigen;9606;
4ZRQ;C;E88 deletion mutant of CD320 in complex with TC2;2.6;CA;CALCIUM ION;CD320 antigen;9606;
4ZRQ;D;E88 deletion mutant of CD320 in complex with TC2;2.6;CA;CALCIUM ION;CD320 antigen;9606;
4ZRV;A;Structure of cow mincle CRD complexed with trehalose mono butyrate;2.1;CA;CALCIUM ION;Mincle CRD;9913;
4ZRV;B;Structure of cow mincle CRD complexed with trehalose mono butyrate;2.1;CA;CALCIUM ION;Mincle CRD;9913;
4ZRV;C;Structure of cow mincle CRD complexed with trehalose mono butyrate;2.1;CA;CALCIUM ION;Mincle CRD;9913;
4ZRW;A;Structure of cow mincle complexed with trehalose;2.6;CA;CALCIUM ION;mincle protein;9913;
4ZSF;A;Crystal structure of pre-specific restriction endonuclease BsaWI-DNA complex;1.8;CA;CALCIUM ION;BsaWI endonuclease;1422;
4ZT1;A;Crystal structure of human E-Cadherin (residues 3-213) in x-dimer conformation;1.92;CA;CALCIUM ION;Cadherin-1;9606;
4ZT1;B;Crystal structure of human E-Cadherin (residues 3-213) in x-dimer conformation;1.92;CA;CALCIUM ION;Cadherin-1;9606;
4ZTE;A;Crystal structure of human E-Cadherin (residues 3-213) in complex with a peptidomimetic inhibitor;2.13;CA;CALCIUM ION;Cadherin-1;9606;
4ZTE;B;Crystal structure of human E-Cadherin (residues 3-213) in complex with a peptidomimetic inhibitor;2.13;CA;CALCIUM ION;Cadherin-1;9606;
4ZUI;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS V23H at cryogenic temperature;1.7;CA;CALCIUM ION;Thermonuclease;1280;
4ZUJ;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS Y91H at cryogenic temperature;1.72;CA;CALCIUM ION;Thermonuclease;1280;
4ZVF;A;Crystal structure of GGDEF domain of the E. coli DosC - form II (GTP-alpha-S-bound);1.15;CA;CALCIUM ION;Diguanylate cyclase DosC;562;
4ZXQ;A;P22 Tail Needle Gp26 1-140 crystallized at pH 3.9;2.75;CA;CALCIUM ION;Tail needle protein gp26;10754;
4ZXQ;D;P22 Tail Needle Gp26 1-140 crystallized at pH 3.9;2.75;CA;CALCIUM ION;Tail needle protein gp26;10754;
4ZXX;H;FACTOR VIIA IN COMPLEX WITH THE INHIBITOR N-{3-[(2R)-1-{(2R)-2-[(1-aminoisoquinolin-6-yl)amino]-2-phenylacetyl}pyrrolidin-2-yl]-4-(propan-2-ylsulfonyl)phenyl}acetamide;2.6;CA;CALCIUM ION;Coagulation factor VIIa heavy chain;9606;
4ZXY;H;FACTOR VIIA IN COMPLEX WITH THE INHIBITOR (2R)-2-[(1-aminoisoquinolin-6-yl)amino]-4,11-diazatricyclo[14.2.2.1~6,10~]henicosa-1(18),6(21),7,9,16,19-hexaene-3,12-dione;2.06;CA;CALCIUM ION;Coagulation factor VIIa heavy chain;9606;
4ZYB;A;High resolution structure of M23 peptidase LytM with substrate analogue;1.5;CA;CALCIUM ION;Glycyl-glycine endopeptidase LytM;1280;
4ZYB;B;High resolution structure of M23 peptidase LytM with substrate analogue;1.5;CA;CALCIUM ION;Glycyl-glycine endopeptidase LytM;1280;
4ZYB;C;High resolution structure of M23 peptidase LytM with substrate analogue;1.5;CA;CALCIUM ION;Glycyl-glycine endopeptidase LytM;1280;
4ZYB;D;High resolution structure of M23 peptidase LytM with substrate analogue;1.5;CA;CALCIUM ION;Glycyl-glycine endopeptidase LytM;1280;
5A08;B;X-ray structure of the mannosyltransferase Ktr4p from S. cerevisiae;2.21;CA;CALCIUM ION;PROBABLE MANNOSYLTRANSFERASE KTR4;4932;
5A1M;A;Crystal structure of calcium-bound human adseverin domain A3;1.81;CA;CALCIUM ION;ADSEVERIN;9606;
5A2A;A;Crystal Structure of Anoxybacillus Alpha-amylase Provides Insights into a New Glycosyl Hydrolase Subclass;1.9;CA;CALCIUM ION;APO FORM OF ANOXYBACILLUS ALPHA-AMYLASES;265546;
5A2B;A;Crystal Structure of Anoxybacillus Alpha-amylase Provides Insights into a New Glycosyl Hydrolase Subclass;1.85;CA;CALCIUM ION;ANOXYBACILLUS ALPHA-AMYLASE;265546;
5A2C;A;Crystal Structure of Anoxybacillus Alpha-amylase Provides Insights into a New Glycosyl Hydrolase Subclass;1.9;CA;CALCIUM ION;ALPHA-AMYLASE;265546;
5A2H;A;Crystal Structure of Arabidopsis thaliana Calmodulin-7;2.27;CA;CALCIUM ION;CALMODULIN;3702;
5A3L;A;Structure of Cea1A in complex with N-Acetylglucosamine;1.66;CA;CALCIUM ION;CEA1;4922;
5A3L;B;Structure of Cea1A in complex with N-Acetylglucosamine;1.66;CA;CALCIUM ION;CEA1;4922;
5A3L;C;Structure of Cea1A in complex with N-Acetylglucosamine;1.66;CA;CALCIUM ION;CEA1;4922;
5A3L;D;Structure of Cea1A in complex with N-Acetylglucosamine;1.66;CA;CALCIUM ION;CEA1;4922;
5A3M;A;Structure of Cea1A in complex with Chitobiose;1.75;CA;CALCIUM ION;CEA1;4922;
5A3M;B;Structure of Cea1A in complex with Chitobiose;1.75;CA;CALCIUM ION;CEA1;4922;
5A3M;C;Structure of Cea1A in complex with Chitobiose;1.75;CA;CALCIUM ION;CEA1;4922;
5A3M;D;Structure of Cea1A in complex with Chitobiose;1.75;CA;CALCIUM ION;CEA1;4922;
5A3O;A;Crystal structure of the LecB lectin from Pseudomonas aeruginosa in complex with Methyl 6-(cinnamido)-6-deoxy-alpha-D-mannopyranoside at 1.6 ansgtrom;1.6;CA;CALCIUM ION;FUCOSE-BINDING LECTIN PA-IIL;287;
5A3O;B;Crystal structure of the LecB lectin from Pseudomonas aeruginosa in complex with Methyl 6-(cinnamido)-6-deoxy-alpha-D-mannopyranoside at 1.6 ansgtrom;1.6;CA;CALCIUM ION;FUCOSE-BINDING LECTIN PA-IIL;287;
5A3O;C;Crystal structure of the LecB lectin from Pseudomonas aeruginosa in complex with Methyl 6-(cinnamido)-6-deoxy-alpha-D-mannopyranoside at 1.6 ansgtrom;1.6;CA;CALCIUM ION;FUCOSE-BINDING LECTIN PA-IIL;287;
5A3O;D;Crystal structure of the LecB lectin from Pseudomonas aeruginosa in complex with Methyl 6-(cinnamido)-6-deoxy-alpha-D-mannopyranoside at 1.6 ansgtrom;1.6;CA;CALCIUM ION;FUCOSE-BINDING LECTIN PA-IIL;287;
5A3Y;A;SAD structure of Thermolysin obtained by multi crystal data collection;1.27;CA;CALCIUM ION;THERMOLYSIN;1427;
5A4X;A;The crystal structure of Arabidopsis thaliana CAR4 in complex with two calcium ions and Zn;2.2;CA;CALCIUM ION;AT3G17980;3702;
5A4X;B;The crystal structure of Arabidopsis thaliana CAR4 in complex with two calcium ions and Zn;2.2;CA;CALCIUM ION;AT3G17980;3702;
5A50;A;The crystal structure of Arabidopsis thaliana CAR4 in complex with two calcium ions, Zn and Phopho Choline;2.4;CA;CALCIUM ION;AT3G17980;3702;
5A50;B;The crystal structure of Arabidopsis thaliana CAR4 in complex with two calcium ions, Zn and Phopho Choline;2.4;CA;CALCIUM ION;AT3G17980;3702;
5A51;A;The crystal structure of Arabidopsis thaliana CAR4 in complex with two calcium ions and phophatidyl serine;1.6;CA;CALCIUM ION;AT3G17980;3702;
5A51;B;The crystal structure of Arabidopsis thaliana CAR4 in complex with two calcium ions and phophatidyl serine;1.6;CA;CALCIUM ION;AT3G17980;3702;
5A52;A;The crystal structure of Arabidopsis thaliana CAR1 in complex with one calcium ion;1.65;CA;CALCIUM ION;CALCIUM-DEPENDENT LIPID-BINDING DOMAIN-CONTAINING PROTEIN;3702;
5A55;A;The native structure of GH101 from Streptococcus pneumoniae TIGR4;1.85;CA;CALCIUM ION;ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE;1313;
5A56;A;The structure of GH101 from Streptococcus pneumoniae TIGR4 in complex with 1-O-methyl-T-antigen;1.8;CA;CALCIUM ION;ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE;1313;
5A57;A;The structure of GH101 from Streptococcus pneumoniae TIGR4 in complex with PUGT;1.46;CA;CALCIUM ION;ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE;1313;
5A58;A;The structure of GH101 D764N mutant from Streptococcus pneumoniae TIGR4 in complex with serinyl T-antigen;1.8;CA;CALCIUM ION;ENDO-ALPHA-GALACTOSAMINIDASE;1313;
5A59;A;The structure of GH101 E796Q mutant from Streptococcus pneumoniae TIGR4 in complex with T-antigen;2.5;CA;CALCIUM ION;ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE;1313;
5A5A;A;The structure of GH101 E796Q mutant from Streptococcus pneumoniae TIGR4 in complex with PNP-T-antigen;1.75;CA;CALCIUM ION;ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE;1313;
5A6Q;A;Native structure of the LecB lectin from Pseudomonas aeruginosa strain PA14;1.7;CA;CALCIUM ION;FUCOSE-BINDING LECTIN PA-IIL;287;
5A6Q;B;Native structure of the LecB lectin from Pseudomonas aeruginosa strain PA14;1.7;CA;CALCIUM ION;FUCOSE-BINDING LECTIN PA-IIL;287;
5A6Q;C;Native structure of the LecB lectin from Pseudomonas aeruginosa strain PA14;1.7;CA;CALCIUM ION;FUCOSE-BINDING LECTIN PA-IIL;287;
5A6Q;D;Native structure of the LecB lectin from Pseudomonas aeruginosa strain PA14;1.7;CA;CALCIUM ION;FUCOSE-BINDING LECTIN PA-IIL;287;
5A6X;A;Structure of the LecB lectin from Pseudomonas aeruginosa strain PA14 in complex with alpha-methyl-fucoside;1.55;CA;CALCIUM ION;FUCOSE-BINDING LECTIN PA-IIL;287;
5A6X;B;Structure of the LecB lectin from Pseudomonas aeruginosa strain PA14 in complex with alpha-methyl-fucoside;1.55;CA;CALCIUM ION;FUCOSE-BINDING LECTIN PA-IIL;287;
5A6X;C;Structure of the LecB lectin from Pseudomonas aeruginosa strain PA14 in complex with alpha-methyl-fucoside;1.55;CA;CALCIUM ION;FUCOSE-BINDING LECTIN PA-IIL;287;
5A6X;D;Structure of the LecB lectin from Pseudomonas aeruginosa strain PA14 in complex with alpha-methyl-fucoside;1.55;CA;CALCIUM ION;FUCOSE-BINDING LECTIN PA-IIL;287;
5A6Y;A;Structure of the LecB lectin from Pseudomonas aeruginosa strain PA14 in complex with mannose-alpha1,3mannoside;1.4;CA;CALCIUM ION;FUCOSE-BINDING LECTIN PA-IIL;287;
5A6Y;B;Structure of the LecB lectin from Pseudomonas aeruginosa strain PA14 in complex with mannose-alpha1,3mannoside;1.4;CA;CALCIUM ION;FUCOSE-BINDING LECTIN PA-IIL;287;
5A6Y;C;Structure of the LecB lectin from Pseudomonas aeruginosa strain PA14 in complex with mannose-alpha1,3mannoside;1.4;CA;CALCIUM ION;FUCOSE-BINDING LECTIN PA-IIL;287;
5A6Y;D;Structure of the LecB lectin from Pseudomonas aeruginosa strain PA14 in complex with mannose-alpha1,3mannoside;1.4;CA;CALCIUM ION;FUCOSE-BINDING LECTIN PA-IIL;287;
5A6Z;A;Structure of the LecB lectin from Pseudomonas aeruginosa strain PA14 in complex with lewis a;1.5;CA;CALCIUM ION;LECB;287;
5A6Z;B;Structure of the LecB lectin from Pseudomonas aeruginosa strain PA14 in complex with lewis a;1.5;CA;CALCIUM ION;LECB;287;
5A6Z;C;Structure of the LecB lectin from Pseudomonas aeruginosa strain PA14 in complex with lewis a;1.5;CA;CALCIUM ION;LECB;287;
5A6Z;D;Structure of the LecB lectin from Pseudomonas aeruginosa strain PA14 in complex with lewis a;1.5;CA;CALCIUM ION;LECB;287;
5A70;A;Structure of the LecB lectin from Pseudomonas aeruginosa strain PA14 in complex with lewis x tetrasaccharide;1.6;CA;CALCIUM ION;LECB;287;
5A70;B;Structure of the LecB lectin from Pseudomonas aeruginosa strain PA14 in complex with lewis x tetrasaccharide;1.6;CA;CALCIUM ION;LECB;287;
5A70;C;Structure of the LecB lectin from Pseudomonas aeruginosa strain PA14 in complex with lewis x tetrasaccharide;1.6;CA;CALCIUM ION;LECB;287;
5A70;D;Structure of the LecB lectin from Pseudomonas aeruginosa strain PA14 in complex with lewis x tetrasaccharide;1.6;CA;CALCIUM ION;LECB;287;
5A72;A;Crystal structure of the homing endonuclease I-CvuI in complex with its target (Sro1.3) in the presence of 2 mM Ca;2.6;CA;CALCIUM ION;DNA ENDONUCLEASE I-CVUI;3077;
5A72;B;Crystal structure of the homing endonuclease I-CvuI in complex with its target (Sro1.3) in the presence of 2 mM Ca;2.6;CA;CALCIUM ION;DNA ENDONUCLEASE I-CVUI;3077;
5A88;A;Crystal structure of the riboflavin kinase module of FAD synthetase from Corynebacterium ammoniagenes in complex with ADP;2.08;CA;CALCIUM ION;RIBOFLAVIN BIOSYNTHESIS PROTEIN RIBF;1697;
5A88;B;Crystal structure of the riboflavin kinase module of FAD synthetase from Corynebacterium ammoniagenes in complex with ADP;2.08;CA;CALCIUM ION;RIBOFLAVIN BIOSYNTHESIS PROTEIN RIBF;1697;
5A88;C;Crystal structure of the riboflavin kinase module of FAD synthetase from Corynebacterium ammoniagenes in complex with ADP;2.08;CA;CALCIUM ION;RIBOFLAVIN BIOSYNTHESIS PROTEIN RIBF;1697;
5A88;D;Crystal structure of the riboflavin kinase module of FAD synthetase from Corynebacterium ammoniagenes in complex with ADP;2.08;CA;CALCIUM ION;RIBOFLAVIN BIOSYNTHESIS PROTEIN RIBF;1697;
5A8C;A;The ultra high resolution structure of a novel alpha-L-arabinofuranosidase (CtGH43) from Clostridium thermocellum ATCC 27405 with bound trimethyl N-Oxide (TRS);0.97;CA;CALCIUM ION;CARBOHYDRATE BINDING FAMILY 6;1515;
5A8K;A;METHYL-COENZYME M REDUCTASE FROM METHANOTHERMOBACTER WOLFEII AT 1.4 A RESOLUTION;1.41;CA;CALCIUM ION;METHYL-COENZYME M REDUCTASE;145261;
5A8K;B;METHYL-COENZYME M REDUCTASE FROM METHANOTHERMOBACTER WOLFEII AT 1.4 A RESOLUTION;1.41;CA;CALCIUM ION;METHYL-COENZYME M REDUCTASE;145261;
5A8K;D;METHYL-COENZYME M REDUCTASE FROM METHANOTHERMOBACTER WOLFEII AT 1.4 A RESOLUTION;1.41;CA;CALCIUM ION;METHYL-COENZYME M REDUCTASE;145261;
5A8K;E;METHYL-COENZYME M REDUCTASE FROM METHANOTHERMOBACTER WOLFEII AT 1.4 A RESOLUTION;1.41;CA;CALCIUM ION;METHYL-COENZYME M REDUCTASE;145261;
5A8K;F;METHYL-COENZYME M REDUCTASE FROM METHANOTHERMOBACTER WOLFEII AT 1.4 A RESOLUTION;1.41;CA;CALCIUM ION;METHYL-COENZYME M REDUCTASE;145261;
5A8V;A;Crystal structure of Orgyia pseudotsugata CPV5 polyhedra with SeMet substitution;2.07;CA;CALCIUM ION;POLYHEDRIN;205899;
5A9S;A;NADPH complex of Imine Reductase from Amycolatopsis orientalis;2.06;CA;CALCIUM ION;IMINE REDUCTASE;31958;
5A9S;B;NADPH complex of Imine Reductase from Amycolatopsis orientalis;2.06;CA;CALCIUM ION;IMINE REDUCTASE;31958;
5A9T;A;Imine Reductase from Amycolatopsis orientalis in complex with (R)- Methyltetrahydroisoquinoline;1.5;CA;CALCIUM ION;PUTATIVE DEHYDROGENASE;31958;
5AAN;A;Crystal structure of Drosophila NCS-1 bound to penothiazine FD44;1.6;CA;CALCIUM ION;CG5907-PA, ISOFORM A;7227;
5ABE;B;Structure of GH84 with ligand;2;CA;CALCIUM ION;O-GLCNACASE BT_4395;818;
5ABF;B;Structure of GH84 with ligand;2.1;CA;CALCIUM ION;O-GLCNACASE BT_4395;818;
5ABG;B;Structure of GH84 with ligand;2;CA;CALCIUM ION;O-GLCNACASE BT_4395;818;
5ABH;B;Structure of GH84 with ligand;1.95;CA;CALCIUM ION;O-GLCNACASE BT_4395;818;
5ABN;A;CRYSTAL STRUCTURE ANALYSIS OF FUNGAL VERSATILE PEROXIDASE FROM PLEUROTUS ERYNGII. MUTANT VPi. MUTATED RESIDUES D69S, T70D, S86E, D146T, Q202L, H232E, Q239R AND S301K.;2.19;CA;CALCIUM ION;VERSATILE PEROXIDASE VPL2;5323;
5ABO;A;CRYSTAL STRUCTURE ANALYSIS OF FUNGAL VERSATILE PEROXIDASE FROM PLEUROTUS ERYNGII. MUTANT VPi-br. MUTATED RESIDUES T2K, D69S, T70D, S86E, A131K, D146T, Q202L, Q219K, H232E, Q239R, L288R, S301K, A308R, A309K AND A314R.;1.1;CA;CALCIUM ION;VERSATILE PEROXIDASE VPL2;5323;
5ABQ;A;CRYSTAL STRUCTURE ANALYSIS OF FUNGAL VERSATILE PEROXIDASE FROM PLEUROTUS ERYNGII. MUTANT VPi-SS. MUTATED RESIDUES T2K, A49C, A61C, D69S, T70D, S86E, A131K, D146T, Q202L, Q219K, H232E, Q239R, L288R, S301K, A308R,A309K AND A314R.;2.29;CA;CALCIUM ION;VERSATILE PEROXIDASE;5323;
5ACR;A;W228Y-Investigation of the impact from residues W228 and Y233 in the metallo-beta-lactamase GIM-1;1.9;CA;CALCIUM ION;GIM-1 PROTEIN;287;
5AD0;C;COMPLEX OF A B21 CHICKEN MHC CLASS I MOLECULE AND A 11MER CHICKEN PEPTIDE;2.84;CA;CALCIUM ION;11MER PEPTIDE;9031;
5AED;A;A bacterial protein structure in glycoside hydrolase family 31;1.91;CA;CALCIUM ION;ALPHA-GLUCOSIDASE YIHQ;562;
5AED;B;A bacterial protein structure in glycoside hydrolase family 31;1.91;CA;CALCIUM ION;ALPHA-GLUCOSIDASE YIHQ;562;
5AEE;A;A bacterial protein structure in glycoside hydrolase family 31;1.85;CA;CALCIUM ION;ALPHA-GLUCOSIDASE YIHQ;562;
5AEE;B;A bacterial protein structure in glycoside hydrolase family 31;1.85;CA;CALCIUM ION;ALPHA-GLUCOSIDASE YIHQ;562;
5AEG;A;A bacterial protein structure in glycoside hydrolase family 31.;1.85;CA;CALCIUM ION;ALPHA-GLUCOSIDASE YIHQ;562;
5AEG;B;A bacterial protein structure in glycoside hydrolase family 31.;1.85;CA;CALCIUM ION;ALPHA-GLUCOSIDASE YIHQ;562;
5AEI;A;Designed Armadillo repeat protein YIIIM5AII in complex with peptide (KR)5;1.83;CA;CALCIUM ION;DESIGNED ARMADILLO REPEAT PROTEIN YIIIM5AII;32630;
5AEI;B;Designed Armadillo repeat protein YIIIM5AII in complex with peptide (KR)5;1.83;CA;CALCIUM ION;DESIGNED ARMADILLO REPEAT PROTEIN YIIIM5AII;32630;
5AEI;C;Designed Armadillo repeat protein YIIIM5AII in complex with peptide (KR)5;1.83;CA;CALCIUM ION;DESIGNED ARMADILLO REPEAT PROTEIN YIIIM5AII;32630;
5AEQ;A;Neuronal calcium sensor (NCS-1)from Rattus norvegicus;1.95;CA;CALCIUM ION;NEURONAL CALCIUM SENSOR 1;10116;
5AEQ;B;Neuronal calcium sensor (NCS-1)from Rattus norvegicus;1.95;CA;CALCIUM ION;NEURONAL CALCIUM SENSOR 1;10116;
5AER;A;Neuronal calcium sensor-1 (NCS-1)from Rattus norvegicus complex with D2 dopamine receptor peptide from Homo sapiens;2.19;CA;CALCIUM ION;NEURONAL CALCIUM SENSOR 1;10116;
5AFB;A;Crystal structure of the Latrophilin3 Lectin and Olfactomedin Domains;2.16;CA;CALCIUM ION;LATROPHILIN-3;9606;
5AFP;A;Neuronal calcium sensor-1 (NCS-1)from Rattus norvegicus complex with rhodopsin kinase peptide from Homo sapiens;2.3;CA;CALCIUM ION;NEURONAL CALCIUM SENSOR 1;10116;
5AFP;B;Neuronal calcium sensor-1 (NCS-1)from Rattus norvegicus complex with rhodopsin kinase peptide from Homo sapiens;2.3;CA;CALCIUM ION;NEURONAL CALCIUM SENSOR 1;10116;
5AGV;A;The sliding clamp of Mycobacterium tuberculosis in complex with a natural product.;1.93;CA;CALCIUM ION;DNA POLYMERASE III SUBUNIT BETA;1773;
5AGV;B;The sliding clamp of Mycobacterium tuberculosis in complex with a natural product.;1.93;CA;CALCIUM ION;DNA POLYMERASE III SUBUNIT BETA;1773;
5AJ9;A;G7 mutant of PAS, arylsulfatase from Pseudomonas Aeruginosa;2;CA;CALCIUM ION;ARYLSULFATASE;287;
5AJ9;B;G7 mutant of PAS, arylsulfatase from Pseudomonas Aeruginosa;2;CA;CALCIUM ION;ARYLSULFATASE;287;
5AL9;A;Structure of Leishmania major peroxidase D211R mutant (high res);1.37;CA;CALCIUM ION;ASCORBATE PEROXIDASE;5664;
5ALA;A;Structure of Leishmania major peroxidase D211R mutant (low res);2.73;CA;CALCIUM ION;ASCORBATE PEROXIDASE;5664;
5AM9;B;Crystal structure of the Angiotensin-1 converting enzyme N-domain in complex with amyloid-beta 10-16;1.8;CA;CALCIUM ION;ANGIOTENSIN-CONVERTING ENZYME;9606;
5AM9;C;Crystal structure of the Angiotensin-1 converting enzyme N-domain in complex with amyloid-beta 10-16;1.8;CA;CALCIUM ION;ANGIOTENSIN-CONVERTING ENZYME;9606;
5AMH;A;Cereblon isoform 4 from Magnetospirillum gryphiswaldense in complex with Thalidomide, trigonal crystal form;1.2;CA;CALCIUM ION;CEREBLON ISOFORM 4;55518;
5AMM;A;Structure of Leishmania major peroxidase D211N mutant;2.09;CA;CALCIUM ION;ASCORBATE PEROXIDASE;5664;
5AMM;B;Structure of Leishmania major peroxidase D211N mutant;2.09;CA;CALCIUM ION;ASCORBATE PEROXIDASE;5664;
5AMV;A;Structural insights into the loss of catalytic competence in pectate lyase at low pH;1.57;CA;CALCIUM ION;PECTATE LYASE;1423;
5ANZ;A;Crystal Structure of SltB3 from Pseudomonas aeruginosa.;1.61;CA;CALCIUM ION;SOLUBLE LYTIC TRANSGLYCOSYLASE B3;287;
5AO7;A;Crystal Structure of SltB3 from Pseudomonas aeruginosa in complex with NAG-anhNAM-pentapeptide;2.09;CA;CALCIUM ION;SOLUBLE LYTIC TRANSGLYCOSYLASE B3;287;
5AO8;A;Crystal Structure of SltB3 from Pseudomonas aeruginosa in complex with NAG-NAM-pentapeptide;2.23;CA;CALCIUM ION;SOLUBLE LYTIC TRANGLYCOSILASE B3;287;
5AOG;A;Structure of Sorghum peroxidase;1.27;CA;CALCIUM ION;CATIONIC PEROXIDASE SPC4;4558;
5APR;I;STRUCTURES OF COMPLEXES OF RHIZOPUSPEPSIN WITH PEPSTATIN AND OTHER STATINE-CONTAINING INHIBITORS;2.1;CA;CALCIUM ION;PEPSTATIN-LIKE RENIN INHIBITOR;;
5APW;B;Sequence MATKDD inserted between GCN4 adaptors - Structure T6;1.6;CA;CALCIUM ION;GENERAL CONTROL PROTEIN GCN4;4932;
5AQE;A;Cooperative bio-metallic selectivity in a tailored protease enables creation of a C-C cross-coupling Heckase;1.1;CA;CALCIUM ION;SUBTILISIN SAVINASE;1467;
5AR2;B;RIP2 Kinase Catalytic Domain (1 - 310);2.44;CA;CALCIUM ION;RECEPTOR-INTERACTING SERINE/THREONINE-PROTEIN KINASE 2;9606;
5AR5;A;RIP2 Kinase Catalytic Domain (1 - 310) complex with Benzimidazole;2.66;CA;CALCIUM ION;RECEPTOR-INTERACTING SERINE/THREONINE-PROTEIN KINASE 2;9606;
5ARB;A;Cooperative bio-metallic selectivity in a tailored protease enables creation of a C-C cross-coupling Heckase;1.15;CA;CALCIUM ION;SUBTILISIN SAVINASE;1467;
5ARC;A;Cooperative bio-metallic selectivity in a tailored protease enables creation of a C-C cross-coupling Heckase;1.1;CA;CALCIUM ION;SUBTILISIN SAVINASE;1467;
5ARD;A;Cooperative bio-metallic selectivity in a tailored protease enables creation of a C-C cross-coupling Heckase;1.55;CA;CALCIUM ION;SUBTILISIN SAVINASE;1467;
5AVA;A;Crystal structure of PHA-E lectin in complex with bisected glycan;3;CA;CALCIUM ION;Erythroagglutinin;3885;
5AVA;B;Crystal structure of PHA-E lectin in complex with bisected glycan;3;CA;CALCIUM ION;Erythroagglutinin;3885;
5AVA;C;Crystal structure of PHA-E lectin in complex with bisected glycan;3;CA;CALCIUM ION;Erythroagglutinin;3885;
5AVA;D;Crystal structure of PHA-E lectin in complex with bisected glycan;3;CA;CALCIUM ION;Erythroagglutinin;3885;
5AVA;E;Crystal structure of PHA-E lectin in complex with bisected glycan;3;CA;CALCIUM ION;Erythroagglutinin;3885;
5AVA;F;Crystal structure of PHA-E lectin in complex with bisected glycan;3;CA;CALCIUM ION;Erythroagglutinin;3885;
5AVA;G;Crystal structure of PHA-E lectin in complex with bisected glycan;3;CA;CALCIUM ION;Erythroagglutinin;3885;
5AVA;H;Crystal structure of PHA-E lectin in complex with bisected glycan;3;CA;CALCIUM ION;Erythroagglutinin;3885;
5AVJ;A;Crystal structure of proteinase K from Engyodontium album;1.45;CA;CALCIUM ION;Proteinase K;37998;
5AVN;A;The 1.03 angstrom structure (P212121) of glucose isomerase crystallized in high-strength agarose hydrogel;1.03;CA;CALCIUM ION;Xylose isomerase;1929;
5AVN;B;The 1.03 angstrom structure (P212121) of glucose isomerase crystallized in high-strength agarose hydrogel;1.03;CA;CALCIUM ION;Xylose isomerase;1929;
5AXI;A;Crystal structure of Cbl-b TKB domain in complex with Cblin;2.5;CA;CALCIUM ION;E3 ubiquitin-protein ligase CBL-B;10090;
5AXI;B;Crystal structure of Cbl-b TKB domain in complex with Cblin;2.5;CA;CALCIUM ION;E3 ubiquitin-protein ligase CBL-B;10090;
5AXI;C;Crystal structure of Cbl-b TKB domain in complex with Cblin;2.5;CA;CALCIUM ION;E3 ubiquitin-protein ligase CBL-B;10090;
5AZ0;A;Crystal structure of aldo-keto reductase (AKR2E5) of the silkworm, Bombyx mori;2.2;CA;CALCIUM ION;Uncharacterized protein;7091;
5AZ1;A;Crystal structure of aldo-keto reductase (AKR2E5) complexed with NADPH;2.3;CA;CALCIUM ION;Uncharacterized protein;7091;
5AZA;A;Crystal structure of MBP-sAglB fusion protein with a 20-residue spacer in the connector helix;2.08;CA;CALCIUM ION;Maltose-binding periplasmic protein,Oligosaccharyl transferase stt3 subunit related protein;5,622,261;
5AZE;H;Fab fragment of calcium-dependent antigen binding antibody, 6RL#9;2.2;CA;CALCIUM ION;6RL#9 FAB HEAVY CHAIN;9606;
5B1D;A;Crystal structure of proteinase K from Engyodontium album;2.3;CA;CALCIUM ION;Proteinase K;37998;
5B1E;A;Crystal structure of proteinase K from Engyodontium album;2.3;CA;CALCIUM ION;Proteinase K;37998;
5B1W;A;Crystal structure of human dendritic cell inhibitory receptor (DCIR) C-type lectin domain in ligand-free form;3.05;CA;CALCIUM ION;C-type lectin domain family 4 member A;9606;
5B1W;B;Crystal structure of human dendritic cell inhibitory receptor (DCIR) C-type lectin domain in ligand-free form;3.05;CA;CALCIUM ION;C-type lectin domain family 4 member A;9606;
5B1W;C;Crystal structure of human dendritic cell inhibitory receptor (DCIR) C-type lectin domain in ligand-free form;3.05;CA;CALCIUM ION;C-type lectin domain family 4 member A;9606;
5B1W;D;Crystal structure of human dendritic cell inhibitory receptor (DCIR) C-type lectin domain in ligand-free form;3.05;CA;CALCIUM ION;C-type lectin domain family 4 member A;9606;
5B1X;A;Crystal structure of human dendritic cell inhibitory receptor (DCIR) C-type lectin domain in complex with biantennary glycan;2.9;CA;CALCIUM ION;C-type lectin domain family 4 member A;9606;
5B1X;B;Crystal structure of human dendritic cell inhibitory receptor (DCIR) C-type lectin domain in complex with biantennary glycan;2.9;CA;CALCIUM ION;C-type lectin domain family 4 member A;9606;
5B1X;C;Crystal structure of human dendritic cell inhibitory receptor (DCIR) C-type lectin domain in complex with biantennary glycan;2.9;CA;CALCIUM ION;C-type lectin domain family 4 member A;9606;
5B1X;D;Crystal structure of human dendritic cell inhibitory receptor (DCIR) C-type lectin domain in complex with biantennary glycan;2.9;CA;CALCIUM ION;C-type lectin domain family 4 member A;9606;
5B2O;A;Crystal structure of Francisella novicida Cas9 in complex with sgRNA and target DNA (TGG PAM);1.7;CA;CALCIUM ION;CRISPR-associated endonuclease Cas9;263;
5B2O;B;Crystal structure of Francisella novicida Cas9 in complex with sgRNA and target DNA (TGG PAM);1.7;CA;CALCIUM ION;Guide RNA;32630;
5B2P;A;Crystal structure of Francisella novicida Cas9 in complex with sgRNA and target DNA (TGA PAM);1.7;CA;CALCIUM ION;CRISPR-associated endonuclease Cas9;263;
5B2P;B;Crystal structure of Francisella novicida Cas9 in complex with sgRNA and target DNA (TGA PAM);1.7;CA;CALCIUM ION;Guide RNA;32630;
5B2Q;A;Crystal structure of Francisella novicida Cas9 RHA in complex with sgRNA and target DNA (TGG PAM);1.7;CA;CALCIUM ION;CRISPR-associated endonuclease Cas9;263;
5B2Q;B;Crystal structure of Francisella novicida Cas9 RHA in complex with sgRNA and target DNA (TGG PAM);1.7;CA;CALCIUM ION;Guide RNA;32630;
5B2Z;A;H-Ras WT in complex with GppNHp (state 2*) before structural transition by humidity control;1.56;CA;CALCIUM ION;GTPase HRas;9606;
5B30;A;H-Ras WT in complex with GppNHp (state 1) after structural transition by humidity control;1.6;CA;CALCIUM ION;GTPase HRas;9606;
5B3P;A;Nqo5 of the trypsin-resistant fragment (1-134) in P212121 form;1.65;CA;CALCIUM ION;NADH-quinone oxidoreductase subunit 5;274;
5B4X;A;Crystal structure of the ApoER2 ectodomain in complex with the Reelin R56 fragment;3.2;CA;CALCIUM ION;Reelin;10090;
5B4X;B;Crystal structure of the ApoER2 ectodomain in complex with the Reelin R56 fragment;3.2;CA;CALCIUM ION;Low density lipoprotein receptor-related protein 8, apolipoprotein e receptor, isoform CRA_e;9606;
5B4X;C;Crystal structure of the ApoER2 ectodomain in complex with the Reelin R56 fragment;3.2;CA;CALCIUM ION;Reelin;10090;
5B4X;D;Crystal structure of the ApoER2 ectodomain in complex with the Reelin R56 fragment;3.2;CA;CALCIUM ION;Low density lipoprotein receptor-related protein 8, apolipoprotein e receptor, isoform CRA_e;9606;
5B4Y;B;Crystal structure of the LA12 fragment of ApoER2;1.9;CA;CALCIUM ION;Low-density lipoprotein receptor-related protein 8;9606;
5B5E;B;Crystal structure analysis of Photosystem II complex;1.87;CA;CALCIUM ION;Photosystem II CP47 reaction center protein;32053;
5B5E;O;Crystal structure analysis of Photosystem II complex;1.87;CA;CALCIUM ION;Photosystem II manganese-stabilizing polypeptide;32053;
5B5E;b;Crystal structure analysis of Photosystem II complex;1.87;CA;CALCIUM ION;Photosystem II CP47 reaction center protein;32053;
5B5E;c;Crystal structure analysis of Photosystem II complex;1.87;CA;CALCIUM ION;Photosystem II CP43 reaction center protein;32053;
5B5E;o;Crystal structure analysis of Photosystem II complex;1.87;CA;CALCIUM ION;Photosystem II manganese-stabilizing polypeptide;32053;
5B5L;A;Crystal structure of acetyl esterase mutant S10A with acetate ion;1.4;CA;CALCIUM ION;acetyl esterase;1472165;
5B5O;A;Crystal structure of the catalytic domain of MMP-13 complexed with N-phenyl-4-((4H-1,2,4-triazol-3-ylsulfanyl)methyl)-1,3-thiazol-2-amine;1.2;CA;CALCIUM ION;Collagenase 3;9606;
5B5O;B;Crystal structure of the catalytic domain of MMP-13 complexed with N-phenyl-4-((4H-1,2,4-triazol-3-ylsulfanyl)methyl)-1,3-thiazol-2-amine;1.2;CA;CALCIUM ION;Collagenase 3;9606;
5B5P;A;Crystal structure of the catalytic domain of MMP-13 complexed with 4-oxo-N-(3-(2-(1H-1,2,4-triazol-3-ylsulfanyl)ethoxy)benzyl)-3,4-dihydroquinazoline-2-carboxamide;1.6;CA;CALCIUM ION;Collagenase 3;9606;
5B5P;B;Crystal structure of the catalytic domain of MMP-13 complexed with 4-oxo-N-(3-(2-(1H-1,2,4-triazol-3-ylsulfanyl)ethoxy)benzyl)-3,4-dihydroquinazoline-2-carboxamide;1.6;CA;CALCIUM ION;Collagenase 3;9606;
5B5S;A;Crystal structure of a carbohydrate esterase family 3 from Talaromyces cellulolyticus;1.5;CA;CALCIUM ION;Acetic acid;1472165;
5B5T;B;Crystal Structure of Escherichia coli Gamma-Glutamyltranspeptidase in Complex with peptidyl phosphonate inhibitor 1b;1.7;CA;CALCIUM ION;Gamma-glutamyltranspeptidase small chain;562;
5B5T;D;Crystal Structure of Escherichia coli Gamma-Glutamyltranspeptidase in Complex with peptidyl phosphonate inhibitor 1b;1.7;CA;CALCIUM ION;Gamma-glutamyltranspeptidase small chain;562;
5B66;B;Crystal structure analysis of Photosystem II complex;1.85;CA;CALCIUM ION;Photosystem II CP47 reaction center protein;32053;
5B66;O;Crystal structure analysis of Photosystem II complex;1.85;CA;CALCIUM ION;Photosystem II manganese-stabilizing polypeptide;32053;
5B66;V;Crystal structure analysis of Photosystem II complex;1.85;CA;CALCIUM ION;Cytochrome c-550;32053;
5B66;b;Crystal structure analysis of Photosystem II complex;1.85;CA;CALCIUM ION;Photosystem II CP47 reaction center protein;32053;
5B66;c;Crystal structure analysis of Photosystem II complex;1.85;CA;CALCIUM ION;Photosystem II CP43 reaction center protein;32053;
5B66;o;Crystal structure analysis of Photosystem II complex;1.85;CA;CALCIUM ION;Photosystem II manganese-stabilizing polypeptide;32053;
5B6S;A;Catalytic domain of Coprinopsis cinerea GH62 alpha-L-arabinofuranosidase;1.7;CA;CALCIUM ION;Glycosyl hydrolase family 62 protein;5346;
5B6S;B;Catalytic domain of Coprinopsis cinerea GH62 alpha-L-arabinofuranosidase;1.7;CA;CALCIUM ION;Glycosyl hydrolase family 62 protein;5346;
5B6T;A;Catalytic domain of Coprinopsis cinerea GH62 alpha-L-arabinofuranosidase complexed with Pb;1.48;CA;CALCIUM ION;Glycosyl hydrolase family 62 protein;5346;
5B6T;B;Catalytic domain of Coprinopsis cinerea GH62 alpha-L-arabinofuranosidase complexed with Pb;1.48;CA;CALCIUM ION;Glycosyl hydrolase family 62 protein;5346;
5B72;A;Crystal structure of bovine lactoperoxidase with a broken covalent bond between Glu258 and heme moiety at 1.98 A resolution.;1.98;CA;CALCIUM ION;Lactoperoxidase;9913;
5B7F;A;Structure of CueO - the signal peptide was truncated by HRV3C protease;1.45;CA;CALCIUM ION;Blue copper oxidase CueO;562;
5B7I;A;Cas3-AcrF3 complex;2.6;CA;CALCIUM ION;CRISPR-associated nuclease/helicase Cas3 subtype I-F/YPEST;287;
5B7X;A;NMR Solution structure of an EF-hand Calcium binding protein (EhCaBP6) from Entamoeba Histolytica;;CA;CALCIUM ION;Calmodulin, putative;5759;
5B8I;B;Crystal structure of Calcineurin A and Calcineurin B in complex with FKBP12 and FK506 from Coccidioides immitis RS;1.85;CA;CALCIUM ION;Calcineurin subunit B, variant;5501;
5BCA;A;BETA-AMYLASE FROM BACILLUS CEREUS VAR. MYCOIDES;2.2;CA;CALCIUM ION;PROTEIN (1,4-ALPHA-D-GLUCAN MALTOHYDROLASE.);1396;
5BCA;B;BETA-AMYLASE FROM BACILLUS CEREUS VAR. MYCOIDES;2.2;CA;CALCIUM ION;PROTEIN (1,4-ALPHA-D-GLUCAN MALTOHYDROLASE.);1396;
5BCA;C;BETA-AMYLASE FROM BACILLUS CEREUS VAR. MYCOIDES;2.2;CA;CALCIUM ION;PROTEIN (1,4-ALPHA-D-GLUCAN MALTOHYDROLASE.);1396;
5BCA;D;BETA-AMYLASE FROM BACILLUS CEREUS VAR. MYCOIDES;2.2;CA;CALCIUM ION;PROTEIN (1,4-ALPHA-D-GLUCAN MALTOHYDROLASE.);1396;
5BIR;B;DISECTING HISTIDINE INTERACTIONS IN RIBONUCLEASE T1 USING ASN AND GLN MUTATIONS;2;CA;CALCIUM ION;RIBONUCLEASE T1;5062;
5BMV;A;CRYSTAL STRUCTURE OF TUBULIN-STATHMIN-TTL-Vinblastine COMPLEX;2.5;CA;CALCIUM ION;Tubulin alpha-1B chain;9913;
5BMV;B;CRYSTAL STRUCTURE OF TUBULIN-STATHMIN-TTL-Vinblastine COMPLEX;2.5;CA;CALCIUM ION;Tubulin beta chain;9823;
5BMV;C;CRYSTAL STRUCTURE OF TUBULIN-STATHMIN-TTL-Vinblastine COMPLEX;2.5;CA;CALCIUM ION;Tubulin alpha-1B chain;9913;
5BMW;A;Crystal structure of T75V mutant of Triosephosphate isomerase from Plasmodium falciparum;1.86;CA;CALCIUM ION;Triosephosphate isomerase;5833;
5BN2;A;Room Temperature Structure of Pichia pastoris aquaporin at 1.3 A;1.3;CA;CALCIUM ION;AQY1 protein;4922;
5BOT;A;X-RAY Co-structure of MMP-13 with ethyl 5-carbamoyl-1H-indole-2-carboxylate;1.85;CA;CALCIUM ION;Collagenase 3;9606;
5BOT;B;X-RAY Co-structure of MMP-13 with ethyl 5-carbamoyl-1H-indole-2-carboxylate;1.85;CA;CALCIUM ION;Collagenase 3;9606;
5BOY;A;X-RAY Co-structure of MMP-13 with ethyl 5-(1-methyl-1H-imidazol-5-yl)-1H-indole-2-Carboxylate;2.03;CA;CALCIUM ION;Collagenase 3;9606;
5BOY;B;X-RAY Co-structure of MMP-13 with ethyl 5-(1-methyl-1H-imidazol-5-yl)-1H-indole-2-Carboxylate;2.03;CA;CALCIUM ION;Collagenase 3;9606;
5BPA;A;X-RAY Co-structure of MMP-13 with 4-[({5-[2-(ethoxycarbonyl)-1H-indol-5-yl]-1-methyl-1H-pyrazol-3-yl}formamido)methyl]benzoate;1.79;CA;CALCIUM ION;Collagenase 3;9606;
5BPA;B;X-RAY Co-structure of MMP-13 with 4-[({5-[2-(ethoxycarbonyl)-1H-indol-5-yl]-1-methyl-1H-pyrazol-3-yl}formamido)methyl]benzoate;1.79;CA;CALCIUM ION;Collagenase 3;9606;
5BQT;B;Structure of TrmBL2, an archaeal chromatin protein, shows a novel mode of DNA binding.;3;CA;CALCIUM ION;Putative HTH-type transcriptional regulator TrmBL2;2261;
5BQT;D;Structure of TrmBL2, an archaeal chromatin protein, shows a novel mode of DNA binding.;3;CA;CALCIUM ION;Putative HTH-type transcriptional regulator TrmBL2;2261;
5BTV;A;Crystal structure of human 14-3-3 sigma in complex with a Tau-protein peptide surrounding pS324;1.7;CA;CALCIUM ION;14-3-3 protein sigma;9606;
5BU4;A;RIBONUCLEASE T1 COMPLEX WITH 2'GMP;1.77;CA;CALCIUM ION;PROTEIN (RIBONUCLEASE T1);5062;
5BU5;A;HK620 Tail Needle crystallized at pH 9 (crystal form I);1.95;CA;CALCIUM ION;DNA stabilization protein;155148;
5BU5;D;HK620 Tail Needle crystallized at pH 9 (crystal form I);1.95;CA;CALCIUM ION;DNA stabilization protein;155148;
5BU8;A;HK620 Tail Needle crystallized at pH 7.5 and derivatized with Xenon;2.2;CA;CALCIUM ION;DNA stabilization protein;155148;
5BU8;B;HK620 Tail Needle crystallized at pH 7.5 and derivatized with Xenon;2.2;CA;CALCIUM ION;DNA stabilization protein;155148;
5BUO;A;A receptor molecule;2.31;CA;CALCIUM ION;Amyloid beta A4 protein;9606;
5BUQ;B;Unliganded Form of O-succinylbenzoate Coenzyme A Synthetase (MenE) from Bacillus Subtilis, Solved at 1.98 Angstroms;1.98;CA;CALCIUM ION;2-succinylbenzoate--CoA ligase;1423;
5BV6;A;PKG II's Carboxyl Terminal Cyclic Nucleotide Binding Domain (CNB-B) in a complex with cGMP;1.94;CA;CALCIUM ION;cGMP-dependent protein kinase 2;9606;
5BV9;A;The Structure of Bacillus pumilus GH48 in complex with cellobiose;1.93;CA;CALCIUM ION;Cellulose 1,4-beta-cellobiosidase;1408;
5BVU;A;Crystal structure of Thermoanaerobacterium xylolyticum GH116 beta-glucosidase;1.61;CA;CALCIUM ION;beta-glucosidase;29329;
5BVZ;A;HK620 Tail Needle crystallized at pH 9 (Crystal form II);2.5;CA;CALCIUM ION;DNA stabilization protein;155148;
5BVZ;D;HK620 Tail Needle crystallized at pH 9 (Crystal form II);2.5;CA;CALCIUM ION;DNA stabilization protein;155148;
5BWG;B;Structure of H200C variant of Homoprotocatechuate 2,3-Dioxygenase from B.fuscum at 1.75 Ang resolution;1.75;CA;CALCIUM ION;Homoprotocatechuate 2,3-dioxygenase;47914;
5BWH;B;Structure of H200C variant of Homoprotocatechuate 2,3-Dioxygenase from B.fuscum in complex with HPCA at 1.46 Ang resolution;1.46;CA;CALCIUM ION;Homoprotocatechuate 2,3-dioxygenase;47914;
5BX2;A;Crystal structure of Thermoanaerobacterium xylanolyticum GH116 beta-glucosidase with 2-deoxy-2-fluoroglucoside;1.61;CA;CALCIUM ION;beta-glucosidase;29329;
5BX3;A;Crystal structure of Thermoanaerobacterium xylanolyticum GH116 beta-glucosidase with deoxynojirimycin;1.96;CA;CALCIUM ION;beta-glucosidase;29329;
5BX4;A;Crystal structure of Thermoanaerobacterium xylanolyticum GH116 beta-glucosidase with Glucoimidazole;1.65;CA;CALCIUM ION;beta-glucosidase;29329;
5BX5;A;Crystal structure of Thermoanaerobacterium xylanolyticum GH116 beta-glucosidase with glucose;1.85;CA;CALCIUM ION;beta-glucosidase;29329;
5BYN;A;Canavalia maritima lectin complexed with synthetic selenoamino acid;2.65;CA;CALCIUM ION;Concanavalin-A;28957;
5BYN;B;Canavalia maritima lectin complexed with synthetic selenoamino acid;2.65;CA;CALCIUM ION;Concanavalin-A;28957;
5C02;A;Influenza A M2 transmembrane domain drug-resistant S31N mutant at pH 8.0;1.59;CA;CALCIUM ION;Matrix protein 2;11320;
5C0I;B;HAL-A02 carrying RQFGPDFPTI;1.53;CA;CALCIUM ION;Beta-2-microglobulin;9606;
5C0J;B;HLA-A02 carrying RQFGPDWIVA;1.64;CA;CALCIUM ION;Beta-2-microglobulin;9606;
5C2D;A;K428A mutant gp2c of large terminase subunit from bacteriophage sf6 with calcium;1.59;CA;CALCIUM ION;Gene 2 protein;10761;
5C2V;A;Kuenenia stuttgartiensis Hydrazine Synthase;2.7;CA;CALCIUM ION;HYDRAZINE SYNTHASE ALPHA SUBUNIT;174633;
5C2V;B;Kuenenia stuttgartiensis Hydrazine Synthase;2.7;CA;CALCIUM ION;HYDRAZINE SYNTHASE BETA SUBUNIT;174633;
5C2V;C;Kuenenia stuttgartiensis Hydrazine Synthase;2.7;CA;CALCIUM ION;HYDRAZINE SYNTHASE GAMMA SUBUNIT;174633;
5C2V;D;Kuenenia stuttgartiensis Hydrazine Synthase;2.7;CA;CALCIUM ION;HYDRAZINE SYNTHASE ALPHA SUBUNIT;174633;
5C2V;E;Kuenenia stuttgartiensis Hydrazine Synthase;2.7;CA;CALCIUM ION;HYDRAZINE SYNTHASE BETA SUBUNIT;174633;
5C2V;F;Kuenenia stuttgartiensis Hydrazine Synthase;2.7;CA;CALCIUM ION;HYDRAZINE SYNTHASE GAMMA SUBUNIT;174633;
5C2W;A;Kuenenia stuttgartiensis Hydrazine Synthase Pressurized with 20 bar Xenon;3.2;CA;CALCIUM ION;HYDRAZINE SYNTHASE ALPHA SUBUNIT;174633;
5C2W;B;Kuenenia stuttgartiensis Hydrazine Synthase Pressurized with 20 bar Xenon;3.2;CA;CALCIUM ION;HYDRAZINE SYNTHASE BETA SUBUNIT;174633;
5C2W;C;Kuenenia stuttgartiensis Hydrazine Synthase Pressurized with 20 bar Xenon;3.2;CA;CALCIUM ION;Hypothetical (Di heme) protein;174633;
5C2W;D;Kuenenia stuttgartiensis Hydrazine Synthase Pressurized with 20 bar Xenon;3.2;CA;CALCIUM ION;HYDRAZINE SYNTHASE ALPHA SUBUNIT;174633;
5C2W;E;Kuenenia stuttgartiensis Hydrazine Synthase Pressurized with 20 bar Xenon;3.2;CA;CALCIUM ION;HYDRAZINE SYNTHASE BETA SUBUNIT;174633;
5C2W;F;Kuenenia stuttgartiensis Hydrazine Synthase Pressurized with 20 bar Xenon;3.2;CA;CALCIUM ION;Hypothetical (Di heme) protein;174633;
5C3O;A;Crystal structure of the C-terminal truncated Neurospora crassa T7H (NcT7HdeltaC) in apo form;2.3;CA;CALCIUM ION;Thymine dioxygenase;5141;
5C3W;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS V66H at cryogenic temperature;1.72;CA;CALCIUM ION;Thermonuclease;1280;
5C3X;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS I72D/N100E at cryogenic temperature;1.95;CA;CALCIUM ION;Thermonuclease;1280;
5C4H;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS I92H at cryogenic temperature;1.8;CA;CALCIUM ION;Thermonuclease;1280;
5C4Z;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS L25H at cryogenic temperature;1.62;CA;CALCIUM ION;Thermonuclease;1280;
5C5C;A;Human metabotropic glutamate receptor 7, extracellular ligand binding domain;1.86;CA;CALCIUM ION;Metabotropic glutamate receptor 7;9606;
5C5L;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS T62E / L125E at cryogenic temperature;1.75;CA;CALCIUM ION;Thermonuclease;1280;
5C5M;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS T62D / V104E at cryogenic temperature;1.7;CA;CALCIUM ION;Thermonuclease;1280;
5C6A;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS L25E / N100E at cryogenic temperature;1.85;CA;CALCIUM ION;Thermonuclease;1280;
5C6C;A;PKG II's Amino Terminal Cyclic Nucleotide Binding Domain (CNB-A) in a complex with cAMP;2.05;CA;CALCIUM ION;cGMP-dependent protein kinase 2;9606;
5C6C;B;PKG II's Amino Terminal Cyclic Nucleotide Binding Domain (CNB-A) in a complex with cAMP;2.05;CA;CALCIUM ION;cGMP-dependent protein kinase 2;9606;
5C8Y;A;Crystal structure of T2R-TTL-Plinabulin complex;2.59;CA;CALCIUM ION;Tubulin alpha;41807;
5C8Y;C;Crystal structure of T2R-TTL-Plinabulin complex;2.59;CA;CALCIUM ION;Tubulin alpha;41807;
5C9L;A;Crystal structure of native PLL lectin from Photorhabdus luminescens at 1.65 A resolution;1.65;CA;CALCIUM ION;PLL lectin;29488;
5CA0;A;Crystal structure of T2R-TTL-Lexibulin complex;2.5;CA;CALCIUM ION;Tubulin alpha-1B chain;9823;
5CA0;C;Crystal structure of T2R-TTL-Lexibulin complex;2.5;CA;CALCIUM ION;Tubulin alpha-1B chain;9823;
5CA1;A;Crystal structure of T2R-TTL-Nocodazole complex;2.4;CA;CALCIUM ION;Tubulin alpha;41807;
5CA1;C;Crystal structure of T2R-TTL-Nocodazole complex;2.4;CA;CALCIUM ION;Tubulin alpha;41807;
5CA3;A;Crystal structure of the glycosynthase mutant D324N of Escherichia coli GH63 glycosidase in complex with glucose and lactose;1.8;CA;CALCIUM ION;Glucosidase YgjK;562;
5CA3;B;Crystal structure of the glycosynthase mutant D324N of Escherichia coli GH63 glycosidase in complex with glucose and lactose;1.8;CA;CALCIUM ION;Glucosidase YgjK;562;
5CB4;A;Crystal structure of T2R-TTL-Tivantinib complex;2.19;CA;CALCIUM ION;Tubulin alpha;41807;
5CB4;C;Crystal structure of T2R-TTL-Tivantinib complex;2.19;CA;CALCIUM ION;Tubulin alpha;41807;
5CBF;A;Structural and Functional Characterization of a Calcium-activated Cation channel from Tsukamurella Paurometabola;3.61;CA;CALCIUM ION;Ion transport 2 domain protein;2061;
5CBF;B;Structural and Functional Characterization of a Calcium-activated Cation channel from Tsukamurella Paurometabola;3.61;CA;CALCIUM ION;Ion transport 2 domain protein;2061;
5CBF;E;Structural and Functional Characterization of a Calcium-activated Cation channel from Tsukamurella Paurometabola;3.61;CA;CALCIUM ION;Ion transport 2 domain protein;2061;
5CBG;A;Calcium activated non-selective cation channel;3.14;CA;CALCIUM ION;Ion transport 2 domain protein;2061;
5CBG;B;Calcium activated non-selective cation channel;3.14;CA;CALCIUM ION;Ion transport 2 domain protein;2061;
5CBG;C;Calcium activated non-selective cation channel;3.14;CA;CALCIUM ION;Ion transport 2 domain protein;2061;
5CBG;E;Calcium activated non-selective cation channel;3.14;CA;CALCIUM ION;Ion transport 2 domain protein;2061;
5CBG;F;Calcium activated non-selective cation channel;3.14;CA;CALCIUM ION;Ion transport 2 domain protein;2061;
5CBH;A;Structural and Functional Characterization of a Calcium-activated Cation channel from Tsukamurella Paurometabola;3.37;CA;CALCIUM ION;Ion transport 2 domain protein;2061;
5CBH;D;Structural and Functional Characterization of a Calcium-activated Cation channel from Tsukamurella Paurometabola;3.37;CA;CALCIUM ION;Ion transport 2 domain protein;2061;
5CBH;E;Structural and Functional Characterization of a Calcium-activated Cation channel from Tsukamurella Paurometabola;3.37;CA;CALCIUM ION;Ion transport 2 domain protein;2061;
5CBH;F;Structural and Functional Characterization of a Calcium-activated Cation channel from Tsukamurella Paurometabola;3.37;CA;CALCIUM ION;Ion transport 2 domain protein;2061;
5CC4;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS T62E/V66E at cryogenic temperature;1.9;CA;CALCIUM ION;Thermonuclease;1280;
5CCG;A;Structure of the Ca2+-bound synaptotagmin-1 SNARE complex (long unit cell form);3.5;CA;CALCIUM ION;Vesicle-associated membrane protein 2;10116;
5CCG;C;Structure of the Ca2+-bound synaptotagmin-1 SNARE complex (long unit cell form);3.5;CA;CALCIUM ION;Synaptosomal-associated protein 25;10116;
5CCG;D;Structure of the Ca2+-bound synaptotagmin-1 SNARE complex (long unit cell form);3.5;CA;CALCIUM ION;Synaptosomal-associated protein 25;10116;
5CCG;E;Structure of the Ca2+-bound synaptotagmin-1 SNARE complex (long unit cell form);3.5;CA;CALCIUM ION;Synaptotagmin-1;10116;
5CCG;F;Structure of the Ca2+-bound synaptotagmin-1 SNARE complex (long unit cell form);3.5;CA;CALCIUM ION;Synaptotagmin-1;10116;
5CCG;G;Structure of the Ca2+-bound synaptotagmin-1 SNARE complex (long unit cell form);3.5;CA;CALCIUM ION;Vesicle-associated membrane protein 2;10116;
5CCG;K;Structure of the Ca2+-bound synaptotagmin-1 SNARE complex (long unit cell form);3.5;CA;CALCIUM ION;Synaptotagmin-1;10116;
5CCH;E;Structure of the Ca2+-bound synaptotagmin-1 SNARE complex (short unit cell form);3.6;CA;CALCIUM ION;Synaptotagmin-1;10116;
5CCH;F;Structure of the Ca2+-bound synaptotagmin-1 SNARE complex (short unit cell form);3.6;CA;CALCIUM ION;Synaptotagmin-1;10116;
5CD6;A;Crystal structure of a TPR-domain containing protein (BDI_1685) from Parabacteroides distasonis ATCC 8503 at 2.26 A resolution;2.26;CA;CALCIUM ION;TPR-domain containing protein;823;
5CD6;B;Crystal structure of a TPR-domain containing protein (BDI_1685) from Parabacteroides distasonis ATCC 8503 at 2.26 A resolution;2.26;CA;CALCIUM ION;TPR-domain containing protein;823;
5CD6;C;Crystal structure of a TPR-domain containing protein (BDI_1685) from Parabacteroides distasonis ATCC 8503 at 2.26 A resolution;2.26;CA;CALCIUM ION;TPR-domain containing protein;823;
5CE3;A;The Yersinia YopO - actin complex with MgADP;2.93;CA;CALCIUM ION;Actin;7108;
5CE3;C;The Yersinia YopO - actin complex with MgADP;2.93;CA;CALCIUM ION;Actin;7108;
5CE5;A;Probing the roles of two tryptophans surrounding the unique zinc coordination site in lipase family I.5;2;CA;CALCIUM ION;Triacylglycerol lipase;33938;
5CF3;A;Crystal structures of Bbp from Staphylococcus aureus;2.03;CA;CALCIUM ION;Bone sialoprotein-binding protein;1280;
5CFE;A;Bacillus subtilis AP endonuclease ExoA;1.84;CA;CALCIUM ION;Exodeoxyribonuclease;1423;
5CFR;A;Crystal structure of anemone STING (Nematostella vectensis) in apo 'unrotated' closed conformation;2.85;CA;CALCIUM ION;Stimulator of Interferon Genes;45351;
5CFR;B;Crystal structure of anemone STING (Nematostella vectensis) in apo 'unrotated' closed conformation;2.85;CA;CALCIUM ION;Stimulator of Interferon Genes;45351;
5CGK;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS V66D/N100E at cryogenic temperature;1.85;CA;CALCIUM ION;Thermonuclease;1280;
5CGT;A;MALTOTRIOSE COMPLEX OF PRECONDITIONED CYCLODEXTRIN GLYCOSYLTRANSFERASE MUTANT;2.5;CA;CALCIUM ION;CYCLODEXTRIN GLYCOSYLTRANSFERASE;1397;
5CHY;A;STRUCTURE OF CHEMOTAXIS PROTEIN CHEY;2;CA;CALCIUM ION;CHEY;562;
5CIS;A;The CUB1-EGF-CUB2 domains of rat MBL-associated serine protease-2 (MASP-2) bound to Ca2+;2.58;CA;CALCIUM ION;Mannan-binding lectin serine peptidase 2;10116;
5CJZ;A;BT4246 with galactose;1.8;CA;CALCIUM ION;SusD homolog;818;
5CK1;A;selenomethionine BT4246;1.84;CA;CALCIUM ION;SusD homolog;818;
5CKM;A;The CUB1-EGF-CUB2 domains of rat MBL-associated serine protease-2 (MASP-2) bound to Ca2+;2.73;CA;CALCIUM ION;Mannan-binding lectin serine peptidase 2;10116;
5CKN;A;The CUB1-EGF-CUB2 domains of rat MBL-associated serine protease-2 (MASP-2) bound to Ca2+;2.6;CA;CALCIUM ION;Mannan-binding lectin serine peptidase 2;10116;
5CKN;D;The CUB1-EGF-CUB2 domains of rat MBL-associated serine protease-2 (MASP-2) bound to Ca2+;2.6;CA;CALCIUM ION;Mannan-binding lectin serine peptidase 2;10116;
5CKQ;A;CUB1-EGF-CUB2 domains of rat MASP-1;3.7;CA;CALCIUM ION;Mannan-binding lectin serine protease 1;10116;
5CKW;A;Crystal structure of LegK4_AMPPNP Kinase;2.49;CA;CALCIUM ION;LegK4;446;
5CKW;B;Crystal structure of LegK4_AMPPNP Kinase;2.49;CA;CALCIUM ION;LegK4;446;
5CM7;A;Structure of thiamine-monophosphate kinase from Acinetobacter baumannii in complex with adenosine diphosphate (ADP) and thiamine diphosphate (TPP);1.55;CA;CALCIUM ION;Thiamine-monophosphate kinase;470;
5CM7;B;Structure of thiamine-monophosphate kinase from Acinetobacter baumannii in complex with adenosine diphosphate (ADP) and thiamine diphosphate (TPP);1.55;CA;CALCIUM ION;Thiamine-monophosphate kinase;470;
5CMN;E;FLRT3 LRR domain in complex with LPHN3 Olfactomedin domain;3.61;CA;CALCIUM ION;Latrophilin-3;9606;
5CMN;F;FLRT3 LRR domain in complex with LPHN3 Olfactomedin domain;3.61;CA;CALCIUM ION;Latrophilin-3;9606;
5CMN;G;FLRT3 LRR domain in complex with LPHN3 Olfactomedin domain;3.61;CA;CALCIUM ION;Latrophilin-3;9606;
5CMN;H;FLRT3 LRR domain in complex with LPHN3 Olfactomedin domain;3.61;CA;CALCIUM ION;Latrophilin-3;9606;
5CNA;A;REFINED STRUCTURE OF CONCANAVALIN A COMPLEXED WITH ALPHA-METHYL-D-MANNOPYRANOSIDE AT 2.0 ANGSTROMS RESOLUTION AND COMPARISON WITH THE SACCHARIDE-FREE STRUCTURE;2;CA;CALCIUM ION;CONCANAVALIN A;3823;
5CNA;B;REFINED STRUCTURE OF CONCANAVALIN A COMPLEXED WITH ALPHA-METHYL-D-MANNOPYRANOSIDE AT 2.0 ANGSTROMS RESOLUTION AND COMPARISON WITH THE SACCHARIDE-FREE STRUCTURE;2;CA;CALCIUM ION;CONCANAVALIN A;3823;
5CNA;C;REFINED STRUCTURE OF CONCANAVALIN A COMPLEXED WITH ALPHA-METHYL-D-MANNOPYRANOSIDE AT 2.0 ANGSTROMS RESOLUTION AND COMPARISON WITH THE SACCHARIDE-FREE STRUCTURE;2;CA;CALCIUM ION;CONCANAVALIN A;3823;
5CNA;D;REFINED STRUCTURE OF CONCANAVALIN A COMPLEXED WITH ALPHA-METHYL-D-MANNOPYRANOSIDE AT 2.0 ANGSTROMS RESOLUTION AND COMPARISON WITH THE SACCHARIDE-FREE STRUCTURE;2;CA;CALCIUM ION;CONCANAVALIN A;3823;
5CO1;A;Crystal Structure of Zebrafish Protocadherin-19 EC3-4;2.51;CA;CALCIUM ION;Protocadherin-19 isoform 1;7955;
5CO1;B;Crystal Structure of Zebrafish Protocadherin-19 EC3-4;2.51;CA;CALCIUM ION;Protocadherin-19 isoform 1;7955;
5CO1;C;Crystal Structure of Zebrafish Protocadherin-19 EC3-4;2.51;CA;CALCIUM ION;Protocadherin-19 isoform 1;7955;
5CO1;D;Crystal Structure of Zebrafish Protocadherin-19 EC3-4;2.51;CA;CALCIUM ION;Protocadherin-19 isoform 1;7955;
5COC;A;Fusion protein of human calmodulin and B4 domain of protein A from staphylococcal aureus;2.67;CA;CALCIUM ION;Immunoglobulin G-binding protein A,Calmodulin;12,809,606;
5COF;A;Crystal structure of Uncharacterised protein Q1R1X2 from Escherichia coli UTI89;1.35;CA;CALCIUM ION;Uncharacterized protein;562;
5CP3;A;Crystal Structure of an Antigen-Binding Fragment of Monoclonal Antibody against Sulfonamides in Complex with Sulfathiazole;1.99;CA;CALCIUM ION;Light Chain of Antigen-Binding Fragment of Monoclonal Antibody of 4C7;10090;
5CPL;B;The crystal structure of Xenobiotic reductase A (XenA) from Pseudomonas putida in complex with a nicotinamide mimic (mNH2);1.57;CA;CALCIUM ION;Xenobiotic reductase;303;
5CPO;B;Crystal structure of XenA from Pseudomonas putida in complex with an NADH mimic (mBu);1.65;CA;CALCIUM ION;Xenobiotic reductase;303;
5CPV;A;RESTRAINED LEAST SQUARES REFINEMENT OF NATIVE (CALCIUM) AND CADMIUM-SUBSTITUTED CARP PARVALBUMIN USING X-RAY CRYSTALLOGRAPHIC DATA AT 1.6-ANGSTROMS RESOLUTION;1.6;CA;CALCIUM ION;CALCIUM-BINDING PARVALBUMIN B;7962;
5CR3;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS V104E/L125E at cryogenic temperature;1.8;CA;CALCIUM ION;Thermonuclease;1280;
5CRD;A;Wild-type human skeletal calsequestrin;2.08;CA;CALCIUM ION;Calsequestrin-1;9606;
5CRE;A;Human skeletal calsequestrin, D210G mutant low-calcium complex;3.32;CA;CALCIUM ION;Calsequestrin-1;9606;
5CRG;A;Human skeletal calsequestrin, D210G mutant high-calcium complex;1.97;CA;CALCIUM ION;Calsequestrin-1;9606;
5CRG;B;Human skeletal calsequestrin, D210G mutant high-calcium complex;1.97;CA;CALCIUM ION;Calsequestrin-1;9606;
5CRG;C;Human skeletal calsequestrin, D210G mutant high-calcium complex;1.97;CA;CALCIUM ION;Calsequestrin-1;9606;
5CRG;D;Human skeletal calsequestrin, D210G mutant high-calcium complex;1.97;CA;CALCIUM ION;Calsequestrin-1;9606;
5CRH;A;Human skeletal calsequestrin, M53T mutant high-calcium complex;2.03;CA;CALCIUM ION;Calsequestrin-1;9606;
5CRH;B;Human skeletal calsequestrin, M53T mutant high-calcium complex;2.03;CA;CALCIUM ION;Calsequestrin-1;9606;
5CSF;A;S100B-RSK1 crystal structure A;2.4;CA;CALCIUM ION;Protein S100-B;9606;
5CSF;B;S100B-RSK1 crystal structure A;2.4;CA;CALCIUM ION;Protein S100-B;9606;
5CSI;A;S100B-RSK1 crystal structure A';2.13;CA;CALCIUM ION;Protein S100-B;9606;
5CSI;B;S100B-RSK1 crystal structure A';2.13;CA;CALCIUM ION;Protein S100-B;9606;
5CSJ;A;S100B-RSK1 crystal structure B;2.7;CA;CALCIUM ION;Protein S100-B;9606;
5CSJ;B;S100B-RSK1 crystal structure B;2.7;CA;CALCIUM ION;Protein S100-B;9606;
5CSN;A;S100B-RSK1 crystal structure C;2.95;CA;CALCIUM ION;Protein S100-B;9606;
5CSN;B;S100B-RSK1 crystal structure C;2.95;CA;CALCIUM ION;Protein S100-B;9606;
5CUH;A;Crystal structure MMP-9 complexes with a constrained hydroxamate based inhibitor LT4;1.83;CA;CALCIUM ION;Matrix metalloproteinase-9,Matrix metalloproteinase-9;9606;
5CUH;B;Crystal structure MMP-9 complexes with a constrained hydroxamate based inhibitor LT4;1.83;CA;CALCIUM ION;Matrix metalloproteinase-9,Matrix metalloproteinase-9;9606;
5CUJ;A;Crystal structure of Human Defensin-5 Y27A mutant crystal form 2.;2.08;CA;CALCIUM ION;Defensin-5;9606;
5CUJ;B;Crystal structure of Human Defensin-5 Y27A mutant crystal form 2.;2.08;CA;CALCIUM ION;Defensin-5;9606;
5CUM;A;Crystal structure of Human Defensin-5 Y27A mutant crystal form 1.;1.75;CA;CALCIUM ION;Defensin-5;9606;
5CV4;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS V23D/V66H at cryogenic temperature;1.8;CA;CALCIUM ION;Thermonuclease;1280;
5CV5;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS K64G/V66K/E67G at cryogenic temperature;1.8;CA;CALCIUM ION;Thermonuclease;1280;
5CV5;B;Crystal structure of Staphylococcal nuclease variant Delta+PHS K64G/V66K/E67G at cryogenic temperature;1.8;CA;CALCIUM ION;Thermonuclease;1280;
5CV6;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS V66H/I92E at cryogenic temperature;1.95;CA;CALCIUM ION;Thermonuclease;1280;
5CV7;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS V66H/I92D at cryogenic temperature;1.65;CA;CALCIUM ION;Thermonuclease;1280;
5CV8;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS V23D/T62H at cryogenic temperature;1.58;CA;CALCIUM ION;Thermonuclease;1280;
5CV9;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS L36E/V66H at cryogenic temperature;1.62;CA;CALCIUM ION;Thermonuclease;1280;
5CVW;A;CRYSTAL STRUCTURE OF RTX DOMAIN BLOCK V OF ADENYLATE CYCLASE TOXIN FROM BORDETELLA PERTUSSIS;1.25;CA;CALCIUM ION;Bifunctional hemolysin/adenylate cyclase;520;
5CVY;A;The Structure of Bacillus pumilus GH48 in complex with cellobiose and cellohexaose;2;CA;CALCIUM ION;Glycoside hydrolase;1408;
5CWF;A;Crystal structure of de novo designed helical repeat protein DHR8;1.8;CA;CALCIUM ION;Designed helical repeat protein;32630;
5CWF;B;Crystal structure of de novo designed helical repeat protein DHR8;1.8;CA;CALCIUM ION;Designed helical repeat protein;32630;
5CWF;C;Crystal structure of de novo designed helical repeat protein DHR8;1.8;CA;CALCIUM ION;Designed helical repeat protein;32630;
5CWF;D;Crystal structure of de novo designed helical repeat protein DHR8;1.8;CA;CALCIUM ION;Designed helical repeat protein;32630;
5CWR;A;Crystal Structure of human DNA polymerase lambda L431A mutant in complex with a one nucleotide DNA gap and dCTP;2.5;CA;CALCIUM ION;DNA polymerase lambda;9606;
5CWR;B;Crystal Structure of human DNA polymerase lambda L431A mutant in complex with a one nucleotide DNA gap and dCTP;2.5;CA;CALCIUM ION;DNA polymerase lambda;9606;
5CX1;B;Nitrogenase molybdenum-iron protein beta-K400E mutant;1.75;CA;CALCIUM ION;Nitrogenase molybdenum-iron protein beta chain;354;
5CX1;D;Nitrogenase molybdenum-iron protein beta-K400E mutant;1.75;CA;CALCIUM ION;Nitrogenase molybdenum-iron protein beta chain;354;
5CX1;F;Nitrogenase molybdenum-iron protein beta-K400E mutant;1.75;CA;CALCIUM ION;Nitrogenase molybdenum-iron protein beta chain;354;
5CX1;H;Nitrogenase molybdenum-iron protein beta-K400E mutant;1.75;CA;CALCIUM ION;Nitrogenase molybdenum-iron protein beta chain;354;
5CX1;J;Nitrogenase molybdenum-iron protein beta-K400E mutant;1.75;CA;CALCIUM ION;Nitrogenase molybdenum-iron protein beta chain;354;
5CX1;L;Nitrogenase molybdenum-iron protein beta-K400E mutant;1.75;CA;CALCIUM ION;Nitrogenase molybdenum-iron protein beta chain;354;
5CX1;N;Nitrogenase molybdenum-iron protein beta-K400E mutant;1.75;CA;CALCIUM ION;Nitrogenase molybdenum-iron protein beta chain;354;
5CX1;P;Nitrogenase molybdenum-iron protein beta-K400E mutant;1.75;CA;CALCIUM ION;Nitrogenase molybdenum-iron protein beta chain;354;
5CXA;A;Crystal structure of the catalytic domain of Human MMP12 in complex with a carboxylate inhibitor related to RXP470;1.3;CA;CALCIUM ION;Macrophage metalloelastase;9606;
5CXF;A;Crystal structure of the extracellular domain of glycoprotein B from Human Cytomegalovirus;3.6;CA;CALCIUM ION;Envelope glycoprotein B;10359;
5CXL;A;CRYSTAL STRUCTURE OF RTX DOMAIN BLOCK V OF ADENYLATE CYCLASE TOXIN FROM BORDETELLA PERTUSSIS;1.45;CA;CALCIUM ION;Bifunctional hemolysin/adenylate cyclase;520;
5CXL;B;CRYSTAL STRUCTURE OF RTX DOMAIN BLOCK V OF ADENYLATE CYCLASE TOXIN FROM BORDETELLA PERTUSSIS;1.45;CA;CALCIUM ION;Bifunctional hemolysin/adenylate cyclase;520;
5CY4;A;Crystal structure of an oligoribonuclease from Acinetobacter baumannii;2.25;CA;CALCIUM ION;Oligoribonuclease;470;
5CY4;B;Crystal structure of an oligoribonuclease from Acinetobacter baumannii;2.25;CA;CALCIUM ION;Oligoribonuclease;470;
5CY4;C;Crystal structure of an oligoribonuclease from Acinetobacter baumannii;2.25;CA;CALCIUM ION;Oligoribonuclease;470;
5CY4;D;Crystal structure of an oligoribonuclease from Acinetobacter baumannii;2.25;CA;CALCIUM ION;Oligoribonuclease;470;
5CY4;E;Crystal structure of an oligoribonuclease from Acinetobacter baumannii;2.25;CA;CALCIUM ION;Oligoribonuclease;470;
5CY4;F;Crystal structure of an oligoribonuclease from Acinetobacter baumannii;2.25;CA;CALCIUM ION;Oligoribonuclease;470;
5CYB;A;Structure of a lipocalin lipoprotein affecting virulence in Streptococcus pneumoniae;2.1;CA;CALCIUM ION;Lipoprotein;1313;
5CYX;A;Crystal Structure of Mouse Protocadherin-24 EC1-3;2.1;CA;CALCIUM ION;Protein Cdhr2;10090;
5CZC;A;The structure of VinK;1.8;CA;CALCIUM ION;Malonyl-CoA-[acyl-carrier-protein] transacylase;1944;
5CZC;B;The structure of VinK;1.8;CA;CALCIUM ION;Malonyl-CoA-[acyl-carrier-protein] transacylase;1944;
5CZM;A;Crystal structure of a mutated catalytic domain of Human MMP12 in complex with RXP470;1.3;CA;CALCIUM ION;Macrophage metalloelastase;9606;
5CZR;A;Crystal Structure of Human Protocadherin-24 EC1-2;2.3;CA;CALCIUM ION;Cadherin-related family member 2;9606;
5CZR;B;Crystal Structure of Human Protocadherin-24 EC1-2;2.3;CA;CALCIUM ION;Cadherin-related family member 2;9606;
5CZR;C;Crystal Structure of Human Protocadherin-24 EC1-2;2.3;CA;CALCIUM ION;Cadherin-related family member 2;9606;
5CZR;D;Crystal Structure of Human Protocadherin-24 EC1-2;2.3;CA;CALCIUM ION;Cadherin-related family member 2;9606;
5CZV;A;Crystal structure of Notch3 NRR in complex with 20350 Fab;3.19;CA;CALCIUM ION;Neurogenic locus notch homolog protein 3;9606;
5CZX;A;Crystal structure of Notch3 NRR in complex with 20358 Fab;2.1;CA;CALCIUM ION;Neurogenic locus notch homolog protein 3;9606;
5CZX;B;Crystal structure of Notch3 NRR in complex with 20358 Fab;2.1;CA;CALCIUM ION;Neurogenic locus notch homolog protein 3;9606;
5D0E;A;Crystal Structure of an adenylyl cyclase Ma1120-Cat in complex with GTP and calcium from Mycobacterium avium;1.48;CA;CALCIUM ION;Cyclase;1764;
5D0E;B;Crystal Structure of an adenylyl cyclase Ma1120-Cat in complex with GTP and calcium from Mycobacterium avium;1.48;CA;CALCIUM ION;Cyclase;1764;
5D0G;A;Crystal structure of triple mutant (KDA to EGY) of adenylyl cyclase Ma1120 from Mycobacterium avium in complex with GTP and calcium ion;1.6;CA;CALCIUM ION;Cyclase;1764;
5D0G;B;Crystal structure of triple mutant (KDA to EGY) of adenylyl cyclase Ma1120 from Mycobacterium avium in complex with GTP and calcium ion;1.6;CA;CALCIUM ION;Cyclase;1764;
5D0H;A;Crystal Structure of triple mutant (KDA to EGY) of an adenylyl cyclase Ma1120 from Mycobacterium avium in complex with ATP and calcium ion;2.1;CA;CALCIUM ION;Cyclase;1764;
5D0H;B;Crystal Structure of triple mutant (KDA to EGY) of an adenylyl cyclase Ma1120 from Mycobacterium avium in complex with ATP and calcium ion;2.1;CA;CALCIUM ION;Cyclase;1764;
5D15;A;Crystal structure of an adenylyl cyclase Ma1120 from Mycobacterium avium in complex with ATP and calcium ion;1.5;CA;CALCIUM ION;Cyclase;1764;
5D15;B;Crystal structure of an adenylyl cyclase Ma1120 from Mycobacterium avium in complex with ATP and calcium ion;1.5;CA;CALCIUM ION;Cyclase;1764;
5D21;A;Multivalency Effects in Glycopeptide Dendrimer Inhibitors of Pseudomonas aeruginosa Biofilms Targeting Lectin LecA;1.9;CA;CALCIUM ION;LecA;287;
5D21;B;Multivalency Effects in Glycopeptide Dendrimer Inhibitors of Pseudomonas aeruginosa Biofilms Targeting Lectin LecA;1.9;CA;CALCIUM ION;LecA;287;
5D21;C;Multivalency Effects in Glycopeptide Dendrimer Inhibitors of Pseudomonas aeruginosa Biofilms Targeting Lectin LecA;1.9;CA;CALCIUM ION;LecA;287;
5D21;D;Multivalency Effects in Glycopeptide Dendrimer Inhibitors of Pseudomonas aeruginosa Biofilms Targeting Lectin LecA;1.9;CA;CALCIUM ION;LecA;287;
5D29;A;X-ray structure of human glutamate carboxypeptidase II (GCPII) in complex with a hydroxamate inhibitor JHU241;1.8;CA;CALCIUM ION;Glutamate carboxypeptidase 2;9606;
5D2A;A;Bifunctional dendrimers;2.13;CA;CALCIUM ION;Fucose-binding lectin;287;
5D2A;B;Bifunctional dendrimers;2.13;CA;CALCIUM ION;Fucose-binding lectin;287;
5D2B;A;Crystal structure of a mutated catalytic domain of Human MMP12 in complex with an hydroxamate analogue of RXP470;1.2;CA;CALCIUM ION;Macrophage metalloelastase;9606;
5D2I;A;4-oxalocrotonate decarboxylase from Pseudomonas putida G7 - complexed with calcium and acetate;1.78;CA;CALCIUM ION;4-oxalocrotonate decarboxylase NahK;303;
5D2I;B;4-oxalocrotonate decarboxylase from Pseudomonas putida G7 - complexed with calcium and acetate;1.78;CA;CALCIUM ION;4-oxalocrotonate decarboxylase NahK;303;
5D2U;A;Crystal structure of tPphA Variant - H39A;1.8;CA;CALCIUM ION;Protein serin-threonin phosphatase;146786;
5D3C;A;Crystal structure of a double mutant catalytic domain of Human MMP12 in complex with an hydroxamate analogue of RXP470;1.31;CA;CALCIUM ION;Macrophage metalloelastase;9606;
5D3K;A;Crystal structure of the thioesterase domain of deoxyerythronolide B synthase;1.7;CA;CALCIUM ION;Erythronolide synthase, modules 5 and 6;1836;
5D3Z;A;Crystal structure of the thioesterase domain of deoxyerythronolide B synthase in complex with a small phosphonate inhibitor;2.1;CA;CALCIUM ION;Erythronolide synthase, modules 5 and 6;1836;
5D43;A;crystal structrue of Mouse centrin 1 in calcium-saturated form;2.82;CA;CALCIUM ION;Centrin-1;10090;
5D43;B;crystal structrue of Mouse centrin 1 in calcium-saturated form;2.82;CA;CALCIUM ION;Centrin-1;10090;
5D5D;A;In meso in situ serial X-ray crystallography structure of AlgE at 100 K;2.4;CA;CALCIUM ION;Alginate production protein AlgE;287;
5D61;A;MOA-Z-VAD-fmk complex, direct orientation;1.6;CA;CALCIUM ION;Agglutinin;181124;
5D62;A;MOA-Z-VAD-fmk complex, inverted orientation;1.7;CA;CALCIUM ION;Agglutinin;181124;
5D63;A;MOA-Z-VAD-fmk inhibitor complex, direct/inverted dual orientation;1.65;CA;CALCIUM ION;Agglutinin;181124;
5D69;A;Human calpain PEF(S) with (2Z,2Z')-2,2'-disulfanediylbis(3-(6-iodoindol-3-yl)acrylic acid) bound;1.97;CA;CALCIUM ION;Calpain small subunit 1;9606;
5D69;B;Human calpain PEF(S) with (2Z,2Z')-2,2'-disulfanediylbis(3-(6-iodoindol-3-yl)acrylic acid) bound;1.97;CA;CALCIUM ION;Calpain small subunit 1;9606;
5D6C;A;Structure of 4497 Fab bound to synthetic wall teichoic acid fragment;1.72;CA;CALCIUM ION;4497 antibody IgK (VL and CL);9606;
5D6C;H;Structure of 4497 Fab bound to synthetic wall teichoic acid fragment;1.72;CA;CALCIUM ION;4497 antibody IgG1 (VH and CH1);9606;
5D6C;L;Structure of 4497 Fab bound to synthetic wall teichoic acid fragment;1.72;CA;CALCIUM ION;4497 antibody IgK (VL and CL);9606;
5D7F;A;X-ray structure of Ca(2+)-S100B with human RAGE-derived W72 peptide;1.3;CA;CALCIUM ION;Protein S100-B;9606;
5D7F;B;X-ray structure of Ca(2+)-S100B with human RAGE-derived W72 peptide;1.3;CA;CALCIUM ION;Protein S100-B;9606;
5D7W;A;Crystal structure of serralysin;1.1;CA;CALCIUM ION;Serralysin;615;
5D8G;A;A structural view on the dissociation of E. coli Tryptophanase;1.89;CA;CALCIUM ION;Tryptophanase;562;
5D9I;B;SV40 Large T antigen origin binding domain bound to artificial DNA fork;1.7;CA;CALCIUM ION;Large T antigen;1891767;
5D9I;Y;SV40 Large T antigen origin binding domain bound to artificial DNA fork;1.7;CA;CALCIUM ION;DNA (5'-D(*AP*CP*TP*CP*CP*TP*CP*CP*GP*AP*AP*AP*AP*AP*AP*CP*CP*TP*CP*CP*GP*GP*A)-3');32630;
5D9N;A;Crystal structure of PbGH5A, a glycoside hydrolase family 5 member from Prevotella bryantii B14, in complex with the xyloglucan heptasaccharide XXXG;1.86;CA;CALCIUM ION;B-1,4-endoglucanase;77095;
5D9N;B;Crystal structure of PbGH5A, a glycoside hydrolase family 5 member from Prevotella bryantii B14, in complex with the xyloglucan heptasaccharide XXXG;1.86;CA;CALCIUM ION;B-1,4-endoglucanase;77095;
5D9O;A;Crystal structure of PbGH5A, a glycoside hydrolase family 5 enzyme from Prevotella bryantii B14, E280A mutant in complex with cellotetraose;1.55;CA;CALCIUM ION;B-1,4-endoglucanase;77095;
5D9O;B;Crystal structure of PbGH5A, a glycoside hydrolase family 5 enzyme from Prevotella bryantii B14, E280A mutant in complex with cellotetraose;1.55;CA;CALCIUM ION;B-1,4-endoglucanase;77095;
5D9P;A;Crystal structure of PbGH5A, a glycoside hydrolase family 5 enzyme from Prevotella bryantii B14, in complex with an inhibitory N-bromoacetylglycosylamine derivative of XXXG;1.8;CA;CALCIUM ION;B-1,4-endoglucanase;77095;
5D9P;B;Crystal structure of PbGH5A, a glycoside hydrolase family 5 enzyme from Prevotella bryantii B14, in complex with an inhibitory N-bromoacetylglycosylamine derivative of XXXG;1.8;CA;CALCIUM ION;B-1,4-endoglucanase;77095;
5D9V;A;Crystal structure of oxidized dehydroascorbate reductase (OsDHAR) from Oryza sativa L. japonica;1.69;CA;CALCIUM ION;Dehydroascorbate reductase;4530;
5D9X;A;Dehydroascorbate reductase complexed with GSH;1.68;CA;CALCIUM ION;Dehydroascorbate reductase;4530;
5DA5;A;Crystal structure of Rhodospirillum rubrum Rru_A0973;2.06;CA;CALCIUM ION;Rru_A0973;1085;
5DA5;B;Crystal structure of Rhodospirillum rubrum Rru_A0973;2.06;CA;CALCIUM ION;Rru_A0973;1085;
5DA5;C;Crystal structure of Rhodospirillum rubrum Rru_A0973;2.06;CA;CALCIUM ION;Rru_A0973;1085;
5DA5;D;Crystal structure of Rhodospirillum rubrum Rru_A0973;2.06;CA;CALCIUM ION;Rru_A0973;1085;
5DA5;F;Crystal structure of Rhodospirillum rubrum Rru_A0973;2.06;CA;CALCIUM ION;Rru_A0973;1085;
5DA5;G;Crystal structure of Rhodospirillum rubrum Rru_A0973;2.06;CA;CALCIUM ION;Rru_A0973;1085;
5DA5;I;Crystal structure of Rhodospirillum rubrum Rru_A0973;2.06;CA;CALCIUM ION;Rru_A0973;1085;
5DA5;J;Crystal structure of Rhodospirillum rubrum Rru_A0973;2.06;CA;CALCIUM ION;Rru_A0973;1085;
5DA5;K;Crystal structure of Rhodospirillum rubrum Rru_A0973;2.06;CA;CALCIUM ION;Rru_A0973;1085;
5DA5;L;Crystal structure of Rhodospirillum rubrum Rru_A0973;2.06;CA;CALCIUM ION;Rru_A0973;1085;
5DA5;N;Crystal structure of Rhodospirillum rubrum Rru_A0973;2.06;CA;CALCIUM ION;Rru_A0973;1085;
5DA5;P;Crystal structure of Rhodospirillum rubrum Rru_A0973;2.06;CA;CALCIUM ION;Rru_A0973;1085;
5DA5;Q;Crystal structure of Rhodospirillum rubrum Rru_A0973;2.06;CA;CALCIUM ION;Rru_A0973;1085;
5DA5;U;Crystal structure of Rhodospirillum rubrum Rru_A0973;2.06;CA;CALCIUM ION;Rru_A0973;1085;
5DA5;V;Crystal structure of Rhodospirillum rubrum Rru_A0973;2.06;CA;CALCIUM ION;Rru_A0973;1085;
5DA5;X;Crystal structure of Rhodospirillum rubrum Rru_A0973;2.06;CA;CALCIUM ION;Rru_A0973;1085;
5DA5;Z;Crystal structure of Rhodospirillum rubrum Rru_A0973;2.06;CA;CALCIUM ION;Rru_A0973;1085;
5DA5;a;Crystal structure of Rhodospirillum rubrum Rru_A0973;2.06;CA;CALCIUM ION;Rru_A0973;1085;
5DA5;c;Crystal structure of Rhodospirillum rubrum Rru_A0973;2.06;CA;CALCIUM ION;Rru_A0973;1085;
5DA8;A;Crystal structure of chaperonin GroEL from;3;CA;CALCIUM ION;60 kDa chaperonin;1097;
5DA8;B;Crystal structure of chaperonin GroEL from;3;CA;CALCIUM ION;60 kDa chaperonin;1097;
5DA8;F;Crystal structure of chaperonin GroEL from;3;CA;CALCIUM ION;60 kDa chaperonin;1097;
5DA8;G;Crystal structure of chaperonin GroEL from;3;CA;CALCIUM ION;60 kDa chaperonin;1097;
5DA8;I;Crystal structure of chaperonin GroEL from;3;CA;CALCIUM ION;60 kDa chaperonin;1097;
5DA8;J;Crystal structure of chaperonin GroEL from;3;CA;CALCIUM ION;60 kDa chaperonin;1097;
5DA8;K;Crystal structure of chaperonin GroEL from;3;CA;CALCIUM ION;60 kDa chaperonin;1097;
5DA8;M;Crystal structure of chaperonin GroEL from;3;CA;CALCIUM ION;60 kDa chaperonin;1097;
5DA8;O;Crystal structure of chaperonin GroEL from;3;CA;CALCIUM ION;60 kDa chaperonin;1097;
5DA8;P;Crystal structure of chaperonin GroEL from;3;CA;CALCIUM ION;60 kDa chaperonin;1097;
5DA8;Q;Crystal structure of chaperonin GroEL from;3;CA;CALCIUM ION;60 kDa chaperonin;1097;
5DA8;R;Crystal structure of chaperonin GroEL from;3;CA;CALCIUM ION;60 kDa chaperonin;1097;
5DA8;T;Crystal structure of chaperonin GroEL from;3;CA;CALCIUM ION;60 kDa chaperonin;1097;
5DA8;U;Crystal structure of chaperonin GroEL from;3;CA;CALCIUM ION;60 kDa chaperonin;1097;
5DA8;V;Crystal structure of chaperonin GroEL from;3;CA;CALCIUM ION;60 kDa chaperonin;1097;
5DA8;Y;Crystal structure of chaperonin GroEL from;3;CA;CALCIUM ION;60 kDa chaperonin;1097;
5DA8;Z;Crystal structure of chaperonin GroEL from;3;CA;CALCIUM ION;60 kDa chaperonin;1097;
5DA8;a;Crystal structure of chaperonin GroEL from;3;CA;CALCIUM ION;60 kDa chaperonin;1097;
5DAU;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS V39E/V104E at cryogenic temperature;1.5;CA;CALCIUM ION;Thermonuclease;1280;
5DAY;A;The structure of NAP1-Related Protein(NRP1) in Arabidopsis;2.33;CA;CALCIUM ION;NAP1-related protein 1;3702;
5DAY;B;The structure of NAP1-Related Protein(NRP1) in Arabidopsis;2.33;CA;CALCIUM ION;NAP1-related protein 1;3702;
5DBR;A;Ca2+ CaM with human cardiac Na+ channel (NaV1.5) inactivation gate;2.25;CA;CALCIUM ION;Calmodulin;9606;
5DCG;B;Crystal Structure of WT Apo Human Glutathione Transferase Pi;2.01;CA;CALCIUM ION;Glutathione S-transferase P;9606;
5DD2;A;Human gelsolin from residues Glu28 to Arg161 with Calcium;2.6;CA;CALCIUM ION;Gelsolin;9606;
5DD2;G;Human gelsolin from residues Glu28 to Arg161 with Calcium;2.6;CA;CALCIUM ION;Gelsolin;9606;
5DDL;B;Crystal Structure of WT Human Glutathione Transferase Pi soaked with a metalloid then back-soaked with glutathione;1.98;CA;CALCIUM ION;Glutathione S-transferase P;9606;
5DEH;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS N100D at cryogenic temperature;1.7;CA;CALCIUM ION;Thermonuclease;1280;
5DEI;A;BENZOYLFORMATE DECARBOXYLASE FROM PSEUDOMONAS PUTIDA;1.3;CA;CALCIUM ION;Benzoylformate decarboxylase;303;
5DEI;B;BENZOYLFORMATE DECARBOXYLASE FROM PSEUDOMONAS PUTIDA;1.3;CA;CALCIUM ION;Benzoylformate decarboxylase;303;
5DEI;C;BENZOYLFORMATE DECARBOXYLASE FROM PSEUDOMONAS PUTIDA;1.3;CA;CALCIUM ION;Benzoylformate decarboxylase;303;
5DEI;D;BENZOYLFORMATE DECARBOXYLASE FROM PSEUDOMONAS PUTIDA;1.3;CA;CALCIUM ION;Benzoylformate decarboxylase;303;
5DEJ;A;Transthyretin natural mutant A19D;1.37;CA;CALCIUM ION;Transthyretin;9606;
5DG7;A;CRYSTAL STRUCTURE OF HUMAN DNA POLYMERASE ETA INSERTING dTTP ACROSS A DNA TEMPLATE CONTAINING 1,N6-ETHENODEOXYADENOSINE LESION;2.26;CA;CALCIUM ION;DNA polymerase eta;9606;
5DGD;A;Benzoylformate decarboxylase F464I and A460V mutant from Pseudomonas putida;1.13;CA;CALCIUM ION;Benzoylformate decarboxylase;303;
5DGT;A;BENZOYLFORMATE DECARBOXYLASE H70A MUTANT at pH 8.5 FROM PSEUDOMONAS PUTIDA;1.08;CA;CALCIUM ION;Benzoylformate decarboxylase;303;
5DJK;A;Structure of M. tuberculosis CysQ, a PAP phosphatase with PO4 and 2Ca bound;1.8;CA;CALCIUM ION;3'-phosphoadenosine 5'-phosphate phosphatase;1773;
5DJL;B;Structure of WT Human Glutathione Transferase in complex with cisplatin in the presence of glutathione.;1.8;CA;CALCIUM ION;Glutathione S-transferase P;9606;
5DJQ;A;The structure of CBB3 cytochrome oxidase.;3.2;CA;CALCIUM ION;Cbb3-type cytochrome c oxidase subunit CcoN1;316;
5DJQ;D;The structure of CBB3 cytochrome oxidase.;3.2;CA;CALCIUM ION;Cbb3-type cytochrome c oxidase subunit CcoN1;316;
5DJQ;G;The structure of CBB3 cytochrome oxidase.;3.2;CA;CALCIUM ION;Cbb3-type cytochrome c oxidase subunit CcoN1;316;
5DJQ;K;The structure of CBB3 cytochrome oxidase.;3.2;CA;CALCIUM ION;Cbb3-type cytochrome c oxidase subunit CcoN1;316;
5DKN;A;Crystal Structure of Calcium-loaded S100B bound to SBi4225;1.53;CA;CALCIUM ION;Protein S100-B;9913;
5DKQ;A;Crystal Structure of Calcium-loaded S100B bound to SBi4214;1.59;CA;CALCIUM ION;Protein S100-B;9913;
5DKR;A;Crystal Structure of Calcium-loaded S100B bound to SBi29;1.74;CA;CALCIUM ION;Protein S100-B;9913;
5DKR;B;Crystal Structure of Calcium-loaded S100B bound to SBi29;1.74;CA;CALCIUM ION;Protein S100-B;9913;
5DKW;A;Ternary crystal structure of polymerase lambda with a GA mispair at the primer terminus with Ca2+ in the active;2.69;CA;CALCIUM ION;DNA polymerase lambda;9606;
5DKW;B;Ternary crystal structure of polymerase lambda with a GA mispair at the primer terminus with Ca2+ in the active;2.69;CA;CALCIUM ION;DNA polymerase lambda;9606;
5DL7;A;Crystal structure of Acinetobacter baumannii OccAB3;1.75;CA;CALCIUM ION;Porin;470;
5DL8;A;Crystal structure of Acinetobacter baumannii OccAB4;2.2;CA;CALCIUM ION;Benzoate transport porin BenP;470;
5DL8;B;Crystal structure of Acinetobacter baumannii OccAB4;2.2;CA;CALCIUM ION;Benzoate transport porin BenP;470;
5DLF;A;Crystal Structure of Human DNA Polymerase Eta Inserting dATP Opposite O4-Methylhymidine;1.97;CA;CALCIUM ION;DNA polymerase eta;9606;
5DLH;A;SFX structure of thermolysin;2.25;CA;CALCIUM ION;Thermolysin;1422;
5DLT;A;Crystal structure of Autotaxin (ENPP2) with 7-alpha-hydroxycholesterol;1.6;CA;CALCIUM ION;Ectonucleotide pyrophosphatase/phosphodiesterase family member 2;10116;
5DLV;A;Crystal structure of Autotaxin (ENPP2) with tauroursodeoxycholic acid (TUDCA);2;CA;CALCIUM ION;Ectonucleotide pyrophosphatase/phosphodiesterase family member 2;10116;
5DLV;B;Crystal structure of Autotaxin (ENPP2) with tauroursodeoxycholic acid (TUDCA);2;CA;CALCIUM ION;Ectonucleotide pyrophosphatase/phosphodiesterase family member 2;10116;
5DLW;A;Crystal structure of Autotaxin (ENPP2) with tauroursodeoxycholic acid (TUDCA) and lysophosphatidic acid (LPA);1.8;CA;CALCIUM ION;Ectonucleotide pyrophosphatase/phosphodiesterase family member 2;10116;
5DO4;H;Thrombin-RNA aptamer complex;1.86;CA;CALCIUM ION;Thrombin heavy chain;9606;
5DOB;A;Crystal structure of the Human Cytomegalovirus Nuclear Egress Complex (NEC);2.47;CA;CALCIUM ION;Virion egress protein UL31 homolog;10359;
5DOO;A;The structure of PKMT2 from Rickettsia typhi;3.13;CA;CALCIUM ION;protein lysine methyltransferase 2;785;
5DOW;A;Solution of the Variably-Twinned Structure of a Novel Calmodulin-Peptide Complex in a Novel Configuration;1.7;CA;CALCIUM ION;Calmodulin;9606;
5DOW;C;Solution of the Variably-Twinned Structure of a Novel Calmodulin-Peptide Complex in a Novel Configuration;1.7;CA;CALCIUM ION;Calmodulin;9606;
5DOW;E;Solution of the Variably-Twinned Structure of a Novel Calmodulin-Peptide Complex in a Novel Configuration;1.7;CA;CALCIUM ION;Calmodulin;9606;
5DOW;G;Solution of the Variably-Twinned Structure of a Novel Calmodulin-Peptide Complex in a Novel Configuration;1.7;CA;CALCIUM ION;Calmodulin;9606;
5DPE;E;Thermolysin in complex with inhibitor.;1.34;CA;CALCIUM ION;Thermolysin;1427;
5DPF;E;Thermolysin in complex with inhibitor.;1.47;CA;CALCIUM ION;Thermolysin;1427;
5DPK;A;MutY adenine glycosylase bound to a transition state analog (1N) paired with d(8-oxoG) in duplexed DNA to 2.2 A;2.2;CA;CALCIUM ION;A/G-specific adenine glycosylase;1422;
5DPN;A;Engineered CBM X-2 L110F in complex with branched carbohydrate XXXG.;;CA;CALCIUM ION;Xylanase;29549;
5DQI;A;Crystal Structure of Human DNA Polymerase Eta Extending an O4-Ethylthymidine : dA Pair By Inserting dCTP Opposite dG;2.3;CA;CALCIUM ION;DNA polymerase eta;9606;
5DQQ;A;Structure, inhibition and regulation of two-pore channel TPC1 from Arabidopsis thaliana;2.87;CA;CALCIUM ION;Two pore calcium channel protein 1;3702;
5DQX;A;Crystal structure of salmonella typhi - OMPLA with inherent bound cofactor;2.95;CA;CALCIUM ION;Phospholipase A1;28901;
5DSA;A;Crystal structure of Holliday junctions stabilized by 5-methylcytosine in GCC junction core;1.69;CA;CALCIUM ION;5'-D(*CP*CP*GP*GP*CP*GP*5CMP*CP*GP*G)-3';32630;
5DSB;B;Crystal structure of Holliday junctions stabilized by 5-hydroxymethylcytosine in GCC junction core;1.5;CA;CALCIUM ION;5'-D(*CP*CP*GP*GP*CP*GP*5HCP*CP*GP*G)-3';32630;
5DSU;A;Crystal structure of double mutant of N-domain of human calmodulin;1.93;CA;CALCIUM ION;Calmodulin;9606;
5DUV;A;Crystal structure of the human galectin-4 N-terminal carbohydrate recognition domain in complex with lactose;1.9;CA;CALCIUM ION;Galectin-4;9606;
5DUV;B;Crystal structure of the human galectin-4 N-terminal carbohydrate recognition domain in complex with lactose;1.9;CA;CALCIUM ION;Galectin-4;9606;
5DUV;C;Crystal structure of the human galectin-4 N-terminal carbohydrate recognition domain in complex with lactose;1.9;CA;CALCIUM ION;Galectin-4;9606;
5DUV;D;Crystal structure of the human galectin-4 N-terminal carbohydrate recognition domain in complex with lactose;1.9;CA;CALCIUM ION;Galectin-4;9606;
5DW8;A;Crystal structure of 2'AMP bound SaIMPase-II;2.4;CA;CALCIUM ION;Inositol monophosphatase;1280;
5DW8;B;Crystal structure of 2'AMP bound SaIMPase-II;2.4;CA;CALCIUM ION;Inositol monophosphatase;1280;
5DY1;A;Crystal of Selenomethionine substituted AmtR from Corynebacterium glutamicum;2.65;CA;CALCIUM ION;TetR family transcriptional regulator;1718;
5DY1;B;Crystal of Selenomethionine substituted AmtR from Corynebacterium glutamicum;2.65;CA;CALCIUM ION;TetR family transcriptional regulator;1718;
5DZV;A;Protocadherin alpha 7 extracellular cadherin domains 1-5;3.6;CA;CALCIUM ION;Protein Pcdha7;10090;
5DZV;B;Protocadherin alpha 7 extracellular cadherin domains 1-5;3.6;CA;CALCIUM ION;Protein Pcdha7;10090;
5DZW;A;Protocadherin alpha 4 extracellular cadherin domains 1-4;2.43;CA;CALCIUM ION;Protocadherin alpha-4;10090;
5DZX;A;Protocadherin beta 6 extracellular cadherin domains 1-4;2.88;CA;CALCIUM ION;Protocadherin beta 6;10090;
5DZX;B;Protocadherin beta 6 extracellular cadherin domains 1-4;2.88;CA;CALCIUM ION;Protocadherin beta 6;10090;
5DZY;A;Protocadherin beta 8 extracellular cadherin domains 1-4;2.9;CA;CALCIUM ION;Pcdhb8 protein;10090;
5DZY;B;Protocadherin beta 8 extracellular cadherin domains 1-4;2.9;CA;CALCIUM ION;Pcdhb8 protein;10090;
5DZY;C;Protocadherin beta 8 extracellular cadherin domains 1-4;2.9;CA;CALCIUM ION;Pcdhb8 protein;10090;
5DZY;D;Protocadherin beta 8 extracellular cadherin domains 1-4;2.9;CA;CALCIUM ION;Pcdhb8 protein;10090;
5DZY;E;Protocadherin beta 8 extracellular cadherin domains 1-4;2.9;CA;CALCIUM ION;Pcdhb8 protein;10090;
5DZY;F;Protocadherin beta 8 extracellular cadherin domains 1-4;2.9;CA;CALCIUM ION;Pcdhb8 protein;10090;
5E0F;A;Human pancreatic alpha-amylase in complex with mini-montbretin A;1.4;CA;CALCIUM ION;Pancreatic alpha-amylase;9606;
5E1F;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS G20E at cryogenic temperature;1.9;CA;CALCIUM ION;Thermonuclease;1280;
5E1J;A;Structure of voltage-gated two-pore channel TPC1 from Arabidopsis thaliana;3.31;CA;CALCIUM ION;Two pore calcium channel protein 1;3702;
5E1K;A;Selenomethionine Ca2+-Calmodulin from Paramecium tetraurelia SAD data;1;CA;CALCIUM ION;Calmodulin;5888;
5E1N;A;Selenomethionine Ca2+-Calmodulin from Paramecium tetraurelia qFit disorder model;1;CA;CALCIUM ION;Calmodulin;5888;
5E1P;A;Ca(2+)-Calmodulin from Paramecium tetraurelia qFit disorder model;1.01;CA;CALCIUM ION;Calmodulin;5888;
5E1Q;A;Mutant (D415G) GH97 alpha-galactosidase in complex with Gal-Lac;1.94;CA;CALCIUM ION;Retaining alpha-galactosidase;818;
5E1Q;B;Mutant (D415G) GH97 alpha-galactosidase in complex with Gal-Lac;1.94;CA;CALCIUM ION;Retaining alpha-galactosidase;818;
5E2F;A;Crystal Structure of Beta-lactamase class D from Bacillus subtilis;1.3;CA;CALCIUM ION;Beta-lactamase YbxI;1423;
5E2F;B;Crystal Structure of Beta-lactamase class D from Bacillus subtilis;1.3;CA;CALCIUM ION;Beta-lactamase YbxI;1423;
5E2J;A;Crystal structure of single mutant thermostable endoglucanase (D468A) from Alicyclobacillus acidocaldarius;2.1;CA;CALCIUM ION;Endoglucanase;405212;
5E2J;B;Crystal structure of single mutant thermostable endoglucanase (D468A) from Alicyclobacillus acidocaldarius;2.1;CA;CALCIUM ION;Endoglucanase;405212;
5E2T;H;Crystal structure of anti-TAU antibody AT8 FAB;2.1;CA;CALCIUM ION;AT8 HEAVY CHAIN;10090;
5.00E+37;A;Redox protein from Chlamydomonas reinhardtii;1.6;CA;CALCIUM ION;EF-Hand domain-containing thioredoxin;3055;
5.00E+37;C;Redox protein from Chlamydomonas reinhardtii;1.6;CA;CALCIUM ION;EF-Hand domain-containing thioredoxin;3055;
5E3F;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS I92K at cryogenic temperature;1.75;CA;CALCIUM ION;Thermonuclease;1280;
5E4K;A;Structure of ligand binding region of uPARAP at pH 7.4;2.58;CA;CALCIUM ION;C-type mannose receptor 2;9606;
5E4L;A;Structure of ligand binding region of uPARAP at pH 5.3;2.44;CA;CALCIUM ION;C-type mannose receptor 2;9606;
5E4L;B;Structure of ligand binding region of uPARAP at pH 5.3;2.44;CA;CALCIUM ION;C-type mannose receptor 2;9606;
5E4W;C;Crystal structure of cpSRP43 chromodomains 2 and 3 in complex with the Alb3 tail;2.8;CA;CALCIUM ION;Signal recognition particle 43 kDa protein, chloroplastic;3702;
5E4W;D;Crystal structure of cpSRP43 chromodomains 2 and 3 in complex with the Alb3 tail;2.8;CA;CALCIUM ION;Signal recognition particle 43 kDa protein, chloroplastic;3702;
5E5O;A;I-SmaMI bound to uncleaved DNA target in the presence of Calcium ions;2.36;CA;CALCIUM ION;I-SmaMI LAGLIDADG endonuclease;5147;
5E6R;A;Structures of leukocyte integrin aLb2: The aI domain, the headpiece, and the pocket for the internal ligand;2.9;CA;CALCIUM ION;Integrin alpha-L;9606;
5E6R;B;Structures of leukocyte integrin aLb2: The aI domain, the headpiece, and the pocket for the internal ligand;2.9;CA;CALCIUM ION;Integrin beta-2;9606;
5E6S;A;Structures of leukocyte integrin aLB2: The aI domain, the headpiece, and the pocket for the internal ligand;2.15;CA;CALCIUM ION;Integrin alpha-L;9606;
5E6S;B;Structures of leukocyte integrin aLB2: The aI domain, the headpiece, and the pocket for the internal ligand;2.15;CA;CALCIUM ION;Integrin beta-2;9606;
5E6S;C;Structures of leukocyte integrin aLB2: The aI domain, the headpiece, and the pocket for the internal ligand;2.15;CA;CALCIUM ION;Integrin alpha-L;9606;
5E6S;D;Structures of leukocyte integrin aLB2: The aI domain, the headpiece, and the pocket for the internal ligand;2.15;CA;CALCIUM ION;Integrin beta-2;9606;
5E6S;E;Structures of leukocyte integrin aLB2: The aI domain, the headpiece, and the pocket for the internal ligand;2.15;CA;CALCIUM ION;Integrin alpha-L;9606;
5E6S;F;Structures of leukocyte integrin aLB2: The aI domain, the headpiece, and the pocket for the internal ligand;2.15;CA;CALCIUM ION;Integrin beta-2;9606;
5E6U;A;Structures of leukocyte integrin aLb2: The aI domain, the headpiece, and the pocket for the internal ligand;2.5;CA;CALCIUM ION;Integrin alpha-L;9606;
5E6U;B;Structures of leukocyte integrin aLb2: The aI domain, the headpiece, and the pocket for the internal ligand;2.5;CA;CALCIUM ION;Integrin beta-2;9606;
5.00E+79;B;Macromolecular diffractive imaging using imperfect crystals;3.5;CA;CALCIUM ION;Photosystem II CP47 reaction center protein;146786;
5.00E+79;F;Macromolecular diffractive imaging using imperfect crystals;3.5;CA;CALCIUM ION;Cytochrome b559 subunit beta;146786;
5.00E+79;O;Macromolecular diffractive imaging using imperfect crystals;3.5;CA;CALCIUM ION;Photosystem II manganese-stabilizing polypeptide;146786;
5.00E+79;b;Macromolecular diffractive imaging using imperfect crystals;3.5;CA;CALCIUM ION;Photosystem II CP47 reaction center protein;146786;
5.00E+79;f;Macromolecular diffractive imaging using imperfect crystals;3.5;CA;CALCIUM ION;Cytochrome b559 subunit beta;146786;
5.00E+79;o;Macromolecular diffractive imaging using imperfect crystals;3.5;CA;CALCIUM ION;Photosystem II manganese-stabilizing polypeptide;146786;
5E7C;B;Macromolecular diffractive imaging using imperfect crystals - Bragg data;4.5;CA;CALCIUM ION;Photosystem II CP47 reaction center protein;146786;
5E7C;F;Macromolecular diffractive imaging using imperfect crystals - Bragg data;4.5;CA;CALCIUM ION;Cytochrome b559 subunit beta;146786;
5E7C;O;Macromolecular diffractive imaging using imperfect crystals - Bragg data;4.5;CA;CALCIUM ION;Photosystem II manganese-stabilizing polypeptide;146786;
5E7C;b;Macromolecular diffractive imaging using imperfect crystals - Bragg data;4.5;CA;CALCIUM ION;Photosystem II CP47 reaction center protein;146786;
5E7C;f;Macromolecular diffractive imaging using imperfect crystals - Bragg data;4.5;CA;CALCIUM ION;Cytochrome b559 subunit beta;146786;
5E7C;o;Macromolecular diffractive imaging using imperfect crystals - Bragg data;4.5;CA;CALCIUM ION;Photosystem II manganese-stabilizing polypeptide;146786;
5E7G;A;Crystal structure of Bacova_02650 with xylogluco-oligosaccharide;2.37;CA;CALCIUM ION;IPT/TIG domain-containing protein BACOVA_02650;28116;
5E7T;L;Structure of the tripod (BppUct-A-L) from the baseplate of bacteriophage Tuc2009;2.9;CA;CALCIUM ION;Major structural protein 1;35241;
5E8I;B;Crystal structure of the DNA binding domain of human transcription factor FLI1 in complex with a 10-mer DNA ACCGGAAGTG;3.45;CA;CALCIUM ION;DNA (5'-D(*AP*CP*CP*GP*GP*AP*AP*GP*TP*G)-3');40263;
5E8I;C;Crystal structure of the DNA binding domain of human transcription factor FLI1 in complex with a 10-mer DNA ACCGGAAGTG;3.45;CA;CALCIUM ION;DNA (5'-D(*CP*AP*CP*TP*TP*CP*CP*GP*GP*T)-3');40263;
5E8I;F;Crystal structure of the DNA binding domain of human transcription factor FLI1 in complex with a 10-mer DNA ACCGGAAGTG;3.45;CA;CALCIUM ION;DNA (5'-D(*CP*AP*CP*TP*TP*CP*CP*GP*GP*T)-3');40263;
5E8I;H;Crystal structure of the DNA binding domain of human transcription factor FLI1 in complex with a 10-mer DNA ACCGGAAGTG;3.45;CA;CALCIUM ION;DNA (5'-D(*AP*CP*CP*GP*GP*AP*AP*GP*TP*G)-3');40263;
5E8I;I;Crystal structure of the DNA binding domain of human transcription factor FLI1 in complex with a 10-mer DNA ACCGGAAGTG;3.45;CA;CALCIUM ION;DNA (5'-D(*CP*AP*CP*TP*TP*CP*CP*GP*GP*T)-3');40263;
5E8I;L;Crystal structure of the DNA binding domain of human transcription factor FLI1 in complex with a 10-mer DNA ACCGGAAGTG;3.45;CA;CALCIUM ION;DNA (5'-D(*CP*AP*CP*TP*TP*CP*CP*GP*GP*T)-3');40263;
5E8Q;B;Crystal structure of DHFR in 20% Isopropanol;1.8;CA;CALCIUM ION;Dihydrofolate reductase;562;
5EAJ;B;Crystal structure of DHFR in 0% Isopropanol;1.7;CA;CALCIUM ION;Dihydrofolate reductase;562;
5EAN;A;Crystal structure of Dna2 in complex with a 5' overhang DNA;2.36;CA;CALCIUM ION;DNA replication ATP-dependent helicase/nuclease DNA2;10090;
5EAN;B;Crystal structure of Dna2 in complex with a 5' overhang DNA;2.36;CA;CALCIUM ION;DNA (5'-D(P*AP*CP*TP*CP*TP*GP*CP*CP*AP*AP*GP*AP*GP*GP*A)-3');10090;
5EBC;A;Crystal structure of EccB1 of Mycobacterium tuberculosis in spacegroup P21 (state III);3;CA;CALCIUM ION;ESX-1 secretion system protein eccB1;1773;
5EBD;A;Crystal structure of EccB1 of Mycobacterium tuberculosis in spacegroup P21 (state IV);2.6;CA;CALCIUM ION;ESX-1 secretion system protein eccB1;1773;
5ECC;A;Klebsiella pneumoniae DfrA1 complexed with NADPH and 6-ethyl-5-(3-(2-methoxy-5-(pyridin-4-yl)phenyl)prop-1-yn-1-yl)pyrimidine-2,4-diamine;1.87;CA;CALCIUM ION;Dehydrofolate reductase type I;573;
5ECC;B;Klebsiella pneumoniae DfrA1 complexed with NADPH and 6-ethyl-5-(3-(2-methoxy-5-(pyridin-4-yl)phenyl)prop-1-yn-1-yl)pyrimidine-2,4-diamine;1.87;CA;CALCIUM ION;Dehydrofolate reductase type I;573;
5ECU;A;The unliganded structure of Caldicellulosiruptor saccharolyticus GH5;1.5;CA;CALCIUM ION;Cellulase;44001;
5ED4;A;Structure of a PhoP-DNA complex;2.4;CA;CALCIUM ION;Response regulator;1773;
5ED4;B;Structure of a PhoP-DNA complex;2.4;CA;CALCIUM ION;Response regulator;1773;
5ED4;E;Structure of a PhoP-DNA complex;2.4;CA;CALCIUM ION;Response regulator;1773;
5ED4;F;Structure of a PhoP-DNA complex;2.4;CA;CALCIUM ION;Response regulator;1773;
5EDW;A;Ternary structure of Dpo4 bound to G in the template base paired with incoming dTTP;2.62;CA;CALCIUM ION;DNA polymerase IV;2287;
5EG4;A;BOVINE TRYPSIN IN COMPLEX WITH CYCLIC INHIBITOR;1.32;CA;CALCIUM ION;Cationic trypsin;9913;
5EG5;A;As (III) S-adenosylmethyltransferase cysteine mutant C72A bound Phenylarsine oxide (PhAs(III) in the arsenic binding site;1.97;CA;CALCIUM ION;Arsenic methyltransferase;610260;
5EGI;B;Structure of a Trimeric Intracellular Cation channel from C. elegans with bound Ca2+;3.3;CA;CALCIUM ION;Uncharacterized protein Y57A10A.10;6239;
5EGT;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS V66E at cryogenic temperature;1.85;CA;CALCIUM ION;Thermonuclease;1280;
5EKK;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS V39D/L125E at cryogenic temperature;2.1;CA;CALCIUM ION;Thermonuclease;1280;
5EKL;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS T62D/N100E at cryogenic temperature;2.1;CA;CALCIUM ION;Thermonuclease;1280;
5EL0;A;Crystal structure of an Oxidoreductase (short chain dehydrogenase/reductase family) from Brucella ovis in complex with a partially ordered NAD;1.85;CA;CALCIUM ION;Oxidoreductase, short chain dehydrogenase/reductase family;236;
5ELB;A;Cholera toxin classical B-pentamer in complex with Lewis-y;1.08;CA;CALCIUM ION;Cholera enterotoxin B subunit;666;
5ELB;B;Cholera toxin classical B-pentamer in complex with Lewis-y;1.08;CA;CALCIUM ION;Cholera enterotoxin B subunit;666;
5ELB;C;Cholera toxin classical B-pentamer in complex with Lewis-y;1.08;CA;CALCIUM ION;Cholera enterotoxin B subunit;666;
5ELB;D;Cholera toxin classical B-pentamer in complex with Lewis-y;1.08;CA;CALCIUM ION;Cholera enterotoxin B subunit;666;
5ELB;E;Cholera toxin classical B-pentamer in complex with Lewis-y;1.08;CA;CALCIUM ION;Cholera enterotoxin B subunit;666;
5ELC;A;Cholera toxin El Tor B-pentamer in complex with Lewis-y;1.5;CA;CALCIUM ION;Cholera enterotoxin subunit B;666;
5ELC;B;Cholera toxin El Tor B-pentamer in complex with Lewis-y;1.5;CA;CALCIUM ION;Cholera enterotoxin subunit B;666;
5ELC;C;Cholera toxin El Tor B-pentamer in complex with Lewis-y;1.5;CA;CALCIUM ION;Cholera enterotoxin subunit B;666;
5ELC;D;Cholera toxin El Tor B-pentamer in complex with Lewis-y;1.5;CA;CALCIUM ION;Cholera enterotoxin subunit B;666;
5ELC;E;Cholera toxin El Tor B-pentamer in complex with Lewis-y;1.5;CA;CALCIUM ION;Cholera enterotoxin subunit B;666;
5ELE;A;Cholera toxin El Tor B-pentamer in complex with A Lewis-y;1.6;CA;CALCIUM ION;Cholera enterotoxin subunit B;666;
5ELE;B;Cholera toxin El Tor B-pentamer in complex with A Lewis-y;1.6;CA;CALCIUM ION;Cholera enterotoxin subunit B;666;
5ELE;C;Cholera toxin El Tor B-pentamer in complex with A Lewis-y;1.6;CA;CALCIUM ION;Cholera enterotoxin subunit B;666;
5ELE;D;Cholera toxin El Tor B-pentamer in complex with A Lewis-y;1.6;CA;CALCIUM ION;Cholera enterotoxin subunit B;666;
5ELE;E;Cholera toxin El Tor B-pentamer in complex with A Lewis-y;1.6;CA;CALCIUM ION;Cholera enterotoxin subunit B;666;
5ELF;A;Cholera toxin El Tor B-pentamer in complex with A-pentasaccharide;1.55;CA;CALCIUM ION;Cholera enterotoxin subunit B;666;
5ELF;B;Cholera toxin El Tor B-pentamer in complex with A-pentasaccharide;1.55;CA;CALCIUM ION;Cholera enterotoxin subunit B;666;
5ELF;C;Cholera toxin El Tor B-pentamer in complex with A-pentasaccharide;1.55;CA;CALCIUM ION;Cholera enterotoxin subunit B;666;
5ELF;D;Cholera toxin El Tor B-pentamer in complex with A-pentasaccharide;1.55;CA;CALCIUM ION;Cholera enterotoxin subunit B;666;
5ELF;E;Cholera toxin El Tor B-pentamer in complex with A-pentasaccharide;1.55;CA;CALCIUM ION;Cholera enterotoxin subunit B;666;
5ELY;A;X-ray structure of human glutamate carboxypeptidase II (GCPII) in complex with a hydroxamate inhibitor JHU242;1.81;CA;CALCIUM ION;Glutamate carboxypeptidase 2;9606;
5EMW;B;Crystal structure of the palmitoylated human TEAD3 transcription factor;2.55;CA;CALCIUM ION;Transcriptional enhancer factor TEF-5;9606;
5EMW;D;Crystal structure of the palmitoylated human TEAD3 transcription factor;2.55;CA;CALCIUM ION;Transcriptional enhancer factor TEF-5;9606;
5EMY;A;Human Pancreatic Alpha-Amylase in complex with the mechanism based inactivator glucosyl epi-cyclophellitol;1.23;CA;CALCIUM ION;Pancreatic alpha-amylase;9606;
5ENL;A;INHIBITION OF ENOLASE: THE CRYSTAL STRUCTURES OF ENOLASE-CA2+-PHOSPHOGLYCERATE AND ENOLASE-ZN2+-PHOSPHOGLYCOLATE COMPLEXES AT 2.2-ANGSTROMS RESOLUTION;2.2;CA;CALCIUM ION;ENOLASE;4932;
5EQ2;A;Crystal Structure of the SrpA Adhesin from Streptococcus sanguinis;1.8;CA;CALCIUM ION;Platelet-binding glycoprotein;1305;
5EQ2;B;Crystal Structure of the SrpA Adhesin from Streptococcus sanguinis;1.8;CA;CALCIUM ION;Platelet-binding glycoprotein;1305;
5EQ3;A;Crystal structure of the SrpA adhesin from Streptococcus sanguinis with a sialyl galactose disaccharide bound;2;CA;CALCIUM ION;Platelet-binding glycoprotein;1305;
5EQ3;B;Crystal structure of the SrpA adhesin from Streptococcus sanguinis with a sialyl galactose disaccharide bound;2;CA;CALCIUM ION;Platelet-binding glycoprotein;1305;
5EQ4;A;Crystal structure of the SrpA adhesin R347E mutant from Streptococcus sanguinis;2.3;CA;CALCIUM ION;Platelet-binding glycoprotein;1305;
5EQ4;B;Crystal structure of the SrpA adhesin R347E mutant from Streptococcus sanguinis;2.3;CA;CALCIUM ION;Platelet-binding glycoprotein;1305;
5EQ4;C;Crystal structure of the SrpA adhesin R347E mutant from Streptococcus sanguinis;2.3;CA;CALCIUM ION;Platelet-binding glycoprotein;1305;
5EQ4;D;Crystal structure of the SrpA adhesin R347E mutant from Streptococcus sanguinis;2.3;CA;CALCIUM ION;Platelet-binding glycoprotein;1305;
5EQX;A;Crystal structure of human Desmoglein-3 ectodomain;3.05;CA;CALCIUM ION;Desmoglein-3;9606;
5ER3;A;Crystal structure of ABC transporter system solute-binding protein from Rhodopirellula baltica SH 1;2.11;CA;CALCIUM ION;Sugar ABC transporter, periplasmic sugar-binding protein;265606;
5ER4;X;Crystal Structure of Calcium-loaded S100B bound to SC0025;1.81;CA;CALCIUM ION;Protein S100-B;9913;
5ER5;A;Crystal Structure of Calcium-loaded S100B bound to SC1990;1.26;CA;CALCIUM ION;Protein S100-B;9913;
5ER7;A;Connexin-26 Bound to Calcium;3.29;CA;CALCIUM ION;Gap junction beta-2 protein;9606;
5ER7;B;Connexin-26 Bound to Calcium;3.29;CA;CALCIUM ION;Gap junction beta-2 protein;9606;
5ERC;A;X-ray crystal structure of BRPF1 PZP domain;2.05;CA;CALCIUM ION;Peregrin;9606;
5ERD;A;Crystal structure of human Desmoglein-2 ectodomain;2.9;CA;CALCIUM ION;Desmoglein-2;9606;
5ERD;B;Crystal structure of human Desmoglein-2 ectodomain;2.9;CA;CALCIUM ION;Desmoglein-2;9606;
5ERE;A;Extracellular ligand binding receptor from Desulfohalobium retbaense DSM5692;2;CA;CALCIUM ION;Extracellular ligand-binding receptor;45663;
5ERP;A;Crystal structure of human Desmocollin-2 ectodomain fragment EC2-5;2.7;CA;CALCIUM ION;Desmocollin-2;9606;
5ERP;B;Crystal structure of human Desmocollin-2 ectodomain fragment EC2-5;2.7;CA;CALCIUM ION;Desmocollin-2;9606;
5ERU;A;Ternary complex of GephE - ADP - Molybdenum cluster;1.6;CA;CALCIUM ION;Gephyrin;10116;
5ERV;A;Ternary complex of GephE - ADP - Tungsten cluster;1.8;CA;CALCIUM ION;Gephyrin;10116;
5ES4;A;RE-REFINEMENT OF INTEGRIN ALPHAXBETA2 ECTODOMAIN IN THE CLOSED/BENT CONFORMATION;3.3;CA;CALCIUM ION;Integrin alpha-X;9606;
5ES4;B;RE-REFINEMENT OF INTEGRIN ALPHAXBETA2 ECTODOMAIN IN THE CLOSED/BENT CONFORMATION;3.3;CA;CALCIUM ION;Integrin beta-2;9606;
5ES4;C;RE-REFINEMENT OF INTEGRIN ALPHAXBETA2 ECTODOMAIN IN THE CLOSED/BENT CONFORMATION;3.3;CA;CALCIUM ION;Integrin alpha-X;9606;
5ES4;D;RE-REFINEMENT OF INTEGRIN ALPHAXBETA2 ECTODOMAIN IN THE CLOSED/BENT CONFORMATION;3.3;CA;CALCIUM ION;Integrin beta-2;9606;
5ES4;E;RE-REFINEMENT OF INTEGRIN ALPHAXBETA2 ECTODOMAIN IN THE CLOSED/BENT CONFORMATION;3.3;CA;CALCIUM ION;Integrin alpha-X;9606;
5ES4;F;RE-REFINEMENT OF INTEGRIN ALPHAXBETA2 ECTODOMAIN IN THE CLOSED/BENT CONFORMATION;3.3;CA;CALCIUM ION;Integrin beta-2;9606;
5ES4;G;RE-REFINEMENT OF INTEGRIN ALPHAXBETA2 ECTODOMAIN IN THE CLOSED/BENT CONFORMATION;3.3;CA;CALCIUM ION;Integrin alpha-X;9606;
5ES4;H;RE-REFINEMENT OF INTEGRIN ALPHAXBETA2 ECTODOMAIN IN THE CLOSED/BENT CONFORMATION;3.3;CA;CALCIUM ION;Integrin beta-2;9606;
5ESP;A;Crystal Structure of LAGLIDADG Meganuclease I-PanMI with coordinated Calcium ions;2.99;CA;CALCIUM ION;I-PanMI;5145;
5ESP;B;Crystal Structure of LAGLIDADG Meganuclease I-PanMI with coordinated Calcium ions;2.99;CA;CALCIUM ION;I-PanMI;5145;
5EST;E;Crystallographic analysis of the inhibition of porcine pancreatic elastase by a peptidyl boronic acid: structure of a reaction intermediate;2.09;CA;CALCIUM ION;ELASTASE;9823;
5ETK;A;E. coli 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase complexed with AMPCPP and inhibitor at 1.09 angstrom resolution;1.09;CA;CALCIUM ION;2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase;562;
5ETL;A;E. coli 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase complexed with AMPCPP and inhibitor at 1.82 angstrom resolution;1.82;CA;CALCIUM ION;2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase;562;
5ETL;B;E. coli 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase complexed with AMPCPP and inhibitor at 1.82 angstrom resolution;1.82;CA;CALCIUM ION;2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase;562;
5ETL;C;E. coli 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase complexed with AMPCPP and inhibitor at 1.82 angstrom resolution;1.82;CA;CALCIUM ION;2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase;562;
5ETL;D;E. coli 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase complexed with AMPCPP and inhibitor at 1.82 angstrom resolution;1.82;CA;CALCIUM ION;2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase;562;
5ETM;A;E. coli 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase complexed with AMPCPP and inhibitor at 1.46 angstrom resolution;1.46;CA;CALCIUM ION;2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase;562;
5ETN;A;E. coli 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase complexed with AMPCPP and inhibitor at 1.40 angstrom resolution;1.4;CA;CALCIUM ION;2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase;562;
5ETO;A;E. coli 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase complexed with AMPCPP and inhibitor at 1.07 angstrom resolution;1.07;CA;CALCIUM ION;2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase;562;
5ETP;A;E. coli 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase complexed with AMPCPP and inhibitor at 1.05 angstrom resolution;1.05;CA;CALCIUM ION;2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase;562;
5EWE;A;Ternary complex of human DNA polymerase eta inserting rCTP opposite template G;1.66;CA;CALCIUM ION;DNA polymerase eta;9606;
5EWF;A;Ternary complex of human DNA polymerase eta inserting rCTP opposite an 8-Oxodeoxyguanosine Lesion;1.78;CA;CALCIUM ION;DNA polymerase eta;9606;
5EWG;A;Ternary complex of human DNA polymerase eta inserting rATP opposite an 8-Oxodeoxyguanosine Lesion;1.75;CA;CALCIUM ION;DNA polymerase eta;9606;
5EX2;B;Crystal structure of cyclophilin AquaCyp293 from Hirschia baltica;1.29;CA;CALCIUM ION;Peptidyl-prolyl cis-trans isomerase;2724;
5EYG;A;Crystal structure of IMPase/NADP phosphatase complexed with NADP and Ca2+;2.2;CA;CALCIUM ION;Inositol monophosphatase;1280;
5EYG;B;Crystal structure of IMPase/NADP phosphatase complexed with NADP and Ca2+;2.2;CA;CALCIUM ION;Inositol monophosphatase;1280;
5EYH;A;Crystal Structure of IMPase/NADP phosphatase complexed with NADP and Ca2+ at pH 7.0;2.5;CA;CALCIUM ION;Inositol monophosphatase;1280;
5EYH;B;Crystal Structure of IMPase/NADP phosphatase complexed with NADP and Ca2+ at pH 7.0;2.5;CA;CALCIUM ION;Inositol monophosphatase;1280;
5EYM;A;MEK1 IN COMPLEX WITH BI 847325;2.7;CA;CALCIUM ION;Dual specificity mitogen-activated protein kinase kinase 1;9606;
5EYN;A;Crystal structure of Fructokinase from Vibrio cholerae O395 in fructose, ADP, Beryllium trifluoride and calcium ion bound form;1.29;CA;CALCIUM ION;Fructokinase;666;
5EYX;A;Monoclinic Form of Centrolobium tomentosum seed lectin (CTL) complexed with Man1-3Man-OMe.;2.25;CA;CALCIUM ION;Centrolobium tomentosum lectin;500182;
5EYX;B;Monoclinic Form of Centrolobium tomentosum seed lectin (CTL) complexed with Man1-3Man-OMe.;2.25;CA;CALCIUM ION;Centrolobium tomentosum lectin;500182;
5EYY;A;Tetragonal Form of Centrolobium tomentosum seed lectin (CTL) complexed with Man1-3Man-OMe.;1.9;CA;CALCIUM ION;Centrolobium tomentosum lectin;500182;
5EZF;B;Racemic crystal structures of Pribnow box consensus promoter sequence (Pbca);1.65;CA;CALCIUM ION;Complementary strand;32630;
5EZY;A;Crystal structure of T2R-TTL-taccalonolide AJ complex;2.05;CA;CALCIUM ION;Tubulin alpha-1B chain;9823;
5EZY;C;Crystal structure of T2R-TTL-taccalonolide AJ complex;2.05;CA;CALCIUM ION;Tubulin alpha-1B chain;9823;
5F09;A;Structure of inactive GCPII mutant in complex with beta-citryl glutamate;1.85;CA;CALCIUM ION;Glutamate carboxypeptidase 2;9606;
5F0E;B;Murine endoplasmic reticulum alpha-glucosidase II;1.74;CA;CALCIUM ION;Glucosidase 2 subunit beta;10090;
5F0Z;A;Crystal structure of Fructokinase from Vibrio cholerae O395 in fructose, ADP and calcium ion bound form;1.75;CA;CALCIUM ION;Fructokinase;666;
5F24;A;Crystal structure of dual specific IMPase/NADP phosphatase bound with D-inositol-1-phosphate;2.5;CA;CALCIUM ION;Inositol monophosphatase;1280;
5F24;B;Crystal structure of dual specific IMPase/NADP phosphatase bound with D-inositol-1-phosphate;2.5;CA;CALCIUM ION;Inositol monophosphatase;1280;
5F2D;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS I92N/V99T at cryogenic temperature;1.7;CA;CALCIUM ION;Thermonuclease;1280;
5F2G;A;Tagatose-1,6-bisphosphate aldolase from Streptococcus pyogenes Glu164Gln mutant in complex with FBP;1.92;CA;CALCIUM ION;Tagatose 1,6-diphosphate aldolase 2;1314;
5F2G;B;Tagatose-1,6-bisphosphate aldolase from Streptococcus pyogenes Glu164Gln mutant in complex with FBP;1.92;CA;CALCIUM ION;Tagatose 1,6-diphosphate aldolase 2;1314;
5F2I;A;Tagatose-1,6-bisphosphate aldolase from Streptococcus pyogenes Glu163Gln mutant;1.95;CA;CALCIUM ION;Tagatose 1,6-diphosphate aldolase 2;1314;
5F2I;B;Tagatose-1,6-bisphosphate aldolase from Streptococcus pyogenes Glu163Gln mutant;1.95;CA;CALCIUM ION;Tagatose 1,6-diphosphate aldolase 2;1314;
5F2I;C;Tagatose-1,6-bisphosphate aldolase from Streptococcus pyogenes Glu163Gln mutant;1.95;CA;CALCIUM ION;Tagatose 1,6-diphosphate aldolase 2;1314;
5F2I;D;Tagatose-1,6-bisphosphate aldolase from Streptococcus pyogenes Glu163Gln mutant;1.95;CA;CALCIUM ION;Tagatose 1,6-diphosphate aldolase 2;1314;
5F2L;A;Tagatose-1,6-bisphosphate aldolase from Streptococcus pyogenes in complex with competitive inhibitor talitol-1,6-bisphosphate;1.75;CA;CALCIUM ION;Tagatose 1,6-diphosphate aldolase 2;1314;
5F2L;B;Tagatose-1,6-bisphosphate aldolase from Streptococcus pyogenes in complex with competitive inhibitor talitol-1,6-bisphosphate;1.75;CA;CALCIUM ION;Tagatose 1,6-diphosphate aldolase 2;1314;
5F2L;C;Tagatose-1,6-bisphosphate aldolase from Streptococcus pyogenes in complex with competitive inhibitor talitol-1,6-bisphosphate;1.75;CA;CALCIUM ION;Tagatose 1,6-diphosphate aldolase 2;1314;
5F2M;A;Tagatose-1,6-bisphosphate aldolase from Streptococcus pyogenes in complex with competitive inhibitor hexitol-1,6-bisphosphate;1.92;CA;CALCIUM ION;Tagatose 1,6-diphosphate aldolase 2;1314;
5F2M;B;Tagatose-1,6-bisphosphate aldolase from Streptococcus pyogenes in complex with competitive inhibitor hexitol-1,6-bisphosphate;1.92;CA;CALCIUM ION;Tagatose 1,6-diphosphate aldolase 2;1314;
5F2M;C;Tagatose-1,6-bisphosphate aldolase from Streptococcus pyogenes in complex with competitive inhibitor hexitol-1,6-bisphosphate;1.92;CA;CALCIUM ION;Tagatose 1,6-diphosphate aldolase 2;1314;
5F2M;D;Tagatose-1,6-bisphosphate aldolase from Streptococcus pyogenes in complex with competitive inhibitor hexitol-1,6-bisphosphate;1.92;CA;CALCIUM ION;Tagatose 1,6-diphosphate aldolase 2;1314;
5F2Q;A;C-type lectin from Bothrops jararacussu;2.95;CA;CALCIUM ION;C-type lectin BJcuL;8726;
5F2Q;B;C-type lectin from Bothrops jararacussu;2.95;CA;CALCIUM ION;C-type lectin BJcuL;8726;
5F2Q;C;C-type lectin from Bothrops jararacussu;2.95;CA;CALCIUM ION;C-type lectin BJcuL;8726;
5F2Q;D;C-type lectin from Bothrops jararacussu;2.95;CA;CALCIUM ION;C-type lectin BJcuL;8726;
5F2Q;E;C-type lectin from Bothrops jararacussu;2.95;CA;CALCIUM ION;C-type lectin BJcuL;8726;
5F2Q;F;C-type lectin from Bothrops jararacussu;2.95;CA;CALCIUM ION;C-type lectin BJcuL;8726;
5F2Q;G;C-type lectin from Bothrops jararacussu;2.95;CA;CALCIUM ION;C-type lectin BJcuL;8726;
5F2Q;H;C-type lectin from Bothrops jararacussu;2.95;CA;CALCIUM ION;C-type lectin BJcuL;8726;
5F2Q;I;C-type lectin from Bothrops jararacussu;2.95;CA;CALCIUM ION;C-type lectin BJcuL;8726;
5F2Q;J;C-type lectin from Bothrops jararacussu;2.95;CA;CALCIUM ION;C-type lectin BJcuL;8726;
5F47;A;Crystal structure of an aminoglycoside acetyltransferase meta-AAC0020 from an uncultured soil metagenomic sample in complex with trehalose;1.5;CA;CALCIUM ION;aminoglycoside acetyltransferase meta-AAC0020;77133;
5F47;B;Crystal structure of an aminoglycoside acetyltransferase meta-AAC0020 from an uncultured soil metagenomic sample in complex with trehalose;1.5;CA;CALCIUM ION;aminoglycoside acetyltransferase meta-AAC0020;77133;
5F4S;A;Tagatose-1,6-bisphosphate aldolase from Streptococcus pyogenes in complex with FBP;1.72;CA;CALCIUM ION;Tagatose 1,6-diphosphate aldolase 2;1314;
5F4S;B;Tagatose-1,6-bisphosphate aldolase from Streptococcus pyogenes in complex with FBP;1.72;CA;CALCIUM ION;Tagatose 1,6-diphosphate aldolase 2;1314;
5F4S;C;Tagatose-1,6-bisphosphate aldolase from Streptococcus pyogenes in complex with FBP;1.72;CA;CALCIUM ION;Tagatose 1,6-diphosphate aldolase 2;1314;
5F4W;A;Tagatose-1,6-bisphosphate aldolase from Streptococcus pyogenes in complex with TBP;1.66;CA;CALCIUM ION;Tagatose 1,6-diphosphate aldolase 2;1314;
5F4W;C;Tagatose-1,6-bisphosphate aldolase from Streptococcus pyogenes in complex with TBP;1.66;CA;CALCIUM ION;Tagatose 1,6-diphosphate aldolase 2;1314;
5F4W;D;Tagatose-1,6-bisphosphate aldolase from Streptococcus pyogenes in complex with TBP;1.66;CA;CALCIUM ION;Tagatose 1,6-diphosphate aldolase 2;1314;
5F5Q;A;Crystal structure of Canavalia virosa lectin in complex with alpha-methyl-mannoside;2.52;CA;CALCIUM ION;Concanavalin-A;28958;
5F5Q;B;Crystal structure of Canavalia virosa lectin in complex with alpha-methyl-mannoside;2.52;CA;CALCIUM ION;Concanavalin-A;28958;
5F6M;A;Isotropic Trypsin Model for Comparison of Diffuse Scattering;1.1;CA;CALCIUM ION;Cationic trypsin;9913;
5F6T;A;Structure of calexcitin-Gd3+ complex.;2.2;CA;CALCIUM ION;Calexcitin;1051067;
5F7H;A;Human T-cell immunoglobulin and mucin domain protein 4 (hTIM-4) complex with phosphoserine;2.5;CA;CALCIUM ION;T-cell immunoglobulin and mucin domain-containing protein 4;9606;
5F7H;B;Human T-cell immunoglobulin and mucin domain protein 4 (hTIM-4) complex with phosphoserine;2.5;CA;CALCIUM ION;T-cell immunoglobulin and mucin domain-containing protein 4;9606;
5F7H;C;Human T-cell immunoglobulin and mucin domain protein 4 (hTIM-4) complex with phosphoserine;2.5;CA;CALCIUM ION;T-cell immunoglobulin and mucin domain-containing protein 4;9606;
5F7H;D;Human T-cell immunoglobulin and mucin domain protein 4 (hTIM-4) complex with phosphoserine;2.5;CA;CALCIUM ION;T-cell immunoglobulin and mucin domain-containing protein 4;9606;
5F7H;E;Human T-cell immunoglobulin and mucin domain protein 4 (hTIM-4) complex with phosphoserine;2.5;CA;CALCIUM ION;T-cell immunoglobulin and mucin domain-containing protein 4;9606;
5F7H;F;Human T-cell immunoglobulin and mucin domain protein 4 (hTIM-4) complex with phosphoserine;2.5;CA;CALCIUM ION;T-cell immunoglobulin and mucin domain-containing protein 4;9606;
5F7S;A;Cycloalternan-degrading enzyme from Trueperella pyogenes;2.3;CA;CALCIUM ION;Glycoside hydrolase family 31;1661;
5F7S;B;Cycloalternan-degrading enzyme from Trueperella pyogenes;2.3;CA;CALCIUM ION;Glycoside hydrolase family 31;1661;
5FAE;A;N184K pathological variant of gelsolin domain 2 (trigonal form);1.7;CA;CALCIUM ION;Gelsolin;9606;
5FAF;A;N184K pathological variant of gelsolin domain 2 (orthorhombic form);1.05;CA;CALCIUM ION;Gelsolin;9606;
5FAX;A;Structure of subtilase SubHal from Bacillus halmapalus;2;CA;CALCIUM ION;Subtilase SubHal from Bacillus halmapalus;79882;
5FAX;B;Structure of subtilase SubHal from Bacillus halmapalus;2;CA;CALCIUM ION;Subtilase SubHal from Bacillus halmapalus;79882;
5FBB;A;S1 nuclease from Aspergillus oryzae in complex with phosphate and adenosine 5'-monophosphate;1.75;CA;CALCIUM ION;Nuclease S1;5062;
5FBB;B;S1 nuclease from Aspergillus oryzae in complex with phosphate and adenosine 5'-monophosphate;1.75;CA;CALCIUM ION;Nuclease S1;5062;
5FBZ;A;Structure of subtilase SubHal from Bacillus halmapalus - complex with chymotrypsin inhibitor CI2A;1.9;CA;CALCIUM ION;Enzyme subtilase SubHal from Bacillus halmapalus;79882;
5FBZ;C;Structure of subtilase SubHal from Bacillus halmapalus - complex with chymotrypsin inhibitor CI2A;1.9;CA;CALCIUM ION;Enzyme subtilase SubHal from Bacillus halmapalus;79882;
5FF1;A;Two way mode of binding of antithyroid drug methimazole to mammalian heme peroxidases: Structure of the complex of lactoperoxidase with methimazole at 1.97 Angstrom resolution;1.97;CA;CALCIUM ION;Lactoperoxidase;9925;
5FF1;B;Two way mode of binding of antithyroid drug methimazole to mammalian heme peroxidases: Structure of the complex of lactoperoxidase with methimazole at 1.97 Angstrom resolution;1.97;CA;CALCIUM ION;Lactoperoxidase;9925;
5FF7;A;Tagatose-1,6-bisphosphate aldolase from Streptococcus pyogenes in complex with DHAP and G3P;2.09;CA;CALCIUM ION;Tagatose 1,6-diphosphate aldolase 2;1314;
5FF7;B;Tagatose-1,6-bisphosphate aldolase from Streptococcus pyogenes in complex with DHAP and G3P;2.09;CA;CALCIUM ION;Tagatose 1,6-diphosphate aldolase 2;1314;
5FF7;C;Tagatose-1,6-bisphosphate aldolase from Streptococcus pyogenes in complex with DHAP and G3P;2.09;CA;CALCIUM ION;Tagatose 1,6-diphosphate aldolase 2;1314;
5FF7;D;Tagatose-1,6-bisphosphate aldolase from Streptococcus pyogenes in complex with DHAP and G3P;2.09;CA;CALCIUM ION;Tagatose 1,6-diphosphate aldolase 2;1314;
5FFG;A;Crystal structure of integrin alpha V beta 6 head;2.25;CA;CALCIUM ION;Integrin alpha-V;9606;
5FFG;B;Crystal structure of integrin alpha V beta 6 head;2.25;CA;CALCIUM ION;Integrin beta-6;9606;
5FFN;A;Complex of subtilase SubTY from Bacillus sp. TY145 with chymotrypsin inhibitor CI2A;1.8;CA;CALCIUM ION;Enzyme subtilase SubTY from Bacillus sp. TY145;1409;
5FFO;A;Integrin alpha V beta 6 in complex with pro-TGF-beta;3.49;CA;CALCIUM ION;Integrin alpha-V;9606;
5FFO;E;Integrin alpha V beta 6 in complex with pro-TGF-beta;3.49;CA;CALCIUM ION;Integrin alpha-V;9606;
5FFR;A;Crystal Structure of Surfactant Protein-A complexed with phosphocholine;2.2;CA;CALCIUM ION;Pulmonary surfactant-associated protein A;10116;
5FFS;A;Crystal Structure of Surfactant Protein-A Y164A Mutant;1.8;CA;CALCIUM ION;Pulmonary surfactant-associated protein A;10116;
5FFT;A;Crystal Structure of Surfactant Protein-A Y221A Mutant;2.2;CA;CALCIUM ION;Pulmonary surfactant-associated protein A;10116;
5FIW;C;CRYSTAL STRUCTURE OF HUMAN MYELOPEROXIDASE AT 1.7 ANGSTROMS RESOLUTION;1.7;CA;CALCIUM ION;MYELOPEROXIDASE;9606;
5FIW;D;CRYSTAL STRUCTURE OF HUMAN MYELOPEROXIDASE AT 1.7 ANGSTROMS RESOLUTION;1.7;CA;CALCIUM ION;MYELOPEROXIDASE;9606;
5FJS;A;Bacterial beta-glucosidase reveals the structural and functional basis of genetic defects in human glucocerebrosidase 2 (GBA2);2.6;CA;CALCIUM ION;GLUCOSYLCERAMIDASE;29329;
5FJS;B;Bacterial beta-glucosidase reveals the structural and functional basis of genetic defects in human glucocerebrosidase 2 (GBA2);2.6;CA;CALCIUM ION;GLUCOSYLCERAMIDASE;29329;
5FK0;A;Yeast delta-COP-I mu-homology domain;3;CA;CALCIUM ION;COATOMER SUBUNIT DELTA;4932;
5FK0;B;Yeast delta-COP-I mu-homology domain;3;CA;CALCIUM ION;COATOMER SUBUNIT DELTA;4932;
5FL0;B;Structure of a hydrolase with an inhibitor;1.95;CA;CALCIUM ION;O-GLCNACASE BT_4395;818;
5FL1;B;Structure of a hydrolase with an inhibitor;1.95;CA;CALCIUM ION;O-GLCNACASE BT_4395;818;
5FM9;A;human Notch 1, EGF 4-7;2.92;CA;CALCIUM ION;NEUROGENIC LOCUS NOTCH HOMOLOG PROTEIN 1;9606;
5FMA;A;human Notch 1, EGF 4-7;2.46;CA;CALCIUM ION;NEUROGENIC LOCUS NOTCH HOMOLOG PROTEIN 1;9606;
5FMA;B;human Notch 1, EGF 4-7;2.46;CA;CALCIUM ION;NEUROGENIC LOCUS NOTCH HOMOLOG PROTEIN 1;9606;
5FNB;A;CRYSTAL STRUCTURE OF FUNGAL VERSATILE PEROXIDASE FROM PLEUROTUS ERYNGII SEPTUPLE MUTANT E37K, H39R, V160A, T184M, Q202L, D213A & G330R;1.79;CA;CALCIUM ION;VERSATILE PEROXIDASE VPL2;5323;
5FNB;B;CRYSTAL STRUCTURE OF FUNGAL VERSATILE PEROXIDASE FROM PLEUROTUS ERYNGII SEPTUPLE MUTANT E37K, H39R, V160A, T184M, Q202L, D213A & G330R;1.79;CA;CALCIUM ION;VERSATILE PEROXIDASE VPL2;5323;
5FNE;A;CRYSTAL STRUCTURE OF FUNGAL VERSATILE PEROXIDASE FROM PLEUROTUS ERYNGII TRIPLE MUTANT E37K, H39R & G330R;1.5;CA;CALCIUM ION;VERSATILE PEROXIDASE;5323;
5FNV;A;a new complex structure of tubulin with an alpha-beta unsaturated lactone;2.61;CA;CALCIUM ION;TUBULIN ALPHA-1B CHAIN;9031;
5FNV;B;a new complex structure of tubulin with an alpha-beta unsaturated lactone;2.61;CA;CALCIUM ION;TUBULIN BETA CHAIN;10116;
5FNV;C;a new complex structure of tubulin with an alpha-beta unsaturated lactone;2.61;CA;CALCIUM ION;TUBULIN ALPHA-1B CHAIN;9031;
5FQ4;A;Crystal structure of the lipoprotein BT2263 from Bacteroides thetaiotaomicron;1.9;CA;CALCIUM ION;PUTATIVE LIPOPROTEIN;818;
5FQ4;B;Crystal structure of the lipoprotein BT2263 from Bacteroides thetaiotaomicron;1.9;CA;CALCIUM ION;PUTATIVE LIPOPROTEIN;818;
5FQ6;B;Crystal structure of the SusCD complex BT2261-2264 from Bacteroides thetaiotaomicron;2.8;CA;CALCIUM ION;SUSC/RAGA FAMILY TONB-LINKED OUTER MEMBRANE PROTEIN;818;
5FQ6;D;Crystal structure of the SusCD complex BT2261-2264 from Bacteroides thetaiotaomicron;2.8;CA;CALCIUM ION;SUSC/RAGA FAMILY TONB-LINKED OUTER MEMBRANE PROTEIN;818;
5FQ6;I;Crystal structure of the SusCD complex BT2261-2264 from Bacteroides thetaiotaomicron;2.8;CA;CALCIUM ION;SUSC/RAGA FAMILY TONB-LINKED OUTER MEMBRANE PROTEIN;818;
5FQ6;M;Crystal structure of the SusCD complex BT2261-2264 from Bacteroides thetaiotaomicron;2.8;CA;CALCIUM ION;SUSC/RAGA FAMILY TONB-LINKED OUTER MEMBRANE PROTEIN;818;
5FQ8;B;Crystal structure of the SusCD complex BT2261-2264 from Bacteroides thetaiotaomicron;2.75;CA;CALCIUM ION;OUTER MEMBRANE PROTEIN OMP121;818;
5FQ8;D;Crystal structure of the SusCD complex BT2261-2264 from Bacteroides thetaiotaomicron;2.75;CA;CALCIUM ION;OUTER MEMBRANE PROTEIN OMP121;818;
5FQL;A;Insights into Hunter syndrome from the structure of iduronate-2- sulfatase;2.3;CA;CALCIUM ION;IDURONATE-2-SULFATASE;9606;
5FR3;A;X-ray crystal structure of aggregation-resistant protective antigen of Bacillus anthracis (mutant S559L T576E);1.93;CA;CALCIUM ION;PROTECTIVE ANTIGEN;1392;
5FRE;A;Characterization of a novel CBM from Clostridium perfringens;1.9;CA;CALCIUM ION;EXO-ALPHA-SIALIDASE;1502;
5FRE;B;Characterization of a novel CBM from Clostridium perfringens;1.9;CA;CALCIUM ION;EXO-ALPHA-SIALIDASE;1502;
5FRE;C;Characterization of a novel CBM from Clostridium perfringens;1.9;CA;CALCIUM ION;EXO-ALPHA-SIALIDASE;1502;
5FSJ;A;Structure of thermolysin prepared by the 'soak-and-freeze' method under 45 bar of oxygen pressure;1.2;CA;CALCIUM ION;THERMOLYSIN;1427;
5FSP;A;Structure of thermolysin prepared by the 'soak-and-freeze' method under 100 bar of krypton pressure;1.7;CA;CALCIUM ION;THERMOLYSIN;1427;
5FSS;A;Structure of thermolysin prepared by the 'soak-and-freeze' method under 40 bar of krypton pressure;1.5;CA;CALCIUM ION;THERMOLYSIN;1427;
5FTC;A;Crystal structure of Pif1 helicase from Bacteroides in complex with ADP;2.27;CA;CALCIUM ION;TPR DOMAIN PROTEIN;457390;
5FTT;C;Octameric complex of Latrophilin 3 (Lec, Olf) , Unc5D (Ig, Ig2, TSP1) and FLRT2 (LRR);3.4;CA;CALCIUM ION;ADHESION G PROTEIN-COUPLED RECEPTOR L3;10090;
5FTT;D;Octameric complex of Latrophilin 3 (Lec, Olf) , Unc5D (Ig, Ig2, TSP1) and FLRT2 (LRR);3.4;CA;CALCIUM ION;ADHESION G PROTEIN-COUPLED RECEPTOR L3;10090;
5FTT;G;Octameric complex of Latrophilin 3 (Lec, Olf) , Unc5D (Ig, Ig2, TSP1) and FLRT2 (LRR);3.4;CA;CALCIUM ION;ADHESION G PROTEIN-COUPLED RECEPTOR L3;10090;
5FTT;H;Octameric complex of Latrophilin 3 (Lec, Olf) , Unc5D (Ig, Ig2, TSP1) and FLRT2 (LRR);3.4;CA;CALCIUM ION;ADHESION G PROTEIN-COUPLED RECEPTOR L3;10090;
5FTU;C;Tetrameric complex of Latrophilin 3, Unc5D and FLRT2;6.01;CA;CALCIUM ION;ADHESION G PROTEIN-COUPLED RECEPTOR L3;10090;
5FTU;D;Tetrameric complex of Latrophilin 3, Unc5D and FLRT2;6.01;CA;CALCIUM ION;ADHESION G PROTEIN-COUPLED RECEPTOR L3;10090;
5FTU;G;Tetrameric complex of Latrophilin 3, Unc5D and FLRT2;6.01;CA;CALCIUM ION;ADHESION G PROTEIN-COUPLED RECEPTOR L3;10090;
5FTU;H;Tetrameric complex of Latrophilin 3, Unc5D and FLRT2;6.01;CA;CALCIUM ION;ADHESION G PROTEIN-COUPLED RECEPTOR L3;10090;
5FTU;K;Tetrameric complex of Latrophilin 3, Unc5D and FLRT2;6.01;CA;CALCIUM ION;ADHESION G PROTEIN-COUPLED RECEPTOR L3;10090;
5FTU;L;Tetrameric complex of Latrophilin 3, Unc5D and FLRT2;6.01;CA;CALCIUM ION;ADHESION G PROTEIN-COUPLED RECEPTOR L3;10090;
5FTX;A;Structure of surface layer protein SbsC, domains 4-9;4.1;CA;CALCIUM ION;SURFACE LAYER PROTEIN;1422;
5FTY;A;Structure of surface layer protein SbsC, domains 6-7 (monoclinic form);2.6;CA;CALCIUM ION;SURFACE LAYER PROTEIN;1422;
5FTY;B;Structure of surface layer protein SbsC, domains 6-7 (monoclinic form);2.6;CA;CALCIUM ION;SURFACE LAYER PROTEIN;1422;
5FU2;B;The complexity of the Ruminococcus flavefaciens cellulosome reflects an expansion in glycan recognition;1.4;CA;CALCIUM ION;CBM74-RFGH5;1265;
5FUL;A;Crystal Structure of Mus musculus Protein Arginine Methyltransferase 2 with SAH;1.89;CA;CALCIUM ION;PROTEIN ARGININE N-METHYLTRANSFERASE 2;10090;
5FVN;C;X-ray crystal structure of Enterobacter cloacae OmpE36 porin;1.45;CA;CALCIUM ION;OMPC PORIN;550;
5FVN;F;X-ray crystal structure of Enterobacter cloacae OmpE36 porin;1.45;CA;CALCIUM ION;OMPC PORIN;550;
5FWA;A;Crystal Structure of Mus musculus Protein Arginine Methyltransferase 2 with CP1;1.8;CA;CALCIUM ION;PROTEIN ARGININE N-METHYLTRANSFERASE 2;10090;
5FWD;A;Crystal Structure of Mus musculus Protein Arginine Methyltransferase 2 with CP2;2;CA;CALCIUM ION;PROTEIN ARGININE N-METHYLTRANSFERASE 2;10090;
5FWS;A;Wnt modulator Kremen crystal form I at 1.90A;1.9;CA;CALCIUM ION;KREMEN PROTEIN 1;9606;
5FWT;A;Wnt modulator Kremen crystal form I at 2.10A;2.1;CA;CALCIUM ION;KREMEN PROTEIN 1;9606;
5FWW;B;Wnt modulator Kremen in complex with DKK1 (CRD2) and LRP6 (PE3PE4);3.5;CA;CALCIUM ION;KREMEN PROTEIN 1;9606;
5FXL;A;Structure of trypsin solved by MR from data collected by Direct Data Collection (DDC) using the ESRF RoboDiff goniometer;1.78;CA;CALCIUM ION;CATIONIC TRYPSIN;9913;
5FXN;A;Structure of thermolysin solved by SAD from data collected by Direct Data Collection (DDC) using the ESRF RoboDiff goniometer;1.45;CA;CALCIUM ION;THERMOLYSIN;1427;
5FYO;A;Calcium-dependent phosphoinositol-specific phospholipase C from a Gram-negative bacterium, Pseudomonas sp, apo form, crystal form 1;1.5;CA;CALCIUM ION;PHOSPHOINOSITOL-SPECIFIC PHOSPHOLIPASE C;306;
5FYO;B;Calcium-dependent phosphoinositol-specific phospholipase C from a Gram-negative bacterium, Pseudomonas sp, apo form, crystal form 1;1.5;CA;CALCIUM ION;PHOSPHOINOSITOL-SPECIFIC PHOSPHOLIPASE C;306;
5FYP;A;Calcium-dependent phosphoinositol-specific phospholipase C from a Gram-negative bacterium, Pseudomonas sp, apo form, crystal form 2;1.17;CA;CALCIUM ION;PHOSPHOINOSITOL-SPECIFIC PHOSPHOLIPASE C;306;
5FYP;B;Calcium-dependent phosphoinositol-specific phospholipase C from a Gram-negative bacterium, Pseudomonas sp, apo form, crystal form 2;1.17;CA;CALCIUM ION;PHOSPHOINOSITOL-SPECIFIC PHOSPHOLIPASE C;306;
5FYP;C;Calcium-dependent phosphoinositol-specific phospholipase C from a Gram-negative bacterium, Pseudomonas sp, apo form, crystal form 2;1.17;CA;CALCIUM ION;PHOSPHOINOSITOL-SPECIFIC PHOSPHOLIPASE C;306;
5FYP;D;Calcium-dependent phosphoinositol-specific phospholipase C from a Gram-negative bacterium, Pseudomonas sp, apo form, crystal form 2;1.17;CA;CALCIUM ION;PHOSPHOINOSITOL-SPECIFIC PHOSPHOLIPASE C;306;
5FYR;A;Calcium-dependent phosphoinositol-specific phospholipase C from a Gram-negative bacterium, Pseudomonas sp, apo form, myoinositol complex;1.45;CA;CALCIUM ION;PHOSPHOINOSITOL-SPECIFIC PHOSPHOLIPASE C;306;
5FYR;B;Calcium-dependent phosphoinositol-specific phospholipase C from a Gram-negative bacterium, Pseudomonas sp, apo form, myoinositol complex;1.45;CA;CALCIUM ION;PHOSPHOINOSITOL-SPECIFIC PHOSPHOLIPASE C;306;
5FYR;C;Calcium-dependent phosphoinositol-specific phospholipase C from a Gram-negative bacterium, Pseudomonas sp, apo form, myoinositol complex;1.45;CA;CALCIUM ION;PHOSPHOINOSITOL-SPECIFIC PHOSPHOLIPASE C;306;
5FYR;D;Calcium-dependent phosphoinositol-specific phospholipase C from a Gram-negative bacterium, Pseudomonas sp, apo form, myoinositol complex;1.45;CA;CALCIUM ION;PHOSPHOINOSITOL-SPECIFIC PHOSPHOLIPASE C;306;
5FYX;A;Crystal structure of Drosophila NCS-1 bound to penothiazine FD16;1.8;CA;CALCIUM ION;FREQUENIN 2;7227;
5FZP;A;Structure of the dispase autolysis inducing protein from Streptomyces mobaraensis;1.7;CA;CALCIUM ION;DISPASE AUTOLYSIS-INDUCING PROTEIN;35621;
5FZP;B;Structure of the dispase autolysis inducing protein from Streptomyces mobaraensis;1.7;CA;CALCIUM ION;DISPASE AUTOLYSIS-INDUCING PROTEIN;35621;
5G08;A;Crystal structure of Drosophila NCS-1 bound to chlorpromazine;1.52;CA;CALCIUM ION;FREQUENIN 2;7227;
5G2V;A;Structure of BT4656 in complex with its substrate D-Glucosamine-2-N, 6-O-disulfate.;1.39;CA;CALCIUM ION;N-ACETYLGLUCOSAMINE-6-SULFATASE;818;
5G38;A;PsbO subunit of Photosystem II, beta barrel domain at 100K, pH 6;1.15;CA;CALCIUM ION;PHOTOSYSTEM II MANGANESE-STABILIZING POLYPEPTIDE;146786;
5G39;A;PsbO subunit of Photosystem II, beta barrel domain at 297K, pH 6;1.5;CA;CALCIUM ION;PHOTOSYSTEM II MANGANESE-STABILIZING POLYPEPTIDE;146786;
5G3A;A;PsbO subunit of Photosystem II, beta barrel domain at 100K, pH 10;1.22;CA;CALCIUM ION;PHOTOSYSTEM II MANGANESE-STABILIZING POLYPEPTIDE;146786;
5G3M;A;Discovery of a novel secreted phospholipase A2 (sPLA2) inhibitor.;1.85;CA;CALCIUM ION;GROUP 10 SECRETORY PHOSPHOLIPASE A2;9606;
5G3M;B;Discovery of a novel secreted phospholipase A2 (sPLA2) inhibitor.;1.85;CA;CALCIUM ION;GROUP 10 SECRETORY PHOSPHOLIPASE A2;9606;
5G3N;A;Discovery of a novel secreted phospholipase A2 (sPLA2) inhibitor.;1.8;CA;CALCIUM ION;PHOSPHOLIPASE A2, MEMBRANE ASSOCIATED;9606;
5G3N;B;Discovery of a novel secreted phospholipase A2 (sPLA2) inhibitor.;1.8;CA;CALCIUM ION;PHOSPHOLIPASE A2, MEMBRANE ASSOCIATED;9606;
5G49;B;Crystal structure of the Arabodopsis thaliana histone-fold dimer L1L NF-YC3;2.3;CA;CALCIUM ION;NUCLEAR TRANSCRIPTION FACTOR Y SUBUNIT C-3;3702;
5G4P;A;Crystal structure of human hippocalcin at 2.4 A resolution;2.42;CA;CALCIUM ION;Neuron-specific calcium-binding protein hippocalcin;9606;
5G4P;E;Crystal structure of human hippocalcin at 2.4 A resolution;2.42;CA;CALCIUM ION;Neuron-specific calcium-binding protein hippocalcin;9606;
5G56;A;THE TETRA-MODULAR CELLULOSOMAL ARABINOXYLANASE CtXyl5A STRUCTURE AS REVEALED BY X-RAY CRYSTALLOGRAPHY;2.64;CA;CALCIUM ION;CARBOHYDRATE BINDING FAMILY 6;1515;
5G58;A;Crystal structure of A190T mutant of human hippocalcin AT 2.5 A resolution;2.54;CA;CALCIUM ION;Neuron-specific calcium-binding protein hippocalcin;9606;
5G58;E;Crystal structure of A190T mutant of human hippocalcin AT 2.5 A resolution;2.54;CA;CALCIUM ION;Neuron-specific calcium-binding protein hippocalcin;9606;
5G5D;B;Crystal Structure of the CohScaC2-XDocCipA type II complex from Clostridium thermocellum;3;CA;CALCIUM ION;CELLULOSOMAL-SCAFFOLDING PROTEIN A;1515;
5G5Y;A;S.pneumoniae ABC-transporter substrate binding protein FusA apo structure;1.73;CA;CALCIUM ION;ABC TRANSPORTER, SUBSTRATE-BINDING PROTEIN;1313;
5G5Y;B;S.pneumoniae ABC-transporter substrate binding protein FusA apo structure;1.73;CA;CALCIUM ION;ABC TRANSPORTER, SUBSTRATE-BINDING PROTEIN;1313;
5G5Z;A;S.pneumoniae ABC-transporter substrate binding protein FusA in complex with kestose;2.01;CA;CALCIUM ION;ABC TRANSPORTER, SUBSTRATE-BINDING PROTEIN;1313;
5G5Z;B;S.pneumoniae ABC-transporter substrate binding protein FusA in complex with kestose;2.01;CA;CALCIUM ION;ABC TRANSPORTER, SUBSTRATE-BINDING PROTEIN;1313;
5G5Z;C;S.pneumoniae ABC-transporter substrate binding protein FusA in complex with kestose;2.01;CA;CALCIUM ION;ABC TRANSPORTER, SUBSTRATE-BINDING PROTEIN;1313;
5G5Z;D;S.pneumoniae ABC-transporter substrate binding protein FusA in complex with kestose;2.01;CA;CALCIUM ION;ABC TRANSPORTER, SUBSTRATE-BINDING PROTEIN;1313;
5G60;A;S.pneumoniae ABC-transporter substrate binding protein FusA in complex with nystose;1.99;CA;CALCIUM ION;ABC TRANSPORTER, SUBSTRATE-BINDING PROTEIN;1313;
5G60;B;S.pneumoniae ABC-transporter substrate binding protein FusA in complex with nystose;1.99;CA;CALCIUM ION;ABC TRANSPORTER, SUBSTRATE-BINDING PROTEIN;1313;
5G60;C;S.pneumoniae ABC-transporter substrate binding protein FusA in complex with nystose;1.99;CA;CALCIUM ION;ABC TRANSPORTER, SUBSTRATE-BINDING PROTEIN;1313;
5G60;D;S.pneumoniae ABC-transporter substrate binding protein FusA in complex with nystose;1.99;CA;CALCIUM ION;ABC TRANSPORTER, SUBSTRATE-BINDING PROTEIN;1313;
5G61;A;S.pneumoniae ABC-transporter substrate binding protein FusA in complex with fructo-nystose;2.4;CA;CALCIUM ION;ABC TRANSPORTER, SUBSTRATE-BINDING PROTEIN;1313;
5G61;B;S.pneumoniae ABC-transporter substrate binding protein FusA in complex with fructo-nystose;2.4;CA;CALCIUM ION;ABC TRANSPORTER, SUBSTRATE-BINDING PROTEIN;1313;
5G61;C;S.pneumoniae ABC-transporter substrate binding protein FusA in complex with fructo-nystose;2.4;CA;CALCIUM ION;ABC TRANSPORTER, SUBSTRATE-BINDING PROTEIN;1313;
5G61;D;S.pneumoniae ABC-transporter substrate binding protein FusA in complex with fructo-nystose;2.4;CA;CALCIUM ION;ABC TRANSPORTER, SUBSTRATE-BINDING PROTEIN;1313;
5G62;A;S.pneumoniae ABC-transporter substrate binding protein FusA EF-hand mutant in complex with fructo-nystose;1.99;CA;CALCIUM ION;ABC TRANSPORTER, SUBSTRATE-BINDING PROTEIN;1313;
5G62;B;S.pneumoniae ABC-transporter substrate binding protein FusA EF-hand mutant in complex with fructo-nystose;1.99;CA;CALCIUM ION;ABC TRANSPORTER, SUBSTRATE-BINDING PROTEIN;1313;
5G6U;A;Crystal structure of langerin carbohydrate recognition domain with GlcNS6S;1.84;CA;CALCIUM ION;LANGERIN;9606;
5G6U;B;Crystal structure of langerin carbohydrate recognition domain with GlcNS6S;1.84;CA;CALCIUM ION;LANGERIN;9606;
5G6U;C;Crystal structure of langerin carbohydrate recognition domain with GlcNS6S;1.84;CA;CALCIUM ION;LANGERIN;9606;
5G6U;D;Crystal structure of langerin carbohydrate recognition domain with GlcNS6S;1.84;CA;CALCIUM ION;LANGERIN;9606;
5GGM;A;The NMR structure of calmodulin in CTAB reverse micelles;;CA;CALCIUM ION;Calmodulin;9606;
5GH0;A;Crystal structure of the complex of bovine lactoperoxidase with mercaptoimidazole at 2.3 A resolution;2.3;CA;CALCIUM ION;Lactoperoxidase;9913;
5GIB;A;Succinic acid bound trypsin crystallized as dimer;2.7;CA;CALCIUM ION;Cationic trypsin;9913;
5GIB;B;Succinic acid bound trypsin crystallized as dimer;2.7;CA;CALCIUM ION;Cationic trypsin;9913;
5GJV;A;Structure of the mammalian voltage-gated calcium channel Cav1.1 complex at near atomic resolution;3.6;CA;CALCIUM ION;Voltage-dependent L-type calcium channel subunit alpha-1S;9986;
5GJV;F;Structure of the mammalian voltage-gated calcium channel Cav1.1 complex at near atomic resolution;3.6;CA;CALCIUM ION;Voltage-dependent calcium channel subunit alpha-2/delta-1;9986;
5GJW;A;Structure of the mammalian voltage-gated calcium channel Cav1.1 complex for ClassII map;3.9;CA;CALCIUM ION;Voltage-dependent L-type calcium channel subunit alpha-1S;9986;
5GJW;F;Structure of the mammalian voltage-gated calcium channel Cav1.1 complex for ClassII map;3.9;CA;CALCIUM ION;Voltage-dependent calcium channel subunit alpha-2/delta-1;9986;
5GKD;A;Structure of PL6 family alginate lyase AlyGC;2.19;CA;CALCIUM ION;AlyGC;368405;
5GKD;B;Structure of PL6 family alginate lyase AlyGC;2.19;CA;CALCIUM ION;AlyGC;368405;
5GKD;C;Structure of PL6 family alginate lyase AlyGC;2.19;CA;CALCIUM ION;AlyGC;368405;
5GKD;D;Structure of PL6 family alginate lyase AlyGC;2.19;CA;CALCIUM ION;AlyGC;368405;
5GKQ;A;Structure of PL6 family alginate lyase AlyGC mutant-R241A;2.57;CA;CALCIUM ION;AlyGC mutant - R241A;368405;
5GKQ;B;Structure of PL6 family alginate lyase AlyGC mutant-R241A;2.57;CA;CALCIUM ION;AlyGC mutant - R241A;368405;
5GL2;A;Crystal structure of TON_0340 in complex with Ca;2.03;CA;CALCIUM ION;Uncharacterized protein;342948;
5GL2;B;Crystal structure of TON_0340 in complex with Ca;2.03;CA;CALCIUM ION;Uncharacterized protein;342948;
5GL2;C;Crystal structure of TON_0340 in complex with Ca;2.03;CA;CALCIUM ION;Uncharacterized protein;342948;
5GL2;D;Crystal structure of TON_0340 in complex with Ca;2.03;CA;CALCIUM ION;Uncharacterized protein;342948;
5GL2;E;Crystal structure of TON_0340 in complex with Ca;2.03;CA;CALCIUM ION;Uncharacterized protein;342948;
5GL2;F;Crystal structure of TON_0340 in complex with Ca;2.03;CA;CALCIUM ION;Uncharacterized protein;342948;
5GL8;B;The crystal structure of Nattokinase fragments;1.8;CA;CALCIUM ION;Subtilisin NAT;1423;
5GLL;A;Crystal structure of CoXyl43, GH43 beta-xylosidase/alpha-arabinofuranosidase from a compostmicrobial metagenome, calcium-bound form;1.8;CA;CALCIUM ION;Glycoside hydrolase family 43;77133;
5GLL;B;Crystal structure of CoXyl43, GH43 beta-xylosidase/alpha-arabinofuranosidase from a compostmicrobial metagenome, calcium-bound form;1.8;CA;CALCIUM ION;Glycoside hydrolase family 43;77133;
5GLN;A;Crystal structure of CoXyl43, GH43 beta-xylosidase/alpha-arabinofuranosidase from a compostmicrobial metagenome in complex with xylotriose, calcium-bound form;1.7;CA;CALCIUM ION;Glycoside hydrolase family 43;77133;
5GLN;B;Crystal structure of CoXyl43, GH43 beta-xylosidase/alpha-arabinofuranosidase from a compostmicrobial metagenome in complex with xylotriose, calcium-bound form;1.7;CA;CALCIUM ION;Glycoside hydrolase family 43;77133;
5GLP;A;Crystal structure of CoXyl43, GH43 beta-xylosidase/alpha-arabinofuranosidase from a compostmicrobial metagenome in complex with l-arabinose, calcium-bound form;1.8;CA;CALCIUM ION;Glycoside hydrolase family 43;77133;
5GLP;B;Crystal structure of CoXyl43, GH43 beta-xylosidase/alpha-arabinofuranosidase from a compostmicrobial metagenome in complex with l-arabinose, calcium-bound form;1.8;CA;CALCIUM ION;Glycoside hydrolase family 43;77133;
5GLR;A;Crystal structure of CoXyl43, GH43 beta-xylosidase/alpha-arabinofuranosidase from a compostmicrobial metagenome in complex with l-arabinose and xylotriose, calcium-bound form;1.7;CA;CALCIUM ION;Glycoside hydrolase family 43;77133;
5GLR;B;Crystal structure of CoXyl43, GH43 beta-xylosidase/alpha-arabinofuranosidase from a compostmicrobial metagenome in complex with l-arabinose and xylotriose, calcium-bound form;1.7;CA;CALCIUM ION;Glycoside hydrolase family 43;77133;
5GLS;A;Structure of bovine Lactoperoxidase with a partially modified covalent bond with heme moiety;1.93;CA;CALCIUM ION;Lactoperoxidase;9913;
5GMF;A;Crystal structure of monkey TLR7 in complex with guanosine and polyU;2.5;CA;CALCIUM ION;Toll-like receptor 7;9544;
5GMF;B;Crystal structure of monkey TLR7 in complex with guanosine and polyU;2.5;CA;CALCIUM ION;Toll-like receptor 7;9544;
5GMF;D;Crystal structure of monkey TLR7 in complex with guanosine and polyU;2.5;CA;CALCIUM ION;Toll-like receptor 7;9544;
5GN8;A;Structure of a 48-mer protein nanocage fabricated from its 24-mer analogue by subunit interface redesign;2.81;CA;CALCIUM ION;Ferritin heavy chain;9606;
5GN8;B;Structure of a 48-mer protein nanocage fabricated from its 24-mer analogue by subunit interface redesign;2.81;CA;CALCIUM ION;Ferritin heavy chain;9606;
5GNF;A;Crystal structure of anti-CRISPR protein AcrF3;1.5;CA;CALCIUM ION;Uncharacterized protein AcrF3;1223261;
5GNF;B;Crystal structure of anti-CRISPR protein AcrF3;1.5;CA;CALCIUM ION;Uncharacterized protein AcrF3;1223261;
5GNQ;A;Crystal structure of replisomal dimer of DNA polymerase from bacteriophage RB69 with DNA duplexes;2.1;CA;CALCIUM ION;DNA polymerase;1914161;
5GNQ;B;Crystal structure of replisomal dimer of DNA polymerase from bacteriophage RB69 with DNA duplexes;2.1;CA;CALCIUM ION;DNA polymerase;1914161;
5GON;A;Structures of a beta-lactam bridged analogue in complex with tubulin;2.48;CA;CALCIUM ION;Tubulin alpha-1B chain;9913;
5GON;B;Structures of a beta-lactam bridged analogue in complex with tubulin;2.48;CA;CALCIUM ION;Tubulin beta-2B chain;9913;
5GON;C;Structures of a beta-lactam bridged analogue in complex with tubulin;2.48;CA;CALCIUM ION;Tubulin alpha-1B chain;9913;
5GQC;B;Crystal structure of lacto-N-biosidase LnbX from Bifidobacterium longum subsp. longum, ligand-free form;2.36;CA;CALCIUM ION;Lacto-N-biosidase;216816;
5GQC;C;Crystal structure of lacto-N-biosidase LnbX from Bifidobacterium longum subsp. longum, ligand-free form;2.36;CA;CALCIUM ION;Lacto-N-biosidase;216816;
5GQC;D;Crystal structure of lacto-N-biosidase LnbX from Bifidobacterium longum subsp. longum, ligand-free form;2.36;CA;CALCIUM ION;Lacto-N-biosidase;216816;
5GQC;E;Crystal structure of lacto-N-biosidase LnbX from Bifidobacterium longum subsp. longum, ligand-free form;2.36;CA;CALCIUM ION;Lacto-N-biosidase;216816;
5GQC;F;Crystal structure of lacto-N-biosidase LnbX from Bifidobacterium longum subsp. longum, ligand-free form;2.36;CA;CALCIUM ION;Lacto-N-biosidase;216816;
5GQC;G;Crystal structure of lacto-N-biosidase LnbX from Bifidobacterium longum subsp. longum, ligand-free form;2.36;CA;CALCIUM ION;Lacto-N-biosidase;216816;
5GQC;H;Crystal structure of lacto-N-biosidase LnbX from Bifidobacterium longum subsp. longum, ligand-free form;2.36;CA;CALCIUM ION;Lacto-N-biosidase;216816;
5GQF;A;Crystal structure of lacto-N-biosidase LnbX from Bifidobacterium longum subsp. longum, lacto-N-biose complex;1.82;CA;CALCIUM ION;Lacto-N-biosidase;216816;
5GQF;B;Crystal structure of lacto-N-biosidase LnbX from Bifidobacterium longum subsp. longum, lacto-N-biose complex;1.82;CA;CALCIUM ION;Lacto-N-biosidase;216816;
5GQG;A;Crystal structure of lacto-N-biosidase LnbX from Bifidobacterium longum subsp. longum, galacto-N-biose complex;2.7;CA;CALCIUM ION;Lacto-N-biosidase;216816;
5GQG;B;Crystal structure of lacto-N-biosidase LnbX from Bifidobacterium longum subsp. longum, galacto-N-biose complex;2.7;CA;CALCIUM ION;Lacto-N-biosidase;216816;
5GQO;A;Structure of the second Single Stranded DNA Binding protein (SSBb) from Mycobacterium smegmatis;2.5;CA;CALCIUM ION;Single-stranded DNA-binding protein;1772;
5GQQ;C;Structure of ALG-2/HEBP2 Complex;2.2;CA;CALCIUM ION;Programmed cell death protein 6;9606;
5GQQ;D;Structure of ALG-2/HEBP2 Complex;2.2;CA;CALCIUM ION;Programmed cell death protein 6;9606;
5GSP;A;RIBONUCLEASE T1/3'-GMP, 9 WEEKS;1.8;CA;CALCIUM ION;RIBONUCLEASE T1;5062;
5GTH;C;Native XFEL structure of photosystem II (dark dataset);2.5;CA;CALCIUM ION;Photosystem II CP43 reaction center protein;32053;
5GTH;O;Native XFEL structure of photosystem II (dark dataset);2.5;CA;CALCIUM ION;Photosystem II manganese-stabilizing polypeptide;32053;
5GTH;V;Native XFEL structure of photosystem II (dark dataset);2.5;CA;CALCIUM ION;Cytochrome c-550;32053;
5GTH;c;Native XFEL structure of photosystem II (dark dataset);2.5;CA;CALCIUM ION;Photosystem II CP43 reaction center protein;32053;
5GTH;o;Native XFEL structure of photosystem II (dark dataset);2.5;CA;CALCIUM ION;Photosystem II manganese-stabilizing polypeptide;32053;
5GTI;B;Native XFEL structure of photosystem II (two flash dataset);2.5;CA;CALCIUM ION;Photosystem II CP47 reaction center protein;32053;
5GTI;C;Native XFEL structure of photosystem II (two flash dataset);2.5;CA;CALCIUM ION;Photosystem II CP43 protein;32053;
5GTI;O;Native XFEL structure of photosystem II (two flash dataset);2.5;CA;CALCIUM ION;Photosystem II manganese-stabilizing polypeptide;32053;
5GTI;V;Native XFEL structure of photosystem II (two flash dataset);2.5;CA;CALCIUM ION;Cytochrome c-550;32053;
5GTI;c;Native XFEL structure of photosystem II (two flash dataset);2.5;CA;CALCIUM ION;Photosystem II CP43 protein;32053;
5GTI;o;Native XFEL structure of photosystem II (two flash dataset);2.5;CA;CALCIUM ION;Photosystem II manganese-stabilizing polypeptide;32053;
5GTW;A;The N253R mutant structures of trehalose synthase from Deinococcus radiodurans display two different active-site conformations;2.93;CA;CALCIUM ION;Trehalose synthase;1299;
5GTW;B;The N253R mutant structures of trehalose synthase from Deinococcus radiodurans display two different active-site conformations;2.93;CA;CALCIUM ION;Trehalose synthase;1299;
5GTW;C;The N253R mutant structures of trehalose synthase from Deinococcus radiodurans display two different active-site conformations;2.93;CA;CALCIUM ION;Trehalose synthase;1299;
5GTW;D;The N253R mutant structures of trehalose synthase from Deinococcus radiodurans display two different active-site conformations;2.93;CA;CALCIUM ION;Trehalose synthase;1299;
5GUB;A;Crystal structure of solute-binding protein complexed with sulfate group-free unsaturated chondroitin disaccharide;1.78;CA;CALCIUM ION;Extracellular solute-binding protein family 1;34105;
5GUB;B;Crystal structure of solute-binding protein complexed with sulfate group-free unsaturated chondroitin disaccharide;1.78;CA;CALCIUM ION;Extracellular solute-binding protein family 1;34105;
5GUB;C;Crystal structure of solute-binding protein complexed with sulfate group-free unsaturated chondroitin disaccharide;1.78;CA;CALCIUM ION;Extracellular solute-binding protein family 1;34105;
5GUW;A;Complex of Cytochrome cd1 Nitrite Reductase and Nitric Oxide Reductase in Denitrification of Pseudomonas aeruginosa;3.2;CA;CALCIUM ION;Nitric oxide reductase subunit C;287;
5GUW;C;Complex of Cytochrome cd1 Nitrite Reductase and Nitric Oxide Reductase in Denitrification of Pseudomonas aeruginosa;3.2;CA;CALCIUM ION;Nitric oxide reductase subunit C;287;
5GUX;B;Cytochrome c-dependent nitric oxide reductase (cNOR) from Pseudomonas aeruginosa in complex with xenon;3.3;CA;CALCIUM ION;Nitric oxide reductase subunit B;287;
5GW7;A;Crystal structure of the glycosynthase mutant E727A of Escherichia coli GH63 glycosidase in complex with glucose and lactose;2.2;CA;CALCIUM ION;Glucosidase YgjK;562;
5GW7;B;Crystal structure of the glycosynthase mutant E727A of Escherichia coli GH63 glycosidase in complex with glucose and lactose;2.2;CA;CALCIUM ION;Glucosidase YgjK;562;
5GX6;A;Crystal structure of solute-binding protein complexed with unsaturated chondroitin disaccharide with a sulfate group at C-4 position of GalNAc;1.81;CA;CALCIUM ION;Extracellular solute-binding protein family 1;34105;
5GX6;B;Crystal structure of solute-binding protein complexed with unsaturated chondroitin disaccharide with a sulfate group at C-4 position of GalNAc;1.81;CA;CALCIUM ION;Extracellular solute-binding protein family 1;34105;
5GX6;C;Crystal structure of solute-binding protein complexed with unsaturated chondroitin disaccharide with a sulfate group at C-4 position of GalNAc;1.81;CA;CALCIUM ION;Extracellular solute-binding protein family 1;34105;
5GX7;A;Crystal structure of solute-binding protein complexed with unsaturated chondroitin disaccharide with a sulfate group at C-6 position of GalNAc;1.99;CA;CALCIUM ION;Extracellular solute-binding protein family 1;34105;
5GX7;B;Crystal structure of solute-binding protein complexed with unsaturated chondroitin disaccharide with a sulfate group at C-6 position of GalNAc;1.99;CA;CALCIUM ION;Extracellular solute-binding protein family 1;34105;
5GX7;C;Crystal structure of solute-binding protein complexed with unsaturated chondroitin disaccharide with a sulfate group at C-6 position of GalNAc;1.99;CA;CALCIUM ION;Extracellular solute-binding protein family 1;34105;
5GX8;A;Crystal structure of solute-binding protein related to glycosaminoglycans;1.78;CA;CALCIUM ION;Extracellular solute-binding protein family 1;34105;
5GX8;B;Crystal structure of solute-binding protein related to glycosaminoglycans;1.78;CA;CALCIUM ION;Extracellular solute-binding protein family 1;34105;
5GXP;A;Cationic Trypsin With GOL/PGE as Dimer at pH 4.6;2.8;CA;CALCIUM ION;Cationic trypsin;9913;
5GXP;B;Cationic Trypsin With GOL/PGE as Dimer at pH 4.6;2.8;CA;CALCIUM ION;Cationic trypsin;9913;
5GXX;A;Crystal structure of endoglucanase CelQ from Clostridium thermocellum complexed with Tris;1.5;CA;CALCIUM ION;Glucanase;1515;
5GXX;B;Crystal structure of endoglucanase CelQ from Clostridium thermocellum complexed with Tris;1.5;CA;CALCIUM ION;Glucanase;1515;
5GXY;A;Crystal structure of endoglucanase CelQ from Clostridium thermocellum complexed with cellobiose and Tris;1.7;CA;CALCIUM ION;Glucanase;1515;
5GXY;B;Crystal structure of endoglucanase CelQ from Clostridium thermocellum complexed with cellobiose and Tris;1.7;CA;CALCIUM ION;Glucanase;1515;
5GXZ;A;Crystal structure of endoglucanase CelQ from Clostridium thermocellum complexed with cellobiose and cellotriose;2.05;CA;CALCIUM ION;Glucanase;1515;
5GXZ;B;Crystal structure of endoglucanase CelQ from Clostridium thermocellum complexed with cellobiose and cellotriose;2.05;CA;CALCIUM ION;Glucanase;1515;
5GY0;A;Crystal structure of endoglucanase CelQ from Clostridium thermocellum complexed with cellotetraose;1.74;CA;CALCIUM ION;Glucanase;1515;
5GY0;B;Crystal structure of endoglucanase CelQ from Clostridium thermocellum complexed with cellotetraose;1.74;CA;CALCIUM ION;Glucanase;1515;
5GY1;A;Crystal structure of endoglucanase CelQ from Clostridium thermocellum complexed with cellotriose;1.99;CA;CALCIUM ION;Glucanase;1515;
5GY1;B;Crystal structure of endoglucanase CelQ from Clostridium thermocellum complexed with cellotriose;1.99;CA;CALCIUM ION;Glucanase;1515;
5GZ4;A;Crystal structure of snake venom phosphodiesterase (PDE) from Taiwan cobra (Naja atra atra);2.55;CA;CALCIUM ION;Snake venom phosphodiesterase (PDE);8656;
5GZ5;A;Crystal structure of snake venom phosphodiesterase (PDE) from Taiwan cobra (Naja atra atra) in complex with AMP;2.09;CA;CALCIUM ION;Snake venom phosphodiesterase (PDE);8656;
5H05;A;Crystal structure of AmyP E221Q in complex with MALTOTRIOSE;2.55;CA;CALCIUM ION;AmyP;408172;
5H05;B;Crystal structure of AmyP E221Q in complex with MALTOTRIOSE;2.55;CA;CALCIUM ION;AmyP;408172;
5H05;C;Crystal structure of AmyP E221Q in complex with MALTOTRIOSE;2.55;CA;CALCIUM ION;AmyP;408172;
5H05;D;Crystal structure of AmyP E221Q in complex with MALTOTRIOSE;2.55;CA;CALCIUM ION;AmyP;408172;
5H06;A;Crystal structure of AmyP in complex with maltose;1.95;CA;CALCIUM ION;AmyP;408172;
5H06;B;Crystal structure of AmyP in complex with maltose;1.95;CA;CALCIUM ION;AmyP;408172;
5H06;C;Crystal structure of AmyP in complex with maltose;1.95;CA;CALCIUM ION;AmyP;408172;
5H06;D;Crystal structure of AmyP in complex with maltose;1.95;CA;CALCIUM ION;AmyP;408172;
5H0P;A;Crystal structure of EF-hand protein mutant;1.86;CA;CALCIUM ION;EF-hand domain-containing protein D2;9606;
5H0U;A;Crystal structure of the catalytic domain of membrane type 1 matrix metalloproteinase;2.24;CA;CALCIUM ION;Matrix metalloproteinase-14;9606;
5H18;A;Crystal structure of catalytic domain of UGGT (UDP-glucose-bound form) from Thermomyces dupontii;1.4;CA;CALCIUM ION;UGGT;28565;
5H2F;B;Crystal structure of the PsbM-deletion mutant of photosystem II;2.2;CA;CALCIUM ION;Photosystem II CP47 reaction center protein;146786;
5H2F;O;Crystal structure of the PsbM-deletion mutant of photosystem II;2.2;CA;CALCIUM ION;Photosystem II manganese-stabilizing polypeptide;146786;
5H2F;b;Crystal structure of the PsbM-deletion mutant of photosystem II;2.2;CA;CALCIUM ION;Photosystem II CP47 reaction center protein;146786;
5H2F;c;Crystal structure of the PsbM-deletion mutant of photosystem II;2.2;CA;CALCIUM ION;Photosystem II CP43 reaction center protein;146786;
5H2F;o;Crystal structure of the PsbM-deletion mutant of photosystem II;2.2;CA;CALCIUM ION;Photosystem II manganese-stabilizing polypeptide;146786;
5H3Z;A;Crystal Structure of 1,2-beta-oligoglucan phosphorylase from Lachnoclostridium phytofermentans;2;CA;CALCIUM ION;Uncharacterized protein;66219;
5H3Z;B;Crystal Structure of 1,2-beta-oligoglucan phosphorylase from Lachnoclostridium phytofermentans;2;CA;CALCIUM ION;Uncharacterized protein;66219;
5H40;A;Crystal Structure of 1,2-beta-oligoglucan phosphorylase from Lachnoclostridium phytofermentans in complex with sophorose;2.2;CA;CALCIUM ION;Uncharacterized protein;66219;
5H40;B;Crystal Structure of 1,2-beta-oligoglucan phosphorylase from Lachnoclostridium phytofermentans in complex with sophorose;2.2;CA;CALCIUM ION;Uncharacterized protein;66219;
5H4Y;A;Crystal structure of human synaptotagmin 5 C2A domain;1.9;CA;CALCIUM ION;Synaptotagmin-5;9606;
5H4Z;A;Crystal structure of S202G mutant of human SYT-5 C2A domain;3.01;CA;CALCIUM ION;Synaptotagmin-5;9606;
5H4Z;B;Crystal structure of S202G mutant of human SYT-5 C2A domain;3.01;CA;CALCIUM ION;Synaptotagmin-5;9606;
5H56;A;ADP and dTDP bound Crystal structure of thymidylate kinase (aq_969) from Aquifex Aeolicus VF5;1.7;CA;CALCIUM ION;Thymidylate kinase;63363;
5H5G;A;Staphylococcus aureus FtsZ-GDP in T and R states;2.2;CA;CALCIUM ION;Cell division protein FtsZ;1280;
5H5H;A;Staphylococcus aureus FtsZ-GDP R29A mutant in T state;1.7;CA;CALCIUM ION;Cell division protein FtsZ;1280;
5H6U;A;Structure of alginate-binding protein AlgQ2 in complex with an alginate pentasaccharide;2.01;CA;CALCIUM ION;AlgQ2;28214;
5H6U;B;Structure of alginate-binding protein AlgQ2 in complex with an alginate pentasaccharide;2.01;CA;CALCIUM ION;AlgQ2;28214;
5H71;A;Structure of alginate-binding protein AlgQ2 in complex with an alginate trisaccharide;1.55;CA;CALCIUM ION;AlgQ2;28214;
5H71;B;Structure of alginate-binding protein AlgQ2 in complex with an alginate trisaccharide;1.55;CA;CALCIUM ION;AlgQ2;28214;
5H74;A;Crystal structure of T2R-TTL-14b complex;2.6;CA;CALCIUM ION;Tubulin alpha-1B chain;9823;
5H74;C;Crystal structure of T2R-TTL-14b complex;2.6;CA;CALCIUM ION;Tubulin alpha-1B chain;9823;
5H7D;E;Crystal structure of the YgjG-protein A-Zpa963-calmodulin complex;2.57;CA;CALCIUM ION;Zpa963,Calmodulin;623,932,630;
5H7D;F;Crystal structure of the YgjG-protein A-Zpa963-calmodulin complex;2.57;CA;CALCIUM ION;Zpa963,Calmodulin;623,932,630;
5H7D;G;Crystal structure of the YgjG-protein A-Zpa963-calmodulin complex;2.57;CA;CALCIUM ION;Zpa963,Calmodulin;623,932,630;
5H7D;H;Crystal structure of the YgjG-protein A-Zpa963-calmodulin complex;2.57;CA;CALCIUM ION;Zpa963,Calmodulin;623,932,630;
5H7D;K;Crystal structure of the YgjG-protein A-Zpa963-calmodulin complex;2.57;CA;CALCIUM ION;Zpa963,Calmodulin;623,932,630;
5H7D;L;Crystal structure of the YgjG-protein A-Zpa963-calmodulin complex;2.57;CA;CALCIUM ION;Zpa963,Calmodulin;623,932,630;
5H7D;O;Crystal structure of the YgjG-protein A-Zpa963-calmodulin complex;2.57;CA;CALCIUM ION;Zpa963,Calmodulin;623,932,630;
5H7D;P;Crystal structure of the YgjG-protein A-Zpa963-calmodulin complex;2.57;CA;CALCIUM ION;Zpa963,Calmodulin;623,932,630;
5H7O;A;Crystal structure of DJ-101 in complex with tubulin protein;2.8;CA;CALCIUM ION;Tubulin alpha-1B chain;9823;
5H7O;C;Crystal structure of DJ-101 in complex with tubulin protein;2.8;CA;CALCIUM ION;Tubulin alpha-1B chain;9823;
5H7W;A;Crystal structure of 5'-nucleotidase from venom of Naja atra;1.9;CA;CALCIUM ION;venom 5'-nucleotidase;8656;
5H7W;B;Crystal structure of 5'-nucleotidase from venom of Naja atra;1.9;CA;CALCIUM ION;venom 5'-nucleotidase;8656;
5H8H;B;Structure of the human GluN1/GluN2A LBD in complex with GNE3419;2.23;CA;CALCIUM ION;Glutamate receptor ionotropic, NMDA 1,Glutamate receptor ionotropic, NMDA 1;9606;
5H8N;B;Structure of the human GluN1/GluN2A LBD in complex with NAM;2.5;CA;CALCIUM ION;Glutamate receptor ionotropic, NMDA 1,Glutamate receptor ionotropic, NMDA 1;9606;
5H8X;A;Crystal structure of the complex MMP-8/BF471 (catechol inhibitor);1.3;CA;CALCIUM ION;Neutrophil collagenase;9606;
5H9O;B;Complex of Murine endoplasmic reticulum alpha-glucosidase II with D-Glucose;2.37;CA;CALCIUM ION;Glucosidase 2 subunit beta;10090;
5H9O;D;Complex of Murine endoplasmic reticulum alpha-glucosidase II with D-Glucose;2.37;CA;CALCIUM ION;Glucosidase 2 subunit beta;10090;
5HCA;A;Globular Domain of the Entamoeba histolytica calreticulin in complex with glucose;2.15;CA;CALCIUM ION;Calreticulin,Calreticulin;5759;
5HCA;B;Globular Domain of the Entamoeba histolytica calreticulin in complex with glucose;2.15;CA;CALCIUM ION;Calreticulin,Calreticulin;5759;
5HCA;C;Globular Domain of the Entamoeba histolytica calreticulin in complex with glucose;2.15;CA;CALCIUM ION;Calreticulin,Calreticulin;5759;
5HCB;A;Globular Domain of the Entamoeba histolytica calreticulin in complex with glucose;2.9;CA;CALCIUM ION;Calreticulin;5759;
5HCB;B;Globular Domain of the Entamoeba histolytica calreticulin in complex with glucose;2.9;CA;CALCIUM ION;Calreticulin;5759;
5HCH;A;X-ray structure of a lectin-bound DNA duplex containing an unnatural phenanthrenyl pair;2.9;CA;CALCIUM ION;Fucose-binding lectin;287;
5HDB;A;Integrin alphaIIbbeta3 in complex with Ro-435054;2.7;CA;CALCIUM ION;Integrin alpha-IIb;9606;
5HDB;B;Integrin alphaIIbbeta3 in complex with Ro-435054;2.7;CA;CALCIUM ION;Integrin beta-3;9606;
5HDB;C;Integrin alphaIIbbeta3 in complex with Ro-435054;2.7;CA;CALCIUM ION;Integrin alpha-IIb;9606;
5HDB;D;Integrin alphaIIbbeta3 in complex with Ro-435054;2.7;CA;CALCIUM ION;Integrin beta-3;9606;
5HFS;A;CRYSTAL STRUCTURE OF C-TERMINAL DOMAIN OF CARGO PROTEINS OF TYPE IX SECRETION SYSTEM;1.97;CA;CALCIUM ION;Gingipain R2;837;
5HGJ;A;Structure of integrin alpha1beta1 and alpha2beta1 I-domains explain differential calcium-mediated ligand recognition;1.4;CA;CALCIUM ION;Integrin alpha-1;9606;
5HGJ;B;Structure of integrin alpha1beta1 and alpha2beta1 I-domains explain differential calcium-mediated ligand recognition;1.4;CA;CALCIUM ION;Integrin alpha-1;9606;
5HGT;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS L25K/I92T at cryogenic temperature;1.75;CA;CALCIUM ION;Thermonuclease;1280;
5HHA;A;Structure of PvdO from Pseudomonas aeruginosa;1.24;CA;CALCIUM ION;PvdO;287;
5HHA;B;Structure of PvdO from Pseudomonas aeruginosa;1.24;CA;CALCIUM ION;PvdO;287;
5HHT;A;Crystal structure of E. coli transketolase triple variant Ser385Tyr/Asp469Thr/Arg520Gln;1.5;CA;CALCIUM ION;Transketolase 1;562;
5HHT;B;Crystal structure of E. coli transketolase triple variant Ser385Tyr/Asp469Thr/Arg520Gln;1.5;CA;CALCIUM ION;Transketolase 1;562;
5HI6;A;The high resolution structure of dihydrofolate reductase from Yersinia pestis complex with methotrexate as closed form;2.05;CA;CALCIUM ION;Dihydrofolate reductase;632;
5HIT;A;Crystal Structure Analysis of Ca2+-calmodulin and a C-terminal EAG1 channel fragment;2.85;CA;CALCIUM ION;Calmodulin;9031;
5HJ2;A;Integrin alpha2beta1 I-domain;2.15;CA;CALCIUM ION;Integrin alpha-2;9606;
5HJ2;B;Integrin alpha2beta1 I-domain;2.15;CA;CALCIUM ION;Integrin alpha-2;9606;
5HJ2;C;Integrin alpha2beta1 I-domain;2.15;CA;CALCIUM ION;Integrin alpha-2;9606;
5HJ2;D;Integrin alpha2beta1 I-domain;2.15;CA;CALCIUM ION;Integrin alpha-2;9606;
5HJ2;E;Integrin alpha2beta1 I-domain;2.15;CA;CALCIUM ION;Integrin alpha-2;9606;
5HJ8;A;Bacterial sodium channel neck 3G mutant;3.7;CA;CALCIUM ION;Ion transport protein;351052;
5HJE;A;Crystal Structure of Transketolase complex with sedoheptulose-7-phoaphate from Pichia Stipitis;1.4;CA;CALCIUM ION;Transketolase;4924;
5HJO;B;Murine endoplasmic reticulum alpha-glucosidase II with bound substrate analogue;2.29;CA;CALCIUM ION;Glucosidase 2 subunit beta;10090;
5HJO;D;Murine endoplasmic reticulum alpha-glucosidase II with bound substrate analogue;2.29;CA;CALCIUM ION;Glucosidase 2 subunit beta;10090;
5HJR;B;Murine endoplasmic reticulum alpha-glucosidase II with bound covalent intermediate;2.4;CA;CALCIUM ION;Glucosidase 2 subunit beta;10090;
5HJR;D;Murine endoplasmic reticulum alpha-glucosidase II with bound covalent intermediate;2.4;CA;CALCIUM ION;Glucosidase 2 subunit beta;10090;
5HKD;B;Bacterial sodium channel neck 7G mutant;3.8;CA;CALCIUM ION;Ion transport protein;351052;
5HKJ;A;Single Chain Recombinant Globular Head of the Complement System Protein C1q;1.35;CA;CALCIUM ION;Complement C1q subcomponent subunit A,Complement C1q subcomponent subunit C,Complement C1q subcomponent subunit B;9606;
5HKV;Y;The crystal structure of the large ribosomal subunit of Staphylococcus aureus in complex with lincomycin;3.66;CA;CALCIUM ION;5S ribosomal RNA;1280;
5HL3;A;Crystal structure of Listeria monocytogenes InlP;1.4;CA;CALCIUM ION;Lmo2470 protein;1639;
5HLO;A;Crystal structure of calcium and zinc-bound human S100A8 in space group C2221;2.1;CA;CALCIUM ION;Protein S100-A8;9606;
5HLO;B;Crystal structure of calcium and zinc-bound human S100A8 in space group C2221;2.1;CA;CALCIUM ION;Protein S100-A8;9606;
5HLO;C;Crystal structure of calcium and zinc-bound human S100A8 in space group C2221;2.1;CA;CALCIUM ION;Protein S100-A8;9606;
5HLO;D;Crystal structure of calcium and zinc-bound human S100A8 in space group C2221;2.1;CA;CALCIUM ION;Protein S100-A8;9606;
5HLV;A;Crystal structure of calcium and zinc-bound human S100A8 in space group P212121;2.2;CA;CALCIUM ION;Protein S100-A8;9606;
5HLV;B;Crystal structure of calcium and zinc-bound human S100A8 in space group P212121;2.2;CA;CALCIUM ION;Protein S100-A8;9606;
5HLV;C;Crystal structure of calcium and zinc-bound human S100A8 in space group P212121;2.2;CA;CALCIUM ION;Protein S100-A8;9606;
5HLV;D;Crystal structure of calcium and zinc-bound human S100A8 in space group P212121;2.2;CA;CALCIUM ION;Protein S100-A8;9606;
5HLV;E;Crystal structure of calcium and zinc-bound human S100A8 in space group P212121;2.2;CA;CALCIUM ION;Protein S100-A8;9606;
5HLV;F;Crystal structure of calcium and zinc-bound human S100A8 in space group P212121;2.2;CA;CALCIUM ION;Protein S100-A8;9606;
5HLV;G;Crystal structure of calcium and zinc-bound human S100A8 in space group P212121;2.2;CA;CALCIUM ION;Protein S100-A8;9606;
5HLV;H;Crystal structure of calcium and zinc-bound human S100A8 in space group P212121;2.2;CA;CALCIUM ION;Protein S100-A8;9606;
5HM4;B;Crystal structure of oligopeptide ABC transporter, periplasmic oligopeptide-binding protein (TM1226) from THERMOTOGA MARITIMA at 2.0 A resolution;2;CA;CALCIUM ION;Mannoside ABC transport system, sugar-binding protein;2336;
5HO0;A;Crystal structure of AbnA (closed conformation), a GH43 extracellular arabinanase from Geobacillus stearothermophilus;2.35;CA;CALCIUM ION;Extracellular arabinanase;1422;
5HO2;A;Crystal structure of AbnA (open conformation), a GH43 extracellular arabinanase from Geobacillus stearothermophilus;2.37;CA;CALCIUM ION;Extracellular arabinanase;1422;
5HOF;A;Crystal structure of AbnA, a GH43 extracellular arabinanase from Geobacillus stearothermophilus, in complex with arabinopentaose;2.96;CA;CALCIUM ION;Extracellular arabinanase;1422;
5HOH;C;RIBONUCLEASE T1 (ASN9ALA/THR93ALA DOUBLEMUTANT) COMPLEXED WITH 2'GMP;2;CA;CALCIUM ION;PROTEIN (RIBONUCLEASE T1);5062;
5HOH;D;RIBONUCLEASE T1 (ASN9ALA/THR93ALA DOUBLEMUTANT) COMPLEXED WITH 2'GMP;2;CA;CALCIUM ION;PROTEIN (RIBONUCLEASE T1);5062;
5HON;A;Structure of Domain 4 of AbnA, a GH43 extracellular arabinanase from Geobacillus stearothermophilus, in complex with arabinotriose;2;CA;CALCIUM ION;Extracellular arabinanase;1422;
5HON;B;Structure of Domain 4 of AbnA, a GH43 extracellular arabinanase from Geobacillus stearothermophilus, in complex with arabinotriose;2;CA;CALCIUM ION;Extracellular arabinanase;1422;
5HP4;A;Crystal structure bacteriohage T5 D15 flap endonuclease (D155K) pseudo-enzyme-product complex with DNA and metal ions;1.86;CA;CALCIUM ION;Exodeoxyribonuclease;10726;
5HP4;X;Crystal structure bacteriohage T5 D15 flap endonuclease (D155K) pseudo-enzyme-product complex with DNA and metal ions;1.86;CA;CALCIUM ION;DNA (5'-D(*GP*AP*TP*CP*TP*AP*TP*AP*TP*GP*CP*CP*AP*TP*CP*GP*G)-3');32630;
5HP5;A;Srtucture of human peptidylarginine deiminase type I (PAD1);3.2;CA;CALCIUM ION;Protein-arginine deiminase type-1;9606;
5HP5;B;Srtucture of human peptidylarginine deiminase type I (PAD1);3.2;CA;CALCIUM ION;Protein-arginine deiminase type-1;9606;
5HP6;A;Structure of AbnA, a GH43 extracellular arabinanase from Geobacillus stearothermophilus (a new conformational state);2.09;CA;CALCIUM ION;Extracellular arabinanase;1422;
5HPO;A;Cycloalternan-forming enzyme from Listeria monocytogenes in complex with maltopentaose;1.8;CA;CALCIUM ION;Lmo2446 protein;1639;
5HPW;A;Mode of binding of antithyroid drug, propylthiouracil to lactoperoxidase: Binding studies and structure determination;2.5;CA;CALCIUM ION;Lactoperoxidase;9925;
5HPW;B;Mode of binding of antithyroid drug, propylthiouracil to lactoperoxidase: Binding studies and structure determination;2.5;CA;CALCIUM ION;Lactoperoxidase;9925;
5HPW;C;Mode of binding of antithyroid drug, propylthiouracil to lactoperoxidase: Binding studies and structure determination;2.5;CA;CALCIUM ION;Lactoperoxidase;9925;
5HPW;D;Mode of binding of antithyroid drug, propylthiouracil to lactoperoxidase: Binding studies and structure determination;2.5;CA;CALCIUM ION;Lactoperoxidase;9925;
5HQ4;A;A Glycoside Hydrolase Family 97 enzyme from Pseudoalteromonas sp. strain K8;1.93;CA;CALCIUM ION;Alpha-glucosidase;1719649;
5HQA;A;A Glycoside Hydrolase Family 97 enzyme in complex with Acarbose from Pseudoalteromonas sp. strain K8;1.75;CA;CALCIUM ION;Alpha-glucosidase;1719649;
5HQB;A;A Glycoside Hydrolase Family 97 enzyme (E480Q) in complex with Panose from Pseudoalteromonas sp. strain K8;1.8;CA;CALCIUM ION;Alpha-glucosidase;1719649;
5HQC;A;A Glycoside Hydrolase Family 97 enzyme R171K variant from Pseudoalteromonas sp. strain K8;2;CA;CALCIUM ION;Glycoside Hydrolase Family 97 enzyme;1719649;
5HQD;A;Acoustic injectors for drop-on-demand serial femtosecond crystallography;2.52;CA;CALCIUM ION;Thermolysin;274;
5HR4;C;Structure of Type IIL restriction-modification enzyme MmeI in complex with DNA has implications for engineering of new specificities;2.6;CA;CALCIUM ION;MmeI;17;
5HR4;J;Structure of Type IIL restriction-modification enzyme MmeI in complex with DNA has implications for engineering of new specificities;2.6;CA;CALCIUM ION;MmeI;17;
5HRT;A;Crystal structure of mouse autotaxin in complex with a DNA aptamer;2;CA;CALCIUM ION;Ectonucleotide pyrophosphatase/phosphodiesterase family member 2;10090;
5HRT;B;Crystal structure of mouse autotaxin in complex with a DNA aptamer;2;CA;CALCIUM ION;modified DNA (34-MER);9606;
5HSA;A;Alcohol Oxidase AOX1 from Pichia Pastoris;2.35;CA;CALCIUM ION;Alcohol oxidase 1;460519;
5HSA;B;Alcohol Oxidase AOX1 from Pichia Pastoris;2.35;CA;CALCIUM ION;Alcohol oxidase 1;460519;
5HSA;C;Alcohol Oxidase AOX1 from Pichia Pastoris;2.35;CA;CALCIUM ION;Alcohol oxidase 1;460519;
5HSA;D;Alcohol Oxidase AOX1 from Pichia Pastoris;2.35;CA;CALCIUM ION;Alcohol oxidase 1;460519;
5HSA;E;Alcohol Oxidase AOX1 from Pichia Pastoris;2.35;CA;CALCIUM ION;Alcohol oxidase 1;460519;
5HSA;F;Alcohol Oxidase AOX1 from Pichia Pastoris;2.35;CA;CALCIUM ION;Alcohol oxidase 1;460519;
5HSA;G;Alcohol Oxidase AOX1 from Pichia Pastoris;2.35;CA;CALCIUM ION;Alcohol oxidase 1;460519;
5HSQ;A;The surface engineered photosensory module (PAS-GAF-PHY) of the bacterial phytochrome Agp1 (AtBphP1) in the Pr form, chromophore modelled with an endocyclic double bond in pyrrole ring A.;1.85;CA;CALCIUM ION;Bacteriophytochrome protein;1176649;
5HUG;A;The crystal structure of neuraminidase from A/American green-winged teal/Washington/195750/2014 influenza virus;1.85;CA;CALCIUM ION;neuraminidase;11320;
5HUK;A;The crystal structure of neuraminidase from A/Northern pintail/Washington/40964/2014 influenza virus;2.45;CA;CALCIUM ION;Neuraminidase;11320;
5HUK;B;The crystal structure of neuraminidase from A/Northern pintail/Washington/40964/2014 influenza virus;2.45;CA;CALCIUM ION;Neuraminidase;11320;
5HUK;C;The crystal structure of neuraminidase from A/Northern pintail/Washington/40964/2014 influenza virus;2.45;CA;CALCIUM ION;Neuraminidase;11320;
5HUK;D;The crystal structure of neuraminidase from A/Northern pintail/Washington/40964/2014 influenza virus;2.45;CA;CALCIUM ION;Neuraminidase;11320;
5HUM;A;The crystal structure of neuraminidase from A/Sichuan/26221/2014 influenza virus;1.6;CA;CALCIUM ION;neuraminidase;11320;
5HUM;B;The crystal structure of neuraminidase from A/Sichuan/26221/2014 influenza virus;1.6;CA;CALCIUM ION;neuraminidase;11320;
5HUM;C;The crystal structure of neuraminidase from A/Sichuan/26221/2014 influenza virus;1.6;CA;CALCIUM ION;neuraminidase;11320;
5HUM;D;The crystal structure of neuraminidase from A/Sichuan/26221/2014 influenza virus;1.6;CA;CALCIUM ION;neuraminidase;11320;
5HUN;A;The crystal structure of neuraminidase from A/gyrfalcon/Washington/41088-6/2014 influenza virus;2.3;CA;CALCIUM ION;Neuraminidase;11320;
5HUR;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS L25T/I92K at cryogenic temperature;1.5;CA;CALCIUM ION;Thermonuclease;1280;
5HXC;A;Structural mechanisms of extracellular ion exchange and induced binding-site occlusion in the sodium-calcium exchanger NCX_Mj soaked with 20 mM Na+ and zero Ca2+;2.1;CA;CALCIUM ION;sodium,calcium exchanger;2190;
5HXH;A;Structural mechanisms of extracellular ion exchange and induced binding-site occlusion in the sodium-calcium exchanger NCX_Mj soaked with zero Na+ and Ca2+;2.8;CA;CALCIUM ION;sodium,calcium exchanger;2190;
5HXH;B;Structural mechanisms of extracellular ion exchange and induced binding-site occlusion in the sodium-calcium exchanger NCX_Mj soaked with zero Na+ and Ca2+;2.8;CA;CALCIUM ION;sodium,calcium exchanger;2190;
5HXM;A;Cycloalternan-forming enzyme from Listeria monocytogenes in complex with panose;1.9;CA;CALCIUM ION;Alpha-xylosidase;1639;
5HXR;A;Structural mechanisms of extracellular ion exchange and induced binding-site occlusion in the sodium-calcium exchanger NCX_Mj soaked with 2.5 mM Na+ and 10mM Ca2+;2.46;CA;CALCIUM ION;sodium,calcium exchanger;2190;
5HY7;A;SF3B10-SF3B130 from Chaetomium thermophilum;2.9;CA;CALCIUM ION;Putative pre-mRNA splicing protein;209285;
5HY7;B;SF3B10-SF3B130 from Chaetomium thermophilum;2.9;CA;CALCIUM ION;Putative pre-mRNA splicing protein;209285;
5HYA;A;Structural mechanisms of extracellular ion exchange and induced binding-site occlusion in the sodium-calcium exchangerNCX_Mj soaked with 150 mM Na+ and nominal Ca2+;1.9;CA;CALCIUM ION;sodium,calcium exchanger;2190;
5HYV;A;Crystal Structure of Transketolase with ThDP from Pichia Stipitis;1.03;CA;CALCIUM ION;Transketolase;4924;
5HZH;A;Crystal structure of photoinhibitable Rac1 containing C450A mutant LOV2 domain;2.6;CA;CALCIUM ION;Ras-related C3 botulinum toxin substrate 1,NPH1-1,Ras-related C3 botulinum toxin substrate 1;44,989,606;
5HZL;B;Secreted Internalin-like protein Lmo2445 from Listeria monocytogenes;2.75;CA;CALCIUM ION;Lmo2445 protein;1639;
5I0D;A;Cycloalternan-forming enzyme from Listeria monocytogenes in complex with cycloalternan;1.77;CA;CALCIUM ION;Lmo2446 protein;1639;
5I0D;B;Cycloalternan-forming enzyme from Listeria monocytogenes in complex with cycloalternan;1.77;CA;CALCIUM ION;Lmo2446 protein;1639;
5I0E;B;Cycloalternan-degrading enzyme from Trueperella pyogenes in complex with isomaltose;2.3;CA;CALCIUM ION;Glycoside hydrolase family 31;1661;
5I0F;B;Cycloalternan-degrading enzyme from Trueperella pyogenes in complex with covalent intermediate;1.85;CA;CALCIUM ION;Glycoside hydrolase family 31;1661;
5I0L;A;Crystal structure of the catalytic domain of MMP-12 in complex with a selective sugar-conjugated arylsulfonamide carboxylate water-soluble inhibitor (DC27).;2.45;CA;CALCIUM ION;Macrophage metalloelastase;9606;
5I0L;B;Crystal structure of the catalytic domain of MMP-12 in complex with a selective sugar-conjugated arylsulfonamide carboxylate water-soluble inhibitor (DC27).;2.45;CA;CALCIUM ION;Macrophage metalloelastase;9606;
5I0N;A;PI4K IIalpha bound to calcium;2.28;CA;CALCIUM ION;Phosphatidylinositol 4-kinase type 2-alpha,Lysozyme,Phosphatidylinositol 4-kinase type 2-alpha;960,610,665;
5I12;A;Crystal structure of the catalytic domain of MMP-9 in complex with a selective sugar-conjugated arylsulfonamide carboxylate water-soluble inhibitor (DC27).;1.59;CA;CALCIUM ION;Matrix metalloproteinase-9,Matrix metalloproteinase-9;9606;
5I29;A;TAF1(2) bound to a pyrrolopyridone compound;1.21;CA;CALCIUM ION;Transcription initiation factor TFIID subunit 1;9606;
5I2L;A;Structure of EF-hand containing protein;1.85;CA;CALCIUM ION;EF-hand domain-containing protein D2;9606;
5I2M;C;CRYSTAL STRUCTURE OF VSV-INDIANA (MUDD-SUMMERS STRAIN) GLYCOPROTEIN UNDER ITS ACIDIC CONFORMATION;2.4;CA;CALCIUM ION;Glycoprotein G;1972577;
5I2N;A;Structure of the human GluN1/GluN2A LBD in complex with N-ethyl-7-{[2-fluoro-3-(trifluoromethyl)phenyl]methyl}-2-methyl-5-oxo-5H-[1,3]thiazolo[3,2-a]pyrimidine-3-carboxamide (compound 29);2.12;CA;CALCIUM ION;Glutamate receptor ionotropic, NMDA 2A;9606;
5I2O;A;Structure of EF-hand containing protein;1.95;CA;CALCIUM ION;EF-hand domain-containing protein D2;9606;
5I2Q;A;Structure of EF-hand containing protein;1.93;CA;CALCIUM ION;EF-hand domain-containing protein D2;9606;
5I2Z;A;Crystal structure of the catalytic domain of MMP-12 in complex with a selective sugar-conjugated triazole-linked carboxylate chelating water-soluble inhibitor (DC24).;2.3;CA;CALCIUM ION;Macrophage metalloelastase;9606;
5I2Z;B;Crystal structure of the catalytic domain of MMP-12 in complex with a selective sugar-conjugated triazole-linked carboxylate chelating water-soluble inhibitor (DC24).;2.3;CA;CALCIUM ION;Macrophage metalloelastase;9606;
5I2Z;C;Crystal structure of the catalytic domain of MMP-12 in complex with a selective sugar-conjugated triazole-linked carboxylate chelating water-soluble inhibitor (DC24).;2.3;CA;CALCIUM ION;Macrophage metalloelastase;9606;
5I2Z;D;Crystal structure of the catalytic domain of MMP-12 in complex with a selective sugar-conjugated triazole-linked carboxylate chelating water-soluble inhibitor (DC24).;2.3;CA;CALCIUM ION;Macrophage metalloelastase;9606;
5I3M;A;Crystal structure of the catalytic domain of MMP-12 in complex with a selective sugar-conjugated thiourea-linked carboxylate zinc-chelator water-soluble inhibitor (DC31).;2.17;CA;CALCIUM ION;Macrophage metalloelastase;9606;
5I3M;B;Crystal structure of the catalytic domain of MMP-12 in complex with a selective sugar-conjugated thiourea-linked carboxylate zinc-chelator water-soluble inhibitor (DC31).;2.17;CA;CALCIUM ION;Macrophage metalloelastase;9606;
5I3M;C;Crystal structure of the catalytic domain of MMP-12 in complex with a selective sugar-conjugated thiourea-linked carboxylate zinc-chelator water-soluble inhibitor (DC31).;2.17;CA;CALCIUM ION;Macrophage metalloelastase;9606;
5I3M;D;Crystal structure of the catalytic domain of MMP-12 in complex with a selective sugar-conjugated thiourea-linked carboxylate zinc-chelator water-soluble inhibitor (DC31).;2.17;CA;CALCIUM ION;Macrophage metalloelastase;9606;
5I42;A;Structure of HIV-1 Reverse Transcriptase in complex with a DNA aptamer, AZTTP, and CA(2+) ion;3.3;CA;CALCIUM ION;HIV-1 REVERSE TRANSCRIPTASE P66 SUBUNIT;11676;
5I42;C;Structure of HIV-1 Reverse Transcriptase in complex with a DNA aptamer, AZTTP, and CA(2+) ion;3.3;CA;CALCIUM ION;HIV-1 REVERSE TRANSCRIPTASE P66 SUBUNIT;11676;
5I43;A;Crystal structure of the catalytic domain of MMP-12 in complex with a selective sugar-conjugated triazole-linked carboxylate chelator water-soluble inhibitor (DC32).;1.95;CA;CALCIUM ION;Macrophage metalloelastase;9606;
5I43;B;Crystal structure of the catalytic domain of MMP-12 in complex with a selective sugar-conjugated triazole-linked carboxylate chelator water-soluble inhibitor (DC32).;1.95;CA;CALCIUM ION;Macrophage metalloelastase;9606;
5I43;C;Crystal structure of the catalytic domain of MMP-12 in complex with a selective sugar-conjugated triazole-linked carboxylate chelator water-soluble inhibitor (DC32).;1.95;CA;CALCIUM ION;Macrophage metalloelastase;9606;
5I43;D;Crystal structure of the catalytic domain of MMP-12 in complex with a selective sugar-conjugated triazole-linked carboxylate chelator water-soluble inhibitor (DC32).;1.95;CA;CALCIUM ION;Macrophage metalloelastase;9606;
5I46;H;Factor VIIA in complex with the inhibitor (2R,15R)-2-[(1-aminoisoquinolin-6-yl)amino]-8-fluoro-7-hydroxy-4,15,17-trimethyl-13-oxa-4,11-diazatricyclo[14.2.2.1~6,10~]henicosa-1(18),6(21),7,9,16,19-hexaene-3,12-dione;2.06;CA;CALCIUM ION;Coagulation factor VII (Heavy Chain);9606;
5I4O;A;Crystal structure of the catalytic domain of MMP-12 in complex with a selective sugar-conjugated triazole-linked carboxylate zinc-chelator water-soluble inhibitor (DC28).;2.05;CA;CALCIUM ION;Macrophage metalloelastase;9606;
5I4O;B;Crystal structure of the catalytic domain of MMP-12 in complex with a selective sugar-conjugated triazole-linked carboxylate zinc-chelator water-soluble inhibitor (DC28).;2.05;CA;CALCIUM ION;Macrophage metalloelastase;9606;
5I4O;C;Crystal structure of the catalytic domain of MMP-12 in complex with a selective sugar-conjugated triazole-linked carboxylate zinc-chelator water-soluble inhibitor (DC28).;2.05;CA;CALCIUM ION;Macrophage metalloelastase;9606;
5I4O;D;Crystal structure of the catalytic domain of MMP-12 in complex with a selective sugar-conjugated triazole-linked carboxylate zinc-chelator water-soluble inhibitor (DC28).;2.05;CA;CALCIUM ION;Macrophage metalloelastase;9606;
5I4S;A;Non-natural DNA pair Z (6-amino-5-nitro-2[1H] pyridone heterocycle)-Guanosine;2.46;CA;CALCIUM ION;DNA (5'-D(P*GP*CP*GP*AP*AP*TP*TP*(D8Z)P*GP*CP*G)-3');32630;
5I4S;B;Non-natural DNA pair Z (6-amino-5-nitro-2[1H] pyridone heterocycle)-Guanosine;2.46;CA;CALCIUM ION;DNA (5'-D(P*GP*CP*GP*AP*AP*TP*TP*(D8Z)P*GP*CP*G)-3');32630;
5I51;A;Crystal Structure of Transketolase mutant-R356L complex with fructose-6-phoaphate from Pichia Stipitis;1.54;CA;CALCIUM ION;Transketolase;4924;
5I5E;A;Crystal Structure of Transketolase mutants-H66/261C complex with xylulose-5-phoaphate from Pichia Stipitis;1.62;CA;CALCIUM ION;Transketolase;4924;
5I5L;A;The photosensory module (PAS-GAF-PHY) of the bacterial phytochrome Agp1 (AtBphP1) in the Pr form, chromophore modelled with an endocyclic double bond in pyrrole ring A;2.7;CA;CALCIUM ION;Bacteriophytochrome protein;1176649;
5I5M;A;Shewanella denitrificans nitrous oxide reductase, Ca2+-reconstituted form;1.37;CA;CALCIUM ION;Nitrous-oxide reductase;192073;
5I5M;B;Shewanella denitrificans nitrous oxide reductase, Ca2+-reconstituted form;1.37;CA;CALCIUM ION;Nitrous-oxide reductase;192073;
5I6W;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS A58D at cryogenic temperature;1.9;CA;CALCIUM ION;Thermonuclease;1280;
5I6Y;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS A90E at cryogenic temperature;1.9;CA;CALCIUM ION;Thermonuclease;1280;
5I77;A;Crystal structure of a beta-1,4-endoglucanase from Aspergillus niger;1.8;CA;CALCIUM ION;Endo-beta-1, 4-glucanase;5061;
5I78;A;Crystal structure of a beta-1,4-endoglucanase from Aspergillus niger;1.58;CA;CALCIUM ION;Endo-beta-1, 4-glucanase;5061;
5I79;B;Crystal structure of a beta-1,4-endoglucanase mutant from Aspergillus niger in complex with sugar;2.35;CA;CALCIUM ION;Endo-beta-1, 4-glucanase;5061;
5I89;A;Crystal structure of the bromodomain of human CREBBP bound to the benzodiazepinone G02857790;1.07;CA;CALCIUM ION;CREB-binding protein;9606;
5I8D;A;Crystal Structure of Mouse Cadherin-23 EC19-21 S2064P;2.69;CA;CALCIUM ION;Cadherin-23;10090;
5I8M;A;Bicyclic antimibrocial peptides;2.13;CA;CALCIUM ION;Fucose-binding lectin;287;
5I8M;B;Bicyclic antimibrocial peptides;2.13;CA;CALCIUM ION;Fucose-binding lectin;287;
5I8M;C;Bicyclic antimibrocial peptides;2.13;CA;CALCIUM ION;Fucose-binding lectin;287;
5I8M;D;Bicyclic antimibrocial peptides;2.13;CA;CALCIUM ION;Fucose-binding lectin;287;
5I8X;A;Bicyclic antimibrocial peptides;1.89;CA;CALCIUM ION;Fucose-binding lectin;287;
5I8X;B;Bicyclic antimibrocial peptides;1.89;CA;CALCIUM ION;Fucose-binding lectin;287;
5I8X;C;Bicyclic antimibrocial peptides;1.89;CA;CALCIUM ION;Fucose-binding lectin;287;
5I8X;D;Bicyclic antimibrocial peptides;1.89;CA;CALCIUM ION;Fucose-binding lectin;287;
5I95;A;Crystal Structure of Human Mitochondrial Isocitrate Dehydrogenase R140Q Mutant Homodimer bound to NADPH and alpha-Ketoglutaric acid;1.54;CA;CALCIUM ION;Isocitrate dehydrogenase [NADP], mitochondrial;9606;
5I96;A;Crystal Structure of Human Mitochondrial Isocitrate Dehydrogenase (IDH2) R140Q Mutant Homodimer in Complex with AG-221 (Enasidenib) Inhibitor.;1.55;CA;CALCIUM ION;Isocitrate dehydrogenase [NADP], mitochondrial;9606;
5I9O;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS L36K L103K at cryogenic temperature;1.95;CA;CALCIUM ION;Thermonuclease;1280;
5I9O;B;Crystal structure of Staphylococcal nuclease variant Delta+PHS L36K L103K at cryogenic temperature;1.95;CA;CALCIUM ION;Thermonuclease;1280;
5I9P;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS T62H at cryogenic temperature;1.85;CA;CALCIUM ION;Thermonuclease;1280;
5IBQ;A;Crystal structure of an ABC solute binding protein from Rhizobium etli CFN 42 (RHE_PF00037,TARGET EFI-511357) in complex with alpha-D-apiose;1.2;CA;CALCIUM ION;Probable ribose ABC transporter, substrate-binding protein;29449;
5IED;B;Murine endoplasmic reticulum alpha-glucosidase II with castanospermine;1.81;CA;CALCIUM ION;Glucosidase 2 subunit beta;10090;
5IEE;B;Murine endoplasmic reticulum alpha-glucosidase II with 1-deoxynojirimycin;1.92;CA;CALCIUM ION;Glucosidase 2 subunit beta;10090;
5IEF;B;Murine endoplasmic reticulum alpha-glucosidase II with N-butyl-1-deoxynojirimycin;2.38;CA;CALCIUM ION;Glucosidase 2 subunit beta;10090;
5IEG;B;Murine endoplasmic reticulum alpha-glucosidase II with N-9'-methoxynonyl-1-deoxynojirimycin;1.82;CA;CALCIUM ION;Glucosidase 2 subunit beta;10090;
5IGB;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS L36D/V66H at cryogenic temperature;1.8;CA;CALCIUM ION;Thermonuclease;1280;
5IGC;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS V23E/V66H at cryogenic temperature;1.8;CA;CALCIUM ION;Thermonuclease;1280;
5IGD;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS T62H/I92E at cryogenic temperature;1.8;CA;CALCIUM ION;Thermonuclease;1280;
5IGE;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS T62H/V99D at cryogenic temperature;1.8;CA;CALCIUM ION;Thermonuclease;1280;
5IGF;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS T62H/V66D at cryogenic temperature;1.7;CA;CALCIUM ION;Thermonuclease;1280;
5IGG;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS V66H/I72E at cryogenic temperature;1.7;CA;CALCIUM ION;Thermonuclease;1280;
5IGV;A;Macrolide 2'-phosphotransferase type II - complex with GDP and azithromycin;1.55;CA;CALCIUM ION;Macrolide 2'-phosphotransferase II;562;
5IGY;A;Macrolide 2'-phosphotransferase type II - complex with GDP and erythromycin;1.45;CA;CALCIUM ION;Macrolide 2'-phosphotransferase II;562;
5IH1;A;Macrolide 2'-phosphotransferase type II - complex with GDP and phosphorylated josamycin;1.31;CA;CALCIUM ION;Macrolide 2'-phosphotransferase II;562;
5IHD;A;Calcium(II) and copper(II) bound to the Z-DNA form of d(CGCGCG), complexed by L-lactate and succinate;1.57;CA;CALCIUM ION;DNA (5'-D(*CP*GP*CP*GP*CP*G)-3');32630;
5IHD;C;Calcium(II) and copper(II) bound to the Z-DNA form of d(CGCGCG), complexed by L-lactate and succinate;1.57;CA;CALCIUM ION;DNA (5'-D(*CP*GP*CP*GP*CP*G)-3');32630;
5IHE;A;D-family DNA polymerase - DP1 subunit (3'-5' proof-reading exonuclease);2.5;CA;CALCIUM ION;DNA polymerase II small subunit;29292;
5IHE;B;D-family DNA polymerase - DP1 subunit (3'-5' proof-reading exonuclease);2.5;CA;CALCIUM ION;DNA polymerase II small subunit;29292;
5IHJ;A;Fusion of Maltose-binding Protein and PilA from Acinetobacter baumannii BIDMC57;2.2;CA;CALCIUM ION;Maltose-binding periplasmic protein,Fimbrial protein;5,621,310,734;
5IIF;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS T62D at cryogenic temperature;1.85;CA;CALCIUM ION;Thermonuclease;1280;
5IIY;A;SrpA adhesin in complex with the Neu5Ac-galactoside disaccharide;1.89;CA;CALCIUM ION;Platelet-binding glycoprotein;1305;
5IIY;B;SrpA adhesin in complex with the Neu5Ac-galactoside disaccharide;1.89;CA;CALCIUM ION;Platelet-binding glycoprotein;1305;
5IJ1;A;SrpA adhesin in complex with sialyllactose;1.8;CA;CALCIUM ION;Platelet-binding glycoprotein;1305;
5IJ1;B;SrpA adhesin in complex with sialyllactose;1.8;CA;CALCIUM ION;Platelet-binding glycoprotein;1305;
5IJ2;A;SrpA adhesin in complex with sialyllactosamine;1.68;CA;CALCIUM ION;Platelet-binding glycoprotein;1305;
5IJ2;B;SrpA adhesin in complex with sialyllactosamine;1.68;CA;CALCIUM ION;Platelet-binding glycoprotein;1305;
5IJ3;A;SrpA adhesin in complex with sialyl T antigen;1.7;CA;CALCIUM ION;Platelet-binding glycoprotein;1305;
5IJ3;B;SrpA adhesin in complex with sialyl T antigen;1.7;CA;CALCIUM ION;Platelet-binding glycoprotein;1305;
5IJQ;A;Crystal structure of autotaxin (ENPP2) re-refined;2.05;CA;CALCIUM ION;Ectonucleotide pyrophosphatase/phosphodiesterase family member 2;10116;
5IJS;A;Crystal structure of autotaxin with orthovanadate bound as a trigonal bipyramidal intermediate analog;2.2;CA;CALCIUM ION;Ectonucleotide pyrophosphatase/phosphodiesterase family member 2;10116;
5IJU;B;Structure of an AA10 Lytic Polysaccharide Monooxygenase from Bacillus amyloliquefaciens with Cu(II) bound;1.7;CA;CALCIUM ION;BaAA10 Lytic Polysaccharide Monooxygenase;1390;
5IK4;A;Laminin A2LG45 C-form, Apo.;1.27;CA;CALCIUM ION;Laminin subunit alpha-2;10090;
5IK5;A;Laminin A2LG45 C-form, G6/7 bound.;1.39;CA;CALCIUM ION;Laminin subunit alpha-2;10090;
5IK7;A;Laminin A2LG45 I-form, Apo.;2;CA;CALCIUM ION;Laminin subunit alpha-2;10090;
5IK7;B;Laminin A2LG45 I-form, Apo.;2;CA;CALCIUM ION;Laminin subunit alpha-2;10090;
5IK8;A;Laminin A2LG45 I-form, G6/7 bound.;2;CA;CALCIUM ION;Laminin subunit alpha-2;10090;
5IK8;B;Laminin A2LG45 I-form, G6/7 bound.;2;CA;CALCIUM ION;Laminin subunit alpha-2;10090;
5IKU;A;Crystal structure of the Clostridium histolyticum ColG tandem collagen-binding domain s3as3b in the presence of calcium at 1.9 Angstrom resolution;1.9;CA;CALCIUM ION;Collagenase;1498;
5IL8;A;Tobacco 5-epi-aristolochene synthase with MOPSO buffer molecule and Ca2+ ions;2.3;CA;CALCIUM ION;5-epi-aristolochene synthase;4097;
5ILH;A;Tobacco 5-epi-aristolochene synthase with CAPSO buffer molecule and Ca2+ ions;2.1;CA;CALCIUM ION;5-epi-aristolochene synthase;4097;
5INH;A;Crystal structure of Autotaxin/ENPP2 with a covalent fragment;1.84;CA;CALCIUM ION;Ectonucleotide pyrophosphatase/phosphodiesterase family member 2;10090;
5INQ;A;Mouse Tdp2 reaction product (5'-phosphorylated DNA)-Ca2+ complex;1.85;CA;CALCIUM ION;Tyrosyl-DNA phosphodiesterase 2;10090;
5INQ;B;Mouse Tdp2 reaction product (5'-phosphorylated DNA)-Ca2+ complex;1.85;CA;CALCIUM ION;Tyrosyl-DNA phosphodiesterase 2;10090;
5IOC;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS V66H/V99D at cryogenic temperature;1.9;CA;CALCIUM ION;Thermonuclease;1280;
5IOD;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS V66H/V99E at cryogenic temperature;1.6;CA;CALCIUM ION;Thermonuclease;1280;
5IRB;A;Structural insight into host cell surface retention of a 1.5-MDa bacterial ice-binding adhesin;2;CA;CALCIUM ION;RTX-adhesin;178399;
5IRB;B;Structural insight into host cell surface retention of a 1.5-MDa bacterial ice-binding adhesin;2;CA;CALCIUM ION;RTX-adhesin;178399;
5IRY;A;Crystal structure of human Desmocollin-1 ectodomain;3.1;CA;CALCIUM ION;Desmocollin-1;9606;
5IRY;B;Crystal structure of human Desmocollin-1 ectodomain;3.1;CA;CALCIUM ION;Desmocollin-1;9606;
5ISR;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS L38E at cryogenic temperature;1.9;CA;CALCIUM ION;Thermonuclease;1280;
5ITI;A;A cynobacterial PP2C (tPphA) structure;1.95;CA;CALCIUM ION;Protein serin-threonin phosphatase;146786;
5IU9;A;Crystal Structure of Zebrafish Protocadherin-19 EC1-4;3.59;CA;CALCIUM ION;Protocadherin-19 isoform 1;7955;
5IU9;B;Crystal Structure of Zebrafish Protocadherin-19 EC1-4;3.59;CA;CALCIUM ION;Protocadherin-19 isoform 1;7955;
5IV3;A;Crystal structure of human soluble adenylyl cyclase in complex with alpha,beta-methyleneadenosine-5'-triphosphate and the allosteric inhibitor LRE1;1.86;CA;CALCIUM ION;Adenylate cyclase type 10;9606;
5IWG;A;HDAC2 WITH LIGAND BRD4884;1.66;CA;CALCIUM ION;Histone deacetylase 2;9606;
5IWG;B;HDAC2 WITH LIGAND BRD4884;1.66;CA;CALCIUM ION;Histone deacetylase 2;9606;
5IWG;C;HDAC2 WITH LIGAND BRD4884;1.66;CA;CALCIUM ION;Histone deacetylase 2;9606;
5IWK;A;Structure of Transient Receptor Potential (TRP) channel TRPV6;3.25;CA;CALCIUM ION;Transient receptor potential cation channel subfamily V member 6;10116;
5IWP;A;Structure of Transient Receptor Potential (TRP) channel TRPV6 in the presence of calcium;3.65;CA;CALCIUM ION;Transient receptor potential cation channel subfamily V member 6;10116;
5IWU;A;Macrolide 2'-phosphotransferase type II complexed with erythromycin;1.3;CA;CALCIUM ION;Macrolide 2'-phosphotransferase II;562;
5IX0;A;HDAC2 WITH LIGAND BRD7232;1.72;CA;CALCIUM ION;Histone deacetylase 2;9606;
5IX0;B;HDAC2 WITH LIGAND BRD7232;1.72;CA;CALCIUM ION;Histone deacetylase 2;9606;
5IX0;C;HDAC2 WITH LIGAND BRD7232;1.72;CA;CALCIUM ION;Histone deacetylase 2;9606;
5IYZ;A;Tubulin-MMAE complex;1.8;CA;CALCIUM ION;Tubulin alpha-1B chain;9913;
5IYZ;C;Tubulin-MMAE complex;1.8;CA;CALCIUM ION;Tubulin alpha-1B chain;9913;
5J03;B;Crystal Structure of a chimeric Kv7.2 - Kv7.3 proximal C-terminal Domain in Complex with Calmodulin;2;CA;CALCIUM ION;Calmodulin;9606;
5J04;A;Crystal structure of Enolase from Synechococcus elongatus, complex with phosphoenolpyruvate;2.3;CA;CALCIUM ION;Enolase;32046;
5J04;B;Crystal structure of Enolase from Synechococcus elongatus, complex with phosphoenolpyruvate;2.3;CA;CALCIUM ION;Enolase;32046;
5J16;A;Crystal structure of Inositol monophosphate bound SaIMPase-II;2.4;CA;CALCIUM ION;Inositol monophosphatase family protein;1280;
5J16;B;Crystal structure of Inositol monophosphate bound SaIMPase-II;2.4;CA;CALCIUM ION;Inositol monophosphatase family protein;1280;
5J16;C;Crystal structure of Inositol monophosphate bound SaIMPase-II;2.4;CA;CALCIUM ION;Inositol monophosphatase family protein;1280;
5J16;D;Crystal structure of Inositol monophosphate bound SaIMPase-II;2.4;CA;CALCIUM ION;Inositol monophosphatase family protein;1280;
5J1Z;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS A90D at cryogenic temperature;1.73;CA;CALCIUM ION;Thermonuclease;1280;
5J22;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS L103D at cryogenic temperature;1.9;CA;CALCIUM ION;Thermonuclease;1280;
5J2T;A;Tubulin-vinblastine complex;2.2;CA;CALCIUM ION;Tubulin alpha-1B chain;9913;
5J2U;A;Tubulin-MMAF complex;2.5;CA;CALCIUM ION;Tubulin alpha-1B chain;9913;
5J2Z;A;PRV UL37 N-terminal half (R2 mutant);2.5;CA;CALCIUM ION;UL37;10345;
5J3X;A;Structure of c-CBL Y371F;2.82;CA;CALCIUM ION;E3 ubiquitin-protein ligase CBL;9606;
5J3X;B;Structure of c-CBL Y371F;2.82;CA;CALCIUM ION;E3 ubiquitin-protein ligase CBL;9606;
5J3X;C;Structure of c-CBL Y371F;2.82;CA;CALCIUM ION;E3 ubiquitin-protein ligase CBL;9606;
5J3X;D;Structure of c-CBL Y371F;2.82;CA;CALCIUM ION;E3 ubiquitin-protein ligase CBL;9606;
5J3X;E;Structure of c-CBL Y371F;2.82;CA;CALCIUM ION;E3 ubiquitin-protein ligase CBL;9606;
5J3X;F;Structure of c-CBL Y371F;2.82;CA;CALCIUM ION;E3 ubiquitin-protein ligase CBL;9606;
5J48;B;PKG I's Carboyl Terminal Cyclic Nucleotide Binding Domain (CNB-B) in a complex with 8-pCPT-cGMP;1.49;CA;CALCIUM ION;cGMP-dependent protein kinase 1;9606;
5J4H;A;Structure of humanised RadA-mutant humRadA22F in complex with indole-6-carboxylic acid;1.37;CA;CALCIUM ION;DNA repair and recombination protein RadA;2261;
5J4K;A;Structure of humanised RadA-mutant humRadA22F in complex with 1-Indane-6-carboxylic acid;1.35;CA;CALCIUM ION;DNA repair and recombination protein RadA;2261;
5J5J;A;Crystal structure of a chimera of human Desmocollin-2 EC1 and human Desmoglein-2 EC2-EC5;3.29;CA;CALCIUM ION;Desmocollin-2,Desmoglein-2;9606;
5J60;A;Structure of a thioredoxin reductase from Gloeobacter violaceus;1.9;CA;CALCIUM ION;Thioredoxin reductase;33072;
5J60;B;Structure of a thioredoxin reductase from Gloeobacter violaceus;1.9;CA;CALCIUM ION;Thioredoxin reductase;33072;
5J6Y;A;Crystal structure of PA14 domain of MpAFP Antifreeze protein;1.03;CA;CALCIUM ION;Antifreeze protein;178399;
5J72;A;Cwp6 from Clostridium difficile;1.7;CA;CALCIUM ION;Putative N-acetylmuramoyl-L-alanine amidase,autolysin cwp6;1496;
5J72;B;Cwp6 from Clostridium difficile;1.7;CA;CALCIUM ION;Putative N-acetylmuramoyl-L-alanine amidase,autolysin cwp6;1496;
5J7J;A;NMR Derived Structure of Ca2+ Calmodulin bound to Phosphorylated PSD-95;;CA;CALCIUM ION;Calmodulin;8355;
5J8H;A;Structure of calmodulin in a complex with a peptide derived from a calmodulin-dependent kinase;;CA;CALCIUM ION;Calmodulin;9606;
5J8T;A;NMR structure of Excalibur domain of CbpL;;CA;CALCIUM ION;Choline binding protein;1313;
5JAN;A;Exploitation of a Novel Binding Pocket in Human Lipoprotein-Associated Phospholipase A2 (Lp-PLA<sub>2</sub>) Discovered Through X-Ray Fragment Screening;2.12;CA;CALCIUM ION;Platelet-activating factor acetylhydrolase;9606;
5JAO;A;Exploitation of a Novel Binding Pocket in Human Lipoprotein-Associated Phospholipase A2 (Lp-PLA<sub>2</sub>) Discovered Through X-Ray Fragment Screening;2.06;CA;CALCIUM ION;Platelet-activating factor acetylhydrolase;9606;
5JAP;A;Exploitation of a Novel Binding Pocket in Human Lipoprotein-Associated Phospholipase A2 (Lp-PLA<sub>2</sub>) Discovered Through X-Ray Fragment Screening;2.46;CA;CALCIUM ION;Platelet-activating factor acetylhydrolase;9606;
5JAV;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS Y91D at cryogenic temperature;1.89;CA;CALCIUM ION;Thermonuclease;1280;
5JAX;A;PKG I's Carboyl Terminal Cyclic Nucleotide Binding Domain (CNB-B) in a complex with 8-Br-cGMP;1.49;CA;CALCIUM ION;cGMP-dependent protein kinase 1;9606;
5JB8;S;Crystal structure of factor IXa variant K98T in complex with EGR-chloromethylketone;1.45;CA;CALCIUM ION;Coagulation factor IX;9606;
5JB9;S;Crystal structure of factor IXa K98T variant in complex with PPACK;1.3;CA;CALCIUM ION;Coagulation factor IX;9606;
5JBA;S;Crystal structure of factor IXa variant V16I K98T Y177T I212V in complex with PPACK;1.4;CA;CALCIUM ION;Coagulation factor IX;9606;
5JBB;S;Crystal structure of factor IXa variant V16I K98T Y177T I213V in complex with EGR-chloromethylketone;1.56;CA;CALCIUM ION;Coagulation factor IX;9606;
5JBC;S;Crystal structure of factor IXa variant V16I K98T Y177T I213V in complex with PPACK;1.9;CA;CALCIUM ION;Coagulation factor IX;9606;
5JBD;A;4,6-alpha-glucanotransferase GTFB from Lactobacillus reuteri 121;1.8;CA;CALCIUM ION;Inactive glucansucrase;1598;
5JBD;B;4,6-alpha-glucanotransferase GTFB from Lactobacillus reuteri 121;1.8;CA;CALCIUM ION;Inactive glucansucrase;1598;
5JBE;A;4,6-alpha-glucanotransferase GTFB from Lactobacillus reuteri 121 complexed with an isomalto-maltopentasaccharide;2.1;CA;CALCIUM ION;Inactive glucansucrase;1598;
5JBE;B;4,6-alpha-glucanotransferase GTFB from Lactobacillus reuteri 121 complexed with an isomalto-maltopentasaccharide;2.1;CA;CALCIUM ION;Inactive glucansucrase;1598;
5JBF;A;4,6-alpha-glucanotransferase GTFB (D1015N mutant) from Lactobacillus reuteri 121 complexed with maltopentaose;2.19;CA;CALCIUM ION;Inactive glucansucrase;1598;
5JBF;B;4,6-alpha-glucanotransferase GTFB (D1015N mutant) from Lactobacillus reuteri 121 complexed with maltopentaose;2.19;CA;CALCIUM ION;Inactive glucansucrase;1598;
5JBT;A;Mesotrypsin in complex with cleaved amyloid precursor like protein 2 inhibitor (APLP2);1.4;CA;CALCIUM ION;PRSS3 protein;9606;
5JCB;A;Microtubule depolymerizing agent podophyllotoxin derivative YJTSF1;2.3;CA;CALCIUM ION;Tubulin alpha-1B chain;9823;
5JCB;C;Microtubule depolymerizing agent podophyllotoxin derivative YJTSF1;2.3;CA;CALCIUM ION;Tubulin alpha-1B chain;9823;
5JCW;A;Crystal Structure of hGSTP1-1 with Glutathione Adduct of Phenethyl Isothiocyanate;1.95;CA;CALCIUM ION;Glutathione S-transferase P;9606;
5JCW;B;Crystal Structure of hGSTP1-1 with Glutathione Adduct of Phenethyl Isothiocyanate;1.95;CA;CALCIUM ION;Glutathione S-transferase P;9606;
5JDF;A;Structural mechanisms of extracellular ion exchange and induced binding-site occlusion in the sodium-calcium exchanger NCX_Mj soaked with 2.5 mM Na+ and 1mM Ca2+;2.65;CA;CALCIUM ION;Uncharacterized membrane protein MJ0091;2190;
5JDG;A;Structural mechanisms of extracellular ion exchange and induced binding-site occlusion in the sodium-calcium exchanger NCX_Mj soaked with 2.5 mM Na+ and 0.1mM Ca2+;2.41;CA;CALCIUM ION;sodium-calcium exchanger NCX_Mj;2190;
5JDH;A;Structural mechanisms of extracellular ion exchange and induced binding-site occlusion in the sodium-calcium exchanger NCX_Mj soaked with 10 mM Na+ and 10mM Ca2+;2.2;CA;CALCIUM ION;Uncharacterized membrane protein MJ0091;2190;
5JDJ;A;Crystal structure of domain I10 from titin in space group P212121;1.74;CA;CALCIUM ION;Titin;9606;
5JDJ;B;Crystal structure of domain I10 from titin in space group P212121;1.74;CA;CALCIUM ION;Titin;9606;
5JDJ;E;Crystal structure of domain I10 from titin in space group P212121;1.74;CA;CALCIUM ION;Titin;9606;
5JDJ;I;Crystal structure of domain I10 from titin in space group P212121;1.74;CA;CALCIUM ION;Titin;9606;
5JDJ;L;Crystal structure of domain I10 from titin in space group P212121;1.74;CA;CALCIUM ION;Titin;9606;
5JEE;A;Apo-structure of humanised RadA-mutant humRadA26F;1.49;CA;CALCIUM ION;DNA repair and recombination protein RadA;2261;
5JFG;A;Structure of humanised RadA-mutant humRadA22F in complex with peptide FHTA;1.77;CA;CALCIUM ION;DNA repair and recombination protein RadA;2261;
5JH7;A;Tubulin-Eribulin complex;2.25;CA;CALCIUM ION;Tubulin alpha-1B chain;9913;
5JH7;B;Tubulin-Eribulin complex;2.25;CA;CALCIUM ION;Tubulin beta-2B chain;9913;
5JH7;C;Tubulin-Eribulin complex;2.25;CA;CALCIUM ION;Tubulin alpha-1B chain;9913;
5JH7;E;Tubulin-Eribulin complex;2.25;CA;CALCIUM ION;Stathmin-4;10116;
5JIX;A;PKG II's Carboxyl Terminal Cyclic Nucleotide Binding Domain (CNB-B) in a complex with 8-Br-cGMP;1.47;CA;CALCIUM ION;cGMP-dependent protein kinase 2;9606;
5JIZ;A;PKG II's Carboxyl Terminal Cyclic Nucleotide Binding Domain (CNB-B) in a complex with 8-pCPT-cGMP;1.5;CA;CALCIUM ION;cGMP-dependent protein kinase 2;9606;
5JJ4;A;Crystal Structure of a Variant Human Activation-induced Deoxycytidine Deaminase as an MBP fusion protein;2.81;CA;CALCIUM ION;Maltose-binding periplasmic protein,Single-stranded DNA cytosine deaminase;5,629,606;
5JJ4;B;Crystal Structure of a Variant Human Activation-induced Deoxycytidine Deaminase as an MBP fusion protein;2.81;CA;CALCIUM ION;Maltose-binding periplasmic protein,Single-stranded DNA cytosine deaminase;5,629,606;
5JJ4;C;Crystal Structure of a Variant Human Activation-induced Deoxycytidine Deaminase as an MBP fusion protein;2.81;CA;CALCIUM ION;Maltose-binding periplasmic protein,Single-stranded DNA cytosine deaminase;5,629,606;
5JMO;A;X-ray structure of furin in complex with the inhibitory antibody Nb14;2;CA;CALCIUM ION;Furin;9606;
5JMO;B;X-ray structure of furin in complex with the inhibitory antibody Nb14;2;CA;CALCIUM ION;Furin;9606;
5JMQ;A;Crystal structures of a Methyl transferase;1.79;CA;CALCIUM ION;Protein arginine N-methyltransferase 2;10090;
5JMS;A;Crystal structure of TgCDPK1 bound to CGP060476;2.3;CA;CALCIUM ION;Calmodulin-domain protein kinase 1;5811;
5JN2;A;Crystal structure of TgCDPK1 bound to NVPACU106;2.2;CA;CALCIUM ION;Calmodulin-domain protein kinase 1;5811;
5JN5;A;Crystal structure of the D263Y missense variant of human PGM1;1.75;CA;CALCIUM ION;Phosphoglucomutase-1;9606;
5JN5;B;Crystal structure of the D263Y missense variant of human PGM1;1.75;CA;CALCIUM ION;Phosphoglucomutase-1;9606;
5JOB;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS L25K/I92A at cryogenic temperature;1.45;CA;CALCIUM ION;Thermonuclease;1280;
5JOJ;A;Calcium-loaded EF-hand domain of L-plastin;;CA;CALCIUM ION;Plastin-2;9606;
5JOO;A;XFEL structure of influenza A M2 wild type TM domain at low pH in the lipidic cubic phase at room temperature;1.41;CA;CALCIUM ION;Matrix protein 2;11320;
5JOZ;A;Bacteroides ovatus Xyloglucan PUL GH43B;2.28;CA;CALCIUM ION;Non-reducing end alpha-L-arabinofuranosidase BoGH43B;28116;
5JOZ;B;Bacteroides ovatus Xyloglucan PUL GH43B;2.28;CA;CALCIUM ION;Non-reducing end alpha-L-arabinofuranosidase BoGH43B;28116;
5JPV;A;Efficient targeting of the asialoglycoprotein receptor by polyvalent display of a compact galactoseamine mimic;1.9;CA;CALCIUM ION;Asialoglycoprotein receptor 1;9606;
5JPV;B;Efficient targeting of the asialoglycoprotein receptor by polyvalent display of a compact galactoseamine mimic;1.9;CA;CALCIUM ION;Asialoglycoprotein receptor 1;9606;
5JQ1;A;Efficient targeting of the asialoglycoprotein receptor by polyvalent display of a compact galactosamine mimic;1.83;CA;CALCIUM ION;Asialoglycoprotein receptor 1;9606;
5JQ1;B;Efficient targeting of the asialoglycoprotein receptor by polyvalent display of a compact galactosamine mimic;1.83;CA;CALCIUM ION;Asialoglycoprotein receptor 1;9606;
5JQA;A;CaM:RM20 complex;1.8;CA;CALCIUM ION;Calmodulin;9606;
5JQG;A;An apo tubulin-RB-TTL complex structure used for side-by-side comparison;2.24;CA;CALCIUM ION;Tubulin alpha-1B chain;9823;
5JQG;B;An apo tubulin-RB-TTL complex structure used for side-by-side comparison;2.24;CA;CALCIUM ION;Tubulin beta chain;9823;
5JQG;C;An apo tubulin-RB-TTL complex structure used for side-by-side comparison;2.24;CA;CALCIUM ION;Tubulin alpha-1B chain;9823;
5JQP;B;Crystal structure of ER glucosidase II heterodimeric complex consisting of catalytic subunit and the binding domain of regulatory subunit;2.2;CA;CALCIUM ION;Glucosidase 2 subunit beta-like protein;209285;
5JR4;B;Crystal structure of FimH A27V/V163A from E. coli UTI89 bound to FimG N-terminal extension;2.6;CA;CALCIUM ION;FimG N-terminal extension;562;
5JRC;A;Crystal structure of NeC3PO in complex with ssRNA.;1.9;CA;CALCIUM ION;NEQ131;160232;
5JRC;B;Crystal structure of NeC3PO in complex with ssRNA.;1.9;CA;CALCIUM ION;NEQ131;160232;
5JRC;C;Crystal structure of NeC3PO in complex with ssRNA.;1.9;CA;CALCIUM ION;NEQ131;160232;
5JRC;D;Crystal structure of NeC3PO in complex with ssRNA.;1.9;CA;CALCIUM ION;NEQ131;160232;
5JRJ;A;Crystal Structure of Herbaspirillum seropedicae RecA;1.7;CA;CALCIUM ION;Protein RecA;964;
5JS3;E;Thermolysin in complex with JC114.;1.16;CA;CALCIUM ION;Thermolysin;1427;
5JSS;E;Thermolysin in complex with JC149.;1.19;CA;CALCIUM ION;Thermolysin;1427;
5JT9;E;Thermolysin in complex with JC106.;1.26;CA;CALCIUM ION;Thermolysin;1427;
5JTH;A;Crystal structure of E67A calmodulin - CaM:RM20 complex;1.84;CA;CALCIUM ION;Calmodulin;9606;
5JTJ;A;USP7CD-CTP in complex with Ubiquitin;3.32;CA;CALCIUM ION;Ubiquitin carboxyl-terminal hydrolase 7,Ubiquitin carboxyl-terminal hydrolase 7;9606;
5JUH;A;Crystal structure of C-terminal domain (RV) of MpAFP;1.35;CA;CALCIUM ION;Antifreeze protein;178399;
5JUM;A;Crystal Structure of Human DNA Polymerase Eta Inserting dCTP Opposite N-(2'-deoxyguanosin-8- yl)-3-aminobenzanthrone (C8-dG-ABA);2.6;CA;CALCIUM ION;DNA polymerase eta;9606;
5JV3;D;The neck-linker and alpha 7 helix of Homo sapiens Eg5 fused to EB1;2.01;CA;CALCIUM ION;Chimera protein of Kinesin-like protein KIF11 and Microtubule-associated protein RP/EB family member 1;9606;
5JVD;A;Tubulin-TUB092 complex;2.39;CA;CALCIUM ION;Tubulin alpha-1B chain;9913;
5JVD;B;Tubulin-TUB092 complex;2.39;CA;CALCIUM ION;Tubulin beta-2B chain;9913;
5JVD;C;Tubulin-TUB092 complex;2.39;CA;CALCIUM ION;Tubulin alpha-1B chain;9913;
5JVD;E;Tubulin-TUB092 complex;2.39;CA;CALCIUM ION;Stathmin-4;10116;
5JVI;E;Thermolysin in complex with JC148.;1.12;CA;CALCIUM ION;Thermolysin;1427;
5JWZ;A;Structure of a Putative Xyloglucanase from the Cellulolytic Bacteria Streptomyces sp. SirexAA-E;1.7;CA;CALCIUM ION;Cellulose-binding family II;862751;
5JWZ;B;Structure of a Putative Xyloglucanase from the Cellulolytic Bacteria Streptomyces sp. SirexAA-E;1.7;CA;CALCIUM ION;Cellulose-binding family II;862751;
5JX2;A;Crystal structure of MglB-2 (Tp0684) from Treponema pallidum;2.05;CA;CALCIUM ION;Glucose/galactose-binding lipoprotein;160;
5JX7;A;Cysteine mutant (C224A) structure of As (III) S-adenosyl methyltransferase;2.3;CA;CALCIUM ION;Arsenic methyltransferase;610260;
5JXG;A;Structure of the unliganded form of the proprotein convertase furin.;1.8;CA;CALCIUM ION;Furin;9606;
5JXH;A;Structure the proprotein convertase furin in complex with meta-guanidinomethyl-Phac-RVR-Amba at 2.0 Angstrom resolution.;2;CA;CALCIUM ION;Furin;9606;
5JXI;A;Structure of the unliganded form of the proprotein convertase furin in presence of EDTA.;2;CA;CALCIUM ION;Furin;9606;
5JXJ;A;Structure of the proprotein convertase furin complexed to meta-guanidinomethyl-Phac-RVR-Amba in presence of EDTA;2;CA;CALCIUM ION;Furin;9606;
5JXN;E;Thermolysin in complex with JC240.;1.38;CA;CALCIUM ION;Thermolysin;1427;
5JXP;A;Crystal structure of Porphyromonas endodontalis DPP11 in alternate conformation;2.5;CA;CALCIUM ION;Asp/Glu-specific dipeptidyl-peptidase;28124;
5JY7;A;Complex of Mycobacterium smegmatis trehalose synthase with maltokinase;3.6;CA;CALCIUM ION;Trehalose synthase/amylase TreS;1772;
5JY7;B;Complex of Mycobacterium smegmatis trehalose synthase with maltokinase;3.6;CA;CALCIUM ION;Trehalose synthase/amylase TreS;1772;
5JY7;C;Complex of Mycobacterium smegmatis trehalose synthase with maltokinase;3.6;CA;CALCIUM ION;Trehalose synthase/amylase TreS;1772;
5JY7;D;Complex of Mycobacterium smegmatis trehalose synthase with maltokinase;3.6;CA;CALCIUM ION;Trehalose synthase/amylase TreS;1772;
5JY7;E;Complex of Mycobacterium smegmatis trehalose synthase with maltokinase;3.6;CA;CALCIUM ION;Trehalose synthase/amylase TreS;1772;
5JY7;F;Complex of Mycobacterium smegmatis trehalose synthase with maltokinase;3.6;CA;CALCIUM ION;Trehalose synthase/amylase TreS;1772;
5JY7;G;Complex of Mycobacterium smegmatis trehalose synthase with maltokinase;3.6;CA;CALCIUM ION;Trehalose synthase/amylase TreS;1772;
5JY7;H;Complex of Mycobacterium smegmatis trehalose synthase with maltokinase;3.6;CA;CALCIUM ION;Trehalose synthase/amylase TreS;1772;
5JYI;A;Trypsin bound with succinic acid at 1.9A;1.91;CA;CALCIUM ION;Cationic trypsin;9913;
5JYM;A;Human P-cadherin EC12 with scFv TSP11 bound;2.45;CA;CALCIUM ION;Cadherin-3;9606;
5JYM;C;Human P-cadherin EC12 with scFv TSP11 bound;2.45;CA;CALCIUM ION;Cadherin-3;9606;
5JYY;A;Structure-based Tetravalent Zanamivir with Potent Inhibitory Activity against Drug-resistant Influenza Viruses;2.1;CA;CALCIUM ION;Neuraminidase;11320;
5K0H;A;Human factor Xa in complex with synthetic inhibitor benzylsulfonyl-dSer(Benzyl)-Gly-4-amidinobenzylamide;2.2;CA;CALCIUM ION;Coagulation factor X;9606;
5K21;A;Pyocyanin demethylase;1.8;CA;CALCIUM ION;Pyocyanin demethylase;1766;
5K21;B;Pyocyanin demethylase;1.8;CA;CALCIUM ION;Pyocyanin demethylase;1766;
5K21;C;Pyocyanin demethylase;1.8;CA;CALCIUM ION;Pyocyanin demethylase;1766;
5K31;A;Crystal structure of Human fibrillar procollagen type I C-propeptide Homo-trimer;2.2;CA;CALCIUM ION;Collagen alpha-1(I) chain;9606;
5K31;B;Crystal structure of Human fibrillar procollagen type I C-propeptide Homo-trimer;2.2;CA;CALCIUM ION;Collagen alpha-1(I) chain;9606;
5K31;C;Crystal structure of Human fibrillar procollagen type I C-propeptide Homo-trimer;2.2;CA;CALCIUM ION;Collagen alpha-1(I) chain;9606;
5K31;D;Crystal structure of Human fibrillar procollagen type I C-propeptide Homo-trimer;2.2;CA;CALCIUM ION;Collagen alpha-1(I) chain;9606;
5K31;E;Crystal structure of Human fibrillar procollagen type I C-propeptide Homo-trimer;2.2;CA;CALCIUM ION;Collagen alpha-1(I) chain;9606;
5K31;F;Crystal structure of Human fibrillar procollagen type I C-propeptide Homo-trimer;2.2;CA;CALCIUM ION;Collagen alpha-1(I) chain;9606;
5K39;B;THE TYPE II COHESIN DOCKERIN COMPLEX FROM CLOSTRIDIUM THERMOCELLUM;1.98;CA;CALCIUM ION;Dockerin module from a protein of unknown function;1515;
5K5S;A;Crystal structure of the active form of human calcium-sensing receptor extracellular domain;2.6;CA;CALCIUM ION;Extracellular calcium-sensing receptor;9606;
5K5S;B;Crystal structure of the active form of human calcium-sensing receptor extracellular domain;2.6;CA;CALCIUM ION;Extracellular calcium-sensing receptor;9606;
5K5T;A;Crystal structure of the inactive form of human calcium-sensing receptor extracellular domain;3.1;CA;CALCIUM ION;Extracellular calcium-sensing receptor;9606;
5K7R;A;MicroED structure of trypsin at 1.7 A resolution;1.7;CA;CALCIUM ION;Cationic trypsin;9913;
5K7S;A;MicroED structure of proteinase K at 1.6 A resolution;1.6;CA;CALCIUM ION;Proteinase K;37998;
5K7T;A;MicroED structure of thermolysin at 2.5 A resolution;2.5;CA;CALCIUM ION;Thermolysin;1427;
5K89;A;Crystal Structure of Human Calcium-Bound S100A1;2.25;CA;CALCIUM ION;Protein S100-A1;9606;
5K89;C;Crystal Structure of Human Calcium-Bound S100A1;2.25;CA;CALCIUM ION;Protein S100-A1;9606;
5K89;H;Crystal Structure of Human Calcium-Bound S100A1;2.25;CA;CALCIUM ION;Protein S100-A1;9606;
5K8D;A;Crystal structure of rFVIIIFc;4.19;CA;CALCIUM ION;Coagulation factor VIII;9606;
5K8G;A;Crystal structure of a putative peptide-binding domain of MpAFP;2;CA;CALCIUM ION;Antifreeze protein;178399;
5K8Q;A;Crystal Structure of Calcium-loaded Calmodulin in complex with STRA6 CaMBP2-site peptide.;1.74;CA;CALCIUM ION;Calmodulin;9606;
5K8R;A;Structure of human clustered protocadherin gamma B3 EC1-4;2.5;CA;CALCIUM ION;Protocadherin gamma-B3;9606;
5K8Y;A;Structure of the Mus musclus Langerin carbohydrate recognition domain;2.4;CA;CALCIUM ION;C-type lectin domain family 4 member K;10090;
5K8Y;B;Structure of the Mus musclus Langerin carbohydrate recognition domain;2.4;CA;CALCIUM ION;C-type lectin domain family 4 member K;10090;
5KC8;A;Crystal structure of the amino-terminal domain (ATD) of iGluR Delta-2 (GluD2);1.75;CA;CALCIUM ION;Glutamate receptor ionotropic, delta-2;9606;
5KCA;A;Crystal structure of the Cbln1 C1q domain trimer in complex with the amino-terminal domain (ATD) of iGluR Delta-2 (GluD2);3.1;CA;CALCIUM ION;Cerebellin-1,Cerebellin-1,Cerebellin-1,Glutamate receptor ionotropic, delta-2;9606;
5KDF;A;Inorganic pyrophosphatase from Mycobacterium tuberculosis in complex with inhibitor 6 and inorganic pyrophosphate;2.45;CA;CALCIUM ION;Inorganic pyrophosphatase;1773;
5KEE;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS L25K/I92F at cryogenic temperature;1.5;CA;CALCIUM ION;Thermonuclease;1280;
5KEG;A;Crystal structure of APOBEC3A in complex with a single-stranded DNA;2.2;CA;CALCIUM ION;DNA dC->dU-editing enzyme APOBEC-3A;9606;
5KEZ;A;Selective and potent inhibition of the glycosidase human amylase by the short and extremely compact peptide piHA from mRNA display;1.83;CA;CALCIUM ION;Pancreatic alpha-amylase;9606;
5KFA;A;Human DNA polymerase eta-DNA ternary complex: ground state at pH7.0 (K+ MES) with 1 Ca2+ ion;1.51;CA;CALCIUM ION;DNA polymerase eta;9606;
5KFB;A;Human DNA polymerase eta-DNA ternary complex: reaction with 1 mM Mn2+ for 90s;1.55;CA;CALCIUM ION;DNA polymerase eta;9606;
5KFC;A;Human DNA polymerase eta-DNA ternary complex: reaction with 1 mM Mn2+ for 180s;1.5;CA;CALCIUM ION;DNA polymerase eta;9606;
5KFD;A;Human DNA polymerase eta-DNA ternary complex: reaction with 1 mM Mn2+ for 300s;1.65;CA;CALCIUM ION;DNA polymerase eta;9606;
5KFE;A;Human DNA polymerase eta-DNA ternary complex: reaction with 1 mM Mn2+ for 600s;1.55;CA;CALCIUM ION;DNA polymerase eta;9606;
5KFG;A;Human DNA polymerase eta-DNA ternary complex: reaction with 10 mM Mn2+ for 30s;1.55;CA;CALCIUM ION;DNA polymerase eta;9606;
5KFH;A;Human DNA polymerase eta-DNA ternary complex: reaction with 10 mM Mn2+ for 90s;1.72;CA;CALCIUM ION;DNA polymerase eta;9606;
5KFI;A;Human DNA polymerase eta-DNA ternary complex: reaction with 10 mM Mn2+ for 120s;1.65;CA;CALCIUM ION;DNA polymerase eta;9606;
5KFJ;A;Human DNA polymerase eta-DNA ternary complex: reaction with 10 mM Mn2+ for 180s;1.7;CA;CALCIUM ION;DNA polymerase eta;9606;
5KFK;A;Human DNA polymerase eta-DNA ternary complex: reaction with 10 mM Mn2+ for 300s;1.7;CA;CALCIUM ION;DNA polymerase eta;9606;
5KFM;A;Human DNA polymerase eta-DNA ternary complex with Sp-dATP-alpha-S: ground state at pH7.0 (K+ MES) with 1 Ca2+ ion;1.6;CA;CALCIUM ION;DNA polymerase eta;9606;
5KFN;A;Human DNA polymerase eta-DNA ternary complex with Sp-dATP-alpha-S: reaction with 1 mM Mg2+ for 1800s;1.45;CA;CALCIUM ION;DNA polymerase eta;9606;
5KFO;A;Human DNA polymerase eta-DNA ternary complex with Sp-dATP-alpha-S: reaction with 1 mM Mn2+ for 1800s;1.52;CA;CALCIUM ION;DNA polymerase eta;9606;
5KFP;A;Human DNA polymerase eta-DNA ternary complex with Sp-dATP-alpha-S: reaction with 20 mM Mg2+ for 600s;1.7;CA;CALCIUM ION;DNA polymerase eta;9606;
5KFQ;A;Human DNA polymerase eta-DNA ternary complex with Sp-dATP-alpha-S: reaction with 10 mM Mn2+ for 600s;1.55;CA;CALCIUM ION;DNA polymerase eta;9606;
5KFS;A;Human DNA polymerase eta R61A-DNA ternary complex: ground state at pH7.0 (K+ MES) with 1 Ca2+ ion;1.46;CA;CALCIUM ION;DNA polymerase eta;9606;
5KFT;A;Human DNA polymerase eta R61A-DNA ternary complex: reaction with 1 mM Mg2+ for 40s;1.52;CA;CALCIUM ION;DNA polymerase eta;9606;
5KFU;A;Human DNA polymerase eta R61A-DNA ternary complex: reaction with 1 mM Mg2+ for 80s;1.55;CA;CALCIUM ION;DNA polymerase eta;9606;
5KFV;A;Human DNA polymerase eta R61A-DNA ternary complex: reaction with 1 mM Mg2+ for 140s;1.6;CA;CALCIUM ION;DNA polymerase eta;9606;
5KFW;A;Human DNA polymerase eta R61A-DNA ternary complex: reaction with 1 mM Mg2+ for 200s;1.62;CA;CALCIUM ION;DNA polymerase eta;9606;
5KFX;A;Human DNA polymerase eta R61A-DNA ternary complex: reaction with 1 mM Mg2+ for 300s;1.52;CA;CALCIUM ION;DNA polymerase eta;9606;
5KGU;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS N118D at cryogenic temperature;1.9;CA;CALCIUM ION;Thermonuclease;1280;
5KIA;A;Crystal structure of L-threonine 3-dehydrogenase from Burkholderia thailandensis;2.1;CA;CALCIUM ION;L-threonine 3-dehydrogenase;57975;
5KIQ;A;SrpA with sialyl LewisX;1.64;CA;CALCIUM ION;Platelet-binding glycoprotein;1305;
5KIQ;B;SrpA with sialyl LewisX;1.64;CA;CALCIUM ION;Platelet-binding glycoprotein;1305;
5KIS;A;YenB/RHS2 complex;2.4;CA;CALCIUM ION;YenB;935293;
5KIX;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS I92E at cryogenic temperature;1.75;CA;CALCIUM ION;Thermonuclease;1280;
5KJ4;A;Crystal Structure of Mouse Protocadherin-15 EC9-10;3.35;CA;CALCIUM ION;Protocadherin-15;10090;
5KJ4;B;Crystal Structure of Mouse Protocadherin-15 EC9-10;3.35;CA;CALCIUM ION;Protocadherin-15;10090;
5KJ4;C;Crystal Structure of Mouse Protocadherin-15 EC9-10;3.35;CA;CALCIUM ION;Protocadherin-15;10090;
5KJ4;D;Crystal Structure of Mouse Protocadherin-15 EC9-10;3.35;CA;CALCIUM ION;Protocadherin-15;10090;
5KJ7;A;Structure of the Ca2+-bound synaptotagmin-1 SNARE complex (long unit cell form) - from XFEL diffraction;3.5;CA;CALCIUM ION;Vesicle-associated membrane protein 3;10116;
5KJ7;C;Structure of the Ca2+-bound synaptotagmin-1 SNARE complex (long unit cell form) - from XFEL diffraction;3.5;CA;CALCIUM ION;Synaptosomal-associated protein 25;10116;
5KJ7;D;Structure of the Ca2+-bound synaptotagmin-1 SNARE complex (long unit cell form) - from XFEL diffraction;3.5;CA;CALCIUM ION;Synaptosomal-associated protein 25;10116;
5KJ7;E;Structure of the Ca2+-bound synaptotagmin-1 SNARE complex (long unit cell form) - from XFEL diffraction;3.5;CA;CALCIUM ION;Synaptotagmin-1;10116;
5KJ7;F;Structure of the Ca2+-bound synaptotagmin-1 SNARE complex (long unit cell form) - from XFEL diffraction;3.5;CA;CALCIUM ION;Synaptotagmin-1;10116;
5KJ7;G;Structure of the Ca2+-bound synaptotagmin-1 SNARE complex (long unit cell form) - from XFEL diffraction;3.5;CA;CALCIUM ION;Vesicle-associated membrane protein 3;10116;
5KJ7;K;Structure of the Ca2+-bound synaptotagmin-1 SNARE complex (long unit cell form) - from XFEL diffraction;3.5;CA;CALCIUM ION;Synaptotagmin-1;10116;
5KJ8;C;Structure of the Ca2+-bound synaptotagmin-1 SNARE complex (long unit cell form) - from synchrotron diffraction;4.1;CA;CALCIUM ION;Synaptosomal-associated protein 25;10116;
5KJ8;E;Structure of the Ca2+-bound synaptotagmin-1 SNARE complex (long unit cell form) - from synchrotron diffraction;4.1;CA;CALCIUM ION;Synaptotagmin-1;10116;
5KJ8;F;Structure of the Ca2+-bound synaptotagmin-1 SNARE complex (long unit cell form) - from synchrotron diffraction;4.1;CA;CALCIUM ION;Synaptotagmin-1;10116;
5KJ8;K;Structure of the Ca2+-bound synaptotagmin-1 SNARE complex (long unit cell form) - from synchrotron diffraction;4.1;CA;CALCIUM ION;Synaptotagmin-1;10116;
5KK7;A;Crystal structure of the class I human endoplasmic reticulum 1,2-alpha-mannosidase T688A mutant and Thio-disaccharide substrate analog complex;1.73;CA;CALCIUM ION;Endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase;9606;
5KK7;B;Crystal structure of the class I human endoplasmic reticulum 1,2-alpha-mannosidase T688A mutant and Thio-disaccharide substrate analog complex;1.73;CA;CALCIUM ION;Endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase;9606;
5KL4;A;Wilms Tumor Protein (WT1) ZnF2-4 Q369H in complex with formylated DNA;1.78;CA;CALCIUM ION;Wilms tumor protein;9606;
5KL4;D;Wilms Tumor Protein (WT1) ZnF2-4 Q369H in complex with formylated DNA;1.78;CA;CALCIUM ION;Wilms tumor protein;9606;
5KLB;A;Crystal structure of the CavAb voltage-gated calcium channel(wild-type, 2.7A);2.7;CA;CALCIUM ION;Ion transport protein;28197;
5KLB;B;Crystal structure of the CavAb voltage-gated calcium channel(wild-type, 2.7A);2.7;CA;CALCIUM ION;Ion transport protein;28197;
5KLB;D;Crystal structure of the CavAb voltage-gated calcium channel(wild-type, 2.7A);2.7;CA;CALCIUM ION;Ion transport protein;28197;
5KLG;A;Structure of CavAb(W195Y) in complex with Br-dihydropyridine derivative UK-59811;3.3;CA;CALCIUM ION;Ion transport protein;28197;
5KLG;D;Structure of CavAb(W195Y) in complex with Br-dihydropyridine derivative UK-59811;3.3;CA;CALCIUM ION;Ion transport protein;28197;
5KLS;C;Structure of CavAb in complex with Br-dihydropyridine derivative UK-59811;3.3;CA;CALCIUM ION;Ion transport protein;28197;
5KLS;D;Structure of CavAb in complex with Br-dihydropyridine derivative UK-59811;3.3;CA;CALCIUM ION;Ion transport protein;28197;
5KMD;C;Structure of CavAb in complex with amlodipine;3.2;CA;CALCIUM ION;Ion transport protein;28197;
5KMD;D;Structure of CavAb in complex with amlodipine;3.2;CA;CALCIUM ION;Ion transport protein;28197;
5KMF;C;Structure of CavAb in complex with nimodipine;3.2;CA;CALCIUM ION;Ion transport protein;28197;
5KMF;D;Structure of CavAb in complex with nimodipine;3.2;CA;CALCIUM ION;Ion transport protein;28197;
5KMH;A;Structure of CavAb in complex with Br-verapamil;3.2;CA;CALCIUM ION;Ion transport protein;28197;
5KMH;D;Structure of CavAb in complex with Br-verapamil;3.2;CA;CALCIUM ION;Ion transport protein;28197;
5KN0;A;Native bovine skeletal calsequestrin, low-Ca2+ form;2.73;CA;CALCIUM ION;Calsequestrin;9913;
5KN0;B;Native bovine skeletal calsequestrin, low-Ca2+ form;2.73;CA;CALCIUM ION;Calsequestrin;9913;
5KN0;C;Native bovine skeletal calsequestrin, low-Ca2+ form;2.73;CA;CALCIUM ION;Calsequestrin;9913;
5KN0;D;Native bovine skeletal calsequestrin, low-Ca2+ form;2.73;CA;CALCIUM ION;Calsequestrin;9913;
5KN1;A;Recombinant bovine skeletal calsequestrin, high-Ca2+ form;2.14;CA;CALCIUM ION;Calsequestrin;9913;
5KN1;B;Recombinant bovine skeletal calsequestrin, high-Ca2+ form;2.14;CA;CALCIUM ION;Calsequestrin;9913;
5KN1;C;Recombinant bovine skeletal calsequestrin, high-Ca2+ form;2.14;CA;CALCIUM ION;Calsequestrin;9913;
5KN2;A;Native bovine skeletal calsequestrin, high-Ca2+ form;2.6;CA;CALCIUM ION;Calsequestrin;9913;
5KN2;B;Native bovine skeletal calsequestrin, high-Ca2+ form;2.6;CA;CALCIUM ION;Calsequestrin;9913;
5KN2;C;Native bovine skeletal calsequestrin, high-Ca2+ form;2.6;CA;CALCIUM ION;Calsequestrin;9913;
5KN3;A;Recombinant bovine skeletal calsequestrin, low-Ca2+ form;1.85;CA;CALCIUM ION;Calsequestrin;9913;
5KN8;A;MutY N-terminal domain in complex with undamaged DNA;1.81;CA;CALCIUM ION;Adenine DNA glycosylase;1422;
5KN9;A;MutY N-terminal domain in complex with DNA containing an intrahelical oxoG:A base-pair;1.93;CA;CALCIUM ION;Adenine DNA glycosylase;1422;
5KN9;C;MutY N-terminal domain in complex with DNA containing an intrahelical oxoG:A base-pair;1.93;CA;CALCIUM ION;DNA (5'-D(*AP*TP*CP*CP*(8OG)P*GP*TP*GP*CP*T)-3');1422;
5KR5;A;Directed Evolution of Transaminases By Ancestral Reconstruction. Using Old Proteins for New Chemistries;2.1;CA;CALCIUM ION;4-aminobutyrate transaminase;286;
5KR5;B;Directed Evolution of Transaminases By Ancestral Reconstruction. Using Old Proteins for New Chemistries;2.1;CA;CALCIUM ION;4-aminobutyrate transaminase;286;
5KRU;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS T62E/V66K at cryogenic temperature;1.6;CA;CALCIUM ION;Thermonuclease;1280;
5KS9;A;Bel502-DQ8-glia-alpha1 complex;2.55;CA;CALCIUM ION;HLA class II histocompatibility antigen, DQ alpha 1 chain;9606;
5KS9;C;Bel502-DQ8-glia-alpha1 complex;2.55;CA;CALCIUM ION;HLA class II histocompatibility antigen, DQ alpha 1 chain;9606;
5KS9;E;Bel502-DQ8-glia-alpha1 complex;2.55;CA;CALCIUM ION;Bel502 TCR alpha TRAV20*01;9606;
5KS9;G;Bel502-DQ8-glia-alpha1 complex;2.55;CA;CALCIUM ION;Bel502 TCR alpha TRAV20*01;9606;
5KSA;A;Bel602-DQ8.5-glia-gamma1 complex;2;CA;CALCIUM ION;HLA class II histocompatibility antigen, DQ alpha 1 chain;9606;
5KTH;A;Structure of cow mincle complexed with brartemicin;2.21;CA;CALCIUM ION;mincle protein;9913;
5KTI;A;Structure of cow mincle complexed with KMJ1;1.8;CA;CALCIUM ION;mincle protein;9913;
5KTV;A;Mis-pairing of unnatural base Z-G DNA duplex at pH 8.5;2.35;CA;CALCIUM ION;DNA (5'-D(P*GP*CP*GP*AP*AP*TP*TP*(1W5)P*GP*CP*G)-3');32630;
5KTV;B;Mis-pairing of unnatural base Z-G DNA duplex at pH 8.5;2.35;CA;CALCIUM ION;DNA (5'-D(P*GP*CP*GP*AP*AP*TP*TP*(1W5)P*GP*CP*G)-3');32630;
5KTY;A;hMiro EF hand and cGTPase domains, GDP and Ca2+ bound state;2.52;CA;CALCIUM ION;Mitochondrial Rho GTPase 1;9606;
5KV8;A;Crystal structure of a hPIV haemagglutinin-neuraminidase-inhibitor complex;1.95;CA;CALCIUM ION;Hemagglutinin-neuraminidase;11216;
5KV8;B;Crystal structure of a hPIV haemagglutinin-neuraminidase-inhibitor complex;1.95;CA;CALCIUM ION;Hemagglutinin-neuraminidase;11216;
5KV9;B;Crystal structure of a hPIV haemagglutinin-neuraminidase-inhibitor complex;2;CA;CALCIUM ION;Hemagglutinin-neuraminidase;11216;
5KVA;A;Crystal Structure of sorghum caffeoyl-CoA O-methyltransferase (CCoAOMT);1.83;CA;CALCIUM ION;caffeoyl-CoA O-methyltransferase;4558;
5KVA;B;Crystal Structure of sorghum caffeoyl-CoA O-methyltransferase (CCoAOMT);1.83;CA;CALCIUM ION;caffeoyl-CoA O-methyltransferase;4558;
5KWS;A;Crystal Structure of Galactose Binding Protein from Yersinia pestis in the Complex with beta D Glucose;1.32;CA;CALCIUM ION;Galactose-binding protein;632;
5KX5;A;Crystal structure of tubulin-stathmin-TTL-Compound 11 complex;2.5;CA;CALCIUM ION;Tubulin alpha chain;9940;
5KX5;B;Crystal structure of tubulin-stathmin-TTL-Compound 11 complex;2.5;CA;CALCIUM ION;Tubulin beta chain;9940;
5KX5;C;Crystal structure of tubulin-stathmin-TTL-Compound 11 complex;2.5;CA;CALCIUM ION;Tubulin alpha chain;9940;
5KX5;E;Crystal structure of tubulin-stathmin-TTL-Compound 11 complex;2.5;CA;CALCIUM ION;Stathmin-4;10116;
5KXA;A;Selective Inhibition of Autotaxin is Effective in Mouse Models of Liver Fibrosis;2.59;CA;CALCIUM ION;Ectonucleotide pyrophosphatase/phosphodiesterase family member 2;9606;
5KXB;A;Wisteria floribunda lectin in complex with GalNAc;2.33;CA;CALCIUM ION;Wisteria floribunda agglutinin;3922;
5KXB;B;Wisteria floribunda lectin in complex with GalNAc;2.33;CA;CALCIUM ION;Wisteria floribunda agglutinin;3922;
5KXB;C;Wisteria floribunda lectin in complex with GalNAc;2.33;CA;CALCIUM ION;Wisteria floribunda agglutinin;3922;
5KXB;D;Wisteria floribunda lectin in complex with GalNAc;2.33;CA;CALCIUM ION;Wisteria floribunda agglutinin;3922;
5KXC;A;Wisteria floribunda lectin in complex with GalNAc(beta1-4)GlcNAc (LacdiNAc) at pH 8.5.;1.8;CA;CALCIUM ION;Wisteria floribunda agglutinin;3922;
5KXC;B;Wisteria floribunda lectin in complex with GalNAc(beta1-4)GlcNAc (LacdiNAc) at pH 8.5.;1.8;CA;CALCIUM ION;Wisteria floribunda agglutinin;3922;
5KXC;C;Wisteria floribunda lectin in complex with GalNAc(beta1-4)GlcNAc (LacdiNAc) at pH 8.5.;1.8;CA;CALCIUM ION;Wisteria floribunda agglutinin;3922;
5KXC;D;Wisteria floribunda lectin in complex with GalNAc(beta1-4)GlcNAc (LacdiNAc) at pH 8.5.;1.8;CA;CALCIUM ION;Wisteria floribunda agglutinin;3922;
5KXD;A;Wisteria floribunda lectin in complex with GalNAc(beta1-4)GlcNAc (LacdiNAc) at pH 6.5;1.95;CA;CALCIUM ION;Wisteria floribunda agglutinin;3922;
5KXD;B;Wisteria floribunda lectin in complex with GalNAc(beta1-4)GlcNAc (LacdiNAc) at pH 6.5;1.95;CA;CALCIUM ION;Wisteria floribunda agglutinin;3922;
5KXD;C;Wisteria floribunda lectin in complex with GalNAc(beta1-4)GlcNAc (LacdiNAc) at pH 6.5;1.95;CA;CALCIUM ION;Wisteria floribunda agglutinin;3922;
5KXD;D;Wisteria floribunda lectin in complex with GalNAc(beta1-4)GlcNAc (LacdiNAc) at pH 6.5;1.95;CA;CALCIUM ION;Wisteria floribunda agglutinin;3922;
5KXE;A;Wisteria floribunda lectin in complex with GalNAc(beta1-4)GlcNAc (LacdiNAc) at pH 4.2;2.09;CA;CALCIUM ION;Wisteria floribunda agglutinin;3922;
5KXE;B;Wisteria floribunda lectin in complex with GalNAc(beta1-4)GlcNAc (LacdiNAc) at pH 4.2;2.09;CA;CALCIUM ION;Wisteria floribunda agglutinin;3922;
5KXE;C;Wisteria floribunda lectin in complex with GalNAc(beta1-4)GlcNAc (LacdiNAc) at pH 4.2;2.09;CA;CALCIUM ION;Wisteria floribunda agglutinin;3922;
5KXE;D;Wisteria floribunda lectin in complex with GalNAc(beta1-4)GlcNAc (LacdiNAc) at pH 4.2;2.09;CA;CALCIUM ION;Wisteria floribunda agglutinin;3922;
5KXU;A;Structure Proteinase K determined by SACLA;1.2;CA;CALCIUM ION;Proteinase K;37998;
5KXV;A;Structure Proteinase K at 0.98 Angstroms;0.98;CA;CALCIUM ION;Proteinase K;37998;
5KYI;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS T62K/V66E pH 9 at cryogenic temperature;1.7;CA;CALCIUM ION;Thermonuclease;1280;
5KYL;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS T62K/V66E pH 7 at cryogenic temperature;1.85;CA;CALCIUM ION;Thermonuclease;1280;
5KZM;B;Crystal structure of Tryptophan synthase alpha-beta chain complex from Francisella tularensis;2.8;CA;CALCIUM ION;Tryptophan synthase beta chain;263;
5KZP;A;Structure of the HCV1-C1 Antibody-Antigen Complex;2.26;CA;CALCIUM ION;C1 Epitope;11103;
5KZP;C;Structure of the HCV1-C1 Antibody-Antigen Complex;2.26;CA;CALCIUM ION;C1 Epitope;11103;
5KZP;E;Structure of the HCV1-C1 Antibody-Antigen Complex;2.26;CA;CALCIUM ION;HCV1-C1 Antibody Fab Heavy Chain;9606;
5KZP;F;Structure of the HCV1-C1 Antibody-Antigen Complex;2.26;CA;CALCIUM ION;HCV1-C1 Antibody Fab Heavy Chain;9606;
5KZP;G;Structure of the HCV1-C1 Antibody-Antigen Complex;2.26;CA;CALCIUM ION;HCV1-C1 Antibody Fab Heavy Chain;9606;
5KZP;H;Structure of the HCV1-C1 Antibody-Antigen Complex;2.26;CA;CALCIUM ION;HCV1-C1 Antibody Fab Heavy Chain;9606;
5KZP;I;Structure of the HCV1-C1 Antibody-Antigen Complex;2.26;CA;CALCIUM ION;HCV1-C1 Antibody Fab Light Chain;9606;
5KZP;J;Structure of the HCV1-C1 Antibody-Antigen Complex;2.26;CA;CALCIUM ION;HCV1-C1 Antibody Fab Light Chain;9606;
5KZP;K;Structure of the HCV1-C1 Antibody-Antigen Complex;2.26;CA;CALCIUM ION;HCV1-C1 Antibody Fab Light Chain;9606;
5KZP;L;Structure of the HCV1-C1 Antibody-Antigen Complex;2.26;CA;CALCIUM ION;HCV1-C1 Antibody Fab Light Chain;9606;
5L0K;A;Crystal Structure of Autotaxin and Compound PF-8380;2.73;CA;CALCIUM ION;Ectonucleotide pyrophosphatase/phosphodiesterase family member 2;10116;
5L0K;B;Crystal Structure of Autotaxin and Compound PF-8380;2.73;CA;CALCIUM ION;Ectonucleotide pyrophosphatase/phosphodiesterase family member 2;10116;
5L0N;A;PKG I's Carboxyl Terminal Cyclic Nucleotide Binding Domain (CNB-B) in a complex with RP-cGMP;1.28;CA;CALCIUM ION;cGMP-dependent protein kinase 1;9606;
5L0R;B;human POGLUT1 in complex with Notch1 EGF12 and UDP;1.5;CA;CALCIUM ION;Neurogenic locus notch homolog protein 1;9606;
5L0S;B;human POGLUT1 in complex with Factor VII EGF1 and UDP;1.45;CA;CALCIUM ION;Coagulation factor VII;9606;
5L0T;A;human POGLUT1 in complex with EGF(+) and UDP;1.43;CA;CALCIUM ION;Protein O-glucosyltransferase 1;9606;
5L0T;B;human POGLUT1 in complex with EGF(+) and UDP;1.43;CA;CALCIUM ION;EGF(+);32630;
5L0U;B;human POGLUT1 in complex with EGF(+) and UDP-phosphono-glucose;1.8;CA;CALCIUM ION;EGF(+);32630;
5L0V;B;human POGLUT1 in complex with 2F-glucose modified EGF(+) and UDP;1.3;CA;CALCIUM ION;EGF(+);32630;
5L14;A;The crystal structure of neuraminidase from A/Shanghai/2/2013 (H7N9) influenza virus;1.9;CA;CALCIUM ION;Neuraminidase;11320;
5L15;A;The crystal structure of neuraminidase in complex with oseltamivir from A/Shanghai/2/2013 (H7N9) influenza virus;2.4;CA;CALCIUM ION;Neuraminidase;11320;
5L17;A;The crystal structure of neuraminidase in complex with zanamivir from A/Shanghai/2/2013 (H7N9) influenza virus;2.4;CA;CALCIUM ION;Neuraminidase;11320;
5L18;A;The crystal structure of neuraminidase in complex with sialic acid from A/Shanghai/2/2013 (H7N9) influenza virus;1.8;CA;CALCIUM ION;Neuraminidase;11320;
5L1I;A;Crystal Structure of Human DNA Polymerase Eta Inserting dCTP Opposite O6-Methyl-2'-deoxyguanosine;2.78;CA;CALCIUM ION;DNA polymerase eta;9606;
5L2X;A;Crystal structure of human PrimPol ternary complex;2.2;CA;CALCIUM ION;DNA-directed primase/polymerase protein;9606;
5L2X;B;Crystal structure of human PrimPol ternary complex;2.2;CA;CALCIUM ION;DNA-directed primase/polymerase protein;9606;
5L2Y;H;Factor VIIa in complex with the inhibitor 1-[(2R,15R)-2-[(1-amino-4-fluoroisoquinolin-6-yl)amino]-4,15,20-trimethyl-3,12-dioxo-13-oxa-4,11-diazatricyclo[14.2.2.1~6,10~]henicosa-1(18),6,8,10(21),16,19-hexaen-7-yl] cyclobutane-1-carboxylic acid;1.82;CA;CALCIUM ION;Coagulation factor VII (Heavy Chain);9606;
5L2Z;H;Factor VIIa in complex with the inhibitor 1-[(2R,15R)-2-[(1-amino-4-fluoroisoquinolin-6-yl)amino]-4,15,17-trimethyl-3,12-dioxo-13-oxa-4,11-diazatricyclo[14.2.2.1~6,10~]henicosa-1(18),6(21),7,9,16,19-hexaen-7-yl]cyclohexane-1-carboxylic acid;1.79;CA;CALCIUM ION;Coagulation factor VII (Heavy Chain);9606;
5L30;H;Factor VIIa in complex with the inhibitor (2R,15R)-2-[(1-aminoisoquinolin-6-yl)amino]-4,15,17-trimethyl-7-[1-(1H-tetrazol-5-yl)cyclopropyl]-13-oxa-4,11-diazatricyclo[14.2.2.1~6,10~]henicosa-1(18),6(21),7,9,16,19-hexaene-3,12-dione;1.73;CA;CALCIUM ION;Coagulation factor VII (Heavy Chain);9606;
5L3U;E;Thermolysin in complex with JC149 (MPD cryo protectant);1.23;CA;CALCIUM ION;Thermolysin;1427;
5L41;E;Thermolysin in complex with JC148 (MPD cryo protectant);1.25;CA;CALCIUM ION;Thermolysin;1427;
5L73;A;MAM domain of human neuropilin-1;2.24;CA;CALCIUM ION;Neuropilin-1;9606;
5L73;B;MAM domain of human neuropilin-1;2.24;CA;CALCIUM ION;Neuropilin-1;9606;
5L79;A;Crystal structure of MMP12 in complex with RXP470.1 conjugated with fluorophore Cy5,5 in space group P21212.;2.07;CA;CALCIUM ION;Macrophage metalloelastase;9606;
5L7F;A;Crystal structure of MMP12 mutant K421A in complex with RXP470.1 conjugated with fluorophore Cy5,5 in space group P21.;1.8;CA;CALCIUM ION;Macrophage metalloelastase;9606;
5L7F;B;Crystal structure of MMP12 mutant K421A in complex with RXP470.1 conjugated with fluorophore Cy5,5 in space group P21.;1.8;CA;CALCIUM ION;Macrophage metalloelastase;9606;
5L7P;A;In silico-powered specific incorporation of photocaged Dopa at multiple protein sites;1.9;CA;CALCIUM ION;Tyrosine--tRNA ligase;2190;
5L89;C;Crystal structure of Rhodospirillum rubrum Rru_A0973 mutant E32A;2.59;CA;CALCIUM ION;Rru_A0973;1085;
5L89;G;Crystal structure of Rhodospirillum rubrum Rru_A0973 mutant E32A;2.59;CA;CALCIUM ION;Rru_A0973;1085;
5L89;L;Crystal structure of Rhodospirillum rubrum Rru_A0973 mutant E32A;2.59;CA;CALCIUM ION;Rru_A0973;1085;
5L89;N;Crystal structure of Rhodospirillum rubrum Rru_A0973 mutant E32A;2.59;CA;CALCIUM ION;Rru_A0973;1085;
5L89;P;Crystal structure of Rhodospirillum rubrum Rru_A0973 mutant E32A;2.59;CA;CALCIUM ION;Rru_A0973;1085;
5L89;Q;Crystal structure of Rhodospirillum rubrum Rru_A0973 mutant E32A;2.59;CA;CALCIUM ION;Rru_A0973;1085;
5L89;U;Crystal structure of Rhodospirillum rubrum Rru_A0973 mutant E32A;2.59;CA;CALCIUM ION;Rru_A0973;1085;
5L89;V;Crystal structure of Rhodospirillum rubrum Rru_A0973 mutant E32A;2.59;CA;CALCIUM ION;Rru_A0973;1085;
5L89;d;Crystal structure of Rhodospirillum rubrum Rru_A0973 mutant E32A;2.59;CA;CALCIUM ION;Rru_A0973;1085;
5L8B;A;Crystal structure of Rhodospirillum rubrum Rru_A0973 mutant E62A;2.21;CA;CALCIUM ION;Uncharacterized protein;1085;
5L8B;B;Crystal structure of Rhodospirillum rubrum Rru_A0973 mutant E62A;2.21;CA;CALCIUM ION;Uncharacterized protein;1085;
5L8B;C;Crystal structure of Rhodospirillum rubrum Rru_A0973 mutant E62A;2.21;CA;CALCIUM ION;Uncharacterized protein;1085;
5L8B;D;Crystal structure of Rhodospirillum rubrum Rru_A0973 mutant E62A;2.21;CA;CALCIUM ION;Uncharacterized protein;1085;
5L8B;F;Crystal structure of Rhodospirillum rubrum Rru_A0973 mutant E62A;2.21;CA;CALCIUM ION;Uncharacterized protein;1085;
5L8B;G;Crystal structure of Rhodospirillum rubrum Rru_A0973 mutant E62A;2.21;CA;CALCIUM ION;Uncharacterized protein;1085;
5L8B;H;Crystal structure of Rhodospirillum rubrum Rru_A0973 mutant E62A;2.21;CA;CALCIUM ION;Uncharacterized protein;1085;
5L8B;I;Crystal structure of Rhodospirillum rubrum Rru_A0973 mutant E62A;2.21;CA;CALCIUM ION;Uncharacterized protein;1085;
5L8B;K;Crystal structure of Rhodospirillum rubrum Rru_A0973 mutant E62A;2.21;CA;CALCIUM ION;Uncharacterized protein;1085;
5L8B;M;Crystal structure of Rhodospirillum rubrum Rru_A0973 mutant E62A;2.21;CA;CALCIUM ION;Uncharacterized protein;1085;
5L8B;N;Crystal structure of Rhodospirillum rubrum Rru_A0973 mutant E62A;2.21;CA;CALCIUM ION;Uncharacterized protein;1085;
5L8B;O;Crystal structure of Rhodospirillum rubrum Rru_A0973 mutant E62A;2.21;CA;CALCIUM ION;Uncharacterized protein;1085;
5L8B;P;Crystal structure of Rhodospirillum rubrum Rru_A0973 mutant E62A;2.21;CA;CALCIUM ION;Uncharacterized protein;1085;
5L8B;Q;Crystal structure of Rhodospirillum rubrum Rru_A0973 mutant E62A;2.21;CA;CALCIUM ION;Uncharacterized protein;1085;
5L8B;U;Crystal structure of Rhodospirillum rubrum Rru_A0973 mutant E62A;2.21;CA;CALCIUM ION;Uncharacterized protein;1085;
5L8B;V;Crystal structure of Rhodospirillum rubrum Rru_A0973 mutant E62A;2.21;CA;CALCIUM ION;Uncharacterized protein;1085;
5L8B;X;Crystal structure of Rhodospirillum rubrum Rru_A0973 mutant E62A;2.21;CA;CALCIUM ION;Uncharacterized protein;1085;
5L8B;Z;Crystal structure of Rhodospirillum rubrum Rru_A0973 mutant E62A;2.21;CA;CALCIUM ION;Uncharacterized protein;1085;
5L8B;a;Crystal structure of Rhodospirillum rubrum Rru_A0973 mutant E62A;2.21;CA;CALCIUM ION;Uncharacterized protein;1085;
5L8G;A;Crystal structure of Rhodospirillum rubrum Rru_A0973 mutant H65A;2.97;CA;CALCIUM ION;Uncharacterized protein;1085;
5L8G;B;Crystal structure of Rhodospirillum rubrum Rru_A0973 mutant H65A;2.97;CA;CALCIUM ION;Uncharacterized protein;1085;
5L8G;C;Crystal structure of Rhodospirillum rubrum Rru_A0973 mutant H65A;2.97;CA;CALCIUM ION;Uncharacterized protein;1085;
5L8G;D;Crystal structure of Rhodospirillum rubrum Rru_A0973 mutant H65A;2.97;CA;CALCIUM ION;Uncharacterized protein;1085;
5L8G;E;Crystal structure of Rhodospirillum rubrum Rru_A0973 mutant H65A;2.97;CA;CALCIUM ION;Uncharacterized protein;1085;
5L8G;F;Crystal structure of Rhodospirillum rubrum Rru_A0973 mutant H65A;2.97;CA;CALCIUM ION;Uncharacterized protein;1085;
5L8G;G;Crystal structure of Rhodospirillum rubrum Rru_A0973 mutant H65A;2.97;CA;CALCIUM ION;Uncharacterized protein;1085;
5L8G;H;Crystal structure of Rhodospirillum rubrum Rru_A0973 mutant H65A;2.97;CA;CALCIUM ION;Uncharacterized protein;1085;
5L8G;I;Crystal structure of Rhodospirillum rubrum Rru_A0973 mutant H65A;2.97;CA;CALCIUM ION;Uncharacterized protein;1085;
5L8G;J;Crystal structure of Rhodospirillum rubrum Rru_A0973 mutant H65A;2.97;CA;CALCIUM ION;Uncharacterized protein;1085;
5L8G;K;Crystal structure of Rhodospirillum rubrum Rru_A0973 mutant H65A;2.97;CA;CALCIUM ION;Uncharacterized protein;1085;
5L8G;L;Crystal structure of Rhodospirillum rubrum Rru_A0973 mutant H65A;2.97;CA;CALCIUM ION;Uncharacterized protein;1085;
5L8G;M;Crystal structure of Rhodospirillum rubrum Rru_A0973 mutant H65A;2.97;CA;CALCIUM ION;Uncharacterized protein;1085;
5L8G;N;Crystal structure of Rhodospirillum rubrum Rru_A0973 mutant H65A;2.97;CA;CALCIUM ION;Uncharacterized protein;1085;
5L8G;O;Crystal structure of Rhodospirillum rubrum Rru_A0973 mutant H65A;2.97;CA;CALCIUM ION;Uncharacterized protein;1085;
5L8G;P;Crystal structure of Rhodospirillum rubrum Rru_A0973 mutant H65A;2.97;CA;CALCIUM ION;Uncharacterized protein;1085;
5L8G;Q;Crystal structure of Rhodospirillum rubrum Rru_A0973 mutant H65A;2.97;CA;CALCIUM ION;Uncharacterized protein;1085;
5L8G;S;Crystal structure of Rhodospirillum rubrum Rru_A0973 mutant H65A;2.97;CA;CALCIUM ION;Uncharacterized protein;1085;
5L8G;T;Crystal structure of Rhodospirillum rubrum Rru_A0973 mutant H65A;2.97;CA;CALCIUM ION;Uncharacterized protein;1085;
5L8G;U;Crystal structure of Rhodospirillum rubrum Rru_A0973 mutant H65A;2.97;CA;CALCIUM ION;Uncharacterized protein;1085;
5L8G;V;Crystal structure of Rhodospirillum rubrum Rru_A0973 mutant H65A;2.97;CA;CALCIUM ION;Uncharacterized protein;1085;
5L8G;W;Crystal structure of Rhodospirillum rubrum Rru_A0973 mutant H65A;2.97;CA;CALCIUM ION;Uncharacterized protein;1085;
5L8G;X;Crystal structure of Rhodospirillum rubrum Rru_A0973 mutant H65A;2.97;CA;CALCIUM ION;Uncharacterized protein;1085;
5L8G;Z;Crystal structure of Rhodospirillum rubrum Rru_A0973 mutant H65A;2.97;CA;CALCIUM ION;Uncharacterized protein;1085;
5L8G;a;Crystal structure of Rhodospirillum rubrum Rru_A0973 mutant H65A;2.97;CA;CALCIUM ION;Uncharacterized protein;1085;
5L8G;b;Crystal structure of Rhodospirillum rubrum Rru_A0973 mutant H65A;2.97;CA;CALCIUM ION;Uncharacterized protein;1085;
5L8G;c;Crystal structure of Rhodospirillum rubrum Rru_A0973 mutant H65A;2.97;CA;CALCIUM ION;Uncharacterized protein;1085;
5L8G;d;Crystal structure of Rhodospirillum rubrum Rru_A0973 mutant H65A;2.97;CA;CALCIUM ION;Uncharacterized protein;1085;
5L8P;E;Thermolysin in complex with JC114 (PEG400 cryo protectant);1.29;CA;CALCIUM ION;Thermolysin;1427;
5L8R;3;The structure of plant photosystem I super-complex at 2.6 angstrom resolution.;2.6;CA;CALCIUM ION;Chlorophyll a-b binding protein 3, chloroplastic;3888;
5L8R;B;The structure of plant photosystem I super-complex at 2.6 angstrom resolution.;2.6;CA;CALCIUM ION;Photosystem I P700 chlorophyll a apoprotein A2;3888;
5L9G;A;Crystal Structure of the PBP MotA in complex with mannopine from A. tumefaciens B6;1.75;CA;CALCIUM ION;periplasmic binding protein;358;
5L9G;B;Crystal Structure of the PBP MotA in complex with mannopine from A. tumefaciens B6;1.75;CA;CALCIUM ION;periplasmic binding protein;358;
5L9I;A;Crystal structure of the periplasmic binding protein MotA in complex with DFG from A. tumefaciens B6;1.9;CA;CALCIUM ION;periplasmic binding protein;358;
5L9I;B;Crystal structure of the periplasmic binding protein MotA in complex with DFG from A. tumefaciens B6;1.9;CA;CALCIUM ION;periplasmic binding protein;358;
5L9L;A;Crystal structure of the PBP MotA from A. tumefaciens B6 in complex with glucopine;1.8;CA;CALCIUM ION;periplasmic binding protein;358;
5L9L;B;Crystal structure of the PBP MotA from A. tumefaciens B6 in complex with glucopine;1.8;CA;CALCIUM ION;periplasmic binding protein;358;
5L9O;A;Crystal structure of Agrobacterium tumefaciens C58 strain PBP SocA in complex with glucopine;1.84;CA;CALCIUM ION;Deoxyfructosyl-amino Acid Transporter Periplasmic Binding Protein;1176649;
5L9O;B;Crystal structure of Agrobacterium tumefaciens C58 strain PBP SocA in complex with glucopine;1.84;CA;CALCIUM ION;Deoxyfructosyl-amino Acid Transporter Periplasmic Binding Protein;1176649;
5L9X;A;Human DNA polymerase eta-DNA ternary complex: reaction with 10 mM Mn2+ for 60s;1.9;CA;CALCIUM ION;DNA polymerase eta;9606;
5LA0;A;The mechanism by which arabinoxylanases can recognise highly decorated xylans;1.65;CA;CALCIUM ION;Carbohydrate binding family 6;1515;
5LA1;A;The mechanism by which arabinoxylanases can recognise highly decorated xylans;1.9;CA;CALCIUM ION;Carbohydrate binding family 6;1515;
5LA2;A;The mechanism by which arabinoxylanases can recognise highly decorated xylans;1.65;CA;CALCIUM ION;Carbohydrate binding family 6;1515;
5LA2;B;The mechanism by which arabinoxylanases can recognise highly decorated xylans;1.65;CA;CALCIUM ION;Carbohydrate binding family 6;1515;
5LA6;A;Tubulin-pironetin complex;2.1;CA;CALCIUM ION;Tubulin alpha-1B chain;9913;
5LA6;B;Tubulin-pironetin complex;2.1;CA;CALCIUM ION;Tubulin beta-2B chain;9913;
5LA6;C;Tubulin-pironetin complex;2.1;CA;CALCIUM ION;Tubulin alpha-1B chain;9913;
5LAB;A;Crystal structure of the catalytic domain of human MMP12 complexed with the inhibitor NNGH;1.34;CA;CALCIUM ION;Macrophage metalloelastase;9606;
5LBI;A;Apo-structure of humanised RadA-mutant humRadA3;1.43;CA;CALCIUM ION;DNA repair and recombination protein RadA;2261;
5LDT;A;Crystal Structures of MOMP from Campylobacter jejuni;2.88;CA;CALCIUM ION;MOMP porin;197;
5LDT;B;Crystal Structures of MOMP from Campylobacter jejuni;2.88;CA;CALCIUM ION;MOMP porin;197;
5LDT;C;Crystal Structures of MOMP from Campylobacter jejuni;2.88;CA;CALCIUM ION;MOMP porin;197;
5LDV;A;Crystal Structures of MOMP from Campylobacter jejuni;2.1;CA;CALCIUM ION;MOMP porin;197;
5LF2;A;Crystal structure of laminin beta2 LE5-LF-LE6;1.85;CA;CALCIUM ION;Laminin subunit beta-2;10116;
5LF2;B;Crystal structure of laminin beta2 LE5-LF-LE6;1.85;CA;CALCIUM ION;Laminin subunit beta-2;10116;
5LFC;A;Crystal structure of Leuconostoc citreum NRRL B-1299 N-terminally truncated dextransucrase DSR-M;3.2;CA;CALCIUM ION;DsrV;33964;
5LFC;B;Crystal structure of Leuconostoc citreum NRRL B-1299 N-terminally truncated dextransucrase DSR-M;3.2;CA;CALCIUM ION;DsrV;33964;
5LGO;A;Trypsin inhibitors for the treatment of pancreatitis - cpd 15;1.12;CA;CALCIUM ION;Cationic trypsin;9913;
5LH4;A;Trypsin inhibitors for the treatment of pancreatitis - cpd 1;1.37;CA;CALCIUM ION;Cationic trypsin;9913;
5LH8;A;Trypsin inhibitors for the treatment of pancreatitis - cpd 8;1.54;CA;CALCIUM ION;Cationic trypsin;9913;
5LIA;A;Crystal structure of murine autotaxin in complex with a small molecule inhibitor;1.92;CA;CALCIUM ION;Ectonucleotide pyrophosphatase/phosphodiesterase family member 2;10090;
5LIF;E;Thermolysin in complex with inhibitor;1.31;CA;CALCIUM ION;Thermolysin;1427;
5LIP;A;PSEUDOMONAS LIPASE COMPLEXED WITH RC-(RP, SP)-1,2-DIOCTYLCARBAMOYLGLYCERO-3-O-OCTYLPHOSPHONATE;2.9;CA;CALCIUM ION;TRIACYL-GLYCEROL HYDROLASE;292;
5LJ4;A;Crystal structure of DNA duplex containing ZP base pair;2.17;CA;CALCIUM ION;ODN2;9606;
5LJ4;B;Crystal structure of DNA duplex containing ZP base pair;2.17;CA;CALCIUM ION;ODN2;9606;
5LJI;A;Streptococcus pneumonia TIGR4 flavodoxin: structural and biophysical characterization of a novel drug target;2.07;CA;CALCIUM ION;Flavodoxin;1313;
5LJI;C;Streptococcus pneumonia TIGR4 flavodoxin: structural and biophysical characterization of a novel drug target;2.07;CA;CALCIUM ION;Flavodoxin;1313;
5LK5;A;Crystal structure of the globular domain of human calreticulin mutant D71K;2.3;CA;CALCIUM ION;Calreticulin,Calreticulin;9606;
5LK5;B;Crystal structure of the globular domain of human calreticulin mutant D71K;2.3;CA;CALCIUM ION;Calreticulin,Calreticulin;9606;
5LK5;C;Crystal structure of the globular domain of human calreticulin mutant D71K;2.3;CA;CALCIUM ION;Calreticulin,Calreticulin;9606;
5LK5;D;Crystal structure of the globular domain of human calreticulin mutant D71K;2.3;CA;CALCIUM ION;Calreticulin,Calreticulin;9606;
5LK5;E;Crystal structure of the globular domain of human calreticulin mutant D71K;2.3;CA;CALCIUM ION;Calreticulin,Calreticulin;9606;
5LK5;F;Crystal structure of the globular domain of human calreticulin mutant D71K;2.3;CA;CALCIUM ION;Calreticulin,Calreticulin;9606;
5LK5;G;Crystal structure of the globular domain of human calreticulin mutant D71K;2.3;CA;CALCIUM ION;Calreticulin,Calreticulin;9606;
5LK5;H;Crystal structure of the globular domain of human calreticulin mutant D71K;2.3;CA;CALCIUM ION;Calreticulin,Calreticulin;9606;
5LK5;I;Crystal structure of the globular domain of human calreticulin mutant D71K;2.3;CA;CALCIUM ION;Calreticulin,Calreticulin;9606;
5LK5;J;Crystal structure of the globular domain of human calreticulin mutant D71K;2.3;CA;CALCIUM ION;Calreticulin,Calreticulin;9606;
5LO8;A;The C2B domain of Rabphilin 3A in complex with PI(4,5)P2;2.5;CA;CALCIUM ION;Rabphilin-3A;10116;
5LO8;B;The C2B domain of Rabphilin 3A in complex with PI(4,5)P2;2.5;CA;CALCIUM ION;Rabphilin-3A;10116;
5LOB;A;Structure of the Ca2+-bound Rabphilin3A C2B- SNAP25 complex (C2 space group);3.3;CA;CALCIUM ION;Rabphilin-3A;10116;
5LOB;B;Structure of the Ca2+-bound Rabphilin3A C2B- SNAP25 complex (C2 space group);3.3;CA;CALCIUM ION;Rabphilin-3A;10116;
5LOB;C;Structure of the Ca2+-bound Rabphilin3A C2B- SNAP25 complex (C2 space group);3.3;CA;CALCIUM ION;Rabphilin-3A;10116;
5LOV;A;DZ-2384 tubulin complex;2.4;CA;CALCIUM ION;Tubulin alpha-1B chain;9913;
5LOW;A;Structure of the Ca2+-bound Rabphilin 3A C2B domain SNAP25 complex (P21 space group);2.8;CA;CALCIUM ION;Rabphilin-3A;10116;
5LOW;B;Structure of the Ca2+-bound Rabphilin 3A C2B domain SNAP25 complex (P21 space group);2.8;CA;CALCIUM ION;Rabphilin-3A;10116;
5LOW;C;Structure of the Ca2+-bound Rabphilin 3A C2B domain SNAP25 complex (P21 space group);2.8;CA;CALCIUM ION;Rabphilin-3A;10116;
5LOW;H;Structure of the Ca2+-bound Rabphilin 3A C2B domain SNAP25 complex (P21 space group);2.8;CA;CALCIUM ION;Rabphilin-3A;10116;
5LOW;I;Structure of the Ca2+-bound Rabphilin 3A C2B domain SNAP25 complex (P21 space group);2.8;CA;CALCIUM ION;Rabphilin-3A;10116;
5LOW;J;Structure of the Ca2+-bound Rabphilin 3A C2B domain SNAP25 complex (P21 space group);2.8;CA;CALCIUM ION;Rabphilin-3A;10116;
5LP6;C;Crystal structure of Tubulin-Stathmin-TTL-Thiocolchicine Complex;2.9;CA;CALCIUM ION;Tubulin alpha-1B chain;9913;
5LPA;A;AadA E87Q in complex with ATP, calcium and dihydrostreptomycin;1.4;CA;CALCIUM ION;Streptomycin 3''-adenylyltransferase;28901;
5LPA;B;AadA E87Q in complex with ATP, calcium and dihydrostreptomycin;1.4;CA;CALCIUM ION;Streptomycin 3''-adenylyltransferase;28901;
5LPU;A;Crystal structure of Annexin A2 complexed with S100A4;2.1;CA;CALCIUM ION;Annexin A2;9606;
5LPU;B;Crystal structure of Annexin A2 complexed with S100A4;2.1;CA;CALCIUM ION;Annexin A2;9606;
5LPU;C;Crystal structure of Annexin A2 complexed with S100A4;2.1;CA;CALCIUM ION;Protein S100-A4;9606;
5LPU;D;Crystal structure of Annexin A2 complexed with S100A4;2.1;CA;CALCIUM ION;Protein S100-A4;9606;
5LPX;A;Crystal structure of PKC phosphorylation-mimicking mutant (S26E) Annexin A2;1.9;CA;CALCIUM ION;Annexin A2;9606;
5LQ0;A;Crystal structure of Tyr24 phosphorylated Annexin A2 at 2.9 A resolution;2.9;CA;CALCIUM ION;Annexin A2;9606;
5LQ0;B;Crystal structure of Tyr24 phosphorylated Annexin A2 at 2.9 A resolution;2.9;CA;CALCIUM ION;Annexin A2;9606;
5LQ2;A;Crystal structure of Tyr24 phosphorylated Annexin A2 at 3.4 A resolution;3.4;CA;CALCIUM ION;Annexin A2;9606;
5LQ2;B;Crystal structure of Tyr24 phosphorylated Annexin A2 at 3.4 A resolution;3.4;CA;CALCIUM ION;Annexin A2;9606;
5LQQ;A;Structure of Autotaxin (ENPP2) with LM350;2.4;CA;CALCIUM ION;Ectonucleotide pyrophosphatase/phosphodiesterase family member 2;10116;
5LQT;A;RNA duplex has central consecutive GA pairs flanked by G-C basepairs;1.5;CA;CALCIUM ION;RNA (5'-R(*GP*(CBV)P*CP*GP*GP*(6MZ)P*CP*GP*GP*C)-3');9606;
5LS4;A;Mopeia virus exonuclease domain complexed with Calcium;1.47;CA;CALCIUM ION;Nucleoprotein;11629;
5LSF;A;Sacbrood honeybee virus;2.1;CA;CALCIUM ION;VP1;89463;
5LSF;B;Sacbrood honeybee virus;2.1;CA;CALCIUM ION;VP2;89463;
5LU3;A;The Structure of Spirochaeta thermophila CBM64;1.5;CA;CALCIUM ION;Glycoside hydrolase family 12;154;
5LUH;A;AadA E87Q in complex with ATP, calcium and streptomycin;1.73;CA;CALCIUM ION;Streptomycin 3''-adenylyltransferase;28901;
5LUH;B;AadA E87Q in complex with ATP, calcium and streptomycin;1.73;CA;CALCIUM ION;Streptomycin 3''-adenylyltransferase;28901;
5LUL;A;Structure of a triple variant of cutinase 2 from Thermobifida cellulosilytica;1.9;CA;CALCIUM ION;Cutinase 2;144786;
5LVD;E;Thermolysin in complex with inhibitor (JC67);1.25;CA;CALCIUM ION;Thermolysin;1427;
5LW3;A;Azotobacter vinelandii Mannuronan C-5 epimerase AlgE6 A-module;1.19;CA;CALCIUM ION;Poly(beta-D-mannuronate) C5 epimerase 6;354;
5LWD;E;Thermolysin in complex with inhibitor (JC96);1.23;CA;CALCIUM ION;Thermolysin;1427;
5LXS;A;Tubulin-KS-1-199-32 complex;2.2;CA;CALCIUM ION;Tubulin alpha-1B chain;9913;
5LXS;B;Tubulin-KS-1-199-32 complex;2.2;CA;CALCIUM ION;Tubulin beta-2B chain;9913;
5LXS;C;Tubulin-KS-1-199-32 complex;2.2;CA;CALCIUM ION;Tubulin alpha-1B chain;9913;
5LXS;E;Tubulin-KS-1-199-32 complex;2.2;CA;CALCIUM ION;Stathmin-4;10116;
5LXT;A;Tubulin-Discodermolide complex;1.9;CA;CALCIUM ION;Tubulin alpha-1B chain;9913;
5LXT;B;Tubulin-Discodermolide complex;1.9;CA;CALCIUM ION;Tubulin beta-2B chain;9913;
5LXT;C;Tubulin-Discodermolide complex;1.9;CA;CALCIUM ION;Tubulin alpha-1B chain;9913;
5LXV;B;Crystal structure of Ruminococcus flavefaciens scaffoldin C cohesin in complex with a dockerin from an uncharacterized CBM-containing protein;2.4;CA;CALCIUM ION;Carbohydrate-binding protein WP_009985128;1265;
5LXV;D;Crystal structure of Ruminococcus flavefaciens scaffoldin C cohesin in complex with a dockerin from an uncharacterized CBM-containing protein;2.4;CA;CALCIUM ION;Carbohydrate-binding protein WP_009985128;1265;
5LYJ;A;Tubulin-Combretastatin A4 complex;2.4;CA;CALCIUM ION;Tubulin alpha-1B chain;9913;
5LYJ;B;Tubulin-Combretastatin A4 complex;2.4;CA;CALCIUM ION;Tubulin beta-2B chain;9913;
5LYJ;C;Tubulin-Combretastatin A4 complex;2.4;CA;CALCIUM ION;Tubulin alpha-1B chain;9913;
5LYJ;E;Tubulin-Combretastatin A4 complex;2.4;CA;CALCIUM ION;Stathmin-4;10116;
5LZH;C;Cholera toxin classical B-pentamer in complex with inhibitor PC262;1.13;CA;CALCIUM ION;Cholera enterotoxin B subunit;666;
5LZH;E;Cholera toxin classical B-pentamer in complex with inhibitor PC262;1.13;CA;CALCIUM ION;Cholera enterotoxin B subunit;666;
5M06;B;Crystal structure of Mycobacterium tuberculosis PknI kinase domain;2;CA;CALCIUM ION;Serine/threonine-protein kinase PknI;1773;
5M0D;A;Structure-based evolution of a hybrid steroid series of Autotaxin inhibitors;2.4;CA;CALCIUM ION;Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2;10116;
5M0E;A;Structure-based evolution of a hybrid steroid series of Autotaxin inhibitors;1.95;CA;CALCIUM ION;Ectonucleotide pyrophosphatase/phosphodiesterase family member 2;10116;
5M0M;A;Structure-based evolution of a hybrid steroid series of Autotaxin inhibitors;2.1;CA;CALCIUM ION;Ectonucleotide pyrophosphatase/phosphodiesterase family member 2;10116;
5M0S;A;Structure-based evolution of a hybrid steroid series of Autotaxin inhibitors;2.1;CA;CALCIUM ION;Ectonucleotide pyrophosphatase/phosphodiesterase family member 2;10116;
5M0Y;B;Crystal Structure of the CohScaA-XDocCipB type II complex from Clostridium thermocellum at 1.5Angstrom resolution;1.5;CA;CALCIUM ION;Ig domain protein group 2 domain protein;1515;
5M11;A;Structural and functional probing of PorZ, an essential bacterial surface component of the type-IX secretion system of human oral-microbiomic Porphyromonas gingivalis.;2.9;CA;CALCIUM ION;Immunoreactive 84kD antigen PG93;837;
5M1P;A;Crystal structure of the large terminase nuclease from thermophilic phage G20c with bound Calcium;1.1;CA;CALCIUM ION;Terminase large subunit;1406341;
5M1P;B;Crystal structure of the large terminase nuclease from thermophilic phage G20c with bound Calcium;1.1;CA;CALCIUM ION;Terminase large subunit;1406341;
5M27;A;Structure of a bacterial light-regulated adenylyl cylcase;2;CA;CALCIUM ION;Beta subunit of photoactivated adenylyl cyclase;422289;
5M27;B;Structure of a bacterial light-regulated adenylyl cylcase;2;CA;CALCIUM ION;Beta subunit of photoactivated adenylyl cyclase;422289;
5M2O;B;R. flavefaciens' third ScaB cohesin in complex with a group 1 dockerin;1.26;CA;CALCIUM ION;Group I Dockerin;1265;
5M2S;A;R. flavefaciens' third ScaB cohesin in complex with a group 1 dockerin;1.7;CA;CALCIUM ION;Putative cellulosomal scaffoldin protein;1265;
5M2S;B;R. flavefaciens' third ScaB cohesin in complex with a group 1 dockerin;1.7;CA;CALCIUM ION;Doc8: Type I dockerin repeat domain from family 9 glycoside hydrolase WP_009982745[Ruminococcus flavefaciens];1265;
5M3C;A;Structure of the hybrid domain (GGDEF-EAL) of PA0575 from Pseudomonas aeruginosa PAO1 at 2.8 Ang. with GTP and Ca2+ bound to the active site of the GGDEF domain;2.8;CA;CALCIUM ION;Diguanylate cyclase;287;
5M3C;B;Structure of the hybrid domain (GGDEF-EAL) of PA0575 from Pseudomonas aeruginosa PAO1 at 2.8 Ang. with GTP and Ca2+ bound to the active site of the GGDEF domain;2.8;CA;CALCIUM ION;Diguanylate cyclase;287;
5M5F;E;Thermolysin in complex with inhibitor and krypton;1.33;CA;CALCIUM ION;Thermolysin;1427;
5M62;A;Structure of the Mus musclus Langerin carbohydrate recognition domain in complex with glucose;1.7;CA;CALCIUM ION;C-type lectin domain family 4 member K;10090;
5M62;B;Structure of the Mus musclus Langerin carbohydrate recognition domain in complex with glucose;1.7;CA;CALCIUM ION;C-type lectin domain family 4 member K;10090;
5M69;E;Thermolysin in complex with inhibitor and xenon;1.44;CA;CALCIUM ION;Thermolysin;1427;
5M6C;A;CRYSTAL STRUCTURE OF T71N MUTANT OF HUMAN HIPPOCALCIN;3;CA;CALCIUM ION;Neuron-specific calcium-binding protein hippocalcin;9606;
5M6C;E;CRYSTAL STRUCTURE OF T71N MUTANT OF HUMAN HIPPOCALCIN;3;CA;CALCIUM ION;Neuron-specific calcium-binding protein hippocalcin;9606;
5M6D;A;Streptococcus pneumoniae Glyceraldehyde-3-Phosphate Dehydrogenase (SpGAPDH) crystal structure;2;CA;CALCIUM ION;Glyceraldehyde-3-phosphate dehydrogenase;1313;
5M7E;A;Tubulin-BKM120 complex;2.05;CA;CALCIUM ION;Tubulin alpha-1B chain;9913;
5M7E;B;Tubulin-BKM120 complex;2.05;CA;CALCIUM ION;Tubulin beta-2B chain;9913;
5M7E;C;Tubulin-BKM120 complex;2.05;CA;CALCIUM ION;Tubulin alpha-1B chain;9913;
5M7G;A;Tubulin-MTD147 complex;2.25;CA;CALCIUM ION;Tubulin alpha-1B chain;9913;
5M7G;B;Tubulin-MTD147 complex;2.25;CA;CALCIUM ION;Tubulin beta-2B chain;9913;
5M7G;C;Tubulin-MTD147 complex;2.25;CA;CALCIUM ION;Tubulin alpha-1B chain;9913;
5M86;A;Crystal Structure of the Thermoplasma acidophilum Protein Ta1207;2.4;CA;CALCIUM ION;Ta1207;2303;
5M86;B;Crystal Structure of the Thermoplasma acidophilum Protein Ta1207;2.4;CA;CALCIUM ION;Ta1207;2303;
5M86;C;Crystal Structure of the Thermoplasma acidophilum Protein Ta1207;2.4;CA;CALCIUM ION;Ta1207;2303;
5M86;D;Crystal Structure of the Thermoplasma acidophilum Protein Ta1207;2.4;CA;CALCIUM ION;Ta1207;2303;
5M86;E;Crystal Structure of the Thermoplasma acidophilum Protein Ta1207;2.4;CA;CALCIUM ION;Ta1207;2303;
5M86;F;Crystal Structure of the Thermoplasma acidophilum Protein Ta1207;2.4;CA;CALCIUM ION;Ta1207;2303;
5M86;G;Crystal Structure of the Thermoplasma acidophilum Protein Ta1207;2.4;CA;CALCIUM ION;Ta1207;2303;
5M86;H;Crystal Structure of the Thermoplasma acidophilum Protein Ta1207;2.4;CA;CALCIUM ION;Ta1207;2303;
5M86;I;Crystal Structure of the Thermoplasma acidophilum Protein Ta1207;2.4;CA;CALCIUM ION;Ta1207;2303;
5M86;J;Crystal Structure of the Thermoplasma acidophilum Protein Ta1207;2.4;CA;CALCIUM ION;Ta1207;2303;
5M8D;A;Tubulin MTD265-R1 complex;2.25;CA;CALCIUM ION;Tubulin alpha-1B chain;9913;
5M8D;B;Tubulin MTD265-R1 complex;2.25;CA;CALCIUM ION;Tubulin beta-2B chain;9913;
5M8D;C;Tubulin MTD265-R1 complex;2.25;CA;CALCIUM ION;Tubulin alpha-1B chain;9913;
5M8E;A;Crystal structure of a GH43 arabonofuranosidase from Weissella sp. strain 142;2;CA;CALCIUM ION;Alpha-N-arabinofuranosidase;137591;
5M8E;B;Crystal structure of a GH43 arabonofuranosidase from Weissella sp. strain 142;2;CA;CALCIUM ION;Alpha-N-arabinofuranosidase;137591;
5M8G;A;Tubulin-MTD265 complex;2.15;CA;CALCIUM ION;Tubulin alpha-1B chain;9913;
5M8G;B;Tubulin-MTD265 complex;2.15;CA;CALCIUM ION;Tubulin beta-2B chain;9913;
5M8G;C;Tubulin-MTD265 complex;2.15;CA;CALCIUM ION;Tubulin alpha-1B chain;9913;
5M99;A;Functional Characterization and Crystal Structure of Thermostable Amylase from Thermotoga petrophila, reveals High Thermostability and an Archaic form of Dimerization;1.96;CA;CALCIUM ION;Alpha-amylase;93929;
5M99;B;Functional Characterization and Crystal Structure of Thermostable Amylase from Thermotoga petrophila, reveals High Thermostability and an Archaic form of Dimerization;1.96;CA;CALCIUM ION;Alpha-amylase;93929;
5M9W;A;Experimental MAD phased structure of thermolysin in complex with inhibitor JC65.;1.21;CA;CALCIUM ION;Thermolysin;1427;
5MA7;E;Structure of thermolysin in complex with inhibitor (JC306).;1.3;CA;CALCIUM ION;Thermolysin;1427;
5-may;A;STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PA14 IN COMPLEX WITH 2-Thiophenesulfonamide-N-(beta-L-fucopyranosyl methyl);1.65;CA;CALCIUM ION;Fucose-binding lectin PA-IIL;287;
5-may;B;STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PA14 IN COMPLEX WITH 2-Thiophenesulfonamide-N-(beta-L-fucopyranosyl methyl);1.65;CA;CALCIUM ION;Fucose-binding lectin PA-IIL;287;
5-may;C;STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PA14 IN COMPLEX WITH 2-Thiophenesulfonamide-N-(beta-L-fucopyranosyl methyl);1.65;CA;CALCIUM ION;Fucose-binding lectin PA-IIL;287;
5-may;D;STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PA14 IN COMPLEX WITH 2-Thiophenesulfonamide-N-(beta-L-fucopyranosyl methyl);1.65;CA;CALCIUM ION;Fucose-binding lectin PA-IIL;287;
5MAZ;A;STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PA14 IN COMPLEX WITH 3-Thiophenesulfonamide-2,5-dimethyl-N-methyl-beta-L-fucopyranoside;1.45;CA;CALCIUM ION;Fucose-binding lectin PA-IIL;287;
5MAZ;B;STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PA14 IN COMPLEX WITH 3-Thiophenesulfonamide-2,5-dimethyl-N-methyl-beta-L-fucopyranoside;1.45;CA;CALCIUM ION;Fucose-binding lectin PA-IIL;287;
5MAZ;C;STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PA14 IN COMPLEX WITH 3-Thiophenesulfonamide-2,5-dimethyl-N-methyl-beta-L-fucopyranoside;1.45;CA;CALCIUM ION;Fucose-binding lectin PA-IIL;287;
5MAZ;D;STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PA14 IN COMPLEX WITH 3-Thiophenesulfonamide-2,5-dimethyl-N-methyl-beta-L-fucopyranoside;1.45;CA;CALCIUM ION;Fucose-binding lectin PA-IIL;287;
5MB1;A;STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PA14 IN COMPLEX WITH 2,4,6-Trimethylphenylsulfonamide-N-methyl-L-fucopyranoside;1.65;CA;CALCIUM ION;Fucose-binding lectin PA-IIL;287;
5MB1;B;STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PA14 IN COMPLEX WITH 2,4,6-Trimethylphenylsulfonamide-N-methyl-L-fucopyranoside;1.65;CA;CALCIUM ION;Fucose-binding lectin PA-IIL;287;
5MB1;C;STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PA14 IN COMPLEX WITH 2,4,6-Trimethylphenylsulfonamide-N-methyl-L-fucopyranoside;1.65;CA;CALCIUM ION;Fucose-binding lectin PA-IIL;287;
5MB1;D;STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PA14 IN COMPLEX WITH 2,4,6-Trimethylphenylsulfonamide-N-methyl-L-fucopyranoside;1.65;CA;CALCIUM ION;Fucose-binding lectin PA-IIL;287;
5MC9;A;Crystal structure of the heterotrimeric integrin-binding region of laminin-111;2.13;CA;CALCIUM ION;Laminin subunit alpha-1;10090;
5MEH;A;Crystal structure of alpha-1,2-mannosidase from Caulobacter K31 strain in complex with 1-deoxymannojirimycin;0.95;CA;CALCIUM ION;Mannosyl-oligosaccharide 1,2-alpha-mannosidase;366602;
5MER;A;Human Leukocyte Antigen A02 presenting ILAKFLHEL;1.88;CA;CALCIUM ION;HLA class I histocompatibility antigen, A-2 alpha chain;9606;
5MER;D;Human Leukocyte Antigen A02 presenting ILAKFLHEL;1.88;CA;CALCIUM ION;HLA class I histocompatibility antigen, A-2 alpha chain;9606;
5MEY;D;Crystal structure of Smad4-MH1 bound to the GGCGC site.;2.05;CA;CALCIUM ION;DNA (5'-D(P*AP*TP*GP*CP*GP*GP*GP*CP*GP*CP*GP*CP*CP*CP*GP*CP*AP*T)-3');9606;
5MF4;A;Tubulin-Dictyostatin complex;2.3;CA;CALCIUM ION;Tubulin alpha-1B chain;9913;
5MF4;C;Tubulin-Dictyostatin complex;2.3;CA;CALCIUM ION;Tubulin alpha-1B chain;9913;
5MF4;F;Tubulin-Dictyostatin complex;2.3;CA;CALCIUM ION;Uncharacterized protein;9031;
5MFA;A;Crystal structure of human promyeloperoxidase (proMPO);1.2;CA;CALCIUM ION;Myeloperoxidase;9606;
5MFD;A;Designed armadillo repeat protein YIIIM''6AII in complex with pD_(KR)5;2.3;CA;CALCIUM ION;YIIIM''6AII;32630;
5MFD;C;Designed armadillo repeat protein YIIIM''6AII in complex with pD_(KR)5;2.3;CA;CALCIUM ION;YIIIM''6AII;32630;
5MFD;E;Designed armadillo repeat protein YIIIM''6AII in complex with pD_(KR)5;2.3;CA;CALCIUM ION;YIIIM''6AII;32630;
5MFD;F;Designed armadillo repeat protein YIIIM''6AII in complex with pD_(KR)5;2.3;CA;CALCIUM ION;Capsid decoration protein,pD_(KR)5;10710;
5MFD;G;Designed armadillo repeat protein YIIIM''6AII in complex with pD_(KR)5;2.3;CA;CALCIUM ION;YIIIM''6AII;32630;
5MFD;H;Designed armadillo repeat protein YIIIM''6AII in complex with pD_(KR)5;2.3;CA;CALCIUM ION;Capsid decoration protein,pD_(KR)5;10710;
5MFD;I;Designed armadillo repeat protein YIIIM''6AII in complex with pD_(KR)5;2.3;CA;CALCIUM ION;YIIIM''6AII;32630;
5MFD;J;Designed armadillo repeat protein YIIIM''6AII in complex with pD_(KR)5;2.3;CA;CALCIUM ION;YIIIM''6AII;32630;
5MFD;K;Designed armadillo repeat protein YIIIM''6AII in complex with pD_(KR)5;2.3;CA;CALCIUM ION;YIIIM''6AII;32630;
5MFD;L;Designed armadillo repeat protein YIIIM''6AII in complex with pD_(KR)5;2.3;CA;CALCIUM ION;YIIIM''6AII;32630;
5MFE;A;Designed armadillo repeat protein YIIIM5AII in complex with (RR)4 peptide;1.95;CA;CALCIUM ION;YIIIM5AII;32630;
5MFE;B;Designed armadillo repeat protein YIIIM5AII in complex with (RR)4 peptide;1.95;CA;CALCIUM ION;YIIIM5AII;32630;
5MFE;C;Designed armadillo repeat protein YIIIM5AII in complex with (RR)4 peptide;1.95;CA;CALCIUM ION;YIIIM5AII;32630;
5MFE;D;Designed armadillo repeat protein YIIIM5AII in complex with (RR)4 peptide;1.95;CA;CALCIUM ION;YIIIM5AII;32630;
5MFG;A;Designed armadillo repeat protein YIIIM5AII in complex with peptide (RR)4;1.9;CA;CALCIUM ION;YIIIM5AII;32630;
5MFG;B;Designed armadillo repeat protein YIIIM5AII in complex with peptide (RR)4;1.9;CA;CALCIUM ION;YIIIM5AII;32630;
5MFG;D;Designed armadillo repeat protein YIIIM5AII in complex with peptide (RR)4;1.9;CA;CALCIUM ION;YIIIM5AII;32630;
5MFH;A;Designed armadillo repeat protein YIIIM5AII in complex with peptide (RR)5;2;CA;CALCIUM ION;YIIIM5AII;32630;
5MFH;B;Designed armadillo repeat protein YIIIM5AII in complex with peptide (RR)5;2;CA;CALCIUM ION;YIIIM5AII;32630;
5MFH;C;Designed armadillo repeat protein YIIIM5AII in complex with peptide (RR)5;2;CA;CALCIUM ION;YIIIM5AII;32630;
5MFH;D;Designed armadillo repeat protein YIIIM5AII in complex with peptide (RR)5;2;CA;CALCIUM ION;YIIIM5AII;32630;
5MFL;A;Designed armadillo repeat protein (KR)5_GS10_YIIIM6AII;2.5;CA;CALCIUM ION;(KR)5_GS10_YIIIM6AII;32630;
5MFL;B;Designed armadillo repeat protein (KR)5_GS10_YIIIM6AII;2.5;CA;CALCIUM ION;(KR)5_GS10_YIIIM6AII;32630;
5MFL;C;Designed armadillo repeat protein (KR)5_GS10_YIIIM6AII;2.5;CA;CALCIUM ION;(KR)5_GS10_YIIIM6AII;32630;
5MFM;A;Designed armadillo repeat protein peptide fusion YIIIM6AII_GS11_(KR)5;2.3;CA;CALCIUM ION;YIIIM6AII_GS11_(KR)5;32630;
5MFM;B;Designed armadillo repeat protein peptide fusion YIIIM6AII_GS11_(KR)5;2.3;CA;CALCIUM ION;YIIIM6AII_GS11_(KR)5;32630;
5MFM;C;Designed armadillo repeat protein peptide fusion YIIIM6AII_GS11_(KR)5;2.3;CA;CALCIUM ION;Importin subunit alpha;5478;
5MFM;D;Designed armadillo repeat protein peptide fusion YIIIM6AII_GS11_(KR)5;2.3;CA;CALCIUM ION;YIIIM6AII_GS11_(KR)5;32630;
5MFN;A;Designed armadillo repeat protein YIIIM5AII;2.8;CA;CALCIUM ION;YIIIM5AII;32630;
5MFN;B;Designed armadillo repeat protein YIIIM5AII;2.8;CA;CALCIUM ION;YIIIM5AII;32630;
5MFO;A;Designed armadillo repeat protein YIIIM3AIII;1.3;CA;CALCIUM ION;YIIIM3AIII;32630;
5MFO;B;Designed armadillo repeat protein YIIIM3AIII;1.3;CA;CALCIUM ION;YIIIM3AIII;32630;
5MFO;C;Designed armadillo repeat protein YIIIM3AIII;1.3;CA;CALCIUM ION;YIIIM3AIII;32630;
5MFO;D;Designed armadillo repeat protein YIIIM3AIII;1.3;CA;CALCIUM ION;YIIIM3AIII;32630;
5MFO;E;Designed armadillo repeat protein YIIIM3AIII;1.3;CA;CALCIUM ION;YIIIM3AIII;32630;
5MFO;F;Designed armadillo repeat protein YIIIM3AIII;1.3;CA;CALCIUM ION;YIIIM3AIII;32630;
5MHC;A;Crystal structure of 14-3-3sigma and a p53 C-terminal 12-mer synthetic phosphopeptide;1.2;CA;CALCIUM ION;14-3-3 protein sigma;9606;
5MHL;A;FXIIIa in complex with the inhibitor Mi0621;2.4;CA;CALCIUM ION;Coagulation factor XIII A chain;9606;
5MHL;B;FXIIIa in complex with the inhibitor Mi0621;2.4;CA;CALCIUM ION;Coagulation factor XIII A chain;9606;
5MHM;A;FXIIIa in complex with the inhibitor ZED1630;2.12;CA;CALCIUM ION;Coagulation factor XIII A chain;9606;
5MHM;B;FXIIIa in complex with the inhibitor ZED1630;2.12;CA;CALCIUM ION;Coagulation factor XIII A chain;9606;
5MHN;A;FXIIIa in complex with the inhibitor ZED2360;2.48;CA;CALCIUM ION;Coagulation factor XIII A chain;9606;
5MHN;B;FXIIIa in complex with the inhibitor ZED2360;2.48;CA;CALCIUM ION;Coagulation factor XIII A chain;9606;
5MHO;A;FXIIIa in complex with the inhibitor ZED2369;2.92;CA;CALCIUM ION;Coagulation factor XIII A chain;9606;
5MHO;B;FXIIIa in complex with the inhibitor ZED2369;2.92;CA;CALCIUM ION;Coagulation factor XIII A chain;9606;
5MHP;A;Novel Imidazo[1,2-a]pyridine Derivatives with Potent Autotaxin/ENPP2 Inhibitor Activity;2.43;CA;CALCIUM ION;Ectonucleotide pyrophosphatase/phosphodiesterase family member 2;9606;
5MI4;A;BtGH84 mutant with covalent modification by MA3;1.8;CA;CALCIUM ION;O-GlcNAcase BT_4395;818;
5MI5;A;BtGH84 mutant with covalent modification by MA3 in complex with PUGNAc;2.15;CA;CALCIUM ION;O-GlcNAcase BT_4395;818;
5MI6;A;BtGH84 mutant with covalent modification by MA3 in complex with Thiamet G;2;CA;CALCIUM ION;O-GlcNAcase BT_4395;818;
5MI7;A;BtGH84 mutant with covalent modification by MA4 in complex with PUGNAc;2.1;CA;CALCIUM ION;O-GlcNAcase BT_4395;818;
5MIH;A;Crystal structure of the lectin LecA from Pseudomonas aeruginosa in complex with a phenyl-epoxy-galactopyranoside;1.8;CA;CALCIUM ION;PA-I galactophilic lectin;287;
5MIH;B;Crystal structure of the lectin LecA from Pseudomonas aeruginosa in complex with a phenyl-epoxy-galactopyranoside;1.8;CA;CALCIUM ION;PA-I galactophilic lectin;287;
5MIH;C;Crystal structure of the lectin LecA from Pseudomonas aeruginosa in complex with a phenyl-epoxy-galactopyranoside;1.8;CA;CALCIUM ION;PA-I galactophilic lectin;287;
5MIH;D;Crystal structure of the lectin LecA from Pseudomonas aeruginosa in complex with a phenyl-epoxy-galactopyranoside;1.8;CA;CALCIUM ION;PA-I galactophilic lectin;287;
5MIM;A;Xray structure of human furin bound with the 2,5-dideoxystreptamine derived small molecule inhibitor 1n;1.9;CA;CALCIUM ION;Furin;9606;
5MIN;A;Apo form of the soluble PQQ-dependent Glucose Dehydrogenase from Acinetobacter calcoaceticus;1.76;CA;CALCIUM ION;Quinoprotein glucose dehydrogenase B;471;
5MIN;B;Apo form of the soluble PQQ-dependent Glucose Dehydrogenase from Acinetobacter calcoaceticus;1.76;CA;CALCIUM ION;Quinoprotein glucose dehydrogenase B;471;
5MJ7;A;Structure of the C. elegans nucleoside hydrolase;1.65;CA;CALCIUM ION;Uncharacterized protein;6239;
5MJ7;B;Structure of the C. elegans nucleoside hydrolase;1.65;CA;CALCIUM ION;Uncharacterized protein;6239;
5MJL;A;Single-shot pink beam serial crystallography: Proteinase K;2.21;CA;CALCIUM ION;Proteinase K;37998;
5MKC;C;Crystal structure of the RrgA Jo.In complex;2.04;CA;CALCIUM ION;Cell wall surface anchor family protein (Jo),Cell wall surface anchor family protein (In);1313;
5MKC;E;Crystal structure of the RrgA Jo.In complex;2.04;CA;CALCIUM ION;Cell wall surface anchor family protein (Jo),Cell wall surface anchor family protein (In);1313;
5MKC;F;Crystal structure of the RrgA Jo.In complex;2.04;CA;CALCIUM ION;Cell wall surface anchor family protein (Jo),Cell wall surface anchor family protein (In);1313;
5MKE;A;cryoEM Structure of Polycystin-2 in complex with cations and lipids;4.3;CA;CALCIUM ION;Polycystin-2;9606;
5MKF;A;cryoEM Structure of Polycystin-2 in complex with calcium and lipids;4.2;CA;CALCIUM ION;Polycystin-2;9606;
5MKF;B;cryoEM Structure of Polycystin-2 in complex with calcium and lipids;4.2;CA;CALCIUM ION;Polycystin-2;9606;
5MKG;A;PA3825-EAL Ca-CdG Structure;2.44;CA;CALCIUM ION;Diguanylate phosphodiesterase;287;
5MKG;B;PA3825-EAL Ca-CdG Structure;2.44;CA;CALCIUM ION;Diguanylate phosphodiesterase;287;
5MKI;C;Crystal structure of SmAP (LSm) protein from Methanococcus vannielii;2.05;CA;CALCIUM ION;Like-Sm ribonucleoprotein core;2187;
5MKI;D;Crystal structure of SmAP (LSm) protein from Methanococcus vannielii;2.05;CA;CALCIUM ION;Like-Sm ribonucleoprotein core;2187;
5MKI;E;Crystal structure of SmAP (LSm) protein from Methanococcus vannielii;2.05;CA;CALCIUM ION;Like-Sm ribonucleoprotein core;2187;
5MKI;F;Crystal structure of SmAP (LSm) protein from Methanococcus vannielii;2.05;CA;CALCIUM ION;Like-Sm ribonucleoprotein core;2187;
5MKI;G;Crystal structure of SmAP (LSm) protein from Methanococcus vannielii;2.05;CA;CALCIUM ION;Like-Sm ribonucleoprotein core;2187;
5MKI;I;Crystal structure of SmAP (LSm) protein from Methanococcus vannielii;2.05;CA;CALCIUM ION;Like-Sm ribonucleoprotein core;2187;
5MKI;J;Crystal structure of SmAP (LSm) protein from Methanococcus vannielii;2.05;CA;CALCIUM ION;Like-Sm ribonucleoprotein core;2187;
5MKI;K;Crystal structure of SmAP (LSm) protein from Methanococcus vannielii;2.05;CA;CALCIUM ION;Like-Sm ribonucleoprotein core;2187;
5MKI;L;Crystal structure of SmAP (LSm) protein from Methanococcus vannielii;2.05;CA;CALCIUM ION;Like-Sm ribonucleoprotein core;2187;
5MKI;M;Crystal structure of SmAP (LSm) protein from Methanococcus vannielii;2.05;CA;CALCIUM ION;Like-Sm ribonucleoprotein core;2187;
5ML7;A;CRYSTAL STRUCTURE OF L1-STALK FRAGMENT OF 23S rRNA FROM HALOARCULA MARISMORTUI;3.3;CA;CALCIUM ION;23S ribosomal RNA;2238;
5MLH;A;Plantago Major multifunctional oxidoreductase in complex with 8-oxogeranial and NADP+;1.86;CA;CALCIUM ION;Progesterone 5-beta-reductase;29818;
5MN1;A;Cationic trypsin in complex with 2-aminopyridine (deuterated sample at 100 K);0.79;CA;CALCIUM ION;Cationic trypsin;9913;
5MNA;A;Cationic trypsin in complex with aniline (deuterated sample at 295 K);1.44;CA;CALCIUM ION;Cationic trypsin;9913;
5MNB;A;Cationic trypsin in complex with 2-aminopyridine (deuterated sample at 295 K);0.94;CA;CALCIUM ION;Cationic trypsin;9913;
5MNC;A;Cationic trypsin in complex with aniline (deuterated sample at 100 K);0.92;CA;CALCIUM ION;Cationic trypsin;9913;
5MNE;A;Cationic trypsin in its apo form (deuterated sample at 100 K);1.01;CA;CALCIUM ION;Cationic trypsin;9913;
5MNF;A;Cationic trypsin in its apo form (deuterated sample at 295 K);0.99;CA;CALCIUM ION;Cationic trypsin;9913;
5MNG;A;Cationic trypsin in complex with benzamidine (deuterated sample at 100 K);0.86;CA;CALCIUM ION;Cationic trypsin;9913;
5MNH;A;Cationic trypsin in complex with benzamidine (deuterated sample at 295 K);0.93;CA;CALCIUM ION;Cationic trypsin;9913;
5MNK;A;Cationic trypsin in complex with benzylamine (deuterated sample at 100 K);0.8;CA;CALCIUM ION;Cationic trypsin;9913;
5MNL;A;Cationic trypsin in complex with benzylamine (deuterated sample at 295 K);1.04;CA;CALCIUM ION;Cationic trypsin;9913;
5MNM;A;Cationic trypsin in complex with benzylamine (at 295 K);0.98;CA;CALCIUM ION;Cationic trypsin;9913;
5MNN;A;Cationic trypsin in complex with N-amidinopiperidine (deuterated sample at 100 K);0.86;CA;CALCIUM ION;Cationic trypsin;9913;
5MNO;A;Cationic trypsin in complex with N-amidinopiperidine (deuterated sample at 295 K);0.96;CA;CALCIUM ION;Cationic trypsin;9913;
5MNP;A;Cationic trypsin in complex with N-amidinopiperidine (at 295 K);1.01;CA;CALCIUM ION;Cationic trypsin;9913;
5MNQ;A;Cationic trypsin in complex with a derivative of N-amidinopiperidine;1.34;CA;CALCIUM ION;Cationic trypsin;9913;
5MNR;E;Thermolysin in complex with inhibitor JC256;1.25;CA;CALCIUM ION;Thermolysin;1427;
5MNX;A;Neutron structure of cationic trypsin in complex with 2-aminopyridine;1.42;CA;CALCIUM ION;Cationic trypsin;9913;
5MNY;A;Neutron structure of cationic trypsin in complex with aniline;1.43;CA;CALCIUM ION;Cationic trypsin;9913;
5MNZ;A;Neutron structure of cationic trypsin in its apo form;1.45;CA;CALCIUM ION;Cationic trypsin;9913;
5MO0;A;Neutron structure of cationic trypsin in complex with benzamidine;1.5;CA;CALCIUM ION;Cationic trypsin;9913;
5MO1;A;Neutron structure of cationic trypsin in complex with benzylamine;1.49;CA;CALCIUM ION;Cationic trypsin;9913;
5MO2;A;Neutron structure of cationic trypsin in complex with N-amidinopiperidine;1.5;CA;CALCIUM ION;Cationic trypsin;9913;
5MON;A;Joint X-ray/neutron structure of cationic trypsin in complex with 2-aminopyridine;;CA;CALCIUM ION;Cationic trypsin;9913;
5MOO;A;Joint X-ray/neutron structure of cationic trypsin in complex with aniline;;CA;CALCIUM ION;Cationic trypsin;9913;
5MOP;A;Joint X-ray/neutron structure of cationic trypsin in its apo form;;CA;CALCIUM ION;Cationic trypsin;9913;
5MOQ;A;Joint X-ray/neutron structure of cationic trypsin in complex with benzamidine;;CA;CALCIUM ION;Cationic trypsin;9913;
5MOR;A;Joint X-ray/neutron structure of cationic trypsin in complex with benzylamine;;CA;CALCIUM ION;Cationic trypsin;9913;
5MOS;A;Joint X-ray/neutron structure of cationic trypsin in complex with N-amidinopiperidine;;CA;CALCIUM ION;Cationic trypsin;9913;
5MPY;A;Crystal structure of Arabidopsis thaliana RNA editing factor MORF9;2.25;CA;CALCIUM ION;Multiple organellar RNA editing factor 9, chloroplastic;3702;
5MPY;B;Crystal structure of Arabidopsis thaliana RNA editing factor MORF9;2.25;CA;CALCIUM ION;Multiple organellar RNA editing factor 9, chloroplastic;3702;
5MQM;A;Glycoside hydrolase BT_0986;2.11;CA;CALCIUM ION;Glycosyl hydrolases family 2, sugar binding domain;818;
5MQN;A;Glycoside hydrolase BT_0986;1.9;CA;CALCIUM ION;Glycosyl hydrolases family 2, sugar binding domain;818;
5MQP;A;Glycoside hydrolase BT_1002;2;CA;CALCIUM ION;Glycoside hydrolase BT_1002;818;
5MQP;B;Glycoside hydrolase BT_1002;2;CA;CALCIUM ION;Glycoside hydrolase BT_1002;818;
5MQP;C;Glycoside hydrolase BT_1002;2;CA;CALCIUM ION;Glycoside hydrolase BT_1002;818;
5MQP;D;Glycoside hydrolase BT_1002;2;CA;CALCIUM ION;Glycoside hydrolase BT_1002;818;
5MQP;E;Glycoside hydrolase BT_1002;2;CA;CALCIUM ION;Glycoside hydrolase BT_1002;818;
5MQP;F;Glycoside hydrolase BT_1002;2;CA;CALCIUM ION;Glycoside hydrolase BT_1002;818;
5MQP;G;Glycoside hydrolase BT_1002;2;CA;CALCIUM ION;Glycoside hydrolase BT_1002;818;
5MQP;H;Glycoside hydrolase BT_1002;2;CA;CALCIUM ION;Glycoside hydrolase BT_1002;818;
5MQR;A;Sialidase BT_1020;2.2;CA;CALCIUM ION;Beta-L-arabinobiosidase;818;
5MQS;A;Sialidase BT_1020;3;CA;CALCIUM ION;Beta-L-arabinobiosidase;818;
5MS3;A;Kallikrein-related peptidase 8 calcium complex;2.3;CA;CALCIUM ION;Kallikrein-8;9606;
5MS4;A;Kallikrein-related peptidase 8 leupeptin inhibitor complex;2.1;CA;CALCIUM ION;Kallikrein-8;9606;
5MS4;B;Kallikrein-related peptidase 8 leupeptin inhibitor complex;2.1;CA;CALCIUM ION;Kallikrein-8;9606;
5MS4;C;Kallikrein-related peptidase 8 leupeptin inhibitor complex;2.1;CA;CALCIUM ION;Kallikrein-8;9606;
5MS4;D;Kallikrein-related peptidase 8 leupeptin inhibitor complex;2.1;CA;CALCIUM ION;Kallikrein-8;9606;
5MS9;A;Solution structure of Human Fibrillin-1 EGF2-EGF3-Hybrid1-cbEGF1 four domain fragment;;CA;CALCIUM ION;Fibrillin-1;9606;
5MST;A;Structure of the A domain of carboxylic acid reductase (CAR) from Segniliparus rugosus in complex with AMP and a co-purified carboxylic acid;1.72;CA;CALCIUM ION;Thioester reductase domain-containing protein;286804;
5MST;B;Structure of the A domain of carboxylic acid reductase (CAR) from Segniliparus rugosus in complex with AMP and a co-purified carboxylic acid;1.72;CA;CALCIUM ION;Thioester reductase domain-containing protein;286804;
5MSX;A;Glycoside hydrolase BT_3662;2.1;CA;CALCIUM ION;Putative endo-1,4-beta-xylanase;818;
5MSX;B;Glycoside hydrolase BT_3662;2.1;CA;CALCIUM ION;Putative endo-1,4-beta-xylanase;818;
5MSX;C;Glycoside hydrolase BT_3662;2.1;CA;CALCIUM ION;Putative endo-1,4-beta-xylanase;818;
5MTW;A;Mycobacterium tuberculosis Rv1957 SecB-like chaperone in complex with a ChAD peptide from Rv1956 HigA1 antitoxin;1.84;CA;CALCIUM ION;SecB-like chaperone Rv1957;1773;
5MTW;B;Mycobacterium tuberculosis Rv1957 SecB-like chaperone in complex with a ChAD peptide from Rv1956 HigA1 antitoxin;1.84;CA;CALCIUM ION;SecB-like chaperone Rv1957;1773;
5MTW;D;Mycobacterium tuberculosis Rv1957 SecB-like chaperone in complex with a ChAD peptide from Rv1956 HigA1 antitoxin;1.84;CA;CALCIUM ION;SecB-like chaperone Rv1957;1773;
5MU1;A;UDP-Glucose Glycoprotein Glucosyltransferase from Chaetomium thermophilum soaked with K2PtI6;3.48;CA;CALCIUM ION;UDP-glucose-glycoprotein glucosyltransferase-like protein;209285;
5MU9;A;MOA-E-64 complex;1.3;CA;CALCIUM ION;Agglutinin;181124;
5MUA;A;PSL1a-E64 complex;1.49;CA;CALCIUM ION;Ricin B-related lectin;5640;
5MUV;A;Atomic structure fitted into a localized reconstruction of bacteriophage phi6 packaging hexamer P4;9.1;CA;CALCIUM ION;Packaging enzyme P4;10879;
5MUV;B;Atomic structure fitted into a localized reconstruction of bacteriophage phi6 packaging hexamer P4;9.1;CA;CALCIUM ION;Packaging enzyme P4;10879;
5MUV;I;Atomic structure fitted into a localized reconstruction of bacteriophage phi6 packaging hexamer P4;9.1;CA;CALCIUM ION;Packaging enzyme P4;10879;
5MUV;J;Atomic structure fitted into a localized reconstruction of bacteriophage phi6 packaging hexamer P4;9.1;CA;CALCIUM ION;Packaging enzyme P4;10879;
5MUV;K;Atomic structure fitted into a localized reconstruction of bacteriophage phi6 packaging hexamer P4;9.1;CA;CALCIUM ION;Packaging enzyme P4;10879;
5MUV;L;Atomic structure fitted into a localized reconstruction of bacteriophage phi6 packaging hexamer P4;9.1;CA;CALCIUM ION;Packaging enzyme P4;10879;
5MUW;A;Atomic structure of P4 packaging enzyme fitted into a localized reconstruction of bacteriophage phi6 vertex;9.1;CA;CALCIUM ION;Packaging enzyme P4;10879;
5MUW;B;Atomic structure of P4 packaging enzyme fitted into a localized reconstruction of bacteriophage phi6 vertex;9.1;CA;CALCIUM ION;Packaging enzyme P4;10879;
5MUW;I;Atomic structure of P4 packaging enzyme fitted into a localized reconstruction of bacteriophage phi6 vertex;9.1;CA;CALCIUM ION;Packaging enzyme P4;10879;
5MUW;J;Atomic structure of P4 packaging enzyme fitted into a localized reconstruction of bacteriophage phi6 vertex;9.1;CA;CALCIUM ION;Packaging enzyme P4;10879;
5MUW;K;Atomic structure of P4 packaging enzyme fitted into a localized reconstruction of bacteriophage phi6 vertex;9.1;CA;CALCIUM ION;Packaging enzyme P4;10879;
5MUW;L;Atomic structure of P4 packaging enzyme fitted into a localized reconstruction of bacteriophage phi6 vertex;9.1;CA;CALCIUM ION;Packaging enzyme P4;10879;
5MVV;A;Crystal structure of Plasmodium falciparum actin I- gelsolin segment 1 -CdATP complex;1.4;CA;CALCIUM ION;Actin-1;5833;
5MVV;G;Crystal structure of Plasmodium falciparum actin I- gelsolin segment 1 -CdATP complex;1.4;CA;CALCIUM ION;Gelsolin;10090;
5MW5;A;Human Jagged2 C2-EGF2;2.7;CA;CALCIUM ION;Protein jagged-2;9606;
5MWB;A;Human Notch-2 EGF11-13;1.86;CA;CALCIUM ION;Neurogenic locus notch homolog protein 2;9606;
5MWC;A;Crystal structure of the genetically-encoded green calcium indicator NTnC in its calcium bound state;2.45;CA;CALCIUM ION;genetically-encoded green calcium indicator NTnC;32630;
5MWC;D;Crystal structure of the genetically-encoded green calcium indicator NTnC in its calcium bound state;2.45;CA;CALCIUM ION;genetically-encoded green calcium indicator NTnC;32630;
5MWF;A;Human Jagged2 C2-EGF2;2.8;CA;CALCIUM ION;Protein jagged-2;9606;
5MWF;B;Human Jagged2 C2-EGF2;2.8;CA;CALCIUM ION;Protein jagged-2;9606;
5MWF;C;Human Jagged2 C2-EGF2;2.8;CA;CALCIUM ION;Protein jagged-2;9606;
5MWF;D;Human Jagged2 C2-EGF2;2.8;CA;CALCIUM ION;Protein jagged-2;9606;
5MWF;E;Human Jagged2 C2-EGF2;2.8;CA;CALCIUM ION;Protein jagged-2;9606;
5MWF;F;Human Jagged2 C2-EGF2;2.8;CA;CALCIUM ION;Protein jagged-2;9606;
5MWK;A;Glycoside hydrolase BT_0986;2;CA;CALCIUM ION;Glycoside hydrolase family 2, sugar binding protein;818;
5MXX;A;Crystal structure of human SR protein kinase 1 (SRPK1) in complex with compound 1;1.75;CA;CALCIUM ION;SRPK1;9606;
5MY9;A;Crystal structure of human 14-3-3 sigma in complex with LRRK2 peptide pS935;1.33;CA;CALCIUM ION;14-3-3 protein sigma;9606;
5MYC;A;Crystal structure of human 14-3-3 sigma in complex with LRRK2 peptide pS910;1.46;CA;CALCIUM ION;14-3-3 protein sigma;9606;
5MYH;A;Carboxypeptidase T with N-sulfamoyl-L-glutamic acid;1.93;CA;CALCIUM ION;Carboxypeptidase T;2026;
5MYI;D;Convergent evolution involving dimeric and trimeric dUTPases in signalling.;1.9;CA;CALCIUM ION;dUTPase from DI S. aureus phage;1280;
5MZO;A;UDP-Glucose Glycoprotein Glucosyltransferase from Chaetomium thermophilum (open conformation);3.48;CA;CALCIUM ION;UDP-glucose-glycoprotein glucosyltransferase-like protein;209285;
5N0K;A;Rat ceruloplasmin orthorhombic form;2.3;CA;CALCIUM ION;Ceruloplasmin;10116;
5N0M;A;hPAD4 crystal complex with BB-F-amidine;2.18;CA;CALCIUM ION;Protein-arginine deiminase type-4;9606;
5N0Y;A;hPAD4 crystal complex with AFM-30a;2.23;CA;CALCIUM ION;Protein-arginine deiminase type-4;9606;
5N0Z;A;hPAD4 crystal complex with AFM-41a;2.52;CA;CALCIUM ION;Protein-arginine deiminase type-4;9606;
5N1B;A;hPAD4 crystal complex with AFM-14a;2.9;CA;CALCIUM ION;Protein-arginine deiminase type-4;9606;
5N2J;A;UDP-Glucose Glycoprotein Glucosyltransferase from Chaetomium thermophilum (closed form);4.4;CA;CALCIUM ION;UDP-glucose-glycoprotein glucosyltransferase-like protein;209285;
5N2J;B;UDP-Glucose Glycoprotein Glucosyltransferase from Chaetomium thermophilum (closed form);4.4;CA;CALCIUM ION;UDP-glucose-glycoprotein glucosyltransferase-like protein;209285;
5N2T;E;Thermolysin in complex with inhibitor JC287;1.38;CA;CALCIUM ION;Thermolysin;1427;
5N2X;E;Thermolysin in complex with inhibitor JC272;1.21;CA;CALCIUM ION;Thermolysin;1427;
5N2Z;E;Thermolysin in complex with inhibitor JC286;1.37;CA;CALCIUM ION;Thermolysin;1427;
5N31;E;Thermolysin in complex with inhibitor JC277;1.37;CA;CALCIUM ION;Thermolysin;1427;
5N34;E;Thermolysin in complex with inhibitor JC276;1.22;CA;CALCIUM ION;Thermolysin;1427;
5N3V;E;Thermolysin in complex with inhibitor JC292;1.12;CA;CALCIUM ION;Thermolysin;1427;
5N3Y;E;Thermolysin in complex with inhibitor JC267;1.34;CA;CALCIUM ION;Thermolysin;1427;
5N4L;A;Rat ceruloplasmin trigonal form;3.2;CA;CALCIUM ION;Ceruloplasmin;10116;
5N4L;B;Rat ceruloplasmin trigonal form;3.2;CA;CALCIUM ION;Ceruloplasmin;10116;
5N5J;A;Human MMP12 in complex with 3-(5-(1,2-dithiolan-3-yl)pentanamido)propane-1-sulfonate;1.8;CA;CALCIUM ION;Macrophage metalloelastase;9606;
5N5K;A;Human catalytic MMP-12 in complex with 5-(1,2-dithiolan-3-yl)-N-(3-hydroxypropyl)pentanamide;1.8;CA;CALCIUM ION;Macrophage metalloelastase;9606;
5N5P;B;Crystal structure of Ruminococcus flavefaciens' type III complex containing the fifth cohesin from scaffoldin B and the dockerin from scaffoldin A;1.98;CA;CALCIUM ION;Putative cellulosomal scaffoldin protein;1265;
5N5P;D;Crystal structure of Ruminococcus flavefaciens' type III complex containing the fifth cohesin from scaffoldin B and the dockerin from scaffoldin A;1.98;CA;CALCIUM ION;Putative cellulosomal scaffoldin protein;1265;
5N5W;A;14-3-3 sigma in complex with TAZ pS89 peptide and fragment NV3;1.37;CA;CALCIUM ION;14-3-3 protein sigma;9606;
5N6N;C;CRYSTAL STRUCTURE OF THE 14-3-3:NEUTRAL TREHALASE NTH1 COMPLEX;2.29;CA;CALCIUM ION;Neutral trehalase;4932;
5N7D;A;MAGI-1 complexed with a RSK1 peptide;2.3;CA;CALCIUM ION;Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1,Annexin A2;9606;
5N7D;B;MAGI-1 complexed with a RSK1 peptide;2.3;CA;CALCIUM ION;Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1,Annexin A2;9606;
5N7F;A;MAGI-1 complexed with a pRSK1 peptide;2.3;CA;CALCIUM ION;Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1,Annexin A2;9606;
5N7F;B;MAGI-1 complexed with a pRSK1 peptide;2.3;CA;CALCIUM ION;Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1,Annexin A2;9606;
5N7G;A;MAGI-1 complexed with a synthetic pRSK1 peptide;2.95;CA;CALCIUM ION;Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1,Annexin A2;9606;
5N7G;B;MAGI-1 complexed with a synthetic pRSK1 peptide;2.95;CA;CALCIUM ION;Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1,Annexin A2;9606;
5N8P;A;S-layer protein RsaA from C. crescentus;2.7;CA;CALCIUM ION;S-layer protein;155892;
5N8P;B;S-layer protein RsaA from C. crescentus;2.7;CA;CALCIUM ION;S-layer protein;155892;
5N8P;C;S-layer protein RsaA from C. crescentus;2.7;CA;CALCIUM ION;S-layer protein;155892;
5N8P;D;S-layer protein RsaA from C. crescentus;2.7;CA;CALCIUM ION;S-layer protein;155892;
5N8P;E;S-layer protein RsaA from C. crescentus;2.7;CA;CALCIUM ION;S-layer protein;155892;
5N8P;F;S-layer protein RsaA from C. crescentus;2.7;CA;CALCIUM ION;S-layer protein;155892;
5N97;A;Structure of the C. crescentus S-layer;7.4;CA;CALCIUM ION;S-layer protein rsaA;155892;
5N97;B;Structure of the C. crescentus S-layer;7.4;CA;CALCIUM ION;S-layer protein rsaA;155892;
5N97;C;Structure of the C. crescentus S-layer;7.4;CA;CALCIUM ION;S-layer protein rsaA;155892;
5N97;D;Structure of the C. crescentus S-layer;7.4;CA;CALCIUM ION;S-layer protein rsaA;155892;
5N97;E;Structure of the C. crescentus S-layer;7.4;CA;CALCIUM ION;S-layer protein rsaA;155892;
5N97;F;Structure of the C. crescentus S-layer;7.4;CA;CALCIUM ION;S-layer protein rsaA;155892;
5NBL;A;Crystal structure of the Arp4-N-actin(APO-state) heterodimer bound by a nanobody;2.8;CA;CALCIUM ION;Actin-related protein 4;4932;
5NBL;B;Crystal structure of the Arp4-N-actin(APO-state) heterodimer bound by a nanobody;2.8;CA;CALCIUM ION;Actin-related protein 4;4932;
5NBM;A;Crystal structure of the Arp4-N-actin(ATP-state) heterodimer bound by a nanobody;3.4;CA;CALCIUM ION;Actin-related protein 4;4932;
5NBM;B;Crystal structure of the Arp4-N-actin(ATP-state) heterodimer bound by a nanobody;3.4;CA;CALCIUM ION;Actin-related protein 4;4932;
5NBM;C;Crystal structure of the Arp4-N-actin(ATP-state) heterodimer bound by a nanobody;3.4;CA;CALCIUM ION;Actin;4932;
5NBM;D;Crystal structure of the Arp4-N-actin(ATP-state) heterodimer bound by a nanobody;3.4;CA;CALCIUM ION;Actin;4932;
5NBN;A;Crystal structure of the Arp4-N-actin-Arp8-Ino80HSA module of INO80;4;CA;CALCIUM ION;Actin-related protein 4;4932;
5NBN;B;Crystal structure of the Arp4-N-actin-Arp8-Ino80HSA module of INO80;4;CA;CALCIUM ION;Actin-related protein 4;4932;
5NBN;C;Crystal structure of the Arp4-N-actin-Arp8-Ino80HSA module of INO80;4;CA;CALCIUM ION;Actin;4932;
5NBN;D;Crystal structure of the Arp4-N-actin-Arp8-Ino80HSA module of INO80;4;CA;CALCIUM ION;Actin;4932;
5NBP;A;Bacteroides ovatus mixed linkage glucan PUL (MLGUL) GH16 in complex with G4G4G3G Product;1.8;CA;CALCIUM ION;Glycosyl hydrolase family 16;28116;
5NBP;B;Bacteroides ovatus mixed linkage glucan PUL (MLGUL) GH16 in complex with G4G4G3G Product;1.8;CA;CALCIUM ION;Glycosyl hydrolase family 16;28116;
5NCX;A;Crystal structure of Thermoanaerobacterium xylolyticum GH116 beta-glucosidase with an covalent inhibitor;1.7;CA;CALCIUM ION;Glucosylceramidase;29329;
5NE5;A;Crystal structure of family 47 alpha-1,2-mannosidase from Caulobacter K31 strain in complex with kifunensine;1.05;CA;CALCIUM ION;Mannosyl-oligosaccharide 1,2-alpha-mannosidase;366602;
5NEM;A;Localised reconstruction of alpha v beta 6 bound to Foot and Mouth Disease Virus O PanAsia - Pose A.;10.8;CA;CALCIUM ION;Integrin alpha-V;9606;
5NER;A;Localised reconstruction of alpha v beta 6 bound to Foot and Mouth Disease Virus O PanAsia - Pose A prime.;11.5;CA;CALCIUM ION;Integrin alpha-V;9606;
5NES;A;Discovery, crystal structures and atomic force microscopy study of thioether ligated D,L-cyclic antimicrobial peptides against multidrug resistant Pseudomonas aeruginosa;1.61;CA;CALCIUM ION;Fucose-binding lectin II (PA-IIL);287;
5NES;B;Discovery, crystal structures and atomic force microscopy study of thioether ligated D,L-cyclic antimicrobial peptides against multidrug resistant Pseudomonas aeruginosa;1.61;CA;CALCIUM ION;Fucose-binding lectin II (PA-IIL);287;
5NES;C;Discovery, crystal structures and atomic force microscopy study of thioether ligated D,L-cyclic antimicrobial peptides against multidrug resistant Pseudomonas aeruginosa;1.61;CA;CALCIUM ION;Fucose-binding lectin II (PA-IIL);287;
5NES;D;Discovery, crystal structures and atomic force microscopy study of thioether ligated D,L-cyclic antimicrobial peptides against multidrug resistant Pseudomonas aeruginosa;1.61;CA;CALCIUM ION;Fucose-binding lectin II (PA-IIL);287;
5NET;A;Localised Reconstruction of Integrin alpha V beta 6 bound to Foot and Mouth Disease Virus O1 Manisa - Pose A.;8.6;CA;CALCIUM ION;Integrin alpha-V;9606;
5NEU;B;Localised Reconstruction of Integrin alpha V beta 6 bound to Foot and Mouth Disease Virus O1 Manisa - Pose B.;12.3;CA;CALCIUM ION;Integrin beta-6;9606;
5NEY;A;Discovery, crystal structures and atomic force microscopy study of thioether ligated D,L-cyclic antimicrobial peptides against multidrug resistant Pseudomonas aeruginosa;1.55;CA;CALCIUM ION;Fucose-binding lectin II (PA-IIL);287;
5NEY;B;Discovery, crystal structures and atomic force microscopy study of thioether ligated D,L-cyclic antimicrobial peptides against multidrug resistant Pseudomonas aeruginosa;1.55;CA;CALCIUM ION;Fucose-binding lectin II (PA-IIL);287;
5NEY;C;Discovery, crystal structures and atomic force microscopy study of thioether ligated D,L-cyclic antimicrobial peptides against multidrug resistant Pseudomonas aeruginosa;1.55;CA;CALCIUM ION;Fucose-binding lectin II (PA-IIL);287;
5NEY;D;Discovery, crystal structures and atomic force microscopy study of thioether ligated D,L-cyclic antimicrobial peptides against multidrug resistant Pseudomonas aeruginosa;1.55;CA;CALCIUM ION;Fucose-binding lectin II (PA-IIL);287;
5NF0;A;Discovery, crystal structures and atomic force microscopy study of thioether ligated D,L-cyclic antimicrobial peptides against multidrug resistant Pseudomonas aeruginosa;1.27;CA;CALCIUM ION;Fucose-binding lectin II (PA-IIL);287;
5NF0;B;Discovery, crystal structures and atomic force microscopy study of thioether ligated D,L-cyclic antimicrobial peptides against multidrug resistant Pseudomonas aeruginosa;1.27;CA;CALCIUM ION;Fucose-binding lectin II (PA-IIL);287;
5NF0;C;Discovery, crystal structures and atomic force microscopy study of thioether ligated D,L-cyclic antimicrobial peptides against multidrug resistant Pseudomonas aeruginosa;1.27;CA;CALCIUM ION;Fucose-binding lectin II (PA-IIL);287;
5NF0;D;Discovery, crystal structures and atomic force microscopy study of thioether ligated D,L-cyclic antimicrobial peptides against multidrug resistant Pseudomonas aeruginosa;1.27;CA;CALCIUM ION;Fucose-binding lectin II (PA-IIL);287;
5NF2;A;The fimbrial shaft protein Mfa1 from Porphyromonas gingivalis;1.73;CA;CALCIUM ION;Minor fimbrium subunit Mfa1;837;
5NF3;A;The fimbrial shaft protein Mfa1 from Porphyromonas gingivalis-C-terminal deletion;1.97;CA;CALCIUM ION;Minor fimbrium subunit Mfa1;837;
5NFZ;A;TUBULIN-MTC complex;2.1;CA;CALCIUM ION;Tubulin alpha-1B chain;9913;
5NFZ;B;TUBULIN-MTC complex;2.1;CA;CALCIUM ION;Tubulin beta-2B chain;9913;
5NFZ;C;TUBULIN-MTC complex;2.1;CA;CALCIUM ION;Tubulin alpha-1B chain;9913;
5NG1;A;TUBULIN-MTC-zampanolide complex;2.2;CA;CALCIUM ION;Tubulin alpha-1B chain;9913;
5NG1;C;TUBULIN-MTC-zampanolide complex;2.2;CA;CALCIUM ION;Tubulin alpha-1B chain;9913;
5NGQ;A;Bicyclic antimicrobial peptides;1.17;CA;CALCIUM ION;Fucose-binding lectin II (PA-IIL);287;
5NGQ;B;Bicyclic antimicrobial peptides;1.17;CA;CALCIUM ION;Fucose-binding lectin II (PA-IIL);287;
5NGQ;C;Bicyclic antimicrobial peptides;1.17;CA;CALCIUM ION;Fucose-binding lectin II (PA-IIL);287;
5NGQ;D;Bicyclic antimicrobial peptides;1.17;CA;CALCIUM ION;Fucose-binding lectin II (PA-IIL);287;
5NGY;A;Crystal structure of Leuconostoc citreum NRRL B-1299 dextransucrase DSR-M;3.7;CA;CALCIUM ION;DSR-M glucansucrase inactive mutant E715Q;33964;
5NGY;B;Crystal structure of Leuconostoc citreum NRRL B-1299 dextransucrase DSR-M;3.7;CA;CALCIUM ION;DSR-M glucansucrase inactive mutant E715Q;33964;
5NH5;A;Crystal structure of native xylose isomerase from Piromyces E2;1.8;CA;CALCIUM ION;Xylose isomerase;73868;
5NH5;B;Crystal structure of native xylose isomerase from Piromyces E2;1.8;CA;CALCIUM ION;Xylose isomerase;73868;
5NH5;C;Crystal structure of native xylose isomerase from Piromyces E2;1.8;CA;CALCIUM ION;Xylose isomerase;73868;
5NH5;D;Crystal structure of native xylose isomerase from Piromyces E2;1.8;CA;CALCIUM ION;Xylose isomerase;73868;
5NH8;A;Crystal structure of xylose isomerase from Piromyces E2 in complex with two Ca2+ ions and xylose;1.86;CA;CALCIUM ION;Xylose isomerase;73868;
5NH8;B;Crystal structure of xylose isomerase from Piromyces E2 in complex with two Ca2+ ions and xylose;1.86;CA;CALCIUM ION;Xylose isomerase;73868;
5NH8;C;Crystal structure of xylose isomerase from Piromyces E2 in complex with two Ca2+ ions and xylose;1.86;CA;CALCIUM ION;Xylose isomerase;73868;
5NH8;D;Crystal structure of xylose isomerase from Piromyces E2 in complex with two Ca2+ ions and xylose;1.86;CA;CALCIUM ION;Xylose isomerase;73868;
5NIN;A;Crystal Structure of AKAP79 calmodulin binding domain peptide in complex with Ca2+/Calmodulin;1.7;CA;CALCIUM ION;Calmodulin;9606;
5NIN;B;Crystal Structure of AKAP79 calmodulin binding domain peptide in complex with Ca2+/Calmodulin;1.7;CA;CALCIUM ION;Calmodulin;9606;
5NL7;A;The crystal structure of the Actin Binding Domain (ABD) of alpha actinin from Entamoeba histolytica;2.48;CA;CALCIUM ION;Calponin homology domain protein putative;5759;
5NM8;B;Structure of PipY, the COG0325 family member of Synechococcus elongatus PCC7942, with PLP bound;1.93;CA;CALCIUM ION;PipY;32046;
5NMR;A;Monomeric mouse Sortilin extracellular domain;2.1;CA;CALCIUM ION;Sortilin;10090;
5NN9;A;REFINED ATOMIC STRUCTURES OF N9 SUBTYPE INFLUENZA VIRUS NEURAMINIDASE AND ESCAPE MUTANTS;2.3;CA;CALCIUM ION;NEURAMINIDASE N9;11320;
5NPF;A;Crystal structure of txGH116 (beta-glucosidase from Thermoanaerobacterium xylolyticum) in complex with beta Cyclophellitol Cyclosulfate probe ME594;1.38;CA;CALCIUM ION;Glucosylceramidase;29329;
5NQ2;A;'Porcine (Sus scrofa) Major Histocompatibility Complex, class I, presenting IAYERMCNI;1.54;CA;CALCIUM ION;MHC class I antigen;9823;
5NRK;B;Crystal structure of the sixth cohesin from Acetivibrio cellulolyticus' scaffoldin B in complex with Cel5 dockerin S15I, I16N mutant;1.45;CA;CALCIUM ION;DocCel5: Type I dockerin repeat domain from A. cellulolyticus family 5 endoglucanase WP_010249057 S15I, I16N mutant;35830;
5NRK;D;Crystal structure of the sixth cohesin from Acetivibrio cellulolyticus' scaffoldin B in complex with Cel5 dockerin S15I, I16N mutant;1.45;CA;CALCIUM ION;DocCel5: Type I dockerin repeat domain from A. cellulolyticus family 5 endoglucanase WP_010249057 S15I, I16N mutant;35830;
5NRM;B;Crystal structure of the sixth cohesin from Acetivibrio cellulolyticus' scaffoldin B in complex with Cel5 dockerin S51I, L52N mutant;1.4;CA;CALCIUM ION;DocCel5: Type I dockerin repeat domain from A. cellulolyticus family 5 endoglucanase WP_010249057 S51I, L52N mutant;35830;
5NRT;A;Cys-Gly dipeptidase GliJ in complex with Ca2+;2.2;CA;CALCIUM ION;Dipeptidase gliJ;746128;
5NSA;A;Beta domain of human transcobalamin bound to Co-beta-[2-(2,4-difluorophenyl)ethinyl]cobalamin;1.27;CA;CALCIUM ION;Transcobalamin-2;9606;
5NSF;A;Structure of AzuAla;2.43;CA;CALCIUM ION;Tyrosine--tRNA ligase;2190;
5NSF;B;Structure of AzuAla;2.43;CA;CALCIUM ION;Tyrosine--tRNA ligase;2190;
5NUC;A;STAPHYLOCOCCAL NUCLEASE, 1-N-PENTANE THIOL DISULFIDE TO V23C VARIANT;2.1;CA;CALCIUM ION;STAPHYLOCOCCAL NUCLEASE;1280;
5NUR;A;Structural basis for maintenance of bacterial outer membrane lipid asymmetry;3.29;CA;CALCIUM ION;Outer membrane protein F;562;
5NUR;C;Structural basis for maintenance of bacterial outer membrane lipid asymmetry;3.29;CA;CALCIUM ION;Outer membrane protein F;562;
5NUR;E;Structural basis for maintenance of bacterial outer membrane lipid asymmetry;3.29;CA;CALCIUM ION;Outer membrane protein F;562;
5NWE;A;Complex of H275Y mutant variant of neuraminidase from H1N1 influenza virus with oseltamivir;2;CA;CALCIUM ION;Neuraminidase;11320;
5NWE;B;Complex of H275Y mutant variant of neuraminidase from H1N1 influenza virus with oseltamivir;2;CA;CALCIUM ION;Neuraminidase;11320;
5NWE;C;Complex of H275Y mutant variant of neuraminidase from H1N1 influenza virus with oseltamivir;2;CA;CALCIUM ION;Neuraminidase;11320;
5NWE;D;Complex of H275Y mutant variant of neuraminidase from H1N1 influenza virus with oseltamivir;2;CA;CALCIUM ION;Neuraminidase;11320;
5NXB;A;Mouse galactocerebrosidase in complex with saposin A;3.6;CA;CALCIUM ION;Galactocerebrosidase;10090;
5NXB;B;Mouse galactocerebrosidase in complex with saposin A;3.6;CA;CALCIUM ION;Galactocerebrosidase;10090;
5NXL;A;Formylglycine generating enzyme from T. curvata in complex with Ag(I);1.66;CA;CALCIUM ION;Non-specific serine/threonine protein kinase;2020;
5NXN;A;Structure of a L5-deletion mutant of Providencia stuartii Omp-Pst1;3.12;CA;CALCIUM ION;Porin 1;588;
5NXR;A;Trimeric structure of Omp-Pst1, the major porin from Providencia stuartii;2.7;CA;CALCIUM ION;Porin 1;588;
5NXU;B;Complex structure with maltose of Providencia stuartii Omp-Pst1 porin;3;CA;CALCIUM ION;Porin 1;588;
5NYY;A;Formylglycine generating enzyme from T. curvata in complex with Cd(II);1.28;CA;CALCIUM ION;Non-specific serine/threonine protein kinase;2020;
5NZ4;A;Complex of I223V mutant variant of neuraminidase from H1N1 influenza virus with oseltamivir;1.36;CA;CALCIUM ION;neuraminidase;11309;
5NZ4;B;Complex of I223V mutant variant of neuraminidase from H1N1 influenza virus with oseltamivir;1.36;CA;CALCIUM ION;neuraminidase;11309;
5NZE;A;Complex of S247N mutant variant of neuraminidase from H1N1 influenza virus with oseltamivir;1.69;CA;CALCIUM ION;Neuraminidase;11309;
5NZE;B;Complex of S247N mutant variant of neuraminidase from H1N1 influenza virus with oseltamivir;1.69;CA;CALCIUM ION;Neuraminidase;11309;
5NZF;A;Complex of H275Y/I223V mutant variant of neuraminidase from H1N1 influenza virus with oseltamivir;1.75;CA;CALCIUM ION;Neuraminidase;11309;
5NZF;B;Complex of H275Y/I223V mutant variant of neuraminidase from H1N1 influenza virus with oseltamivir;1.75;CA;CALCIUM ION;Neuraminidase;11309;
5NZF;C;Complex of H275Y/I223V mutant variant of neuraminidase from H1N1 influenza virus with oseltamivir;1.75;CA;CALCIUM ION;Neuraminidase;11309;
5NZF;D;Complex of H275Y/I223V mutant variant of neuraminidase from H1N1 influenza virus with oseltamivir;1.75;CA;CALCIUM ION;Neuraminidase;11309;
5NZN;A;Complex of H275Y/S247N mutant variant of neuraminidase from H1N1 influenza virus with oseltamivir;1.73;CA;CALCIUM ION;Neuraminidase;11309;
5NZN;B;Complex of H275Y/S247N mutant variant of neuraminidase from H1N1 influenza virus with oseltamivir;1.73;CA;CALCIUM ION;Neuraminidase;11309;
5NZN;C;Complex of H275Y/S247N mutant variant of neuraminidase from H1N1 influenza virus with oseltamivir;1.73;CA;CALCIUM ION;Neuraminidase;11309;
5NZN;D;Complex of H275Y/S247N mutant variant of neuraminidase from H1N1 influenza virus with oseltamivir;1.73;CA;CALCIUM ION;Neuraminidase;11309;
5O0S;A;Crystal structure of txGH116 (beta-glucosidase from Thermoanaerobacterium xylolyticum) in complex with unreacted beta Cyclophellitol Cyclosulfate probe ME711;1.16;CA;CALCIUM ION;Glucosylceramidase;29329;
5O0Z;A;Structure of laspartomycin C in complex with geranyl-phosphate;1.28;CA;CALCIUM ION;Laspartomycin C;1938;
5O0Z;B;Structure of laspartomycin C in complex with geranyl-phosphate;1.28;CA;CALCIUM ION;Laspartomycin C;1938;
5O1U;B;Structure of wildtype T.maritima PDE (TM1595) with AMP and Mn2+;1.9;CA;CALCIUM ION;Phosphodiesterase;2336;
5O25;B;Structure of wildtype T.maritima PDE (TM1595) in ligand-free state;1.75;CA;CALCIUM ION;TmPDE;2336;
5O2Y;A;NMR structure of the calcium bound form of PulG, major pseudopilin from Klebsiella oxytoca T2SS;;CA;CALCIUM ION;General secretion pathway protein G;571;
5O2Z;A;Domain swap dimer of the G167R variant of gelsolin second domain;1.7;CA;CALCIUM ION;Gelsolin;9606;
5O2Z;B;Domain swap dimer of the G167R variant of gelsolin second domain;1.7;CA;CALCIUM ION;Gelsolin;9606;
5O32;A;The structure of complement complex;4.21;CA;CALCIUM ION;Complement C3;9606;
5O32;D;The structure of complement complex;4.21;CA;CALCIUM ION;Complement factor I;9606;
5O32;E;The structure of complement complex;4.21;CA;CALCIUM ION;Complement C3;9606;
5O32;H;The structure of complement complex;4.21;CA;CALCIUM ION;Complement factor I;9606;
5O5R;A;X-ray structure of human glutamate carboxypeptidase II (GCPII) in complex with a urea based inhibitor PSMA 1023;1.65;CA;CALCIUM ION;Glutamate carboxypeptidase 2;9606;
5O5T;A;X-ray structure of human glutamate carboxypeptidase II (GCPII) in complex with a urea based inhibitor PSMA 1007;1.43;CA;CALCIUM ION;Glutamate carboxypeptidase 2;9606;
5O5U;A;X-ray structure of human glutamate carboxypeptidase II (GCPII) in complex with a urea based inhibitor PSMA 1027;1.53;CA;CALCIUM ION;Glutamate carboxypeptidase 2;9606;
5O6N;A;High pressure flash cooled concanavalin A;1.35;CA;CALCIUM ION;Concanavalin-A,Concanavalin-A;3823;
5O76;A;Structure of phosphoY371 c-CBL in complex with ZAP70-peptide and UbV.pCBL ubiquitin variant;2.47;CA;CALCIUM ION;E3 ubiquitin-protein ligase CBL;9606;
5O76;C;Structure of phosphoY371 c-CBL in complex with ZAP70-peptide and UbV.pCBL ubiquitin variant;2.47;CA;CALCIUM ION;E3 ubiquitin-protein ligase CBL;9606;
5O7E;A;Crystal structure of the peptidase domain of collagenase H from Clostridium histolyticum in complex with N-aryl mercaptoacetamide-based inhibitor;1.87;CA;CALCIUM ION;ColH protein;1498;
5O7U;B;Crystal structure of the 7-Fluorotryptophan RSL lectin in complex with Lewis x tetrasaccharide;1.15;CA;CALCIUM ION;Putative fucose-binding lectin protein;305;
5O7W;B;Crystal structure of the 4-FLUORO RSL lectin in complex with Lewis x tetrasaccharide;1.35;CA;CALCIUM ION;Putative fucose-binding lectin protein;305;
5O8L;A;Crystal structure of Leuconostoc citreum NRRL B-1299 N-terminally truncated dextransucrase DSR-M in complex with sucrose;3.6;CA;CALCIUM ION;Alternansucrase;33964;
5O8N;A;Structure of thermolysin at room temperature via a method of acoustically induced rotation.;1.9;CA;CALCIUM ION;Thermolysin;1427;
5O8X;A;The X-ray Structure of Catenated Lytic Transglycosylase SltB1 from Pseudomonas aeruginosa;2.5;CA;CALCIUM ION;Soluble lytic transglycosylase B;287;
5O8X;B;The X-ray Structure of Catenated Lytic Transglycosylase SltB1 from Pseudomonas aeruginosa;2.5;CA;CALCIUM ION;Soluble lytic transglycosylase B;287;
5OC9;A;Crystal Structure of human TMEM16K / Anoctamin 10;3.2;CA;CALCIUM ION;Anoctamin-10;9606;
5OC9;B;Crystal Structure of human TMEM16K / Anoctamin 10;3.2;CA;CALCIUM ION;Anoctamin-10;9606;
5ODC;F;Heterodisulfide reductase / [NiFe]-hydrogenase complex from Methanothermococcus thermolithotrophicus at 2.3 A resolution;2.3;CA;CALCIUM ION;Methyl-viologen reducing hydrogenase subunit A;2186;
5ODC;L;Heterodisulfide reductase / [NiFe]-hydrogenase complex from Methanothermococcus thermolithotrophicus at 2.3 A resolution;2.3;CA;CALCIUM ION;Methyl-viologen reducing hydrogenase subunit A;2186;
5ODU;A;PllA lectin, monosaccharide complex;1.56;CA;CALCIUM ION;PllA;29488;
5ODU;B;PllA lectin, monosaccharide complex;1.56;CA;CALCIUM ION;PllA;29488;
5ODU;C;PllA lectin, monosaccharide complex;1.56;CA;CALCIUM ION;PllA;29488;
5ODU;D;PllA lectin, monosaccharide complex;1.56;CA;CALCIUM ION;PllA;29488;
5ODU;E;PllA lectin, monosaccharide complex;1.56;CA;CALCIUM ION;PllA;29488;
5ODU;F;PllA lectin, monosaccharide complex;1.56;CA;CALCIUM ION;PllA;29488;
5ODU;G;PllA lectin, monosaccharide complex;1.56;CA;CALCIUM ION;PllA;29488;
5ODU;H;PllA lectin, monosaccharide complex;1.56;CA;CALCIUM ION;PllA;29488;
5OEO;A;Solution structure of the complex of TRPV5(655-725) with a Calmodulin E32Q/E68Q double mutant;;CA;CALCIUM ION;Calmodulin-1;9606;
5OF0;A;X-ray structure of human glutamate carboxypeptidase II (GCPII), the E424M inactive mutant, in complex with a inhibitor CFBzOG;1.48;CA;CALCIUM ION;Glutamate carboxypeptidase 2;9606;
5OFI;A;PllA lectin, Fluorophore carbohydrate complex;2;CA;CALCIUM ION;PIIA;29488;
5OFI;B;PllA lectin, Fluorophore carbohydrate complex;2;CA;CALCIUM ION;PIIA;29488;
5OFI;C;PllA lectin, Fluorophore carbohydrate complex;2;CA;CALCIUM ION;PIIA;29488;
5OFI;D;PllA lectin, Fluorophore carbohydrate complex;2;CA;CALCIUM ION;PIIA;29488;
5OFI;E;PllA lectin, Fluorophore carbohydrate complex;2;CA;CALCIUM ION;PIIA;29488;
5OFI;F;PllA lectin, Fluorophore carbohydrate complex;2;CA;CALCIUM ION;PIIA;29488;
5OFI;G;PllA lectin, Fluorophore carbohydrate complex;2;CA;CALCIUM ION;PIIA;29488;
5OFI;H;PllA lectin, Fluorophore carbohydrate complex;2;CA;CALCIUM ION;PIIA;29488;
5OFX;A;Plla lectin, trisaccharide complex;1.75;CA;CALCIUM ION;PllA;2218628;
5OFX;B;Plla lectin, trisaccharide complex;1.75;CA;CALCIUM ION;PllA;2218628;
5OFX;C;Plla lectin, trisaccharide complex;1.75;CA;CALCIUM ION;PllA;2218628;
5OFX;D;Plla lectin, trisaccharide complex;1.75;CA;CALCIUM ION;PllA;2218628;
5OFX;E;Plla lectin, trisaccharide complex;1.75;CA;CALCIUM ION;PllA;2218628;
5OFX;F;Plla lectin, trisaccharide complex;1.75;CA;CALCIUM ION;PllA;2218628;
5OFX;G;Plla lectin, trisaccharide complex;1.75;CA;CALCIUM ION;PllA;2218628;
5OFX;H;Plla lectin, trisaccharide complex;1.75;CA;CALCIUM ION;PllA;2218628;
5OHI;A;Crystal structure of autotaxin in complex with BI-2545;1.66;CA;CALCIUM ION;Ectonucleotide pyrophosphatase/phosphodiesterase family member 2;10090;
5OHT;A;A GH31 family sulfoquinovosidase from E. coli in complex with aza-sugar inhibitor IFGSQ;1.87;CA;CALCIUM ION;Sulfoquinovosidase;562;
5OHT;B;A GH31 family sulfoquinovosidase from E. coli in complex with aza-sugar inhibitor IFGSQ;1.87;CA;CALCIUM ION;Sulfoquinovosidase;562;
5OK8;B;Crystal structure of protein Lpp20 (HP1456) from Helicobacter pylori;1.87;CA;CALCIUM ION;LPP20 lipoprotein;210;
5OL2;A;The electron transferring flavoprotein/butyryl-CoA dehydrogenase complex from Clostridium difficile;3.1;CA;CALCIUM ION;Electron transfer flavoprotein large subunit;1496;
5OL2;C;The electron transferring flavoprotein/butyryl-CoA dehydrogenase complex from Clostridium difficile;3.1;CA;CALCIUM ION;Acyl-CoA dehydrogenase;1496;
5OL2;D;The electron transferring flavoprotein/butyryl-CoA dehydrogenase complex from Clostridium difficile;3.1;CA;CALCIUM ION;Electron transfer flavoprotein large subunit;1496;
5OL2;E;The electron transferring flavoprotein/butyryl-CoA dehydrogenase complex from Clostridium difficile;3.1;CA;CALCIUM ION;Electron transfer flavoprotein small subunit;1496;
5OL2;F;The electron transferring flavoprotein/butyryl-CoA dehydrogenase complex from Clostridium difficile;3.1;CA;CALCIUM ION;Acyl-CoA dehydrogenase;1496;
5OL7;A;Crystal structure of an inactivated Npu SICLOPPS intein with CFAHPQ extein;1.6;CA;CALCIUM ION;DNA-directed DNA polymerase,DNA-directed DNA polymerase;272131;
5OLB;A;crystal structure of autotaxin in complex with PF-8380;1.82;CA;CALCIUM ION;Ectonucleotide pyrophosphatase/phosphodiesterase family member 2;10090;
5OLP;A;Galacturonidase;2;CA;CALCIUM ION;Pectate lyase;818;
5OLP;B;Galacturonidase;2;CA;CALCIUM ION;Pectate lyase;818;
5OLQ;A;Rhamnogalacturonan lyase;1.48;CA;CALCIUM ION;Rhamnogalacturonan lyase;818;
5OLQ;B;Rhamnogalacturonan lyase;1.48;CA;CALCIUM ION;Rhamnogalacturonan lyase;818;
5OLQ;C;Rhamnogalacturonan lyase;1.48;CA;CALCIUM ION;Rhamnogalacturonan lyase;818;
5OLR;A;Rhamnogalacturonan lyase;1.07;CA;CALCIUM ION;Rhamnogalacturonan lyase;818;
5OLR;B;Rhamnogalacturonan lyase;1.07;CA;CALCIUM ION;Rhamnogalacturonan lyase;818;
5OLR;C;Rhamnogalacturonan lyase;1.07;CA;CALCIUM ION;Rhamnogalacturonan lyase;818;
5OLS;A;Rhamnogalacturonan lyase;2.2;CA;CALCIUM ION;Rhamnogalacturonan lyase;818;
5OLW;A;5-fluorotryptophan labeled beta-phosphoglucomutase in an open conformation;2.28;CA;CALCIUM ION;Beta-phosphoglucomutase;1358;
5OLW;B;5-fluorotryptophan labeled beta-phosphoglucomutase in an open conformation;2.28;CA;CALCIUM ION;Beta-phosphoglucomutase;1358;
5ONP;A;Alzheimer's Amyloid-Beta Peptide Fragment 1-40 in Complex with Cd-substituted Thermolysin;1.34;CA;CALCIUM ION;Thermolysin;1422;
5ONQ;A;Alzheimer's Amyloid-Beta Peptide Fragment 29-40 in Complex with Cd-substituted Thermolysin;1.17;CA;CALCIUM ION;Thermolysin;1422;
5ONR;A;Alzheimer's Amyloid-Beta Peptide Fragment 1-40 in Complex with Thermolysin;1.39;CA;CALCIUM ION;Thermolysin;1427;
5OP3;A;Designed Ankyrin Repeat Protein (DARPin) NDNH-1 selected by directed evolution against Lysozyme;1.36;CA;CALCIUM ION;DARPin NDNH-1;32630;
5OSK;C;Tubulin-7j complex;2.11;CA;CALCIUM ION;Tubulin alpha-1B chain;9913;
5OSQ;A;ZP-N domain of mammalian sperm receptor ZP3 (crystal form II, processed in P21221);2.05;CA;CALCIUM ION;Maltose-binding periplasmic protein,Zona pellucida sperm-binding protein 3;56,210,090;
5OSQ;B;ZP-N domain of mammalian sperm receptor ZP3 (crystal form II, processed in P21221);2.05;CA;CALCIUM ION;Maltose-binding periplasmic protein,Zona pellucida sperm-binding protein 3;56,210,090;
5OST;A;Beta-glucosidase from Thermoanaerobacterium xylolyticum GH116 in complex with Gluco-1H-imidazole;2.1;CA;CALCIUM ION;Glucosylceramidase;29329;
5OT1;A;The type III pullulan hydrolase from Thermococcus kodakarensis;2.8;CA;CALCIUM ION;Pullulanase type II, GH13 family;311400;
5OTJ;C;Monomeric polcalcin (Phl p 7) in complex with two identical allergen-specific antibodies;2.35;CA;CALCIUM ION;Polcalcin Phl p 7;15957;
5OTJ;D;Monomeric polcalcin (Phl p 7) in complex with two identical allergen-specific antibodies;2.35;CA;CALCIUM ION;Polcalcin Phl p 7;15957;
5OTN;A;Crystal structure of zebrafish MTH1 in complex with O6-methyl-dGMP;0.99;CA;CALCIUM ION;Nudix (Nucleoside diphosphate linked moiety X)-type motif 1;7955;
5OV7;A;tubulin - rigosertib complex;2.4;CA;CALCIUM ION;Tubulin alpha-1B chain;9913;
5OW8;A;Indole-2 carboxamides as selective secreted phospholipase A2 type X (sPLA2-X) inhibitors;1.9;CA;CALCIUM ION;Group 10 secretory phospholipase A2;9606;
5OW8;B;Indole-2 carboxamides as selective secreted phospholipase A2 type X (sPLA2-X) inhibitors;1.9;CA;CALCIUM ION;Group 10 secretory phospholipase A2;9606;
5OWC;A;Indole-2 carboxamides as selective secreted phospholipase A2 type X (sPLA2-X) inhibitors;1.75;CA;CALCIUM ION;Group 10 secretory phospholipase A2;9606;
5OWC;B;Indole-2 carboxamides as selective secreted phospholipase A2 type X (sPLA2-X) inhibitors;1.75;CA;CALCIUM ION;Group 10 secretory phospholipase A2;9606;
5OWO;A;Human cytoplasmic Dynein N-Terminus dimerization domain at 1.8 Angstrom resolution;1.79;CA;CALCIUM ION;Cytoplasmic dynein 1 heavy chain 1;9606;
5OWO;D;Human cytoplasmic Dynein N-Terminus dimerization domain at 1.8 Angstrom resolution;1.79;CA;CALCIUM ION;Cytoplasmic dynein 1 heavy chain 1;9606;
5OWR;A;Human STK10 bound to dasatinib;2.3;CA;CALCIUM ION;Serine/threonine-protein kinase 10;9606;
5OXG;A;Crystal structure of the ACVR1 (ALK2) kinase in complex with LDN-212854;2.13;CA;CALCIUM ION;Activin receptor type-1;9606;
5OXG;B;Crystal structure of the ACVR1 (ALK2) kinase in complex with LDN-212854;2.13;CA;CALCIUM ION;Activin receptor type-1;9606;
5OXG;C;Crystal structure of the ACVR1 (ALK2) kinase in complex with LDN-212854;2.13;CA;CALCIUM ION;Activin receptor type-1;9606;
5OXG;D;Crystal structure of the ACVR1 (ALK2) kinase in complex with LDN-212854;2.13;CA;CALCIUM ION;Activin receptor type-1;9606;
5OXR;A;Crystal structure of human lung surfactant protein D trimeric fragment with bound ligand Salmonella enterica Minnesota R7 oligosaccharide;1.75;CA;CALCIUM ION;Pulmonary surfactant-associated protein D;9606;
5OXR;B;Crystal structure of human lung surfactant protein D trimeric fragment with bound ligand Salmonella enterica Minnesota R7 oligosaccharide;1.75;CA;CALCIUM ION;Pulmonary surfactant-associated protein D;9606;
5OXR;C;Crystal structure of human lung surfactant protein D trimeric fragment with bound ligand Salmonella enterica Minnesota R7 oligosaccharide;1.75;CA;CALCIUM ION;Pulmonary surfactant-associated protein D;9606;
5OXS;A;Crystal structure of human lung surfactant protein D trimeric fragment with bound ligand Salmonella enterica Minnesota R5 oligosaccharide;1.65;CA;CALCIUM ION;Pulmonary surfactant-associated protein D;9606;
5OXS;B;Crystal structure of human lung surfactant protein D trimeric fragment with bound ligand Salmonella enterica Minnesota R5 oligosaccharide;1.65;CA;CALCIUM ION;Pulmonary surfactant-associated protein D;9606;
5OXS;C;Crystal structure of human lung surfactant protein D trimeric fragment with bound ligand Salmonella enterica Minnesota R5 oligosaccharide;1.65;CA;CALCIUM ION;Pulmonary surfactant-associated protein D;9606;
5OY0;2;Structure of synechocystis photosystem I trimer at 2.5A resolution;2.5;CA;CALCIUM ION;Photosystem I P700 chlorophyll a apoprotein A2;1148;
5OY0;B;Structure of synechocystis photosystem I trimer at 2.5A resolution;2.5;CA;CALCIUM ION;Photosystem I P700 chlorophyll a apoprotein A2;1148;
5OY0;L;Structure of synechocystis photosystem I trimer at 2.5A resolution;2.5;CA;CALCIUM ION;Photosystem I reaction center subunit XI;1148;
5OY0;b;Structure of synechocystis photosystem I trimer at 2.5A resolution;2.5;CA;CALCIUM ION;Photosystem I P700 chlorophyll a apoprotein A2;1148;
5OY0;l;Structure of synechocystis photosystem I trimer at 2.5A resolution;2.5;CA;CALCIUM ION;Photosystem I reaction center subunit XI;1148;
5OY9;A;VSV G CR3;3.6;CA;CALCIUM ION;Glycoprotein G;1972577;
5OY9;D;VSV G CR3;3.6;CA;CALCIUM ION;Low-density lipoprotein receptor;9606;
5OYB;A;Structure of calcium-bound mTMEM16A chloride channel at 3.75 A resolution;3.75;CA;CALCIUM ION;Anoctamin-1;10090;
5OYB;B;Structure of calcium-bound mTMEM16A chloride channel at 3.75 A resolution;3.75;CA;CALCIUM ION;Anoctamin-1;10090;
5OYH;A;crystal structure of the catalytic core of a rhodopsin-guanylyl cyclase with converted specificity in complex with ATPalphaS;2.25;CA;CALCIUM ION;Nucleotide cyclase;109876;
5OYH;B;crystal structure of the catalytic core of a rhodopsin-guanylyl cyclase with converted specificity in complex with ATPalphaS;2.25;CA;CALCIUM ION;Nucleotide cyclase;109876;
5OYH;C;crystal structure of the catalytic core of a rhodopsin-guanylyl cyclase with converted specificity in complex with ATPalphaS;2.25;CA;CALCIUM ION;Nucleotide cyclase;109876;
5OYH;D;crystal structure of the catalytic core of a rhodopsin-guanylyl cyclase with converted specificity in complex with ATPalphaS;2.25;CA;CALCIUM ION;Nucleotide cyclase;109876;
5OYH;E;crystal structure of the catalytic core of a rhodopsin-guanylyl cyclase with converted specificity in complex with ATPalphaS;2.25;CA;CALCIUM ION;Nucleotide cyclase;109876;
5OYH;F;crystal structure of the catalytic core of a rhodopsin-guanylyl cyclase with converted specificity in complex with ATPalphaS;2.25;CA;CALCIUM ION;Nucleotide cyclase;109876;
5OYH;G;crystal structure of the catalytic core of a rhodopsin-guanylyl cyclase with converted specificity in complex with ATPalphaS;2.25;CA;CALCIUM ION;Nucleotide cyclase;109876;
5OYH;H;crystal structure of the catalytic core of a rhodopsin-guanylyl cyclase with converted specificity in complex with ATPalphaS;2.25;CA;CALCIUM ION;Nucleotide cyclase;109876;
5OYH;I;crystal structure of the catalytic core of a rhodopsin-guanylyl cyclase with converted specificity in complex with ATPalphaS;2.25;CA;CALCIUM ION;Nucleotide cyclase;109876;
5OYH;J;crystal structure of the catalytic core of a rhodopsin-guanylyl cyclase with converted specificity in complex with ATPalphaS;2.25;CA;CALCIUM ION;Nucleotide cyclase;109876;
5OYH;K;crystal structure of the catalytic core of a rhodopsin-guanylyl cyclase with converted specificity in complex with ATPalphaS;2.25;CA;CALCIUM ION;Nucleotide cyclase;109876;
5OYH;L;crystal structure of the catalytic core of a rhodopsin-guanylyl cyclase with converted specificity in complex with ATPalphaS;2.25;CA;CALCIUM ION;Nucleotide cyclase;109876;
5OYH;M;crystal structure of the catalytic core of a rhodopsin-guanylyl cyclase with converted specificity in complex with ATPalphaS;2.25;CA;CALCIUM ION;Nucleotide cyclase;109876;
5OYH;N;crystal structure of the catalytic core of a rhodopsin-guanylyl cyclase with converted specificity in complex with ATPalphaS;2.25;CA;CALCIUM ION;Nucleotide cyclase;109876;
5OYH;O;crystal structure of the catalytic core of a rhodopsin-guanylyl cyclase with converted specificity in complex with ATPalphaS;2.25;CA;CALCIUM ION;Nucleotide cyclase;109876;
5OYH;P;crystal structure of the catalytic core of a rhodopsin-guanylyl cyclase with converted specificity in complex with ATPalphaS;2.25;CA;CALCIUM ION;Nucleotide cyclase;109876;
5OYJ;A;Crystal structure of VEGFR-2 domains 4-5 in complex with DARPin D4b;2.38;CA;CALCIUM ION;DARPin D4b;32630;
5OYJ;C;Crystal structure of VEGFR-2 domains 4-5 in complex with DARPin D4b;2.38;CA;CALCIUM ION;Vascular endothelial growth factor receptor 2;9606;
5OYL;A;VSV G CR2;2.25;CA;CALCIUM ION;Glycoprotein;582817;
5OYL;D;VSV G CR2;2.25;CA;CALCIUM ION;Low-density lipoprotein receptor;9606;
5P2P;A;X-RAY STRUCTURE OF PHOSPHOLIPASE A2 COMPLEXED WITH A SUBSTRATE-DERIVED INHIBITOR;2.4;CA;CALCIUM ION;PHOSPHOLIPASE A2;9823;
5P2P;B;X-RAY STRUCTURE OF PHOSPHOLIPASE A2 COMPLEXED WITH A SUBSTRATE-DERIVED INHIBITOR;2.4;CA;CALCIUM ION;PHOSPHOLIPASE A2;9823;
5PA8;C;Crystal Structure of Factor VIIa in complex with cyclohexanamine;1.98;CA;CALCIUM ION;Coagulation factor VII heavy chain;9606;
5PAA;C;Crystal Structure of Factor VIIa in complex with cyclohexylmethanamine;1.98;CA;CALCIUM ION;Coagulation factor VII heavy chain;9606;
5PAB;H;Crystal Structure of Factor VIIa in complex with 1-[[3-[2-hydroxy-3-(1H-pyrrolo[3,2-c]pyridin-2-yl)phenyl]phenyl]methyl]-3-phenylurea;1.99;CA;CALCIUM ION;Coagulation factor VII heavy chain;9606;
5PAC;B;human factor VIIa in complex with 5-hydroxy-N-(4-oxo-3H-quinazolin-6-yl)-1-[3-[(phenylcarbamoylamino)methyl]phenyl]pyrazole-4-carboxamide at 1.50A;1.5;CA;CALCIUM ION;Coagulation factor VII heavy chain;9606;
5PAE;B;Crystal Structure of Factor VIIa in complex with (2S)-2-hydroxy-N-[[3-[5-hydroxy-4-(1H-pyrrolo[3,2-c]pyridin-2-yl)pyrazol-1-yl]phenyl]methyl]propanamide;1.45;CA;CALCIUM ION;Coagulation factor VII heavy chain;9606;
5PAI;B;human factor VIIa in complex with N-(2-amino-1H-benzimidazol-5-yl)-1-[3-[[(3,5-dimethyl-1,2-oxazol-4-yl)carbamoylamino]methyl]phenyl]-5-hydroxypyrazole-4-carboxamide at 1.73A;1.73;CA;CALCIUM ION;Coagulation factor VII heavy chain;9606;
5PAJ;B;Crystal Structure of Factor VIIa in complex with 1-(1-aminoisoquinolin-6-yl)-3-benzylurea;1.7;CA;CALCIUM ION;Coagulation factor VII heavy chain;9606;
5PAL;A;CRYSTAL STRUCTURE OF THE UNIQUE PARVALBUMIN COMPONENT FROM MUSCLE OF THE LEOPARD SHARK (TRIAKIS SEMIFASCIATA). THE FIRST X-RAY STUDY OF AN ALPHA-PARVALBUMIN;1.54;CA;CALCIUM ION;PARVALBUMIN;30493;
5PAM;B;Crystal Structure of Factor VIIa in complex with 2-[(1-aminoisoquinolin-6-yl)amino]-2-(5-ethoxy-2-fluorophenyl)-1-(2-phenylpyrrolidin-1-yl)ethanone;1.6;CA;CALCIUM ION;Coagulation factor VII heavy chain;9606;
5PAN;B;Crystal Structure of Factor VIIa in complex with 5-hydroxy-N-(3-oxo-1,2-dihydroisoindol-5-yl)-1-[3-[(phenylcarbamoylamino)methyl]phenyl]pyrazole-4-carboxamide;1.62;CA;CALCIUM ION;Coagulation factor VII heavy chain;9606;
5PAQ;B;Crystal Structure of Factor VIIa in complex with 2-[(1-aminoisoquinolin-6-yl)amino]-2-(3-ethoxy-4-propan-2-yloxyphenyl)-1-(2-phenylpyrrolidin-1-yl)ethanone;1.59;CA;CALCIUM ION;Coagulation factor VII heavy chain;9606;
5PAR;C;Crystal Structure of Factor VIIa in complex with 1H-benzimidazol-2-amine;2.1;CA;CALCIUM ION;Coagulation factor VII heavy chain;9606;
5PAS;C;Crystal Structure of Factor VIIa in complex with (2S)-2-hydroxy-N-[[3-[5-hydroxy-4-(1H-pyrrolo[3,2-c]pyridin-2-yl)pyrazol-1-yl]phenyl]methyl]-3-phenylpropanamide;1.48;CA;CALCIUM ION;Coagulation factor VII heavy chain;9606;
5PAV;C;Crystal Structure of Factor VIIa in complex with N-(6-aminopyridin-3-yl)-5-hydroxy-1-phenylpyrazole-4-carboxamide;1.4;CA;CALCIUM ION;Coagulation factor VII heavy chain;9606;
5PAW;B;Crystal Structure of Factor VIIa in complex with isoquinoline-1,6-diamine;2.2;CA;CALCIUM ION;Coagulation factor VII heavy chain;9606;
5PAX;C;Crystal Structure of Factor VIIa in complex with 1-(2,6-difluorophenyl)-3-[[3-[5-hydroxy-4-(1H-pyrrolo[3,2-c]pyridin-2-yl)pyrazol-1-yl]phenyl]methyl]urea;1.36;CA;CALCIUM ION;Coagulation factor VII heavy chain;9606;
5PAY;C;Crystal Structure of Factor VIIa in complex with 1-[[3-[5-hydroxy-4-(1H-pyrrolo[3,2-c]pyridin-2-yl)pyrazol-1-yl]phenyl]methyl]-3-phenylurea;1.66;CA;CALCIUM ION;Coagulation factor VII heavy chain;9606;
5PB0;B;Crystal Structure of Factor VIIa in complex with 2-(4-ethoxy-3-methoxyphenyl)-2-(isoquinolin-6-ylamino)acetic acid;1.98;CA;CALCIUM ION;Coagulation factor VII heavy chain;9606;
5PB1;D;Crystal Structure of Factor VIIa in complex with benzenecarboximidamide;1.9;CA;CALCIUM ION;Coagulation factor VII heavy chain;9606;
5PB2;C;Crystal Structure of Factor VIIa in complex with 2-phenyl-4-(1H-pyrrolo[3,2-c]pyridin-2-yl)pyrazol-3-ol;1.45;CA;CALCIUM ION;Coagulation factor VII heavy chain;9606;
5PB3;C;Crystal Structure of Factor VIIa in complex with 1-[[3-[4-(5-amino-1H-pyrrolo[3,2-b]pyridin-2-yl)-5-hydroxypyrazol-1-yl]phenyl]methyl]-3-phenylurea;1.9;CA;CALCIUM ION;Coagulation factor VII heavy chain;9606;
5PB4;C;human factor VIIa in complex with 1-[[3-[5-hydroxy-3-methyl-4-(1H-pyrrolo[3,2-c]pyridin-2-yl)pyrazol-1-yl]phenyl]methyl]-3-phenylurea at 2.43A;2.43;CA;CALCIUM ION;Coagulation factor VII heavy chain;9606;
5PB5;B;human factor VIIa in complex with 1-[[3-[5-hydroxy-4-(7H-pyrrolo[2,3-d]pyrimidin-6-yl)pyrazol-1-yl]phenyl]methyl]-3-phenylurea at 1.84A;1.84;CA;CALCIUM ION;Coagulation factor VII heavy chain;9606;
5PB6;C;Crystal Structure of Factor VIIa in complex with N-[[3-[5-hydroxy-4-(1H-pyrrolo[3,2-c]pyridin-2-yl)pyrazol-1-yl]phenyl]methyl]pentanamide;1.9;CA;CALCIUM ION;Coagulation factor VII heavy chain;9606;
5PTP;A;STRUCTURE OF HYDROLASE (SERINE PROTEINASE);1.34;CA;CALCIUM ION;BETA TRYPSIN;9913;
5QJ2;B;CRYSTAL STRUCTURE OF MYELOPEROXIDASE SUBFORM C (MPO) OMPLEX WITH COMPOUND-20 AKA 7-((3-(1-METHYL-1H-PYRAZOL-3- YL)BENZYL)OXY)- 1H-[1,2,3]TRIAZOLO[4,5-B]PYRIDIN-5-AMINE;2.82;CA;CALCIUM ION;Myeloperoxidase;9606;
5QJ2;E;CRYSTAL STRUCTURE OF MYELOPEROXIDASE SUBFORM C (MPO) OMPLEX WITH COMPOUND-20 AKA 7-((3-(1-METHYL-1H-PYRAZOL-3- YL)BENZYL)OXY)- 1H-[1,2,3]TRIAZOLO[4,5-B]PYRIDIN-5-AMINE;2.82;CA;CALCIUM ION;Myeloperoxidase;9606;
5QJ2;G;CRYSTAL STRUCTURE OF MYELOPEROXIDASE SUBFORM C (MPO) OMPLEX WITH COMPOUND-20 AKA 7-((3-(1-METHYL-1H-PYRAZOL-3- YL)BENZYL)OXY)- 1H-[1,2,3]TRIAZOLO[4,5-B]PYRIDIN-5-AMINE;2.82;CA;CALCIUM ION;Myeloperoxidase;9606;
5QJ2;I;CRYSTAL STRUCTURE OF MYELOPEROXIDASE SUBFORM C (MPO) OMPLEX WITH COMPOUND-20 AKA 7-((3-(1-METHYL-1H-PYRAZOL-3- YL)BENZYL)OXY)- 1H-[1,2,3]TRIAZOLO[4,5-B]PYRIDIN-5-AMINE;2.82;CA;CALCIUM ION;Myeloperoxidase;9606;
5QJ3;B;CRYSTAL STRUCTURE OF MYELOPEROXIDASE SUBFORM C (MPO) COMPLEX WITH COMPOUND-24 AKA 7-({4-CHLORO-3'-FLUORO-[1,1'- BIPHENYL]-3-YL}METHOXY)-3H-[1,2,3]TRIAZOLO[4,5-B]PYRIDIN- 5-AMINE;2.76;CA;CALCIUM ION;Myeloperoxidase;9606;
5QJ3;E;CRYSTAL STRUCTURE OF MYELOPEROXIDASE SUBFORM C (MPO) COMPLEX WITH COMPOUND-24 AKA 7-({4-CHLORO-3'-FLUORO-[1,1'- BIPHENYL]-3-YL}METHOXY)-3H-[1,2,3]TRIAZOLO[4,5-B]PYRIDIN- 5-AMINE;2.76;CA;CALCIUM ION;Myeloperoxidase;9606;
5SIC;E;MOLECULAR RECOGNITION AT THE ACTIVE SITE OF SUBTILISIN BPN': CRYSTALLOGRAPHIC STUDIES USING GENETICALLY ENGINEERED PROTEINACEOUS INHIBITOR SSI (STREPTOMYCES SUBTILISIN INHIBITOR);2.2;CA;CALCIUM ION;SUBTILISIN BPN';1390;
5STD;A;SCYTALONE DEHYDRATASE PLUS INHIBITOR 2;1.95;CA;CALCIUM ION;Scytalone dehydratase;148305;
5STD;B;SCYTALONE DEHYDRATASE PLUS INHIBITOR 2;1.95;CA;CALCIUM ION;Scytalone dehydratase;148305;
5STD;C;SCYTALONE DEHYDRATASE PLUS INHIBITOR 2;1.95;CA;CALCIUM ION;Scytalone dehydratase;148305;
5SV0;A;Structure of the ExbB/ExbD complex from E. coli at pH 7.0;2.6;CA;CALCIUM ION;Biopolymer transport protein ExbB;562;
5SV0;I;Structure of the ExbB/ExbD complex from E. coli at pH 7.0;2.6;CA;CALCIUM ION;Biopolymer transport protein ExbB;562;
5SVE;B;Structure of Calcineurin in complex with NFATc1 LxVP peptide;2.6;CA;CALCIUM ION;Calcineurin subunit B type 1;9606;
5SWI;A;Crystal structure of SpGH92 in complex with mannose;2.15;CA;CALCIUM ION;Sugar hydrolase;1313;
5SWI;B;Crystal structure of SpGH92 in complex with mannose;2.15;CA;CALCIUM ION;Sugar hydrolase;1313;
5SWI;C;Crystal structure of SpGH92 in complex with mannose;2.15;CA;CALCIUM ION;Sugar hydrolase;1313;
5SWI;D;Crystal structure of SpGH92 in complex with mannose;2.15;CA;CALCIUM ION;Sugar hydrolase;1313;
5SY1;C;Structure of the STRA6 receptor for retinol uptake in complex with calmodulin;3.9;CA;CALCIUM ION;Calmodulin;7108;
5SY1;D;Structure of the STRA6 receptor for retinol uptake in complex with calmodulin;3.9;CA;CALCIUM ION;Calmodulin;7108;
5SZL;A;Protocadherin gamma A1 extracellular cadherin domains 1-4;4.2;CA;CALCIUM ION;PROTOCADHERIN GAMMA A1 EXTRACELLULAR CADHERIN DOMAINS 1-4, Protein Pcdhga1;10090;
5SZL;B;Protocadherin gamma A1 extracellular cadherin domains 1-4;4.2;CA;CALCIUM ION;PROTOCADHERIN GAMMA A1 EXTRACELLULAR CADHERIN DOMAINS 1-4, Protein Pcdhga1;10090;
5SZL;C;Protocadherin gamma A1 extracellular cadherin domains 1-4;4.2;CA;CALCIUM ION;PROTOCADHERIN GAMMA A1 EXTRACELLULAR CADHERIN DOMAINS 1-4, Protein Pcdhga1;10090;
5SZL;D;Protocadherin gamma A1 extracellular cadherin domains 1-4;4.2;CA;CALCIUM ION;PROTOCADHERIN GAMMA A1 EXTRACELLULAR CADHERIN DOMAINS 1-4, Protein Pcdhga1;10090;
5SZM;A;Protocadherin gamma A8 extracellular cadherin domains 1-4;3.6;CA;CALCIUM ION;PcdhgA8 or protocadherin gamma A8;10090;
5SZN;A;Protocadherin gamma A9 extracellular cadherin domains 1-5;2.94;CA;CALCIUM ION;Protocadherin gamma A9;10090;
5SZO;A;Protocadherin Gamma B7 extracellular cadherin domains 1-4 P41212 crystal form;3.61;CA;CALCIUM ION;Protocadherin Gamma B7;10090;
5SZO;B;Protocadherin Gamma B7 extracellular cadherin domains 1-4 P41212 crystal form;3.61;CA;CALCIUM ION;Protocadherin Gamma B7;10090;
5SZP;A;Protocadherin Gamma B7 extracellular cadherin domains 1-4 P21 crystal form;3.1;CA;CALCIUM ION;Protocadherin Gamma B7;10090;
5SZP;B;Protocadherin Gamma B7 extracellular cadherin domains 1-4 P21 crystal form;3.1;CA;CALCIUM ION;Protocadherin Gamma B7;10090;
5SZQ;A;Protocadherin Gamma A4 extracellular cadherin domains 3-6;2.61;CA;CALCIUM ION;Protocadherin gamma-A4;10090;
5SZR;A;Protocadherin Gamma B2 extracellular cadherin domains 3-6;2.3;CA;CALCIUM ION;Protein Pcdhgb2;10090;
5SZR;B;Protocadherin Gamma B2 extracellular cadherin domains 3-6;2.3;CA;CALCIUM ION;Protein Pcdhgb2;10090;
5SZR;C;Protocadherin Gamma B2 extracellular cadherin domains 3-6;2.3;CA;CALCIUM ION;Protein Pcdhgb2;10090;
5T0X;A;Solution NMR-derived structure of calmodulin bound with ER alpha peptides;;CA;CALCIUM ION;Calmodulin;8355;
5T15;B;Structural basis for gating and activation of RyR1 (30 uM Ca2+ dataset, all particles);3.6;CA;CALCIUM ION;Ryanodine receptor 1,Ryanodine receptor 1,Ryanodine receptor 1,Ryanodine receptor 1,Ryanodine receptor 1,Ryanodine receptor 1,Ryanodine receptor 1;9986;
5T15;E;Structural basis for gating and activation of RyR1 (30 uM Ca2+ dataset, all particles);3.6;CA;CALCIUM ION;Ryanodine receptor 1,Ryanodine receptor 1,Ryanodine receptor 1,Ryanodine receptor 1,Ryanodine receptor 1,Ryanodine receptor 1,Ryanodine receptor 1;9986;
5T15;G;Structural basis for gating and activation of RyR1 (30 uM Ca2+ dataset, all particles);3.6;CA;CALCIUM ION;Ryanodine receptor 1,Ryanodine receptor 1,Ryanodine receptor 1,Ryanodine receptor 1,Ryanodine receptor 1,Ryanodine receptor 1,Ryanodine receptor 1;9986;
5T15;I;Structural basis for gating and activation of RyR1 (30 uM Ca2+ dataset, all particles);3.6;CA;CALCIUM ION;Ryanodine receptor 1,Ryanodine receptor 1,Ryanodine receptor 1,Ryanodine receptor 1,Ryanodine receptor 1,Ryanodine receptor 1,Ryanodine receptor 1;9986;
5T3H;A;bovine trypsin soaked with selenourea for 5 min;1.55;CA;CALCIUM ION;Cationic trypsin;9913;
5T4M;A;Crystal Structure of Human Protocadherin-15 EC3-5;2.24;CA;CALCIUM ION;Protocadherin-15;9606;
5T4M;B;Crystal Structure of Human Protocadherin-15 EC3-5;2.24;CA;CALCIUM ION;Protocadherin-15;9606;
5T4N;A;Crystal Structure of Human Protocadherin-15 EC3-5 D414A Variant;2.7;CA;CALCIUM ION;Protocadherin-15;9606;
5T4N;B;Crystal Structure of Human Protocadherin-15 EC3-5 D414A Variant;2.7;CA;CALCIUM ION;Protocadherin-15;9606;
5T4Z;H;STRUCTURE OF THE ANTI-HIV ANTIBODY DH501 THAT BINDS GP120 V3 GLYCAN AND THE BASE OF V3 WITH FREE MAN9 GLYCAN;1.99;CA;CALCIUM ION;antibody DH501 Fab heavy chain;9544;
5T4Z;L;STRUCTURE OF THE ANTI-HIV ANTIBODY DH501 THAT BINDS GP120 V3 GLYCAN AND THE BASE OF V3 WITH FREE MAN9 GLYCAN;1.99;CA;CALCIUM ION;antibody DH501 Fab light chain;9544;
5T50;A;LIGAND-FREE LECTIN FROM BAUHINIA FORFICATA;1.43;CA;CALCIUM ION;Lectin;413686;
5T50;B;LIGAND-FREE LECTIN FROM BAUHINIA FORFICATA;1.43;CA;CALCIUM ION;Lectin;413686;
5T52;A;LECTIN FROM BAUHINIA FORFICATA IN COMPLEX WITH GALNAC;1.7;CA;CALCIUM ION;Lectin;413686;
5T52;B;LECTIN FROM BAUHINIA FORFICATA IN COMPLEX WITH GALNAC;1.7;CA;CALCIUM ION;Lectin;413686;
5T54;A;LECTIN FROM BAUHINIA FORFICATA IN COMPLEX WITH BLOOD GROUP A ANTIGEN;1.65;CA;CALCIUM ION;Lectin;413686;
5T54;B;LECTIN FROM BAUHINIA FORFICATA IN COMPLEX WITH BLOOD GROUP A ANTIGEN;1.65;CA;CALCIUM ION;Lectin;413686;
5T55;A;LECTIN FROM BAUHINIA FORFICATA IN COMPLEX WITH GLOBOTETRAOSE;1.43;CA;CALCIUM ION;Lectin;413686;
5T55;B;LECTIN FROM BAUHINIA FORFICATA IN COMPLEX WITH GLOBOTETRAOSE;1.43;CA;CALCIUM ION;Lectin;413686;
5T57;A;Crystal Structure of a Semialdehyde dehydrogenase NAD-binding Protein from Cupriavidus necator in Complex with Calcium and NAD;1.65;CA;CALCIUM ION;Semialdehyde dehydrogenase NAD-binding protein;106590;
5T5I;B;TUNGSTEN-CONTAINING FORMYLMETHANOFURAN DEHYDROGENASE FROM METHANOTHERMOBACTER WOLFEII, ORTHORHOMBIC FORM AT 1.9 A;1.9;CA;CALCIUM ION;Tungsten formylmethanofuran dehydrogenase subunit B;866790;
5T5I;J;TUNGSTEN-CONTAINING FORMYLMETHANOFURAN DEHYDROGENASE FROM METHANOTHERMOBACTER WOLFEII, ORTHORHOMBIC FORM AT 1.9 A;1.9;CA;CALCIUM ION;Tungsten formylmethanofuran dehydrogenase subunit B;866790;
5T5J;A;LECTIN FROM BAUHINIA FORFICATA IN COMPLEX WITH TN-PEPTIDE;1.35;CA;CALCIUM ION;Lectin;413686;
5T5J;B;LECTIN FROM BAUHINIA FORFICATA IN COMPLEX WITH TN-PEPTIDE;1.35;CA;CALCIUM ION;Lectin;413686;
5T5L;A;LECTIN FROM BAUHINIA FORFICATA IN COMPLEX WITH TN-PEPTIDE;1.17;CA;CALCIUM ION;Lectin;413686;
5T5L;B;LECTIN FROM BAUHINIA FORFICATA IN COMPLEX WITH TN-PEPTIDE;1.17;CA;CALCIUM ION;Lectin;413686;
5T5O;A;LECTIN FROM BAUHINIA FORFICATA IN COMPLEX WITH TN-PEPTIDE;2.75;CA;CALCIUM ION;Lectin;413686;
5T5O;B;LECTIN FROM BAUHINIA FORFICATA IN COMPLEX WITH TN-PEPTIDE;2.75;CA;CALCIUM ION;Lectin;413686;
5T5O;C;LECTIN FROM BAUHINIA FORFICATA IN COMPLEX WITH TN-PEPTIDE;2.75;CA;CALCIUM ION;Lectin;413686;
5T5O;D;LECTIN FROM BAUHINIA FORFICATA IN COMPLEX WITH TN-PEPTIDE;2.75;CA;CALCIUM ION;Lectin;413686;
5T5O;E;LECTIN FROM BAUHINIA FORFICATA IN COMPLEX WITH TN-PEPTIDE;2.75;CA;CALCIUM ION;Lectin;413686;
5T5O;F;LECTIN FROM BAUHINIA FORFICATA IN COMPLEX WITH TN-PEPTIDE;2.75;CA;CALCIUM ION;Lectin;413686;
5T5O;G;LECTIN FROM BAUHINIA FORFICATA IN COMPLEX WITH TN-PEPTIDE;2.75;CA;CALCIUM ION;Lectin;413686;
5T5O;H;LECTIN FROM BAUHINIA FORFICATA IN COMPLEX WITH TN-PEPTIDE;2.75;CA;CALCIUM ION;Lectin;413686;
5T5O;I;LECTIN FROM BAUHINIA FORFICATA IN COMPLEX WITH TN-PEPTIDE;2.75;CA;CALCIUM ION;Lectin;413686;
5T5O;J;LECTIN FROM BAUHINIA FORFICATA IN COMPLEX WITH TN-PEPTIDE;2.75;CA;CALCIUM ION;Lectin;413686;
5T5P;A;LECTIN FROM BAUHINIA FORFICATA IN COMPLEX WITH TN-PEPTIDE;1.66;CA;CALCIUM ION;Lectin;413686;
5T5P;B;LECTIN FROM BAUHINIA FORFICATA IN COMPLEX WITH TN-PEPTIDE;1.66;CA;CALCIUM ION;Lectin;413686;
5T77;A;Crystal structure of the MOP flippase MurJ;2;CA;CALCIUM ION;Putative lipid II flippase MurJ;2421;
5T7P;A;Crystal structure of Pisum arvense lectin (PAL) complexed with X-Man;2.16;CA;CALCIUM ION;Lectin;3888;
5T7P;B;Crystal structure of Pisum arvense lectin (PAL) complexed with X-Man;2.16;CA;CALCIUM ION;Lectin;3888;
5T91;A;Crystal structure of B. subtilis 168 GlpQ in complex with bicine;1.53;CA;CALCIUM ION;Glycerophosphoryl diester phosphodiesterase;1423;
5T9B;G;Crystal structure of B. subtilis 168 GlpQ in complex with glycerol-3-phosphate (5 minute soak);1.62;CA;CALCIUM ION;Glycerophosphoryl diester phosphodiesterase;1423;
5T9C;E;Crystal structure of B. subtilis 168 GlpQ in complex with glycerol-3-phosphate (1 hour soak);1.48;CA;CALCIUM ION;Glycerophosphoryl diester phosphodiesterase;1423;
5T9I;A;Conformational Sampling Differences across the Arrhenius Plot Biphasic Break Point at Ambient Temperature in the Enzyme Thermolysin;2.09;CA;CALCIUM ION;Thermolysin;1427;
5T9K;A;Conformational Sampling Differences across the Arrhenius Plot Biphasic Break Point at Ambient Temperature in the Enzyme Thermolysin;2.1;CA;CALCIUM ION;Thermolysin;1427;
5T9M;B;Structure of rabbit RyR1 (Ca2+-only dataset, class 1);4;CA;CALCIUM ION;Ryanodine receptor 1;9986;
5T9M;E;Structure of rabbit RyR1 (Ca2+-only dataset, class 1);4;CA;CALCIUM ION;Ryanodine receptor 1;9986;
5T9M;G;Structure of rabbit RyR1 (Ca2+-only dataset, class 1);4;CA;CALCIUM ION;Ryanodine receptor 1;9986;
5T9M;I;Structure of rabbit RyR1 (Ca2+-only dataset, class 1);4;CA;CALCIUM ION;Ryanodine receptor 1;9986;
5T9N;B;Structure of rabbit RyR1 (Ca2+-only dataset, class 2);3.8;CA;CALCIUM ION;Ryanodine receptor 1;9986;
5T9N;E;Structure of rabbit RyR1 (Ca2+-only dataset, class 2);3.8;CA;CALCIUM ION;Ryanodine receptor 1;9986;
5T9N;G;Structure of rabbit RyR1 (Ca2+-only dataset, class 2);3.8;CA;CALCIUM ION;Ryanodine receptor 1;9986;
5T9N;I;Structure of rabbit RyR1 (Ca2+-only dataset, class 2);3.8;CA;CALCIUM ION;Ryanodine receptor 1;9986;
5T9Q;A;Conformational Sampling Differences across the Arrhenius Plot Biphasic Break Point at Ambient Temperature in the Enzyme Thermolysin;2.1;CA;CALCIUM ION;Thermolysin;1427;
5T9R;B;Structure of rabbit RyR1 (Ca2+-only dataset, class 3);5.8;CA;CALCIUM ION;Ryanodine receptor 1;9986;
5T9R;E;Structure of rabbit RyR1 (Ca2+-only dataset, class 3);5.8;CA;CALCIUM ION;Ryanodine receptor 1;9986;
5T9R;G;Structure of rabbit RyR1 (Ca2+-only dataset, class 3);5.8;CA;CALCIUM ION;Ryanodine receptor 1;9986;
5T9R;I;Structure of rabbit RyR1 (Ca2+-only dataset, class 3);5.8;CA;CALCIUM ION;Ryanodine receptor 1;9986;
5T9S;B;Structure of rabbit RyR1 (Ca2+-only dataset, class 4);4.2;CA;CALCIUM ION;Ryanodine receptor 1;9986;
5T9S;E;Structure of rabbit RyR1 (Ca2+-only dataset, class 4);4.2;CA;CALCIUM ION;Ryanodine receptor 1;9986;
5T9S;G;Structure of rabbit RyR1 (Ca2+-only dataset, class 4);4.2;CA;CALCIUM ION;Ryanodine receptor 1;9986;
5T9S;I;Structure of rabbit RyR1 (Ca2+-only dataset, class 4);4.2;CA;CALCIUM ION;Ryanodine receptor 1;9986;
5T9T;A;Protocadherin Gamma B2 extracellular cadherin domains 1-5;3.5;CA;CALCIUM ION;Protocadherin gamma B2-alpha C;10090;
5T9T;B;Protocadherin Gamma B2 extracellular cadherin domains 1-5;3.5;CA;CALCIUM ION;Protocadherin gamma B2-alpha C;10090;
5T9V;B;Structure of rabbit RyR1 (Caffeine/ATP/Ca2+ dataset, class 1);4.4;CA;CALCIUM ION;Ryanodine receptor 1;9986;
5T9V;E;Structure of rabbit RyR1 (Caffeine/ATP/Ca2+ dataset, class 1);4.4;CA;CALCIUM ION;Ryanodine receptor 1;9986;
5T9V;G;Structure of rabbit RyR1 (Caffeine/ATP/Ca2+ dataset, class 1);4.4;CA;CALCIUM ION;Ryanodine receptor 1;9986;
5T9V;I;Structure of rabbit RyR1 (Caffeine/ATP/Ca2+ dataset, class 1);4.4;CA;CALCIUM ION;Ryanodine receptor 1;9986;
5TA0;A;Crystal structure of BuGH86E322Q in complex with neoagarooctaose;1.4;CA;CALCIUM ION;Glycoside Hydrolase;820;
5TA0;B;Crystal structure of BuGH86E322Q in complex with neoagarooctaose;1.4;CA;CALCIUM ION;Glycoside Hydrolase;820;
5TA1;A;Crystal structure of BuGH86wt;2.3;CA;CALCIUM ION;Glycoside Hydrolase;820;
5TA3;B;Structure of rabbit RyR1 (Caffeine/ATP/Ca2+ dataset, class 2);4.4;CA;CALCIUM ION;Ryanodine receptor 1;9986;
5TA3;E;Structure of rabbit RyR1 (Caffeine/ATP/Ca2+ dataset, class 2);4.4;CA;CALCIUM ION;Ryanodine receptor 1;9986;
5TA3;G;Structure of rabbit RyR1 (Caffeine/ATP/Ca2+ dataset, class 2);4.4;CA;CALCIUM ION;Ryanodine receptor 1;9986;
5TA3;I;Structure of rabbit RyR1 (Caffeine/ATP/Ca2+ dataset, class 2);4.4;CA;CALCIUM ION;Ryanodine receptor 1;9986;
5TA5;A;Crystal structure of BuGH86wt in complex with neoagarooctaose;1.65;CA;CALCIUM ION;Glycoside Hydrolase;820;
5TA5;B;Crystal structure of BuGH86wt in complex with neoagarooctaose;1.65;CA;CALCIUM ION;Glycoside Hydrolase;820;
5TAC;A;Conformational Sampling Differences across the Arrhenius Plot Biphasic Break Point at Ambient Temperature in the Enzyme Thermolysin;2.04;CA;CALCIUM ION;Thermolysin;1427;
5TAD;A;Conformational Sampling Differences across the Arrhenius Plot Biphasic Break Point at Ambient Temperature in the Enzyme Thermolysin;2.09;CA;CALCIUM ION;Thermolysin;1427;
5TAE;A;Conformational Sampling Differences across the Arrhenius Plot Biphasic Break Point at Ambient Temperature in the Enzyme Thermolysin;2.3;CA;CALCIUM ION;Thermolysin;1427;
5TAI;A;Conformational Sampling Differences across the Arrhenius Plot Biphasic Break Point at Ambient Temperature in the Enzyme Thermolysin;2.3;CA;CALCIUM ION;Thermolysin;1427;
5TAJ;A;Conformational Sampling Differences across the Arrhenius Plot Biphasic Break Point at Ambient Temperature in the Enzyme Thermolysin;2.03;CA;CALCIUM ION;Thermolysin;1427;
5TAK;A;Conformational Sampling Differences across the Arrhenius Plot Biphasic Break Point at Ambient Temperature in the Enzyme Thermolysin;2;CA;CALCIUM ION;Thermolysin;1427;
5TAL;B;Structure of rabbit RyR1 (Caffeine/ATP/Ca2+ dataset, class 1&2);4.3;CA;CALCIUM ION;Ryanodine receptor 1;9986;
5TAL;E;Structure of rabbit RyR1 (Caffeine/ATP/Ca2+ dataset, class 1&2);4.3;CA;CALCIUM ION;Ryanodine receptor 1;9986;
5TAL;G;Structure of rabbit RyR1 (Caffeine/ATP/Ca2+ dataset, class 1&2);4.3;CA;CALCIUM ION;Ryanodine receptor 1;9986;
5TAL;I;Structure of rabbit RyR1 (Caffeine/ATP/Ca2+ dataset, class 1&2);4.3;CA;CALCIUM ION;Ryanodine receptor 1;9986;
5TAM;B;Structure of rabbit RyR1 (Caffeine/ATP/Ca2+ dataset, class 4);4.3;CA;CALCIUM ION;Ryanodine receptor 1;9986;
5TAM;E;Structure of rabbit RyR1 (Caffeine/ATP/Ca2+ dataset, class 4);4.3;CA;CALCIUM ION;Ryanodine receptor 1;9986;
5TAM;G;Structure of rabbit RyR1 (Caffeine/ATP/Ca2+ dataset, class 4);4.3;CA;CALCIUM ION;Ryanodine receptor 1;9986;
5TAM;I;Structure of rabbit RyR1 (Caffeine/ATP/Ca2+ dataset, class 4);4.3;CA;CALCIUM ION;Ryanodine receptor 1;9986;
5TAN;B;Structure of rabbit RyR1 (Caffeine/ATP/Ca2+ dataset, class 3);4.3;CA;CALCIUM ION;Ryanodine receptor 1;9986;
5TAN;E;Structure of rabbit RyR1 (Caffeine/ATP/Ca2+ dataset, class 3);4.3;CA;CALCIUM ION;Ryanodine receptor 1;9986;
5TAN;G;Structure of rabbit RyR1 (Caffeine/ATP/Ca2+ dataset, class 3);4.3;CA;CALCIUM ION;Ryanodine receptor 1;9986;
5TAN;I;Structure of rabbit RyR1 (Caffeine/ATP/Ca2+ dataset, class 3);4.3;CA;CALCIUM ION;Ryanodine receptor 1;9986;
5TAQ;B;Structure of rabbit RyR1 (Caffeine/ATP/Ca2+ dataset, class 3&4);4.1;CA;CALCIUM ION;Ryanodine receptor 1;9986;
5TAQ;E;Structure of rabbit RyR1 (Caffeine/ATP/Ca2+ dataset, class 3&4);4.1;CA;CALCIUM ION;Ryanodine receptor 1;9986;
5TAQ;G;Structure of rabbit RyR1 (Caffeine/ATP/Ca2+ dataset, class 3&4);4.1;CA;CALCIUM ION;Ryanodine receptor 1;9986;
5TAQ;I;Structure of rabbit RyR1 (Caffeine/ATP/Ca2+ dataset, class 3&4);4.1;CA;CALCIUM ION;Ryanodine receptor 1;9986;
5TAW;B;Structure of rabbit RyR1 (ryanodine dataset, all particles);4.4;CA;CALCIUM ION;Ryanodine receptor 1;9986;
5TAW;E;Structure of rabbit RyR1 (ryanodine dataset, all particles);4.4;CA;CALCIUM ION;Ryanodine receptor 1;9986;
5TAW;G;Structure of rabbit RyR1 (ryanodine dataset, all particles);4.4;CA;CALCIUM ION;Ryanodine receptor 1;9986;
5TAW;I;Structure of rabbit RyR1 (ryanodine dataset, all particles);4.4;CA;CALCIUM ION;Ryanodine receptor 1;9986;
5TAX;B;Structure of rabbit RyR1 (ryanodine dataset, class 1);6.6;CA;CALCIUM ION;Ryanodine receptor 1;9986;
5TAX;E;Structure of rabbit RyR1 (ryanodine dataset, class 1);6.6;CA;CALCIUM ION;Ryanodine receptor 1;9986;
5TAX;G;Structure of rabbit RyR1 (ryanodine dataset, class 1);6.6;CA;CALCIUM ION;Ryanodine receptor 1;9986;
5TAX;I;Structure of rabbit RyR1 (ryanodine dataset, class 1);6.6;CA;CALCIUM ION;Ryanodine receptor 1;9986;
5TAY;B;Structure of rabbit RyR1 (ryanodine dataset, class 2);4.6;CA;CALCIUM ION;Ryanodine receptor 1;9986;
5TAY;E;Structure of rabbit RyR1 (ryanodine dataset, class 2);4.6;CA;CALCIUM ION;Ryanodine receptor 1;9986;
5TAY;G;Structure of rabbit RyR1 (ryanodine dataset, class 2);4.6;CA;CALCIUM ION;Ryanodine receptor 1;9986;
5TAY;I;Structure of rabbit RyR1 (ryanodine dataset, class 2);4.6;CA;CALCIUM ION;Ryanodine receptor 1;9986;
5TAZ;B;Structure of rabbit RyR1 (ryanodine dataset, class 3);4.3;CA;CALCIUM ION;Ryanodine receptor 1;9986;
5TAZ;E;Structure of rabbit RyR1 (ryanodine dataset, class 3);4.3;CA;CALCIUM ION;Ryanodine receptor 1;9986;
5TAZ;G;Structure of rabbit RyR1 (ryanodine dataset, class 3);4.3;CA;CALCIUM ION;Ryanodine receptor 1;9986;
5TAZ;I;Structure of rabbit RyR1 (ryanodine dataset, class 3);4.3;CA;CALCIUM ION;Ryanodine receptor 1;9986;
5TD4;A;Starch binding sites on the Human pancreatic alpha amylase D300N variant complexed with an octaose substrate.;2.3;CA;CALCIUM ION;Pancreatic alpha-amylase;9606;
5TEA;A;Crystal structure of an inorganic pyrophosphatase from Neisseria gonorrhoeae;1.85;CA;CALCIUM ION;Inorganic pyrophosphatase;485;
5TEA;B;Crystal structure of an inorganic pyrophosphatase from Neisseria gonorrhoeae;1.85;CA;CALCIUM ION;Inorganic pyrophosphatase;485;
5TEA;C;Crystal structure of an inorganic pyrophosphatase from Neisseria gonorrhoeae;1.85;CA;CALCIUM ION;Inorganic pyrophosphatase;485;
5TEA;D;Crystal structure of an inorganic pyrophosphatase from Neisseria gonorrhoeae;1.85;CA;CALCIUM ION;Inorganic pyrophosphatase;485;
5TEA;E;Crystal structure of an inorganic pyrophosphatase from Neisseria gonorrhoeae;1.85;CA;CALCIUM ION;Inorganic pyrophosphatase;485;
5TEA;F;Crystal structure of an inorganic pyrophosphatase from Neisseria gonorrhoeae;1.85;CA;CALCIUM ION;Inorganic pyrophosphatase;485;
5TF9;A;Crystal structure of WNK1 in complex with Mn2+AMPPNP and WNK476;2.5;CA;CALCIUM ION;Serine/threonine-protein kinase WNK1;9606;
5TFK;A;Crystal Structure of Mouse Cadherin-23 EC19-21 WT;2.8;CA;CALCIUM ION;Cadherin-23;10090;
5TFL;A;Crystal Structure of Mouse Cadherin-23 EC7+8;3.56;CA;CALCIUM ION;Cadherin-23;10090;
5TFL;B;Crystal Structure of Mouse Cadherin-23 EC7+8;3.56;CA;CALCIUM ION;Cadherin-23;10090;
5TFM;A;Crystal Structure of Human Cadherin-23 EC6-8;2.92;CA;CALCIUM ION;Cadherin-23;9606;
5TG3;A;Crystal Structure of Dioclea reflexa seed lectin (DrfL) in complex with X-Man;1.76;CA;CALCIUM ION;Dioclea reflexa lectin;1048258;
5TG3;B;Crystal Structure of Dioclea reflexa seed lectin (DrfL) in complex with X-Man;1.76;CA;CALCIUM ION;Dioclea reflexa lectin;1048258;
5TG3;C;Crystal Structure of Dioclea reflexa seed lectin (DrfL) in complex with X-Man;1.76;CA;CALCIUM ION;Dioclea reflexa lectin;1048258;
5TG3;D;Crystal Structure of Dioclea reflexa seed lectin (DrfL) in complex with X-Man;1.76;CA;CALCIUM ION;Dioclea reflexa lectin;1048258;
5TGF;C;Crystal structure of putative beta-lactamase from Bacteroides dorei DSM 17855;1.81;CA;CALCIUM ION;Uncharacterized protein;357276;
5TGF;D;Crystal structure of putative beta-lactamase from Bacteroides dorei DSM 17855;1.81;CA;CALCIUM ION;Uncharacterized protein;357276;
5TGQ;A;Restriction-modification system Type II R.SwaI, DNA free;1.88;CA;CALCIUM ION;R.SwaI protein;1292;
5TGX;A;Restriction/modification system-Type II R-SwaI complexed with partially cleaved DNA;2.3;CA;CALCIUM ION;R-SwaI protein;1292;
5TGX;B;Restriction/modification system-Type II R-SwaI complexed with partially cleaved DNA;2.3;CA;CALCIUM ION;R-SwaI protein;1292;
5TGX;C;Restriction/modification system-Type II R-SwaI complexed with partially cleaved DNA;2.3;CA;CALCIUM ION;R-SwaI protein;1292;
5TGX;D;Restriction/modification system-Type II R-SwaI complexed with partially cleaved DNA;2.3;CA;CALCIUM ION;R-SwaI protein;1292;
5TH6;A;Structure determination of a potent, selective antibody inhibitor of human MMP9 (apo MMP9);1.7;CA;CALCIUM ION;Matrix metalloproteinase-9,Matrix metalloproteinase-9;9606;
5TH6;B;Structure determination of a potent, selective antibody inhibitor of human MMP9 (apo MMP9);1.7;CA;CALCIUM ION;Matrix metalloproteinase-9,Matrix metalloproteinase-9;9606;
5TH6;C;Structure determination of a potent, selective antibody inhibitor of human MMP9 (apo MMP9);1.7;CA;CALCIUM ION;Matrix metalloproteinase-9,Matrix metalloproteinase-9;9606;
5TH6;D;Structure determination of a potent, selective antibody inhibitor of human MMP9 (apo MMP9);1.7;CA;CALCIUM ION;Matrix metalloproteinase-9,Matrix metalloproteinase-9;9606;
5TH9;A;Structure determination of a potent, selective antibody inhibitor of human MMP9 (GS-5745 bound to MMP-9);3;CA;CALCIUM ION;Matrix metalloproteinase-9,Matrix metalloproteinase-9;9606;
5TH9;B;Structure determination of a potent, selective antibody inhibitor of human MMP9 (GS-5745 bound to MMP-9);3;CA;CALCIUM ION;Matrix metalloproteinase-9,Matrix metalloproteinase-9;9606;
5TH9;C;Structure determination of a potent, selective antibody inhibitor of human MMP9 (GS-5745 bound to MMP-9);3;CA;CALCIUM ION;Matrix metalloproteinase-9,Matrix metalloproteinase-9;9606;
5TI8;A;Crystal Structure of an aspartate aminotransferase from Pseudomonas;2.07;CA;CALCIUM ION;Aminotransferase;95619;
5TI8;B;Crystal Structure of an aspartate aminotransferase from Pseudomonas;2.07;CA;CALCIUM ION;Aminotransferase;95619;
5TIW;A;Schistosoma haematobium (Blood Fluke) Sulfotransferase/Racemic Oxamniquine Complex;1.66;CA;CALCIUM ION;Sulfotransferase;6185;
5TIW;B;Schistosoma haematobium (Blood Fluke) Sulfotransferase/Racemic Oxamniquine Complex;1.66;CA;CALCIUM ION;Sulfotransferase;6185;
5TJ6;A;Ca2+ bound aplysia Slo1;3.5;CA;CALCIUM ION;High conductance calcium-activated potassium channel;6500;
5TL8;A;Naegleria fowleri CYP51-posaconazole complex;1.71;CA;CALCIUM ION;Protein CYP51;5763;
5TLI;A;THERMOLYSIN (60% ISOPROPANOL SOAKED CRYSTALS);2.1;CA;CALCIUM ION;PROTEIN (THERMOLYSIN);1427;
5TLN;A;BINDING OF HYDROXAMIC ACID INHIBITORS TO CRYSTALLINE THERMOLYSIN SUGGESTS A PENTACOORDINATE ZINC INTERMEDIATE IN CATALYSIS;2.3;CA;CALCIUM ION;THERMOLYSIN;1427;
5TMN;E;Slow-and fast-binding inhibitors of thermolysin display different modes of binding. crystallographic analysis of extended phosphonamidate transition-state analogues;1.6;CA;CALCIUM ION;THERMOLYSIN;1427;
5TNC;A;REFINED CRYSTAL STRUCTURE OF TROPONIN C FROM TURKEY SKELETAL MUSCLE AT 2.0 ANGSTROMS RESOLUTION;2;CA;CALCIUM ION;TROPONIN-C;9103;
5TP0;A;Human mesotrypsin in complex with diminazene;1.25;CA;CALCIUM ION;Trypsin-3;9606;
5TP9;B;Structure of the human GluN1/GluN2A LBD in complex with compound 2 (GNE9178);2.4;CA;CALCIUM ION;Glutamate receptor ionotropic, NMDA 1;9606;
5TPK;A;Crystal Structure of Mouse Protocadherin-15 EC7-8 V875A;2;CA;CALCIUM ION;Protocadherin-15;10090;
5TQE;H;Factor VIIa in complex with the inhibitor (5R)-5-[(1-aminoisoquinolin-6-yl)amino]-19-(cyclopropylsulfonyl)-3-methyl-13-oxa-3,15-diazatricyclo[14.3.1.1~6,10~]henicosa-1(20),6(21),7,9,16,18-hexaene-4,14-dione;1.9;CA;CALCIUM ION;Factor VIIa (Heavy Chain);9606;
5TQF;H;Factor VIIa in complex with the inhibitor (11R)-11-[(1-aminoisoquinolin-6-yl)amino]-16-(cyclopropylsulfonyl)-13-methyl-2,13-diazatricyclo[13.3.1.1~6,10~]icosa-1(19),6(20),7,9,15,17-hexaene-3,12-dione;1.85;CA;CALCIUM ION;Factor VIIa (Heavy Chain);9606;
5TQG;H;Factor VIIa in complex with the inhibitor (5R,11R)-11-[(1-amino-4-fluoroisoquinolin-6-yl)amino]-16-(cyclopropylsulfonyl)-7-(2,2-difluoroethoxy)-5,13-dimethyl-2,13-diazatricyclo[13.3.1.1~6,10~]icosa-1(19),6(20),7,9,15,17-hexaene-3,12-dione;1.9;CA;CALCIUM ION;Factor VIIa (Heavy Chain);9606;
5TR2;A;Crystal structure of the D263G missense variant of human PGM1;2.5;CA;CALCIUM ION;Phosphoglucomutase-1;9606;
5TR2;B;Crystal structure of the D263G missense variant of human PGM1;2.5;CA;CALCIUM ION;Phosphoglucomutase-1;9606;
5TRQ;A;WELO5 SMALL MOLECULE HALOGENASE WITH NI(II) AND SUCCINATE;1.3;CA;CALCIUM ION;WelO5;162986;
5TRX;B;Room temperature structure of an extradiol ring-cleaving dioxygenase from B.fuscum determined using serial femtosecond crystallography;2.38;CA;CALCIUM ION;Homoprotocatechuate 2,3-dioxygenase;47914;
5TS2;A;Crystal structure of a phosphopantetheine adenylyltransferase (CoaD, PPAT) from Pseudomonas aeruginosa bound to dephospho coenzyme A;2.3;CA;CALCIUM ION;Phosphopantetheine adenylyltransferase;287;
5TS2;E;Crystal structure of a phosphopantetheine adenylyltransferase (CoaD, PPAT) from Pseudomonas aeruginosa bound to dephospho coenzyme A;2.3;CA;CALCIUM ION;Phosphopantetheine adenylyltransferase;287;
5TSP;A;Crystal structure of the catalytic domain of Clostridium perfringens neuraminidase (NanI) in complex with a CHES;1.24;CA;CALCIUM ION;Sialidase;1502;
5TSP;B;Crystal structure of the catalytic domain of Clostridium perfringens neuraminidase (NanI) in complex with a CHES;1.24;CA;CALCIUM ION;Sialidase;1502;
5TSQ;A;Crystal structure of IUnH from Leishmania braziliensis in complex with D-Ribose;1.53;CA;CALCIUM ION;IUnH;5660;
5TTC;A;XFEL structure of influenza A M2 wild type TM domain at high pH in the lipidic cubic phase at room temperature;1.4;CA;CALCIUM ION;Matrix protein 2;11320;
5TUA;A;structure of a Na+-selective mutant of two-pore channel from Arabidopsis thaliana AtTPC1;3.3;CA;CALCIUM ION;Two pore calcium channel protein 1;3702;
5TVQ;A;Mouse Tdp2 catalytic domain bound to SUMO2;2.35;CA;CALCIUM ION;Tyrosyl-DNA phosphodiesterase 2;10090;
5TWT;A;Characterization of class III peroxidase from switchgrass (Panicum virgatum);1.3;CA;CALCIUM ION;Peroxidase Pvi9;38727;
5TX6;A;Structure of TGF-beta2 derivative with deletion of residues 52-71 and 10 single amino acid mutations (mmTGF-beta2-7M);2.75;CA;CALCIUM ION;Transforming growth factor beta-2;10090;
5TXX;A;DNA Polymerase Mu Pre-Catalytic Ground State Ternary Complex, Ca2+;1.95;CA;CALCIUM ION;DNA-directed DNA/RNA polymerase mu;9606;
5TXZ;A;DNA Polymerase Mu Reactant Complex, 100mM Mg2+ (15 min);1.65;CA;CALCIUM ION;DNA-directed DNA/RNA polymerase mu;9606;
5TYB;A;DNA Polymerase Mu Reactant Complex, 10mM Mg2+ (7.5 min);1.85;CA;CALCIUM ION;DNA-directed DNA/RNA polymerase mu;9606;
5TYC;A;DNA Polymerase Mu Reactant Complex, 10mM Mg2+ (15 min);2.1;CA;CALCIUM ION;DNA-directed DNA/RNA polymerase mu;9606;
5TYU;A;DNA Polymerase Mu Reactant Complex, Mn2+ (4 min);2.05;CA;CALCIUM ION;DNA-directed DNA/RNA polymerase mu;9606;
5TZB;A;Burkholderia sp. beta-aminopeptidase;1.98;CA;CALCIUM ION;D-aminopeptidase;1628208;
5TZB;B;Burkholderia sp. beta-aminopeptidase;1.98;CA;CALCIUM ION;D-aminopeptidase;1628208;
5TZB;E;Burkholderia sp. beta-aminopeptidase;1.98;CA;CALCIUM ION;D-aminopeptidase;1628208;
5TZB;G;Burkholderia sp. beta-aminopeptidase;1.98;CA;CALCIUM ION;D-aminopeptidase;1628208;
5U08;A;Crystal structure of an aminoglycoside acetyltransferase meta-AAC0020 from an uncultured soil metagenomic sample in complex with sisomicin;1.52;CA;CALCIUM ION;aminoglycoside acetyltransferase meta-AAC0020;77133;
5U08;B;Crystal structure of an aminoglycoside acetyltransferase meta-AAC0020 from an uncultured soil metagenomic sample in complex with sisomicin;1.52;CA;CALCIUM ION;aminoglycoside acetyltransferase meta-AAC0020;77133;
5U08;C;Crystal structure of an aminoglycoside acetyltransferase meta-AAC0020 from an uncultured soil metagenomic sample in complex with sisomicin;1.52;CA;CALCIUM ION;aminoglycoside acetyltransferase meta-AAC0020;77133;
5U1I;A;Crystal structure of a methyltransferase involved in the biosynthesis of gentamicin in complex with the methylated Kanamycin B;1.93;CA;CALCIUM ION;Putative gentamicin methyltransferase;1877;
5U2R;A;PRECATALYTIC TERNARY COMPLEX OF HUMAN DNA POLYMERASE BETA WITH GAPPED DNA SUBSTARTE, INCOMING L-DCTP AND CA2+;1.8;CA;CALCIUM ION;DNA polymerase beta;9606;
5U2S;A;Pre-catalytic ternary complex of Human DNA Polymerase Beta With Gapped DNA substrate incoming (-)3TC-TP and Ca2+.;2.3;CA;CALCIUM ION;DNA polymerase beta;9606;
5U2T;A;Pre-catalytic ternary complex of Human DNA Polymerase Beta With Gapped DNA substrate incoming (-)FTC-TP and Ca2+.;1.79;CA;CALCIUM ION;DNA polymerase beta;9606;
5U38;A;Crystal structure of native lectin from Platypodium elegans seeds (PELa) complexed with Man1-3Man-OMe.;1.6;CA;CALCIUM ION;Lectin;115002;
5U3A;A;Ultra High Resolution Crystal Structure of Human Pancreatic Alpha Amylase;0.95;CA;CALCIUM ION;Pancreatic alpha-amylase;9606;
5U3E;A;Crystal Structure of Native Lectin from Canavalia bonariensis Seeds (CaBo) complexed with alpha-methyl-D-mannoside;2.3;CA;CALCIUM ION;Canavalia bonariensis seed lectin;192414;
5U3K;H;Crystal Structure of DH511.2 Fab in Complex with HIV-1 gp41 MPER 662-683 Peptide;2.64;CA;CALCIUM ION;DH511.2 Fab Heavy Chain;9606;
5U5I;A;The dimeric crystal structure of the selenomethionine derivative of HTPA Reductase from Sellaginella moellendorffii;2.2;CA;CALCIUM ION;HTPA Reductase;88036;
5U5N;A;The dimeric crystal structure of HTPA Reductase from Sellaginella moellendorffii;2.1;CA;CALCIUM ION;HTPA Reductase;88036;
5U6J;H;Factor VIIa in complex with the inhibitor 3-{[(2R)-17-ethyl-4-methyl-3,12-dioxo-7-[(propan-2-yl)sulfonyl]-13-oxa-4,11-diazatricyclo[14.2.2.1~6,10~]henicosa-1(18),6(21),7,9,16,19-hexaen-2-yl]amino}benzamide;2.3;CA;CALCIUM ION;Coagulation factor VII Heavy Chain;9606;
5U8O;A;Crystal Structure of Beta-lactamase domain protein, from Burkholderia multivorans;2.4;CA;CALCIUM ION;Zn-dependent hydrolase;87883;
5U95;A;Structure of the open conformation of 4-coumarate-CoA ligase from Nicotiana tabacum;2.25;CA;CALCIUM ION;4-coumarate--CoA ligase 2;4097;
5U95;B;Structure of the open conformation of 4-coumarate-CoA ligase from Nicotiana tabacum;2.25;CA;CALCIUM ION;4-coumarate--CoA ligase 2;4097;
5U95;C;Structure of the open conformation of 4-coumarate-CoA ligase from Nicotiana tabacum;2.25;CA;CALCIUM ION;4-coumarate--CoA ligase 2;4097;
5U95;D;Structure of the open conformation of 4-coumarate-CoA ligase from Nicotiana tabacum;2.25;CA;CALCIUM ION;4-coumarate--CoA ligase 2;4097;
5UB5;B;human POGLUT1 in complex with human Notch1 EGF12 S458T mutant and UDP;2.09;CA;CALCIUM ION;Neurogenic locus notch homolog protein 1;9606;
5UBA;A;Human RNA Pseudouridylate Synthase Domain Containing 4;1.54;CA;CALCIUM ION;RNA pseudouridylate synthase domain-containing protein 4;9606;
5UBJ;A;Structure of an alpha-L-arabinofuranosidase (GH62) from Aspergillus nidulans;1.7;CA;CALCIUM ION;Alpha-L-arabinofuranosidase axhA-2;162425;
5UBO;A;Mical-oxidized Actin complex with Gelsolin Segment 1;2.39;CA;CALCIUM ION;Actin, alpha skeletal muscle;9986;
5UBO;S;Mical-oxidized Actin complex with Gelsolin Segment 1;2.39;CA;CALCIUM ION;Gelsolin;9606;
5UCQ;A;The structure of archaeal Inorganic Pyrophosphatase in complex with pyrophosphate;1.4;CA;CALCIUM ION;Inorganic pyrophosphatase;277988;
5UCQ;B;The structure of archaeal Inorganic Pyrophosphatase in complex with pyrophosphate;1.4;CA;CALCIUM ION;Inorganic pyrophosphatase;277988;
5UCQ;C;The structure of archaeal Inorganic Pyrophosphatase in complex with pyrophosphate;1.4;CA;CALCIUM ION;Inorganic pyrophosphatase;277988;
5UD0;B;Class II fructose-1,6-bisphosphate aldolase E149A variant of Helicobacter pylori with cleavage products;1.65;CA;CALCIUM ION;Fructose-bisphosphate aldolase;210;
5UD6;A;Crystal structure of DHDPS from Cyanidioschyzon merolae with lysine bound;2.4;CA;CALCIUM ION;Dihydrodipicolinate synthase;45157;
5UD6;B;Crystal structure of DHDPS from Cyanidioschyzon merolae with lysine bound;2.4;CA;CALCIUM ION;Dihydrodipicolinate synthase;45157;
5UD6;C;Crystal structure of DHDPS from Cyanidioschyzon merolae with lysine bound;2.4;CA;CALCIUM ION;Dihydrodipicolinate synthase;45157;
5UD6;D;Crystal structure of DHDPS from Cyanidioschyzon merolae with lysine bound;2.4;CA;CALCIUM ION;Dihydrodipicolinate synthase;45157;
5UDI;A;IFIT1 monomeric mutant (L457E/L464E) with m7Gppp-AAAA (syn and anti conformations of cap);1.58;CA;CALCIUM ION;Interferon-induced protein with tetratricopeptide repeats 1;9606;
5UDJ;A;IFIT1 monomeric mutant (L457E/L464E) with Gppp-AAAA;1.69;CA;CALCIUM ION;Interferon-induced protein with tetratricopeptide repeats 1;9606;
5UDK;A;IFIT1 monomeric mutant (L457E/L464E) with PPP-AAAA;1.65;CA;CALCIUM ION;Interferon-induced protein with tetratricopeptide repeats 1;9606;
5UDL;A;IFIT1 N216A monomeric mutant (L457E/L464E) with m7Gppp-AAAA (anti conformation of cap);1.65;CA;CALCIUM ION;Interferon-induced protein with tetratricopeptide repeats 1;9606;
5UE1;A;Crystal structure of 5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase in complex with adenine from Vibrio fischeri ES114;1.14;CA;CALCIUM ION;5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase;668;
5UE2;A;proMMP-7 with heparin octasaccharide bridging between domains;;CA;CALCIUM ION;Matrilysin;9606;
5UE3;A;proMMP-9desFnII;1.6;CA;CALCIUM ION;Matrix metalloproteinase-9;9606;
5UE3;B;proMMP-9desFnII;1.6;CA;CALCIUM ION;Matrix metalloproteinase-9;9606;
5UE4;A;proMMP-9desFnII complexed to JNJ0966 INHIBITOR;1.8;CA;CALCIUM ION;Matrix metalloproteinase-9;9606;
5UE4;B;proMMP-9desFnII complexed to JNJ0966 INHIBITOR;1.8;CA;CALCIUM ION;Matrix metalloproteinase-9;9606;
5UE5;A;proMMP-7 with heparin octasaccharide bound to the catalytic domain;;CA;CALCIUM ION;Matrilysin;9606;
5UFE;A;Wild-type K-Ras(GNP)/R11.1.6 complex;2.3;CA;CALCIUM ION;GTPase KRas;9606;
5UFE;B;Wild-type K-Ras(GNP)/R11.1.6 complex;2.3;CA;CALCIUM ION;R11.1.6;2287;
5UFQ;A;K-RasG12D(GNP)/R11.1.6 complex;2.2;CA;CALCIUM ION;GTPase KRas;9606;
5UFQ;B;K-RasG12D(GNP)/R11.1.6 complex;2.2;CA;CALCIUM ION;GTPase KRas;9606;
5UG4;A;Structure of spermidine N-acetyltransferase SpeG from Vibrio cholerae;2.15;CA;CALCIUM ION;Spermidine N(1)-acetyltransferase;666;
5UG4;B;Structure of spermidine N-acetyltransferase SpeG from Vibrio cholerae;2.15;CA;CALCIUM ION;Spermidine N(1)-acetyltransferase;666;
5UG4;C;Structure of spermidine N-acetyltransferase SpeG from Vibrio cholerae;2.15;CA;CALCIUM ION;Spermidine N(1)-acetyltransferase;666;
5UG7;A;Calcium bound Perforin C2 Domain - T431D;1.8;CA;CALCIUM ION;Perforin-1;10090;
5UGO;A;DNA polymerase beta nick complex with imidodiphosphate;1.9;CA;CALCIUM ION;DNA polymerase beta;9606;
5UII;A;structure of DHFR with bound buformin and NADP;1.35;CA;CALCIUM ION;Dihydrofolate reductase;562;
5UJ6;A;Crystal Structure of Bacteroides Uniformis beta-glucuronidase;1.9;CA;CALCIUM ION;Glycosyl hydrolases family 2, sugar binding domain protein;820;
5UJ6;B;Crystal Structure of Bacteroides Uniformis beta-glucuronidase;1.9;CA;CALCIUM ION;Glycosyl hydrolases family 2, sugar binding domain protein;820;
5UJK;A;Malate dehydrogenase from Methylobacterium extorquens, complexed with NAD;1.53;CA;CALCIUM ION;Malate dehydrogenase;408;
5UJP;A;The crystal structure of a glyoxalase/bleomycin resistance protein from Streptomyces sp. CB03234;1.42;CA;CALCIUM ION;Glyoxalase/bleomycin resisance protein/dioxygenase;1703937;
5UJX;B;Crystal structure of DHFR in 20% Isopropanol;1.8;CA;CALCIUM ION;Dihydrofolate reductase;562;
5UK5;A;Complex of Notch1(EGF8-12) bound to Jagged1(N-EGF3);2.51;CA;CALCIUM ION;Neurogenic locus notch homolog protein 1;10116;
5UKG;A;Crystal Structure of the genetically encoded calcium indicator K-GECO;2.36;CA;CALCIUM ION;K-GECO;6118;
5UKG;B;Crystal Structure of the genetically encoded calcium indicator K-GECO;2.36;CA;CALCIUM ION;K-GECO;6118;
5UKH;A;Structure of TelC from Streptococcus intermedius B196;1.98;CA;CALCIUM ION;Uncharacterized protein;1338;
5ULI;A;Crystal Structure of mouse DXO in complex with (3'-NADP)+ and calcium ion;2.1;CA;CALCIUM ION;Decapping and exoribonuclease protein;10090;
5ULJ;A;Crystal structure of Scheffersomyces stipitis Rai1 in complex with (3'-NADP)+ and calcium ion;1.91;CA;CALCIUM ION;RAI1;4924;
5ULJ;B;Crystal structure of Scheffersomyces stipitis Rai1 in complex with (3'-NADP)+ and calcium ion;1.91;CA;CALCIUM ION;RAI1;4924;
5ULU;A;Crystal Structure of Mouse Cadherin-23 EC19-21 (S2087P) with non-syndromic deafness (DFNB12) associated mutation D2148N;2.85;CA;CALCIUM ION;Cadherin-23;10090;
5ULV;A;Malate dehydrogenase from Methylobacterium extorquens;1.66;CA;CALCIUM ION;Malate dehydrogenase;408;
5ULY;A;Crystal Structure of Human Protocadherin-15 EC2-3;2.64;CA;CALCIUM ION;Protocadherin-15;9606;
5ULY;B;Crystal Structure of Human Protocadherin-15 EC2-3;2.64;CA;CALCIUM ION;Protocadherin-15;9606;
5ULY;C;Crystal Structure of Human Protocadherin-15 EC2-3;2.64;CA;CALCIUM ION;Protocadherin-15;9606;
5ULY;D;Crystal Structure of Human Protocadherin-15 EC2-3;2.64;CA;CALCIUM ION;Protocadherin-15;9606;
5UM1;A;XFEL structure of influenza A M2 wild type TM domain at intermediate pH in the lipidic cubic phase at room temperature;1.45;CA;CALCIUM ION;Matrix protein 2;11320;
5UMH;A;Crystal Structure of Catechol 1,2-dioxygenase protein from Burkholderia multivorans;1.35;CA;CALCIUM ION;Catechol 1,2-dioxygenase;87883;
5UN2;A;Crystal Structure of Mouse Cadherin-23 EC19-21 with non-syndromic deafness (DFNB12) associated mutation R2029W;2.96;CA;CALCIUM ION;Cadherin-23;10090;
5UN3;A;Tetragonal thermolysin (295 K) in the presence of 50% xylose;1.6;CA;CALCIUM ION;Thermolysin;1427;
5UO9;A;Structure of human endothelial nitric oxide synthase heme domain in complex with 7-[(3-Ethyl-5-((methylamino)methyl)phenoxy)methyl]quinolin-2-amine;2.19;CA;CALCIUM ION;Nitric oxide synthase, endothelial;9606;
5UP7;A;Crystal Structure of the Ni-bound Human Heavy-Chain Ferritin 122H-delta C-star variant;1.79;CA;CALCIUM ION;Ferritin heavy chain;9606;
5UQZ;A;Structural Analysis of the Glucan Binding Protein C of Streptococcus mutans Provides Evidence that it Mediates both Sucrose-Independent and -Dependent Adherence;1.15;CA;CALCIUM ION;Glucan-binding protein C, GbpC;1309;
5UU7;A;Tetragonal thermolysin (295 K) in the presence of 50% mpd;1.6;CA;CALCIUM ION;Thermolysin;1427;
5UU8;A;Tetragonal thermolysin cryocooled to 100 K with 30% xylose as cryoprotectant;2.5;CA;CALCIUM ION;Thermolysin;1427;
5UU9;A;Tetragonal thermolysin cryocooled to 100 K with 40% xylose as cryoprotectant;1.6;CA;CALCIUM ION;Thermolysin;1427;
5UUA;A;Tetragonal thermolysin cryocooled to 100 K with 50% xylose as cryoprotectant;1.6;CA;CALCIUM ION;Thermolysin;1427;
5UUB;A;Tetragonal thermolysin cryocooled to 100 K with 25% xylose/25% mpd as cryoprotectant;1.6;CA;CALCIUM ION;Thermolysin;1427;
5UUC;A;Tetragonal thermolysin cryocooled to 100 K with 50% mpd as cryoprotectant;1.6;CA;CALCIUM ION;Thermolysin;1427;
5UUD;A;Tetragonal thermolysin cryocooled to 100 K with 50% dmf as cryoprotectant;1.6;CA;CALCIUM ION;Thermolysin;1427;
5UUE;A;Tetragonal thermolysin cryocooled to 100 K with 50% methanol as cryoprotectant;1.6;CA;CALCIUM ION;Thermolysin;1427;
5UUG;A;Bacillus cereus DNA glycosylase AlkD bound to a yatakemycin-adenine nucleobase adduct and DNA containing an abasic site (9-mer product complex);1.71;CA;CALCIUM ION;DNA-7-methylguanine glycosylase;1396;
5UUH;A;Bacillus cereus DNA glycosylase AlkD bound to a yatakemycin-adenine nucleobase adduct and DNA containing a fluorinated abasic site (9-mer product complex);1.57;CA;CALCIUM ION;DNA-7-methylguanine glycosylase;1396;
5UUY;A;Crystal structure of Dioclea lasiocarpa lectin (DLL) complexed with X-MAN;1.88;CA;CALCIUM ION;Dioclea lasiocarpa lectin (DLL);3836;
5UVE;A;Crystal Structure of the ABC Transporter Substrate-binding protein BAB1_0226 from Brucella abortus;2.5;CA;CALCIUM ION;Substrate-binding region of ABC-type glycine betaine transport system;235;
5UVE;B;Crystal Structure of the ABC Transporter Substrate-binding protein BAB1_0226 from Brucella abortus;2.5;CA;CALCIUM ION;Substrate-binding region of ABC-type glycine betaine transport system;235;
5UVE;C;Crystal Structure of the ABC Transporter Substrate-binding protein BAB1_0226 from Brucella abortus;2.5;CA;CALCIUM ION;Substrate-binding region of ABC-type glycine betaine transport system;235;
5UVE;D;Crystal Structure of the ABC Transporter Substrate-binding protein BAB1_0226 from Brucella abortus;2.5;CA;CALCIUM ION;Substrate-binding region of ABC-type glycine betaine transport system;235;
5UVE;E;Crystal Structure of the ABC Transporter Substrate-binding protein BAB1_0226 from Brucella abortus;2.5;CA;CALCIUM ION;Substrate-binding region of ABC-type glycine betaine transport system;235;
5UVE;F;Crystal Structure of the ABC Transporter Substrate-binding protein BAB1_0226 from Brucella abortus;2.5;CA;CALCIUM ION;Substrate-binding region of ABC-type glycine betaine transport system;235;
5UVE;G;Crystal Structure of the ABC Transporter Substrate-binding protein BAB1_0226 from Brucella abortus;2.5;CA;CALCIUM ION;Substrate-binding region of ABC-type glycine betaine transport system;235;
5UVE;H;Crystal Structure of the ABC Transporter Substrate-binding protein BAB1_0226 from Brucella abortus;2.5;CA;CALCIUM ION;Substrate-binding region of ABC-type glycine betaine transport system;235;
5UVG;A;Crystal structure of the human neutral sphingomyelinase 2 (nSMase2) catalytic domain with insertion deleted and calcium bound;1.85;CA;CALCIUM ION;Sphingomyelin phosphodiesterase 3,Sphingomyelin phosphodiesterase 3;9606;
5UVL;A;Serial Millisecond Crystallography of Membrane and Soluble Protein Micro-crystals using Synchrotron Radiation;2.65;CA;CALCIUM ION;Proteinase K;37998;
5UW5;A;PCY1 H695A Variant in Complex with Follower Peptide;2.94;CA;CALCIUM ION;Peptide cyclase 1;39387;
5UW5;B;PCY1 H695A Variant in Complex with Follower Peptide;2.94;CA;CALCIUM ION;Peptide cyclase 1;39387;
5UW5;C;PCY1 H695A Variant in Complex with Follower Peptide;2.94;CA;CALCIUM ION;Peptide cyclase 1;39387;
5UW6;A;PCY1 in Complex with Follower Peptide and Covalent Inhibitor ZPP;3.3;CA;CALCIUM ION;Peptide cyclase 1;39387;
5UW6;B;PCY1 in Complex with Follower Peptide and Covalent Inhibitor ZPP;3.3;CA;CALCIUM ION;Peptide cyclase 1;39387;
5UW6;C;PCY1 in Complex with Follower Peptide and Covalent Inhibitor ZPP;3.3;CA;CALCIUM ION;Peptide cyclase 1;39387;
5UWK;A;Matrix metalloproteinase-13 complexed with selective inhibitor compound (S)-10a;1.6;CA;CALCIUM ION;Collagenase 3;9606;
5UWK;B;Matrix metalloproteinase-13 complexed with selective inhibitor compound (S)-10a;1.6;CA;CALCIUM ION;Collagenase 3;9606;
5UWL;A;Matrix metalloproteinase-13 complexed with selective inhibitor compound (S)-17a;2.55;CA;CALCIUM ION;Collagenase 3;9606;
5UWL;B;Matrix metalloproteinase-13 complexed with selective inhibitor compound (S)-17a;2.55;CA;CALCIUM ION;Collagenase 3;9606;
5UWM;A;Matrix metalloproteinase-13 complexed with selective inhibitor compound (R)-17a;1.62;CA;CALCIUM ION;Collagenase 3;9606;
5UWM;B;Matrix metalloproteinase-13 complexed with selective inhibitor compound (R)-17a;1.62;CA;CALCIUM ION;Collagenase 3;9606;
5UWN;A;Matrix metalloproteinase-13 complexed with selective inhibitor compound 10d;3.2;CA;CALCIUM ION;Collagenase 3;9606;
5UWN;B;Matrix metalloproteinase-13 complexed with selective inhibitor compound 10d;3.2;CA;CALCIUM ION;Collagenase 3;9606;
5UWN;C;Matrix metalloproteinase-13 complexed with selective inhibitor compound 10d;3.2;CA;CALCIUM ION;Collagenase 3;9606;
5UWN;D;Matrix metalloproteinase-13 complexed with selective inhibitor compound 10d;3.2;CA;CALCIUM ION;Collagenase 3;9606;
5UWN;E;Matrix metalloproteinase-13 complexed with selective inhibitor compound 10d;3.2;CA;CALCIUM ION;Collagenase 3;9606;
5UXA;A;Crystal structure of macrolide 2'-phosphotransferase MphB from Escherichia coli;1.95;CA;CALCIUM ION;Macrolide 2'-phosphotransferase II;562;
5UZ8;A;Crystal Structure of Mouse Cadherin-23 EC22-24;1.85;CA;CALCIUM ION;Cadherin-23;10090;
5UZU;A;Immune evasion by a Staphylococcal Peroxidase Inhibitor that blocks myeloperoxidase;2.4;CA;CALCIUM ION;Myeloperoxidase;9606;
5UZW;A;PCY1 G696Insertion Variant in Complex with Follower Peptide and the Covalent Inhibitor ZPP;2.82;CA;CALCIUM ION;Peptide cyclase 1;39387;
5UZW;B;PCY1 G696Insertion Variant in Complex with Follower Peptide and the Covalent Inhibitor ZPP;2.82;CA;CALCIUM ION;Peptide cyclase 1;39387;
5V02;R;A positive allosteric modulator binding pocket in SK2 ion channels is shared by Riluzole and CyPPA;1.78;CA;CALCIUM ION;Calmodulin-1;9606;
5V03;R;A positive allosteric modulator binding pocket in SK2 ion channels is shared by Riluzole and CyPPA;1.58;CA;CALCIUM ION;Calmodulin;9606;
5V0S;A;Crystal structure of the ACT domain of prephenate dehydrogenase tyrA from Bacillus anthracis;2.01;CA;CALCIUM ION;Prephenate dehydrogenase;1392;
5V0S;B;Crystal structure of the ACT domain of prephenate dehydrogenase tyrA from Bacillus anthracis;2.01;CA;CALCIUM ION;Prephenate dehydrogenase;1392;
5V1F;A;DNA polymerase beta substrate complex with 8-oxoG at the primer terminus and incoming dCTP;2.18;CA;CALCIUM ION;DNA polymerase beta;9606;
5V1N;A;DNA polymerase beta substrate complex with 8-oxoG:A at the primer terminus and incoming dCTP;2.01;CA;CALCIUM ION;DNA polymerase beta;9606;
5V2C;B;RE-REFINEMENT OF CRYSTAL STRUCTURE OF PHOTOSYSTEM II COMPLEX;1.9;CA;CALCIUM ION;Photosystem II CP47 reaction center protein;32053;
5V2C;O;RE-REFINEMENT OF CRYSTAL STRUCTURE OF PHOTOSYSTEM II COMPLEX;1.9;CA;CALCIUM ION;Photosystem II manganese-stabilizing polypeptide;32053;
5V2C;b;RE-REFINEMENT OF CRYSTAL STRUCTURE OF PHOTOSYSTEM II COMPLEX;1.9;CA;CALCIUM ION;Photosystem II CP47 reaction center protein;32053;
5V2C;c;RE-REFINEMENT OF CRYSTAL STRUCTURE OF PHOTOSYSTEM II COMPLEX;1.9;CA;CALCIUM ION;Photosystem II CP43 reaction center protein;32053;
5V2C;h;RE-REFINEMENT OF CRYSTAL STRUCTURE OF PHOTOSYSTEM II COMPLEX;1.9;CA;CALCIUM ION;Photosystem II reaction center protein H;32053;
5V2C;o;RE-REFINEMENT OF CRYSTAL STRUCTURE OF PHOTOSYSTEM II COMPLEX;1.9;CA;CALCIUM ION;Photosystem II manganese-stabilizing polypeptide;32053;
5V4D;A;Crystal Structure of the Protein of Unknown Function of the Conserved Rid Protein Family YyfA from Yersinia pestis;1.6;CA;CALCIUM ION;Putative translational inhibitor protein;632;
5V4D;B;Crystal Structure of the Protein of Unknown Function of the Conserved Rid Protein Family YyfA from Yersinia pestis;1.6;CA;CALCIUM ION;Putative translational inhibitor protein;632;
5V4D;E;Crystal Structure of the Protein of Unknown Function of the Conserved Rid Protein Family YyfA from Yersinia pestis;1.6;CA;CALCIUM ION;Putative translational inhibitor protein;632;
5V4D;F;Crystal Structure of the Protein of Unknown Function of the Conserved Rid Protein Family YyfA from Yersinia pestis;1.6;CA;CALCIUM ION;Putative translational inhibitor protein;632;
5V5X;A;Protocadherin gammaB7 EC3-6 cis-dimer structure;3.5;CA;CALCIUM ION;MCG133388, isoform CRA_y;10090;
5V5X;B;Protocadherin gammaB7 EC3-6 cis-dimer structure;3.5;CA;CALCIUM ION;MCG133388, isoform CRA_y;10090;
5V5X;C;Protocadherin gammaB7 EC3-6 cis-dimer structure;3.5;CA;CALCIUM ION;MCG133388, isoform CRA_y;10090;
5V5X;D;Protocadherin gammaB7 EC3-6 cis-dimer structure;3.5;CA;CALCIUM ION;MCG133388, isoform CRA_y;10090;
5V6M;H;Crystal Structure of Rabbit Anti-HIV-1 gp120 V3 Fab 10A3 in complex with V3 peptide ConB;1.9;CA;CALCIUM ION;Heavy chain of Fab fragment of rabbit anti-HIV1 gp120 V3 mAb 10A3;9986;
5V6V;A;Crystal structure of small molecule aziridine 3 covalently bound to K-Ras G12C;1.72;CA;CALCIUM ION;GTPase KRas;9606;
5V6V;B;Crystal structure of small molecule aziridine 3 covalently bound to K-Ras G12C;1.72;CA;CALCIUM ION;GTPase KRas;9606;
5V8K;A;Homodimeric reaction center of H. modesticaldum;2.2;CA;CALCIUM ION;p800 reaction center core protein;35701;
5V9U;A;Crystal Structure of small molecule ARS-1620 covalently bound to K-Ras G12C;1.38;CA;CALCIUM ION;GTPase KRas;9606;
5V9U;B;Crystal Structure of small molecule ARS-1620 covalently bound to K-Ras G12C;1.38;CA;CALCIUM ION;GTPase KRas;9606;
5VA9;A;Human pancreatic alpha amylase in complex with peptide inhibitor piHA-L5(d10Y);2.55;CA;CALCIUM ION;Pancreatic alpha-amylase;9606;
5VA9;B;Human pancreatic alpha amylase in complex with peptide inhibitor piHA-L5(d10Y);2.55;CA;CALCIUM ION;Pancreatic alpha-amylase;9606;
5VAO;D;Crystal structure of eVP30 C-terminus and eNP peptide;2.56;CA;CALCIUM ION;Minor nucleoprotein VP30;186538;
5VBJ;B;Sulfur as a bromine biomolecular halogen-bond acceptor;1.94;CA;CALCIUM ION;DNA (5'-D(*CP*CP*GP*AP*TP*(AS)P*(BRU)P*CP*GP*G)-3');32630;
5VC1;A;Crystal structure of L-selectin lectin/EGF domains;1.94;CA;CALCIUM ION;L-selectin;9606;
5VCN;A;THE CRYSTAL STRUCTURE OF DER P 1 ALLERGEN COMPLEXED WITH FAB FRAGMENT OF MAB 5H8;3;CA;CALCIUM ION;PEPTIDASE 1;6956;
5VCN;B;THE CRYSTAL STRUCTURE OF DER P 1 ALLERGEN COMPLEXED WITH FAB FRAGMENT OF MAB 5H8;3;CA;CALCIUM ION;PEPTIDASE 1;6956;
5VCO;E;THE CRYSTAL STRUCTURE OF DER P 1 ALLERGEN COMPLEXED WITH FAB FRAGMENT OF MAB 10B9;2.74;CA;CALCIUM ION;PEPTIDASE 1;6956;
5VCO;F;THE CRYSTAL STRUCTURE OF DER P 1 ALLERGEN COMPLEXED WITH FAB FRAGMENT OF MAB 10B9;2.74;CA;CALCIUM ION;PEPTIDASE 1;6956;
5VE9;A;Structure of hACF7 EF1-EF2-GAR domains;2.8;CA;CALCIUM ION;Microtubule-actin cross-linking factor 1, isoforms 1/2/3/5;9606;
5VE9;B;Structure of hACF7 EF1-EF2-GAR domains;2.8;CA;CALCIUM ION;Microtubule-actin cross-linking factor 1, isoforms 1/2/3/5;9606;
5VEP;A;MOUSE KYNURENINE AMINOTRANSFERASE III, RE-REFINEMENT OF THE PDB STRUCTURE 3E2F;2.59;CA;CALCIUM ION;Kynurenine--oxoglutarate transaminase 3;10090;
5VEP;B;MOUSE KYNURENINE AMINOTRANSFERASE III, RE-REFINEMENT OF THE PDB STRUCTURE 3E2F;2.59;CA;CALCIUM ION;Kynurenine--oxoglutarate transaminase 3;10090;
5VEQ;A;MOUSE KYNURENINE AMINOTRANSFERASE III, RE-REFINEMENT OF THE PDB STRUCTURE 3E2Y;2.26;CA;CALCIUM ION;Kynurenine--oxoglutarate transaminase 3;10090;
5VEQ;B;MOUSE KYNURENINE AMINOTRANSFERASE III, RE-REFINEMENT OF THE PDB STRUCTURE 3E2Y;2.26;CA;CALCIUM ION;Kynurenine--oxoglutarate transaminase 3;10090;
5VER;A;MOUSE KYNURENINE AMINOTRANSFERASE III, RE-REFINEMENT OF THE PDB STRUCTURE 3E2Z;2.81;CA;CALCIUM ION;Kynurenine--oxoglutarate transaminase 3;10090;
5VER;B;MOUSE KYNURENINE AMINOTRANSFERASE III, RE-REFINEMENT OF THE PDB STRUCTURE 3E2Z;2.81;CA;CALCIUM ION;Kynurenine--oxoglutarate transaminase 3;10090;
5VF4;A;Thermus aquaticus variable protein (TaqVP) from diversity-generating retroelements (DGR);2.81;CA;CALCIUM ION;Uncharacterized protein;271;
5VF4;B;Thermus aquaticus variable protein (TaqVP) from diversity-generating retroelements (DGR);2.81;CA;CALCIUM ION;Uncharacterized protein;271;
5VF4;C;Thermus aquaticus variable protein (TaqVP) from diversity-generating retroelements (DGR);2.81;CA;CALCIUM ION;Uncharacterized protein;271;
5VF4;D;Thermus aquaticus variable protein (TaqVP) from diversity-generating retroelements (DGR);2.81;CA;CALCIUM ION;Uncharacterized protein;271;
5VGC;A;Crystal structure of the NleG5-1 effector (C200A) from Escherichia coli O157:H7 str. Sakai;2.6;CA;CALCIUM ION;NleG5-1 effector;564886;
5VGT;A;X-ray structure of bacteriophage Sf6 tail adaptor protein gp7;1.78;CA;CALCIUM ION;Gene 7 protein;10761;
5VGT;B;X-ray structure of bacteriophage Sf6 tail adaptor protein gp7;1.78;CA;CALCIUM ION;Gene 7 protein;10761;
5VH2;A;Crystal Structure of Mouse Cadherin-23 EC12-13 with Engineered Mutation S1339D;2.84;CA;CALCIUM ION;Cadherin-23;10090;
5VH2;B;Crystal Structure of Mouse Cadherin-23 EC12-13 with Engineered Mutation S1339D;2.84;CA;CALCIUM ION;Cadherin-23;10090;
5VH2;C;Crystal Structure of Mouse Cadherin-23 EC12-13 with Engineered Mutation S1339D;2.84;CA;CALCIUM ION;Cadherin-23;10090;
5VH2;D;Crystal Structure of Mouse Cadherin-23 EC12-13 with Engineered Mutation S1339D;2.84;CA;CALCIUM ION;Cadherin-23;10090;
5VJF;A;Class II fructose-1,6-bisphosphate aldolase of Helicobacter pylori with DHAP;1.85;CA;CALCIUM ION;Fructose-bisphosphate aldolase;210;
5VJF;B;Class II fructose-1,6-bisphosphate aldolase of Helicobacter pylori with DHAP;1.85;CA;CALCIUM ION;Fructose-bisphosphate aldolase;210;
5VKW;B;Crystal structure of adenylosuccinate lyase ADE13 from Candida albicans;2;CA;CALCIUM ION;Adenylosuccinate lyase;5476;
5VLA;A;Short PCSK9 delta-P' complex with Fusion2 peptide;2.4;CA;CALCIUM ION;Proprotein convertase subtilisin/kexin type 9;9606;
5VLH;A;Short PCSK9 delta-P' complex with peptide Pep1;2.86;CA;CALCIUM ION;Proprotein convertase subtilisin/kexin type 9;9606;
5VLK;A;Short PCSK9 delta-P' complex with shrunken peptide bearing homo-Arginine;2.2;CA;CALCIUM ION;Proprotein convertase subtilisin/kexin type 9;9606;
5VLL;A;Short PCSK9 delta-P' complex with peptide Pep3;2.37;CA;CALCIUM ION;Proprotein convertase subtilisin/kexin type 9;9606;
5VMA;A;Structure of B. pumilus GH48 in complex with a cellobio-derived isofagomine;1.95;CA;CALCIUM ION;Glycoside hydrolase;1408;
5VMQ;C;STRUCTURE OF THE R105A MUTANT CATALYTIC TRIMER OF ESCHERICHIA COLI ASPARTATE TRANSCARBAMOYLASE AT 2.0-A RESOLUTION;2.01;CA;CALCIUM ION;Aspartate carbamoyltransferase;562;
5VMS;B;CryoEM structure of Xenopus KCNQ1 channel;3.7;CA;CALCIUM ION;Calmodulin;9606;
5VOE;H;DesGla-XaS195A Bound to Aptamer 11F7t;2;CA;CALCIUM ION;Coagulation factor X;9606;
5VOF;H;DesGla-XaS195A Bound to Aptamer 11F7t and Rivaroxaban;2.25;CA;CALCIUM ION;Coagulation factor X;9606;
5VOL;A;Bacint_04212 ferulic acid esterase;1.98;CA;CALCIUM ION;Putative esterase;329854;
5VOL;B;Bacint_04212 ferulic acid esterase;1.98;CA;CALCIUM ION;Putative esterase;329854;
5VOL;C;Bacint_04212 ferulic acid esterase;1.98;CA;CALCIUM ION;Putative esterase;329854;
5VOL;D;Bacint_04212 ferulic acid esterase;1.98;CA;CALCIUM ION;Putative esterase;329854;
5VOL;E;Bacint_04212 ferulic acid esterase;1.98;CA;CALCIUM ION;Putative esterase;329854;
5VOL;F;Bacint_04212 ferulic acid esterase;1.98;CA;CALCIUM ION;Putative esterase;329854;
5VOL;G;Bacint_04212 ferulic acid esterase;1.98;CA;CALCIUM ION;Putative esterase;329854;
5VOL;H;Bacint_04212 ferulic acid esterase;1.98;CA;CALCIUM ION;Putative esterase;329854;
5VPG;A;CRYSTAL STRUCTURE OF DER P 1 COMPLEXED WITH FAB 4C1;1.95;CA;CALCIUM ION;Der p 1 allergen;6956;
5VPH;A;CRYSTAL STRUCTURE OF DER P 1 COMPLEXED WITH FAB 4C1;2.5;CA;CALCIUM ION;Der p 1 allergen;6956;
5VPL;A;CRYSTAL STRUCTURE OF DER F 1 COMPLEXED WITH FAB 4C1;1.9;CA;CALCIUM ION;Der f 1 variant;6954;
5VR0;A;Crystal structure of glucose isomerase from Streptomyces rubiginosus;1.7;CA;CALCIUM ION;Xylose isomerase;1929;
5VRB;A;Crystal structure of a transketolase from Neisseria gonorrhoeae;1.85;CA;CALCIUM ION;Transketolase;485;
5VRB;B;Crystal structure of a transketolase from Neisseria gonorrhoeae;1.85;CA;CALCIUM ION;Transketolase;485;
5VRB;C;Crystal structure of a transketolase from Neisseria gonorrhoeae;1.85;CA;CALCIUM ION;Transketolase;485;
5VRB;D;Crystal structure of a transketolase from Neisseria gonorrhoeae;1.85;CA;CALCIUM ION;Transketolase;485;
5VRW;A;Human DNA polymerase beta pre-catalytic 8-oxoG:dC extension complex with dTTP bound in non-planar conformation;2.58;CA;CALCIUM ION;DNA polymerase beta;9606;
5VRW;D;Human DNA polymerase beta pre-catalytic 8-oxoG:dC extension complex with dTTP bound in non-planar conformation;2.58;CA;CALCIUM ION;DNA (5'-D(P*GP*TP*CP*GP*G)-3');32630;
5VRW;P;Human DNA polymerase beta pre-catalytic 8-oxoG:dC extension complex with dTTP bound in non-planar conformation;2.58;CA;CALCIUM ION;DNA (5'-D(*CP*TP*GP*AP*TP*GP*CP*GP*CP*C)-3');32630;
5VRX;A;Human DNA polymerase beta pre-catalytic 8-oxoG:dC extension complex with dTTP bound in Watson-Crick conformation;2.2;CA;CALCIUM ION;DNA polymerase beta;9606;
5VRX;D;Human DNA polymerase beta pre-catalytic 8-oxoG:dC extension complex with dTTP bound in Watson-Crick conformation;2.2;CA;CALCIUM ION;DNA (5'-D(P*GP*TP*CP*GP*G)-3');32630;
5VRX;P;Human DNA polymerase beta pre-catalytic 8-oxoG:dC extension complex with dTTP bound in Watson-Crick conformation;2.2;CA;CALCIUM ION;DNA (5'-D(*CP*TP*GP*AP*TP*GP*CP*GP*CP*C)-3');32630;
5VS1;A;Human DNA polymerase beta pre-catalytic 8-oxoG:dA extension complex with dTTP bound in non-planar conformation;2.5;CA;CALCIUM ION;DNA polymerase beta;9606;
5VS1;D;Human DNA polymerase beta pre-catalytic 8-oxoG:dA extension complex with dTTP bound in non-planar conformation;2.5;CA;CALCIUM ION;DNA (5'-D(P*GP*TP*CP*GP*G)-3');32630;
5VS1;P;Human DNA polymerase beta pre-catalytic 8-oxoG:dA extension complex with dTTP bound in non-planar conformation;2.5;CA;CALCIUM ION;DNA (5'-D(*CP*TP*GP*AP*TP*GP*CP*GP*CP*A)-3');32630;
5VS2;A;Human DNA polymerase beta pre-catalytic 8-oxoG:dA extension complex with dTTP bound in Watson-Crick conformation;2.33;CA;CALCIUM ION;DNA polymerase beta;9606;
5VS2;P;Human DNA polymerase beta pre-catalytic 8-oxoG:dA extension complex with dTTP bound in Watson-Crick conformation;2.33;CA;CALCIUM ION;DNA (5'-D(*CP*TP*GP*AP*TP*GP*CP*GP*CP*A)-3');32630;
5VT8;A;Crystal Structure of Mouse Cadherin-23 EC24-25;2.92;CA;CALCIUM ION;Cadherin-23;10090;
5VT8;B;Crystal Structure of Mouse Cadherin-23 EC24-25;2.92;CA;CALCIUM ION;Cadherin-23;10090;
5VT8;C;Crystal Structure of Mouse Cadherin-23 EC24-25;2.92;CA;CALCIUM ION;Cadherin-23;10090;
5VT8;D;Crystal Structure of Mouse Cadherin-23 EC24-25;2.92;CA;CALCIUM ION;Cadherin-23;10090;
5VTD;A;Crystal Structure of the Co-bound Human Heavy-Chain Ferritin variant 122H-delta C-star;1.95;CA;CALCIUM ION;Ferritin heavy chain;9606;
5VTM;X;The crystal structure of minor pseudopilin ternary complex of XcpVWX from the Type 2 secretion system of Pseudomonas aeruginosa;2.04;CA;CALCIUM ION;Type II secretion system protein K;287;
5VUG;A;Crystal Structure of Glycerophosphoryl Diester Phosphodiesterase Domain of Uncharacterized Protein Rv2277c from Mycobacterium tuberculosis;1.5;CA;CALCIUM ION;Uncharacterized protein Rv2277c;1773;
5VVM;A;Crystal structure of human CDH23 EC21-23;3.54;CA;CALCIUM ION;Cadherin-23;9606;
5VVM;B;Crystal structure of human CDH23 EC21-23;3.54;CA;CALCIUM ION;Cadherin-23;9606;
5VWM;A;Crystal structure of UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase (LpxC) from Pseudomonas aeruginosa in complex with CHIR-090 inhibitor;1.8;CA;CALCIUM ION;UDP-3-O-acyl-N-acetylglucosamine deacetylase;287;
5VXZ;A;High-affinity AXL decoy receptor;2.3;CA;CALCIUM ION;Growth arrest-specific protein 6;9606;
5VXZ;B;High-affinity AXL decoy receptor;2.3;CA;CALCIUM ION;Growth arrest-specific protein 6;9606;
5VYB;A;Structure of the carbohydrate recognition domain of Dectin-2 complexed with a mammalian-type high mannose Man9GlcNAc2 oligosaccharide;2.4;CA;CALCIUM ION;C-type lectin domain family 6 member A;9606;
5VYF;C;Structure of single chain Fel d 1 bound to a neutralizing antibody;2.9;CA;CALCIUM ION;Chimera of Major allergen I polypeptide chain 2,Major allergen I polypeptide chain 1;9685;
5VYF;F;Structure of single chain Fel d 1 bound to a neutralizing antibody;2.9;CA;CALCIUM ION;Chimera of Major allergen I polypeptide chain 2,Major allergen I polypeptide chain 1;9685;
5VYG;B;Crystal structure of hFA9 EGF repeat with O-glucose trisaccharide;2.2;CA;CALCIUM ION;Coagulation factor IX;9606;
5VYG;C;Crystal structure of hFA9 EGF repeat with O-glucose trisaccharide;2.2;CA;CALCIUM ION;Coagulation factor IX;9606;
5W0R;A;Crystal structure of MBP fused activation-induced cytidine deaminase (AID) in complex with cacodylic acid;2.4;CA;CALCIUM ION;MBP fused activation-induced cytidine deaminase;5,629,606;
5W0R;B;Crystal structure of MBP fused activation-induced cytidine deaminase (AID) in complex with cacodylic acid;2.4;CA;CALCIUM ION;MBP fused activation-induced cytidine deaminase;5,629,606;
5W0U;A;Crystal structure of MBP fused activation-induced cytidine deaminase (AID) in complex with dCMP;2.9;CA;CALCIUM ION;Maltose-binding periplasmic protein,Single-stranded DNA cytosine deaminase;5,629,606;
5W0U;B;Crystal structure of MBP fused activation-induced cytidine deaminase (AID) in complex with dCMP;2.9;CA;CALCIUM ION;Maltose-binding periplasmic protein,Single-stranded DNA cytosine deaminase;5,629,606;
5W1C;A;Crystal structure of MBP fused activation-induced cytidine deaminase (AID) in complex with cytidine;3.18;CA;CALCIUM ION;MBP fused activation-induced cytidine deaminase;5,629,606;
5W1C;B;Crystal structure of MBP fused activation-induced cytidine deaminase (AID) in complex with cytidine;3.18;CA;CALCIUM ION;MBP fused activation-induced cytidine deaminase;5,629,606;
5W1D;A;Crystal Structure of Mouse Protocadherin-15 EC4-7;3.35;CA;CALCIUM ION;Protocadherin-15;10090;
5W1F;A;Crystal structure of Ni(II)- and Ca(II)-bound human calprotectin;2.6;CA;CALCIUM ION;Protein S100-A8;9606;
5W1F;B;Crystal structure of Ni(II)- and Ca(II)-bound human calprotectin;2.6;CA;CALCIUM ION;Protein S100-A9;9606;
5W1F;C;Crystal structure of Ni(II)- and Ca(II)-bound human calprotectin;2.6;CA;CALCIUM ION;Protein S100-A8;9606;
5W1F;D;Crystal structure of Ni(II)- and Ca(II)-bound human calprotectin;2.6;CA;CALCIUM ION;Protein S100-A9;9606;
5W1F;E;Crystal structure of Ni(II)- and Ca(II)-bound human calprotectin;2.6;CA;CALCIUM ION;Protein S100-A8;9606;
5W1F;F;Crystal structure of Ni(II)- and Ca(II)-bound human calprotectin;2.6;CA;CALCIUM ION;Protein S100-A9;9606;
5W1F;G;Crystal structure of Ni(II)- and Ca(II)-bound human calprotectin;2.6;CA;CALCIUM ION;Protein S100-A8;9606;
5W1F;H;Crystal structure of Ni(II)- and Ca(II)-bound human calprotectin;2.6;CA;CALCIUM ION;Protein S100-A9;9606;
5W26;A;INFLUENZA VIRUS NEURAMINIDASE N9 IN COMPLEX WITH 4-DEOXYGENATED 2,3-DIFLUORO-N-ACETYLNEURAMINIC ACID;1.9;CA;CALCIUM ION;Neuraminidase;11320;
5W2U;A;INFLUENZA VIRUS NEURAMINIDASE N9 IN COMPLEX WITH 7-DEOXYGENATED 2,3-DIFLUORO-N-ACETYLNEURAMINIC ACID;2;CA;CALCIUM ION;Neuraminidase;11320;
5W2W;A;INFLUENZA VIRUS NEURAMINIDASE N9 IN COMPLEX WITH 8-DEOXYGENATED 2,3-DIFLUORO-N-ACETYLNEURAMINIC ACID;1.85;CA;CALCIUM ION;Neuraminidase;11320;
5W2Y;A;INFLUENZA VIRUS NEURAMINIDASE N9 IN COMPLEX WITH 9-DEOXYGENATED 2,3-DIFLUORO-N-ACETYLNEURAMINIC ACID;2.39;CA;CALCIUM ION;Neuraminidase;11320;
5W3Q;A;L28F E.coli DHFR in complex with NADPH;1.4;CA;CALCIUM ION;Dihydrofolate reductase;562;
5W4C;A;Crystal structure of thioredoxin reductase from Cryptococcus neoformans in complex with FAD (FO conformation);2.26;CA;CALCIUM ION;Thioredoxin reductase;5207;
5W4C;B;Crystal structure of thioredoxin reductase from Cryptococcus neoformans in complex with FAD (FO conformation);2.26;CA;CALCIUM ION;Thioredoxin reductase;5207;
5W4S;A;Solution structure of C2 domain from protein kinase C alpha in ternary complex with calcium and V5-pHM peptide;;CA;CALCIUM ION;Protein kinase C alpha type;10116;
5W4T;A;Crystal Structure of Fish Cadherin-23 EC1-3;2.65;CA;CALCIUM ION;Cadherin 23;7955;
5W4T;B;Crystal Structure of Fish Cadherin-23 EC1-3;2.65;CA;CALCIUM ION;Cadherin 23;7955;
5W4T;C;Crystal Structure of Fish Cadherin-23 EC1-3;2.65;CA;CALCIUM ION;Cadherin 23;7955;
5W4T;D;Crystal Structure of Fish Cadherin-23 EC1-3;2.65;CA;CALCIUM ION;Cadherin 23;7955;
5W78;B;Human acyloxyacyl hydrolase (AOAH), proteolytically processed;2.27;CA;CALCIUM ION;Acyloxyacyl hydrolase;9606;
5W7A;B;Rabbit acyloxyacyl hydrolase (AOAH), proteolytically processed, S262A mutant, with LPS (low quality saposin domain);2.3;CA;CALCIUM ION;Acyloxyacyl hydrolase large subunit;9986;
5W7B;C;Rabbit acyloxyacyl hydrolase (AOAH), proteolytically processed, S262A mutant, with LPS;1.9;CA;CALCIUM ION;Acyloxyacyl hydrolase large subunit;9986;
5W7B;D;Rabbit acyloxyacyl hydrolase (AOAH), proteolytically processed, S262A mutant, with LPS;1.9;CA;CALCIUM ION;Acyloxyacyl hydrolase large subunit;9986;
5W7C;C;Human acyloxyacyl hydrolase (AOAH), proteolytically processed, S263A mutant, with LPS;2.23;CA;CALCIUM ION;Acyloxyacyl hydrolase;9606;
5W7C;D;Human acyloxyacyl hydrolase (AOAH), proteolytically processed, S263A mutant, with LPS;2.23;CA;CALCIUM ION;Acyloxyacyl hydrolase;9606;
5W7D;A;Murine acyloxyacyl hydrolase (AOAH), S262A mutant;1.75;CA;CALCIUM ION;Acyloxyacyl hydrolase;10090;
5W7E;A;Murine acyloxyacyl hydrolase (AOAH), S262A mutant, with dimyristoyl phosphatidylcholine;1.83;CA;CALCIUM ION;Acyloxyacyl hydrolase;10090;
5W7E;B;Murine acyloxyacyl hydrolase (AOAH), S262A mutant, with dimyristoyl phosphatidylcholine;1.83;CA;CALCIUM ION;Acyloxyacyl hydrolase;10090;
5W7F;A;Murine acyloxyacyl hydrolase (AOAH), S262A mutant, with lipid A;2.8;CA;CALCIUM ION;Acyloxyacyl hydrolase;10090;
5W7F;B;Murine acyloxyacyl hydrolase (AOAH), S262A mutant, with lipid A;2.8;CA;CALCIUM ION;Acyloxyacyl hydrolase;10090;
5W80;A;Toxoplasma Gondii CDPK1 in complex with inhibitor GXJ-237;2;CA;CALCIUM ION;Calmodulin-domain protein kinase 1;5811;
5W8O;A;Homoserine transacetylase MetA from Mycobacterium hassiacum;1.47;CA;CALCIUM ION;Homoserine O-acetyltransferase;46351;
5W8O;B;Homoserine transacetylase MetA from Mycobacterium hassiacum;1.47;CA;CALCIUM ION;Homoserine O-acetyltransferase;46351;
5W8R;A;Toxoplasma Gondii CDPK1 in complex with inhibitor 3CIB-PPI;2.2;CA;CALCIUM ION;Calmodulin-domain protein kinase 1;5811;
5W91;A;Toxoplasma Gondii CDPK1 in complex with inhibitor LZH118;2.4;CA;CALCIUM ION;Calmodulin-domain protein kinase 1;5811;
5WBX;R;Structural insights into the potency of SK/IK channel positive modulators;1.9;CA;CALCIUM ION;Calmodulin-1;9606;
5WC5;R;Structural insights into the potency of SK/IK channel positive modulators;2.3;CA;CALCIUM ION;Calmodulin-1;9606;
5WCX;A;Streptococcus pyogenes phosphoglycerol transferase GacH in complex with sn-glycerol-1-phosphate, crystal form 1;2;CA;CALCIUM ION;Phosphoglycerol transferase GacH;1314;
5WD6;A;bovine salivary protein form 30b;2;CA;CALCIUM ION;Short palate, lung and nasal epithelium carcinoma-associated protein 2B;9913;
5WDA;A;Structure of the PulG pseudopilus;5;CA;CALCIUM ION;General secretion pathway protein G;571;
5WDA;B;Structure of the PulG pseudopilus;5;CA;CALCIUM ION;General secretion pathway protein G;571;
5WDA;C;Structure of the PulG pseudopilus;5;CA;CALCIUM ION;General secretion pathway protein G;571;
5WDA;D;Structure of the PulG pseudopilus;5;CA;CALCIUM ION;General secretion pathway protein G;571;
5WDA;E;Structure of the PulG pseudopilus;5;CA;CALCIUM ION;General secretion pathway protein G;571;
5WDA;F;Structure of the PulG pseudopilus;5;CA;CALCIUM ION;General secretion pathway protein G;571;
5WDA;G;Structure of the PulG pseudopilus;5;CA;CALCIUM ION;General secretion pathway protein G;571;
5WDA;H;Structure of the PulG pseudopilus;5;CA;CALCIUM ION;General secretion pathway protein G;571;
5WDA;I;Structure of the PulG pseudopilus;5;CA;CALCIUM ION;General secretion pathway protein G;571;
5WDA;J;Structure of the PulG pseudopilus;5;CA;CALCIUM ION;General secretion pathway protein G;571;
5WDA;K;Structure of the PulG pseudopilus;5;CA;CALCIUM ION;General secretion pathway protein G;571;
5WDA;L;Structure of the PulG pseudopilus;5;CA;CALCIUM ION;General secretion pathway protein G;571;
5WDA;M;Structure of the PulG pseudopilus;5;CA;CALCIUM ION;General secretion pathway protein G;571;
5WDA;N;Structure of the PulG pseudopilus;5;CA;CALCIUM ION;General secretion pathway protein G;571;
5WDA;O;Structure of the PulG pseudopilus;5;CA;CALCIUM ION;General secretion pathway protein G;571;
5WDA;P;Structure of the PulG pseudopilus;5;CA;CALCIUM ION;General secretion pathway protein G;571;
5WDA;Q;Structure of the PulG pseudopilus;5;CA;CALCIUM ION;General secretion pathway protein G;571;
5WDA;R;Structure of the PulG pseudopilus;5;CA;CALCIUM ION;General secretion pathway protein G;571;
5WDA;S;Structure of the PulG pseudopilus;5;CA;CALCIUM ION;General secretion pathway protein G;571;
5WDA;T;Structure of the PulG pseudopilus;5;CA;CALCIUM ION;General secretion pathway protein G;571;
5WDA;U;Structure of the PulG pseudopilus;5;CA;CALCIUM ION;General secretion pathway protein G;571;
5WDA;V;Structure of the PulG pseudopilus;5;CA;CALCIUM ION;General secretion pathway protein G;571;
5WDA;W;Structure of the PulG pseudopilus;5;CA;CALCIUM ION;General secretion pathway protein G;571;
5WDA;X;Structure of the PulG pseudopilus;5;CA;CALCIUM ION;General secretion pathway protein G;571;
5WDA;Y;Structure of the PulG pseudopilus;5;CA;CALCIUM ION;General secretion pathway protein G;571;
5WDJ;A;CRYSTAL STRUCTURE OF MYELOPEROXIDASE SUBFORM C (MPO) COMPLEX WITH COMPOUND-6 AKA 7-(BENZYLOXY)-1H-[1,2, 3]TRIAZOLO[4,5-D]PYRIMIDIN-5-AMINE;2.4;CA;CALCIUM ION;Myeloperoxidase;9606;
5WDJ;D;CRYSTAL STRUCTURE OF MYELOPEROXIDASE SUBFORM C (MPO) COMPLEX WITH COMPOUND-6 AKA 7-(BENZYLOXY)-1H-[1,2, 3]TRIAZOLO[4,5-D]PYRIMIDIN-5-AMINE;2.4;CA;CALCIUM ION;Myeloperoxidase;9606;
5WDO;A;H-Ras bound to GMP-PNP at 277K;1.65;CA;CALCIUM ION;GTPase HRas;9606;
5WDP;A;H-Ras mutant L120A bound to GMP-PNP at 277K;1.35;CA;CALCIUM ION;GTPase HRas;9606;
5WDQ;A;H-Ras mutant L120A bound to GMP-PNP at 100K;1.25;CA;CALCIUM ION;GTPase HRas;9606;
5WEH;A;Cytochrome c oxidase from Rhodobacter sphaeroides in the reduced state;3.45;CA;CALCIUM ION;Cytochrome c oxidase subunit 1;1063;
5WEH;G;Cytochrome c oxidase from Rhodobacter sphaeroides in the reduced state;3.45;CA;CALCIUM ION;Cytochrome c oxidase subunit 1;1063;
5WEY;A;Joint X-ray/neutron structure of Concanavalin A with alpha1-2 D-mannobiose;;CA;CALCIUM ION;Concanavalin-A;3823;
5WGG;A;Structural Insights into Thioether Bond Formation in the Biosynthesis of Sactipeptides;2.04;CA;CALCIUM ION;Radical SAM domain protein;1515;
5WHA;A;KRas G12V, bound to GDP and miniprotein 225-11;2.04;CA;CALCIUM ION;GTPase KRas;9606;
5WHA;D;KRas G12V, bound to GDP and miniprotein 225-11;2.04;CA;CALCIUM ION;GTPase KRas;9606;
5WHA;G;KRas G12V, bound to GDP and miniprotein 225-11;2.04;CA;CALCIUM ION;GTPase KRas;9606;
5WHA;I;KRas G12V, bound to GDP and miniprotein 225-11;2.04;CA;CALCIUM ION;miniprotein 225-11;32630;
5WHB;A;KRas G12V, bound to GDP and miniprotein 225-11(A30R);2.18;CA;CALCIUM ION;GTPase KRas;9606;
5WHB;C;KRas G12V, bound to GDP and miniprotein 225-11(A30R);2.18;CA;CALCIUM ION;Ras binder peptide: 225-11 (A30R);32630;
5WHB;D;KRas G12V, bound to GDP and miniprotein 225-11(A30R);2.18;CA;CALCIUM ION;GTPase KRas;9606;
5WHB;F;KRas G12V, bound to GDP and miniprotein 225-11(A30R);2.18;CA;CALCIUM ION;Ras binder peptide: 225-11 (A30R);32630;
5WHB;J;KRas G12V, bound to GDP and miniprotein 225-11(A30R);2.18;CA;CALCIUM ION;GTPase KRas;9606;
5WHE;A;KRas G12V/D38P, bound to GppNHp and miniprotein 225-11;1.91;CA;CALCIUM ION;GTPase KRas;9606;
5WHE;D;KRas G12V/D38P, bound to GppNHp and miniprotein 225-11;1.91;CA;CALCIUM ION;GTPase KRas;9606;
5WHE;F;KRas G12V/D38P, bound to GppNHp and miniprotein 225-11;1.91;CA;CALCIUM ION;Miniprotein 225-11;32630;
5WHE;G;KRas G12V/D38P, bound to GppNHp and miniprotein 225-11;1.91;CA;CALCIUM ION;GTPase KRas;9606;
5WHM;A;Crystal Structure of IclR Family Transcriptional Regulator from Brucella abortus;1.95;CA;CALCIUM ION;IclR family transcriptional regulator;235;
5WHU;E;Crystal structure of 3'SL bound ArtB;2.2;CA;CALCIUM ION;ArtB protein;28901;
5WHU;F;Crystal structure of 3'SL bound ArtB;2.2;CA;CALCIUM ION;ArtB protein;28901;
5WHU;G;Crystal structure of 3'SL bound ArtB;2.2;CA;CALCIUM ION;ArtB protein;28901;
5WHU;H;Crystal structure of 3'SL bound ArtB;2.2;CA;CALCIUM ION;ArtB protein;28901;
5WHU;I;Crystal structure of 3'SL bound ArtB;2.2;CA;CALCIUM ION;ArtB protein;28901;
5WHU;J;Crystal structure of 3'SL bound ArtB;2.2;CA;CALCIUM ION;ArtB protein;28901;
5WHV;A;Crystal structure of ArtB;2.3;CA;CALCIUM ION;ArtB protein;28901;
5WHV;B;Crystal structure of ArtB;2.3;CA;CALCIUM ION;ArtB protein;28901;
5WHV;E;Crystal structure of ArtB;2.3;CA;CALCIUM ION;ArtB protein;28901;
5WHV;F;Crystal structure of ArtB;2.3;CA;CALCIUM ION;ArtB protein;28901;
5WHV;G;Crystal structure of ArtB;2.3;CA;CALCIUM ION;ArtB protein;28901;
5WHV;H;Crystal structure of ArtB;2.3;CA;CALCIUM ION;ArtB protein;28901;
5WHV;I;Crystal structure of ArtB;2.3;CA;CALCIUM ION;ArtB protein;28901;
5WHV;J;Crystal structure of ArtB;2.3;CA;CALCIUM ION;ArtB protein;28901;
5WHW;A;Using sound pulses to solve the crystal harvesting bottleneck;1.71;CA;CALCIUM ION;Proteinase K;37998;
5WHY;A;Structural Insights into Thioether Bond Formation in the Biosynthesis of Sactipeptides;2.69;CA;CALCIUM ION;Radical SAM domain protein;1515;
5WHY;B;Structural Insights into Thioether Bond Formation in the Biosynthesis of Sactipeptides;2.69;CA;CALCIUM ION;Radical SAM domain protein;1515;
5WJ8;A;Crystal Structure of Human Cadherin-23 EC13-14;1.86;CA;CALCIUM ION;Cadherin-23;9606;
5WJG;A;Using sound pulses to solve the crystal harvesting bottleneck;1.5;CA;CALCIUM ION;Proteinase K;37998;
5WJH;A;Using sound pulses to solve the crystal harvesting bottleneck;1.63;CA;CALCIUM ION;Proteinase K;37998;
5WJM;A;Crystal Structure of Mouse Cadherin-23 EC17-18;2.9;CA;CALCIUM ION;Cadherin-23;10090;
5WKJ;A;2.05 A resolution structure of MERS 3CL protease in complex with inhibitor GC376;2.05;CA;CALCIUM ION;Orf1a protein;1335626;
5WKV;A;Structure of an acid sensing ion channel in a resting state with calcium;3.2;CA;CALCIUM ION;Acid-sensing ion channel 1;9031;
5WKV;B;Structure of an acid sensing ion channel in a resting state with calcium;3.2;CA;CALCIUM ION;Acid-sensing ion channel 1;9031;
5WKV;C;Structure of an acid sensing ion channel in a resting state with calcium;3.2;CA;CALCIUM ION;Acid-sensing ion channel 1;9031;
5WMM;A;Crystal structure of an adenylation domain interrupted by a methylation domain (AMA4) from nonribosomal peptide synthetase TioS;2.9;CA;CALCIUM ION;NRPS;349725;
5WN1;E;APE1 exonuclease product complex;2.3;CA;CALCIUM ION;DNA (5'-D(*GP*GP*AP*TP*CP*CP*GP*TP*CP*GP*AP*TP*CP*GP*CP*AP*TP*CP*AP*GP*C)-3');32630;
5WN2;E;APE1 exonuclease substrate complex with phosphoglycolate;2.29;CA;CALCIUM ION;DNA (5'-D(*GP*GP*AP*TP*CP*CP*GP*TP*CP*GP*AP*CP*CP*GP*CP*AP*TP*CP*AP*GP*C)-3');32630;
5WN3;D;APE1 F266A exonuclease substrate complex with a C/T mismatch;2;CA;CALCIUM ION;DNA (5'-D(*GP*CP*TP*GP*AP*TP*GP*CP*GP*(DV3))-3');32630;
5WN4;D;APE1 exonuclease substrate complex with a C/T mismatch;2.1;CA;CALCIUM ION;DNA (5'-D(*GP*CP*TP*GP*AP*TP*GP*CP*GP*(DV3))-3');32630;
5WNX;A;DNA polymerase beta substrate complex with incoming 6-TdGTP;2.55;CA;CALCIUM ION;DNA polymerase beta;9606;
5WNY;A;DNA polymerase beta substrate complex with incoming 5-FdUTP;2.1;CA;CALCIUM ION;DNA polymerase beta;9606;
5WNZ;A;DNA polymerase beta substrate complex with incoming 5-FodCTP;2.2;CA;CALCIUM ION;DNA polymerase beta;9606;
5WO0;A;DNA polymerase beta substrate complex with incoming 5-FodUTP;1.6;CA;CALCIUM ION;DNA polymerase beta;9606;
5WO0;P;DNA polymerase beta substrate complex with incoming 5-FodUTP;1.6;CA;CALCIUM ION;DNA (5'-D(*GP*CP*TP*GP*AP*TP*GP*CP*GP*C)-3');32630;
5WO6;A;Crystal Structure of Transient Receptor Potential (TRP) channel TRPV6cryst;3.31;CA;CALCIUM ION;Transient receptor potential cation channel subfamily V member 6;10116;
5WO7;A;Crystal Structure of Transient Receptor Potential (TRP) channel TRPV6*;3.25;CA;CALCIUM ION;Transient receptor potential cation channel subfamily V member 6;10116;
5WO8;A;Crystal Structure of Transient Receptor Potential (TRP) channel TRPV6*-Del1;3.4;CA;CALCIUM ION;Transient receptor potential cation channel subfamily V member 6;10116;
5WO9;A;Crystal Structure of Transient Receptor Potential (TRP) channel TRPV6* in the presence of Calcium;3.7;CA;CALCIUM ION;Transient receptor potential cation channel subfamily V member 6;10116;
5WPL;A;KRas G12V, bound to GppNHp and miniprotein 225-11;2.15;CA;CALCIUM ION;GTPase HRas;9606;
5WPL;D;KRas G12V, bound to GppNHp and miniprotein 225-11;2.15;CA;CALCIUM ION;GTPase HRas;9606;
5WPL;G;KRas G12V, bound to GppNHp and miniprotein 225-11;2.15;CA;CALCIUM ION;GTPase HRas;9606;
5WPL;J;KRas G12V, bound to GppNHp and miniprotein 225-11;2.15;CA;CALCIUM ION;GTPase HRas;9606;
5WPL;L;KRas G12V, bound to GppNHp and miniprotein 225-11;2.15;CA;CALCIUM ION;Ras-binding peptide;4932;
5WPN;A;Zn-bound Structure of Chaetopterus variopedatus Ferritin;1.57;CA;CALCIUM ION;Ferritin;34590;
5WPP;A;Crystal structure HpiC1 W73M/K132M;1.7;CA;CALCIUM ION;12-epi-hapalindole C/U synthase;1535197;
5WPP;B;Crystal structure HpiC1 W73M/K132M;1.7;CA;CALCIUM ION;12-epi-hapalindole C/U synthase;1535197;
5WPR;A;Crystal structure HpiC1 in C2 space group;1.49;CA;CALCIUM ION;12-epi-hapalindole C/U synthase;1535197;
5WPS;A;Crystal structure HpiC1 Y101F;1.39;CA;CALCIUM ION;12-epi-hapalindole C/U synthase;1535197;
5WPU;A;Crystal structure HpiC1 Y101S;1.39;CA;CALCIUM ION;12-epi-hapalindole C/U synthase;1535197;
5WQF;A;Strucutre of fungal meroterpenoid isomerase Trt14;2;CA;CALCIUM ION;Isomerase trt14;33178;
5WQF;B;Strucutre of fungal meroterpenoid isomerase Trt14;2;CA;CALCIUM ION;Isomerase trt14;33178;
5WQF;C;Strucutre of fungal meroterpenoid isomerase Trt14;2;CA;CALCIUM ION;Isomerase trt14;33178;
5WQF;D;Strucutre of fungal meroterpenoid isomerase Trt14;2;CA;CALCIUM ION;Isomerase trt14;33178;
5WQF;E;Strucutre of fungal meroterpenoid isomerase Trt14;2;CA;CALCIUM ION;Isomerase trt14;33178;
5WQF;F;Strucutre of fungal meroterpenoid isomerase Trt14;2;CA;CALCIUM ION;Isomerase trt14;33178;
5WQG;A;Structure of fungal meroterpenoid isomerase Trt14 complexed with terretonin D;2.3;CA;CALCIUM ION;Isomerase trt14;33178;
5WQG;B;Structure of fungal meroterpenoid isomerase Trt14 complexed with terretonin D;2.3;CA;CALCIUM ION;Isomerase trt14;33178;
5WQG;C;Structure of fungal meroterpenoid isomerase Trt14 complexed with terretonin D;2.3;CA;CALCIUM ION;Isomerase trt14;33178;
5WQG;D;Structure of fungal meroterpenoid isomerase Trt14 complexed with terretonin D;2.3;CA;CALCIUM ION;Isomerase trt14;33178;
5WQG;E;Structure of fungal meroterpenoid isomerase Trt14 complexed with terretonin D;2.3;CA;CALCIUM ION;Isomerase trt14;33178;
5WQG;F;Structure of fungal meroterpenoid isomerase Trt14 complexed with terretonin D;2.3;CA;CALCIUM ION;Isomerase trt14;33178;
5WQH;A;Structure of fungal meroterpenoid isomerase Trt14 complexed with substrate analog and endo-terretonin D;2.1;CA;CALCIUM ION;Isomerase trt14;33178;
5WQH;B;Structure of fungal meroterpenoid isomerase Trt14 complexed with substrate analog and endo-terretonin D;2.1;CA;CALCIUM ION;Isomerase trt14;33178;
5WQH;E;Structure of fungal meroterpenoid isomerase Trt14 complexed with substrate analog and endo-terretonin D;2.1;CA;CALCIUM ION;Isomerase trt14;33178;
5WQH;F;Structure of fungal meroterpenoid isomerase Trt14 complexed with substrate analog and endo-terretonin D;2.1;CA;CALCIUM ION;Isomerase trt14;33178;
5WQI;A;Structure of fungal meroterpenoid isomerase Trt14 complexed with hydrolyzed product;1.9;CA;CALCIUM ION;Isomerase trt14;33178;
5WQI;B;Structure of fungal meroterpenoid isomerase Trt14 complexed with hydrolyzed product;1.9;CA;CALCIUM ION;Isomerase trt14;33178;
5WQI;C;Structure of fungal meroterpenoid isomerase Trt14 complexed with hydrolyzed product;1.9;CA;CALCIUM ION;Isomerase trt14;33178;
5WQI;D;Structure of fungal meroterpenoid isomerase Trt14 complexed with hydrolyzed product;1.9;CA;CALCIUM ION;Isomerase trt14;33178;
5WQI;E;Structure of fungal meroterpenoid isomerase Trt14 complexed with hydrolyzed product;1.9;CA;CALCIUM ION;Isomerase trt14;33178;
5WQI;F;Structure of fungal meroterpenoid isomerase Trt14 complexed with hydrolyzed product;1.9;CA;CALCIUM ION;Isomerase trt14;33178;
5WR2;A;Thermolysin, SFX liganded form with oil-based carrier;2;CA;CALCIUM ION;Thermolysin;1422;
5WR3;A;Thermolysin, SFX liganded form with water-based carrier;2.1;CA;CALCIUM ION;Thermolysin;1422;
5WR4;A;Thermolysin, SFX unliganded form with oil-based carrier;2.1;CA;CALCIUM ION;Thermolysin;1422;
5WR5;A;Thermolysin, liganded form with cryo condition 1;1.9;CA;CALCIUM ION;Thermolysin;1422;
5WR6;A;Thermolysin, liganded form with cryo condition 2;2.3;CA;CALCIUM ION;Thermolysin;1422;
5WS5;C;Native XFEL structure of photosystem II (preflash dark dataset);2.35;CA;CALCIUM ION;Photosystem II CP43 protein;32053;
5WS5;F;Native XFEL structure of photosystem II (preflash dark dataset);2.35;CA;CALCIUM ION;Cytochrome b559 subunit beta;32053;
5WS5;O;Native XFEL structure of photosystem II (preflash dark dataset);2.35;CA;CALCIUM ION;Photosystem II manganese-stabilizing polypeptide;32053;
5WS5;c;Native XFEL structure of photosystem II (preflash dark dataset);2.35;CA;CALCIUM ION;Photosystem II CP43 protein;32053;
5WS5;f;Native XFEL structure of photosystem II (preflash dark dataset);2.35;CA;CALCIUM ION;Cytochrome b559 subunit beta;32053;
5WS5;o;Native XFEL structure of photosystem II (preflash dark dataset);2.35;CA;CALCIUM ION;Photosystem II manganese-stabilizing polypeptide;32053;
5WS6;C;Native XFEL structure of Photosystem II (preflash two-flash dataset;2.35;CA;CALCIUM ION;Photosystem II CP43 chlorophyll protein;32053;
5WS6;O;Native XFEL structure of Photosystem II (preflash two-flash dataset;2.35;CA;CALCIUM ION;Photosystem II manganese-stabilizing polypeptide;32053;
5WS6;V;Native XFEL structure of Photosystem II (preflash two-flash dataset;2.35;CA;CALCIUM ION;Cytochrome c-550;32053;
5WS6;b;Native XFEL structure of Photosystem II (preflash two-flash dataset;2.35;CA;CALCIUM ION;Photosystem II CP47 reaction center protein;32053;
5WS6;c;Native XFEL structure of Photosystem II (preflash two-flash dataset;2.35;CA;CALCIUM ION;Photosystem II CP43 chlorophyll protein;32053;
5WS6;o;Native XFEL structure of Photosystem II (preflash two-flash dataset;2.35;CA;CALCIUM ION;Photosystem II manganese-stabilizing polypeptide;32053;
5WS6;v;Native XFEL structure of Photosystem II (preflash two-flash dataset;2.35;CA;CALCIUM ION;Cytochrome c-550;32053;
5WSL;A;Structural studies of keratinase from Meiothermus taiwanensis WR-220;1.5;CA;CALCIUM ION;keratinase;172827;
5WSL;B;Structural studies of keratinase from Meiothermus taiwanensis WR-220;1.5;CA;CALCIUM ION;keratinase;172827;
5WSL;C;Structural studies of keratinase from Meiothermus taiwanensis WR-220;1.5;CA;CALCIUM ION;keratinase;172827;
5WSV;A;Crystal structure of Myosin VIIa IQ5 in complex with Ca2+-CaM;2.33;CA;CALCIUM ION;Calmodulin;9606;
5WSV;C;Crystal structure of Myosin VIIa IQ5 in complex with Ca2+-CaM;2.33;CA;CALCIUM ION;Calmodulin;9606;
5WTL;A;Crystal structure of the periplasmic portion of outer membrane protein A (OmpA) from Capnocytophaga gingivalis;2.3;CA;CALCIUM ION;OmpA family protein;1017;
5WTL;B;Crystal structure of the periplasmic portion of outer membrane protein A (OmpA) from Capnocytophaga gingivalis;2.3;CA;CALCIUM ION;OmpA family protein;1017;
5WTL;C;Crystal structure of the periplasmic portion of outer membrane protein A (OmpA) from Capnocytophaga gingivalis;2.3;CA;CALCIUM ION;OmpA family protein;1017;
5WTL;D;Crystal structure of the periplasmic portion of outer membrane protein A (OmpA) from Capnocytophaga gingivalis;2.3;CA;CALCIUM ION;OmpA family protein;1017;
5WV3;A;Crystal structure of bovine lactoperoxidase with a partial Glu258-heme linkage at 2.07 A resolution.;2.07;CA;CALCIUM ION;Lactoperoxidase;9913;
5WZE;A;The structure of Pseudomonas aeruginosa aminopeptidase PepP;1.78;CA;CALCIUM ION;Aminopeptidase P;287;
5WZE;B;The structure of Pseudomonas aeruginosa aminopeptidase PepP;1.78;CA;CALCIUM ION;Aminopeptidase P;287;
5WZE;C;The structure of Pseudomonas aeruginosa aminopeptidase PepP;1.78;CA;CALCIUM ION;Aminopeptidase P;287;
5WZM;A;Crystal structure of human secreted phospholipase A2 group IIE;2;CA;CALCIUM ION;Group IIE secretory phospholipase A2;9606;
5WZN;A;Alpha-N-acetylgalactosaminidase NagBb from Bifidobacterium bifidum - GalNAc complex;2.1;CA;CALCIUM ION;Alpha-N-acetylgalactosaminidase;1681;
5WZN;B;Alpha-N-acetylgalactosaminidase NagBb from Bifidobacterium bifidum - GalNAc complex;2.1;CA;CALCIUM ION;Alpha-N-acetylgalactosaminidase;1681;
5WZO;A;Crystal structure of human secreted phospholipase A2 group IIE, crystallized with calcium;1.9;CA;CALCIUM ION;Group IIE secretory phospholipase A2;9606;
5WZP;A;Alpha-N-acetylgalactosaminidase NagBb from Bifidobacterium bifidum - ligand free;2.64;CA;CALCIUM ION;Alpha-N-acetylgalactosaminidase;1681;
5WZP;B;Alpha-N-acetylgalactosaminidase NagBb from Bifidobacterium bifidum - ligand free;2.64;CA;CALCIUM ION;Alpha-N-acetylgalactosaminidase;1681;
5WZR;A;Alpha-N-acetylgalactosaminidase NagBb from Bifidobacterium bifidum - Gal-NHAc-DNJ complex;2.79;CA;CALCIUM ION;Alpha-N-acetylgalactosaminidase;1681;
5WZR;B;Alpha-N-acetylgalactosaminidase NagBb from Bifidobacterium bifidum - Gal-NHAc-DNJ complex;2.79;CA;CALCIUM ION;Alpha-N-acetylgalactosaminidase;1681;
5WZS;A;Crystal structure of human secreted phospholipase A2 group IIE with Compound 8;2.3;CA;CALCIUM ION;Group IIE secretory phospholipase A2;9606;
5WZT;A;Crystal structure of human secreted phospholipase A2 group IIE with Compound 14;2.4;CA;CALCIUM ION;Group IIE secretory phospholipase A2;9606;
5WZU;A;Crystal structure of human secreted phospholipase A2 group IIE with Compound 24;2.2;CA;CALCIUM ION;Group IIE secretory phospholipase A2;9606;
5WZV;A;Crystal structure of human secreted phospholipase A2 group IIE with Me-indoxam;2.2;CA;CALCIUM ION;Group IIE secretory phospholipase A2;9606;
5WZW;A;Crystal structure of human secreted phospholipase A2 group IIE with LY311727;1.95;CA;CALCIUM ION;Group IIE secretory phospholipase A2;9606;
5X2B;A;Crystal structure of mouse sulfotransferase SULT7A1 complexed with PAP;2.08;CA;CALCIUM ION;Sulfotransferase;10090;
5X2B;B;Crystal structure of mouse sulfotransferase SULT7A1 complexed with PAP;2.08;CA;CALCIUM ION;Sulfotransferase;10090;
5X2B;C;Crystal structure of mouse sulfotransferase SULT7A1 complexed with PAP;2.08;CA;CALCIUM ION;Sulfotransferase;10090;
5X2B;D;Crystal structure of mouse sulfotransferase SULT7A1 complexed with PAP;2.08;CA;CALCIUM ION;Sulfotransferase;10090;
5X2B;E;Crystal structure of mouse sulfotransferase SULT7A1 complexed with PAP;2.08;CA;CALCIUM ION;Sulfotransferase;10090;
5X2B;F;Crystal structure of mouse sulfotransferase SULT7A1 complexed with PAP;2.08;CA;CALCIUM ION;Sulfotransferase;10090;
5X2B;G;Crystal structure of mouse sulfotransferase SULT7A1 complexed with PAP;2.08;CA;CALCIUM ION;Sulfotransferase;10090;
5X2B;H;Crystal structure of mouse sulfotransferase SULT7A1 complexed with PAP;2.08;CA;CALCIUM ION;Sulfotransferase;10090;
5X2B;I;Crystal structure of mouse sulfotransferase SULT7A1 complexed with PAP;2.08;CA;CALCIUM ION;Sulfotransferase;10090;
5X2B;J;Crystal structure of mouse sulfotransferase SULT7A1 complexed with PAP;2.08;CA;CALCIUM ION;Sulfotransferase;10090;
5X2B;K;Crystal structure of mouse sulfotransferase SULT7A1 complexed with PAP;2.08;CA;CALCIUM ION;Sulfotransferase;10090;
5X2B;L;Crystal structure of mouse sulfotransferase SULT7A1 complexed with PAP;2.08;CA;CALCIUM ION;Sulfotransferase;10090;
5X2E;A;Crystal structure of Calmodulin like domain of CsTAL3 (1-81aa);1.3;CA;CALCIUM ION;Tegumental protein 20.8 kDa;79923;
5X2I;A;Polygalacturonate Lyase by Fusing with a Self-assembling Amphipathic Peptide;2.05;CA;CALCIUM ION;Pectate lyase;1423;
5X2M;L;Crystal structure of the medaka fish taste receptor T1r2a-T1r3 ligand binding domains in complex with L-glutamine;2.21;CA;CALCIUM ION;Fab16A Light chain;10090;
5X2O;K;Crystal structure of the medaka fish taste receptor T1r2a-T1r3 ligand binding domains in complex with L-arginine;2.6;CA;CALCIUM ION;Fab16A Light chain;10090;
5X2P;K;Crystal structure of the medaka fish taste receptor T1r2a-T1r3 ligand binding domains in complex with L-glutamate;2.61;CA;CALCIUM ION;Fab16A Light chain;10090;
5X2Q;K;Crystal structure of the medaka fish taste receptor T1r2a-T1r3 ligand binding domains in complex with glycine;2.6;CA;CALCIUM ION;Fab16A Light chain;10090;
5X6I;A;Crystal structure of B. subtilis adenylate kinase variant;2;CA;CALCIUM ION;Adenylate kinase;1423;
5X7G;A;Crystal Structure of Paenibacillus sp. 598K cycloisomaltooligosaccharide glucanotransferase;2.2;CA;CALCIUM ION;Cycloisomaltooligosaccharide glucanotransferase;1117987;
5X7H;A;Crystal Structure of Paenibacillus sp. 598K cycloisomaltooligosaccharide glucanotransferase complexed with cycloisomaltoheptaose;2.6;CA;CALCIUM ION;Cycloisomaltooligosaccharide glucanotransferase;1117987;
5X7J;A;Crystal structure of thymidylate kinase from thermus thermophilus HB8;1.84;CA;CALCIUM ION;Thymidylate kinase;274;
5X7J;B;Crystal structure of thymidylate kinase from thermus thermophilus HB8;1.84;CA;CALCIUM ION;Thymidylate kinase;274;
5X7O;A;Crystal structure of Paenibacillus sp. 598K alpha-1,6-glucosyltransferase;2;CA;CALCIUM ION;Glycoside hydrolase family 31 alpha-glucosidase;1117987;
5X7O;B;Crystal structure of Paenibacillus sp. 598K alpha-1,6-glucosyltransferase;2;CA;CALCIUM ION;Glycoside hydrolase family 31 alpha-glucosidase;1117987;
5X7P;A;Crystal structure of Paenibacillus sp. 598K alpha-1,6-glucosyltransferase complexed with acarbose;2.4;CA;CALCIUM ION;Glycoside hydrolase family 31 alpha-glucosidase;1117987;
5X7P;B;Crystal structure of Paenibacillus sp. 598K alpha-1,6-glucosyltransferase complexed with acarbose;2.4;CA;CALCIUM ION;Glycoside hydrolase family 31 alpha-glucosidase;1117987;
5X7Q;A;Crystal structure of Paenibacillus sp. 598K alpha-1,6-glucosyltransferase complexed with maltohexaose;1.95;CA;CALCIUM ION;Glycoside hydrolase family 31 alpha-glucosidase;1117987;
5X7Q;B;Crystal structure of Paenibacillus sp. 598K alpha-1,6-glucosyltransferase complexed with maltohexaose;1.95;CA;CALCIUM ION;Glycoside hydrolase family 31 alpha-glucosidase;1117987;
5X7R;A;Crystal structure of Paenibacillus sp. 598K alpha-1,6-glucosyltransferase complexed with isomaltohexaose;1.95;CA;CALCIUM ION;Glycoside hydrolase family 31 alpha-glucosidase;1117987;
5X7R;B;Crystal structure of Paenibacillus sp. 598K alpha-1,6-glucosyltransferase complexed with isomaltohexaose;1.95;CA;CALCIUM ION;Glycoside hydrolase family 31 alpha-glucosidase;1117987;
5X7S;A;Crystal structure of Paenibacillus sp. 598K alpha-1,6-glucosyltransferase, terbium derivative;2.4;CA;CALCIUM ION;Glycoside hydrolase family 31 alpha-glucosidase;1117987;
5X7S;B;Crystal structure of Paenibacillus sp. 598K alpha-1,6-glucosyltransferase, terbium derivative;2.4;CA;CALCIUM ION;Glycoside hydrolase family 31 alpha-glucosidase;1117987;
5X8F;A;Ternary complex structure of a double mutant I454RA456K of o-Succinylbenzoate CoA Synthetase (MenE) from Bacillus Subtilis bound with AMP and its product analogue OSB-NCoA at 1.76 angstrom;1.76;CA;CALCIUM ION;2-succinylbenzoate--CoA ligase;1423;
5X8F;B;Ternary complex structure of a double mutant I454RA456K of o-Succinylbenzoate CoA Synthetase (MenE) from Bacillus Subtilis bound with AMP and its product analogue OSB-NCoA at 1.76 angstrom;1.76;CA;CALCIUM ION;2-succinylbenzoate--CoA ligase;1423;
5X8F;C;Ternary complex structure of a double mutant I454RA456K of o-Succinylbenzoate CoA Synthetase (MenE) from Bacillus Subtilis bound with AMP and its product analogue OSB-NCoA at 1.76 angstrom;1.76;CA;CALCIUM ION;2-succinylbenzoate--CoA ligase;1423;
5X8G;A;Binary complex structure of a double mutant I454RA456K of o-Succinylbenzoate CoA Synthetase (MenE) from Bacillus Subtilis bound with its product analogue OSB-NCoA at 1.90 angstrom;1.9;CA;CALCIUM ION;2-succinylbenzoate--CoA ligase;1423;
5X8G;B;Binary complex structure of a double mutant I454RA456K of o-Succinylbenzoate CoA Synthetase (MenE) from Bacillus Subtilis bound with its product analogue OSB-NCoA at 1.90 angstrom;1.9;CA;CALCIUM ION;2-succinylbenzoate--CoA ligase;1423;
5X8G;C;Binary complex structure of a double mutant I454RA456K of o-Succinylbenzoate CoA Synthetase (MenE) from Bacillus Subtilis bound with its product analogue OSB-NCoA at 1.90 angstrom;1.9;CA;CALCIUM ION;2-succinylbenzoate--CoA ligase;1423;
5X8G;D;Binary complex structure of a double mutant I454RA456K of o-Succinylbenzoate CoA Synthetase (MenE) from Bacillus Subtilis bound with its product analogue OSB-NCoA at 1.90 angstrom;1.9;CA;CALCIUM ION;2-succinylbenzoate--CoA ligase;1423;
5X9A;A;Crystal structure of calaxin with calcium;1.85;CA;CALCIUM ION;Calaxin;7719;
5X9A;B;Crystal structure of calaxin with calcium;1.85;CA;CALCIUM ION;Calaxin;7719;
5X9S;A;Crystal structure of fully modified H-Ras-GppNHp;2.5;CA;CALCIUM ION;GTPase HRas;9606;
5XA7;A;Complete structure factors and an atomic model of the calcium pump (SERCA1A) and associated phospholipids in the E1-2CA2+ crystals;3.2;CA;CALCIUM ION;Sarcoplasmic/endoplasmic reticulum calcium ATPase 1;9986;
5XA8;A;Complete structure factors and an atomic model of the calcium pump (SERCA1A) and associated phospholipids in the E1-ALF4-ADP-2CA2+ crystals;3.2;CA;CALCIUM ION;Sarcoplasmic/endoplasmic reticulum calcium ATPase 1;9986;
5XAF;A;Crystal structure of tubulin-stathmin-TTL-Compound Z1 complex;2.55;CA;CALCIUM ION;Tubulin alpha-1B chain;9913;
5XAF;B;Crystal structure of tubulin-stathmin-TTL-Compound Z1 complex;2.55;CA;CALCIUM ION;Tubulin beta-2B chain;9913;
5XAF;C;Crystal structure of tubulin-stathmin-TTL-Compound Z1 complex;2.55;CA;CALCIUM ION;Tubulin alpha-1B chain;9913;
5XAG;A;Crystal structure of tubulin-stathmin-TTL-Compound Z2 complex;2.56;CA;CALCIUM ION;Tubulin alpha-1B chain;9913;
5XAG;B;Crystal structure of tubulin-stathmin-TTL-Compound Z2 complex;2.56;CA;CALCIUM ION;Tubulin beta-2B chain;9913;
5XAG;C;Crystal structure of tubulin-stathmin-TTL-Compound Z2 complex;2.56;CA;CALCIUM ION;Tubulin alpha-1B chain;9913;
5XAU;A;Crystal structure of integrin binding fragment of laminin-511;1.8;CA;CALCIUM ION;Laminin subunit alpha-5;9606;
5XAU;D;Crystal structure of integrin binding fragment of laminin-511;1.8;CA;CALCIUM ION;Laminin subunit alpha-5;9606;
5XCV;A;Crystal structure of NZ-1 Fv-clasp fragment with its antigen peptide;2.14;CA;CALCIUM ION;VH(S112C)-SARAH chimera,VH(S112C)-SARAH chimera;960,610,114;
5XDT;A;Staphylococcus aureus FtsZ 12-316 complexed with TXA707;1.3;CA;CALCIUM ION;Cell division protein FtsZ;1280;
5XDU;A;Staphylococcus aureus FtsZ 12-316 complexed with TXA6101;2;CA;CALCIUM ION;Cell division protein FtsZ;1280;
5XDV;A;Staphylococcus aureus FtsZ 12-316 G196S complexed with TXA6101;1.7;CA;CALCIUM ION;Cell division protein FtsZ;1280;
5XDW;A;Staphylococcus aureus FtsZ 12-316 G196S;2;CA;CALCIUM ION;Cell division protein FtsZ;1280;
5XEM;A;Crystal structure of a hydrogen sulfide-producing enzyme (Fn1220) from Fusobacterium nucleatum in complex with L-lanthionine-PLP Schiff base;1.84;CA;CALCIUM ION;Cysteine synthase;851;
5XEM;B;Crystal structure of a hydrogen sulfide-producing enzyme (Fn1220) from Fusobacterium nucleatum in complex with L-lanthionine-PLP Schiff base;1.84;CA;CALCIUM ION;Cysteine synthase;851;
5XEN;A;Crystal structure of a hydrogen sulfide-producing enzyme (Fn1220) from Fusobacterium nucleatum in complex with L-serine-PLP Schiff base;1.94;CA;CALCIUM ION;Cysteine synthase;851;
5XEN;B;Crystal structure of a hydrogen sulfide-producing enzyme (Fn1220) from Fusobacterium nucleatum in complex with L-serine-PLP Schiff base;1.94;CA;CALCIUM ION;Cysteine synthase;851;
5XEO;A;Crystal structure of a hydrogen sulfide-producing enzyme (Fn1220) from Fusobacterium nucleatum;2.03;CA;CALCIUM ION;Cysteine synthase;851;
5XEO;B;Crystal structure of a hydrogen sulfide-producing enzyme (Fn1220) from Fusobacterium nucleatum;2.03;CA;CALCIUM ION;Cysteine synthase;851;
5XFM;A;Crystal structure of beta-arabinopyranosidase;2.3;CA;CALCIUM ION;Alpha-glucosidase;818;
5XFM;B;Crystal structure of beta-arabinopyranosidase;2.3;CA;CALCIUM ION;Alpha-glucosidase;818;
5XFM;C;Crystal structure of beta-arabinopyranosidase;2.3;CA;CALCIUM ION;Alpha-glucosidase;818;
5XFM;D;Crystal structure of beta-arabinopyranosidase;2.3;CA;CALCIUM ION;Alpha-glucosidase;818;
5XHC;A;Crystal structure of T2R-TTL-PO10 complex;2.75;CA;CALCIUM ION;Tubulin alpha chain;41807;
5XHC;B;Crystal structure of T2R-TTL-PO10 complex;2.75;CA;CALCIUM ION;Tubulin beta chain;41807;
5XHC;C;Crystal structure of T2R-TTL-PO10 complex;2.75;CA;CALCIUM ION;Tubulin alpha chain;41807;
5XI5;A;Crystal structure of T2R-TTL-PO5 complex;2.81;CA;CALCIUM ION;Tubulin alpha chain;41807;
5XI5;B;Crystal structure of T2R-TTL-PO5 complex;2.81;CA;CALCIUM ION;Tubulin beta chain;41807;
5XI5;C;Crystal structure of T2R-TTL-PO5 complex;2.81;CA;CALCIUM ION;Tubulin alpha chain;41807;
5XI7;A;Crystal structure of T2R-TTL bound with PO-7;2.99;CA;CALCIUM ION;Tubulin alpha chain;41807;
5XI7;B;Crystal structure of T2R-TTL bound with PO-7;2.99;CA;CALCIUM ION;Tubulin beta chain;41807;
5XI7;C;Crystal structure of T2R-TTL bound with PO-7;2.99;CA;CALCIUM ION;Tubulin alpha chain;41807;
5XIW;A;Crystal structure of T2R-TTL-Colchicine complex;2.9;CA;CALCIUM ION;Tubulin alpha-1B chain;9823;
5XIW;C;Crystal structure of T2R-TTL-Colchicine complex;2.9;CA;CALCIUM ION;Tubulin alpha-1B chain;9823;
5XKE;A;Crystal structure of T2R-TTL-Demecolcine complex;2.6;CA;CALCIUM ION;Tubulin alpha-1B chain;9823;
5XKE;C;Crystal structure of T2R-TTL-Demecolcine complex;2.6;CA;CALCIUM ION;Tubulin alpha-1B chain;9823;
5XKF;A;Crystal structure of T2R-TTL-MPC6827 complex;2.8;CA;CALCIUM ION;Tubulin alpha-1B chain;9823;
5XKF;C;Crystal structure of T2R-TTL-MPC6827 complex;2.8;CA;CALCIUM ION;Tubulin alpha-1B chain;9823;
5XKG;A;Crystal structure of T2R-TTL-CH1 complex;2.2;CA;CALCIUM ION;Tubulin alpha-1B chain;9823;
5XKG;C;Crystal structure of T2R-TTL-CH1 complex;2.2;CA;CALCIUM ION;Tubulin alpha-1B chain;9823;
5XKH;A;Crystal structure of T2R-TTL-CF1 complex;2.25;CA;CALCIUM ION;Tubulin alpha-1B chain;9823;
5XKH;C;Crystal structure of T2R-TTL-CF1 complex;2.25;CA;CALCIUM ION;Tubulin alpha-1B chain;9823;
5XLT;A;The crystal structure of tubulin in complex with 4'-demethylepipodophyllotoxin;2.81;CA;CALCIUM ION;Tubulin alpha-1B chain;9913;
5XLT;C;The crystal structure of tubulin in complex with 4'-demethylepipodophyllotoxin;2.81;CA;CALCIUM ION;Tubulin alpha-1B chain;9913;
5XLU;B;High Resolution Crystal Structure of Bacillus Licheniformis Gamma Glutamyl Transpeptidase with Acivicin;1.45;CA;CALCIUM ION;Gamma glutamyl transpeptidase;1402;
5XLZ;A;The crystal structure of tubulin complexed with a benzylidene derivative of 9(10H)-anthracenone;2.3;CA;CALCIUM ION;Tubulin alpha-1B chain;9913;
5XLZ;C;The crystal structure of tubulin complexed with a benzylidene derivative of 9(10H)-anthracenone;2.3;CA;CALCIUM ION;Tubulin alpha-1B chain;9913;
5XMZ;A;Verticillium effector PevD1;1.85;CA;CALCIUM ION;Effector protein PevD1;27337;
5XND;A;Solution structure of the major fish allergen parvalbumin Sco j 1 derived from the Pacific mackerel;;CA;CALCIUM ION;Parvalbumin beta;13676;
5XNP;A;Crystal structures of human SALM5 in complex with human PTPdelta;3.73;CA;CALCIUM ION;Leucine-rich repeat and fibronectin type-III domain-containing protein 5;9606;
5XNP;B;Crystal structures of human SALM5 in complex with human PTPdelta;3.73;CA;CALCIUM ION;Leucine-rich repeat and fibronectin type-III domain-containing protein 5;9606;
5XNQ;A;Crystal structures of human SALM5;2.8;CA;CALCIUM ION;Leucine-rich repeat and fibronectin type-III domain-containing protein 5;9606;
5XNR;A;Truncated AlyQ with CBM32 and alginate lyase domains;2.3;CA;CALCIUM ION;AlyQ;1561025;
5XOP;A;Crystal Structure of N-terminal domain EhCaBP1 EF-2 mutant;1.9;CA;CALCIUM ION;Calcium-binding protein 1 (EhCBP1), putative;5759;
5XOP;B;Crystal Structure of N-terminal domain EhCaBP1 EF-2 mutant;1.9;CA;CALCIUM ION;Calcium-binding protein 1 (EhCBP1), putative;5759;
5XOP;C;Crystal Structure of N-terminal domain EhCaBP1 EF-2 mutant;1.9;CA;CALCIUM ION;Calcium-binding protein 1 (EhCBP1), putative;5759;
5XOP;D;Crystal Structure of N-terminal domain EhCaBP1 EF-2 mutant;1.9;CA;CALCIUM ION;Calcium-binding protein 1 (EhCBP1), putative;5759;
5XOP;E;Crystal Structure of N-terminal domain EhCaBP1 EF-2 mutant;1.9;CA;CALCIUM ION;Calcium-binding protein 1 (EhCBP1), putative;5759;
5XOP;F;Crystal Structure of N-terminal domain EhCaBP1 EF-2 mutant;1.9;CA;CALCIUM ION;Calcium-binding protein 1 (EhCBP1), putative;5759;
5XP3;A;Crystal structure of apo T2R-TTL;2.3;CA;CALCIUM ION;Tubulin alpha-1B chain;9823;
5XP3;C;Crystal structure of apo T2R-TTL;2.3;CA;CALCIUM ION;Tubulin alpha-1B chain;9823;
5XPS;A;Crystal Structure of Transketolase in complex with erythrose-4-phosphate from Pichia Stipitis;1.07;CA;CALCIUM ION;Transketolase;4924;
5XPX;A;Structure elucidation of truncated AMS3 lipase from an Antarctic Pseudomonas;2.77;CA;CALCIUM ION;Lipase;1680634;
5XPX;E;Structure elucidation of truncated AMS3 lipase from an Antarctic Pseudomonas;2.77;CA;CALCIUM ION;Lipase;1680634;
5XQ3;A;Crystal structure of a PL 26 exo-rhamnogalacturonan lyase from Penicillium chrysogenum;2.85;CA;CALCIUM ION;Pcrglx protein;5076;
5XQ3;B;Crystal structure of a PL 26 exo-rhamnogalacturonan lyase from Penicillium chrysogenum;2.85;CA;CALCIUM ION;Pcrglx protein;5076;
5XQA;A;Crystal Structure of Transketolase in complex with ribose-5-phosphate from Pichia Stipitis;1.14;CA;CALCIUM ION;Transketolase;4924;
5XQG;A;Crystal structure of a PL 26 exo-rhamnogalacturonan lyase from Penicillium chrysogenum complexed with unsaturated galacturonosyl rhamnose;2.74;CA;CALCIUM ION;Pcrglx protein;5076;
5XQG;B;Crystal structure of a PL 26 exo-rhamnogalacturonan lyase from Penicillium chrysogenum complexed with unsaturated galacturonosyl rhamnose;2.74;CA;CALCIUM ION;Pcrglx protein;5076;
5XQG;C;Crystal structure of a PL 26 exo-rhamnogalacturonan lyase from Penicillium chrysogenum complexed with unsaturated galacturonosyl rhamnose;2.74;CA;CALCIUM ION;Pcrglx protein;5076;
5XQG;D;Crystal structure of a PL 26 exo-rhamnogalacturonan lyase from Penicillium chrysogenum complexed with unsaturated galacturonosyl rhamnose;2.74;CA;CALCIUM ION;Pcrglx protein;5076;
5XQG;E;Crystal structure of a PL 26 exo-rhamnogalacturonan lyase from Penicillium chrysogenum complexed with unsaturated galacturonosyl rhamnose;2.74;CA;CALCIUM ION;Pcrglx protein;5076;
5XQG;F;Crystal structure of a PL 26 exo-rhamnogalacturonan lyase from Penicillium chrysogenum complexed with unsaturated galacturonosyl rhamnose;2.74;CA;CALCIUM ION;Pcrglx protein;5076;
5XQG;G;Crystal structure of a PL 26 exo-rhamnogalacturonan lyase from Penicillium chrysogenum complexed with unsaturated galacturonosyl rhamnose;2.74;CA;CALCIUM ION;Pcrglx protein;5076;
5XQG;H;Crystal structure of a PL 26 exo-rhamnogalacturonan lyase from Penicillium chrysogenum complexed with unsaturated galacturonosyl rhamnose;2.74;CA;CALCIUM ION;Pcrglx protein;5076;
5XQJ;A;Crystal structure of a PL 26 exo-rhamnogalacturonan lyase from Penicillium chrysogenum complexed with unsaturated galacturonosyl rhamnose substituted with galactose;2.75;CA;CALCIUM ION;Pcrglx protein;5076;
5XQJ;B;Crystal structure of a PL 26 exo-rhamnogalacturonan lyase from Penicillium chrysogenum complexed with unsaturated galacturonosyl rhamnose substituted with galactose;2.75;CA;CALCIUM ION;Pcrglx protein;5076;
5XQJ;C;Crystal structure of a PL 26 exo-rhamnogalacturonan lyase from Penicillium chrysogenum complexed with unsaturated galacturonosyl rhamnose substituted with galactose;2.75;CA;CALCIUM ION;Pcrglx protein;5076;
5XQJ;D;Crystal structure of a PL 26 exo-rhamnogalacturonan lyase from Penicillium chrysogenum complexed with unsaturated galacturonosyl rhamnose substituted with galactose;2.75;CA;CALCIUM ION;Pcrglx protein;5076;
5XQJ;E;Crystal structure of a PL 26 exo-rhamnogalacturonan lyase from Penicillium chrysogenum complexed with unsaturated galacturonosyl rhamnose substituted with galactose;2.75;CA;CALCIUM ION;Pcrglx protein;5076;
5XQJ;F;Crystal structure of a PL 26 exo-rhamnogalacturonan lyase from Penicillium chrysogenum complexed with unsaturated galacturonosyl rhamnose substituted with galactose;2.75;CA;CALCIUM ION;Pcrglx protein;5076;
5XQJ;G;Crystal structure of a PL 26 exo-rhamnogalacturonan lyase from Penicillium chrysogenum complexed with unsaturated galacturonosyl rhamnose substituted with galactose;2.75;CA;CALCIUM ION;Pcrglx protein;5076;
5XQJ;H;Crystal structure of a PL 26 exo-rhamnogalacturonan lyase from Penicillium chrysogenum complexed with unsaturated galacturonosyl rhamnose substituted with galactose;2.75;CA;CALCIUM ION;Pcrglx protein;5076;
5XQK;A;Crystal Structure of Transketolase in complex with xylulose-5-phosphate from Pichia Stipitis;1.12;CA;CALCIUM ION;Transketolase;4924;
5XQO;A;Crystal structure of a PL 26 exo-rhamnogalacturonan lyase from Penicillium chrysogenum complexed with tetrameric substrate;3.2;CA;CALCIUM ION;Pcrglx protein;5076;
5XQO;B;Crystal structure of a PL 26 exo-rhamnogalacturonan lyase from Penicillium chrysogenum complexed with tetrameric substrate;3.2;CA;CALCIUM ION;Pcrglx protein;5076;
5XRV;A;Crystal Structure of Transketolase in complex with TPP_V and fructose-6-phosphate from Pichia Stipitis;1.4;CA;CALCIUM ION;Transketolase;4924;
5XRY;A;Crystal Structure of Transketolase contains cysteinesufonic acid from Pichia Stipitis;1.3;CA;CALCIUM ION;Transketolase;4924;
5XS6;A;Crystal Structure of Transketolase in complex with TPP Pichia Stipitis;0.97;CA;CALCIUM ION;Transketolase;4924;
5XS8;A;Crystal structure of solute-binding protein complexed with unsaturated chondroitin disaccharide with two sulfate groups at C-4 and C-6 positions of GalNAc;1.95;CA;CALCIUM ION;Extracellular solute-binding protein family 1;34105;
5XS8;B;Crystal structure of solute-binding protein complexed with unsaturated chondroitin disaccharide with two sulfate groups at C-4 and C-6 positions of GalNAc;1.95;CA;CALCIUM ION;Extracellular solute-binding protein family 1;34105;
5XS8;C;Crystal structure of solute-binding protein complexed with unsaturated chondroitin disaccharide with two sulfate groups at C-4 and C-6 positions of GalNAc;1.95;CA;CALCIUM ION;Extracellular solute-binding protein family 1;34105;
5XS8;D;Crystal structure of solute-binding protein complexed with unsaturated chondroitin disaccharide with two sulfate groups at C-4 and C-6 positions of GalNAc;1.95;CA;CALCIUM ION;Extracellular solute-binding protein family 1;34105;
5XSA;A;Crystal Structure of Transketolase in complex with TPP intermediate III from Pichia Stipitis;0.98;CA;CALCIUM ION;Transketolase;4924;
5XSB;A;Crystal Structure of Transketolase in complex with TPP intermediate III from Pichia Stipitis;0.92;CA;CALCIUM ION;Transketolase;4924;
5XSM;A;Crystal Structure of Transketolase in complex with TPP intermediate IV from Pichia Stipitis;0.97;CA;CALCIUM ION;Transketolase;4924;
5XT0;A;Crystal Structure of Transketolase in complex with TPP intermediate VIII from Pichia Stipitis;1.15;CA;CALCIUM ION;Transketolase;4924;
5XT4;A;Crystal Structure of Transketolase in complex with TPP intermediate VIII' from Pichia Stipitis;1.06;CA;CALCIUM ION;Transketolase;4924;
5XTL;A;Crystal Structure of Transketolase in complex with aminopyrimidine and cysteine sulfonic acid adduct from Pichia Stipitis;1.1;CA;CALCIUM ION;Transketolase;4924;
5XTS;A;Crystal structure of the CysR-CTLD3 fragment of human MR at basic/neutral pH;2;CA;CALCIUM ION;Macrophage mannose receptor 1;9606;
5XTU;A;Crystal Structure of GDSL Esterase of Photobacterium sp. J15;1.38;CA;CALCIUM ION;GDSL-family esterase;1109422;
5XTV;A;Crystal Structure of Transketolase in complex with TPP intermediate V from Pichia Stipitis;0.93;CA;CALCIUM ION;Transketolase;4924;
5XTW;A;Crystal structure of the CysR-CTLD2 fragment of human MR at acidic pH;3.2;CA;CALCIUM ION;Macrophage mannose receptor 1;9606;
5XTW;C;Crystal structure of the CysR-CTLD2 fragment of human MR at acidic pH;3.2;CA;CALCIUM ION;Macrophage mannose receptor 1;9606;
5XTW;D;Crystal structure of the CysR-CTLD2 fragment of human MR at acidic pH;3.2;CA;CALCIUM ION;Macrophage mannose receptor 1;9606;
5XTW;E;Crystal structure of the CysR-CTLD2 fragment of human MR at acidic pH;3.2;CA;CALCIUM ION;Macrophage mannose receptor 1;9606;
5XTW;F;Crystal structure of the CysR-CTLD2 fragment of human MR at acidic pH;3.2;CA;CALCIUM ION;Macrophage mannose receptor 1;9606;
5XTW;H;Crystal structure of the CysR-CTLD2 fragment of human MR at acidic pH;3.2;CA;CALCIUM ION;Macrophage mannose receptor 1;9606;
5XTX;A;Crystal Structure of Transketolase in complex with TPP intermediate VII from Pichia Stipitis;1.05;CA;CALCIUM ION;Transketolase;4924;
5XU2;A;Crystal Structure of Transketolase in complex with TPP_III and fructose-6-phosphate from Pichia Stipitis;0.97;CA;CALCIUM ION;Transketolase;4924;
5XU9;A;Crystal Structure of Transketolase in complex with TPP intermediate IX and gauche form erythrose-4-phosphate from Pichia Stipitis;1.17;CA;CALCIUM ION;Transketolase;4924;
5XUF;A;Crystal Structure of Transketolase in complex with hydroxylated TPP from Pichia Stipitis, crystal I;0.88;CA;CALCIUM ION;Transketolase;4924;
5XUW;A;Crystal structure of lysozyme from Equus asinus;1.76;CA;CALCIUM ION;Lysozyme C;9793;
5XUW;B;Crystal structure of lysozyme from Equus asinus;1.76;CA;CALCIUM ION;Lysozyme C;9793;
5XVT;A;Crystal Structure of Transketolase in complex with hydroxylated TPP from Pichia Stipitis, crystal 2;0.85;CA;CALCIUM ION;Transketolase;4924;
5XVZ;A;CATPO mutant - H246W;1.9;CA;CALCIUM ION;Catalase;85995;
5XVZ;B;CATPO mutant - H246W;1.9;CA;CALCIUM ION;Catalase;85995;
5XVZ;C;CATPO mutant - H246W;1.9;CA;CALCIUM ION;Catalase;85995;
5XVZ;D;CATPO mutant - H246W;1.9;CA;CALCIUM ION;Catalase;85995;
5XW1;A;Crystal Structure of Porcine pancreatic trypsin with tripeptide inhibitor, PRN, at pH10;1.9;CA;CALCIUM ION;Trypsin;9823;
5XW8;A;Crystal Structure of Porcine pancreatic trypsin with tripeptide inhibitor, PRN, at pH 7;2;CA;CALCIUM ION;Trypsin;9823;
5XW9;A;Crystal Structure of Porcine pancreatic trypsin with tripeptide inhibitor, PRY, at pH 7;2;CA;CALCIUM ION;Trypsin;9823;
5XWA;A;Crystal Structure of Porcine pancreatic trypsin with tripeptide inhibitor, PRY, at pH 10;1.9;CA;CALCIUM ION;Trypsin;9823;
5XWI;A;Crystal Structure of SPAP, an alkaline phosphatase from Sphingomonas showing covalent intermediate;1.87;CA;CALCIUM ION;Alkaline phosphatase PhoK;28214;
5XWJ;A;Crystal Structure of Porcine pancreatic trypsin with tripeptide inhibitor, TRE, at pH 7;1.8;CA;CALCIUM ION;Trypsin;9823;
5XWJ;B;Crystal Structure of Porcine pancreatic trypsin with tripeptide inhibitor, TRE, at pH 7;1.8;CA;CALCIUM ION;Trypsin;9823;
5XWK;A;Crystal Structure of SPAP, an alkaline phosphatase from Sphingomonas in complex with inorganic phosphate;1.9;CA;CALCIUM ION;Alkaline phosphatase PhoK;28214;
5XWL;A;Crystal Structure of Porcine pancreatic trypsin with tripeptide inhibitor, TRE, at pH 10;2.1;CA;CALCIUM ION;Trypsin;9823;
5XWL;B;Crystal Structure of Porcine pancreatic trypsin with tripeptide inhibitor, TRE, at pH 10;2.1;CA;CALCIUM ION;Trypsin;9823;
5XXZ;A;Crystal structure of a serine protease from Streptococcus species;3.09;CA;CALCIUM ION;Chemokine protease C;1314;
5XXZ;B;Crystal structure of a serine protease from Streptococcus species;3.09;CA;CALCIUM ION;Chemokine protease C;1314;
5XY4;A;CATPO mutant - V536W;1.8;CA;CALCIUM ION;Catalase;85995;
5XY4;B;CATPO mutant - V536W;1.8;CA;CALCIUM ION;Catalase;85995;
5XY4;C;CATPO mutant - V536W;1.8;CA;CALCIUM ION;Catalase;85995;
5XY4;D;CATPO mutant - V536W;1.8;CA;CALCIUM ION;Catalase;85995;
5XYA;A;Crystal structure of a serine protease from Streptococcus species;3;CA;CALCIUM ION;Chemokine protease C;1314;
5XYR;A;Crystal structure of a serine protease from Streptococcus species;2.8;CA;CALCIUM ION;Chemokine protease C;1314;
5XZM;A;CATPO mutant - V228I;1.41;CA;CALCIUM ION;Catalase;85995;
5XZM;B;CATPO mutant - V228I;1.41;CA;CALCIUM ION;Catalase;85995;
5XZM;C;CATPO mutant - V228I;1.41;CA;CALCIUM ION;Catalase;85995;
5XZM;D;CATPO mutant - V228I;1.41;CA;CALCIUM ION;Catalase;85995;
5XZN;A;CATPO mutant - V228C;1.47;CA;CALCIUM ION;Catalase;85995;
5XZN;B;CATPO mutant - V228C;1.47;CA;CALCIUM ION;Catalase;85995;
5XZN;C;CATPO mutant - V228C;1.47;CA;CALCIUM ION;Catalase;85995;
5XZN;D;CATPO mutant - V228C;1.47;CA;CALCIUM ION;Catalase;85995;
5Y17;A;CATPO mutant - E316F;2.3;CA;CALCIUM ION;Catalase;85995;
5Y17;B;CATPO mutant - E316F;2.3;CA;CALCIUM ION;Catalase;85995;
5Y17;C;CATPO mutant - E316F;2.3;CA;CALCIUM ION;Catalase;85995;
5Y17;D;CATPO mutant - E316F;2.3;CA;CALCIUM ION;Catalase;85995;
5Y2Z;A;Crystal structure of human LGI1 EPTP-ADAM22 complex;2.67;CA;CALCIUM ION;Disintegrin and metalloproteinase domain-containing protein 22;9606;
5Y2Z;B;Crystal structure of human LGI1 EPTP-ADAM22 complex;2.67;CA;CALCIUM ION;Leucine-rich glioma-inactivated protein 1;9606;
5Y2Z;C;Crystal structure of human LGI1 EPTP-ADAM22 complex;2.67;CA;CALCIUM ION;Disintegrin and metalloproteinase domain-containing protein 22;9606;
5Y2Z;D;Crystal structure of human LGI1 EPTP-ADAM22 complex;2.67;CA;CALCIUM ION;Leucine-rich glioma-inactivated protein 1;9606;
5Y2Z;E;Crystal structure of human LGI1 EPTP-ADAM22 complex;2.67;CA;CALCIUM ION;Disintegrin and metalloproteinase domain-containing protein 22;9606;
5Y2Z;F;Crystal structure of human LGI1 EPTP-ADAM22 complex;2.67;CA;CALCIUM ION;Leucine-rich glioma-inactivated protein 1;9606;
5Y2Z;G;Crystal structure of human LGI1 EPTP-ADAM22 complex;2.67;CA;CALCIUM ION;Disintegrin and metalloproteinase domain-containing protein 22;9606;
5Y2Z;H;Crystal structure of human LGI1 EPTP-ADAM22 complex;2.67;CA;CALCIUM ION;Leucine-rich glioma-inactivated protein 1;9606;
5Y2Z;I;Crystal structure of human LGI1 EPTP-ADAM22 complex;2.67;CA;CALCIUM ION;Disintegrin and metalloproteinase domain-containing protein 22;9606;
5Y2Z;J;Crystal structure of human LGI1 EPTP-ADAM22 complex;2.67;CA;CALCIUM ION;Leucine-rich glioma-inactivated protein 1;9606;
5Y2Z;K;Crystal structure of human LGI1 EPTP-ADAM22 complex;2.67;CA;CALCIUM ION;Disintegrin and metalloproteinase domain-containing protein 22;9606;
5Y2Z;L;Crystal structure of human LGI1 EPTP-ADAM22 complex;2.67;CA;CALCIUM ION;Leucine-rich glioma-inactivated protein 1;9606;
5Y31;A;Crystal structure of human LGI1-ADAM22 complex;7.12;CA;CALCIUM ION;Disintegrin and metalloproteinase domain-containing protein 22;9606;
5Y31;B;Crystal structure of human LGI1-ADAM22 complex;7.12;CA;CALCIUM ION;Leucine-rich glioma-inactivated protein 1;9606;
5Y31;C;Crystal structure of human LGI1-ADAM22 complex;7.12;CA;CALCIUM ION;Disintegrin and metalloproteinase domain-containing protein 22;9606;
5Y31;D;Crystal structure of human LGI1-ADAM22 complex;7.12;CA;CALCIUM ION;Leucine-rich glioma-inactivated protein 1;9606;
5Y4F;B;Crystal Structure of AnkB Ankyrin Repeats R13-24 in complex with autoinhibition segment AI-c;1.95;CA;CALCIUM ION;Ankyrin-2;9606;
5Y5E;A;Crystal structure of phospholipase A2 with inhibitor;1.8;CA;CALCIUM ION;Group IIE secretory phospholipase A2;9606;
5Y5S;2;Structure of photosynthetic LH1-RC super-complex at 1.9 angstrom resolution;1.9;CA;CALCIUM ION;LH1 beta polypeptide;1050;
5Y5S;4;Structure of photosynthetic LH1-RC super-complex at 1.9 angstrom resolution;1.9;CA;CALCIUM ION;LH1 beta polypeptide;1050;
5Y5S;6;Structure of photosynthetic LH1-RC super-complex at 1.9 angstrom resolution;1.9;CA;CALCIUM ION;LH1 beta polypeptide;1050;
5Y5S;8;Structure of photosynthetic LH1-RC super-complex at 1.9 angstrom resolution;1.9;CA;CALCIUM ION;LH1 beta polypeptide;1050;
5Y5S;A;Structure of photosynthetic LH1-RC super-complex at 1.9 angstrom resolution;1.9;CA;CALCIUM ION;LH1 alpha polypeptide;1050;
5Y5S;B;Structure of photosynthetic LH1-RC super-complex at 1.9 angstrom resolution;1.9;CA;CALCIUM ION;LH1 beta polypeptide;1050;
5Y5S;E;Structure of photosynthetic LH1-RC super-complex at 1.9 angstrom resolution;1.9;CA;CALCIUM ION;LH1 beta polypeptide;1050;
5Y5S;G;Structure of photosynthetic LH1-RC super-complex at 1.9 angstrom resolution;1.9;CA;CALCIUM ION;LH1 beta polypeptide;1050;
5Y5S;J;Structure of photosynthetic LH1-RC super-complex at 1.9 angstrom resolution;1.9;CA;CALCIUM ION;LH1 beta polypeptide;1050;
5Y5S;N;Structure of photosynthetic LH1-RC super-complex at 1.9 angstrom resolution;1.9;CA;CALCIUM ION;LH1 beta polypeptide;1050;
5Y5S;P;Structure of photosynthetic LH1-RC super-complex at 1.9 angstrom resolution;1.9;CA;CALCIUM ION;LH1 beta polypeptide;1050;
5Y5S;R;Structure of photosynthetic LH1-RC super-complex at 1.9 angstrom resolution;1.9;CA;CALCIUM ION;LH1 beta polypeptide;1050;
5Y5S;T;Structure of photosynthetic LH1-RC super-complex at 1.9 angstrom resolution;1.9;CA;CALCIUM ION;LH1 beta polypeptide;1050;
5Y5S;V;Structure of photosynthetic LH1-RC super-complex at 1.9 angstrom resolution;1.9;CA;CALCIUM ION;LH1 beta polypeptide;1050;
5Y5S;X;Structure of photosynthetic LH1-RC super-complex at 1.9 angstrom resolution;1.9;CA;CALCIUM ION;LH1 beta polypeptide;1050;
5Y5S;Z;Structure of photosynthetic LH1-RC super-complex at 1.9 angstrom resolution;1.9;CA;CALCIUM ION;LH1 beta polypeptide;1050;
5Y7F;A;Crystal structure of catalytic domain of UGGT (UDP-bound form) from Thermomyces dupontii;1.35;CA;CALCIUM ION;UGGT;28565;
5Y7G;A;Crystal structure of paFAN1 bound to 1nt 5'flap DNA with gap;3.4;CA;CALCIUM ION;Fanconi-associated nuclease 1 homolog;287;
5Y7G;B;Crystal structure of paFAN1 bound to 1nt 5'flap DNA with gap;3.4;CA;CALCIUM ION;Fanconi-associated nuclease 1 homolog;287;
5Y7G;C;Crystal structure of paFAN1 bound to 1nt 5'flap DNA with gap;3.4;CA;CALCIUM ION;Fanconi-associated nuclease 1 homolog;287;
5Y8A;B;Periplasmic heme-binding protein BhuT in complex with two hemes (holo-2 form);2;CA;CALCIUM ION;Putative hemin transport system, substrate-binding protein;95486;
5Y8X;A;Crystal structure of Bacillus licheniformis Gamma glutamyl transpeptidase with Azaserine;1.97;CA;CALCIUM ION;Gamma glutamyl transpeptidase;1402;
5Y8X;B;Crystal structure of Bacillus licheniformis Gamma glutamyl transpeptidase with Azaserine;1.97;CA;CALCIUM ION;Gamma glutamyl transpeptidase;1402;
5Y9B;B;Crystal structure of Bacillus licheniformis Gamma glutamyl transpeptidase with DON;2.15;CA;CALCIUM ION;Gamma glutamyl transpeptidase;1402;
5YA6;A;Crystal structure of archaeal flagellin FlaB1 from Methanocaldococcus jannaschii;1.5;CA;CALCIUM ION;Flagellin B1;2190;
5YA6;B;Crystal structure of archaeal flagellin FlaB1 from Methanocaldococcus jannaschii;1.5;CA;CALCIUM ION;Flagellin B1;2190;
5YBY;A;Structure of human Gliomedin;1.43;CA;CALCIUM ION;Gliomedin;9606;
5YBZ;C;High resolution structure of complement C1q-like protein 3 C1q domain;1.71;CA;CALCIUM ION;Complement C1q-like protein 3;10090;
5YEM;A;CATPO mutant - T188F;1.49;CA;CALCIUM ION;Catalase;85995;
5YEM;B;CATPO mutant - T188F;1.49;CA;CALCIUM ION;Catalase;85995;
5YEM;C;CATPO mutant - T188F;1.49;CA;CALCIUM ION;Catalase;85995;
5YEM;D;CATPO mutant - T188F;1.49;CA;CALCIUM ION;Catalase;85995;
5YF0;B;Crystal structure of CARNMT1 bound to SAM;2.25;CA;CALCIUM ION;Carnosine N-methyltransferase;9606;
5YF1;B;Crystal structure of CARNMT1 bound to carnosine and SFG;2.4;CA;CALCIUM ION;Carnosine N-methyltransferase;9606;
5YF2;A;Crystal structure of CARNMT1 bound to anserine and SAH;2.8;CA;CALCIUM ION;Carnosine N-methyltransferase;9606;
5YF2;B;Crystal structure of CARNMT1 bound to anserine and SAH;2.8;CA;CALCIUM ION;Carnosine N-methyltransferase;9606;
5YGG;A;Crystal structure of Fructokinase Double-Mutant (T261C-H108C) from Vibrio cholerae O395 in fructose, ADP and potassium ion bound form;1.67;CA;CALCIUM ION;Fructokinase;666;
5YGM;A;Monomeric structure of concanavalin A at pH 7.5 from Carnivalia ensiformis;1.6;CA;CALCIUM ION;Concanavalin-A;3823;
5YHR;A;Crystal structure of the anti-CRISPR protein, AcrF2;1.34;CA;CALCIUM ION;Anti-CRISPR protein 30;10708;
5YJ7;A;Structural insight into the beta-GH1 glucosidase BGLN1 from oleaginous microalgae Nannochloropsis;1.61;CA;CALCIUM ION;Glycoside hydrolase;3187;
5YJ7;C;Structural insight into the beta-GH1 glucosidase BGLN1 from oleaginous microalgae Nannochloropsis;1.61;CA;CALCIUM ION;Glycoside hydrolase;3187;
5YJD;A;Structural insights into the CRISPR-Cas-associated ribonuclease activity of Staphylococcus epidermidis Csm3;2.26;CA;CALCIUM ION;Csm3;1282;
5YJG;A;Structural insights into periostin functions;2.4;CA;CALCIUM ION;Periostin;9606;
5YJH;A;Structural insights into periostin functions;2.96;CA;CALCIUM ION;Periostin;9606;
5YKB;A;The N253F mutant structure of trehalose synthase from Deinococcus radiodurans reveals an open active-site conformation;2.76;CA;CALCIUM ION;Trehalose synthase;1299;
5YKB;B;The N253F mutant structure of trehalose synthase from Deinococcus radiodurans reveals an open active-site conformation;2.76;CA;CALCIUM ION;Trehalose synthase;1299;
5YKB;C;The N253F mutant structure of trehalose synthase from Deinococcus radiodurans reveals an open active-site conformation;2.76;CA;CALCIUM ION;Trehalose synthase;1299;
5YKB;D;The N253F mutant structure of trehalose synthase from Deinococcus radiodurans reveals an open active-site conformation;2.76;CA;CALCIUM ION;Trehalose synthase;1299;
5YL1;A;T=1 subviral particle of Penaeus vannamei nodavirus capsid protein deletion mutant (delta 1-37 & 251-368);3.12;CA;CALCIUM ION;Capsid protein;430911;
5YL2;A;Crystal structure of T2R-TTL-Y28 complex;2.09;CA;CALCIUM ION;Tubulin alpha-1B chain;9823;
5YL2;C;Crystal structure of T2R-TTL-Y28 complex;2.09;CA;CALCIUM ION;Tubulin alpha-1B chain;9823;
5YL4;A;CRYSTAL STRUCTURE OF T2R-TTL-8WR COMPLEX;2.64;CA;CALCIUM ION;Tubulin alpha chain;41807;
5YL4;B;CRYSTAL STRUCTURE OF T2R-TTL-8WR COMPLEX;2.64;CA;CALCIUM ION;Tubulin beta chain;41807;
5YL4;C;CRYSTAL STRUCTURE OF T2R-TTL-8WR COMPLEX;2.64;CA;CALCIUM ION;Tubulin alpha chain;41807;
5YL7;A;Proteases from Pseudoalteromonas arctica PAMC 21717 (Pro21717);1.4;CA;CALCIUM ION;Pseudoalteromonas arctica PAMC 21717;394751;
5YLJ;A;Crystal structure of T2R-TTL-Millepachine complex;2.7;CA;CALCIUM ION;Tubulin alpha-1B chain;9823;
5YLJ;C;Crystal structure of T2R-TTL-Millepachine complex;2.7;CA;CALCIUM ION;Tubulin alpha-1B chain;9823;
5YLS;A;Crystal structure of T2R-TTL-Y50 complex;3;CA;CALCIUM ION;Tubulin alpha-1B chain;9823;
5YLS;C;Crystal structure of T2R-TTL-Y50 complex;3;CA;CALCIUM ION;Tubulin alpha-1B chain;9823;
5YN2;A;Crystal structure of apo Pullulanase from Klebsiella pneumoniae in space group P43212;2.3;CA;CALCIUM ION;PulA protein;573;
5YN7;A;Crystal structure of Pullulanase from Klebsiella pneumoniae complex at 0.1 mM beta-cyclodextrin;2.59;CA;CALCIUM ION;PulA protein;573;
5YNA;A;Crystal structure of Pullulanase from Klebsiella pneumoniae complex at 1 mM alpha-cyclodextrin;1.96;CA;CALCIUM ION;PulA protein;573;
5YNC;A;Crystal structure of Pullulanase from Klebsiella pneumoniae complex at 1 mM beta-cyclodextrin;2.32;CA;CALCIUM ION;PulA protein;573;
5YND;A;Crystal structure of Pullulanase from Klebsiella pneumoniae complex at 1 mM gamma-cyclodextrin;2.23;CA;CALCIUM ION;DUF3372 domain-containing protein;573;
5YNE;A;Crystal structure of Pullulanase from Klebsiella pneumoniae complex at 10 mM alpha-cyclodextrin;2.2;CA;CALCIUM ION;PulA protein;573;
5YNH;A;Crystal structure of Pullulanase from Klebsiella pneumoniae complex at 10 mM gamma-cyclodextrin;2.05;CA;CALCIUM ION;PulA protein;573;
5YOT;A;Isoprimeverose-producing enzyme from Aspergillus oryzae in complex with isoprimeverose;1.98;CA;CALCIUM ION;Isoprimeverose-producing enzyme;5062;
5YOT;B;Isoprimeverose-producing enzyme from Aspergillus oryzae in complex with isoprimeverose;1.98;CA;CALCIUM ION;Isoprimeverose-producing enzyme;5062;
5YPS;A;The structural basis of histone chaperoneVps75;2.1;CA;CALCIUM ION;Vacuolar protein sorting-associated protein 75;4754;
5YPS;B;The structural basis of histone chaperoneVps75;2.1;CA;CALCIUM ION;Vacuolar protein sorting-associated protein 75;4754;
5YPS;C;The structural basis of histone chaperoneVps75;2.1;CA;CALCIUM ION;Vacuolar protein sorting-associated protein 75;4754;
5YPS;D;The structural basis of histone chaperoneVps75;2.1;CA;CALCIUM ION;Vacuolar protein sorting-associated protein 75;4754;
5YPS;E;The structural basis of histone chaperoneVps75;2.1;CA;CALCIUM ION;Vacuolar protein sorting-associated protein 75;4754;
5YPS;F;The structural basis of histone chaperoneVps75;2.1;CA;CALCIUM ION;Vacuolar protein sorting-associated protein 75;4754;
5YPU;A;Crystal structure of an actin monomer in complex with the nucleator Cordon-Bleu MET72NLE WH2-motif peptide;2;CA;CALCIUM ION;Actin, alpha skeletal muscle;9986;
5YPU;B;Crystal structure of an actin monomer in complex with the nucleator Cordon-Bleu MET72NLE WH2-motif peptide;2;CA;CALCIUM ION;Cordon-Bleu WH2 motif;10090;
5YPU;C;Crystal structure of an actin monomer in complex with the nucleator Cordon-Bleu MET72NLE WH2-motif peptide;2;CA;CALCIUM ION;Actin, alpha skeletal muscle;9986;
5YPU;D;Crystal structure of an actin monomer in complex with the nucleator Cordon-Bleu MET72NLE WH2-motif peptide;2;CA;CALCIUM ION;Cordon-Bleu WH2 motif;10090;
5YQ0;C;Crystal structure of secreted protein CofJ from ETEC.;1.76;CA;CALCIUM ION;CofJ;562;
5YQ0;E;Crystal structure of secreted protein CofJ from ETEC.;1.76;CA;CALCIUM ION;CofJ;562;
5YQ0;H;Crystal structure of secreted protein CofJ from ETEC.;1.76;CA;CALCIUM ION;CofJ;562;
5YQS;A;Isoprimeverose-producing enzyme from Aspergillus oryzae in complex with isoprimeverose;2.4;CA;CALCIUM ION;Isoprimeverose-producing enzyme;5062;
5YQS;B;Isoprimeverose-producing enzyme from Aspergillus oryzae in complex with isoprimeverose;2.4;CA;CALCIUM ION;Isoprimeverose-producing enzyme;5062;
5YRT;A;Diol dehydratase, AdoCbl/substrate-free, anaerobically-prepared crystal;1.7;CA;CALCIUM ION;Diol dehydrase alpha subunit;571;
5YRT;D;Diol dehydratase, AdoCbl/substrate-free, anaerobically-prepared crystal;1.7;CA;CALCIUM ION;Diol dehydrase alpha subunit;571;
5YRT;G;Diol dehydratase, AdoCbl/substrate-free, anaerobically-prepared crystal;1.7;CA;CALCIUM ION;Diol dehydrase alpha subunit;571;
5YRT;J;Diol dehydratase, AdoCbl/substrate-free, anaerobically-prepared crystal;1.7;CA;CALCIUM ION;Diol dehydrase alpha subunit;571;
5YRV;A;Diol dehydratase, AdoCbl/1,2-propanediol, anaerobically-prepared crystal;1.55;CA;CALCIUM ION;Diol dehydrase alpha subunit;571;
5YRV;D;Diol dehydratase, AdoCbl/1,2-propanediol, anaerobically-prepared crystal;1.55;CA;CALCIUM ION;Diol dehydrase alpha subunit;571;
5YRV;G;Diol dehydratase, AdoCbl/1,2-propanediol, anaerobically-prepared crystal;1.55;CA;CALCIUM ION;Diol dehydrase alpha subunit;571;
5YRV;J;Diol dehydratase, AdoCbl/1,2-propanediol, anaerobically-prepared crystal;1.55;CA;CALCIUM ION;Diol dehydrase alpha subunit;571;
5YSH;A;Diol dehydratase - alpha/T172A mutant complexed with AdoCbl, aerobically-prepared crystal;1.9;CA;CALCIUM ION;Diol dehydrase alpha subunit;571;
5YSH;D;Diol dehydratase - alpha/T172A mutant complexed with AdoCbl, aerobically-prepared crystal;1.9;CA;CALCIUM ION;Diol dehydrase alpha subunit;571;
5YSH;G;Diol dehydratase - alpha/T172A mutant complexed with AdoCbl, aerobically-prepared crystal;1.9;CA;CALCIUM ION;Diol dehydrase alpha subunit;571;
5YSH;J;Diol dehydratase - alpha/T172A mutant complexed with AdoCbl, aerobically-prepared crystal;1.9;CA;CALCIUM ION;Diol dehydrase alpha subunit;571;
5YT7;A;crystal structure of circularly permutated Azurin 3;1.66;CA;CALCIUM ION;Azurin;287;
5YT7;B;crystal structure of circularly permutated Azurin 3;1.66;CA;CALCIUM ION;Azurin;287;
5YUA;A;Crystal structure of voltage-gated sodium channel NavAb in high-pH condition;2.8;CA;CALCIUM ION;Ion transport protein;28197;
5YUB;A;Crystal structure of voltage-gated sodium channel NavAb E32Q mutant;3.4;CA;CALCIUM ION;Ion transport protein;28197;
5YUC;A;Crystal structure of voltage-gated sodium channel NavAb N49K mutant;3.4;CA;CALCIUM ION;Ion transport protein;28197;
5YVK;A;Crystal structure of a cyclase Famc1 from Fischerella ambigua UTEX 1903;1.29;CA;CALCIUM ION;cyclase;56108;
5YVL;A;Crystal structure of a cyclase Hpiu5 from Fischerella sp. ATCC 43239;2.06;CA;CALCIUM ION;cyclase;1535197;
5YVL;B;Crystal structure of a cyclase Hpiu5 from Fischerella sp. ATCC 43239;2.06;CA;CALCIUM ION;cyclase;1535197;
5YVL;C;Crystal structure of a cyclase Hpiu5 from Fischerella sp. ATCC 43239;2.06;CA;CALCIUM ION;cyclase;1535197;
5YVL;D;Crystal structure of a cyclase Hpiu5 from Fischerella sp. ATCC 43239;2.06;CA;CALCIUM ION;cyclase;1535197;
5YVP;A;Crystal structure of an apo form cyclase Filc1 from Fischerella sp. TAU;2.05;CA;CALCIUM ION;cyclase A;1930928;
5YVP;B;Crystal structure of an apo form cyclase Filc1 from Fischerella sp. TAU;2.05;CA;CALCIUM ION;cyclase A;1930928;
5YVP;C;Crystal structure of an apo form cyclase Filc1 from Fischerella sp. TAU;2.05;CA;CALCIUM ION;cyclase A;1930928;
5YVP;D;Crystal structure of an apo form cyclase Filc1 from Fischerella sp. TAU;2.05;CA;CALCIUM ION;cyclase A;1930928;
5YZ3;A;Crystal structure of T2R-TTL-28 complex;2.55;CA;CALCIUM ION;Tubulin alpha-1B chain;9913;
5YZ3;C;Crystal structure of T2R-TTL-28 complex;2.55;CA;CALCIUM ION;Tubulin alpha-1B chain;9913;
5YZ4;A;Structure of the PIN domain endonuclease Utp24;2.13;CA;CALCIUM ION;rRNA-processing protein fcf1;4896;
5YZX;A;Crystal structure of E.coli LysU T146D mutant;3.2;CA;CALCIUM ION;Lysine--tRNA ligase, heat inducible;562;
5YZX;B;Crystal structure of E.coli LysU T146D mutant;3.2;CA;CALCIUM ION;Lysine--tRNA ligase, heat inducible;562;
5YZX;C;Crystal structure of E.coli LysU T146D mutant;3.2;CA;CALCIUM ION;Lysine--tRNA ligase, heat inducible;562;
5Z06;A;Crystal structure of beta-1,2-glucanase from Parabacteroides distasonis;2.1;CA;CALCIUM ION;BDI_3064 protein;823;
5Z06;B;Crystal structure of beta-1,2-glucanase from Parabacteroides distasonis;2.1;CA;CALCIUM ION;BDI_3064 protein;823;
5Z0T;A;Thermoactinomyces vulgaris R-47 alpha-amylase I (TVA I) mutant A357V/Q359N/Y360E (AQY/VNE);1.5;CA;CALCIUM ION;Neopullulanase 1;2026;
5Z0T;B;Thermoactinomyces vulgaris R-47 alpha-amylase I (TVA I) mutant A357V/Q359N/Y360E (AQY/VNE);1.5;CA;CALCIUM ION;Neopullulanase 1;2026;
5Z0U;A;Thermoactinomyces vulgaris R-47 alpha-amylase I (TVA I) 11 residues (from A363 to N373) deletion mutant (Del11);1.37;CA;CALCIUM ION;Neopullulanase 1;2026;
5Z1Q;A;Crystal structures of the trimeric N-terminal domain of Ciliate Euplotes octocarinatus Centrin;2.3;CA;CALCIUM ION;Centrin protein;2507429;
5Z1Q;B;Crystal structures of the trimeric N-terminal domain of Ciliate Euplotes octocarinatus Centrin;2.3;CA;CALCIUM ION;Centrin protein;2507429;
5Z1Q;C;Crystal structures of the trimeric N-terminal domain of Ciliate Euplotes octocarinatus Centrin;2.3;CA;CALCIUM ION;Centrin protein;2507429;
5Z4P;A;Crystal structure of tubulin-stathmin-TTL-Compound TCA complex;2.5;CA;CALCIUM ION;Tubulin alpha-1B chain;9913;
5Z4P;B;Crystal structure of tubulin-stathmin-TTL-Compound TCA complex;2.5;CA;CALCIUM ION;Tubulin beta-2B chain;9913;
5Z4P;C;Crystal structure of tubulin-stathmin-TTL-Compound TCA complex;2.5;CA;CALCIUM ION;Tubulin alpha-1B chain;9913;
5Z4U;A;Crystal Structure of T2R-TTL complex with 7a3;3.18;CA;CALCIUM ION;Tubulin alpha-1B chain;9823;
5Z4U;B;Crystal Structure of T2R-TTL complex with 7a3;3.18;CA;CALCIUM ION;Tubulin beta-2B chain;9913;
5Z4U;C;Crystal Structure of T2R-TTL complex with 7a3;3.18;CA;CALCIUM ION;Tubulin alpha-1B chain;9823;
5Z53;A;Crystal structure of a cyclase Filc from Fischerella sp. in complex with cyclo-L-Arg-D-Pro;1.86;CA;CALCIUM ION;12-epi-hapalindole U synthase;1930928;
5Z53;B;Crystal structure of a cyclase Filc from Fischerella sp. in complex with cyclo-L-Arg-D-Pro;1.86;CA;CALCIUM ION;12-epi-hapalindole U synthase;1930928;
5Z53;C;Crystal structure of a cyclase Filc from Fischerella sp. in complex with cyclo-L-Arg-D-Pro;1.86;CA;CALCIUM ION;12-epi-hapalindole U synthase;1930928;
5Z53;D;Crystal structure of a cyclase Filc from Fischerella sp. in complex with cyclo-L-Arg-D-Pro;1.86;CA;CALCIUM ION;12-epi-hapalindole U synthase;1930928;
5Z54;A;Crystal structure of a cyclase Hpiu5 from Fischerella sp. ATCC 43239 in complex with cyclo-L-Arg-D-Pro;2.16;CA;CALCIUM ION;12-epi-hapalindole C/U synthase;56108;
5Z54;B;Crystal structure of a cyclase Hpiu5 from Fischerella sp. ATCC 43239 in complex with cyclo-L-Arg-D-Pro;2.16;CA;CALCIUM ION;12-epi-hapalindole C/U synthase;56108;
5Z54;C;Crystal structure of a cyclase Hpiu5 from Fischerella sp. ATCC 43239 in complex with cyclo-L-Arg-D-Pro;2.16;CA;CALCIUM ION;12-epi-hapalindole C/U synthase;56108;
5Z54;D;Crystal structure of a cyclase Hpiu5 from Fischerella sp. ATCC 43239 in complex with cyclo-L-Arg-D-Pro;2.16;CA;CALCIUM ION;12-epi-hapalindole C/U synthase;56108;
5Z5D;A;Crystal structure of a thermostable glycoside hydrolase family 43 {beta}-1,4-xylosidase from Geobacillus thermoleovorans IT-08;1.7;CA;CALCIUM ION;Beta-xylosidase;33941;
5Z5F;A;Crystal structure of a thermostable glycoside hydrolase family 43 {beta}-1,4-xylosidase from Geobacillus thermoleovorans IT-08 in complex with L-arabinose;2.1;CA;CALCIUM ION;Beta-xylosidase;33941;
5Z5H;A;Crystal structure of a thermostable glycoside hydrolase family 43 {beta}-1,4-xylosidase from Geobacillus thermoleovorans IT-08 in complex with D-xylose;1.9;CA;CALCIUM ION;Beta-xylosidase;33941;
5Z5I;A;Crystal structure of a thermostable glycoside hydrolase family 43 {beta}-1,4-xylosidase from Geobacillus thermoleovorans IT-08 in complex with L-arabinose and D-xylose;1.7;CA;CALCIUM ION;Beta-xylosidase;33941;
5Z5L;A;Crystal structure of ConA-R5M;2.3;CA;CALCIUM ION;Concanavalin-A;3823;
5Z5L;B;Crystal structure of ConA-R5M;2.3;CA;CALCIUM ION;Concanavalin-A;3823;
5Z5L;C;Crystal structure of ConA-R5M;2.3;CA;CALCIUM ION;Concanavalin-A;3823;
5Z5L;D;Crystal structure of ConA-R5M;2.3;CA;CALCIUM ION;Concanavalin-A;3823;
5Z5N;A;Crystal structure of ConA-R1M;2.04;CA;CALCIUM ION;Concanavalin-A;3823;
5Z5N;B;Crystal structure of ConA-R1M;2.04;CA;CALCIUM ION;Concanavalin-A;3823;
5Z5N;C;Crystal structure of ConA-R1M;2.04;CA;CALCIUM ION;Concanavalin-A;3823;
5Z5N;D;Crystal structure of ConA-R1M;2.04;CA;CALCIUM ION;Concanavalin-A;3823;
5Z5P;A;Crystal structure of ConA-R3M;1.4;CA;CALCIUM ION;Concanavalin-A;3823;
5Z5P;B;Crystal structure of ConA-R3M;1.4;CA;CALCIUM ION;Concanavalin-A;3823;
5Z5Y;A;Crystal structure of ConA-R4M;1.89;CA;CALCIUM ION;Concanavalin-A;3823;
5Z5Y;B;Crystal structure of ConA-R4M;1.89;CA;CALCIUM ION;Concanavalin-A;3823;
5Z6E;A;Crystal structure of a beta gamma-crystallin domain of Abundant Perithecial Protein (APP) from Neurospora crassa in the Ca2+-bound form;1.86;CA;CALCIUM ION;DUF1881 domain-containing protein;5141;
5Z6O;A;Crystal structure of Penicillium cyclopium protease;1.7;CA;CALCIUM ION;protease;60167;
5Z8Y;B;Crystal structure of human LRRTM2 in complex with Neurexin 1beta;3.4;CA;CALCIUM ION;Neurexin-1-beta;9606;
5Z8Y;D;Crystal structure of human LRRTM2 in complex with Neurexin 1beta;3.4;CA;CALCIUM ION;Neurexin-1-beta;9606;
5Z8Y;F;Crystal structure of human LRRTM2 in complex with Neurexin 1beta;3.4;CA;CALCIUM ION;Neurexin-1-beta;9606;
5Z8Y;H;Crystal structure of human LRRTM2 in complex with Neurexin 1beta;3.4;CA;CALCIUM ION;Neurexin-1-beta;9606;
5ZAC;A;Crystal structure of ConA-R2M;2.59;CA;CALCIUM ION;Concanavalin-A;3823;
5ZAC;B;Crystal structure of ConA-R2M;2.59;CA;CALCIUM ION;Concanavalin-A;3823;
5ZAC;C;Crystal structure of ConA-R2M;2.59;CA;CALCIUM ION;Concanavalin-A;3823;
5ZAC;D;Crystal structure of ConA-R2M;2.59;CA;CALCIUM ION;Concanavalin-A;3823;
5ZB4;A;Crystal structure of thymidylate kinase in complex with ADP and TMP from thermus thermophilus HB8;1.92;CA;CALCIUM ION;Thymidylate kinase;274;
5ZB4;B;Crystal structure of thymidylate kinase in complex with ADP and TMP from thermus thermophilus HB8;1.92;CA;CALCIUM ION;Thymidylate kinase;274;
5ZC0;A;Crystal structure of Xenopus embryonic epidermal lectin in complex with Samarium ions;2.75;CA;CALCIUM ION;Xenopus Embryonic Epidermal Lectin;8355;
5ZC0;B;Crystal structure of Xenopus embryonic epidermal lectin in complex with Samarium ions;2.75;CA;CALCIUM ION;Xenopus Embryonic Epidermal Lectin;8355;
5ZC0;C;Crystal structure of Xenopus embryonic epidermal lectin in complex with Samarium ions;2.75;CA;CALCIUM ION;Xenopus Embryonic Epidermal Lectin;8355;
5ZC0;D;Crystal structure of Xenopus embryonic epidermal lectin in complex with Samarium ions;2.75;CA;CALCIUM ION;Xenopus Embryonic Epidermal Lectin;8355;
5ZC0;E;Crystal structure of Xenopus embryonic epidermal lectin in complex with Samarium ions;2.75;CA;CALCIUM ION;Xenopus Embryonic Epidermal Lectin;8355;
5ZC0;F;Crystal structure of Xenopus embryonic epidermal lectin in complex with Samarium ions;2.75;CA;CALCIUM ION;Xenopus Embryonic Epidermal Lectin;8355;
5ZCB;A;Crystal structure of Alpha-glucosidase;2.5;CA;CALCIUM ION;Alpha-glucosidase;1409;
5ZCC;A;Crystal structure of Alpha-glucosidase in complex with maltose;1.7;CA;CALCIUM ION;Alpha-glucosidase;1409;
5ZCD;A;Crystal structure of Alpha-glucosidase in complex with maltotriose;1.71;CA;CALCIUM ION;Alpha-glucosidase;1409;
5ZCE;A;Crystal structure of Alpha-glucosidase in complex with maltotetraose;1.55;CA;CALCIUM ION;Alpha-glucosidase;1409;
5ZDM;A;The ligand-free structure of FomD;1.38;CA;CALCIUM ION;FomD;1906;
5ZDZ;A;Hairpin Forming Complex, RAG1/2-Nicked 12RSS/23RSS complex in Ca2+;2.8;CA;CALCIUM ION;mouse RAG1;10090;
5ZDZ;C;Hairpin Forming Complex, RAG1/2-Nicked 12RSS/23RSS complex in Ca2+;2.8;CA;CALCIUM ION;mouse RAG1;10090;
5ZE3;A;Crystal structure of human lysyl oxidase-like 2 (hLOXL2) in a precursor state;2.4;CA;CALCIUM ION;Lysyl oxidase homolog 2;9606;
5ZE3;B;Crystal structure of human lysyl oxidase-like 2 (hLOXL2) in a precursor state;2.4;CA;CALCIUM ION;Lysyl oxidase homolog 2;9606;
5ZF0;L1;X-ray Structure of the Electron Transfer Complex between Ferredoxin and Photosystem I;4.2;CA;CALCIUM ION;Photosystem I reaction center subunit XI;146786;
5ZF0;L2;X-ray Structure of the Electron Transfer Complex between Ferredoxin and Photosystem I;4.2;CA;CALCIUM ION;Photosystem I reaction center subunit XI;146786;
5ZF0;L4;X-ray Structure of the Electron Transfer Complex between Ferredoxin and Photosystem I;4.2;CA;CALCIUM ION;Photosystem I reaction center subunit XI;146786;
5ZF0;L6;X-ray Structure of the Electron Transfer Complex between Ferredoxin and Photosystem I;4.2;CA;CALCIUM ION;Photosystem I reaction center subunit XI;146786;
5ZFJ;A;Crystal structure of a cyclase Filc from Fischerella sp. in complex with 4-(1H-Indol-3-yl)butan-2-one;1.86;CA;CALCIUM ION;acyclase;83541;
5ZFJ;B;Crystal structure of a cyclase Filc from Fischerella sp. in complex with 4-(1H-Indol-3-yl)butan-2-one;1.86;CA;CALCIUM ION;acyclase;83541;
5ZFJ;C;Crystal structure of a cyclase Filc from Fischerella sp. in complex with 4-(1H-Indol-3-yl)butan-2-one;1.86;CA;CALCIUM ION;acyclase;83541;
5ZFJ;D;Crystal structure of a cyclase Filc from Fischerella sp. in complex with 4-(1H-Indol-3-yl)butan-2-one;1.86;CA;CALCIUM ION;acyclase;83541;
5ZGM;A;Crystal Structure of Parvalbumin SPVI, the Major Allergens in Mustelus griseus;1.4;CA;CALCIUM ION;Parvalbumin SPVI;89020;
5ZGM;B;Crystal Structure of Parvalbumin SPVI, the Major Allergens in Mustelus griseus;1.4;CA;CALCIUM ION;Parvalbumin SPVI;89020;
5ZGS;A;Crystal structure of the complex of bovine lactoperoxidase with multiple SCN and OSCN ions in the distal heme cavity;2.2;CA;CALCIUM ION;Lactoperoxidase;9913;
5ZH6;A;Crystal structure of Parvalbumin SPV-II of Mustelus griseus;1.54;CA;CALCIUM ION;Parvalbumin SPV-II;89020;
5ZH6;B;Crystal structure of Parvalbumin SPV-II of Mustelus griseus;1.54;CA;CALCIUM ION;Parvalbumin SPV-II;89020;
5ZL1;A;Hexameric structure of copper-containing nitrite reductase of an anammox organism KSU-1;3.2;CA;CALCIUM ION;Putative copper-type nitrite reductase;247490;
5ZL1;B;Hexameric structure of copper-containing nitrite reductase of an anammox organism KSU-1;3.2;CA;CALCIUM ION;Putative copper-type nitrite reductase;247490;
5ZL1;C;Hexameric structure of copper-containing nitrite reductase of an anammox organism KSU-1;3.2;CA;CALCIUM ION;Putative copper-type nitrite reductase;247490;
5ZL1;D;Hexameric structure of copper-containing nitrite reductase of an anammox organism KSU-1;3.2;CA;CALCIUM ION;Putative copper-type nitrite reductase;247490;
5ZNH;A;Catechol 2,3-dioxygenase with 4-methyl catechol from Diaphorobacter sp DS2;2.4;CA;CALCIUM ION;Catechol 2,3-dioxygenase, extradiol protein;1302548;
5ZNO;A;Crystal structure of PET-degrading cutinase Cut190 S176A/S226P/R228S/ mutant in Ca(2+)-bound state;1.6;CA;CALCIUM ION;Alpha/beta hydrolase family protein;1852;
5ZNO;B;Crystal structure of PET-degrading cutinase Cut190 S176A/S226P/R228S/ mutant in Ca(2+)-bound state;1.6;CA;CALCIUM ION;Alpha/beta hydrolase family protein;1852;
5ZOV;A;Inward-facing conformation of L-ascorbate transporter UlaA;3.33;CA;CALCIUM ION;PTS ascorbate-specific subunit IIBC;747;
5ZOV;B;Inward-facing conformation of L-ascorbate transporter UlaA;3.33;CA;CALCIUM ION;PTS ascorbate-specific subunit IIBC;747;
5ZRQ;A;Crystal structure of PET-degrading cutinase Cut190 S176A/S226P/R228S mutant in Zn(2+)-bound state;1.12;CA;CALCIUM ION;Alpha/beta hydrolase family protein;1852;
5ZRS;A;Crystal structure of PET-degrading cutinase Cut190 S176A/S226P/R228S mutant in monoethyl adipate bound state;1.4;CA;CALCIUM ION;Alpha/beta hydrolase family protein;1852;
5ZSX;A;Catechol 2,3-dioxygenase with 3-fluorocatechol from Diaphorobacter sp DS2;2.2;CA;CALCIUM ION;Catechol 2,3-dioxygenase, extradiol protein;1302548;
5ZSZ;A;Catechol 2,3-dioxygenase (C23O64) from Diaphorobacter sp DS2;2.4;CA;CALCIUM ION;Catechol 2,3-dioxygenase, Extradiol ring cleavage protein;1302548;
5ZTF;A;Structure of Ca2+ ATPase;3.45;CA;CALCIUM ION;Sarcoplasmic/endoplasmic reticulum calcium ATPase 2;9606;
5ZWW;A;CRYSTAL STRUCTURE OF THE COMPLEX OF LACTOPEROXIDASE WITH HYDROGEN PEROXIDE AT 1.77A RESOLUTION;1.77;CA;CALCIUM ION;Lactoperoxidase;9913;
5ZXG;A;Cyclic alpha-maltosyl-(1-->6)-maltose hydrolase from Arthrobacter globiformis, ligand-free form;2.4;CA;CALCIUM ION;Cyclic maltosyl-maltose hydrolase;1665;
5ZXH;A;The structure of MT189-tubulin complex;2.8;CA;CALCIUM ION;Tubulin alpha-1B chain;9823;
5ZXH;B;The structure of MT189-tubulin complex;2.8;CA;CALCIUM ION;Tubulin beta-2B chain;9913;
5ZXH;C;The structure of MT189-tubulin complex;2.8;CA;CALCIUM ION;Tubulin alpha-1B chain;9823;
5ZYV;A;Crystal structure of human MGME1 with single strand DNA2 and Ca2+;2.72;CA;CALCIUM ION;Mitochondrial genome maintenance exonuclease 1;9606;
5ZZ0;A;HUMAN GELSOLIN FROM RESIDUES GLU28 TO ARG161 WITH CALCIUM;2.63;CA;CALCIUM ION;Gelsolin;9606;
5ZZ0;G;HUMAN GELSOLIN FROM RESIDUES GLU28 TO ARG161 WITH CALCIUM;2.63;CA;CALCIUM ION;Gelsolin;9606;
5ZZ1;A;Probing the active center of catalase-phenol oxidase from Scytalidium thermophilum;1.91;CA;CALCIUM ION;Catalase;85995;
5ZZ1;B;Probing the active center of catalase-phenol oxidase from Scytalidium thermophilum;1.91;CA;CALCIUM ION;Catalase;85995;
5ZZ1;C;Probing the active center of catalase-phenol oxidase from Scytalidium thermophilum;1.91;CA;CALCIUM ION;Catalase;85995;
5ZZ1;D;Probing the active center of catalase-phenol oxidase from Scytalidium thermophilum;1.91;CA;CALCIUM ION;Catalase;85995;
5ZZA;A;OdinProfilin/Rabbit Actin Complex;1.53;CA;CALCIUM ION;Actin, alpha skeletal muscle;9986;
5ZZB;B;LokiProfilin2/Rabbit Actin Complex;2.3;CA;CALCIUM ION;Actin, alpha skeletal muscle;9986;
5ZZB;D;LokiProfilin2/Rabbit Actin Complex;2.3;CA;CALCIUM ION;Actin, alpha skeletal muscle;9986;
5ZZN;B;Crystal structure of photosystem II from an SQDG-deficient mutant of Thermosynechococcus elongatus;2.1;CA;CALCIUM ION;Photosystem II CP47 reaction center protein;146786;
5ZZN;O;Crystal structure of photosystem II from an SQDG-deficient mutant of Thermosynechococcus elongatus;2.1;CA;CALCIUM ION;Photosystem II manganese-stabilizing polypeptide;146786;
5ZZN;V;Crystal structure of photosystem II from an SQDG-deficient mutant of Thermosynechococcus elongatus;2.1;CA;CALCIUM ION;Cytochrome c-550;146786;
5ZZN;b;Crystal structure of photosystem II from an SQDG-deficient mutant of Thermosynechococcus elongatus;2.1;CA;CALCIUM ION;Photosystem II CP47 reaction center protein;146786;
5ZZN;c;Crystal structure of photosystem II from an SQDG-deficient mutant of Thermosynechococcus elongatus;2.1;CA;CALCIUM ION;Photosystem II CP43 reaction center protein;146786;
5ZZN;o;Crystal structure of photosystem II from an SQDG-deficient mutant of Thermosynechococcus elongatus;2.1;CA;CALCIUM ION;Photosystem II manganese-stabilizing polypeptide;146786;
5ZZN;v;Crystal structure of photosystem II from an SQDG-deficient mutant of Thermosynechococcus elongatus;2.1;CA;CALCIUM ION;Cytochrome c-550;146786;
6A0J;A;Cyclic alpha-maltosyl-(1-->6)-maltose hydrolase from Arthrobacter globiformis, complex with Cyclic alpha-maltosyl-(1-->6)-maltose;1.6;CA;CALCIUM ION;Cyclic maltosyl-maltose hydrolase;1665;
6A0K;B;Cyclic alpha-maltosyl-(1-->6)-maltose hydrolase from Arthrobacter globiformis, complex with panose;1.94;CA;CALCIUM ION;Cyclic maltosyl-maltose hydrolase;1665;
6A12;A;X-ray structure of lipase from Geobacillus thermoleovorans;2.14;CA;CALCIUM ION;Lipase;33941;
6A2W;A;Crystal structure of fucoxanthin chlorophyll a/c complex from Phaeodactylum tricornutum;1.8;CA;CALCIUM ION;Protein fucoxanthin chlorophyl a/c protein;2850;
6A46;A;Structure of TREX2 in complex with a nucleotide (dCMP);2;CA;CALCIUM ION;Three prime repair exonuclease 2;10090;
6A46;B;Structure of TREX2 in complex with a nucleotide (dCMP);2;CA;CALCIUM ION;Three prime repair exonuclease 2;10090;
6A48;A;Crystal structure of reelin N-terminal region;2;CA;CALCIUM ION;Reelin;10090;
6A4K;A;Human antibody 32D6 Fab in complex with H1N1 influenza A virus HA1;3.15;CA;CALCIUM ION;Hemagglutinin;11320;
6A4K;B;Human antibody 32D6 Fab in complex with H1N1 influenza A virus HA1;3.15;CA;CALCIUM ION;Hemagglutinin;11320;
6A4K;C;Human antibody 32D6 Fab in complex with H1N1 influenza A virus HA1;3.15;CA;CALCIUM ION;Hemagglutinin;11320;
6A4K;D;Human antibody 32D6 Fab in complex with H1N1 influenza A virus HA1;3.15;CA;CALCIUM ION;Hemagglutinin;11320;
6A4K;O;Human antibody 32D6 Fab in complex with H1N1 influenza A virus HA1;3.15;CA;CALCIUM ION;immunoglobulin Fab light chain;9606;
6A4Y;A;Crystal structure of bovine lactoperoxidase with partial occupancies of iodide and SCN- ions at the substrate binding site on the distal heme side at 1.92 A resolution;1.92;CA;CALCIUM ION;Lactoperoxidase;9913;
6A56;A;AJLec from the Sea Anemone Anthopleura japonica;1.2;CA;CALCIUM ION;AJLec;67755;
6A56;B;AJLec from the Sea Anemone Anthopleura japonica;1.2;CA;CALCIUM ION;AJLec;67755;
6A6Q;A;Crystal strcuture of a lignin peroxidase isozyme H8 variant that is stable at very acidic pH;1.67;CA;CALCIUM ION;Ligninase H8;5306;
6A71;A;Crystal Structure of Human ATP7B and TM Complex;1.6;CA;CALCIUM ION;ATP7B protein;9606;
6A72;B;Copper transporter protein;2.1;CA;CALCIUM ION;ATP7B protein;9606;
6A7S;B;Ca2+-independent C-type lectin SPL-2 from Saxidomus purpuratus;2;CA;CALCIUM ION;N-acetylglucosamine-specific lectin;311201;
6A7T;A;Ca2+-independent C-type lectin SPL-1 from Saxidomus purpuratus;1.6;CA;CALCIUM ION;N-acetylglucosamine-specific lectin;311201;
6A7T;B;Ca2+-independent C-type lectin SPL-1 from Saxidomus purpuratus;1.6;CA;CALCIUM ION;N-acetylglucosamine-specific lectin;311201;
6A8H;A;Crystal structure of endo-arabinanase ABN-TS D27A mutant in complex with arabinotriose;1.65;CA;CALCIUM ION;endo-alpha-(1->5)-L-arabinanase;33940;
6A8I;A;Crystal structure of endo-arabinanase ABN-TS D147N mutant in complex with arabinohexaose;1.9;CA;CALCIUM ION;endo-alpha-(1->5)-L-arabinanase;33940;
6A8I;B;Crystal structure of endo-arabinanase ABN-TS D147N mutant in complex with arabinohexaose;1.9;CA;CALCIUM ION;endo-alpha-(1->5)-L-arabinanase;33940;
6A8X;A;Crystal structure of a apo form cyclase from Fischerella sp.;2.35;CA;CALCIUM ION;aromatic prenyltransferase;56108;
6A8X;B;Crystal structure of a apo form cyclase from Fischerella sp.;2.35;CA;CALCIUM ION;aromatic prenyltransferase;56108;
6A92;A;Crystal structure of a cyclase Filc1 from Fischerella sp.;1.58;CA;CALCIUM ION;acyclase;1190;
6A92;B;Crystal structure of a cyclase Filc1 from Fischerella sp.;1.58;CA;CALCIUM ION;acyclase;1190;
6A92;C;Crystal structure of a cyclase Filc1 from Fischerella sp.;1.58;CA;CALCIUM ION;acyclase;1190;
6A92;D;Crystal structure of a cyclase Filc1 from Fischerella sp.;1.58;CA;CALCIUM ION;acyclase;1190;
6A98;A;Crystal structure of a cyclase from Fischerella sp. TAU;1.82;CA;CALCIUM ION;aromatic prenyltransferase;56108;
6A98;B;Crystal structure of a cyclase from Fischerella sp. TAU;1.82;CA;CALCIUM ION;aromatic prenyltransferase;56108;
6A98;C;Crystal structure of a cyclase from Fischerella sp. TAU;1.82;CA;CALCIUM ION;aromatic prenyltransferase;56108;
6A98;D;Crystal structure of a cyclase from Fischerella sp. TAU;1.82;CA;CALCIUM ION;aromatic prenyltransferase;56108;
6A99;A;Crystal structure of a Stig cyclases Fisc from Fischerella sp. TAU in complex with (3Z)-3-(1-methyl-2-pyrrolidinylidene)-3H-indole;2.29;CA;CALCIUM ION;aromatic prenyltransferase;83541;
6A99;B;Crystal structure of a Stig cyclases Fisc from Fischerella sp. TAU in complex with (3Z)-3-(1-methyl-2-pyrrolidinylidene)-3H-indole;2.29;CA;CALCIUM ION;aromatic prenyltransferase;83541;
6A99;C;Crystal structure of a Stig cyclases Fisc from Fischerella sp. TAU in complex with (3Z)-3-(1-methyl-2-pyrrolidinylidene)-3H-indole;2.29;CA;CALCIUM ION;aromatic prenyltransferase;83541;
6A99;D;Crystal structure of a Stig cyclases Fisc from Fischerella sp. TAU in complex with (3Z)-3-(1-methyl-2-pyrrolidinylidene)-3H-indole;2.29;CA;CALCIUM ION;aromatic prenyltransferase;83541;
6A9F;A;Crystal structure of a cyclase from Fischerella sp. TAU in complex with 4-(1H-Indol-3-yl)butan-2-one;1.7;CA;CALCIUM ION;aromatic prenyltransferase;83541;
6A9F;B;Crystal structure of a cyclase from Fischerella sp. TAU in complex with 4-(1H-Indol-3-yl)butan-2-one;1.7;CA;CALCIUM ION;aromatic prenyltransferase;83541;
6A9F;C;Crystal structure of a cyclase from Fischerella sp. TAU in complex with 4-(1H-Indol-3-yl)butan-2-one;1.7;CA;CALCIUM ION;aromatic prenyltransferase;83541;
6A9F;D;Crystal structure of a cyclase from Fischerella sp. TAU in complex with 4-(1H-Indol-3-yl)butan-2-one;1.7;CA;CALCIUM ION;aromatic prenyltransferase;83541;
6AB6;A;Cryo-EM structure of T=3 Penaeus vannamei nodavirus;3.5;CA;CALCIUM ION;Capsid protein;430911;
6AB6;B;Cryo-EM structure of T=3 Penaeus vannamei nodavirus;3.5;CA;CALCIUM ION;Capsid protein;430911;
6AB6;C;Cryo-EM structure of T=3 Penaeus vannamei nodavirus;3.5;CA;CALCIUM ION;Capsid protein;430911;
6AEK;A;Crystal structure of ENPP1 in complex with pApG;1.8;CA;CALCIUM ION;Ectonucleotide pyrophosphatase/phosphodiesterase 1, isoform CRA_d;10090;
6AEL;A;Crystal structure of ENPP1 in complex with 3'3'-cGAMP;1.9;CA;CALCIUM ION;Ectonucleotide pyrophosphatase/phosphodiesterase 1, isoform CRA_d;10090;
6AEM;A;Crystal structure of the PKD1 domain of Vibrio anguillarum Epp;1.27;CA;CALCIUM ION;PKD domain;55601;
6AEM;B;Crystal structure of the PKD1 domain of Vibrio anguillarum Epp;1.27;CA;CALCIUM ION;PKD domain;55601;
6AG0;A;The X-ray Crystallographic Structure of Maltooligosaccharide-forming Amylase from Bacillus stearothermophilus STB04;2.2;CA;CALCIUM ION;Alpha-amylase;1422;
6AG0;C;The X-ray Crystallographic Structure of Maltooligosaccharide-forming Amylase from Bacillus stearothermophilus STB04;2.2;CA;CALCIUM ION;Alpha-amylase;1422;
6AGI;A;Crystal Structure of EFHA2 in Ca-binding State;2.8;CA;CALCIUM ION;Calcium uptake protein 3, mitochondrial;9606;
6AGI;B;Crystal Structure of EFHA2 in Ca-binding State;2.8;CA;CALCIUM ION;Calcium uptake protein 3, mitochondrial;9606;
6AH4;A;Structure of human P2X3 receptor in complex with ATP and Ca2+ ion;3.3;CA;CALCIUM ION;P2X purinoceptor 3;9606;
6AH4;B;Structure of human P2X3 receptor in complex with ATP and Ca2+ ion;3.3;CA;CALCIUM ION;P2X purinoceptor 3;9606;
6AH4;C;Structure of human P2X3 receptor in complex with ATP and Ca2+ ion;3.3;CA;CALCIUM ION;P2X purinoceptor 3;9606;
6AHG;A;Trimeric structure of concanavalin A from Canavalia ensiformis;2.83;CA;CALCIUM ION;Concanavalin-A,Concanavalin-A;3823;
6AHG;B;Trimeric structure of concanavalin A from Canavalia ensiformis;2.83;CA;CALCIUM ION;Concanavalin-A,Concanavalin-A;3823;
6AHG;C;Trimeric structure of concanavalin A from Canavalia ensiformis;2.83;CA;CALCIUM ION;Concanavalin-A,Concanavalin-A;3823;
6AI0;A;Structure of the 328-692 fragment of FlhA (orthorhombic form);2.4;CA;CALCIUM ION;Flagellar biosynthesis protein FlhA;28901;
6AI0;B;Structure of the 328-692 fragment of FlhA (orthorhombic form);2.4;CA;CALCIUM ION;Flagellar biosynthesis protein FlhA;28901;
6AID;A;Structural insights into the unique polylactate degrading mechanism of Thermobifida alba cutinase;1.3;CA;CALCIUM ION;Esterase;53522;
6AIJ;A;Cyclodextrin glycosyltransferase from Paenibacillus macerans mutant N603D;2.1;CA;CALCIUM ION;Cyclomaltodextrin glucanotransferase;44252;
6AK8;A;Pre-catalytic Ternary Complex of Human DNA Polymerase Mu with Templating Adenine and Incoming Ca-8oxodGTP;1.74;CA;CALCIUM ION;DNA-directed DNA/RNA polymerase mu;9606;
6AK9;A;Pre-catalytic Ternary Complex of Human DNA Polymerase Mu with Templating Cytosine and Incoming Ca-8oxodGTP;1.91;CA;CALCIUM ION;DNA-directed DNA/RNA polymerase mu;9606;
6AL6;A;Crystal structure HpiC1 in P42 space group;2.09;CA;CALCIUM ION;12-epi-hapalindole C/U synthase;1535197;
6AL6;B;Crystal structure HpiC1 in P42 space group;2.09;CA;CALCIUM ION;12-epi-hapalindole C/U synthase;1535197;
6AL7;A;Crystal structure HpiC1 F138S;1.69;CA;CALCIUM ION;12-epi-hapalindole C/U synthase;1535197;
6AL7;B;Crystal structure HpiC1 F138S;1.69;CA;CALCIUM ION;12-epi-hapalindole C/U synthase;1535197;
6AL7;D;Crystal structure HpiC1 F138S;1.69;CA;CALCIUM ION;12-epi-hapalindole C/U synthase;1535197;
6AL7;E;Crystal structure HpiC1 F138S;1.69;CA;CALCIUM ION;12-epi-hapalindole C/U synthase;1535197;
6AL8;A;Crystal structure HpiC1 Y101F/F138S;1.64;CA;CALCIUM ION;12-epi-hapalindole C/U synthase;1535197;
6AL8;B;Crystal structure HpiC1 Y101F/F138S;1.64;CA;CALCIUM ION;12-epi-hapalindole C/U synthase;1535197;
6AL8;D;Crystal structure HpiC1 Y101F/F138S;1.64;CA;CALCIUM ION;12-epi-hapalindole C/U synthase;1535197;
6AL8;E;Crystal structure HpiC1 Y101F/F138S;1.64;CA;CALCIUM ION;12-epi-hapalindole C/U synthase;1535197;
6ALE;R;A V-to-F substitution in SK2 channels causes Ca2+ hypersensitivity and improves locomotion in a C. elegans ALS model;2.5;CA;CALCIUM ION;Calmodulin-2;10116;
6AM3;A;Regulator of G protein signaling (RGS) 17 in complex with Ca2+;1.53;CA;CALCIUM ION;Regulator of G-protein signaling 17;9606;
6AM3;X;Regulator of G protein signaling (RGS) 17 in complex with Ca2+;1.53;CA;CALCIUM ION;Regulator of G-protein signaling 17;9606;
6AMF;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS V23K/L36E at cryogenic temperature;1.85;CA;CALCIUM ION;Thermonuclease;1280;
6AMZ;A;Crystal structure of a domain swapped 2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-succinyltransferase from Acinetobacter baumannii;2.05;CA;CALCIUM ION;2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-succinyltransferase;470;
6ANJ;A;Synaptotagmin-7, C2A domain;1.7;CA;CALCIUM ION;Synaptotagmin-7;10116;
6ANK;A;Synaptotagmin-7, C2A- and C2B-domains;2.25;CA;CALCIUM ION;Synaptotagmin-7;10116;
6ANK;B;Synaptotagmin-7, C2A- and C2B-domains;2.25;CA;CALCIUM ION;Synaptotagmin-7;10116;
6AO1;A;Crystal structure of a beta-lactamase from Burkholderia phymatum;1.8;CA;CALCIUM ION;Beta-lactamase domain protein;148447;
6AO1;B;Crystal structure of a beta-lactamase from Burkholderia phymatum;1.8;CA;CALCIUM ION;Beta-lactamase domain protein;148447;
6AO1;C;Crystal structure of a beta-lactamase from Burkholderia phymatum;1.8;CA;CALCIUM ION;Beta-lactamase domain protein;148447;
6AO1;D;Crystal structure of a beta-lactamase from Burkholderia phymatum;1.8;CA;CALCIUM ION;Beta-lactamase domain protein;148447;
6AON;A;1.72 Angstrom Resolution Crystal Structure of 2-Oxoglutarate Dehydrogenase Complex Subunit Dihydrolipoamide Dehydrogenase from Bordetella pertussis in Complex with FAD;1.72;CA;CALCIUM ION;Dihydrolipoyl dehydrogenase;520;
6AP9;A;Crystal Structure of hGSTP1-1 with S-nitrosation of Cys101;1.55;CA;CALCIUM ION;Glutathione S-transferase P;9606;
6AP9;B;Crystal Structure of hGSTP1-1 with S-nitrosation of Cys101;1.55;CA;CALCIUM ION;Glutathione S-transferase P;9606;
6APG;A;Trans-acting transferase from Disorazole synthase with malonate;2;CA;CALCIUM ION;DisD protein;56;
6AQ5;A;X-ray crystal structure of Erythrina crista-galli lectin in complex with epilactose;2.19;CA;CALCIUM ION;Lectin;49817;
6AQ5;B;X-ray crystal structure of Erythrina crista-galli lectin in complex with epilactose;2.19;CA;CALCIUM ION;Lectin;49817;
6AQ6;A;X-ray crystal structure of Erythrina crista-galli lectin in complex with N-acetyllactosamine;1.9;CA;CALCIUM ION;Lectin;49817;
6AQ6;B;X-ray crystal structure of Erythrina crista-galli lectin in complex with N-acetyllactosamine;1.9;CA;CALCIUM ION;Lectin;49817;
6ATJ;A;RECOMBINANT HORSERADISH PEROXIDASE C COMPLEX WITH FERULIC ACID;2;CA;CALCIUM ION;PEROXIDASE C1A;3704;
6AVL;A;Orthorhombic Trypsin (295 K) in the presence of 50% xylose;2;CA;CALCIUM ION;Cationic trypsin;9913;
6AVZ;B;Crystal structure of the HopQ-CEACAM3 WT complex;2.05;CA;CALCIUM ION;HopQ;210;
6AW7;A;2.15A resolution structure of SAH bound catechol O-methyltransferase (COMT) from Nannospalax galili;2.15;CA;CALCIUM ION;Catechol O-methyltransferase;1026970;
6AW7;B;2.15A resolution structure of SAH bound catechol O-methyltransferase (COMT) from Nannospalax galili;2.15;CA;CALCIUM ION;Catechol O-methyltransferase;1026970;
6AW8;A;2.25A resolution domain swapped dimer structure of SAH bound catechol O-methyltransferase (COMT) from Nannospalax galili;2.25;CA;CALCIUM ION;Catechol O-methyltransferase;1026970;
6AW8;B;2.25A resolution domain swapped dimer structure of SAH bound catechol O-methyltransferase (COMT) from Nannospalax galili;2.25;CA;CALCIUM ION;Catechol O-methyltransferase;1026970;
6AW8;C;2.25A resolution domain swapped dimer structure of SAH bound catechol O-methyltransferase (COMT) from Nannospalax galili;2.25;CA;CALCIUM ION;Catechol O-methyltransferase;1026970;
6AW9;A;2.55A resolution structure of SAH bound catechol O-methyltransferase (COMT) L136M from Nannospalax galili;2.55;CA;CALCIUM ION;Catechol O-methyltransferase;1026970;
6AW9;B;2.55A resolution structure of SAH bound catechol O-methyltransferase (COMT) L136M from Nannospalax galili;2.55;CA;CALCIUM ION;Catechol O-methyltransferase;1026970;
6AW9;C;2.55A resolution structure of SAH bound catechol O-methyltransferase (COMT) L136M from Nannospalax galili;2.55;CA;CALCIUM ION;Catechol O-methyltransferase;1026970;
6AYB;A;Naegleria fowleri CYP51-ketoconazole complex;1.87;CA;CALCIUM ION;CYP51, sterol 14alpha-demethylase;5763;
6AZP;A;A Structurally Dynamic N-terminal Region Drives Function of the Staphylococcal Peroxidase Inhibitor (SPIN);2.29;CA;CALCIUM ION;Myeloperoxidase;9606;
6AZQ;B;Structural and biochemical characterization of a non-canonical biuret hydrolase (BiuH) from the cyanuric acid catabolism pathway of Rhizobium leguminasorum bv. viciae 3841;2.22;CA;CALCIUM ION;Putative amidase;384;
6AZQ;C;Structural and biochemical characterization of a non-canonical biuret hydrolase (BiuH) from the cyanuric acid catabolism pathway of Rhizobium leguminasorum bv. viciae 3841;2.22;CA;CALCIUM ION;Putative amidase;384;
6AZQ;F;Structural and biochemical characterization of a non-canonical biuret hydrolase (BiuH) from the cyanuric acid catabolism pathway of Rhizobium leguminasorum bv. viciae 3841;2.22;CA;CALCIUM ION;Putative amidase;384;
6AZQ;G;Structural and biochemical characterization of a non-canonical biuret hydrolase (BiuH) from the cyanuric acid catabolism pathway of Rhizobium leguminasorum bv. viciae 3841;2.22;CA;CALCIUM ION;Putative amidase;384;
6B0J;A;Crystal structure of Ps i-CgsB in complex with k-i-k-neocarrahexaose;2.5;CA;CALCIUM ION;Iota-carrageenan sulfatase;53246;
6B0J;B;Crystal structure of Ps i-CgsB in complex with k-i-k-neocarrahexaose;2.5;CA;CALCIUM ION;Iota-carrageenan sulfatase;53246;
6B0J;C;Crystal structure of Ps i-CgsB in complex with k-i-k-neocarrahexaose;2.5;CA;CALCIUM ION;Iota-carrageenan sulfatase;53246;
6B0K;A;Crystal structure of Ps i-CgsB C78S in complex with k-carrapentaose;2.15;CA;CALCIUM ION;Iota-carrageenan sulfatase;53246;
6B0K;B;Crystal structure of Ps i-CgsB C78S in complex with k-carrapentaose;2.15;CA;CALCIUM ION;Iota-carrageenan sulfatase;53246;
6B0K;C;Crystal structure of Ps i-CgsB C78S in complex with k-carrapentaose;2.15;CA;CALCIUM ION;Iota-carrageenan sulfatase;53246;
6B0V;A;Crystal Structure of small molecule ARS-107 covalently bound to K-Ras G12C;1.29;CA;CALCIUM ION;GTPase KRas;9606;
6B0V;B;Crystal Structure of small molecule ARS-107 covalently bound to K-Ras G12C;1.29;CA;CALCIUM ION;GTPase KRas;9606;
6B0Y;A;Crystal Structure of small molecule ARS-917 covalently bound to K-Ras G12C;1.43;CA;CALCIUM ION;GTPase KRas;9606;
6B0Y;B;Crystal Structure of small molecule ARS-917 covalently bound to K-Ras G12C;1.43;CA;CALCIUM ION;GTPase KRas;9606;
6B1V;A;Crystal structure of Ps i-CgsB C78S in complex with i-neocarratetraose;2.84;CA;CALCIUM ION;Iota-carrageenan sulfatase;53246;
6B1V;B;Crystal structure of Ps i-CgsB C78S in complex with i-neocarratetraose;2.84;CA;CALCIUM ION;Iota-carrageenan sulfatase;53246;
6B1V;C;Crystal structure of Ps i-CgsB C78S in complex with i-neocarratetraose;2.84;CA;CALCIUM ION;Iota-carrageenan sulfatase;53246;
6B40;A;BbRAGL-3'TIR synaptic complex with nicked DNA refined with C2 symmetry;4.3;CA;CALCIUM ION;RAG1L,RAG1L;7741;
6B40;E;BbRAGL-3'TIR synaptic complex with nicked DNA refined with C2 symmetry;4.3;CA;CALCIUM ION;RAG1L,RAG1L;7741;
6B5V;A;Structure of TRPV5 in complex with econazole;4.8;CA;CALCIUM ION;Transient receptor potential cation channel subfamily V member 5;9986;
6B67;A;Human PP2Calpha (PPM1A) complexed with cyclic peptide c(MpSIpYVA);2.2;CA;CALCIUM ION;Protein phosphatase 1A;9606;
6B67;B;Human PP2Calpha (PPM1A) complexed with cyclic peptide c(MpSIpYVA);2.2;CA;CALCIUM ION;Protein phosphatase 1A;9606;
6B67;C;Human PP2Calpha (PPM1A) complexed with cyclic peptide c(MpSIpYVA);2.2;CA;CALCIUM ION;Protein phosphatase 1A;9606;
6B6N;A;Orthorhombic trypsin (295 K) in the presence of 50% mpd;2;CA;CALCIUM ION;Cationic trypsin;9913;
6B6O;A;Orthorhombic trypsin cryocooled to 100 K with 20% xylose as cryoprotectant;2.4;CA;CALCIUM ION;Cationic trypsin;9913;
6B6P;A;Orthorhombic trypsin cryocooled to 100 K with 30% xylose as cryoprotectant;2;CA;CALCIUM ION;Cationic trypsin;9913;
6B6Q;A;Orthorhombic trypsin cryocooled to 100 K with 50% xylose as cryoprotectant;2;CA;CALCIUM ION;Cationic trypsin;9913;
6B6R;A;Orthorhombic trypsin cryocooled to 100 K with 50% mpd as cryoprotectant;2;CA;CALCIUM ION;Cationic trypsin;9913;
6B6S;A;Orthorhombic trypsin cryocooled to 100 K with 50% ethanol as cryoprotectant;2;CA;CALCIUM ION;Cationic trypsin;9913;
6B6T;A;Orthorhombic trypsin cryocooled to 100 K with 50% methanol as cryoprotectant;2;CA;CALCIUM ION;Cationic trypsin;9913;
6B7H;A;Structure of mGluR3 with an agonist;2.82;CA;CALCIUM ION;Metabotropic glutamate receptor 3;9606;
6B7K;A;GH43 Endo-Arabinanase from Bacillus licheniformis;2.55;CA;CALCIUM ION;Endo-alpha-(1->5)-L-arabinanase;1402;
6B7K;B;GH43 Endo-Arabinanase from Bacillus licheniformis;2.55;CA;CALCIUM ION;Endo-alpha-(1->5)-L-arabinanase;1402;
6B7K;C;GH43 Endo-Arabinanase from Bacillus licheniformis;2.55;CA;CALCIUM ION;Endo-alpha-(1->5)-L-arabinanase;1402;
6B7K;D;GH43 Endo-Arabinanase from Bacillus licheniformis;2.55;CA;CALCIUM ION;Endo-alpha-(1->5)-L-arabinanase;1402;
6B8F;A;Contracted Human Heavy-Chain Ferritin Crystal-Hydrogel Hybrid;1.06;CA;CALCIUM ION;Ferritin heavy chain;9606;
6B8G;A;Twice-Contracted Human Heavy-Chain Ferritin Crystal-Hydrogel Hybrid;1.13;CA;CALCIUM ION;Ferritin heavy chain;9606;
6B8M;B;Crystal Structure of the Ca2+/CaM:Kv7.4 (KCNQ4) AB Domain Complex, 1 mM CaCl2 soak;2.3;CA;CALCIUM ION;Calmodulin-1;9606;
6B8M;D;Crystal Structure of the Ca2+/CaM:Kv7.4 (KCNQ4) AB Domain Complex, 1 mM CaCl2 soak;2.3;CA;CALCIUM ION;Calmodulin-1;9606;
6B8M;F;Crystal Structure of the Ca2+/CaM:Kv7.4 (KCNQ4) AB Domain Complex, 1 mM CaCl2 soak;2.3;CA;CALCIUM ION;Calmodulin-1;9606;
6B8M;H;Crystal Structure of the Ca2+/CaM:Kv7.4 (KCNQ4) AB Domain Complex, 1 mM CaCl2 soak;2.3;CA;CALCIUM ION;Calmodulin-1;9606;
6B8N;B;Crystal Structure of the Ca2+/CaM:Kv7.4 (KCNQ4) AB Domain Complex, 10 uM CaCl2 soak;2.2;CA;CALCIUM ION;Calmodulin-1;9606;
6B8N;D;Crystal Structure of the Ca2+/CaM:Kv7.4 (KCNQ4) AB Domain Complex, 10 uM CaCl2 soak;2.2;CA;CALCIUM ION;Calmodulin-1;9606;
6B8N;F;Crystal Structure of the Ca2+/CaM:Kv7.4 (KCNQ4) AB Domain Complex, 10 uM CaCl2 soak;2.2;CA;CALCIUM ION;Calmodulin-1;9606;
6B8N;H;Crystal Structure of the Ca2+/CaM:Kv7.4 (KCNQ4) AB Domain Complex, 10 uM CaCl2 soak;2.2;CA;CALCIUM ION;Calmodulin-1;9606;
6B8R;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS V23K/L36Q at cryogenic temperature;1.65;CA;CALCIUM ION;Thermonuclease;1280;
6BA0;A;Pyrimidine-specific Ribonucleoside Hydrolase from Gardnerella vaginalis;2.03;CA;CALCIUM ION;Cytidine/uridine-specific hydrolase;2702;
6BA0;B;Pyrimidine-specific Ribonucleoside Hydrolase from Gardnerella vaginalis;2.03;CA;CALCIUM ION;Cytidine/uridine-specific hydrolase;2702;
6BA0;C;Pyrimidine-specific Ribonucleoside Hydrolase from Gardnerella vaginalis;2.03;CA;CALCIUM ION;Cytidine/uridine-specific hydrolase;2702;
6BA0;D;Pyrimidine-specific Ribonucleoside Hydrolase from Gardnerella vaginalis;2.03;CA;CALCIUM ION;Cytidine/uridine-specific hydrolase;2702;
6BA1;A;Purine-Preferring Ribonucleoside Hydrolase from Gardnerella vaginalis;2.9;CA;CALCIUM ION;Inosine-uridine preferring nucleoside hydrolase;2702;
6BA1;B;Purine-Preferring Ribonucleoside Hydrolase from Gardnerella vaginalis;2.9;CA;CALCIUM ION;Inosine-uridine preferring nucleoside hydrolase;2702;
6BA1;C;Purine-Preferring Ribonucleoside Hydrolase from Gardnerella vaginalis;2.9;CA;CALCIUM ION;Inosine-uridine preferring nucleoside hydrolase;2702;
6BA1;D;Purine-Preferring Ribonucleoside Hydrolase from Gardnerella vaginalis;2.9;CA;CALCIUM ION;Inosine-uridine preferring nucleoside hydrolase;2702;
6BA1;E;Purine-Preferring Ribonucleoside Hydrolase from Gardnerella vaginalis;2.9;CA;CALCIUM ION;Inosine-uridine preferring nucleoside hydrolase;2702;
6BA1;F;Purine-Preferring Ribonucleoside Hydrolase from Gardnerella vaginalis;2.9;CA;CALCIUM ION;Inosine-uridine preferring nucleoside hydrolase;2702;
6BA1;G;Purine-Preferring Ribonucleoside Hydrolase from Gardnerella vaginalis;2.9;CA;CALCIUM ION;Inosine-uridine preferring nucleoside hydrolase;2702;
6BA1;H;Purine-Preferring Ribonucleoside Hydrolase from Gardnerella vaginalis;2.9;CA;CALCIUM ION;Inosine-uridine preferring nucleoside hydrolase;2702;
6BA1;I;Purine-Preferring Ribonucleoside Hydrolase from Gardnerella vaginalis;2.9;CA;CALCIUM ION;Inosine-uridine preferring nucleoside hydrolase;2702;
6BA1;J;Purine-Preferring Ribonucleoside Hydrolase from Gardnerella vaginalis;2.9;CA;CALCIUM ION;Inosine-uridine preferring nucleoside hydrolase;2702;
6BA1;K;Purine-Preferring Ribonucleoside Hydrolase from Gardnerella vaginalis;2.9;CA;CALCIUM ION;Inosine-uridine preferring nucleoside hydrolase;2702;
6BA1;L;Purine-Preferring Ribonucleoside Hydrolase from Gardnerella vaginalis;2.9;CA;CALCIUM ION;Inosine-uridine preferring nucleoside hydrolase;2702;
6BA1;M;Purine-Preferring Ribonucleoside Hydrolase from Gardnerella vaginalis;2.9;CA;CALCIUM ION;Inosine-uridine preferring nucleoside hydrolase;2702;
6BA1;N;Purine-Preferring Ribonucleoside Hydrolase from Gardnerella vaginalis;2.9;CA;CALCIUM ION;Inosine-uridine preferring nucleoside hydrolase;2702;
6BA1;O;Purine-Preferring Ribonucleoside Hydrolase from Gardnerella vaginalis;2.9;CA;CALCIUM ION;Inosine-uridine preferring nucleoside hydrolase;2702;
6BA1;P;Purine-Preferring Ribonucleoside Hydrolase from Gardnerella vaginalis;2.9;CA;CALCIUM ION;Inosine-uridine preferring nucleoside hydrolase;2702;
6BA1;Q;Purine-Preferring Ribonucleoside Hydrolase from Gardnerella vaginalis;2.9;CA;CALCIUM ION;Inosine-uridine preferring nucleoside hydrolase;2702;
6BA1;R;Purine-Preferring Ribonucleoside Hydrolase from Gardnerella vaginalis;2.9;CA;CALCIUM ION;Inosine-uridine preferring nucleoside hydrolase;2702;
6BBD;A;Structure of N-glycosylated porcine surfactant protein-D complexed with glycerol;1.9;CA;CALCIUM ION;Pulmonary surfactant-associated protein D;9823;
6BBE;A;Structure of N-glycosylated porcine surfactant protein-D;1.9;CA;CALCIUM ION;Pulmonary surfactant-associated protein D;9823;
6BBT;B;Structure of the major pilin protein (T-13) from Streptococcus pyogenes serotype GAS131465;1.9;CA;CALCIUM ION;Major pilin backbone protein T-antigen, T13;1314;
6BBW;A;Structure of the major pilin protein (T3.2) from Streptococcus pyogenes serotype GAS13637;1.8;CA;CALCIUM ION;Major pilin backbone protein T-antigen, T3.2.;1314;
6BBW;B;Structure of the major pilin protein (T3.2) from Streptococcus pyogenes serotype GAS13637;1.8;CA;CALCIUM ION;Major pilin backbone protein T-antigen, T3.2.;1314;
6BCE;A;Wild-type I-LtrI bound to cognate substrate (pre-cleavage complex);1.75;CA;CALCIUM ION;Ribosomal protein 3/homing endonuclease-like fusion protein;330483;
6BCF;A;I-LtrI G183A bound to cognate substrate (pre-cleavage complex);2.92;CA;CALCIUM ION;Ribosomal protein 3/homing endonuclease-like fusion protein;330483;
6BCF;B;I-LtrI G183A bound to cognate substrate (pre-cleavage complex);2.92;CA;CALCIUM ION;DNA (26-MER);330483;
6BCF;D;I-LtrI G183A bound to cognate substrate (pre-cleavage complex);2.92;CA;CALCIUM ION;Ribosomal protein 3/homing endonuclease-like fusion protein;330483;
6BCF;G;I-LtrI G183A bound to cognate substrate (pre-cleavage complex);2.92;CA;CALCIUM ION;Ribosomal protein 3/homing endonuclease-like fusion protein;330483;
6BCF;H;I-LtrI G183A bound to cognate substrate (pre-cleavage complex);2.92;CA;CALCIUM ION;DNA (26-MER);330483;
6BCF;J;I-LtrI G183A bound to cognate substrate (pre-cleavage complex);2.92;CA;CALCIUM ION;Ribosomal protein 3/homing endonuclease-like fusion protein;330483;
6BCF;L;I-LtrI G183A bound to cognate substrate (pre-cleavage complex);2.92;CA;CALCIUM ION;DNA (26-MER);330483;
6BCG;A;I-LtrI A28G bound to cognate substrate (pre-cleavage complex);2.9;CA;CALCIUM ION;Ribosomal protein 3/homing endonuclease-like fusion protein;330483;
6BCG;D;I-LtrI A28G bound to cognate substrate (pre-cleavage complex);2.9;CA;CALCIUM ION;Ribosomal protein 3/homing endonuclease-like fusion protein;330483;
6BCG;G;I-LtrI A28G bound to cognate substrate (pre-cleavage complex);2.9;CA;CALCIUM ION;Ribosomal protein 3/homing endonuclease-like fusion protein;330483;
6BCG;J;I-LtrI A28G bound to cognate substrate (pre-cleavage complex);2.9;CA;CALCIUM ION;Ribosomal protein 3/homing endonuclease-like fusion protein;330483;
6BCI;A;Wild-type I-LtrI bound to non-cognate C4 substrate (pre-cleavage complex);2.28;CA;CALCIUM ION;Ribosomal protein 3/homing endonuclease-like fusion protein;330483;
6BCN;A;I-LtrI E184D bound to cognate substrate (pre-cleavage complex);2.5;CA;CALCIUM ION;Ribosomal protein 3/homing endonuclease-like fusion protein;330483;
6BCN;B;I-LtrI E184D bound to cognate substrate (pre-cleavage complex);2.5;CA;CALCIUM ION;DNA (26-MER);330483;
6BCN;C;I-LtrI E184D bound to cognate substrate (pre-cleavage complex);2.5;CA;CALCIUM ION;Ribosomal protein 3/homing endonuclease-like fusion protein;330483;
6BCN;E;I-LtrI E184D bound to cognate substrate (pre-cleavage complex);2.5;CA;CALCIUM ION;DNA (26-MER);330483;
6BCN;G;I-LtrI E184D bound to cognate substrate (pre-cleavage complex);2.5;CA;CALCIUM ION;Ribosomal protein 3/homing endonuclease-like fusion protein;330483;
6BCN;J;I-LtrI E184D bound to cognate substrate (pre-cleavage complex);2.5;CA;CALCIUM ION;Ribosomal protein 3/homing endonuclease-like fusion protein;330483;
6BCT;A;I-LtrI E184D bound to non-cognate C4 substrate (pre-cleavage complex);2.73;CA;CALCIUM ION;Ribosomal protein 3/homing endonuclease-like fusion protein;330483;
6BD0;A;I-OnuI K227Y, D236A bound to cognate substrate (pre-cleavage complex);1.45;CA;CALCIUM ION;Ribosomal protein 3/homing endonuclease-like protein fusion;42373;
6BDT;A;Crystal Structure of Human Calpain-3 Protease Core Mutant-C129S;2.3;CA;CALCIUM ION;Calpain-3;9606;
6BDT;B;Crystal Structure of Human Calpain-3 Protease Core Mutant-C129S;2.3;CA;CALCIUM ION;Calpain-3;9606;
6BDT;C;Crystal Structure of Human Calpain-3 Protease Core Mutant-C129S;2.3;CA;CALCIUM ION;Calpain-3;9606;
6BDT;D;Crystal Structure of Human Calpain-3 Protease Core Mutant-C129S;2.3;CA;CALCIUM ION;Calpain-3;9606;
6BDZ;A;ADAM10 Extracellular Domain Bound by the 11G2 Fab;3.1;CA;CALCIUM ION;Disintegrin and metalloproteinase domain-containing protein 10;9606;
6BE6;A;ADAM10 Extracellular Domain;2.8;CA;CALCIUM ION;Disintegrin and metalloproteinase domain-containing protein 10;9606;
6BE6;B;ADAM10 Extracellular Domain;2.8;CA;CALCIUM ION;Disintegrin and metalloproteinase domain-containing protein 10;9606;
6BE6;C;ADAM10 Extracellular Domain;2.8;CA;CALCIUM ION;Disintegrin and metalloproteinase domain-containing protein 10;9606;
6BE6;D;ADAM10 Extracellular Domain;2.8;CA;CALCIUM ION;Disintegrin and metalloproteinase domain-containing protein 10;9606;
6BEA;A;Crystal structure of the autotransporter UpaB from E. coli strain CFT073;1.97;CA;CALCIUM ION;Autotransporter protein UpaB;562;
6BFP;A;Bovine trypsin bound to potent inhibitor;1.29;CA;CALCIUM ION;Cationic trypsin;9913;
6BGC;A;The crystal structure of the W145A variant of TpMglB-2 (Tp0684) with bound glucose;2.08;CA;CALCIUM ION;Glucose/galactose-binding lipoprotein;160;
6BGC;B;The crystal structure of the W145A variant of TpMglB-2 (Tp0684) with bound glucose;2.08;CA;CALCIUM ION;Glucose/galactose-binding lipoprotein;160;
6BGD;A;The crystal structure of the W145A variant of TpMglB-2 (Tp0684) with bound glucose;1.47;CA;CALCIUM ION;Glucose/galactose-binding lipoprotein;160;
6BGI;A;Cryo-EM structure of the TMEM16A calcium-activated chloride channel in nanodisc;3.8;CA;CALCIUM ION;Anoctamin-1;10090;
6BGI;B;Cryo-EM structure of the TMEM16A calcium-activated chloride channel in nanodisc;3.8;CA;CALCIUM ION;Anoctamin-1;10090;
6BGJ;A;Cryo-EM structure of the TMEM16A calcium-activated chloride channel in LMNG;3.8;CA;CALCIUM ION;Anoctamin-1;10090;
6BGJ;B;Cryo-EM structure of the TMEM16A calcium-activated chloride channel in LMNG;3.8;CA;CALCIUM ION;Anoctamin-1;10090;
6BGP;A;Crystal Structure of Human Calpain-3 Protease Core Mutant-C129A;2.75;CA;CALCIUM ION;Calpain-3;9606;
6BGP;B;Crystal Structure of Human Calpain-3 Protease Core Mutant-C129A;2.75;CA;CALCIUM ION;Calpain-3;9606;
6BGP;C;Crystal Structure of Human Calpain-3 Protease Core Mutant-C129A;2.75;CA;CALCIUM ION;Calpain-3;9606;
6BGP;D;Crystal Structure of Human Calpain-3 Protease Core Mutant-C129A;2.75;CA;CALCIUM ION;Calpain-3;9606;
6BIA;A;Crystal structure of Ps i-CgsB;2.8;CA;CALCIUM ION;Sulfatase;1872678;
6BIA;B;Crystal structure of Ps i-CgsB;2.8;CA;CALCIUM ION;Sulfatase;1872678;
6BIA;C;Crystal structure of Ps i-CgsB;2.8;CA;CALCIUM ION;Sulfatase;1872678;
6BJD;A;Crystal Structure of Human Calpain-3 Protease Core in Complex with E-64;2.8;CA;CALCIUM ION;Calpain-3;9606;
6BJD;B;Crystal Structure of Human Calpain-3 Protease Core in Complex with E-64;2.8;CA;CALCIUM ION;Calpain-3;9606;
6BJD;C;Crystal Structure of Human Calpain-3 Protease Core in Complex with E-64;2.8;CA;CALCIUM ION;Calpain-3;9606;
6BJD;D;Crystal Structure of Human Calpain-3 Protease Core in Complex with E-64;2.8;CA;CALCIUM ION;Calpain-3;9606;
6BK5;A;Inactive choanoflagellate E3 ubiquitin ligase Cbl TKB;2.4;CA;CALCIUM ION;Ubiquitin Ligase Cbl;946362;
6BKJ;A;Crystal Structure of Human Calpain-3 Protease Core in Complex with Leupeptin;3.2;CA;CALCIUM ION;Calpain-3;9606;
6BKJ;B;Crystal Structure of Human Calpain-3 Protease Core in Complex with Leupeptin;3.2;CA;CALCIUM ION;Calpain-3;9606;
6BKJ;C;Crystal Structure of Human Calpain-3 Protease Core in Complex with Leupeptin;3.2;CA;CALCIUM ION;Calpain-3;9606;
6BKJ;D;Crystal Structure of Human Calpain-3 Protease Core in Complex with Leupeptin;3.2;CA;CALCIUM ION;Calpain-3;9606;
6BKX;B;Novel Modes of Inhibition of Wild-Type IDH1: Direct Covalent Modification of His315 with Cmpd1;1.65;CA;CALCIUM ION;Isocitrate dehydrogenase [NADP] cytoplasmic;9606;
6BKX;C;Novel Modes of Inhibition of Wild-Type IDH1: Direct Covalent Modification of His315 with Cmpd1;1.65;CA;CALCIUM ION;Isocitrate dehydrogenase [NADP] cytoplasmic;9606;
6BL1;B;Novel Modes of Inhibition of Wild-Type IDH1: Direct Covalent Modification of His315 with Cmpd13;2.02;CA;CALCIUM ION;Isocitrate dehydrogenase [NADP] cytoplasmic;9606;
6BL1;C;Novel Modes of Inhibition of Wild-Type IDH1: Direct Covalent Modification of His315 with Cmpd13;2.02;CA;CALCIUM ION;Isocitrate dehydrogenase [NADP] cytoplasmic;9606;
6BL2;A;Novel Modes of Inhibition of Wild-Type IDH1: Direct Covalent Modification of His315 with Cmpd15;1.92;CA;CALCIUM ION;Isocitrate dehydrogenase [NADP] cytoplasmic;9606;
6BL2;B;Novel Modes of Inhibition of Wild-Type IDH1: Direct Covalent Modification of His315 with Cmpd15;1.92;CA;CALCIUM ION;Isocitrate dehydrogenase [NADP] cytoplasmic;9606;
6BMT;A;Crystal Structure of a Recombinant form of Human Myeloperoxidase Bound to an Inhibitor from Staphylococcus delphini;2.4;CA;CALCIUM ION;Myeloperoxidase;9606;
6BN2;A;Crystal structure of Acetyl-CoA acetyltransferase from Elizabethkingia anophelis NUHP1;1.65;CA;CALCIUM ION;Acetyl-CoA acetyltransferase;1117645;
6BQV;A;Human TRPM4 ion channel in lipid nanodiscs in a calcium-bound state;3.1;CA;CALCIUM ION;Transient receptor potential cation channel subfamily M member 4;9606;
6BQV;B;Human TRPM4 ion channel in lipid nanodiscs in a calcium-bound state;3.1;CA;CALCIUM ION;Transient receptor potential cation channel subfamily M member 4;9606;
6BQV;C;Human TRPM4 ion channel in lipid nanodiscs in a calcium-bound state;3.1;CA;CALCIUM ION;Transient receptor potential cation channel subfamily M member 4;9606;
6BQV;D;Human TRPM4 ion channel in lipid nanodiscs in a calcium-bound state;3.1;CA;CALCIUM ION;Transient receptor potential cation channel subfamily M member 4;9606;
6BR1;A;Tubulin-RB3_SLD-TTL in complex with heterocyclic pyrimidine compound 4a;2.3;CA;CALCIUM ION;Tubulin alpha-1B chain;9823;
6BR1;C;Tubulin-RB3_SLD-TTL in complex with heterocyclic pyrimidine compound 4a;2.3;CA;CALCIUM ION;Tubulin alpha-1B chain;9823;
6BR5;A;N2 neuraminidase in complex with a novel antiviral compound;2.04;CA;CALCIUM ION;Neuraminidase;11320;
6BR6;A;N2 neuraminidase in complex with a novel antiviral compound;2.04;CA;CALCIUM ION;Neuraminidase;11320;
6BRF;A;Tubulin-RB3_SLD-TTL in complex with heterocyclic pyrimidine compound 4b;2.5;CA;CALCIUM ION;Tubulin alpha-1B chain;9823;
6BRF;C;Tubulin-RB3_SLD-TTL in complex with heterocyclic pyrimidine compound 4b;2.5;CA;CALCIUM ION;Tubulin alpha-1B chain;9823;
6BRY;A;Tubulin-RB3_SLD-TTL in complex with heterocyclic pyrimidine compound 6a;2.7;CA;CALCIUM ION;Tubulin alpha-1B chain;9823;
6BRY;C;Tubulin-RB3_SLD-TTL in complex with heterocyclic pyrimidine compound 6a;2.7;CA;CALCIUM ION;Tubulin alpha-1B chain;9823;
6BS2;A;Tubulin-RB3_SLD-TTL in complex with heterocyclic pyrimidine compound 8b;2.65;CA;CALCIUM ION;Tubulin alpha-1B chain;9823;
6BS2;C;Tubulin-RB3_SLD-TTL in complex with heterocyclic pyrimidine compound 8b;2.65;CA;CALCIUM ION;Tubulin alpha-1B chain;9823;
6BS3;B;Crystal structure of ADP-bound bacterial Get3-like A and B in Mycobacterium tuberculosis;2.3;CA;CALCIUM ION;Anion transporter;1773;
6BS6;A;SusG with mixed linkage amylosaccharide;2.17;CA;CALCIUM ION;Alpha-amylase SusG;818;
6BS6;B;SusG with mixed linkage amylosaccharide;2.17;CA;CALCIUM ION;Alpha-amylase SusG;818;
6BSG;A;Structure of HIV-1 RT complexed with RNA/DNA hybrid in an RNA hydrolysis-off mode;2.44;CA;CALCIUM ION;REVERSE TRANSCRIPTASE P66 SUBUNIT;11676;
6BSH;A;Structure of HIV-1 RT complexed with RNA/DNA hybrid in the RNA hydrolysis mode;2.65;CA;CALCIUM ION;REVERSE TRANSCRIPTASE P66 SUBUNIT;11676;
6BSI;A;Structure of HIV-1 RT complexed with an RNA/DNA hybrid containing the polypurine-tract sequence;3.25;CA;CALCIUM ION;REVERSE TRANSCRIPTASE P66 SUBUNIT;11676;
6BSI;D;Structure of HIV-1 RT complexed with an RNA/DNA hybrid containing the polypurine-tract sequence;3.25;CA;CALCIUM ION;DNA (5'-D(*GP*TP*TP*TP*TP*TP*CP*TP*TP*TP*TP*GP*TP*TP*AP*TP*TP*GP*TP*GP*GP*CP*C)-3');9606;
6BSJ;A;Structure of HIV-1 RT complexed with an RNA/DNA hybrid sequence non-preferred for RNA hydrolysis;2.89;CA;CALCIUM ION;REVERSE TRANSCRIPTASE P66 SUBUNIT;11676;
6BST;B;CRYSTAL STRUCTURE OF Z-DNA WITH UNTYPICALLY COORDINATED CA2+ ION;1.45;CA;CALCIUM ION;DNA (5'-D(*CP*GP*CP*GP*CP*G)-3');32630;
6BT9;A;Chitinase ChiA74 from Bacillus thuringiensis;2.26;CA;CALCIUM ION;Chitinase;1428;
6BT9;B;Chitinase ChiA74 from Bacillus thuringiensis;2.26;CA;CALCIUM ION;Chitinase;1428;
6BTX;A;Structure of a bacterial metal transporter;3.2;CA;CALCIUM ION;Solute carrier family 39 (Iron-regulated transporter);959;
6BUM;A;Crystal structures of cyanuric acid hydrolase from Moorella thermoacetica;1.51;CA;CALCIUM ION;Cyanuric acid amidohydrolase;1525;
6BUM;B;Crystal structures of cyanuric acid hydrolase from Moorella thermoacetica;1.51;CA;CALCIUM ION;Cyanuric acid amidohydrolase;1525;
6BUM;C;Crystal structures of cyanuric acid hydrolase from Moorella thermoacetica;1.51;CA;CALCIUM ION;Cyanuric acid amidohydrolase;1525;
6BUM;D;Crystal structures of cyanuric acid hydrolase from Moorella thermoacetica;1.51;CA;CALCIUM ION;Cyanuric acid amidohydrolase;1525;
6BUN;A;Crystal structures of cyanuric acid hydrolase from Moorella thermoacetica;1.78;CA;CALCIUM ION;Cyanuric acid amidohydrolase;1525;
6BUN;B;Crystal structures of cyanuric acid hydrolase from Moorella thermoacetica;1.78;CA;CALCIUM ION;Cyanuric acid amidohydrolase;1525;
6BUN;C;Crystal structures of cyanuric acid hydrolase from Moorella thermoacetica;1.78;CA;CALCIUM ION;Cyanuric acid amidohydrolase;1525;
6BUN;D;Crystal structures of cyanuric acid hydrolase from Moorella thermoacetica;1.78;CA;CALCIUM ION;Cyanuric acid amidohydrolase;1525;
6BUO;A;Crystal structures of cyanuric acid hydrolase from Moorella thermoacetica;1.85;CA;CALCIUM ION;Cyanuric acid amidohydrolase;1525;
6BUO;B;Crystal structures of cyanuric acid hydrolase from Moorella thermoacetica;1.85;CA;CALCIUM ION;Cyanuric acid amidohydrolase;1525;
6BUO;C;Crystal structures of cyanuric acid hydrolase from Moorella thermoacetica;1.85;CA;CALCIUM ION;Cyanuric acid amidohydrolase;1525;
6BUO;D;Crystal structures of cyanuric acid hydrolase from Moorella thermoacetica;1.85;CA;CALCIUM ION;Cyanuric acid amidohydrolase;1525;
6BUP;A;Crystal structures of cyanuric acid hydrolase from Moorella thermoacetica complexed with cyanuric acid;1.88;CA;CALCIUM ION;Cyanuric acid amidohydrolase;1525;
6BUP;B;Crystal structures of cyanuric acid hydrolase from Moorella thermoacetica complexed with cyanuric acid;1.88;CA;CALCIUM ION;Cyanuric acid amidohydrolase;1525;
6BUP;C;Crystal structures of cyanuric acid hydrolase from Moorella thermoacetica complexed with cyanuric acid;1.88;CA;CALCIUM ION;Cyanuric acid amidohydrolase;1525;
6BUP;D;Crystal structures of cyanuric acid hydrolase from Moorella thermoacetica complexed with cyanuric acid;1.88;CA;CALCIUM ION;Cyanuric acid amidohydrolase;1525;
6BUQ;A;Crystal structures of cyanuric acid hydrolase from Moorella thermoacetica complexed with barbituric acid;1.88;CA;CALCIUM ION;Cyanuric acid amidohydrolase;1525;
6BUQ;B;Crystal structures of cyanuric acid hydrolase from Moorella thermoacetica complexed with barbituric acid;1.88;CA;CALCIUM ION;Cyanuric acid amidohydrolase;1525;
6BUQ;C;Crystal structures of cyanuric acid hydrolase from Moorella thermoacetica complexed with barbituric acid;1.88;CA;CALCIUM ION;Cyanuric acid amidohydrolase;1525;
6BUQ;D;Crystal structures of cyanuric acid hydrolase from Moorella thermoacetica complexed with barbituric acid;1.88;CA;CALCIUM ION;Cyanuric acid amidohydrolase;1525;
6BUR;A;Crystal structures of cyanuric acid hydrolase from Moorella thermoacetica complexed with barbituric acid;2.18;CA;CALCIUM ION;Cyanuric acid amidohydrolase;1525;
6BUR;B;Crystal structures of cyanuric acid hydrolase from Moorella thermoacetica complexed with barbituric acid;2.18;CA;CALCIUM ION;Cyanuric acid amidohydrolase;1525;
6BUR;C;Crystal structures of cyanuric acid hydrolase from Moorella thermoacetica complexed with barbituric acid;2.18;CA;CALCIUM ION;Cyanuric acid amidohydrolase;1525;
6BUR;D;Crystal structures of cyanuric acid hydrolase from Moorella thermoacetica complexed with barbituric acid;2.18;CA;CALCIUM ION;Cyanuric acid amidohydrolase;1525;
6BVD;A;Structure of Botulinum Neurotoxin Serotype HA Light Chain;2.09;CA;CALCIUM ION;Light Chain;1491;
6BVH;A;Trypsin complexed with a modified sunflower trypsin inhibitor, SFTI-TCTR(N12,N14);1.93;CA;CALCIUM ION;Cationic trypsin;9913;
6BWJ;B;Crystal structure of the TRPV2 ion channel in complex with RTx;3.1;CA;CALCIUM ION;Transient receptor potential cation channel subfamily V member 2;9986;
6BWM;B;Crystal structure of the TRPV2 ion channel;3.9;CA;CALCIUM ION;Transient receptor potential cation channel subfamily V member 2;9986;
6BWN;A;Crystal Structure of Mouse Protocadherin-15 EC6-7;2.94;CA;CALCIUM ION;Protocadherin-15;10090;
6BX7;A;Crystal Structure of Human Protocadherin-1 EC1-4;2.85;CA;CALCIUM ION;Protocadherin-1;9606;
6BXB;A;Crystal structure of an extended b3 integrin P33;2.39;CA;CALCIUM ION;Chimera protein of Integrin beta-3 and Integrin alpha-L;9606;
6BXF;A;Crystal structure of an extended b3 integrin L33;3.2;CA;CALCIUM ION;Chimera protein of Integrin beta-3 and Integrin alpha-L;9606;
6BXU;A;Crystal Structure of Mouse Protocadherin-15 EC5-7 I582T;3.79;CA;CALCIUM ION;Protocadherin-15;10090;
6BXU;B;Crystal Structure of Mouse Protocadherin-15 EC5-7 I582T;3.79;CA;CALCIUM ION;Protocadherin-15;10090;
6BXZ;A;Crystal Structure of Pig Protocadherin-15 EC10-MAD12;2.09;CA;CALCIUM ION;Protocadherin related 15;9823;
6BXZ;C;Crystal Structure of Pig Protocadherin-15 EC10-MAD12;2.09;CA;CALCIUM ION;Protocadherin related 15;9823;
6BYP;A;Structure of PL24 family Polysaccharide lyase-LOR107;1.9;CA;CALCIUM ION;Short ulvan lyase;1537994;
6BYP;B;Structure of PL24 family Polysaccharide lyase-LOR107;1.9;CA;CALCIUM ION;Short ulvan lyase;1537994;
6BYT;A;Complex structure of LOR107 mutant (R320) with tetrasaccharide substrate;2.2;CA;CALCIUM ION;Short ulvan lyase;1537994;
6BYT;B;Complex structure of LOR107 mutant (R320) with tetrasaccharide substrate;2.2;CA;CALCIUM ION;Short ulvan lyase;1537994;
6BYV;A;Solution NMR structure of cysteine-rich calcium bound domains of very low density lipoprotein receptor;;CA;CALCIUM ION;Very low-density lipoprotein receptor;9606;
6BYX;A;Complex structure of LOR107 mutant (R259N) with tetrasaccharide substrate;2.21;CA;CALCIUM ION;Short ulvan lyase;1537994;
6BYX;B;Complex structure of LOR107 mutant (R259N) with tetrasaccharide substrate;2.21;CA;CALCIUM ION;Short ulvan lyase;1537994;
6BZ3;A;Complex structure of FAK FAT domain and DCC P3 motif;2.5;CA;CALCIUM ION;Focal adhesion kinase 1;10090;
6BZI;A;Crystal structure of halogenase PltM in complex with ethyl mercury and mercury;2.4;CA;CALCIUM ION;Halogenase PltM;380021;
6BZI;B;Crystal structure of halogenase PltM in complex with ethyl mercury and mercury;2.4;CA;CALCIUM ION;Halogenase PltM;380021;
6BZI;C;Crystal structure of halogenase PltM in complex with ethyl mercury and mercury;2.4;CA;CALCIUM ION;Halogenase PltM;380021;
6BZI;D;Crystal structure of halogenase PltM in complex with ethyl mercury and mercury;2.4;CA;CALCIUM ION;Halogenase PltM;380021;
6BZN;A;Crystal structure of halogenase PltM;1.8;CA;CALCIUM ION;Halogenase PltM;380021;
6BZN;B;Crystal structure of halogenase PltM;1.8;CA;CALCIUM ION;Halogenase PltM;380021;
6BZN;C;Crystal structure of halogenase PltM;1.8;CA;CALCIUM ION;Halogenase PltM;380021;
6BZN;D;Crystal structure of halogenase PltM;1.8;CA;CALCIUM ION;Halogenase PltM;380021;
6BZT;A;Crystal structure of halogenase PltM L111Y mutant in complex with FAD;2.1;CA;CALCIUM ION;Halogenase PltM;380021;
6BZT;B;Crystal structure of halogenase PltM L111Y mutant in complex with FAD;2.1;CA;CALCIUM ION;Halogenase PltM;380021;
6BZZ;A;Crystal structure of halogenase PltM in complex with partially bound FAD;2.05;CA;CALCIUM ION;Halogenase PltM;380021;
6BZZ;B;Crystal structure of halogenase PltM in complex with partially bound FAD;2.05;CA;CALCIUM ION;Halogenase PltM;380021;
6BZZ;C;Crystal structure of halogenase PltM in complex with partially bound FAD;2.05;CA;CALCIUM ION;Halogenase PltM;380021;
6BZZ;D;Crystal structure of halogenase PltM in complex with partially bound FAD;2.05;CA;CALCIUM ION;Halogenase PltM;380021;
6C01;A;Human ectonucleotide pyrophosphatase / phosphodiesterase 3 (ENPP3, NPP3, CD203c);2.3;CA;CALCIUM ION;Ectonucleotide pyrophosphatase/phosphodiesterase family member 3;9606;
6C01;B;Human ectonucleotide pyrophosphatase / phosphodiesterase 3 (ENPP3, NPP3, CD203c);2.3;CA;CALCIUM ION;Ectonucleotide pyrophosphatase/phosphodiesterase family member 3;9606;
6C02;A;Human ectonucleotide pyrophosphatase / phosphodiesterase 3 (ENPP3, NPP3, CD203c), inactive (T205A), N594S, with alpha,beta-methylene-ATP (AMPCPP);1.94;CA;CALCIUM ION;Ectonucleotide pyrophosphatase/phosphodiesterase family member 3;9606;
6C02;B;Human ectonucleotide pyrophosphatase / phosphodiesterase 3 (ENPP3, NPP3, CD203c), inactive (T205A), N594S, with alpha,beta-methylene-ATP (AMPCPP);1.94;CA;CALCIUM ION;Ectonucleotide pyrophosphatase/phosphodiesterase family member 3;9606;
6C0M;A;The synthesis, biological evaluation and structural insights of unsaturated 3-N-substituted sialic acids as probes of human parainfluenza virus-3 haemagglutinin-neuraminidase;1.83;CA;CALCIUM ION;Hemagglutinin-neuraminidase;11216;
6C0M;B;The synthesis, biological evaluation and structural insights of unsaturated 3-N-substituted sialic acids as probes of human parainfluenza virus-3 haemagglutinin-neuraminidase;1.83;CA;CALCIUM ION;Hemagglutinin-neuraminidase;11216;
6C2H;A;Crystal Structures of Cystathionine beta-Synthase from Saccharomyces cerevisiae: the Structure of the Catalytic Core;1.49;CA;CALCIUM ION;Cystathionine beta-synthase;4932;
6C2Q;A;Crystal Structures of Cystathionine beta-Synthase from Saccharomyces cerevisiae: the Structure of the PLP-L-Serine Intermediate;2.17;CA;CALCIUM ION;Cystathionine beta-synthase;4932;
6C2Z;A;Crystal Structures of Cystathionine beta-Synthase from Saccharomyces cerevisiae: the Structure of the PLP-Aminoacrylate Intermediate;1.37;CA;CALCIUM ION;Cystathionine beta-synthase;4932;
6C46;A;Crystal structure of dTDP-4-dehydrorhamnose 3,5-epimerase from Elizabethkingia anophelis NUHP1;1.95;CA;CALCIUM ION;dTDP-4-dehydrorhamnose 3,5-epimerase;1117645;
6C46;D;Crystal structure of dTDP-4-dehydrorhamnose 3,5-epimerase from Elizabethkingia anophelis NUHP1;1.95;CA;CALCIUM ION;dTDP-4-dehydrorhamnose 3,5-epimerase;1117645;
6C4P;A;Crystal Structures of Cystathionine beta-Synthase from Saccharomyces cerevisiae: the Structure of the PMP Complex;2.3;CA;CALCIUM ION;Cystathionine beta-synthase;4932;
6C5W;A;Crystal structure of the mitochondrial calcium uniporter;3.1;CA;CALCIUM ION;calcium uniporter;92637;
6C6G;A;An unexpected vestigial protein complex reveals the evolutionary origins of an s-triazine catabolic enzyme. Inhibitor bound complex.;2.1;CA;CALCIUM ION;Biuret hydrolase;47660;
6C6G;B;An unexpected vestigial protein complex reveals the evolutionary origins of an s-triazine catabolic enzyme. Inhibitor bound complex.;2.1;CA;CALCIUM ION;Biuret hydrolase;47660;
6C74;A;Crystal Structure of Murine CD300lf in complex with phosphocholine;1.36;CA;CALCIUM ION;CMRF35-like molecule-1;10090;
6CAC;A;Crystal structure of NDM-1 metallo-beta-lactamase harboring an insertion of a Pro residue in L3 loop;1.79;CA;CALCIUM ION;Metallo-beta-lactamase type 2;573;
6CAC;B;Crystal structure of NDM-1 metallo-beta-lactamase harboring an insertion of a Pro residue in L3 loop;1.79;CA;CALCIUM ION;Metallo-beta-lactamase type 2;573;
6CAC;C;Crystal structure of NDM-1 metallo-beta-lactamase harboring an insertion of a Pro residue in L3 loop;1.79;CA;CALCIUM ION;Metallo-beta-lactamase type 2;573;
6CAC;D;Crystal structure of NDM-1 metallo-beta-lactamase harboring an insertion of a Pro residue in L3 loop;1.79;CA;CALCIUM ION;Metallo-beta-lactamase type 2;573;
6CAM;A;Glucan Binding Protein C of Streptococcus mutans Mediates both Sucrose-Independent and Sucrose-Dependent Adherence;1.75;CA;CALCIUM ION;Glucan-binding protein C;1309;
6CC7;A;Structure of Fungal GH62 from Thielavia terretris;1.87;CA;CALCIUM ION;Glycoside hydrolase family 62 protein;35720;
6CCI;A;The Crystal Structure of XOAT1;1.85;CA;CALCIUM ION;Protein ESKIMO 1;3702;
6CDF;A;Human CtBP1 (28-378);2.6;CA;CALCIUM ION;C-terminal-binding protein 1;9606;
6CG0;A;Cryo-EM structure of mouse RAG1/2 HFC complex (3.17 A);3.17;CA;CALCIUM ION;V(D)J recombination-activating protein 1;10090;
6CG0;C;Cryo-EM structure of mouse RAG1/2 HFC complex (3.17 A);3.17;CA;CALCIUM ION;V(D)J recombination-activating protein 1;10090;
6CG6;A;mouse cadherin-10 EC1-2 adhesive fragment;2.71;CA;CALCIUM ION;Cadherin-10;10090;
6CG7;A;mouse cadherin-22 EC1-2 adhesive fragment;2.7;CA;CALCIUM ION;Cadherin-22;10090;
6CG7;B;mouse cadherin-22 EC1-2 adhesive fragment;2.7;CA;CALCIUM ION;Cadherin-22;10090;
6CGB;A;chimera of mouse cadherin-11 EC1 and mouse cadherin-6 EC2;2.99;CA;CALCIUM ION;Cadherin-11, Cadherin-6 chimera;10090;
6CGS;A;mouse cadherin-7 EC1-2 adhesive fragment;1.72;CA;CALCIUM ION;Cadherin-7;10090;
6CGS;B;mouse cadherin-7 EC1-2 adhesive fragment;1.72;CA;CALCIUM ION;Cadherin-7;10090;
6CGT;A;HOXA COMPLEX OF CYCLODEXTRIN GLYCOSYLTRANSFERASE MUTANT;2.6;CA;CALCIUM ION;CYCLODEXTRIN GLYCOSYLTRANSFERASE;1397;
6CGU;A;mouse cadherin-6 EC1-2 adhesive fragment;1.9;CA;CALCIUM ION;Cadherin-6;10090;
6CGU;B;mouse cadherin-6 EC1-2 adhesive fragment;1.9;CA;CALCIUM ION;Cadherin-6;10090;
6CGU;C;mouse cadherin-6 EC1-2 adhesive fragment;1.9;CA;CALCIUM ION;Cadherin-6;10090;
6CGU;D;mouse cadherin-6 EC1-2 adhesive fragment;1.9;CA;CALCIUM ION;Cadherin-6;10090;
6CI0;A;Catalytic core subunits (I and II) of cytochrome C oxidase from Rhodobacter sphaeroides with E101A (II) mutation;2.4;CA;CALCIUM ION;Cytochrome c oxidase subunit 1;1063;
6CI0;C;Catalytic core subunits (I and II) of cytochrome C oxidase from Rhodobacter sphaeroides with E101A (II) mutation;2.4;CA;CALCIUM ION;Cytochrome c oxidase subunit 1;1063;
6CIJ;A;Cryo-EM structure of mouse RAG1/2 HFC complex containing partial HMGB1 linker(3.9 A);3.9;CA;CALCIUM ION;V(D)J recombination-activating protein 1;10090;
6CIJ;C;Cryo-EM structure of mouse RAG1/2 HFC complex containing partial HMGB1 linker(3.9 A);3.9;CA;CALCIUM ION;V(D)J recombination-activating protein 1;10090;
6CJ9;A;Crystal structure of lectin from Dioclea lasiophylla seeds (DlyL) complexed with X-Man;1.7;CA;CALCIUM ION;Lectin;1457464;
6CKB;B;Crystal structure of an extended beta3 integrin P33;2.8;CA;CALCIUM ION;Chimera protein of Integrin beta-3 and Integrin alpha-L;9606;
6CKJ;A;N. meningitidis CMP-sialic acid synthetase, ligand-free;1.75;CA;CALCIUM ION;N-acylneuraminate cytidylyltransferase;487;
6CKK;A;N. meningitidis CMP-sialic acid synthetase in the presence of CTP and Ca2+;1.8;CA;CALCIUM ION;N-acylneuraminate cytidylyltransferase;487;
6CKK;B;N. meningitidis CMP-sialic acid synthetase in the presence of CTP and Ca2+;1.8;CA;CALCIUM ION;N-acylneuraminate cytidylyltransferase;487;
6CKM;A;N. meningitidis CMP-sialic acid synthetase in the presence of CMP-sialic acid and Ca2+;1.54;CA;CALCIUM ION;N-acylneuraminate cytidylyltransferase;487;
6CL6;A;Structure of P. aeruginosa R2 pyocin fiber PA0620 comprising C-terminal residues 323-691;1.9;CA;CALCIUM ION;Tail fiber protein;287;
6CL6;B;Structure of P. aeruginosa R2 pyocin fiber PA0620 comprising C-terminal residues 323-691;1.9;CA;CALCIUM ION;Tail fiber protein;287;
6CL6;D;Structure of P. aeruginosa R2 pyocin fiber PA0620 comprising C-terminal residues 323-691;1.9;CA;CALCIUM ION;Tail fiber protein;287;
6CL6;E;Structure of P. aeruginosa R2 pyocin fiber PA0620 comprising C-terminal residues 323-691;1.9;CA;CALCIUM ION;Tail fiber protein;287;
6CMW;A;Crystal structure of zebrafish Phosphatidylinositol-4-phosphate 5- kinase alpha isoform with bound ATP/Ca2+;3.15;CA;CALCIUM ION;Phosphatidylinositol-4-phosphate 5-kinase, type I, alpha;7955;
6CN2;A;Crystal structure of zebrafish Phosphatidylinositol-4-phosphate 5- kinase alpha isoform D236N with bound ATP/Ca2+;3.1;CA;CALCIUM ION;Phosphatidylinositol-4-phosphate 5-kinase, type I, alpha;7955;
6CNN;E;Cryo-EM structure of the human SK4/calmodulin channel complex in the Ca2+ bound state I;3.5;CA;CALCIUM ION;Calmodulin-1;9606;
6CNN;F;Cryo-EM structure of the human SK4/calmodulin channel complex in the Ca2+ bound state I;3.5;CA;CALCIUM ION;Calmodulin-1;9606;
6CNN;G;Cryo-EM structure of the human SK4/calmodulin channel complex in the Ca2+ bound state I;3.5;CA;CALCIUM ION;Calmodulin-1;9606;
6CNN;H;Cryo-EM structure of the human SK4/calmodulin channel complex in the Ca2+ bound state I;3.5;CA;CALCIUM ION;Calmodulin-1;9606;
6CNO;E;Cryo-EM structure of the human SK4/calmodulin channel complex in the Ca2+ bound state II;4.7;CA;CALCIUM ION;Calmodulin-1;9606;
6CNO;F;Cryo-EM structure of the human SK4/calmodulin channel complex in the Ca2+ bound state II;4.7;CA;CALCIUM ION;Calmodulin-1;9606;
6CNO;G;Cryo-EM structure of the human SK4/calmodulin channel complex in the Ca2+ bound state II;4.7;CA;CALCIUM ION;Calmodulin-1;9606;
6CNO;H;Cryo-EM structure of the human SK4/calmodulin channel complex in the Ca2+ bound state II;4.7;CA;CALCIUM ION;Calmodulin-1;9606;
6CNP;A;Crystal structure of MBD2 complex with methylated CpG island;2.1;CA;CALCIUM ION;Methyl-CpG-binding domain protein 2;9606;
6CO7;A;Structure of the nvTRPM2 channel in complex with Ca2+;3.07;CA;CALCIUM ION;Predicted protein;45351;
6CO7;B;Structure of the nvTRPM2 channel in complex with Ca2+;3.07;CA;CALCIUM ION;Predicted protein;45351;
6CO7;C;Structure of the nvTRPM2 channel in complex with Ca2+;3.07;CA;CALCIUM ION;Predicted protein;45351;
6CO7;D;Structure of the nvTRPM2 channel in complex with Ca2+;3.07;CA;CALCIUM ION;Predicted protein;45351;
6COM;A;Mutagenic studies of E.coli PCK with Asp269Asn mutation was purified crystallized and the structure was solved to 2.3A;2.3;CA;CALCIUM ION;Phosphoenolpyruvate carboxykinase (ATP);562;
6CPM;C;Structure of the USP15 deubiquitinase domain in complex with a third-generation inhibitory Ubv;2.01;CA;CALCIUM ION;Ubiquitin carboxyl-terminal hydrolase 15;9606;
6CPM;D;Structure of the USP15 deubiquitinase domain in complex with a third-generation inhibitory Ubv;2.01;CA;CALCIUM ION;Ubiquitin carboxyl-terminal hydrolase 15;9606;
6CPM;E;Structure of the USP15 deubiquitinase domain in complex with a third-generation inhibitory Ubv;2.01;CA;CALCIUM ION;Ubiquitin variant 15.1d;9606;
6CR0;A;1.55 A resolution structure of (S)-6-hydroxynicotine oxidase from Shinella HZN7;1.55;CA;CALCIUM ION;(S)-6-hydroxynicotine oxidase;879274;
6CU4;A;Crystal structure of E. coli phosphoenolpyruvate carboxykinase mutant Lys254Ser;1.8;CA;CALCIUM ION;Phosphoenolpyruvate carboxykinase (ATP);562;
6CV7;A;Mouse Protocadherin-15 Extracellular Cadherin Domains 1 through 3;1.69;CA;CALCIUM ION;Protocadherin-15;10090;
6CWJ;A;Crystal structures of cyanuric acid hydrolase from Moorella thermoacetica complexed with 1,3-Acetone Dicarboxylic Acid;2.25;CA;CALCIUM ION;Cyanuric acid amidohydrolase;1525;
6CWJ;B;Crystal structures of cyanuric acid hydrolase from Moorella thermoacetica complexed with 1,3-Acetone Dicarboxylic Acid;2.25;CA;CALCIUM ION;Cyanuric acid amidohydrolase;1525;
6CWJ;C;Crystal structures of cyanuric acid hydrolase from Moorella thermoacetica complexed with 1,3-Acetone Dicarboxylic Acid;2.25;CA;CALCIUM ION;Cyanuric acid amidohydrolase;1525;
6CWJ;D;Crystal structures of cyanuric acid hydrolase from Moorella thermoacetica complexed with 1,3-Acetone Dicarboxylic Acid;2.25;CA;CALCIUM ION;Cyanuric acid amidohydrolase;1525;
6CX0;A;Structure of AtTPC1 D376A;3.5;CA;CALCIUM ION;Two pore calcium channel protein 1;3702;
6CXO;A;Complement component-9;2.2;CA;CALCIUM ION;Complement component C9;10090;
6CXO;B;Complement component-9;2.2;CA;CALCIUM ION;Complement component C9;10090;
6CXY;C;Crystal Structure of Human E-cadherin bound by mouse monoclonal antibody Fab mAb-1_19A11;2.2;CA;CALCIUM ION;Cadherin-1;9606;
6CZQ;R;A V-to-F substitution in SK2 channels causes Ca2+ hypersensitivity and improves locomotion in a C. elegans ALS model;2.2;CA;CALCIUM ION;Calmodulin-1;10116;
6D14;A;Zebrafish TRAP1 bound to AMPPNP and calcium in the asymmetric closed state;2.5;CA;CALCIUM ION;TNF receptor-associated protein 1;7955;
6D14;B;Zebrafish TRAP1 bound to AMPPNP and calcium in the asymmetric closed state;2.5;CA;CALCIUM ION;TNF receptor-associated protein 1;7955;
6D2C;A;Structure of Ulvan lyase from Nonlaben Ulvanivorans- NLR48;1.91;CA;CALCIUM ION;Ulvan lyase;906888;
6D2C;B;Structure of Ulvan lyase from Nonlaben Ulvanivorans- NLR48;1.91;CA;CALCIUM ION;Ulvan lyase;906888;
6D2S;A;Mycobacterium tuberculosis transcriptional regulator;1.82;CA;CALCIUM ION;HTH-type transcriptional regulator PrpR;1773;
6D3B;A;INFLUENZA VIRUS NEURAMINIDASE SUBTYPE N9 (TERN) APO FORM;1.4;CA;CALCIUM ION;Neuraminidase;11320;
6D3U;A;Complex structure of Ulvan lyase from Nonlaben Ulvanivorans- NLR48;2.21;CA;CALCIUM ION;Ulvan lyase;906888;
6D3U;B;Complex structure of Ulvan lyase from Nonlaben Ulvanivorans- NLR48;2.21;CA;CALCIUM ION;Ulvan lyase;906888;
6D3W;A;Chromosomal trehalose-6-phosphate phosphatase from P. aeruginosa;1.9;CA;CALCIUM ION;Trehalose phosphatase;1608908;
6D3W;B;Chromosomal trehalose-6-phosphate phosphatase from P. aeruginosa;1.9;CA;CALCIUM ION;Trehalose phosphatase;1608908;
6D4K;A;Crystal structure of L,D-transpeptidase 3 from Mycobacterium tuberculosis at 1.32 A resolution;1.32;CA;CALCIUM ION;Probable L,D-transpeptidase 3;1773;
6D50;A;Bacteroides uniforms beta-glucuronidase 2 bound to D-glucaro-1,5-lactone;2.5;CA;CALCIUM ION;Glycosyl hydrolases family 2, sugar binding domain protein;820;
6D50;B;Bacteroides uniforms beta-glucuronidase 2 bound to D-glucaro-1,5-lactone;2.5;CA;CALCIUM ION;Glycosyl hydrolases family 2, sugar binding domain protein;820;
6D51;A;Crystal structure of L,D-transpeptidase 3 from Mycobacterium tuberculosis in complex with a faropenem-derived adduct;1.83;CA;CALCIUM ION;Probable L,D-transpeptidase 3;1773;
6D5B;A;Structure of Caldicellulosiruptor danielii CBM3 module of glycoside hydrolase WP_045175321;2;CA;CALCIUM ION;glycoside hydrolase WP_045175321;1387557;
6D5B;B;Structure of Caldicellulosiruptor danielii CBM3 module of glycoside hydrolase WP_045175321;2;CA;CALCIUM ION;glycoside hydrolase WP_045175321;1387557;
6D5B;C;Structure of Caldicellulosiruptor danielii CBM3 module of glycoside hydrolase WP_045175321;2;CA;CALCIUM ION;glycoside hydrolase WP_045175321;1387557;
6D5B;D;Structure of Caldicellulosiruptor danielii CBM3 module of glycoside hydrolase WP_045175321;2;CA;CALCIUM ION;glycoside hydrolase WP_045175321;1387557;
6D5B;E;Structure of Caldicellulosiruptor danielii CBM3 module of glycoside hydrolase WP_045175321;2;CA;CALCIUM ION;glycoside hydrolase WP_045175321;1387557;
6D5B;F;Structure of Caldicellulosiruptor danielii CBM3 module of glycoside hydrolase WP_045175321;2;CA;CALCIUM ION;glycoside hydrolase WP_045175321;1387557;
6D5B;G;Structure of Caldicellulosiruptor danielii CBM3 module of glycoside hydrolase WP_045175321;2;CA;CALCIUM ION;glycoside hydrolase WP_045175321;1387557;
6D5B;H;Structure of Caldicellulosiruptor danielii CBM3 module of glycoside hydrolase WP_045175321;2;CA;CALCIUM ION;glycoside hydrolase WP_045175321;1387557;
6D5B;I;Structure of Caldicellulosiruptor danielii CBM3 module of glycoside hydrolase WP_045175321;2;CA;CALCIUM ION;glycoside hydrolase WP_045175321;1387557;
6D5B;J;Structure of Caldicellulosiruptor danielii CBM3 module of glycoside hydrolase WP_045175321;2;CA;CALCIUM ION;glycoside hydrolase WP_045175321;1387557;
6D5B;K;Structure of Caldicellulosiruptor danielii CBM3 module of glycoside hydrolase WP_045175321;2;CA;CALCIUM ION;glycoside hydrolase WP_045175321;1387557;
6D5B;L;Structure of Caldicellulosiruptor danielii CBM3 module of glycoside hydrolase WP_045175321;2;CA;CALCIUM ION;glycoside hydrolase WP_045175321;1387557;
6D5D;A;Structure of Caldicellulosiruptor danielii GH48 module of glycoside hydrolase WP_045175321;1.9;CA;CALCIUM ION;glycoside hydrolase WP_045175321;1387557;
6D5N;A;Hexagonal thermolysin (295) in the presence of 50% xylose;2;CA;CALCIUM ION;Thermolysin;1427;
6D5O;A;Hexagonal thermolysin (295 K) in the presence of 50% DMF;2;CA;CALCIUM ION;Thermolysin;1427;
6D5P;A;Hexagonal thermolysin cryocooled to 100 K with 20% xylose as cryoprotectant;3;CA;CALCIUM ION;Thermolysin;1427;
6D5Q;A;Hexagonal thermolysin cryocooled to 100 K with 30% xylose as cryoprotectant;2;CA;CALCIUM ION;Thermolysin;1427;
6D5R;A;Hexagonal thermolysin cryocooled to 100 K with 50% xylose as cryoprotectant;2;CA;CALCIUM ION;Thermolysin;1427;
6D5S;A;Hexagonal thermolysin cryocooled to 100 K with 50% MPD as cryoprotectant;2;CA;CALCIUM ION;Thermolysin;1427;
6D5T;A;Hexagonal thermolysin cryocooled to 100 K with 50% MPD as cryoprotectant;2;CA;CALCIUM ION;Thermolysin;1427;
6D5U;A;Hexagonal thermolysin cryocooled to 100 K with 50% methanol as cryoprotectant;2;CA;CALCIUM ION;Thermolysin;1427;
6D72;A;Crystal structure of spermidine/spermine N-acetyltransferase SpeG from Yersinia pestis in complex with calcium ions.;2.17;CA;CALCIUM ION;Spermidine N1-acetyltransferase;632;
6D72;C;Crystal structure of spermidine/spermine N-acetyltransferase SpeG from Yersinia pestis in complex with calcium ions.;2.17;CA;CALCIUM ION;Spermidine N1-acetyltransferase;632;
6D73;A;Cryo-EM structure of the zebrafish TRPM2 channel in the presence of Ca2+M2;3.8;CA;CALCIUM ION;Transient receptor potential cation channel, subfamily M;7955;
6D73;B;Cryo-EM structure of the zebrafish TRPM2 channel in the presence of Ca2+M2;3.8;CA;CALCIUM ION;Transient receptor potential cation channel, subfamily M;7955;
6D73;C;Cryo-EM structure of the zebrafish TRPM2 channel in the presence of Ca2+M2;3.8;CA;CALCIUM ION;Transient receptor potential cation channel, subfamily M;7955;
6D73;D;Cryo-EM structure of the zebrafish TRPM2 channel in the presence of Ca2+M2;3.8;CA;CALCIUM ION;Transient receptor potential cation channel, subfamily M;7955;
6D7O;A;Crystal Structure of Rat TRPV6* in complex with 2-Aminoethoxydiphenyl borate (2-APB);3.45;CA;CALCIUM ION;Transient receptor potential cation channel subfamily V member 6;10116;
6D7P;A;Crystal Structure of Rat TRPV6*-Y466A;3.37;CA;CALCIUM ION;Transient receptor potential cation channel subfamily V member 6;10116;
6D7Q;A;Crystal Structure of Rat TRPV6*-Y466A in complex with 2-Aminoethoxydiphenyl borate (2-APB);3.5;CA;CALCIUM ION;Transient receptor potential cation channel subfamily V member 6;10116;
6D7T;A;Cryo-EM structure of human TRPV6-Y467A in complex with 2-Aminoethoxydiphenyl borate (2-APB);4.44;CA;CALCIUM ION;Transient receptor potential cation channel subfamily V member 6;9606;
6D7V;A;Crystal Structure of Rat TRPV6*- in complex with brominated 2-Aminoethoxydiphenyl borate (2-APB-Br);4.3;CA;CALCIUM ION;Transient receptor potential cation channel subfamily V member 6;10116;
6D7W;A;Cryo-EM structure of the mitochondrial calcium uniporter from N. fischeri at 3.8 Angstrom resolution;3.8;CA;CALCIUM ION;Mitochondrial calcium uniporter;36630;
6D7X;A;Crystal Structure of Rat TRPV6*-Y466A- in complex with brominated 2-Aminoethoxydiphenyl borate (2-APB-Br);3.6;CA;CALCIUM ION;Transient receptor potential cation channel subfamily V member 6;10116;
6D80;A;Cryo-EM structure of the mitochondrial calcium uniporter from N. fischeri bound to saposin;5;CA;CALCIUM ION;Mitochondrial calcium uniporter;36630;
6D88;A;Tubulin-RB3_SLD-TTL in complex with compound 13f;2.85;CA;CALCIUM ION;Tubulin alpha-1B chain;9823;
6D88;C;Tubulin-RB3_SLD-TTL in complex with compound 13f;2.85;CA;CALCIUM ION;Tubulin alpha-1B chain;9823;
6D8I;A;Mycobacterium tuberculosis polyketide synthase 13 N-terminal acyl carrier protein domain;1.65;CA;CALCIUM ION;Polyketide synthase;1773;
6D8J;A;Mycobacterium tuberculosis polyketide synthase 13 N-terminal acyl carrier protein domain;1.63;CA;CALCIUM ION;Polyketide synthase;1773;
6D96;A;Structure of influenza neuraminidase from strain A/BrevigMission/1/1918(H1N1) expressed in HEK-293E cells;2.15;CA;CALCIUM ION;Neuraminidase;11320;
6D96;B;Structure of influenza neuraminidase from strain A/BrevigMission/1/1918(H1N1) expressed in HEK-293E cells;2.15;CA;CALCIUM ION;Neuraminidase;11320;
6D96;C;Structure of influenza neuraminidase from strain A/BrevigMission/1/1918(H1N1) expressed in HEK-293E cells;2.15;CA;CALCIUM ION;Neuraminidase;11320;
6D96;D;Structure of influenza neuraminidase from strain A/BrevigMission/1/1918(H1N1) expressed in HEK-293E cells;2.15;CA;CALCIUM ION;Neuraminidase;11320;
6D96;E;Structure of influenza neuraminidase from strain A/BrevigMission/1/1918(H1N1) expressed in HEK-293E cells;2.15;CA;CALCIUM ION;Neuraminidase;11320;
6D96;F;Structure of influenza neuraminidase from strain A/BrevigMission/1/1918(H1N1) expressed in HEK-293E cells;2.15;CA;CALCIUM ION;Neuraminidase;11320;
6D96;G;Structure of influenza neuraminidase from strain A/BrevigMission/1/1918(H1N1) expressed in HEK-293E cells;2.15;CA;CALCIUM ION;Neuraminidase;11320;
6D96;H;Structure of influenza neuraminidase from strain A/BrevigMission/1/1918(H1N1) expressed in HEK-293E cells;2.15;CA;CALCIUM ION;Neuraminidase;11320;
6DAD;A;1.65 Angstrom crystal structure of the N97I Ca/CaM:CaV1.2 IQ domain complex;1.65;CA;CALCIUM ION;Calmodulin-1;9606;
6DAD;B;1.65 Angstrom crystal structure of the N97I Ca/CaM:CaV1.2 IQ domain complex;1.65;CA;CALCIUM ION;Calmodulin-1;9606;
6DAE;A;2.0 Angstrom crystal structure of the D95V Ca/CaM:CaV1.2 IQ domain complex;2;CA;CALCIUM ION;Calmodulin-1;9606;
6DAE;B;2.0 Angstrom crystal structure of the D95V Ca/CaM:CaV1.2 IQ domain complex;2;CA;CALCIUM ION;Calmodulin-1;9606;
6DAF;A;2.4 Angstrom crystal structure of the F141L Ca/CaM:CaV1.2 IQ domain complex;2.4;CA;CALCIUM ION;Calmodulin-1;9606;
6DAF;B;2.4 Angstrom crystal structure of the F141L Ca/CaM:CaV1.2 IQ domain complex;2.4;CA;CALCIUM ION;Calmodulin-1;9606;
6DAH;A;2.5 Angstrom crystal structure of the N97S CaM mutant;2.5;CA;CALCIUM ION;Calmodulin-1;9606;
6DAH;B;2.5 Angstrom crystal structure of the N97S CaM mutant;2.5;CA;CALCIUM ION;Calmodulin-1;9606;
6DAH;C;2.5 Angstrom crystal structure of the N97S CaM mutant;2.5;CA;CALCIUM ION;Calmodulin-1;9606;
6DAH;D;2.5 Angstrom crystal structure of the N97S CaM mutant;2.5;CA;CALCIUM ION;Calmodulin-1;9606;
6DBI;A;Cryo-EM structure of RAG in complex with 12-RSS and 23-RSS nicked DNA intermediates;3.4;CA;CALCIUM ION;Recombination activating gene 1 - MBP chimera;5,627,955;
6DBI;C;Cryo-EM structure of RAG in complex with 12-RSS and 23-RSS nicked DNA intermediates;3.4;CA;CALCIUM ION;Recombination activating gene 1 - MBP chimera;5,627,955;
6DBJ;A;Cryo-EM structure of RAG in complex with 12-RSS and 23-RSS nicked DNA intermediates;3;CA;CALCIUM ION;Recombination activating gene 1 - MBP chimera;5,627,955;
6DBJ;C;Cryo-EM structure of RAG in complex with 12-RSS and 23-RSS nicked DNA intermediates;3;CA;CALCIUM ION;Recombination activating gene 1 - MBP chimera;5,627,955;
6DBL;A;Cryo-EM structure of RAG in complex with 12-RSS and 23-RSS substrate DNAs;5;CA;CALCIUM ION;Recombination activating gene 1 - MBP chimera;5,627,955;
6DBL;C;Cryo-EM structure of RAG in complex with 12-RSS and 23-RSS substrate DNAs;5;CA;CALCIUM ION;Recombination activating gene 1 - MBP chimera;5,627,955;
6DBL;E;Cryo-EM structure of RAG in complex with 12-RSS and 23-RSS substrate DNAs;5;CA;CALCIUM ION;Molecule name: Forward strand of 12-RSS substrate DNA;7955;
6DBL;G;Cryo-EM structure of RAG in complex with 12-RSS and 23-RSS substrate DNAs;5;CA;CALCIUM ION;Molecule name: Forward strand of 23-RSS substrate DNA;7955;
6DBO;A;Cryo-EM structure of RAG in complex with 12-RSS and 23-RSS substrate DNAs;4.4;CA;CALCIUM ION;Recombination activating gene 1 - MBP chimera;5,627,955;
6DBO;C;Cryo-EM structure of RAG in complex with 12-RSS and 23-RSS substrate DNAs;4.4;CA;CALCIUM ION;Recombination activating gene 1 - MBP chimera;5,627,955;
6DBQ;A;Cryo-EM structure of RAG in complex with 12-RSS and 23-RSS substrate DNAs;4.22;CA;CALCIUM ION;Recombination activating gene 1 - MBP chimera;5,627,955;
6DBQ;C;Cryo-EM structure of RAG in complex with 12-RSS and 23-RSS substrate DNAs;4.22;CA;CALCIUM ION;Recombination activating gene 1 - MBP chimera;5,627,955;
6DBR;A;Cryo-EM structure of RAG in complex with one melted RSS and one unmelted RSS;4;CA;CALCIUM ION;Recombination activating gene 1 - MBP chimera;5,627,955;
6DBR;C;Cryo-EM structure of RAG in complex with one melted RSS and one unmelted RSS;4;CA;CALCIUM ION;Recombination activating gene 1 - MBP chimera;5,627,955;
6DBT;A;Cryo-EM structure of RAG in complex with 12-RSS and 23-RSS substrate DNAs;4.3;CA;CALCIUM ION;Recombination activating gene 1 - MBP chimera;5,627,955;
6DBT;C;Cryo-EM structure of RAG in complex with 12-RSS and 23-RSS substrate DNAs;4.3;CA;CALCIUM ION;Recombination activating gene 1 - MBP chimera;5,627,955;
6DBU;A;Cryo-EM structure of RAG in complex with 12-RSS and 23-RSS substrate DNAs;3.9;CA;CALCIUM ION;Recombination activating gene 1 - MBP chimera;5,627,955;
6DBU;C;Cryo-EM structure of RAG in complex with 12-RSS and 23-RSS substrate DNAs;3.9;CA;CALCIUM ION;Recombination activating gene 1 - MBP chimera;5,627,955;
6DBV;A;Cryo-EM structure of RAG in complex with 12-RSS and 23-RSS substrate DNAs;4.29;CA;CALCIUM ION;Recombination activating gene 1 - MBP chimera;5,627,955;
6DBV;C;Cryo-EM structure of RAG in complex with 12-RSS and 23-RSS substrate DNAs;4.29;CA;CALCIUM ION;Recombination activating gene 1 - MBP chimera;5,627,955;
6DBW;A;Cryo-EM structure of RAG in complex with 12-RSS substrate DNA;4.7;CA;CALCIUM ION;Recombination activating gene 1 - MBP chimera;5,627,955;
6DBW;C;Cryo-EM structure of RAG in complex with 12-RSS substrate DNA;4.7;CA;CALCIUM ION;Recombination activating gene 1 - MBP chimera;5,627,955;
6DBX;A;Cryo-EM structure of RAG in complex with 12-RSS substrate DNA;4.2;CA;CALCIUM ION;Recombination activating gene 1 - MBP chimera;5,627,955;
6DBX;C;Cryo-EM structure of RAG in complex with 12-RSS substrate DNA;4.2;CA;CALCIUM ION;Recombination activating gene 1 - MBP chimera;5,627,955;
6DDT;A;mouse beta-mannosidase (MANBA);2.1;CA;CALCIUM ION;Beta-mannosidase;10090;
6DDU;A;mouse beta-mannosidase bound to beta-D-mannose (MANBA);2.67;CA;CALCIUM ION;Beta-mannosidase;10090;
6DE4;B;Homo sapiens dihydrofolate reductase complexed with beta-NADPH and 3'-[(2R)-4-(2,4-diamino-6-ethylphenyl)but-3-yn-2-yl]-5'-methoxy-[1,1'-biphenyl]-4-carboxylic acid;2.41;CA;CALCIUM ION;Dihydrofolate reductase;9606;
6DEC;A;Crystal structure of Bos taurus Arp2/3 complex binding with C-terminus of Homo sapiens SPIN90;4.6;CA;CALCIUM ION;Actin-related protein 3;9913;
6DEC;B;Crystal structure of Bos taurus Arp2/3 complex binding with C-terminus of Homo sapiens SPIN90;4.6;CA;CALCIUM ION;Actin-related protein 2;9913;
6DEC;H;Crystal structure of Bos taurus Arp2/3 complex binding with C-terminus of Homo sapiens SPIN90;4.6;CA;CALCIUM ION;Actin-related protein 3;9913;
6DEC;I;Crystal structure of Bos taurus Arp2/3 complex binding with C-terminus of Homo sapiens SPIN90;4.6;CA;CALCIUM ION;Actin-related protein 2;9913;
6DFQ;C;mouse diabetogenic TCR I.29;2.6;CA;CALCIUM ION;TCR alpha chain;10090;
6DFR;A;CRYSTAL STRUCTURES OF ESCHERICHIA COLI DIHYDROFOLATE REDUCTASE. THE NADP+ HOLOENZYME AND THE FOLATE(DOT)NADP+ TERNARY COMPLEX. SUBSTRATE BINDING AND A MODEL FOR THE TRANSITION STATE;2.4;CA;CALCIUM ION;DIHYDROFOLATE REDUCTASE;562;
6DGM;A;Streptococcus pyogenes phosphoglycerol transferase GacH in complex with sn-glycerol-1-phosphate;1.49;CA;CALCIUM ION;Phosphoglycerol transferase GacH;1314;
6DGM;B;Streptococcus pyogenes phosphoglycerol transferase GacH in complex with sn-glycerol-1-phosphate;1.49;CA;CALCIUM ION;Phosphoglycerol transferase GacH;1314;
6DHB;A;Crystal structure of the human TIM-3 with bound Calcium;1.7;CA;CALCIUM ION;Hepatitis A virus cellular receptor 2;9606;
6DHT;A;Bacteroides ovatus GH9 Bacova_02649;1.42;CA;CALCIUM ION;Xyloglucan-specific endo-beta-1,4-glucanase BoGH9A;28116;
6DHY;A;Crystallogrpahic tetramer of Zn-bound RIDC1 variant bearing two disulfide bonded cysteines;2.22;CA;CALCIUM ION;Soluble cytochrome b562;562;
6DHY;C;Crystallogrpahic tetramer of Zn-bound RIDC1 variant bearing two disulfide bonded cysteines;2.22;CA;CALCIUM ION;Soluble cytochrome b562;562;
6DHZ;A;Crystallographic octamer of a metal-free RIDC1 variant bearing two disulfide bonded cysteines;2.8;CA;CALCIUM ION;Soluble cytochrome b562;562;
6DHZ;B;Crystallographic octamer of a metal-free RIDC1 variant bearing two disulfide bonded cysteines;2.8;CA;CALCIUM ION;Soluble cytochrome b562;562;
6DHZ;C;Crystallographic octamer of a metal-free RIDC1 variant bearing two disulfide bonded cysteines;2.8;CA;CALCIUM ION;Soluble cytochrome b562;562;
6DHZ;D;Crystallographic octamer of a metal-free RIDC1 variant bearing two disulfide bonded cysteines;2.8;CA;CALCIUM ION;Soluble cytochrome b562;562;
6DIA;A;DNA polymerase beta substrate complex with templating cytosine and incoming Fapy-dGTP analog;1.97;CA;CALCIUM ION;DNA polymerase beta;9606;
6DIA;T;DNA polymerase beta substrate complex with templating cytosine and incoming Fapy-dGTP analog;1.97;CA;CALCIUM ION;DNA (5'-D(*CP*CP*GP*AP*CP*CP*GP*CP*GP*CP*AP*TP*CP*AP*GP*C)-3');32630;
6-dic;A;D276G DNA polymerase beta substrate complex with templating cytosine and incoming Fapy-dGTP analog;1.99;CA;CALCIUM ION;DNA polymerase beta;9606;
6DLH;A;Endo-fucoidan hydrolase MfFcnA4 from glycoside hydrolase family 107;2.2;CA;CALCIUM ION;Alpha-1,4-endofucoidanase;264023;
6DMN;A;Crystal Structure of Bacillus Halodurans Ribonuclease H1 in Complex with an RNA/DNA Hybrid: Soaked in 2 mM Ca2+ and 200 mM K+ at 21 C;1.27;CA;CALCIUM ION;Ribonuclease H;86665;
6DMS;A;Endo-fucoidan hydrolase MfFcnA4_H294Q from glycoside hydrolase family 107;2.85;CA;CALCIUM ION;Alpha-1,4-endofucoidanase;264023;
6DMW;E;Calmodulin-bound full-length rbTRPV5;4.4;CA;CALCIUM ION;Calmodulin-1;10116;
6DMY;B;Cryo-EM structure of human Ptch1 and ShhN complex;3.6;CA;CALCIUM ION;Sonic hedgehog protein;9606;
6DNF;A;Cryo-EM structure of the mitochondrial calcium uniporter MCU from the fungus Cyphellophora europaea;3.2;CA;CALCIUM ION;Mitochondrial calcium uniporter MCU;293227;
6DNF;B;Cryo-EM structure of the mitochondrial calcium uniporter MCU from the fungus Cyphellophora europaea;3.2;CA;CALCIUM ION;Mitochondrial calcium uniporter MCU;293227;
6DNS;A;Endo-fucoidan hydrolase MfFcnA9 from glycoside hydrolase family 107;2.24;CA;CALCIUM ION;Alpha-1,4-endofucoidanase;264023;
6DOH;A;Crystal Structure of Bacillus Halodurans Ribonuclease H1 in Complex with an RNA/DNA Hybrid: Soak in 0.5 mM EGTA and 200 mM K+ at 21 C;1.36;CA;CALCIUM ION;Ribonuclease H;86665;
6DOI;A;Crystal Structure of Bacillus Halodurans Ribonuclease H1 in Complex with an RNA/DNA Hybrid (1.54 Angstrom wavelength): Soak in 0.5 mM EGTA and 200 mM K+ at 21 C;1.95;CA;CALCIUM ION;Ribonuclease H;86665;
6DR2;A;Ca2+-bound human type 3 1,4,5-inositol trisphosphate receptor;4.33;CA;CALCIUM ION;Inositol 1,4,5-trisphosphate receptor type 3;9606;
6DR2;B;Ca2+-bound human type 3 1,4,5-inositol trisphosphate receptor;4.33;CA;CALCIUM ION;Inositol 1,4,5-trisphosphate receptor type 3;9606;
6DR2;C;Ca2+-bound human type 3 1,4,5-inositol trisphosphate receptor;4.33;CA;CALCIUM ION;Inositol 1,4,5-trisphosphate receptor type 3;9606;
6DR2;D;Ca2+-bound human type 3 1,4,5-inositol trisphosphate receptor;4.33;CA;CALCIUM ION;Inositol 1,4,5-trisphosphate receptor type 3;9606;
6DRA;A;Low IP3 Ca2+ human type 3 1,4,5-inositol trisphosphate receptor;3.96;CA;CALCIUM ION;Inositol 1,4,5-trisphosphate receptor type 3;9606;
6DRA;B;Low IP3 Ca2+ human type 3 1,4,5-inositol trisphosphate receptor;3.96;CA;CALCIUM ION;Inositol 1,4,5-trisphosphate receptor type 3;9606;
6DRA;C;Low IP3 Ca2+ human type 3 1,4,5-inositol trisphosphate receptor;3.96;CA;CALCIUM ION;Inositol 1,4,5-trisphosphate receptor type 3;9606;
6DRA;D;Low IP3 Ca2+ human type 3 1,4,5-inositol trisphosphate receptor;3.96;CA;CALCIUM ION;Inositol 1,4,5-trisphosphate receptor type 3;9606;
6DRC;A;High IP3 Ca2+ human type 3 1,4,5-inositol trisphosphate receptor;3.92;CA;CALCIUM ION;Inositol 1,4,5-trisphosphate receptor type 3;9606;
6DRC;B;High IP3 Ca2+ human type 3 1,4,5-inositol trisphosphate receptor;3.92;CA;CALCIUM ION;Inositol 1,4,5-trisphosphate receptor type 3;9606;
6DRC;C;High IP3 Ca2+ human type 3 1,4,5-inositol trisphosphate receptor;3.92;CA;CALCIUM ION;Inositol 1,4,5-trisphosphate receptor type 3;9606;
6DRC;D;High IP3 Ca2+ human type 3 1,4,5-inositol trisphosphate receptor;3.92;CA;CALCIUM ION;Inositol 1,4,5-trisphosphate receptor type 3;9606;
6DRJ;A;Structure of TRPM2 ion channel receptor by single particle electron cryo-microscopy, ADPR/Ca2+ bound state;3.3;CA;CALCIUM ION;Transient receptor potential cation channel, subfamily M, member 2;7955;
6DRJ;B;Structure of TRPM2 ion channel receptor by single particle electron cryo-microscopy, ADPR/Ca2+ bound state;3.3;CA;CALCIUM ION;Transient receptor potential cation channel, subfamily M, member 2;7955;
6DRJ;C;Structure of TRPM2 ion channel receptor by single particle electron cryo-microscopy, ADPR/Ca2+ bound state;3.3;CA;CALCIUM ION;Transient receptor potential cation channel, subfamily M, member 2;7955;
6DRJ;D;Structure of TRPM2 ion channel receptor by single particle electron cryo-microscopy, ADPR/Ca2+ bound state;3.3;CA;CALCIUM ION;Transient receptor potential cation channel, subfamily M, member 2;7955;
6DT0;A;Cryo-EM structure of a mitochondrial calcium uniporter;3.7;CA;CALCIUM ION;Mitochondrial calcium uniporter;5141;
6DWY;A;Hermes transposase deletion dimer complex with (C/G) DNA and Ca2+;3.2;CA;CALCIUM ION;Hermes transposase;7370;
6DXG;A;amidobenzimidazole (ABZI) STING agonists;1.9;CA;CALCIUM ION;Stimulator of interferon protein;9606;
6DXL;A;Linked amidobenzimidazole STING agonist;2.45;CA;CALCIUM ION;Stimulator of interferon protein;9606;
6DXL;B;Linked amidobenzimidazole STING agonist;2.45;CA;CALCIUM ION;Stimulator of interferon protein;9606;
6DYB;A;Metal-free structure of the engineered cyt cb562 variant, CH3;2.75;CA;CALCIUM ION;Soluble cytochrome b562;562;
6DYB;C;Metal-free structure of the engineered cyt cb562 variant, CH3;2.75;CA;CALCIUM ION;Soluble cytochrome b562;562;
6DYC;B;Co(II)-bound structure of the engineered cyt cb562 variant, CH3;1.33;CA;CALCIUM ION;Soluble cytochrome b562;562;
6DYD;A;Cu(II)-bound structure of the engineered cyt cb562 variant, CH3;1.72;CA;CALCIUM ION;Soluble cytochrome b562;562;
6DYD;C;Cu(II)-bound structure of the engineered cyt cb562 variant, CH3;1.72;CA;CALCIUM ION;Soluble cytochrome b562;562;
6DYE;A;Fe(II)-bound structure of the engineered cyt cb562 variant, CH3;2.25;CA;CALCIUM ION;Soluble cytochrome b562;562;
6DYI;B;Co(II)-bound structure of the engineered cyt cb562 variant, H3;1.96;CA;CALCIUM ION;Soluble cytochrome b562;562;
6DYM;A;C-terminal condensation domain of Ebony;2.02;CA;CALCIUM ION;Ebony;7227;
6DYN;A;C-terminal condensation domain of Ebony in complex with Histamine;2.1;CA;CALCIUM ION;Ebony;7227;
6DYO;A;C-terminal condensation domain of Ebony in complex with L-Dopamine;2.84;CA;CALCIUM ION;Ebony;7227;
6DYS;A;C-terminal condensation domain of Ebony in complex with beta-alanyl-dopamine;2.3;CA;CALCIUM ION;Ebony;7227;
6DZF;A;Orthorhombic trypsin cryocooled to 100 K with 20% xylose as cryoprotectant;2.2;CA;CALCIUM ION;Cationic trypsin;9913;
6E0A;B;Crystal Structure of Helicobacter pylori TlpA Chemoreceptor Ligand Binding Domain;2.43;CA;CALCIUM ION;Methyl-accepting chemotaxis protein TlpA;210;
6E0H;A;PDB: afTMEM16 reconstituted in nanodiscs in the presence of Ca2+;4.05;CA;CALCIUM ION;Plasma membrane channel protein (Aqy1), putative;746128;
6E0H;B;PDB: afTMEM16 reconstituted in nanodiscs in the presence of Ca2+;4.05;CA;CALCIUM ION;Plasma membrane channel protein (Aqy1), putative;746128;
6E1H;C;Structure of 2:1 human Ptch1-Shh-N complex;3.5;CA;CALCIUM ION;Sonic hedgehog protein N-product;9606;
6E1K;A;Structure of AtTPC1(DDE) reconstituted in saposin A with cat06 Fab;3.3;CA;CALCIUM ION;Two pore calcium channel protein 1;3702;
6E1K;B;Structure of AtTPC1(DDE) reconstituted in saposin A with cat06 Fab;3.3;CA;CALCIUM ION;Two pore calcium channel protein 1;3702;
6E1M;A;Structure of AtTPC1(DDE) reconstituted in saposin A;3.3;CA;CALCIUM ION;Two pore calcium channel protein 1;3702;
6E1M;B;Structure of AtTPC1(DDE) reconstituted in saposin A;3.3;CA;CALCIUM ION;Two pore calcium channel protein 1;3702;
6E1N;A;Structure of AtTPC1(DDE) in state 1;3.7;CA;CALCIUM ION;Two pore calcium channel protein 1;3702;
6E1N;B;Structure of AtTPC1(DDE) in state 1;3.7;CA;CALCIUM ION;Two pore calcium channel protein 1;3702;
6E1O;A;afTMEM16 reconstituted in nanodiscs in the presence of Ca2+ and ceramide 24:0;3.59;CA;CALCIUM ION;Plasma membrane channel protein (Aqy1), putative;746128;
6E1O;B;afTMEM16 reconstituted in nanodiscs in the presence of Ca2+ and ceramide 24:0;3.59;CA;CALCIUM ION;Plasma membrane channel protein (Aqy1), putative;746128;
6E1P;A;Structure of AtTPC1(DDE) in state 2;3.7;CA;CALCIUM ION;Two pore calcium channel protein 1;3702;
6E1P;B;Structure of AtTPC1(DDE) in state 2;3.7;CA;CALCIUM ION;Two pore calcium channel protein 1;3702;
6E2F;A;Cryo-EM structure of human TRPV6 in complex with Calmodulin;3.9;CA;CALCIUM ION;Transient receptor potential cation channel subfamily V member 6;9606;
6E2F;E;Cryo-EM structure of human TRPV6 in complex with Calmodulin;3.9;CA;CALCIUM ION;Calmodulin-1;9606;
6E2G;A;Cryo-EM structure of rat TRPV6 in complex with Calmodulin;3.6;CA;CALCIUM ION;Transient receptor potential cation channel subfamily V member 6;10116;
6E2G;E;Cryo-EM structure of rat TRPV6 in complex with Calmodulin;3.6;CA;CALCIUM ION;Calmodulin-1;9606;
6.00E+48;A;Crystal Structure of the Murine Norovirus VP1 P domain in complex with the CD300lf Receptor and Lithocholic Acid;1.8;CA;CALCIUM ION;VP1 P domain;11983;
6.00E+48;B;Crystal Structure of the Murine Norovirus VP1 P domain in complex with the CD300lf Receptor and Lithocholic Acid;1.8;CA;CALCIUM ION;VP1 P domain;11983;
6.00E+48;F;Crystal Structure of the Murine Norovirus VP1 P domain in complex with the CD300lf Receptor and Lithocholic Acid;1.8;CA;CALCIUM ION;CMRF35-like molecule 1;10090;
6.00E+58;A;Crystal structure of Streptococcus pyogenes endo-beta-N-acetylglucosaminidase (EndoS2);2.75;CA;CALCIUM ION;Secreted Endo-beta-N-acetylglucosaminidase (EndoS);1314;
6.00E+58;B;Crystal structure of Streptococcus pyogenes endo-beta-N-acetylglucosaminidase (EndoS2);2.75;CA;CALCIUM ION;Secreted Endo-beta-N-acetylglucosaminidase (EndoS);1314;
6E5M;A;Crystallographic structure of the cyclic nonapeptide derived from the BTCI inhibitor bound to beta-trypsin in space group P 32 2 1;1.61;CA;CALCIUM ION;Cationic trypsin;9913;
6E5X;A;Crystal structure of Ebola virus VP30 C-terminus/RBBP6 peptide complex;1.5;CA;CALCIUM ION;Minor nucleoprotein VP30;186538;
6E6B;A;Crystal structure of the Protocadherin GammaB4 extracellular domain;4.52;CA;CALCIUM ION;Protocadherin gamma B4;10090;
6E6B;B;Crystal structure of the Protocadherin GammaB4 extracellular domain;4.52;CA;CALCIUM ION;Protocadherin gamma B4;10090;
6E7K;A;Structure of the lipoprotein lipase GPIHBP1 complex that mediates plasma triglyceride hydrolysis;2.8;CA;CALCIUM ION;Lipoprotein lipase;9606;
6E7K;B;Structure of the lipoprotein lipase GPIHBP1 complex that mediates plasma triglyceride hydrolysis;2.8;CA;CALCIUM ION;Lipoprotein lipase;9606;
6.00E+90;A;Ternary complex of human glycerol 3-phosphate dehydrogenase;2.05;CA;CALCIUM ION;Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic;9606;
6.00E+90;B;Ternary complex of human glycerol 3-phosphate dehydrogenase;2.05;CA;CALCIUM ION;Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic;9606;
6EAC;A;Pseudomonas syringae SelO;2.27;CA;CALCIUM ION;SelO;317;
6EAC;B;Pseudomonas syringae SelO;2.27;CA;CALCIUM ION;SelO;317;
6EAC;C;Pseudomonas syringae SelO;2.27;CA;CALCIUM ION;SelO;317;
6EAC;D;Pseudomonas syringae SelO;2.27;CA;CALCIUM ION;SelO;317;
6EAT;A;Crystallographic structure of the cyclic nonapeptide derived from the BTCI inhibitor bound to beta-trypsin in space group P 21 21 21.;1.15;CA;CALCIUM ION;Cationic trypsin;9913;
6EBO;A;Crystal Structure of the Class Ie Ribonucleotide Reductase Beta Subunit from Aerococcus urinae in Unactivated Form;1.58;CA;CALCIUM ION;Ribonucleoside-diphosphate reductase, beta subunit;1376;
6EBO;B;Crystal Structure of the Class Ie Ribonucleotide Reductase Beta Subunit from Aerococcus urinae in Unactivated Form;1.58;CA;CALCIUM ION;Ribonucleoside-diphosphate reductase, beta subunit;1376;
6EBO;C;Crystal Structure of the Class Ie Ribonucleotide Reductase Beta Subunit from Aerococcus urinae in Unactivated Form;1.58;CA;CALCIUM ION;Ribonucleoside-diphosphate reductase, beta subunit;1376;
6EBO;D;Crystal Structure of the Class Ie Ribonucleotide Reductase Beta Subunit from Aerococcus urinae in Unactivated Form;1.58;CA;CALCIUM ION;Ribonucleoside-diphosphate reductase, beta subunit;1376;
6EBP;A;Crystal Structure of the Class Ie Ribonucleotide Reductase Beta Subunit from Aerococcus urinae in Activated Form;1.59;CA;CALCIUM ION;Ribonucleoside-diphosphate reductase, beta subunit;1376;
6EBP;B;Crystal Structure of the Class Ie Ribonucleotide Reductase Beta Subunit from Aerococcus urinae in Activated Form;1.59;CA;CALCIUM ION;Ribonucleoside-diphosphate reductase, beta subunit;1376;
6EBP;C;Crystal Structure of the Class Ie Ribonucleotide Reductase Beta Subunit from Aerococcus urinae in Activated Form;1.59;CA;CALCIUM ION;Ribonucleoside-diphosphate reductase, beta subunit;1376;
6EBP;D;Crystal Structure of the Class Ie Ribonucleotide Reductase Beta Subunit from Aerococcus urinae in Activated Form;1.59;CA;CALCIUM ION;Ribonucleoside-diphosphate reductase, beta subunit;1376;
6EBZ;A;Crystal Structure of the Class Ie Ribonucleotide Reductase Beta Subunit from Aerococcus urinae in Activated Form with Thiocyanate Bound;1.66;CA;CALCIUM ION;Ribonucleoside-diphosphate reductase, beta subunit;1376;
6EBZ;B;Crystal Structure of the Class Ie Ribonucleotide Reductase Beta Subunit from Aerococcus urinae in Activated Form with Thiocyanate Bound;1.66;CA;CALCIUM ION;Ribonucleoside-diphosphate reductase, beta subunit;1376;
6EBZ;C;Crystal Structure of the Class Ie Ribonucleotide Reductase Beta Subunit from Aerococcus urinae in Activated Form with Thiocyanate Bound;1.66;CA;CALCIUM ION;Ribonucleoside-diphosphate reductase, beta subunit;1376;
6EBZ;D;Crystal Structure of the Class Ie Ribonucleotide Reductase Beta Subunit from Aerococcus urinae in Activated Form with Thiocyanate Bound;1.66;CA;CALCIUM ION;Ribonucleoside-diphosphate reductase, beta subunit;1376;
6EDV;A;Structure of a GNAT superfamily acetyltransferase PA3944 in complex with CoA;1.35;CA;CALCIUM ION;Acetyltransferase PA3944;287;
6EEG;A;Crystal structure of Staphylcoccal nuclease variant Delta+PHS T62E at cryogenic temperature;1.95;CA;CALCIUM ION;Thermonuclease;1280;
6EEW;A;Crystal structure of Catharanthus roseus tryptophan decarboxylase in complex with L-tryptophan;2.05;CA;CALCIUM ION;Aromatic-L-amino-acid decarboxylase;4058;
6EEW;B;Crystal structure of Catharanthus roseus tryptophan decarboxylase in complex with L-tryptophan;2.05;CA;CALCIUM ION;Aromatic-L-amino-acid decarboxylase;4058;
6EEW;C;Crystal structure of Catharanthus roseus tryptophan decarboxylase in complex with L-tryptophan;2.05;CA;CALCIUM ION;Aromatic-L-amino-acid decarboxylase;4058;
6EEW;D;Crystal structure of Catharanthus roseus tryptophan decarboxylase in complex with L-tryptophan;2.05;CA;CALCIUM ION;Aromatic-L-amino-acid decarboxylase;4058;
6EHF;A;OmpT (in-vitro folded), an outer membrane protein Vibrio cholerae (trimer form);2.72;CA;CALCIUM ION;OmpT protein;666;
6EKN;A;Crystal structure of MMP12 in complex with inhibitor BE7.;1.2;CA;CALCIUM ION;Macrophage metalloelastase;9606;
6EKO;A;Crystal structure of Type IIP restriction endonuclease PfoI with cognate DNA;2.28;CA;CALCIUM ION;Restriction endonuclease PfoI;294;
6EKO;B;Crystal structure of Type IIP restriction endonuclease PfoI with cognate DNA;2.28;CA;CALCIUM ION;Restriction endonuclease PfoI;294;
6EKS;A;Vibrio cholerae neuraminidase complexed with oseltamivir carboxylate;1.87;CA;CALCIUM ION;Sialidase;666;
6EKU;A;Vibrio cholerae neuraminidase complexed with zanamivir;1.75;CA;CALCIUM ION;Sialidase;666;
6ELA;A;Crystal structure of MMP12 in complex with inhibitor BE4.;1.49;CA;CALCIUM ION;Macrophage metalloelastase;9606;
6ELA;B;Crystal structure of MMP12 in complex with inhibitor BE4.;1.49;CA;CALCIUM ION;Macrophage metalloelastase;9606;
6ELA;C;Crystal structure of MMP12 in complex with inhibitor BE4.;1.49;CA;CALCIUM ION;Macrophage metalloelastase;9606;
6ELA;D;Crystal structure of MMP12 in complex with inhibitor BE4.;1.49;CA;CALCIUM ION;Macrophage metalloelastase;9606;
6ELT;A;C-terminal domain of MdPPO1 upon self-cleavage (Ccleaved-domain);1.35;CA;CALCIUM ION;Polyphenol oxidase, chloroplastic;3750;
6ELV;A;Recombinantly expressed C-terminal domain of MdPPO1 (Csole-domain);1.05;CA;CALCIUM ION;Polyphenol oxidase, chloroplastic;3750;
6EN3;A;Crystal structure of full length EndoS from Streptococcus pyogenes in complex with G2 oligosaccharide.;2.9;CA;CALCIUM ION;Endo-beta-N-acetylglucosaminidase F2,Multifunctional-autoprocessing repeats-in-toxin;6,661,314;
6ENM;A;Crystal structure of MMP12 in complex with hydroxamate inhibitor LP168.;1.59;CA;CALCIUM ION;Macrophage metalloelastase;9606;
6ENM;B;Crystal structure of MMP12 in complex with hydroxamate inhibitor LP168.;1.59;CA;CALCIUM ION;Macrophage metalloelastase;9606;
6EON;A;Galactanase BT0290;1.75;CA;CALCIUM ION;Beta-galactosidase;818;
6EOP;A;DPP8 - SLRFLYEG, space group 20;2.4;CA;CALCIUM ION;Dipeptidyl peptidase 8;9606;
6EOP;B;DPP8 - SLRFLYEG, space group 20;2.4;CA;CALCIUM ION;Dipeptidyl peptidase 8;9606;
6EOP;C;DPP8 - SLRFLYEG, space group 20;2.4;CA;CALCIUM ION;Dipeptidyl peptidase 8;9606;
6EOX;A;Crystal structure of MMP12 in complex with carboxylic inhibitor LP165.;1.3;CA;CALCIUM ION;Macrophage metalloelastase;9606;
6EP0;A;Enterococcus faecalis FIC protein in complex with AMP and calcium ion.;2.35;CA;CALCIUM ION;Fic family protein;1351;
6EP0;B;Enterococcus faecalis FIC protein in complex with AMP and calcium ion.;2.35;CA;CALCIUM ION;Fic family protein;1351;
6EP2;A;Enterococcus faecalis FIC protein in complex with ADP and calcium ion.;2.15;CA;CALCIUM ION;Fic family protein;1351;
6EP2;B;Enterococcus faecalis FIC protein in complex with ADP and calcium ion.;2.15;CA;CALCIUM ION;Fic family protein;1351;
6EP2;C;Enterococcus faecalis FIC protein in complex with ADP and calcium ion.;2.15;CA;CALCIUM ION;Fic family protein;1351;
6EP2;D;Enterococcus faecalis FIC protein in complex with ADP and calcium ion.;2.15;CA;CALCIUM ION;Fic family protein;1351;
6EP2;E;Enterococcus faecalis FIC protein in complex with ADP and calcium ion.;2.15;CA;CALCIUM ION;Fic family protein;1351;
6EP2;F;Enterococcus faecalis FIC protein in complex with ADP and calcium ion.;2.15;CA;CALCIUM ION;Fic family protein;1351;
6EP2;G;Enterococcus faecalis FIC protein in complex with ADP and calcium ion.;2.15;CA;CALCIUM ION;Fic family protein;1351;
6EP2;H;Enterococcus faecalis FIC protein in complex with ADP and calcium ion.;2.15;CA;CALCIUM ION;Fic family protein;1351;
6EP2;I;Enterococcus faecalis FIC protein in complex with ADP and calcium ion.;2.15;CA;CALCIUM ION;Fic family protein;1351;
6EP2;J;Enterococcus faecalis FIC protein in complex with ADP and calcium ion.;2.15;CA;CALCIUM ION;Fic family protein;1351;
6EP2;K;Enterococcus faecalis FIC protein in complex with ADP and calcium ion.;2.15;CA;CALCIUM ION;Fic family protein;1351;
6EP2;L;Enterococcus faecalis FIC protein in complex with ADP and calcium ion.;2.15;CA;CALCIUM ION;Fic family protein;1351;
6EPA;A;Structure of dNCS-1 bound to the NCS-1/Ric8a protein/protein interaction regulator IGS-1.76;1.82;CA;CALCIUM ION;FI18190p1;7227;
6EPY;A;Structure of the PBP MelB (Atu4661) in complex with raffinose from A.fabrum C58;2.04;CA;CALCIUM ION;Periplasmic alpha-galactoside-binding protein;358;
6EPY;B;Structure of the PBP MelB (Atu4661) in complex with raffinose from A.fabrum C58;2.04;CA;CALCIUM ION;Periplasmic alpha-galactoside-binding protein;358;
6EPY;C;Structure of the PBP MelB (Atu4661) in complex with raffinose from A.fabrum C58;2.04;CA;CALCIUM ION;Periplasmic alpha-galactoside-binding protein;358;
6EPY;D;Structure of the PBP MelB (Atu4661) in complex with raffinose from A.fabrum C58;2.04;CA;CALCIUM ION;Periplasmic alpha-galactoside-binding protein;358;
6EQ0;A;Structure of the periplasmic binding protein (PBP) MelB (atu4661) in complex with galactose from agrobacterium tumefacien C58;2.45;CA;CALCIUM ION;Periplasmic alpha-galactoside-binding protein;358;
6EQ0;B;Structure of the periplasmic binding protein (PBP) MelB (atu4661) in complex with galactose from agrobacterium tumefacien C58;2.45;CA;CALCIUM ION;Periplasmic alpha-galactoside-binding protein;358;
6EQ1;A;Structure of the periplasmic binding protein (PBP) MelB (Atu4661) in complex with stachyose from agrobacterium fabrum C58;2.1;CA;CALCIUM ION;Periplasmic alpha-galactoside-binding protein;358;
6EQ1;B;Structure of the periplasmic binding protein (PBP) MelB (Atu4661) in complex with stachyose from agrobacterium fabrum C58;2.1;CA;CALCIUM ION;Periplasmic alpha-galactoside-binding protein;358;
6EQ8;A;Structure of the periplasmic binding protein (PBP) MelB (Atu4661) in complex with galactinol from agrobacterium fabrum C58;2.19;CA;CALCIUM ION;Periplasmic alpha-galactoside-binding protein;358;
6EQ8;B;Structure of the periplasmic binding protein (PBP) MelB (Atu4661) in complex with galactinol from agrobacterium fabrum C58;2.19;CA;CALCIUM ION;Periplasmic alpha-galactoside-binding protein;358;
6EQ8;C;Structure of the periplasmic binding protein (PBP) MelB (Atu4661) in complex with galactinol from agrobacterium fabrum C58;2.19;CA;CALCIUM ION;Periplasmic alpha-galactoside-binding protein;358;
6EQ8;D;Structure of the periplasmic binding protein (PBP) MelB (Atu4661) in complex with galactinol from agrobacterium fabrum C58;2.19;CA;CALCIUM ION;Periplasmic alpha-galactoside-binding protein;358;
6EQV;A;X-ray structure of the proprotein convertase furin bound with the competitive inhibitor Phac-Cit-Val-Arg-Amba;1.89;CA;CALCIUM ION;Furin;9606;
6EQW;A;X-ray structure of the proprotein convertase furin bound with the competitive inhibitor 4-aminomethyl-phenylacetyl-Arg-Val-Arg-Amba;1.99;CA;CALCIUM ION;Furin;9606;
6EQX;A;X-ray structure of the proprotein convertase furin bound with the competitive inhibitor Arg-Arg-Arg-Val-Arg-Amba;1.99;CA;CALCIUM ION;Furin;9606;
6ERC;A;Peroxidase A from Dictyostelium discoideum (DdPoxA);2.5;CA;CALCIUM ION;Peroxinectin A;44689;
6ERC;B;Peroxidase A from Dictyostelium discoideum (DdPoxA);2.5;CA;CALCIUM ION;Peroxinectin A;44689;
6ESB;1;BK polyomavirus + 20 mM GT1b oligosaccharide;3.4;CA;CALCIUM ION;Capsid protein VP1;1891762;
6ESB;2;BK polyomavirus + 20 mM GT1b oligosaccharide;3.4;CA;CALCIUM ION;Capsid protein VP1;1891762;
6ESB;3;BK polyomavirus + 20 mM GT1b oligosaccharide;3.4;CA;CALCIUM ION;Capsid protein VP1;1891762;
6ESB;4;BK polyomavirus + 20 mM GT1b oligosaccharide;3.4;CA;CALCIUM ION;Capsid protein VP1;1891762;
6ESM;A;Crystal structure of MMP9 in complex with inhibitor BE4.;1.1;CA;CALCIUM ION;Matrix metalloproteinase-9,Matrix metalloproteinase-9;9606;
6EST;A;INTERACTION OF THE PEPTIDE CF3-LEU-ALA-NH-C6H4-CF3(TFLA) WITH PORCINE PANCREATIC ELASTASE. X-RAY STUDIES AT 1.8 ANGSTROMS;1.8;CA;CALCIUM ION;PORCINE PANCREATIC ELASTASE;9823;
6ETY;A;X-ray structure of human glutamate carboxypeptidase II (GCPII) in complex with a inhibitor JHU3371;1.68;CA;CALCIUM ION;Glutamate carboxypeptidase 2;9606;
6EUH;A;The GH43, Beta 1,3 Galactosidase, BT3683 with galactodeoxynojirimycin;2;CA;CALCIUM ION;Beta-glucanase;818;
6EUH;B;The GH43, Beta 1,3 Galactosidase, BT3683 with galactodeoxynojirimycin;2;CA;CALCIUM ION;Beta-glucanase;818;
6EUH;C;The GH43, Beta 1,3 Galactosidase, BT3683 with galactodeoxynojirimycin;2;CA;CALCIUM ION;Beta-glucanase;818;
6EUI;A;The GH43, Beta 1,3 Galactosidase, BT3683 with galactose;1.76;CA;CALCIUM ION;Beta-glucanase;818;
6EW9;A;CRYSTAL STRUCTURE OF DEGS STRESS SENSOR PROTEASE IN COMPLEX WITH ACTIVATING DNRLGLVYQF PEPTIDE;2.2;CA;CALCIUM ION;Serine endoprotease DegS;562;
6EW9;B;CRYSTAL STRUCTURE OF DEGS STRESS SENSOR PROTEASE IN COMPLEX WITH ACTIVATING DNRLGLVYQF PEPTIDE;2.2;CA;CALCIUM ION;Serine endoprotease DegS;562;
6EW9;C;CRYSTAL STRUCTURE OF DEGS STRESS SENSOR PROTEASE IN COMPLEX WITH ACTIVATING DNRLGLVYQF PEPTIDE;2.2;CA;CALCIUM ION;Serine endoprotease DegS;562;
6EYI;A;E-selectin lectin, EGF-like and two SCR domains complexed with glycomimetic ligand BW69669;2.04;CA;CALCIUM ION;E-selectin;9606;
6EYJ;A;E-selectin lectin, EGF-like and two SCR domains complexed with glycomimetic ligand NV354;2.2;CA;CALCIUM ION;E-selectin;9606;
6EYJ;B;E-selectin lectin, EGF-like and two SCR domains complexed with glycomimetic ligand NV354;2.2;CA;CALCIUM ION;E-selectin;9606;
6EYK;A;E-selectin lectin, EGF-like and two SCR domains complexed with glycomimetic ligand NV355;2.21;CA;CALCIUM ION;E-selectin;9606;
6EZ9;A;X-ray structure of human glutamate carboxypeptidase II (GCPII) - the E424M inactive mutant, in complex with a inhibitor JHU3372;1.61;CA;CALCIUM ION;Glutamate carboxypeptidase 2;9606;
6EZZ;A;Crystal structure of Escherichia coli amine oxidase mutant E573Q;1.8;CA;CALCIUM ION;Primary amine oxidase;562;
6EZZ;B;Crystal structure of Escherichia coli amine oxidase mutant E573Q;1.8;CA;CALCIUM ION;Primary amine oxidase;562;
6F03;A;The crystal structure of secreted antigen BPSL2520;2.2;CA;CALCIUM ION;BPSL2520;28450;
6F1C;A;C1rC1s complex;4.2;CA;CALCIUM ION;Complement C1r subcomponent;9606;
6F1C;B;C1rC1s complex;4.2;CA;CALCIUM ION;Complement C1s subcomponent;9606;
6F1C;C;C1rC1s complex;4.2;CA;CALCIUM ION;Complement C1r subcomponent;9606;
6F1C;D;C1rC1s complex;4.2;CA;CALCIUM ION;Complement C1s subcomponent;9606;
6F1D;A;CUB2 domain of C1r;1.95;CA;CALCIUM ION;Complement C1r subcomponent;9606;
6F1G;A;The structure of AbnB-E201A, an intracellular 1,5-alpha-L-arabinanase from Geobacillus stearothermophilus, in complex with arabinopentaose;1.67;CA;CALCIUM ION;Intracellular endo-alpha-(1->5)-L-arabinanase;1422;
6F1H;A;C1rC1s complex;4.5;CA;CALCIUM ION;Complement C1r subcomponent;9606;
6F1H;B;C1rC1s complex;4.5;CA;CALCIUM ION;Complement C1s subcomponent;9606;
6F1H;C;C1rC1s complex;4.5;CA;CALCIUM ION;Complement C1r subcomponent;9606;
6F1H;D;C1rC1s complex;4.5;CA;CALCIUM ION;Complement C1s subcomponent;9606;
6F1J;A;Structure of a Talaromyces pinophilus GH62 Arabinofuranosidase in complex with AraDNJ at 1.25A resolution;1.25;CA;CALCIUM ION;protein;128442;
6F1J;B;Structure of a Talaromyces pinophilus GH62 Arabinofuranosidase in complex with AraDNJ at 1.25A resolution;1.25;CA;CALCIUM ION;protein;128442;
6F2P;A;Structure of Paenibacillus xanthan lyase to 2.6 A resolution;2.6;CA;CALCIUM ION;Paenibacillus xanthan lyase;44249;
6F2T;A;Crystal structure of ectonucleotide phosphodiesterase/pyrophosphatase-3 (NPP3);2.4;CA;CALCIUM ION;Ectonucleotide pyrophosphatase/phosphodiesterase family member 3;10116;
6F2T;B;Crystal structure of ectonucleotide phosphodiesterase/pyrophosphatase-3 (NPP3);2.4;CA;CALCIUM ION;Ectonucleotide pyrophosphatase/phosphodiesterase family member 3;10116;
6F2V;A;Crystal structure of ectonucleotide phosphodiesterase/pyrophosphatase-3 (NPP3) in complex with AMP;2.5;CA;CALCIUM ION;Ectonucleotide pyrophosphatase/phosphodiesterase family member 3;10116;
6F2V;B;Crystal structure of ectonucleotide phosphodiesterase/pyrophosphatase-3 (NPP3) in complex with AMP;2.5;CA;CALCIUM ION;Ectonucleotide pyrophosphatase/phosphodiesterase family member 3;10116;
6F2Y;A;Crystal structure of ectonucleotide phosphodiesterase/pyrophosphatase-3 (NPP3) in complex with Ap4A;2.4;CA;CALCIUM ION;Ectonucleotide pyrophosphatase/phosphodiesterase family member 3;10116;
6F2Y;B;Crystal structure of ectonucleotide phosphodiesterase/pyrophosphatase-3 (NPP3) in complex with Ap4A;2.4;CA;CALCIUM ION;Ectonucleotide pyrophosphatase/phosphodiesterase family member 3;10116;
6F30;A;Crystal structure of ectonucleotide phosphodiesterase/pyrophosphatase-3 (NPP3) in complex with UDPGlcNAc;2.3;CA;CALCIUM ION;Ectonucleotide pyrophosphatase/phosphodiesterase family member 3;10116;
6F30;B;Crystal structure of ectonucleotide phosphodiesterase/pyrophosphatase-3 (NPP3) in complex with UDPGlcNAc;2.3;CA;CALCIUM ION;Ectonucleotide pyrophosphatase/phosphodiesterase family member 3;10116;
6F32;A;Crystal structure of a dual function amine oxidase/cyclase in complex with substrate analogues;2.8;CA;CALCIUM ION;Amine oxidase LkcE;1928;
6F32;B;Crystal structure of a dual function amine oxidase/cyclase in complex with substrate analogues;2.8;CA;CALCIUM ION;Amine oxidase LkcE;1928;
6F33;A;Crystal structure of ectonucleotide phosphodiesterase/pyrophosphatase-3 (NPP3) in complex with AMPNPP;3;CA;CALCIUM ION;Ectonucleotide pyrophosphatase/phosphodiesterase family member 3;10116;
6F33;B;Crystal structure of ectonucleotide phosphodiesterase/pyrophosphatase-3 (NPP3) in complex with AMPNPP;3;CA;CALCIUM ION;Ectonucleotide pyrophosphatase/phosphodiesterase family member 3;10116;
6F39;A;C1r homodimer CUB1-EGF-CUB2;5.8;CA;CALCIUM ION;Complement C1r subcomponent;9606;
6F39;B;C1r homodimer CUB1-EGF-CUB2;5.8;CA;CALCIUM ION;Complement C1r subcomponent;9606;
6F43;B;Crystal structure of apo form of Glutathione transferase Omega 3S from Trametes versicolor;1.35;CA;CALCIUM ION;glutathione transferase;5325;
6F4F;B;Crystal structure of glutathione transferase Omega 3S from Trametes versicolor in complex with glutathionyl-S-dinitrobenzene;1.75;CA;CALCIUM ION;Glutathione transferase;5325;
6F4K;B;Crystal structure of glutathione transferase Omega 3S from Trametes versicolor in complex with hexyl-glutathione;1.55;CA;CALCIUM ION;Glutathione transferase;5325;
6F51;B;Crystal structure of glutathione transferase Omega 3S from Trametes versicolor in complex with glutathionyl-phenylacetophenone;1.92;CA;CALCIUM ION;glutathione transferase;5325;
6F5K;A;Crystal structure of laccase from Myceliophthora thermophila;1.62;CA;CALCIUM ION;Extracellular laccase, lcc1;78579;
6F5L;A;X-ray structure of human glutamate carboxypeptidase II (GCPII) in complex with a inhibitor JHU2379;1.63;CA;CALCIUM ION;Glutamate carboxypeptidase 2;9606;
6F66;B;Crystal structure of glutathione transferase Omega 3S from Trametes versicolor in complex with 2,4-Dihydroxybenzophenone;1.75;CA;CALCIUM ION;glutathione transferase;5325;
6F67;B;Crystal structure of glutathione transferase Omega 3S from Trametes versicolor in complex with 3,4-Dihydroxybenzophenone;2.4;CA;CALCIUM ION;glutathione transferase;5325;
6F68;B;Crystal structure glutathione transferase Omega 3S from Trametes versicolor in complex with 2,4,4'-trihydroxybenzophenone;1.7;CA;CALCIUM ION;glutathione transferase;5325;
6F69;B;Crystal structure of glutathione transferase Omega 3S from Trametes versicolor in complex with 2,3,4-Trihydroxybenzophenone;1.8;CA;CALCIUM ION;glutathione transferase;5325;
6F6A;B;Crystal structure of glutathione transferase Omega 3S from Trametes versicolor in complex with dihydrowogonin from wild-cherry extract;1.7;CA;CALCIUM ION;glutathione transferase;5325;
6F6Q;A;Carboxypeptidase T mutant L254N with Sulphamoil Arginine;1.79;CA;CALCIUM ION;Carboxypeptidase T;2026;
6F75;A;Carboxypeptidase T mutant L254N with Sulphamoil Leucine;1.89;CA;CALCIUM ION;Carboxypeptidase T;2026;
6F79;A;Carboxypeptidase T mutant L211Q with Sulphamoil Arginine;1.9;CA;CALCIUM ION;Carboxypeptidase T;2026;
6F7C;A;TUBULIN-Compound 12 complex;2;CA;CALCIUM ION;Tubulin alpha-1B chain;9913;
6F7C;C;TUBULIN-Compound 12 complex;2;CA;CALCIUM ION;Tubulin alpha-1B chain;9913;
6F7L;A;Crystal structure of LkcE R326Q mutant in complex with its substrate;2.5;CA;CALCIUM ION;Amine oxidase LkcE;1928;
6F7L;B;Crystal structure of LkcE R326Q mutant in complex with its substrate;2.5;CA;CALCIUM ION;Amine oxidase LkcE;1928;
6F7V;A;Crystal structure of LkcE E64Q mutant in complex with LC-KA05;3.03;CA;CALCIUM ION;LkcE;1928;
6F8B;A;LasB bound to thiol based inhibitor;1.3;CA;CALCIUM ION;Elastase;287;
6F8Z;A;Structure of the family GH92 alpha-mannosidase BT3130 from Bacteroides thetaiotaomicron;2.5;CA;CALCIUM ION;Alpha-1,2-mannosidase, putative;818;
6F8Z;B;Structure of the family GH92 alpha-mannosidase BT3130 from Bacteroides thetaiotaomicron;2.5;CA;CALCIUM ION;Alpha-1,2-mannosidase, putative;818;
6F8Z;C;Structure of the family GH92 alpha-mannosidase BT3130 from Bacteroides thetaiotaomicron;2.5;CA;CALCIUM ION;Alpha-1,2-mannosidase, putative;818;
6F90;A;Structure of the family GH92 alpha-mannosidase BT3130 from Bacteroides thetaiotaomicron in complex with Mannoimidazole (ManI);2.4;CA;CALCIUM ION;Alpha-1,2-mannosidase, putative;818;
6F90;B;Structure of the family GH92 alpha-mannosidase BT3130 from Bacteroides thetaiotaomicron in complex with Mannoimidazole (ManI);2.4;CA;CALCIUM ION;Alpha-1,2-mannosidase, putative;818;
6F90;C;Structure of the family GH92 alpha-mannosidase BT3130 from Bacteroides thetaiotaomicron in complex with Mannoimidazole (ManI);2.4;CA;CALCIUM ION;Alpha-1,2-mannosidase, putative;818;
6F91;A;Structure of the family GH92 alpha-mannosidase BT3965 from Bacteroides thetaiotaomicron;1.8;CA;CALCIUM ION;Putative alpha-1,2-mannosidase;818;
6F91;B;Structure of the family GH92 alpha-mannosidase BT3965 from Bacteroides thetaiotaomicron;1.8;CA;CALCIUM ION;Putative alpha-1,2-mannosidase;818;
6F91;C;Structure of the family GH92 alpha-mannosidase BT3965 from Bacteroides thetaiotaomicron;1.8;CA;CALCIUM ION;Putative alpha-1,2-mannosidase;818;
6F91;D;Structure of the family GH92 alpha-mannosidase BT3965 from Bacteroides thetaiotaomicron;1.8;CA;CALCIUM ION;Putative alpha-1,2-mannosidase;818;
6F91;E;Structure of the family GH92 alpha-mannosidase BT3965 from Bacteroides thetaiotaomicron;1.8;CA;CALCIUM ION;Putative alpha-1,2-mannosidase;818;
6F91;F;Structure of the family GH92 alpha-mannosidase BT3965 from Bacteroides thetaiotaomicron;1.8;CA;CALCIUM ION;Putative alpha-1,2-mannosidase;818;
6F91;G;Structure of the family GH92 alpha-mannosidase BT3965 from Bacteroides thetaiotaomicron;1.8;CA;CALCIUM ION;Putative alpha-1,2-mannosidase;818;
6F91;H;Structure of the family GH92 alpha-mannosidase BT3965 from Bacteroides thetaiotaomicron;1.8;CA;CALCIUM ION;Putative alpha-1,2-mannosidase;818;
6F92;A;Structure of the family GH92 alpha-mannosidase BT3965 from Bacteroides thetaiotaomicron in complex with Mannoimidazole (ManI);1.9;CA;CALCIUM ION;Putative alpha-1,2-mannosidase;818;
6F92;B;Structure of the family GH92 alpha-mannosidase BT3965 from Bacteroides thetaiotaomicron in complex with Mannoimidazole (ManI);1.9;CA;CALCIUM ION;Putative alpha-1,2-mannosidase;818;
6F92;C;Structure of the family GH92 alpha-mannosidase BT3965 from Bacteroides thetaiotaomicron in complex with Mannoimidazole (ManI);1.9;CA;CALCIUM ION;Putative alpha-1,2-mannosidase;818;
6F92;D;Structure of the family GH92 alpha-mannosidase BT3965 from Bacteroides thetaiotaomicron in complex with Mannoimidazole (ManI);1.9;CA;CALCIUM ION;Putative alpha-1,2-mannosidase;818;
6FAT;A;The crystal structure of a feruloyl esterase C from Fusarium oxysporum.;2.3;CA;CALCIUM ION;Carboxylic ester hydrolase;5507;
6FAT;B;The crystal structure of a feruloyl esterase C from Fusarium oxysporum.;2.3;CA;CALCIUM ION;Carboxylic ester hydrolase;5507;
6FB0;A;Crystal Structure of a Tailored I-CreI Homing Endonuclease Protein (3115 variant) in complex with its target DNA (Haemoglobin beta subunit gene) in the presence of Calcium;2.15;CA;CALCIUM ION;DNA endonuclease I-CreI;3055;
6FB0;B;Crystal Structure of a Tailored I-CreI Homing Endonuclease Protein (3115 variant) in complex with its target DNA (Haemoglobin beta subunit gene) in the presence of Calcium;2.15;CA;CALCIUM ION;DNA endonuclease I-CreI;3055;
6FC2;A;Crystal structure of the eIF4E-Eap1p complex from Saccharomyces cerevisiae;1.92;CA;CALCIUM ION;Eukaryotic translation initiation factor 4E;4932;
6FCG;B;Crystal structure of an endo-laminarinase from Formosa Hel1_33_131;2.6;CA;CALCIUM ION;Glycoside hydrolase, GH17 family;1336794;
6FCG;C;Crystal structure of an endo-laminarinase from Formosa Hel1_33_131;2.6;CA;CALCIUM ION;Glycoside hydrolase, GH17 family;1336794;
6FE5;A;X-ray structure of human glutamate carboxypeptidase II (GCPII) - the E424M inactive mutant, in complex with a inhibitor JHU 2249;1.52;CA;CALCIUM ION;Glutamate carboxypeptidase 2;9606;
6FEG;B;Solution Structure of CaM/Kv7.2-hAB Complex;;CA;CALCIUM ION;Calmodulin-1;9606;
6FEH;B;Solution Structure of CaM/Kv7.2-hAB Complex;;CA;CALCIUM ION;Calmodulin-1;9606;
6FF1;A;CsoZ metallochaperone;1.3;CA;CALCIUM ION;CsoZ;1280;
6FG3;A;Structure of Ryanodine receptor 1 in nanodiscs in the presence of calcium, ATP and ryanodine;7.3;CA;CALCIUM ION;Ryanodine receptor 1;9986;
6FG3;B;Structure of Ryanodine receptor 1 in nanodiscs in the presence of calcium, ATP and ryanodine;7.3;CA;CALCIUM ION;Ryanodine receptor 1;9986;
6FG3;C;Structure of Ryanodine receptor 1 in nanodiscs in the presence of calcium, ATP and ryanodine;7.3;CA;CALCIUM ION;Ryanodine receptor 1;9986;
6FG3;D;Structure of Ryanodine receptor 1 in nanodiscs in the presence of calcium, ATP and ryanodine;7.3;CA;CALCIUM ION;Ryanodine receptor 1;9986;
6FGC;A;Crystal structure of Gephyrin E domain in complex with Artesunate;1.5;CA;CALCIUM ION;Gephyrin;10116;
6FGD;A;Crystal structure of Gephyrin E domain in complex with Artemether;1.5;CA;CALCIUM ION;Gephyrin;10116;
6FGO;E;Fc in complex with engineered calcium binding domain Z;2.5;CA;CALCIUM ION;Z-Ca;1280;
6FGO;F;Fc in complex with engineered calcium binding domain Z;2.5;CA;CALCIUM ION;Z-Ca;1280;
6FGO;G;Fc in complex with engineered calcium binding domain Z;2.5;CA;CALCIUM ION;Z-Ca;1280;
6FGO;H;Fc in complex with engineered calcium binding domain Z;2.5;CA;CALCIUM ION;Z-Ca;1280;
6FHJ;A;Structural dynamics and catalytic properties of a multi-modular xanthanase, native.;2.04;CA;CALCIUM ION;protein,protein;44249;
6FHN;A;Structural dynamics and catalytic properties of a multi-modular xanthanase (Pt derivative);2;CA;CALCIUM ION;protein;58172;
6FI4;A;Crystal structure of C-terminal modified Tau peptide-hybrid 3.2e with 14-3-3sigma;2;CA;CALCIUM ION;14-3-3 protein sigma;9606;
6FI8;A;Crystal structure of the IS608 transposase in complex with left end 29-mer DNA hairpin and a 6-mer DNA representing the intact target site: pre-cleavage target capture complex;2.6;CA;CALCIUM ION;Putative transposase;210;
6FI8;C;Crystal structure of the IS608 transposase in complex with left end 29-mer DNA hairpin and a 6-mer DNA representing the intact target site: pre-cleavage target capture complex;2.6;CA;CALCIUM ION;DNA 29-MER (LE29);210;
6FI8;D;Crystal structure of the IS608 transposase in complex with left end 29-mer DNA hairpin and a 6-mer DNA representing the intact target site: pre-cleavage target capture complex;2.6;CA;CALCIUM ION;DNA 29-MER (LE29);210;
6FI8;F;Crystal structure of the IS608 transposase in complex with left end 29-mer DNA hairpin and a 6-mer DNA representing the intact target site: pre-cleavage target capture complex;2.6;CA;CALCIUM ION;DNA 6-MER (T6');210;
6FI8;G;Crystal structure of the IS608 transposase in complex with left end 29-mer DNA hairpin and a 6-mer DNA representing the intact target site: pre-cleavage target capture complex;2.6;CA;CALCIUM ION;Putative transposase;210;
6FI8;H;Crystal structure of the IS608 transposase in complex with left end 29-mer DNA hairpin and a 6-mer DNA representing the intact target site: pre-cleavage target capture complex;2.6;CA;CALCIUM ION;Putative transposase;210;
6FI8;I;Crystal structure of the IS608 transposase in complex with left end 29-mer DNA hairpin and a 6-mer DNA representing the intact target site: pre-cleavage target capture complex;2.6;CA;CALCIUM ION;DNA 29-MER (LE29);210;
6FI8;J;Crystal structure of the IS608 transposase in complex with left end 29-mer DNA hairpin and a 6-mer DNA representing the intact target site: pre-cleavage target capture complex;2.6;CA;CALCIUM ION;DNA 29-MER (LE29);210;
6FI8;K;Crystal structure of the IS608 transposase in complex with left end 29-mer DNA hairpin and a 6-mer DNA representing the intact target site: pre-cleavage target capture complex;2.6;CA;CALCIUM ION;DNA 6-MER (T6');210;
6FID;A;Bovine trypsin solved by S-SAD on ID30B;2.2;CA;CALCIUM ION;Cationic trypsin;9913;
6FIE;B;Crystallographic structure of calcium loaded Calbindin-D28K.;1.51;CA;CALCIUM ION;Calbindin;9606;
6FIG;A;Crystal structure of the ANX1 ectodomain from Arabidopsis thaliana;1.48;CA;CALCIUM ION;Receptor-like protein kinase ANXUR1;3702;
6FIG;B;Crystal structure of the ANX1 ectodomain from Arabidopsis thaliana;1.48;CA;CALCIUM ION;Receptor-like protein kinase ANXUR1;3702;
6FIH;A;Crystal structure of the ANX2 ectodomain from Arabidopsis thaliana;1.08;CA;CALCIUM ION;Receptor-like protein kinase ANXUR2;3702;
6FII;A;Tubulin-Spongistatin complex;2.4;CA;CALCIUM ION;Tubulin alpha-1B chain;9913;
6FII;B;Tubulin-Spongistatin complex;2.4;CA;CALCIUM ION;Tubulin beta-2B chain;9913;
6FII;C;Tubulin-Spongistatin complex;2.4;CA;CALCIUM ION;Tubulin alpha-1B chain;9913;
6FJ2;A;Structure of Thermolysin solved from SAD data collected at the peak of the Zn absorption edge on ID30B;1.43;CA;CALCIUM ION;Thermolysin;1427;
6FJF;A;Tubulin-FcMaytansine complex;2.4;CA;CALCIUM ION;Tubulin alpha-1B chain;9913;
6FJF;C;Tubulin-FcMaytansine complex;2.4;CA;CALCIUM ION;Tubulin alpha-1B chain;9913;
6FJM;A;tubulin-Disorazole Z complex;2.1;CA;CALCIUM ION;Tubulin alpha-1B chain;9913;
6FJM;B;tubulin-Disorazole Z complex;2.1;CA;CALCIUM ION;Tubulin beta-2B chain;9913;
6FJM;C;tubulin-Disorazole Z complex;2.1;CA;CALCIUM ION;Tubulin alpha-1B chain;9913;
6FJM;D;tubulin-Disorazole Z complex;2.1;CA;CALCIUM ION;Tubulin beta-2B chain;9913;
6FJM;E;tubulin-Disorazole Z complex;2.1;CA;CALCIUM ION;Stathmin-4;10116;
6FJS;A;Proteinase~K SIRAS phased structure of room-temperature, serially collected synchrotron data;1.9;CA;CALCIUM ION;Proteinase K;37998;
6FJW;A;Streptococcus thermophilus Cas6;2.7;CA;CALCIUM ION;Cas6 protein;1308;
6FKJ;A;Tubulin-TUB075 complex;2.15;CA;CALCIUM ION;Tubulin alpha-1B chain;9913;
6FKJ;B;Tubulin-TUB075 complex;2.15;CA;CALCIUM ION;Tubulin beta-2B chain;9913;
6FKJ;C;Tubulin-TUB075 complex;2.15;CA;CALCIUM ION;Tubulin alpha-1B chain;9913;
6FKJ;E;Tubulin-TUB075 complex;2.15;CA;CALCIUM ION;Stathmin-4;10116;
6FKL;A;Tubulin-TUB015 complex;2.1;CA;CALCIUM ION;Tubulin alpha-1B chain;9913;
6FKL;B;Tubulin-TUB015 complex;2.1;CA;CALCIUM ION;Tubulin beta-2B chain;9913;
6FKL;C;Tubulin-TUB015 complex;2.1;CA;CALCIUM ION;Tubulin alpha-1B chain;9913;
6FKQ;A;THE CRYSTAL STRUCTURE OF A FRAGMENT OF NETRIN-1 IN COMPLEX WITH A FRAGMENT OF DRAXIN;3.07;CA;CALCIUM ION;Netrin-1;9606;
6FNA;A;Mono- and bivalent 14-3-3 inhibitors for characterizing supramolecular lysine-PEG interactions in proteins;2.12;CA;CALCIUM ION;14-3-3 protein zeta/delta;9606;
6FNA;B;Mono- and bivalent 14-3-3 inhibitors for characterizing supramolecular lysine-PEG interactions in proteins;2.12;CA;CALCIUM ION;14-3-3 protein zeta/delta;9606;
6FNB;A;Mono- and bivalent 14-3-3 inhibitors for characterizing supramolecular lysine-PEG interactions in proteins;2.3;CA;CALCIUM ION;14-3-3 protein zeta/delta;9606;
6FNB;B;Mono- and bivalent 14-3-3 inhibitors for characterizing supramolecular lysine-PEG interactions in proteins;2.3;CA;CALCIUM ION;14-3-3 protein zeta/delta;9606;
6FNC;A;Mono- and bivalent 14-3-3 inhibitors for characterizing supramolecular lysine-PEG interactions in proteins;2.12;CA;CALCIUM ION;14-3-3 protein zeta/delta;9606;
6FNC;B;Mono- and bivalent 14-3-3 inhibitors for characterizing supramolecular lysine-PEG interactions in proteins;2.12;CA;CALCIUM ION;14-3-3 protein zeta/delta;9606;
6FNY;A;CRYSTAL STRUCTURE OF A CHOLINE SULFATASE FROM SINORHIZOBIUM MELLILOTI;2.79;CA;CALCIUM ION;Choline-sulfatase;382;
6FNY;B;CRYSTAL STRUCTURE OF A CHOLINE SULFATASE FROM SINORHIZOBIUM MELLILOTI;2.79;CA;CALCIUM ION;Choline-sulfatase;382;
6FNY;C;CRYSTAL STRUCTURE OF A CHOLINE SULFATASE FROM SINORHIZOBIUM MELLILOTI;2.79;CA;CALCIUM ION;Choline-sulfatase;382;
6FNY;D;CRYSTAL STRUCTURE OF A CHOLINE SULFATASE FROM SINORHIZOBIUM MELLILOTI;2.79;CA;CALCIUM ION;Choline-sulfatase;382;
6FNY;E;CRYSTAL STRUCTURE OF A CHOLINE SULFATASE FROM SINORHIZOBIUM MELLILOTI;2.79;CA;CALCIUM ION;Choline-sulfatase;382;
6FNY;F;CRYSTAL STRUCTURE OF A CHOLINE SULFATASE FROM SINORHIZOBIUM MELLILOTI;2.79;CA;CALCIUM ION;Choline-sulfatase;382;
6FNY;G;CRYSTAL STRUCTURE OF A CHOLINE SULFATASE FROM SINORHIZOBIUM MELLILOTI;2.79;CA;CALCIUM ION;Choline-sulfatase;382;
6FNY;H;CRYSTAL STRUCTURE OF A CHOLINE SULFATASE FROM SINORHIZOBIUM MELLILOTI;2.79;CA;CALCIUM ION;Choline-sulfatase;382;
6FOP;A;Glycoside hydrolase family 81 from Clostridium thermocellum (CtLam81A), Mutant E515A;1.4;CA;CALCIUM ION;Glycoside hydrolase family 81;1515;
6FQP;L;Crystal structure of TALE homeobox domain transcription factor TGIF1 with its consensus DNA;2.42;CA;CALCIUM ION;DNA (5'-D(P*AP*TP*TP*GP*AP*CP*AP*GP*CP*TP*GP*TP*CP*AP*AP*T)-3');9606;
6FRN;A;Structure of F420H2 oxidase (FprA) co-crystallized with 10mM Tb-Xo4 and calcium chloride;1.74;CA;CALCIUM ION;F420H2 oxidase (FprA);2186;
6FRN;B;Structure of F420H2 oxidase (FprA) co-crystallized with 10mM Tb-Xo4 and calcium chloride;1.74;CA;CALCIUM ION;F420H2 oxidase (FprA);2186;
6FRN;C;Structure of F420H2 oxidase (FprA) co-crystallized with 10mM Tb-Xo4 and calcium chloride;1.74;CA;CALCIUM ION;F420H2 oxidase (FprA);2186;
6FRN;D;Structure of F420H2 oxidase (FprA) co-crystallized with 10mM Tb-Xo4 and calcium chloride;1.74;CA;CALCIUM ION;F420H2 oxidase (FprA);2186;
6FSM;A;Crystal structure of TCE-treated Thermolysin;1.39;CA;CALCIUM ION;Thermolysin;1422;
6FSN;A;Catalytic domain of UDP-Glucose Glycoprotein Glucosyltransferase from Chaetomium thermophilum in complex with UDP-glucose (conformation 1);1.19;CA;CALCIUM ION;UDP-glucose-glycoprotein glucosyltransferase-like protein;209285;
6FU3;A;Structure of the mixed-valence, active form, of cytochrome c peroxidase from obligate human pathogenic bacterium Neisseria gonorrhoeae;1.8;CA;CALCIUM ION;Protein CcpR;485;
6FU3;B;Structure of the mixed-valence, active form, of cytochrome c peroxidase from obligate human pathogenic bacterium Neisseria gonorrhoeae;1.8;CA;CALCIUM ION;Protein CcpR;485;
6FUY;A;Crystal structure of human full-length vinculin-T12-A974K (residues 1-1066);3;CA;CALCIUM ION;Vinculin;9606;
6FVJ;A;TesA a major thioesterase from Mycobacterium tuberculosis;2.6;CA;CALCIUM ION;Thioesterase;1773;
6FVJ;C;TesA a major thioesterase from Mycobacterium tuberculosis;2.6;CA;CALCIUM ION;Thioesterase;1773;
6FVM;A;Mutant DNA polymerase sliding clamp from Escherichia coli with bound P7 peptide;1.63;CA;CALCIUM ION;Beta sliding clamp;562;
6FVO;B;Mutant DNA polymerase sliding clamp from Mycobacterium tuberculosis with bound P7 peptide;2.69;CA;CALCIUM ION;Beta sliding clamp;1773;
6FVO;C;Mutant DNA polymerase sliding clamp from Mycobacterium tuberculosis with bound P7 peptide;2.69;CA;CALCIUM ION;Beta sliding clamp;1773;
6FVO;D;Mutant DNA polymerase sliding clamp from Mycobacterium tuberculosis with bound P7 peptide;2.69;CA;CALCIUM ION;Beta sliding clamp;1773;
6FWF;A;Low resolution structure of Neisseria meningitidis qNOR;4.2;CA;CALCIUM ION;Nitric-oxide reductase;487;
6FWK;A;The crystal structure of Pol2CORE-M644G in complex with DNA and an incoming nucleotide;2.5;CA;CALCIUM ION;DNA polymerase epsilon catalytic subunit A;4932;
6FWK;B;The crystal structure of Pol2CORE-M644G in complex with DNA and an incoming nucleotide;2.5;CA;CALCIUM ION;DNA polymerase epsilon catalytic subunit A;4932;
6FZ1;A;Crystal Structure of lipase from Geobacillus stearothermophilus T6 methanol stable variant L360F;2.2;CA;CALCIUM ION;Lipase;1422;
6FZ7;A;Crystal Structure of lipase from Geobacillus stearothermophilus T6 methanol stable variant L184F;1.74;CA;CALCIUM ION;Lipase;1422;
6FZ8;A;Crystal Structure of lipase from Geobacillus stearothermophilus T6 methanol stable variant L184F/A187F;2.2;CA;CALCIUM ION;Lipase;1422;
6FZ9;A;Crystal Structure of lipase from Geobacillus stearothermophilus T6 methanol stable variant A187F/L360F;1.25;CA;CALCIUM ION;Lipase;1422;
6FZA;A;Crystal Structure of lipase from Geobacillus stearothermophilus T6 methanol stable variant A187F;1.75;CA;CALCIUM ION;Lipase;1422;
6FZC;A;Crystal Structure of lipase from Geobacillus stearothermophilus T6 variant L184F/L360F;2.7;CA;CALCIUM ION;Lipase;1422;
6FZD;A;Crystal Structure of lipase from Geobacillus stearothermophilus T6 variant L184F/A187F/L360F;1.8;CA;CALCIUM ION;Lipase;1422;
6FZV;A;Crystal structure of the metalloproteinase enhancer PCPE-1 bound to the procollagen C propeptide trimer (short);2.7;CA;CALCIUM ION;Collagen alpha-1(III) chain;9606;
6FZV;B;Crystal structure of the metalloproteinase enhancer PCPE-1 bound to the procollagen C propeptide trimer (short);2.7;CA;CALCIUM ION;Collagen alpha-1(III) chain;9606;
6FZV;C;Crystal structure of the metalloproteinase enhancer PCPE-1 bound to the procollagen C propeptide trimer (short);2.7;CA;CALCIUM ION;Collagen alpha-1(III) chain;9606;
6FZV;D;Crystal structure of the metalloproteinase enhancer PCPE-1 bound to the procollagen C propeptide trimer (short);2.7;CA;CALCIUM ION;Procollagen C-endopeptidase enhancer 1;9606;
6FZW;A;Crystal structure of the metalloproteinase enhancer PCPE-1 bound to the procollagen C propeptide trimer (long);2.78;CA;CALCIUM ION;Collagen alpha-1(III) chain;9606;
6FZW;B;Crystal structure of the metalloproteinase enhancer PCPE-1 bound to the procollagen C propeptide trimer (long);2.78;CA;CALCIUM ION;Collagen alpha-1(III) chain;9606;
6FZW;C;Crystal structure of the metalloproteinase enhancer PCPE-1 bound to the procollagen C propeptide trimer (long);2.78;CA;CALCIUM ION;Collagen alpha-1(III) chain;9606;
6FZW;D;Crystal structure of the metalloproteinase enhancer PCPE-1 bound to the procollagen C propeptide trimer (long);2.78;CA;CALCIUM ION;Procollagen C-endopeptidase enhancer 1;9606;
6FZX;A;LasB, hydroxymate Inhibitor Complex;2.1;CA;CALCIUM ION;Keratinase KP2;287;
6G01;A;Complex of neuraminidase from H1N1 influenza virus with tamiphosphor monomethyl ester;1.61;CA;CALCIUM ION;Neuraminidase;11320;
6G01;B;Complex of neuraminidase from H1N1 influenza virus with tamiphosphor monomethyl ester;1.61;CA;CALCIUM ION;Neuraminidase;11320;
6G02;A;Complex of neuraminidase from H1N1 influenza virus with tamiphosphor omega-azidohexyl ester;1.84;CA;CALCIUM ION;Neuraminidase;11320;
6G02;B;Complex of neuraminidase from H1N1 influenza virus with tamiphosphor omega-azidohexyl ester;1.84;CA;CALCIUM ION;Neuraminidase;11320;
6G0A;A;The crystal structure of the Pol2 catalytic domain of DNA polymerase epsilon carrying a P301R substitution.;2.62;CA;CALCIUM ION;DNA polymerase epsilon catalytic subunit A;4932;
6G1O;A;Structure of Pseudomonas aeruginosa Isocitrate Lyase, ICL;1.88;CA;CALCIUM ION;Isocitrate lyase;287;
6G21;A;Crystal structure of an esterase from Aspergillus oryzae;2.1;CA;CALCIUM ION;Probable feruloyl esterase B-2;5062;
6G21;B;Crystal structure of an esterase from Aspergillus oryzae;2.1;CA;CALCIUM ION;Probable feruloyl esterase B-2;5062;
6G3O;A;Crystal structure of human HDAC2 in complex with (R)-6-[3,4-Dioxo-2-(4-trifluoromethoxy-phenylamino)-cyclobut-1-enylamino]-heptanoic acid hydroxyamide;2.27;CA;CALCIUM ION;Histone deacetylase 2;9606;
6G3O;B;Crystal structure of human HDAC2 in complex with (R)-6-[3,4-Dioxo-2-(4-trifluoromethoxy-phenylamino)-cyclobut-1-enylamino]-heptanoic acid hydroxyamide;2.27;CA;CALCIUM ION;Histone deacetylase 2;9606;
6G3O;C;Crystal structure of human HDAC2 in complex with (R)-6-[3,4-Dioxo-2-(4-trifluoromethoxy-phenylamino)-cyclobut-1-enylamino]-heptanoic acid hydroxyamide;2.27;CA;CALCIUM ION;Histone deacetylase 2;9606;
6G4G;A;Full length ectodomain of ectonucleotide phosphodiesterase/pyrophosphatase-3 (NPP3) including the SMB domains but with a partially disordered active site structure;2.8;CA;CALCIUM ION;Ectonucleotide pyrophosphatase/phosphodiesterase family member 3;10116;
6G4G;B;Full length ectodomain of ectonucleotide phosphodiesterase/pyrophosphatase-3 (NPP3) including the SMB domains but with a partially disordered active site structure;2.8;CA;CALCIUM ION;Ectonucleotide pyrophosphatase/phosphodiesterase family member 3;10116;
6G4G;C;Full length ectodomain of ectonucleotide phosphodiesterase/pyrophosphatase-3 (NPP3) including the SMB domains but with a partially disordered active site structure;2.8;CA;CALCIUM ION;Ectonucleotide pyrophosphatase/phosphodiesterase family member 3;10116;
6G4G;D;Full length ectodomain of ectonucleotide phosphodiesterase/pyrophosphatase-3 (NPP3) including the SMB domains but with a partially disordered active site structure;2.8;CA;CALCIUM ION;Ectonucleotide pyrophosphatase/phosphodiesterase family member 3;10116;
6G5J;A;Secreted phospholipase A2 type X in complex with ligand;1.85;CA;CALCIUM ION;Group 10 secretory phospholipase A2;9606;
6G5J;B;Secreted phospholipase A2 type X in complex with ligand;1.85;CA;CALCIUM ION;Group 10 secretory phospholipase A2;9606;
6G7O;A;Crystal structure of human alkaline ceramidase 3 (ACER3) at 2.7 Angstrom resolution;2.7;CA;CALCIUM ION;Alkaline ceramidase 3,Soluble cytochrome b562;5,629,606;
6G82;A;Serum paraoxonase-1 by directed evolution with the L69S/H115W/F222S mutations;2.4;CA;CALCIUM ION;Serum paraoxonase-1 by directed evolution with the L69S/H115W/F222S mutations;9606;
6G84;A;Structure of Cdc14 bound to CBK1 PxL motif;2.47;CA;CALCIUM ION;Tyrosine-protein phosphatase CDC14;4932;
6G84;B;Structure of Cdc14 bound to CBK1 PxL motif;2.47;CA;CALCIUM ION;Tyrosine-protein phosphatase CDC14;4932;
6G8P;A;14-3-3sigma in complex with a P129beta3P and L132beta3L mutated YAP pS127 phosphopeptide;1.9;CA;CALCIUM ION;14-3-3 protein sigma;9606;
6G8Q;A;14-3-3sigma in complex with a A130beta3A and Q133beta3Q mutated YAP pS127 phosphopeptide;1.85;CA;CALCIUM ION;14-3-3 protein sigma;9606;
6GAQ;A;Crystal structure of oxidised Flavodoxin 2 from Bacillus cereus;2.5;CA;CALCIUM ION;Flavodoxin;1396;
6GAQ;B;Crystal structure of oxidised Flavodoxin 2 from Bacillus cereus;2.5;CA;CALCIUM ION;Flavodoxin;1396;
6GDK;A;Calcium bound form of human calmodulin mutant F141L;;CA;CALCIUM ION;Calmodulin-1;9606;
6GF3;A;Tubulin-Jerantinine B acetate complex;2.4;CA;CALCIUM ION;Tubulin alpha-1B chain;9913;
6GF3;C;Tubulin-Jerantinine B acetate complex;2.4;CA;CALCIUM ION;Tubulin alpha-1B chain;9913;
6GFE;H;High-resolution Structure of a therapeutic full-length anti-NPRA Antibody with exceptional Conformational Diversity;1.8;CA;CALCIUM ION;Immunoglobulin gamma-4 heavy chain;9606;
6GFE;K;High-resolution Structure of a therapeutic full-length anti-NPRA Antibody with exceptional Conformational Diversity;1.8;CA;CALCIUM ION;Immunoglobulin gamma-4 heavy chain;9606;
6GH8;A;Crystal structure of GP1 domain of Lujo virus in complex with the first CUB domain of neuropilin-2;2.44;CA;CALCIUM ION;Neuropilin-2;9606;
6GH8;C;Crystal structure of GP1 domain of Lujo virus in complex with the first CUB domain of neuropilin-2;2.44;CA;CALCIUM ION;Neuropilin-2;9606;
6GHW;C;Substituting the prolines of 4-oxalocrotonate tautomerase with non-canonical analogue (2S)-3,4-dehydroproline;2.3;CA;CALCIUM ION;2-hydroxymuconate tautomerase;303;
6GHX;A;Alzheimer's Amyloid-Beta Peptide Fragment 31-35 in Complex with Cd-substituted Thermolysin;1.16;CA;CALCIUM ION;Thermolysin;1422;
6GJ4;A;Tubulin-6j complex;2.4;CA;CALCIUM ION;Tubulin alpha-1B chain;9913;
6GJ4;C;Tubulin-6j complex;2.4;CA;CALCIUM ION;Tubulin alpha-1B chain;9913;
6GKU;A;Structure of galectin-10 in complex with the Fab fragment of a Charcot-Leyden crystal solubilizing antibody, 6F5;1.91;CA;CALCIUM ION;Galectin-10;9606;
6GMU;A;Serum paraoxonase-1 by directed evolution with the L69G/H134R/F222S/T332S mutations;2.7;CA;CALCIUM ION;Serum Paraoxonase-1 by directed evolution with the L69G/H134R/F222S/T332S mutations;9606;
6GO2;A;Carboxypeptidase T with N-sulfamoyl-L-Leucine;1.9;CA;CALCIUM ION;Carboxypeptidase T;2026;
6GP2;A;Ribonucleotide Reductase class Ie R2 from Mesoplasma florum, DOPA-active form;1.48;CA;CALCIUM ION;Ribonucleoside-diphosphate reductase beta chain;2151;
6GP2;B;Ribonucleotide Reductase class Ie R2 from Mesoplasma florum, DOPA-active form;1.48;CA;CALCIUM ION;Ribonucleoside-diphosphate reductase beta chain;2151;
6GP3;A;Ribonucleotide Reductase class Ie R2 from Mesoplasma florum, inactive form;1.23;CA;CALCIUM ION;Ribonucleoside-diphosphate reductase beta chain;2151;
6GP3;B;Ribonucleotide Reductase class Ie R2 from Mesoplasma florum, inactive form;1.23;CA;CALCIUM ION;Ribonucleoside-diphosphate reductase beta chain;2151;
6GQG;A;Structure of GFPmut2 crystallized at pH 8.5;1.79;CA;CALCIUM ION;Green fluorescent protein;6100;
6GQH;A;Structure of GFPmut2 crystallized at pH 8.5 and transferred to pH 6;2.4;CA;CALCIUM ION;Green fluorescent protein;6100;
6GRR;A;Crystal structure of Escherichia coli amine oxidase mutant I342F/E573Q;1.7;CA;CALCIUM ION;Amine oxidase;562;
6GRR;B;Crystal structure of Escherichia coli amine oxidase mutant I342F/E573Q;1.7;CA;CALCIUM ION;Amine oxidase;562;
6GRW;A;Glucuronoyl Esterase from Opitutus terrae (Au derivative);1.5;CA;CALCIUM ION;Putative acetyl xylan esterase;107709;
6GSP;A;RIBONUCLEASE T1/3'-GMP, 15 WEEKS;2.2;CA;CALCIUM ION;RIBONUCLEASE T1;5062;
6GSZ;A;Crystal structure of native alfa-L-rhamnosidase from Aspergillus terreus;1.38;CA;CALCIUM ION;Alpha-L-rhamnosidase;33178;
6GTW;A;Crystal structure of the FimH lectin domain from E.coli F18 in complex with trimannose;2.5;CA;CALCIUM ION;FimH protein;562;
6GTW;B;Crystal structure of the FimH lectin domain from E.coli F18 in complex with trimannose;2.5;CA;CALCIUM ION;FimH protein;562;
6GTW;D;Crystal structure of the FimH lectin domain from E.coli F18 in complex with trimannose;2.5;CA;CALCIUM ION;FimH protein;562;
6GW9;A;Concanavalin A structure determined with data from the EuXFEL, the first MHz free electron laser;2.1;CA;CALCIUM ION;Concanavalin V;28958;
6GXV;A;Amylase in complex with acarbose;2.07;CA;CALCIUM ION;A-amylase;61169;
6GXV;B;Amylase in complex with acarbose;2.07;CA;CALCIUM ION;A-amylase;61169;
6GXZ;A;Crystal structure of the human RPAP3(TPR2)-PIH1D1(CS) complex;2.96;CA;CALCIUM ION;RNA polymerase II-associated protein 3;9606;
6GYA;A;Amylase in complex with branched ligand;2.95;CA;CALCIUM ION;A-amylase;61169;
6GYA;B;Amylase in complex with branched ligand;2.95;CA;CALCIUM ION;A-amylase;61169;
6GYA;C;Amylase in complex with branched ligand;2.95;CA;CALCIUM ION;A-amylase;61169;
6GYA;D;Amylase in complex with branched ligand;2.95;CA;CALCIUM ION;A-amylase;61169;
6GYI;A;Azurin fom Pseudomonas aeruginosa treated with hydrosulfide;1.6;CA;CALCIUM ION;Azurin;287;
6GYI;B;Azurin fom Pseudomonas aeruginosa treated with hydrosulfide;1.6;CA;CALCIUM ION;Azurin;287;
6GYI;C;Azurin fom Pseudomonas aeruginosa treated with hydrosulfide;1.6;CA;CALCIUM ION;Azurin;287;
6GYI;D;Azurin fom Pseudomonas aeruginosa treated with hydrosulfide;1.6;CA;CALCIUM ION;Azurin;287;
6H16;A;Structure of LRP6 P3E3P4E4 in complex with VHH L-P2-D07;2.9;CA;CALCIUM ION;Low-density lipoprotein receptor-related protein 6;9606;
6H2B;A;Structure of the Macrobrachium rosenbergii Nodavirus;3.28;CA;CALCIUM ION;Capsid protein;222557;
6H2B;B;Structure of the Macrobrachium rosenbergii Nodavirus;3.28;CA;CALCIUM ION;Capsid protein;222557;
6H2B;C;Structure of the Macrobrachium rosenbergii Nodavirus;3.28;CA;CALCIUM ION;Capsid protein;222557;
6H2M;A;Long wavelength Mesh&Collect native SAD phasing on microcrystals;1.93;CA;CALCIUM ION;Concanavalin-A,Concanavalin-A;3823;
6H6N;A;UbiJ-SCP2 Ubiquinone synthesis protein;2.12;CA;CALCIUM ION;Ubiquinone biosynthesis protein UbiJ;562;
6H6N;B;UbiJ-SCP2 Ubiquinone synthesis protein;2.12;CA;CALCIUM ION;Ubiquinone biosynthesis protein UbiJ;562;
6H6O;A;UbiJ-SCP2 Ubiquinone synthesis protein;1.7;CA;CALCIUM ION;Ubiquinone biosynthesis protein UbiJ;562;
6H6O;B;UbiJ-SCP2 Ubiquinone synthesis protein;1.7;CA;CALCIUM ION;Ubiquinone biosynthesis protein UbiJ;562;
6H6P;A;UbiJ-SCP2 Ubiquinone synthesis protein;2.5;CA;CALCIUM ION;Ubiquinone biosynthesis protein UbiJ;562;
6H6P;B;UbiJ-SCP2 Ubiquinone synthesis protein;2.5;CA;CALCIUM ION;Ubiquinone biosynthesis protein UbiJ;562;
6H6P;C;UbiJ-SCP2 Ubiquinone synthesis protein;2.5;CA;CALCIUM ION;Ubiquinone biosynthesis protein UbiJ;562;
6H6P;D;UbiJ-SCP2 Ubiquinone synthesis protein;2.5;CA;CALCIUM ION;Ubiquinone biosynthesis protein UbiJ;562;
6H6V;A;Structure of the UbiD-class enzyme HmfF from Pelotomaculum thermopropionicum in complex with FMN;2.66;CA;CALCIUM ION;3-polyprenyl-4-hydroxybenzoate decarboxylase and related decarboxylases;110500;
6H6V;B;Structure of the UbiD-class enzyme HmfF from Pelotomaculum thermopropionicum in complex with FMN;2.66;CA;CALCIUM ION;3-polyprenyl-4-hydroxybenzoate decarboxylase and related decarboxylases;110500;
6H6V;C;Structure of the UbiD-class enzyme HmfF from Pelotomaculum thermopropionicum in complex with FMN;2.66;CA;CALCIUM ION;3-polyprenyl-4-hydroxybenzoate decarboxylase and related decarboxylases;110500;
6H6V;D;Structure of the UbiD-class enzyme HmfF from Pelotomaculum thermopropionicum in complex with FMN;2.66;CA;CALCIUM ION;3-polyprenyl-4-hydroxybenzoate decarboxylase and related decarboxylases;110500;
6H6V;E;Structure of the UbiD-class enzyme HmfF from Pelotomaculum thermopropionicum in complex with FMN;2.66;CA;CALCIUM ION;3-polyprenyl-4-hydroxybenzoate decarboxylase and related decarboxylases;110500;
6H6V;F;Structure of the UbiD-class enzyme HmfF from Pelotomaculum thermopropionicum in complex with FMN;2.66;CA;CALCIUM ION;3-polyprenyl-4-hydroxybenzoate decarboxylase and related decarboxylases;110500;
6H6X;A;Structure of an evolved dimeric form of the UbiD-class enzyme HmfF from Pelotomaculum thermopropionicum in complex with prFMN;2.25;CA;CALCIUM ION;3-polyprenyl-4-hydroxybenzoate decarboxylase and related decarboxylases;110500;
6H6X;B;Structure of an evolved dimeric form of the UbiD-class enzyme HmfF from Pelotomaculum thermopropionicum in complex with prFMN;2.25;CA;CALCIUM ION;3-polyprenyl-4-hydroxybenzoate decarboxylase and related decarboxylases;110500;
6H7Y;A;X-ray structure of human glutamate carboxypeptidase II (GCPII) in complex with a inhibitor RNA 1-79-1;1.81;CA;CALCIUM ION;Glutamate carboxypeptidase 2;9606;
6H7Z;A;X-ray structure of human glutamate carboxypeptidase II (GCPII) in complex with a inhibitor RNA 2-65-1;2;CA;CALCIUM ION;Glutamate carboxypeptidase 2;9606;
6H9X;A;Klebsiella pneumoniae Seryl-tRNA Synthetase in Complex with the Intermediate Analog 5'-O-(N-(L-Seryl)-Sulfamoyl)Adenosine;2.1;CA;CALCIUM ION;Serine--tRNA ligase;573;
6HAR;A;Crystal structure of Mesotrypsin in complex with APPI-M17C/I18F/F34C;1.5;CA;CALCIUM ION;PRSS3 protein;9606;
6HBE;A;Cu-containing nitrite reductase (NirK) from Thermus scotoductus SA-01;1.63;CA;CALCIUM ION;Copper-containing nitrite reductase;37636;
6HBE;B;Cu-containing nitrite reductase (NirK) from Thermus scotoductus SA-01;1.63;CA;CALCIUM ION;Copper-containing nitrite reductase;37636;
6HBE;C;Cu-containing nitrite reductase (NirK) from Thermus scotoductus SA-01;1.63;CA;CALCIUM ION;Copper-containing nitrite reductase;37636;
6HCS;A;Crystal structure of CaM-peptide complex containing AzF at position 108;2;CA;CALCIUM ION;Calmodulin-1;9606;
6HCS;C;Crystal structure of CaM-peptide complex containing AzF at position 108;2;CA;CALCIUM ION;Calmodulin-1;9606;
6HCS;E;Crystal structure of CaM-peptide complex containing AzF at position 108;2;CA;CALCIUM ION;Calmodulin-1;9606;
6HCS;G;Crystal structure of CaM-peptide complex containing AzF at position 108;2;CA;CALCIUM ION;Calmodulin-1;9606;
6HCX;A;Influenza Virus N9 Neuraminidase A complex with Zanamivir molecule (Tern).;1.3;CA;CALCIUM ION;Neuraminidase;11320;
6HEB;A;Influenza A Virus N9 Neuraminidase complex with Oseltamivir (Tern).;1.75;CA;CALCIUM ION;Neuraminidase;11320;
6HEF;A;Room temperature structure of the (SR)Ca2+-ATPase Ca2-E1-CaAMPPCP form;3.54;CA;CALCIUM ION;Sarcoplasmic/endoplasmic reticulum calcium ATPase 1;9986;
6HF2;A;The structure of BoMan26B, a GH26 beta-mannanase from Bacteroides ovatus;1.69;CA;CALCIUM ION;Glycosyl hydrolase family 26;28116;
6HF4;A;The structure of BoMan26B, a GH26 beta-mannanase from Bacteroides ovatus, complexed with G1M4;1.78;CA;CALCIUM ION;Glycosyl hydrolase family 26;28116;
6HFC;A;Influenza A Virus N9 Neuraminidase Native (Tern).;1.29;CA;CALCIUM ION;Neuraminidase;11320;
6HFY;A;Influenza A virus N6 neuraminidase complex with DANA (Duck/England/56).;1.65;CA;CALCIUM ION;Neuraminidase;11320;
6HFY;B;Influenza A virus N6 neuraminidase complex with DANA (Duck/England/56).;1.65;CA;CALCIUM ION;Neuraminidase;11320;
6HFY;C;Influenza A virus N6 neuraminidase complex with DANA (Duck/England/56).;1.65;CA;CALCIUM ION;Neuraminidase;11320;
6HFY;D;Influenza A virus N6 neuraminidase complex with DANA (Duck/England/56).;1.65;CA;CALCIUM ION;Neuraminidase;11320;
6HG0;A;Influenza A Virus N9 Neuraminidase complex with NANA (Tern/Australia).;1.3;CA;CALCIUM ION;Neuraminidase;11320;
6HG5;A;Influenza A virus N6 neuraminidase complex with Oseltamivir (Duck/England/56).;1.6;CA;CALCIUM ION;Neuraminidase;11320;
6HG5;B;Influenza A virus N6 neuraminidase complex with Oseltamivir (Duck/England/56).;1.6;CA;CALCIUM ION;Neuraminidase;11320;
6HG5;C;Influenza A virus N6 neuraminidase complex with Oseltamivir (Duck/England/56).;1.6;CA;CALCIUM ION;Neuraminidase;11320;
6HG5;D;Influenza A virus N6 neuraminidase complex with Oseltamivir (Duck/England/56).;1.6;CA;CALCIUM ION;Neuraminidase;11320;
6HGB;A;Influenza A virus N6 neuraminidase native structure (Duck/England/56).;1.5;CA;CALCIUM ION;Neuraminidase;11320;
6HGB;B;Influenza A virus N6 neuraminidase native structure (Duck/England/56).;1.5;CA;CALCIUM ION;Neuraminidase;11320;
6HGB;C;Influenza A virus N6 neuraminidase native structure (Duck/England/56).;1.5;CA;CALCIUM ION;Neuraminidase;11320;
6HGB;D;Influenza A virus N6 neuraminidase native structure (Duck/England/56).;1.5;CA;CALCIUM ION;Neuraminidase;11320;
6HGM;A;Crystal structure of Alpha1-antichymotrypsin variant NewBG-III-allo: an allosterically controlled new binding globulin with an unprecedentedly high ligand release efficacy;1.37;CA;CALCIUM ION;Alpha-1-antichymotrypsin;9606;
6HK5;C;X-ray structure of a truncated mutant of the metallochaperone CooJ with a high-affinity nickel-binding site;2.04;CA;CALCIUM ION;CooJ;1085;
6HKJ;A;X-ray structure of human glutamate carboxypeptidase II (GCPII) in complex with a inhibitor RNA 2-19-1;2.09;CA;CALCIUM ION;Glutamate carboxypeptidase 2;9606;
6HKZ;A;X-ray structure of human glutamate carboxypeptidase II (GCPII) in complex with a inhibitor RNA 2-49-1;2.09;CA;CALCIUM ION;Glutamate carboxypeptidase 2;9606;
6HLB;A;X-ray structure of furin in complex with the cyclic peptide c[succinyl-Phe-2-Nal-(Arg)4-Lys]-Arg-4-Amba;2;CA;CALCIUM ION;Furin;9606;
6HLD;A;X-ray structure of furin in complex with the cyclic peptide c[succinyl-Phe-2-Nal-(Arg)3-Lys]-Lys-4-Amba;2.1;CA;CALCIUM ION;Furin;9606;
6HLE;A;X-ray structure of furin in complex with the P6-P2-cyclized peptide H-Lys-Arg-Arg-Tle-Lys-4-Amba;1.99;CA;CALCIUM ION;Furin;9606;
6HM3;A;Crystal structure of Rad4 BRCT1,2 in complex with a Sld3 phosphopeptide;1.77;CA;CALCIUM ION;S-M checkpoint control protein rad4;4896;
6HMF;B;D-family DNA polymerase - DP1 subunit (3'-5' proof-reading exonuclease) H451 proof-reading deficient variant;2.6;CA;CALCIUM ION;DNA polymerase II small subunit;29292;
6HOS;A;Structure of the KpFlo2 adhesin domain in complex with glycerol;2.15;CA;CALCIUM ION;BA75_04148T0;4922;
6HOS;B;Structure of the KpFlo2 adhesin domain in complex with glycerol;2.15;CA;CALCIUM ION;BA75_04148T0;4922;
6HPE;B;Crystal structure of glutathione transferase Omega 3S from Trametes versicolor in complex with the glutathione adduct of phenethyl-isothiocyanate;1.45;CA;CALCIUM ION;Glutathione transferase Omega 3S;5325;
6HQB;B;Monomeric cyanobacterial photosystem I;4;CA;CALCIUM ION;Photosystem I P700 chlorophyll a apoprotein A2;1148;
6HQB;L;Monomeric cyanobacterial photosystem I;4;CA;CALCIUM ION;Photosystem I reaction center subunit XI;1148;
6HS5;A;N-terminal domain including the conserved ImpA_N region of the TssA component of the type VI secretion system from Burkholderia cenocepacia;1.8;CA;CALCIUM ION;TssA;95486;
6HTL;A;Measles Phosphoprotein Coiled-Coil Domain IPKI Variant;2.3;CA;CALCIUM ION;Phosphoprotein;11234;
6HU9;a;III2-IV2 mitochondrial respiratory supercomplex from S. cerevisiae;3.35;CA;CALCIUM ION;Cytochrome c oxidase subunit 1;4932;
6HU9;m;III2-IV2 mitochondrial respiratory supercomplex from S. cerevisiae;3.35;CA;CALCIUM ION;Cytochrome c oxidase subunit 1;4932;
6HUN;A;Dimeric Archeal Rubisco from Hyperthermus butylicus;1.8;CA;CALCIUM ION;Ribulose bisphosphate carboxylase;54248;
6HV2;A;MMP-13 in complex with the peptide IMISF;1.71;CA;CALCIUM ION;Collagenase 3;9606;
6HVG;A;Crystal Structure of Truncated Alternansucrase from Leuconostoc mesenteroides NRRL B-1355;2.8;CA;CALCIUM ION;Alternansucrase;1245;
6HVG;B;Crystal Structure of Truncated Alternansucrase from Leuconostoc mesenteroides NRRL B-1355;2.8;CA;CALCIUM ION;Alternansucrase;1245;
6HX8;A;Tubulin-STX3451 complex;2.4;CA;CALCIUM ION;Tubulin alpha-1B chain;9913;
6HX8;C;Tubulin-STX3451 complex;2.4;CA;CALCIUM ION;Tubulin alpha-1B chain;9913;
6HXB;A;SERCA2a from pig heart;4;CA;CALCIUM ION;Sarcoplasmic/endoplasmic reticulum calcium ATPase 2;9823;
6HYJ;A;PSPH Human phosphoserine phosphatase;1.93;CA;CALCIUM ION;Phosphoserine phosphatase;9606;
6HYJ;B;PSPH Human phosphoserine phosphatase;1.93;CA;CALCIUM ION;Phosphoserine phosphatase;9606;
6HYY;B;Human phosphoserine phosphatase with serine and phosphate;1.57;CA;CALCIUM ION;Phosphoserine phosphatase;9606;
6HZA;A;X-ray structure of furin in complex with the cyclic peptide c[glutaryl-Arg-Arg-Lys]-Arg-4-Amba;1.9;CA;CALCIUM ION;Furin;9606;
6HZB;A;X-ray structure of furin in complex with the cyclic inhibitor c[glutaryl-Arg-Arg-Lys]-Lys-4-Amba;1.9;CA;CALCIUM ION;Furin;9606;
6HZC;A;X-ray structure of furin in complex with the cyclic inhibitor c[glutaryl-BVK-Lys-Arg-Arg-Tle-Lys]-4-Amba;1.9;CA;CALCIUM ION;Furin;9606;
6HZD;A;X-ray structure of furin in complex with the cyclic inhibitor c[glutaryl-Arg-Arg-Arg-Lys]-Arg-4-Amba;1.9;CA;CALCIUM ION;Furin;9606;
6HZZ;A;Structure of human D-glucuronyl C5 epimerase;2.52;CA;CALCIUM ION;D-glucuronyl C5-epimerase;9606;
6HZZ;B;Structure of human D-glucuronyl C5 epimerase;2.52;CA;CALCIUM ION;D-glucuronyl C5-epimerase;9606;
6I01;A;Structure of human D-glucuronyl C5 epimerase in complex with substrate;2.1;CA;CALCIUM ION;D-glucuronyl C5-epimerase;9606;
6I01;B;Structure of human D-glucuronyl C5 epimerase in complex with substrate;2.1;CA;CALCIUM ION;D-glucuronyl C5-epimerase;9606;
6I02;A;Structure of human D-glucuronyl C5 epimerase in complex with product;2.45;CA;CALCIUM ION;D-glucuronyl C5-epimerase;9606;
6I02;B;Structure of human D-glucuronyl C5 epimerase in complex with product;2.45;CA;CALCIUM ION;D-glucuronyl C5-epimerase;9606;
6I28;A;Crystal Structure of Cydia Pomonella PTP-2 phosphatase;1.65;CA;CALCIUM ION;ORF98 PTP-2;28289;
6I2Q;A;Crystal structure of the wild-type SucA domain of Mycobacterium smegmatis KGD (alpha-ketoglutarate decarboxylase), in complex with GarA;2.15;CA;CALCIUM ION;Multifunctional 2-oxoglutarate metabolism enzyme;1772;
6I2R;A;Crystal structure of the SucA domain of Mycobacterium smegmatis KGD (alpha-ketoglutarate decarboxylase), mutant R802A, in complex with GarA;2.2;CA;CALCIUM ION;Multifunctional 2-oxoglutarate metabolism enzyme;1772;
6I2R;C;Crystal structure of the SucA domain of Mycobacterium smegmatis KGD (alpha-ketoglutarate decarboxylase), mutant R802A, in complex with GarA;2.2;CA;CALCIUM ION;Multifunctional 2-oxoglutarate metabolism enzyme;1772;
6I2S;A;Crystal structure of the SucA domain of Mycobacterium smegmatis KGD (R802A) in complex with GarA, following 2-oxoglutarate soak;2.4;CA;CALCIUM ION;Multifunctional 2-oxoglutarate metabolism enzyme;1772;
6I5C;A;Long wavelength native-SAD phasing of Tubulin-Stathmin-TTL complex;2.95;CA;CALCIUM ION;Tubulin alpha-1B chain;9913;
6I5C;B;Long wavelength native-SAD phasing of Tubulin-Stathmin-TTL complex;2.95;CA;CALCIUM ION;Tubulin beta-2B chain;9913;
6I5C;C;Long wavelength native-SAD phasing of Tubulin-Stathmin-TTL complex;2.95;CA;CALCIUM ION;Tubulin alpha-1B chain;9913;
6I5C;D;Long wavelength native-SAD phasing of Tubulin-Stathmin-TTL complex;2.95;CA;CALCIUM ION;Tubulin beta-2B chain;9913;
6I8A;A;The crystal structure of the Pol2 catalytic domain of DNA polymerase epsilon carrying a P301R substitution.;2.65;CA;CALCIUM ION;DNA polymerase epsilon catalytic subunit A;4932;
6I8A;B;The crystal structure of the Pol2 catalytic domain of DNA polymerase epsilon carrying a P301R substitution.;2.65;CA;CALCIUM ION;DNA polymerase epsilon catalytic subunit A;4932;
6I9A;A;Porphyromonas gingivalis gingipain K (Kgp) in complex with inhibitor KYT-36;1.2;CA;CALCIUM ION;Lys-gingipain W83;837;
6I9A;B;Porphyromonas gingivalis gingipain K (Kgp) in complex with inhibitor KYT-36;1.2;CA;CALCIUM ION;Lys-gingipain W83;837;
6IA7;A;T. brucei IFT22 GTP-bound crystal structure;2.3;CA;CALCIUM ION;Intraflagellar transport protein 22;5691;
6IAL;B;Porcine E.coli heat-labile enterotoxin B-pentamer in complex with Lacto-N-neohexaose;1.45;CA;CALCIUM ION;Heat-labile enterotoxin B chain;562;
6IAV;A;CO-AZURIN FROM PSEUDOMONAS AERUGINOSA TREATED WITH HYDROSULFIDE;2;CA;CALCIUM ION;Azurin;287;
6IAV;B;CO-AZURIN FROM PSEUDOMONAS AERUGINOSA TREATED WITH HYDROSULFIDE;2;CA;CALCIUM ION;Azurin;287;
6IAV;C;CO-AZURIN FROM PSEUDOMONAS AERUGINOSA TREATED WITH HYDROSULFIDE;2;CA;CALCIUM ION;Azurin;287;
6IBS;A;Crystal structure of NDM-1 beta-lactamase in complex with boronic inhibitor cpd 6;1.37;CA;CALCIUM ION;Metallo-beta-lactamase type 2;573;
6IBS;B;Crystal structure of NDM-1 beta-lactamase in complex with boronic inhibitor cpd 6;1.37;CA;CALCIUM ION;Metallo-beta-lactamase type 2;573;
6IBV;A;Crystal structure of NDM-1 beta-lactamase in complex with broad spectrum boronic inhibitor cpd 1;1.4;CA;CALCIUM ION;Metallo-beta-lactamase type 2;573;
6IBV;B;Crystal structure of NDM-1 beta-lactamase in complex with broad spectrum boronic inhibitor cpd 1;1.4;CA;CALCIUM ION;Metallo-beta-lactamase type 2;573;
6IDN;A;Crystal structure of ICChI chitinase from ipomoea carnea;1.5;CA;CALCIUM ION;ICChI, a glycosylated chitinase;89640;
6IEJ;A;The C2 domain of cytosolic phospholipase A2 alpha bound to phosphatidylcholine;2.21;CA;CALCIUM ION;Cytosolic phospholipase A2;9031;
6IEJ;B;The C2 domain of cytosolic phospholipase A2 alpha bound to phosphatidylcholine;2.21;CA;CALCIUM ION;Cytosolic phospholipase A2;9031;
6IEJ;C;The C2 domain of cytosolic phospholipase A2 alpha bound to phosphatidylcholine;2.21;CA;CALCIUM ION;Cytosolic phospholipase A2;9031;
6IG7;A;Crystal structure of thermolysin delivered in polyacrylamide using x-ray free electron laser;1.8;CA;CALCIUM ION;Thermolysin;1427;
6IIE;A;Crystal structure of human diacylglycerol kinase alpha EF-hand domains bound to Ca2+;2.14;CA;CALCIUM ION;Diacylglycerol kinase alpha;9606;
6IM7;A;CueO-12.1 multicopper oxidase;1.97;CA;CALCIUM ION;Blue copper oxidase CueO,12.1 peptide,Blue copper oxidase CueO;56,232,630;
6INT;A;xylose isomerase from Paenibacillus sp. R4;1.94;CA;CALCIUM ION;Xylose isomerase;1079050;
6INT;B;xylose isomerase from Paenibacillus sp. R4;1.94;CA;CALCIUM ION;Xylose isomerase;1079050;
6INT;C;xylose isomerase from Paenibacillus sp. R4;1.94;CA;CALCIUM ION;Xylose isomerase;1079050;
6INT;D;xylose isomerase from Paenibacillus sp. R4;1.94;CA;CALCIUM ION;Xylose isomerase;1079050;
6INT;E;xylose isomerase from Paenibacillus sp. R4;1.94;CA;CALCIUM ION;Xylose isomerase;1079050;
6INT;F;xylose isomerase from Paenibacillus sp. R4;1.94;CA;CALCIUM ION;Xylose isomerase;1079050;
6INT;G;xylose isomerase from Paenibacillus sp. R4;1.94;CA;CALCIUM ION;Xylose isomerase;1079050;
6INT;H;xylose isomerase from Paenibacillus sp. R4;1.94;CA;CALCIUM ION;Xylose isomerase;1079050;
6IOP;A;The ligand binding domain of Mlp24;2.3;CA;CALCIUM ION;Methyl-accepting chemotaxis protein;666;
6IOP;B;The ligand binding domain of Mlp24;2.3;CA;CALCIUM ION;Methyl-accepting chemotaxis protein;666;
6IOQ;A;The ligand binding domain of Mlp24 with glycine;2.14;CA;CALCIUM ION;Methyl-accepting chemotaxis protein;666;
6IOR;A;The ligand binding domain of Mlp24 with asparagine;2.5;CA;CALCIUM ION;Methyl-accepting chemotaxis protein;666;
6IOR;B;The ligand binding domain of Mlp24 with asparagine;2.5;CA;CALCIUM ION;Methyl-accepting chemotaxis protein;666;
6IOR;C;The ligand binding domain of Mlp24 with asparagine;2.5;CA;CALCIUM ION;Methyl-accepting chemotaxis protein;666;
6IOR;D;The ligand binding domain of Mlp24 with asparagine;2.5;CA;CALCIUM ION;Methyl-accepting chemotaxis protein;666;
6IOS;A;The ligand binding domain of Mlp24 with proline;2.35;CA;CALCIUM ION;Methyl-accepting chemotaxis protein;666;
6IOT;A;The ligand binding domain of Mlp24 with arginine;2.7;CA;CALCIUM ION;Methyl-accepting chemotaxis protein;666;
6IOT;B;The ligand binding domain of Mlp24 with arginine;2.7;CA;CALCIUM ION;Methyl-accepting chemotaxis protein;666;
6IOT;C;The ligand binding domain of Mlp24 with arginine;2.7;CA;CALCIUM ION;Methyl-accepting chemotaxis protein;666;
6IOT;D;The ligand binding domain of Mlp24 with arginine;2.7;CA;CALCIUM ION;Methyl-accepting chemotaxis protein;666;
6IOU;A;The ligand binding domain of Mlp24 with serine;2.1;CA;CALCIUM ION;Methyl-accepting chemotaxis protein;666;
6IOU;B;The ligand binding domain of Mlp24 with serine;2.1;CA;CALCIUM ION;Methyl-accepting chemotaxis protein;666;
6IOZ;A;Structural insights of idursulfase beta;3.1;CA;CALCIUM ION;Iduronate 2-sulfatase;9606;
6IPT;B;Crystal structure of a fosfomycin and bleomycin resistant protein from Anabaena/Nostoc cyanobacterium at 1.70 A resolution;1.7;CA;CALCIUM ION;All3014 protein;103690;
6IQ7;A;Crystal structure of CrmE10, a SGNH-hydrolase family esterase;1.9;CA;CALCIUM ION;Carboxylesterase;450378;
6IQ8;A;Esterase CrmE10 mutant-D178A;2.24;CA;CALCIUM ION;Carboxylesterase;450378;
6IQ8;B;Esterase CrmE10 mutant-D178A;2.24;CA;CALCIUM ION;Carboxylesterase;450378;
6IQY;A;High resolution structure of bilirubin oxidase from Myrothecium verrucaria - M467Q mutant, anaerobically prepared;1.6;CA;CALCIUM ION;Bilirubin oxidase;1859699;
6IQY;B;High resolution structure of bilirubin oxidase from Myrothecium verrucaria - M467Q mutant, anaerobically prepared;1.6;CA;CALCIUM ION;Bilirubin oxidase;1859699;
6IYU;A;Crystal Structure Analysis of an Eukaryotic Membrane Protein;2.2;CA;CALCIUM ION;Trimeric intracellular cation channel type A;9031;
6IYX;A;Crystal Structure Analysis of a Eukaryotic Membrane Protein;1.8;CA;CALCIUM ION;Trimeric intracellular cation channel type A;9031;
6IZ0;A;Crystal Structure Analysis of a Eukaryotic Membrane Protein;2.3;CA;CALCIUM ION;Trimeric intracellular cation channel type A;9031;
6IZ1;A;Crystal Structure Analysis of a Eukaryotic Membrane Protein;2.4;CA;CALCIUM ION;Trimeric intracellular cation channel type A;9031;
6IZ6;A;Crystal Structure Analysis of TRIC counter-ion channels in calcium release;3.29;CA;CALCIUM ION;Trimeric intracellular cation channel type B-B;8355;
6IZF;A;Structural basis for activity of TRIC counter-ion channels in calcium release;2;CA;CALCIUM ION;Trimeric intracellular cation channel type A;9031;
6J06;B;Crystal structure of intracellular B30.2 domain of BTN3A1 in complex with HMBPP-08;2.65;CA;CALCIUM ION;Butyrophilin subfamily 3 member A1;9606;
6J3G;A;Crystal structure of an apo form of the glutathione S-transferase, CsGST83044, of Ceriporiopsis subvermispora;1.95;CA;CALCIUM ION;Glutathione S-transferase;42742;
6JCJ;A;Structure of crolibulin in complex with tubulin;2.5;CA;CALCIUM ION;Tubulin alpha-1B chain;9823;
6JCJ;C;Structure of crolibulin in complex with tubulin;2.5;CA;CALCIUM ION;Tubulin alpha-1B chain;9823;
6JEQ;A;Crystal structure of Pullulanase from Paenibacillus barengoltzii complex with beta-cyclodextrin;1.8;CA;CALCIUM ION;Pulullanase;343517;
6JFJ;A;Crystal structure of Pullulanase from Paenibacillus barengoltzii complex with maltohexaose and alpha-cyclodextrin;1.93;CA;CALCIUM ION;Pulullanase;343517;
6JFX;A;Crystal structure of Pullulanase from Paenibacillus barengoltzii complex with maltopentaose;1.98;CA;CALCIUM ION;Pulullanase;343517;
6JH5;A;Structure of Marine bacterial laminarinase;1.54;CA;CALCIUM ION;LamCAT;290174;
6JHF;A;Crystal structure of apo Pullulanase from Paenibacillus barengoltzii;1.71;CA;CALCIUM ION;Pulullanase;343517;
6JHG;A;Crystal structure of apo Pullulanase from Paenibacillus barengoltzii in space group P212121;1.89;CA;CALCIUM ION;Pulullanase;343517;
6JHH;A;Crystal structure of mutant D350A of Pullulanase from Paenibacillus barengoltzii complexed with maltotriose;2.03;CA;CALCIUM ION;Pulullanase;343517;
6JHI;A;Crystal structure of mutant D470A of Pullulanase from Paenibacillus barengoltzii complexed with maltotetraose;2.32;CA;CALCIUM ION;Pulullanase;343517;
6JHJ;A;Structure of Marine bacterial laminarinase mutant-E135A;1.69;CA;CALCIUM ION;LamCAT;290174;
6JIA;A;Marine bacterial laminarinase mutant E135A complex with laminaritetraose;1.9;CA;CALCIUM ION;LamCAT;290174;
6JJC;A;Cryo-EM structure of giant freshwater prawn Macrobrachium rosenbergii nodavirus (MrNV) semi-empty VLP;2.92;CA;CALCIUM ION;Capsid protein;222557;
6JJC;B;Cryo-EM structure of giant freshwater prawn Macrobrachium rosenbergii nodavirus (MrNV) semi-empty VLP;2.92;CA;CALCIUM ION;Capsid protein;222557;
6JJD;A;Cryo-EM structure of giant freshwater prawn Macrobrachium rosenbergii nodavirus (MrNV) full VLP;3.21;CA;CALCIUM ION;Capsid protein;222557;
6JJD;B;Cryo-EM structure of giant freshwater prawn Macrobrachium rosenbergii nodavirus (MrNV) full VLP;3.21;CA;CALCIUM ION;Capsid protein;222557;
6JJU;A;Structure of Ca2+ ATPase;3.2;CA;CALCIUM ION;Sarcoplasmic/endoplasmic reticulum calcium ATPase 2;9606;
6JP5;A;Rabbit Cav1.1-Nifedipine Complex;2.9;CA;CALCIUM ION;Voltage-dependent L-type calcium channel subunit alpha-1S;9986;
6JP8;A;Rabbit Cav1.1-Bay K8644 Complex;2.7;CA;CALCIUM ION;Voltage-dependent L-type calcium channel subunit alpha-1S;9986;
6JPA;A;Rabbit Cav1.1-Verapamil Complex;2.6;CA;CALCIUM ION;Voltage-dependent L-type calcium channel subunit alpha-1S;9986;
6JPB;A;Rabbit Cav1.1-Diltiazem Complex;2.9;CA;CALCIUM ION;Voltage-dependent L-type calcium channel subunit alpha-1S;9986;
6JPB;F;Rabbit Cav1.1-Diltiazem Complex;2.9;CA;CALCIUM ION;Voltage-dependent calcium channel subunit alpha-2/delta-1;9986;
6M7T;A;Human DNA polymerase eta in a non-productive ternary complex with Ca2+ and dTTP oppositing cdA;2.8;CA;CALCIUM ION;DNA polymerase eta;9606;
6M8N;A;Endo-fucoidan hydrolase P5AFcnA from glycoside hydrolase family 107;1.55;CA;CALCIUM ION;P5AFcnA;67572;
6M8W;A;PSEUDOMONAS SERINE-CARBOXYL PROTEINASE (SEDOLISIN) COMPLEXED WITH THE INHIBITOR AIAF;1.1;CA;CALCIUM ION;SEDOLISIN;33067;
6M8Y;A;PSEUDOMONAS SERINE-CARBOXYL PROTEINASE (SEDOLISIN) COMPLEXED WITH THE INHIBITOR AIPF;1.1;CA;CALCIUM ION;SEDOLISIN;33067;
6M9A;A;Bordetella pertussis globin coupled sensor regulatory domain (BpeGReg);2.3;CA;CALCIUM ION;Signaling protein;520;
6M9A;B;Bordetella pertussis globin coupled sensor regulatory domain (BpeGReg);2.3;CA;CALCIUM ION;Signaling protein;520;
6M9A;C;Bordetella pertussis globin coupled sensor regulatory domain (BpeGReg);2.3;CA;CALCIUM ION;Signaling protein;520;
6M9C;A;PSEUDOMONAS SERINE-CARBOXYL PROTEINASE (SEDOLISIN) COMPLEXED WITH THE INHIBITOR Pseudotyrostatin;1.8;CA;CALCIUM ION;SEDOLISIN;33067;
6M9D;A;PSEUDOMONAS SERINE-CARBOXYL PROTEINASE (SEDOLISIN) COMPLEXED WITH THE INHIBITOR Chymostatin;2;CA;CALCIUM ION;SEDOLISIN;33067;
6M9F;A;PSEUDOMONAS SERINE-CARBOXYL PROTEINASE (SEDOLISIN) COMPLEXED WITH THE INHIBITOR Tyrostatin;1.3;CA;CALCIUM ION;SEDOLISIN;33067;
6MAV;A;Complex of tissue inhibitor of metalloproteinase-1 (TIMP-1) mutant L34G with matrix metalloproteinase-3 catalytic domain (MMP-3cd);2.37;CA;CALCIUM ION;Stromelysin-1;9606;
6MC4;A;Crystal structure of a tetrameric DNA fold-back quadruplex;2.25;CA;CALCIUM ION;DNA (5'-D(*CP*GP*TP*CP*AP*GP*GP*CP*G)-3');32630;
6MC4;C;Crystal structure of a tetrameric DNA fold-back quadruplex;2.25;CA;CALCIUM ION;DNA (5'-D(*CP*GP*TP*CP*AP*GP*GP*CP*G)-3');32630;
6MC4;D;Crystal structure of a tetrameric DNA fold-back quadruplex;2.25;CA;CALCIUM ION;DNA (5'-D(*CP*GP*TP*CP*AP*GP*GP*CP*G)-3');32630;
6MC4;E;Crystal structure of a tetrameric DNA fold-back quadruplex;2.25;CA;CALCIUM ION;DNA (5'-D(*CP*GP*TP*CP*AP*GP*GP*CP*G)-3');32630;
6MC4;F;Crystal structure of a tetrameric DNA fold-back quadruplex;2.25;CA;CALCIUM ION;DNA (5'-D(*CP*GP*TP*CP*AP*GP*GP*CP*G)-3');32630;
6MC4;H;Crystal structure of a tetrameric DNA fold-back quadruplex;2.25;CA;CALCIUM ION;DNA (5'-D(*CP*GP*TP*CP*AP*GP*GP*CP*G)-3');32630;
6MC9;B;Crystal Structure of Human Nav1.4 C-Terminal (1599-1754) domain in complex with calcium-bound calmodulin;3.3;CA;CALCIUM ION;Calmodulin-1;10116;
6MCX;A;INFLUENZA VIRUS NEURAMINIDASE SUBTYPE N9 (TERN) RECOMBINANT HEAD DOMAIN;2.3;CA;CALCIUM ION;Neuraminidase;11320;
6MDS;A;Crystal structure of Streptococcus pyogenes endo-beta-N-acetylglucosaminidase (EndoS2) with complex biantennary glycan;2.5;CA;CALCIUM ION;Endo-beta-N-acetylglucosaminidase;1314;
6MDS;B;Crystal structure of Streptococcus pyogenes endo-beta-N-acetylglucosaminidase (EndoS2) with complex biantennary glycan;2.5;CA;CALCIUM ION;Endo-beta-N-acetylglucosaminidase;1314;
6MDV;A;Crystal structure of Streptococcus pyogenes endo-beta-N-acetylglucosaminidase (EndoS2) with high-mannose glycan;2.5;CA;CALCIUM ION;Endo-beta-N-acetylglucosaminidase;1314;
6MDV;B;Crystal structure of Streptococcus pyogenes endo-beta-N-acetylglucosaminidase (EndoS2) with high-mannose glycan;2.5;CA;CALCIUM ION;Endo-beta-N-acetylglucosaminidase;1314;
6MGO;A;Structure of rabbit actin in complex with Mycalolide B;2.2;CA;CALCIUM ION;Actin, alpha skeletal muscle;9986;
6MH6;A;High-viscosity injector-based Pink Beam Serial Crystallography of Micro-crystals at a Synchrotron Radiation Source.;1.8;CA;CALCIUM ION;Proteinase K;37998;
6MJ2;A;Human TRPM2 ion channel in a calcium- and ADPR-bound state;6.36;CA;CALCIUM ION;Transient receptor potential cation channel subfamily M member 2;9606;
6MJ2;B;Human TRPM2 ion channel in a calcium- and ADPR-bound state;6.36;CA;CALCIUM ION;Transient receptor potential cation channel subfamily M member 2;9606;
6MJ2;C;Human TRPM2 ion channel in a calcium- and ADPR-bound state;6.36;CA;CALCIUM ION;Transient receptor potential cation channel subfamily M member 2;9606;
6MJ2;D;Human TRPM2 ion channel in a calcium- and ADPR-bound state;6.36;CA;CALCIUM ION;Transient receptor potential cation channel subfamily M member 2;9606;
6MJP;A;LptB(E163Q)FGC from Vibrio cholerae;2.85;CA;CALCIUM ION;ABC transporter ATP-binding protein;666;
6ML1;A;Structure of the USP15 deubiquitinase domain in complex with an affinity-matured inhibitory Ubv;1.9;CA;CALCIUM ION;Ubiquitin carboxyl-terminal hydrolase 15,Ubiquitin carboxyl-terminal hydrolase 15,Ubiquitin carboxyl-terminal hydrolase 15;9606;
6ML1;B;Structure of the USP15 deubiquitinase domain in complex with an affinity-matured inhibitory Ubv;1.9;CA;CALCIUM ION;Ubiquitin carboxyl-terminal hydrolase 15,Ubiquitin carboxyl-terminal hydrolase 15,Ubiquitin carboxyl-terminal hydrolase 15;9606;
6ML1;C;Structure of the USP15 deubiquitinase domain in complex with an affinity-matured inhibitory Ubv;1.9;CA;CALCIUM ION;Ubiquitin variant 15.1a;9606;
6MR7;A;DNA polymerase beta substrate complex with templating adenine and incoming Fapy-dGTP analog;2.14;CA;CALCIUM ION;DNA polymerase beta;9606;
6MR8;A;D276G DNA polymerase beta substrate complex with templating adenine and incoming Fapy-dGTP analog;1.9;CA;CALCIUM ION;DNA polymerase beta;9606;
6MRO;A;Crystal structure of methyl transferase from Methanosarcina acetivorans at 1.6 Angstroms resolution, Northeast Structural Genomics Consortium (NESG) Target MvR53.;1.6;CA;CALCIUM ION;methyl transferase from Methanosarcina acetivorans;2214;
6MS2;A;Crystal structure of the GH43 BlXynB protein from Bacillus licheniformis;2.49;CA;CALCIUM ION;Glycoside Hydrolase Family 43;1402;
6MS3;A;Crystal structure of the GH43 protein BlXynB mutant (K247S) from Bacillus licheniformis;1.95;CA;CALCIUM ION;Glycoside Hydrolase Family 43;1402;
6MS3;B;Crystal structure of the GH43 protein BlXynB mutant (K247S) from Bacillus licheniformis;1.95;CA;CALCIUM ION;Glycoside Hydrolase Family 43;1402;
6MUD;A;Voltage-gated sodium channel NaV1.5 C-terminal domain in complex with Ca2+/Calmodulin;2.69;CA;CALCIUM ION;Calmodulin-1;9606;
6MUE;A;Voltage-gated sodium channel NaV1.4 IQ domain in complex with Ca2+/Calmodulin;1.9;CA;CALCIUM ION;Calmodulin-1;9606;
6MUJ;A;Formylglycine generating enzyme bound to copper;2.25;CA;CALCIUM ION;Formylglycine-generating enzyme;1902;
6MUJ;B;Formylglycine generating enzyme bound to copper;2.25;CA;CALCIUM ION;Formylglycine-generating enzyme;1902;
6MUJ;C;Formylglycine generating enzyme bound to copper;2.25;CA;CALCIUM ION;Formylglycine-generating enzyme;1902;
6MUJ;D;Formylglycine generating enzyme bound to copper;2.25;CA;CALCIUM ION;Formylglycine-generating enzyme;1902;
6MUJ;E;Formylglycine generating enzyme bound to copper;2.25;CA;CALCIUM ION;Formylglycine-generating enzyme;1902;
6MUY;B;Fluoroacetate dehalogenase, room temperature structure solved by serial 3 degree oscillation crystallography;1.8;CA;CALCIUM ION;Fluoroacetate dehalogenase;1076;
6MV3;A;NMR structure of the cNTnC-cTnI chimera bound to calcium desensitizer W7;;CA;CALCIUM ION;Troponin C, slow skeletal and cardiac muscles,Troponin I, cardiac muscle chimera;9606;
6MV4;H;CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR IXa;1.37;CA;CALCIUM ION;Coagulation factor IX;9606;
6MVG;A;Crystal structure of FMN-binding beta-glucuronidase from Ruminococcus gnavus;2.8;CA;CALCIUM ION;beta-glucuronidase;33038;
6MVG;B;Crystal structure of FMN-binding beta-glucuronidase from Ruminococcus gnavus;2.8;CA;CALCIUM ION;beta-glucuronidase;33038;
6MVG;C;Crystal structure of FMN-binding beta-glucuronidase from Ruminococcus gnavus;2.8;CA;CALCIUM ION;beta-glucuronidase;33038;
6MVH;A;Crystal structure of FMN-binding beta-glucuronidase from Roseburia hominis;2.4;CA;CALCIUM ION;Beta-galactosidase;301301;
6MVH;B;Crystal structure of FMN-binding beta-glucuronidase from Roseburia hominis;2.4;CA;CALCIUM ION;Beta-galactosidase;301301;
6MVH;C;Crystal structure of FMN-binding beta-glucuronidase from Roseburia hominis;2.4;CA;CALCIUM ION;Beta-galactosidase;301301;
6MVH;D;Crystal structure of FMN-binding beta-glucuronidase from Roseburia hominis;2.4;CA;CALCIUM ION;Beta-galactosidase;301301;
6MX0;B;Crystal structure of human STING apoprotein (G230A, H232R, R293Q);1.73;CA;CALCIUM ION;Stimulator of interferon genes protein;9606;
6MX3;B;Crystal structure of human STING (G230A, H232R, R293Q) in complex with Compound 1;1.36;CA;CALCIUM ION;Stimulator of interferon genes protein;9606;
6MXE;B;Crystal structure of human STING (G230A, H232R, R293Q) in complex with Compound 18;2.47;CA;CALCIUM ION;Stimulator of interferon genes protein;9606;
6MZZ;B;Fluoroacetate dehalogenase, room temperature structure, using first 1 degree of total 3 degree oscillation;1.8;CA;CALCIUM ION;Fluoroacetate dehalogenase;1076;
6N00;B;Fluoroacetate dehalogenase, room temperature structure, using last 1 degree of total 3 degree oscillation and 144 kGy dose;1.9;CA;CALCIUM ION;Fluoroacetate dehalogenase;1076;
6N0A;A;Structure of the major pilin protein (T-18.1) from Streptococcus pyogenes serotype MGAS8232;1.75;CA;CALCIUM ION;Major pilin backbone protein T-antigen;1314;
6N0A;B;Structure of the major pilin protein (T-18.1) from Streptococcus pyogenes serotype MGAS8232;1.75;CA;CALCIUM ION;Major pilin backbone protein T-antigen;1314;
6N1A;A;Crystal structure of an N-acetylgalactosamine deacetylase from F. plautii;1.6;CA;CALCIUM ION;Carbohydrate-binding protein;292800;
6N1B;A;Crystal structure of an N-acetylgalactosamine deacetylase from F. plautii in complex with blood group B trisaccharide;1.3;CA;CALCIUM ION;Carbohydrate-binding protein;292800;
6N23;A;BEST1 in a calcium-bound inactivated state;3.1;CA;CALCIUM ION;Bestrophin homolog;9031;
6N23;B;BEST1 in a calcium-bound inactivated state;3.1;CA;CALCIUM ION;Bestrophin homolog;9031;
6N23;C;BEST1 in a calcium-bound inactivated state;3.1;CA;CALCIUM ION;Bestrophin homolog;9031;
6N23;D;BEST1 in a calcium-bound inactivated state;3.1;CA;CALCIUM ION;Bestrophin homolog;9031;
6N23;E;BEST1 in a calcium-bound inactivated state;3.1;CA;CALCIUM ION;Bestrophin homolog;9031;
6N25;A;BEST1 open state W287F mutant, calcium-bound;2.7;CA;CALCIUM ION;Bestrophin homolog;9031;
6N25;B;BEST1 open state W287F mutant, calcium-bound;2.7;CA;CALCIUM ION;Bestrophin homolog;9031;
6N25;C;BEST1 open state W287F mutant, calcium-bound;2.7;CA;CALCIUM ION;Bestrophin homolog;9031;
6N25;D;BEST1 open state W287F mutant, calcium-bound;2.7;CA;CALCIUM ION;Bestrophin homolog;9031;
6N25;E;BEST1 open state W287F mutant, calcium-bound;2.7;CA;CALCIUM ION;Bestrophin homolog;9031;
6N27;A;BEST1 calcium-bound closed state;3;CA;CALCIUM ION;Bestrophin homolog;9031;
6N27;B;BEST1 calcium-bound closed state;3;CA;CALCIUM ION;Bestrophin homolog;9031;
6N27;C;BEST1 calcium-bound closed state;3;CA;CALCIUM ION;Bestrophin homolog;9031;
6N27;D;BEST1 calcium-bound closed state;3;CA;CALCIUM ION;Bestrophin homolog;9031;
6N27;E;BEST1 calcium-bound closed state;3;CA;CALCIUM ION;Bestrophin homolog;9031;
6N28;A;BEST1 calcium-bound open state;2.9;CA;CALCIUM ION;Bestrophin homolog;9031;
6N28;B;BEST1 calcium-bound open state;2.9;CA;CALCIUM ION;Bestrophin homolog;9031;
6N28;C;BEST1 calcium-bound open state;2.9;CA;CALCIUM ION;Bestrophin homolog;9031;
6N28;D;BEST1 calcium-bound open state;2.9;CA;CALCIUM ION;Bestrophin homolog;9031;
6N28;E;BEST1 calcium-bound open state;2.9;CA;CALCIUM ION;Bestrophin homolog;9031;
6N29;A;Crystal structure of monomeric von Willebrand Factor D`D3 assembly;2.5;CA;CALCIUM ION;von Willebrand factor;9606;
6N29;B;Crystal structure of monomeric von Willebrand Factor D`D3 assembly;2.5;CA;CALCIUM ION;von Willebrand factor;9606;
6N2B;A;The Crystal Structure of Caldicellulosiruptor kristjanssonii Tapirin C-terminal domain;2.65;CA;CALCIUM ION;Tapirin;52765;
6N2B;B;The Crystal Structure of Caldicellulosiruptor kristjanssonii Tapirin C-terminal domain;2.65;CA;CALCIUM ION;Tapirin;52765;
6N4D;A;The crystal structure of neuramindase from A/canine/IL/11613/2015 (H3N2) influenza virus.;1.8;CA;CALCIUM ION;Neuraminidase;11309;
6N4D;B;The crystal structure of neuramindase from A/canine/IL/11613/2015 (H3N2) influenza virus.;1.8;CA;CALCIUM ION;Neuraminidase;11309;
6N4D;C;The crystal structure of neuramindase from A/canine/IL/11613/2015 (H3N2) influenza virus.;1.8;CA;CALCIUM ION;Neuraminidase;11309;
6N4D;D;The crystal structure of neuramindase from A/canine/IL/11613/2015 (H3N2) influenza virus.;1.8;CA;CALCIUM ION;Neuraminidase;11309;
6N4U;A;MicroED structure of Proteinase K at 2.75A resolution from a single milled crystal.;2.75;CA;CALCIUM ION;Proteinase K;37998;
6N5W;C;Crystal structure of the Ca2+/CaM complex with independent peptides of Kv7.4 (KCNQ4) A & B domains;2.15;CA;CALCIUM ION;Calmodulin-1;9606;
6N7G;C;Cryo-EM structure of tetrameric Ptch1 in complex with ShhNp (form I);6.8;CA;CALCIUM ION;Sonic hedgehog protein;9606;
6N7G;F;Cryo-EM structure of tetrameric Ptch1 in complex with ShhNp (form I);6.8;CA;CALCIUM ION;Sonic hedgehog protein;9606;
6N7H;C;Cryo-EM structure of the 2:1 hPtch1-Shhp complex;3.6;CA;CALCIUM ION;Sonic hedgehog protein;9606;
6N7K;C;Cryo-EM structure of tetrameric Ptch1 in complex with ShhNp (form II);6.5;CA;CALCIUM ION;Sonic hedgehog protein;9606;
6N7K;F;Cryo-EM structure of tetrameric Ptch1 in complex with ShhNp (form II);6.5;CA;CALCIUM ION;Sonic hedgehog protein;9606;
6N9D;A;Complex of tissue inhibitor of metalloproteinases-1 (TIMP-1) mutant (L34G/L133P/L151C/G154A) with matrix metalloproteinase-3 catalytic domain (MMP-3cd);2.67;CA;CALCIUM ION;Stromelysin-1;9606;
6N9M;A;Crystal Structure of Adenosine Deaminase from Salmonella typhimurium with Pentostatin (Deoxycoformycin);1.45;CA;CALCIUM ION;Adenosine deaminase;28901;
6NAX;A;Olfactomedin domain of mouse myocilin;1.55;CA;CALCIUM ION;Myocilin;10090;
6NAX;B;Olfactomedin domain of mouse myocilin;1.55;CA;CALCIUM ION;Myocilin;10090;
6NBK;A;Crystal structure of Arginase from Bacillus cereus;1.91;CA;CALCIUM ION;Arginase;1428;
6NBK;B;Crystal structure of Arginase from Bacillus cereus;1.91;CA;CALCIUM ION;Arginase;1428;
6NBK;C;Crystal structure of Arginase from Bacillus cereus;1.91;CA;CALCIUM ION;Arginase;1428;
6NBL;A;Cytochrome P450cam-putidaredoxin complex bound to camphor and cyanide;2.15;CA;CALCIUM ION;Camphor 5-monooxygenase;303;
6NBL;B;Cytochrome P450cam-putidaredoxin complex bound to camphor and cyanide;2.15;CA;CALCIUM ION;Camphor 5-monooxygenase;303;
6NBT;A;CRISPR Complex Subunit Csm3 from Staphylococcus epidermidis RP62a;2.4;CA;CALCIUM ION;CRISPR-associated protein;1282;
6NBT;B;CRISPR Complex Subunit Csm3 from Staphylococcus epidermidis RP62a;2.4;CA;CALCIUM ION;CRISPR-associated protein;1282;
6NCR;A;Crystal Structure of Tryptophan-tRNA ligase from Chlamydia trachomatis with bound L-tryptophan;1.75;CA;CALCIUM ION;Tryptophan--tRNA ligase;813;
6ND9;C;RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN WITH CALCIUM;2.9;CA;CALCIUM ION;Integrin alpha-2;9606;
6ND9;F;RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN WITH CALCIUM;2.9;CA;CALCIUM ION;Integrin alpha-2;9606;
6ND9;I;RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN WITH CALCIUM;2.9;CA;CALCIUM ION;Integrin alpha-2;9606;
6ND9;L;RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN WITH CALCIUM;2.9;CA;CALCIUM ION;Integrin alpha-2;9606;
6ND9;O;RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN WITH CALCIUM;2.9;CA;CALCIUM ION;Integrin alpha-2;9606;
6ND9;R;RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN WITH CALCIUM;2.9;CA;CALCIUM ION;Integrin alpha-2;9606;
6NF0;A;Nocturnin with bound NADPH substrate;2.7;CA;CALCIUM ION;Nocturnin;9606;
6NKQ;B;The structure of bovine beta-lactoglobulin in novel crystals grown at pH 3.8;2.3;CA;CALCIUM ION;Beta-lactoglobulin;9913;
6NN2;A;Xanthomonas citri PGM Apo-Phospho;1.44;CA;CALCIUM ION;Phosphoglucomutase;346;
6NN9;A;REFINED ATOMIC STRUCTURES OF N9 SUBTYPE INFLUENZA VIRUS NEURAMINIDASE AND ESCAPE MUTANTS;2.3;CA;CALCIUM ION;NEURAMINIDASE N9;11320;
6NNO;A;Xanthomonas citri Phospho-PGM in complex with glucose-1-phosphate;1.57;CA;CALCIUM ION;Phosphoglucomutase;346;
6NNS;A;Xanthomonas citri Phospho-PGM in complex with glucose-6-phosphate;1.45;CA;CALCIUM ION;Phosphoglucomutase;346;
6NNU;A;Xanthomonas citri Phospho-PGM in complex with glucose-1,6-phosphate;1.46;CA;CALCIUM ION;Phosphoglucomutase;346;
6NP8;A;Xanthomonas citri Phospho-PGM in complex with mannose-6-phosphate;1.41;CA;CALCIUM ION;Phosphoglucomutase;346;
6NQF;A;Xanthomonas citri PGM Apo-Phospho at room temperature;1.9;CA;CALCIUM ION;Phosphoglucomutase;346;
6NQG;A;Xanthomonas citri Phospho-PGM in complex with glucopyranosyl-1-methyl-phosphonic acid at room temperature;2.05;CA;CALCIUM ION;Phosphoglucomutase;346;
6NR3;A;Cryo-EM structure of the TRPM8 ion channel in complex with high occupancy icilin, PI(4,5)P2, and calcium;3.4;CA;CALCIUM ION;Transient receptor potential cation channel subfamily M member 8;59894;
6NR3;B;Cryo-EM structure of the TRPM8 ion channel in complex with high occupancy icilin, PI(4,5)P2, and calcium;3.4;CA;CALCIUM ION;Transient receptor potential cation channel subfamily M member 8;59894;
6NR3;C;Cryo-EM structure of the TRPM8 ion channel in complex with high occupancy icilin, PI(4,5)P2, and calcium;3.4;CA;CALCIUM ION;Transient receptor potential cation channel subfamily M member 8;59894;
6NR3;D;Cryo-EM structure of the TRPM8 ion channel in complex with high occupancy icilin, PI(4,5)P2, and calcium;3.4;CA;CALCIUM ION;Transient receptor potential cation channel subfamily M member 8;59894;
6NWA;L;The structure of the photosystem I IsiA super-complex;3.48;CA;CALCIUM ION;Photosystem I reaction center subunit XI;1148;
6NWA;U;The structure of the photosystem I IsiA super-complex;3.48;CA;CALCIUM ION;Photosystem I reaction center subunit XI;1148;
6NWA;l;The structure of the photosystem I IsiA super-complex;3.48;CA;CALCIUM ION;Photosystem I reaction center subunit XI;1148;
6NYT;A;Munc13-1 C2B-domain, calcium bound;1.37;CA;CALCIUM ION;Protein unc-13 homolog A;10116;
6O1T;A;BOVINE SALIVARY PROTEIN FORM 30B WITH OLEIC ACID;2.3;CA;CALCIUM ION;Short palate, lung and nasal epithelium carcinoma-associated protein 2B;9913;
6O20;F;Cryo-EM structure of TRPV5 with calmodulin bound;3.3;CA;CALCIUM ION;Calmodulin;9913;
6O44;A;Insight into subtilisin E-S7 cleavage pattern based on crystal structure and hydrolysates peptide analysis;1.83;CA;CALCIUM ION;Nattokinase;1423;
6O44;B;Insight into subtilisin E-S7 cleavage pattern based on crystal structure and hydrolysates peptide analysis;1.83;CA;CALCIUM ION;Nattokinase;1423;
6O58;A;Human MCU-EMRE complex, dimer of channel;3.8;CA;CALCIUM ION;Calcium uniporter protein, mitochondrial;9606;
6O58;I;Human MCU-EMRE complex, dimer of channel;3.8;CA;CALCIUM ION;Calcium uniporter protein, mitochondrial;9606;
6O5B;G;Monomer of a cation channel;3.6;CA;CALCIUM ION;Calcium uniporter protein, mitochondrial;9606;
6O83;A;S. pombe ubiquitin E1~ubiquitin-AMP tetrahedral intermediate mimic;3.15;CA;CALCIUM ION;Ubiquitin-activating enzyme E1 1;4896;
6O83;C;S. pombe ubiquitin E1~ubiquitin-AMP tetrahedral intermediate mimic;3.15;CA;CALCIUM ION;Ubiquitin-activating enzyme E1 1;4896;
6O94;A;Structure of the IRAK4 kinase domain with compound 17;1.98;CA;CALCIUM ION;Interleukin-1 receptor-associated kinase 4;9606;
6O94;B;Structure of the IRAK4 kinase domain with compound 17;1.98;CA;CALCIUM ION;Interleukin-1 receptor-associated kinase 4;9606;
6OAD;A;2.05 Angstrom Resolution Crystal Structure of Aminopeptidase B from Escherichia coli str. K-12 substr. MG1655.;2.05;CA;CALCIUM ION;Peptidase B;562;
6OAD;B;2.05 Angstrom Resolution Crystal Structure of Aminopeptidase B from Escherichia coli str. K-12 substr. MG1655.;2.05;CA;CALCIUM ION;Peptidase B;562;
6OAD;C;2.05 Angstrom Resolution Crystal Structure of Aminopeptidase B from Escherichia coli str. K-12 substr. MG1655.;2.05;CA;CALCIUM ION;Peptidase B;562;
6OAD;D;2.05 Angstrom Resolution Crystal Structure of Aminopeptidase B from Escherichia coli str. K-12 substr. MG1655.;2.05;CA;CALCIUM ION;Peptidase B;562;
6OAD;E;2.05 Angstrom Resolution Crystal Structure of Aminopeptidase B from Escherichia coli str. K-12 substr. MG1655.;2.05;CA;CALCIUM ION;Peptidase B;562;
6OAD;F;2.05 Angstrom Resolution Crystal Structure of Aminopeptidase B from Escherichia coli str. K-12 substr. MG1655.;2.05;CA;CALCIUM ION;Peptidase B;562;
6OAD;G;2.05 Angstrom Resolution Crystal Structure of Aminopeptidase B from Escherichia coli str. K-12 substr. MG1655.;2.05;CA;CALCIUM ION;Peptidase B;562;
6OAD;H;2.05 Angstrom Resolution Crystal Structure of Aminopeptidase B from Escherichia coli str. K-12 substr. MG1655.;2.05;CA;CALCIUM ION;Peptidase B;562;
6OAD;I;2.05 Angstrom Resolution Crystal Structure of Aminopeptidase B from Escherichia coli str. K-12 substr. MG1655.;2.05;CA;CALCIUM ION;Peptidase B;562;
6OAD;J;2.05 Angstrom Resolution Crystal Structure of Aminopeptidase B from Escherichia coli str. K-12 substr. MG1655.;2.05;CA;CALCIUM ION;Peptidase B;562;
6OAD;K;2.05 Angstrom Resolution Crystal Structure of Aminopeptidase B from Escherichia coli str. K-12 substr. MG1655.;2.05;CA;CALCIUM ION;Peptidase B;562;
6OAD;L;2.05 Angstrom Resolution Crystal Structure of Aminopeptidase B from Escherichia coli str. K-12 substr. MG1655.;2.05;CA;CALCIUM ION;Peptidase B;562;
6OAU;A;Apo Structure of WT Lipoprotein Lipase in Complex with GPIHBP1 Mutant N78D N82D produced in GnTI-deficient HEK293-F cells;2.48;CA;CALCIUM ION;Lipoprotein lipase;9606;
6OAU;B;Apo Structure of WT Lipoprotein Lipase in Complex with GPIHBP1 Mutant N78D N82D produced in GnTI-deficient HEK293-F cells;2.48;CA;CALCIUM ION;Lipoprotein lipase;9606;
6OAZ;A;Apo Structure of WT Lipoprotein Lipase in Complex with GPIHBP1 Mutant N78D N82D produced in HEK293-F cells;3.04;CA;CALCIUM ION;Lipoprotein lipase;9606;
6OAZ;B;Apo Structure of WT Lipoprotein Lipase in Complex with GPIHBP1 Mutant N78D N82D produced in HEK293-F cells;3.04;CA;CALCIUM ION;Lipoprotein lipase;9606;
6OAZ;C;Apo Structure of WT Lipoprotein Lipase in Complex with GPIHBP1 Mutant N78D N82D produced in HEK293-F cells;3.04;CA;CALCIUM ION;Lipoprotein lipase;9606;
6OAZ;D;Apo Structure of WT Lipoprotein Lipase in Complex with GPIHBP1 Mutant N78D N82D produced in HEK293-F cells;3.04;CA;CALCIUM ION;Lipoprotein lipase;9606;
6OB0;A;Compound 2 bound structure of WT Lipoprotein Lipase in Complex with GPIHBP1 Mutant N78D N82D produced in HEK293-F cells;2.81;CA;CALCIUM ION;Lipoprotein lipase;9606;
6OB0;B;Compound 2 bound structure of WT Lipoprotein Lipase in Complex with GPIHBP1 Mutant N78D N82D produced in HEK293-F cells;2.81;CA;CALCIUM ION;Lipoprotein lipase;9606;
6OB0;C;Compound 2 bound structure of WT Lipoprotein Lipase in Complex with GPIHBP1 Mutant N78D N82D produced in HEK293-F cells;2.81;CA;CALCIUM ION;Lipoprotein lipase;9606;
6OB0;D;Compound 2 bound structure of WT Lipoprotein Lipase in Complex with GPIHBP1 Mutant N78D N82D produced in HEK293-F cells;2.81;CA;CALCIUM ION;Lipoprotein lipase;9606;
6OEC;B;Yeast Spc42 Trimeric Coiled-Coil Amino Acids 181-211 fused to PDB: 3H5I;2.51;CA;CALCIUM ION;Response regulator/sensory box protein/GGDEF domain protein,Spindle pole body component SPC42;4,932,129,958;
6OEC;C;Yeast Spc42 Trimeric Coiled-Coil Amino Acids 181-211 fused to PDB: 3H5I;2.51;CA;CALCIUM ION;Response regulator/sensory box protein/GGDEF domain protein,Spindle pole body component SPC42;4,932,129,958;
6OEC;E;Yeast Spc42 Trimeric Coiled-Coil Amino Acids 181-211 fused to PDB: 3H5I;2.51;CA;CALCIUM ION;Response regulator/sensory box protein/GGDEF domain protein,Spindle pole body component SPC42;4,932,129,958;
6OEC;F;Yeast Spc42 Trimeric Coiled-Coil Amino Acids 181-211 fused to PDB: 3H5I;2.51;CA;CALCIUM ION;Response regulator/sensory box protein/GGDEF domain protein,Spindle pole body component SPC42;4,932,129,958;
6OEC;G;Yeast Spc42 Trimeric Coiled-Coil Amino Acids 181-211 fused to PDB: 3H5I;2.51;CA;CALCIUM ION;Response regulator/sensory box protein/GGDEF domain protein,Spindle pole body component SPC42;4,932,129,958;
6OEC;I;Yeast Spc42 Trimeric Coiled-Coil Amino Acids 181-211 fused to PDB: 3H5I;2.51;CA;CALCIUM ION;Response regulator/sensory box protein/GGDEF domain protein,Spindle pole body component SPC42;4,932,129,958;
6OEC;L;Yeast Spc42 Trimeric Coiled-Coil Amino Acids 181-211 fused to PDB: 3H5I;2.51;CA;CALCIUM ION;Response regulator/sensory box protein/GGDEF domain protein,Spindle pole body component SPC42;4,932,129,958;
6OGK;A;MeCP2 MBD in complex with DNA;1.65;CA;CALCIUM ION;Methyl-CpG-binding protein 2;9606;
6OK8;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS K127L at cryogenic temperature;1.8;CA;CALCIUM ION;Thermonuclease;1280;
6OK9;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS K133M at cryogenic temperature;1.9;CA;CALCIUM ION;Thermonuclease;1280;
6OKA;A;Crystal structure of Staphylococcal nuclease variant Delta+PHS Q123D at cryogenic temperature;1.86;CA;CALCIUM ION;Thermonuclease;1280;
6OQQ;B;Legionella pneumophila SidJ/Saccharomyces cerevisiae calmodulin complex;2.1;CA;CALCIUM ION;Calmodulin;4932;
6OQQ;D;Legionella pneumophila SidJ/Saccharomyces cerevisiae calmodulin complex;2.1;CA;CALCIUM ION;Calmodulin;4932;
6OVZ;A;Crystal structure of the New Delhi metallo-beta-lactamase-1 adduct with a lysine-targeted affinity label;2.02;CA;CALCIUM ION;Beta-lactamase;562;
6OVZ;B;Crystal structure of the New Delhi metallo-beta-lactamase-1 adduct with a lysine-targeted affinity label;2.02;CA;CALCIUM ION;Beta-lactamase;562;
6OZ7;A;Putative oxidoreductase from Escherichia coli str. K-12;1.36;CA;CALCIUM ION;Uncharacterized oxidoreductase YohF;562;
6OZ7;B;Putative oxidoreductase from Escherichia coli str. K-12;1.36;CA;CALCIUM ION;Uncharacterized oxidoreductase YohF;562;
6OZ7;C;Putative oxidoreductase from Escherichia coli str. K-12;1.36;CA;CALCIUM ION;Uncharacterized oxidoreductase YohF;562;
6OZ7;D;Putative oxidoreductase from Escherichia coli str. K-12;1.36;CA;CALCIUM ION;Uncharacterized oxidoreductase YohF;562;
6OZ7;E;Putative oxidoreductase from Escherichia coli str. K-12;1.36;CA;CALCIUM ION;Uncharacterized oxidoreductase YohF;562;
6OZ7;F;Putative oxidoreductase from Escherichia coli str. K-12;1.36;CA;CALCIUM ION;Uncharacterized oxidoreductase YohF;562;
6OZ7;G;Putative oxidoreductase from Escherichia coli str. K-12;1.36;CA;CALCIUM ION;Uncharacterized oxidoreductase YohF;562;
6OZ7;H;Putative oxidoreductase from Escherichia coli str. K-12;1.36;CA;CALCIUM ION;Uncharacterized oxidoreductase YohF;562;
6Q2Y;A;Crystal structure of NDM-1 beta-lactamase in complex with broad spectrum boronic inhibitor cpd3;1;CA;CALCIUM ION;Metallo-beta-lactamase type 2;573;
6Q2Y;B;Crystal structure of NDM-1 beta-lactamase in complex with broad spectrum boronic inhibitor cpd3;1;CA;CALCIUM ION;Metallo-beta-lactamase type 2;573;
6Q30;A;Crystal structure of NDM-1 beta-lactamase in complex with boronic inhibitor cpd 5;1.5;CA;CALCIUM ION;Metallo-beta-lactamase type 2;573;
6Q30;B;Crystal structure of NDM-1 beta-lactamase in complex with boronic inhibitor cpd 5;1.5;CA;CALCIUM ION;Metallo-beta-lactamase type 2;573;
6Q3R;A;ASPERGILLUS ACULEATUS GALACTANASE;2.69;CA;CALCIUM ION;Arabinogalactan endo-beta-1,4-galactanase;5053;
6Q3R;B;ASPERGILLUS ACULEATUS GALACTANASE;2.69;CA;CALCIUM ION;Arabinogalactan endo-beta-1,4-galactanase;5053;
6Q4L;A;Carboxypeptidase T mutant L254N with with N-sulfamoyl-L-glutamic acid;2.3;CA;CALCIUM ION;Carboxypeptidase T;2026;
6Q63;A;BT0459;2.44;CA;CALCIUM ION;Beta-hexosaminidase;818;
6Q63;B;BT0459;2.44;CA;CALCIUM ION;Beta-hexosaminidase;818;
6Q63;C;BT0459;2.44;CA;CALCIUM ION;Beta-hexosaminidase;818;
6Q6J;A;Human phosphoserine phosphatase with substrate analogue homo-cysteic acid;1.99;CA;CALCIUM ION;Phosphoserine phosphatase;9606;
6Q6J;B;Human phosphoserine phosphatase with substrate analogue homo-cysteic acid;1.99;CA;CALCIUM ION;Phosphoserine phosphatase;9606;
6Q6W;A;Structure of Fucosylated D-antimicrobial peptide SB5 in complex with the Fucose-binding lectin PA-IIL at 1.438 Angstrom resolution;1.44;CA;CALCIUM ION;Fucose-binding lectin;287;
6Q6X;A;Structure of Fucosylated D-antimicrobial peptide SB6 in complex with the Fucose-binding lectin PA-IIL at 1.525 Angstrom resolution;1.52;CA;CALCIUM ION;Fucose-binding lectin;287;
6Q6X;B;Structure of Fucosylated D-antimicrobial peptide SB6 in complex with the Fucose-binding lectin PA-IIL at 1.525 Angstrom resolution;1.52;CA;CALCIUM ION;Fucose-binding lectin;287;
6Q6X;C;Structure of Fucosylated D-antimicrobial peptide SB6 in complex with the Fucose-binding lectin PA-IIL at 1.525 Angstrom resolution;1.52;CA;CALCIUM ION;Fucose-binding lectin;287;
6Q6X;D;Structure of Fucosylated D-antimicrobial peptide SB6 in complex with the Fucose-binding lectin PA-IIL at 1.525 Angstrom resolution;1.52;CA;CALCIUM ION;Fucose-binding lectin;287;
6Q77;A;Structure of Fucosylated D-antimicrobial peptide SB12 in complex with the Fucose-binding lectin PA-IIL at 2.002 Angstrom resolution;2;CA;CALCIUM ION;Fucose-binding lectin;287;
6Q79;A;Structure of Fucosylated D-antimicrobial peptide SB4 in complex with the Fucose-binding lectin PA-IIL at 2.009 Angstrom resolution;2.01;CA;CALCIUM ION;Fucose-binding lectin;287;
6Q79;B;Structure of Fucosylated D-antimicrobial peptide SB4 in complex with the Fucose-binding lectin PA-IIL at 2.009 Angstrom resolution;2.01;CA;CALCIUM ION;Fucose-binding lectin;287;
6Q79;C;Structure of Fucosylated D-antimicrobial peptide SB4 in complex with the Fucose-binding lectin PA-IIL at 2.009 Angstrom resolution;2.01;CA;CALCIUM ION;Fucose-binding lectin;287;
6Q79;D;Structure of Fucosylated D-antimicrobial peptide SB4 in complex with the Fucose-binding lectin PA-IIL at 2.009 Angstrom resolution;2.01;CA;CALCIUM ION;Fucose-binding lectin;287;
6Q7O;A;Crystal structure of OE1;2;CA;CALCIUM ION;OE1;53953;
6Q85;A;Structure of Fucosylated D-antimicrobial peptide SB11 in complex with the Fucose-binding lectin PA-IIL at 1.990 Angstrom resolution;1.99;CA;CALCIUM ION;Fucose-binding lectin;287;
6Q85;B;Structure of Fucosylated D-antimicrobial peptide SB11 in complex with the Fucose-binding lectin PA-IIL at 1.990 Angstrom resolution;1.99;CA;CALCIUM ION;Fucose-binding lectin;287;
6Q85;C;Structure of Fucosylated D-antimicrobial peptide SB11 in complex with the Fucose-binding lectin PA-IIL at 1.990 Angstrom resolution;1.99;CA;CALCIUM ION;Fucose-binding lectin;287;
6Q85;D;Structure of Fucosylated D-antimicrobial peptide SB11 in complex with the Fucose-binding lectin PA-IIL at 1.990 Angstrom resolution;1.99;CA;CALCIUM ION;Fucose-binding lectin;287;
6Q86;A;Structure of Fucosylated D-antimicrobial peptide SB4 in complex with the Fucose-binding lectin PA-IIL at 2.008 Angstrom resolution;2.01;CA;CALCIUM ION;Fucose-binding lectin;287;
6Q86;B;Structure of Fucosylated D-antimicrobial peptide SB4 in complex with the Fucose-binding lectin PA-IIL at 2.008 Angstrom resolution;2.01;CA;CALCIUM ION;Fucose-binding lectin;287;
6Q87;A;Structure of Fucosylated D-antimicrobial peptide SB10 in complex with the Fucose-binding lectin PA-IIL at 2.541 Angstrom resolution;2.54;CA;CALCIUM ION;Fucose-binding lectin;287;
6Q8D;A;Structure of Fucosylated D-antimicrobial peptide SB15 in complex with the Fucose-binding lectin PA-IIL at 1.630 Angstrom resolution;1.63;CA;CALCIUM ION;Fucose-binding lectin;287;
6Q8G;A;Structure of Fucosylated D-antimicrobial peptide SB8 in complex with the Fucose-binding lectin PA-IIL at 1.190 Angstrom resolution;1.19;CA;CALCIUM ION;Fucose-binding lectin;287;
6Q8G;B;Structure of Fucosylated D-antimicrobial peptide SB8 in complex with the Fucose-binding lectin PA-IIL at 1.190 Angstrom resolution;1.19;CA;CALCIUM ION;Fucose-binding lectin;287;
6Q8G;C;Structure of Fucosylated D-antimicrobial peptide SB8 in complex with the Fucose-binding lectin PA-IIL at 1.190 Angstrom resolution;1.19;CA;CALCIUM ION;Fucose-binding lectin;287;
6Q8G;D;Structure of Fucosylated D-antimicrobial peptide SB8 in complex with the Fucose-binding lectin PA-IIL at 1.190 Angstrom resolution;1.19;CA;CALCIUM ION;Fucose-binding lectin;287;
6Q8H;A;Structure of Fucosylated D-antimicrobial peptide SB10 in complex with the Fucose-binding lectin PA-IIL at 1.707 Angstrom resolution;1.71;CA;CALCIUM ION;Fucose-binding lectin;287;
6QBS;A;The Alkyne Moiety as a Latent Electrophile in Irreversible Covalent Small Molecule Inhibitors of Cathepsin K;1.7;CA;CALCIUM ION;Cathepsin K;9606;
6QCL;A;Citryl-CoA lyase core module of Chlorobium limicola ATP citrate lyase in complex with acetyl-CoA and L-malate;1.6;CA;CALCIUM ION;ATP-citrate lyase alpha-subunit;1092;
6QCL;B;Citryl-CoA lyase core module of Chlorobium limicola ATP citrate lyase in complex with acetyl-CoA and L-malate;1.6;CA;CALCIUM ION;ATP-citrate lyase alpha-subunit;1092;
6QDI;A;anti-sigma factor domain-containing protein from Clostridium clariflavum;1.13;CA;CALCIUM ION;PA14 domain-containing protein;288965;
6QE7;A;anti-sigma factor domain-containing protein;2.06;CA;CALCIUM ION;anti-sigma factor domain-containing protein;1515;
6QE7;B;anti-sigma factor domain-containing protein;2.06;CA;CALCIUM ION;anti-sigma factor domain-containing protein;1515;
6QE7;C;anti-sigma factor domain-containing protein;2.06;CA;CALCIUM ION;anti-sigma factor domain-containing protein;1515;
6QG9;A;Crystal structure of Ideonella sakaiensis MHETase;2.05;CA;CALCIUM ION;Mono(2-hydroxyethyl) terephthalate hydrolase;1547922;
6QG9;B;Crystal structure of Ideonella sakaiensis MHETase;2.05;CA;CALCIUM ION;Mono(2-hydroxyethyl) terephthalate hydrolase;1547922;
6QG9;C;Crystal structure of Ideonella sakaiensis MHETase;2.05;CA;CALCIUM ION;Mono(2-hydroxyethyl) terephthalate hydrolase;1547922;
6QG9;D;Crystal structure of Ideonella sakaiensis MHETase;2.05;CA;CALCIUM ION;Mono(2-hydroxyethyl) terephthalate hydrolase;1547922;
6QG9;E;Crystal structure of Ideonella sakaiensis MHETase;2.05;CA;CALCIUM ION;Mono(2-hydroxyethyl) terephthalate hydrolase;1547922;
6QG9;F;Crystal structure of Ideonella sakaiensis MHETase;2.05;CA;CALCIUM ION;Mono(2-hydroxyethyl) terephthalate hydrolase;1547922;
6QG9;G;Crystal structure of Ideonella sakaiensis MHETase;2.05;CA;CALCIUM ION;Mono(2-hydroxyethyl) terephthalate hydrolase;1547922;
6QG9;H;Crystal structure of Ideonella sakaiensis MHETase;2.05;CA;CALCIUM ION;Mono(2-hydroxyethyl) terephthalate hydrolase;1547922;
6QG9;I;Crystal structure of Ideonella sakaiensis MHETase;2.05;CA;CALCIUM ION;Mono(2-hydroxyethyl) terephthalate hydrolase;1547922;
6QG9;J;Crystal structure of Ideonella sakaiensis MHETase;2.05;CA;CALCIUM ION;Mono(2-hydroxyethyl) terephthalate hydrolase;1547922;
6QGA;A;Crystal structure of Ideonella sakaiensis MHETase bound to the non-hydrolyzable ligand MHETA;2.1;CA;CALCIUM ION;Mono(2-hydroxyethyl) terephthalate hydrolase;1547922;
6QGA;B;Crystal structure of Ideonella sakaiensis MHETase bound to the non-hydrolyzable ligand MHETA;2.1;CA;CALCIUM ION;Mono(2-hydroxyethyl) terephthalate hydrolase;1547922;
6QGA;C;Crystal structure of Ideonella sakaiensis MHETase bound to the non-hydrolyzable ligand MHETA;2.1;CA;CALCIUM ION;Mono(2-hydroxyethyl) terephthalate hydrolase;1547922;
6QGA;D;Crystal structure of Ideonella sakaiensis MHETase bound to the non-hydrolyzable ligand MHETA;2.1;CA;CALCIUM ION;Mono(2-hydroxyethyl) terephthalate hydrolase;1547922;
6QGA;E;Crystal structure of Ideonella sakaiensis MHETase bound to the non-hydrolyzable ligand MHETA;2.1;CA;CALCIUM ION;Mono(2-hydroxyethyl) terephthalate hydrolase;1547922;
6QGA;F;Crystal structure of Ideonella sakaiensis MHETase bound to the non-hydrolyzable ligand MHETA;2.1;CA;CALCIUM ION;Mono(2-hydroxyethyl) terephthalate hydrolase;1547922;
6QGB;A;Crystal structure of Ideonella sakaiensis MHETase bound to benzoic acid;2.2;CA;CALCIUM ION;Mono(2-hydroxyethyl) terephthalate hydrolase;1547922;
6QGB;B;Crystal structure of Ideonella sakaiensis MHETase bound to benzoic acid;2.2;CA;CALCIUM ION;Mono(2-hydroxyethyl) terephthalate hydrolase;1547922;
6QGB;C;Crystal structure of Ideonella sakaiensis MHETase bound to benzoic acid;2.2;CA;CALCIUM ION;Mono(2-hydroxyethyl) terephthalate hydrolase;1547922;
6QGB;D;Crystal structure of Ideonella sakaiensis MHETase bound to benzoic acid;2.2;CA;CALCIUM ION;Mono(2-hydroxyethyl) terephthalate hydrolase;1547922;
6QGB;E;Crystal structure of Ideonella sakaiensis MHETase bound to benzoic acid;2.2;CA;CALCIUM ION;Mono(2-hydroxyethyl) terephthalate hydrolase;1547922;
6QGB;F;Crystal structure of Ideonella sakaiensis MHETase bound to benzoic acid;2.2;CA;CALCIUM ION;Mono(2-hydroxyethyl) terephthalate hydrolase;1547922;
6QIX;A;The crystal structure of Trichuris muris p43;1.65;CA;CALCIUM ION;P43;70415;
6QM5;A;Cryo-EM structure of calcium-bound nhTMEM16 lipid scramblase in DDM;3.6;CA;CALCIUM ION;Predicted protein;140110;
6QM5;B;Cryo-EM structure of calcium-bound nhTMEM16 lipid scramblase in DDM;3.6;CA;CALCIUM ION;Predicted protein;140110;
6QM9;A;Cryo-EM structure of calcium-bound nhTMEM16 lipid scramblase in nanodisc (open state);3.6;CA;CALCIUM ION;Predicted protein;140110;
6QM9;B;Cryo-EM structure of calcium-bound nhTMEM16 lipid scramblase in nanodisc (open state);3.6;CA;CALCIUM ION;Predicted protein;140110;
6QMA;A;Cryo-EM structure of calcium-bound nhTMEM16 lipid scramblase in nanodisc (intermediate state);3.7;CA;CALCIUM ION;Predicted protein;140110;
6QMA;B;Cryo-EM structure of calcium-bound nhTMEM16 lipid scramblase in nanodisc (intermediate state);3.7;CA;CALCIUM ION;Predicted protein;140110;
6QMB;A;Cryo-EM structure of calcium-bound nhTMEM16 lipid scramblase in nanodisc (closed state);3.6;CA;CALCIUM ION;Predicted protein;140110;
6QMB;B;Cryo-EM structure of calcium-bound nhTMEM16 lipid scramblase in nanodisc (closed state);3.6;CA;CALCIUM ION;Predicted protein;140110;
6QP6;A;Cryo-EM structure of calcium-bound mTMEM16F lipid scramblase in digitonin;3.2;CA;CALCIUM ION;Anoctamin-6;10090;
6QP6;B;Cryo-EM structure of calcium-bound mTMEM16F lipid scramblase in digitonin;3.2;CA;CALCIUM ION;Anoctamin-6;10090;
6QPC;A;Cryo-EM structure of calcium-bound mTMEM16F lipid scramblase in nanodisc;3.5;CA;CALCIUM ION;Anoctamin-6;10090;
6QPC;B;Cryo-EM structure of calcium-bound mTMEM16F lipid scramblase in nanodisc;3.5;CA;CALCIUM ION;Anoctamin-6;10090;
6QTN;A;Tubulin-cyclostreptin complex;1.9;CA;CALCIUM ION;Tubulin alpha-1B chain;9913;
6QTN;C;Tubulin-cyclostreptin complex;1.9;CA;CALCIUM ION;Tubulin alpha-1B chain;9913;
6QXF;A;Cas1-Cas2-Csn2-DNA complex from the Type II-A CRISPR-Cas system;3.6;CA;CALCIUM ION;CRISPR-associated protein Csn2;1308;
6QXF;B;Cas1-Cas2-Csn2-DNA complex from the Type II-A CRISPR-Cas system;3.6;CA;CALCIUM ION;CRISPR-associated protein Csn2;1308;
6QXF;C;Cas1-Cas2-Csn2-DNA complex from the Type II-A CRISPR-Cas system;3.6;CA;CALCIUM ION;CRISPR-associated protein Csn2;1308;
6QXF;D;Cas1-Cas2-Csn2-DNA complex from the Type II-A CRISPR-Cas system;3.6;CA;CALCIUM ION;CRISPR-associated protein Csn2;1308;
6QXF;E;Cas1-Cas2-Csn2-DNA complex from the Type II-A CRISPR-Cas system;3.6;CA;CALCIUM ION;CRISPR-associated protein Csn2;1308;
6QXF;F;Cas1-Cas2-Csn2-DNA complex from the Type II-A CRISPR-Cas system;3.6;CA;CALCIUM ION;CRISPR-associated protein Csn2;1308;
6QXF;G;Cas1-Cas2-Csn2-DNA complex from the Type II-A CRISPR-Cas system;3.6;CA;CALCIUM ION;CRISPR-associated protein Csn2;1308;
6QXF;H;Cas1-Cas2-Csn2-DNA complex from the Type II-A CRISPR-Cas system;3.6;CA;CALCIUM ION;CRISPR-associated protein Csn2;1308;
6QXT;A;Cas1-Cas2-Csn2-DNA dimer complex from the Type II-A CRISPR-Cas system;8.9;CA;CALCIUM ION;CRISPR-associated protein Csn2;1308;
6QXT;B;Cas1-Cas2-Csn2-DNA dimer complex from the Type II-A CRISPR-Cas system;8.9;CA;CALCIUM ION;CRISPR-associated protein Csn2;1308;
6QXT;E;Cas1-Cas2-Csn2-DNA dimer complex from the Type II-A CRISPR-Cas system;8.9;CA;CALCIUM ION;CRISPR-associated protein Csn2;1308;
6QXT;F;Cas1-Cas2-Csn2-DNA dimer complex from the Type II-A CRISPR-Cas system;8.9;CA;CALCIUM ION;CRISPR-associated protein Csn2;1308;
6QXT;a;Cas1-Cas2-Csn2-DNA dimer complex from the Type II-A CRISPR-Cas system;8.9;CA;CALCIUM ION;CRISPR-associated protein Csn2;1308;
6QXT;b;Cas1-Cas2-Csn2-DNA dimer complex from the Type II-A CRISPR-Cas system;8.9;CA;CALCIUM ION;CRISPR-associated protein Csn2;1308;
6QXT;e;Cas1-Cas2-Csn2-DNA dimer complex from the Type II-A CRISPR-Cas system;8.9;CA;CALCIUM ION;CRISPR-associated protein Csn2;1308;
6QXT;f;Cas1-Cas2-Csn2-DNA dimer complex from the Type II-A CRISPR-Cas system;8.9;CA;CALCIUM ION;CRISPR-associated protein Csn2;1308;
6QY3;A;Segment of the Cas1-Cas2-Csn2-DNA filament complex from the Type II-A CRISPR-Cas system;9.1;CA;CALCIUM ION;CRISPR-associated protein Csn2;1308;
6QY3;B;Segment of the Cas1-Cas2-Csn2-DNA filament complex from the Type II-A CRISPR-Cas system;9.1;CA;CALCIUM ION;CRISPR-associated protein Csn2;1308;
6QY3;E;Segment of the Cas1-Cas2-Csn2-DNA filament complex from the Type II-A CRISPR-Cas system;9.1;CA;CALCIUM ION;CRISPR-associated protein Csn2;1308;
6QY3;F;Segment of the Cas1-Cas2-Csn2-DNA filament complex from the Type II-A CRISPR-Cas system;9.1;CA;CALCIUM ION;CRISPR-associated protein Csn2;1308;
6QY3;a;Segment of the Cas1-Cas2-Csn2-DNA filament complex from the Type II-A CRISPR-Cas system;9.1;CA;CALCIUM ION;CRISPR-associated protein Csn2;1308;
6QY3;b;Segment of the Cas1-Cas2-Csn2-DNA filament complex from the Type II-A CRISPR-Cas system;9.1;CA;CALCIUM ION;CRISPR-associated protein Csn2;1308;
6QY3;e;Segment of the Cas1-Cas2-Csn2-DNA filament complex from the Type II-A CRISPR-Cas system;9.1;CA;CALCIUM ION;CRISPR-associated protein Csn2;1308;
6QY3;f;Segment of the Cas1-Cas2-Csn2-DNA filament complex from the Type II-A CRISPR-Cas system;9.1;CA;CALCIUM ION;CRISPR-associated protein Csn2;1308;
6QYH;A;Structure of Apo HPAB from E.coli;1.94;CA;CALCIUM ION;4-hydroxyphenylacetate 3-monooxygenase oxygenase component;562;
6QYH;B;Structure of Apo HPAB from E.coli;1.94;CA;CALCIUM ION;4-hydroxyphenylacetate 3-monooxygenase oxygenase component;562;
6R35;A;Structure of the LecB lectin from Pseudomonas aeruginosa strain PAO1 in complex with lewis x tetrasaccharide;1.8;CA;CALCIUM ION;Fucose-binding lectin PA-IIL;287;
6R35;B;Structure of the LecB lectin from Pseudomonas aeruginosa strain PAO1 in complex with lewis x tetrasaccharide;1.8;CA;CALCIUM ION;Fucose-binding lectin PA-IIL;287;
6R35;C;Structure of the LecB lectin from Pseudomonas aeruginosa strain PAO1 in complex with lewis x tetrasaccharide;1.8;CA;CALCIUM ION;Fucose-binding lectin PA-IIL;287;
6R35;D;Structure of the LecB lectin from Pseudomonas aeruginosa strain PAO1 in complex with lewis x tetrasaccharide;1.8;CA;CALCIUM ION;Fucose-binding lectin PA-IIL;287;
6R65;A;Crystal Structure of human TMEM16K / Anoctamin 10 (Form 2);3.5;CA;CALCIUM ION;Anoctamin-10;9606;
6R65;B;Crystal Structure of human TMEM16K / Anoctamin 10 (Form 2);3.5;CA;CALCIUM ION;Anoctamin-10;9606;
6R7X;A;CryoEM structure of calcium-bound human TMEM16K / Anoctamin 10 in detergent (2mM Ca2+, closed form);3.47;CA;CALCIUM ION;Anoctamin-10;9606;
6R7X;B;CryoEM structure of calcium-bound human TMEM16K / Anoctamin 10 in detergent (2mM Ca2+, closed form);3.47;CA;CALCIUM ION;Anoctamin-10;9606;
6R7Y;A;CryoEM structure of calcium-bound human TMEM16K / Anoctamin 10 in detergent (low Ca2+, closed form);4.2;CA;CALCIUM ION;Anoctamin-10;9606;
6R7Y;B;CryoEM structure of calcium-bound human TMEM16K / Anoctamin 10 in detergent (low Ca2+, closed form);4.2;CA;CALCIUM ION;Anoctamin-10;9606;
6RFK;S;Crystal structure of EGRCK-inhibited Gla-domainless fIXa (K148Q, R150Q variant);1.6;CA;CALCIUM ION;Coagulation factor IX;9606;
6RIM;A;Crystal structure of the catalytic domain of the Weissela oryzae botulinum like toxin;1.6;CA;CALCIUM ION;Putative botulinum-like toxin Wo;1129792;
6RIM;B;Crystal structure of the catalytic domain of the Weissela oryzae botulinum like toxin;1.6;CA;CALCIUM ION;Putative botulinum-like toxin Wo;1129792;
6RIM;C;Crystal structure of the catalytic domain of the Weissela oryzae botulinum like toxin;1.6;CA;CALCIUM ION;Putative botulinum-like toxin Wo;1129792;
6RIM;D;Crystal structure of the catalytic domain of the Weissela oryzae botulinum like toxin;1.6;CA;CALCIUM ION;Putative botulinum-like toxin Wo;1129792;
6RIM;E;Crystal structure of the catalytic domain of the Weissela oryzae botulinum like toxin;1.6;CA;CALCIUM ION;Putative botulinum-like toxin Wo;1129792;
6RIM;F;Crystal structure of the catalytic domain of the Weissela oryzae botulinum like toxin;1.6;CA;CALCIUM ION;Putative botulinum-like toxin Wo;1129792;
6RIM;G;Crystal structure of the catalytic domain of the Weissela oryzae botulinum like toxin;1.6;CA;CALCIUM ION;Putative botulinum-like toxin Wo;1129792;
6RIM;H;Crystal structure of the catalytic domain of the Weissela oryzae botulinum like toxin;1.6;CA;CALCIUM ION;Putative botulinum-like toxin Wo;1129792;
6RNT;A;CRYSTAL STRUCTURE OF RIBONUCLEASE T1 COMPLEXED WITH ADENOSINE 2'-MONOPHOSPHATE AT 1.8-ANGSTROMS RESOLUTION;1.8;CA;CALCIUM ION;RIBONUCLEASE T1;5062;
6STD;A;SCYTALONE DEHYDRATASE PLUS INHIBITOR 3;1.8;CA;CALCIUM ION;Scytalone dehydratase;148305;
6STD;B;SCYTALONE DEHYDRATASE PLUS INHIBITOR 3;1.8;CA;CALCIUM ION;Scytalone dehydratase;148305;
6STD;C;SCYTALONE DEHYDRATASE PLUS INHIBITOR 3;1.8;CA;CALCIUM ION;Scytalone dehydratase;148305;
6TAA;A;STRUCTURE AND MOLECULAR MODEL REFINEMENT OF ASPERGILLUS ORYZAE (TAKA) ALPHA-AMYLASE: AN APPLICATION OF THE SIMULATED-ANNEALING METHOD;2.1;CA;CALCIUM ION;ALPHA-AMYLASE;5062;
6TLI;A;THERMOLYSIN (60% ISOPROPANOL SOAKED CRYSTALS);2.1;CA;CALCIUM ION;PROTEIN (THERMOLYSIN);1427;
6TMN;E;Structures of two thermolysin-inhibitor complexes that differ by a single hydrogen bond;1.6;CA;CALCIUM ION;THERMOLYSIN;1427;
7ATJ;A;RECOMBINANT HORSERADISH PEROXIDASE C1A COMPLEX WITH CYANIDE AND FERULIC ACID;1.47;CA;CALCIUM ION;PEROXIDASE C1A;3704;
7CGT;A;RAMEB COMPLEX OF CYCLODEXTRIN GLYCOSYLTRANSFERASE MUTANT;3;CA;CALCIUM ION;CYCLODEXTRIN GLYCOSYLTRANSFERASE;1397;
7EST;E;Interaction of the peptide CF3-LEU-ALA-NH-C6H4-CF3(TFLA) with porcine pancreatic elastase. X-ray studies at 1.8 Angstroms;1.8;CA;CALCIUM ION;ELASTASE;9823;
7NN9;A;NATIVE INFLUENZA VIRUS NEURAMINIDASE SUBTYPE N9 (TERN);2;CA;CALCIUM ION;NEURAMINIDASE N9;11320;
7RNT;A;CRYSTAL STRUCTURE OF THE TYR45TRP MUTANT OF RIBONUCLEASE T1 IN A COMPLEX WITH 2'-ADENYLIC ACID;1.9;CA;CALCIUM ION;RIBONUCLEASE T1;5062;
7STD;A;SCYTALONE DEHYDRATASE PLUS INHIBITOR 4;1.8;CA;CALCIUM ION;Scytalone dehydratase;148305;
7STD;B;SCYTALONE DEHYDRATASE PLUS INHIBITOR 4;1.8;CA;CALCIUM ION;Scytalone dehydratase;148305;
7STD;C;SCYTALONE DEHYDRATASE PLUS INHIBITOR 4;1.8;CA;CALCIUM ION;Scytalone dehydratase;148305;
7TAA;A;FAMILY 13 ALPHA AMYLASE IN COMPLEX WITH ACARBOSE;1.98;CA;CALCIUM ION;TAKA AMYLASE;5062;
7TLI;A;THERMOLYSIN (90% ISOPROPANOL SOAKED CRYSTALS);1.95;CA;CALCIUM ION;PROTEIN (THERMOLYSIN);1427;
7TLN;A;STRUCTURAL ANALYSIS OF THE INHIBITION OF THERMOLYSIN BY AN ACTIVE-SITE-DIRECTED IRREVERSIBLE INHIBITOR;2.3;CA;CALCIUM ION;THERMOLYSIN;1427;
830C;A;COLLAGENASE-3 (MMP-13) COMPLEXED TO A SULPHONE-BASED HYDROXAMIC ACID;1.6;CA;CALCIUM ION;MMP-13;9606;
830C;B;COLLAGENASE-3 (MMP-13) COMPLEXED TO A SULPHONE-BASED HYDROXAMIC ACID;1.6;CA;CALCIUM ION;MMP-13;9606;
8CGT;A;STRUCTURE OF CYCLODEXTRIN GLYCOSYLTRANSFERASE COMPLEXED WITH A THIO-MALTOHEXAOSE;2.4;CA;CALCIUM ION;PROTEIN (CYCLODEXTRIN-GLYCOSYLTRANSFERASE);1397;
8DFR;A;REFINED CRYSTAL STRUCTURES OF CHICKEN LIVER DIHYDROFOLATE REDUCTASE. 3 ANGSTROMS APO-ENZYME AND 1.7 ANGSTROMS NADPH HOLO-ENZYME COMPLEX;1.7;CA;CALCIUM ION;DIHYDROFOLATE REDUCTASE;9031;
8EST;E;REACTION OF PORCINE PANCREATIC ELASTASE WITH 7-SUBSTITUTED 3-ALKOXY-4-CHLOROISOCOUMARINS: DESIGN OF POTENT INHIBITORS USING THE CRYSTAL STRUCTURE OF THE COMPLEX FORMED WITH 4-CHLORO-3-ETHOXY-7-GUANIDINO-ISOCOUMARIN;1.78;CA;CALCIUM ION;PORCINE PANCREATIC ELASTASE;9823;
8TLI;A;THERMOLYSIN (100% ISOPROPANOL SOAKED CRYSTALS);2.2;CA;CALCIUM ION;PROTEIN (THERMOLYSIN);1427;
8TLN;E;STRUCTURAL COMPARISON SUGGESTS THAT THERMOLYSIN AND RELATED NEUTRAL PROTEASES UNDERGO HINGE-BENDING MOTION DURING CATALYSIS;1.6;CA;CALCIUM ION;THERMOLYSIN;1427;
966C;A;CRYSTAL STRUCTURE OF FIBROBLAST COLLAGENASE-1 COMPLEXED TO A DIPHENYL-ETHER SULPHONE BASED HYDROXAMIC ACID;1.9;CA;CALCIUM ION;MMP-1;9606;
9CGT;A;STRUCTURE OF CYCLODEXTRIN GLYCOSYLTRANSFERASE COMPLEXED WITH A THIO-MALTOPENTAOSE;2.5;CA;CALCIUM ION;PROTEIN (CYCLODEXTRIN-GLYCOSYLTRANSFERASE);1397;
9EST;A;STRUCTURAL STUDY OF PORCINE PANCREATIC ELASTASE COMPLEXED WITH 7-AMINO-3-(2-BROMOETHOXY)-4-CHLOROISOCOUMARIN AS A NONREACTIVATABLE DOUBLY COVALENT ENZYME-INHIBITOR COMPLEX;1.9;CA;CALCIUM ION;PORCINE PANCREATIC ELASTASE;9823;
9RNT;A;RIBONUCLEASE T1 WITH FREE RECOGNITION AND CATALYTIC SITE: CRYSTAL STRUCTURE ANALYSIS AT 1.5 ANGSTROMS RESOLUTION;1.5;CA;CALCIUM ION;RIBONUCLEASE T1;5062;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
;;;;;;;;
